PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Liu, YS; Lin, HY; Lai, SW; Huang, CY; Huang, BR; Chen, PY; Wei, KC; Lu, DY				Liu, Y-S; Lin, H-Y; Lai, S-W; Huang, C-Y; Huang, B-R; Chen, P-Y; Wei, K-C; Lu, D-Y			MiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma	ONCOGENE			English	Article							EPIDERMAL-GROWTH-FACTOR; CANCER-RELATED INFLAMMATION; PROTEIN PHOSPHATASE 2A; TUMOR IMMUNE EVASION; FACTOR RECEPTOR; GLIOMA-CELLS; STIMULATING FACTOR; BREAST-CANCER; STEM-CELLS; MACROPHAGE	Tumor-associated macrophages (TAMs) originate as circulating monocytes, and are recruited to gliomas, where they facilitate tumor growth and migration. Understanding the interaction between TAM and cancer cells may identify therapeutic targets for glioblastoma multiforme (GBM). Vascular cell adhesion molecule-1 (VCAM-1) is a cytokine-induced adhesion molecule expressed on the surface of cancer cells, which is involved in interactions with immune cells. Analysis of the glioma patient database and tissue immunohistochemistry showed that VCAM-1 expression correlated with the clinico-pathological grade of gliomas. Here, we found that VCAM-1 expression correlated positively with monocyte adhesion to GBM, and knockdown of VCAM-1 abolished the enhancement of monocyte adhesion. Importantly, upregulation of VCAM-1 is dependent on epidermal-growth-factor-receptor (EGFR) expression, and inhibition of EGFR effectively reduced VCAM-1 expression and monocyte adhesion activity. Moreover, GBM possessing higher EGFR levels (U251 cells) had higher VCAM-1 levels compared to GBMs with lower levels of EGFR (GL261 cells). Using two-and three-dimensional cultures, we found that monocyte adhesion to GBM occurs via integrin alpha 4 beta 1, which promotes tumor growth and invasion activity. Increased proliferation and tumor necrosis factor-alpha and IFN-gamma levels were also observed in the adherent monocytes. Using a genetic modification approach, we demonstrated that VCAM-1 expression and monocyte adhesion were regulated by the miR-181 family, and lower levels of miR-181b correlated with high-grade glioma patients. Our results also demonstrated that miR-181b/protein phosphatase 2A-modulated SP-1 de-phosphorylation, which mediated the EGFR-dependent VCAM-1 expression and monocyte adhesion to GBM. We also found that the EGFR-dependent VCAM-1 expression is mediated by the p38/STAT3 signaling pathway. Our study suggested that VCAM-1 is a critical modulator of EGFR-dependent interaction of monocytes with GBM, which raises the possibility of developing effective and improved therapies for GBM.	[Liu, Y-S; Lai, S-W] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Lin, H-Y; Lu, D-Y] China Med Univ, Sch Med, Dept Pharmacol, 91 Hsueh Shih Rd, Taichung 40402, Taiwan; [Huang, C-Y; Wei, K-C] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Neurosurg, Taoyuan 33302, Taiwan; [Huang, C-Y; Wei, K-C] Chang Gung Univ, Coll Med, Taoyuan 33302, Taiwan; [Huang, B-R] Taichung Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Neurosurg, Taichung, Taiwan; [Chen, P-Y] Chang Gung Mem Hosp, Dept Neurosurg, Keelung, Taiwan; [Chen, P-Y] Chang Gung Univ, Sch Med, Taoyuan, Taiwan; [Lu, D-Y] Asia Univ, Dept Photon & Commun Engn, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; Chang Gung Memorial Hospital; Chang Gung University; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Chang Gung Memorial Hospital; Chang Gung University; Asia University Taiwan	Lu, DY (corresponding author), China Med Univ, Sch Med, Dept Pharmacol, 91 Hsueh Shih Rd, Taichung 40402, Taiwan.; Wei, KC (corresponding author), Chang Gung Mem Hosp, Linkou Med Ctr, Dept Neurosurg, Taoyuan 33302, Taiwan.; Wei, KC (corresponding author), Chang Gung Univ, Coll Med, Taoyuan 33302, Taiwan.	kuochenwei@adm.cgmh.org.tw; dahyuu@mail.cmu.edu.tw		Wei, Kuochen/0000-0003-3505-2196	Ministry of Science Technology [102-2320-B-039-051-MY3, 105-2628-B-039-007-MY3]; China Medical University [CMU104-S-12, CMU105-AWARD-01]; Chang Gung Memorial Hospital [CIRPG3E0032, CMRPG3D1113]; National Health Research Institutes [NHRI-EX106-10502NI]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW106-TDU-B-212-113004]	Ministry of Science Technology; China Medical University(China Medical University); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan); Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This work was partly supported by grants from the Ministry of Science & Technology (102-2320-B-039-051-MY3 and 105-2628-B-039-007-MY3) and China Medical University (CMU104-S-12 and CMU105-AWARD-01), Chang Gung Memorial Hospital Research Grant (CIRPG3E0032 and CMRPG3D1113), National Health Research Institutes (NHRI-EX106-10502NI) and Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW106-TDU-B-212-113004).	Abou-Ghazal M, 2008, CLIN CANCER RES, V14, P8228, DOI 10.1158/1078-0432.CCR-08-1329; Alvarez James V, 2007, Transl Oncogenomics, V2, P99; Avdi NJ, 2002, J BIOL CHEM, V277, P40687, DOI 10.1074/jbc.M204455200; Benasciutti E, 2004, BLOOD, V104, P256, DOI 10.1182/blood-2003-08-2661; Bhat FA, 2014, J NUTR BIOCHEM, V25, P1132, DOI 10.1016/j.jnutbio.2014.06.008; Chen G, 2010, ONCOL REP, V23, P997, DOI 10.3892/or_00000725; Chen JH, 2016, MOL NEUROBIOL, V53, P6218, DOI 10.1007/s12035-015-9529-z; Chen Q, 2012, CLIN CANCER RES, V18, P5520, DOI 10.1158/1078-0432.CCR-11-2904; Chen Q, 2011, CANCER CELL, V20, P538, DOI 10.1016/j.ccr.2011.08.025; Clarke J, 2010, ARCH NEUROL-CHICAGO, V67, P279, DOI 10.1001/archneurol.2010.5; Coniglio SJ, 2012, MOL MED, V18, P519, DOI 10.2119/molmed.2011.00217; Conti A, 2009, J NEURO-ONCOL, V93, P325, DOI 10.1007/s11060-009-9797-4; Crusz SM, 2015, NAT REV CLIN ONCOL, V12, P584, DOI 10.1038/nrclinonc.2015.105; de Groot J, 2012, ONCOTARGET, V3, P1036; Ding YB, 2003, WORLD J GASTROENTERO, V9, P1409, DOI 10.3748/wjg.v9.i7.1409; Feng X, 2015, ONCOTARGET, V6, P15077, DOI 10.18632/oncotarget.3730; Germano G, 2008, CYTOKINE, V43, P374, DOI 10.1016/j.cyto.2008.07.014; Gopisetty G, 2013, ONCOGENE, V32, P3119, DOI 10.1038/onc.2012.331; Gordon IK, 2015, MOL CANCER THER, V14, P1540, DOI 10.1158/1535-7163.MCT-14-0614; Greenwood J, 2011, NEUROPATH APPL NEURO, V37, P24, DOI 10.1111/j.1365-2990.2010.01140.x; Guan HY, 2012, INT J CANCER, V130, P593, DOI 10.1002/ijc.26049; Halatsch ME, 2006, CANCER TREAT REV, V32, P74, DOI 10.1016/j.ctrv.2006.01.003; Hambardzumyan D, 2016, NAT NEUROSCI, V19, P20, DOI 10.1038/nn.4185; Hara-Chikuma M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8454; Hofstetter CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030059; HURTT MR, 1992, J NEUROPATH EXP NEUR, V51, P84, DOI 10.1097/00005072-199201000-00010; Hussain SF, 2006, NEURO-ONCOLOGY, V8, P261, DOI 10.1215/15228517-2006-008; Chimal-Ramirez GK, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/6031486; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Kumar D, 2009, J IMMUNOL, V182, P1011, DOI 10.4049/jimmunol.182.2.1011; Lacroix I, 2002, J BIOL CHEM, V277, P9598, DOI 10.1074/jbc.M111444200; Lewis C, 2005, AM J PATHOL, V167, P627, DOI 10.1016/S0002-9440(10)62038-X; Lin KY, 2007, CANCER RES, V67, P1832, DOI 10.1158/0008-5472.CAN-06-3014; Lindemann C, 2011, ACTA NEUROPATHOL, V122, P241, DOI 10.1007/s00401-011-0832-0; Lo HW, 2008, CLIN CANCER RES, V14, P6042, DOI 10.1158/1078-0432.CCR-07-4923; Lu J, 2009, P NATL ACAD SCI USA, V106, P11697, DOI 10.1073/pnas.0905930106; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Luo JY, 2015, MOL BIOL CELL, V26, P430, DOI 10.1091/mbc.E14-10-1443; Maenpaa A, 1997, ACTA NEUROPATHOL, V94, P216, DOI 10.1007/s004010050696; Mandal T, 2014, CELL SIGNAL, V26, P1725, DOI 10.1016/j.cellsig.2014.04.003; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2007, NATURE, V448, P547, DOI 10.1038/448547a; Markovic DS, 2009, P NATL ACAD SCI USA, V106, P12530, DOI 10.1073/pnas.0804273106; Maruno M, 1997, J CLIN PATHOL, V50, P559, DOI 10.1136/jcp.50.7.559; MEERSCHAERT J, 1995, J IMMUNOL, V154, P4099; MUNN DH, 1990, J EXP MED, V172, P231, DOI 10.1084/jem.172.1.231; Nicholas MK, 2006, CLIN CANCER RES, V12, P7261, DOI 10.1158/1078-0432.CCR-06-0874; Parney IF, 2009, J NEUROSURG, V110, P572, DOI 10.3171/2008.7.JNS08475; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Ruano Y, 2009, AM J CLIN PATHOL, V131, P257, DOI 10.1309/AJCP64YBDVCTIRWV; Schonthal AH, 2001, CANCER LETT, V170, P1, DOI 10.1016/S0304-3835(01)00561-4; Seznec J, 2011, J NEURO-ONCOL, V101, P365, DOI 10.1007/s11060-010-0266-x; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Shinojima N, 2003, CANCER RES, V63, P6962; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495; Sun YC, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-611; Talasila KM, 2013, ACTA NEUROPATHOL, V125, P683, DOI 10.1007/s00401-013-1101-1; Tran CT, 1998, NEUROPATH APPL NEURO, V24, P293, DOI 10.1046/j.1365-2990.1998.00120.x; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vicart A, 2006, J MOL BIOL, V364, P897, DOI 10.1016/j.jmb.2006.09.036; Wang YZ, 2000, ONCOGENE, V19, P2075, DOI 10.1038/sj.onc.1203548; Wu TC, 2007, CANCER RES, V67, P6003, DOI 10.1158/0008-5472.CAN-07-1543; Yeh WL, 2012, J CELL PHYSIOL, V227, P558, DOI 10.1002/jcp.22746; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zahonero C, 2014, CELL MOL LIFE SCI, V71, P3465, DOI 10.1007/s00018-014-1608-1; Zhan Q, 2011, BRAZ J MED BIOL RES, V44, P489, DOI 10.1590/S0100-879X2011007500052; Zhang LY, 2007, J NEUROIMMUNOL, V184, P188, DOI 10.1016/j.jneuroim.2006.12.006; Zheng QF, 2014, NEURO-ONCOLOGY, V16, P1229, DOI 10.1093/neuonc/nou046; Zheng YH, 2013, J BIOL CHEM, V288, P31488, DOI 10.1074/jbc.M113.499020; Zhi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109124; Zhi F, 2010, EUR J CANCER, V46, P1640, DOI 10.1016/j.ejca.2010.02.003; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zhou WC, 2015, NAT CELL BIOL, V17, P170, DOI 10.1038/ncb3090	77	46	50	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 31	2017	36	35					5006	5022		10.1038/onc.2017.129	http://dx.doi.org/10.1038/onc.2017.129			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FF3AV	28459461				2022-12-26	WOS:000408768800006
J	Sadler, E; Porat, T; Marshall, I; Hoang, U; Curcin, V; Wolfe, CDA; McKevitt, C				Sadler, Euan; Porat, Talya; Marshall, Iain; Hoang, Uy; Curcin, Vasa; Wolfe, Charles D. A.; McKevitt, Christopher			Shaping innovations in long-term care for stroke survivors with multimorbidity through stakeholder engagement	PLOS ONE			English	Article							SELF-MANAGEMENT PROGRAMS; RISK-FACTORS; PREVALENCE; RECOVERY; EFFICACY; PATIENT; TRENDS	Background Stroke, like many long-term conditions, tends to be managed in isolation of its associated risk factors and multimorbidity. With increasing access to clinical and research data there is the potential to combine data from a variety of sources to inform interventions to improve healthcare. A 'Learning Health System' (LHS) is an innovative model of care which transforms integrated data into knowledge to improve healthcare. The objective of this study is to develop a process of engaging stakeholders in the use of clinical and research data to co-produce potential solutions, informed by a LHS, to improve long-term care for stroke survivors with multimorbidity. Methods We used a stakeholder engagement study design informed by co-production principles to engage stakeholders, including service users, carers, general practitioners and other health and social care professionals, service managers, commissioners of services, policy makers, third sector representatives and researchers. Over a 10 month period we used a range of methods including stakeholder group meetings, focus groups, nominal group techniques (priority setting and consensus building) and interviews. Qualitative data were recorded, transcribed and analysed thematically. Results 37 participants took part in the study. The concept of how data might drive intervention development was difficult to convey and understand. The engagement process led to four priority areas for needs for data and information being identified by stakeholders: 1) improving continuity of care; 2) improving management of mental health consequences; 3) better access to health and social care; and 4) targeting multiple risk factors. These priorities informed preliminary design interventions. The final choice of intervention was agreed by consensus, informed by consideration of the gap in evidence and local service provision, and availability of robust data. This shaped a co-produced decision support tool to improve secondary prevention after stroke for further development. Conclusions Stakeholder engagement to identify data-driven solutions is feasible but requires resources. While a number of potential interventions were identified, the final choice rested not just on stakeholder priorities but also on data availability. Further work is required to evaluate the impact and implementation of data-driven interventions for long-term stroke survivors.	[Sadler, Euan; Porat, Talya; Marshall, Iain; Hoang, Uy; Curcin, Vasa; Wolfe, Charles D. A.] Kings Coll London, Fac Life Sci & Med, Div Hlth & Social Care Res, London, England; [Sadler, Euan] Kings Coll London, Inst Psychiat Psychol & Neurosci, Ctr Implementat Sci, Kings Improvement Sci,Hlth Serv & Populat Res Dep, London, England; [Wolfe, Charles D. A.; McKevitt, Christopher] Kings Coll Hosp NHS Fdn Trust, Natl Inst Hlth Res Collaborat Leadership Appl Hlt, London, England; [Wolfe, Charles D. A.; McKevitt, Christopher] Kings Coll London, London, England; [Wolfe, Charles D. A.; McKevitt, Christopher] Guys & St Thomas NHS Fdn Trust & Kings Coll Londo, Biomed Res Ctr, Natl Inst Hlth Res, London, England	University of London; King's College London; University of London; King's College London; King's College Hospital NHS Foundation Trust; University of London; King's College London; University of London; King's College London	Sadler, E (corresponding author), Kings Coll London, Fac Life Sci & Med, Div Hlth & Social Care Res, London, England.; Sadler, E (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Ctr Implementat Sci, Kings Improvement Sci,Hlth Serv & Populat Res Dep, London, England.	euan.sadler@kcl.ac.uk	mckevitt, christopher/AAN-7271-2021; Hoang, Uy/AAD-9445-2022	Hoang, Uy/0000-0002-8428-5140; Curcin, Vasa/0000-0002-8308-2886; Sadler, Euan/0000-0003-3827-224X; Marshall, Iain/0000-0003-2594-2654; MCKEVITT, CHRISTOPHER/0000-0002-5290-4613	National Institute for Health Research (NIHR); Care South London at King's College Hospital NHS Foundation Trust [NIHR CLAHRC-2013-10022]; MRC [MR/N015185/1] Funding Source: UKRI	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Care South London at King's College Hospital NHS Foundation Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	There search was funded by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South London at King's College Hospital NHS Foundation Trust (award number NIHR CLAHRC-2013-10022), Prof Charles DA Wolfe (stroke themelead), http://www.nihr.ac.uk/about-us/how-we-are-managed/our-structure/infrastructure/ collaborations-for-leadership-in-applied-health-research-and-care.htm. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, S LONDON STROK UNPUB; Bamford David, 2013, J Health Organ Manag, V27, P548; Batalden M, 2016, BMJ QUAL SAF, V25, P509, DOI 10.1136/bmjqs-2015-004315; Bovaird T, 2007, PUBLIC ADMIN REV, V67, P846, DOI 10.1111/j.1540-6210.2007.00773.x; Boyle D, 2006, ASPECTS COPRODUCTION; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Chen RL, 2014, J NEUROL NEUROSUR PS, V85, P1294, DOI 10.1136/jnnp-2013-306413; Crandall W, 2011, INFLAMM BOWEL DIS, V17, P450, DOI 10.1002/ibd.21394; Curcin V, 2016, EMBEDDING DATA PROVE; Dawes M, 2010, FAM PRACT, V27, P1, DOI 10.1093/fampra/cmp106; Delaney BC, 2012, ANN FAM MED, V10, P54, DOI 10.1370/afm.1313; Ellis G, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005066.pub2; Forster A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001919.pub3; Fortin M, 2006, QUAL LIFE RES, V15, P83, DOI 10.1007/s11136-005-8661-z; Fraccaro P, 2015, JMIR MED INF, V3, DOI 10.2196/medinform.3503; Glynn LG, 2011, FAM PRACT, V28, P516, DOI 10.1093/fampra/cmr013; Governance International, 2013, ACH CIT OUTC; Hackett ML, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003437.pub3; Heaton J, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0383-9; Heuschmann PU, 2008, STROKE, V39, P2204, DOI 10.1161/STROKEAHA.107.507285; Intercollegiate Stroke Working Party, 2016, NAT CLIN GUID STROK; Jones F, 2011, DISABIL REHABIL, V33, P797, DOI 10.3109/09638288.2010.511415; Kendall E, 2007, SOC SCI MED, V64, P735, DOI 10.1016/j.socscimed.2006.09.012; Kenning C, 2013, SAGE OPEN MED, V1, DOI 10.1177/2050312113510001; Kirkevold M, 2012, INT J NURS STUD, V49, P386, DOI 10.1016/j.ijnurstu.2011.10.006; Korpershoek C, 2011, J ADV NURS, V67, P1876, DOI 10.1111/j.1365-2648.2011.05659.x; Lager KE, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009103.pub2; Lawrence M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120902; Lennon S, 2013, CLIN REHABIL, V27, P867, DOI 10.1177/0269215513481045; MacKay-Lyons M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008656.pub2; Marshall IJ, 2013, STROKE, V44, P1809, DOI 10.1161/STROKEAHA.111.000655; Mason B, 2016, BMJ SUPPORT PALLIAT, V6, P60, DOI 10.1136/bmjspcare-2013-000639; McKevitt C, 2011, STROKE, V42, P1398, DOI 10.1161/STROKEAHA.110.598839; McKevitt C, 2010, HEALTH EXPECT, V13, P86, DOI 10.1111/j.1369-7625.2009.00573.x; Morris RL, 2011, CHRONIC ILLN, V7, P147, DOI 10.1177/1742395310393365; National Audit Office, 2010, DEP HLTH PROGR IMPR; NIHR, 2015, GOING EXTR MIL IMPR; Olsen L., 2007, LEARNING HEALTHCARE, DOI DOI 10.17226/; Ottmann G, 2011, SYST PRACT ACT RES, V24, P413, DOI 10.1007/s11213-011-9192-x; Pawson R., 1997, REALIST EVALUATION; Pollock A, 2014, INT J STROKE, V9, P313, DOI 10.1111/j.1747-4949.2012.00942.x; Reeve J, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-112; Roshanov PS, 2011, IMPLEMENT SCI, V6, DOI [10.1186/1748-5908-6-92, 10.1186/1748-5908-6-88]; Smith SM, 2016, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006560.pub3, 10.1002/14651858.CD006560.pub4]; Smith SM, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X514756; Social Care Institute of Excellence, 2015, SCIE GUID, V51; Starks H, 2015, QUAL LIFE RES, V24, P1097, DOI 10.1007/s11136-014-0810-9; Su P, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0352-9; Wallace E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h176; Warner G, 2015, DISABIL REHABIL, V37, P2141, DOI 10.3109/09638288.2014.996674; Wherton J, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0271-8; Wolfe CDA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001033; Wolfe CDA, 2010, STROKE, V41, P2470, DOI 10.1161/STROKEAHA.110.588046; Young J, 2003, REV CLIN GERONTOL, V13, P55	54	12	12	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177102	10.1371/journal.pone.0177102	http://dx.doi.org/10.1371/journal.pone.0177102			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SX	28475606	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000400649500047
J	Yi, K; Hatayama, N; Hirai, S; Qu, N; Hayashi, S; Kawata, S; Nagahori, K; Naito, M; Itoh, M				Yi, Kai; Hatayama, Naoyuki; Hirai, Shuichi; Qu, Ning; Hayashi, Shogo; Kawata, Shinichi; Nagahori, Kenta; Naito, Munekazu; Itoh, Masahiro			Development of heterotopic transplantation of the testis with the epididymis to evaluate an aspect of testicular immunology in rats	PLOS ONE			English	Article							HEART-TRANSPLANTATION; ADULT-RATS; MICE; MODEL; CRYPTORCHIDISM; INFILTRATION; VASECTOMY; TISSUE; SPERM	Transplantation of testicular cells and tissues has been studied for the investigation of immunology of the testis, which is an immunologically privileged organ. However, reports of transplant of the testis at organ level have been extremely limited because of technical difficulties of the orthotopic testis transplantation (OTT) in experimental animals. In the present study, we developed a new and simple model of the heterotopic testis transplantation (HTT), which is donor testis transplantation into the cervical region of recipients, in a syngeneic model in rats [donor Lewis (LEW) graft to LEW recipient]. The duration of HTT was significantly shorter and success rate higher than that of OTT. To histologically evaluate HTT, the local immune responses were compared among the syngeneic model, an acute rejection allogeneic model [donor Augustus Copenhagen Irish (ACI) graft to LEW recipient] and a chronic rejection allogeneic model (donor F344 graft to LEW recipient) at postoperative day 3. We found that allogeneic ACI grafts resulted in mild and not severe orchitic lesions, whereas immune responses of allogeneic F344 grafts seemed intact and were not significantly different from those of syngeneic LEW grafts. These results suggest that our new operative procedure will be useful in future for the investigation of the testicular immunology.	[Yi, Kai; Hatayama, Naoyuki; Qu, Ning; Hayashi, Shogo; Kawata, Shinichi; Nagahori, Kenta; Itoh, Masahiro] Tokyo Med Univ, Dept Anat, Tokyo, Japan; [Hatayama, Naoyuki; Hirai, Shuichi; Naito, Munekazu] Aichi Med Univ, Dept Anat, Aichi, Japan	Tokyo Medical University; Aichi Medical University	Hatayama, N (corresponding author), Tokyo Med Univ, Dept Anat, Tokyo, Japan.; Hatayama, N (corresponding author), Aichi Med Univ, Dept Anat, Aichi, Japan.	naoyuki@tokyo-med.ac.jp	Hayashi, Shogo/K-7268-2015; HIRAI, SHUICHI/AAQ-6081-2020; Qu, Ning/X-1827-2019	Hayashi, Shogo/0000-0003-0302-7658; 	JSPS KAKENHI [15K08159]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Author Mashahiro Itoh received funding from JSPS KAKENHI (15K08159). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTWEIN JE, 1972, ENDOCRINOLOGY, V91, P312, DOI 10.1210/endo-91-1-312; Bergh A, 2001, BIOL REPROD, V64, P13, DOI 10.1095/biolreprod64.1.13; Fuse H., 1993, International Urology and Nephrology, V25, P491; Ghabriel MN, 2002, REPRODUCTION, V123, P389, DOI 10.1530/reprod/123.3.389; GILBERT P, 1986, UROL INT, V41, P145, DOI 10.1159/000281184; GOLDSTEIN M, 1983, BIOL REPROD, V28, P971, DOI 10.1095/biolreprod28.4.971; HEAD JR, 1985, TRANSPLANTATION, V40, P269, DOI 10.1097/00007890-198509000-00010; HERON I, 1971, ACTA PATH MICRO IM A, VA 79, P366; Honaramooz A, 2002, NATURE, V418, P778, DOI 10.1038/nature00918; Itoh M, 2005, J REPROD IMMUNOL, V67, P57, DOI 10.1016/j.jri.2005.06.007; JEGOU B, 1983, J ANDROL, V4, P88; JEGOU B, 1983, J REPROD FERTIL, V69, P137, DOI 10.1530/jrf.0.0690137; JOHNSEN S G, 1970, Hormones (Basel), V1, P2, DOI 10.1159/000178170; Johnson L, 1996, BIOL REPROD, V54, P948, DOI 10.1095/biolreprod54.5.948; KAZEEM AA, 1988, SCAND J IMMUNOL, V27, P149, DOI 10.1111/j.1365-3083.1988.tb02333.x; LEE S, 1971, TRANSPLANT P, V3, P586; Li JH, 2010, REPRODUCTION, V139, P447, DOI 10.1530/REP-08-0464; MADDOCKS S, 1990, J REPROD IMMUNOL, V18, P9, DOI 10.1016/0165-0378(90)90021-W; Marco ML, 2006, NEPHROL DIAL TRANSPL, V21, P3082, DOI 10.1093/ndt/gfl451; Martins PNA, 2008, MICROSURG, V28, P565, DOI 10.1002/micr.20544; McDonald SW, 2000, INT REV CYTOL, V199, P295, DOI 10.1016/S0074-7696(00)99006-5; MCDONALD SW, 1991, J ANAT, V176, P35; Naito M, 2008, AM J REPROD IMMUNOL, V59, P55, DOI 10.1111/j.1600-0897.2007.00556.x; Nakao A, 2002, ACTA MED OKAYAMA, V56, P69; Nunes Sergio Ibañez, 2013, Rev. Col. Bras. Cir., V40, P60; Okuno M, 2014, J ORTHOP RES, V32, P928, DOI 10.1002/jor.22614; PARADYSZ JM, 1981, TRANSPLANT P, V13, P1120; Rodriguez-Sosa JR, 2010, REPRODUCTION, V139, P227, DOI 10.1530/REP-09-0176; Schlatt S, 2002, REPRODUCTION, V124, P339, DOI 10.1530/rep.0.1240339; Song YH, 2007, BIOL REPROD, V76, P598, DOI 10.1095/biolreprod.106.058032; Spanjol J, 2011, COLLEGIUM ANTROPOL, V35, P87; STERNBERGER NH, 1987, P NATL ACAD SCI USA, V84, P8169, DOI 10.1073/pnas.84.22.8169; Su LL, 2011, J ENDOCRINOL, V209, P337, DOI 10.1530/JOE-10-0474; Tan Fu-qing, 2006, Zhejiang Da Xue Xue Bao Yi Xue Ban, V35, P297; TODO S, 1988, TRANSPLANT P, V20, P215; TUNG KSK, 1970, AM J PATHOL, V60, P313; Visser AJ, 2003, BJU INT, V92, P200, DOI 10.1046/j.1464-410X.2003.04307.x; Winnall WR, 2011, J LEUKOCYTE BIOL, V90, P133, DOI 10.1189/jlb.1010557; Zhang WX, 2005, CHINESE MED J-PEKING, V118, P850	39	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177067	10.1371/journal.pone.0177067	http://dx.doi.org/10.1371/journal.pone.0177067			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475594	Green Submitted, Green Published, gold			2022-12-26	WOS:000400649500040
J	Bader, M; Schroger, E; Grimm, S				Bader, Maria; Schroeger, Erich; Grimm, Sabine			How regularity representations of short sound patterns that are based on relative or absolute pitch information establish over time: An EEG study	PLOS ONE			English	Article							HUMAN AUDITORY-CORTEX; EVENT-RELATED POTENTIALS; MEMORY-TRACE FORMATION; INDEPENDENT COMPONENT ANALYSIS; MISMATCH NEGATIVITY; INVOLUNTARY ATTENTION; COMPLEX-SOUND; HUMAN BRAIN; REPETITION SUPPRESSION; FEATURE CONJUNCTIONS	The recognition of sound patterns in speech or music (e.g., a melody that is played in different keys) requires knowledge about pitch relations between successive sounds. We investigated the formation of regularity representations for sound patterns in an event-related potential (ERP) study. A pattern, which consisted of six concatenated 50 ms tone segments differing in fundamental frequency, was presented 1, 2, 3, 6, or 12 times and then replaced by another pattern by randomly changing the pitch of the tonal segments (roving standard paradigm). In an absolute repetition condition, patterns were repeated identically, whereas in a transposed condition, only the pitch relations of the tonal segments of the patterns were repeated, while the entire patterns were shifted up or down in pitch. During ERP measurement participants were not informed about the pattern repetition rule, but were instructed to discriminate rarely occurring targets of lower or higher sound intensity. EPRs for pattern changes (mismatch negativity, MMN; and P3a) and for pattern repetitions (repetition positivity, RP) revealed that the auditory system is able to rapidly extract regularities from unfamiliar complex sound patterns even when absolute pitch varies. Yet, enhanced RP and P3a amplitudes, and improved behavioral performance measured in a post-hoc test, in the absolute as compared with the transposed condition suggest that it is more difficult to encode patterns without absolute pitch information. This is explained by dissociable processing of standards and deviants as well as a back propagation mechanism to early sensory processing stages, which is effective after less repetitions of a standard stimulus for absolute pitch.	[Bader, Maria; Schroeger, Erich; Grimm, Sabine] Univ Leipzig, Inst Psychol, Leipzig, Germany	Leipzig University	Bader, M (corresponding author), Univ Leipzig, Inst Psychol, Leipzig, Germany.	maria.bader@uni-leipzig.de	Grimm, Sabine/AAO-1547-2021; Schröger, Erich/C-3079-2009	Schröger, Erich/0000-0002-8321-6629; Grimm, Sabine/0000-0002-9071-5944	German Research Foundation [GR 3412/2-1]; German Research Foundation (DFG); Leipzig University	German Research Foundation(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University	The study was funded by the German Research Foundation (www.dfg.de) with the project number GR 3412/2-1. Furthermore we acknowledged support from the German Research Foundation (DFG) and the Leipzig University within the program of Open Access Publishing. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 1999, NEUROREPORT, V10, P2429, DOI 10.1097/00001756-199908020-00038; Alho K, 1998, PSYCHOPHYSIOLOGY, V35, P211, DOI 10.1111/1469-8986.3520211; Alho K, 1997, NEUROREPORT, V8, P3233, DOI 10.1097/00001756-199710200-00010; ALHO K, 1993, NEUROREPORT, V4, P391, DOI 10.1097/00001756-199304000-00012; Alho K, 1996, PSYCHOPHYSIOLOGY, V33, P369, DOI 10.1111/j.1469-8986.1996.tb01061.x; Baldeweg T, 2004, SCHIZOPHR RES, V69, P203, DOI 10.1016/j.schres.2003.09.009; Baldeweg T, 2007, J PSYCHOPHYSIOL, V21, P204, DOI 10.1027/0269-8803.21.34.204; Barascud N, 2016, P NATL ACAD SCI USA, V113, pE616, DOI 10.1073/pnas.1508523113; Bendixen A, 2008, BIOL PSYCHOL, V78, P231, DOI 10.1016/j.biopsycho.2008.03.005; Bendixen A, 2007, J COGNITIVE NEUROSCI, V19, P1664, DOI 10.1162/jocn.2007.19.10.1664; Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; Bizley JK, 2013, NAT REV NEUROSCI, V14, P693, DOI 10.1038/nrn3565; Carral V, 2005, NEUROREPORT, V16, P301, DOI 10.1097/00001756-200502280-00020; Cooper RJ, 2013, INT J PSYCHOPHYSIOL, V88, P74, DOI 10.1016/j.ijpsycho.2013.02.003; Costa-Faidella J, 2011, J NEUROSCI, V31, P18590, DOI 10.1523/JNEUROSCI.2599-11.2011; Costa-Faidella J, 2011, PSYCHOPHYSIOLOGY, V48, P774, DOI 10.1111/j.1469-8986.2010.01144.x; COWAN N, 1993, J EXP PSYCHOL LEARN, V19, P909, DOI 10.1037/0278-7393.19.4.909; Cycowicz YM, 1998, BRAIN COGNITION, V36, P30, DOI 10.1006/brcg.1997.0955; Debener S, 2005, COGNITIVE BRAIN RES, V22, P309, DOI 10.1016/j.cogbrainres.2004.09.006; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dowling W. J., 1981, PSYCHOMUSICOLOGY, V1, P30, DOI [10.1037/h0094275, DOI 10.1037/H0094275]; Escera C, 2000, AUDIOL NEURO-OTOL, V5, P151, DOI 10.1159/000013877; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Escera C, 2001, EUR J NEUROSCI, V14, P877, DOI 10.1046/j.0953-816x.2001.01707.x; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Friston K., 2005, PHILOS T R SOC LON B, V360, P815; Garrido MI, 2008, NEUROIMAGE, V42, P936, DOI 10.1016/j.neuroimage.2008.05.018; Garrido MI, 2009, NEUROIMAGE, V48, P269, DOI 10.1016/j.neuroimage.2009.06.034; Gomes H, 1997, PSYCHOPHYSIOLOGY, V34, P712, DOI 10.1111/j.1469-8986.1997.tb02146.x; Haenschel C, 2005, J NEUROSCI, V25, P10494, DOI 10.1523/JNEUROSCI.1227-05.2005; Horvath J, 2001, COGNITIVE BRAIN RES, V12, P131, DOI 10.1016/S0926-6410(01)00038-6; Horvath J, 2008, BIOL PSYCHOL, V79, P139, DOI 10.1016/j.biopsycho.2008.04.001; Huotilainen M, 2001, INT J PSYCHOPHYSIOL, V41, P226; Katayama J, 1996, EVOKED POTENTIAL, V100, P555, DOI 10.1016/S0168-5597(96)95171-0; Kiesel A, 2008, PSYCHOPHYSIOLOGY, V45, P250, DOI 10.1111/j.1469-8986.2007.00618.x; Kujala T, 2007, BIOL PSYCHOL, V74, P1, DOI 10.1016/j.biopsycho.2006.06.001; Langers DRM, 2007, NEUROIMAGE, V34, P264, DOI 10.1016/j.neuroimage.2006.09.002; LEVITIN DJ, 1994, PERCEPT PSYCHOPHYS, V56, P414, DOI 10.3758/BF03206733; Macmillan N. A., 1991, DETECTION THEORY USE; McDermott JH, 2011, P NATL ACAD SCI USA, V108, P1188, DOI 10.1073/pnas.1004765108; Miller J, 1998, PSYCHOPHYSIOLOGY, V35, P99, DOI 10.1111/1469-8986.3510099; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1993, NEUROREPORT, V4, P503; Neuloh G, 2004, NEUROREPORT, V15, P2471, DOI 10.1097/00001756-200411150-00008; Nikjeh DA, 2009, EAR HEARING, V30, P432, DOI 10.1097/AUD.0b013e3181a61bf2; Novitski N, 2004, COGNITIVE BRAIN RES, V20, P26, DOI 10.1016/j.cogbrainres.2003.12.011; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; PAAVILAINEN P, 1993, BIOL PSYCHOL, V37, P23, DOI 10.1016/0301-0511(93)90025-4; Pannese A, 2015, BRAIN TOPOGR, V28, P411, DOI 10.1007/s10548-014-0368-4; Peretz I, 2005, ANNU REV PSYCHOL, V56, P89, DOI 10.1146/annurev.psych.56.091103.070225; Plantinga J, 2005, COGNITION, V98, P1, DOI 10.1016/j.cognition.2004.09.008; Rahne T, 2008, J NEUROSCI METH, V172, P74, DOI 10.1016/j.jneumeth.2008.04.006; Roeber U, 2003, CLIN NEUROPHYSIOL, V114, P341, DOI 10.1016/S1388-2457(02)00377-2; Romero R, 1996, PHYSIOL BEHAV, V59, P517, DOI 10.1016/0031-9384(95)02099-3; Rushby JA, 2005, CLIN NEUROPHYSIOL, V116, P2363, DOI 10.1016/j.clinph.2005.06.008; SAARINEN J, 1992, NEUROREPORT, V3, P1149, DOI 10.1097/00001756-199212000-00030; Saffran JR, 2003, DEVELOPMENTAL SCI, V6, P35, DOI 10.1111/1467-7687.00250; Saffran JR, 2001, DEV PSYCHOL, V37, P74, DOI 10.1037//0012-1649.37.1.74; SAMS M, 1983, BIOL PSYCHOL, V17, P41, DOI 10.1016/0301-0511(83)90065-0; Schindler A, 2013, CEREB CORTEX, V23, P2987, DOI 10.1093/cercor/bhs289; Schonwiesner M, 2002, NEUROIMAGE, V17, P1144, DOI 10.1006/nimg.2002.1250; Schroger E, 1996, J COGNITIVE NEUROSCI, V8, P527, DOI 10.1162/jocn.1996.8.6.527; Schroger E, 1998, BEHAV RES METH INS C, V30, P131, DOI 10.3758/BF03209423; Schroger E, 1998, COGNITIVE BRAIN RES, V7, P71, DOI 10.1016/S0926-6410(98)00013-5; Schroger E, 1998, NEUROREPORT, V9, P3355, DOI 10.1097/00001756-199810260-00003; SCHROGER E, 1994, PSYCHOPHYSIOLOGY, V31, P175, DOI 10.1111/j.1469-8986.1994.tb01037.x; Shinn-Cunningham BG, 2008, TRENDS COGN SCI, V12, P182, DOI 10.1016/j.tics.2008.02.003; Sussman E, 1998, BRAIN RES, V793, P95, DOI 10.1016/S0006-8993(98)00164-4; Tervaniemi M, 2000, NEUROSCI LETT, V290, P66, DOI 10.1016/S0304-3940(00)01290-8; Urbach TP, 2006, BIOL PSYCHOL, V72, P333, DOI 10.1016/j.biopsycho.2005.11.012; Verleger R, 1997, PSYCHOPHYSIOLOGY, V34, P131, DOI 10.1111/j.1469-8986.1997.tb02125.x; Von Ehrenfels C, 1937, PSYCHOL REV, V44, P521, DOI 10.1037/h0056968; Wallentin M, 2010, LEARN INDIVID DIFFER, V20, P188, DOI 10.1016/j.lindif.2010.02.004; Widmann A, 2015, J NEUROSCI METH, V250, P34, DOI 10.1016/j.jneumeth.2014.08.002; Winkler I, 1996, J COGNITIVE NEUROSCI, V8, P403, DOI 10.1162/jocn.1996.8.5.403; Zatorre RJ, 2003, NAT NEUROSCI, V6, P692, DOI 10.1038/nn1085	76	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176981	10.1371/journal.pone.0176981	http://dx.doi.org/10.1371/journal.pone.0176981			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472146	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500109
J	Berbasova, T; Nallur, S; Sells, T; Smith, KD; Gordon, PB; Tausta, SL; Strobel, SA				Berbasova, Tetyana; Nallur, Sunitha; Sells, Taylor; Smith, Kathryn D.; Gordon, Patricia B.; Tausta, Susan Lori; Strobel, Scott A.			Fluoride export (FEX) proteins from fungi, plants and animals are 'single barreled' channels containing one functional and one vestigial ion pore	PLOS ONE			English	Article							TOXICITY; RESISTANCE; ORGANISMS; GENOME; MODEL; WATER	The fluoride export protein (FEX) in yeast and other fungi provides tolerance to fluoride (F-), an environmentally ubiquitous anion. FEX efficiently eliminates intracellular fluoride that otherwise would accumulate at toxic concentrations. The FEX homolog in bacteria, Fluc, is a 'double-barreled' channel formed by dimerization of two identical or similar subunits. FEX in yeast and other eukaryotes is a monomer resulting from covalent fusion of the two subunits. As a result, both potential fluoride pores are created from different parts of the same protein. Here we identify FEX proteins from two multicellular eukaryotes, a plant Arabidopsis thaliana and an animal Amphimedon queenslandica, by demonstrating significant fluoride tolerance when these proteins are heterologously expressed in the yeast Saccharomyces cerevisiae. Residues important for eukaryotic FEX function were determined by phylogenetic sequence alignment and functional analysis using a yeast growth assay. Key residues of the fluoride channel are conserved in only one of the two potential fluoride-transporting pores. FEX activity is abolished upon mutation of residues in this conserved pore, suggesting that only one of the pores is functional. The same topology is conserved for the newly identified FEX proteins from plant and animal. These data suggest that FEX family of fluoride channels in eukaryotes are 'single-barreled' transporters containing one functional pore and a second non-functional vestigial remnant of a homologous gene fusion event.	[Berbasova, Tetyana; Nallur, Sunitha; Sells, Taylor; Smith, Kathryn D.; Tausta, Susan Lori; Strobel, Scott A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Berbasova, Tetyana; Nallur, Sunitha; Sells, Taylor; Smith, Kathryn D.; Tausta, Susan Lori; Strobel, Scott A.] Yale Univ, Chem Biol Inst, West Haven, CT 06520 USA; [Gordon, Patricia B.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA	Yale University; Yale University; Fred Hutchinson Cancer Center	Strobel, SA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.; Strobel, SA (corresponding author), Yale Univ, Chem Biol Inst, West Haven, CT 06520 USA.	scott.strobel@yale.edu	Tausta, Lori/GXH-7773-2022	Tausta, Lori/0000-0003-0720-1182	National Institutes of Health [GM022778]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM022778 (to SAS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalakova NI, 2011, J EVOL BIOCHEM PHYS+, V47, P393, DOI 10.1134/S002209301105001X; Akers HF, 2004, AUST DENT J, V49, P61, DOI 10.1111/j.1834-7819.2004.tb00051.x; Ayoob S, 2006, CRIT REV ENV SCI TEC, V36, P433, DOI 10.1080/10643380600678112; Baker JL, 2012, SCIENCE, V335, P233, DOI 10.1126/science.1215063; Barbier O, 2010, CHEM-BIOL INTERACT, V188, P319, DOI 10.1016/j.cbi.2010.07.011; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Camargo JA, 2003, CHEMOSPHERE, V50, P251, DOI 10.1016/S0045-6535(02)00498-8; Cametti M, 2009, CHEM COMMUN, P2809, DOI 10.1039/b902069a; Fawell J., 2006, FLUORIDE DRINKING WA; Fernandez R, 2016, YEAST, V33, P549, DOI 10.1002/yea.3178; Gazzano E, 2010, CURR MED CHEM, V17, P2431, DOI 10.2174/092986710791698503; Golicnik M, 2010, ACTA CHIM SLOV, V57, P272; HORNER JM, 1995, AGR ECOSYST ENVIRON, V52, P205, DOI 10.1016/0167-8809(94)00533-K; Jha SK, 2009, CHEMOSPHERE, V76, P353, DOI 10.1016/j.chemosphere.2009.03.044; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Last NB, 2016, ELIFE, V5, DOI 10.7554/eLife.18767; Lee ST, 2014, J AGR FOOD CHEM, V62, P7345, DOI 10.1021/jf500563h; Li SS, 2013, P NATL ACAD SCI USA, V110, P19018, DOI 10.1073/pnas.1310439110; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Pulyaevskaya MA, 2011, RUSS J PLANT PHYSL+, V58, P589, DOI 10.1134/S1021443711040108; Ram A, 2014, FLUORIDE, V47, P49; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Smith KD, 2015, J BIOL CHEM, V290, P19874, DOI 10.1074/jbc.M115.651976; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Stockbridge RB, 2015, NATURE, V525, P548, DOI 10.1038/nature14981; Stockbridge RB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6120; Stockbridge RB, 2012, P NATL ACAD SCI USA, V109, P15289, DOI 10.1073/pnas.1210896109; Stockbridge RB, 2013, ELIFE, V2; Strunecka A, 2007, CURR SIGNAL TRANSD T, V2, P190, DOI 10.2174/157436207781745300; Vithanage M, 2015, ENVIRON CHEM LETT, V13, P131, DOI 10.1007/s10311-015-0496-4; Weinstein L.H., 2004, FLUORIDES ENV; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yang Y, 2016, PLANT SOIL, V402, P179, DOI 10.1007/s11104-015-2787-8	34	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177096	10.1371/journal.pone.0177096	http://dx.doi.org/10.1371/journal.pone.0177096			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472134	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500134
J	Curtis, KA; Hanson, DL; Price, KA; Owen, SM				Curtis, Kelly A.; Hanson, Debra L.; Price, Krystin Ambrose; Owen, S. Michele			Performance characteristics of an antibody-based multiplex kit for determining recent HIV-1 infection	PLOS ONE			English	Article							HOMOSEXUAL-MEN; LYMPHADENOPATHY SYNDROME; CONTINUING RISK; AVIDITY; ASSAYS; SEROCONVERSION; VACCINE; TRIALS	The availability of reliable laboratory methods for determining recent HIV infection is vital for accurate estimation of population-based incidence. The mean duration of recent infection (MDRI) and false recent rate (FRR) are critical parameters for HIV incidence assays, as they impact HIV incidence estimates and provide a measure of assay performance. The HIV-1 Multiplex assay is an in-house developed, magnetic bead-based assay that measures virus-specific antibody levels and avidity to multiple analytes. To ensure quality control and to facilitate transfer of the assay to external laboratories or testing facilities, the in-house assay has been adapted and produced in kit form. Here, we describe the performance characteristics of the multiplex kit and demonstrate the stability of the kit components over a one-year period. Two statistical methods were employed to estimate the MDRI of the individual analytes and five different algorithms, combining multiple analyte values. The MDRI estimates for the individual analytes and five algorithms were all between 200 and 300 days post-seroconversion, with no notable difference between the two statistical approaches. All five algorithms exhibited a 0% FRR with specimens from long-term, subtype B HIV-1-infected individuals. The assay parameters described in this study provide the necessary tools to implement the HIV-1 multiplex assay and improves the utility of the assay for field use.	[Curtis, Kelly A.; Hanson, Debra L.; Price, Krystin Ambrose; Owen, S. Michele] Natl Ctr HIV AIDS Hepatitis STD & TB Prevent, Div HIV AIDS Prevent, Ctr Dis Control, Atlanta, GA 30329 USA; [Curtis, Kelly A.; Hanson, Debra L.; Price, Krystin Ambrose; Owen, S. Michele] Natl Ctr HIV AIDS Hepatitis STD & TB Prevent, Div HIV AIDS Prevent, Ctr Prevent, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Curtis, KA (corresponding author), Natl Ctr HIV AIDS Hepatitis STD & TB Prevent, Div HIV AIDS Prevent, Ctr Dis Control, Atlanta, GA 30329 USA.; Curtis, KA (corresponding author), Natl Ctr HIV AIDS Hepatitis STD & TB Prevent, Div HIV AIDS Prevent, Ctr Prevent, Atlanta, GA 30329 USA.	czv2@cdc.gov			CDC intramural funding; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention	CDC intramural funding; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The research study was supported through CDC intramural funding and by the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have not received any additional external funding for this work.	Brookmeyer R, 2013, JAIDS-J ACQ IMM DEF, V63, pS233, DOI 10.1097/QAI.0b013e3182986fdf; Brookmeyer R, 2013, AM J EPIDEMIOL, V177, P264, DOI 10.1093/aje/kws436; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; Celum CL, 2001, J INFECT DIS, V183, P23, DOI 10.1086/317658; Cousins MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101043; Cousins MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027211; Curtis KA, 2016, AIDS RES HUM RETROV, V32, P561, DOI [10.1089/aid.2015.0247, 10.1089/AID.2015.0247]; Curtis KA, 2014, AIDS RES HUM RETROV, V30, P1099, DOI 10.1089/aid.2014.0105; Curtis KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107153; Curtis KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077765; Curtis KA, 2012, AIDS RES HUM RETROV, V28, P188, DOI [10.1089/aid.2011.0037, 10.1089/AID.2011.0037]; Curtis KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064201; Duong YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114947; Duong YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033328; FISHBEIN DB, 1985, JAMA-J AM MED ASSOC, V254, P930, DOI 10.1001/jama.254.7.930; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hanson DL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152327; Hauser A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098038; Incidence Assay Critical Path Working G, 2011, PLOS MED, V8; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; KAPLAN JE, 1992, J ACQ IMMUN DEF SYND, V5, P565; KAPLAN JE, 1987, JAMA-J AM MED ASSOC, V257, P335, DOI 10.1001/jama.257.3.335; Kassanjee R, 2014, AIDS, V28, P2439, DOI 10.1097/QAD.0000000000000429; Keating SM, 2012, J CLIN MICROBIOL, V50, P3968, DOI 10.1128/JCM.01454-12; Konikoff J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082772; Laeyendecker O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078818; Laeyendecker O, 2013, J INFECT DIS, V207, P232, DOI 10.1093/infdis/jis659; Longosz AF, 2014, AIDS, V28, P1227, DOI 10.1097/QAD.0000000000000221; Mastro Timothy D, 2010, J HIV AIDS Surveill Epidemiol, V2, P1; Mei JV, 2011, JAIDS-J ACQ IMM DEF, V58, P482, DOI 10.1097/QAI.0b013e318230dd77; Moyo S, 2015, VIRUSES-BASEL, V7, P5508, DOI 10.3390/v7102887; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Rawal BD, 2003, JAIDS-J ACQ IMM DEF, V33, P349, DOI 10.1097/00126334-200307010-00009; Seage GR, 2001, AM J EPIDEMIOL, V153, P619, DOI 10.1093/aje/153.7.619; Sharma Usha K, 2012, AIDS Res Hum Retroviruses, V28, P532, DOI 10.1089/AID.2011.0332; STEVENS J, 1986, APPL MULTIVARIATE ST; Suligoi B, 2003, JAIDS-J ACQ IMM DEF, V32, P424, DOI 10.1097/00126334-200304010-00012; UNAIDS Reference Group, 2006, WKLY EPIDEMIOL REC, V81, P40; Wei XR, 2010, AIDS RES HUM RETROV, V26, P61, DOI 10.1089/aid.2009.0133; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884	43	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176593	10.1371/journal.pone.0176593	http://dx.doi.org/10.1371/journal.pone.0176593			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472089	gold, Green Published, Green Submitted			2022-12-26	WOS:000400648500057
J	Liu, WT; Wu, HT; Juang, JN; Wisniewski, A; Lee, HC; Wu, D; Lo, YL				Liu, Wen-Te; Wu, Hau-tieng; Juang, Jer-Nan; Wisniewski, Adam; Lee, Hsin-Chien; Wu, Dean; Lo, Yu-Lun			Prediction of the severity of obstructive sleep apnea by anthropometric features via support vector machine	PLOS ONE			English	Article							FAT DISTRIBUTION; BODY-FAT; POSTMENOPAUSAL WOMEN; ADULTS; GENDER; PREVALENCE; OBESITY; IMPACT; INDEX; RATIO	To develop an applicable prediction for obstructive sleep apnea (OSA) is still a challenge in clinical practice. We apply a modern machine learning method, the support vector machine to establish a predicting model for the severity of OSA. The support vector machine was applied to build up a prediction model based on three anthropometric features (neck circumference, waist circumference, and body mass index) and age on the first database. The established model was then valided independently on the second database. The anthropometric features and age were combined to generate powerful predictors for OSA. Following the common practice, we predict if a subject has the apnea-hypopnea index greater then 15 or not as well as 30 or not. Dividing by genders and age, for the AHI threhosld 15 (respectively 30), the cross validation and testing accuracy for the prediction were 85.3% and 76.7% (respectively 83.7% and 75.5%) in young female, while the negative likelihood ratio for the AHI threhosld 15 (respectively 30) for the cross validation and testing were 0.2 and 0.32 (respectively 0.06 and 0.1) in young female. The more accurate results with lower negative likelihood ratio in the younger patients, especially the female subgroup, reflect the potential of the proposed model for the screening purpose and the importance of approaching by different genders and the effects of aging.	[Liu, Wen-Te] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Pulm Med, New Taipei, Taiwan; [Liu, Wen-Te] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan; [Liu, Wen-Te] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan; [Liu, Wen-Te; Juang, Jer-Nan] Natl Cheng Kung Univ, Dept Engn Sci, Tainan, Taiwan; [Liu, Wen-Te; Lee, Hsin-Chien] Taipei Med Univ, Taipei Med Univ Hosp, Sleep Sci Ctr, Taipei, Taiwan; [Liu, Wen-Te; Lee, Hsin-Chien; Wu, Dean] Taipei Med Univ, Shuang Ho Hosp, Sleep Ctr, New Taipei, Taiwan; [Wu, Hau-tieng; Wisniewski, Adam] Univ Toronto, Dept Math, Toronto, ON, Canada; [Lee, Hsin-Chien] Taipei Med Univ, Shuang Ho Hosp, Dept Psychiat, New Taipei, Taiwan; [Lee, Hsin-Chien] Taipei Med Univ, Coll Med, Sch Med, Dept Psychiat & Med Humanities, Taipei, Taiwan; [Wu, Dean] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei, Taiwan; [Wu, Dean] Taipei Med Univ, Coll Med, Sch Med, Dept Neurol, Taipei, Taiwan; [Lo, Yu-Lun] Chang Gung Univ, Chang Gung Mem Hosp, Healthcare Ctr, Sch Med,Dept Thorac Med, Taoyuan, Taiwan	Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; National Cheng Kung University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Shuang Ho Hospital; University of Toronto; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Chang Gung Memorial Hospital; Chang Gung University	Lo, YL (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Healthcare Ctr, Sch Med,Dept Thorac Med, Taoyuan, Taiwan.	lo3043@cgmh.org.tw		lee, hsin-chien/0000-0002-7557-8259; Wu, Hau-Tieng/0000-0002-0253-3156				Banhiran Wish, 2014, Journal of the Medical Association of Thailand, V97, P644; Canessa N, 2011, AM J RESP CRIT CARE, V183, P1419, DOI 10.1164/rccm.201005-0693OC; Caixexa JAD, 2015, SLEEP BREATH, V19, P231, DOI 10.1007/s11325-014-1001-1; Deurenberg P, 1999, INT J OBESITY, V23, P537, DOI 10.1038/sj.ijo.0800868; Edwards BA, 2014, SLEEP, V37, P1227, DOI 10.5665/sleep.3844; Gibson GJ, 2005, BRIT MED BULL, V72, P49, DOI 10.1093/bmb/ldh044; Golbidi S, 2012, LUNG, V190, P113, DOI 10.1007/s00408-011-9340-1; Hastie T., 2009, UNSUPERVISED LEARNIN; Iber C., 2007, AASM MANUAL SCORING; Kapur V, 1999, SLEEP, V22, P749, DOI 10.1093/sleep/22.6.749; Katz SL, 2014, J CLIN SLEEP MED, V10, P1303, DOI 10.5664/jcsm.4284; Lee RWW, 2010, SLEEP, V33, P1075, DOI 10.1093/sleep/33.8.1075; Leger D, 2012, SLEEP MED REV, V16, P455, DOI 10.1016/j.smrv.2011.10.001; Li KK, 2000, LARYNGOSCOPE, V110, P1689, DOI 10.1097/00005537-200010000-00022; Lim YH, 2014, ANN OTO RHINOL LARYN, V123, P517, DOI 10.1177/0003489414526134; Lin C, 2014, NEUROCOMPUTING, V123, P424, DOI 10.1016/j.neucom.2013.08.004; Manber R, 2003, SLEEP, V26, P163; Mazzuca E, 2014, J SLEEP RES, V23, P13, DOI 10.1111/jsr.12088; McNicholas Walter T, 2008, Proc Am Thorac Soc, V5, P154, DOI 10.1513/pats.200708-118MG; Medicine PMTFotAAoS, 2007, J CLIN SLEEP MED JCS, V3, P737; MILLMAN RP, 1995, CHEST, V107, P362, DOI 10.1378/chest.107.2.362; Mirrakhimov AE, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-10; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Ogretmenoglu O, 2005, LARYNGOSCOPE, V115, P1493, DOI 10.1097/01.mlg.0000172204.82314.c3; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Ralls FM, 2012, CURR OPIN PULM MED, V18, P568, DOI 10.1097/MCP.0b013e328358be05; Simpson L, 2010, SLEEP, V33, P467, DOI 10.1093/sleep/33.4.467; Subramanian S, 2012, SLEEP BREATH, V16, P1091, DOI 10.1007/s11325-011-0607-9; Tremollieres FA, 1996, AM J OBSTET GYNECOL, V175, P1594, DOI 10.1016/S0002-9378(96)70111-4; Vgontzas AN, 2000, J CLIN ENDOCR METAB, V85, P1151, DOI 10.1210/jc.85.3.1151; Whittle AT, 1999, THORAX, V54, P323, DOI 10.1136/thx.54.4.323; Wysocki J, 2015, FOLIA MORPHOL WARSZ; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Young Terry, 2009, WMJ, V108, P246	34	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176991	10.1371/journal.pone.0176991	http://dx.doi.org/10.1371/journal.pone.0176991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472141	gold, Green Published, Green Submitted			2022-12-26	WOS:000400648500110
J	Ma, YC; Liu, RL; Lv, HQ; Han, JQ; Zhong, DX; Zhang, XM				Ma, Yucheng; Liu, Ruiling; Lv, Hongqiang; Han, Jiuqiang; Zhong, Dexing; Zhang, Xinman			A computational method for prediction of matrix proteins in endogenous retroviruses	PLOS ONE			English	Article							MURINE LEUKEMIA-VIRUS; LARGE WHITE-PIG; REPLICATION-COMPETENT; NUCLEOTIDE-SEQUENCE; HUMAN-CELLS; MOLECULAR CLONES; MINIATURE SWINE; DNA-SEQUENCE; IN-VIVO; IDENTIFICATION	Human endogenous retroviruses (HERVs) encode active retroviral proteins, which may be involved in the progression of cancer and other diseases. Matrix protein (MA), in groupspecific antigen genes (gag) of retroviruses, is associated with the virus envelope glycoproteins in most mammalian retroviruses and may be involved in virus particle assembly, transport and budding. However, the amount of annotated MAs in ERVs is still at a low level so far. No computational method to predict the exact start and end coordinates of MAs in gags has been proposed yet. In this paper, a computational method to identify MAs in ERVs is proposed. A divide and conquer technique was designed and applied to the conventional prediction model to acquire better results when dealing with gene sequences with various lengths. Initiation sites and termination sites were predicted separately and then combined according to their intervals. Three different algorithms were applied and compared: weighted support vector machine (WSVM), weighted extreme learning machine (WELM) and random forest (RF). G-mean (geometric mean of sensitivity and specificity) values of initiation sites and termination sites under 5-fold cross validation generated by random forest models are 0.9869 and 0.9755 respectively, highest among the algorithms applied. Our prediction models combine RF & WSVM algorithms to achieve the best prediction results. 98.4% of all the collected ERV sequences with complete MAs (125 in total) could be predicted exactly correct by the models. 94,671 HERV sequences from 118 families were scanned by the model, 104 new putative MAs were predicted in human chromosomes. Distributions of the putative MAs and optimizations of model parameters were also analyzed. The usage of our predicting method was also expanded to other retroviruses and satisfying results were acquired.	[Ma, Yucheng; Liu, Ruiling; Lv, Hongqiang; Han, Jiuqiang; Zhong, Dexing; Zhang, Xinman] Xi An Jiao Tong Univ, Sch Elect & Informat Engn, Xian, Peoples R China	Xi'an Jiaotong University	Liu, RL; Lv, HQ (corresponding author), Xi An Jiao Tong Univ, Sch Elect & Informat Engn, Xian, Peoples R China.	meggie@mail.xjtu.edu.cn; hongqianglv@mail.xjtu.edu.cn		Ma, Yucheng/0000-0002-9498-3452	National Natural Science Foundation of Shaanxi Province [2012JQ8042]; China Postdoctoral Science Foundation [2015M580851]	National Natural Science Foundation of Shaanxi Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grant from National Natural Science Foundation of Shaanxi Province (No. 2012JQ8042) at http://www.sninfo.gov.cn and by grant from China Postdoctoral Science Foundation (No. 2015M580851) at http://chinapostdoctor.org.cn The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahi YS, 2016, MBIO, V7, DOI 10.1128/mBio.01985-16; Akiyoshi DE, 1998, J VIROL, V72, P4503, DOI 10.1128/JVI.72.5.4503-4507.1998; Anai Y, 2012, J VIROL, V86, P8634, DOI 10.1128/JVI.00280-12; Barbulescu M, 1999, CURR BIOL, V9, P861, DOI 10.1016/S0960-9822(99)80390-X; BARTMAN T, 1995, J VIROL, V69, P3224, DOI 10.1128/JVI.69.5.3224-3228.1995; Bartosch B, 2004, J VIROL, V78, P13880, DOI 10.1128/JVI.78.24.13880-13890.2004; Bartosch B, 2002, J GEN VIROL, V83, P2231, DOI 10.1099/0022-1317-83-9-2231; Beck-Engeser GB, 2015, J GEN VIROL, V96, P3396, DOI 10.1099/jgv.0.000271; Boller K, 1997, J VIROL, V71, P4581, DOI 10.1128/JVI.71.6.4581-4588.1997; Breiman L, 1992, SUBMODEL SELECTION E, P291; Cingoz O, 2012, J VIROL, V86, P328, DOI 10.1128/JVI.06022-11; COPELAND NG, 1988, J VIROL, V62, P479, DOI 10.1128/JVI.62.2.479-487.1988; Cornelis G, 2015, P NATL ACAD SCI USA, V112, pE487, DOI 10.1073/pnas.1417000112; Cui Y, 2013, BIOCHEM BIOPH RES CO, V431, P221, DOI 10.1016/j.bbrc.2012.12.131; Czauderna F, 2000, J VIROL, V74, P4028, DOI 10.1128/JVI.74.9.4028-4038.2000; de Parseval N, 2001, VIROLOGY, V279, P558, DOI 10.1006/viro.2000.0737; Deng YM, 2000, TRANSPLANTATION, V70, P1010, DOI 10.1097/00007890-200010150-00004; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Escalera-Zamudio M, 2015, J VIROL, V89, P5180, DOI 10.1128/JVI.03452-14; FREED EO, 1994, J VIROL, V68, P5311, DOI 10.1128/JVI.68.8.5311-5320.1994; Gifford R, 2003, VIRUS GENES, V26, P291, DOI 10.1023/A:1024455415443; Griffiths DJ, 2002, J VIROL, V76, P7094, DOI 10.1128/JVI.76.14.7094-7102.2002; Hanger JJ, 2000, J VIROL, V74, P4264, DOI 10.1128/JVI.74.9.4264-4272.2000; HERR W, 1984, J VIROL, V49, P471, DOI 10.1128/JVI.49.2.471-478.1984; Herring C, 2001, J VIROL, V75, P12252, DOI 10.1128/JVI.75.24.12252-12265.2001; Hirschl S, 2007, VIRUS RES, V123, P211, DOI 10.1016/j.virusres.2006.08.010; Ho TK, 1995, RANDOM DECISION FORE, V271, P278; Huang GB, 2011, INT J MACH LEARN CYB, V2, P107, DOI 10.1007/s13042-011-0019-y; Huder JB, 2002, J VIROL, V76, P7607, DOI 10.1128/JVI.76.15.7607-7615.2002; Jern P, 2008, ANNU REV GENET, V42, P709, DOI 10.1146/annurev.genet.42.110807.091501; Jung WY, 2010, ANIM GENET, V41, P89, DOI 10.1111/j.1365-2052.2009.01953.x; Kim HS, 2001, AIDS RES HUM RETROV, V17, P1665, DOI 10.1089/088922201753342086; Kim NY, 2009, VIRUS GENES, V39, P210, DOI 10.1007/s11262-009-0377-7; Krach U, 2001, J VIROL, V75, P5465, DOI 10.1128/JVI.75.12.5465-5472.2001; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; LOWER R, 1993, P NATL ACAD SCI USA, V90, P4480, DOI 10.1073/pnas.90.10.4480; Ma YY, 2010, COMP IMMUNOL MICROB, V33, P323, DOI 10.1016/j.cimid.2008.10.007; Machnik G, 2014, FOLIA BIOL-PRAGUE, V60, P35; Marsh AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040158; Martin J, 2004, NATURE, V432, P988, DOI 10.1038/nature03187; Mayer J, 1999, NAT GENET, V21, P257, DOI 10.1038/6766; Mendoza R, 2011, J VIROL, V85, P9247, DOI 10.1128/JVI.05137-11; Miller AD, 2008, J VIROL, V82, P6862, DOI 10.1128/JVI.00397-08; Monde K, 2012, J VIROL, V86, P11194, DOI 10.1128/JVI.00301-12; Niebert M, 2002, J VIROL, V76, P2714, DOI 10.1128/JVI.76.6.2714-2720.2002; Onions D, 2011, VACCINE, V29, P7117, DOI 10.1016/j.vaccine.2011.05.071; ONO M, 1986, J VIROL, V60, P589, DOI 10.1128/JVI.60.2.589-598.1986; POLICASTRO PF, 1989, J VIROL, V63, P4136, DOI 10.1128/JVI.63.10.4136-4147.1989; Pothlichet J, 2006, INT J CANCER, V119, P1869, DOI 10.1002/ijc.22066; Pothlichet J, 2006, INT J CANCER, V119, P815, DOI 10.1002/ijc.21935; PRATS AC, 1989, J MOL BIOL, V205, P363, DOI 10.1016/0022-2836(89)90347-1; Preuss T, 2006, J VIROL, V80, P10258, DOI 10.1128/JVI.01140-06; Reis BS, 2013, CLIN CANCER RES, V19, P6112, DOI 10.1158/1078-0432.CCR-12-3580; Scherer SE, 2006, NATURE, V440, P346, DOI 10.1038/nature04569; Scobie L, 2004, J VIROL, V78, P2502, DOI 10.1128/JVI.78.5.2502-2509.2004; Shimode S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08164; Sperber GO, 2007, NUCLEIC ACIDS RES, V35, P4964, DOI 10.1093/nar/gkm515; STORMO GD, 1982, NUCLEIC ACIDS RES, V10, P2997, DOI 10.1093/nar/10.9.2997; Sugimoto J, 2001, GENOMICS, V72, P137, DOI 10.1006/geno.2001.6473; Summers MF, 2009, P NATL ACAD SCI USA, P11364; Suntsova M, 2015, CELL MOL LIFE SCI, V72, P3653, DOI 10.1007/s00018-015-1947-6; Tang HB, 2015, GENOME ANNOUNC, V3; Tian F, 2009, AMINO ACIDS, V36, P535, DOI 10.1007/s00726-008-0116-8; Tonjes RR, 1997, VIROLOGY, V233, P280, DOI 10.1006/viro.1997.8614; Tonjes RR, 1999, J VIROL, V73, P9187; Triviai I, 2014, P NATL ACAD SCI USA, V111, P8595, DOI 10.1073/pnas.1401215111; Turner G, 2001, CURR BIOL, V11, P1531, DOI 10.1016/S0960-9822(01)00455-9; vanderKuyl AC, 1997, J VIROL, V71, P3666, DOI 10.1128/JVI.71.5.3666-3676.1997; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Villesen Palle, 2004, Retrovirology, V1, P32, DOI 10.1186/1742-4690-1-32; Voisset C, 2000, AIDS RES HUM RETROV, V16, P731, DOI 10.1089/088922200308738; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; Wu HL, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0238-0; Wu TY, 2005, J VIROL, V79, P9677, DOI 10.1128/JVI.79.15.9677-9684.2005; Xiang SL, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-228; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191; Yoshikawa R, 2015, VIRUS RES, V196, P128, DOI 10.1016/j.virusres.2014.11.020; Yu SL, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/482568	78	2	2	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176909	10.1371/journal.pone.0176909	http://dx.doi.org/10.1371/journal.pone.0176909			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472185	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500095
J	Tanaka, T; Terai, Y; Ashihara, K; Fujiwara, S; Tanaka, Y; Sasaki, H; Tsunetoh, S; Ohmichi, M				Tanaka, Tomohito; Terai, Yoshito; Ashihara, Keisuke; Fujiwara, Satoe; Tanaka, Yoshimichi; Sasaki, Hiroshi; Tsunetoh, Satoshi; Ohmichi, Masahide			The efficacy of the cyclin-dependent kinase 4/6 inhibitor in endometrial cancer	PLOS ONE			English	Article							CDK4/6 INHIBITION; CELL-CYCLE; PD 0332991; PALBOCICLIB; PD-0332991; EXPRESSION; PD0332991; PROTEIN	Background PD-0332991, the selective cyclin-dependent kinase 4/6 inhibitor palbociclib, causes cell cycle arrest by inhibiting phosphorylation of retinoblastoma (Rb) protein. The aim of this study was to evaluate the therapeutic potential of PD-0332991 in endometrial cancer. Methods and findings Four human endometrial cancer cell lines, ECC, HEC1A, HEC108 and TEN, were treated with PD-0332991 and their function was evaluated. In vivo, the therapeutic efficacy was evaluated in a model of subcutaneous endometrial cancer. An immunohistochemical analysis was performed in 337 endometrial cancer specimens. A proliferation assay revealed that 2 of the 4 cell lines that expressed Rb were sensitive to PD-0332991 with an IC50 of 0.65 mu M ( HEC1A) and 0.58 mu M( HEC108), respectively. Both cell lines had G0/G1 cell cycle arrest after treatment with PD-0332991 according to flow cytometry. In vivo, PD-0332991 had anti-tumoral efficacy with a reduction in the activity of Ki67 and phosphorylation of Rb. Immunohistochemical analyses revealed that the positive rate of Rb was 67.7%, however, there was no significant relationship between the expression levels of Rb and the tumor grade. Conclusions PD-0332991 had therapeutic potential against endometrial cancer cell lines expressing Rb protein. Our immunohistochemical analysis revealed that approximately 70% of patients with endometrial cancer might have therapeutic indications for PD-0332991. Of note, the tumor grade had no impact on the indications for treatment.	[Tanaka, Tomohito; Terai, Yoshito; Ashihara, Keisuke; Fujiwara, Satoe; Tanaka, Yoshimichi; Sasaki, Hiroshi; Tsunetoh, Satoshi; Ohmichi, Masahide] Osaka Med Coll, Dept Obstet & Gynecol, Takatsuki, Osaka, Japan	Osaka Medical College	Tanaka, T (corresponding author), Osaka Med Coll, Dept Obstet & Gynecol, Takatsuki, Osaka, Japan.	gyn123@osaka-med.ac.jp		tanaka, tomohito/0000-0003-4210-701X	JSPS KAKENHI [25462621]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a JSPS KAKENHI Grant, Number 25462621 (to Y. Terai).	BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Bollard J, 2016, GUT; BUCKLEY MF, 1993, ONCOGENE, V8, P2127; Caldon CE, 2006, J CELL BIOCHEM, V97, P261, DOI 10.1002/jcb.20690; Comstock CES, 2013, ONCOGENE, V32, P5481, DOI 10.1038/onc.2013.83; Creasman WT., 2007, CLIN GYNECOLOGIC ONC; DeMichele A, 2015, CLIN CANCER RES, V21, P995, DOI 10.1158/1078-0432.CCR-14-2258; Ferrandina G, 2005, GYNECOL ONCOL, V98, P383, DOI 10.1016/j.ygyno.2005.04.024; Finn RS, 2015, LANCET ONCOL, V16, P25, DOI 10.1016/S1470-2045(14)71159-3; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Flaherty KT, 2012, CLIN CANCER RES, V18, P568, DOI 10.1158/1078-0432.CCR-11-0509; Fry DW, 2004, MOL CANCER THER, V3, P1427; Hirahatake K, 1997, J SURG ONCOL, V65, P82, DOI 10.1002/(SICI)1096-9098(199706)65:2<82::AID-JSO3>3.0.CO;2-J; Iglesias DA, 2011, GYNECOLOGIC ONCOLOGY; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Konecny GE, 2011, CLIN CANCER RES, V17, P1591, DOI 10.1158/1078-0432.CCR-10-2307; Leonard JP, 2012, BLOOD, V119, P4597, DOI 10.1182/blood-2011-10-388298; MORROW CP, 1991, GYNECOL ONCOL, V40, P55, DOI 10.1016/0090-8258(91)90086-K; Parrish KE, 2015, J PHARMACOL EXP THER, V355, P264, DOI 10.1124/jpet.115.228213; Schwartz GK, 2011, BRIT J CANCER, V104, P1862, DOI 10.1038/bjc.2011.177; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Silververg SG, 2003, TUMOURS BREAST FEMAL; Toogood PL, 2005, J MED CHEM, V48, P2388, DOI 10.1021/jm049354h; Turner NC, 2015, N ENGL J MED; Vaughn DJ, 2015, CANCER-AM CANCER SOC, V121, P1463, DOI 10.1002/cncr.29213; Wiedemeyer WR, 2010, P NATL ACAD SCI USA, V107, P11501, DOI 10.1073/pnas.1001613107; Yang BY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155145	28	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177019	10.1371/journal.pone.0177019	http://dx.doi.org/10.1371/journal.pone.0177019			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472136	Green Submitted, gold, Green Published			2022-12-26	WOS:000400648500120
J	Andreu-Sanchez, C; Martin-Pascual, MA; Gruart, A; Delgado-Garcia, JM				Andreu-Sanchez, Celia; Angel Martin-Pascual, Miguel; Gruart, Agnes; Maria Delgado-Garcia, Jose			Looking at reality versus watching screens: Media professionalization effects on the spontaneous eyeblink rate	PLOS ONE			English	Article							COMPUTER VISION SYNDROME; BRAIN; SEGMENTATION; PERFORMANCE; EYE	This article explores whether there are differences in visual perception of narrative between theatrical performances and screens, and whether media professionalization affects visual perception. We created a live theatrical stimulus and three audio-visual stimuli (each one with a different video editing style) having the same narrative, and displayed them randomly to participants (20 media professionals and 20 non-media professionals). For media professionals, watching movies on screens evoked a significantly lower spontaneous blink rate (SBR) than looking at theatrical performances. Media professionals presented a substantially lower SBR than non-media professionals when watching screens, and more surprisingly, also when seeing reality. According to our results, media professionals pay higher attention to both screens and the real world than do non-media professionals.	[Andreu-Sanchez, Celia; Angel Martin-Pascual, Miguel] Univ Autonoma Barcelona, Fac Ciencies Comunicacio, Neurocom Res Grp, Edifici 1,Campus Bellaterra, Barcelona, Spain; [Gruart, Agnes; Maria Delgado-Garcia, Jose] Pablo de Olavide Univ, Div Neurosci, Seville, Spain	Autonomous University of Barcelona; Universidad Pablo de Olavide	Andreu-Sanchez, C (corresponding author), Univ Autonoma Barcelona, Fac Ciencies Comunicacio, Neurocom Res Grp, Edifici 1,Campus Bellaterra, Barcelona, Spain.	celia.andreu@uab.cat	Martín-Pascual, Miguel Ángel/A-1451-2011; Andreu-Sánchez, Celia/A-1454-2011; Delgado-Garcia, Jose M./V-1567-2019					Acosta MC, 1999, EXP EYE RES, V68, P663, DOI 10.1006/exer.1998.0656; Andreu-Sanchez C, 2017, SCI REP-UK, V7, DOI 10.1038/srep43267; Blehm C, 2005, SURV OPHTHALMOL, V50, P253, DOI 10.1016/j.survophthal.2005.02.008; Bordwell D, 2002, FILM QUART, V55, P16, DOI 10.1525/fq.2002.55.3.16; Bordwell D, 2006, WAY HOLLYWOOD TELLS IT: STORY AND STYLE IN MODERN MOVIES, P1; Bordwell David, 1988, CLASSICAL HOLLYWOOD, P536, DOI [10.4324/9780203358818, DOI 10.4324/9780203358818]; Bour LJ, 2000, J NEUROPHYSIOL, V83, P166, DOI 10.1152/jn.2000.83.1.166; Briggs ST, 1999, INT CONTACT LENS CLI, V26, P29, DOI [10.1016/S0892-8967(99)00016-4, DOI 10.1016/S0892-8967(99)00016-4]; Cardona G, 2014, CONTACT LENS ANTERIO, V37, P363, DOI 10.1016/j.clae.2014.05.005; Carroll N., 2013, PSYCHOCINEMATICS EXP, P53, DOI [10.1093/acprof:oso/9780199862139.003.0003, DOI 10.1093/ACPROF:OSO/9780199862139.003.0003]; Delgado-Garcia JM, 2002, MOVEMENT DISORD, V17, pS33, DOI 10.1002/mds.10055; Divjak M., 2009, INT ASS PATT REC C M, P350; Falck-Ytter T, 2012, J AUTISM DEV DISORD, V42, P2236, DOI 10.1007/s10803-012-1471-6; Faubert J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01154; Freudenthaler N, 2003, GRAEF ARCH CLIN EXP, V241, P914, DOI 10.1007/s00417-003-0786-6; Haak M., 2009, PROCEEDING 1 DRIVER, P35; Kaiser MD, 2009, PSYCHON B REV, V16, P761, DOI 10.3758/PBR.16.5.761; Lotze M, 2003, NEUROIMAGE, V20, P1817, DOI 10.1016/j.neuroimage.2003.07.018; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Maguire EA, 2006, HIPPOCAMPUS, V16, P1091, DOI 10.1002/hipo.20233; Morcom AM, 2007, NEUROIMAGE, V37, P1097, DOI 10.1016/j.neuroimage.2007.07.018; Nakano T., 2013, P NATL ACAD SCI USA, V110, P3; Nakano T, 2011, NEUROPSYCHOLOGIA, V49, P2784, DOI 10.1016/j.neuropsychologia.2011.06.007; Nakano T, 2010, EXP BRAIN RES, V205, P577, DOI 10.1007/s00221-010-2387-z; Nakano T, 2009, P ROY SOC B-BIOL SCI, V276, P3635, DOI 10.1098/rspb.2009.0828; Nielsen, 2016, TOT AUD REP Q1 2016; Nielsen, 2016, COMP METR REP Q1 201; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Shultz S, 2011, P NATL ACAD SCI US; Skotte JH, 2007, EUR J APPL PHYSIOL, V99, P113, DOI 10.1007/s00421-006-0322-6; Smith TJ, 2013, J VISION, V13, DOI 10.1167/13.8.16; Smith TJ, 2012, CURR DIR PSYCHOL SCI, V21, P107, DOI 10.1177/0963721412437407; Tadel A. F., 2015, BRAINSTORM TUTORIALS; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; TSUBOTA K, 1993, NEW ENGL J MED, V328, P584, DOI 10.1056/NEJM199302253280817; Vilaro A., 2013, J EYE MOVEMENT RES, V6, P26; Wiseman RJ, 2016, PEERJ, V4, DOI 10.7717/peerj.1873; Wong K, 2002, BR J OPHTHALMOL, P476; Yan Z, 2008, COMPUT HUM BEHAV, V24, P2026, DOI 10.1016/j.chb.2007.09.004; Zacks JM, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00168; Zacks JM, 2009, J EXP PSYCHOL GEN, V138, P307, DOI 10.1037/a0015305; Zacks JM, 2001, NAT NEUROSCI, V4, P651, DOI 10.1038/88486; Zheng B, 2012, SURG ENDOSC, V26, P2746, DOI 10.1007/s00464-012-2268-6	43	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176030	10.1371/journal.pone.0176030	http://dx.doi.org/10.1371/journal.pone.0176030			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SB	28467449	Green Published, Green Submitted, gold			2022-12-26	WOS:000400647000033
J	Kawaguchi, Y; Nakano, M; Yasuda, T; Seki, S; Suzuki, K; Yahara, Y; Makino, H; Kitajima, I; Kimura, T				Kawaguchi, Yoshiharu; Nakano, Masato; Yasuda, Taketoshi; Seki, Shoji; Suzuki, Kayo; Yahara, Yasuhito; Makino, Hiroto; Kitajima, Isao; Kimura, Tomoatsu			Serum biomarkers in patients with ossification of the posterior longitudinal ligament (OPLL): Inflammation in OPLL	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BONE MORPHOGENETIC PROTEIN-2; TOTAL HIP-ARTHROPLASTY; SPINAL-CORD-INJURY; GROWTH-FACTOR-BETA; HETEROTOPIC OSSIFICATION; CARDIOVASCULAR-DISEASE; CERVICAL LAMINOPLASTY; ANTIINFLAMMATORY DRUGS; WHOLE-SPINE	Backgroud Ossification of the posterior longitudinal ligament (OPLL) is characterized by replacement of ligamentous tissue by ectopic new bone formation. OPLL causes narrowing of the spinal canal, resulting in neurological impairment. However, the pathogenesis of OPLL has not been fully elucidated. We investigated whether inflammation occurs in OPLL or not using high-sensitivity CRP (hs-CRP) in a case-control study. Methods and findings This study included 103 patients with OPLL in the patient group and 95 age-and sex-matched volunteers with degenerative spinal disease in the control group. Of the 103 OPLL patients, 88 patients who were available for more than 2 years follow-up were checked for OPLL progression. A blood sample was obtained and Hs-CRP, and other routine data, including total protein (TP), albumin (ALB), lactate dehydrogenase (LDH), alkaline phosphatase (ALP), glucose (Glu), calcium (Ca), inorganic phosphate (Pi), white blood cell count (WBC), hemoglobin (Hb) and platelet (PLT), were analyzed. The data were compared between the patients with OPLL and the controls. The severity of the ossified lesions in the whole spine were evaluated by the ossification index (OS index) in patients with OPLL. The data were also compared between the patients with OPLL progression (the progression group) and the patients without OPLL progression (the non-progression group). In the results, the mean hs-CRP in the OPLL group was higher than that in the controls. The Pi in the OPLL group was lower than that in the control group. A negative correlation was found between the Pi and the OS index. The mean hs-CRP in the progression group was higher than that in the non-progression group. There was a positive correlation between the average length of the OPLL progression per year and the hs-CRP. Conclusions The results may suggest the occurrence of local inflammation in OPLL and the inflammation might cause OPLL progression. These facts are important for understanding the pathology of OPLL.	[Kawaguchi, Yoshiharu; Nakano, Masato; Yasuda, Taketoshi; Seki, Shoji; Suzuki, Kayo; Yahara, Yasuhito; Makino, Hiroto; Kimura, Tomoatsu] Toyama Univ, Dept Orthopaed Surg, Toyama, Japan; [Kitajima, Isao] Toyama Univ, Dept Clin Lab Med, Toyama, Japan	University of Toyama; University of Toyama	Kawaguchi, Y (corresponding author), Toyama Univ, Dept Orthopaed Surg, Toyama, Japan.	zenji@med.u-toyama.ac.jp	Yahara, Yasuhito/AAO-7487-2020	Makino, Hiroto/0000-0003-0286-4489	Ministry of Health, Labour and Welfare of Japan: Committee for Study of Ossification of Spinal Ligament; Ministry of Health, Labour and Welfare of Japan: Ligament and Committee for Research and Development of Therapies for Ossification of Posterior Longitudinal Ligament; Grants-in-Aid for Scientific Research [16K10815] Funding Source: KAKEN	Ministry of Health, Labour and Welfare of Japan: Committee for Study of Ossification of Spinal Ligament; Ministry of Health, Labour and Welfare of Japan: Ligament and Committee for Research and Development of Therapies for Ossification of Posterior Longitudinal Ligament; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work reported in this article was supported by grants from the Ministry of Health, Labour and Welfare of Japan: Committee for Study of Ossification of Spinal Ligament and Committee for Research and Development of Therapies for Ossification of Posterior Longitudinal Ligament.	Akune T, 2001, J BONE JOINT SURG AM, V83A, P1537, DOI 10.2106/00004623-200110000-00013; Beckmann JT, 2015, J BONE JOINT SURG AM, V97A, P2032, DOI 10.2106/JBJS.N.01156; Citak M, 2016, TECHNOL HEALTH CARE, V24, P87, DOI 10.3233/THC-151070; EPSTEIN NE, 1994, SPINE, V19, P664, DOI 10.1097/00007632-199403001-00005; Estrores IM, 2004, J SPINAL CORD MED, V27, P434, DOI 10.1080/10790268.2004.11752233; Fargen KM, 2012, J NEUROSURG-SPINE, V17, P512, DOI 10.3171/2012.9.SPINE12548; Fujimori T, 2016, SPINE, V41, P1668, DOI 10.1097/BRS.0000000000001643; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Galper BZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138092; Hirai T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160117; Hirao Y, 2016, INT J SURG CASE REP, V27, P125, DOI 10.1016/j.ijscr.2016.08.038; Hori T, 2007, SPINE, V32, pE551, DOI 10.1097/BRS.0b013e31814614f3; Hori T, 2006, SPINE, V31, P2807, DOI 10.1097/01.brs.0000245870.97231.65; Ikeda Y, 2011, EUR SPINE J, V20, P1450, DOI 10.1007/s00586-011-1688-7; Ikegawa S., 2006, TIPTOE WALKING TTW M, P71; Kan SL, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000828; KAWAGUCHI H, 1992, SPINE, V17, pS33; Kawaguchi Y, 2001, J BONE JOINT SURG AM, V83A, P1798, DOI 10.2106/00004623-200112000-00005; Kawaguchi Y, 2014, SPINE J, V14, P955, DOI 10.1016/j.spinee.2013.07.457; Kawaguchi Y, 2013, SPINE, V38, pE1477, DOI 10.1097/BRS.0b013e3182a54f00; Kawauchi T, 1996, ENDOCRINE, V5, P307, DOI 10.1007/BF02739064; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Koenig W, 2013, INT J CARDIOL, V168, P5126, DOI 10.1016/j.ijcard.2013.07.113; Lee KB, 2012, J ORTHOP RES, V30, P1985, DOI 10.1002/jor.22160; Lee KB, 2011, SPINE J, V11, P568, DOI 10.1016/j.spinee.2011.02.001; Moreira DM, 2015, AM J CARDIOVASC DRUG, V15, P1, DOI 10.1007/s40256-014-0094-z; Mori K, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1350-y; Nakajima M, 2014, NAT GENET, V46, P1012, DOI 10.1038/ng.3045; OKAZAKI T, 1984, METABOLISM, V33, P710, DOI 10.1016/0026-0495(84)90209-9; Oni JK, 2014, HIP INT, V24, P256, DOI 10.5301/hipint.5000109; ONJI Y, 1967, J BONE JOINT SURG AM, VA 49, P1314, DOI 10.2106/00004623-196749070-00007; RESNICK D, 1975, RADIOLOGY, V115, P513, DOI 10.1148/15.3.513; Ridker PM, 2001, CIRCULATION, V103, P1813, DOI 10.1161/01.CIR.103.13.1813; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rifai N, 1999, CLIN CHEM, V45, P2136; Rivera JC, 2015, CTS-CLIN TRANSL SCI, V8, P591, DOI 10.1111/cts.12300; Sagi HC, 2014, J ORTHOP TRAUMA, V28, P377, DOI 10.1097/BOT.0000000000000049; Saito T, 2011, BONE, V49, P913, DOI 10.1016/j.bone.2011.06.029; Sell S, 1999, ARCH ORTHOP TRAUM SU, V119, P205, DOI 10.1007/s004020050391; Shi L, 2016, EXP CELL RES, V349, P53, DOI 10.1016/j.yexcr.2016.09.019; Sugimori K, 2003, J BONE JOINT SURG BR, V85B, P1151, DOI 10.1302/0301-620X.85B8.14538; Sun YB, 2015, J SHOULDER ELB SURG, V24, P1735, DOI 10.1016/j.jse.2015.07.006; Takeda E, 2004, J CELL MOL MED, V8, P191, DOI 10.1111/j.1582-4934.2004.tb00274.x; TAKUWA Y, 1985, ACTA ENDOCRINOL-COP, V109, P428, DOI 10.1530/acta.0.1090428; Tsukimoto H., 1960, ARCH JPN CHIR, V29, P1003; Tsuzuki N., 2006, REV HISTOPATHOLOGICA, P41; Tu TH, 2015, J NEUROSURG-SPINE, V22, P447, DOI 10.3171/2014.10.SPINE14333; Tucker KL, 2006, AM J CLIN NUTR, V84, P936, DOI 10.1093/ajcn/84.4.936; Uchida K, 2012, EUR SPINE J, V21, P149, DOI 10.1007/s00586-011-1971-7; Vaucher J, 2014, CYTOKINE, V66, P95, DOI 10.1016/j.cyto.2014.01.003; Werner Clement M L, 2013, HSS J, V9, P166, DOI 10.1007/s11420-013-9335-y; YOSHIKAW.S, 1968, J BONE JOINT SURG AM, VA 50, P734, DOI 10.2106/00004623-196850040-00010	53	25	26	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0174881	10.1371/journal.pone.0174881	http://dx.doi.org/10.1371/journal.pone.0174881			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467440	Green Submitted, Green Published, gold			2022-12-26	WOS:000400647000009
J	Willkomm, L; Gehlert, S; Jacko, D; Schiffer, T; Bloch, W				Willkomm, Lena; Gehlert, Sebastian; Jacko, Daniel; Schiffer, Thorsten; Bloch, Wilhelm			p38 MAPK activation and H3K4 trimethylation is decreased by lactate in vitro and high intensity resistance training in human skeletal muscle	PLOS ONE			English	Article							LENGTHENING CONTRACTIONS; HISTONE MODIFICATIONS; SIGNALING PATHWAYS; GENE-EXPRESSION; EXERCISE; RECRUITMENT; RESPONSES; COMPLEXES; CELLS; PHOSPHORYLATION	Exercise induces adaptation of skeletal muscle by acutely modulating intracellular signaling, gene expression, protein turnover and myogenic activation of skeletal muscle stem cells (Satellite cells, SCs). Lactate (La)-induced metabolic stimulation alone has been shown to modify SC proliferation and differentiation. Although the mechanistic basis remains elusive, it was demonstrated that La affects signaling via p38 mitogen activated protein kinase (p38 MAPK) which might contribute to trimethylation of histone 3 lysine 4 (H3K4me3) known to regulate satellite cell proliferation and differentiation. We investigated the effects of La on p38 MAPK and H3K4me3 in a model of activated SCs. Differentiating C2C12 myoblasts were treated with La (20 mM) and samples analysed using qRT-PCR, immunofluorescence, and western blotting. We determined a reduction of p38 MAPK phosphorylation, decreased H3K4me3 and reduced expression of Myf5, myogenin, and myosin heavy chain (MHC) leading to decreased differentiation of La-treated C2C12 cells after 5 days of repeated La treatment. We further investigated whether this regulatory pathway would be affected in human skeletal muscle by the application of two different resistance exercise regimes (RE) associated with distinct metabolic demands and blood La accumulation. Muscle biopsies were obtained 15, 30 min, 1, 4, and 24 h post exercise after moderate intensity RE (STD) vs. high intensity RE (HIT). Consistent with in vitro results, reduced p38 phosphorylation and blunted H3K4me3 were also observed upon metabolically demanding HIT RE in human skeletal muscle. Our data provide evidence that La-accumulation acutely affects p38 MAPK signaling, gene expression and thereby cell differentiation and adaptation in vitro, and likely in vivo.	[Willkomm, Lena; Gehlert, Sebastian; Jacko, Daniel; Bloch, Wilhelm] German Sport Univ Cologne, Dept Mol & Cellular Sports Med, Inst Cardiovasc Res & Sports Med, Cologne, Germany; [Schiffer, Thorsten] German Sport Univ Cologne, Outpatient Clin Sports Traumatol, Cologne, Germany; [Willkomm, Lena] Bayer Pharma AG, Cross Indicat Platform, Dis Genom, Wuppertal, Germany	German Sport University Cologne; German Sport University Cologne; Bayer AG; Bayer Healthcare Pharmaceuticals	Gehlert, S (corresponding author), German Sport Univ Cologne, Dept Mol & Cellular Sports Med, Inst Cardiovasc Res & Sports Med, Cologne, Germany.	gehlert@dshs-koeln.de	Gehlert, Sebastian/P-7687-2016; Gehlert, Sebastian/AAU-7086-2021	Gehlert, Sebastian/0000-0001-6940-3084; 	Federal Institute of Sport Science (BISp) [IIA1-507070103-09-10]	Federal Institute of Sport Science (BISp)	The human study was funded by the Federal Institute of Sport Science (BISp), Project # IIA1-507070103-09-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenburg TM, 2007, J APPL PHYSIOL, V103, P1752, DOI 10.1152/japplphysiol.00496.2007; Aziz A, 2010, EPIGENETICS-US, V5, P691, DOI 10.4161/epi.5.8.13045; Baker JS, 2010, J NUTR METAB, V2010, DOI 10.1155/2010/905612; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Beltman JGM, 2004, EUR J APPL PHYSIOL, V92, P485, DOI 10.1007/s00421-004-1105-6; Bergman BC, 1999, J APPL PHYSIOL, P87; BIGLANDRITCHIE B, 1976, J PHYSIOL-LONDON, V260, P267, DOI 10.1113/jphysiol.1976.sp011515; Buitrago S, 2013, J STRENGTH COND RES, V27, P1091, DOI 10.1519/JSC.0b013e318260ec77; Coffey VG, 2007, SPORTS MED, V37, P737, DOI 10.2165/00007256-200737090-00001; Cole F, 2004, DEV CELL, V7, P843, DOI 10.1016/j.devcel.2004.10.009; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; FITTS RH, 1994, PHYSIOL REV, V74, P49, DOI 10.1152/physrev.1994.74.1.49; Gehlert S, 2014, PFLUGERS ARCH; Gibala M, 2009, APPL PHYSIOL NUTR ME, V34, P428, DOI 10.1139/H09-046; Godin R, 2010, J PHYSIOL-LONDON, V588, P4073, DOI 10.1113/jphysiol.2010.195925; Hashimoto T, 2008, MED SCI SPORT EXER, V40, P486, DOI [10.1249/MSS.0b013e31815fcb04, 10.1249/mss.0b013e31815fcb04]; Hashimoto T, 2007, FASEB J, V21, P2602, DOI 10.1096/fj.07-8174com; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hunter GR, 2003, J STRENGTH COND RES, V17, P76, DOI 10.1519/00124278-200302000-00013; JACOBS I, 1981, ACTA PHYSIOL SCAND, V111, P465, DOI 10.1111/j.1748-1716.1981.tb06764.x; JACOBS I, 1982, MED SCI SPORT EXER, V14, P457, DOI 10.1249/00005768-198206000-00009; JACOBS I, 1983, J APPL PHYSIOL, V55, P365, DOI 10.1152/jappl.1983.55.2.365; Kadi F, 2000, HISTOCHEM CELL BIOL, V113, P99, DOI 10.1007/s004180050012; KARLSSON J, 1971, ACTA PHYSIOL SCAND, P1; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Krustrup P, 2004, PFLUG ARCH EUR J PHY, V449, P56, DOI 10.1007/s00424-004-1304-3; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lagally KM, 2002, MED SCI SPORT EXER, V34, P552, DOI 10.1097/00005768-200203000-00025; Lluis F, 2005, EMBO J, V24, P974, DOI 10.1038/sj.emboj.7600528; Martineau LC, 2001, J APPL PHYSIOL, V91, P693, DOI 10.1152/jappl.2001.91.2.693; Mcgee SL, 2011, J APPL PHYSIOL, V110, P258, DOI 10.1152/japplphysiol.00979.2010; McGee SL, 2009, J PHYSIOL-LONDON, V587, P5951, DOI 10.1113/jphysiol.2009.181065; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Mendler AN, 2012, INT J CANCER, V131, P633, DOI 10.1002/ijc.26410; Milovanova TN, 2008, MOL CELL BIOL, V28, P6248, DOI 10.1128/MCB.00795-08; Moller AB, 2013, PFLUG ARCH EUR J PHY, V465, P1785, DOI 10.1007/s00424-013-1318-9; NARDONE A, 1988, J PHYSIOL-LONDON, V395, P363, DOI 10.1113/jphysiol.1988.sp016924; Petrella JK, 2006, AM J PHYSIOL-ENDOC M, V291, pE937, DOI 10.1152/ajpendo.00190.2006; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Szivak TK, 2013, J STRENGTH COND RES, V27, P748, DOI 10.1519/JSC.0b013e318259e009; Takaesu G, 2006, J CELL BIOL, V175, P383, DOI 10.1083/jcb.200608031; Tannerstedt J, 2009, J APPL PHYSIOL, V106, P1412, DOI 10.1152/japplphysiol.91243.2008; Tesch P, 1980, Acta Physiol Scand Suppl, V480, P1; Thornton MK, 2002, MED SCI SPORT EXER, V34, P715, DOI 10.1249/00005768-200204000-00024; Widegren U, 1998, FASEB J, V12, P1379, DOI 10.1096/fasebj.12.13.1379; Willkomm L, 2014, STEM CELL RES, V12, P742, DOI 10.1016/j.scr.2014.03.004	50	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176609	10.1371/journal.pone.0176609	http://dx.doi.org/10.1371/journal.pone.0176609			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467493	Green Published, gold, Green Submitted			2022-12-26	WOS:000400647000061
J	Bao, CM; Liu, YQ; Sun, X; Xing, CC; Zeng, LT; Sun, GC				Bao, Chunmei; Liu, Yingqin; Sun, Xin; Xing, Congcong; Zeng, Luting; Sun, Guangchen			Periploca forrestii saponin ameliorates CIA via suppressing proinflammatory cytokines and nuclear factor kappa-B pathways	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; CANCER IN-VITRO; CHEMICAL-CONSTITUENTS; TISSUE HOMEOSTASIS; ANTITUMOR FRACTION; BONE DESTRUCTION; CATHEPSIN-K; INFLAMMATION; EXPRESSION; OSTEOCLASTOGENESIS	Objective Periploca forrestii Schltr has been used as a Chinese folk medicine for the treatment of rheumatism, arthralgia and fractures. However, the anti-arthritic activity of Periploca forrestii saponin (PFS) and the active compound has still not been revealed. This study aimed to investigate the protective effects and mechanisms of PFS on collagen type II (CII) collageninduced arthritis (CIA) mice. We sought to investigate whether PFS and Periplocin could regulate osteoclastogenesis, and if so, further investigation on its mechanism of action. Methods Arthritis was induced in female BALB/c mice by CIA method. PFS was administered at a dose of 50 mg/kg body weight once daily for five weeks. The effects of treatment in mice were assessed by histological and biochemical evaluation in sera and paws. Anti-osteoclastogenic action of PFS and Periplocin was identified using an osteoclast formation model induced by RANKL. Results PFS ameliorated paw erythema and swelling, inhibited bone erosion in ankle joint histopathological examination. PFS treatment resulted in decreased IgG2a, and increased IgG1 levels in the serum of CIA mice. Decreased TNF-alpha, and increased interleukin (IL)-4 and IL-22 levels were also found in PFS-treated mice. PFS inhibited the I-kappa B alpha phosphorylation, blocked nuclear factor (NF)-kappa B/p65 phosphorylation and abrogated AP-1/c-Fos activity. PFS downregulated toll-like receptor (TLR) 4, STAT3 and MMP-9 expression in CIA mice and RANKL-induced osteoclastogenesis. PFS and Periplocin inhibited RANKL-induced osteoclast formation in a dose dependent manner within nongrowth inhibitory concentration, and PFS decreased osteoclastogenesis-related marker expression, including cathepsin K and MMP-9. Conclusion This study revealed that the protective mechanism of PFS on CIA was associated with regulatory effects on proinflammatory factors and further on the crosstalk between NF-kappa B and cFos/AP-1 in vivo and in vitro. Therefore, PFS is a promising therapeutic alternative for the treatment of RA, evidencing the need to conduct further studies that can identify their active components in treating and preventing RA.	[Bao, Chunmei] Guilin Med Univ, Dept Nephrol, Guilin, Guangxi, Peoples R China; [Liu, Yingqin] Guilin Med Univ, Biotechnol Coll, Guilin, Guangxi, Peoples R China; [Sun, Xin] Xiamen Univ, Coll Med, Xiamen, Fujian, Peoples R China; [Xing, Congcong; Zeng, Luting; Sun, Guangchen] Guilin Med Univ, Coll Pharm, Guilin, Guangxi, Peoples R China	Guilin Medical University; Guilin Medical University; Xiamen University; Guilin Medical University	Sun, GC (corresponding author), Guilin Med Univ, Coll Pharm, Guilin, Guangxi, Peoples R China.	sungc@gimaedu.cn	Sun, Guangchen/ABI-7533-2020	Sun, Guangchen/0000-0001-8266-6014	National Natural Science Foundation of China [81260462, 81460474]; Nature Science Foundation of Guangxi Province [2015GXNFAA139104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Guangxi Province(National Natural Science Foundation of Guangxi Province)	The study was supported by the grants of National Natural Science Foundation of China (81260462 and 81460474; https://isisn.nsfc.gov.cn/egrantweb/) and Nature Science Foundation of Guangxi Province (2015GXNFAA139104; http://gxnsf.gxsti.net/stms/login.jsp). The funding bodies were not involved in any aspects of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa Y, 2008, NAT BIOTECHNOL, V26, P817, DOI 10.1038/nbt1412; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Bevaart L, 2010, METHODS MOL BIOL, V602, P181, DOI 10.1007/978-1-60761-058-8_11; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Cheng CF, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/613950, 10.1155/2013/958025]; Dudler J, 2000, ANN RHEUM DIS, V59, P529, DOI 10.1136/ard.59.7.529; Feldmann M, 2003, NAT MED, V9, P1245, DOI 10.1038/nm939; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heilpern AJ, 2009, INFECT IMMUN, V77, P2643, DOI 10.1128/IAI.00214-09; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hou WS, 2001, AM J PATHOL, V159, P2167, DOI 10.1016/S0002-9440(10)63068-4; Imboden JB, 2009, ANNU REV PATHOL-MECH, V4, P417, DOI 10.1146/annurev.pathol.4.110807.092254; ITOKAWA H, 1988, CHEM PHARM BULL, V36, P4441; ITOKAWA H, 1987, CHEM PHARM BULL, V35, P4524; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; Joosten LAB, 1999, ARTHRITIS RES, V1, P81, DOI 10.1186/ar14; Joung YH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159891; Justa S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093279; Kiyeko GW, 2016, EUR J IMMUNOL, V46, P2629, DOI 10.1002/eji.201646453; KNIGHT B, 1992, CLIN EXP IMMUNOL, V90, P459; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Lee ZH, 2003, BIOCHEM BIOPH RES CO, V305, P211, DOI 10.1016/S0006-291X(03)00695-8; Leibbrandt A, 2008, ANN NY ACAD SCI, V1143, P123, DOI 10.1196/annals.1443.016; Liu YQ, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/7941684; Lu ZJ, 2010, CELL PHYSIOL BIOCHEM, V26, P609, DOI 10.1159/000322328; Morko J, 2005, ARTHRITIS RHEUM-US, V52, P3713, DOI 10.1002/art.21423; Mukherjee P, 2003, ANN RHEUM DIS, V62, P707, DOI 10.1136/ard.62.8.707; Murphy G, 2002, ARTHRITIS RES THER, V4, DOI 10.1186/ar572; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Salminen-Mankonen HJ, 2007, CURR DRUG TARGETS, V8, P315, DOI 10.2174/138945007779940188; Sarkar S, 2013, ARTHRITIS RHEUM-US, V65, P960, DOI 10.1002/art.37849; Son DJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep36852; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; van den Berg Wim B., 2007, V136, P243; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wang Jin, 2009, Zhongguo Zhong Yao Za Zhi, V34, P3214; WILLIAMS RO, 1992, P NATL ACAD SCI USA, V89, P9784, DOI 10.1073/pnas.89.20.9784; Xu Ran, 2012, Zhongguo Zhong Yao Za Zhi, V37, P2286; Zhao LM, 2010, ONCOL REP, V24, P375, DOI 10.3892/or_00000870	46	5	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176672	10.1371/journal.pone.0176672	http://dx.doi.org/10.1371/journal.pone.0176672			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28463993	Green Submitted, gold, Green Published			2022-12-26	WOS:000400646300041
J	Goode, G; Gunda, V; Chaika, NV; Purohit, V; Yu, F; Singh, PK				Goode, Gennifer; Gunda, Venugopal; Chaika, Nina V.; Purohit, Vinee; Yu, Fang; Singh, Pankaj K.			MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer	PLOS ONE			English	Article							PANCREATIC-CANCER; GLUTAMINE-METABOLISM; OVARIAN-CANCER; CELL BIOLOGY; BETA-CATENIN; PATHWAY; MUCINS; GROWTH; TRANSCRIPTION; EXPRESSION	Background Mucin1 (MUC1), a glycoprotein associated with chemoresistance and an aggressive cancer phenotype, is aberrantly overexpressed in triple-negative breast cancer (TNBC). Recent studies suggest that MUC1 plays a role in modulating cancer cell metabolism and thereby supports tumor growth. Herein, we examined the role of MUC1 in metabolic reprogramming in TNBC. Methods MUC1 was stably overexpressed in MDA-MB-231 TNBC cells and stably knocked down in MDA-MB-468 cells. We performed liquid chromatography-coupled tandem mass spectrometry- assisted metabolomic analyses and physiological assays, which indicated significant alterations in the metabolism of TNBC cells due to MUC1 expression. Results Differential analyses identified significant differences in metabolic pathways implicated in cancer cell growth. In particular, MUC1 expression altered glutamine dependency of the cells, which can be attributed in part to the changes in the expression of genes that regulate glutamine metabolism, as observed by real-time PCR analysis. Furthermore, MUC1 expression altered the sensitivity of cells to transaminase inhibitor aminooxyacetate (AOA), potentially by altering glutamine metabolism. Conclusions Collectively, these results suggest that MUC1 serves as a metabolic regulator in TNBC, facilitating the metabolic reprogramming of glutamine utilization that influences TNBC tumor growth.	[Goode, Gennifer; Gunda, Venugopal; Chaika, Nina V.; Purohit, Vinee; Singh, Pankaj K.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Yu, Fang] Univ Nebraska Med Ctr, Dept Biostat, Omaha, NE USA; [Singh, Pankaj K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Singh, Pankaj K.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Singh, Pankaj K.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Singh, PK (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.; Singh, PK (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.; Singh, PK (corresponding author), Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA.; Singh, PK (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA.	pankaj.singh@unmc.edu	Purohit, Vinee/AAA-3991-2019; gunda, venugopal/A-5658-2018; Purohit, Vinee/GSO-0751-2022	Purohit, Vinee/0000-0001-8093-5540; gunda, venugopal/0000-0002-9156-2580; Singh, Pankaj/0000-0001-8903-0131	National Institutes of Health grant (NCI) [R01 CA163649, R01 CA210439, R01 CA216853]; Specialized Programs of Research Excellence (SPORE) (NCI) [2P50 CA127297]; Breast Cancer Research Program Idea Award (DOD) [13-1-0315]; Competitive Research Supplement to Promote Diversity in Health-Related Research (NCI) [R01CA163649]; Fred & Pamela Buffett Cancer Center Support Grant (NCI) [P30CA036727]; NATIONAL CANCER INSTITUTE [P30CA036727, R01CA210439, R01CA216853, P50CA127297, R01CA163649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106397] Funding Source: NIH RePORTER	National Institutes of Health grant (NCI); Specialized Programs of Research Excellence (SPORE) (NCI); Breast Cancer Research Program Idea Award (DOD); Competitive Research Supplement to Promote Diversity in Health-Related Research (NCI); Fred & Pamela Buffett Cancer Center Support Grant (NCI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by funding from the National Institutes of Health grant (R01 CA163649, R01 CA210439, and R01 CA216853, NCI) to PKS, the Specialized Programs of Research Excellence (SPORE, 2P50 CA127297, NCI) to PKS, Breast Cancer Research Program Idea Award (13-1-0315, DOD) to PKS, and Competitive Research Supplement to Promote Diversity in Health-Related Research (R01CA163649, NCI) to GG. We would also like to acknowledge the Fred & Pamela Buffett Cancer Center Support Grant (P30CA036727, NCI) for supporting shared resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alteri R, 2011, BREAST CANC FACTS FI; Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Behrens ME, 2010, ONCOGENE, V29, P5667, DOI 10.1038/onc.2010.327; Bunik V, 2016, ONCOTARGET, V7, P26400, DOI 10.18632/oncotarget.8387; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Chaika NV, 2012, P NATL ACAD SCI USA, V109, P13787, DOI 10.1073/pnas.1203339109; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Gunda V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154416; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Jin CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039432; Kim S, 2011, NAT REV CANCER, V11, P708, DOI 10.1038/nrc3124; Kung HN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002229; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Liem Minh Phan, 2014, Cancer Biology Medicine, V11, P1, DOI 10.7497/j.issn.2095-3941.2014.01.001; Liu X, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.19; Lloyd KO, 2000, BBA-GEN SUBJECTS, V1474, P410, DOI 10.1016/S0304-4165(00)00037-4; Mehla K, 2014, BBA-REV CANCER, V1845, P126, DOI 10.1016/j.bbcan.2014.01.001; Meng M, 2010, CELL CYCLE, V9, P3921, DOI 10.4161/cc.9.19.13139; Pastrello C, 2005, DIS MARKERS, V21, P121, DOI 10.1155/2005/370908; Rakha EA, 2005, MODERN PATHOL, V18, P1295, DOI 10.1038/modpathol.3800445; Schroeder JA, 2003, ONCOGENE, V22, P1324, DOI 10.1038/sj.onc.1206291; Shukla SK, 2015, ONCOTARGET; Shukla SK, 2015, ONCOTARGET, V6, P19118, DOI 10.18632/oncotarget.4078; Shukla SK, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-18; Singh PK, 2007, CANCER RES, V67, P5201, DOI 10.1158/0008-5472.CAN-06-4647; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; SPICER AP, 1995, J BIOL CHEM, V270, P30093; Takano M, 2004, ONCOL REP, V12, P1177; Wei XL, 2005, CANCER CELL, V7, P167, DOI 10.1016/j.ccr.2005.01.008; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Yuan LQ, 2015, ENDOCR-RELAT CANCER, V22, P577, DOI 10.1530/ERC-15-0192; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60	39	20	21	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176820	10.1371/journal.pone.0176820	http://dx.doi.org/10.1371/journal.pone.0176820			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28464016	gold, Green Published, Green Submitted			2022-12-26	WOS:000400646300059
J	Lorenz, CS; Wicht, AJ; Guluzada, L; Luo, LL; Jager, L; Crone, B; Karst, U; Triebskorn, R; Liang, Y; Anwander, R; Haderlein, SB; Huhn, C; Kohler, HR				Lorenz, Carla S.; Wicht, Anna-J.; Guluzada, Leyla; Luo, Leilei; Jaeger, Leonie; Crone, Barbara; Karst, Uwe; Triebskorn, Rita; Liang, Yucang; Anwander, Reiner; Haderlein, Stefan B.; Huhn, Carolin; Koehler, Heinz-R.			Nano-sized Al2O3 reduces acute toxic effects of thiacloprid on the non-biting midge Chironomus riparius	PLOS ONE			English	Article							ENGINEERED NANOPARTICLES; MANUFACTURED NANOPARTICLES; DAPHNIA-MAGNA; BEHAVIOR; ENVIRONMENT; EXPOSURE; INVERTEBRATES; EXTRACTION; POLLUTANTS; CHEMISTRY	This study focuses on interactions between nanoparticles and a pesticide. The aim was to investigate how nano-sized aluminum oxide (410 nm) can alter the toxic effects of thiacloprid, even if no sorption between particles and the insecticide takes place. Thus, our study investigated a rather unexplored interaction. We conducted our research with larvae of Chironomus riparius and used thiacloprid as test substance as its toxicity to C. riparius is well described. The used nano-Al2O3 particles where chosen due to their suitable properties. For testing the acute effects of the interaction, we exposed larvae to thiacloprid (0.5, 1.0, 2.0, and 5.0 mu g/L) and nano-Al2O3 (300 and 1000 mg/L), either solely or in binary mixtures. While thiacloprid resulted in elevated mortality, nano-Al2O3 solely did not exert any effects. Moreover, we observed an aggregation of nano-Al2O3 within the lumen of the intestinal tract of the larvae. Further results showed a significantly reduced mortality of fourth instar larvae when they were exposed to mixtures of nanoparticles and the pesticide, compared to thiacloprid alone. With increasing nano-Al2O3 concentration, this effect became gradually stronger. Additionally, chemical analyses of internal thiacloprid concentrations implicate reduced uptake of thiacloprid in animals exposed to mixtures. However, as larvae exposed to thiacloprid concentrations > 0.5 mu g/L showed severe convulsions, independent of the presence or concentration of nano-Al2O3, we assume that nano-Al2O3 leads to a delay of mortality and does not entirely prevent it. As sorption measurements on pristine or defecated nano-Al2O3 did not reveal any sorptive interaction with thiacloprid, we can exclude sorption-based reduction of thiacloprid bioavailability as a mechanism behind our results. Even though we used test substances which might not co-occur in the environment in the tested concentrations, our study gives evidence for an interaction besides adsorption, which is important to generally understand how nanoparticles might affect biota.	[Lorenz, Carla S.; Jaeger, Leonie; Triebskorn, Rita; Koehler, Heinz-R.] Univ Tubingen, Inst Evolut & Ecol, Anim Physiol Ecol, Tubingen, Germany; [Wicht, Anna-J.; Huhn, Carolin] Univ Tubingen, Inst Phys & Theoret Chem, Tubingen, Germany; [Guluzada, Leyla; Haderlein, Stefan B.] Univ Tubingen, Ctr Appl Geosci Environm Mineral & Chem, Tubingen, Germany; [Luo, Leilei; Liang, Yucang; Anwander, Reiner] Univ Tubingen, Inst Inorgan Chem, Tubingen, Germany; [Crone, Barbara; Karst, Uwe] Univ Munster, Inst Inorgan & Analyt Chem, Munster, Germany; [Triebskorn, Rita] Steinbeis Transfer Ctr Ecotoxicol & Ecophysiol, Rottenburg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; University of Munster	Lorenz, CS (corresponding author), Univ Tubingen, Inst Evolut & Ecol, Anim Physiol Ecol, Tubingen, Germany.	lorenz.carla@web.de	Köhler, Heinz-R./AAL-1350-2021; Haderlein, Stefan B./GPT-3542-2022; Haderlein, Stefan B/D-1192-2012	Haderlein, Stefan B./0000-0002-9309-8523; Haderlein, Stefan B/0000-0002-9309-8523; Huhn, Carolin/0000-0001-6865-1043	Excellence Initiative of Eberhard Karls University Tubingen; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of University of Tubingen	Excellence Initiative of Eberhard Karls University Tubingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of University of Tubingen	The study is part of the intramural graduate program "EXPAND" and is funded by the Excellence Initiative of Eberhard Karls University Tubingen. We also acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiades M, 2003, J AOAC INT, V86, P412; Armitage P., 1995, THE CHIRONOMIDAE, VXII, P572, DOI 10.1007/978-94-011-0715-0; Azevedo-Pereira HMVS, 2011, ECOTOX ENVIRON SAFE, V74, P1210, DOI 10.1016/j.ecoenv.2011.03.018; Azevedo-Pereira HMVS, 2011, WATER AIR SOIL POLL, V219, P215, DOI 10.1007/s11270-010-0700-x; Baun A, 2008, AQUAT TOXICOL, V86, P379, DOI 10.1016/j.aquatox.2007.11.019; Berlioz-Barbier A, 2014, J CHROMATOGR A, V1367, P16, DOI 10.1016/j.chroma.2014.09.044; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Gorth DJ, 2011, INT J NANOMED, V6, P343, DOI 10.2147/IJN.S16881; Handy RD, 2008, ECOTOXICOLOGY, V17, P287, DOI 10.1007/s10646-008-0199-8; Hartland A., 2013, NAT ED KNOWL, V4, P7; Hirabayashi K, 1998, HYDROBIOLOGIA, V382, P151, DOI 10.1023/A:1003472329603; HOLM S, 1979, SCAND J STAT, V6, P65; Inostroza PA, 2016, ENVIRON POLLUT, V214, P77, DOI 10.1016/j.envpol.2016.03.064; Ispas C, 2009, ENVIRON SCI TECHNOL, V43, P6349, DOI 10.1021/es9010543; Ju-Nam Y, 2008, SCI TOTAL ENVIRON, V400, P396, DOI 10.1016/j.scitotenv.2008.06.042; Langer-Jaesrich M, 2010, ARCH ENVIRON CON TOX, V58, P963, DOI 10.1007/s00244-009-9420-x; Lead JR, 2006, ENVIRON CHEM, V3, P159, DOI 10.1071/EN06025; Li YX, 2012, J HAZARD MATER, V219, P221, DOI 10.1016/j.jhazmat.2012.03.083; Navarro E, 2008, ECOTOXICOLOGY, V17, P372, DOI 10.1007/s10646-008-0214-0; Nowack B, 2007, ENVIRON POLLUT, V150, P5, DOI 10.1016/j.envpol.2007.06.006; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Oberholster PJ, 2011, ECOTOX ENVIRON SAFE, V74, P416, DOI 10.1016/j.ecoenv.2010.12.012; OECD, 2004, 218 OECD; OECD, 2004, GUID TEST CHEM SECT, DOI [10.1787/20745761, DOI 10.1787/20745761]; Petersen EJ, 2009, ENVIRON SCI TECHNOL, V43, P2969, DOI 10.1021/es8029363; Roberts AP, 2007, ENVIRON SCI TECHNOL, V41, P3025, DOI 10.1021/es062572a; Roh HS, 2011, DALTON T, V40, P6901, DOI 10.1039/c1dt10418g; Schultz C, 2015, ECOTOXICOLOGY, V24, P239, DOI 10.1007/s10646-014-1387-3; Scown TM, 2010, CRIT REV TOXICOL, V40, P653, DOI 10.3109/10408444.2010.494174; Wagner S, 2014, ANGEW CHEM INT EDIT, V53, P12398, DOI 10.1002/anie.201405050; Wiesner MR, 2006, ENVIRON SCI TECHNOL, V40, P4336, DOI 10.1021/es062726m; Zhu XS, 2010, CHEMOSPHERE, V78, P209, DOI 10.1016/j.chemosphere.2009.11.013; Zhu XS, 2009, J NANOPART RES, V11, P67, DOI 10.1007/s11051-008-9426-8	33	4	4	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176356	10.1371/journal.pone.0176356	http://dx.doi.org/10.1371/journal.pone.0176356			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28464012	Green Published, gold, Green Submitted			2022-12-26	WOS:000400646300017
J	Yadav, S; Pandey, SK; Singh, VK; Goel, Y; Kumar, A; Singh, SM				Yadav, Saveg; Pandey, Shrish Kumar; Singh, Vinay Kumar; Goel, Yugal; Kumar, Ajay; Singh, Sukh Mahendra			Molecular docking studies of 3-bromopyruvate and its derivatives to metabolic regulatory enzymes: Implication in designing of novel anticancer therapeutic strategies	PLOS ONE			English	Article							ACTIVE-SITE; PROTEIN STRUCTURES; PROPIONIC-ACID; CANCER-THERAPY; INHIBITION; ALKYLATION; POWERFUL; RESIDUES; PATTERNS; BIOLOGY	Altered metabolism is an emerging hallmark of cancer, as malignant cells display a mammoth up-regulation of enzymes responsible for steering their bioenergetic and biosynthetic machinery. Thus, the recent anticancer therapeutic strategies focus on the targeting of metabolic enzymes, which has led to the identification of specific metabolic inhibitors. One of such inhibitors is 3-bromopyruvate (3-BP), with broad spectrum of anticancer activity due to its ability to inhibit multiple metabolic enzymes. However, the molecular characterization of its binding to the wide spectrum of target enzymes remains largely elusive. Therefore, in the present study we undertook in silico investigations to decipher the molecular nature of the docking of 3-BP with key target enzymes of glycolysis and TCA cycle by PatchDock and YASARA docking tools. Additionally, derivatives of 3-BP, dibromopyruvate (DBPA) and propionic acid (PA), with reported biological activity, were also investigated for docking to important target metabolic enzymes of 3-BP, in order to predict their therapeutic efficacy versus that of 3-BP. A comparison of the docking scores with respect to 3-BP indicated that both of these derivatives display a better binding strength to metabolic enzymes. Further, analysis of the drug likeness of 3-BP, DBPA and PA by Lipinski filter, admetSAR and FAF Drug3 indicated that all of these agents showed desirable drug-like criteria. The outcome of this investigation sheds light on the molecular characteristics of the binding of 3-BP and its derivatives with metabolic enzymes and thus may significantly contribute in designing and optimizing therapeutic strategies against cancer by using these agents.	[Yadav, Saveg; Pandey, Shrish Kumar; Goel, Yugal; Singh, Sukh Mahendra] Banaras Hindu Univ, Inst Sci, Sch Biotechnol, Varanasi, Uttar Pradesh, India; [Singh, Vinay Kumar] Banaras Hindu Univ, Inst Sci, Sch Biotechnol, Ctr Bioinformat, Varanasi, Uttar Pradesh, India; [Kumar, Ajay] Banaras Hindu Univ, Inst Sci, Dept Zool, Varanasi, Uttar Pradesh, India	Banaras Hindu University (BHU); Banaras Hindu University (BHU); Banaras Hindu University (BHU)	Singh, SM (corresponding author), Banaras Hindu Univ, Inst Sci, Sch Biotechnol, Varanasi, Uttar Pradesh, India.	sukhmahendrasingh@yahoo.com	Kumar, Ajay/AER-0947-2022; pandey, shrish kumar/AAC-8107-2021	Yadav, Saveg/0000-0001-8401-7894; Kumar, Ajay/0000-0002-6635-0586	CSIR, New Delhi [09/013(0577)/2015-EMRI]; ICMR, New Delhi [3/1/3/JRF-2015(2) HRD]; DBT, New Delhi; ISLS; UGC-UPE; Banaras Hindu University	CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); ICMR, New Delhi(Indian Council of Medical Research (ICMR)); DBT, New Delhi(Department of Biotechnology (DBT) India); ISLS; UGC-UPE(University Grants Commission, India); Banaras Hindu University	We thank fully acknowledge fellowship support to Saveg Yadav (Award No. 09/013(0577)/2015-EMR-I) from CSIR, New Delhi, and Shrish Kumar Pandey (Award No. 3/1/3/JRF-2015(2) HRD) from ICMR, New Delhi. Funding from DBT, New Delhi, ISLS and UGC-UPE, Banaras Hindu University is acknowledged.	Acan NL, 2001, J ENZYM INHIB, V16, P457, DOI 10.1080/14756360109162395; Al-Lahham SH, 2010, BBA-MOL CELL BIOL L, V1801, P1175, DOI 10.1016/j.bbalip.2010.07.007; Azevedo-Silva J, 2016, J BIOENERG BIOMEMBR, V48, P349, DOI 10.1007/s10863-016-9670-z; Berjanskii M, 2012, J BIOMOL NMR, V53, P167, DOI 10.1007/s10858-012-9637-2; Cardaci S, 2012, CANCER RES, V72, P4526, DOI 10.1158/0008-5472.CAN-12-1741; Chelliah V, 2006, J MOL BIOL, V357, P1669, DOI 10.1016/j.jmb.2006.01.001; Cheng FX, 2012, J CHEM INF MODEL, V52, P3099, DOI 10.1021/ci300367a; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Dang CV, 2011, J MOL MED, V89, P205, DOI 10.1007/s00109-011-0730-x; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Elipilla P., 2015, EUR J BIOTECHNOL BIO, V3, P27; Fukuda M, 2013, SIMULATION STUDY PRO; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HEINRIKSON RL, 1966, J BIOL CHEM, V241, P1393; Housman G, 2014, CANCERS, V6, P1769, DOI 10.3390/cancers6031769; Huang BD, 2009, OMICS, V13, P325, DOI 10.1089/omi.2009.0045; Jardim-Messeder D, 2016, ANTICANCER RES, V36, P2233; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Kuntal Bhusan K, 2010, BMC Res Notes, V3, P226, DOI 10.1186/1756-0500-3-226; Lagorce D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-396; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007; Lis P., 2016, MOL BASEL SWITZ, V21; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MacFabe DF, 2007, BEHAV BRAIN RES, V176, P149, DOI 10.1016/j.bbr.2006.07.025; MARTIN WR, 1958, J PHARMACOL EXP THER, V124, P64; Oronsky BT, 2012, TRANSL ONCOL, V5, P226, DOI 10.1593/tlo.12187; Paiardini A, 2016, BBA-PROTEINS PROTEOM, V1864, P1506, DOI 10.1016/j.bbapap.2016.08.010; Pedersen PL, 2012, J BIOENERG BIOMEMBR, V44, P1, DOI 10.1007/s10863-012-9425-4; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Petrelli A, 2008, CURR MED CHEM, V15, P422; Schmidt T, 2014, DRUG DISCOV TODAY, V19, P890, DOI 10.1016/j.drudis.2013.10.027; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Shoshan MC, 2012, J BIOENERG BIOMEMBR, V44, P7, DOI 10.1007/s10863-012-9419-2; Smith BR, 2011, United States Patent, Patent No. 8026278; Suda K, 2014, PROG TUMOR RES, V41, P62, DOI 10.1159/000355902; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; VLAHOS CJ, 1990, J BIOL CHEM, V265, P20384; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Xiang ZX, 2006, CURR PROTEIN PEPT SC, V7, P217, DOI 10.2174/138920306777452312; Zhao HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019923	44	36	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176403	10.1371/journal.pone.0176403	http://dx.doi.org/10.1371/journal.pone.0176403			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28463978	Green Published, gold, Green Submitted			2022-12-26	WOS:000400646300019
J	Moeller, J; Farmer, J; Quinonez, C				Moeller, Jamie; Farmer, Julie; Quinonez, Carlos			Patterns of analgesic use to relieve tooth pain among residents in British Columbia, Canada	PLOS ONE			English	Article							ORAL-HEALTH; SOCIOECONOMIC-STATUS; DENTAL-CARE; CHRONIC DISEASES; DECISION-MAKING; INEQUALITIES; PATIENT; PREVALENCE; PREDICTORS; MAGNITUDE	The use of prescription opioids has increased dramatically in Canada in recent decades. This rise in opioid prescriptions has been accompanied by increasing rates of opioid-related abuse and addiction, creating serious public health challenges in British Columbia (BC), one of Canada's most populated provinces. Our study explores the relationship between dental pain and prescription opioid use among residents in BC. We used data from the 2003 Canadian Community Health Survey (CCHS), which asked respondents about their use of specific analgesic medications, including opioids, and their history of tooth pain in the past month. We used logistic regression, controlling for potential confounding variables, to identify the predictive value of socioeconomic factors, oral health-related variables, and dental care utilization indicators. The Relative Index of Inequality (RII) was calculated to assess the magnitude of socioeconomic inequalities in the use of particular analgesics by incorporating income-derived ridit values into a binary logistic regression model. Our results showed that conventional non-opioid based analgesics (such as aspirin or Tylenol) and opioids were more likely to be used by those who had experienced a toothache in the past month than those who did not report experiencing a toothache. The use of non-opioid painkillers to relieve tooth pain was associated with more recent and more frequent dental visits, better self-reported oral health, and a greater income. Conversely, a lower household income was associated with a preference for opioid use to relieve tooth pain. The RII for recent opioid use and conventional painkiller use were 2.06 (95% CI: 1.75-2.37) and 0.62 (95% CI: 0.35-0.91), respectively, among those who experienced recent tooth pain, suggesting that adverse socioeconomic conditions may influence the need for opioid analgesics to relieve dental pain. We conclude that programs and policies targeted at improving the dental health of the poor may help to reduce the use of prescription opioids, thereby narrowing health inequalities within the broader society.	[Moeller, Jamie; Farmer, Julie; Quinonez, Carlos] Univ Toronto, Fac Dent, Discipline Dent Publ Hlth, Toronto, ON, Canada	University of Toronto	Moeller, J (corresponding author), Univ Toronto, Fac Dent, Discipline Dent Publ Hlth, Toronto, ON, Canada.	jamie.moeller@mail.utoronto.ca	Farmer, Julie/AAJ-8013-2021	Farmer, Julie/0000-0001-5361-2180	Canadian Institutes for Health Research [362473]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This project was funded by the Canadian Institutes for Health Research (Application No. 362473). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ballantyne JC, 2012, J MED TOXICOL, V8, P417, DOI 10.1007/s13181-012-0257-8; Bhatti T, 2007, J CAN DENT ASSOC, V73, P57; Blair YI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058593; BROSS IDJ, 1958, BIOMETRICS, V14, P18, DOI 10.2307/2527727; Burt BA, 2005, COMMUNITY DENT ORAL, V33, P240, DOI 10.1111/j.1600-0528.2005.00231.x; Burt BA., 1999, DENT DENT PRACTICE C; Buttar R., 2014, THESIS; Centers for Disease and Prevention, 2011, MMWR-MORBID MORTAL W, V60, P1487; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Cirone S, 2014, CAN J ADDICT, V5, P14; Compton WM, 2015, PREV MED, V80, P5, DOI 10.1016/j.ypmed.2015.04.003; Dhalla IA, 2009, CAN MED ASSOC J, V181, P891, DOI 10.1503/cmaj.090784; Eachus J, 1999, J EPIDEMIOL COMMUN H, V53, P603, DOI 10.1136/jech.53.10.603; Fields HL, 2011, NEURON, V69, P591, DOI 10.1016/j.neuron.2011.02.001; Fischer B, 2016, SUBST ABUSE TREAT PR, V11, DOI 10.1186/s13011-016-0055-4; Fischer B, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-90; Fuentes M, 2007, J NATL MED ASSOC, V99, P1160; Furlan AD, 2006, CMAJ, V174, P1489; Gerstman BB, 2008, BASIC BIOSTATISTICS; Goldberg DS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-770; Grossschadl F, 2016, WIEN KLIN WOCHENSCHR, V128, P6, DOI 10.1007/s00508-015-0857-9; Guadagnoli-Closs MS, 2013, INTERDISCIPLINARY, V5, P1; Guarnizo-Herreno CC, 2013, J EPIDEMIOL COMMUN H, V67, P728, DOI 10.1136/jech-2013-202714; Haas Daniel A, 2002, J Can Dent Assoc, V68, P476; Harel Zeev, 2006, J Pediatr Adolesc Gynecol, V19, P363, DOI 10.1016/j.jpag.2006.09.001; Howlett K., 2016, GLOBE MAIL; Hunter Justine, 2017, GLOBE MAIL; Jones AM, 2014, SOCIOECONOMIC INEQUA; Kalso E, 2004, PAIN, V112, P372, DOI 10.1016/j.pain.2004.09.019; Kikano GE, 1996, ARCH FAM MED, V5, P267, DOI 10.1001/archfami.5.5.267; Kolodny A, 2015, ANNU REV PUBL HEALTH, V36, P559, DOI 10.1146/annurev-publhealth-031914-122957; LIPTON JA, 1993, J AM DENT ASSOC, V124, P115, DOI 10.14219/jada.archive.1993.0200; Locker D, 2000, COMMUNITY DENT ORAL, V28, P161, DOI 10.1034/j.1600-0528.2000.280301.x; Locker D, 2009, J PUBLIC HEALTH DENT, V69, P1, DOI 10.1111/j.1752-7325.2008.00087.x; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Madadi P, PLOS ONE, V8, P1; Matthew Riggan, 2012, REASON RIGOR CONCEPT; Michael G., 2017, 2017 DRAFT RECEOMMEN; Mielck A, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-58; Moulin Dwight E, 2002, Pain Res Manag, V7, P179; Muirhead VE, 2009, COMMUNITY DENT ORAL, V37, P199, DOI 10.1111/j.1600-0528.2009.00471.x; O'Driscoll PT, 2001, AM J PUBLIC HEALTH, V91, P984, DOI 10.2105/AJPH.91.6.984; Origer A, 2015, EUR PSYCHIAT, V30, pS28; Origer A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125568; Origer A, 2014, INT J DRUG POLICY, V25, P911, DOI 10.1016/j.drugpo.2014.05.015; Orueta JF, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-870; Palos GR, 2004, J PAIN SYMPTOM MANAG, V28, P460, DOI 10.1016/j.jpainsymman.2004.02.016; Pasternak GW, 2011, RECEPT SER, P1, DOI 10.1007/978-1-60761-993-2; Paulozzi LJ, 2012, CTR DIS CONTROL PREV, V63, P563; Penny KI, 1999, PAIN, V79, P275, DOI 10.1016/S0304-3959(98)00166-3; PINCUS T, 1987, J CHRON DIS, V40, P865, DOI 10.1016/0021-9681(87)90186-X; Ravaghi V, 2013, J CAN DENT ASSOC, V79, P1; Ravaghi V, 2013, CAN J PUBLIC HEALTH, V104, pE466, DOI 10.17269/cjph.104.3983; Ravaghi V, 2013, COMMUNITY DENT ORAL, V41, P490, DOI 10.1111/cdoe.12043; Robertson G, 2016, GLOBE MAIL; Sagan A., 2015, CBC NEWS; Scott A, 1996, SOC SCI MED, V42, P35, DOI 10.1016/0277-9536(95)00063-1; Seddon T, 2000, J SOC POLICY, V29, P95, DOI 10.1017/S0047279400005833; Smolina K, 2016, PHARMACOEPIDEM DR S, V25, P553, DOI 10.1002/pds.3989; Sproule B, 2009, CAN FAM PHYSICIAN, V55, P68; Statistics Canada, 2005, 2003 CAN COMM HLTH S; Sullivan MD, 2013, PAIN, V154, pS94, DOI 10.1016/j.pain.2013.09.009; Teater D., 2015, EVIDENCE EFFICACY PA; The Canadian Press, 2016, BC 1 CAN DECL PUBL H; Thompson B, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-78; Torralba L, 1996, ADDICTION, V91, P419, DOI 10.1111/j.1360-0443.1996.tb02291.x; U. S. Department of Health and Human Services, 2014, ADDR PRESCR DRUG AB; United States Institute of Medicine, 2011, REL PAIN AM BLUEPR T; Vargas CM, 2000, PAIN, V85, P87, DOI 10.1016/S0304-3959(99)00250-X; Volkow ND, 2014, NEW ENGL J MED, V370, P2063, DOI 10.1056/NEJMp1402780; Vukovic D, 2008, CROAT MED J, V49, P832, DOI 10.3325/cmj.2008.49.832; Wall R, 2000, J URBAN HEALTH, V77, P688, DOI 10.1007/BF02344032; Watt RG, 2007, COMMUNITY DENT ORAL, V35, P1, DOI 10.1111/j.1600-0528.2007.00348.x; Weeks C., 2016, GLOBE MAIL; White AP, 2011, SPINE, V36, pS131, DOI 10.1097/BRS.0b013e31822f178f; Willems S, 2005, PATIENT EDUC COUNS, V56, P139, DOI 10.1016/j.pec.2004.02.011; Williams MV, 2002, FAM MED, V34, P383; Woo A., 2016, GLOBE MAIL; Zhang W, 2004, ANN RHEUM DIS, V63, P901, DOI 10.1136/ard.2003.018531	80	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176125	10.1371/journal.pone.0176125	http://dx.doi.org/10.1371/journal.pone.0176125			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9RJ	28459825	Green Published, gold, Green Submitted			2022-12-26	WOS:000400645000015
J	Bickelhaupt, S; Steudle, F; Paech, D; Mlynarska, A; Kuder, TA; Lederer, W; Daniel, H; Freitag, M; Delorme, S; Schlemmer, HP; Laun, FB				Bickelhaupt, Sebastian; Steudle, Franziska; Paech, Daniel; Mlynarska, Anna; Kuder, Tristan Anselm; Lederer, Wolfgang; Daniel, Heidi; Freitag, Martin; Delorme, Stefan; Schlemmer, Heinz-Peter; Laun, Frederik Bernd			On a fractional order calculus model in diffusion weighted breast imaging to differentiate between malignant and benign breast lesions detected on X-ray screening mammography	PLOS ONE			English	Article							INTRAVOXEL INCOHERENT MOTION; ANOMALOUS DIFFUSION; GLOBUS-PALLIDUS; DENTATE NUCLEUS; T2-WEIGHTED TSE; MRI; CHALLENGES; INTENSITY; IMAGES; SIGNAL	Objective To evaluate a fractional order calculus (FROC) model in diffusion weighted imaging to differentiate between malignant and benign breast lesions in breast cancer screening work-up using recently introduced parameters (a FROC, DFROC and ae FROC). Materials and methods This retrospective analysis within a prospective IRB-approved study included 51 participants (mean 58.4 years) after written informed consent. All patients had suspicious screening mammograms and indication for biopsy. Prior to biopsy, full diagnostic contrastenhanced MRI examination was acquired including diffusion-weighted-imaging (DWI, b = 0,100,750,1500 s/mm(2)). Conventional apparent diffusion coefficient D-app and FROC parameters (beta(FROC), D-FROC and mu(FROC)) as suggested further indicators of diffusivity components were measured in benign and malignant lesions. Receiver operating characteristics (ROC) were calculated to evaluate the diagnostic performance of the parameters. Results 29/51 patients histopathologically revealed malignant lesions. The analysis revealed an AUC for Dapp of 0.89 (95% CI 0.80 - 0.98). For FROC derived parameters, AUC was 0.75 (0.60 -0.89) for DFROC, 0.59 (0.43 - 0.75) for alpha FROC and 0.59 (0.42 - 0.77) for mu(FROC). Comparison of the AUC curves revealed a significantly higher AUC of Dapp compared to the FROC parameters D-FROC (p = 0.009), beta(FROC) (p = 0.003) and mu(FROC) (p = 0.001). Conclusion In contrast to recent description in brain tumors, the apparent diffusion coefficient D-app showed a significantly higher AUC than the recently proposed FROC parameters beta(FROC), D-FROC and mu(FROC) for differentiating between malignant and benign breast lesions. This might be related to the intrinsic high heterogeneity within breast tissue or to the lower maximal b-value used in our study.	[Bickelhaupt, Sebastian; Steudle, Franziska; Paech, Daniel; Freitag, Martin; Delorme, Stefan; Schlemmer, Heinz-Peter] German Canc Res Ctr, Dept Radiol, Neuenheimer Feld 280, Heidelberg, Germany; [Mlynarska, Anna; Kuder, Tristan Anselm; Laun, Frederik Bernd] German Canc Res Ctr, Med Phys Radiol, Neuenheimer Feld 280, Heidelberg, Germany; [Lederer, Wolfgang] ATOS Clin Heidelberg, Radiol Clin, Bismarckpl 9-15, Heidelberg, Germany; [Daniel, Heidi] Radiol Ctr Mannheim RZM, Rosengartenpl 7, Mannheim, Germany; [Laun, Frederik Bernd] Univ Hosp Erlangen, Dept Radiol, Maximilianspl 3, Erlangen, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Erlangen Nuremberg	Bickelhaupt, S (corresponding author), German Canc Res Ctr, Dept Radiol, Neuenheimer Feld 280, Heidelberg, Germany.	S.Bickelhaupt@dkfz.de	Kuder, Tristan Anselm/AAF-2136-2019; Delorme, Stefan/AAM-7271-2021; Laun, Frederik Bernd/O-4810-2016	Kuder, Tristan Anselm/0000-0001-6439-8124; Delorme, Stefan/0000-0002-1000-2582; Laun, Frederik Bernd/0000-0002-9269-5609; Paech, Daniel/0000-0001-5755-6833	Dietmar Hopp Foundation	Dietmar Hopp Foundation	We thank the Dietmar Hopp Foundation for supporting this research.	Ahlgren A, 2016, NMR BIOMED, V29, P640, DOI 10.1002/nbm.3505; Alcusky M, 2014, J WOMENS HEALTH, V23; Baltzer PAT, 2010, EUR RADIOL, V20, P1101, DOI 10.1007/s00330-009-1654-5; Berlin CMgKM, 2014, RES MAMM SCREEN PROG; Bickelhaupt S., 2017, J MAGN RESON IMAGING; Bickelhaupt S, 2015, RADIOLOGY; Bickelhaupt S, 2016, EUR RADIOL; Bickelhaupt S, 2016, RADIOLOGY, V278, P689, DOI 10.1148/radiol.2015150425; Bock K, 2014, RADIOLOGE, V54, P205, DOI 10.1007/s00117-013-2581-7; Freitag MT, 2016, RADIOLOGE, V56, P137, DOI 10.1007/s00117-015-0066-6; Hering J, 2015, J COMPUTED ASS UNPUB; Iima M, 2015, INVEST RADIOL, V50, P205, DOI 10.1097/RLI.0000000000000094; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Kanda T, 2014, RADIOLOGY, V270, P834, DOI 10.1148/radiol.13131669; Koh DM, 2011, AM J ROENTGENOL, V196, P1351, DOI 10.2214/AJR.10.5515; Kuhl CK, 2014, J CLIN ONCOL, V32, P2304, DOI 10.1200/JCO.2013.52.5386; Kuhl Christiane K, 2006, Magn Reson Imaging Clin N Am, V14, P391, DOI 10.1016/j.mric.2006.07.003; Kul S, 2015, DIAGN INTERV RADIOL, V21, P287, DOI 10.5152/dir.2014.14333; Lauby-Secretan B, 2015, NEW ENGL J MED, V372, P2353, DOI 10.1056/NEJMsr1504363; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Lemke A, 2010, MAGN RESON MED, V64, P1580, DOI 10.1002/mrm.22565; Magin RL, 2008, J MAGN RESON, V190, P255, DOI 10.1016/j.jmr.2007.11.007; Magin RL, 2013, MICROPOR MESOPOR MAT, V178, P39, DOI 10.1016/j.micromeso.2013.02.054; Martelotto LG, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3658; Partridge SC, 2010, J MAGN RESON IMAGING, V31, P562, DOI 10.1002/jmri.22078; Pfeuffer J, 1999, MAGN RESON MATER PHY, V8, P98; Radbruch A, 2015, RADIOLOGY, V275, P783, DOI 10.1148/radiol.2015150337; Smith RA, 2012, ONCOLOGY-NY, V26, P471; Sui Y, 2016, AJNR AM J NEURORADIO; Sui Y, 2015, RADIOLOGY, V277, P489, DOI 10.1148/radiol.2015142156; Sun K, 2015, RADIOLOGY; Telegrafo M, 2015, MAGN RESON IMAGING, V33, P951, DOI 10.1016/j.mri.2015.06.002; Thomassin-Naggara I, 2013, EUR J RADIOL, V82, P435, DOI 10.1016/j.ejrad.2012.03.002; Wan CWS, 2016, CLIN RADIOL, V71, P170, DOI 10.1016/j.crad.2015.11.006; Wenkel E, 2014, RADIOLOGE, V54, P224, DOI 10.1007/s00117-013-2588-0; Wetscherek A, 2015, MAGN RESON MED, V74, P410, DOI 10.1002/mrm.25410; Wu DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113240; Yablonskiy DA, 2003, MAGNET RESON MED, V50, P664, DOI 10.1002/mrm.10578; Yabuuchi H, 2011, EUR RADIOL, V21, P11, DOI 10.1007/s00330-010-1890-8; Zhou XJ, 2010, MAGN RESON MED, V63, P562, DOI 10.1002/mrm.22285	40	17	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176077	10.1371/journal.pone.0176077	http://dx.doi.org/10.1371/journal.pone.0176077			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453516	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383900011
J	Deneka, AY; Haber, L; Kopp, MC; Gaponova, AV; Nikonova, AS; Golemis, EA				Deneka, Alexander Y.; Haber, Leora; Kopp, Meghan C.; Gaponova, Anna V.; Nikonova, Anna S.; Golemis, Erica A.			Tumor-targeted SN38 inhibits growth of early stage non-small cell lung cancer (NSCLC) in a KRas/p53 transgenic mouse model	PLOS ONE			English	Article							GENE COPY NUMBER; PROTEIN EXPRESSION; P53; CONJUGATE; INDUCTION; PROGNOSIS; CARCINOMA; DELIVERY; AFFINITY; ANTIGEN	Non-small cell lung cancer(NSCLC) is the leading cause of cancer death worldwide, with a 5-year survival of only similar to 16%. Potential strategies to address NSCLC mortality include improvements in early detection and prevention, and development of new therapies suitable for use in patients with early and late stage diagnoses. Controlling the growth of early stage tumors could yield significant clinical benefits for patients with comorbidities that make them poor candidates for surgery: however, many drugs that limit cancer growth are not useful in the setting of long-term use or in comorbid patients, because of associated toxicities. In this study, we explored the use of a recently described small molecule agent, STA-8666, as a potential agent for controlling early stage tumor growth. STA-8666 uses a cleavable linker to merge a tumor-targeting moiety that binds heat shock protein 90(HSP90) with the cytotoxic chemical SN38, and has been shown to have high efficacy and low toxicity, associated with efficient tumor targeting, in preclinical studies using patient-derived and other xenograft models for pancreatic, bladder, and small cell lung cancer. Using a genetically engineered model of NSCLC arising from induced mutation of KRas and knockout of Trp53, we continuously dosed mice with STA-8666 from immediately after tumor induction for 15 weeks. STA-8666 significantly slowed the rate of tumor growth, and was well tolerated over this extended dosing period. STA-8666 induced DNA damage and apoptosis, and reduced proliferation and phosphorylation of the proliferation-associated protein ERK1/2, selectively in tumor tissue. In contrast, STA-8666 did not affect tumor features, such as degree of vimentin staining, associated with epithelial-mesenchymal transition( EMT), or downregulate tumor expression of HSP90. These data suggest STA-8666 and other similar targeted compounds may be useful additions to control the growth of early stage NSCLC in patient populations.	[Deneka, Alexander Y.; Haber, Leora; Kopp, Meghan C.; Nikonova, Anna S.; Golemis, Erica A.] Fox Chase Canc Ctr, Program Mol Therapeut, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Deneka, Alexander Y.] Kazan Fed Univ, Dept Biochem, Kazan, Russia; [Kopp, Meghan C.] Drexel Univ, Coll Med, Program Mol & Cell Biol & Genet, Philadelphia, PA 19104 USA; [Gaponova, Anna V.] Moscow Inst Phys & Technol, Lab Genome Engn, Dolgoprudnyi, Russia; [Gaponova, Anna V.] Immanuel Kant Balt Fed Univ, Konigsberg, Russia	Fox Chase Cancer Center; Kazan Federal University; Drexel University; Moscow Institute of Physics & Technology; Immanuel Kant Baltic Federal University	Deneka, AY; Golemis, EA (corresponding author), Fox Chase Canc Ctr, Program Mol Therapeut, 7701 Burholme Ave, Philadelphia, PA 19111 USA.; Deneka, AY (corresponding author), Kazan Fed Univ, Dept Biochem, Kazan, Russia.	Alexander.Deneka@fccc.edu; Erica.Golemis@fccc.edu	Deneka, Alexander/AAE-9202-2020; Deneka, Alexander/Q-7273-2017	Deneka, Alexander/0000-0003-2448-5156; Golemis, Erica/0000-0003-3618-3673	NIH [CM 81287]; American Hellenic Educational Progressive Association (AHEPA); Russian Government Program for Competitive Growth of Kazan Federal University; NCI Cancer Center Core Grant [CA006927]; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Hellenic Educational Progressive Association (AHEPA); Russian Government Program for Competitive Growth of Kazan Federal University; NCI Cancer Center Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank David Proia and Synta Pharmaceuticals for providing STA-8666 for this study. The authors were supported by NIH CM 81287, and an award from the American Hellenic Educational Progressive Association (AHEPA) (to EAG); by the Russian Government Program for Competitive Growth of Kazan Federal University (to AD); and by NCI Cancer Center Core Grant CA006927 (to Fox Chase Cancer Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck TN, 2016, CELL REP, V16, P657, DOI 10.1016/j.celrep.2016.06.043; Bhonde MR, 2006, ONCOGENE, V25, P165, DOI 10.1038/sj.onc.1209017; Bobrov E, 2017, ONCOTARGET, V8, P4399, DOI 10.18632/oncotarget.12642; Broutin S, 2016, BRIT J CANCER, V115, P549, DOI 10.1038/bjc.2016.220; Fasbender A, 1998, J CLIN INVEST, V102, P184, DOI 10.1172/JCI2732; Gaponova AV, 2016, CLIN CANC RES; Garcia-Campelo R, 2015, CLIN TRANSL ONCOL, V17, P1020, DOI 10.1007/s12094-015-1455-z; Girones R, 2012, CLIN TRANSL ONCOL, V14, P183, DOI 10.1007/s12094-012-0782-6; Harrington HA, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-26; Heske CM, 2016, ONCOTARGET, V7, P65540, DOI 10.18632/oncotarget.11869; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Howlader N, 2015, SEER CANC STAT REV 1; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; John T, 2009, ONCOGENE, V28, pS14, DOI 10.1038/onc.2009.197; Lavelle F, 1996, SEMIN ONCOL, V23, P11; Liu SL, 2016, SCI REP-UK, V6, DOI 10.1038/srep38834; Marino S, 2000, GENE DEV, V14, P994; McDonald AC, 1998, BRIT J CANCER, V78, P745, DOI 10.1038/bjc.1998.571; Meuwissen R, 2005, GENE DEV, V19, P643, DOI 10.1101/gad.1284505; MITSUDOMI T, 1991, ONCOGENE, V6, P1353; Nikonova AS, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00228; Proia DA, 2015, MOL CANCER THER, V14, P2422, DOI 10.1158/1535-7163.MCT-15-0455; Rasband W., 2006, IMAGEJ; Reichardt W, 2009, MAGN RESON MATER PHY, V22, P143, DOI 10.1007/s10334-008-0158-7; Rudnick SI, 2011, CANCER RES, V71, P2250, DOI 10.1158/0008-5472.CAN-10-2277; Saba NF, 2016, ASS CYTOPLASMIC CXCR; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Solit DB, 2008, DRUG DISCOV TODAY, V13, P38, DOI 10.1016/j.drudis.2007.10.007; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; Tang Y, 2007, J IMMUNOL, V179, P2815, DOI 10.4049/jimmunol.179.5.2815; Tomicic MT, 2013, BBA-REV CANCER, V1835, P11, DOI 10.1016/j.bbcan.2012.09.002; Vijayvergia N, 2015, J NATL COMPR CANC NE, V13, P1151, DOI 10.6004/jnccn.2015.0140; White D, 2012, MOL CANCER RES, V10, P401, DOI 10.1158/1541-7786.MCR-11-0134; Workman P, 2004, CANCER LETT, V206, P149, DOI 10.1016/j.canlet.2003.08.032	34	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176747	10.1371/journal.pone.0176747	http://dx.doi.org/10.1371/journal.pone.0176747			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453558	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383900051
J	Zhang, S; Xiao, QY; Shi, ZQ; Yu, GP; Ma, XP; Chen, HT; Zhang, PY; Shen, SQ; Sai-Yin, HXG; Chen, TY; Lu, PX; Wang, NJ; Ren, WH; Huang, P; Xie, J; Conran, C; Zheng, SL; Yu, L; Xu, JF; Jiang, DK				Zhang, Song; Xiao, Qianyi; Shi, Zhuqing; Yu, Guopeng; Ma, Xiao-Pin; Chen, Haitao; Zhang, Pengyin; Shen, Suqin; Sai-Yin, He-Xi Ge; Chen, Tao-Yang; Lu, Pei-Xin; Wang, Neng-Jin; Ren, Weihua; Huang, Peng; Xie, Jun; Conran, Carly; Zheng, S. Lilly; Yu, Long; Xu, Jianfeng; Jiang, De-Ke			Caspase polymorphisms and prognosis of hepatocellular carcinoma	PLOS ONE			English	Article							PROMOTER POLYMORPHISMS; LUNG-CANCER; GENETIC POLYMORPHISMS; BREAST-CANCER; RISK; SUSCEPTIBILITY; ASSOCIATION; APOPTOSIS; EXPRESSION	The aim of our study was to determine the impact of genetic polymorphisms in the caspase (CASP) genes on prognosis of hepatocellular carcinoma (HCC). We genotyped 7 potentially functional polymorphisms in CASP3, CASP7, CASP8, CASP9, CASP10 genes in 362 HCC patients of receiving surgical resection of HCC tumor. The associations of genotype and haplotype with overall survival (OS) and disease free survival (DFS) were analyzed by using the Cox proportional hazards model. We found that the CASP9 rs4645981 C allele was significantly associated with positive effect on DFS (P = 0.011 and 0.016 for CT+ CC vs. TT in univariate and multivariate analysis, respectively), CT genotype was associated with a better OS of HCC than the TT genotype both in univariate and multivariate analysis (P = 0.048 and 0.041, respectively). Moreover, the CASP3 rs2705897 GT genotype showed marginally significant association with decreased OS and DFS, compared with the GG genotype. One haplotype TT/TG in CASP3 (constructed by rs12108497 T>C and rs2705897 T>G) was significantly associated with decreased OS and DFS, compared to the common haplotype TT/ TT both in univariate analysis (P = 0.021 and 0.026, respectively) and multivariate analysis (P = 0.025 and 0.030, respectively). The haplotype GT/GT in CASP9 (constructed by rs4645978 A>G and rs4645981 C>T) was significantly associated with decreased DFS both in univariate and multivariate analysis (P = 0.012 and 0.010, respectively). In conclusion, the CASP9 rs4645981 polymorphism, CASP3 and CASP9 haplotypes may be useful prognosis markers for HCC patients with surgical resection of tumor.	[Zhang, Song; Shi, Zhuqing; Ma, Xiao-Pin; Zhang, Pengyin; Shen, Suqin; Sai-Yin, He-Xi Ge; Xie, Jun; Yu, Long; Xu, Jianfeng; Jiang, De-Ke] Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Sch Life Sci, State Key Lab Genet Engn, Shanghai, Peoples R China; [Zhang, Song; Shi, Zhuqing; Zhang, Pengyin; Xu, Jianfeng; Jiang, De-Ke] Fudan Univ, Sch Life Sci, Key Lab Contemporary Anthropol, Minist Educ, Shanghai, Peoples R China; [Zhang, Song; Shi, Zhuqing; Zhang, Pengyin; Xu, Jianfeng; Jiang, De-Ke] Fudan Univ, Sch Life Sci, Ctr Genet Epidemiol, Shanghai, Peoples R China; [Xiao, Qianyi; Chen, Haitao; Zhang, Pengyin; Xu, Jianfeng; Jiang, De-Ke] Fudan Univ, Sch Publ Hlth, Ctr Genet Translat Med & Prevent, Shanghai, Peoples R China; [Yu, Guopeng] Shanghai Jiao Tong Univ, Peoples Hosp Shanghai 9, Sch Med, Dept Urol, Shanghai, Peoples R China; [Chen, Tao-Yang; Lu, Pei-Xin; Wang, Neng-Jin] Qidong Peoples Hosp, Qidong Liver Canc Inst, Qidong, Jiangsu, Peoples R China; [Ren, Weihua] Zhengzhou Univ, Luoyang Cent Hosp, Cent Lab, Luoyang, Herts, Peoples R China; [Huang, Peng; Xu, Jianfeng] Shanghai Univ Med & Hlth Sci, Coll Basic Med, Shanghai, Peoples R China; [Conran, Carly; Zheng, S. Lilly] Univ Chicago, NorthShore Univ HealthSystem, Pritzker Sch Med, Program Personalized Canc Care, Evanston, IL USA; [Xu, Jianfeng] Fudan Univ, Huashan Hosp, Fudan Inst Urol, Shanghai, Peoples R China; [Jiang, De-Ke] Southern Med Univ, Nanfang Hosp, Dept Infect Dis, State Key Lab Organ Failure Res,Guangdong Key Lab, Guangzhou, Guangdong, Peoples R China; [Jiang, De-Ke] Southern Med Univ, Nanfang Hosp, Hepatol Unit, Guangzhou, Guangdong, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Shanghai Jiao Tong University; Zhengzhou University; Shanghai University of Medicine & Health Sciences; NorthShore University Health System; University of Chicago; Fudan University; Southern Medical University - China; Southern Medical University - China	Jiang, DK (corresponding author), Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Sch Life Sci, State Key Lab Genet Engn, Shanghai, Peoples R China.; Jiang, DK (corresponding author), Fudan Univ, Sch Life Sci, Key Lab Contemporary Anthropol, Minist Educ, Shanghai, Peoples R China.; Jiang, DK (corresponding author), Fudan Univ, Sch Life Sci, Ctr Genet Epidemiol, Shanghai, Peoples R China.; Jiang, DK (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Infect Dis, State Key Lab Organ Failure Res,Guangdong Key Lab, Guangzhou, Guangdong, Peoples R China.; Jiang, DK (corresponding author), Southern Med Univ, Nanfang Hosp, Hepatol Unit, Guangzhou, Guangdong, Peoples R China.	dekejiang@gmail.com	Shi, Zhuqing/D-5876-2019	Shi, Zhuqing/0000-0001-6321-950X	National Natural Science Foundation of China [31100895/81472618/81670535]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was funded by the National Natural Science Foundation of China (Grant # 31100895/81472618/81670535) to De-Ke Jiang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cho S, 2010, PATHOL INT, V60, P203, DOI 10.1111/j.1440-1827.2009.02507.x; Cingeetham A, 2014, TUMOR BIOL, V35, P8813, DOI 10.1007/s13277-014-2096-5; Dabrowska C, 2016, ADV EXP MED BIOL, V930, P89, DOI 10.1007/978-3-319-39406-0_4; Deng BY, 2016, TUMOR BIOL, V37, P8985, DOI 10.1007/s13277-015-4779-y; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Frank B, 2006, CARCINOGENESIS, V27, P606, DOI 10.1093/carcin/bgi248; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Huang H, 2010, CANCER SCI, V101, P1314, DOI 10.1111/j.1349-7006.2010.01524.x; Jang JS, 2008, MOL CARCINOGEN, V47, P383, DOI 10.1002/mc.20397; Lin J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164358; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Park JY, 2006, HUM MOL GENET, V15, P1963, DOI 10.1093/hmg/ddl119; Persad R, 2004, MODERN PATHOL, V17, P861, DOI 10.1038/modpathol.3800146; Pu X, 2016, APOPTOSIS; Raff M, 1998, NATURE, V396, P119, DOI 10.1038/24055; Shivapurkar N, 2003, J CELL BIOCHEM, V88, P885, DOI 10.1002/jcb.10440; Singhal A, 2012, CRIT REV ONCOL HEMAT, V82, P116, DOI 10.1016/j.critrevonc.2011.05.005; Soung YH, 2004, HUM GENET, V115, P112, DOI 10.1007/s00439-004-1129-3; Strater J, 2010, INT J CANCER, V127, P873, DOI 10.1002/ijc.25111; Sun T, 2007, NAT GENET, V39, P605, DOI 10.1038/ng2030; Theodoropoulos GE, 2012, CANCER GENET-NY, V205, P508, DOI 10.1016/j.cancergen.2012.08.001; Theodoropoulos GE, 2011, INT J COLORECTAL DIS, V26, P1113, DOI 10.1007/s00384-011-1217-5; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Waziry R, 2016, J HEPATOL, V65, P1086, DOI 10.1016/j.jhep.2016.08.010; Yan S, 2013, GENET MOL RES, V12, P1561, DOI 10.4238/2013.May.13.10; Yoo SS, 2009, J CLIN ONCOL, V27, P5823, DOI 10.1200/JCO.2009.23.1738	26	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176802	10.1371/journal.pone.0176802	http://dx.doi.org/10.1371/journal.pone.0176802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453560	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383900058
J	Trieu, MM; Devine, EL; Lamarche, LB; Ammerman, AE; Greco, JA; Birge, RR; Theobald, DL; Oprian, DD				Trieu, Melissa M.; Devine, Erin L.; Lamarche, Lindsey B.; Ammerman, Aaron E.; Greco, Jordan A.; Birge, Robert R.; Theobald, Douglas L.; Oprian, Daniel D.			Expression, purification, and spectral tuning of RhoGC, a retinylidene/guanylyl cyclase fusion protein and optogenetics tool from the aquatic fungus Blastocladiella emersonii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adenylate cyclase (adenylyl cyclase); cyclic nucleotide; optogenetics; photoreceptor; rhodopsin; spectral tuning	RHODOPSIN-GUANYLYL CYCLASE; ADENYLYL-CYCLASE; COMPLEX; BACTERIORHODOPSIN; BILAYERS; BIOLOGY; PIGMENT; CELLS; GENE; CGMP	RhoGC is a rhodopsin (Rho)-guanylyl cyclase (GC) gene fusion molecule that is central to zoospore phototaxis in the aquatic fungus Blastocladiella emersonii. It has generated considerable excitement because of its demonstrated potential as a tool for optogenetic manipulation of cell-signaling pathways involving cyclic nucleotides. However, a reliable method for expressing and purifying RhoGC is currently lacking. We present here an expression and purification system for isolation of the full-length RhoGC protein expressed in HEK293 cells in detergent solution. The protein exhibits robust light-dependent guanylyl cyclase activity, whereas a truncated form lacking the 17- to 20-kDa N-terminal domain is completely inactive under identical conditions. Moreover, we designed several RhoGC mutants to increase the utility of the protein for optogenetic studies. The first class we generated has altered absorption spectra designed for selective activation by different wavelengths of light. Two mutants were created with blue-shifted (E254D, (max) = 390 nm; D380N, (max) = 506 nm) and one with red-shifted (D380E, (max) = 533 nm) absorption maxima relative to the wild-type protein ((max) = 527 nm). We also engineered a double mutant, E497K/C566D, that changes the enzyme to a specific, light-stimulated adenylyl cyclase that catalyzes the formation of cAMP from ATP. We anticipate that this expression/purification system and these RhoGC mutants will facilitate mechanistic and structural exploration of this important enzyme.	[Trieu, Melissa M.; Devine, Erin L.; Lamarche, Lindsey B.; Ammerman, Aaron E.; Theobald, Douglas L.; Oprian, Daniel D.] Brandeis Univ, Dept Biochem, 415 South St, Waltham, MA 02454 USA; [Greco, Jordan A.; Birge, Robert R.] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA; [Greco, Jordan A.; Birge, Robert R.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	Brandeis University; University of Connecticut; University of Connecticut	Theobald, DL; Oprian, DD (corresponding author), Brandeis Univ, Dept Biochem, 415 South St, Waltham, MA 02454 USA.	dtheobald@brandeis.edu; oprian@brandeis.edu	Theobald, Douglas L/F-3514-2013	Theobald, Douglas L/0000-0002-2695-8343; Ammerman, Aaron/0000-0001-9245-4015	Adar family and friends; Brandeis University Provost's research fund; NATIONAL EYE INSTITUTE [R01EY007965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007596, R01GM034548, R01GM096053, R01GM094468] Funding Source: NIH RePORTER	Adar family and friends; Brandeis University Provost's research fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Adar family and friends for continued support throughout this work. We appreciate the Harold S. Schwenk, Sr. Distinguished Chair in Chemistry (University of Connecticut) and support from the Brandeis University Provost's research fund. We thank Dr. Julius Rentergent for invaluable help with the COPASI software. We also thank Dr. Leigh Plant for time and effort spent to guide us through the procedures for immunofluorescence staining of CHO cells.	APARICIO JG, 1995, PROTEIN EXPRES PURIF, V6, P501, DOI 10.1006/prep.1995.1067; Avelar GM, 2014, CURR BIOL, V24, P1234, DOI 10.1016/j.cub.2014.04.009; D'Antona AM, 2014, BIOCHEMISTRY-US, V53, P127, DOI 10.1021/bi4012995; Devine EL, 2013, P NATL ACAD SCI USA, V110, P13351, DOI 10.1073/pnas.1306826110; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Fasick JI, 1999, BIOCHEMISTRY-US, V38, P11593, DOI 10.1021/bi991600h; Gao SQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9046; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; MARTI T, 1991, J BIOL CHEM, V266, P18674; Mendes P, 2009, METHOD ENZYMOL, V467, P583, DOI 10.1016/S0076-6879(09)67022-1; MOGI T, 1988, P NATL ACAD SCI USA, V85, P4148, DOI 10.1073/pnas.85.12.4148; Molday LL, 2014, METHODS MOL BIOL, V1177, P1, DOI 10.1007/978-1-4939-1034-2_1; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Palczewski K, 2012, J BIOL CHEM, V287, P1612, DOI 10.1074/jbc.R111.301150; Plant LD, 2010, P NATL ACAD SCI USA, V107, P10743, DOI 10.1073/pnas.1004712107; Ranaghan MJ, 2011, J AM CHEM SOC, V133, P18318, DOI 10.1021/ja2070957; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; Scheib U, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab0611; Smith SO, 2010, ANNU REV BIOPHYS, V39, P309, DOI 10.1146/annurev-biophys-101209-104901; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Strassmaier T., 2002, THESIS; Sunahara RK, 1998, J BIOL CHEM, V273, P16332, DOI 10.1074/jbc.273.26.16332; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; Xie GF, 2011, BIOCHEMISTRY-US, V50, P10399, DOI 10.1021/bi201126r	27	17	17	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10379	10389		10.1074/jbc.M117.789636	http://dx.doi.org/10.1074/jbc.M117.789636			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28473465	Green Published, hybrid			2022-12-26	WOS:000404115400005
J	Chen, R; Jin, G; McIntyre, TM				Chen, Rui; Jin, Ge; McIntyre, Thomas M.			The soluble protease ADAMDEC1 released from activated platelets hydrolyzes platelet membrane pro-epidermal growth factor (EGF) to active high-molecular-weight EGF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTOR; FACTOR PRECURSOR; TYROSINE KINASE; HUMAN-SERUM; IN-VITRO; METALLOPROTEASE; LIGANDS; ADAM17; CARCINOMA; FAMILY	Platelets are the sole source of EGF in circulation, yet how EGF is stored or released from stimulated cells is undefined. In fact, we found platelets did not store EGF, synthesized as a single 6-kDa domain in pro-EGF, but rather expressed intact pro-EGF precursor on granular and plasma membranes. Activated platelets released high-molecular-weight (HMW)-EGF, produced by a single cleavage between the EGF and the transmembrane domains of pro-EGF. We synthesized a fluorogenic peptide encompassing residues surrounding the putative sessile arginyl residue and found stimulated platelets released soluble activity that cleaved this pro-EGF(1020-1027) peptide. High throughput screening identified chymostatins, bacterial peptides with a central cyclic arginyl structure, as inhibitors of this activity. In contrast, the matrix metalloproteinase/TACE (tumor necrosis factor-alpha-converting enzyme) inhibitor GM6001 was ineffective. Stimulated platelets released the soluble protease ADAMDEC1, recombinant ADAMDEC1 hydrolyzed pro-EGF(1020-1027), and this activity was inhibited by chymostatin and not GM6001. Biotinylating platelet surface proteins showed ADAMDEC1 hydrolyzed surface pro-EGF to HMW-EGF that stimulated HeLa EGF receptor (EGFR) reporter cells and EGFR-dependent tumor cell migration. This proteolysis was inhibited by chymostatin and not GM6001. Metabolizing pro-EGF Arg(1023) to citrulline with recombinant polypeptide arginine deiminase 4 (PAD4) abolished ADAMDEC1-catalyzed pro-EGF(1020-1027) peptidolysis, while pretreating intact platelets with PAD4 suppressed ADAMDEC1-, thrombin-, or collagen-induced release of HMW-EGF. We conclude that activated platelets release ADAMDEC1, which hydrolyzes pro-EGF to soluble HMW-EGF, that HMW-EGF is active, that proteolytic cleavage of pro-EGF first occurs at the C-terminal arginyl residue of the EGF domain, and that proteolysis is the regulated and rate-limiting step in generating soluble EGF bioactivity from activated platelets.	[Chen, Rui; McIntyre, Thomas M.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [McIntyre, Thomas M.] Cleveland Clin, Lerner Res Inst, Dept Mol Med, Cleveland, OH 44195 USA; [Jin, Ge] Case Western Reserve Univ, Sch Dent Med, Dept Biol Sci, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University	McIntyre, TM (corresponding author), Cleveland Clin, Lerner Res Inst, Lerner Coll Med, Dept Cellular & Mol Med, NE10,9500 Euclid Ave, Cleveland, OH 44195 USA.	mcintyt@ccf.org		McIntyre, Thomas/0000-0001-7802-5900	CTSC Core Utilization Pilot Grant Program [4UL1TR000439]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025284] Funding Source: NIH RePORTER	CTSC Core Utilization Pilot Grant Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We appreciate the help of Dr. E. Poptic and the Molecular Screening Core, and we greatly appreciate the help of Dr. S. Bandyopadhyay and W.-Z. Shen in the Molecular Biotechnology core for synthesis and purification of the fluorogenic pro-EGF peptide. We also thank our many blood donors. The Clinical and Translational Science Collaborative of Cleveland, 4UL1TR000439, supported the inhibitor screen under the CTSC Core Utilization Pilot Grant Program.	Ang KK, 2004, INT J RADIAT ONCOL, V58, P959, DOI 10.1016/j.ijrobp.2003.07.010; Aybay C, 2006, CYTOKINE, V35, P36, DOI 10.1016/j.cyto.2006.07.005; Bates EEM, 2002, IMMUNOGENETICS, V54, P96, DOI 10.1007/s00251-002-0430-3; Bazley LA, 2005, ENDOCR-RELAT CANCER, V12, pS17, DOI 10.1677/erc.1.01032; BELL GI, 1986, NUCLEIC ACIDS RES, V14, P8427, DOI 10.1093/nar/14.21.8427; BENEZRA J, 1990, AM J PATHOL, V137, P755; Berger M, 2008, THROMB HAEMOSTASIS, V99, P905, DOI [10.1160/THOB-01-0059, 10.1160/TH08-01-0059]; Bertrand-Duchesne MP, 2010, J PERIODONTAL RES, V45, P87, DOI 10.1111/j.1600-0765.2009.01205.x; Bodnar RJ, 2013, ADV WOUND CARE, V2, P24, DOI 10.1089/wound.2011.0326; Brown GT, 2013, J IMMUNOL, V191, P5196, DOI 10.4049/jimmunol.1300354; Brown GT, 2011, J IMMUNOL, V186, P5489, DOI 10.4049/jimmunol.1001623; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Discafani CM, 1999, BIOCHEM PHARMACOL, V57, P917, DOI 10.1016/S0006-2952(98)00356-6; Dreux AC, 2006, ATHEROSCLEROSIS, V186, P38, DOI 10.1016/j.atherosclerosis.2005.06.038; Durante C, 2013, VOX SANG, V105, P129, DOI 10.1111/vox.12039; Fadini GP, 2016, DIABETES, V65, P1061, DOI 10.2337/db15-0863; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; HIRATA Y, 1979, J CLIN ENDOCR METAB, V49, P481, DOI 10.1210/jcem-49-3-481; HWANG DL, 1992, REGUL PEPTIDES, V37, P95, DOI 10.1016/0167-0115(92)90658-H; JOH T, 1986, CLIN CHIM ACTA, V158, P81, DOI 10.1016/0009-8981(86)90118-X; KIURU J, 1991, LIFE SCI, V49, P1997, DOI 10.1016/0024-3205(91)90642-O; Lamb DJ, 2004, ATHEROSCLEROSIS, V176, P21, DOI 10.1016/j.atherosclerosis.2004.04.012; Le Gall SM, 2003, J BIOL CHEM, V278, P45255, DOI 10.1074/jbc.M307745200; Lee DC, 2003, ANN NY ACAD SCI, V995, P22, DOI 10.1111/j.1749-6632.2003.tb03207.x; Lund J, 2015, J BIOL CHEM, V290, P6620, DOI 10.1074/jbc.M114.601724; Lund J, 2013, J BIOL CHEM, V288, P21367, DOI 10.1074/jbc.M113.474536; Markovic A, 2012, EXPERT REV ANTICANC, V12, P1149, DOI [10.1586/ERA.12.91, 10.1586/era.12.91]; Mazzoleni S, 2010, CANCER RES, V70, P7500, DOI 10.1158/0008-5472.CAN-10-2353; Mezyk-Kopec R, 2009, CYTOKINE, V46, P309, DOI 10.1016/j.cyto.2009.03.002; Moss ML, 2007, ANAL BIOCHEM, V366, P144, DOI 10.1016/j.ab.2007.04.043; MROCZKOWSKI B, 1989, MOL CELL BIOL, V9, P2771, DOI 10.1128/MCB.9.7.2771; Mueller CGF, 1997, J EXP MED, V186, P655, DOI 10.1084/jem.186.5.655; MURAMATSU H, 1995, CANCER RES, V55, P6210; O'Shea NR, 2016, J CROHNS COLITIS, V10, P1417, DOI 10.1093/ecco-jcc/jjw111; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Ohnishi Y, 2008, ORAL ONCOL, V44, P1155, DOI 10.1016/j.oraloncology.2008.02.015; OKA Y, 1983, J CLIN INVEST, V72, P249, DOI 10.1172/JCI110964; PESONEN K, 1989, J CLIN ENDOCR METAB, V68, P486, DOI 10.1210/jcem-68-2-486; Pyrc K, 2013, INFECT IMMUN, V81, P55, DOI 10.1128/IAI.00830-12; Rabie T, 2005, J BIOL CHEM, V280, P14462, DOI 10.1074/jbc.M500041200; RALL LB, 1985, NATURE, V313, P228, DOI 10.1038/313228a0; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sanderson MP, 2006, GROWTH FACTORS, V24, P121, DOI 10.1080/08977190600634373; SAVAGE AP, 1986, REGUL PEPTIDES, V16, P199, DOI 10.1016/0167-0115(86)90019-4; Schreier B, 2014, CURR OPIN NEPHROL HY, V23, P113, DOI 10.1097/01.mnh.0000441152.62943.29; Su CY, 2008, TRANSFUSION, V48, P2414, DOI 10.1111/j.1537-2995.2008.01862.x; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; TAYLOR JM, 1974, J BIOL CHEM, V249, P2188; TAYLOR JM, 1970, P NATL ACAD SCI USA, V67, P164, DOI 10.1073/pnas.67.1.164; Tucher J, 2014, J PROTEOME RES, V13, P2205, DOI 10.1021/pr401135u; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Umeda N, 2016, CLIN RHEUMATOL, V35, P1181, DOI 10.1007/s10067-015-3082-z; UMEZAWA H, 1970, J ANTIBIOT, V23, P425, DOI 10.7164/antibiotics.23.425; Wang S, 2013, BBA-GENE REGUL MECH, V1829, P1126, DOI 10.1016/j.bbagrm.2013.07.003; Wijten P, 2013, ARTERIOSCL THROM VAS, V33, P1635, DOI 10.1161/ATVBAHA.113.301147; Wong SL, 2015, NAT MED, V21, P815, DOI 10.1038/nm.3887; Yamamoto K, 2015, MATRIX BIOL, V44-46, P255, DOI 10.1016/j.matbio.2015.02.007	58	17	19	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10112	10122		10.1074/jbc.M116.771642	http://dx.doi.org/10.1074/jbc.M116.771642			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28455445	Green Published, hybrid			2022-12-26	WOS:000403580600022
J	Bridge, K; Revill, C; Macrae, F; Bailey, M; Yuldasheva, N; Wheatcroft, S; Butlin, R; Foster, R; Scott, DJ; Gils, A; Ariens, R				Bridge, Katherine; Revill, Charlotte; Macrae, Fraser; Bailey, Marc; Yuldasheva, Nadira; Wheatcroft, Stephen; Butlin, Roger; Foster, Richard; Scott, D. Julian; Gils, Ann; Ariens, Robert			Inhibition of plasmin-mediated TAFI activation may affect development but not progression of abdominal aortic aneurysms	PLOS ONE			English	Article							FIBRINOLYSIS INHIBITOR; DEFICIENT MICE; INTRALUMINAL THROMBUS; OPEN REPAIR; MORTALITY; OSTEOPONTIN; MEN	Objective Thrombin-activatable fibrinolysis inhibitor (TAFI) reduces the breakdown of fibrin clots through its action as an indirect inhibitor of plasmin. Studies in TAFI-deficient mice have implicated a potential role for TAFI in Abdominal Aortic Aneurysm (AAA) disease. The role of TAFI inhibition on AAA formation in adult ApoE-/- mice is unknown. The aim of this paper was to investigate the effects of TAFI inhibition on AAA development and progression. Methods Using the Angiotensin II model of AAA, male ApoE-/- mice were infused with Angiotensin II 750ng/kg/min with or without a monoclonal antibody inhibitor of plasmin-mediated activation of TAFI, MA-TCK26D6, or a competitive small molecule inhibitor of TAFI, UK-396082. Results Inhibition of TAFI in the Angiotensin II model resulted in a decrease in the mortality associated with AAA rupture (from 40.0% to 16.6% with MA-TCK26D6 (log-rank Mantel Cox test p = 0.16), and 8.3% with UK-396082 (log-rank Mantel Cox test p = 0.05)). Inhibition of plasmin- mediated TAFI activation reduced the incidence of AAA from 52.4% to 30.0%. However, late treatment with MA-TCK26D6 once AAA were already established had no effect on the progression of AAA in this model. Conclusions The formation of intra-mural thrombus is responsible for the dissection and early rupture in the angiotensin II model of AAA, and this process can be prevented through inhibition of TAFI. Late treatment with a TAFI inhibitor does not prevent AAA progression. These data may indicate a role for inhibition of plasmin-mediated TAFI activation in the early stages of AAA development, but not in its progression.	[Bridge, Katherine; Macrae, Fraser; Bailey, Marc; Yuldasheva, Nadira; Wheatcroft, Stephen; Scott, D. Julian; Ariens, Robert] Univ Leeds, Leeds Inst Cardiovasc & Metab Res, Div Cardiovasc & Diabet Res, Thrombosis & Tissue Repair Grp, Leeds, W Yorkshire, England; [Bridge, Katherine; Bailey, Marc; Scott, D. Julian] Leeds Gen Infirm, Leeds Vasc Inst, Leeds, W Yorkshire, England; [Revill, Charlotte; Butlin, Roger; Foster, Richard] Univ Leeds, Sch Chem, Leeds, W Yorkshire, England; [Gils, Ann] Univ Leuven, KU Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Therapeut & Diagnost Antibodies, Leuven, Belgium	University of Leeds; Leeds General Infirmary; University of Leeds; University of Leeds; KU Leuven	Ariens, R (corresponding author), Univ Leeds, Leeds Inst Cardiovasc & Metab Res, Div Cardiovasc & Diabet Res, Thrombosis & Tissue Repair Grp, Leeds, W Yorkshire, England.	r.a.s.ariens@leeds.ac.uk	Macrae, Fraser/AAN-8377-2021; Yuldasheva, Dr. Nadira Yusupovna/GXM-9013-2022; Butlin, Roger/F-7709-2013	Yuldasheva, Dr. Nadira Yusupovna/0000-0001-6213-6358; Bailey, Marc/0000-0001-5038-1970; Macrae, Fraser/0000-0002-7092-0422; Ariens, Robert/0000-0002-6310-5745; Foster, Richard/0000-0002-2361-3884; Butlin, Roger/0000-0003-4736-0954	Clinical Research Training Fellowship from the British Heart Foundation [FS/12/26/29395]; British Heart Foundation [FS/12/26/29395] Funding Source: researchfish	Clinical Research Training Fellowship from the British Heart Foundation; British Heart Foundation(British Heart Foundation)	This work was funded by a Clinical Research Training Fellowship from the British Heart Foundation (ref. FS/12/26/29395) awarded to Katherine Bridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton HA, 2002, LANCET, V360, P1531, DOI 10.1016/S0140-6736(02)11522-4; Bailey MA, 2013, J VASC SURG, V57, P1512, DOI 10.1016/j.jvs.2012.12.030; Bouma BN, 2006, ANN MED, V38, P378, DOI 10.1080/07853890600852898; Brady AR, 2001, ARTERIOSCL THROM VAS, V21, P1203, DOI 10.1161/hq0701.091999; Bridge KI, 2014, THROMB HAEMOSTASIS, V112, P901, DOI 10.1160/TH14-02-0184; Bruemmer D, 2003, J CLIN INVEST, V112, P1318, DOI 10.1172/JCI200318141; Buelens K, 2010, J THROMB HAEMOST, V8, P1302, DOI 10.1111/j.1538-7836.2010.03816.x; Bunnage ME, 2007, J MED CHEM, V50, P6095, DOI 10.1021/jm0702433; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; Dubis J, 2014, BLOOD COAGUL FIBRIN, V25, P226, DOI 10.1097/MBC.0000000000000028; Foley JH, 2013, J THROMB HAEMOST, V11, P306, DOI 10.1111/jth.12216; Folkesson M, 2011, ATHEROSCLEROSIS, V218, P294, DOI 10.1016/j.atherosclerosis.2011.05.002; Gils A, 2005, J THROMB HAEMOST, V3, P2745, DOI 10.1111/j.1538-7836.2005.01629.x; Hobbs SD, 2007, J VASC SURG, V46, P682, DOI 10.1016/j.jvs.2007.05.057; Lederle FA, 2011, CIRCULATION, V124, P1097, DOI 10.1161/CIRCULATIONAHA.111.052365; Lindholt JS, 2001, J VASC SURG, V34, P611, DOI 10.1067/mva.2001.119040; Parry DJ, 2009, BRIT J SURG, V96, P870, DOI 10.1002/bjs.6632; Schultz G, 2010, ARTERIOSCL THROM VAS, V30, P1363, DOI 10.1161/ATVBAHA.109.202259; Scott DJA, 2011, ARTERIOSCL THROM VAS, V31, P3004, DOI 10.1161/ATVBAHA.111.236786; Semeraro F, 2013, J THROMB HAEMOST, V11, P2137, DOI 10.1111/jth.12431; Sidloff D, 2014, CIRCULATION, V129, P747, DOI 10.1161/CIRCULATIONAHA.113.005457; Vercauteren E, 2011, BLOOD, V117, P4615, DOI 10.1182/blood-2010-08-303677; Vorp DA, 2001, J VASC SURG, V34, P291, DOI 10.1067/mva.2001.114813; Wyseure T, 2015, BLOOD, V125, P1325, DOI 10.1182/blood-2014-07-588319	25	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177117	10.1371/journal.pone.0177117	http://dx.doi.org/10.1371/journal.pone.0177117			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472123	Green Published, gold			2022-12-26	WOS:000400648500138
J	Gadoev, J; Asadov, D; Harries, AD; Parpiev, N; Tayler-Smith, K; Isaakidis, P; Ali, E; Hinderaker, SG; Ogtay, G; Ramsay, A; Jalolov, A; Dara, M				Gadoev, Jamshid; Asadov, Damin; Harries, Anthony D.; Parpiev, Nargiza; Tayler-Smith, Katie; Isaakidis, Petros; Ali, Engy; Hinderaker, Sven Gudmund; Ogtay, Gozalov; Ramsay, Andrew; Jalolov, Avazbek; Dara, Masoud			Recurrent tuberculosis and associated factors: A five - year countrywide study in Uzbekistan	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; RELAPSE; REINFECTION	Background In Uzbekistan, despite stable and relatively high tuberculosis treatment success rates, relatively high rates of recurrent tuberculosis have recently been reported. Recurrent tuberculosis is when a patient who was treated for pulmonary tuberculosis and cured, later develops the disease again. This requires closer analysis to identify possible causes and recommend interventions to improve the situation. Using countrywide data, this study aimed to analyse trends in recurrent tuberculosis cases and describe their associations with socio-demographic and clinical factors. Method Countrywide retrospective cohort study comparing recurrent tuberculosis patients with all new tuberculosis patients registered within the NTP between January 2006 and December 2010 using routinely collected data. Determinants studied were baseline characteristics and treatment outcomes. Results Of 107,380 registered patients during the period January 2006 and December 2010, 9358 (8.7%) were recurrent cases. Between 2006 and 2008, the number of recurrent cases per annum increased from 1530 to 2081, then fell slightly thereafter from 2081 to 1888 cases. The proportion of all notified cases during this period increased from 6.5% to 9.9%. Factors associated with recurrent tuberculosis included age (35-55 years old), having smear positive pulmonary tuberculosis, residing in certain areas of Uzbekistan, having particular comorbidities (including chronic obstructive pulmonary disease and HIV), and being unemployed, a pensioner or disabled. Recurrent tuberculosis patients also had a higher likelihood of having an unfavourable treatment outcome Conclusion Despite signs of declining national tuberculosis notifications between 2006 and 2010, the relative proportion of recurrent cases appears to have increased. These findings, together with the identification of possible risk factors associated with recurrent tuberculosis, highlight various areas where Uzbekistan needs to focus its tuberculosis control efforts, particularly in light of the country's rapidly emerging multi drug resistant tuberculosis epidemic.	[Gadoev, Jamshid] World Hlth Org Country Off Uzbekistan, Tashkent, Uzbekistan; [Asadov, Damin] State Post Grad Inst Med Educ, Tashkent, Uzbekistan; [Harries, Anthony D.] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony D.] London Sch Hyg & Trop Med, London, England; [Parpiev, Nargiza] Republican Specialized Sci Pract Med Ctr Phthisio, Tashkent, Uzbekistan; [Tayler-Smith, Katie; Isaakidis, Petros; Ali, Engy] MSF Luxembourg, Operat Ctr Brussels, Operat Res Unit, Luxembourg, Luxembourg; [Hinderaker, Sven Gudmund] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Ogtay, Gozalov; Dara, Masoud] WHO Reg Off Europe Joint TB HIV & Hepatitis Progr, Copenhagen, Denmark; [Ramsay, Andrew] World Bank, UNDP, UNICEF, Geneva, Switzerland; [Ramsay, Andrew] World Hlth Org, WHO Special Programme Res & Training Trop Dis TDR, Geneva, Switzerland; [Ramsay, Andrew] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland; [Jalolov, Avazbek] Minist Hlth Republ Uzbekistan, Tashkent, Uzbekistan	World Health Organization; University of London; London School of Hygiene & Tropical Medicine; Doctors Without Borders; University of Bergen; The World Bank; World Health Organization; University of St Andrews	Gadoev, J (corresponding author), World Hlth Org Country Off Uzbekistan, Tashkent, Uzbekistan.	gadoevj@who.int		Gadoev, Jamshid/0000-0003-3998-5786; Asadov, Damin/0000-0003-2192-1418; Isaakidis, Petros/0000-0002-7881-1554	USAID in Uzbekistan; National Tuberculosis programme; WHO Country Office in Uzbekistan	USAID in Uzbekistan(United States Agency for International Development (USAID)); National Tuberculosis programme; WHO Country Office in Uzbekistan	This research was conducted through the Structured Operational Research and Training Initiative (SORT IT), a global partnership led by the Special Programme for Research and Training in Tropical Diseases at the World Health Organization (WHO/TDR) and "Partnership project for TB control" funded by USAID in Uzbekistan. The specific SORT IT programme which resulted in this publication was jointly developed and implemented by: WHO-TDR, WHO Regional Office for Europe, Republican DOTS center, Uzbekistan, the Operational Research Unit (LUXOR), Medecins Sans Frontieres, Brussels Operational Center, Luxembourg; the Centre for Operational Research, International Union Against Tuberculosis and Lung Disease, France; The Union South-East Asia Regional Office, New Delhi, India; Centre for International Health, University of Bergen, Norway. We also appreciate the active involvement of the National Tuberculosis programme and WHO Country Office in Uzbekistan and support provided during the study.	[Anonymous], 2014, ORDER MOH REPUBLIC U; Cox H, 2006, PLOS MED, V3, P1836, DOI 10.1371/journal.pmed.0030384; Cynthia R, 2001, CLIN INFECT DIS, V33, P1762; d'Arc Lyra B. J., 2008, INT J EPIDEMIOL, V37, P841; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Didilescu C, 2000, Pneumologia, V49, P247; El Sahly HM, 2004, INT J TUBERC LUNG D, V8, P333; Gadoev J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128907; Garcia V. D., 2002, ARCH INTERN MED, V162, P1873; Gulrez S. A., 2012, LUNG INDIA, V29, P147; Hovitz D. J, 2014, CURR HIV-AIDS REP, V11, P168; Hung CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124822; Jasmer RM, 2004, AM J RESP CRIT CARE, V170, P1360, DOI 10.1164/rccm.200408-1081OC; Jick SS, 2006, ARTHRIT RHEUM-ARTHR, V55, P19, DOI 10.1002/art.21705; Kumar A, 2013, TROP MED INT HEALTH, V18, P636, DOI 10.1111/tmi.12084; Millet JP, 2009, J EPIDEMIOL COMMUN H, V63, P799, DOI 10.1136/jech.2008.077560; Millet JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064898; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Murray J, 2014, EUROPEAN RESP J S58, V44, P4546; Quy HTW, 2003, INT J TUBERC LUNG D, V7, P631; Rangaka MX, 2014, LANCET, V384, P682, DOI 10.1016/S0140-6736(14)60162-8; Sanghani RN, 2013, THORAX, V68, P202, DOI 10.1136/thoraxjnl-2012-202976; Shu CC, 2010, MEDICINE, V89, P53, DOI 10.1097/MD.0b013e3181cafcd3; Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5; Thomas A, 2005, INT J TUBERC LUNG D, V9, P556; Ulmasova DJ, 2013, EUROSURVEILLANCE, V18, P5, DOI 10.2807/1560-7917.ES2013.18.42.20609; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; World Health Organization, 2013, DEFINITIONS REPORTIN; Yusupova S., 2016, PUBLIC HLTH PANORAMA, V2, P1	29	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176473	10.1371/journal.pone.0176473	http://dx.doi.org/10.1371/journal.pone.0176473			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472053	Green Published, Green Accepted, gold			2022-12-26	WOS:000400648500048
J	Jackwood, MW; Lee, DH				Jackwood, Mark W.; Lee, Dong-Hun			Different evolutionary trajectories of vaccine-controlled and non-controlled avian infectious bronchitis viruses in commercial poultry	PLOS ONE			English	Article							RNA VIRUS; SEROTYPE	To determine the genetic and epidemiological relationship of infectious bronchitis virus (IBV) isolates from commercial poultry to attenuated live IBV vaccines we conducted a phylogenetic network analysis on the full-length S1 sequence for Arkansas (Ark), Massachusetts (Mass) and Delmarva/1639 (DMV/1639) type viruses isolated in 2015 from clinical cases by 3 different diagnostic laboratories. Phylogenetic network analysis of Ark isolates showed two predominant groups linked by 2 mutations, consistent with subpopulations found in commercial vaccines for this IBV type. In addition, a number of satellite groups surrounding the two predominant populations were observed for the Ark type virus, which is likely due to mutations associated with the nature of this vaccine to persist in flocks. The phylogenetic network analysis of Mass-type viruses shows two groupings corresponding to different manufacturers vaccine sequences. No satellite groups were observed for Masstype viruses, which is consistent with no persistence of this vaccine type in the field. At the time of collection, no vaccine was being used for the DMV/1639 type viruses and phylogenetic network analysis showed a dispersed network suggesting no clear change in genetic distribution. Selection pressure analysis showed that the DMV/1639 and Mass-type strains were evolving under negative selection, whereas the Ark type viruses had evolved under positive selection. This data supports the hypothesis that live attenuated vaccine usage does play a role in the genetic profile of similar IB viruses in the field and phylogenetic network analysis can be used to identify vaccine and vaccine origin isolates, which is important for our understanding of the role live vaccines play in the evolutionary trajectory of those viruses.	[Jackwood, Mark W.] Univ Georgia, Coll Vet Med, Poultry Diagnost & Res Ctr, Dept Populat Hlth, Athens, GA 30602 USA; [Lee, Dong-Hun] USDA ARS, US Natl Poultry Res Ctr, Southeast Poultry Res Lab, Athens, GA 30613 USA	University System of Georgia; University of Georgia; United States Department of Agriculture (USDA)	Jackwood, MW (corresponding author), Univ Georgia, Coll Vet Med, Poultry Diagnost & Res Ctr, Dept Populat Hlth, Athens, GA 30602 USA.	mjackwoo@uga.edu	Lee, Dong-hun/H-5082-2019					Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Chauhan JS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067008, 10.1371/journal.pone.0080000]; Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017; Holmes EC, 2009, ANNU REV ECOL EVOL S, V40, P353, DOI 10.1146/annurev.ecolsys.110308.120248; Jackwood MW, 2012, INFECT GENET EVOL, V12, P1305, DOI 10.1016/j.meegid.2012.05.003; Jackwood MW, 2013, DIS POULTRY, P139, DOI DOI 10.1002/9781119421481.CH4; KANT A, 1992, J GEN VIROL, V73, P591, DOI 10.1099/0022-1317-73-3-591; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Lee CW, 2000, AVIAN DIS, V44, P650, DOI 10.2307/1593106; Lee CW, 2001, VIRUS RES, V80, P33, DOI 10.1016/S0168-1702(01)00345-8; Leyson C, 2016, VIROLOGY, V498, P218, DOI 10.1016/j.virol.2016.08.030; Lim TH, 2011, INFECT GENET EVOL, V11, P678, DOI 10.1016/j.meegid.2011.01.007; McKinley ET, 2008, VACCINE, V26, P1274, DOI 10.1016/j.vaccine.2008.01.006; Minskaia E, 2006, P NATL ACAD SCI USA, V103, P5108, DOI 10.1073/pnas.0508200103; Moore KM, 1997, ARCH VIROL, V142, P2249, DOI 10.1007/s007050050239; Roh HJ, 2013, AVIAN DIS, V57, P248, DOI 10.1637/10459-112812-Reg.1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]	17	32	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176709	10.1371/journal.pone.0176709	http://dx.doi.org/10.1371/journal.pone.0176709			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472110	gold, Green Published, Green Submitted			2022-12-26	WOS:000400648500065
J	Masubuchi, Y; Nakagawa, Y; Medina, J; Nagasawa, M; Kojima, I; Rasenick, MM; Inagaki, T; Shibata, H				Masubuchi, Yosuke; Nakagawa, Yuko; Medina, Johan; Nagasawa, Masahiro; Kojima, Itaru; Rasenick, Mark M.; Inagaki, Takeshi; Shibata, Hiroshi			T1R3 homomeric sweet taste receptor regulates adipogenesis through G alpha s-mediated microtubules disassembly and Rho activation in 3T3-L1 cells	PLOS ONE			English	Article							NUCLEOTIDE-EXCHANGE-FACTOR; ADIPOCYTE DIFFERENTIATION; PROTEIN; TRANSCRIPTION; MODULATION; G-ALPHA(S); DYNAMICS; GROWTH; ACTIN	We previously reported that 3T3-L1 cells express a functional sweet taste receptor possibly as a T1R3 homomer that is coupled to Gs and negatively regulates adipogenesis by a G alpha s-mediated but cAMP-independent mechanism. Here, we show that stimulation of this receptor with sucralose or saccharin induced disassembly of the microtubules in 3T3-L1 preadipocytes, which was attenuated by overexpression of the dominant-negative mutant of G alpha s (G alpha s-G226A). In contrast, overexpression of the constitutively active mutant of G alpha s (G alpha sQ227L) as well as treatment with cholera toxin or isoproterenol but not with forskolin caused disassembly of the microtubules. Sweetener-induced microtubule disassembly was accompanied by activation of RhoA and Rho-associated kinase (ROCK). This was attenuated with by knockdown of GEF-H1, a microtubule-localized guanine nucleotide exchange factor for Rho GTPase. Furthermore, overexpression of the dominant-negative mutant of RhoA (RhoA-T19N) blocked sweetener-induced dephosphorylation of Akt and repression of PPAR. and C/EBP alpha in the early phase of adipogenic differentiation. These results suggest that the T1R3 homomeric sweet taste receptor negatively regulates adipogenesis through G alpha s-mediated microtubule disassembly and consequent activation of the Rho/ROCK pathway.	[Masubuchi, Yosuke; Nakagawa, Yuko; Medina, Johan; Nagasawa, Masahiro; Kojima, Itaru; Inagaki, Takeshi; Shibata, Hiroshi] Gunma Univ, Inst Mol & Cellular Regulat, Dept Mol & Cellular Biol, 3-39-15 Showa Machi, Maebashi, Gunma, Japan; [Rasenick, Mark M.] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60680 USA; [Rasenick, Mark M.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; [Rasenick, Mark M.] Jesse Brown VA Med Ctr, Chicago, IL USA	Gunma University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Shibata, H (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Dept Mol & Cellular Biol, 3-39-15 Showa Machi, Maebashi, Gunma, Japan.	hshibata@gunma-u.ac.jp	Inagaki, Takeshi/J-8802-2013	Inagaki, Takeshi/0000-0003-1711-8286	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP26461325]; USPHS-NIH grant [AT009169]; US Veterans Administration Merit award [BX001149]; National Center for Complementary & Integrative Health [R01AT009169] Funding Source: NIH RePORTER; Veterans Affairs [IK6BX004475, I01BX001149] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); USPHS-NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Veterans Administration Merit award; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Japan Society for the Promotion of Science (JSPS) (https.//www.jsps.go.jp/) KAKENHI Grant Number JP26461325. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MMR is supported by USPHS-NIH grant AT009169 and US Veterans Administration Merit award BX001149.; This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number JP26461325. M.M.R. is supported by USPHS-NIH grant AT009169 and US Veterans Administration Merit award BX001149. We are grateful to Dr. Michiyuki Matsuda for Raichu1237X and Dr. Takashi Matozaki for the expression plasmids for RhoA. We also thank to Dr. Howard Green for 3T3-L1 cells.	Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Bryan BA, 2005, MOL CELL BIOL, V25, P11089, DOI 10.1128/MCB.25.24.11089-11101.2005; DJIAN P, 1985, J CELL PHYSIOL, V124, P554, DOI 10.1002/jcp.1041240327; Fischer-Posovszky P, 2012, MOL CELL ENDOCRINOL, V358, P135, DOI 10.1016/j.mce.2012.03.018; Hara Y, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001227; Hewavitharana T, 2012, CELL SIGNAL, V24, P25, DOI 10.1016/j.cellsig.2011.08.014; Horii T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005809; JONES DT, 1987, J BIOL CHEM, V262, P14241; Kanda T, 2005, FASEB J, V19, P169, DOI 10.1096/fj.05-4197fje; Kim JJ, 2009, DIABETES, V58, P1275, DOI 10.2337/db08-1001; Kojima I, 2011, DIABETES METAB J, V35, P451, DOI 10.4093/dmj.2011.35.5.451; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Laffitte A, 2014, CURR OPIN CLIN NUTR, V17, P379, DOI 10.1097/MCO.0000000000000058; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Liu LB, 2007, DIABETES, V56, P1977, DOI 10.2337/db06-1100; Magun R, 1996, ENDOCRINOLOGY, V137, P3590, DOI 10.1210/en.137.8.3590; Masubuchi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054500; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Noda K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110446; Noguchi M, 2007, J BIOL CHEM, V282, P29574, DOI 10.1074/jbc.M705972200; Roper SD, 2007, PFLUG ARCH EUR J PHY, V454, P759, DOI 10.1007/s00424-007-0247-x; Sarma T, 2015, J BIOL CHEM, V290, P10045, DOI 10.1074/jbc.M114.630632; Schappi JM, 2014, BBA-BIOMEMBRANES, V1838, P674, DOI 10.1016/j.bbamem.2013.08.026; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Tomiyama K, 1995, BIOCHEM BIOPH RES CO, V212, P263; Worby CA, 2014, ANNU REV BIOCHEM, V83, P641, DOI 10.1146/annurev-biochem-082411-113907; Xu JF, 2004, J BIOL CHEM, V279, P35914, DOI 10.1074/jbc.M402297200; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Yu JZ, 2009, J BIOL CHEM, V284, P10462, DOI 10.1074/jbc.M809166200; Yu JZ, 2002, MOL PHARMACOL, V61, P352, DOI 10.1124/mol.61.2.352; Yun SJ, 2008, BIOCHEM BIOPH RES CO, V371, P138, DOI 10.1016/j.bbrc.2008.04.029	32	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176841	10.1371/journal.pone.0176841	http://dx.doi.org/10.1371/journal.pone.0176841			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472098	Green Submitted, Green Published, gold			2022-12-26	WOS:000400648500083
J	Sevic, I; Ledesma, MMGL; Flichman, DM; Campos, RH				Sevic, Ina; Lopez Ledesma, Maria Mora Gonzalez; Martin Flichman, Diego; Hector Campos, Rodolfo			HBV DNA genome co-transfection procedure for the evaluation of relative fitness	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CORE PROMOTER; ANTIGEN	Hepatitis B virus (HBV) has a high mutation rate and exists as a mixture of genetically different but closely related variants. We present a HBV DNA co-transfection fitness assay and use it to evaluate the relative fitness of different HBV variants in two scenarios: seroconversion process and occupation of an ecological niche. In the seroconversion experiment, subgenotype D1 (sgtD1) deletion (1763-1770) had significantly lower fitness comparing with both sgtD1 wild type and sgtD1mut G1896A, while, in the case of occupation of ecological niche experiment, the results showed the same relative fitness between all of the genotype combinations, except F1b-F4. In this case sgtF1b clearly overgrow sgtF4, which is in accordance with the observation that F1b is the most prevalent in the new infections in Argentina. In summary, we present a method aimed to evaluate HBV viral fitness which improve the analysis of the relative frequency of viral variants during the HBV infection process.	[Sevic, Ina; Lopez Ledesma, Maria Mora Gonzalez; Martin Flichman, Diego; Hector Campos, Rodolfo] Univ Buenos Aires, Fac Farm Bioguim, Dept Microbiol Inmunol & Biotecnol Catedra Virol, Buenos Aires, DF, Argentina; [Sevic, Ina; Lopez Ledesma, Maria Mora Gonzalez; Martin Flichman, Diego; Hector Campos, Rodolfo] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Campos, RH (corresponding author), Univ Buenos Aires, Fac Farm Bioguim, Dept Microbiol Inmunol & Biotecnol Catedra Virol, Buenos Aires, DF, Argentina.; Campos, RH (corresponding author), Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina.	rcampos@ffyb.uba.ar	Sevic, Ina/ABF-2898-2021	Sevic, Ina/0000-0002-4920-5096; Gonzalez Lopez Ledesma, Maria Mora/0000-0002-2189-8388	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP2015-0595C0]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT2014-1672]; UBACyT [20020130100505BA]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); UBACyT	This work was supported by: Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP2015-0595C0], Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT2014-1672] and UBACyT [20020130100505BA 2014-2017].	Andino R, 2015, VIROLOGY, V479, P46, DOI 10.1016/j.virol.2015.03.022; Rodrigo MB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159509; Domingo E, 2000, REV SCI TECH OIE, V19, P55, DOI 10.20506/rst.19.1.1210; Domingo E, 2007, VIRUS RES, V127, P131, DOI 10.1016/j.virusres.2007.02.001; Fischer SF, 2006, WORLD J GASTROENTERO, V12, P6054, DOI 10.3748/wjg.v12.i37.6054; Gao S, 2015, WORLD J HEPATOL, V7, P1086, DOI 10.4254/wjh.v7.i8.1086; Geng Y, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002657; Jammeh S, 2008, J GEN VIROL, V89, P901, DOI 10.1099/vir.0.83468-0; Ledesma MMGL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121436; Ledesma MMGL, 2011, INT J INFECT DIS, V15, pE314, DOI 10.1016/j.ijid.2010.12.009; Milich D, 2003, HEPATOLOGY, V38, P1075, DOI 10.1053/jhep.2003.50453; Moriyama K, 1997, J GEN VIROL, V78, P1479, DOI 10.1099/0022-1317-78-6-1479; Pezzano SC, 2011, CLIN MICROBIOL INFEC, V17, P223, DOI 10.1111/j.1469-0691.2010.03283.x; Sallam TA, 2002, J MED VIROL, V68, P328, DOI 10.1002/jmv.10207; Sede M, 2014, J VIRAL HEPATITIS, V21, P650, DOI 10.1111/jvh.12196; Sozzi V, 2016, J VIROL	16	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0175543	10.1371/journal.pone.0175543	http://dx.doi.org/10.1371/journal.pone.0175543			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472081	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500012
J	Dosunmu, EF; Emeh, RO; Dixit, S; Bakeer, MK; Coats, MT; Owen, DR; Pillai, SR; Singh, SR; Dennis, VA				Dosunmu, Ejovwoke F.; Emeh, Robert O.; Dixit, Saurabh; Bakeer, Mona K.; Coats, Mamie T.; Owen, Donald R.; Pillai, Shreekumar R.; Singh, Shree R.; Dennis, Vida A.			The anti-microbial peptide TP359 attenuates inflammation in human lung cells infected with Pseudomonas aeruginosa via TLR5 and MAPK pathways	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; AIRWAY EPITHELIAL-CELLS; CYSTIC-FIBROSIS; BACTERIAL FLAGELLIN; TNF-ALPHA; TOLL-LIKE-RECEPTOR-5; LIPOPOLYSACCHARIDE; INTERLEUKIN-8; RECOGNITION; MACROPHAGES	Pseudomonas aeruginosa infection induces vigorous inflammatory mediators secreted by epithelial cells, which do not necessarily eradicate the pathogen. Nonetheless, it reduces lung function due to significant airway damage, most importantly in cystic fibrosis patients. Recently, we published that TP359, a proprietary cationic peptide had potent bactericidal effects against P. aeruginosa, which were mediated by down-regulating its outer membrane biogenesis genes. Herein, we hypothesized that TP359 bactericidal effects could also serve to regulate P. aeruginosa-induced lung inflammation. We explored this hypothesis by infecting human A549 lung cells with live P. aeruginosa non-isogenic, mucoid and non-mucoid strains and assessed the capacity of TP359 to regulate the levels of elicited TNF alpha, IL-6 and IL-8 inflammatory cytokines. In all instances, the mucoid strain elicited higher concentrations of cytokines in comparison to the non-mucoid strain, and TP359 dose-dependently downregulated their respective levels, suggesting its regulation of lung inflammation. Surprisingly, P. aeruginosa flagellin, and not its lipopolysaccharide moiety, was the primary inducer of inflammatory cytokines in lung cells, which were similarly down-regulated by TP359. Blocking of TLR5, the putative flagellin receptor, completely abrogated the capacity of infected lung cells to secrete cytokines, underscoring that TP359 regulates inflammation via the TLR5-dependent signaling pathway. Downstream pathway-specific inhibition studies further revealed that the MAPK pathway, essentially p38 and JNK are necessary for induction of P. aeruginosa elicited inflammatory cytokines and their down-regulation by TP359. Collectively, our data provides evidence to support exploring the relevancy of TP359 as an antimicrobial and anti-inflammatory agent against P. aeruginosa for clinical applications.	[Dosunmu, Ejovwoke F.; Emeh, Robert O.; Dixit, Saurabh; Coats, Mamie T.; Pillai, Shreekumar R.; Singh, Shree R.; Dennis, Vida A.] Alabama State Univ, Ctr NanoBiotechnol Res, Montgomery, AL 36101 USA; [Bakeer, Mona K.] Lousiana State Univ, Hlth Sci Ctr, Sch Allied Hlth Profess, New Orleans, LA USA; [Owen, Donald R.] Therapeut Peptides Inc, Baton Rouge, LA USA; [Dosunmu, Ejovwoke F.] USDA, US Salin Lab, Riverside, CA USA; [Dixit, Saurabh] NIEHS, NIH, POB 12233, Res Triangle Pk, NC 27709 USA	Louisiana State University System; Louisiana State University; United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Dennis, VA (corresponding author), Alabama State Univ, Ctr NanoBiotechnol Res, Montgomery, AL 36101 USA.	vdennis@alasu.edu	; dixit, saurabh/E-3296-2013	Singh, Shree R./0000-0002-3571-2222; dixit, saurabh/0000-0002-9140-9543	National Science Foundation (NSF)-CREST [HRD-1241701]; NSF-HBCU-RISE [HRD-1646729]; National Institutes of Health-NIGMS-RISE [1R25GM106995-01]	National Science Foundation (NSF)-CREST(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU)); NSF-HBCU-RISE(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU)); National Institutes of Health-NIGMS-RISE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The project described was supported by federal funding from the National Science Foundation (NSF)-CREST (HRD-1241701), NSF-HBCU-RISE (HRD-1646729) and the National Institutes of Health-NIGMS-RISE (1R25GM106995-01) grants. Therapeutic Peptides Inc. also provided research materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorn C, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-67; BONFIELD TL, 1995, AM J RESP CRIT CARE, V152, P2111, DOI 10.1164/ajrccm.152.6.8520783; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Campbell EL, 2011, J IMMUNOL, V187, P3475, DOI 10.4049/jimmunol.1100150; Carnpodonico VL, 2008, TRENDS MOL MED, V14, P120, DOI 10.1016/j.molmed.2008.01.002; Cobb LM, 2004, J IMMUNOL, V173, P5659, DOI 10.4049/jimmunol.173.9.5659; Courtney J M, 2004, J Cyst Fibros, V3, P223, DOI 10.1016/j.jcf.2004.06.006; Davies Jane C, 2002, Paediatr Respir Rev, V3, P128, DOI 10.1016/S1526-0550(02)00003-3; Delgado MA, 2006, INFECT IMMUN, V74, P2975, DOI 10.1128/IAI.74.5.2975-2984.2006; DIMANGO E, 1995, J CLIN INVEST, V96, P2204, DOI 10.1172/JCI118275; Dosunmu EF, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0808-2; Garrett ES, 1999, J BACTERIOL, V181, P7401, DOI 10.1128/JB.181.23.7401-7404.1999; Harder J, 2000, AM J RESP CELL MOL, V22, P714, DOI 10.1165/ajrcmb.22.6.4023; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; Hybiske K, 2004, CELL MICROBIOL, V6, P49, DOI 10.1046/j.1462-5822.2003.00342.x; Kipnis E, 2006, MED MALADIES INFECT, V36, P78, DOI 10.1016/j.medmal.2005.10.007; Kube D, 2001, AM J PHYSIOL-LUNG C, V280, pL493, DOI 10.1152/ajplung.2001.280.3.L493; Lavoie EG, 2011, MICROBES INFECT, V13, P1133, DOI 10.1016/j.micinf.2011.07.011; Lee J, 2015, J MICROBIOL BIOTECHN, V25, P759, DOI 10.4014/jmb.1411.11058; Lee YY, 2015, J AGR FOOD CHEM, V63, P3472, DOI 10.1021/jf506110y; Li ZH, 2005, JAMA-J AM MED ASSOC, V293, P581, DOI 10.1001/jama.293.5.581; Lo JCY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/189016; Mohamed MF, 2014, DRUG DES DEV THER, V8, P1979, DOI 10.2147/DDDT.S72129; Pena J, 2009, INFECT IMMUN, V77, P2857, DOI 10.1128/IAI.01355-08; Pier GB, 2007, INT J MED MICROBIOL, V297, P277, DOI 10.1016/j.ijmm.2007.03.012; Prince A, 2006, AM J RESP CELL MOL, V34, P548, DOI 10.1165/rcmb.2006-0022SF; Pritt B, 2007, AM J CLIN PATHOL, V128, P32, DOI 10.1309/KJRPC7DD5TR9NTDM; Raoust E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007259; Reinholz M, 2012, ANN DERMATOL, V24, P126, DOI 10.5021/ad.2012.24.2.126; Reuben R, 2008, J IMMUNOL, V181, P586; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Salas CE, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/102129; Schuerholz T, 2013, CRIT CARE, V17, DOI 10.1186/cc11920; Scott MG, 1999, INFECT IMMUN, V67, P2005; Seo MD, 2012, MOLECULES, V17, P12276, DOI 10.3390/molecules171012276; Shim DW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126871; Som A, 2012, CLIN VACCINE IMMUNOL, V19, P1784, DOI 10.1128/CVI.00291-12; Steiner TS, 2007, INFECT IMMUN, V75, P545, DOI 10.1128/IAI.01506-06; Tseng J, 2006, AM J PHYSIOL-CELL PH, V290, pC678, DOI 10.1152/ajpcell.00166.2005; Vikstrom E, 2005, MICROBES INFECT, V7, P1512, DOI 10.1016/j.micinf.2005.05.012; Wei L, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1149-y; Wu J, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1176-8; Yoo DG, 2014, J IMMUNOL, V192, P4728, DOI 10.4049/jimmunol.1301589; Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584; Yu H, 1998, INFECT IMMUN, V66, P280, DOI 10.1128/IAI.66.1.280-288.1998; Zhang J, 2005, CURR EYE RES, V30, P527, DOI 10.1080/02713680590968150; Zhang LJ, 2005, ANTIMICROB AGENTS CH, V49, P2921, DOI 10.1128/AAC.49.7.2921-2927.2005; Zhang Z, 2005, INFECT IMMUN, V73, P7151, DOI 10.1128/IAI.73.11.7151-7160.2005; Zhang Z, 2007, INFECT IMMUN, V75, P5985, DOI 10.1128/IAI.00678-07	51	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176640	10.1371/journal.pone.0176640	http://dx.doi.org/10.1371/journal.pone.0176640			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467446	Green Submitted, gold, Green Published			2022-12-26	WOS:000400647000063
J	Echternach, M; Burk, F; Koberlein, M; Selamtzis, A; Dollinger, M; Burdumy, M; Richter, B; Herbst, CT				Echternach, Matthias; Burk, Fabian; Koeberlein, Marie; Selamtzis, Andreas; Doellinger, Michael; Burdumy, Michael; Richter, Bernhard; Herbst, Christian Thomas			Laryngeal evidence for the first and second passaggio in professionally trained sopranos	PLOS ONE			English	Article							VOCAL FOLD ADDUCTION; REGISTER TRANSITIONS; TRACT; PITCH; VOICE; VIDEOKYMOGRAPHY; MECHANISMS; RESONANCES; PHONATION; ACOUSTICS	Introduction Due to a lack of empirical data, the current understanding of the laryngeal mechanics in the passaggio regions (i.e., the fundamental frequency ranges where vocal registration events usually occur) of the female singing voice is still limited. Material and methods In this study the first and second passaggio regions of 10 professionally trained female classical soprano singers were analyzed. The sopranos performed pitch glides from A3 (f(o) = 220 Hz) to A4 (f(o) = 440 Hz) and from A4 (f(o) = 440 Hz) to A5 (f(o) = 880 Hz) on the vowel [i:]. Vocal fold vibration was assessed with trans-nasal high speed videoendoscopy at 20,000 fps, complemented by simultaneous electroglottographic (EGG) and acoustic recordings. Register breaks were perceptually rated by 12 voice experts. Voice stability was documented with the EGG-based sample entropy. Glottal opening and closing patterns during the passaggi were analyzed, supplemented with open quotient data extracted from the glottal area waveform. Results In both the first and the second passaggio, variations of vocal fold vibration patterns were found. Four distinct patterns emerged: smooth transitions with either increasing or decreasing durations of glottal closure, abrupt register transitions, and intermediate loss of vocal fold contact. Audible register transitions (in both the first and second passaggi) generally coincided with higher sample entropy values and higher open quotient variance through the respective passaggi. Conclusions Noteworthy vocal fold oscillatory registration events occur in both the first and the second passaggio even in professional sopranos. The respective transitions are hypothesized to be caused by either (a) a change of laryngeal biomechanical properties; or by (b) vocal tract resonance effects, constituting level 2 source-filter interactions.	[Echternach, Matthias; Burk, Fabian; Koeberlein, Marie; Richter, Bernhard] Univ Freiburg, Fac Med, Med Ctr, Inst Musicians Med, Freiburg, Germany; [Selamtzis, Andreas] Royal Tech Univ, Mus Acoust, Lindstedtsvagen 24, Stockholm, Sweden; [Doellinger, Michael] Univ Hosp Erlangen, Div Phoniatr & Pediat Audiol, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Waldstr 1, Erlangen, Germany; [Burdumy, Michael] Univ Freiburg, Fac Med, Med Ctr, Dept Med Phys, Freiburg, Germany; [Herbst, Christian Thomas] Univ Vienna, Dept Cognit Biol, Lab Bioacoust, Althanstr 14, Vienna, Austria	University of Freiburg; Royal Institute of Technology; University of Erlangen Nuremberg; University of Freiburg; University of Vienna	Herbst, CT (corresponding author), Univ Vienna, Dept Cognit Biol, Lab Bioacoust, Althanstr 14, Vienna, Austria.	herbst@ccrma.stanford.edu	Burdumy, Michael/M-6212-2017	Burdumy, Michael/0000-0003-4577-5515; Echternach, Matthias/0000-0003-0095-5360; Herbst, Christian/0000-0001-9095-3953; Doellinger, Michael/0000-0003-2717-4820; Selamtzis, Andreas/0000-0003-2995-1363	Deutsche Forschungsgemeinschaft (DFG) [Ec409/1-1, Ri1050/4-3, DO 1247/8-1]; Austrian Academy of Sciences; Swedish Research Council (Vetenskapsradet) [2010-4565, 2013-0642]; German Research Foundation (DFG); University of Freiburg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Austrian Academy of Sciences; Swedish Research Council (Vetenskapsradet)(Swedish Research Council); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	Matthias Echternach (grant Ec409/1-1), Bernhard Richter (grant Ri1050/4-3) and Michael Dollinger (grant DO 1247/8-1) are supported by the Deutsche Forschungsgemeinschaft (DFG). Christian T. Herbst's contribution was supported by an APART grant received from the Austrian Academy of Sciences. Andreas Selamtzis's contribution was supported by the Swedish Research Council (Vetenskapsradet) Contracts No. 2010-4565 and 2013-0642. The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing. All fundings had no role in the study, at all. There are no financial interests of the authors in relation to the work.; Matthias Echternach (grant Ec409/1-1), Bernhard Richter (grant Ri1050/ 43) and Michael Dollinger (grant DO 1247/8-1) are supported by the Deutsche Forschungsgemeinschaft (DFG). Christian T. Herbsts contribution was supported by an APART grant received from the Austrian Academy of Sciences. Andreas Selamtzis contribution was supported by the Swedish Research Council (Vetenskapsradet) Contracts No. 20104565 and 20130642. The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing. The authors thank Sten Ternstrom, PhD, (KTH Stockholm, Sweden) for his help in integration of the sample entropy, Manfred Nusseck (Institute of Musicians'Medicine, Freiburg, Germany) for statistical help and the twelve raters for their willingness to participate in this study.	BERKE GS, 1993, J VOICE, V7, P123, DOI 10.1016/S0892-1997(05)80341-8; Berry DA, 2001, J PHONETICS, V29, P431, DOI 10.1006/jpho.2001.0148; Bresch E, 2010, J ACOUST SOC AM, V128, pEL335, DOI 10.1121/1.3499700; Bruton A, 2000, PHYSIOTHERAPY, V86, P94, DOI [10.1016/S0031-9406(05)61211-4, DOI 10.1016/S0031-9406(05)61211-4, 10.1016/s0031-9406(05)61211-4]; Bunch M, 2000, J VOICE, V14, P363, DOI 10.1016/S0892-1997(00)80081-8; Castellengo M, 2004, P INT S MUS AC; Colton R H, 1972, Folia Phoniatr (Basel), V24, P337; Colton R H, 1973, Folia Phoniatr (Basel), V25, P62; Echternach M, 2016, J VOICE; Echternach M, 2010, UNTERSUCHUNGEN REGIS; Echternach M, 2010, UNTERSUCHUNG ANAL ST, P97; Echternach M, 2014, J VOICE, V28, p262e1; Echternach M, 2008, LOGOP PHONIATR VOCO, V33, P67, DOI 10.1080/14015430701875653; Echternach M, 2016, LOGOP PHONIATR VOCO, V41, P1, DOI 10.3109/14015439.2014.936499; Echternach M, 2015, J ACOUST SOC AM, V137, P2586, DOI 10.1121/1.4919356; Echternach M, 2012, J VOICE, V26, DOI 10.1016/j.jvoice.2012.02.003; Echternach M, 2012, J VOICE, V26, P440, DOI 10.1016/j.jvoice.2011.03.004; Echternach M, 2011, J VOICE, V25, P670, DOI 10.1016/j.jvoice.2010.09.008; Echternach M, 2011, J VOICE, V25, P663, DOI 10.1016/j.jvoice.2010.01.013; Echternach M, 2011, J ACOUST SOC AM, V129, P3955, DOI 10.1121/1.3589249; Echternach M, 2010, J VOICE, V24, P133, DOI 10.1016/j.jvoice.2008.06.004; Fant G., 1960, ACOUSTIC THEORY SPEE; Garcia M, 1841, ESCULAPE, V3, P105; Hampala V, 2016, J VOICE, V30, P161, DOI 10.1016/j.jvoice.2015.03.018; Henrich Nathalie, 2006, Logoped Phoniatr Vocol, V31, P3; Henrich N, 2011, J ACOUST SOC AM, V129, P1024, DOI 10.1121/1.3518766; Herbst CT, 2011, J ACOUST SOC AM, V129, P2253, DOI 10.1121/1.3552874; Herbst CT, 2010, J ACOUST SOC AM, V128, P3070, DOI 10.1121/1.3493423; HIRANO M, 1970, FOLIA PHONIATR, V22, P1, DOI 10.1159/000263363; Hollien H, 1983, STOCKH MUS AC C SMAC, P27; Inwald EC, 2011, J VOICE, V25, P576, DOI 10.1016/j.jvoice.2010.04.004; Joliveau E, 2004, NATURE, V427, P116, DOI 10.1038/427116a; Kochis-Jennings KA, 2012, J VOICE, V26, P182, DOI 10.1016/j.jvoice.2010.11.002; Large J, 1968, NATS B, V24, P12; Large J, 1972, NATS B, V28, P18; Lehfeldt C, 1835, HDB PHYSL MENSCHEN V; Merkel CL, 1863, ANATOMIE PHYSL MENSC; Miller D., 2000, REGISTERS SINGING EM; MILLER DG, 1993, J VOICE, V7, P206, DOI 10.1016/S0892-1997(05)80328-5; Miller R., 1986, STRUCTURE SINGING; Muller J., 1840, HDB PHYSIOLOGIE MENS; Nadoleczny M, 1923, UNTERSUCHUNGEN KUNST; Neumann K, 2005, FOLIA PHONIATR LOGO, V57, P308, DOI 10.1159/000087084; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Roubeau B, 2009, J VOICE, V23, P425, DOI 10.1016/j.jvoice.2007.10.014; RUBIN HENRY J., 1960, LARYNGOSCOPE, V70, P1305; Seidner W, 2004, DIE SANGERSTIMME; Selamtzis A, 2014, J ACOUST SOC AM, V136, P2773, DOI 10.1121/1.4896466; Sonninen A, 1999, J VOICE, V13, P319, DOI 10.1016/S0892-1997(99)80039-3; SUNDBERG J, 1975, ACUSTICA, V32, P89; Sundberg J, 2001, Logoped Phoniatr Vocol, V26, P26, DOI 10.1080/140154301300109107; Sundberg J, 1999, LOGOP PHONIATR VOCO, V24, P76; Sundberg J., 1987, SCI SINGING VOICE; Sundberg J, 2009, J VOICE, V23, P546, DOI 10.1016/j.jvoice.2008.02.003; Svec JG, 2008, J ACOUST SOC AM, V123, P347, DOI 10.1121/1.2804939; Svec JG, 1999, J ACOUST SOC AM, V106, P1523, DOI 10.1121/1.427149; Svec JG, 1996, J VOICE, V10, P201, DOI 10.1016/S0892-1997(96)80047-6; Titze IR, 2008, J ACOUST SOC AM, V123, P2733, DOI 10.1121/1.2832337; Titze IR, 2015, J ACOUST SOC AM, V137, P3005, DOI 10.1121/1.4919349; Titze IR, 2014, J ACOUST SOC AM, V135, P2091, DOI 10.1121/1.4868355; Titze IR, 2009, J ACOUST SOC AM, V126, P1530, DOI 10.1121/1.3160296; Titze IR, 1994, PRINCIPLES VOICE PRO; Titze IR, 1988, J VOICE, V2, P183, DOI [10.1016/S0892-1997(88)80075-4, DOI 10.1016/S0892-1997(88)80075-4]; Tokuda IT, 2010, J ACOUST SOC AM, V127, P1528, DOI 10.1121/1.3299201; Van den Berg JW, 1963, NATS B, V20, P16; Vennard W., 1967, SINGING MECH TECHNIC; Zanartu M, 2011, J ACOUST SOC AM, V129, P326, DOI 10.1121/1.3514536	68	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0175865	10.1371/journal.pone.0175865	http://dx.doi.org/10.1371/journal.pone.0175865			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467509	Green Published, Green Submitted, gold			2022-12-26	WOS:000400647000027
J	Seo, Y; Kim, YS; Lee, KE; Park, TH; Kim, Y				Seo, Yoona; Kim, Yoo-Sun; Lee, Kyung Eun; Park, Tai Hyun; Kim, Yuri			Anti-cancer stemness and anti-invasive activity of bitter taste receptors, TAS2R8 and TAS2R10, in human neuroblastoma cells	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; PROTEIN-COUPLED RECEPTORS; GENE-EXPRESSION; TUMOR-METASTASIS; BETA-CAROTENE; WILLOW BARK; IN-VITRO; CANCER; DIFFERENTIATION; MOLECULES	Neuroblastoma (NB) originates from immature neuronal cells and currently has a poor clinical outcome. NB cells possess cancer stem cells (CSCs) characteristics that facilitate the initiation of a tumor, as well as its metastasis. Human bitter taste receptors, referred to as TAS2Rs, are one of five types of basic taste receptors and they belong to a family of G-protein coupled receptors. The recent finding that taste receptors are expressed in non-gustatory tissues suggest that they mediate additional functions distinct from taste perception. While it is generally admitted that the recognition of bitter tastes may be associated with a self-defense system to prevent the ingestion of poisonous food compounds, this recognition may also serve as a disease-related function in the human body. In particular, the anti-cancer stemness and invasion effects of TAS2Rs on NB cells remain poorly understood. In the present study, endogenous expression of TAS2R8 and TAS2R10 in SK-N-BE(2) C and SH-SY5Y cells was examined. In addition, higher levels of TAS2R8 and TAS2R10 expression were investigated in more differentiated SY5Y cells. Both TAS2Rs were up-regulated following the induction of neuronal cell differentiation by retinoic acid. In addition, ectopic transfection of the two TAS2Rs induced neurite elongation in the BE(2) C cells, and down-regulated CSCs markers (including DLK1, CD133, Notch1, and Sox2), and suppressed self-renewal characteristics. In particular, TAS2RS inhibited tumorigenicity. Furthermore, when TAS2Rs was over-expressed, cell migration, cell invasion, and matrix metalloproteinases activity were inhibited. Expression levels of hypoxia-inducible factor-1 alpha, a well-known regulator of tumor metastasis, as well as its downstream targets, vascular endothelial growth factor and glucose transporter-1, were also suppressed by TAS2Rs. Taken together, these novel findings suggest that TAS2Rs targets CSCs by suppressing cancer stemness characteristics and NB cell invasion, thereby highlighting the chemotherapeutic potential of bitter taste receptors.	[Seo, Yoona; Kim, Yoo-Sun; Lee, Kyung Eun; Kim, Yuri] Ewha Womans Univ, Dept Nutr Sci & Food Management, Seoul, South Korea; [Park, Tai Hyun] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul, South Korea	Ewha Womans University; Seoul National University (SNU)	Kim, Y (corresponding author), Ewha Womans Univ, Dept Nutr Sci & Food Management, Seoul, South Korea.	yuri.kim@ewha.ac.kr	Park, Tai Hyun/C-6529-2013	Seo, Yoona/0000-0001-7510-2501	Brain Korea 21 Plus [22A20130012143]	Brain Korea 21 Plus	This work was supported by the Brain Korea 21 Plus (Project No. 22A20130012143). The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta S, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-12; American Cancer Society, 2016, CANC FACTS FIGURES 2; Avau B, 2016, ACTA PHYSIOL, V216, P407, DOI 10.1111/apha.12621; Begum A, 2012, CANCER LETT, V318, P26, DOI 10.1016/j.canlet.2011.11.032; Behrens M, 2004, BIOCHEM BIOPH RES CO, V319, P479, DOI 10.1016/j.bbrc.2004.05.019; Behrens M, 2009, RESULTS PROBL CELL D, V47, P203, DOI 10.1007/400_2008_5; Brockhoff A, 2007, J AGR FOOD CHEM, V55, P6236, DOI 10.1021/jf070503p; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Catapano LA, 2007, BBA-BIOMEMBRANES, V1768, P976, DOI 10.1016/j.bbamem.2006.09.025; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chen K, 2013, ACTA PHARMACOL SIN, V34, P732, DOI 10.1038/aps.2013.27; CICCARONE V, 1989, CANCER RES, V49, P219; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Das S, 2003, MOL CELL BIOCHEM, V253, P31, DOI 10.1023/A:1026093016148; Dehkordi O, 2012, BRAIN RES, V1475, P1, DOI 10.1016/j.brainres.2012.07.038; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Foster SR, 2014, PHARMACOL THERAPEUT, V142, P41, DOI 10.1016/j.pharmthera.2013.11.004; Gaida MM, 2016, ONCOTARGET, V7, P12623, DOI 10.18632/oncotarget.7206; Garcia-Esparcia P, 2013, J NEUROPATH EXP NEUR, V72, P524, DOI 10.1097/NEN.0b013e318294fd76; Hussein D, 2006, MOL CANCER THER, V5, P2241, DOI 10.1158/1535-7163.MCT-06-0145; Jaggupilli A, 2016, INT J BIOCHEM CELL B, V77, P184, DOI 10.1016/j.biocel.2016.03.005; Jogi A, 2002, P NATL ACAD SCI USA, V99, P7021, DOI 10.1073/pnas.102660199; Kamijo T, 2012, PEDIATR RES, V71, P511, DOI 10.1038/pr.2011.54; Kaur S, 2014, J CANCER RES THER, V10, P846, DOI 10.4103/0973-1482.139264; Kim SY, 2010, NEUROCHEM INT, V56, P437, DOI 10.1016/j.neuint.2009.11.019; Kim Y, 2009, CANCER RES, V69, P9271, DOI 10.1158/0008-5472.CAN-09-1605; Kong CS, 2014, PHYTOTHER RES, V28, P1246, DOI 10.1002/ptr.5126; Krishnakumar N., 2011, PREV NUTR FOOD SCI, V1, P223, DOI DOI 10.1016/J.BIONUT.2011.09.003; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lee HA, 2013, ONCOL REP, V30, P1869, DOI 10.3892/or.2013.2643; Lee YH, 2015, NEOPLASMA, V62, P230, DOI 10.4149/neo_2015_028; Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329; Lim JY, 2014, BIOCHEM BIOPH RES CO, V450, P1475, DOI 10.1016/j.bbrc.2014.07.021; Lu P, 2017, J GEN PHYSIOL, V149, P181, DOI 10.1085/jgp.201611637; Lynch JR, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050707; Mahller YY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004235; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Navarro G, 2016, NEUROPHARMACOLOGY, V104, P161, DOI 10.1016/j.neuropharm.2015.07.024; Orsmark-Pietrast C, 2013, EUR RESPIR J, V42, P65, DOI 10.1183/09031936.00077712; Park S, 2013, BIOSCI BIOTECH BIOCH, V77, P722, DOI 10.1271/bbb.120763; Priya ES, 2014, NEUROL SCI, V35, P163, DOI 10.1007/s10072-013-1462-1; Puppo M, 2008, MOL CANCER THER, V7, P1974, DOI 10.1158/1535-7163.MCT-07-2059; Rask-Andersen M, 2014, ANNU REV PHARMACOL, V54, P9, DOI 10.1146/annurev-pharmtox-011613-135943; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Roomi MW, 2009, ONCOL REP, V21, P1323, DOI 10.3892/or_00000358; Shaik FA, 2016, INT J BIOCHEM CELL B, V77, P197, DOI 10.1016/j.biocel.2016.03.011; Singh N, 2014, BIOCHEM BIOPH RES CO, V446, P499, DOI 10.1016/j.bbrc.2014.02.140; Singh N, 2011, BIOCHEM BIOPH RES CO, V406, P146, DOI 10.1016/j.bbrc.2011.02.016; Sporn MB, 1996, LANCET, V347, P1377, DOI 10.1016/S0140-6736(96)91015-6; Stetler-Stevenson W G, 2001, Surg Oncol Clin N Am, V10, P383; Sugiura Y, 1998, CANCER RES, V58, P2209; Tsai YP, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-102; Ueno Y, 2011, BIOSCI BIOTECH BIOCH, V75, P1188, DOI 10.1271/bbb.100893; Upadhyaya J, 2010, BIOCHEM BIOPH RES CO, V398, P331, DOI 10.1016/j.bbrc.2010.06.097; Vegezzi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107732; Wiener A, 2012, NUCLEIC ACIDS RES, V40, pD413, DOI 10.1093/nar/gkr755; Wolfle U, 2015, PHYTOTHER RES, V29, P1494, DOI 10.1002/ptr.5400; Xiang ZL, 2011, CLIN CANCER RES, V17, P5463, DOI 10.1158/1078-0432.CCR-10-3096; Xu L, 2010, CLIN EXP METASTAS, V27, P241, DOI 10.1007/s10585-010-9322-3; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Yu B, 2017, J ETHNOPHARMACOL, V195, P71, DOI 10.1016/j.jep.2016.11.049; ZETTER BR, 1993, SEMIN CANCER BIOL, V4, P219; Zhang YS, 2010, MOL NUTR FOOD RES, V54, P127, DOI 10.1002/mnfr.200900323; Zhou Q, 2002, BREAST CANCER RES TR, V75, P107, DOI 10.1023/A:1019698807564	67	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e176851	10.1371/journal.pone.0176851	http://dx.doi.org/10.1371/journal.pone.0176851			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467517	Green Published, Green Submitted, gold			2022-12-26	WOS:000400647000079
J	Jun, DY; Kim, HJ; Jong, WY; Lee, JY; Fukui, K; Kim, YH				Jun, Do Youn; Kim, Hyejin; Jong, Won Young; Lee, Ji Young; Fukui, Kiyoshi; Kim, Young Ho			Ectopic overexpression of LAPTM5 results in lysosomal targeting and induces Mcl-1 down-regulation, Bak activation, and mitochondria-dependent apoptosis in human HeLa cells	PLOS ONE			English	Article							JURKAT T-CELLS; HL-60 CELLS; CASPASE-8 ACTIVATION; SIGNALING PATHWAY; MEMBRANE-PROTEIN; TRANSMEMBRANE 5; BID CLEAVAGE; DIFFERENTIATION; EXPRESSION; GENE	Human lysosomal-associated protein multispanning membrane 5 (LAPTM5) was identified by an ordered differential display-polymerase chain reaction (ODD-PCR) as an up-regulated cDNA fragment during 12-O-tetradecanoylphorbol 13-acetate (TPA)-induced differentiation of U937 cells into monocytes/macrophages. After TPA-treatment, the levels of LAPTM5 mRNA and protein increased and reached a maximum at 18-36 h. In healthy human tissues, LAPTM5 mRNA was expressed at high levels in hematopoietic cells and tissues, at low levels in the lung and fetal liver, and was not detected in other non-hematopoietic tissues. LAPTM5 mRNA was detected in immature malignant cells of myeloid lineage, such as K562, HL-60, U937, and THP-1 cells, and in unstimulated peripheral T cells, but was absent or barely detectable in lymphoid malignant or non-hematopoietic malignant cells. The LAPTM5 level in HL-60 cells increased more significantly during TPA-induced monocyte/macrophage differentiation than during DMSO-induced granulocyte differentiation. Ectopic expression of GFP-LAPTM5 or LAPTM5 in HeLa cells exhibited the localization of LAPTM5 to the lysosome. In HeLa cells overexpressing LAPTM5, the Mcl-1 and Bid levels declined markedly and apoptosis was induced via Bak activation, Delta psi m loss, activation of caspase-9, -8 and -3, and PARP degradation without accompanying necrosis. However, these LAPTM5-induced apoptotic events except for the decline of Bid level were completely abrogated by concomitant overexpression of Mcl-1. The pan-caspase inhibitor (z-VAD-fmk) could suppress the LAPTM5-induced apoptotic sub-G(1) peak by similar to 40% but failed to block the induced Delta psi m loss, whereas the broad-range inhibitor of cathepsins (Cathepsin Inhibitor I) could suppress the LAPTM5-induced apoptotic sub-G1 peak and Delta psi m loss, by similar to 22% and similar to 23%, respectively, suggesting that the LAPTM5-mediated Delta psi m loss was exerted at least in part in a cathepsin-dependent manner. Together, these results demonstrate that ectopic overexpression of LAPTM5 in HeLa cells induced apoptosis via cleavage of Mcl-1 and Bid by a LAPTM5-associated lysosomal pathway, and subsequent activation of the mitochondria-dependent caspase cascade.	[Jun, Do Youn; Kim, Hyejin; Jong, Won Young; Lee, Ji Young; Kim, Young Ho] Kyungpook Natl Univ, Coll Nat Sci, Sch Life Sci & Biotechnol, Lab Immunobiol, Daegu, South Korea; [Jun, Do Youn] Kyungpook Natl Univ, Inst Life Sci & Biotechnol, Daegu, South Korea; [Fukui, Kiyoshi] Univ Tokushima, Inst Enzyme Res, Div Gene Regulator, Kuramoto Cho, Tokushima, Japan	Kyungpook National University; Kyungpook National University; Tokushima University	Kim, YH (corresponding author), Kyungpook Natl Univ, Coll Nat Sci, Sch Life Sci & Biotechnol, Lab Immunobiol, Daegu, South Korea.	ykim@knu.ac.ar		Fukui, Kiyoshi/0000-0002-7438-4938	National Research Foundation of Korea Grant - Korean Government [NRF-353-2009-2-F00021]	National Research Foundation of Korea Grant - Korean Government	This work was supported by the National Research Foundation of Korea Grant funded by the Korean Government (NRF-353-2009-2-F00021), recipient: DYJ.; We thank Dr. Takahiro Nagase (Kazusa DNA Research Institute, Kisarazu, Chiba 292, Japan) for kindly providing full-length cDNA of human LAPTM5 (KIAA0085; GenBank D42042). This work was supported by the National Research Foundation of Korea Grant funded by the Korean Government (NRF-353-2009-2-F00021).	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Adra CN, 1996, GENOMICS, V35, P328, DOI 10.1006/geno.1996.0364; Anto RJ, 2002, CARCINOGENESIS, V23, P143, DOI 10.1093/carcin/23.1.143; Blomgran R, 2007, J LEUKOCYTE BIOL, V81, P1213, DOI 10.1189/jlb.0506359; Bokoch GM, 2003, TRENDS BIOCHEM SCI, V28, P502, DOI 10.1016/S0968-0004(03)00194-4; Botling J, 1995, LEUKEMIA, V9, P2034; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; Cabrita MA, 1999, CANCER RES, V59, P4890; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chun EM, 2001, J LEUKOCYTE BIOL, V69, P645; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; Dale DC, 2008, BLOOD, V112, P935, DOI 10.1182/blood-2007-12-077917; Glowacka WK, 2012, J BIOL CHEM, V287, P27691, DOI 10.1074/jbc.M112.355917; Han CR, 2013, BIOCHIM BIOPHYS ACTA, V1833, P2220; HASS R, 1989, EUR J CELL BIOL, V48, P282; Hayami Y, 2003, LEUKEMIA, V17, P1650, DOI 10.1038/sj.leu.2403026; HORIGUCHIYAMADA J, 1993, MOL CELL BIOCHEM, V119, P29, DOI 10.1007/BF00926850; Inoue J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007099; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Jun DY, 2007, CARCINOGENESIS, V28, P1303, DOI 10.1093/carcin/bgm028; Jun DY, 1996, J MICROBIOL BIOTECHN, V6, P474; Kim SM, 2009, TOXICOL APPL PHARM, V241, P210, DOI 10.1016/j.taap.2009.08.024; KIM YH, 1992, J IMMUNOL, V149, P17; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Matz M, 1997, NUCLEIC ACIDS RES, V25, P2541, DOI 10.1093/nar/25.12.2541; MCCARTHY DM, 1983, LEUKEMIA RES, V7, P51, DOI 10.1016/0145-2126(83)90057-7; Milkereit R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027478; Nuylan M, 2016, ONCOTARGET, V7, P28320, DOI 10.18632/oncotarget.8614; Origasa M, 2001, MOL BRAIN RES, V88, P1, DOI 10.1016/S0169-328X(01)00005-5; Ouchida R, 2008, IMMUNITY, V29, P33, DOI 10.1016/j.immuni.2008.04.024; Ouchida R, 2010, J IMMUNOL, V185, P294, DOI 10.4049/jimmunol.1000371; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Park HS, 2011, BIOCHEM PHARMACOL, V82, P1110, DOI 10.1016/j.bcp.2011.07.085; Repnik U, 2012, BBA-PROTEINS PROTEOM, V1824, P22, DOI 10.1016/j.bbapap.2011.08.016; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Tada-Oikawa S, 1998, BIOCHEM BIOPH RES CO, V247, P693, DOI 10.1006/bbrc.1998.8869; Tang DM, 2000, J BIOL CHEM, V275, P9303, DOI 10.1074/jbc.275.13.9303; TARELLA C, 1982, CANCER RES, V42, P445; Walker MG, 2002, BBA-GENE STRUCT EXPR, V1574, P387, DOI 10.1016/S0167-4781(01)00358-X; Woo HJ, 2012, PROCESS BIOCHEM, V47, P1861, DOI 10.1016/j.procbio.2012.06.012	44	7	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176544	10.1371/journal.pone.0176544	http://dx.doi.org/10.1371/journal.pone.0176544			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28464033	gold, Green Published, Green Submitted			2022-12-26	WOS:000400646300031
J	Wang, FJ; Wang, CB; Zou, TL; Xu, NJ; Sun, X				Wang, Fangjun; Wang, Chongbin; Zou, Tonglei; Xu, Nianjun; Sun, Xue			Comparative transcriptional profiling of Gracilariopsis lemaneiformis in response to salicylic acid- and methyl jasmonate-mediated heat resistance	PLOS ONE			English	Article							SIGNALING PATHWAYS; BASAL THERMOTOLERANCE; ARABIDOPSIS-THALIANA; STRESS-RESPONSE; PLANTS; TOLERANCE; GENE; PHOTOSYNTHESIS; ACCLIMATION; EXPRESSION	Culturing the economically important macroalga Gracilariopsis lemaneiformis (Rhodophyta) is limited due to the high temperatures in the summertime on the southern Chinese coast. Previous studies have demonstrated that two phytohormones, salicylic acid (SA) and methyl jasmonate (MJ), can alleviate the adverse effects of high-temperature stress on Gp. lemaneiformis. To elucidate the molecular mechanisms underlying SA-and MJ-mediated heat tolerance, we performed comprehensive analyses of transcriptome-wide gene expression profiles using RNA sequencing (RNA-seq) technology. A total of 14,644 unigenes were assembled, and 10,501 unigenes (71.71%) were annotated to the reference databases. In the SA, MJ and SA/MJ treatment groups, 519, 830, and 974 differentially expressed unigenes were detected, respectively. Unigenes related to photosynthesis and glycometabolism were enriched by SA, while unigenes associated with glycometabolism, protein synthesis, heat shock and signal transduction were increased by MJ. A crosstalk analysis revealed that 216 genes were synergistically regulated, while 18 genes were antagonistically regulated by SA and MJ. The results indicated that the two phytohormones could mitigate the adverse effects of heat on multiple pathways, and they predominantly acted synergistically to resist heat stress. These results will provide new insights into how SA and MJ modulate the molecular mechanisms that counteract heat stress in algae.	[Wang, Fangjun; Wang, Chongbin; Zou, Tonglei; Xu, Nianjun; Sun, Xue] Ningbo Univ, Sch Marine Sci, Ningbo, Zhejiang, Peoples R China; [Wang, Fangjun; Wang, Chongbin; Zou, Tonglei; Xu, Nianjun; Sun, Xue] Key Lab Marine Biotechnol Zhejiang Prov, Ningbo, Zhejiang, Peoples R China	Ningbo University	Sun, X (corresponding author), Ningbo Univ, Sch Marine Sci, Ningbo, Zhejiang, Peoples R China.; Sun, X (corresponding author), Key Lab Marine Biotechnol Zhejiang Prov, Ningbo, Zhejiang, Peoples R China.	sunxue@nbu.edu.cn			National Natural Science Foundation of China [41376151, 31672674]; K. C. Wong Magna Fund from Ningbo University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); K. C. Wong Magna Fund from Ningbo University	l This work was supported by National Natural Science Foundation of China (41376151, 31672674). This research was also sponsored by the K. C. Wong Magna Fund from Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (41376151, 31672674). This research was also sponsored by the K. C. Wong Magna Fund in Ningbo University.	An FY, 2010, PLANT CELL, V22, P2384, DOI 10.1105/tpc.110.076588; Batistic O, 2012, BBA-GEN SUBJECTS, V1820, P1283, DOI 10.1016/j.bbagen.2011.10.012; Chakraborty U, 2005, CURR SCI INDIA, V89, P384; Cheong YH, 2010, MOL CELLS, V29, P159, DOI 10.1007/s10059-010-0025-z; Clarke SM, 2009, NEW PHYTOL, V182, P175, DOI 10.1111/j.1469-8137.2008.02735.x; Clarke SM, 2004, PLANT J, V38, P432, DOI 10.1111/j.1365-313X.2004.02054.x; Dat JF, 1998, PLANT PHYSIOL, V116, P1351, DOI 10.1104/pp.116.4.1351; Fei XG, 2004, HYDROBIOLOGIA, V512, P145, DOI 10.1023/B:HYDR.0000020320.68331.ce; Foyer CH, 2012, PLANT SIGNAL BEHAV, V7, P276, DOI 10.4161/psb.18770; Hayat Q, 2010, ENVIRON EXP BOT, V68, P14, DOI 10.1016/j.envexpbot.2009.08.005; Hey SJ, 2010, ANN BOT-LONDON, V105, P197, DOI 10.1093/aob/mcp285; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Leon-Reyes A, 2010, PLANTA, V232, P1423, DOI 10.1007/s00425-010-1265-z; Li TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109492; Liu Y, 2005, SCI CHINA SER C, V48, P202, DOI 10.1360/04yc0088; Liu YuePing, 2005, Acta Horticulturae Sinica, V32, P381; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Moon JC, 2014, GENES GENOM, V36, P151, DOI 10.1007/s13258-013-0152-y; Niki T, 1998, PLANT CELL PHYSIOL, V39, P500, DOI 10.1093/oxfordjournals.pcp.a029397; Salzman RA, 2005, PLANT PHYSIOL, V138, P352, DOI 10.1104/pp.104.058206; Takahashi S, 2004, PLANT CELL PHYSIOL, V45, P251, DOI 10.1093/pcp/pch028; Tang Ting, 2012, Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao, V28, P127; Velitchkova M, 1998, PHOTOSYNTHETICA, V35, P89, DOI 10.1023/A:1006878016556; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wang ChongBin, 2015, Oceanologia et Limnologia Sinica / Hai Yang Yu Hu Chao, V46, P1132; Wang LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-34; Wang LJ, 2006, PLANT SCI, V170, P685, DOI 10.1016/j.plantsci.2005.09.005; Wang Y, 2016, J APPL PHYCOL, V28, P1847, DOI 10.1007/s10811-015-0723-1; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Wei JN, 2014, J EXP BOT, V65, P3289, DOI 10.1093/jxb/eru181; Xu S, 2006, ENVIRON EXP BOT, V56, P274, DOI 10.1016/j.envexpbot.2005.03.002; Yang HR, 2011, SCI HORTIC-AMSTERDAM, V128, P166, DOI 10.1016/j.scienta.2011.01.015; [杨华庚 Yang Huageng], 2011, [中国农学通报, Chinese Agricultural Science Bulletin], V27, P150; Yang YX, 2015, CURR PROTEIN PEPT SC, V16, P450, DOI 10.2174/1389203716666150330141638; Zhang Q, 2012, PLANT J, V72, P805, DOI 10.1111/j.1365-313X.2012.05121.x; Zhao YY, 2014, MOL PLANT MICROBE IN, V27, P638, DOI 10.1094/MPMI-08-13-0250-R; Zhou RG, 2009, PROG NAT SCI-MATER, V19, P1201, DOI 10.1016/j.pnsc.2008.12.011; Zou QC, 2011, J PLANT PHYSL, V47, P913	40	17	20	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176531	10.1371/journal.pone.0176531	http://dx.doi.org/10.1371/journal.pone.0176531			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28464018	Green Published, Green Submitted, gold			2022-12-26	WOS:000400646300029
J	Grant, WB; Boucher, BJ				Grant, William B.; Boucher, Barbara J.			Randomized controlled trials of vitamin D and cancer incidence: A modeling study	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; D SUPPLEMENTATION; CALCIUM SUPPLEMENTATION; RISK; WOMEN; DIAGNOSIS; SURVIVAL; HEALTH; UVB	Although geographic ecological studies and observational studies find that ultraviolet B exposure and 25-hydroxyvitamin D [25(OH) D] concentrations are inversely correlated with 15 - 20 types of cancer, few randomized controlled trials (RCTs) of vitamin D support those findings. The poor design of some RCTs may account for that lack of support. Most vitamin D RCTs to date have considered the vitamin D dose, rather than initial, final, or changes in, serum 25(OH) D concentrations. Here a model is developed for use in designing and analyzing vitamin D RCTs with application to cancer incidence. The input variables of the model are vitamin D dose, baseline and achieved 25(OH) D concentrations, known rates of cancer for the population, and numbers of participants for the treatment and placebo arms is estimated - vitamin D dosage and numbers of participants are varied to achieve desired hazard ratio significance, using information from two vitamin D RCTs on cancer incidence conducted in Nebraska with good agreement between the model estimates and reported hazard ratios. Further improvements to the conduct of vitamin D RCTs would be to start the trial with a moderate bolus dose to achieve the desired 25(OH) D concentrations, and bloodspot 25(OH) D assay use in summer and winter annually to monitor seasonal and long-term changes in 25(OH) D concentration and compliance, and to allow dosage adjustment for achievement of desired vitamin D status.	[Grant, William B.] Sunlight Nutr & Hlth Res Ctr, San Francisco, CA 94164 USA; [Boucher, Barbara J.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England	University of London; Queen Mary University London	Grant, WB (corresponding author), Sunlight Nutr & Hlth Res Ctr, San Francisco, CA 94164 USA.	wbgrant@infionline.net	Grant, William B./B-8311-2009	Grant, William B./0000-0002-1439-3285				Afzal S, 2013, CLIN CHEM, V59, P771, DOI 10.1373/clinchem.2012.201939; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Berry DJ, 2016, J CLIN LAB ANAL; Bikle DD, 2014, ENDOCRINE, V46, P29, DOI 10.1007/s12020-013-0146-1; Bolland MJ, 2014, LANCET DIABETES ENDO, V2, P307, DOI 10.1016/S2213-8587(13)70212-2; Bolland MJ, 2011, AM J CLIN NUTR, V94, P1144, DOI 10.3945/ajcn.111.015032; Canada S, CONS PRIC IND HIST S; Carlberg C., 2016, J STEROID BIOCHEM; Engelman CD, 2013, J NUTR, V143, P17, DOI 10.3945/jn.112.169482; Fanidi A, 2016, SCI REP-UK, V6, DOI 10.1038/srep36017; Fedirko V, 2012, CANCER CAUSE CONTROL, V23, P1149, DOI 10.1007/s10552-012-9984-z; Garland CF, 2011, ANTICANCER RES, V31, P607; GARLAND CF, 1980, INT J EPIDEMIOL, V9, P227, DOI 10.1093/ije/9.3.227; Grant WB, 2006, ANTICANCER RES, V26, P2687; Grant WB, 2016, DERM-ENDOCRINOL, V8, DOI 10.1080/19381980.2016.1248324; Grant WB, 2016, ANTICANCER RES, V36, P1357; Grant WB, 2015, ANTICANCER RES, V35, P1154; Grant WB, 2014, CLIN CANCER RES, V20, P2241, DOI 10.1158/1078-0432.CCR-14-0369; Grant WB, 2012, DERM-ENDOCRINOL, V4, P198, DOI 10.4161/derm.20514; Heaney RP, 2014, NUTR REV, V72, P48, DOI 10.1111/nure.12090; Heaney RP, 2003, AM J CLIN NUTR, V77, P204, DOI 10.1093/ajcn/77.1.204; Kelly JL, 2012, CANCER CAUSE CONTROL, V23, P1017, DOI 10.1007/s10552-012-9967-0; Kroll MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118108; Kulcsar-Jakab E, 2017, J ESTABLISHED RESULT; Lappe J, 2017, JAMA-J AM MED ASSOC, V317, P1234, DOI 10.1001/jama.2017.2115; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Marshall JE, 2017, OFFICIAL J EUROPEAN; McCullough ML, 2008, PREV MED, V46, P298, DOI 10.1016/j.ypmed.2007.11.010; McDonnell SL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152441; McNally JD, 2015, PEDIATRICS, V135, pE152, DOI 10.1542/peds.2014-1703; Mirzakhani H, 2016, J CLIN INVEST, V126, P4702, DOI 10.1172/JCI89031; Moukayed M, 2017, REV ENDOCR METAB DIS; Moukayed M, 2013, NUTRIENTS, V5, P3993, DOI 10.3390/nu5103993; Muller DC, 2015, CANCER EPIDEM BIOMAR, V24, P1277, DOI 10.1158/1055-9965.EPI-14-1351; Nikooyeh B, 2017, J CLIN LAB ANAL, V31, DOI 10.1002/jcla.22117; Qin B, 2016, BRIT J CANCER, V115, P1122, DOI 10.1038/bjc.2016.289; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Spedding S, 2013, NUTRIENTS, V5, P5127, DOI 10.3390/nu5125127; Thakkar JP, 2014, AM J MED SCI, V348, P65, DOI 10.1097/MAJ.0000000000000281; Theodoratou E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2035; von Hurst PR, 2010, BRIT J NUTR, V103, P549, DOI 10.1017/S0007114509992017; Wagner CL, 2016, J STEROID BIOCHEM, V155, P245, DOI 10.1016/j.jsbmb.2015.10.022; Wagner CL, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.10.888; Wolpin BM, 2012, CANCER EPIDEM BIOMAR, V21, P82, DOI 10.1158/1055-9965.EPI-11-0836; Zhang MZ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40593; Zittermann A, 2014, EUR J NUTR, V53, P367, DOI 10.1007/s00394-013-0634-3	46	38	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176448	10.1371/journal.pone.0176448	http://dx.doi.org/10.1371/journal.pone.0176448			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459861	gold, Green Submitted, Green Published			2022-12-26	WOS:000400645000034
J	Duruz, S; Flury, C; Matasci, G; Joerin, F; Widmer, I; Joost, S				Duruz, Solange; Flury, Christine; Matasci, Giona; Joerin, Florent; Widmer, Ivo; Joost, Stephane			A WebGIS platform for the monitoring of Farm Animal Genetic Resources (GENMON)	PLOS ONE			English	Article							LIVESTOCK BREEDS; CONSERVATION; DIVERSITY; POPULATIONS; MANAGEMENT; BIODIVERSITY; RELATEDNESS; DECISION; CRITERIA; TOOLS	Background In 2007, the Food and Agriculture Organization of the United Nations (FAO) initiated the Global plan of action for Farm Animal Genetic Resources (FAnGR). The main goal of this plan is to reduce further loss of genetic diversity in farm animals, so as to protect and promote the diversity of farm animal resources. An important step to reach this goal is to monitor and prioritize endangered breeds in the context of conservation programs. Methodology/Web portal implementation The GENMON WebGIS platform is able to monitor FAnGR and to evaluate the degree of endangerment of livestock breeds. The system takes into account pedigree and introgression information, the geographical concentration of animals, the cryo-conservation plan and the sustainability of breeding activities based on socio-economic data as well as present and future land use conditions. A multi-criteria decision tool supports the aggregation of the multi-thematic indices mentioned above using the MACBETH method, which is based on a weighted average using satisfaction thresholds. GENMON is a monitoring tool to reach subjective decisions made by a government agency. It relies on open source software and is available at http://lasigsrv2.epfl.ch/genmon-ch. Results/Significance GENMON allows users to upload pedigree-information (animal ID, parents, birthdate, sex, location and introgression) from a specific livestock breed and to define species and/or region-specific weighting parameters and thresholds. The program then completes a pedigree analysis and derives several indices that are used to calculate an integrated score of conservation prioritization for the breeds under investigation. The score can be visualized on a geographic map and allows a fast, intuitive and regional identification of breeds in danger. Appropriate conservation actions and breeding programs can thus be undertaken in order to promote the recovery of the genetic diversity in livestock breeds in need. The use of the platform is illustrated by means of an example based on three local livestock breeds from different species in Switzerland.	[Duruz, Solange; Widmer, Ivo; Joost, Stephane] Ecole Polytech Fed Lausanne, Sch Architecture Civil & Environm Engn ENAC, Lab Geog Informat Syst LASIG, Lausanne, Switzerland; [Flury, Christine] Bern Univ Appl Sci, Sch Agr Forest & Food Sci, Zollikofen, Switzerland; [Matasci, Giona] Univ Lausanne, Fac Geosci & Environm, Inst Earth Surface Dynam, Lausanne, Switzerland; [Joerin, Florent] Haute Ecole Ingn & Gest Canton Vaud HEIG VD, Inst Geomat Genie Environm & Construct G2C, Yverdon, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne	Duruz, S (corresponding author), Ecole Polytech Fed Lausanne, Sch Architecture Civil & Environm Engn ENAC, Lab Geog Informat Syst LASIG, Lausanne, Switzerland.	solange.duruz@epfl.ch	Joost, Stéphane/B-4152-2010	Joost, Stéphane/0000-0002-1184-7501; Duruz, Solange/0000-0002-1235-6747; Flury, Christine/0000-0002-8649-5571	Swiss Federal Office for Agriculture (FOAG)	Swiss Federal Office for Agriculture (FOAG)	This work was supported by Swiss Federal Office for Agriculture (FOAG, http://www.blw.admin.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderson L., 2010, CRIT CLASS REP SEM, P16; Alderson L, 1999, ANIMAL GENETIC RESOU, V33, P1, DOI [10.1017/S101423390000537X, DOI 10.1017/S101423390000537X]; Alderson L, 2009, LIVEST SCI, V123, P23, DOI 10.1016/j.livsci.2008.10.001; [Anonymous], 2000, SPECIAL REPORT EMISS; AVON L, 1992, SURVEY SMALL BREEDS; Bana E, 1994, INT T OPER RES, V1, P489, DOI [DOI 10.1016/0969-6016(94)90010-8, 10.1111/j.1475-3995.1994.00325.x]; Beissinger S. R., 2002, POPULATION VIABILITY; Bertaglia M, 2007, AGR SYST, V94, P657, DOI 10.1016/j.agsy.2007.02.006; BMELV, GEN RES GERM; Boettcher PJ, 2010, ANIM GENET, V41, P64, DOI 10.1111/j.1365-2052.2010.02050.x; Boettcher PJ, 2005, GENET SEL EVOL, V37, P657, DOI 10.1051/gse:2005022; Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203; Bruford MW, 2015, FRONT GENET, V6; Burren A., 2014, Animal Genetic Resources, V55, P67, DOI 10.1017/S2078633614000253; Caballero A, 2000, GENET RES, V75, P331, DOI 10.1017/S0016672399004449; Cunningham EP, 2001, ANIM GENET, V32, P360, DOI 10.1046/j.1365-2052.2001.00785.x; Curry MR, 2000, REV REPROD, V5, P46, DOI 10.1530/ror.0.0050046; Ertz O, 2014, J SPAT INT SCI, P67, DOI 10.5311/JOSIS.2014.8.182; Fadlaoui A, 2006, EUR REV AGRIC ECON, V33, P173, DOI 10.1093/erae/jbl004; FAO, 2012, CRYOC AN GEN RES; FOAG, 2002, RESS GEN SUISS; Food and Agriculture Organisation (FAO), 2015, 2 FAO; Gandini GC, 2004, LIVEST PROD SCI, V91, P173, DOI 10.1016/j.livprodsci.2004.08.001; Gandini GC, 2003, J ANIM BREED GENET, V120, P1, DOI 10.1046/j.1439-0388.2003.00365.x; GASTON KJ, 1991, OIKOS, V61, P434, DOI 10.2307/3545251; Giuffra E, 2000, GENETICS, V154, P1785; Glowatzki-Mullis ML, 2009, J ANIM BREED GENET, V126, P164, DOI 10.1111/j.1439-0388.2008.00768.x; Glowatzki-Mullis ML, 2006, ANIM GENET, V37, P33, DOI 10.1111/j.1365-2052.2005.01376.x; Groeneveld E, 2009, GENET MOL RES, V8, P1158, DOI 10.4238/vol8-3gmr648; Gutierrez JP, 2005, J ANIM BREED GENET, V122, P172, DOI 10.1111/j.1439-0388.2005.00512.x; Gutierrez JP, 2008, GENET SEL EVOL, V40, P359, DOI 10.1051/gse:2008008; Huang IB, 2011, SCI TOTAL ENVIRON, V409, P3578, DOI 10.1016/j.scitotenv.2011.06.022; Joost S, 2010, ANIM GENET, V41, P47, DOI 10.1111/j.1365-2052.2010.02037.x; Joost S, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00333; KEENEY RL, 1977, WATER RESOUR RES, V13, P705, DOI 10.1029/WR013i004p00705; Loftus R., 1993, WORLD WATCH LIST DOM, V1; Martinez-Alier J, 1999, ADV ECOL ECON, P37; Meuwissen T, 2009, ACTA AGR SCAND A-AN, V59, P71, DOI 10.1080/09064700903118148; Notter DR, 1999, J ANIM SCI, V77, P61; Price B, 2015, APPL GEOGR, V57, P32, DOI 10.1016/j.apgeog.2014.12.009; Rasul G, 2004, AGR SYST, V79, P327, DOI 10.1016/S0308-521X(03)00090-8; Reist-Marti SB, 2003, CONSERV BIOL, V17, P1299, DOI 10.1046/j.1523-1739.2003.01587.x; Rischkowsky B, 2007, STAT WORLDS AN GEN R; Rousset F, 2002, HEREDITY, V88, P371, DOI 10.1038/sj.hdy.6800065; ROY B, 1981, EUR J OPER RES, V8, P207, DOI 10.1016/0377-2217(81)90168-5; ROY B, 1991, THEOR DECIS, V31, P49, DOI 10.1007/BF00134132; Ruane J, 2000, CONSERV BIOL, V14, P1385, DOI 10.1046/j.1523-1739.2000.99276.x; SAATY TL, 1990, EUR J OPER RES, V48, P9, DOI 10.1016/0377-2217(90)90057-I; Sargolzaei M., 2006, Proceedings of the 8th World Congress on Genetics Applied to Livestock Production, Belo Horizonte, Minas Gerais, Brazil, 13-18 August, 2006, P27; Sarkar S, 2006, ANNU REV ENV RESOUR, V31, P123, DOI 10.1146/annurev.energy.31.042606.085844; Simon D.L., 1993, GENETIC DIVERSITY EU; Steiniger S., 2012, GEOSPATIAL FREE OPEN, P247, DOI [DOI 10.1007/978-3-642-10595-1_15, 10.1007/978-3-642-10595-1-15]; Swiss Federal Statistical Office, 2014, PORTR COMM; Swiss Federal Statistical Office, 2012, STAT TAB LANDW BETR; Thrupp LA., 1997, LINKING BIODIVERSITY; VanRaden P, 2008, CHANG EVAL SYST  APR; Verrier E., 2015, Animal Genetic Resources, V57, P105, DOI 10.1017/S2078633615000260	57	5	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176362	10.1371/journal.pone.0176362	http://dx.doi.org/10.1371/journal.pone.0176362			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET6EO	28453561	Green Submitted, Green Published, gold			2022-12-26	WOS:000400383900023
J	Guo, HJ; Novozhilova, NM; Bandini, G; Turco, SJ; Ferguson, MAJ; Beverley, SM				Guo, Hongjie; Novozhilova, Natalia M.; Bandini, Giulia; Turco, Salvatore J.; Ferguson, Michael A. J.; Beverley, Stephen M.			Genetic metabolic complementation establishes a requirement for GDP-fucose in Leishmania	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesin; glycoconjugate; Leishmania; parasite metabolism; protozoan; virulence factor; D-Arabinopyranose; Fucose; Trypanosomatidae; nucleotide sugar	PROTOZOAN PARASITE LEISHMANIA; NUCLEOTIDE-SUGAR TRANSPORTERS; FORM TRYPANOSOMA-BRUCEI; SAND FLY INTERACTIONS; MAJOR PROMASTIGOTES; DEVELOPMENTAL MODIFICATION; MONOCLONAL-ANTIBODIES; MASS-SPECTROMETRY; D-ARABINOPYRANOSE; BLOOD STAGES	To survive in its sand fly vector, the trypanosomatid protozoan parasite Leishmania first attaches to the midgut to avoid excretion, but eventually it must detach for transmission by the next bite. In Leishmania major strain Friedlin, this is controlled by modifications of the stage-specific adhesin lipophosphoglycan (LPG). During differentiation to infective metacyclics, d-arabinopyranose (d-Arap) caps the LPG side-chain galactose residues, blocking interaction with the midgut lectin PpGalec, thereby leading to parasite detachment and transmission. Previously, we characterized two closely related L. major genes (FKP40 and AFKP80) encoding bifunctional proteins with kinase/pyrophosphorylase activities required for salvage and conversion of l-fucose and/or d-Arap into the nucleotide-sugar substrates required by glycosyltransferases. Whereas only AFKP80 yielded GDP-d-Arap from exogenous d-Arap, both proteins were able to salvage l-fucose to GDP-fucose. We now show that afkp80(-) null mutants ablated d-Arap modifications of LPG as predicted, whereas fkp40(-) null mutants resembled wild type (WT). Fucoconjugates had not been reported previously in L. major, but unexpectedly, we were unable to generate fkp40(-)/afkp80(-) double mutants, unless one of the A/FKPs was expressed ectopically. To test whether GDP-fucose itself was essential for Leishmania viability, we employed genetic metabolite complementation. First, the trypanosome de novo pathway enzymes GDP-mannose dehydratase (GMD) and GDP-fucose synthetase (GMER) were expressed ectopically; from these cells, the fkp40(-)/afkp80(-) double mutant was now readily obtained. As expected, the fkp40(-)/afkp80(-)/+TbGMD-GMER line lacked the capacity to generate GDP-Arap, while synthesizing abundant GDP-fucose. These results establish a requirement for GDP-fucose for L. major viability and predict the existence of an essential fucoconjugate(s).	[Guo, Hongjie; Beverley, Stephen M.] Washington Univ, Sch Med, Dept Mol Microbiol, Campus Box 8230,660 S Euclid Ave, St Louis, MO 63110 USA; [Novozhilova, Natalia M.; Turco, Salvatore J.] Univ Kentucky, Med Ctr, Dept Biochem, Lexington, KY 40536 USA; [Bandini, Giulia; Ferguson, Michael A. J.] Univ Dundee, Sch Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland; [Bandini, Giulia] Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA	Washington University (WUSTL); University of Kentucky; University of Dundee; Boston University	Beverley, SM (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, Campus Box 8230,660 S Euclid Ave, St Louis, MO 63110 USA.	stephen.beverley@wustl.edu	Bandini, Giulia/ABC-4413-2021	Beverley, Stephen/0000-0001-5319-0811; Ferguson, Michael/0000-0003-1321-8714; Bandini, Giulia/0000-0002-8885-3643	Berg postdoctoral fellowship from the Department of Molecular Microbiology, Washington University School of Medicine; National Institutes of Health [R01 AI031078]; Wellcome Trust Senior Investigator Award [10182]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031078] Funding Source: NIH RePORTER	Berg postdoctoral fellowship from the Department of Molecular Microbiology, Washington University School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust Senior Investigator Award(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Berg postdoctoral fellowship from the Department of Molecular Microbiology, Washington University School of Medicine (to H. G.), National Institutes of Health Grant R01 AI031078 (to S. J. T. and S. M. B.), and Wellcome Trust Senior Investigator Award 10182 (to M. A. J. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen S, 2013, J BIOL CHEM, V288, P11093, DOI 10.1074/jbc.M113.452763; Bandini G, 2016, P NATL ACAD SCI USA, V113, P11567, DOI 10.1073/pnas.1613653113; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Beverley SM, 1998, TRENDS MICROBIOL, V6, P35, DOI 10.1016/S0966-842X(97)01180-3; Breitling R, 2002, PROTEIN EXPRES PURIF, V25, P209, DOI 10.1016/S1046-5928(02)00001-3; Butcher BA, 1996, J BIOL CHEM, V271, P20573, DOI 10.1074/jbc.271.34.20573; Capul AA, 2007, INFECT IMMUN, V75, P4629, DOI 10.1128/IAI.00735-07; Capul AA, 2007, J BIOL CHEM, V282, P14006, DOI 10.1074/jbc.M610869200; Coyne MJ, 2005, SCIENCE, V307, P1778, DOI 10.1126/science.1106469; CRUZ A, 1990, NATURE, V348, P171, DOI 10.1038/348171a0; CRUZ AK, 1993, P NATL ACAD SCI USA, V90, P1599, DOI 10.1073/pnas.90.4.1599; Da Silveira EX, 1998, BIOCHEM J, V329, P665; Damerow S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004205; DEIBARRA AAL, 1982, PARASITOLOGY, V85, P523, DOI 10.1017/S0031182000056304; DESCOTEAUX A, 1995, SCIENCE, V269, P1869, DOI 10.1126/science.7569927; Dobson DE, 2003, J BIOL CHEM, V278, P28840, DOI 10.1074/jbc.M302728200; FERGUSON MAJ, 1983, BIOCHEM J, V213, P313, DOI 10.1042/bj2130313; Goswami M, 2006, GLYCOBIOLOGY, V16, P230, DOI 10.1093/glycob/cwj054; Guther MLS, 2014, J PROTEOME RES, V13, P2796, DOI 10.1021/pr401209w; Guther MLS, 2009, EUKARYOT CELL, V8, P1407, DOI 10.1128/EC.00178-09; Haynes PA, 1996, GLYCOBIOLOGY, V6, P869, DOI 10.1093/glycob/6.8.869; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; Hong KJ, 2000, BIOCHEMISTRY-US, V39, P2013, DOI 10.1021/bi992363l; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Kamhawi S, 2004, CELL, V119, P329, DOI 10.1016/j.cell.2004.10.009; Kamhawi S, 2006, TRENDS PARASITOL, V22, P439, DOI 10.1016/j.pt.2006.06.012; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; KELLEHER M, 1994, MOL BIOCHEM PARASIT, V66, P187, DOI 10.1016/0166-6851(94)90146-5; LaCount DJ, 2002, J BIOL CHEM, V277, P17580, DOI 10.1074/jbc.M200873200; Ma DQ, 1997, J BIOL CHEM, V272, P3799, DOI 10.1074/jbc.272.6.3799; MCCONVILLE MJ, 1992, EMBO J, V11, P3593, DOI 10.1002/j.1460-2075.1992.tb05443.x; MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P19611; Murta SMF, 2009, MOL MICROBIOL, V71, P1386, DOI 10.1111/j.1365-2958.2009.06610.x; Novozhilova NM, 2009, ACTA NATURAE, V1, P81, DOI 10.32607/20758251-2009-1-3-81-83; Novozhilova NM, 2008, GLYCOBIOLOGY, V18, P1005; Nozaki T, 1996, MOL BIOCHEM PARASIT, V82, P245, DOI 10.1016/0166-6851(96)02741-7; NOZAKI T, 1994, MOL BIOCHEM PARASIT, V67, P91, DOI 10.1016/0166-6851(94)90099-X; ORLANDI PA, 1987, J BIOL CHEM, V262, P10384; Palatnik-de-Sousa CB, 2008, EXPERT REV VACCINES, V7, P833, DOI 10.1586/14760584.7.6.833; Park S, 1997, ANAL BIOCHEM, V244, P321, DOI 10.1006/abio.1996.9906; PIMENTA PFP, 1992, SCIENCE, V256, P1812, DOI 10.1126/science.1615326; Rabina J, 2001, GLYCOCONJUGATE J, V18, P799, DOI 10.1023/A:1021107602535; Rahman K, 2016, J BIOL CHEM, V291, P4268, DOI 10.1074/jbc.M115.703751; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Rogers MB, 2011, GENOME RES, V21, P2129, DOI 10.1101/gr.122945.111; Rosenzweig D, 2008, PROTEOMICS, V8, P1843, DOI 10.1002/pmic.200701043; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453; SACKS DL, 1990, MOL BIOCHEM PARASIT, V42, P225, DOI 10.1016/0166-6851(90)90165-I; Sacks DL, 2001, CELL MICROBIOL, V3, P189, DOI 10.1046/j.1462-5822.2001.00115.x; Sacks DL, 2000, P NATL ACAD SCI USA, V97, P406, DOI 10.1073/pnas.97.1.406; SACKS DL, 1987, J IMMUNOL, V139, P3099; Sanz S, 2016, SCI REP-UK, V6, DOI 10.1038/srep37230; Sanz S, 2013, J BIOL CHEM, V288, P16506, DOI 10.1074/jbc.M112.439828; SCHNEIDER P, 1994, J BIOL CHEM, V269, P18332; Schneider P, 1996, BIOCHEM J, V313, P963, DOI 10.1042/bj3130963; Segawa H, 2005, J BIOL CHEM, V280, P2028, DOI 10.1074/jbc.M404915200; Spath GF, 1998, J CELL BIOL, V140, P935, DOI 10.1083/jcb.140.4.935; Sterkers Y, 2012, MOL MICROBIOL, V86, P15, DOI 10.1111/j.1365-2958.2012.08185.x; SUGII S, 1982, CARBOHYD RES, V99, P99, DOI 10.1016/S0008-6215(00)80982-9; Swearingen KE, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005606; Turnock DC, 2007, J BIOL CHEM, V282, P28853, DOI 10.1074/jbc.M704742200; Turnock DC, 2007, EUKARYOT CELL, V6, P1450, DOI 10.1128/EC.00175-07; van der Wel H, 2001, J BIOL CHEM, V276, P33952, DOI 10.1074/jbc.M102555200; WAIT R, 1994, BRAZ J MED BIOL RES, V27, P203; Wilson IBH, 1999, MOL BIOCHEM PARASIT, V100, P207, DOI 10.1016/S0166-6851(99)00061-4; Wyder MA, 1999, J PARASITOL, V85, P771, DOI 10.2307/3285810	67	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10696	10708		10.1074/jbc.M117.778480	http://dx.doi.org/10.1074/jbc.M117.778480			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28465349	Green Published, hybrid			2022-12-26	WOS:000404115400028
J	Koziel, JA; Frana, TS; Ahn, H; Glanville, TD; Nguyen, LT; van Leeuwen, J				Koziel, Jacek A.; Frana, Timothy S.; Ahn, Heekwon; Glanville, Thomas D.; Nguyen, Lam T.; van Leeuwen, J. (Hans)			Efficacy of NH3 as a secondary barrier treatment for inactivation of Salmonella Typhimurium and methicillin-resistant Staphylococcus aureus in digestate of animal carcasses: Proof-of-concept	PLOS ONE			English	Article							SWINE MANURE; ANAEROBIC-DIGESTION; AMMONIA TOXICITY; BACTERIA; PATHOGENS; RISK; PH; CONTAMINATION; DISINFECTION; ENVIRONMENT	Managing the disposal of infectious animal carcasses from routine and catastrophic disease outbreaks is a global concern. Recent research suggests that burial in lined and aerated trenches provides the rapid pathogen containment provided by burial, while reducing air and water pollution potential and the length of time that land is taken out of agricultural production. Survival of pathogens in the digestate remains a concern, however. A potential answer is a `dual'-barrier approach in which ammonia is used as a secondary barrier treatment to reduce the risk of pathogen contamination when trench liners ultimately leak. Results of this study showed that the minimum inhibitory concentration (MIC) of NH3 is 0.1 M (similar to 1,468 NH3-N mg/L), and 0.5 M NH3 (similar to 7,340 NH3-N mg/L) for ST4232 & MRSA43300, respectively at 24 h and pH = 9 +/- 0.1 and inactivation was increased by increasing NH3 concentration and/or treatment time. Results for digestate treated with NH3 were consistent with the MICs, and both pathogens were completely inactivated within 24 h.	[Koziel, Jacek A.; Glanville, Thomas D.; Nguyen, Lam T.; van Leeuwen, J. (Hans)] Iowa State Univ, Dept Agr & Biosyst Engn, Ames, IA 50011 USA; [Koziel, Jacek A.; van Leeuwen, J. (Hans)] Iowa State Univ, Dept Civil Construct & Environm Engn, Ames, IA 50011 USA; [Koziel, Jacek A.; van Leeuwen, J. (Hans)] Iowa State Univ, Dept Food Sci & Human Nutr, Ames, IA 50011 USA; [Frana, Timothy S.] Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA; [Ahn, Heekwon] Chungnam Natl Univ, Dept Anim Biosyst Sci, Daejeon, South Korea	Iowa State University; Iowa State University; Iowa State University; Iowa State University; Chungnam National University	Koziel, JA (corresponding author), Iowa State Univ, Dept Agr & Biosyst Engn, Ames, IA 50011 USA.; Koziel, JA (corresponding author), Iowa State Univ, Dept Civil Construct & Environm Engn, Ames, IA 50011 USA.; Koziel, JA (corresponding author), Iowa State Univ, Dept Food Sci & Human Nutr, Ames, IA 50011 USA.	koziel@iastate.edu	Koziel, Jacek A./B-5483-2014	Koziel, Jacek A./0000-0002-2387-0354; Ahn, Heekwon/0000-0002-3487-0640	National Institute of Animal Science [PJ90713006]; Korea Rural Development Administration	National Institute of Animal Science(National Institute of Animal Science, Republic of Korea); Korea Rural Development Administration(Rural Development Administration (RDA), Republic of Korea)	This work was supported by Republic of Korea Rural Development Administration through a grant from the National Institute of Animal Science (Project title: Development of environmentally friendly live stock mortality disposal system using aerobic digestion. Project no.: PJ90713006). The under had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by Republic of Korea Rural Development Administration through a grant from the National Institute of Animal Science (Project Title: Development of environmentally friendly livestock mortality disposal system using aerobic digestion. Project no.: PJ90713006, PI Prof. Thomas Glanville). The authors gratefully acknowledge Brad Bearson at the USDA-ARS, National Laboratory for Agriculture and the Environment, Ames, IA for providing Salmonella enterica ser. Typhimurium strain BSX 8 (chi 4232). The authors also would like to thank ISU, VDPAM for providing methicillin-resistant Staphylococcus aureus - ATCC 43300 strain and conducting the microbiological analysis. Special thanks to Joann Kinyon and Susan Cramer for their support with microbiological analyses. Special thanks to Dr. Susan Lamont and the staff of the ISU Poultry Research and Teaching facility for their assistance with raising and euthanizing poultry (IACUC log #4-03-5425-G).	ALBERTSON OE, 1961, J WATER POLLUT CON F, V33, P978; Anderson TC, 2016, MULTISTATE OUTBREAK; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Animal and Plant Health Inspection Service, 2005, NAT AN HLTH EM MAN S; [Anonymous], 2005, STANDARD METHODS EXA; Bell C, 2002, SALMONELLA PRACTICAL; Bendinelli M, 2002, STAPHYLOCOCCUS AUREU; Bolder NM, 1997, TRENDS FOOD SCI TECH, V8, P221, DOI 10.1016/S0924-2244(97)01040-6; Borgmann U, 1997, ENVIRON POLLUT, V95, P325, DOI 10.1016/S0269-7491(96)00138-8; Brglez B, 2009, METHODS DISPOSAL POU, P333; Brooks JP, 2014, WATER RES, V57, P96, DOI 10.1016/j.watres.2014.03.017; Cabello F, 1993, BIOL SALMONELLA; Carrel M, 2014, INFECT CONT HOSP EP, V35, P190, DOI 10.1086/674860; Casey JA, 2013, JAMA INTERN MED, V173, P1980, DOI 10.1001/jamainternmed.2013.10408; Cohen ML, 2000, NATURE, V406, P762, DOI 10.1038/35021206; Council for Agricultural Science and Technology (CAST), 2008, 40 CAST; Dahms C, 2014, GMS HYG INFECT CONTR, V9, DOI 10.3205/dgkh000241; EMERSON K, 1975, J FISH RES BOARD CAN, V32, P2379, DOI 10.1139/f75-274; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Fasina FO, 2015, ONDERSTEPOORT J VET, V82, DOI 10.4102/ojvr.v82i1.986; Fischer J, 2016, VET MICROBI IN PRESS; Ganidi N, 2009, BIORESOURCE TECHNOL, V100, P5546, DOI 10.1016/j.biortech.2009.06.024; Guan TY, 2003, J ENVIRON QUAL, V32, P383, DOI 10.2134/jeq2003.0383; Guerra B, 2014, VET MICROBIOL, V171, P290, DOI 10.1016/j.vetmic.2014.02.001; Gwyther CL, 2012, WASTE MANAGE, V32, P933, DOI 10.1016/j.wasman.2011.10.031; Hansen KH, 1998, WATER RES, V32, P5, DOI 10.1016/S0043-1354(97)00201-7; Hatcher SM, 2016, SCI TOTAL ENVIRON, V565, P1028, DOI 10.1016/j.scitotenv.2016.05.083; Himathongkham S, 1999, FEMS MICROBIOL LETT, V171, P179, DOI 10.1111/j.1574-6968.1999.tb13430.x; Himathongkham S, 1999, FEMS MICROBIOL LETT, V178, P251, DOI 10.1111/j.1574-6968.1999.tb08684.x; Himathongkham S, 2001, J FOOD PROTECT, V64, P1817, DOI 10.4315/0362-028X-64.11.1817; Huong VTL, 2016, EPIDEMIOL INFECT, V144, P35, DOI 10.1017/S0950268815000990; Ip Y.K., 2001, Fish Physiology, V20, P109; Kawakami VM, 2016, MMWR-MORBID MORTAL W, V65, P379, DOI 10.15585/mmwr.mm6514a4; Kim HS, 2012, GEOSCI J, V16, P479, DOI 10.1007/s12303-012-0036-1; Kleiner D, 1998, B I PASTEUR, V96, P257, DOI 10.1016/S0020-2452(99)80006-2; Koziel JA, 2017, WASTE MANAG IN PRESS; Leejeerajumnean A, 2000, LETT APPL MICROBIOL, V30, P385, DOI 10.1046/j.1472-765X.2000.00734.x; Mendez JM, 2004, WATER SCI TECHNOL, V50, P67, DOI 10.2166/wst.2004.0536; Metcalf Eddy, 2005, WASTEWATER ENG TREAT; Michitsch R, 2015, J ENVIRON QUAL, V44, P1355, DOI 10.2134/jeq2015.01.0034; Mohaibes M, 2004, BIORESOURCE TECHNOL, V95, P245, DOI 10.1016/j.biortech.2004.02.022; Mohammed AN, 2016, PARASITOL RES, V115, P3889, DOI 10.1007/s00436-016-5154-7; Mohler VL, 2009, VET CLIN N AM-FOOD A, V25, P37, DOI 10.1016/j.cvfa.2008.10.009; Muller T, 2006, CURR MICROBIOL, V52, P400, DOI 10.1007/s00284-005-0370-x; Niebuhr SE, 2003, J FOOD PROTECT, V66, P874, DOI 10.4315/0362-028X-66.5.874; Nutsch A, 2010, WILEY HDB SCI TECHNO, P1959; Persoons D, 2009, EMERG INFECT DIS, V15, P452, DOI 10.3201/eid1503.080696; REDDY KR, 1975, SOIL BIOL BIOCHEM, V7, P87, DOI 10.1016/0038-0717(75)90004-8; Sahlstrom L, 2003, BIORESOURCE TECHNOL, V87, P161, DOI 10.1016/S0960-8524(02)00168-2; Schulz J, 2012, APPL ENVIRON MICROB, V78, P5666, DOI 10.1128/AEM.00550-12; Sparks Companies Inc, 2002, LIV MORT METH DISP T; SPROTT GD, 1984, J BIOL CHEM, V259, P2602; Tajkarli-Ni M, 2008, INT J FOOD MICROBIOL, V122, P23, DOI 10.1016/j.ijfoodmicro.2007.11.040; TAYLOR BL, 1983, TRENDS BIOCHEM SCI, V8, P438, DOI 10.1016/0968-0004(83)90030-0; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Tenuta M, 2002, PHYTOPATHOLOGY, V92, P255, DOI 10.1094/PHYTO.2002.92.3.255; Ugwuanyi JO, 2006, J CHEM TECHNOL BIOT, V81, P1641, DOI 10.1002/jctb.1574; WARD RL, 1977, APPL ENVIRON MICROB, V33, P860, DOI 10.1128/AEM.33.4.860-864.1977; WARREN KS, 1962, NATURE, V195, P47, DOI 10.1038/195047a0; Williams AP, 2009, BIORESOURCE TECHNOL, V100, P4032, DOI 10.1016/j.biortech.2009.03.018	60	18	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176825	10.1371/journal.pone.0176825	http://dx.doi.org/10.1371/journal.pone.0176825			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475586	Green Published, gold, Green Submitted			2022-12-26	WOS:000400649500016
J	Gencay, M; Hubner, K; Gohl, P; Seffner, A; Weizenegger, M; Neofytos, D; Batrle, R; Woeste, A; Kim, HS; Westergaard, G; Reinsch, C; Brill, E; Thuy, PTT; Hoang, BH; Sonderup, M; Spearman, CW; Pabinger, S; Gautier, J; Brancaccio, G; Fasano, M; Santantonio, T; Gaeta, GB; Nauck, M; Kaminski, WE				Gencay, Mikael; Huebner, Kirsten; Gohl, Peter; Seffner, Anja; Weizenegger, Michael; Neofytos, Dionysios; Batrle, Richard; Woeste, Andreas; Kim, Hyon-suk; Westergaard, Gaston; Reinsch, Christine; Brill, Eva; Pham Thi Thu Thuy; Hoang, Bui Huu; Sonderup, Mark; Spearman, C. Wendy; Pabinger, Stephan; Gautier, Jeremie; Brancaccio, Giuseppina; Fasano, Massimo; Santantonio, Teresa; Gaeta, Giovanni B.; Nauck, Markus; Kaminski, Wolfgang E.			Ultra-deep sequencing reveals high prevalence and broad structural diversity of hepatitis B surface antigen mutations in a global population	PLOS ONE			English	Article							MAJOR HYDROPHILIC REGION; GENE VARIANTS; DETERMINANT VARIANTS; VIRUS; HBSAG; GENOTYPES; RESISTANCE; MUTANTS; EPIDEMIOLOGY; FREQUENCY	The diversity of the hepatitis B surface antigen (HBsAg) has a significant impact on the performance of diagnostic screening tests and the clinical outcome of hepatitis B infection. Neutralizing or diagnostic antibodies against the HBsAg are directed towards its highly conserved major hydrophilic region (MHR), in particular towards its "a" determinant subdomain. Here, we explored, on a global scale, the genetic diversity of the HBsAg MHR in a large, multi-ethnic cohort of randomly selected subjects with HBV infection from four continents. A total of 1553 HBsAg positive blood samples of subjects originating from 20 different countries across Africa, America, Asia and central Europe were characterized for amino acid variation in the MHR. Using highly sensitive ultra-deep sequencing, we found 72.8% of the successfully sequenced subjects (n = 1391) demonstrated amino acid sequence variation in the HBsAg MHR. This indicates that the global variation frequency in the HBsAg MHR is threefold higher than previously reported. The majority of the amino acid mutations were found in the HBV genotypes B (28.9%) and C (25.4%). Collectively, we identified 345 distinct amino acid mutations in the MHR. Among these, we report 62 previously unknown mutations, which extends the worldwide pool of currently known HBsAg MHR mutations by 22%. Importantly, topological analysis identified the "a" determinant upstream flanking region as the structurally most diverse subdomain of the HBsAg MHR. The highest prevalence of "a" determinant region mutations was observed in subjects from Asia, followed by the African, American and European cohorts, respectively. Finally, we found that more than half (59.3%) of all HBV subjects investigated carried multiple MHR mutations. Together, this worldwide ultra-deep sequencing based genotyping study reveals that the global prevalence and structural complexity of variation in the hepatitis B surface antigen have, to date, been significantly underappreciated.	[Gencay, Mikael; Neofytos, Dionysios; Batrle, Richard; Westergaard, Gaston] Roche Diagnost Int Ltd, Rotkreuz, Germany; [Huebner, Kirsten; Gohl, Peter; Brill, Eva; Nauck, Markus; Kaminski, Wolfgang E.] Bioscientia Inst Med Diagnost, Ingelheim, Germany; [Seffner, Anja; Weizenegger, Michael] MVZ Labor Dr Limbach & Kollegen GbR, Dept Mol Genet & Microbiol, Heidelberg, Germany; [Woeste, Andreas] Roche Diagnost GmbH, Penzberg, Germany; [Kim, Hyon-suk] Yonsei Univ, Severance Hosp, Coll Med, Dept Lab Med, Seoul, South Korea; [Reinsch, Christine] Roche Diagnost GmbH, Mannheim, Germany; [Pham Thi Thu Thuy] Medic Med Ctr, Hepatol Dept, Ho Chi Minh City, Vietnam; [Hoang, Bui Huu] Ho Chi Minh City Univ, Med Ctr, Gastroenterol Dept, Ho Chi Minh City, Vietnam; [Sonderup, Mark; Spearman, C. Wendy] Univ Cape Town, Div Hepatol, Cape Town, South Africa; [Sonderup, Mark; Spearman, C. Wendy] Univ Cape Town, Dept Med, Cape Town, South Africa; [Sonderup, Mark; Spearman, C. Wendy] Groote Schuur Hosp, Cape Town, South Africa; [Pabinger, Stephan] AIT, Hlth & Environm Dept, Mol Diagnost, Vienna, Austria; [Gautier, Jeremie] Cerba Specimen Serv, St Ouen Aumone, France; [Brancaccio, Giuseppina; Gaeta, Giovanni B.] Univ Naples 2, Infect Dis & Viral Hepatitis Unit, Naples, Italy; [Fasano, Massimo; Santantonio, Teresa] Univ Foggia, Dept Clin & Expt Med, Infect Dis Unit, Foggia, Italy	Roche Holding; Yonsei University; Yonsei University Health System; Roche Holding; Vietnam National University Hochiminh City; University of Cape Town; University of Cape Town; University of Cape Town; Austrian Institute of Technology (AIT); Universita della Campania Vanvitelli; University of Foggia	Nauck, M; Kaminski, WE (corresponding author), Bioscientia Inst Med Diagnost, Ingelheim, Germany.	markus.nauck@bioscientia.de; wolfgang.kaminski@bioscientia.de	Sonderup, Mark W/H-8582-2015; Kim, Hyon-Suk/R-4113-2017; Spearman, C.Wendy/R-8173-2019; Neofytos, Dionysios/ABE-2214-2020; Gaeta, Giovanni/AAQ-4294-2021	Sonderup, Mark W/0000-0001-7128-8329; Kim, Hyon-Suk/0000-0001-5662-7740; Neofytos, Dionysios/0000-0001-6970-2869; Crisanti, Andrea/0000-0002-2406-4426; Brancaccio, Giuseppina/0000-0001-5643-0139; Pabinger, Stephan/0000-0001-9876-5965; Spearman, Catherine Wendy/0000-0003-3199-301X	Roche Diagnostics	Roche Diagnostics	The study was sponsored by Roche Diagnostics, who were involved in the study design, data collection, interpretation, and analysis. Editorial support was provided by Kim Brown, Roche Diagnostics International Ltd.	Al-Qudari AY, 2016, SAUDI J GASTROENTERO, V22, P133, DOI 10.4103/1319-3767.167186; Alvarado-Mora MV, 2013, ANTIVIR THER, V18, P459, DOI 10.3851/IMP2599; Amini-Bavil-Olyaee S, 2009, AIDS, V23, P268, DOI 10.1097/QAD.0b013e3283224316; Avellon A, 2006, J MED VIROL, V78, P24, DOI 10.1002/jmv.20516; Bian T, 2013, J VIROL, V87, P12196, DOI 10.1128/JVI.02127-13; Brunetto MR, 2009, HEPATOLOGY, V49, P1141, DOI 10.1002/hep.22760; Caligiuri P, 2016, WORLD J GASTROENTERO, V22, P145, DOI 10.3748/wjg.v22.i1.145; Chiou HL, 1997, J GEN VIROL, V78, P2639, DOI 10.1099/0022-1317-78-10-2639; Chong-Jin O, 1999, J INFECT DIS, V179, P259, DOI 10.1086/314553; Coleman PF, 2006, J MED VIROL, V78, pS56, DOI 10.1002/jmv.20609; Croagh CMN, 2015, WORLD J HEPATOL, V7, P289, DOI 10.4254/wjh.v7.i3.289; Davaalkham D, 2007, ARCH VIROL, V152, P575, DOI 10.1007/s00705-006-0863-3; Flanagan E, 2014, INTERN MED J, V44, P709, DOI 10.1111/imj.12465; Gededzha MP, 2016, J MED VIROL, V88, P1560, DOI 10.1002/jmv.24502; Hollinger FB, 2007, J VIRAL HEPATITIS, V14, P11, DOI 10.1111/j.1365-2893.2007.00910.x; Hou JL, 2001, HEPATOLOGY, V34, P1027, DOI 10.1053/jhep.2001.28708; Hsu HY, 2013, J INFECT DIS, V207, P1047, DOI 10.1093/infdis/jis943; Hsu HY, 2010, J INFECT DIS, V201, P1192, DOI 10.1086/651378; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054486; Kim KH, 2014, CLIN MOL HEPATOL, V20, P251, DOI 10.3350/cmh.2014.20.3.251; Larralde O, 2013, MED MICROBIOL IMMUN, V202, P207, DOI 10.1007/s00430-012-0283-9; Liao CC, 2015, BIOMED J, V38, P250, DOI 10.4103/2319-4170.143485; Lieshout-Krikke RW, 2014, EUR J CLIN MICROBIOL, V33, P69, DOI 10.1007/s10096-013-1930-9; Ma Q, 2012, J MED VIROL, V84, P198, DOI 10.1002/jmv.23183; Mallory MA, 2011, J VIROL METHODS, V177, P31, DOI 10.1016/j.jviromet.2011.06.009; Mohamed S, 2014, AIDS, V28, P1315, DOI 10.1097/QAD.0000000000000267; Neumann-Fraune M, 2014, INTERVIROLOGY, V57, P232, DOI 10.1159/000361076; Neumann-Fraune M, 2013, J MED VIROL, V85, P775, DOI 10.1002/jmv.23530; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575; Leone FGPY, 2008, J CLIN VIROL, V42, P381, DOI 10.1016/j.jcv.2008.01.018; Pollicino T, 2014, J HEPATOL, V61, P408, DOI 10.1016/j.jhep.2014.04.041; Powell EA, 2016, J GEN VIROLOGY; Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014; Rodriguez-Frias F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037874; Salpini R, 2015, HEPATOLOGY, V61, P823, DOI 10.1002/hep.27604; Sayan M, 2012, JPN J INFECT DIS, V65, P495, DOI 10.7883/yoken.65.495; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Seddigh-Tonekaboni S, 2000, J MED VIROL, V60, P113, DOI 10.1002/(SICI)1096-9071(200002)60:2<113::AID-JMV2>3.0.CO;2-0; Servant-Delmas A, 2010, TRANSFUSION, V50, P2607, DOI 10.1111/j.1537-2995.2010.02725.x; Shi WF, 2013, INFECT GENET EVOL, V16, P355, DOI 10.1016/j.meegid.2013.03.021; Solmone M, 2009, J VIROL, V83, P1718, DOI 10.1128/JVI.02011-08; Song BC, 2005, J MED VIROL, V76, P194, DOI 10.1002/jmv.20354; Sticchi L, 2013, HUM VACC IMMUNOTHER, V9, P568, DOI 10.4161/hv.23236; Sunbul M, 2014, WORLD J GASTROENTERO, V20, P5427, DOI 10.3748/wjg.v20.i18.5427; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Teo CG, 2010, ANTIVIR THER, V15, P445, DOI 10.3851/IMP1556; Verheyen J, 2012, J CLIN VIROL, V54, P279, DOI 10.1016/j.jcv.2012.04.010; WALLACE LA, 1994, J INFECT DIS, V170, P1300, DOI 10.1093/infdis/170.5.1300; Wu CC, 2012, J VIROL, V86, P4658, DOI 10.1128/JVI.06353-11; Yamani LN, 2015, J CLIN MICROBIOL, V53, P3165, DOI 10.1128/JCM.00602-15; Yang YL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-82; Yu H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009297	53	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0172101	10.1371/journal.pone.0172101	http://dx.doi.org/10.1371/journal.pone.0172101			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472040	Green Published, gold, Green Submitted			2022-12-26	WOS:000400648500001
J	Hassan, KA; Fagerlund, A; Elbourne, LDH; Voros, A; Kroeger, JK; Simm, R; Tourasse, NJ; Finke, S; Henderson, PJF; Okstad, OA; Paulsen, IT; Kolsto, AB				Hassan, Karl A.; Fagerlund, Annette; Elbourne, Liam D. H.; Voros, Aniko; Kroeger, Jasmin K.; Simm, Roger; Tourasse, Nicolas J.; Finke, Sarah; Henderson, Peter J. F.; Okstad, Ole Andreas; Paulsen, Ian T.; Kolsto, Anne-Brit			The putative drug efflux systems of the Bacillus cereus group	PLOS ONE			English	Article							MULTIDRUG TRANSPORTER; ABC TRANSPORTER; GENE-EXPRESSION; RESISTANCE; SUBTILIS; THURINGIENSIS; VIRULENCE; ANTHRACIS; PUMP; OVEREXPRESSION	The Bacillus cereus group of bacteria includes seven closely related species, three of which, B. anthracis, B. cereus and B. thuringiensis, are pathogens of humans, animals and/or insects. Preliminary investigations into the transport capabilities of different bacterial lineages suggested that genes encoding putative efflux systems were unusually abundant in the B. cereus group compared to other bacteria. To explore the drug efflux potential of the B. cereus group all putative efflux systems were identified in the genomes of prototypical strains of B. cereus, B. anthracis and B. thuringiensis using our Transporter Automated Annotation Pipeline. More than 90 putative drug efflux systems were found within each of these strains, accounting for up to 2.7% of their protein coding potential. Comparative analyses demonstrated that the efflux systems are highly conserved between these species; 70-80% of the putative efflux pumps were shared between all three strains studied. Furthermore, 82% of the putative efflux system proteins encoded by the prototypical B. cereus strain ATCC 14579 (type strain) were found to be conserved in at least 80% of 169 B. cereus group strains that have high quality genome sequences available. However, only a handful of these efflux pumps have been functionally characterized. Deletion of individual efflux pump genes from B. cereus typically had little impact to drug resistance phenotypes or the general fitness of the strains, possibly because of the large numbers of alternative efflux systems that may have overlapping substrate specificities. Therefore, to gain insight into the possible transport functions of efflux systems in B. cereus, we undertook large-scale qRT-PCR analyses of efflux pump gene expression following drug shocks and other stress treatments. Clustering of gene expression changes identified several groups of similarly regulated systems that may have overlapping drug resistance functions. In this article we review current knowledge of the small molecule efflux pumps encoded by the B. cereus group and suggest the likely functions of numerous uncharacterised pumps.	[Hassan, Karl A.; Elbourne, Liam D. H.; Paulsen, Ian T.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW, Australia; [Hassan, Karl A.; Henderson, Peter J. F.] Univ Leeds, Sch Biomed Sci, Leeds, W Yorkshire, England; [Hassan, Karl A.; Henderson, Peter J. F.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; [Fagerlund, Annette; Voros, Aniko; Kroeger, Jasmin K.; Simm, Roger; Tourasse, Nicolas J.; Finke, Sarah; Okstad, Ole Andreas; Kolsto, Anne-Brit] Univ Oslo, Sch Pharm, Lab Microbial Dynam LaMDa, Sect Pharmaceut Biosci, Oslo, Norway; [Kroeger, Jasmin K.] Albert Ludwigs Univ, Inst Pharmazeut Biol & Biotechnol, Freiburg, Germany; [Finke, Sarah; Okstad, Ole Andreas; Kolsto, Anne-Brit] Univ Oslo, Fac Math & Nat Sci, CIME, N-0316 Oslo, Norway; [Fagerlund, Annette] Nofima, PB210, N-1431 As, Norway; [Simm, Roger] Univ Oslo, Fac Dent, Dept Oral Biol, Oslo, Norway; [Tourasse, Nicolas J.] Univ Bordeaux 2, CNRS, INSERM, ARNA Lab,UMR5320, 146 Rue Leo Saignat, Bordeaux, France	Macquarie University; University of Leeds; University of Leeds; University of Oslo; University of Freiburg; University of Oslo; Nofima; University of Oslo; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Paulsen, IT (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW, Australia.; Kolsto, AB (corresponding author), Univ Oslo, Sch Pharm, Lab Microbial Dynam LaMDa, Sect Pharmaceut Biosci, Oslo, Norway.; Kolsto, AB (corresponding author), Univ Oslo, Fac Math & Nat Sci, CIME, N-0316 Oslo, Norway.	ian.paulsen@mq.edu.au; a.b.koisto@farmasi.uio.no	Henderson, Peter JF/Q-1907-2018; Elbourne, Liam/G-6150-2011; Okstad, Ole Andreas/ABE-4202-2020; Simm, Roger/AAN-8965-2020; Paulsen, Ian/K-3832-2012; Hassan, Karl/B-2802-2013	Elbourne, Liam/0000-0002-9784-0959; Simm, Roger/0000-0001-5187-2456; Fagerlund, Annette/0000-0001-7146-4265; Paulsen, Ian/0000-0001-9015-9418; Okstad, Ole Andreas/0000-0001-9351-8535; Hassan, Karl/0000-0003-2031-9679; Kroeger, Jasmin Kaori/0000-0002-7747-3223; Henderson, Peter/0000-0002-9187-0938	Norwegian Research Council [183421]; Australian National Health and Medical Research Council [1060895]; Australian Academy of Science [247634]; Macquarie University [9201401563]; Marie Slowdoska Curie Research Fellowship; Leverhulme Trust; EU BacMT; ATENS	Norwegian Research Council(Research Council of NorwayEuropean Commission); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Academy of Science; Macquarie University; Marie Slowdoska Curie Research Fellowship; Leverhulme Trust(Leverhulme Trust); EU BacMT; ATENS	This research was funded by the Norwegian Research Council (FUGE II Program, Project ID 183421) to ABK and OAO, an Australian National Health and Medical Research Council Project Grant (1060895) to ITP, KAH and PJFH, an Australian Academy of Science Grant (247634) and a Research Development Grant from Macquarie University to KAH and LDHE (9201401563). KAH thanks the EU for the award of a Marie Slowdoska Curie Research Fellowship and PJFH thanks the Leverhulme Trust for an Emeritus Research Fellowship. Consortium collaborations between laboratories (ABK, PJFH, ITP) are funded by the EU BacMT and ATENS initiatives.; This research was funded by the Norwegian Research Council (FUGE II Program, Project ID 183421) to ABK and OAO, an Australian National Health and Medical Research Council Project Grant (1060895) to ITP, KAH and PJFH, an Australian Academy of Science Grant (247634) and a Research Development Grant from Macquarie University to KAH and LDHE (9201401563). KAH thanks the EU for the award of a Marie Slowdoska Curie Research Fellowship and PJFH thanks the Leverhulme Trust for an Emeritus Research Fellowship. Consortium collaborations between laboratories (ABK, PJFH, ITP) are funded by the EU BacMT and ATENS initiatives.	Agaisse H, 1999, MOL MICROBIOL, V32, P1043, DOI 10.1046/j.1365-2958.1999.01419.x; AHMED M, 1995, J BACTERIOL, V177, P3904, DOI 10.1128/jb.177.14.3904-3910.1995; Auger S, 2006, APPL ENVIRON MICROB, V72, P937, DOI 10.1128/AEM.72.1.937-941.2006; Bechet M, 2012, APPL MICROBIOL BIOT, V95, P593, DOI 10.1007/s00253-012-4181-2; Bottone E. J., 2003, Clinical Microbiology Newsletter, V25, P49, DOI 10.1016/S0196-4399(03)80005-3; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; CAMPBELL NRC, 1992, BRIT J CLIN PHARMACO, V33, P115, DOI 10.1111/j.1365-2125.1992.tb04010.x; Caro-Astorga Joaquin, 2014, Front Microbiol, V5, P745, DOI 10.3389/fmicb.2014.00745; Doganay Mehmet, 2015, Recent Pat Antiinfect Drug Discov, V10, P10; DROBNIEWSKI FA, 1993, CLIN MICROBIOL REV, V6, P324, DOI 10.1128/CMR.6.4.324-338.1993; Ehling-Schulz M, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-20; Elbourne LDH, 2017, NUCLEIC ACIDS RES, V45, pD320, DOI 10.1093/nar/gkw1068; Espinasse S, 2004, J BACTERIOL, V186, P3108, DOI 10.1128/JB.186.10.3108-3116.2004; Espinasse S, 2002, J BACTERIOL, V184, P5848, DOI 10.1128/JB.184.21.5848-5854.2002; Fuangthong M, 2003, J BACTERIOL, V185, P6348, DOI 10.1128/JB.185.21.6348-6357.2003; Galian C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019677; Ganas P, 2007, MICROBIOL-SGM, V153, P1546, DOI 10.1099/mic.0.2006/004234-0; Gelis-Jeanvoine S, 2016, RES MICROBIOL; Hassan KA, 2015, MBIO, V6, DOI 10.1128/mBio.01982-14; Hassan KA, 2013, P NATL ACAD SCI USA, V110, P20254, DOI 10.1073/pnas.1317052110; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Hoggard SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021763; Hoton FM, 2005, MICROBIOL-SGM, V151, P2121, DOI 10.1099/mic.0.28069-0; Hotta K, 2010, MICROBIOL-SGM, V156, P1918, DOI 10.1099/mic.0.039404-0; Huang JZ, 2004, ANTIMICROB AGENTS CH, V48, P909, DOI 10.1128/AAC.48.3.909-917.2004; Jack DL, 2000, J BACTERIOL, V182, P2311, DOI 10.1128/JB.182.8.2311-2313.2000; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Khattar ZA, 2009, J BACTERIOL, V191, P7063, DOI 10.1128/JB.00892-09; Klee SR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010986; Kristoffersen SM, 2007, J BACTERIOL, V189, P5302, DOI 10.1128/JB.00239-07; Kristoffersen SM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r30; Kroeger JK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01063; Kumano M, 2003, ANTIMICROB AGENTS CH, V47, P432, DOI 10.1128/AAC.47.1.432-435.2003; Lechner M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124; Leendertz FH, 2004, NATURE, V430, P451, DOI 10.1038/nature02722; Li X, 2015, J IND MICROBIOL BIOT, V42, P93, DOI 10.1007/s10295-014-1527-z; Lim CK, 2013, APPL ENVIRON MICROB, V79, P3141, DOI 10.1128/AEM.03101-12; Lopez D, 2009, GENE DEV, V23, P1631, DOI 10.1101/gad.1813709; Muller RT, 2015, BIOL CHEM, V396, P1083, DOI 10.1515/hsz-2015-0150; Ohki R, 1997, J BACTERIOL, V179, P1423, DOI 10.1128/jb.179.4.1423-1427.1997; PAULSEN IT, 1995, J BACTERIOL, V177, P2827, DOI 10.1128/jb.177.10.2827-2833.1995; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poole K, 2000, ANTIMICROB AGENTS CH, V44, P2595, DOI 10.1128/AAC.44.10.2595-2599.2000; Priest F.G., 1993, BACILLUS SUBTILIS OT; PRIEST FG, 1988, J GEN MICROBIOL, V134, P1847; Radchenko M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8995; Reilman E, 2014, NUCLEIC ACIDS RES, V42, P11393, DOI 10.1093/nar/gku832; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saier MH, 2014, NUCLEIC ACIDS RES, V42, pD251, DOI 10.1093/nar/gkt1097; Serizawa M, 2005, MICROBIOL-SGM, V151, P1769, DOI 10.1099/mic.0.27619-0; Serizawa M, 2010, ANTIMICROB AGENTS CH, V54, P2787, DOI 10.1128/AAC.01405-09; Simm R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036720; Soukas A, 2000, GENE DEV, V14, P963; Torres C, 2009, BBA-BIOMEMBRANES, V1788, P615, DOI 10.1016/j.bbamem.2008.12.012; Tsuge K, 2001, ANTIMICROB AGENTS CH, V45, P3566, DOI 10.1128/AAC.45.12.3566-3573.2001; Turillazzi S, 2006, J AM SOC MASS SPECTR, V17, P376, DOI 10.1016/j.jasms.2005.11.017; Varela MF, 1995, MOL MEMBR BIOL, V12, P313, DOI 10.3109/09687689509072433; Voros A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103326; Wijman JGE, 2007, APPL ENVIRON MICROB, V73, P1481, DOI 10.1128/AEM.01781-06; Woolridge DP, 1997, J BIOL CHEM, V272, P8864; Zwick ME, 2012, GENOME RES, V22, P1512, DOI 10.1101/gr.134437.111	64	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176188	10.1371/journal.pone.0176188	http://dx.doi.org/10.1371/journal.pone.0176188			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472044	gold, Green Published			2022-12-26	WOS:000400648500027
J	Hovhannisyan, N; Dhilly, M; Fidalgo, M; Fillesoye, F; Guillouet, S; Sola, B; Barre, L				Hovhannisyan, Narinee; Dhilly, Martine; Fidalgo, Martin; Fillesoye, Fabien; Guillouet, Stephane; Sola, Brigitte; Barre, Louisa			[F-18] Fludarabine-PET in a murine model of multiple myeloma	PLOS ONE			English	Article							EMISSION-TOMOGRAPHY PET; LYMPHOMA; THERAPY	Purpose Multiple myeloma (MM) is a haematological malignancy that affects plasma cells in the bone marrow. Recently, [F-18] fludarabine has been introduced as an innovative PET radiotracer for imaging lymphoma. It demonstrated a great potential for accurate imaging of lymphoproliferative disorders. With the goal to question the usefulness of [F-18] fludarabine-PET in other haematological diseases, an in vivo MM model was investigated. Methods RPMI8226-GFP-Luc MM cells expressing the green fluorescent protein (GFP) as well as the luciferase reporter (Luc) were derived from the parental RPMI8226 cells. They were injected subcutaneously into the flank of nude mice. Myeloma tumour growth was followed using bioluminescence-based imaging (BLI) and characterised by immunohistochemistry (IHC). The tumour specificity of [F-18] fludarabine was evaluated and compared to [F-18]FDG. Results The tumoural uptake of [F-18] FDG was greater than that of [F-18] fludarabine. However, the quantitative data extracted from IHC stainings were in better agreement with [F-18] fludarabine, when compared to [F-18] FDG. The relationship between the tumoural uptake of [F-18]labelled tracers and the BLI quantitative data was also in favour of [F-18] fludarabine. Conclusion Our results suggest that [F-18] fludarabine-PET might represent an alternative and perhaps more specific modality for MM imaging when compared to [F-18] FDG. Nevertheless, more investigations are required to extend this conclusion to humans.	[Hovhannisyan, Narinee; Dhilly, Martine; Fillesoye, Fabien; Guillouet, Stephane; Barre, Louisa] GIP Cyceron, CEA, DRF I2BM, LDM TEP Grp, Caen, France; [Hovhannisyan, Narinee; Dhilly, Martine; Fillesoye, Fabien; Guillouet, Stephane; Barre, Louisa] Normandie Univ, UNICAEN, CHU Caen, CNRS,CEA,ISTCT LDM TEP Grp, Caen, France; [Fidalgo, Martin; Sola, Brigitte] Normandie Univ, UNICAEN, UNIROUEN, INSERM UMR1245, Caen, France	CEA; Universite de Caen Normandie; CEA; Centre National de la Recherche Scientifique (CNRS); CHU de Caen NORMANDIE; Universite de Caen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie	Hovhannisyan, N (corresponding author), GIP Cyceron, CEA, DRF I2BM, LDM TEP Grp, Caen, France.; Hovhannisyan, N (corresponding author), Normandie Univ, UNICAEN, CHU Caen, CNRS,CEA,ISTCT LDM TEP Grp, Caen, France.	hovhannisyan@cyceron.fr		Sola, Brigitte/0000-0001-7278-9651	French National Agency [ANR-11-LABEX-0018-01]; Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA)	French National Agency(French National Research Agency (ANR)); Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA)(French Atomic Energy Commission)	This research was supported by a grant from the French National Agency for Research called "Investissements d'Avenir" ANR-11-LABEX-0018-01, by the Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA).	Caers J, 2014, HAEMATOLOGICA, V99, P629, DOI 10.3324/haematol.2013.091918; Chantepie S, 2015, BLOOD, V126, P3917; Dhilly M, 2014, MOL IMAGING BIOL, V16, P118, DOI 10.1007/s11307-013-0659-2; Gallamini A, 2014, CANCERS, V6, P1821, DOI 10.3390/cancers6041821; Gandhi V, 2002, CLIN PHARMACOKINET, V41, P93, DOI 10.2165/00003088-200241020-00002; Gaudichon J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107009; Guillouet S, 2014, MOL IMAGING BIOL, V16, P28, DOI 10.1007/s11307-013-0657-4; Hovhannisyan N, 2016, MOL PHARMACEUT, V13, P2136, DOI 10.1021/acs.molpharmaceut.6b00050; Hovhannisyan N, 2015, EJNMMI RES, V5, DOI 10.1186/s13550-015-0101-7; Luckerath K, 2015, ONCOTARGET, V6, P8418; Mesguich C, 2016, THERANOSTICS, V6, P287, DOI 10.7150/thno.14400; Mihailovic J, 2015, SEMIN NUCL MED, V45, P16, DOI 10.1053/j.semnuclmed.2014.08.002; Rozemuller H, 2008, HAEMATOL-HEMATOL J, V93, P1049, DOI 10.3324/haematol.12349	13	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177125	10.1371/journal.pone.0177125	http://dx.doi.org/10.1371/journal.pone.0177125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472196	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500140
J	Kremers, RMW; Kleinegris, MC; Ninivaggi, M; de Laat, B; ten Cate, H; Koek, GH; Wagenvoord, RJ; Hemker, HC				Kremers, Romy M. W.; Kleinegris, Marie-Claire; Ninivaggi, Marisa; de Laat, Bas; ten Cate, Hugo; Koek, Ger H.; Wagenvoord, Rob J.; Hemker, H. Coenraad			Decreased prothrombin conversion and reduced thrombin inactivation explain rebalanced thrombin generation in liver cirrhosis	PLOS ONE			English	Article							MOLECULAR-WEIGHT HEPARIN; CONVENTIONAL COAGULATION TESTS; HEPATITIS-C PATIENTS; PROTEIN-C; VENOUS THROMBOEMBOLISM; CLINICAL CONSEQUENCES; PLASMA; DISEASE; COAGULOPATHY; INHIBITION	Impaired coagulation factor synthesis in cirrhosis causes a reduction of most pro-and anticoagulant factors. Cirrhosis patients show no clear bleeding or thrombotic phenotype, although they are at risk for both types of hemostatic event. Thrombin generation (TG) is a global coagulation test and its outcome depends on underlying pro-and anticoagulant processes (prothrombin conversion and thrombin inactivation). We quantified the prothrombin conversion and thrombin inactivation during TG in 30 healthy subjects and 52 Child-Pugh (CP-) A, 15 CP-B and 6 CP-C cirrhosis patients to test the hypothesis that coagulation is rebalanced in liver cirrhosis patients. Both prothrombin conversion and thrombin inactivation are reduced in cirrhosis patients. The effect on pro-and anticoagulant processes partially cancel each other out and as a result TG is comparable at 5 pM tissue factor between healthy subjects and patients. This supports the hypothesis of rebalanced hemostasis, as TG in cirrhosis patients remains within the normal range, despite large changes in prothrombin conversion and thrombin inactivation. Nevertheless, in silico analysis shows that normalization of either prothrombin conversion or thrombin inactivation to physiological levels, by for example the administration of prothrombin complex concentrates would cause an elevation of TG, whereas the normalization of both simultaneously maintains a balanced TG. Therefore, cirrhosis patients might require adapted hemostatic treatment.	[Kremers, Romy M. W.; Ninivaggi, Marisa; de Laat, Bas; Wagenvoord, Rob J.; Hemker, H. Coenraad] Maastricht Univ, Cardiovasc Res Inst Maastricht, Synapse Res Inst, Maastricht, Netherlands; [Kremers, Romy M. W.; Kleinegris, Marie-Claire; de Laat, Bas; ten Cate, Hugo] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands; [Koek, Ger H.] Maastricht Univ, Med Ctr, Dept Internal Med, Div Gastroenterol & Hepatol, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University	Kremers, RMW (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Synapse Res Inst, Maastricht, Netherlands.; Kremers, RMW (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands.	r.kremers@thrombin.com	de Laat-Kremers, Romy MW/E-1253-2016; Cate, Hugo ten/AAM-4000-2021	de Laat-Kremers, Romy MW/0000-0001-6526-0338; ten Cate, Hugo/0000-0001-7796-4463	CTMM, the Center for translational Molecular Medicine, project INCOAG [01C-201]; Dutch Heart Foundation; Center for Translational and Molecular Medicine, program INCOAG; Netherlands Heart Foundation	CTMM, the Center for translational Molecular Medicine, project INCOAG; Dutch Heart Foundation(Netherlands Heart Foundation); Center for Translational and Molecular Medicine, program INCOAG; Netherlands Heart Foundation(Netherlands Heart Foundation)	This research was performed within the framework of CTMM, the Center for translational Molecular Medicine (http://www.ctmm.ni), project INCOAG (grant 01C-201), and supported by the Dutch Heart Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank J. Crombag measuring plasma fibrinogen levels, P. Kluskens for the plasma and serum prothrombin measurements and Thrombinoscope by for providing thrombomodulin. This work was supported by a grant from the Center for Translational and Molecular Medicine, program INCOAG and the Netherlands Heart Foundation (patient samples).	Bechmann LP, 2011, LIVER INT, V31, P1064, DOI 10.1111/j.1478-3231.2011.02548.x; Chaireti R, 2014, THROMB RES, V134, P455, DOI 10.1016/j.thromres.2014.05.012; Chandler WL, 2014, BLOOD COAGUL FIBRINO; Choi HS, 2009, J GASTROEN HEPATOL, V24, pA94; CHURCH FC, 1986, ANAL BIOCHEM, V157, P77, DOI 10.1016/0003-2697(86)90198-3; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; Delahousse B, 2010, THROMB HAEMOSTASIS, V104, P741, DOI 10.1160/TH10-01-0040; DOWNING MR, 1978, BIOCHEMISTRY-US, V17, P2649, DOI 10.1021/bi00606a030; Esmon CT, 1999, HAEMATOLOGICA, V84, P363; Gangadharan B, 2007, CLIN CHEM, V53, P1792, DOI 10.1373/clinchem.2007.089144; Gatt A, 2010, J THROMB HAEMOST, V8, P1994, DOI 10.1111/j.1538-7836.2010.03937.x; Groeneveld D, 2014, THROMB RES, V134, P753, DOI 10.1016/j.thromres.2014.07.010; Hemker HC, 2013, THROMB RES, V131, P3, DOI 10.1016/j.thromres.2012.10.011; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; HENDRIX H, 1983, J BIOL CHEM, V258, P3637; Ho AS, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-58; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; JESTY J, 1986, J BIOL CHEM, V261, P313; Kleinegris MC, 2014, J THROMB HAEMOST, V12, P1647, DOI 10.1111/jth.12706; Kremers RMW, 2015, J THROMB HAEMOST, V13, P437, DOI 10.1111/jth.12798; Kremers RMW, 2016, THROMB HAEM IN PRESS; Kremers RMW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141491; Kremers RMW, 2014, THROMB HAEMOSTASIS, V112, P486, DOI 10.1160/TH14-02-0172; Lisman T, 2007, DIGEST SURG, V24, P250, DOI 10.1159/000103655; Lisman T, 2011, LIVER INT, V31, P1063, DOI 10.1111/j.1478-3231.2011.02489.x; Lisman T, 2010, BLOOD, V116, P878, DOI 10.1182/blood-2010-02-261891; Lisman T, 2010, J HEPATOL, V52, P355, DOI 10.1016/j.jhep.2009.12.001; Mann KG, 2012, J THROMB HAEMOST, V10, P1463, DOI 10.1111/j.1538-7836.2012.04799.x; Marlar R A, 1981, Ann N Y Acad Sci, V370, P303, DOI 10.1111/j.1749-6632.1981.tb29743.x; MOR E, 1993, SURG GYNECOL OBSTET, V176, P219; Northup PG, 2008, J THROMB HAEMOST, V6, P2; Northup PG, 2006, AM J GASTROENTEROL, V101, P1524, DOI 10.1111/j.1572-0241.2006.00588.x; OHISHI R, 1993, THROMB HAEMOSTASIS, V70, P423; Potze W, 2014, HEPATOLOGY; Potze W, 2013, BRIT J HAEMATOL, V163, P666, DOI 10.1111/bjh.12593; Potze W, 2013, BRIT J HAEMATOL, V162, P819, DOI 10.1111/bjh.12462; Senzolo M, 2012, J THROMB HAEMOST, V10, P1823, DOI 10.1111/j.1538-7836.2012.04824.x; Sharara AI, 2001, NEW ENGL J MED, V345, P669, DOI 10.1056/NEJMra003007; Sogaard KK, 2009, AM J GASTROENTEROL, V104, P96, DOI 10.1038/ajg.2008.34; Stellingwerff M, 2012, SEMIN THROMB HEMOST, V38, P244, DOI 10.1055/s-0032-1302440; THALER E, 1975, BRIT J HAEMATOL, V31, P233, DOI 10.1111/j.1365-2141.1975.tb00853.x; Tripodi A, 2007, ALIMENT PHARM THERAP, V26, P141, DOI 10.1111/j.1365-2036.2007.03369.x; Tripodi A, 2005, HEPATOLOGY, V41, P553, DOI 10.1002/hep.20569; Tripodi A, 2007, J HEPATOL, V46, P727, DOI 10.1016/j.jhep.2007.01.015; Tripodi A, 2006, HEPATOLOGY, V44, P440, DOI 10.1002/hep.21266; Tripodi A, 2013, J HEPATOL, V59, P265, DOI 10.1016/j.jhep.2013.03.036; Tripodi A, 2012, INTERN EMERG MED, V7, P139, DOI 10.1007/s11739-011-0528-4; Tripodi A, 2010, HEPATOLOGY, V52, P249, DOI 10.1002/hep.23653; Westerkamp AC, 2009, HPB, V11, P453, DOI 10.1111/j.1477-2574.2009.00078.x; Youngwon N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/856754	50	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177020	10.1371/journal.pone.0177020	http://dx.doi.org/10.1371/journal.pone.0177020			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472132	gold, Green Submitted, Green Published			2022-12-26	WOS:000400648500121
J	Matsuura, M; Hirasawa, K; Murata, H; Nakakura, S; Kiuchi, Y; Asaoka, R				Matsuura, Masato; Hirasawa, Kazunori; Murata, Hiroshi; Nakakura, Shunsuke; Kiuchi, Yoshiaki; Asaoka, Ryo			Using CorvisST tonometry to assess glaucoma progression	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; CENTRAL CORNEAL THICKNESS; GOLDMANN APPLANATION TONOMETER; OCULAR HYPERTENSION TREATMENT; INTRAOCULAR-PRESSURE; VISUAL-FIELD; BIOMECHANICAL PROPERTIES; BLOOD-FLOW; TONO-PEN; DEFORMATION	Purpose To investigate the utility of the Corneal Visualization Scheimpflug Technology instrument (CST) to assess the progression of visual field (VF) damage in primary open angle glaucoma patients. Method A total of 75 eyes from 111 patients with primary open-angle glaucoma were investigated. All patients underwent at least nine VF measurements with the Humphrey Field Analyzer, CST measurements, axial length (AL), central corneal thickness (CCT) and intraocular pressure (IOP) with Goldmann applanation tonometry (GAT). Mean total deviation (mTD) progression rates of the eight VFs, excluding the first VF, were calculated and the association between progression rate and the other listed measurements was analyzed using linear regression, and the optimal to describe mTD progression rate was selected based on the second order bias corrected Akaike Information Criterion (AICc) index. Results VF progression was described best in a model that included CST parameters as well as other ocular measurements. The optimal linear model to describe mTD progression rate was given by the equation: -8.9-0.068 x mean GAT + 0.68 x A1 time + 0.31 x A2 time -0.39 x A2 length- 1.26 x highest deformation amplitude. Conclusion CST measurements are useful when assessing VF progression in glaucoma patients. In particular, careful consideration should be given to patients where: (i) an eye is observed to be applanated fast in the first and second applanations, (ii) the applanated area is wide in the second applanation and (iii) the indentation is deep at the maximum deformation, since these eyes appear to be at greater risk of VF progression.	[Matsuura, Masato; Hirasawa, Kazunori; Murata, Hiroshi; Asaoka, Ryo] Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan; [Hirasawa, Kazunori] Kitasato Univ, Sch Allied Hlth Sci, Dept Rehabil, Orthopt & Visual Sci, Kanagawa, Japan; [Nakakura, Shunsuke] Saneikai Tsukazaki Hosp, Dept Ophthalmol, Himeji, Hyogo, Japan; [Kiuchi, Yoshiaki] Hiroshima Univ, Dept Ophthalmol & Visual Sci, Hiroshima, Japan	University of Tokyo; Kitasato University; Hiroshima University	Asaoka, R (corresponding author), Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan.	rasaoka-tky@umin.ac.jp		Hirasawa, Kazunori/0000-0001-5100-005X	Japan Science and Technology Agency (JST)-CREST; Ministry of Education, Culture, Sports, Science and Technology of Japan [26462679]	Japan Science and Technology Agency (JST)-CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	All the funding supported this work are Japan Science and Technology Agency (JST)-CREST and Grant 26462679 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. There was no additional external funding received for this study.	Alward WL, 1998, AM J OPHTHALMOL, V126, P498; Asaoka R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140385; Bengtsson B, 2009, ARCH OPHTHALMOL-CHIC, V127, P1610, DOI 10.1001/archophthalmol.2009.297; Bhan A, 2002, INVEST OPHTH VIS SCI, V43, P1389; BROWN RH, 1994, CONTROL CLIN TRIALS, V15, P299; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; De Moraes CG, 2012, AM J OPHTHALMOL, V154, P702, DOI 10.1016/j.ajo.2012.04.015; Ehlers N, 1975, ACTA OPHTHALMOL S, V32; Ewing JA, 1889, HYSTERESIS RELATION, P502; Feltgen N, 2001, BRIT J OPHTHALMOL, V85, P85, DOI 10.1136/bjo.85.1.85; FORBES M, 1974, ARCH OPHTHALMOL-CHIC, V91, P134, DOI 10.1001/archopht.1974.03900060140012; Foster PJ, 1998, OPHTHALMOLOGY, V105, P969, DOI 10.1016/S0161-6420(98)96021-3; Fujino Y, INVEST OPHT IN PRESS; Garway-Heath DF, 2015, LANCET, V385, P1295, DOI 10.1016/S0140-6736(14)62111-5; Gordon MO, 2007, OPHTHALMOLOGY, V114, P10, DOI 10.1016/j.ophtha.2006.08.031; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Gunvant P, 2004, BRIT J OPHTHALMOL, V88, P518, DOI 10.1136/bjo.2003.019331; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; HOLMIN C, 1982, ACTA OPHTHALMOL, V60, P267; HOLMIN C, 1988, ACTA OPHTHALMOL, V66, P170; Inoue K, 2003, JPN J OPHTHALMOL, V47, P129, DOI 10.1016/S0021-5155(02)00667-6; JAY JL, 1988, BRIT J OPHTHALMOL, V72, P881, DOI 10.1136/bjo.72.12.881; Jonas JB, 2005, INVEST OPHTH VIS SCI, V46, P1275, DOI 10.1167/iovs.04-0851; Jung Y, 2016, OPHTHALMOLOGY, V123, P959, DOI 10.1016/j.ophtha.2015.12.043; Kaminski S, 1998, ACTA OPHTHALMOL SCAN, V76, P78, DOI 10.1034/j.1600-0420.1998.760114.x; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kim YW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159663; Koprowski R, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-150; Kotecha A, 2005, BRIT J OPHTHALMOL, V89, P1572, DOI 10.1136/bjo.2005.075580; Kotecha A, 2006, INVEST OPHTH VIS SCI, V47, P5337, DOI 10.1167/iovs.06-0557; KRAKAU CET, 1985, ACTA OPHTHALMOL, V63, P19; Lascaratos G, 2014, INTRAOCULAR PRESSURE; Lee JM, 2014, INVEST OPHTH VIS SCI, V55, P2228, DOI 10.1167/iovs.13-12261; Lesk MR, 2006, ARCH OPHTHALMOL-CHIC, V124, P1568, DOI 10.1001/archopht.124.11.1568; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Lichter PR, 2001, OPHTHALMOLOGY, V108, P1943, DOI 10.1016/S0161-6420(01)00873-9; Liu J, 2005, J CATARACT REFR SURG, V31, P146, DOI 10.1016/j.jcrs.2004.09.031; MALLOWS CL, 1973, TECHNOMETRICS, V15, P661, DOI 10.2307/1267380; Medeiros FA, 2005, ARCH OPHTHALMOL-CHIC, V123, P1351, DOI 10.1001/archopht.123.10.1351; Medeiros FA, 2013, OPHTHALMOLOGY, V120, P1533, DOI 10.1016/j.ophtha.2013.01.032; MIGDAL C, 1994, OPHTHALMOLOGY, V101, P1651; Musch DC, 2009, OPHTHALMOLOGY, V116, P200, DOI 10.1016/j.ophtha.2008.08.051; NIELSEN CB, 1985, ACTA OPHTHALMOL, V63, P351; Pajic B, 2010, CURR MED RES OPIN, V26, P2213, DOI 10.1185/03007995.2010.508702; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Ritch R, 1996, Trans Am Ophthalmol Soc, V94, P381; Salvetat ML, 2015, J GLAUCOMA, V24, P568, DOI 10.1097/IJG.0000000000000133; Shah S, 1999, OPHTHALMOLOGY, V106, P2154, DOI 10.1016/S0161-6420(99)90498-0; Shimmyo M, 2003, AM J OPHTHALMOL, V136, P603, DOI 10.1016/S0002-9394(03)00424-0; Singh K, 2011, INVEST OPHTH VIS SCI, V52, P8927, DOI 10.1167/iovs.11-7854; Spry PGD, 2000, INVEST OPHTH VIS SCI, V41, P2192; Stodtmeister R, 1998, ACTA OPHTHALMOL SCAN, V76, P319, DOI 10.1034/j.1600-0420.1998.760313.x; Taketani Y, 2015, INVEST OPHTH VIS SCI, V56, P4076, DOI 10.1167/iovs.14-16341; Tibshirani RJ, 2012, ANN STAT, V40, P1198, DOI 10.1214/12-AOS1003; Tonnu PA, 2005, BRIT J OPHTHALMOL, V89, P851, DOI 10.1136/bjo.2004.056622; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Wang W, 2015, INVEST OPHTH VIS SCI, V56, P5557, DOI 10.1167/iovs.15-16926; Wang XF, 2016, INVEST OPHTH VIS SCI, V57, P2452, DOI 10.1167/iovs.15-18986; Wang YX, 2015, OPHTHALMOLOGY, V122, P2022, DOI 10.1016/j.ophtha.2015.06.005; Wells AP, 2008, INVEST OPHTH VIS SCI, V49, P3262, DOI 10.1167/iovs.07-1556; WHITACRE MM, 1993, AM J OPHTHALMOL, V115, P592, DOI 10.1016/S0002-9394(14)71455-2; WHITACRE MM, 1993, SURV OPHTHALMOL, V38, P1, DOI 10.1016/0039-6257(93)90053-A; Wolfs RC, 1997, AM J OPHTHALMOL, V123, P767, DOI 10.1016/S0002-9394(14)71125-0; Zhong YS, 2011, CORNEA, V30, P861, DOI 10.1097/ICO.0b013e3182000c27	65	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176380	10.1371/journal.pone.0176380	http://dx.doi.org/10.1371/journal.pone.0176380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472062	gold, Green Submitted, Green Published			2022-12-26	WOS:000400648500042
J	Mauer, J; Peltomaki, M; Poblete, S; Gompper, G; Fedosov, DA				Mauer, Johannes; Peltomaeki, Matti; Poblete, Simon; Gompper, Gerhard; Fedosov, Dmitry A.			Static and dynamic light scattering by red blood cells: A numerical study	PLOS ONE			English	Article							DISSIPATIVE PARTICLE DYNAMICS; DIFFUSING-WAVE SPECTROSCOPY; SIMULATIONS; MODEL; FLOW; MACROMOLECULES; APPROXIMATION; CYTOSKELETON; SUSPENSIONS; MECHANICS	Light scattering is a well-established experimental technique, which gains more and more popularity in the biological field because it offers the means for non-invasive imaging and detection. However, the interpretation of light-scattering signals remains challenging due to the complexity of most biological systems. Here, we investigate static and dynamic scattering properties of red blood cells (RBCs) using two mesoscopic hydrodynamics simulation methods-multi-particle collision dynamics and dissipative particle dynamics. Light scattering is studied for various membrane shear elasticities, bending rigidities, and RBC shapes (e.g., biconcave and stomatocyte). Simulation results from the two simulation methods show good agreement, and demonstrate that the static light scattering of a diffusing RBC is not very sensitive to the changes in membrane properties and moderate alterations in cell shapes. We also compute dynamic light scattering of a diffusing RBC, from which dynamic properties of RBCs such as diffusion coefficients can be accessed. In contrast to static light scattering, the dynamic measurements can be employed to differentiate between the biconcave and stomatocytic RBC shapes and generally allow the differentiation based on the membrane properties. Our simulation results can be used for better understanding of light scattering by RBCs and the development of new non-invasive methods for blood-flow monitoring.	[Fedosov, Dmitry A.] Forschungszentrum Julich, Inst Complex Syst, Theoret Soft Matter & Biophys, D-52425 Julich, Germany; Forschungszentrum Julich, Inst Adv Simulat, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich	Fedosov, DA (corresponding author), Forschungszentrum Julich, Inst Complex Syst, Theoret Soft Matter & Biophys, D-52425 Julich, Germany.	d.fedosov@fz.juelich.de	Fedosov, Dmitry/G-4110-2013; Gompper, Gerhard/I-4886-2012	Fedosov, Dmitry/0000-0001-7469-9844; Gompper, Gerhard/0000-0002-8904-0986	FP7-PEOPLE-ITN LAPASO "Label-free particle sorting"; Alexander von Humboldt Foundation	FP7-PEOPLE-ITN LAPASO "Label-free particle sorting"; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We acknowledge the FP7-PEOPLE-2013-ITN LAPASO "Label-free particle sorting" for financial support. D.A.F. acknowledges funding by the Alexander von Humboldt Foundation.	Allen M.P., 1991, COMPUTER SIMULATION; Arifler D, 2014, BIOMED OPT EXPRESS, V5, P485, DOI 10.1364/BOE.5.000485; Belau M, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3503398; Berne B. J., 2000, DYNAMIC LIGHT SCATTE; Bi L, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.5.055001; Born M., 1959, PRINCIPLES OPTICS; BROCHARD F, 1975, J PHYS-PARIS, V36, P1035, DOI 10.1051/jphys:0197500360110103500; Cordasco D, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4871300; DELATORRE JG, 1994, BIOPHYS J, V67, P530, DOI 10.1016/S0006-3495(94)80512-0; Dhont, 1996, INTRO DYNAMICS COLLO; Discher DE, 1998, BIOPHYS J, V75, P1584, DOI 10.1016/S0006-3495(98)74076-7; DRAINE BT, 1994, J OPT SOC AM A, V11, P1491, DOI 10.1364/JOSAA.11.001491; Dunn A K, 1997, J Biomed Opt, V2, P262, DOI 10.1117/12.275219; ESPANOL P, 1995, EUROPHYS LETT, V30, P191, DOI 10.1209/0295-5075/30/4/001; Evans E.A., 1980, MECH THERMODYNAMICS; Fedosov DA, 2014, BIOMECH MODEL MECHAN, V13, P239, DOI 10.1007/s10237-013-0497-9; Fedosov DA, 2011, P NATL ACAD SCI USA, V108, P11772, DOI 10.1073/pnas.1101210108; Fedosov DA, 2010, BIOPHYS J, V98, P2215, DOI 10.1016/j.bpj.2010.02.002; Freund JB, 2014, ANNU REV FLUID MECH, V46, P67, DOI 10.1146/annurev-fluid-010313-141349; FUJIME S, 1985, BIOPHYS CHEM, V23, P1, DOI 10.1016/0301-4622(85)80059-4; de la Torre JG, 2007, J PHYS CHEM B, V111, P955, DOI 10.1021/jp0647941; Gompper G, 2009, ADV POLYM SCI, V221, P1, DOI 10.1007/12_2008_5; Gompper G, 1996, J PHYS I, V6, P1305, DOI 10.1051/jp1:1996246; He JP, 2004, J OPT SOC AM A, V21, P1953, DOI 10.1364/JOSAA.21.001953; HOOGERBRUGGE PJ, 1992, EUROPHYS LETT, V19, P155, DOI 10.1209/0295-5075/19/3/001; Huang CC, 2010, J COMPUT PHYS, V229, P168, DOI 10.1016/j.jcp.2009.09.024; Ihle T, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.066706; Ihle T, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.020201; ITZYKSON C, 1986, NUCL PHYS B, V275, P580, DOI 10.1016/0550-3213(86)90576-6; Kim Y, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.4.040501; Kruger T, 2011, COMPUT MATH APPL, V61, P3485, DOI 10.1016/j.camwa.2010.03.057; KUNZ D, 1983, COLLOID POLYM SCI, V261, P635, DOI 10.1007/BF01415033; Lanotte L, 2016, P NATL ACAD SCI USA, V113, P13289, DOI 10.1073/pnas.1608074113; Li J, 2008, OPT LETT, V33, P2233, DOI 10.1364/OL.33.002233; Lim J, 2011, BIOMED OPT EXPRESS, V2, P2784, DOI 10.1364/BOE.2.002784; Liu T, 2012, MACROMOL CHEM PHYS, V213, P1697, DOI 10.1002/macp.201200154; Lu JQ, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1897397; MAEDA T, 1985, MACROMOLECULES, V18, P2430, DOI 10.1021/ma00154a016; Malevanets A, 1999, J CHEM PHYS, V110, P8605, DOI 10.1063/1.478857; Meinke MC, 2011, ADV OPTICAL FLOW CYT, P95; Nikitin SY, 2013, QUANTUM ELECTRON+, V43, P90, DOI 10.1070/QE2013v043n01ABEH014968; Ninck M, 2010, BIOMED OPT EXPRESS, V1, P1502, DOI 10.1364/BOE.1.001502; Noguchi H, 2005, P NATL ACAD SCI USA, V102, P14159, DOI 10.1073/pnas.0504243102; Noguchi H, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016706; Okubo T, 1996, COLLOID POLYM SCI, V274, P93, DOI 10.1007/BF00663441; Park Y, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3524509; Park Y, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3369966; Park YK, 2010, P NATL ACAD SCI USA, V107, P1289, DOI 10.1073/pnas.0910785107; Pecora R, 2000, J NANOPART RES, V2, P123, DOI 10.1023/A:1010067107182; Peltomaki M, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3701265; Peng ZL, 2014, J FLUID MECH, V742, P96, DOI 10.1017/jfm.2014.14; Poblete S, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.033314; Tsinopoulos SV, 1999, APPL OPTICS, V38, P5499, DOI 10.1364/AO.38.005499; Turlier H, 2016, NAT PHYS, V12, P513, DOI [10.1038/nphys3621, 10.1038/NPHYS3621]; TYCKO DH, 1985, APPL OPTICS, V24, P1355, DOI 10.1364/AO.24.001355; Zohdi TI, 2006, J R SOC INTERFACE, V3, P823, DOI 10.1098/rsif.2006.0139	56	10	10	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176799	10.1371/journal.pone.0176799	http://dx.doi.org/10.1371/journal.pone.0176799			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472125	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500073
J	Niegowska, M; Delitala, A; Pes, GM; Delitala, G; Sechi, LA				Niegowska, Magdalena; Delitala, Alessandro; Pes, Giovanni Mario; Delitala, Giuseppe; Sechi, Leonardo A.			Increased seroreactivity to proinsulin and homologous mycobacterial peptides in latent autoimmune diabetes in adults	PLOS ONE			English	Article							AVIUM SUBSP PARATUBERCULOSIS; TCF7L2 GENE; TYPE-1; ASSOCIATION; LADA; EXPRESSION; EPITOPES; CHILDREN; NIRAD; TITER	Latent Autoimmune Diabetes in Adults (LADA) is a slowly progressing form of immune-mediated diabetes that combines phenotypical features of type 2 diabetes (T2D) with the presence of islet cell antigens detected in type 1 diabetes (T1D). Heterogeneous clinical picture have led to the classification of patients based on the levels of antibodies against glutamic acid decarboxylase 65 (GADA) that correlate with clinical phenotypes closer to T1D or T2D when GADA titers are high or low, respectively. To date, LADA etiology remains elusive despite numerous studies investigating on genetic predisposition and environmental risk factors. To our knowledge, this is the first study aimed at evaluation of a putative role played by Mycobacterium avium subsp. paratuberculosis (MAP) as an infective agent in LADA pathogenesis. MAP is known to cause chronic enteritis in ruminants and has been associated with autoimmune disorders in humans. We analyzed seroreactivity of 223 Sardinian LADA subjects and 182 healthy volunteers against MAP-derived peptides and their human homologs of proinsulin and zinc transporter 8 protein. A significantly elevated positivity for MAP/proinsulin was detected among patients, with the highest prevalence in the 32-41year- old T1D-like LADA subgroup, supporting our hypothesis of a possible MAP contribution in the development of autoimmunity.	[Niegowska, Magdalena; Sechi, Leonardo A.] Univ Sassari, Dept Biomed Sci, Sassari, Italy; [Delitala, Alessandro] Univ Sassari, Azienda Osped, Sassari, Italy; [Pes, Giovanni Mario; Delitala, Giuseppe] Univ Sassari, Dept Clin & Expt Med, Sassari, Italy	University of Sassari; University of Sassari; University of Sassari	Sechi, LA (corresponding author), Univ Sassari, Dept Biomed Sci, Sassari, Italy.	sechila@uniss.it	Pes, Giovanni Mario/AAH-3340-2019; Delitala, Alessandro/AAH-2697-2020; Sechi, Leonardo Antonio/Y-3109-2018; Delitala, Alessandro/L-3194-2016	Pes, Giovanni Mario/0000-0003-3265-2823; Delitala, Alessandro/0000-0003-1729-8969; sechi, leonardo antonio/0000-0003-0566-2049				Atreya R, 2014, INT J MED MICROBIOL, V304, P858, DOI 10.1016/j.ijmm.2014.07.006; Barros CMAR, 2014, GENET MOL RES, V13, P7889, DOI 10.4238/2014.September.29.1; Carlsson S, 2007, DIABETES CARE, V30, P3040, DOI 10.2337/dc07-0718; Cervin C, 2008, DIABETES, V57, P1433, DOI 10.2337/db07-0299; Delitala AP, 2016, ENDOCR RES, V41, P207, DOI 10.3109/07435800.2015.1136934; Delitala AP, 2015, J DIABETES, V7, P68, DOI 10.1111/1753-0407.12137; Desai M, 2007, DIABETOLOGIA, V50, P68, DOI 10.1007/s00125-006-0513-z; Di Gaetano C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091237; Falorni A, 2002, ANN NY ACAD SCI, V958, P99; Gale EAM, 2001, DIABETOLOGIA, V44, P3, DOI 10.1007/s001250051573; Guglielmi C, 2012, DIABETES-METAB RES, V28, P40, DOI 10.1002/dmrr.2345; Hawa MI, 2013, DIABETES CARE, V36, P908, DOI 10.2337/dc12-0931; Hermon-Taylor J, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-15; Hjort R, 2015, DIABETOLOGIA, V58, P2525, DOI 10.1007/s00125-015-3711-8; Liao Yu, 2012, Front Med, V6, P243, DOI 10.1007/s11684-012-0201-y; Lofvenborg JE, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.36; Lukacs K, 2012, DIABETOLOGIA, V55, P689, DOI 10.1007/s00125-011-2378-z; Maioli M, 2010, EUR J ENDOCRINOL, V163, P541, DOI 10.1530/EJE-10-0427; Masala S, 2014, PLOS ONE, V15; Masala S, 2015, PEDIATR DIABETES, V16, P189, DOI 10.1111/pedi.12269; Masala S, 2014, ACTA DIABETOL, V51, P577, DOI 10.1007/s00592-014-0558-2; Masala S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063371; Masala S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026931; Niegowska M, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/5842701; Niegowska M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22266; Niegowska M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133497; Ostergaard JA, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0780-0; Patel D, 2006, INFECT IMMUN, V74, P2849, DOI 10.1128/IAI.74.5.2849-2855.2006; Pes GM, 2016, INTERN EMERG MED, V11, P561, DOI 10.1007/s11739-015-1352-z; Pettersen E, 2010, DIABETES, V59, P302, DOI 10.2337/db09-0923; Rasouli B, 2014, EUR J ENDOCRINOL, V171, P535, DOI 10.1530/EJE-14-0403; Rasuoli B, 2016, DIABET MED; Redondo MJ, 2013, DIABETES, V62, P339, DOI 10.2337/db12-1171; Rosu V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004386; Sardu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032487; Savic D, 2011, GENOME RES, V21, P1417, DOI 10.1101/gr.123745.111; Shin MK, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv031; Stenstrom G, 2002, AM J EPIDEMIOL, V156, P787, DOI 10.1093/aje/kwf115; Tanaka S, 2005, VET PATHOL, V42, P579, DOI 10.1354/vp.42-5-579; Weber P, 2011, Adv Gerontol, V24, P312; Zampetti S, 2010, DIABETIC MED, V27, P701, DOI 10.1111/j.1464-5491.2010.02997.x; Zampetti S, 2012, J CLIN ENDOCR METAB, V97, P3759, DOI 10.1210/jc.2012-2037	42	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176584	10.1371/journal.pone.0176584	http://dx.doi.org/10.1371/journal.pone.0176584			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472070	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500055
J	Sayre, EC; Guermazi, A; Esdaile, JM; Kopec, JA; Singer, J; Thorne, A; Nicolaou, S; Cibere, J				Sayre, Eric C.; Guermazi, Ali; Esdaile, John M.; Kopec, Jacek A.; Singer, Joel; Thorne, Anona; Nicolaou, Savvas; Cibere, Jolanda			Associations between MRI features versus knee pain severity and progression: Data from the Vancouver Longitudinal Study of Early Knee Osteoarthritis	PLOS ONE			English	Article							SUBCHONDRAL BONE; EPIDEMIOLOGY; POPULATION; BIOMARKERS; ARTHRITIS; OUTCOMES; THERAPY; HEALTH; DAMAGE; JOINT	Objective To determine associations between features of osteoarthritis (OA) on MRI and knee pain severity and knee pain progression. Design Baseline, 3.3- and 7.5-year assessments were performed for 122 subjects with baseline knee pain (age 40-79), sample-weighted for population (with knee pain) representativeness. MRIs were scored for: osteophytes (0: absent to 3: large); cartilage (0: normal to 4: full thickness defect; 0/1 collapsed); subchondral sclerosis (0: none to 3:>50% of site), subchondral cyst (0: absent to 3: severe), bone marrow lesions (0: none to 3:>= 50% of site); and meniscus (0: normal to 3: maceration/resection), in 6-8 regions each. Per feature, scores were averaged across regions. Effusion/synovitis (0: absent to 3: severe) was analyzed as >= 2 vs. <2. Linear models predicted WOMAC knee pain severity (0-100), and binary models predicted 10+ (minimum perceptible clinical improvement [ MPCI]) and 20+ (minimum clinically important difference [ MCID]) increases. Models were adjusted for age, sex, BMI (and follow-up time for longitudinal models). Results Pain severity was associated with osteophytes (7.17 per unit average; 95% CI = 3.19, 11.15) and subchondral sclerosis (11.03; 0.68, 21.39). MPCI-based pain increase was associated with osteophytes (odds ratio per unit average 3.20; 1.36, 7.55), subchondral sclerosis (5.69; 1.06, 30.44), meniscal damage (1.68; 1.08, 2.61) and effusion/synovitis >= 2 (2.25; 1.07, 4.71). MCID-based pain increase was associated with osteophytes ( 3.79; 1.41, 10.20) and cartilage defects ( 2.42; 1.24, 4.74). Conclusions Of the features investigated, only osteophytes were consistently associated with pain cross-sectionally and longitudinally in all models. This suggests an important role of bone in early knee osteoarthritis.	[Sayre, Eric C.; Esdaile, John M.; Kopec, Jacek A.; Cibere, Jolanda] Arthrit Res Canada, Richmond, BC, Canada; [Guermazi, Ali] Boston Univ, Sch Med, Radiol, Boston, MA 02215 USA; [Esdaile, John M.; Cibere, Jolanda] Univ British Columbia, Med, Vancouver, BC, Canada; [Esdaile, John M.] Univ Calgary, Med, Calgary, AB, Canada; [Esdaile, John M.] Univ Queensland, Sch Med, St Lucia, Qld, Australia; [Kopec, Jacek A.; Singer, Joel; Thorne, Anona] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Nicolaou, Savvas] Univ British Columbia, Radiol, Vancouver, BC, Canada	Arthritis Research Canada; Boston University; University of British Columbia; University of Calgary; University of Queensland; University of British Columbia; University of British Columbia	Sayre, EC (corresponding author), Arthrit Res Canada, Richmond, BC, Canada.	esayre@arthritisresearch.ca		Nicolaou, Savvas/0000-0002-4203-6605	Canadian Institutes of Health Research [89890, 89997]; Canadian Arthritis Network [01-MNO-09N]; The Arthritis Society [TAS04/0063, INS-12-027]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Arthritis Network; The Arthritis Society	This cohort study was funded by grants from the Canadian Institutes of Health Research (#89890, #89997), the Canadian Arthritis Network (01-MNO-09N), and The Arthritis Society (TAS04/0063). Dr. Cibere was supported by an Investigator Award from The Arthritis Society (INS-12-027).	Ai F, 2010, J HUAZHONG U SCI-MED, V30, P248, DOI 10.1007/s11596-010-0223-0; Baert IAC, 2014, KNEE SURG SPORT TR A, V22, P2013, DOI 10.1007/s00167-013-2434-y; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bilgici A, 2010, TURK J RHEUMATOL, V25, P184, DOI 10.5152/tjr.2010.26; Chopra A, 2008, BEST PRACT RES CL RH, V22, P583, DOI 10.1016/j.berh.2008.07.001; Cibere J, 2011, OSTEOARTHR CARTILAGE, V19, P683, DOI 10.1016/j.joca.2011.02.008; Cibere J, 2010, ARTHRIT CARE RES, V62, P1691, DOI 10.1002/acr.20314; Cibere J, 2009, ARTHRITIS RHEUM-US, V60, P1372, DOI 10.1002/art.24473; Cotofana S, 2013, OSTEOARTHR CARTILAGE, V21, P1214, DOI 10.1016/j.joca.2013.04.001; Disler DG, 1996, AM J ROENTGENOL, V167, P127, DOI 10.2214/ajr.167.1.8659356; Ehrich EW, 2000, J RHEUMATOL, V27, P2635; Engelhardt M, 2003, DEUT Z SPORTMED, V54, P171; Galvan-Tejada JI, P SPIE; Guermazi A, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5339; Hernandez-Molina G, 2008, ANN RHEUM DIS, V67, P43, DOI 10.1136/ard.2007.070565; Hunter DJ, 2013, OSTEOARTHR CARTILAGE, V21, P1170, DOI 10.1016/j.joca.2013.05.017; Hunter DJ, 2011, OSTEOARTHR CARTILAGE, V19, P557, DOI 10.1016/j.joca.2010.10.029; Ip S, 2011, J RHEUMATOL, V38, P1079, DOI 10.3899/jrheum.100587; Javaid MK, 2012, ARTHRITIS RHEUM-US, V64, P3246, DOI 10.1002/art.34594; Javaid MK, 2010, OSTEOARTHR CARTILAGE, V18, P323, DOI 10.1016/j.joca.2009.11.002; Joubert J, 2007, SAMJ S AFR MED J, V97, P683; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kim HA, 2011, OSTEOARTHR CARTILAGE, V19, P1422, DOI 10.1016/j.joca.2011.09.002; Kopec JA, 2007, J RHEUMATOL, V34, P386; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Link TM, 2009, J BONE JOINT SURG AM, V91A, P30, DOI 10.2106/JBJS.H.01313; Lo GH, 2009, OSTEOARTHR CARTILAGE, V17, P1562, DOI 10.1016/j.joca.2009.06.006; Niethammer TR, 2015, AM J SPORT MED, V43, P1172, DOI 10.1177/0363546515573935; Ratzlaff C, 2013, OSTEOARTHR CARTILAGE, V21, P806, DOI 10.1016/j.joca.2013.03.007; Sowers M, 2011, J BONE JOINT SURG AM, V93A, P241, DOI 10.2106/JBJS.I.00667; Stefanik JJ, 2015, OSTEOARTHR CARTILAGE, V23, P565, DOI 10.1016/j.joca.2014.12.023; Tubach F, 2005, ANN RHEUM DIS, V64, P29, DOI 10.1136/ard.2004.022905; White AG, 2008, J OCCUP ENVIRON MED, V50, P998, DOI 10.1097/JOM.0b013e3181715111; Wildi LM, 2010, ANN RHEUM DIS, V69, P2118, DOI 10.1136/ard.2009.127993; Yusuf E, 2011, ANN RHEUM DIS, V70, P60, DOI 10.1136/ard.2010.131904; Zhai G, 2007, CLIN RHEUMATOL, V26, P75, DOI 10.1007/s10067-006-0248-8	37	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176833	10.1371/journal.pone.0176833	http://dx.doi.org/10.1371/journal.pone.0176833			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472071	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500080
J	Moqueet, N; Kanagaratham, C; Gill, MJ; Hull, M; Walmsley, S; Radzioch, D; Saeed, S; Platt, RW; Klein, MB				Moqueet, Nasheed; Kanagaratham, Cynthia; Gill, M. John; Hull, Mark; Walmsley, Sharon; Radzioch, Danuta; Saeed, Sahar; Platt, Robert W.; Klein, Marina B.		Canadian Co-Infect Cohort Study	A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROGRESSION; INFECTION; PREDICTION; GENOTYPE; RISK; POLYMORPHISMS; PATHOGENESIS; ASSOCIATION; VALIDATION	Background Liver fibrosis progresses rapidly in HIV-Hepatitis C virus (HCV) co-infected individuals partially due to heightened inflammation. Immune markers targeting stages of fibrogenesis could aid in prognosis of fibrosis. Methods A case-cohort study was nested in the prospective Canadian Co-infection Cohort (n = 1119). HCV RNA positive individuals without fibrosis, end-stage liver disease or chronic Hepatitis B at baseline (n = 679) were eligible. A random subcohort (n = 236) was selected from those eligible. Pro-fibrogenic markers and Interferon Lambda (IFNL) rs8099917 genotype were measured from first available sample in all fibrosis cases (APRI >= 1.5 during follow- up) and the subcohort. We used Cox proportional hazards and compared Model 1 (selected clinical predictors only) to Model 2 (Model 1 plus selected markers) for predicting 3-year risk of liver fibrosis using weighted Harrell's C and Net Reclassification Improvement indices. Results 113 individuals developed significant liver fibrosis over 1300 person-years (8.63 per 100 person-years 95% CI: 7.08, 10.60). Model 1 (age, sex, current alcohol use, HIV RNA, baseline APRI, HCV genotype) was nested in model 2, which also included IFNL genotype and IL-8, sICAM-1, RANTES, hsCRP, and sCD14. The C indexes (95% CI) for model 1 vs. model 2 were 0.720 (0.649, 0.791) and 0.756 (0.688, 0.825), respectively. Model 2 classified risk more appropriately (overall net reclassification improvement, p< 0.05). Conclusions Including IFNL genotype and inflammatory markers IL-8, sICAM-1, RANTES, hs-CRP, and sCD14 enabled better prediction of the 3-year risk of significant liver fibrosis over clinical predictors alone. Whether this modest improvement in prediction justifies their additional cost requires further cost-benefit analyses.	[Moqueet, Nasheed; Saeed, Sahar; Platt, Robert W.; Klein, Marina B.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Kanagaratham, Cynthia; Radzioch, Danuta] McGill Univ, Dept Med, Montreal, PQ, Canada; [Kanagaratham, Cynthia; Radzioch, Danuta] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Gill, M. John] Southern Alberta HIV Clin, Calgary, AB, Canada; [Hull, Mark] St Pauls Hosp, BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Walmsley, Sharon] Univ Toronto, Toronto Gen Res Inst, Univ Hlth Network, Toronto, ON, Canada; [Klein, Marina B.] McGill Univ, Ctr Hlth, Div Infect Dis, Montreal, PQ, Canada; [Klein, Marina B.] McGill Univ, Ctr Hlth, Chron Viral Illness Serv, Montreal, PQ, Canada	McGill University; McGill University; McGill University; B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; McGill University; McGill University	Klein, MB (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.; Klein, MB (corresponding author), McGill Univ, Ctr Hlth, Div Infect Dis, Montreal, PQ, Canada.; Klein, MB (corresponding author), McGill Univ, Ctr Hlth, Chron Viral Illness Serv, Montreal, PQ, Canada.	marina.klein@mcgill.ca	Dodsley, Maria/G-7083-2016; Gill, Michael John/G-7083-2016	Dodsley, Maria/0000-0001-7587-558X; Radzioch, Danuta/0000-0002-1601-2757; Gill, Michael John/0000-0002-8546-8790; Klein, Marina/0000-0002-3063-8430; Saeed, Sahar/0000-0002-0224-379X; Walmsley, Sharon/0000-0002-3959-5692; Moqueet, Nasheed/0000-0001-9123-482X	Canadian Institutes of Health Research [HEO-115694, FDN-143270]; Fonds de recherche Quebec-Sante, Reseau SIDA/maladies infectieuses; CIHR Canadian HIV Trials Network [CTN222]; Chercheur National career award from the FRQ-S [27267]; Canadian Institutes of Health Research (CIHR DRA) [201010MDR]; Canadian Network on Hepatitis C	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de recherche Quebec-Sante, Reseau SIDA/maladies infectieuses; CIHR Canadian HIV Trials Network(Canadian Institutes of Health Research (CIHR)); Chercheur National career award from the FRQ-S; Canadian Institutes of Health Research (CIHR DRA); Canadian Network on Hepatitis C	This work was funded by the Canadian Institutes of Health Research (#HEO-115694; http://www.cihr-irsc.gc.ca/). The Canadian Co-infection Cohort is funded by Fonds de recherche Quebec-Sante, Reseau SIDA/maladies infectieuses (#n/a; http://www.reseausidami.quebec/), the Canadian Institutes of Health Research (#FDN-143270; http://www.cihr-irsc.gc.ca/), and the CIHR Canadian HIV Trials Network (#CTN222; http://www.hivnet.ubc.ca/); Dr. Marina B. Klein is supported by a Chercheur National career award from the FRQ-S (#27267;http://www.frqs.gouv.qc.ca/). Nasheed Moqueet was supported by a doctoral research award from the Canadian Institutes of Health Research (CIHR DRA; 201010MDR) and the Canadian Network on Hepatitis C (#n/a; http://www.canhepc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2010, J HEPATOL, V53, P439, DOI 10.1016/j.jhep.2010.03.022; Adams LA, 2005, CLIN CHEM, V51, P1867, DOI 10.1373/clinchem.2005.048389; Al-Mohri H, 2005, HIV MED, V6, P375, DOI 10.1111/j.1468-1293.2005.00330.x; Al-Mohri H, 2007, JAIDS-J ACQ IMM DEF, V44, P463, DOI 10.1097/QAI.0b013e318030ff8e; American Association for the Study of Liver Diseases, 2015, HCV GUID REC TEST MA; [Anonymous], 2015, J HEPATOL, V63, P237, DOI 10.1016/j.jhep.2015.04.006; [Anonymous], 2014, BRIT COL PHARMACARE; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Barreiro P, 2011, J INFECT DIS, V203, P1629, DOI 10.1093/infdis/jir113; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Bochud PY, 2011, J HEPATOL, V54, pS539, DOI 10.1016/S0168-8278(11)61363-9; Caradonna L, 2002, CURR PHARM DESIGN, V8, P995, DOI 10.2174/1381612024606983; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; D'Ambrosio R, 2014, INT J MOL SCI, V15, P7213, DOI 10.3390/ijms15057213; Eslam M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7422; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Ghany MG, 2003, GASTROENTEROLOGY, V124, P97, DOI 10.1053/gast.2003.50018; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Greenland P, 2005, ARCH INTERN MED, V165, P2454, DOI 10.1001/archinte.165.21.2454; Gronnesby J K, 1996, Lifetime Data Anal, V2, P315, DOI 10.1007/BF00127305; Hull M, 2014, CAN J INFECT DIS MED, V25, P311, DOI 10.1155/2014/251989; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kelleher TB, 2005, J HEPATOL, V43, P78, DOI 10.1016/j.jhep.2005.02.025; Klein MB, 2010, INT J EPIDEMIOL, V39, P1162, DOI 10.1093/ije/dyp297; Leening MJG, 2014, ANN INTERN MED, V160, P122, DOI 10.7326/M13-1522; Lo Re V, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv109; Lo Re V, 2014, ANN INTERN MED, V160, P369, DOI 10.7326/M13-1829; Macias J, 2006, GUT, V55, P409, DOI 10.1136/gut.2005.065904; Macias J, 2011, HIV MED, V12, P14, DOI 10.1111/j.1468-1293.2010.00836.x; Marchetti G, 2013, CLIN MICROBIOL REV, V26, P2, DOI 10.1128/CMR.00050-12; Marti H, 2011, STAT MED, V30, P1595, DOI 10.1002/sim.4130; Moqueet N, 2016, J INFECT DIS, V214, P80, DOI 10.1093/infdis/jiw088; Moqueet N, 2015, INT J MOL SCI, V16, P6496, DOI 10.3390/ijms16036496; Naggie S, 2012, HEPATOLOGY, V56, P444, DOI 10.1002/hep.25647; Newson RB, 2010, STATA J, V10, P339, DOI 10.1177/1536867X1001000303; Patel K, 2003, J GASTROEN HEPATOL, V18, P253, DOI 10.1046/j.1440-1746.2003.02930.x; Peltekian KM, 2014, CAN J GASTROENTEROL, V28, P417, DOI 10.1155/2014/140864; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Price JC, 2010, CLIN GASTROENTEROL H, V8, P1002, DOI 10.1016/j.cgh.2010.08.024; Probst A, 2011, J VIRAL HEPATITIS, V18, P745, DOI 10.1111/j.1365-2893.2011.01481.x; Rembeck K, 2012, HEPATOLOGY, V56, P394, DOI 10.1002/hep.25598; Roe Barbara, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000847; Romero-Gomez M, 2011, LIVER INT, V31, P443, DOI 10.1111/j.1478-3231.2011.02449.x; Royston P, 2015, STATA J, V15, P275, DOI 10.1177/1536867X1501500116; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Sanderson J, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-113; Suppiah V, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001092; Tate JP, 2013, AIDS, V27, P563, DOI 10.1097/QAD.0b013e32835b8c7f; Vergniol J, 2014, HEPATOLOGY, V60, P65, DOI 10.1002/hep.27069; Wald O, 2007, CYTOKINE, V39, P50, DOI 10.1016/j.cyto.2007.05.013; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966	53	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176282	10.1371/journal.pone.0176282	http://dx.doi.org/10.1371/journal.pone.0176282			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467457	gold, Green Published, Green Submitted			2022-12-26	WOS:000400647000045
J	Blackburn, HD; Krehbiel, B; Ericsson, SA; Wilson, C; Caetano, AR; Paiva, SR				Blackburn, H. D.; Krehbiel, B.; Ericsson, S. A.; Wilson, C.; Caetano, A. R.; Paiva, S. R.			A fine structure genetic analysis evaluating ecoregional adaptability of a Bos taurus breed (Hereford)	PLOS ONE			English	Article							ENVIRONMENT INTERACTION; CLIMATE-CHANGE; ZEBU CATTLE; MILES CITY; LINE 1; GENOTYPE; ANCESTRY; TEMPERATURE; POPULATIONS; ADAPTATIONS	Ecoregional differences contribute to genetic environmental interactions and impact animal performance. These differences may become more important under climate change scenarios. Utilizing genetic diversity within a species to address such problems has not been fully explored. In this study Hereford cattle were genotyped with 50K Bead Chip or 770K Bovine Bead Chip to test the existence of genetic structure in five U.S. ecoregions characterized by precipitation, temperature and humidity and designated: cool arid (CA), cool humid (CH), transition zone (TZ), warm arid (WA), and warm humid (WH). SNP data were analyzed in three sequential analyses. Broad genetic structure was evaluated with STRUCTURE, and ADMIXTURE software using 14,312 SNPs after passing quality control variables. The second analysis was performed using principal coordinate analysis with 66 Tag SNPs associated in the literature with various aspects of environmental stressors (e.g., heat tolerance) or production (e.g., milk production). In the third analysis TreeSelect was used with the 66 SNPs to evaluate if ecoregional allelic frequencies deviated from a central frequency and by so doing are indicative of directional selection. The three analyses suggested subpopulation structures associated with ecoregions from where animals were derived. ADMIXTURE and PCA results illustrated the importance of temperature and humidity and confirm subpopulation assignments. Comparisons of allele frequencies with TreeSelect showed ecoregion differences, in particular the divergence between arid and humid regions. Patterns of genetic variability obtained by medium and high density SNP chips can be used to acclimatize a temperately derived breed to various ecoregions. As climate change becomes an important factor in cattle production, this study should be used as a proof of concept to review future breeding and conservation schemes aimed at adaptation to climatic events.	[Blackburn, H. D.; Krehbiel, B.; Wilson, C.] USDA ARS, Natl Anim Germplasm Program, Ft Collins, CO 80522 USA; [Krehbiel, B.] Colorado State Univ, Dept Anim Sci, Ft Collins, CO 80523 USA; [Ericsson, S. A.] Sul Ross Univ, Alpine, TX USA; [Caetano, A. R.; Paiva, S. R.] EMBRAPA Recursos Genet & Biotechnol Brasilia, Brasilia, DF, Brazil; [Caetano, A. R.; Paiva, S. R.] EMBRAPA LABEX, Ft Collins, CO USA	United States Department of Agriculture (USDA); Colorado State University; Texas State University System; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Blackburn, HD (corresponding author), USDA ARS, Natl Anim Germplasm Program, Ft Collins, CO 80522 USA.	Harvey.Blackburn@ars.usda.gov	Paiva, Samuel R/G-6404-2012	Paiva, Samuel R/0000-0001-6687-2491	USDA-ARS; Dixon Water Foundation; Dixon Water Foundation (Marfa, TX)	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Dixon Water Foundation; Dixon Water Foundation (Marfa, TX)	USDA-ARS provided funding through there normal program funding to the National Animal Germplasm Program. The Dixon Water Foundation provided funds for genotyping a portion of the cattle. None of these funds were obtained via a competitive grant system.; The American Hereford Association (Kansas City, MO) for providing pedigree and genomic information for this study; Dixon Water Foundation (Marfa, TX) for supporting a portion of the genotyping expenses; and Dr. Larry Kuehn ARS/USDA (Clay Center, NB) for contributing the Hereford genotypes from the "2000 Bull Project".	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Arguez A., 2012, 7 NCDC; Arguez A, 2012, B AM METEOROL SOC, V93, P1687, DOI 10.1175/BAMS-D-11-00197.1; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Bhatia G, 2011, AM J HUM GENET, V89, P368, DOI 10.1016/j.ajhg.2011.07.025; Blackburn H.D., 2014, P WORLD C GENETICS A; Bohmanova J, 2008, J DAIRY SCI, V91, P840, DOI 10.3168/jds.2006-142; Bohmanova J, 2007, J DAIRY SCI, V90, P1947, DOI 10.3168/jds.2006-513; Bray TC, 2009, ANIM GENET, V40, P393, DOI 10.1111/j.1365-2052.2009.01850.x; CARTWRIGHT TC, 1955, J ANIM SCI, V14, P350, DOI 10.2527/jas1955.142350x; CARTWRIGHT TC, 1980, J ANIM SCI, V50, P1221, DOI 10.2527/jas1980.5061221x; Cleveland MA, 2005, J ANIM SCI, V83, P992; Collier RJ, 2008, J DAIRY SCI, V91, P445, DOI 10.3168/jds.2007-0540; de Jong G, 2002, LIVEST PROD SCI, V78, P195, DOI 10.1016/S0301-6226(02)00096-9; Easterling W, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P273; Edea Zewdu, 2013, Frontiers in Genetics, V4, P35, DOI 10.3389/fgene.2013.00035; Falconer D. S., INTRO QUANTITATIVE G, P464; FRISCH JE, 1981, J AGR SCI-CAMBRIDGE, V96, P23, DOI 10.1017/S0021859600031841; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Golden B.L., 1992, AGR EXPT STATION TEC; Hammond AC, 1996, J ANIM SCI, V74, P295; Hansen PJ, 2004, ANIM REPROD SCI, V82-3, P349, DOI 10.1016/j.anireprosci.2004.04.011; Hayes BJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006676; Hoffmann I, 2010, ANIM GENET, V41, P32, DOI 10.1111/j.1365-2052.2010.02043.x; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; KOGER M, 1979, J ANIM SCI, V49, P396, DOI 10.2527/jas1979.492396x; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Kuehn LA, 2011, J ANIM SCI, V89, P1742, DOI 10.2527/jas.2010-3530; LCI, 1970, PATT TRANS LOSS; Leesburg VLR, 2014, J ANIM SCI, V92, P2387, DOI 10.2527/jas.2013-6890; Lin BZ, 2010, ANIM SCI J, V81, P281, DOI 10.1111/j.1740-0929.2010.00744.x; MacNeil MD, 2009, J ANIM SCI, V87, P2489, DOI 10.2527/jas.2009-1909; Mattar M, 2011, J ANIM SCI, V89, P2349, DOI 10.2527/jas.2010-3770; Menne MJ, 2012, J ATMOS OCEAN TECH, V29, P897, DOI 10.1175/JTECH-D-11-00103.1; Nardone A, 2010, LIVEST SCI, V130, P57, DOI 10.1016/j.livsci.2010.02.011; Norman HD, 2005, J DAIRY SCI, V88, P812, DOI 10.3168/jds.S0022-0302(05)72746-6; O'Neill CJ, 2010, EVOL APPL, V3, P422, DOI 10.1111/j.1752-4571.2010.00151.x; PAHNISH OF, 1985, J ANIM SCI, V61, P1146, DOI 10.2527/jas1985.6151146x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Pritchard JK, 2000, GENETICS, V155, P945; REYNOLDS WL, 1980, J ANIM SCI, V51, P860, DOI 10.2527/jas1980.514860x; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; SCOTT IM, 1983, INT J BIOMETEOROL, V27, P47, DOI 10.1007/BF02186300; Seo SN, 2008, AGR ECON-BLACKWELL, V38, P151, DOI 10.1111/j.1574-0862.2008.00289.x; Sere C, 1996, 127 FAO; WHEELER TL, 1990, J ANIM SCI, V68, P4206; Wright S, 1932, P 6 INT C GEN, P355	48	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176474	10.1371/journal.pone.0176474	http://dx.doi.org/10.1371/journal.pone.0176474			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459870	Green Published, Green Submitted, gold			2022-12-26	WOS:000400645000035
J	Kim, JE; Hong, YH; Kim, JY; Jeon, GS; Jung, JH; Yoon, BN; Son, SY; Lee, KW; Kim, JI; Sung, JJ				Kim, Jee-Eun; Hong, Yoon Ho; Kim, Jin Young; Jeon, Gye Sun; Jung, Jung Hee; Yoon, Byung-Nam; Son, Sung-Yeon; Lee, Kwang-Woo; Kim, Jong-Il; Sung, Jung-Joon			Altered nucleocytoplasmic proteome and transcriptome distributions in an in vitro model of amyotrophic lateral sclerosis	PLOS ONE			English	Article							QUANTITATIVE PROTEOMICS; REPEAT EXPANSION; YEAST PROTEOME; TDP-43; REVEALS; TOXICITY; SOD1; ALS; QUANTIFICATION; AGGREGATION	Aberrant nucleocytoplasmic localization of proteins has been implicated in many neurode-generative diseases. Evidence suggests that cytoplasmic mislocalization of nuclear proteins such as transactive response DNA-binding protein 43 (TDP-43) and fused in sarcoma (FUS) may be associated with neurotoxicity in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration. This study investigated the changes in nucleocytoplasmic distributions of the proteome and transcriptome in an in vitro model of ALS. After subcellular fractionation of motor neuron-like cell lines expressing wild-type or G93A mutant hSOD1, quantitative mass spectrometry and next-generation RNA sequencing (RNA-seq) were performed for the nuclear and cytoplasmic compartments. A subset of the results was validated via immunoblotting. A total of 1,925 proteins were identified in either the nuclear or cytoplasmic fractions, and 32% of these proteins were quantified in both fractions. The nucleocytoplasmic distribution of 37 proteins was significantly changed in mutant cells with nuclear and cytoplasmic shifts in 13 and 24 proteins, respectively (p<0.05). The proteins shifted towards the nucleus were enriched regarding pathways of RNA transport and processing (Dhx9, Fmr1, Srsf3, Srsf6, Tra2b), whereas protein folding (Cct5, Cct7, Cct8), aminoacyl-tRNA biosynthesis (Farsb, Nars, Txnrd1), synaptic vesicle cycle (Cltc, Nsf), Wnt signalling (Cltc, Plcb3, Plec, Psmd3, Ruvbl1) and Hippo signalling (Camk2d, Plcb3, Ruvbl1) pathways were over-represented in the proteins shifted to the cytoplasm. A weak correlation between the changes in protein and mRNA levels was found only in the nucleus, where mRNA was relatively abundant in mutant cells. This study provides a comprehensive dataset of the nucleocytoplasmic distribution of the proteome and transcriptome in an in vitro model of ALS. An integrated analysis of the nucleocytoplasmic distribution of the proteome and transcriptome demonstrated multiple candidate pathways including RNA processing/transport and protein synthesis and folding that may be relevant to the pathomechanism of ALS.	[Kim, Jee-Eun] Seoul Med Ctr, Dept Neurol, Seoul, South Korea; [Hong, Yoon Ho] Seoul Natl Univ, Seoul Metropolitan Govt Boramae Med Ctr, Dept Neurol, Seoul, South Korea; [Kim, Jin Young] Korea Basic Sci Inst, Div Mass Spectrometry Res, Daejun, South Korea; [Jeon, Gye Sun; Lee, Kwang-Woo; Sung, Jung-Joon] Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea; [Jung, Jung Hee] Macrogen Inc, Seoul, South Korea; [Yoon, Byung-Nam] Inha Univ Hosp, Dept Neurol, Incheon, South Korea; [Son, Sung-Yeon] Eulji Univ Hosp, Dept Neurol, Daejun, South Korea; [Kim, Jong-Il] Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea	Seoul Medical Center; Seoul National University (SNU); Korea Basic Science Institute (KBSI); Seoul National University (SNU); Seoul National University Hospital; Macrogen, Inc.; Inha University; Inha University Hospital; Eulji University; Seoul National University (SNU)	Kim, JY (corresponding author), Korea Basic Sci Inst, Div Mass Spectrometry Res, Daejun, South Korea.; Sung, JJ (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea.; Kim, JI (corresponding author), Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea.	jinyoung@kbsi.re.kr; jongil@snu.ac.kr; jjsaint@snu.ac.kr	KIM, JONG-IL/D-1019-2011; Hong, Yoon-Ho/D-1564-2011; Hong, Yoon-Ho/AAP-1225-2020	KIM, JONG-IL/0000-0002-7240-3744; Hong, Yoon-Ho/0000-0002-3325-6358	SK Telecom Research Fund [34-2013-0120]; Korea Healthcare Technology RD project; Ministry of health and Welfare, Republic of Korea [HI14C3347]	SK Telecom Research Fund; Korea Healthcare Technology RD project; Ministry of health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by Grants from the SK Telecom Research Fund (34-2013-0120) and from the Korea Healthcare Technology R&D project, Ministry of health and Welfare, Republic of Korea (HI14C3347). The funder provided support in the form of salaries for one of the authors [JHJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Grants from the SK Telecom Research Fund (34-2013-0120) and from the Korea Healthcare Technology R&D project, Ministry of health and Welfare, Republic of Korea (HI14C3347).; There is no any conflict of interest with this study. One of the authors [JHJ] is an employee of commercial company (Macrogen Inc). The Macrogen provided support in the form of salaries for [JHJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2003, J BIOL CHEM, V278, P6371, DOI 10.1074/jbc.M209915200; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Boeynaems S, 2016, ACTA NEUROPATHOL, V132, P159, DOI 10.1007/s00401-016-1586-5; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9; Byun K, 2012, ELECTROPHORESIS, V33, P3756, DOI 10.1002/elps.201200345; Carvalho PC, 2009, BIOINFORMATICS, V25, P2734, DOI 10.1093/bioinformatics/btp489; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Dormann D, 2011, TRENDS NEUROSCI, V34, P339, DOI 10.1016/j.tins.2011.05.002; DURHAM HD, 1993, NEUROTOXICOLOGY, V14, P387; Freibaum BD, 2015, NATURE, V525, P129, DOI 10.1038/nature14974; Fukada K, 2004, MOL CELL PROTEOMICS, V3, P1211, DOI 10.1074/mcp.M400094-MCP200; Gatto L, 2014, BIOINFORMATICS, V30, P1322, DOI 10.1093/bioinformatics/btu013; Groh KJ, 2011, FISH PHYSIOL BIOCHEM, V37, P619, DOI 10.1007/s10695-010-9464-x; Gunaratne J, 2013, MOL CELL PROTEOMICS, V12, P1741, DOI 10.1074/mcp.M112.023754; Hong I, 2013, BIOCHEM BIOPH RES CO, V434, P87, DOI 10.1016/j.bbrc.2013.03.060; Inoue A, 2014, NAT STRUCT MOL BIOL, V21, P609, DOI 10.1038/nsmb.2839; Ito D, 2011, ANN NEUROL, V69, P152, DOI 10.1002/ana.22246; Jain MR, 2008, PROTEOM CLIN APPL, V2, P670, DOI 10.1002/prca.200780023; Jovicic A, 2015, NAT NEUROSCI, V18, P1226, DOI 10.1038/nn.4085; Kim SH, 2000, CELL MOL LIFE SCI, V57, P1810, DOI 10.1007/PL00000661; Kwon OK, 2014, J PROTEOME RES, V13, P1327, DOI 10.1021/pr400911x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li Z, 2012, J PROTEOME RES, V11, P1582, DOI 10.1021/pr200748h; Luger K, 2012, NAT REV MOL CELL BIO, V13, P436, DOI 10.1038/nrm3382; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Robertson J, 2007, NEUROSCI LETT, V420, P128, DOI 10.1016/j.neulet.2007.03.066; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048; Shahmoradian SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00710; Shan XY, 2009, NEUROSCI LETT, V458, P70, DOI 10.1016/j.neulet.2009.04.031; Shen K, 2013, PROTEIN QUALITY CONT, P121; Strey CW, 2004, AM J PATHOL, V165, P1701, DOI 10.1016/S0002-9440(10)63426-8; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Turner BJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-104; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973	48	17	17	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176462	10.1371/journal.pone.0176462	http://dx.doi.org/10.1371/journal.pone.0176462			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453527	gold, Green Submitted, Green Published			2022-12-26	WOS:000400383900025
J	Sandvig, EM; Coulson, T; Kikkawa, J; Clegg, SM				Sandvig, Erik M.; Coulson, Tim; Kikkawa, Jiro; Clegg, Sonya M.			The influence of climatic variation and density on the survival of an insular passerine Zosterops lateralis	PLOS ONE			English	Article							HERON ISLAND SILVEREYES; EL-NINO EVENT; POPULATION-DYNAMICS; REPRODUCTIVE SUCCESS; LONG-TERM; LOCAL RECRUITMENT; FOOD AVAILABILITY; BREEDING SUCCESS; GREAT TITS; DEPENDENCE	Understanding the influence of environmental factors on population dynamics is fundamental to many areas in biology. Survival is a key factor of population biology, as it is thought to be the predominant driver of growth in long-lived passerines, which can be influenced by both biotic and abiotic environmental conditions. We used mark-recapture methods and generalized linear mixed models to test the influence of density and climatic variation, measured at a regional and local scale (Southern Oscillation Index [SOI] and rainfall, respectively), on seasonal variation in survival rates of an insular population of Silvereyes (Zosterops lateralis chlorocephalus), during a 15-year study period, off the east coast of Australia. We found overall high survival rates for adults and juveniles (81% and 59%, respectively). Local scale climate (i.e. rainfall) and density were the principal environmental factors influencing their survival, both with a negative relationship. A significant interactive effect of density and rainfall influenced survival as they both increased. However, survival remained low when density was at it highest, independent of the amount of rainfall. Nestling survival was negatively influenced by rainfall and density, positively by SOI, and chicks that hatched later in the breeding season had higher survival rates. The regional scale climate variable (i.e. SOI) did not explain survival rates as strongly as rainfall in any age class. Our results contribute to the understanding of insular avian population dynamics and the differential effects of environmental factors across age classes. Climatic predictions expect El Nino events to increase, meaning dryer conditions in eastern Australia, potentially increasing Silvereye survival across age classes. However, the long-term effect of lower rainfall on food availability is unknown; consequently, the outcome of lower rainfall on Silvereye survival rates is uncertain.	[Sandvig, Erik M.; Coulson, Tim; Clegg, Sonya M.] Univ Oxford, Dept Zool, Oxford, England; [Sandvig, Erik M.; Clegg, Sonya M.] Univ Oxford, Edward Grey Inst Field Ornithol, Dept Zool, Oxford, England; [Kikkawa, Jiro] Univ Queensland, Sch Integrat Biol, Brisbane, Qld, Australia	University of Oxford; University of Oxford; University of Queensland	Sandvig, EM (corresponding author), Univ Oxford, Dept Zool, Oxford, England.; Sandvig, EM (corresponding author), Univ Oxford, Edward Grey Inst Field Ornithol, Dept Zool, Oxford, England.	erik.sandvig@zoo.ox.ac.uk	Coulson, Tim/AAL-8148-2021; Sandvig, Erik/I-2472-2019	Coulson, Tim/0000-0001-9371-9003; Sandvig, Erik/0000-0002-4180-000X	Comision Nacional de Investigacion Cientifica y Tecnologica; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT, Chile)	Comision Nacional de Investigacion Cientifica y Tecnologica; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT, Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	EMS received funding from the Comision Nacional de Investigacion Cientifica y Tecnologica for the doctoral program Programa de Capital Humano Avanzado scholarship under which this manuscripts was written. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the invaluable contribution of all those that helped in collecting the data used in this paper. A special thanks to J. Massey for sharing his knowledge of capture recapture methods. The study program under which this study was conducted was funded by the Programa de Capital Humano Avanzado scholarship from the Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT, Chile).	ALATALO RV, 1984, J ANIM ECOL, V53, P969, DOI 10.2307/4671; ALLAN RJ, 1988, PROG PHYS GEOG, V12, P313, DOI 10.1177/030913338801200301; ARCESE P, 1988, J ANIM ECOL, V57, P119, DOI 10.2307/4768; Arnold JM, 2006, IBIS, V148, P98, DOI 10.1111/j.1474-919X.2006.00487.x; Barbraud C, 2003, P ROY SOC B-BIOL SCI, V270, P2111, DOI 10.1098/rspb.2003.2488; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bergallo HG, 1999, J MAMMAL, V80, P472, DOI 10.2307/1383294; Brook BW, 1998, J APPL ECOL, V35, P491, DOI 10.1046/j.1365-2664.1998.3540491.x; Bunce A, 2002, MAR BIOL, V141, P263, DOI 10.1007/s00227-002-0838-1; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; CATTERALL CP, 1982, IBIS, V124, P405, DOI 10.1111/j.1474-919X.1982.tb03789.x; Catterall CP, 1982, IBIS LOND 1859, P124; Chambers LE, 2011, EMU, V111, P235, DOI 10.1071/MU10033; Choquet R, 2010, E SURGE 1 7 USERS MA; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Clegg SM, 2008, EVOLUTION, V62, P2393, DOI 10.1111/j.1558-5646.2008.00437.x; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; DUNN EH, 1975, CONDOR, V77, P288, DOI 10.2307/1366224; EGUCHI K, 1993, ECOL RES, V8, P319, DOI 10.1007/BF02347191; Forchhammer MC, 1998, P ROY SOC B-BIOL SCI, V265, P341, DOI 10.1098/rspb.1998.0301; Gibbs HM, 2011, EMU, V111, P283, DOI 10.1071/MU10083; GIBBS HL, 1987, ECOLOGY, V68, P1735, DOI 10.2307/1939865; GRANT BR, 1993, P ROY SOC B-BIOL SCI, V251, P111, DOI 10.1098/rspb.1993.0016; GRANT PR, 1987, OIKOS, V49, P55, DOI 10.2307/3565554; Grant PR, 2000, ECOLOGY, V81, P2442, DOI 10.2307/177466; Hallett TB, 2004, NATURE, V430, P71, DOI 10.1038/nature02708; Holmgren M, 2006, FRONT ECOL ENVIRON, V4, P87, DOI 10.1890/1540-9295(2006)004[0087:ECESAA]2.0.CO;2; Holmgren M, 2001, TRENDS ECOL EVOL, V16, P89, DOI 10.1016/S0169-5347(00)02052-8; Illera JC, 2006, J AVIAN BIOL, V37, P447, DOI 10.1111/j.2006.0908-8857.03676.x; Jaksic FM, 2004, ORNITOL NEOTROP, V15, P61; Jaksic FM, 1997, OIKOS, V78, P341, DOI 10.2307/3546302; Jenouvrier S, 2013, GLOBAL CHANGE BIOL, V19, P2036, DOI 10.1111/gcb.12195; Johnston JP, 1997, AM NAT, V150, P771, DOI 10.1086/286093; Karl TR, 2003, SCIENCE, V302, P1719, DOI 10.1126/science.1090228; KIKKAWA J, 1977, Australian Journal of Ecology, V2, P121, DOI 10.1111/j.1442-9993.1977.tb01132.x; KIKKAWA J, 1980, IBIS, V122, P437, DOI 10.1111/j.1474-919X.1980.tb00899.x; KIKKAWA J, 1983, EMU, V83, P181, DOI 10.1071/MU9830181; Kikkawa J., 1976, BIOL GEOLOGY CORAL R, VIII; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lima M, 1999, AM NAT, V153, P476, DOI 10.1086/303191; MAKEPEACE M, 1980, Wildfowl, V31, P57; Martin TE, 1996, J AVIAN BIOL, V27, P263, DOI 10.2307/3677257; Massoni V, 2007, IBIS, V149, P10; Mazerolle DF, 2005, J AVIAN BIOL, V36, P155, DOI 10.1111/j.0908-8857.2005.03289.x; MCBRIDE JL, 1983, MON WEATHER REV, V111, P1998, DOI 10.1175/1520-0493(1983)111<1998:SRBARA>2.0.CO;2; McCallum H, 2000, ECOL LETT, V3, P95, DOI 10.1046/j.1461-0248.2000.00120.x; McDonald PG, 2004, J ANIM ECOL, V73, P683; Muller M, 2005, OECOLOGIA, V143, P37, DOI 10.1007/s00442-004-1770-5; Nott P, 2002, ECOLOGY, V11, P333, DOI DOI 10.1046/J.1466-822X.2002.00296.X; Oro D, 2010, ECOLOGY, V91, P1205, DOI 10.1890/09-0939.1; Owen-Smith N, 2005, J ANIM ECOL, V74, P774, DOI 10.1111/j.1365-2656.2005.00974.x; PearceHiggins JW, 2014, ECOL BIODIVERS CONS, P1; PERRINS CM, 1965, J ANIM ECOL, V34, P601, DOI 10.2307/2453; Post E, 2002, NATURE, V420, P168, DOI 10.1038/nature01064; Poulsen BO, 1996, IBIS, V138, P466, DOI 10.1111/j.1474-919X.1996.tb08066.x; Pradhan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047531; Radford AN, 2001, BIRD STUDY, V48, P214, DOI 10.1080/00063650109461220; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Sandvik H, 2005, J ANIM ECOL, V74, P817, DOI 10.1111/j.1365-2656.2005.00981.x; Siikamaki P, 1998, ECOLOGY, V79, P1789, DOI 10.1890/0012-9658(1998)079[1789:LORSBF]2.0.CO;2; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Smithers BV, 2003, MAR FRESHWATER RES, V54, P973, DOI 10.1071/MF02137; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; SULLIVAN KA, 1989, J ANIM ECOL, V58, P275, DOI 10.2307/5000; Suppiah R, 2004, INT J CLIMATOL, V24, P269, DOI 10.1002/joc.1001; Tarof SA, 2011, AUK, V128, P716, DOI 10.1525/auk.2011.11087; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505; TOROK J, 1988, J ANIM ECOL, V57, P251, DOI 10.2307/4776; Verboven N, 1998, OIKOS, V81, P511, DOI 10.2307/3546771; VERHULST S, 1991, J ANIM ECOL, V60, P269, DOI 10.2307/5459; Whitford W., 2002, ECOLOGY DESERT SYSTE; Yom-tov Y, 1991, IBIS LOND 1859, V134, P374	74	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176360	10.1371/journal.pone.0176360	http://dx.doi.org/10.1371/journal.pone.0176360			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453564	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383900022
J	Wei, SJ; Li, D; Zhang, Y; Su, LN; Zhang, YR; Wang, Q; Yang, DC; Li, D; Yang, YJ; Ma, ST				Wei, Shujie; Li, Dan; Zhang, Yan; Su, Linan; Zhang, Yunrong; Wang, Qiang; Yang, Dachun; Li, De; Yang, Yongjian; Ma, Shuangtao			Perivascular radiofrequency renal denervation lowers blood pressure and ameliorates cardiorenal fibrosis in spontaneously hypertensive rats	PLOS ONE			English	Article							RESISTANT HYPERTENSION; ARTERY-STENOSIS; SYMPATHETIC DENERVATION; EFFICACY; SAFETY	Background Catheter-based renal denervation (RDN) is a promising approach to treat hypertension, but innervation patterns limit the response to endovascular RDN and the post-procedural renal artery narrowing or stenosis questions the endovascular ablation strategy. This study was performed to investigate the anti-hypertensive and target organ protective effects of perivascular RDN in spontaneously hypertensive rats (SHR). Methods SHR and normotensive Wistar-Kyoto (WKY) rats were divided into sham group (n = 10), radiofrequency ablation group (n = 20) in which rats received bilateral perivascular ablation with radiofrequency energy (2 watts), and chemical (10% phenol in 95% ethanol) ablation group (n = 12). The tail-cuff blood pressure was measured before the ablation and on day 14 and day 28 after the procedure. The plasma levels of creatinine, urea nitrogen, and catecholamines, urinary excretion of electrolytes and protein, and myocardial and glomerular fibrosis were analyzed and compared among the groups on day 28 after the procedure. Results We identified that 2-watt is the optimal radiofrequency power for perivascular RDN in rats. Perivascular radiofrequency and chemical ablation achieved roughly comparable blood pressure reduction in SHR but not in WKY on day 14 and day 28 following the procedure. Radiofrequency-mediated ablation substantially destroyed the renal nerves surrounding the renal arteries of both SHR and WKY without damaging the renal arteries and diminished the expression of tyrosine hydroxylase, the enzyme marker for postganglionic sympathetic nerves. Additionally, perivascular radiofrequency ablation also decreased the plasma catecholamines of SHR. Interestingly, both radiofrequency and chemical ablation decreased the myocardial and glomerular fibrosis of SHR, while neither increased the plasma creatinine and blood urea nitrogen nor affected the urinary excretion of electrolytes and protein when compared to sham group. Conclusions Radiofrequency-mediated perivascular RDN may become a feasible procedure against hypertension, and provide similar anti-hypertensive and target organ protective effects as does the chemical ablation.	[Wei, Shujie; Li, Dan; Zhang, Yan; Su, Linan; Zhang, Yunrong; Wang, Qiang; Yang, Dachun; Li, De; Yang, Yongjian; Ma, Shuangtao] Chengdu Mil Gen Hosp, Dept Cardiol, Chengdu, Sichuan, Peoples R China; [Li, Dan] Shapingba Peoples Hosp, Dept Internal Med, Chongqing, Peoples R China		Yang, YJ; Ma, ST (corresponding author), Chengdu Mil Gen Hosp, Dept Cardiol, Chengdu, Sichuan, Peoples R China.	yangyongjian38@yahoo.com; ma.shuangtao@gmail.com		Yang, Yongjian/0000-0003-1268-166X	Natural Science Foundation of China [81470589]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the Natural Science Foundation of China (No. 81470589 to SM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armaganijan LV, 2015, JACC-CARDIOVASC INTE, V8, P984, DOI 10.1016/j.jcin.2015.03.012; Bhamra-Ariza P, 2014, CATHETER CARDIO INTE, V84, P1180, DOI 10.1002/ccd.25546; Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; Blankestijn PJ, 2012, NAT REV NEPHROL, V8, P439, DOI 10.1038/nrneph.2012.143; Celik IE, 2015, J CLIN HYPERTENS, V17, P242, DOI 10.1111/jch.12482; Cordeanu ME, 2014, INT J CARDIOL, V177, pE117, DOI 10.1016/j.ijcard.2014.09.079; Diego-Nieto A, 2015, JACC-CARDIOVASC INTE, V8, pE193, DOI 10.1016/j.jcin.2015.05.022; Esler MD, 2012, CIRCULATION, V126, P2976, DOI 10.1161/CIRCULATIONAHA.112.130880; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; Fischell TA, 2016, JACC-CARDIOVASC INTE, V9, P589, DOI 10.1016/j.jcin.2015.11.041; Fischell TA, 2013, EUROINTERVENTION, V9, P140, DOI 10.4244/EIJV9I1A20; Gao J, 2016, AM J HYPERTENS, V29, P1394, DOI 10.1093/ajh/hpw089; Hu JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096996; Krum H, 2014, LANCET, V383, P622, DOI 10.1016/S0140-6736(13)62192-3; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Lambert T, 2014, J CARDIOVASC MED HAG; Lambert T, 2015, AM J CARDIOL, V115, P1545, DOI 10.1016/j.amjcard.2015.02.055; Li D, 2016, AM J HYPERTENS, V29, P63, DOI 10.1093/ajh/hpv066; Machino T, 2014, LIFE SCI, V110, P86, DOI 10.1016/j.lfs.2014.06.015; Mahfoud F, 2014, EUR HEART J, V35, P2224, DOI 10.1093/eurheartj/ehu093; Mahfoud F, 2011, CIRCULATION, V123, P1940, DOI 10.1161/CIRCULATIONAHA.110.991869; May C, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00311; Mente A, 2014, NEW ENGL J MED, V371, P601, DOI 10.1056/NEJMoa1311989; Nakagawa T, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000375; Persu A, 2014, J HYPERTENS, V32, P2101, DOI 10.1097/HJH.0000000000000323; Reddy VY, 2014, J AM COLL CARDIOL, V64, P1088, DOI 10.1016/j.jacc.2014.07.947; Sadowski J, 2011, HYPERTENSION, V57, P911, DOI 10.1161/HYPERTENSIONAHA.110.163014; Schirmer SH, 2014, J AM COLL CARDIOL, V63, P1916, DOI 10.1016/j.jacc.2013.10.073; Schmieder RE, 2014, NAT REV CARDIOL, V11, P638, DOI 10.1038/nrcardio.2014.70-c2; Tofield A, 2015, EUR HEART J, V36, P257; Tzafriri AR, 2014, J AM COLL CARDIOL, V64, P1079, DOI 10.1016/j.jacc.2014.07.937; Wei SJ, 2015, ATHEROSCLEROSIS, V243, P589, DOI 10.1016/j.atherosclerosis.2015.10.093; Worthley SG, 2013, EUR HEART J, V34, P2132, DOI 10.1093/eurheartj/eht197; Yang DC, 2010, CELL METAB, V12, P130, DOI 10.1016/j.cmet.2010.05.015; Ye TQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120178	35	5	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176888	10.1371/journal.pone.0176888	http://dx.doi.org/10.1371/journal.pone.0176888			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453557	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383900062
J	Essalmani, R; Susan-Resiga, D; Guillemot, J; Kim, W; Sachan, V; Awan, Z; Chamberland, A; Asselin, MC; Ly, K; Desjardins, R; Day, R; Prat, A; Seidah, NG				Essalmani, Rachid; Susan-Resiga, Delia; Guillemot, Johann; Kim, Woojin; Sachan, Vatsal; Awan, Zuhier; Chamberland, Ann; Asselin, Marie-Claude; Ly, Kevin; Desjardins, Roxane; Day, Robert; Prat, Annik; Seidah, Nabil G.			Thrombin activation of protein C requires prior processing by a liver proprotein convertase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						furin; hepatocyte; liver; serine protease; thrombin; vitamin K; anticoagulant serine pro; proprotein convertase; protein C; thrombin activation	ANTICOAGULANT ACTIVITY; MAMMALIAN-CELLS; HUMAN-PLASMA; RECEPTOR 1; FURIN; PRECURSOR; MOUSE; ACID; MICE; INHIBITION	Protein C, a secretory vitamin K-dependent anticoagulant serine protease, inactivates factors Va/VIIIa. It is exclusively synthesized in liver hepatocytes as an inactive zymogen (proprotein C). In humans, thrombin cleavage of the propeptide at PR221 results in activated protein C (APC; residues 222-461). However, the propeptide is also cleaved by a furin-like proprotein convertase(s) (PCs) at KKRSHLKR199 (underlined basic residues critical for the recognition by PCs), but the order of cleavage is unknown. Herein, we present evidence that at the surface of COS-1 cells, mouse proprotein C is first cleaved by the convertases furin, PC5/6A, and PACE4. In mice, this cleavage occurs at the equivalent site, KKRKILKR198, and requires the presence of Arg(198) at P1 and a combination of two other basic residues at either P2 (Lys(197)), P6 (Arg(193)), or P8 (Lys(191)) positions. Notably, the thrombin-resistant R221A mutant is still cleaved by these PCs, revealing that convertase cleavage can precede thrombin activation. This conclusion was supported by the fact that the APC-specific activity in the medium of COS-1 cells is exclusively dependent on prior cleavage by the convertases, because both R198A and R221A lack protein C activity. Primary cultures of hepatocytes derived from wild-type or hepatocyte-specific furin, PC5/6, or complete PACE4 knock-out mice suggested that the cleavage of overexpressed proprotein C is predominantly performed by furin intracellularly and by all three proprotein convertases at the cell surface. Indeed, plasma analyses of single-proprotein convertase-knock-out mice showed that loss of the convertase furin or PC5/6 in hepatocytes results in a approximate to 30% decrease in APC levels, with no significant contribution from PACE4. We conclude that prior convertase cleavage of protein C in hepatocytes is critical for its thrombin activation.	[Essalmani, Rachid; Susan-Resiga, Delia; Guillemot, Johann; Kim, Woojin; Sachan, Vatsal; Awan, Zuhier; Chamberland, Ann; Asselin, Marie-Claude; Prat, Annik; Seidah, Nabil G.] Univ Montreal, Inst Rech Clin Monreal, Labs Biochem Neuroendocrinol, Montreal, PQ H2W IR7, Canada; [Ly, Kevin; Desjardins, Roxane; Day, Robert] Univ Sherbrooke, Fac Med & Sci Sante, Urol Div, Inst Pharmacol Sherbrooke,Dept Surg, Sherbrooke, PQ J1K 2R1, Canada; [Awan, Zuhier] King Abdulaziz Univ, Clin Biochem Dept, Jeddah 21589, Saudi Arabia	Universite de Montreal; University of Sherbrooke; King Abdulaziz University	Seidah, NG (corresponding author), Inst Rech Clin Montreal, Lab Biochem Neuroendocrinol, 110 Pine Ave West, Montreal, PQ H2W 1R7, Canada.	zawan@kau.edu.sa; seidahn@ircm.qc.ca	Prat, Annik/S-6757-2018; Seidah, Nabil/I-3596-2013; Susan-Resiga@ircm.qc.ca, Delia/O-2548-2017; Guillemot, Johann/O-1066-2013	Prat, Annik/0000-0002-8007-5277; Seidah, Nabil/0000-0001-6503-9342; Susan-Resiga@ircm.qc.ca, Delia/0000-0002-4856-090X; Guillemot, Johann/0000-0002-5902-9188; Awan, Zuhier/0000-0002-4176-335X	CIHR Foundation Scheme Grant [148363]; Canada Research Chair [216684]; King Abdulaziz University	CIHR Foundation Scheme Grant(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); King Abdulaziz University	This work was supported by CIHR Foundation Scheme Grant 148363 and Canada Research Chair 216684. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by King Abdulaziz University. Present address: Clinical Biochemistry Dept., King Abdulaziz University, Jeddah 21589, Saudi Arabia. E-mail: zawan@kau.edu.sa.	ANDERSON ED, 1993, J BIOL CHEM, V268, P24887; Constam DB, 2000, GENE DEV, V14, P1146; Couture F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/824014; DISCIPIO RG, 1979, BIOCHEMISTRY-US, V18, P899, DOI 10.1021/bi00572a026; DREWS R, 1995, P NATL ACAD SCI USA, V92, P10462, DOI 10.1073/pnas.92.23.10462; ESMON CT, 1987, SCIENCE, V235, P1348, DOI 10.1126/science.3029867; Essalmani R, 2006, MOL CELL BIOL, V26, P354, DOI 10.1128/MCB.26.1.354-361.2006; Essalmani R, 2008, P NATL ACAD SCI USA, V105, P5750, DOI 10.1073/pnas.0709428105; Essalmani R, 2013, J BIOL CHEM, V288, P26410, DOI 10.1074/jbc.M113.501304; Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104; FERNLUND P, 1982, J BIOL CHEM, V257, P2170; FOSTER DC, 1991, BIOCHEMISTRY-US, V30, P367, DOI 10.1021/bi00216a009; FOSTER DC, 1990, BIOCHEMISTRY-US, V29, P347, DOI 10.1021/bi00454a007; FOSTER DC, 1987, BIOCHEMISTRY-US, V26, P7003, DOI 10.1021/bi00396a022; GANDRILLE S, 1993, BLOOD, V82, P159, DOI 10.1182/blood.V82.1.159.bloodjournal821159; Gempeler-Messina PM, 2001, HAEMOSTASIS, V31, P266; Griffin JH, 2007, J THROMB HAEMOST, V5, P73, DOI 10.1111/j.1538-7836.2007.02491.x; GRINNELL BW, 1994, BIOCHEM J, V303, P929, DOI 10.1042/bj3030929; Guillemot J, 2013, HEPATOLOGY, V57, P2514, DOI 10.1002/hep.26297; Jackson CJ, 2008, INT J BIOCHEM CELL B, V40, P2692, DOI 10.1016/j.biocel.2007.12.013; Junker R, 2005, CLIN CHEM LAB MED, V43, P244, DOI 10.1515/CCLM.2005.041; Kim W, 2015, MOL CELL BIOL, V35, P3684, DOI 10.1128/MCB.00764-15; Kim WJ, 2012, MOL CELL BIOL, V32, P3382, DOI 10.1128/MCB.06331-11; KISIEL W, 1979, J CLIN INVEST, V64, P761, DOI 10.1172/JCI109521; Ladunga I, 2000, CURR OPIN BIOTECH, V11, P13, DOI 10.1016/S0958-1669(99)00048-8; Lay AJ, 2005, J CLIN INVEST, V115, P1552, DOI 10.1172/JCI24030; Ly K, 2014, J BIOL CHEM, V289, P17732, DOI 10.1074/jbc.M113.541094; Marchesi C, 2011, J MOL MED, V89, P1103, DOI 10.1007/s00109-011-0776-9; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; MCMULLEN BA, 1983, BIOCHEM BIOPH RES CO, V115, P8, DOI 10.1016/0006-291X(83)90961-0; MIYATA T, 1995, THROMB HAEMOSTASIS, V74, P1003; Navarro S, 2011, THROMB RES, V128, P410, DOI 10.1016/j.thromres.2011.08.001; Peinado JR, 2004, BIOCHEM BIOPH RES CO, V321, P601, DOI 10.1016/j.bbrc.2004.07.012; Preston RJS, 2006, J BIOL CHEM, V281, P28850, DOI 10.1074/jbc.M604966200; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Roebroek AJM, 2004, J BIOL CHEM, V279, P53442, DOI 10.1074/jbc.M407152200; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Schuepbach RA, 2012, J THROMB HAEMOST, V10, P1675, DOI 10.1111/j.1538-7836.2012.04825.x; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2013, J BIOL CHEM, V288, P21473, DOI 10.1074/jbc.R113.481549; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2016, MOL NEUROENDOCRINOLO, P171; Susan-Resiga D, 2011, J BIOL CHEM, V286, P22785, DOI 10.1074/jbc.M111.233577; Szumska D, 2008, GENE DEV, V22, P1465, DOI 10.1101/gad.479408; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; WATANABE T, 1993, FEBS LETT, V320, P215, DOI 10.1016/0014-5793(93)80589-M; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Wetsel WC, 2013, P NATL ACAD SCI USA, V110, P17362, DOI 10.1073/pnas.1314698110	48	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10564	10573		10.1074/jbc.M116.770040	http://dx.doi.org/10.1074/jbc.M116.770040			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28468828	Green Published, hybrid			2022-12-26	WOS:000404115400017
J	Carballo, A; Murillo, R; Jakubowska, A; Herrero, S; Williams, T; Caballero, P				Carballo, Arkaitz; Murillo, Rosa; Jakubowska, Agata; Herrero, Salvador; Williams, Trevor; Caballero, Primitivo			Co-infection with iflaviruses influences the insecticidal properties of Spodoptera exigua multiple nucleopolyhedrovirus occlusion bodies: Implications for the production and biosecurity of baculovirus insecticides	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; PICORNA-LIKE VIRUS; LEPIDOPTERA-NOCTUIDAE; GENOME SEQUENCE; RNA VIRUS; MICRORNAS; SUSCEPTIBILITY; INFECTIONS; DIVERSITY; INCREASES	Biological insecticides based on Spodoptera exigua multiple nucleopolyhedrovirus (SeMNPV) can efficiently control S. exigua larvae on field and greenhouse crops in many parts of the world. Spanish wild populations and laboratory colonies of S. exigua are infected by two iflaviruses (SeIV-1 and SeIV-2). Here we evaluated the effect of iflavirus co-infection on the insecticidal characteristics of SeMNPV occlusion bodies (OBs). Overall, iflavirus co-inoculation consistently reduced median lethal concentrations (LC50) for SeMNPV OBs compared to larvae infected with SeMNPV alone. However, the speed of kill of SeMNPV was similar in the presence or absence of the iflaviruses. A reduction of the weight gain (27%) associated with iflavirus infection resulted in a 30% reduction in total OB production per larva. Adult survivors of SeMNPV OB inoculation were examined for covert infection. SeMNPV DNA was found to be present at a high prevalence in all SeIV-1 and SeIV-2 co-infection treatments. Interestingly, co-inoculation of SeMNPV with SeIV-2 alone or in mixtures with SeIV-1 resulted in a significant increase in the SeMNPV load of sublethally infected adults, suggesting a role for SeIV-2 in vertical transmission or reactivation of sublethal SeMNPV infections. In conclusion, iflaviruses are not desirable in insect colonies used for large scale baculovirus production, as they may result in diminished larval growth, reduced OB production and, depending on their host-range, potential risks to non-target Lepidoptera.	[Carballo, Arkaitz; Murillo, Rosa; Caballero, Primitivo] CSIC Gobierno Navarra, Inst Agrobiotecnol, Navarra, Spain; [Carballo, Arkaitz; Murillo, Rosa; Caballero, Primitivo] Univ Publ Navarra, Dept Prod Agr, Navarra, Spain; [Jakubowska, Agata; Herrero, Salvador] Univ Valencia, Dept Genet, Valencia, Spain; [Williams, Trevor] Inst Ecol AC, Xalapa, Veracruz, Mexico	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra; University of Valencia; Instituto de Ecologia - Mexico	Caballero, P (corresponding author), CSIC Gobierno Navarra, Inst Agrobiotecnol, Navarra, Spain.; Caballero, P (corresponding author), Univ Publ Navarra, Dept Prod Agr, Navarra, Spain.; Williams, T (corresponding author), Inst Ecol AC, Xalapa, Veracruz, Mexico.	trevor.inecol@gmail.com; pcm92@unavarra.es	Caballero, Primitivo/D-5063-2009; Williams, Trevor/ABG-3961-2020; Herrero, Salvador/J-5767-2013; Williams, Trevor/F-1447-2011; Herrero, Salva/ABE-5123-2020; Murillo, Rosa/G-5506-2010	Caballero, Primitivo/0000-0003-0065-9625; Herrero, Salvador/0000-0001-5690-2108; Williams, Trevor/0000-0003-3414-3440; Herrero, Salva/0000-0001-5690-2108; Murillo, Rosa/0000-0001-9535-0000	Spanish Ministerio de Cienciae Innovacion [AGL2011-30352-C02-01]; Ministerio de Economoia y Competitividad	Spanish Ministerio de Cienciae Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Economoia y Competitividad	This study was funded by the Spanish Ministerio de Cienciae Innovacion, project number AGL2011-30352-C02-01. AC received a student scholarship from the Ministerio de Economoia y Competitividad.	Asgari S, 2015, CURR OPIN INSECT SCI, V8, P104, DOI 10.1016/j.cois.2014.12.008; Berenyi O, 2006, APPL ENVIRON MICROB, V72, P2414, DOI 10.1128/AEM.72.4.2414-2420.2006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caballero P., 1992, Biocontrol Science and Technology, V2, P35, DOI 10.1080/09583159209355215; Caballero P, 2009, REV COLOMB ENTOMOL, V35, P105; CABI, 2016, CROP PROT COMP INT; Cabodevilla O, 2011, BIOL CONTROL, V56, P184, DOI 10.1016/j.biocontrol.2010.10.007; Chen YP, 2012, INSECT PATHOLOGY, 2ND EDITION, P133, DOI 10.1016/B978-0-12-384984-7.00005-1; Choi JY, 2012, J ASIA-PAC ENTOMOL, V15, P259, DOI 10.1016/j.aspen.2012.01.006; Cory JS, 2003, ANNU REV ECOL EVOL S, V34, P239, DOI 10.1146/annurev.ecolsys.34.011802.132402; Crawley M.J., 1993, GLIM ECOLOGISTS; Eberle KE, 2012, INTEGRATED PEST MANAGEMENT, P281, DOI 10.1079/9781845938086.0281; Eilenberg J, 2015, J INSECTS FOOD FEED, V1, P87, DOI 10.3920/JIFF2014.0022; Elvira S, 2010, J ECON ENTOMOL, V103, P17, DOI 10.1603/EC09246; Farrar RR, 1998, ENVIRON ENTOMOL, V27, P1289, DOI 10.1093/ee/27.6.1289; Francis B, 1993, NUMERICAL ALGORITHMS; Fuxa JR, 2001, APPL ENVIRON MICROB, V67, P5166, DOI 10.1128/AEM.67.11.5166-5170.2001; Geng P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092107; Graham RI, 2012, ECOL LETT, V15, P993, DOI 10.1111/j.1461-0248.2012.01820.x; HIMENO M, 1974, J INVERTEBR PATHOL, V23, P164, DOI 10.1016/0022-2011(74)90180-3; HUGHES PR, 1981, J INVERTEBR PATHOL, V37, P154, DOI 10.1016/0022-2011(81)90069-0; Hussain M, 2014, J INSECT PHYSIOL, V70, P151, DOI 10.1016/j.jinsphys.2014.08.003; Ikeda M, 2013, VIROLOGY, V435, P1, DOI 10.1016/j.virol.2012.10.016; Jakubowska AK, 2016, PEERJ, V4, DOI 10.7717/peerj.1687; Jakubowska AK, 2014, J INVERTEBR PATHOL, V121, P56, DOI 10.1016/j.jip.2014.06.009; Jakubowska AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003379; Junglen S, 2013, CURR OPIN MICROBIOL, V16, P507, DOI 10.1016/j.mib.2013.06.005; Kariithi Henry M, 2013, Insects, V4, P287, DOI 10.3390/insects4030287; Kaya, 1993, INSECT PATHOLOGY; Kemp EM, 2011, J INVERTEBR PATHOL, V107, P202, DOI 10.1016/j.jip.2011.05.015; Lacey LA, 2015, J INVERTEBR PATHOL, V132, P1, DOI 10.1016/j.jip.2015.07.009; Magholli Z, 2013, J PLANT DIS PROTECT, V120, P173, DOI 10.1007/BF03356471; Mehrabadi M, 2015, J VIROL, V89, P8182, DOI 10.1128/JVI.00802-15; Millan-Leiva A, 2012, J INVERTEBR PATHOL, V109, P127, DOI 10.1016/j.jip.2011.10.009; Mordecai GJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34983; Moscardi F, 2011, MICROBES AND MICROBIAL TECHNOLOGY: AGRICULTURAL AND ENVIRONMENTAL APPLICATIONS, P415, DOI 10.1007/978-1-4419-7931-5_16; Pascual L, 2012, INSECT BIOCHEM MOLEC, V42, P557, DOI 10.1016/j.ibmb.2012.04.003; Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167; Singh J, 2010, VIROLOGY, V407, P120, DOI 10.1016/j.virol.2010.07.033; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; SMITS PH, 1987, ENTOMOL EXP APPL, V43, P73, DOI 10.1007/BF00350378; Sundararajan K. T., 2012, P IEEE INT S HIGH PE, P1; Szelei J, 2011, J INVERTEBR PATHOL, V106, P394, DOI 10.1016/j.jip.2010.12.009; Tapparel C, 2013, INFECT GENET EVOL, V14, P282, DOI 10.1016/j.meegid.2012.10.016; VAIL PV, 1983, J INVERTEBR PATHOL, V41, P179, DOI 10.1016/0022-2011(83)90217-3; VAIL PV, 1983, J INVERTEBR PATHOL, V41, P171, DOI 10.1016/0022-2011(83)90216-1; van Oers MM, 2010, INSECT VIROLOGY, P231; Vilaplana L, 2010, EVOL ECOL, V24, P147, DOI 10.1007/s10682-009-9296-2; Virto C, 2017, J APPL ENTOMOL; Virto C, 2014, J INVERTEBR PATHOL, V122, P22, DOI 10.1016/j.jip.2014.07.007; Virto C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070932; Wang CH, 1999, J INVERTEBR PATHOL, V74, P62, DOI 10.1006/jipa.1999.4842; Wu P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165865; Xu PJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004490; Yuan H, 2017, J INVERTEBR PATHOL, V144, P65, DOI 10.1016/j.jip.2017.01.011; Yue C, 2007, J GEN VIROL, V88, P2329, DOI 10.1099/vir.0.83101-0; Zheng XL, 2011, J ENTOMOL RES SOC, V13, P39	57	22	22	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177301	10.1371/journal.pone.0177301	http://dx.doi.org/10.1371/journal.pone.0177301			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475633	Green Published, gold			2022-12-26	WOS:000400649500062
J	James, S; Bell, OA; Nazli, MAM; Pearce, RE; Spencer, J; Tyrrell, K; Paine, PJ; Heaton, TJ; Anderson, S; Da Lio, M; Gurney, K				James, Sebastian; Bell, Olivia A.; Nazli, Muhammed A. M.; Pearce, Rachel E.; Spencer, Jonathan; Tyrrell, Katie; Paine, Phillip J.; Heaton, Timothy J.; Anderson, Sean; Da Lio, Mauro; Gurney, Kevin			Target-distractor synchrony affects performance in a novel motor task for studying action selection	PLOS ONE			English	Article							OPTIMAL DECISION-MAKING; EYE-HAND COORDINATION; BASAL GANGLIA; VISUAL-SEARCH; SUPERIOR COLLICULUS; CORTICAL MECHANISMS; NEURONAL-ACTIVITY; ARM MOVEMENTS; TRACKING; CORTEX	The study of action selection in humans can present challenges of task design since our actions are usually defined by many degrees of freedom and therefore occupy a large action-space. While saccadic eye-movement offers a more constrained paradigm for investigating action selection, the study of reach-and-grasp in upper limbs has often been defined by more complex scenarios, not easily interpretable in terms of such selection. Here we present a novel motor behaviour task which addresses this by limiting the action space to a single degree of freedom in which subjects have to track (using a stylus) a vertical coloured target line displayed on a tablet computer, whilst ignoring a similarly oriented distractor line in a different colour. We ran this task with 55 subjects and showed that, in agreement with previous studies, the presence of the distractor generally increases the movement latency and directional error rate. Further, we used two distractor conditions according to whether the distractor's location changes asynchronously or synchronously with the location of the target. We found that the asynchronous distractor yielded poorer performance than its synchronous counterpart, with significantly higher movement latencies and higher error rates. We interpret these results in an action selection framework with two actions (move left or right) and competing 'action requests' offered by the target and distractor. As such, the results provide insights into action selection performance in humans and supply data for directly constraining future computational models therein.	[James, Sebastian; Bell, Olivia A.; Nazli, Muhammed A. M.; Pearce, Rachel E.; Spencer, Jonathan; Tyrrell, Katie; Gurney, Kevin] Univ Sheffield, Dept Psychol, Adapt Behav Res Grp, Sheffield, S Yorkshire, England; [James, Sebastian; Anderson, Sean; Gurney, Kevin] Univ Sheffield, Insigne Inst Insilico Med, Sheffield, S Yorkshire, England; [Anderson, Sean] Univ Sheffield, Dept Automat Control Syst Engn, Sheffield, S Yorkshire, England; [Da Lio, Mauro] Univ Trento, Dept Ind Engn, Trento, Italy; [Paine, Phillip J.; Heaton, Timothy J.] Univ Sheffield, Sch Math & Stat, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield; University of Trento; University of Sheffield	Gurney, K (corresponding author), Univ Sheffield, Dept Psychol, Adapt Behav Res Grp, Sheffield, S Yorkshire, England.; Gurney, K (corresponding author), Univ Sheffield, Insigne Inst Insilico Med, Sheffield, S Yorkshire, England.	k.gurney@sheffield.ac.uk	Heaton, Timothy J/AFJ-8295-2022; Heaton, Tim/AAF-5132-2022; James, Sebastian/B-2932-2019	Heaton, Timothy J/0000-0002-9994-142X; James, Sebastian/0000-0003-0208-0588; Anderson, Sean/0000-0002-7452-5681; Da Lio, Mauro/0000-0002-6619-9484; Tyrrell, Katie/0000-0002-3333-415X	EC FP7 project NoTremor-Virtual, Physiological and Computational Neuromuscular Models for the Predictive Treatment of Parkinson's Disease [610391]	EC FP7 project NoTremor-Virtual, Physiological and Computational Neuromuscular Models for the Predictive Treatment of Parkinson's Disease	This work was partially funded by the EC FP7 project NoTremor-Virtual, Physiological and Computational Neuromuscular Models for the Predictive Treatment of Parkinson's Disease, Grant Agreement No. 610391. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially funded by the EC FP7 project NoTremor-Virtual, Physiological and Computational Neuromuscular Models for the Predictive Treatment of Parkinson's Disease, Grant Agreement No. 610391.	Antoniades C, 2013, VISION RES, V84, P1, DOI 10.1016/j.visres.2013.02.007; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; BIGUER B, 1982, EXP BRAIN RES, V46, P301; Bogacz R, 2007, NEURAL COMPUT, V19, P442, DOI 10.1162/neco.2007.19.2.442; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Bompas A, 2011, J NEUROSCI, V31, P12501, DOI 10.1523/JNEUROSCI.2234-11.2011; Carey DP, 2000, CURR BIOL, V10, pR416, DOI 10.1016/S0960-9822(00)00508-X; Carpenter RHS, 2004, CURR BIOL, V14, P1576, DOI 10.1016/j.cub.2004.08.058; Castiello U, 1999, TRENDS COGN SCI, V3, P264, DOI 10.1016/S1364-6613(99)01346-7; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Cisek P, 2007, PHILOS T R SOC B, V362, P1585, DOI 10.1098/rstb.2007.2054; Cisek P, 2006, J NEUROSCI, V26, P9761, DOI 10.1523/JNEUROSCI.5605-05.2006; Da Lio M, NOTREMOR D LINE TRAC; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Elsner B, 2001, J EXP PSYCHOL HUMAN, V27, P229, DOI 10.1037/0096-1523.27.1.229; FISK JD, 1985, EXP BRAIN RES, V60, P159; FORTIER PA, 1989, J NEUROPHYSIOL, V62, P198, DOI 10.1152/jn.1989.62.1.198; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Gibson J.J., 1986, ECOLOGICAL APPROACH; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Gribble PL, 2002, EXP BRAIN RES, V145, P372, DOI 10.1007/s00221-002-1122-9; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; Gurney K, 2001, BIOL CYBERN, V84, P411, DOI 10.1007/PL00007985; HALLETT M, 1975, J NEUROL NEUROSUR PS, V38, P1154, DOI 10.1136/jnnp.38.12.1154; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Haruno M, 2005, J NEUROPHYSIOL, V94, P4244, DOI 10.1152/jn.00404.2005; HIRSCH J, 1989, VISION RES, V29, P1095, DOI 10.1016/0042-6989(89)90058-8; Hocherman S, 2004, COGNITIVE BRAIN RES, V21, P77, DOI 10.1016/j.cogbrainres.2004.05.008; HOFFMAN DS, 1986, J NEUROSCI, V6, P3309; Houghton G, 1996, VIS COGN, V3, P119, DOI 10.1080/713756733; Houghton George, 1994, P53; Houk JC, 2007, PHILOS T R SOC B, V362, P1573, DOI 10.1098/rstb.2007.2063; Howard LA, 1997, EXP BRAIN RES, V113, P144, DOI 10.1007/BF02454150; Humphries MD, 2002, NETWORK-COMP NEURAL, V13, P131, DOI 10.1088/0954-898X/13/1/305; Iglewicz B., 1993, DETECT HANDLE OUTLIE, V16, P1; JACKSON SR, 1995, EXP BRAIN RES, V102, P519; Jax SA, 2007, J EXP PSYCHOL HUMAN, V33, P425, DOI 10.1037/0096-1523.33.2.425; JONAS JB, 1992, GRAEF ARCH CLIN EXP, V230, P505, DOI 10.1007/BF00181769; KALASKA JF, 1983, EXP BRAIN RES, V51, P247; Maes P., 1990, Robotics and Autonomous Systems, V6, P49, DOI 10.1016/S0921-8890(05)80028-4; Maes P., 1989, DYNAMICS ACTION SELE; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; McPeek RM, 2002, J NEUROPHYSIOL, V88, P2019, DOI 10.1152/jn.2002.88.4.2019; Meegan DV, 1999, J EXP PSYCHOL HUMAN, V25, P1347, DOI 10.1037/0096-1523.25.5.1347; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; Moschovakis AK, 1996, PROG NEUROBIOL, V50, P133, DOI 10.1016/S0301-0082(96)00034-2; MOSCHOVAKIS AK, 1994, ANNU REV NEUROSCI, V17, P465; Neggers SFW, 2000, J NEUROPHYSIOL, V83, P639, DOI 10.1152/jn.2000.83.2.639; Neggers SFW, 2001, J NEUROPHYSIOL, V86, P961, DOI 10.1152/jn.2001.86.2.961; Norman D. A., 1986, CONSCIOUSNESS SELF R, V4, P1; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; PRABLANC C, 1979, BIOL CYBERN, V35, P113, DOI 10.1007/BF00337436; PRATT J, 1994, HUM MOVEMENT SCI, V13, P245, DOI 10.1016/0167-9457(94)90039-6; R Core Team, 2021, R LANGUAGE ENV STAT; Ratcliff R, 2003, J NEUROPHYSIOL, V90, P1392, DOI 10.1152/jn.01049.2002; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Reppert TR, 2015, J NEUROSCI, V35, P15369, DOI 10.1523/JNEUROSCI.2621-15.2015; RIZZOLATTI G, 1994, ATTENTION PERFORM, V15, P231; Rorie AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009308; Roseberry TK, 2016, CELL, V164, P526, DOI 10.1016/j.cell.2015.12.037; SASLOW MG, 1967, J OPT SOC AM, V57, P1024, DOI 10.1364/JOSA.57.001024; SCHALL JD, 1993, NATURE, V366, P467, DOI 10.1038/366467a0; Snyder LH, 2002, J NEUROPHYSIOL, V87, P2279, DOI 10.1152/jn.00854.2001; Song JH, 2008, VISION RES, V48, P853, DOI 10.1016/j.visres.2007.12.015; Song JH, 2007, J VISION, V7, DOI 10.1167/7.5.2; Sparks DL, 2002, NAT REV NEUROSCI, V3, P952, DOI 10.1038/nrn986; TIPPER SP, 1992, J EXP PSYCHOL HUMAN, V18, P891, DOI 10.1037/0096-1523.18.4.891; Tipper SP, 1998, PHILOS T R SOC B, V353, P1385, DOI 10.1098/rstb.1998.0292; Tipper SP, 1997, VIS COGN, V4, P1, DOI 10.1080/713756749; Tipper SP, 2001, EXP BRAIN RES, V136, P241, DOI 10.1007/s002210000577; TRUMBO D, 1963, Percept Mot Skills, V16, P649; TRUMBO D, 1968, J EXP PSYCHOL, V77, P397, DOI 10.1037/h0025935; Waszak F, 2005, EXP BRAIN RES, V162, P346, DOI 10.1007/s00221-004-2183-8; WATERS P, 1981, BRAIN RES, V207, P189, DOI 10.1016/0006-8993(81)90692-2; Watson RW, 1997, MED BIOL ENG COMPUT, V35, P141, DOI 10.1007/BF02534145; Welsh TN, 2004, Q J EXP PSYCHOL-A, V57, P1031, DOI 10.1080/02724980343000666; ZARZECKI P, 1991, SOMATOSENS MOT RES, V8, P313, DOI 10.3109/08990229109144755	79	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176945	10.1371/journal.pone.0176945	http://dx.doi.org/10.1371/journal.pone.0176945			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SX	28475622	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000400649500030
J	Dzieciolowska, S; Drapeau, P; Armstrong, GAB				Dzieciolowska, Stefania; Drapeau, Pierre; Armstrong, Gary Alan Barclay			Augmented quantal release of acetylcholine at the vertebrate neuromuscular junction following tdp-43 depletion	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; WHITE MUSCLE-FIBERS; EMBRYONIC RED; MOTOR-NEURON; RNA TARGETS; IN-VIVO; ZEBRAFISH; ALS; DYSFUNCTION; MODEL	TAR DNA binding protein (TDP-43) is a 43 kD, predominately nuclear, protein involved in RNA metabolism. Of clinical significance is that the majority of amyotrophic lateral sclerosis (ALS) patients display abnormal accumulation of misfolded TDP-43 in the cytoplasm, which is coincident with a loss of nuclear localization in the afflicted regions of the central nervous system. Little is known about defects that arise in loss-of-function models, in particular synaptic defects that arise at the neuromuscular junction (NMJ). In this report, we examined abnormalities arising at the NMJ following depletion of tdp-43 using a previously characterized mutant tardbp (encoding tdp-43) zebrafish line containing a premature stop codon (Y220X) that results in an unstable and degraded protein. Homozygous tardbp(Y220X/Y220X) zebrafish do not produce tdp-43 but develop normally due to expression of an alternative splice variant of tardbpl (tardbp paralog). Using an antisense morpholino oligonucleotide to knockdown expression of the tardbpl in tardbp(Y220X/Y220X) embryos, we examined locomotor defects, NMJ structural abnormalities and release of quantal synaptic vesicles at the NMJ. As in previous reports, larvae depleted of tdp-43 display reduced survival, gross morphological defects and severely impaired locomotor activity. These larvae also displayed an increased number of orphaned pre- and postsynaptic NMJ markers but surprisingly, we observed a significant increase (3.5 times) in the frequency of quantal acetylcholine release at the NMJ in larvae depleted of tdp-43. These results indicate that reduced TDP-43 levels alter quantal vesicle release at the NMJ during vertebrate development and may be relevant for understanding synaptic dysfunction in ALS.	[Dzieciolowska, Stefania; Drapeau, Pierre; Armstrong, Gary Alan Barclay] CRCHUM, Montreal, PQ, Canada; [Dzieciolowska, Stefania; Drapeau, Pierre; Armstrong, Gary Alan Barclay] CRCHUM, Dept Neurosci, Montreal, PQ, Canada; [Dzieciolowska, Stefania] McGill Univ, Integrated Neurosci Program, Montreal, PQ, Canada; [Armstrong, Gary Alan Barclay] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; McGill University; McGill University	Armstrong, GAB (corresponding author), CRCHUM, Montreal, PQ, Canada.; Armstrong, GAB (corresponding author), CRCHUM, Dept Neurosci, Montreal, PQ, Canada.; Armstrong, GAB (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada.	gary.ab.armstrong@gmail.com		Armstrong, Gary/0000-0003-4613-8817	Weston Brain Institute, grant [RR130306]; Muscular Dystrophy Association, grant [351000]; Canadian Institutes of Health Research	Weston Brain Institute, grant; Muscular Dystrophy Association, grant(Muscular Dystrophy Association); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Weston Brain Institute, grant # RR130306 (http // westonbraininstitute.ca/) (GA); Muscular Dystrophy Association, grant #351000 (https:// www.mda.org/) (GA); Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) (PD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KT, 2016, DEV NEUROBIOL, V76, P916, DOI 10.1002/dneu.22366; Armstrong GAB, 2013, J NEUROSCI, V33, P1741, DOI 10.1523/JNEUROSCI.4003-12.2013; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buss RR, 2002, J NEUROPHYSIOL, V87, P1244, DOI 10.1152/jn.00659.2001; Buss RR, 2000, J NEUROPHYSIOL, V84, P1545, DOI 10.1152/jn.2000.84.3.1545; Cui YW, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-42; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Frey D, 2000, J NEUROSCI, V20, P2534; Hewamadduma CAA, 2013, HUM MOL GENET, V22, P2376, DOI 10.1093/hmg/ddt082; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kleopa KA, 2004, GLIA, V47, P346, DOI 10.1002/glia.20043; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; McGown A, 2013, ANN NEUROL, V73, P246, DOI 10.1002/ana.23780; Moon Y, 2010, NEUROREPORT, V21, P1135, DOI 10.1097/WNR.0b013e32834051c7; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nguyen PV, 1999, J NEUROPHYSIOL, V81, P2852, DOI 10.1152/jn.1999.81.6.2852; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Schmid B, 2013, P NATL ACAD SCI USA, V110, P4986, DOI 10.1073/pnas.1218311110; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Walker AK, 2015, ACTA NEUROPATHOL, V130, P643, DOI 10.1007/s00401-015-1460-x; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584	28	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177005	10.1371/journal.pone.0177005	http://dx.doi.org/10.1371/journal.pone.0177005			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472174	Green Published, gold, Green Submitted			2022-12-26	WOS:000400648500114
J	Fan, XG; Wu, HY; Li, GL; Yuan, H; Zhang, HC; Li, YJ; Xie, XX; Chen, N				Fan, Xiaoguang; Wu, Heyun; Li, Guoliang; Yuan, Hui; Zhang, Hongchao; Li, Yanjun; Xie, Xixian; Chen, Ning			Improvement of uridine production of Bacillus subtilis by atmospheric and room temperature plasma mutagenesis and high-throughput screening	PLOS ONE			English	Article							CARBAMOYL-PHOSPHATE SYNTHETASE; PYR MESSENGER-RNA; TRANSCRIPTIONAL ATTENUATION; REGULATORY PROTEIN; ETHANOL-PRODUCTION; METABOLIC FLUXES; BINDING-SITE; WILD-TYPE; MUTANT; RESIDUES	In the present study, a novel breeding strategy of atmospheric and room temperature plasma (ARTP) mutagenesis was used to improve the uridine production of engineered Bacillus subtilis TD12np. A high-throughput screening method was established using both resistant plates and 96-well microplates to select the ideal mutants with diverse phenotypes. Mutant F126 accumulated 5.7 and 30.3 g/L uridine after 30 h in shake-flask and 48 h in fed-batch fermentation, respectively, which represented a 4.4- and 8.7-fold increase over the parent strain. Sequence analysis of the pyrimidine nucleotide biosynthetic operon in the representative mutants showed that proline 1016 and glutamate 949 in the large subunit of B. subtilis carbamoyl phosphate synthetase were of importance for the allosteric regulation caused by uridine 5'- monophosphate. The proposed mutation method with efficient high-throughput screening assay was proved to be an appropriate strategy to obtain uridine-overproducing strain.	[Fan, Xiaoguang; Wu, Heyun; Li, Guoliang; Yuan, Hui; Zhang, Hongchao; Li, Yanjun; Xie, Xixian; Chen, Ning] Tianjin Univ Sci & Technol, Natl & Local United Engn Lab Metab Control Fermen, Tianjin, Peoples R China; [Fan, Xiaoguang; Li, Yanjun; Xie, Xixian; Chen, Ning] Tianjin Univ Sci & Technol, Key Lab Microbial Engn China Light Ind, Tianjin, Peoples R China; [Fan, Xiaoguang; Wu, Heyun; Li, Guoliang; Yuan, Hui; Zhang, Hongchao; Li, Yanjun; Xie, Xixian; Chen, Ning] Tianjin Univ Sci & Technol, Coll Biotechnol, Tianjin, Peoples R China	Tianjin University Science & Technology; Tianjin University Science & Technology; Tianjin University Science & Technology	Xie, XX; Chen, N (corresponding author), Tianjin Univ Sci & Technol, Natl & Local United Engn Lab Metab Control Fermen, Tianjin, Peoples R China.; Xie, XX; Chen, N (corresponding author), Tianjin Univ Sci & Technol, Key Lab Microbial Engn China Light Ind, Tianjin, Peoples R China.; Xie, XX; Chen, N (corresponding author), Tianjin Univ Sci & Technol, Coll Biotechnol, Tianjin, Peoples R China.	xixianxie@tust.edu.cn; ningch@tust.edu.cn			Key Technologies Research and Development Program of Tianjin [16YEZCSY00770]; Innovation Fund for Youth of Tianjin University of Science and Technology [2015LG19]; Tianjin Municipal Science and Technology Commission [15JCTPJC62800]; Dr. Rui Ban from Tianjin University; Dr. Leonardo Rios from Joint BioEnergy Institute	Key Technologies Research and Development Program of Tianjin; Innovation Fund for Youth of Tianjin University of Science and Technology; Tianjin Municipal Science and Technology Commission; Dr. Rui Ban from Tianjin University; Dr. Leonardo Rios from Joint BioEnergy Institute	This work was supported by Key Technologies Research and Development Program of Tianjin (16YEZCSY00770), Innovation Fund for Youth of Tianjin University of Science and Technology (2015LG19) and Tianjin Municipal Science and Technology Commission (15JCTPJC62800). All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the generous support of Dr. Rui Ban from Tianjin University and Dr. Leonardo Rios from Joint BioEnergy Institute.	ASAHI S, 1995, BIOSCI BIOTECH BIOCH, V59, P2123, DOI 10.1271/bbb.59.2123; ASAHI S, 1995, BIOSCI BIOTECH BIOCH, V59, P915, DOI 10.1271/bbb.59.915; ASAHI S, 1994, BIOSCI BIOTECH BIOCH, V58, P1399, DOI 10.1271/bbb.58.1399; Bonner ER, 2001, NUCLEIC ACIDS RES, V29, P4851, DOI 10.1093/nar/29.23.4851; Braxton BL, 1999, BIOCHEMISTRY-US, V38, P1394, DOI 10.1021/bi982097w; CERVERA J, 1993, J BIOL CHEM, V268, P12504; Cervera J, 1996, BIOCHEMISTRY-US, V35, P7247, DOI 10.1021/bi952549u; Chen XC, 2013, BIOPROC BIOSYST ENG, V36, P1851, DOI 10.1007/s00449-013-0959-6; Cheng KG, 2016, CHEM BIOL DRUG DESIG; CZERWINSKI RM, 1995, BIOCHEMISTRY-US, V34, P13920, DOI 10.1021/bi00042a025; Delannay S, 1999, J MOL BIOL, V286, P1217, DOI 10.1006/jmbi.1999.2561; Dobolyi A, 2011, CURR TOP MED CHEM, V11, P1058, DOI 10.2174/156802611795347618; Dong HN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121612; Fang MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077046; Hobl B, 2007, MICROBIOL-SGM, V153, P693, DOI 10.1099/mic.0.2006/003772-0; Iglesias LE, 2015, BIOTECHNOL ADV, V33, P412, DOI 10.1016/j.biotechadv.2015.03.009; Jiang T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149101; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Li HG, 2013, BIORESOURCE TECHNOL, V137, P254, DOI 10.1016/j.biortech.2013.03.084; Li XY, 2015, BIORESOURCE TECHNOL, V177, P134, DOI 10.1016/j.biortech.2014.11.051; Long Q, 2014, J BIOTECHNOL, V192, P323, DOI 10.1016/j.jbiotec.2014.03.028; Lu Y, 1996, J BACTERIOL, V178, P7206, DOI 10.1128/jb.178.24.7206-7211.1996; Lu Y, 1996, P NATL ACAD SCI USA, V93, P14462, DOI 10.1073/pnas.93.25.14462; Moffatt Barbara A, 2002, Arabidopsis Book, V1, pe0018, DOI 10.1199/tab.0018; QUINN CL, 1991, J BIOL CHEM, V266, P9113; RUBIO V, 1991, BIOCHEMISTRY-US, V30, P1068, DOI 10.1021/bi00218a027; Sauer U, 1997, NAT BIOTECHNOL, V15, P448, DOI 10.1038/nbt0597-448; Sauer U, 1996, APPL ENVIRON MICROB, V62, P3687, DOI 10.1128/AEM.62.10.3687-3696.1996; Savacool HK, 2002, J BACTERIOL, V184, P2521, DOI 10.1128/JB.184.9.2521-2528.2002; Stapleton MA, 1996, BIOCHEMISTRY-US, V35, P14352, DOI 10.1021/bi961183y; Sun JD, 2015, BIOTECHNOL APPL BIOC, V62, P287, DOI 10.1002/bab.1267; Switzer RL, 1999, PROG NUCLEIC ACID RE, V62, P329; Thoden JB, 1997, BIOCHEMISTRY-US, V36, P6305, DOI 10.1021/bi970503q; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; Wang L, 2015, ANN MICROBIOL, V65, P2009, DOI 10.1007/s13213-015-1039-8; Watanabe T, 2011, BIORESOURCE TECHNOL, V102, P1844, DOI 10.1016/j.biortech.2010.09.087; Zhang X, 2014, APPL MICROBIOL BIOT, V98, P5387, DOI 10.1007/s00253-014-5755-y; Zhu H, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0237-1	38	21	24	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176545	10.1371/journal.pone.0176545	http://dx.doi.org/10.1371/journal.pone.0176545			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472077	Green Published, gold, Green Submitted			2022-12-26	WOS:000400648500051
J	Chen, SJ; Tao, JL; Zhong, FY; Jiao, Y; Xu, JY; Shen, Q; Wang, HC; Fan, SJ; Zhang, YS				Chen, Sijia; Tao, Jialong; Zhong, Fengyun; Jiao, Yang; Xu, Jiaying; Shen, Qiang; Wang, Haichao; Fan, Saijun; Zhang, Yusong			Polydatin down-regulates the phosphorylation level of Creb and induces apoptosis in human breast cancer cell	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; RESVERATROL; EXPRESSION; CARCINOMA; TUMOR; GROWTH; MICE; ADENOCARCINOMA; PROGNOSIS; ANTITUMOR	Polydatin (PD), a component isolated from Polygonum cuspidatum, has a number of biological functions. However, the antitumor activity of PD has been poorly investigated. In this study, the effect of PD on cell proliferation was evaluated by thiazolyl blue tetrazolium bromide assay. Cell cycle distribution and apoptosis were investigated by flow cytometry. The phosphorylation levels of panel of phosphor-kinases were detected by human phosphokinase arrays. The expression of several proteins associated with cell cycle and apoptosis were analyzed by Western blot analysis. Results showed that PD effectively inhibited the growth of MDA-MB-231 and MCF-7 breast cancer cell lines. Cell cycle analysis demonstrated that PD induced S-phase cell cycle arrest. Human phosphor-kinase arrays showed that the phosphorylation level of cAMP response element-bingding proteins(Creb) was down-regulated, and the results were further confirmed by Western blot analysis. Western blot analysis showed that the expression of protein of cyclin D1 decreased in a time-and dose-dependent manner. Results suggest that PD is a potential therapeutic natural compound.	[Chen, Sijia; Tao, Jialong; Zhong, Fengyun; Zhang, Yusong] Soochow Univ, Affiliated Hosp 2, Dept Oncol, Suzhou, Jiangsu, Peoples R China; [Jiao, Yang; Xu, Jiaying; Fan, Saijun] Soochow Univ, Coll Med, Sch Radiat Med & Protect, Suzhou, Jiangsu, Peoples R China; [Shen, Qiang] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Div Canc Prevent & Populat Sci, Houston, TX 77030 USA; [Wang, Haichao] Feinstein Inst Med Res, 350 Community Dr, Manhasset, NY USA	Soochow University - China; Soochow University - China; University of Texas System; UTMD Anderson Cancer Center; Northwell Health	Zhang, YS (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Oncol, Suzhou, Jiangsu, Peoples R China.; Fan, SJ (corresponding author), Soochow Univ, Coll Med, Sch Radiat Med & Protect, Suzhou, Jiangsu, Peoples R China.	fansaijun36@163.com; zhangyusong19@163.com	xu, jia/GSD-6347-2022; Wang, Haichao/AAU-2237-2021	Wang, Haichao/0000-0002-0211-9000; Shen, Qiang/0000-0002-1491-5434	Suzhou Science and Technology Program [SYS201345]; Bureau of Public Health of Jiangsu Province [H201413]; second affiliated hospital of Soochow university pre-research project [SDFEYGJ1609]; second affiliated hospital of Soochow university clinical discipline group project funding [XKQ 2015008]	Suzhou Science and Technology Program; Bureau of Public Health of Jiangsu Province; second affiliated hospital of Soochow university pre-research project; second affiliated hospital of Soochow university clinical discipline group project funding	The current study was supported by grants from Suzhou Science and Technology Program (SYS201345), Bureau of Public Health of Jiangsu Province (H201413), the second affiliated hospital of Soochow university pre-research project (SDFEYGJ1609) and the second affiliated hospital of Soochow university clinical discipline group project funding (XKQ 2015008).; The current study was supported by grants from Suzhou Science and Technology Program (SYS201345), Bureau of Public Health of Jiangsu Province (H201413), pre-research project from the second affiliated hospital of Soochow university pre-research project (SDFEYGJ1609) and the second affiliated hospital of Soochow university clinical discipline group project funding (XKQ 2015008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; Chen JC, 2006, ANTICANCER RES, V26, P1237; Chhabra A, 2007, ONCOL REP, V18, P953; Coughlin SS, 2009, CANCER EPIDEMIOL, V33, P315, DOI 10.1016/j.canep.2009.10.003; Davidson B, 2006, GYNECOL ONCOL, V102, P453, DOI 10.1016/j.ygyno.2006.01.034; Fan MY, 2001, DRUG RESIST UPDATE, V4, P253, DOI 10.1054/drup.2001.0214; Fan SJ, 2005, ONCOGENE, V24, P1749, DOI 10.1038/sj.onc.1208327; Fan SJ, 1998, ONCOGENE, V16, P3069, DOI 10.1038/sj.onc.1202116; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Joe AK, 2002, CLIN CANCER RES, V8, P893; Li T, 2007, INT IMMUNOPHARMACOL, V7, P1221, DOI 10.1016/j.intimp.2007.05.008; Liu HS, 2003, WORLD J GASTROENTERO, V9, P1474, DOI 10.3748/wjg.v9.i7.1474; Liu PL, 2010, MOL NUTR FOOD RES, V54, pS196, DOI 10.1002/mnfr.200900550; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Pan MH, 2008, MOL CARCINOGEN, V47, P184, DOI 10.1002/mc.20352; Rezk Youssef A, 2006, Am J Obstet Gynecol, V194, pe23, DOI 10.1016/j.ajog.2005.11.030; Roy HK, 2002, CARCINOGENESIS, V23, P201, DOI 10.1093/carcin/23.1.201; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shibata MA, 2007, CANCER CHEMOTH PHARM, V60, P681, DOI 10.1007/s00280-007-0414-y; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Xu XD, 2004, ONCOL REP, V11, P25; Yamamoto S, 2004, CLIN CANCER RES, V10, P2846, DOI 10.1158/1078-0432.CCR-02-1441; Yang K, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-32; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zhang YS, 2014, ONCOL LETT, V7, P295, DOI 10.3892/ol.2013.1696; Zhou HB, 2005, WORLD J GASTROENTERO, V11, P280, DOI 10.3748/wjg.v11.i2.280	28	28	30	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176501	10.1371/journal.pone.0176501	http://dx.doi.org/10.1371/journal.pone.0176501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467448	Green Published, Green Submitted, gold			2022-12-26	WOS:000400647000057
J	Howell, KR; Floyd, K; Law, AJ				Howell, Kristy R.; Floyd, Kirsten; Law, Amanda J.			PKB gamma/AKT3 loss-of-function causes learning and memory deficits and deregulation of AKT/mTORC2 signaling: Relevance for schizophrenia	PLOS ONE			English	Article							KINASE-B-GAMMA; ASSOCIATION ANALYSIS; AKT PHOSPHORYLATION; CORTICAL THICKNESS; WORKING-MEMORY; BRAIN; PATHWAY; CORTEX; RISK; METAANALYSIS	Psychiatric genetic studies have identified genome-wide significant loci for schizophrenia. The AKT3/1q44 locus is a principal risk region and gene-network analyses identify AKT3 polymorphisms as a constituent of several neurobiological pathways relevant to psychiatric risk; the neurobiological mechanisms remain unknown. AKT3 shows prenatal enrichment during human neocortical development and recurrent copy number variations involving the 1q43-44 locus are associated with cortical malformations and intellectual disability, implicating an essential role in early brain development. Here, we investigated the role of AKT3 as it relates to aspects of learning and memory and behavioral function, relevant to schizophrenia and cognitive disability, utilizing a novel murine model of Akt3 genetic deficiency. Akt3 heterozygous (Akt3(-/+)) or null mice (Akt3(-/-)) were assessed in a comprehensive test battery. Brain biochemical studies were conducted to assess the impact of Akt3 deficiency on cortical Akt/mTOR signaling. Akt3(-/+) and Akt3(-/-) mice exhibited selective deficits of temporal order discrimination and spatial memory, tasks critically dependent on intact prefrontal-hippocampal circuitry, but showed normal prepulse inhibition, fear conditioned learning, memory for novel objects and social function. Akt3 loss-of-function, reduced brain size and dramatically impaired cortical Akt Ser(473) activation in an allele-dose dependent manner. Such changes were observed in the absence of altered Akt1 or Akt2 protein expression. Concomitant reduction of the mTORC2 complex proteins, Rictor and Sin1 identifies a potential mechanism. Our findings provide novel insight into the neurodevelopmental role of Akt3, identify a non-redundant role for Akt3 in the development of prefrontal cortical-mediated cognitive function and show that Akt3 is potentially the dominant regulator of AKT/mTOR signaling in brain.	[Howell, Kristy R.; Floyd, Kirsten; Law, Amanda J.] Univ Colorado, Sch Med, Dept Psychiat, Aurora, CO 80045 USA; [Law, Amanda J.] Univ Colorado, Sch Med, Dept Cell & Dev Biol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Law, AJ (corresponding author), Univ Colorado, Sch Med, Dept Psychiat, Aurora, CO 80045 USA.; Law, AJ (corresponding author), Univ Colorado, Sch Med, Dept Cell & Dev Biol, Aurora, CO 80045 USA.	Amanda.Law@ucdenver.edu	Law, Amanda J/G-6372-2012	Law, Amanda J/0000-0002-2574-1564; Howell, Kristy/0000-0002-0872-5335	National Institute of Mental Health of the National Institutes of Health [R01MH103716, T32MH015442]; University of Colorado, Denver; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH103716] Funding Source: NIH RePORTER	National Institute of Mental Health of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); University of Colorado, Denver; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research reported in this publication was supported by the National Institute of Mental Health of the National Institutes of Health under Award Number R01MH103716 (AJL) and via T32MH015442, an institutional postdoctoral research training program at University of Colorado, Denver, to KRH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HHH, 2016, NAT NEUROSCI, V19, P1569, DOI 10.1038/nn.4398; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Arguello PA, 2008, J CLIN INVEST, V118, P2018, DOI 10.1172/JCI35931; Bajestan SN, 2006, AM J MED GENET B, V141B, P383, DOI 10.1002/ajmg.b.30291; Ballif BC, 2012, HUM GENET, V131, P145, DOI 10.1007/s00439-011-1073-y; Balu DT, 2012, HIPPOCAMPUS, V22, P230, DOI 10.1002/hipo.20887; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Bartholomeusz CF, 2016, AUST NZ J PSYCHIAT; Beaulieu JM, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00038; Beaulieu JM, 2009, ANNU REV PHARMACOL, V49, P327, DOI 10.1146/annurev.pharmtox.011008.145634; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; BENES FM, 1995, ARCH GEN PSYCHIAT, V52, P1015; Birnbaum R, 2015, BIOL PSYCHIAT, V77, pE43, DOI 10.1016/j.biopsych.2014.10.008; Blasi G, 2011, P NATL ACAD SCI USA, V108, P1158, DOI 10.1073/pnas.1013535108; Boland E, 2007, AM J HUM GENET, V81, P292, DOI 10.1086/519999; BRAFF DL, 1992, ARCH GEN PSYCHIAT, V49, P206; Callicott JH, 2003, AM J PSYCHIAT, V160, P2209, DOI 10.1176/appi.ajp.160.12.2209; Chen YW, 2014, SCHIZOPHRENIA BULL, V40, P388, DOI 10.1093/schbul/sbt031; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Clark AR, 2014, BIOCHEM SOC T, V42, P1349, DOI 10.1042/BST20140160; Cohen MM, 2013, AM J MED GENET A, V161, P2931, DOI 10.1002/ajmg.a.36101; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; Dickinson D, 2011, SCHIZOPHRENIA BULL, V37, P1157, DOI 10.1093/schbul/sbq018; Diez H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032715; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Eisener-Dorman AF, 2009, BRAIN BEHAV IMMUN, V23, P318, DOI 10.1016/j.bbi.2008.09.001; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Falkai P, 2016, SCHIZOPHRENIA BULL, V42, pS4, DOI 10.1093/schbul/sbv157; Featherstone RE, 2013, PSYCHOPHARMACOLOGY, V227, P639, DOI 10.1007/s00213-013-2997-9; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; Folley BS, 2010, NEUROIMAGE, V49, P3373, DOI 10.1016/j.neuroimage.2009.11.034; Franke TF, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe29; Gai D, 2015, AM J MED GENET A, V167, P174, DOI 10.1002/ajmg.a.36710; Gautam P, 2015, BEHAV BRAIN RES, V287, P331, DOI 10.1016/j.bbr.2015.03.018; Goldman AL, 2008, BIOL PSYCHIAT, V63, P475, DOI 10.1016/j.biopsych.2007.06.006; Goldman AL, 2009, ARCH GEN PSYCHIAT, V66, P467, DOI 10.1001/archgenpsychiatry.2009.24; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Haijma SV, 2013, SCHIZOPHRENIA BULL, V39, P1129, DOI 10.1093/schbul/sbs118; Hamshere ML, 2013, MOL PSYCHIATR, V18, P708, DOI 10.1038/mp.2012.67; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Harrison PJ, 2003, SCHIZOPHR RES, V64, P25, DOI 10.1016/S0920-9964(02)00502-9; Howes OD, 2014, LANCET, V383, P1677, DOI 10.1016/S0140-6736(13)62036-X; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kim J, 2007, P NATL ACAD SCI USA, V104, P20955, DOI 10.1073/pnas.0710548105; Lai WS, 2006, P NATL ACAD SCI USA, V103, P16906, DOI 10.1073/pnas.0604994103; Law AJ, 2006, P NATL ACAD SCI USA, V103, P6747, DOI 10.1073/pnas.0602002103; Law AJ, 2012, P NATL ACAD SCI USA, V109, P12165, DOI 10.1073/pnas.1206118109; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Lee KH, 2004, PSYCHOL MED, V34, P391, DOI 10.1017/S0033291703001284; Lee PH, 2016, MOL PSYCHIAT; Lee Rachel S, 2011, Enzyme Res, V2011, P720985, DOI 10.4061/2011/720985; Leibrock C, 2013, CELL PHYSIOL BIOCHEM, V32, P766, DOI 10.1159/000354478; Lewis DA, 2000, BRAIN RES REV, V31, P270, DOI 10.1016/S0165-0173(99)00042-9; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Masure S, 1999, EUR J BIOCHEM, V265, P353, DOI 10.1046/j.1432-1327.1999.00774.x; Mathur A, 2010, PSYCHIAT GENET, V20, P118, DOI 10.1097/YPG.0b013e32833a2234; Meyer-Lindenberg AS, 2005, ARCH GEN PSYCHIAT, V62, P379, DOI 10.1001/archpsyc.62.4.379; Miao LQ, 2016, ELIFE, V5, DOI 10.7554/eLife.14908; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Norton N, 2007, SCHIZOPHR RES, V93, P58, DOI 10.1016/j.schres.2007.02.006; O'Dushlaine C, 2015, NAT NEUROSCI, V18, P199, DOI 10.1038/nn.3922; Papaleo F, 2008, J NEUROSCI, V28, P8709, DOI 10.1523/JNEUROSCI.2077-08.2008; Papaleo F, 2016, J NEUROSCI, V36, P4859, DOI 10.1523/JNEUROSCI.4632-15.2016; Paterson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104172; Pietilainen OPH, 2009, AM J MED GENET B, V150B, P683, DOI 10.1002/ajmg.b.30890; Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010; Rasetti R, 2011, ARCH GEN PSYCHIAT, V68, P1207, DOI 10.1001/archgenpsychiatry.2011.103; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Rizzo L, 1996, BRIT J PSYCHIAT, V168, P427, DOI 10.1192/bjp.168.4.427; Rosner M, 2010, AMINO ACIDS, V38, P223, DOI 10.1007/s00726-008-0230-7; Ruderfer DM, 2016, LANCET PSYCHIAT, V3, P350, DOI 10.1016/S2215-0366(15)00553-2; Santi SA, 2010, AM J PHYSIOL-CELL PH, V298, pC580, DOI 10.1152/ajpcell.00375.2009; Schaefer J, 2013, SCHIZOPHR RES, V150, P42, DOI 10.1016/j.schres.2013.07.009; Schwab SG, 2005, BIOL PSYCHIAT, V58, P446, DOI 10.1016/j.biopsych.2005.05.005; SCHWARTZ BL, 1991, BIOL PSYCHIAT, V29, P329, DOI 10.1016/0006-3223(91)90218-B; Sei Y, 2007, MOL PSYCHIATR, V12, P946, DOI 10.1038/sj.mp.4001994; Selemon LD, 2001, SCHIZOPHRENIA BULL, V27, P349, DOI 10.1093/oxfordjournals.schbul.a006881; Senkowski D, 2015, BIOL PSYCHIAT, V77, P1010, DOI 10.1016/j.biopsych.2015.02.034; Seres I, 2010, NEUROCHEM INT, V56, P906, DOI 10.1016/j.neuint.2010.03.018; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Steen RG, 2006, BRIT J PSYCHIAT, V188, P510, DOI 10.1192/bjp.188.6.510; Sun T, 2014, NAT REV NEUROSCI, V15, P217, DOI 10.1038/nrn3707; Tan HY, 2012, BRAIN, V135, P1436, DOI 10.1093/brain/aws068; Tan HY, 2008, J CLIN INVEST, V118, P2200, DOI [10.1172/JCI3472S, 10.1172/JCI34725]; Thiselton DL, 2008, BIOL PSYCHIAT, V63, P449, DOI 10.1016/j.biopsych.2007.06.005; Thomanetz V, 2013, J CELL BIOL, V201, P293, DOI 10.1083/jcb.201205030; Toulopoulou T, 2010, ARCH GEN PSYCHIAT, V67, P905, DOI 10.1001/archgenpsychiatry.2010.99; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; van Beveren NJM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032618; Xie R, 2013, J CEREBR BLOOD F MET, V33, P1875, DOI 10.1038/jcbfm.2013.132; Zheng WH, 2012, BRAIN RES, V1470, P145, DOI 10.1016/j.brainres.2012.06.032; Zipursky RB, 1998, SCHIZOPHR RES, V30, P81, DOI 10.1016/S0920-9964(97)00126-6; Zipursky RB, 2013, SCHIZOPHRENIA BULL, V39, P1363, DOI 10.1093/schbul/sbs135	97	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0175993	10.1371/journal.pone.0175993	http://dx.doi.org/10.1371/journal.pone.0175993			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SB	28467426	gold, Green Submitted, Green Published			2022-12-26	WOS:000400647000030
J	Liversage, K				Liversage, Kiran			First evidence of biogenic habitat from tubeworms providing a near-absolute habitat requirement for high-intertidal Ulva macroalgae	PLOS ONE			English	Article							NEW-SOUTH-WALES; TIDAL ALGAL COMMUNITY; NATURAL COMMUNITIES; NULL HYPOTHESIS; BOULDER FIELDS; WAVE-EXPOSURE; ROCKY SHORES; DISTURBANCE; PATTERNS; FACILITATION	Disturbances in ecological systems can cause new resources to become available and can free the resources held by strongly competitive species. In intertidal boulder fields, wave-action causes disturbance by overturning boulders and freeing space for re-colonisation. In this study, mensurative experiments showed that boulder disturbance may also cause new biogenic-habitat resources to become available, if pre-disturbance boulders originally had tubeworm encrustations on their undersides. On the high-shore of a South Australian rocky coast, a small proportion of boulders had extensive encrustations of serpulid and spirorbid worm-tubes on their uppersides, and were likely to have recently been overturned, as spirorbid tubeworms are almost always only underneath boulders while living. Ulva macroalgae was absent from all boulders, except those with worm-tubes, where up to 61% Ulva cover was observed. Many boulders with tubes did not, however, have much algae, and this was likely caused by grazing. While limpets were seldom observed attached to tube encrustations, snails such as Nerita atramentosa and Bembicium nanum were equally abundant on and off tubes. N. atramentosa was likely the main grazer, as its densities were negatively correlated with Ulva cover. The mechanism causing association of Ulva and worm-tubes is unknown, but may be related to retention of moisture or algal spores within the complex topography of the tubes. Alternatively, some tubes may still have been living and providing nutrients for Ulva from excretory products. This study takes the first step towards understanding a very distinct habitat requirement which allows an important alga to persist in the hostile environment of the rocky-intertidal high shore.	[Liversage, Kiran] Govt South Australia, Dept Environm Water & Nat Resources, Mt Gambier, SA, Australia		Liversage, K (corresponding author), Govt South Australia, Dept Environm Water & Nat Resources, Mt Gambier, SA, Australia.	kiran.liversage@gmail.com		Liversage, Kiran/0000-0001-9971-0907				ADDESSI L, 1994, ECOL APPL, V4, P786, DOI 10.2307/1942008; Airoldi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022985; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Benedetti-Cecchi L, 2001, MAR ECOL PROG SER, V214, P137, DOI 10.3354/meps214137; Bracken MES, 2004, ECOLOGY, V85, P2828, DOI 10.1890/03-0651; Bulleri F, 2016, FUNCT ECOL, V30, P70, DOI 10.1111/1365-2435.12528; Bulleri F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033825; Callow M. E., 2002, BIOFOULING, V18, P229, DOI [DOI 10.1080/08927010290014908), DOI 10.1080/08927010290014908]; CANHAM CD, 1990, CAN J FOREST RES, V20, P620, DOI 10.1139/x90-084; Chapman MG, 1996, J EXP MAR BIOL ECOL, V196, P213, DOI 10.1016/0022-0981(95)00131-X; Chapman MG, 2003, J MAR BIOL ASSOC UK, V83, P415, DOI 10.1017/S0025315403007276h; Chapman MG, 2002, AUSTRAL ECOL, V27, P211, DOI 10.1046/j.1442-9993.2002.01172.x; Chapperon C, 2013, ECOL RES, V28, P407, DOI 10.1007/s11284-013-1030-4; CHILTON NB, 1984, MAR BIOL, V83, P163, DOI 10.1007/BF00394724; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Davison IR, 1996, J PHYCOL, V32, P197, DOI 10.1111/j.0022-3646.1996.00197.x; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; DENNY MW, 1987, J EXP MAR BIOL ECOL, V113, P231, DOI 10.1016/0022-0981(87)90103-1; DETHIER MN, 1984, ECOL MONOGR, V54, P99, DOI 10.2307/1942457; FARRELL TM, 1991, ECOL MONOGR, V61, P95, DOI 10.2307/1943001; FOSTER MS, 1990, HYDROBIOLOGIA, V192, P21, DOI 10.1007/BF00006225; Guo D, 2002, J ECOL, V90, P338, DOI 10.1046/j.1365-2745.2001.00667.x; HARLIN MM, 1977, MAR BIOL, V40, P33, DOI 10.1007/BF00390625; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; JAMES RJ, 1994, J EXP MAR BIOL ECOL, V181, P105, DOI 10.1016/0022-0981(94)90107-4; KENSLER CB, 1967, J ANIM ECOL, V36, P391, DOI 10.2307/2921; Knight-Jones EW, 2002, J NAT HIST, V36, P1397, DOI 10.1080/00222930110052454; Kotta J, 2006, HELGOLAND MAR RES, V60, P106, DOI 10.1007/s10152-006-0027-6; Kupriyanova EK, 2001, OCEANOGR MAR BIOL, V39, P1; LITTLER MM, 1980, BOT MAR, V23, P161, DOI 10.1515/botm.1980.23.3.161; Liversage K, 2012, THESIS; Liversage Kiran, 2015, Pacific Conservation Biology, V21, P234, DOI 10.1071/PC15017; Liversage K, 2015, P EST ACAD SCI, V64, P53, DOI 10.3176/proc.2015.1.07; Liversage K, 2014, MAR ECOL PROG SER, V505, P131, DOI 10.3354/meps10755; Liversage K, 2013, MOLLUSCAN RES, V33, P24, DOI 10.1080/13235818.2012.754145; MARION GM, 1991, SOIL SCI SOC AM J, V55, P235, DOI 10.2136/sssaj1991.03615995005500010040x; MCGUINNESS KA, 1986, J EXP MAR BIOL ECOL, V104, P97, DOI 10.1016/0022-0981(86)90099-7; MCGUINNESS KA, 1984, J BIOGEOGR, V11, P439, DOI 10.2307/2844807; MCGUINNESS KA, 1987, OECOLOGIA, V71, P409, DOI 10.1007/BF00378715; McIntire EJB, 2014, NEW PHYTOL, V201, P403, DOI 10.1111/nph.12478; Moore CG, 1998, AQUAT CONSERV, V8, P645, DOI 10.1002/(SICI)1099-0755(199809/10)8:5<645::AID-AQC295>3.0.CO;2-G; Nicastro KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047382; ROBERTSON GP, 1993, OECOLOGIA, V96, P451, DOI 10.1007/BF00320501; ROBLES C, 1982, OECOLOGIA, V54, P23, DOI 10.1007/BF00541103; Schumacher JF, 2007, BIOFOULING, V23, P55, DOI 10.1080/08927010601136957; SHANKS AL, 1986, OECOLOGIA, V69, P420, DOI 10.1007/BF00377065; Soliveres S, 2015, BIOL REV, V90, P297, DOI 10.1111/brv.12110; SOUSA WP, 1979, ECOLOGY, V60, P1225, DOI 10.2307/1936969; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; SOUSA WP, 1979, ECOL MONOGR, V49, P227, DOI 10.2307/1942484; Swain G, 2006, BIOFOULING, V22, P425, DOI 10.1080/08927010601037163; Taylor RB, 1998, LIMNOL OCEANOGR, V43, P600, DOI 10.4319/lo.1998.43.4.0600; Thomsen MS, 2010, INTEGR COMP BIOL, V50, P158, DOI 10.1093/icb/icq042; Thomsen MS, 2005, ESTUAR COAST SHELF S, V62, P63, DOI 10.1016/j.ecss.2004.08.007; TILMAN D, 1985, AM NAT, V125, P827, DOI 10.1086/284382; TURNER T, 1983, AM NAT, V121, P729, DOI 10.1086/284098; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Underwood AJ, 2000, J EXP MAR BIOL ECOL, V250, P97, DOI 10.1016/S0022-0981(00)00181-7; UNDERWOOD AJ, 1984, J EXP MAR BIOL ECOL, V75, P71, DOI 10.1016/0022-0981(84)90024-8; UNDERWOOD AJ, 1981, OECOLOGIA, V48, P221, DOI 10.1007/BF00347968; UNDERWOOD AJ, 1983, OECOLOGIA, V56, P202, DOI 10.1007/BF00379692; UNDERWOOD AJ, 1978, OECOLOGIA, V33, P185, DOI 10.1007/BF00344847; UNDERWOOD AJ, 1990, AUST J ECOL, V15, P365, DOI 10.1111/j.1442-9993.1990.tb01464.x; UNDERWOOD AJ, 1980, OECOLOGIA, V46, P201, DOI 10.1007/BF00540127; Underwood AJ, 1993, SPECIES DIVERSITY EC, P38; Wernberg T, 2008, J SEA RES, V59, P237, DOI 10.1016/j.seares.2008.02.005; WILLIAMSON JE, 1994, OECOLOGIA, V99, P16, DOI 10.1007/BF00317078; Wright JT, 2016, BIOL INVASIONS, V18, P3163, DOI 10.1007/s10530-016-1206-2	71	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176952	10.1371/journal.pone.0176952	http://dx.doi.org/10.1371/journal.pone.0176952			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467512	Green Published, gold, Green Submitted			2022-12-26	WOS:000400647000090
J	Ruan, RX; Wang, MS; Liu, X; Sun, XP; Chung, KR; Li, HY				Ruan, Ruoxin; Wang, Mingshuang; Liu, Xin; Sun, Xuepeng; Chung, Kuang-Ren; Li, Hongye			Functional analysis of two sterol regulatory element binding proteins in Penicillium digitatum	PLOS ONE			English	Article							AZOLE ANTIFUNGAL AGENTS; TRANSCRIPTION FACTORS; FUNGICIDE RESISTANCE; DMI RESISTANCE; CITRUS-FRUIT; GENE CYP51; VIRULENCE; HOMEOSTASIS; TRANSPORTER; SENSITIVITY	The sterol regulatory element binding proteins (SREBPs) are key regulators for sterol homeostasis in most fungi. In the citrus postharvest pathogen Penicillium digitatum, the SREBP homolog is required for fungicide resistance and regulation of CYP51 expression. In this study, we identified another SREBP transcription factor PdSreB in P. digitatum, and the biological functions of both SREBPs were characterized and compared. Inactivation of PdsreA, PdsreB or both genes in P. digitatum reduced ergosterol contents and increased sensitivities to sterol 14-alpha-demethylation inhibitors (DMIs) and cobalt chloride. Fungal strains impaired at PdsreA but not PdsreB increased sensitivity to tridemorph and an iron chelator 2,2'-dipyridyl. Virulence assays on citrus fruit revealed that fungal strains impaired at PdsreA, PdsreB or both induce maceration lesions similar to those induced by wild-type. However, Delta PdsreA, Delta PdsreB or the double mutant strain rarely produce aerial mycelia on infected citrus fruit peels. RNA-Seq analysis showed the broad regulatory functions of both SREBPs in biosynthesis, transmembrane transportation and stress responses. Our results provide new insights into the conserved and differentiated regulatory functions of SREBP homologs in plant pathogenic fungi.	[Ruan, Ruoxin; Wang, Mingshuang; Liu, Xin; Sun, Xuepeng; Li, Hongye] Zhejiang Univ, Inst Biotechnol, Hangzhou, Zhejiang, Peoples R China; [Chung, Kuang-Ren] Natl Chung Hsing Univ, Dept Plant Pathol, Taichung, Taiwan	Zhejiang University; National Chung Hsing University	Li, HY (corresponding author), Zhejiang Univ, Inst Biotechnol, Hangzhou, Zhejiang, Peoples R China.; Chung, KR (corresponding author), Natl Chung Hsing Univ, Dept Plant Pathol, Taichung, Taiwan.	krchung@nchu.edu.tw; hyli@zju.edu.cn	Li, Hong-Ye/AAX-2736-2020; Chung, Kuang-Ren/Q-1157-2019	Li, Hong-Ye/0000-0001-7427-0706; 	National Foundation of Natural Science of China [31371961]; China Agriculture Research System [CARS-27]	National Foundation of Natural Science of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System	This study was funded by the National Foundation of Natural Science of China (31371961) and the earmarked fund for China Agriculture Research System (CARS-27). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bien CM, 2010, EUKARYOT CELL, V9, P352, DOI 10.1128/EC.00358-09; Blatzer M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002374; BUS VG, 1991, PLANT DIS, V75, P1098, DOI 10.1094/PD-75-1098; Chang YC, 2007, MOL MICROBIOL, V64, P614, DOI 10.1111/j.1365-2958.2007.05676.x; Chang YC, 2009, EUKARYOT CELL, V8, P1770, DOI 10.1128/EC.00207-09; Choi JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115034; Chung D, 2014, PLOS PATHOG, V10; Condon BJ, 2014, MOL PLANT MICROBE IN, V27, P793, DOI 10.1094/MPMI-11-13-0328-R; Cools HJ, 2011, APPL ENVIRON MICROB, V77, P3830, DOI 10.1128/AEM.00027-11; DuBois JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163849; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Eckert J, 1987, PHYTOPATHOLOGY; Espenshade PJ, 2007, GENETICS, P41; Fan JR, 2013, NEW PHYTOL, V198, P821, DOI 10.1111/nph.12193; Ghosoph JM, 2007, POSTHARVEST BIOL TEC, V44, P9, DOI 10.1016/j.postharvbio.2006.11.008; Hamamoto H, 2000, APPL ENVIRON MICROB, V66, P3421, DOI 10.1128/AEM.66.8.3421-3426.2000; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Ingavale SS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000155; Kanetis L, 2007, PLANT DIS, V91, P1502, DOI 10.1094/PDIS-91-11-1502; Kaplan CD, 2009, CHEM REV, V109, P4536, DOI 10.1021/cr9001676; KIM JB, 1995, MOL CELL BIOL, V15, P2582; Kretschmer M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000696; Lacka Izabela, 2008, Postepy Biochem, V54, P24; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Liu JC, 2015, PLOS ONE, V10; Ma HJ, 2016, INT J FOOD MICROBIOL, V236, P167, DOI 10.1016/j.ijfoodmicro.2016.08.001; Ma ZH, 2006, APPL ENVIRON MICROB, V72, P2581, DOI 10.1128/AEM.72.4.2581-2585.2006; Macarisin D, 2007, PHYTOPATHOLOGY, V97, P1491, DOI 10.1094/PHYTO-97-11-1491; Marcet-Houben M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-646; MONKS TJ, 1992, TOXICOL APPL PHARM, V112, P2, DOI 10.1016/0041-008X(92)90273-U; Nakaune R, 1998, APPL ENVIRON MICROB, V64, P3983; Priebe S, 2015, BIOINFORMATICS, V31, P445, DOI 10.1093/bioinformatics/btu627; Sanchez-Torres P, 2011, POSTHARVEST BIOL TEC, V59, P159, DOI 10.1016/j.postharvbio.2010.08.017; Sang H, 2015, MOL PLANT PATHOL, V16, P251, DOI 10.1111/mpp.12174; SANGLARD D, 1995, ANTIMICROB AGENTS CH, V39, P2378, DOI 10.1128/AAC.39.11.2378; Schnabel G, 2001, PHYTOPATHOLOGY, V91, P102, DOI 10.1094/PHYTO.2001.91.1.102; Sun XP, 2013, ENV MICROBIOL REP, V5, P135, DOI 10.1111/1758-2229.12012; Sun XP, 2011, APPL MICROBIOL BIOT, V91, P1107, DOI 10.1007/s00253-011-3355-7; vandenBrink HJM, 1996, J BIOTECHNOL, V49, P13, DOI 10.1016/0168-1656(96)01403-4; Wang JY, 2008, J ZHEJIANG UNIV-SC B, V9, P823, DOI 10.1631/jzus.B0860006; Wang MS, 2014, MICROBIOL RES, V169, P511, DOI 10.1016/j.micres.2013.12.004; Willger SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000200; YOSHIDA Y, 1987, BIOCHEM PHARMACOL, V36, P229, DOI 10.1016/0006-2952(87)90694-0; Yoshida Y, 1988, Curr Top Med Mycol, V2, P388; Zhang TY, 2013, MICROBIOL RES, V168, P211, DOI 10.1016/j.micres.2012.11.006; Zhang ZF, 2009, INT J FOOD MICROBIOL, V131, P157, DOI 10.1016/j.ijfoodmicro.2009.02.015; Zhu J, 2006, J ZHEJIANG UNIV-SC A, V7, P362, DOI DOI 10.1631/JZUS.2006.AS0362	49	20	21	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176485	10.1371/journal.pone.0176485	http://dx.doi.org/10.1371/journal.pone.0176485			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467453	Green Published, Green Submitted, gold			2022-12-26	WOS:000400647000055
J	Burall, LS; Grim, CJ; Datta, AR				Burall, Laurel S.; Grim, Christopher J.; Datta, Atin R.			A clade of Listeria monocytogenes serotype 4b variant strains linked to recent listeriosis outbreaks associated with produce from a defined geographic region in the US	PLOS ONE			English	Article							EPIDEMIC CLONES; UNITED-STATES; VIRULENCE; PREVALENCE; EVOLUTION; SEQUENCES; FOODS	Four listeriosis incidences/outbreaks, spanning 19 months, have been linked to Listeria monocytogenes serotype 4b variant (4bV) strains. Three of these incidents can be linked to a defined geographical region, while the fourth is likely to be linked. In this study, whole genome sequencing (WGS) of strains from these incidents was used for genomic comparisons using two approached. The first was JSpecies tetramer, which analyzed tetranucleotide frequency to assess relatedness. The second, the CFSAN SNP Pipeline, was used to perform WGS SNP analyses against three different reference genomes to evaluate relatedness by SNP distances. In each case, unrelated strains were included as controls. The analyses showed that strains from these incidents form a highly related clade with SNP differences of <= 101 within the clade and >9000 against other strains. Multi-Virulence-Locus Sequence Typing, a third standardized approach for evaluation relatedness, was used to assess the genetic drift in six conserved, known virulence loci and showed a different clustering pattern indicating possible differences in selection pressure experienced by these genes. These data suggest a high degree of relatedness among these 4bV strains linked to a defined geographic region and also highlight the possibility of alterations related to adaptation and virulence.	[Burall, Laurel S.; Grim, Christopher J.; Datta, Atin R.] US FDA, Ctr Food Safety & Appl Nutr, Laurel, MD 20708 USA	US Food & Drug Administration (FDA)	Burall, LS; Datta, AR (corresponding author), US FDA, Ctr Food Safety & Appl Nutr, Laurel, MD 20708 USA.	Laurel.Burall@fda.hhs.gov; Atin.Datta@fda.hhs.gov						Allard MW, 2016, J CLIN MICROBIOL, V54, P1975, DOI 10.1128/JCM.00081-16; Bergholz TM, 2016, APPL ENVIRON MICROB, V82, P928, DOI 10.1128/AEM.02440-15; Burall LS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150797; Burall LS, 2011, J FOOD PROTECT, V74, P403, DOI 10.4315/0362-028X.JFP-10-355; Cantinelli T, 2013, J CLIN MICROBIOL, V51, P3770, DOI 10.1128/JCM.01874-13; Cartwright EJ, 2013, EMERG INFECT DIS, V19, P1, DOI [10.3201/eid1901.120393, 10.3201/eid1908.121511]; CDC, 2015, MULT OUTBR LIST LINK; Chen MT, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01026; Chen Y, 2011, J BACTERIOL, V193, P3424, DOI 10.1128/JB.05048-11; Chen Y, 2015, ISOLATION ENUM UNPUB; Chen Y, 2016, APPL ENV MICROBIOL; Chen Y, 2007, J CLIN MICROBIOL, V45, P835, DOI 10.1128/JCM.01575-06; Chen Y, 2016, J FOOD PROTECT, V79, P1828, DOI 10.4315/0362-028X.JFP-16-208; Cosgrove Shaun, 2011, Morbidity and Mortality Weekly Report, V60, P1357; Davis S, 2015, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.20; Doumith M, 2004, J CLIN MICROBIOL, V42, P3819, DOI 10.1128/JCM.42.8.3819-3822.2004; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Gray MJ, 2004, APPL ENVIRON MICROB, V70, P5833, DOI 10.1128/AEM.70.10.5833-5841.2004; Hoffmann M, 2016, J INFECT DIS, V213, P502, DOI 10.1093/infdis/jiv297; Jackson BR, 2015, MMWR-MORBID MORTAL W, V64, P282; Laksanalamai P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089024; Laksanalamai P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042448; Laksanalamai P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032896; Leclercq A, 2011, INT J FOOD MICROBIOL, V147, P74, DOI 10.1016/j.ijfoodmicro.2011.03.010; Lee S, 2012, APPL ENVIRON MICROB, V78, P660, DOI 10.1128/AEM.06378-11; Leekitcharoenphon P, 2016, APPL ENVIRON MICROB, V82, P2516, DOI 10.1128/AEM.03821-15; Leong D, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00683, 10.3389/fmicb.2014.00436, 10.3389/fmicb.2014.00241]; Liu Donyou, 2008, P27, DOI 10.1201/9781420051414.ch2; Lomonaco S, 2015, INFECT GENET EVOL, V35, P172, DOI 10.1016/j.meegid.2015.08.008; Lomonaco S, 2011, APPL ENVIRON MICROB, V77, P6290, DOI 10.1128/AEM.00429-11; Milillo SR, 2009, FOOD MICROBIOL, V26, P212, DOI 10.1016/j.fm.2008.08.010; Pettengill JB, 2014, PEERJ, V2, DOI 10.7717/peerj.620; Pightling Arthur W, 2015, BMC Res Notes, V8, P748, DOI 10.1186/s13104-015-1689-4; Pightling AW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104579; Prevention CfDCa, 2015, MMWR-MORBID MORTAL W, V64, P282; Prevention CfDCa, 2015, MULT OUTBR LIST LINK; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Self JL, 2016, MMWR-MORBID MORTAL W, V65, P879, DOI 10.15585/mmwr.mm6533a6; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Vazquez-Boland JA, 2001, MICROBES INFECT, V3, P571, DOI 10.1016/S1286-4579(01)01413-7; Wilson MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146929; Yin YL, 2015, MICROBIOL RES, V175, P84, DOI 10.1016/j.micres.2015.04.002	43	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176912	10.1371/journal.pone.0176912	http://dx.doi.org/10.1371/journal.pone.0176912			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28464038	Green Published, Green Submitted, gold			2022-12-26	WOS:000400646300063
J	Gao, W; Sun, W; Yin, JF; Lv, XY; Bao, JJ; Yu, JR; Wang, LH; Jin, CY; Hu, L				Gao, Wen; Sun, Wei; Yin, Jinfeng; Lv, Xiaoyang; Bao, Jianjun; Yu, Jiarui; Wang, Lihong; Jin, Chengyan; Hu, Liang			Screening candidate microRNAs (miRNAs) in different lambskin hair follicles in Hu sheep	PLOS ONE			English	Article							LIM-DOMAIN; EXPRESSED MICRORNAS; CELL PROLIFERATION; EPITHELIAL-CELLS; SKIN DEVELOPMENT; DOWN-REGULATION; GROWTH; MORPHOGENESIS; PROTEIN; CANCER	Hu sheep lambskin is a unique white lambskin from China that exhibits three types of flower patterns, including small waves, medium waves, and large waves, with small waves considered the best quality. However, our understanding of the molecular mechanism underlying flower pattern formation in Hu sheep lambskin is limited. The aim of the present study was to further explore the relevance between candidate microRNAs (miRNAs) and developmental characteristics of hair follicles and screen miRNAs for later functional validation. Herein, we employed Illumina Hiseq 2500 to identify differentially expressed miRNAs in hair follicles of different flower patterns with small, medium, and large waves to construct a comprehensive sequence database on the mechanism of hair follicle development. Paraffin sections of lambskin tissue were prepared to assess the structure of different hair follicles. Expression levels of candidate miRNAs in different flower patterns were analyzed by relative quantitation using real-time PCR, combined with histological observation and micro-observation technologies, and the correlation between expression levels of candidate miRNAs and histological properties of hair follicles was analyzed by using SPSS 17.0. A total of 522 differentially expressed miRNAs were identified, and RNA-seq analysis detected 7,266 target genes in different groups of flower patterns. Gene ontological analysis indicated these target genes were mainly involved in cell proliferation, differentiation, growth, apoptosis, and ion transport, and 14 miRNAs, including miR-143, miR-10a, and let-7 were screened as candidate miRNAs in Hu sheep hair follicle growth and development. In the same field of vision, variance analysis showed that the number of secondary follicles in small waves was significantly larger than that in large and medium waves (P<0.01); the diameter of the primary and secondary follicles in large waves was respectively larger than those in medium and small waves (P<0.01). Combined with correlation analysis between miRNA expression and histological properties of hair follicles, highly significant differences in miRNA-143 expression levels between large and small waves were observed (P<0.01), and significant differences in the miRNA-10a expression levels between large and small waves (P<0.05) and in let-7i expression levels between large and medium waves were observed (P<0.05). Significant differences in the expression of novel miRNAs of NW_004080184.1_6326 between medium and large waves were detected (P<0.05), and highly significant differences between medium and small waves were observed (P<0.01). Highly significant differences in the expression level of NW_004080165.1_8572 between medium and large and small waves (P<0.01), in that of NW_004080181.1_3961 between medium and small waves (P<0.01), and in that of NW_004080190.1_13733 between medium and large waves were observed, whereas no significant differences in the other miRNAs among large, medium, and small waves were detected. Overall, the present study showed that miRNA-143, miRNA-10a, let-7i, NW_004080184.1_6326, NW_004080165.1_8572, NW_004080181.1_3961, and NW_004080190.1_13733 could be considered as important candidate genes, indicating these seven miRNAs may play significant roles in hair follicle growth and development in Hu sheep lambskin.	[Gao, Wen; Sun, Wei; Yin, Jinfeng; Lv, Xiaoyang; Bao, Jianjun; Yu, Jiarui; Wang, Lihong; Jin, Chengyan; Hu, Liang] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China	Yangzhou University	Sun, W (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China.	sunwei@yzu.edu.cn			Graduate Education Innovation Project of Jiangsu province of China [KYLX16_1402]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Project of Jiangsu Province Engineering Research Center of China [BM2012308]; Key Project of the National Spark Program of China [2012GA690003]; Subei Science and Technology Program of Jiangsu Province of China [BN2014003, BN2015013, BN2015014]; Project of Jiangsu Province Agricultural Science and Technology Innovation Fund [CX(14)2073]; Project of Six Peak of Talents of Jiangsu Province of China	Graduate Education Innovation Project of Jiangsu province of China; Priority Academic Program Development of Jiangsu Higher Education Institutions; Project of Jiangsu Province Engineering Research Center of China; Key Project of the National Spark Program of China; Subei Science and Technology Program of Jiangsu Province of China; Project of Jiangsu Province Agricultural Science and Technology Innovation Fund; Project of Six Peak of Talents of Jiangsu Province of China	This work was performed by the Projects of Domesticated Animals Platform of the Ministry of Science and Technology of China, the Graduate Education Innovation Project of Jiangsu province of China (KYLX16_1402), the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, the Project of Jiangsu Province Engineering Research Center of China (BM2012308), the Key Project of the National Spark Program of China (2012GA690003), the Subei Science and Technology Program of Jiangsu Province of China (BN2014003, BN2015013, BN2015014), the Project of Jiangsu Province Agricultural Science and Technology Innovation Fund (CX(14)2073) and the Project of Six Peak of Talents of Jiangsu Province of China.	Agirre X, 2008, MOL CANCER RES, V6, P1830, DOI 10.1158/1541-7786.MCR-08-0167; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Andl T, 2015, EXP DERMATOL, V24, P821, DOI 10.1111/exd.12785; Assa-Kunik E, 2007, DEVELOPMENT, V134, P1161, DOI 10.1242/dev.02800; Boras K, 2002, J BIOL CHEM, V277, P1120, DOI 10.1074/jbc.M109912200; Botchkarev VA, 2004, DIFFERENTIATION, V72, P512, DOI 10.1111/j.1432-0436.2004.07209005.x; Botchkareva NV, 2012, CELL CYCLE, V11, P468, DOI 10.4161/cc.11.3.19058; Cai Ting, 2013, Yichuan, V35, P1087, DOI 10.3724/SP.J.1005.2013.01087; Cheng R. H., 1980, J EC ANIMAL, P40; Cheung HH, 2011, ONCOGENE, V30, P3404, DOI 10.1038/onc.2011.60; Foitzik K, 1999, DEV BIOL, V212, P278, DOI 10.1006/dbio.1999.9325; Grose R, 2005, CYTOKINE GROWTH F R, V16, P179, DOI 10.1016/j.cytogfr.2005.01.003; He Xiao-Yan, 2010, Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao, V26, P1016; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Holik AZ, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0228-0; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Jiang Q., 2015, THESIS; [李长青 Li Changqing], 2005, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V36, P674; Lin TX, 2009, J UROLOGY, V181, P1372, DOI 10.1016/j.juro.2008.10.149; Liu GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077801; Liu ZD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050367; Lu Z, 2006, ONCOGENE, V25, P2920, DOI 10.1038/sj.onc.1209318; Mardaryev AN, 2010, FASEB J, V24, P3869, DOI 10.1096/fj.10-160663; Navarro A, 2011, J SURG ONCOL, V103, P411, DOI 10.1002/jso.21847; Pave A, 2014, CANCER RES, V74, P6758; Polajeva J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-378; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Santos-Sacchi J, 2011, NEUROSCI LETT, V493, P44; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Sennett R, 2012, SEMIN CELL DEV BIOL, V23, P917, DOI 10.1016/j.semcdb.2012.08.011; Shen L, 2015, TUMOR BIOL, V36, P6929, DOI 10.1007/s13277-015-3409-z; Stauffer BL, 2013, J MOL CELL CARDIOL, V57, P43, DOI 10.1016/j.yjmcc.2013.01.005; Sugihara TM, 1998, P NATL ACAD SCI USA, V95, P15418, DOI 10.1073/pnas.95.26.15418; Sum EYM, 2005, J HISTOCHEM CYTOCHEM, V53, P475, DOI 10.1369/jhc.4A6553.2005; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Takagi T, 2009, ONCOLOGY-BASEL, V77, P12, DOI 10.1159/000218166; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tang XiaoHui, 2012, Journal of Agricultural Biotechnology, V20, P1178; Tazawa H, 2011, EXPERT OPIN BIOL TH, V11, P145, DOI 10.1517/14712598.2011.542749; Timoneda O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055402; Wang N, 2004, ONCOGENE, V23, P1507, DOI 10.1038/sj.onc.1207288; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Wu BL, 2011, WORLD J GASTROENTERO, V17, P79, DOI 10.3748/wjg.v17.i1.79; Wu Jiang-Hong, 2010, Yichuan, V32, P656, DOI 10.3724/SP.J.1005.2010.00656; Wu ZY, 2014, INT J MOL SCI, V15, P9531, DOI 10.3390/ijms15069531; Yan Y, 2013, HEPATOLOGY, V57, P667, DOI 10.1002/hep.26071; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang WB, 2016, FRONT AGRIC SCI ENG, V3, P72, DOI 10.15302/J-FASE-2016089; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yi R, 2010, CELL DEATH DIFFER, V17, P229, DOI 10.1038/cdd.2009.92; Zhang L, 2013, GENE, V519, P77, DOI 10.1016/j.gene.2013.01.043; Zhang WG, 2007, OMICS, V11, P385, DOI 10.1089/omi.2006.0031; Zhang YQ, 2012, J BIOL CHEM, V287, P14851, DOI 10.1074/jbc.M111.314922; Zhu Z, 2010, DOMEST ANIM ENDOCRIN, V38, P200, DOI 10.1016/j.domaniend.2009.10.004	55	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176532	10.1371/journal.pone.0176532	http://dx.doi.org/10.1371/journal.pone.0176532			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28464030	Green Published, gold, Green Submitted			2022-12-26	WOS:000400646300030
J	Poor, HD; Kawut, SM; Liu, CY; Smith, BM; Hoffman, EA; Lima, JA; Ambale-Venkatesh, B; Michos, ED; Prince, MR; Barr, RG				Poor, Hooman D.; Kawut, Steven M.; Liu, Chia-Ying; Smith, Benjamin M.; Hoffman, Eric A.; Lima, Joao A.; Ambale-Venkatesh, Bharath; Michos, Erin D.; Prince, Martin R.; Barr, R. Graham			Pulmonary hyperinflation due to gas trapping and pulmonary artery size: The MESA COPD Study	PLOS ONE			English	Article							LEFT-VENTRICULAR MASS; VASCULAR-RESISTANCE; LUNG-VOLUMES; ATHEROSCLEROSIS COPD; MAGNETIC-RESONANCE; CHRONIC-BRONCHITIS; DISEASE; EMPHYSEMA; HYPERTENSION; PRESSURE	Background Pulmonary hypertension is associated with increased morbidity and mortality in chronic obstructive pulmonary disease (COPD). Since pulmonary artery (PA) size increases in pulmonary hypertension, we measured PA cross-sectional area using magnetic resonance imaging (MRI) to test the hypothesis that pulmonary hyperinflation due to gas trapping is associated with PA cross-sectional area in COPD. Methods The MESA COPD Study recruited participants with COPD and controls from two population- based cohort studies ages 50-79 years with 10 or more pack-years and free of clinical cardiovascular disease. Body plethysmography was performed according to standard criteria. Cardiac MRI was performed at functional residual capacity to measure the cross-sectional area of the main PA. Percent emphysema was defined as the percentage of lung voxels less than -950 Hounsfield units as assessed via x-ray computed tomography. Analyses were adjusted for age, gender, height, weight, race-ethnicity, the forced expiratory volume in one second, smoking status, pack-years, lung function, oxygen saturation, blood pressure, left ventricular ejection fraction and percent emphysema. Results Among 106 participants, mean residual volume was 1.98 +/- 0.71 L and the mean PA cross-sectional area was 7.23 +/- 1.72 cm(2). A one standard deviation increase in residual volume was independently associated with an increase in main PA cross-sectional area of 0.55 cm(2) (95% CI 0.18 to 0.92; p = 0.003). In contrast, there was no evidence for an association with percent emphysema or total lung capacity. Conclusion Increased residual volume was associated with a larger PA in COPD, suggesting that gas trapping may contribute to pulmonary hypertension in COPD.	[Poor, Hooman D.; Smith, Benjamin M.; Barr, R. Graham] Columbia Univ, Dept Med, Med Ctr, New York, NY 10027 USA; [Kawut, Steven M.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Liu, Chia-Ying; Lima, Joao A.; Ambale-Venkatesh, Bharath] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA; [Hoffman, Eric A.] Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA; [Michos, Erin D.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Prince, Martin R.] Columbia Univ, Med Ctr, Dept Radiol, New York, NY USA; [Barr, R. Graham] Columbia Univ, Med Ctr, Dept Epidemiol, New York, NY 10027 USA	Columbia University; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; University of Iowa; Johns Hopkins University; Columbia University; Columbia University	Barr, RG (corresponding author), Columbia Univ, Dept Med, Med Ctr, New York, NY 10027 USA.; Barr, RG (corresponding author), Columbia Univ, Med Ctr, Dept Epidemiol, New York, NY 10027 USA.	rgb9@cumc.columbia.edu	; Ambale Venkatesh, Bharath/F-4941-2016	Hoffman, Eric/0000-0001-8456-9437; Ambale Venkatesh, Bharath/0000-0002-2330-2373	National Institutes of Health [R01-HL093081, R01-HL077612, R01-HL075476];  [N01-HC95159-HC95169];  [UL1-RR024156]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077612, K24HL103844, R01HL093081, R01HL112986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The MESA COPD Study is supported by the National Institutes of Health R01-HL093081, R01-HL077612 and R01-HL075476. MESA is supported by N01-HC95159-HC95169 and UL1-RR024156.	Akcay M, 2010, EUR J ECHOCARDIOGR, V11, P530, DOI 10.1093/ejechocard/jeq013; Alford SK, 2010, P NATL ACAD SCI USA, V107, P7485, DOI 10.1073/pnas.0913880107; Arcasoy SM, 2003, AM J RESP CRIT CARE, V167, P735, DOI 10.1164/rccm.200210-1130OC; Balanos GM, 2003, J APPL PHYSIOL, V94, P1543, DOI 10.1152/japplphysiol.00890.2002; Barr RG, 2010, NEW ENGL J MED, V362, P217, DOI 10.1056/NEJMoa0808836; BIERNACKI W, 1989, AM REV RESPIR DIS, V139, P1509, DOI 10.1164/ajrccm/139.6.1509; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Boerrigter B, 2010, CHEST, V138, P1395, DOI 10.1378/chest.10-0363; Boerrigter BG, 2012, CHEST; BURROWS B, 1972, NEW ENGL J MED, V286, P912, DOI 10.1056/NEJM197204272861703; BUTLER J, 1988, AM REV RESPIR DIS, V138, P350, DOI 10.1164/ajrccm/138.2.350; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Chaouat A, 2005, AM J RESP CRIT CARE, V172, P189, DOI 10.1164/rccm.200401-006OC; CRAPO RO, 1982, B EUR PHYSIOPATH RES, V18, P419; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Dessap AM, 2009, INTENS CARE MED, V35, P1850, DOI 10.1007/s00134-009-1569-2; Fisher MR, 2007, EUR RESPIR J, V30, P914, DOI 10.1183/09031936.00033007; FRANK H, 1993, AM J ROENTGENOL, V161, P27, DOI 10.2214/ajr.161.1.8517315; Fuld MK, 2013, RADIOLOGY, V267, P747, DOI 10.1148/radiol.12112789; Garcia-Rio F, 2009, AM J RESP CRIT CARE, V180, P1083, DOI 10.1164/rccm.200901-0127OC; GEVENOIS PA, 1995, AM J RESP CRIT CARE, V152, P653, DOI 10.1164/ajrccm.152.2.7633722; HAKIM TS, 1982, J APPL PHYSIOL, V53, P1110, DOI 10.1152/jappl.1982.53.5.1110; HALES CA, 1985, CHEST, V88, pS235, DOI 10.1378/chest.88.4.235S; Hankinson JL, 2010, CHEST, V137, P138, DOI 10.1378/chest.09-0919; HARRIS P, 1968, CARDIOVASC RES, V2, P84, DOI 10.1093/cvr/2.1.84; Kawut SM, 2014, J AM COLL CARDIOL, V64, P2000, DOI 10.1016/j.jacc.2014.07.991; Kessler R, 1999, AM J RESP CRIT CARE, V159, P158, DOI 10.1164/ajrccm.159.1.9803117; Leith DE, 1999, EUR RESPIR J, V13, P468, DOI 10.1183/09031936.99.13246899; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; MESA-NHLBI, 2010, EX 5 FIELD CTR PROC; Mesia-Vela S, 2008, BIOMARKERS, V13, P422, DOI [10.1080/13547500802002859, 10.1080/13547500802002859 ]; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Minai OA, 2010, CHEST, V137, p39S, DOI 10.1378/chest.10-0087; OSWALDMAMMOSSER M, 1995, CHEST, V107, P1193, DOI 10.1378/chest.107.5.1193; Peinado VI, 2013, J HEART LUNG TRANSPL, V32, P1262, DOI 10.1016/j.healun.2013.09.007; Penaloza D, 2007, CIRCULATION, V115, P1132, DOI 10.1161/CIRCULATIONAHA.106.624544; Sanz J, 2007, RADIOLOGY, V243, P70, DOI 10.1148/radiol.2431060477; Sanz J, 2009, JACC-CARDIOVASC IMAG, V2, P286, DOI 10.1016/j.jcmg.2008.08.007; Scharf SM, 2002, AM J RESP CRIT CARE, V166, P314, DOI 10.1164/rccm.2107027; SCHRIJEN FV, 1989, CLIN PHYSIOL, V9, P143, DOI 10.1111/j.1475-097X.1989.tb00965.x; Sims MW, 2009, CHEST, V136, P412, DOI 10.1378/chest.08-2739; Smith BM, 2013, CHEST, V144, P1143, DOI 10.1378/chest.13-0183; Smith BM, 2013, CIRCULATION, V127, P1503, DOI 10.1161/CIRCULATIONAHA.113.001653; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Wells JM, 2012, NEW ENGL J MED, V367, P913, DOI 10.1056/NEJMoa1203830; WEST JB, 1964, J APPL PHYSIOL, V19, P713, DOI 10.1152/jappl.1964.19.4.713; Wrobel JP, 2012, J HEART LUNG TRANSPL, V31, P557, DOI 10.1016/j.healun.2012.02.029; Young AA, 2000, RADIOLOGY, V216, P597, DOI 10.1148/radiology.216.2.r00au14597; Zareian M, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0152-y	50	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176812	10.1371/journal.pone.0176812	http://dx.doi.org/10.1371/journal.pone.0176812			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28463971	Green Submitted, gold, Green Published			2022-12-26	WOS:000400646300056
J	Rueegg, CS; Gianinazzi, ME; Michel, G; Zwahlen, M; von der Weid, NX; Kuehni, CE				Rueegg, Corina S.; Gianinazzi, Micol E.; Michel, Gisela; Zwahlen, Marcel; von der Weid, Nicolas X.; Kuehni, Claudia E.		Swiss Paediat Oncology Grp SPOG	No evidence of response bias in a populationbased childhood cancer survivor questionnaire survey - Results from the Swiss Childhood Cancer Survivor Study	PLOS ONE			English	Article							ADULT SURVIVORS; NONRESPONSE BIAS; HEALTH-STATUS; FOLLOW-UP; COHORT; RATES; PARTICIPATION	Purpose This is the first study to quantify potential nonresponse bias in a childhood cancer survivor questionnaire survey. We describe early and late responders and nonresponders, and estimate nonresponse bias in a nationwide questionnaire survey of survivors. Methods In the Swiss Childhood Cancer Survivor Study, we compared characteristics of early responders (who answered an initial questionnaire), late responders (who answered after >= 1 reminder) and nonresponders. Sociodemographic and cancer-related information was available for the whole population from the Swiss Childhood Cancer Registry. We compared observed prevalence of typical outcomes in responders to the expected prevalence in a complete (100% response) representative population we constructed in order to estimate the effect of nonresponse bias. We constructed the complete population using inverse probability of participation weights. Results Of 2328 survivors, 930 returned the initial questionnaire (40%); 671 returned the questionnaire after >= 1reminder (29%). Compared to early and late responders, we found that the 727 nonresponders (31%) were more likely male, aged <20 years, French or Italian speaking, of foreign nationality, diagnosed with lymphoma or a CNS or germ cell tumor, and treated only with surgery. But observed prevalence of typical estimates (somatic health, medical care, mental health, health behaviors) was similar among the sample of early responders (40%), all responders (69%), and the complete representative population (100%). In this survey, nonresponse bias did not seem to influence observed prevalence estimates. Conclusion Nonresponse bias may play only a minor role in childhood cancer survivor studies, suggesting that results can be generalized to the whole population of such cancer survivors and applied in clinical practice.	[Rueegg, Corina S.; Michel, Gisela; Zwahlen, Marcel; Kuehni, Claudia E.] Univ Bern, Inst Social & Prevent Med, Swiss Childhood Canc Registry, Bern, Switzerland; [Rueegg, Corina S.] Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo Ctr Biostat & Epidemiol, Oslo, Norway; [Gianinazzi, Micol E.; Michel, Gisela] Univ Lucerne, Dept Hlth Sci & Hlth Policy, Luzern, Switzerland; [von der Weid, Nicolas X.] Univ Basel, Univ Childrens Hosp Basel UKBB, Paediat Hematol Oncol Unit, Basel, Switzerland; [Kuehni, Claudia E.] Univ Bern, Childrens Univ Hosp Bern, Paediat Epidemiol, Bern, Switzerland	University of Bern; University of Oslo; University of Lucerne; University of Basel; University of Bern; University Hospital of Bern	Rueegg, CS (corresponding author), Univ Bern, Inst Social & Prevent Med, Swiss Childhood Canc Registry, Bern, Switzerland.; Rueegg, CS (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo Ctr Biostat & Epidemiol, Oslo, Norway.	c.s.rueegg@medisin.uio.no	Michel, Gisela/G-1081-2018; ANSARI, Marc/V-3334-2017; Zwahlen, Marcel/AFF-8559-2022; Rueegg, Corina Silvia/H-7128-2019	Michel, Gisela/0000-0002-9589-0928; Zwahlen, Marcel/0000-0002-6772-6346; Rueegg, Corina Silvia/0000-0003-3720-4659; ansari, marc/0000-0002-9649-6498	European Union Seventh Framework Programme [609020 - Scientia Fellows]; Swiss Cancer League [KLS-2215-02-2008, LV-3220-06-2012, KLS-3412-02-2014, KLS-3644-02-2015, KLS-3886-022016]; Swiss Cancer Research [KFS-02631-08-2010, KFS-02783-02-2011]; Kinderkrebshilfe Schweiz; Swiss Paediatric Oncology Group; Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren; Swiss Cancer Research; ErnstGohner Stiftung; Federal Office of Public Health (FOPH); National Institute of Cancer Epidemiology and Registration	European Union Seventh Framework Programme(European Commission); Swiss Cancer League; Swiss Cancer Research; Kinderkrebshilfe Schweiz; Swiss Paediatric Oncology Group; Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren; Swiss Cancer Research; ErnstGohner Stiftung; Federal Office of Public Health (FOPH); National Institute of Cancer Epidemiology and Registration	CSR has received funding from the European Union Seventh Framework Programme (FP7-PEOPLE-2013-COFUND) under grant agreement no 609020 - Scientia Fellows (www.ec.europa.eu/). The Swiss Childhood Cancer Survivor Study was funded by the Swiss Cancer League (KLS-2215-02-2008, LV-3220-06-2012, KLS-3412-02-2014, KLS-3644-02-2015, KLS-3886-022016; www.krebsliga.ch/), Swiss Cancer Research (KFS-02631-08-2010, KFS-02783-02-2011; www.krebsforschung.ch/), and Kinderkrebshilfe Schweiz (www.kinderkrebshilfe.ch/). The work of the Swiss Childhood Cancer Registry is supported by the Swiss Paediatric Oncology Group (www.spog.ch/), Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren (www.gdk-cds.ch/), Swiss Cancer Research (www.krebsforschung.ch/), Kinderkrebshilfe Schweiz (www.kinderkrebshilfe.ch/), ErnstGohner Stiftung (www.ernst-goehner-stiftung.ch/), the Federal Office of Public Health (FOPH; www.bag.admin.ch/), and National Institute of Cancer Epidemiology and Registration (www.nicer.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atherton H, 2010, J EPIDEMIOL COMMUN H, V64, P580, DOI 10.1136/jech.2009.098830; Essig S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038015; Etter JF, 1997, J CLIN EPIDEMIOL, V50, P1123, DOI 10.1016/S0895-4356(97)00166-2; Frobisher C, 2010, PEDIATR BLOOD CANCER, V54, P116, DOI 10.1002/pbc.22290; Gatta G, 2009, EUR J CANCER, V45, P992, DOI DOI 10.1016/j.ejca.2008.11.04; Geddes Barbara., 1990, POLIT ANAL, V2, P131, DOI DOI 10.1093/PAN/2.1.131; Goldberg M, 2001, AM J EPIDEMIOL, V154, P373, DOI 10.1093/aje/154.4.373; Greene N, 2011, EPIDEMIOLOGY, V22, P815, DOI 10.1097/EDE.0b013e31822939fd; Groves RM, 2000, PUBLIC OPIN QUART, V64, P299, DOI 10.1086/317990; Groves RM, 2006, PUBLIC OPIN QUART, V70, P646, DOI 10.1093/poq/nfl033; Hawkins MM, 2008, PEDIATR BLOOD CANCER, V50, P1018, DOI 10.1002/pbc.21335; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hill BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065782; Hudson MM, 2003, JAMA-J AM MED ASSOC, V290, P1583, DOI 10.1001/jama.290.12.1583; Keeter S, 2006, PUBLIC OPIN QUART, V70, P759, DOI 10.1093/poq/nfl035; Korkeila K, 2001, EUR J EPIDEMIOL, V17, P991, DOI 10.1023/A:1020016922473; KRISTAL AR, 1993, PUBLIC HEALTH REP, V108, P372; Kuehni CE, 2012, INT J EPIDEMIOL, V41, P1553, DOI 10.1093/ije/dyr142; Kuehni CE, 2012, CANCER-AM CANCER SOC, V118, P1439, DOI 10.1002/cncr.26418; Michel G, 2008, PEDIATR BLOOD CANCER, V50, P46, DOI 10.1002/pbc.21129; Michel G, 2007, SWISS MED WKLY, V137, P502; Michel G, 2010, J CLIN ONCOL, V28, P1740, DOI 10.1200/JCO.2009.23.4534; Moradi T, 2010, SCAND J PUBLIC HEALT, V38, P889, DOI 10.1177/1403494810374220; Ness KK, 2010, PEDIATR BLOOD CANCER, V55, P165, DOI 10.1002/pbc.22513; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Ojha RP, 2013, PEDIATR BLOOD CANCER, V60, P856, DOI 10.1002/pbc.24348; Panczak R, 2012, J EPIDEMIOLOGY COMMU, V66, P1129; Rajmil L, 2015, AN PEDIATR, V83, P26, DOI 10.1016/j.anpedi.2014.07.017; Rebholz CE, 2012, BRIT J CANCER, V107, P234, DOI 10.1038/bjc.2012.250; Rebholz CE, 2012, PEDIATR BLOOD CANCER, V58, P256, DOI 10.1002/pbc.23289; Rebholz CE, 2011, EUR J CANCER, V47, P221, DOI 10.1016/j.ejca.2010.09.017; Reulen RC, 2007, INT J CANCER, V121, P633, DOI 10.1002/ijc.22658; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Rueegg CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034930; Savitz DA, 2003, INTERPRETING EPIDEMI; Shaw Amanda K, 2004, Chronic Dis Can, V25, P119; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Suominen S, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000657	39	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176442	10.1371/journal.pone.0176442	http://dx.doi.org/10.1371/journal.pone.0176442			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9RV	28463966	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000400646300020
J	de Oliveira, HC; Garcia, AAP; Grombonl, JGG; Farias, RV; do Nascimento, CS; Wenceslau, AA				de Oliveira, Haniel Cedraz; Pinto Garcia Junior, Antonio Amandio; Gonzaga Grombonl, Juliana Gracielle; Farias Filho, Ronaldo Vasconcelos; do Nascimento, Carlos Souza; Wenceslau, Amauri Arias			Influence of heat stress, sex and genetic groups on reference genes stability in muscle tissue of chicken	PLOS ONE			English	Article							REAL-TIME PCR; RT-PCR; HOUSEKEEPING GENES; EXPRESSION; QUANTIFICATION; PITUITARY; SELECTION	Quantitative RT-PCR is an important technique for assessing gene expression. However, a proper normalization of reference genes prior to expression analyses of target genes is necessary. The best normalizer is that gene which remains stable in all samples from different treatments. The aim of this study was to identify stable reference genes for normalization of target genes in muscle tissue from three genetically divergent chickens groups (Peloco, Cobb 500 (R) and Caneluda) under environmental (heat stress and comfort) and sex influence. Expressions of ten reference genes were tested for stability in breast muscular tissue (Pectoralis major muscle). Samples were obtained from 36 males and females of two backyard breeds (Caneluda and Peloco) and one commercial line (Cobb 500 (R)) under two environments. The heat stress and comfort temperature were 39 and 23 degrees C, respectively. Animals were housed in the Animal Science Department at Universidade Estadual do Sudoeste da Bahia. We analyzed the expression data by four statistical tools (SLqPCR, NormFinder, Bestkeeper and Comparative CT). According to these tools, genes stability varied according to sex, genetic group and environment, however, some genes remained stable in all analyzes. There was no difference between the most stable genes for sex effect, being MRPS27 more stable for both males and females. In general, MRPS27 was the most stable gene. Within the three genetic groups, the most stable genes were RPL5, HMBS and EEF1 to Cobb 500 (R), Peloco and Caneluda, respectively. Within the environment, the most stable gene under comfort and heat stress conditions was HMBS and MRPS27, respectively. BestKeeper and Comparative Ct were less correlated (28%) and SLqPCR and NormFinder were the most correlated (98%). MRPS27, RPL5 and MRPS30 genes were considered stable according the overall ranking and can be used as normalizer of relative expression of target genes in muscle tissue of chickens under heat stress.	[de Oliveira, Haniel Cedraz; Pinto Garcia Junior, Antonio Amandio; Gonzaga Grombonl, Juliana Gracielle; Wenceslau, Amauri Arias] Univ Estadual Santa Cruz, Post Grad Program Anim Sci, Ilheus, BA, Brazil; [Farias Filho, Ronaldo Vasconcelos] Univ Estadual Sudoeste Bahia, Dept Rural & Anim Technol, Campus Itapetinga UESB, Itapetinga, BA, Brazil; [do Nascimento, Carlos Souza] Univ Fed Sergipe, Dept Anim Sci, Sao Cristovao, Sergipe, Brazil	Universidade Estadual de Santa Cruz; Universidade Estadual do Sudoeste da Bahia; Universidade Federal de Sergipe	de Oliveira, HC (corresponding author), Univ Estadual Santa Cruz, Post Grad Program Anim Sci, Ilheus, BA, Brazil.	hanielcedraz@gmail.com		do Nascimento, Carlos/0000-0001-8471-4542	Fundacao de Amparo a Pesquisa no Estado da Bahia (FAPESB); Universidade Estadual de Santa Cruz (UESC); Universidade Estadual do Sudoeste da Bahia (UESB)	Fundacao de Amparo a Pesquisa no Estado da Bahia (FAPESB); Universidade Estadual de Santa Cruz (UESC); Universidade Estadual do Sudoeste da Bahia (UESB)	This study was financially supported by Fundacao de Amparo a Pesquisa no Estado da Bahia (FAPESB), Universidade Estadual de Santa Cruz (UESC) and Universidade Estadual do Sudoeste da Bahia (UESB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was financially supported by Fundacao de Amparo a Pesquisa no Estado da Bahia (FAPESB), Universidade Estadual de Santa Cruz (UESC) and Universidade Estadual do Sudoeste da Bahia (UESB).	Ahn K, 2011, GENES GENOM, V33, P245, DOI 10.1007/s13258-010-0114-6; Andersen CL, 2004, CANC RES; Bages S, 2015, GENE, V561, P82, DOI 10.1016/j.gene.2015.02.016; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Kohl M., 2010, SLQPCR FUNCTIONS ANA, P1; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Lisowski P, 2008, J APPL GENET, V49, P367, DOI 10.1007/BF03195635; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Martinez-Giner M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066023; Najafpanah MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083041; Nascimento CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127935; NCBI, 2016, REFSEQ; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Olias P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099678; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pihur V, 2007, BIOINFORMATICS, V23, P1607, DOI 10.1093/bioinformatics/btm158; Porterfield A., 2015, WHAT IS CT VALUE; Rostagno H. S., 2011, COMPOSICAO ALIMENTOS; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Team RC, 2015, LANG ENV STAT COMP; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Q, 2012, INT J LEGAL MED, V126, P943, DOI 10.1007/s00414-012-0774-7; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yang CG, 2013, GENE, V527, P183, DOI 10.1016/j.gene.2013.06.013; Zang R, 2011, ASIAN J ANIM VET ADV, V6, P789, DOI 10.3923/ajava.2011.789.804; Zheng WJ, 2011, FISH SHELLFISH IMMUN, V30, P638, DOI 10.1016/j.fsi.2010.12.014; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]; Zinzow-Kramer WM, 2014, HORM BEHAV, V66, P267, DOI 10.1016/j.yhbeh.2014.04.011	33	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176402	10.1371/journal.pone.0176402	http://dx.doi.org/10.1371/journal.pone.0176402			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459824	Green Published, Green Submitted, gold			2022-12-26	WOS:000400645000032
J	Tian, XX; Yan, CH; Liu, ML; Zhang, QY; Liu, D; Liu, YX; Li, SH; Han, YL				Tian, Xiaoxiang; Yan, Chenghui; Liu, Meili; Zhang, Quanyu; Liu, Dan; Liu, Yanxia; Li, Shaohua; Han, Yaling			CREG1 heterozygous mice are susceptible to high fat diet-induced obesity and insulin resistance	PLOS ONE			English	Article							ADIPOSE-TISSUE INFLAMMATION; LOW-GRADE INFLAMMATION; CELLULAR REPRESSOR; E1A-STIMULATED GENES; RISK-FACTOR; ACTIVATION; LIPOLYSIS; PROMOTES; OVEREXPRESSION; DYSFUNCTION	(C) under bar ellular (r) under bar epressor of (E) under bar 1A-stimulated genes 1 (CREG1) is a small glycoprotein whose physiological function is unknown. In cell culture studies, CREG1 promotes cellular differentiation and maturation. To elucidate its physiological functions, we deleted the Creg1 gene in mice and found that loss of CREG1 leads to early embryonic death, suggesting that it is essential for early development. In the analysis of Creg1 heterozygous mice, we unexpectedly observed that they developed obesity as they get older. In this study, we further studied this phenotype by feeding wild type (WT) and Creg1 heterozygote (Creg1(+/-)) mice a high fat diet (HFD) for 16 weeks. Our data showed that Creg1(+/-) mice exhibited a more prominent obesity phenotype with no change in food intake compared with WT controls when challenged with HFD. Creg1 haploinsufficiency also exacerbated HFD-induced liver steatosis, dyslipidemia and insulin resistance. In addition, HFD markedly increased pro-inflammatory cytokines in plasma and epididymal adipose tissue in Creg1(+/-) mice as compared with WT controls. The activation level of NF-kappa B, a major regulator of inflammatory response, in epididymal adipose tissue was also elevated in parallel with the cytokines in Creg1(+/-) mice. These pro-inflammatory responses elicited by CREG1 reduction were confirmed in 3T3-L1 -derived adipocytes with CREG1 depletion by siRNA transfection. Given that adipose tissue inflammation has been shown to play a key role in obesity-induced insulin resistance and metabolic syndrome, our results suggest that Creg1 haploinsufficiency confers increased susceptibility of adipose tissue to inflammation, leading to aggravated obesity and insulin resistance when challenged with HFD. This study uncovered a novel function of CREG1 in metabolic disorders.	[Tian, Xiaoxiang; Yan, Chenghui; Liu, Meili; Zhang, Quanyu; Liu, Dan; Liu, Yanxia; Han, Yaling] Gen Hosp Shenyang Mil Reg, Cardiovasc Res Inst, Shenyang, Peoples R China; [Tian, Xiaoxiang; Yan, Chenghui; Liu, Meili; Zhang, Quanyu; Liu, Dan; Liu, Yanxia; Han, Yaling] Gen Hosp Shenyang Mil Reg, Dept Cardiol, Shenyang, Peoples R China; [Tian, Xiaoxiang; Yan, Chenghui; Liu, Meili; Zhang, Quanyu; Liu, Dan; Liu, Yanxia; Han, Yaling] Cardiovasc Ctr Translat Med Liaoning Prov, Shenyang, Peoples R China; [Tian, Xiaoxiang; Yan, Chenghui; Liu, Meili; Zhang, Quanyu; Liu, Dan; Liu, Yanxia; Han, Yaling] Cardiovasc Core Lab Translat Med Liaoning Prov, Shenyang, Peoples R China; [Li, Shaohua] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Han, YL (corresponding author), Gen Hosp Shenyang Mil Reg, Cardiovasc Res Inst, Shenyang, Peoples R China.; Han, YL (corresponding author), Gen Hosp Shenyang Mil Reg, Dept Cardiol, Shenyang, Peoples R China.; Han, YL (corresponding author), Cardiovasc Ctr Translat Med Liaoning Prov, Shenyang, Peoples R China.; Han, YL (corresponding author), Cardiovasc Core Lab Translat Med Liaoning Prov, Shenyang, Peoples R China.	yalinghan@gmail.com			National Nature Science Foundation of China [81570767, 81670267, 81370243, 81570265, 81500329]; Nature Science Foundation of Liaoning Province [201602791]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province)	This work was supported by grants from the National Nature Science Foundation of China to XT (No. 81570767), YH (No. 81670267 and No. 81370243), CY (No. 81570265), QZ (No. 81500329) and the Nature Science Foundation of Liaoning Province to XT (No. 201602791). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MI, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12630; Arce-Cerezo A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14487; ARNER P, 1988, DIABETES METAB REV, V4, P507; Arner P, 2014, TRENDS ENDOCRIN MET, V25, P255, DOI 10.1016/j.tem.2014.03.002; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Bian ZY, 2009, J CELL MOL MED, V13, P1302, DOI 10.1111/j.1582-4934.2008.00633.x; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Cooke AA, 2016, EUR J PHARMACOL, V785, P207, DOI 10.1016/j.ejphar.2016.04.021; Costa M, 2016, METAB SYNDR RELAT D, V14, P449, DOI 10.1089/met.2016.0055; Di Bacco A, 2003, ONCOGENE, V22, P5436, DOI 10.1038/sj.onc.1206670; Duan Y, 2013, MOL BIOL REP, V40, P3891, DOI 10.1007/s11033-012-2373-6; Guo R, 2013, BBA-MOL BASIS DIS, V1832, P1136, DOI 10.1016/j.bbadis.2013.03.013; Han YL, 2008, CARDIOVASC RES, V78, P597, DOI 10.1093/cvr/cvn036; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Inagaki T, 2016, NAT REV MOL CELL BIO; Klil-Drori AJ, 2016, NATURE REV CLIN ONCO; Kunita R, 2002, GENOMICS, V80, P456, DOI 10.1006/geno.2002.6857; Lee BC, 2014, BBA-MOL BASIS DIS, V1842, P446, DOI 10.1016/j.bbadis.2013.05.017; Li JJ, 2015, ENDOCRINOLOGY, V156, P1283, DOI 10.1210/en.2014-1909; Li L, 2016, OBES REV, V17, P510, DOI 10.1111/obr.12407; Li Y, 2012, MED HYPOTHESES, V79, P95, DOI 10.1016/j.mehy.2012.04.011; Liu J, 2016, STEM CELLS; Lumeng CN, J CLIN INVESTIGATION, V121, P2111; Mandviwala T, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0575-4; Mitchell AB, 2015, STROKE, V46, P1690, DOI 10.1161/STROKEAHA.115.008940; Monteiro R, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/289645; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Park HK, 2015, METABOLISM, V64, P24, DOI 10.1016/j.metabol.2014.08.004; Peirce V, 2014, NATURE, V510, P76, DOI 10.1038/nature13477; Peng F, 2011, BIOCHEM BIOPH RES CO, V406, P601, DOI 10.1016/j.bbrc.2011.02.100; Piquemal D, 2002, GENOMICS, V80, P361, DOI 10.1006/geno.2002.6836; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Sacher M, 2005, P NATL ACAD SCI USA, V102, P18326, DOI 10.1073/pnas.0505071102; Schahs P, 2008, EXP CELL RES, V314, P3036, DOI 10.1016/j.yexcr.2008.06.015; Song H, 2016, BIOCH BIOPHYSICA ACT; Sun MY, 2015, J MOL CELL CARDIOL, V86, P32, DOI 10.1016/j.yjmcc.2015.07.001; Tam CS, 2013, HORM MOL BIOL CLIN I, V15, P19, DOI 10.1515/hmbci-2013-0032; Tian XX, 2014, FRONT BIOSCI-LANDMRK, V19, P1215, DOI 10.2741/4277; van der Heijden RA, 2015, AGING-US, V7, P256, DOI 10.18632/aging.100738; Veal E, 1998, MOL CELL BIOL, V18, P5032, DOI 10.1128/MCB.18.9.5032; Veal E, 2000, ONCOGENE, V19, P2120, DOI 10.1038/sj.onc.1203529; Wang N, 2011, ATHEROSCLEROSIS, V218, P543, DOI 10.1016/j.atherosclerosis.2011.08.002; Xu L, 2004, J HYPERTENS, V22, P1579, DOI 10.1097/01.hjh.0000133717.48334.cf; Yan CH, 2015, BBA-MOL BASIS DIS, V1852, P353, DOI 10.1016/j.bbadis.2014.05.027; Yan CH, 2014, FRONT BIOSCI-LANDMRK, V19, P1151, DOI 10.2741/4272; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zhang Y, 2012, HYPERTENSION, V59, P680; Zobel EH, 2016, CURR OBES REP, V5, P449, DOI 10.1007/s13679-016-0233-8	50	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176873	10.1371/journal.pone.0176873	http://dx.doi.org/10.1371/journal.pone.0176873			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459882	Green Published, gold, Green Submitted			2022-12-26	WOS:000400645000065
J	Zech, A; Wellmann, K				Zech, Astrid; Wellmann, Kai			Perceptions of football players regarding injury risk factors and prevention strategies	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; DYNAMIC POSTURAL CONTROL; FEMALE SOCCER PLAYERS; FIFA WORLD CUP; SPORTS INJURIES; ANKLE SPRAIN; PROFESSIONAL FOOTBALL; YOUTH FOOTBALL; OLYMPIC GAMES; WARM-UP	Current approaches regarding injury prevention focus on the transfer of evidence into daily practice. One promising approach is to influence attitudes and beliefs of players. The objective of this study was to record player's perceptions on injury prevention. A survey was performed among players of one German high-level football (soccer) club. 139 professional and youth players between age 13 and 35 years completed a standardized questionnaire (response rate = 98%). It included categories with (1) history of lower extremity injuries, (2) perceptions regarding risk factors and (3) regularly used prevention strategies. The majority of players (84.2%) had a previous injury. 47.5% of respondents believe that contact with other players is a risk factor, followed by fatigue (38.1%) and environmental factors (25.9%). The relevance of previous injuries as a risk factor is differently perceived between injured (25%) and uninjured players (0.0%). Nearly all players (91.5%) perform stretching to prevent injuries, followed by neuromuscular warm up exercises (54.0%). Taping is used by 40.2% of previously injured players and 13.6% of players without a history of injuries. In conclusion, the perception of risk factors and performed preventive strategies are inconsistent with scientific evidence. Future transfer strategies should incorporate the players beliefs and attitudes.	[Zech, Astrid; Wellmann, Kai] Univ Jena, Inst Sports Sci, Jena, Germany; [Wellmann, Kai] Univ Hamburg, Inst Human Movement Sci, Hamburg, Germany	Friedrich Schiller University of Jena; University of Hamburg	Zech, A (corresponding author), Univ Jena, Inst Sports Sci, Jena, Germany.	astrid.zech@uni-jena.de	Zech, Astrid/AAS-1760-2020	Zech, Astrid/0000-0001-7147-4113				Aaltonen S, 2007, ARCH INTERN MED, V167, P1585, DOI 10.1001/archinte.167.15.1585; Adams GR, 2003, J APPL PHYSIOL, V95, P2185, DOI 10.1152/japplphysiol.00346.2003; Alentorn-Geli E, 2009, KNEE SURG SPORT TR A, V17, P705, DOI 10.1007/s00167-009-0813-1; Arnason A, 2004, AM J SPORT MED, V32, p5S, DOI 10.1177/0363546503258912; Bahr R, 2005, BRIT J SPORT MED, V39, P324, DOI 10.1136/bjsm.2005.018341; Bjorneboe J, 2011, SCAND J MED SCI SPOR, V21, P713, DOI 10.1111/j.1600-0838.2009.01085.x; Carey JL, 2006, AM J SPORT MED, V34, P1911, DOI 10.1177/0363546506290186; Chomiak J, 2000, AM J SPORT MED, V28, pS58; de Noronha M, 2006, BRIT J SPORT MED, V40, P824, DOI 10.1136/bjsm.2006.029645; Dvorak J, 2011, BRIT J SPORT MED, V45, P626, DOI 10.1136/bjsm.2010.079905; Ekstrand J, 2011, BRIT J SPORT MED, V45, P553, DOI 10.1136/bjsm.2009.060582; Engebretsen L, 2013, BRIT J SPORT MED, V47, P407, DOI 10.1136/bjsports-2013-092380; Faude O, 2005, AM J SPORT MED, V33, P1694, DOI 10.1177/0363546505275011; Finch CF, 2014, BRIT J SPORT MED, V48, P718, DOI 10.1136/bjsports-2012-091797; Freckleton G, 2013, BRIT J SPORT MED, V47, P351, DOI 10.1136/bjsports-2011-090664; Frisch A, 2011, SCAND J MED SCI SPOR, V21, pE468, DOI 10.1111/j.1600-0838.2011.01369.x; Hagglund M, 2009, SCAND J MED SCI SPOR, V19, P819, DOI 10.1111/j.1600-0838.2008.00861.x; Hawkins RD, 1999, BRIT J SPORT MED, V33, P196, DOI 10.1136/bjsm.33.3.196; Hewett TE, 2012, CLIN ORTHOP RELAT R, V470, P2930, DOI 10.1007/s11999-012-2440-2; Hubscher M, 2010, MED SCI SPORT EXER, V42, P413, DOI 10.1249/MSS.0b013e3181b88d37; Hupperets MDW, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2684; Janssen KW, 2014, BRIT J SPORT MED, V48, P1235, DOI 10.1136/bjsports-2013-092947; Junge A, 2000, AM J SPORT MED, V28, pS40; Junge A, 2006, AM J SPORT MED, V34, P565, DOI 10.1177/0363546505281807; Junge A, 2015, BRIT J SPORT MED, V49, P599, DOI 10.1136/bjsports-2014-094469; Junge A, 2011, AM J SPORT MED, V39, P57, DOI 10.1177/0363546510377424; Lund J, 2004, SAFETY SCI, V42, P271, DOI 10.1016/S0925-7535(03)00045-6; McCall A, 2015, BRIT J SPORT MED, V49, P603, DOI 10.1136/bjsports-2015-094747; Meeuwisse WH, 2007, CLIN J SPORT MED, V17, P205, DOI 10.1097/JSM.0b013e318057518f; Peterson L, 2000, AM J SPORT MED, V28, pS51; Refshauge KM, 2006, BRIT J SPORT MED, V40, P8; Shrier I, 2004, CLIN J SPORT MED, V14, P267, DOI 10.1097/00042752-200409000-00004; Soderman K, 2001, KNEE SURG SPORT TR A, V9, P313, DOI 10.1007/s001670100228; Soligard T, 2010, BRIT J SPORT MED, V44, P787, DOI 10.1136/bjsm.2009.070672; Steffen K, 2013, BRIT J SPORT MED, V47, P480, DOI 10.1136/bjsports-2012-091887; Steib S, 2013, J ATHL TRAINING, V48, P203, DOI 10.4085/1062-6050-48.1.08; Tegnander A, 2008, KNEE SURG SPORT TR A, V16, P194, DOI 10.1007/s00167-007-0403-z; Thacker SB, 2004, MED SCI SPORT EXER, V36, P371, DOI 10.1249/01.MSS.0000117134.83018.F7; Van Tiggelen D, 2008, BRIT J SPORT MED, V42, P648, DOI 10.1136/bjsm.2008.046441; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Verhagen EALM, 2010, BRIT J SPORT MED, V44, P1082, DOI 10.1136/bjsm.2010.076406; Whittaker JL, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094287; WORRELL TW, 1992, J ORTHOP SPORT PHYS, V16, P12, DOI 10.2519/jospt.1992.16.1.12; Zech A, 2012, J STRENGTH COND RES, V26, P1162, DOI 10.1519/JSC.0b013e31822dfbbb	44	17	18	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176829	10.1371/journal.pone.0176829	http://dx.doi.org/10.1371/journal.pone.0176829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459845	gold, Green Published, Green Submitted			2022-12-26	WOS:000400645000062
J	Granja-Salcedo, YT; Ramirez-Uscategui, RA; Machado, EG; Messana, JD; Kishi, LT; Dias, AVL; Berchielli, TT				Granja-Salcedo, Yury Tatiana; Ramirez-Uscategui, Ricardo Andres; Guillermo Machado, Elwi; Messana, Juliana Duarte; Kishi, Luciano Takeshi; Lino Dias, Ana Veronica; Berchielli, Telma Teresinha			Studies on bacterial community composition are affected by the time and storage method of the rumen content	PLOS ONE			English	Article							RIBOSOMAL-RNA; RUMINAL BIOHYDROGENATION; MICROBIAL COMMUNITIES; METAGENOMIC ANALYSIS; DNA EXTRACTION; FERMENTATION; MICROORGANISMS; CONCENTRATE; POPULATION; DIVERSITY	The objective of this study was to investigate three storage methods and four storage times for rumen sampling in terms of quality and yield of extracted metagenomic DNA as well as the composition of the rumen bacterial community. One Nellore steer fitted with a ruminal silicone- type cannula was used as a donor of ruminal contents. The experiment comprised 11 experimental groups: pellet control (PC), lyophilized control (LC), P-20: pellet stored frozen at -20 degrees C for a period of 3, 6, and 12 months, P-80: pellet stored frozen at -80 E C for a period of 3, 6, and 12 months, and L-20: lyophilized sample stored frozen at -20 E C for a period of 3, 6, and 12 months. Metagenomic DNA concentrations were measured spectrophotometrically and fluorometrically and ion torrent sequencing was used to assess the bacterial community composition. The L-20 method could not maintain the yield of DNA during storage. In addition, the P-80 group showed a greater yield of metagenomic DNA than the other groups after 6 months of storage. Rumen samples stored as pellets (P-20 and P-80) resulted in lower richness Chao 1, ACE, and Shannon Wiener indices when compared to PC, while LC and PC were only different in richness ACE. The storage method and storage time influenced the proportions of 14 of 17 phyla identified by sequencing. In the P-20 group, the proportion of Cyanobacteria, Elusimicrobia, Fibrobacteres, Lentisphaerae, Proteobacteria, and Spirochaetes phyla identified was lower than 1%. In the P-80 group, there was an increase in the proportion of the Bacteroidetes phylum (p = 0.010); however, the proportion of Actino-bacteria, Chloroflexi, SR1, Synergistetes, TM7, and WPS. 2 phyla were unchanged compared to the PC group (p > 0.05). The class Clostridium was the most abundant in all stored groups and increased in its proportion, especially in the L-20 group. The rumen sample storage time significantly reduced the yield of metagenomic DNA extracted. Therefore, the storage method can influence the abundance of phyla, classes, and bacterial families studied in rumen samples and affect the richness and diversity index.	[Granja-Salcedo, Yury Tatiana; Messana, Juliana Duarte; Lino Dias, Ana Veronica; Berchielli, Telma Teresinha] UNESP Univ Estadual Paulista, FCAV, Dept Anim Sci, Jaboticabal, SP, Brazil; [Ramirez-Uscategui, Ricardo Andres] UNESP Univ Estadual Paulista, FCAV, Dept Clin & Vet Surg, Jaboticabal, SP, Brazil; [Guillermo Machado, Elwi] Univ Simon Bolivar, Grupo Invest Med Genom GIMEGEN, Barranquilla, Colombia; [Kishi, Luciano Takeshi] UNESP Univ Estadual Paulista, FCAV, Dept Technol, Jaboticabal, SP, Brazil; [Berchielli, Telma Teresinha] Univ Fed Vicosa, INCT CA, Dept Anim Sci, Vicosa, MG, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Federal de Vicosa	Granja-Salcedo, YT (corresponding author), UNESP Univ Estadual Paulista, FCAV, Dept Anim Sci, Jaboticabal, SP, Brazil.	yurygranja@hotmail.com	Granja Salcedo, Yury Tatiana/A-8992-2017; Uscategui, Ricardo Andres Ramirez/K-9407-2017; Berchielli, Telma T/K-7540-2012; Messana, Juliana/O-9612-2016	Granja Salcedo, Yury Tatiana/0000-0003-4783-999X; Uscategui, Ricardo Andres Ramirez/0000-0002-9760-8631; Berchielli, Telma T/0000-0002-8026-7324; Messana, Juliana/0000-0001-7462-9010; Machado Sierra, Elwi Guillermo/0000-0003-3639-1990	National Council of Technological and Scientific Development [CNPq - 475844/2012-2]; Sao Paulo Research Foundation [FAPESP - 2013/23851-6, 2015/17966-0]	National Council of Technological and Scientific Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the National Council of Technological and Scientific Development (CNPq - 475844/2012-2) and the Sao Paulo Research Foundation (FAPESP - 2013/23851-6 and 2015/17966-0).	[Anonymous], 2013, DIVERSITY-BASEL, DOI DOI 10.3390/d5030627; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen YB, 2015, POL J MICROBIOL, V64, P29; Cherdthong A, 2015, TROP ANIM HEALTH PRO, V47, P921, DOI 10.1007/s11250-015-0809-4; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Deng WD, 2008, MOL BIOL REP, V35, P265, DOI 10.1007/s11033-007-9079-1; Fernando SC, 2010, APPL ENVIRON MICROB, V76, P7482, DOI 10.1128/AEM.00388-10; Fliegerova K, 2014, ANAEROBE, V29, P80, DOI 10.1016/j.anaerobe.2013.09.015; Fouts DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048289; Geishauser T, 1996, SMALL RUMINANT RES, V21, P63, DOI 10.1016/0921-4488(95)00810-1; Granja-Salcedo YT, 2016, ARCH ANIM NUTR, V70, P17, DOI 10.1080/1745039X.2015.1117562; Henderson G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074787; Jalanka-Tuovinen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023035; Jiang SZ, 2015, J ANIM SCI, V93, P5378, DOI 10.2527/jas.2015-9547; Kirsop BE., 1991, MAINTENANCE MICROORG; Kobayashi Y, 2008, FOLIA MICROBIOL, V53, P195, DOI 10.1007/s12223-008-0024-z; Kumar S, 2012, ANALYZING MICROBES; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Ma T, 2015, J ANIM PHYSIOL AN N, V99, P676, DOI 10.1111/jpn.12264; Makkar H.P., 2005, METHODS GUT MICROBIA, VVolume 10; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; MCALLISTER TA, 1994, J ANIM SCI, V72, P3004, DOI 10.2527/1994.72113004x; McCann JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091864; Mesapogu S, 2012, ANALYZING MICROBES, P1; Messana JD, 2016, J AGR SCI-CAMBRIDGE, V154, P928, DOI 10.1017/S0021859616000204; MINATO H, 1966, J GEN APPL MICROBIOL, V12, P53, DOI 10.2323/jgam.12.53; Morgan CA, 2006, J MICROBIOL METH, V66, P183, DOI 10.1016/j.mimet.2006.02.017; Patel DD, 2014, GENE, V545, P88, DOI 10.1016/j.gene.2014.05.003; Petri RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083424; Petri RM, 2015, PLOS ONE, V9; Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6; Ransom-Jones E, 2012, MICROB ECOL, V63, P267, DOI 10.1007/s00248-011-9998-1; Ribeiro CS, 2015, J AGR SCI-CAMBRIDGE, V153, P1116, DOI 10.1017/S0021859615000337; Ribeiro CS, 2016, ARCH ANIM NUTR, V70, P402, DOI 10.1080/1745039X.2016.1206737; San Vito E, 2016, LIVEST SCI, V192, P17, DOI 10.1016/j.livsci.2016.08.011; Saro C, 2012, J ANIM SCI, V90, P4487, DOI 10.2527/jas.2012-5265; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shingfield KJ, 2012, J NUTR, V142, P1437, DOI 10.3945/jn.112.158576; Singh KM, 2014, META GENE, V2, P252, DOI 10.1016/j.mgene.2014.01.005; Singh KM, 2012, GENE, V507, P146, DOI 10.1016/j.gene.2012.07.037; de Oliveira MNV, 2013, VET MICROBIOL, V164, P307, DOI 10.1016/j.vetmic.2013.02.013; Vargas-Bello-Perez E, 2016, ANIMAL, V10, P1821, DOI 10.1017/S1751731116000756; Villegas-Rivera G, 2013, WORLD J MICROB BIOT, V29, P301, DOI 10.1007/s11274-012-1183-2; Yang SL, 2009, ANIMAL, V3, P1562, DOI 10.1017/S1751731109990462; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zhao LP, 2015, ASIAN AUSTRAL J ANIM, V28, P1433, DOI 10.5713/ajas.15.0091; Zhou YW, 2012, ANIMAL, V6, P815, DOI 10.1017/S1751731111002102; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x	49	13	13	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176701	10.1371/journal.pone.0176701	http://dx.doi.org/10.1371/journal.pone.0176701			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453579	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383900044
J	Bodmann, EL; Krett, AL; Bunemann, M				Bodmann, Eva-Lisa; Krett, Anna-Lena; Buenemann, Moritz			Potentiation of receptor responses induced by prolonged binding of G alpha(13) and leukemia-associated RhoGEF	FASEB JOURNAL			English	Article						ARHGEF12; G protein; thromboxane; FRET; Rho	NUCLEOTIDE EXCHANGE FACTOR; G-PROTEIN ACTIVATION; PDZ-RHOGEF; DYNAMICS; LARG; RHOA; OLIGOMERIZATION; IDENTIFICATION; P115-RHOGEF; EXPRESSION	Diverse cellular functions are controlled by RhoA-GTPases, which are activated by trimeric G proteins via RhoGEFs, among others. In this study, we focused on the signaling from GPCRs to RhoA via G alpha(13) and leukemia-associated RhoGEF (LARG). The activation of G alpha(13) was elucidated in living cells with high temporal and spatial resolution by means of FRET. The inactivation after agonist withdrawal occurred in the same range (t(1/2)=25.3 +/- 2.2 s; mean +/- SEM; n=22) as described for other G alpha proteins. The interaction of G alpha(13) and LARG and the thereby-induced LARG translocation to the plasma membrane were at least 1 order of magnitude more stable after agonist withdrawal, exceeding G alpha(13) deactivation in the absence of LARG several fold. Consequently, we observed an almost 100-fold higher agonist sensitivity of the G alpha(13) LARG interaction compared to the G alpha(13) activation in the absence of LARG.	[Bodmann, Eva-Lisa; Krett, Anna-Lena; Buenemann, Moritz] Philipps Univ Marburg, Dept Pharmacol & Clin Pharm, Marburg, Germany	Philipps University Marburg	Bunemann, M (corresponding author), Philipps Univ Marburg, Dept Pharmacol & Clin Pharm, Marburg, Germany.; Bunemann, M (corresponding author), Karl von Frisch Str 1, D-35043 Marburg, Germany.	moritz.buenemann@staff.uni-marburg.de		Buenemann, Moritz/0000-0002-2259-4378	U.S. National Institutes of Health, National Institute of General Medical Sciences [P41-GM103311]; Deutsche Forschungsgemeinschaft [SFB 593]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The pcDNA3-mRFP plasmid was kindly provided by Doug Golenbock (University of Massachusetts Medical School, Worcester, MA, USA), the pSRE.L was kindly provided by Barbara Moepps (Institute of Pharmacology and Toxicology, University of Ulm, Ulm, Germany), and the pHyg-LARG was a gift from T. Wieland (University of Heidelberg, Mannheim, Germany). The University of California, San Francisco (UCSF; San Francisco, CA, USA) chimera was developed by the Resource for Biocomputing, Visualization, and Informatics at UCSF (supported by U.S. National Institutes of Health, National Institute of General Medical Sciences Grant P41-GM103311). Mouse thrombocytes were kindly provided by Prof. Dr. Bernhard Nieswandt (Rudolf Virchow Research Center for Experimental Biomedicine, University of Wurzburg, Wurzburg, Germany). This work was funded by the Deutsche Forschungsgemeinschaft as part of the project A13 as part of the SFB 593. The authors declare no conflicts of interest.	Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Banerjee J, 2004, MOL BIOL CELL, V15, P1760, DOI 10.1091/mbc.E03-07-0527; Bodmann EL, 2014, BIOCHEM J, V458, P131, DOI 10.1042/BJ20130782; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Bunemann M, 2001, J BIOL CHEM, V276, P47512, DOI 10.1074/jbc.M108652200; Carter AM, 2014, J BIOL CHEM, V289, P19737, DOI 10.1074/jbc.M114.564930; Chen Z, 2012, J BIOL CHEM, V287, P25490, DOI 10.1074/jbc.M111.333716; Chikumi H, 2002, J BIOL CHEM, V277, P27130, DOI 10.1074/jbc.M204715200; Digby GJ, 2006, P NATL ACAD SCI USA, V103, P17789, DOI 10.1073/pnas.0607116103; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Doupnik CA, 1997, P NATL ACAD SCI USA, V94, P10461, DOI 10.1073/pnas.94.19.10461; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Frank M, 2005, J BIOL CHEM, V280, P24584, DOI 10.1074/jbc.M414630200; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Gohla A, 2000, CIRC RES, V87, P221, DOI 10.1161/01.RES.87.3.221; Grabocka E, 2007, MOL PHARMACOL, V72, P993, DOI 10.1124/mol.107.035162; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Kourlas PJ, 2000, P NATL ACAD SCI USA, V97, P2145, DOI 10.1073/pnas.040569197; Kreutz B, 2006, BIOCHEMISTRY-US, V45, P167, DOI 10.1021/bi051729t; Kuner R, 2002, EUR J NEUROSCI, V16, P2333, DOI 10.1046/j.1460-9568.2002.02402.x; Lutz S, 2004, N-S ARCH PHARMACOL, V369, P540, DOI 10.1007/s00210-004-0926-5; Mao JH, 1998, J BIOL CHEM, V273, P27118, DOI 10.1074/jbc.273.42.27118; Marinissen MJ, 2003, J BIOL CHEM, V278, P46814, DOI 10.1074/jbc.M305709200; Meyer BH, 2008, J CELL BIOCHEM, V104, P1660, DOI 10.1002/jcb.21732; Milde M, 2013, BIOCHEM J, V454, P515, DOI 10.1042/BJ20130554; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Moers A, 2003, NAT MED, V9, P1418, DOI 10.1038/nm943; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfreimer M, 2012, CELL SIGNAL, V24, P652, DOI 10.1016/j.cellsig.2011.10.014; Reuther GW, 2001, J BIOL CHEM, V276, P27145, DOI 10.1074/jbc.M103565200; Riobo NA, 2005, TRENDS PHARMACOL SCI, V26, P146, DOI 10.1016/j.tips.2005.01.007; Siehler S, 2009, BRIT J PHARMACOL, V158, P41, DOI 10.1111/j.1476-5381.2009.00121.x; Sivaraj KK, 2013, DEV CELL, V25, P427, DOI 10.1016/j.devcel.2013.04.008; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P733, DOI 10.1073/pnas.0234057100; Takefuji M, 2013, J EXP MED, V210, P665, DOI 10.1084/jem.20122126; Wachter RM, 1998, STRUCTURE, V6, P1267, DOI 10.1016/S0969-2126(98)00127-0; Wolters V, 2015, MOL PHARMACOL, V87, P9, DOI 10.1124/mol.114.094722; Worzfeld T, 2008, TRENDS PHARMACOL SCI, V29, P582, DOI 10.1016/j.tips.2008.08.002; Zhang L, 2009, MOL PHARMACOL, V75, P235, DOI 10.1124/mol.108.050906; Zou SY, 2016, THROMB HAEMOSTASIS, V116, P506, DOI 10.1160/TH15-11-0848	44	10	10	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3663	3676		10.1096/fj.201700026R	http://dx.doi.org/10.1096/fj.201700026R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28465324	Green Published			2022-12-26	WOS:000405932400037
J	Michelucci, A; Paolini, C; Boncompagni, S; Canato, M; Reggiani, C; Protasi, F				Michelucci, Antonio; Paolini, Cecilia; Boncompagni, Simona; Canato, Marta; Reggiani, Carlo; Protasi, Feliciano			Strenuous exercise triggers a life-threatening response in mice susceptible to malignant hyperthermia	FASEB JOURNAL			English	Article						calsequestrin-1; excitation-contraction coupling; ryanodine receptor; sarcoplasmic reticulum; skeletal muscle	SKELETAL-MUSCLE FIBERS; OPERATED CA2+ ENTRY; SARCOPLASMIC-RETICULUM; CALCIUM-RELEASE; INTRACELLULAR CALCIUM; RYANODINE RECEPTORS; OXIDATIVE STRESS; GENE-EXPRESSION; BINDING-SITES; SUDDEN-DEATH	In humans, hyperthermic episodes can be triggered by halogenated anesthetics [malignant hyperthermia (MH) susceptibility] and by high temperature [environmental heat stroke (HS)]. Correlation between MH susceptibility and HS is supported by extensive work in mouse models that carry a mutation in ryanodine receptor type-1 (RYR1(Y522S/WT)) and calsequestrin-1 knockout (CASQ1-null), 2 proteins that control Ca2+ release in skeletal muscle. As overheating episodes in humans have also been described during exertion, here we subjected RYR1(Y522S/WT) and CASQ1-null mice to an exertional-stress protocol (incremental running on a treadmill at 34 degrees C and 40% humidity). The mortality rate was 80 and 78.6% in RYR1(Y522S/WT) and CASQ1-null mice, respectively, vs. 0% in wild-type mice. Lethal crises were characterized by hyperthermia and rhabdomyolysis, classic features of MH episodes. Of importance, pretreatment with azumolene, an analog of the drug used in humans to treat MH crises, reduced mortality to 0 and 12.5% in RYR1(Y522S/WT) and CASQ1-null mice, respectively, thanks to a striking reduction of hyperthermia and rhabdomyolysis. At the molecular level, azumolene strongly prevented Ca2+-dependent activation of calpains and NF-kappa B by lowering myoplasmic Ca2+ concentration and nitro-oxidative stress, parameters that were elevated in RYR1(Y522S/WT) and CASQ1-null mice. These results suggest that common molecular mechanisms underlie MH crises and exertional HS in mice.	[Michelucci, Antonio; Paolini, Cecilia; Boncompagni, Simona; Protasi, Feliciano] Univ G dAnnunzio Chieti, Dept Neurosci Imaging & Clin Sci DNICS, Ctr Res Ageing & Translat Med CeSI MeT, Chieti, Italy; [Protasi, Feliciano] Univ G dAnnunzio Chieti, Dept Med & Aging Sci, Chieti, Italy; [Canato, Marta; Reggiani, Carlo] Univ Padua, Dept Biomed Sci, Padua, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Padua	Protasi, F (corresponding author), Univ G dAnnunzio Chieti, Ctr Res Ageing & Translat Med, CeSI MeT, I-66100 Chieti, Italy.	feliciano.protasi@unich.it	Paolini, Cecilia/AAI-4444-2021; Michelucci, Antonio/AAG-4579-2021		Italian Telethon Organizzazione non Lucrativa di Utilita Sociale (ONLUS) Foundation (Rome, Italy) [GGP13213]; U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR053349-06]; Italian Ministry of Education, University and Research (Rome, Italy) [RBFR13A20K]; Italian Ministry of Health (Rome, Italy) [GR-2011-02350912]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053349] Funding Source: NIH RePORTER	Italian Telethon Organizzazione non Lucrativa di Utilita Sociale (ONLUS) Foundation (Rome, Italy)(Fondazione Telethon); U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Italian Ministry of Education, University and Research (Rome, Italy)(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health (Rome, Italy)(Ministry of Health, Italy); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by the following grants: GGP13213 from the Italian Telethon Organizzazione non Lucrativa di Utilita Sociale (ONLUS) Foundation (Rome, Italy; to F.P. and C.R.); AR053349-06 from the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (subcontract to F.P.); RBFR13A20K from the Italian Ministry of Education, University and Research (Rome, Italy; to S.B.); and GR-2011-02350912 from the Italian Ministry of Health (Rome, Italy; to C.P.). The authors thank Dr. S. L. Hamilton (Baylor College of Medicine, Houston, TX, USA), who generated and kindly provided the RYR1<SUP>Y522S/WT</SUP> mouse line.	ADNET PJ, 1991, ANESTHESIOLOGY, V75, P413, DOI 10.1097/00000542-199109000-00006; Altamirano F, 2012, J BIOL CHEM, V287, P20876, DOI 10.1074/jbc.M112.344929; Badalamente MA, 2000, MUSCLE NERVE, V23, P106, DOI 10.1002/(SICI)1097-4598(200001)23:1<106::AID-MUS14>3.0.CO;2-D; Beard NA, 2002, BIOPHYS J, V82, P310, DOI 10.1016/S0006-3495(02)75396-4; Boncompagni S, 2009, P NATL ACAD SCI USA, V106, P21996, DOI 10.1073/pnas.0911496106; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; BOURDON L, 1995, MED HYPOTHESES, V45, P268, DOI 10.1016/0306-9877(95)90116-7; Canato M, 2010, P NATL ACAD SCI USA, V107, P22326, DOI 10.1073/pnas.1009168108; Capacchione JF, 2010, ANESTHESIOLOGY, V112, P239, DOI 10.1097/ALN.0b013e3181c29504; Carpenter D, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-104; Chelu MG, 2006, FASEB J, V20, P329, DOI 10.1096/fj.05-4497fje; Cherednichenko G, 2008, MOL PHARMACOL, V73, P1203, DOI 10.1124/mol.107.043299; Dainese M, 2009, FASEB J, V23, P1710, DOI 10.1096/fj.08-121335; Davis M, 2002, BRIT J ANAESTH, V88, P508, DOI 10.1093/bja/88.4.508; Defranchi E, 2005, MICROSC RES TECHNIQ, V67, P27, DOI 10.1002/jemt.20177; DENBOROUGH MA, 1962, BRIT J ANAESTH, V34, P395, DOI 10.1093/bja/34.6.395; DENBOROUGH MA, 1988, BRIT MED J, V296, P1442, DOI 10.1136/bmj.296.6634.1442-a; Di Blasi C, 2015, J MED GENET, V52, P617, DOI 10.1136/jmedgenet-2014-102882; Diaz-Sylvester PL, 2008, AM J PHYSIOL-CELL PH, V294, pC1103, DOI 10.1152/ajpcell.90642.2007; do Carmo PL, 2010, FUND CLIN PHARMACOL, V24, P491, DOI 10.1111/j.1472-8206.2009.00787.x; Duke AM, 2010, J BIOL CHEM, V285, P25645, DOI 10.1074/jbc.M110.104976; DUNCAN CJ, 1978, EXPERIENTIA, V34, P1531, DOI 10.1007/BF02034655; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; ELLIS FR, 1984, BRIT J ANAESTH, V56, P1267; Finsterer Josef, 2002, J Clin Neuromuscul Dis, V4, P64, DOI 10.1097/00131402-200212000-00004; FLETCHER JE, 1990, CAN J ANAESTH, V37, P695, DOI 10.1007/BF03006495; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Fruen BR, 1997, J BIOL CHEM, V272, P26965, DOI 10.1074/jbc.272.43.26965; Galli L, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9442; Glahn KPE, 2010, BRIT J ANAESTH, V105, P417, DOI 10.1093/bja/aeq243; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Groom L, 2011, ANESTHESIOLOGY, V115, P938, DOI 10.1097/ALN.0b013e3182320068; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; Henriquez-Olguin C, 2015, BBA-MOL BASIS DIS, V1852, P1410, DOI 10.1016/j.bbadis.2015.03.012; Hopkins PM, 2011, BRIT J ANAESTH, V107, P48, DOI 10.1093/bja/aer132; HOPKINS PM, 1991, LANCET, V338, P1491, DOI 10.1016/0140-6736(91)92304-K; Huang J, 1998, P NATL ACAD SCI USA, V95, P12100, DOI 10.1073/pnas.95.21.12100; JONES EW, 1972, ANESTHESIOLOGY, V36, P42, DOI 10.1097/00000542-197201000-00008; Kobayashi S, 2005, J BIOL CHEM, V280, P6580, DOI 10.1074/jbc.M408375200; Kochling A, 1998, ANAESTH INTENS CARE, V26, P315, DOI 10.1177/0310057X9802600317; Kraeva N, 2013, ANESTHESIOLOGY, V118, P344, DOI [10.1097/01.anes.0000530185.78660.da, 10.1097/ALN.0b013e318279f925]; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; LARACH MG, 1989, ANESTH ANALG, V69, P511; LEDBETTER MW, 1994, J BIOL CHEM, V269, P31544; Lehmann-Horn F, 2011, ANESTHESIOLOGY, V115, P915, DOI 10.1097/ALN.0b013e318232008f; MACLENNAN DH, 1992, SCIENCE, V256, P789, DOI 10.1126/science.1589759; Michelucci A, 2015, ANESTHESIOLOGY, V123, P603, DOI 10.1097/ALN.0000000000000748; Monnier N, 1997, AM J HUM GENET, V60, P1316, DOI 10.1086/515454; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Murphy RM, 2010, CLIN EXP PHARMACOL P, V37, P385, DOI 10.1111/j.1440-1681.2009.05310.x; NELSON TE, 1975, ANESTHESIOLOGY, V42, P301, DOI 10.1097/00000542-197503000-00011; NELSON TE, 1983, J CLIN INVEST, V72, P862, DOI 10.1172/JCI111057; NELSON TE, 1972, ANESTHESIOLOGY, V36, P52, DOI 10.1097/00000542-197201000-00009; Ogino K, 2007, ACTA MED OKAYAMA, V61, P181; Palnitkar SS, 1997, BIOCHEM J, V326, P847, DOI 10.1042/bj3260847; Paolini C, 2007, J PHYSIOL-LONDON, V583, P767, DOI 10.1113/jphysiol.2007.138024; Paolini C, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0035-9; PARNESS J, 1995, J BIOL CHEM, V270, P18465, DOI 10.1074/jbc.270.31.18465; Powers SK, 2012, CURR OPIN CLIN NUTR, V15, P240, DOI 10.1097/MCO.0b013e328352b4c2; Protasi F, 2009, J PHYSIOL-LONDON, V587, P3095, DOI 10.1113/jphysiol.2009.171967; Rando TA, 1998, NEUROMUSCULAR DISORD, V8, P14, DOI 10.1016/S0960-8966(97)00124-7; Richard I, 2000, J CELL BIOL, V151, P1583, DOI 10.1083/jcb.151.7.1583; Robinson RL, 1997, HUM MOL GENET, V6, P953, DOI 10.1093/hmg/6.6.953; Rosenberg H, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-21; Rosenberg H, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0310-1; Rossi D, 2014, HUM MUTAT, V35, P1163, DOI 10.1002/humu.22631; SCHNEIDER MF, 1994, ANNU REV PHYSIOL, V56, P463, DOI 10.1146/annurev.ph.56.030194.002335; Smuder AJ, 2010, FREE RADICAL BIO MED, V49, P1152, DOI 10.1016/j.freeradbiomed.2010.06.025; Spencer MJ, 2002, HUM MOL GENET, V11, P2645, DOI 10.1093/hmg/11.21.2645; Tidball JG, 2000, INT J BIOCHEM CELL B, V32, P1, DOI 10.1016/S1357-2725(99)00095-3; Tobin JR, 2001, JAMA-J AM MED ASSOC, V286, P168, DOI 10.1001/jama.286.2.168; Wappler F, 2001, ANESTHESIOLOGY, V94, P95, DOI 10.1097/00000542-200101000-00019; WEDEL DJ, 1995, MAYO CLIN PROC, V70, P241, DOI 10.4065/70.3.241; Wei L, 2011, FASEB J, V25, P3068, DOI 10.1096/fj.11-187252; Wu SW, 2006, BRAIN, V129, P1470, DOI 10.1093/brain/awl077; Yang TZ, 2006, ANESTHESIOLOGY, V105, P1164, DOI 10.1097/00000542-200612000-00016; Yarotskyy V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077633; Zhang YF, 2005, J PHARMACOL EXP THER, V314, P94, DOI 10.1124/jpet.105.084046; Zhao XL, 2006, J BIOL CHEM, V281, P33477, DOI 10.1074/jbc.M602306200; Zhao XL, 2010, BIOPHYS J, V99, P1556, DOI 10.1016/j.bpj.2010.06.050	80	28	29	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3649	3662		10.1096/fj.201601292R	http://dx.doi.org/10.1096/fj.201601292R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28465322	Green Published			2022-12-26	WOS:000405932400036
J	Alsop, J; Medin, J; Cornelissen, C; Vormfelde, SV; Ziemssen, T				Alsop, Jonathan; Medin, Jennie; Cornelissen, Christian; Vormfelde, Stefan Viktor; Ziemssen, Tjalf			Two studies in one: A propensity-score-matched comparison of fingolimod versus interferons and glatiramer acetate using real-world data from the independent German studies, PANGAEA and PEARL	PLOS ONE			English	Article							REMITTING MULTIPLE-SCLEROSIS; INTRAMUSCULAR INTERFERON; CLINICAL-RELEVANCE; ORAL FINGOLIMOD; BETA THERAPY; DOUBLE-BLIND; FREEDOMS II; DISEASE; NATALIZUMAB; COHORT	Background This study compared outcomes following fingolimod or BRACE treatments (beta-interferons/glatiramer acetate) in patients with active MS (>= 1 relapse in the previous year) following previous BRACE treatment. Methods and findings Patients with active MS who previously received BRACE were identified from German prospective, observational studies, PANGAEA and PEARL. A novel methodology was developed to compare outcomes between propensity-score-matched cohorts (3: 1 ratio) from the independent single-arm studies. Patients in PANGAEA (n = 1287) experienced 48% fewer relapses per year than those in PEARL (n = 429; annualized relapse rate ratio: 0.52; p < 0.001). The risk of 3-month or 6-month confirmed disability progression (CDP) was reduced in PANGAEA versus PEARL (3-month: 37% reduction; hazard ratio [HR], 0.63; p < 0.001; 6-month: 47% reduction; HR, 0.53; p < 0.001). A higher proportion of patients in PANGAEA (n = 1234) than PEARL (n = 401) were free from relapses and 3-month (65.7% vs 38.7%; p < 0.001) or 6-month (68.2% vs 39.2%; p < 0.001) CDP. The probability of confirmed disability improvement was higher in PANGAEA (n = 1163) than PEARL (n = 372; 3-month: 175% increase; HR, 2.75; p < 0.001; 6-month: 126% increase; HR, 2.26; p < 0.001). Patients in PANGAEA (n = 149) were less likely than those in PEARL (n = 307) to have taken sick leave (proportion with 0 days off work: 62.4% vs 44.6%; p = 0.0005). For change in disease severity from baseline (assessed by clinicians using the Clinical Global Impressions scale; PANGAEA, n = 1207; PEARL, n = 427), a larger proportion of patients had subjective improvement and a smaller proportion had worsening status in PANGAEA than PEARL (improvement: 28.2% vs 15.2%; worsening: 16.4% vs 30.4%; p < 0.0001). Conclusions Fingolimod appears to be more effective than BRACE in improving clinical and physician-/patient-reported outcomes in individuals with active MS.	[Alsop, Jonathan] Numerus Ltd, Wokingham, England; [Medin, Jennie] Novartis Pharma AG, Basel, Switzerland; [Cornelissen, Christian; Vormfelde, Stefan Viktor] Novartis Pharma GmbH, Nurnberg, Germany; [Ziemssen, Tjalf] Tech Univ Dresden, Carl Gustav Carus Univ Clin, Ctr Clin Neurosci, Dresden, Germany	Novartis; Novartis; Technische Universitat Dresden	Ziemssen, T (corresponding author), Tech Univ Dresden, Carl Gustav Carus Univ Clin, Ctr Clin Neurosci, Dresden, Germany.	Tjalf.Ziemssen@uniklinikum-dresden.de	Ziemssen, Tjalf/J-2017-2019	Ziemssen, Tjalf/0000-0001-8799-8202; Vormfelde, Stefan/0000-0003-4046-745X; Cornelissen, Christian/0000-0001-7983-657X	Novartis Pharma GmbH, Nuremberg, Germany; Novartis Pharma AG, Basel, Switzerland; Novartis Pharma GmbH; Novartis Pharma	Novartis Pharma GmbH, Nuremberg, Germany; Novartis Pharma AG, Basel, Switzerland; Novartis Pharma GmbH; Novartis Pharma	The funders (Novartis Pharma GmbH and Novartis Pharma AG) had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. The design of the study and the collection, analysis and interpretation of data were funded by Novartis Pharma GmbH, Nuremberg, Germany. The writing of the manuscript was funded by Novartis Pharma AG, Basel, Switzerland. Novartis Pharma GmbH provided support in the form of salaries for two authors [CC, SVV (at the time of manuscript preparation)]. Novartis Pharma AG provided support in the form of salaries for one author [JM]. One author was employed by Numerus [JA] which received funding from Novartis Pharma GmbH and Novartis Pharma AG to conduct the data analysis. The specific roles of these authors are articulated in the 'author contributions' section.; The authors take full responsibility for the content of the paper. The authors thank Dr Colin Glen, Dr Anne-Marie Couto and Dr Gemma Carter of Oxford PharmaGenesis, Oxford, UK for medical writing support, editorial assistance and collation and incorporation of comments from all authors (funded by Novartis Pharma AG, Basel, Switzerland).	Agashivala N, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-138; [Anonymous], 2008, VAL PAT REG CLIN RES; Barbin L, 2016, NEUROLOGY, V86, P771, DOI 10.1212/WNL.0000000000002395; Baroncini D, 2016, MULT SCLER J, V22, P1315, DOI 10.1177/1352458516650736; Bergvall N, 2014, MULT SCLER J, V20, P117; Bergvall N, 2013, NEUROLOGY S7, V80; Bergvall N, 2014, CURR MED RES OPIN, V30, P1461, DOI 10.1185/03007995.2014.915802; Bergvall N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088472; Bergvall N, 2013, CURR MED RES OPIN, V29, P1647, DOI 10.1185/03007995.2013.847411; Bermel RA, 2006, LANCET NEUROL, V5, P158, DOI 10.1016/S1474-4422(06)70349-0; Busner Joan, 2007, Psychiatry (Edgmont), V4, P28; Calabresi PA, 2014, LANCET NEUROL, V13, P545, DOI 10.1016/S1474-4422(14)70049-3; Carruthers RL, 2014, MULT SCLER J, V20, P1381, DOI 10.1177/1352458514535282; Castillo-Trivino T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016664; Cohen JA, 2013, J NEUROL, V260, P2023, DOI 10.1007/s00415-013-6932-0; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; De Stefano N, 2014, CNS DRUGS, V28, P147, DOI 10.1007/s40263-014-0140-z; Derwenskus J, 2011, MT SINAI J MED, V78, P161, DOI 10.1002/msj.20239; Devonshire V, 2012, LANCET NEUROL, V11, P420, DOI 10.1016/S1474-4422(12)70056-X; European Medicines Agency, 2014, GIL EPAR PROD INF; European Medicines Agency, 2013, TYS EPAR PROD INF; Filippi M, 2005, J NEUROL, V252, pV16, DOI 10.1007/s00415-005-5004-5; Fusco C, 2001, NEUROLOGY, V57, P1976, DOI 10.1212/WNL.57.11.1976; Haase R, 2016, THER ADV NEUROL DISO, V9, P250, DOI 10.1177/1756285616634247; He A, 2015, JAMA NEUROL, V72, P405, DOI 10.1001/jamaneurol.2014.4147; Kalincik T, 2015, ANN NEUROL, V77, P425, DOI 10.1002/ana.24339; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS34; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS5; Koch-Henriksen N, 2016, MULTIPLE SCLEROSIS; Kutzelnigg A, 2014, HAND CLINIC, V122, P15, DOI 10.1016/B978-0-444-52001-2.00002-9; Multiple Sclerosis International Federation, 2013, ATL OF MS DAT; Orme M, 2007, VALUE HEALTH, V10, P54, DOI 10.1111/j.1524-4733.2006.00144.x; Portaccio E, 2008, EUR NEUROL, V59, P131, DOI 10.1159/000111875; Portaccio E, 2006, MULT SCLER J, V12, P281, DOI 10.1191/135248506ms1278oa; Prosperini L, 2014, DEGENER NEUROL NEURO, V4, P75, DOI 10.2147/DNND.S42734; Reese JP, 2011, EUR NEUROL, V66, P311, DOI 10.1159/000331043; Rice GP, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002002; Pereira VCS, 2012, ARQ NEURO-PSIQUIAT, V70, P774, DOI 10.1590/S0004-282X2012001000005; Sobocki P, 2007, MULT SCLER J, V13, P1054, DOI 10.1177/1352458507077941; Sorensen H T, 1997, Int J Risk Saf Med, V10, P1, DOI 10.3233/JRS-1997-10101; Spelman T, 2013, MULT SCLER J, V19, P514; Vormfelde SV, 2016, JMIR RES PROTOC, V5, DOI 10.2196/resprot.4473; Ziemssen T, BMC MED, V14, P81; Ziemssen T, 2016, J NEUROL, V263, P1053, DOI 10.1007/s00415-015-7986-y; Ziemssen T, 2016, J NEUROL, V263, P784, DOI 10.1007/s00415-016-8058-7; Ziemssen T, 2015, MULT SCLER RELAT DIS, V4, P460, DOI 10.1016/j.msard.2015.07.007; Ziemssen T, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0342-0; Ziemssen T, 2014, J NEUROL, V261, P2101, DOI 10.1007/s00415-014-7446-0; Ziemssen T, 2013, J NEURAL TRANSM, V120, pS61, DOI 10.1007/s00702-013-1041-x; Zwibel HL, 2006, ACTA NEUROL SCAND, V113, P378, DOI 10.1111/j.1600-0404.2006.00627.x	53	15	15	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0173353	10.1371/journal.pone.0173353	http://dx.doi.org/10.1371/journal.pone.0173353			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475587	Green Submitted, Green Published, gold			2022-12-26	WOS:000400649500002
J	Ohta, M; Midorikawa, T; Hikihara, Y; Sakamoto, S; Kawakami, Y; Fukunaga, T; Kanehisa, H				Ohta, Megumi; Midorikawa, Taishi; Hikihara, Yuki; Sakamoto, Shizuo; Kawakami, Yasuo; Fukunaga, Tetsuo; Kanehisa, Hiroaki			Body mass-to-waist ratio strongly correlates with skeletal muscle volume in children	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; HIP RATIO; PREDICTION; INDEX; CIRCUMFERENCE; FAT; VALIDATION; ADIPOSITY; GIRTH	Purpose We hypothesized that body mass-to-waist ratio is strongly associated with the total-body skeletal muscle volume (SMV) in children. The purpose of the present study was to examine this hypothesis. Methods By using magnetic resonance imaging, total-body SMV (SMVMRI) was determined in 70 boys and 53 girls aged 6 to 12 years. Waist was measured at each of the level of umbilicus (Wumb) and the minimum circumference (Wmin), and the ratio of body mass to each of the two measured values was calculated (BM/Wumb and BM/Wmin, respectively). A single regression analysis was used to examine the relationships between SMVMRI and either BM/Wumb or BM/Wmin. On the basis of the obtained regression equations, SMVMRI was estimated and referred to as SMVBM/Wumb or SMVBM/Wmin. Results In both boys and girls, SMVMRI was highly correlated to BM/Wumb (r = 0.937 for boys and r = 0.939 for girls, P < 0.0001) and BM/Wmin (r = 0.915 and 0.942, P < 0.0001). R-2 and the standard error of estimate for SMVBM/Wumb were 0.878 and 706.2 cm(3), respectively, in boys and 0.882 and 825.3 cm(3), respectively, in girls, and those for SMVBM/Wmin were 0.837 and 814.0 cm(3), respectively, in boys and 0.888 and 804.1 cm(3), respectively, in girls. In both boys and girls, there were no significant differences between SMVMRI and either SMVBM/Wumb or SMVBM/Wmin, without systematic errors in Band-Altman plots. There was no significant effect of model on the absolute values of the residuals in both boys and girls. Conclusion The current results indicate that body mass-to-waist ratio can be a convenient outcome measure for assessing the total-body skeletal muscle volume in children.	[Ohta, Megumi] Chukyo Univ, Sch Int Liberal Studies, Toyota, Aichi, Japan; [Midorikawa, Taishi] JF Oberlin Univ, Coll Hlth & Welf, Machida, Tokyo, Japan; [Hikihara, Yuki] Chiba Inst Technol, Fac Engn, Narashino, Chiba, Japan; [Sakamoto, Shizuo; Kawakami, Yasuo] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Fukunaga, Tetsuo; Kanehisa, Hiroaki] Natl Inst Fitness & Sports Kanoya, Kanoya, Kagoshima, Japan	Chukyo University; Chiba Institute of Technology; Waseda University; National Institute Fitness & Sports Kanoya	Ohta, M (corresponding author), Chukyo Univ, Sch Int Liberal Studies, Toyota, Aichi, Japan.	m-ohta@lets.chukyo-u.ac.jp	Kawakami, Yasuo/AAH-3075-2022; Kawakami, Yasuo/AFM-0651-2022	Kawakami, Yasuo/0000-0003-0588-4039; Kawakami, Yasuo/0000-0003-0588-4039	JSPS KAKENHI [18800054, 22700623, 24680069]; Grants-in-Aid for Scientific Research [16K01601, 16H01870] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Support was provided by JSPS KAKENHI Grant Number 18800054, 22700623 and 24680069 [https://kaken.nii.ac.jp/].	Abe T, 2003, BRIT J SPORT MED, V37, P436, DOI 10.1136/bjsm.37.5.436; Abe T, 2014, J CLIN GERONTOL GERI, V5, P58, DOI 10.1016/j.jcgg.2014.01.006; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248; Corvalan C, 2010, AM J CLIN NUTR, V91, P166, DOI 10.3945/ajcn.2009.27547; Goran MI, 1998, INT J OBESITY, V22, P549, DOI 10.1038/sj.ijo.0800624; Hubert H, 2009, J SCI MED SPORT, V12, P449, DOI 10.1016/j.jsams.2008.05.002; KANEHISA H, 1994, INT J SPORTS MED, V15, P420, DOI 10.1055/s-2007-1021081; Kim J, 2006, AM J CLIN NUTR, V84, P1014, DOI 10.1093/ajcn/84.5.1014; Lee RC, 2000, AM J CLIN NUTR, V72, P796, DOI 10.1093/ajcn/72.3.796; Midorikawa T, 2009, BRIT J NUTR, V101, P72, DOI 10.1017/S000711450899440X; Midorikawa T, 2015, BRIT J NUTR, V114, P1209, DOI 10.1017/S0007114515002585; Nakatani M, 2016, EUR J APPL PHYSIOL, V116, P2125, DOI 10.1007/s00421-016-3464-1; Poortmans JR, 2005, MED SCI SPORT EXER, V37, P316, DOI 10.1249/01.MSS.0000152804.93039.CE; Rankinen T, 1999, INT J OBESITY, V23, P801, DOI 10.1038/sj.ijo.0800929; Sijtsma A, 2014, CLIN NUTR, V33, P311, DOI 10.1016/j.clnu.2013.05.010; Sisson SB, 2009, OBESITY, V17, P2075, DOI 10.1038/oby.2009.132; Taylor RW, 2000, AM J CLIN NUTR, V72, P490; Taylor RW, 1998, AM J CLIN NUTR, V67, P44, DOI 10.1093/ajcn/67.1.44; Wang J, 2003, AM J CLIN NUTR, V77, P379, DOI 10.1093/ajcn/77.2.379; Yang CR, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7678613	21	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177155	10.1371/journal.pone.0177155	http://dx.doi.org/10.1371/journal.pone.0177155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475638	Green Published, Green Submitted, gold			2022-12-26	WOS:000400649500052
J	Hayashida, T; Tsuchiya, K; Kikuchi, Y; Oka, S; Gatanaga, H				Hayashida, Tsunefusa; Tsuchiya, Kiyoto; Kikuchi, Yoshimi; Oka, Shinichi; Gatanaga, Hiroyuki			Emergence of CXCR4-tropic HIV-1 variants followed by rapid disease progression in hemophiliac slow progressors	PLOS ONE			English	Article							TREATMENT-NAIVE PATIENTS; REVERSE-TRANSCRIPTASE; ULTRA-DEEP; CORECEPTOR USAGE; TYPE-1 TROPISM; V3 REGION; IN-VIVO; POPULATION; MUTATIONS; AIDS	Objective The association between emergence of CXCR4-tropic HIV-1 variants (X4 variants) and disease progression of HIV-1 infection has been reported. However, it is not known whether the emergence of X4 variants is the cause or result of HIV-1 disease progression. We tried to answer this question. Design HIV-1 env sequences around the V3 region were analyzed in serially stocked samples in order to determine whether X4 variants emerged before or after the fall in CD4+ T-cell count. Methods The study subjects were five HIV-1-infected hemophiliac slow progressors. Deep sequencing around the HIV-1 env V3 region was conducted in duplicate. Tropism was predicted by geno2pheno [coreceptor] 2.5 with cutoff value of false positive ratio at <5%. When X4 variant was identified in the latest stocked sample before the introduction of antiretroviral therapy, we checked viral genotype in previously stocked samples to determine the time of emergence of X4 variants. Results Emergence of X4 variants was noted in two of the five patients when their CD4+ T-cell counts were still high. The rate of decrease of CD4+ T-cell count or of rise of HIV-1 load accelerated significantly after the emergence of X4 variants in these two cases. Phylogenetic analysis showed that these X4 variants emerged from CCR5-tropic HIV-1 viruses with several amino acid changes in the V3 region. Conclusions The emergence of X4 variants preceded HIV-1 disease progression in two hemophiliac slow progressors.	[Hayashida, Tsunefusa; Tsuchiya, Kiyoto; Kikuchi, Yoshimi; Oka, Shinichi; Gatanaga, Hiroyuki] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Oka, Shinichi; Gatanaga, Hiroyuki] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan	National Center for Global Health & Medicine - Japan; Kumamoto University	Gatanaga, H (corresponding author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan.; Gatanaga, H (corresponding author), Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan.	higatana@acc.ncgm.go.jp	Tsuchiya, Kiyoto/L-8650-2013	Tsuchiya, Kiyoto/0000-0002-8233-6653	Grant for National Center for Global Health and Medicine [28-SI-1102]; Japan Agency for Medical Research and Development (AMED) [AIDS-H26]	Grant for National Center for Global Health and Medicine; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by a Grant for National Center for Global Health and Medicine [28-SI-1102]; and a Grant from the Japan Agency for Medical Research and Development (AMED) [AIDS-H26]), which were received by HG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Archer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049602; Armenia D, 2012, J INFECT DIS, V205, P557, DOI 10.1093/infdis/jir821; Bunnik EM, 2007, J VIROL, V81, P525, DOI 10.1128/JVI.01983-06; Bunnik EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002106; CORNELISSEN M, 1995, J VIROL, V69, P1810, DOI 10.1128/JVI.69.3.1810-1818.1995; Delobel P, 2007, J CLIN MICROBIOL, V45, P1572, DOI 10.1128/JCM.02090-06; Delobel P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021655; FENYO EM, 1989, AIDS, V3, pS5, DOI 10.1097/00002030-198901001-00002; Fisher R, 2012, J VIROL, V86, P6231, DOI 10.1128/JVI.06541-11; Gibson RM, 2014, ANTIMICROB AGENTS CH, V58, P2167, DOI 10.1128/AAC.02710-13; Gorry Paul R, 2011, Curr HIV/AIDS Rep, V8, P45, DOI 10.1007/s11904-010-0069-x; Hayashida T, 2016, J ANTIMICROB CHEMOTH, V71, P2760, DOI 10.1093/jac/dkw224; Hazenberg MD, 2003, AIDS, V17, P1419, DOI 10.1097/00002030-200307040-00001; Hedskog C, 2013, AIDS RES HUM RETROV, V29, P1237, DOI [10.1089/aid.2012.0349, 10.1089/AID.2012.0349]; Ida S, 1997, AIDS RES HUM RETROV, V13, P1597, DOI 10.1089/aid.1997.13.1597; JI JP, 1994, VIROLOGY, V199, P323, DOI 10.1006/viro.1994.1130; Knoepfel SA, 2011, J VIROL METHODS, V171, P329, DOI 10.1016/j.jviromet.2010.11.016; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Lee GQ, 2013, AIDS RES HUM RETROV, V29, P979, DOI [10.1089/aid.2012.0338, 10.1089/AID.2012.0338]; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Messiaen P, 2012, VIROLOGY, V426, P7, DOI 10.1016/j.virol.2012.01.002; Ministry of Health Labour And Welfare, 2016, NAT SURV COAG DIS 20; Mohamed S, 2014, AIDS, V28, P1315, DOI 10.1097/QAD.0000000000000267; Mortier V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080259; Naganawa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003206; Naif HM, 2013, INFECT DIS REP, V5, P26, DOI 10.4081/idr.2013.s1.e6; Poon AFY, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002753; Pou C, 2014, CLIN INFECT DIS, V59, P578, DOI 10.1093/cid/ciu287; Poveda E, 2012, AIDS REV, V14, P208; PRATT RD, 1995, J INFECT DIS, V172, P851, DOI 10.1093/infdis/172.3.851; Raymond S, 2011, AIDS, V25, P1668, DOI 10.1097/QAD.0b013e3283498305; Raymond S, 2010, AIDS, V24, P2305, DOI 10.1097/QAD.0b013e32833e50bb; Saliou A, 2011, ANTIMICROB AGENTS CH, V55, P2831, DOI 10.1128/AAC.00091-11; Shepherd JC, 2008, J INFECT DIS, V198, P1104, DOI 10.1086/591623; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; Telenti A, 2014, NATURE, V511, P537, DOI 10.1038/nature13517; TERSMETTE M, 1989, LANCET, V1, P983; Tsibris AMN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005683; Tsuchiya K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02389; Vandekerckhove LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4; Verhofstede C, 2012, CURR OPIN HIV AIDS, V7, P432, DOI 10.1097/COH.0b013e328356f6f2; Waters L, 2008, CLIN INFECT DIS, V46, P1617, DOI 10.1086/587660; Yin L, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-108	45	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177033	10.1371/journal.pone.0177033	http://dx.doi.org/10.1371/journal.pone.0177033			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472121	Green Published, gold, Green Submitted			2022-12-26	WOS:000400648500125
J	Hinz, L; Ahles, A; Ruprecht, B; Kuster, B; Engelhardt, S				Hinz, Laura; Ahles, Andrea; Ruprecht, Benjamin; Kuester, Bernhard; Engelhardt, Stefan			Two serines in the distal C-terminus of the human beta(1)-adrenoceptor determine beta-arrestin2 recruitment	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; BETA-ARRESTIN-BINDING; BIOSENSORS REVEAL; KINASE-A; PHOSPHORYLATION; ACTIVATION; INTERNALIZATION; VARIANTS; ADRENOCEPTORS; PHARMACOLOGY	G protein-coupled receptors (GPCRs) undergo phosphorylation at several intracellular residues by G protein-coupled receptor kinases. The resulting phosphorylation pattern triggers arrestin recruitment and receptor desensitization. The exact sites of phosphorylation and their function remained largely unknown for the human beta(1)-adrenoceptor (ADRB1), a key GPCR in adrenergic signal transduction and the target of widely used drugs such as beta-blockers. The present study aimed to identify the intracellular phosphorylation sites in the ADRB1 and to delineate their function. The human ADRB1 was expressed in HEK293 cells and its phosphorylation pattern was determined by mass spectrometric analysis before and after stimulation with a receptor agonist. We identified a total of eight phosphorylation sites in the receptor's third intracellular loop and C-terminus. Analyzing the functional relevance of individual sites using phosphosite-deficient receptor mutants we found phosphorylation of the ADRB1 at Ser461/Ser462 in the distal part of the C-terminus to determine beta-arrestin2 recruitment and receptor internalization. Our data reveal the phosphorylation pattern of the human ADRB1 and the site that mediates recruitment of beta-arrestin2.	[Hinz, Laura; Ahles, Andrea; Engelhardt, Stefan] Tech Univ Munich, Inst Pharmacol & Toxicol, Munich, Germany; [Ruprecht, Benjamin; Kuester, Bernhard] Tech Univ Munich, Chair Prote & Bioanalyt, Freising Weihenstephan, Germany; [Ruprecht, Benjamin; Kuester, Bernhard] Ctr Prot Sci Munich CIPSM, Freising Weihenstephan, Germany; [Kuester, Bernhard] German Canc Consortium DKTK, Heidelberg, Germany; [Kuester, Bernhard] German Canc Res Ctr, Heidelberg, Germany; [Kuester, Bernhard] Tech Univ Munich, Bavarian Biomol Mass Spectrometry Ctr, Freising Weihenstephan, Germany; [Engelhardt, Stefan] German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany	Technical University of Munich; Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance	Ahles, A; Engelhardt, S (corresponding author), Tech Univ Munich, Inst Pharmacol & Toxicol, Munich, Germany.; Engelhardt, S (corresponding author), German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany.	andrea.ahles@tum.de; stefan.engelhardt@tum.de	Engelhardt, Stefan/AAA-9329-2019	Engelhardt, Stefan/0000-0001-5378-8661	Deutsche Forschungsgemeinschaft (DEG); Bundesministerium fOr Bildung und Forschung (BMBF); Otto-Hess-Scholarship from the German Cardiac Society (DGK)	Deutsche Forschungsgemeinschaft (DEG)(German Research Foundation (DFG)); Bundesministerium fOr Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Otto-Hess-Scholarship from the German Cardiac Society (DGK)	The research was supported by grants of the Deutsche Forschungsgemeinschaft (DEG) and the Bundesministerium fOr Bildung und Forschung (BMBF). Laura Hinz received the Otto-Hess-Scholarship from the German Cardiac Society (DGK).	Ahles A, 2015, J BIOL CHEM, V290, P1760, DOI 10.1074/jbc.M114.607333; Ahles A, 2014, PHARMACOL REV, V66, P598, DOI 10.1124/pr.113.008219; Alvarez-Curto E, 2016, J BIOL CHEM, V291, P27147, DOI 10.1074/jbc.M116.754887; ANDERSSON L, 1986, ANAL BIOCHEM, V154, P250, DOI 10.1016/0003-2697(86)90523-3; Boucrot E, 2015, NATURE, V517, P460, DOI 10.1038/nature14067; Buitrago M, 2005, NAT MED, V11, P837, DOI 10.1038/nm1272; Chen Q, 2014, ARRESTINS PHARM THER; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Eichel K, 2016, NAT CELL BIOL, V18, P303, DOI 10.1038/ncb3307; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Evans BA, 2010, BRIT J PHARMACOL, V159, P1022, DOI 10.1111/j.1476-5381.2009.00602.x; FREEDMAN NJ, 1995, J BIOL CHEM, V270, P17953, DOI 10.1074/jbc.270.30.17953; Gardner LA, 2004, J BIOL CHEM, V279, P21135, DOI 10.1074/jbc.M313652200; Gavi S, 2007, ENDOCRINOLOGY, V148, P2653, DOI 10.1210/en.2006-1569; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Hakalahti AE, 2013, MOL PHARMACOL, V83, P129, DOI 10.1124/mol.112.080440; Insel PA, 2007, BBA-BIOMEMBRANES, V1768, P994, DOI 10.1016/j.bbamem.2006.09.029; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Kettenbach AN, 2011, ANAL CHEM, V83, P7635, DOI 10.1021/ac201894j; Klotz KN, 1998, N-S ARCH PHARMACOL, V357, P1; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; Laporte SA, 2002, J BIOL CHEM, V277, P9247, DOI 10.1074/jbc.M108490200; Lee MH, 2016, NATURE, V531, P665, DOI 10.1038/nature17154; Lefkowitz RJ, 2013, ANGEW CHEM INT EDIT, V52, P6366, DOI 10.1002/anie.201301924; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Liang W, 2003, J BIOL CHEM, V278, P39773, DOI 10.1074/jbc.M304482200; Lymperopoulos A, 2013, CIRC RES, V113, P739, DOI 10.1161/CIRCRESAHA.113.300308; McCrink KA, 2016, PHARMACOGENOMICS, V17, P1611, DOI 10.2217/pgs-2016-0094; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Nooh MM, 2014, J BIOL CHEM, V289, P2277, DOI 10.1074/jbc.M113.513481; Nuber S, 2016, NATURE, V531, P661, DOI 10.1038/nature17198; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Orpana AK, 2012, ANAL CHEM, V84, P2081, DOI 10.1021/ac300040j; Ostermaier MK, 2014, CURR OPIN STRUC BIOL, V29, P143, DOI 10.1016/j.sbi.2014.07.006; Patel PA, 2008, CIRC J, V72, P1725, DOI 10.1253/circj.CJ-08-0734; Prihandoko R, 2016, MOL PHARMACOL, V89, P505, DOI 10.1124/mol.115.101949; Rapacciuolo A, 2003, J BIOL CHEM, V278, P35403, DOI 10.1074/jbc.M305675200; Ruprecht B, 2016, PROTEOMICS, V16, P1447, DOI 10.1002/pmic.201500523; Salon JA, 2011, PHARMACOL REV, V63, P901, DOI 10.1124/pr.110.003350; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Smith JS, 2016, J BIOL CHEM; Tilley DG, 2009, J BIOL CHEM, V284, P20375, DOI 10.1074/jbc.M109.005793; VANBIESEN T, 1995, NATURE, V376, P781, DOI 10.1038/376781a0; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; Zindel D, 2015, MOL PHARMACOL, V87, P349, DOI 10.1124/mol.114.095422	49	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176450	10.1371/journal.pone.0176450	http://dx.doi.org/10.1371/journal.pone.0176450			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472170	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500047
J	Kim, GR; Choi, JS; Han, BK; Ko, EY; Ko, ES; Hahn, SY				Kim, Ga Ram; Choi, Ji Soo; Han, Boo-Kyung; Ko, Eun Young; Ko, Eun Sook; Hahn, Soo Yeon			Combination of shear-wave elastography and color Doppler: Feasible method to avoid unnecessary breast excision of fibroepithelial lesions diagnosed by core needle biopsy	PLOS ONE			English	Article							PHYLLODES TUMORS; HISTOLOGICAL FEATURES; US; FIBROADENOMA; SPECIFICITY; PROGRESSION; SONOGRAPHY	Background We evaluated shear-wave elastography (SWE) and color Doppler ultrasonography (US) features for fibroepithelial lesions (FELs), and to evaluate their utility to differentiate fibroadenomas (FAs) and phyllodes tumors (PTs). Methods This retrospective study included 67 FELs pathologically confirmed (49 FAs, 18 PTs). B-mode US, SWE and color Doppler US were performed for each lesion. Mean elasticity (E-mean), maximum elasticity (E-max), and vascularity were determined by SWE and Doppler US. Diagnostic performances were calculated to differentiate FAs and PTs. Equivocal FELs diagnosed by core needle biopsy (CNB) were further analyzed. Results Median E-mean and E-max were significantly lower for FAs than PTs (E-mean, 15.7 vs. 66.7 kPa; E-max, 21.0 vs. 76.7 kPa, P<0.01). Low vascularity (0-1 vessel flow) on color Doppler US were more frequent in FAs than in PTs (P<0.01). SWE showed significantly higher specificities (E-mean >43.9 kPa, 89.8%; E-max >46.1 kPa, 79.6%) than B-mode US (42.9%) (P<0.01) for differentiating PTs from FAs. Other diagnostic values of SWE and overall diagnostic values of Doppler US were not significantly different from B-mode US (P>0.05). The combination of SWE and Doppler US with 'E-mean>43.9 kPa or high vascularity (>= 2 vessel flows)' showed a higher area under the curve (0.786 vs. 0.687) and higher diagnostic values than B-mode US (sensitivity, 100 vs. 94.4%; specificity, 57.1 vs. 42.9%; positive predictive value, 46.2 vs. 37.8%; negative predictive value, 100 vs. 95.5%), without statistical significance (P>0.05). Of the 30 equivocal FELs, all lesions with 'E-mean <= 43.9 kPa and low vascularity (0-1 vessel flow)' (23.3%, 7/30) were finally confirmed as FAs by excision. Conclusion FAs have a tendency to have less stiffness and lower vascularity than PTs. Combined SWE and color Doppler US may help patients with equivocal FELs diagnosed by CNB avoid unnecessary excision.	[Kim, Ga Ram; Choi, Ji Soo; Han, Boo-Kyung; Ko, Eun Young; Ko, Eun Sook; Hahn, Soo Yeon] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Radiol, Seoul, South Korea; [Kim, Ga Ram] Inha Univ, Inha Univ Hosp, Dept Radiol, Incheon, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Inha University; Inha University Hospital	Choi, JS (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Radiol, Seoul, South Korea.	jisoo.choi@samsung.com						Adamietz BR, 2011, ULTRASCHALL MED, V32, P67, DOI 10.1055/s-0031-1282024; Bae JS, 2017, EUR RADIOL, V27, P7, DOI 10.1007/s00330-016-4359-6; Ben hassouna J, 2006, AM J SURG, V192, P141, DOI 10.1016/j.amjsurg.2006.04.007; BENNETT BM, 1972, BIOMETRICS, V28, P793, DOI 10.2307/2528763; Berg WA, 2012, RADIOLOGY, V262, P435, DOI 10.1148/radiol.11110640; Blanco AJ, 1999, EUR RADIOL, V9, P356, DOI 10.1007/s003300050680; Chao TC, 2003, EUR RADIOL, V13, P88, DOI 10.1007/s00330-002-1370-x; Chao TC, 2002, ULTRASOUND OBST GYN, V20, P64, DOI 10.1046/j.1469-0705.2002.00736.x; Choi JS, 2016, EUR RADIOL, V26, P3542, DOI 10.1007/s00330-015-4201-6; Choi J, 2012, PATHOL INT, V62, P120, DOI 10.1111/j.1440-1827.2011.02761.x; Ciatto S, 2007, BREAST CANCER RES TR, V101, P291, DOI 10.1007/s10549-006-9289-6; D'Orsi CJ., 2013, ACR BI RADS ATLAS BR; Duman L, 2016, BREAST CARE, V11, P123, DOI 10.1159/000444377; Jacklin RK, 2006, J CLIN PATHOL, V59, P454, DOI 10.1136/jcp.2005.025866; Jacobs TW, 2005, AM J CLIN PATHOL, V124, P342, DOI 10.1309/5N2C4N5XCV8XW8JL; Karim RZ, 2013, J CLIN PATHOL, V66, P496, DOI 10.1136/jclinpath-2012-201082; KEELAN PA, 1992, HUM PATHOL, V23, P1048, DOI 10.1016/0046-8177(92)90268-8; Kim EK, 2008, AM J ROENTGENOL, V190, P1209, DOI 10.2214/AJR.07.3259; Kuijper A, 2002, J PATHOL, V197, P575, DOI 10.1002/path.1161; Lee AHS, 2007, HISTOPATHOLOGY, V51, P336, DOI 10.1111/j.1365-2559.2007.02786.x; Lee SH, 2014, RADIOLOGY, V273, P61, DOI 10.1148/radiol.14132443; Li LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085257; MCNICHOLAS MMJ, 1993, AM J ROENTGENOL, V161, P765, DOI 10.2214/ajr.161.4.8372754; Mishra SP, 2013, ISRN SURG, V2013, DOI [DOI 10.1155/2013/361469, 10.1155/2013/361469]; NOGUCHI S, 1995, CANCER, V76, P1779, DOI 10.1002/1097-0142(19951115)76:10<1779::AID-CNCR2820761015>3.0.CO;2-0; Ozdemir A, 2001, J ULTRAS MED, V20, P1091; Ozdemir A, 2001, J ULTRAS MED, V20, P1102; Park HL, 2012, J BREAST CANCER, V15, P224, DOI 10.4048/jbc.2012.15.2.224; Raza S, 1997, RADIOLOGY, V203, P164, DOI 10.1148/radiology.203.1.9122386; Resetkova E, 2010, BREAST J, V16, P573, DOI 10.1111/j.1524-4741.2010.01013.x; ROWELL MD, 1993, AM J SURG, V165, P376, DOI 10.1016/S0002-9610(05)80849-9; Simsir A, 2012, DIAGN CYTOPATHOL, V40, P262, DOI 10.1002/dc.21630; Skerl K, 2015, CLIN RADIOL, V70, P1421, DOI 10.1016/j.crad.2015.08.010; Tan PH, 2013, J CLIN PATHOL, V66, P465, DOI 10.1136/jclinpath-2012-201078; Wiratkapun C, 2014, DIAGN INTERV RADIOL, V20, P27, DOI 10.5152/dir.2013.13133; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	36	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0175380	10.1371/journal.pone.0175380	http://dx.doi.org/10.1371/journal.pone.0175380			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472030	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500010
J	Rame, M; Caudal, D; Schenker, E; Svenningsson, P; Spedding, M; Jay, TM; Godsil, BP				Rame, Marion; Caudal, Dorian; Schenker, Esther; Svenningsson, Per; Spedding, Michael; Jay, Therese M.; Godsil, Bill P.			Clozapine counteracts a ketamine-induced depression of hippocampal-prefrontal neuroplasticity and alters signaling pathway phosphorylation	PLOS ONE			English	Article							METHYL-D-ASPARTATE; NMDA RECEPTOR BLOCKADE; FUNCTIONAL CONNECTIVITY; SYNAPTIC PLASTICITY; PSYCHOTIC SYMPTOMS; AMPA-RECEPTOR; CORTEX; RAT; DOPAMINE; STRESS	Single sub-anesthetic doses of ketamine can exacerbate the symptoms of patients diagnosed with schizophrenia, yet similar ketamine treatments rapidly reduce depressive symptoms in major depression. Acute doses of the atypical antipsychotic drug clozapine have also been shown to counteract ketamine-induced psychotic effects. In the interest of understanding whether these drug effects could be modeled with alterations in neuroplasticity, we examined the impact of acutely-administered ketamine and clozapine on in vivo long-term potentiation (LTP) in the rat's hippocampus-to-prefrontal cortex (H-PFC) pathway. We found that a low dose of ketamine depressed H-PFC LTP, whereas animals that were co-administrated the two drugs displayed LTP that was similar to a saline-treated control. To address which signaling molecules might mediate such effects, we also examined phosphorylation and total protein levels of GSK3 beta, GluA1, TrkB, ERK, and mTOR in prefrontal and hippocampal sub-regions. Among the statistically significant effects that were detected (a) both ketamine and clozapine increased the phosphorylation of Ser9-GSK3 beta throughout the prefrontal cortex and of Ser2481-mTOR in the dorsal hippocampus (DH), (b) clozapine increased the phosphorylation of Ser831-GluA1 throughout the prefrontal cortex and of Ser845-GluA1 in the ventral hippocampus, (c) ketamine treatment increased the phosphorylation of Thr202/ Tyr204-ERK in the medial PFC (mPFC), and (d) clozapine treatment was associated with decreases in the phosphorylation of Tyr705-TrkB in the DH and of Try816-TrkB in the mPFC. Further analyses involving phosphorylation effect sizes also suggested Ser831-GluA1 in the PFC displayed the highest degree of clozapine-responsivity relative to ketamine. These results provide evidence for how ketamine and clozapine treatments affect neuroplasticity and signaling pathways in the stress-sensitive H-PFC network. They also demonstrate the potential relevance of H-PFC pathway neuroplasticity for modeling ketamine-clozapine interactions in regards to psychosis.	[Rame, Marion; Jay, Therese M.; Godsil, Bill P.] Ctr Psychiat & Neurosci, INSERM, Lab Physiopathol Malad Psychiat, UMR S894, Paris, France; [Rame, Marion; Jay, Therese M.; Godsil, Bill P.] Sorbonne Paris Cite, Univ Paris Descartes, Paris, France; [Caudal, Dorian; Svenningsson, Per] Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Stockholm, Sweden; [Schenker, Esther; Spedding, Michael] Inst Rech Servier, Croissy Sur Seine, France; [Spedding, Michael] Spedding Res Solut SAS, Le Vesinet, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet; Servier; Institut de Recherches Internationales Servier	Godsil, BP (corresponding author), Ctr Psychiat & Neurosci, INSERM, Lab Physiopathol Malad Psychiat, UMR S894, Paris, France.; Godsil, BP (corresponding author), Sorbonne Paris Cite, Univ Paris Descartes, Paris, France.	bp.godsil@gmail.com	Spedding, Michael/AAE-7342-2019; Jay, Therese M/G-2297-2015; Svenningsson, Per JL/K-5210-2014	Spedding, Michael/0000-0002-1248-8221; Jay, Therese M/0000-0002-2468-1141; Caudal, Dorian/0000-0003-4288-3801; Godsil, Bill/0000-0001-7248-4292	Innovative Medicines Initiative Joint Undertaking (IMI) [115008]; INSERM; University Paris Descartes; La Fondation Deniker; Servier	Innovative Medicines Initiative Joint Undertaking (IMI); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Paris Descartes; La Fondation Deniker; Servier(Servier)	The research leading to these results was carried out as part of the Innovative Medicines Initiative Joint Undertaking (IMI) under Grant Agreement No 115008. IMI is a public-private partnership between the European Union and the European Federation of Pharmaceutical Industries and Associations. http://www.newmeds-europe.com/. The Karolinska Institute and Servier were partners in NEWMEDS and Servier was subcontracting TMJ. Part of the present study was financed as in-cash-contributions by Servier. These in-cash contributions went to TMJ and PS. Additional support came from grants from INSERM, University Paris Descartes, and La Fondation Deniker. The funders provided support in the form of salaries for authors MR, DC, and BPG. ES is a full-time employee of Servier. MS was a full-time employee of Servier and is now a consultant (Spedding Research Solutions SAS). The specific roles of these authors are articulated in the 'author contributions' section.	Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Adler CM, 1999, AM J PSYCHIAT, V156, P1646, DOI 10.1176/ajp.156.10.1646; Ahs F, 2015, NEUROIMAGE, V122, P262, DOI 10.1016/j.neuroimage.2015.07.051; Amargos-Bosch M, 2006, INT J NEUROPSYCHOPH, V9, P565, DOI 10.1017/S1461145705005900; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beurel E, 2011, MOL PSYCHIATR, V16, P1068, DOI 10.1038/mp.2011.47; Blot K, 2015, CEREB CORTEX, V25, P1348, DOI 10.1093/cercor/bht329; Bunzow JR, 1991, CLONING GENE HUMAN D; Carreno FR, 2016, MOL PSYCHIATR, V21, P1298, DOI 10.1038/mp.2015.176; Caudal D, 2016, CELLULAR MOL NEUROBI; Cerqueira JJ, 2007, J NEUROSCI, V27, P2781, DOI 10.1523/JNEUROSCI.4372-06.2007; Chen L, 2002, J NEUROPHYSIOL, V87, P2324, DOI 10.1152/jn.2002.87.5.2324; Coe R., 2002, STUPID WHAT EFFECT S; Corcoran C, 2003, SCHIZOPHRENIA BULL, V29, P671, DOI 10.1093/oxfordjournals.schbul.a007038; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; Duman RS, 2012, NEUROPHARMACOLOGY, V62, P35, DOI 10.1016/j.neuropharm.2011.08.044; Duncan GE, 1998, BRAIN RES, V812, P65, DOI 10.1016/S0006-8993(98)00926-3; Freyberg Z, 2010, AM J PSYCHIAT, V167, P388, DOI 10.1176/appi.ajp.2009.08121873; Gao WJ, 2007, J NEUROPHYSIOL, V97, P1196, DOI 10.1152/jn.00400.2006; Gass N, 2014, NEUROPSYCHOPHARMACOL, V39, P895, DOI 10.1038/npp.2013.290; Godsil BP, 2013, EUR NEUROPSYCHOPHARM, V23, P1165, DOI 10.1016/j.euroneuro.2012.10.018; Grimm O, 2015, PSYCHOPHARMACOLOGY, V232, P4231, DOI 10.1007/s00213-015-4022-y; Hadley JA, 2014, NEUROPSYCHOPHARMACOL, V39, P1020, DOI 10.1038/npp.2013.305; Homayoun H, 2007, J NEUROSCI, V27, P11496, DOI 10.1523/JNEUROSCI.2213-07.2007; Hudson MR, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.51; JAY TM, 1991, J COMP NEUROL, V313, P574, DOI 10.1002/cne.903130404; JAY TM, 1995, EUR J NEUROSCI, V7, P247, DOI 10.1111/j.1460-9568.1995.tb01060.x; Jin J, 2015, SCI REPORTS, P5; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kamiyama H, 2011, NEUROSCIENCE, V177, P159, DOI 10.1016/j.neuroscience.2010.12.012; KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789; Kole MHP, 2002, EUR J NEUROSCI, V16, P807, DOI 10.1046/j.1460-9568.2002.02136.x; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Kubota T, 1996, NEUROSCI LETT, V211, P21, DOI 10.1016/0304-3940(96)12709-9; Kubota T, 1999, CAN J ANAESTH, V46, P388, DOI 10.1007/BF03013235; LAHTI AC, 1995, NEUROPSYCHOPHARMACOL, V13, P9, DOI 10.1016/0893-133X(94)00131-I; Li J, 2014, NEUROPSYCHOPHARMACOL, V39, P1635, DOI 10.1038/npp.2014.10; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Liu RJ, 2013, NEUROPSYCHOPHARMACOL, V38, P2268, DOI 10.1038/npp.2013.128; Llado-Pelfort L, 2016, EUR NEUROPSYCHOPHARM, V26, P614, DOI 10.1016/j.euroneuro.2015.11.015; Lopez JF, 1999, BIOL PSYCHIAT, V46, P1461, DOI 10.1016/S0006-3223(99)00266-8; Lorrain DS, 2003, NEUROSCIENCE, V117, P697, DOI 10.1016/S0306-4522(02)00652-8; Luckenbaugh DA, 2014, J AFFECT DISORDERS, V159, P56, DOI 10.1016/j.jad.2014.02.017; MACDONALD JF, 1991, J PHYSIOL-LONDON, V432, P483, DOI 10.1113/jphysiol.1991.sp018396; Mailliet F, 2008, EXP NEUROL, V211, P593, DOI 10.1016/j.expneurol.2008.02.030; Malhotra AK, 1997, NEUROPSYCHOPHARMACOL, V17, P141; Malhotra AK, 1997, BIOL PSYCHIAT, V42, P664, DOI 10.1016/S0006-3223(96)00546-X; Matsumoto M, 2008, BRAIN RES, V1195, P50, DOI 10.1016/j.brainres.2007.12.010; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Naughton M, 2014, J AFFECT DISORDERS, V156, P24, DOI 10.1016/j.jad.2013.11.014; Nelson CL, 2002, PSYCHOPHARMACOLOGY, V161, P168, DOI 10.1007/s00213-002-1004-7; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Popp S., 2016, F1000RESEARCH, V5; Qi HS, 2009, NEUROPHARMACOLOGY, V56, P37, DOI 10.1016/j.neuropharm.2008.06.068; Rocher C, 2004, CEREB CORTEX, V14, P224, DOI 10.1093/cercor/bhg122; Rocher C, 2003, ACUTE LOW DOSE CLOZA; Roh MS, 2007, EXP MOL MED, V39, P353, DOI 10.1038/emm.2007.39; Rotarska-Jagiela A, 2010, SCHIZOPHR RES, V117, P21, DOI 10.1016/j.schres.2010.01.001; Rubinstein M, 2001, J NEUROSCI, V21, P3756, DOI 10.1523/JNEUROSCI.21-11-03756.2001; Schwarz AJ, 2013, NEUROSCIENCE, V228, P243, DOI 10.1016/j.neuroscience.2012.10.032; Sebban C, 2002, BRIT J PHARMACOL, V135, P65, DOI 10.1038/sj.bjp.0704451; Sebban C, 1999, BRIT J PHARMACOL, V128, P1055, DOI 10.1038/sj.bjp.0702893; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sotres-Bayon F, 2012, NEURON, V76, P804, DOI 10.1016/j.neuron.2012.09.028; Spellman T, 2015, NATURE, V522, P309, DOI 10.1038/nature14445; Svenningsson P, 2000, P NATL ACAD SCI USA, V97, P1856, DOI 10.1073/pnas.97.4.1856; Swerdlow NR, 1998, PSYCHOPHARMACOLOGY, V140, P75, DOI 10.1007/s002130050741; Troyano-Rodriguez E, 2014, BIOL PSYCHIAT, V76, P937, DOI 10.1016/j.biopsych.2014.05.019; Varese F, 2012, SCHIZOPHRENIA B; Wedzony K, 2000, J PHYSIOL PHARMACOL, V51, P205; Yuen EY, 2010, P NATL ACAD SCI USA, V107, P22308, DOI 10.1073/pnas.1010025108; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zhang H, 2013, MOL PSYCHIATR, V18, P471, DOI 10.1038/mp.2012.80; Zheng WH, 2012, BRAIN RES, V1470, P145, DOI 10.1016/j.brainres.2012.06.032; Zhou YA, 2008, SCHIZOPHR RES, V100, P120, DOI 10.1016/j.schres.2007.11.039	79	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177036	10.1371/journal.pone.0177036	http://dx.doi.org/10.1371/journal.pone.0177036			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472198	Green Published, gold, Green Submitted			2022-12-26	WOS:000400648500126
J	Riley, ME; Griffen, BD				Riley, Megan E.; Griffen, Blaine D.			Habitat-specific differences alter traditional biogeographic patterns of life history in a climate-change induced range expansion	PLOS ONE			English	Article							MANGROVE TREE CRAB; BERGMANNS RULE; EVOLUTION; TEMPERATURE; RESPONSES; SIZE; PREDATION; CONSEQUENCES; GRADIENT; ECOLOGY	Range shifts and expansions resulting from global climate change have the potential to create novel communities with unique plant-animal interactions. Organisms expanding their range into novel biotic and abiotic environments may encounter selection pressures that alter traditional biogeographic patterns of life history traits. Here, we used field surveys to examine latitudinal patterns of life history traits in a broadly distributed ectotherm (mangrove tree crab Aratus pisonii) that has recently experienced a climate change-induced range expansion into a novel habitat type. Additionally, we conducted laboratory and field experiments to investigate characteristics associated with these life history traits (e.g. fecundity, offspring quality, and potential selection pressures). We compared these characteristics in native mangrove habitats in which the species has historically dwelled and novel salt marsh habitats into which the species has recently expanded its range. Consistent with traditional biogeographic concepts (i.e. Bergmann's clines), size at maturity and mean body size of reproductive females increased with latitude within the native habitat. However, they decreased significantly in novel habitats at the highest latitudes of the species' range, which was consistent with habitat-specific differences in both biotic (predation) and abiotic (temperature) selection pressures. Although initial maternal investment (egg volume and weight) did not differ between habitats, fecundity was lower in novel habitats as a result of differences in size at reproduction. Offspring quality, as measured by larval starvation resistance, was likewise diminished in novel habitats relative to native habitats. These differences in off-spring quality may have enduring consequences for species success and persistence in novel habitats. Life history characteristics such as those investigated here are fundamental organismal traits; consequently, understanding the potential impacts of climate change responses on latitudinal patterns of these traits is key to understanding climate change impacts on natural systems.	[Riley, Megan E.; Griffen, Blaine D.] Univ South Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Griffen, Blaine D.] Univ South Carolina, Sch Earth Ocean & Environm, Marine Sci Program, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia	Riley, ME (corresponding author), Univ South Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	riley.megan.e@gmail.com	Griffen, Blaine/AAC-6384-2021		National Science Foundation [OCE-1129166]; Smithsonian Institution Predoctoral Fellowship; Slocum-Lunz Foundation; University of South Carolina SPARC Graduate Research Fellowship	National Science Foundation(National Science Foundation (NSF)); Smithsonian Institution Predoctoral Fellowship(Smithsonian Institution); Slocum-Lunz Foundation; University of South Carolina SPARC Graduate Research Fellowship	This research was supported by a National Science Foundation grant to BG (OCE-1129166), a Smithsonian Institution Predoctoral Fellowship to MR, a Slocum-Lunz Foundation grant to MR, and a University of South Carolina SPARC Graduate Research Fellowship to MR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2003, AM NAT, V162, P332; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; BEEVER JW, 1979, OECOLOGIA, V43, P317, DOI 10.1007/BF00344958; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Blackburn Tim M., 1999, Diversity and Distributions, V5, P165, DOI 10.1046/j.1472-4642.1999.00046.x; Burton OJ, 2010, ECOL LETT, V13, P1210, DOI 10.1111/j.1461-0248.2010.01505.x; Cahill AE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.1890; Cavanaugh KC, 2014, P NATL ACAD SCI USA, V111, P723, DOI 10.1073/pnas.1315800111; Chapperon C, 2011, GLOBAL CHANGE BIOL, V17, P1740, DOI 10.1111/j.1365-2486.2010.02356.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chuang A, 2016, GLOBAL CHANGE BIOL, V22, P494, DOI 10.1111/gcb.13107; CONDE JE, 1989, ESTUAR COAST SHELF S, V28, P639, DOI 10.1016/0272-7714(89)90051-6; D'Odorico P, 2013, GLOBAL ECOL BIOGEOGR, V22, P364, DOI 10.1111/geb.12000; Diamond SE, 2010, AM NAT, V175, P1, DOI 10.1086/648602; Erickson AA, 2003, J EXP MAR BIOL ECOL, V289, P123, DOI 10.1016/S0022-0981(03)00039-X; Griffen BD, 2014, OECOLOGIA, V174, P121, DOI 10.1007/s00442-013-2751-3; Gutowsky LFG, 2012, FISHERIES MANAG ECOL, V19, P78, DOI 10.1111/j.1365-2400.2011.00831.x; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hartnoll RG, 2001, HYDROBIOLOGIA, V449, P111, DOI 10.1023/A:1017597104367; Hassall C, 2014, GLOBAL CHANGE BIOL, V20, P475, DOI 10.1111/gcb.12340; Hildrew Alan G., 2007, P326; Hill JK, 2002, P ROY SOC B-BIOL SCI, V269, P2163, DOI 10.1098/rspb.2002.2134; HINES AH, 1982, MAR BIOL, V69, P309, DOI 10.1007/BF00397496; Horne CR, 2015, ECOL LETT, V18, P327, DOI 10.1111/ele.12413; Jannett FJ, 2007, AM MIDL NAT, V158, P168, DOI 10.1674/0003-0031(2007)158[168:NREOMS]2.0.CO;2; Jorgensen C, 2007, SCIENCE, V318, P1247, DOI 10.1126/science.1148089; Kilada R, 2012, CAN J FISH AQUAT SCI, V69, P1728, DOI 10.1139/cjfas-2012-0254; Kingsolver JG, 2008, EVOL ECOL RES, V10, P251; le Roux PC, 2008, GLOBAL CHANGE BIOL, V14, P2950, DOI 10.1111/j.1365-2486.2008.01687.x; Lurgi M, 2012, PHILOS T R SOC B, V367, P2913, DOI 10.1098/rstb.2012.0238; Manyak-Davis A, 2013, AM NAT, V182, P347, DOI 10.1086/671170; Merila J, 2014, EVOL APPL, V7, P1, DOI 10.1111/eva.12137; Osland MJ, 2013, GLOBAL CHANGE BIOL, V19, P1482, DOI 10.1111/gcb.12126; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pedraza-Garcia M, 2012, CRUSTACEANA, V85, P635, DOI 10.1163/156854012X643924; PETERSON CH, 1994, MAR ECOL PROG SER, V111, P289, DOI 10.3354/meps111289; Phillips BL, 2010, ECOLOGY, V91, P1617, DOI 10.1890/09-0910.1; Pitt NR, 2010, MAR FRESHWATER RES, V61, P963, DOI 10.1071/MF09225; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Prowse TAA, 2015, J ANIM ECOL, V84, P299, DOI 10.1111/1365-2656.12273; Ray C., 1960, J MORPHOL, V106, P88; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Riley ME, 2014, SOUTHEAST NAT, V13, pN43, DOI 10.1656/058.013.0405; Riley ME, 2014, AQUAT BIOL, V20, P35, DOI 10.3354/ab00543; Sanford E, 2006, ECOLOGY, V87, P2882, DOI 10.1890/0012-9658(2006)87[2882:LTGFAT]2.0.CO;2; Schweiger O, 2008, ECOLOGY, V89, P3472, DOI 10.1890/07-1748.1; Suarez AV, 2008, MOL ECOL, V17, P351, DOI 10.1111/j.1365-294X.2007.03456.x; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Vogt G, 2012, ZOOL ANZ, V251, P1, DOI 10.1016/j.jcz.2011.05.003; Walsh MR, 2009, EVOLUTION, V63, P3201, DOI 10.1111/j.1558-5646.2009.00785.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WARNER GF, 1967, J ZOOL, V153, P321, DOI 10.1111/j.1469-7998.1967.tb04066.x; Watt C, 2010, OIKOS, V119, P89, DOI 10.1111/j.1600-0706.2009.17959.x; Williams AA, 2014, SOUTHEAST NAT, V13, P56, DOI 10.1656/058.013.0104; WILSON KA, 1989, B MAR SCI, V44, P263	55	15	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176263	10.1371/journal.pone.0176263	http://dx.doi.org/10.1371/journal.pone.0176263			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472189	gold, Green Published, Green Submitted			2022-12-26	WOS:000400648500032
J	De Gregorio, PR; Michavila, G; Muller, LR; Borges, CD; Pomares, MF; de Sa, ELS; Pereira, C; Vincent, PA				Romina De Gregorio, Priscilla; Michavila, Gabriela; Muller, Lenise Ricciardi; Borges, Clarissa de Souza; Fernanda Pomares, Maria; Sacco de Sa, Enilson Luiz; Pereira, Claudio; Andrea Vincent, Paula			Beneficial rhizobacteria immobilized in nanofibers for potential application as soybean seed bioinoculants	PLOS ONE			English	Article							GROWTH-PROMOTING RHIZOBACTERIA; NITROGEN-FIXATION; AZOSPIRILLUM-BRASILENSE; POLY(VINYL ALCOHOL); PLANT; ENCAPSULATION; BACTERIA; INOCULATION; IMPROVEMENT; NODULATION	Seed inoculation with plant growth promoting rhizobacteria (PGPR) is an ideal tool to supply the soil with a high density of beneficial microorganisms. However, maintaining viable microorganisms is a major problem during seed treatment and storage. In this work, an evaluation was made of the effect of bacterial immobilization in nanofibers on the stability (viability and maintenance of beneficial properties) of two potential PGPR, Pantoea agglomerans ISIB55 and Burkholderia caribensis ISIB40. Moreover, the impact of soybean seed coating with nanofiber-immobilized rhizobacteria on bacterial survival during seed storage and on germination and plant growth parameters was determined. Bacterial nanoimmobilization and subsequent seed coating with nanofiber-immobilized rhizobacteria were carried out by electrospinning. The results demonstrate that this technique successfully immobilized P. agglomerans ISIB55 and B. caribensis ISIB40 because it did not affect the viability or beneficial properties of either rhizobacteria. Seed coating with nanofiber-immobilized rhizobacteria improved P. agglomerans ISIB55 and B. caribensis ISIB40 survival on seeds stored for 30 days and contributed to the successful colonization of both bacteria on the plant root. Moreover, seed coating with P. agglomerans ISIB55 increased germination, length and dry weight of the root. Furthermore, seed coating with B. caribensis ISIB40 increased leaf number and dry weight of the shoot. Therefore, the technique applied in the present work to coat seeds with nanofiber-immobilized PGPR could be considered a promising eco-friendly approach to improve soybean production using a microbial inoculant.	[Romina De Gregorio, Priscilla; Michavila, Gabriela; Fernanda Pomares, Maria; Andrea Vincent, Paula] UNT, CONICET, Inst Super Invest Biol INSIBIO, Chacabuco 461, San Miguel De Tucuman, Argentina; [Romina De Gregorio, Priscilla; Michavila, Gabriela; Fernanda Pomares, Maria; Andrea Vincent, Paula] UNT, Fac Bioquim Quim & Farm, Inst Quim Biol Dr Bernabe Bloj, Chacabuco 461, Porto Alegre, RS, Brazil; [Muller, Lenise Ricciardi; Pereira, Claudio] Tecnano Prod & Serv Ltda, Rua Washington Luiz 675, Porto Alegre, RS, Brazil; [Borges, Clarissa de Souza; Sacco de Sa, Enilson Luiz] Univ Fed Rio Grande do Sul, Fac Agron, Dept Solos, Ave Bento Goncalves 7712, Porto Alegre, RS, Brazil	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Tucuman; Universidade Federal do Rio Grande do Sul	Vincent, PA (corresponding author), UNT, CONICET, Inst Super Invest Biol INSIBIO, Chacabuco 461, San Miguel De Tucuman, Argentina.; Vincent, PA (corresponding author), UNT, Fac Bioquim Quim & Farm, Inst Quim Biol Dr Bernabe Bloj, Chacabuco 461, Porto Alegre, RS, Brazil.	pvincent@fbqf.unt.edu.ar	de Sá, Enilson Luiz Saccol/AAE-1486-2019; De Gregorio, Priscilla/AAC-9013-2022	de Sá, Enilson Luiz Saccol/0000-0002-7796-0857; De Gregorio, Priscilla Romina/0000-0002-9697-0911	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPGyT) [PICT 2991, PICT 2222]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 0972]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) [FAPERGS 16/2013 - TECNOVA/RS, 1433-2551/14-8]; CONICET; CNPq	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPGyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by grants PICT 2991 and PICT 2222 from the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPGyT), PIP 0972 from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil) and FAPERGS 16/2013 - TECNOVA/RS, 1433-2551/14-8 from the Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS). PRD and GM were recipients of a fellowship from CONICET. LM is a Tecnano Ltda. technician. CSB was a recipient of a fellowship from CNPq. MFP and PAV are Career Investigators from CONICET. ELS is Associate professor at the Federal University of Rio Grande do Sul. CP is Tecnano Ltda. Researcher. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesemoye AO, 2009, MICROB ECOL, V58, P921, DOI 10.1007/s00248-009-9531-y; Ahmed A, 2014, POL J MICROBIOL, V63, P261; Albareda M, 2009, F CROP RES, V113, P325; Ali N, 2010, SOYBEAN: BOTANY, PRODUCTION AND USES, P345, DOI 10.1079/9781845936440.0345; Amalraj L., 2013, J PLANT PHYSL PATHOL, V1; Asghar HN, 2002, BIOL FERT SOILS, V35, P231, DOI 10.1007/s00374-002-0462-8; Atefan M., 2008, ANALELE STIINTIFICE, V3, P105; Bashan Y, 2002, BIOL FERT SOILS, V35, P359, DOI 10.1007/s00374-002-0481-5; Bashan Y, 1999, APPL MICROBIOL BIOT, V51, P262, DOI 10.1007/s002530051391; Bashan Y, 2014, PLANT SOIL, V378, P1, DOI 10.1007/s11104-013-1956-x; Beneduzi A, 2012, GENET MOL BIOL, V35, P1044, DOI 10.1590/S1415-47572012000600020; Benizri E, 2001, BIOCONTROL SCI TECHN, V11, P557, DOI 10.1080/09583150120076120; Castaneda L., 2014, J RES UPDAT POLYM SC, V3, P33, DOI [10.6000/1929-5995.2014.03.01.5, DOI 10.6000/1929-5995.2014.03.01.5]; Castanheira EG, 2013, J CLEAN PROD, V54, P49, DOI 10.1016/j.jclepro.2013.05.026; Cavalett O, 2010, J CLEAN PROD, V18, P55, DOI 10.1016/j.jclepro.2009.09.008; Chen WM, 2003, J BACTERIOL, V185, P7266, DOI 10.1128/JB.185.24.7266-7272.2003; Chiarini L, 2006, TRENDS MICROBIOL, V14, P277, DOI 10.1016/j.tim.2006.04.006; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Damasceno R, 2013, CAN J MICROBIOL, V59, P716, DOI 10.1139/cjm-2013-0508; Datta C, 2000, MICROBIOL RES, V155, P123, DOI 10.1016/S0944-5013(00)80047-6; Deaker R, 2004, SOIL BIOL BIOCHEM, V36, P1275, DOI 10.1016/j.soilbio.2004.04.009; Deaker R, 2007, SOIL BIOL BIOCHEM, V39, P573, DOI 10.1016/j.soilbio.2006.09.005; Deaker R, 2012, AGRICULTURE-BASEL, V2, P38, DOI 10.3390/agriculture2010038; Denardin ND, 2000, WORLD J MICROB BIOT, V16, P215, DOI 10.1023/A:1008914223467; Fernandes PI, 2009, PESQUI AGROPECU BRAS, V44, P1184, DOI 10.1590/S0100-204X2009000900017; Figueiredo MVB, 2008, WORLD J MICROB BIOT, V24, P1187, DOI 10.1007/s11274-007-9591-4; Frickmann H, 2014, EUR J MICROBIOL IMMU, V4, P106, DOI 10.1556/EuJMI.4.2014.2.3; Fung WY, 2011, J AGR FOOD CHEM, V59, P8140, DOI 10.1021/jf2009342; Garret RD, 2013, ENVIRON RES LETT, V8, P1; GHOLAMI A, 2009, WORLD ACAD SCI ENG T, V49, P19; Gui-Bo Y, 2010, J BIOMED MATER RES A, V93A, P158, DOI 10.1002/jbm.a.32496; Hartmann A, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P115, DOI 10.1007/0-387-30745-1_6; HUME DJ, 1992, CAN J MICROBIOL, V38, P588, DOI 10.1139/m92-097; John RP, 2011, CRIT REV BIOTECHNOL, V31, P211, DOI 10.3109/07388551.2010.513327; Tomas MSJ, 2015, EUR J PHARM SCI, V79, P87, DOI 10.1016/j.ejps.2015.08.010; Kan GZ, 2015, MOL GENET GENOMICS, V290, P2147, DOI 10.1007/s00438-015-1066-y; Koberg M, 2011, BIORESOURCE TECHNOL, V102, P1073, DOI 10.1016/j.biortech.2010.08.055; Krishnamoorthy V, 2016, NEW J CHEM, V40, P3268, DOI 10.1039/c5nj03008k; Lin QQ, 2012, SENSOR ACTUAT B-CHEM, V161, P967, DOI 10.1016/j.snb.2011.11.074; Linu M. S., 2009, International Journal of Agricultural Research, V4, P79; Lopez-Rubio A, 2009, BIOMACROMOLECULES, V10, P2823, DOI 10.1021/bm900660b; Lupwayi NZ, 2000, FIELD CROP RES, V65, P259, DOI 10.1016/S0378-4290(99)00091-X; Martins LMV, 2003, BIOL FERT SOILS, V38, P333, DOI 10.1007/s00374-003-0668-4; Mohite B, 2013, J SOIL SCI PLANT NUT, V13, P638, DOI 10.4067/S0718-95162013005000051; O'Callaghan M., 2012, Agronomy New Zealand, V42, P149; O'Callaghan M, 2016, APPL MICROBIOL BIOT, V100, P5729, DOI 10.1007/s00253-016-7590-9; Oteino N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00745; Pajak J, 2010, CHEMIK, V64, P523; Pan YL, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0109-7; Parra-Cota FI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088094; Paungfoo-Lonhienne C, 2014, MICROB BIOTECHNOL, V7, P142, DOI 10.1111/1751-7915.12105; Raj N, 2004, INT J PEST MANAGE, V50, P41, DOI 10.1080/09670870310001626365; Raju NS, 1999, J SCI FOOD AGR, V79, P206, DOI 10.1002/(SICI)1097-0010(199902)79:2&lt;206::AID-JSFA167&gt;3.0.CO;2-Y; Roy B. D., 2013, African Journal of Agricultural Research, V8, P349; Saharan BC, 2011, LIFE SCI MED RES, V21, P1, DOI DOI 10.4172/2157-7471.1000266; Salalha W, 2006, NANOTECHNOLOGY, V17, P4675, DOI 10.1088/0957-4484/17/18/025; Santoro MV, 2015, PLANT BIOLOGY, V17, P1218, DOI 10.1111/plb.12351; Sayyed R. Z., 2005, Indian Journal of Biotechnology, V4, P484; Silini-Cherif H, 2012, Pak J Biol Sci, V15, P267, DOI 10.3923/pjbs.2012.267.276; Tortora ML, 2011, ARCH MICROBIOL, V193, P275, DOI 10.1007/s00203-010-0672-7; Ulzen J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01770; Vejan P, 2016, MOLECULES, V21, DOI 10.3390/molecules21050573; Verma S, 2012, FOLIA MICROBIOL, V57, P525, DOI 10.1007/s12223-012-0163-0; Wang HS, 2009, RECENT PAT NANOTECH, V3, P21, DOI 10.2174/187221009787003285; Wang SD, 2014, MATER RES EXPRESS, V1, DOI 10.1088/2053-1591/1/2/025406; Wang X, 2013, CATAL COMMUN, V31, P37, DOI 10.1016/j.catcom.2012.11.009; WEAVER RW, 1974, AGRON J, V66, P233, DOI 10.2134/agronj1974.00021962006600020015x; Yates RJ, 2004, SOIL BIOL BIOCHEM, V36, P1319, DOI 10.1016/j.soilbio.2004.04.013; Zhang CX, 2005, EUR POLYM J, V41, P423, DOI 10.1016/j.eurpolymj.2004.10.027; Zhou GC, 2013, APPL MICROBIOL BIOT, V97, P4065, DOI 10.1007/s00253-012-4638-3	70	42	43	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176930	10.1371/journal.pone.0176930	http://dx.doi.org/10.1371/journal.pone.0176930			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472087	gold, Green Published, Green Submitted			2022-12-26	WOS:000400648500099
J	Sheen, YS; Liao, YH; Lin, MH; Chen, JS; Liau, JY; Liang, CW; Chang, YL; Chu, CY				Sheen, Yi-Shuan; Liao, Yi-Hua; Lin, Ming-Hsien; Chen, Jau-Shiuh; Liau, Jau-Yu; Liang, Cher-Wei; Chang, Yih-Leong; Chu, Chia-Yu			Clinicopathological features and prognosis of patients with de novo versus nevus-associated melanoma in Taiwan	PLOS ONE			English	Article							MALIGNANT-MELANOMA; MELANOCYTIC NEVUS; PRECURSOR	Studies surveying melanomas associated with melanocytic nevi in Asia are rare. In this study, we examined whether nevus-associated melanomas differ from de novo melanomas in terms of their associations with clinical factors, histologic characteristics, and patient survival in Taiwan. Using data on cancer cases obtained from the Department of Pathology archives and the Cancer Registry of National Taiwan University Hospital, we conducted a retrospective analysis of 103 consecutive melanoma patients who were diagnosed between 2010 and 2015 and received follow-up through November 2016. Approximately 17.5% of the melanomas in question were associated with a nevus. In patients under 65 years of age, non-acral lentiginous melanomas were significantly associated with a higher percentage of nevus-associated melanomas. The superficial spreading subtype, younger patient age, thinner tumor, intermittent solar exposure, and early stage were significant predictors of a melanoma being histologically associated with a nevus. The appearance of a nevus associated with a melanoma predicted better recurrence-free survival compared with de novo melanomas. Although acral lentiginous melanomas (70.9%) constituted the most common histologic subtype, only 9.6% of the acral lentiginous melanomas were associated with a nevus. Furthermore, there was no statistically significant difference between the nevus-associated and de novo acral lentiginous melanomas with regard to clinicopathological factors and survival. In conclusion, nevus-associated melanomas were uncommon among acral lentiginous melanomas. Relatedly, because over half of all melanomas in Asians are acral lentiginous melanomas, Asians are less likely than Caucasians to have nevus-associated melanomas.	[Sheen, Yi-Shuan; Chang, Yih-Leong] Natl Taiwan Univ, Coll Med, Grad Inst Pathol, Taipei, Taiwan; [Sheen, Yi-Shuan; Liao, Yi-Hua; Chen, Jau-Shiuh; Chu, Chia-Yu] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan; [Sheen, Yi-Shuan; Liao, Yi-Hua; Chen, Jau-Shiuh; Chu, Chia-Yu] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Lin, Ming-Hsien] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Lin, Ming-Hsien] Natl Taiwan Univ Hosp, Dept Surg, Hsinchu Branch, Hsinchu, Taiwan; [Liau, Jau-Yu; Liang, Cher-Wei; Chang, Yih-Leong] Natl Taiwan Univ Hosp, Dept Pathol, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Chang, YL (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Pathol, Taipei, Taiwan.; Chu, CY (corresponding author), Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan.; Chu, CY (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.; Chang, YL (corresponding author), Natl Taiwan Univ Hosp, Dept Pathol, Taipei, Taiwan.	ntuhylc@gmail.com; chiayu@ntu.edu.tw	Sheen, Yi-Shuan/HGA-1172-2022	LIANG, CHER-WEI/0000-0001-8903-6082; Sheen, Yi-Shuan/0000-0002-8743-7496; Chen, Jau-Shiuh/0000-0002-5701-0109; CHANG, YIH-LEONG/0000-0001-5309-0554; LIAO, YI-HUA/0000-0002-4434-3780; CHU, CHIA-YU/0000-0002-9370-3279	Ministry of Science and Technology of Taiwan [MOST 103-2314-B-002-065-MY3, MOST 104-2314-B-002-116-MY3]; National Taiwan University Hospital [NTUH 105-M3349, 106-M3737]; National Taiwan University Hospital Hsin-Chu Branch [HCH 105-029]; Department of Medical Research of National Taiwan University Hospital	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University); National Taiwan University Hospital Hsin-Chu Branch; Department of Medical Research of National Taiwan University Hospital	This study was supported by grants MOST 103-2314-B-002-065-MY3 (CYC) and MOST 104-2314-B-002-116-MY3 (YSS) from the Ministry of Science and Technology of Taiwan (http://www.most.gov.tw), by grants NTUH 105-M3349 and "NTUH" 106-M3737 (YSS) from the National Taiwan University Hospital (https://www.ntuh.gov.tw) and by grants HCH 105-029 (MHL) from the National Taiwan University Hospital Hsin-Chu Branch.; We are grateful for the statistical assistance provided by the Taiwan Clinical Trial Bioinformatics and Statistical Center, Training Center, and Pharmacogenomics Laboratory (which was founded by the National Research Program for Biopharmaceuticals (NRPB) at the Ministry of Science and Technology of Taiwan; MOST 103-2325-B-002-033). The authors also wish to acknowledge the support provided by the Department of Medical Research of National Taiwan University Hospital.	ACKERMAN AB, 1988, HISTOPATHOLOGY, V13, P241, DOI 10.1111/j.1365-2559.1988.tb02036.x; Al-Jamal MS, 2014, DERMATOL SIN, V32, P217, DOI 10.1016/j.dsi.2014.09.001; BAER SC, 1995, CANCER, V76, P2242, DOI 10.1002/1097-0142(19951201)76:11<2242::AID-CNCR2820761110>3.0.CO;2-I; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Betti R, 2014, J EUR ACAD DERMATOL, V28, P1738, DOI 10.1111/jdv.12395; Bevona C, 2003, ARCH DERMATOL, V139, P1620, DOI 10.1001/archderm.139.12.1620; Chang John Wen-Cheng, 2010, Chang Gung Med J, V33, P602; Chen YJ, 1999, J AM ACAD DERMATOL, V41, P945, DOI 10.1016/S0190-9622(99)70251-3; Cormier JN, 2006, ARCH INTERN MED, V166, P1907, DOI 10.1001/archinte.166.17.1907; Cymerman RM, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw121; Duman N, 2015, DERMATOPATHOLOGY, V2, P46, DOI 10.1159/000375490; Fernandez LP, 2009, EXP DERMATOL, V18, P634, DOI 10.1111/j.1600-0625.2009.00846.x; FRIEDMAN RJ, 1983, ARCH DERMATOL, V119, P455, DOI 10.1001/archderm.119.6.455; Green A, 1999, CANCER CAUSE CONTROL, V10, P21, DOI 10.1023/A:1008872014889; Haenssle HA, 2015, JAMA DERMATOL, P1; Harley S, 1996, AM J DERMATOPATH, V18, P137, DOI 10.1097/00000372-199604000-00005; Jung HJ, 2013, JAMA DERMATOL, V149, P1281, DOI 10.1001/jamadermatol.2013.5853; Kaddu S, 2002, MELANOMA RES, V12, P271, DOI 10.1097/00008390-200206000-00011; Lin WM, 2015, J AM ACAD DERMATOL, V72, P54, DOI 10.1016/j.jaad.2014.09.028; Lv JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep31432; Mervic L, 2012, ACTA DERMATOVEN ALP, V21, P27, DOI 10.2478/v10162-012-0008-1; Minagawa A, 2016, NEW ENGL J MED, V374, P2404, DOI 10.1056/NEJMc1512354; REINTGEN DS, 1982, JAMA-J AM MED ASSOC, V248, P1856, DOI 10.1001/jama.248.15.1856; RHODES AR, 1983, J AM ACAD DERMATOL, V9, P563, DOI 10.1016/S0190-9622(83)70171-4; Shain AH, 2015, NEW ENGL J MED, V373, P1926, DOI 10.1056/NEJMoa1502583; Sheen YS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147431; Sheen YS, 2015, J INVEST DERMATOL, V135, P1065, DOI 10.1038/jid.2014.480; Shitara D, 2014, AM J CLIN PATHOL, V142, P485, DOI 10.1309/AJCP4L5CJGKTJVDD; Smoller BR, 2006, MODERN PATHOL, V19, pS34, DOI 10.1038/modpathol.3800508; Togawa Y, 2010, INT J DERMATOL, V49, P1362, DOI 10.1111/j.1365-4632.2010.04602.x; Tzen CY, 2014, DERMATOL SIN, V32, P7, DOI 10.1016/j.dsi.2013.05.005; Weatherhead SC, 2007, BRIT J DERMATOL, V156, P72, DOI 10.1111/j.1365-2133.2006.07570.x	32	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177126	10.1371/journal.pone.0177126	http://dx.doi.org/10.1371/journal.pone.0177126			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472158	gold, Green Published, Green Submitted			2022-12-26	WOS:000400648500141
J	Brandt, EE; Masta, SE				Brandt, Erin E.; Masta, Susan E.			Females are the brighter sex: Differences in external fluorescence across sexes and life stages of a crab spider	PLOS ONE			English	Article							MISUMENA-VATIA ARANEAE; PREY CAPTURE; COLOR; PREDATOR; ADULT; SIZE; SIT; UV; REFLECTANCE; CAMOUFLAGE	Fluorescence is increasingly recognized to be widespread in nature. In particular, some arachnids fluoresce externally, and in spiders the hemolymph fluoresces. In this study, we examined the external fluorescence and the fluorophores of different sexes and life stages of the crab spider Misumena vatia (Clerk 1757), a sit-and-wait predator that feeds on insects as they visit flowers. We designed novel instrumentation to measure external fluorescence in whole specimens. We found that although males and females possess internal fluorophores with similar properties, the external expression of fluorescence varies across sexes and life stages. Spiders fluoresce brightly as immatures. Females maintain their brightness to adulthood, whereas males become increasingly dim as they mature. We suggest that external fluorescence likely contributes to visual signaling in these animals, and that it differs between the sexes as a result of differences in foraging ecology and behavior.	[Brandt, Erin E.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Masta, Susan E.] Portland State Univ, Dept Biol, Portland, OR 97207 USA	University of California System; University of California Berkeley; Portland State University	Masta, SE (corresponding author), Portland State Univ, Dept Biol, Portland, OR 97207 USA.	smasta@pdx.edu			National Science Foundation [0920762]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation, award number 0920762 to SEM. NSF website: https://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JT, 2001, BEHAV ECOL, V12, P360, DOI 10.1093/beheco/12.3.360; Andrews K, 2007, BIOL LETTERS, V3, P265, DOI 10.1098/rsbl.2007.0016; Arnold KE, 2002, SCIENCE, V295, P92, DOI 10.1126/science.295.5552.92; BIRD RE, 1983, SOL ENERGY, V30, P563, DOI 10.1016/0038-092X(83)90068-3; Brechbuhl R, 2010, P ROY SOC B-BIOL SCI, V277, P739, DOI 10.1098/rspb.2009.1632; Bush AA, 2008, P ROY SOC B-BIOL SCI, V275, P1337, DOI 10.1098/rspb.2008.0062; Cheng RC, 2007, BEHAV ECOL, V18, P1085, DOI 10.1093/beheco/arm081; Chien SA, 1998, J ARACHNOL, V26, P238; Defrize J, 2011, J INSECT PHYSIOL, V57, P508, DOI 10.1016/j.jinsphys.2011.01.016; Defrize J, 2010, J EXP BIOL, V213, P1425, DOI 10.1242/jeb.039743; Diclaro JW, 2012, J MED ENTOMOL, V49, P94, DOI 10.1603/ME10257; Dukas R, 2005, ECOSCIENCE, V12, P244, DOI 10.2980/i1195-6860-12-2-244.1; Dukas R, 2003, OIKOS, V101, P157, DOI 10.1034/j.1600-0706.2003.12143.x; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Erickson KS, 1997, OECOLOGIA, V109, P608, DOI 10.1007/s004420050123; Foelix RF, 1982, BIOL SPIDERS; Fuchs E, 2001, APPL OPTICS, V40, P3614, DOI 10.1364/AO.40.003614; Lagorio MG, 2015, PHOTOCH PHOTOBIO SCI, V14, P1538, DOI 10.1039/c5pp00122f; Gallagher RP, 2006, PROG BIOPHYS MOL BIO, V92, P119, DOI 10.1016/j.pbiomolbio.2006.02.011; Gandia-Herrero F, 2005, NATURE, V437, P334, DOI 10.1038/437334a; Gawryszewski FM, 2015, FUNCT ECOL, V29, P44, DOI 10.1111/1365-2435.12300; Haddock SHD, 2015, BIOL OPEN, V4, P1094, DOI 10.1242/bio.012138; Harland Duane P., 2000, Cimbebasia, V16, P231; Heiling AM, 2005, J EXP BIOL, V208, P3925, DOI 10.1242/jeb.01861; Heiling AM, 2005, J EXP BIOL, V208, P1785, DOI 10.1242/jeb.01585; Heiling AM, 2003, NATURE, V421, P334, DOI 10.1038/421334a; Herberstein ME, 2009, EVOL ECOL, V23, P621, DOI 10.1007/s10682-008-9260-6; Hsiung BK, 2014, PROC SPIE, V9187, DOI 10.1117/12.2060831; Insausti TC, 2009, TISSUE CELL, V41, P421, DOI 10.1016/j.tice.2009.05.002; Insausti TC, 2008, J EXP BIOL, V211, P780, DOI 10.1242/jeb.014043; Insausti TC, 2012, ARTHROPOD STRUCT DEV, V41, P155, DOI 10.1016/j.asd.2011.11.003; Johnsen S., 2012, THE OPTICS OF LIFE; Kevan P, 1996, TRENDS PLANT SCI, V1, P280; Kloock CT, 2010, J ARACHNOL, V38, P441, DOI 10.1636/B09-111.1; Kurup R, 2013, PLANT BIOLOGY, V15, P611, DOI 10.1111/j.1438-8677.2012.00709.x; Legrand RS, 2000, BIOL J LINN SOC, V71, P643, DOI 10.1006/bijl.2000.0466; Lim MLM, 2007, SCIENCE, V315, P481, DOI 10.1126/science.1134254; Llandres AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017136; Llandres AL, 2011, ECOL ENTOMOL, V36, P72, DOI 10.1111/j.1365-2311.2010.01246.x; Lourenco Wilson R., 1996, Revue Suisse de Zoologie Volume Hors Serie, V2, P449; Mazel CH, 2004, SCIENCE, V303, P51, DOI 10.1126/science.1089803; Michiels Nico K., 2008, BMC Ecology, V8, P16, DOI 10.1186/1472-6785-8-16; Morse D. H., 2007, PREDATOR FLOWER LIFE; Morse DH, 2006, BEHAV ECOL, V17, P405, DOI 10.1093/beheco/arj053; MORSE DH, 1981, AM MIDL NAT, V105, P358, DOI 10.2307/2424754; Morse DH, 1996, EVOL ECOL, V10, P361, DOI 10.1007/BF01237723; MORSE DH, 1979, OECOLOGIA, V39, P309, DOI 10.1007/BF00345442; MORSE DH, 1992, ECOLOGY, V73, P1814, DOI 10.2307/1940032; Morse DH, 2007, J ARACHNOL, V35, P475, DOI 10.1636/T07-06.1; Morse DH, 2010, J ARACHNOL, V38, P309, DOI 10.1636/JOA_P09-18.1; Morse DH, 2009, J ARACHNOL, V37, P72, DOI 10.1636/SH07-145.1; Oxford GS, 1998, ANNU REV ENTOMOL, V43, P619, DOI 10.1146/annurev.ento.43.1.619; PEASLEE AG, 1989, J COMP PHYSIOL A, V164, P359, DOI 10.1007/BF00612995; Rao S, 2015, J COMP PHYSIOL A; Reef R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007995; Romero GQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020689; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; Schneider Jutta, 2011, P215; Sparks JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083259; Sullivan HL, 2004, J ARACHNOL, V32, P276, DOI 10.1636/S03-5; Thery M, 2005, BEHAV ECOL, V16, P25, DOI 10.1093/beheco/arh130; Thery M, 2002, NATURE, V415, P133, DOI 10.1038/415133a; Uhl Gabriele, 2011, P127; Welch VL, 2012, P SOC PHOTO-OPT INS, V8480	64	4	5	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0175667	10.1371/journal.pone.0175667	http://dx.doi.org/10.1371/journal.pone.0175667			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467416	Green Published, gold, Green Submitted			2022-12-26	WOS:000400647000020
J	Ding, R; Zhang, H; Zhang, LH; Zhao, WW; Li, YY; Yang, JY; Zhang, YX; Ma, SW				Ding, Rong; Zhang, Hui; Zhang, Lihong; Zhao, Wenwen; Li, Yongyin; Yang, Jianyong; Zhang, Yuanxu; Ma, Shiwu			Assessment of sequence homology and immunologic cross-reactivity between tree shrew (Tupaia belangeri) and human IL-21	PLOS ONE			English	Article							ANIMAL-MODEL; T-CELLS; HEPATITIS; INTERLEUKIN-21; RECEPTOR; SEROCONVERSION; CANCER; LIVER	Many studies have indicated that the expression of interleukin-21 (IL-21) is associated with the pathogenesis of certain liver diseases. However, in alternative animal models of liver diseases, it remains unknown whether the tree shrew could be utilized to analyze the relationship between IL-21 and liver diseases. Here, the phylogenetic tree, sequence alignment and protein structure model of tree shrew and human IL-21 were analyzed using bioinformatics software. A pEGFP-N3/tsIL-21 eukaryotic expression vector of tree shrew IL-21 (tsIL-21) was constructed, and IL-21 expression by the vector-transfected Huh7 cells was evaluated using the newly established quantitative real-time PCR and immunologic protocols for assessing human IL-21. The cytokine profiles were also evaluated in tree shrew spleen lymphocytes induced by recombinant human IL-21 or concanavalin A. It was found that the coding sequence (CDS) of tsIL-21 amplified from spleen lymphocytes belonged to the predicted sequence. The tsIL-21 was closely clustered with primate IL-21 rather than rodent IL-21, and it had an alignment of 83.33% with the human IL-21 nucleotide sequence and 69.93% with the amino acid sequence. The profiles of secondary structure, hydrophobicity and surface charge of tsIL-21 were also similar with those of human IL-21. The tsIL-21 expressed by the vector-transfected Huh7 cells could be identified by their different sources of antibodies against human IL-21, which were all dose-dependent. Recombinant human IL-21 could induce the change of the cytokine profiles of tree shrew spleen lymphocytes, which showed a higher expression of IL-10 and IFN-gamma rather than IL-2, IL-4, IL-17, TNF-a and IL-21 during the five-day stimulation. These results indicate that tsIL-21 has a high degree of homology, structural similarity and immunological cross-reactivity with human IL-21 and also confirm the accuracy of this predicted tsIL-21CDS. The protocols utilized in this study will lead to the experimental feasibility of further IL-21-related studies in vivo.	[Ding, Rong; Zhang, Lihong; Ma, Shiwu] Chengdu Mil Reg, Kunming Gen Hosp, Dept Infect Dis, Kunming, Peoples R China; [Zhang, Hui; Zhao, Wenwen; Li, Yongyin; Ma, Shiwu] Southern Med Univ, Nanfang Hosp, Dept Infect Dis, State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China; [Yang, Jianyong] Chengdu Mil Reg, Kunming Gen Hosp, Cell Biol Therapy Ctr, Kunming, Peoples R China; [Zhang, Yuanxu] Jinan Univ, Coll Life Sci & Technol, Guangzhou, Guangdong, Peoples R China	Kunming General Hospital; Southern Medical University - China; Kunming General Hospital; Jinan University	Ma, SW (corresponding author), Chengdu Mil Reg, Kunming Gen Hosp, Dept Infect Dis, Kunming, Peoples R China.; Ma, SW (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Infect Dis, State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China.	mashiwu@hotmail.com			Natural Science Foundation of China [81270025]; Natural Science Foundation of Yunnan [2013FB099]; Yunnan province	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan(Natural Science Foundation of Yunnan Province); Yunnan province	This work was supported by the Natural Science Foundation of China (81270025), the Natural Science Foundation of Yunnan (2013FB099) and the 18th Yunnan province cultivation project of the skilled personnel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chayama K, 2011, J GASTROEN HEPATOL, V26, P13, DOI 10.1111/j.1440-1746.2010.06470.x; Chen GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098231; Fan Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2416; Feng GH, 2014, HEPATOL RES, V44, pE198, DOI 10.1111/hepr.12215; Hu X, 2011, J VIRAL HEPATITIS, V18, P458, DOI 10.1111/j.1365-2893.2011.01475.x; Hua F, 2014, J CLIN PHARMACOL, V54, P14, DOI 10.1002/jcph.158; Huang Xiao-Yan, 2013, Zoological Research, V34, P121, DOI 10.3724/SP.J.1141.2013.02121; Johnson LDS, 2009, SCIENCE, V324, P1525, DOI 10.1126/science.1176487; Li JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152570; Li RX, 2012, PROTEIN CELL, V3, P691, DOI 10.1007/s13238-012-2039-0; Li YY, 2013, HEPATOLOGY, V58, P1277, DOI 10.1002/hep.26489; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma SW, 2012, J HEPATOL, V56, P775, DOI 10.1016/j.jhep.2011.10.020; Micci L, 2015, J CLIN INVEST, V125, P4497, DOI 10.1172/JCI81400; Monteleone G, 2009, TRENDS PHARMACOL SCI, V30, P441, DOI 10.1016/j.tips.2009.05.006; Pang YL, 2009, CANCER IMMUNOL IMMUN, V58, P877, DOI 10.1007/s00262-008-0603-5; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Stolfi C, 2012, ONCOIMMUNOLOGY, V1, P351, DOI 10.4161/onci.19122; Tsukiyama-Kohara K, 2014, EXP ANIM TOKYO, V63, P367, DOI 10.1538/expanim.14-0007; Wang Xin-Xing, 2011, Zoological Research, V32, P66, DOI 10.3724/SP.J.1141.2011.01066; Yan HD, 2014, ELIFE, V3, DOI 10.7554/eLife.04193; Yang EB, 2005, HEPATO-GASTROENTEROL, V52, P613; Yang MC, 2010, INT IMMUNOL, V22, P661, DOI 10.1093/intimm/dxq050; Yang ZF, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-111; Yu DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099859; Zanin-Zhorov A, 2014, P NATL ACAD SCI USA, V111, P16814, DOI 10.1073/pnas.1414189111; Zheng Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098552	28	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176707	10.1371/journal.pone.0176707	http://dx.doi.org/10.1371/journal.pone.0176707			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467480	Green Published, gold, Green Submitted			2022-12-26	WOS:000400647000069
J	Murakami, Y; Ito, M; Ohsawa, I				Murakami, Yayoi; Ito, Masafumi; Ohsawa, Ikuroh			Molecular hydrogen protects against oxidative stress-induced SH-SY5Y neuroblastoma cell death through the process of mitohormesis	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; RICH SALINE; RAT MODEL; MICE; APOPTOSIS; INJURY; MITOCHONDRIA; INHALATION; RADICALS; DAMAGE	Inhalation of molecular hydrogen (H-2) gas ameliorates oxidative stress-induced acute injuries in the brain. Consumption of water nearly saturated with H-2 also prevents chronic neurodegenerative diseases including Parkinson's disease in animal and clinical studies. However, the molecular mechanisms underlying the remarkable effect of a small amount of H-2 remain unclear. Here, we investigated the effect of H-2 on mitochondria in cultured human neuroblastoma SH-SY5Y cells. H-2 increased the mitochondrial membrane potential and the cellular ATP level, which were accompanied by a decrease in the reduced glutathione level and an increase in the superoxide level. Pretreatment with H-2 suppressed H2O2-induced cell death, whereas post-treatment did not. Increases in the expression of anti-oxidative enzymes underlying the Nrf2 pathway in H-2-treated cells indicated that mild stress caused by H-2 induced increased resistance to exacerbated oxidative stress. We propose that H-2 functions both as a radical scavenger and a mitohormetic effector against oxidative stress in cells.	[Murakami, Yayoi; Ohsawa, Ikuroh] Tokyo Metropolitan Inst Gerontol, Biol Proc Aging, Tokyo, Japan; [Ito, Masafumi] Tokyo Metropolitan Inst Gerontol, Res Team Mech Aging, Tokyo, Japan	Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan Institute of Gerontology	Ohsawa, I (corresponding author), Tokyo Metropolitan Inst Gerontol, Biol Proc Aging, Tokyo, Japan.	iohsawa@tmig.or.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [24500882, 16H03267]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science (JSPS) KAKENHI (https://www.jsps.go.jp/english/e-grants/) Grant Number 24500882 and 16H03267 for IO. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028536; Chazotte Brad, 2011, Cold Spring Harb Protoc, V2011, P990, DOI 10.1101/pdb.prot5648; Chuai YH, 2012, BIOCHEM J, V442, P49, DOI 10.1042/BJ20111786; Circu ML, 2008, FREE RADICAL RES, V42, P689, DOI 10.1080/10715760802317663; HALLIWELL B, 1987, FASEB J, V1, P358, DOI 10.1096/fasebj.1.5.2824268; Hayashida K, 2014, CIRCULATION, V130, P2173, DOI 10.1161/CIRCULATIONAHA.114.011848; Huttemann M, 2012, BBA-BIOENERGETICS, V1817, P598, DOI 10.1016/j.bbabio.2011.07.001; Hugyecz M, 2011, BRAIN RES, V1404, P31, DOI 10.1016/j.brainres.2011.05.068; Ichihara M, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0035-1; Igarashi T, 2016, SCI REP-UK, V6, DOI 10.1038/srep31190; Iketani M, 2016, PREADMINISTRATION HY; Iketani M, 2016, CURR NEUROPHARMACOL; Iuchi K, 2016, SCI REP-UK, V6, DOI 10.1038/srep18971; Kamimura N, 2011, OBESITY, V19, P1396, DOI 10.1038/oby.2011.6; Kawamura T, 2013, AM J PHYSIOL-LUNG C, V304, pL646, DOI 10.1152/ajplung.00164.2012; Kawamura T, 2011, SURGERY, V150, P240, DOI 10.1016/j.surg.2011.05.019; Li JJ, 2012, BRAIN RES, V1486, P103, DOI 10.1016/j.brainres.2012.09.031; Ludovico P, 2014, FEMS YEAST RES, V14, P33, DOI 10.1111/1567-1364.12070; Oharazawa H, 2010, INVEST OPHTH VIS SCI, V51, P487, DOI 10.1167/iovs.09-4089; Ohno K, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/353152; Ohsawa I, 1999, EUR J NEUROSCI, V11, P1907, DOI 10.1046/j.1460-9568.1999.00601.x; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ohta S, 2015, METHOD ENZYMOL, V555, P289, DOI 10.1016/bs.mie.2014.11.038; Patergnani S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-19; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5; Sato Y, 2008, BIOCHEM BIOPH RES CO, V375, P346, DOI 10.1016/j.bbrc.2008.08.020; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Seppet E, 2009, INT J MOL SCI, V10, P2252, DOI 10.3390/ijms10052252; Shimada S, 2016, ARTIF ORGANS; Terasaki Y, 2011, AM J PHYSIOL-LUNG C, V301, pL415, DOI 10.1152/ajplung.00008.2011; Texel SJ, 2011, ANTIOXID REDOX SIGN, V14, P1519, DOI 10.1089/ars.2010.3569; Yonamine R, 2013, ANESTHESIOLOGY, V118, P105, DOI 10.1097/ALN.0b013e318275146d	33	50	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176992	10.1371/journal.pone.0176992	http://dx.doi.org/10.1371/journal.pone.0176992			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467497	Green Published, gold, Green Submitted			2022-12-26	WOS:000400647000093
J	Schunk, M; Reitmeir, P; Ruckert-Eheberg, IM; Tamayo, T; Schipf, S; Meisinger, C; Peters, A; Scheidt-Nave, C; Ellert, U; Hartwig, S; Kluttig, A; Volzke, H; Holle, R				Schunk, Michaela; Reitmeir, Peter; Rueckert-Eheberg, Ina-Maria; Tamayo, Teresa; Schipf, Sabine; Meisinger, Christa; Peters, Annette; Scheidt-Nave, Christa; Ellert, Ute; Hartwig, Saskia; Kluttig, Alexander; Voelzke, Henry; Holle, Rolf			Longitudinal change in health-related quality of life in people with prevalent and incident type 2 diabetes compared to diabetes-free controls	PLOS ONE			English	Article							IMPROVE EARLY EVALUATION; GERMAN POPULATION; ADULTS; INTERVIEW; MANAGEMENT; EQ-5D; RISK; INDIVIDUALS; MELLITUS; PATIENT	Objective The objective of this analysis is to compare people with prevalent type 2 diabetes, incident type 2 diabetes and without diabetes with respect to longitudinal change in health-related quality of life (HRQOL) when adjusting for baseline determinants of HRQOL. Research design and methods Primary baseline and follow-up data from three regional and one national population-based cohort studies in Germany were pooled for analysis. HRQOL was measured using physical and mental health summary scores (PCS and MCS) from the German version of the Short Form Health Survey with 36 or 12 items. Mean score change per observation year was compared between the three groups (prevalent diabetes, incident diabetes, no diabetes) based on linear regression models. Results The analysis included pooled data from 5367 people aged 45-74 years at baseline. Of these, 85.5% reported no diabetes at baseline and follow-up, 6.3% reported diabetes at both baseline and follow-up (prevalent diabetes), and 8.2% reported diabetes only at followup (incident diabetes). Over a mean observation period of 8.7 years, annual decline in HRQOL scores is pronounced at 0.27-0.32 (PCS) and 0.34-0.38 (MCS) in the group with prevalent diabetes compared with people without diabetes. Those with incident diabetes showed intermediate values but did not differ significantly from people without diabetes after adjustment for covariates in the full model. Conclusion Compared with data from cross-sectional analysis, the HRQOL loss associated with prevalent diabetes appears to be much larger than previously assumed.	[Schunk, Michaela; Reitmeir, Peter; Holle, Rolf] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany; [Schunk, Michaela; Reitmeir, Peter; Rueckert-Eheberg, Ina-Maria; Meisinger, Christa; Peters, Annette; Holle, Rolf] German Ctr Diabet Res DZD, Partner Site Helmholtz Zentrum, Munich, Germany; [Rueckert-Eheberg, Ina-Maria; Meisinger, Christa; Peters, Annette] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Tamayo, Teresa] Heinrich Heine Univ, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Tamayo, Teresa] German Ctr Diabet Res DZD, Partner Site DDZ Dusseldorf, Dusseldorf, Germany; [Schipf, Sabine; Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, Greifswald, Germany; [Schipf, Sabine; Voelzke, Henry] German Ctr Diabet Res DZD, Project Partner Site Uni Greifswald, Greifswald, Germany; [Scheidt-Nave, Christa; Ellert, Ute] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany; [Scheidt-Nave, Christa; Ellert, Ute] German Ctr Diabet Res DZD, Project Partner Site RKI, Berlin, Germany; [Hartwig, Saskia; Kluttig, Alexander] Martin Luther Univers Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, Halle, Germany; [Hartwig, Saskia; Kluttig, Alexander] German Ctr Diabet Res DZD, Project Partner Site Uni Halle Wittenberg, Halle, Saale, Germany; [Voelzke, Henry] German Ctr Cardiovasc Res, Partner Site Greifswald, Berlin, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Ernst Moritz Arndt Universitat Greifswald; Robert Koch Institute; Robert Koch Institute; German Centre for Cardiovascular Research	Schunk, M (corresponding author), German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany.; Schunk, M (corresponding author), German Ctr Diabet Res DZD, Partner Site Helmholtz Zentrum, Munich, Germany.	Michaela.Schunk@helmholtz-muenchen.de	Holle, Rolf/D-9333-2013; Meisinger, Christine/B-5358-2014; Peters, Annette/A-6117-2011	Holle, Rolf/0000-0001-5395-2695; Peters, Annette/0000-0001-6645-0985; Schunk, Michaela/0000-0002-1200-1903	"Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus)" - German Federal Ministry of Education and Research [FKZ 01G11110E]; Helmholtz Zentrum Munchen German Research Center for Environmental Health - German Federal Ministry of Education and Research; State of Bavaria; Deutsche Forschungsgemeinschaft as part of the Collaborative Research Center 598 "Heart failure in the elderly cellular mechanisms and therapy" at the Medical Faculty of the Martin-Luther-University Halle-Wittenberg [598]; Federal Employment Office; German Federal Ministry of Education and Research (BMBF) [01ZZ0403]; Ministry for Education, Research and Cultural Affairs; Ministry for Social Affairs of the Federal State of Mecklenburg West Pomerania; German National Health Interview and Examination Survey [GNHIES98]; German Ministry of Health	"Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus)" - German Federal Ministry of Education and Research; Helmholtz Zentrum Munchen German Research Center for Environmental Health - German Federal Ministry of Education and Research; State of Bavaria; Deutsche Forschungsgemeinschaft as part of the Collaborative Research Center 598 "Heart failure in the elderly cellular mechanisms and therapy" at the Medical Faculty of the Martin-Luther-University Halle-Wittenberg; Federal Employment Office; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Ministry for Education, Research and Cultural Affairs; Ministry for Social Affairs of the Federal State of Mecklenburg West Pomerania; German National Health Interview and Examination Survey; German Ministry of Health	This work was supported by "Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus)" funded by the German Federal Ministry of Education and Research (https://www.bmbf.de/). Grant no.: FKZ 01G11110E. The KORA research platform (KORA, Cooperative Research in the Region of Augsburg) was initiated and financed by the Helmholtz Zentrum Munchen German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research and by the State of Bavaria. The Helmholtz Zentrum Muchen is a member of the German Center for Diabetes Research. The CARLA study was funded by a grant from the Deutsche Forschungsgemeinschaft as part of the Collaborative Research Center 598 "Heart failure in the elderly cellular mechanisms and therapy" at the Medical Faculty of the Martin-Luther-University Halle-Wittenberg, by a grant from the Wilhelm Roux Programme of the Martin-Luther-University Halle-Wittenberg, by the Ministry of Education and Cultural Affairs of Saxony-Anhalt, and by the Federal Employment Office. The SHIP is part of the Community Medicine Research net (http://www. community-medicine.de) at the University of Greifswald, Germany. Funding was provided by grants from the German Federal Ministry of Education and Research (BMBF, grant 01ZZ0403), the Ministry for Education, Research and Cultural Affairs, and the Ministry for Social Affairs of the Federal State of Mecklenburg West Pomerania. The German National Health Interview and Examination Survey (GNHIES98) and follow-up study DEGS1 were funded by the German Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05; Alva M, 2014, HEALTH ECON, V23, P487, DOI 10.1002/hec.2930; Bayliss Elizabeth A, 2004, Health Qual Life Outcomes, V2, P47, DOI 10.1186/1477-7525-2-47; Bullinger M., 1995, J PUBLIC HEALTH-UK, V3, P21, DOI [DOI 10.1007/BF02959944, 10.1007/BF02959944]; Chittleborough CR, 2006, QUAL LIFE RES, V15, P687, DOI 10.1007/s11136-005-3570-8; De Smedt D, 2014, VALUE HEALTH, V17, P84, DOI 10.1016/j.jval.2013.10.010; Der-Martirosian C, 2010, QUAL LIFE RES, V19, P1333, DOI 10.1007/s11136-010-9700-y; Ellert U, 2013, BUNDESGESUNDHEITSBLA, V56, P643, DOI 10.1007/s00103-013-1700-y; Grandy S, 2008, INT J CLIN PRACT, V62, P562, DOI 10.1111/j.1742-1241.2008.01703.x; Grandy S, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-99; Grandy S, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-18; Greiser Karin H, 2005, BMC Cardiovasc Disord, V5, P33, DOI 10.1186/1471-2261-5-33; Hunger M, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-53; Jacobi F, 2002, INT J METH PSYCH RES, V11, P1, DOI 10.1002/mpr.118; Jayasinghe UW, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-50; Kamtsiuris P, 2013, BUNDESGESUNDHEITSBLA, V56, P620, DOI 10.1007/s00103-012-1650-9; Maatouk I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031088; Maddigan SL, 2006, AM J PUBLIC HEALTH, V96, P1649, DOI 10.2105/AJPH.2005.067728; Maddigan SL, 2005, QUAL LIFE RES, V14, P1311, DOI 10.1007/s11136-004-6640-4; Margolis KL, 2008, CLIN TRIALS, V5, P240, DOI 10.1177/1740774508091749; Molenaar EA, 2007, EUR J PUBLIC HEALTH, V17, P199, DOI 10.1093/eurpub/ckl113; Norris SL, 2011, J CLIN EPIDEMIOL, V64, P358, DOI 10.1016/j.jclinepi.2010.04.016; Orpana Heather M, 2009, Health Rep, V20, P29; Rathmann W, 2009, DIABETIC MED, V26, P1212, DOI 10.1111/j.1464-5491.2009.02863.x; Rose M, 2014, J CLIN EPIDEMIOL, V67, P516, DOI 10.1016/j.jclinepi.2013.10.024; Ruckert IM, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-50; Scheidt-Nave C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-730; Schipf S, 2012, DIABETIC MED, V29, pE88, DOI 10.1111/j.1464-5491.2012.03578.x; Schipf S, 2014, J EPIDEMIOL COMMUN H, V68, P1088, DOI 10.1136/jech-2014-203998; Schunk M, 2015, J DIABETES COMPLICAT, V29, P203, DOI 10.1016/j.jdiacomp.2014.11.010; Schunk M, 2012, DIABETIC MED, V29, P646, DOI 10.1111/j.1464-5491.2011.03465.x; Speight J, 2009, DIABETIC MED, V26, P315, DOI 10.1111/j.1464-5491.2009.02682.x; Sprangers MAG, 2000, J CLIN EPIDEMIOL, V53, P895, DOI 10.1016/S0895-4356(00)00204-3; Tapp RJ, 2006, DIABETES RES CLIN PR, V74, P154, DOI 10.1016/j.diabres.2006.03.012; Thefeld W, 1999, Gesundheitswesen, V61 Spec No, pS57; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Ware J., 1993, SF 36 HLTH SURVEY MA; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Ware JE, 2007, USERS MANUAL SF 36V2; Wee CC, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-11; Wee HL, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-93; WHO, 2002, PREVENTION CONTROL S	42	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176895	10.1371/journal.pone.0176895	http://dx.doi.org/10.1371/journal.pone.0176895			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SB	28467489	Green Published, gold			2022-12-26	WOS:000400647000084
J	Simoes, TR; Vernygora, O; Paparella, I; Jimenez-Huidobro, P; Caldwell, MW				Simoes, Tiago R.; Vernygora, Oksana; Paparella, Ilaria; Jimenez-Huidobro, Pauline; Caldwell, Michael W.			Mosasauroid phylogeny under multiple phylogenetic methods provides new insights on the evolution of aquatic adaptations in the group	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; SQUAMATE PHYLOGENY; MORPHOLOGICAL DATA; TREE; SYSTEMATICS; INFERENCE; PARSIMONY; REPTILIA; SNAKES; GENUS	Mosasauroids were a successful lineage of squamate reptiles (lizards and snakes) that radiated during the Late Cretaceous (95-66 million years ago). They can be considered one of the few lineages in the evolutionary history of tetrapods to have acquired a fully aquatic lifestyle, similarly to whales, ichthyosaurs and plesiosaurs. Despite a long history of research on this group, their phylogenetic relationships have only been tested so far using traditional (unweighted) maximum parsimony. However, hypotheses of mosasauroid relationships and the recently proposed multiple origins of aquatically adapted pelvic and pedal features in this group can be more thoroughly tested by methods that take into account variation in branch lengths and evolutionary rates. In this study, we present the first mosasauroid phylogenetic analysis performed under different analytical methods, including maximum likelihood, Bayesian inference, and implied weighting maximum parsimony. The results indicate a lack of congruence in the topological position of halisaurines and Dallasaurus. Additionally, the genus Prognathodon is paraphyletic under all hypotheses. Interestingly, a number of traditional mosasauroid clades become weakly supported, or unresolved, under Bayesian analyses. The reduced resolutions in some consensus trees create ambiguities concerning the evolution of fully aquatic pelvic/pedal conditions under many analyses. However, when enough resolution was obtained, reversals of the pelvic/pedal conditions were favoured by parsimony and likelihood ancestral state reconstructions instead of independent origins of aquatic features in mosasauroids. It is concluded that most of the observed discrepancies among the results can be associated with different analytical procedures, but also due to limited postcranial data on halisaurines, yaguarasaurines and Dallasaurus.	[Simoes, Tiago R.; Vernygora, Oksana; Paparella, Ilaria; Jimenez-Huidobro, Pauline; Caldwell, Michael W.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Caldwell, Michael W.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB, Canada	University of Alberta; University of Alberta	Simoes, TR (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	tsimoes@ualberta.ca	Caldwell, Michael/A-2622-2014	Caldwell, Michael/0000-0002-2377-3925; Paparella, Ilaria/0000-0002-4645-5962; Simoes, Tiago/0000-0003-4716-649X	NSERC Discovery Grant [23458]; Izaak Walton Killam Memorial Scholarship program	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Izaak Walton Killam Memorial Scholarship program	Support for this project came from a PhD scholarship to TRS (lzaak Walton Killam Memorial Scholarship) and by an NSERC Discovery Grant (#23458) to MC.; TRS thanks the Izaak Walton Killam Memorial Scholarship program for a PhD scholarship. Funding for this study was provided by an NSERC Discovery Grant (#23458) to MC. We also thank the Willi Hennig Society for the free availability of the software T.N.T.	Ayache NC, 2009, B PEABODY MUS NAT HI, V50, P327, DOI 10.3374/014.050.0203; Bardet N, 2003, CR PALEVOL, V2, P607, DOI 10.1016/j.crpv.2003.09.006; Bell GL, 2005, NETH J GEOSCI, V84, P177, DOI 10.1017/S0016774600020965; Bell Gorden L. Jr, 1997, P293, DOI 10.1016/B978-012155210-7/50017-X; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Caldwell MW, 2007, J VERTEBR PALEONTOL, V27, P863, DOI 10.1671/0272-4634(2007)27[863:ANBMFT]2.0.CO;2; Caldwell Michael W., 2006, Memorie della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V34, P1; Caldwell MW, 2012, B SOC GEOL FR, V183, P7, DOI 10.2113/gssgfbull.183.1.7; Caldwell MW, 1999, ZOOL J LINN SOC-LOND, V125, P115; Caldwell MW, 1995, J VERTEBR PALEONTOL, V15, P516, DOI 10.1080/02724634.1995.10011245; Caldwell MW, 1999, J VERTEBR PALEONTOL, V19, P438, DOI 10.1080/02724634.1999.10011157; Caldwell MW, 2000, J VERTEBR PALEONTOL, V20, P720, DOI 10.1671/0272-4634(2000)020[0720:OTASDL]2.0.CO;2; Conrad JL, 2008, B AM MUS NAT HIST, P1, DOI 10.1206/310.1; Conrad JL, 2011, CLADISTICS, V27, P230, DOI 10.1111/j.1096-0031.2010.00330.x; Cuthbertson RS, 2007, CAN J EARTH SCI, V44, P593, DOI 10.1139/E07-006; Dutchak AR, 2006, CAN J EARTH SCI, V43, P1821, DOI 10.1139/E06-086; Dutchak AR, 2009, J VERTEBR PALEONTOL, V29, P437, DOI 10.1671/039.029.0206; Evans SE, 2005, J SYST PALAEONTOL, V3, P319, DOI 10.1017/S1477201905001641; Evans SE, 2005, ACTA PALAEONTOL POL, V50, P725; FARRIS JS, 1970, SYST ZOOL, V19, P83, DOI 10.2307/2412028; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Forey PL, 2000, HOMOLOGY SYSTEMATICS, P54; Frobisch NB, 2009, SYST BIOL, V58, P312, DOI 10.1093/sysbio/syp029; Garcia G, 2015, CR PALEVOL, V14, P495, DOI 10.1016/j.crpv.2015.05.002; Gauthier JA, 2012, B PEABODY MUS NAT HI, V53, P3, DOI 10.3374/014.053.0101; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Goloboff PA, 2008, CLADISTICS, V24, P758, DOI 10.1111/j.1096-0031.2008.00209.x; Harrell TL, 2015, NETH J GEOSCI, V94, P23, DOI 10.1017/njg.2014.27; Harrison LB, 2015, SYST BIOL, V64, P307, DOI 10.1093/sysbio/syu098; Hawkins JA, 1997, CLADISTICS, V13, P275, DOI 10.1111/j.1096-0031.1997.tb00320.x; Huelsenbeck JP, 1997, SCIENCE, V276, P227, DOI 10.1126/science.276.5310.227; Jimenez-Huidobro P, 2016, CRETACEOUS RES, V65, P68, DOI 10.1016/j.cretres.2016.04.008; Jimenez-Huidobro P, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2016.1096275; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kim J, 1998, SYST BIOL, V47, P43, DOI 10.1080/106351598261021; Kitching I. J., 1998, CLADISTICS THEORY PR; Kocsis L, 2009, PALAEOGEOGR PALAEOCL, V280, P532, DOI 10.1016/j.palaeo.2009.07.009; Konishi T, 2007, J VERTEBR PALEONTOL, V27, P59, DOI 10.1671/0272-4634(2007)27[59:NSOPPC]2.0.CO;2; Konishi T, 2011, J VERTEBR PALEONTOL, V31, P754, DOI 10.1080/02724634.2011.579023; Konishi T, 2009, J VERTEBR PALEONTOL, V29, P417, DOI 10.1671/039.029.0225; Kornhuber, 1901, ABHANDLUNGEN GEOLOGI, V17, P1; Kramberger KG, 1892, GLASNIK HUVATSKOGA N, V7, P74; KUHNER MK, 1994, MOL BIOL EVOL, V11, P459; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; LeBlanc ARH, 2012, J VERTEBR PALEONTOL, V32, P82, DOI 10.1080/02724634.2012.624145; Lee MSY, 2005, BIOL LETTERS, V1, P227, DOI 10.1098/rsbl.2004.0282; Lee MSY, 2005, ORG DIVERS EVOL, V5, P25, DOI 10.1016/j.ode.2004.05.003; Lee MSY, 1998, BIOL J LINN SOC, V65, P369, DOI 10.1111/j.1095-8312.1998.tb01148.x; Lee MSY, 1997, PHILOS T R SOC B, V352, P53, DOI 10.1098/rstb.1997.0005; Lee MSY, 2000, J PALEONTOL, V74, P915, DOI 10.1666/0022-3360(2000)074<0915:AATAOM>2.0.CO;2; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Maddison W. P, 2014, MESQUITE MODULAR SYS; Motani Ryosuke., 2009, Evolution Education and Outreach, V2, P224; Muller J, 2006, SYSTEMATIC BIOL, V55, P503, DOI 10.1080/10635150600755396; Mulder EWA, 1999, GEOL MIJNBOUW-N J G, V78, P281, DOI 10.1023/A:1003838929257; NIXON KC, 1993, CLADISTICS, V9, P413, DOI 10.1111/j.1096-0031.1993.tb00234.x; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; OREILLY JE, 2016, BIOL LETT, V12; Owen R, 1850, GEOLOGY FOSSILS TERT, P378; Palci A, 2013, J VERTEBR PALEONTOL, V33, P599, DOI 10.1080/02724634.2013.731024; Polcyn MJ, 2005, NETH J GEOSCI, V84, P321, DOI 10.1017/S0016774600021107; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; Puttick MN, 2017, P ROY SOC LOND B BIO, P284; Rambaut A., 2016, TREEANNOTATOR V 2 4; Rambaut A., 2014, TRACER V1 6; Reeder TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118199; Ronquist F., 2011, DRAFT MRBAYES VERSIO; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ronquist F, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P210; Russell D. A., 1967, Bulletin of the Peabody Museum of Natural History, V23, P1; SAITOU N, 1989, MOL BIOL EVOL, V6, P514; Seeley HG, 1881, Q J GEOL SOC LOND, V37, P52, DOI DOI 10.1144/GSL.JGS.1881.037.01-04.07; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Simoes TR, 2017, CLADISTICS, V33, P198, DOI 10.1111/cla.12163; Simoes TR, 2014, J SYST PALAEONT; Street H. P, 2016, GEOLOGICAL MAGAZINE, P1; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x; Trifinopoulos J, 2016, NUCL ACIDS RES; Wagner PJ, 2012, BIOL LETTERS, V8, P143, DOI 10.1098/rsbl.2011.0523; Wiens JJ, 2005, SYST BIOL, V54, P91, DOI 10.1080/10635150590906037; Wiens JJ, 2010, SYST BIOL, V59, P674, DOI 10.1093/sysbio/syq048; Wright AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109210; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 2012, NAT REV GENET, V13, P303, DOI 10.1038/nrg3186	88	21	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176773	10.1371/journal.pone.0176773	http://dx.doi.org/10.1371/journal.pone.0176773			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467456	gold, Green Published, Green Submitted			2022-12-26	WOS:000400647000072
J	Jwanoswki, K; Wells, C; Bruce, T; Rutt, J; Banks, T; McNealy, TL				Jwanoswki, Kathleen; Wells, Christina; Bruce, Terri; Rutt, Jennifer; Banks, Tabitha; McNealy, Tamara L.			The Legionella pneumophila GIG operon responds to gold and copper in planktonic and biofilm cultures	PLOS ONE			English	Article							STATIONARY-PHASE; DRINKING-WATER; TRANSMISSION PHENOTYPE; RPOS; VIRULENCE; SILVER; PERFORMANCE; IONIZATION; RESISTANCE; METALS	Legionella pneumophila contaminates man-made water systems and creates numerous exposure risks for Legionnaires' Disease. Because copper/silver ionization is commonly used to control L. pneumophila, its mechanisms of metal response and detoxification are of significant interest. Here we describe an L. pneumophila operon with significant similarity to the GIG operon of Cupriavidus metallidurans. The Legionella GIG operon is present in a subset of strains and has been acquired as part of the ICE-beta ox 65-kB integrative conjugative element. We assessed GIG promoter activity following exposure of L. pneumophila to multiple concentrations of HAuCl4, CuSO4 and AgNO3. At 37 degrees C, control stationary phase cultures exhibited GIG promoter activity. This activity increased significantly in response to 20 and 50uM HAuCl4 and CuSO4 but not in response to AgNO3. Conversely, at 26 degrees C, cultures exhibited decreased promoter response to copper. GIG promoter activity was also induced by HAuCl4 or CuSO4 during early biofilm establishment at both temperatures. When an L. pneumophila GIG promoter construct was transformed into E. coli DH5 alpha, cultures showed baseline expression levels that did not increase following metal addition. Analysis of L. pneumophila transcriptional regulatory mutants suggested that GIG up-regulation in the presence of metal ions may be influenced by the stationary phase sigma factor, RpoS.	[Jwanoswki, Kathleen; Wells, Christina; Rutt, Jennifer; Banks, Tabitha; McNealy, Tamara L.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Bruce, Terri] Clemson Univ, Clemson Light Imaging Facil, Clemson, SC USA	Clemson University; Clemson University	McNealy, TL (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.	tmcneal@g.clemson.edu			Clemson University Creative Inquiry Program	Clemson University Creative Inquiry Program	Clemson University Creative Inquiry Program provided funding through JR and TB participation in the project.	Abbott ZD, 2016, J BACTERIOL, V198, P553, DOI 10.1128/JB.00732-15; Andreozzi E, 2014, CURR MICROBIOL, V69, P769, DOI 10.1007/s00284-014-0648-y; Ashbolt NJ, 2015, PATHOGENS, V4, P390, DOI 10.3390/pathogens4020390; Bachman MA, 2004, INFECT IMMUN, V72, P2468, DOI 10.1128/IAI.72.5.2468-2476.2004; Bachman MA, 2001, MOL MICROBIOL, V40, P1201, DOI 10.1046/j.1365-2958.2001.02465.x; Berjeaud JM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00486; Brassinga AKC, 2003, J BACTERIOL, V185, P4630, DOI 10.1128/JB.185.15.4630-4637.2003; Braymer JJ, 2014, CURR OPIN CHEM BIOL, V19, P59, DOI 10.1016/j.cbpa.2013.12.021; Bruins MR, 2000, ECOTOX ENVIRON SAFE, V45, P198, DOI 10.1006/eesa.1999.1860; Buse HY, 2014, INT J HYG ENVIR HEAL, V217, P219, DOI 10.1016/j.ijheh.2013.04.005; Checa SK, 2007, MOL MICROBIOL, V63, P1307, DOI 10.1111/j.1365-2958.2007.05590.x; Chen P, 2004, J AM CHEM SOC, V126, P728, DOI 10.1021/ja0383975; Das D, 2010, ACTA CRYSTALLOGR F, V66, P1174, DOI 10.1107/S1744309109022672; Dong T, 2010, INFECT IMMUN, V78, P887, DOI 10.1128/IAI.00882-09; Edwards RL, 2010, INFECT IMMUN, V78, P2571, DOI 10.1128/IAI.01107-09; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Flynn KJ, 2014, MBIO, V5, DOI 10.1128/mBio.01091-14; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hales LM, 1999, J BACTERIOL, V181, P4879, DOI 10.1128/JB.181.16.4879-4889.1999; Hammer BK, 1999, MOL MICROBIOL, V33, P721, DOI 10.1046/j.1365-2958.1999.01519.x; Hammer BK, 2002, MOL MICROBIOL, V44, P107, DOI 10.1046/j.1365-2958.2002.02884.x; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Jacques PE, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-423; Jian X, 2009, J AM CHEM SOC, V131, P10869, DOI 10.1021/ja904279n; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kenney GE, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-17; Kim EH, 2009, FEMS MICROBIOL LETT, V301, P164, DOI 10.1111/j.1574-6968.2009.01813.x; LANDEEN LK, 1989, APPL ENVIRON MICROB, V55, P3045, DOI 10.1128/AEM.55.12.3045-3050.1989; Liles MR, 1998, INFECT IMMUN, V66, P1776, DOI 10.1128/IAI.66.4.1776-1782.1998; Lin YE, 2011, INFECT CONT HOSP EP, V32, P166, DOI 10.1086/657934; Lynch D, 2003, FEMS MICROBIOL LETT, V219, P241, DOI 10.1016/S0378-1097(03)00050-8; Mathys W, 2002, EFFICACY COPPER SILV, P419; MAUCHLINE WS, 1992, J GEN MICROBIOL, V138, P2371, DOI 10.1099/00221287-138-11-2371; McClain MS, 1996, INFECT IMMUN, V64, P1532, DOI 10.1128/IAI.64.5.1532-1540.1996; MMWR. Centers for Disease Control and Prevention, 2013, MMWR-MORBID MORTAL W, V62, P714; Molofsky AB, 2003, MOL MICROBIOL, V50, P445, DOI 10.1046/j.1365-2958.2003.03706.x; Muller FH, 2004, MOL MICROBIOL, V53, P1147, DOI 10.1111/j.1365-2958.2004.04193.x; Nies DH, 1999, APPL MICROBIOL BIOT, V51, P730, DOI 10.1007/s002530051457; Piao ZY, 2006, APPL ENVIRON MICROB, V72, P1613, DOI 10.1128/AEM.72.2.1613-1622.2006; Raftery TD, 2014, NANOTOXICOLOGY, V8, P477, DOI 10.3109/17435390.2013.796537; Rasis M, 2009, MOL MICROBIOL, V72, P995, DOI 10.1111/j.1365-2958.2009.06705.x; Reith F, 2009, P NATL ACAD SCI USA, V106, P17757, DOI 10.1073/pnas.0904583106; Rohmer L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r102; Rohr U, 1996, ZBL HYG UMWELTMED, V198, P514; Rohr U, 1999, CLIN INFECT DIS, V29, P1507, DOI 10.1086/313512; Shi CW, 2006, INT J MED MICROBIOL, V296, P15, DOI 10.1016/j.ijmm.2005.09.003; Siddaramappa S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-422; STATES SJ, 1985, APPL ENVIRON MICROB, V50, P1149, DOI 10.1128/AEM.50.5.1149-1154.1985; Stojak AR, 2011, NANOTOXICOLOGY, V5, P730, DOI 10.3109/17435390.2010.550696; Stout JE, 2003, INFECT CONT HOSP EP, V24, P563, DOI 10.1086/502251; Tiaden A, 2007, CELL MICROBIOL, V9, P2903, DOI 10.1111/j.1462-5822.2007.01005.x; Weissenmayer BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017570	52	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0174245	10.1371/journal.pone.0174245	http://dx.doi.org/10.1371/journal.pone.0174245			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28463986	gold, Green Published, Green Submitted			2022-12-26	WOS:000400646300002
J	Morawska-Kochman, M; Marycz, K; Jermakow, K; Nelke, K; Pawlak, W; Bochnia, M				Morawska-Kochman, Monika; Marycz, Krzysztof; Jermakow, Katarzyna; Nelke, Kamil; Pawlak, Wojciech; Bochnia, Marek			The presence of bacterial microcolonies on the maxillary sinus ciliary epithelium in healthy young individuals	PLOS ONE			English	Article							BIOFILMS; RHINOSINUSITIS; MICROBIOMES; MUCOSA; FLORA	Objective The aim of this cross-sectional in vitro study was to evaluate the mucosal surfaces of healthy maxillary sinuses, explore different forms of bacterial microorganism colonies present on the mucous membrane, and determine a mucosal surface area they occupy. Methods Samples of the maxillary sinus mucosa were collected from 30 healthy patients (M = 11; F = 19). The material was obtained during the Le Fort I osteotomy performed during corrective jaw surgery. The morphological and morphometric analysis of sinus mucosa and bacterial film that was grown on it was performed using scanning electron microscopy (SEM) as well as imaging software. Results Scanning electron microscopy analysis showed the presence of different bacterium and bacteria-like structures in all the analyzed samples. In most cases, the bacterial film was mostly composed of diplococci-like and streptococci-like structures on the mucosa of the paranasal sinus. In any case, the mucous layer did not cover the whole lining of the evaluated sample. Each colony consists of more than 20 single bacterial cells, which has grown in aggregates. Conclusions Under the conditions of normal homeostasis of the body, the maxillary sinuses present diverse bacterial colonization. The bacteria are dispersed or concentrated in single microcolonies of the biofilm on the border of the mucous covering the ciliary epithelium. There is no uniform layer of the biofilm covering the mucosa of the maxillary sinuses. Because the biofilm is detected on healthy individuals sinus mucosa, the clinical question if it may become pathogenic is unclear and require an explanation.	[Morawska-Kochman, Monika; Bochnia, Marek] Med Univ, Dept Otolaryngol Head & Neck Surg, Wroclaw, Poland; [Marycz, Krzysztof] Environm & Life Sci Univ, Electron Microscope Lab, Dept Hyg & Ichthyol, Wroclaw, Poland; [Jermakow, Katarzyna] Med Univ, Dept Microbiol, Wroclaw, Poland; [Nelke, Kamil; Pawlak, Wojciech] Med Univ, Dept Maxillofacial Surg, Wroclaw, Poland	Wroclaw Medical University; Wroclaw University of Environmental & Life Sciences; Wroclaw Medical University; Wroclaw Medical University	Morawska-Kochman, M (corresponding author), Med Univ, Dept Otolaryngol Head & Neck Surg, Wroclaw, Poland.	mkochman@mp.pl	Marycz, Krzysztof/A-2249-2017; Nelke, Kamil/I-1849-2019; Bochnia, Marek/S-4327-2018; Morawska-Kochman, Monika/S-3401-2018	Bochnia, Marek/0000-0002-2499-4746; Morawska-Kochman, Monika/0000-0001-6551-7535; /0000-0003-4215-0798; Jermakow, Katarzyna/0000-0001-9889-4265				Abou Hamad W, 2009, AM J RHINOL ALLERGY, V23, P261, DOI 10.2500/ajra.2009.23.3317; Albu S, 2013, AM J OTOLARYNG, V34, P327, DOI 10.1016/j.amjoto.2013.01.001; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Aurora R, 2013, JAMA OTOLARYNGOL, V139, P1328, DOI 10.1001/jamaoto.2013.5465; Belizario JE, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2015.01050, 10.1186/1476-069X-6-20, 10.3389/fmicb.2015.1050]; Bendouah Z, 2006, OTOLARYNG HEAD NECK, V134, P991, DOI 10.1016/j.otohns.2006.03.001; Bjarnsholt T, 2013, TRENDS MICROBIOL, V21, P466, DOI 10.1016/j.tim.2013.06.002; Bjarnsholt T, 2013, APMIS, V121, P1, DOI 10.1111/apm.12099; BROOK I, 1981, LARYNGOSCOPE, V91, P372; Brook I, 2016, EUR J CLIN MICROBIOL, V35, P1059, DOI 10.1007/s10096-016-2640-x; COOK HE, 1987, J ORAL MAXIL SURG, V45, P1011, DOI 10.1016/0278-2391(87)90155-8; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cryer J, 2004, ORL-J OTO-RHIN-LARYN, V66, P155, DOI 10.1159/000079994; El-Kholey KE, 2014, INT J ORAL MAX SURG, V43, P487, DOI 10.1016/j.ijom.2013.09.013; EVANS FO, 1975, NEW ENGL J MED, V293, P735, DOI 10.1056/NEJM197510092931502; Fastenberg JH, 2015, WORLD J OTORHINOLARY, V1, P219; Ferguson BJ, 2005, AM J RHINOL, V19, P452, DOI 10.1177/194589240501900506; Ferrer MD, 2017, J APPL MICROBIOL, V122, P640, DOI 10.1111/jam.13368; Fokkens W, 2007, RHINOLOGY, V45, P97; Hall-Stoodley L, 2012, FEMS IMMUNOL MED MIC, V65, P127, DOI 10.1111/j.1574-695X.2012.00968.x; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hamilos DL, 2014, J ALLERGY CLIN IMMUN, V133, P640, DOI 10.1016/j.jaci.2013.06.049; Jiang RS, 1999, J LARYNGOL OTOL, V113, P825, DOI 10.1017/S0022215100145311; JOUSIMIESSOMER HR, 1989, J CLIN MICROBIOL, V27, P2736, DOI 10.1128/JCM.27.12.2736-2743.1989; Lund B, 2015, CLIN ORAL IMPLAN RES, V26, P1, DOI 10.1111/clr.12637; Marycz K, 2014, J BIOMED MATER RES A, V102, P4017, DOI 10.1002/jbm.a.35072; Mladina R, 2010, CLIN OTOLARYNGOL, V35, P104, DOI 10.1111/j.1749-4486.2010.02097.x; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Psaltis AJ, 2007, LARYNGOSCOPE, V117, P1302, DOI 10.1097/MLG.0b013e31806009b0; Riiser A, 2015, ALLERGY ASTHMA CL IM, V11, DOI 10.1186/s13223-015-0102-0; Sanclement JA, 2005, LARYNGOSCOPE, V115, P578, DOI 10.1097/01.mlg.0000161346.30752.18; SAVOLAINEN S, 1986, Rhinology (Utrecht), V24, P249; Scheid DC, 2004, AM FAM PHYSICIAN, V70, P1685; Sibila O, 2015, RESPIROLOGY, V20, P1082, DOI 10.1111/resp.12595; Singh P, 2015, J LARYNGOL OTOL, V129, P46, DOI 10.1017/S002221511400303X; Singhal D, 2010, AM J RHINOL ALLERGY, V24, P169, DOI 10.2500/ajra.2010.24.3462; SOBIN J, 1992, SCAND J INFECT DIS, V24, P633, DOI 10.3109/00365549209054650; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Zhang Z, 2009, AM J RHINOL ALLERGY, V23, P506, DOI 10.2500/ajra.2009.23.3376	39	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176776	10.1371/journal.pone.0176776	http://dx.doi.org/10.1371/journal.pone.0176776			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28463990	gold, Green Published, Green Submitted			2022-12-26	WOS:000400646300051
J	Brown, RB; Madrid, NJ; Suzuki, H; Ness, SA				Brown, Roger B.; Madrid, Nathaniel J.; Suzuki, Hideaki; Ness, Scott A.			Optimized approach for Ion Proton RNA sequencing reveals details of RNA splicing and editing features of the transcriptome	PLOS ONE			English	Article							C-MYB; CELL; DATABASE; SEQ; DIFFERENTIATION; PROTEINS; LEUKEMIA	RNA-sequencing (RNA-seq) has become the standard method for unbiased analysis of gene expression but also provides access to more complex transcriptome features, including alternative RNA splicing, RNA editing, and even detection of fusion transcripts formed through chromosomal translocations. However, differences in library methods can adversely affect the ability to recover these different types of transcriptome data. For example, some methods have bias for one end of transcripts or rely on low-efficiency steps that limit the complexity of the resulting library, making detection of rare transcripts less likely. We tested several commonly used methods of RNA-seq library preparation and found vast differences in the detection of advanced transcriptome features, such as alternatively spliced isoforms and RNA editing sites. By comparing several different protocols available for the Ion Proton sequencer and by utilizing detailed bioinformatics analysis tools, we were able to develop an optimized random primer based RNA-seq technique that is reliable at uncovering rare transcript isoforms and RNA editing features, as well as fusion reads from oncogenic chromosome rearrangements. The combination of optimized libraries and rapid Ion Proton sequencing provides a powerful platform for the transcriptome analysis of research and clinical samples.	[Brown, Roger B.; Madrid, Nathaniel J.; Suzuki, Hideaki; Ness, Scott A.] Univ New Mexico, Hlth Sci Ctr, Div Mol Med, Dept Internal Med, Albuquerque, NM 87131 USA; [Ness, Scott A.] Univ New Mexico, UNM Comprehens Canc Ctr, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico	Ness, SA (corresponding author), Univ New Mexico, Hlth Sci Ctr, Div Mol Med, Dept Internal Med, Albuquerque, NM 87131 USA.; Ness, SA (corresponding author), Univ New Mexico, UNM Comprehens Canc Ctr, Albuquerque, NM 87131 USA.	sness@salud.unm.edu	Ness, Scott/AAV-4009-2020	Ness, Scott/0000-0001-6965-8909	National Institutes of Health [5R01CA170250, 5R01DE023222, 2P30CA118100, 5T32AI007538]; NATIONAL CANCER INSTITUTE [R01CA170250, P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institutes of Health 5R01CA170250, 5R01DE023222, 2P30CA118100, 5T32AI007538.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Brayer KJ, 2016, CANCER DISCOV, V6, P176, DOI 10.1158/2159-8290.CD-15-0859; Cretu C, 2016, MOL CELL, V64, P307, DOI 10.1016/j.molcel.2016.08.036; Crews LA, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-014-0370-3; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; George OL, 2014, CANCERS, V6, P2049, DOI 10.3390/cancers6042049; Han L, 2015, CANCER CELL, V28, P1; Jiang QF, 2013, P NATL ACAD SCI USA, V110, P1041, DOI 10.1073/pnas.1213021110; Kersey PJ, 2016, NUCLEIC ACIDS RES, V44, pD574, DOI 10.1093/nar/gkv1209; Kiran A, 2010, BIOINFORMATICS, V26, P1772, DOI 10.1093/bioinformatics/btq285; Kiran AM, 2013, NUCLEIC ACIDS RES, V41, pD258, DOI 10.1093/nar/gks961; Lei WL, 2005, BLOOD, V105, P3855, DOI 10.1182/blood-2004-08-3342; Liu F, 2006, ONCOGENE, V25, P795, DOI 10.1038/sj.onc.1209105; Ness SA, SCRIPTS ANAL RNA SEQ; Nigita G, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00037; O'Rourke JP, 2008, MOL CELL BIOL, V28, P2091, DOI 10.1128/MCB.01870-07; Pickrell JK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001236; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Reynolds AP, SAMPLE PERFORMS MEMO; Rushton JJ, 2003, ONCOGENE, V22, P308, DOI 10.1038/sj.onc.1206131; Rushton JJ, 2001, BLOOD CELL MOL DIS, V27, P459, DOI 10.1006/bcmd.2001.0405; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; van Dijk EL, 2014, EXP CELL RES, V322, P12, DOI 10.1016/j.yexcr.2014.01.008; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang LL, 2016, CANCER CELL, V30, P750, DOI 10.1016/j.ccell.2016.10.005; Yuan YX, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2745-8; Zhou Y, 2011, FRONT BIOSCI-LANDMRK, V16, P1109, DOI 10.2741/3738; Zhou YE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022880; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	31	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176675	10.1371/journal.pone.0176675	http://dx.doi.org/10.1371/journal.pone.0176675			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459821	gold, Green Published, Green Submitted			2022-12-26	WOS:000400645000044
J	Zhao, J; Wang, Y; Mu, C; Xu, Y; Sang, J				Zhao, J.; Wang, Y.; Mu, C.; Xu, Y.; Sang, J.			MAGEA1 interacts with FBXW7 and regulates ubiquitin ligase-mediated turnover of NICD1 in breast and ovarian cancer cells	ONCOGENE			English	Article							NOTCH SIGNALING PATHWAY; STEM-CELLS; CANCER/TESTIS ANTIGENS; GENE-EXPRESSION; C-JUN; PROTEIN; FAMILY; RESISTANCE; PHENOTYPE; MIGRATION	Melanoma-associated antigen A1 (MAGEA1) is member of the MAGE gene family that is expressed in male germ line cells and placenta under normal physiological conditions. Although MAGEA1's expression levels have been evaluated as one of the cancer testis (CT) antigens for immunotherapy in melanoma and several other cancers, its functional role and signaling mechanisms are largely unknown. In this study, we examined the functional involvement and signaling mechanisms of MAGEA1 in breast and ovarian cancer cells. Inhibitory effects of MAGEA1 on cell proliferation and migration were observed using both gain-of-(MAGEA1 overexpression) and loss-of-(siRNA interference) function approaches in breast (MCF-7 and MDA-MB-231) and ovarian (SKOV3 and SKOV3ip) cancer cell lines. We revealed a novel interaction between MAGEA1 and the intracellular segment of NOTCH1 receptor (NICD1). MAGEA1 reduced NICD1's stability by promoting the ubiquitin modification of NICD1. MAGEA1 also interacted with FBXW7, a subunit of E3 ubiquitin protein ligase complex SCF, and the latter was functionally involved in NICD1 ubiquitination and degradation. In addition, siRNA interference of FBXW7 reversed the inhibitory effect of MAGEA1 on migration and proliferation of MCF-7 and MDA-MB-231 cells. These newly discovered MAGEA1-NICD1 and MAGEA1-FBXW7 interactions have potential clinical implications in breast and ovarian cancer treatment.	[Zhao, J.; Wang, Y.; Mu, C.; Xu, Y.; Sang, J.] Beijing Normal Univ, Coll Life Sci, Key Lab Cell Proliferat & Regulat, 19 XinJieKouWai St, Beijing 100875, Peoples R China; [Xu, Y.] Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA	Beijing Normal University; Indiana University System; Indiana University Bloomington	Xu, Y; Sang, J (corresponding author), Beijing Normal Univ, Coll Life Sci, Key Lab Cell Proliferat & Regulat, 19 XinJieKouWai St, Beijing 100875, Peoples R China.	xu2@iupui.edu; jlsang@bnu.edu.cn			National Basic Research Program of China [2007CB914401]; National High Technology Research and Development Program of China [2006AA02Z4A6]; Mary Fendrich-Hulman Charitable Trust Fund	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Mary Fendrich-Hulman Charitable Trust Fund	This work was supported in part by The National Basic Research Program of China (Grant no. 2007CB914401) and the National High Technology Research and Development Program of China (Grant no. 2006AA02Z4A6) to JS; as well as in part by the Mary Fendrich-Hulman Charitable Trust Fund to YX. We would like to thank Kevin McClelland for editing the manuscript.	Abd-Elsalam EA, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0285-0; Acar A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2498764; Askew EB, 2009, J BIOL CHEM, V284, P34793, DOI 10.1074/jbc.M109.065979; Bao B, 2011, CANCER LETT, V307, P26, DOI 10.1016/j.canlet.2011.03.012; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bolos V, 2013, BREAST CANCER RES, V15, P15; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brzozowa-Zasada M, 2016, WSPOLCZESNA ONKOL, V20, P267, DOI 10.5114/wo.2016.61845; Daudi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104099; De Plaen E, 1999, GENOMICS, V55, P176, DOI 10.1006/geno.1998.5638; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Ladelfa MF, 2012, CANCER LETT, V325, P11, DOI 10.1016/j.canlet.2012.05.031; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gillespie AM, 1999, CANCER TREAT REV, V25, P219, DOI 10.1053/ctrv.1999.0126; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Hao JQ, 2015, ONCOTARGET, V6, P42028, DOI 10.18632/oncotarget.5973; Heasley LE, 2006, MOL CELLS, V21, P167; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hu YY, 2012, ADV EXP MED BIOL, V727, P186, DOI 10.1007/978-1-4614-0899-4_14; Kim HL, 2001, CANCER RES, V61, P2833; Kitade S, 2016, CANCER SCI, V107, P1399, DOI 10.1111/cas.13026; Kloudova K, 2016, ONCOTARGET, V7, P46120, DOI 10.18632/oncotarget.10028; Kozakova L, 2015, CELL CYCLE, V14, P920, DOI 10.1080/15384101.2014.1000112; Laduron S, 2004, NUCLEIC ACIDS RES, V32, P4340, DOI 10.1093/nar/gkh735; LARSEN RD, 1989, P NATL ACAD SCI USA, V86, P8227, DOI 10.1073/pnas.86.21.8227; Marcar L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127713; Marcar L, 2010, CANCER RES, V70, P10362, DOI 10.1158/0008-5472.CAN-10-1341; Matkovic B, 2011, CROAT MED J, V52, P171, DOI 10.3325/cmj.2011.52.171; Minges JT, 2013, J BIOL CHEM, V288, P1939, DOI 10.1074/jbc.M112.428409; Monte M, 2006, P NATL ACAD SCI USA, V103, P11160, DOI 10.1073/pnas.0510834103; Nickoloff BJ, 2003, ONCOGENE, V22, P6598, DOI 10.1038/sj.onc.1206758; Otte M, 2001, CANCER RES, V61, P6682; Peche LY, 2012, CELL DEATH DIFFER, V19, P926, DOI 10.1038/cdd.2011.173; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Potapova O, 2001, J BIOL CHEM, V276, P28546, DOI 10.1074/jbc.M102075200; Pui CH, 2009, CANCER CELL, V15, P85, DOI 10.1016/j.ccr.2009.01.007; Saha SK, 2017, ONCOGENE, V36, P332, DOI 10.1038/onc.2016.221; She QB, 2002, CANCER RES, V62, P1343; Shukla G, 2017, CURR STEM CELL RES T, V12, P207, DOI 10.2174/1574888X11666161028143224; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Takebe N, 2015, NAT REV CLIN ONCOL, V12, P445, DOI 10.1038/nrclinonc.2015.61; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; TRAVERSARI C, 1992, IMMUNOGENETICS, V35, P145, DOI 10.1007/BF00185107; Tseng HY, 2012, CARCINOGENESIS, V33, P1871, DOI 10.1093/carcin/bgs236; Uhlirova M, 2005, P NATL ACAD SCI USA, V102, P13123, DOI 10.1073/pnas.0504170102; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Wang D, 2016, BIOCHEM BIOPH RES CO, V473, P959, DOI 10.1016/j.bbrc.2016.03.161; WEINBERGER M, 1989, ARTHRITIS RHEUM, V32, P1577, DOI 10.1002/anr.1780321212; Weon JL, 2015, CURR OPIN CELL BIOL, V37, P1, DOI 10.1016/j.ceb.2015.08.002; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Zhang SQ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-163; Zhou SF, 2000, MOL CELL BIOL, V20, P2400, DOI 10.1128/MCB.20.7.2400-2410.2000	54	21	22	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 31	2017	36	35					5023	5034		10.1038/onc.2017.131	http://dx.doi.org/10.1038/onc.2017.131			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FF3AV	28459460				2022-12-26	WOS:000408768800007
J	Itoh, E; Odakura, R; Oinuma, KI; Shimizu, M; Masuo, S; Takaya, N				Itoh, Eriko; Odakura, Rika; Oinuma, Ken-Ichi; Shimizu, Motoyuki; Masuo, Shunsuke; Takaya, Naoki			Sirtuin E is a fungal global transcriptional regulator that determines the transition from the primary growth to the stationary phase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT HISTONE DEACETYLASE; CARBON CATABOLITE REPRESSION; RNA-SEQ DATA; ASPERGILLUS-NIDULANS; SIR2-LIKE PROTEINS; GENE; SIR2; NAD; CHROMATIN; ORYZAE	In response to limited nutrients, fungal cells exit the primary growth phase, enter the stationary phase, and cease proliferation. Although fundamental to microbial physiology in many environments, the regulation of this transition is poorly understood but likely involves many transcriptional regulators. These may include the sirtuins, which deacetylate acetyllysine residues of histones and epigenetically regulate global transcription. Therefore, we investigated the role of a nuclear sirtuin, sirtuin E (SirE), from the ascomycete fungus Aspergillus nidulans. An A. nidulans strain with a disrupted sirE gene (SirE Delta) accumulated more acetylated histone H3 during the stationary growth phase when sirE was expressed at increased levels in the wild type. SirE Delta exhibited decreased mycelial autolysis, conidiophore development, sterigmatocystin biosynthesis, and production of extracellular hydrolases. Moreover, the transcription of the genes involved in these processes was also decreased, indicating that SirE is a histone deacetylase that up-regulates these activities in the stationary growth phase. Transcriptome analyses indicated that SirE repressed primary carbon and nitrogen metabolism and cell-wall synthesis. Chromatin immunoprecipitation demonstrated that SirE deacetylates acetylated Lys-9 residues in histone H3 at the gene promoters of alpha-1,3-glucan synthase (agsB), glycolytic phosphofructokinase (pfkA), and glyceraldehyde 3-phosphate (gpdA), indicating that SirE represses the expression of these primary metabolic genes. In summary, these results indicate that SirE facilitates the metabolic transition from the primary growth phase to the stationary phase. Because the observed gene expression profiles in stationary phase matched those resulting from carbon starvation, SirE appears to control this metabolic transition via a mechanism associated with the starvation response.	[Itoh, Eriko; Odakura, Rika; Oinuma, Ken-Ichi; Shimizu, Motoyuki; Masuo, Shunsuke; Takaya, Naoki] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	University of Tsukuba	Takaya, N (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.	takaya.naoki.ge@u.tsukuba.ac.jp		Masuo, Shunsuke/0000-0002-0454-3315	Japan Society for the Promotion of Science KAKENHI [15H02487, 24380041]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants-in-aid for Scientific Research 15H02487 and 24380041 (to N. T.). The authors declare that they have no conflicts of interest with the contents of this article.	ADAMS TH, 1988, CELL, V54, P353, DOI 10.1016/0092-8674(88)90198-5; Al-Nasiry S, 2007, HUM REPROD, V22, P1304, DOI 10.1093/humrep/dem011; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Bernreiter A, 2007, MOL CELL BIOL, V27, P791, DOI 10.1128/MCB.00761-06; Cerqueira GC, 2014, NUCLEIC ACIDS RES, V42, pD705, DOI 10.1093/nar/gkt1029; de Groot PWJ, 2009, FUNGAL GENET BIOL, V46, pS72, DOI 10.1016/j.fgb.2008.07.022; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Emri T, 2004, FOLIA MICROBIOL, V49, P277, DOI 10.1007/BF02931043; ESPESO EA, 1992, MOL MICROBIOL, V6, P1457, DOI 10.1111/j.1365-2958.1992.tb00866.x; Fernandez J, 2014, MOL MICROBIOL, V94, P70, DOI 10.1111/mmi.12743; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kawauchi M, 2014, J BIOSCI BIOENG, V118, P172, DOI 10.1016/j.jbiosc.2014.02.004; Kawauchi M, 2013, EUKARYOT CELL, V12, P1087, DOI 10.1128/EC.00003-13; Kim S, 2002, BIOSCI BIOTECH BIOCH, V66, P2168, DOI 10.1271/bbb.66.2168; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee I, 2009, FUNGAL GENET BIOL, V46, P782, DOI 10.1016/j.fgb.2009.06.007; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r48; Li MG, 2010, MOL CELL BIOL, V30, P3329, DOI 10.1128/MCB.01590-09; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Masuo S, 2010, MOL GENET GENOMICS, V284, P415, DOI 10.1007/s00438-010-0576-x; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Motoyama T, 1997, MOL GEN GENET, V253, P520, DOI 10.1007/s004380050353; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Ruijter GJG, 1997, FEMS MICROBIOL LETT, V151, P103, DOI 10.1016/S0378-1097(97)00161-4; Saikia R, 2005, CURR SCI INDIA, V89, P659; Saykhedkar S, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-52; Sherman JM, 1999, MOL BIOL CELL, V10, P3045, DOI 10.1091/mbc.10.9.3045; Shimizu M, 2009, PROTEOMICS, V9, P7, DOI 10.1002/pmic.200701163; Shimizu M, 2012, MOL CELL BIOL, V32, P3743, DOI 10.1128/MCB.00032-12; Shroff RA, 1997, FUNGAL GENET BIOL, V22, P28, DOI 10.1006/fgbi.1997.0989; Shwab EK, 2007, EUKARYOT CELL, V6, P1656, DOI 10.1128/EC.00186-07; Szilagyi M, 2010, J APPL MICROBIOL, V109, P1498, DOI 10.1111/j.1365-2672.2010.04782.x; Szilagyi M, 2013, MICROBIOL-SGM, V159, P176, DOI 10.1099/mic.0.062935-0; Takasaki K, 2004, J BIOL CHEM, V279, P12414, DOI 10.1074/jbc.M313761200; Yamazaki H, 2007, CURR GENET, V51, P89, DOI 10.1007/s00294-006-0109-7; YANAI K, 1992, J BACTERIOL, V174, P7398, DOI 10.1128/jb.174.22.7398-7406.1992; Yang B, 2008, MOL BIOL CELL, V19, P4993, DOI 10.1091/mbc.E08-05-0524; Yu JH, 1996, CURR GENET, V29, P549, DOI 10.1007/s002940050084	48	13	13	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					11043	11054		10.1074/jbc.M116.753772	http://dx.doi.org/10.1074/jbc.M116.753772			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28465348	Green Published, hybrid			2022-12-26	WOS:000404391000025
J	Mehta, MB; Shewale, SV; Sequeira, RN; Millar, JS; Hand, NJ; Rader, DJ				Mehta, Minal B.; Shewale, Swapnil V.; Sequeira, Raymond N.; Millar, John S.; Hand, Nicholas J.; Rader, Daniel J.			Hepatic protein phosphatase 1 regulatory subunit 3B (Ppp1r3b) promotes hepatic glycogen synthesis and thereby regulates fasting energy homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gluconeogenesis; glycogen; glycogen storage disease; glycogen synthase; glycolysis; liver; Alb-Cre; Ppp1r3b	GLUCOSE-HOMEOSTASIS; TARGETING SUBUNITS; INSULIN-RESISTANCE; LIVER; METABOLISM; PTG; VARIANTS; SYNTHASE; HEPATOCYTES; EXPRESSION	Maintenance of whole-body glucose homeostasis is critical to glycemic function. Genetic variants mapping to chromosome 8p23.1 in genome-wide association studies have been linked to glycemic traits in humans. The gene of known function closest to the mapped region, PPP1R3B (protein phosphatase 1 regulatory subunit 3B), encodes a protein (G(L)) that regulates glycogen metabolism in the liver. We therefore sought to test the hypothesis that hepatic PPP1R3B is associated with glycemic traits. We generated mice with either liver-specific deletion (Ppp1r3b(hep)) or liver-specific overexpression of Ppp1r3b. The Ppp1r3b deletion significantly reduced glycogen synthase protein abundance, and the remaining protein was predominantly phosphorylated and inactive. As a consequence, glucose incorporation into hepatic glycogen was significantly impaired, total hepatic glycogen content was substantially decreased, and mice lacking hepatic Ppp1r3b had lower fasting plasma glucose than controls. The concomitant loss of liver glycogen impaired whole-body glucose homeostasis and increased hepatic expression of glycolytic enzymes in Ppp1r3b(hep) mice relative to controls in the postprandial state. Eight hours of fasting significantly increased the expression of two critical gluconeogenic enzymes, phosphoenolpyruvate carboxykinase and glucose-6-phosphatase, above the levels in control livers. Conversely, the liver-specific overexpression of Ppp1r3b enhanced hepatic glycogen storage above that of controls and, as a result, delayed the onset of fasting-induced hypoglycemia. Moreover, mice overexpressing hepatic Ppp1r3b upon long-term fasting (12-36 h) were protected from blood ketone-body accumulation, unlike control and Ppp1r3b(hep) mice. These findings indicate a major role for Ppp1r3b in regulating hepatic glycogen stores and whole-body glucose/energy homeostasis.	[Mehta, Minal B.; Shewale, Swapnil V.; Sequeira, Raymond N.; Millar, John S.; Rader, Daniel J.] Univ Penn, Perelman Sch Med, Div Translat Med & Human Genet, Philadelphia, PA 19104 USA; [Mehta, Minal B.; Shewale, Swapnil V.; Hand, Nicholas J.; Rader, Daniel J.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Rader, Daniel J.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Rader, DJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Genet, Smilow Ctr Translat Res, SCTR 11-125,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	rader@mail.med.upenn.edu	Hand, Nicholas/Q-4235-2019; Shewale, Swapnil/S-8144-2019	Hand, Nicholas/0000-0002-8172-1816; Rader, Daniel/0000-0002-9245-9876; Mehta, Minal/0000-0001-9062-8317	National Institutes of Health [RC2HL101864, R01HL089309]; American Diabetes Association [1-17-PDF-060]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101864, R01HL089309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants RC2HL101864 and R01HL089309 (to D. J. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by an American Diabetes Association Postdoctoral Fellowship Grant 1-17-PDF-060.	Bollen M, 1998, BIOCHEM J, V336, P19, DOI 10.1042/bj3360019; Brady MJ, 1997, J BIOL CHEM, V272, P20198, DOI 10.1074/jbc.272.32.20198; Cohen PTW, 2002, J CELL SCI, V115, P241; Crosson SM, 2003, J CLIN INVEST, V111, P1423, DOI 10.1172/JCI200317975; DOHERTY MJ, 1995, FEBS LETT, V375, P294, DOI 10.1016/0014-5793(95)01184-G; Ferrer JC, 2003, FEBS LETT, V546, P127, DOI 10.1016/S0014-5793(03)00565-9; GAIN KR, 1981, J CLIN INVEST, V67, P1569, DOI 10.1172/JCI110188; Gasa R, 2000, J BIOL CHEM, V275, P26396, DOI 10.1074/jbc.M002427200; Hernaez R, 2013, CLIN GASTROENTEROL H, V11, P1183, DOI 10.1016/j.cgh.2013.02.011; HUBBARD MJ, 1989, EUR J BIOCHEM, V186, P701, DOI 10.1111/j.1432-1033.1989.tb15263.x; Irimia JM, 2010, J BIOL CHEM, V285, P12851, DOI 10.1074/jbc.M110.106534; Kelsall IR, 2009, CELL SIGNAL, V21, P1123, DOI 10.1016/j.cellsig.2009.03.001; Li WC, 2010, METHODS MOL BIOL, V633, P185, DOI 10.1007/978-1-59745-019-5_13; Lopez-Soldado I, 2015, DIABETES, V64, P796, DOI 10.2337/db14-0728; Lu BB, 2014, DIABETES, V63, P2935, DOI 10.2337/db13-1531; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Montori-Grau M, 2007, BIOCHEM J, V405, P107, DOI 10.1042/BJ20061572; MOORHEAD G, 1995, FEBS LETT, V362, P101, DOI 10.1016/0014-5793(95)00197-H; Newgard CB, 2000, DIABETES, V49, P1967, DOI 10.2337/diabetes.49.12.1967; O'Doherty RM, 2000, J CLIN INVEST, V105, P479, DOI 10.1172/JCI8673; Palmer ND, 2013, HEPATOLOGY, V58, P966, DOI 10.1002/hep.26440; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; Saitoh Y, 2010, HISTOCHEM CELL BIOL, V133, P229, DOI 10.1007/s00418-009-0663-4; STALMANS W, 1987, Diabetes Metabolism Reviews, V3, P127; Szymanska E, 2015, MOLEC GENET METAB RE, V4, P83, DOI 10.1016/j.ymgmr.2015.07.003; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tin A, 2016, DIABETIC MED, V33, P968, DOI 10.1111/dme.12971; VillarPalasi C, 1997, FASEB J, V11, P544, DOI 10.1096/fasebj.11.7.9212078; Wang LL, 2010, MOL THER, V18, P118, DOI 10.1038/mt.2009.246; Weinstein DA, 2006, MOL GENET METAB, V87, P284, DOI 10.1016/j.ymgme.2005.10.006	34	39	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10444	10454		10.1074/jbc.M116.766329	http://dx.doi.org/10.1074/jbc.M116.766329			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28473467	Green Published, hybrid			2022-12-26	WOS:000404115400010
J	Wang, CY; Sun, MH; Yuan, XH; Ji, LF; Jin, Y; Cardona, CJ; Xing, Z				Wang, Chunyang; Sun, Menghuai; Yuan, Xinhui; Ji, Lianfu; Jin, Yu; Cardona, Carol J.; Xing, Zheng			Enterovirus 71 suppresses interferon responses by blocking Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling through inducing karyopherin-alpha 1 degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR IMPORT; MOUTH-DISEASE; ANTIVIRAL RESPONSES; PROTEIN; VIRUS; ALPHA; ANTAGONIZES; INFECTION; PATHWAYS; CLEAVAGE	Enterovirus 71 (EV71) has emerged as one of the most important enteroviruses since the eradication of poliovirus, and it causes severe neurological symptoms for which no effective antiviral drugs are available. Type I interferons (IFN)alpha/beta have been used clinically as antiviral therapy as the first line of defense against virus infections successfully for decades. However, treatment with type I interferons has not been effective in patients with EV71 infection. In this study, we found that in cells pretreated with IFN-beta, EV71 infection could still lead to a cytopathic effect, and the viral replication was not affected. The mechanism by which EV71 antagonizes interferon signaling, however, has been controversial. Our study indicated that EV71 infection did not inhibit phosphorylation of STAT1/2 induced by IFN-beta stimulation, but p-STAT1/2 transport into the nucleus was significantly blocked. We showed that EV71 infection reduced the formation of STAT/karyopherin-alpha 1 (KPNA1) complex upon interferon stimulation and that the virus down-regulated the expression of KPNA1, a nuclear localization signal receptor for p-STAT1. Using specific caspase inhibitors and siRNA for caspase-3, we demonstrated that EV71 infection induced degradation of cellular KPNA1 in a caspase-3-dependent manner, which led to decreased induction of interferon-inducible genes and IFN response. Viral 2A and 3C proteases did not degrade KPNA1, inhibit the activity of ISRE or suppress the transcription of interferon-inducible genes induced by IFN-beta. Our study demonstrates a novel mechanism by which antiviral signaling is suppressed through degradation of KPNA1 by activated caspase-3 induced in an enteroviral infection.	[Wang, Chunyang; Sun, Menghuai; Yuan, Xinhui; Ji, Lianfu; Jin, Yu; Xing, Zheng] Nanjing Univ, Med Sch, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Chunyang; Sun, Menghuai; Yuan, Xinhui; Ji, Lianfu; Jin, Yu; Xing, Zheng] Nanjing Univ, Jiangsu Prov Key Lab Med, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Chunyang] Xian Med Univ, Clin Med Coll, Xian 710021, Peoples R China; [Wang, Chunyang; Sun, Menghuai; Yuan, Xinhui; Ji, Lianfu; Jin, Yu] Nanjing Med Univ, Nanjing Childrens Hosp, Nanjing 210029, Jiangsu, Peoples R China; [Cardona, Carol J.; Xing, Zheng] Univ Minnesota Twin Cities, Coll Vet Med, Dept Vet Biomed Sci, St Paul, MN 55108 USA	Nanjing University; Nanjing University; Xi'an Medical University; Nanjing Medical University; University of Minnesota System; University of Minnesota Twin Cities	Jin, Y (corresponding author), Nanjing Med Univ, Nanjing Childrens Hosp, Nanjing 210029, Jiangsu, Peoples R China.; Xing, Z (corresponding author), Univ Minnesota Twin Cities, 300D Vet Sci Bldg,1971 Commonwealth Ave, St Paul, MN 55108 USA.	jinyuldyy@163.com; zxing@umn.edu	Xing, Zheng/O-3137-2015	Xing, Zheng/0000-0002-7288-0268	National Natural Science Foundation of China [81571993]; Natural Science Foundation of Jiangsu Province [BK20141078]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by National Natural Science Foundation of China Grant 81571993 (to Z. X.) and Natural Science Foundation of Jiangsu Province Grant BK20141078 (to Y. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Best SM, 2002, VIROLOGY, V292, P224, DOI 10.1006/viro.2001.1238; Chi CZ, 2013, VIRUS RES, V176, P53, DOI 10.1016/j.virusres.2013.05.002; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Du YJ, 2014, J VIROL, V88, P4908, DOI 10.1128/JVI.03668-13; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Frieman M, 2007, J VIROL, V81, P9812, DOI 10.1128/JVI.01012-07; Ghosh Roy Sounak, 2014, World J Biol Chem, V5, P93, DOI 10.4331/wjbc.v5.i2.93; Johnson CL, 2006, TRENDS IMMUNOL, V27, P1, DOI 10.1016/j.it.2005.11.004; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kuo RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063431; Lei XB, 2013, J VIROL, V87, P1690, DOI 10.1128/JVI.01855-12; Lei XB, 2011, J VIROL, V85, P8811, DOI 10.1128/JVI.00447-11; Lei XB, 2010, J VIROL, V84, P8051, DOI 10.1128/JVI.02491-09; Liang CY, 2015, NAT REV MICROBIOL, V13, P7, DOI 10.1038/nrmicro3369; Liu ML, 2005, J GEN VIROL, V86, P3263, DOI 10.1099/vir.0.81195-0; Liu Y, 2014, VIRAL IMMUNOL, V27, P267, DOI 10.1089/vim.2013.0127; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2012, J VIROL, V86, P3767, DOI 10.1128/JVI.06687-11; McBride KM, 2002, EMBO J, V21, P1754, DOI 10.1093/emboj/21.7.1754; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Prevot D, 2003, BIOL CELL, V95, P141, DOI 10.1016/S0248-4900(03)00031-5; Reid SP, 2006, J VIROL, V80, P5156, DOI 10.1128/JVI.02349-05; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Wang B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003231; Wang CY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152177; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Wang R, 2013, J VIROL, V87, P5219, DOI 10.1128/JVI.02643-12; Weber F, 2004, VIRAL IMMUNOL, V17, P498, DOI 10.1089/vim.2004.17.498; Wong SSY, 2010, EPIDEMIOL INFECT, V138, P1071, DOI 10.1017/S0950268809991555; Xu W, 2014, CELL HOST MICROBE, V16, P187, DOI 10.1016/j.chom.2014.07.008; Yi LN, 2011, CRIT REV MICROBIOL, V37, P313, DOI 10.3109/1040841X.2011.580723; Yi LN, 2011, ANTIVIR THER, V16, P51, DOI 10.3851/IMP1720; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94	36	40	45	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10262	10274		10.1074/jbc.M116.745729	http://dx.doi.org/10.1074/jbc.M116.745729			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28455446	hybrid, Green Published			2022-12-26	WOS:000403580600034
J	Cook, J; Lewandowsky, S; Ecker, UKH				Cook, John; Lewandowsky, Stephan; Ecker, Ullrich K. H.			Neutralizing misinformation through inoculation: Exposing misleading argumentation techniques reduces their influence	PLOS ONE			English	Article							CLIMATE-CHANGE; CONTINUED INFLUENCE; MEDIA COVERAGE; FALSE BALANCE; SCIENCE; POLARIZATION; VACCINE; CONSTRUCTION; CONTROVERSY; VALIDATION	Misinformation can undermine a well-functioning democracy. For example, public misconceptions about climate change can lead to lowered acceptance of the reality of climate change and lowered support for mitigation policies. This study experimentally explored the impact of misinformation about climate change and tested several pre-emptive interventions designed to reduce the influence of misinformation. We found that false-balance media coverage (giving contrarian views equal voice with climate scientists) lowered perceived consensus overall, although the effect was greater among free-market supporters. Likewise, misinformation that confuses people about the level of scientific agreement regarding anthropogenic global warming (AGW) had a polarizing effect, with free-market supporters reducing their acceptance of AGW and those with low free-market support increasing their acceptance of AGW. However, we found that inoculating messages that (1) explain the flawed argumentation technique used in the misinformation or that (2) highlight the scientific consensus on climate change were effective in neutralizing those adverse effects of misinformation. We recommend that climate communication messages should take into account ways in which scientific content can be distorted, and include pre-emptive inoculation messages.	[Cook, John] George Mason Univ, Ctr Climate Change Commun, Fairfax, VA 22030 USA; [Cook, John; Lewandowsky, Stephan; Ecker, Ullrich K. H.] Univ Western Australia, Sch Psychol Sci, Perth, WA, Australia; [Lewandowsky, Stephan] Univ Bristol, Sch Expt Psychol, Bristol, Avon, England; [Lewandowsky, Stephan] Univ Bristol, Cabot Inst, Bristol, Avon, England	George Mason University; University of Western Australia; University of Bristol; University of Bristol	Cook, J (corresponding author), George Mason Univ, Ctr Climate Change Commun, Fairfax, VA 22030 USA.; Cook, J (corresponding author), Univ Western Australia, Sch Psychol Sci, Perth, WA, Australia.	jcook20@gmu.edu	Ecker, Ullrich K H/A-2043-2010; Lewandowsky, Stephan/L-4272-2019	Ecker, Ullrich K H/0000-0003-4743-313X; Lewandowsky, Stephan/0000-0003-1655-2013; Cook, John/0000-0001-8488-6766	Australian Research Council; Royal Society; Psychonomics Society	Australian Research Council(Australian Research Council); Royal Society(Royal Society of London); Psychonomics Society	Support was provided by the Australian Research Council, the Royal Society, and the Psychonomics Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae J, 2006, PUBLIC RELAT REV, V32, P144, DOI 10.1016/j.pubrev.2006.02.007; Banas JA, 2013, HUM COMMUN RES, V39, P184, DOI 10.1111/hcre.12000; Banas JA, 2010, COMMUN MONOGR, V77, P281, DOI 10.1080/03637751003758193; Bedford D, 2010, J GEOGR, V109, P159, DOI 10.1080/00221341.2010.498121; Berrens RP, 2003, POLIT ANAL, V11, P1, DOI 10.1093/pan/11.1.1; Boykoff MT, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/2/024002; Boykoff MT, 2004, GLOBAL ENVIRON CHANG, V14, P125, DOI 10.1016/j.gloenvcha.2003.10.001; Brehm J.W., 1966, THEORY PSYCHOL REACT; Carrillo-Santisteve P, 2012, CLIN MICROBIOL INFEC, V18, P50, DOI 10.1111/j.1469-0691.2012.03982.x; CDC, 2017, MEASL CAS OUTBR; Chigwedere P, 2008, JAIDS-J ACQ IMM DEF, V49, P410, DOI 10.1097/QAI.0b013e31818a6cd5; Clarke CE, 2008, SCI COMMUN, V30, P77, DOI 10.1177/1075547008320262; Compton J., 2013, SAGE HDB PERSUASION, V2nd ed, P220; Cook J., 2016, OXFORD ENCY CLIMATE; Cook J, 2014, REPORTS NATL CTR SCI, V34; Cook J, 2015, MAKING SENSE CLIMATE; Cook J, 2014, J GEOSCI ED, V62, P296, DOI [DOI 10.5408/13-071.1, 10.5408/13-071.1]; Cook J, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/4/048002; Cook J, 2016, TOP COGN SCI, V8, P160, DOI 10.1111/tops.12186; Cook J, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024024; Deryugina T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151469; Diethelm P, 2009, EUR J PUBLIC HEALTH, V19, P2, DOI 10.1093/eurpub/ckn139; Dixon GN, 2013, SCI COMMUN, V35, P358, DOI 10.1177/1075547012458290; Dunlap RE, 2016, ENVIRONMENT, V58, P4, DOI 10.1080/00139157.2016.1208995; DURYEA EJ, 1983, J SCHOOL HEALTH, V53, P250, DOI 10.1111/j.1746-1561.1983.tb01139.x; Ecker UKH, 2017, J APPL RES MEMORY CO; Ecker UKH, 2014, PROCESSING INACCURATE INFORMATION: THEORETICAL AND APPLIED PERSPECTIVES FROM COGNITIVE SCIENCE AND THE EDUCATIONAL SCIENCES, P13; Ecker UKH, 2010, MEM COGNITION, V38, P1087, DOI 10.3758/MC.38.8.1087; Elsasser SW, 2012, AM BEHAV SCI; Gardner MN, 2006, AM J PUBLIC HEALTH, V96, P222, DOI 10.2105/AJPH.2005.066654; Heath Y, 2006, ENVIRON BEHAV, V38, P48, DOI 10.1177/0013916505277998; HOAGLIN DC, 1986, J AM STAT ASSOC, V81, P991, DOI 10.2307/2289073; Jensen C., 1998, MANY CLIMATE RESEARC; Johnson TJ, 2009, J COMPUT-MEDIAT COMM, V15, P60, DOI 10.1111/j.1083-6101.2009.01492.x; Kahan DM, 2011, J RISK RES, V14, P147, DOI 10.1080/13669877.2010.511246; Kahneman D, 2003, AM ECON REV, V93, P1449, DOI 10.1257/000282803322655392; Koehler DJ, 2016, J EXP PSYCHOL-APPL, V22, P24, DOI 10.1037/xap0000073; Kortenkamp KV, 2015, SCI COMMUNICATION; Kowalski P, 2009, TEACH PSYCHOL, V36, P153, DOI 10.1080/00986280902959986; Leiserowitz A., 2015, CLIMATE CHANGE AM MI; Lewandowsky S, 2005, PSYCHOL SCI, V16, P190, DOI 10.1111/j.0956-7976.2005.00802.x; Lewandowsky S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075637; Lewandowsky S, 2013, NAT CLIM CHANGE, V3, P399, DOI [10.1038/nclimate1720, 10.1038/NCLIMATE1720]; Lewandowsky S, 2013, PSYCHOL SCI, V24, P622, DOI 10.1177/0956797612457686; Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018; Luntz F., 2002, ENV CLEANER SAFER HE; Maibach E, 2014, EARTHS FUTURE, V2, P295, DOI 10.1002/2013EF000226; Majumder MS, 2015, JAMA PEDIATR, V169, P494, DOI 10.1001/jamapediatrics.2015.0384; Malka A, 2009, FEATURING SKEPTICS N; Malka A, 2009, RISK ANAL, V29, P633, DOI 10.1111/j.1539-6924.2009.01220.x; McCright AM, 2016, TOP COGN SCI, V8, P76, DOI 10.1111/tops.12171; McCright AM, 2011, SOCIOL QUART, V52, P155, DOI 10.1111/j.1533-8525.2011.01198.x; McCuin JL, 2014, J GEOL EDUC, V62, P445, DOI [DOI 10.5408/13-068.1, 10.5408/13-068.1]; MCGUIRE WJ, 1962, PUBLIC OPIN QUART, V26, P24, DOI 10.1086/267068; Miller CH, 2013, HUM COMMUN RES, V39, P127, DOI 10.1111/j.1468-2958.2012.01438.x; Muller A, 2008, J COMPUT ASSIST LEAR, V24, P144, DOI 10.1111/j.1365-2729.2007.00248.x; Muller DA, 2008, RAISING COGNITIVE LO; NCES, 2009, DIG ED STUD 2008; Niederdeppe J, 2014, PUBLIC OPIN QUART, V78, P634, DOI 10.1093/poq/nfu026; Nyhan B, 2010, POLIT BEHAV, V32, P303, DOI 10.1007/s11109-010-9112-2; OHANIAN R, 1990, J ADVERTISING, V19, P39, DOI 10.1080/00913367.1990.10673191; Oreskes N, 2004, SCIENCE, V306, P1686, DOI 10.1126/science.1103618; Painter J., 2013, CLIMATE CHANGE MEDIA; PFAU M, 1992, COMMUN MONOGR, V59, P213, DOI 10.1080/03637759209376266; Richter T, 2009, J PERS SOC PSYCHOL, V96, P538, DOI 10.1037/a0014038; Smith MJ, 2008, PEDIATRICS, V121, pE836, DOI 10.1542/peds.2007-1760; Smith N, 2012, RISK ANAL, V32, P1021, DOI 10.1111/j.1539-6924.2012.01801.x; Stenhouse N, 2013, B AM METEOROLOGICAL; Stocking SH, 2009, PUBLIC UNDERST SCI, V18, P23, DOI 10.1177/0963662507079373; Tippett CD, 2010, INT J SCI MATH EDUC, V8, P951, DOI 10.1007/s10763-010-9203-x; van der Linden S, 2017, GLOB CHALL, V1, DOI 10.1002/gch2.201600008; van der Linden SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118489; Walker J., 1998, DRAFT GLOBAL CLIMATE; Wood MLM, 2007, HUM COMMUN RES, V33, P357, DOI 10.1111/j.1468-2958.2007.00303.x; Zimmerman M., 2009, EOS T AM GEOPHYS UN, V99, P22, DOI DOI 10.1029/2009EO030002	77	272	274	10	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0175799	10.1371/journal.pone.0175799	http://dx.doi.org/10.1371/journal.pone.0175799			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SX	28475576	Green Published, gold			2022-12-26	WOS:000400649500005
J	Vegter, EL; Ovchinnikova, ES; Sillje, HHW; Meems, LMG; van der Pol, A; van der Velde, AR; Berezikov, E; Voors, AA; de Boer, RA; van der Meer, P				Vegter, Eline L.; Ovchinnikova, Ekaterina S.; Sillje, Herman H. W.; Meems, Laura M. G.; van der Pol, Atze; van der Velde, A. Rogier; Berezikov, Eugene; Voors, Adriaan A.; de Boer, Rudolf A.; van der Meer, Peter			Rodent heart failure models do not reflect the human circulating microRNA signature in heart failure	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; BIOMARKERS; HYPERTENSION; PROGRESSION; DISEASE; INJURY; KINASE	Introduction We recently identified a set of plasma microRNAs (miRNAs) that are downregulated in patients with heart failure in comparison with control subjects. To better understand their meaning and function, we sought to validate these circulating miRNAs in 3 different well-established rat and mouse heart failure models, and correlated the miRNAs to parameters of cardiac function. Methods The previously identified let-7i-5p, miR-16-5p, miR-18a-5p, miR-26b-5p, miR-27a-3p, miR30e-5p, miR-199a-3p, miR-223-3p, miR-423-3p, miR-423-5p and miR-652-3p were measured by means of quantitative real time polymerase chain reaction (qRT-PCR) in plasma samples of 8 homozygous TGR(mREN2)27 (Ren2) transgenic rats and 8 (control) Sprague-Dawley rats, 6 mice with angiotensin II-induced heart failure (AngII) and 6 control mice, and 8 mice with ischemic heart failure and 6 controls. Circulating miRNA levels were compared between the heart failure animals and healthy controls. Results Ren2 rats, AngII mice and mice with ischemic heart failure showed clear signs of heart failure, exemplified by increased left ventricular and lung weights, elevated end-diastolic left ventricular pressures, increased expression of cardiac stress markers and reduced left ventricular ejection fraction. All miRNAs were detectable in plasma from rats and mice. No significant differences were observed between the circulating miRNAs in heart failure animals when compared to the healthy controls (all P>0.05) and no robust associations with cardiac function could be found. Conclusions The previous observation that miRNAs circulate in lower levels in human patients with heart failure could not be validated in well-established rat and mouse heart failure models. These results question the translation of data on human circulating miRNA levels to experimental models, and vice versa the validity of experimental miRNA data for human heart failure.	[Vegter, Eline L.; Ovchinnikova, Ekaterina S.; Sillje, Herman H. W.; Meems, Laura M. G.; van der Pol, Atze; van der Velde, A. Rogier; Voors, Adriaan A.; de Boer, Rudolf A.; van der Meer, Peter] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Ovchinnikova, Ekaterina S.; Berezikov, Eugene] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, Groningen, Netherlands	University of Groningen; University of Groningen	van der Meer, P (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands.	p.van.der.meer@umcg.nl	de Boer, Rudolf/ABE-9879-2020; Meems, Laura M.G./J-7979-2016; Berezikov, Eugene/D-3363-2013; Voors, Adriaan/ABE-6784-2020	Meems, Laura M.G./0000-0001-8627-7139; Berezikov, Eugene/0000-0002-1145-2884; van der Pol, Atze/0000-0003-1182-5051	Innovational Research Incentives Scheme Program of the Netherlands Organization for Scientific Research (NWO VIDI) [917.13.350]; Netherlands Heart Foundation: Approaching Heart Failure By Translational Research Of RNA Mechanisms (ARENA) [2011-11]; Netherlands CardioVascular Research Initiative; Netherlands Heart Foundation; Dutch Federation of University Medical Centres; Netherlands Organization for Health Research and Development; Royal Netherlands Academy of Sciences	Innovational Research Incentives Scheme Program of the Netherlands Organization for Scientific Research (NWO VIDI); Netherlands Heart Foundation: Approaching Heart Failure By Translational Research Of RNA Mechanisms (ARENA); Netherlands CardioVascular Research Initiative; Netherlands Heart Foundation(Netherlands Heart Foundation); Dutch Federation of University Medical Centres; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Royal Netherlands Academy of Sciences	This study is supported by the Innovational Research Incentives Scheme Program of the Netherlands Organization for Scientific Research (NWO VIDI, grant 917.13.350 to Dr. de Boer). This study was further subsidized by a grant from the Netherlands Heart Foundation: Approaching Heart Failure By Translational Research Of RNA Mechanisms (ARENA, 2011-11). We also acknowledge the support from the Netherlands CardioVascular Research Initiative: the Netherlands Heart Foundation, Dutch Federation of University Medical Centres, the Netherlands Organization for Health Research and Development and the Royal Netherlands Academy of Sciences.	Akat KM, 2014, P NATL ACAD SCI USA, V111, P11151, DOI 10.1073/pnas.1401724111; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Bernardo BC, 2014, FASEB J, V28, P5097, DOI 10.1096/fj.14-253856; Booij HG, 2016, CARDIOVASC RES, V111, P217, DOI 10.1093/cvr/cvw161; Cannon MV, 2015, EMBO MOL MED, V7, P1229, DOI 10.15252/emmm.201404669; de Boer RA, 2004, J MOL MED, V82, P678, DOI 10.1007/s00109-004-0579-3; Deddens JC, 2016, J CARDIOVASC TRANSL, V9, P291, DOI 10.1007/s12265-016-9705-1; Dickinson BA, 2013, EUR J HEART FAIL, V15, P650, DOI 10.1093/eurjhf/hft018; Emanueli C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154274; Kaneko M, 2016, BIOMARKERS, V11, P1; Ludwig N, 2016, NUCLEIC ACIDS RES, V44, P3865, DOI 10.1093/nar/gkw116; Ovchinnikova ES, 2016, EUR J HEART FAIL, V18, P414, DOI 10.1002/ejhf.332; Piubelli Chiara, 2014, Cells, V3, P802, DOI 10.3390/cells3030802; Romaine SPR, 2015, HEART, V101, P921, DOI 10.1136/heartjnl-2013-305402; Schlosser K, 2015, CHEST, V148, P481, DOI 10.1378/chest.14-2169; Shah R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153691; Sopel MJ, 2011, LAB INVEST, V91, P565, DOI 10.1038/labinvest.2010.190; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tijsen AJ, 2014, CARDIOVASC RES, V104, P61, DOI 10.1093/cvr/cvu184; Vegter EL, 2017, CLIN RES CARDIOL; Vegter EL, 2016, INT J CARDIOL, V224, P231, DOI 10.1016/j.ijcard.2016.09.010; Vegter EL, 2016, EUR J HEART FAIL, V18, P457, DOI 10.1002/ejhf.495; Yu LL, 2013, CIRC-HEART FAIL, V6, P107, DOI 10.1161/CIRCHEARTFAILURE.112.971168; Zolk O, 1998, CARDIOVASC RES, V39, P242, DOI 10.1016/S0008-6363(98)00081-9	25	18	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177242	10.1371/journal.pone.0177242	http://dx.doi.org/10.1371/journal.pone.0177242			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475616	Green Published, gold, Green Submitted			2022-12-26	WOS:000400649500056
J	Blythe, DAJ; Nikulin, VV				Blythe, Duncan A. J.; Nikulin, Vadim V.			Long-range temporal correlations in neural narrowband time-series arise due to critical dynamics	PLOS ONE			English	Article							NEURONAL AVALANCHES; HUMAN BRAIN; OSCILLATIONS; NOISE; NETWORKS; EEG	We show theoretically that the hypothesis of criticality as a theory of long-range fluctuation in the human brain may be distinguished from the theory of passive filtering on the basis of macroscopic neuronal signals such as the electroencephalogram, using novel theory of narrowband amplitude time-series at criticality. Our theory predicts the division of critical activity into meta-universality classes. As a consequence our analysis shows that experimental electroencephalography data favours the hypothesis of criticality in the human brain.	[Blythe, Duncan A. J.] Zalando SE, Zalando Res, Berlin, Germany; [Nikulin, Vadim V.] Charite, Dept Neurol, Neurophys Grp, Berlin, Germany; [Nikulin, Vadim V.] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany; [Nikulin, Vadim V.] Natl Res Univ, Ctr Cognit & Decis Making, Higher Sch Econ, Moscow, Russia	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; HSE University (National Research University Higher School of Economics)	Blythe, DAJ (corresponding author), Zalando SE, Zalando Res, Berlin, Germany.; Nikulin, VV (corresponding author), Charite, Dept Neurol, Neurophys Grp, Berlin, Germany.; Nikulin, VV (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany.; Nikulin, VV (corresponding author), Natl Res Univ, Ctr Cognit & Decis Making, Higher Sch Econ, Moscow, Russia.	duncanblythe@gmail.com; vadim.nikulin@charite.de	Nikulin, Vadim V/A-6050-2014	Nikulin, Vadim V/0000-0001-6082-3859	DFG [GRK 1589/1]; Russian Academic Excellence Project '5-100'	DFG(German Research Foundation (DFG)); Russian Academic Excellence Project '5-100'(Ministry of Education and Science, Russian FederationProject 5-100, Ministry of Education and Science, Russian Federation)	DAJB was supported by a grant from the training group DFG, GRK 1589/1 'Sensory Computation in Neural Systems'; VVN acknowledges support from the Russian Academic Excellence Project '5-100'.; We thank Daniel Bartz for a critical reading of the manuscript. Financial support; DAJB was supported by a grant from the training group DFG, GRK 1589/1 'Sensory Computation in Neural Systems'; VVN acknowledges support from the Russian Academic Excellence Project `5-100'.	Abry P., 1998, J TIME SER ANAL, V19, P253, DOI DOI 10.1111/1467-9892.00090; Amblard P. O., 2013, SEMIN C, V28, P65; Arviv O, 2015, J NEUROSCI, V35, P13927, DOI 10.1523/JNEUROSCI.0477-15.2015; BAK P, 1988, PHYS REV A, V38, P364, DOI 10.1103/PhysRevA.38.364; Bedard C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.118102; Bedard C, 2009, BIOPHYS J, V96, P2589; Beggs JM, 2003, J NEUROSCI, V23, P11167; Beggs JM, 2008, PHILOS T R SOC A, V366, P329, DOI 10.1098/rsta.2007.2092; Billingsley P, 1995, WILEY SERIES PROBABI; Blythe DAJ, 2014, NEUROIMAGE, V99, P377, DOI 10.1016/j.neuroimage.2014.05.041; Buzsaki G., 2006, RHYTHMS BRAIN; Dehghani N, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00302; Eurich CW, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.066137; Foldiak P, 1995, HDB BRAIN THEORY NEU, V1, P1064; Friedman N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.208102; Giraitis L, 2000, J MULTIVARIATE ANAL, V72, P183, DOI 10.1006/jmva.1999.1865; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; Griffiths, 1999, INTRO ELECTRODYNAMIC, V3; Hardstone R, 2012, SCALE FREE DYNAMICS, P75; JENSEN HJ, 1989, PHYS REV B, V40, P7425, DOI 10.1103/PhysRevB.40.7425; Kantelhardt JW, 2001, PHYSICA A, V295, P441, DOI 10.1016/S0378-4371(01)00144-3; KASDIN NJ, 1995, P IEEE, V83, P802, DOI 10.1109/5.381848; Kristoufek L, 2014, PHYSICA A, V402, P291, DOI 10.1016/j.physa.2014.01.058; Kuntz MC, 2000, PHYS REV B, V62, P11699, DOI 10.1103/PhysRevB.62.11699; Mallat S., 1999, WAVELET TOUR SIGNAL, DOI 10.1016/B978-012466606-1/50008-8; MANDELBROT BB, 1968, SIAM REV, V10, P422, DOI 10.1137/1010093; Marinucci D, 2000, STOCH PROC APPL, V86, P103, DOI 10.1016/S0304-4149(99)00088-5; Mehta AP, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.046139; Miller KJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000609; Nikulin VV, 2011, NEUROIMAGE, V55, P1528, DOI 10.1016/j.neuroimage.2011.01.057; Nikulin VV, 2005, NEUROSCIENCE, V130, P549, DOI 10.1016/j.neuroscience.2004.10.007; Nikulin VV, 2004, CLIN NEUROPHYSIOL, V115, P1896, DOI 10.1016/j.clinph.2004.03.019; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; Palva JM, 2013, P NATL ACAD SCI USA, V110, P3585, DOI 10.1073/pnas.1216855110; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Podobnik B, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.084102; Poil SS, 2012, J NEUROSCI, V32, P9817, DOI 10.1523/JNEUROSCI.5990-11.2012; Rea W, 2009, ARXIV09010762; Ribeiro TL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014129; Robinson PM, 1995, ANN STAT, V23, P1630, DOI 10.1214/aos/1176324317; Sethna JP, 2001, NATURE, V410, P242, DOI 10.1038/35065675; Shriki O, 2013, J NEUROSCI, V33, P7079, DOI 10.1523/JNEUROSCI.4286-12.2013; Srinivasan R, 1996, BRAIN TOPOGR, V8, P355, DOI 10.1007/BF01186911; Taqqu MS, 1975, PROBAB THEORY REL, V31, P287; Weron R, 2002, PHYSICA A, V312, P285, DOI 10.1016/S0378-4371(02)00961-5; Zebende GF, 2011, PHYSICA A, V390, P1677, DOI 10.1016/j.physa.2010.12.038	48	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0175628	10.1371/journal.pone.0175628	http://dx.doi.org/10.1371/journal.pone.0175628			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472078	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500013
J	Hernandez-Jimenez, M; Pena-Martinez, C; Godino, MD; Diaz-Guzman, J; Moro, MA; Lizasoain, I				Hernandez-Jimenez, Macarena; Pena-Martinez, Carolina; del Carmen Godino, Maria; Diaz-Guzman, Jaime; Angeles Moro, Maria; Lizasoain, Ignacio			Test repositioning for functional assessment of neurological outcome after experimental stroke in mice	PLOS ONE			English	Article							MIDDLE CEREBRAL-ARTERY; ISCHEMIC-STROKE; MOTOR DEFICITS; RODENT MODELS; RATS; INFARCTION; BRAIN; VALIDATION; DEPRESSION; OCCLUSION	Stroke is a cerebrovascular pathology for which the only approved treatment is fibrinolysis. Several studies have focused on the development of new drugs but none has led to effective therapies to date, due, among others, to the difficulty to evaluate clinical deficits in experimental animal models. The present study aims to explore the applicability of known behavioral tests not commonly used in ischemia for the neurological assessment of mice after experimental stroke in different brain areas. A total of 225 CD1 male mice were randomly assigned to permanent middle cerebral artery occlusion by ligature (pMCAO) or permanent anterior cerebral artery occlusion by photothrombosis (pACAO) models. Modified neuroseverity score, footprint test, forced swim test and elevated plus maze were performed. Under these experimental conditions, modified neuroseverity score showed neurological impairment early after experimental stroke in both models. By contrast, the footprint test and the elevated plus maze detected short-term neurological deterioration in the pMCAO model but not in the pACAO model. Furthermore, the forced swim test identified depression-like behavior in mice after ischemia only when the left hemisphere was affected. In conclusion, we propose the repositioning of known neurobehavioral tests, but not commonly used in the stroke field, for the fast detection of neurological impairments early after ischemia, and even specific to discriminate the territory affected by arterial occlusion as well as the hemisphere where brain damage occurs. All these findings may prove useful to improve the experimental design of neuroprotective drugs in order to bridge the gap between experimental studies and clinical trials.	[Hernandez-Jimenez, Macarena; Pena-Martinez, Carolina; del Carmen Godino, Maria; Angeles Moro, Maria; Lizasoain, Ignacio] Univ Complutense, Fac Med, Dept Farmacol, Unidad Invest Neurovasc, Madrid, Spain; [Hernandez-Jimenez, Macarena; Pena-Martinez, Carolina; del Carmen Godino, Maria; Diaz-Guzman, Jaime; Angeles Moro, Maria; Lizasoain, Ignacio] Inst Invest Hosp 12 Octubre i 12, Madrid, Spain; [Hernandez-Jimenez, Macarena; Pena-Martinez, Carolina; del Carmen Godino, Maria; Angeles Moro, Maria; Lizasoain, Ignacio] Inst Univ Invest Neuroquirn, Madrid, Spain; [Diaz-Guzman, Jaime] Hosp Univ 12 Octubre, Serv Neurol, Madrid, Spain	Complutense University of Madrid; Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre	Hernandez-Jimenez, M; Lizasoain, I (corresponding author), Univ Complutense, Fac Med, Dept Farmacol, Unidad Invest Neurovasc, Madrid, Spain.; Hernandez-Jimenez, M; Lizasoain, I (corresponding author), Inst Invest Hosp 12 Octubre i 12, Madrid, Spain.; Hernandez-Jimenez, M; Lizasoain, I (corresponding author), Inst Univ Invest Neuroquirn, Madrid, Spain.	macarenh@ucm.es; ignacio.lizasoain@med.ucm.es	Moro, María Ángeles/K-6396-2014; Lizasoain, Ignacio/K-9844-2014	Moro, María Ángeles/0000-0003-1010-8237; Lizasoain, Ignacio/0000-0002-6028-7379; Hernandez Jimenez, Macarena/0000-0003-3329-3965	Spanish Ministry of Economy and Competitiveness [SAF2014-52225, 5AF2015-68632-R]; Fondo Europeo de Desarrollo Regional (FEDER) "Una manera de hacer Europa" RETICS INVICTUS PLUS [RD16/0019/0009]; Instituto de Salud Carlos III	Spanish Ministry of Economy and Competitiveness(Spanish Government); Fondo Europeo de Desarrollo Regional (FEDER) "Una manera de hacer Europa" RETICS INVICTUS PLUS; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by grants from Spanish Ministry of Economy and Competitiveness SAF2014-52225 (IL) and 5AF2015-68632-R (MAM), and from Instituto de Salud Carlos III and cofinanced by Fondo Europeo de Desarrollo Regional (FEDER) "Una manera de hacer Europa" RETICS INVICTUS PLUS RD16/0019/0009 (IL).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arboix A, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-30; Bhogal SK, 2004, STROKE, V35, P794, DOI 10.1161/01.STR.0000117237.98749.26; Carter RJ, 1999, J NEUROSCI, V19, P3248; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Chen JR, 2008, J ANAT, V213, P249, DOI 10.1111/j.1469-7580.2008.00948.x; CHEN ST, 1986, STROKE, V17, P738, DOI 10.1161/01.STR.17.4.738; DeVries AC, 2001, NEUROSCI BIOBEHAV R, V25, P325, DOI 10.1016/S0149-7634(01)00017-3; Dorr A, 2007, NEUROIMAGE, V35, P1409, DOI 10.1016/j.neuroimage.2006.12.040; Engels AS, 2007, PSYCHOPHYSIOLOGY, V44, P352, DOI 10.1111/j.1469-8986.2007.00518.x; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; GARCIA JH, 1995, STROKE, V26, P636, DOI 10.1161/01.STR.26.4.636; Hackett ML, 2005, STROKE, V36, P1330, DOI 10.1161/01.STR.0000165928.19135.35; Hernandez-Jimenez M, 2013, STROKE, V44, P2333, DOI 10.1161/STROKEAHA.113.001715; Hossmann KA, 2008, NEUROPHARMACOLOGY, V55, P257, DOI 10.1016/j.neuropharm.2007.12.004; James ML, 2009, STROKE, V40, P632, DOI 10.1161/STROKEAHA.108.530402; Lee HY, 2012, MED BIOL ENG COMPUT, V50, P937, DOI 10.1007/s11517-012-0933-5; Livingston-Thomas JM, 2015, BEHAV BRAIN RES, V294, P102, DOI 10.1016/j.bbr.2015.07.053; Macrae IM, 2011, BRIT J PHARMACOL, V164, P1062, DOI 10.1111/j.1476-5381.2011.01398.x; Manwani B, 2011, BRAIN BEHAV IMMUN, V25, P1689, DOI 10.1016/j.bbi.2011.06.015; MATSUNO H, 1993, J PHARMACOL TOX MET, V29, P165, DOI 10.1016/1056-8719(93)90068-P; Nagano K, 2015, J PHYS THER SCI, V27, P357, DOI 10.1589/jpts.27.357; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Peng CG, 2015, NEURAL REGEN RES, V10, P1477, DOI 10.4103/1673-5374.165520; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; ROBINSON RG, 1984, BRAIN, V107, P81, DOI 10.1093/brain/107.1.81; Rosell A, 2013, TRANSL STROKE RES, V4, P297, DOI 10.1007/s12975-012-0234-1; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Sugimoto H, 2014, BEHAV BRAIN RES, V272, P100, DOI 10.1016/j.bbr.2014.06.048; Tennant KA, 2011, CEREB CORTEX, V21, P865, DOI 10.1093/cercor/bhq159; TITIANOVA EB, 1995, J REHABIL RES DEV, V32, P236; Vahid-Ansari F, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.124; Winter B, 2005, BIOL PSYCHIAT, V57, P1166, DOI 10.1016/j.biopsych.2005.02.010; Zarruk JG, 2011, REV NEUROLOGIA, V53, P607, DOI 10.33588/rn.5310.2011016; Zhu J, 2015, J PERIODONTAL RES, V50, P683, DOI 10.1111/jre.12251	36	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176770	10.1371/journal.pone.0176770	http://dx.doi.org/10.1371/journal.pone.0176770			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472090	gold, Green Published, Green Submitted			2022-12-26	WOS:000400648500070
J	Pennekamp, F; Griffiths, JI; Fronhofer, EA; Garnier, A; Seymour, M; Altermatt, F; Petchey, OL				Pennekamp, Frank; Griffiths, Jason I.; Fronhofer, Emanuel A.; Garnier, Aurelie; Seymour, Mathew; Altermatt, Florian; Petchey, Owen L.			Dynamic species classification of microorganisms across time, abiotic and biotic environments-A sliding window approach	PLOS ONE			English	Article							IMAGE-ANALYSIS; PHENOTYPIC PLASTICITY; SMALL WORLDS; ECOLOGY; DIVERSITY; IDENTIFICATION; COMMUNITIES; TEMPERATURE; EVOLUTION; PREDATION	The development of video-based monitoring methods allows for rapid, dynamic and accurate monitoring of individuals or communities, compared to slower traditional methods, with far reaching ecological and evolutionary applications. Large amounts of data are generated using video-based methods, which can be effectively processed using machine learning (ML) algorithms into meaningful ecological information. ML uses user defined classes (e.g. species), derived from a subset (i.e. training data) of video-observed quantitative features (e.g. phenotypic variation), to infer classes in subsequent observations. However, phenotypic variation often changes due to environmental conditions, which may lead to poor classification, if environmentally induced variation in phenotypes is not accounted for. Here we describe a framework for classifying species under changing environmental conditions based on the random forest classification. A sliding window approach was developed that restricts temporal and environmentally conditions to improve the classification. We tested our approach by applying the classification framework to experimental data. The experiment used a set of six ciliate species to monitor changes in community structure and behavior over hundreds of generations, in dozens of species combinations and across a temperature gradient. Differences in biotic and abiotic conditions caused simplistic classification approaches to be unsuccessful. In contrast, the sliding window approach allowed classification to be highly successful, as phenotypic differences driven by environmental change, could be captured by the classifier. Importantly, classification using the random forest algorithm showed comparable success when validated against traditional, slower, manual identification. Our framework allows for reliable classification in dynamic environments, and may help to improve strategies for long-term monitoring of species in changing environments. Our classification pipeline can be applied in fields assessing species community dynamics, such as eco-toxicology, ecology and evolutionary ecology.	[Pennekamp, Frank; Fronhofer, Emanuel A.; Garnier, Aurelie; Altermatt, Florian; Petchey, Owen L.] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Griffiths, Jason I.] Univ Sheffield, Dept Anim & Plant Sci, Western Bank, Sheffield S10 2TN, S Yorkshire, England; [Fronhofer, Emanuel A.; Seymour, Mathew; Altermatt, Florian] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Uberlandstr 133, CH-8600 Dubendorf, Switzerland; [Seymour, Mathew] Bangor Univ, Sch Biol Sci, Mol Ecol & Fisheries Genet Lab, Deiniol Rd, Bangor LL57 2UW, Gwynedd, Wales	University of Zurich; University of Sheffield; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Bangor University	Pennekamp, F (corresponding author), Univ Zurich, Dept Evolutionary Biol & Environm Studies, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	frank.pennekamp@ieu.uzh	Fronhofer, Emanuel A./AAY-3186-2021; Seymour, Mat/AAT-2716-2020; Garnier, Aurelie/AAJ-2073-2021; Pennekamp, Frank/ABD-3597-2020; Fronhofer, Emanuel A./J-9784-2013; Petchey, Owen/D-8851-2011	Fronhofer, Emanuel A./0000-0002-2219-784X; Pennekamp, Frank/0000-0003-0679-1045; Fronhofer, Emanuel A./0000-0002-2219-784X; Petchey, Owen/0000-0002-7724-1633; Altermatt, Florian/0000-0002-4831-6958; Garnier, Aurelie/0000-0002-3712-4301; seymour, mathew/0000-0002-3654-4857	Swiss National Science Foundation [31003A_159498, 31003A_135622, PP00P3_150698]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation 31003A_159498 to OLP and Swiss National Science Foundation 31003A_135622 and PP00P3_150698 to FA.; The data used in this study was collected in a joint effort of the Altermatt and Petchey groups, University of Zurich. We thank Roman Alther, Yves Choffat, Pravin Ganesanandamoorthy, Suzanne Greene, Katherine Horgan, Thomas Massie, Elvira M achler, Gian-Marco Palamara and Mikael Pontarp for their help in collecting the experimental data. We also thank S3IT at University of Zurich for adapting the tracking functionality of the R package BEMOVI to the ScienceCloud computing infrastructure and assistance in processing the video raw data. FP and OLP were financially supported by Swiss National Science Foundation Grant 31003A_159498, FA received funding by the Swiss National Science Foundation Grants 31003A_135622 and PP00P3_150698.	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Altermatt F, 2015, METHODS ECOL EVOL, V6, P218, DOI 10.1111/2041-210X.12312; Amaral AL, 2008, ANAL BIOANAL CHEM, V391, P1321, DOI 10.1007/s00216-008-1845-y; Amaral AL, 2004, ENVIRONMETRICS, V15, P381, DOI 10.1002/env.652; Atkinson D, 2003, P ROY SOC B-BIOL SCI, V270, P2605, DOI 10.1098/rspb.2003.2538; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bell JL, 2008, J PLANKTON RES, V30, P1351, DOI 10.1093/plankt/fbn092; Benton TG, 2007, TRENDS ECOL EVOL, V22, P516, DOI 10.1016/j.tree.2007.08.003; Bi HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127121; Biard T, 2016, NATURE, V532, P504, DOI 10.1038/nature17652; Blumenshine SC, 2000, ECOLOGY, V81, P374, DOI 10.1890/0012-9658(2000)081[0374:GOFPAB]2.0.CO;2; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cadotte MW, 2005, ADV ECOLOGICAL RES; Carrara F, 2015, METHODS ECOL EVOL, V6, P895, DOI 10.1111/2041-210X.12363; Carrara F, 2015, ECOLOGY, V96, P1340, DOI 10.1890/14-1324.1; Culverhouse PF, 2006, MAR ECOL PROG SER, V312, P297, DOI 10.3354/meps312297; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dell AI, 2014, TRENDS ECOL EVOL, V29, P417, DOI 10.1016/j.tree.2014.05.004; Depraetere M, 2012, ECOL INDIC, V13, P46, DOI 10.1016/j.ecolind.2011.05.006; Fernandez-Delgado M, 2014, J MACH LEARN RES, V15, P3133; Gao ZK, 2016, EPL-EUROPHYS LETT, V116, DOI 10.1209/0295-5075/116/50001; Gao ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep35622; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Hammill E, 2010, AM NAT, V176, P723, DOI 10.1086/657040; Harrison XA, 2015, PEERJ, V3, DOI 10.7717/peerj.1114; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Jiang L, 2004, OIKOS, V106, P217, DOI 10.1111/j.0030-1299.2004.13056.x; Jiang L, 2004, J ANIM ECOL, V73, P569, DOI 10.1111/j.0021-8790.2004.00830.x; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Karanth KU, 2006, ECOLOGY, V87, P2925, DOI 10.1890/0012-9658(2006)87[2925:ATPDUP]2.0.CO;2; Kotsiantis S., 2006, GESTS INT T COMPUTER, V30, P25, DOI DOI 10.1007/978-0-387-09823-4_45; Kuhl HS, 2013, TRENDS ECOL EVOL, V28, P432, DOI 10.1016/j.tree.2013.02.013; Kuhn M., 2013, APPL PREDICTIVE MODE, DOI 10.1007/978-1-4614-6849-3; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; KUSCH J, 1993, OECOLOGIA, V96, P354, DOI 10.1007/BF00317505; Leary DJ, 2009, J ANIM ECOL, V78, P1143, DOI 10.1111/j.1365-2656.2009.01586.x; MacLeod N, 2010, NATURE, V467, P154, DOI 10.1038/467154a; Mayumi Oshiro Thais, 2012, Machine Learning and Data Mining in Pattern Recognition. Proceedings 8th International Conference, MLDM 2012, P154, DOI 10.1007/978-3-642-31537-4_13; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Nathan R, 2012, J EXP BIOL, V215, P986, DOI 10.1242/jeb.058602; Ozgul A, 2009, SCIENCE, V325, P464, DOI 10.1126/science.1173668; Pennekamp F, 2015, ECOL EVOL, V5, P2584, DOI 10.1002/ece3.1529; Pennekamp F, 2014, EVOLUTION, V68, P2319, DOI 10.1111/evo.12428; Pennekamp F, 2013, METHODS ECOL EVOL, V4, P483, DOI 10.1111/2041-210X.12036; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Peters DPC, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00295.1; Pons M N, 2000, Adv Biochem Eng Biotechnol, V66, P133; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Quinn G.P., 2002, EXPT DESIGN DATA ANA; R Core Team, 2021, R LANGUAGE ENV STAT; Russo D, 2016, ECOL INDIC, V66, P598, DOI 10.1016/j.ecolind.2016.02.036; Seymour M, 2015, OIKOS, V124, P908, DOI 10.1111/oik.02354; Soleymani A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145345; Sommer C, 2013, J CELL SCI, V126, P5529, DOI 10.1242/jcs.123604; Swinnen KRR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098881; Tarca AL, 2007, PLOS COMPUT BIOL, V3, P953, DOI 10.1371/journal.pcbi.0030116; Travis J, 2014, P NATL ACAD SCI USA, V111, P581, DOI 10.1073/pnas.1305853111; Vrijenhoek RC, 2009, DEEP-SEA RES PT II, V56, P1713, DOI 10.1016/j.dsr2.2009.05.016; Weinstein BG, 2015, METHODS ECOL EVOL, V6, P357, DOI 10.1111/2041-210X.12320	61	16	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176682	10.1371/journal.pone.0176682	http://dx.doi.org/10.1371/journal.pone.0176682			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472193	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000400648500064
J	Signes-Pastor, AJ; Woodside, JV; McMullan, P; Mullan, K; Carey, M; Karagas, MR; Meharg, AA				Signes-Pastor, Antonio J.; Woodside, Jayne V.; McMullan, Paul; Mullan, Karen; Carey, Manus; Karagas, Margaret R.; Meharg, Andrew A.			Levels of infants' urinary arsenic metabolites related to formula feeding and weaning with rice products exceeding the EU inorganic arsenic standard	PLOS ONE			English	Article							GEOGRAPHICAL VARIATION; EXPOSURE; SAMPLES; SPECIATION; HEALTH; WHITE; FOODS	Early childhood inorganic arsenic (i-As) exposure is of particular concern since it may adversely impact on lifetime health outcomes. Infants' urinary arsenic (As) metabolites were analysed in 79 infants by inductively coupled plasma D mass spectrometric detection (ICICP- MS) to evaluate i-As exposure pre-and post-weaning. Levels of i-As in rice-based weaning and infants' foods were also determined to relate to urinary As levels. Higher As levels, especially of monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA), were found in urine from formula fed infants compared to those breastfed. Urine from infants post-weaning consuming rice-products resulted in higher urinary MMA and DMA compared to the paired pre-weaning urine samples. The European Union (EU) has regulated i-As in rice since 1 st January 2016. Comparing infants' rice-based foods before and after this date, little change was found. Nearly of the rice-based products specifically marketed for infants and young children contained i-As over the 0.1 mg/kg EU limit. Efforts should be made to provide low i-As rice and rice-based products consumed by infants and young children that do not exceed the maximum i-As level to protect this vulnerable subpopulation.	[Signes-Pastor, Antonio J.; Woodside, Jayne V.; Carey, Manus; Meharg, Andrew A.] Queens Univ Belfast, Inst Global Food Secur, David Keir Bldg, Belfast, Antrim, North Ireland; [Signes-Pastor, Antonio J.; Karagas, Margaret R.] Dartmouth Coll, Geisel Sch Med, Dept Epidemiol, 1 Med Ctr Dr,7927 Rubin Bldg, Lebanon, NH 03755 USA; [Woodside, Jayne V.; McMullan, Paul; Mullan, Karen] Royal Victoria Hosp, UKCRC Ctr Excellence Publ Hlth, Inst Clin Sci B, Belfast, Antrim, North Ireland	Queens University Belfast; Dartmouth College	Signes-Pastor, AJ (corresponding author), Queens Univ Belfast, Inst Global Food Secur, David Keir Bldg, Belfast, Antrim, North Ireland.; Signes-Pastor, AJ (corresponding author), Dartmouth Coll, Geisel Sch Med, Dept Epidemiol, 1 Med Ctr Dr,7927 Rubin Bldg, Lebanon, NH 03755 USA.	antonio.j.signes-pastor@dartmouth.edu	Meharg, Andrew Alexander/F-8182-2014; Signes-Pastor, Antonio/N-9700-2019; Carey, Manus/K-8180-2015	Meharg, Andrew Alexander/0000-0003-2019-0449; Signes-Pastor, Antonio/0000-0003-4898-2480; Mullan, Karen R/0000-0002-6355-1964; Carey, Manus/0000-0002-1065-4943; Woodside, Jayne/0000-0002-5691-4659	Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme [PIEF-GA-2013-622096]; Metabolic Unit Research funds (charitable funds) Belfast Health and Social Care Trust	Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme(European Commission); Metabolic Unit Research funds (charitable funds) Belfast Health and Social Care Trust	This work was funded by a Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme (PIEF-GA-2013-622096) and the Metabolic Unit Research funds (charitable funds) Belfast Health and Social Care Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by a Marie Curie Intra-European Fellowship within the 7<SUP>th</SUP> European Community Framework Programme (PIEF-GA-2013-622096) and the Metabolic Unit Research funds (charitable funds) Belfast Health and Social Care Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carey M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131608; Carignan CC, 2015, ENVIRON HEALTH PERSP, V123, P500, DOI 10.1289/ehp.1408789; Da Sacco L, 2013, J GEOCHEM EXPLOR, V131, P45, DOI 10.1016/j.gexplo.2012.11.014; EFSA. European Food Safety Authority, 2009, SCI OP ARS FOOD EFS; Fangstrom B, 2008, ENVIRON HEALTH PERSP, V116, P963, DOI 10.1289/ehp.11094; Farzan SF, 2013, TOXICOL APPL PHARM, V272, P384, DOI 10.1016/j.taap.2013.06.030; FDA, 2016, FDA PROC LIM IN ARS; Hinwood AL, 2002, ENVIRON RES, V88, P219, DOI 10.1006/enrs.2002.4339; IARC, 2004, INT AG RES CANC MON; Jackson BP, 2012, ENVIRON HEALTH PERSP, V120, P623, DOI 10.1289/ehp.1104619; Jackson BP, 2012, PURE APPL CHEM, V84, P215, DOI 10.1351/PAC-CON-11-09-17; Karagas MR, 2016, JAMA PEDIATR, V170, P609, DOI 10.1001/jamapediatrics.2016.0120; Kordas K, 2016, ENVIRON RES, V147, P16, DOI 10.1016/j.envres.2016.01.022; Ljung K, 2011, FOOD CHEM, V127, P943, DOI 10.1016/j.foodchem.2011.01.062; Lovebom HSkroder, 2016, TOXICOL SCI, P1; Meharg AA, 2014, ENVIRON POLLUT, V194, P181, DOI 10.1016/j.envpol.2014.07.031; Meharg AA, 2008, ENVIRON POLLUT, V152, P746, DOI 10.1016/j.envpol.2008.01.043; Meharg AA, 2008, ENVIRON SCI TECHNOL, V42, P1051, DOI 10.1021/es702212p; Munera-Picazo S, 2014, J FOOD SCI, V79, pT122, DOI 10.1111/1750-3841.12310; Nermell B, 2008, ENVIRON RES, V106, P212, DOI 10.1016/j.envres.2007.08.005; NI Water, 2013, DRINK WAT QUAL ANN R, V67; R Code Team, 2015, LANG ENV STAT COMP; Rivera-Nunez Z, 2010, INT J HYG ENVIR HEAL, V213, P259, DOI 10.1016/j.ijheh.2010.03.003; Rodriguez-Barranco M., 2016, CORTEX, V4; Sanchez TR, 2016, ENVIRON RES, V147, P537, DOI 10.1016/j.envres.2016.02.009; Signes-Pastor AJ, 2016, EXPO HEAL, P4; Signes-Pastor AJ, 2016, FOOD CHEM, V202, P356, DOI 10.1016/j.foodchem.2016.01.117; Signes-Pastor AJ, 2016, FOOD CHEM, V191, P128, DOI 10.1016/j.foodchem.2014.11.078; Vahter M, 2002, TOXICOLOGY, V181, P211, DOI 10.1016/S0300-483X(02)00285-8; Vahter M, 2009, ANNU REV NUTR, V29, P381, DOI 10.1146/annurev-nutr-080508-141102; Williams PN, 2007, ENVIRON SCI TECHNOL, V41, P6854, DOI 10.1021/es070627i	32	26	27	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176923	10.1371/journal.pone.0176923	http://dx.doi.org/10.1371/journal.pone.0176923			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472079	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500098
J	Wu, BH; Kou, XX; Zhang, C; Zhang, YM; Cui, Z; Wang, XD; Liu, Y; Liu, DW; Zhou, YH				Wu, Bo-Hai; Kou, Xiao-Xing; Zhang, Ci; Zhang, Yi-Mei; Cui, Zhen; Wang, Xue-Dong; Liu, Yan; Liu, Da-Wei; Zhou, Yan-Heng			Stretch force guides finger-like pattern of bone formation in suture	PLOS ONE			English	Article							RAPID PALATAL EXPANSION; MIDPALATAL SUTURE; CRANIAL SUTURES; MAXILLARY EXPANSION; TRANSCRIPTIONAL REGULATION; CIRCUMMAXILLARY SUTURES; CRANIOFACIAL SUTURES; STRAIN; RATS; OSTEOGENESIS	Mechanical tension is widely applied on the suture to modulate the growth of craniofacial bones. Deeply understanding the features of bone formation in expanding sutures could help us to improve the outcomes of clinical treatment and avoid some side effects. Although there are reports that have uncovered some biological characteristics, the regular pattern of sutural bone formation in response to expansion forces is still unknown. Our study was to investigate the shape, arrangement and orientation of new bone formation in expanding sutures and explore related clinical implications. The premaxillary sutures of rat, which histologically resembles the sutures of human beings, became wider progressively under stretch force. Micro-CT detected new bones at day 3. Morphologically, these bones were forming in a finger-like pattern, projecting from the maxillae into the expanded sutures. There were about 4 finger-like bones appearing on the selected micro-CT sections at day 3 and this number increased to about 18 at day 7. The average length of these projections increased from 0.14 mm at day 3 to 0.81 mm at day 7. The volume of these bony protuberances increased to the highest level of 0.12 mm(3) at day 7. HE staining demonstrated that these finger-like bones had thick bases connecting with the maxillae and thin fronts stretching into the expanded suture. Nasal sections had a higher frequency of finger-like bones occuring than the oral sections at day 3 and day 5. Masson-stained sections showed stretched fibers embedding into maxillary margins. Osteocalcin-positive osteoblasts changed their shapes from cuboidal to spindle and covered the surfaces of finger-like bones continuously. Alizarin red S and calcein deposited in the inner and outer layers of finger-like bones respectively, which showed that longer and larger bones formed on the nasal side of expanded sutures compared with the oral side. Interestingly, these finger-like bones were almost paralleling with the direction of stretch force. Inclined force led to inclined finger-like bones formation and deflection of bilateral maxillae. Additionally, heavily compressive force caused fracture of finger-like bones in the sutures. These data together proposed the special finger-like pattern of bone formation in sutures guided by stretch force, providing important implications for maxillary expansion.	[Wu, Bo-Hai; Kou, Xiao-Xing; Zhang, Ci; Zhang, Yi-Mei; Cui, Zhen; Wang, Xue-Dong; Liu, Yan; Liu, Da-Wei; Zhou, Yan-Heng] Peking Univ, Sch & Hosp Stomatol, Dept Orthodont, Beijing, Peoples R China; [Wu, Bo-Hai; Kou, Xiao-Xing; Zhang, Ci; Zhang, Yi-Mei; Cui, Zhen; Wang, Xue-Dong; Liu, Yan; Liu, Da-Wei; Zhou, Yan-Heng] Peking Univ, Sch & Hosp Stomatol, Ctr Craniofacial Stem Cell Res & Regenerat, Beijing, Peoples R China	Peking University; Peking University	Liu, DW; Zhou, YH (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Orthodont, Beijing, Peoples R China.; Liu, DW; Zhou, YH (corresponding author), Peking Univ, Sch & Hosp Stomatol, Ctr Craniofacial Stem Cell Res & Regenerat, Beijing, Peoples R China.	liudawei@bjmu.edu.cn; yanhengzhou@vip.163.com	, 许开源 18362929861 赛德阳光口腔/AFX-1820-2022; Zhou, Yanheng/ABG-5432-2021; Liu, Dawei/AAD-3130-2019	Zhou, Yanheng/0000-0002-5610-9967; Kou, Xiaoxing/0000-0001-9680-0077	International Science & Technology Cooperation Program of China [2015DFB30040]; National Science Foundation of China [81300897, 81300850, 81470717]; Beijing Municipal Natural Science Foundation [7152156]	International Science & Technology Cooperation Program of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by International Science & Technology Cooperation Program of China no. 2015DFB30040 (YZ), the National Science Foundation of China no. 81300897 (XK), no. 81571815 (YL), no. 81300850 (XW), no. 81470717 (YZ), the Beijing Municipal Natural Science Foundation no. 7152156 (YL).	Borke JL, 2003, ANN PLAS SURG, V51, P499, DOI 10.1097/01.SAP.0000067964.14122.3E; Borke JL, 2003, CLEFT PALATE-CRAN J, V40, P284, DOI 10.1597/1545-1569(2003)040<0284:NTROCB>2.0.CO;2; BURSTONE CHARLES J., 1959, JOUR DENTAL RES, V38, P534, DOI 10.1177/00220345590380031501; Byron CD, 2004, ANAT REC PART A, V279A, P676, DOI 10.1002/ar.a.20055; Chang HN, 1996, ARCH ORAL BIOL, V41, P985, DOI 10.1016/S0003-9969(96)00041-6; CLEALL J F, 1965, Angle Orthod, V35, P23; Cray J, 2014, J MORPHOL, V275, P342, DOI 10.1002/jmor.20218; Cray J, 2011, J ANAT, V218, P471, DOI 10.1111/j.1469-7580.2011.01358.x; Cray J, 2011, ANAT REC, V294, P676, DOI 10.1002/ar.21345; Cray J, 2010, AM J PHYS ANTHROPOL, V143, P473, DOI 10.1002/ajpa.21367; Ghoneima A, 2011, AM J ORTHOD DENTOFAC, V140, P510, DOI 10.1016/j.ajodo.2010.10.024; Gurel HG, 2010, ANGLE ORTHOD, V80, P5, DOI 10.2319/011209-22.1; Hermann CD, 2016, J DENT RES, V95, P846, DOI 10.1177/0022034516643315; Hou B, 2007, BONE, V40, P1483, DOI 10.1016/j.bone.2007.01.019; KAMBARA T, 1977, AM J ORTHOD DENTOFAC, V71, P249, DOI 10.1016/0002-9416(77)90187-7; Kariya T, 2015, J CELL BIOCHEM, V116, P12, DOI 10.1002/jcb.24863; Kobayashi ET, 1999, J DENT RES, V78, P1495, DOI 10.1177/00220345990780090301; Kopher RA, 2003, J BONE MINER RES, V18, P521, DOI 10.1359/jbmr.2003.18.3.521; LATHAM RA, 1971, J ANAT, V108, P31; Liu SSY, 2011, AM J ORTHOD DENTOFAC, V139, P446, DOI 10.1016/j.ajodo.2009.03.056; Liu SSY, 2010, EUR J ORTHODONT, V32, P371, DOI 10.1093/ejo/cjp103; Liu WT, 2015, AM J ORTHOD DENTOFAC, V148, P641, DOI 10.1016/j.ajodo.2015.04.038; Mao JJ, 2002, J DENT RES, V81, P810, DOI 10.1177/154405910208101203; Mao JJ, 2003, ANGLE ORTHOD, V73, P128; Mao JJ, 2003, FRONT BIOSCI-LANDMRK, V8, pA10, DOI 10.2741/917; Meikle MC, 2007, J DENT RES, V86, P12, DOI 10.1177/154405910708600103; MELSEN B, 1982, AM J ORTHOD DENTOFAC, V82, P329, DOI 10.1016/0002-9416(82)90467-5; MURRAY JMG, 1971, J DENT RES, V50, P1654, DOI 10.1177/00220345710500065101; Opperman LA, 2000, DEV DYNAM, V219, P472, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1073>3.0.CO;2-F; PRITCHARD JJ, 1956, J ANAT, V90, P73; Shibazaki R, 2007, PLAST RECONSTR SURG, V119, P2167, DOI 10.1097/01.prs.0000260705.70329.38; Sun ZY, 2011, AM J ORTHOD DENTOFAC, V139, DOI 10.1016/j.ajodo.2009.12.029; Takahashi I, 1996, BONE, V18, P341, DOI 10.1016/8756-3282(96)00012-9; Takenouchi H, 2014, ARCH ORAL BIOL, V59, P414, DOI 10.1016/j.archoralbio.2014.01.010; Vardimon AD, 1998, AM J ORTHOD DENTOFAC, V113, P488, DOI 10.1016/S0889-5406(98)70259-8; Vardimon AD, 1998, AM J ORTHOD DENTOFAC, V113, P371, DOI 10.1016/S0889-5406(98)80006-1; Wu YD, 2007, CLEFT PALATE-CRAN J, V44, P482, DOI 10.1597/06-122.1; Yu Jack C, 2004, Semin Pediatr Neurol, V11, P249, DOI 10.1016/j.spen.2004.10.002; Yu JC, 2009, PLAST RECONSTR SURG, V123, p83S, DOI 10.1097/PRS.0b013e318191c029; Yu JC, 2003, CLEFT PALATE-CRAN J, V40, P409, DOI 10.1597/1545-1569(2003)040<0409:AFAOHC>2.0.CO;2; Yu JC, 2001, J CRANIOFAC SURG, V12, P391, DOI 10.1097/00001665-200107000-00018; ZAHROWSKI JJ, 1992, ANGLE ORTHOD, V62, P197	42	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177159	10.1371/journal.pone.0177159	http://dx.doi.org/10.1371/journal.pone.0177159			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472133	Green Submitted, gold, Green Published			2022-12-26	WOS:000400648500147
J	Patel, D; Kuyucak, S				Patel, Dharmeshkumar; Kuyucak, Serdar			Computational study of aggregation mechanism in human lysozyme[D67H]	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; HUMAN LYSOZYME; FREE-ENERGY; PROTEIN; DOCKING; DISEASE; SELECTIVITY; CHANNELS; INSIGHTS; AFFINITY	Aggregation of proteins is an undesired phenomena that affects both human health and bio-engineered products such as therapeutic proteins. Finding preventative measures could be facilitated by a molecular-level understanding of dimer formation, which is the first step in aggregation. Here we present a molecular dynamics (MD) study of dimer formation propensity in human lysozyme and its D67H variant. Because the latter protein aggregates while the former does not, they offer an ideal system for testing the feasibility of the proposed MD approach which comprises three stages: i) partially unfolded conformers involved in dimer formation are generated via high-temperature MD simulations, ii) potential dimer structures are searched using docking and refined with MD, iii) free energy calculations are performed to find the most stable dimer structure. Our results provide a detailed explanation for how a single mutation (D67H) turns human lysozyme from non-aggregating to an aggregating protein. Conversely, the proposed method can be used to identify the residues causing aggregation in a protein, which can be mutated to prevent it.	[Patel, Dharmeshkumar; Kuyucak, Serdar] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia	University of Sydney	Kuyucak, S (corresponding author), Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia.	serdar@physics.usyd.edu.au	Kuyucak, Serdar/AAH-8417-2021; Patel, Dharmeshkumar Jethalal/J-6231-2019	Patel, Dharmeshkumar Jethalal/0000-0003-1601-256X; Kuyucak, Serdar/0000-0003-4315-9532				Agrawal NJ, 2011, J PHARM SCI-US, V100, P5081, DOI 10.1002/jps.22705; Alonso H, 2006, MED RES REV, V26, P531, DOI 10.1002/med.20067; ARTYMIUK PJ, 1981, J MOL BIOL, V152, P737, DOI 10.1016/0022-2836(81)90125-X; Bastug T, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2904461; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Canet D, 1999, BIOCHEMISTRY-US, V38, P6419, DOI 10.1021/bi983037t; Chen PC, 2012, TOXINS, V4, P110, DOI 10.3390/toxins4020110; Chen PC, 2011, BIOPHYS J, V100, P2466, DOI 10.1016/j.bpj.2011.03.052; Chennamsetty N, 2009, P NATL ACAD SCI USA, V106, P11937, DOI 10.1073/pnas.0904191106; Chipot C, 2014, WIRES COMPUT MOL SCI, V4, P71, DOI 10.1002/wcms.1157; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Day R, 2002, J MOL BIOL, V322, P189, DOI 10.1016/S0022-2836(02)00672-1; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dumoulin M, 2006, ACCOUNTS CHEM RES, V39, P603, DOI 10.1021/ar050070g; Eleftheriou M, 2006, J AM CHEM SOC, V128, P13388, DOI 10.1021/ja060972s; Elvin JG, 2013, INT J PHARMACEUT, V440, P83, DOI 10.1016/j.ijpharm.2011.12.039; Gilquin B, 2000, PROTEINS, V41, P58, DOI 10.1002/1097-0134(20001001)41:1<58::AID-PROT90>3.3.CO;2-V; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Kazmirski SL, 1998, J MOL BIOL, V284, P793, DOI 10.1006/jmbi.1998.2192; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kuyucak S, 2014, FUTURE MED CHEM, V6, P1645, DOI [10.4155/fmc.14.98, 10.4155/FMC.14.98]; Liu HL, 2007, BIOTECHNOL PROGR, V23, P246, DOI 10.1021/bp060264a; Liu HL, 2006, J BIOMOL STRUCT DYN, V24, P229, DOI 10.1080/07391102.2006.10507115; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Meersman F, 2010, BIOPHYS J, V99, P2255, DOI 10.1016/j.bpj.2010.07.060; Moraitakis G, 2003, BIOPHYS J, V84, P2149, DOI 10.1016/S0006-3495(03)75021-8; Morozova-Roche LA, 2000, J STRUCT BIOL, V130, P339, DOI 10.1006/jsbi.2000.4264; Morriss-Andrews A, 2015, ANNU REV PHYS CHEM, V66, P643, DOI 10.1146/annurev-physchem-040513-103738; Muraki M, 1996, BIOCHEMISTRY-US, V35, P13562, DOI 10.1021/bi9613180; Nguyent P, 2014, ACCOUNTS CHEM RES, V47, P603, DOI 10.1021/ar4002075; Patel D, 2016, BIOCHEMISTRY-US, V55, P1929, DOI 10.1021/acs.biochem.5b01324; PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0; Perchiacca JM, 2012, ANNU REV CHEM BIOMOL, V3, P263, DOI 10.1146/annurev-chembioeng-062011-081052; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rashid MH, 2012, J PHYS CHEM B, V116, P4812, DOI 10.1021/jp300639x; Re F, 2010, CURR MED CHEM, V17, P2990, DOI 10.2174/092986710791959729; Roberts CJ, 2014, TRENDS BIOTECHNOL, V32, P372, DOI 10.1016/j.tibtech.2014.05.005; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Scheraga HA, 2007, ANNU REV PHYS CHEM, V58, P57, DOI 10.1146/annurev.physchem.58.032806.104614; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Steel BC, 2006, BIOPHYS J, V91, pL66, DOI 10.1529/biophysj.106.090944; Straub JE, 2011, ANNU REV PHYS CHEM, V62, P437, DOI 10.1146/annurev-physchem-032210-103526; Swaminathan R, 2011, ADV PROTEIN CHEM STR, V84, P63, DOI 10.1016/B978-0-12-386483-3.00003-3; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Toofanny RD, 2012, WIRES COMPUT MOL SCI, V2, P405, DOI 10.1002/wcms.1088; Trexler AJ, 2007, CURR PROTEIN PEPT SC, V8, P537, DOI 10.2174/138920307783018659; Wang W., 2010, AGGREGATION THERAPEU, V1st ed., DOI [10.1002/9780470769829.ch1, DOI 10.1002/9780470769829.CH1]; Zhou R, 2008, IBM J RES DEV, V52, P19, DOI 10.1147/rd.521.0019	50	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5								10.1371/journal.pone.0176886	http://dx.doi.org/10.1371/journal.pone.0176886			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467454	Green Submitted, Green Published, gold			2022-12-26	WOS:000400647000082
J	Abela, L; Spiegel, R; Crowther, LM; Klein, A; Steindl, K; Papuc, SM; Joset, P; Zehavi, Y; Rauch, A; Plecko, B; Simmons, TL				Abela, Lucia; Spiegel, Ronen; Crowther, Lisa M.; Klein, Andrea; Steindl, Katharina; Papuc, Sorina Mihaela; Joset, Pascal; Zehavi, Yoav; Rauch, Anita; Plecko, Barbara; Simmons, Thomas Luke			Plasma metabolomics reveals a diagnostic metabolic fingerprint for mitochondrial aconitase (ACO2) deficiency	PLOS ONE			English	Article							HUNTINGTONS-DISEASE; ENERGY-METABOLISM; MALONYL-COA; ACID; IRON; DYSFUNCTION; PROTEINS; CITRATE; CYCLE; RAT	Mitochondrial respiratory chain dysfunction has been identified in a number of neurodegenerative disorders. Infantile cerebellar-retinal degeneration associated with mutations in the mitochondrial aconitase 2 gene (ACO2) has been recently described as a neurodegenerative disease of autosomal recessive inheritance. To date there is no biomarker for ACO2 deficiency and diagnosis relies on genetic analysis. Here we report global metabolic profiling in eight patients with ACO2 deficiency. Using an LC-MS-based metabolomics platform we have identified several metabolites with affected plasma concentrations including the tricarboxylic acid cycle metabolites cis-aconitate, isocitrate and alpha-ketoglutarate, as well as phosphoenolpyruvate and hydroxybutyrate. Taken together we report a diagnostic metabolic fingerprint for mitochondrial aconitase 2 deficiency.	[Abela, Lucia; Crowther, Lisa M.; Klein, Andrea; Plecko, Barbara; Simmons, Thomas Luke] Univ Childrens Hosp Zurich, Div Child Neurol, Zurich, Switzerland; [Abela, Lucia; Crowther, Lisa M.; Plecko, Barbara; Simmons, Thomas Luke] Univ Childrens Hosp Zurich, Childrens Res Ctr, Zurich, Switzerland; [Abela, Lucia; Crowther, Lisa M.; Steindl, Katharina; Papuc, Sorina Mihaela; Joset, Pascal; Rauch, Anita; Plecko, Barbara; Simmons, Thomas Luke] Univ Zurich, Clin Res Prior Program Rare Dis, Radiz Rare Dis Initiat Zurich, Zurich, Switzerland; [Spiegel, Ronen; Zehavi, Yoav] Technion, Rappaport Fac Med, Emek Med Ctr, Dept Pediat B, Afula, Israel; [Steindl, Katharina; Papuc, Sorina Mihaela; Joset, Pascal; Zehavi, Yoav] Univ Zurich, Inst Med Genet, Schlieren, Switzerland; [Klein, Andrea] Univ Basel, Childrens Hosp, Pediat Neurol, Basel, Switzerland; [Simmons, Thomas Luke] Evolve AG, Reinach, Switzerland	University Children's Hospital Zurich; University Children's Hospital Zurich; University of Zurich; Emek Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Basel	Simmons, TL (corresponding author), Univ Childrens Hosp Zurich, Div Child Neurol, Zurich, Switzerland.; Simmons, TL (corresponding author), Univ Childrens Hosp Zurich, Childrens Res Ctr, Zurich, Switzerland.; Simmons, TL (corresponding author), Univ Zurich, Clin Res Prior Program Rare Dis, Radiz Rare Dis Initiat Zurich, Zurich, Switzerland.; Simmons, TL (corresponding author), Evolve AG, Reinach, Switzerland.	lukes@evolva.com	Rauch, Anita/C-5568-2014; Abela-Arnold, Lucia/GWB-9431-2022	Rauch, Anita/0000-0003-2930-3163; Abela-Arnold, Lucia/0000-0002-8328-5042; Papuc, Sorina Mihaela/0000-0002-1352-3535; Plecko, Barbara/0000-0002-3203-1325	Novartis Stiftung fur Medizinisch-Biologische Forschung [15A039]; Clinical Research Priority Program (CRPP) radiz - Rare Disease Initiative Zurich; Emek Medical Center; Division of Child Neurology and Clinical Chemistry at the University Children's Hospital Zurich; Rappaport Faculty of Medicine	Novartis Stiftung fur Medizinisch-Biologische Forschung; Clinical Research Priority Program (CRPP) radiz - Rare Disease Initiative Zurich; Emek Medical Center; Division of Child Neurology and Clinical Chemistry at the University Children's Hospital Zurich; Rappaport Faculty of Medicine	TLS received financial support from Novartis Stiftung fur Medizinisch-Biologische Forschung Nr. 15A039 http://www.stiftungmedbiol.novartis.com/ to support this research. The awarded funds went into a general account for consumables and were not used for salaries or personnel costs. The salaries of LMC and SMP are funded through the Clinical Research Priority Program (CRPP) radiz - Rare Disease Initiative Zurich http://www.radiz.uzh.ch/en.html.; We are grateful for the cooperation of all families involved in this study. We would also like to acknowledge the support of various collaborators within the Emek Medical Center and Rappaport Faculty of Medicine, as well as the Division of Child Neurology and Clinical Chemistry at the University Children's Hospital Zurich.	Abela L, 2015, J INHERITED METABOLI, V39, P131; Baron M, 2007, BIOCHEM SOC T, V35, P1228, DOI 10.1042/BST0351228; Barrera G, 2016, ANTIOXIDANTS-BASEL, V5, DOI 10.3390/antiox5010007; Bhat AH, 2015, BIOMED PHARMACOTHER, V74, P101, DOI 10.1016/j.biopha.2015.07.025; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Cairo G, 2002, FREE RADICAL BIO MED, V32, P1237, DOI 10.1016/S0891-5849(02)00825-0; Cantu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007095; Caspi R, 2014, NUCLEIC ACIDS RES, V42, pD459, DOI 10.1093/nar/gkt1103; Cheng Z, 2013, BIOCHEM BIOPH RES CO, V433, P145, DOI 10.1016/j.bbrc.2013.02.040; Crutchfield CA, 2016, CLIN PROTEOM, V13, DOI 10.1186/s12014-015-9102-9; DENTON RM, 1966, BIOCHEM J, V100, P420, DOI 10.1042/bj1000420; Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843; Gaude E, 2013, CURR METABOL, V1, P180, DOI 10.2174/2213235X11301020005; He LQ, 2015, CURR PROTEIN PEPT SC, V16, P576, DOI 10.2174/1389203716666150630140157; Iacobazzi V, 2014, BIOL CHEM, V395, P387, DOI 10.1515/hsz-2013-0271; Kerrigan JF, 2000, ANN NEUROL, V47, P583, DOI 10.1002/1531-8249(200005)47:5<583::AID-ANA5>3.3.CO;2-P; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; KREBS HA, 1980, FEBS LETT, V117, pK2, DOI 10.1016/0014-5793(80)80564-3; Li SZ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003123; Lushchak OV, 2014, REDOX REP, V19, P8, DOI 10.1179/1351000213Y.0000000073; MCGARRY JD, 1977, J CLIN INVEST, V60, P265, DOI 10.1172/JCI108764; Metodiev MD, 2014, J MED GENET, V51, P834, DOI 10.1136/jmedgenet-2014-102532; Mroch AR, 2012, AM J MED GENET A, V158A, P155, DOI 10.1002/ajmg.a.34344; Park LCH, 2001, J NEUROSCI RES, V66, P1028, DOI 10.1002/jnr.10062; Patti GJ, 2012, NAT PROTOC, V7, P508, DOI 10.1038/nprot.2011.454; Perluigi M, 2009, PROTEOM CLIN APPL, V3, P682, DOI 10.1002/prca.200800161; PLAITAKIS A, 1982, SCIENCE, V216, P193, DOI 10.1126/science.6121377; Sadat R, 2016, MOL GENET METAB, V118, P28, DOI 10.1016/j.ymgme.2016.03.004; Saha AK, 2003, MOL CELL BIOCHEM, V253, P65, DOI 10.1023/A:1026053302036; Schapira AHV, 1999, BBA-BIOENERGETICS, V1410, P159, DOI 10.1016/S0005-2728(98)00164-9; Schwender H, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-144; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; SPENCER AF, 1967, BIOCHEM J, V103, P342, DOI 10.1042/bj1030342; Spiegel K, 2012, AM J HUM GENET, V90, P518, DOI 10.1016/j.ajhg.2012.01.009; Tabrizi SJ, 1999, ANN NEUROL, V45, P25, DOI 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E; Tautenhahn R., 2008, BMC BIOINFORMATICS, V9; Wei Yau-Huei, 2009, Chang Gung Med J, V32, P113; Yamamoto H, 2003, TOXICOL LETT, V143, P115, DOI 10.1016/S0378-4274(03)00114-0; Zahavi M., 1965, Journal of Insect Physiology, V11, P811, DOI 10.1016/0022-1910(65)90160-5	40	24	24	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176363	10.1371/journal.pone.0176363	http://dx.doi.org/10.1371/journal.pone.0176363			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28463998	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000400646300018
J	Acevedo, N; Ezer, S; Merid, SK; Gaertner, VD; Soderhall, C; D'Amato, M; Kabesch, M; Melen, E; Kere, J; Pulkkinen, V				Acevedo, Nathalle; Ezer, Sini; Merid, Simon Kebede; Gaertner, Vincent D.; Soderhall, Cilia; D'Amato, Mauro; Kabesch, Michael; Melen, Erik; Kere, Juha; Pulkkinen, Ville			Neuropeptide S (NPS) variants modify the signaling and risk effects of NPS Receptor 1 (NPSR1) variants in asthma	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR-154; GENOME-WIDE ASSOCIATION; RHEUMATOID-ARTHRITIS; GENE POLYMORPHISM; CHILDHOOD ASTHMA; PANIC DISORDER; IGE LEVELS; EXPRESSION; POPULATION; RESPONSES	Single nucleotide polymorphisms (SNPs) close to the gain-of-function substitution, Asn(107) Ile (rs324981, A>T), in Neuropeptide S Receptor 1 (NPSR1) have been associated with asthma. Furthermore, a functional SNP (rs4751440, G>C) in Neuropeptide S (NPS) encodes a Val(6)Leu substitution on the mature peptide that results in reduced bioactivity. We sought to examine the effects of different combinations of these NPS and NPSR1 variants on downstream signaling and genetic risk of asthma. In transfected cells, the magnitude of NPSR1-induced activation of cAMP/PKA signal transduction pathways and downstream gene expression was dependent on the combination of the NPS and NPSR1 variants with NPS-Val(6)/NPSR1-Ile(107) resulting in strongest and NPS-Leu(6)/NPSR1-Asn(107) in weakest effects, respectively. One or two copies of the NPS-Leu(6) (rs4751440) were associated with physician-diagnosed childhood asthma (OR: 0.67, 95% CI 0.49-0.92, p = 0.01) and together with two other linked NPS variants (rs1931704 and rs10830123) formed a protective haplotype (p = 0.008) in the Swedish birth cohort BAMSE (2033 children). NPS rs10830123 showed epistasis with NPSR1 rs324981 encoding Asn(107)Ile (p = 0.009) in BAMSE and with the linked NPSR1 rs17199659 (p = 0.005) in the German MAGIC/ISAAC II cohort (1454 children). In conclusion, NPS variants modify asthma risk and should be considered in genetic association studies of NPSR1 with asthma and other complex diseases.	[Acevedo, Nathalle] Soder Sjukhuset, Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Acevedo, Nathalle] Soder Sjukhuset, Sachs Children & Youth Hosp, Stockholm, Sweden; [Ezer, Sini; Kere, Juha] Univ Helsinki, Program Mol Neurol, Res Programs Unit, Helsinki, Finland; [Ezer, Sini; Kere, Juha] Folkhalsan Inst Genet, Helsinki, Finland; [Merid, Simon Kebede; Melen, Erik] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Gaertner, Vincent D.; Kabesch, Michael] Univ Childrens Hosp Regensburg KUNO, Dept Pediat Pneumol & Allergy, Regensburg, Germany; [Soderhall, Cilia; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Soderhall, Cilia] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [D'Amato, Mauro] Basque Fdn Sci, BioDonostia Hlth Res Inst, San Sebastian, Spain; [D'Amato, Mauro] Basque Fdn Sci, IKERBASQUE, San Sebastian, Spain; [D'Amato, Mauro] Karolinska Inst, Clin Epidemiol Unit, Dept Med Solna, Stockholm, Sweden; [Melen, Erik] Sachs Childrens Hosp, Stockholm, Sweden; [Pulkkinen, Ville] Univ Helsinki, Heart & Lung Ctr, Div Pulm Med, FIN-00014 Helsinki, Finland; [Pulkkinen, Ville] Univ Helsinki, Helsinki Univ Hosp, FIN-00014 Helsinki, Finland	Karolinska Institutet; Sodersjukhuset Hospital; Sodersjukhuset Hospital; University of Helsinki; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Basque Foundation for Science; Instituto de Investigacion Sanitaria Biodonostia; Basque Foundation for Science; Karolinska Institutet; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Kere, J (corresponding author), Univ Helsinki, Program Mol Neurol, Res Programs Unit, Helsinki, Finland.; Kere, J (corresponding author), Folkhalsan Inst Genet, Helsinki, Finland.; Kere, J (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden.	juha.kere@ki.se	Kabesch, Michael/GZM-1583-2022; Kere, Juha/AAX-9117-2021; D'Amato, Mauro/B-5050-2019; Kere, Juha/A-9179-2008; Kabesch, Michael/AAB-5701-2020; D'Amato, Mauro/F-2450-2010; Gaertner, Vincent/E-2049-2014	Kere, Juha/0000-0003-1974-0271; D'Amato, Mauro/0000-0003-2743-5197; Kere, Juha/0000-0003-1974-0271; D'Amato, Mauro/0000-0003-2743-5197; Acevedo, Nathalie/0000-0002-5154-2964; Gaertner, Vincent/0000-0001-5330-652X; Kebede Merid, Simon/0000-0001-5974-7676	Sigrid Juselius Foundation; Research Funds of the University of Helsinki; Paulo Foundation; Finnish Anti-Tuberculosis Association Foundation; Finnish Cultural Foundation; Helsinki University Hospital; Swedish Research Council; Swedish Heart-Lung Foundation; Stockholm County Council (ALF); Swedish Foundation for Strategic Research (SSF)	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Research Funds of the University of Helsinki; Paulo Foundation; Finnish Anti-Tuberculosis Association Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Helsinki University Hospital; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Stockholm County Council (ALF)(Stockholm County Council); Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research)	VP is financially supported by the Sigrid Juselius Foundation, Research Funds of the University of Helsinki, the Paulo Foundation, Finnish Anti-Tuberculosis Association Foundation, the Finnish Cultural Foundation, and the EVO funding of the Helsinki University Hospital. In addition, this work was supported by the Swedish Research Council, Swedish Heart-Lung Foundation, Stockholm County Council (ALF), and Swedish Foundation for Strategic Research (SSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060111; Anedda F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029523; Castro-Giner F, 2010, THORAX, V65, P124, DOI 10.1136/thx.2009.119628; D'Amato M, 2007, GASTROENTEROLOGY, V133, P808, DOI 10.1053/j.gastro.2007.06.012; D'Amato M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009315; Deng CW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003524; Depner M, 2014, AM J RESP CRIT CARE, V189, P129, DOI 10.1164/rccm.201307-1198OC; Domschke K, 2011, MOL PSYCHIATR, V16, P938, DOI 10.1038/mp.2010.81; Donner J, 2010, BIOL PSYCHIAT, V68, P474, DOI 10.1016/j.biopsych.2010.05.039; Erdmann F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117319; Feng Y, 2006, J ALLERGY CLIN IMMUN, V117, P612, DOI 10.1016/j.jaci.2005.11.045; Filaferro M, 2013, PEPTIDES, V39, P16, DOI 10.1016/j.peptides.2012.10.013; Gottlieb DJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S9; Guerrini R, 2010, MED RES REV, V30, P751, DOI 10.1002/med.20180; Hamsten C, 2016, ALLERGY; Hanna RN, 2012, CIRC RES, V110, P416, DOI 10.1161/CIRCRESAHA.111.253377; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Heath SC, 2008, EUR J HUM GENET, V16, P1413, DOI 10.1038/ejhg.2008.210; Henstrom M, 2014, NEUROGASTROENT MOTIL, V26, P1417, DOI 10.1111/nmo.12401; Hersh CP, 2007, AM J RESP CRIT CARE, V176, P849, DOI 10.1164/rccm.200704-592OC; Ilmarinen P, 2014, PEPTIDES, V51, P100, DOI 10.1016/j.peptides.2013.10.030; Jungling K, 2008, NEURON, V59, P298, DOI 10.1016/j.neuron.2008.07.002; Kormann MSD, 2005, AM J RESP CRIT CARE, V171, P1358, DOI 10.1164/rccm.200410-1312OC; Kull I, 2010, J ALLERGY CLIN IMMUN, V125, P1013, DOI 10.1016/j.jaci.2010.01.051; Kumsta R, 2013, BIOL PSYCHOL, V93, P304, DOI 10.1016/j.biopsycho.2013.02.018; Laitinen T, 2004, SCIENCE, V304, P300, DOI 10.1126/science.1090010; Liao Y, 2016, J BIOL CHEM, V291, P7505, DOI 10.1074/jbc.M115.704122; Malerba G, 2007, CLIN EXP ALLERGY, V37, P83, DOI 10.1111/j.1365-2222.2006.02615.x; Melen E, 2005, AM J RESP CRIT CARE, V171, P1089, DOI 10.1164/rccm.200410-1317OC; Melen E, 2013, CLIN EXP ALLERGY, V43, P463, DOI 10.1111/cea.12054; Michel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013894; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Murk W, 2015, HUM GENET, V134, P837, DOI 10.1007/s00439-015-1564-3; Murphy EP, 2015, BIOMOLECULES, V5, P1302, DOI 10.3390/biom5031302; Okamura N, 2007, PROG NEURO-PSYCHOPH, V31, P1444, DOI 10.1016/j.pnpbp.2007.06.026; Okamura N, 2007, STRESS, V10, P221, DOI 10.1080/10253890701248673; Pape HC, 2010, NEUROPHARMACOLOGY, V58, P29, DOI 10.1016/j.neuropharm.2009.06.001; Pietras CO, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-39; Potaczek DP, 2013, PEDIAT ALLERG IMM-UK, V24, P441, DOI 10.1111/pai.12083; Pulkkinen V, 2006, HUM MOL GENET, V15, P1667, DOI 10.1093/hmg/ddl090; Pulkkinen V, 2014, VIRCHOWS ARCH, V465, P173, DOI 10.1007/s00428-014-1602-x; Raczka KA, 2010, MOL PSYCHIATR, V15, P1067, DOI 10.1038/mp.2010.79; Reinscheid RK, 2005, J PHARMACOL EXP THER, V315, P1338, DOI 10.1124/jpet.105.093427; Robledo G, 2012, J RHEUMATOL, V39, P1166, DOI 10.3899/jrheum.111205; Schieck M, 2014, J ALLERGY CLIN IMMUN, V133, P888, DOI 10.1016/j.jaci.2013.08.048; Shaked I, 2015, NAT IMMUNOL, V16, P1228, DOI 10.1038/ni.3321; Spada J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098789; Sundman L, 2010, NEUROGASTROENT MOTIL, V22, P79, DOI 10.1111/j.1365-2982.2009.01366.x; Sundman L, 2010, NEUROGASTROENT MOTIL, V22, pe30; Talbot S, 2015, NEURON, V87, P341, DOI 10.1016/j.neuron.2015.06.007; Vendelin J, 2006, HUM MOL GENET, V15, P2923, DOI 10.1093/hmg/ddl234; Vergara C, 2009, CLIN EXP ALLERGY, V39, P1558, DOI 10.1111/j.1365-2222.2009.03311.x; von Mutius E, 1998, LANCET, V351, P862, DOI 10.1016/S0140-6736(97)10100-3; Weiland SK, 1999, EUR RESPIR J, V14, P862, DOI 10.1034/j.1399-3003.1999.14d23.x; Wickman M, 2002, PEDIATR ALLERGY IMMU, V13, P11, DOI 10.1034/j.1399-3038.13.s.15.10.x; Xu YL, 2004, NEURON, V43, P487, DOI 10.1016/j.neuron.2004.08.005; Yao Y, 2014, NEUROIMMUNOMODULAT, V21, P45, DOI 10.1159/000355977; Yao YA, 2011, PEPTIDES, V32, P118, DOI 10.1016/j.peptides.2010.09.021	59	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176568	10.1371/journal.pone.0176568	http://dx.doi.org/10.1371/journal.pone.0176568			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28463995	Green Published, gold, Green Submitted			2022-12-26	WOS:000400646300034
J	Thamotharan, S; Chu, A; Kempf, K; Janzen, C; Grogan, T; Elashoff, DA; Devaskar, SU				Thamotharan, Shanthie; Chu, Alison; Kempf, Katie; Janzen, Carla; Grogan, Tristan; Elashoff, David A.; Devaskar, Sherin U.			Differential microRNA expression in human placentas of term intra-uterine growth restriction that regulates target genes mediating angiogenesis and amino acid transport	PLOS ONE			English	Article							LEUCINE TRANSPORT; FETAL-GROWTH; GLUCOSE; PLASMA; CELLS; TROPHOBLAST; CHILDREN; PREECLAMPSIA; RETARDATION; PROFILES	Placental insufficiency leading to intrauterine growth restriction (IUGR) demonstrates perturbed gene expression affecting placental angiogenesis and nutrient transfer from mother to fetus. To understand the post-transcriptional mechanisms underlying such placental gene expression changes, our objective was to identify key non-coding microRNAs that express biological function. To this end, we initially undertook microarrays targeting microRNAs in a small sub-set of placentas of appropriate (AGA) versus small for gestational age (SGA) weight infants, and observed up-regulation of 97 miRs and down-regulation of 44 miRs in SGA versus AGA. In a larger cohort of samples (AGA, n = 21; SGA, n = 11; IUGR subset, n = 5), we validated by qRT-PCR differential expression of three specific microRNAs (miR-10b, -363 and -149) that target genes mediating angiogenesis and nutrient transfer. Validation yielded an increase in miR-10b and -363 expression of similar to 2.5-fold (p<0.02 each) in SGA versus AGA, and of similar to 3-fold (p<0.005) in IUGR versus AGA, with no significant change despite a trending increase in miR-149. To further establish a cause-and-effect paradigm, employing human HTR8 trophoblast cells, we assessed the effect of nutrient deprivation on miR expression and inhibition of endogenous miRs on target gene expression. In-vitro nutrient deprivation (similar to 50%) increased the expression of miR-10b and miR-149 by 1.5-fold (p<0.02) while decreasing miR-363 (p<0.0001). Inhibition of endogenous miRs employing antisense sequences against miR-10b, -363 and -149 revealed an increase respectively in the expression of the target genes KLF-4 (transcription factor which regulates angiogenesis), SNAT1 and 2 (sodium coupled neutral amino acid transporters) and LAT2 (leucine amino acid transporter), which translated into a similar change in the corresponding proteins. Finally to establish functional significance we performed dual-luciferase reporter assays with 3'-insertion of miR-10b alone and observed a similar to 10% reduction in the 5'-luciferase activity versus the control. Lastly, we further validated by microarray and employing MirWalk software that the pathways and target genes identified by differentially expressed miRs in SGA/IUGR compared to AGA are consistent in a larger cohort. We have established the biological significance of various miRs that target common transcripts mediating pathways of importance, which are perturbed in the human IUGR placenta.	[Thamotharan, Shanthie; Chu, Alison; Kempf, Katie; Devaskar, Sherin U.] Univ Calif Los Angeles, David Geffen Sch Med, Div Neonatol & Dev Biol, Dept Pediat, Los Angeles, CA 90095 USA; [Janzen, Carla] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Grogan, Tristan; Elashoff, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med Stat Core, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Devaskar, SU (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Neonatol & Dev Biol, Dept Pediat, Los Angeles, CA 90095 USA.	sdevaskar@mednet.ucla.edu			NIH [HD-08971, U01HD08722, HD-089714]; National Center for Advancing Translational Sciences through UCLA CTSI Grant [UL1TR001881]; UCLA CTSI [KL2TR001882];  [K12HD034610];  [HD 081206];  [HD 041230]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD089714] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001882] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences through UCLA CTSI Grant; UCLA CTSI; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by grants from NIH HD-08971 and U01HD08722 (to SUD) and the National Center for Advancing Translational Sciences through UCLA CTSI Grant UL1TR001881 (to SUD). AC was supported by K12HD034610 (PI: SUD) and UCLA CTSI KL2TR001882 (PI: MW). SUD is supported by HD 081206 and HD 041230. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from NIH HD-089714, and U01HD08722 (to SUD) and the National Center for Advancing Translational Sciences through UCLA CTSI Grant UL1TR001881 (to SUD). AC was supported by K12HD034610 (PI: SUD) and UCLA CTSI KL2TR001882 (PI: MW). SUD is supported by HD 081206 and HD 041230. We thank Ravi Jhaveri (Duke University) for the gift of HTR8 cell line. We also thank Yun Yong Margarida Lei for her help in collecting and providing human placental samples and acknowledge the initial help of William Frieje with the microarray experiments.	Ackerman WE, 2016, PLACENTA, V44, P23, DOI 10.1016/j.placenta.2016.05.010; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen YY, 2015, CLIN SCI, V129, P1131, DOI 10.1042/CS20150511; Chen ZG, 2015, SCI REP-UK, V5, DOI 10.1038/srep12650; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Chu A, 2015, PEDIATR ANN, V44, pE254, DOI 10.3928/00904481-20151112-07; Day PE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143653; de Jong VM, 2013, GENES IMMUN, V14, P58, DOI 10.1038/gene.2012.38; Delic D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150154; Devaskar SU, 2016, PHYSIOLOGY, V31, P131, DOI 10.1152/physiol.00033.2015; Dong YS, 2012, J BIOL CHEM, V287, P32172, DOI 10.1074/jbc.M112.393462; Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485; Ganguly A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1241, DOI 10.1152/ajpendo.00344.2006; Ganguly A, 2016, ENDOCRINOLOGY, V157, P4041, DOI 10.1210/en.2016-1259; Ganguly A, 2014, J NUTR BIOCHEM, V25, P259, DOI 10.1016/j.jnutbio.2013.10.015; Ganguly A, 2012, ENDOCRINOLOGY, V153, P3995, DOI 10.1210/en.2011-1973; Geva R, 2006, PEDIATRICS, V118, P91, DOI 10.1542/peds.2005-2343; Gierman LM, 2015, PLACENTA, V36, P1246, DOI 10.1016/j.placenta.2015.09.004; Guo L, 2013, PLACENTA, V34, P599, DOI 10.1016/j.placenta.2013.04.007; Hale AT, 2014, J BIOL CHEM, V289, P12016, DOI 10.1074/jbc.M113.530956; Hromadnikova I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138383; Hromadnikova I, 2015, DNA CELL BIOL, V34, P437, DOI 10.1089/dna.2014.2687; Janzen C, 2013, PLACENTA, V34, P1072, DOI 10.1016/j.placenta.2013.08.010; Joseph G, 2016, AM J PHYSIOL-HEART C; Kavitha JV, 2014, FASEB J, V28, P1294, DOI 10.1096/fj.13-242271; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Klaric AS, 2012, EUR J PAEDIATR NEURO, V16, P132, DOI 10.1016/j.ejpn.2011.06.003; Labialle S, 2014, EMBO J, V33, P2216, DOI 10.15252/embj.201387038; Lager S, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/179827; Leitner Y, 2007, J CHILD NEUROL, V22, P580, DOI 10.1177/0883073807302605; Li Q, 2015, BIOMED REP, V3, P792, DOI 10.3892/br.2015.524; Li YZ, 2016, ONCOL REP, V36, P1569, DOI 10.3892/or.2016.4912; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liu LM, 2016, AM J PHYSIOL-HEART C, V310, pH206, DOI 10.1152/ajpheart.00651.2014; Liu Y, 2012, MED SCI MONITOR, V18, pBR299, DOI 10.12659/MSM.883262; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longo S, 2013, J MATERN-FETAL NEO M, V26, P222, DOI 10.3109/14767058.2012.715006; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Maccani MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021210; Morales-Prieto DM, 2012, PLACENTA, V33, P725, DOI 10.1016/j.placenta.2012.05.009; Mouillet JF, 2010, PLACENTA, V31, P781, DOI 10.1016/j.placenta.2010.07.001; Nicholas LM, 2016, INT J OBESITY, V40, P229, DOI 10.1038/ijo.2015.178; Pallotto EK, 2006, CLIN OBSTET GYNECOL, V49, P257, DOI 10.1097/00003081-200606000-00008; Qin B, 2017, MOL CELL BIOCHEM; Ramalinga M, 2015, ONCOTARGET, V6, P34446, DOI 10.18632/oncotarget.5920; Santa LMR, 2015, J PREGNANCY, V2015, DOI 10.1155/2015/320386; Roos S, 2009, AM J PHYSIOL-CELL PH, V297, pC723, DOI 10.1152/ajpcell.00191.2009; Roos S, 2007, J PHYSIOL-LONDON, V582, P449, DOI 10.1113/jphysiol.2007.129676; Rosario FJ, 2011, ENDOCRINOLOGY, V152, P1119, DOI 10.1210/en.2010-1153; Rotllan N, 2012, CHOLESTEROL, DOI 10.1155/2012/847849; Rudra C, 2011, AM J OBSTET GYNECOL, V204, pS222; Sadeghi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168760; Sandovici I, 2012, REPROD BIOMED ONLINE, V25, P68, DOI 10.1016/j.rbmo.2012.03.017; Sankar R, 2002, MOL BRAIN RES, V107, P157, DOI 10.1016/S0169-328X(02)00487-4; Shi XF, 2016, BIOCHEM BIOPH RES CO, V470, P670, DOI 10.1016/j.bbrc.2016.01.084; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; SPINILLO A, 1995, J REPROD MED, V40, P209; Stojadinovic O, 2016, ARCH DERMATOL RES; Sun XX, 2016, INT J MOL MED, V38, P1303, DOI 10.3892/ijmm.2016.2719; Sun Y, 2016, MOL CELL ENDOCRINOL, V433, P75, DOI 10.1016/j.mce.2016.06.004; Vashukova ES, 2016, MOL MED REP, V14, P22, DOI 10.3892/mmr.2016.5268; Wang D, 2014, AM J PERINAT, V31, P729, DOI 10.1055/s-0033-1361832; Wang W, 2012, J CLIN ENDOCR METAB, V97, pE1051, DOI 10.1210/jc.2011-3131; Wang YN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130341; Wang ZX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141138; Xu P, 2014, HYPERTENSION, V63, P1276, DOI 10.1161/HYPERTENSIONAHA.113.02647; Xu ZH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/849475; Yan SY, 2016, ACTA DIABETOL, V53, P693, DOI 10.1007/s00592-016-0837-1; Yang B, 2014, CLIN TRANSL ONCOL, V16, P374, DOI 10.1007/s12094-013-1081-6; Yang S, 2015, MOL MED REP, V12, P527, DOI 10.3892/mmr.2015.3414; Zhang C, 2015, PLACENTA, V36, P250, DOI 10.1016/j.placenta.2014.11.020; Zhang H, 2016, ONCOTARGET; Zhang WW, 2015, CLIN BIOCHEM, V48, P988, DOI 10.1016/j.clinbiochem.2015.04.016; Zhu HJ, 2016, LIFE SCI; Zhu XM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.045	77	40	41	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176493	10.1371/journal.pone.0176493	http://dx.doi.org/10.1371/journal.pone.0176493			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28463968	Green Published, Green Submitted, gold			2022-12-26	WOS:000400646300024
J	Minami, C; Shimizu, T; Mitani, A				Minami, Chihiro; Shimizu, Tomoko; Mitani, Akira			Neural activity in the prelimbic and infralimbic cortices of freely moving rats during social interaction: Effect of isolation rearing	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; AGGRESSIVE-BEHAVIOR; INDUCED DEFICITS; FEAR EXTINCTION; ADULT RATS; MODULATION; NEURONS; PLAY; RESPONSES; DISORDER	Sociability promotes a sound daily life for individuals. Reduced sociability is a central symptom of various neuropsychiatric disorders, and yet the neural mechanisms underlying reduced sociability remain unclear. The prelimbic cortex (PL) and infralimbic cortex (IL) have been suggested to play an important role in the neural mechanisms underlying sociability because isolation rearing in rats results in impairment of social behavior and structural changes in the PL and IL. One possible mechanism underlying reduced sociability involves dysfunction of the PL and IL. We made a wireless telemetry system to record multiunit activity in the PL and IL of pairs of freely moving rats during social interaction and examined the influence of isolation rearing on this activity. In group-reared rats, PL neurons increased firing when the rat showed approaching behavior and also contact behavior, especially when the rat attacked the partner. Conversely, IL neurons increased firing when the rat exhibited leaving behavior, especially when the partner left on its own accord. In social interaction, the PL may be involved in active actions toward others, whereas the IL may be involved in passive relief from cautionary subjects. Isolation rearing altered social behavior and neural activity. Isolation-reared rats showed an increased frequency and decreased duration of contact behavior. The increased firing of PL neurons during approaching and contact behavior, observed in group-reared rats, was preserved in isolation-reared rats, whereas the increased firing of IL neurons during leaving behavior, observed in group-reared rats, was suppressed in isolation-reared rats. This result indicates that isolation rearing differentially alters neural activity in the PL and IL during social behavior. The differential influence of isolation rearing on neural activity in the PL and IL may be one of the neural bases of isolation rearing-induced behavior.	[Minami, Chihiro; Shimizu, Tomoko; Mitani, Akira] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Physiol Lab, Kyoto, Japan	Kyoto University	Mitani, A (corresponding author), Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Physiol Lab, Kyoto, Japan.	mitani.akita.6z@kyoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [KAKENHI 26282155, 226578, 267534]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research (B) from Japan Society for the Promotion of Science (JSPS) to A.M. (KAKENHI 26282155) and Grant-in-Aid for JSPS Fellows to C.M. (226578) and T.S. (267534). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams RC, 1998, AM J GERIAT PSYCHIAT, V6, P24; Bakshi VP, 1999, PHYSIOL BEHAV, V67, P385, DOI 10.1016/S0031-9384(99)00082-7; Bell HC, 2009, BEHAV NEUROSCI, V123, P1158, DOI 10.1037/a0017617; Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2; Cambon K, 2010, NEUROSCIENCE, V171, P840, DOI 10.1016/j.neuroscience.2010.09.015; Day-Wilson KM, 2006, NEUROSCIENCE, V141, P1113, DOI 10.1016/j.neuroscience.2006.04.048; Di Martino A, 2009, BIOL PSYCHIAT, V65, P63, DOI 10.1016/j.biopsych.2008.09.022; Faccidomo S, 2012, PSYCHOPHARMACOLOGY, V222, P117, DOI 10.1007/s00213-011-2629-1; Ferdman N, 2007, BEHAV BRAIN RES, V180, P174, DOI 10.1016/j.bbr.2007.03.011; Fitzgerald PJ, 2014, NEUROBIOL LEARN MEM, V113, P69, DOI 10.1016/j.nlm.2013.11.002; Fone KCF, 2008, NEUROSCI BIOBEHAV R, V32, P1087, DOI 10.1016/j.neubiorev.2008.03.003; GENTSCH C, 1982, BEHAV BRAIN RES, V6, P93, DOI 10.1016/0166-4328(82)90084-5; Gilmartin MR, 2005, BEHAV NEUROSCI, V119, P1496, DOI 10.1037/0735-7044.119.6.1496; Goldberg JO, 2001, SCHIZOPHR RES, V48, P343, DOI 10.1016/S0920-9964(00)00143-2; Gourley SL, 2016, NAT NEUROSCI, V19, P656, DOI 10.1038/nn.4275; Gradin VB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042608; Hall FS, 1997, PHYSIOL BEHAV, V62, P299, DOI 10.1016/S0031-9384(97)00117-0; Jimenez-Sanchez L, 2016, CEREB CORTEX, V26, P2778, DOI 10.1093/cercor/bhv133; Jinks AL, 1997, BRAIN RES, V772, P181, DOI 10.1016/S0006-8993(97)00810-X; KOLB B, 1974, PHYSIOL BEHAV, V13, P637, DOI 10.1016/0031-9384(74)90234-0; Lapiz M D S, 2003, Neurosci Behav Physiol, V33, P13, DOI 10.1023/A:1021171129766; Laurent V, 2009, LEARN MEMORY, V16, P520, DOI 10.1101/lm.1474609; Lee E, 2016, J NEUROSCI, V36, P6926, DOI 10.1523/JNEUROSCI.0307-16.2016; Lehmann ML, 2011, J NEUROSCI, V31, P6159, DOI 10.1523/JNEUROSCI.0577-11.2011; Lisboa SF, 2010, NEUROSCIENCE, V171, P760, DOI 10.1016/j.neuroscience.2010.09.048; Lukkes JL, 2009, NEUROSCIENCE, V158, P845, DOI 10.1016/j.neuroscience.2008.10.036; Lukkes JL, 2009, HORM BEHAV, V55, P248, DOI 10.1016/j.yhbeh.2008.10.014; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Nieuwenhuis ILC, 2011, BEHAV BRAIN RES, V218, P325, DOI 10.1016/j.bbr.2010.12.009; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pellis SM, 2006, BEHAV NEUROSCI, V120, P72, DOI 10.1037/0735-7044.120.1.72; PELLIS SM, 1990, DEV PSYCHOBIOL, V23, P215, DOI 10.1002/dev.420230303; Pellis SM, 1997, DEV PSYCHOBIOL, V31, P193; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Rapin I, 1998, ANN NEUROL, V43, P7, DOI 10.1002/ana.410430106; Rich EL, 2009, J NEUROSCI, V29, P7208, DOI 10.1523/JNEUROSCI.6068-08.2009; Schubert MI, 2009, NEUROSCIENCE, V159, P21, DOI 10.1016/j.neuroscience.2008.12.019; Sciolino NR, 2010, NEUROSCIENCE, V168, P371, DOI 10.1016/j.neuroscience.2010.04.007; Scopinho AA, 2010, BEHAV BRAIN RES, V214, P437, DOI 10.1016/j.bbr.2010.06.018; Shah AA, 2003, BRAIN RES, V969, P183, DOI 10.1016/S0006-8993(03)02299-6; Silva-Gomez AB, 2003, BRAIN RES, V983, P128, DOI 10.1016/S0006-8993(03)03042-7; Tang Y, 2013, PSYCHOL MED, V43, P1921, DOI 10.1017/S0033291712002759; THOR DH, 1984, NEUROSCI BIOBEHAV R, V8, P455, DOI 10.1016/0149-7634(84)90004-6; Treadway MT, 2015, BIOL PSYCHIAT, V77, P285, DOI 10.1016/j.biopsych.2014.06.018; Valk SL, 2015, HUM BRAIN MAPP, V36, P2364, DOI 10.1002/hbm.22776; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Vidal-Gonzalez I, 2006, LEARN MEMORY, V13, P728, DOI 10.1101/lm.306106; Wongwitdecha N, 1996, BEHAV BRAIN RES, V75, P27, DOI 10.1016/0166-4328(96)00181-7; Yamada M, 2007, NEUROIMAGE, V35, P292, DOI 10.1016/j.neuroimage.2006.10.046; Yorgason JT, 2013, EUR J NEUROSCI, V37, P1022, DOI 10.1111/ejn.12113	50	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176740	10.1371/journal.pone.0176740	http://dx.doi.org/10.1371/journal.pone.0176740			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459875	Green Submitted, Green Published, gold			2022-12-26	WOS:000400645000057
J	Shokryazdan, P; Jahromi, MF; Liang, JB; Ramasamy, K; Sieo, CC; Ho, YW				Shokryazdan, Parisa; Jahromi, Mohammad Faseleh; Liang, Juan Boo; Ramasamy, Kalavathy; Sieo, Chin Chin; Ho, Yin Wan			Effects of a Lactobacillus salivarius mixture on performance, intestinal health and serum lipids of broiler chickens	PLOS ONE			English	Article							GROWTH-PERFORMANCE; FED DIETS; PROBIOTIC SUPPLEMENTATION; BIFIDOBACTERIUM-BIFIDUM; ENZYME-ACTIVITIES; CECAL MICROFLORA; CHOLESTEROL; STRAINS; MORPHOLOGY; CULTURES	The ban or severe restriction on the use of antibiotics in poultry feeds to promote growth has led to considerable interest to find alternative approaches. Probiotics have been considered as such alternatives. In the present study, the effects of a Lactobacillus mixture composed from three previously isolated Lactobacillus salivarius strains (CI1, CI2 and CI3) from chicken intestines on performance, intestinal health status and serum lipids of broiler chickens has been evaluated. Supplementation of the mixture at a concentration of 0.5 or 1 g kg(-1) of diet to broilers for 42 days improved body weight, body weight gain and FCR, reduced total cholesterol, LDL-cholesterol and triglycerides, increased populations of beneficial bacteria such as lactobacilli and bifidobacteria, decreased harmful bacteria such as E. coli and total aerobes, reduced harmful cecal bacterial enzymes such as beta-glucosidase and beta-glucuronidase, and improved intestinal histomorphology of broilers. Because of its remarkable efficacy on broiler chickens, the L. salivarius mixture could be considered as a good potential probiotic for chickens, and its benefits should be further evaluated on a commercial scale.	[Shokryazdan, Parisa; Jahromi, Mohammad Faseleh; Liang, Juan Boo] Univ Putra Malaysia, Inst Trop Agr, Serdang, Selangor, Malaysia; [Ramasamy, Kalavathy] Univ Teknol MARA, Fac Pharm, Puncak Alam, Selangor, Malaysia; [Sieo, Chin Chin; Ho, Yin Wan] Univ Putra Malaysia, Inst Biosci, Serdang, Selangor, Malaysia; [Shokryazdan, Parisa; Jahromi, Mohammad Faseleh] ABRII, East & North East Branch, Mashhad, Iran; [Sieo, Chin Chin] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Teknologi MARA; Universiti Putra Malaysia; Universiti Putra Malaysia	Liang, JB (corresponding author), Univ Putra Malaysia, Inst Trop Agr, Serdang, Selangor, Malaysia.; Sieo, CC (corresponding author), Univ Putra Malaysia, Inst Biosci, Serdang, Selangor, Malaysia.	jbliang@upm.edu.my; ccsieo@upm.edu.my	Ramasamy, Kala/ABA-8532-2021	Ramasamy, Kalavathy/0000-0002-1666-9230	Ministry of Education, Malaysia [LRGS Fasa 1/2012]	Ministry of Education, Malaysia(Ministry of Education, Malaysia)	This study was supported by the LRGS Fasa 1/2012 (UniversitiPutraMalaysia) provided by the Ministry of Education, Malaysia.	Afsharmanesh M, 2011, COMP CLIN PATH, V22, P245; Ashayerizadeh O, 2009, J ANIM VET ADV, V8, P1772; Awad WA, 2009, POULTRY SCI, V88, P49, DOI 10.3382/ps.2008-00244; Bartosch S, 2005, CLIN INFECT DIS, V40, P28, DOI 10.1086/426027; Chiang YR, 2008, J BACTERIOL, V190, P905, DOI 10.1128/JB.01525-07; COLE CB, 1984, FOOD MICROBIOL, V1, P217; Drasar BS, HUMAN INTESTINAL FLO; Federation of Animal Science Societies, 1999, GUID CAR US AGR AN R; Ferket P. R., 2006, INT J POULT SCI, V5, P905, DOI [10.3923/IJPS.2006.905.911, DOI 10.3923/IJPS.2006.905.911]; Frahm E, 2003, J MICROBIOL METH, V52, P123, DOI 10.1016/S0167-7012(02)00150-1; FUKUSHIMA M, 1995, BRIT J NUTR, V73, P701, DOI 10.1079/BJN19950074; FULLER R, 1989, J APPL BACTERIOL, V66, P365; FULLER R, 1973, J APPL BACTERIOL, V36, P131, DOI 10.1111/j.1365-2672.1973.tb04080.x; Fuller R., 2001, POULTRY SCI, V38, P189, DOI [10.2141/jpsa. 38. 189, DOI 10.2141/JPSA.38.189]; GADELLE D, 1985, APPL ENVIRON MICROB, V49, P682, DOI 10.1128/AEM.49.3.682-685.1985; GILLILAND SE, 1985, APPL ENVIRON MICROB, V49, P377, DOI 10.1128/AEM.49.2.377-381.1985; GOLDIN BR, 1984, J NATL CANCER I, V73, P689; GORBACH SL, 1986, SCAND J INFECT DIS, P17; Gunal M., 2006, International Journal of Poultry Science, V5, P149; Han I. K., 1984, Korean Journal of Animal Sciences, V26, P150; Hayek S.A., 2013, MICROBIAL PATHOGENS, P910; Houshmand M, 2011, J APPL POULTRY RES, V20, P121, DOI 10.3382/japr.2010-00171; Jin L. Z., 1996, Asian-Australasian Journal of Animal Sciences, V9, P397; Jin LZ, 1998, ANIM FEED SCI TECH, V70, P197, DOI 10.1016/S0377-8401(97)00080-1; Jin LZ, 1998, POULTRY SCI, V77, P1259, DOI 10.1093/ps/77.9.1259; Jin LZ, 2000, POULTRY SCI, V79, P886, DOI 10.1093/ps/79.6.886; Kalavathy R., 2008, International Journal of Poultry Science, V7, P385; Kalavathy R, 2006, ANIM RES, V55, P77, DOI 10.1051/animres:2005043; Kalavathy R, 2003, BRIT POULTRY SCI, V44, P139, DOI 10.1080/0007166031000085445; Khaksefidi Ahmad, 2006, Journal of Poultry Science, V43, P296, DOI 10.2141/jpsa.43.296; Kizerwetter-Swida Magdalena, 2005, Polish Journal of Microbiology, V54, P287; KLAVER FAM, 1993, APPL ENVIRON MICROB, V59, P1120, DOI 10.1128/AEM.59.4.1120-1124.1993; Lan PTN, 2003, J GEN APPL MICROBIOL, V49, P29; Lee DK, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-21; Lye HS, 2010, INT DAIRY J, V20, P169, DOI 10.1016/j.idairyj.2009.10.003; Mansoub N. H., 2010, Global Veterinaria, V5, P184; Mayahi M, 2009, EFFECTS DIETARY PROB, P589; Mohan B, 1996, BRIT POULTRY SCI, V37, P395, DOI 10.1080/00071669608417870; Mookiah S, 2014, J SCI FOOD AGR, V94, P341, DOI 10.1002/jsfa.6365; Mountzouris KC, 2007, POULTRY SCI, V86, P309, DOI 10.1093/ps/86.2.309; NAHASHON S N, 1992, Poultry Science, V71, P111; Nahashon S. N., 1993, Poultry Science, V72, P87; Nahashon SN, 1996, ANIM FEED SCI TECH, V57, P25, DOI 10.1016/0377-8401(95)00852-7; Nayebpor M., 2007, Journal of Animal and Veterinary Advances, V6, P1308; NRC-National Research Council, 1994, NUTR REQ POULTR, P157; Ooi LG, 2010, INT J MOL SCI, V11, P2499, DOI 10.3390/ijms11062499; Panda Arun K., 2006, Journal of Poultry Science, V43, P235, DOI 10.2141/jpsa.43.235; Pappenheimer JR, 2003, J PHYSIOL-LONDON, V553, P561, DOI 10.1113/jphysiol.2003.043257; Peric L, 2010, ARCH TIERZUCHT, V53, P350, DOI 10.5194/aab-53-350-2010; Ramasamy K, 2009, J SCI FOOD AGR, V89, P482, DOI 10.1002/jsfa.3477; Ramasamy K, 2010, J SCI FOOD AGR, V90, P65, DOI 10.1002/jsfa.3780; Resta SC, 2009, J PHYSIOL-LONDON, V587, P4169, DOI 10.1113/jphysiol.2009.176370; Samanya M, 2002, COMP BIOCHEM PHYS A, V133, P95, DOI 10.1016/S1095-6433(02)00121-6; SAS, 2008, SAS ONL DOC 9 2; Shokryazdan P., 2014, Pertanika Journal of Tropical Agricultural Science, V37, P141; Shokryazdan P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/927268; Song D, RECENT APPL PROBIOTI; Timmerman HM, 2006, POULTRY SCI, V85, P1383, DOI 10.1093/ps/85.8.1383; Usman, 1999, J DAIRY SCI, V82, P243, DOI 10.3168/jds.S0022-0302(99)75229-X; Wang RF, 1996, APPL ENVIRON MICROB, V62, P1242, DOI 10.1128/AEM.62.4.1242-1247.1996; WATKINS BA, 1983, POULTRY SCI, V62, P2088, DOI 10.3382/ps.0622088; Willis WL, 2007, POULTRY SCI, V86, P1856, DOI 10.1093/ps/86.9.1856; Xu ZR, 2003, POULTRY SCI, V82, P1030, DOI 10.1093/ps/82.6.1030; Yeo J, 1997, POULTRY SCI, V76, P381, DOI 10.1093/ps/76.2.381; Zulkifli I, 2000, BRIT POULTRY SCI, V41, P593, DOI 10.1080/713654979	65	45	54	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0175959	10.1371/journal.pone.0175959	http://dx.doi.org/10.1371/journal.pone.0175959			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459856	gold, Green Published, Green Submitted			2022-12-26	WOS:000400645000010
J	Simoes, MJ; Bettencourt, C; De Paola, R; Giuliani, M; Pizza, M; Moschioni, M; Machado, J				Simoes, Maria Joao; Bettencourt, Celia; De Paola, Rosita; Giuliani, Maria; Pizza, Mariagrazia; Moschioni, Monica; Machado, Jorge			Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Portugal	PLOS ONE			English	Article							B VACCINE; MATS; IDENTIFICATION	Objective Although the incidence of meningococcal disease has been declining over the past decade in Portugal MenB meningococci is still an important cause of meningitis and sepsis. The aim of this study was to estimate the strain coverage of the 4CMenB vaccine in Portugal in order to support health policies for prevention and control of meningococcal disease. Methods Since 2002 the clinical and laboratory notification of meningococcal disease is mandatory in Portugal. National database includes since then all confirmed cases notified to the reference laboratory or to the Directorate of Health. Strains included in this study were all the invasive MenB isolated from the 1(st) July 2011 to the 30(th) June 2015, sent to the reference laboratory. To predict the vaccine strain coverage of the 4CMenB the expression and cross-reactivity of the surface antigens fHbp, NadA, NHBA were assessed by the Meningococcal Antigen Typing System (MATS) whereas PorA typing was performed by sequencing. The presence of at least one antigen with a Relative Potency (RP) greater than its MATS-positive bactericidal threshold RP value or the presence of PorA VR2 = 4 was considered to be predictive for a strain to be covered by the 4CMenB vaccine. Results The estimated 4CMenB strain coverage in Portugal was 67.9%. The percentage of strain coverage in each of the four epidemiological years ranged from 63.9% to 73.7%. Strains covered by one antigen represent 32.1% of the total of isolates, 29.2% of strains were covered by two antigens and 6.6% by three antigens. No strain had all the four antigens. Antigens that most contributed for coverage were NHBA and fHbp. Data from Portugal is in accordance with the MATS predicted strain coverage in five European countries (England and Wales, France, Germany, Italy and Norway) that pointed to 78% coverage for strains collected in the epidemiological year 2007-2008.	[Simoes, Maria Joao; Bettencourt, Celia; Machado, Jorge] Natl Inst Hlth Dr Ricardo Jorge, Dept Infect Dis, Lisbon, Portugal; [De Paola, Rosita; Giuliani, Maria; Pizza, Mariagrazia; Moschioni, Monica] GSK Vaccines, Siena, Italy	Instituto Nacional de Saude Dr. Ricardo Jorge; GlaxoSmithKline	Simoes, MJ (corresponding author), Natl Inst Hlth Dr Ricardo Jorge, Dept Infect Dis, Lisbon, Portugal.	m.joao.simoes@insa.min-saude.pt		Bettencourt, Celia/0000-0001-7827-8887				Abad R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150721; [Anonymous], 2011, LAB METHODS DIAGNOSI, V2nd; Basta NE, 2016, NEW ENGL J MED, V375, P220, DOI 10.1056/NEJMoa1514866; Donnelly J, 2010, P NATL ACAD SCI USA, V107, P19490, DOI 10.1073/pnas.1013758107; European Centre for Disease Prevention and Control, 2015, SURV INV BACT DIS EU; Frosi G, 2013, VACCINE, V31, P4968, DOI 10.1016/j.vaccine.2013.08.006; Gasparini R, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/189153; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Harrison OB, 2013, EMERG INFECT DIS, V19, P566, DOI 10.3201/eid1904.111799; Holst J, 2013, HUM VACC IMMUNOTHER, V9, P1241, DOI 10.4161/hv.24129; Hong E, 2013, VACCINE, V31, P1113, DOI 10.1016/j.vaccine.2012.12.022; Lesinski GB, 2001, J MICROBIOL METH, V47, P135, DOI 10.1016/S0167-7012(01)00290-1; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Medini D, 2015, VACCINE, V33, P2629, DOI 10.1016/j.vaccine.2015.04.015; Molling P, 2002, J CLIN MICROBIOL, V40, P4531, DOI 10.1128/JCM.40.12.4531-4535.2002; Plikaytis BD, 2012, CLIN VACCINE IMMUNOL, V19, P1609, DOI 10.1128/CVI.00202-12; Rouphael NG, 2012, METHODS MOL BIOL, V799, P1, DOI 10.1007/978-1-61779-346-2_1; Simoes MJ, 2015, DOENCA MENINGOCOCICA; Vogel U, 2013, LANCET INFECT DIS, V13, P416, DOI 10.1016/S1473-3099(13)70006-9	19	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176177	10.1371/journal.pone.0176177	http://dx.doi.org/10.1371/journal.pone.0176177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459837	Green Published, gold, Green Submitted			2022-12-26	WOS:000400645000018
J	Luo, J; Dong, BY; Wang, K; Cai, SQ; Liu, TJ; Cheng, XJ; Lei, DQ; Chen, YL; Li, YN; Kong, JL; Chen, YQ				Luo, Jing; Dong, Biying; Wang, Ke; Cai, Shuangqi; Liu, Tangjuan; Cheng, Xiaojing; Lei, Danqing; Chen, Yanling; Li, Yanan; Kong, Jinliang; Chen, Yiqiang			Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model	PLOS ONE			English	Article							TO-CELL COMMUNICATION; SYNERGISTIC ANTIBACTERIAL EFFICACY; EARLY COMBINATION TREATMENT; IN-VITRO; TWITCHING MOTILITY; BACTERIAL BIOFILMS; CYSTIC-FIBROSIS; LUNG INFECTION; IV PILI; SUSCEPTIBILITY	The quorum sensing (QS) circuit plays a role in the precise regulation of genes controlling virulence factors and biofilm formation in Pseudomonas aeruginosa. QS-controlled biofilm formation by Pseudomonas aeruginosa in clinical settings has remained controversial due to emerging drug resistance; therefore, screening diverse compounds for anti-biofilm or anti-QS activities is important. This study demonstrates the ability of sub-minimum inhibitory concentrations (sub-MICs) of baicalin, an active natural compound extracted from the traditional Chinese medicinal Scutellaria baicalensis, to inhibit the formation of Pseudomonas aeruginosa biofilms and enhance the bactericidal effects of various conventional antibiotics in vitro. In addition, baicalin exerted dose-dependent inhibitory effects on virulence phenotypes (LasA protease, LasB elastase, pyocyanin, rhamnolipid, motilities and exotoxin A) regulated by QS in Pseudomonas aeruginosa. Moreover, the expression levels of QS-regulatory genes, including lasI, lasR, rhlI, rhlR, pqsR and pqsA, were repressed after sub-MIC baicalin treatment, resulting in significant decreases in the QS signaling molecules 3-oxo-C12- HSL and C4-HSL, confirming the ability of baicalin-mediated QS inhibition to alter gene and protein expression. In vivo experiments indicated that baicalin treatment reduces Pseudomonas aeruginosa pathogenicity in Caenorhabditis elegans. Greater worm survival in the baicalin-treated group manifested as an increase in the LT50 from 24 to 96 h. In a mouse peritoneal implant infection model, baicalin treatment enhanced the clearance of Pseudomonas aeruginosa from the implants of mice infected with Pseudomonas aeruginosa compared with the control group. Moreover, the combination of baicalin and antibiotics significantly reduced the numbers of colony-forming units in the implants to a significantly greater degree than antibiotic treatment alone. Pathological and histological analyses revealed mitigation of the inflammatory response and reduced cell infiltration in the peritoneal tissue surrounding the implants after baicalin treatment. Measurement of the cytokine levels in the peritoneal lavage fluid of mice in the baicalin treatment group revealed a decrease in IL-4, an increase in interferon gamma (IFN-gamma), and a reversed IFN-gamma/IL-4 ratio compared with the control group, indicating that baicalin treatment activated the Th1-induced immune response to expedite bacterial load clearance. Based on these results, baicalin might be a potent QS inhibitor and anti-biofilm agent for combating Pseudomonas aeruginosa biofilm-related infections.	[Luo, Jing; Dong, Biying; Wang, Ke; Cai, Shuangqi; Liu, Tangjuan; Chen, Yanling; Li, Yanan; Kong, Jinliang; Chen, Yiqiang] Guangxi Med Univ, Affiliated Hosp 1, Dept Resp Dis, Nanning, Guangxi, Peoples R China; [Cheng, Xiaojing; Lei, Danqing] Guangxi Med Univ, Inst Life Sci, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University	Kong, JL; Chen, YQ (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Resp Dis, Nanning, Guangxi, Peoples R China.	kjl71@126.com; chenyiq0708@163.com	chen, yanling/GRE-8287-2022		National Natural Science Foundation of China [81260663, 81570006, 81260002]; Innovation Project of Guangxi Graduate Education [YCBZ2013014]; Program for the Cultivation of 139 High-Level Backbone Medical Talents in Guangxi Province [2014GWKJF14]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Project of Guangxi Graduate Education; Program for the Cultivation of 139 High-Level Backbone Medical Talents in Guangxi Province	This work was funded by the National Natural Science Foundation of China (grant numbers 81260663, 81570006 and 81260002; website: www.nsfc.gov.cn), the Innovation Project of Guangxi Graduate Education (YCBZ2013014; website: www.gxedu.gov.cn) and the Program for the Cultivation of 139 High-Level Backbone Medical Talents in Guangxi Province (2014GWKJF14; website: www.gxws.gov.cn). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alasil S. M., 2015, INT J BACTERIOL, V2015, P16, DOI 10.1155/2015/671562; Antunes LCM, 2010, MICROBIOL-SGM, V156, P2271, DOI 10.1099/mic.0.038794-0; Arciola CR, 2005, INT J ARTIF ORGANS, V28, P1091, DOI 10.1177/039139880502801106; Brackman G, 2009, RES MICROBIOL, V160, P144, DOI 10.1016/j.resmic.2008.12.003; Brackman G, 2015, CURR PHARM DESIGN, V21, P5; Brackman G, 2013, J ANTIMICROB CHEMOTH, V68, P2176, DOI 10.1093/jac/dkt151; Brackman G, 2011, ANTIMICROB AGENTS CH, V55, P2655, DOI 10.1128/AAC.00045-11; Cataldi TRI, 2009, J MASS SPECTROM, V44, P182, DOI 10.1002/jms.1479; Chen Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153468; Christensen LD, 2007, MICROBIOL-SGM, V153, P2312, DOI 10.1099/mic.0.2007/006122-0; Christensen LD, 2012, J ANTIMICROB CHEMOTH, V67, P1198, DOI 10.1093/jac/dks002; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062, DOI 10.1177/039139880502801103; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Girennavar B, 2008, INT J FOOD MICROBIOL, V125, P204, DOI 10.1016/j.ijfoodmicro.2008.03.028; Glessner A, 1999, J BACTERIOL, V181, P1623, DOI 10.1128/JB.181.5.1623-1629.1999; Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X; He XJ, 2014, MICROBIOL RES, V169, P759, DOI 10.1016/j.micres.2014.01.001; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Hentzer M, 2002, MICROBIOL-SGM, V148, P87, DOI 10.1099/00221287-148-1-87; Hoiby N, 2015, CLIN MICROBIOL INFEC, V21, pS1, DOI 10.1016/j.cmi.2014.10.024; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Huang YQ, 2015, WORLD J GASTROENTERO, V21, P4225, DOI 10.3748/wjg.v21.i14.4225; Jensen PO, 2007, MICROBIOL-SGM, V153, P1329, DOI 10.1099/mic.0.2006/003863-0; Johansen HK, 1996, CLIN EXP IMMUNOL, V103, P212, DOI 10.1046/j.1365-2249.1996.d01-618.x; Kalia M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135495; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Kouidhi B, 2015, MICROB PATHOGENESIS, V80, P39, DOI 10.1016/j.micpath.2015.02.007; Lau GW, 2004, INFECT IMMUN, V72, P4275, DOI 10.1128/IAI.72.7.4275-4278.2004; Li X, 2015, VIRUSES-BASEL, V7, P4756, DOI 10.3390/v7082841; Luo Jing, 2016, Drug Des Devel Ther, V10, P183, DOI 10.2147/DDDT.S97221; Ma L, 2012, ANTIMICROB AGENTS CH, V56, P6088, DOI 10.1128/AAC.01119-12; Mack D, 1999, J HOSP INFECT, V43, pS113, DOI 10.1016/S0195-6701(99)90074-9; Makemson J, 2006, LUMINESCENCE, V21, P1, DOI 10.1002/bio.873; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Moser C, 2000, APMIS, V108, P329, DOI 10.1034/j.1600-0463.2000.d01-64.x; Mu HB, 2014, INT J MOL SCI, V15, P22296, DOI 10.3390/ijms151222296; Novy P, 2011, J ANTIMICROB CHEMOTH, V66, P1298, DOI 10.1093/jac/dkr108; O'May C, 2011, APPL ENVIRON MICROB, V77, P3061, DOI 10.1128/AEM.02677-10; OHMAN DE, 1980, J BACTERIOL, V142, P836, DOI 10.1128/JB.142.3.836-842.1980; OHMAN DE, 1980, INFECT IMMUN, V28, P899; PASSADOR L, 1993, SCIENCE, V260, P1127, DOI 10.1126/science.8493556; Pearson JP, 1999, J BACTERIOL, V181, P1203, DOI 10.1128/JB.181.4.1203-1210.1999; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Pham TH, 2004, MICROBIOL-SGM, V150, P3405, DOI 10.1099/mic.0.27357-0; Qu L, 2016, MICROBIOLOGYOPEN, V5, P402, DOI 10.1002/mbo3.338; Rasmussen TB, 2006, MICROBIOL-SGM, V152, P895, DOI 10.1099/mic.0.28601-0; Sadlon AE, 2010, ALTERN MED REV, V15, P33; Sarabhai S, 2015, J APPL MICROBIOL, V118, P817, DOI 10.1111/jam.12733; Sarabhai S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053441; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Singh BR, 2015, SCI REP-UK, V5, DOI 10.1038/srep13719; Stehling EG, 2008, BRAZ J INFECT DIS, V12, P86, DOI 10.1590/S1413-86702008000100018; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Thadepalli H, 2004, CHEMOTHERAPY, V50, P76, DOI 10.1159/000077806; Utari PD, 2013, TRENDS MICROBIOL, V21, P315, DOI 10.1016/j.tim.2013.04.006; Vandeputte OM, 2010, APPL ENVIRON MICROB, V76, P243, DOI 10.1128/AEM.01059-09; Wang TM, 2015, MICROB PATHOGENESIS, V87, P21, DOI 10.1016/j.micpath.2015.07.006; Wikler MA, 2009, M07A8 CLSI; Wu DQ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00635; Wu H, 2011, FEMS IMMUNOL MED MIC, V62, P49, DOI 10.1111/j.1574-695X.2011.00787.x; Xu ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057050; Yin HG, 2015, SCI REP-UK, V5, DOI 10.1038/srep16158; Zeng Z, 2008, APPL MICROBIOL BIOT, V79, P119, DOI 10.1007/s00253-008-1406-5; Zhang F, 2016, CHIN J NAT MEDICINES, V14, P769, DOI 10.1016/S1875-5364(16)30091-7; Zhang HW, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/987326; Zhou YY, 2016, MAT SCI ENG C-MATER, V67, P336, DOI 10.1016/j.msec.2016.05.063	70	150	164	7	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176883	10.1371/journal.pone.0176883	http://dx.doi.org/10.1371/journal.pone.0176883			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453568	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383900061
J	Meyers, N; Sukopp, M; Jager, R; Steiner, M; Matthys, R; Lapatki, B; Ignatius, A; Claes, L				Meyers, Nicholaus; Sukopp, Matthias; Jaeger, Rudolf; Steiner, Malte; Matthys, Romano; Lapatki, Bernd; Ignatius, Anita; Claes, Lutz			Characterization of interfragmentary motion associated with common osteosynthesis devices for rat fracture healing studies	PLOS ONE			English	Article							REDUCED FIXATION STIFFNESS; MECHANICAL STRAIN; BONE REGENERATION; DOSE-RESPONSE; SIZE; DICLOFENAC; STABILITY; DIFFERENTIATION; DYNAMIZATION; OSTEOBLASTS	Rat models are widely used in preclinical studies investigating fracture healing. The inter-fragmentary movement at a fracture site is critical to the course of healing and therefore demands definition in order to aptly interpret the experimental results. Estimation of this movement requires knowledge of the fixation stiffness and loading. The characteristic loading for the rat femur has been estimated, but the stiffness of fixation used in rat studies has yet to be fully described. This study aimed to determine the 6 degree of freedom stiffness of four commonly used implants, two external fixators (RatExFix and UlmExFix), a locking plate, and a locking intramedullary nail, in all degrees of freedom and estimate the interfragmentary movement under specific physiological loads. The external fixator systems allow the greatest movement. Mounted 45 E anterolateral on the femur, the RatExFix allows an average of 0.88 mm of motion in each anatomic direction while the stiffer UlmExFix allows about 0.6 mm of motion. The nail is far stiffer than the other implants investigated while the plate allows movement of an intermediate magnitude. Both the nail and plate demonstrate higher axial than shear stiffness. The relatively large standard deviations in external fixator shear motion imply strong dependence on bone axis alignment across the gap and the precise orientation of the specimen relative to the loading. The smaller standard deviation associated with the nail and plate results from improved alignment and minimization of the influence of rotational positioning of the specimen due to the reduced implant eccentricity relative to the specimen axis. These results show that the interfragmentary movement is complex and varies significantly between fixation devices but establishes a baseline for the evaluation of the results of different studies.	[Meyers, Nicholaus; Sukopp, Matthias; Steiner, Malte; Ignatius, Anita; Claes, Lutz] Univ Hosp Ulm, Ctr Musculoskeletal Res Ulm, Inst Orthoped Res & Biomech, Baden, Switzerland; [Jaeger, Rudolf; Lapatki, Bernd] Univ Hosp Ulm, Dept Orthodont, Baden Baden, Germany; [Matthys, Romano] RISystem AG, Davos, Switzerland		Meyers, N (corresponding author), Univ Hosp Ulm, Ctr Musculoskeletal Res Ulm, Inst Orthoped Res & Biomech, Baden, Switzerland.	nicholaus.meyers@uni-ulm.de	Claes, Lutz/O-4697-2014; Ignatius, Anita/M-6012-2013; Meyers, Nicholaus/R-7482-2016	Ignatius, Anita/0000-0002-4782-1979; Meyers, Nicholaus/0000-0001-7614-1203; Matthys, Romano/0000-0001-9600-7060				ARO HT, 1993, CLIN ORTHOP RELAT R, P8; Augat P, 1998, J ORTHOPAED RES, V16, P475, DOI 10.1002/jor.1100160413; Augat P, 2003, J ORTHOP RES, V21, P1011, DOI 10.1016/S0736-0266(03)00098-6; Beck A, 2003, ARCH ORTHOP TRAUM SU, V123, P327, DOI 10.1007/s00402-003-0537-5; Bosemark P, 2015, J ORTHOP RES, V33, P488, DOI 10.1002/jor.22815; Chatterjea A, 2014, J BIOMED MATER RES A, V102, P1399, DOI 10.1002/jbm.a.34815; Claes L, 2003, LANGENBECK ARCH SURG, V388, P316, DOI 10.1007/s00423-003-0396-0; Claes L, 1997, J ORTHOP RES, V15, P577, DOI 10.1002/jor.1100150414; Claes L, 2011, J ORTHOP TRAUMA, V25, P169, DOI 10.1097/BOT.0b013e3181e3d994; Claes L, 2009, J ORTHOP RES, V27, P22, DOI 10.1002/jor.20712; Duda GN, 1998, J BIOMECH, V31, P247, DOI 10.1016/S0021-9290(97)00115-2; FERRETTI JL, 1992, CALCIFIED TISSUE INT, V50, P49, DOI 10.1007/BF00297297; Garcia P, 2013, EUR CELLS MATER, V26, P1; Gardner TN, 1999, MED ENG PHYS, V21, P65, DOI 10.1016/S1350-4533(99)00036-3; Glatt V, 2012, EUR CELLS MATER, V23, P289, DOI 10.22203/eCM.v023a22; GOODSHIP AE, 1993, J BIOMECH, V26, P1027, DOI 10.1016/S0021-9290(05)80002-8; Heiner DE, 2006, J ORTHOP TRAUMA, V20, P27, DOI 10.1097/01.bot.0000184143.90448.aa; Histing T, 2011, BONE, V49, P591, DOI 10.1016/j.bone.2011.07.007; Histing T, 2009, J ORTHOP RES, V27, P1152, DOI 10.1002/jor.20849; Koike M, 2005, J BONE MINER METAB, V23, P219, DOI 10.1007/s00774-004-0587-y; Krischak GD, 2007, ARCH ORTHOP TRAUM SU, V127, P453, DOI 10.1007/s00402-007-0288-9; Krischak GD, 2007, ARCH ORTHOP TRAUM SU, V127, P3, DOI 10.1007/s00402-006-0202-x; MARKBREITER LA, 1989, J ORTHOP RES, V7, P178, DOI 10.1002/jor.1100070204; Poser L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/348635; Recknagel S, 2011, J ORTHOP RES, V29, P734, DOI 10.1002/jor.21299; Schell H, 2005, J ORTHOP RES, V23, P1022, DOI 10.1016/j.orthres.2005.03.005; Sebald HJ, 2012, ACTA BIOMATER, V8, P3816, DOI 10.1016/j.actbio.2012.06.036; Seebach E, 2015, ACTA BIOMATER, V21, P165, DOI 10.1016/j.actbio.2015.03.019; Seebach E, 2014, ACTA BIOMATER, V10, P4730, DOI 10.1016/j.actbio.2014.07.017; Takiguchi T, 1999, J PERIODONTAL RES, V34, P431; Tang L, 2006, BIOCHEM BIOPH RES CO, V344, P122, DOI 10.1016/j.bbrc.2006.03.123; van der Stok J, 2014, EUR CELLS MATER, V27, P137, DOI 10.22203/eCM.v027a11; Van der Stok J, 2013, J ORTHOP RES, V31, P792, DOI 10.1002/jor.22293; Wehner T, 2010, J BIOMECH, V43, P2473, DOI 10.1016/j.jbiomech.2010.05.028; Williams JC, 2015, J ORTHOP TRAUMA, V29, pE336, DOI 10.1097/BOT.0000000000000307; Willie B, 2009, J ORTHOP RES, V27, P687, DOI 10.1002/jor.20792; Willie BM, 2011, CLIN ORTHOP RELAT R, V469, P3094, DOI 10.1007/s11999-011-1866-2; Yavari SA, 2014, J BIOMECH, V47, P2700, DOI 10.1016/j.jbiomech.2014.05.006	38	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176735	10.1371/journal.pone.0176735	http://dx.doi.org/10.1371/journal.pone.0176735			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453556	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383900050
J	Muhlberg, A; Museyko, O; Laredo, JD; Engelke, K				Muehlberg, Alexander; Museyko, Oleg; Laredo, Jean-Denis; Engelke, Klaus			A reproducible semi-automatic method to quantify the muscle-lipid distribution in clinical 3D CT images of the thigh	PLOS ONE			English	Article							QUANTITATIVE COMPUTED-TOMOGRAPHY; SKELETAL-MUSCLE; SEGMENTATION METHOD; BODY-COMPOSITION; HIP FRACTURE; OLDER-ADULTS; HEALTH ABC; ATTENUATION; FAT; STRENGTH	Many studies use threshold-based techniques to assess in vivo the muscle, bone and adipose tissue distribution of the legs using computed tomography (CT) imaging. More advanced techniques divide the legs into subcutaneous adipose tissue (SAT), anatomical muscle (muscle tissue and adipocytes within the muscle border) and intra- and perimuscular adipose tissue. In addition, a so-called muscle density directly derived from the CT-values is often measured. We introduce a new integrated approach to quantify the muscle-lipid system (MLS) using quantitative CT in patients with sarcopenia or osteoporosis. The analysis targets the thigh as many CT studies of the hip do not include entire legs The framework consists of an anatomic coordinate system, allowing delineation of reproducible volumes of interest, a robust semi-automatic 3D segmentation of the fascia and a comprehensive method to quantify of the muscle and lipid distribution within the fascia. CT density-dependent features are calibrated using subject-specific internal CT values of the SAT and external CT values of an in scan calibration phantom. Robustness of the framework with respect to operator interaction, image noise and calibration was evaluated. Specifically, the impact of inter-and intra- operator reanalysis precision and addition of Gaussian noise to simulate lower radiation exposure on muscle and AT volumes, muscle density and 3D texture features quantifying MLS within the fascia, were analyzed. Existing data of 25 subjects (age: 75.6 +/- 8.7) with porous and low-contrast muscle structures were included in the analysis. Intra -and inter-operator reanalysis precision errors were below 1% and mostly comparable to 1% of cohort variation of the corresponding features. Doubling the noise changed most 3D texture features by up to 15% of the cohort variation but did not affect density and volume measurements. The application of the novel technique is easy with acceptable processing time. It can thus be employed for a comprehensive quantification of the muscle-lipid system enabling radiomics approaches to musculoskeletal disorders.	[Muehlberg, Alexander; Museyko, Oleg; Engelke, Klaus] Friedrich Alexander Univ Erlangen Nuremberg, Inst Med Phys, Erlangen, Germany; [Laredo, Jean-Denis] Univ Paris VII Denis Diderot, Hop Lariboisiere, AP HP, Radiol Osteoarticulaire, Paris, France	University of Erlangen Nuremberg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Muhlberg, A (corresponding author), Friedrich Alexander Univ Erlangen Nuremberg, Inst Med Phys, Erlangen, Germany.	alexander.muehlberg@imp.uni-erlangen.de			FORMOSA project of the Bavarian Research Foundation, Munich, Germany [AZ-1044-12]; Bavarian Research Foundation (FORMOSA project) [AZ-1044-12]	FORMOSA project of the Bavarian Research Foundation, Munich, Germany; Bavarian Research Foundation (FORMOSA project)	The work was supported by the FORMOSA project (AZ-1044-12) of the Bavarian Research Foundation, Munich, Germany.; The authors acknowledge support from the Bavarian Research Foundation (FORMOSA project, grant number AZ-1044-12). The present work was performed in partial fulfilment of the requirements for obtaining the PhD degree Dr. rer. biol. hum. at the University of ErlangenNuremberg. The authors would like to thank Bastian Gerner and Andreas Friedberger for their repeat segmentation of data sets required for the inter-operator-precision analysis.	Arnold BA., 2003, US Patent, Patent No. [20,030,095,695, 20030095695]; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bousson VD, 2011, J BONE MINER RES, V26, P881, DOI 10.1002/jbmr.270; Coen PM, 2012, TRENDS ENDOCRIN MET, V23, P391, DOI 10.1016/j.tem.2012.05.009; Daguet E, 2011, J BONE JOINT SURG AM, V93A, P1897, DOI 10.2106/JBJS.J.00509; Engelke K, 2008, J CLIN DENSITOM, V11, P123, DOI 10.1016/j.jocd.2007.12.010; Fischer D, 2008, NEUROLOGY, V71, P758, DOI 10.1212/01.wnl.0000324927.28817.9b; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; GLUER CC, 1995, OSTEOPOROSIS INT, V5, P262, DOI 10.1007/BF01774016; Goodpaster BH, 2000, AM J CLIN NUTR, V71, P885; Goodpaster BH, 2000, J APPL PHYSIOL, V89, P104, DOI 10.1152/jappl.2000.89.1.104; Goodpaster BH, 2001, J APPL PHYSIOL, V90, P2157, DOI 10.1152/jappl.2001.90.6.2157; Goodpaster BH, 2008, J APPL PHYSIOL, V105, P1498, DOI 10.1152/japplphysiol.90425.2008; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; Gudjonsdottir Jonina, 2010, Radiol Technol, V81, P309; Kang Y, 2003, IEEE T MED IMAGING, V22, P586, DOI 10.1109/TMI.2003.812265; Kim JH, 2013, CLIN ENDOCRINOL, V78, P512, DOI 10.1111/cen.12016; Kornblum C, 2006, J NEUROL, V253, P753, DOI 10.1007/s00415-006-0111-5; Kramer HR, 2012, ARTHRITIS RHEUM-US, V64, P2438, DOI 10.1002/art.34464; Kumar V, 2012, MAGN RESON IMAGING, V30, P1234, DOI 10.1016/j.mri.2012.06.010; Lang T, 2010, J BONE MINER RES, V25, P513, DOI 10.1359/jbmr.090807; Marcus RL, INTERMUSCULAR FAT RE; Mastmeyer A, 2006, MED IMAGE ANAL, V10, P560, DOI 10.1016/j.media.2006.05.005; Mercuri E, 2002, NEUROMUSCULAR DISORD, V12, P631, DOI 10.1016/S0960-8966(02)00023-8; Miller C.G, 2014, MED IMAGING CLIN TRI; Ohshima Shunsuke, 2008, Nihon Hoshasen Gijutsu Gakkai Zasshi, V64, P1177; Popuri K, 2013, BIOM IM ISBI 2013 IE; Press W. H., 1996, NUMERICAL RECIPES C; Prodanov D, 2006, J NEUROSCI METH, V151, P168, DOI 10.1016/j.jneumeth.2005.07.011; SARKAR N, 1994, IEEE T SYST MAN CYB, V24, P115, DOI 10.1109/21.259692; Senseney J, 2009, AUTOMATED SEGMENTATI; Snijder MB, 2005, DIABETOLOGIA, V48, P301, DOI 10.1007/s00125-004-1637-7; SWASH M, 1995, MUSCLE NERVE, V18, P708, DOI 10.1002/mus.880180706; Watties MP, 2013, NEUROMUSCULAR IMAGIN; Zhao BS, 2006, J COMPUT ASSIST TOMO, V30, P777, DOI 10.1097/01.rct.0000228164.08968.e8	35	12	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0175174	10.1371/journal.pone.0175174	http://dx.doi.org/10.1371/journal.pone.0175174			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453512	gold, Green Published, Green Submitted			2022-12-26	WOS:000400383900003
J	Fusco, R; Gugliandolo, E; Biundo, F; Campolo, M; Di Paola, R; Cuzzocrea, S				Fusco, Roberta; Gugliandolo, Enrico; Biundo, Flavia; Campolo, Michela; Di Paola, Rosanna; Cuzzocrea, Salvatore			Inhibition of inflammasome activation improves lung acute injury induced by carrageenan in a mouse model of pleurisy	FASEB JOURNAL			English	Article						BAY 11-7082; BBG; pathway; Nf-kappa B	KAPPA-B ACTIVATION; NLRP3 INFLAMMASOME; OXIDATIVE STRESS; P2X(7) RECEPTOR; P2X7 RECEPTOR; NITRIC-OXIDE; SYNTHASE; RELEASE; DISEASE; ASTHMA	The inflammasome NLRP3 is a molecular pathway activated by a wide range of cellular insults to elicit innate immune defenses through the activation of caspase-1 and the maturation of proinflammatory cytokines, such as IL-1 beta and IL-18. The expression of NRLP3 is abnormally elevated in numerous human inflammatory diseases, including pulmonary diseases. An injection of carrageenan (CAR) into the pleural cavity triggered an acute inflammatory response, leading to tissue damage, inflammatory exudates, leukocyte infiltration, and increased myeloperoxidase activity. The aim of this study was to assess the effect of the inflammasome blocking agents BAY 11-7082 (30 mg/kg, i.p.) and Brilliant Blue G (BBG) (45.5 mg/kg, i.p.) in a mouse model of CAR-induced pleurisy. Treatment with BAY 11-7082 or BBG 1 h after CAR injection attenuated pulmonary membrane thickening and polymorphonuclear leukocyte infiltration, reduced NF-kappa B translocation in the nucleus, and inhibited the assembly of the NRLP3/ASC/caspase-1 complex. Treatment with BAY 11-7082 or BBG also down-regulated iNOS, nitrotyrosine, and poly-ADP-ribosyl polymerase expression and inhibited CAR-induced apoptosis. Our results demonstrate that treatment with inflammasome-blocking agents can significantly reduce the development of acute CAR-induced lung injury.	[Fusco, Roberta; Gugliandolo, Enrico; Biundo, Flavia; Campolo, Michela; Di Paola, Rosanna; Cuzzocrea, Salvatore] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Messina, Italy; [Cuzzocrea, Salvatore] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA	University of Messina; Saint Louis University	Di Paola, R; Cuzzocrea, S (corresponding author), Univ Messina, Dept Biol & Environm Sci, Viale Ferdinando Stagno DAlcontres, I-98166 Messina, Italy.	dipaolar@unime.it; salvator@unime.it	Gugliandolo, Enrico/AAB-9972-2019; di paola, rosanna/U-4356-2019; Campolo, Michela/K-6432-2016; FUSCO, Roberta/AAC-1745-2019	Gugliandolo, Enrico/0000-0001-6840-3154; di paola, rosanna/0000-0001-6725-8581; FUSCO, Roberta/0000-0003-0223-1403; Cuzzocrea, Salvatore/0000-0001-6131-3690; Campolo, Michela/0000-0002-5124-3876				Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Belete HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027469; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; Burnstock G, 2011, ADV PHARMACOL, V61, P333, DOI 10.1016/B978-0-12-385526-8.00011-4; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Cuzzocrea S, 1998, EUR J PHARMACOL, V342, P67, DOI 10.1016/S0014-2999(97)01417-9; Cuzzocrea S, 2000, AM J RESP CRIT CARE, V162, P1859, DOI 10.1164/ajrccm.162.5.9912125; Cuzzocrea S, 2006, J LEUKOCYTE BIOL, V79, P999, DOI 10.1189/jlb.0605341; Denlinger LC, 2009, AM J RESP CRIT CARE, V179, P265, DOI 10.1164/rccm.200802-293OC; Diaz-Hernandez M, 2009, FASEB J, V23, P1893, DOI 10.1096/fj.08-122275; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eltom S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024097; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Grailer JJ, 2014, J IMMUNOL, V192, P5974, DOI 10.4049/jimmunol.1400368; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Impellizzeri D, 2011, EUR J PHARMACOL, V668, P305, DOI 10.1016/j.ejphar.2011.06.049; Impellizzeri D, 2011, CLIN NUTR, V30, P533, DOI 10.1016/j.clnu.2011.02.004; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Kon OM, 2001, EUR RESPIR J, V18, P45, DOI 10.1183/09031936.01.00064101; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Minutoli L, 2015, J PHARMACOL EXP THER, V355, P370, DOI 10.1124/jpet.115.226936; Moncao-Ribeiro LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110185; Moncao-Ribeiro LC, 2011, RESP PHYSIOL NEUROBI, V179, P314, DOI 10.1016/j.resp.2011.09.015; MULLANE KM, 1985, J PHARMACOL METHOD, V14, P157, DOI 10.1016/0160-5402(85)90029-4; Oliveira C, 2010, BRIT J PHARMACOL, V161, P899, DOI 10.1111/j.1476-5381.2010.00924.x; Proell M, 2013, BIOCHEM J, V449, P613, DOI 10.1042/BJ20121198; Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC; Said-Sadier Najwane, 2012, Biomed J, V35, P437, DOI 10.4103/2319-4170.104408; Salvemini D, 1996, BRIT J PHARMACOL, V118, P829, DOI 10.1111/j.1476-5381.1996.tb15475.x; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Stutz Andrea, 2013, Methods Mol Biol, V1040, P91, DOI 10.1007/978-1-62703-523-1_8; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Uberti D, 2004, BIOCHEM PHARMACOL, V67, P1743, DOI 10.1016/j.bcp.2004.01.012; Wang Cheng-yi, 2015, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V37, P618, DOI 10.3881/j.issn.1000-503X.2015.05.022; Ward PA, 2010, ANN NY ACAD SCI, V1203, P53, DOI 10.1111/j.1749-6632.2010.05552.x; Woods LT, 2012, AM J PHYSIOL-CELL PH, V303, pC790, DOI 10.1152/ajpcell.00072.2012; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273; Zhao JJ, 2013, INT IMMUNOPHARMACOL, V17, P116, DOI 10.1016/j.intimp.2013.05.027	41	40	41	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3497	3511		10.1096/fj.201601349R	http://dx.doi.org/10.1096/fj.201601349R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28461340				2022-12-26	WOS:000405932400026
J	Morimoto, A; Kannari, M; Tsuchida, Y; Sasaki, S; Saito, C; Matsuta, T; Maeda, T; Akiyama, M; Nakamura, T; Sakaguchi, M; Nameki, N; Gonzalez, FJ; Inoue, Y				Morimoto, Aoi; Kannari, Mana; Tsuchida, Yuichi; Sasaki, Shota; Saito, Chinatsu; Matsuta, Tsuyoshi; Maeda, Tsukasa; Akiyama, Megumi; Nakamura, Takahiro; Sakaguchi, Masakiyo; Nameki, Nobukazu; Gonzalez, Frank J.; Inoue, Yusuke			An HNF4-microRNA-194/192 signaling axis maintains hepatic cell function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; hepatocyte nuclear factor 4 (HNF-4); liver; microRNA (miRNA); transcription	NUCLEAR FACTOR 4-ALPHA; EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION; HEPATOCELLULAR-CARCINOMA; LIVER-CANCER; DOWN-REGULATION; TRANSCRIPTION FACTORS; MIR-122 EXPRESSION; HEPATOCYTE; MICRORNAS	Hepatocyte nuclear factor 4 (HNF4) controls the expression of liver-specific protein-coding genes. However, some microRNAs are also modulated by HNF4, and it is not known whether they are direct targets of HNF4 and whether they influence hepatic function. In this study, we found that HNF4 regulates microRNAs, indicated by marked down-regulation of miR-194 and miR-192 (miR-194/192) in liver-specific Hnf4a-null (Hnf4a(H)) mice. Transactivation of the shared miR-194/192 promoter was dependent on HNF4 expression, indicating that miR-194/192 is a target gene of HNF4. Screening of potential mRNAs targeted by miR-194/192 revealed that expression of genes involved in glucose metabolism (glycogenin 1 (Gyg1)), cell adhesion and migration (activated leukocyte cell adhesion molecule (Alcam)), tumorigenesis and tumor progression (Rap2b and epiregulin (Ereg)), protein SUMOylation (Sumo2), epigenetic regulation (Setd5 and Cullin 4B (Cln4b)), and the epithelial-mesenchymal transition (moesin (Msn)) was up-regulated in Hnf4a(H) mice. Moreover, we also found that miR-194/192 binds the 3-UTR of these mRNAs. siRNA knockdown of HNF4 suppressed miR-194/192 expression in human hepatocellular carcinoma (HCC) cells and resulted in up-regulation of their mRNA targets. Inhibition and overexpression experiments with miR-194/192 revealed that Gyg1, Setd5, Sumo2, Cln4b, and Rap2b are miR-194 targets, whereas Ereg, Alcam, and Msn are miR-192 targets. These findings reveal a novel HNF4 network controlled by miR-194/192 that may play a critical role in maintaining the hepatocyte-differentiated state by inhibiting expression of genes involved in dedifferentiation and tumorigenesis. These insights may contribute to the development of diagnostic markers for early HCC detection, and targeting of the miR-194/192 pathway could be useful for managing HCC.	[Morimoto, Aoi; Kannari, Mana; Tsuchida, Yuichi; Sasaki, Shota; Saito, Chinatsu; Matsuta, Tsuyoshi; Maeda, Tsukasa; Akiyama, Megumi; Nakamura, Takahiro; Nameki, Nobukazu; Inoue, Yusuke] Gunma Univ, Fac Sci & Technol, Div Mol Sci, Lab Mol Life Sci, Kiryu, Gunma 3768515, Japan; [Sakaguchi, Masakiyo] Okayama Univ, Dept Cell Biol, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008558, Japan; [Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Rockville, MD 20852 USA	Gunma University; Okayama University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Inoue, Y (corresponding author), Gunma Univ, Fac Sci & Technol, Div Mol Sci, Lab Mol Life Sci, Kiryu, Gunma 3768515, Japan.	yinoue@gunma-u.ac.jp	Sakaguchi, Masakiyo/B-2280-2011; Nameki, Nobukazu/H-1764-2013; Inoue, Yusuke/O-6207-2018	Inoue, Yusuke/0000-0002-9710-7482	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25460490]; JGC-S scholarship Foundation; Gunma University; Akita University; Nagoya University; Collaborative Investigation Project; Gunma University Medical Innovation Project; NATIONAL CANCER INSTITUTE [ZIABC005562] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JGC-S scholarship Foundation; Gunma University; Akita University; Nagoya University; Collaborative Investigation Project; Gunma University Medical Innovation Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grant-in-aid for Scientific Research 25460490) (to Y. I.), the JGC-S scholarship Foundation (to Y. I.), Gunma University, Akita University, Nagoya University, Collaborative Investigation Project (to Y. I.), and Gunma University Medical Innovation Project (to Y. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Bengochea A, 2008, BRIT J CANCER, V99, P143, DOI 10.1038/sj.bjc.6604422; Bonzo JA, 2012, J BIOL CHEM, V287, P7345, DOI 10.1074/jbc.M111.334599; Charafe-Jauffret E, 2007, INT J CANCER, V121, P1779, DOI 10.1002/ijc.22923; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Chen YM, 2014, LIVER INT, V34, P976, DOI 10.1111/liv.12496; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Cui CY, 2013, J INVEST DERMATOL, V133, P1990, DOI 10.1038/jid.2013.84; Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Green EM, 2012, NAT STRUCT MOL BIOL, V19, P361, DOI 10.1038/nsmb.2252; Grozeva D, 2014, AM J HUM GENET, V94, P618, DOI 10.1016/j.ajhg.2014.03.006; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hino K, 2008, RNA, V14, P1433, DOI 10.1261/rna.810208; Hu HL, 2012, CANCER CELL, V22, P781, DOI 10.1016/j.ccr.2012.10.024; Inoue Y, 2004, J BIOL CHEM, V279, P2480, DOI 10.1074/jbc.M311015200; Inoue Y, 2002, J BIOL CHEM, V277, P25257, DOI 10.1074/jbc.M203126200; Inoue Y, 2006, J MOL MED, V84, P334, DOI 10.1007/s00109-005-0013-5; Jenkins RH, 2012, BIOCHEM J, V443, P407, DOI 10.1042/BJ20111861; Jin Z, 2011, ONCOGENE, V30, P1577, DOI 10.1038/onc.2010.534; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Krutzfeldt J, 2012, HEPATOLOGY, V55, P98, DOI 10.1002/hep.24658; KUO CJ, 1992, NATURE, V355, P457, DOI 10.1038/355457a0; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155; Le XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041170; Lee YH, 1998, MOL CELL BIOL, V18, P3059, DOI 10.1128/MCB.18.5.3059; Levin TG, 2010, GASTROENTEROLOGY, V139, P2072, DOI 10.1053/j.gastro.2010.08.053; Li ZY, 2011, J HEPATOL, V55, P602, DOI 10.1016/j.jhep.2010.12.023; Ma LF, 2014, J BIOL CHEM, V289, P6921, DOI 10.1074/jbc.M113.524819; Mandard S, 2007, CELL MOL LIFE SCI, V64, P1145, DOI 10.1007/s00018-007-7006-1; Meng ZP, 2010, HEPATOLOGY, V52, P2148, DOI 10.1002/hep.23915; Ning BF, 2014, HEPATOLOGY, V60, P1607, DOI 10.1002/hep.27177; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; Riese DJ, 2014, SEMIN CELL DEV BIOL, V28, P49, DOI 10.1016/j.semcdb.2014.03.005; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Santangelo L, 2011, HEPATOLOGY, V53, P2063, DOI 10.1002/hep.24280; Schrem H, 2002, PHARMACOL REV, V54, P129, DOI 10.1124/pr.54.1.129; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Sladek F. M., 2001, HEPATOCYTE NUCL FACT, P309; Spath GF, 1998, J CELL BIOL, V140, P935, DOI 10.1083/jcb.140.4.935; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Walesky C, 2013, HEPATOLOGY, V57, P2480, DOI 10.1002/hep.26251; Wang CC, 2012, HISTOPATHOLOGY, V61, P78, DOI 10.1111/j.1365-2559.2012.04204.x; Wang XW, 2012, GASTROENTEROLOGY, V142, P1431, DOI 10.1053/j.gastro.2012.04.007; Wiwi CA, 2004, MOL ENDOCRINOL, V18, P1975, DOI 10.1210/me.2004-0129; Yin C, 2008, HEPATOLOGY, V48, P1528, DOI 10.1002/hep.22510; Yin C, 2013, HEPATOLOGY, V58, P1964, DOI 10.1002/hep.26573; Zhang XY, 2013, CELL CYCLE, V12, P1279, DOI 10.4161/cc.24364; Zhao M, 2009, BIOCHEM BIOPH RES CO, V387, P239, DOI 10.1016/j.bbrc.2009.06.128; Zhou WL, 2012, J CELL SCI, V125, P3630, DOI 10.1242/jcs.102889	56	54	54	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10574	10585		10.1074/jbc.M117.785592	http://dx.doi.org/10.1074/jbc.M117.785592			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28465351	Green Published, hybrid			2022-12-26	WOS:000404115400018
J	Casaroli, G; Galbusera, F; Jonas, R; Schlager, B; Wilke, HJ; Villa, T				Casaroli, Gloria; Galbusera, Fabio; Jonas, Rene; Schlager, Benedikt; Wilke, Hans-Joachim; Villa, Tomaso			A novel finite element model of the ovine lumbar intervertebral disc with anisotropic hyperelastic material properties	PLOS ONE			English	Article							ISSLS PRIZE WINNER; SHEEP; FAILURE; MECHANICS; FIBROSUS; SPINE; CALF	The Ovine spine is an accepted model to investigate the biomechanical behaviour of the human lumbar one. Indeed, the use of animal models for in vitro studies is necessary to investigate the mechanical behaviour of biological tissue, but needs to be reduced for ethical and social reasons. The aim of this study was to create a finite element model of the lumbar intervertebral disc of the sheep that may help to refine the understanding of parallel in vitro experiments and that can be used to predict when mechanical failure occurs. Anisotropic hyperelastic material properties were assigned to the annulus fibrosus and factorial optimization analyses were performed to find out the optimal parameters of the ground substance and of the collagen fibers. For the ground substance of the annulus fibrosus the investigation was based on experimental data taken from the literature, while for the collagen fibers tensile tests on annulus specimens were conducted. Flexibility analysis in flexion-extension, lateral bending and axial rotation were conducted. Different material properties for the anterior, lateral and posterior regions of the annulus were found. The posterior part resulted the stiffest region in compression whereas the anterior one the stiffest region in tension. Since the flexibility outcomes were in a good agreement with the literature data, we considered this model suitable to be used in conjunction with in vitro and in vivo tests to investigate the mechanical behaviour of the ovine lumbar disc.	[Casaroli, Gloria; Villa, Tomaso] Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, Lab Biol Struct Mech LaBS, Milan, Italy; [Galbusera, Fabio; Villa, Tomaso] IRCCS Ist Ortoped Galeazzi, Milan, Italy; [Jonas, Rene; Schlager, Benedikt; Wilke, Hans-Joachim] Univ Ulm, Ctr Musculoskeletal Res zmfu, Inst Orthopaed Res & Biomech, Ulm, Germany	Polytechnic University of Milan; IRCCS Istituto Ortopedico Galeazzi; Ulm University	Casaroli, G (corresponding author), Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, Lab Biol Struct Mech LaBS, Milan, Italy.	gloria.casaroli@polimi.it	Galbusera, Fabio/J-8618-2016; Wilke, Hans-Joachim/M-6440-2014	Galbusera, Fabio/0000-0003-1826-9190; Wilke, Hans-Joachim/0000-0001-6007-8844; VILLA, TOMASO MARIA TOBIA/0000-0003-2663-6755; Schlager, Benedikt/0000-0003-2371-851X				Alini M, 2008, EUR SPINE J, V17, P2, DOI 10.1007/s00586-007-0414-y; Ayturk UM, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4007632; Badyal DK, 2014, INDIAN J PHARMACOL, V46, P257, DOI 10.4103/0253-7613.132153; Beckstein JC, 2008, SPINE, V33, pE166, DOI 10.1097/BRS.0b013e318166e001; Berger-Roscher N, 1976, SPINE PHILA PA 1976; Casaroli G, 2017, MATERIALS, V10, DOI 10.3390/ma10010031; CASSIDY JJ, 1989, CONNECT TISSUE RES, V23, P75, DOI 10.3109/03008208909103905; Cortes DH, 2014, J BIOMECH, V47, P2088, DOI 10.1016/j.jbiomech.2013.12.021; Ebara S, 1996, TENSILE PROPERTIES N, P452; Eberlein R., 2001, COMPUT METHOD BIOMEC, V4, P209, DOI [DOI 10.1080/10255840108908005, 10.1080/10255840108908005]; Elliott DM, 2001, J BIOMECH ENG-T ASME, V123, P256, DOI 10.1115/1.1374202; Freeman AL, 2013, J BIOMECH, V46, P1714, DOI 10.1016/j.jbiomech.2013.03.034; Galbusera F, 2011, EUR SPINE J, V20, P563, DOI 10.1007/s00586-010-1586-4; Holzapfel GA, 2005, BIOMECH MODEL MECHAN, V3, P125, DOI 10.1007/s10237-004-0053-8; Isaacs JL, 2014, J MECH BEHAV BIOMED, V40, P75, DOI 10.1016/j.jmbbm.2014.08.012; Kasra M, 2004, Technol Health Care, V12, P333; Kettler A, 2007, EUR SPINE J, V16, P2186, DOI 10.1007/s00586-007-0485-9; Little JP, 2010, J MECH BEHAV BIOMED, V3, P146, DOI 10.1016/j.jmbbm.2009.09.002; Lovati AB, 2016, CALCIFIED TISSUE INT, V99, P209, DOI 10.1007/s00223-016-0140-8; Malandrino A, 2011, COMPUT METHOD BIOMEC, P1; Noailly J, 2011, BIOMECH MODEL MECHAN, V10, P203, DOI 10.1007/s10237-010-0227-5; Reid JE, 2002, CLIN BIOMECH, V17, P312, DOI 10.1016/S0268-0033(02)00009-8; Reitmaier S, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0650; Reitmaier S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069610; Reutlinger C, 2014, J MECH BEHAV BIOMED, V30, P279, DOI 10.1016/j.jmbbm.2013.11.019; Schmidt H, 2013, J BIOMECH, V46, P2513, DOI 10.1016/j.jbiomech.2013.06.038; Schmidt H, 2013, J MECH BEHAV BIOMED, V17, P229, DOI 10.1016/j.jmbbm.2012.09.010; Schmidt H, 2010, J BIOMECH, V43, P1849, DOI 10.1016/j.jbiomech.2010.03.035; Schollum ML, 2008, SPINE, V33, P2702, DOI 10.1097/BRS.0b013e31817bb92c; SKAGGS DL, 1994, SPINE, V19, P1310, DOI 10.1097/00007632-199406000-00002; SLATER R, 1988, J ORTHOPAED RES, V6, P138, DOI 10.1002/jor.1100060118; Vena Pasquale, 2005, Computer Methods in Biomechanics and Biomedical Engineering, V8, P7, DOI 10.1080/10255840500062914; Veres SP, 2010, SPINE, V35, P1897, DOI 10.1097/BRS.0b013e3181d9b69e; Veres SP, 2010, EUR SPINE J, V19, P1468, DOI 10.1007/s00586-010-1383-0; Wade KR, 2014, SPINE, V39, P1018, DOI 10.1097/BRS.0000000000000262; Wilke H-J, 1997, ARE SHEEP SPINES VAL, P2365; Wilke HJ, 1996, J ORTHOPAED RES, V14, P500, DOI 10.1002/jor.1100140321; Wilke HJ, 1997, ANAT RECORD, V247, P542, DOI 10.1002/(SICI)1097-0185(199704)247:4<542::AID-AR13>3.0.CO;2-P; YAMAMURO T, 1990, J BONE JOINT SURG BR, V72, P889, DOI 10.1302/0301-620X.72B5.2211778	39	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177088	10.1371/journal.pone.0177088	http://dx.doi.org/10.1371/journal.pone.0177088			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472100	Green Submitted, Green Published, gold			2022-12-26	WOS:000400648500132
J	Coskran, TM; Jiang, ZJ; Klaunig, JE; Mager, DL; Obert, L; Robertson, A; Tsinoremas, N; Wang, ZM; Gosink, M				Coskran, Timothy M.; Jiang, Zhijie; Klaunig, James E.; Mager, Dixie L.; Obert, Leslie; Robertson, Andrew; Tsinoremas, Nicholas; Wang, Zemin; Gosink, Mark			Induction of endogenous retroelements as a potential mechanism for mouse-specific drug-induced carcinogenicity	PLOS ONE			English	Article							PEROXISOME PROLIFERATOR WY-14,643; ACTIVATED RECEPTOR-ALPHA; GENE-EXPRESSION; EPIGENETIC REGULATION; RETROVIRAL ELEMENTS; ADAPTIVE IMMUNITY; INDUCED-TUMORS; LIVER-TUMORS; CANCER-RISK; PPAR-ALPHA	A number of chemical compounds have been shown to induce liver tumors in mice but not in other species. While several mechanisms for this species-specific tumorigenicity have been proposed, no definitive mechanism has been established. We examined the effects of the nongenotoxic rodent hepatic carcinogen, WY-14,643, in male mice from a high liver tumor susceptible strain (C3H/HeJ), and from a low tumor susceptible strain (C57BL/6). WY-14,643, a PPAR alpha activator induced widespread increases in the expression of some endogenous retroelements, namely members of LTR and LINE elements in both strains. The expression of a number of known retroviral defense genes was also elevated. We also demonstrated that basal immune-mediated viral defense was elevated in C57BL/6 mice (the resistant strain) and that WY-14,643 further activated those immuno-defense processes. We propose that the previously reported > 100X activity of retroelements in mice drives mouse-specific tumorigenicity. We also propose that C57BL/6's competent immune to retroviral activation allows it to remove cells before the activation of these elements can result in significant chromosomal insertions and mutation. Finally, we showed that WY-14,643 treatment induced gene signatures of DNA recombination in the sensitive C3H/HeJ strain.	[Coskran, Timothy M.; Robertson, Andrew; Gosink, Mark] Pfizer Inc, Drug Safety Res & Dev, Groton, CT 06340 USA; [Jiang, Zhijie; Tsinoremas, Nicholas] Univ Miami, Dept Comp Sci, Miami, FL USA; [Klaunig, James E.; Wang, Zemin] Indiana Univ, Environm Hlth, Bloomington, IN USA; [Mager, Dixie L.] BC Canc Agcy, Terry Fox Lab, Vancouver, BC, Canada; [Obert, Leslie] GlaxoSmithKline plc, King Of Prussia, PA USA	Pfizer; University of Miami; Indiana University System; Indiana University Bloomington; British Columbia Cancer Agency; GlaxoSmithKline	Gosink, M (corresponding author), Pfizer Inc, Drug Safety Res & Dev, Groton, CT 06340 USA.	Mark.M.Gosink@Pfizer.com		Mager, Dixie/0000-0002-5955-2550; Gosink, Mark/0000-0003-3009-3941; Klaunig, James/0000-0002-4736-2223	Pfizer	Pfizer(Pfizer)	Pfizer provided support in the form of salaries for authors MG, TC, AR & LO and paid the sequencing costs, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.	Bhan U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009896; Bloom DC, 2010, BBA-GENE REGUL MECH, V1799, P246, DOI 10.1016/j.bbagrm.2009.12.001; BROWN LP, 1990, MUTAT RES, V244, P67, DOI 10.1016/0165-7992(90)90110-6; Carthagena L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004894; Cloonan SM, 2013, CURR OPIN MICROBIOL, V16, P327, DOI 10.1016/j.mib.2013.05.005; Corton JC, 2014, CRIT REV TOXICOL, V44, P1, DOI 10.3109/10408444.2013.835784; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Douville RN, 2010, CYTOKINE, V52, P108, DOI 10.1016/j.cyto.2010.04.010; Dragan Y, 1998, TOXICOL SCI, V41, P3; Duperray A, 2015, INTERNATIONAL IMMUNO; Friedrich A, 2011, REGUL TOXICOL PHARM, V60, P225, DOI 10.1016/j.yrtph.2011.04.001; Goldsworthy TL, 2002, TOXICOL PATHOL, V30, P97, DOI 10.1080/01926230252824770; Nunez NG, 2012, CANCER RES, V72, P592, DOI 10.1158/0008-5472.CAN-11-0534; Hakre S, 2011, CURR OPIN HIV AIDS, V6, P19, DOI 10.1097/COH.0b013e3283412384; Herquel B, 2013, NAT STRUCT MOL BIOL, V20, P339, DOI 10.1038/nsmb.2496; Holsapple MP, 2006, TOXICOL SCI, V89, P51, DOI 10.1093/toxsci/kfj001; Howard G, 2008, ONCOGENE, V27, P404, DOI 10.1038/sj.onc.1210631; Isenberg JS, 1997, CARCINOGENESIS, V18, P1511, DOI 10.1093/carcin/18.8.1511; Iyer SS, 2010, J IMMUNOL, V185, P6599, DOI 10.4049/jimmunol.1002041; Kaer K, 2013, GENE, V518, P231, DOI 10.1016/j.gene.2013.01.008; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Kinnier CV, 2011, TRANSPL IMMUNOL, V24, P83, DOI 10.1016/j.trim.2010.11.004; Klaunig JE, 2003, CRIT REV TOXICOL, V33, P655, DOI 10.1080/713608372; Koturbash I, 2011, TOXICOL MECH METHOD, V21, P289, DOI 10.3109/15376516.2011.557881; Kremer D, 2013, ANN NEUROL, V74, P721, DOI 10.1002/ana.23970; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; LOVE BA, 1992, CAN J CARDIOL, V8, P347; Lu MY, 2011, CELL DEATH DIFFER, V18, P925, DOI 10.1038/cdd.2010.160; Maksakova IA, 2008, CELL MOL LIFE SCI, V65, P3329, DOI 10.1007/s00018-008-8494-3; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Marsili G, 2012, CYTOKINE GROWTH F R, V23, P255, DOI 10.1016/j.cytogfr.2012.06.001; Meyer U, 2014, BIOL PSYCHIAT, V75, P307, DOI 10.1016/j.biopsych.2013.07.011; Morimura K, 2006, CARCINOGENESIS, V27, P1074, DOI 10.1093/carcin/bgi329; Niller HH, 2011, ADV EXP MED BIOL, V711, P82; Norris PJ, 2006, AIDS RES HUM RETROV, V22, P757, DOI 10.1089/aid.2006.22.757; Pantry SN, 2009, SEMIN CANCER BIOL, V19, P153, DOI 10.1016/j.semcancer.2009.02.010; Park S, 2013, J IMMUNOL, V191, P4358, DOI 10.4049/jimmunol.1301170; Perron H, 2010, CLIN REV ALLERG IMMU, V39, P51, DOI 10.1007/s12016-009-8170-x; Peters JM, 1997, CARCINOGENESIS, V18, P2029, DOI 10.1093/carcin/18.11.2029; Pogribny IP, 2007, MUTAT RES-FUND MOL M, V625, P62, DOI 10.1016/j.mrfmmm.2007.05.004; Pogribny IP, 2012, CANC LETT; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rassa JC, 2002, P NATL ACAD SCI USA, V99, P2281, DOI 10.1073/pnas.042355399; Richardson SR, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0061-2014; Sobieszczyk ME, 2011, CURR OPIN HIV AIDS, V6, P427, DOI 10.1097/COH.0b013e3283497155; Stocking C, 2008, CELL MOL LIFE SCI, V65, P3383, DOI 10.1007/s00018-008-8497-0; Sturgill D, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-320; Swenberg J A, 1992, IARC Sci Publ, P477; TAKATSUKI A, 1969, APPL MICROBIOL, V18, P660, DOI 10.1128/AEM.18.4.660-667.1969; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vazquez-Torres A, 2004, J IMMUNOL, V172, P6202, DOI 10.4049/jimmunol.172.10.6202; Waldschmidt I, 2013, VET IMMUNOL IMMUNOP, V155, P30, DOI 10.1016/j.vetimm.2013.05.017; Wang ZM, 2015, TOXICOL SCI, V147, P549, DOI 10.1093/toxsci/kfv151; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; Yu P, 2012, IMMUNITY, V37, P867, DOI 10.1016/j.immuni.2012.07.018; Zhang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000007	56	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176768	10.1371/journal.pone.0176768	http://dx.doi.org/10.1371/journal.pone.0176768			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472135	Green Submitted, Green Published, gold			2022-12-26	WOS:000400648500069
J	Delea, TE; Weycker, D; Atwood, M; Neame, D; Alvarez, FP; Forget, E; Langley, JM; Chit, A				Delea, Thomas E.; Weycker, Derek; Atwood, Mark; Neame, Dion; Alvarez, Fabian P.; Forget, Evelyn; Langley, Joanne M.; Chit, Ayman			Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada	PLOS ONE			English	Article							SEROGROUP-C; EPIDEMIOLOGY; CHILDREN; IMPACT	Background Public health programs to prevent invasive meningococcal disease (IMD) with monovalent serogroup C meningococcal conjugate vaccine (MCV-C) and quadrivalent meningococcal conjugate vaccines (MCV-4) in infancy and adolescence vary across Canadian provinces. This study evaluated the cost-effectiveness of various vaccination strategies against IMD using current and anticipated future pricing and recent epidemiology. Methods A cohort model was developed to estimate the clinical burden and costs (CAN$2014) of IMD in the Canadian population over a 100-year time horizon for three strategies: (1) MCVC in infants and adolescents (MCV-C/C); (2) MCV-C in infants and MCV-4 in adolescents (MCV-C/4); and (3) MCV-4 in infants (2 doses) and adolescents (MCV-4/4). The source for IMD incidence was Canadian surveillance data. The effectiveness of MCV-C was based on published literature. The effectiveness of MCV-4 against all vaccination regimens was assumed to be the same as for MCV-C regimens against serogroup C. Herd effects were estimated by calibration to estimates reported in prior analyses. Costs were from published sources. Vaccines prices were projected to decline over time reflecting historical procurement trends. Results Over the modeling horizon there are a projected 11,438 IMD cases and 1,195 IMD deaths with MCV-C/C; expected total costs are $597.5 million. MCV-C/4 is projected to reduce cases of IMD by 1,826 (16%) and IMD deaths by 161 (13%). Vaccination costs are increased by $32 million but direct and indirect IMD costs are projected to be reduced by $46 million. MCV-C/4 is therefore dominant vs. MCV-C/C in the base case. Cost-effectiveness of MCV-4/4 was $111,286 per QALY gained versus MCV-C/4 (2575/206 IMD cases/ deaths prevented; incremental costs $68 million). Conclusions If historical trends in Canadian vaccines prices continue, use of MCV-4 instead of MCV-C in adolescents may be cost-effective. From an economic perspective, switching to MCV-4 as the adolescent booster should be considered.	[Delea, Thomas E.; Weycker, Derek; Atwood, Mark] Policy Anal Inc PAI, Brookline, MA 02445 USA; [Neame, Dion] Sanofi Pasteur, Toronto, ON, Canada; [Alvarez, Fabian P.] Sanofi Pasteur, Lyon, France; [Forget, Evelyn] Univ Manitoba, Fac Med, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Langley, Joanne M.] Dalhousie Univ, Canadian Ctr Vaccinol, Halifax, NS, Canada; [Langley, Joanne M.] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; [Langley, Joanne M.] Dalhousie Univ, Dept Community Hlth, Halifax, NS, Canada; [Langley, Joanne M.] Dalhousie Univ, Dept Epidemiol, Halifax, NS, Canada; [Chit, Ayman] Sanofi Pasteur, Swiftwater, PA USA; [Chit, Ayman] Univ Toronto, Lesli Dan Fac Pharm, Toronto, ON, Canada	Policy Analysis Inc; Sanofi-Aventis; University of Manitoba; Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; Sanofi-Aventis; University of Toronto	Delea, TE (corresponding author), Policy Anal Inc PAI, Brookline, MA 02445 USA.	tdelea@pai2.com	Alvarez, Fabian P./AAD-6455-2020	Alvarez, Fabian P./0000-0003-3085-6275; Langley, Joanne/0000-0003-3270-7345	Sanofi Pasteur; Canadian Institutes of Health Research-GlaxoSmithKline Chair in Pediatric Vaccinology at Dalhousie University, Halifax, Canada; Policy Analysis Inc. (PAI)	Sanofi Pasteur; Canadian Institutes of Health Research-GlaxoSmithKline Chair in Pediatric Vaccinology at Dalhousie University, Halifax, Canada(Canadian Institutes of Health Research (CIHR)); Policy Analysis Inc. (PAI)	Funding for this research was provided by Sanofi Pasteur to Policy Analysis Inc. (PAI). Mark Atwood, Thomas Delea, and Derek Weycker are employed by PAI. Ayman Chit, Dion Neame, and Fabian Alvarez are employed by Sanofi Pasteur. J Langley holds the Canadian Institutes of Health Research-GlaxoSmithKline Chair in Pediatric Vaccinology at Dalhousie University, Halifax, Canada. Sanofi Pasteur was provided a review of the study research plan and study manuscript; model development and estimation, analyses, and all final decisions related to analytics and the manuscript were made by study authors. Policy Analysis Inc. (PAI) provided support in the form of salaries for authors TED, DW and MA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Sanofi Pasteur provided support in the form of salaries for authors DN, FPA and AC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bauch CT, 2009, MED DECIS MAKING, V29, P557, DOI 10.1177/0272989X09334419; Bogaert D, 2005, CLIN INFECT DIS, V40, P899, DOI 10.1086/428351; Campbell H, 2009, VACCINE, V27, pB20, DOI 10.1016/j.vaccine.2009.04.067; Canadian Agency for Drugs and Technologies in Health (CADTH), 2017, GUID EC EV HLTH TECH; Caro JJ, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-130; Cohn AC, 2013, MMWR RECOMM REP, V62, P1; De Wals P, 2007, VACCINE, V25, P5433, DOI 10.1016/j.vaccine.2007.04.071; De Wals P, 2011, PEDIATR INFECT DIS J, V30, P566, DOI 10.1097/INF.0b013e31820e8638; Erickson LJ, 2001, CLIN INFECT DIS, V33, P737, DOI 10.1086/322587; Government of Canada, 2015, LAND US MAP IST METR; Hepkema H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065036; Ladhani SN, 2015, CLIN INFECT DIS, V60, P578, DOI 10.1093/cid/ciu881; Larrauri A, 2005, VACCINE, V23, P4097, DOI 10.1016/j.vaccine.2005.03.045; Li YA, 2014, CANADA COMMUNICABLE, V40; National Advisory Committee on Immunization (NACI), 2009, Can Commun Dis Rep, V35, P1; National Advisory Committee on Immunization (NACI), 2015, UPD QUADR MEN VACC A; Novartis Vaccines and Diagnostics Inc, 2014, NOV VACC DIAGN INC P; Ortega-Sanchez IR, 2008, CLIN INFECT DIS, V46, P1, DOI 10.1086/524041; Pitman R, 2012, MED DECIS MAKING, V32, P712, DOI 10.1177/0272989X12454578; Public Health Agency of Canada, 2012, INV MEN DIS IMD; Public Health Agency of Canada, 2002, ENH SURV INV MEN DIS; Public Health Ontario Partners for Health, 2013, MONTHL INF DIS SURV, V2, P1; Rocchi A, 2008, VALUE HEALTH, V11, P771, DOI 10.1111/j.1524-4733.2007.00298.x; Sadarangani M, 2015, CLIN INFECT DIS, V60, pE27, DOI 10.1093/cid/civ028; Sadarangani M, 2014, CLIN INFECT DIS, V59, P1208, DOI 10.1093/cid/ciu597; Sanofi Pasteur Limited, 2012, SAN PAST LTD PROD MO; Shepard CW, 2005, PEDIATRICS, V115, P1220, DOI 10.1542/peds.2004-2514; Statistics Canada, 2015, CONS PRIC IND HLTH P; Statistics of Kalimantan Barat Province, 2014, POP CENS PROV 2014; Stovall SH, 2002, PEDIATR INFECT DIS J, V21, P366, DOI 10.1097/00006454-200205000-00003; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; Van Vlaenderen I, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-25; World Bank, 2014, GLOB PURCH POW PAR R; World Bank, 2014, GDP PER CAP; World Health Organization, 2014, COST EFF STRAT PLANN; Wormsbecker AE, 2015, VACCINE, V33, P5678, DOI 10.1016/j.vaccine.2015.08.023	36	7	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0175721	10.1371/journal.pone.0175721	http://dx.doi.org/10.1371/journal.pone.0175721			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472165	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500015
J	Griffiths, SR; Rowland, JA; Briscoe, NJ; Lentini, PE; Handasyde, KA; Lumsden, LF; Robert, KA				Griffiths, Stephen R.; Rowland, Jessica A.; Briscoe, Natalie J.; Lentini, Pia E.; Handasyde, Kathrine A.; Lumsden, Linda F.; Robert, Kylie A.			Surface reflectance drives nest box temperature profiles and thermal suitability for target wildlife	PLOS ONE			English	Article							POSSUMS TRICHOSURUS-VULPECULA; SOUTH-EASTERN AUSTRALIA; BAT BOXES; PIPISTRELLUS-PYGMAEUS; CONSERVATION EFFORTS; BODY-TEMPERATURE; ROOST SELECTION; BIRDS; MICROCLIMATE; SIZE	Thermal properties of tree hollows play a major role in survival and reproduction of hollow-dependent fauna. Artificial hollows (nest boxes) are increasingly being used to supplement the loss of natural hollows; however, the factors that drive nest box thermal profiles have received surprisingly little attention. We investigated how differences in surface reflectance influenced temperature profiles of nest boxes painted three different colors (dark-green, light-green, and white: total solar reflectance 5.9%, 64.4%, and 90.3% respectively) using boxes designed for three groups of mammals: insectivorous bats, marsupial gliders and brushtail possums. Across the three different box designs, dark-green (low reflectance) boxes experienced the highest average and maximum daytime temperatures, had the greatest magnitude of variation in daytime temperatures within the box, and were consistently substantially warmer than light-green boxes (medium reflectance), white boxes (high reflectance), and ambient air temperatures. Results from biophysical model simulations demonstrated that variation in diurnal temperature profiles generated by painting boxes either high or low reflectance colors could have significant ecophysiological consequences for animals occupying boxes, with animals in dark-green boxes at high risk of acute heat-stress and dehydration during extreme heat events. Conversely in cold weather, our modelling indicated that there are higher cumulative energy costs for mammals, particularly smaller animals, occupying light-green boxes. Given their widespread use as a conservation tool, we suggest that before boxes are installed, consideration should be given to the effect of color on nest box temperature profiles, and the resultant thermal suitability of boxes for wildlife, particularly during extremes in weather. Managers of nest box programs should consider using several different colors and installing boxes across a range of both orientations and shade profiles (i.e., levels of canopy cover), to ensure target animals have access to artificial hollows with a broad range of thermal profiles, and can therefore choose boxes with optimal thermal conditions across different seasons.	[Griffiths, Stephen R.; Robert, Kylie A.] La Trobe Univ, Dept Ecol Environm & Evolut, Bundoora, Vic, Australia; [Rowland, Jessica A.; Briscoe, Natalie J.; Lentini, Pia E.; Handasyde, Kathrine A.] Univ Melbourne, Sch Biosci, Parkville, Vic, Australia; [Lumsden, Linda F.] Arthur Rylah Inst Environm Res, Dept Environm Land Water & Planning, Heidelberg, Vic, Australia	La Trobe University; University of Melbourne; Arthur Rylah Institute for Environmental Research (ARI)	Griffiths, SR (corresponding author), La Trobe Univ, Dept Ecol Environm & Evolut, Bundoora, Vic, Australia.	s.griffiths@latrobe.edu.au	Rowland, Jessica A/Q-9851-2019; Lentini, Pia/H-3254-2019; Rowland, Jessica/HHN-8649-2022; Griffiths, Stephen/AAT-9401-2020; Robert, Kylie/C-5181-2009; Li, Mengqi/AAG-6804-2021	Rowland, Jessica A/0000-0001-9831-681X; Rowland, Jessica/0000-0001-9831-681X; Griffiths, Stephen/0000-0003-3882-3654; Robert, Kylie/0000-0002-8554-8440; Lumsden, Lindy/0000-0002-4967-4626; Briscoe, Natalie/0000-0003-0049-8956; Lentini, Pia/0000-0002-3520-3460	Holsworth Wildlife Research Endowment; Parks Victoria Research Partners Panel [RPP1314P18]; Normal Wettenhall Foundation; Department of Environment, Land, Water and Planning's Communities for Nature; Australian Government's National Environmental Science Program Threatened Species Recovery Hub; Australian Government Research Training Program Scholarship	Holsworth Wildlife Research Endowment; Parks Victoria Research Partners Panel; Normal Wettenhall Foundation; Department of Environment, Land, Water and Planning's Communities for Nature; Australian Government's National Environmental Science Program Threatened Species Recovery Hub(Australian Government); Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	This study was funded by the Holsworth Wildlife Research Endowment (grant to SRG), the Parks Victoria Research Partners Panel (grant RPP1314P18 to SRG and KAR), the Normal Wettenhall Foundation (grant to SRG) and the Department of Environment, Land, Water and Planning's Communities for Nature (grant to SRG and PEL). PEL and NJB are supported by the Australian Government's National Environmental Science Program Threatened Species Recovery Hub. SRG is supported by an Australian Government Research Training Program Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Sonja Dechian, Robert Bender, John Salisbury, Michael Bajer, Peter Rowland, Susan Pepper and Kristin Semmens for assistance during fieldwork, and Casey Visintin for drafting the CAD nest box diagrams. SRG is supported by an Australian Government Research Training Program Scholarship. PEL and NJB are supported by the Australian Government's National Environmental Science Program Threatened Species Recovery Hub.	Amat-Valero M, 2014, INT J BIOMETEOROL, V58, P1983, DOI 10.1007/s00484-014-0801-0; [Anonymous], 1999, WALKERS MAMMALS WORL; [Anonymous], 2013, BAT HOUSE BUILDERS H; Ardia DR, 2006, J FIELD ORNITHOL, V77, P339, DOI 10.1111/j.1557-9263.2006.00064.x; ASCHOFF J, 1981, COMP BIOCHEM PHYS A, V69, P611, DOI 10.1016/0300-9629(81)90145-6; Australian Bureau of Meteorology, 2016, CLIM DAT ONL; Bartonicka T, 2007, ACTA CHIROPTEROL, V9, P517, DOI 10.3161/1733-5329(2007)9[517:IOTMOB]2.0.CO;2; Beckschafer P, 2013, IFOREST, V6, P228, DOI [10.3832/ifor0957-006, 10.3832/ifor0968-006]; Berthier K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036028; Beyer GL, 2006, WILDLIFE RES, V33, P161, DOI 10.1071/WR04109; Bondarenco A, 2014, NATURWISSENSCHAFTEN, V101, P679, DOI 10.1007/s00114-014-1202-2; Boyles JG, 2008, FUNCT ECOL, V22, P632, DOI 10.1111/j.1365-2435.2008.01423.x; Brittingham MC, 2000, WILDLIFE SOC B, V28, P197; Bronner GN, 1999, S AFR J ZOOL, V34, P1; Catry I, 2011, BIOL CONSERV, V144, P1111, DOI 10.1016/j.biocon.2010.12.030; Clinchy M, 2004, MOL ECOL, V13, P195, DOI 10.1046/j.1365-294X.2003.02029.x; Currie SE, 2015, AM J PHYSIOL-REG I, V308, pR34, DOI 10.1152/ajpregu.00341.2014; DAWSON TJ, 1970, AM J PHYSIOL, V218, P1233, DOI 10.1152/ajplegacy.1970.218.4.1233; DAWSON TJ, 1969, COMP BIOCHEM PHYSIOL, V28, P401, DOI 10.1016/0010-406X(69)91353-X; Doty AC, 2016, J THERM BIOL, V60, P162, DOI 10.1016/j.jtherbio.2016.07.015; Fitzpatrick MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136677; Flaquer C, 2006, BIOL CONSERV, V128, P223, DOI 10.1016/j.biocon.2005.09.030; Fokidis HB, 2005, SOUTHEAST NAT, V4, P447, DOI 10.1656/1528-7092(2005)004[0447:TUONBT]2.0.CO;2; Franks A., 2003, NEST BOXES WILDLIFE; Frazer GW, 1999, GAP LIGHT ANAL GLA V; Fukui D, 2010, MAMM STUDY, V35, P99, DOI 10.3106/041.035.0207; Geiser F, 2000, J COMP PHYSIOL B, V170, P153, DOI 10.1007/s003600050270; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Geosciences Australia, 2004, GEOD COAST 100K 2004; Gibbons P, 2002, BIOL CONSERV, V103, P1, DOI 10.1016/S0006-3207(01)00109-4; Gibbons P., 2002, TREE HOLLOWS WILDLIF, DOI [10.1071/9780643090033, DOI 10.1071/9780643090033]; Glorioso BM, 2014, HERPETOL CONSERV BIO, V9, P609; Goldingay RL, 2015, AUST MAMMAL, V37, P225, DOI 10.1071/AM14040; Goldingay RL, 2015, RESTOR ECOL, V23, P482, DOI 10.1111/rec.12208; Goldingay RL, 2009, WILDLIFE RES, V36, P81, DOI 10.1071/WR08064; Harley Dan K.P., 2004, P318; HAVERA SP, 1979, J WILDLIFE MANAGE, V43, P251, DOI 10.2307/3800666; Hodgkison S, 2007, BIOL CONSERV, V135, P576, DOI 10.1016/j.biocon.2006.11.001; Holloway JC, 2000, J ZOOL, V252, P389, DOI 10.1017/S0952836900000133; HUEY RB, 1991, AM NAT, V137, pS91, DOI 10.1086/285141; Isaac JL, 2008, WILDLIFE RES, V35, P441, DOI 10.1071/WR08016; Kavanagh RP, 2007, AUSTRAL ECOL, V32, P635, DOI 10.1111/j.1442-9993.2007.01746.x; Kearney M, 2011, AUSTRAL ECOL, V36, P297, DOI 10.1111/j.1442-9993.2010.02150.x; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kerth G, 2001, OECOLOGIA, V126, P1, DOI 10.1007/s004420000489; Kunz TH, 2003, BAT ECOLOGY, P3; Lambrechts MM, 2010, ACTA ORNITHOL, V45, P1, DOI 10.3161/000164510X516047; Le Roux DS, 2016, FOREST ECOL MANAG, V366, P135, DOI 10.1016/j.foreco.2016.02.017; Le Roux DS, 2016, RESTOR ECOL, V24, P252, DOI 10.1111/rec.12303; Lentini PE, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0371; LICHT P, 1967, J MAMMAL, V48, P52, DOI 10.2307/1378169; Lindenmayer DB, 2011, ECOL MONOGR, V81, P557, DOI 10.1890/11-0279.1; Lindenmayer D, 2016, RESTOR ECOL, V24, P244, DOI 10.1111/rec.12306; Lindenmayer DB, 2009, BIOL CONSERV, V142, P33, DOI 10.1016/j.biocon.2008.09.026; Lourenco SI, 2004, BIOL CONSERV, V119, P237, DOI 10.1016/j.biocon.2003.11.006; Mainwaring MC, 2015, J NAT CONSERV, V25, P17, DOI 10.1016/j.jnc.2015.02.007; Mainwaring MC, 2011, ARDEA, V99, P167, DOI 10.5253/078.099.0206; Manning AD, 2013, ANIM CONSERV, V16, P395, DOI 10.1111/acv.12006; Mathewson PD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072863; MCCOMB W C, 1981, Wildlife Society Bulletin, V9, P261; MCCOMB WC, 1982, AM MIDL NAT, V107, P163, DOI 10.2307/2425197; MCCOMB WC, 1981, J WILDLIFE MANAGE, V45, P284, DOI 10.2307/3807906; Mclean JA, 1999, FUNCT ECOL, V13, P360, DOI 10.1046/j.1365-2435.1999.00321.x; Mering ED, 2014, WILDLIFE SOC B, V38, P741, DOI 10.1002/wsb.461; MOLLER AP, 1989, OIKOS, V56, P421, DOI 10.2307/3565628; NEWTON I, 1994, BIOL CONSERV, V70, P265, DOI 10.1016/0006-3207(94)90172-4; Nussear KE, 2000, HERPETOL J, V10, P119; Porter WP, 2009, P NATL ACAD SCI USA, V106, P19666, DOI 10.1073/pnas.0907321106; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rhodes M, 2007, J MAMMAL, V88, P1252, DOI 10.1644/06-MAMM-A-374R1.1; Roads and Traffic Authority, 2011, BIOD GUID PROT MAN B; ROBINSON KW, 1957, J CELL COMPAR PHYSL, V49, P455, DOI 10.1002/jcp.1030490306; Rowland JA, 2017, BIOL CONSERV, V209, P341, DOI 10.1016/j.biocon.2017.02.006; Rueegger N, 2016, ACTA CHIROPTEROL, V18, P279, DOI 10.3161/15081109ACC2016.18.1.017; Speakman J, 1997, P NUTR SOC, V56, P1119, DOI 10.1079/PNS19970115; SPEAKMAN JR, 1994, J ZOOL, V233, P318, DOI 10.1111/j.1469-7998.1994.tb08593.x; The State of Victoria Department of Environment, 2017, PLANN SCHEM URB GROW; Turbill C, 2008, J COMP PHYSIOL B, V178, P597, DOI 10.1007/s00360-007-0249-1; vandenOord QGW, 1995, NEW ZEAL VET J, V43, P328, DOI 10.1080/00480169./1995.35914; Velky M, 2010, J ORNITHOL, V151, P147, DOI 10.1007/s10336-009-0436-9; Webb JK, 1997, BIOL CONSERV, V81, P21, DOI 10.1016/S0006-3207(96)00160-7; Wendlandt W.W., 1966, REFLECTANCE SPECTROS; Wiebe KL, 2011, J FIELD ORNITHOL, V82, P239, DOI 10.1111/j.1557-9263.2011.00327.x; Wiebe KL, 2001, AUK, V118, P412, DOI 10.1642/0004-8038(2001)118[0412:MOTCNI]2.0.CO;2; Willis CKR, 2007, BEHAV ECOL SOCIOBIOL, V62, P97, DOI 10.1007/s00265-007-0442-y	85	31	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176951	10.1371/journal.pone.0176951	http://dx.doi.org/10.1371/journal.pone.0176951			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472147	gold, Green Published, Green Submitted			2022-12-26	WOS:000400648500101
J	Inagaki, T; Watanabe, T; Tsuchikawa, S				Inagaki, Tetsuya; Watanabe, Tomoko; Tsuchikawa, Satoru			The effect of path length, light intensity and co-added time on the detection limit associated with NIR spectroscopy of potassium hydrogen phthalate in aqueous solution	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; TRANSMISSION SPECTROSCOPY; GLUCOSE; CALIBRATION; WATER; REGRESSION; SUGAR	Near infrared (NIR) spectroscopy is a common means of non-invasively determining the concentrations of organic compounds in relatively transparent aqueous solutions. Rigorous determination for limit of detection (LOD) is of importance for the application use of NIR spectroscopy. The work reported herein determined the LOD with the analysis of potassium hydrogen phthalate (KHP) in water with partial least square (PLS) calibration in the range of 6300 - 5800 cm (-1) between the two strong absorption bands of water, in which the C-H overtone bands of KHP are located. A comparison of the LOD estimated when using various condition (path length, aperture and co-added scan times) showed that the lowest LOD for KHP obtained with a fiber optic cable attachment equipped NIR spectrometer is approximately 150 ppm.	[Inagaki, Tetsuya; Watanabe, Tomoko; Tsuchikawa, Satoru] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi, Japan	Nagoya University	Inagaki, T (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi, Japan.	inatetsu@agr.nagoya-u.ac.jp						Allegrini F, 2014, ANAL CHEM, V86, P7858, DOI 10.1021/ac501786u; Amerov AK, 2004, APPL SPECTROSC, V58, P1195, DOI 10.1366/0003702042336136; [Anonymous], 1999, ISO8245; Chang CW, 2001, SOIL SCI SOC AM J, V65, P480, DOI 10.2136/sssaj2001.652480x; CHOPPIN GR, 1978, J MOL STRUCT, V45, P39, DOI 10.1016/0022-2860(78)87057-4; CHUNG HI, 1995, APPL BIOCHEM BIOTECH, V50, P109, DOI 10.1007/BF02783448; Ding Q, 2000, APPL SPECTROSC, V54, P1047, DOI 10.1366/0003702001950553; Giangiacomo R, 2006, FOOD CHEM, V96, P371, DOI 10.1016/j.foodchem.2005.02.051; Griffiths PR., 2007, FOURIER TRANSFORM IN, V2nd ed.; HAALAND DM, 1988, ANAL CHEM, V60, P1193, DOI 10.1021/ac00162a020; Hazen KH, 1998, APPL SPECTROSC, V52, P1597, DOI 10.1366/0003702981943103; Hazen KH, 1998, ANAL CHIM ACTA, V371, P255, DOI 10.1016/S0003-2670(98)00318-3; Jensen PS, 2002, APPL SPECTROSC, V56, P1600, DOI 10.1366/000370202321115878; Le LMM, 2014, TALANTA, V119, P361, DOI 10.1016/j.talanta.2013.10.060; Mauer LJ, 2009, J AGR FOOD CHEM, V57, P3974, DOI 10.1021/jf900587m; Meyer T, 2006, NIR NEWS, V7, P12; Olivieri AC, 2015, ANAL CHIM ACTA, V868, P10, DOI 10.1016/j.aca.2015.01.017; Olivieri AC, 2014, CHEM REV, V114, P5358, DOI 10.1021/cr400455s; Pearson EJ, 2014, GEOCHEM GEOPHY GEOSY, V15, P292, DOI 10.1002/2013GC004928; Rambla FJ, 1997, ANAL CHIM ACTA, V344, P41, DOI 10.1016/S0003-2670(97)00032-9; Raposo F, 2016, TRAC-TREND ANAL CHEM, V77, P167, DOI 10.1016/j.trac.2015.12.006	21	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176920	10.1371/journal.pone.0176920	http://dx.doi.org/10.1371/journal.pone.0176920			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472128	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500097
J	Rudra, S; Kalra, A; Kumar, A; Joe, W				Rudra, Shalini; Kalra, Aakshi; Kumar, Abhishek; Joe, William			Utilization of alternative systems of medicine as health care services in India: Evidence on AYUSH care from NSS 2014	PLOS ONE			English	Article							TRADITIONAL MEDICINE	AYUSH, an acronym for Ayurveda, Yoga and Naturopathy, Unani, Siddha, Sowa-Rigpa and Homeopathy represents the alternative systems of medicine recognized by the Government of India. Understanding the patterns of utilization of AYUSH care has been important for various reasons including an increased focus on its mainstreaming and integration with biomedicine-based health care system. Based on a nationally representative health survey 2014, we present an analysis to understand utilization of AYUSH care across socioeconomic and demographic groups in India. Overall, 6.9% of all patients seeking outpatient care in the reference period of last two weeks have used AYUSH services without any significant differentials across rural and urban India. Importantly, public health facilities play a key role in provisioning of AYUSH care in rural areas with higher utilization in Chhattisgarh, Kerala and West Bengal. Use of AYUSH among middle-income households is lower when compared with poorer and richer households. We also find that low-income households display a greater tendency for AYUSH self-medication. AYUSH care utilization is higher among patients with chronic diseases and also for treating skin-related and musculo-skeletal ailments. Although the overall share of AYUSH prescription drugs in total medical expenditure is only about 6% but the average expenditure for drugs on AYUSH and allopathy did not differ hugely. The discussion compares our estimates and findings with other studies and also highlights major policy issues around mainstreaming of AYUSH care.	[Rudra, Shalini] Observer Res Fdn, New Delhi, India; [Kalra, Aakshi; Kumar, Abhishek; Joe, William] Delhi Univ, Populat Res Ctr, Inst Econ Growth, North Campus, Delhi, India	University of Delhi	Joe, W (corresponding author), Delhi Univ, Populat Res Ctr, Inst Econ Growth, North Campus, Delhi, India.	william@iegindia.org		Joe, William/0000-0003-3282-658X				Abraham L, 2005, INDIAN SYSTEMS MED I; Ahmad S S, 2007, INT J ALTERN MED, V6, P1; Bannerman RH, 1988, TRADITIONAL MED HLTH; BHARDWAJ SM, 1975, SOC SCI MED, V9, P603, DOI 10.1016/0037-7856(75)90174-2; BHATIA JC, 1975, SOC SCI MED, V9, P15, DOI 10.1016/0037-7856(75)90153-5; Chandra Shailaja, 2012, Ayu, V33, P461, DOI 10.4103/0974-8520.110504; Das J, 2016, AM ECON REV, V106, P3765, DOI 10.1257/aer.20151138; Ebrahimnejad H, 2009, ROY ASIAT SOC BOOKS, P1; Elwell-Sutton TM, 2013, HEALTH POLICY PLANN, V28, P467, DOI 10.1093/heapol/czs077; Erreygers G, 2009, J HEALTH ECON, V28, P504, DOI 10.1016/j.jhealeco.2008.02.003; Gautham Meenakshi, 2011, Indian J Med Res, V134, P627, DOI 10.4103/0971-5916.90987; George A, 2013, SOC SCI MED, V96, P297, DOI 10.1016/j.socscimed.2013.01.022; Gopichandran Vijayaprasad, 2012, Indian J Med Ethics, V9, P272; Government of India, 2015, KEY IND SOC CONS IND; Greene H., 2003, ECONOMETRIC ANAL; Harilal M. S., 2009, ECON POLIT WEEKLY, V44, P44; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Herman PM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001046; Jaggi OP., 2000, MED INDIA MODERN PER; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jeffery R., 1988, POLITICS HLTH INDIA; Kumar C, 2011, PUBLIC PRIVATE DICHO; Kumar Deepak, 2010, INDIAN HIST REV, V37; Kumar Deepak, 2001, DIS MED INDIA HIST O; Lakshmi JK, 2015, HEALTH POLICY PLANN, V30, P1067, DOI 10.1093/heapol/czu096; Mahal A, 2001, HNP DISCUSSION PAPER; Mazumdar PG, 2007, J BIOSOC SCI, V39, P819, DOI 10.1017/S0021932007002106; Ministry of Textiles Government of India, 2015, ANN REP 2014 15; Mira Sadgopal, 2009, Economic and Political Weekly, V44, P52; Mohanan M, 2015, JAMA PEDIATR, V169, P349, DOI 10.1001/jamapediatrics.2014.3445; Mukherjee PK, 2012, J ETHNOPHARMACOL, V143, P424, DOI 10.1016/j.jep.2012.07.036; Mushtaq Muhammad Umair, 2009, Indian J Community Med, V34, P6, DOI 10.4103/0970-0218.45369; National Rural Health Mission, 2005, INDIAN J PUBLIC HLTH, V49, P175; NEUMANN AK, 1971, SOC SCI MED, V5, P137, DOI 10.1016/0037-7856(71)90094-1; Oyebode O, 2016, USE TRADITIONAL MED; Patwardhan Bhushan, 2015, J Ayurveda Integr Med, V6, P147, DOI 10.4103/0975-9476.166389; Planning Commission of India, 2011, REP STEER COMM AYUSH; Powell-Jackson T, 2016, SCIENCE, V354, P34, DOI 10.1126/science.aai8652; Priya R., 2010, STATUS ROLE AYUSH LO; RAMESH A, 1981, SOC SCI MED-MED GEOG, V15, P69, DOI 10.1016/0160-8002(81)90017-4; Raut B, 2011, INT J RES AYURVEDA P, V2, P876; Rohde J.E., 1995, RURAL PRIVATE PRACTI; Ruchika Nandha, 2013, International Journal of Green Pharmacy, V7, P173, DOI 10.4103/0973-8258.120184; Samal J, 2015, J INTERCULT ETHNOPHA, V4, P348, DOI 10.5455/jice.20151101093011; Schensul SL, 2006, SOC SCI MED, V62, P2774, DOI 10.1016/j.socscimed.2005.11.003; Sheehan Helen E, 2009, Indian J Med Ethics, V6, P138; Shyam Ashtekar, 2001, Economic and Political Weekly, V36, P448; Singh P, 2005, INDIAN J MED RES, V122, P137; Sivaramakrishnan K., 2006, OLD POTIONS NEW BOTT; Song F, 1991, HLTH POLICY PLAN, V6, P64; Srinivasan P, 1995, World Health Forum, V16, P190; Sujatha V., 2009, Economic and Political Weekly, V44, P76; Sujatha V., 2009, Economic and Political Weekly, V44, P35; Sunil Amrith, 2007, Economic and Political Weekly, V42, P114; Thorsen RS, 2016, HEALTH POLICY PLANN, V31, P314, DOI 10.1093/heapol/czv060; Vaidya A D B National Commission on Macroeconomics and Health, 2005, EFF INT IND SYST MED; VANDEVEN WPMM, 1981, J ECONOMETRICS, V17, P229, DOI 10.1016/0304-4076(81)90028-2; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; World Health Organization, 2013, WHO TRAD MED STRAT 2; World Health Organization, 2000, US	60	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176916	10.1371/journal.pone.0176916	http://dx.doi.org/10.1371/journal.pone.0176916			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SP	28472197	Green Published, gold, Green Submitted			2022-12-26	WOS:000400648500096
J	Khare, S; Nick, JA; Zhang, YL; Galeano, K; Butler, B; Khoshbouei, H; Rayaprolu, S; Hathorn, T; Ranum, LPW; Smithson, L; Golde, TE; Paucar, M; Morse, R; Raff, M; Simon, J; Ld, MNE; Wirdefeldt, K; Rincon-Limas, DE; Lewis, J; Kaczmarek, LK; Fernandez-Funez, P; Nick, HS; Waters, MF				Khare, Swati; Nick, Jerelyn A.; Zhang, Yalan; Galeano, Kira; Butler, Brittany; Khoshbouei, Habibeh; Rayaprolu, Sruti; Hathorn, Tyisha; Ranum, Laura P. W.; Smithson, Lisa; Golde, Todd E.; Paucar, Martin; Morse, Richard; Raff, Michael; Simon, Julie; Ld, Magnus Nordenskjo E.; Wirdefeldt, Karin; Rincon-Limas, Diego E.; Lewis, Jada; Kaczmarek, Leonard K.; Fernandez-Funez, Pedro; Nick, Harry S.; Waters, Michael F.			A KCNC3 mutation causes a neurodevelopmental, non-progressive SCA13 subtype associated with dominant negative effects and aberrant EGFR trafficking	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; SPINOCEREBELLAR ATAXIA 13; DROSOPHILA EYE; SIGNALING PATHWAYS; POTASSIUM CHANNELS; PATTERN-FORMATION; PLASMA-MEMBRANE; CELL-SURFACE; NEURODEGENERATION; EXPRESSION	The autosomal dominant spinocerebellar ataxias (SCAs) are a diverse group of neurological disorders anchored by the phenotypes of motor incoordination and cerebellar atrophy. Disease heterogeneity is appreciated through varying comorbidities: dysarthria, dysphagia, oculomotor and/or retinal abnormalities, motor neuron pathology, epilepsy, cognitive impairment, autonomic dysfunction, and psychiatric manifestations. Our study focuses on SCA13, which is caused by several allelic variants in the voltage-gated potassium channel KCNC3 (Kv3.3). We detail the clinical phenotype of four SCA13 kindreds that confirm causation of the KCNC3(R423H) allele. The heralding features demonstrate congenital onset with non-progressive, neurodevelopmental cerebellar hypoplasia and lifetime improvement in motor and cognitive function that implicate compensatory neural mechanisms. Targeted expression of human KCNC3(R423H) in Drosophila triggers aberrant wing veins, maldeveloped eyes, and fused ommatidia consistent with the neurodevelopmental presentation of patients. Furthermore, human KCNC3(R423H) expression in mammalian cells results in altered glycosylation and aberrant retention of the channel in anterograde and/or endosomal vesicles. Confirmation of the absence of plasma membrane targeting was based on the loss of current conductance in cells expressing the mutant channel. Mechanistically, genetic studies in Drosophila, along with cellular and biophysical studies in mammalian systems, demonstrate the dominant negative effect exerted by the mutant on the wild-type (WT) protein, which explains dominant inheritance. We demonstrate that ocular co-expression of KCNC3(R423H) with Drosophila epidermal growth factor receptor (dEgfr) results in striking rescue of the eye phenotype, whereas KCNC3(R423H) expression in mammalian cells results in aberrant intracellular retention of human epidermal growth factor receptor (EGFR). Together, these results indicate that the neurodevelopmental consequences of KCNC3(R423H) may be mediated through indirect effects on EGFR signaling in the developing cerebellum. Our results therefore confirm the KCNC3(R423H) allele as causative for SCA13, through a dominant negative effect on KCNC3 WT and links with EGFR that account for dominant inheritance, congenital onset, and disease pathology.	[Khare, Swati; Nick, Jerelyn A.; Galeano, Kira; Fernandez-Funez, Pedro; Waters, Michael F.] Univ Florida, Dept Neurol, Gainesville, FL 32611 USA; [Khare, Swati; Nick, Jerelyn A.; Galeano, Kira; Butler, Brittany; Khoshbouei, Habibeh; Smithson, Lisa; Golde, Todd E.; Rincon-Limas, Diego E.; Lewis, Jada; Fernandez-Funez, Pedro; Nick, Harry S.; Waters, Michael F.] Univ Florida, McKnight Brain Inst, Gainesville, FL 32611 USA; [Khare, Swati; Waters, Michael F.] Univ Florida, Dept Biomed Engn, Gainesville, FL 32611 USA; [Zhang, Yalan; Kaczmarek, Leonard K.] Yale Univ, Dept Pharmacol, New Haven, CT USA; [Butler, Brittany; Khoshbouei, Habibeh; Rayaprolu, Sruti; Smithson, Lisa; Golde, Todd E.; Waters, Michael F.] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Hathorn, Tyisha; Ranum, Laura P. W.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Paucar, Martin] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden; [Paucar, Martin] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Morse, Richard] Dartmouth Hitchcock Med Ctr, Dept Neurol, Lebanon, NH 03766 USA; [Raff, Michael; Simon, Julie] Multicare Hlth Syst, Genom Inst, Tacoma, WA USA; [Ld, Magnus Nordenskjo E.] Karolinska Univ Hosp, Dept Genet, Stockholm, Sweden; [Ld, Magnus Nordenskjo E.] Karolinska Inst, Dept Mol Med & Surg, Ctr Mol Med, Stockholm, Sweden; [Wirdefeldt, Karin] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Waters, Michael F.] St Josephs Hosp, Dept Neurol, Barrow Neurol Inst, Phoenix, AZ 85013 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Yale University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Dartmouth College; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center	Waters, MF (corresponding author), Univ Florida, Dept Neurol, Gainesville, FL 32611 USA.; Waters, MF (corresponding author), Univ Florida, McKnight Brain Inst, Gainesville, FL 32611 USA.; Waters, MF (corresponding author), Univ Florida, Dept Biomed Engn, Gainesville, FL 32611 USA.; Waters, MF (corresponding author), Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA.; Waters, MF (corresponding author), St Josephs Hosp, Dept Neurol, Barrow Neurol Inst, Phoenix, AZ 85013 USA.	Michael.Waters@DignityHealth.org	Khare, Dr Swati/AHB-3194-2022	Khoshbouei, Habibeh/0000-0002-1533-8771; Nordenskjold, Magnus/0000-0002-4974-425X; Rayaprolu, Sruti/0000-0002-5212-3745	NIH NINDS [K23 NS054715]; McKnight Brain Institute at the University of Florida; Rosalyn Heilman Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS054715, R37NS040389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001919] Funding Source: NIH RePORTER	NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); McKnight Brain Institute at the University of Florida; Rosalyn Heilman Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Support was provided by NIH NINDS K23 NS054715 (MFW), the McKnight Brain Institute at the University of Florida, and the Rosalyn Heilman Research Foundation.	[Anonymous], 2013, MAMMALIAN PHOSPHATID; [Anonymous], 2014, MECH ACTIVATION VOLT; [Anonymous], 2015, SIGMA 1 RECEPTOR NOV; [Anonymous], 1997, NEUROTROPHIC ACTION; [Anonymous], 1993, GENE ELAV DROSOPHILA; Bauer P, 2010, J NEUROL NEUROSUR PS, V81, P1229, DOI 10.1136/jnnp.2009.202150; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Chang SY, 2007, J COMP NEUROL, V502, P953, DOI 10.1002/cne.21353; Coutts AS, 2009, P NATL ACAD SCI USA, V106, P19872, DOI 10.1073/pnas.0906785106; Craige B, 2008, MOL BIOL CELL, V19, P1415, DOI 10.1091/mbc.E07-12-1239; Doroquez DB, 2007, MECH DEVELOP, V124, P792, DOI 10.1016/j.mod.2007.05.002; Doroquez DB, 2006, CRIT REV BIOCHEM MOL, V41, P339, DOI 10.1080/10409230600914344; Duarri A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116599; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Figueroa KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017811; Figueroa KP, 2010, HUM MUTAT, V31, P191, DOI 10.1002/humu.21165; Fort AG, 2011, J BIOL CHEM, V286, P22875, DOI 10.1074/jbc.M111.219709; Freeman M, 1997, DEVELOPMENT, V124, P261; Gallego-Iradi C, 2014, NEUROBIOL DIS, V71, P270, DOI 10.1016/j.nbd.2014.08.020; GOMEZPINILLA F, 1988, BRAIN RES, V438, P385, DOI 10.1016/0006-8993(88)91369-8; Guichard A, 2002, P NATL ACAD SCI USA, V99, P3752, DOI 10.1073/pnas.052028699; Haerry TE, 1998, DEVELOPMENT, V125, P3977; Hancock WO, 2014, NAT REV MOL CELL BIO, V15, P615, DOI 10.1038/nrm3853; Herman-Bert A, 2000, AM J HUM GENET, V67, P229, DOI 10.1086/302958; Hurlock EC, 2008, J NEUROSCI, V28, P4640, DOI 10.1523/JNEUROSCI.5486-07.2008; Irie T, 2014, J PHYSIOL-LONDON, V592, P229, DOI 10.1113/jphysiol.2013.264309; Jayadev S, 2013, GENET MED, V15, P673, DOI 10.1038/gim.2013.28; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Kim BR, 2011, ANN REHABIL MED-ARM, V35, P772, DOI 10.5535/arm.2011.35.6.772; Kumar JP, 2001, NAT REV GENET, V2, P846, DOI 10.1038/35098564; Kurada P, 1999, APOPTOSIS, V4, P239, DOI 10.1023/A:1009648724937; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Lorenzo DN, 2010, J CELL BIOL, V189, P143, DOI 10.1083/jcb.200905158; Maity A, 2000, CANCER RES, V60, P5879; Marelli C, 2011, ARCH NEUROL-CHICAGO, V68, P637, DOI 10.1001/archneurol.2011.81; Markwardt ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017896; Matilla-Duenas A, 2014, CONSENSUS PAPER PATH; Matilla-Duenas A, 2012, CEREBELLUM, V11, P821, DOI 10.1007/s12311-012-0376-4; Minassian NA, 2012, J PHYSIOL-LONDON, V590, P1599, DOI 10.1113/jphysiol.2012.228205; Minogue S, 2006, J CELL SCI, V119, P571, DOI 10.1242/jcs.02752; Mutsuddi M, 2004, CURR BIOL, V14, P302, DOI 10.1016/j.cub.2004.01.034; Nagaraj R, 2004, INT J DEV BIOL, V48, P755, DOI 10.1387/ijdb.041881rn; Nechiporuk T, 2007, DEV CELL, V13, P338, DOI 10.1016/j.devcel.2007.07.017; Offterdinger M, 2008, TRAFFIC, V9, P147, DOI 10.1111/j.1600-0854.2007.00665.x; Orr HT, 2012, J CELL BIOL, V197, P167, DOI 10.1083/jcb.201105092; Park J, 2013, NATURE, V498, P325, DOI 10.1038/nature12204; Price JV, 1997, GENETICS, V147, P1139; REINKE R, 1988, CELL, V52, P291, DOI 10.1016/0092-8674(88)90518-1; Roignant JY, 2009, INT J DEV BIOL, V53, P795, DOI 10.1387/ijdb.072483jr; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Schluter K, 2014, EUR J CELL BIOL, V93, P194, DOI 10.1016/j.ejcb.2014.06.001; Seidel K, 2012, ACTA NEUROPATHOL, V124, P1, DOI 10.1007/s00401-012-1000-x; Singh A, 2002, DEVELOPMENT, V129, P4271; Smith JE, 2001, DEVELOPMENT, V128, P4705; Smyth JW, 2012, CIRC RES, V110, P978, DOI 10.1161/CIRCRESAHA.111.257964; Snijder PM, 2015, OVEREXPRESSION CYSTA, V53, P160; Subramony SH, 2013, CEREBELLUM, V12, P932, DOI 10.1007/s12311-013-0507-6; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Waters MF, 2008, CEREBELLUM, V7, P165, DOI 10.1007/s12311-008-0039-7; Waters MF, 2006, NAT GENET, V38, P447, DOI 10.1038/ng1758; Waters MF, 2005, NEUROLOGY, V65, P1111, DOI 10.1212/01.wnl.0000177490.05162.41; WOLFF T, 1991, DEVELOPMENT, V113, P841; Zagha E, 2010, J NEUROPHYSIOL, V103, P3516, DOI 10.1152/jn.00982.2009; Zhang YC, 2016, J BUS ETHICS, V139, P455, DOI 10.1007/s10551-015-2657-6; Zhao J, 2013, BIOCHEM J, V454, P259, DOI 10.1042/BJ20130034; Zuchero JB, 2009, NAT CELL BIOL, V11, P451, DOI 10.1038/ncb1852	68	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0173565	10.1371/journal.pone.0173565	http://dx.doi.org/10.1371/journal.pone.0173565			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467418	Green Submitted, Green Published, gold			2022-12-26	WOS:000400647000003
J	Wong, KLM; Restrepo-Mendez, MC; Barros, AJD; Victora, CG				Wong, Kerry L. M.; Restrepo-Mendez, Maria Clara; Barros, Aluisio J. D.; Victora, Cesar G.			Socioeconomic inequalities in skilled birth attendance and child stunting in selected low and middle income countries: Wealth quintiles or deciles?	PLOS ONE			English	Article							NATIONAL SURVEYS; HEALTH; INTERVENTIONS; POSITION; TRENDS	Background Wealth quintiles derived from household asset indices are routinely used for measuring socioeconomic inequalities in the health of women and children in low and middle-income countries. We explore whether the use of wealth deciles rather than quintiles may be advantageous. Methods We selected 46 countries with available national surveys carried out between 2003 and 2013 and with a sample size of at least 3000 children. The outcomes were prevalence of under-five stunting and delivery by a skilled birth attendant (SBA). Differences and ratios between extreme groups for deciles (D1 and D10) and quintiles (Q1 and Q5) were calculated, as well as two summary measures: the slope index of inequality (SII) and concentration index (CIX). Results In virtually all countries, stunting prevalence was highest among the poor, and there were larger differences between D1 and D10 than between Q1 and Q5. SBA coverage showed pro-rich patterns in all countries; in four countries the gap was greater than 80 pct points. With one exception, differences between extreme deciles were larger than between quintiles. Similar patterns emerged when using ratios instead of differences. The two summary measures provide very similar results for quintiles and deciles. Patterns of top or bottom inequality varied with national coverage levels. Conclusion Researchers and policymakers should consider breakdowns by wealth deciles, when sample sizes allow. Use of deciles may contribute to advocacy efforts, monitoring inequalities over time, and targeting health interventions. Summary indices of inequalities were unaffected by the use of quintiles or deciles in their calculation.	[Wong, Kerry L. M.; Restrepo-Mendez, Maria Clara; Barros, Aluisio J. D.; Victora, Cesar G.] Univ Fed Pelotas, Postgrad Program Epidemiol, Int Ctr Equity Hlth, Rua Marechal Deodoro,1160 3 Piso, Pelotas, Brazil; [Wong, Kerry L. M.] London Sch Hyg & Trop Med, London, England; [Restrepo-Mendez, Maria Clara] Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unit, Oakfield House, Bristol, Avon, England	Universidade Federal de Pelotas; University of London; London School of Hygiene & Tropical Medicine; University of Bristol	Wong, KLM (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, Int Ctr Equity Hlth, Rua Marechal Deodoro,1160 3 Piso, Pelotas, Brazil.; Wong, KLM (corresponding author), London Sch Hyg & Trop Med, London, England.	kwong@equidade.org	Barros, Aluisio JD/A-7417-2008; Victora, Cesar Gomes/Y-2455-2019	Barros, Aluisio JD/0000-0002-2022-8729; Victora, Cesar Gomes/0000-0002-2465-2180; Restrepo-Mendez, Maria Clara/0000-0001-7714-7340; Wong, Kerry/0000-0002-4400-2257	Wellcome Trust [101815/Z/13/Z]; Bill & Melinda Gates Foundation; Brazilian Public Health Association (ABRASCO)	Wellcome Trust(Wellcome TrustEuropean Commission); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Brazilian Public Health Association (ABRASCO)	This work was supported by Wellcome Trust [Grant Number: 101815/Z/13/Z]; Bill & Melinda Gates Foundation; Brazilian Public Health Association (ABRASCO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, ASSESSING ASSET INDI; Barros AJD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001390; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Bouchard L, 2015, SOC SCI MED, V141, P100, DOI 10.1016/j.socscimed.2015.07.022; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Harper S, 2008, AM J EPIDEMIOL, V167, P889, DOI 10.1093/aje/kwn016; Houweling Tanja AJ, 2003, Int J Equity Health, V2, P8, DOI 10.1186/1475-9276-2-8; Howe LD, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-3; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Morris SS, 2000, J EPIDEMIOL COMMUN H, V54, P381, DOI 10.1136/jech.54.5.381; Restrepo-Mendez MC, 2015, PUBLIC HEALTH NUTR, V18, P2097, DOI 10.1017/S1368980014002924; Victora C, 2000, POVERTY INEQUALITY H, P125; Victora CG, 2005, LANCET, V366, P1460, DOI 10.1016/S0140-6736(05)67599-X; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; World Health Organization (WHO), 2008, PROP BIRTHS ATT SKIL	15	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0174823	10.1371/journal.pone.0174823	http://dx.doi.org/10.1371/journal.pone.0174823			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SB	28467411	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000400647000007
J	Kim, JH; Jiang, YP; Cohen, IS; Lin, RZ; Mathias, RT				Kim, Jeremy H.; Jiang, Ya-Ping; Cohen, Ira S.; Lin, Richard Z.; Mathias, Richard T.			Pressure-overload-induced angiotensin-mediated early remodeling in mouse heart	PLOS ONE			English	Article							OUTWARD K+ CURRENTS; CARDIAC-HYPERTROPHY; VENTRICULAR MYOCYTES; MECHANICAL-STRESS; CA2+ CURRENT; RECEPTOR; FAILURE; MYOCARDIUM; CHANNEL; SYSTEM	Our previous work on angiotensin II-mediated electrical-remodeling in canine left ventricle, in connection with a long history of other studies, suggested the hypothesis: increases in mechanical load induce autocrine secretion of angiotensin II (A2), which coherently regulates a coterie of membrane ion transporters in a manner that increases contractility. However, the relation between load and A2 secretion was correlative. We subsequently showed a similar or identical system was present in murine heart. To investigate whether the relation between mechanical load and A2-mediated electrical remodeling was causal, we employed transverse aortic constriction in mice to subject the left ventricle to pressure overload for short-term (1 to 2 days) or long- term (1 to 2 weeks) periods. Heart-to-body weight ratios and cell capacitance measurements were used to determine hypertrophy. Whole-cell patch clamp recordings of the predominant repolarization currents I-to,I-fast and I-K,I-slow were used to assess electrical remodeling. Hearts or myocytes subjected to long- term load displayed significant hypertrophy, which was not evident in short-term load. However, short-term load induced significant reductions in I-to,I-fast and I-K,I-slow. Incubation of these myocytes with the angiotensin II type 1 receptor inhibitor saralasin for 2 hours restored I-to,I-fast and I-K,I-slow to control levels. The number of I-to.fast or I-K,I-slow channels did not change with A2 or long- term load, however the hypertrophic increase in membrane area reduced the current densities for both channels. For I-to,I-fast but not I-K,I-slow there was an additional reduction that was reversed by inhibition of angiotensin receptors. These results suggest increased load activates an endogenous renin angiotensin system that initially reduces I-to,I-fast and I-K,I-slow prior to the onset of hypertrophic growth. However, there are functional interactions between electrical and anatomical remodeling. First, hypertrophy tends to reduce all current densities. Second, the hypertrophic program can modify signaling between the angiotensin receptor and target current.	[Kim, Jeremy H.; Jiang, Ya-Ping; Cohen, Ira S.; Lin, Richard Z.; Mathias, Richard T.] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Mathias, RT (corresponding author), SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA.	richard.mathias@sunysb.edu			National Institute of Health/National Heart, Lung and Blood Institute [HL085221]; National Heart, Lung and Blood Institute [HL094910]; National Institutes of Health/National Instiute of Diabetes and Digestive and Kidney Diseases [DK108989]; National Institutes of Health/National Cancer Institute [CA136754]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK108989] Funding Source: NIH RePORTER	National Institute of Health/National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health/National Instiute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Health/National Heart, Lung and Blood Institute: HL085221 (RTM); National Heart, Lung and Blood Institute: HL094910 (ISC); National Institutes of Health/National Instiute of Diabetes and Digestive and Kidney Diseases DK108989 (RZL); National Institutes of Health/National Cancer Institute CA136754 (RZL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Aiello EA, 2001, AM J PHYSIOL-HEART C, V280, pH1528, DOI 10.1152/ajpheart.2001.280.4.H1528; BAKER KM, 1990, AM J PHYSIOL, V259, pH610, DOI 10.1152/ajpheart.1990.259.2.H610; Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020; BROWN VI, 1991, DNA CELL BIOL, V10, P399, DOI 10.1089/dna.1991.10.399; Cutler MJ, 2011, TRENDS PHARMACOL SCI, V32, P174, DOI 10.1016/j.tips.2010.12.001; DAngelo DD, 1997, P NATL ACAD SCI USA, V94, P8121, DOI 10.1073/pnas.94.15.8121; Deckmann AC, 2010, GENET MOL BIOL, V33, P12, DOI 10.1590/S1415-47572010005000004; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; Doronin SV, 2004, J BIOL CHEM, V279, P48231, DOI 10.1074/jbc.M405789200; Dou ZX, 2010, J CELL BIOL, V191, P827, DOI 10.1083/jcb.201006056; FREER RJ, 1976, CIRC RES, V39, P178, DOI 10.1161/01.RES.39.2.178; Gao JY, 2014, BIOPHYS J, V106, P2364, DOI 10.1016/j.bpj.2014.04.042; Guo WN, 2002, CIRC RES, V90, P586, DOI 10.1161/01.RES.0000012664.05949.E0; Harada K, 1998, CIRCULATION, V97, P1952, DOI 10.1161/01.CIR.97.19.1952; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Ichiyanagi O, 2002, PFLUG ARCH EUR J PHY, V444, P107, DOI 10.1007/s00424-002-0808-y; Jeyaraj D, 2007, CIRCULATION, V115, P3145, DOI 10.1161/CIRCULATIONAHA.107.688317; Kim J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138711; Lammerding J, 2004, ANN NY ACAD SCI, V1015, P53, DOI 10.1196/annals.1302.005; Marionneau C, 2008, CIRC RES, V102, P1406, DOI 10.1161/CIRCRESAHA.107.170050; Ozgen N, 2012, HEART RHYTHM, V9, P1865, DOI 10.1016/j.hrthm.2012.07.014; Rosati B, 2001, J PHYSL, V15, P119; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; SADOSHIMA J, 1993, CELL, V75, P977, DOI 10.1016/0092-8674(93)90541-W; Spruill LS, 2008, J MOL CELL CARDIOL, V44, P69, DOI 10.1016/j.yjmcc.2007.10.011; van Kats JP, 1998, CIRCULATION, V98, P73, DOI 10.1161/01.CIR.98.1.73; Waldman LK, 1985, CIRC RES, V846, P179; Wang YG, 2007, J CARDIOVASC ELECTR, V18, P869, DOI 10.1111/j.1540-8167.2007.00864.x; Xu HD, 1999, J GEN PHYSIOL, V113, P661, DOI 10.1085/jgp.113.5.661; Yasuno S, 2013, BRIT J PHARMACOL, V170, P1384, DOI 10.1111/bph.12328; Yu HG, 2000, CIRC RES, V86, P1062, DOI 10.1161/01.RES.86.10.1062; Zengyi W, 2001, CIRCULATION, V104, P1657; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	34	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176713	10.1371/journal.pone.0176713	http://dx.doi.org/10.1371/journal.pone.0176713			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28464037	gold, Green Published, Green Submitted			2022-12-26	WOS:000400646300046
J	Sun, Y; Jiang, WB; Cory, E; Caffrey, JP; Hsu, FH; Chen, AC; Wang, JC; Sah, RL; Bugbee, WD				Sun, Yang; Jiang, Weibo; Cory, Esther; Caffrey, Jason P.; Hsu, Felix H.; Chen, Albert C.; Wang, Jincheng; Sah, Robert L.; Bugbee, William D.			Pulsed lavage cleansing of osteochondral grafts depends on lavage duration, flow intensity, and graft storage condition	PLOS ONE			English	Article							ALLOGRAFT TRANSPLANTATION; IMMUNOLOGICAL RESPONSES; CARTILAGE DEFECTS; STORED ALLOGRAFTS; FRESH; BONE; KNEE; AUTOGRAFTS; TOMOGRAPHY; MARROW	Introduction Osteochondral allograft (OCA) transplantation is generally effective for treating large cartilage lesions. Cleansing OCA subchondral bone to remove donor marrow elements is typically performed with pulsed lavage. However, the effects of clinical and experimental parameters on OCA marrow removal by pulsed lavage are unknown. The aim of the current study was to determine the effects on marrow cleansing in human osteochondral cores (OCs) of (1) lavage duration, (2) lavage flow intensity, and (3) OC sample type and storage condition. Methods OCs were harvested from human femoral condyles and prepared to a clinical geometry (cylinder, diameter = 20 mm). The OCs were from discarded remnants of Allograft tissues (OCA) or osteoarthritis patients undergoing Total Knee Replacement (OCT). The experimental groups subjected to standard flow lavage for 45 seconds (430 mL of fluid) and 120 seconds (1,150 mL) were (1) OCT/FROZEN (stored at -80 degrees C), (2) OCT/FRESH (stored at 4 degrees C), and (3) OCA/FRESH. The OCA/FRESH group was subsequently lavaged at high flow for 45 seconds (660 mL) and 120 seconds (1,750 mL). Marrow cleansing was assessed grossly and by micro-computed tomography (mu CT). Results Gross and mu CT images indicated that marrow cleansing progressed from the OC base toward the cartilage. Empty marrow volume fraction (EMa.V/Ma.V) increased between 0, 45, and 120 seconds of standard flow lavage, and varied between groups, being higher after FROZEN storage (86-92% after 45-120 seconds) than FRESH storage of either OCT or OCA samples (36% and 55% after 45 and 120 seconds, respectively). With a subsequent 120 seconds of high flow lavage, EMa.V/Ma. V of OCA/FRESH samples increased from 61% to 78%. Conclusions The spatial and temporal pattern of marrow space clearance was consistent with gradual fluid-induced extrusion of marrow components. Pulsed lavage of OCAs with consistent time and flow intensity will help standardize marrow cleansing and may improve clinical outcomes.	[Sun, Yang; Jiang, Weibo; Wang, Jincheng] Jilin Univ, Hosp 2, Div Orthopaed Surg, Changchun, Jilin, Peoples R China; [Sun, Yang; Jiang, Weibo; Cory, Esther; Caffrey, Jason P.; Hsu, Felix H.; Chen, Albert C.; Sah, Robert L.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Sah, Robert L.] Univ Calif San Diego, Inst Engn Med, Ctr Musculoskeletal Res, La Jolla, CA 92093 USA; [Bugbee, William D.] Scripps Clin, Div Orthopaed Surg, La Jolla, CA 92037 USA	Jilin University; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute	Wang, JC (corresponding author), Jilin Univ, Hosp 2, Div Orthopaed Surg, Changchun, Jilin, Peoples R China.; Sah, RL (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.; Sah, RL (corresponding author), Univ Calif San Diego, Inst Engn Med, Ctr Musculoskeletal Res, La Jolla, CA 92093 USA.; Bugbee, WD (corresponding author), Scripps Clin, Div Orthopaed Surg, La Jolla, CA 92037 USA.	jcwang_jlu@hotmail.com; rsah@ucsd.edu; Bugbee.william@scrippshealth.org	; Sun, Yang/H-7503-2017	Wang, Jincheng/0000-0002-1217-5962; Sun, Yang/0000-0003-1479-5222; Jiang, Weibo/0000-0002-7241-9578	National Institutes of Health [R01 AR055637]; NIH [P01 AG07996]; China Scholarship Council (CSC) [201406170147, 201509260025]; National Science Foundation [DGE-1144086]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council (CSC)(China Scholarship Council); National Science Foundation(National Science Foundation (NSF))	One or more of the authors has the following potential conflict of interest or source of funding: The project was funded by the National Institutes of Health (https://www.nih.gov) R01 AR055637 (WDB) and NIH P01 AG07996 (RLS). YS and WJ were supported by the China Scholarship Council (CSC 201406170147; 201509260025) (http://en.csc.edu.cn/). JPC was supported by a National Science Foundation Graduate Research Fellowship under Grant No DGE-1144086 (https://www.nsfgrfp.org/).	Aubin PP, 2001, CLIN ORTHOP RELAT R, pS318, DOI 10.1097/00003086-200110001-00029; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brown K, 2014, J MICROSC-OXFORD, V253, P171, DOI 10.1111/jmi.12106; Bugbee WD, 1999, CLIN SPORT MED, V18, P67, DOI 10.1016/S0278-5919(05)70130-7; Bugbee WD, 2016, J ORTHOP RES, V34, P31, DOI 10.1002/jor.22998; Bugbee WD, 2013, J BONE JOINT SURG AM, V95A, P426, DOI 10.2106/JBJS.L.00165; Clarius M, 2009, INT ORTHOP, V33, P1585, DOI 10.1007/s00264-009-0736-y; Cook JL, 2014, CLIN ORTHOP RELAT R, V472, P3404, DOI 10.1007/s11999-014-3773-9; Demontiero O, 2011, EXP GERONTOL, V46, P435, DOI 10.1016/j.exger.2011.01.001; DESJARDINS MR, 1991, VET SURG, V20, P446, DOI 10.1111/j.1532-950X.1991.tb00353.x; ENNEKING WF, 1991, J BONE JOINT SURG AM, V73A, P1123, DOI 10.2106/00004623-199173080-00002; GARRETT JC, 1994, CLIN ORTHOP RELAT R, P33; Glenn RE, 2006, AM J SPORT MED, V34, P1084, DOI 10.1177/0363546505284846; Gortz Simon, 2007, Instr Course Lect, V56, P469; Gross AE, 2005, CLIN ORTHOP RELAT R, P79, DOI 10.1097/01.blo.0000165845.21735.05; Haimi S, 2008, ACTA ORTHOP, V79, P94, DOI 10.1080/17453670710014824; Hunt HE, 2014, AM J SPORT MED, V42, P886, DOI 10.1177/0363546513518733; Kalteis T, 2007, ARCH ORTHOP TRAUM SU, V127, P873, DOI 10.1007/s00402-007-0418-4; LaPrade RE, 2009, J BONE JOINT SURG AM, V91A, P805, DOI 10.2106/JBJS.H.00703; Lewandrowski K U, 2001, J Orthop Sci, V6, P545, DOI 10.1007/s007760100011; Li X, 2014, ADV DRUG DELIVER REV, V76, P116, DOI 10.1016/j.addr.2014.07.013; McCulloch PC, 2007, AM J SPORT MED, V35, P411, DOI 10.1177/0363546506295178; Metzger TA, 2014, J MECH BEHAV BIOMED, V40, P307, DOI 10.1016/j.jmbbm.2014.09.008; MNAYMNEH W, 1985, CLIN ORTHOP RELAT R, P76; MOORE SG, 1990, RADIOLOGY, V175, P219, DOI 10.1148/radiology.175.1.2315484; OAKESHOTT RD, 1988, CLIN ORTHOP RELAT R, P283; Pallante AL, 2012, J BONE JOINT SURG AM, V94A, P1984, DOI 10.2106/JBJS.K.00439; Pallante-Kichura AL, 2013, BONE, V57, P259, DOI 10.1016/j.bone.2013.08.011; Palmer AW, 2006, P NATL ACAD SCI USA, V103, P19255, DOI 10.1073/pnas.0606406103; Ranawat AS, 2008, CLIN ORTHOP RELAT R, V466, P1826, DOI 10.1007/s11999-008-0311-7; RODRIGO JJ, 1987, CLIN ORTHOP RELAT R, V218, P268; Sadr KN, 2016, AM J SPORT MED, V44, P2870, DOI 10.1177/0363546516657526; Schlegel UJ, 2014, INT ORTHOP, V38, P967, DOI 10.1007/s00264-014-2303-4; Schoenfeld Andrew J, 2007, J Foot Ankle Surg, V46, P144, DOI 10.1053/j.jfas.2006.10.004; Sherman SL, 2014, J AM ACAD ORTHOP SUR, V22, P121, DOI 10.5435/JAAOS-22-02-121; Sirlin CB, 2001, RADIOLOGY, V219, P35, DOI 10.1148/radiology.219.1.r01ap0435; STEVENSON S, 1987, J BONE JOINT SURG AM, V69A, P573, DOI 10.2106/00004623-198769040-00015; Strong DM, 1996, CLIN ORTHOP RELAT R, P107; VandeVord PJ, 2005, J ORTHOP RES, V23, P1059, DOI 10.1016/j.orthres.2004.12.004; Williams RJ, 2007, J BONE JOINT SURG AM, V89A, P718, DOI 10.2106/JBJS.F.00625	40	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176934	10.1371/journal.pone.0176934	http://dx.doi.org/10.1371/journal.pone.0176934			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28464040	Green Submitted, Green Published, gold			2022-12-26	WOS:000400646300067
J	Karah, N; Jolley, KA; Hall, RM; Uhlin, BE				Karah, Nabil; Jolley, Keith A.; Hall, Ruth M.; Uhlin, Bernt Eric			Database for the ampC alleles in Acinetobacter baumannii	PLOS ONE			English	Article							HORIZONTAL TRANSFER; BETA-LACTAMASE; RESISTANCE; GENE; CEPHALOSPORINASE; IDENTIFICATION	Acinetobacter baumannii is a troublesome opportunistic pathogen with a high capacity for clonal dissemination. We announce the establishment of a database for the ampC locus in A. baumannii, in which novel ampC alleles are differentiated based on the occurrence of >= 1 nucleotide change, regardless of whether it is silent or missense. The database is openly accessible at the pubmlst platform for A. baumannii (http://pubmlst.org/abaumannii/). Forty-eight distinctive alleles of the ampC locus have so far been identified and deposited in the database. Isolates from clonal complex 1 (CC1), according to the Pasteur multilocus sequence typing scheme, had a variety of the ampC locus alleles, including alleles 1, 3, 4, 5, 6, 7, 8, 13, 14, 17, and 18. On the other hand, isolates from CC2 had the ampC alleles 2, 3, 19, 20, 21, 22, 23, 24, 26, 27, 28, and 46. Allele 3 was characteristic for sequence types ST3 or ST32. The ampC alleles 10, 16, and 25 were characteristic for CC10, ST16, and CC25, respectively. Our study points out that novel gene databases, in which alleles are numbered based on differences in their nucleotide identities, should replace traditional records that use amino acid substitutions to define new alleles.	[Karah, Nabil; Uhlin, Bernt Eric] Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea, Sweden; [Karah, Nabil; Uhlin, Bernt Eric] Umea Univ, Dept Mol Biol, Umea, Sweden; [Karah, Nabil; Uhlin, Bernt Eric] Umea Univ, Umea Ctr Microbial Res, Umea, Sweden; [Jolley, Keith A.] Univ Oxford, Dept Zool, Oxford, England; [Hall, Ruth M.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia	Umea University; Umea University; Umea University; University of Oxford; University of Sydney	Karah, N (corresponding author), Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea, Sweden.; Karah, N (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.; Karah, N (corresponding author), Umea Univ, Umea Ctr Microbial Res, Umea, Sweden.	nabil.karah@umu.se	Jolley, Keith/ABE-8587-2020; Uhlin, Bernt Eric/AAO-6292-2021	Jolley, Keith/0000-0002-0751-0287; Uhlin, Bernt Eric/0000-0002-2991-8072	Swedish Research Council [VR-NT 2012-4638, VR-MH 2013-3878, VR-MH 2015-03007, 349-2007-8673]; Kempe Foundations [JCK-1527]; Umea Centre for Microbial Research (UCMR)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Kempe Foundations; Umea Centre for Microbial Research (UCMR)	This work was supported by project grants from the Swedish Research Council (VR-NT 2012-4638,VR-MH 2013-3878, and VR-MH 2015-03007) and The Kempe Foundations (JCK-1527). The work was performed as part of the Umea Centre for Microbial Research (UCMR) Linnaeus Program supported by Umea University and the Swedish Research Council (349-2007-8673). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bou G, 2000, ANTIMICROB AGENTS CH, V44, P428, DOI 10.1128/AAC.44.2.428-432.2000; Hamidian M, 2014, J ANTIMICROB CHEMOTH, V69, P2865, DOI 10.1093/jac/dku202; Hamidian M, 2014, J ANTIMICROB CHEMOTH, V69, P77, DOI 10.1093/jac/dkt312; Hamidian M, 2013, J ANTIMICROB CHEMOTH, V68, P2682, DOI 10.1093/jac/dkt233; Hamidian M, 2013, J ANTIMICROB CHEMOTH, V68, P244, DOI 10.1093/jac/dks345; Holt KE, 2016, MICROBIAL GENOMICS, V2; Hujer KM, 2005, ANTIMICROB AGENTS CH, V49, P2941, DOI 10.1128/AAC.49.7.2941-2948.2005; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Karah N, 2016, ANTIMICROB AGENTS CH, V60, P1801, DOI 10.1128/AAC.02143-15; Karah N, 2012, DRUG RESIST UPDATE, V15, P237, DOI 10.1016/j.drup.2012.06.001; Mammeri H, 2003, ANTIMICROB AGENTS CH, V47, P1536, DOI 10.1128/AAC.47.5.1536-1542.2003; Perichon B, 2014, ANTIMICROB AGENTS CH, V58, P936, DOI 10.1128/AAC.01261-13; Pournaras S, 2014, J CLIN MICROBIOL, V52, P1653, DOI 10.1128/JCM.03565-13; Rafei R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115969; Revathi G, 2013, INT J INFECT DIS, V17, pE1255, DOI 10.1016/j.ijid.2013.07.016; Rodriguez-Martinez JM, 2010, ANTIMICROB AGENTS CH, V54, P3484, DOI 10.1128/AAC.00050-10; Tian GB, 2011, ANTIMICROB AGENTS CH, V55, P4922, DOI 10.1128/AAC.00704-11	17	26	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176695	10.1371/journal.pone.0176695	http://dx.doi.org/10.1371/journal.pone.0176695			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459877	gold, Green Published, Green Submitted			2022-12-26	WOS:000400645000049
J	Liu, YY; Zhou, XY; Yang, LN; Wang, HY; Zhang, YQ; Pu, JC; Liu, LX; Gui, SW; Zeng, L; Chen, JJ; Zhou, CJ; Xie, P				Liu, Yi-Yun; Zhou, Xin-Yu; Yang, Li-Ning; Wang, Hai-Yang; Zhang, Yu-Qing; Pu, Jun-Cai; Liu, Lan-Xiang; Gui, Si-Wen; Zeng, Li; Chen, Jian-Jun; Zhou, Chan-Juan; Xie, Peng			Social defeat stress causes depression-like behavior with metabolite changes in the prefrontal cortex of rats	PLOS ONE			English	Article							ARACHIDONIC-ACID CASCADE; CHRONIC MILD STRESS; FORCED SWIM TEST; LIFE EVENTS; MASS-SPECTROMETRY; BIPOLAR DISORDER; MOOD DISORDERS; NERVOUS-SYSTEM; MODEL; BRAIN	Major depressive disorder is a serious mental disorder with high morbidity and mortality. The role of social stress in the development of depression remains unclear. Here, we used the social defeat stress paradigm to induce depression-like behavior in rats, then evaluated the behavior of the rats and measured metabolic changes in the prefrontal cortex using gas chromatography-mass spectrometry. Within the first week after the social defeat procedure, the sucrose preference test (SPT), open field test (OFT), elevated plus maze (EPM) and forced swim test (FST) were conducted to examine the depressive-like and anxiety-like behaviors. For our metabolite analysis, multivariate statistics were applied to observe the distribution of all samples and to differentiate the socially defeated group from the control group. Ingenuity pathway analysis was used to find the potential relationships among the differential metabolites. In the OFT and EPM, there were no significant differences between the two experimental groups. In the SPT and FST, socially defeated rats showed less sucrose intake and longer immobility time compared with control rats. Metabolic profiling identified 25 significant variables with good predictability. Ingenuity pathways analysis revealed that | Hereditary Disorder, Neurological Disease, Lipid Metabolism was the most significantly altered network. Stress-induced alterations of low molecular weight metabolites were observed in the prefrontal cortex of rats. Particularly, lipid metabolism, amino acid metabolism, and energy metabolism were significantly perturbed. The results of this study suggest that repeated social defeat can lead to metabolic changes and depression-like behavior in rats.	[Liu, Yi-Yun; Zhou, Xin-Yu; Yang, Li-Ning; Zhang, Yu-Qing; Pu, Jun-Cai; Liu, Lan-Xiang; Zeng, Li; Zhou, Chan-Juan; Xie, Peng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Liu, Yi-Yun; Zhou, Xin-Yu; Yang, Li-Ning; Wang, Hai-Yang; Zhang, Yu-Qing; Pu, Jun-Cai; Liu, Lan-Xiang; Gui, Si-Wen; Zeng, Li; Chen, Jian-Jun; Zhou, Chan-Juan; Xie, Peng] Chongqing Med Univ, Chongqing Key Lab Neurobiol, Chongqing, Peoples R China; [Liu, Yi-Yun; Zhou, Xin-Yu; Yang, Li-Ning; Wang, Hai-Yang; Zhang, Yu-Qing; Pu, Jun-Cai; Liu, Lan-Xiang; Gui, Si-Wen; Zeng, Li; Chen, Jian-Jun; Zhou, Chan-Juan; Xie, Peng] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China; [Liu, Yi-Yun; Zhou, Xin-Yu; Yang, Li-Ning; Wang, Hai-Yang; Zhang, Yu-Qing; Pu, Jun-Cai; Liu, Lan-Xiang; Gui, Si-Wen; Zeng, Li; Chen, Jian-Jun; Zhou, Chan-Juan; Xie, Peng] Chongqing Med Univ, Collaborat Innovat Ctr Brain Sci, Chongqing, Peoples R China; [Wang, Hai-Yang] Chongqing Med Univ, Sch Publ Hlth & Management, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Xie, P (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China.; Xie, P (corresponding author), Chongqing Med Univ, Chongqing Key Lab Neurobiol, Chongqing, Peoples R China.; Xie, P (corresponding author), Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China.; Xie, P (corresponding author), Chongqing Med Univ, Collaborat Innovat Ctr Brain Sci, Chongqing, Peoples R China.	xiepeng@cqmu.edu.cn	chen, jian-jun/J-9118-2019	chen, jian-jun/0000-0002-6439-5123	National Natural Science Foundation of China [31440050]; National Basic Research Program of China (973 Program) [2009CB918300]; National Key Clinical Specialties Construction Program of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Key Clinical Specialties Construction Program of China	PX was supported by the National Natural Science Foundation of China (grant number 31440050) (http://www.nsfc.gov.cn/), the National Basic Research Program of China (973 Program) (grant number 2009CB918300) (http://www.most gov.cr/), and National Key Clinical Specialties Construction Program of China (http://www.nhfpc. gov.cn/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2008, CHEM REV, V108, P1687, DOI 10.1021/cr0782067; Allen PJ, 2010, NEUROPSYCHOPHARMACOL, V35, P534, DOI 10.1038/npp.2009.160; Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; Bartolomucci A, 2005, NEUROSCI BIOBEHAV R, V29, P67, DOI 10.1016/j.neubiorev.2004.06.009; Baslow MH, 2000, J NEUROCHEM, V75, P453, DOI 10.1046/j.1471-4159.2000.0750453.x; Becker C, 2008, MOL PSYCHIATR, V13, P1079, DOI 10.1038/sj.mp.4002097; Bhattacharjee AK, 2005, PSYCHOPHARMACOLOGY, V180, P735, DOI 10.1007/s00213-005-2208-4; Bjorkqvist K, 2001, PHYSIOL BEHAV, V73, P435, DOI 10.1016/S0031-9384(01)00490-5; BROADHEAD WE, 1990, JAMA-J AM MED ASSOC, V264, P2524, DOI 10.1001/jama.264.19.2524; BROWN GW, 1973, PSYCHOL MED, V3, P159, DOI 10.1017/S0033291700048492; Cao X, 2013, NAT MED, V19, P773, DOI 10.1038/nm.3162; Carnevali L, 2017, NEUROSCI BIOBEHAV R, V74, P444, DOI 10.1016/j.neubiorev.2016.04.013; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chen GH, 2015, BEHAV BRAIN RES, V278, P286, DOI 10.1016/j.bbr.2014.05.027; Cotter D, 2002, CEREB CORTEX, V12, P386, DOI 10.1093/cercor/12.4.386; Cryan JF, 2007, CURR OPIN PSYCHIATR, V20, P1, DOI 10.1097/YCO.0b013e3280117733; Czeh B, 2007, NEUROPSYCHOPHARMACOL, V32, P1490, DOI 10.1038/sj.npp.1301275; Ding XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097479; Drugan RC, 2013, NEUROSCIENCE, V253, P221, DOI 10.1016/j.neuroscience.2013.08.038; DUMUIS A, 1988, NATURE, V336, P68, DOI 10.1038/336068a0; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Evans DL, 2005, BIOL PSYCHIAT, V58, P175, DOI 10.1016/j.biopsych.2005.05.001; Fischer R, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013904; Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11; HEINZ A, 1994, PHARMACOPSYCHIATRY, V27, P7, DOI 10.1055/s-2007-1014317; JEFFERYS D, 1994, EUR J PHARMACOL, V253, P91, DOI 10.1016/0014-2999(94)90761-7; Kendler KS, 2005, ARCH GEN PSYCHIAT, V62, P529, DOI 10.1001/archpsyc.62.5.529; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Lapillonne A, 2002, J NUTR, V132, P2319, DOI 10.1093/jn/132.8.2319; Li J, 2014, MOL BIOSYST, V10, P2994, DOI 10.1039/c4mb00388h; Liu ML, 2014, MOL BIOSYST, V10, P2398, DOI 10.1039/c4mb00157e; Liu XY, 2015, J PROTEOME RES, V14, P2322, DOI 10.1021/acs.jproteome.5b00144; Martinez M, 1998, AGGRESSIVE BEHAV, V24, P241; McLaughlin RJ, 2014, NEUROSCI BIOBEHAV R, V42, P116, DOI 10.1016/j.neubiorev.2014.02.006; Meldrum B S, 1986, Adv Neurol, V43, P687; MELILLO G, 1994, J BIOL CHEM, V269, P8128; Modica-Napolitano JS, 2004, BIOL PSYCHIAT, V55, P273, DOI 10.1016/S0006-3223(03)00784-4; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Ota KT, 2014, NAT MED, V20, P535, DOI 10.1038/nm.3513; Oxenkrug G, 2005, ANN NY ACAD SCI, V1053, P334, DOI 10.1196/annals.1344.029; Patki G, 2013, BRAIN RES, V1539, P73, DOI 10.1016/j.brainres.2013.09.033; Pinter O, 2011, ENDOCR J, V58, P395, DOI 10.1507/endocrj.K10E-375; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Qi Y, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011072; Qu Y, 2003, NEUROPSYCHOPHARMACOL, V28, P244, DOI 10.1038/sj.npp.1300022; Rao JS, 2008, MOL PSYCHIATR, V13, P585, DOI 10.1038/mp.2008.31; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; Roiser JP, 2005, NEUROPSYCHOPHARMACOL, V30, P775, DOI 10.1038/sj.npp.1300659; Rygula R, 2005, BEHAV BRAIN RES, V162, P127, DOI 10.1016/j.bbr.2005.03.009; Sachser N, 1998, PSYCHONEUROENDOCRINO, V23, P891, DOI 10.1016/S0306-4530(98)00059-6; Shao WH, 2013, METABOLOMICS, V9, P433, DOI 10.1007/s11306-012-0460-2; Sheline YI, 2003, BIOL PSYCHIAT, V54, P338, DOI 10.1016/S0006-3223(03)00347-0; SIMMONS ML, 1991, NEUROSCIENCE, V45, P37, DOI 10.1016/0306-4522(91)90101-S; Smith KA, 1997, LANCET, V349, P915, DOI 10.1016/S0140-6736(96)07044-4; Suo L, 2013, NEUROPSYCHOPHARMACOL, V38, P1387, DOI 10.1038/npp.2013.67; Ustun TB, 1999, LANCET, V354, P111, DOI 10.1016/S0140-6736(98)07507-2; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Xu F, 2015, SCI REP-UK, V5, DOI 10.1038/srep09220; Xu XJ, 2014, MOL BIOSYST, V10, P813, DOI 10.1039/c3mb70614a; Zhang FX, 2010, MOL BIOSYST, V6, P852, DOI 10.1039/b914751a; Zhang ZJ, 2006, HUM MOL GENET, V15, P337, DOI 10.1093/hmg/ddi451; Zheng P, 2013, MOL CELL PROTEOMICS, V12, P207, DOI 10.1074/mcp.M112.021816; Zheng P, 2012, J PROTEOME RES, V11, P1741, DOI 10.1021/pr2010082	63	39	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176725	10.1371/journal.pone.0176725	http://dx.doi.org/10.1371/journal.pone.0176725			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453574	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383900049
J	Tkachuk, AP; Gushchin, VA; Potapov, VD; Demidenko, AV; Lunin, VG; Gintsburg, AL				Tkachuk, A. P.; Gushchin, V. A.; Potapov, V. D.; Demidenko, A. V.; Lunin, V. G.; Gintsburg, A. L.			Multi-subunit BCG booster vaccine GamTBvac: Assessment of immunogenicity and protective efficacy in murine and guinea pig TB models	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; TUBERCULOSIS VACCINE; PROSPECTS; RESPONSES; DURATION; FAILURE; PROTEIN	New innovative vaccines are highly needed to combat the global threat posed by tuberculosis. Efficient components-antigens and adjuvants-are crucial for development of modern recombinant TB vaccines. This study describes a new vaccine (GamTBvac) consisting of two mycobacterial antigen fusions (Ag85A and ESAT6-CFP10)-with dextran-binding domain immobilized on dextran and mixed with an adjuvant consisting of DEAE-dextran core, and with CpG oligodeoxynucleotides (TLR9 agonists). GamTBvac and its components were assessed for immunogenicity and protective efficacy in GamTBvac-prime/boost and BCG-prime/GamTBvac-boost in murine and guinea pig TB models. Results show that in both infectious models, GamTBvac has a strong immunogenicity and significant protective effect against Mycobacterium tuberculosis strain H37Rv under aerosol and intravenous challenges. GamTBvac showed a particularly strong protective effect as a BCG booster vaccine.	[Tkachuk, A. P.; Gushchin, V. A.] NF Gamaleya Fed Res Ctr Epidemiol & Microbiol, Translat Biomed Lab, Moscow, Russia; [Gushchin, V. A.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia; [Potapov, V. D.] State Res Ctr Appl Microbiol & Biotechnol, Obolensk, Russia; [Demidenko, A. V.; Lunin, V. G.] NF Gamaleya Fed Res Ctr Epidemiol & Microbiol, Lab Bioact Nanostructures, Moscow, Russia; [Gintsburg, A. L.] NF Gamaleya Fed Res Ctr Epidemiol & Microbiol, Moscow, Russia	Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS; Lomonosov Moscow State University; Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS; Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS	Gushchin, VA (corresponding author), NF Gamaleya Fed Res Ctr Epidemiol & Microbiol, Translat Biomed Lab, Moscow, Russia.; Gushchin, VA (corresponding author), Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia.	vladimir.a.gushchin@gamaleya.org	Gushchin, Vladimir A/F-7207-2017; Gushchin, Vladimir/AAW-8501-2021; Demidenko, Artem/AAE-5497-2021; Tkachuk, Artem/AAU-1208-2021	Gushchin, Vladimir A/0000-0002-9397-3762; Gushchin, Vladimir/0000-0002-9397-3762; Demidenko, Artem/0000-0002-3429-6933; Gintsburg, Alexander/0000-0003-1769-5059; Tkachuk, Artem/0000-0003-3262-4873	Ministry of Industry of the Russian Federation [11411.1008700.13.019, 11411.1008700.13.022]	Ministry of Industry of the Russian Federation	This study was supported by grants #11411.1008700.13.019 and #11411.1008700.13.022 awarded by the Ministry of Industry of the Russian Federation.; This study was supported by grants #11411.1008700.13.019 and #11411.1008700.13.022 awarded by the Ministry of Industry of the Russian Federation. We are grateful to Dr. A.M. Lyashchuk for construction of plasmids and Dr V.P. Gudov for synthesis of CpG oligonucleotides. We are equally thankful to A.V. Grishin and Dr E.V. Vasilieva for their thorough review, critical comments and editorial assistance. We are also grateful to Dr Anthony Nwohiri for English grammar check and spelling correction.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Abubakar I, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17370; Agger EM, 2006, VACCINE, V24, P5452, DOI 10.1016/j.vaccine.2006.03.072; Agger EM, 2015, ADV DRUG DELIV REV; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Andersen P, 2015, CURR OPIN IMMUNOL, V35, P55, DOI 10.1016/j.coi.2015.06.001; Aronson NE, 2004, JAMA-J AM MED ASSOC, V291, P2086, DOI 10.1001/jama.291.17.2086; Baldwin SL, 2012, J IMMUNOL, V188, P2189, DOI 10.4049/jimmunol.1102696; Beverley P, 2013, NATURE, V503, P469, DOI 10.1038/503469e; Billeskov R, 2012, PLOS ONE, P7; Carpenter C, 2015, TUBERCULOSIS, V95, P713, DOI 10.1016/j.tube.2015.07.001; Chen Y, 2014, 2014 27TH BIENNIAL SYMPOSIUM ON COMMUNICATIONS (QBSC), P10, DOI 10.1109/QBSC.2014.6841174; Cox JC, 1997, VACCINE, V15, P248, DOI 10.1016/S0264-410X(96)00183-1; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Ershova AS, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1884-5; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Frick B.M., 2016, TUBERCULOSIS PREVENT, P143; Frick M, 2015, HIV HCV TB PIPELINE; Geldenhuys H, 2015, VACCINE, V33, P3592, DOI 10.1016/j.vaccine.2015.05.036; Glaziou P, 2015, COLD SPRING HARB PER, P1; Hoft DF, 2016, EBIOMEDICINE, V7, P278, DOI 10.1016/j.ebiom.2016.04.010; Karp CL, 2015, IMMUNOL REV, V264, P363, DOI 10.1111/imr.12270; Knudsen NPH, 2016, DIFFERENT HUMAN VACC, P1; Li W, 2015, MOL MED REP, V12, P3073, DOI 10.3892/mmr.2015.3770; Mangtani P, 2014, CLIN INFECT DIS, V58, P470, DOI 10.1093/cid/cit790; Millington KA, 2011, P NATL ACAD SCI USA, V108, P5730, DOI 10.1073/pnas.1015153108; Mohamed W, 2016, BMC MICROBIOL, P1; Nguipdop-Djomo P, 2016, LANCET INFECT DIS, V16, P219, DOI 10.1016/S1473-3099(15)00400-4; Niu H, 2015, PLOS ONE, V10, P1; Olsen AW, 2001, INFECT IMMUN, V69, P2773, DOI 10.1128/IAI.69.5.2773-2778.2001; Pang Y., 2016, HUM VACC IMMUNOTHER, P1; Pustylnikov S, 2014, J PHARM PHARM SCI, V17, P371, DOI 10.18433/J3N590; Reither K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114602; Rodrigues LC, 2005, LANCET, V366, P1290, DOI 10.1016/S0140-6736(05)67145-0; Cordeiro AS, 2015, BIOTECHNOL ADV, V33, P1279, DOI 10.1016/j.biotechadv.2015.05.010; Skeiky YAW, 2010, VACCINE, V28, P1084, DOI 10.1016/j.vaccine.2009.10.114; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Tkachuk AB, 2014, JAIDS-J ACQ IMM DEF, V65, P43, DOI 10.1097/01.qai.0000446689.08492.a0; Tukhvatulin AI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155650; van Dissel JT, 2011, VACCINE, V29, P2100, DOI 10.1016/j.vaccine.2010.12.135; van Dissel JT, 2010, VACCINE, V28, P3571, DOI 10.1016/j.vaccine.2010.02.094; van Zyl-Smit RN, 2009, AM J RESP CRIT CARE, V180, P49, DOI 10.1164/rccm.200811-1704OC; Woodworth JS, 2016, MUCOSAL IMMUNOL; World Health Organization, 2016, GLOB TUB REP 2016, P214; Xin Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072745	45	23	25	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e176784	10.1371/journal.pone.0176784	http://dx.doi.org/10.1371/journal.pone.0176784			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453555	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383900056
J	Leblanc, C; Langlois, MJ; Coulombe, G; Vaillancourt-Lavigueur, V; Jones, C; Carrier, JC; Boudreau, F; Rivard, N				Leblanc, Caroline; Langlois, Marie-Josee; Coulombe, Genevieve; Vaillancourt-Lavigueur, Vanessa; Jones, Christine; Carrier, Julie C.; Boudreau, Francois; Rivard, Nathalie			Epithelial Src homology region 2 domain-containing phosphatase-1 restrains intestinal growth, secretory cell differentiation, and tumorigenesis	FASEB JOURNAL			English	Article						Shp-1; intestinal epithelial cells; PI3K; beta-catenin; secretory cell fate	PROTEIN-TYROSINE-PHOSPHATASE; BETA-CATENIN; MOTH-EATEN; STEM-CELLS; WNT/BETA-CATENIN; GENE-EXPRESSION; T-CELLS; SHP-1; RECEPTOR; PANETH	Shp-1 (Src homology region 2 domain-containing protein tyrosine phosphatase-1) is a phosphatase that is highly expressed in hematopoietic and epithelial cells. Whereas its function is largely characterized in hematopoietic cells, its role in epithelial cells, such as intestinal epithelial cells (IECs), is not well known. Here, we generated mice with an IEC-specific knockout of Shp-1 (Srchomology region 2 domain-containing phosphatase-1; Shp-1(IEC-KO)). We showed that the loss of epithelial Shp-1 leads to an intestinalomegaly that is associated with an increase in epithelial cell proliferation and size. Histologic analysis demonstrates significant perturbation of the crypt-villus architecture with an apparent increase in the number of goblet and Paneth cells and increased expression of their respective markers {Muc2 (mucin 2), alpha Def, and Sox9 [SRY (sex determining region Y)-box 9]}. Expansion of intermediate cells-common progenitors of goblet and Paneth cell lineages-is also observed in Shp-1(IEC-KO) mice. Although sustained activation of Wnt/beta-catenin and PI3K/Akt/mammalian target of rapamycin signaling is observed, Shp-1(IEC-KO) mice fail to develop any intestinal tumors after 15 mo; however, the loss of Shp-1 in IECs markedly enhances tumor load Apc(Min/+) mice. These findings show a novel role for Shp-1 in the regulation of IEC growth and secretory lineage allocation, possibly via modulation of PI3K/Akt-dependent signaling pathways. Finally, Shp-1 does not function as a classic tumor suppressor gene in the intestinal epithelium.	[Leblanc, Caroline; Langlois, Marie-Josee; Coulombe, Genevieve; Vaillancourt-Lavigueur, Vanessa; Jones, Christine; Carrier, Julie C.; Boudreau, Francois; Rivard, Nathalie] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Anat & Biol Cellulaire, Canc Res Pavil,3201 Jean Mignault, Sherbrooke, PQ J1E 4K8, Canada	University of Sherbrooke	Rivard, N (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Dept Anat & Biol Cellulaire, Canc Res Pavil,3201 Jean Mignault, Sherbrooke, PQ J1E 4K8, Canada.	nathalie.rivard@usherbrooke.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research; Fonds de la Recherche en Sante du Quebec; Canadian Research Chair in colorectal cancer and inflammatory cell signaling	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Research Chair in colorectal cancer and inflammatory cell signaling	This work was supported by a grant from Natural Sciences and Engineering Research Council of Canada (NSERC; to N.R.). The biobank of colorectal cancer specimens was supported by a team grant on digestive epithelium from the Canadian Institutes of Health Research. C.L. is a NSERC Alexander Graham Bell student scholar. N.R., J.C.C., and F.B. are members of the Fonds de la Recherche en Sante du Quebec-funded Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke. N.R. is a recipient of a Canadian Research Chair in colorectal cancer and inflammatory cell signaling. The authors thank Gerald Bernatchez (Universite de Sherbrooke) for technical assistance. The authors thank the RNomics and Electron Microscopy and Histology Platforms of the Faculte de Medecine et des Sciences de la Sante at the Universite de Sherbrooke for their services. The authors declare no conflicts of interest.	Abram CL, 2013, IMMUNITY, V38, P489, DOI 10.1016/j.immuni.2013.02.018; Andreu P, 2005, DEVELOPMENT, V132, P1443, DOI 10.1242/dev.01700; Andreu P, 2008, DEV BIOL, V324, P288, DOI 10.1016/j.ydbio.2008.09.027; Bergeron S, 2011, ENDOCRINOLOGY, V152, P4581, DOI 10.1210/en.2011-1268; Bian B, 2016, MOL CARCINOGEN, V55, P671, DOI 10.1002/mc.22312; Boudreau F, 2007, FASEB J, V21, P3853, DOI 10.1096/fj.07-8113com; Brockdorff J, 1999, EUR J IMMUNOL, V29, P2539, DOI 10.1002/(SICI)1521-4141(199908)29:08<2539::AID-IMMU2539>3.0.CO;2-M; Bruecher-Encke B, 2001, LEUKEMIA, V15, P1424, DOI 10.1038/sj.leu.2402214; CALVERT R, 1988, ANAT REC, V220, P291, DOI 10.1002/ar.1092200310; CAMPBELL MA, 1995, EUR J IMMUNOL, V25, P1573, DOI 10.1002/eji.1830250616; Chen HE, 1996, MOL CELL BIOL, V16, P3685, DOI 10.1128/mcb.16.7.3685; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Cuevas B, 1999, J BIOL CHEM, V274, P27583, DOI 10.1074/jbc.274.39.27583; Diez-Villanueva A, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0014-8; Dubois MJ, 2006, NAT MED, V12, P549, DOI 10.1038/nm1397; Duchesne C, 2003, J BIOL CHEM, V278, P14274, DOI 10.1074/jbc.M300425200; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Gao N, 2010, GENE DEV, V24, P1295, DOI 10.1101/gad.1921510; Garneau H, 2009, J CELL PHYSIOL, V221, P350, DOI 10.1002/jcp.21859; Gonneaud A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38195; Goodman CA, 2014, REV PHYSIOL BIOCH P, V166, P43, DOI 10.1007/112_2013_17; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; GREEN MC, 1975, J HERED, V66, P250, DOI 10.1093/oxfordjournals.jhered.a108625; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Jiao HY, 1997, EXP HEMATOL, V25, P592; Jiao HY, 1996, MOL CELL BIOL, V16, P6985; Kamal M, 2001, CLIN EXP IMMUNOL, V126, P117, DOI 10.1046/j.1365-2249.2001.01589.x; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kenerson HL, 2013, GASTROENTEROLOGY, V144, P1055, DOI 10.1053/j.gastro.2013.01.053; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kozlowski M, 1998, MOL CELL BIOL, V18, P2089, DOI 10.1128/MCB.18.4.2089; Krausova M, 2014, CELL SIGNAL, V26, P570, DOI 10.1016/j.cellsig.2013.11.032; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Langlois MJ, 2009, FASEB J, V23, P1835, DOI 10.1096/fj.08-123125; Li YH, 2014, ONCOL REP, V31, P2438, DOI 10.3892/or.2014.3098; Liu B, 2013, AM J PHYSIOL-GASTR L, V305, pG573, DOI 10.1152/ajpgi.00071.2013; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Ma XZ, 2003, EXP HEMATOL, V31, P131, DOI 10.1016/S0301-472X(02)01025-1; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mizuno K, 2005, EUR J IMMUNOL, V35, P644, DOI 10.1002/eji.200425465; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Noah TK, 2010, EXP CELL RES, V316, P452, DOI 10.1016/j.yexcr.2009.09.020; Oka T, 2001, AM J PATHOL, V159, P1495, DOI 10.1016/S0002-9440(10)62535-7; Onuma K, 2013, P NATL ACAD SCI USA, V110, P11127, DOI 10.1073/pnas.1221926110; Pao LI, 2007, IMMUNITY, V27, P35, DOI 10.1016/j.immuni.2007.04.016; Perreault N, 2005, GENE DEV, V19, P311, DOI 10.1101/gad.1260605; PLUTZKY J, 1992, P NATL ACAD SCI USA, V89, P1123, DOI 10.1073/pnas.89.3.1123; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sato H, 2010, AM J PATHOL, V176, P402, DOI 10.2353/ajpath.2010.090236; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Siminovitch KA, 1999, CURR TOP MICROBIOL, V246, P291; Simoneau M, 2011, CELL SIGNAL, V23, P269, DOI 10.1016/j.cellsig.2010.09.011; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Suzuki A, 2003, CANCER RES, V63, P674; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Wang SY, 2004, J HISTOCHEM CYTOCHEM, V52, P53, DOI 10.1177/002215540405200106; Winterford CM, 1999, J HISTOCHEM CYTOCHEM, V47, P1063, DOI 10.1177/002215549904700811; Wu CY, 2003, GENE, V306, P1, DOI 10.1016/S0378-1119(03)00400-1; Wu YF, 2015, ONCOTARGETS THER, V8, P2577, DOI 10.2147/OTT.S82225; Yu ZB, 1998, J BIOL CHEM, V273, P3687, DOI 10.1074/jbc.273.6.3687; Zatelli MC, 2005, ENDOCRINOLOGY, V146, P2692, DOI 10.1210/en.2005-0001	72	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3512	3526		10.1096/fj.201601378R	http://dx.doi.org/10.1096/fj.201601378R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28465325				2022-12-26	WOS:000405932400027
J	Zhang, YX; Bharathi, SS; Rardin, MJ; Lu, J; Maringer, KV; Sims-Lucas, S; Prochownik, EV; Gibson, BW; Goetzman, ES				Zhang, Yuxun; Bharathi, Sivakama S.; Rardin, Matthew J.; Lu, Jie; Maringer, Katherine V.; Sims-Lucas, Sunder; Prochownik, Edward V.; Gibson, Bradford W.; Goetzman, Eric S.			Lysine desuccinylase SIRT5 binds to cardiolipin and regulates the electron transport chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL; SUCCINYLATION; IDENTIFICATION; DEHYDROGENASE; ACETYLATION; OXIDATION; PATHWAY	SIRT5 is a lysine desuccinylase known to regulate mitochondrial fatty acid oxidation and the urea cycle. Here, SIRT5 was observed to bind to cardiolipin via an amphipathic helix on itsN terminus. In vitro, succinyl-CoA was used to succinylate liver mitochondrial membrane proteins. SIRT5 largely reversed the succinyl-CoA-driven lysine succinylation. Quantitative mass spectrometry of SIRT5-treated membrane proteins pointed to the electron transport chain, particularly Complex I, as being highly targeted for desuccinylation by SIRT5. Correspondingly, SIRT5(-/)-HEK293 cells showed defects in both Complex I-and Complex II-driven respiration. In mouse liver, SIRT5 expression was observed to localize strictly to the periportal hepatocytes. However, homogenates prepared from whole SIRT5(-/)-liver did show reduced Complex II-driven respiration. The enzymatic activities of Complex II and ATP synthase were also significantly reduced. Three-dimensional modeling of Complex II suggested that several SIRT5-targeted lysine residues lie at the protein-lipid interface of succinate dehydrogenase subunit B. We postulate that succinylation at these sites may disrupt Complex II subunit-subunit interactions and electron transfer. Lastly, SIRT5(-/)-mice, like humans with Complex II deficiency, were found to have mild lactic acidosis. Our findings suggest that SIRT5 is targeted to protein complexes on the inner mitochondrial membrane via affinity for cardiolipin to promote respiratory chain function.	[Zhang, Yuxun; Bharathi, Sivakama S.; Lu, Jie; Maringer, Katherine V.; Sims-Lucas, Sunder; Prochownik, Edward V.; Goetzman, Eric S.] Univ Pittsburgh, Med Ctr, Dept Pediat, Sch Med,Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA; [Rardin, Matthew J.; Gibson, Bradford W.] Buck Inst Res Aging, Novato, CA 94945 USA; [Rardin, Matthew J.; Gibson, Bradford W.] Amgen Inc, Discovery Attribute Sci Prote & Prot Characteriza, San Francisco, CA 94080 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Buck Institute for Research on Aging; Amgen	Goetzman, ES (corresponding author), Univ Pittsburgh, Med Ctr, Dept Pediat, Sch Med,Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA.	eric.goetzman@chp.edu			National Institutes of Health [DK090242, CA174713, DK096996, DK111165]; NATIONAL CANCER INSTITUTE [R01CA174713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK096996, R01DK090242, F32DK111165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK090242 (to E. S. G.), CA174713 (to E. V. P.), DK096996 (to S. S.-L.), and DK111165 (to K. V. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baeza J, 2015, ACS CHEM BIOL, V10, P122, DOI 10.1021/cb500848p; Bharathi SS, 2013, J BIOL CHEM, V288, P33837, DOI 10.1074/jbc.M113.510354; Dudek J, 2016, EMBO MOL MED, V8, P139, DOI 10.15252/emmm.201505644; Edmunds LR, 2016, ONCOTARGET, V7, P30379, DOI 10.18632/oncotarget.8856; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Fould B, 2010, BIOCHEMISTRY-US, V49, P8608, DOI 10.1021/bi100742w; Friedman JR, 2015, ELIFE, V4, DOI 10.7554/eLife.07739; Huang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128561; Kashfi K, 2011, BIOCHEM SOC T, V39, P833, DOI 10.1042/BST0390833; Li F, 2015, MOL CELL, V60, P661, DOI 10.1016/j.molcel.2015.10.017; Marom M, 2011, J BIOL CHEM, V286, P43809, DOI 10.1074/jbc.M111.261040; Matsushita N, 2011, GENES CELLS, V16, P190, DOI 10.1111/j.1365-2443.2010.01475.x; Mileykovskaya E, 2014, CHEM PHYS LIPIDS, V179, P42, DOI 10.1016/j.chemphyslip.2013.10.012; Munnik Teun, 2013, Methods Mol Biol, V1009, P253, DOI 10.1007/978-1-62703-401-2_23; Nadanaciva S, 2007, TOXICOL IN VITRO, V21, P902, DOI 10.1016/j.tiv.2007.01.011; Park J, 2013, MOL CELL, V50, P919, DOI 10.1016/j.molcel.2013.06.001; Poirier Y, 2006, BBA-MOL CELL RES, V1763, P1413, DOI 10.1016/j.bbamcr.2006.08.034; Rardin MJ, 2013, CELL METAB, V18, P920, DOI 10.1016/j.cmet.2013.11.013; Rustin P, 1997, BBA-MOL BASIS DIS, V1361, P185, DOI 10.1016/S0925-4439(97)00035-5; Sadhukhan S, 2016, P NATL ACAD SCI USA, V113, P4320, DOI 10.1073/pnas.1519858113; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; Schwall CT, 2012, BBA-BIOENERGETICS, V1817, P1588, DOI 10.1016/j.bbabio.2012.04.015; Uppala R, 2017, BIOCHEM BIOPH RES CO, V482, P346, DOI 10.1016/j.bbrc.2016.11.066; Vergeade A, 2016, MITOCHONDRION, V28, P88, DOI 10.1016/j.mito.2016.04.002; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Wang YD, 2010, J BIOL CHEM, V285, P29834, DOI 10.1074/jbc.M110.139493; Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024; West DB, 2015, GENOME RES, V25, P598, DOI 10.1101/gr.184184.114; Westin MAK, 2005, J BIOL CHEM, V280, P38125, DOI 10.1074/jbc.M508479200; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Yuan XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep20005; Zhang YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122297; Zhou LS, 2016, EMBO REP, V17, P811, DOI 10.15252/embr.201541643	33	62	61	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10239	10249		10.1074/jbc.M117.785022	http://dx.doi.org/10.1074/jbc.M117.785022			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28458255	hybrid, Green Published			2022-12-26	WOS:000403580600032
J	Wasitthankasem, R; Vichaiwattana, P; Siripon, N; Posuwan, N; Auphimai, C; Klinfueng, S; Thaneskongtong, N; Vuthitanachot, V; Saiyatha, S; Thongmai, C; Suwanpatoomlerd, S; Sochoo, S; Pongsuwan, N; Poovorawan, K; Tangkijvanich, P; Vongpunsawad, S; Poovorawan, Y				Wasitthankasem, Rujipat; Vichaiwattana, Preeyaporn; Siripon, Nipaporn; Posuwan, Nawarat; Auphimai, Chompoonut; Klinfueng, Sirapa; Thaneskongtong, Napha; Vuthitanachot, Viboonsak; Saiyatha, Supapith; Thongmai, Chaiwat; Suwanpatoomlerd, Sarawut; Sochoo, Saowakon; Pongsuwan, Natnada; Poovorawan, Kittiyod; Tangkijvanich, Pisit; Vongpunsawad, Sompong; Poovorawan, Yong			Assessment of hepatitis C virus infection in two adjacent Thai provinces with drastically different seroprevalence	PLOS ONE			English	Article							RISK-FACTORS; BLOOD-DONORS; NORTHERN THAILAND; HCV INFECTION; UNITED-STATES; PREVALENCE; CLASSIFICATION; EPIDEMIOLOGY; DIVERSITY; GENOTYPES	Improved awareness of the hepatitis C virus (HCV) transmission has contributed to the overall decline in the HCV infection rate in some developing countries including Thailand. Chronic HCV infection in some rural Thai communities, however, presents a challenge in the efforts to treat and manage HCV-related diseases. Published and unpublished studies have suggested an unusually high incidence of HCV infection in a Thai province of Phetchabun compared to elsewhere in Thailand. To determine the magnitude of HCV infection and identify potential factors contributing to the higher rate of HCV infection in this province, we performed a population-based study in Phetchabun (n = 1667) and the neighboring Khon Kaen province (n = 1410) where HCV prevalence is much lower. Individuals between 30 and 64 years old completed detailed questionnaires designed to identify HCV risk factors and provided blood samples for anti-HCV antibody screening. The anti-HCV seropositive rates were 15.5% (259/1667) in Phetchabun and 3.6% (51/1410) in Khon Kaen. Positive samples were subsequently genotyped for HCV core gene sequence and assessed for the hepatitis B virus surface antigen (HBsAg) and human immunodeficiency virus antigen/antibody (HIV Ag/Ab). More individuals in Phetchabun possessed the combined presence of HBsAg (5.0%) and HIV Ag/Ab (0.4%) than those in Khon Kaen (3.9% HBsAg and 0.0% HIV Ag/Ab). While male gender, intravenous drug use (IVDU) and tattoos were significant HCV risk factors in both provinces (p < 0.05), education less than high school and agriculturerelated occupation were additionally associated with HCV in Phetchabun. HCV genotypes 6, 3, and 1 were identified in similar frequency in both provinces. We estimated that prevalence of HCV seropositivity and viremic carriers were higher in Phetchabun (143 and 111 per 1000) than in Khon Kaen (34 and 22 per 1000). Finally, we derived a simple risk factorbased scoring system as a useful preclinical tool to screen individuals at risk of chronic HCV infection prior to intervention. Knowledge gained from this study will assist in HCV screening and promote access to anti-viral treatment in high-risk groups.	[Wasitthankasem, Rujipat; Vichaiwattana, Preeyaporn; Siripon, Nipaporn; Posuwan, Nawarat; Auphimai, Chompoonut; Klinfueng, Sirapa; Vongpunsawad, Sompong; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok, Thailand; [Thaneskongtong, Napha; Vuthitanachot, Viboonsak] Chumpae Hosp, Khon Kaen, Thailand; [Saiyatha, Supapith; Thongmai, Chaiwat] Phetchabun Prov Publ Hlth Off, Phetchabun, Thailand; [Suwanpatoomlerd, Sarawut; Sochoo, Saowakon; Pongsuwan, Natnada] Lomkao Crown Prince Hosp, Lom Kao, Phetchabun, Thailand; [Poovorawan, Kittiyod] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand; [Tangkijvanich, Pisit] Chulalongkorn Univ, Fac Med, Dept Biochem, Res Unit Hepatitis & Liver Canc, Bangkok, Thailand	Chulalongkorn University; Mahidol University; Chulalongkorn University	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok, Thailand.	yong.p@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	vongpunsawad, sompong/0000-0001-7520-8728; Poovorawan, Kittiyod/0000-0001-7016-7605	National Research Council of Thailand (NRCT); National Research University Project, Office of Higher Education Commission [NRU-59-002-HR]; Research Chair Grant from the National Science and Technology Development Agency, Chulalongkorn University Centenary Academic Development Project [CU56-HR01]; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University [RES560530093]; Outstanding Professor of Thailand Research Fund [DPG5480002]; Ratchadaphiseksomphot Endowment Fund for Postdoctoral Fellowship; Center of Excellence in Clinical Virology, Chulalongkorn University [GCE58- 014-30-004]; King Chulalongkorn Memorial Hospital	National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT)); National Research University Project, Office of Higher Education Commission; Research Chair Grant from the National Science and Technology Development Agency, Chulalongkorn University Centenary Academic Development Project; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University(Chulalongkorn University); Outstanding Professor of Thailand Research Fund; Ratchadaphiseksomphot Endowment Fund for Postdoctoral Fellowship; Center of Excellence in Clinical Virology, Chulalongkorn University(Chulalongkorn University); King Chulalongkorn Memorial Hospital(Chulalongkorn University)	This work was supported by the National Research Council of Thailand (NRCT), the National Research University Project, Office of Higher Education Commission (NRU-59-002-HR), the Research Chair Grant from the National Science and Technology Development Agency, Chulalongkorn University Centenary Academic Development Project (CU56-HR01), Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (RES560530093) the Outstanding Professor of Thailand Research Fund (DPG5480002), Ratchadaphiseksomphot Endowment Fund for Postdoctoral Fellowship to Rujipat Wasitthankasem, the Center of Excellence in Clinical Virology, Chulalongkorn University (GCE58- 014-30-004) and King Chulalongkorn Memorial Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkarathamrongsin S, 2010, J MED VIROL, V82, P257; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Buathong R, 2013, WEEKLY EPIDEMIOLOGIC, V44, pS47; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Engle RE, 2014, TRANSFUSION, V54, P2833, DOI 10.1111/trf.12682; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Ishida T, 2002, J CLIN VIROL, V24, P31, DOI 10.1016/S1386-6532(01)00222-0; Jaeckel E, 2001, NEW ENGL J MED, V345, P1452, DOI 10.1056/NEJMoa011232; Jatapai A, 2010, AM J TROP MED HYG, V83, P433, DOI 10.4269/ajtmh.2010.09-0749; Lu L, 2007, J GEN VIROL, V88, P1505, DOI 10.1099/vir.0.82604-0; Luksamijarulkul Pipat, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P147; Luksamijarulkul Pipat, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P272; Meffre C, 2010, J MED VIROL, V82, P546, DOI 10.1002/jmv.21734; MELLOR J, 1995, J GEN VIROL, V76, P2493, DOI 10.1099/0022-1317-76-10-2493; Morisco F, 2017, J MED VIROL, V89, P291, DOI 10.1002/jmv.24635; Omland Lars Haukali, 2013, Clin Epidemiol, V5, P163, DOI 10.2147/CLEP.S43926; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Poovorawan K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163095; Posuwan N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150499; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Rangsin R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136555; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Songsivilai S, 1997, AM J TROP MED HYG, V57, P66, DOI 10.4269/ajtmh.1997.57.66; Sunanchaikarn S, 2007, ASIAN PAC J ALLERGY, V25, P175; Tanwandee Tawesak, 2006, J Med Assoc Thai, V89 Suppl 5, pS79; Thaikruea L, 2004, TRANSFUSION, V44, P1433, DOI 10.1111/j.1537-2995.2004.04073.x; Verachai Viroj, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P849; Wasitthankasem R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152451; Wasitthankasem R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126764; WHO, 2016, HEP C	33	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177022	10.1371/journal.pone.0177022	http://dx.doi.org/10.1371/journal.pone.0177022			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475637	gold, Green Submitted, Green Published			2022-12-26	WOS:000400649500036
J	Couch, CE; Movius, MA; Jolles, AE; Gorman, ME; Rigas, JD; Beechler, BR				Couch, Claire E.; Movius, Morgan A.; Jolles, Anna E.; Gorman, M. Elena; Rigas, Johanna D.; Beechler, Brianna R.			Serum biochemistry panels in African buffalo: Defining reference intervals and assessing variability across season, age and sex	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; DEER DAMA-DAMA; CHEMISTRY VALUES; BLOOD PARAMETERS; SYNCERUS-CAFFER; HEMATOLOGY; CATTLE; COINFECTIONS; ASSOCIATIONS; SPECIFICITY	Serum biochemical parameters can be utilized to evaluate the physiological status of an animal, and relate it to the animal's health. In order to accurately interpret individual animal biochemical results, species-specific reference intervals (RI) must be established. Reference intervals for biochemical parameters differ between species, and physiological differences including reproductive status, nutritional resource availability, disease status, and age affect parameters within the same species. The objectives of this study were to (1) establish RI for biochemical parameters in managed African buffalo (Syncerus caffer), (2) assess the effects of age, sex, pregnancy, and season on serum biochemistry values, and (3) compare serum biochemistry values from a managed herd to a free-ranging buffalo herd and to values previously published for captive (zoo) buffalo. Season profoundly affected all biochemistry parameters, possibly due to changes in nutrition and disease exposure. Age also affected all biochemical parameters except gamma glutamyl transferase and magnesium, consistent with patterns seen in cattle. Sex and reproductive status had no detectable effects on the parameters that were measured. The biochemical profiles of managed buffalo were distinct from those observed in the free-ranging herd and captive buffalo. Biochemical differences between buffalo from captive, managed, and free-ranging populations may be related to nutritional restriction or lack of predation in the context of management or captivity. The reference intervals provided in this study, in addition to the seasonal and age-related patterns observed, provide a foundation for health investigations that may inform management strategies in this ecologically and economically important species.	[Couch, Claire E.; Jolles, Anna E.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR USA; [Movius, Morgan A.; Jolles, Anna E.; Gorman, M. Elena; Beechler, Brianna R.] Oregon State Univ, Coll Vet Med, Corvallis, OR 97331 USA; [Rigas, Johanna D.] Utah State Univ, Sch Vet Med, Logan, UT 84322 USA	Oregon State University; Oregon State University; Utah System of Higher Education; Utah State University	Beechler, BR (corresponding author), Oregon State Univ, Coll Vet Med, Corvallis, OR 97331 USA.	brianna.beechler@oregonstate.edu	Beechler, Brianna R/H-7972-2019	Beechler, Brianna R/0000-0002-9711-4340; Jolles, Anna/0000-0003-3074-9912	USDA-NIFA AFRI [2013-67015-21291]; UK Biotechnology and Biological Sciences Research Council [BB/L011085/1]; BBSRC [BB/L011085/1] Funding Source: UKRI	USDA-NIFA AFRI(United States Department of Agriculture (USDA)); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	All data collection was funded by USDA-NIFA AFRI grant # 2013-67015-21291and by the UK Biotechnology and Biological Sciences Research Council grant # BB/L011085/1 as part of the joint USDA-NSF-NIH-BBSRC Ecology and Evolution of Infectious Diseases program. Coauthor Morgan Movius had travel and a stipend for fieldwork provided by the Oregon State University College of Veterinary Medicine Summer Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Alberghina D, 2011, J VET DIAGN INVEST, V23, P111, DOI 10.1177/104063871102300119; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; [Anonymous], 2009, AB VETSCAN OP MAN; [Anonymous], 2001, VETSCAN LARG AN PROF; Barton K., 2016, MUMIN MULTIMODEL INF; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beechler BR, 2015, TRANSBOUND EMERG DIS, V62, P24, DOI 10.1111/tbed.12197; Beechler BR, 2009, J WILDLIFE DIS, V45, P57, DOI 10.7589/0090-3558-45.1.57; Beechler BR, 2012, PHYSIOL BIOCHEM ZOOL, V85, P255, DOI 10.1086/665276; Borjesson DL, 2009, J WILDLIFE DIS, V36, P294; BRAUN JP, 1995, REV MED VET-TOULOUSE, V146, P615; Broughton H, J ZOO WILDL IN PRESS; Budischak SA, 2015, MOL ECOL RESOUR, V15, P1112, DOI 10.1111/1755-0998.12382; BUSH M, 1981, J WILDLIFE DIS, V17, P135, DOI 10.7589/0090-3558-17.1.135; Casas-Diaz E, 2008, J WILDLIFE DIS, V44, P965, DOI 10.7589/0090-3558-44.4.965; Constable P, 1998, J ZOO WILDLIFE MED, V29, P435; Cozzi G, 2011, J DAIRY SCI, V94, P3895, DOI 10.3168/jds.2010-3687; Cross PC, 2009, J APPL ECOL, V46, P467, DOI 10.1111/j.1365-2664.2008.01589.x; Cross PC, 2005, ANIM BEHAV, V69, P499, DOI 10.1016/j.anbehav.2004.08.006; Dayger CA, 2013, HORM BEHAV, V64, P748, DOI 10.1016/j.yhbeh.2013.09.003; DOORNENBAL H, 1988, CAN J VET RES, V52, P99; ENGLISH AW, 1981, J WILDLIFE DIS, V17, P289, DOI 10.7589/0090-3558-17.2.289; Ezenwa VO, 2015, SCIENCE, V347, P175, DOI 10.1126/science.1261714; Ezenwa VO, 2009, AFR J ECOL, V47, P476, DOI 10.1111/j.1365-2028.2008.00960.x; Geffre A, 2011, VET CLIN PATH, V40, P107, DOI 10.1111/j.1939-165X.2011.00287.x; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Gorsich EE, 2015, J WILDLIFE DIS, V51, P9, DOI 10.7589/2013-12-334; Gorsich Erin E., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P124, DOI 10.1016/j.ijppaw.2014.05.003; Gurgoze SY, 2010, J EQUINE VET SCI, V30, P569, DOI 10.1016/j.jevs.2010.09.006; Henrichs B., 2014, THESIS; Henrichs B, 2016, J ANIM ECOL, V85, P1025, DOI 10.1111/1365-2656.12535; Horn PS, 1998, CLIN CHEM, V44, P622; Hoste H, 2005, SMALL RUMINANT RES, V60, P141, DOI 10.1016/j.smallrumres.2005.06.008; Huber D, 1997, J WILDLIFE DIS, V33, P790, DOI 10.7589/0090-3558-33.4.790; Husakova T, 2014, ANIMAL, V8, P1448, DOI 10.1017/S1751731114001256; Jolles AE, 2015, PARASITE IMMUNOL, V37, P255, DOI 10.1111/pim.12153; Kale VP, 2012, J AM ASSOC LAB ANIM, V51, P475; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Le Boedec K, 2016, VET CLIN PATH, V45, P648, DOI 10.1111/vcp.12390; LINCOLN SD, 1990, J AM VET MED ASSOC, V197, P1471; LOCHMILLER R L, 1984, Journal of Wildlife Diseases, V20, P134; Maceda-Veiga A, 2015, SCI TOTAL ENVIRON, V514, P322, DOI 10.1016/j.scitotenv.2015.02.004; MARLER R J, 1975, Journal of Wildlife Diseases, V11, P97; Michel AL, 2012, ONDERSTEPOORT J VET, V79, DOI 10.4102/ojvr.v79i2.453; Miller L D, 1989, J Vet Diagn Invest, V1, P219; Miller M, 2010, J ZOO WILDLIFE MED, V41, P404, DOI 10.1638/2009-0001.1; Moen R, 2010, J WILDLIFE DIS, V46, P13, DOI 10.7589/0090-3558-46.1.13; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Perez JM, 2015, J WILDLIFE DIS, V51, P148, DOI 10.7589/2014-01-008; Poljicak-Milas N, 2004, EUR J WILDLIFE RES, V50, P7, DOI 10.1007/s10344-003-0003-2; RODGERS JD, 1983, EXP GERONTOL, V18, P39, DOI 10.1016/0531-5565(83)90049-9; Ryan S. J., 2005, Koedoe, V48, P117; Ryan SJ, 2006, J WILDLIFE MANAGE, V70, P764, DOI 10.2193/0022-541X(2006)70[764:RAHSOA]2.0.CO;2; Ryan SJ, 2012, J WILDLIFE MANAGE, V76, P1499, DOI 10.1002/jwmg.407; Schmidt DA, 2011, J ZOO WILDLIFE MED, V42, P33, DOI 10.1638/2009-0218.1; Sinclair A.R.E., 1977, AFRICAN BUFFALO STUD; South African National Parks, 2006, AV MONTHL SEAS TEMP; Spaan RS., 2016, THESIS; Spears JW, 2000, P NUTR SOC, V59, P587, DOI 10.1017/S0029665100000835; Stockham SL., 2008, FUNDAMENTALS CLIN PA, V2; Sullivan K, 2010, ZOO BIOL, V29, P457, DOI 10.1002/zoo.20278; TSUCHIYA N, 1995, EXP ANIM TOKYO, V43, P671; Tukey JW, 1977, EXPLORATORY DATA ANA; VAHALA J, 1993, COMP BIOCHEM PHYS B, V106, P47, DOI 10.1016/0305-0491(93)90005-P; Van Hooft P, 2001, THESIS; Yokus B, 2006, BIOL TRACE ELEM RES, V109, P255, DOI 10.1385/BTER:109:3:255	67	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176830	10.1371/journal.pone.0176830	http://dx.doi.org/10.1371/journal.pone.0176830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472180	gold, Green Published, Green Submitted			2022-12-26	WOS:000400648500079
J	Goda, H; Yamaoka, H; Nakayama-Imaohji, H; Kawata, H; Horiuchi, I; Fujita, Y; Nagao, T; Tada, A; Terada, A; Kuwahara, T				Goda, Hisataka; Yamaoka, Hitoshi; Nakayama-Imaohji, Haruyuki; Kawata, Hiroyuki; Horiuchi, Isanori; Fujita, Yatsuka; Nagao, Tamiko; Tada, Ayano; Terada, Atsushi; Kuwahara, Tomomi			Microbicidal effects of weakly acidified chlorous acid water against feline calicivirus and Clostridium difficile spores under protein-rich conditions	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; NOSOCOMIAL PATHOGENS; CHLORINE DIOXIDE; SODIUM-CHLORITE; CONTAMINATION; SURFACES; NOROVIRUS; DISINFECTION; GLUTATHIONE; SANITIZERS	Sanitation of environmental surfaces with chlorine based-disinfectants is a principal measure to control outbreaks of norovirus or Clostridium difficile. The microbicidal activity of chlorine-based disinfectants depends on the free available chlorine (FAC), but their oxidative potential is rapidly eliminated by organic matter. In this study, the microbicidal activities of weakly acidified chlorous acid water (WACAW) and sodium hypochlorite solution (NaClO) against feline calcivirus (FCV) and C. difficile spores were compared in protein-rich conditions. WACAW inactivated FCV and C. difficile spores better than NaClO under all experimental conditions used in this study. WACAW above 100 ppm FAC decreased FCV >4 log(10) within 30 sec in the presence of 0.5% each of bovine serum albumin (BSA), polypeptone or meat extract. Even in the presence of 5% BSA, WACAW at 600 ppm FAC reduced FCV >4 log(10) within 30 sec. Polypeptone inhibited the virucidal activity of WACAW against FCV more so than BSA or meat extract. WACAW at 200 ppm FAC decreased C. difficile spores >3 log(10) within 1 min in the presence of 0.5% polypeptone. The microbicidal activity of NaClO was extensively diminished in the presence of organic matter. WACAW recovered its FAC to the initial level after partial neutralization by sodium thiosulfate, while no restoration of the FAC was observed in NaClO. These results indicate that WACAW is relatively stable under organic matter-rich conditions and therefore may be useful for treating environmental surfaces contaminated by human excretions.	[Goda, Hisataka; Yamaoka, Hitoshi; Kawata, Hiroyuki; Horiuchi, Isanori; Fujita, Yatsuka] Honbu Sankei Co Ltd, Chuou Ku, 2-2-53 Shiromi, Osaka, Japan; [Yamaoka, Hitoshi; Nakayama-Imaohji, Haruyuki; Tada, Ayano; Kuwahara, Tomomi] Kagawa Univ, Fac Med, Dept Microbiol, 1750-1 Miki, Kagawa, Japan; [Nagao, Tamiko] Shikoku Univ, Fac Nursing, Ojin Cho, Furukawa, Tokushima, Japan; [Terada, Atsushi] Nihon Univ, Dept Vet Med, Fujisawa, Kanagawa, Japan	Kagawa University; Nihon University	Kuwahara, T (corresponding author), Kagawa Univ, Fac Med, Dept Microbiol, 1750-1 Miki, Kagawa, Japan.	tomomi@med.kagawa-u.ac.jp			Kagawa University; Honbu Sankei Co. Ltd.	Kagawa University; Honbu Sankei Co. Ltd.	This study was supported by the collaboration research fund between Kagawa University and Honbu Sankei Co. Ltd. The study design, data collection and analysis, decision to publish or preparation of the manuscript was done under discussion between Kagawa University and Honbu Sankei Co. Ltd.	[Anonymous], 1998, ENCY ENV ANAL REMEDI; Barker J, 2004, J HOSP INFECT, V58, P42, DOI 10.1016/j.jhin.2004.04.021; Boyce JM, 2002, AM J INFECT CONTROL, V30, pS1, DOI 10.1067/mic.2002.130391; BUTTERFIELD C. T., 1948, JOUR AMER WATER WORKS ASSOC, V40, P1305; Castillo A, 1999, J FOOD PROTECT, V62, P580, DOI 10.4315/0362-028X-62.6.580; Chitnis V, 2004, AM J INFECT CONTROL, V32, P306, DOI 10.1016/j.ajic.2003.10.007; Cohen S. H., 2013, INFECT CONT HOSP EP, V31, P423; Dancer SJ, 2009, J HOSP INFECT, V73, P378, DOI 10.1016/j.jhin.2009.03.030; Dubberke ER, 2014, INFECT CONTROL HO S2, V35, P48; Evans MR, 2002, EPIDEMIOL INFECT, V129, P355, DOI 10.1017/S0950268802007446; Gagnon GA, 2005, WATER RES, V39, P1809, DOI 10.1016/j.watres.2005.02.004; Gordon G., 1972, PROGR INORGANIC CHEM, P201; HAAS CN, 1980, J WATER POLLUT CON F, V52, P1976; Horiuchi I, 2015, BIOCONTROL SCI, V20, P43, DOI 10.4265/bio.20.43; Ingram PR, 2004, FREE RADICAL RES, V38, P739, DOI 10.1080/10715760410001712773; Ingram PR, 2003, ARCH BIOCHEM BIOPHYS, V410, P121, DOI 10.1016/S0003-9861(02)00659-8; Japan Food Hygiene Association, 2015, STAND METH AN FOOD S; Kampf G, 2004, CLIN MICROBIOL REV, V17, P863, DOI 10.1128/CMR.17.4.863-893.2004; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Kumar M, 2006, J FOOD PROTECT, V69, P1571, DOI 10.4315/0362-028X-69.7.1571; Lawley TD, 2009, J BACTERIOL, V191, P5377, DOI 10.1128/JB.00597-09; Ling ML, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0099-7; Liu PB, 2010, APPL ENVIRON MICROB, V76, P394, DOI 10.1128/AEM.01729-09; MacCannell T, 2011, STAND PREV CONTR NOR; Moberg L, 2000, ANAL CHIM ACTA, V29, P123; Okabayashi T, 2008, J CLIN MICROBIOL, V46, P1985, DOI 10.1128/JCM.00305-08; Otter JA, 2011, INFECT CONT HOSP EP, V32, P687, DOI 10.1086/660363; Park GW, 2010, J FOOD PROTECT, V73, P2232, DOI 10.4315/0362-028X-73.12.2232; Richardson S.D., 1998, ENCY ENV ANAL REMEDI, V3, P1398; Richardson SD, 1998, FOOD TECHNOL-CHICAGO, V52, P58; RIDENOUR GM, 1946, AM J PUBLIC HEALTH, V36, P639; Sehulster Lynne, 2003, MMWR Recomm Rep, V52, P1; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; Stopforth JD, 2008, J FOOD PROTECT, V71, P625, DOI 10.4315/0362-028X-71.3.625; Todd ECD, 2008, J FOOD PROTECT, V71, P2582, DOI 10.4315/0362-028X-71.12.2582; Van Aken B, 2011, WATER SCI TECHNOL, V64, P1226, DOI 10.2166/wst.2011.684; Verani M, 2014, AM J INFECT CONTROL, V42, P758, DOI 10.1016/j.ajic.2014.03.026; Weber DJ, 2010, AM J INFECT CONTROL, V38, pS25, DOI 10.1016/j.ajic.2010.04.196; Yamaoka H, 2016, LETT APPL MICROBIOL, V62, P47, DOI 10.1111/lam.12506; Young SB, 2003, J APPL MICROBIOL, V95, P54, DOI 10.1046/j.1365-2672.2003.01960.x	40	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176718	10.1371/journal.pone.0176718	http://dx.doi.org/10.1371/journal.pone.0176718			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472060	gold, Green Submitted, Green Published			2022-12-26	WOS:000400648500066
J	Stanikova, D; Buzga, M; Krumpolec, P; Skopkova, M; Surova, M; Ukropcova, B; Ticha, L; Petrasova, M; Gabcova, D; Huckova, M; Piskorova, L; Bozensky, J; Mokan, M; Ukropec, J; Zavacka, I; Klimes, I; Stanik, J; Gasperikova, D				Stanikova, Daniela; Buzga, Marek; Krumpolec, Patrik; Skopkova, Martina; Surova, Martina; Ukropcova, Barbara; Ticha, Lubica; Petrasova, Miroslava; Gabcova, Dominika; Huckova, Miroslava; Piskorova, Lucie; Bozensky, Jan; Mokan, Marian; Ukropec, Jozef; Zavacka, Ivona; Klimes, Iwar; Stanik, Juraj; Gasperikova, Daniela			Genetic analysis of single-minded 1 gene in early-onset severely obese children and adolescents	PLOS ONE			English	Article							MELANOCORTIN-4 RECEPTOR GENE; FOOD-INTAKE; INSULIN SENSITIVITY; GLUCOSE-TOLERANCE; MORBID-OBESITY; UNITED-STATES; PIMA-INDIANS; WEB SERVER; SIM1 GENE; MUTATIONS	Background Inactivating mutations of the hypothalamic transcription factor singleminded1 (SIM1) have been shown as a cause of early-onset severe obesity. However, to date, the contribution of SIM1 mutations to the obesity phenotype has only been studied in a few populations. In this study, we screened the functional regions of SIM1 in severely obese children of Slovak and Moravian descent to determine if genetic variants within SIM1 may influence the development of obesity in these populations. Methods The SIM1 promoter region, exons and exon-intron boundaries were sequenced in 126 unrelated obese children and adolescents (2-18 years of age) and 41 adult lean controls of Slovak and Moravian origin. Inclusion criteria for the children and adolescents were a body mass index standard deviation score higher than 2 SD for an appropriate age and sex, and obesity onset at less than 5 years of age. The clinical phenotypes of the SIM1 variant carriers were compared with clinical phenotypes of 4 MC4R variant carriers and with 27 unrelated SIM1 and MC4R mutation negative obese controls that were matched for age and gender. Results Seven previously described SIM1 variants and one novel heterozygous variant p.D134N were identified. The novel variant was predicted to be pathogenic by 7 in silico software analyses and is located at a highly conserved position of the SIM1 protein. The p.D134N variant was found in an 18 year old female proband (BMI 44.2kg/m(2); +7.5 SD), and in 3 obese family members. Regardless of early onset severe obesity, the proband and her brother (age 16 years) did not fulfill the criteria of metabolic syndrome. Moreover, the variant carriers had significantly lower preferences for high sugar (p = 0.02) and low fat, low carbohydrate, high protein (p = 0.02) foods compared to the obese controls. Conclusions We have identified a novel SIM1 variant, p. D134N, in 4 obese individuals from a single pedigree which is also associated with lower preference for certain foods.	[Stanikova, Daniela; Krumpolec, Patrik; Skopkova, Martina; Surova, Martina; Ukropcova, Barbara; Gabcova, Dominika; Huckova, Miroslava; Klimes, Iwar; Stanik, Juraj; Gasperikova, Daniela] Slovak Acad Sci, Biomed Res Ctr, Inst Expt Endocrinol, Lab Diabet & Metab Disorders, Bratislava, Slovakia; [Stanikova, Daniela; Ticha, Lubica; Stanik, Juraj] Comenius Univ, Med Fac, Dept Pediat, Bratislava, Slovakia; [Stanikova, Daniela] Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, Leipzig, Germany; [Buzga, Marek] Univ Ostrava, Fac Med, Dept Physiol & Pathophysiol, Ostrava, Czech Republic; [Ukropcova, Barbara] Comenius Univ, Fac Med, Inst Pathophysiol, Bratislava, Slovakia; [Petrasova, Miroslava] Safarik Univ, Med Fac, Dept Pediat, Kosice, Slovakia; [Piskorova, Lucie; Bozensky, Jan] Vitkovice Hosp, Dept Pediat, Ostrava, Czech Republic; [Mokan, Marian] Comenius Univ, Jessenius Med Fac, Dept Internal Med, Martin, Slovakia; [Zavacka, Ivona] Univ Ostrava, Fac Med, Dept Biomed Sci, Ostrava, Czech Republic; [Stanik, Juraj] Univ Leipzig, Univ Hosp Children & Adolescents, Ctr Pediat Res Leipzig, Leipzig, Germany	Slovak Academy of Sciences; Comenius University Bratislava; Leipzig University; University of Ostrava; Comenius University Bratislava; University of Pavol Jozef Safarik Kosice; University Hospital Ostrava; Comenius University Bratislava; University of Ostrava; Leipzig University	Gasperikova, D (corresponding author), Slovak Acad Sci, Biomed Res Ctr, Inst Expt Endocrinol, Lab Diabet & Metab Disorders, Bratislava, Slovakia.	daniela.gasperikova@savba.sk	Ukropec, Jozef/AAI-5590-2020; Gasperikova, Daniela/E-7824-2018; Stanik, Juraj/AAQ-6217-2021; Ukropec, Jozef/D-5960-2018; Závacká, Ivona/D-8782-2014; Buzga, Marek/D-6288-2014; Ukropcova, Barbara/E-7644-2018; Buzga, Marek/ABC-1449-2021; Ukropcova, Barbara/ABE-6186-2020; Skopkova, Martina/AAO-1640-2021; Skopkova, Martina/B-4176-2014	Gasperikova, Daniela/0000-0002-5725-6424; Stanik, Juraj/0000-0002-0538-1274; Ukropec, Jozef/0000-0001-8401-6621; Buzga, Marek/0000-0002-9554-737X; Ukropcova, Barbara/0000-0002-3309-7713; Skopkova, Martina/0000-0001-7927-9777; Petrasova, Miroslava/0000-0003-4156-7073	Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic; Slovak Academy of Sciences [VEGA 2/0166/14]; European Regional Development Fund [Transendogen/26240220051]; ESPE (European Society of Pediatric Endocrinology) Research Fellowship	Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic; Slovak Academy of Sciences(Slovak Academy of Sciences); European Regional Development Fund(European Commission); ESPE (European Society of Pediatric Endocrinology) Research Fellowship	1. Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic and the Slovak Academy of Sciences - VEGA 2/0166/14, www.vega.sav.sk recieved by DaG; 2. Research&Development Operational Program funded by the European Regional Development Fund - Transendogen/26240220051 recieved by IK; 3. JS was supported by ESPE (European Society of Pediatric Endocrinology) Research Fellowship.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Bonnefond A, 2013, J CLIN INVEST, V123, P3037, DOI 10.1172/JCI68035; Capriotti E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S6; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Faivre L, 2002, J MED GENET, V39, P594, DOI 10.1136/jmg.39.8.594; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Geiselman PJ, 1998, PHYSIOL BEHAV, V63, P919, DOI 10.1016/S0031-9384(97)00542-8; Geistanger A, 2008, CLIN CHEM, V54, P1379, DOI 10.1373/clinchem.2008.103556; Hanson RL, 2000, AM J EPIDEMIOL, V151, P190; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; Holder JL, 2000, HUM MOL GENET, V9, P101; Hossain MS, 2016, SCI REP-UK, V6, DOI 10.1038/srep32453; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kobzova J., 2004, Central European Journal of Public Health, V12, P126; Kublaoui BM, 2006, MOL ENDOCRINOL, V20, P2483, DOI 10.1210/me.2005-0483; Kublaoui BM, 2006, ENDOCRINOLOGY, V147, P4542, DOI 10.1210/en.2006-0453; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kurdiova T, 2014, J PHYSIOL-LONDON, V592, P1091, DOI 10.1113/jphysiol.2013.264655; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Melchior C, 2012, HORM RES PAEDIAT, V78, P237, DOI 10.1159/000343816; Michaud JL, 2000, MECH DEVELOP, V90, P253, DOI 10.1016/S0925-4773(99)00328-7; Michaud JL, 1998, GENE DEV, V12, P3264, DOI 10.1101/gad.12.20.3264; Montagne L, 2014, OBESITY, V22, P2621, DOI 10.1002/oby.20886; Ramachandrappa S, 2013, J CLIN INVEST, V123, P3042, DOI 10.1172/JCI68016; REAVEN GM, 1993, J CLIN ENDOCR METAB, V76, P44, DOI 10.1210/jc.76.1.44; Retnakaran R, 2009, DIABETIC MED, V26, P1198, DOI 10.1111/j.1464-5491.2009.02841.x; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Swarbrick MM, 2011, OBESITY, V19, P2394, DOI 10.1038/oby.2011.79; Tapia LU, 2013, NUTR HOSP, V28, P1552, DOI 10.3305/nh.2013.28.5.6735; Thearle MS, 2012, DIABETES, V61, P250, DOI 10.2337/db11-0708; Traurig M, 2009, DIABETES, V58, P1682, DOI 10.2337/db09-0028; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Xi D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081087; Yang C, 2006, J NEUROSCI, V26, P7116, DOI 10.1523/JNEUROSCI.0672-06.2006; Yeo GSH, 2003, HUM MOL GENET, V12, P561, DOI 10.1093/hmg/ddg057; Zegers D, 2014, INTJ OBESITY LOND, V38, P1000; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	46	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177222	10.1371/journal.pone.0177222	http://dx.doi.org/10.1371/journal.pone.0177222			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472148	Green Published, gold, Green Submitted			2022-12-26	WOS:000400648500153
J	Vidal, T; Calado, AJ; Moita, MT; Cunha, MR				Vidal, Tania; Calado, Antonio Jose; Moita, Maria Teresa; Cunha, Marina R.			Phytoplankton dynamics in relation to seasonal variability and upwelling and relaxation patterns at the mouth of Ria de Aveiro (West Iberian Margin) over a four-year period	PLOS ONE			English	Article							NW-SPAIN; COMMUNITY STRUCTURE; CLIMATE-CHANGE; PHYSICAL OCEANOGRAPHY; COASTAL LAGOON; COOP-WEST; PORTUGAL; PENINSULA; ASSEMBLAGES; CHLOROPHYLL	From June 2004 to December 2007, samples were weekly collected at a fixed station located at the mouth of Ria de Aveiro (West Iberian Margin). We examined the seasonal and inter-annual fluctuations in composition and community structure of the phytoplankton in relation to the main environmental drivers and assessed the influence of the oceano-graphic regime, namely changes in frequency and intensity of upwelling events, over the dynamics of the phytoplankton assemblage. The samples were consistently handled and a final subset of 136 OTUs (taxa with relative abundance > 0.01%) was subsequently submitted to various multivariate analyses. The phytoplankton assemblage showed significant changes at all temporal scales but with an overriding importance of seasonality over longer-(inter-annual) or shorter-term fluctuations (upwelling-related). Sea-surface temperature, salinity and maximum upwelling index were retrieved as the main driver of seasonal change. Seasonal signal was most evident in the fluctuations of chlorophyll a concentration and in the high turnover from the winter to spring phytoplankton assemblage. The seasonal cycle of production and succession was disturbed by upwelling events known to disrupt thermal stratification and induce changes in the phytoplankton assemblage. Our results indicate that both the frequency and intensity of physical forcing were important drivers of such variability, but the outcome in terms of species composition was highly dependent on the available local pool of species and the timing of those events in relation to the seasonal cycle. We conclude that duration, frequency and intensity of upwelling events, which vary seasonally and inter-annually, are paramount for maintaining long-term phytoplankton diversity likely by allowing unstable coexistence and incorporating species turnover at different scales. Our results contribute to the understanding of the complex mechanisms of coastal phytoplankton dynamics in relation to changing physical forcing which is fundamental to improve predictability of future prospects under climate change.	[Vidal, Tania; Calado, Antonio Jose; Cunha, Marina R.] Univ Aveiro, Dept Biol, Campus Univ Santiago, Aveiro, Portugal; [Vidal, Tania; Cunha, Marina R.] Univ Aveiro, CESAM, Campus Univ Santiago, Aveiro, Portugal; [Vidal, Tania; Moita, Maria Teresa] IPMA, IP Portuguese Inst Ocean & Atmosphere, Lisbon, Portugal; [Calado, Antonio Jose] Univ Aveiro, GeoBioTec, Campus Univ Santiago, Aveiro, Portugal; [Moita, Maria Teresa] Univ Algarve, CCMAR, Campus Gambelas, Faro, Portugal	Universidade de Aveiro; Universidade de Aveiro; Instituto Portugues do Mar e da Atmosfera; Universidade de Aveiro; Universidade do Algarve	Vidal, T (corresponding author), Univ Aveiro, Dept Biol, Campus Univ Santiago, Aveiro, Portugal.; Vidal, T (corresponding author), Univ Aveiro, CESAM, Campus Univ Santiago, Aveiro, Portugal.; Vidal, T (corresponding author), IPMA, IP Portuguese Inst Ocean & Atmosphere, Lisbon, Portugal.	taniavidal@ua.pt	Calado, António José/D-6263-2015; Cunha, Marina R/B-7644-2008; Calado, António José/AAC-8269-2019; Vidal, Tânia/B-7566-2014; Calixto de Jesus Moita Garnel, Maria Teresa/M-4039-2013	Calado, António José/0000-0002-9711-0593; Cunha, Marina R/0000-0001-8833-6980; Calado, António José/0000-0002-9711-0593; Vidal, Tânia/0000-0002-2846-1306; Calixto de Jesus Moita Garnel, Maria Teresa/0000-0002-8995-7516	Portuguese Foundation for Science and Technology (FCT, Portugal) [SFRH/BPD/ 94562/2013]; FEDER funds; national funds; CESAM [UID/AMB/50017]; FCT/MEC through national funds; FEDER; Fundação para a Ciência e a Tecnologia [UID/AMB/50017/2013] Funding Source: FCT	Portuguese Foundation for Science and Technology (FCT, Portugal)(Portuguese Foundation for Science and Technology); FEDER funds(European Commission); national funds; CESAM; FCT/MEC through national funds; FEDER(European Commission); Fundação para a Ciência e a Tecnologia	The Portuguese Foundation for Science and Technology (FCT, Portugal) financed Tania Vidal (SFRH/BPD/ 94562/2013) by individual research grants. This study was supported by FEDER funds through the programme COMPETE and by national funds. We would like to thank to European Project SI MCLAVE and HABSPOT. Thanks are due, for the financial support to CESAM (UID/AMB/50017), to FCT/MEC through national funds, and the co-funding by the FEDER, within the PT2020 Partnership Agreement and Compete 2020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2003, ESTUAR COAST SHELF S, V56, P869, DOI 10.1016/S0272-7714(02)00309-8; Anderson DM, 1997, NATURE, V388, P513, DOI 10.1038/41415; Aristegui J, 2005, SEA GLOBAL COASTAL O, V14B, P879; Bakun A., 1973, COASTAL UPWELLING IN; Bode A, 1998, SCI MAR, V62, P319; Bode A, 2015, MAR ENVIRON RES, V110, P81, DOI 10.1016/j.marenvres.2015.07.017; Bode Antonio, 1994, Scientia Marina, V58, P131; BROWN PC, 1986, J PLANKTON RES, V8, P55, DOI 10.1093/plankt/8.1.55; Casabella N, 2014, J SEA RES, V93, P23, DOI 10.1016/j.seares.2014.01.013; Casas B, 1997, ESTUAR COAST SHELF S, V44, P767, DOI 10.1006/ecss.1996.0155; Casas B., 1995, THESIS; Cerejo M, 2007, MAR ENVIRON RES, V63, P313, DOI 10.1016/j.marenvres.2006.10.005; Cermeno P, 2006, ESTUAR COAST SHELF S, V67, P251, DOI 10.1016/j.ecss.2005.11.027; Chavez FP, 2009, PROG OCEANOGR, V83, P80, DOI 10.1016/j.pocean.2009.07.032; CHISHOLM SW, 1991, LIMNOL OCEANOGR, V36, pU1507; Churro CI, 2009, DIATOM RES, V24, P35; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cloern JE, 2005, MAR ECOL PROG SER, V285, P11, DOI 10.3354/meps285011; Cuadrado MMS, 2002, 21 ANN S EUR ASS REM, P87; da Silva JF, 2002, HYDROBIOLOGIA, V475, P379, DOI 10.1023/A:1020347610968; Dias JM, 1999, OCEANOL ACTA, V22, P473, DOI 10.1016/S0399-1784(00)87681-1; DORMAN CE, 1995, J GEOPHYS RES-OCEANS, V100, P16029, DOI 10.1029/95JC00964; Du XN, 2014, ESTUAR COAST, V37, P299, DOI 10.1007/s12237-013-9679-z; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Escalera L, 2010, HARMFUL ALGAE, V9, P312, DOI 10.1016/j.hal.2009.12.002; Estrada M, 2008, UNITY DIVERSITY REFL, P191; Estrada M, 1985, INT S UPW AR W AFR B, P379; Fehling J, 2006, MAR ECOL PROG SER, V323, P91, DOI 10.3354/meps323091; FIELD JG, 1982, MAR ECOL PROG SER, V8, P37, DOI 10.3354/meps008037; FIUZA AFD, 1982, OCEANOL ACTA, V5, P31; Freon P, 2009, PROG OCEANOGR, V83, P97, DOI 10.1016/j.pocean.2009.07.034; Goebel NL, 2013, ECOL MODEL, V264, P37, DOI 10.1016/j.ecolmodel.2012.11.008; Gorley C.K., 2006, GETTING STARTED PRIM; Harris GP., 1986, PHYTOPLANKTON ECOLOG; HOLM-HANSEN OSMUND, 1965, J CONS CONS PERMS INTE EXPLOR MER, V30, P3; Howarth RW, 2006, LIMNOL OCEANOGR, V51, P364, DOI 10.4319/lo.2006.51.1_part_2.0364; Kudela Raphael, 2005, Oceanography, V18, P184; LAMBSHEAD PJD, 1983, J NAT HIST, V17, P859, DOI 10.1080/00222938300770671; Lamont T, 2014, DEEP-SEA RES PT I, V90, P1, DOI 10.1016/j.dsr.2014.03.003; Largier JL, 2006, DEEP-SEA RES PT II, V53, P2833, DOI 10.1016/j.dsr2.2006.08.018; Lassiter AM, 2006, DEEP-SEA RES PT II, V53, P3063, DOI 10.1016/j.dsr2.2006.07.013; Legendre L, 1996, MAR ECOL PROG SER, V145, P179, DOI 10.3354/meps145179; Legendre L., 1981, ELSEVIER OCEANOGRAPH, V32, P191; Lemos RT, 2004, INT J CLIMATOL, V24, P511, DOI 10.1002/joc.1009; Lopes CB, 2007, ESTUAR COAST SHELF S, V71, P480, DOI 10.1016/j.ecss.2006.09.015; Lopes JF, 2014, J MARINE SYST, V129, P271, DOI 10.1016/j.jmarsys.2013.07.002; Lopes JF, 2009, ECOL MODEL, V220, P940, DOI 10.1016/j.ecolmodel.2008.11.024; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Margalef R., 1963, ADV FRONTIERS PLANT, P137; Margalef R., 1978, OECOLOGIA AQUATICA, V3, P97; Mercado JM, 2005, SCI MAR, V69, P451, DOI 10.3989/scimar.2005.69n4451; Moita M. T., 2001, ESTRUTURA VARIABILID; Moita MT, 2003, ACTA OECOL, V24, pS125, DOI 10.1016/S1146-609X(03)00011-0; Ojaveer H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012467; Palma S, 2010, HARMFUL ALGAE, V9, P294, DOI 10.1016/j.hal.2009.11.006; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Peliz A, 2005, DEEP-SEA RES PT I, V52, P621, DOI 10.1016/j.dsr.2004.11.005; Perez FF, 2010, GLOBAL CHANGE BIOL, V16, P1258, DOI 10.1111/j.1365-2486.2009.02125.x; Picado A, 2014, J SEA RES, V93, P2, DOI 10.1016/j.seares.2014.01.008; Pitcher GC, 2010, PROG OCEANOGR, V85, P5, DOI 10.1016/j.pocean.2010.02.002; PITCHER GC, 1991, PROG OCEANOGR, V28, P39, DOI 10.1016/0079-6611(91)90020-M; Poll WH, 2013, BIOGEOSCIENCES, V10, P4227; Prego R, 2007, ESTUAR COAST SHELF S, V73, P409, DOI 10.1016/j.ecss.2007.02.004; Relvas P, 2007, PROG OCEANOGR, V74, P149, DOI 10.1016/j.pocean.2007.04.021; Silva A, 2009, J SEA RES, V62, P238, DOI 10.1016/j.seares.2009.05.001; Smayda Theodore J., 2002, Harmful Algae, V1, P95, DOI 10.1016/S1568-9883(02)00010-0; Smayda TJ, 2001, J PLANKTON RES, V23, P447, DOI 10.1093/plankt/23.5.447; Stoecker DK, 1999, J EUKARYOT MICROBIOL, V46, P397, DOI 10.1111/j.1550-7408.1999.tb04619.x; Stoecker DK, 1997, MAR ECOL PROG SER, V152, P1, DOI 10.3354/meps152001; Trainer VL, 2010, PROG OCEANOGR, V85, P33, DOI 10.1016/j.pocean.2010.02.003; Tseng YF, 2014, BIOGEOSCIENCES, V11, P409, DOI 10.5194/bg-11-409-2014; Utermohl H, 1958, MITT INT VER LIMNOL, V9, P1; Uusitalo L, 2013, ICES J MAR SCI, V70, P408, DOI 10.1093/icesjms/fss198; Vale P, 2008, HARMFUL ALGAE, V7, P11, DOI 10.1016/j.hal.2007.05.002; Varela M, 2008, MAR BIOL, V154, P483, DOI 10.1007/s00227-008-0943-x; Varkitzi I, 2010, HARMFUL ALGAE, V9, P304, DOI 10.1016/j.hal.2009.12.001; Venrick EL, 2009, J MAR RES, V67, P89, DOI 10.1357/002224009788597917; WALSH JJ, 1991, NATURE, V350, P53, DOI 10.1038/350053a0; Wang DW, 2015, NATURE, V518, P390, DOI 10.1038/nature14235; Wilkerson FP, 2006, DEEP-SEA RES PT II, V53, P3023, DOI 10.1016/j.dsr2.2006.07.007	82	30	30	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177237	10.1371/journal.pone.0177237	http://dx.doi.org/10.1371/journal.pone.0177237			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472179	Green Submitted, Green Published, gold			2022-12-26	WOS:000400648500154
J	Zlitni, A; Yin, M; Janzen, N; Chatterjee, S; Lisok, A; Gabrielson, KL; Nimmagadda, S; Pomper, MG; Foster, FS; Valliant, JF				Zlitni, Aimen; Yin, Melissa; Janzen, Nancy; Chatterjee, Samit; Lisok, Ala; Gabrielson, Kathleen L.; Nimmagadda, Sridhar; Pomper, Martin G.; Foster, F. Stuart; Valliant, John F.			Development of prostate specific membrane antigen targeted ultrasound microbubbles using bioorthogonal chemistry	PLOS ONE			English	Article							J591 ANTIBODY; MONOCLONAL-ANTIBODIES; PRECLINICAL EVALUATION; EXTRACELLULAR DOMAIN; SMALL MOLECULES; IN-VITRO; CANCER; PSMA; EXPRESSION; INHIBITORS	Prostate specific membrane antigen (PSMA) targeted microbubbles (MBs) were developed using bioorthogonal chemistry. Streptavidin-labeled MBs were treated with a biotinylated tetrazine (MBTz) and targeted to PSMA expressing cells using trans-cyclooctene (TCO)-functionalized anti-PSMA antibodies (TCO-anti-PSMA). The extent of MB binding to PSMA positive cells for two different targeting strategies was determined using an in vitro flow chamber. The initial approach involved pretargeting, where TCO-anti-PSMA was first incubated with PSMA expressing cells and followed by MBTz, which subsequently showed a 2.8 fold increase in the number of bound MBs compared to experiments performed in the absence of TCO-anti-PSMA. Using direct targeting, where TCO-anti-PSMA was linked to MBTz prior to initiation of the assay, a 5-fold increase in binding compared to controls was observed. The direct targeting approach was subsequently evaluated in vivo using a human xenograft tumor model and two different PSMA-targeting antibodies. The US signal enhancements observed were 1.6- and 5.9-fold greater than that for non-targeted MBs. The lead construct was also evaluated in a head-to-head study using mice bearing both PSMA positive or negative tumors in separate limbs. The human PSMA expressing tumors exhibited a 2-fold higher US signal compared to those tumors deficient in human PSMA. The results demonstrate both the feasibility of preparing PSMA-targeted MBs and the benefits of using bioorthogonal chemistry to create targeted US probes.	[Zlitni, Aimen; Janzen, Nancy; Valliant, John F.] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON, Canada; [Yin, Melissa; Foster, F. Stuart] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Chatterjee, Samit; Lisok, Ala; Gabrielson, Kathleen L.; Nimmagadda, Sridhar; Pomper, Martin G.] Johns Hopkins Med Inst, Russell H Morgan Dept Radiol & Radiol Sci, 600 N Wolfe St, Baltimore, MD 21205 USA; [Valliant, John F.] Ctr Probe Dev & Commercializat, Hamilton, ON, Canada; [Zlitni, Aimen] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA	McMaster University; University of Toronto; Johns Hopkins University; Johns Hopkins Medicine; McMaster University; Stanford University	Valliant, JF (corresponding author), McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON, Canada.; Foster, FS (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.; Valliant, JF (corresponding author), Ctr Probe Dev & Commercializat, Hamilton, ON, Canada.	stuart@sri.utoronto.ca; valliant@mcmaster.ca	Chatterjee, Samit/ABZ-2522-2022	Chatterjee, Samit/0000-0001-8176-3410; Zlitni, Aimen/0000-0002-4790-1573; Foster, F. Stuart/0000-0003-3972-8296; Nimmagadda, Sridhar/0000-0002-6413-7191	Natural Sciences and Engineering Research Council of Canada [227514]; Ontario Institute for Cancer Research [P.SI.015.8]; Canadian Cancer Society [703857]; Terry Fox Research Institute	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Institute for Cancer Research; Canadian Cancer Society(Canadian Cancer Society (CCS)); Terry Fox Research Institute	This study was supported by the Natural Sciences and Engineering Research Council of Canada (# 227514), http://www.nserc-crsng.gc.ca./, recipient JFV; Ontario Institute for Cancer Research (# P.SI.015.8), https://oicr.on.ca/, recipient JFV; Canadian Cancer Society (# 703857), http://www.cancer.ca, recipients JFV and FSF; Terry Fox Research Institute, http://www.tfri.ca, recipient FSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elkacem L, 2015, EUR J RADIOL, V84, P1685, DOI 10.1016/j.ejrad.2015.03.016; Afshar-Oromieh A, 2014, EUR J NUCL MED MOL I, V41, P887, DOI 10.1007/s00259-013-2660-z; Banerjee SR, 2014, J MED CHEM, V57, P2657, DOI 10.1021/jm401921j; Barrett JA, 2013, J NUCL MED, V54, P380, DOI 10.2967/jnumed.112.111203; Canadian Cancer Society's Advisory Committee on Cancer Statistics, 2015, CANADIAN CANC STAT; Castanares MA, 2014, J NUCL MED, V55, P805, DOI 10.2967/jnumed.113.134031; Chang SS, 1999, CLIN CANCER RES, V5, P2674; Eder M, 2013, EUR J NUCL MED MOL I, V40, P819, DOI 10.1007/s00259-013-2374-2; El-Zaria ME, 2014, DALTON T, V43, P4950, DOI 10.1039/c3dt53189a; Elsasser-Beile U, 2009, J NUCL MED, V50, P606, DOI 10.2967/jnumed.108.058487; Fan XZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127419; Foss CA, 2005, CLIN CANCER RES, V11, P4022, DOI 10.1158/1078-0432.CCR-04-2690; Genady AR, 2016, J MED CHEM, V59, P2660, DOI 10.1021/acs.jmedchem.5b01881; Ghosh A, 2004, J CELL BIOCHEM, V91, P528, DOI 10.1002/jcb.10661; Haberkorn U, 2016, CLIN CANCER RES, V22, P9, DOI 10.1158/1078-0432.CCR-15-0820; Han M, 2001, Rev Urol, V3, P165; Hillier SM, 2009, CANCER RES, V69, P6932, DOI 10.1158/0008-5472.CAN-09-1682; Holland JP, 2010, J NUCL MED, V51, P1293, DOI 10.2967/jnumed.110.076174; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; ISRAELI RS, 1994, CANCER RES, V54, P1807; JAIN RK, 1988, CANCER RES, V48, P2641; Kaufmann S, 2015, UROL INT, V94, P319, DOI 10.1159/000365397; Kinoshita Y, 2006, WORLD J SURG, V30, P628, DOI 10.1007/s00268-005-0544-5; Lehr HA, 1997, INT J MICROCIRC, V17, P138, DOI 10.1159/000179221; Li Y, 2002, PROSTATE CANCER P D, V5, P36, DOI 10.1038/sj/pcan/4500543; Liu H, 1997, CANCER RES, V57, P3629; Liu H, 1998, CANCER RES, V58, P4055; Maurer T, 2016, NAT REV UROL, V13, P226, DOI 10.1038/nrurol.2016.26; Mottet N, 2016, EAU ESTRO SIOG GUIDE; Nakajima T, 2011, BIOCONJUGATE CHEM, V22, P1700, DOI 10.1021/bc2002715; Nguyen DP, 2016, MOL CANCER RES, V14, P1045, DOI 10.1158/1541-7786.MCR-16-0193; Norberg M, 1997, UROLOGY, V50, P562, DOI 10.1016/S0090-4295(97)00306-3; Osborne JR, 2013, UROL ONCOL-SEMIN ORI, V31, P144, DOI 10.1016/j.urolonc.2012.04.016; Pallwein L, 2008, EUR RADIOL, V18, P707, DOI 10.1007/s00330-007-0779-7; Pandit-Taskar N, 2015, CLIN CANCER RES, V21, P5277, DOI 10.1158/1078-0432.CCR-15-0552; Patri AK, 2004, BIOCONJUGATE CHEM, V15, P1174, DOI 10.1021/bc0499127; Perner S, 2007, HUM PATHOL, V38, P696, DOI 10.1016/j.humpath.2006.11.012; Regino CAS, 2009, CURR RADIOPHARM, V2, P9, DOI 10.2174/1874471010902010009; Roethke M, 2012, WORLD J UROL, V30, P213, DOI 10.1007/s00345-011-0675-2; Ross JS, 2003, CLIN CANCER RES, V9, P6357; Sanna V, 2011, MOL PHARMACEUT, V8, P748, DOI 10.1021/mp100360g; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Smeenge M, 2012, BJU INT, V110, P942, DOI 10.1111/j.1464-410X.2012.11072.x; Smith-Jones PM, 2003, J NUCL MED, V44, P610; Sokoloff RL, 2000, PROSTATE, V43, P150; SU SL, 1995, CANCER RES, V55, P1441; Sweat SD, 1998, UROLOGY, V52, P637, DOI 10.1016/S0090-4295(98)00278-7; Troyer JK, 1997, PROSTATE, V30, P232, DOI 10.1002/(SICI)1097-0045(19970301)30:4<232::AID-PROS2>3.0.CO;2-N; Turkbey B, 2009, NAT REV UROL, V6, P191, DOI 10.1038/nrurol.2009.27; Tykvart J, 2014, PROSTATE, V74, P1674, DOI 10.1002/pros.22887; Vallabhajosula S, 2005, J NUCL MED, V46, P634; Wang LF, 2013, PROSTATE, V73, P1147, DOI 10.1002/pros.22663; Willmann JK, 2008, RADIOLOGY, V246, P508, DOI 10.1148/radiol.2462070536; Yang X, 2016, J MED CHEM, V59, P206, DOI 10.1021/acs.jmedchem.5b01268; Zhou J, 2005, NAT REV DRUG DISCOV, V4, P1015, DOI 10.1038/nrd1903; Zlitni A, 2014, ANGEW CHEM INT EDIT, V53, P6459, DOI 10.1002/anie.201402473	57	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176958	10.1371/journal.pone.0176958	http://dx.doi.org/10.1371/journal.pone.0176958			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472168	Green Published, gold, Green Submitted			2022-12-26	WOS:000400648500103
J	Al Aameri, RFH; Sheth, S; Alanisi, EMA; Borse, V; Mukherjea, D; Rybak, LP; Ramkumar, V				Al Aameri, Raheem F. H.; Sheth, Sandeep; Alanisi, Entkhab M. A.; Borse, Vikrant; Mukherjea, Debashree; Rybak, Leonard P.; Ramkumar, Vickram			Tonic suppression of PCAT29 by the IL-6 signaling pathway in prostate cancer: Reversal by resveratrol	PLOS ONE			English	Article							LONG NONCODING RNA; CLINICOPATHOLOGICAL FEATURES; COLORECTAL-CANCER; MESSENGER-RNA; CELL-LINES; GENE; EXPRESSION; APOPTOSIS; MICRORNA; LNCRNAS	Prostate cancer (PCa) is the second leading cause of cancer deaths in men. A better understanding of the molecular basis of prostate cancer proliferation and metastasis should enable development of more effective treatments. In this study we focused on the lncRNA, prostate cancer associated transcript 29 (PCAT29), a putative tumor suppressive gene. Our data show that the expression of PCAT29 was reduced in prostate cancer tumors compared to paired perinormal prostate tissues. We also observed substantially lower levels of PCAT29 in DU145 and LNCaP cells compared to normal prostate (RWPE-1) cells. IL-6, a cytokine which is elevated in prostate tumors, reduced the expression of PCAT29 in both DU145 and LNCaP cells by activating signal transducer and activator of transcription 3 (STAT3). One downstream target of STAT3 is microRNA (miR)-21, inhibition of which enhanced basal PCAT29 expression. In addition, we show that resveratrol is a potent stimulator of PCAT29 expression under basal condition and reversed the down regulation of this lncRNA by IL-6. Furthermore, we show that knock down of PCAT29 expression by siRNA in DU145 and LNCaP cells increased cell viability while increasing PCAT29 expression with resveratrol decreased cell viability. Immunohistochemistry studies showed increased levels of STAT3 and IL-6, but low levels of programmed cell death protein 4 (PDCD4), in prostate tumor epithelial cells compared to adjacent perinormal prostate epithelial cells. These data show that the IL-6/STAT3/miR-21 pathway mediates tonic suppression of PCAT29 expression and function. Inhibition of this signaling pathway by resveratrol induces PCAT29 expression and tumor suppressor function.	[Al Aameri, Raheem F. H.; Sheth, Sandeep; Borse, Vikrant; Ramkumar, Vickram] Southern Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA; [Alanisi, Entkhab M. A.] Southern Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62794 USA; [Mukherjea, Debashree; Rybak, Leonard P.] Southern Illinois Univ, Sch Med, Dept Surg, Springfield, IL 62794 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Ramkumar, V (corresponding author), Southern Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA.	vramkumar@siumed.edu	Mukherjea, Debashree/AAR-5651-2020; Borse, Vikrant/J-4977-2019; Sheth, Sandeep/B-7839-2015	Borse, Vikrant/0000-0002-5280-2879; Sheth, Sandeep/0000-0001-6570-8120	National Cancer Institute [R01 CA166907]; NIH [RO1 CA166907]; NATIONAL CANCER INSTITUTE [R01CA166907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002396] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors received funding from National Cancer Institute (R01 CA166907). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported in part by an NIH grant, RO1 CA166907, to VR. We would like to thank Dr. Daotai Nie (Department of Medical Microbiology, Immunology and Cell Biology, Southern Illinois University School of Medicine, Springfield, IL) for providing us RWPE-1, DU145 and LNCaP cells. We also like to thank The Tissue Banking Facility of Simmons Cancer Institute of SIU School of Medicine for providing us the FFPE and RNA samples of prostate tissues.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bayoumi AS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030356; Beckedorff FC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003705; Benitez DA, 2007, J ANDROL, V28, P282, DOI 10.2164/jandrol.106.000968; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Carpenter RL, 2014, CANCERS, V6, P897, DOI 10.3390/cancers6020897; Chung SY, 2011, CANCER SCI, V102, P245, DOI 10.1111/j.1349-7006.2010.01737.x; Cui ZL, 2013, UROL ONCOL-SEMIN ORI, V31, P1117, DOI 10.1016/j.urolonc.2011.11.030; Dong BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134366; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; Jajoo S, 2013, ANTIOXID REDOX SIGN, V19, P1863, DOI 10.1089/ars.2012.4820; Jeronimo C, 2011, EUR UROL, V60, P753, DOI 10.1016/j.eururo.2011.06.035; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Liu Y, 2016, TOXICOL LETT, V240, P60, DOI 10.1016/j.toxlet.2015.10.016; Lou W, 2000, PROSTATE, V42, P239, DOI 10.1002/(SICI)1097-0045(20000215)42:3<239::AID-PROS10>3.0.CO;2-G; Malik R, 2014, MOL CANCER RES, V12, P1081, DOI 10.1158/1541-7786.MCR-14-0257; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Michalaki V, 2004, BRIT J CANCER, V90, P2312, DOI 10.1038/sj.bjc.6601814; Mourtada-Maarabouni M, 2009, ONCOGENE, V28, P195, DOI 10.1038/onc.2008.373; Ou HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109929; Pickard MR, 2013, BBA-MOL BASIS DIS, V1832, P1613, DOI 10.1016/j.bbadis.2013.05.005; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Sakurai K, 2015, MOL CANCER RES, V13, P828, DOI 10.1158/1541-7786.MCR-15-0016-T; Schetter AJ, 2010, CARCINOGENESIS, V31, P37, DOI 10.1093/carcin/bgp272; Sheth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051655; SIEGSMUND MJ, 1994, J UROLOGY, V151, P1396, DOI 10.1016/S0022-5347(17)35267-9; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Srikantan V, 2000, P NATL ACAD SCI USA, V97, P12216, DOI 10.1073/pnas.97.22.12216; Takayama K, 2013, EMBO J, V32, P1665, DOI 10.1038/emboj.2013.99; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang LJ, 2014, INT J ONCOL, V44, P2041, DOI 10.3892/ijo.2014.2363; Weischenfeldt J, 2013, CANCER CELL, V23, P159, DOI 10.1016/j.ccr.2013.01.002; Weiss M, 2014, BIOL CHEM, V395, P1275, DOI 10.1515/hsz-2014-0201; Williams GT, 2012, NAT REV CANCER, V12, P84, DOI 10.1038/nrc3195; Wu J, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0229-3; Yang GD, 2014, BBA-GENE REGUL MECH, V1839, P1097, DOI 10.1016/j.bbagrm.2014.08.012; Yang QY, 2015, TOXICOL APPL PHARM, V285, P79, DOI 10.1016/j.taap.2015.04.003; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Zhang X, 2010, CANCER RES, V70, P2350, DOI 10.1158/0008-5472.CAN-09-3885; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200	52	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0177198	10.1371/journal.pone.0177198	http://dx.doi.org/10.1371/journal.pone.0177198			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467474	Green Published, gold, Green Submitted			2022-12-26	WOS:000400647000097
J	Yokoyama, S; Furukawa, S; Kitada, S; Mori, M; Saito, T; Kawakami, K; Belmonte, JCI; Kawakami, Y; Ito, Y; Sato, T; Asahara, H				Yokoyama, Shigetoshi; Furukawa, Soichi; Kitada, Shoya; Mori, Masaki; Saito, Takeshi; Kawakami, Koichi; Belmonte, Juan Carlos Izpisua; Kawakami, Yasuhiko; Ito, Yoshiaki; Sato, Tempei; Asahara, Hiroshi			Analysis of transcription factors expressed at the anterior mouse limb bud	PLOS ONE			English	Article							IROQUOIS HOMEOBOX GENES; VERTEBRATE LIMB; KIDNEY DEVELOPMENT; DEVELOPING HEART; CRE RECOMBINASE; NERVOUS-SYSTEM; GOOSECOID GENE; CHICK LIMB; HOX GENES; XENOPUS	Limb bud patterning, outgrowth, and differentiation are precisely regulated in a spatio-temporal manner through integrated networks of transcription factors, signaling molecules, and downstream genes. However, the exact mechanisms that orchestrate morphogenesis of the limb remain to be elucidated. Previously, we have established EMBRYS, a whole-mount in situ hybridization database of transcription factors. Based on the findings from EMBRYS, we focused our expression pattern analysis on a selection of transcription factor genes that exhibit spatially localized and temporally dynamic expression patterns with respect to the anterior-posterior axis in the E9.5-E11.5 limb bud. Among these genes, Irx3 showed a posteriorly expanded expression domain in Shh(-/-) limb buds and an anteriorly reduced expression domain in Gli3(-/-) limb buds, suggesting their importance in anterior-posterior patterning. To assess the stepwise EMBRYS-based screening system for anterior regulators, we generated Irx3 transgenic mice in which Irx3 was expressed in the entire limb mesenchyme under the Prrx1 regulatory element. The Irx3 gain-of-function model displayed complex phenotypes in the autopods, including digit loss, radial flexion, and fusion of the metacarpal bones, suggesting that Irx3 may contribute to the regulation of limb patterning, especially in the autopods. Our results demonstrate that gene expression analysis based on EMBRYS could contribute to the identification of genes that play a role in patterning of the limb mesenchyme.	[Yokoyama, Shigetoshi; Saito, Takeshi; Asahara, Hiroshi] Natl Inst Child Hlth & Dev, Dept Syst Biomed, Setagaya Ku, Tokyo, Japan; [Furukawa, Soichi; Kitada, Shoya; Mori, Masaki; Ito, Yoshiaki; Sato, Tempei; Asahara, Hiroshi] Tokyo Med & Dent Univ, Dept Syst BioMed, Bunkyo Ku, Tokyo, Japan; [Kawakami, Koichi] SOKENDAI, Div Mol & Dev Biol, Natl Inst Genet, Mishima, Shizuoka, Japan; [Kawakami, Koichi] SOKENDAI, Dept Genet, Mishima, Shizuoka, Japan; [Belmonte, Juan Carlos Izpisua; Kawakami, Yasuhiko] Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Asahara, Hiroshi] Scripps Res Inst, Dept Expt Med, La Jolla, CA 92037 USA; [Yokoyama, Shigetoshi] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Mori, Masaki] Shiga Univ Med Sci, Dept Med Chem, MNRC, Otsu, Shiga, Japan; [Kawakami, Yasuhiko] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA	National Center for Child Health & Development - Japan; Tokyo Medical & Dental University (TMDU); Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Salk Institute; Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Shiga University of Medical Science; University of Minnesota System; University of Minnesota Twin Cities	Asahara, H (corresponding author), Natl Inst Child Hlth & Dev, Dept Syst Biomed, Setagaya Ku, Tokyo, Japan.; Asahara, H (corresponding author), Tokyo Med & Dent Univ, Dept Syst BioMed, Bunkyo Ku, Tokyo, Japan.; Asahara, H (corresponding author), Scripps Res Inst, Dept Expt Med, La Jolla, CA 92037 USA.	asahara.syst@tmd.ac.jp	Kawakami, Koichi/AAF-1380-2019	Sato, Tempei/0000-0002-8966-3374; Kawakami, Yasuhiko/0000-0002-0043-9705	AMED (Japan Agency for Medical Research and Development); JSPS KAKENHI [26113008, 15H02560, 15K15544]; National Institutes of Health [AR050631, AR065379, AR064195]; Naito Foundation; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Universidad Catolica de Murcia (UCAM); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064195, R01AR065379, R01AR050631] Funding Source: NIH RePORTER	AMED (Japan Agency for Medical Research and Development)(Japan Agency for Medical Research and Development (AMED)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Naito Foundation(Naito Memorial Foundation); G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Universidad Catolica de Murcia (UCAM); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research is supported by AMED-CREST (the Core Research for the Evolutionary Science and Technology) from AMED (the Japan Agency for Medical Research and Development), JSPS KAKENHI [Grant Numbers: 26113008, 15H02560, 15K15544], grants from the National Institutes of Health [Grant Numbers: AR050631, AR065379], and the Naito Foundation to H.A., grants from the National Institutes of Health [Grant Number: AR064195] to Y.K., and grants from the G. Harold and Leila Y. Mathers Charitable Foundation, The Leona M. and Harry B. Helmsley Charitable Trust and the Universidad Catolica de Murcia (UCAM) to J.C.I.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HA, 2015, ONLINE J BIOL SCI, V15, P162; Alarcon P, 2008, DEVELOPMENT, V135, P3197, DOI 10.1242/dev.023697; ARAKI K, 1995, P NATL ACAD SCI USA, V92, P160, DOI 10.1073/pnas.92.1.160; Bao ZZ, 1999, SCIENCE, V283, P1161, DOI 10.1126/science.283.5405.1161; Barbera JPM, 2000, DEVELOPMENT, V127, P2433; Bellefroid EJ, 1998, EMBO J, V17, P191, DOI 10.1093/emboj/17.1.191; Benazet JD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001339; Bosse A, 2000, DEV DYNAM, V218, P160, DOI 10.1002/(SICI)1097-0177(200005)218:1<160::AID-DVDY14>3.0.CO;2-2; Bosse A, 1997, MECH DEVELOP, V69, P169, DOI 10.1016/S0925-4773(97)00165-2; Bulfone A, 1999, MECH DEVELOP, V84, P133, DOI 10.1016/S0925-4773(99)00053-2; Burglin TR, 1997, NUCLEIC ACIDS RES, V25, P4173, DOI 10.1093/nar/25.21.4173; BURKE AC, 1995, DEVELOPMENT, V121, P333; Cavodeassi F, 2001, DEVELOPMENT, V128, P2847; Chiang C, 1996, CYCLOPIA DEFECTIVE A; CHO KWY, 1991, CELL, V67, P1111, DOI 10.1016/0092-8674(91)90288-A; Christoffels VM, 2000, DEV BIOL, V224, P263, DOI 10.1006/dbio.2000.9801; Cohen DR, 2000, MECH DEVELOP, V91, P317, DOI 10.1016/S0925-4773(99)00263-4; Costello I, 2011, NAT CELL BIOL, V13, P1084, DOI 10.1038/ncb2304; DAMBLYCHAUDIERE C, 1992, CELL, V69, P159, DOI 10.1016/0092-8674(92)90127-X; de la Calle-Mustienes E, 2005, GENOME RES, V15, P1061, DOI 10.1101/gr.4004805; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Ferguson JE, 2007, MOL CELL BIOL, V27, P6407, DOI 10.1128/MCB.00511-07; Fernandez-Teran M, 2008, APICAL ECTODERMAL RI; Gaborit N, 2012, DEVELOPMENT, V139, P4007, DOI 10.1242/dev.081703; Galli A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000901; Garriock RJ, 2001, DEV GENES EVOL, V211, P257, DOI 10.1007/s004270100147; GAUNT SJ, 1993, DEVELOPMENT, V117, P769; Gomez-Skarmeta JL, 2002, CURR OPIN GENET DEV, V12, P403, DOI 10.1016/S0959-437X(02)00317-9; Gomez-Skarmeta JL, 1998, EMBO J, V17, P181, DOI 10.1093/emboj/17.1.181; Goodman FR, 2002, AM J MED GENET, V112, P256, DOI 10.1002/ajmg.10776; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Hallaq H, 2004, DEVELOPMENT, V131, P5197, DOI 10.1242/dev.01393; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Houweling AC, 2001, MECH DEVELOP, V107, P169, DOI 10.1016/S0925-4773(01)00451-8; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jorgensen JS, 2005, GENE EXPR PATTERNS, V5, P756, DOI 10.1016/j.modgep.2005.04.011; Kanegae Y, 1998, NATURE, V392, P611, DOI 10.1038/33429; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kawakami K, 2004, GENETICS, V166, P895, DOI 10.1534/genetics.166.2.895; Kawakami K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S7; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; Kim JY, 2003, J NEUROCHEM, V85, P1443, DOI 10.1046/j.1471-4159.2003.01780.x; Kimura N, 1999, DEV BRAIN RES, V115, P183, DOI 10.1016/S0165-3806(99)00064-4; Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189; Lan Y, 2004, DEVELOPMENT, V131, P3207, DOI 10.1242/dev.01175; Lecaudey V, 2005, J COMP NEUROL, V492, P289, DOI 10.1002/cne.20765; Lee CT, 2004, MOL CELL BIOL, V24, P10835, DOI 10.1128/MCB.24.24.10835-10843.2004; Leyns L, 1996, MECH DEVELOP, V59, P63, DOI 10.1016/0925-4773(96)00577-1; Li DY, 2014, DEV CELL, V29, P233, DOI 10.1016/j.devcel.2014.03.001; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; MOLVEN A, 1990, DEVELOPMENT, V109, P279; Niederreither K, 2002, DEVELOPMENT, V129, P3563; OLIVER G, 1988, CELL, V55, P1017, DOI 10.1016/0092-8674(88)90246-2; Peters T, 2000, GENOME RES, V10, P1453, DOI 10.1101/gr.144100; Reggiani L, 2007, GENE DEV, V21, P2358, DOI 10.1101/gad.450707; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; RIVERAPEREZ JA, 1995, DEVELOPMENT, V121, P3005; Robertshaw E, 2013, P NATL ACAD SCI USA, V110, pE3919, DOI 10.1073/pnas.1304311110; Rodriguez-Esteban C, 1998, DEVELOPMENT, V125, P3925; Rodriguez-Seguel E, 2009, DEV BIOL, V329, P258, DOI 10.1016/j.ydbio.2009.02.028; Ryan K, 1996, CELL, V87, P989, DOI 10.1016/S0092-8674(00)81794-8; Sacchetti P, 2006, NUCLEIC ACIDS RES, V34, P5515, DOI 10.1093/nar/gkl712; Saunders J. W., 1968, EPITHELIAL MESENCHYM, P78; SAUNDERS JW, 1948, J EXP ZOOL, V108, P363, DOI 10.1002/jez.1401080304; SAUNDERS JW, 1974, DEV BIOL, V38, P41, DOI 10.1016/0012-1606(74)90257-7; Stricker S, 2006, GENE EXPR PATTERNS, V6, P826, DOI 10.1016/j.modgep.2006.02.003; Tabin C, 2007, GENE DEV, V21, P1433, DOI 10.1101/gad.1547407; Tena JJ, 2007, DEV BIOL, V301, P518, DOI 10.1016/j.ydbio.2006.08.063; TICKLE C, 1975, NATURE, V254, P199, DOI 10.1038/254199a0; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; Wang QR, 2005, DEV BIOL, V288, P582, DOI 10.1016/j.ydbio.2005.09.024; Wassarman KM, 1997, DEVELOPMENT, V124, P2923; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; Welscher PT, 2002, GENE DEV, V16, P421, DOI 10.1101/gad.219202; Yamada G, 1997, BIOCHEM BIOPH RES CO, V233, P161, DOI 10.1006/bbrc.1997.6315; Yang Y, 1997, DEVELOPMENT, V124, P4393; Yokoyama S, 2009, DEV CELL, V17, P836, DOI 10.1016/j.devcel.2009.10.011; Zamparini AL, 2006, DEVELOPMENT, V133, P3709, DOI 10.1242/dev.02516; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zhu YB, 2010, J IMMUNOL, V185, P3174, DOI 10.4049/jimmunol.1000749; Zhulyn O, 2014, DEV CELL, V29, P241, DOI 10.1016/j.devcel.2014.03.002; Zulch A, 2001, MECH DEVELOP, V106, P159, DOI 10.1016/S0925-4773(01)00411-7; Zuniga A, 1999, DEVELOPMENT, V126, P13	86	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5								10.1371/journal.pone.0175673	http://dx.doi.org/10.1371/journal.pone.0175673			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467430	Green Submitted, Green Published, gold			2022-12-26	WOS:000400647000021
J	Hsieh, CC; Sun, YH; Lin, SW; Yeh, YC; Chan, ML				Hsieh, Chih-Cheng; Sun, Yung-Han; Lin, Shih-Wei; Yeh, Yi-Chen; Chan, Mei-Lin			Surgical outcomes of pulmonary mucoepidermoid carcinoma: A review of 41 cases	PLOS ONE			English	Review							CELL LUNG-CANCER; PROGNOSTIC-FACTORS; CLINICAL-FEATURES; TUMORS; PREDICTION; SURVIVAL; GLANDS; GRADE	Introduction Pulmonary mucoepidermoid carcinoma is a rare cancer that occurs primarily in younger patients. The prognostic factors of pulmonary mucoepidermoid carcinoma are largely undetermined, especially in elderly patients. The aim of this study was to examine the clinical characteristics and prognostic factors influencing survival after surgical resection in patients with pulmonary mucoepidermoid carcinoma and also analyze the clinical manifestations and prognostic factors in elderly patients. Materials and methods The pathological records of 41 pulmonary mucoepidermoid carcinoma patients (mean age, 61.4 years) who underwent surgical resection at our hospital between January 1991 and July 2015 were retrospectively reviewed. Subjects >65 years of age (n = 22) were considered elderly. Results The median follow-up duration was 42.9 (interquartile range, 15.0-120.8) months. Sixteen patients (39.0%) experienced tumor relapse, including 13 patients (81.3%) within 2 years. The 5-year disease-free survival rate was 57.9%. Tumor grade did not influence diseasefree survival (P = 0.286). In the multivariate analysis, age, tumor size, pathological T3-4 status, and pathological N2 status were independent predictors of disease-free survival. The 5-year overall survival rate was 57.0%. Tumor grade also did not influence overall survival (P = 0.170). Age, tumor size, pathological T status, and pathological N2 status were independent predictors of overall survival. In elderly patients, the 5-year disease-free survival and overall survival rates were 41.4% and 41.5%, respectively. Pathological T status was the only independent predictor of both disease-free survival and overall survival in elderly patients. Conclusions Prognostic factors identified for pulmonary mucoepidermoid carcinoma in this study differ from those of previous studies. Principally, tumor grade did not influence either disease-free survival or overall survival. Age, tumor size, and pathological factors were independent predictors of disease-free survival and overall survival. In elderly patients, pathological T status was the only independent predictor of disease-free survival and overall survival.	[Hsieh, Chih-Cheng; Sun, Yung-Han] Taipei Vet Gen Hosp, Dept Surg, Div Thorac Surg, Taipei, Taiwan; [Hsieh, Chih-Cheng] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei, Taiwan; [Hsieh, Chih-Cheng] Natl Yang Ming Univ, Sch Med, Dept Surg, Taipei, Taiwan; [Sun, Yung-Han] Chang Gung Univ, Grad Inst Business & Management, Taoyuan, Taiwan; [Lin, Shih-Wei] Chang Gung Univ, Dept Informat Management, Taoyuan, Taiwan; [Lin, Shih-Wei] Ming Chi Univ Technol, Dept Ind Engn & Management, Taipei, Taiwan; [Lin, Shih-Wei] Linkou Chang Gung Mem Hosp, Stroke Ctr, Taoyuan, Taiwan; [Lin, Shih-Wei] Linkou Chang Gung Mem Hosp, Dept Neurol, Taoyuan, Taiwan; [Yeh, Yi-Chen] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan; [Chan, Mei-Lin] Mackay Mem Hosp, Dept Surg, Thorac Surg Div, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Chang Gung University; Chang Gung University; Ming Chi University of Technology; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Taipei Veterans General Hospital; Mackay Memorial Hospital	Lin, SW (corresponding author), Chang Gung Univ, Dept Informat Management, Taoyuan, Taiwan.; Lin, SW (corresponding author), Ming Chi Univ Technol, Dept Ind Engn & Management, Taipei, Taiwan.; Lin, SW (corresponding author), Linkou Chang Gung Mem Hosp, Stroke Ctr, Taoyuan, Taiwan.; Lin, SW (corresponding author), Linkou Chang Gung Mem Hosp, Dept Neurol, Taoyuan, Taiwan.	swlin@mail.cgu.edu.tw	Lin, Shih-Wei/F-7247-2011	Lin, Shih-Wei/0000-0003-1343-0838	Ministry of Science and Technology, Republic of China (Taiwan) [MOST105-2410-H-182-009-MY2, MOST105-2632-H-182-001]; Linkou Chang Gung Memorial Hospital [BMRPA19, CMRPD3G0011]; Veterans General Hospital and University System of Taiwan Joint Research Program [VGHUST 106-G7-7-1]; Taipei Veterans General Hospital Research Program [V104A-041]	Ministry of Science and Technology, Republic of China (Taiwan); Linkou Chang Gung Memorial Hospital; Veterans General Hospital and University System of Taiwan Joint Research Program; Taipei Veterans General Hospital Research Program	Shih-Wei Lin is grateful to the Ministry of Science and Technology, Republic of China (Taiwan), and the Linkou Chang Gung Memorial Hospital for financially supporting this study with research grants MOST105-2410-H-182-009-MY2, MOST105-2632-H-182-001 and BMRPA19, CMRPD3G0011, respectively. Chih-Cheng Hsieh was supported by Veterans General Hospital and University System of Taiwan Joint Research Program (VGHUST 106-G7-7-1). Yung-Han Sun was supported by Taipei Veterans General Hospital Research Program (V104A-041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achcar RDD, 2009, HUM PATHOL, V40, P854, DOI 10.1016/j.humpath.2008.11.007; American Joint Committee on Cancer, 2010, AJCC CANC STAGING MA, P251; Chin CH, 2008, RESPIROLOGY, V13, P275, DOI 10.1111/j.1440-1843.2007.01207.x; Ha SY, 2011, KOREAN J PATHOL, V45, P175, DOI 10.4132/KoreanJPathol.2011.45.2.175; HEITMILLER RF, 1989, ANN THORAC SURG, V47, P394, DOI 10.1016/0003-4975(89)90380-9; Hsu CP, 2009, J THORAC CARDIOV SUR, V138, P426, DOI 10.1016/j.jtcvs.2008.12.035; Huo Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143169; Jiang L, 2014, INT J CLIN EXP PATHO, V7, P6792; Komiya T, 2015, CLIN RESP J; Lee GD, 2014, THORAC CARDIOV SURG, V62, P140, DOI 10.1055/s-0033-1342943; LEONARDI HK, 1978, J THORAC CARDIOV SUR, V76, P431; Li N, 2012, CANCER-AM CANCER SOC, V118, P3945, DOI 10.1002/cncr.26740; Liu XL, 2007, ARCH PATHOL LAB MED, V131, P1400; Molina JR, 2007, CANCER-AM CANCER SOC, V110, P2253, DOI 10.1002/cncr.23048; MORAN CA, 1995, SEMIN DIAGN PATHOL, V12, P106; Park B, 2015, KOREAN J RADIOL, V16, P929, DOI 10.3348/kjr.2015.16.4.929; Roden AC, 2014, MODERN PATHOL, V27, P1479, DOI 10.1038/modpathol.2014.72; Schuchert MJ, 2011, ANN THORAC SURG, V91, P1059, DOI 10.1016/j.athoracsur.2010.11.038; SMETANA H F, 1952, Mil Surg, V111, P335; Song ZB, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-62; SPENCER H, 1979, VIRCHOWS ARCH A, V383, P101, DOI 10.1007/BF00427013; Stenner M, 2009, EUR ARCH OTO-RHINO-L, V266, P333, DOI 10.1007/s00405-008-0882-7; Travis W. D., 2015, THYMUS AND HEART; TURNBULL AD, 1971, CANCER, V28, P539, DOI 10.1002/1097-0142(197109)28:3<539::AID-CNCR2820280302>3.0.CO;2-G; Vadasz P, 2000, EUR J CARDIO-THORAC, V17, P566, DOI 10.1016/S1010-7940(00)00386-9; Wang MG, 2015, INT J CLIN EXP PATHO, V8, P3001; Wang YQ, 2015, AM J ROENTGENOL, V205, P1160, DOI 10.2214/AJR.14.14153; Wu CY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002013; Xi JJ, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-232; Yamatani C, 2014, LUNG CANCER, V84, P45, DOI 10.1016/j.lungcan.2014.01.010; Yang Chia-Shen, 2004, J Chin Med Assoc, V67, P565; YOUSEM SA, 1987, CANCER-AM CANCER SOC, V60, P1346, DOI 10.1002/1097-0142(19870915)60:6<1346::AID-CNCR2820600631>3.0.CO;2-0; Zhu F, 2013, J THORAC ONCOL, V8, P1578, DOI 10.1097/JTO.0b013e3182a7d272	33	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176918	10.1371/journal.pone.0176918	http://dx.doi.org/10.1371/journal.pone.0176918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28463970	Green Published, gold, Green Submitted			2022-12-26	WOS:000400646300064
J	Manion, M; Hullsiek, KH; Wilson, EMP; Rhame, F; Kojic, E; Gibson, D; Hammer, J; Patel, P; Brooks, JT; Baker, JV; Sereti, I				Manion, Maura; Hullsiek, Katherine Huppler; Wilson, Eleanor M. P.; Rhame, Frank; Kojic, Erna; Gibson, David; Hammer, John; Patel, Pragna; Brooks, John T.; Baker, Jason V.; Sereti, Irini		Study Understand Natural Hist HIV	Vitamin D deficiency is associated with IL-6 levels and monocyte activation in HIV-infected persons	PLOS ONE			English	Article							INFLAMMATORY MARKERS; ALL-CAUSE; PROGRESSION	Background Immune activation plays a key role in HIV pathogenesis. Markers of inflammation have been associated with vitamin D deficiency in the general population. Studies have also demonstrated associations of vitamin D deficiency with increased risk of HIV progression and death. The relationship between persistent inflammation and immune activation during chronic HIV infection and vitamin D deficiency remains unclear. Methods Cryopreserved specimens were analyzed from 663 participants at the time of enrollment from the Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study) from 2004 to 2006. Biomarkers of inflammation, atherosclerosis, and coagulation were measured using enzyme-linked immunosorbent assays (ELISAs) and electrochemiluminescence. 25(OH) D, the stable precursor form of vitamin D, was measured using a radioimmunoassay with levels defined as: normal (>= 30ng/mL), insufficient (20-29 ng/mL) and deficient (<20 ng/mL). Monocyte phenotypes were assessed by flow cytometry. Linear and logistic regression models were used to determine statistical associations between biomarkers and vitamin D deficiency. Results 25(OH) D levels were deficient in 251 (38%) participants, insufficient in 222 (34%), and normal in 190 (29%). Patients with vitamin D deficiency, when compared to those with insufficient or normal vitamin D levels, had increased levels of IL-6 (23%; p< 0.01), TNF-alpha (21%, p = 0.03), D-dimer (24%, p = 0.01), higher proportions of CD14(dim) CD16+ (22%, p< 0.01) and CX3CR1 + monocytes (48%; p<0.001) and decreased frequency of CCR2+ monocytes (-3.4%, p<0.001). In fully adjusted models, vitamin D associations with abnormal biomarker levels persisted for IL-6 levels and CX3CR1+ and CCR2+ phenotypes. Conclusions Vitamin D deficiency is associated with greater inflammation and activated monocyte phenotypes. The role of vitamin D deficiency in persistent immune activation and associated complications during chronic HIV disease should be further evaluated as a possible target for intervention.	[Manion, Maura; Sereti, Irini] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Hullsiek, Katherine Huppler] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [Wilson, Eleanor M. P.] Univ Maryland, Sch Med, Inst Virol, Baltimore, MD 21201 USA; [Rhame, Frank; Baker, Jason V.] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Rhame, Frank] Abbott NW Hosp, Minneapolis, MN USA; [Kojic, Erna] Miriam Hosp, Providence, RI 02906 USA; [Gibson, David] Washington Univ, St Louis, MO USA; [Hammer, John] Denver Infect Dis Consultants, Denver, CO USA; [Patel, Pragna; Brooks, John T.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA; [Baker, Jason V.] Hennepin Cty Med Ctr, Div Infect Dis, Minneapolis, MN 55415 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Minnesota System; University of Minnesota Twin Cities; University System of Maryland; University of Maryland Baltimore; University of Minnesota System; University of Minnesota Twin Cities; Lifespan Health Rhode Island; Miriam Hospital; Washington University (WUSTL); Centers for Disease Control & Prevention - USA; Hennepin County Medical Center	Manion, M (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	maura.manion@nih.gov		Wilson, Eleanor/0000-0002-4855-514X; Overton, Edgar/0000-0002-4013-536X	Centers for Disease Control and Prevention [200-2002-00610, 200-2002-00611, 200-2002-00612, 200-2002-00613, 200-2007-23633, 200-2007-23634, 200-2007-23635, 200-2007-23636]; Intramural Research Program of the National Institute of Allergy and Infectious Diseases; Intramural Research Program of the NIAID, NIH;  [NIH1KL2RR033182-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001121] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Intramural Research Program of the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural Research Program of the NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Centers for Disease Control and Prevention contract numbers 200-2002-00610, 200-2002-00611, 200-2002-00612, 200-2002-00613, 200-2007-23633, 200-2007-23634,200-2007-23635, and 200-2007-23636. Additional support was provided by the NIH1KL2RR033182-01. This project has also been funded in part by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, including the National Institutes of Health and the Centers for Disease and Control and Prevention, nor does the mention of trade names, commercial products, or organizations imply endorsement by the U.S. Governmentarticulated in the 'authors contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported in part by the Intramural Research Program of the NIAID, NIH. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The authors thank the Membership of the Study to Understand the Natural History of HIV/AIDS in the Era of Effective Antiretroviral (SUN Study) participants and the clinical site investigators and staff. The investigators of the SUN Study consortium include: Charles Carpenter, Keith Henry, E. Turner Overton, John Hammer, Pragna Patel, and John T. Brooks*. *Lead Author of the SUN Study. E-mail: zud4@cdc.gov. The authors also thank Adam Rupert of Leidos Biomedical Research, Inc. for help with IL-6 and sCD163 measurements. Finally, we would like to acknowledge the work of the late Edie Gunderson, who conducted SUN Study visits in Minneapolis. Edie, loved by staff and participants alike, was known for her boundless energy, dedicated work ethic, and playful demeanor.	Ansemant T, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-7; Baker JV, 2014, AIDS, V28, P831, DOI 10.1097/QAD.0000000000000145; Coussens AK, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/903680; Dao CN, 2011, CLIN INFECT DIS, V52, P396, DOI 10.1093/cid/ciq158; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Fabre-Mersseman V, 2014, AIDS, V500, P14; Grund B, 2013, 20 C RETR OPP INF AT; Havers F, 2014, J INFECT DIS, V210, P244, DOI 10.1093/infdis/jiu259; Hewison M, 2012, P NUTR SOC, V71, P50, DOI 10.1017/S0029665111001650; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Krishnan S, 2014, J INFECT DIS, V209, P931, DOI 10.1093/infdis/jit581; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Pilz S, 2009, CLIN ENDOCRINOL, V71, P666, DOI 10.1111/j.1365-2265.2009.03548.x; Shepherd L, 2014, J INFECT DIS, V210, P234, DOI 10.1093/infdis/jiu074; Vellozzi C, 2009, AM J EPIDEMIOL, V169, P642, DOI 10.1093/aje/kwn361; Westhorpe CLV, 2014, IMMUNOL CELL BIOL, V92, P133, DOI 10.1038/icb.2013.84; Wilson EMP, 2014, J INFECT DIS, V210, P1396, DOI 10.1093/infdis/jiu275	17	52	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0175517	10.1371/journal.pone.0175517	http://dx.doi.org/10.1371/journal.pone.0175517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28464004	gold, Green Published, Green Submitted			2022-12-26	WOS:000400646300005
J	Schulthess, CP; Ndu, U				Schulthess, Cristian P.; Ndu, Udonna			Modeling the adsorption of hydrogen, sodium, chloride and phthalate on goethite using a strict charge-neutral ion-exchange theory	PLOS ONE			English	Article							INTRINSIC PROTON AFFINITY; REACTIVE SURFACE GROUPS; RETENTION MECHANISMS; CARBONATE ADSORPTION; METAL (HYDR)OXIDES; BASE-EXCHANGE; CRYSTAL FACES; SELENATE; SULFATE; COMPLEXATION	Simultaneous adsorption modeling of four ions was predicted with a strict net charge-neutral ion-exchange theory and its corresponding equilibrium and mass balance equations. An important key to the success of this approach was the proper collection of all the data, particularly the proton adsorption data, and the inclusion of variable concentrations of conjugate ions from the experimental pH adjustments. Using IExFit software, the ion-exchange model used here predicted the competitive retention of several ions on goethite by assuming that the co-adsorption or desorption of all ions occurred in the correct stoichiometries needed to maintain electroneutrality. This approach also revealed that the retention strength of Cl- ions on goethite increases in the presence of phthalate ions. That is, an anion-anion enhancement effect was observed. The retention of Cl- ions was much weaker than phthalate ions, and this also resulted in a higher sensitivity of the Cl- ions toward minor variations in the surface reactivity. The proposed model uses four goethite surface sites. The drop in retention of phthalate ions at low pH was fully described here as resulting from competitive Cl- reactions, which were introduced in increasing concentrations into the matrix as the conjugate base to the acid added to lower the pH.	[Schulthess, Cristian P.] Univ Connecticut, Dept Plant Sci & Landscape Architecture, Storrs, CT 06269 USA; [Ndu, Udonna] Duke Univ, Dept Civil & Environm Engn, Durham, NC 27706 USA	University of Connecticut; Duke University	Schulthess, CP (corresponding author), Univ Connecticut, Dept Plant Sci & Landscape Architecture, Storrs, CT 06269 USA.	c.schulthess@uconn.edu			University of Connecticut, Department of Plant Sciences and Landscape Architecture [0201385]; United States Department of Agriculture, National Institute of Food and Agriculture [0201385, CONS00777]	University of Connecticut, Department of Plant Sciences and Landscape Architecture; United States Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This research was funded by the University of Connecticut, Department of Plant Sciences and Landscape Architecture, and by a United States Department of Agriculture, National Institute of Food and Agriculture Grant (Accession #0201385, Station #CONS00777) to the University of Connecticut (CPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; In addition to the United States Department of Agriculture, National Institute of Food and Agriculture (Accession #0201385) for funding this project, we also thank the University of Connecticut, Department of Plant Sciences and Landscape Architecture, for supplying additional funds toward this project and for supplying the needed environment for development of the IExFit software code that was needed for model fitting the data presented here.	Amir S, 2005, PROCESS BIOCHEM, V40, P2183, DOI 10.1016/j.procbio.2004.08.012; Aqvist J, 2017, ACCOUNTS CHEM RES, V50, P199, DOI 10.1021/acs.accounts.6b00321; ARCHER DW, 1965, J CHEM SOC, P720, DOI 10.1039/jr9650000720; Barron V, 1996, J COLLOID INTERF SCI, V177, P407, DOI 10.1006/jcis.1996.0051; BECKETT PHT, 1964, J SOIL SCI, V15, P1, DOI 10.1111/j.1365-2389.1964.tb00239.x; Boily JF, 2014, GEOCHIM COSMOCHIM AC, V141, P567, DOI 10.1016/j.gca.2014.06.016; Boily JF, 2000, GEOCHIM COSMOCHIM AC, V64, P3453, DOI 10.1016/S0016-7037(00)00453-1; Castillo M, 1997, TRAC-TREND ANAL CHEM, V16, P574, DOI 10.1016/S0165-9936(97)00090-3; Cornell RM, 2003, IRON OXIDES STRUCTUR, DOI [10.1002/3527602097.ins, DOI 10.1002/]; DAVIS JA, 1990, REV MINERAL, V23, P177; DUBININ MM, 1960, CHEM REV, V60, P235, DOI 10.1021/cr60204a006; Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005; Ferreira DR, 2012, ENVIRON SCI TECHNOL, V46, P300, DOI 10.1021/es2033394; Gaboriaud F, 2003, GEOCHIM COSMOCHIM AC, V67, P967, DOI 10.1016/S0016-7037(02)00988-2; GAINES GL, 1953, J CHEM PHYS, V21, P714, DOI 10.1063/1.1698996; Gapon E., 1933, J GEN CHEM USSR ENGL, V3, P144; Grossl PR, 1997, ENVIRON SCI TECHNOL, V31, P321, DOI 10.1021/es950654l; Henry DC, 1922, PHILOS MAG, V44, P689, DOI 10.1080/14786441108634035; HIEMSTRA T, 1989, J COLLOID INTERF SCI, V133, P91, DOI 10.1016/0021-9797(89)90284-1; Hiemstra T, 1996, J COLLOID INTERF SCI, V184, P680, DOI 10.1006/jcis.1996.0666; HOLFORD ICR, 1974, J SOIL SCI, V25, P242, DOI 10.1111/j.1365-2389.1974.tb01121.x; Huang C.P., 1981, CHEM WATER REUSE, V2, P355; James R. O., 1982, SURFACE COLLOID SCI, P119, DOI DOI 10.1007/978-1-4613-3204-6_2; Kerisit S, 2006, J PHYS CHEM B, V110, P20491, DOI 10.1021/jp0636569; Kerr HW, 1928, SOIL SCI, V26, P385, DOI 10.1097/00010694-192811000-00006; KERR HW, 1928, J AM SOC AGRON, V20, P309; KRISHNAMOORTHY C, 1949, SOIL SCI, V68, P307, DOI 10.1097/00010694-194910000-00003; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Leung K, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/12/124105; MIDGLEY D, 1991, POTENTIOMETRIC WATER; NANZYO M, 1982, SOIL SCI PLANT NUTR, V28, P359, DOI 10.1080/00380768.1982.10433651; Ndu U, 2014, SOIL SCI SOC AM J, V78, P465, DOI 10.2136/sssaj2013.06.0234; Pauling L, 1929, J AM CHEM SOC, V51, P1010, DOI 10.1021/ja01379a006; POPP JA, 1987, TOXICOL IND HEALTH, V3, P151, DOI 10.1177/074823378700300211; POSNER AM, 1980, J SOIL SCI, V31, P1, DOI 10.1111/j.1365-2389.1980.tb02059.x; RAAB D, 1993, WATER AIR SOIL POLL, V68, P199, DOI 10.1007/BF00479403; Schulthess C. P., 1991, Advances in Soil Science, V16, P121; SCHULTHESS CP, 1986, SOIL SCI SOC AM J, V50, P1406, DOI 10.2136/sssaj1986.03615995005000060007x; Schwertmann U, 1991, IRON OXIDES LAB PREP; Segel I.H., 1975, ENZYME KINETICS; Shen HY, 2005, TALANTA, V66, P734, DOI 10.1016/j.talanta.2004.12.021; STUMM W, 1970, CROAT CHEM ACTA, V42, P223; Tempkin M.I., 1940, ACTA PHYS CHIM USSR, V12, P327; Thomas G. W., 1974, The Plant Root and its Environment. Proceedings held at Virginia Polytechnic and State University, 1971. E.W.Carson (Editor), P483; THOMAS GW, 1977, SOIL SCI SOC AM J, V41, P230, DOI 10.2136/sssaj1977.03615995004100020015x; Vanselow AP, 1932, SOIL SCI, V33, P95, DOI 10.1097/00010694-193202000-00002; Venema P, 1998, J COLLOID INTERF SCI, V198, P282, DOI 10.1006/jcis.1997.5245; Villalobos M, 2001, J COLLOID INTERF SCI, V235, P15, DOI 10.1006/jcis.2000.7341; Villalobos M, 2008, J COLLOID INTERF SCI, V326, P307, DOI 10.1016/j.jcis.2008.06.026; Wijnja H, 2000, SOIL SCI SOC AM J, V64, P898, DOI 10.2136/sssaj2000.643898x; Wijnja H, 2000, J COLLOID INTERF SCI, V229, P286, DOI 10.1006/jcis.2000.6960; Wijnja H, 2002, SOIL SCI SOC AM J, V66, P1190, DOI 10.2136/sssaj2002.1190; Wijnja H, 2001, SOIL SCI SOC AM J, V65, P324, DOI 10.2136/sssaj2001.652324x; Wijnja H., 1999, THESIS; Xu RK, 2007, EUR J SOIL SCI, V58, P335, DOI 10.1111/j.1365-2389.2006.00842.x	55	2	2	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176743	10.1371/journal.pone.0176743	http://dx.doi.org/10.1371/journal.pone.0176743			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28464020	Green Published, Green Submitted, gold			2022-12-26	WOS:000400646300049
J	Dion, F; Dumayne, C; Henley, N; Beauchemin, S; Arias, EB; Leblond, FA; Lesage, S; Lefrancois, S; Cartee, GD; Pichette, V				Dion, Francois; Dumayne, Christopher; Henley, Nathalie; Beauchemin, Stephanie; Arias, Edward B.; Leblond, Francois A.; Lesage, Sylvie; Lefrancois, Stephane; Cartee, Gregory D.; Pichette, Vincent			Mechanism of insulin resistance in a rat model of kidney disease and the risk of developing type 2 diabetes	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; SKELETAL-MUSCLE; GLUCOSE-UPTAKE; CARDIOVASCULAR EVENTS; ADIPOSE-TISSUE; METABOLISM; TRANSPORT; CYTOCHROME-P450; HYPERGLYCEMIA; HOMEOSTASIS	Chronic kidney disease is associated with homeostatic imbalances such as insulin resistance. However, the underlying mechanisms leading to these imbalances and whether they promote the development of type 2 diabetes is unknown. The effect of chronic kidney disease on insulin resistance was studied on two different rat strains. First, in a 5/6(th) nephrectomised Sprague-Dawley rat model of chronic kidney disease, we observed a correlation between the severity of chronic kidney disease and hyperglycemia as evaluated by serum fructosamine levels (p < 0.0001). Further, glucose tolerance tests indicated an increase of 25% in glycemia in chronic kidney disease rats (p < 0.0001) as compared to controls whereas insulin levels remained unchanged. We also observed modulation of glucose transporters expression in several tissues such as the liver (decrease of approximate to 40%, p <= 0.01) and muscles (decrease of approximate to 29%, p <= 0.05). Despite a significant reduction of approximate to 37% in insulin-dependent glucose uptake in the muscles of chronic kidney disease rats (p <= 0.0001), the development of type 2 diabetes was never observed. Second, in a rat model of metabolic syndrome (Zucker Lepr (fa/fa)), chronic kidney disease caused a 50% increased fasting hyperglycemia (p < 0.0001) and an exacerbated glycemic response (p < 0.0001) during glucose challenge. Similar modulations of glucose transporters expression and glucose uptake were observed in the two models. However, 30% (p < 0.05) of chronic kidney disease Zucker rats developed characteristics of type 2 diabetes. Thus, our results suggest that downregulation of GLUT4 in skeletal muscle may be associated with insulin resistance in chronic kidney disease and could lead to type 2 diabetes in predisposed animals.	[Dion, Francois; Dumayne, Christopher; Henley, Nathalie; Beauchemin, Stephanie; Arias, Edward B.; Leblond, Francois A.; Lesage, Sylvie; Lefrancois, Stephane; Pichette, Vincent] Univ Montreal, Fac Med, Ctr Rech, Hop Maisonneuve Rosemt, Montreal, PQ, Canada; [Dion, Francois; Dumayne, Christopher; Pichette, Vincent] Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ, Canada; [Arias, Edward B.; Cartee, Gregory D.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA; [Lesage, Sylvie] Univ Montreal, Fac Med, Dept Microbiol, Infectiol & immunol, Montreal, PQ, Canada; [Lefrancois, Stephane] Inst Natl Rech Scientif, Ctr INRS Inst Armand Frappier, Laval, PQ, Canada; [Lefrancois, Stephane] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; University of Michigan System; University of Michigan; Universite de Montreal; University of Quebec; Institut national de la recherche scientifique (INRS); McGill University	Dion, F (corresponding author), Univ Montreal, Fac Med, Ctr Rech, Hop Maisonneuve Rosemt, Montreal, PQ, Canada.; Dion, F (corresponding author), Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ, Canada.	francois.dion@umontreal.ca; vpichette.hmr@ssss.gouv.qc.ca		LEBLOND, AGNES/0000-0001-9136-4544; Lesage, Sylvie/0000-0002-0968-2795	Fondation de l'Hopital Maisonneuve-Rosemont; Diabete quebec; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	Fondation de l'Hopital Maisonneuve-Rosemont; Diabete quebec; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support was provided by Fondation de l'Hopital Maisonneuve-Rosemont [http://www. fondationhmr.ca/] to VP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Support was also provided by Diabete quebec [http://www.diabete.qc.ca/] to FD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud H, 2010, NEW ENGL J MED, V362, P56, DOI 10.1056/NEJMcp0906797; Abdul-Ghani MA, 2013, AM J MANAG CARE, V19, pS43; Aksentijevic D, 2009, KIDNEY INT, V75, P711, DOI 10.1038/ki.2008.691; Basu A, 2000, DIABETES, V49, P272, DOI 10.2337/diabetes.49.2.272; Bowe JE, 2014, J ENDOCRINOL, V222, pG13, DOI 10.1530/JOE-14-0182; Byrdwell WC, 2002, LIPIDS, V37, P1087, DOI 10.1007/s11745-002-1004-1; Calado J, 2011, KIDNEY INT, V79, pS7, DOI 10.1038/ki.2010.510; Cartee GD, 2016, AM J PHYSIOL-ENDOC M, V311, pE818, DOI 10.1152/ajpendo.00289.2016; Castorena CM, 2011, J APPL PHYSIOL, V111, P1106, DOI 10.1152/japplphysiol.00631.2011; Chung BH, 2005, AM J TRANSPLANT, V5, P1856, DOI 10.1111/j.1600-6143.2005.00979.x; Cibulka R, 2007, PHYSIOL RES, V56, P697, DOI 10.33549/physiolres.931128; de Boer IH, 2016, J AM SOC NEPHROL, V27, P2861, DOI 10.1681/ASN.2015070756; DEFRONZO RA, 1981, J CLIN INVEST, V67, P563, DOI 10.1172/JCI110067; Fox CS, 2015, CIRCULATION, V132, P691, DOI 10.1161/CIR.0000000000000230; FRIEDMAN JE, 1991, AM J PHYSIOL, V261, pE87, DOI 10.1152/ajpendo.1991.261.1.E87; George C, 2011, J ETHNOPHARMACOL, V137, P298, DOI 10.1016/j.jep.2011.05.023; HENRIKSEN EJ, 1990, AM J PHYSIOL, V259, pE593, DOI 10.1152/ajpendo.1990.259.4.E593; HIDAKA H, 1982, J CLIN ENDOCR METAB, V54, P217, DOI 10.1210/jcem-54-2-217; Hung AM, 2011, CONTRIB NEPHROL, V171, P127, DOI 10.1159/000327177; JACOBS DB, 1989, AM J PHYSIOL, V257, pE193, DOI 10.1152/ajpendo.1989.257.2.E193; Jia T, 2015, J CLIN ENDOCR METAB, V100, P587, DOI 10.1210/jc.2014-3313; Koppe L, 2016, J CLIN INVESTIGATION; Koppe L, 2014, NEPHROL DIAL TRANSPL, V29, P1666, DOI 10.1093/ndt/gft435; Leblond F, 2001, J AM SOC NEPHROL, V12, P326, DOI 10.1681/ASN.V122326; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Liao MT, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/691369; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marsenic O, 2009, AM J KIDNEY DIS, V53, P875, DOI 10.1053/j.ajkd.2008.12.031; Massry SG, 2011, J RENAL NUTR, V21, P92, DOI 10.1053/j.jrn.2010.11.001; Moore MC, 2012, ADV NUTR, V3, P286, DOI 10.3945/an.112.002089; Naud J, 2008, DRUG METAB DISPOS, V36, P124, DOI 10.1124/dmd.107.018192; Naud J, 2011, DRUG METAB DISPOS, V39, P1363, DOI 10.1124/dmd.111.039115; Nawano M, 2000, AM J PHYSIOL-ENDOC M, V278, pE535, DOI 10.1152/ajpendo.2000.278.3.E535; Niewczas MA, 2014, KIDNEY INT, V85, P1214, DOI 10.1038/ki.2013.497; ROSSETTI L, 1995, CLIN INVEST MED, V18, P255; Rutter MK, 2005, DIABETES, V54, P3252, DOI 10.2337/diabetes.54.11.3252; Sandsmark DK, 2015, STROKE, V46, P2075, DOI 10.1161/STROKEAHA.115.009861; SCHMITZ O, 1991, DAN MED BULL, V38, P36; Sharma N, 2011, AM J PHYSIOL-ENDOC M, V300, pE966, DOI 10.1152/ajpendo.00659.2010; Shinohara K, 2002, J AM SOC NEPHROL, V13, P1894, DOI 10.1097/01.ASN.0000019900.87535.43; Shipman KE, 2015, PRIM CARE DIABETES, V9, P142, DOI 10.1016/j.pcd.2014.05.001; Sit D, 2006, ADV THER, V23, P988, DOI 10.1007/BF02850219; Slee AD, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-36; St-Pierre P, 2010, DIABETES OBES METAB, V12, P798, DOI 10.1111/j.1463-1326.2010.01235.x; Sud M, 2014, CIRCULATION, V130, P458, DOI 10.1161/CIRCULATIONAHA.113.007106; Sun H, 2006, PHARMACOL THERAPEUT, V109, P1, DOI 10.1016/j.pharmthera.2005.05.010; Szolkiewicz M, 2005, J RENAL NUTR, V15, P166, DOI 10.1053/j.jrn.2004.09.030; Tataranni P A, 2002, Eur Rev Med Pharmacol Sci, V6, P27; Wang H, 2015, J GERONTOLOGY A; Youd JM, 2000, DIABETES, V49, P1904, DOI 10.2337/diabetes.49.11.1904	51	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176650	10.1371/journal.pone.0176650	http://dx.doi.org/10.1371/journal.pone.0176650			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459862	Green Published, Green Submitted, gold			2022-12-26	WOS:000400645000042
J	Myers, RR; Smith, TD; Elsawa, SF; Puel, O; Tadrist, S; Calvo, AM				Myers, Ryan R.; Smith, Timothy D.; Elsawa, Sherine F.; Puel, Olivier; Tadrist, Souraia; Calvo, Ana M.			rtfA controls development, secondary metabolism, and virulence in Aspergillus fumigatus	PLOS ONE			English	Article							RNA-POLYMERASE-II; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; INVASIVE PULMONARY ASPERGILLOSIS; CELL TRANSPLANT RECIPIENTS; TRANSCRIPTION ELONGATION; SACCHAROMYCES-CEREVISIAE; HUMAN PATHOGEN; PAF1 COMPLEX; HISTONE H2B; HEMATOLOGIC MALIGNANCIES	Invasive aspergillosis by Aspergillus fumigatus is a leading cause of infection-related mortality in immune-compromised patients. In order to discover potential genetic targets to control A. fumigatus infections we characterized rtfA, a gene encoding a putative RNA polymerase II transcription elongation factor-like protein. Our recent work has shown that the rtfA ortholog in the model fungus Aspergillus nidulans regulates morphogenesis and secondary metabolism. The present study on the opportunistic pathogen A. fumigatus rtfA gene revealed that this gene influences fungal growth and conidiation, as well as production of the secondary metabolites tryptoquivaline F, pseurotin A, fumiquinazoline C, festuclavine, and fumigaclavines A, B and C. Additionally, rtfA influences protease activity levels, the sensitivity to oxidative stress and adhesion capacity, all factors important in pathogenicity. Furthermore, rtfA was shown to be indispensable for normal virulence using Galleria mellonella as well as murine infection model systems.	[Myers, Ryan R.; Smith, Timothy D.; Elsawa, Sherine F.; Calvo, Ana M.] Noorthern Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA; [Puel, Olivier; Tadrist, Souraia] Univ Toulouse, UPS, INRA, ENVT,NPP Purpan,Toxalim Res Ctr Food Toxicol, Toulouse, France	INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Toulouse III - Paul Sabatier	Calvo, AM (corresponding author), Noorthern Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA.	amcalvo@niu.edu		Elsawa, Sherine/0000-0002-3917-3078; Puel, Olivier/0000-0003-1946-5310	Northern Illinois University	Northern Illinois University	Internal funding from Northern Illinois University supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was funded by Northern Illinois University. The authors thank Sourabh Dhingra, Corinna Kashuba, Scott Grayburn, and Xue-Huan Feng for their technical support.	ADAMS TH, 1988, CELL, V54, P353, DOI 10.1016/0092-8674(88)90198-5; Akanuma T, 2007, EMBO REP, V8, P858, DOI 10.1038/sj.embor.7401045; ARCHAMBAULT J, 1992, MOL CELL BIOL, V12, P4142, DOI 10.1128/MCB.12.9.4142; Beauvais A, 2007, CELL MICROBIOL, V9, P1588, DOI 10.1111/j.1462-5822.2007.00895.x; Bergmann A, 2009, INFECT IMMUN, V77, P4041, DOI 10.1128/IAI.00425-09; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Calera JA, 1997, INFECT IMMUN, V65, P4718, DOI 10.1128/IAI.65.11.4718-4724.1997; Cano PM, 2013, ANAL CHEM, V85, P8412, DOI 10.1021/ac401872f; Chen JJ, 2013, INT J MED SCI, V10, P1625, DOI 10.7150/ijms.6824; Costa PJ, 2000, GENETICS, V156, P535; Coyle CM, 2007, MYCOLOGIA, V99, P804, DOI 10.3852/mycologia.99.6.804; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Damveld RA, 2005, FUNGAL GENET BIOL, V42, P165, DOI 10.1016/j.fgb.2004.11.006; De Groot PWJ, 2005, FUNGAL GENET BIOL, V42, P657, DOI 10.1016/j.fgb.2005.04.002; de Jong RN, 2008, STRUCTURE, V16, P149, DOI 10.1016/j.str.2007.10.018; de Sa RA, 2013, BRAZ J MICROBIOL, V44, P993, DOI 10.1590/S1517-83822013005000062; de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Desai JV, 2014, COLD SPRING HARB PER, P4, DOI [10.1101/chsperspect.a019729, DOI 10.1101/CHSPERSPECT.A019729]; Dhingra S, 2012, EUKARYOT CELL, V11, P1531, DOI 10.1128/EC.00222-12; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; EXINGER F, 1992, CURR GENET, V22, P9, DOI 10.1007/BF00351735; Fallon John, 2012, Methods Mol Biol, V845, P469, DOI 10.1007/978-1-61779-539-8_33; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fuchs BB, 2010, VIRULENCE, V1, P475, DOI 10.4161/viru.1.6.12985; Gauthier T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029906; [韩小贤 HAN Xiaoxian], 2007, [中国药物化学杂志, Chinese Journal of Medicinal Chemistry], V17, P232; Hedayati MT, 2007, MICROBIOL-SGM, V153, P1677, DOI 10.1099/mic.0.2007/007641-0; Hill TW, 2006, MYCOLOGIA, V98, P399, DOI 10.3852/mycologia.98.3.399; JATONOGAY K, 1994, MOL MICROBIOL, V14, P917, DOI 10.1111/j.1365-2958.1994.tb01327.x; KELLEHER RJ, 1990, CELL, V61, P1209, DOI 10.1016/0092-8674(90)90685-8; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Klyasova GA, 2005, TERAPEVT ARKH, V77, P65; Knutsen Alan P, 2002, J Cyst Fibros, V1, P76; KOLATTUKUDY PE, 1993, INFECT IMMUN, V61, P2357, DOI 10.1128/IAI.61.6.2357-2368.1993; Kontoyiannis DP, 2002, EUR J CLIN MICROBIOL, V21, P161, DOI 10.1007/s10096-002-0699-z; KOTHARY MH, 1984, INFECT IMMUN, V43, P320, DOI 10.1128/IAI.43.1.320-325.1984; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kurup Viswanath P., 2009, P351, DOI 10.1007/978-4-431-88317-3_22; Latge JP, 2001, TRENDS MICROBIOL, V9, P382, DOI 10.1016/S0966-842X(01)02104-7; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li YX, 2013, MAR DRUGS, V11, P5063, DOI 10.3390/md11125063; Lim FY, 2014, CELL MICROBIOL, V16, P1267, DOI 10.1111/cmi.12284; Lind AL, 2016, G3-GENES GENOM GENET, V6, P4023, DOI 10.1534/g3.116.033084; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohmar JM, 2016, APPL MICROBIOL BIOT, V100, P5029, DOI 10.1007/s00253-016-7418-7; Loussert C, 2010, CELL MICROBIOL, V12, P405, DOI 10.1111/j.1462-5822.2009.01409.x; Maiya S, 2007, CHEMBIOCHEM, V8, P1736, DOI 10.1002/cbic.200700202; Marr KA, 2002, BLOOD, V100, P4358, DOI 10.1182/blood-2002-05-1496; Martinez-Luis S, 2012, NAT PROD COMMUN, V7, P165; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Oren I, 2002, CURR OPIN PULM MED, V8, P195, DOI 10.1097/00063198-200205000-00008; Osherov Nir, 2007, P185, DOI 10.1007/978-1-4020-6397-8_8; Pagano L, 2001, HAEMATOLOGICA, V86, P862; Panaccione DG, 2005, APPL ENVIRON MICROB, V71, P3106, DOI 10.1128/AEM.71.6.3106-3111.2005; PANCALDI S, 1984, ARCH MICROBIOL, V137, P185, DOI 10.1007/BF00414540; PATTERSON R, 1982, ANN INTERN MED, V96, P286, DOI 10.7326/0003-4819-96-3-286; Penalva MA, 2005, FUNGAL GENET BIOL, V42, P963, DOI 10.1016/j.fgb.2005.09.004; Post MJ, 2007, TRANSPL INFECT DIS, V9, P189, DOI 10.1111/j.1399-3062.2007.00219.x; Ramage G, 2005, EUKARYOT CELL, V4, P633, DOI 10.1128/EC.4.4.633-638.2005; Ramamoorthy V, 2012, MOL MICROBIOL, V85, P795, DOI 10.1111/j.1365-2958.2012.08142.x; Ramarao N, 2012, JOVE-J VIS EXP, DOI 10.3791/4392; Reichard U, 1997, J MED VET MYCOL, V35, P189; Richie DL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000258; RONCERO C, 1985, J BACTERIOL, V163, P1180, DOI 10.1128/JB.163.3.1180-1185.1985; ROSENBERG M, 1977, ANN INTERN MED, V86, P405, DOI 10.7326/0003-4819-86-4-405; Ruchel R, 1999, Contrib Microbiol, V2, P21; Samson R A, 1999, Contrib Microbiol, V2, P5; SCHMITT HJ, 1990, MYCOSES, V33, P539, DOI 10.1111/myc.1990.33.11-12.539; Seidler MJ, 2008, ANTIMICROB AGENTS CH, V52, P4130, DOI 10.1128/AAC.00234-08; Sherif R, 2010, CURR OPIN PULM MED, V16, P242, DOI 10.1097/MCP.0b013e328337d6de; Shibuya Kazutoshi, 2006, Nihon Ishinkin Gakkai Zasshi, V47, P249, DOI 10.3314/jjmm.47.249; Smith TD, 2014, EUKARYOT CELL, V13, P766, DOI 10.1128/EC.00075-14; Son H, 2014, EUKARYOT CELL, V13, P87, DOI 10.1128/EC.00220-13; Stevens DA, 2003, CLIN INFECT DIS, V37, pS225, DOI 10.1086/376525; Stolinski LA, 1997, MOL CELL BIOL, V17, P4490, DOI 10.1128/MCB.17.8.4490; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Wallwey C, 2010, ARCH MICROBIOL, V192, P127, DOI 10.1007/s00203-009-0536-1; Warner MH, 2007, MOL CELL BIOL, V27, P6103, DOI 10.1128/MCB.00772-07; Wiederhold NP, 2003, PHARMACOTHERAPY, V23, P1592, DOI 10.1592/phco.23.15.1592.31965; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; WOOD PJ, 1980, CARBOHYD RES, V85, P271, DOI 10.1016/S0008-6215(00)84676-5; Wuren T, 2014, JPN J INFECT DIS, V67, P172, DOI 10.7883/yoken.67.172	88	8	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176702	10.1371/journal.pone.0176702	http://dx.doi.org/10.1371/journal.pone.0176702			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453536	Green Published, gold			2022-12-26	WOS:000400383900045
J	Benjdia, A; Decamps, L; Guillot, A; Kubiak, X; Ruffie, P; Sandstrom, C; Berteau, O				Benjdia, Alhosna; Decamps, Laure; Guillot, Alain; Kubiak, Xavier; Ruffie, Pauline; Sandstrom, Corine; Berteau, Olivier			Insights into the catalysis of a lysine-tryptophan bond in bacterial peptides by a SPASM domain radical S-adenosylmethionine (SAM) peptide cyclase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFATASE-MATURATING ENZYMES; H-ATOM ABSTRACTION; POSTTRANSLATIONAL MODIFICATION; IRON-SULFUR; LIPOYL SYNTHASE; ADOMET ENZYME; BIOSYNTHESIS; CHEMISTRY; THIOSTREPTON; PROKARYOTES	Radical S-adenosylmethionine (SAM) enzymes are emerging as a major superfamily of biological catalysts involved in the biosynthesis of the broad family of bioactive peptides called ribosomally synthesized and post-translationally modified peptides (RiPPs). These enzymes have been shown to catalyze unconventional reactions, such as methyl transfer to electrophilic carbon atoms, sulfur to C-alpha atom thioether bonds, or carbon-carbon bond formation. Recently, a novel radical SAM enzyme catalyzing the formation of a lysine-tryptophanbondhas been identified in Streptococcus thermophilus, and a reaction mechanism has been proposed. By combining site-directed mutagenesis, biochemical assays, and spectroscopic analyses, we show here that this enzyme, belonging to the emerging family of SPASM domain radical SAM enzymes, likely contains three [4Fe-4S] clusters. Notably, our data support that the seven conserved cysteine residues, present within the SPASM domain, are critical for enzyme activity. In addition, we uncovered the minimum substrate requirements and demonstrate that KW cyclic peptides are more widespread than anticipated, notably in pathogenic bacteria. Finally, we show a strict specificity of the enzyme for lysine and tryptophan residues and the dependence of an eight-amino acid leader peptide for activity. Altogether, our study suggests novel mechanistic links among SPASM domain radical SAM enzymes and supports the involvement of non-cysteinyl ligands in the coordination of auxiliary clusters.	[Benjdia, Alhosna; Decamps, Laure; Guillot, Alain; Kubiak, Xavier; Ruffie, Pauline; Berteau, Olivier] Univ Paris Saclay, AgroParisTech, Micalis Inst, ChemSyBio,INRA, F-78350 Jouy En Josas, France; [Sandstrom, Corine] Swedish Univ Agr Sci, Uppsala BioCtr, Dept Mol Sci, POB 7015, S-75007 Uppsala, Sweden	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Swedish University of Agricultural Sciences	Benjdia, A; Berteau, O (corresponding author), Univ Paris Saclay, AgroParisTech, Micalis Inst, ChemSyBio,INRA, F-78350 Jouy En Josas, France.	Alhosna.Benjdia@inra.fr; Olivier.Berteau@inra.fr	Decamps, Laure/ABH-2891-2020; Benjdia, Alhosna/AAM-7415-2021; Berteau, Olivier/AAF-9080-2019	Benjdia, Alhosna/0000-0002-3544-2541; Berteau, Olivier/0000-0002-3434-5168	European Research Council [617053]	European Research Council(European Research Council (ERC)European Commission)	This work was supported in part by European Research Council Consolidator Grant 617053 (to O. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Barr I, 2016, J BIOL CHEM, V291, P8877, DOI 10.1074/jbc.C115.699918; Benjdia A, 2008, J BIOL CHEM, V283, P17815, DOI 10.1074/jbc.M710074200; Benjdia A, 2007, J AM CHEM SOC, V129, P3462, DOI 10.1021/ja067175e; Benjdia A, 2007, FEBS LETT, V581, P1009, DOI 10.1016/j.febslet.2007.01.076; Benjdia A, 2017, NAT CHEM, V9, P698, DOI [10.1038/NCHEM.2714, 10.1038/nchem.2714]; Benjdia A, 2016, CHEM COMMUN, V52, P6249, DOI 10.1039/c6cc01317a; Benjdia A, 2016, BIOCHEM SOC T, V44, P109, DOI 10.1042/BST20150191; Benjdia A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9377; Benjdia A, 2011, J BIOL CHEM, V286, P25973, DOI 10.1074/jbc.M111.228841; Benjdia A, 2010, FEBS J, V277, P1906, DOI 10.1111/j.1742-4658.2010.07613.x; Benjdia A, 2009, J AM CHEM SOC, V131, P8348, DOI 10.1021/ja901571p; Berteau O, 2006, J BIOL CHEM, V281, P22464, DOI 10.1074/jbc.M602504200; Berteau O, 2017, PHOTOCHEM PHOTOBIOL, V93, P67, DOI 10.1111/php.12702; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Bruender NA, 2016, BIOCHEMISTRY-US, V55, P2813, DOI 10.1021/acs.biochem.6b00355; Cheng VWT, 2013, BBA-BIOENERGETICS, V1827, P1141, DOI 10.1016/j.bbabio.2013.05.004; Fluhe E, 2012, NAT CHEM BIOL, V8, P350, DOI [10.1038/NCHEMBIO.798, 10.1038/nchembio.798]; Fluhe L, 2013, J AM CHEM SOC, V135, P959, DOI 10.1021/ja310542g; Goldman PJ, 2013, P NATL ACAD SCI USA, V110, P8519, DOI 10.1073/pnas.1302417110; Grell TAJ, 2015, J BIOL CHEM, V290, P3964, DOI 10.1074/jbc.R114.581249; Haft DH, 2011, J BACTERIOL, V193, P2745, DOI 10.1128/JB.00040-11; Harmer JE, 2014, BIOCHEM J, V464, P123, DOI 10.1042/BJ20140895; Ibrahim M, 2007, J BACTERIOL, V189, P8844, DOI 10.1128/JB.01057-07; Li HR, 2011, J BIOL CHEM, V286, P867, DOI 10.1074/jbc.M110.184176; McLaughlin MI, 2016, P NATL ACAD SCI USA, V113, P9446, DOI 10.1073/pnas.1602486113; Mehta AP, 2015, J BIOL CHEM, V290, P3980, DOI 10.1074/jbc.R114.623793; Nakai T, 2015, J BIOL CHEM, V290, P11144, DOI 10.1074/jbc.M115.638320; Parent A, 2016, J AM CHEM SOC, V138, P15515, DOI 10.1021/jacs.6b06697; Pierre S, 2012, NAT CHEM BIOL, V8, P957, DOI [10.1038/NCHEMBIO.1091, 10.1038/nchembio.1091]; Qi WB, 2011, COORDIN CHEM REV, V255, P688, DOI 10.1016/j.ccr.2010.10.016; Schramma KR, 2015, NAT CHEM, V7, P431, DOI [10.1038/NCHEM.2237, 10.1038/nchem.2237]; Wecksler SR, 2009, BIOCHEMISTRY-US, V48, P10151, DOI 10.1021/bi900918b; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	34	13	13	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10835	10844		10.1074/jbc.M117.783464	http://dx.doi.org/10.1074/jbc.M117.783464			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28476884	Green Published, hybrid			2022-12-26	WOS:000404391000008
J	Chang, JS; Ha, K				Chang, Ji Suk; Ha, Kyoungsoo			An unexpected role for the transcriptional coactivator isoform NT-PGC-1 alpha in the regulation of mitochondrial respiration in brown adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN CREB; GENE-EXPRESSION; ADAPTIVE THERMOGENESIS; ADIPOSE-TISSUE; T3 RECEPTOR; COMPLEX-I; PGC-1-ALPHA; BIOGENESIS; DNA; DIFFERENTIATION	Brown adipose tissue dissipates energy as heat, a process that relies on a high abundance of mitochondria and high levels of electron transport chain (ETC) complexes within these mitochondria. Two regulators of mitochondrial respiration and heat production in brown adipocytes are the transcriptional coactivator PGC-1 alpha and its splicing isoform NT-PGC-1 alpha, which control mitochondrial gene expression in the nucleus. Surprisingly, we found that, in brown adipocytes, some NT-PGC-1 alpha localizes to mitochondria, whereas PGC-1 alpha resides in the nucleus. Here we sought to investigate the role of NT-PGC-1 alpha in brown adipocyte mitochondria. Immunocytochemistry, immunotransmission electron microscopy, and biochemical analyses indicated that NT-PGC-1 alpha was located in the mitochondrial matrix in brown adipocytes. NT-PGC-1 alpha was specifically enriched at the D-loop region of the mtDNA, which contains the promoters for several essential ETC complex genes, and was associated with LRP130, an activator of mitochondrial transcription. Selective expression of NT-PGC-1 alpha and PGC-1 alpha in PGC-1 alpha(-/-) brown adipocytes similarly induced expression of nuclear DNA-encoded mitochondrial ETC genes, including the key mitochondrial transcription factor A(TFAM). Despite having comparable levels of TFAM expression, PGC-1 alpha(-/-) brown adipocytes expressing NT-PGC-1 alpha had higher expression of mtDNA-encoded ETC genes than PGC-1 alpha(-/-) brown adipocytes expressing PGC-1 alpha, suggesting a direct effect of NT-PGC-1 alpha on mtDNA transcription. Moreover, this increase in mtDNA-encoded ETC gene expression was associated with enhanced respiration in NT-PGC-1 alpha-expressing PGC-1 alpha(-/-) brown adipocytes. Our findings reveal a previously unappreciated and isoform-specific role for NT-PGC-1 alpha in the regulation of mitochondrial transcription in brown adipocytes and provide new insight into the transcriptional control of mitochondrial respiration.	[Chang, Ji Suk; Ha, Kyoungsoo] Pennington Biomed Res Ctr, Lab Gene Regulat & Metab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Chang, JS (corresponding author), Pennington Biomed Res Ctr, Lab Gene Regulat & Metab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	jisuk.chang@pbrc.edu	Chang, Ji Suk/N-1957-2017		COBRE grant from the National Institutes of Health [NIH8 1P30GM118430-01]; NORC (National Institutes of Health) center grant from the National Institutes of Health [1P30-DK072476]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104748, P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103528, P30GM118430] Funding Source: NIH RePORTER	COBRE grant from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NORC (National Institutes of Health) center grant from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Tom Gettys (Pennington Biomedical Research Center) for kindly providing anti-PGC-1 alpha and anti-UCP1 antibodies. We also thank Ying Xiao (LSU Socolofsky Microscopy Center) for technical assistance and Cindi Tramonte for administrative support. We used Cell Biology and Bioimaging and Genomics Core facilities that are supported in part by COBRE (NIH8 1P30GM118430-01) and NORC (National Institutes of Health 1P30-DK072476) center grants from the National Institutes of Health.	Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200; Aquilano K, 2010, J BIOL CHEM, V285, P21590, DOI 10.1074/jbc.M109.070169; Bereziat V, 2005, BIOCHIMIE, V87, P951, DOI 10.1016/j.biochi.2005.05.010; Bourges I, 2004, BIOCHEM J, V383, P491, DOI 10.1042/BJ20040256; Casas F, 1999, MOL CELL BIOL, V19, P7913; Casas F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002501; Chang JS, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.13013; Chang JS, 2012, J BIOL CHEM, V287, P9100, DOI 10.1074/jbc.M111.320200; Chang JS, 2010, J BIOL CHEM, V285, P18039, DOI 10.1074/jbc.M109.083121; CHOMYN A, 1985, NATURE, V314, P592, DOI 10.1038/314592a0; Commins SP, 1999, ENDOCRINOLOGY, V140, P292, DOI 10.1210/en.140.1.292; Cooper MP, 2008, J BIOL CHEM, V283, P31960, DOI 10.1074/jbc.M805431200; Cooper MP, 2006, GENE DEV, V20, P2996, DOI 10.1101/gad.1483906; Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424; De Rasmo D, 2009, FEBS J, V276, P4325, DOI 10.1111/j.1742-4658.2009.07133.x; Jun HJ, 2014, DIABETES, V63, P3615, DOI 10.2337/db13-1837; Kim J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159990; Lee J, 2005, J BIOL CHEM, V280, P40398, DOI 10.1074/jbc.C500140200; Liu LJ, 2011, J BIOL CHEM, V286, P41253, DOI 10.1074/jbc.M111.276121; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Macias E, 2014, J INVEST DERMATOL, V134, P1971, DOI 10.1038/jid.2014.68; Montoya J, 1997, MOL CELL BIOCHEM, V174, P227, DOI 10.1023/A:1006812625445; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Pessemesse L, 2012, FASEB J, V26, P748, DOI 10.1096/fj.11-195933; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; She H, 2011, J CLIN INVEST, V121, P930, DOI 10.1172/JCI43871; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Takamatsu C, 2002, EMBO REP, V3, P451, DOI 10.1093/embo-reports/kvf099; Tiranti V, 1997, HUM MOL GENET, V6, P615, DOI 10.1093/hmg/6.4.615; WRUTNIAK C, 1995, J BIOL CHEM, V270, P16347, DOI 10.1074/jbc.270.27.16347; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zalk R, 2005, BIOCHEM J, V386, P73, DOI 10.1042/BJ20041356; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556	39	14	14	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					9958	9966		10.1074/jbc.M117.778373	http://dx.doi.org/10.1074/jbc.M117.778373			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28473468	Green Published, hybrid			2022-12-26	WOS:000403580600009
J	Banu, S; Pholwat, S; Foongladda, S; Chinli, R; Boonlert, D; Ferdous, SS; Rahman, SMM; Rahman, A; Ahmed, S; Houpt, ER				Banu, Sayera; Pholwat, Suporn; Foongladda, Suporn; Chinli, Rattapha; Boonlert, Duangjai; Ferdous, Sara Sabrina; Rahman, S. M. Mazidur; Rahman, Arfatur; Ahmed, Shahriar; Houpt, Eric R.			Performance of TaqMan array card to detect TB drug resistance on direct specimens	PLOS ONE			English	Article							GENOTYPE(R) MTBDRPLUS ASSAY; XPERT MTB/RIF ASSAY; REAL-TIME PCR; MYCOBACTERIUM-TUBERCULOSIS; RIFAMPIN RESISTANCE; MDR-TB; DNA	Culture based phenotypic drug susceptibility testing (DST) for Mycobacterium tuberculosis (TB) is time consuming therefore rapid genotypic methods are increasingly being utilized. We previously developed and evaluated on TB isolates a rapid genotypic TaqMan array card (TAC) that detects mutations in several resistance-associated genes using dozens of primer pairs, probes, and high resolution melt analysis, with >96% accuracy versus Sanger sequencing. In this study we examined the performance of TAC on sputum, comparing results between 71 paired sputum and TB isolates of which 62 were MDR-TB. We also adapted the TAC to include wild-type probes and broadened coverage for rpoB and gyrA mutations. TAC was 89% successful at detecting wild-type or mutations within inhA, katG, rpoB, eis, gyrA, rplC, and pncA on smear positive sputa and 33% successful on smear negative sputa. The overall accuracy of these detections as compared to the TAC results of the paired isolate was 95% +/- 7 (average sensitivity 98% +/- 3; specificity 92% +/- 14). Accuracy of sputum TAC results versus phenotypic DST for isoniazid, rifampin, ofloxacin/moxifloxacin, and pyrazinamide was 85% +/- 12. This was similar to that of the isolate TAC results (accuracy 88% +/- 13), thus inaccuracies primarily reflected intrinsic genotypic-phenotypic discordance. The TAC is a rapid, modular, comprehensive, and accurate TB DST for the major first and second line TB drugs and could be used for supplemental testing of GeneXpert resistant smear positive sputum.	[Banu, Sayera; Ferdous, Sara Sabrina; Rahman, S. M. Mazidur; Rahman, Arfatur; Ahmed, Shahriar] Int Ctr Diarrhoeal Dis Res, Infect Dis Div, Mycobacteriol Lab, Dhaka, Bangladesh; [Pholwat, Suporn; Houpt, Eric R.] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22903 USA; [Foongladda, Suporn; Chinli, Rattapha; Boonlert, Duangjai] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok, Thailand	International Centre for Diarrhoeal Disease Research (ICDDR); University of Virginia; Mahidol University	Houpt, ER (corresponding author), Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22903 USA.	erh6k@virginia.edu	Ahmed, Shahriar/A-3109-2019; Pholwat, Suporn/CAG-9380-2022; AHMED, SHAHRIAR/N-8532-2019; Rahman, Arfatur/AAC-1482-2022	Ahmed, Shahriar/0000-0002-8833-4130; AHMED, SHAHRIAR/0000-0002-8833-4130; Rahman, Arfatur/0000-0001-8749-0337; Rahman, Syed Mohammad Mazidur/0000-0003-2887-6250; Banu, Sayera/0000-0002-5121-1962	National Institute of Health (NIH) [R01 A1093358, K24 A1102972]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093358] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Health (NIH) grants R01 A1093358 and K24 A1102972 (to EH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous WK, 2005, J CLIN MICROBIOL, V43, P2471, DOI 10.1128/JCM.43.5.2471-2473.2005; Anek-vorapong R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-123; Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Campbell PJ, 2011, ANTIMICROB AGENTS CH, V55, P2032, DOI 10.1128/AAC.01550-10; Chakravorty S, 2011, J CLIN MICROBIOL, V49, P932, DOI 10.1128/JCM.02271-10; Clinical and Laboratory Standards Institute (CLSI), 2011, M24A2 CLSI; Foongladda S, 2016, INT J TUBERC LUNG D, V20, P1105, DOI 10.5588/ijtld.15.0896; Georghiou SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033275; Heysell SK, 2015, ANTIMICROB AGENTS CH, V59, P7104, DOI 10.1128/AAC.01117-15; Hillemann D, 2008, ANTIMICROB AGENTS CH, V52, P800, DOI 10.1128/AAC.01189-07; Liu J, 2016, LANCET, V388, P1291, DOI 10.1016/S0140-6736(16)31529-X; McAlister AJ, 2015, J CLIN MICROBIOL, V53, P1752, DOI 10.1128/JCM.03433-14; Meka VG, 2004, CLIN INFECT DIS, V39, P1010, DOI 10.1086/423841; Nikolayevskyy V, 2009, BMC CLIN PATHOL, V9, DOI 10.1186/1472-6890-9-2; Pholwat S, 2015, MBIO, V6, DOI 10.1128/mBio.02273-14; Pholwat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057238; Prystowsky J, 2001, ANTIMICROB AGENTS CH, V45, P2154, DOI 10.1128/AAC.45.7.2154-2156.2001; Ramirez MV, 2010, J CLIN MICROBIOL, V48, P4003, DOI 10.1128/JCM.00812-10; Salamon H, 2015, J INFECT DIS, V211, pS50, DOI 10.1093/infdis/jiu816; Starks AM, 2015, INFECT DIS SOC AM S3, V61, pS141; Theron G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010705.pub2; Yadav RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072036; Yakrus MA, 2014, J CLIN MICROBIOL, V52, P1932, DOI 10.1128/JCM.00417-14	24	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177167	10.1371/journal.pone.0177167	http://dx.doi.org/10.1371/journal.pone.0177167			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472124	Green Submitted, Green Published, gold			2022-12-26	WOS:000400648500149
J	Falda-Buscaiot, T; Hintzy, F; Rougier, P; Lacouture, P; Coulmy, N				Falda-Buscaiot, Thomas; Hintzy, Frederique; Rougier, Patrice; Lacouture, Patrick; Coulmy, Nicolas			Influence of slope steepness, foot position and turn phase on plantar pressure distribution during giant slalom alpine ski racing	PLOS ONE			English	Article							GROUND REACTION FORCES; SYSTEM; IMPACT; PLATE	The purpose of this study was to investigate the evolution of ground reaction force during alpine skiing turns. Specifically, this study investigated how turn phases and slope steepness affected the whole foot normal GRF pattern while performing giant slalom turns in a race-like setting. Moreover, the outside foot was divided into different plantar regions to see whether those parameters affected the plantar pressure distribution. Eleven skiers performed one giant slalom course at race intensity. Runs were recorded synchronously using a video camera in the frontal plane and pressure insoles under both feet's plantar surface. Turns were divided according to kinematic criteria into four consecutive phases: initiation, steering1, steering2 and completion; both steering phases being separated by the gate passage. Component of the averaged Ground Reaction Force normal to the ski's surface ((nGRF) over bar,/BW), and Pressure Time Integral relative to the entire foot surface (relPTI, %) parameters were calculated for each turn phases based on plantar pressure data. Results indicated that (nGRF) over bar under the total foot surface differed significantly depending on the slope (higher in steep sections vs. flat sections), and the turn phase (higher during steering2 vs. three other phases), although such modifications were observable only on the outside foot. Moreover, (nGRF) over bar under the outside foot was significantly greater than under the inside foot. RelPTI under different foot regions of the outside foot revealed a global shift from forefoot loading during initiation phase, toward heel loading during steering2 phase, but this was dependent on the slope studied. These results suggest a differentiated role played by each foot in alpine skiing turns: the outside foot has an active role in the turning process, while the inside foot may only play a role in stability.	[Falda-Buscaiot, Thomas; Hintzy, Frederique; Rougier, Patrice] Univ Savoie Mt Blanc, Lab Interuniv Biol Motricite, Chambery, France; [Falda-Buscaiot, Thomas] Cluster Sporaltec, Saint Etienne, France; [Lacouture, Patrick] Univ Poitiers, CNRS, Inst Pprime, Lab RoBioSS UPR 3346, Poitiers, France; Fed Francaise Ski, Dept Sportif & Sci, Annecy, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Poitiers	Falda-Buscaiot, T (corresponding author), Univ Savoie Mt Blanc, Lab Interuniv Biol Motricite, Chambery, France.; Falda-Buscaiot, T (corresponding author), Cluster Sporaltec, Saint Etienne, France.	thomas.falda@univ-savoie.fr						Bentley JR, 2010, J STRENGTH COND RES, V24, P1414, DOI 10.1519/JSC.0b013e3181cb27e7; Chesnin KJ, 2000, GAIT POSTURE, V12, P128, DOI 10.1016/S0966-6362(00)00071-0; Federolf P, 2008, SCAND J MED SCI SPOR, V18, P790, DOI 10.1111/j.1600-0838.2007.00745.x; Forner Cordero A, 2004, J BIOMECH, V37, P1427, DOI 10.1016/j.jbiomech.2003.12.016; Fourchet F, 2012, GAIT POSTURE, V35, P685, DOI 10.1016/j.gaitpost.2011.12.004; Gilgien M, 2015, PLOS ONE, V10; Gilgien M, 2014, BRIT J SPORT MED, V48, P742, DOI 10.1136/bjsports-2013-092994; Gilgien M, 2013, SENSORS-BASEL, V13, P9821, DOI 10.3390/s130809821; Girard O, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.036707; HINTERMEISTER RA, 1995, MED SCI SPORT EXER, V27, P315; Keranen T, 2010, 5 INT C SCI SKIING S; Kersting UG, 2010, EM SCI M ESM PROV RI, P55; Kroll J, 2010, MED SCI SPORT EXER, V42, P1545, DOI 10.1249/MSS.0b013e3181d299cf; Kroll J, 2015, 33 INT SOC BIOM SPOR; Lafontaine D, 1998, 16 INT S BIOM SPORTS; Lafontaine D, 1998, 6 EM SCI M BRISB AUS; Lamontagne M., 2001, 19 INT S BIOM SPORTS, P211; Luthi A., 2005, SCINCE SKIING, VIII, P96; Marginson V, 2001, J SPORT SCI, V19, P875, DOI 10.1080/026404101753113822; Melai T, 2011, GAIT POSTURE, V34, P379, DOI 10.1016/j.gaitpost.2011.06.005; Meyer F., 2011, BIOMECHANICAL ANAL A; Muller E, 2003, J SPORT SCI, V21, P679, DOI 10.1080/0264041031000140284; Nakazato K, 2013, SPORTS ENG, V16, P297, DOI 10.1007/s12283-013-0119-x; Nakazato K, 2011, J SPORT SCI MED, V10, P754; Niessen W, 1999, 26 INT S BIOM SPORTS; Petrone N, 2013, SPORTS ENG, V16, P265, DOI 10.1007/s12283-013-0133-z; Reid R.C, 2010, KINEMATIC KINETIC ST; Schaff P., 1997, SCI SKIING, V1st, P159; Scheiber P, 2006, 24 INT S BIOM SPORTS, P564; Senner V, 2016, POINT FORCE APPL TUR; Stoggl T, 2008, J SPORT SCI, V26, P1225, DOI 10.1080/02640410802027386; Stricker G, 2010, EUR J SPORT SCI, V10, P31, DOI 10.1080/17461390903108141; Supej M, 2008, J APPL BIOMECH, V24, P121, DOI 10.1123/jab.24.2.121; Supej M, 2015, INT J SPORT PHYSIOL, V10, P361, DOI 10.1123/ijspp.2014-0200; Yoneyama T, 2010, PROCEDIA ENGINEER, V2, P2901, DOI 10.1016/j.proeng.2010.04.085	35	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176975	10.1371/journal.pone.0176975	http://dx.doi.org/10.1371/journal.pone.0176975			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472092	Green Published, gold, Green Submitted			2022-12-26	WOS:000400648500107
J	Kitamura, S; Morisseau, C; Harris, TR; Inceoglu, B; Hammock, BD				Kitamura, Seiya; Morisseau, Christophe; Harris, Todd R.; Inceoglu, Bora; Hammock, Bruce D.			Occurrence of urea-based soluble epoxide hydrolase inhibitors from the plants in the order Brassicales	PLOS ONE			English	Article							NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE NAMPT; BENZYL ISOTHIOCYANATE; EPOXYEICOSATRIENOIC ACIDS; PENTADIPLANDRA-BRAZZEANA; DOCOSAHEXAENOIC ACID; INFLAMMATORY PAIN; POTENT INHIBITORS; BROCCOLI SPROUTS; MORINGA-OLEIFERA; BLOOD-PRESSURE	Recently, dibenzylurea-based potent soluble epoxide hydrolase (sEH) inhibitors were identified in Pentadiplandra brazzeana, a plant in the order Brassicales. In an effort to generalize the concept, we hypothesized that plants that produce benzyl glucosinolates and corresponding isothiocyanates also produce these dibenzylurea derivatives. Our overall aim here was to examine the occurrence of urea derivatives in Brassicales, hoping to find biologically active urea derivatives from plants. First, plants in the order Brassicales were analyzed for the presence of 1, 3-dibenzylurea (compound 1), showing that three additional plants in the order Brassicales produce the urea derivatives. Based on the hypothesis, three dibenzylurea derivatives with sEH inhibitory activity were isolated from maca (Lepidium meyenii) roots. Topical application of one of the identified compounds (compound 3, human sEH IC50 = 222 nM) effectively reduced pain in rat inflammatory pain model, and this compound was bioavailable after oral administration in mice. The biosynthetic pathway of these urea derivatives was investigated using papaya (Carica papaya) seed as a model system. Finally, a small collection of plants from the Brassicales order was grown, collected, extracted and screened for sEH inhibitory activity. Results show that several plants of the Brassicales order could be potential sources of urea-based sEH inhibitors.	[Kitamura, Seiya; Morisseau, Christophe; Harris, Todd R.; Inceoglu, Bora; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol & Hematol, Davis, CA 95616 USA; [Kitamura, Seiya; Morisseau, Christophe; Harris, Todd R.; Inceoglu, Bora; Hammock, Bruce D.] Univ Calif Davis, Ctr Comprehens Canc, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Hammock, BD (corresponding author), Univ Calif Davis, Dept Entomol & Hematol, Davis, CA 95616 USA.; Hammock, BD (corresponding author), Univ Calif Davis, Ctr Comprehens Canc, Davis, CA 95616 USA.	bdhammock@ucdavis.edu			National Institute of Environmental Health Sciences (NIEHS) [R01ES002710]; NIEHS Superfund Research Program grant [P42 ES04699]; Japan Student Services Organization; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002710, P42ES004699] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS Superfund Research Program grant; Japan Student Services Organization(Japan Student Services Organization); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was partially funded by National Institute of Environmental Health Sciences (NIEHS, http://www.niehs.nih.gov/) grant R01ES002710, and NIEHS Superfund Research Program grant P42 ES04699. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. SK was financially supported by Japan Student Services Organization (http://www.jasso.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandan SK, 2011, BIOORG MED CHEM LETT, V21, P983, DOI 10.1016/j.bmcl.2010.12.042; Bahadoran Z, 2013, J MED FOOD, V16, P375, DOI 10.1089/jmf.2012.2559; Bahroun A, 1985, J SOC CHIMIQUE TUNIS, V2, P15; Barillari J, 2001, FITOTERAPIA, V72, P760, DOI 10.1016/S0367-326X(01)00320-3; BEETHAM JK, 1993, ARCH BIOCHEM BIOPHYS, V305, P197, DOI 10.1006/abbi.1993.1411; Bennett RN, 2004, J AGR FOOD CHEM, V52, P428, DOI 10.1021/jf030530p; Bennett RN, 2003, J AGR FOOD CHEM, V51, P3546, DOI 10.1021/jf0211480; Chen HX, 2012, NAT PROD RES, V26, P1016, DOI 10.1080/14786419.2010.535148; Clarke DB, 2010, ANAL METHODS-UK, V2, P310, DOI 10.1039/b9ay00280d; De Nicola GR, 2012, PHYTOCHEMISTRY, V73, P51, DOI 10.1016/j.phytochem.2011.09.006; Dragovich PS, 2013, BIOORG MED CHEM LETT, V23, P4875, DOI 10.1016/j.bmcl.2013.06.090; Eldrup AB, 2010, BIOORG MED CHEM LETT, V20, P571, DOI 10.1016/j.bmcl.2009.11.091; Engelen-Eigles G, 2006, J AGR FOOD CHEM, V54, P328, DOI 10.1021/jf051857o; Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Fell RT, 2000, CR ACAD SCI II C, V3, P285, DOI 10.1016/S1387-1609(00)00123-7; Garofalo A, 2012, J MED CHEM, V55, P1189, DOI 10.1021/jm2013453; Gieling RG, 2012, J MED CHEM, V55, P5591, DOI 10.1021/jm300529u; GIL V, 1980, PHYTOCHEMISTRY, V19, P1369, DOI 10.1016/0031-9422(80)80176-2; Gill CIR, 2007, AM J CLIN NUTR, V85, P504, DOI 10.1093/ajcn/85.2.504; Goosen TC, 2001, J PHARMACOL EXP THER, V296, P198; Guedes AGP, 2013, VET ANAESTH ANALG, V40, P440, DOI 10.1111/vaa.12030; Gunzner-Toste J, 2013, BIOORG MED CHEM LETT, V23, P3531, DOI 10.1016/j.bmcl.2013.04.040; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hwang SH, 2007, J MED CHEM, V50, P3825, DOI 10.1021/jm070270t; Ikhlas AK, 2014, ENCY DIETARY SUPPLEM, P518; Imig JD, 2002, HYPERTENSION, V39, P690, DOI 10.1161/hy0202.103788; Inceoglu B, 2007, PROSTAG OTH LIPID M, V82, P42; Inceoglu B, 2006, LIFE SCI, V79, P2311, DOI 10.1016/j.lfs.2006.07.031; Inceoglu B, 2012, P NATL ACAD SCI USA, V109, P11390, DOI 10.1073/pnas.1208708109; Inceoglu B, 2008, P NATL ACAD SCI USA, V105, P18901, DOI 10.1073/pnas.0809765105; Intanon S, 2014, J AGR FOOD CHEM, V62, P7423, DOI 10.1021/jf5018687; Jones PD, 2005, ANAL BIOCHEM, V343, P66, DOI 10.1016/j.ab.2005.03.041; Kermanshai R, 2001, PHYTOCHEMISTRY, V57, P427, DOI 10.1016/S0031-9422(01)00077-2; Kim IH, 2007, J MED CHEM, V50, P5217, DOI 10.1021/jm070705c; Kim J, 2014, AM J PHYSIOL-RENAL, V307, pF971, DOI 10.1152/ajprenal.00256.2014; Kitamura S, 2016, J MED CHEM, V59, P4790, DOI 10.1021/acs.jmedchem.6b00173; Kitamura S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117438; Kleinwachter M, 2008, J AGR FOOD CHEM, V56, P11165, DOI 10.1021/jf802053n; la Buscato E, 2013, CHEMMEDCHEM, V8, P919, DOI 10.1002/cmdc.201300057; Lee GH, 2014, FOOD CHEM TOXICOL, V64, P225, DOI 10.1016/j.fct.2013.11.042; Lee MS, 1996, CHEM RES TOXICOL, V9, P1072, DOI 10.1021/tx950213f; Lehmann F, 2006, J MED CHEM, V49, P2232, DOI 10.1021/jm051121i; Li GQ, 2006, BIOORG MED CHEM LETT, V16, P2293, DOI 10.1016/j.bmcl.2006.01.028; Li GY, 2001, ECON BOT, V55, P255, DOI 10.1007/BF02864563; LIN WK, 1990, BIOCHEM BIOPH RES CO, V167, P977, DOI 10.1016/0006-291X(90)90619-X; Liu JY, 2013, EUR J PHARM SCI, V48, P619, DOI 10.1016/j.ejps.2012.12.013; Liu JY, 2011, TOXICOL APPL PHARM, V255, P200, DOI 10.1016/j.taap.2011.06.017; Lo Monte F, 2011, BIOORG MED CHEM LETT, V21, P5610, DOI 10.1016/j.bmcl.2011.06.131; Mithen R, 2010, PHYTOCHEMISTRY, V71, P2074, DOI 10.1016/j.phytochem.2010.09.017; Morisseau C, 1999, P NATL ACAD SCI USA, V96, P8849, DOI 10.1073/pnas.96.16.8849; Morisseau C, 2002, BIOCHEM PHARMACOL, V63, P1599, DOI 10.1016/S0006-2952(02)00952-8; Morisseau C, 2013, ANNU REV PHARMACOL, V53, P37, DOI 10.1146/annurev-pharmtox-011112-140244; Morisseau C, 2010, J LIPID RES, V51, P3481, DOI 10.1194/jlr.M006007; Nakagawa Y, 2000, BIOORGAN MED CHEM, V8, P2663, DOI 10.1016/S0968-0896(00)00198-X; Nakamura Y, 2007, J AGR FOOD CHEM, V55, P4407, DOI 10.1021/jf070159w; Piacente S, 2002, J AGR FOOD CHEM, V50, P5621, DOI 10.1021/jf020280x; RAY AB, 1975, CHEM IND-LONDON, P517; Rose TE, 2010, J MED CHEM, V53, P7067, DOI 10.1021/jm100691c; Sahu S, 2011, J SULFUR CHEM, V32, P171, DOI 10.1080/17415993.2010.550294; Sashidhara KV, 2009, EUR J MED CHEM, V44, P432, DOI 10.1016/j.ejmech.2007.12.018; Schebb NH, 2011, ENVIRON SCI TECHNOL, V45, P3109, DOI 10.1021/es103650m; Schieber A, 2001, TRENDS FOOD SCI TECH, V12, P401, DOI 10.1016/S0924-2244(02)00012-2; Schmelzer KR, 2006, P NATL ACAD SCI USA, V103, P13646, DOI 10.1073/pnas.0605908103; Shen HC, 2012, J MED CHEM, V55, P1789, DOI 10.1021/jm201468j; Sofrata A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023045; TANG CS, 1971, PHYTOCHEMISTRY, V10, P117, DOI 10.1016/S0031-9422(00)90258-9; Tsopmo A, 1999, J NAT PROD, V62, P1435, DOI 10.1021/np990111f; Ulu A, 2008, J CARDIOVASC PHARM, V52, P314, DOI 10.1097/FJC.0b013e318185fa3c; Wagner K, 2011, J AGR FOOD CHEM, V59, P2816, DOI 10.1021/jf102559q; Wang HF, 2010, BIOORG MED CHEM LETT, V20, P392, DOI 10.1016/j.bmcl.2009.10.061; Wang L, 2012, AM J RESP CELL MOL, V46, P614, DOI 10.1165/rcmb.2011-0359OC; Watanabe T, 2006, ANAL CHIM ACTA, V559, P37, DOI 10.1016/j.aca.2005.11.049; WIXTROM RN, 1988, ANAL BIOCHEM, V169, P71, DOI 10.1016/0003-2697(88)90256-4; Wu LY, 2004, P NATL ACAD SCI USA, V101, P7094, DOI 10.1073/pnas.0402004101; Xu D, 2006, P NATL ACAD SCI USA, V103, P18733, DOI 10.1073/pnas.0609158103; Yu ZG, 2000, CIRC RES, V87, P992, DOI 10.1161/01.RES.87.11.992; Zhang GD, 2014, P NATL ACAD SCI USA, V111, P11127, DOI 10.1073/pnas.1410432111; Zhang GD, 2013, P NATL ACAD SCI USA, V110, P6530, DOI 10.1073/pnas.1304321110	79	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176571	10.1371/journal.pone.0176571	http://dx.doi.org/10.1371/journal.pone.0176571			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472063	Green Submitted, Green Published, gold			2022-12-26	WOS:000400648500053
J	Ly, C; Doiron, B				Ly, Cheng; Doiron, Brent			Noise-enhanced coding in phasic neuron spike trains	PLOS ONE			English	Article							STOCHASTIC RESONANCE; SIGNAL TRANSMISSION; FIRE NEURONS; INPUT; OSCILLATIONS; BENEFITS; CURRENTS; SYSTEMS; SOUNDS; MODEL	The stochastic nature of neuronal response has lead to conjectures about the impact of input fluctuations on the neural coding. For the most part, low pass membrane integration and spike threshold dynamics have been the primary features assumed in the transfer from synaptic input to output spiking. Phasic neurons are a common, but understudied, neuron class that are characterized by a subthreshold negative feedback that suppresses spike train responses to low frequency signals. Past work has shown that when a low frequency signal is accompanied by moderate intensity broadband noise, phasic neurons spike trains are well locked to the signal. We extend these results with a simple, reduced model of phasic activity that demonstrates that a non-Markovian spike train structure caused by the negative feedback produces a noise-enhanced coding. Further, this enhancement is sensitive to the timescales, as opposed to the intensity, of a driving signal. Reduced hazard function models show that noise-enhanced phasic codes are both novel and separate from classical stochastic resonance reported in non-phasic neurons. The general features of our theory suggest that noise-enhanced codes in excitable systems with subthreshold negative feedback are a particularly rich framework to study.	[Ly, Cheng] Virginia Commonwealth Univ, Dept Stat Sci & Operat Res, Richmond, VA 23284 USA; [Doiron, Brent] Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA; [Doiron, Brent] Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA	Virginia Commonwealth University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ly, C (corresponding author), Virginia Commonwealth Univ, Dept Stat Sci & Operat Res, Richmond, VA 23284 USA.	CLy@vcu.edu			Simons Foundation [355173, 32529MC]; National Science Foundation [DMS-1313225, DMS-1517082]; National Institutes of Health [R01NS070865, R01DC015139]	Simons Foundation; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Simons Foundation, https://www.simonsfoundation.org/,#355173 (CL); National Science Foundation, https://www.nsf.gov/index.jsp?div=DMS, #DMS-1313225 (BD); National Science Foundation, https://www.nsf.gov/div/index.jsp?dive=DMS,#DMS-1517082 (BD); National Institutes of Health, https://grants.nih.gov/grants/oer.htm, #R01NS070865 (BD); National Institutes of Health https://grants.nil.gov/grants/oer.htm, #R01DC015139 (BD); and Simons Foundation, https://www.simonsfoundation.org/, SCGB#32529MC (BD).	Barreiro AK, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.011916; Benda J, 2010, J NEUROPHYSIOL, V104, P2806, DOI 10.1152/jn.00240.2010; Burkitt AN, 2001, NEURAL COMPUT, V13, P2639, DOI 10.1162/089976601317098475; Chacron MJ, 2005, NAT NEUROSCI, V8, P673, DOI 10.1038/nn1433; Chacron MJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.080601; Chacron MJ, 2001, J NEUROSCI, V21, P5328, DOI 10.1523/JNEUROSCI.21-14-05328.2001; Chen YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056822; Cox D. R., 1962, RENEWAL THEORY; Cox DR, 1966, STAT ANAL SERIES EVE; Dayan P, 2001, COMPUTATIONAL NEUROS; Desroches M, 2012, SIAM REV, V54, P211, DOI 10.1137/100791233; DeVille REL, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031105; DeVille REL, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2217013; Ermentrout B, 1996, NEURAL COMPUT, V8, P979, DOI 10.1162/neco.1996.8.5.979; Gai Y, 2014, J NEUROPHYSIOL, V112, P802, DOI 10.1152/jn.00044.2013; Gai Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000825; Gai Y, 2009, J NEUROPHYSIOL, V102, P3447, DOI 10.1152/jn.00538.2009; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gao X, 2015, NEURON, V86, P292, DOI 10.1016/j.neuron.2015.03.004; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Goychuk I, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.021104; Goychuk I, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.070601; HODGKIN AL, 1948, J PHYSIOL-LONDON, V107, P165, DOI 10.1113/jphysiol.1948.sp004260; HUDSON JL, 1979, J CHEM PHYS, V71, P1601, DOI 10.1063/1.438487; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; JUNG P, 1991, PHYS REV A, V44, P8032, DOI 10.1103/PhysRevA.44.8032; Kloeden PE., 2012, SPRINGER VERLAG, DOI [10.1007/978-3-642-57913-4, DOI 10.1007/978-3-642-57913-4]; Kramers H., 1940, PHYS UTRECHT, V1940, P284; Lindner B, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021911; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; LONGTIN A, 1993, J STAT PHYS, V70, P309, DOI 10.1007/BF01053970; Lundstrom BN, 2008, NEURAL COMPUT, V20, P1239, DOI 10.1162/neco.2007.05-07-536; Lundstrom BN, 2009, J COMPUT NEUROSCI, V27, P277, DOI 10.1007/s10827-009-0142-x; Mapelli J, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00014; McDonnell MD, 2011, NAT REV NEUROSCI, V12, P415, DOI 10.1038/nrn3061; MCNAMARA B, 1989, PHYS REV A, V39, P4854, DOI 10.1103/PhysRevA.39.4854; O'Haver T., 2008, FAST SMOOTHING FUNCT; Plesser HE, 2000, NEURAL COMPUT, V12, P367, DOI 10.1162/089976600300015835; Prescott SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000198; Ratte S, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00452; Rinzel J., 1989, METHODS NEURONAL MOD, P135; Rothman JS, 2003, J NEUROPHYSIOL, V89, P3097, DOI 10.1152/jn.00127.2002; RUSH ME, 1995, B MATH BIOL, V57, P899, DOI 10.1016/S0092-8240(95)80006-9; Shimokawa T, 1999, PHYS REV E, V59, P3427, DOI 10.1103/PhysRevE.59.3427; Slee SJ, 2005, J NEUROSCI, V25, P9978, DOI 10.1523/JNEUROSCI.2666-05.2005; St-Hilaire M, 2004, J COMPUT NEUROSCI, V16, P299, DOI 10.1023/B:JCNS.0000025690.02886.93; Svirskis G, 2002, J NEUROSCI, V22, P11019; Vanag VK, 2000, NATURE, V406, P389, DOI 10.1038/35019038; Vo T, 2010, J COMPUT NEUROSCI, V28, P443, DOI 10.1007/s10827-010-0226-7; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0	50	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176963	10.1371/journal.pone.0176963	http://dx.doi.org/10.1371/journal.pone.0176963			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472143	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500105
J	Ordelheide, AM; Bohm, A; Kempe-Teufel, D; Wagner, R; Machicao, F; Heni, M; Stefan, N; Fritsche, A; Haring, HU; Staiger, H				Ordelheide, Anna-Maria; Boehm, Anja; Kempe-Teufel, Daniela; Wagner, Robert; Machicao, Fausto; Heni, Martin; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich; Staiger, Harald			Common variation in the sodium/glucose cotransporter 2 gene SLC5A2 does neither affect fasting nor glucose-suppressed plasma glucagon concentrations	PLOS ONE			English	Article							INSULIN SENSITIVITY; SGLT2; DAPAGLIFLOZIN; POLYMORPHISMS; INHIBITION	Aim Inhibition of sodium/glucose cotransporter 2 (SGLT2), the key transport protein in renal glucose reabsorption, promotes glucose excretion and represents a new concept in the therapy of type-2 diabetes. In addition, SGLT2 inhibition elevates circulating glucagon concentrations and enhances hepatic glucose production. Since SGLT2 is expressed in human pancreatic alpha-cells and regulates glucagon release, we tested whether common variants of the SGLT2 gene SLC5A2 associate with altered plasma glucagon concentrations in the fasting state and upon glucose challenge. Methods A study population of 375 healthy subjects at increased risk for type-2 diabetes, phenotyped by a 5-point oral glucose tolerance test (OGTT) and genotyped for recently described SLC5A2 tagging single nucleotide polymorphisms (SNPs), was selected for plasma glucagon measurements. Results After adjustment for gender, age, body mass index, and insulin sensitivity, the four tagging SNPs (rs9924771, rs3116150, rs3813008, rs9934336), tested separately or as genetic score, were neither significantly nor nominally associated with plasma glucagon concentrations at any time during the OGTT, with the inverse AUC of glucagon or the glucagon fold-change during the OGTT (p >= 0.2, all). Testing for genotype-related differences in the time course of the glucagon response using MANOVA did also not reveal any significant or nominal associations (p >= 0.5, all). Conclusion We could not obtain statistically significant evidence for a role of common SLC5A2 variants in the regulation of glucagon release in the fasting state or upon glucose challenge. Moreover, the reported nominal effects of individual SLC5A2 variants on fasting and post-challenge glucose levels may probably not be mediated by altered glucagon release.	[Ordelheide, Anna-Maria; Boehm, Anja; Kempe-Teufel, Daniela; Wagner, Robert; Machicao, Fausto; Heni, Martin; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich; Staiger, Harald] Eberhard Karls Univ Tubingen, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis, Otfried Muller Str 10, Tubingen, Germany; [Ordelheide, Anna-Maria; Boehm, Anja; Kempe-Teufel, Daniela; Wagner, Robert; Machicao, Fausto; Heni, Martin; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich; Staiger, Harald] German Ctr Diabet Res DZD, Otfried Muller Str 10, Tubingen, Germany; [Boehm, Anja; Kempe-Teufel, Daniela; Wagner, Robert; Heni, Martin; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich] Univ Tubingen Hosp, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, Otfried Muller Str 10, Tubingen, Germany; [Machicao, Fausto; Staiger, Harald] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Expt Genet, Ingolstadter Landstr 1, Neuherberg, Germany; [Fritsche, Andreas] Univ Tubingen Hosp, Dept Internal Med, Div Nutr & Prevent Med, Otfried Muller Str 10, Tubingen, Germany; [Haering, Hans-Ulrich; Staiger, Harald] Eberhard Karls Univ Tubingen, Nterfac Ctr Pharmacogen & Pharma Res, Morgenstelle 8, Tubingen, Germany; [Staiger, Harald] Eberhard Karls Univ Tubingen, Dept Pharm & Biochem, Inst Pharmaceut Sci, Morgenstelle 8, Tubingen, Germany	Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Staiger, H (corresponding author), Eberhard Karls Univ Tubingen, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis, Otfried Muller Str 10, Tubingen, Germany.; Staiger, H (corresponding author), German Ctr Diabet Res DZD, Otfried Muller Str 10, Tubingen, Germany.; Staiger, H (corresponding author), German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Expt Genet, Ingolstadter Landstr 1, Neuherberg, Germany.; Staiger, H (corresponding author), Eberhard Karls Univ Tubingen, Nterfac Ctr Pharmacogen & Pharma Res, Morgenstelle 8, Tubingen, Germany.; Staiger, H (corresponding author), Eberhard Karls Univ Tubingen, Dept Pharm & Biochem, Inst Pharmaceut Sci, Morgenstelle 8, Tubingen, Germany.	harald.staiger@med.uni-tuebingen.de	Wagner, Robert/B-3689-2012	Wagner, Robert/0000-0002-6120-0191; Stefan, Norbert/0000-0002-2186-9595; Heni, Martin/0000-0002-8462-3832; Staiger, Harald/0000-0002-9507-5333; Moller, Anja/0000-0002-5344-8533	Bundesministerium fur Bildung and Forschung (DE) [01G10925]	Bundesministerium fur Bildung and Forschung (DE)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Bundesministerium fur Bildung and Forschung (DE) (https//www.bmbf.de/) Grant number 01G10925. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonner C, 2015, NAT MED, V21, P512, DOI 10.1038/nm.3828; Crane RK, 1983, COMPREHENSIVE BIOCH, P43; Dusaulcy R, 2016, ENDOCRINOLOGY, V157, P536, DOI 10.1210/en.2015-1725; Enigk U, 2011, PHARMACOGENOMICS, V12, P1119, DOI [10.2217/PGS.11.69, 10.2217/pgs.11.69]; Ferrannini E, 2014, J CLIN INVEST, V124, P499, DOI 10.1172/JCI72227; Heikkinen S, 2007, CURR PROTOC MOL BIOL, DOI DOI 10.1002/0471142727.MB29B03S77; Mather A, 2011, KIDNEY INT, V79, pS1, DOI 10.1038/ki.2010.509; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Merovci A, 2014, J CLIN INVEST, V124, P509, DOI 10.1172/JCI70704; Poulsen SB, 2015, CURR OPIN NEPHROL HY, V24, P463, DOI 10.1097/MNH.0000000000000152; Stefan N, 2005, DIABETOLOGIA, V48, P2282, DOI 10.1007/s00125-005-1948-3; Vallon V, 2015, ANNU REV MED, V66, P255, DOI 10.1146/annurev-med-051013-110046; von Mering J, 1885, CENTRALBL MED WISS, V23, P531; Wagner R, 2016, DIABETES; Zimdahl H, 2017, PHARMACOGENET GENOM, V27, P135, DOI 10.1097/FPC.0000000000000268	15	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177148	10.1371/journal.pone.0177148	http://dx.doi.org/10.1371/journal.pone.0177148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472182	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500146
J	Spielman, DJ; Zaidi, F; Zambrano, P; Khan, AA; Ali, S; Cheema, HMN; Nazli, H; Khan, RSA; Iqbal, A; Zia, MA; Ali, GM				Spielman, David J.; Zaidi, Fatima; Zambrano, Patricia; Khan, Asif Ali; Ali, Shaukat; Cheema, H. Masooma Naseer; Nazli, Hina; Khan, Rao Sohail Ahmad; Iqbal, Arshad; Zia, Muhammad Amir; Ali, Ghulam Muhammad			What are farmers really planting? Measuring the presence and effectiveness of Bt cotton in Pakistan	PLOS ONE			English	Article							YANGTZE-RIVER VALLEY; HELICOVERPA-ARMIGERA; EXPRESSION; PROTEIN; CRY1AC; RESISTANCE	Genetically modified, insect-resistant Bacillus thuringiensis (Bt) cotton is cultivated extensively in Pakistan. Past studies, however, have raised concerns about the prevalence of Bt cotton varieties possessing weak or nonperforming insect-resistance traits conferred by the cry gene. We examine this issue using data drawn from a representative sample of cotton- growing households that were surveyed in six agroclimatic zones spanning 28 districts in Pakistan in 2013, as well as measurements of Cry protein levels in cotton tissue samples collected from the sampled households' main fields. The resultant dataset combines information from 593 sampled households with corresponding plant tissue diagnostics from 70 days after sowing, as well as information from 589 sampled households with corresponding diagnostics from 120 days after sowing. Our analysis indicates that 11 percent of farmers believed they were cultivating Bt cotton when, in fact, the Cry toxin was not present in the tested tissue at 70 days after sowing (i.e., a Type I error). The analysis further indicates that 5 percent of farmers believed they were cultivating non-Bt cotton when, in fact, the Cry toxin was present in the tested tissue (i.e., a Type II error). In addition, 17 percent of all sampled farmers were uncertain whether or not they were cultivating Bt cotton. Overall, 33 percent of farmers either did not know or were mistaken in their beliefs about the presence of the cry gene in the cotton they cultivated. Results also indicate that toxic protein levels in the plant tissue samples occurred below threshold levels for lethality in a significant percentage of cases, although these measurements may also be affected by factors related to tissue sample collection, handling, storage, and testing procedures. Nonetheless, results strongly suggest wide variability both in farmers' beliefs and in gene expression. Such variability has implications for policy and regulation in Pakistan's transgenic cotton seed market.	[Spielman, David J.; Zaidi, Fatima; Zambrano, Patricia] Int Food Policy Res Inst, Environm & Prod Technol Div, Washington, DC 20036 USA; [Khan, Asif Ali] Muhammad Nawaz Shareef Univ Agr, Multan, Pakistan; [Khan, Asif Ali] Univ Agr Faisalabad, Off Res Innovat & Commercializat, Faisalabad, Pakistan; [Ali, Shaukat; Iqbal, Arshad; Zia, Muhammad Amir; Ali, Ghulam Muhammad] Pakistan Agr Res Council, Natl Inst Genom & Adv Biotechnol, Islamabad, Pakistan; [Cheema, H. Masooma Naseer] Univ Agr Faisalabad, Dept Plant Breeding & Genet, Faisalabad, Pakistan; [Nazli, Hina] Int Food Policy Res Inst, Pakistan Strategy Support Program, Islamabad, Pakistan; [Khan, Rao Sohail Ahmad] Univ Agr Faisalabad, Ctr Agr Biochem & Biotechnol, Faisalabad, Pakistan	CGIAR; International Food Policy Research Institute (IFPRI); University of Agriculture Faisalabad; National Agricultural Research Council - Pakistan; University of Agriculture Faisalabad; CGIAR; International Food Policy Research Institute (IFPRI); University of Agriculture Faisalabad	Spielman, DJ (corresponding author), Int Food Policy Res Inst, Environm & Prod Technol Div, Washington, DC 20036 USA.	d.spielman@cgiar.org	Cheema, H. Masooma Naseer/L-6918-2017; Asif, Ali/P-9684-2017; Khan, Rao Sohail Ahmad/AAA-6364-2019; Cheema, Hafiza Masooma Naseer/V-3865-2019	Cheema, H. Masooma Naseer/0000-0003-3285-0037; Asif, Ali/0000-0002-4474-164X; Khan, Rao Sohail Ahmad/0000-0002-1118-9000; Cheema, Hafiza Masooma Naseer/0000-0003-3285-0037; Spielman, David/0000-0002-6889-7358	Pakistan Strategy Support Program of the International Food Policy Research Institute; U.S. Agency for International Development; CGIAR Research Program on Policies, Institutions, and Markets	Pakistan Strategy Support Program of the International Food Policy Research Institute; U.S. Agency for International Development(United States Agency for International Development (USAID)); CGIAR Research Program on Policies, Institutions, and Markets(CGIAR)	This work was supported by the Pakistan Strategy Support Program of the International Food Policy Research Institute, with funding from the U.S. Agency for International Development, and by the CGIAR Research Program on Policies, Institutions, and Markets. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedullah, 2015, J AGR ECON, V66, P66, DOI 10.1111/1477-9552.12072; Adamczyk J. J. Jr., 2004, Journal of Cotton Science, V8, P17; Ali A, 2010, J AGR ECON, V61, P175, DOI 10.1111/j.1477-9552.2009.00227.x; Ali S, 2012, CURR SCI INDIA, V102, P1632; Ali S, 2010, PAK J BOT, V42, P1583; [Anonymous], 2015, DAWN; BARTON KA, 1987, PLANT PHYSIOL, V85, P1103, DOI 10.1104/pp.85.4.1103; Benedict JH, 1996, J ECON ENTOMOL, V89, P230, DOI 10.1093/jee/89.1.230; Cheema HM, 2015, J AGR SCI, V153, P1; *FAO, 2004, FERT US CROP PAK; Fuchs RL, 1990, ACS S SERIES, V432; Government of Punjab (Pakistan), 2015, COTT PEST SCOUT REP; Greenplate JT, 1999, J ECON ENTOMOL, V92, P1377, DOI 10.1093/jee/92.6.1377; Guo Wang-Zhen, 2001, Acta Genetica Sinica, V28, P668; Hayee A, 2004, CULTIVATION BT COTTO; Kouser S, 2014, ENVIRON DEV ECON, V19, P704, DOI 10.1017/S1355770X1300051X; Kranthi KR, 2005, CURR SCI INDIA, V89, P291; Liu YM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23507; Ma X, 2016, J AGR EC IN PRESS; Maredia M, 2016, INT DEV WORKING PAPE, V246950; Monsanto, 2009, PINK BOLLW RES GM CO; Nazli H, 2012, BT COTTON ADOPTION W; Pemsl D, 2007, AGR SYST, V95, P28, DOI 10.1016/j.agsy.2007.02.013; Pemsl D, 2003, 7 INT CONS AGR BIOT; PERLAK FJ, 1990, BIO-TECHNOL, V8, P939, DOI 10.1038/nbt1090-939; Rana M. A., 2013, WORKING PAPER; Rana MA., 2010, THESIS; Rana MA., 2014, 19 PSSP INT FOOD POL; Rochester IJ, 2006, J COTTON SCI, V10, P252; Shan G, 2011, IMMUNOASSAYS AGR BIO; Showalter AM, 2009, BIOTECHNOLOGY AGR DE; Spielman D. J., 2015, AgBioForum, V18, P98; VAECK M, 1987, NATURE, V328, P33, DOI 10.1038/328033a0; Wan P, 2005, J ECON ENTOMOL, V98, P195, DOI 10.1603/0022-0493-98.1.195; Xia LanQin, 2005, Acta Agronomica Sinica, V31, P197; Xu NY, 2008, CROP PROT, V27, P1269, DOI 10.1016/j.cropro.2008.04.003; Zhao QC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110006	37	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176592	10.1371/journal.pone.0176592	http://dx.doi.org/10.1371/journal.pone.0176592			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472094	gold, Green Submitted, Green Published			2022-12-26	WOS:000400648500056
J	Bruck, I; Dhingra, N; Martinez, MP; Kaplan, DL				Bruck, Irina; Dhingra, Nalini; Martinez, Matthew P.; Kaplan, Daniel L.			Dpb11 may function with RPA and DNA to initiate DNA replication	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; STRUCTURAL BASIS; MCM2-7 HELICASE; FORK HELICASE; SACCHAROMYCES-CEREVISIAE; ATP-HYDROLYSIS; BUDDING YEAST; ORIGIN DNA; S-PHASE; PROTEIN	Dpb11 is required for the initiation of DNA replication in budding yeast. We found that Dpb11 binds tightly to single-stranded DNA (ssDNA) or branched DNA structures, while its human homolog, TopBP1, binds tightly to branched-DNA structures. We also found that Dpb11 binds stably to CDK-phosphorylated RPA, the eukaryotic ssDNA binding protein, in the presence of branched DNA. A Dpb11 mutant specifically defective for DNA binding did not exhibit tight binding to RPA in the presence of DNA, suggesting that Dpb11-interaction with DNA may promote the recruitment of RPA to melted DNA. We then characterized a mutant of Dpb11 that is specifically defective in DNA binding in budding yeast cells. Expression of dpb11-m1,2,3,5,Delta C results in a substantial decrease in RPA recruitment to origins, suggesting that Dpb11 interaction with DNA may be required for RPA recruitment to origins. Expression of dpb11-m1,2,3,5,Delta C also results in diminished GINS interaction with Mcm2-7 during S phase, while Cdc45 interaction with Mcm2-7 is like wild-type. The reduced GINS interaction with Mcm2-7 may be an indirect consequence of diminished origin melting. We propose that the tight interaction between Dpb11, CDK-phosphorylated RPA, and branched-DNA may be required for the essential function of stabilizing melted origin DNA in vivo. We also propose an alternative model, wherein Dpb11-DNA interaction is required for some other function in DNA replication initiation, such as helicase activation.	[Bruck, Irina; Dhingra, Nalini; Martinez, Matthew P.; Kaplan, Daniel L.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Dhingra, Nalini] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA	State University System of Florida; Florida State University; Memorial Sloan Kettering Cancer Center	Kaplan, DL (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA.	Daniel.Kaplan@med.fsu.edu		Kaplan, Daniel/0000-0003-2760-7745; Martinez, Matthew/0000-0003-2559-1794; Dhingra, Nalini/0000-0003-0949-883X	National Institute of General Medical Sciences of the National Institutes of Health [R15GM113167]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM113167] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R15GM113167 to DLK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo J, 2016, J BIOL CHEM, V291, P13124, DOI 10.1074/jbc.M116.729194; Bell S., 2016, GENETICS, V203; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Boos D, 2011, CURR BIOL, V21, P1152, DOI 10.1016/j.cub.2011.05.057; Bruck I, 2015, J BIOL CHEM, V290, P27414, DOI 10.1074/jbc.M115.688424; Bruck I, 2015, P NATL ACAD SCI USA, V112, P11223, DOI 10.1073/pnas.1509608112; Bruck I, 2015, J BIOL CHEM, V290, P1210, DOI 10.1074/jbc.M114.608232; Bruck I, 2014, J BIOL CHEM, V289, P1948, DOI 10.1074/jbc.M113.532085; Bruck I, 2013, J BIOL CHEM, V288, P7550, DOI 10.1074/jbc.M112.440941; Bruck I, 2011, J BIOL CHEM, V286, P36414, DOI 10.1074/jbc.M111.282822; Bruck I, 2011, J BIOL CHEM, V286, P18602, DOI 10.1074/jbc.M111.226332; Bruck I, 2011, J BIOL CHEM, V286, P14157, DOI 10.1074/jbc.M111.218305; Bruck I, 2009, J BIOL CHEM, V284, P28823, DOI 10.1074/jbc.M109.039123; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Davey MJ, 2002, EMBO J, V21, P3148, DOI 10.1093/emboj/cdf308; Deegan TD, 2016, EMBO J, V35, P961, DOI 10.15252/embj.201593552; Dhingra N, 2015, J BIOL CHEM, V290, P7586, DOI 10.1074/jbc.M115.640383; Eisenberg S, 2009, J BIOL CHEM, V284, P25412, DOI 10.1074/jbc.M109.033175; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Georgescu RE, 2015, ELIFE, V4, DOI 10.7554/eLife.04988; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kanter DM, 2011, NUCLEIC ACIDS RES, V39, P2580, DOI 10.1093/nar/gkq1222; Lindsey-Boltz LA, 2011, J BIOL CHEM, V286, P19229, DOI 10.1074/jbc.M111.237958; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Ning BT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116093; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Perez-Arnaiz P, 2016, J MOL BIOL, V428, P4608, DOI 10.1016/j.jmb.2016.10.014; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Sanders CM, 2008, NUCLEIC ACIDS RES, V36, P1891, DOI 10.1093/nar/gkn041; Schuck S, 2011, MOL CELL, V43, P776, DOI 10.1016/j.molcel.2011.06.026; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanaka S, 2013, MOL CELL BIOL, V33, P2614, DOI 10.1128/MCB.00431-13; Tognetti S, 2015, CHROMOSOMA, V124, P13, DOI 10.1007/s00412-014-0489-2; Valle M, 2006, J MOL BIOL, V357, P1295, DOI 10.1016/j.jmb.2006.01.021; van Deursen F, 2012, EMBO J, V31, P2195, DOI 10.1038/emboj.2012.69; Warren EM, 2008, STRUCTURE, V16, P1892, DOI 10.1016/j.str.2008.10.005; Yeeles JTP, 2015, NATURE, V519, P431, DOI 10.1038/nature14285; Yuan ZN, 2016, NAT STRUCT MOL BIOL, V23, P217, DOI 10.1038/nsmb.3170; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	48	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0177147	10.1371/journal.pone.0177147	http://dx.doi.org/10.1371/journal.pone.0177147			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467467	Green Submitted, Green Published, gold			2022-12-26	WOS:000400647000095
J	Gunaseelan, S; Balupillai, A; Govindasamy, K; Ramasamy, K; Muthusamy, G; Shanmugam, M; Thangaiyan, R; Robert, BM; Nagarajan, RP; Ponniresan, VK; Rathinaraj, P				Gunaseelan, Srithar; Balupillai, Agilan; Govindasamy, Kanimozhi; Ramasamy, Karthikeyan; Muthusamy, Ganesan; Shanmugam, Mohana; Thangaiyan, Radhiga; Robert, Beaulah Mary; Nagarajan, Rajendra Prasad; Ponniresan, Veeramani Kandan; Rathinaraj, Pierson			Linalool prevents oxidative stress activated protein kinases in single UVB-exposed human skin cells	PLOS ONE			English	Article							NF-KAPPA-B; REACTIVE OXYGEN; SIGNALING PATHWAY; DNA-DAMAGE; ASSAY; ACID; RADIATION; MELATONIN; PHOTOCARCINOGENESIS; INFLAMMATION	Ultraviolet-B radiation (285-320 nm) elicits a number of cellular signaling elements. We investigated the preventive effect of linalool, a natural monoterpene, against UVB-induced oxidative imbalance, activation of mitogen-activated protein kinase (MAPK) and nuclear factor kappa-B (NF-kappa B) signaling in HDFa cells. We observed that linalool treatment (30 mu M) prevented acute UVB-irradiation (20 mJ/cm(2)) mediated loss of activities of antioxidant enzymes in HDFa cells. The comet assay results illustrate that linalool significantly prevents UVB-mediated 8-deoxy guanosine formation (oxidative DNA damage) rather than UVB-induced cyclobutane pyrimidine (CPD) formation. This might be due to its ability to prevent UVB-induced ROS formation and to restore the oxidative imbalance of cells. This has been reflected in UVB-induced overexpression of MAPK and NF-kappa B signaling. We observed that linalool inhibited UVB-induced phosphorylation of ERK1, JNK and p38 proteins of MAPK family. Linalool inhibited UVB-induced activation of NF-kappa B/p65 by activating I kappa Ba. We further observed that UVB-induced expression of TNF-alpha, IL6, IL-10, MMP-2 and MMP-9 was modulated by linalool treatment in HDFa cells. Thus, linalool protects the human skin cells from the oxidative damages of UVB radiation and modulates MAPK and NF-kappa B signaling in HDFa cells. The present findings substantiate that linalool may act as a photoprotective agent against UVB-induced skin damages.	[Gunaseelan, Srithar; Balupillai, Agilan; Govindasamy, Kanimozhi; Ramasamy, Karthikeyan; Muthusamy, Ganesan; Shanmugam, Mohana; Thangaiyan, Radhiga; Robert, Beaulah Mary; Nagarajan, Rajendra Prasad; Ponniresan, Veeramani Kandan] Annamalai Univ, Dept Biochem & Biotechnol, Annamalainagar, Tamil Nadu, India; [Govindasamy, Kanimozhi] Dharumapuram Gnanambigai Govt Arts Coll Women, Dept Biochem, Mailaduthurai, Tamil Nadu, India; [Rathinaraj, Pierson] Waikato Mail Ctr, Ctr Transdisciplinary Res & Innovat Wintec Privat, Hamilton, New Zealand	Annamalai University	Nagarajan, RP (corresponding author), Annamalai Univ, Dept Biochem & Biotechnol, Annamalainagar, Tamil Nadu, India.	drprasadnr@gmail.com	THANGAIYAN, RADHIGA/AAG-8769-2021; R, Beaulah Mary/AAP-5283-2021; Balupillai, Agilan/AAJ-9773-2020; N, Rajendra Prasad/X-1743-2019	N, Rajendra Prasad/0000-0002-3937-8735; Muthusamy, Ganesan/0000-0001-5684-6871; Thangaiyan, Radhiga/0000-0002-8052-2057	Indian council of Medical Research (ICMR), New Delhi, India [3/2/2/259/2014-NCDIII, IRIS ID: 2014-22090]	Indian council of Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR))	Mr. G. Srithar acknowledges the financial assistance awarded by Indian council of Medical Research (ICMR) (Ref. No: 3/2/2/259/2014-NCDIII, IRIS ID: 2014-22090), New Delhi, India in the form of Senior Research Fellowship.; Mr. G. Srithar acknowledges a Senior Research Fellowship from the Indian Council of Medical Research (ICMR) New Delhi, India. The funders had no role in preparation of the manuscript or decision to publish.	Agilan B, 2016, PHOTOCHEM PHOTOBIOL, V92, P467, DOI 10.1111/php.12588; Ambothi K, 2015, FOOD CHEM TOXICOL, V82, P72, DOI 10.1016/j.fct.2015.04.031; Balupillai A, 2015, PHOTOCHEM PHOTOBIOL, V91, P1458, DOI 10.1111/php.12522; Bhosle SM, 2005, CLIN CHIM ACTA, V359, P89, DOI 10.1016/j.cccn.2005.03.037; Bosch R, 2015, ANTIOXIDANTS-BASEL, V4, P248, DOI 10.3390/antiox4020248; Choi YJ, 2014, BIOORG MED CHEM LETT, V24, P1344, DOI 10.1016/j.bmcl.2014.01.040; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Divya S. P., 2015, TOXICOL APPL PHARM, V8, P13295; Divya SP, 2015, TOXICOL APPL PHARM, V284, P92, DOI 10.1016/j.taap.2015.02.003; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Farrukh MR, 2015, J PHOTOCH PHOTOBIO B, V148, P351, DOI 10.1016/j.jphotobiol.2015.05.003; Fischer TW, 2004, J PINEAL RES, V37, P107, DOI 10.1111/j.1600-079X.2004.00142.x; Gunaseelan Srithar, 2013, International Journal of Pharmaceutical and Biological Archives, V4, P758; Gupta A, 2014, AGEING RES REV, V13, P65, DOI 10.1016/j.arr.2013.12.001; Hafer K, 2008, RADIAT RES, V169, P460, DOI 10.1667/RR1212.1; HALLIWELL B, 1987, ANAL BIOCHEM, V165, P215, DOI 10.1016/0003-2697(87)90222-3; Hardeland R, 2011, PROG NEUROBIOL, V93, P350, DOI 10.1016/j.pneurobio.2010.12.004; Hong Q, 2007, BMC MOL BIOL, V13, P8; Hou WG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120151; Huang X, 2015, EVID-BASED COMPL ALT, V27, P24; Janjetovic Z, 2014, J PINEAL RES, V57, P90, DOI 10.1111/jpi.12146; KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130; Karthikeyan R, 2016, J PHOTOCH PHOTOBIO B, V161, P170, DOI 10.1016/j.jphotobiol.2016.04.027; Karthikeyan S, 2011, TOXICOL IN VITRO, V25, P1366, DOI 10.1016/j.tiv.2011.05.007; Kwon Y, 2013, SCIENCE, V342, P737, DOI 10.1126/science.1243971; Lee CH, 2013, INT J MOL SCI, V14, P6414, DOI 10.3390/ijms14036414; Loizzo MR, 2008, CHEM BIODIVERS, V5, P461, DOI 10.1002/cbdv.200890045; Lopez-Camarillo C, 2012, INT J MOL SCI, V13, P142, DOI 10.3390/ijms13010142; Munshi Anupama, 2013, Genes Cancer, V4, P401, DOI 10.1177/1947601913485414; Muthusamy G., 2017, THE J, V8, P82; Nichols JA, 2010, ARCH DERMATOL RES, V302, P71, DOI 10.1007/s00403-009-1001-3; NIEHAUS WG, 1968, EUR J BIOCHEM, V6, P126, DOI 10.1111/j.1432-1033.1968.tb00428.x; NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3; Nishisgori C, 2015, PHOTOCH PHOTOBIO SCI, V14, P1713, DOI 10.1039/c5pp00185d; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Ramachandran S., 2008, Asian Journal of Biochemistry, V3, P11; Rinnerthaler M, 2015, BIOMOLECULES, V5, P545, DOI 10.3390/biom5020545; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Sastre MP, 2001, PHOTOCHEM PHOTOBIOL, V74, P55, DOI 10.1562/0031-8655(2001)074<0055:SCGCAA>2.0.CO;2; Shen YL, 2014, BIOMARKERS GENOMIC M, V5, P131; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2015, STEROIDS, V103, P72, DOI 10.1016/j.steroids.2015.04.006; Slominski AT, 2014, INT J MOL SCI, V15, P17705, DOI 10.3390/ijms151017705; SLOMINSKI AT, 2014, ANTI-CANCER AGENT ME, V14, P77, DOI DOI 10.2174/18715206113139990308; Smith CC, 2006, MUTAGENESIS, V21, P185, DOI 10.1093/mutage/gel019; Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x; Wang W, 2012, MOLECULES, V17, P2704, DOI 10.3390/molecules17032704; Yin YQ, 2013, TOXICOL APPL PHARM, V269, P89, DOI 10.1016/j.taap.2013.03.015; Zmijewski MA, 2011, DERM-ENDOCRINOL, V3, P3, DOI 10.4161/derm.3.1.14617; Zmijewski MA, 2011, STEROIDS, V76, P193, DOI 10.1016/j.steroids.2010.10.009; 이삼윤, 2012, [Journal of Physiology & Pathology in Korean Medicine, 동의생리병리학회지], V26, P922	54	57	57	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176699	10.1371/journal.pone.0176699	http://dx.doi.org/10.1371/journal.pone.0176699			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467450	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000400647000068
J	Li, ZY; Jiang, J; Tian, L; Li, X; Chen, J; Li, ST; Li, CY; Yang, ZC				Li, Zhuoying; Jiang, Jie; Tian, Lang; Li, Xin; Chen, Jia; Li, Shentang; Li, Chunyun; Yang, Zuocheng			A plasma mir-125a-5p as a novel biomarker for Kawasaki disease and induces apoptosis in HUVECs	PLOS ONE			English	Article							CIRCULATING MICRORNAS; MYOCARDIAL-INFARCTION; CANCER; CELLS; MKK7; SUPPRESSION; EXPRESSION; DIAGNOSIS; SERUM; MIRNA	Background Kawasaki disease (KD) is a childhood systemic vasculitis that exhibits a specific preference for the coronary arteries. The aetiology remains unknown and there are no especially diagnostic tests. microRNAs (miRNAs) are 18 to 23 nucleotides non-coding RNAs that are negative regulator of gene expression and play a crucial role in the regulatory network of the genome. Recently, circulating miRNAs have been found presentation in human plasma and displayed some characteristics of the ideal biomarker. However, few researches explored differentially expressed miRNAs in the plasma of KD patients. Our study is to identify circulating miRNAs in KD plasma which can serve as potential biomarkers of KD diagnosis. Materials and methods The total of five pairs of acute KD and normal plasma samples were analyzed using ABI miRNAs TLDA Assay chip. Differentially expression of miR-125a-5p in plasma were confirmed by quantitative real-time PCR (qRT-PCR) in independent cohort (acute KD = 30, convalescent KD = 30 and healthy control = 32). After bioinformatics prediction, miR-125a-5p vector and inhibitor were transfected into HUVECs respectively, to observe MKK7 expression as a potential target gene. Flow cytometry was used to analyze apoptosis. The mRNA and protein levels of desired genes including MKK7, Caspase-3, Bax and Bcl2 were detected by qRT-PCR and western blotting. Results Eighteen miRNAs were differentially expressed in acute KD's plasma compared with healthy control. miR-125a-5p was significantly increased in plasma of KD patients (p = 0.000), but no variation between acute and convalescent KD (p = 0.357). Moreover, the results from the gain and loss functions of miR-125a-5p in HUVECs have shown that miR125a- 5p remarkably suppressed MKK7 expression, as a novel target gene. Importantly, miR-125a-5p also induced apoptosis in HUVECs through inhibition MKK7 levels to regulate Bax/Bcl2 pathway resulting to activate Caspase-3. Conclusion Our study indicated that the circulating miR-125a-5p levels in KD's plasma have remarkably evaluated compared with healthy individuals. miR-125a-5p might play a role in the development of KD by regulating target gene MKK7 to induce apoptosis in vascular endothelial cells. Therefore, our findings have suggested that detected miR-125a-5p levels in plasma could be used as a potential biomarker in early KD diagnosis.	[Li, Zhuoying; Jiang, Jie; Tian, Lang; Li, Xin; Chen, Jia; Li, Shentang; Li, Chunyun; Yang, Zuocheng] Cent S Univ, Xiangya Hosptial 3, Dept Pediat, Changsha, Hunan, Peoples R China	Central South University	Yang, ZC (corresponding author), Cent S Univ, Xiangya Hosptial 3, Dept Pediat, Changsha, Hunan, Peoples R China.	yang_zcr@126.com		Li, Zhuoying/0000-0002-2193-537X	Science and technology projects of Changsha City [kq1602042]; Hunan provincial Natural Science Foundation [2015JJ6111]	Science and technology projects of Changsha City; Hunan provincial Natural Science Foundation(Natural Science Foundation of Hunan Province)	This work was supported by grants from the Science and technology projects of Changsha City (No: kq1602042), and Hunan provincial Natural Science Foundation (No: 2015JJ6111), and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Barry SE, 2015, J CELL MOL MED, V19, P1606, DOI 10.1111/jcmm.12535; Bauters C, 2016, CARDIOLOGY, V133, P262, DOI 10.1159/000443204; Becker S, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0244-3; Bi Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040169; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Byun JY, 2009, CARCINOGENESIS, V30, P1880, DOI 10.1093/carcin/bgp235; Che P, 2014, AGING CELL, V13, P926, DOI 10.1111/acel.12252; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Cui WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022988; Fan SJ, 2016, LEUKEMIA RES, V41, P62, DOI 10.1016/j.leukres.2015.11.016; Fukushima Y, 2011, CIRC J, V75, P336, DOI 10.1253/circj.CJ-10-0457; He WW, 2016, ONCOTARGET, V7, P6727, DOI 10.18632/oncotarget.6797; Huang YF, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004020; Ju A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164259; Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379; Kosaka N, 2012, J BIOL CHEM, V287, P1397, DOI 10.1074/jbc.M111.288662; Li Q, 2016, ATHEROSCLEROSIS, V254, P184, DOI 10.1016/j.atherosclerosis.2016.10.007; Lia D, 2010, J HYPERTENS, V28, P1646, DOI 10.1097/HJH.0b013e32833a4922; Maciejak A, 2016, MOL MED REP, V14, P2867, DOI 10.3892/mmr.2016.5566; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Parrizas M, 2016, BEST PRACT RES CL EN, V30, P591, DOI 10.1016/j.beem.2016.08.001; Rowley AH, 2011, ANNU REV MED, V62, P69, DOI 10.1146/annurev-med-042409-151944; Sanchez-Manubens J, 2014, J AUTOIMMUN, V48-49, P113, DOI 10.1016/j.jaut.2014.01.010; Shimizu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058159; Singh R, 2016, CANCER LETT, V381, P113, DOI 10.1016/j.canlet.2016.07.002; Singh S, 2016, INDIAN J PEDIATR, V83, P880, DOI 10.1007/s12098-016-2087-1; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tang RX, 2012, WORLD J GASTROENTERO, V18, P1485, DOI 10.3748/wjg.v18.i13.1485; Turchinovich A, 2012, TRENDS BIOCHEM SCI, V37, P460, DOI 10.1016/j.tibs.2012.08.003; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang J, 2011, MOL BIOL CELL, V22, P117, DOI 10.1091/mbc.E10-06-0492; Wang S, 2016, APOPTOSIS INT J PROG; Wang SY, 2017, APOPTOSIS, V22, P449, DOI 10.1007/s10495-016-1329-z; Zheng H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077853; Zou HY, 2007, FEBS LETT, V581, P196, DOI 10.1016/j.febslet.2006.12.012	41	17	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0175407	10.1371/journal.pone.0175407	http://dx.doi.org/10.1371/journal.pone.0175407			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467514	Green Submitted, Green Published, gold			2022-12-26	WOS:000400647000014
J	Polilov, AA				Polilov, Alexey A.			Anatomy of adult Megaphragma (Hymenoptera: Trichogrammatidae), one of the smallest insects, and new insight into insect miniaturization	PLOS ONE			English	Article							COLEOPTERA PTILIIDAE; COMPOUND EYE; BODY-SIZE; ULTRASTRUCTURE; MYMARIDAE; FEATURES; HEXAPODA; LARVAE; LIMITS; BRAIN	The body size, especially in cases of extreme reduction, is an important characteristic that strongly determines the morphology, physiology, and biology of animals. Miniaturization is a widespread trend in animal evolution and one of the principal directions of evolution in insects. Miniaturization-related features of insect morphology have been subject to intensive studies during the last few years, but the structure of the smallest insects remains insufficiently known. It is especially important to study hymenopterans of the genus Megaphragma, which include the smallest flying insects and a species in which an almost anucleate nervous system was recently discovered. This article is the first detailed study of the external and internal morphology of adults of Megaphragma mymaripenne and M. amalphitanum using histological methods, 3D computer modeling and other techniques. It is shown that in spite of the extremely small size the organization of Megaphragma retains a considerkable level of structural complexity. On the other hand, miniaturization leads to re-organizations of several organ systems. Unique structural features related to miniaturization have been found in both species: lysis of cell bodies and nuclei of neurons at late stages of pupal development, absence of the heart, and considerable reductions in the set of muscles. Comparative analysis of structure in the smallest insects representing different taxa has revealed common features of the evolutionary process of miniaturization in insects.	[Polilov, Alexey A.] Lomonosov Moscow State Univ, Fac Biol, Dept Entomol, Moscow, Russia	Lomonosov Moscow State University	Polilov, AA (corresponding author), Lomonosov Moscow State Univ, Fac Biol, Dept Entomol, Moscow, Russia.	polilov@gmail.com	Polilov, Alexey/K-4599-2013	Polilov, Alexey/0000-0002-6214-3627	Russian Foundation for Basic Research [14-04-00638, 15-34-20490]; Russian Science Foundation [14-14-00208]; Russian Science Foundation [17-14-00049] Funding Source: Russian Science Foundation	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	The collection of material and study of musculature was supported by the Russian Foundation for Basic Research (project nos. 14-04-00638, 15-34-20490); the rest of the study was supported by the Russian Science Foundation (project no. 14-14-00208).	Boivin G, 2010, PROG BIOL CONTROL, V9, P1, DOI 10.1007/978-1-4020-9110-0_1; Bradley J. C., 1955, Memoires de la Societe Entomologique de Belgique, V27, P127; Burks B. D., 1938, Annals of the Entomological Society of America, V31, P157; Chumakova BM., 1966, BIOL METODY BORBY S, P66; Chumakova BM, 1968, T VIZR, V31, P164; Fischer S, 2011, VISUAL NEUROSCI, V28, P295, DOI 10.1017/S0952523810000192; Flanders S. E., 1937, ANN ENTOMOL SOC AM, VXXX, P304; Friedrich F, 2008, ARTHROPOD STRUCT DEV, V37, P29, DOI 10.1016/j.asd.2007.04.003; GORODKOV KB, 1984, ZOOL ZH, V63, P1765; Huber JT, 2013, J HYMENOPT RES, V32, P17, DOI 10.3897/JHR.32.4663; Ivanova-Kazas O. M., 1952, Trudy Leningradskogo Obshchestva Estestvoispytatelei Leningrad (Zool), V71, P165; Knauthe P, 2016, ARTHROPOD SYST PHYLO, V74, P107; Lino-Neto J, 2000, ACTA ZOOL-STOCKHOLM, V81, P205, DOI 10.1046/j.1463-6395.2000.00050.x; Lino-Neto J, 2001, ACTA ZOOL-STOCKHOLM, V82, P159, DOI 10.1046/j.1463-6395.2001.00082.x; Makarova AA, 2013, ZOOL ZH, V92, P695, DOI 10.7868/S004451341306007X; Makarova AA, 2013, ZOOL ZH, V92, P523, DOI 10.7868/S0044513413050073; Makarova A, 2015, ARTHROPOD STRUCT DEV, V44, P21, DOI 10.1016/j.asd.2014.11.001; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; NAGARKATTI S, 1977, ANNU REV ENTOMOL, V22, P157, DOI 10.1146/annurev.en.22.010177.001105; Osswald J, 2010, ARTHROPOD STRUCT DEV, V39, P287, DOI 10.1016/j.asd.2009.10.005; Pinto JD, 2006, J HYMENOPT RES, V15, P38; Pinto John D., 2004, Journal of Hymenoptera Research, V13, P269; Polilov AA, 2016, ZOOL ZH, V95, P567, DOI 10.7868/S004451341605010X; Polilov A.A., 2008, ENTOMOLOGICAL REV, V88, P26, DOI DOI 10.1134/S0013873808010041; Polilov A. A., 2016, ENTOMOL REV, V96, P419; Polilov AA, 2005, ZOOL ZH, V84, P181; Polilov AA, 2016, SIZE LIMIT D EFFECTS; Polilov AA, 2017, SCI REP-UK, V7, DOI 10.1038/srep43095; Polilov AA, 2016, ARTHROPOD STRUCT DEV, V45, P496, DOI 10.1016/j.asd.2016.09.002; Polilov AA, 2015, ANNU REV ENTOMOL, V60, P103, DOI 10.1146/annurev-ento-010814-020924; Polilov AA, 2012, ARTHROPOD STRUCT DEV, V41, P29, DOI 10.1016/j.asd.2011.09.001; Polilov AA, 2010, ARTHROPOD STRUCT DEV, V39, P52, DOI 10.1016/j.asd.2009.08.005; Polilov AA, 2009, ARTHROPOD STRUCT DEV, V38, P247, DOI 10.1016/j.asd.2008.11.003; Snodgrass R. E., 1942, SMITHSONIAN MISC COLL, V103, P1; Sorokina AP, 1993, GUIDE SPECIES GENUS; Sylvere AP, 1976, TETRAPODILI FORE LEG; Viggiani Gennaro, 1997, Bollettino del Laboratorio di Entomologia Agraria Filippo Silvestri, V53, P117; Vilhelmsen L, 2010, ZOOL J LINN SOC-LOND, V159, P22, DOI 10.1111/j.1096-3642.2009.00576.x; Wipfler B, 2011, SYST ENTOMOL, V36, P241, DOI 10.1111/j.1365-3113.2010.00556.x; Yavorskaya M. I., 2016, ENTOMOL REV, V96, P395; Yavorskaya MI, 2014, ARTHROPOD STRUCT DEV, V43, P153, DOI 10.1016/j.asd.2013.11.001; Yoder MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015991	42	23	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0175566	10.1371/journal.pone.0175566	http://dx.doi.org/10.1371/journal.pone.0175566			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467417	gold, Green Submitted, Green Published			2022-12-26	WOS:000400647000018
J	Ferrian, S; Manca, C; Lubbe, S; Conradie, F; Ismail, N; Kaplan, G; Gray, CM; Fallows, D				Ferrian, Selena; Manca, Claudia; Lubbe, Sugnet; Conradie, Francesca; Ismail, Nazir; Kaplan, Gilla; Gray, Clive M.; Fallows, Dorothy			A combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; SOLUBLE INTERLEUKIN-2 RECEPTOR; SPUTUM CULTURE CONVERSION; C-REACTIVE PROTEIN; ACTIVE TUBERCULOSIS; CLINICAL-MANIFESTATIONS; INTERFERON-GAMMA; DISEASE-ACTIVITY; T-CELLS	Objective To identify plasma markers predictive of therapeutic response in patients with multidrug resistant tuberculosis (MDR-TB). Methods Fifty HIV-negative patients with active pulmonary MDR-TB were analysed for six soluble analytes in plasma at the time of initiating treatment (baseline) and over six months thereafter. Patients were identified as sputum culture positive or negative at baseline. Culture positive patients were further stratified by the median time to sputum culture conversion (SCC) as fast responders (< 76 days) or slow responders (>= 76 days). Chest X-ray scores, body mass index, and sputum smear microscopy results were obtained at baseline. Results Unsupervised hierarchical clustering revealed that baseline plasma levels of IP-10/ CXCL10, VEGF-A, SAA and CRP could distinguish sputum culture and cavitation status of patients. Among patients who were culture positive at baseline, there were significant positive correlations between plasma levels of CRP, SAA, VEGF-A, sIL-2R alpha/CD40, and IP-10 and delayed SCC. Using linear discriminant analysis (LDA) and Receiver Operating Curves (ROC), we showed that a combination of MCP-1/CCL2, IP-10, sIL-2R alpha, SAA, CRP and AFB smear could distinguish fast from slow responders and were predictive of delayed SCC with high sensitivity and specificity. Conclusion Plasma levels of specific chemokines and inflammatory markers measured before MDR-TB treatment are candidate predictive markers of delayed SCC. These findings require validation in a larger study.	[Ferrian, Selena; Gray, Clive M.] Univ Cape Town, Div Immunol, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Ferrian, Selena; Gray, Clive M.] Univ Cape Town, Natl Hlth Lab Serv, Cape Town, South Africa; [Manca, Claudia; Fallows, Dorothy] Rutgers State Univ, Publ Hlth Res Inst, Newark, NJ 07102 USA; [Lubbe, Sugnet] Univ Cape Town, Dept Stat Sci, Cape Town, South Africa; [Conradie, Francesca] Univ Witwatersrand, Right Care & Clin HIV Res Unit, Johannesburg, South Africa; [Ismail, Nazir] Natl Inst Communicable Dis, Ctr TB, Johannesburg, South Africa; [Kaplan, Gilla] Bill & Melinda Gates Fdn, Seattle, WA USA	University of Cape Town; University of Cape Town; Rutgers State University Newark; Rutgers State University New Brunswick; University of Cape Town; University of Witwatersrand; National Institute for Communicable Diseases (NICD); Bill & Melinda Gates Foundation	Fallows, D (corresponding author), Rutgers State Univ, Publ Hlth Res Inst, Newark, NJ 07102 USA.	fallowda@njms.rutgers.edu	Ferrian, Selena/ABC-4857-2021	Ferrian, Selena/0000-0002-6240-0953; Gray, Clive/0000-0002-9293-901X	National Institute of Allergy and Infectious Diseases [RO10AI80737]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080737] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institute of Allergy and Infectious Diseases (RO10AI80737) to GK, transferred to DF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2015, J CLIN INVEST, V125, P1827, DOI 10.1172/JCI77990; Agranoff D, 2006, LANCET, V368, P1012, DOI 10.1016/S0140-6736(06)69342-2; Alatas F, 2004, CHEST, V125, P2156, DOI 10.1378/chest.125.6.2156; Alvarez GG, 2012, INT J TUBERC LUNG D, V16, P1247, DOI 10.5588/ijtld.11.0743; BAJAJ G, 1989, Indian Pediatrics, V26, P1010; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Brahmbhatt S, 2006, CLIN EXP IMMUNOL, V146, P243, DOI 10.1111/j.1365-2249.2006.03211.x; Cagatay T, 2005, RESPIROLOGY, V10, P290, DOI 10.1111/j.1440-1843.2005.00711.x; CHAN CHS, 1995, EUR RESPIR J, V8, P70, DOI 10.1183/09031936.95.08010070; Churina E G, 2012, Tuberc Res Treat, V2012, P931291, DOI 10.1155/2012/931291; Datta M, 2015, P NATL ACAD SCI USA, V112, P1827, DOI 10.1073/pnas.1424563112; De Groote MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061002; Diacon AH, 2014, NEW ENGL J MED, V371, P723, DOI 10.1056/NEJMoa1313865; Djoba Siawaya JF, 2009, CLIN EXP IMMUNOL, V156, P69, DOI 10.1111/j.1365-2249.2009.03875.x; Dominguez-Castellano A, 2003, INT J TUBERC LUNG D, V7, P432; Essone PN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102584; Fortes A, 2005, CLIN EXP IMMUNOL, V141, P541, DOI 10.1111/j.1365-2249.2005.02872.x; Gruys E, 2005, J Zhejiang Univ Sci B, V6, P1045, DOI 10.1631/jzus.2005.B1045; HAGHIGHI L, 1966, DIS CHEST, V50, P624, DOI 10.1378/chest.50.6.624; Holtz TH, 2006, ANN INTERN MED, V144, P650, DOI 10.7326/0003-4819-144-9-200605020-00008; Hur YG, 2015, J INFECTION, V70, P346, DOI 10.1016/j.jinf.2014.10.019; Husain N, 2008, J INFECTION, V56, P114, DOI 10.1016/j.jinf.2007.11.004; INGLES MJA, 1995, TUBERCLE LUNG DIS, V76, P130, DOI 10.1016/0962-8479(95)90555-3; Jacobs R, 2016, ONCOTARGET; Jayakumar A, 2015, TUBERCULOSIS, V95, P415, DOI 10.1016/j.tube.2015.04.011; Kart L, 2003, MEDIAT INFLAMM, V12, P9, DOI 10.1080/0962935031000096926; Kumar NP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146318; Kurbatova EV, 2015, LANCET RESP MED, V3, P201, DOI 10.1016/S2213-2600(15)00036-3; Lawn SD, 2013, INT J TUBERC LUNG D, V17, P636, DOI 10.5588/ijtld.12.0811; Li N, 2015, INT J TUBERC LUNG D, V19, P1230, DOI 10.5588/ijtld.15.0148; Matsuyama W, 2000, AM J RESP CRIT CARE, V162, P1120, DOI 10.1164/ajrccm.162.3.9911010; McDyer JF, 1997, J IMMUNOL, V158, P492; Mihret A, 2013, J INFECTION, V66, P357, DOI 10.1016/j.jinf.2012.11.005; Nahid P, 2014, TUBERCULOSIS, V94, P187, DOI 10.1016/j.tube.2014.01.006; Park SK, 2011, TUBERCULOSIS, V91, P300, DOI 10.1016/j.tube.2011.02.003; Phalane KG, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/981984; Plit ML, 1998, EUR RESPIR J, V12, P351, DOI 10.1183/09031936.98.12020351; Rajalingam R, 1996, TUBERCLE LUNG DIS, V77, P374, DOI 10.1016/S0962-8479(96)90105-7; Rao S., 2009, INFECT DIS CLIN PRAC, V17, P314; Riou C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102178; Riou C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036886; Shaikh M. K., 2012, World Applied Sciences Journal, V17, P140; Sharma S, 2004, IMMUNOL CELL BIOL, V82, P377, DOI 10.1111/j.0818-9641.2004.01245.x; Siawaya JFD, 2008, J INFECTION, V56, P340, DOI 10.1016/j.jinf.2008.02.007; Siawaya JFD, 2009, CYTOKINE, V47, P132, DOI 10.1016/j.cyto.2009.05.016; Singh A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030947, 10.1371/journal.pone.0044728, 10.1371/journal.pone.0039812, 10.1371/journal.pone.0044931]; TAKAHASHI S, 1991, CHEST, V99, P310, DOI 10.1378/chest.99.2.310; Tan Q, 2012, EUR J CLIN MICROBIOL, V31, P1233, DOI 10.1007/s10096-011-1434-4; Tsao TCY, 2002, INT J TUBERC LUNG D, V6, P720; Wallis RS, 2015, CLIN INFECT DIS, V61, pS160, DOI 10.1093/cid/civ612; Wallis RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071116; Wallis RS, 2010, LANCET INFECT DIS, V10, P68, DOI 10.1016/S1473-3099(10)70003-7; Wang XJ, 2012, TUBERCULOSIS, V92, P513, DOI 10.1016/j.tube.2012.06.005; Wergeland I, 2015, J INFECTION, V70, P381, DOI 10.1016/j.jinf.2014.12.019; Wilson DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027826; World Health Organization, 2015, GLOB TUB REP 2015; Yuen CM, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001932; Zumla AI, 2014, LANCET INFECT DIS, V14, P327, DOI 10.1016/S1473-3099(13)70328-1	58	12	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176660	10.1371/journal.pone.0176660	http://dx.doi.org/10.1371/journal.pone.0176660			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28464011	Green Submitted, Green Published, gold			2022-12-26	WOS:000400646300040
J	Nicholas, DA; Zhang, K; Hung, C; Glasgow, S; Aruni, AW; Unternaehrer, J; Payne, KJ; Langridge, WHR; De Leon, M				Nicholas, Dequina A.; Zhang, Kangling; Hung, Christopher; Glasgow, Shane; Aruni, Wilson Aruni; Unternaehrer, Juli; Payne, Kimberly J.; Langridge, William H. R.; De Leon, Marino			Palmitic acid is a toll-like receptor 4 ligand that induces human dendritic cell secretion of IL-1 beta	PLOS ONE			English	Article							SATURATED FATTY-ACIDS; NF-KAPPA-B; INDUCED INSULIN-RESISTANCE; NECROSIS-FACTOR-ALPHA; INFLAMMASOME ACTIVATION; SIGNALING PATHWAYS; NLRP3 INFLAMMASOME; HYDROGEN-PEROXIDE; INNATE IMMUNITY; SERUM-LIPIDS	Palmitic acid (PA) and other saturated fatty acids are known to stimulate pro-inflammatory responses in human immune cells via Toll-like receptor 4 (TLR4). However, the molecular mechanism responsible for fatty acid stimulation of TLR4 remains unknown. Here, we demonstrate that PA functions as a ligand for TLR4 on human monocyte derived dendritic cells (MoDCs). Hydrophobicity protein modeling indicated PA can associate with the hydrophobic binding pocket of TLR4 adaptor protein MD-2. Isothermal titration calorimetry quantified heat absorption that occurred during PA titration into TLR4/MD2, indicating that PA binds to TLR4/MD2. Treatment of human MoDCs with PA resulted in endocytosis of TLR4, further supporting the function of PA as a TLR4 agonist. In addition, PA stimulated DC maturation and activation based on the upregulation of DC costimulatory factors CD86 and CD83. Further experiments showed that PA induced TLR4 dependent secretion of the pro-inflammatory cytokine IL-1 beta. Lastly, our experimental data show that PA stimulation of NF-kappa B canonical pathway activation is regulated by TLR4 signaling and that reactive oxygen species may be important in upregulating this pro-inflammatory response. Our experiments demonstrate for the first time that PA activation of TLR4 occurs in response to direct molecular interactions between PA and MD-2. In summary, our findings suggest a likely molecular mechanism for PA induction of pro-inflammatory immune responses in human dendritic cells expressing TLR4.	[Nicholas, Dequina A.; Hung, Christopher; Glasgow, Shane; Unternaehrer, Juli; Payne, Kimberly J.; Langridge, William H. R.; De Leon, Marino] Loma Linda Univ, Sch Med, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92350 USA; [Nicholas, Dequina A.; Hung, Christopher; Glasgow, Shane; Unternaehrer, Juli; Langridge, William H. R.] Loma Linda Univ, Sch Med, Dept Basic Sci, Div Biochem, Loma Linda, CA 92350 USA; [Zhang, Kangling] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Aruni, Wilson Aruni] Loma Linda Univ, Sch Med, Dept Basic Sci, Div Microbiol & Mol Genet, Loma Linda, CA 92350 USA; [Payne, Kimberly J.] Loma Linda Univ, Sch Med, Dept Anat & Physiol, Loma Linda, CA 92350 USA; [De Leon, Marino] Loma Linda Univ, Sch Med, Dept Basic Sci, Div Physiol, Loma Linda, CA 92350 USA	Loma Linda University; Loma Linda University; University of Texas System; University of Texas Medical Branch Galveston; Loma Linda University; Loma Linda University; Loma Linda University	De Leon, M (corresponding author), Loma Linda Univ, Sch Med, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92350 USA.; De Leon, M (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Div Physiol, Loma Linda, CA 92350 USA.	madeleon@llu.edu	WILSON, ARUNI/AAU-1908-2020; Nicholas, Dequina/AAF-1412-2019; De Leon, Marino/A-6922-2009; Payne, Kimberly/AAS-6814-2020	De Leon, Marino/0000-0001-6576-785X; Payne, Kimberly/0000-0002-7025-5821; Unternaehrer-Hamm, Julia/0000-0001-5864-4704; Aruni, Wilson/0000-0002-9208-0153; Nicholas, Dequina/0000-0003-4996-2190	National Institute on Minority Health and Health Disparities grant [P20 MD006988 03, F31 GM101961 02]; National Institute of General Medical Sciences grant [R25 GM060507 14]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM101961] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities grant; National Institute of General Medical Sciences grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute on Minority Health and Health Disparities grant P20 MD006988 03 (awarded to MD) and F31 GM101961 02 (awarded to DN) and National Institute of General Medical Sciences grant R25 GM060507 14 (awarded to MD). The authors received no specific funding for this work.	Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Almaguel FG, 2009, J NEUROSCI RES, V87, P1207, DOI 10.1002/jnr.21918; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Bachmann A, 2002, J VIROL, V76, P280, DOI 10.1128/JVI.76.1.280-291.2002; Basu S, 2014, MOL VIS, V20, P458; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Cleary PA, 2006, DIABETES, V55, P3556, DOI 10.2337/db06-0653; Cullberg KB, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.10; da Silva RB, 2011, CELL MOL LIFE SCI, V68, P3505, DOI 10.1007/s00018-011-0801-8; de Felipe Pablo, 2004, Genet Vaccines Ther, V2, P13, DOI 10.1186/1479-0556-2-13; Demarse NA, 2011, ANAL BIOCHEM, V417, P247, DOI 10.1016/j.ab.2011.06.014; Dinarello CA, 2010, CURR OPIN ENDOCRINOL, V17, P314, DOI 10.1097/MED.0b013e32833bf6dc; Erridge C, 2009, ARTERIOSCL THROM VAS, V29, P1944, DOI 10.1161/ATVBAHA.109.194050; Finkel T, 1999, J LEUKOCYTE BIOL, V65, P337, DOI 10.1002/jlb.65.3.337; Forman HJ, 2015, FREE RADICAL BIO MED, V78, P233, DOI 10.1016/j.freeradbiomed.2014.10.504; Fujiwara SI, 2008, BIOPHYS J, V94, P95, DOI 10.1529/biophysj.107.111377; Gagliardi MC, 2009, INFECT IMMUN, V77, P4947, DOI 10.1128/IAI.00607-09; Grishman EK, 2012, PEDIATR RES, V71, P626, DOI 10.1038/pr.2012.24; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Hirasawa A, 2008, BIOL PHARM BULL, V31, P1847, DOI 10.1248/bpb.31.1847; Huang P, 2013, MOL CLIN ONCOL, V1, P180, DOI 10.3892/mco.2012.29; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Ii M, 2006, MOL PHARMACOL, V69, P1288, DOI 10.1124/mol.105.019695; Ikeda S, 2014, J IMMUNOL, V192, P1449, DOI 10.4049/jimmunol.1300387; Illana V, 2012, BIOPROTOCOL, V2; Ip B, 2016, OBESITY, V24, P102, DOI 10.1002/oby.21243; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Kanemaki T, 1998, HEPATOLOGY, V27, P1296, DOI 10.1002/hep.510270515; Karolina DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022839; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kennedy A, 2009, J NUTR, V139, P1, DOI 10.3945/jn.108.098269; Kopp A, 2009, EUR J CLIN INVEST, V39, P924, DOI 10.1111/j.1365-2362.2009.02185.x; Korani M, 2012, CLIN LAB, V58, P1283, DOI 10.7754/Clin.Lab.2012.120212; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Layne MD, 2001, FASEB J, V15, P2733, DOI 10.1096/fj.01-0374fje; Lechmann M, 2002, TRENDS IMMUNOL, V23, P273, DOI 10.1016/S1471-4906(02)02214-7; Lee JY, 2004, J BIOL CHEM, V279, P16971, DOI 10.1074/jbc.M312990200; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Lee JY, 2003, J BIOL CHEM, V278, P37041, DOI 10.1074/jbc.M305213200; Leonarduzzi G, 2012, FREE RADICAL BIO MED, V52, P19, DOI 10.1016/j.freeradbiomed.2011.09.031; Leslie DS, 2008, IMMUNOLOGY, V125, P289, DOI 10.1111/j.1365-2567.2008.02842.x; Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001; Luo XQ, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-34; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Mailer RKW, 2015, SCI REP-UK, V5, DOI 10.1038/srep14674; Maloney E, 2009, ARTERIOSCL THROM VAS, V29, P1370, DOI 10.1161/ATVBAHA.109.188813; Mbongue JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118562; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Muroi M, 2006, J BIOL CHEM, V281, P5484, DOI 10.1074/jbc.M509193200; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Nicholas D, 2015, MOL CELL PROTEOMICS, V14, P15, DOI 10.1074/mcp.M113.035089; Nicholas DA, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/196297; Nov O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053626; Padilla A, 2011, BRAIN RES, V1370, P64, DOI 10.1016/j.brainres.2010.11.013; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Pasare C, 2004, MICROBES INFECT, V6, P1382, DOI 10.1016/j.micinf.2004.08.018; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Probst HC, 2003, IMMUNITY, V18, P713, DOI 10.1016/S1074-7613(03)00120-1; Rajaiah R, 2015, P NATL ACAD SCI USA, V112, P8391, DOI 10.1073/pnas.1424980112; Reth M, 2002, NAT IMMUNOL, V3, P1129, DOI 10.1038/ni1202-1129; Reynolds CM, 2012, MOL NUTR FOOD RES, V56, P1212, DOI 10.1002/mnfr.201200058; Rolph MS, 2006, J IMMUNOL, V177, P7794, DOI 10.4049/jimmunol.177.11.7794; Segura E, 2009, P NATL ACAD SCI USA, V106, P20377, DOI 10.1073/pnas.0910295106; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shaikh SR, 2012, MOL ASPECTS MED, V33, P46, DOI 10.1016/j.mam.2011.10.002; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Snodgrass RG, 2013, J IMMUNOL, V191, P4337, DOI 10.4049/jimmunol.1300298; STEINMAN RM, 1995, J EXP MED, V182, P283, DOI 10.1084/jem.182.2.283; Stelzner K, 2016, EUR J IMMUNOL, V46, P2043, DOI 10.1002/eji.201546263; Teghanemt A, 2005, J IMMUNOL, V175, P4669, DOI 10.4049/jimmunol.175.7.4669; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Ulloth JE, 2003, J NEUROCHEM, V84, P655, DOI 10.1046/j.1471-4159.2003.01571.x; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wang N, 2010, ANAL CHEM, V82, P2262, DOI 10.1021/ac9023022; Wang Z, 2012, BRIT J NUTR, V107, P229, DOI 10.1017/S0007114511002868; Weatherill AR, 2005, J IMMUNOL, V174, P5390, DOI 10.4049/jimmunol.174.9.5390; Wong SW, 2009, J BIOL CHEM, V284, P27384, DOI 10.1074/jbc.M109.044065; Xu Wen, 2016, Nan Fang Yi Ke Da Xue Xue Bao, V36, P655; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	86	60	66	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176793	10.1371/journal.pone.0176793	http://dx.doi.org/10.1371/journal.pone.0176793			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28463985	Green Published, gold, Green Submitted			2022-12-26	WOS:000400646300054
J	Marino, KR; Lundberg, RL; Jasrotia, A; Maranda, LS; Thompson, MJ; Barton, BA; Alonso, LC; Nwosu, BU				Marino, Katherine R.; Lundberg, Rachel L.; Jasrotia, Aastha; Maranda, Louise S.; Thompson, Michael J.; Barton, Bruce A.; Alonso, Laura C.; Nwosu, Benjamin Udoka			A predictive model for lack of partial clinical remission in new-onset pediatric type 1 diabetes	PLOS ONE			English	Article							BETA-CELL FUNCTION; VITAMIN-D DEFICIENCY; ISLET ANTIBODIES; YOUNG-ADULTS; INSULIN; CHILDREN; DIAGNOSIS; DURATION; MELLITUS; COMPLICATIONS	Importance >50% of patients with new-onset type 1 diabetes (T1D) do not enter partial clinical remission (PCR); early identification of these patients may improve initial glycemic control and reduce long-term complications. Aim To determine whether routinely obtainable clinical parameters predict non-remission in children and adolescents with new-onset T1D. Subjects and methods Data on remission were collected for the first 36 months of disease in 204 subjects of ages 2-14 years with new-onset type 1 diabetes. There were 86 remitters (age 9.1 +/- 3.0y; male 57%), and 118 non-remitters (age 7.0 +/- 3.1y; male 40.7%). PCR was defined as insulin-dose adjusted hemoglobin A1c of <= 9. Results Non-remission occurred in 57.8% of subjects. Univariable analysis showed that the risk for non-remission was increased 9-fold in patients with 4 diabetes-associated auto-antibodies (OR = 9.90, p = 0.010); 5-fold in patients <5 years old (odds ratio = 5.38, p = 0.032), 3-fold in those with bicarbonate of <15 mg/dL at diagnosis (OR = 3.71, p = 0.008). Combined estimates of risk potential for HC0(3) and the number of autoantibodies by multivariable analysis, adjusted for BMI standard deviation score, showed HC03 <15 mg/dL with a clinically significant 10-fold risk (OR = 10.1, p = 0.074); and the number of autoantibodies with a 2-fold risk for non-remission (OR = 1.9, p = 0.105). Male sex and older age were associated with decreased risk for non-remission. A receiver-operating characteristic curve model depicting sensitivity by 1-specificity for non-remission as predicted by bicarbonate <15 mg/dL, age <5y, female sex, and >3 diabetes-associated autoantibodies had an area under the curve of 0.73. Conclusions More than 50% of children and adolescents with new-onset T1D do not undergo partial clinical remission and are thus at an increased risk for long-term complications of diabetes mellitus. A predictive model comprising of bicarbonate <15 mg/dL, age <5y, female sex, and >3 diabetes-associated autoantibodies has 73% power for correctly predicting non-remission in children and adolescents with new-onset T1D. Early identification of these non-remitters may guide the institution of targeted therapy to limit dysglycemia and reduce the prevalence of long-term deleterious complications.	[Marino, Katherine R.; Lundberg, Rachel L.; Jasrotia, Aastha; Nwosu, Benjamin Udoka] Univ Massachusetts, Med Sch, Dept Pediat, Div Endocrinol, Worcester, MA 01605 USA; [Maranda, Louise S.; Barton, Bruce A.] Univ Massachusetts, Med Sch, Dept Quantitat Hlth Sci, Worcester, MA 01605 USA; [Thompson, Michael J.; Alonso, Laura C.] Univ Massachusetts, Med Sch, Dept Med, Diabet Div, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Nwosu, BU (corresponding author), Univ Massachusetts, Med Sch, Dept Pediat, Div Endocrinol, Worcester, MA 01605 USA.	Benjamin.Nwosu@umassmemorial.org		Nwosu, Benjamin/0000-0003-2212-0276	NIDDK NIH HHS [R21 DK113353] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andersen MLCM, 2014, PEDIATR DIABETES, V15, P469, DOI 10.1111/pedi.12208; [Anonymous], 2016, DIABETES CARE S1, V39, pS4; Bizzarri C, 2013, HORM RES PAEDIAT, V80, P287, DOI 10.1159/000355116; Borg H, 2001, J CLIN ENDOCR METAB, V86, P3032, DOI 10.1210/jc.86.7.3032; Cengiz E, 2016, PEDIAT DIABETES; Chen YC, 2016, J FORMOS MED ASS; Chmelova H, 2015, DIABETES, V64, P2148, DOI 10.2337/db14-1055; Cigolini M, 2006, DIABETES CARE, V29, P722, DOI 10.2337/diacare.29.03.06.dc05-2148; FORRESTER RL, 1976, CLIN CHEM, V22, P243; Gabbay MAL, 2012, ARCH PEDIAT ADOL MED, V166, P601, DOI 10.1001/archpediatrics.2012.164; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Komulainen J, 1996, ARCH DIS CHILD, V75, P410, DOI 10.1136/adc.75.5.410; Kuczmarski RJ., 2000, ADV DATA, P1; Meier JJ, 2006, DIABETES, V55, P1051, DOI 10.2337/diabetes.55.04.06.db05-1449; Mishra A, 2015, J PEDIAT ENDOCRINOL; Mortensen HB, 2009, DIABETES CARE, V32, P1384, DOI 10.2337/dc08-1987; Nagl K, 2016, PEDIAT DIABETES; Nakanishi K, 2008, J CLIN ENDOCR METAB, V93, P4759, DOI 10.1210/jc.2008-1209; Neylon OM, 2013, DIABETIC MED, V30, P627, DOI 10.1111/dme.12097; Niedzwiecki P, 2015, J DIABETES COMPLICAT, V29, P1105, DOI 10.1016/j.jdiacomp.2015.09.002; Nwosu BU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099646; Oram RA, 2014, DIABETOLOGIA, V57, P187, DOI 10.1007/s00125-013-3067-x; Pozzilli P, 2001, EUR J ENDOCRINOL, V145, P757, DOI 10.1530/eje.0.1450757; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Sacheck J, 2011, J PEDIATR-US, V159, P945, DOI 10.1016/j.jpeds.2011.06.001; Scholin A, 2004, DIABETIC MED, V21, P447, DOI 10.1111/j.1464-5491.2004.01175.x; Scholin A, 2004, J INTERN MED, V255, P384, DOI 10.1046/j.1365-2796.2003.01273.x; Scholin A, 2011, DIABETIC MED, V28, P156, DOI 10.1111/j.1464-5491.2010.03191.x; Scholin A, 1999, J INTERN MED, V245, P155, DOI 10.1046/j.1365-2796.1999.00426.x; Sherry NA, 2005, DIABETES, V54, pS32, DOI 10.2337/diabetes.54.suppl_2.S32; Sorensen JS, 2013, DIABETES CARE, V36, P3454, DOI 10.2337/dc13-0418; Steffes MW, 2003, DIABETES CARE, V26, P832, DOI 10.2337/diacare.26.3.832; Tamborlane WV, 2005, PEDIATR DIABETES, V6, P13; Torn C, 2000, J CLIN ENDOCR METAB, V85, P4619, DOI 10.1210/jc.85.12.4619; Van den Berghe G, 2003, J CLIN ENDOCR METAB, V88, P4623, DOI 10.1210/jc.2003-030358; Veit LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101583; Veit LE, 2015, NUTR IN PRESS; Willcox A, 2009, CLIN EXP IMMUNOL, V155, P173, DOI 10.1111/j.1365-2249.2008.03860.x	38	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176860	10.1371/journal.pone.0176860	http://dx.doi.org/10.1371/journal.pone.0176860			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459844	Green Submitted, Green Published, gold			2022-12-26	WOS:000400645000064
J	Rong, SL; Wang, XL; Zhang, CY; Song, ZH; Cui, LH; He, XF; Li, XJ; Du, HJ; Li, B				Rong, Shu-Ling; Wang, Xiao-Lin; Zhang, Cui-Ying; Song, Zhuo-Hui; Cui, Lu-Hua; He, Xiao-Feng; Li, Xu-Jiong; Du, Hui-Jin; Li, Bao			Transplantation of HGF gene-engineered skeletal myoblasts improve infarction recovery in a rat myocardial ischemia model	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; STEM-CELLS; HEART FUNCTION; THERAPY; CARDIOPROTECTION; CARDIOMYOCYTE; TRANSFECTION; APOPTOSIS	Background Skeletal myoblast transplantation seems a promising approach for the repair of myocardial infarction (MI). However, the low engraftment efficacy and impaired angiogenic ability limit the clinical efficiency of the myoblasts. Gene engineering with angiogenic growth factors promotes angiogenesis and enhances engraftment of transplanted skeletal myoblasts, leading to improved infarction recovery in myocardial ischemia. The present study evaluated the therapeutic effects of hepatocyte growth factor (HGF) gene-engineered skeletal myoblasts on tissue regeneration and restoration of heart function in a rat MI model. Methods and results The skeletal myoblasts were isolated, expanded, and transduced with adenovirus carrying the HGF gene (Ad-HGF). Male SD rats underwent ligation of the left anterior descending coronary artery. After 2 weeks, the surviving rats were randomized into four groups and treated with skeletal myoblasts by direct injection into the myocardium. The survival and engraftment of skeletal myoblasts were determined by real-time PCR and in situ hybridization. The cardiac function with hemodynamic index and left ventricular architecture were monitored; The adenovirus-mediated-HGF gene transfection increases the HGF expression and promotes the proliferation of skeletal myoblasts in vitro. Transplantation of HGF-engineered skeletal myoblasts results in reduced infarct size and collagen deposition, increased vessel density, and improved cardiac function in a rat MI model. HGF gene modification also increases the myocardial levels of HGF, VEGF, and Bcl-2 and enhances the survival and engraftment of skeletal myoblasts. Conclusions HGF engineering improves the regenerative effect of skeletal myoblasts on MI by enhancing their survival and engraftment ability.	[Rong, Shu-Ling; Cui, Lu-Hua; Du, Hui-Jin] Changzhi Med Coll, Heping Hosp, Dept Cardiol, Changzhi, Peoples R China; [Rong, Shu-Ling; Wang, Xiao-Lin; Cui, Lu-Hua; Du, Hui-Jin] Changzhi Med Coll, Inst Cardiovasc Dis, Changzhi, Peoples R China; [Rong, Shu-Ling; Li, Bao] Shanxi Med Univ, Hosp 2, Dept Cardiol, Taiyuan, Shanxi, Peoples R China; [Wang, Xiao-Lin] Changzhi Med Coll, Heping Hosp, Dept Pediat, Changzhi, Peoples R China; [Zhang, Cui-Ying; Song, Zhuo-Hui; Li, Xu-Jiong] Changzhi Med Coll, Dept Physiol, Changzhi, Peoples R China; [He, Xiao-Feng] Changzhi Med Coll, Heping Hosp, Dept Res, Changzhi, Peoples R China	Changzhi Medical College; Changzhi Medical College; Shanxi Medical University; Changzhi Medical College; Changzhi Medical College; Changzhi Medical College	Wang, XL (corresponding author), Changzhi Med Coll, Inst Cardiovasc Dis, Changzhi, Peoples R China.; Li, B (corresponding author), Shanxi Med Univ, Hosp 2, Dept Cardiol, Taiyuan, Shanxi, Peoples R China.; Wang, XL (corresponding author), Changzhi Med Coll, Heping Hosp, Dept Pediat, Changzhi, Peoples R China.	czsrsl@sina.com; 2306673817@qq.com			Shanxi Province Natural Science Foundation [2012011040-3, 2013011049-4]; Scientific Research Foundation of High Education Institutions of Shanxi Province [200811034]; Program for Innovative Research Team in Changzhi Medical College [cx201406]; Research Project of Shanxi Provincial Health and Family Planning Commission [201602026, 201602028]; High School 131 Leading Talent Project of Shanxi Province; National Undergraduate Innovation and Entrepreneurship Training Programs [201610117001]	Shanxi Province Natural Science Foundation(Natural Science Foundation of Shanxi Province); Scientific Research Foundation of High Education Institutions of Shanxi Province; Program for Innovative Research Team in Changzhi Medical College; Research Project of Shanxi Provincial Health and Family Planning Commission; High School 131 Leading Talent Project of Shanxi Province; National Undergraduate Innovation and Entrepreneurship Training Programs	This work was supported by the Shanxi Province Natural Science Foundation (No. 2012011040-3 to XW, 2013011049-4 to SLR); the Scientific Research Foundation of High Education Institutions of Shanxi Province (No.200811034 to SLR); the Program for Innovative Research Team in Changzhi Medical College (cx201406 to SLR); the Research Project of Shanxi Provincial Health and Family Planning Commission (201602026 to SLR, 201602028 to XW); the High School 131 Leading Talent Project of Shanxi Province to SLR; the National Undergraduate Innovation and Entrepreneurship Training Programs (201610117001 to SLR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharinejad S, 2008, CARDIOVASC RES, V79, P395, DOI 10.1093/cvr/cvn097; An J, 1997, J ANDROL, V18, P289; Cui ZW, 2015, BIOSCI TRENDS, V9, P122, DOI 10.5582/bst.2014.01133; Don CW, 2013, J CELL MOL MED, V17, P1355, DOI 10.1111/jcmm.12147; Duan HF, 2003, MOL THER, V8, P467, DOI 10.1016/S1525-0016(03)00186-2; Guarita-Souza LC, 2006, CIRCULATION, V114, pI120, DOI 10.1161/CIRCULATIONAHA.105.000646; Henning RJ, 2011, FUTUR CARDIOL, V7, P99, DOI 10.2217/FCA.10.109; Hodgkinson CP, 2010, HUM GENE THER, V21, P1513, DOI 10.1089/hum.2010.165; Kanashiro-Takeuchi RM, 2011, J MOL CELL CARDIOL, V51, P619, DOI 10.1016/j.yjmcc.2011.05.015; Lavu M, 2011, J MOL CELL CARDIOL, V50, P742, DOI 10.1016/j.yjmcc.2010.06.007; Li WZ, 2007, STEM CELLS, V25, P2118, DOI 10.1634/stemcells.2006-0771; Lin YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050924; Liu Y, 2012, BIOL PHARM BULL, V35, P1150, DOI 10.1248/bpb.b12-00197; Madonna R, 2015, INT J CARDIOL, V191, P203, DOI 10.1016/j.ijcard.2015.04.232; Madonna R, 2012, THROMB HAEMOSTASIS, V107, P656, DOI 10.1160/TH11-10-0711; Maslov L N, 2013, Vestn Ross Akad Med Nauk, P16; Matsumura A, 2013, INT J ONCOL, V42, P535, DOI 10.3892/ijo.2012.1728; Menasche P, 2001, LANCET, V357, P279, DOI 10.1016/S0140-6736(00)03617-5; Molnarfi N, 2015, AUTOIMMUN REV, V14, P293, DOI 10.1016/j.autrev.2014.11.013; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; Pons J, 2009, J GENE MED, V11, P743, DOI 10.1002/jgm.1362; Rong SL, 2010, CHINESE MED J-PEKING, V123, P3626, DOI 10.3760/cma.j.issn.0366-6999.2010.24.022; Rong SL, 2009, CHINESE MED J-PEKING, V122, P2352, DOI 10.3760/cma.j.issn.0366-6999.2009.19.030; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Schoenhard JA, 2010, J CARDIOVASC TRANSL, V3, P49, DOI 10.1007/s12265-009-9148-z; Scorsin M, 2000, J THORAC CARDIOV SUR, V119, P1169, DOI 10.1067/mtc.2000.104865; Shimamura M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/186215; Song MB, 2009, VASC PHARMACOL, V51, P205, DOI 10.1016/j.vph.2009.06.009; Suresh SC, 2015, INT J CARDIOL, V201, P517, DOI 10.1016/j.ijcard.2015.08.117; Taylor Doris A, 2007, Curr Heart Fail Rep, V4, P3, DOI 10.1007/s11897-007-0019-0; Van Belle E, 1998, CIRCULATION, V97, P381; von Degenfeld G, 2003, BRIT J PHARMACOL, V140, P620, DOI 10.1038/sj.bjp.0705492; Walker N, 2015, GROWTH FACTORS, V33, P229, DOI 10.3109/08977194.2015.1058260; Wang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124420; Wang H, 2013, HUM GENE THER, V24, P343, DOI 10.1089/hum.2012.177; Wang W, 2016, HUM GENE THER, V27, P643, DOI 10.1089/hum.2015.119; Wang XY, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/135023; Yuan B, 2008, IN VIVO, V22, P629; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111246	40	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0175807	10.1371/journal.pone.0175807	http://dx.doi.org/10.1371/journal.pone.0175807			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459804	Green Published, Green Submitted, gold			2022-12-26	WOS:000400645000005
J	Benavides-Serrato, A; Lee, J; Holmes, B; Landon, KA; Bashir, T; Jung, ME; Lichtenstein, A; Gera, J				Benavides-Serrato, Angelica; Lee, Jihye; Holmes, Brent; Landon, Kenna A.; Bashir, Tariq; Jung, Michael E.; Lichtenstein, Alan; Gera, Joseph			Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma	PLOS ONE			English	Article							TARGETED INHIBITION; MAMMALIAN TARGET; COMPLEX; CANCER; KINASE; GROWTH; TRANSLATION; GENETICS; PATHWAY; DEFINES	A small molecule which specifically blocks the interaction of Rictor and mTOR was identified utilizing a high-throughput yeast two-hybrid screen and evaluated as a potential inhibitor of mTORC2 activity in glioblastoma multiforme (GBM). In vitro, CID613034 inhibited mTORC2 kinase activity at submicromolar concentrations and in cellular assays specifically inhibited phosphorylation of mTORC2 substrates, including AKT (Ser-473), NDRG1 (Thr-346) and PKCa (Ser-657), while having no appreciable effects on the phosphorylation status of the mTORC1 substrate S6K (Thr-389) or mTORC1-dependent negative feedback loops. CID613034 demonstrated significant inhibitory effects on cell growth, motility and invasiveness in GBM cell lines and sensitivity correlated with relative Rictor or SIN1 expression. Structure-activity relationship analyses afforded an inhibitor, JR-AB2-011, with improved anti-GBM properties and blocked mTORC2 signaling and Rictor association with mTOR at lower effective concentrations. In GBM xenograft studies, JR-AB2-011 demonstrated significant anti-tumor properties. These data support mTORC2 as a viable therapeutic target in GBM and suggest that targeting protein-protein interactions critical for mTORC2 function is an effective strategy to achieve therapeutic responses.	[Benavides-Serrato, Angelica; Holmes, Brent; Lichtenstein, Alan; Gera, Joseph] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Benavides-Serrato, Angelica; Holmes, Brent; Landon, Kenna A.; Bashir, Tariq; Lichtenstein, Alan; Gera, Joseph] Greater Los Angeles Vet Affairs Healthcare Syst, Dept Res & Dev, Los Angeles, CA 90073 USA; [Lee, Jihye; Jung, Michael E.] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Jung, Michael E.; Lichtenstein, Alan; Gera, Joseph] Calif State Univ Los Angeles, Jonnson Comprehens Canc Ctr, Los Angeles, CA 90032 USA; [Jung, Michael E.; Gera, Joseph] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Lee, Jihye] Gachon Univ, Neurosci Res Inst, 24 Namdong Daero 774 Beon Gil, Incheon, South Korea	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; California State University System; California State University Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Gachon University	Gera, J (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.; Gera, J (corresponding author), Greater Los Angeles Vet Affairs Healthcare Syst, Dept Res & Dev, Los Angeles, CA 90073 USA.; Gera, J (corresponding author), Calif State Univ Los Angeles, Jonnson Comprehens Canc Ctr, Los Angeles, CA 90032 USA.; Gera, J (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA.	jgera.@mednet.ucla.edu		Holmes, Brent/0000-0002-2768-2991; Gera, Joseph/0000-0002-2908-6894	National Institutes of Health [R01CA168700]; Department of Veterans Affairs MERIT grant [I01BX002665]; NIH grants [R01CA168700, R01CA132778]; Veteran's Administration [I01BX002665]; NATIONAL CANCER INSTITUTE [R01CA168700] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs MERIT grant(US Department of Veterans Affairs); NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran's Administration(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Bing Su, David Sabatini, Jie Chen, Jacob Fleischmann, Paul Mischel and Norimoto Yanagawa for reagents and cell lines. We also are grateful to YiJiang Shi and Cheri Cloninger for technical assistance and thank Richard Weisbart and Robert Nishimura for comments on the manuscript. This paper is dedicated to the memory of our wonderful colleague, Dr. Richard Weisbart, who passed away November 11, 2016. This work was supported, in whole or in part, by National Institutes of Health Grant R01CA168700 and by Department of Veterans Affairs MERIT grant I01BX002665.; This work was supported, in whole or in part, by NIH grants R01CA132778, R01CA168700 and research funds of the Veteran's Administration I01BX002665. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashir T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047741; Benavides-Serrato Angelica, 2014, Genes Cancer, V5, P393; Cheng HY, 2015, CANCER DISCOV, V5, P1262, DOI 10.1158/2159-8290.CD-14-0971; Cloninger C, 2011, MOL CANCER THER, V10, P2244, DOI 10.1158/1535-7163.MCT-11-0478; Cloughesy TF, 2014, ANNU REV PATHOL-MECH, V9, P1, DOI 10.1146/annurev-pathol-011110-130324; Cloughesy TF, 2011, CLIN CANCER RES, V17, P6, DOI 10.1158/1078-0432.CCR-09-2268; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Fan QW, 2011, CURR TOP MICROBIOL, V347, P279, DOI 10.1007/82_2010_67; Gao DM, 2010, MOL CELL, V39, P797, DOI 10.1016/j.molcel.2010.08.016; Gaubitz C, 2016, TRENDS BIOCHEM SCI, V41, P532, DOI 10.1016/j.tibs.2016.04.001; Gulhati P, 2009, CLIN CANCER RES, V15, P7207, DOI 10.1158/1078-0432.CCR-09-1249; Hagan GN, 2008, MOL CELL BIOL, V28, P4215, DOI 10.1128/MCB.00867-07; Holmes B, 2016, J BIOL CHEM, V291, P14146, DOI 10.1074/jbc.M116.726927; Kato-Stankiewicz J, 2002, P NATL ACAD SCI USA, V99, P14398, DOI 10.1073/pnas.222222699; Khazak V, 2006, METHOD ENZYMOL, V407, P612, DOI 10.1016/S0076-6879(05)07048-5; Kliegman JI, 2013, CELL REP, V5, P1725, DOI 10.1016/j.celrep.2013.11.040; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LI B, 1993, FASEB J, V7, P957, DOI 10.1096/fasebj.7.10.8344494; Liu Qingsong, 2009, Drug Discov Today Ther Strateg, V6, P47; Martin J, 2008, BIOCHEM BIOPH RES CO, V372, P578, DOI 10.1016/j.bbrc.2008.05.086; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; Masui K, 2015, BRAIN PATHOL, V25, P755, DOI 10.1111/bpa.12307; Masui K, 2015, P NATL ACAD SCI USA, V112, P9406, DOI 10.1073/pnas.1511759112; Nourani A, 1997, MOL CELL BIOL, V17, P5453, DOI 10.1128/MCB.17.9.5453; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Rispal D, 2015, J BIOL CHEM, V290, P14963, DOI 10.1074/jbc.M114.627794; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Serrano I, 2013, ONCOGENE, V32, P50, DOI 10.1038/onc.2012.30; Shi YJ, 2016, CANCER RES, V76, P5822, DOI 10.1158/0008-5472.CAN-16-1019; Shi YJ, 2005, MOL CANCER THER, V4, P1533, DOI 10.1158/1535-7163.MCT-05-0068; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Tanaka K, 2011, CANCER DISCOV, V1, P524, DOI 10.1158/2159-8290.CD-11-0124; Westphal M, 2011, NAT REV NEUROSCI, V12, P495, DOI 10.1038/nrn3060; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Wingfield Paul T, 2015, Curr Protoc Protein Sci, V80, DOI 10.1002/0471140864.ps0601s80; Wu Si-Han, 2014, Cancer Biology Medicine, V11, P255, DOI 10.7497/j.issn.2095-3941.2014.04.004; Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200; Zhang F, 2010, CANCER RES, V70, P9360, DOI 10.1158/0008-5472.CAN-10-0207; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; Zou ZP, 2016, CURR CANCER DRUG TAR, V16, P288, DOI 10.2174/1568009616666151113120830	44	47	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176599	10.1371/journal.pone.0176599	http://dx.doi.org/10.1371/journal.pone.0176599			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453552	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383900032
J	Lee, YP; Fujii, M; Kikuchi, T; Terao, K; Yoshimura, C				Lee, Ying Ping; Fujii, Manabu; Kikuchi, Tetsuro; Terao, Koumei; Yoshimura, Chihiro			Variation of iron redox kinetics and its relation with molecular composition of standard humic substances at circumneutral pH	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; FULVIC ACID INTERACTIONS; FE(II) OXIDATION; NATURAL-WATERS; COMPLEXING LIGANDS; IONIC-STRENGTH; FERRIC IRON; FE-II; REDUCTION; SUPEROXIDE	Oxidation and reduction kinetics of iron (Fe) and proportion of steady-state Fe(II) concentration relative to total dissolved Fe (steady-state Fe(II) fraction) were investigated in the presence of various types of standard humic substances (HS) with particular emphasis on the photochemical and thermal reduction of Fe(III) and oxidation of Fe(II) by dissolved oxygen (O-2) and hydrogen peroxide (H2O2) at circumneutral pH (pH 7-8). Rates of Fe(III) reduction were spectrophotometrically determined by a ferrozine method under the simulated sunlight and dark conditions, whereas rates of Fe(II) oxidation were examined in air-saturated solution using luminol chemiluminescence technique. The reduction and oxidation rate constants were determined to substantially vary depending on the type of HS. For example, the first-order rate constants varied by up to 10-fold for photochemical reduction and 7-fold for thermal reduction. The degree of variation in Fe(II) oxidation was larger for the H2O2-mediated reaction compared to the O-2-mediated reaction (e.g., 15-and 3-fold changes for the former and latter reactions, respectively, at pH 8). The steady-state Fe(II) fraction under the simulated sunlight indicated that the Fe(II) fraction varies by up to 12-fold. The correlation analysis indicated that variation of Fe(II) oxidation is significantly associated with aliphatic content of HS, suggesting that Fe(II) complexation by aliphatic components accelerates Fe (II) oxidation. The reduction rate constant and steady-state Fe(II) fractions in the presence of sunlight had relatively strong positive relations with free radical content of HS, possibly due to the reductive property of radical semiquinone in HS. Overall, the findings in this study indicated that the Fe reduction and oxidation kinetics and resultant Fe(II) formation are substantially influenced by chemical properties of HS.	[Lee, Ying Ping; Fujii, Manabu; Kikuchi, Tetsuro; Terao, Koumei; Yoshimura, Chihiro] Tokyo Inst Technol, Sch Environm & Soc, Dept Civil & Environm Engn, Meguro Ku, Tokyo, Japan; [Kikuchi, Tetsuro] Ibaraki Kasumigaura Environm Sci Ctr, Tsuchiura, Ibaraki, Japan	Tokyo Institute of Technology	Fujii, M (corresponding author), Tokyo Inst Technol, Sch Environm & Soc, Dept Civil & Environm Engn, Meguro Ku, Tokyo, Japan.	fujii.m.ah@m.titech.ac.jp	Fujii, Manabu/A-2624-2013	Fujii, Manabu/0000-0001-7319-6014	JSPS [25709045]; Bilateral joint Research Project	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Bilateral joint Research Project	Support was provided by JSPS Young Scientists (A) (25709045) and the Bilateral joint Research Project.	Barbeau K, 2006, PHOTOCHEM PHOTOBIOL, V82, P1505, DOI 10.1562/2006-06-16-IR-935; Bauer I, 2009, ENVIRON SCI TECHNOL, V43, P4902, DOI 10.1021/es900179s; Borer P, 2009, ENVIRON SCI TECHNOL, V43, P1864, DOI 10.1021/es801352k; Borman CJ, 2010, CHEM GEOL, V269, P33, DOI 10.1016/j.chemgeo.2009.07.011; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Brezonik P. L., 2011, WATER CHEM INTRO CHE; Chen J, 2003, SCI TOTAL ENVIRON, V307, P167, DOI 10.1016/S0048-9697(02)00538-7; Crichton R., 2002, INORGANIC BIOCH IRON, V2, DOI DOI 10.1002/AOC.289; Croot PL, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00219; Croot PL, 2001, GEOPHYS RES LETT, V28, P3425, DOI 10.1029/2001GL013023; de Baar H.J.W., 2001, BIOGEOCHEMISTRY IRON, P123; DePalma SGS, 2011, APPL GEOCHEM, V26, P394, DOI 10.1016/j.apgeochem.2011.01.022; Emmenegger L, 1998, ENVIRON SCI TECHNOL, V32, P2990, DOI 10.1021/es980207g; Fujii M, 2014, ENVIRON SCI TECHNOL, V48, P365, DOI 10.1021/es404090h; Fujii M, 2011, ENVIRON SCI TECHNOL, V45, P1391, DOI 10.1021/es103311h; Fujii M, 2014, ENVIRON SCI TECHNOL, V48, P4414, DOI 10.1021/es405496b; Fujii M, 2010, ENVIRON SCI TECHNOL, V44, P9337, DOI 10.1021/es102583c; Fujitake N., 2009, HUMIC SUBST RES, V5, P45; GIBBS CR, 1976, ANAL CHEM, V48, P1197, DOI 10.1021/ac50002a034; Gonzalez AG, 2014, ENVIRON SCI TECHNOL, V48, P7933, DOI 10.1021/es5013092; Hay MB, 2007, GEOCHIM COSMOCHIM AC, V71, P3518, DOI 10.1016/j.gca.2007.03.038; Hopwood MJ, 2015, MAR CHEM, V173, P173, DOI 10.1016/j.marchem.2014.11.004; Hopwood MJ, 2014, ESTUAR COAST SHELF S, V151, P1, DOI 10.1016/j.ecss.2014.09.015; KING DW, 1995, ENVIRON SCI TECHNOL, V29, P818, DOI 10.1021/es00003a033; Kramer JR, 2007, APPL GEOCHEM, V22, P1606, DOI 10.1016/j.apgeochem.2007.03.026; Laglera LM, 2009, LIMNOL OCEANOGR, V54, P610, DOI 10.4319/lo.2009.54.2.0610; Lee YP, 2016, WATER RES, V103, P160, DOI 10.1016/j.watres.2016.07.033; Leenheer JA, 1998, ENVIRON SCI TECHNOL, V32, P2410, DOI 10.1021/es9708979; Liu XW, 2002, MAR CHEM, V77, P43, DOI 10.1016/S0304-4203(01)00074-3; Liu XW, 1999, GEOCHIM COSMOCHIM AC, V63, P3487, DOI 10.1016/S0016-7037(99)00270-7; Manceau A, 2010, GEOCHIM COSMOCHIM AC, V74, P2556, DOI 10.1016/j.gca.2010.01.027; Meunier L, 2005, AQUAT SCI, V67, P292, DOI 10.1007/s00027-005-0779-0; MILES CJ, 1981, ENVIRON SCI TECHNOL, V15, P1089, DOI 10.1021/es00091a010; Miller CJ, 2009, GEOCHIM COSMOCHIM AC, V73, P2758, DOI 10.1016/j.gca.2009.02.027; MILLERO FJ, 1987, GEOCHIM COSMOCHIM AC, V51, P793, DOI 10.1016/0016-7037(87)90093-7; Moffett J. W., 2001, BIOGEOCHEMISTRY IRON, P343; Pham AN, 2008, GEOCHIM COSMOCHIM AC, V72, P3616, DOI 10.1016/j.gca.2008.05.032; Pullin MJ, 2003, GEOCHIM COSMOCHIM AC, V67, P4067, DOI 10.1016/S0016-7037(03)00366-1; Pullin MJ, 2003, GEOCHIM COSMOCHIM AC, V67, P4079, DOI 10.1016/S0016-7037(03)00367-3; Rakshit S, 2009, SOIL SCI SOC AM J, V73, P65, DOI 10.2136/sssaj2007.0418; Rijkenberg MJA, 2006, GEOCHIM COSMOCHIM AC, V70, P2790, DOI 10.1016/j.gca.2006.03.004; Rose AL, 2005, ENVIRON SCI TECHNOL, V39, P2645, DOI 10.1021/es048765k; Rose AL, 2003, ENVIRON SCI TECHNOL, V37, P4877, DOI 10.1021/es034152g; Rose AL, 2002, ENVIRON SCI TECHNOL, V36, P433, DOI 10.1021/es0109242; Rose AL, 2006, GEOCHIM COSMOCHIM AC, V70, P3869, DOI 10.1016/j.gca.2006.06.008; Roy EG, 2011, MAR CHEM, V127, P115, DOI 10.1016/j.marchem.2011.08.006; Royer RA, 2002, ENVIRON SCI TECHNOL, V36, P2897, DOI 10.1021/es015735y; Royer RA, 2002, ENVIRON SCI TECHNOL, V36, P1939, DOI 10.1021/es011139s; Rozan TF, 2000, NATURE, V406, P879, DOI 10.1038/35022561; Santana-Casiano JM, 2006, MAR CHEM, V99, P70, DOI 10.1016/j.marchem.2005.03.010; Santana-Casiano JM, 2005, ENVIRON SCI TECHNOL, V39, P2073, DOI 10.1021/es049748y; Santana-Casiano JM, 2000, MAR CHEM, V70, P211, DOI 10.1016/S0304-4203(00)00027-X; Scott DT, 1998, ENVIRON SCI TECHNOL, V32, P2984, DOI 10.1021/es980272q; SENESI N, 1989, HUMIC SUBSTANCES, V2, P373; Shaked Y, 2008, GEOCHIM COSMOCHIM AC, V72, P1540, DOI 10.1016/j.gca.2008.01.005; Sharpless CM, 2014, ENVIRON SCI-PROC IMP, V16, P654, DOI 10.1039/c3em00573a; Song WJ, 2005, ENVIRON SCI TECHNOL, V39, P3121, DOI 10.1021/es0483701; Statham PJ, 2012, ANAL CHIM ACTA, V743, P111, DOI 10.1016/j.aca.2012.07.014; Stumm W, 1996, AQUATIC CHEM; Sunda W.G., 2001, IUPAC SER ANAL PHYS, V49, P1024; Tipping E., 2002, CATION BINDING HUMIC; VOELKER BM, 1995, MAR CHEM, V50, P93, DOI 10.1016/0304-4203(95)00029-Q; WAITE TD, 1995, MAR CHEM, V50, P79, DOI 10.1016/0304-4203(95)00028-P; Wang ZH, 2012, J PHYS CHEM LETT, V3, P2044, DOI 10.1021/jz3005333; WATANABE A, 1994, SOIL SCI PLANT NUTR, V40, P601, DOI 10.1080/00380768.1994.10414299; Wolf M, 2009, ENVIRON SCI TECHNOL, V43, P5679, DOI 10.1021/es803647r; Xie HX, 2004, ENVIRON SCI TECHNOL, V38, P4113, DOI 10.1021/es035407t; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	68	47	47	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176484	10.1371/journal.pone.0176484	http://dx.doi.org/10.1371/journal.pone.0176484			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453538	gold, Green Submitted, Green Published			2022-12-26	WOS:000400383900027
J	Talwar, T; Vidhyasagar, V; Qing, J; Guo, MH; Kariem, A; Lu, Y; Singh, RS; Lukong, KE; Wu, YL				Talwar, Tanu; Vidhyasagar, Venkatasubramanian; Qing, Jennifer; Guo, Manhong; Kariem, Ahmad; Lu, Yi; Singh, Ravi Shankar; Lukong, Kiven Erique; Wu, Yuliang			The DEAD-box protein DDX43 (HAGE) is a dual RNA-DNA helicase and has a K-homology domain required for full nucleic acid unwinding activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA; DNA enzyme; DNA helicase; DNA-protein interaction; RNA; RNA-binding protein; RNA helicase; RNA metabolism	FRAGILE-X-SYNDROME; MELANOMA-INITIATING CELLS; C-TERMINAL DOMAIN; MOLECULAR INSIGHTS; BINDING PROTEINS; SPLICING FACTOR; MESSENGER-RNAS; ATP HYDROLYSIS; BREAST-CANCER; GENERAL RNA	The K-homology (KH) domain is a nucleic acid-binding domain present in many proteins but has not been reported in helicases. DDX43, also known as HAGE (helicase antigen gene), is a member of the DEAD-box protein family. It contains a helicase core domain in its C terminus and a potential KH domain in its N terminus. DDX43 is highly expressed in many tumors and is, therefore, considered a potential target for immunotherapy. Despite its potential as a therapeutic target, little is known about its activities. Here, we purified recombinant DDX43 protein to near homogeneity and found that it exists as a monomer in solution. Biochemical assays demonstrated that it is an ATP-dependent RNA and DNA helicase. Although DDX43 was active on duplex RNA regardless of the orientation of the single-stranded RNA tail, it preferred a 5 to 3 polarity on RNA and a 3 to 5 direction on DNA. Truncation mutations and site-directed mutagenesis confirmed that the KH domain in DDX43 is responsible for nucleic acid binding. Compared with the activity of the full-length protein, the C-terminal helicase domain had no unwinding activity on RNA substrates and had significantly reduced unwinding activity on DNA. Moreover, the full-length DDX43 protein, with single amino acid change in the KH domain, had reduced unwinding and binding activates on RNA and DNA substrates. Our results demonstrate that DDX43 is a dual helicase and the KH domain is required for its full unwinding activity.	[Talwar, Tanu; Vidhyasagar, Venkatasubramanian; Qing, Jennifer; Guo, Manhong; Kariem, Ahmad; Lu, Yi; Singh, Ravi Shankar; Lukong, Kiven Erique; Wu, Yuliang] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan	Wu, YL (corresponding author), Univ Saskatchewan, Hlth Sci Bldg,107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	yuliang.wu@usask.ca	Vidhyasagar, Venkatasubramanian/M-9442-2013; Singh, Ravi Shankar/ADM-2908-2022	Vidhyasagar, Venkatasubramanian/0000-0001-8679-4021; Singh, Ravi Shankar/0000-0001-8698-4562	Canadian Breast Cancer Foundation	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS))	This work was supported by the Canadian Breast Cancer Foundation (to Y. W. and K. E. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdel-Fatah TMA, 2014, BRIT J CANCER, V110, P2450, DOI 10.1038/bjc.2014.168; Abdel-Fatah TMA, 2016, CLIN CANCER RES, V22, P905, DOI 10.1158/1078-0432.CCR-15-0610; Adams SP, 2002, LEUKEMIA, V16, P2238, DOI 10.1038/sj.leu.2402732; Adinolfi S, 1999, RNA, V5, P1248, DOI 10.1017/S1355838299990647; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Backe PH, 2005, STRUCTURE, V13, P1055, DOI 10.1016/j.str.2005.04.008; Barnes M, 2015, J BIOL CHEM, V290, P625, DOI 10.1074/jbc.M114.614735; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; Bizebard T, 2004, BIOCHEMISTRY-US, V43, P7857, DOI 10.1021/bi049852s; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Chen Qin, 2011, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V19, P1171; Chen YF, 2008, P NATL ACAD SCI USA, V105, P20203, DOI 10.1073/pnas.0811075106; Chmiel NH, 2006, RNA, V12, P283, DOI 10.1261/rna.2175706; Chuang RY, 1997, SCIENCE, V275, P1468, DOI 10.1126/science.275.5305.1468; Collins R, 2009, J BIOL CHEM, V284, P10296, DOI 10.1074/jbc.C900018200; COMBEAU C, 1989, J BIOL CHEM, V264, P19017; Del Campo M, 2009, MOL CELL, V35, P598, DOI 10.1016/j.molcel.2009.07.032; Diges CM, 2001, EMBO J, V20, P5503, DOI 10.1093/emboj/20.19.5503; Ding H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140755; FLORESROZAS H, 1993, J BIOL CHEM, V268, P21372; Gatfield D, 2001, CURR BIOL, V11, P1716, DOI 10.1016/S0960-9822(01)00532-2; GIBSON TJ, 1993, FEBS LETT, V324, P361, DOI 10.1016/0014-5793(93)80152-K; Gilhooly NS, 2014, NUCLEIC ACIDS RES, V42, P5633, DOI 10.1093/nar/gku188; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P638, DOI 10.1093/nar/29.3.638; Grohman JK, 2007, BIOCHEMISTRY-US, V46, P3013, DOI 10.1021/bi0619472; Guo MH, 2016, METHODS, V108, P118, DOI 10.1016/j.ymeth.2016.04.023; Guo MH, 2014, J BIOL CHEM, V289, P10551, DOI 10.1074/jbc.M113.538892; Halls C, 2007, J MOL BIOL, V365, P835, DOI 10.1016/j.jmb.2006.09.083; HIRLING H, 1989, NATURE, V339, P562, DOI 10.1038/339562a0; Honig A, 2002, MOL CELL BIOL, V22, P5698, DOI 10.1128/MCB.22.16.5698-5707.2002; Hopfner KP, 2007, CURR OPIN STRUC BIOL, V17, P87, DOI 10.1016/j.sbi.2006.11.003; Huang YL, 2002, J BIOL CHEM, V277, P12810, DOI 10.1074/jbc.M200182200; Jankowsky E, 2007, CURR OPIN STRUC BIOL, V17, P316, DOI 10.1016/j.sbi.2007.05.007; Jankowsky E, 2010, METHODS MOL BIOL, V587, P245, DOI 10.1007/978-1-60327-355-8_18; Jarmoskaite I, 2014, ANNU REV BIOCHEM, V83, P697, DOI 10.1146/annurev-biochem-060713-035546; Kawaoka J, 2005, NUCLEIC ACIDS RES, V33, P644, DOI 10.1093/nar/gki208; Kellner JN, 2015, NUCLEIC ACIDS RES, V43, P2813, DOI 10.1093/nar/gkv106; Kikuma T, 2004, J BIOL CHEM, V279, P20692, DOI 10.1074/jbc.M400231200; LAHUE EE, 1988, J BIOL CHEM, V263, P3208; Lee JK, 2001, P NATL ACAD SCI USA, V98, P54, DOI 10.1073/pnas.98.1.54; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Li L, 2008, MOL CELL BIOL, V28, P6413, DOI 10.1128/MCB.01053-08; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Linley AJ, 2012, J BIOL CHEM, V287, P13633, DOI 10.1074/jbc.M111.308973; Liu F, 2008, P NATL ACAD SCI USA, V105, P20209, DOI 10.1073/pnas.0811115106; Liu ZR, 2002, MOL CELL BIOL, V22, P5443, DOI 10.1128/MCB.22.15.5443-5450.2002; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Magnusdottir A, 2009, NAT METHODS, V6, P477, DOI 10.1038/nmeth0709-477; Mallam AL, 2014, ELIFE, V3, DOI 10.7554/eLife.04630; Mallam AL, 2012, NATURE, V490, P121, DOI 10.1038/nature11402; Martelange V, 2000, CANCER RES, V60, P3848; Mathieu MG, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.29; Mathieu Morgan G, 2010, Cancer Immun, V10, P2; MATUNIS MJ, 1992, MOL CELL BIOL, V12, P164, DOI 10.1128/MCB.12.1.164; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Missel A, 1997, MOL CELL BIOL, V17, P4895, DOI 10.1128/MCB.17.9.4895; Mohr G, 2008, J MOL BIOL, V375, P1344, DOI 10.1016/j.jmb.2007.11.041; Musco G, 1996, CELL, V85, P237, DOI 10.1016/S0092-8674(00)81100-9; Nicastro G, 2015, CURR OPIN STRUC BIOL, V30, P63, DOI 10.1016/j.sbi.2015.01.002; Patrick EM, 2017, NAT CHEM BIOL, V13, P99, DOI [10.1038/NCHEMBIO.2234, 10.1038/nchembio.2234]; Pozdnyakova I, 2005, FEBS J, V272, P872, DOI 10.1111/j.1742-4658.2004.04527.x; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Rocak S, 2005, NUCLEIC ACIDS RES, V33, P999, DOI 10.1093/nar/gki244; Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236; Rossler OG, 2001, NUCLEIC ACIDS RES, V29, P2088, DOI 10.1093/nar/29.10.2088; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Spingola M, 2004, NUCLEIC ACIDS RES, V32, P1242, DOI 10.1093/nar/gkh281; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Steimer L, 2013, NUCLEIC ACIDS RES, V41, P6259, DOI 10.1093/nar/gkt323; Tang PZ, 1999, J BIOL CHEM, V274, P37932, DOI 10.1074/jbc.274.53.37932; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Tuteja N, 2014, PLANT MOL BIOL, V85, P639, DOI 10.1007/s11103-014-0209-6; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Yan XM, 2003, MOL CELL BIOL, V23, P414, DOI 10.1128/MCB.23.1.414-423.2003; Yang QS, 2006, NAT STRUCT MOL BIOL, V13, P981, DOI 10.1038/nsmb1165; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; Zhou Y, 2002, J MOL BIOL, V318, P1175, DOI 10.1016/S0022-2836(02)00238-3	84	19	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10429	10443		10.1074/jbc.M117.774950	http://dx.doi.org/10.1074/jbc.M117.774950			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28468824	Green Published, hybrid			2022-12-26	WOS:000404115400009
J	Ovejero, CA; Affranchino, JL; Gonzalez, SA				Ovejero, Cesar A.; Affranchino, Jose L.; Gonzalez, Silvia A.			Analysis of the functional compatibility of SIV capsid sequences in the context of the FIV gag precursor	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN INCORPORATION; MAJOR HOMOLOGY REGION; MATRIX PROTEIN; NUCLEOCAPSID PROTEIN; CRYOELECTRON MICROSCOPY; NUCLEAR IMPORT; ALPHA-HELIX; HIV-1; FELINE	The formation of immature lentiviral particles is dependent on the multimerization of the Gag polyprotein at the plasma membrane of the infected cells. One key player in the virus assembly process is the capsid (CA) domain of Gag, which establishes the protein-protein interactions that give rise to the hexagonal lattice of Gag molecules in the immature virion. To gain a better understanding of the functional equivalence between the CA proteins of simian and feline immunodeficiency viruses (SIV and FIV, respectively), we generated a series of chimeric FIV Gag proteins in which the CA-coding region was partially or totally replaced by its SIV counterpart. All the FIV Gag chimeras were found to be assembly-defective; however, all of them are able to interact with wild-type SIV Gag and be recruited into extracellular virus-like particles, regardless of the SIV CA sequences present in the chimeric FIV Gag. The results presented here markedly contrast with our previous findings showing that chimeric SIVs carrying FIV CA-derived sequences are assembly-competent. Overall, our data support the notion that although the SIV and FIV CA proteins share 51% amino acid sequence similarity and exhibit a similar organization, i.e., an N-terminal domain joined by a flexible linker to a C-terminal domain, their functional exchange between these different lentiviruses is strictly dependent on the context of the recipient Gag precursor.	[Ovejero, Cesar A.; Affranchino, Jose L.; Gonzalez, Silvia A.] Univ Belgrano, CONICET, Lab Virol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Gonzalez, SA (corresponding author), Univ Belgrano, CONICET, Lab Virol, Buenos Aires, DF, Argentina.	silvia.gonzalez@comunidad.ub.edu.ar		Affranchino, Jose/0000-0002-1287-9636; Gonzalez, Silvia Adriana/0000-0001-8744-0874	National Scientific and Technical Research Council of Argentina (CONICET) [PIP 0600]	National Scientific and Technical Research Council of Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by the National Scientific and Technical Research Council of Argentina (CONICET; www.conicet.gov.ar) Grant PIP 0600 to SAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all the authors are articulated in the author contributions' section.	Cerfoglio JCA, 2014, J GEN VIROL, V95, P2050, DOI 10.1099/vir.0.065151-0; Affranchino JL, 2014, VIRUSES-BASEL, V6, P264, DOI 10.3390/v6010264; Affranchino JL, 2010, VIRUS RES, V150, P153, DOI 10.1016/j.virusres.2010.03.012; Ako-Adjei D, 2005, J VIROL, V79, P13463, DOI 10.1128/JVI.79.21.13463-13472.2005; Bell NM, 2013, TRENDS MICROBIOL, V21, P136, DOI 10.1016/j.tim.2012.11.006; Bharat TAM, 2012, NATURE, V487, P385, DOI 10.1038/nature11169; Bowzard JB, 1998, J VIROL, V72, P9034, DOI 10.1128/JVI.72.11.9034-9044.1998; Briggs JAG, 2009, P NATL ACAD SCI USA, V106, P11090, DOI 10.1073/pnas.0903535106; Calistri A, 2009, J CELL PHYSIOL, V218, P175, DOI 10.1002/jcp.21587; Campos-Olivas R, 2000, J MOL BIOL, V296, P633, DOI 10.1006/jmbi.1999.3475; Cardone G, 2009, NATURE, V457, P694, DOI 10.1038/nature07724; Chen K, 2013, J BIOL CHEM, V288, P1511, DOI 10.1074/jbc.M112.425140; Chukkapalli V, 2011, J MOL BIOL, V410, P512, DOI 10.1016/j.jmb.2011.04.015; CRAVEN RC, 1995, J VIROL, V69, P4213, DOI 10.1128/JVI.69.7.4213-4227.1995; de Marco A, 2010, J VIROL, V84, P11729, DOI 10.1128/JVI.01423-10; DORFMAN T, 1994, J VIROL, V68, P1689, DOI 10.1128/JVI.68.3.1689-1696.1994; Dussupt V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000339; Elder JH, 2010, CURR HIV RES, V8, P73, DOI 10.2174/157016210790416389; Esteva MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114299; Fassati A, 2012, VIRUS RES, V170, P15, DOI 10.1016/j.virusres.2012.09.012; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; GONZALEZ SA, 1993, VIROLOGY, V194, P548, DOI 10.1006/viro.1993.1293; Gonzalez SA, 1998, VIROLOGY, V240, P27, DOI 10.1006/viro.1997.8919; Gorelick RJ, 1999, VIROLOGY, V253, P259, DOI 10.1006/viro.1998.9513; Gres AT, 2015, SCIENCE, V349, P99, DOI 10.1126/science.aaa5936; Jacques DA, 2016, NATURE, V536, P349, DOI 10.1038/nature19098; Johnson MC, 2002, J VIROL, V76, P11177, DOI 10.1128/JVI.76.22.11177-11185.2002; Khwaja A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24957; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Liang C, 2003, J VIROL, V77, P1772, DOI 10.1128/JVI.77.3.1772-1783.2003; Liang C, 2002, J VIROL, V76, P11729, DOI 10.1128/JVI.76.22.11729-11737.2002; Logue EC, 2011, J VIROL, V85, P12950, DOI 10.1128/JVI.05384-11; Luttge BG, 2008, J VIROL, V82, P2106, DOI 10.1128/JVI.02337-07; MAMMANO F, 1994, J VIROL, V68, P4927, DOI 10.1128/JVI.68.8.4927-4936.1994; Manrique JM, 2003, J VIROL, V77, P10881, DOI 10.1128/JVI.77.20.10881-10888.2003; Manrique JM, 2008, VIROLOGY, V374, P273, DOI 10.1016/j.virol.2008.01.015; Manrique ML, 2004, VIROLOGY, V329, P157, DOI 10.1016/j.virol.2004.07.029; Manrique ML, 2004, VIROLOGY, V327, P83, DOI 10.1016/j.virol.2004.06.019; Manrique ML, 2001, VIRUS RES, V76, P103, DOI 10.1016/S0168-1702(01)00249-0; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Murakami T, 2000, J VIROL, V74, P3548, DOI 10.1128/JVI.74.8.3548-3554.2000; Muriaux D, 2010, RNA BIOL, V7, P744, DOI 10.4161/rna.7.6.14065; OLMSTED RA, 1989, P NATL ACAD SCI USA, V86, P8088, DOI 10.1073/pnas.86.20.8088; Ono A, 1999, J VIROL, V73, P4136, DOI 10.1128/JVI.73.5.4136-4144.1999; Popov S, 2008, J VIROL, V82, P1389, DOI 10.1128/JVI.01912-07; Rauddi ML, 2011, AIDS RES HUM RETROV, V27, P303, DOI 10.1089/aid.2010.0137; Robinson BA, 2014, J VIROL, V88, P5718, DOI 10.1128/JVI.03609-13; Sandefur S, 2000, J VIROL, V74, P7238, DOI 10.1128/JVI.74.16.7238-7249.2000; Sanders-Beer BE, 2012, VIROLOGY, V422, P402, DOI 10.1016/j.virol.2011.11.003; Schur FKM, 2016, SCIENCE, V353, P506, DOI 10.1126/science.aaf9620; Schur FKM, 2015, NATURE, V517, P505, DOI 10.1038/nature13838; Sette P, 2016, CELL HOST MICROBE, V19, P336, DOI 10.1016/j.chom.2016.02.004; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Tipper C, 2014, J VIROL, V88, P10289, DOI 10.1128/JVI.01388-14; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; Wright ER, 2007, EMBO J, V26, P2218, DOI 10.1038/sj.emboj.7601664; Zhang YQ, 1998, J VIROL, V72, P1782, DOI 10.1128/JVI.72.3.1782-1789.1998; Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162	60	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177297	10.1371/journal.pone.0177297	http://dx.doi.org/10.1371/journal.pone.0177297			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475623	Green Submitted, Green Published, gold			2022-12-26	WOS:000400649500059
J	Higuchi, T; Ishizaki, Y; Noritake, A; Yanagimoto, Y; Kobayashi, H; Nakamura, K; Kaneko, K				Higuchi, Takahiro; Ishizaki, Yuko; Noritake, Atsushi; Yanagimoto, Yoshitoki; Kobayashi, Hodaka; Nakamura, Kae; Kaneko, Kazunari			Spatiotemporal characteristics of gaze of children with autism spectrum disorders while looking at classroom scenes	PLOS ONE			English	Article							JOINT ATTENTION; RATING-SCALE; CHILDHOOD AUTISM; SOCIAL ATTENTION; PATTERNS; LANGUAGE	Children with autism spectrum disorders (ASD) who have neurodevelopmental impairments in social communication often refuse to go to school because of difficulties in learning in class. The exact cause of maladaptation to school in such children is unknown. We hypothesized that these children have difficulty in paying attention to objects at which teachers are pointing. We performed gaze behavior analysis of children with ASD to understand their difficulties in the classroom. The subjects were 26 children with ASD (19 boys and 7 girls; mean age, 8.6 years) and 27 age-matched children with typical development (TD) (14 boys and 13 girls; mean age, 8.2 years). We measured eye movements of the children while they performed free viewing of two movies depicting actual classes: a Japanese class in which a teacher pointed at cartoon characters and an arithmetic class in which the teacher pointed at geometric figures. In the analysis, we defined the regions of interest (ROIs) as the teacher's face and finger, the cartoon characters and geometric figures at which the teacher pointed, and the classroom wall that contained no objects. We then compared total gaze time for each ROI between the children with ASD and TD by two-way ANOVA. Children with ASD spent less gaze time on the cartoon characters pointed at by the teacher; they spent more gaze time on the wall in both classroom scenes. We could differentiate children with ASD from those with TD almost perfectly by the proportion of total gaze time that children with ASD spent looking at the wall. These results suggest that children with ASD do not follow the teacher's instructions in class and persist in gazing at inappropriate visual areas such as walls. Thus, they may have difficulties in understanding content in class, leading to maladaptation to school.	[Higuchi, Takahiro; Ishizaki, Yuko; Yanagimoto, Yoshitoki; Kobayashi, Hodaka; Kaneko, Kazunari] Kansai Med Univ, Dept Pediat, Hirakata, Osaka, Japan; [Noritake, Atsushi; Nakamura, Kae] Kansai Med Univ, Dept Physiol, Hirakata, Osaka, Japan	Kansai Medical University; Kansai Medical University	Ishizaki, Y (corresponding author), Kansai Med Univ, Dept Pediat, Hirakata, Osaka, Japan.	ishizaky@takii.kmu.ac.jp	Ishizaki, Yuko/AAM-9735-2020; Noritake, Atsushi/AAZ-7912-2020	Noritake, Atsushi/0000-0002-5081-6257	JSPS KAKENHI - Ministry of Education, Culture, Sports, Science and Technology, Japan [25461566]; JSPS KAKENHI [25461566]	JSPS KAKENHI - Ministry of Education, Culture, Sports, Science and Technology, Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI Grant Number 25461566 (https://kaken.nii.ac.jp/ja/grant/KAKENHIPROJECT.25461566/) to Y.I. funded by the Ministry of Education, Culture, Sports, Science and Technology, Japan.; This work was supported by JSPS KAKENHI Grant Number 25461566. We thank Dr. Yasuko Nagao, Dr. Yuri Fuji, and Ms. Azusa Oshima for their assessment of the subjects' development. The authors declare no competing financial interests.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, Vxxxvii; Berney T., 2004, ADV PSYCHIAT TREATME, V10, P341, DOI [10.1192/apt.10.5.341, DOI 10.1192/APT.10.5.341]; Bruinsma Y, 2004, MENT RETARD DEV D R, V10, P169, DOI 10.1002/mrdd.20036; Charman T, 2003, PHILOS T R SOC B, V358, P315, DOI 10.1098/rstb.2002.1199; Chawarska K, 2012, J CHILD PSYCHOL PSYC, V53, P903, DOI 10.1111/j.1469-7610.2012.02538.x; Dawson G, 2004, DEV PSYCHOL, V40, P271, DOI 10.1037/0012-1649.40.2.271; Falck-Ytter T, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-28; Falck-Ytter T, 2012, J AUTISM DEV DISORD, V42, P2236, DOI 10.1007/s10803-012-1471-6; Ghaziuddin M, 2002, J AUTISM DEV DISORD, V32, P299, DOI 10.1023/A:1016330802348; Guillon Q, 2014, NEUROSCI BIOBEHAV R, V42, P279, DOI 10.1016/j.neubiorev.2014.03.013; Irwin JR, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00397; Ito H, 2012, RES AUTISM SPECT DIS, V6, P1265, DOI 10.1016/j.rasd.2012.04.002; Jones E. A., 2004, FOCUS AUTISM OTHER D, V19, P13, DOI DOI 10.1177/10883576040190010301; Kamio Y., 2006, SEISHINIGAKU, V48, P495; Keita L, 2011, BIOL PSYCHIAT, V70, P806, DOI 10.1016/j.biopsych.2011.07.031; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Koyama T, 2009, PSYCHIAT CLIN NEUROS, V63, P241, DOI 10.1111/j.1440-1819.2009.01931.x; Liberati A, 2017, PERCEPTION, DOI 10:1177/0301006616685976; LOVELAND KA, 1986, J AUTISM DEV DISORD, V16, P335, DOI 10.1007/BF01531663; McArthur D, 1996, J AUTISM DEV DISORD, V26, P481, DOI 10.1007/BF02172271; Parsons T., 2014, SCH SOC SOCIOLOGICAL, P35; PIAGET J, 1972, HUM DEV, V15, P1, DOI 10.1159/000271225; Pierce K, 2016, BIOL PSYCHIAT, V79, P657, DOI 10.1016/j.biopsych.2015.03.032; Pierce K, 2011, ARCH GEN PSYCHIAT, V68, P101, DOI 10.1001/archgenpsychiatry.2010.113; Riby D, 2009, J INTELL DISABIL RES, V53, P169, DOI 10.1111/j.1365-2788.2008.01142.x; Riby DM, 2013, J NEURODEVELOPMENTAL, V5, P1, DOI DOI 10.1186/1866-1955-5-13; SCHOPLER E, 1980, J AUTISM DEV DISORD, V10, P91, DOI 10.1007/BF02408436; Shic F, 2014, BIOL PSYCHIAT, V75, P231, DOI 10.1016/j.biopsych.2013.07.009; Shic F, 2011, BRAIN RES, V1380, P246, DOI 10.1016/j.brainres.2010.11.074; Simmons DR, 2009, VISION RES, V49, P2705, DOI 10.1016/j.visres.2009.08.005; Tachimori H, 2003, PSYCHIAT CLIN NEUROS, V57, P113, DOI 10.1046/j.1440-1819.2003.01087.x; Wang S, 2015, NEURON, V88, P604, DOI 10.1016/j.neuron.2015.09.042; Wechsler D, 1974, WECHSLER INTELLIGENC; Whitby PJS, 2009, EDUC TRAIN DEV DISAB, V44, P551; Yi L, 2013, J VISION, V13, DOI 10.1167/13.10.5	35	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0175912	10.1371/journal.pone.0175912	http://dx.doi.org/10.1371/journal.pone.0175912			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SP	28472111	gold, Green Submitted, Green Published			2022-12-26	WOS:000400648500018
J	Johansen, C; Rittig, AH; Mose, M; Bertelsen, T; Weimar, I; Nielsen, J; Andersen, T; Rasmussen, TK; Deleuran, B; Iversen, L				Johansen, Claus; Rittig, Anne Hald; Mose, Maike; Bertelsen, Trine; Weimar, Isabella; Nielsen, Jakob; Andersen, Thomas; Rasmussen, Tue Kruse; Deleuran, Bent; Iversen, Lars			STAT2 is involved in the pathogenesis of psoriasis by promoting CXCL11 and CCL5 production by keratinocytes	PLOS ONE			English	Article							CHRONIC PLAQUE PSORIASIS; SELF-DNA; SKIN; INFLAMMATION; TOFACITINIB; INHIBITION; MECHANISMS; EXPRESSION; BINDING; CELLS	The JAK/STAT signaling pathway is suggested to play an important role in the pathogenesis of psoriasis, and recently JAK/STAT inhibitors have shown promising results in psoriasis treatment. The present study aimed to characterize the role of STAT2 in psoriasis. We demonstrated an increased expression of STAT2 and an increased level of phosphorylated/activated STAT2 in lesional compared with nonlesional psoriatic skin. Gene silencing of STAT2 by siRNA in human keratinocytes revealed that upon IFN alpha stimulation CXCL11 and CCL5 were the only two cytokines, among 102 analyzed, found to be regulated through a STAT2-dependent mechanism. Moreover, the regulation of CXCL11 and CCL5 depended on IRF9, but not on STAT1 and STAT6. The CXCL11 and CCL5 expression was increased in lesional compared with nonlesional psoriatic skin, and analysis demonstrated positive correlation between the expression of CXCL11 and IFN gamma and between the expression of CCL5 and IFN gamma in lesional psoriatic skin. In contrast, no correlation between the expression of CXCL11 and IL-17A and the expression of CCL5 and IL-17A in lesional psoriatic skin was found. Our data suggest that STAT2 plays a role in the psoriasis pathogenesis by regulating the expression of CXCL11 and CCL5, and thereby attracting IFN gamma producing immune cells to the skin.	[Johansen, Claus; Rittig, Anne Hald; Mose, Maike; Bertelsen, Trine; Weimar, Isabella; Nielsen, Jakob; Iversen, Lars] Aarhus Univ Hosp, Dept Dermatol, Aarhus C, Denmark; [Andersen, Thomas; Rasmussen, Tue Kruse; Deleuran, Bent] Aarhus Univ, Dept Biomed, Aarhus C, Denmark	Aarhus University; Aarhus University	Johansen, C (corresponding author), Aarhus Univ Hosp, Dept Dermatol, Aarhus C, Denmark.	claus.johansen@clin.au.dk		Johansen, Claus/0000-0002-5665-5212; Iversen, Lars/0000-0003-1816-4508; Johansen, Claus/0000-0003-0240-5127; Deleuran, Bent/0000-0002-7079-1587	Danish Medical Research Council [10-093826]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Support was provided by the Danish Medical Research Council, grant number: 10-093826 [http//ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-Independent-research/the-council/the-danish-council-for-independent-research-merdical-sciences?set language=en&cl=en].The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres RM, 2013, EXP DERMATOL, V22, P323, DOI 10.1111/exd.12128; Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; Bissonnette R, 2015, BRIT J DERMATOL, V172, P1395, DOI 10.1111/bjd.13551; Chang BY, 2009, J IMMUNOL, V183, P2183, DOI 10.4049/jimmunol.0804063; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Eriksen KW, 2005, J INVEST DERMATOL, V125, P936, DOI 10.1111/j.0022-202X.2005.23864.x; Fink Karin, 2013, JAKSTAT, V2, pe27521, DOI 10.4161/jkst.27521; Fridman JS, 2011, J INVEST DERMATOL, V131, P1838, DOI 10.1038/jid.2011.140; Funding AT, 2007, J INVEST DERMATOL, V127, P2012, DOI 10.1038/sj.jid.5700821; Ghislain JJ, 2001, J INTERF CYTOK RES, V21, P379, DOI 10.1089/107999001750277853; Gilliet M, 2008, CURR OPIN IMMUNOL, V20, P401, DOI 10.1016/j.coi.2008.06.008; Gupta S, 1999, J IMMUNOL, V163, P3834; Hald A, 2013, BRIT J DERMATOL, V168, P302, DOI 10.1111/bjd.12049; Kjellerup RB, 2008, EXP DERMATOL, V17, P498, DOI 10.1111/j.1600-0625.2007.00672.x; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; KRAGBALLE K, 1985, BRIT J DERMATOL, V112, P263, DOI 10.1111/j.1365-2133.1985.tb04852.x; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Ludbrook VJ, 2016, BRIT J DERMATOL, V174, P985, DOI 10.1111/bjd.14399; Menter MA, 2016, J DRUGS DERMATOL, V15, P568; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nickoloff BJ, 2007, CLIN REV ALLERG IMMU, V33, P45, DOI 10.1007/s12016-007-0039-2; Nickoloff BJ, 2007, NAT MED, V13, P242, DOI 10.1038/nm0307-242; O'Shea JJ, 2005, CURR OPIN RHEUMATOL, V17, P305, DOI 10.1097/01.bor.0000160781.07174.db; Pfitzner E, 2004, CURR PHARM DESIGN, V10, P2839; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Punwani N, 2012, J AM ACAD DERMATOL, V67, P658, DOI 10.1016/j.jaad.2011.12.018; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Steen Hakan C, 2013, JAKSTAT, V2, pe25790, DOI 10.4161/jkst.25790; Van der Fits L, 2004, J INVEST DERMATOL, V122, P51, DOI 10.1046/j.0022-202X.2003.22113.x; Villanova F, 2014, COLD SPRING HARB PER, V4, P2157; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737	32	29	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176994	10.1371/journal.pone.0176994	http://dx.doi.org/10.1371/journal.pone.0176994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472186	Green Submitted, gold, Green Published			2022-12-26	WOS:000400648500111
J	Martinez-Canales, S; Cifuentes, F; Gregorio, MLD; Serrano-Oviedo, L; Galan-Moya, EM; Amir, E; Pandiella, A; Gyorffy, B; Ocana, A				Martinez-Canales, Sandra; Cifuentes, Francisco; De Rodas Gregorio, Miguel Lopez; Serrano-Oviedo, Leticia; Maria Galan-Moya, Eva; Amir, Eitan; Pandiella, Atanasio; Gyorffy, Balazs; Ocana, Alberto			Transcriptomic immunologic signature associated with favorable clinical outcome in basal-like breast tumors	PLOS ONE			English	Article							INFILTRATING LYMPHOCYTES; CANCER	Background Most patients with early stage triple negative breast cancer (TNBC) receive adjuvant chemotherapy. Activation of the immune system is associated with tumor response and may help identify TNBC with favorable outcome. Methods Gene expression data were obtained from the GEO Dataset GDS2250/GSE3744. Affymetrix CEL files were downloaded and analyzed with Affymetrix Transcriptome Analysis Console 3.0. Functional genomics was implemented with David Bioinformatics Resources 6.8. Data contained at Oncomine were used to identify genes upregulated in basal-like cancer compared to normal breast tissue. Data contained at cBioportal were used to assess for molecular alterations. The KMPlotter online tool, METABRIC and GSE25066 datasets were used to associate gene signatures with clinical outcome. Results 1564 upregulated genes were identified as differentially expressed between normal and basal-like tumors. Of these, 16 genes associated with immune function were linked with clinical outcome. HLA-C, HLA-F, HLA-G and TIGIT were associated with both improved relapse-free survival (RFS) and overall survival (OS). The combination of HLA-F/TIGIT and HLA-C/HLA-F/TIGIT showed the most favorable outcome (HR for RFS 0.44, p< 0.001; HR for OS 0.22, p< 0.001; and HR for RFS 0.46, p< 0.001; HR for OS 0.15, p< 0.001; respectively). The association of HLA-C/HLA-F with outcome was confirmed using the METABRIC and GSE25066 datasets. No copy number alterations of these genes were identified. Conclusion We describe a gene signature associated with immune function and favorable outcome in basal-like breast cancer. Incorporation of this signature in prospective studies may help to stratify risk of early stage TNBC.	[Martinez-Canales, Sandra; Cifuentes, Francisco; De Rodas Gregorio, Miguel Lopez; Serrano-Oviedo, Leticia; Ocana, Alberto] Albacete Univ Hosp, Translat Res Unit, Albacete, Spain; [Martinez-Canales, Sandra; Cifuentes, Francisco; De Rodas Gregorio, Miguel Lopez; Serrano-Oviedo, Leticia; Ocana, Alberto] CIBERONC, Albacete, Spain; [Maria Galan-Moya, Eva; Ocana, Alberto] Univ Castilla La Mancha, CRIB, Albacete, Spain; [Amir, Eitan] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Pandiella, Atanasio] Univ Salamanca, CSIC, Canc Res Ctr, Salamanca, Spain; [Pandiella, Atanasio] Univ Salamanca, CSIC, CIBERONC, Salamanca, Spain; [Gyorffy, Balazs] MTA TTK Lendulet Canc Biomarker Res Grp, Budapest, Hungary; [Gyorffy, Balazs] Semmelweis Univ, Dept Pediat 2, Budapest, Hungary	CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Universidad de Castilla-La Mancha; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Consejo Superior de Investigaciones Cientificas (CSIC); University of Salamanca; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Semmelweis University	Ocana, A (corresponding author), Albacete Univ Hosp, Translat Res Unit, Albacete, Spain.; Ocana, A (corresponding author), CIBERONC, Albacete, Spain.; Ocana, A (corresponding author), Univ Castilla La Mancha, CRIB, Albacete, Spain.	albertoo@sescam.jccm.es	Galan-Moya, Eva M/I-2912-2015; Gyorffy, Balazs/AAA-9135-2021; Lopez de Rodas Gregorio, Miguel/ABA-1757-2021; Lopez de Rodas Gregorio, Miguel/ABA-1769-2021; Amir, Eitan/L-6052-2019; Pandiella, Atanasio/O-5180-2014; Martinez Canales, Sandra/AAI-2732-2020	Galan-Moya, Eva M/0000-0001-5758-7592; Gyorffy, Balazs/0000-0002-5772-3766; Lopez de Rodas Gregorio, Miguel/0000-0002-6062-4064; Lopez de Rodas Gregorio, Miguel/0000-0002-6062-4064; Pandiella, Atanasio/0000-0002-4704-8971; Ocana, Alberto/0000-0002-1067-9630; Serrano Oviedo, Leticia/0000-0003-3876-2919; Martinez Canales, Sandra/0000-0002-4262-0262	Institute de Salud Carlos III [PI16/0121]; Diputacion de Albacete; CRIS Cancer Foundation; ACEPAIN; Institute de Salud Carlos III through the Spanish Cancer Centers Network Program [RD12/0036/0003]; European Community through the regional development funding program (FEDER)	Institute de Salud Carlos III(Instituto de Salud Carlos III); Diputacion de Albacete; CRIS Cancer Foundation; ACEPAIN; Institute de Salud Carlos III through the Spanish Cancer Centers Network Program; European Community through the regional development funding program (FEDER)	This study was supported in part by the Institute de Salud Carlos III (PI16/0121), ACEPAIN; Diputacion de Albacete and CRIS Cancer Foundation (to AO). BAE (Beca Ampliacion de Estudios) and Spanish Society of Medical Oncology (SEOM) to AO for his stay at Yale University. Ministry of Economy and Competitiveness of Spain (BFU2015-71371-R), the Institute de Salud Carlos III through the Spanish Cancer Centers Network Program (RD12/0036/0003) and CIBERONC, the scientific foundation of the AECC and the CRIS Foundation (to AP). The work carried out in our laboratories received support from the European Community through the regional development funding program (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2014, J CLIN ONCOL, V32, P2959, DOI 10.1200/JCO.2013.55.0491; Bianchini G, 2016, NAT REV CLIN ONCOL, V13, P674, DOI 10.1038/nrclinonc.2016.66; Blake SJ, 2016, CLIN CANCER RES, V13, P674; Chauvin JM, 2015, J CLIN INVEST, V125, P2046, DOI 10.1172/JCI80445; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Itoh M, 2014, BREAST CANCER RES TR, V143, P403, DOI 10.1007/s10549-013-2763-z; Mihaly Zsuzsanna, 2013, Microarrays (Basel), V2, P228, DOI 10.3390/microarrays2030228; Ocana A, 2017, ONCOTARGET; Ocana A, 2008, CLIN CANCER RES, V14, P961, DOI 10.1158/1078-0432.CCR-07-1630; Ocana A, 2015, J CLIN ONCOL, V33, P1298, DOI 10.1200/JCO.2014.59.7286; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Shin DS, 2015, CURR OPIN IMMUNOL, V33, P23, DOI 10.1016/j.coi.2015.01.006; Speiser DE, 2016, NAT REV IMMUNOL, V16, P500, DOI 10.1038/nri.2016.80	16	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0175128	10.1371/journal.pone.0175128	http://dx.doi.org/10.1371/journal.pone.0175128			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472085	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000400648500008
J	Etterson, M; Garber, K; Odenkirchen, E				Etterson, Matthew; Garber, Kristina; Odenkirchen, Edward			Mechanistic modeling of insecticide risks to breeding birds in North American agroecosystems	PLOS ONE			English	Article							ECOLOGICAL MODELS; REPRODUCTIVE SUCCESS; PESTICIDES; EXTRAPOLATION; TOXICITY; EXPOSURE; MORTALITY	Insecticide usage in the United States is ubiquitous in urban, suburban, and rural environments. There is accumulating evidence that insecticides adversely affect non-target wildlife species, including birds, causing mortality, reproductive impairment, and indirect effects through loss of prey base, and the type and magnitude of such effects differs by chemical class, or mode of action. In evaluating data for an insecticide registration application and for registration review, scientists at the United States Environmental Protection Agency (USEPA) assess the fate of the insecticide and the risk the insecticide poses to the environment and non-target wildlife. Current USEPA risk assessments for pesticides generally rely on endpoints from laboratory based toxicity studies focused on groups of individuals and do not directly assess population-level endpoints. In this paper, we present a mechanistic model, which allows risk assessors to estimate the effects of insecticide exposure on the survival and seasonal productivity of birds known to forage in agricultural fields during their breeding season. This model relies on individual-based toxicity data and translates effects into endpoints meaningful at the population level (i.e., magnitude of mortality and reproductive impairment). The model was created from two existing USEPA avian risk assessment models, the Terrestrial Investigation Model (TIM v.3.0) and the Markov Chain Nest Productivity model (MCnest). The integrated TIM/MCnest model was used to assess the relative risk of 12 insecticides applied via aerial spray to control corn pests on a suite of 31 avian species known to forage in cornfields in agroecosystems of the Midwest, USA. We found extensive differences in risk to birds among insecticides, with chlorpyrifos and malathion (organophosphates) generally posing the greatest risk, and bifenthrin and.-cyhalothrin (pyrethroids) posing the least risk. Comparative sensitivity analysis across the 31 species showed that ecological trait parameters related to the timing of breeding and reproductive output per nest attempt offered the greatest explanatory power for predicting the magnitude of risk. An important advantage of TIM/MCnest is that it allows risk assessors to rationally combine both acute (lethal) and chronic (reproductive) effects into a single unified measure of risk.	[Etterson, Matthew] US EPA, Off Res & Dev, Mid Continent Ecol Div, Natl Hlth & Environm Effects Res Lab, Duluth, MN USA; [Garber, Kristina; Odenkirchen, Edward] US EPA, Off Pesticide Programs, Environm Fate & Effects Div, Duluth, MN USA	United States Environmental Protection Agency; United States Environmental Protection Agency	Etterson, M (corresponding author), US EPA, Off Res & Dev, Mid Continent Ecol Div, Natl Hlth & Environm Effects Res Lab, Duluth, MN USA.	etterson.matthew@epa.gov			US Environmental Protection Agency	US Environmental Protection Agency(United States Environmental Protection Agency)	This work was funded by the US Environmental Protection Agency, by which all of the authors are employed.	[Anonymous], 1996, 8601480 USEPA OFF CH; [Anonymous], 1998, 8701300 USEPA OFF CH; [Anonymous], 2002, 8701100 USEPA OFF CH; Aspelin A. L., 2003, CIPM TECHNICAL B, V105; Augusiak J, 2014, ECOL MODEL, V280, P117, DOI 10.1016/j.ecolmodel.2013.11.009; Bennett P. M., 2002, OX ECOL EV; Bennett RS, 2007, INTEGR ENVIRON ASSES, V3, P498, DOI 10.1897/IEAM_2007-029.1; Bennett RS, 2006, HUM ECOL RISK ASSESS, V12, P762, DOI 10.1080/10807030500531489; Bennett RS, 2013, EPA600R13034; Bennett RS, 2013, EPA600R13033; Bennett RS, 2013, EPA600R14009; BEST LB, 1990, AM MIDL NAT, V123, P84, DOI 10.2307/2425762; Boatman ND, 2004, IBIS, V146, P131, DOI 10.1111/j.1474-919X.2004.00347.x; Booth G, 1990, A903147 ENV LABS INC; Booth G, 1989, A8723062307 B YOUNG; Bright J.A., 2008, 28 RSPB CTR CONS SCI; Cariboni J, 2007, ECOL MODEL, V203, P167, DOI 10.1016/j.ecolmodel.2005.10.045; Custer CM, 2014, ARCH ENVIRON CON TOX, V66, P120, DOI 10.1007/s00244-013-9934-0; de Snoo GR, 1999, PESTIC SCI, V55, P47, DOI 10.1002/(SICI)1096-9063(199901)55:1&lt;47::AID-PS859&gt;3.0.CO;2-#; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; ECOFRAM, 1999, ECOFRAM TERR DRAFT R ECOFRAM TERR DRAFT R; Etterson MA, 2014, CONDOR, V116, P205, DOI 10.1650/CONDOR-13-045.1; Etterson MA, 2013, ECOL APPL, V23, P1915, DOI 10.1890/12-1166.1; Etterson MA, 2013, INTEGR ENVIRON ASSES, V9, P590, DOI 10.1002/ieam.1450; Etterson MA, 2011, ECOL MODEL, V222, P2178, DOI 10.1016/j.ecolmodel.2010.10.013; Etterson MA, 2009, ECOL APPL, V19, P622, DOI 10.1890/08-0499.1; Fleischli MA, 2004, ARCH ENVIRON CON TOX, V46, P542, DOI 10.1007/s00244-003-3065-y; FLETCHER JS, 1994, ENVIRON TOXICOL CHEM, V13, P1383; Forbes Valery E., 2009, Integrated Environmental Assessment and Management, V5, P167, DOI 10.1897/IEAM_2008-029.1; FRY DM, 1995, ENVIRON HEALTH PERSP, V103, P165, DOI 10.2307/3432528; Gabsi F, 2014, ECOL MODEL, V280, P18, DOI 10.1016/j.ecolmodel.2013.06.018; Gibbons D, 2015, ENVIRON SCI POLLUT R, V22, P103, DOI 10.1007/s11356-014-3180-5; Godfrey LD, 2008, USITC PUBL, V3443; Grimm V, 2014, ECOL MODEL, V280, P1, DOI 10.1016/j.ecolmodel.2014.01.017; Hallmann CA, 2014, NATURE, V511, P341, DOI 10.1038/nature13531; HOERGER F., 1972, Pesticide residues on plants : correlation of representative data as a basis for estimation of their magnitude in the environment., P9; Jackson AK, 2011, AUK, V128, P759, DOI 10.1525/auk.2011.11106; Johnson D., 2014, ENT 16 INSECTICIDE R; Johnson TN, 2012, J WILDLIFE MANAGE, V76, P1607, DOI 10.1002/jwmg.437; Kramer VJ, 2011, ENVIRON TOXICOL CHEM, V30, P64, DOI 10.1002/etc.375; Krupke CH, 2015, CORN INSECT CONTROL; LINCER JL, 1975, J APPL ECOL, V12, P781, DOI 10.2307/2402090; Luttik R, 2005, ECOTOXICOLOGY, V14, P817, DOI 10.1007/s10646-005-0030-8; Luttik R, 1997, ENVIRON TOXICOL CHEM, V16, P1785, DOI [10.1002/etc.5620160904, 10.1897/1551-5028(1997)016&lt;1785:EFFSSO&gt;2.3.CO;2]; Luttik R, 1995, 79102029 RIVM; Macneale KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092436; Mathworks, 2013, MATHW MATL R2013B; Mineau P, 1996, REGUL TOXICOL PHARM, V24, P24, DOI 10.1006/rtph.1996.0061; Mineau P, 1999, J RAPTOR RES, V33, P1; Mineau P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057457; National Research Council (NRC), 2013, ASS RISKS END THREAT; ODay M, 1998, CORN PESTS DIAGNOSTI; Rodewald P., 2015, BIRDS N AM ONLINE 20; Ruskin KJ, 2015, BEHAV ECOL SOCIOBIOL, V69, P1639, DOI 10.1007/s00265-015-1975-0; Russom CL, 2014, ENVIRON TOXICOL CHEM, V33, P2157, DOI 10.1002/etc.2662; Rykiel EJ, 1996, ECOL MODEL, V90, P229, DOI 10.1016/0304-3800(95)00152-2; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; U.S. Department of Agriculture, 2014, USDA GEOGR AR SER 51, V1; UC IPM, 2011, USITC PUBL, V3443; USEPA, 2006, EPAHQOPP200710880003; USEPA, PEST PEST IND SAL US; USEPA, 2015, TECHN DESCR US GUID; USEPA, 2012, 8502100 USEPA OCSPP; USEPA, 2012, 8502200 USEPA OCSPP; *USEPA, 2004, OV EC RISK ASS PROC; USEPA, 2012, 8502300 USEPA OCSPP; [USEPA] US Environmental Protection Agency, 2012, US GUID T REX VERS 1	67	23	24	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176998	10.1371/journal.pone.0176998	http://dx.doi.org/10.1371/journal.pone.0176998			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467479	Green Published, gold, Green Submitted			2022-12-26	WOS:000400647000094
J	Smith, JN; Richter, C; Fabricius, KE; Cornils, A				Smith, Joy N.; Richter, Claudio; Fabricius, Katharina E.; Cornils, Astrid			Pontellid copepods, Labidocera spp., affected by ocean acidification: A field study at natural CO2 seeps	PLOS ONE			English	Article							ELEVATED CARBON-DIOXIDE; GREAT-BARRIER-REEF; CALANUS-FINMARCHICUS; MARINE COPEPODS; CO2-INDUCED ACIDIFICATION; MOUTHPART STRUCTURES; FAMILY PONTELLIDAE; OOCYTE DEVELOPMENT; GONAD MORPHOLOGY; HATCHING SUCCESS	CO2 seeps in coral reefs were used as natural laboratories to study the impacts of ocean acidification on the pontellid copepod, Labidocera spp. Pontellid abundances were reduced by similar to 70% under high-CO2 conditions. Biological parameters and substratum preferences of the copepods were explored to determine the underlying causes of such reduced abundances. Stage-and sex-specific copepod lengths, feeding ability, and egg development were unaffected by ocean acidification, thus changes in these physiological parameters were not the driving factor for reduced abundances under high-CO2 exposure. Labidocera spp. are demersal copepods, hence they live amongst reef substrata during the day and emerge into the water column at night. Deployments of emergence traps showed that their preferred reef substrata at control sites were coral rubble, macro algae, and turf algae. However, under high-CO2 conditions they no longer had an association with any specific substrata. Results from this study indicate that even though the biology of a copepod might be unaffected by high-CO2, Labidocera spp. are highly vulnerable to ocean acidification.	[Smith, Joy N.; Fabricius, Katharina E.] Australian Inst Marine Sci, Townsville, Qld, Australia; [Smith, Joy N.; Richter, Claudio; Cornils, Astrid] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany; [Smith, Joy N.; Richter, Claudio] Univ Bremen, Bremen, Germany	Australian Institute of Marine Science; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Bremen	Smith, JN (corresponding author), Australian Inst Marine Sci, Townsville, Qld, Australia.; Smith, JN (corresponding author), Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany.; Smith, JN (corresponding author), Univ Bremen, Bremen, Germany.	JZ.Smith@aims.gov.au	Cornils, Astrid/P-2943-2014; Richter, Claudio/AAT-1212-2020; Fabricius, Katharina/F-1759-2010	Cornils, Astrid/0000-0003-4536-9015; Richter, Claudio/0000-0002-8182-6896; Fabricius, Katharina/0000-0001-7671-4358	MARES [EPA 2011-0016]; Great Barrier Reef Foundation; Australian Government; German Science Ministry BMBF [03F0655B]; Australian Institute of Marine Science	MARES; Great Barrier Reef Foundation; Australian Government(Australian GovernmentCGIAR); German Science Ministry BMBF(Federal Ministry of Education & Research (BMBF)); Australian Institute of Marine Science	This project was funded in part by the Erasmus Mundus funded joint doctoral program MARES (EPA 2011-0016), the Great Barrier Reef Foundation's 'Resilient Coral Reefs Successfully Adapting to Climate Change' Program in collaboration with the Australian Government, the BIOACID Phase II Programme of the German Science Ministry BMBF (Grant 03F0655B), and the Australian Institute of Marine Science.	ALLDREDGE AL, 1977, MAR BIOL, V41, P317, DOI 10.1007/BF00389098; Almen AK, 2014, J EXP MAR BIOL ECOL, V460, P120, DOI 10.1016/j.jembe.2014.07.001; Atkinson MJ, 2008, MAR ECOL PROG SER, V373, P249, DOI 10.3354/meps07867; Barnett TP, 2005, SCIENCE, V309, P284, DOI 10.1126/science.1112418; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; BLADESECKELBARGER PI, 1984, J MORPHOL, V179, P33, DOI 10.1002/jmor.1051790105; Boxshall GA, 2008, HYDROBIOLOGIA, V595, P195, DOI 10.1007/s10750-007-9014-4; BRETELER WCMK, 1982, NETH J SEA RES, V16, P195, DOI 10.1016/0077-7579(82)90030-8; Broglio E, 2003, AQUAT MICROB ECOL, V31, P267, DOI 10.3354/ame031267; Bucklin Ann, 2010, P247, DOI 10.1002/9781444325508.ch13; Cao L, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028605; Cohen Y., 2008, STAT DATA R APPL APP, DOI 10.1002/9780470721896; Comeau S, 2010, MAR BIOL, V157, P2341, DOI 10.1007/s00227-010-1493-6; Comeau S, 2009, BIOGEOSCIENCES, V6, P1877, DOI 10.5194/bg-6-1877-2009; Comeau S, 2012, P ROY SOC B-BIOL SCI, V279, P732, DOI 10.1098/rspb.2011.0910; CONLEY WJ, 1985, MAR ECOL PROG SER, V21, P113, DOI 10.3354/meps021113; Conway DVP, 2005, INDIAN J MAR SCI, V34, P50; Cripps G, 2014, GLOBAL CHANGE BIOL, P1; Cripps G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151739; Cripps G, 2014, J PLANKTON RES, V36, P1165, DOI 10.1093/plankt/fbu052; DAGG MJ, 1987, LIMNOL OCEANOGR, V32, P178, DOI 10.4319/lo.1987.32.1.0178; Devine BM, 2012, CORAL REEFS, V31, P229, DOI 10.1007/s00338-011-0837-0; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Eisfeld SM, 2007, HELGOLAND MAR RES, V61, P193, DOI 10.1007/s10152-007-0066-7; EMERY AR, 1968, LIMNOL OCEANOGR, V13, P293, DOI 10.4319/lo.1968.13.2.0293; Fabricius KE, 2015, SCI REP-UK, V5, DOI 10.1038/srep09537; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; FENCHEL T, 1988, ANNU REV ECOL SYST, V19, P19, DOI 10.1146/annurev.es.19.110188.000315; Fitzer SC, 2012, J EXP MAR BIOL ECOL, V418, P30, DOI 10.1016/j.jembe.2012.03.009; Genin A, 2005, SCIENCE, V308, P860, DOI 10.1126/science.1107834; HAMMER WM, 1979, LIMNOL OCEANOGR, V24, P1; HAMNER WM, 1988, B MAR SCI, V42, P459; HAYWARD TL, 1980, MAR BIOL, V58, P295, DOI 10.1007/BF00390778; Heuschele J, 2014, J PLANKTON RES, V36, P895, DOI 10.1093/plankt/fbu025; Hildebrandt N, 2016, ICES J MAR SCI, V73, P927, DOI 10.1093/icesjms/fsv226; Hildebrandt N, 2014, MAR POLLUT BULL, V80, P59, DOI 10.1016/j.marpolbul.2014.01.050; Hirabayashi T, 2014, ZOOKEYS, P21, DOI 10.3897/zookeys.447.8171; IPCC, 2007, CONTRIBUTION WORKING; Isari S, 2016, ICES J MAR SCI, V73, P650, DOI 10.1093/icesjms/fsv078; Isari S, 2015, J PLANKTON RES, V37, P912, DOI 10.1093/plankt/fbv057; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Kurihara H, 2008, MAR POLLUT BULL, V56, P1086, DOI 10.1016/j.marpolbul.2008.03.023; Lecchini D, 2010, BEHAV ECOL; Lecchini D, 2014, MAR BIOL, V161, P1677, DOI 10.1007/s00227-014-2451-5; Lecchini D, 2011, CR BIOL, V334, P911, DOI 10.1016/j.crvi.2011.08.003; Lewis CN, 2013, P NATL ACAD SCI USA, V110, pE4960, DOI 10.1073/pnas.1315162110; Lewis E., 1998, PROGRAM DEV CO2 SYST; Li W, 2012, MAR POLLUT BULL, V64, P699, DOI 10.1016/j.marpolbul.2012.01.033; LONGHURST AR, 1989, PROG OCEANOGR, V22, P47, DOI 10.1016/0079-6611(89)90010-4; Mayor DJ, 2007, MAR ECOL PROG SER, V350, P91, DOI 10.3354/meps07142; McConville K, 2013, MAR POLLUT BULL, V73, P428, DOI 10.1016/j.marpolbul.2013.02.010; Montgomery JC, 2006, ADV MAR BIOL, V51, P143, DOI 10.1016/S0065-2881(06)51003-X; Mulyadi, 2002, CAL COP FAM PONT IND; Munday PL, 2014, NAT CLIM CHANGE, V4, P487, DOI [10.1038/nclimate2195, 10.1038/NCLIMATE2195]; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Nejstgaard JC, 1997, MAR ECOL PROG SER, V147, P197, DOI 10.3354/meps147197; Niehoff B, 2003, MAR BIOL, V143, P759, DOI 10.1007/s00227-003-1034-7; OHTSUKA S, 1991, MAR BIOL, V111, P213, DOI 10.1007/BF01319703; Olson MB, 2011, WORKSH IMP OC AC ZOO; Pedersen SA, 2014, ENVIRON SCI TECHNOL, V48, P12275, DOI 10.1021/es501581j; PORTER JW, 1977, LIMNOL OCEANOGR, V22, P553, DOI 10.4319/lo.1977.22.3.0553; Rombouts I, 2009, P R SOC B; Rossoll D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034737; Seuront L., 2014, COPEPODS DIVERSITY H; Smith JN, MAR BIODIVE IN PRESS; Smith JN, 2016, NAT CLIM CHANGE, V6, P1124, DOI 10.1038/NCLIMATE3122; Smith JN, 2016, SCI REP-UK, V6, DOI 10.1038/srep27019; Souza CP, 2011, MAR BIOTECHNOL, V13, P823, DOI 10.1007/s10126-011-9388-1; Swearer SE, 2002, B MAR SCI, V70, P251; Thor P, 2015, GLOBAL CHANGE BIOL, V21, P2261, DOI 10.1111/gcb.12815; TURNER JT, 1978, B MAR SCI, V28, P487; Turner JT, 2004, ZOOL STUD, V43, P255; Weydmann A, 2012, J EXP MAR BIOL ECOL, V428, P39, DOI 10.1016/j.jembe.2012.06.002; Zeebe RE, 2008, SCIENCE, V321, P51, DOI 10.1126/science.1159124; Zhang DJ, 2011, ACTA OCEANOL SIN, V30, P86, DOI 10.1007/s13131-011-0165-9	76	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0175663	10.1371/journal.pone.0175663	http://dx.doi.org/10.1371/journal.pone.0175663			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467414	Green Submitted, gold, Green Published			2022-12-26	WOS:000400647000019
J	Creech, TG; Epps, CW; Landguth, EL; Wehausen, JD; Crowhurst, RS; Holton, B; Monello, RJ				Creech, Tyler G.; Epps, Clinton W.; Landguth, Erin L.; Wehausen, John D.; Crowhurst, Rachel S.; Holton, Brandon; Monello, Ryan J.			Simulating the spread of selection-driven genotypes using landscape resistance models for desert bighorn sheep	PLOS ONE			English	Article							GENE FLOW; MOUNTAIN SHEEP; COMPUTER-PROGRAM; POPULATION; MANAGEMENT; DISPERSAL; DIVERSITY; TIME; DIFFERENTIATION; CONSERVATION	Landscape genetic studies based on neutral genetic markers have contributed to our understanding of the influence of landscape composition and configuration on gene flow and genetic variation. However, the potential for species to adapt to changing landscapes will depend on how natural selection influences adaptive genetic variation. We demonstrate how landscape resistance models can be combined with genetic simulations incorporating natural selection to explore how the spread of adaptive variation is affected by landscape characteristics, using desert bighorn sheep (Ovis canadensis nelsoni) in three differing regions of the southwestern United States as an example. We conducted genetic sampling and least-cost path modeling to optimize landscape resistance models independently for each region, and then simulated the spread of an adaptive allele favored by selection across each region. Optimized landscape resistance models differed between regions with respect to landscape variables included and their relationships to resistance, but the slope of terrain and the presence of water barriers and major roads had the greatest impacts on gene flow. Genetic simulations showed that differences among landscapes strongly influenced spread of adaptive genetic variation, with faster spread (1) in landscapes with more continuously distributed habitat and (2) when a pre-existing allele (i.e., standing genetic variation) rather than a novel allele (i.e., mutation) served as the source of adaptive genetic variation. The combination of landscape resistance models and genetic simulations has broad conservation applications and can facilitate comparisons of adaptive potential within and between landscapes.	[Creech, Tyler G.; Epps, Clinton W.; Crowhurst, Rachel S.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Landguth, Erin L.] Univ Montana, Div Biol Sci, Computat Ecol Lab, Missoula, MT 59812 USA; [Wehausen, John D.] Univ Calif, White Mt Res Ctr, Bishop, CA USA; [Holton, Brandon] Natl Pk Serv, Grand Canyon Natl Pk, Grand Canyon, AZ USA; [Monello, Ryan J.] Natl Pk Serv, Biol Resources Div, Ft Collins, CO USA; [Creech, Tyler G.] Ctr Large Landscape Conservat, Bozeman, MT 59715 USA; [Monello, Ryan J.] Natl Pk Serv, Pacific Isl Network Inventory & Monitoring Progra, Hawaii Natl Pk, HI USA	Oregon State University; University of Montana System; University of Montana; United States Department of the Interior; United States Department of the Interior; United States Department of the Interior	Creech, TG (corresponding author), Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA.; Creech, TG (corresponding author), Ctr Large Landscape Conservat, Bozeman, MT 59715 USA.	tyler@largelandscapes.org	Epps, Clinton/AAX-3971-2021; Landguth, Erin/ABB-8941-2020	Epps, Clinton/0000-0001-6577-1840; 	National Park Service's Climate Change Response Program [PMIS 162673]; Oregon State University's Thomas G. Scott Publication Fund	National Park Service's Climate Change Response Program; Oregon State University's Thomas G. Scott Publication Fund	Research was supported by a grant to CE and RM from the National Park Service's Climate Change Response Program (PMIS 162673). Publication of this paper was supported by Oregon State University's Thomas G. Scott Publication Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank S. Ratchford, W. Sloan, S. Holt, and L. Manning for collecting genetic samples; C. Peterson and M. Corbin for assistance with genotyping; J. Jaeger and K. Longshore for sharing genetic data for portions of the DEVA region; and L. Hall and S. Banks for helpful comments on the manuscript. Funding for this research was provided by the National Park Service's Climate Change Response Program (PMIS 162673). Publication of this paper was supported by Oregon State University's Thomas G. Scott Publication Fund.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; Allendorf FW., 2009, CONSERV GENET; B³rger R., 2000, MATH THEORY SELECTIO; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; BERGER J, 1982, MAMMALIA, V46, P183, DOI 10.1515/mamm.1982.46.2.183; Bleich Vernon C., 1996, P353; Bolliger J, 2014, LANDSCAPE ECOL, V29, P361, DOI 10.1007/s10980-013-9982-x; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Bull RAS, 2011, MOL ECOL, V20, P1092, DOI 10.1111/j.1365-294X.2010.04944.x; Castillo JA, 2014, MOL ECOL, V23, P843, DOI 10.1111/mec.12650; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cherry JL, 2004, GENETICS, V166, P1105, DOI 10.1534/genetics.166.2.1105; Cherry JL, 2003, GENETICS, V164, P789; Conner J. K., 2004, PRIMER ECOLOGICAL GE; Creech TG, 2016, THESIS; Creech TG, 2016, J ARID ENVIRON, V127, P160, DOI 10.1016/j.jaridenv.2015.11.011; Creech TG, 2014, LANDSCAPE ECOL, V29, P605, DOI 10.1007/s10980-014-0016-0; Cushman SA, 2006, AM NAT, V168, P486, DOI 10.1086/506976; Cushman Samuel A., 2013, Diversity-Basel, V5, P51; Cushman SA, 2013, CONSERV GENET, V14, P263, DOI 10.1007/s10592-012-0396-0; Cushman SA, 2012, LANDSCAPE ECOL, V27, P369, DOI 10.1007/s10980-011-9693-0; Diniz JAF, 2013, GENET MOL BIOL, V36, P475, DOI 10.1590/S1415-47572013000400002; Dudaniec RY, 2016, MOL ECOL, V25, P470, DOI 10.1111/mec.13482; Dudaniec RY, 2013, MOL ECOL, V22, P3752, DOI 10.1111/mec.12359; Epps CW, 2007, J APPL ECOL, V44, P714, DOI 10.1111/j.1365-2664.2007.01325.x; Epps CW, 2006, MOL ECOL, V15, P4295, DOI 10.1111/j.1365-294X.2006.03103.x; Epps CW, 2005, ECOL LETT, V8, P1029, DOI 10.1111/j.1461-0248.2005.00804.x; Epps CW, 2004, CONSERV BIOL, V18, P102, DOI 10.1111/j.1523-1739.2004.00023.x; ESRI, 2010, ARCGIS DESKT REL 10; Fisher RA, 1937, ANN EUGENIC, V7, P355, DOI 10.1111/j.1469-1809.1937.tb02153.x; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Gagnon J. W., 2013, P 2013 INT C EC TRAN; Garfin G., 2014, CLIMATE CHANGE IMPAC, P462, DOI [DOI 10.7930/J08G8HMN, 10.7930/J08G8HMN.]; GEIST V, 1971, MOUNTAIN SHEEP; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Graves TA, 2013, MOL ECOL, V22, P3888, DOI 10.1111/mec.12348; Guillot G, 2013, METHODS ECOL EVOL, V4, P336, DOI 10.1111/2041-210x.12018; Hamel S, 2009, J APPL ECOL, V46, P582, DOI 10.1111/j.1365-2664.2009.01643.x; Hartfield M, 2012, J EVOLUTION BIOL, V25, P1751, DOI 10.1111/j.1420-9101.2012.02560.x; Hedrick P.W., 2011, GENETICS POPULATIONS, V4th ed.; Hijmans R.J., 2014, RASTER GEOGRAPHIC DA, V2, P15; Holderegger R, 2008, BIOSCIENCE, V58, P199, DOI 10.1641/B580306; Holderegger R, 2006, LANDSCAPE ECOL, V21, P793, DOI 10.1007/s10980-005-6058-6; Jaeger J. R., 2012, DEV HABITAT MANAGEME; Jansen BD, 2007, SOUTHWEST NAT, V52, P418, DOI 10.1894/0038-4909(2007)52[418:IOMOBO]2.0.CO;2; Jones MR, 2013, EVOLUTION, V67, P3455, DOI 10.1111/evo.12237; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Keyghobadi N, 2005, MOL ECOL, V14, P1897, DOI 10.1111/j.1365-294X.2005.02563.x; Kierepka EM, 2015, MOL ECOL RESOUR, V15, P512, DOI 10.1111/1755-0998.12332; Krausman PR, 1999, MOUNTAIN SHEEP OF NORTH AMERICA, P139; Landguth EL, 2012, MOL ECOL RESOUR, V12, P363, DOI 10.1111/j.1755-0998.2011.03075.x; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Landguth EL, 2010, MOL ECOL RESOUR, V10, P156, DOI 10.1111/j.1755-0998.2009.02719.x; Lovich JE, 2011, BIOSCIENCE, V61, P982, DOI 10.1525/bio.2011.61.12.8; Manel S, 2013, TRENDS ECOL EVOL, V28, P614, DOI 10.1016/j.tree.2013.05.012; Mehner T, 2009, J APPL ECOL, V46, P1340, DOI 10.1111/j.1365-2664.2009.01733.x; Miller G., 1985, DESERT BIGHORN COUNC, V29, P4; Monson G., 1980, DESERT BIGHORN ITS L; Morjan CL, 2004, MOL ECOL, V13, P1341, DOI 10.1111/j.1365-294X.2004.02164.x; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Nickerson B. S., 2014, THESIS; Oakleaf JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138334; Paquette SR, 2014, EVOL APPL, V7, P734, DOI 10.1111/eva.12161; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Prunier JG, 2013, MOL ECOL, V22, P5516, DOI 10.1111/mec.12499; R Development Core Team, 2014, R LANG ENV STAT COMP; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rebaudo F, 2013, METHODS ECOL EVOL, V4, P595, DOI [10.1111/2041-210X.12041, 10.1111/2041-210X.120]; Rieseberg LH, 2001, TAXON, V50, P47, DOI 10.2307/1224511; Rubin ES, 2002, J WILDLIFE MANAGE, V66, P796, DOI 10.2307/3803144; Schaeffer RJ, 2000, CALIF FISH GAME, V86, P127; Schoville SD, 2012, ANNU REV ECOL EVOL S, V43, P23, DOI 10.1146/annurev-ecolsys-110411-160248; Schwartz MK, 2009, ECOLOGY, V90, P3222, DOI 10.1890/08-1287.1; SCHWARTZ OA, 1986, BIOL CONSERV, V37, P179, DOI 10.1016/0006-3207(86)90090-X; Seager R, 2013, NAT CLIM CHANGE, V3, P482, DOI [10.1038/nclimate1787, 10.1038/NCLIMATE1787]; Shirk AJ, 2010, MOL ECOL, V19, P3603, DOI 10.1111/j.1365-294X.2010.04745.x; Shoemaker DDW, 1997, EVOLUTION, V51, P1326, DOI 10.1111/j.1558-5646.1997.tb03981.x; Slatkin M., 1976, P767; Smith SJ, 2015, NAT CLIM CHANGE, V5, P333, DOI 10.1038/nclimate2552; Sniezko RA, 2006, CAN J PLANT PATHOL, V28, pS270, DOI 10.1080/07060660609507384; Sork VL, 2010, MOL ECOL, V19, P3489, DOI 10.1111/j.1365-294X.2010.04786.x; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; U. S. Bureau of Land Management, 2015, SOD MOUNT SOL PROJ F; U.S. Fish and Wildlife Service [USFWS], 2007, REC PLAN SIERR NEV B; Valdez R., 1999, MOUNTAIN SHEEP N AM; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; van Etten J, 2012, GDISTANCE DISTANCE R; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Whitlock MC, 2003, GENETICS, V164, P767; Wilmer JW, 2008, MOL ECOL, V17, P3733, DOI 10.1111/j.1365-294X.2008.03861.x; Wilson L, 1980, DESERT BIGHORN COUNC, V24, P7; Zeller KA, 2016, ECOL EVOL, V6, P4115, DOI 10.1002/ece3.2154; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0	94	16	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176960	10.1371/journal.pone.0176960	http://dx.doi.org/10.1371/journal.pone.0176960			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28464013	gold, Green Published, Green Submitted			2022-12-26	WOS:000400646300070
J	Kim, JY; Kwon, MS; Son, J; Kang, SW; Song, Y				Kim, Ji-Young; Kwon, Min-Seo; Son, Junghyun; Kang, Sang-Wook; Song, Youngsup			Selective effect of phosphatidylcholine on the lysis of adipocytes	PLOS ONE			English	Article							LOCALIZED FAT DEPOSITS; SODIUM DEOXYCHOLATE; ADIPOSE-TISSUE; CONTROLLED-TRIAL; OBESITY; MICE; LIPOLYSIS; PROTECTS; MOUSE; DIET	Obesity, a serious health risk factor, is often associated with depression and negatively affects many aspects of life. Injection of a formula comprising phosphatidylcholine (PPC) and deoxycholate (DC) has emerged as an alternative to liposuction in the reduction of local fat deposits. However, the formula component mainly responsible for this effect and the mechanism behind the actions of the components with respect to fat reduction are unknown. Here, we investigate the specific effects of PPC and DC on adipocyte viability. When exposed to PPC or DC, 3T3L1 preadipocytes and differentiated adipocytes showed dose dependent decrease in cell viability. Interestingly, while DC mediated cell death was nonspecific to both preadipocytes and adipocytes, PPC specifically induced a decrease in mature adipocyte viability, but had less effect on preadipocytes. Injection of PPC and DC into inguinal fat pads caused reduction in size. PPC injections preferentially decreased gene expression in mature adipocytes, while a strong inflammatory response was elicited by DC injection. In line with the decreased adipocyte viability, exposure of differentiated adipocytes to PPC resulted in triglyceride release, with a minimal effect on free fatty acids release, suggesting that its fat-reducing effect mediated mainly through the induction of adipocyte cell death rather than lipolysis. Taken together, it appears that PPC specifically affects adipocytes, and has less effect on preadipocyte viability. It can therefore be a promising agent to selectively reduce adipose tissue mass.	[Kim, Ji-Young; Kwon, Min-Seo; Kang, Sang-Wook; Song, Youngsup] Univ Ulsan, Coll Med, Asan Inst Life Sci, Dept Biomed Sci,Asan Med Ctr, Seoul, South Korea; [Kim, Ji-Young; Kwon, Min-Seo] Univ Ulsan, Coll Med, Biomed Inst Technol, Seoul, South Korea; [Son, Junghyun] Korea Univ Sci & Technol, Dept Biol Chem, Daejeon, South Korea; [Son, Junghyun] Korea Inst Sci & Technol, Doping Control Ctr, Seoul, South Korea	University of Ulsan; University of Ulsan; University of Science & Technology (UST); Korea Institute of Science & Technology (KIST)	Song, Y (corresponding author), Univ Ulsan, Coll Med, Asan Inst Life Sci, Dept Biomed Sci,Asan Med Ctr, Seoul, South Korea.	ysong@amc.seoul.kr		Song, Youngsup/0000-0002-6268-5223	National Research Foundation of Korea [2014R1A2A1A11050599]; Asan Institute for Life Sciences and Basic Science Program [YS 2017-611]	National Research Foundation of Korea(National Research Foundation of Korea); Asan Institute for Life Sciences and Basic Science Program	2014R1A2A1A11050599, www.nrf.re.kr, National Research Foundation of Korea, YS 2017-611, www.amc.seoul.kr, Asan Institute for Life Sciences and Basic Science Program, YS The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bartness TJ, 2007, J LIPID RES, V48, P1655, DOI 10.1194/jlr.R700006-JLR200; Buko V, 1996, CELL BIOCHEM FUNCT, V14, P131; Cho HM, 2014, BIOCHEM BIOPH RES CO, V447, P644, DOI 10.1016/j.bbrc.2014.04.056; CHUNG SY, 1995, J NUTR, V125, P1484; Frayn KN, 2003, INT J OBESITY, V27, P875, DOI 10.1038/sj.ijo.0802326; Hexsel Doris, 2003, J Drugs Dermatol, V2, P511; Higgins JP, 2003, COCHRANE DB SYST REV; Humphrey S, 2016, J AM ACAD DERMATOL, V75, P788, DOI 10.1016/j.jaad.2016.04.028; Hung MC, 2001, BRIT J NUTR, V86, P163, DOI 10.1079/BJN2001391; Kang YH, 2016, ONCOTARGET, V7, P35577, DOI 10.18632/oncotarget.9590; Kim IS, 2014, J DERMATOL TREAT, V25, P308, DOI 10.3109/09546634.2013.783198; Lee HS, 2014, LIFE SCI, V118, P7, DOI 10.1016/j.lfs.2014.09.027; LICHTENBERG D, 1979, BIOCHEMISTRY-US, V18, P3517, DOI 10.1021/bi00583a013; LIEBER CS, 1994, GASTROENTEROLOGY, V106, P152, DOI 10.1016/S0016-5085(94)95023-7; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Niebergall LJ, 2011, BBA-MOL CELL BIOL L, V1811, P1177, DOI 10.1016/j.bbalip.2011.06.021; Reeds DN, 2013, AESTHET SURG J, V33, P400, DOI 10.1177/1090820X13478630; Rittes PG, 2003, AESTHET PLAST SURG, V27, P315, DOI 10.1007/s00266-003-3033-y; Rose Paul T, 2005, J Cosmet Laser Ther, V7, P17, DOI 10.1080/14764170510037743; Rotunda AM, 2004, DERMATOL SURG, V30, P1001, DOI 10.1111/j.1524-4725.2004.30305.x; Salti G, 2008, DERMATOL SURG, V34, P60, DOI 10.1111/j.1524-4725.2007.34009.x; Seretis K, 2015, OBES SURG, V25, P1950, DOI 10.1007/s11695-015-1797-1; Song Y, 2010, NATURE, V468, P933, DOI 10.1038/nature09564; Tandy S, 2010, ATHEROSCLEROSIS, V213, P142, DOI 10.1016/j.atherosclerosis.2010.07.050; Tierney EP, 2011, J DRUGS DERMATOL, V10, P1363; Vaidya V, 2006, ADV PSYCHOSOM MED, V27, P73, DOI 10.1159/000090965; Won TJ, 2013, FOOD CHEM TOXICOL, V60, P263, DOI 10.1016/j.fct.2013.07.057; Yao Y, 2009, CELL RES, V19, P497, DOI 10.1038/cr.2009.27; Young V Leroy, 2003, Aesthet Surg J, V23, P413, DOI 10.1016/S1090-820X(03)00211-5; Zeghari N, 2000, INT J OBESITY, V24, P1600, DOI 10.1038/sj.ijo.0801459; Zeng WW, 2015, CELL, V163, P84, DOI 10.1016/j.cell.2015.08.055	31	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176722	10.1371/journal.pone.0176722	http://dx.doi.org/10.1371/journal.pone.0176722			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28463991	Green Submitted, Green Published, gold			2022-12-26	WOS:000400646300047
J	Miftahussurur, M; Nusi, IA; Akil, F; Syam, AF; Wibawa, IDN; Rezkitha, YAA; Maimunah, U; Subsomwong, P; Parewangi, ML; Mariadi, IK; Adi, P; Uchida, T; Purbayu, H; Sugihartono, T; Waskito, LA; Hidayati, HB; Lusida, MI; Yamaoka, Y				Miftahussurur, Muhammad; Nusi, Iswan Abbas; Akil, Fardah; Syam, Ari Fahrial; Wibawa, I. Dewa Nyoman; Rezkitha, Yudith Annisa Ayu; Maimunah, Ummi; Subsomwong, Phawinee; Parewangi, Muhammad Luthfi; Mariadi, I. Ketut; Adi, Pangestu; Uchida, Tomohisa; Purbayu, Herry; Sugihartono, Titong; Waskito, Langgeng Agung; Hidayati, Hanik Badriyah; Lusida, Maria Inge; Yamaoka, Yoshio			Gastric mucosal status in populations with a low prevalence of Helicobacter pylori in Indonesia	PLOS ONE			English	Article							SERUM PEPSINOGEN LEVELS; ATROPHIC GASTRITIS; CONSENSUS REPORT; VIRULENCE GENES; INFECTION; CANCER; MANAGEMENT; AGE; IDENTIFICATION; INFLAMMATION	In Indonesia, endoscopy services are limited and studies about gastric mucosal status by using pepsinogens (PGs) are rare. We measured PG levels, and calculated the best cutoff and predictive values for discriminating gastric mucosal status among ethnic groups in Indonesia. We collected gastric biopsy specimens and sera from 233 patients with dyspepsia living in three Indonesian islands. When >= 5.5 U/mL was used as the best cutoff value of Helicobacter pylori antibody titer, 8.6% (20 of 233) were positive for H. pylori infection. PG I and II levels were higher among smokers, and PG I was higher in alcohol drinkers than in their counterparts. PG II level was significantly higher, whereas PG I/II ratios were lower in H. pylori-positive than in H. pylori-negative patients. PG I/II ratios showed a significant inverse correlation with the inflammation and atrophy scores of the antrum. The best cutoff values of PG I/II were 4.05 and 3.55 for discriminating chronic and atrophic gastritis, respectively. PG I, PG II, and PG I/II ratios were significantly lower in subjects from Bangli than in those from Makassar and Surabaya, and concordant with the ABC group distribution; however, group D (H. pylori negative/PG positive) was the lowest in subjects from Bangli. In conclusion, validation of indirect methods is necessary before their application. We confirmed that serum PG level is a useful biomarker determining chronic gastritis, but a modest sensitivity for atrophic gastritis in Indonesia. The ABC method should be used with caution in areas with a low prevalence of H. pylori.	[Miftahussurur, Muhammad; Subsomwong, Phawinee; Waskito, Langgeng Agung; Yamaoka, Yoshio] Oita Univ, Fac Med, Dept Environm & Prevent Med, Yufu, Japan; [Miftahussurur, Muhammad; Yamaoka, Yoshio] Baylor Coll Med, Dept Med, Gastroenterol & Hepatol Sect, Houston, TX 77030 USA; [Miftahussurur, Muhammad; Nusi, Iswan Abbas; Maimunah, Ummi; Purbayu, Herry; Sugihartono, Titong] Univ Airlangga, Dr Soetomo Teaching Hosp, Fac Med, Div Gastroenterohepatol,Dept Internal Med, Surabaya, Indonesia; [Miftahussurur, Muhammad; Rezkitha, Yudith Annisa Ayu; Adi, Pangestu; Waskito, Langgeng Agung; Hidayati, Hanik Badriyah; Lusida, Maria Inge] Univ Airlangga, Inst Trop Dis, Surabaya, Indonesia; [Akil, Fardah] Hasanuddin Univ, Dept Internal Med, Fac Med, Ctr Gastroenterohepatol, Makassar, Indonesia; [Syam, Ari Fahrial; Parewangi, Muhammad Luthfi] Univ Indonesia, Div Gastroenterol, Dept Internal Med, Fac Med, Jakarta, Indonesia; [Wibawa, I. Dewa Nyoman; Mariadi, I. Ketut] Univ Udayana, Dept Internal Med, Fac Med, Div Gastroenterohepatol, Denpasar, Indonesia; [Uchida, Tomohisa] Oita Univ, Fac Med, Dept Mol Pathol, Hasama Machi, Yufu, Oita, Japan	Oita University; Baylor College of Medicine; Airlangga University; Airlangga University; Universitas Hasanuddin; University of Indonesia; Universitas Udayana; Oita University	Yamaoka, Y (corresponding author), Oita Univ, Fac Med, Dept Environm & Prevent Med, Yufu, Japan.; Yamaoka, Y (corresponding author), Baylor Coll Med, Dept Med, Gastroenterol & Hepatol Sect, Houston, TX 77030 USA.	yyamaoka@oita-u.ac.jp	Syam, Ari Fahrial/ABI-4994-2020; Hidayati, Hanik Badriyah/ABF-7531-2020; Miftahussurur, Muhammad/AAB-6151-2021; Parewangi, Muhammad Luthfi/Q-3126-2018; MAIMUNAH, UMMI/GQH-0117-2022	Parewangi, Muhammad Luthfi/0000-0001-9257-9344; Yamaoka, Yoshio/0000-0002-1222-5819; Miftahussurur, Muhammad/0000-0003-1415-6033; Syam, Ari Fahrial/0000-0003-0041-3553; Rezkitha, Yudith Annisa Ayu/0000-0001-7600-9114; Akil, Fardah/0000-0002-4222-6011; Subsomwong, Phawinee/0000-0002-9961-9350	National Institutes of Health [DK62813]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [25293104, 26640114, 15H02657]; Japan Society for the Promotion of Science (JSPS); Japan Science and Technology Agency (JST); Japanese government (MEXT)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japanese government (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from the National Institutes of Health (DK62813) and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (25293104, 26640114, and 15H02657) (YY). Support was also provided by the Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits (YY), the Strategic Funds for the Promotion of Science and Technology from the Japan Science and Technology Agency (JST and YY). MM was a previous PhD student, and PS and LAW are PhD students supported by the Japanese government (MEXT) scholarship program for 2012, 2013, and 2015, respectively.	ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Ang TL, 2005, J GASTROEN HEPATOL, V20, P1603, DOI 10.1111/j.1440-1746.2005.03898.x; Arinton I Gede, 2010, Acta Med Indones, V42, P142; Atisook K, 2003, HELICOBACTER, V8, P132, DOI 10.1046/j.1523-5378.2003.00134.x; Aulia Diana, 2009, Acta Med Indones, V41, P107; Bornschein J, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-10; Burucoa C, 2013, HELICOBACTER, V18, P169, DOI 10.1111/hel.12030; CARPENTER HA, 1995, GASTROENTEROLOGY, V108, P917, DOI 10.1016/0016-5085(95)90468-9; Chey WD, 2007, AM J GASTROENTEROL, V102, P1808, DOI 10.1111/j.1572-0241.2007.01393.x; CORREA P, 1992, CANCER RES, V52, P6735; Di Mario F, 2006, DIGEST DIS SCI, V51, P1791, DOI 10.1007/s10620-006-9206-1; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Gritti I, 2000, PHARMACOL RES, V41, P265, DOI 10.1006/phrs.1999.0586; KIKUCHI S, 1995, INT J EPIDEMIOL, V24, P346, DOI 10.1093/ije/24.2.346; Kikuchi Shogo, 2002, J Epidemiol, V12, P351; Kim N, 2010, GUT LIVER, V4, P307, DOI 10.5009/gnl.2010.4.3.307; Kitamura Y, 2015, J GASTROEN HEPATOL, V30, P1473, DOI 10.1111/jgh.12987; Kiyohira K, 2003, J GASTROENTEROL, V38, P332, DOI 10.1007/s005350300060; Kuipers EJ, 1999, ALIMENT PHARM THERAP, V13, P3, DOI 10.1046/j.1365-2036.1999.00002.x; Kumala Widyasari, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P970; Laheij RJF, 1998, J CLIN MICROBIOL, V36, P2803, DOI 10.1128/JCM.36.10.2803-2809.1998; Leja M, 2012, DIGEST DIS, V30, P268, DOI 10.1159/000336990; Lorente S, 2002, GUT, V50, P13, DOI 10.1136/gut.50.1.13; Makmun D, 2014, DIGEST ENDOSC, V26, P2, DOI 10.1111/den.12245; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Malfertheiner P, 2016, GUT; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Matsuo Keitaro, 2001, Asian Pac J Cancer Prev, V2, P155; Miftahussurur M, 2015, EPIDEMIOL INFECT, V143, P986, DOI 10.1017/S095026881400154X; Miftahussurur M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166199; Miftahussurur M, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4819423; Miftahussurur Muhammad, 2015, Asian Pac J Cancer Prev, V16, P7911; Miftahussurur M, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0072-2; Miftahussurur M, 2014, GUT PATHOG, V6, DOI 10.1186/s13099-014-0042-0; Miki Kazumasa, 2006, Gastric Cancer, V9, P245, DOI 10.1007/s10120-006-0397-0; Miki K, 2011, P JPN ACAD B-PHYS, V87, P405, DOI 10.2183/pjab.87.405; MIRSKY IA, 1952, J LAB CLIN MED, V40, P188; MOSSI S, 1993, GUT, V34, P752, DOI 10.1136/gut.34.6.752; Myint T, 2015, WORLD J GASTROENTERO, V21, P629, DOI 10.3748/wjg.v21.i2.629; Nguyen LT, 2010, EUR J CLIN MICROBIOL, V29, P651, DOI 10.1007/s10096-010-0909-z; Nguyen TL, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-114; PALS G, 1985, ANN HUM BIOL, V12, P403, DOI 10.1080/03014468500007961; SAMLOFF IM, 1982, GASTROENTEROLOGY, V82, P26; Shiota S, 2014, J MED MICROBIOL, V63, P1189, DOI 10.1099/jmm.0.075275-0; Shiota S, 2013, J MED MICROBIOL, V62, P1571, DOI 10.1099/jmm.0.060905-0; Shiota S, 2010, EXPERT REV GASTROENT, V4, P149, DOI [10.1586/egh.10.7, 10.1586/EGH.10.7]; Sipponen P, 2007, SCAND J GASTROENTERO, V42, P2, DOI 10.1080/00365520600863720; Syam AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140186; Uchida T, 2007, CANCER SCI, V98, P521, DOI 10.1111/j.1349-7006.2007.00415.x; VEENENDAAL RA, 1992, GUT, V33, P452, DOI 10.1136/gut.33.4.452; Vilaichone RK, 2013, WORLD J GASTROENTERO, V19, P2806, DOI 10.3748/wjg.v19.i18.2806; WAGNER S, 1994, AM J GASTROENTEROL, V89, P1211; YOUNG GO, 1992, ALIMENT PHARM THERAP, V6, P169	53	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176203	10.1371/journal.pone.0176203	http://dx.doi.org/10.1371/journal.pone.0176203			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28463979	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000400646300013
J	Lucassen, EA; de Mutsert, R; le Cessie, S; Appelman-Dijkstra, NM; Rosendaal, FR; van Heemst, D; den Heijer, M; Biermasz, NR				Lucassen, Eliane A.; de Mutsert, Renee; le Cessie, Saskia; Appelman-Dijkstra, Natasha M.; Rosendaal, Frits R.; van Heemst, Diana; den Heijer, Martin; Biermasz, Nienke R.		NEO Study Grp	Poor sleep quality and later sleep timing are risk factors for osteopenia and sarcopenia in middle-aged men and women: The NEO study	PLOS ONE			English	Article							BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; HIP FRACTURE; PHYSICAL-ACTIVITY; OSTEOPOROSIS; HEALTH; DURATION; QUESTIONNAIRE; CHRONOTYPE; OBESITY	Context Sleep deprivation has detrimental metabolic consequences. Osteopenia and sarcopenia usually occur together and increase risk of fractures and disease. Results from studies linking sleep parameters to osteopenia or sarcopenia are scarce and inconsistent. Objective To examine the associations of sleep parameters with osteopenia and sarcopenia, considering the influence of sex and menopause. Design, setting and participants Cross-sectional analysis of 915 participants (45-65 years, 56% women, BMI 26 (range: 18-56) kg/m(2)) in the Netherlands Epidemiology of Obesity (NEO) study, a population-based cohort study. Sleep duration, quality, and timing were assessed with the Pittsburgh Sleep Quality Index (PSQI); bone mineral density and relative appendicular muscle mass were measured by DXA scans. Linear and logistic regressions were performed to associate sleep parameters to bone mineral density, relative appendicular muscle mass, osteopenia (t-score between -1 and -2.5) and sarcopenia (1 SD below average muscle mass). Results After adjustment for confounding factors, one unit increase in PSQI score (OR and 95% CI, 1.09, 1.03-1.14), declined self-rated sleep quality (1.76, 1.03-3.01), sleep latency (1.18, 1.06-1.31), and a one hour later sleep timing (1.51, 1.08-2.11), but not sleep duration (1.05, 0.90-1.23), were associated with osteopenia. PSQI score (1.10, 1.02-1.19) was also associated with sarcopenia; OR's of sleep latency and later mid-sleep time with sarcopenia were 1.14 (0.99-1.31) and 1.54 (0.91-2.61), respectively. Associations were somewhat stronger in women and varied per menopausal status. Conclusions These results suggest that decreased sleep quality and a later sleep timing are risk factors for osteopenia and sarcopenia in middle aged individuals.	[Lucassen, Eliane A.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Neurophysiol Lab, Leiden, Netherlands; [Lucassen, Eliane A.] Medisch Ctr Haaglanden, Dept Internal Med, The Hague, Netherlands; [de Mutsert, Renee; Rosendaal, Frits R.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [le Cessie, Saskia] Leiden Univ, Med Ctr, Dept Med Stat, Leiden, Netherlands; [Appelman-Dijkstra, Natasha M.; Biermasz, Nienke R.] Leiden Univ, Med Ctr, Dept Endocrinol, Leiden, Netherlands; [van Heemst, Diana] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [den Heijer, Martin] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [den Heijer, Martin] Vrije Univ Amsterdam Med Ctr, Dept Internal Med, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Lucassen, EA (corresponding author), Leiden Univ, Med Ctr, Dept Mol Cell Biol, Neurophysiol Lab, Leiden, Netherlands.; Lucassen, EA (corresponding author), Medisch Ctr Haaglanden, Dept Internal Med, The Hague, Netherlands.	e.a.lucassen@lumc.nl	Appelman-Dijkstra, Natasha/V-7322-2018; Appelman-Dijkstra, Natasha/CAE-9054-2022; Biermasz, Nienke/ABE-9436-2021; Rosendaal, Frits/Q-3842-2017; le+Cessie, Saskia/HGC-8966-2022; den Heijer, Martin/J-8036-2015	Appelman-Dijkstra, Natasha/0000-0001-5035-127X; Appelman-Dijkstra, Natasha/0000-0001-5035-127X; Biermasz, Nienke/0000-0001-5817-3594; Rosendaal, Frits/0000-0003-2558-7496; Cobbaert, Christa/0000-0003-3565-1404; le Cessie, Saskia/0000-0003-2154-4923; den Heijer, Martin/0000-0003-3620-5617	Netherlands Organization for Scientific Research (NOW-VENI) [016.136.125]; Division and the Board of Directors of the Leiden University Medical Centre; Leiden University	Netherlands Organization for Scientific Research (NOW-VENI)(Netherlands Organization for Scientific Research (NWO)); Division and the Board of Directors of the Leiden University Medical Centre; Leiden University	The NEO study is supported by the participating Departments, the Division and the Board of Directors of the Leiden University Medical Centre, and by the Leiden University, Research Profile Area 'Vascular and Regenerative Medicine'. This study was supported by grant from the Netherlands Organization for Scientific Research (NOW-VENI grant 016.136.125 to N.R.B.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2002, J BONE MINER RES, V17, P2061, DOI 10.1359/jbmr.2002.17.11.2061; Agarwal M, 2006, POSTGRAD MED, V119, P17, DOI 10.3810/pgm.2006.06.1636; [Anonymous], 1994, ASS FRACT RISK ITS A; ARMAMENTOVILLAREAL R, 1992, J CLIN INVEST, V90, P2464, DOI 10.1172/JCI116138; Binkley N, 2013, OSTEOPOROSIS INT, V24, P2955, DOI 10.1007/s00198-013-2427-1; Bonjour Jean-Philippe, 1996, P465; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chen G, 2014, J CLIN ENDOCR METAB, V99, P2869, DOI 10.1210/jc.2013-3629; de Hollander EL, 2012, J CLIN EPIDEMIOL, V65, P73, DOI 10.1016/j.jclinepi.2011.05.005; de Mutsert R, 2013, EUR J EPIDEMIOL, V28, P513, DOI 10.1007/s10654-013-9801-3; Dockray S, 2011, PSYCHONEUROENDOCRINO, V36, P649, DOI 10.1016/j.psyneuen.2010.09.008; FEUNEKES GIJ, 1993, AM J CLIN NUTR, V58, P489, DOI 10.1093/ajcn/58.4.489; Fex A, 2012, J CLIN SLEEP MED, V8, P309, DOI 10.5664/jcsm.1922; Fu XH, 2011, BONE, V49, P1062, DOI 10.1016/j.bone.2011.08.008; GAMBACCIANI M, 1993, J CLIN ENDOCR METAB, V77, P1148, DOI 10.1210/jcem.77.5.8077305; Holmberg AH, 2006, OSTEOPOROSIS INT, V17, P1065, DOI 10.1007/s00198-006-0137-7; Hume KI, 1998, J SLEEP RES, V7, P85, DOI 10.1046/j.1365-2869.1998.00103.x; Kanis J, 1999, OSTEOPOROSIS INT, V9, P45, DOI 10.1007/s001980050115; Kanis JA, 2000, BONE, V27, P585, DOI 10.1016/S8756-3282(00)00381-1; Karasik D, 2011, AGE, V33, P49, DOI 10.1007/s11357-010-9159-3; Kim N, 2014, KOREAN J FAM MED, V35, P90, DOI 10.4082/kjfm.2014.35.2.90; Kobayashi D, 2012, SLEEP BREATH, V16, P579, DOI 10.1007/s11325-011-0545-6; KORN EL, 1991, AM J PUBLIC HEALTH, V81, P1166, DOI 10.2105/AJPH.81.9.1166; Leproult R, 2014, DIABETES, V63, P1860, DOI 10.2337/db13-1546; Lim S, 2010, DIABETES CARE, V33, P1652, DOI 10.2337/dc10-0107; LOOKER AC, 1995, J BONE MINER RES, V10, P796; Lucassen EA, 2016, CURR BIOL, V26, P1843, DOI 10.1016/j.cub.2016.05.038; Lucassen EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084832; Lucassen EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056519; Lucassen EA, 2012, ANN NY ACAD SCI, V1264, P110, DOI 10.1111/j.1749-6632.2012.06655.x; Lumley T., ANAL COMPLEX SURVEY; McCormick RK, 2007, ALTERN MED REV, V12, P113; Nguyen ND, 2005, J BONE MINER RES, V20, P1921, DOI 10.1359/JBMR.050520; NGUYEN T, 1993, BRIT MED J, V307, P1111, DOI 10.1136/bmj.307.6912.1111; Park S, 2004, J NUTR HEALTH AGING, V18, P806; Perrini S, 2010, J ENDOCRINOL, V205, P201, DOI 10.1677/JOE-09-0431; PRINZ PN, 1995, J GERONTOL A-BIOL, V50, pM222, DOI 10.1093/gerona/50A.4.M222; Redline S, 2004, ARCH INTERN MED, V164, P406, DOI 10.1001/archinte.164.4.406; Rusch HL, 2015, J CLIN SLEEP MED, V11, P615, DOI 10.5664/jcsm.4770; Saaf M, 1999, EUR J ENDOCRINOL, V140, P390, DOI 10.1530/eje.0.1400390; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Siris ES, 2006, OSTEOPOROSIS INT, V17, P565, DOI 10.1007/s00198-005-0027-4; Sivertsen B, 2014, J SLEEP RES, V23, P124, DOI [10.1111/jsr.12102, 10.1111/jsr.12254]; Specker BL, 2007, OSTEOPOROSIS INT, V18, P93, DOI 10.1007/s00198-006-0207-x; Stamatakis KA, 2010, CHEST, V137, P95, DOI 10.1378/chest.09-0791; Stichting NEVO, 2011, NEVO TAB NED VOED 20; Tasali E, 2008, P NATL ACAD SCI USA, V105, P1044, DOI 10.1073/pnas.0706446105; Tonetti L, 2008, CHRONOBIOL INT, V25, P745, DOI 10.1080/07420520802394191; VanCauter E, 1996, J PEDIATR-US, V128, pS32, DOI 10.1016/S0022-3476(96)70008-2; Verschueren S, 2013, OSTEOPOROSIS INT, V24, P87, DOI 10.1007/s00198-012-2057-z; Wang K, 2015, ENDOCRINE, V49, P538, DOI 10.1007/s12020-014-0493-6; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Wittmann M, 2010, SUBST USE MISUSE, V45, P15, DOI 10.3109/10826080903498952; Yu JH, 2015, J CLIN ENDOCR METAB, V100, P1494, DOI 10.1210/jc.2014-3754; Zavada A, 2005, CHRONOBIOL INT, V22, P267, DOI 10.1081/CBI-200053536	56	48	50	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176685	10.1371/journal.pone.0176685	http://dx.doi.org/10.1371/journal.pone.0176685			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9RJ	28459884	gold, Green Published, Green Submitted			2022-12-26	WOS:000400645000046
J	Theocharopoulos, G; Danis, K; Greig, J; Hoffmann, A; De Valk, H; Jimissa, A; Tejan, S; Sankoh, M; Kleijer, K; Turner, W; Achar, J; Duncombe, J; Lokuge, K; Gayton, I; Broeder, R; Kremer, R; Caleo, G				Theocharopoulos, Georgios; Danis, Kostas; Greig, Jane; Hoffmann, Alexandra; De Valk, Henriette; Jimissa, Augustine; Tejan, Sumaila; Sankoh, Mohammed; Kleijer, Karline; Turner, Will; Achar, Jay; Duncombe, Jennifer; Lokuge, Kamalini; Gayton, Ivan; Broeder, Rob; Kremer, Ronald; Caleo, Grazia			Ebola management centre proximity associated with reduced delays of healthcare of Ebola Virus Disease (EVD) patients, Tonkolili, Sierra Leone, 2014-15	PLOS ONE			English	Article							TRANSMISSION	Between August-December 2014, Ebola Virus Disease (EVD) patients from Tonkolili District were referred for care to two Medecins Sans Frontieres (MSF) Ebola Management Centres (EMCs) outside the district (distant EMCs). In December 2014, MSF opened an EMC in Tonkolili District (district EMC). We examined the effect of opening a district-based EMC on time to admission and number of suspect cases dead on arrival (DOA), and identified factors associated with fatality in EVD patients, residents in Tonkolili District. Residents of Tonkolili district who presented between 12 September 2014 and 23 February 2015 to the district EMC and the two distant EMCs were identified from EMC line-lists. EVD cases were confirmed by a positive Ebola PCR test. We calculated time to admission since the onset of symptoms, case-fatality and adjusted Risk Ratios (aRR) using Binomial regression. Of 249 confirmed Ebola cases, 206 (83%) were admitted to the distant EMCs and 43 (17%) to the district EMC. Of them 110 (45%) have died. Confirmed cases dead on arrival (n = 10) were observed only in the distant EMCs. The median time from symptom onset to admission was 6 days (IQR 4,8) in distant EMCs and 3 days (IQR 2,7) in the district EMC (p<0.001). Cases were 2.0 (95% CI 1.4-2.9) times more likely to have delayed admission (>3 days after symptom onset) in the distant compared with the district EMC, but were less likely (aRR = 0.8; 95% CI 0.6-1.0) to have a high viral load (cycle threshold <= 22). A fatal outcome was associated with a high viral load (aRR 2.6; 95% CI 1.8-3.6) and vomiting at first presentation (aRR 1.4; 95% CI 1.0-2.0). The opening of a district EMC was associated with earlier admission of cases to appropriate care facilities, an essential component of reducing EVD transmission. High viral load and vomiting at admission predicted fatality. Healthcare providers should consider the location of EMCs to ensure equitable access during Ebola outbreaks.	[Theocharopoulos, Georgios; Danis, Kostas; Hoffmann, Alexandra] European Ctr Dis Prevent & Control ECDC, European Programme Intervent Epidemiol Training, Stockholm, Sweden; [Tejan, Sumaila; Duncombe, Jennifer; Kremer, Ronald] Inst Veille Sanitaire, St Martin Dheres, France; [Hoffmann, Alexandra; Tejan, Sumaila; Kleijer, Karline; Lokuge, Kamalini] Med Sans Frontieres, Magburaka, Sierra Leone; [Duncombe, Jennifer; Lokuge, Kamalini; Broeder, Rob; Kremer, Ronald] Manson Unit, Medecins Sans Frontieres, London, ON, Canada; [Danis, Kostas; De Valk, Henriette; Sankoh, Mohammed; Turner, Will; Duncombe, Jennifer; Broeder, Rob] State Off Hlth & Social Affairs, Berlin, Germany; [Tejan, Sumaila; Kleijer, Karline; Gayton, Ivan] Dist Hlth Management Team, Hlth & Sanitat, Magburaka, Magburaka, Sierra Leone	European Centre for Disease Prevention & Control; Institute of Public Health Surveillance; Ministry of Health & Sanitation Sierra Leone	Theocharopoulos, G (corresponding author), European Ctr Dis Prevent & Control ECDC, European Programme Intervent Epidemiol Training, Stockholm, Sweden.	theocharopoulos1@yahoo.com	Danis, Kostas/ABD-7357-2020; Achar, Jay/AAB-2710-2022	Achar, Jay/0000-0002-2521-4422; Greig, Jane/0000-0003-2732-0023; Lokuge, Kamalini/0000-0002-6287-1296; de Valk, Henriette/0000-0002-5928-7689				Agua-Agum J, 2015, W AFR EB EP ONE YEAR, V372; [Anonymous], 2014, WHO STAT M INT HLTH; Borchert M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-357; Brainard J, 2016, INT J EPIDEMIOL, V45, P102, DOI 10.1093/ije/dyv307; Centers for Disease Control and Prevention, 2015, INT REC AMB SERV PRO; Crowe SJ, 2016, EMERG INFECT DIS, V22, P217, DOI 10.3201/eid2202.151250; Dallatomasina S, 2015, TROP MED INT HEALTH, V20, P448, DOI 10.1111/tmi.12454; de La Vega MA, 2016, EXPERT REV ANTI-INFE, V14, P557, DOI 10.1080/14787210.2016.1176912; Faye O, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001908; Fitzpatrick G, 2015, J INFECT DIS, V212, P1752, DOI 10.1093/infdis/jiv304; Flint M, 2015, J INFECT DIS, V212, pS350, DOI 10.1093/infdis/jiv361; Frieden TR, 2014, NEW ENGL J MED, V371, P1177, DOI 10.1056/NEJMp1409903; JOHNSON E, 1995, INT J EXP PATHOL, V76, P227; Kutalek R, 2015, LANCET GLOB HEALTH, V3, pE131, DOI 10.1016/S2214-109X(15)70010-0; Lindblade KA, 2015, EMERG INFECT DIS, V21, P1800, DOI 10.3201/eid2110.150912; Lokuge K, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004498; Marzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036192; Medecins Sans Frontieres, 2013, ETH REV BOARD STAND; MMWRC, 2014, UPD EB VIR DIS EPI W; Muyembe-Tamfum JJ, 1999, J INFECT DIS S1, V179; Olu O, 2015, PAN AFR MED J, V22, DOI 10.11694/pamj.supp.2015.22.1.6521; Osterholm MT, 2015, MBIO, V6, DOI 10.1128/mBio.00137-15; Pathmanathan I, 2014, RAPID ASSESSMENT EBO; Spengler JR, 2015, J INFECT DIS S2, V212; WHO, 2014, 1 WHO; Wolz A, 2014, NEW ENGL J MED, V371, P1081, DOI 10.1056/NEJMp1410179; World Health Organization, 2014, 2 WHO; Yan T, 2015, EUR J CLIN MICROBIOL, V34, P2089, DOI 10.1007/s10096-015-2457-z	28	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176692	10.1371/journal.pone.0176692	http://dx.doi.org/10.1371/journal.pone.0176692			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459838	Green Published, Green Submitted, gold			2022-12-26	WOS:000400645000048
J	Emmerich, T; Zakirova, Z; Klimas, N; Sullivan, K; Shetty, AK; Evans, JE; Ait-Ghezala, G; Laco, GS; Hattiangady, B; Shetty, GA; Mullan, M; Crynen, G; Abdullah, L; Crawford, F				Emmerich, Tanja; Zakirova, Zuchra; Klimas, Nancy; Sullivan, Kimberly; Shetty, Ashok K.; Evans, James E.; Ait-Ghezala, Ghania; Laco, Gary S.; Hattiangady, Bharathi; Shetty, Geetha A.; Mullan, Michael; Crynen, Gogce; Abdullah, Laila; Crawford, Fiona			Phospholipid profiling of plasma from GW veterans and rodent models to identify potential biomarkers of Gulf War Illness	PLOS ONE			English	Article							PYRIDOSTIGMINE BROMIDE; REPEATED STRESS; MOUSE MODEL; COGNITIVE IMPAIRMENT; RAT MODEL; EXPOSURE; DEET; PERMETHRIN; MICE; LIPIDS	Gulf War Illness (GWI), which affects at least one fourth of the 700,000 veterans deployed to the Gulf War (GW), is characterized by persistent and heterogeneous symptoms, including pain, fatigue and cognitive problems. As a consequence, this illness remains difficult to diagnose. Rodent models have been shown to exhibit different symptomatic features of GWI following exposure to particular GW agents (e.g. pyridostigmine bromide, permethrin and DEET) and/or stress. Preclinical analyses have shown the activation of microglia and astroglia as a pathological hallmark in these mouse and rat models. Although much has been learned in recent years from these different rodent models and independent clinical studies, characterization studies to identify overlapping features of GWI in animals and humans have been missing. Thus, we aimed to identify biomarkers that co-occur in the plasma of rodent models of GWI and human GWI patients. We observed increases of multiple phospholipid (PL) species across all studied cohorts. Furthermore, these data suggested dysfunction within ether and docosahexaenoic acid and arachidonic acid containing PL species in relation to GWI. As these PL species play a role in inflammatory processes, these findings suggest a possible role for inflammatory imbalance in GWI. Overall, we show that the peripheral lipid disturbances are present both in human GWI patients and in the preclinical rodent models of GWI, highlighting the importance of lipidomics as a potential platform for further biomarker discovery and supporting the value of GW agent exposed models of GWI.	[Emmerich, Tanja; Zakirova, Zuchra; Evans, James E.; Ait-Ghezala, Ghania; Laco, Gary S.; Mullan, Michael; Crynen, Gogce; Abdullah, Laila; Crawford, Fiona] Roskamp Inst, Sarasota, FL 34243 USA; [Emmerich, Tanja; Ait-Ghezala, Ghania; Crynen, Gogce; Abdullah, Laila; Crawford, Fiona] Open Univ, Milton Keynes, Bucks, England; [Emmerich, Tanja; Evans, James E.; Ait-Ghezala, Ghania; Abdullah, Laila; Crawford, Fiona] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Klimas, Nancy] Nova Southeastern Univ, Ft Lauderdale & Miami VAMC, Miami, FL USA; [Sullivan, Kimberly] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Shetty, Ashok K.; Hattiangady, Bharathi; Shetty, Geetha A.] Olin E Teague Vet Med Ctr, Res Serv, Temple, TX USA; [Shetty, Ashok K.; Hattiangady, Bharathi; Shetty, Geetha A.] Texas A&M Univ, Coll Med, Inst Regenerat Med, College Stn, TX 77843 USA	Open University - UK; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; Nova Southeastern University; Boston University; Texas A&M University System; Texas A&M University College Station	Emmerich, T (corresponding author), Roskamp Inst, Sarasota, FL 34243 USA.; Emmerich, T (corresponding author), Open Univ, Milton Keynes, Bucks, England.; Emmerich, T (corresponding author), James A Haley Vet Hosp, Tampa, FL 33612 USA.	temmerich@roskampinstiute.net	Shetty, Ashok K/A-2428-2008; Shetty, Ashok/AAT-7273-2020	Shetty, Ashok K/0000-0001-5049-6671; Shetty, Ashok/0000-0001-5049-6671; Ait-Ghezala, Ghania/0000-0002-9836-8617; Sullivan, Kimberly/0000-0001-7940-6123; Crynen, Gogce/0000-0001-6066-9900	VA Merit award [1101CX000469, 5101BX000883-05]; CDMRP award [GW080094, GW1300045, GWRB-011-04S, W81XWH-09-2-0071]; Department of Defense [GW100076]; Roskamp Foundation; CDMRP GWI consortium award [GW120037]; Veterans Affairs [I01BX002084] Funding Source: NIH RePORTER	VA Merit award(US Department of Veterans Affairs); CDMRP award(United States Department of Defense); Department of Defense(United States Department of Defense); Roskamp Foundation; CDMRP GWI consortium award; Veterans Affairs(US Department of Veterans Affairs)	This work is supported by a VA Merit award (1101CX000469) and a CDMRP award (GW080094) to Dr. Fiona Crawford, a CDMRP award (GW1300045) to Dr. Laila Abdullah, an award given by Department of Defense (GW100076) to Dr. Ghania Ait-Ghezala as well as by the Roskamp Foundation. Plasma samples from GW veterans were made possible through a CDMRP GWI consortium award (GW120037) to Dr. Kimberly Sullivan and a CDMRP award (GWRB-011-04S and W81XWH-09-2-0071) to Dr. Klimas. Plasma samples from a rat GWI model were made possible through a VA Merit award (5101BX000883-05) to Dr. Ashok K. Shetty. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman A, 2004, J TOXICOL ENV HEAL A, V67, P163, DOI 10.1080/15287390490264802; Abdullah L, 2016, TOXICOLOGY, V372, P22, DOI 10.1016/j.tox.2016.10.012; Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; Abdullah L, 2013, NEUROTOXICOL TERATOL, V40, P74, DOI 10.1016/j.ntt.2013.10.002; Abdullah L, 2012, NEUROMOL MED, V14, P349, DOI 10.1007/s12017-012-8192-z; Abdullah L, 2011, NEUROMOL MED, V13, P275, DOI 10.1007/s12017-011-8160-z; Abou-Donia MB, 2004, PHARMACOL BIOCHEM BE, V77, P253, DOI 10.1016/j.pbb.2003.10.018; Amenta F, 2008, CURR MED CHEM, V15, P488, DOI 10.2174/092986708783503203; Amourette C, 2009, BEHAV BRAIN RES, V203, P207, DOI 10.1016/j.bbr.2009.05.002; Barbier L, 2009, BEHAV BRAIN RES, V197, P292, DOI 10.1016/j.bbr.2008.08.032; Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820; Binns J, 2008, GULF WAR ILLNESS HLT, P1; Broderick G, 2013, BRAIN BEHAV IMMUN, V28, P159, DOI 10.1016/j.bbi.2012.11.007; Broderick G, 2011, BRAIN BEHAV IMMUN, V25, P302, DOI 10.1016/j.bbi.2010.10.011; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; CHAJEKSHAUL T, 1991, P NATL ACAD SCI USA, V88, P6731, DOI 10.1073/pnas.88.15.6731; Chaney LA, 2002, INT J TOXICOL, V21, P287, DOI 10.1080/10915810290096450; Chaney LM, 1997, TOXICOLOGIST, V106, P21; Chen CT, 2015, SCI REP-UK, V5, DOI 10.1038/srep15791; David AS, 2002, PSYCHOL MED, V32, P1357, DOI 10.1017/S0033291702006359; Dodd CA, 2009, TOXICOL IND HEALTH, V25, P25, DOI 10.1177/0748233709102752; Emmerich T, 2016, NEUROMOLECULAR MED; Emmerich T, 2016, J NEUROTRAUM, V33, P1331, DOI 10.1089/neu.2015.4061; Farooqui AA, 2007, J NEUROSCI RES, V85, P1834, DOI 10.1002/jnr.21268; Flunker LK, 2017, TOXICOL APPL PHARM, V316, P48, DOI 10.1016/j.taap.2016.12.014; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fredman G, 2011, BIOCHEM J, V437, P185, DOI 10.1042/BJ20110327; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Fulco CE, 2003, GULF WAR HLTH, V2; Gibellini F, 2010, IUBMB LIFE, V62, P414, DOI 10.1002/iub.337; Golomb B, 2014, NEURAL COMPUT, V1872, P1840; Golomb BA, 2012, NAT PRECEEDINGS; Gordon SM, 2015, J PROTEOME RES, V14, P2686, DOI 10.1021/acs.jproteome.5b00213; Gray GC, 1999, AM J TROP MED HYG, V60, P758, DOI 10.4269/ajtmh.1999.60.758; Hattiangady B, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00078; Hilborne LH, 2005, EXAMINING POSSIBLE C; Hoy JB, 2000, VET HUM TOXICOL, V42, P72; Karen DJ, 2001, NEUROTOXICOLOGY, V22, P811, DOI 10.1016/S0161-813X(01)00063-8; Khaiboullina SF, 2015, CYTOKINE, V72, P1, DOI 10.1016/j.cyto.2014.11.019; Koslik HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092887; Lamproglou I, 2009, BEHAV BRAIN RES, V197, P301, DOI 10.1016/j.bbr.2008.08.031; Megahed T, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00447; Mejia EM, 2016, J BIOENERG BIOMEMBR, V48, P99, DOI 10.1007/s10863-015-9601-4; Murphy EJ, 2005, BIOCHEMISTRY-US, V44, P6350, DOI 10.1021/bi047292r; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; O'Callaghan JP, 2015, J NEUROCHEM, P1; Parihar VK, 2013, NEUROPSYCHOPHARMACOL, V38, P2348, DOI 10.1038/npp.2013.158; Persian Gulf Veterans Coordinating Board, 1995, ARCH INTERN MED, V155, P262; Phillips KF, 2016, NEUROTOXICOLOGY, V52, P127, DOI 10.1016/j.neuro.2015.11.014; Pittman JT, 2003, INT J TOXICOL, V22, P359, DOI 10.1080/10915810390232358; RAC, 2014, GULF WAR ILLN HLTH G, P1; Rayhan RU, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058493, 10.1371/journal.pone.0063903]; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Skowera A, 2004, J CLIN IMMUNOL, V24, P66, DOI 10.1023/B:JOCI.0000018065.64685.82; Smith BN, 2013, JOEM, P55; Smylie AL, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-29; Spencer PS, 2001, J OCCUP ENVIRON MED, V43, P1041; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Sullivan K, 2003, J PSYCHOPATHOL BEHAV, V25, P95, DOI 10.1023/A:1023342915425; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terry Jr AV, 2012, PHARMACOL THERAPEUT, V134, P335; Toomey R, 2009, J INT NEUROPSYCH SOC, V15, P717, DOI 10.1017/S1355617709990294; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; von Bohlen und Halbach O, 2013, CELL TISSUE RES, V354, P41, DOI 10.1007/s00441-012-1547-9; Vythilingam M, 2005, PSYCHIAT RES-NEUROIM, V139, P89, DOI 10.1016/j.pscychresns.2005.04.003; Whistler T, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-12; White RF, 2015, RECENT RES GULF WAR, P1; White RF, 2001, NEUROPSYCHOLOGICAL F, V54, P42; White RF, 2016, CORTEX, V74, P449, DOI 10.1016/j.cortex.2015.08.022; WILLIAMSON EG, 1989, ECOTOX ENVIRON SAFE, V18, P27, DOI 10.1016/0147-6513(89)90089-4; Zakirova Z, 2016, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00071; Zakirova Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119579	74	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176634	10.1371/journal.pone.0176634	http://dx.doi.org/10.1371/journal.pone.0176634			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453542	gold, Green Submitted, Green Published			2022-12-26	WOS:000400383900036
J	Shi, Y; Tham, YC; Cheung, N; Chua, J; Tan, G; Mitchell, P; Wang, JJ; Cheung, YB; Cheng, CY; Wong, TY				Shi, Yuan; Tham, Yih-Chung; Cheung, Ning; Chua, Jacqueline; Tan, Gavin; Mitchell, Paul; Wang, Jie Jin; Cheung, Yin Bun; Cheng, Ching-Yu; Wong, Tien Yin			Is aspirin associated with diabetic retinopathy? The Singapore Epidemiology of Eye Disease (SEED) study	PLOS ONE			English	Article							RISK-FACTORS; PREVALENCE; POPULATION; VISION	Background/Aims To determine the association between aspirin use and diabetic retinopathy (DR) among persons with diabetes, in a population-based, cross-sectional study. Methods Subjects with diabetes aged >40 years from the Singapore Epidemiology of Eye Diseases Study were enrolled in this study. Retinal photographs were graded for DR according to the modified Airlie House classification system. Vision threatening diabetic retinopathy (VTDR) was defined as the presence of severe non-proliferative DR, or proliferative DR, or clinically significant macular oedema. The association between aspirin use and the presence of DR or VTDR was assessed using multivariable logistic regression models including age, gender, ethnicity, socioeconomic status, HbA1c, systolic blood pressure, anti-hypertension medicine, total cholesterol, anti-cholesterol medicine, BMI, current smoking status, diabetes duration, history of cardiovascular disease (CVD) and chronic kidney disease (CKD.). Results A total of 2,061 participants with diabetes and complete record of relevant systemic and DR data were included. Of these, 711 (34.5%) had any stage of DR, and among these 177 (8.6%) had VTDR. After adjusting for co-variables listed, the association between aspirin use and VTDR was significant (OR = 1.69, P = 0.019), while the association between aspirin use and any DR was borderline (OR = 1.31, P = 0.063). Aspirin use was not associated with either DR or VTDR after additional adjustment of CVD and CKD. Further stratification by history of CVD or CKD showed no association between aspirin use and DR/VTDR in either subgroup. Conclusion Aspirin use was not significantly associated with DR but might be an indicator of diabetic complications (CVD, CKD) that were co-present with more severe DR type. Future longitudinal studies are warranted to confirm our findings.	[Shi, Yuan; Tham, Yih-Chung; Cheung, Ning; Chua, Jacqueline; Tan, Gavin; Cheng, Ching-Yu; Wong, Tien Yin] Singapore Eye Res Inst, Singapore Natl Eye Ctr, Singapore, Singapore; [Tham, Yih-Chung; Cheng, Ching-Yu; Wong, Tien Yin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore, Singapore; [Mitchell, Paul; Wang, Jie Jin] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW, Australia; [Mitchell, Paul; Wang, Jie Jin] Univ Sydney, Westmead Inst Med Res, Sydney, NSW, Australia; [Wang, Jie Jin; Cheung, Yin Bun; Cheng, Ching-Yu; Wong, Tien Yin] Duke NUS Med Sch, Singapore, Singapore; [Cheung, Yin Bun] Univ Tampere, Tampere Ctr Child Hlth Res, Tampere, Finland; [Cheung, Yin Bun] Tampere Univ Hosp, Tampere, Finland	National University of Singapore; Singapore National Eye Center; National University of Singapore; University of Sydney; University of Sydney; Westmead Institute for Medical Research; National University of Singapore; Tampere University; Tampere University; Tampere University Hospital	Wong, TY (corresponding author), Singapore Eye Res Inst, Singapore Natl Eye Ctr, Singapore, Singapore.; Wong, TY (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore, Singapore.; Wong, TY (corresponding author), Duke NUS Med Sch, Singapore, Singapore.	ophwty@nus.edu.sg	Mitchell, Paul/P-1498-2014; Chung, Yih/AIF-2414-2022; Wong, Tien Yin/AAC-9724-2020; Wang, Jie Jin/P-1499-2014; Cheng, Ching-Yu/Y-2229-2019; wang, jie/GRS-0942-2022	Chung, Yih/0000-0002-6752-797X; Wong, Tien Yin/0000-0002-8448-1264; Wang, Jie Jin/0000-0001-9491-4898; Cheng, Ching-Yu/0000-0003-0655-885X; Chua, Jacqueline/0000-0002-6474-5293	National Medical Research Council of Singapore [NMRC/0796/2003, 1176/2008, 1149/2008]; Biomedical Research Council grant of Singapore [BMRC/08/1/35/19/550]	National Medical Research Council of Singapore(National Medical Research Council, Singapore); Biomedical Research Council grant of Singapore	Support was provided by National Medical Research Council of Singapore (NMRC/0796/2003, 1176/2008, 1149/2008) and Biomedical Research Council grant of Singapore (BMRC/08/1/35/19/550).	[Anonymous], 1991, OPHTHALMOLOGY, V98, P823; [Anonymous], 1991, OPHTHALMOLOGY, V98, P741; [Anonymous], 2008, INTRO R NOTES R PROG; BAUDOIN C, 1989, DIABETES, V38, P491; Chew E, 1995, ARCH OPHTHALMOLOGY; Cikamatana L, 2007, EYE, V21, P465, DOI 10.1038/sj.eye.6702771; Colwell JA, 1997, DIABETES CARE, V20, P1767, DOI 10.2337/diacare.20.11.1767; Fowler MJ, 2008, CLIN DIABETES, V26, P77, DOI [DOI 10.2337/DIACLIN.26.2.77, 10.2337/diaclin.26.2.77]; Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552; KLEIN BEK, 1987, DIABETES CARE, V10, P600, DOI 10.2337/diacare.10.5.600; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; Lee R, 2015, EYE VISION, V2, DOI 10.1186/s40662-015-0026-2; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Mitchell P, 1998, OPHTHALMOLOGY, V105, P406, DOI 10.1016/S0161-6420(98)93019-6; Mohamed Q, 2007, JAMA-J AM MED ASSOC, V298, P902, DOI 10.1001/jama.298.8.902; Pan CW, 2011, INVEST OPHTH VIS SCI, V52, P6636, DOI 10.1167/iovs.10-7148; Raman R, 2009, OPHTHALMOLOGY, V116, P311, DOI 10.1016/j.ophtha.2008.09.010; Salinero-fort MA, 2013, PLOS ONE, V17, P10; Scanlon PH, 2008, J MED SCREEN, V15, P118, DOI 10.1258/jms.2008.008013; Valmadrid CT, 2000, ARCH INTERN MED, V160, P1093, DOI 10.1001/archinte.160.8.1093; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Wong TY, 2008, OPHTHALMOLOGY, V115, P1869, DOI 10.1016/j.ophtha.2008.05.014; Wong TY, 2008, ARCH OPHTHALMOL-CHIC, V126, P1091, DOI 10.1001/archopht.126.8.1091; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Zheng YF, 2012, INDIAN J OPHTHALMOL, V60, P428, DOI 10.4103/0301-4738.100542	25	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0175966	10.1371/journal.pone.0175966	http://dx.doi.org/10.1371/journal.pone.0175966			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453510	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383900008
J	Yang, N; Leung, EH; Liu, C; Li, L; Eguether, T; Yao, XJJ; Jones, EC; Norris, DA; Liu, A; Clark, RA; Roop, DR; Pazour, GJ; Shroyer, KR; Chen, J				Yang, N.; Leung, EL-H; Liu, C.; Li, L.; Eguether, T.; Yao, X-J Jun; Jones, E. C.; Norris, D. A.; Liu, A.; Clark, R. A.; Roop, D. R.; Pazour, G. J.; Shroyer, K. R.; Chen, J.			INTU is essential for oncogenic Hh signaling through regulating primary cilia formation in basal cell carcinoma	ONCOGENE			English	Article							HEDGEHOG PATHWAY; HAIR FOLLICLE; VERTEBRATE DEVELOPMENT; EMBRYONIC-DEVELOPMENT; HUMAN HOMOLOG; STEM-CELLS; POLARITY; MOUSE; DIFFERENTIATION; CILIOGENESIS	Inturned (INTU), a cilia and planar polarity effector, performs prominent ciliogenic functions during morphogenesis, such as in the skin. INTU is expressed in adult tissues but its role in tissue maintenance is unknown. Here, we report that the expression of the INTU gene is aberrantly elevated in human basal cell carcinoma (BCC), coinciding with increased primary cilia formation and activated hedgehog (Hh) signaling. Disrupting Intu in an oncogenic mutant Smo (SmoM2)-driven BCC mouse model prevented the formation of BCC through suppressing primary cilia formation and Hh signaling, suggesting that Intu performs a permissive role during BCC formation. INTU is essential for intraflagellar transport A complex assembly during ciliogenesis. To further determine whether Intu is directly involved in the activation of Hh signaling downstream of ciliogenesis, we examined the Hh signaling pathway in mouse embryonic fibroblasts, which readily responds to the Hh pathway activation. Depleting Intu blocked Smo agonist-induced Hh pathway activation, whereas the expression of Gli2 Delta N, a constitutively active Gli2, restored Hh pathway activation in Intu-deficient cells, suggesting that INTU functions upstream of Gli2 activation. In contrast, overexpressing Intu did not promote ciliogenesis or Hh signaling. Taken together, data obtained from this study suggest that INTU is indispensable during BCC tumorigenesis and that its aberrant upregulation is likely a prerequisite for primary cilia formation during Hh-dependent tumorigenesis.	[Yang, N.; Liu, C.; Shroyer, K. R.; Chen, J.] SUNY Stony Brook, Dept Pathol, Basic Sci Tower,Level 9,Room 151, Stony Brook, NY 11794 USA; [Leung, EL-H; Yao, X-J Jun; Chen, J.] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Li, L.] Beijing Union Med Coll Hosp, Dept Dermatol, Beijing, Peoples R China; [Eguether, T.; Pazour, G. J.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Jones, E. C.; Clark, R. A.; Chen, J.] SUNY Stony Brook, Dept Dermatol, Basic Sci Tower,Level 9,Room 151, Stony Brook, NY 11794 USA; [Norris, D. A.; Roop, D. R.] Univ Colorado Denver, Charles C Gates Ctr Regenerat Med, Aurora, CO USA; [Liu, A.] Penn State Univ, Dept Biol, Eberly Coll Sci, University Pk, PA 16802 USA; [Roop, D. R.] Univ Colorado Denver, Dept Dermatol, Aurora, CO USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Macau University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; University of Massachusetts System; University of Massachusetts Worcester; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Chen, J (corresponding author), SUNY Stony Brook, Dept Pathol, Sch Med, Basic Sci Tower,Level 9,Room 151, Stony Brook, NY 11794 USA.	jiang.chen@stonybrook.edu	Eguether, Thibaut/AAZ-5403-2020	Eguether, Thibaut/0000-0003-1891-9253; Liu, Aimin/0000-0003-0099-0879	Research Histology Core Laboratory of the Department of Pathology; Cancer Center of Stony Brook University; NIH [AR061485, AR060388, CA052607]; PKD foundation [02YI08A]; SDRC of University of Colorado Denver (NIH) [AR057212]; REACH program of Stony Brook University (NIH) [U01HL127522]; REACH program of Stony Brook University (NYS Department of Economic Development) [C140151]; NATIONAL CANCER INSTITUTE [R01CA052607] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL127522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061485, R01AR060388, P30AR057212] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060992] Funding Source: NIH RePORTER	Research Histology Core Laboratory of the Department of Pathology; Cancer Center of Stony Brook University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PKD foundation; SDRC of University of Colorado Denver (NIH); REACH program of Stony Brook University (NIH); REACH program of Stony Brook University (NYS Department of Economic Development); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Stephanie Burke and Mallory Korman for histology assistance. This study is supported by the Research Histology Core Laboratory of the Department of Pathology, the Cancer Center of Stony Brook University, and research grants from NIH (AR061485 to JC; AR060388 and CA052607 to DRR), a Young Investigator Career Development Award from the PKD foundation (02YI08A to AL), a Pilot and Feasibility Award from the SDRC of University of Colorado Denver (NIH, AR057212), and the REACH program of Stony Brook University (NIH, U01HL127522 and the NYS Department of Economic Development, C140151).	Aszterbaum M, 1999, J INVEST DERM SYMP P, V4, P41, DOI 10.1038/sj.jidsp.5640179; Atwood SX, 2015, CANCER CELL, V27, P342, DOI 10.1016/j.ccell.2015.02.002; Atwood SX, 2012, J CELL BIOL, V199, P193, DOI 10.1083/jcb.201207140; Basset-Seguin N, 2015, MOL CANCER THER, V14, P633, DOI 10.1158/1535-7163.MCT-14-0703; Chang R, 2015, DEV DYNAM, V244, P736, DOI 10.1002/dvdy.24272; Cui C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001720; Dai D, 2013, CELL DEATH DIFFER, V20, P130, DOI 10.1038/cdd.2012.104; Dai D, 2011, J INVEST DERMATOL, V131, P302, DOI 10.1038/jid.2010.306; DeRouen MC, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-112; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Grachtchouk M, 2011, J CLIN INVEST, V121, P1768, DOI 10.1172/JCI46307; Gray RS, 2009, NAT CELL BIOL, V11, P1225, DOI 10.1038/ncb1966; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Han YG, 2009, NAT MED, V15, P1062, DOI 10.1038/nm.2020; Heydeck W, 2011, DEV DYNAM, V240, P1938, DOI 10.1002/dvdy.22696; Heydeck W, 2009, DEV DYNAM, V238, P3035, DOI 10.1002/dvdy.22130; Infante P, 2015, TRENDS PHARMACOL SCI, V36, P547, DOI 10.1016/j.tips.2015.05.006; Kim DJ, 2014, J CLIN ONCOL, V32, P745, DOI 10.1200/JCO.2013.49.9525; Kim J, 2010, CANCER CELL, V17, P388, DOI 10.1016/j.ccr.2010.02.027; Metcalfe C, 2011, CANCER RES, V71, P5057, DOI 10.1158/0008-5472.CAN-11-0923; Oh EC, 2012, DEVELOPMENT, V139, P443, DOI 10.1242/dev.050054; Oro AE, 1997, SCIENCE, V276, P817, DOI 10.1126/science.276.5313.817; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Park WJ, 1996, DEVELOPMENT, V122, P961; Peterson SC, 2015, CELL STEM CELL, V16, P400, DOI 10.1016/j.stem.2015.02.006; Pricl S, 2015, MOL ONCOL, V9, P389, DOI 10.1016/j.molonc.2014.09.003; Sanchez-Danes A, 2016, NATURE, V536, P298, DOI 10.1038/nature19069; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Toriyama M, 2016, NAT GENET, V48, P648, DOI 10.1038/ng.3558; Villumsen BH, 2013, EMBO J, V32, P3029, DOI 10.1038/emboj.2013.223; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Wang GY, 2011, CANCER CELL, V19, P114, DOI 10.1016/j.ccr.2010.11.007; Wong SY, 2014, J INVEST DERMATOL, V134, pE18, DOI 10.1038/skinbio.2014.4; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yasuda Masahito, 2013, Methods Mol Biol, V989, P143, DOI 10.1007/978-1-62703-330-5_12; Youssef KK, 2012, NAT CELL BIOL, V14, P1282, DOI 10.1038/ncb2628; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207; Zeng HQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015900; Zeng HQ, 2010, DEV BIOL, V339, P418, DOI 10.1016/j.ydbio.2010.01.003; Zhang ZC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024608, 10.1371/journal.pone.0028817]; Zilber Y, 2013, MOL BIOL CELL, V24, P555, DOI 10.1091/mbc.E12-06-0437	45	14	15	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 31	2017	36	35					4997	5005		10.1038/onc.2017.117	http://dx.doi.org/10.1038/onc.2017.117			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FF3AV	28459465	Green Accepted			2022-12-26	WOS:000408768800005
J	Kerros, C; Tripathi, SC; Zha, DX; Mehrens, JM; Sergeeva, A; Philips, AV; Qiao, N; Peters, HL; Katayama, H; Sukhumalchandra, P; Ruisaard, KE; Perakis, AA; John, LSS; Lu, SJ; Mittendorf, EA; Clise-Dwyer, K; Herrmann, AC; Alatrash, G; Toniatti, C; Hanash, SM; Ma, Q; Molldrem, JJ				Kerros, Celine; Tripathi, Satyendra C.; Zha, Dongxing; Mehrens, Jennifer M.; Sergeeva, Anna; Philips, Anne V.; Qiao, Na; Peters, Haley L.; Katayama, Hiroyuki; Sukhumalchandra, Pariya; Ruisaard, Kathryn E.; Perakis, Alexander A.; John, Lisa S. St.; Lu, Sijie; Mittendorf, Elizabeth A.; Clise-Dwyer, Karen; Herrmann, Amanda C.; Alatrash, Gheath; Toniatti, Carlo; Hanash, Samir M.; Ma, Qing; Molldrem, Jeffrey J.			Neuropilin-1 mediates neutrophil elastase uptake and cross-presentation in breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; END-RULE PEPTIDES; CATHEPSIN-G; MYELOID MALIGNANCIES; IMMUNE-RESPONSE; T-CELLS; RECEPTOR; PR1; PROGRESSION; LEUKEMIA	Neutrophil elastase (NE) can be rapidly taken up by tumor cells that lack endogenous NE expression, including breast cancer, which results in cross-presentation of PR1, an NE-derived HLA-A2-restricted peptide that is an immunotherapy target in hematological and solid tumor malignancies. The mechanism of NE uptake, however, remains unknown. Using the mass spectrometry-based approach, we identify neuropilin-1 (NRP1) as a NE receptor that mediates uptake and PR1 cross-presentation in breast cancer cells. We demonstrated that soluble NE is a specific, high-affinity ligand for NRP1 with a calculated Kd of 38.7nM. Furthermore, we showed that NRP1 binds to the RRXR motif in NE. Notably, NRP1 knockdown with interfering RNA or CRISPR-cas9 system and blocking using anti-NRP1 antibody decreased NE uptake and, subsequently, susceptibility to lysis by PR1-specific cytotoxic T cells. Expression of NRP1 in NRP1 deficient cells was sufficient to induce NE uptake. Altogether, because NRP1 is broadly expressed in tumors, our findings suggest a role for this receptor in immunotherapy strategies that target cross-presented antigens.	[Kerros, Celine; Tripathi, Satyendra C.; Zha, Dongxing; Mehrens, Jennifer M.; Sergeeva, Anna; Philips, Anne V.; Qiao, Na; Peters, Haley L.; Katayama, Hiroyuki; Sukhumalchandra, Pariya; Ruisaard, Kathryn E.; Perakis, Alexander A.; John, Lisa S. St.; Lu, Sijie; Mittendorf, Elizabeth A.; Clise-Dwyer, Karen; Herrmann, Amanda C.; Alatrash, Gheath; Toniatti, Carlo; Hanash, Samir M.; Ma, Qing; Molldrem, Jeffrey J.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Molldrem, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Sect Transplantat Immunol, Unit 900, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jmolldre@mdanderson.org	Tripathi, Satyendra Chandra/L-9352-2017	Tripathi, Satyendra Chandra/0000-0003-3917-9645; Toniatti, Carlo/0000-0001-9493-344X; Perakis, Alexander/0000-0002-8172-7281; Alatrash, Gheath/0000-0002-7648-4377; kerros, celine/0000-0002-7826-4167	Leukemia and Lymphoma Society Translational Research Program Grant [6030-12]; National Institutes of Health (NIH) SPORE [P50 CA100632]; NIH Training Program in Cancer Immunobiology [T32 CA009598]; National Cancer Institute Grant [P30CA16672];  [P01 CA049639];  [P01 CA148600]; NATIONAL CANCER INSTITUTE [P50CA100632, T32CA009598, P30CA016672, P01CA148600, P01CA049639] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society Translational Research Program Grant(Leukemia and Lymphoma Society); National Institutes of Health (NIH) SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Training Program in Cancer Immunobiology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Leukemia and Lymphoma Society Translational Research Program Grant (6030-12), National Institutes of Health (NIH) SPORE (P50 CA100632), Research Program Project (P01 CA049639 and P01 CA148600) grants (to J. J. M), NIH Training Program in Cancer Immunobiology T32 CA009598 (to H. L. P and C. K.), and National Cancer Institute Grant P30CA16672 (to the South Campus Flow Cytometry & Cell Sorting Core Facility and the Characterized Cell Line Core Facility at MDACC). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akizuki M, 2007, NEOPLASIA, V9, P260, DOI 10.1593/neo.06808; Alatrash G, 2012, J IMMUNOL, V189, P5476, DOI 10.4049/jimmunol.1201221; Alatrash G, 2012, J IMMUNOTHER, V35, P309, DOI 10.1097/CJI.0b013e31824b3b14; Bagheri-Yarmand R, 2010, CANCER RES, V70, P5074, DOI 10.1158/0008-5472.CAN-09-4094; CAMPBELL EJ, 1982, P NATL ACAD SCI-BIOL, V79, P6941, DOI 10.1073/pnas.79.22.6941; Chaudhary B, 2014, CANCER IMMUNOL IMMUN, V63, P81, DOI 10.1007/s00262-013-1500-0; Cheng W, 2014, TUMOR BIOL, V35, P6089, DOI 10.1007/s13277-014-1806-3; Djordjevic S, 2013, DRUG DISCOV TODAY, V18, P447, DOI 10.1016/j.drudis.2012.11.013; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Ghosh S, 2008, HUM PATHOL, V39, P1835, DOI 10.1016/j.humpath.2008.06.004; Glinka Y, 2011, CARCINOGENESIS, V32, P613, DOI 10.1093/carcin/bgq281; Grandclement Camille, 2011, Cancers (Basel), V3, P1899, DOI 10.3390/cancers3021899; Gregory AD, 2012, J BIOL CHEM, V287, P35341, DOI 10.1074/jbc.M112.385617; Hattar K, 2014, CANCER IMMUNOL IMMUN, V63, P1297, DOI 10.1007/s00262-014-1606-z; Henriksen PA, 2014, CURR OPIN HEMATOL, V21, P23, DOI 10.1097/MOH.0000000000000001; Houghton AM, 2010, NAT MED, V16, P219, DOI 10.1038/nm.2084; Janssen BJC, 2012, NAT STRUCT MOL BIOL, V19, P1293, DOI 10.1038/nsmb.2416; Jensen TO, 2012, CANCER-AM CANCER SOC, V118, P2476, DOI 10.1002/cncr.26511; Jia HY, 2006, J BIOL CHEM, V281, P13493, DOI 10.1074/jbc.M512121200; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Latil A, 2000, INT J CANCER, V89, P167, DOI 10.1002/(SICI)1097-0215(20000320)89:2<167::AID-IJC11>3.0.CO;2-9; Li LH, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0291-5; Ma Q, 2016, CYTOTHERAPY, V18, P985, DOI 10.1016/j.jcyt.2016.05.001; MCGOWAN SE, 1983, AM REV RESPIR DIS, V128, P688; Metz HE, 2011, CLIN CANCER RES, V17, P206, DOI 10.1158/1078-0432.CCR-10-0434; Mittendorf EA, 2012, CANCER RES, V72, P3153, DOI 10.1158/0008-5472.CAN-11-4135; Molldrem JJ, 2000, NAT MED, V6, P1018, DOI 10.1038/79526; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Nawa M, 2012, ANTICANCER RES, V32, P13; Porter DC, 2001, MOL CELL BIOL, V21, P6254, DOI 10.1128/MCB.21.18.6254-6269.2001; Qazilbash MH, 2017, LEUKEMIA, V31, P697, DOI 10.1038/leu.2016.254; Rezvani K, 2011, HAEMATOL-HEMATOL J, V96, P432, DOI 10.3324/haematol.2010.031674; Sato Nagato, 2007, Nihon Kokyuki Gakkai Zasshi, V45, P237; Sergeeva A, 2016, LEUKEMIA, V30, P1475, DOI 10.1038/leu.2016.57; Sergeeva A, 2011, BLOOD, V117, P4262, DOI 10.1182/blood-2010-07-299248; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Stephenson JM, 2002, INT J CANCER, V101, P409, DOI 10.1002/ijc.10611; Sun ZF, 2004, LANCET ONCOL, V5, P182, DOI 10.1016/S1470-2045(04)01414-7; Taguchi K, 2014, BIOANALYSIS, V6, P1679, DOI 10.4155/bio.14.120; Teesalu T, 2009, P NATL ACAD SCI USA, V106, P16157, DOI 10.1073/pnas.0908201106; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; Yamashita JI, 2006, BREAST J, V12, P288, DOI 10.1111/j.1075-122X.2006.00265.x; Zanuy D, 2013, J STRUCT BIOL, V182, P78, DOI 10.1016/j.jsb.2013.02.006; Zhao PS, 2015, J BIOL CHEM, V290, P13875, DOI 10.1074/jbc.M115.642736	44	22	25	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10295	10305		10.1074/jbc.M116.773051	http://dx.doi.org/10.1074/jbc.M116.773051			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28468826	Green Published, hybrid			2022-12-26	WOS:000403580600037
J	Lee, JY; Lee, MK; Kim, NK; Chu, SH; Lee, DC; Lee, HS; Lee, JW; Jeon, JY				Lee, Jee-Yon; Lee, Mi-Kyung; Kim, Nam-Kyu; Chu, Sang-Hui; Lee, Duk-Chul; Lee, Hye-Sun; Lee, Ji-Won; Jeon, Justin Y.			Serum chemerin levels are independently associated with quality of life in colorectal cancer survivors: A pilot study	PLOS ONE			English	Article							FATIGUE; INFLAMMATION; CELLS; CHEMOATTRACTANT; STATISTICS; ADIPOKINE; SYMPTOMS; BEHAVIOR; LIGAND	Background Colorectal cancer (CRC) survivors are known to experience various symptoms that significantly affect their quality of life (QOL); therefore, it is important to identify clinical markers related with CRC survivor QOL. Here we investigated the relationship between serum chemerin levels, a newly identified proinflammatory adipokine, and QOL in CRC survivors. Methods A data of total of 110 CRC survivors were analysed in the study. Serum chemerin levels were measured with an enzyme immunoassay analyser. Functional Assessment of Cancer Therapy (FACT) scores were used as an indicator of QOL in CRC survivors. Results Weak but not negligible relationships were observed between serum chemerin levels and FACT-General (G) (r = -0.22, p<0.02), FACT-Colorectal cancer (C) (r = -0.23, p<0.02) and FACT-Fatigue (F) scores (r = -0.27, p<0.01) after adjusting for confounding factors. Both stepwise and enter method multiple linear regression analyses confirmed that serum chemerin levels were independently associated with FACT-G (stepwise: beta = -0.15, p<0.01; enter: beta = -0.12, p = 0.02), FACT-C (stepwise: beta = -0.19, p<0.01; enter; beta = -0.14, p = 0.02) and FACT-F scores (stepwise: beta = -0.23, p<0.01; enter: beta = -0.20, p<0.01). Conclusions Our results demonstrate a weak inverse relationship between serum chemerin and CRC survivor QOL. Although it is impossible to determine causality, our findings suggest that serum chemerin levels may have a significant association with CRC survivor QOL. Further prospective studies are required to confirm the clinical significance of our pilot study.	[Lee, Jee-Yon; Lee, Duk-Chul] Yonsei Univ, Coll Med, Dept Family Med, Seoul, South Korea; [Lee, Jee-Yon; Jeon, Justin Y.] CHA Univ, Coll Med, CHA Bundang Med Ctr, Dept Family Med, Seoul, South Korea; [Lee, Mi-Kyung] Yonsei Univ, Dept Sport & Leisure Studies, Sports Med Lab, 250 Seongsan Ro, Seoul, South Korea; [Kim, Nam-Kyu] Yonsei Univ, Dept Gen Surg, Coll Med, Seoul, South Korea; [Chu, Sang-Hui] Yonsei Univ, Coll Nursing, Nursing Policy Res Inst, Biobehav Res Ctr,Dept Clin Nursing Sci, Seoul, South Korea; [Lee, Hye-Sun] Yonsei Univ, Coll Med, Dept Biostat, Seoul, South Korea; [Lee, Ji-Won] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Family Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Pochon Cha University; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Jeon, JY (corresponding author), CHA Univ, Coll Med, CHA Bundang Med Ctr, Dept Family Med, Seoul, South Korea.; Lee, JW (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Family Med, Seoul, South Korea.	indi5645@yuhs.ac; jjeon@yonsei.ac.kr	; Lee, Hye Sun/J-2154-2015	CHU, Sang Hui/0000-0001-6877-5599; Jeon, Justin/0000-0001-7978-4271; LEE, JI WON/0000-0002-2666-4249; Kim, Nam-Kyu/0000-0003-0639-5632; Lee, Duk Chul/0000-0001-9166-1813; Lee, Hye Sun/0000-0001-6328-6948	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning, Republic of Korea [NRF-2013M3A9B6046416]	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning, Republic of Korea	This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning, Republic of Korea (NRF-2013M3A9B6046416). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning, Republic of Korea (NRF-2013M3A9B6046416).	Banas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058709; Berg V, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3215; Bower JE, 2007, BRAIN BEHAV IMMUN, V21, P863, DOI 10.1016/j.bbi.2007.03.013; Bower JE, 2013, J CLIN ONCOL, V31, P1656, DOI 10.1200/JCO.2012.46.2143; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Buechler C, 2014, CELLULAR MOL IMMUNOL; CELLA DF, 1993, J CLIN ONCOL, V11, P570, DOI 10.1200/JCO.1993.11.3.570; Dantzer R, 2008, PSYCHONEUROENDOCRINO, V33, P18, DOI 10.1016/j.psyneuen.2007.10.008; Dranse H., 2016, CHEMERIN SIGNALLING; Fung FY, 2013, LEUKEMIA RES, V37, P274, DOI 10.1016/j.leukres.2012.11.013; Garcia E., 2014, TUTORIAL CORRELATION, V6; Gobert AP, 2016, SCI REP-UK, V6, DOI 10.1038/srep39399; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kaneko K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3475; Konsman JP, 2002, TRENDS NEUROSCI, V25, P154, DOI 10.1016/S0166-2236(00)02088-9; Kulig P, 2011, J IMMUNOL, V187, P1403, DOI 10.4049/jimmunol.1002352; Lertkhachonsuk AA, 2013, LANCET ONCOL, V14, pE497, DOI 10.1016/S1470-2045(13)70350-4; Yang LY, 2006, WORLD J GASTROENTERO, V12, P6741, DOI 10.3748/wjg.v12.i42.6741; Maheshwari A, 2009, AM J PHYSIOL-GASTR L, V297, pG1, DOI 10.1152/ajpgi.90730.2008; Morant R, 1996, CANCER TREAT REV, V22, P117, DOI 10.1016/S0305-7372(96)90073-0; Mukaka MM, 2012, MALAWI MED J, V24, P69; Pachynski RK, 2012, J EXP MED, V209, P1427, DOI 10.1084/jem.20112124; Phipps E, 2008, J EVAL CLIN PRACT, V14, P254, DOI 10.1111/j.1365-2753.2007.00842.x; Rama D, 2011, CELL IMMUNOL, V271, P134, DOI 10.1016/j.cellimm.2011.06.016; Reyes-Gibby CC, 2008, LANCET ONCOL, V9, P777, DOI 10.1016/S1470-2045(08)70197-9; Rich T, 2005, CLIN CANCER RES, V11, P1757, DOI 10.1158/1078-0432.CCR-04-2000; Rigsbee L, 2012, AM J GASTROENTEROL, V107, P1740, DOI 10.1038/ajg.2012.287; Rourke JL, 2013, OBES REV, V14, P245, DOI 10.1111/obr.12009; Schubert C, 2007, BRAIN BEHAV IMMUN, V21, P413, DOI 10.1016/j.bbi.2006.11.004; Takahashi M, 2008, FEBS LETT, V582, P573, DOI 10.1016/j.febslet.2008.01.023; Temple LK, 2005, DIS COLON RECTUM, V48, P1353, DOI 10.1007/s10350-004-0942-z; Vironen JH, 2006, DIS COLON RECTUM, V49, P568, DOI 10.1007/s10350-006-0513-6; Weigert J, 2010, INFLAMM BOWEL DIS, V16, P630, DOI 10.1002/ibd.21091; Wittamer V, 2005, J IMMUNOL, V175, P487, DOI 10.4049/jimmunol.175.1.487; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382	36	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176929	10.1371/journal.pone.0176929	http://dx.doi.org/10.1371/journal.pone.0176929			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475614	Green Published, gold, Green Submitted			2022-12-26	WOS:000400649500029
J	Martinez, ME; Unkart, JT; Tao, L; Kroenke, CH; Schwab, R; Komenaka, I; Gomez, SL				Martinez, Maria Elena; Unkart, Jonathan T.; Tao, Li; Kroenke, Candyce H.; Schwab, Richard; Komenaka, Ian; Gomez, Scarlett Lin			Prognostic significance of marital status in breast cancer survival: A population-based study	PLOS ONE			English	Article							DIURNAL CORTISOL RHYTHM; SOCIAL SUPPORT; IMMIGRANT STATUS; BIRTHPLACE DATA; YOUNG-WOMEN; ASIAN WOMEN; ETHNICITY; QUALITY; CALIFORNIA; MORTALITY	Research shows that married cancer patients have lower mortality than unmarried patients but few data exist for breast cancer. We assessed total mortality associated with marital status, with attention to differences by race/ethnicity, tumor subtype, and neighborhood socioeconomic status (nSES). We included, from the population-based California Cancer Registry, women ages 18 and older with invasive breast cancer diagnosed between 2005 and 2012 with follow-up through December 2013. We estimated mortality rate ratios (MRR) and 95% confidence intervals (CI) for total mortality by nSES, race/ethnicity, and tumor subtype. Among 145,564 breast cancer cases, 42.7% were unmarried at the time of diagnosis. In multivariable-adjusted models, the MRR (95% CI) for unmarried compared to married women was 1.28 (1.24-1.32) for total mortality. Significant interactions were observed by race/ethnicity (P<0.001), tumor subtype (P<0.001), and nSES (P = 0.009). Higher MRRs were observed for non-Hispanic whites and Asians/Pacific Islanders than for blacks or Hispanics, and for HR+/HER2+ tumors than other subtypes. Assessment of interactive effect between marital status and nSES showed that unmarried women living in low SES neighborhoods had a higher risk of dying compared with married women in high SES neighborhoods (MRR = 1.60; 95% CI: 1.53-1.67). Unmarried breast cancer patients have higher total mortality than married patients; the association varies by race/ethnicity, tumor subtype, and nSES. Unmarried status should be further evaluated as a breast cancer prognostic factor. Identification of underlying causes of the marital status associations is needed to design interventions that could improve survival for unmarried breast cancer patients.	[Martinez, Maria Elena; Unkart, Jonathan T.; Schwab, Richard] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA; [Martinez, Maria Elena] Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92103 USA; [Unkart, Jonathan T.] Univ Calif San Diego, Dept Surg, San Diego, CA USA; [Tao, Li; Gomez, Scarlett Lin] Canc Prevent Inst Calif, Fremont, CA USA; [Kroenke, Candyce H.] Kaiser Permanente, Div Res, Oakland, CA USA; [Komenaka, Ian] Maricopa Cty Gen Hosp, Dept Surg, Phoenix, AZ USA; [Gomez, Scarlett Lin] Stanford Canc Inst, Palo Alto, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Cancer Prevention Institute of California; Kaiser Permanente; Maricopa County General Hospital; Stanford Cancer Institute	Martinez, ME (corresponding author), Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA.; Martinez, ME (corresponding author), Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92103 USA.	e8martinez@ucsd.edu	Unkart, Jonathan/AAC-6098-2020; Komenaka, Ian/ABC-5161-2021; Schwab, Richard/AAX-9262-2020	Martinez, Maria Elena/0000-0002-6728-1834; Unkart, Jonathan/0000-0001-9041-5119	Specialized Cancer Center [CA023100-29]; Stanford Cancer Institute; California Department of Public Health [103885]; National Cancer Institute's Surveillance, Epidemiology and End Results Program [HHSN261201000140C]; Centers for Disease Control and Prevention's National Program of Cancer Registries [U58DP003862-01];  [HHSN261201000035C];  [HHSN261201000034C]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U58DP003862] Funding Source: NIH RePORTER	Specialized Cancer Center; Stanford Cancer Institute; California Department of Public Health; National Cancer Institute's Surveillance, Epidemiology and End Results Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Centers for Disease Control and Prevention's National Program of Cancer Registries(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); ; ; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the Specialized Cancer Center Support Grant to the University of California San Diego Moores Cancer Center (CA023100-29) and the Stanford Cancer Institute. The collection of cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; the National Cancer Institute's Surveillance, Epidemiology and End Results Program under contract HHSN261201000140C awarded to the Cancer Prevention Institute of California, contract HHSN261201000035C awarded to the University of Southern California, and contract HHSN261201000034C awarded to the Public Health Institute; and the Centers for Disease Control and Prevention's National Program of Cancer Registries, under agreement U58DP003862-01 awarded to the California Department of Public Health. The ideas and opinions expressed here in are those of the author (s) and endorsement by the State of California, Department of Public Health the National Cancer Institute, and the Centers for Disease Control and Prevention or their Contractors and Subcontractors is not intended nor should be inferred.; The collection of cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; the National Cancer Institute's Surveillance, Epidemiology and End Results Program under contract HHSN261201000140C awarded to the Cancer Prevention Institute of California, contract HHSN261201000035C awarded to the University of Southern California, and contract HHSN261201000034C awarded to the Public Health Institute; and the Centers for Disease Control and Prevention's National Program of Cancer Registries, under agreement U58DP003862-01 awarded to the California Department of Public Health. The ideas and opinions expressed herein are those of the author (s) and endorsement by the State of California, Department of Public Health the National Cancer Institute and the Centers for Disease Control and Prevention or their Contractors and Subcontractors is not intended nor should be inferred.	Aizer AA, 2013, J CLIN ONCOL, V31, P3869, DOI 10.1200/JCO.2013.49.6489; Ali AA, 2014, AM J MANAG CARE, V20, P502; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Bernstein L, 2011, JNCI-J NATL CANCER I, V103, P451, DOI 10.1093/jnci/djr046; Bhuyan SS, 2014, BREAST CANCER RES TR, V146, P221, DOI 10.1007/s10549-014-2992-9; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chen DN, 2015, ONCOTARGET, V6, P12774, DOI 10.18632/oncotarget.3666; Chou AF, 2012, PSYCHO-ONCOLOGY, V21, P125, DOI 10.1002/pon.1863; Clegg LX, 2007, CANCER CAUSE CONTROL, V18, P177, DOI 10.1007/s10552-006-0089-4; Cluze C, 2012, ANN ONCOL, V23, P882, DOI 10.1093/annonc/mdr330; Elmore L, 2015, J SURG RES, V199, P90, DOI 10.1016/j.jss.2015.04.012; Epplein M, 2011, J CLIN ONCOL, V29, P406, DOI 10.1200/JCO.2010.30.6951; Gomez SL, 2006, CANCER CAUSE CONTROL, V17, P771, DOI 10.1007/s10552-006-0013-y; Gomez SL, 2016, CANCER-AM CANCER SOC, V122, P1618, DOI 10.1002/cncr.29885; Gomez SL, 2010, AM J PUBLIC HEALTH, V100, P861, DOI 10.2105/AJPH.2009.176651; Gomez SL, 2010, AM J PUBLIC HEALTH, V100, pS125, DOI 10.2105/AJPH.2009.163931; Gomez SL, 2005, CANCER CAUSE CONTROL, V16, P713, DOI 10.1007/s10552-005-0694-7; Gomez SL, 2004, ETHNIC DIS, V14, P292; Gomez SL, 2004, CANCER CAUSE CONTROL, V15, P243, DOI 10.1023/B:CACO.0000024244.91775.64; Gomez SL, 2003, AM J PUBLIC HEALTH, V93, P1685, DOI 10.2105/AJPH.93.10.1685; GOODWIN JS, 1987, JAMA-J AM MED ASSOC, V258, P3125, DOI 10.1001/jama.258.21.3125; Hawley ST, 2009, JNCI-J NATL CANCER I, V101, P1337, DOI 10.1093/jnci/djp271; Hinzey A, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0700-x; Keegan THM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-603; Keegan THM, 2010, CANCER EPIDEM BIOMAR, V19, P1208, DOI 10.1158/1055-9965.EPI-10-0021; Kravdal O, 2001, SOC SCI MED, V52, P357, DOI 10.1016/S0277-9536(00)00139-8; Kroenke CH, 2013, BREAST CANCER RES TR, V139, P515, DOI 10.1007/s10549-013-2477-2; Kroenke CH, 2013, BREAST CANCER RES TR, V137, P261, DOI 10.1007/s10549-012-2253-8; Kroenke CH, 2006, J CLIN ONCOL, V24, P1105, DOI 10.1200/JCO.2005.04.2846; Kroenke CH, 2016, PSYCHOONCOLOGY; Lai H, 1999, INT J BEHAV MED, V6, P150, DOI 10.1207/s15327558ijbm0602_4; Lutgendorf SK, 2011, PSYCHOSOM MED, V73, P724, DOI 10.1097/PSY.0b013e318235be76; Manzoli L, 2007, SOC SCI MED, V64, P77, DOI 10.1016/j.socscimed.2006.08.031; Martinez ME, 2016, CANCER-AM CANCER SOC, V122, P1570, DOI 10.1002/cncr.29886; Osborne C, 2005, BREAST CANCER RES TR, V93, P41, DOI 10.1007/s10549-005-3702-4; Parikh DA, 2015, INT J BREAST CANCER, V2015, DOI 10.1155/2015/835074; Patel K, 2014, J COMMUN HEALTH, V39, P943, DOI 10.1007/s10900-014-9834-x; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pinquart M, 2010, CRIT REV ONCOL HEMAT, V75, P122, DOI 10.1016/j.critrevonc.2009.06.003; Rendall MS, 2011, DEMOGRAPHY, V48, P481, DOI 10.1007/s13524-011-0032-5; Ro A, 2015, SOC SCI MED, V144, P39, DOI 10.1016/j.socscimed.2015.09.001; Sephton SE, 2013, BRAIN BEHAV IMMUN, V30, pS163, DOI 10.1016/j.bbi.2012.07.019; Sephton SE, 2000, J NATL CANCER I, V92, P994, DOI 10.1093/jnci/92.12.994; Shelton RC, 2013, BREAST CANCER RES TR, V137, P817, DOI 10.1007/s10549-012-2370-4; Thompson AS, 2016, J MULTILING MULTICUL, V37, P115, DOI 10.1080/01434632.2015.1031136; U. S. Census Bureau, 2016, FAM LIV ARR; Waite LJ, 2003, POPUL DEV REV, V29, P255, DOI 10.1111/j.1728-4457.2003.00255.x; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yang J., 2014, DEV AREA BASED SOCIO; Yost K, 2001, CANCER CAUSE CONTROL, V12, P703, DOI 10.1023/A:1011240019516	50	47	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0175515	10.1371/journal.pone.0175515	http://dx.doi.org/10.1371/journal.pone.0175515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SX	28475579	Green Published, gold, Green Submitted			2022-12-26	WOS:000400649500003
J	Rosa, M; Roberts, CJ; Rodrigues, MA				Rosa, Monica; Roberts, Christopher J.; Rodrigues, Miguel A.			Connecting high-temperature and low-temperature protein stability and aggregation	PLOS ONE			English	Article							NUCLEATED-POLYMERIZATION MODEL; LUMRY-EYRING MODELS; COLD DENATURATION; ALPHA-CHYMOTRYPSINOGEN; NONNATIVE AGGREGATION; ACTIVATION-ENERGIES; COMPETING GROWTH; SHELF-LIFE; KINETICS; MECHANISMS	Protein aggregation is a long-standing problem for preservation of proteins in both laboratory settings and for commercial biotechnology products. It is well established that heating (cooling) can accelerate (slow) aggregation by populating (depopulating) unfolded or partially unfolded monomer states that are key intermediates in aggregation processes. However, there is a long-standing question of whether the same mechanism(s) that lead to aggregation under high-temperature stress are relevant for low-temperature stress such as in refrigerated or supercooled liquids. This report shows the first direct comparison of "hot" and "cold" aggregation kinetics and folding/unfolding thermodynamics, using bovine hemoglobin as a model system. The results suggest that the same mechanism for non-native aggregation holds from "hot" to "cold" temperatures, with an aggregation temperature-of-maximum-stability slightly below 0 degrees C. This highlights that sub-zero temperatures can induce cold-mediated aggregation, even in the absence of freezing stresses. From a practical perspective, the results suggests the possibility that cold-stress may be a useful alternative to heat-stress for extrapolating predictions of protein shelf life at refrigerated conditions, as well as providing a foundation for more mechanistic studies of cold-stress conditions in future work. A comparison between isochoric and isobaric methods is also briefly discussed.	[Rosa, Monica; Rodrigues, Miguel A.] Univ Lisbon, Ctr Quim Estrutural, Inst Super Tecn, Dept Chem Engn, Lisbon, Portugal; [Roberts, Christopher J.] Univ Delaware, Dept Chem & Biomol Engn, Newark, DE USA	Universidade de Lisboa; Instituto Superior Tecnico; University of Delaware	Rodrigues, MA (corresponding author), Univ Lisbon, Ctr Quim Estrutural, Inst Super Tecn, Dept Chem Engn, Lisbon, Portugal.	miguelrodrigues@tecnico.ulisboa.pt	Rodrigues, Miguel/H-9329-2012	Rodrigues, Miguel/0000-0001-9841-441X	Fundacao para a Ciencia e Tecnologia (Portugal) [PTDC/EQU-EQU/104318/2008, PTDC/QUI-BIQ/119677/2010, SFRH/BD/79046/2011, IF/01183/2013]; National Science Foundation [NSF-CBET1264329]; National Institute of Standards and Technology [NIST 70NANB12H239]; National Institutes of Health [R01 EB006006]	Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); National Science Foundation(National Science Foundation (NSF)); National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Fundacao para a Ciencia e Tecnologia (Portugal) PTDC/EQU-EQU/104318/2008, PTDC/QUI-BIQ/119677/2010, SFRH/BD/79046/2011 and IF/01183/2013. CJR gratefully acknowledges support from the National Science Foundation (NSF-CBET1264329), National Institute of Standards and Technology (NIST 70NANB12H239), and National Institutes of Health (R01 EB006006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JM, 2008, BIOCHEMISTRY-US, V47, P2397, DOI 10.1021/bi7019244; Andrews JM, 2007, J PHYS CHEM B, V111, P7897, DOI 10.1021/jp070212j; Andrews JM, 2007, BIOCHEMISTRY-US, V46, P7558, DOI 10.1021/bi700296f; BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; Bhatnagar BS, 2007, PHARM DEV TECHNOL, V12, P505, DOI 10.1080/10837450701481157; Brummitt RK, 2011, J PHARM SCI-US, V100, P2104, DOI 10.1002/jps.22447; CLELAND JL, 1993, CRIT REV THER DRUG, V10, P307; Debenedetti P.G., 1996, METASTABLE LIQUIDS C; Drenski MF, 2013, ANAL BIOCHEM, V437, P185, DOI 10.1016/j.ab.2013.02.014; Englander SW, 2014, P NATL ACAD SCI USA, V111, P15873, DOI 10.1073/pnas.1411798111; Franks F, 2003, BIOPHYS CHEM, V105, P251, DOI 10.1016/S0301-4622(03)00074-7; Hummer G, 1998, P NATL ACAD SCI USA, V95, P1552, DOI 10.1073/pnas.95.4.1552; Kayser V, 2011, J PHARM SCI-US, V100, P2526, DOI 10.1002/jps.22493; Lazar KL, 2010, MABS-AUSTIN, V2, P42, DOI 10.4161/mabs.2.1.10787; Lefebvre BG, 2003, BIOTECHNOL BIOENG, V82, P595, DOI 10.1002/bit.10607; Li Y, 2010, J PHARM SCI-US, V99, P645, DOI 10.1002/jps.21869; Li Y, 2009, J PHYS CHEM B, V113, P7020, DOI 10.1021/jp8083088; Pastore A, 2007, J AM CHEM SOC, V129, P5374, DOI 10.1021/ja0714538; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Roberts CJ, 2014, TRENDS BIOTECHNOL, V32, P372, DOI 10.1016/j.tibtech.2014.05.005; Roberts CJ, 2011, INT J PHARMACEUT, V418, P318, DOI 10.1016/j.ijpharm.2011.03.064; Roberts CJ, 2003, J PHARM SCI-US, V92, P1095, DOI 10.1002/jps.10377; Roberts CJ, 2003, J PHYS CHEM B, V107, P1194, DOI 10.1021/jp026827s; Rosa M, 2013, J PHYS CHEM B, V117, P8939, DOI 10.1021/jp4035369; Saluja A, 2014, PHARM RES; SANCHEZRUIZ JM, 1992, BIOPHYS J, V61, P921, DOI 10.1016/S0006-3495(92)81899-4; Seefeldt MB, 2004, PROTEIN SCI, V13, P2639, DOI 10.1110/ps.04891204; Szyperski T, 2006, EUR BIOPHYS J BIOPHY, V35, P363, DOI 10.1007/s00249-005-0028-4; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Wang W, 2005, INT J PHARMACEUT, V289, P1, DOI 10.1016/j.ijpharm.2004.11.014; Wang W, 2013, AAPS J, V15, P840, DOI 10.1208/s12248-013-9485-3	31	31	32	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176748	10.1371/journal.pone.0176748	http://dx.doi.org/10.1371/journal.pone.0176748			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472066	gold, Green Published, Green Submitted			2022-12-26	WOS:000400648500067
J	Antonioletti, M; Biktashev, VN; Jackson, A; Kharche, SR; Stary, T; Biktasheva, IV				Antonioletti, Mario; Biktashev, Vadim N.; Jackson, Adrian; Kharche, Sanjay R.; Stary, Tomas; Biktasheva, Irina V.			BeatBox-HPC simulation environment for biophysically and anatomically realistic cardiac electrophysiology	PLOS ONE			English	Article							ELECTRICAL-ACTIVITY; MODEL; PROPAGATION; MECHANISMS; WAVES; MONODOMAIN; DYNAMICS; TISSUE	The BeatBox simulation environment combines flexible script language user interface with the robust computational tools, in order to setup cardiac electrophysiology in-silico experiments without re-coding at low-level, so that cell excitation, tissue/anatomy models, stimulation protocols may be included into a BeatBox script, and simulation run either sequentially or in parallel (MPI) without re-compilation. BeatBox is a free software written in C language to be run on a Unix-based platform. It provides the whole spectrum of multi scale tissue modelling from 0-dimensional individual cell simulation, 1-dimensional fibre, 2-dimensional sheet and 3-dimensional slab of tissue, up to anatomically realistic whole heart simulations, with run time measurements including cardiac re-entry tip/filament tracing, ECG, local/global samples of any variables, etc. BeatBox solvers, cell, and tissue/anatomy models repositories are extended via robust and flexible interfaces, thus providing an open framework for new developments in the field. In this paper we give an overview of the BeatBox current state, together with a description of the main computational methods and MPI parallelisation approaches.	[Antonioletti, Mario; Jackson, Adrian] Univ Edinburgh, EPCC, Edinburgh, Midlothian, Scotland; [Biktashev, Vadim N.; Kharche, Sanjay R.; Stary, Tomas; Biktasheva, Irina V.] Univ Exeter, CEMPS, Exeter, Devon, England; [Biktashev, Vadim N.] Univ Exeter, EPSRC Ctr Predict Modelling Healthcare, Exeter, Devon, England; [Kharche, Sanjay R.] Univ Manchester, Sch Med Sci, Inst Cardiovasc Sci, Manchester, Lancs, England; [Biktasheva, Irina V.] Univ Liverpool, Dept Comp Sci, Liverpool, Merseyside, England	University of Edinburgh; University of Exeter; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of Exeter; University of Manchester; University of Liverpool	Biktasheva, IV (corresponding author), Univ Exeter, CEMPS, Exeter, Devon, England.; Biktasheva, IV (corresponding author), Univ Liverpool, Dept Comp Sci, Liverpool, Merseyside, England.	ivb@liv.ac.uk	Kharche, Sanjay Ram/I-2130-2014	Kharche, Sanjay Ram/0000-0002-2634-4894; Biktasheva, Irina/0000-0003-2906-2881; Jackson, Adrian/0000-0003-0073-682X	Engineering and Physical Sciences Research Council (UK) [EP/1029664, EP/N014391/1, EP/P008690/1]; EPSRC (UK) [EP/1029664, EP/N014391/1, EP/P008690/1]; EPSRC [EP/E018548/1, EP/I030158/1, EP/I029664/1, EP/D074789/1, EP/P008690/1, EP/I029664/2, EP/N014391/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I029664/2, EP/I029664/1, EP/D500338/1, EP/I030158/1, EP/D074789/1, EP/P008690/1, EP/N014391/1, EP/E018548/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Engineering and Physical Sciences Research Council (UK), https://www.epsrc.ac.uk/, supported the recent HPC development of the BeatBox cardiac simulation environment, including design, data collection and analysis, submission of the manuscript; grant number EP/1029664, VNB, IVB. Engineering and Physical Sciences Research Council (UK), htips://www.epsrc.ac.uk/, supported development of the BeatBox cardiac simulation environment, including design, data collection and analysis, submission of the manuscript; grant number EP/N014391/1, VNB. Engineering and Physical Sciences Research Council (UK), htips:// www.epsrc.ac.uk/, supported development of the BeatBox cardiac simulation environment, including design, data collection and analysis, submission of the manuscript; grant number EP/P008690/1, IVB.; The human atrium DT-MRI data sets used in BeatBox simulation presented in Fig 9 were provided by G. Seemann et al. [61]. The human foetal heart DT-MRI data sets used in BeatBox simulation presented in Fig 10 were provided by E. Pervolaraki et al. [71]. The recent development of BeatBox was supported by EPSRC grant EP/1029664 (UK). VNB gratefully acknowledges the current financial support of the EPSRC via grant EP/N014391/1 (UK). IVB gratefully acknowledges the current financial support of the EPSRC via grant EP/P008690/1 (UK).	Aranson IS, 2002, REV MOD PHYS, V74, P99, DOI 10.1103/RevModPhys.74.99; Ayachit U., 2015, PARAVIEW GUIDE PARAL, DOI 10.5555/2789330; BARKLEY D, 1991, PHYSICA D, V49, P61, DOI 10.1016/0167-2789(91)90194-E; Barkley D., 2007, CODE SIMULATING SPIR; Barkley D, 2007, EZ SCROLL CODE SIMUL; BEELER GW, 1977, J PHYSIOL-LONDON, V268, P177, DOI 10.1113/jphysiol.1977.sp011853; Biktashev VN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024388; Biktashev VN, 1998, INT J BIFURCAT CHAOS, V8, P677, DOI 10.1142/S0218127498000474; BIKTASHEV VN, 1994, PHILOS T R SOC A, V347, P611, DOI 10.1098/rsta.1994.0070; Biktashev VN, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.168102; BIKTASHEV VN, 1994, J THEOR BIOL, V169, P101, DOI 10.1006/jtbi.1994.1132; Biktashev VN, 2016, BEATBOX; Biktashev VN, 2016, BEATBOX HPC ENV BIOP; Biktasheva IV, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.068302; Biktasheva IV, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026221; Biktasheva IV, 2003, INT J BIFURCAT CHAOS, V13, P3645, DOI 10.1142/S0218127403008909; Bishop MJ, 2011, IEEE T BIO-MED ENG, V58, P1066, DOI 10.1109/TBME.2010.2096425; Bishop MJ, 2010, AM J PHYSIOL-HEART C, V298, pH699, DOI 10.1152/ajpheart.00606.2009; Clancy CE, 1999, NATURE, V400, P566, DOI 10.1038/23034; Clayton RH, 2008, PROG BIOPHYS MOL BIO, V96, P19, DOI 10.1016/j.pbiomolbio.2007.07.004; Clayton RH, 2011, PROG BIOPHYS MOL BIO, V104, P22, DOI 10.1016/j.pbiomolbio.2010.05.008; Clerx M, 2016, PROG BIOPHYS MOL BIO, V120, P100, DOI 10.1016/j.pbiomolbio.2015.12.008; Colli-Franzone P, 2005, MATH BIOSCI, V197, P35, DOI 10.1016/j.mbs.2005.04.003; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; Dowle M, 1997, INT J BIFURCAT CHAOS, V7, P2529, DOI 10.1142/S0218127497001692; Fenton F, 1998, CHAOS, V8, P20, DOI 10.1063/1.166311; Fenton FH, 2005, CHAOS, V15, DOI 10.1063/1.1840311; Fenton FH, 2002, CHAOS, V12, P852, DOI 10.1063/1.1504242; Fink M, 2011, PROG BIOPHYS MOL BIO, V104, P2, DOI 10.1016/j.pbiomolbio.2010.03.002; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Gomes JM, 2015, IEEE T BIO-MED ENG, V62, P600, DOI 10.1109/TBME.2014.2361325; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hundsdorfer WH., 2003, NUMERICAL SOLUTION T; Hunter P, 2012, INTERACTIVE COMPUTER; Karypis G, 2013, METIS A SOFTWARE PAC; Kharche SR, 2015, LECT NOTES COMPUT SC, V9126, P421, DOI 10.1007/978-3-319-20309-6_48; Kharche SR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/731386; Land S, 2015, P ROY SOC A-MATH PHY, V471, DOI 10.1098/rspa.2015.0641; LaSalle D, 2015, 5 WORKSH IRR APPL AR, pa14; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; McCulloch A, 2010, CONTINUITY 6 D PROBL; McFarlane R, 2008, COMP SCI BSC INT AC, P99; McFarlane R., 2010, HIGH PERFORMANCE COM; MCKEAN HP, 1970, ADV MATH, V4, P209, DOI 10.1016/0001-8708(70)90023-X; Montani C., 1994, Visual Computer, V10, P353, DOI 10.1007/BF01900830; NAGUMO J, 1962, P IRE, V50, P2061, DOI 10.1109/JRPROC.1962.288235; Nash MP, 2004, PROG BIOPHYS MOL BIO, V85, P501, DOI 10.1016/j.pbiomolbio.2004.01.016; Nichols M., 2012, EUROPEAN CARDIOVASCU; Nicolis G., 2007, SCHOLARPEDIA, V2, P1475, DOI [10.4249/scholarpedia.1475, DOI 10.4249/SCHOLARPEDIA.1475]; Niederer SA, 2011, PHILOS T R SOC A, V369, P4331, DOI 10.1098/rsta.2011.0139; Nielsen BF, 2007, APPL MATH COMPUT, V184, P276, DOI 10.1016/j.amc.2006.05.158; Noble D, 2002, P NATL ACAD SCI USA, V99, P5755, DOI 10.1073/pnas.102171699; Nordsletten DA, 2011, PROG BIOPHYS MOL BIO, V104, P77, DOI 10.1016/j.pbiomolbio.2009.11.001; Pervolaraki E, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0065; Pitt-Francis J, 2008, PHILOS T R SOC A, V366, P3111, DOI 10.1098/rsta.2008.0096; Poskanzer J, 2014, NETPBM; Potse M, 2006, IEEE T BIO-MED ENG, V53, P2425, DOI 10.1109/TBME.2006.880875; Roberts SF, 2008, BIOPHYS J, V95, P3724, DOI 10.1529/biophysj.108.137349; RUSH S, 1978, IEEE T BIO-MED ENG, V25, P389, DOI 10.1109/TBME.1978.326270; Saucerman JJ, 2004, PROG BIOPHYS MOL BIO, V85, P261, DOI 10.1016/j.pbiomolbio.2004.01.005; SCHLOGL F, 1972, Z PHYS, V253, P147, DOI 10.1007/BF01379769; Scott L. Ridgway, 2011, NUMERICAL ANAL; Seemann G, 2006, PHILOS T R SOC A, V364, P1465, DOI 10.1098/rsta.2006.1781; Stary T, 2015, IEEE T BIO-MED ENG, V62, P1070, DOI 10.1109/TBME.2014.2366466; Stinstra Jg, 2006, Comput Cardiol, V33, P41; STRANG G, 1968, SIAM J NUMER ANAL, V5, P506, DOI 10.1137/0705041; Sundnes J, 2009, IEEE T BIO-MED ENG, V56, P2546, DOI 10.1109/TBME.2009.2014739; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Trayanova Natalia, 2011, IEEE Rev Biomed Eng, V4, P89, DOI 10.1109/RBME.2011.2173761; Veldkamp MW, 2000, CIRC RES, V86, pE91, DOI 10.1161/01.RES.86.9.e91; Vigmond EJ, 2003, J ELECTROCARDIOL, V36, P69, DOI 10.1016/j.jelectrocard.2003.09.017; Walker MA, 2016, BIOPHYS J, V110, P1038, DOI 10.1016/j.bpj.2015.12.041; Walton J., 2003, VISUALIZATION HDB, P633; Waters SL, 2011, PROG BIOPHYS MOL BIO, V104, P49, DOI 10.1016/j.pbiomolbio.2010.10.001; Winfree AT, 1991, CHAOS, V1; ZELDOVICH YB, 1938, DOKL AKAD NAUK SSSR, V19, P693, DOI DOI 10.1016/0010-2180(59)90007-0; Zipes DP, 2014, CARDIAC ELECTROPHYSI	79	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0172292	10.1371/journal.pone.0172292	http://dx.doi.org/10.1371/journal.pone.0172292			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467407	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000400647000002
J	Gattringer, JP; Donath, TW; Eckstein, RL; Ludewig, K; Otte, A; Harvolk-Schoning, S				Gattringer, Johannes P.; Donath, Tobias W.; Eckstein, R. Lutz; Ludewig, Kristin; Otte, Annette; Harvolk-Schoening, Sarah			Flooding tolerance of four floodplain meadow species depends on age	PLOS ONE			English	Article							SOIL SEED BANK; CLIMATE-CHANGE; DISTRIBUTION PATTERNS; WATER-LEVEL; LAND-USE; IMPACT; PLANTS; RHINE; RESTORATION; VEGETATION	Numerous restoration campaigns focused on re-establishing species-rich floodplain meadows of Central Europe, whose species composition is essentially controlled by regular flooding. Climate change predictions expect strong alterations on the discharge regime of Europe's large rivers with little-known consequences on floodplain meadow plants. In this study, we aim to determine the effects of flooding on seedlings of different ages of four typical flood meadow species. To this end, we flooded seedlings of two familial pairs of flood meadow species of wetter and dryer microhabitats for 2 weeks each, starting 2, 4, 6, and 8 weeks after seedling germination, respectively. We show that a 2-week-flooding treatment had a negative effect on performance of seedlings younger than 6 weeks. Summer floods with high floodwater temperatures may have especially detrimental effects on seedlings, which is corroborated by previous findings. As expected, the plants from wet floodplain meadow microhabitats coped better with the flooding treatment than those from dryer microhabitats. In conclusion, our results suggest that restoration measures may perform more successfully if seedlings of restored species are older than the critical age of about 6 weeks before a spring flooding begins. Seasonal flow patterns may influence vegetation dynamics of floodplain meadows and should, therefore, be taken into account when timing future restoration campaigns.	[Gattringer, Johannes P.; Ludewig, Kristin; Otte, Annette; Harvolk-Schoening, Sarah] Justus Liebig Univ Giessen, Res Ctr Biosyst Land Use & Nutr IFZ, Div Landscape Ecol & Landscape Planning, Giessen, Germany; [Donath, Tobias W.] Univ Kiel, Inst Nat Resource Conservat, Dept Landscape Ecol, Kiel, Germany; [Eckstein, R. Lutz] Karlstad Univ, Dept Environm & Life Sci Biol, Karlstad, Sweden	Justus Liebig University Giessen; University of Kiel; Karlstad University	Gattringer, JP (corresponding author), Justus Liebig Univ Giessen, Res Ctr Biosyst Land Use & Nutr IFZ, Div Landscape Ecol & Landscape Planning, Giessen, Germany.	johannes.gattringer@umweit.uni-giessen.de	Donath, Tobias W./B-2856-2012; Ludewig, Kristin/X-4204-2019; Eckstein, Lutz/A-9241-2012	Donath, Tobias W./0000-0003-1874-1096; Ludewig, Kristin/0000-0003-2665-2712; Gattringer, Johannes/0000-0003-4865-2430	Deutsche Bundesstiftung Umwelt DBU [31612/01]	Deutsche Bundesstiftung Umwelt DBU	This research was funded by the Deutsche Bundesstiftung Umwelt DBU (Project No. 31612/01; www.dbu.de). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2009, VEGETATION ECOLOGY C; [Anonymous], 2001, DESIGN ANAL ECOLOGIC; Asselman NEM, 2003, HYDROL PROCESS, V17, P3225, DOI 10.1002/hyp.1384; BEARD JB, 1970, AGRON J, V62, P257, DOI 10.2134/agronj1970.00021962006200020024x; Brunotte E, 2009, NATURSCHUTZ BIOL VIE, V87; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; Burkart M, 2001, GLOBAL ECOL BIOGEOGR, V10, P449, DOI 10.1046/j.1466-822x.2001.00270.x; Burkart M, 2004, SYNOP PFLANZENGESELL, P1; Crawley MJ, 2013, R BOOK, P557; Donath TW, 2007, BIOL CONSERV, V138, P224, DOI 10.1016/j.biocon.2007.04.020; Ellenberg H., 1991, SCR GEOBOT, DOI DOI 10.1002/FEDR.19931040323; Eriksson Ove, 2008, P239; Fay MP, 2010, J STAT SOFTW, V36, P1; Gitzendanner MA, 2000, AM J BOT, V87, P783, DOI 10.2307/2656886; Goldberg D.E., 2001, DESIGN ANAL EXPT, P77; Greet J, 2011, FRESHWATER BIOL, V56, P1231, DOI 10.1111/j.1365-2427.2011.02564.x; Groom M.J., 2006, PRINCIPLES CONSERVAT; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Harvolk S, 2015, ECOL ENG, V84, P463, DOI 10.1016/j.ecoleng.2015.09.019; Hidding B, 2014, AQUAT BOT, V113, P83, DOI 10.1016/j.aquabot.2013.11.003; Holzel N, 2004, PLANT ECOL, V174, P279, DOI 10.1023/B:VEGE.0000049108.04955.e2; Holzel N, 2001, J VEG SCI, V12, P209, DOI 10.2307/3236605; HOSNER JF, 1958, ECOLOGY, V39, P371, DOI 10.2307/1931886; Joyce CB, 1998, LANDSCAPE ECOL SER, P1; Juger E.J., 2017, ROTHMALER EXKURSIONS, DOI 10.1007/978-3-662-49708-1; Jung V, 2009, PLANT ECOL, V201, P589, DOI 10.1007/s11258-008-9508-9; Kalbfleisch JD, 2002, STAT ANAL FAILURE TI, P31, DOI 10.1002/9781118032985.ch2; Kiehl K, 2010, BASIC APPL ECOL, V11, P285, DOI 10.1016/j.baae.2009.12.004; Koike T, 2003, PLANT SOIL, V255, P303, DOI 10.1023/A:1026199402085; Lenssen JPM, 2005, J ECOL, V93, P138, DOI 10.1111/j.1365-2745.2004.00957.x; Lenssen JPM, 1999, AQUAT BOT, V64, P151, DOI 10.1016/S0304-3770(99)00012-1; Leyer I, 2005, J APPL ECOL, V42, P239, DOI 10.1111/j.1365-2664.2005.01009.x; Leyer I, 2006, J VEG SCI, V17, P407, DOI 10.1111/j.1654-1103.2006.tb02461.x; Ludewig K, 2014, FLORA, V209, P446, DOI 10.1016/j.flora.2014.04.006; MAHONEY JM, 1992, FOREST ECOL MANAG, V54, P141, DOI 10.1016/0378-1127(92)90009-X; Malanson G.P., 1993, RIPARIAN LANDSCAPES; Mathar W, 2015, J VEG SCI, V26, P480, DOI 10.1111/jvs.12254; Mauchamp A, 2001, AQUAT BOT, V69, P147, DOI 10.1016/S0304-3770(01)00135-8; Merlin A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130152; Middelkoop H, 2001, CLIMATIC CHANGE, V49, P105, DOI 10.1023/A:1010784727448; Mommer L, 2005, ANN BOT-LONDON, V96, P581, DOI 10.1093/aob/mci212; Mosner E, 2015, ECOL ENG, V82, P493, DOI 10.1016/j.ecoleng.2015.05.013; Nabben RHM, 1999, NEW PHYTOL, V144, P313, DOI 10.1046/j.1469-8137.1999.00519.x; NAIMAN RJ, 1993, ECOL APPL, V3, P209, DOI 10.2307/1941822; Rapacz M, 2014, PLANT SCI, V225, P34, DOI 10.1016/j.plantsci.2014.05.009; Riecken U., 2006, NATURSCHUTZ BIOL VIE, V34, P1, DOI DOI 10.1002/9783527678471; Schipper AM, 2011, ENVIRON POLLUT, V159, P182, DOI 10.1016/j.envpol.2010.09.006; Schmiede R, 2009, BIOL CONSERV, V142, P404, DOI 10.1016/j.biocon.2008.11.001; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stammel Barbara, 2012, River Systems, V20, P55, DOI 10.1127/1868-5749/2011/020-0033; Stocker T. F., 2013, PHYS SCI BASIS CONTR; Sun JG, 1996, STAT MED, V15, P1387, DOI 10.1002/(SICI)1097-0258(19960715)15:13&lt;1387::AID-SIM268&gt;3.0.CO;2-R; Tanuwidjaja D., 2010, WATER QUALITY TECHNO; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; Tockner K, 2010, FRESHWATER BIOL, V55, P135, DOI 10.1111/j.1365-2427.2009.02371.x; van Eck WHJM, 2006, HYDROBIOLOGIA, V565, P59, DOI 10.1007/s10750-005-1905-7; van Eck WHJM, 2004, OIKOS, V107, P393, DOI 10.1111/j.0030-1299.2004.13083.x; Vervuren PJA, 2003, J ECOL, V91, P135, DOI 10.1046/j.1365-2745.2003.00749.x; Weiland FCS, 2012, HYDROL EARTH SYST SC, V16, P1047, DOI 10.5194/hess-16-1047-2012; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	69	13	14	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176869	10.1371/journal.pone.0176869	http://dx.doi.org/10.1371/journal.pone.0176869			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467463	Green Published, Green Submitted, gold			2022-12-26	WOS:000400647000081
J	Arribas-Bel, D; Patino, JE; Duque, JC				Arribas-Bel, Daniel; Patino, Jorge E.; Duque, Juan C.			Remote sensing-based measurement of Living Environment Deprivation: Improving classical approaches with machine learning	PLOS ONE			English	Article							QUALITY-OF-LIFE; URBAN GREEN SPACE; SURFACE-TEMPERATURE; SATELLITE IMAGERY; RESIDENTIAL LAND; GOOGLE EARTH; CENSUS-DATA; POVERTY; NEIGHBORHOOD; VEGETATION	This paper provides evidence on the usefulness of very high spatial resolution (VHR) imagery in gathering socioeconomic information in urban settlements. We use land cover, spectral, structure and texture features extracted from a Google Earth image of Liverpool (UK) to evaluate their potential to predict Living Environment Deprivation at a small statistical area level. We also contribute to the methodological literature on the estimation of socioeconomic indices with remote-sensing data by introducing elements from modern machine learning. In addition to classical approaches such as Ordinary Least Squares (OLS) regression and a spatial lag model, we explore the potential of the Gradient Boost Regressor and Random Forests to improve predictive performance and accuracy. In addition to novel predicting methods, we also introduce tools for model interpretation and evaluation such as feature importance and partial dependence plots, or cross-validation. Our results show that Random Forest proved to be the best model with an R-2 of around 0.54, followed by Gradient Boost Regressor with 0.5. Both the spatial lag model and the OLS fall behind with significantly lower performances of 0.43 and 0.3, respectively.	[Arribas-Bel, Daniel] Univ Liverpool, Dept Geog & Planning, Liverpool, Merseyside, England; [Patino, Jorge E.; Duque, Juan C.] Univ EAFIT, Dept Econ, Res Spatial Econ RiSE Grp, Medellin, Colombia	University of Liverpool; Universidad EAFIT	Arribas-Bel, D (corresponding author), Univ Liverpool, Dept Geog & Planning, Liverpool, Merseyside, England.	D.Arribas-Bel@liverpool.ac.uk	Duque, Juan C./AAC-3331-2019; Patino, Jorge E./AAB-6129-2020; Arribas-Bel, Daniel/K-8105-2017	Duque, Juan C./0000-0002-4016-681X; Patino, Jorge E./0000-0002-1591-9138; Arribas-Bel, Daniel/0000-0002-6274-1619				Allen R. G., 1998, FAO Irrigation and Drainage Paper; Anselin L., 2014, MODERN SPATIAL ECONO; Arraiz I, 2010, J REGIONAL SCI, V50, P592, DOI 10.1111/j.1467-9787.2009.00618.x; Balaguer A, 2010, COMPUT GEOSCI-UK, V36, P231, DOI 10.1016/j.cageo.2009.05.003; Balaguer-Beser A, 2013, COMPUT GEOSCI-UK, V50, P115, DOI 10.1016/j.cageo.2012.08.001; Barrett M, 2005, STUD DEV PSYCHOL, P1; Barros M., 2008, EC DRUG USAGE IRISH, P1; Baud I, 2010, INT J APPL EARTH OBS, V12, P359, DOI 10.1016/j.jag.2010.04.008; Besussi E, 2010, REMOTE SENS DIGIT IM, V10, P13, DOI 10.1007/978-1-4020-4385-7_2; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cabrera-Barona P, 2016, APPL GEOGR, V70, P1, DOI 10.1016/j.apgeog.2016.02.009; Carrier M, 2016, ANN AM ASSOC GEOGR, V106, P1268, DOI 10.1080/24694452.2016.1197766; Chen J, 2015, HABITAT INT, V46, P101, DOI 10.1016/j.habitatint.2014.11.002; Cho SH, 2006, J AGR RESOUR ECON, V31, P485; Duncan Dustin T, 2014, Spat Demogr, V2, P1, DOI 10.1007/BF03354902; Duncan DT, 2012, DEMOGR RES, V26, P409, DOI 10.4054/DemRes.2012.26.17; Duque JC, 2013, QUANTIFYING SLUMNESS; Duque JC, 2015, LANDSCAPE URBAN PLAN, V135, P11, DOI 10.1016/j.landurbplan.2014.11.009; Duque JC, 2012, J REGIONAL SCI, V52, P397, DOI 10.1111/j.1467-9787.2011.00743.x; Emmanuel R, 1997, ENVIRON PLANN B, V24, P415, DOI 10.1068/b240415; Engstrom R, 2015, INT GEOSCI REMOTE SE, P2544, DOI 10.1109/IGARSS.2015.7326330; FORSTER B, 1983, PHOTOGRAMM ENG REM S, V49, P1693; Gelman A., 2007, DATA ANAL USING REGR, DOI 10.1017/CBO9780511790942; Grace K, 2016, ANN AM ASSOC GEOGR, V4452, P1; Gupta K, 2012, LANDSCAPE URBAN PLAN, V105, P325, DOI 10.1016/j.landurbplan.2012.01.003; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hofmann P., 2008, DETECTING INFORMAL S, P531, DOI DOI 10.1007/978-3-540-77058-9_29; Holt James B, 2007, PREVENTING CHRONIC D, V4, P1; Hu Q, 2013, REMOTE SENS-BASEL, V5, P6026, DOI 10.3390/rs5116026; Hu SG, 2016, APPL GEOGR, V68, P48, DOI 10.1016/j.apgeog.2016.01.006; Huang X, 2015, IEEE T GEOSCI REMOTE, V53, P3639, DOI 10.1109/TGRS.2014.2380779; Jain S, 2008, INT J APPL EARTH OBS, V10, P109, DOI 10.1016/j.jag.2007.10.008; James G., 2014, INTRO STAT LEARNING; Janhall S, 2015, ATMOS ENVIRON, V105, P130, DOI 10.1016/j.atmosenv.2015.01.052; Jean N, 2016, SCIENCE, V353, P790, DOI 10.1126/science.aaf7894; Jenerette GD, 2007, LANDSCAPE ECOL, V22, P353, DOI 10.1007/s10980-006-9032-z; Jensen R, 2004, ECOL SOC, V9; Jorgensen A, 2010, NAT CULT, V5, P338, DOI 10.3167/nc.2010.050307; Kelejian HH, 1999, INT ECON REV, V40, P509, DOI 10.1111/1468-2354.00027; Kelejian HH, 1998, J REAL ESTATE FINANC, V17, P99, DOI 10.1023/A:1007707430416; Kelejian HH, 2010, J ECONOMETRICS; Kit O, 2012, APPL GEOGR, V32, P660, DOI 10.1016/j.apgeog.2011.07.016; Kohli D, 2016, J SPAT SCI, V61, P405, DOI 10.1080/14498596.2016.1138247; Kohli D, 2013, REMOTE SENS-BASEL, V5, P4209, DOI 10.3390/rs5094209; Kohli D, 2012, COMPUT ENVIRON URBAN, V36, P154, DOI 10.1016/j.compenvurbsys.2011.11.001; Kuffer M, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8060455; Kuffer M, 2016, IEEE J-STARS, V9, P1830, DOI 10.1109/JSTARS.2016.2538563; Li G, 2007, INT J REMOTE SENS, V28, P249, DOI 10.1080/01431160600735624; Li XJ, 2015, URBAN FOR URBAN GREE, V14, P675, DOI 10.1016/j.ufug.2015.06.006; Lo C. P., 1997, Computers, Environment and Urban Systems, V21, P259, DOI 10.1016/S0198-9715(97)01002-8; Lo CP, 1997, REMOTE SENS ENVIRON, V62, P143, DOI 10.1016/S0034-4257(97)00088-6; Mennis J., 2005, T GIS, V9, P5, DOI DOI 10.1016/J.ADAJ.2018.05.034; Mennis J, 2006, PHOTOGRAMM ENG REM S, V72, P911, DOI 10.14358/PERS.72.8.911; Niebergall S, 2007, 2007 URBAN REMOTE SE, P0; Nilsson P, 2014, LANDSCAPE URBAN PLAN, V121, P45, DOI 10.1016/j.landurbplan.2013.08.017; Noonan DS, 2007, ECON DEV Q, V21, P17, DOI 10.1177/0891242406296326; Office of National Statistics, 2011, CENS GEOGR OV VAR GE; Ogneva-Himmelberger Y, 2009, APPL GEOGR, V29, P478, DOI 10.1016/j.apgeog.2009.03.001; Okwi PO, 2007, P NATL ACAD SCI USA, V104, P16769, DOI 10.1073/pnas.0611107104; Openshaw S, 1984, CATMOG 38, V38; Orford S., 2004, COMPUTERS ENV URBAN, V28, P701, DOI DOI 10.1016/j.compenvurbsys.2003.07.003; Owen KK, 2013, APPL GEOGR, V38, P107, DOI 10.1016/j.apgeog.2012.11.016; Panagopoulos T, 2016, ENVIRON POLLUT, V208, P137, DOI 10.1016/j.envpol.2015.07.038; Patino JE, 2014, APPL GEOGR, V55, P48, DOI 10.1016/j.apgeog.2014.08.016; Patino JE, 2013, COMPUT ENVIRON URBAN, V37, P1, DOI 10.1016/j.compenvurbsys.2012.06.003; Pearsall H, 2012, APPL GEOGR, V35, P257, DOI 10.1016/j.apgeog.2012.07.006; Rajasekar U, 2009, PHOTOGRAMM ENG REM S, V75, P385, DOI 10.14358/PERS.75.4.385; Rashed T, 2007, INTEGRATION GIS REMO, P199; Rashed T, 2006, GIS FOR SUSTAINABLE DEVELOPMENT, P287; Rey S. J., 2010, HDB APPL SPATIAL ANA, P175, DOI [10.1007/978-3-642-03647-7_11, DOI 10.1007/978-3-642-03647-7_11]; Rhinane H., 2011, J GEOGR INF SYST, V3, P217, DOI DOI 10.4236/JGIS.2011.33018; Ruiz LA, 2011, COMPUT ELECTRON AGR, V76, P284, DOI 10.1016/j.compag.2011.02.007; Sandborn A, 2016, IEEE J-STARS, V9, P1970, DOI 10.1109/JSTARS.2016.2519843; Serag E.l., 2012, HBRC J, V9, P86, DOI [10.1016/j.hbrcj.2013.02.007, DOI 10.1016/J.HBRCJ.2013.02.007]; Shekhar S, 2012, INT ARCH PHOTOGRAMM, V39-B8, P519; Sherbinin A.., 2002, THEMATIC GUIDE LAND; Smith T., 2015, ENGLISH INDICES DEPR; Sowunmi FA, 2012, AM J EC, V2, P61; Stasolla M, 2006, P IGARSS06, V30; Steele JE, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2016.0690; Stokes P., 2011, 2011 CENSUS CHARACTE; Stoler J, 2012, GISCI REMOTE SENS, V49, P31, DOI 10.2747/1548-1603.49.1.31; Sykes O, 2013, CITIES, V35, P299, DOI 10.1016/j.cities.2013.03.013; Tapiador FJ, 2011, INT J REMOTE SENS, V32, P6437, DOI 10.1080/01431161.2010.512928; Taubenbock H, 2014, J HOUS BUILT ENVIRON, V29, P15, DOI 10.1007/s10901-013-9333-x; Taubenbock H, 2009, COMPUT ENVIRON URBAN, V33, P179, DOI 10.1016/j.compenvurbsys.2008.09.003; Tooke TR, 2010, ENVIRON PLANN B, V37, P1040, DOI 10.1068/b36044; Voss PR, 2006, POPUL RES POLICY REV, V25, P369, DOI 10.1007/s11113-006-9007-4; Watmough GR, 2016, WORLD DEV, V78, P188, DOI 10.1016/j.worlddev.2015.10.031; WEBER C, 1992, INT J REMOTE SENS, V13, P3251, DOI 10.1080/01431169208904116; Weeks JR, 2007, GEOJOURNAL, V69, P9, DOI 10.1007/s10708-007-9098-4; Weng QH, 2014, GEOCARTO INT, V29, P3, DOI 10.1080/10106049.2013.838311; Wolch JR, 2014, LANDSCAPE URBAN PLAN, V125, P234, DOI 10.1016/j.landurbplan.2014.01.017; Yang XY, 2012, APPL GEOGR, V32, P221, DOI 10.1016/j.apgeog.2011.05.008; Zainal NR, 2012, PROCD SOC BEHV, V50, P827, DOI 10.1016/j.sbspro.2012.08.085	97	23	24	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176684	10.1371/journal.pone.0176684	http://dx.doi.org/10.1371/journal.pone.0176684			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9RV	28464010	gold, Green Submitted, Green Published			2022-12-26	WOS:000400646300043
J	Ermini, L; Morganti, E; Post, A; Yeganeh, B; Caniggia, I; Leadley, M; Faria, CC; Rutka, JT; Post, M				Ermini, Leonardo; Morganti, Elena; Post, Alexander; Yeganeh, Behzad; Caniggia, Isabella; Leadley, Michael; Faria, Claudia C.; Rutka, James T.; Post, Martin			Imaging mass spectrometry identifies prognostic ganglioside species in rodent intracranial transplants of glioma and medulloblastoma	PLOS ONE			English	Article							TUMOR-CELLS; MOUSE-BRAIN; EXPRESSION; APOPTOSIS; GLYCOSPHINGOLIPIDS; GROWTH; LOCALIZATION; MODULATORS; FETAL	Matrix-assisted laser desorption ionization (MALDI) imaging mass spectrometry (MALDI-MSI) allows us to investigate the distribution of lipid molecules within tissues. We used MALDI-MSI to identify prognostic gangliosides in tissue sections of rat intracranial allografts of rat glioma and mouse intracranial xenografts of human medulloblastoma. In the healthy adult rodent brain, GM1 and GD1 were the main types of glycolipids. Both gangliosides were absent in both intracranial transplants. The ganglioside GM3 was not present in the healthy adult brain but was highly expressed in rat glioma allografts. In combination with tandem mass spectrometry GM3 (d18:1/C24:0) was identified as the most abundant ganglioside species in the glioma allotransplant. By contrast, mouse xenografts of human medulloblastoma were characterized by prominent expression of the ganglioside GM2 (d18:0/C18:0). Together, these data demonstrate that tissue-based MALDI-MSI of gangliosides is able to discriminate between different brain tumors and may be a useful clinical tool for their classification and grading.	[Ermini, Leonardo; Morganti, Elena; Post, Alexander; Yeganeh, Behzad; Leadley, Michael; Post, Martin] Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Program Physiol & Expt Med, Toronto, ON, Canada; [Caniggia, Isabella] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Caniggia, Isabella; Post, Martin] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Caniggia, Isabella; Post, Martin] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Faria, Claudia C.; Rutka, James T.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Div Neurosurg, Toronto, ON, Canada; [Faria, Claudia C.] Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Universidade de Lisboa	Post, M (corresponding author), Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Program Physiol & Expt Med, Toronto, ON, Canada.; Post, M (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.; Post, M (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.	martin.post@sickkids.ca	Caniggia, Isabella/G-6466-2013	Caniggia, Isabella/0000-0001-7340-2359; Ermini, Leonardo/0000-0002-7444-4064; Faria, Claudia/0000-0003-1259-9922; Yeganeh, Behzad/0000-0002-2315-7620	Canadian Institutes of Health Research (CIHR) [FND-143309, MOP-14096]; Canadian Foundation for Innovation [12156]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	This work was supported by operating grants (FND-143309 to MP; MOP-14096 to IC) from the Canadian Institutes of Health Research (CIHR) and an infrastructure grant from the Canadian Foundation for Innovation (12156 to MP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel Peggi M, 2016, J Heart Valve Dis, V25, P240; Boggio KJ, 2011, EXPERT REV PROTEOMIC, V8, P591, DOI [10.1586/epr.11.53, 10.1586/EPR.11.53]; Chan K, 2009, ANAL CHIM ACTA, V639, P57, DOI 10.1016/j.aca.2009.02.051; Chang FM, 1997, GLYCOBIOLOGY, V7, P523, DOI 10.1093/glycob/7.4.523; Chen CT, 2015, SCI REP-UK, V5, DOI 10.1038/srep15791; Chen LK, 2013, J BIOMED NANOTECHNOL, V9, P559, DOI 10.1166/jbn.2013.1624; Colsch B, 2010, GLYCOBIOLOGY, V20, P661, DOI 10.1093/glycob/cwq031; Cornett DS, 2007, NAT METHODS, V4, P828, DOI 10.1038/NMETH1094; Dufresne M, 2017, ADV CANCER RES, V134, P67, DOI 10.1016/bs.acr.2016.11.003; FREDMAN P, 1986, Neurological Research, V8, P123; Giussani P, 2014, INT J MOL SCI, V15, P4356, DOI 10.3390/ijms15034356; Hakomori S, 2002, FEBS LETT, V531, P88, DOI 10.1016/S0014-5793(02)03479-8; HAKOMORI SI, 1993, ADV LIPID RES, V25, P147; HAKOMORI SI, 1990, J BIOL CHEM, V265, P18713; HAMILTON WB, 1993, INT J CANCER, V53, P566, DOI 10.1002/ijc.2910530407; Hanai N, 2000, CANCER CHEMOTH PHARM, V46, pS13, DOI 10.1007/PL00014042; HefferLauc M, 1996, NEUROSCI LETT, V213, P91, DOI 10.1016/0304-3940(96)12831-7; JACOBSEN PF, 1985, J NEUROPATH EXP NEUR, V44, P472, DOI 10.1097/00005072-198509000-00003; Joza S, 2013, AM J RESP CELL MOL, V49, P627, DOI 10.1165/rcmb.2012-0407OC; Kettling H, 2014, ANAL CHEM, V86, P7798, DOI 10.1021/ac5017248; Kiura K, 1998, ANTICANCER RES, V18, P2957; LADISCH S, 1994, P NATL ACAD SCI USA, V91, P1974, DOI 10.1073/pnas.91.5.1974; LADISCH S, 1987, J CLIN INVEST, V79, P1879, DOI 10.1172/JCI113031; Melland-Smith M, 2015, AUTOPHAGY, V11, P653, DOI 10.1080/15548627.2015.1034414; NATOLI EJ, 1986, CANCER RES, V46, P4116; Rodighiero C, 2001, J BIOL CHEM, V276, P36939, DOI 10.1074/jbc.M104245200; SCHMIDEK HH, 1971, J NEUROSURG, V34, P335, DOI 10.3171/jns.1971.34.3.0335; Seyfried TN, 2010, J ONCOL, V2010, DOI 10.1155/2010/961243; Shimizu Y, 2017, ANAL BIOANAL CHEM, V409, P1007, DOI 10.1007/s00216-016-0015-x; Snuderl M, 2013, CELL, V152, P1065, DOI 10.1016/j.cell.2013.01.036; Sparvero LJ, 2016, J NEUROCHEM, V139, P659, DOI 10.1111/jnc.13840; Sugiura Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003232; Tringali C, 2009, CELL DEATH DIFFER, V16, P164, DOI 10.1038/cdd.2008.141; TSUCHIDA T, 1989, CANCER, V63, P1166, DOI 10.1002/1097-0142(19890315)63:6<1166::AID-CNCR2820630621>3.0.CO;2-5; Uemura S, 2003, GLYCOBIOLOGY, V13, P207, DOI 10.1093/glycob/cwg022; van Echten-Deckert G, 2008, CURR DRUG TARGETS, V9, P282; Watanabe R, 2002, CANCER RES, V62, P3850; Whitehead SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020808; WIKSTRAND CJ, 1994, MOL CHEM NEUROPATHOL, V21, P129, DOI 10.1007/BF02815347; Woods AS, 2013, ACS CHEM NEUROSCI, V4, P594, DOI 10.1021/cn300216h; WU ZL, 1986, CANCER RES, V46, P440; Yu RK, 2011, J OLEO SCI, V60, P537, DOI 10.5650/jos.60.537; Zamfir AD, 2014, ADV EXP MED BIOL, V806, P153, DOI 10.1007/978-3-319-06068-2_8; Zhang YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep25289; Zou J, 2015, ANAL CHEM, V87, P12071, DOI 10.1021/acs.analchem.5b02756	45	7	7	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176254	10.1371/journal.pone.0176254	http://dx.doi.org/10.1371/journal.pone.0176254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28463983	Green Published, Green Submitted, gold			2022-12-26	WOS:000400646300015
J	Lebedev, A; Jiao, J; Lee, JS; Yang, F; Allison, N; Herschman, H; Sadeghi, S				Lebedev, Artem; Jiao, Jing; Lee, Jason; Yang, Fan; Allison, Nathanael; Herschman, Harvey; Sadeghi, Saman			Radiochemistry on electrodes: Synthesis of an F-18-labelled and in vivo stable COX-2 inhibitor	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; VASCULAR ENDOTHELIAL-CELLS; LATE-STAGE FLUORINATION; CYCLOOXYGENASE-2 EXPRESSION; OXIDATIVE FLUORINATION; ANODIC-OXIDATION; CANCER-CELLS; PET; CELECOXIB; MICE	New radiochemistry techniques can yield novel PET tracers for COX-2 and address the shortcomings in in vivo stability and specificity, which have held back clinical translation of tracers to image COX-2 expression. Current techniques limit radiosynthesis to analogs of the COX-2 inhibitors with fluorine-18 added via a carbon chain, or on an aromatic position which renders the radiolabeled analog less specific towards COX-2, resulting in tracers with low in vivo stability or specificity. To solve this problem, we have developed a new high affinity, 18 F-labelled COX-2 inhibitor that is radiolabeled directly on a heteroaromatic ring. This molecule exhibits favorable biodistribution and increased metabolic stability. Synthesis of this molecule cannot be achieved by traditional means; consequently, we have developed an automated electrochemical radiosynthesis platform to synthesize up to 5 mCi of radiochemically pure F-18-COX-2ib in 4 hours (2% decay-corrected radiochemical yield). In vitro studies demonstrated clear correlation between COX-2 expression and uptake of the tracer. PET imaging of healthy animals confirmed that the molecule is excreted from blood within an hour, mainly through the hepatobiliary excretion pathway. In vivo metabolism data demonstrated that > 95% of the injected radioactivity remains in the form of the parent molecule 1 hour after injection.	[Lebedev, Artem; Jiao, Jing; Lee, Jason; Herschman, Harvey; Sadeghi, Saman] UCLA, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Lebedev, Artem] Traceabil, Culver City, CA USA; [Lee, Jason; Herschman, Harvey; Sadeghi, Saman] UCLA, Crump Inst Mol Imaging, Los Angeles, CA 90095 USA; [Yang, Fan] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Allison, Nathanael; Sadeghi, Saman] UCLA, Biomed Phys Interdept Program, Los Angeles, CA 90095 USA; [Herschman, Harvey; Sadeghi, Saman] Univ Calif Los Angeles, Ahmanson Translat Imagining Div, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Scripps Research Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Sadeghi, S (corresponding author), UCLA, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.; Sadeghi, S (corresponding author), UCLA, Crump Inst Mol Imaging, Los Angeles, CA 90095 USA.; Sadeghi, S (corresponding author), UCLA, Biomed Phys Interdept Program, Los Angeles, CA 90095 USA.; Sadeghi, S (corresponding author), Univ Calif Los Angeles, Ahmanson Translat Imagining Div, Los Angeles, CA 90095 USA.	samsadeghi@mednet.ucla.edu	Lebedev, Artem/J-2969-2019	Lebedev, Artem/0000-0001-5366-9793; Lee, Jason/0000-0003-2590-2011	NATIONAL CANCER INSTITUTE [R21CA186842] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA186842] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Blobaum AL, 2015, J BIOL CHEM, V290, P12793, DOI 10.1074/jbc.M114.635987; Breyer MD, 2001, CURR OPIN NEPHROL HY, V10, P89, DOI 10.1097/00041552-200101000-00014; Cherukuri DP, 2014, MOL ONCOL, V8, P169, DOI 10.1016/j.molonc.2013.10.009; Choi SH, 2009, TRENDS PHARMACOL SCI, V30, P174, DOI 10.1016/j.tips.2009.01.002; Cole EL, 2014, CURR TOP MED CHEM, V14, P875, DOI 10.2174/1568026614666140202205035; de Vries EFJ, 2003, J NUCL MED, V44, P1700; Edelman MJ, 2008, J CLIN ONCOL, V26, P848, DOI 10.1200/JCO.2007.13.8081; Esbona K, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0695-3; Fujiwaki R, 2002, HUM PATHOL, V33, P213, DOI 10.1053/hupa.2002.31292; Gao ZH, 2012, ANGEW CHEM INT EDIT, V51, P6733, DOI 10.1002/anie.201201502; Gong L, 2012, PHARMACOGENET GENOM, V22, P310, DOI 10.1097/FPC.0b013e32834f94cb; Harris RE, 2005, ONCOL REP, V13, P559; He QG, 2014, APPL RADIAT ISOTOPES, V92, P52, DOI 10.1016/j.apradiso.2014.06.013; Inoue H, 2002, ARTERIOSCL THROM VAS, V22, P1415, DOI 10.1161/01.ATV.0000028816.13582.13; KHARASCH ED, 1993, ANESTHESIOLOGY, V79, P795, DOI 10.1097/00000542-199310000-00023; Kienzle GJ, 2005, J LABELLED COMPD RAD, V48, P259, DOI 10.1002/jlcr.918; Kniess T, 2012, BIOORGAN MED CHEM, V20, P3410, DOI 10.1016/j.bmc.2012.04.022; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Koole M, 2009, J NUCL MED, V50, P818, DOI 10.2967/jnumed.108.060756; Laube M, 2013, MOLECULES, V18, P6311, DOI 10.3390/molecules18066311; Lee E, 2012, J AM CHEM SOC, V134, P17456, DOI 10.1021/ja3084797; Lee E, 2011, SCIENCE, V334, P639, DOI 10.1126/science.1212625; Liou JY, 2005, EXP CELL RES, V306, P75, DOI 10.1016/j.yexcr.2005.01.011; Liu CH, 2001, J BIOL CHEM, V276, P18563, DOI 10.1074/jbc.M010787200; MAKINO K, 1988, J FLUORINE CHEM, V39, P435, DOI 10.1016/S0022-1139(00)81615-2; McCarthy TJ, 2002, J NUCL MED, V43, P117; Minghetti L, 2004, J NEUROPATH EXP NEUR, V63, P901, DOI 10.1093/jnen/63.9.901; Mosessian S, 2014, MOL IMAGING BIOL MIB; Noel M, 2004, J APPL ELECTROCHEM, V34, P357, DOI 10.1023/B:JACH.0000016670.97434.c7; Parfenova H, 2001, AM J PHYSIOL-CELL PH, V281, pC166, DOI 10.1152/ajpcell.2001.281.1.C166; Park BK, 2001, ANNU REV PHARMACOL, V41, P443, DOI 10.1146/annurev.pharmtox.41.1.443; Paulson SK, 1999, BIOPHARM DRUG DISPOS, V20, P293, DOI 10.1002/(SICI)1099-081X(199909)20:6<293::AID-BDD188>3.0.CO;2-X; Penning TD, 1997, J MED CHEM, V40, P1347, DOI 10.1021/jm960803q; Phelps ME, 2000, P NATL ACAD SCI USA, V97, P9226, DOI 10.1073/pnas.97.16.9226; Prabhakaran J, 2007, BIOORGAN MED CHEM, V15, P1802, DOI 10.1016/j.bmc.2006.11.033; Preshlock S, 2016, CHEM REV, V116, P719, DOI 10.1021/acs.chemrev.5b00493; Rotstein BH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5365; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Rozhkov I. N., 1976, RUSS CHEM REV, V45, P615; Simeon FG, 2010, TETRAHEDRON LETT, V51, P6034, DOI 10.1016/j.tetlet.2010.09.037; Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774; Suga S, 2002, J AM CHEM SOC, V124, P30, DOI 10.1021/ja0171759; Tian HB, 2006, J LABELLED COMPD RAD, V49, P583, DOI 10.1002/jlcr.1074; Tredwell M, 2012, ANGEW CHEM INT EDIT, V51, P11426, DOI 10.1002/anie.201204687; Tsujii M, 1997, P NATL ACAD SCI USA, V94, P3336, DOI 10.1073/pnas.94.7.3336; Wadleigh DJ, 2000, J BIOL CHEM, V275, P6259, DOI 10.1074/jbc.275.9.6259	46	18	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176606	10.1371/journal.pone.0176606	http://dx.doi.org/10.1371/journal.pone.0176606			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28464017	Green Published, gold, Green Submitted			2022-12-26	WOS:000400646300037
J	Castro, JA; Ferreira, MDG; Silva, RJS; Andrade, BS; Micheli, F				Castro, Jacqueline Araujo; Gomes Ferreira, Monique Drielle; Santana Silva, Raner Jose; Andrade, Bruno Silva; Micheli, Fabienne			Alternative oxidase (AOX) constitutes a small family of proteins in Citrus clementina and Citrus sinensis L. Osb	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; PHYSIOLOGICAL-ROLE; GENE FAMILY; ARABIDOPSIS; RESPIRATION; INVOLVEMENT; INDUCTION; SEQUENCE; INSIGHTS; PATHWAY	The alternative oxidase (AOX) protein is present in plants, fungi, protozoa and some invertebrates. It is involved in the mitochondrial respiratory chain, providing an alternative route for the transport of electrons, leading to the reduction of oxygen to form water. The present study aimed to characterize the family of AOX genes in mandarin (Citrus clementina) and sweet orange (Citrus sinensis) at nucleotide and protein levels, including promoter analysis, phylogenetic analysis and C. sinensis gene expression. This study also aimed to do the homology modeling of one AOX isoform (CcAOXd). Moreover, the molecular docking of the CcAOXd protein with the ubiquinone (UQ) was performed. Four AOX genes were identified in each citrus species. These genes have an open reading frame (ORF) ranging from 852 bp to 1150 bp and a number of exons ranging from 4 to 9. The 1500 bp-upstream region of each AOX gene contained regulatory cis-elements related to internal and external response factors. CsAOX genes showed a differential expression in citrus tissues. All AOX proteins were predicted to be located in mitochondria. They contained the conserved motifs LET, NERMHL, LEEEA and RADE-H as well as several putative post-translational modification sites. The CcAOXd protein was modeled by homology to the AOX of Trypanosona brucei (45% of identity). The 3-D structure of CcAOXd showed the presence of two hydrophobic helices that could be involved in the anchoring of the protein in the inner mitochondrial membrane. The active site of the protein is located in a hydrophobic environment deep inside the AOX structure and contains a diiron center. The molecular docking of CcAOXd with UQ showed that the binding site is a recessed pocket formed by the helices and submerged in the membrane. These data are important for future functional studies of citrus AOX genes and/or proteins, as well as for biotechnological approaches leading to AOX inhibition using UQ homologs.	[Castro, Jacqueline Araujo; Gomes Ferreira, Monique Drielle; Santana Silva, Raner Jose; Micheli, Fabienne] UESC, CBG, MMus, Iiheus, Bahia, Brazil; [Castro, Jacqueline Araujo] Inst Fed Educ Ciencia Tecnol Baiano IFBaiano, Ciencia Tecnol Baiano IFBaiano, Santa Ines, Bahia, Brazil; [Andrade, Bruno Silva] UESB, Av Jose Moreira Sobrinho, Jequie, Bahia, Brazil; [Micheli, Fabienne] CIRAD, UMR AGAP, F-34398 Montpellier, France	Universidade Estadual de Santa Cruz; Instituto Federal Baiano (IFBAIANO); Universidade Estadual do Sudoeste da Bahia; CIRAD; Universite de Montpellier	Micheli, F (corresponding author), UESC, CBG, MMus, Iiheus, Bahia, Brazil.; Micheli, F (corresponding author), CIRAD, UMR AGAP, F-34398 Montpellier, France.	fabienne.micheli@cirad.fr	Andrade, Bruno S/C-8170-2013; Araújo Castro, Jacqueline/GYJ-2968-2022; Andrade, Bruno/AAP-8926-2020; Micheli, Fabienne/AAL-9895-2021	Andrade, Bruno/0000-0002-8031-9454; Micheli, Fabienne/0000-0002-9031-362X	CNPq [471742/2013-9, PQ1]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB))	This work was supported by CNPq Universal project no 471742/2013-9. JAC and MDGF were supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); RJSS was supported by the Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB), FM was supported by a CNPq Productivity Grant (PQ1).	Allario T, 2011, J EXP BOT, V62, P2507, DOI 10.1093/jxb/erq467; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Berthold DA, 2000, BBA-BIOENERGETICS, V1460, P241, DOI 10.1016/S0005-2728(00)00149-3; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Borecky J, 2005, BIOSCIENCE REP, V25, P271, DOI 10.1007/s10540-005-2889-2; Chai TT, 2010, PLANT SIGNAL BEHAV, V5, P604, DOI 10.4161/psb.11502; Chaudhuri M, 1998, MOL BIOCHEM PARASIT, V95, P53, DOI 10.1016/S0166-6851(98)00091-7; Clifton R, 2006, BBA-BIOENERGETICS, V1757, P730, DOI 10.1016/j.bbabio.2006.03.009; Considine MJ, 2002, PLANT PHYSIOL, V129, P949, DOI 10.1104/pp.004150; Considine MJ, 2001, PLANT PHYSIOL, V126, P1619, DOI 10.1104/pp.126.4.1619; Daurelio LD, 2010, BIOSCIENCE REP, V30, P59, DOI 10.1042/BSR20080180; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Djajanegara I, 2002, PLANT MOL BIOL, V50, P735, DOI 10.1023/A:1019942720636; Feng HQ, 2013, ACTA BIOCH BIOPH SIN, V45, P985, DOI 10.1093/abbs/gmt094; Finnegan PM, 2004, ADV PHOTO RESPIRAT, V17, P163; Guex N, 1999, TRENDS BIOCHEM SCI, V24, P364, DOI 10.1016/S0968-0004(99)01427-9; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Guo P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00898; Hansen LD, 2002, THERMOCHIM ACTA, V388, P415, DOI 10.1016/S0040-6031(02)00021-7; Hofmann, 1993, BIOL CHEM HOPPE SEYL, V374; Huang X, 2002, PLANTA, V215, P914, DOI 10.1007/s00425-002-0828-z; Jeffares DC, 2008, TRENDS GENET, V24, P375, DOI 10.1016/j.tig.2008.05.006; Karpova OV, 2002, PLANT CELL, V14, P3271, DOI 10.1105/tpc.005603; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Magnani T, 2007, FEMS MICROBIOL LETT, V271, P230, DOI 10.1111/j.1574-6968.2007.00716.x; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; Medentsev AG, 1999, BIOCHEMISTRY-MOSCOW+, V64, P1230; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Millenaar FF, 2003, PLANT BIOLOGY, V5, P2, DOI 10.1055/s-2003-37974; Moore AL, 2002, TRENDS PLANT SCI, V7, P478, DOI 10.1016/S1360-1385(02)02366-X; Moore AL, 2008, BBA-BIOENERGETICS, V1777, P327, DOI 10.1016/j.bbabio.2008.01.004; Moore AL, 2013, ANNU REV PLANT BIOL, V64, P637, DOI 10.1146/annurev-arplant-042811-105432; Neimanis K, 2013, GENE, V526, P275, DOI 10.1016/j.gene.2013.04.072; Oliveira MG, 2015, J PLANT PHYSIOL, V189, P42, DOI 10.1016/j.jplph.2015.10.001; Polidoros AN, 2009, PHYSIOL PLANTARUM, V137, P342, DOI 10.1111/j.1399-3054.2009.01284.x; RHOADS DM, 1993, PLANT PHYSIOL, V103, P877, DOI 10.1104/pp.103.3.877; Rogov AG, 2015, BIOCHEMISTRY-MOSCOW+, V80, P400, DOI 10.1134/S0006297915040021; Saha B, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1256530; Saika H, 2002, GENES GENET SYST, V77, P31, DOI 10.1266/ggs.77.31; Saisho D, 1997, PLANT MOL BIOL, V35, P585, DOI 10.1023/A:1005818507743; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shiba T, 2013, P NATL ACAD SCI USA, V110, P4580, DOI 10.1073/pnas.1218386110; SIEDOW JN, 1995, FEBS LETT, V362, P10, DOI 10.1016/0014-5793(95)00196-G; Takumi S, 2002, GENES GENET SYST, V77, P81, DOI 10.1266/ggs.77.81; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vanlerberghe GC, 1997, ANNU REV PLANT PHYS, V48, P703, DOI 10.1146/annurev.arplant.48.1.703; Velada I, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01043; Wang HH, 2012, PLANTA, V235, P53, DOI 10.1007/s00425-011-1488-7; Wang J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087451, 10.1371/journal.pone.0107012]; Wang J, 2008, BIOSCIENCE REP, V28, P259, DOI 10.1042/BSR20080025; Xiong L, 2002, PLANT CELL ENVIRON, V25, P131, DOI 10.1046/j.1365-3040.2002.00782.x; Xu F, 2012, J EXP BOT, V63, P5705, DOI 10.1093/jxb/ers226; Zhang DW, 2010, PLANT CELL ENVIRON, V33, P2121, DOI 10.1111/j.1365-3040.2010.02211.x	58	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176878	10.1371/journal.pone.0176878	http://dx.doi.org/10.1371/journal.pone.0176878			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459876	Green Published, Green Submitted, gold			2022-12-26	WOS:000400645000066
J	Dirksen, K; Spee, B; Penning, LC; van den Ingh, TSGAM; Burgener, IA; Watson, AL; Koerkamp, MG; Rothuizen, J; van Steenbeek, FG; Fieten, H				Dirksen, Karen; Spee, Bart; Penning, Louis C.; van den Ingh, Ted S. G. A. M.; Burgener, Iwan A.; Watson, Adrian L.; Koerkamp, Marian Groot; Rothuizen, Jan; van Steenbeek, Frank G.; Fieten, Hille			Gene expression patterns in the progression of canine copper-associated chronic hepatitis	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; CINNAMON LEC RATS; WILSONS-DISEASE; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; S-ADENOSYLMETHIONINE; BEDLINGTON TERRIERS; LABRADOR RETRIEVERS; LIVER-CIRRHOSIS; IN-VIVO	Copper is an essential trace element, but can become toxic when present in abundance. The severe effects of copper-metabolism imbalance are illustrated by the inherited disorders Wilson disease and Menkes disease. The Labrador retriever dog breed is a novel non-rodent model for copper-storage disorders carrying mutations in genes known to be involved in copper transport. Besides disease initiation and progression of copper accumulation, the molecular mechanisms and pathways involved in progression towards copper-associated chronic hepatitis still remain unclear. Using expression levels of targeted candidate genes as well as transcriptome micro-arrays in liver tissue of Labrador retrievers in different stages of copper-associated hepatitis, pathways involved in progression of the disease were studied. At the initial phase of increased hepatic copper levels, transcriptomic alterations in livers mainly revealed enrichment for cell adhesion, developmental, inflammatory, and cytoskeleton pathways. Upregulation of targeted MT1A and COMMD1 mRNA shows the liver's first response to rising intrahepatic copper concentrations. In livers with copper-associated hepatitis mainly an activation of inflammatory pathways is detected. Once the hepatitis is in the chronic stage, transcriptional differences are found in cell adhesion adaptations and cytoskeleton remodelling. In view of the high similarities in copper-associated hepatopathies between men and dog extrapolation of these dog data into human biomedicine seems feasible.	[Dirksen, Karen; Spee, Bart; Penning, Louis C.; Burgener, Iwan A.; Rothuizen, Jan; van Steenbeek, Frank G.; Fieten, Hille] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [van den Ingh, Ted S. G. A. M.] TCCI Consultancy BV, Cicerolaan 1,AJ, Utrecht, Netherlands; [Burgener, Iwan A.] Vet Med Univ Wien, Dept Kleintiere & Pferde, Vienna, Austria; [Watson, Adrian L.] Royal Canin Res Ctr, Aimargues, France; [Koerkamp, Marian Groot] Princess Maxima Ctr, Lundlaan 6,EA, Utrecht, Netherlands	Utrecht University; University of Veterinary Medicine Vienna	Fieten, H (corresponding author), Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands.	H.fieten@uu.nl	van Steenbeek, F.G./AFL-0046-2022; Penning, Louis/AAC-7524-2019	van Steenbeek, F.G./0000-0001-5460-6540; Groot Koerkamp, Marian JA/0000-0002-0867-0821	TCCI Consultancy BV; Royal Canin Research Center	TCCI Consultancy BV; Royal Canin Research Center	The authors received no specific funding for this work. TCCI Consultancy BV and The Royal Canin Research Center provided support in the form of salaries for authors Ted S.G.A.M. van den Ingh and Adrian L. Watson but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Acevedo KM, 2014, J BIOL CHEM, V289, P11007, DOI 10.1074/jbc.M113.538710; Acevedo KM, 2011, J BIOL CHEM, V286, P8252, DOI 10.1074/jbc.M110.128512; Amaravadi R, 1997, HUM GENET, V99, P329, DOI 10.1007/s004390050367; [Anonymous], 2006, WSAVA STANDARDS CLIN; Armendariz AD, 2004, PHYSIOL GENOMICS, V20, P45, DOI 10.1152/physiolgenomics.00196.2003; Asselah T, 2005, GASTROENTEROLOGY, V129, P2064, DOI 10.1053/j.gastro.2005.09.010; Avila MA, 2000, J HEPATOL, V33, P907, DOI 10.1016/S0168-8278(00)80122-1; Bellingham SA, 2004, J BIOL CHEM, V279, P20378, DOI 10.1074/jbc.M400805200; Bertinato J, 2003, J BIOL CHEM, V278, P35071, DOI 10.1074/jbc.M302242200; Bieche I, 2005, VIROLOGY, V332, P130, DOI 10.1016/j.virol.2004.11.009; Bode P., 1990, J TRACE MICROPROBE T, V8, P139; Brady GF, 2010, MOL CELL BIOL, V30, P1923, DOI 10.1128/MCB.00900-09; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Center SA, 2005, J VET INTERN MED, V19, P303, DOI 10.1892/0891-6640(2005)19[303:TEOSOC]2.0.CO;2; Cooper VL, 1997, J VET DIAGN INVEST, V9, P201, DOI 10.1177/104063879700900217; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; De Bie P, 2005, J HERED, V96, P803, DOI 10.1093/jhered/esi110; de Bie P, 2007, GASTROENTEROLOGY, V133, P1316, DOI 10.1053/j.gastro.2007.07.020; Delgado M, 2008, CELL MOL LIFE SCI, V65, P2080, DOI 10.1007/s00018-008-8201-4; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Favier RP, 2015, J TRACE ELEM MED BIO, V29, P347, DOI 10.1016/j.jtemb.2014.06.007; Favier RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042158; Fedoseienko A, 2014, ANN NY ACAD SCI, V1314, P6, DOI 10.1111/nyas.12353; Fieten H, 2012, J VET INTERN MED, V26, P1274, DOI 10.1111/j.1939-1676.2012.01001.x; Fieten H, 2016, DIS MODEL MECH, V9, P25, DOI 10.1242/dmm.020263; Fieten H, 2014, ANN NY ACAD SCI, V1314, P42, DOI 10.1111/nyas.12442; FREEDMAN JH, 1989, J BIOL CHEM, V264, P5598; Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8; Gitlin JD, 2003, GASTROENTEROLOGY, V125, P1868, DOI 10.1053/j.gastro.2003.05.010; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; GOLDFISCHER S, 1968, AM J PATHOL, V53, P883; Gordon H, 1936, AM J PATHOL, V12, P545; Greenough M, 2004, AM J PHYSIOL-CELL PH, V287, pC1463, DOI 10.1152/ajpcell.00179.2004; Gu M, 2000, LANCET, V356, P469, DOI 10.1016/S0140-6736(00)02556-3; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Haywood S, 2005, J COMP PATHOL, V133, P114, DOI 10.1016/j.jcpa.2005.02.001; HAYWOOD S, 1988, VET PATHOL, V25, P408, DOI 10.1177/030098588802500602; Hellman NE, 2002, J BIOL CHEM, V277, P46632, DOI 10.1074/jbc.M206246200; Hoffmann G, 2008, ANIM GENET, V39, P454, DOI 10.1111/j.1365-2052.2008.01722.x; Hoffmann G, 2006, J VET INTERN MED, V20, P856, DOI 10.1892/0891-6640(2006)20[856:CCHILR]2.0.CO;2; Huster D, 2007, J BIOL CHEM, V282, P8343, DOI 10.1074/jbc.M607496200; Hytonen MK, 2016, ANIM GENET; Johnston AN, 2013, JAVMA-J AM VET MED A, V242, P372, DOI 10.2460/javma.242.3.372; Kaler SG, 2011, NAT REV NEUROL, V7, P15, DOI 10.1038/nrneurol.2010.180; Kanemoto H, 2011, VET PATHOL, V48, P839, DOI 10.1177/0300985810388523; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Kim BE, 2010, CELL METAB, V11, P353, DOI 10.1016/j.cmet.2010.04.003; Kim H, 2009, IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN CYBER SECURITY, P1; Klein D, 2003, ARCH TOXICOL, V77, P568, DOI 10.1007/s00204-003-0493-4; Klein D, 1998, EUR J CLIN INVEST, V28, P302; Klomp AEM, 2003, J HEPATOL, V39, P703, DOI 10.1016/S0168-8278(03)00380-5; Kong GKW, 2008, EUR BIOPHYS J BIOPHY, V37, P269, DOI 10.1007/s00249-007-0234-3; de Romana DL, 2011, J TRACE ELEM MED BIO, V25, P3, DOI 10.1016/j.jtemb.2010.11.004; Lu SC, 2001, P NATL ACAD SCI USA, V98, P5560, DOI 10.1073/pnas.091016398; Mandigers PJJ, 2004, J VET INTERN MED, V18, P647, DOI 10.1892/0891-6640(2004)18&lt;647:ABLCCA&gt;2.0.CO;2; Margaritis T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.21; Materia S, 2012, J BIOL CHEM, V287, P2485, DOI 10.1074/jbc.M111.302216; Mato JM, 1999, J HEPATOL, V30, P1081, DOI 10.1016/S0168-8278(99)80263-3; Mattie MD, 2004, AM J PHYSIOL-CELL PH, V286, pC293, DOI 10.1152/ajpcell.00293.2003; Maynard CJ, 2002, J BIOL CHEM, V277, P44670, DOI 10.1074/jbc.M204379200; MULDER TPJ, 1992, J HEPATOL, V16, P346, DOI 10.1016/S0168-8278(05)80667-1; Muller P, 2007, J BIOL INORG CHEM, V12, P495, DOI 10.1007/s00775-006-0201-y; Narindrasorasak S, 2007, BIOCHEMISTRY-US, V46, P3116, DOI 10.1021/bi0620656; Polishchuk EV, 2014, DEV CELL, V29, P686, DOI 10.1016/j.devcel.2014.04.033; PULS R, 1994, MINERAL LEVELS ANIMA; Roelofsen H, 2000, GASTROENTEROLOGY, V119, P782, DOI 10.1053/gast.2000.17834; Roepman P, 2005, NAT GENET, V37, P182, DOI 10.1038/ng1502; Simpson Deborah M, 2006, BMC Vet Res, V2, P36, DOI 10.1186/1746-6148-2-36; Simpson DM, 2004, PROTEOMICS, V4, P524, DOI 10.1002/pmic.200300557; Smedley R, 2009, VET PATHOL, V46, P484, DOI 10.1354/vp.08-VP-0197-S-FL; SOKOL RJ, 1994, GASTROENTEROLOGY, V107, P1788, DOI 10.1016/0016-5085(94)90822-2; Spee B, 2006, J VET INTERN MED, V20, P1085, DOI 10.1892/0891-6640(2006)20[1085:CMAOSI]2.0.CO;2; Spee Bart, 2005, Comp Hepatol, V4, P3, DOI 10.1186/1476-5926-4-3; SU LC, 1982, AM J PHYSIOL, V243, pG226, DOI 10.1152/ajpgi.1982.243.3.G226; SUGAWARA N, 1991, EXPERIENTIA, V47, P1060, DOI 10.1007/BF01923342; Tao TY, 2003, J BIOL CHEM, V278, P41593, DOI 10.1074/jbc.C300391200; Thornburg LP, 1996, VET PATHOL, V33, P656, DOI 10.1177/030098589603300604; THORNBURG LP, 1986, VET PATHOL, V23, P148, DOI 10.1177/030098588602300207; Thornburg LP, 2000, J VET DIAGN INVEST, V12, P101, DOI 10.1177/104063870001200201; Treiber C, 2004, J BIOL CHEM, V279, P51958, DOI 10.1074/jbc.M407410200; UZMAN LL, 1956, LAB INVEST, V5, P299; Valko M, 2016, ARCH TOXICOL, V90, P1, DOI 10.1007/s00204-015-1579-5; van de Peppel J, 2003, EMBO REP, V4, P387, DOI 10.1038/sj.embor.embor798; van de Sluis B, 2002, HUM MOL GENET, V11, P165, DOI 10.1093/hmg/11.2.165; van den Berghe PVE, 2010, J BIOL INORG CHEM, V15, P37, DOI 10.1007/s00775-009-0592-7; van den Berghe PVE, 2009, NUTR REV, V67, P658, DOI 10.1111/j.1753-4887.2009.00250.x; Van den Ingh TSGAM, 2006, WSAVA STANDARDS CLIN, P85; van Steenbeek FG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057662; Vonk WIM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029183; Wallace KP, 2002, J AM ANIM HOSP ASSOC, V38, P246, DOI 10.5326/0380246; Weiss KH, 2008, AM J PATHOL, V173, P1783, DOI 10.2353/ajpath.2008.071134; White AR, 1999, BRAIN RES, V842, P439, DOI 10.1016/S0006-8993(99)01861-2; Wu XY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020196; Yamamoto H, 2001, FREE RADICAL BIO MED, V30, P547, DOI 10.1016/S0891-5849(00)00496-2; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	97	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176826	10.1371/journal.pone.0176826	http://dx.doi.org/10.1371/journal.pone.0176826			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459846	Green Submitted, Green Published, gold			2022-12-26	WOS:000400645000061
J	Jia, CH; Shin, JA; Kim, YM; Lee, KT				Jia, Cai-Hua; Shin, Jung-Ah; Kim, Young-Min; Lee, Ki-Teak			Effect of processing on composition changes of selected spices	PLOS ONE			English	Article							DIFFERENT COOKING METHODS; ALPHA-TOCOPHEROL; BETA-CAROTENE; VEGETABLES; RETENTION; FOOD; VITAMINS	The present investigation was conducted to study the true retentions of a-tocopherol, toco-trienols and beta-carotene in crown daisy, unripe hot pepper, onion, garlic, and red pepper as affected by various domestic cooking methods, those were, boiling, baking, stir-frying, deep-frying, steaming, roasting, and microwaving. Fatty acid compositions were determined by GC, and HPLC were used for quantification of a-tocopherol, tocotrienols, and beta-carotene. True retentions of a-tocopherol in cooked foods were as follows: boiling (77.74-242.73%), baking (85.99-212.39%), stir-frying (83.12-957.08%), deep-frying (162.48-4214.53%), steaming (45.97-179.57%), roasting (49.65-253.69%), and microwaving (44.67-230.13%). Similarly for true retention of beta-carotene were: boiling (65.69-313.75%), baking (71.46-330.16%), stir-frying (89.62-362.46%), deep-frying (178.22-529.16%), steaming (50.39-240.92%), roasting (73.54-361.47%), and microwaving (78.60-339.87%).	[Jia, Cai-Hua] Huazhong Agr Univ, Coll Food Sci & Technol, Minist Educ, Key Lab Environm Correlat Dietol, Wuhan, Hubei, Peoples R China; [Jia, Cai-Hua; Shin, Jung-Ah; Kim, Young-Min; Lee, Ki-Teak] Chungnam Natl Univ, Dept Food Sci & Technol, Daejeon, South Korea	Huazhong Agricultural University; Chungnam National University	Lee, KT (corresponding author), Chungnam Natl Univ, Dept Food Sci & Technol, Daejeon, South Korea.	ktlee@cnu.ac.kr			Ministry of Food and Drug Safety [13162MFDS162/15162MFDS039]	Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	There search was supported by grants (13162MFDS162/15162MFDS039) from Ministry of Food and Drug Safety in 2014 and 2015. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, DIET NUTR PREV CHRON; Arab-Tehrany E, 2012, TRENDS FOOD SCI TECH, V25, P24, DOI 10.1016/j.tifs.2011.12.002; Bernhardt S, 2006, J FOOD ENG, V77, P327, DOI 10.1016/j.jfoodeng.2005.06.040; Bognar A., 2000, Journal of Food Composition and Analysis, V13, P391, DOI 10.1006/jfca.2000.0922; Castenmiller JJM, 1998, ANNU REV NUTR, V18, P19, DOI 10.1146/annurev.nutr.18.1.19; de Sa MC, 2004, J FOOD COMPOS ANAL, V17, P37, DOI 10.1016/S0889-1575(03)00100-5; DeVries JW, 2002, J AOAC INT, V85, P424; Dobarganes C, 2000, EUR J LIPID SCI TECH, V102, P521, DOI 10.1002/1438-9312(200009)102:8/9<521::AID-EJLT521>3.0.CO;2-A; Frano ML, 2015, EUROPEAN J NUTR FOOD, V5, P390; Fu JH, 2007, J SHELLFISH RES, V26, P809, DOI 10.2983/0730-8000(2007)26[809:EOVEOA]2.0.CO;2; Gan LJ, 2012, J AGR FOOD CHEM, V60, P467, DOI 10.1021/jf203708y; Harada T, 2015, PULM PHARMACOL THER, V32, P45, DOI 10.1016/j.pupt.2015.04.003; Hirata K., 1998, Souken Houkoku, P1; Jaswir I, 2011, J MED PLANTS RES, V5, P7119, DOI 10.5897/JMPRx11.011; Jump DB, 2011, CURR OPIN CLIN NUTR, V14, P115, DOI 10.1097/MCO.0b013e328342991c; Karimian-khosroshahi N, 2015, INT J FOOD PROP; Karmowski J, 2015, FOOD CHEM, V175, P593, DOI 10.1016/j.foodchem.2014.12.010; Koch M, 2002, J PLANT PHYSIOL, V159, P1015, DOI 10.1078/0176-1617-00746; Korea Food and Drug Administration, 2012, NLS STAND OP PROC AN, P99; Lynch SM, 2011, CANCER PREV RES, V4, P1912, DOI 10.1158/1940-6207.CAPR-11-0002; Masrizal MA, 1997, J FOOD QUALITY, V20, P403, DOI 10.1111/j.1745-4557.1997.tb00483.x; McClements DJ, 2013, PROG LIPID RES, V52, P409, DOI 10.1016/j.plipres.2013.04.008; Miglio C, 2008, J AGR FOOD CHEM, V56, P139, DOI 10.1021/jf072304b; MURPHY EW, 1975, J AGR FOOD CHEM, V23, P1153, DOI 10.1021/jf60202a021; Niki E, 2015, KOREAN J INTERN MED, V30, P571, DOI 10.3904/kjim.2015.30.5.571; Ratnayake WN, 2014, AM J CLIN NUTR, V100, P1036; Rizvi S., 2014, SULTAN QABOOS U MED, V14, P157; Rodriguez-Amaya DB, CAROTENOIDS FOOD PRE, P199; Vahlquist A, 2007, RETINOIDS CAROTENOID, P333; Vimala B, 2011, INT J FOOD SCI TECH, V46, P166, DOI 10.1111/j.1365-2621.2010.02478.x; Vishnevetsky M, 1999, TRENDS PLANT SCI, V4, P232, DOI 10.1016/S1360-1385(99)01414-4; Yang D, 2013, J FOOD SCI, V78, pC43, DOI 10.1111/j.1750-3841.2012.03010.x	32	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176037	10.1371/journal.pone.0176037	http://dx.doi.org/10.1371/journal.pone.0176037			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459863	gold, Green Published, Green Submitted			2022-12-26	WOS:000400645000011
J	Jiang, QY; Sun, XJ; Niu, FJ; Hu, Z; Chen, R; Zhang, H				Jiang, Qiyan; Sun, Xianjun; Niu, Fengjuan; Hu, Zheng; Chen, Rui; Zhang, Hui			GmDREB1 overexpression affects the expression of microRNAs in GM wheat seeds	PLOS ONE			English	Article							PLANT MICRORNAS; SALT TOLERANCE; TIME; IDENTIFICATION; PROVIDE; PATHWAY; TARGETS; MIRNAS; GENES; PCR	MicroRNAs (miRNAs) are small regulators of gene expression that act on many different molecular and biochemical processes in eukaryotes. To date, miRNAs have not been considered in the current evaluation system for GM crops. In this study, small RNAs from the dry seeds of a GM wheat line overexpressing GmDREB1 and non-GM wheat cultivars were investigated using deep sequencing technology and bioinformatic approaches. As a result, 23 differentially expressed miRNAs in dry seeds were identified and confirmed between GM wheat and a non-GM acceptor. Notably, more differentially expressed tae-miRNAs between non-GM wheat varieties were found, indicating that the degree of variance between non-GM cultivars was considerably higher than that induced by the transgenic event. Most of the target genes of these differentially expressed miRNAs between GM wheat and a non-GM acceptor were associated with abiotic stress, in accordance with the product concept of GM wheat in improving drought and salt tolerance. Our data provided useful information and insights into the evaluation of miRNA expression in edible GM crops.	[Jiang, Qiyan; Sun, Xianjun; Niu, Fengjuan; Hu, Zheng; Zhang, Hui] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China; [Chen, Rui] Tianjin Acad Agr Sci, Tianjin Inst Agr Qual Standard & Testing Technol, Tianjin, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Zhang, H (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China.; Chen, R (corresponding author), Tianjin Acad Agr Sci, Tianjin Inst Agr Qual Standard & Testing Technol, Tianjin, Peoples R China.	chenrui.2011@outlook.com; zhanghui06@caas.on	Sun, xianjun/AAG-1739-2020; 陈, 锐/AAA-2120-2020		National Transgenic Key Project from Ministry of Agriculture of China [2016ZX08011-003]; National Natural Science Foundation of China [31671964]; Agricultural Science and Technology Program	National Transgenic Key Project from Ministry of Agriculture of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Science and Technology Program	This study was supported by the National Transgenic Key Project from the Ministry of Agriculture of China (2016ZX08011-003), General Project, National Natural Science Foundation of China (No. 31671964) and the Agricultural Science and Technology Program for Innovation Team on Identification and Excavation of Elite Crop Germplasm, CAAS.; This study was supported by the National Transgenic Key Project from the Ministry of Agriculture of China (2016ZX08011-003), National Natural Science Foundation of China (No. 31671964) and the Agricultural Science and Technology Program for Innovation Team on Identification and Excavation of Elite Crop Germplasm, CAAS.	Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Akdogan G, 2016, FUNCT INTEGR GENOMIC, V16, P221, DOI 10.1007/s10142-015-0452-1; Alvarez S, 2014, J PROTEOME RES, V13, P1688, DOI 10.1021/pr401165b; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Burge SW, 2012, NUCL ACIDS RES, DOI 101093/nar/gks1005; Cao D, 2015, PLANT MOL BIOL, V89, P353, DOI 10.1007/s11103-015-0371-5; Chen R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104956; Cui LG, 2014, PLANT J, V80, P1108, DOI 10.1111/tpj.12712; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Domingo JL, 2016, FOOD CHEM TOXICOL, V95, P12, DOI 10.1016/j.fct.2016.06.013; Eldem V, 2013, TURK J AGRIC FOR, V37, P1, DOI 10.3906/tar-1206-50; Ewen SWB, 1999, LANCET, V354, P1353, DOI 10.1016/S0140-6736(98)05860-7; Feng H, 2012, PLANT PHYSIOL BIOCH, V51, P116, DOI 10.1016/j.plaphy.2011.10.010; Frazier TP, 2011, METHODS MOL BIOL, V678, P13, DOI 10.1007/978-1-60761-682-5_2; Gao SQ, 2005, CHINESE SCI BULL, V50, P2714, DOI 10.1360/982005-1234; Hackenberg M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042030; Hajyzadeh M, 2015, GENE, V555, P186, DOI 10.1016/j.gene.2014.11.002; Jiang MX, 2012, BIOESSAYS, V34, P280, DOI 10.1002/bies.201100181; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; Kinoshita N, 2012, PLANT CELL, V24, P3590, DOI 10.1105/tpc.112.097006; Knip M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004602; Koch A, 2013, P NATL ACAD SCI USA, V110, P19324, DOI 10.1073/pnas.1306373110; Koyama T, 2010, PLANT CELL, V22, P3574, DOI 10.1105/tpc.110.075598; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Li CL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-277; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Liu J, 2015, PLANT BIOTECHNOL J, V13, P319, DOI 10.1111/pbi.12336; Losey JE, 1999, NATURE, V399, P214, DOI 10.1038/20338; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Nag A, 2009, P NATL ACAD SCI USA, V106, P22534, DOI 10.1073/pnas.0908718106; Nowara D, 2010, PLANT CELL, V22, P3130, DOI 10.1105/tpc.110.077040; Nunes CC, 2012, MOL PLANT PATHOL, V13, P519, DOI 10.1111/j.1364-3703.2011.00766.x; Pastrello C, 2016, SCI REP-UK, V6, DOI 10.1038/srep32773; Phookaew P, 2014, BIOL PLANTARUM, V58, P469, DOI 10.1007/s10535-014-0410-0; Quist D, 2001, NATURE, V414, P541, DOI 10.1038/35107068; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Unver Turgay, 2009, Int J Plant Genomics, V2009, P262463, DOI 10.1155/2009/262463; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang K, 2012, PLOS ONE, V7; Wang Y, 2015, PLANT PHYSIOL; Wang Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155896; Weiberg A, 2013, SCIENCE, V342, P118, DOI 10.1126/science.1239705; Witwer KW, 2013, RNA BIOL, V10, P1080, DOI 10.4161/rna.25246; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Wu L, 2009, PLANT CELL, V21, P3421, DOI 10.1105/tpc.109.070938; Xie Z, 2010, SEMINARS CELL DEV BI; Zhang BH, 2015, J EXP BOT, V66, P1749, DOI 10.1093/jxb/erv013; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zhang YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-381; Zhou M, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.28700	54	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0175924	10.1371/journal.pone.0175924	http://dx.doi.org/10.1371/journal.pone.0175924			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459812	Green Published, gold, Green Submitted			2022-12-26	WOS:000400645000009
J	Meeuwsen, JAL; van't Hof, FNG; van Rheenen, W; Rinkel, GJE; Veldink, JH; Ruigrok, YM				Meeuwsen, John A. L.; van't Hof, Femke N. G.; van Rheenen, Wouter; Rinkel, Gabriel J. E.; Veldink, Jan H.; Ruigrok, Ynte M.			Circulating microRNAs in patients with intracranial aneurysms	PLOS ONE			English	Article							ABDOMINAL AORTIC-ANEURYSMS; SUBARACHNOID HEMORRHAGE; GENE-EXPRESSION; RISK; RELATIVES	Introduction We compared circulating microRNA (miRNA) levels in plasma of patients with intracranial aneurysms (IA) to those of controls as a first step towards finding potential biomarkers for individuals at high risk of IA development and its subsequent rupture. Patients and methods Using a PCR array we measured 370 miRNAs in plasma of 15 patients with prior aneurysmal subarachnoid hemorrhage (aSAH), of whom 11 had an additional unruptured IA (UIA), and of 15 controls. MiRNAs with a difference in levels with an absolute fold change (FC) > 1.2 and p<0.01 were further tested using real-time (RT) PCR in an additional independent set of 15 aSAH patients, 15 untreated UIA patients and 15 controls for replication (absolute FC > 1.2 and p<0.05). We used receiver operating characteristic (ROC) curves to illustrate the diagnostic potential of these miRNAs. Results Three of five miRNAs with a difference in levels in the PCR array study were replicated with miRNA-183-5p decreased in all patients (FC = -2.2, p = 1.7x10(-3)), miRNA-200a-3p increased in aSAH patients (FC = 1.8, p = 2.8x10(-2)) and miRNA-let7b-5p decreased in UIA patients (FC = -1.7, p = 1.27x10(-3)) as compared to controls. In distinguishing aSAH patients from controls, the area under the ROC curve (AUC) was 0.80 (95% confidence interval (95% CI) 0.63-0.97) for miRNA-183-5p, and 0.74 (95% CI 0.55-0.94) for miRNA-200a-3p. In distinguishing untreated UIA patients from controls, AUC was 0.83 (95% CI 0.69-0.98) for miRNA-183-5p and 0.92 (95% CI 0.81-1) for miRNA-let-7b. Discussion/Conclusions We identified three specific circulating miRNAs that are able to discriminate between IA patients and controls. Follow-up studies should assess if these miRNAs may be used biomarkers for identifying individuals at high risk of IA development and its subsequent rupture.	[Meeuwsen, John A. L.; van't Hof, Femke N. G.; van Rheenen, Wouter; Rinkel, Gabriel J. E.; Veldink, Jan H.; Ruigrok, Ynte M.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Ruigrok, YM (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, Utrecht, Netherlands.	ij.m.rugrok@umcutrecht.nl			clinical fellowship grant from The Netherlands Organization for Scientific Research (NWO) [40-00703-98-13533]; Netherlands Brain Foundation [2012(1)-115]	clinical fellowship grant from The Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Brain Foundation	YMR was supported by a clinical fellowship grant from The Netherlands Organization for Scientific Research (NWO) (project no. 40-00703-98-13533). This work was supported by The Netherlands Brain Foundation, project no. 2012(1)-115. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bekelis K, 2016, J NEUROSURG, V125, P1390, DOI 10.3171/2015.11.JNS151841; Biros E, 2014, CLIN SCI, V126, P795, DOI 10.1042/CS20130599; Bor ASE, 2008, BRAIN, V131, P2662, DOI 10.1093/brain/awn187; Bor ASE, 2010, NEUROLOGY, V74, P1671, DOI 10.1212/WNL.0b013e3181e04297; Bor ASE, 2014, LANCET NEUROL, V13, P385, DOI 10.1016/S1474-4422(14)70021-3; BROMBERG JEC, 1995, BRIT MED J, V311, P288, DOI 10.1136/bmj.311.7000.288; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Condorelli G, 2014, J AM COLL CARDIOL, V63, P2177, DOI 10.1016/j.jacc.2014.01.050; Jiang YG, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-36; Jin HW, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-296; Lee HJ, 2013, J KOREAN NEUROSURG S, V53, P72, DOI 10.3340/jkns.2013.53.2.72; Li PX, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000972; Liu DH, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0188-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McManus DD, 2015, NAT REV CARDIOL, V12, P711, DOI 10.1038/nrcardio.2015.101; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; R Core Team, 2012, R LANG ENV STAT COMP; Raaymakers TWM, 1999, NEW ENGL J MED, V341, P1344; Roder C, 2012, NEUROSCIENCE, V201, P105, DOI 10.1016/j.neuroscience.2011.10.033; Stather PW, 2015, BRIT J SURG, V102, P755, DOI 10.1002/bjs.9802; Van 't Hof FNG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139352; Vlak MHM, 2013, J NEUROL NEUROSUR PS, V84, P619, DOI 10.1136/jnnp-2012-303783; Wermer MJH, 2008, NEUROLOGY, V70, P2053, DOI 10.1212/01.wnl.0000304372.01248.02; Wermer MJH, 2005, STROKE, V36, P2394, DOI 10.1161/01.STR.0000185686.28035.d2; Wermer MJH, 2005, BRAIN, V128, P2421, DOI 10.1093/brain/awh587; Wu X, 2015, CELL MOL BIOL, V61, P44; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yasuno K, 2011, P NATL ACAD SCI USA, V108, P19707, DOI 10.1073/pnas.1117137108; Yasuno K, 2010, NAT GENET, V42, P420, DOI 10.1038/ng.563; Zhang J, 2008, INT J STROKE, V3, P272, DOI 10.1111/j.1747-4949.2008.00224.x; Zhang WW, 2015, CLIN BIOCHEM, V48, P988, DOI 10.1016/j.clinbiochem.2015.04.016	32	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176558	10.1371/journal.pone.0176558	http://dx.doi.org/10.1371/journal.pone.0176558			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459827	Green Published, gold, Green Submitted			2022-12-26	WOS:000400645000037
J	Huber, F; Merceron, A; Madec, Y; Gadio, G; About, V; Pastre, A; Coupez, I; Adenis, A; Adriouch, L; Nacher, M				Huber, Florence; Merceron, Alice; Madec, Yoann; Gadio, Gueda; About, Vincent; Pastre, Agathe; Coupez, Isabelle; Adenis, Antoine; Adriouch, Leila; Nacher, Mathieu			High mortality among male HIV-infected patients after prison release: ART is not enough after incarceration with HIV	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY USE; FRENCH-GUIANA; MEDICAL-CARE; ALL-CAUSE; INMATES; PEOPLE; DEATH; RISK; JAIL; DETERMINANTS	Context French Guiana is a South American French territory, where HIV prevalence consistently exceeds 1% in the adult population. In the only correctional facility, HIV prevalence fluctuates at around 4%. Aims After describing the population of HIV-positive inmates, we aimed to evaluate mortality after release from the correctional facility, and to identify its predictive factors. Rationale Outside North American settings, data on treatment outcome and vital status of HIV-positive former inmates are scarce. There were no data in French Guiana. Filling this gap represents a basis for potential improvements. Methods All HIV-infected adults released from an incarceration of 30 days or more, between 2007 and 2013, were enrolled in a retrospective cohort study. Mortality was described over time, one to seven years following release, using Kaplan-Meier estimates. Factors associated with mortality were identified through a non-parametric survival regression model. Results 147 former inmates were included. The male to female ratio was 4.4. The median age was 37.3 years. The majority were migrants, 25.8% were homeless, 70.1% suffered from substance abuse, with 34.0% of crack-cocaine users. On admission, 78.1% had an early HIV-stage infection (CDC-stage A), with a median CD4 count of 397.5/mm3, 34.0% had one comorbidity, mainly hypertension. Upon release, 50.3% were on ART. Reasons for not being treated were not fulfilling the criteria for 74.6%, and refusing for 15.1%. Before release, 84.5% of the patients on ART had a viral load <= 200cp/ml. After release, 8.2% of the cohort had died, with a crude incidence of 33.8/1000 person-years. All recorded deaths were males, with an incidence of 42.2/1000 person-years. Comparing with the age-specific mortality rates for males in French Guiana, the standardized mortality ratio was 14.8. In multivariate analysis, factors associated with death were age and CD4 count before release. Conclusion Despite access to ART while incarcerated, with good virological outcome, the post-release mortality was very high for males, almost 15 times what is observed in the general male population living in French Guiana, after age standardization. Access to ART in correctional facilities may be a necessary, but not sufficient condition to protect male inmates from death after release.	[Huber, Florence; Adriouch, Leila; Nacher, Mathieu] Cayenne Gen Hosp, COREVIH, Cayenne, French Guiana, France; [Huber, Florence] Cayenne Gen Hosp, Day Hosp, Cayenne, French Guiana, France; [Huber, Florence] Reseau Kikiwi, Cayenne, French Guiana, France; [Merceron, Alice; Nacher, Mathieu] Univ French Guiana, Fac Med Hyacinthe Basturaud, Cayenne, French Guiana, France; [Madec, Yoann] Pasteur Inst, Emerging Dis Epidemiol Unit, Paris, France; [Gadio, Gueda; Adenis, Antoine; Nacher, Mathieu] Cayenne Gen Hosp, INSERM, CIC 1424, Ctr Invest Clin Epidemiol Clin Antilles Guyane, Cayenne, French Guiana, France; [About, Vincent; Pastre, Agathe; Coupez, Isabelle] Cayenne Gen Hosp, UCSA, Cayenne, French Guiana, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Huber, F (corresponding author), Cayenne Gen Hosp, COREVIH, Cayenne, French Guiana, France.; Huber, F (corresponding author), Cayenne Gen Hosp, Day Hosp, Cayenne, French Guiana, France.; Huber, F (corresponding author), Reseau Kikiwi, Cayenne, French Guiana, France.	florence.huber@ch-cayenne.fr	Adenis, Antoine/AAI-1059-2021; nacher, mathieu/AAH-4796-2021	Adenis, Antoine/0000-0003-4000-4981; nacher, mathieu/0000-0001-9397-3204; Madec, Yoann/0000-0002-6201-1261				About V., 2014, RAPPORT ANNUEL ACTIV; Aidala AA, 2016, AM J PUBLIC HEALTH, V106, pE1, DOI 10.2105/AJPH.2015.302905; Althoff AL, 2013, AIDS BEHAV, V17, P156, DOI 10.1007/s10461-012-0372-1; Ayhan G, RISQUE SUICIDAIRE FA; Baillargeon J, 1999, AIDS PATIENT CARE ST, V13, P355, DOI 10.1089/apc.1999.13.355; Baillargeon J, 1999, INT J STD AIDS, V10, P22, DOI 10.1258/0956462991913033; Baillargeon J, 2009, JAMA-J AM MED ASSOC, V301, P848, DOI 10.1001/jama.2009.202; Baillargeon JG, 2010, PUBLIC HEALTH REP, V125, P64, DOI 10.1177/00333549101250S109; Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Buchanan David, 2009, Am J Public Health, V99 Suppl 3, pS675, DOI 10.2105/AJPH.2008.137810; Center for Disease Control and Prevention (CDC), 2011, MMWR-MORBID MORTAL W, P60; Chen NE, 2013, AIDS BEHAV, V17, P2654, DOI 10.1007/s10461-011-0080-2; Clements-Nolle K, 2008, AM J PUBLIC HEALTH, V98, P661, DOI 10.2105/AJPH.2007.112656; Combessie P., 2009, SOCIOLOGIE PRISON; Departement de La Guyane, RES STAT; Dolan K, 2016, LANCET LOND ENGL; Dolan K, 2007, LANCET INFECT DIS, V7, P32, DOI 10.1016/S1473-3099(06)70685-5; Kariminia A, 2007, INT J EPIDEMIOL, V36, P310, DOI 10.1093/ije/dyl225; Lemly DC, 2009, J INFECT DIS, V199, P991, DOI 10.1086/597124; Lert F., 2013, Bulletin Epidemiologique Hebdomadaire, P300; Lieb S, 2002, J ACQ IMMUN DEF SYND, V30, P351, DOI [10.1097/01.QAI.0000014766.47046.81, 10.1097/00126334-200207010-00012]; Marie C-V, 2012, MIGRATIONS FAMILLE V; Meyer JP, 2014, LANCET HIV, V1, pE77, DOI 10.1016/S2352-3018(14)70022-0; Meyer JP, 2014, JAMA INTERN MED, V174, P721, DOI 10.1001/jamainternmed.2014.601; Nacher M, 2010, INT J STD AIDS, V21, P359, DOI 10.1258/ijsa.2010.009570; Nacher M, 2009, AIDS, V23, P2223, DOI 10.1097/QAD.0b013e32833147c2; Nunn A, 2010, J URBAN HEALTH, V87, P954, DOI 10.1007/s11524-010-9496-7; Preston S, PSC WORK PAP SER U P; Rich JD, 2001, J URBAN HEALTH, V78, P279, DOI 10.1093/jurban/78.2.279; Rich JD, 2016, LANCET, V388, P1103, DOI 10.1016/S0140-6736(16)30379-8; Rosen DL, 2016, JAIDS-J ACQ IMM DEF, V71, pE85, DOI 10.1097/QAI.0000000000000889; Rosen DL, 2015, AIDS CARE, V27, P545, DOI 10.1080/09540121.2014.989486; Rosen DL, 2011, ANN EPIDEMIOL, V21, P719, DOI 10.1016/j.annepidem.2011.04.007; Rosen DL, 2009, AM J PUBLIC HEALTH, V99, P1123, DOI 10.2105/AJPH.2007.133389; Rosen DL, 2008, AM J PUBLIC HEALTH, V98, P2278, DOI 10.2105/AJPH.2007.121855; Semaille C, 2013, EURO SURVEILL B EUR, V18; Springer SA, 2004, CLIN INFECT DIS, V38, P1754, DOI 10.1086/421392; Stephenson BL, 2005, PUBLIC HEALTH REP, V120, P84, DOI 10.1177/003335490512000114; Treyens P-E, RENOVATION TAUX CHOM; Wohl DA, 2011, AIDS BEHAV, V15, P356, DOI 10.1007/s10461-010-9843-4; Wolitski RJ, 2010, AIDS BEHAV, V14, P493, DOI 10.1007/s10461-009-9643-x; World Health Organization, 2007, GUID PROV IN HIV TES	43	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0175740	10.1371/journal.pone.0175740	http://dx.doi.org/10.1371/journal.pone.0175740			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET6EO	28453525	gold, Green Published, Green Submitted			2022-12-26	WOS:000400383900005
J	Gao, HS; Zhao, Q; Song, ZW; Yang, ZC; Wu, Y; Tang, SS; Alahdal, M; Zhang, YF; Jin, L				Gao, Huashan; Zhao, Qian; Song, Ziwei; Yang, Zhaocong; Wu, You; Tang, Shanshan; Alahdal, Murad; Zhang, Yanfeng; Jin, Liang			PGLP-1, a novel long-acting dual-function GLP-1 analog, ameliorates streptozotocin-induced hyperglycemia and inhibits body weight loss	FASEB JOURNAL			English	Article						beta-cell mass; beta-oxidation; gluconeogenesis; insulinomimetic; insulinotropic	GLUCAGON-LIKE PEPTIDE-1; BETA-CELL MASS; HEPATIC GLUCONEOGENESIS; INSULIN SENSITIVITY; DIABETES-MELLITUS; CLEAVAGE PRODUCT; LIPID-METABOLISM; OBESE MICE; 9-36 AMIDE; IN-VIVO	It is well known that glucagon-like peptide 1 (GLP-1) has antidiabetic action. It has 2 distinct functions, an insulinotropic effect dependent on GLP-1 receptor (GLP-1R) and an insulinomimetic effect independent of GLP-1R. However, use of GLP-1 in vivo is limited by its short half-life. Therefore, our lab designed PGLP-1, a novel 2-function candidate peptide as a potential substitute. Using a streptozotocin-induced hyperglycemic mouse model, we demonstrated in vitro and in vivo that PGLP-1 had insulinotropic actions dependent on GLP-1R and insulinomimetic functions independent of GLP-1R. PGLP-1 treatment increased islet beta-cell mass, plasma insulin, and C-peptide levels and Ki-67-immunoreactive beta-cell numbers, verifying that PGLP-1 can work as a short GLP-1R agonist, similar to commercially available exendin-4. Additionally, PGLP-1 improved insulin sensitivity, inhibited gluconeogenesis by increasing expression of AMPK and receptor subfamily 0, group B, member 2 (SHP), and inhibited body weight loss by inhibiting beta-oxidation, suggesting that PGLP-1 had insulinomimetic action. Taken together, these data indicated that PGLP-1, as a dual-function peptide, improved glycemic control and inhibited body weight loss, suggesting it could be useful for type 1 diabetes mellitus patients as an adjunctive therapy to insulin.	[Gao, Huashan; Zhao, Qian; Song, Ziwei; Yang, Zhaocong; Wu, You; Tang, Shanshan; Alahdal, Murad; Zhang, Yanfeng; Jin, Liang] China Pharmaceut Univ, Sch Life Sci & Technol, State Key Lab Nat Med, Jiangsu Key Lab Drug Screening, Nanjing, Jiangsu, Peoples R China; [Gao, Huashan] Pingdingshan Univ, Coll Chem & Chem Engn, Pingdingshan, Peoples R China	China Pharmaceutical University; Pingdingshan University	Jin, L (corresponding author), China Pharmaceut Univ, Sch Life Sci & Technol, State Key Lab Nat Med, Jiangsu Key Lab Drug Screening, 24 Tongjia Alley, Nanjing Shi 210009, Jiangsu Sheng, Peoples R China.	liangjin1975@cpu.edu.cm	Alahdal, Murad/AAO-2213-2020	Alahdal, Murad/0000-0003-1444-6014	National High Technology Research and Development Program of China (863 Program) [2015AA020314]; National Natural Science Foundation of China [81570696, 31270985]; Excellent Youth Foundation of Jiangsu Scientific Committee [BK20140029]; Fundamental Research Funds for the Central Universities [Z114037]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Top-Notch Academic Programs Project of Jiangsu Higher Education Institutions [PPZY2015A057]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Youth Foundation of Jiangsu Scientific Committee; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Top-Notch Academic Programs Project of Jiangsu Higher Education Institutions	This work was supported, in part, by a project funded by National High Technology Research and Development Program of China (863 Program; 2015AA020314), National Natural Science Foundation of China (81570696 and 31270985), Excellent Youth Foundation of Jiangsu Scientific Committee (BK20140029), Fundamental Research Funds for the Central Universities (Z114037), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and Top-Notch Academic Programs Project of Jiangsu Higher Education Institutions (PPZY2015A057).	Abu-Hamdah R, 2009, J CLIN ENDOCR METAB, V94, P1843, DOI 10.1210/jc.2008-1296; Ban K, 2008, CIRCULATION, V117, P2340, DOI 10.1161/CIRCULATIONAHA.107.739938; Bojic LA, 2014, J LIPID RES, V55, P1254, DOI 10.1194/jlr.M046037; Cai EP, 2012, DIABETES, V61, P1708, DOI 10.2337/db11-1344; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; DEACON CF, 1995, DIABETES, V44, P1126, DOI 10.2337/diabetes.44.9.1126; Devendra D, 2004, BMJ-BRIT MED J, V328, P750, DOI 10.1136/bmj.328.7442.750; Drucker DJ, 2003, ENDOCRINOLOGY, V144, P5145, DOI 10.1210/en.2003-1147; Elahi D, 2008, OBESITY, V16, P1501, DOI 10.1038/oby.2008.229; Farilla L, 2002, ENDOCRINOLOGY, V143, P4397, DOI 10.1210/en.2002-220405; Fitzgerald LR, 1999, ANAL BIOCHEM, V275, P54, DOI 10.1006/abio.1999.4295; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Giorda CB, 2014, ENDOCRINE, V46, P406, DOI 10.1007/s12020-014-0179-0; Giorda CB, 2014, ENDOCRINE, V46, P420, DOI 10.1007/s12020-014-0240-z; Holst JJ, 1999, TRENDS ENDOCRIN MET, V10, P229, DOI 10.1016/S1043-2760(99)00157-5; Hui HX, 2005, DIABETES-METAB RES, V21, P313, DOI 10.1002/dmrr.553; Ip W, 2013, AM J PHYSIOL-ENDOC M, V305, pE1348, DOI 10.1152/ajpendo.00376.2013; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Lee JM, 2010, J BIOL CHEM, V285, P32182, DOI 10.1074/jbc.M110.134890; Lee YS, 2007, DIABETES, V56, P1671, DOI 10.2337/db06-1182; LIKE AA, 1976, SCIENCE, V193, P415, DOI 10.1126/science.180605; Liu ZG, 2012, J ENDOCRINOL, V213, P143, DOI 10.1530/JOE-11-0328; MADSBAD S, 1980, ACTA ENDOCRINOL-COP, V95, P359, DOI 10.1530/acta.0.0950359; Meeran K, 1999, ENDOCRINOLOGY, V140, P244, DOI 10.1210/en.140.1.244; O'Harte FPM, 2000, BBA-GEN SUBJECTS, V1474, P13, DOI 10.1016/S0304-4165(99)00214-7; Oh KJ, 2013, ARCH PHARM RES, V36, P189, DOI 10.1007/s12272-013-0018-5; Perseghin G, 2005, DIABETOLOGIA, V48, P2615, DOI 10.1007/s00125-005-0014-5; ROSSINI AA, 1978, ENDOCRINOLOGY, V103, P1518, DOI 10.1210/endo-103-4-1518; Shao WJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE1263, DOI 10.1152/ajpendo.00600.2012; Sonne DP, 2008, REGUL PEPTIDES, V146, P243, DOI 10.1016/j.regpep.2007.10.001; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Szayna M, 2000, ENDOCRINOLOGY, V141, P1936, DOI 10.1210/en.141.6.1936; Taniguchi C. M., 2006, CELL METAB; Taniguchi CM, 2006, CELL METAB, V3, P343, DOI 10.1016/j.cmet.2006.04.005; Tiwary P, 2015, P NATL ACAD SCI USA, V112, pE386, DOI 10.1073/pnas.1424461112; Tomas E, 2011, DIABETES OBES METAB, V13, P26, DOI 10.1111/j.1463-1326.2010.01316.x; Tomas E, 2010, HORM METAB RES, V42, P657, DOI 10.1055/s-0030-1253421; Tomas E, 2015, DIABETES, V64, P2409, DOI 10.2337/db14-1708; Tomas E, 2010, TRENDS ENDOCRIN MET, V21, P59, DOI 10.1016/j.tem.2009.11.007; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Wan M, 2011, CELL METAB, V14, P516, DOI 10.1016/j.cmet.2011.09.001; Zhang JY, 2015, P NATL ACAD SCI USA, V112, P7954, DOI 10.1073/pnas.1506792112	44	12	13	1	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3527	3539		10.1096/fj.201700002R	http://dx.doi.org/10.1096/fj.201700002R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28461341				2022-12-26	WOS:000405932400028
J	Krementsova, EB; Furuta, K; Oiwa, K; Trybus, KM; Ali, MY				Krementsova, Elena B.; Furuta, Ken'ya; Oiwa, Kazuhiro; Trybus, Kathleen M.; Ali, M. Yusuf			Small teams of myosin Vc motors coordinate their stepping for efficient cargo transport on actin bundles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW DUTY RATIO; TUG-OF-WAR; MOLECULAR MOTORS; CYTOPLASMIC DYNEIN; IN-VITRO; VA; ENSEMBLES; INTERSECTIONS; MICROTUBULES; PROCESSIVITY	Myosin Vc (myoVc) is unique among vertebrate class V myosin isoforms in that it requires teams of motors to move continuously on single actin filaments. Single molecules of myoVc cannot take multiple hand-over-hand steps from one actin-binding site to the next without dissociating, in stark contrast to the well studied myosin Va (myoVa) isoform. At low salt, single myoVc motors can, however, move processively on actin bundles, and at physiologic ionic strength, even teams of myoVc motors require actin bundles to sustain continuous motion. Here, we linked defined numbers of myoVc or myoVa molecules to DNA nanostructures as synthetic cargos. Using total internal reflectance fluorescence microscopy, we compared the stepping behavior of myoVc versus myoVa ensembles and myoVc stepping patterns on single actin filaments versus actin bundles. Run lengths of both myoVc and myoVa teams increased with motor number, but only multiple myoVc motors showed a run-length enhancement on actin bundles compared with actin filaments. By resolving the stepping behavior of individual myoVc motors with a quantum dot bound to the motor domain, we found that coupling of two myoVc motors significantly decreased the futile back and side steps that were frequently observed for single myoVc motors. Changes in the inter-motor distance between two coupled myoVc motors affected stepping dynamics, suggesting that mechanical tension coordinates the stepping behavior of two myoVc motors for efficient directional motion. Our study provides a molecular basis to explain how teams of myoVc motors are suited to transport cargos such as zymogen granules on actin bundles.	[Krementsova, Elena B.; Trybus, Kathleen M.; Ali, M. Yusuf] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [Furuta, Ken'ya; Oiwa, Kazuhiro] Natl Inst Informat & Commun Technol, Adv ICT Res Inst, Kobe, Hyogo 6512492, Japan	University of Vermont; National Institute of Information & Communications Technology (NICT) - Japan	Trybus, KM (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, Hlth Sci Res Facil 132, Burlington, VT 05405 USA.; Ali, MY (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, Hlth Sci Res Facil 131, Burlington, VT 05405 USA.	kathleen.trybus@uvm.edu; yusuf.ali@med.uvm.edu	Oiwa, Kazuhiro/D-7721-2011	Oiwa, Kazuhiro/0000-0002-1281-113X	American Heart Association [12SDG11930002]; National Institutes of Health [GM078097];  [15KT0155]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078097] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association Grant 12SDG11930002 (to M. Y. A.), Grant-in-aid for Scientific Research, Japan, 15KT0155 (to K. F.), and National Institutes of Health Grant GM078097 (to K. M. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali MY, 2007, P NATL ACAD SCI USA, V104, P4332, DOI 10.1073/pnas.0611471104; Ali MY, 2016, BIOPHYS J, V111, P2228, DOI 10.1016/j.bpj.2016.09.046; Ali MY, 2013, TRAFFIC, V14, P70, DOI 10.1111/tra.12017; Ali MY, 2011, P NATL ACAD SCI USA, V108, pE535, DOI 10.1073/pnas.1104298108; Berger F, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.208101; Bui H, 2010, NANO LETT, V10, P3367, DOI 10.1021/nl101079u; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; Derr ND, 2012, SCIENCE, V338, P662, DOI 10.1126/science.1226734; Driller-Colangelo AR, 2016, CYTOSKELETON, V73, P693, DOI 10.1002/cm.21339; Furuta K, 2013, P NATL ACAD SCI USA, V110, P501, DOI 10.1073/pnas.1201390110; Gebhardt JCM, 2006, P NATL ACAD SCI USA, V103, P8680, DOI 10.1073/pnas.0510191103; Geron E, 2013, P NATL ACAD SCI USA, V110, P10652, DOI 10.1073/pnas.1303796110; Gross SP, 2002, J CELL BIOL, V156, P715, DOI 10.1083/jcb.200109047; Gunther LK, 2014, SCI REP-UK, V4, DOI 10.1038/srep04907; Hammer JA, 2012, NAT REV MOL CELL BIO, V13, P13, DOI 10.1038/nrm3248; Hill DB, 2004, EUR BIOPHYS J BIOPHY, V33, P623, DOI 10.1007/s00249-004-0403-6; Hodges AR, 2009, CURR BIOL, V19, P2121, DOI 10.1016/j.cub.2009.10.069; Jacobs DT, 2009, MOL BIOL CELL, V20, P4471, DOI 10.1091/mbc.E08-08-0865; Jamison DK, 2010, BIOPHYS J, V99, P2967, DOI 10.1016/j.bpj.2010.08.025; Kad NM, 2008, J BIOL CHEM, V283, P17477, DOI 10.1074/jbc.M800539200; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Klumpp S, 2005, P NATL ACAD SCI USA, V102, P17284, DOI 10.1073/pnas.0507363102; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Larson AG, 2009, PHYS CHEM CHEM PHYS, V11, P4890, DOI 10.1039/b900968j; Lu HL, 2012, J BIOL CHEM, V287, P27753, DOI 10.1074/jbc.M112.371393; McKenney RJ, 2014, SCIENCE, V345, P337, DOI 10.1126/science.1254198; Muller MJI, 2010, BIOPHYS J, V98, P2610, DOI 10.1016/j.bpj.2010.02.037; Nelson SR, 2014, P NATL ACAD SCI USA, V111, pE3986, DOI 10.1073/pnas.1406535111; Nelson SR, 2011, METHODS MOL BIOL, V778, P111, DOI 10.1007/978-1-61779-261-8_8; Oguchi Y, 2010, NAT CHEM BIOL, V6, P300, DOI [10.1038/NCHEMBIO.322, 10.1038/nchembio.322]; Rogers AR, 2009, PHYS CHEM CHEM PHYS, V11, P4882, DOI 10.1039/b900964g; Schroeder HW, 2010, CURR BIOL, V20, P687, DOI 10.1016/j.cub.2010.03.024; Sladewski TE, 2016, CURR BIOL, V26, P2202, DOI 10.1016/j.cub.2016.06.029; Takagi Y, 2008, J BIOL CHEM, V283, P8527, DOI 10.1074/jbc.M709150200; Torisawa T, 2014, NAT CELL BIOL, V16, P1118, DOI 10.1038/ncb3048; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Watanabe S, 2008, J BIOL CHEM, V283, P10581, DOI 10.1074/jbc.M707657200; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	39	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10998	11008		10.1074/jbc.M117.780791	http://dx.doi.org/10.1074/jbc.M117.780791			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28476885	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000404391000021
J	Qin, YW; Peng, YZ; Zhao, W; Pan, JP; Ksiezak-Reding, H; Cardozo, C; Wu, YJ; Pajevic, PD; Bonewald, LF; Bauman, WA; Qin, WP				Qin, Yiwen; Peng, Yuanzhen; Zhao, Wei; Pan, Jianping; Ksiezak-Reding, Hanna; Cardozo, Christopher; Wu, Yingjie; Pajevic, Paola Divieti; Bonewald, Lynda F.; Bauman, William A.; Qin, Weiping			Myostatin inhibits osteoblastic differentiation by suppressing osteocyte-derived exosomal microRNA-218: A novel mechanism in muscle-bone communication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; MASS; OSTEOCLASTOGENESIS; DENSITY; SYSTEM; PLASMA; RANKL; MICE	Muscle and bone are closely associated in both anatomy and function, but the mechanisms that coordinate their synergistic action remain poorly defined. Myostatin, a myokine secreted by muscles, has been shown to inhibit muscle growth, and the disruption of the myostatin gene has been reported to cause muscle hypertrophy and increase bone mass. Extracellular vesicle-exosomes that carry microRNA (miRNA), mRNA, and proteins are known to perform an important role in cell-cell communication. We hypothesized that myostatin may play a crucial role in muscle-bone interactions and may promote direct effects on osteocytes and on osteocyte-derived exosomal miRNAs, thereby indirectly influencing the function of other bone cells. We report herein that myostatin promotes expression of several bone regulators such as sclerostin (SOST), DKK1, and RANKL in cultured osteocytic (Ocy454) cells, concomitant with the suppression of miR-218 in both parent Ocy454 cells and derived exosomes. Exosomes produced by Ocy454 cells that had been pre-treated with myostatin could be taken up by osteoblastic MC3T3 cells, resulting in a marked reduction of Runx2, a key regulator of osteoblastic differentiation, and in decreased osteoblastic differentiation via the down-regulation of the Wnt signaling pathway. Importantly, the inhibitory effect of myostatin-modified osteocytic exosomes on osteoblast differentiation is completely reversed by expression of exogenous miR-218, through a mechanism involving miR-218-mediated inhibition of SOST. Together, our findings indicate that myostatin directly influences osteocyte function and thereby inhibits osteoblastic differentiation, at least in part, through the suppression of osteocyte-derived exosomal miR-218, suggesting a novel mechanism in muscle-bone communication.	[Qin, Yiwen; Peng, Yuanzhen; Zhao, Wei; Pan, Jianping; Cardozo, Christopher; Bauman, William A.; Qin, Weiping] James J Peters Vet Affairs Med Ctr, Natl Ctr Med Consequences Spinal Cord Injury, Bronx, NY 10468 USA; [Cardozo, Christopher; Wu, Yingjie; Bauman, William A.; Qin, Weiping] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Cardozo, Christopher; Bauman, William A.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Ksiezak-Reding, Hanna] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Wu, Yingjie] Dalian Med Univ, Inst Gene Engn Anim Models Human Dis, Dalian 116044, Peoples R China; [Pajevic, Paola Divieti] Boston Univ, Dept Mol & Cell Biol, Boston, MA 02215 USA; [Bonewald, Lynda F.] Indiana Univ Sch Med, Indiana Ctr Musculoskeletal Hlth, Indianapolis, IN 46202 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Dalian Medical University; Boston University; Indiana University System; Indiana University Bloomington	Qin, WP (corresponding author), James J Peters Vet Affairs Med Ctr, 130 West Kingsbridge Rd, Bronx, NY 10468 USA.	weiping.qin@mssm.edu	Zhao, Wei/A-2206-2010; Cardozo, Christopher/R-6021-2019; Bonewald, Lynda/Q-3638-2019; Pajevic, Paola Divieti/M-3236-2019	Cardozo, Christopher/0000-0003-4013-2537; Zhao, Wei/0000-0002-3449-2395; Divieti Pajevic, Paola/0000-0001-9853-9837	Veterans Health Administration, Rehabilitation Research, and Development Service [5I01RX001313, I01RX002089, 5I01RX000687, B9212-C, B2020-C]; NIH [UH3AR059655]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [UH3AR059655] Funding Source: NIH RePORTER; Veterans Affairs [I01RX002089, I01RX001313, I01RX000687] Funding Source: NIH RePORTER	Veterans Health Administration, Rehabilitation Research, and Development Service(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Veterans Health Administration, Rehabilitation Research, and Development Service (Grants 5I01RX001313, I01RX002089, and 5I01RX000687 to W. Q.; B9212-C and B2020-C to W. A. B.). This work was also supported by NIH-UH3AR059655 to P. D P. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andrews N. A., 2013, IBMS BONEKEY, V10, P377, DOI [10.1038/bonekey.2013.111, DOI 10.1038/BONEKEY.2013.111]; Arounleut P, 2013, EXP GERONTOL, V48, P898, DOI 10.1016/j.exger.2013.06.004; Batra N, 2014, J BIOL CHEM, V289, P10582, DOI 10.1074/jbc.M114.550608; Bauman W.A., 2013, OSTEOPOROSIS, VFourth, P1139, DOI DOI 10.1016/B978-0-12-415853-5.00047-9; Bauman WA, 1999, OSTEOPOROSIS INT, V10, P123, DOI 10.1007/s001980050206; Bloomfield Susan A, 2010, Curr Osteoporos Rep, V8, P91, DOI 10.1007/s11914-010-0013-4; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Bowser M, 2013, EXP GERONTOL, V48, P290, DOI 10.1016/j.exger.2012.11.004; Brown JC, 2016, J CACHEXIA SARCOPENI, V7, P290, DOI 10.1002/jcsm.12073; Buehring B, 2013, CURR OSTEOPOROS REP, V11, P407, DOI 10.1007/s11914-013-0160-5; Burra S, 2010, P NATL ACAD SCI USA, V107, P13648, DOI 10.1073/pnas.1009382107; Clarke BL, 2010, RADIOL CLIN N AM, V48, P483, DOI 10.1016/j.rcl.2010.02.014; Colaianni G, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/902186; Colaianni G, 2015, P NATL ACAD SCI USA, V112, P12157, DOI 10.1073/pnas.1516622112; Dankbar B, 2015, NAT MED, V21, P1085, DOI 10.1038/nm.3917; Elkasrawy MN, 2010, J MUSCULOSKEL NEURON, V10, P56; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Hamrick MW, 2010, J MUSCULOSKEL NEURON, V10, P64; Hamrick Mark W, 2012, Bonekey Rep, V1, P60, DOI 10.1038/bonekey.2012.60; Hamrick MW, 2011, EXERC SPORT SCI REV, V39, P43, DOI 10.1097/JES.0b013e318201f601; Hassan MQ, 2012, J BIOL CHEM, V287, P42084, DOI 10.1074/jbc.M112.377515; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Ito N, 2013, J STEROID BIOCHEM, V136, P183, DOI 10.1016/j.jsbmb.2012.09.029; Jacobs CR, 2010, ANNU REV BIOMED ENG, V12, P369, DOI 10.1146/annurev-bioeng-070909-105302; Jahn K, 2012, EUR CELLS MATER, V24, P197; Jiang SD, 2006, CLIN ENDOCRINOL, V65, P555, DOI 10.1111/j.1365-2265.2006.02683.x; Kalajzic I, 2013, BONE, V54, P296, DOI 10.1016/j.bone.2012.09.040; Kamioka H, 2001, BONE, V28, P145, DOI 10.1016/S8756-3282(00)00421-X; Karinkanta S, 2010, NAT REV ENDOCRINOL, V6, P396, DOI 10.1038/nrendo.2010.70; Kim JS, 2005, AM J PHYSIOL-ENDOC M, V288, pE1110, DOI 10.1152/ajpendo.00464.2004; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Kogianni G, 2008, J BONE MINER RES, V23, P915, DOI 10.1359/JBMR.080207; Kogure Takayuki, 2013, Methods Mol Biol, V1024, P11, DOI 10.1007/978-1-62703-453-1_2; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Kubota T, 2009, J BONE MINER METAB, V27, P265, DOI 10.1007/s00774-009-0064-8; Lasser C, 2012, JOVE-J VIS EXP, DOI 10.3791/3037; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Leigey D, 2009, SPORTS HEALTH, V1, P508, DOI 10.1177/1941738109347979; Li DF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10872; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Mathias Rommel A., 2009, V528, P227, DOI 10.1007/978-1-60327-310-7_16; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Pearsall RS, 2008, P NATL ACAD SCI USA, V105, P7082, DOI 10.1073/pnas.0711263105; Qin WP, 2013, J BIOL CHEM, V288, P13511, DOI 10.1074/jbc.M113.454892; Qin WP, 2010, ANN NY ACAD SCI, V1211, P66, DOI 10.1111/j.1749-6632.2010.05806.x; Qin Weiping, 2010, Curr Osteoporos Rep, V8, P212, DOI 10.1007/s11914-010-0029-9; Rittweger J, 2000, BONE, V27, P319, DOI 10.1016/S8756-3282(00)00327-6; Schoenau E., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P232; Spatz JM, 2015, J BIOL CHEM, V290, P16744, DOI 10.1074/jbc.M114.628313; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Takahashi N, 2011, FRONT BIOSCI-LANDMRK, V16, P21, DOI 10.2741/3673; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983; van Noort M, 2002, EXP CELL RES, V276, P264, DOI 10.1006/excr.2002.5520; Wijenayaka AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025900; Woo SM, 2011, J BONE MINER RES, V26, P2634, DOI 10.1002/jbmr.465; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zeringer Emily, 2013, World J Methodol, V3, P11, DOI 10.5662/wjm.v3.i1.11; Zhu J, 2007, J BIOL CHEM, V282, P25852, DOI 10.1074/jbc.M704146200	66	133	153	3	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					11021	11033		10.1074/jbc.M116.770941	http://dx.doi.org/10.1074/jbc.M116.770941			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28465350	Green Published, hybrid			2022-12-26	WOS:000404391000023
J	Farquhar, M; Penfold, C; Benson, J; Lovick, R; Mahadeva, R; Howson, S; Burkin, J; Booth, S; Gilligan, D; Todd, C; Ewing, G				Farquhar, Morag; Penfold, Clarissa; Benson, John; Lovick, Roberta; Mahadeva, Ravi; Howson, Sophie; Burkin, Julie; Booth, Sara; Gilligan, David; Todd, Christopher; Ewing, Gail			Six key topics informal carers of patients with breathlessness in advanced disease want to learn about and why: MRC phase I study to inform an educational intervention	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; OF-LIFE CARE; PALLIATIVE CARE; LUNG-CANCER; SUPPORT NEEDS; FAMILY CARERS; CAREGIVERS; END; PEOPLE; HEALTH	Introduction Breathlessness is a common symptom of advanced disease placing a huge burden on patients, health systems and informal carers (families and friends providing daily help and support). It causes distress and isolation. Carers provide complex personal, practical and emotional support yet often feel ill-prepared to care. They lack knowledge and confidence in their caring role. The need to educate carers and families about breathlessness is established, yet we lack robustly developed carer-targeted educational interventions to meet their needs. Methods We conducted a qualitative interview study with twenty five purposively-sampled patientcarer dyads living with breathlessness in advanced disease (half living with advanced cancer and half with advanced chronic obstructive pulmonary disease (COPD). We sought to identify carers' educational needs (including what they wanted to learn about) and explore differences by diagnostic group in order to inform an educational intervention for carers of patients with breathlessness in advanced disease. Results There was a strong desire among carers for an educational intervention on breathlessness. Six key topics emerged as salient for them: 1) understanding breathlessness, 2) managing anxiety, panic and breathlessness, 3) managing infections, 4) keeping active, 5) living positively and 6) knowing what to expect in the future. A cross-cutting theme was relationship management: there were tensions within dyads resulting from mismatched expectations related to most topics. Carers felt that knowledge-gains would not only help them to support the patient better, but also help them to manage their own frustrations, anxieties, and quality of life. Different drivers for education need were identified by diagnostic group, possibly related to differences in caring role duration and resulting impacts. Conclusion Meeting the educational needs of carers requires robustly developed and evaluated interventions. This study provides the evidence-base for the content of an educational intervention for carers of patients with breathlessness in advanced disease.	[Farquhar, Morag] Univ East Anglia, Sch Hlth Sci, Norwich, Norfolk, England; [Penfold, Clarissa; Benson, John] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Lovick, Roberta] Lay Carer Representat, Norwich, Norfolk, England; [Mahadeva, Ravi] Univ Cambridge, Dept Resp Med, Hosp NHS Trust, Cambridge, England; [Howson, Sophie] SK Nurses, St Ives, Cambs, England; [Burkin, Julie] Univ Cambridge, Hosp NHS Trust, Palliat Care Team, Cambridge, England; [Burkin, Julie] Univ Cambridge, Hosp NHS Trust, Palliat Care Team, Cambridge, England; [Booth, Sara; Gilligan, David] Univ Cambridge, Dept Oncol, Cambridge, England; [Todd, Christopher] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester, Lancs, England; [Ewing, Gail] Univ Cambridge, Ctr Family Res, Cambridge, England	University of East Anglia; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Manchester; University of Cambridge	Farquhar, M (corresponding author), Univ East Anglia, Sch Hlth Sci, Norwich, Norfolk, England.	mcf22@medschl.cam.ac.uk	Todd, Chris/A-7904-2010; Todd, Chris/AAD-8661-2022; Farquhar, Morag/C-5666-2015	Todd, Chris/0000-0001-6645-4505; Todd, Chris/0000-0001-6645-4505; Farquhar, Morag/0000-0001-7991-7679	Dimbleby Cancer Care; Cambridge National Institute for Health Research (NIHR) Biomedical Research Centre	Dimbleby Cancer Care; Cambridge National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR))	Dimbleby Cancer Care (study funder - no grant number allocated) http://www.dimblebycancercare.org/. The study was funded by Dimbleby Cancer Care. The funder provided support in the form of salaries for authors [CP, MF, GE], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section. SH was latterly employed by SKNurses, however SKNurses played no role in the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are extremely grateful for the time and contribution of participating patients and informal carers. We thank CRN-Eastern, practices within Cambridgeshire and Peterborough CCG and clinical teams at Cambridge University Hospitals NHS Foundation Trust and Papworth for supporting participant recruitment. We thank Kevin Houghton for administrative support and Dimbleby Cancer Care for study funding. RM is supported by Cambridge National Institute for Health Research (NIHR) Biomedical Research Centre.	Aoun SM, 2005, PALLIATIVE MED, V19, P551, DOI 10.1191/0269216305pm1053oa; Bee PE, 2009, J CLIN NURS, V18, P1379, DOI 10.1111/j.1365-2702.2008.02405.x; Bergs D, 2002, J CLIN NURS, V11, P613, DOI 10.1046/j.1365-2702.2002.00651.x; Boland JW, 2016, J PALLIAT MED, V19, P549, DOI 10.1089/jpm.2015.0355; Booth S, 2008, NAT CLIN PRACT ONCOL, V5, P90, DOI 10.1038/ncponc1034; Booth Sara, 2006, Palliat Support Care, V4, P287; Booth Sara, 2003, Palliat Support Care, V1, P337; Booth Sara, 2011, Curr Opin Support Palliat Care, V5, P77, DOI 10.1097/SPC.0b013e3283460c93; Boyle AH., 2009, SO ONLINE J NURSING, V9, P5; British Thoracic Society, 2006, BURD LUNG DIS; British Thoracic Society Pulmonary Rehabilitation Guideline Group, 2013, THORAX, V68, pS2; Bryant J, 2016, INT J CHRONIC OBSTR, V11, P1587, DOI 10.2147/COPD.S107571; Buckner L., 2015, VALUING CARERS 2015; Campbell NC, 2007, BMJ-BRIT MED J, V334, P455, DOI 10.1136/bmj.39108.379965.BE; Candy B, 2011, COCHRANE DB SYST REV, V15; Caress AL, 2009, J CLIN NURS, V18, P479, DOI 10.1111/j.1365-2702.2008.02556.x; Corbin J M, 1984, Image J Nurs Sch, V16, P109; Corry M, 2015, J ADV NURS, V71, P718, DOI 10.1111/jan.12523; Cruz J, 2017, HEALTH SOC CARE COMM, V25, P11, DOI 10.1111/hsc.12292; Currow David C, 2008, Int J Chron Obstruct Pulmon Dis, V3, P753; Currow DC, 2010, J PAIN SYMPTOM MANAG, V39, P680, DOI 10.1016/j.jpainsymman.2009.09.017; Dudgeon DJ, 2001, J PAIN SYMPTOM MANAG, V21, P95, DOI 10.1016/S0885-3924(00)00258-X; Edmonds P, 2001, PALLIATIVE MED, V15, P287, DOI 10.1191/026921601678320278; Ewing G, 2004, PALLIATIVE MED, V18, P452, DOI 10.1191/0269216304pm905oa; Ewing G, 2017, J PAIN SYMPTOM MANAG, V53, P265, DOI 10.1016/j.jpainsymman.2016.08.015; Ewing G, 2013, PALLIATIVE MED, V27, P244, DOI 10.1177/0269216312440607; Farquhar M, 2016, ERS MONOGRAPH, V73; Farquhar M, 2014, BMJ SUPPORT PALLI S1, V4, pA8; Farquhar M, PALLIATIVE NURSING P; Farquhar M, 2016, J PAIN SYMPTOM MANAG, V52, P117, DOI 10.1016/j.jpainsymman.2015.12.341; Farquhar MC, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1304-6; Farquhar MC, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0194-2; Flemming K, 2016, PALL MED, V30, pS11; Fredman L, 2004, J AGING HEALTH, V16, P175, DOI 10.1177/0898264303262639; Funk L, 2010, PALLIATIVE MED, V24, P594, DOI 10.1177/0269216310371411; Gautun H, 2012, SCAND J PUBLIC HEALT, V40, P18, DOI 10.1177/1403494811425712; Gerrish K., 2008, PRIM HEALTH CARE RES, V9, P14; Goodridge D, 2008, RESP MED, V102, P885, DOI 10.1016/j.rmed.2008.01.007; Gore JM, 2000, THORAX, V55, P1000, DOI 10.1136/thorax.55.12.1000; Grant M, 2012, INT J NURS STUD, V49, P1459, DOI 10.1016/j.ijnurstu.2012.02.010; Gysels Marjolein H, 2009, Palliat Support Care, V7, P153, DOI 10.1017/S1478951509000200; Harding R, 2012, PALLIATIVE MED, V26, P7, DOI 10.1177/0269216311409613; Health and Safety Lab, 2009, PROJ MES MORT GREAT; Higginson IJ, 1999, J PUBLIC HEALTH MED, V21, P22, DOI 10.1093/pubmed/21.1.22; Howard C, 2010, PSYCHOL HEALTH MED, V15, P371, DOI 10.1080/13548506.2010.482142; Hudson Peter L, 2010, BMC Palliat Care, V9, P17, DOI 10.1186/1472-684X-9-17; Hynes G, 2012, J CLIN NURS, V21, P1068, DOI 10.1111/j.1365-2702.2011.03944.x; Malik FA, 2013, PALLIATIVE MED, V27, P647, DOI 10.1177/0269216313488812; Mansfield E, 2016, COPD J CHRONIC OBSTR; McPherson KM, 2014, INT J NURS STUD, V51, P418, DOI 10.1016/j.ijnurstu.2013.07.006; Morris SM, 2015, PALLIATIVE MED, V29, P487, DOI 10.1177/0269216314565706; MUERS MF, 1993, THORAX, V48, P339, DOI 10.1136/thx.48.4.339; Mularski Richard A, 2013, Ann Am Thorac Soc, V10, pS98, DOI 10.1513/AnnalsATS.201306-169ST; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Murray SA, 2004, PALLIATIVE MED, V18, P39, DOI 10.1191/0269216304pm837oa; Murray SA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2581; Northouse LL, 2006, RES NURS HEALTH, V29, P199, DOI 10.1002/nur.20128; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Ransom S, 2006, RES NURS HEALTH, V29, P190, DOI 10.1002/nur.20129; Ritchie J, 2002, ANAL QUALITATIVE DAT, P187; ROGERS A, 1986, TEACHING ADULTS; Rolls L, 2011, PALLIATIVE MED, V25, P650, DOI 10.1177/0269216310373165; Schumacher KL, 2000, RES NURS HEALTH, V23, P191, DOI 10.1002/1098-240X(200006)23:3<191::AID-NUR3>3.0.CO;2-B; Simpson A Catherine, 2010, Int J Chron Obstruct Pulmon Dis, V5, P141; Stajduhar KI, 2010, PALLIATIVE MED, V24, P573, DOI 10.1177/0269216310371412; Stajduhar KI, 2008, SOC SCI MED, V67, P1789, DOI 10.1016/j.socscimed.2008.09.012; Walsh K, 2007, BRIT J PSYCHIAT, V190, P142, DOI 10.1192/bjp.bp.106.023960	67	29	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177081	10.1371/journal.pone.0177081	http://dx.doi.org/10.1371/journal.pone.0177081			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SX	28475655	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000400649500044
J	Gu, YF; Van Nostrand, JD; Wu, LY; He, ZL; Qin, YJ; Zhao, FJ; Zhou, JZ				Gu, Yunfu; Van Nostrand, Joy D.; Wu, Liyou; He, Zhili; Qin, Yujia; Zhao, Fang-Jie; Zhou, Jizhong			Bacterial community and arsenic functional genes diversity in arsenic contaminated soils from different geographic locations	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; PADDY SOILS; ABUNDANCE; METABOLISM; OXIDASE; RICE; MICROORGANISMS; RHIZOSPHERE; GROUNDWATER; SPECIATION	To understand how soil microbial communities and arsenic (As) functional genes respond to soil arsenic (As) contamination, five soils contaminated with As at different levels were collected from diverse geographic locations, incubated for 54 days under flooded conditions, and examined by both MiSeq sequencing of 16S rRNA gene amplicons and functional gene microarray (GeoChip 4.0). The results showed that both bacterial community structure and As functional gene structure differed among geographical locations. The diversity of As functional genes correlated positively with the diversity of 16S rRNA genes (P<0.05). Higher diversities of As functional genes and 16S rRNA genes were observed in the soils with higher available As. Soil pH, phosphate-extractable As, and amorphous Fe content were the most important factors in shaping the bacterial community structure and As transformation functional genes. Geographic location was also important in controlling both the bacterial community and As transformation functional potential. These findings provide insights into the variation of As transformation functional genes in soils contaminated with different levels of As at different geographic locations, and the impact of environmental As contamination on the soil bacterial community.	[Gu, Yunfu] Sichuan Agr Univ, Coll Resources Sci & Technol, Dept Microbiol, Chengdu, Peoples R China; [Van Nostrand, Joy D.; Wu, Liyou; He, Zhili; Qin, Yujia; Zhou, Jizhong] Univ Oklahoma, Inst Environm Genom, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Zhao, Fang-Jie] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China; [Zhao, Fang-Jie] Rothamsted Res, Sustainable Soil & Grassland Syst Dept, Harpenden, Herts, England; [Zhou, Jizhong] Tsinghua Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing, Peoples R China; [Zhou, Jizhong] Lawrence Berkeley Natl Lab, Earth Sci Div, Berkeley, CA 94720 USA	Sichuan Agricultural University; University of Oklahoma System; University of Oklahoma - Norman; Nanjing Agricultural University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Tsinghua University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Zhou, JZ (corresponding author), Univ Oklahoma, Inst Environm Genom, Dept Microbiol & Plant Biol, Norman, OK 73019 USA.; Zhao, FJ (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China.; Zhao, FJ (corresponding author), Rothamsted Res, Sustainable Soil & Grassland Syst Dept, Harpenden, Herts, England.; Zhou, JZ (corresponding author), Tsinghua Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing, Peoples R China.; Zhou, JZ (corresponding author), Lawrence Berkeley Natl Lab, Earth Sci Div, Berkeley, CA 94720 USA.	fangjie.zhao@njau.edu.cn; jzhou@ou.edu	He, Zhili/C-2879-2012; Zhao, Fang-Jie/A-8339-2008; 吴, 昊/AAB-1620-2020	He, Zhili/0000-0001-8225-7333; Zhao, Fang-Jie/0000-0002-0164-169X; 				Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bhattacharya P, 2007, SCI TOTAL ENVIRON, V379, P109, DOI 10.1016/j.scitotenv.2007.02.037; Brammer H, 2009, ENVIRON INT, V35, P647, DOI 10.1016/j.envint.2008.10.004; Bruneel O, 2006, APPL ENVIRON MICROB, V72, P551, DOI 10.1128/AEM.72.1.551-556.2006; Bryan CG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-127; Cai L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-4; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Corsini A, 2011, APPL SOIL ECOL, V49, P99, DOI 10.1016/j.apsoil.2011.06.010; Dittmar J, 2010, ENVIRON SCI TECHNOL, V44, P2925, DOI 10.1021/es903117r; Duker AA, 2005, ENVIRON INT, V31, P631, DOI 10.1016/j.envint.2004.10.020; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Engel AS, 2013, FEMS MICROBIOL ECOL, V83, P745, DOI 10.1111/1574-6941.12030; Escudero LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078890; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Frankenberger WT, 1998, SOIL BIOL BIOCHEM, V30, P269, DOI 10.1016/S0038-0717(97)00102-8; Han YH, 2017, J HAZARD MATER, V321, P146, DOI 10.1016/j.jhazmat.2016.08.079; Hassan Z, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv026; Hemme CL, 2010, ISME J, V4, P660, DOI 10.1038/ismej.2009.154; Hohmann C, 2010, ENVIRON SCI TECHNOL, V44, P94, DOI 10.1021/es900708s; Honschopp S, 1996, MICROBIOL RES, V151, P37, DOI 10.1016/S0944-5013(96)80053-X; Hornstrom E, 2002, HYDROBIOLOGIA, V470, P115, DOI 10.1023/A:1015619921119; Jackson CR, 2005, SOIL BIOL BIOCHEM, V37, P2319, DOI 10.1016/j.soilbio.2005.04.010; Jia Y, 2014, ENVIRON SCI TECHNOL, V48, P1001, DOI 10.1021/es403877s; Lami R, 2013, FEMS MICROBIOL ECOL, V84, P270, DOI 10.1111/1574-6941.12061; Lear G, 2007, APPL ENVIRON MICROB, V73, P1041, DOI 10.1128/AEM.01654-06; Li G, 2011, ENVIRON INT, V37, P1219, DOI 10.1016/j.envint.2011.05.007; Liang YT, 2011, ISME J, V5, P403, DOI 10.1038/ismej.2010.142; Lin HZ, 2014, J ENVIRON SCI HEAL A, V49, P1493, DOI 10.1080/10934529.2014.937168; Lombi E, 2000, WATER AIR SOIL POLL, V124, P319, DOI 10.1023/A:1005230628958; Macur RE, 2004, ENVIRON SCI TECHNOL, V38, P104, DOI 10.1021/es034455a; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; MCBRIDE BC, 1971, BIOCHEMISTRY-US, V10, P4312, DOI 10.1021/bi00799a024; Nemergut DR, 2004, APPL ENVIRON MICROB, V70, P1160, DOI 10.1128/AEM.70.2.1160-1168.2004; ODUM EP, 1985, BIOSCIENCE, V35, P419, DOI 10.2307/1310021; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Paez-Espino D, 2009, BIOMETALS, V22, P117, DOI 10.1007/s10534-008-9195-y; Perez-de-Mora A, 2006, SOIL BIOL BIOCHEM, V38, P327, DOI 10.1016/j.soilbio.2005.05.010; Poirel J, 2013, RES MICROBIOL, V164, P457, DOI 10.1016/j.resmic.2013.01.012; Qin J, 2006, P NATL ACAD SCI USA, V103, P2075, DOI 10.1073/pnas.0506836103; Reith F, 2012, ISME J, V6, P2107, DOI 10.1038/ismej.2012.48; Rosen BP, 1999, TRENDS MICROBIOL, V7, P207, DOI 10.1016/S0966-842X(99)01494-8; Rosen BP, 2002, FEBS LETT, V529, P86, DOI 10.1016/S0014-5793(02)03186-1; Sheik CS, 2012, PLOS ONE, V6, P1; Spain AM, 2009, ISME J, V3, P992, DOI 10.1038/ismej.2009.43; Stroud JL, 2011, ENVIRON SCI TECHNOL, V45, P4262, DOI 10.1021/es104080s; Team RDC, 2005, R LANG ENV STAT COMP; Tu QC, 2014, MOL ECOL RESOUR, V14, P914, DOI 10.1111/1755-0998.12239; Turpeinen R, 2004, FEMS MICROBIOL ECOL, V47, P39, DOI 10.1016/S0168-6496(03)00232-0; van der Merwe JA, 2010, HYDROMETALLURGY, V104, P477, DOI 10.1016/j.hydromet.2010.01.017; WALSH LM, 1977, ENVIRON HEALTH PERSP, V19, P67, DOI 10.2307/3428453; WU JH, 1993, MOL MICROBIOL, V8, P615, DOI 10.1111/j.1365-2958.1993.tb01605.x; Xiao KQ, 2016, ENVIRON POLLUT, V211, P1, DOI 10.1016/j.envpol.2015.12.023; Xiong JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050507; Xiong JB, 2010, APPL ENVIRON MICROB, V76, P7277, DOI 10.1128/AEM.00500-10; Yan-Chu H., 1994, ARSENIC ENV 1, P17; Yang CL, 2015, ECOL ENG, V83, P176, DOI 10.1016/j.ecoleng.2015.06.018; Yin HQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14266; Zhang SY, 2015, ENVIRON SCI TECHNOL, V49, P4138, DOI 10.1021/acs.est.5b00028; Zhao FJ, 2013, ENVIRON SCI TECHNOL, V47, P7147, DOI 10.1021/es304977m; Zhao FJ, 2013, ENVIRON SCI TECHNOL, V47, P3957, DOI 10.1021/es304295n; Zhao FJ, 2010, ANNU REV PLANT BIOL, V61, P535, DOI 10.1146/annurev-arplant-042809-112152; Zhao MX, 2014, ISME J, V8, P2045, DOI 10.1038/ismej.2014.46; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996; Zhu YG, 2014, ANNU REV EARTH PL SC, V42, P443, DOI 10.1146/annurev-earth-060313-054942	66	41	41	13	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176696	10.1371/journal.pone.0176696	http://dx.doi.org/10.1371/journal.pone.0176696			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475654	Green Submitted, gold, Green Published			2022-12-26	WOS:000400649500012
J	Shen, XP; Bao, WJ; Yu, W; Liang, R; Nguyen, B; Liu, Y				Shen, Xiaopeng; Bao, Wenjing; Yu, Wei; Liang, Rui; Nguyen, Bao; Liu, Yu			An improved method with high sensitivity and low background in detecting low beta-galactosidase expression in mouse embryos	PLOS ONE			English	Article							MESP1; DIFFERENTIATION; CELLS	LacZ is widely used as a reporter in studies of gene expression patterns. beta-galactosidase, the product of LacZ gene, is usually detected by X-gal/FeCN staining. In X-gal/FeCN staining, beta-galactosidase catalyzes X-gal to produce blue precipitates, which indicate the expression patterns of the gene of interest. A newer LacZ detection method using S-gal/TNBT is more sensitive but plagued by high background. Here, we describe an improved procedure that combines advantageous steps from the two methods. By comparing with X-gal/FeCN and S-gal/TNBT methods in detecting the expression patterns of miR-322/503 and miR-451 at a series of developmental stages, the improved method showed higher sensitivity and lower background. Thus, the improved method could be an alternative way of beta-galactosidase staining in low gene expression situations.	[Shen, Xiaopeng; Yu, Wei; Liang, Rui; Nguyen, Bao; Liu, Yu] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA; [Shen, Xiaopeng] Anhui Normal Univ, Coll Life Sci, Wuhu, Anhui, Peoples R China; [Bao, Wenjing] Liaoning Univ Tradit Chinese Med, Dept Med, Shenyang, Peoples R China	University of Houston System; University of Houston; Anhui Normal University; Liaoning University of Traditional Chinese Medicine	Shen, XP; Liu, Y (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA.; Shen, XP (corresponding author), Anhui Normal Univ, Coll Life Sci, Wuhu, Anhui, Peoples R China.	shenxiaopeng_cn@ahnu.edu.cn; yliu54@uh.edu	Liang, Rui/AAI-2650-2019; Liu, Yu/F-2802-2015	Liang, Rui/0000-0002-4939-9281; Liu, Yu/0000-0002-1282-4897; Shen, Xiaopeng/0000-0002-6116-635X	University of Houston; American Heart Association grants [11SDG55260033, 16GRNT27760164]	University of Houston; American Heart Association grants(American Heart Association)	This work was supported by funds from the University of Houston (to YL) and American Heart Association grants 11SDG55260033 and 16GRNT27760164 (to YL).	BONNEROT C, 1993, METHOD ENZYMOL, V225, P451; COTSON S, 1958, PROC R SOC SER B-BIO, V148, P506, DOI 10.1098/rspb.1958.0042; GUGLIOTTA P, 1992, EUR J HISTOCHEM, V36, P143; Kishigami S, 2006, GENESIS, V44, P57, DOI 10.1002/gene.20186; Liang R, 2016, JOVE-J VIS EXP, DOI 10.3791/54078; LOJDA Z, 1970, HISTOCHEMISTRY, V22, P347; Park CY, 2012, CELL REP, V1, P385, DOI 10.1016/j.celrep.2012.02.008; Patrick DM, 2010, GENE DEV, V24, P1614, DOI 10.1101/gad.1942810; PEARSON B, 1963, LAB INVEST, V12, P1249; Peng XP, 2015, BBA-MOL BASIS DIS, V1852, P1490, DOI 10.1016/j.bbadis.2015.04.010; Saga Y, 1999, DEVELOPMENT, V126, P3437; Saga Y, 1996, DEVELOPMENT, V122, P2769; Shen X, 2016, P NATL ACAD SCI; Soibam B, 2015, STEM CELLS, V33, P3254, DOI 10.1002/stem.2111; Stefanescu E, 1999, Rev Med Chir Soc Med Nat Iasi, V103, P182; STEVENS ME, 1989, EXP CELL RES, V183, P319, DOI 10.1016/0014-4827(89)90392-3; Sundararajan S, 2012, DEVELOPMENT, V139, P4484, DOI 10.1242/dev.078790; Trifonov S, 2016, ANAT SCI INT, V91, P56, DOI 10.1007/s12565-015-0300-3; Yu DN, 2010, GENE DEV, V24, P1620, DOI 10.1101/gad.1942110	19	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176915	10.1371/journal.pone.0176915	http://dx.doi.org/10.1371/journal.pone.0176915			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475610	Green Published, Green Submitted, gold			2022-12-26	WOS:000400649500027
J	Christodoulides, N; Van Dam, AR; Peterson, DA; Frandsen, RJN; Mortensen, UH; Petersen, B; Rasmussen, S; Normark, BB; Hardy, NB				Christodoulides, Nicholas; Van Dam, Alex R.; Peterson, Daniel A.; Frandsen, Rasmus John Normand; Mortensen, Uffe Hasbro; Petersen, Bent; Rasmussen, Simon; Normark, Benjamin B.; Hardy, Nate B.			Gene expression plasticity across hosts of an invasive scale insect species	PLOS ONE			English	Article							RUSSIAN WHEAT; PEA APHID; RNA-SEQ; PLANT; TRANSCRIPTOME; ADAPTATION; DETOXIFICATION; ANNOTATION; MECHANISMS; EVOLUTION	For plant-eating insects, we still have only a nascent understanding of the genetic basis of host-use promiscuity. Here, to improve that situation, we investigated host-induced gene expression plasticity in the invasive lobate lac scale insect, Paratachardina pseudolobata (Hemiptera: Keriidae). We were particularly interested in the differential expression of detoxification and effector genes, which are thought to be critical for overcoming a plant's chemical defenses. We collected RNA samples from P. pseudolobata on three different host plant species, assembled transcriptomes de novo, and identified transcripts with significant-host induced gene expression changes. Gene expression plasticity was pervasive, but the expression of most detoxification and effector genes was insensitive to the host environment. Nevertheless, some types of detoxification genes were more differentially expressed than expected by chance. Moreover, we found evidence of a trade-off between expression of genes involved in primary and secondary metabolism; hosts that induced lower expression of genes for detoxification induced higher expression of genes for growth. Our findings are largely consonant with those of several recently published studies of other plant-eating insect species. Thus, across plant-eating insect species, there may be a common set of gene expression changes that enable host-use promiscuity.	[Christodoulides, Nicholas; Hardy, Nate B.] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA; [Van Dam, Alex R.; Frandsen, Rasmus John Normand; Mortensen, Uffe Hasbro] Denmark Tech Univ, Dept Bioengn, Biosynthet Pathways Engn, Lyngby, Denmark; [Peterson, Daniel A.; Normark, Benjamin B.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Peterson, Daniel A.; Normark, Benjamin B.] Univ Massachusetts, Grad Program Organism & Evolutionary Biol, Amherst, MA 01003 USA; [Petersen, Bent; Rasmussen, Simon] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, Lyngby, Denmark; [Van Dam, Alex R.] Univ Puerto Rico, Dept Biol, Mayaguez, PR USA	Auburn University System; Auburn University; Technical University of Denmark; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Technical University of Denmark; University of Puerto Rico; University of Puerto Rico Mayaguez	Christodoulides, N (corresponding author), Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA.	nzc0035@auburn.edu	Rasmussen, Simon/AAA-2308-2020; Rasmussen, Simon/G-6258-2016; Mortensen, Uffe/AAQ-1150-2021	Rasmussen, Simon/0000-0001-6323-9041; Rasmussen, Simon/0000-0001-6323-9041; Frandsen, Rasmus John Normand/0000-0002-3799-6062; Petersen, Bent/0000-0002-2472-8317	National Science foundation [DBI 1306489]; Alabama Agricultural Experiment Station	National Science foundation(National Science Foundation (NSF)); Alabama Agricultural Experiment Station	This work was supported by National Science foundation awarded to AVD. (DBI 1306489) https://www.nsf.gov/awardsearch/shotwAward?AWD_ID= 1306489. NC thanks the Auburn University Department of Entomology and Plant Pathology for research assistantship support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks to Robin Giblin-Davis, William Kern, Ian Stocks, and Catherine Mannion for helping us find scale insects and learn the southern Florida flora. Thanks also to Mayrolin Garcia Morales for helping with the field work. NC thanks the Auburn University Department of Entomology and Plant Pathology for research assistantship support. We thank Marlene Dalgaard (DMAC) for use of their Qubit and Bioanalyzer. We thank Andrea Schreier for sample processing at UC Davis. We also thank Lutz Froenicke at UC Davis for advice on the sequencing scheme for this project. Funding: This work was supported by the National Science Foundation [DBI 1306489] awarded to AVD; and the Alabama Agricultural Experiment Station.	Adonizio AL, 2006, J ETHNOPHARMACOL, V105, P427, DOI 10.1016/j.jep.2005.11.025; Akhtar Y, 2012, IND CROP PROD, V37, P536, DOI [10.1016/j.indcrop.2011.07.033, 10.1016/j.indCrop.2011.07.033]; Alexa A, 2016, TOPGO ENRICHMENT ANA, V2; Alon M, 2012, INSECT BIOCHEM MOLEC, V42, P251, DOI 10.1016/j.ibmb.2011.12.007; Augustin JM, 2011, PHYTOCHEMISTRY, V72, P435, DOI 10.1016/j.phytochem.2011.01.015; Bascompte J, 2007, APPL MATH, V101, P187; Bellafiore S, 2008, PLOS; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Brown CT, ARXIV201212034802, P1; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carolan JC, 2011, J PROTEOME RES, V10, P1505, DOI 10.1021/pr100881q; Carolan JC, 2009, PROTEOMICS, V9, P2457, DOI 10.1002/pmic.200800692; Celorio-Mancera MD, 2013, MOL ECOL, V22, P4884, DOI 10.1111/mec.12440; Cooper WR, 2010, ENVIRON ENTOMOL, V39, P223, DOI 10.1603/EN09079; Czosnek H, 2016, MANAGEMENT INSECT PE, P1, DOI [10.1007/978-3-319-24049-7, DOI 10.1007/978-3-319-24049-7]; Eyres I, 2016, MOL ECOL, V25, P4197, DOI 10.1111/mec.13771; Forister ML, 2014, P NATL ACAD SCI USA, V112, P1; Geldhof P, 2003, INT J PARASITOL, V33, P129, DOI 10.1016/S0020-7519(02)00260-6; Gilbert D, 2013, EVIDENTIALGENE MRNA; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Govind G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008735; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hardy NB, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0924; Harris MO, 2015, J EXP BOT, V66, P513, DOI 10.1093/jxb/eru465; Hoang K, 2015, MOL ECOL, V24, P5186, DOI 10.1111/mec.13388; Howard FW, 2014, CHAMBERLIN HEMIPTERA, P1; Iberkleid I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064586; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Lukhele T, 2009, ISOLATION CHARACTERI; Mao WF, 2006, J CHEM ECOL, V32, P523, DOI 10.1007/s10886-005-9018-3; Melendez PA, 2006, PHYTOMEDICINE, V13, P272, DOI 10.1016/j.phymed.2004.11.009; Midiwo J, 1995, INT J; MILES PW, 1993, ENTOMOL EXP APPL, V67, P275, DOI 10.1007/BF02383437; Musacchia F, 2015, BIOINFORMATICS, V31, P2199, DOI 10.1093/bioinformatics/btv106; Nicholson SJ, 2012, J PROTEOMICS, V75, P2252, DOI 10.1016/j.jprot.2012.01.031; Pemberton RW, 2003, FLA ENTOMOL, V86, P353, DOI 10.1653/0015-4040(2003)086[0353:PFBCOT]2.0.CO;2; Pemberton RW, 2003, FLORIDA ENTOMOLOGIST, P373; Peng TF, 2016, INSECT BIOCHEM MOLEC, V75, P89, DOI 10.1016/j.ibmb.2016.06.002; Ragland GJ, 2015, MOL ECOL, V24, P2759, DOI 10.1111/mec.13191; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Ross L, 2012, LARGE POPULATION SIZ; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Smith-Unna RD, 2015, BIORXIV, P21626; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Supek F, 1800, PLO E, V6; Vogel H, 2014, ANNU PLANT REV, V47, P197, DOI 10.1002/9781118472507.ch6; Volpicella M, 2011, CURR PROTEIN PEPT SC, V12, P386, DOI 10.2174/138920311796391098; Wang W, 2015, FASEB J, V29, P2032, DOI 10.1096/fj.14-266023; Will T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00336; Wybouw N, 2015, MOL ECOL, V24, P4647, DOI 10.1111/mec.13330; You MS, 2013, NAT GENET, V45, P220, DOI 10.1038/ng.2524; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	56	11	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176956	10.1371/journal.pone.0176956	http://dx.doi.org/10.1371/journal.pone.0176956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472112	Green Published, gold, Green Submitted			2022-12-26	WOS:000400648500102
J	Wang, XQ; Song, F; Liu, YK				Wang, Xi-Qiao; Song, Fei; Liu, Ying-Kai			Hypertrophic scar regression is linked to the occurrence of endothelial dysfunction	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; FIBROBLAST-GROWTH; CELLS CONTRIBUTE; COLLAGEN; HYPOXIA; EXPRESSION; TISSUE	Most microvessels have been shown to become stenosed or completely occluded during hypertrophic scar progression. Here, we examined the morphology of capillary endothelial cells (ECs) and fibroblasts using immunofluorescence staining for CD31 and alpha-smooth muscle actin (alpha-SMA) and electron microscopy. In addition, ECs and fibroblasts were isolated from scar tissues, and the levels of transforming growth factor beta 1 (TGF-beta 1), platelet- derived growth factor (PDGF), endothelin 1 (ET-1), vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) were assayed using ELISAs. Furthermore, we assessed cell viability, total collagen production, and cell apoptosis in hypertrophic scar-derived fibroblasts cultured with EC-conditioned medium. Then, anti-TGF-beta 1, antiPDGF, anti-ET-1, anti-VEGF, and anti-bFGF neutralising antibodies were individually added to the EC medium to identify which growth factor plays a more important role in inhibiting fibroblasts biology. Our results showed microvessel lumen occlusion and EC atrophy during scar development, particularly in regressive scars (RSs). Additionally, EC growth factor secretion decreased and reached the lowest levels in RSs. Furthermore, based on the culture results, RS EC medium inhibited fibroblast viability and collagen production and induced apoptosis. Moreover, TGF-beta 1, PDGF, and bFGF played more important roles in these processes than VEGF and ET-1. The endothelial dysfunction occurring in hypertrophic scars contributes to fibroblast inhibition and scar regression, and reduced TGF-beta 1, PDGF, and bFGF levels play key roles during this process.	[Wang, Xi-Qiao; Song, Fei; Liu, Ying-Kai] Jiao Tong Univ, Ruijin Hosp, Burn Ctr, Med Sch, Shanghai, Peoples R China	Shanghai Jiao Tong University	Wang, XQ (corresponding author), Jiao Tong Univ, Ruijin Hosp, Burn Ctr, Med Sch, Shanghai, Peoples R China.	wxqiao2002@hotmail.com			National Natural Science Foundation of China [81671914]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (No. 81671914), https://isisn.nsfc.gov.cn/egrantweb/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner-Parzer SM, 2001, EXP CLIN ENDOCR DIAB, V109, pS166, DOI 10.1055/s-2001-18579; Belmadani S, 2008, AM J PHYSIOL-HEART C, V295, pH69, DOI 10.1152/ajpheart.00341.2008; CARLEY WW, 1992, AM J RESP CELL MOL, V7, P620, DOI 10.1165/ajrcmb/7.6.620; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; Cohen Z, 1996, PROG NEUROBIOL, V50, P335, DOI 10.1016/S0301-0082(96)00033-0; De Vriese AS, 2000, BRIT J PHARMACOL, V130, P963, DOI 10.1038/sj.bjp.0703393; FALANGA V, 1992, J SURG RES, V53, P515, DOI 10.1016/0022-4804(92)90099-L; Hirase T, 2012, AM J PHYSIOL-HEART C, V302, pH499, DOI 10.1152/ajpheart.00325.2011; Kose O, 2008, DERMATOL SURG, V34, P336, DOI 10.1111/j.1524-4725.2007.34067.x; Kopp J, 2005, J BIOL CHEM, V280, P21570, DOI 10.1074/jbc.m502071200; Kraling BM, 1998, IN VITRO CELL DEV-AN, V34, P308; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lario S, 2003, TRANSPLANTATION, V75, P1647, DOI 10.1097/01.TP.0000063128.86981.B2; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Li WH, 2009, BRAIN RES, V1287, P28, DOI 10.1016/j.brainres.2009.06.057; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Park JA, 2003, BIOCHEM BIOPH RES CO, V311, P247, DOI 10.1016/j.bbrc.2003.09.129; PELTONEN J, 1991, J INVEST DERMATOL, V97, P240, DOI 10.1111/1523-1747.ep12480289; PHILLIPS PG, 1995, AM J PHYSIOL-LUNG C, V268, pL789, DOI 10.1152/ajplung.1995.268.5.L789; Qing C, 2016, INT WOUND J, V13, P257, DOI 10.1111/iwj.12283; Reno F, 2003, WOUND REPAIR REGEN, V11, P331, DOI 10.1046/j.1524-475X.2003.11504.x; Rofstad EK, 2000, CANCER RES, V60, P4932; Salani D, 2000, AM J PATHOL, V157, P1537, DOI 10.1016/S0002-9440(10)64791-8; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Tabit CE, 2010, REV ENDOCR METAB DIS, V11, P61, DOI 10.1007/s11154-010-9134-4; TAN EML, 1995, BIOCHEM J, V310, P585, DOI 10.1042/bj3100585; Vane J R, 1992, J Physiol Pharmacol, V43, P195; Wang XQ, 2008, ENDOTHELIUM-J ENDOTH, V15, P113, DOI 10.1080/10623320802125169; Wang ZY, 2012, INT J LOW EXTR WOUND, V11, P271, DOI 10.1177/1534734612463698; Xi-Qiao W, 2009, MICROVASC RES, V77, P204, DOI 10.1016/j.mvr.2008.08.007; YOUNAI S, 1994, ANN PLAS SURG, V33, P148, DOI 10.1097/00000637-199408000-00005; Zhang LX, 2003, J SURG RES, V114, P262; Zheng JX, 2014, DERMATOL SURG, V40, P511, DOI 10.1111/dsu.12474; Zhu H, 2004, CELL PROLIFERAT, V37, P255, DOI 10.1111/j.1365-2184.2004.00310.x	34	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176681	10.1371/journal.pone.0176681	http://dx.doi.org/10.1371/journal.pone.0176681			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472181	Green Submitted, Green Published, gold			2022-12-26	WOS:000400648500063
J	Flavel, RJ; Guppy, CN; Rabbi, SMR; Young, IM				Flavel, Richard J.; Guppy, Chris N.; Rabbi, Sheikh M. R.; Young, Iain M.			An image processing and analysis tool for identifying and analysing complex plant root systems in 3D soil using non-destructive analysis: Root1	PLOS ONE			English	Article							RAY COMPUTED-TOMOGRAPHY; BIOPHYSICAL INTERACTIONS; ACQUISITION; QUANTIFICATION; VISUALIZATION; ARCHITECTURE; PHOSPHORUS	The objective of this study was to develop a flexible and free image processing and analysis solution, based on the Public Domain ImageJ platform, for the segmentation and analysis of complex biological plant root systems in soil from x-ray tomography 3D images. Contrasting root architectures from wheat, barley and chickpea root systems were grown in soil and scanned using a high resolution micro-tomography system. A macro (Root1) was developed that reliably identified with good to high accuracy complex root systems (10% overestimation for chickpea, 1% underestimation for wheat, 8% underestimation for barley) and provided analysis of root length and angle. In-built flexibility allowed the user interaction to (a) amend any aspect of the macro to account for specific user preferences, and (b) take account of computational limitations of the platform. The platform is free, flexible and accurate in analysing root system metrics.	[Flavel, Richard J.; Guppy, Chris N.] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia; [Rabbi, Sheikh M. R.; Young, Iain M.] Univ Sydney, Sydney Inst Agr, Sch Life & Environm Sci, Sydney, NSW, Australia	University of New England; University of Sydney	Young, IM (corresponding author), Univ Sydney, Sydney Inst Agr, Sch Life & Environm Sci, Sydney, NSW, Australia.	iain.young@sydney.edu.au	Young, Iain McEwing/C-9210-2011; Guppy, Chris N/M-5837-2014; Flavel, Richard/I-6100-2016	Young, Iain McEwing/0000-0002-7588-9006; Guppy, Chris N/0000-0001-7274-607X; Rabbi, Sheikh M. F./0000-0002-1639-8602; Flavel, Richard/0000-0001-7867-2104	Grains Research Development Corporation (GRDC) [DAQ00148]	Grains Research Development Corporation (GRDC)(Grains R&D Corp)	This work was supported by the Grains Research Development Corporation (GRDC) Project Code, DAQ00148. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arganda-Carreras I, 2010, MICROSC RES TECHNIQ, V73, P1019, DOI 10.1002/jemt.20829; Chapagain T., 2014, American Journal of Experimental Agriculture, V4, P849; Clark RT, 2011, PLANT PHYSIOL, V156, P455, DOI 10.1104/pp.110.169102; Downie H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044276; Flavel RJ, 2012, J EXP BOT, V63, P2503, DOI 10.1093/jxb/err421; Flavel RJ, 2014, PLANT SOIL, V385, P303, DOI 10.1007/s11104-014-2191-9; Galkovskyi T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-116; Ge ZY, 2000, PLANT SOIL, V218, P159, DOI 10.1023/A:1014987710937; Gregory PJ, 2009, FUNCT PLANT BIOL, V36, P922, DOI 10.1071/FP09150; Gregory PJ, 2003, PLANT SOIL, V255, P351, DOI 10.1023/A:1026179919689; Haling RE, 2013, PLANT SOIL, V372, P619, DOI 10.1007/s11104-013-1777-y; Heeraman DA, 1997, PLANT SOIL, V189, P167, DOI 10.1023/A:1004258818538; Helliwell J, 2011, RHIZOSPHERE3; Helliwell JR, 2013, EUR J SOIL SCI, V64, P279, DOI 10.1111/ejss.12028; Hodge A, 2004, NEW PHYTOL, V162, P9, DOI 10.1111/j.1469-8137.2004.01015.x; Isbell R.F., 2002, AUSTR SOIL CLASSIFIC; Ketcham RA, 2001, COMPUT GEOSCI-UK, V27, P381, DOI 10.1016/S0098-3004(00)00116-3; Koebernick N, 2014, VADOSE ZONE J, V13, DOI 10.2136/vzj2014.03.0024; Lazarevic B., 2016, COMMUN SOIL SCI PLAN, V47, P263; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Lontoc-Roy M, 2005, CAN J BOT, V83, P1434, DOI 10.1139/b05-118; Lontoc-Roy M, 2006, GEODERMA, V137, P231, DOI 10.1016/j.geoderma.2006.08.025; Lynch JP, 1997, PLANT SOIL, V188, P139, DOI 10.1023/A:1004276724310; Mairhofer S, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-8; Mairhofer S, 2012, PLANT PHYSIOL, V158, P561, DOI 10.1104/pp.111.186221; Paya AM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00274; Perret JS, 2007, SOIL BIOL BIOCHEM, V39, P391, DOI 10.1016/j.soilbio.2006.07.018; Pfeifer J, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0084-4; Pierret A., 2011, ENCY AGROPHYSICS, P628, DOI DOI 10.1007/978-90-481-3585-1_121; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; Schindelin J, NAT METH, V9, P676; Seger O., 1990, MACHINE VISION 3 DIM, P347, DOI DOI 10.1016/B978-0-12-266722-0.50016-6; Tracy SR, 2012, PLANT SOIL, V353, P195, DOI 10.1007/s11104-011-1022-5; Weaver JE, ROOT DEV FIELD CROPS; Wildenschild D, 2002, J HYDROL, V267, P285, DOI 10.1016/S0022-1694(02)00157-9; Young IM, 1998, J AGR SCI, V130, P1, DOI 10.1017/S002185969700498X; Zappala S, 2012, 4 DIMENSIONAL PHENOT; Zuiderveld K.J., 1994, GRAPHICS GEMS, P474, DOI DOI 10.1016/B978-0-12-336156-1.50061-6	38	32	33	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176433	10.1371/journal.pone.0176433	http://dx.doi.org/10.1371/journal.pone.0176433			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467424	gold, Green Published, Green Submitted			2022-12-26	WOS:000400647000052
J	Harrison, U; Fowora, MA; Seriki, AT; Loell, E; Mueller, S; Ugo-Ijeh, M; Onyekwere, CA; Lesi, OA; Otegbayo, JA; Akere, A; Ndububa, DA; Adekanle, O; Anomneze, E; Abdulkareem, FB; Adeleye, IA; Crispin, A; Rieder, G; Fischer, W; Smith, SI; Haas, R				Harrison, Ute; Fowora, Muinah A.; Seriki, Abiodun T.; Loell, Eva; Mueller, Susanna; Ugo-Ijeh, Margaret; Onyekwere, Charles A.; Lesi, Olufunmilayo A.; Otegbayo, Jesse A.; Akere, Adegboyega; Ndububa, Dennis A.; Adekanle, Olusegun; Anomneze, Ebere; Abdulkareem, Fatimah B.; Adeleye, Isaac A.; Crispin, Alexander; Rieder, Gabriele; Fischer, Wolfgang; Smith, Stella I.; Haas, Rainer			Helicobacter pylori strains from a Nigerian cohort show divergent antibiotic resistance rates and a uniform pathogenicity profile	PLOS ONE			English	Article							CAGA; GASTRITIS; ULCER; GENES; TRANSLOCATION; INDUCTION; EVOLUTION; INFECTION; ISLAND; CELLS	Antibiotic resistance in Helicobacter pylori is a factor preventing its successful eradication. Particularly in developing countries, resistance against commonly used antibiotics is widespread. Here, we present an epidemiological study from Nigeria with 111 isolates. We analyzed the associated disease outcome, and performed a detailed characterization of these isolated strains with respect to their antibiotic susceptibility and their virulence characteristics. Furthermore, statistical analysis was performed on microbiological data as well as patient information and the results of the gastroenterological examination. We found that the variability concerning the production of virulence factors between strains was minimal, with 96.4% of isolates being CagA-positive and 92.8% producing detectable VacA levels. In addition, high frequency of bacterial resistance was observed for metronidazole (99.1%), followed by amoxicillin (33.3%), clarithromycin (14.4%) and tetracycline (4.5%). In conclusion, this study indicated that the infection rate of H. pylori infection within the cohort in the present study was surprisingly low (36.6%). Furthermore, an average gastric pathology was observed by histological grading and bacterial isolates showed a uniform pathogenicity profile while indicating divergent antibiotic resistance rates.	[Harrison, Ute; Loell, Eva; Fischer, Wolfgang; Haas, Rainer] Ludwig Maximilians Univ Munchen, Max von Pettenkofer Inst Hyg & Med Mikrobiol, Munich, Germany; [Fowora, Muinah A.; Ugo-Ijeh, Margaret] Nigerian Inst Med Res, Mol Biol & Biotechnol Div, Lagos, Nigeria; [Seriki, Abiodun T.; Adeleye, Isaac A.] Univ Lagos, Dept Microbiol, Lagos, Nigeria; [Mueller, Susanna] Ludwig Maximilians Univ Munchen, Pathol Inst, Munich, Germany; [Onyekwere, Charles A.] Lagos State Univ, Teaching Hosp, Lagos, Nigeria; [Lesi, Olufunmilayo A.; Abdulkareem, Fatimah B.] Univ Lagos, Coll Med, Lagos, Nigeria; [Otegbayo, Jesse A.] Univ Coll Hosp, Ibadan, Nigeria; [Ndububa, Dennis A.; Adekanle, Olusegun] Obafemi Awolowo Univ, Dept Med, Ife, Nigeria; [Anomneze, Ebere] Hlth Gate Clin, Ojuelegba Rd, Lagos, Nigeria; [Crispin, Alexander] Inst Med Informat Verarbeitung Biometrie & Epidem, Munich, Germany; [Rieder, Gabriele] Bavarian Hlth & Food Safety Author, Oberschleissheim, Germany; [Haas, Rainer] Ludwig Maximilians Univ Munchen, German Ctr Infect Res DZIF, Munich, Germany	University of Munich; University of Lagos; University of Munich; Lagos State University; University of Lagos; University of Ibadan; University College Hospital, Ibadan; Obafemi Awolowo University; Bavarian Health & Food Safety Authority; German Center for Infection Research; University of Munich	Harrison, U (corresponding author), Ludwig Maximilians Univ Munchen, Max von Pettenkofer Inst Hyg & Med Mikrobiol, Munich, Germany.	harrison@mvp.uni-muenchen.de	Seriki, Abiodun Tola/ABA-3994-2021; Smith, Stella/AAQ-3023-2021; Akere, Adegboyega/AHD-0744-2022; Otegbayo, Jesse/AGR-5111-2022	onyekwere, Charles/0000-0002-2777-1628; Smith, Stella/0000-0003-2163-1189; Seriki, Abiodun/0000-0001-9406-3691; LESI, Olufunmilayo/0000-0002-6958-1531	Deutsche Forschungsgemeinschaft [HA 2697/12-1, HA 2697/18-1]; Deutsches Zentrum fur Infektionsforschung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsches Zentrum fur Infektionsforschung	This study was supported by Deutsche Forschungsgemeinschaft HA 2697/12-1, Deutsche Forschungsgemeinschaft HA 2697/18-1, Deutsches Zentrum fur Infektionsforschung.; We also thank Evelyn Weiss as well as Emmanuel A Omonigbehin, and Moses Bamidele for their technical support. We thank Rudiger Laubender and Cornelia Klindworth for statistical work and Friederike Aicher for administrative support. Furthermore, we are very grateful to all patients for participating in our study. This project was supported by the Deutsche Forschungsgemeinschaft in the context of the German-African Infectiology Initiative (HA2697/12-1) to RH.	Aboderin Oladiipo A, 2007, Afr Health Sci, V7, P143; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Ani AE, 1999, T ROY SOC TROP MED H, V93, P659, DOI 10.1016/S0035-9203(99)90089-5; [Anonymous], 2014, HELICOBACTER PYLORI; Anukam KC, 2006, MICROBES INFECT, V8, P2772, DOI 10.1016/j.micinf.2006.08.008; Avasthi TS, 2011, J BACTERIOL, V193, P3385, DOI 10.1128/JB.05006-11; Cover TL, 2003, CANCER RES, V63, P951; COVER TL, 1992, J BIOL CHEM, V267, P10570; Depardieu F, 2007, CLIN MICROBIOL REV, V20, P79, DOI 10.1128/CMR.00015-06; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Eslick GD, 1999, AM J GASTROENTEROL, V94, P2373, DOI 10.1111/j.1572-0241.1999.01360.x; Fischer W, 2004, J BACTERIOL, V186, P777, DOI 10.1128/JB.186.3.777-784.2004; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Fischer W, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-310; Fischer W, 2010, NUCLEIC ACIDS RES, V38, P6089, DOI 10.1093/nar/gkq378; Gardner TB, 2001, CLIN MICROBIOL REV, V14, P114, DOI 10.1128/CMR.14.1.114-128.2001; Gebert B, 2003, SCIENCE, V301, P1099, DOI 10.1126/science.1086871; Ghotaslou Reza, 2015, World J Methodol, V5, P164, DOI 10.5662/wjm.v5.i3.164; HAAS R, 1993, MOL MICROBIOL, V8, P753, DOI 10.1111/j.1365-2958.1993.tb01618.x; Hatakeyama M, 2008, CURR OPIN MICROBIOL, V11, P30, DOI 10.1016/j.mib.2007.12.003; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Jimenez-Soto LF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000684; Kariuki S, 2001, CURR OPIN INFECT DIS, V14, P579, DOI 10.1097/00001432-200110000-00012; Kim JM, 2008, J MICROBIOL BIOTECHN, V18, P1584, DOI 10.5352/JLS.2008.18.11.1584; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Manfredi M, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/717349; Murata-Kamiya N, 2011, MICROBES INFECT, V13, P799, DOI 10.1016/j.micinf.2011.03.011; Ndububa D A, 2007, Trop Gastroenterol, V28, P69; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Olokoba A B, 2013, Niger Med J, V54, P1, DOI 10.4103/0300-1652.108884; Oyedeji KS, 2009, BRIT J BIOMED SCI, V66, P10; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Rowe Ryan A, 2009, Clin Lab Sci, V22, P39; Sapkota AR, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-610; Sharbatdaran M, 2013, PAK J MED SCI, V29, P68, DOI 10.12669/pjms.291.2865; SIPPONEN P, 1992, DIGESTION, V51, P70, DOI 10.1159/000200919; SIPPONEN P, 1990, SCAND J GASTROENTERO, V25, P966, DOI 10.3109/00365529008997621; Smith SI, 2001, J GASTROENTEROL, V36, P67, DOI 10.1007/s005350170158; Smith SI, 2012, SPRINGERPLUS, V1, DOI 10.1186/2193-1801-1-78; Sun JJ, 2014, BIOCHEM BIOPH RES CO, V453, P254, DOI 10.1016/j.bbrc.2014.05.090; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Torres-Morquecho A, 2010, INFECT GENET EVOL, V10, P764, DOI 10.1016/j.meegid.2010.04.005; Wueppenhorst N, 2013, J ANTIMICROB CHEMOTH, V68, P1562, DOI 10.1093/jac/dkt061	43	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176454	10.1371/journal.pone.0176454	http://dx.doi.org/10.1371/journal.pone.0176454			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28463973	Green Published, Green Submitted, gold			2022-12-26	WOS:000400646300022
J	Wang, TJ; Tang, HL				Wang, Tengjiao; Tang, Hailin			The physical characteristics of human proteins in different biological functions	PLOS ONE			English	Article							STABILITY; EVOLUTION; TURNOVER; GENES; RATES	The physical properties of gene products are the foundation of their biological functions. In this study, we systematically explored relationships between physical properties and biological functions. The physical properties including origin time, evolution pressure, mRNA and protein stability, molecular weight, hydrophobicity, acidity/alkaline, amino acid compositions, and chromosome location. The biological functions are defined from 4 aspects: biological process, molecular function, cellular component and cell/tissue/organ expression. We found that the proteins associated with basic material and energy metabolism process originated earlier, while the proteins associated with immune, neurological system process etc. originated later. Tissues may have a strong influence on evolution pressure. The proteins associated with energy metabolism are double-stable. Immune and peripheral cell proteins tend to be mRNA stable/protein unstable. There are very few function items with double-unstable of mRNA and protein. The proteins involved in the cell adhesion tend to consist of large proteins with high proportion of small amino acids. The proteins of organic acid transport, neurological system process and amine transport have significantly high hydrophobicity. Interestingly, the proteins involved in olfactory receptor activity tend to have high frequency of aromatic, sulfuric and hydroxyl amino acids.	[Wang, Tengjiao] Second Mil Med Univ, Dept Bioinformat, Shanghai, Peoples R China; [Tang, Hailin] Second Mil Med Univ, Shanghai Key Lab Med Biodefense, Dept Biol Biodef Microbiol, Fac Trop Med & Publ Hlth, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Tang, HL (corresponding author), Second Mil Med Univ, Shanghai Key Lab Med Biodefense, Dept Biol Biodef Microbiol, Fac Trop Med & Publ Hlth, Shanghai, Peoples R China.	hailint@163.com	wang, tengjiao/E-2118-2015	wang, tengjiao/0000-0002-7790-7407	Program of Shanghai Health and Family Planning Commission [20154Y0125]	Program of Shanghai Health and Family Planning Commission	This work is supported by Program of Shanghai Health and Family Planning Commission (20154Y0125).	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Alba MM, 2005, MOL BIOL EVOL, V22, P598, DOI 10.1093/molbev/msi045; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Boyadjiev SA, 2000, CLIN GENET, V57, P253, DOI 10.1034/j.1399-0004.2000.570403.x; Chaurasia G, 2007, FEBS J, V274, P300; Cui QH, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-21; Doherty MK, 2009, J PROTEOME RES, V8, P104, DOI 10.1021/pr800641v; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Hinkson IV, 2011, TRENDS CELL BIOL, V21, P293, DOI 10.1016/j.tcb.2011.02.002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Knight CG, 2004, P NATL ACAD SCI USA, V101, P8390, DOI 10.1073/pnas.0307270101; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Mathivanan S, 2008, NAT BIOTECHNOL, V26, P164, DOI 10.1038/nbt0208-164; NEI M, 1986, MOL BIOL EVOL, V3, P418; Plotkin JB, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.63; Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwartz R, 2001, GENOME RES, V11, P703, DOI 10.1101/gr.GR-1587R; Vogel C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.33; Wolf YI, 2009, P NATL ACAD SCI USA, V106, P7273, DOI 10.1073/pnas.0901808106; Wu SF, 2006, PROTEOMICS, V6, P449, DOI 10.1002/pmic.200500221; Yang E, 2003, GENOME RES, V13, P1863, DOI 10.1101/gr.1272403; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489	31	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176234	10.1371/journal.pone.0176234	http://dx.doi.org/10.1371/journal.pone.0176234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459865	gold, Green Published, Green Submitted			2022-12-26	WOS:000400645000023
J	Kaur, K; Park, H; Pandey, N; Azuma, Y; De Guzman, RN				Kaur, Kawaljit; Park, Hyewon; Pandey, Nootan; Azuma, Yoshiaki; De Guzman, Roberto N.			Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUMO-INTERACTION MOTIFS; TOPOISOMERASE-II; MITOTIC CHROMOSOMES; BINDING SURFACE; SUMOYLATION; COMPLEX; UBC9; RECOGNITION; CONJUGATION; INSIGHTS	Small ubiquitin-like modifier (SUMO) conjugation is a reversible post-translational modification process implicated in the regulation of gene transcription, DNA repair, and cell cycle. SUMOylation depends on the sequential activities of E1 activating, E2 conjugating, and E3 ligating enzymes. SUMO E3 ligases enhance transfer of SUMO from the charged E2 enzyme to the substrate. Wehave previously identified PIASy, a member of the Siz/protein inhibitor of activated STAT (PIAS) RING family of SUMO E3 ligases, as essential for mitotic chromosomal SUMOylation in frog egg extracts and demonstrated that it can mediate effective SUMOylation. To address how PIASy catalyzes SUMOylation, we examined various truncations of PIASy for their ability to mediate SUMOylation. Using NMR chemical shift mapping and mutagenesis, we identified a new SUMO-interacting motif (SIM) in PIASy. The new SIM and the currently known SIM are both located at the C terminus of PIASy, and both are required for the full ligase activity of PIASy. Our results provide novel insights into the mechanism of PIASy-mediated SUMOylation. PIASy adds to the growing list of SUMO E3 ligases containing multiple SIMs that play important roles in the E3 ligase activity.	[Kaur, Kawaljit; Park, Hyewon; Pandey, Nootan; Azuma, Yoshiaki; De Guzman, Roberto N.] Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA	University of Kansas	Azuma, Y; De Guzman, RN (corresponding author), Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA.	azumay@ku.edu; rdguzman@ku.edu	Pandey, Nootan/AAF-8227-2019	Pandey, Nootan/0000-0001-6525-4085	National Institutes of Health [P30-GM110761]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110761, R01GM080278] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Asokan Anbanandam for assistance with NMR spectroscopy and Mark Richter for the use of the fluorescence spectrophotometer. The University of Kansas Biomolecular NMR Core Facility was supported by Grant P30-GM110761 from the National Institutes of Health.	Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Azuma Y, 2005, EMBO J, V24, P2172, DOI 10.1038/sj.emboj.7600700; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; Cappadocia L, 2015, NAT STRUCT MOL BIOL, V22, P968, DOI 10.1038/nsmb.3116; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ding HS, 2005, BIOCHEMISTRY-US, V44, P2790, DOI 10.1021/bi0477586; Eisenhardt N, 2015, NAT STRUCT MOL BIOL, V22, P959, DOI 10.1038/nsmb.3114; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Jardin C, 2015, J MOL MODEL, V21, DOI 10.1007/s00894-015-2597-1; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Mascle XH, 2013, J BIOL CHEM, V288, P36312, DOI 10.1074/jbc.M113.486845; Merrill JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008794; Meulmeester E, 2008, NATURE, V452, P709, DOI 10.1038/452709a; Namanja AT, 2012, J BIOL CHEM, V287, P3231, DOI 10.1074/jbc.M111.293118; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Ryu H, 2010, J CELL BIOL, V191, P783, DOI 10.1083/jcb.201004033; Ryu H, 2010, J BIOL CHEM, V285, P32576, DOI 10.1074/jbc.M110.153817; Ryu H, 2010, J BIOL CHEM, V285, P14415, DOI 10.1074/jbc.M109.074583; Sekiyama N, 2008, J BIOL CHEM, V283, P35966, DOI 10.1074/jbc.M802528200; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Takahashi Y, 2005, J BIOL CHEM, V280, P35822, DOI 10.1074/jbc.M506794200; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013; Zhao Q, 2014, NUCLEIC ACIDS RES, V42, pW325, DOI 10.1093/nar/gku383	32	12	13	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10230	10238		10.1074/jbc.M117.789982	http://dx.doi.org/10.1074/jbc.M117.789982			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28455449	Green Published, hybrid			2022-12-26	WOS:000403580600031
J	Prieto, V; Ludwig, JM; Farris, AB; Nagaraju, GP; Lawal, TO; El-Rayes, B; Kim, HS				Prieto, Veronica; Ludwig, Johannes M.; Farris, Alton B.; Nagaraju, Ganji Purnachandra; Lawal, Taoreed O.; El-Rayes, Bassel; Kim, Hyun S.			Establishment of human metastatic colorectal cancer model in rabbit liver: A pilot study	PLOS ONE			English	Article							VX2 CARCINOMA; CELL-LINE; ANIMAL-MODELS; CHEMOEMBOLIZATION; IRINOTECAN; ANATOMY; TUMOR; IMPLANTATION; INJECTION; RESECTION	Rationale and objectives To develop a human metastatic colorectal cancer (mCRC) model in a rabbit liver. Materials and methods Immunosuppression in 4 adult New Zealand White rabbits weighing 3.5 to 4.5 kg was induced with daily subcutaneous injection of 15 mg/kg Cyclosporine A (CsA). On day 3 open mini-laparotomy was performed and 0.2 ml (1.8x10(5) cells) suspension of HCT-116 and HT-29 human CRC cells were injected into the left and right medial lobe respectively. On day 10 the CsA dose was reduced to 10 mg/kg daily maintenance dose. Rabbits were weighed weekly, closely monitored for CsA side effects (weight loss, gingival hyperplasia and gut modification). Rabbits were sacrificed 5, 6, 7, and 8 weeks after cells injection. Liver tumors were collected for histopathology and immunohistochemical analysis. Results HT-29 Tumor growth was observed in 3 rabbits (75%). Tumors measured 3, 4 and 6 mm after 5, 6 and 8 weeks respectively. Microscopically, tumors contained hyperchromatic, pleomorphic cells that stained for monoclonal carcinoembryonic antigen (CEA), polyclonal CEA, cytokeratin 20, vascular markers (CD31, CD34), and vascular endothelial growth factor (VEGF) by immunohistochemistry, supporting involvement by the poorly differentiated HT-29 colorectal cancer cell line. No gross tumor growth or microscopic viability was observed from HCT-116 cell injection. CsA extra-hepatic manifestations included minimal gum hyperplasia and decrease in gut motility in 3 rabbits (75%), which was treated with Azithromycin 15 mg/kg and Cisapride 0.5 mg/kg every 12 hours, respectively. Conclusion We successfully developed a human metastatic colon cancer model in immunosuppressed rabbit liver using HT-29 cells.	[Prieto, Veronica; Lawal, Taoreed O.] Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Div Intervent Radiol & Image Guided Med, Atlanta, GA USA; [Ludwig, Johannes M.; Kim, Hyun S.] Yale Univ, Sch Med, Dept Diagnost Radiol, Div Intervent Radiol, New Haven, CT 06510 USA; [Farris, Alton B.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Nagaraju, Ganji Purnachandra; El-Rayes, Bassel] Emory Univ, Sch Med, Dept Hematol, Atlanta, GA USA; [Nagaraju, Ganji Purnachandra; El-Rayes, Bassel] Emory Univ, Sch Med, Dept Med Oncol, Atlanta, GA USA; [Kim, Hyun S.] Yale Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA	Emory University; Yale University; Emory University; Emory University; Emory University; Yale University	Kim, HS (corresponding author), Yale Univ, Sch Med, Dept Diagnost Radiol, Div Intervent Radiol, New Haven, CT 06510 USA.; Kim, HS (corresponding author), Yale Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA.	kevin.kim@yale.edu	Nagaraju, Purnachandra/D-4193-2011; el-rayes, bassel/ABD-2901-2021; Farris, Alton Brad/S-6041-2017	Nagaraju, Purnachandra/0000-0002-4989-5234; el-rayes, bassel/0000-0002-2661-5746; Farris, Alton Brad/0000-0001-5534-7763				Aravalli RN, 2015, J CLIN MED, V4, P1989, DOI 10.3390/jcm4121954; Aravalli RN, 2009, EUR RADIOL, V19, P1049, DOI 10.1007/s00330-008-1263-8; Bize P, 2016, RADIOLOGY, V280, P425, DOI 10.1148/radiol.2016150361; Blanco G, 2000, CURR EYE RES, V21, P740, DOI 10.1076/0271-3683(200009)21:3;1-R;FT740; Blanco PL, 2005, INVEST OPHTH VIS SCI, V46, P4376, DOI 10.1167/iovs.04-1103; Brouquet A, 2011, J CLIN ONCOL, V29, P1083, DOI 10.1200/JCO.2010.32.6132; Chen JH, 2004, LAB ANIM-UK, V38, P79, DOI 10.1258/00236770460734434; Choti MA, 2002, ANN SURG, V235, P759, DOI 10.1097/00000658-200206000-00002; de Jong GM, 2009, J SURG RES, V154, P167, DOI 10.1016/j.jss.2008.03.038; Duran R, 2016, THERANOSTICS, V6, P28, DOI 10.7150/thno.13137; EASTY DM, 1982, VIRCHOWS ARCH B, V39, P333, DOI 10.1007/BF02892859; Evans JP, 2016, CRIT REV ONCOL HEMAT, V98, P94, DOI 10.1016/j.critrevonc.2015.10.009; Eyol E, 2008, CLIN EXP METASTAS, V25, P273, DOI 10.1007/s10585-008-9142-x; Fiorentini G, 2012, ANTICANCER RES, V32, P1387; Geschwind JFH, 2000, J VASC INTERV RADIOL, V11, P1245, DOI 10.1016/S1051-0443(07)61299-8; Hong K, 2009, J VASC INTERV RADIOL, V20, P360, DOI 10.1016/j.jvir.2008.11.019; Hurst EW, 1933, J EXP MED, V58, P607, DOI 10.1084/jem.58.5.607; Kang SJ, 2013, BRIT J OPHTHALMOL, V97, P929, DOI 10.1136/bjophthalmol-2013-303343; Kang SJ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/394730; Kawai K, 2013, ONCOL REP, V29, P464, DOI 10.3892/or.2012.2141; Lee DE, 2011, CARCINOGENESIS, V32, P629, DOI 10.1093/carcin/bgr008; Lee KH, 2009, J VASC INTERV RADIOL, V20, P113, DOI 10.1016/j.jvir.2008.09.033; Lin WY, 2002, J VET MED SCI, V64, P649, DOI 10.1292/jvms.64.649; Martin RCG, 2011, ANN SURG ONCOL, V18, P192, DOI 10.1245/s10434-010-1288-5; Martins PNA, 2007, LIVER INT, V27, P384, DOI 10.1111/j.1478-3231.2006.01414.x; Parvinian A, 2014, DIAGN INTERV RADIOL, V20, P335, DOI 10.5152/dir.2014.13415; Petre EN, 2015, HEMATOL ONCOL CLIN N, V29, P117, DOI 10.1016/j.hoc.2014.09.007; Robertson JHP, 2008, INT J EXP PATHOL, V89, P447, DOI 10.1111/j.1365-2613.2008.00605.x; Rous P, 1935, J EXP MED, V62, P523, DOI 10.1084/jem.62.4.523; Seo TS, 2001, INVEST RADIOL, V36, P186, DOI 10.1097/00004424-200103000-00008; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; STRAULI P, 1984, B CANCER, V71, P447; Sun JJ, 2012, ASIAN PAC J CANCER P, V13, P2823, DOI 10.7314/APJCP.2012.13.6.2823; Tam AL, 2014, ACTA RADIOL, V55, P1226, DOI 10.1177/0284185113514050; Van Cutsem E, 2009, ANN ONCOL, V20, P61, DOI 10.1093/annonc/mdp130; Virmani S, 2008, J VASC INTERV RADIOL, V19, P931, DOI 10.1016/j.jvir.2008.02.019; Vogel I, 1998, LANGENBECK ARCH SURG, V383, P466, DOI 10.1007/s004230050162; Zorzi D, 2006, J GASTROINTEST SURG, V10, P86, DOI 10.1016/j.gassur.2005.07.022	38	1	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177212	10.1371/journal.pone.0177212	http://dx.doi.org/10.1371/journal.pone.0177212			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475639	gold, Green Published, Green Submitted			2022-12-26	WOS:000400649500054
J	Simpson, LA; Ambrosio, LJ; Baeza, JA				Simpson, Lunden Alice; Ambrosio, Louis John; Baeza, J. Antonio			A new species of Carcinonemertes, Carcinonemertes conanobrieni sp nov (Nemertea: Carcinonemertidae), an egg predator of the Caribbean spiny lobster, Panulirus argus	PLOS ONE			English	Article							N-SP NEMERTEA; CLIMATE-CHANGE; DISEASES; CRABS; DECAPODA; CALIFORNIA; CRUSTACEA; INFERENCE; PARASITES; ECOLOGY	A new species of nemertean worm belonging to the genus Carcinonemertes is described from egg masses of the Caribbean spiny lobster Panulirus argus from the Florida Keys, Florida, USA. This is the first species of Carcinonemertes reported to infect P. argus or any other lobster species in the greater Caribbean and western Atlantic Ocean. Carcinonemertes conanobrieni sp. nov. varies in body color from a translucent white to a pale orange, with males ranging in total body length from 2.35 to 12.71 mm and females ranging from 0.292 to 16.73 mm. Among the traits that separate this new species from previously described species in the genus Carcinonemertes are a relatively wide stylet basis, minimal sexual size dimorphism, and a unique mucus sheath decorated with external hooks. Also, juvenile worms were found to encyst themselves next to lobster embryos and female worms lay both long strings of eggs wound throughout the lobster's setae as well as spherical cases that are attached to lobster embryos. The stylet length and stylet basis remain unchanged throughout ontogeny for both male and female worms. Maximum likelihood and Bayesian inference phylogenetic analyses separated this newly described species from all other species of Carcinonemertes with available COI sequences. Carcinonemertes spp. are voracious egg predators and have been tied to the collapse of various crustacean fisheries. The formal description of this new species represents the first step to understand putative impacts of this worm on the population health of one of the most lucrative yet already depressed crustacean fisheries.	[Simpson, Lunden Alice; Ambrosio, Louis John; Baeza, J. Antonio] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Baeza, J. Antonio] Smithsonian Marine Stn Ft Pierce, Ft Pierce, FL 34949 USA; [Baeza, J. Antonio] Univ Catolica Norte, Fac Ciencias Mar, Dept Biol Marina, Larrondo, Coquimbo, Chile	Clemson University; Smithsonian Institution; Smithsonian National Museum of Natural History; Universidad Catolica del Norte	Baeza, JA (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.; Baeza, JA (corresponding author), Smithsonian Marine Stn Ft Pierce, Ft Pierce, FL 34949 USA.; Baeza, JA (corresponding author), Univ Catolica Norte, Fac Ciencias Mar, Dept Biol Marina, Larrondo, Coquimbo, Chile.	jbaezam@clemson.edu			Clemson University's Creative Inquiry (CI) program; Clemson University	Clemson University's Creative Inquiry (CI) program; Clemson University	We would like to thank Kyla Salomon for her support over the 2016 field season in the Florida Keys, as well as Clemson University's Creative Inquiry (CI) program for helping to fund her stay. This is Smithsonian Marine Station contribution number 1062.; All funding for this project came from a start-up grant from Clemson University, and there was no additional external funding received for this study.	Andrade SCS, 2012, CLADISTICS, V28, P141, DOI 10.1111/j.1096-0031.2011.00376.x; Baeza JA, 2016, BMC ZOOL, V1, DOI 10.1186/s40850-016-0006-6; Baeza JA., 2016, PEER J; Baker-Austin C, 2013, NAT CLIM CHANGE, V3, P73, DOI [10.1038/nclimate1628, 10.1038/NCLIMATE1628]; BOBES R, 1988, Revista de Investigaciones Marinas, V9, P97; Burge CA, 2014, ANNU REV MAR SCI, V6, P249, DOI 10.1146/annurev-marine-010213-135029; CAMPBELL A, 1989, ZOOL J LINN SOC-LOND, V95, P257; Chollett I, 2012, MAR POLLUT BULL, V64, P956, DOI 10.1016/j.marpolbul.2012.02.016; Coe WR, 1902, AM NAT, V36, P431, DOI 10.1086/278150; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELDRED BONNIE, 1962, CRUSTACEANA, V3, P203, DOI 10.1163/156854062X00427; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gilman EL, 2008, AQUAT BOT, V89, P237, DOI 10.1016/j.aquabot.2007.12.009; Gomez del Prado-Rosas MC, 2003, ANALES I BIOL, V74, P1; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; Harvell D, 2009, ECOLOGY, V90, P912, DOI 10.1890/08-0616.1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Humes Arthur Grover, 1942, ILLINOIS BIOL MONOGR, V18, P1; JMP, 1989, VERS 12; MCDERMOTT JJ, 1993, HYDROBIOLOGIA, V266, P57, DOI 10.1007/BF00013359; Messick GA, 1998, J CRUSTACEAN BIOL, V18, P533, DOI 10.2307/1549418; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Porter L, 2001, MAR FRESHWATER RES, V52, P1401, DOI 10.1071/MF01092; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ruckelshaus M, 2013, MAR POLICY, V40, P154, DOI 10.1016/j.marpol.2013.01.009; Ruiz-Morenol D, 2012, DIS AQUAT ORGAN, V100, P249, DOI 10.3354/dao02488; Sadeghian PS, 2010, J NAT HIST, V44, P2395, DOI 10.1080/00222933.2010.505014; Santos C, 2006, J NAT HIST, V40, P915, DOI 10.1080/00222930600833842; Shields JD, 2011, J INVERTEBR PATHOL, V106, P79, DOI 10.1016/j.jip.2010.09.015; Shields JD, 2004, DIS AQUAT ORGAN, V59, P109, DOI 10.3354/dao059109; SHIELDS JD, 1992, J CRUSTACEAN BIOL, V12, P94, DOI 10.2307/1548723; SHIELDS JD, 1989, CAN J ZOOL, V67, P923, DOI 10.1139/z89-134; SHIELDS JD, 1990, FISH B-NOAA, V88, P279; Shields JD, 2001, J CRUSTACEAN BIOL, V21, P304, DOI 10.1651/0278-0372(2001)021[0304:OJNGNS]2.0.CO;2; Shields JD, 2007, J CRUSTACEAN BIOL, V27, P681, DOI 10.1651/S-2794.1; Shields Jeffrey D., 2006, P146, DOI 10.1002/9780470995969.ch5; Silva dos Fernandes Vieira R.H., 1989, Arquivos de Ciencias do Mar, V26, P1; Staudinger M. D., 2013, IMPACTS CLIMATE CHAN; Sundberg P, 2016, ZOOL SCRIPTA; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Weil E, 2009, CARIBB J SCI, V45, P221; WICKHAM DE, 1985, AM ZOOL, V25, P127; WICKHAM DE, 1980, BIOL BULL, V159, P247, DOI 10.2307/1541022; Wickham DE., 1996, P BIOL SOC WASH, V91, P197	49	7	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177021	10.1371/journal.pone.0177021	http://dx.doi.org/10.1371/journal.pone.0177021			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475595	Green Published, Green Submitted, gold			2022-12-26	WOS:000400649500035
J	Wu, CH; Yang, YW; Hung, SC; Kuo, KL; Wu, KD; Wu, VC; Hsieh, TC				Wu, Che-Hsiung; Yang, Ya-Wen; Hung, Szu-Chun; Kuo, Ko-Lin; Wu, Kwan-Dun; Wu, Vin-Cent; Hsieh, Tsung-Cheng		Natl Taiwan Univ Study Grp Acute	Ketoanalogues supplementation decreases dialysis and mortality risk in patients with anemic advanced chronic kidney disease	PLOS ONE			English	Article							LOW-PROTEIN-DIET; CHRONIC-RENAL-FAILURE; IMPROVES NUTRITIONAL-STATUS; NATIONAL-HEALTH INSURANCE; AMINO-ACID SUPPLEMENT; PREDIALYSIS PATIENTS; CONTROLLED-TRIAL; SERUM PHOSPHATE; TAIWAN; PROGRESSION	Background The benefit of alpha-Ketoanalogues (KA) supplementation for chronic kidney disease (CKD) patients that followed low-protein diet (LPD) remains undetermined. Methods We extracted longitudinal data for all CKD patients in the Taiwan National Health Insurance from January 1, 2000 through December 31, 2010. A total of 1483 patients with anemic advanced CKD treated with LPD, who started KA supplementation, were enrolled in this study. We analyzed the risks of end stage renal disease and all-cause mortality using Cox proportional hazard models with influential drugs as time-dependent variables. Results A total of 1113 events of initiating long-term dialysis and 1228 events of the composite outcome of long-term dialysis or death occurred in patients with advanced CKD after a mean follow-up of 1.57 years. Data analysis suggests KA supplementation is associated with a lower risk for long-term dialysis and the composite outcome when daily dosage is more than 5.5 tablets. The beneficial effect was consistent in subgroup analysis, independent of age, sex, and comorbidities. Conclusions Among advanced CKD patients that followed LPD, KA supplementation at an appropriate dosage may substantially reduce the risk of initiating long-term dialysis or of developing the composite outcome. KA supplementation represents an additional therapeutic strategy to slow the progression of CKD.	[Wu, Che-Hsiung; Hung, Szu-Chun; Kuo, Ko-Lin] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Div Nephrol, Taipei, Taiwan; [Wu, Che-Hsiung; Hsieh, Tsung-Cheng] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Wu, Che-Hsiung] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Yang, Ya-Wen] Natl Taiwan Univ Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan; [Wu, Kwan-Dun; Wu, Vin-Cent] Natl Taiwan Univ Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan	Tzu Chi University; Tzu Chi University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Hsieh, TC (corresponding author), Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan.; Wu, VC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan.	q91421028@ntu.edu.tw; tchsieh@mail.tcu.edu.tw		Hsieh, Tsung-Cheng/0000-0003-3024-8675; Wu, Che-Hsiung/0000-0001-6164-6655; YANG, YA-WEN/0000-0003-0412-584X; Kuo, Ko-Lin/0000-0002-7477-0388; WU, VIN-CENT/0000-0001-7935-0991				Aparicio M, 2012, J RENAL NUTR, V22, pS1, DOI 10.1053/j.jrn.2011.09.005; Bellizzi V, 2007, KIDNEY INT, V71, P245, DOI 10.1038/sj.ki.5001955; Brunori G, 2007, AM J KIDNEY DIS, V49, P569, DOI 10.1053/j.ajkd.2007.02.278; Buckley JP, 2015, EPIDEMIOLOGY, V26, P204, DOI 10.1097/EDE.0000000000000217; Chang JH, 2009, NEPHROLOGY, V14, P750, DOI 10.1111/j.1440-1797.2009.01115.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chauveau P, 2007, J RENAL NUTR, V17, P250, DOI 10.1053/j.jrn.2007.02.007; Chen JB C B, 2012, KIDNEY RES CLIN PRAC, pA24; Chen YR, 2013, NEPHROL DIAL TRANSPL, V28, P671, DOI 10.1093/ndt/gfs469; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Collins Allan J, 2014, Am J Kidney Dis, V63, pA7, DOI 10.1053/j.ajkd.2013.11.001; Cupisti A, 2014, KIDNEY BLOOD PRESS R, V39, P107, DOI 10.1159/000355784; de Brito-Ashurst I, 2009, J AM SOC NEPHROL, V20, P2075, DOI 10.1681/ASN.2008111205; de Zeeuw D, 2004, CIRCULATION, V110, P921, DOI 10.1161/01.CIR.0000139860.33974.28; DRUML W, 1986, INFUSIONSTHERAPIE, V13, P262; Eddington H, 2010, CLIN J AM SOC NEPHRO, V5, P2251, DOI 10.2215/CJN.00810110; Gao X, 2010, BRIT J NUTR, V103, P608, DOI 10.1017/S0007114509992108; Garneata L, 2016, J AM SOC NEPHROL, V27, P2164, DOI 10.1681/ASN.2015040369; Hiroshige K, 2001, NEPHROL DIAL TRANSPL, V16, P1856, DOI 10.1093/ndt/16.9.1856; HOSTETTER TH, 1986, KIDNEY INT, V30, P509, DOI 10.1038/ki.1986.215; Hsu TW, 2014, JAMA INTERN MED, V174, P347, DOI 10.1001/jamainternmed.2013.12700; Huang JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126668; Hwang SJ, 2010, NEPHROL DIAL TRANSPL, V25, P2616, DOI 10.1093/ndt/gfq308; Hwang SJ, 2010, NEPHROLOGY, V15, P3, DOI 10.1111/j.1440-1797.2010.01304.x; Kasiske BL, 1998, AM J KIDNEY DIS, V31, P954, DOI 10.1053/ajkd.1998.v31.pm9631839; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; KING AJ, 1993, J AM SOC NEPHROL, V3, P1723; Kovesdy CP, 2013, AM J CLIN NUTR, V97, P1163, DOI 10.3945/ajcn.112.036418; Lai TS, 2013, CRIT CARE, V17, DOI 10.1186/cc13054; Levesque LE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5087; LEWIS NJW, 1993, PHARMACOECONOMICS, V4, P323, DOI 10.2165/00019053-199304050-00003; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Mircescu G, 2007, J RENAL NUTR, V17, P179, DOI 10.1053/j.jrn.2006.12.012; MITCH WE, 1984, NEW ENGL J MED, V311, P623, DOI 10.1056/NEJM198409063111002; MITCH WE, 1984, BIOCHEM J, V222, P579, DOI 10.1042/bj2220579; NATH KA, 1986, J CLIN INVEST, V78, P1199, DOI 10.1172/JCI112703; Ou SM, 2013, KIDNEY INT, V84, P198, DOI 10.1038/ki.2013.79; Prakash S, 2004, J RENAL NUTR, V14, P89, DOI 10.1053/j.jrn.2004.01.008; Scalone L, 2010, NEPHROL DIAL TRANSPL, V25, P907, DOI 10.1093/ndt/gfp572; Shiao C-C, 2015, NEPHROLOGY; Shih CJ, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0169-3; Teplan V, 2008, WIEN KLIN WOCHENSCHR, V120, P478, DOI 10.1007/s00508-008-0987-4; Voormolen N, 2007, NEPHROL DIAL TRANSPL, V22, P2909, DOI 10.1093/ndt/gfm286; Walser M, 1999, J AM SOC NEPHROL, V10, P110; Walser M, 1999, KIDNEY INT, V55, P771, DOI 10.1046/j.1523-1755.1999.055003771.x; WALSER M, 1993, KIDNEY INT, V43, P933, DOI 10.1038/ki.1993.131; WALSER M, 1992, J AM SOC NEPHROL, V2, P1178; Wang WJ, 2014, J BONE MINER RES, V29, P676, DOI 10.1002/jbmr.2061; Woo MJ, 2008, STAT MED, V27, P3805, DOI 10.1002/sim.3278; Wu CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112257; Wu IW, 2009, NEPHROL DIAL TRANSPL, V24, P3426, DOI 10.1093/ndt/gfp259; Wu PC, 2015, CLIN PHARMACOL THER, V98, P442, DOI 10.1002/cpt.173; Wu VC, 2014, J CLIN EPIDEMIOL, V67, P1139, DOI 10.1016/j.jclinepi.2014.05.012; Wu VC, 2014, J AM SOC NEPHROL, V25, P595, DOI 10.1681/ASN.2013060610; Wu VC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030836; Yang WC, 2008, NEPHROL DIAL TRANSPL, V23, P3977, DOI 10.1093/ndt/gfn406	56	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176847	10.1371/journal.pone.0176847	http://dx.doi.org/10.1371/journal.pone.0176847			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475591	Green Submitted, Green Published, gold			2022-12-26	WOS:000400649500018
J	Hoeger, J; Simon, TP; Beeker, T; Marx, G; Haase, H; Schuerholz, T				Hoeger, Janine; Simon, Tim-Philipp; Beeker, Thorben; Marx, Gernot; Haase, Hajo; Schuerholz, Tobias			Persistent low serum zinc is associated with recurrent sepsis in critically ill patients - A pilot study	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; IMMUNE FUNCTION; MURINE MODEL; DEFICIENCY; GUIDELINES; DAMAGE	Zinc is an essential trace element for both pathogens and hosts. Hypozincemia is a well known phenomenon in sepsis patients and represents the innate immune systems attempt to deprive pathogens of zinc. However little is known about course, restitution and prognostic value of serum zinc levels in sepsis patients. We performed a prospective observational single-center study set in a tertiary care university hospital intensive care unit. Serum zinc levels were singularly measured of healthy controls and sequentially of surgical sepsis patients and surgical patients over a 8-day period. Throughout the study period, we report significantly decreased serum zinc levels in surgical and surgical sepsis patients compared to healthy controls. Lower serum zinc levels in surgical sepsis patients were associated with a higher susceptibility to a recurrent sepsis episode. Furthermore, surgical sepsis patients with a higher number of organ dysfunctions and increased in-hospital mortality at day 28 and 90 showed lower serum zinc levels at admission. We report serum zinc levels as a promising biomarker in the diagnosis and evaluation of sepsis patients. However, it is still unclear whether these findings are caused by an over-amplified redistribution of zinc during acute-phase response, or whether the critically ill patients were zinc deficient before sepsis.	[Hoeger, Janine; Simon, Tim-Philipp; Beeker, Thorben; Marx, Gernot; Schuerholz, Tobias] Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Intens Care & Intermediate Care, Aachen, Germany; [Haase, Hajo] Berlin Inst Technol, Dept Food Chem & Toxicol, Berlin, Germany; [Schuerholz, Tobias] Univ Rostock, Dept Anesthesiol & Intens Care, Rostock, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Technical University of Berlin; University of Rostock	Schuerholz, T (corresponding author), Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Intens Care & Intermediate Care, Aachen, Germany.; Schuerholz, T (corresponding author), Univ Rostock, Dept Anesthesiol & Intens Care, Rostock, Germany.	tobias.schuerholz@med.uni-rostock.de	Haase, Hajo/B-9280-2009	Haase, Hajo/0000-0002-1622-8718	B. Braun Melsungen GmbH; Adrenomed; Astellas Pharma; Bayer Health Care; Astra Zeneca; Astellas Pharma GmbH; German Research Council	B. Braun Melsungen GmbH; Adrenomed; Astellas Pharma(Astellas Pharmaceuticals); Bayer Health Care(Bayer AGBayer Healthcare Pharmaceuticals); Astra Zeneca(AstraZeneca); Astellas Pharma GmbH(Astellas Pharmaceuticals); German Research Council(German Research Foundation (DFG))	GM honoraria fees for consulting and research grants by B. Braun Melsungen GmbH and Adrenomed, lecture fees by B. Braun Melsungen GmbH. TPS received research grants and honoraria for lecture by B. Braun Melsungen. TS received honoraria for board membership by Astellas Pharma GmbH, lecture fees by Astellas Pharma, Bayer Health Care and Astra Zeneca and research grants by Bayer Health Care and Astellas Pharma GmbH. HH received research grants by the German Research Council, honoraria for lectures and development of educational presentations by Novartis Consumer Health and travel expenses by EU cost action TD 1304. This does not alter our adherence to PLOS ONE policies on sharing data and materials. All the other authors declare that they have no competing interests.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; [Anonymous], 2014, J INTENSIVE CARE MED, V29, P87, DOI 10.1177/0885066612467162; [Anonymous], 2009, CHEST; Besecker BY, 2011, AM J CLIN NUTR, V93, P1356, DOI 10.3945/ajcn.110.008417; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Garnacho-Montero J, 2003, CRIT CARE MED, V31, P2742, DOI 10.1097/01.CCM.0000098031.24329.10; Haase H, 2009, ANNU REV NUTR, V29, P133, DOI 10.1146/annurev-nutr-080508-141119; Hoeger J, 2015, BIOMETALS, V28, P693, DOI 10.1007/s10534-015-9858-4; Hofman Z, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0220-y; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Knoell DL, 2009, CRIT CARE MED, V37, P1380, DOI 10.1097/CCM.0b013e31819cefe4; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; Mertens K, 2015, BRIT J ANAESTH, V114, P990, DOI 10.1093/bja/aev073; Nowak JE, 2012, PEDIATR CRIT CARE ME, V13, pE323, DOI 10.1097/PCC.0b013e31824fbd90; Pepersack T, 2001, ARCH GERONTOL GERIAT, V33, P243, DOI 10.1016/S0167-4943(01)00186-8; Rink L, 2000, J NUTR, V130, p1407S, DOI 10.1093/jn/130.5.1407S; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; SHANBHOGUE LKR, 1990, JPEN-PARENTER ENTER, V14, P287, DOI 10.1177/0148607190014003287; Shankar AH, 1998, AM J CLIN NUTR, V68, p447S, DOI 10.1093/ajcn/68.2.447S; van Zanten ARH, 2014, JAMA-J AM MED ASSOC, V312, P514, DOI 10.1001/jama.2014.7698; Wacker C, 2013, LANCET INFECT DIS, V13, P426, DOI 10.1016/S1473-3099(12)70323-7; Wong HR, 2007, PHYSIOL GENOMICS, V30, P146, DOI 10.1152/physiolgenomics.00024.2007; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081	24	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176069	10.1371/journal.pone.0176069	http://dx.doi.org/10.1371/journal.pone.0176069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472045	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500023
J	Mwinyi, J; Bostrom, A; Fehrer, I; Othman, A; Waeber, G; Marti-Soler, H; Vollenweider, P; Marques-Vidal, P; Schioth, HB; von Eckardstein, A; Hornemann, T				Mwinyi, J.; Bostrom, A.; Fehrer, I.; Othman, A.; Waeber, G.; Marti-Soler, H.; Vollenweider, P.; Marques-Vidal, P.; Schioth, H. B.; von Eckardstein, A.; Hornemann, T.			Plasma 1-deoxysphingolipids are early predictors of incident type 2 diabetes mellitus	PLOS ONE			English	Article							BIOMARKERS; NEUROPATHY; DISEASE	1-Deoxysphingolipids (1-deoxySLs) are atypical sphingolipids, which are formed in a side reaction during sphingolipid de-novo synthesis. Recently, we demonstrated that 1-deoxySLs are biomarkers for the prediction of T2DM in obese, non-diabetic patients. Here we investigated the relevance of 1-deoxySLs as long-term predictive biomarkers for the incidence of T2DM in an asymptomatic population. Here, we analyzed the plasma sphingoid base profile in a nested group of non-diabetic individuals (N = 605) selected from a population- based study including 5 year follow-up data (CoLaus study). 1-DeoxySLs at baseline were significantly elevated in individuals who developed T2DM during the follow-up (p<0.001), together with increased glucose (p<5.11E-14), triglycerides (p<0.001)and HOMA-IR indices (p<0.001). 1-Deoxy-sphinganine (1-deoxySA) and 1-deoxy-sphingosine (1-deoxySO) were predictive for T2DM, even after adjusting for fasting glucose levels in the binary regression analyses. The predictive value of the combined markers 1-deoxySA+ glucose were superior to glucose alone in normal-weight subjects (p<0.001) but decreased substantially with increasing BMI. Instead, plasma adiponectin and waist-to-hip ratio appeared to be better risk predictors for obese individuals (BMI>30kg/m(2)). In conclusion, elevated plasma 1-deoxySL levels are strong and independent risk predictors of future T2DM, especially for non-obese individuals in the general population.	[Mwinyi, J.; Schioth, H. B.] Uppsala Univ, Dept Neurosci Funct Pharmacol, Uppsala, Sweden; [Fehrer, I.; Othman, A.; von Eckardstein, A.; Hornemann, T.] Univ Zurich, Inst Clin Chem, Zurich, Switzerland; [Fehrer, I.; Othman, A.; von Eckardstein, A.; Hornemann, T.] Univ Hosp Zurich, Zurich, Switzerland; [Waeber, G.; Marti-Soler, H.; Vollenweider, P.; Marques-Vidal, P.] Univ Lausanne, Lausanne Univ Hosp CHUV, Dept Med, Lausanne, Switzerland; [Waeber, G.; Marti-Soler, H.; Vollenweider, P.; Marques-Vidal, P.] Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland	Uppsala University; University of Zurich; University of Zurich; University Zurich Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Hornemann, T (corresponding author), Univ Zurich, Inst Clin Chem, Zurich, Switzerland.; Hornemann, T (corresponding author), Univ Hosp Zurich, Zurich, Switzerland.	thorsten.hornemann@usz.ch	Desai Boström (formerly Adrian E. Boström), Adrian Emmanuel/AAA-8872-2022; Colaus, PsyColaus/K-6607-2013; Marti-Soler, Helena/AAA-7659-2019; Schioth, Helgi/AAQ-7239-2020; Boström, Adrian/HCG-9089-2022; Othman, Alaa/AAE-5897-2019; Marques-Vidal, Pedro M/C-9449-2009	Desai Boström (formerly Adrian E. Boström), Adrian Emmanuel/0000-0001-8604-9638; Marti-Soler, Helena/0000-0002-7127-205X; Othman, Alaa/0000-0002-0092-5594; Marques-Vidal, Pedro M/0000-0002-4548-8500; Waeber, Gerard/0000-0003-4193-788X	Zurich Center of Integrated Human Physiology, University of Zurich (ZIHP); European Commission [305707]; Swiss National Foundation SNF [31003A_153390/1]; Hurka Foundation; Novartis Foundation; Rare Disease Initiative Zurich ("radiz", Clinical Research Priority Program for Rare Diseases, University of Zurich); GlaxoSmith Kline; Faculty of Biology and Medicine of Lausanne; Swiss National Science Foundation [33CSCO-122661, 33CS30-139468, 33CS30-148401]	Zurich Center of Integrated Human Physiology, University of Zurich (ZIHP); European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Foundation SNF(Swiss National Science Foundation (SNSF)); Hurka Foundation; Novartis Foundation(Novartis); Rare Disease Initiative Zurich ("radiz", Clinical Research Priority Program for Rare Diseases, University of Zurich); GlaxoSmith Kline(GlaxoSmithKline); Faculty of Biology and Medicine of Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grants from the Zurich Center of Integrated Human Physiology, University of Zurich (ZIHP); the 7th Framework Program of the European Commission ("RESOLVE", Project number 305707); the Swiss National Foundation SNF (Project 31003A_153390/1); the Hurka Foundation; the Novartis Foundation and the Rare Disease Initiative Zurich ("radiz", Clinical Research Priority Program for Rare Diseases, University of Zurich) (TH). Further support was obtained from the Swedish Foundation for Medical Research (JM) and from the Swedish Research Council (HBS). The CoLaus study was and is supported by research grants from GlaxoSmith Kline, the Faculty of Biology and Medicine of Lausanne and the Swiss National Science Foundation (grants 33CSCO-122661, 33CS30-139468 and 33CS30-148401).	Bertea M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-84; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Dohrn MF, 2015, EUR J NEUROL, V22, P806, DOI 10.1111/ene.12663; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Fox TE, 2011, J LIPID RES, V52, P509, DOI 10.1194/jlr.M010595; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Gorden DL, 2015, J LIPID RES, V56, P722, DOI 10.1194/jlr.P056002; Manchanayake J, 2011, J GASTROEN HEPATOL, V26, P510, DOI 10.1111/j.1440-1746.2010.06528.x; Nerpin E, 2008, DIABETES CARE, V31, P1550, DOI 10.2337/dc08-0369; Othman A, 2014, ATHEROSCLEROSIS, V235, pE16, DOI 10.1016/j.atherosclerosis.2014.05.015; Othman A, 2015, J CLIN LIPIDOL, V9, P568, DOI 10.1016/j.jacl.2015.03.011; Othman A, 2015, BMJ OPEN DIAB RES CA, V3, DOI 10.1136/bmjdrc-2014-000073; Othman A, 2015, DIABETES, V64, P1035, DOI 10.2337/db14-1325; Wei N, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-161; Zuellig RA, 2014, DIABETES, V63, P1326, DOI 10.2337/db13-1042	15	32	32	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0175776	10.1371/journal.pone.0175776	http://dx.doi.org/10.1371/journal.pone.0175776			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472035	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000400648500016
J	Stromvall, K; Thysell, E; Bergstrom, SH; Bergh, A				Stromvall, Kerstin; Thysell, Elin; Bergstrom, Sofia Halin; Bergh, Anders			Aggressive rat prostate tumors reprogram the benign parts of the prostate and regional lymph nodes prior to metastasis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CANCER PROGRESSION; PREMETASTATIC NICHE; PROMOTE TUMOR; EXTRACELLULAR VESICLES; CELL-PROLIFERATION; EXPRESSION; INVASION; ACTIVATION; MIGRATION	In order to grow and spread tumors need to interact with adjacent tissues. We therefore hypothesized that small but aggressive prostate cancers influence the rest of the prostate and regional lymph nodes differently than tumors that are more indolent. Poorly metastatic (Dunning AT1) or highly metastatic (Dunning MLL) rat prostate tumor cells were injected into the ventral prostate lobe of immunocompetent rats. After 10 days-when the tumors occupied about 30% of the prostate lobe and lymph node metastases were undetectable- the global gene expression in tumors, benign parts of the prostate, and regional iliac lymph nodes were examined to define tumor-induced changes related to preparation for future metastasis. The tumors induced profound effects on the gene expression profiles in the benign parts of the prostate and these were strikingly different in the two tumor models. Gene ontology enrichment analysis suggested that tumors with high metastatic capacity were more successful than less metastatic tumors in inducing tumor-promoting changes and suppressing anti-tumor immune responses in the entire prostate. Some of these differences such as altered angiogenesis, nerve density, accumulation of T-cells and macrophages were verified by immunohistochemistry. Gene expression alterations in the regional lymph nodes suggested decreased quantity and activation of immune cells in MLL-lymph nodes that were also verified by immunostaining. In summary, even when small highly metastatic prostate tumors can affect the entire tumor-bearing organ and pre-metastatic lymph nodes differently than less metastatic tumors. When the kinetics of these extratumoral influences (by us named TINT = tumor instructed normal tissue) are more precisely defined they could potentially be used as markers of disease aggressiveness and become therapeutic targets.	[Stromvall, Kerstin; Thysell, Elin; Bergstrom, Sofia Halin; Bergh, Anders] Umea Univ, Dept Med Biosci Pathol, Umea, Sweden	Umea University	Stromvall, K (corresponding author), Umea Univ, Dept Med Biosci Pathol, Umea, Sweden.	kerstin.stromvall@umu.se		Halin Bergstrom, Sofia/0000-0003-3475-3230	Swedish Research Council [Co257301]; Swedish Cancer Foundation, Umea University [130293]; Lion's Cancer Research Foundation; King Gustaf V and Queen Victoria's Foundation of Freemasons	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation, Umea University; Lion's Cancer Research Foundation; King Gustaf V and Queen Victoria's Foundation of Freemasons	This work was supported by grants from: Swedish Research Council, http://www.vr.se/ (AB), grant number Co257301; The Swedish Cancer Foundation, https://www.cancerfonden.se/ (AB), grant number 130293; The Lion's Cancer Research Foundation, Umea University, http://www.cancerforskningsfonden.se/ (KS, SHB); King Gustaf V and Queen Victoria's Foundation of Freemasons, https://www.frimurarordern.se/organisation/barmhartighetsverksamhet/frimurarstiftelsen/ (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2008, DIFFERENTIATION, V76, P717, DOI 10.1111/j.1432-0436.2008.00292.x; Achkova D, 2016, BIOCHEM SOC T, V44, P333, DOI 10.1042/BST20150245; Adamo HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141601; Adamo HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130076; Aichem A, 2016, INT J BIOCHEM CELL B, V79, P451, DOI 10.1016/j.biocel.2016.07.001; [Anonymous], 1979, STEREOLOGICAL METHOD; Barron DA, 2012, ENDOCR-RELAT CANCER, V19, pR187, DOI 10.1530/ERC-12-0085; Becker A, 2016, CANCER CELL, V30, P836, DOI 10.1016/j.ccell.2016.10.009; Benezech C, 2014, BLOOD, V123, P3200, DOI 10.1182/blood-2013-03-489286; Bergstrom SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep31805; Bergstrom SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157280; Bhalla A, 2009, EUR J CLIN INVEST, V39, P74, DOI 10.1111/j.1365-2362.2009.02123.x; Bruyninx M, 1999, ENDOCRINOLOGY, V140, P4789, DOI 10.1210/en.140.10.4789; Buresh-Stiemke RA, 2012, DEV DYNAM, V241, P2005, DOI 10.1002/dvdy.23886; Cai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053388; Carosella ED, 2015, EUR UROL, V68, P267, DOI 10.1016/j.eururo.2015.02.032; Chen EC, 2015, GASTROENTEROLOGY, V149, P705, DOI 10.1053/j.gastro.2015.05.042; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Cochran AJ, 2015, CANCER J, V21, P39, DOI 10.1097/PPO.0000000000000094; D'Antonio KB, 2010, J UROLOGY, V183, P1604, DOI 10.1016/j.juro.2009.12.006; Dango S, 2008, LUNG CANCER, V60, P426, DOI 10.1016/j.lungcan.2007.11.015; Deng JH, 2012, CANCER CELL, V21, P642, DOI 10.1016/j.ccr.2012.03.039; Di Meo S, 2014, CLIN CANCER RES, V20, P585, DOI 10.1158/1078-0432.CCR-13-2240; Drake CG, 2010, NAT REV IMMUNOL, V10, P580, DOI 10.1038/nri2817; Duda DG, 2010, CANCER RES, V70, P5670, DOI 10.1158/0008-5472.CAN-10-0119; Dunne JC, 2015, CLIN PROTEOM, V12, DOI 10.1186/s12014-015-9096-3; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Fagiani E, 2013, CANCER LETT, V328, P18, DOI 10.1016/j.canlet.2012.08.018; Falasca Marco, 2015, Advances in Biological Regulation, V60, P88, DOI 10.1016/j.jbior.2015.10.003; Fu J, 2014, BIOCHEM BIOPH RES CO, V445, P314, DOI 10.1016/j.bbrc.2014.01.174; Fujita K, 2009, CANCER SCI, V100, P1047, DOI 10.1111/j.1349-7006.2009.01146.x; Gannon PO, 2006, PROSTATE, V66, P1710, DOI 10.1002/pros.20466; Garlanda C, 2013, SEMIN IMMUNOL, V25, P408, DOI 10.1016/j.smim.2013.10.019; Gitenay D, 2009, FUTURE ONCOL, V5, P993, DOI 10.2217/FON.09.67; Gong YX, 2014, CANCERS, V6, P1298, DOI 10.3390/cancers6031298; Gu JJ, 2016, INT J MOL MED, V37, P1587, DOI 10.3892/ijmm.2016.2580; Hagglof Christina, 2012, Cancers (Basel), V4, P531, DOI 10.3390/cancers4020531; Hagglof C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010747; Halin Sofia, 2011, Expert Opin Med Diagn, V5, P37, DOI 10.1517/17530059.2011.540009; Halin S, 2009, NEOPLASIA, V11, P177, DOI 10.1593/neo.81338; Hammarsten P, 2010, CLIN CANCER RES, V16, P1245, DOI 10.1158/1078-0432.CCR-09-0103; Herroon MK, 2013, ONCOTARGET, V4, P2108, DOI 10.18632/oncotarget.1482; Herzog BH, 2013, NATURE, V502, P105, DOI 10.1038/nature12501; Hirakawa S, 2009, CANCER SCI, V100, P983, DOI 10.1111/j.1349-7006.2009.01142.x; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Iguchi K, 2011, J ANDROL, V32, P144, DOI 10.2164/jandrol.110.011205; Ioachim HL, 1994, LYMPH NODE PATHOLOGY; ISAACS JT, 1986, PROSTATE, V9, P261, DOI 10.1002/pros.2990090306; Johansson A, 2010, AM J PATHOL, V177, P1031, DOI 10.2353/ajpath.2010.100070; Josefsson A, 2011, AM J PATHOL, V179, P1961, DOI 10.1016/j.ajpath.2011.06.005; Jung T, 2009, NEOPLASIA, V11, P1093, DOI 10.1593/neo.09822; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kirschmann DA, 2002, CANCER RES, V62, P4478; Knudsen BS, 2016, J MOL DIAGN, V18, P395, DOI 10.1016/j.jmoldx.2015.12.006; Koltai T, 2014, ONCOTARGETS THER, V7, P447, DOI 10.2147/OTT.S58622; Lai TH, 2008, PROSTATE, V68, P1341, DOI 10.1002/pros.20799; Lim SY, 2016, ONCOGENE, V35, P5735, DOI 10.1038/onc.2016.107; Liu Y, 2016, CANCER CELL, V30, P668, DOI 10.1016/j.ccell.2016.09.011; Louis I, 2003, BLOOD, V102, P1397, DOI 10.1182/blood-2003-01-0316; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Matsuda K, 2016, NEURON, V90, P752, DOI 10.1016/j.neuron.2016.04.001; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; McAllister SS, 2010, J CLIN ONCOL, V28, P4022, DOI 10.1200/JCO.2010.28.4257; McMahon BJ, 2015, ADV EXP MED BIOL, V867, P145, DOI 10.1007/978-94-017-7215-0_10; Morfoisse F, 2015, MOL CELL ONCOL, V2, DOI 10.1080/23723556.2015.1024821; Nilsson M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140985; Nishan U, 2015, LIFE SCI, V143, P168, DOI 10.1016/j.lfs.2015.10.036; Nonn L, 2009, PROSTATE, V69, P1470, DOI 10.1002/pros.20983; O'Neill ASG, 2013, IMMUNOLOGY, V138, P198, DOI 10.1111/imm.12042; Ogawa F, 2014, J CLIN INVEST, V124, P4882, DOI 10.1172/JCI73530; Pal SK, 2015, MOL CANCER THER, V14, P2896, DOI 10.1158/1535-7163.MCT-15-0367; Pan J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092815; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Pizzola C, 2016, CURR MOL PHARMACOL, V9, P217, DOI 10.2174/1874467208666150716120551; Place AE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2912; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Qian CN, 2006, CANCER RES, V66, P10365, DOI 10.1158/0008-5472.CAN-06-2977; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rehman I, 2004, HUM PATHOL, V35, P1385, DOI 10.1016/j.humpath.2004.07.015; Rinderknecht M, 2008, J CELL PHYSIOL, V216, P347, DOI 10.1002/jcp.21494; Romanuik TL, 2009, AM J PATHOL, V175, P2264, DOI 10.2353/ajpath.2009.080868; Salazar N, 2013, CRIT REV EUKAR GENE, V23, P77, DOI 10.1615/CritRevEukaryotGeneExpr.2013006905; Sceneay J, 2013, CANCER METAST REV, V32, P449, DOI 10.1007/s10555-013-9420-1; Shaw A, 2007, J UROLOGY, V177, P832, DOI 10.1016/j.juro.2006.10.061; Shen PL, 2014, PROSTATE, V74, P946, DOI 10.1002/pros.22812; Sleeman JP, 2015, J MOL MED, V93, P1173, DOI 10.1007/s00109-015-1351-6; Sleeman JP, 2012, CANCER METAST REV, V31, P429, DOI 10.1007/s10555-012-9373-9; So T, 2006, INT J HEMATOL, V83, P1, DOI 10.1532/IJH97.05120; Stallone G, 2014, CANCER RES, V74, P4230, DOI 10.1158/0008-5472.CAN-14-0369; Sternberg IA, 2016, ANNU REV MED, V67, P119, DOI 10.1146/annurev-med-060413-112226; Tidehag V, 2014, EUR J CANCER, V50, P1829, DOI 10.1016/j.ejca.2014.03.278; Tomita Y, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28100; Trujillo KA, 2012, PROSTATE CANCER, V2012, DOI 10.1155/2012/302894; Turnis ME, 2015, EUR J IMMUNOL, V45, P1892, DOI 10.1002/eji.201344413; Vainio P, 2012, PROSTATE, V72, P789, DOI 10.1002/pros.21487; Vainio P, 2011, ONCOTARGET, V2, P1176; Valverde LD, 2016, TUMOR BIOL, V37, P9233, DOI 10.1007/s13277-015-4763-6; Voskoboinik I, 2015, NAT REV IMMUNOL, V15, P388, DOI 10.1038/nri3839; Weon JL, 2015, CURR OPIN CELL BIOL, V37, P1, DOI 10.1016/j.ceb.2015.08.002; Wiethe C, 2003, J IMMUNOL, V171, P4121, DOI 10.4049/jimmunol.171.8.4121; Wikstrom P, 2009, PROSTATE, V69, P799, DOI 10.1002/pros.20927; Yan L, 2014, ONCOGENE, V33, P157, DOI 10.1038/onc.2012.566; Yang F, 2005, CANCER RES, V65, P8887, DOI 10.1158/0008-5472.CAN-05-1702; Zang X, 2007, P NATL ACAD SCI USA, V104, P19458, DOI 10.1073/pnas.0709802104; Zhang J, 2010, JNCI-J NATL CANCER I, V102, P522, DOI 10.1093/jnci/djq044; Zhao P, 2016, ACTA BIOCH BIOPH SIN, V48, P266, DOI 10.1093/abbs/gmw001; Zhao S, 2016, CLIN CANC RES; Zundler S, 2015, CYTOKINE GROWTH F R, V26, P559, DOI 10.1016/j.cytogfr.2015.07.003	108	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176679	10.1371/journal.pone.0176679	http://dx.doi.org/10.1371/journal.pone.0176679			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472073	gold, Green Published, Green Submitted			2022-12-26	WOS:000400648500061
J	Wang, XH; Shults, NV; Suzuki, YJ				Wang, Xinhong; Shults, Nataliia V.; Suzuki, Yuichiro J.			Oxidative profiling of the failing right heart in rats with pulmonary hypertension	PLOS ONE			English	Article							RIGHT-VENTRICULAR FAILURE; ARTERIAL-HYPERTENSION; PROTEIN CARBONYLATION; MOLECULAR-MECHANISMS; HYPERTROPHY; SURVIVAL	Right heart failure is the major cause of death among patients with pulmonary arterial hypertension (PAH). Understanding the biology of the right ventricle (RV) should help developing new therapeutic strategies. Rats subjected to the injection of Sugen5416 (an inhibitors of vascular endothelial growth factor receptor) plus the ovalbumin immunization had increased pulmonary arterial pressure and severe vascular remodeling. RVs of these rats were hypertrophied and had severe cardiac fibrosis. No apoptosis was, however, detected. Metabolomics analysis revealed that oxidized glutathione, xanthine and uric acid had increased in PAH RVs, suggesting the production of reactive oxygen species by xanthine oxidase. PAH RVs were also found to have a 30-fold lower level of a-tocopherol nicotinate, consistent with oxidative stress decreasing antioxidants and also demonstrating for the first time that the nicotinate ester of vitamin E is endogenously expressed. Oxidative/nitrosative protein modifications including S-glutathionylation, S-nitrosylation and nitrotyrosine formation, but not protein carbonylation, were found to be increased in RVs of rats with PAH. Mass spectrometry identified that S-nitrosylated proteins include heat shock protein 90 and sarcoplasmic reticulum Ca2+-ATPase. These results demonstrate that RV failure is associated with the promotion of specific oxidative and nitrosative stress.	[Wang, Xinhong; Shults, Nataliia V.; Suzuki, Yuichiro J.] Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20007 USA; [Wang, Xinhong] Fudan Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Shanghai, Peoples R China	Georgetown University; Fudan University	Suzuki, YJ (corresponding author), Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20007 USA.	ys82@georgetown.edu	Xinhong, Wang/P-7311-2019	Xinhong, Wang/0000-0001-5363-032X	National Institutes of Health [R01HL72844, R03AG047824]; National Natural Science Foundation of China [81201468]; Fudan University Fund [20520133217]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fudan University Fund	This work was supported in part by National Institutes of Health (R01HL72844 and R03AG047824) to YJS; and the National Natural Science Foundation of China (81201468) and Fudan University Fund (20520133217) to XW.	Alzoubi A, 2013, AM J PHYSIOL-HEART C, V304, pH1708, DOI 10.1152/ajpheart.00746.2012; ARAI M, 1994, CIRC RES, V74, P555, DOI 10.1161/01.RES.74.4.555; Benza RL, 2010, TRANSPLANTATION, V90, P298, DOI 10.1097/TP.0b013e3181e49b83; Boxt LM, 1999, RADIOL CLIN N AM, V37, P379, DOI 10.1016/S0033-8389(05)70100-7; Budev MM, 2003, SEMIN RESP CRIT CARE, V24, P233; Chemla D, 2002, EUR RESPIR J, V20, P1314, DOI 10.1183/09031936.02.00068002; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Delcroix M, 2010, EUR RESPIR REV, V19, P204, DOI 10.1183/09059180.00004910; Farber HW, 2004, NEW ENGL J MED, V351, P1655, DOI 10.1056/NEJMra035488; Fishman AP, 2004, J AM COLL CARDIOL, V43, p2S, DOI 10.1016/j.jacc.2004.03.019; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Halliwell B., 2015, FREE RADICALS BIOL M; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Humbert M, 2010, EUR RESPIR J, V36, P549, DOI 10.1183/09031936.00057010; Ibrahim YF, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000520; Ikeda S, 2014, ARTERIOSCL THROM VAS, V34, P1260, DOI 10.1161/ATVBAHA.114.303320; Mizuno S, 2012, AM J RESP CELL MOL, V47, P679, DOI 10.1165/rcmb.2012-0077OC; Nauser Trenton D, 2003, Congest Heart Fail, V9, P155, DOI 10.1111/j.1527-5299.2002.01050.x; Nicolls Mark R, 2012, Pulm Circ, V2, P434, DOI 10.4103/2045-8932.105031; Qipshidze N, 2012, AM J PHYSIOL-HEART C, V302, pH688, DOI 10.1152/ajpheart.00777.2011; Rawat DK, 2014, HYPERTENSION, V64, P1266, DOI 10.1161/HYPERTENSIONAHA.114.03261; Reddy S, 2015, CIRCULATION, V132, P1734, DOI 10.1161/CIRCULATIONAHA.114.012975; Redout EM, 2007, CARDIOVASC RES, V75, P770, DOI 10.1016/j.cardiores.2007.05.012; Redout EM, 2010, AM J PHYSIOL-HEART C, V298, pH1038, DOI 10.1152/ajpheart.00097.2009; Runo JR, 2003, LANCET, V361, P1533, DOI 10.1016/S0140-6736(03)13167-4; Simonneau G, 2004, J AM COLL CARDIOL, V43, p5S, DOI 10.1016/j.jacc.2004.02.037; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Suzuki YJ, 2011, TEXTBOOK OF PULMONARY VASCULAR DISEASE, P1305, DOI 10.1007/978-0-387-87429-6_93; Suzuki YJ, 2010, ANTIOXID REDOX SIGN, V12, P323, DOI 10.1089/ars.2009.2887; Sztrymf B, 2010, EUR RESPIR J, V35, P1286, DOI 10.1183/09031936.00070209; Tanonaka K, 2001, BIOCHEM BIOPH RES CO, V283, P520, DOI 10.1006/bbrc.2001.4801; Thenappan T, 2010, EUR RESPIR J, V35, P1079, DOI 10.1183/09031936.00072709; Voelkel NF, 2006, CIRCULATION, V114, P1883, DOI 10.1161/CIRCULATIONAHA.106.632208; Wong CM, 2008, CIRC RES, V102, P310, DOI 10.1161/CIRCRESAHA.107.159814	34	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176887	10.1371/journal.pone.0176887	http://dx.doi.org/10.1371/journal.pone.0176887			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472095	gold, Green Published, Green Submitted			2022-12-26	WOS:000400648500093
J	Zhang, YH; Dai, L; Liu, Y; Zhang, YH; Wang, SP				Zhang, Yunhua; Dai, Li; Liu, Ying; Zhang, YuHang; Wang, ShaoPeng			Identifying novel fruit-related genes in Arabidopsis thaliana based on the random walk with restart algorithm	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; ONE-CARBON METABOLISM; SEED-GERMINATION; SHORTEST-PATH; SPECIFICALLY INTERACTS; COMPUTATIONAL METHOD; IDENTIFICATION; NETWORK; PREDICTION; RECEPTOR	Fruit is essential for plant reproduction and is responsible for protection and dispersal of seeds. The development and maturation of fruit is tightly regulated by numerous genetic factors that respond to environmental and internal stimulation. In this study, we attempted to identify novel fruit-related genes in a model organism, Arabidopsis thaliana, using a computational method. Based on validated fruit-related genes, the random walk with restart (RWR) algorithm was applied on a protein-protein interaction (PPI) network using these genes as seeds. The identified genes with high probabilities were filtered by the permutation test and linkage tests. In the permutation test, the genes that were selected due to the structure of the PPI network were discarded. In the linkage tests, the importance of each candidate gene was measured from two aspects: (1) its functional associations with validated genes and (2) its similarity with validated genes on gene ontology (GO) terms and KEGG pathways. Finally, 255 inferred genes were obtained, subsequent extensive analysis of important genes revealed that they mainly contribute to ubiquitination (UBQ9, UBQ8, UBQ11, UBQ10), serine hydroxymethyl transfer (SHM7, SHM5, SHM6) or glycol-metabolism (HXKL2_ARATH, CSY5, GAPCP1), suggesting essential roles during the development and maturation of fruit in Arabidopsis thaliana.	[Zhang, Yunhua; Dai, Li] Anhui Agr Univ, Sch Resources & Environm, Hefei, Peoples R China; [Liu, Ying] Anhui Agr Univ, Sch Forestry & Landscape Architecture, Hefei, Peoples R China; [Zhang, YuHang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Wang, ShaoPeng] Shanghai Univ, Sch Life Sci, Shanghai, Peoples R China	Anhui Agricultural University; Anhui Agricultural University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai University	Zhang, YH (corresponding author), Anhui Agr Univ, Sch Resources & Environm, Hefei, Peoples R China.	yunhua9681@163.com	Zhang, Yu-Hang/AAQ-9012-2021; Zhang, Yu-Hang/O-9774-2015	Zhang, Yu-Hang/0000-0003-3825-0796; Zhang, Yu-Hang/0000-0003-3825-0796; Zhang, Yunhua/0000-0001-5128-6385	Science Foundation of Anhui [1608085MC58]; Science and technology research projects [1604e0302006]	Science Foundation of Anhui; Science and technology research projects	This work was supported by the Science Foundation of Anhui (Grant No. 1608085MC58) and the Science and technology research projects (Grant No. 1604e0302006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by grants from the Science Foundation of Anhui (Grant No. 1608085MC58) and the Science and technology research projects (Grant No. 1604e0302006).	Agrawal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029302; Aloy P, 2003, BIOINFORMATICS, V19, P161, DOI 10.1093/bioinformatics/19.1.161; Andriotis VME, 2010, NEW PHYTOL, V185, P649, DOI 10.1111/j.1469-8137.2009.03113.x; Anoman AD, 2015, PLANT PHYSIOL, V169, P1619, DOI 10.1104/pp.15.00696; [Anonymous], 2005, P 5 INT WORKSH BIOIN, DOI DOI 10.1145/1134030.1134042; Avraham S, 2008, NUCLEIC ACIDS RES, V36, pD449, DOI 10.1093/nar/gkm908; Balanza V, 2016, DEVELOPMENT, V143, P3372, DOI 10.1242/dev.135202; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barkla BJ, 2014, J PROTEOMICS, V111, P128, DOI 10.1016/j.jprot.2014.03.006; Bueso E, 2014, PLANT PHYSIOL, V164, P999, DOI 10.1104/pp.113.232223; Bueso E, 2014, PLANT SCI, V215, P110, DOI 10.1016/j.plantsci.2013.11.004; CALLIS J, 1995, GENETICS, V139, P921; Chen JG, 2004, METHOD ENZYMOL, V389, P338; CHEN L, 2016, MOL GENET GENOMICS, V291, P2065, DOI DOI 10.1007/s00438-016-1240-x; Chen L, 2017, PLOS ONE; Chen L, 2017, AGR FOREST METEOROL, V233, P133, DOI 10.1016/j.agrformet.2016.11.012; Chen L, 2016, PROTEIN PEPTIDE LETT, V23, P1081, DOI 10.2174/0929866523666161021165506; Chen L, 2016, MOL GENET GENOMICS, V291, P913, DOI 10.1007/s00438-015-1157-9; Chen L, 2016, CURR BIOINFORM, V11, P51, DOI 10.2174/1574893611666151119220024; Chen L, 2016, J BIOMOL STRUCT DYN, V34, P664, DOI 10.1080/07391102.2015.1042915; Chen L, 2015, MOL BIOSYST, V11, P2541, DOI 10.1039/c5mb00276a; Dyson BC, 2014, ANN BOT-LONDON, V113, P643, DOI 10.1093/aob/mct298; El-Sharkawy I, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0746-z; Eshed Y, 2001, CURR BIOL, V11, P1251, DOI 10.1016/S0960-9822(01)00392-X; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gene Ontology Consortium, 2015, Nucleic Acids Res, V43, pD1049, DOI 10.1093/nar/gku1179; Gormen T. H., 1990, INTRO ALGORITHMS; Gui TT, 2015, J COMPUT BIOL, V22, P63, DOI 10.1089/cmb.2014.0122; Guo W, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6132436; Ham B, 2013, IEEE T IMAGE PROCESS, V22, P2574, DOI 10.1109/TIP.2013.2253479; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Huang GH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166580; Jalali S, 2015, BIOINFORMATICS, V31, P2241, DOI 10.1093/bioinformatics/btv148; Jander G, 2004, PLANT J, V39, P465, DOI 10.1111/j.1365-313X.2004.02140.x; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jumhawan U, 2013, J AGR FOOD CHEM, V61, P7994, DOI 10.1021/jf401819s; Kawasaki T, 2005, PLANT J, V44, P258, DOI 10.1111/j.1365-313X.2005.02525.x; Kinoshita T, 2008, SEMIN CELL DEV BIOL, V19, P574, DOI 10.1016/j.semcdb.2008.07.018; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Lahaie N, 2016, J BIOL CHEM, V291, P7156, DOI 10.1074/jbc.M115.686907; Lasky JR, 2012, MOL ECOL, V21, P5512, DOI 10.1111/j.1365-294X.2012.05709.x; Leeggangers HACF, 2015, PHYSIOL PLANTARUM, V153, P318, DOI 10.1111/ppl.12231; Lemus Leticia, 2014, Cells, V3, P824, DOI 10.3390/cells3030824; Li M, 2011, PLANT BIOTECHNOL J, V9, P1002, DOI 10.1111/j.1467-7652.2011.00610.x; Li ZD, 2016, SCI REP-UK, V6, DOI 10.1038/srep25515; Liu JX, 2016, NEW PHYTOL, V211, P418, DOI 10.1111/nph.13915; Liu JH, 2013, PLANT CELL REP, V32, P129, DOI 10.1007/s00299-012-1347-4; Liu X, 2014, MOL BIOL REP, V41, P6253, DOI 10.1007/s11033-014-3506-x; Liu Y, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.42; Lugassi N, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01114; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Matella NJ, 2005, J AGR FOOD CHEM, V53, P2268, DOI 10.1021/jf048285c; Meng HY, 2014, PLOS ONE, V9; Miao X., 2016, ADV EN ENV MAT SCI; Ng KL, 2010, COMPUT BIOL MED, V40, P300, DOI 10.1016/j.compbiomed.2010.01.001; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Pinto LVA, 2007, ANN BOT-LONDON, V100, P1175, DOI 10.1093/aob/mcm211; Pracharoenwattana I, 2005, PLANT CELL, V17, P2037, DOI 10.1105/tpc.105.031856; Quatrini L, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab2724; Ravi M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6334; Rizzo AA, 2014, BIOCHEMISTRY-US, V53, P5895, DOI 10.1021/bi500823h; Roeder Adrienne H K, 2006, Arabidopsis Book, V4, pe0075, DOI 10.1199/tab.0075; Roth U, 2006, J EXP BOT, V57, P4003, DOI 10.1093/jxb/erl170; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; SNAPE JW, 1971, HEREDITY, V27, P299, DOI 10.1038/hdy.1971.91; Su R, 2016, J MICROSC-OXFORD, V264, P127, DOI 10.1111/jmi.12421; Sun CW, 1997, PLANT MOL BIOL, V34, P745, DOI 10.1023/A:1005848828368; Wang BM, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/715639; Wang DK, 2015, J INTEGR PLANT BIOL, V57, P745, DOI 10.1111/jipb.12336; Wang SP, 2016, BBA-GEN SUBJECTS, V1860, P2716, DOI 10.1016/j.bbagen.2016.04.010; Wang WQ, 2015, PLANT PHYSIOL, V167, P1332, DOI 10.1104/pp.15.00045; Wei LY, 2017, ARTIF INTELL MED, V83, P67, DOI 10.1016/j.artmed.2017.03.001; Wei LY, 2017, IEEE T NANOBIOSCI, V16, P240, DOI 10.1109/TNB.2017.2661756; Wei LY, 2017, INFORM SCIENCES, V384, P135, DOI 10.1016/j.ins.2016.06.026; WEI LY, IEEE ACM TRANS COMPU, V16, P1264; Wei ZY, 2013, ARCH BIOCHEM BIOPHYS, V536, P87, DOI 10.1016/j.abb.2013.06.004; Yang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107202; Yang XY, 2011, PLANT CELL, V23, P1093, DOI 10.1105/tpc.110.082420; Yoshida H, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-14; Yuan F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/623121; Zeng XX, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005420; Zeng XX, 2017, IEEE ACM T COMPUT BI, V14, P687, DOI 10.1109/TCBB.2016.2520947; Zhang J, 2016, NEUROCOMPUTING, V217, P63, DOI 10.1016/j.neucom.2015.09.136; Zhang J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/450386; Zhang T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/870795; Zhang Y, 2010, BIOCHEM J, V430, P97, DOI 10.1042/BJ20100566; Zhu LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159519	88	15	15	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177017	10.1371/journal.pone.0177017	http://dx.doi.org/10.1371/journal.pone.0177017			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472169	Green Submitted, Green Published, gold			2022-12-26	WOS:000400648500118
J	Zhou, ZL; Cao, C; Cao, LD; Zheng, L; Xu, J; Li, FM; Huang, QL				Zhou, Zhao-Lu; Cao, Chong; Cao, Li-Dong; Zheng, Li; Xu, Jun; Li, Feng-Min; Huang, Qi-Liang			Evaporation kinetics of surfactant solution droplets on rice (Oryza sativa) leaves	PLOS ONE			English	Article							WATER DROPS; SESSILE; WETTABILITY; DYNAMICS; RATES	The dynamics of evaporating sessile droplets on hydrophilic or hydrophobic surfaces is widely studied, and many models for these processes have been developed based on experimental evidence. However, few research has been explored on the evaporation of sessile droplets of surfactant or pesticide solutions on target crop leaves. Thus, in this paper the impact of surfactant concentrations on contact angle, contact diameter, droplet height, and evolution of the droplets' evaporative volume on rice leaf surfaces have been investigated. The results indicate that the evaporation kinetics of surfactant droplets on rice leaves were influenced by both the surfactant concentrations and the hydrophobicity of rice leaf surfaces. When the surfactant concentration is lower than the surfactant CMC (critical micelle concentration), the droplet evaporation time is much longer than that of the high surfactant concentration. This is due to the longer existence time of a narrow wedge region under the lower surfactant concentration, and such narrow wedge region further restricts the droplet evaporation. Besides, our experimental data are shown to roughly collapse onto theoretical curves based on the model presented by Popov. This study could supply theoretical data on the evaporation of the adjuvant or pesticide droplets for practical applications in agriculture.	[Zhou, Zhao-Lu; Cao, Chong; Cao, Li-Dong; Zheng, Li; Xu, Jun; Li, Feng-Min; Huang, Qi-Liang] Chinese Acad Agr Sci, Inst Plant Protect, Key Lab Integrated Pest Management Crops, Minist Agr, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Ministry of Agriculture & Rural Affairs	Huang, QL (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Key Lab Integrated Pest Management Crops, Minist Agr, Beijing, Peoples R China.	qlhuang@ippcaas.cn	Huang, Qiliang/AAC-7178-2022	ZHENG, LI/0000-0002-5329-3762	National Natural Science Foundation of China (NSFC) [31471805, 31601673]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (NSFC), no. 31471805, Prof. Qi-Liang Huang, and the National Natural Science Foundation of China (NSFC), no. 31601673, Dr. Chong Cao.	[Anonymous], 2007, MATLAB REF MAN; Barnes GT, 2008, AGR WATER MANAGE, V95, P339, DOI 10.1016/j.agwat.2007.12.003; BIRDI KS, 1993, J ADHES SCI TECHNOL, V7, P485, DOI 10.1163/156856193X00808; BIRDI KS, 1989, J PHYS CHEM-US, V93, P3702, DOI 10.1021/j100346a065; BOURGESMONNIER C, 1995, LANGMUIR, V11, P2820, DOI 10.1021/la00007a076; BREEZE VG, 1992, PESTIC SCI, V36, P101, DOI 10.1002/ps.2780360204; Calvert P, 2001, CHEM MATER, V13, P3299, DOI 10.1021/cm0101632; Carvalho FP, 2006, ENVIRON SCI POLICY, V9, P685, DOI 10.1016/j.envsci.2006.08.002; Chachalis D, 2001, WEED SCI, V49, P156, DOI 10.1614/0043-1745(2001)049[0156:COLSWC]2.0.CO;2; Choi CH, 2009, LANGMUIR, V25, P7561, DOI 10.1021/la803614h; Dash S, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.042402; Dash S, 2013, LANGMUIR, V29, P10785, DOI 10.1021/la402784c; Deegan RD, 2000, PHYS REV E, V62, P756, DOI 10.1103/PhysRevE.62.756; Doganci MD, 2011, J COLLOID INTERF SCI, V362, P524, DOI 10.1016/j.jcis.2011.06.060; Eral HB, 2013, COLLOID POLYM SCI, V291, P247, DOI 10.1007/s00396-012-2796-6; Gelderblom H, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.026306; Haynes W.M., 2014, CRC HDB CHEM PHYS, V95th ed.; HOLLOWAY P. J., 1970, Pesticide Science, V1, P156, DOI 10.1002/ps.2780010411; Hu H, 2002, J PHYS CHEM B, V106, P1334, DOI 10.1021/jp0118322; Huang J., 2000, FARM PESTICIDE USE R, P901; Huang Y, 2012, J AM CHEM SOC, V134, P17053, DOI 10.1021/ja304751k; Ivanova NA, 2011, CURR OPIN COLLOID IN, V16, P285, DOI 10.1016/j.cocis.2011.06.008; Ivanova N, 2010, COLLOID SURFACE A, V354, P143, DOI 10.1016/j.colsurfa.2009.07.030; Kerstiens G., 1996, J EXP BOT, V25, P41; Li QW, 2006, J PHYS CHEM B, V110, P13926, DOI 10.1021/jp061554c; Liu MJ, 2010, ACCOUNTS CHEM RES, V43, P368, DOI 10.1021/ar900205g; Mao BG, 2012, PLANTA, V235, P39, DOI 10.1007/s00425-011-1481-1; McHale G, 2005, LANGMUIR, V21, P11053, DOI 10.1021/la0518795; McHale G, 1998, J PHYS CHEM B, V102, P1964, DOI 10.1021/jp972552i; Nairn JJ, 2011, PEST MANAG SCI, V67, P1562, DOI 10.1002/ps.2213; PICKNETT RG, 1977, J COLLOID INTERF SCI, V61, P336, DOI 10.1016/0021-9797(77)90396-4; Pittoni PG, 2013, COLLOID SURFACE A, V432, P89, DOI 10.1016/j.colsurfa.2013.04.045; Popov YO, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036313; Priest C, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.026103; Reyssat M, 2008, EPL, V81, P226; ROWAN SM, 1995, J PHYS CHEM-US, V99, P13268, DOI 10.1021/j100035a034; Semenov S, 2013, LANGMUIR, V29, P10028, DOI 10.1021/la401578v; SHANAHAN MER, 1994, INT J ADHES ADHES, V14, P201, DOI 10.1016/0143-7496(94)90031-0; Soboleva OA, 2003, COLLOID J+, V65, P89, DOI 10.1023/A:1022379210765; Starov V, 2010, ADV COLLOID INTERFAC, V161, P153, DOI 10.1016/j.cis.2010.04.001; Stauber JM, 2014, J FLUID MECH, V744, DOI 10.1017/jfm.2014.94; Stauber JM, 2015, PHYS FLUIDS, V27, DOI 10.1063/1.4935232; Stauber JM, 2015, LANGMUIR, V31, P3653, DOI 10.1021/acs.langmuir.5b00286; Tadmor R, 2011, SOFT MATTER, V7, P1577, DOI 10.1039/c0sm00775g; Tadmor R, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.266101; Wang H, 2014, PLOS ONE, V9; WIRTH W, 1991, PESTIC SCI, V33, P411, DOI 10.1002/ps.2780330403; Xu L, 2010, T ASABE, V53, P13; Xu LY, 2011, PEST MANAG SCI, V67, P842, DOI 10.1002/ps.2122; Xu W, 2013, LANGMUIR, V29, P6032, DOI 10.1021/la400452e; Xu W, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.024504; Yu YS, 2012, J COLLOID INTERF SCI, V365, P254, DOI 10.1016/j.jcis.2011.09.007; Zhang XY, 2006, CHEMPHYSCHEM, V7, P2067, DOI 10.1002/cphc.200600229	53	14	17	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176870	10.1371/journal.pone.0176870	http://dx.doi.org/10.1371/journal.pone.0176870			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472108	Green Published, gold, Green Submitted			2022-12-26	WOS:000400648500089
J	Iglesias, PP; Hasson, E				Iglesias, Patricia P.; Hasson, Esteban			The role of courtship song in female mate choice in South American Cactophilic Drosophila	PLOS ONE			English	Article							SPECIES RECOGNITION; SEXUAL SELECTION; REPLETA GROUP; EVOLUTION; MELANOGASTER; BEHAVIOR; POPULATIONS; DIVERGENCE; COMPLEX; TRAITS	Courtship songs have undergone a spectacular diversification in the Drosophila buzzatii cluster. Accordingly, it has been suggested that sexual selection has played a significant role in promoting rapid diversification, reproductive isolation and speciation. However, there is no direct evidence (i.e., song playback experiments with wingless males) supporting this tenet. Moreover, several studies have showed that the courtship song in the genus Drosophila is not always used in female mate choice decisions, nor plays the same role when it is taken into account. In this vein, we use an approach that combines manipulative and playback experiments to explore the importance and the role of courtship song in female mate choice in four species of the D. buzzatii cluster and one species of the closely related D. martensis cluster for outgroup comparison. We also investigate the importance of courtship song in sexual isolation in sympatry between the only semi-cosmopolitan species, D. buzzatii, and the other species of the D. buzzatii cluster. Our study revealed that the courtship song is used by females of the D. buzzatii cluster as a criterion for male acceptance or influences the speed with which males are chosen. In contrast, we showed that this characteristic is not shared by D. venezolana, the representative species of the D. martensis cluster. We also found that the studied species of the D. buzzatii cluster differ in the role that conspecific and heterospecific songs have in female mate choice and in sexual isolation. Our findings support the hypothesis that divergence in female preferences for courtship songs has played a significant role in promoting rapid diversification and reproductive isolation in the D. buzzatii cluster. However, evidence from D. venezolana suggests that the use of the courtship song in female mate choice is not a conserved feature in the D. buzzatii complex.	[Iglesias, Patricia P.; Hasson, Esteban] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ecol Genet & Evoluc, Buenos Aires, DF, Argentina; [Iglesias, Patricia P.; Hasson, Esteban] Consejo Nacl Invest Cient & Tecn, Inst Ecol Genet & Evoluc Buenos Aires, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Iglesias, PP; Hasson, E (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ecol Genet & Evoluc, Buenos Aires, DF, Argentina.; Iglesias, PP; Hasson, E (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Ecol Genet & Evoluc Buenos Aires, Buenos Aires, DF, Argentina.	patricia.p.iglesias@gmail.com; ehasson@ege.fcen.uba.ar			Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2795/2010, 1121/2013]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 11220150100029CO]; Universidad de Buenos Aires [UBACyT 20020130100058BA]; CONICET	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This research was supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica (http://www.agencia.mincyt.gob.ar/, PICT 2795/2010 and 1121/2013), Consejo Nacional de Investigaciones Cientificas y Tecnicas (http://www.conicet.gov.ar/, PIP 11220150100029CO), and Universidad de Buenos Aires (http://exactas.uba.ar/, UBACyT 20020130100058BA). Patricia P. Iglesias is recipient of scholarships awarded by CONICET and Esteban Hasson is member of Carrera del Investigador Cientifico of CONICET (Argentina).	Auguie B, 2017, GRIDEXTRA MISCELLANE; BENNETCLARK HC, 1969, ANIM BEHAV, V17, P755, DOI 10.1016/S0003-3472(69)80023-0; Blows MW, 1998, AM NAT, V152, P826, DOI 10.1086/286211; Blyth JE, 2008, ETHOLOGY, V114, P728, DOI 10.1111/j.1439-0310.2008.01519.x; Boake CRB, 1997, ANIM BEHAV, V54, P699, DOI 10.1006/anbe.1997.0474; Bro-Jorgensen J, 2010, TRENDS ECOL EVOL, V25, P292, DOI 10.1016/j.tree.2009.11.003; Castellano S, 2006, J THEOR BIOL, V242, P529, DOI 10.1016/j.jtbi.2006.04.001; Cerda Hugo, 1998, Drosophila Information Service, V81, P144; COSTA C. T. A., 2002, Braz. J. Biol., V62, P573, DOI 10.1590/S1519-69842002000400003; COWLING DE, 1981, ANIM BEHAV, V29, P924, DOI 10.1016/S0003-3472(81)80030-9; Curtis S, 2013, J CHEM ECOL, V39, P579, DOI 10.1007/s10886-013-0284-1; Darwin C., 1871, P423; de Oliveira CC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-179; Dufour L., 1844, ANN SCI NAT, V1, P244; EBERHARD WG, 1992, EVOLUTION, V46, P1774, DOI 10.1111/j.1558-5646.1992.tb01168.x; Edward DA, 2015, BEHAV ECOL, V26, P301, DOI 10.1093/beheco/aru142; EWING AW, 1979, ANIM BEHAV, V27, P343, DOI 10.1016/0003-3472(79)90167-2; EWING AW, 1986, ANIM BEHAV, V34, P421, DOI 10.1016/S0003-3472(86)80112-9; Hasson Esteban, 2009, P89; Hennig RM, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00286; HOIKKALA A, 1994, ANIM BEHAV, V47, P1363, DOI 10.1006/anbe.1994.1184; HOIKKALA A, 1987, EVOLUTION, V41, P827, DOI 10.1111/j.1558-5646.1987.tb05856.x; Hoikkala A, 2010, HANDBOOK OF BEHAVIOR GENETICS, P187, DOI 10.1007/978-0-387-76727-7_13; Jagadeeshan S, 2006, J EVOLUTION BIOL, V19, P1058, DOI 10.1111/j.1420-9101.2006.01099.x; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Kamimura Y, 2012, ENTOMOL SCI, V15, P197, DOI 10.1111/j.1479-8298.2011.00490.x; Kuhn GCS, 2003, HEREDITAS, V139, P161, DOI 10.1111/j.1601-5223.2003.01797.x; KYRIACOU CP, 1982, ANIM BEHAV, V30, P794, DOI 10.1016/S0003-3472(82)80152-8; LIIMATAINEN J, 1992, ANIM BEHAV, V43, P35, DOI 10.1016/S0003-3472(05)80069-7; Manfrin MH, 2006, GENETICA, V126, P57, DOI 10.1007/s10709-005-1432-5; Markow TA, 2005, ANNU REV GENET, V39, P263, DOI 10.1146/annurev.genet.39.073003.112454; Mas F, 2005, J CHEM ECOL, V31, P2747, DOI 10.1007/s10886-005-7570-5; Masly John P., 2012, International Journal of Evolutionary Biology, P1, DOI 10.1155/2012/247352; Noor MAF, 1999, HEREDITY, V83, P503, DOI 10.1038/sj.hdy.6886320; Oliveira C.C., 2013, SPECIATION NATURAL P, P137; Oliveira DCSG, 2012, MOL PHYLOGENET EVOL, V64, P533, DOI 10.1016/j.ympev.2012.05.012; Ritchie MG, 1998, ANIM BEHAV, V56, P713, DOI 10.1006/anbe.1998.0799; Ritchie MG, 2001, EVOLUTION, V55, P721, DOI 10.1554/0014-3820(2001)055[0721:COFPFF]2.0.CO;2; Ritchie MG, 1999, ANIM BEHAV, V58, P649, DOI 10.1006/anbe.1999.1167; Rodriguez-Trelles F, 2000, MOL BIOL EVOL, V17, P1112, DOI 10.1093/oxfordjournals.molbev.a026392; RUIZ A, 1993, HEREDITY, V70, P582, DOI 10.1038/hdy.1993.85; Rybak F, 2002, CAN J ZOOL, V80, P987, DOI 10.1139/Z02-082; Rybak F, 2002, P ROY SOC B-BIOL SCI, V269, P695, DOI 10.1098/rspb.2001.1919; Saarikettu M, 2005, BEHAV GENET, V35, P257, DOI 10.1007/s10519-005-3218-z; SANTOS MH, 2009, DROS INF SERV, V92, P101; Schielzeth H, 2009, BEHAV ECOL, V20, P416, DOI 10.1093/beheco/arn145; SHAPIRO AM, 1989, ANNU REV ENTOMOL, V34, P231, DOI 10.1146/annurev.en.34.010189.001311; Soto IM, 2012, NEOTROP ENTOMOL, V41, P207, DOI 10.1007/s13744-012-0028-x; Soto IM, 2013, EVOL BIOL, V40, P395, DOI 10.1007/s11692-013-9223-x; Talyn BC, 2004, ANIM BEHAV, V68, P1165, DOI 10.1016/j.anbehav.2003.11.023; Therneau T.M., 2015, SURVIVAL SURVIVAL AN; TOMARU M, 1994, ANIM BEHAV, V47, P133, DOI 10.1006/anbe.1994.1015; TOMARU M, 1995, ANIM BEHAV, V50, P905, DOI 10.1016/0003-3472(95)80093-X; Tomaru M, 2000, ANIM BEHAV, V60, P797, DOI 10.1006/anbe.2000.1543; Tomaru M, 2000, EVOLUTION, V54, P1286, DOI 10.1111/j.0014-3820.2000.tb00561.x; Tomaru M., 2011, LOW TEMP SCI, V69, P61; Wiens JJ, 2001, TRENDS ECOL EVOL, V16, P517, DOI 10.1016/S0169-5347(01)02217-0; Yukilevich R, 2016, EVOLUTION, V70, P526, DOI 10.1111/evo.12870	58	14	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176119	10.1371/journal.pone.0176119	http://dx.doi.org/10.1371/journal.pone.0176119			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467464	Green Published, gold, Green Submitted			2022-12-26	WOS:000400647000036
J	Kwaa, AK; Goldsborough, K; Walker-Sperling, VE; Pianowski, LF; Gama, L; Blankson, JN				Kwaa, Abena K.; Goldsborough, Kennedy; Walker-Sperling, Victoria E.; Pianowski, Luiz F.; Gama, Lucio; Blankson, Joel N.			The effect of Ingenol-B on the suppressive capacity of elite suppressor HIV-specific CD8+T cells	PLOS ONE			English	Article							CD8(+) T-CELLS; EX-VIVO; LATENCY REVERSAL; AGENTS; NONPROGRESSORS; ELIMINATION; ERADICATION; STRATEGIES	Background Some latency-reversing agents (LRAs) inhibit HIV-specific CD8+ T cell responses. In a prior study of protein kinase C (PKC) agonists, we found that bryostatin-1 inhibited elite controller/ suppressor (ES) CD8+ T cell suppressive activity whereas prostratin had no effect. Ingenol- B is another PKC agonist with potent LRA activity both by itself and in combination with the bromodomain inhibitor JQ1; however its effect on CD8+ T cell mediated control of HIV-1 replication is unknown. Methods CD8+ T cells were isolated from ES and treated with bryostatin-1, prostratin, ingenol-B, and JQ1 as well as a combination of each PKC-agonist with JQ1. The cells were then tested in the viral suppression assay. To assess possible mechanisms of inhibition, CD8+ T cells were treated with the LRAs and analyzed for the expression of various immune cell markers. Results Ingenol-B had no effect on the ability of ES CD8+ T cells to suppress viral replication, however, the combination of ingenol-B and JQ1 caused a modest, but significant decrease in this suppressive capacity. The mechanism of the inhibitory effect of the JQ1 and ingenol-B combination relative to ingenol-B alone was unclear but the effect appeared to be dose dependent. Conclusions Ingenol-B does not inhibit HIV-specific CD8+ T cell responses in vitro. These responses are however modestly inhibited when 100 nMingenol-B is combined with JQ1. Since HIV-specific CD8+ T cell activity may be essential for the eradication of reactivated latently infected cells, the potency of latency-reversal activity of drug combinations must be balanced against the effects of the combinations on HIV-specific CD8+ T cell responses.	[Kwaa, Abena K.; Goldsborough, Kennedy; Walker-Sperling, Victoria E.; Blankson, Joel N.] Johns Hopkins Univ, Sch Med, Dept Med, Ctr AIDS Res, Baltimore, MD 21205 USA; [Gama, Lucio] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Med, Baltimore, MD USA; [Pianowski, Luiz F.] Kyolab, Campinas, SP, Brazil; [Goldsborough, Kennedy] Hampton Univ, Dept Biochem, Hampton, VA 23668 USA; [Walker-Sperling, Victoria E.] Leidos Biomed Res Inc, Canc & Inflammat Program, Frederick Natl Lab Canc Res, Frederick, MD USA	Johns Hopkins University; Johns Hopkins University; Hampton University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Blankson, JN (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Ctr AIDS Res, Baltimore, MD 21205 USA.	jblanks@jhmi.edu		Goldsborough, Kennedy/0000-0001-9403-2721	NIH [P30A1094189, 2R56A1080328-05A1, 1R01A1120024-01]; NIGMS MARC [T34GM105550]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007247, R01AI120024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM105550] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS MARC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants (P30A1094189), 2R56A1080328-05A1 and 1R01A1120024-01 (JNB). KG was supported by NIGMS MARC grant #T34GM105550. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of the authors' salaries and research materials. The funder provided support in the form of salaries for authors [JNB, AKK, KG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097257; Akimova T, 2012, BLOOD, V119, P2443, DOI 10.1182/blood-2011-10-292003; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2014, CURR OPIN INFECT DIS, V27, P29, DOI 10.1097/QCO.0000000000000026; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Buckheit RW, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-68; Clutton G, 2016, SCI REP-UK, V6, DOI 10.1038/srep30749; Darcis G, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005063; Elliott JH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004473; Fujiwara M, 1998, ARCH VIROL, V143, P2003, DOI 10.1007/s007050050436; Gama L, 2016, AIDS; Garrido C, 2016, FRONT IMMUN IN PRESS; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Jiang GC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005066; Jones RB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004287; Jose DP, 2014, VIROLOGY, V462, P328, DOI 10.1016/j.virol.2014.05.033; Laird GM, 2015, J CLIN INVEST, V125, P1901, DOI 10.1172/JCI80142; Lucera MB, 2014, J VIROL, V88, P10803, DOI 10.1128/JVI.00320-14; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; O'Connell KA, 2009, TRENDS PHARMACOL SCI, V30, P631, DOI 10.1016/j.tips.2009.09.005; Pace M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005782; Rasmussen TA, 2014, LANCET HIV, V1, pE13, DOI 10.1016/S2352-3018(14)70014-1; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Shang HT, 2015, ACTA PHARMACOL SIN, V36, P908, DOI 10.1038/aps.2015.22; Siliciano JD, 2013, CURR OPIN HIV AIDS, V8, P318, DOI 10.1097/COH.0b013e328361eaca; Smith BD, 2011, LEUKEMIA RES, V35, P87, DOI 10.1016/j.leukres.2010.06.001; Sogaard OS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005142; Spivak AM, 2015, ANTIMICROB AGENTS CH, V59, P5984, DOI 10.1128/AAC.01077-15; Walker-Sperling VE, 2016, EBIOMEDICINE, V8, P217, DOI 10.1016/j.ebiom.2016.04.019	31	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0174516	10.1371/journal.pone.0174516	http://dx.doi.org/10.1371/journal.pone.0174516			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467486	Green Published, Green Submitted, gold			2022-12-26	WOS:000400647000006
J	Shintyapina, AB; Vavilin, VA; Safronova, OG; Lyakhovich, VV				Shintyapina, Alexandra B.; Vavilin, Valentin A.; Safronova, Olga G.; Lyakhovich, Vyacheslav V.			The gene expression profile of a drug metabolism system and signal transduction pathways in the liver of mice treated with tert-butylhydroquinone or 3-(3'-tert-butyl-4'-hydroxyphenyl) propylthiosulfonate of sodium	PLOS ONE			English	Article							NF-KAPPA-B; CONSTITUTIVE ANDROSTANE RECEPTOR; ANTIOXIDANT-RESPONSIVE ELEMENT; HUMAN NEUROBLASTOMA-CELLS; ACTIVATED PROTEIN-KINASE; INDUCED APOPTOSIS; OXIDATIVE STRESS; PHOSPHATIDYLINOSITOL 3-KINASE; INFLAMMATORY RESPONSE; COORDINATE REGULATION	Tert-butylhydroquinone (tBHQ) is a highly effective phenolic antioxidant used in edible oils and fats in foods as well as in medicines and cosmetics. TBHQ has been shown to have both chemoprotective and carcinogenic effects. Furthermore, it has potential anti- inflammatory, antiatherogenic, and neuroprotective activities. TBHQ induces phase II detoxification enzymes via the Keap1/Nrf2/ARE mechanism, which contributes to its chemopreventive functions. Nonetheless, there is growing evidence that biological effects of tBHQ may be mediated by Nrf2-independent mechanisms related to various signaling cascades. Here, we studied changes in gene expression of phase I, II, and III drug metabolizing enzymes/transporters as well as protein levels and activities of cytochromes P450 (CYPs) elicited by tBHQ and its structural homolog TS-13 in the mouse liver. Next, we carried out gene expression analysis to identify signal transduction pathways modulated by the antioxidants. Mice received 100 mg/kg tBHQ or TS-13 per day or only vehicle. The liver was collected at 12 hours and after 7 days of the treatment. Protein and total RNA were extracted. Gene expression was analyzed using Mouse Drug Metabolism and Signal Transduction PathwayFinder RT2 Profiler (TM) PCR Arrays. A western blot analysis was used to measure protein levels and a fluorometric assay was employed to study activities of CYPs. Genes that were affected more than 1.5-fold by tBHQ or TS-13 treatment compared with vehicle were identified. Analysis of the gene expression data revealed changes in various genes that are important for drug metabolism, cellular defense mechanisms, inflammation, apoptosis, and cell cycle regulation. Novel target genes were identified, including xenobiotic metabolism genes encoding CYPs, phase II/III drug metabolizing enzymes/transporters. For Cyp1a2 and Cyp2b, we observed an increase in protein levels and activities during tBHQ or TS-13 treatment. Changes were found in the gene expression regulated by NF kappa B, androgen, retinoic acid, PI3K/AKT, Wnt, Hedgehog and other pathways. [GRAPHICS] .	[Shintyapina, Alexandra B.; Vavilin, Valentin A.; Safronova, Olga G.; Lyakhovich, Vyacheslav V.] Inst Mol Biol & Biophys, Novosibirsk, Russia; [Vavilin, Valentin A.; Lyakhovich, Vyacheslav V.] Novosibirsk State Univ, Novosibirsk, Russia	Novosibirsk State University	Shintyapina, AB (corresponding author), Inst Mol Biol & Biophys, Novosibirsk, Russia.	alexandra.shintyapina@gmail.com	Shintyapina, Alexandra/I-9853-2016; Shintyapina, Alexandra/J-8865-2017; Shintyapina, Alexandra/U-4814-2019; Safronova, Olga/G-5263-2017; Vavilin, Valentin A/K-6100-2012	Shintyapina, Alexandra/0000-0001-6253-6490; Safronova, Olga/0000-0002-7504-0168; Vavivilin, Valentin/0000-0002-9769-6512				Arinze IJ, 2005, J BIOL CHEM, V280, P9786, DOI 10.1074/jbc.M414006200; Auyeung DJ, 2003, MOL PHARMACOL, V63, P119, DOI 10.1124/mol.63.1.119; Bahia PK, 2012, J NEUROCHEM, V123, P182, DOI 10.1111/j.1471-4159.2012.07877.x; Barve A, 2008, J PHARM SCI-US, V97, P4528, DOI 10.1002/jps.21311; Bell KFS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8066; Bensasson RV, 2008, CHEM RES TOXICOL, V21, P805, DOI 10.1021/tx7002883; BURKE MD, 1985, BIOCHEM PHARMACOL, V34, P3337, DOI 10.1016/0006-2952(85)90355-7; Cai YD, 2011, HEPATO-GASTROENTEROL, V58, P2071, DOI 10.5754/hge11155; EFSA, 2004, EFSA J, V84, P1, DOI [10.2903/j.efsa.2007.315, DOI 10.2903/J.EFSA.2007.315, DOI 10.2903/J.EFSA.2004.84]; Fung E, 2015, CLIN RES HEPATOL GAS, V39, pS69, DOI 10.1016/j.clinre.2015.05.017; Gharavi N, 2005, DRUG METAB DISPOS, V33, P365, DOI 10.1124/dmd.104.002253; Gharavi N, 2007, CURR DRUG METAB, V8, P1, DOI 10.2174/138920007779315035; GRISHANOVA AY, 1992, CYTOCHROME P-450 : BIOCHEMISTRY AND BIOPHYSICS, P525; HIROSE M, 1993, CARCINOGENESIS, V14, P2359, DOI 10.1093/carcin/14.11.2359; Ho LC, 2016, J MOL MED, V94, P933, DOI 10.1007/s00109-016-1403-6; Honkakoski P, 2000, BIOCHEM J, V347, P321, DOI 10.1042/0264-6021:3470321; Hu R, 2006, ARCH PHARM RES, V29, P911, DOI 10.1007/BF02973914; Ikeda H, 2002, BIOCHEM J, V364, P563, DOI 10.1042/BJ20011756; Ioannides C., 1996, CYTOCHROMES P450 MET; Jin W, 2014, ANN CLIN LAB SCI, V44, P151; Jin W, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/502564; Kang KW, 2001, MOL PHARMACOL, V59, P1147, DOI 10.1124/mol.59.5.1147; Kang KW, 2005, ANTIOXID REDOX SIGN, V7, P1664, DOI 10.1089/ars.2005.7.1664; Kann S, 2005, TOXICOL SCI, V87, P365, DOI 10.1093/toxsci/kfi253; Kayampilly PP, 2010, ENDOCRINOLOGY, V151, P5030, DOI 10.1210/en.2010-0444; Kebenko M, 2015, CELL SIGNAL, V27, P373, DOI 10.1016/j.cellsig.2014.11.022; Kim J, 2010, MUTAT RES-FUND MOL M, V690, P12, DOI 10.1016/j.mrfmmm.2009.09.007; Kohle C, 2007, BIOCHEM PHARMACOL, V73, P1853, DOI 10.1016/j.bcp.2007.01.009; Lee JM, 2001, J BIOL CHEM, V276, P20011, DOI 10.1074/jbc.M100734200; Li ST, 2014, BBA-MOL CELL BIOL L, V1841, P22, DOI 10.1016/j.bbalip.2013.09.004; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Li WG, 2008, BIOCHEM PHARMACOL, V76, P1485, DOI 10.1016/j.bcp.2008.07.017; Li YS, 2013, GENET MOL RES, V12, P5433, DOI 10.4238/2013.November.11.5; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Lin W, 2008, BIOCHEM PHARMACOL, V76, P967, DOI 10.1016/j.bcp.2008.07.036; Liu H, 2008, P NATL ACAD SCI USA, V105, P15926, DOI 10.1073/pnas.0808346105; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo L, 2015, TOXICOL APPL PHARM, V288, P339, DOI 10.1016/j.taap.2015.08.006; Makia NL, 2014, MOL PHARMACOL, V86, P125, DOI 10.1124/mol.114.092585; Menegon S, 2016, TRENDS MOL MED, V22, P578, DOI 10.1016/j.molmed.2016.05.002; Menshchikova E, 2014, INFLAMM RES, V63, P729, DOI 10.1007/s00011-014-0746-0; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Nair S, 2006, PHARM RES-DORDR, V23, P2621, DOI 10.1007/s11095-006-9099-x; NAKAGAWA Y, 1994, EUR J PHARM-ENVIRON, V270, P341, DOI 10.1016/0926-6917(94)90010-8; Nakaso K, 2003, FEBS LETT, V546, P181, DOI 10.1016/S0014-5793(03)00517-9; Namgaladze D, 2015, J BIOL CHEM, V290, P24484, DOI 10.1074/jbc.M115.678243; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Nieva-Echevarria B, 2015, COMPR REV FOOD SCI F, V14, P67, DOI 10.1111/1541-4337.12121; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Okubo T, 2003, FOOD CHEM TOXICOL, V41, P679, DOI 10.1016/S0278-6915(03)00002-4; Oleynik AS, 2007, RUSS CHEM B+, V56, P1135, DOI 10.1007/s11172-007-0172-3; Petrick JS, 2007, DRUG METAB DISPOS, V35, P1806, DOI 10.1124/dmd.107.015974; Pickell L, 2005, BBA-GENE STRUCT EXPR, V1731, P104, DOI 10.1016/j.bbaexp.2005.09.002; Pokorny J., 2001, ANTIOXIDANTS FOOD PR; POLAND A, 1980, MOL PHARMACOL, V18, P571; Ramaswamy B, 2012, CANCER RES, V72, P5048, DOI 10.1158/0008-5472.CAN-12-1248; Reilly KB, 2004, J BIOL CHEM, V279, P9440, DOI 10.1074/jbc.M303857200; Rendic S, 2015, CHEM RES TOXICOL, V28, P38, DOI 10.1021/tx500444e; Rendic S, 2012, CHEM RES TOXICOL, V25, P1316, DOI 10.1021/tx300132k; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Rushmore TH, 2002, CURR DRUG METAB, V3, P481, DOI 10.2174/1389200023337171; Schreiber TD, 2006, DRUG METAB DISPOS, V34, P1096, DOI 10.1124/dmd.106.009662; Shi XJ, 2016, INT J MOL MED, V38, P123, DOI 10.3892/ijmm.2016.2605; Shindo S, 2007, BIOCHEM J, V401, P735, DOI 10.1042/BJ20061238; Shintyapina AB, 2014, B EXP BIOL MED+, V157, P473, DOI 10.1007/s10517-014-2594-x; Szrok S, 2016, GENES NUTR, V11, DOI 10.1186/s12263-016-0533-3; Talalay P, 2000, BIOFACTORS, V12, P5, DOI 10.1002/biof.5520120102; TATA JR, 1969, SUBCELLULAR COMPONEN, P83; Vavilin V.A., 2014, J PHARM SCI RES, V6, P178; Winterbourn CC, 2004, JPN J INFECT DIS, V57, pS31; Xu CJ, 2005, ONCOGENE, V24, P4486, DOI 10.1038/sj.onc.1208656; Zagorski JW, 2013, TOXICOL SCI, V136, P63, DOI 10.1093/toxsci/kft172; Zhang D, 2007, DRUG METABOLISM DRUG, P123; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003	74	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176939	10.1371/journal.pone.0176939	http://dx.doi.org/10.1371/journal.pone.0176939			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467491	Green Submitted, gold, Green Published			2022-12-26	WOS:000400647000088
J	van Munster, M; Yvon, M; Vile, D; Dader, B; Fereres, A; Blanc, S				van Munster, Manuella; Yvon, Michel; Vile, Denis; Dader, Beatriz; Fereres, Alberto; Blanc, Stephane			Water deficit enhances the transmission of plant viruses by insect vectors	PLOS ONE			English	Article							CUCUMBER-MOSAIC-VIRUS; ELEVATED-TEMPERATURE; BRASSICA-NAPUS; INFECTION; DROUGHT; SHIFTS	Drought is a major threat to crop production worldwide and is accentuated by global warming. Plant responses to this abiotic stress involve physiological changes overlapping, at least partially, the defense pathways elicited both by viruses and their herbivore vectors. Recently, a number of theoretical and empirical studies anticipated the influence of climate changes on vector-borne viruses of plants and animals, mainly addressing the effects on the virus itself or on the vector population dynamics, and inferring possible consequences on virus transmission. Here, we directly assess the effect of a severe water deficit on the efficiency of aphid-transmission of the Cauliflower mosaic virus (CaMV) or the Turnip mosaic virus (TuMV). For both viruses, our results demonstrate that the rate of vector-transmission is significantly increased from water-deprived source plants: CaMV transmission reproducibly increased by 34% and that of TuMV by 100%. In both cases, the enhanced transmission rate could not be explained by a higher virus accumulation, suggesting a more complex drought-induced process that remains to be elucidated. The evidence that infected plants subjected to drought are much better virus sources for insect vectors may have extensive consequences for viral epidemiology, and should be investigated in a wide range of plantvirus-vector systems.	[van Munster, Manuella; Yvon, Michel; Dader, Beatriz; Blanc, Stephane] INRA Montpellier, BGPI UMR385, Montpellier, France; [Vile, Denis] INRA, LEPSE UMR759, Montpellier, France; [Dader, Beatriz; Fereres, Alberto] Inst Ciencias Agr, Dept Protecc Vegetal, Madrid, Spain	INRAE; INRAE; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Agrarias (ICA)	Blanc, S (corresponding author), INRA Montpellier, BGPI UMR385, Montpellier, France.	stephane.blanc@inra.fr	Fereres, Alberto/G-6542-2012; Vile, Denis/A-5637-2008; Fereres, Alberto/F-2990-2011; Blanc, Stéphane/F-5873-2011; Fereres, Alberto/GZG-4690-2022; Dáder, Beatriz/AAR-1987-2020; van Munster, Manuella/AAQ-9599-2021	Fereres, Alberto/0000-0001-6012-3270; Vile, Denis/0000-0002-7948-1462; Fereres, Alberto/0000-0001-6012-3270; Blanc, Stéphane/0000-0002-3412-0989; Dáder, Beatriz/0000-0002-7328-1961; 	INRA [AAP-SPE-2 014-2015]	INRA	This work was supported by a AAP-SPE-2 014-2015 grant awarded to MvM by INRA.r We thank S. Leblaye and J.-L. Macia for technical assistance, plant care and aphid rearing, F. Bonnot and G. Thebaud for interactions and discussions. We particularly thank L. Rimbaud for help in statistical analysis. This work was supported by a AAP-SPE-2014-2015 grant awarded to MvM by INRA.	BANIK MT, 1990, PLANT DIS, V74, P857, DOI 10.1094/PD-74-0857; Becker D, 2003, FEBS LETT, V554, P119, DOI 10.1016/S0014-5793(03)01118-9; BLANC S, 1993, VIROLOGY, V192, P643, DOI 10.1006/viro.1993.1080; Blanc S, 2016, CURR OPIN INSECT SCI, V16, P36, DOI 10.1016/j.cois.2016.05.007; Bragard C, 2013, ANNU REV PHYTOPATHOL, V51, P177, DOI 10.1146/annurev-phyto-082712-102346; Carmo-Sousa M, 2014, VIRUS RES, V186, P38, DOI 10.1016/j.virusres.2013.12.012; Chung BN, 2016, PLANT PATHOLOGY J, V32, P321, DOI 10.5423/PPJ.OA.12.2015.0259; Cook BI, 2014, CLIM DYNAM, V43, P2607, DOI 10.1007/s00382-014-2075-y; Cronin JP, 2010, ECOL LETT, V13, P1221, DOI 10.1111/j.1461-0248.2010.01513.x; Dader B, 2016, SCI REP-UK, V6, DOI 10.1038/srep19120; Davis TS, 2015, J APPL ECOL, V52, P1392, DOI 10.1111/1365-2664.12484; Davis TS, 2015, FRONT ECOL EVOL, V3; DELSENY M, 1983, PLASMID, V9, P31, DOI 10.1016/0147-619X(83)90029-X; Doak DF, 2010, NATURE, V467, P959, DOI 10.1038/nature09439; Drucker M, 2015, CURR OPIN VIROL, V15, P63, DOI 10.1016/j.coviro.2015.08.006; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Escriu F, 2000, PHYTOPATHOLOGY, V90, P1068, DOI 10.1094/PHYTO.2000.90.10.1068; Fereres A, 2009, VIRUS RES, V141, P158, DOI 10.1016/j.virusres.2008.10.020; Franklin J, 2016, P NATL ACAD SCI US; Froissart R, 2010, PHILOS T R SOC B, V365, P1907, DOI 10.1098/rstb.2010.0068; Fu X, 2010, PLANT CELL ENVIRON, V33, P2056, DOI 10.1111/j.1365-3040.2010.02205.x; Gepstein S, 2013, PLANT MOL BIOL, V82, P623, DOI 10.1007/s11103-013-0038-z; Gutierrez S, 2013, FUNCT ECOL, V27, P610, DOI 10.1111/1365-2435.12070; Hull R., 2013, PLANT VIROLOGY; Katis NI, 2007, TRANSMISSION PLANT V; Labonne G, 2001, ACTA HORTIC, P79, DOI 10.17660/ActaHortic.2001.550.8; Martiniere A, 2013, ELIFE, V2, DOI 10.7554/eLife.00183; Mauck K, 2012, FUNCT ECOL, V26, P1162, DOI 10.1111/j.1365-2435.2012.02026.x; Nachappa P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00552; Nancarrow N, 2014, VIRUS RES, V186, P97, DOI 10.1016/j.virusres.2013.12.023; Pagan I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002796; Pandey P, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00723; Pirone TP, 1996, ANNU REV PHYTOPATHOL, V34, P227, DOI 10.1146/annurev.phyto.34.1.227; Prasch CM, 2013, PLANT PHYSIOL, V162, P1849, DOI 10.1104/pp.113.221044; Roossinck MJ, 2012, ANNU REV GENET, V46, P359, DOI 10.1146/annurev-genet-110711-155600; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Scherm H, 2004, CAN J PLANT PATHOL, V26, P267; TOMLINSON JA, 1978, ANN APPL BIOL, V89, P61, DOI 10.1111/j.1744-7348.1978.tb02568.x; Trezbicki P, 2015, GLOBAL CHANGE BIOL, V21, P3511, DOI 10.1111/gcb.12941; TYREE MT, 1972, J EXP BOT, V23, P267, DOI 10.1093/jxb/23.1.267; WALSH JA, 1985, ANN APPL BIOL, V107, P485, DOI 10.1111/j.1744-7348.1985.tb03165.x; Xie HC, 2014, J ECON ENTOMOL, V107, P1411, DOI 10.1603/EC13302; Xu P, 2008, NEW PHYTOL, V180, P911, DOI 10.1111/j.1469-8137.2008.02627.x	43	24	24	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0174398	10.1371/journal.pone.0174398	http://dx.doi.org/10.1371/journal.pone.0174398			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467423	gold, Green Published, Green Submitted			2022-12-26	WOS:000400647000005
J	Chung, CP; Chang, YC; Ding, Y; Lim, K; Liu, QH; Zhu, LJ; Zhang, W; Lu, TS; Molostvov, G; Zehnder, D; Hsiao, LL				Chung, Chih-Ping; Chang, Yu-Chun; Ding, Yan; Lim, Kenneth; Liu, Qinghua; Zhu, Langjing; Zhang, Wei; Lu, Tzong-Shi; Molostvov, Guerman; Zehnder, Daniel; Hsiao, Li-Li			alpha-Klotho expression determines nitric oxide synthesis in response to FGF-23 in human aortic endothelial cells	PLOS ONE			English	Article							CARDIOVASCULAR EVENTS; VASCULAR DYSFUNCTION; PROTECTS; STRESS; FGF23; ATHEROSCLEROSIS; RESISTANCE; MORTALITY; MUTATION; DISEASES	Endothelial cells (ECs) express fibroblast growth factor (FGF) receptors and are metabolically active after treatment with FGF-23. It is not known if this effect is alpha-Klotho independent or mediated by humoral or endogenous endothelial alpha-Klotho. In the present study, we aimed to characterize EC alpha-Klotho expression within the human vascular tree and to investigate the potential role of alpha-Klotho in determining FGF-23 mediated EC regulation. Human tissue and ECs from various organs were used for immunohistochemistry and Western blot. Primary cultures of human aortic endothelial cells (HAECs) and human brain microvascular endothelial cells (HBMECs) were used to generate in vitro cell models. We found endogenous alpha-Klotho expression in ECs from various organs except in microvascular ECs from human brain. Furthermore, FGF-23 stimulated endothelial nitric oxide synthase (eNOS) expression, nitric oxide (NO) production, and cell proliferation in HAECs. Interestingly, these effects were not observed in our HBMEC model in vitro. High phosphate treatment and endothelial alpha-Klotho knockdown mitigated FGF-23 mediated eNOS induction, NO production, and cell proliferation in HAECs. Rescue treatment with soluble alpha-Klotho did not reverse endothelial FGF-23 resistance caused by reduced or absent alpha-Klotho expression in HAECs. These novel observations provide evidence for differential alpha-Klotho functional expression in the human endothelium and its presence may play a role in determining the response to FGF-23 in the vascular tree. alpha-Klotho was not detected in cerebral microvascular ECs and its absence may render these cells nonresponsive to FGF-23.	[Chung, Chih-Ping] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan; [Chung, Chih-Ping] Natl Yang Ming Univ, Taipei, Taiwan; [Chang, Yu-Chun; Ding, Yan; Lim, Kenneth; Lu, Tzong-Shi; Hsiao, Li-Li] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; [Liu, Qinghua] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Key Lab Nephrol,Minist Hlth, Guangzhou, Guangdong, Peoples R China; [Zhu, Langjing] Sun Yat Sen Univ, Affiliated Hosp 8, Dept Nephrol, Shenzhen, Guangdong, Peoples R China; [Zhang, Wei] Guizhou Med Univ, Guizhou Canc Hosp, Dept Gastroenterol, Guiyang, Guizhou, Peoples R China; [Molostvov, Guerman; Zehnder, Daniel] North Cumbria Univ Hosp NHS Trust, Carlisle, Cumbria, England	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Sun Yat Sen University; Sun Yat Sen University; Guizhou Medical University	Hsiao, LL (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA.; Zehnder, D (corresponding author), North Cumbria Univ Hosp NHS Trust, Carlisle, Cumbria, England.	daniel.zehnder@ncuh.nhs.uk; lhsiao@partners.org		Chung, Chih-Ping/0000-0001-9419-9070; Chang, Yu-Chun/0000-0003-0010-2376	SDSC Global Foundation; National Natural Science Foundation of China [81370863]	SDSC Global Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by SDSC Global Foundation, and Dr. Qinghua Liu, one of the co-authors, was supported by grants from National Natural Science Foundation of China (No. 81370863).	Arnlov J, 2013, CLIN J AM SOC NEPHRO, V8, P781, DOI 10.2215/CJN.09570912; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Buendia P, 2015, J GERONTOL A-BIOL, V70, P1198, DOI 10.1093/gerona/glu170; Carracedo J, 2012, MECH AGEING DEV, V133, P647, DOI 10.1016/j.mad.2012.09.002; CRONE C, 1982, BRAIN RES, V241, P49, DOI 10.1016/0006-8993(82)91227-6; Donate-Correa J, 2013, INT J CARDIOL, V165, P179, DOI 10.1016/j.ijcard.2011.08.850; El Assar M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00132; Farrow EG, 2010, J ENDOCRINOL, V207, P67, DOI 10.1677/JOE-10-0181; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Katoh M, 2016, TRENDS PHARMACOL SCI, V37, P1081, DOI 10.1016/j.tips.2016.10.003; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Kusaba T, 2010, P NATL ACAD SCI USA, V107, P19308, DOI 10.1073/pnas.1008544107; Lee J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-109; Lim K, 2015, J CLIN ENDOCR METAB, V100, pE1308, DOI 10.1210/jc.2015-1800; Lim K, 2012, CIRCULATION, V125, P2243, DOI 10.1161/CIRCULATIONAHA.111.053405; Lindberg K, 2014, J AM SOC NEPHROL, V25, P2169, DOI 10.1681/ASN.2013111209; Liu F, 2011, NAT CELL BIOL, V13, P254, DOI 10.1038/ncb2167; London GM, 2004, KIDNEY INT, V65, P700, DOI 10.1111/j.1523-1755.2004.00434.x; Lu TS, 2004, CELL STRESS CHAPERON, V9, P369, DOI 10.1379/CSC-45R1.1; Medici D, 2008, J CELL BIOL, V182, P459, DOI 10.1083/jcb.200803024; Nagai R, 2000, CELL MOL LIFE SCI, V57, P738, DOI 10.1007/s000180050038; Pedersen L, 2013, CLIN BIOCHEM, V46, P1079, DOI 10.1016/j.clinbiochem.2013.05.046; Peng A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023268; Prie D, 2009, KIDNEY INT, V75, P882, DOI 10.1038/ki.2008.643; Richter B, 2016, PFLUG ARCH EUR J PHY, V468, P1621, DOI 10.1007/s00424-016-1858-x; Saito Y, 2000, BIOCHEM BIOPH RES CO, V276, P767, DOI 10.1006/bbrc.2000.3470; Saito Y, 1998, BIOCHEM BIOPH RES CO, V248, P324, DOI 10.1006/bbrc.1998.8943; Shimada T, 2004, BIOCHEM BIOPH RES CO, V314, P409, DOI 10.1016/j.bbrc.2003.12.102; Silswal N, 2014, AM J PHYSIOL-ENDOC M, V307, pE426, DOI 10.1152/ajpendo.00264.2014; Six I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093423; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Xu Y, 2015, ENDOCR REV; Yeboah J, 2009, CIRCULATION, V120, P502, DOI 10.1161/CIRCULATIONAHA.109.864801; Yilmaz MI, 2010, KIDNEY INT, V78, P679, DOI 10.1038/ki.2010.194	35	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176817	10.1371/journal.pone.0176817	http://dx.doi.org/10.1371/journal.pone.0176817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28463984	Green Published, gold, Green Submitted			2022-12-26	WOS:000400646300057
J	Lo, PC; Liu, SH; Nor, SAM; Chen, WJ				Lo, Pei-Chun; Liu, Shu-Hui; Nor, Siti Azizah Mohd; Chen, Wei-Jen			Molecular exploration of hidden diversity in the Indo-West Pacific sciaenid clade	PLOS ONE			English	Article							POPULATION-STRUCTURE; SPECIES DELIMITATION; GENETIC DIVERSITY; NIBEA-ALBIFLORA; PERCIFORMES; BARCODE; FISH; LARIMICHTHYS; EXTINCTION; TELEOSTEI	The family Sciaenidae, known as croakers or drums, is one of the largest perciform fish families. A recent multi-gene based study investigating the phylogeny and biogeography of global sciaenids revealed that the origin and early diversification of this family occurred in tropical America during the Late Oligocene-Early Miocene before undergoing range expansions to other seas including the Indo-West Pacific, where high species richness is observed. Despite this clarification of the overall evolutionary history of the family, knowledge of the taxonomy and phylogeny of sciaenid genera endemic to the Indo-West Pacific is still limited due to lack of a thorough survey of all taxa. In this study, we used DNA-based approaches to investigate the evolutionary relationships, to explore the species diversity, and to elucidate the taxonomic status of sciaenid species/genera within the Indo-West Pacific clade. Three datasets were herein built for the above objectives: the combined dataset (248 samples from 45 currently recognized species) from one nuclear gene (RAG1) and one mitochondrial gene (COI); the dataset with only RAG1 gene sequences (245 samples from 44 currently recognized species); and the dataset with only COI gene sequences (308 samples from 51 currently recognized species). The latter was primarily used for our biodiversity exploration with two different species delimitation methods (Automatic Barcode Gap Discovery, ABGD and Generalized Mixed Yule Coalescent, GMYC). The results were further evaluated with help of four supplementary criteria for species delimitation (genetic similarity, monophyly inferred from individual gene and combined data trees, geographic distribution, and morphology). Our final results confirmed the validity of 32 currently recognized species and identified several potential new species waiting for formal descriptions. We also reexamined the taxonomic status of the genera, Larimichthys, Nibea, Protonibea and Megalonibea, and suggested a revision of Nibea and proposed a new genus Pseudolarimichthys.	[Lo, Pei-Chun; Liu, Shu-Hui; Chen, Wei-Jen] Natl Taiwan Univ, Inst Oceanog, Taipei, Taiwan; [Nor, Siti Azizah Mohd] Univ Sains Malaysia, Sch Biol Sci, Gelugor, Penang, Malaysia	National Taiwan University; Universiti Sains Malaysia	Chen, WJ (corresponding author), Natl Taiwan Univ, Inst Oceanog, Taipei, Taiwan.	wjchen.actinops@gmail.com	CHEN, Wei-Jen/A-2605-2008; Nor, Siti Azizah Mohd/A-8275-2011	CHEN, Wei-Jen/0000-0003-4751-7632; 	Ministry of Science and Technology, Taiwan [MOST 101-2611-M-002-016-MY3, MOST 104-2611-M-002-002-MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The authors wish to thank Hin-Kiu Mok, Kenji Saitoh, Ning Labbish Chao, National Museum of Marine Biology and Aquarium, Taiwan, and Museum and Art Gallery of the Northern Territory, Australia (via Michael Hammer) for the loan or gift of tissue samples, and Dr. Sebastien Lavoue A, Dr. Barry C. Russell, and PCL's Ph.D. committee members for their helpful discussions and comments on the relevance to this work. We would like to thank WJC's lab members, especially Hsiu-Chen Lin, for assistance in the laboratory and sample management. We also wish to thank the lab members of Molecular Ecology Lab 307 in Universiti Sains Malaysia for arranging the field trip in Peninsula Malaysia. This work was supported by research grants from the Ministry of Science and Technology, Taiwan (MOST 101-2611-M-002-016-MY3 and MOST 104-2611-M-002-002-MY3 to WJC).; This work was supported by research grants from the Ministry of Science and Technology, Taiwan (httns://www.most.gov.tw/en/public) (MOST 101-2611-M-002-016-MY3 and MOST 104-2611-M-002-002-MY3 to Wei-Jen Chen). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, FAO YB FISH AQ STAT; [Anonymous], 2002, SE AL SEQUENCE ALIGN; Benson DA, 2000, NUCLEIC ACIDS RES, V28, P15, DOI 10.1093/nar/28.1.15; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Chen WJ, 2010, BIOSCIENCE, V60, P421, DOI 10.1525/bio.2010.60.6.6; Costa MDP, 2014, FISH RES, V160, P77, DOI 10.1016/j.fishres.2013.10.025; Coyne J.A., 2004, SPECIATION; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; de Vasconcellos AV, 2015, FISH RES, V167, P333, DOI 10.1016/j.fishres.2015.03.008; Desse J, 1999, CYBIUM, V23, P345; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; Durand JD, 2012, CR BIOL, V335, P687, DOI 10.1016/j.crvi.2012.09.005; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eschmeyer W.N., 2017, SPECIES FISHES FAMIL; Eschmeyer WN, 2017, GENERA SPECIES REFER; Esselstyn JA, 2012, P ROY SOC B-BIOL SCI, V279, P3678, DOI 10.1098/rspb.2012.0705; Ezard T, 2009, PACKAGE SPLITS SPECI; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Han ZQ, 2008, FISHERIES SCI, V74, P544, DOI 10.1111/j.1444-2906.2008.01557.x; Han ZQ, 2008, FISHERIES SCI, V74, P770, DOI 10.1111/j.1444-2906.2008.01588.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hubbs CL, FISHES GREAT LAKES R; Hung K-W, 2017, ZOOL SCR; IUCN, 2004, IUCN RED LIST THREAT; Iwatsuki Y, 2012, ICHTHYOL RES, V59, P151, DOI 10.1007/s10228-011-0265-8; JAYAPRAKASH A A, 1975, Indian Journal of Fisheries, V22, P259; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kekkonen M, 2014, MOL ECOL RESOUR, V14, P706, DOI 10.1111/1755-0998.12233; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knowles LL, 2011, ESTIMATING SPECIES T, P1; Kuang Y., 1986, FRESHWATER ESTUARIES, P372; Lakra WS, 2011, MOL ECOL RESOUR, V11, P60, DOI 10.1111/j.1755-0998.2010.02894.x; Lal Mohan RS, 1984, FAO SPECIES IDENTIFI, V4; Lin LS, 2009, AFR J BIOTECHNOL, V8, P2700; Lo PC, 2015, MOL PHYLOGENET EVOL, V88, P132, DOI 10.1016/j.ympev.2015.03.025; Lopez JA, 2004, COPEIA, P449, DOI 10.1643/CG-03-087R1; Miller M.A., 2010, P GAT COMP ENV WORKS; Mirimin L, 2016, FISH RES, V176, P100, DOI 10.1016/j.fishres.2015.11.003; Mirimin L, 2016, MAR FRESHWATER RES, V67, P266, DOI 10.1071/MF14345; MOK HK, 1983, B I ZOOL ACAD SINICA, V22, P157; Nelson JS, 2006, FISHES WORLD; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paz A, 2012, J BIOSCIENCES, V37, P887, DOI 10.1007/s12038-012-9255-x; Piner KR, 2004, MAR FRESHWATER RES, V55, P553, DOI 10.1071/MF04038; Pringgenis D, 2016, J TEKNOL, V78, P33; Puillandre N, 2012, MOL ECOL, V21, P2671, DOI 10.1111/j.1365-294X.2012.05559.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Roxo F.F., 2015, DNA BARCODES, V3, P110, DOI DOI 10.1515/dna-2015-0014; Rstudio T, 2020, RSTUDIO INT DEV R; Sadovy Y, 2003, FISH FISH, V4, P86, DOI 10.1046/j.1467-2979.2003.00104.x; Saez AG, 2003, P NATL ACAD SCI USA, V100, P7163, DOI 10.1073/pnas.1132069100; Santos S, 2006, MOL ECOL, V15, P4361, DOI 10.1111/j.1365-294X.2006.03108.x; SASAKI K, 1988, JPN J ICHTHYOL, V35, P261, DOI 10.1007/BF02938426; Sasaki K, 1997, ICHTHYOL RES, V44, P311, DOI 10.1007/BF02678711; Sasaki K., 2001, FAO SPECIES IDENTIFI, V5, P3117; Sasaki Kunio, 1996, Memoirs of the Faculty of Science Kochi University Series D Biology, V16-17, P83; Sauer J, 2012, CLADISTICS, V28, P300, DOI 10.1111/j.1096-0031.2011.00382.x; Seah YG, 2015, ZOOTAXA, V3956, P271, DOI 10.11646/zootaxa.3956.2.7; Seret B., 1990, POISSONS MER OUEST A; Shao K-T, 2010, TAIWAN WILDLIFE GENE; Shen S.-C., 1993, FISHES TAIWAN, P374; Silberschneider V, 2008, J APPL ICHTHYOL, V24, P7, DOI 10.1111/j.1439-0426.2007.00913.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; TREWAVAS E, 1977, Transactions of the Zoological Society of London, V33, P253; Vij S, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00030; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Xu DD, 2012, BIOCHEM SYST ECOL, V45, P158, DOI 10.1016/j.bse.2012.07.028; YANG ZB, 1994, J MOL EVOL, V39, P105	76	13	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176623	10.1371/journal.pone.0176623	http://dx.doi.org/10.1371/journal.pone.0176623			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453569	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383900034
J	Siso-Almirall, A; Kostov, B; Gonzalez, MN; Salami, DC; Jimenez, AP; Sole, RG; Saumell, CB; Bach, LD; Marti, MV; Gonzalez-de Paz, L; Riera, RR; Alonso, VR; Acar-Denizli, N; Almacellas, MF; Ramos-Casals, M; Areu, JB				Siso-Almirall, Antoni; Kostov, Belchin; Navarro Gonzalez, Marta; Cararach Salami, Daniel; Perez Jimenez, Alfonso; Gilabert Sole, Rosa; Bru Saumell, Concepcio; Donoso Bach, Lluis; Villalta Marti, Mireia; Gonzalez-de Paz, Luis; Ruiz Riera, Rafael; Riambau Alonso, Vicenc; Acar-Denizli, Nihan; Farre Almacellas, Marta; Ramos-Casals, Manuel; Benavent Areu, Jaume			Abdominal aortic aneurysm screening program using hand-held ultrasound in primary healthcare	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; SERVICES-TASK-FORCE; EMERGENCY ULTRASOUND; PHYSICAL-EXAMINATION; COST-EFFECTIVENESS; FAMILY-HISTORY; RISK-FACTORS; AGED 65; ULTRASONOGRAPHY; MORTALITY	We determined the feasibility of abdominal aortic aneurysm (AAA) screening program led by family physicians in public primary healthcare setting using hand-held ultrasound device. The potential study population was 11,214 men aged >= 60 years attended by three urban, public primary healthcare centers. Participants were recruited by randomly-selected telephone calls. Ultrasound examinations were performed by four trained family physicians with a hand-held ultrasound device (Vscan (R)). AAA observed were verified by confirmatory imaging using standard ultrasound or computed tomography. Cardiovascular risk factors were determined. The prevalence of AAA was computed as the sum of previously-known aneurysms, aneurysms detected by the screening program and model-based estimated undiagnosed aneurysms. We screened 1,010 men, with mean age of 71.3 (SD 6.9) years; 995 (98.5%) men had normal aortas and 15 (1.5%) had AAA on Vscan (R). Eleven out of 14 AAA-cases (78.6%) had AAA on confirmatory imaging (one patient died). The total prevalence of AAA was 2.49% (95% CI 2.20 to 2.78). The median aortic diameter at diagnosis was 3.5 cm in screened patients and 4.7 cm (p< 0.001) in patients in whom AAA was diagnosed incidentally. Multivariate logistic regression analysis identified coronary heart disease (OR = 4.6, 95% CI 1.3 to 15.9) as the independent factor with the highest odds ratio. A screening program led by trained family physicians using hand-held ultrasound was a feasible, safe and reliable tool for the early detection of AAA.	[Siso-Almirall, Antoni; Kostov, Belchin; Navarro Gonzalez, Marta; Cararach Salami, Daniel; Perez Jimenez, Alfonso; Villalta Marti, Mireia; Gonzalez-de Paz, Luis; Ruiz Riera, Rafael; Benavent Areu, Jaume] CAPSBE, IDIBAPS, Grup Tranversal Recerca Atencio Primaria, Barcelona, Spain; [Gilabert Sole, Rosa; Bru Saumell, Concepcio; Donoso Bach, Lluis] Univ Barcelona, Hosp Clin Barcelona, Ctr Diagnost Imatge, IDIBAPS,Serv Radiodiagnost, Barcelona, Spain; [Riambau Alonso, Vicenc] Hosp Clin Barcelona, Inst Clin Torax, Serv Cirurgia Vasc, Barcelona, Spain; [Acar-Denizli, Nihan] Mimar Sinan Fine Arts Univ, Fac Sci & Letters, Dept Stat, Istanbul, Turkey; [Farre Almacellas, Marta; Ramos-Casals, Manuel] Hosp Clin Barcelona, ICMID, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; Mimar Sinan Guzel Sanatlar University; University of Barcelona; Hospital Clinic de Barcelona	Siso-Almirall, A (corresponding author), CAPSBE, IDIBAPS, Grup Tranversal Recerca Atencio Primaria, Barcelona, Spain.	asiso@clinic.ub.es	Acar-Denizli, Nihan/D-5954-2019	Acar-Denizli, Nihan/0000-0002-0012-8632; Siso Almirall, Antoni/0000-0001-9832-2689; Gonzalez de Paz, Luis/0000-0002-4767-8121; Kostov, Belchin/0000-0002-2126-3892	Medtronic Vascular Inc.	Medtronic Vascular Inc.	This project received financial support from Medtronic Vascular Inc. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akai A, 2015, J VASC SURG, V61, P287, DOI 10.1016/j.jvs.2014.07.007; Alpert JS, 2009, AM J MED, V122, P1, DOI 10.1016/j.amjmed.2008.05.013; Andersen GN, 2011, EUR J ECHOCARDIOGR, V12, P665, DOI 10.1093/ejechocard/jer108; [Anonymous], 2021, LANG ENV STAT COMP; Ashton HA, 2007, BRIT J SURG, V94, P696, DOI 10.1002/bjs.5780; Ashton HA, 2002, LANCET, V360, P1531, DOI 10.1016/S0140-6736(02)11522-4; Bonnafy T, 2013, ARCH CARDIOVASC DIS, V106, P644, DOI 10.1016/j.acvd.2013.08.004; Cosford PA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002945.pub2; Dijos M, 2012, ECHOCARDIOGR-J CARD, V29, P285, DOI 10.1111/j.1540-8175.2011.01559.x; Durham B, 1996, AM J EMERG MED, V14, P309, DOI 10.1016/S0735-6757(96)90184-9; Eaton J, 2012, J EVAL CLIN PRACT, V18, P593, DOI 10.1111/j.1365-2753.2010.01625.x; Eckroth-Bernard K., 2013, ISRN VASCULAR MED, V2013; Ehlers L, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2243; Fleming C, 2006, AM FAM PHYSICIAN, V73, P1157; Fleming C, 2005, ANN INTERN MED, V142, P203, DOI 10.7326/0003-4819-142-3-200502010-00012; Forsdahl SH, 2009, CIRCULATION, V119, P2202, DOI 10.1161/CIRCULATIONAHA.108.817619; Gogalniceanu P, 2010, J SURG EDUC, V67, P152, DOI 10.1016/j.jsurg.2010.02.008; Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1863, DOI 10.1056/NEJMoa0909305; Guirguis-Blake JM, 2014, ANN INTERN MED, V160, P321, DOI 10.7326/M13-1844; Gurtelschmid M, 2014, BRIT J SURG, V101, P633, DOI 10.1002/bjs.9463; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Jamrozik K, 2001, INT J EPIDEMIOL, V30, P1071, DOI 10.1093/ije/30.5.1071; Joergensen TMM, 2014, EUR J VASC ENDOVASC, V48, P669, DOI 10.1016/j.ejvs.2014.09.005; JOHNSTON KW, 1991, J VASC SURG, V13, P452, DOI 10.1067/mva.1991.26737; Kent KC, 2010, J VASC SURG, V52, P539, DOI 10.1016/j.jvs.2010.05.090; Kent KC, 2004, J VASC SURG, V39, P267, DOI 10.1016/j.jvs.2003.08.019; Lederle FA, 2003, J VASC SURG, V38, P329, DOI 10.1016/S0741-5214(03)00136-8; Lederle FA, 2002, JAMA-J AM MED ASSOC, V287, P2968, DOI 10.1001/jama.287.22.2968; LEDERLE FA, 1988, ARCH INTERN MED, V148, P1753, DOI 10.1001/archinte.148.8.1753; Lederle FA, 2002, NEW ENGL J MED, V346, P1437, DOI 10.1056/NEJMoa012573; Lederle FA, 1997, ANN INTERN MED, V126, P441, DOI 10.7326/0003-4819-126-6-199703150-00004; Lee ES, 2009, J VASC SURG, V49, P1107, DOI 10.1016/j.jvs.2008.12.008; Lim LS, 2011, AM J PREV MED, V40, DOI 10.1016/j.amepre.2010.11.021; Lindholt JS, 2010, BRIT J SURG, V97, P826, DOI 10.1002/bjs.7001; Lindholt JS, 2005, BMJ-BRIT MED J, V330, P750, DOI 10.1136/bmj.38369.620162.82; MacDonald AJ, 2008, EUR J VASC ENDOVASC, V35, P698, DOI 10.1016/j.ejvs.2007.11.020; Marrugat J, 2011, REV ESP CARDIOL, V64, P385, DOI 10.1016/j.recesp.2010.12.011; Martin LD, 2009, AM J MED, V122, P35, DOI 10.1016/j.amjmed.2008.07.022; Mastracci TM, 2007, J VASC SURG, V45, P1268, DOI 10.1016/j.jvs.2007.02.041; Moore CL, 2011, NEW ENGL J MED, V364, P749, DOI 10.1056/NEJMra0909487; Norman PE, 2004, BRIT MED J, V329, P1259, DOI 10.1136/bmj.38272.478438.55; Ogata T, 2006, ANN VASC SURG, V20, P312, DOI 10.1007/s10016-006-9056-5; Olchanski N, 2014, J GEN INTERN MED, V29, P1155, DOI 10.1007/s11606-014-2831-z; Palombo D, 2010, J CARDIOVASC SURG, V51, P777; Pleumeekers HJCM, 1995, AM J EPIDEMIOL, V142, P1291, DOI 10.1093/oxfordjournals.aje.a117596; Programa de Actividades Preventivas y de Promocion de la Salud (PAPPS) Sociedad Espanola de Medicina Familiar y Comunitaria (semFYC), 2014, ATEN PRIMARIA S4, V46, P117; Reichmann WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027701; Roentlandt J, 1978, ULTRASOUND MED BIOL, V4, P93; Sakalihasan N, 2014, ANN VASC SURG, V28, P787, DOI 10.1016/j.avsg.2013.11.005; SCOTT RAP, 1995, BRIT J SURG, V82, P1066, DOI 10.1002/bjs.1800820821; Shreibati JB, 2012, ARCH INTERN MED, V172, P1456, DOI 10.1001/archinternmed.2012.4268; Sidloff D, 2014, CIRCULATION, V129, P747, DOI 10.1161/CIRCULATIONAHA.113.005457; Singh K, 2001, AM J EPIDEMIOL, V154, P236; Siso-Almirall A, 2013, MED CLIN-BARCELONA, V141, P417, DOI 10.1016/j.medcli.2013.02.038; Smelser DT, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-174; Svensjo S, 2011, CIRCULATION, V124, P1118, DOI 10.1161/CIRCULATIONAHA.111.030379; Tayal VS, 2003, ACAD EMERG MED, V10, P867, DOI 10.1111/j.1553-2712.2003.tb00630.x; Thompson SG, 2012, BRIT J SURG, V99, P1649, DOI 10.1002/bjs.8897; Thompson SG, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2307; Wanhainen A, 2005, J VASC SURG, V41, P390, DOI 10.1016/j.jvs.2005.01.002	60	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176877	10.1371/journal.pone.0176877	http://dx.doi.org/10.1371/journal.pone.0176877			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453577	Green Submitted, gold, Green Published			2022-12-26	WOS:000400383900060
J	Raja, E; Komuro, A; Tanabe, R; Sakai, S; Ino, Y; Saito, N; Todo, T; Morikawa, M; Aburatani, H; Koinuma, D; Iwata, C; Miyazono, K				Raja, E.; Komuro, A.; Tanabe, R.; Sakai, S.; Ino, Y.; Saito, N.; Todo, T.; Morikawa, M.; Aburatani, H.; Koinuma, D.; Iwata, C.; Miyazono, K.			Bone morphogenetic protein signaling mediated by ALK-2 and DLX2 regulates apoptosis in glioma-initiating cells	ONCOGENE			English	Article							ACTIVATING ACVR1 MUTATIONS; RECEPTOR KINASE INHIBITOR; CANCER STEM-CELLS; NEURONAL DIFFERENTIATION; TRANSCRIPTION FACTORS; MALIGNANT GLIOMA; VALPROIC ACID; I RECEPTORS; GLIOBLASTOMA; PATHWAY	Bone morphogenetic protein (BMP) signaling exerts antitumor activities in glioblastoma; however, its precise mechanisms remain to be elucidated. Here, we demonstrated that the BMP type I receptor ALK-2 (encoded by the ACVR1 gene) has crucial roles in apoptosis induction of patient-derived glioma-initiating cells (GICs), TGS-01 and TGS-04. We also characterized a BMP target gene, Distal-less homeobox 2 (DLX2), and found that DLX2 promoted apoptosis and neural differentiation of GICs. The tumor-suppressive effects of ALK-2 and DLX2 were further confirmed in a mouse orthotopic transplantation model. Interestingly, valproic acid (VPA), an anti-epileptic compound, induced BMP2, BMP4, ACVR1 and DLX2 mRNA expression with a concomitant increase in phosphorylation of Smad1/5. Consistently, we showed that treatment with VPA induced apoptosis of GICs, whereas silencing of ALK-2 or DLX2 expression partially suppressed it. Our study thus reveals BMP-mediated inhibitory mechanisms for glioblastoma, which explains, at least in part, the therapeutic effects of VPA.	[Raja, E.; Komuro, A.; Tanabe, R.; Sakai, S.; Morikawa, M.; Koinuma, D.; Iwata, C.; Miyazono, K.] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo 1130033, Japan; [Ino, Y.; Todo, T.] Univ Tokyo, Inst Med Sci, Div Innovat Canc Therapy, Tokyo, Japan; [Saito, N.] Univ Tokyo, Grad Sch Med, Dept Neurosurg, Tokyo, Japan; [Aburatani, H.] Univ Tokyo, Res Ctr Adv Sci & Technol RCAST, Genome Sci Div, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Miyazono, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo 1130033, Japan.	miyazono@m.u-tokyo.ac.jp	Morikawa, Masato/D-1932-2011; Koinuma, Daizo/Y-8716-2018	Morikawa, Masato/0000-0002-6191-7176; Koinuma, Daizo/0000-0001-5611-2122; Todo, Tomoki/0000-0003-0523-8010	Ministry of Education, Culture, Sports and Technology of Japan (MEXT) [KAKENHI 22112002]; Japan Society for the Promotion of Science (JSPS) [24390070, 15H05774]; Ministry of Health, Labour and Welfare of Japan [201220012C]; JSPS; Naito Foundation; Grants-in-Aid for Scientific Research [15H05774] Funding Source: KAKEN	Ministry of Education, Culture, Sports and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y Kakiuchi for animal care. This work was supported by Grants-in-Aid for Scientific Research (KAKENHI 22112002) from the Ministry of Education, Culture, Sports and Technology of Japan (MEXT) and Scientific Research (B) and (S) (24390070 and 15H05774, respectively, KM) from the Japan Society for the Promotion of Science (JSPS), Grant-in-Aid from the Ministry of Health, Labour and Welfare of Japan (201220012C), the JSPS Core-to-Core Program 'Cooperative International Framework in TGF-beta Family Signalling', and a grant from the Naito Foundation.	Andrews GL, 2003, MOL CELL NEUROSCI, V23, P107, DOI 10.1016/S1044-7431(03)00016-2; Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Bezecny P, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0985-5; Buczkowicz P, 2014, NAT GENET, V46, P451, DOI 10.1038/ng.2936; Cai J, 2015, STEM CELL REP, V5, P963, DOI 10.1016/j.stemcr.2015.10.020; Caren H, 2015, STEM CELL REP, V5, P829, DOI 10.1016/j.stemcr.2015.09.014; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Choe Y, 2013, J NEUROSCI, V33, P6766, DOI 10.1523/JNEUROSCI.0128-13.2013; Davis H, 2016, CYTOKINE GROWTH F R, V27, P81, DOI 10.1016/j.cytogfr.2015.11.009; Dey D, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1090; Du Y, 2010, DIFFERENTIATION, V79, P84, DOI 10.1016/j.diff.2009.10.003; Ehata S, 2007, CANCER SCI, V98, P127, DOI 10.1111/j.1349-7006.2006.00357.x; Fontebasso AM, 2014, NAT GENET, V46, P462, DOI 10.1038/ng.2950; Frew AJ, 2009, CANCER LETT, V280, P125, DOI 10.1016/j.canlet.2009.02.042; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Ghanem N, 2012, J NEUROSCI, V32, P8219, DOI 10.1523/JNEUROSCI.1344-12.2012; Guichet PO, 2013, GLIA, V61, P225, DOI 10.1002/glia.22429; Hallahan AR, 2003, NAT MED, V9, P1033, DOI 10.1038/nm904; Hide T, 2009, CANCER RES, V69, P7953, DOI 10.1158/0008-5472.CAN-09-2006; Hoshino Y, 2015, AM J PATHOL, V185, P1457, DOI 10.1016/j.ajpath.2015.01.011; Hover LD, 2016, NEURO-ONCOLOGY, V18, P928, DOI 10.1093/neuonc/nov310; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Hu WX, 2015, CELL STEM CELL, V17, P204, DOI 10.1016/j.stem.2015.07.006; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Jones C, 2012, NAT REV CLIN ONCOL, V9, P400, DOI 10.1038/nrclinonc.2012.87; Katagiri T, 2016, COLD SPRING HARB PER, V8; Kendall SE, 2005, MOL CELL BIOL, V25, P7711, DOI 10.1128/MCB.25.17.7711-7724.2005; Kodama Y, 2015, NUCLEIC ACIDS RES, V43, pD18, DOI 10.1093/nar/gku1120; Krauze AV, 2015, INT J RADIAT ONCOL, V92, P986, DOI 10.1016/j.ijrobp.2015.04.038; Lathia JD, 2015, GENE DEV, V29, P1203, DOI 10.1101/gad.261982.115; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Li H, 2014, J CELL BIOCHEM, V115, P2004, DOI 10.1002/jcb.24872; Liu S, 2016, ONCOTARGET, V7, P17920, DOI 10.18632/oncotarget.7472; Liu S, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-52; Liu XS, 2012, NEUROSCIENCE, V220, P313, DOI 10.1016/j.neuroscience.2012.06.012; Mehta S, 2011, CANCER CELL, V19, P359, DOI 10.1016/j.ccr.2011.01.035; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Mizutani A, 2016, ONCOGENE, V35, P3514, DOI 10.1038/onc.2015.412; Mohedas AH, 2013, ACS CHEM BIOL, V8, P1291, DOI 10.1021/cb300655w; Moon BS, 2009, EXP MOL MED, V41, P116, DOI 10.3858/emm.2009.41.2.014; Panchision DM, 2001, GENE DEV, V15, P2094, DOI 10.1101/gad.894701; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Park GT, 2001, FEBS LETT, V496, P60, DOI 10.1016/S0014-5793(01)02398-5; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Podkowa M, 2013, MOL CELL NEUROSCI, V57, P83, DOI 10.1016/j.mcn.2013.10.005; Sakurai T, 2016, ONCOGENE, V35, P5000, DOI 10.1038/onc.2016.35; Santra M, 2006, CANCER RES, V66, P11726, DOI 10.1158/0008-5472.CAN-06-1978; Savary K, 2013, ONCOGENE, V32, P5409, DOI 10.1038/onc.2013.67; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Su ZD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4338; Taylor KR, 2014, NAT GENET, V46, P457, DOI 10.1038/ng.2925; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Weller M, 2013, NEURO-ONCOLOGY, V15, P4, DOI 10.1093/neuonc/nos273; Wu XW, 2010, CANCER RES, V70, P2718, DOI 10.1158/0008-5472.CAN-09-3631; Yan K, 2014, GENE DEV, V28, P1085, DOI 10.1101/gad.235515.113; Yu PB, 2008, J BIOL CHEM, V283, P3877, DOI 10.1074/jbc.M706797200; Zhou ZM, 2011, CANCER BIOTHER RADIO, V26, P77, DOI 10.1089/cbr.2010.0857	59	21	22	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 31	2017	36	35					4963	4974		10.1038/onc.2017.112	http://dx.doi.org/10.1038/onc.2017.112			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FF3AV	28459464				2022-12-26	WOS:000408768800002
J	Cashman, CR; Hoke, A				Cashman, Christopher R.; Hoke, Ahmet			Deficiency of adaptive immunity does not interfere with Wallerian degeneration	PLOS ONE			English	Article							FACIAL MOTONEURON SURVIVAL; PERIPHERAL NERVOUS-SYSTEM; IMAGE-ANALYSIS; COMPLEMENT-SYSTEM; INNATE IMMUNITY; LYMPHOCYTES; INJURY; MICE; MACROPHAGES; MOUSE	Following injury, distal axons undergo the process of Wallerian degeneration, and then cell debris is cleared to create a permissive environment for axon regeneration. The innate and adaptive immune systems are believed to be critical for facilitating the clearance of myelin and axonal debris during this process. However, immunodeficient animal models are regularly used in transplantation studies investigating cell therapies to modulate the degenerative/regenerative response. Given the importance of the immune system in preparing a permissive environment for regeneration by clearing debris, animals lacking, in part or in full, a functional immune system may have an impaired ability to regenerate due to poor myelin clearance, and may, thus, be poor hosts to study modulators of regeneration and degeneration. To study this hypothesis, three different mouse models with impaired adaptive immunity were compared to wild type animals in their ability to degenerate axons and clear myelin debris one week following sciatic nerve transection. Immunofluorescent staining for axons and quantitation of axon density with nerve histomorphometry of the distal stump showed no consistent discrepancy between immunodeficient and wild type animals, suggesting axons tended to degenerate equally between the two groups. Debris clearance was assessed by macrophage density and relative myelin basic protein expression within the denervated nerve stump, and no consistent impairment of debris clearance was found. These data suggested deficiency of the adaptive immune system does not have a substantial effect on axon degeneration one week following axonal injury.	[Cashman, Christopher R.] Johns Hopkins Sch Med, MSTP MD PhD Program, Baltimore, MD USA; [Cashman, Christopher R.; Hoke, Ahmet] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Cashman, Christopher R.; Hoke, Ahmet] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Hoke, A (corresponding author), Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.; Hoke, A (corresponding author), Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	ahoke@jhmi.edu			Dr. Miriam and Sheldon G. Adelson Medical Research Foundation [113660]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Dr. Miriam and Sheldon G. Adelson Medical Research Foundation grant 113660 (CRC, AH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Beahrs T, 2010, EXP NEUROL, V221, P225, DOI 10.1016/j.expneurol.2009.11.003; Berghoff M, 2005, MOL CELL NEUROSCI, V28, P118, DOI 10.1016/j.mcn.2004.09.001; BOSMA GC, 1988, J EXP MED, V167, P1016, DOI 10.1084/jem.167.3.1016; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Chaplin DD, 2010, J ALLERGY CLIN IMMUN, V125, pS3, DOI 10.1016/j.jaci.2009.12.980; Chen P, 2015, ACTA NEUROPATHOL, V130, P1; Gaudet AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-110; Ha GK, 2006, J NEUROIMMUNOL, V172, P1, DOI 10.1016/j.jneuroim.2005.10.012; Hirata K, 2002, MICROSC RES TECHNIQ, V57, P541, DOI 10.1002/jemt.10108; Huang Z, 2013, J NEUROL DISORD, V1, P1; Jones KJ, 2005, BRAIN BEHAV IMMUN, V19, P12, DOI 10.1016/j.bbi.2004.05.004; Kiefer R, 2001, PROG NEUROBIOL, V64, P109, DOI 10.1016/S0301-0082(00)00060-5; Kim SJ, 2003, ANN NY ACAD SCI, V987, P68, DOI 10.1111/j.1749-6632.2003.tb06034.x; Mietto BS, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/251204; Miller NM, 2013, ASN NEURO, V5, DOI 10.1042/AN20120087; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nauta AJ, 2004, INT ARCH ALLERGY IMM, V134, P310, DOI 10.1159/000079261; Nave KA, 2014, ANNU REV CELL DEV BI, V30, P503, DOI 10.1146/annurev-cellbio-100913-013101; Patzig J, 2011, J NEUROSCI, V31, P16369, DOI 10.1523/JNEUROSCI.4016-11.2011; Ramaglia V, 2008, MOL IMMUNOL, V45, P3865, DOI 10.1016/j.molimm.2008.06.018; Ramaglia V, 2009, PROG BRAIN RES, V175, P95, DOI 10.1016/S0079-6123(09)17507-6; Sanders VM, 2006, J NEUROIMMUNE PHARM, V1, P11, DOI 10.1007/s11481-005-9004-0; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuurman H. J., 1992, ILAR News, V34, P3; Serpe CJ, 2005, BRAIN BEHAV IMMUN, V19, P173, DOI 10.1016/j.bbi.2004.07.005; Serpe CJ, 2003, BRAIN BEHAV IMMUN, V17, P393, DOI 10.1016/S0889-1591(03)00028-X; Serpe CJ, 2002, BRAIN BEHAV IMMUN, V16, P808, DOI 10.1016/S0889-1591(02)00017-X; STOLL G, 1989, J NEUROCYTOL, V18, P671, DOI 10.1007/BF01187086; Vargas ME, 2010, P NATL ACAD SCI USA, V107, P11993, DOI 10.1073/pnas.1001948107; Waller A., 1850, PHIL T R SOC, V140, P423, DOI DOI 10.1098/RSTL.1850.0021; WINKELSTEIN JA, 1973, J PEDIATR-US, V82, P747, DOI 10.1016/S0022-3476(73)80062-9	35	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177070	10.1371/journal.pone.0177070	http://dx.doi.org/10.1371/journal.pone.0177070			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475650	gold, Green Submitted, Green Published			2022-12-26	WOS:000400649500041
J	Deiner, K; Hull, JM; May, B				Deiner, Kristy; Hull, Joshua M.; May, Bernie			Range-wide phylogeographic structure of the vernal pool fairy shrimp (Branchinecta lynchi)	PLOS ONE			English	Article							GENETIC POPULATION-STRUCTURE; CALIFORNIA; DNA; RARE; CRUSTACEA; BRANCHIOPOD; LANDSCAPE; DIVERSITY; ANOSTRACA; SOFTWARE	Wetland habitats across the world are experiencing rapid modification and loss due to accelerating habitat conversion. Impacts to wetland habitats are particularly acute in California where up to 90% of wetland habitats have been modified or lost. Vernal pool ecosystems have therefore undergone a dramatic loss in habitat and along with them an entire endemic fauna is under threat of extinction. Recent efforts to conserve vernal pool habitat and associated species have involved restoration and creation of vernal pools as well as translocations of threatened species. The vernal pool fairy shrimp, Branchinecta lynchi, is one of several endemic and federally listed species being targeted for translocations. To guide reintroduction and conservation, detailed information on range-wide population structure and diversity is needed. We collected genetic data from two mitochondrial genes throughout the known extant range of B. lynchi to elucidate population structure and diversity of the species. We found support for phylogeographic structure throughout the range of B. lynch associated with isolated watersheds and vernal pool regions previously identified in the recovery plan for the species. The underlying mechanisms responsible for this broad pattern of genetic structure have yet to be identified. However, the evidence of only a few haplotypes being shared across the species range and patterns of isolation by distance within vernal pool regions suggests dispersal limitation may play a role. These results stress that conservation programs, at a minimum, should consider using individuals from regional populations as sources for reintroductions to maintain historical patterns of genetic differentiation. Additionally, because genetic structure is associated with vernal pool regions which are based on local hydrology and geology, translocations should proceed considering the distance between donor and recipient sites.	[Deiner, Kristy; May, Bernie] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Hull, Joshua M.] US Fish & Wildlife Serv, Sacramento Fish & Wildlife Off, Sacramento, CA USA	University of California System; University of California Davis; United States Department of the Interior; US Fish & Wildlife Service	Deiner, K (corresponding author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.	alpinedna@gmail.com	Hull, Joshua/ABD-5438-2020	Deiner, Kristy/0000-0001-9755-3223	U.S. Fish and Wildlife Services Cooperative [81420-9-J511]	U.S. Fish and Wildlife Services Cooperative	This work was supported by U.S. Fish and Wildlife Services Cooperative agreement grant (81420-9-J511), https://www.fws.gov/.	Aguilar A, 2012, CONSERV GENET, V13, P1577, DOI 10.1007/s10592-012-0405-3; Aguilar A, 2011, AQUAT SCI, V73, P15, DOI 10.1007/s00027-010-0155-6; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barbour MG, 2005, PHYTOCOENOLOGIA, V35, P177, DOI 10.1127/0340-269X/2005/0035-0177; Bohonak A., 2005, FINAL REPORT CITY SA; Bohonak AJ, 1998, CAN J ZOOL, V76, P2049, DOI 10.1139/cjz-76-11-2049; Brochet AL, 2010, HYDROBIOLOGIA, V637, P255, DOI 10.1007/s10750-009-9975-6; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Dahl T., 1990, WETLANDS LOSSES US 1, P1; Davies CP, 1997, HYDROBIOLOGIA, V359, P149, DOI 10.1023/A:1003150517472; Deiner K, 2013, J FISH WILDL MANAG, V4, P134, DOI 10.3996/112012-JFWM-096; Eichmiller JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112611; ENG LL, 1990, J CRUSTACEAN BIOL, V10, P247, DOI 10.2307/1548485; Eriksen CH, 1999, FAIRY SHRIMPS CALIFO; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Gordon SP, 2012, CONSERV GENET, V13, P117, DOI 10.1007/s10592-011-0269-y; Graham TB, 2008, HYDROBIOLOGIA, V600, P17, DOI 10.1007/s10750-007-9171-5; GRIGGS FT, 1983, BIOL CONSERV, V27, P171, DOI 10.1016/0006-3207(83)90087-3; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HOLLAND RF, 1981, AM NAT, V117, P24, DOI 10.1086/283684; Holland RF., 1978, GEOGRAPHIC EDAPHIC D; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Keeler-Wolf T, 1998, CALIFORNIA VERNAL PO, P1; Keeley JE, 1998, CHARACTERIZATION GLO; Kneitel JM, 2014, HYDROBIOLOGIA, V732, P71, DOI 10.1007/s10750-014-1845-1; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Machler E, 2014, FRESHW SCI, V33, P1174, DOI 10.1086/678128; McGlaughlin ME, 2015, CONSERV GENET, V16, P253, DOI 10.1007/s10592-014-0655-3; Meglecz E, 2005, ARCH HYDROBIOL, V164, P277, DOI 10.1127/0003-9136/2005/0164-0277; Nhiwatiwa T, 2011, FRESHWATER BIOL, V56, P1992, DOI 10.1111/j.1365-2427.2011.02630.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; QGIS Development Team, 2015, QGIS GEOGR INF SYST; Rains MC, 2008, WETLANDS, V28, P347, DOI 10.1672/07-132.1; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Santana QC, 2009, BIOTECHNIQUES, V46, P217, DOI 10.2144/000113085; Schwentner M, 2014, J ZOOL SYST EVOL RES, V52, P15, DOI 10.1111/jzs.12038; Schwentner M, 2012, ECOL EVOL, V2, P1605, DOI 10.1002/ece3.265; Shaffer HB, 2004, MOL ECOL, V13, P3033, DOI 10.1111/j.1365-294X.2004.02317.x; Simovich MA, 1997, J CRUSTACEAN BIOL, V17, P38, DOI 10.2307/1549460; Simovich MA, 2013, J CRUSTACEAN BIOL, V33, P730, DOI 10.1163/1937240X-00002164; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Soule M., 1987, VIABLE POPULATIONS C; TAJIMA F, 1989, GENETICS, V123, P597; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; USFWS, 2005, REC PLAN VERN POOL E; USFWS, 2007, VERN POOL FAIR SHRIM, P1; Vandergast AG, 2009, MOL ECOL RESOUR, V9, P767, DOI 10.1111/j.1755-0998.2009.02522.x; Wall AR, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.457.6822; Witham C, 2014, CHANGES DISTRIBUTION; Zwickl D. J, 2006, GENETIC ALGORITHM AP	57	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176266	10.1371/journal.pone.0176266	http://dx.doi.org/10.1371/journal.pone.0176266			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472088	Green Submitted, gold, Green Published			2022-12-26	WOS:000400648500033
J	Healy, EF				Healy, Eamonn F.			A prion-like mechanism for the propagated misfolding of SOD1 from in silico modeling of solvated near-native conformers	PLOS ONE			English	Article							HUMAN SUPEROXIDE-DISMUTASE; CU-ZN; PROTEINS; BINDING; AGGREGATION; DYNAMICS; ENERGY	A prion-like mechanism has been developed to explain the observed promotion of amyloid aggregation caused by conversion of structurally intact SOD1 to a misfolded form. Superoxide dismutase [Cu-Zn], or SOD1, is a homo-dimeric protein that functions as an antioxidant by scavenging for superoxide. The misfolding and aggregation of SOD1 is linked to inherited, or familial, amyotrophic lateral sclerosis (FALS), a progressive and fatal neurodegenerative disease. Aberrant SOD1 folding has also been strongly implicated in disease causation for sporadic ALS, or SALS, which accounts for similar to 90% of ALS cases. Studies have found that mutant, misfolded SOD1 can convert wtSOD1 in a prion-like fashion, and that misfolded wtSOD1 can be propagated by release and uptake of protein aggregates. Here it is demonstrated that enervating the SOD1 electrostatic loop can lead to an experimentally observed gain of interaction (GOI) responsible for the formation of SOD1 amyloid-like filaments. This enervation is caused in turn by the formation of transient, non-obligate oligomers between pathogenic SOD1 mutants and wt SOD1.	[Healy, Eamonn F.] St Edwards Univ, Dept Chem, Austin, TX 78704 USA		Healy, EF (corresponding author), St Edwards Univ, Dept Chem, Austin, TX 78704 USA.	healy@stedwards.edu	Healy, Eamonn/AAI-4331-2020	Healy, Eamonn/0000-0001-8479-7712	National Institute of General Medical Services [1K12GM102745]; Welch Foundation [BH-0018]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM102745] Funding Source: NIH RePORTER	National Institute of General Medical Services; Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support was provided by the National Institute of General Medical Services (1K12GM102745) and the Welch Foundation (Grant# BH-0018).; The author wishes to acknowledge the support of the National Institute of General Medical Services (1K12GM102745), as well as Welch Foundation (Grant# BH-0018) for its continuing support of the Chemistry Department at St. Edward's University. The author also is particularly grateful to Luis Cervantes for his help in the preparation of this manuscript.	Antonyuk S, 2010, J MED CHEM, V53, P1402, DOI 10.1021/jm9017948; Banerjee V, 2016, ACS CHEM NEUROSCI, V7, P1595, DOI 10.1021/acschemneuro.6b00227; Bershtein S, 2012, P NATL ACAD SCI USA, V109, P4857, DOI 10.1073/pnas.1118157109; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Dunn ME, 2004, J AM CHEM SOC, V126, P2647, DOI 10.1021/ja038928p; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Fernandez A, 2003, BIOPHYS J, V85, P1914, DOI 10.1016/S0006-3495(03)74619-0; Fernandez A, 2003, P NATL ACAD SCI USA, V100, P113, DOI 10.1073/pnas.0136888100; Fernandez A, 2011, NATURE, V474, P502, DOI 10.1038/nature09992; Ferreiro DU, 2007, P NATL ACAD SCI USA, V104, P19819, DOI 10.1073/pnas.0709915104; Grad LI, 2015, NEUROBIOL DIS, V77, P257, DOI 10.1016/j.nbd.2015.02.009; Grad LI, 2014, P NATL ACAD SCI USA, V111, P3620, DOI 10.1073/pnas.1312245111; Grad LI, 2011, P NATL ACAD SCI USA, V108, P16398, DOI 10.1073/pnas.1102645108; Hart PJ, 1998, PROTEIN SCI, V7, P545; Healy EE, 2016, BIOCHEM BIOPH RES CO, V478, P1634, DOI 10.1016/j.bbrc.2016.08.172; Healy EF, 2016, EUR BIOPHYS J BIOPHY, V45, P853, DOI 10.1007/s00249-016-1163-9; Healy EF, 2015, BIOCHEM BIOPH RES CO, V465, P523, DOI 10.1016/j.bbrc.2015.08.052; Healy EF, 2011, COMPUT THEOR CHEM, V964, P91, DOI 10.1016/j.comptc.2010.12.003; Healy EF, 2009, FEBS LETT, V583, P2899, DOI 10.1016/j.febslet.2009.07.051; Hegler JA, 2008, HFSP J, V2, P307, DOI 10.2976/1.3003931; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Khare SD, 2006, P NATL ACAD SCI USA, V103, P3147, DOI 10.1073/pnas.0511266103; Levy Y, 2004, P NATL ACAD SCI USA, V101, P511, DOI 10.1073/pnas.2534828100; Maddipati S, 2006, BIOMOL ENG, V23, P307, DOI 10.1016/j.bioeng.2006.09.004; Marsh JA, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001870; Munishkina LA, 2008, BIOCHEMISTRY-US, V47, P8993, DOI 10.1021/bi8008399; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Shtilerman MD, 2002, BIOCHEMISTRY-US, V41, P3855, DOI 10.1021/bi0120906; Strange RW, 2006, J MOL BIOL, V356, P1152, DOI 10.1016/j.jmb.2005.11.081; Tsao D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011936	32	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177284	10.1371/journal.pone.0177284	http://dx.doi.org/10.1371/journal.pone.0177284			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472188	Green Submitted, Green Published, gold			2022-12-26	WOS:000400648500156
J	Vallejo, V; Wyss, P; Rampa, L; Mitache, AV; Muri, RM; Mosimann, UP; Nef, T				Vallejo, Vanessa; Wyss, Patric; Rampa, Luca; Mitache, Andrei V.; Mueri, Rene M.; Mosimann, Urs P.; Nef, Tobias			Evaluation of a novel Serious Game based assessment tool for patients with Alzheimer's disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; INSTRUMENTAL ACTIVITIES; FUNCTIONAL IMPAIRMENT; EXECUTIVE FUNCTION; DEMENTIA; POPULATION; REHABILITATION; INFORMATION; ATTENTION; REALITY	Despite growing interest in developing ecological assessment of difficulties in patients with Alzheimer's disease new methods assessing the cognitive difficulties related to functional activities are missing. To complete current evaluation, the use of Serious Games can be a promising approach as it offers the possibility to recreate a virtual environment with daily living activities and a precise and complete cognitive evaluation. The aim of the present study was to evaluate the usability and the screening potential of a new ecological tool for assessment of cognitive functions in patients with Alzheimer's disease. Eighteen patients with Alzheimer's disease and twenty healthy controls participated to the study. They were asked to complete six daily living virtual tasks assessing several cognitive functions: three navigation tasks, one shopping task, one cooking task and one table preparation task following a oneday scenario. Usability of the game was evaluated through a questionnaire and through the analysis of the computer interactions for the two groups. Furthermore, the performances in terms of time to achieve the task and percentage of completion on the several tasks were recorded. Results indicate that both groups subjectively found the game user friendly and they were objectively able to play the game without computer interactions difficulties. Comparison of the performances between the two groups indicated a significant difference in terms of percentage of achievement of the several tasks and in terms of time they needed to achieve the several tasks. This study suggests that this new Serious Game based assessment tool is a user-friendly and ecological method to evaluate the cognitive abilities related to the difficulties patients can encounter in daily living activities and can be used as a screening tool as it allowed to distinguish Alzheimer's patient's performance from healthy controls.	[Vallejo, Vanessa; Wyss, Patric; Mitache, Andrei V.; Mueri, Rene M.; Mosimann, Urs P.; Nef, Tobias] Univ Bern, Gerontechnol & Rehabil Grp, Bern, Switzerland; [Rampa, Luca; Mosimann, Urs P.] Univ Bern, Univ Hosp Old Age Psychiat & Psychotherapy, Bern, Switzerland; [Mueri, Rene M.] Univ Bern, Univ Hosp Inselspital, Dept Neurol & Clin Res, Percept & Eye Movement Lab, Bern, Switzerland; [Mosimann, Urs P.] Private Hosp Wyss, Munchenbuchsee, Switzerland; [Nef, Tobias] Univ Bern, ARTORG Ctr Biomed Engn Res, Bern, Switzerland	University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern	Nef, T (corresponding author), Univ Bern, Gerontechnol & Rehabil Grp, Bern, Switzerland.; Nef, T (corresponding author), Univ Bern, ARTORG Ctr Biomed Engn Res, Bern, Switzerland.	tobias.nef@artorg.unibe.ch	; Muri, Rene/E-9320-2012	Nef, Tobias/0000-0002-8069-9450; Rampa, Luca/0000-0002-2907-667X; Wyss, Patric/0000-0002-8820-2963; Muri, Rene/0000-0001-6990-4188				[Anonymous], [No title captured]; Barberger-Gateau P, 1999, J AM GERIATR SOC, V47, P456, DOI 10.1111/j.1532-5415.1999.tb07239.x; Bouchard Bruno, 2012, Serious Games Development and Applications. Proceedings Third International Conference, SGDA 2012, P243, DOI 10.1007/978-3-642-33687-4_21; Boyle PA, 2003, AM J GERIAT PSYCHIAT, V11, P214, DOI 10.1176/appi.ajgp.11.2.214; Bucks RS, 1996, AGE AGEING, V25, P113, DOI 10.1093/ageing/25.2.113; Clark Christopher M, PERFORMANCE DEMENTIA; Cushman LA, 2008, NEUROLOGY, V71, P888, DOI 10.1212/01.wnl.0000326262.67613.fe; Fillenbaum GG, 1999, AGE AGEING, V28, P161, DOI 10.1093/ageing/28.2.161; Fissler P, 2013, PROG BRAIN RES, V207, P403, DOI 10.1016/B978-0-444-63327-9.00017-5; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Flaherty G, 2006, DEMENTIA WANDERING B; Flores E., 2008, P 2008 INT C ADV COM, P381, DOI [10.1145/1501750.1501839, DOI 10.1145/1501750.1501839]; Fua KC, 2013, DESIGNING SERIOUS GA, P291; HENDERSON VW, 1989, ARCH NEUROL-CHICAGO, V46, P391, DOI 10.1001/archneur.1989.00520400045018; Hollan J., 2000, ACM Transactions on Computer-Human Interaction, V7, P174, DOI 10.1145/353485.353487; Imbeault F., 2011, 2011 IEEE 1 INT C SE, P1, DOI DOI 10.1109/SEGAH.201; Jefferson AL, 2006, ARCH CLIN NEUROPSYCH, V21, P311, DOI 10.1016/j.acn.2006.03.007; Johnson N., ACTIVITIES DAILY LIV; Kluger A, 1997, Int Psychogeriatr, V9 Suppl 1, P307, DOI 10.1017/S1041610297005048; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Logan B, 2007, LECT NOTES COMPUT SC, V4717, P483; Manera V, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00024; Marshall GA, 2011, ALZHEIMERS DEMENT, V7, P300, DOI 10.1016/j.jalz.2010.04.005; Martyr A, 2012, DEMENT GERIATR COGN, V33, P189, DOI 10.1159/000338233; MORRIS JC, 1988, PSYCHOPHARMACOL BULL, V24, P641; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Ng TP, 2006, J GERONTOL A-BIOL, V61, P726, DOI 10.1093/gerona/61.7.726; Nygard L, 2004, AM J OCCUP THER, V58, P435, DOI 10.5014/ajot.58.4.435; Parmelee PA, 1989, PSYCHOL ASSESSMENT J, V1, P331, DOI DOI 10.1037/1040-3590.1.4.331; Parsey CM, 2013, CLIN NEUROPSYCHOL, V27, P1328, DOI 10.1080/13854046.2013.834971; Patton M. Q., 2005, ENCY STAT BEHAV SCI, DOI 10.1002/0470013192.bsa514; Peres K, 2008, J AM GERIATR SOC, V56, P37, DOI 10.1111/j.1532-5415.2007.01499.x; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Pudaric S, 2003, SOC SCI MED, V56, P2493, DOI 10.1016/S0277-9536(02)00284-8; Rego P, 2010, 5 IB C INF SYST TECH, P1; Rizzo AA, 2000, CYBERPSYCHOL BEHAV, V3, P483, DOI 10.1089/10949310050078940; Robert PH, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00054; Schmitter-Edgecombe M, 2012, NEUROPSYCHOLOGY, V26, P631, DOI 10.1037/a0029352; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Sikkes SAM, 2009, J NEUROL NEUROSUR PS, V80, P7, DOI 10.1136/jnnp.2008.155838; Spiers HJ, 2006, NEUROIMAGE, V31, P1826, DOI 10.1016/j.neuroimage.2006.01.037; STEELE C, 1990, AM J PSYCHIAT, V147, P1049; Tanimoto Y, 2012, ARCH GERONTOL GERIAT, V54, pE230, DOI 10.1016/j.archger.2011.06.015; Tarnanas I, 2013, JMIR SERIOUS GAMES, V1, P16, DOI 10.2196/games.2778; Tarnanas I, 2014, ALZHEIMERS DEMENT, V10, P790, DOI 10.1016/j.jalz.2014.01.002; Tekin S, 2001, AM J GERIAT PSYCHIAT, V9, P81, DOI 10.1176/appi.ajgp.9.1.81; Tong T., 2014, INT S HUM FACTORS ER, V3, P28; Torralba A, 2006, PSYCHOL REV, V113, P766, DOI 10.1037/0033-295X.113.4.766; Vallejo V., 2015, J PAIN MANAG, V9, P333; Vallejo V, 2015, IEEE ENG MED BIO, P1327, DOI 10.1109/EMBC.2015.7318613; Wiemeyer J, 2012, EUR REV AGING PHYS A, V9, P41, DOI 10.1007/s11556-011-0093-x; Wlodarczyk JH, 2004, ARCH GERONTOL GERIAT, V39, P25, DOI 10.1016/j.archger.2003.12.004; Zucchella C, 2014, FUNCT NEUROL, V29, P153, DOI 10.11138/FNeur/2014.29.3.153	53	35	35	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0175999	10.1371/journal.pone.0175999	http://dx.doi.org/10.1371/journal.pone.0175999			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SP	28472049	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500020
J	Fair, PA; Schaefer, AM; Houser, DS; Bossart, GD; Romano, TA; Champagne, CD; Stott, JL; Rice, CD; White, N; Reif, JS				Fair, Patricia A.; Schaefer, Adam M.; Houser, Dorian S.; Bossart, Gregory D.; Romano, Tracy A.; Champagne, Cory D.; Stott, Jeffrey L.; Rice, Charles D.; White, Natasha; Reif, John S.			The environment as a driver of immune and endocrine responses in dolphins (Tursiops truncatus)	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; POLYCHLORINATED BIPHENYL EXPOSURE; TRACE-ELEMENT CONCENTRATIONS; INDIAN RIVER LAGOON; PERFLUOROALKYL COMPOUNDS; DELPHINAPTERUS-LEUCAS; THYROID-HORMONES; ESTUARINE AREAS; SOUTH-CAROLINA; LAND-USE	Immune and endocrine responses play a critical role in allowing animals to adjust to environmental perturbations. We measured immune and endocrine related markers in multiple samples from individuals from two managed-care care dolphin groups (n = 82 samples from 17 dolphins and single samples collected from two wild dolphin populations: Indian River Lagoon, (IRL) FL (n = 26); and Charleston, (CHS) SC (n = 19). The immune systems of wild dolphins were more upregulated than those of managed-care-dolphins as shown by higher concentrations of IgG and increases in lysozyme, NK cell function, pathogen antibody titers and leukocyte cytokine transcript levels. Collectively, managed-care care dolphins had significantly lower levels of transcripts encoding pro-inflammatory cytokine TNF, anti-viral MX1 and INFa and regulatory IL-10. IL-2Ra and CD69, markers of lymphocyte activation, were both lower in managed-care care dolphins. IL-4, a cytokine associated with T(H)2 activity, was lower in managed-care care dolphins compared to the free-ranging dolphins. Differences in immune parameters appear to reflect the environmental conditions under which these four dolphin populations live which vary widely in temperature, nutrition, veterinary care, pathogen/contaminant exposures, etc. Many of the differences found were consistent with reduced pathogenic antigenic stimulation in managed-care care dolphins compared to wild dolphins. Managed-care care dolphins had relatively low T(H)2 lymphocyte activity and fewer circulating eosinophils compared to wild dolphins. Both of these immunologic parameters are associated with exposure to helminth parasites which is uncommon in managed-care care dolphins. Less consistent trends were observed in a suite of hormones but significant differences were found for cortisol, ACTH, total T-4, free T-3, and epinephrine. While the underlying mechanisms are likely multiple and complex, the marked differences observed in the immune and endocrine systems of wild and managed-care care dolphins appear to be shaped by their environment.	[Fair, Patricia A.; White, Natasha] Natl Ocean Serv, NOAA, Ctr Coastal Environm Hlth & Biomol Res, Charleston, SC 29412 USA; [Fair, Patricia A.] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Schaefer, Adam M.] Florida Atlantic Univ, Harbor Branch, Oceanog Inst, Ft Pierce, FL USA; [Houser, Dorian S.; Champagne, Cory D.] Marine Mammal Fdn, San Diego, CA USA; [Bossart, Gregory D.] Georgia Aquarium, Atlanta, GA USA; [Bossart, Gregory D.] Univ Miami, Miller Sch Med, Div Comparat Pathol, Miami, FL 33136 USA; [Romano, Tracy A.] Mystic Aquarium, Mystic, CT USA; [Stott, Jeffrey L.] Univ Calif Davis, Davis, CA 95616 USA; [Rice, Charles D.] Clemson Univ, Dept Biol Sci, Grad Program Environm Toxicol, Clemson, SC 29634 USA; [Reif, John S.] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; Medical University of South Carolina; Harbor Branch Oceanographic Institute Foundation; State University System of Florida; Florida Atlantic University; University of Miami; University of California System; University of California Davis; Clemson University; Colorado State University	Fair, PA (corresponding author), Natl Ocean Serv, NOAA, Ctr Coastal Environm Hlth & Biomol Res, Charleston, SC 29412 USA.; Fair, PA (corresponding author), Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA.	pat.fair@noaa.gov	Houser, Dorian/AAG-6359-2020	Schaefer, Adam M/0000-0001-9604-3432	Office of Naval Research [N00014-11-1-0436]	Office of Naval Research(Office of Naval Research)	We include the funding source Office of Naval Research grant number N00014-11-1-0436 (DSH). We also include commercial affiliations, Georgia Aquarium and Mystic Aquarium, and a statement on the role of the funders as follows: The funding organizations, Georgia Aquarium and Mystic Aquarium, provided support in the form of salaries for authors [GDB, TAR] and did not play an additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Abolins SR, 2011, MOL ECOL, V20, P881, DOI 10.1111/j.1365-294X.2010.04910.x; Adams J, 2008, MAR ENVIRON RES, V66, P430, DOI 10.1016/j.marenvres.2008.07.004; Adams J, 2014, ENVIRON RES, V135, P346, DOI 10.1016/j.envres.2014.08.037; [Anonymous], 2002, CELL MOL BIOL MARINE; Asper E.D., 1990, P479; Atkinson S, 2015, J COMP PHYSIOL B, V185, P463, DOI 10.1007/s00360-015-0901-0; Beck BM, 2003, MAR ENVIRON RES, V55, P161, DOI 10.1016/S0141-1136(02)00274-X; Beineke A, 2010, VET IMMUNOL IMMUNOP, V133, P81, DOI 10.1016/j.vetimm.2009.06.019; Bossart, 2006, OCEANOGRAPHY, V19, P134, DOI [10.1177/0300985810388525, DOI 10.5670/OCEANOG.2006.77]; Bossart G, 2011, DIS AQUAT ORG; BOSSART GD, 2001, MARINE MAMMAL MED; Bossart GD, 2010, VET PATHOL, P676; Bossart GD, 2015, DIS AQUAT ORGAN, V115, P175, DOI 10.3354/dao02895; Bossart GD, 2014, DIS AQUAT ORGAN, V108, P71, DOI 10.3354/dao02704; Bossart GD, 2010, VET MICROBIOL, V143, P160, DOI 10.1016/j.vetmic.2009.11.024; Bossart Gregory D., 2008, Aquatic Mammals, V34, P166, DOI 10.1578/AM.34.2.2008.166; Buehler DM, 2008, J AVIAN BIOL, V39, P560, DOI 10.1111/j.0908-8857.2008.04408.x; Champagne C.D., 2016, MAR MAMM SCI; Cray C, 2013, J VET DIAGN INVEST, V25, P107, DOI 10.1177/1040638712467986; Davis SL, 1998, DOMEST ANIM ENDOCRIN, V15, P283, DOI 10.1016/S0739-7240(98)00034-4; Descotes J., 2004, IMMUNOTOXICITY DRUGS, V1; Dorshkind K, 2001, BIOESSAYS, V23, P288, DOI 10.1002/1521-1878(200103)23:3<288::AID-BIES1039>3.0.CO;2-P; Fair Patricia A., 2006, Aquatic Mammals, V32, P182, DOI 10.1578/AM.32.2.2006.182; Fair PA, 2007, ARCH ENVIRON CON TOX, V53, P483, DOI 10.1007/s00244-006-0244-7; Fair PA, 2014, GEN COMP ENDOCR, V206, P203, DOI 10.1016/j.ygcen.2014.07.002; Fair PA, 2013, ENVIRON TOXICOL CHEM, V32, P736, DOI 10.1002/etc.2122; Fair PA, 2011, GEN COMP ENDOCR, V174, P184, DOI 10.1016/j.ygcen.2011.08.021; Fair Patricia A., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P335, DOI 10.1023/A:1009968113079; Fair PA, 2010, SCI TOTAL ENVIRON, V408, P1577, DOI 10.1016/j.scitotenv.2009.12.021; Flies AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137679; Goldstein JD, 2006, J WILDLIFE DIS, V42, P447, DOI 10.7589/0090-3558-42.2.447; Hall AJ, 2006, ENVIRON HEALTH PERSP, V114, P704, DOI 10.1289/ehp.8222; HOHN AA, 1989, MAR MAMMAL SCI, V5, P315, DOI 10.1111/j.1748-7692.1989.tb00346.x; Houde M, 2005, ENVIRON SCI TECHNOL, V39, P6591, DOI 10.1021/es0506556; Houser DS, 2011, J ZOO WILDLIFE MED, V42, P565, DOI 10.1638/2010-0121.1; Kane KL, 1996, CLIN DIAGN LAB IMMUN, V3, P295, DOI 10.1128/CDLI.3.3.295-300.1996; LAHVIS GP, 1995, ENVIRON HEALTH PERSP, V103, P67, DOI 10.2307/3432414; Larsen PR, 1992, THE THYROID GLAND; Lee C-S, 2010, IMMUNOLOGIC MARKERS; Long E, 1998, 12 NOAA NOS ORCA; McDonald TA, 2002, CHEMOSPHERE, V46, P745, DOI 10.1016/S0045-6535(01)00239-9; Myers MJ, 2006, COMP BIOCHEM PHYS A, V145, P90, DOI 10.1016/j.cbpa.2006.05.004; Ortiz RM, 2000, COMP BIOCHEM PHYS A, V125, P317, DOI 10.1016/S1095-6433(00)00158-6; Ortiz RM, 2010, MAR MAMMAL SCI, V26, P409, DOI 10.1111/j.1748-7692.2009.00309.x; Reddy M, 1989, MAR POLL B, V36, P892; Rehtanz M, 2006, J GEN VIROL, V87, P3559, DOI 10.1099/vir.0.82388-0; Rehtanz M, 2012, VET MICROBIOL, V160, P297, DOI 10.1016/j.vetmic.2012.05.042; Reif J. S., 2008, J CLIN MICRO INFEC I, V47, P125, DOI DOI 10.1080/13693780802178493 .; Reif JS, 2008, JAVMA-J AM VET MED A, V233, P299, DOI 10.2460/javma.233.2.299; Romano TA, 2004, CAN J FISH AQUAT SCI, V61, P1124, DOI [10.1139/f04-055, 10.1139/F04-055]; ROMANO TA, 1994, J MORPHOL, V221, P243, DOI 10.1002/jmor.1052210302; Schwacke LH, 2012, P ROY SOC B-BIOL SCI, V279, P48, DOI 10.1098/rspb.2011.0665; Sitt T, 2008, DEV COMP IMMUNOL, V32, P1253, DOI 10.1016/j.dci.2008.05.001; Sitt T, 2010, VET IMMUNOL IMMUNOP, V137, P181, DOI 10.1016/j.vetimm.2010.05.003; SMITH NP, 1993, ESTUARIES, V16, P739, DOI 10.2307/1352432; Soloff AC, 2017, APPL TOXICO IN PRESS; Spoon TR, 2012, BRAIN BEHAV IMMUN, V26, P122, DOI 10.1016/j.bbi.2011.08.003; St Aubin D, 1990, ADV RES BELUGA WHALE, P149; StAubin DJ, 1996, MAR MAMMAL SCI, V12, P1, DOI 10.1111/j.1748-7692.1996.tb00301.x; Stavros HCW, 2008, MAR POLLUT BULL, V56, P371, DOI 10.1016/j.marpolbul.2007.10.030; Stavros HCW, 2007, SCI TOTAL ENVIRON, V388, P300, DOI 10.1016/j.scitotenv.2007.07.030; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Taub DD, 2008, CELL IMMUNOL, V252, P1, DOI 10.1016/j.cellimm.2008.05.006; White ND, 2015, SCI TOTAL ENVIRON, V521, P79, DOI 10.1016/j.scitotenv.2015.03.078; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Zoeller RT, 2007, CRIT REV TOXICOL, V37, P11, DOI 10.1080/10408440601123446; [No title captured], DOI DOI 10.1111/J.1748-7692.TB00301.X.	67	32	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176202	10.1371/journal.pone.0176202	http://dx.doi.org/10.1371/journal.pone.0176202			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467830	gold, Green Published, Green Submitted			2022-12-26	WOS:000400647000044
J	Jiang, XJ; Zhang, J; Xiong, Y; Jahn, G; Xiong, HR; Yang, ZQ; Liu, YY				Jiang, Xiao-Jing; Zhang, Jun; Xiong, Yong; Jahn, Gerhard; Xiong, Hai-Rong; Yang, Zhan-Qiu; Liu, Yuan-Yuan			Human cytomegalovirus glycoprotein polymorphisms and increasing viral load in AIDS patients	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; N GN; GENOTYPE DISTRIBUTION; GENOMIC VARIANTS; DNA LOAD; CMV; GENES; GO; IDENTIFICATION; PREVALENCE	Background Multiple strains infection of human cytomegalovirus (HCMV) was found to be correlated with increased viral load in immunodeficient patients. However, the pathogenic mechanism underlying this correlation remains unclear. To evaluate genetic polymorphisms of HCMV glycoprotein and their potential role in its viral load, HCMV glycoprotein B, N, and O (gB, gN and gO) genotypes was studied in the population of HCMV infected acquired immune deficiency syndrome (AIDS) patients. The association between glycoprotein polymorphisms and HCMV viral load was analyzed. Methods The genetic polymorphisms of glycoprotein from sera of 60 HCMV infected AIDS patients was investigated by multiplex nested PCR and sequencing. HCMV viral load was evaluated by quantitative PCR. Results gB1, gO1a, and gN4a were the predominant glycoprotein genotypes in HCMV infected AIDS patients and composed 86.96%, 78.8%, and 49.2%, respectively. Only gN4a genotype infection significantly increased viral load (P = 0.048). 71% (43/60) of HCMV infected AIDS patients were found to carry multiple HCMV strains infection. A novel potential linkage of gO1a/gN4a was identified from multiple HCMV infected patients. It was the most frequent occurrence, accounted for 51.5% in 33 patients with gO and gN genotypes infection. Furthermore, the gO1a/gN4a linkage was correlated to an increased viral load (P = 0.20) Conclusion The gN4a correlates to higher level HCMV load in AIDS patients. Interestingly, a novel gO1a/gN4a linkage is identified from the patients with multiple HCMV strains infection and is also associated with an increased viral load. Therefore, the pathogenic mechanism underlying glycoprotein polymorphisms and interaction of variants should be analyzed further.	[Jiang, Xiao-Jing] Guangzhou Mil Command, Wuhan Gen Hosp, Dept Infect Dis, Wuhan, Hubei, Peoples R China; [Zhang, Jun] Ganzhou Peoples Hosp, Dept Emergency, Ganzhou, Jiangxi, Peoples R China; [Xiong, Yong] Wuhan Univ, Dept Infect Dis, Zhongnan Hosp, Wuhan, Hubei, Peoples R China; [Jahn, Gerhard] Univ Hosp Tubingen, Inst Med Virol & Epidemiol Viral Dis, Tubingen, Germany; [Xiong, Hai-Rong; Yang, Zhan-Qiu; Liu, Yuan-Yuan] Wuhan Univ, Inst Med Virol, Sch Basic Med Sci, Wuhan, Hubei, Peoples R China	Wuhan University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Wuhan University	Liu, YY (corresponding author), Wuhan Univ, Inst Med Virol, Sch Basic Med Sci, Wuhan, Hubei, Peoples R China.	00009082@whu.edu.cn	xiong, hai/GVT-7305-2022	xiong, yong/0000-0003-0678-4064	National Natural Science Foundation of China [81171586]; Natural Science Foundation of Hubei Province [2010CDB09205]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This work was supported by the National Natural Science Foundation of China (grant numbers: 81171586) and the Natural Science Foundation of Hubei Province (grant numbers: 2010CDB09205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arav-Boger R, 2002, J INFECT DIS, V186, P1057, DOI 10.1086/344238; Arcangeletti MC, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0428-8; Britt WJ, 1996, INTERVIROLOGY, V39, P401, DOI 10.1159/000150510; Burke HG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005227; Cha TA, 1996, J VIROL, V70, P78, DOI 10.1128/JVI.70.1.78-83.1996; Chern KC, 1998, J INFECT DIS, V178, P1149, DOI 10.1086/515672; CHOU SW, 1991, J INFECT DIS, V163, P1229, DOI 10.1093/infdis/163.6.1229; CHOU SW, 1992, J INFECT DIS, V166, P604, DOI 10.1093/infdis/166.3.604; Cicin-Sain L, 2005, J VIROL, V79, P9492, DOI 10.1128/JVI.79.15.9492-9502.2005; Correa C, 2016, J PERINATOL, V36, P837, DOI 10.1038/jp.2016.95; Cunha AA, 2011, REV INST MED TROP SP, V53, P83, DOI 10.1590/S0036-46652011000100005; DREW WL, 1984, J INFECT DIS, V150, P952, DOI 10.1093/infdis/150.6.952; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; Durier N, 2013, CLIN INFECT DIS, V57, P147, DOI 10.1093/cid/cit173; El Amari EB, 2011, HIV MED, V12, P394, DOI 10.1111/j.1468-1293.2010.00900.x; Gilbert C, 1999, J MED VIROL, V59, P98, DOI 10.1002/(SICI)1096-9071(199909)59:1&lt;98::AID-JMV16&gt;3.0.CO;2-A; GOMPELS UA, 1995, VIROLOGY, V209, P29, DOI 10.1006/viro.1995.1228; Hahn G, 2003, VIROLOGY, V307, P164, DOI 10.1016/S0042-6822(02)00061-2; Hamprecht K, 1998, J CLIN VIROL, V11, P125, DOI 10.1016/S1386-6532(98)00046-4; Huber MT, 1997, J VIROL, V71, P5391, DOI 10.1128/JVI.71.7.5391-5398.1997; Jiang XJ, 2008, J VIROL, V82, P2802, DOI 10.1128/JVI.01550-07; Kinzler ER, 2005, J VIROL, V79, P7827, DOI 10.1128/JVI.79.12.7827-7837.2005; Li L, 1997, J VIROL, V71, P3090, DOI 10.1128/JVI.71.4.3090-3097.1997; Lisboa LF, 2012, TRANSPL INFECT DIS, V14, P132, DOI 10.1111/j.1399-3062.2011.00685.x; Mattick C, 2004, VIROLOGY, V318, P582, DOI 10.1016/j.virol.2003.09.036; Micol R, 2009, JAIDS-J ACQ IMM DEF, V51, P486, DOI 10.1097/QAI.0b013e3181a254c2; Paterson DA, 2002, VIROLOGY, V293, P281, DOI 10.1006/viro.2001.1274; Pignatelli S, 2004, REV MED VIROL, V14, P383, DOI 10.1002/rmv.438; Pignatelli S, 2003, J CLIN VIROL, V28, P38, DOI 10.1016/S1386-6532(02)00236-6; Pignatelli S, 2003, AIDS, V17, P761, DOI 10.1097/00002030-200303280-00018; Pignatelli S, 2003, J GEN VIROL, V84, P647, DOI 10.1099/vir.0.18704-0; Pignatelli S, 2001, J GEN VIROL, V82, P2777, DOI 10.1099/0022-1317-82-11-2777; Pignatelli S, 2010, NEW MICROBIOL, V33, P257; Pignatelli S, 2010, CLIN INFECT DIS, V51, P33, DOI 10.1086/653423; Prichard MN, 2001, REV MED VIROL, V11, P191, DOI 10.1002/rmv.315; Rasmussen L, 2002, J VIROL, V76, P10841, DOI 10.1128/JVI.76.21.10841-10848.2002; Rasmussen L, 1999, Transpl Infect Dis, V1, P127, DOI 10.1034/j.1399-3062.1999.010206.x; Rossini G, 2005, MICROBES INFECT, V7, P890, DOI 10.1016/j.micinf.2005.01.016; Shepp DH, 1996, J INFECT DIS, V174, P184, DOI 10.1093/infdis/174.1.184; Shepp DH, 1998, RES VIROLOGY, V149, P109, DOI 10.1016/S0923-2516(98)80086-1; Sowmya P, 2009, J MED VIROL, V81, P861, DOI 10.1002/jmv.21459; Spector SA, 1998, J CLIN INVEST, V101, P497, DOI 10.1172/JCI1101; Stanton R, 2005, J MED VIROL, V75, P42, DOI 10.1002/jmv.20235; Tarrago D, 2003, J CLIN MICROBIOL, V41, P2872, DOI 10.1128/JCM.41.7.2872-2877.2003; Trincado DE, 2000, J MED VIROL, V61, P481, DOI 10.1002/1096-9071(200008)61:4&lt;481::AID-JMV11&gt;3.0.CO;2-H; Vogel JU, 2013, MED MICROBIOL IMMUN, V202, P37, DOI 10.1007/s00430-012-0244-3; Xia CS, 2011, ARCH VIROL, V156, P17, DOI 10.1007/s00705-010-0811-0; Yan HN, 2008, J GEN VIROL, V89, P2275, DOI 10.1099/vir.0.83685-0; Zhang J, 2015, MED SCI MONITOR, V21, P4102, DOI 10.12659/MSM.896071; Zhou MM, 2015, J VIROL, V89, P8999, DOI 10.1128/JVI.01325-15	50	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176160	10.1371/journal.pone.0176160	http://dx.doi.org/10.1371/journal.pone.0176160			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467444	gold, Green Submitted, Green Published			2022-12-26	WOS:000400647000040
J	Lee, SB; Lee, CH; Kim, YJ; Kim, HM				Lee, Sun Bin; Lee, Chang Ho; Kim, Young Ju; Kim, Hyoung-Mi			Biochemical markers of bone turnover in benign paroxysmal positional vertigo	PLOS ONE			English	Article							OSTEOPOROSIS; OTOCONIA; WOMEN; FEATURES; DENSITY	Objective Several studies have suggested a possible relationship between recurrent benign paroxysmal positional vertigo (BPPV) and altered calcium homeostasis in the endolymph of the inner ear. The present study aimed to evaluate the association between Ca2+ and vitamin D status and BPPV occurrence as well as the status of bone biochemical markers in osteoporotic patients who were diagnosed with idiopathic BPPV. Methods The study included total 132 patients who were referred to our clinic between August 2008 and October 2013. Based on the bone mineral density (BMD) results, the subjects were divided into three groups: normal BMD (n = 34), osteopenia (n = 40) and osteoporosis (n = 58). The biochemical markers of bone turnover including serum Carboxy-terminal telopeptide of type I collagen (s-CTX), osteocalcin, alkaline phosphatase (ALP) and urinary free deoxypyridinoline (u-DPD), were analyzed, along with the serum Ca2+ and vitamin D levels. Results The mean serum calcium, phosphate and creatinine clearance levels were within the standard laboratory reference range. The incidence of vitamin D deficiency was 11.8% (4/34) in the normal BMD group, 15% (6/40) in the osteopenia group and 43.1% (25/58) in the osteoporosis group. There was a positive correlation between the 25(OH) D and BMD results in the patients with BPPV. Among the bone turnover markers, the osteocalcin and u-DPD levels were significantly elevated in the osteoporotic patients with BPPV. Multiple logistic regression analyses showed that osteoporosis and vitamin D deficiency were associated with BPPV. Conclusion Our findings suggest that the prevalence of BPPV in osteoporotic patients is associated with vitamin D deficiency and high bone turnover rates at systemic level, which could disturb local Ca2+ homeostasis in the inner ear.	[Lee, Sun Bin; Lee, Chang Ho; Kim, Young Ju; Kim, Hyoung-Mi] CHA Univ, Dept Otorhinolaryngol, Seongnam, South Korea	Pochon Cha University	Kim, HM (corresponding author), CHA Univ, Dept Otorhinolaryngol, Seongnam, South Korea.	hyoungkim@cha.ac.kr						BALOH RW, 1987, NEUROLOGY, V37, P371, DOI 10.1212/WNL.37.3.371; Buki B, 2013, MED HYPOTHESES, V80, P201, DOI 10.1016/j.mehy.2012.11.029; Burch J, 2014, HEALTH TECHNOL ASSES, P18; Carmel AS, 2012, OSTEOPOROSIS INT, V23, P2479, DOI 10.1007/s00198-011-1868-7; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Compston J, 2009, BEST PRACT RES CL RH, V23, P781, DOI 10.1016/j.berh.2009.09.007; Dong Hui, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P1564; Eknoyan G, 2003, AM J KIDNEY DIS, V41, pS1, DOI 10.1016/S0272-6386(03)00111-2; Emaus N, 2009, EUR J EPIDEMIOL, V24, P321, DOI 10.1007/s10654-009-9333-z; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hughes I, 2006, BRAIN RES, V1091, P58, DOI 10.1016/j.brainres.2006.01.074; Jang YS, 2006, LARYNGOSCOPE, V116, P996, DOI 10.1097/01.mlg.0000217238.84401.03; Jang YS, 2009, OTOL NEUROTOL, V30, P95, DOI 10.1097/MAO.0b013e31818f5777; Jeong SH, 2009, NEUROLOGY, V72, P1069, DOI 10.1212/01.wnl.0000345016.33983.e0; Jeong SH, 2013, J NEUROL, V260, P832, DOI 10.1007/s00415-012-6712-2; KAWAMATA S, 1995, ANAT RECORD, V242, P259, DOI 10.1002/ar.1092420216; Kim JS, 2014, NEW ENGL J MED, V370, P1138, DOI 10.1056/NEJMcp1309481; Lee Jongseok, 2013, [Journal of Korean Official Statistics, 통계연구], V18, P42; Mikulec AA, 2010, J LARYNGOL OTOL, V25, P1; Minasyan A, 2009, J STEROID BIOCHEM, V114, P161, DOI 10.1016/j.jsbmb.2009.01.020; Oghalai JS, 2000, OTOLARYNG HEAD NECK, V122, P630, DOI 10.1016/S0194-5998(00)70187-2; Parham K, 2013, LARYNGOSCOPE, V123, P2834, DOI 10.1002/lary.24162; Parnes LS, 2003, CAN MED ASSOC J, V169, P681; Ravn P, 1996, BONE, V19, P291, DOI 10.1016/8756-3282(96)00201-3; Ross M D, 1979, Physiologist, V22, pS63; ROSS MD, 1976, ANN OTO RHINOL LARYN, V85, P310, DOI 10.1177/000348947608500302; Shin CS, 2010, BONE, V47, P378, DOI 10.1016/j.bone.2010.03.017; Takumida M, 1997, ACTA OTO-LARYNGOL, V117, P538, DOI 10.3109/00016489709113434; Takumida Masaya, 1997, Auris Nasus Larynx, V24, P119, DOI 10.1016/S0385-8146(96)00017-X; Tenenhouse A, 2000, OSTEOPOROSIS INT, V11, P897, DOI 10.1007/s001980070050; Vibert D, 2003, ANN OTO RHINOL LARYN, V112, P885, DOI 10.1177/000348940311201010; Vibert D, 2008, AUDIOL NEURO-OTOL, V13, P293, DOI 10.1159/000124277; von Brevern M, 2007, J NEUROL NEUROSUR PS, V78, P710, DOI 10.1136/jnnp.2006.100420; Walther LE, 2007, J VESTIBUL RES-EQUIL, V17, P89; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; Yamanaka T, 2013, LARYNGOSCOPE, V123, P2813, DOI 10.1002/lary.24099; Zucca G, 1998, J VESTIBUL RES-EQUIL, V8, P325	37	14	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176011	10.1371/journal.pone.0176011	http://dx.doi.org/10.1371/journal.pone.0176011			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467451	Green Submitted, Green Published, gold			2022-12-26	WOS:000400647000031
J	Rana, A; Jain, S; Puri, N; Kaw, M; Sirianni, N; Eren, D; Mopidevi, BR; Kumar, A				Rana, Anita; Jain, Sudhir; Puri, Nitin; Kaw, Meenakshi; Sirianni, Natalie; Eren, Deniz; Mopidevi, Brahma Raju; Kumar, Ashok			The transcriptional regulation of the human angiotensinogen gene after high-fat diet is haplotype-dependent: Novel insights into the gene-regulatory networks and implications for human hypertension	PLOS ONE			English	Article							BLOOD-PRESSURE REGULATION; GLUCOCORTICOID-RECEPTOR; TRANSGENIC MICE; INDUCED OBESITY; C/EBP-BETA; INSULIN-RESISTANCE; INFLAMMATION; LIVER; POLYMORPHISMS; EXPRESSION	Single nucleotide polymorphisms (SNPs) in the human angiotensinogen (hAGT) gene may modulate its transcription and affect the regulation of blood pressure via activation of the renin-angiotensin aldosterone system (RAAS). In this regard, we have identified polymorphisms in the 2.5 Kb promoter of the hAGT gene that form two haplotype (Hap) blocks: -6A/G (-1670A/G, -1562C/T, -1561T/C) and -217A/G (-532T/C, -793A/G, -1074T/C & -1178G/A). hAGT gene with Hap -6A/-217A (Hap I) is associated with increased blood pressure whereas, Hap -6G/-217G (Hap II) is associated with normal blood pressure in human subjects. Since RAAS over activity contributes to hypertension in obesity, we have made transgenic mice (TG) containing either Hap I or Hap II of the hAGT gene to understand the role of obesity on its transcriptional regulation. Although, a high-fat diet (60% Kcal from fat, 12 weeks) elevates hAGT and mAGT regardless of haplotype, this effect is significantly (p<0.05) accentuated in Hap I mice, in both adipose and liver tissues. Chromatin Immunoprecipitation (ChIP) assay shows an increased binding of transcription factors including, GR, CEBP beta and STAT3 to the chromatin of the Hap I TG mice after high-fat diet as compared to Hap II TG mice (p<0.05). Differential plasma levels of hAGT in Hap II and I mice, after high-fat diet, further corroborate the variable transcriptional regulation of the hAGT, governed by gene-haplotypes. Taken together, our results show that SNPs in the Hap-I of the hAGT gene promote high-fat diet-induced binding of transcription factors GR, CEBP-beta and STAT3, which lead to elevated expression of the hAGT gene in hepatic and adipose tissues.	[Rana, Anita; Jain, Sudhir; Puri, Nitin; Kaw, Meenakshi; Sirianni, Natalie; Eren, Deniz; Mopidevi, Brahma Raju; Kumar, Ashok] Univ Toledo, Med Ctr, Dept Physiol & Pharmacol, 2801 W Bancroft St, Toledo, OH 43606 USA; [Kumar, Ashok] New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA	University System of Ohio; University of Toledo; New York Medical College	Kumar, A (corresponding author), Univ Toledo, Med Ctr, Dept Physiol & Pharmacol, 2801 W Bancroft St, Toledo, OH 43606 USA.; Kumar, A (corresponding author), New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA.	akumar5@nymc.edu	Mopidevi, Brahmaraju/D-6003-2015	Mopidevi, Brahmaraju/0000-0003-1231-7796; rana, anita/0000-0002-5898-3084	National Institutes of Health [HL81752, HL105113, HL092558]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130344] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health grants HL81752, HL105113, and HL092558 (to A.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAM T, 1993, J BIOL CHEM, V268, P15681; BAUMANN H, 1992, J BIOL CHEM, V267, P19744; Bohlender J, 2000, HYPERTENSION, V35, P780, DOI 10.1161/01.HYP.35.3.780; Boustany CM, 2005, AM J PHYSIOL-REG I, V289, pR181, DOI 10.1152/ajpregu.00507.2004; Boustany CM, 2004, AM J PHYSIOL-REG I, V287, pR943, DOI 10.1152/ajpregu.00265.2004; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Choy MK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-519; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Dobrian AD, 2000, HYPERTENSION, V35, P1009, DOI 10.1161/01.HYP.35.4.1009; FRIEDMAN AD, 1989, GENE DEV, V3, P1314, DOI 10.1101/gad.3.9.1314; Friese RS, 2005, AM J HYPERTENS, V18, P633, DOI 10.1016/j.amjhyper.2004.11.037; GARDES J, 1982, HYPERTENSION, V4, P185, DOI 10.1161/01.HYP.4.2.185; Gotoh T, 1997, J BIOL CHEM, V272, P3694, DOI 10.1074/jbc.272.6.3694; Grontved L, 2013, EMBO J, V32, P1568, DOI 10.1038/emboj.2013.106; Gupte M, 2008, AM J PHYSIOL-REG I, V295, pR781, DOI 10.1152/ajpregu.00183.2008; Hottenga JJ, 2005, TWIN RES HUM GENET, V8, P499, DOI 10.1375/183242705774310123; Jain S, 2005, J MOL MED, V83, P121, DOI 10.1007/s00109-004-0621-5; Jain S, 2010, J BIOL CHEM, V285, P41172, DOI 10.1074/jbc.M110.167585; Jain S, 2008, AM J PHYSIOL-REG I, V295, pR1849, DOI 10.1152/ajpregu.90637.2008; Jenkins LD, 2008, REPROD SCI, V15, P696, DOI 10.1177/1933719108316984; Kalupahana NS, 2011, ADV NUTR, V2, P304, DOI 10.3945/an.111.000505; Kalupahana NS, 2012, OBESITY, V20, P48, DOI 10.1038/oby.2011.299; KIM HS, 1995, P NATL ACAD SCI USA, V92, P2735, DOI 10.1073/pnas.92.7.2735; KIMURA S, 1992, EMBO J, V11, P821, DOI 10.1002/j.1460-2075.1992.tb05119.x; Kitada K, 2014, HYPERTENS RES, V37, P393, DOI 10.1038/hr.2014.54; Kobori H, 2013, PFLUG ARCH EUR J PHY, V465, P3, DOI 10.1007/s00424-012-1143-6; Kupper N, 2005, HYPERTENSION, V45, P80, DOI 10.1161/01.HYP.0000149952.84391.54; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; Leu JI, 2001, MOL CELL BIOL, V21, P414, DOI 10.1128/MCB.21.2.414-424.2001; Markovic D, 2005, HUM HERED, V60, P89, DOI 10.1159/000088657; Massiera F, 2001, FASEB J, V15, P2727, DOI 10.1096/fj.01-0457fje; Matsuno F, 1996, J BIOCHEM-TOKYO, V119, P524; MENARD J, 1991, HYPERTENSION, V18, P705, DOI 10.1161/01.HYP.18.5.705; Pandey VG, 2015, J BIOL CHEM, V290, P5749, DOI 10.1074/jbc.M114.601922; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ray S, 2002, MOL ENDOCRINOL, V16, P824, DOI 10.1210/me.16.4.824; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sherman CT, 2001, MOL ENDOCRINOL, V15, P441, DOI 10.1210/me.15.3.441; Suh DS, 1997, MOL ENDOCRINOL, V11, P1822, DOI 10.1210/me.11.12.1822; TANIMOTO K, 1994, J BIOL CHEM, V269, P31334; von Lueder TG, 2013, CARDIOVASC DRUG THER, V27, P171, DOI 10.1007/s10557-012-6424-y; Watkins WS, 2010, J HYPERTENS, V28, P65, DOI 10.1097/HJH.0b013e328332031a; Wilde DW, 2000, HYPERTENSION, V35, P832, DOI 10.1161/01.HYP.35.3.832; Yasue S, 2010, AM J HYPERTENS, V23, P425, DOI 10.1038/ajh.2009.263; Yiannikouris F, 2012, HYPERTENSION, V60, P1524, DOI 10.1161/HYPERTENSIONAHA.112.192690; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	49	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176373	10.1371/journal.pone.0176373	http://dx.doi.org/10.1371/journal.pone.0176373			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467442	Green Published, Green Submitted, gold			2022-12-26	WOS:000400647000049
J	Sekiya, N; Kuroda, Y; Nakajima, K; Iwamitsu, Y; Kanai, Y; Miyashita, M; Kotani, M; Kitazawa, Y; Yamashita, H; Nakagawa, K				Sekiya, Noriyasu; Kuroda, Yujiro; Nakajima, Kasumi; Iwamitsu, Yumi; Kanai, Yoshiaki; Miyashita, Mitsunori; Kotani, Midori; Kitazawa, Yutaka; Yamashita, Hideomi; Nakagawa, Keiichi			Views on life and death of physicians, nurses, cancer patients and general population in Japan	PLOS ONE			English	Article							TERROR MANAGEMENT; CARE; DECISIONS; ATTITUDES	This study aimed to investigate views on life and death among physicians, nurses, cancer patients, and the general population in Japan and examine factors affecting these views. We targeted 3,140 physicians, 470 nurses, 450 cancer patients, and 3,000 individuals from the general population. We used the Death Attitudes Inventory (DAI) to measure attitudes toward life and death. The collection rates were 35% (1,093/3,140), 78% (366/470), 69% (310/450), and 39% (1,180/3,000) for physicians, nurses, patients, and the general population, respectively. We found that age, sex, social role (i.e., physician, nurse, cancer patient, and general population) were significantly correlated with DAI subscales. Compared with general population, attitudes toward death of physicians, nurses and cancer patients differed significantly even after adjusted their age and sex. Our study is the first to analyze differences in views on life and death among physicians, nurses, cancer patients, and the general population in Japan.	[Sekiya, Noriyasu; Yamashita, Hideomi; Nakagawa, Keiichi] Univ Tokyo Hosp, Dept Radiol, Tokyo, Japan; [Kuroda, Yujiro] Fukushima Med Univ, Sch Med, Dept Publ Hlth, Fukushima, Japan; [Nakajima, Kasumi] Univ Tokyo Hlth Sci, Fac Hlth Sci, Tokyo, Japan; [Iwamitsu, Yumi] Kitasato Univ, Grad Sch Med Sci, Dept Med Psychol, Tokyo, Japan; [Kanai, Yoshiaki] Univ Tokyo Hosp, Dept Palliat Med, Tokyo, Japan; [Miyashita, Mitsunori] Tohoku Univ, Graduat Sch Med, Div Palliat Nursing, Hlth Sci, Sendai, Miyagi, Japan; [Kotani, Midori] Dai Ichi Life Res Inst Inc, Tokyo, Japan; [Kitazawa, Yutaka] Toyo Eiwa Univ, Tokyo, Japan	University of Tokyo; Fukushima Medical University; Kitasato University; University of Tokyo; Tohoku University	Sekiya, N (corresponding author), Univ Tokyo Hosp, Dept Radiol, Tokyo, Japan.	jbnsmdr@gmail.com	Kuroda, Yujiro/T-3302-2019; Miyashita, Mitsunori/T-8327-2019; Nakajima, Kasumi/AAE-2080-2021; Kuroda, Yujiro/Q-4185-2019	Miyashita, Mitsunori/0000-0002-7637-0409; Kuroda, Yujiro/0000-0003-0587-5423	Global CUE Program of The University of Tokyo "development and organization of thanatology"; Dai-ichi Life Research Institute Inc.	Global CUE Program of The University of Tokyo "development and organization of thanatology"; Dai-ichi Life Research Institute Inc.	This study is conducted under the financial support of Global CUE Program of The University of Tokyo "development and organization of thanatology". Dai-ichi Life Research Institute Inc. provided support in the form of salary for author MK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are articulated in the 'author contributions' section.	Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Bulow HH, 2008, INTENS CARE MED, V34, P423, DOI 10.1007/s00134-007-0973-8; Fortner BV, 1999, DEATH STUD, V23, P387, DOI 10.1080/074811899200920; Heine SJ, 2002, ASIAN J SOC PSYCHOL, V5, P187, DOI 10.1111/1467-839X.00103; Hirai K., 2000, JAPANESE J CLIN RES, V23, P71; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; Joanes DN, 1998, J ROY STAT SOC D-STA, V47, P183; Kuroda Y, 2015, PALLIAT SUPPORT CARE, V13, P969, DOI 10.1017/S147895151400056X; Matsumura S, 2002, J GEN INTERN MED, V17, P531, DOI 10.1046/j.1525-1497.2002.10734.x; Powe BD, 2003, CANCER NURS, V26, P454; Pyszczynski T, 2015, ADV EXP SOC PSYCHOL, V52, P1, DOI 10.1016/bs.aesp.2015.03.001; Seymour JE, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4860; Sprung CL, 2007, INTENS CARE MED, V33, P1732, DOI 10.1007/s00134-007-0693-0; Wakimoto R, 2006, ASIAN J SOC PSYCHOL, V9, P176, DOI 10.1111/j.1467-839X.2006.00194.x; Yaguchi A, 2005, ARCH INTERN MED, V165, P1970, DOI 10.1001/archinte.165.17.1970	15	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176648	10.1371/journal.pone.0176648	http://dx.doi.org/10.1371/journal.pone.0176648			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SB	28467469	Green Published, gold, Green Submitted			2022-12-26	WOS:000400647000064
J	Wu, QH; Zhang, SX; Zhu, P; Huang, SM; Wang, BR; Zhao, LP; Xu, MG				Wu, Qihua; Zhang, Shuxiang; Zhu, Ping; Huang, Shaomin; Wang, Boren; Zhao, LinPing; Xu, Minggang			Characterizing differences in the phosphorus activation coefficient of three typical cropland soils and the influencing factors under long-term fertilization	PLOS ONE			English	Article							ORGANIC-MATTER; FRACTIONS; TRANSFORMATIONS; MANAGEMENT; PHOSPHATE; MANURE; WATER; EXTRACTION; CARBON; POOLS	The phosphorus activation coefficient (PAC, the ratio of available P to total P) is an important indicator of soil P availability and the transformation of P fractions. Understanding the details of the PAC is useful to estimate soil available P status and to provide P management guidance. In this research, soils from five long-term (23 years) fertilization treatments in three croplands were selected to examine the relationships between the PAC and P fractions and to analyse the influencing factors. PAC was affected by both soil types and fertilization treatments. Compared to the unfertilized control (CK) treatment, long-term P application significantly increased the PAC, all of the inorganic P (Pi) fractions and most of the organic P (Po) fractions in all the three soils, particularly in chemical fertilizer combined with manure treatment (NPKM). The PAC was significantly correlated to all of the Pi fractions proportions (P<0.05) except for Dil. HCl-Pi and Conc. HCl-Pi. Compared with CK, the chemical P and chemical P combined with manure treatments increased the ratio of total Pi fractions to total Po fractions (P-it/P-ot); furthermore, NPKM significantly increased the organic C (C-o) content and decreased the C-o/P-ot ratio. Stepwise multiple regressions showed that PAC = 0.93 C-o+0.69 P-it/P-ot-0.07 C-o/P-ot-0.27CaCO(3)-3.79 (R-2 = 0.924, P<0.001). In addition, the variance partitioning analysis showed that more variance of PAC is explained by soil factors (29.53%) than by P input (0.19%) and climate (0.25%) factors. Our findings demonstrate that P application increased the PAC by changing the Co content and the proportion of P fractions. Moreover, soil factors were the most important drivers of P transformations, and NPKM was optimal for improving soil fertility in Chinese croplands.	[Wu, Qihua; Zhang, Shuxiang; Wang, Boren; Zhao, LinPing; Xu, Minggang] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Natl Engn Lab Improving Qual Arable Land, Beijing, Peoples R China; [Zhu, Ping] Jilin Acad Agr Sci, Ctr Agr Environm & Resources, Changchun, Peoples R China; [Huang, Shaomin] Henan Acad Agr Sci, Inst Plant Nutr Resources & Environm, Zhengzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Jilin Academy of Agricultural Sciences; Henan Academy of Agricultural Sciences	Zhang, SX (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Natl Engn Lab Improving Qual Arable Land, Beijing, Peoples R China.	zhangshuxiang@caas.cn			National Natural Science Foundation of China [41471249]; Special Fund for Agro-scientific Research in the Public Interest of China [201503120]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest of China	Funding was acquired by Dr. Shuxiang Zhang: The National Natural Science Foundation of China http//www.nsfc.gov.cn/ (41471249); The Special Fund for Agro-scientific Research in the Public Interest of China http://www.moa.gov.cn/ (201503120).	Blake L, 2000, NUTR CYCL AGROECOSYS, V56, P263, DOI 10.1023/A:1009841603931; Bunemann EK, 2004, SOIL SCI SOC AM J, V68, P1645, DOI 10.2136/sssaj2004.1645; Canellas LP, 2010, EUR J SOIL SCI, V61, P375, DOI 10.1111/j.1365-2389.2010.01229.x; Celi L, 2013, PLANT SOIL, V367, P121, DOI 10.1007/s11104-013-1627-y; Chen BL, 2009, J XINJIANG AGR U, V4, P32; Condron LM, 2011, J SOIL SEDIMENT, V11, P830, DOI 10.1007/s11368-011-0363-2; Crews TE, 2014, AGR ECOSYST ENVIRON, V184, P168, DOI 10.1016/j.agee.2013.11.022; De Schrijver A, 2012, OECOLOGIA, V169, P221, DOI 10.1007/s00442-011-2185-8; do Nascimento CAC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17967; Dobermann A, 2002, SOIL SCI SOC AM J, V66, P652, DOI 10.2136/sssaj2002.0652; FROELICH PN, 1988, LIMNOL OCEANOGR, V33, P649, DOI 10.4319/lo.1988.33.4_part_2.0649; Gama-Rodrigues AC, 2014, BIOGEOCHEMISTRY, V118, P453, DOI 10.1007/s10533-013-9946-x; Hansen JC, 2004, J ENVIRON QUAL, V33, P1521, DOI 10.2134/jeq2004.1521; He YT, 2015, SCI TOTAL ENVIRON, V532, P635, DOI 10.1016/j.scitotenv.2015.06.011; HEDLEY MJ, 1982, NEW PHYTOL, V91, P45, DOI 10.1111/j.1469-8137.1982.tb03291.x; Hinsinger P, 2001, PLANT SOIL, V237, P173, DOI 10.1023/A:1013351617532; HOLFORD ICR, 1975, J SOIL SCI, V26, P407, DOI 10.1111/j.1365-2389.1975.tb01964.x; Li M, 2013, APPL GEOCHEM, V33, P213, DOI 10.1016/j.apgeochem.2013.02.014; Liang F, 2016, SCI REP-UK, V6, DOI 10.1038/srep30350; Lu R.K, 2000, ANAL METHOD SOIL AGR; McDowell RW, 2012, NEW ZEAL J AGR RES, V55, P119, DOI 10.1080/00288233.2012.662899; McDowell RW, 2006, GEODERMA, V130, P176, DOI 10.1016/j.geoderma.2005.01.020; Negassa W, 2009, J PLANT NUTR SOIL SC, V172, P305, DOI 10.1002/jpln.200800223; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Pagliari PH, 2013, BIOL FERT SOILS, V49, P987, DOI 10.1007/s00374-013-0798-2; Pagliari PH, 2015, SOIL SCI SOC AM J, V78, P1301; Sharpley A, 2000, J ENVIRON QUAL, V29, P1, DOI 10.2134/jeq2000.00472425002900010001x; SHARPLEY AN, 1985, SOIL SCI SOC AM J, V49, P905, DOI 10.2136/sssaj1985.03615995004900040023x; Shen J, 2004, FIELD CROP RES, V86, P225, DOI 10.1016/j.fcr.2003.08.013; Shen P, 2014, CATENA, V118, P20, DOI 10.1016/j.catena.2014.01.020; Shenker M, 2005, EUR J SOIL SCI, V56, P515, DOI 10.1111/j.1365-2389.2004.00692.x; Song C, 2011, SOIL RES, V49, P253, DOI 10.1071/SR10169; Thomas G. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P475; TIESSEN H, 1984, SOIL SCI SOC AM J, V48, P853, DOI 10.2136/sssaj1984.03615995004800040031x; Tiessen H., 1993, SOIL SAMPLING METHOD, P75, DOI [10.1201/9781420005271.ch25, DOI 10.1201/9781420005271.CH25]; Turner BL, 2007, ECOSYSTEMS, V10, P1166, DOI 10.1007/s10021-007-9086-z; Turner BL, 2003, SOIL SCI SOC AM J, V67, P1168, DOI 10.2136/sssaj2003.1168; Vu DT, 2008, PLANT SOIL, V304, P21, DOI 10.1007/s11104-007-9516-x; Vu DT, 2010, J SOIL SEDIMENT, V10, P18, DOI 10.1007/s11368-009-0068-y; Waldrip HM, 2011, BIOL FERT SOILS, V47, P407, DOI 10.1007/s00374-011-0546-4; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wang BaiRen, 2002, Journal of Hunan Agricultural University, V28, P293; Wang GP, 2006, GEODERMA, V132, P59, DOI 10.1016/j.geoderma.2005.04.021; [王军静 Wang Junjing], 2014, [湿地科学, Wetland Science], V12, P690; Wang Y, 2014, AGRON J, V106, P69; Xiao R, 2012, CATENA, V98, P96, DOI 10.1016/j.catena.2012.06.008	46	24	26	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176437	10.1371/journal.pone.0176437	http://dx.doi.org/10.1371/journal.pone.0176437			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467425	Green Submitted, gold, Green Published			2022-12-26	WOS:000400647000053
J	Kakkar, M; Chaturvedi, S; Saxena, VK; Dhole, TN; Kumar, A; Rogawski, ET; Abbas, S; Venkataramanan, VV; Chatterjee, P				Kakkar, Manish; Chaturvedi, Sanjay; Saxena, Vijay Kumar; Dhole, Tapan N.; Kumar, Ashok; Rogawski, Elizabeth T.; Abbas, Syed; Venkataramanan, Vidya V.; Chatterjee, Pranab			Identifying sources, pathways and risk drivers in ecosystems of Japanese Encephalitis in an epidemic-prone north Indian district	PLOS ONE			English	Article							IMPACT; VIRUS; TRANSMISSION; AREA; PIGS; DIAGNOSIS; ECOLOGY; MALARIA	Japanese Encephalitis (JE) has caused repeated outbreaks in endemic pockets of India. This study was conducted in Kushinagar, a highly endemic district, to understand the human-animal-ecosystem interactions, and the drivers that influence disease transmission. Utilizing the ecosystems approach, a cross-sectional, descriptive study, employing mixed methods design was employed. Four villages (two with pig-rearing and two without) were randomly selected from a high, a medium and a low burden (based on case counts) block of Kushinagar. Children, pigs and vectors were sampled from these villages. A qualitative arm was incorporated to explain the findings from the quantitative surveys. All human serum samples were screened for JE-specific IgM using MAC ELISA and negative samples for JE RNA by rRT-PCR in peripheral blood mononuclear cells. In pigs, IgG ELISA and rRT-PCR for viral RNA were used. Of the 242 children tested, 24 tested positive by either rRT-PCR or MAC ELISA; in pigs, 38 out of the 51 pigs were positive. Of the known vectors, Culex vishnui was most commonly isolated across all biotopes. Analysis of 15 blood meals revealed human blood in 10 samples. Univariable analysis showed that gender, religion, lack of indoor residual spraying of insecticides in the past year, indoor vector density (all species), and not being vaccinated against JE in children were significantly associated with JE positivity. In multivariate analysis, only male gender remained as a significant risk factor. Based on previous estimates of symptomatic: asymptomatic cases of JE, we estimate that there should have been 618 cases from Kushinagar, although only 139 were reported. Vaccination of children and vector control measures emerged as major control activities; they had very poor coverage in the studied villages. In addition, lack of awareness about the cause of JE, lack of faith in the conventional medical healthcare system and multiple referral levels causing delay in diagnosis and treatment emerged as factors likely to result in adverse clinical outcomes.	[Kakkar, Manish; Saxena, Vijay Kumar; Rogawski, Elizabeth T.; Abbas, Syed; Venkataramanan, Vidya V.; Chatterjee, Pranab] Publ Hlth Fdn India, Gurgaon, Haryana, India; [Chaturvedi, Sanjay] Univ Coll Med Sci, Dept Community Med, Delhi, India; [Dhole, Tapan N.] Sanjay Gandhi Post Grad Inst Med Sci, Dept Microbiol, Lucknow, Uttar Pradesh, India; [Kumar, Ashok] Indian Vet Res Inst, Dept Vet Publ Hlth, Izatnagar, Uttar Pradesh, India	Public Health Foundation of India; University of Delhi; University College of Medical Sciences; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute	Kakkar, M (corresponding author), Publ Hlth Fdn India, Gurgaon, Haryana, India.	manish.kakkar@phfi.org	Abbas, Syed Shahid/A-4806-2012; Chatterjee, Pranab/P-6272-2017	Abbas, Syed Shahid/0000-0003-1964-5303; Chatterjee, Pranab/0000-0001-6443-608X; Venkataramanan, Vidya/0000-0002-4986-4884	International Development Research Centre Grant (IDRC) [105509-037]	International Development Research Centre Grant (IDRC)	The study was supported by an International Development Research Centre Grant (IDRC Project Number: 105509-037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135767; [Anonymous], 2006, GUID SURV AC ENC SYN; avanini P, 2012, JAPANESE ENCEPHALITI, V17, P1, DOI DOI 10.2807/ese.17.28.20221-en; Baruah H C, 2002, Indian Pediatr, V39, P1143; Bi P, 2007, J INFECTION, V55, P551, DOI 10.1016/j.jinf.2007.07.004; BRYAN JH, 1992, J AM MOSQUITO CONTR, V8, P398; Burniston S, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/2049-9957-4-11; CAREY DE, 1968, INDIAN J MED RES, V56, P1319; Chaturvedi S, 2014, LTD UNDERSTANDING PE, P207; Das BP., 2013, MOSQUITO VECTORS JAP, P43; de Wispelaere M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005294; Dhillon G P S, 2008, J Indian Med Assoc, V106, P660; Dhiman RC, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00168; Dutta P, 2011, AM J TROP MED HYG, V84, P466, DOI 10.4269/ajtmh.2011.10-0270; Erlanger TE, 2009, PAST PRESENT FUTURE; GAJANANA A, 1995, B WORLD HEALTH ORGAN, V73, P237; GEEVARGHESE G, 1991, INDIAN J MED RES-A, V93, P140; Ghimire S., 2014, INT J APPL SCI BIOTE, V2, P311, DOI DOI 10.3126/IJASBT.V2I3.10639; Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437; Hobbs NT, 2006, ECOL APPL, V16, P5, DOI 10.1890/04-0645; Holt HR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0003913; Ijumba JN, 2001, MED VET ENTOMOL, V15, P1, DOI 10.1046/j.1365-2915.2001.00279.x; Impoinvil DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022192; JOHNSEN DO, 1974, AM J EPIDEMIOL, V100, P57, DOI 10.1093/oxfordjournals.aje.a112009; Kakkar M, 2016, INDIAN PEDIATR, V53, P33, DOI 10.1007/s13312-016-0785-4; Kakoti G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/152656; Kanojia PC, 2004, J MED ENTOMOL, V41, P994, DOI 10.1603/0022-2585-41.5.994; Kanojia PC, 2003, INDIAN J MED RES, V117, P104; Keiser J, 2005, ACTA TROP, V95, P40, DOI 10.1016/j.actatropica.2005.04.012; Khan SU, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003166; Kim H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116547; Kumari Roop, 2012, WHO South East Asia J Public Health, V1, P374, DOI 10.4103/2224-3151.207040; Luo D, 1995, Southeast Asian J Trop Med Public Health, V26, P694; Ministry of Health and Family Welfare Government of India, 2010, OP GUID JAP ENC VACC; Ministry of Health and Family Welfare (India) ORG Centre for Social Research United Nations Children's Fund., 2010, IND COV EV SURV 2009; Mwandawiro C, T R SOC TROP MED HYG, V94, P238; National Vector Borne Disease Control Program, 2015, NAT VECT BORN DIS CO; Ngonghala CN, 2014, J THEOR BIOL, V363, P247, DOI 10.1016/j.jtbi.2014.08.018; Panbio Diagnostics, 2008, PANB DIAGN, P6; PIEPER SJL, 1958, AM J TROP MED HYG, V7, P481, DOI 10.4269/ajtmh.1958.7.481; Ritchie SA, 2008, AUSTR EMERG INFECT D; Robertson C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066168; Robinson JS, 2010, AM J TROP MED HYG, V83, P1146, DOI 10.4269/ajtmh.2010.10-0212; Saul A, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-32; Saxena V, 2008, J BIOSCIENCES, V33, P505, DOI 10.1007/s12038-008-0069-9; Saxena V, 2009, T ROY SOC TROP MED H, V103, P403, DOI 10.1016/j.trstmh.2009.01.021; SHARMA S, 1991, CLIN EXP IMMUNOL, V85, P85, DOI 10.1111/j.1365-2249.1991.tb05687.x; Singh A, 2012, P NATL ACAD SCI IN B; Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263; Stewart T, 2001, FACTORS AFFECT SUCCE; Sugiyama T, 2011, J JAPANESE ASS INFEC, V32, P255; Swami R, 2008, SCAND J INFECT DIS, V40, P815, DOI 10.1080/00365540802227102; Tian HY, 2015, ENVIRON INT, V79, P17, DOI 10.1016/j.envint.2015.03.002; Tiroumourougane SV, 2002, POSTGRAD MED J, V78, P205, DOI 10.1136/pmj.78.918.205; WHO Division of Malaria and Other Parasitic Diseases, 1975, MAN PRACT ENT MAL 1; World Health Organization, 2006, GUID PREV CONTR JAP; Yamanaka A, 2010, JPN J INFECT DIS, V63, P58	57	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0175745	10.1371/journal.pone.0175745	http://dx.doi.org/10.1371/journal.pone.0175745			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28463989	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000400646300006
J	Sheng, M; Liu, PY; Mao, D; Ge, YL; Lu, HZ				Sheng, Min; Liu, Peiying; Mao, Deng; Ge, Yulin; Lu, Hanzhang			The impact of hyperoxia on brain activity: A resting-state and task-evoked electroencephalography (EEG) study	PLOS ONE			English	Article							NORMOBARIC HYPEROXIA; CARBON-DIOXIDE; OXYGEN-THERAPY; HYPOXIA; HYPERCAPNIA; CMRO2; BOLD; METABOLISM; ISCHEMIA; NEURONS	A better understanding of the effect of oxygen on brain electrophysiological activity may provide a more mechanistic insight into clinical studies that use oxygen treatment in pathological conditions, as well as in studies that use oxygen to calibrate functional magnetic resonance imaging (fMRI) signals. This study applied electroencephalography (EEG) in healthy subjects and investigated how high a concentration of oxygen in inhaled air (i.e., nor-mobaric hyperoxia) alters brain activity under resting-state and task-evoked conditions. Study 1 investigated its impact on resting EEG and revealed that hyperoxia suppressed alpha (8-13Hz) and beta (14-35Hz) band power (by 15.6 +/- 2.3% and 14.1 +/- 3.1%, respectively), but did not change the delta (1-3Hz),theta (4-7Hz), and gamma (36-75Hz) bands. Sham control experiments did not result in such changes. Study 2 reproduced these findings, and, furthermore, examined the effect of hyperoxia on visual stimulation event-related potentials (ERP). It was found that the main peaks of visual ERP, specifically N1 and P2, were both delayed during hyperoxia compared to normoxia (P = 0.04 and 0.02, respectively). In contrast, the amplitude of the peaks did not show a change. Our results suggest that hyperoxia has a pronounced effect on brain neural activity, for both resting-state and task-evoked potentials.	[Sheng, Min; Liu, Peiying; Mao, Deng; Lu, Hanzhang] Univ Texas Southwestern Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX USA; [Liu, Peiying; Mao, Deng; Lu, Hanzhang] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA; [Ge, Yulin] NYU, Dept Radiol, Langone Med Ctr, 560 1St Ave, New York, NY 10016 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University; New York University; NYU Langone Medical Center	Lu, HZ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX USA.	hanzhang.lu@jhu.edu		Ge, Yulin/0000-0002-2320-6031	National Institutes of Health [R01 NS067015, R01 MH084021, R01 AG042753, R01 AG047972, R21 NS095342]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was partly supported by National Institutes of Health grants R01 NS067015, (to H.L.), R01 MH084021 (to H.L.), R01 AG042753 (to H.L.), R01 AG047972 (to H.L.), R21 NS095342 (to H.L.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bickford PC, 1999, FREE RADICAL BIO MED, V26, P817, DOI 10.1016/S0891-5849(98)00260-3; Bloch Y, 2012, J CLIN PSYCHOPHARM, V32, P525, DOI 10.1097/JCP.0b013e31825d70b8; Bulte DP, 2012, NEUROIMAGE, V60, P582, DOI 10.1016/j.neuroimage.2011.12.017; Bulte DP, 2007, J CEREBR BLOOD F MET, V27, P69, DOI 10.1038/sj.jcbfm.9600319; Calvert JW, 2002, BRAIN RES, V951, P1, DOI 10.1016/S0006-8993(02)03094-9; Chiarelli PA, 2007, NEUROIMAGE, V37, P808, DOI 10.1016/j.neuroimage.2007.05.033; Croal PL, 2015, NEUROIMAGE, V105, P323, DOI 10.1016/j.neuroimage.2014.10.036; D'Agostino DP, 2007, J NEUROPHYSIOL, V98, P1030, DOI 10.1152/jn.01003.2006; Dean JB, 2004, J APPL PHYSIOL, V96, P784, DOI 10.1152/japplphysiol.00892.2003; Driver ID, 2016, J NEUROSCI, V36, P8541, DOI 10.1523/JNEUROSCI.4263-15.2016; Driver ID, 2016, P ISMRM 24 ANN M SIN, P762; Elraiyah T, 2016, J VASC SURG, V63, p46S, DOI 10.1016/j.jvs.2015.10.007; Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030; Ga BB, 2011, J ALZHEIMERS DIS, V27, P317, DOI 10.3233/JAD-2011-110308; Gauthier CJ, 2012, NEUROIMAGE, V60, P1212, DOI 10.1016/j.neuroimage.2011.12.056; Gill M, 2014, J APPL PHYSIOL, V117, P406, DOI 10.1152/japplphysiol.00995.2013; Kaskinoro K, 2010, EUR J ANAESTH, V27, P121, DOI 10.1097/00003643-201006121-00390; Kiesel A, 2008, PSYCHOPHYSIOLOGY, V45, P250, DOI 10.1111/j.1469-8986.2007.00618.x; KILOH LG, 1972, CLIN ELECTROENCEPHAL; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Levy SD, 2016, LANCET, V387, P1867, DOI 10.1016/S0140-6736(16)30245-8; Lopez-Calderon J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00213; Lu HZ, 2014, JOVE-J VIS EXP, DOI 10.3791/52306; Lu HZ, 2011, CEREB CORTEX, V21, P1426, DOI 10.1093/cercor/bhq224; Magnoni S, 2003, J NEUROSURG, V98, P952, DOI 10.3171/jns.2003.98.5.0952; Malle C, 2016, AEROSP MED HUM PERF, V87, P3, DOI 10.3357/AMHP.4335.2016; Richards EM, 2007, STROKE, V38, P1578, DOI 10.1161/STROKEAHA.106.473967; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Rosenbaum P, 2003, J CHILD NEUROL, V18, pS89, DOI 10.1177/0883073803018001S0101; Shadel GS, 2015, CELL, V163, P560, DOI 10.1016/j.cell.2015.10.001; SHIBATA M, 1991, BRAIN RES BULL, V26, P467, DOI 10.1016/0361-9230(91)90026-G; Shoja MM, 2008, LIFE SCI, V83, P381, DOI 10.1016/j.lfs.2008.07.007; Sicard KM, 2005, NEUROIMAGE, V25, P850, DOI 10.1016/j.neuroimage.2004.12.010; Singhal AB, 2007, STROKE, V38, P2851, DOI 10.1161/STROKEAHA.107.487280; Singhal AB, 2006, INT J STROKE, V1, P191, DOI 10.1111/j.1747-4949.2006.00058.x; SMITH DBD, 1974, ELECTROEN CLIN NEURO, V37, P393, DOI 10.1016/0013-4694(74)90114-X; Smith ZM, 2013, J APPL PHYSIOL, V114, P11, DOI 10.1152/japplphysiol.00703.2012; Wise RG, 2013, NEUROIMAGE, V83, P135, DOI 10.1016/j.neuroimage.2013.06.008; Xu F, 2012, J CEREBR BLOOD F MET, V32, P1909, DOI 10.1038/jcbfm.2012.93; Xu F, 2011, J CEREBR BLOOD F MET, V31, P58, DOI 10.1038/jcbfm.2010.153; Yezhuvath US, 2009, NMR BIOMED, V22, P779, DOI 10.1002/nbm.1392; Zuo L, 2015, ACTA PHYSIOL, V214, P329, DOI 10.1111/apha.12515	42	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176610	10.1371/journal.pone.0176610	http://dx.doi.org/10.1371/journal.pone.0176610			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28464001	gold, Green Published, Green Submitted			2022-12-26	WOS:000400646300038
J	Yu, SD; Wu, SB; Wang, L; Jiang, F; Xie, YQ; Li, LD				Yu, Shaode; Wu, Shibin; Wang, Lei; Jiang, Fan; Xie, Yaoqin; Li, Leida			A shallow convolutional neural network for blind image sharpness assessment	PLOS ONE			English	Article							NATURAL SCENE STATISTICS; QUALITY ASSESSMENT; BLUR ASSESSMENT; REPRESENTATION; INFORMATION; MAGNITUDE	Blind image quality assessment can be modeled as feature extraction followed by score prediction. It necessitates considerable expertise and efforts to handcraft features for optimal representation of perceptual image quality. This paper addresses blind image sharpness assessment by using a shallow convolutional neural network (CNN). The network takes single feature layer to unearth intrinsic features for image sharpness representation and utilizes multilayer perceptron (MLP) to rate image quality. Different from traditional methods, CNN integrates feature extraction and score prediction into an optimization procedure and retrieves features automatically from raw images. Moreover, its prediction performance can be enhanced by replacing MLP with general regression neural network (GRNN) and support vector regression (SVR). Experiments on Gaussian blur images from LIVE-II, CSIQ, TID2008 and TID2013 demonstrate that CNN features with SVR achieves the best overall performance, indicating high correlation with human subjective judgment.	[Yu, Shaode; Wu, Shibin; Wang, Lei; Xie, Yaoqin] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Guangdong, Peoples R China; [Yu, Shaode; Wu, Shibin] Univ Chinese Acad Sci, Shenzhen Coll Adv Technol, Shenzhen, Guangdong, Peoples R China; [Jiang, Fan] Kunming Univ Sci & Technol, Fac Informat Engn & Automat, Kunming, Yunnan, Peoples R China; [Li, Leida] China Univ Min & Technol, Sch Informat & Control Engn, Xuzhou, Jiangsu, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Kunming University of Science & Technology; China University of Mining & Technology	Xie, YQ (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Guangdong, Peoples R China.; Li, LD (corresponding author), China Univ Min & Technol, Sch Informat & Control Engn, Xuzhou, Jiangsu, Peoples R China.	yq.xie@siat.ac.cn; lileda@cumt.edu.cn	Wang, Lei/F-2792-2012; li, li/HII-4157-2022; Li, Li/AEM-3636-2022; Yu, Shaode/AAG-6548-2019	Wang, Lei/0000-0002-7033-9806; Yu, Shaode/0000-0002-3412-2159	National Natural Science Foundation of China [81501463, 61379143]; Natural Science Foundation of Guangdong Province [2014A030310360]; Major Project of Guangdong Province [20146010111008]; Qing Lan Project of Jiangsu Province; National 863 Programs of China [2015AA043203]; National Key Research Program of China [2016YFC0105102]; Guangdong Innovative Research Team Program [2011S013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Major Project of Guangdong Province; Qing Lan Project of Jiangsu Province; National 863 Programs of China(National High Technology Research and Development Program of China); National Key Research Program of China; Guangdong Innovative Research Team Program	This work is supported in part by grants from National Natural Science Foundation of China (Grant Nos. 81501463 and 61379143), Natural Science Foundation of Guangdong Province (Grant No. 2014A030310360), Major Project of Guangdong Province (Grant No. 20146010111008), the Qing Lan Project of Jiangsu Province, National 863 Programs of China (Grant No. 2015AA043203), National Key Research Program of China (Grant No. 2016YFC0105102) and Guangdong Innovative Research Team Program (Grant No. 2011S013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank reviewers for their valuable advices that has helped to improve the paper quality. Thanks are also given to researchers who share their codes for fair comparison. This work is supported in part by grants from National Natural Science Foundation of China (Grant Nos. 81501463 and 61379143), Natural Science Foundation of Guangdong Province (Grant No. 2014A030310360), Major Project of Guangdong Province (Grant No. 2014B010111008), Guangdong Innovative Research Team Program (Grant No. 2011S013), the Qing Lan Project of Jiangsu Province, National 863 Programs of China (Grant No. 2015AA043203) and National Key Research Program of China (Grant No. 2016YFC0105102).	Awad M, 2015, EFFICIENT LEARNING M, P67, DOI DOI 10.1007/978-1-4302-5990-9_4; Bahrami K, 2014, IEEE SIGNAL PROC LET, V21, P751, DOI 10.1109/LSP.2014.2314487; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen LM, 2016, PROCEEDINGS OF THE 2016 12TH WORLD CONGRESS ON INTELLIGENT CONTROL AND AUTOMATION (WCICA), P1377, DOI 10.1109/WCICA.2016.7578241; Chow LS, 2016, MAGN RESON IMAGING, V34, P820, DOI 10.1016/j.mri.2016.03.006; Ciancio A, 2011, IEEE T IMAGE PROCESS, V20, P64, DOI 10.1109/TIP.2010.2053549; Ferzli R, 2009, IEEE T IMAGE PROCESS, V18, P717, DOI 10.1109/TIP.2008.2011760; Gao F, 2015, IEEE T NEUR NET LEAR, V26, P2275, DOI 10.1109/TNNLS.2014.2377181; Gao XB, 2013, IEEE T NEUR NET LEAR, V24, P2013, DOI 10.1109/TNNLS.2013.2271356; Gu K, 2017, IEEE T IND ELECT; Gu K, 2016, IEEE T CYBERNETICS, V46, P284, DOI 10.1109/TCYB.2015.2401732; Gu K, 2015, IEEE T IMAGE PROCESS, V24, DOI 10.1109/TIP.2015.2439035; Gu K, 2015, IEEE T MULTIMEDIA, V17, P50, DOI 10.1109/TMM.2014.2373812; Hassen R, 2013, IEEE T IMAGE PROCESS, V22, P2798, DOI 10.1109/TIP.2013.2251643; Hou WL, 2015, IEEE MULTIMEDIA, V22, P46, DOI 10.1109/MMUL.2014.55; Hou WL, 2015, IEEE T NEUR NET LEAR, V26, P1275, DOI 10.1109/TNNLS.2014.2336852; Kang L, 2014, PROC CVPR IEEE, P1733, DOI 10.1109/CVPR.2014.224; Larson EC, 2010, J ELECTRON IMAGING, V19, DOI 10.1117/1.3267105; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Li J, 2016, SIGNAL IMAGE VIDEO P, V10, P609, DOI 10.1007/s11760-015-0784-2; Li LD, 2016, IEEE T CYBERNETICS, V46, P39, DOI 10.1109/TCYB.2015.2392129; Li LD, 2016, IEEE T MULTIMEDIA, V18, P1085, DOI 10.1109/TMM.2016.2545398; Li LD, 2016, NEUROCOMPUTING, V177, P572, DOI 10.1016/j.neucom.2015.11.063; Li LD, 2014, IEEE SIGNAL PROC LET, V21, P918, DOI 10.1109/LSP.2014.2320743; Li LD, 2014, IEEE SIGNAL PROC LET, V21, P122, DOI 10.1109/LSP.2013.2294333; Li YM, 2015, NEUROCOMPUTING, V154, P94, DOI 10.1016/j.neucom.2014.12.015; Lin WS, 2011, J VIS COMMUN IMAGE R, V22, P297, DOI 10.1016/j.jvcir.2011.01.005; Liu D, 2016, IEEE INT CONF MULTI; Lv YQ, 2015, IEEE IMAGE PROC, P2344, DOI 10.1109/ICIP.2015.7351221; Ma L, 2016, NEUROCOMPUTING, V215, P21, DOI 10.1016/j.neucom.2015.06.116; Manap RA, 2015, INFORM SCIENCES, V301, P141, DOI 10.1016/j.ins.2014.12.055; Mittal A, 2012, IEEE T IMAGE PROCESS, V21, P4695, DOI 10.1109/TIP.2012.2214050; Moorthy AK, 2011, IEEE T IMAGE PROCESS, V20, P3350, DOI 10.1109/TIP.2011.2147325; Narvekar ND, 2011, IEEE T IMAGE PROCESS, V20, P2678, DOI 10.1109/TIP.2011.2131660; Narwaria M, 2010, IEEE T NEURAL NETWOR, V21, P515, DOI 10.1109/TNN.2010.2040192; Oszust M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158333; Ponomarenko N., 2009, ADV MOD RADIOELECTRO, V10, P30; Ponomarenko N, 2015, SIGNAL PROCESS-IMAGE, V30, P57, DOI 10.1016/j.image.2014.10.009; Qian JS, 2014, DIGIT SIGNAL PROCESS, V33, P125, DOI 10.1016/j.dsp.2014.06.009; RUDERMAN DL, 1994, NETWORK-COMP NEURAL, V5, P517, DOI 10.1088/0954-898X/5/4/006; Saad MA, 2012, IEEE T IMAGE PROCESS, V21, P3339, DOI 10.1109/TIP.2012.2191563; Sang QB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108073; Sang QB, 2014, J VIS COMMUN IMAGE R, V25, P1625, DOI 10.1016/j.jvcir.2014.08.002; Sheikh HR, 2006, IEEE T IMAGE PROCESS, V15, P3440, DOI 10.1109/TIP.2006.881959; Solomon SG, 2007, NAT REV NEUROSCI, V8, P276, DOI 10.1038/nrn2094; Soundararajan R, 2012, IEEE T IMAGE PROCESS, V21, P517, DOI 10.1109/TIP.2011.2166082; SPECHT DF, 1991, IEEE T NEURAL NETWOR, V2, P568, DOI 10.1109/72.97934; van de Sande KEA, 2010, IEEE T PATTERN ANAL, V32, P1582, DOI 10.1109/TPAMI.2009.154; Virtanen T, 2015, IEEE T IMAGE PROCESS, V24, P390, DOI 10.1109/TIP.2014.2378061; Vu CT, 2012, IEEE T IMAGE PROCESS, V21, P934, DOI 10.1109/TIP.2011.2169974; Vu PV, 2012, IEEE SIGNAL PROC LET, V19, P423, DOI 10.1109/LSP.2012.2199980; Wang SG, 2017, IEEE T CYBERNETICS, V47, P232, DOI 10.1109/TCYB.2015.2512852; Wang X, 2015, NEUROCOMPUTING, V151, P683, DOI 10.1016/j.neucom.2014.05.090; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wang ZJ, 2011, IEEE SIGNAL PROC MAG, V28, P2, DOI 10.1109/MSP.2011.940297; Wu JJ, 2013, IEEE T MULTIMEDIA, V15, P1700, DOI 10.1109/TMM.2013.2266093; Wu QB, 2016, IEEE T CIRC SYST VID, V26, P425, DOI 10.1109/TCSVT.2015.2412773; Wu QB, 2015, IEEE IMAGE PROC, P339, DOI 10.1109/ICIP.2015.7350816; Wu QB, 2015, J VIS COMMUN IMAGE R, V32, P205, DOI 10.1016/j.jvcir.2015.08.009; Xue WF, 2014, IEEE T IMAGE PROCESS, V23, P4850, DOI 10.1109/TIP.2014.2355716; Yang Y, 2016, MULTIMED TOOLS APPL, V75, P12499, DOI 10.1007/s11042-014-2321-7; Yu SD, 2017, LECT NOTES COMPUT SC, V10116, P50, DOI 10.1007/978-3-319-54407-6_4; Yuan H, 2016, IEEE T BROADCAST, V62, P134, DOI 10.1109/TBC.2015.2492461; Zhang C, 2016, NEUROCOMPUTING, V173, P462, DOI 10.1016/j.neucom.2015.01.105; Zhang L, 2015, IEEE T IMAGE PROCESS, V24, DOI 10.1109/TIP.2015.2426416; Zhang L, 2011, IEEE T IMAGE PROCESS, V20, P2378, DOI 10.1109/TIP.2011.2109730; Zhou F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116312	68	28	28	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176632	10.1371/journal.pone.0176632	http://dx.doi.org/10.1371/journal.pone.0176632			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459832	Green Published, gold, Green Submitted			2022-12-26	WOS:000400645000040
J	Jeanniard-du-Dot, T; Trites, AW; Arnould, JPY; Guinet, C				Jeanniard-du-Dot, Tiphaine; Trites, Andrew W.; Arnould, John P. Y.; Guinet, Christophe			Reproductive success is energetically linked to foraging efficiency in Antarctic fur seals	PLOS ONE			English	Article							ARCTOCEPHALUS-GAZELLA; PREY CONSUMPTION; PINNIPED DIETS; MATERNAL SIZE; GROWTH-RATE; PUP GROWTH; ENERGY; BEHAVIOR; TIME; VARIABILITY	The efficiency with which individuals extract energy from their environment defines their survival and reproductive success, and thus their selective contribution to the population. Individuals that forage more efficiently (i.e., when energy gained exceeds energy expended) are likely to be more successful at raising viable offspring than individuals that forage less efficiently. Our goal was to test this prediction in large long-lived mammals under free-ranging conditions. To do so, we equipped 20 lactating Antarctic fur seals (Arctocephalus gazella) breeding on Kerguelen Island in the Southern Ocean with tags that recorded GPS locations, depth and tri-axial acceleration to determine at-sea behaviours and detailed time-activity budgets during their foraging trips. We also simultaneously measured energy spent at sea using the doubly-labeled water (DLW) method, and estimated the energy acquired while foraging from 1) type and energy content of prey species present in scat remains, and 2) numbers of prey capture attempts determined from head acceleration. Finally, we followed the growth of 36 pups from birth until weaning ( of which 20 were the offspring of our 20 tracked mothers), and used the relative differences in body mass of pups at weaning as an index of first year survival and thus the reproductive success of their mothers. Our results show that females with greater foraging efficiencies produced relatively bigger pups at weaning. These mothers achieved greater foraging efficiency by extracting more energy per minute of diving rather than by reducing energy expenditure. This strategy also resulted in the females spending less time diving and less time overall at sea, which allowed them to deliver higher quality milk to their pups, or allowed their pups to suckle more frequently, or both. The linkage we demonstrate between reproductive success and the quality of individuals as foragers provides an individual-based quantitative framework to investigate how changes in the availability and accessibility of prey can affect fitness of animals.	[Jeanniard-du-Dot, Tiphaine; Trites, Andrew W.] Univ British Columbia, Inst Oceans & Fisheries, Marine Mammal Res Unit, Vancouver, BC, Canada; [Jeanniard-du-Dot, Tiphaine; Guinet, Christophe] CNRS, Ctr Etud Biol Chize, Villiers En Bois, France; [Arnould, John P. Y.] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia	University of British Columbia; Centre National de la Recherche Scientifique (CNRS); Deakin University	Jeanniard-du-Dot, T (corresponding author), Univ British Columbia, Inst Oceans & Fisheries, Marine Mammal Res Unit, Vancouver, BC, Canada.; Jeanniard-du-Dot, T (corresponding author), CNRS, Ctr Etud Biol Chize, Villiers En Bois, France.	tiphainejdd@gmail.com	Guinet, Christophe/AAR-8457-2020; Jeanniard, Tiphaine/ABF-8836-2020	Jeanniard, Tiphaine/0000-0003-1985-8325; Trites, Andrew/0000-0003-0342-5322	Institut Paul-Emile Victor program [109]; NSERC; Natural Sciences and Engineering Research Council of Canada; Institut Polaire Francais Paul-Emile Victor	Institut Paul-Emile Victor program; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Institut Polaire Francais Paul-Emile Victor	The Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) and the Institut Polaire Francais Paul-Emile Victor (http://www.institut-polaire.fr/language/en/) help fund this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Nory El Ksabi and Jade Vacquie Garcia for their help in collecting the data. Field work was conducted as part of the Institut Paul-Emile Victor program No 109 (PI. H. Weimerkirch) who provided their logistic and financial support to the Kerguelen field season, and NSERC for funding part of this project. All data were collected under the University of British Columbia animal care permit # A10-0364 and the ethical regulations approval from the French Polar Institute (IPEV).	Anthony JA, 2000, J EXP MAR BIOL ECOL, V248, P53, DOI 10.1016/S0022-0981(00)00159-3; Arim M, 2003, CAN J ZOOL, V81, P67, DOI 10.1139/Z02-221; ARNOULD JPY, 1995, MAR MAMMAL SCI, V11, P301, DOI 10.1111/j.1748-7692.1995.tb00286.x; Arnould JPY, 1997, MAR MAMMAL SCI, V13, P516, DOI 10.1111/j.1748-7692.1997.tb00662.x; Bailleul F, 2005, MAR ECOL PROG SER, V293, P273, DOI 10.3354/meps293273; Beauplet G, 2006, OIKOS, V112, P430, DOI 10.1111/j.0030-1299.2006.14412.x; Beauplet G, 2005, J ANIM ECOL, V74, P1160, DOI 10.1111/j.1365-2656.2005.01016.x; Bigg M.A., 1985, P284; BOGGS CL, 1992, FUNCT ECOL, V6, P508, DOI 10.2307/2390047; Boltnev AI, 1998, CAN J ZOOL, V76, P843, DOI 10.1139/cjz-76-5-843; Bowen WD, 2000, CAN J FISH AQUAT SCI, V57, P898, DOI 10.1139/cjfas-57-5-898; Boyd IL, 2000, FUNCT ECOL, V14, P623, DOI 10.1046/j.1365-2435.2000.t01-1-00463.x; Boyd IL, 1999, BEHAV ECOL, V10, P198, DOI 10.1093/beheco/10.2.198; BOYD IL, 1995, J ANIM ECOL, V64, P505, DOI 10.2307/5653; BOYD IL, 1991, J ANIM ECOL, V60, P577, DOI 10.2307/5299; BUTLER PJ, 1992, J EXP BIOL, V170, P35; CHASTEL O, 1993, OECOLOGIA, V94, P278, DOI 10.1007/BF00341328; Cherel Y, 2002, MAR ECOL PROG SER, V228, P263, DOI 10.3354/meps228263; Costa D.P., 1991, Ecological Studies, V88, P156; Costa Daniel P., 1993, Symposia of the Zoological Society of London, V66, P293; Costa DP, 2007, AQUAT CONSERV, V17, pS44, DOI 10.1002/aqc.917; COSTA DP, 1989, ECOLOGY, V70, P596, DOI 10.2307/1940211; Dalton AJM, 2014, J EXP MAR BIOL ECOL, V452, P125, DOI 10.1016/j.jembe.2013.12.014; DOIDGE DW, 1989, POLAR BIOL, V9, P155, DOI 10.1007/BF00297170; Fedak MA, 1996, PHYSIOL ZOOL, V69, P887, DOI 10.1086/physzool.69.4.30164234; Fernandez DA, 2009, FISH PHYSIOL BIOCHEM, V35, P181, DOI 10.1007/s10695-008-9234-1; Gentry R.L., 1986, FUR SEALS MATERNAL S; Georges JY, 2000, ECOLOGY, V81, P295, DOI 10.2307/177427; Goundie ET, 2015, J EXP MAR BIOL ECOL, V470, P70, DOI 10.1016/j.jembe.2015.05.008; GREMILLET DJH, 1994, J EXP BIOL, V189, P105; Gudmundson CJ, 2006, FISH B-NOAA, V104, P445; Gudmundson CJ, 2003, COMP 2 METHODOLOGIES; Guinet C, 2001, MAR ECOL PROG SER, V219, P251, DOI 10.3354/meps219251; IVERSON SJ, 1993, PHYSIOL ZOOL, V66, P61, DOI 10.1086/physzool.66.1.30158287; Iwata T, 2012, MAR MAMMAL SCI, V28, P345, DOI 10.1111/j.1748-7692.2011.00482.x; Jeanniard du Dot T, ECOL EVOL IN PRESS; Jeanniard-du-Dot T, 2017, FUNCT ECOL, V31, P377, DOI 10.1111/1365-2435.12729; Karnovsky NJ, 2012, MAR ECOL PROG SER, V451, P263, DOI 10.3354/meps09713; KERLEY GIH, 1985, J ZOOL, V205, P315; Kooyman G.L., 1989, DIVERSE DIVERS PHYSL; Kuhn CE, 2006, J EXP BIOL, V209, P4524, DOI 10.1242/jeb.02530; Lea MA, 2002, MAR ECOL PROG SER, V245, P281, DOI 10.3354/meps245281; Lea MA, 2002, POLAR BIOL, V25, P269, DOI 10.1007/s00300-001-0339-6; Lea MA, 2002, POLAR BIOL, V25, P843, DOI 10.1007/s00300-002-0428-1; Lea MA, 2006, MAR ECOL PROG SER, V310, P77, DOI 10.3354/meps310077; LEMON WC, 1991, NATURE, V352, P153, DOI 10.1038/352153a0; Lescroel A, 2010, ECOLOGY, V91, P2044, DOI 10.1890/09-0766.1; LUNN NJ, 1993, J MAMMAL, V74, P908, DOI 10.2307/1382429; LUNN NJ, 1994, J ANIM ECOL, V63, P827, DOI 10.2307/5260; Luque SP, 2007, BEHAVIOUR, V144, P1315, DOI 10.1163/156853907782418213; Luque SP, 2007, MAR BIOL, V152, P213, DOI 10.1007/s00227-007-0677-1; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Massardier-Galata L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173797; McCafferty DJ, 1998, MAR ECOL PROG SER, V166, P285, DOI 10.3354/meps166285; OLESIUK PF, 1993, FISH B-NOAA, V91, P491; Pomeroy PP, 1999, J ANIM ECOL, V68, P235, DOI 10.1046/j.1365-2656.1999.00281.x; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; RITCHIE ME, 1990, OECOLOGIA, V82, P56, DOI 10.1007/BF00318534; Shaffer SA, 2003, FUNCT ECOL, V17, P66, DOI 10.1046/j.1365-2435.2003.00705.x; Sparling CE, 2008, FUNCT ECOL, V22, P245, DOI 10.1111/j.1365-2435.2007.01368.x; Speakman J.R., 1997, DOUBLY LABELLED WATE; Staniland IJ, 2007, MAR BIOL, V152, P233, DOI 10.1007/s00227-007-0698-9; Stephens D.W., 1986, pi; Suzuki I, 2009, POLAR BIOL, V32, P667, DOI 10.1007/s00300-009-0596-3; Tierney M, 2002, ANTARCT SCI, V14, P225, DOI 10.1017/S0954102002000020; Tollit DJ, 1997, CAN J FISH AQUAT SCI, V54, P105, DOI 10.1139/cjfas-54-1-105; Trites Andrew W., 2008, Aquatic Mammals, V34, P25, DOI 10.1578/AM.34.1.2008.25; TRITES AW, 1993, J ZOOL, V229, P515, DOI 10.1111/j.1469-7998.1993.tb02652.x; Viviant M, 2010, POLAR BIOL, V33, P713, DOI 10.1007/s00300-009-0750-y; Vollenweider JJ, 2011, MAR BIOL, V158, P413, DOI 10.1007/s00227-010-1569-3; Volpov BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128789; von Bertalanffy L, 1938, HUM BIOL, V10, P181, DOI DOI 10.2307/41447359; WALKER BG, 1995, CAN J ZOOL, V73, P1538, DOI 10.1139/z95-182; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Watanabe YY, 2013, P NATL ACAD SCI USA, V110, P2199, DOI 10.1073/pnas.1216244110; Weimerskirch H, 2005, ECOLOGY, V86, P2611, DOI 10.1890/04-1866; WEIMERSKIRCH H, 1992, MAR ECOL PROG SER, V86, P297, DOI 10.3354/meps086297	77	21	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0174001	10.1371/journal.pone.0174001	http://dx.doi.org/10.1371/journal.pone.0174001			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453563	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383900002
J	Fossum, SL; Mutolo, MJ; Tugores, A; Ghosh, S; Randell, SH; Jones, LC; Leir, SH; Harris, A				Fossum, Sara L.; Mutolo, Michael J.; Tugores, Antonio; Ghosh, Sujana; Randell, Scott H.; Jones, Lisa C.; Leir, Shih-Hsing; Harris, Ann			Ets homologous factor (EHF) has critical roles in epithelial dysfunction in airway disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; CYSTIC-FIBROSIS; CELL-DIFFERENTIATION; MODIFIER LOCI; LUNG; INFLAMMATION; EXPRESSION; GENE; SEVERITY; CHILDREN	The airway epithelium forms a barrier between the internal and external environments. Epithelial dysfunction is critical in the pathology of many respiratory diseases, including cystic fibrosis. Ets homologous factor (EHF) is a key member of the transcription factor network that regulates gene expression in the airway epithelium in response to endogenous and exogenous stimuli. EHF, which has altered expression in inflammatory states, maps to the 5' end of an intergenic region on Chr11p13 that is implicated as a modifier of cystic fibrosis airway disease. Here we determine the functions of EHF in primary human bronchial epithelial (HBE) cells and relevant airway cell lines. Using EHF ChIP followed by deep sequencing (ChIP-seq) and RNA sequencing after EHF depletion, we show that EHF targets in HBE cells are enriched for genes involved in inflammation and wound repair. Furthermore, changes in gene expression impact cell phenotype because EHF depletion alters epithelial secretion of a neutrophil chemokine and slows wound closure in HBE cells. EHF activates expression of the SAM pointed domain-containing ETS transcription factor, which contributes to goblet cell hyperplasia. Our data reveal a critical role for EHF in regulating epithelial function in lung disease.	[Fossum, Sara L.; Mutolo, Michael J.; Ghosh, Sujana; Leir, Shih-Hsing; Harris, Ann] Lurie Childrens Res Ctr, Human Mol Genet Program, Chicago, IL 60614 USA; [Fossum, Sara L.; Mutolo, Michael J.; Ghosh, Sujana; Leir, Shih-Hsing; Harris, Ann] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Tugores, Antonio] Complejo Hosp Univ Insular Materno Infantil, Unidad Invest, Las Palmas Gran Canaria 35016, Spain; [Randell, Scott H.; Jones, Lisa C.] Univ N Carolina, Cyst Fibrosis Ctr, Marsico Lung Inst, Chapel Hill, NC 27599 USA; [Leir, Shih-Hsing; Harris, Ann] Case Western Reserve Univ, Dept Genet & Genome Sci, 10900 Euclid Ave, Cleveland, OH 44016 USA	Northwestern University; Feinberg School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Case Western Reserve University	Harris, A (corresponding author), Case Western Reserve Univ, Dept Genet & Genome Sci, 10900 Euclid Ave, Cleveland, OH 44016 USA.	ann.harris@case.edu	Leir, Shih-Hsing/O-6739-2019; Leir, Shih-Hsing/AAG-1086-2019; Tugores, Antonio/AAE-7939-2021	Leir, Shih-Hsing/0000-0001-9524-3379; Tugores, Antonio/0000-0002-1849-9239	National Institutes of Health [R01HL117843, R01HL094585, R01HD068901, F30HL124925, T32GM008061, P30DK065988]; Cystic Fibrosis Foundation [Harris14P0, CFF-Bouch15P0]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068901] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL126458, R01HL117843, R01HL094585, F30HL124925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK065988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01HL117843, R01HL094585, and R01HD068901 (to A. H.); F30HL124925 (to S. F.); T32GM008061; and P30DK065988. This work was also supported by Cystic Fibrosis Foundation Grants Harris14P0 (to A. H) and CFF-Bouch15P0). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albino D, 2012, CANCER RES, V72, P2889, DOI 10.1158/0008-5472.CAN-12-0212; BIRRER P, 1994, AM J RESP CRIT CARE, V150, P207, DOI 10.1164/ajrccm.150.1.7912987; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; Cohen TS, 2012, NAT MED, V18, P509, DOI 10.1038/nm.2715; Corvol H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9382; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Durieu I, 1998, AM J RESP CRIT CARE, V158, P580, DOI 10.1164/ajrccm.158.2.9707126; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Fossum SL, 2014, NUCLEIC ACIDS RES, V42, P13588, DOI 10.1093/nar/gku1146; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Grosse Scott D., 2004, Morbidity and Mortality Weekly Report, V53, P1; Hallstrand TS, 2014, CLIN IMMUNOL, V151, P1, DOI 10.1016/j.clim.2013.12.003; HAMOSH A, 1993, NEW ENGL J MED, V329, P1308; Hamutcu R, 2002, AM J RESP CRIT CARE, V165, P1172, DOI 10.1164/ajrccm.165.8.2104090; Hartl D, 2006, J ALLERGY CLIN IMMUN, V117, P204, DOI 10.1016/j.jaci.2005.09.023; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Herriges M, 2014, DEVELOPMENT, V141, P502, DOI 10.1242/dev.098186; Hilliard TN, 2007, THORAX, V62, P1074, DOI 10.1136/thx.2006.074641; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; Itokazu Y, 2014, AM J PHYSIOL-CELL PH, V306, pC819, DOI 10.1152/ajpcell.00168.2013; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Karmel A., 2014, HOMER IDR 2 PASS UPD, DOI [10.5281/zenodo.11619, DOI 10.5281/ZENODO.11619]; Kas K, 2000, J BIOL CHEM, V275, P2986, DOI 10.1074/jbc.275.4.2986; Kerschner JL, 2014, EPIGENETICS-US, V9, P557, DOI 10.4161/epi.27696; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim Victor, 2008, Proc Am Thorac Soc, V5, P478, DOI 10.1513/pats.200802-014ET; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; KONSTAN MW, 1994, AM J RESP CRIT CARE, V150, P448, DOI 10.1164/ajrccm.150.2.8049828; Korfhagen TR, 2012, P NATL ACAD SCI USA, V109, P16630, DOI 10.1073/pnas.1208092109; Kunderfranco P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010547; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Mollard R, 2000, INT J DEV BIOL, V44, P457; Mossman BT, 2006, AM J RESP CELL MOL, V34, P666, DOI 10.1165/rcmb.2006-0047SF; Park KS, 2007, J CLIN INVEST, V117, P978, DOI 10.1172/JCI29176; Prause O, 2003, EUR J PHARMACOL, V462, P193, DOI 10.1016/S0014-2999(03)01341-4; Rajavelu P, 2015, J CLIN INVEST, V125, P2021, DOI 10.1172/JCI79422; Reddy SPM, 2002, AM J PHYSIOL-LUNG C, V283, pL1161, DOI 10.1152/ajplung.00140.2002; Regamey N, 2011, THORAX, V66, P624, DOI 10.1136/thx.2009.134106; Rosenfeld M, 2001, PEDIATR PULM, V32, P356, DOI 10.1002/ppul.1144; Schiller KR, 2010, AM J PHYSIOL-CELL PH, V299, pC912, DOI 10.1152/ajpcell.00215.2010; Silverman ES, 2002, AM J RESP CELL MOL, V27, P697, DOI 10.1165/rcmb.2002-0011OC; Stephens DN, 2013, J BIOL CHEM, V288, P34304, DOI 10.1074/jbc.M113.504399; Tan HL, 2011, AM J RESP CRIT CARE, V184, P252, DOI 10.1164/rccm.201102-0236OC; Taniue K, 2011, EMBO REP, V12, P682, DOI 10.1038/embor.2011.81; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tiringer K, 2013, AM J RESP CRIT CARE, V187, P621, DOI 10.1164/rccm.201206-1150OC; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tugores A, 2001, J BIOL CHEM, V276, P20397, DOI 10.1074/jbc.M010930200; Vanscoy LL, 2007, AM J RESP CRIT CARE, V175, P1036, DOI 10.1164/rccm.200608-1164OC; Verhaeghe C, 2007, BIOCHEM PHARMACOL, V73, P1982, DOI 10.1016/j.bcp.2007.03.019; Voynow JA, 2008, INT J BIOCHEM CELL B, V40, P1238, DOI 10.1016/j.biocel.2008.03.003; Wan HJ, 2005, J BIOL CHEM, V280, P13809, DOI 10.1074/jbc.M414122200; Wan HJ, 2004, DEVELOPMENT, V131, P953, DOI 10.1242/dev.00966; Wan HJ, 2008, DEVELOPMENT, V135, P2563, DOI 10.1242/dev.021964; Wang S, 2013, NAT PROTOC, V8, P2502, DOI 10.1038/nprot.2013.150; Widdicombe JH, 2015, PHYSIOL REV, V95, P1241, DOI 10.1152/physrev.00039.2014; Wright FA, 2011, NAT GENET, V43, P539, DOI 10.1038/ng.838; Wu J, 2008, CELL RES, V18, P649, DOI 10.1038/cr.2008.57; Yang HH, 2002, DEVELOPMENT, V129, P2233; Yin Z, 2006, AM J PHYSIOL-LUNG C, V291, pL191, DOI 10.1152/ajplung.00385.2005; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157; Zhang YZ, 2007, DEVELOPMENT, V134, P189, DOI 10.1242/dev.02720; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	65	33	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10938	10949		10.1074/jbc.M117.775304	http://dx.doi.org/10.1074/jbc.M117.775304			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28461336	Green Published, hybrid			2022-12-26	WOS:000404391000016
J	Kuttel, MM; Cescutti, P; Distefano, M; Rizzo, R				Kuttel, Michelle M.; Cescutti, Paola; Distefano, Marco; Rizzo, Roberto			Fluorescence and NMR spectroscopy together with molecular simulations reveal amphiphilic characteristics of a Burkholderia biofilm exopolysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEPACIA COMPLEX; FORCE-FIELD; DYNAMICS; MATRIX; PROTEINS; POLYSACCHARIDES; STRATEGIES; BINDING; PROBES; WATER	Biofilms are a collective mode of bacterial life in which a self-produced matrix confines cells in close proximity to each other. Biofilms confer many advantages, including protection from chemicals (including antibiotics), entrapment of useful extracellular enzymes and nutrients, as well as opportunities for efficient recycling of molecules from dead cells. Biofilm matrices are aqueous gel-like structures composed of polysaccharides, proteins, and DNA stabilized by intermolecular interactions that may include non-polar connections. Recently, polysaccharides extracted from biofilms produced by species of the Burkholderia cepacia complex were shown to possess clusters of rhamnose, a 6-deoxy sugar with non-polar characteristics. Molecular dynamics simulations are well suited to characterizing the structure and dynamics of polysaccharides, but only relatively few such studies exist of their interaction with non-polar molecules. Here we report an investigation into the hydrophobic properties of the exopolysaccharide produced by Burkholderia multivorans strain C1576. Fluorescence experiments with two hydrophobic fluorescent probes established that this polysaccharide complexes hydrophobic species, and NMR experiments confirmed these interactions. Molecular simulations to model the hydrodynamics of the polysaccharide and the interaction with guest species revealed a very flexible, amphiphilic carbohydrate chain that has frequent dynamic interactions with apolar molecules; both hexane and a long-chain fatty acid belonging to the quorum-sensing system of B. multivorans were tested. A possible role of the non-polar domains of the exopolysaccharide in facilitating the diffusion of aliphatic species toward specific targets within the biofilm aqueous matrix is proposed.	[Kuttel, Michelle M.] Univ Cape Town, Dept Comp Sci, ZA-7701 Rondebosch, South Africa; [Cescutti, Paola; Distefano, Marco; Rizzo, Roberto] Univ Trieste, Dept Life Sci, Via Licio Giorgieri 1, I-34127 Trieste, Italy	University of Cape Town; University of Trieste	Rizzo, R (corresponding author), Univ Trieste, Dept Life Sci, Via Licio Giorgieri 1, I-34127 Trieste, Italy.	rizzor@units.it	Kuttel, Michelle/B-2941-2009	Kuttel, Michelle/0000-0003-0554-4632; Cescutti, Paola/0000-0003-3744-2198	South African Medical Research Council [SIR 415983]; University of Trieste	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Trieste	The South African Medical Research Council funding agency provided financial support for the modeling component of this work (SIR 415983). The University of Trieste is kindly acknowledged for financial support (FRA2013 and FRA2015). The authors declare that they have no conflicts of interest with the contents of this article.	Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Bryce RA, 2001, BIOPHYS J, V81, P1373, DOI 10.1016/S0006-3495(01)75793-1; Cescutti P, 2000, BIOCHEM BIOPH RES CO, V273, P1088, DOI 10.1006/bbrc.2000.3059; Cheon HS, 2007, CHEMBIOCHEM, V8, P353, DOI 10.1002/cbic.200600499; Coenye T, 2010, FUTURE MICROBIOL, V5, P1087, DOI 10.2217/FMB.10.68; Colombo G, 2004, CARBOHYD RES, V339, P985, DOI 10.1016/j.carres.2003.10.030; CRESCENZI V, 1986, GAZZ CHIM ITAL, V116, P435; Cuzzi B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094372; Del Valle EMM, 2004, PROCESS BIOCHEM, V39, P1033, DOI 10.1016/S0032-9592(03)00258-9; Deng YY, 2010, APPL ENVIRON MICROB, V76, P4675, DOI 10.1128/AEM.00480-10; Dolfi S, 2015, CARBOHYD RES, V411, P42, DOI 10.1016/j.carres.2015.04.012; EDELMAN GM, 1968, ACCOUNTS CHEM RES, V1, P65, DOI 10.1021/ar50003a001; Fadda E, 2010, DRUG DISCOV TODAY, V15, P596, DOI 10.1016/j.drudis.2010.06.001; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07; Flemming HC, 2016, MICROORGANISMS, V4, DOI 10.3390/microorganisms4040041; Flemming HC, 2016, NAT REV MICROBIOL, V14, P563, DOI 10.1038/nrmicro.2016.94; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Galochkina T, 2016, CHEMPHYSCHEM, V17, P2839, DOI 10.1002/cphc.201600524; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Hawver LA, 2016, FEMS MICROBIOL REV, V40, P738, DOI 10.1093/femsre/fuw014; He YW, 2008, FEMS MICROBIOL REV, V32, P842, DOI 10.1111/j.1574-6976.2008.00120.x; Hobley L, 2015, FEMS MICROBIOL REV, V39, P649, DOI 10.1093/femsre/fuv015; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kuttel MM, 2016, J COMPUT CHEM, V37, P2098, DOI 10.1002/jcc.24428; Kuttel MM, 2015, CARBOHYD RES, V406, P27, DOI 10.1016/j.carres.2014.12.013; Limoli DH, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0011-2014; Liu L, 2012, CHEM-EUR J, V18, P12059, DOI 10.1002/chem.201201222; Marques CNH, 2015, PHARMACEUTICALS-BASE, V8, P816, DOI 10.3390/ph8040816; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; MCCLURE WO, 1967, BIOCHEMISTRY-US, V6, P559, DOI 10.1021/bi00854a025; Poveda A, 1998, CHEM SOC REV, V27, P133, DOI 10.1039/a827133z; Stone JE, 2007, J COMPUT CHEM, V28, P2618, DOI 10.1002/jcc.20829; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8	40	9	9	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					11034	11042		10.1074/jbc.M117.785048	http://dx.doi.org/10.1074/jbc.M117.785048			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28468829	Green Published, hybrid			2022-12-26	WOS:000404391000024
J	Desjardins, CA; Naya, FJ				Desjardins, Cody A.; Naya, Francisco J.			Antagonistic regulation of cell-cycle and differentiation gene programs in neonatal cardiomyocytes by homologous MEF2 transcription factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiomyocyte; differentiation; gene regulation; transcription factor; transcriptomics; antagonistic	CARDIAC MORPHOGENESIS; IN-VITRO; HEART; MUSCLE; NOTCH; PROLIFERATION; DEFICIENCY; EXPRESSION; MYOGENESIS; COSTAMERE	Cardiomyocytes acquire their primary specialized function (contraction) before exiting the cell cycle. In this regard, proliferation and differentiation must be precisely coordinated for proper cardiac morphogenesis. Here, we have investigated the complex transcriptional mechanisms employed by cardiomyocytes to coordinate antagonistic cell-cycle and differentiation gene programs through the molecular dissection of the core cardiac transcription factor, MEF2. Knockdown of individual MEF2 proteins, MEF2A, -C, and -D, in primary neonatal cardiomyocytes resulted in radically distinct and opposite effects on cellular homeostasis and gene regulation. MEF2A and MEF2D were absolutely required for cardiomyocyte survival, whereas MEF2C, despite its major role in cardiac morphogenesis and direct reprogramming, was dispensable for this process. Inhibition of MEF2A or -D also resulted in the activation of cell-cycle genes and down-regulation of markers of terminal differentiation. In striking contrast, the regulation of cell-cycle and differentiation gene programs by MEF2C was antagonistic to that of MEF2A and -D. Computational analysis of regulatory regions from MEF2 isoform-dependent gene sets identified the Notch and Hedgehog signaling pathways as key determinants in coordinating MEF2 isoform-specific control of antagonistic gene programs. These results reveal that mammalian MEF2 family members have distinct transcriptional functions in cardiomyocytes and suggest that these differences are critical for proper development and maturation of the heart. Analysis of MEF2 isoform-specific function in neonatal cardiomyocytes has yielded insight into an unexpected transcriptional regulatory mechanism by which these specialized cells utilize homologous members of a core cardiac transcription factor to coordinate cell-cycle and differentiation gene programs.	[Desjardins, Cody A.; Naya, Francisco J.] Boston Univ, Program Cell & Mol Biol, Dept Biol, Boston, MA 02215 USA	Boston University	Naya, FJ (corresponding author), Boston Univ, Dept Biol, 24 Cummington Mall, Boston, MA 02215 USA.	fnaya@bu.edu			National Institutes of Health [HL73304]; Boston University Bioinformatics CTSI Grant [U54-TR001012]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U54TR001012] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073304] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston University Bioinformatics CTSI Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL73304 (to F. J. N.) and Boston University Bioinformatics CTSI Grant U54-TR001012. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abad M, 2017, STEM CELL REP, V8, P548, DOI 10.1016/j.stemcr.2017.01.025; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Bondue A, 2010, CIRC RES, V107, P1414, DOI 10.1161/CIRCRESAHA.110.227058; Campa VM, 2008, J CELL BIOL, V183, P129, DOI 10.1083/jcb.200806104; Conway SJ, 2010, PEDIATR CARDIOL, V31, P318, DOI 10.1007/s00246-009-9608-x; Desjardins CA, 2016, J CARDIOVASC DEV DIS, V3, DOI 10.3390/jcdd3030026; Di Giorgio E, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006752; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Estrella NL, 2015, J BIOL CHEM, V290, P24367, DOI 10.1074/jbc.M115.666461; Estrella NL, 2015, J BIOL CHEM, V290, P1256, DOI 10.1074/jbc.M114.589838; Estrella N, 2014, CELL MOL LIFE SCI, V71, P1641, DOI 10.1007/s00018-013-1512-0; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Ewen EP, 2011, J BIOL CHEM, V286, P29644, DOI 10.1074/jbc.M111.268094; Foglia MJ, 2016, DEVELOPMENT, V143, P729, DOI 10.1242/dev.132910; Gaborit N, 2012, DEVELOPMENT, V139, P4007, DOI 10.1242/dev.081703; Guo YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087294; Hinits Y, 2012, DEV BIOL, V369, P199, DOI 10.1016/j.ydbio.2012.06.019; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; de la Pompa JL, 2012, DEV CELL, V22, P244, DOI 10.1016/j.devcel.2012.01.014; Murphy AM, 1996, CARDIOVASC RES, V31, pE25; Murray TVA, 2014, TRENDS CARDIOVAS MED, V24, P113, DOI 10.1016/j.tcm.2013.09.003; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; Niu Z, 2007, CURR OPIN CELL BIOL, V19, P618, DOI 10.1016/j.ceb.2007.09.013; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Paige SL, 2015, CIRC RES, V116, P341, DOI 10.1161/CIRCRESAHA.116.302752; Pallavi SK, 2012, EMBO J, V31, P2895, DOI 10.1038/emboj.2012.129; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Rochais F, 2009, CIRC RES, V104, P933, DOI 10.1161/CIRCRESAHA.109.194464; Sengupta A, 2013, CIRC RES, V112, P267, DOI 10.1161/CIRCRESAHA.112.277442; Shen HX, 2006, GENE DEV, V20, P675, DOI 10.1101/gad.1383706; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; VanDusen NJ, 2012, DIFFERENTIATION, V84, DOI 10.1016/j.diff.2012.03.002; Vincent SD, 2010, CURR TOP DEV BIOL, V90, P1, DOI 10.1016/S0070-2153(10)90001-X; Voronova A, 2012, NUCLEIC ACIDS RES, V40, P3329, DOI 10.1093/nar/gkr1232; Waardenberg AJ, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a013839; Wales S, 2014, NUCLEIC ACIDS RES, V42, P11349, DOI 10.1093/nar/gku813; Wang YX, 2005, FEBS LETT, V579, P4843, DOI 10.1016/j.febslet.2005.07.068; Wilson-Rawls J, 1999, MOL CELL BIOL, V19, P2853; Zacchigna S, 2014, CARDIOVASC RES, V102, P312, DOI 10.1093/cvr/cvu057	44	17	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10613	10629		10.1074/jbc.M117.776153	http://dx.doi.org/10.1074/jbc.M117.776153			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28473466	hybrid, Green Published			2022-12-26	WOS:000404115400021
J	Head, PE; Zhang, H; Bastien, AJ; Koyen, AE; Withers, AE; Daddacha, WB; Cheng, XD; Yu, DS				Head, PamelaSara E.; Zhang, Hui; Bastien, Amanda J.; Koyen, Allyson E.; Withers, Allison E.; Daddacha, Waaqo B.; Cheng, Xiaodong; Yu, David S.			Sirtuin 2 mutations in human cancers impair its function in genome maintenance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION STRESS-RESPONSE; RESECTED PANCREATIC-CANCER; AMINO-ACID SUBSTITUTIONS; AFFECT PROTEIN FUNCTION; DNA-DAMAGE RESPONSE; TUBULIN DEACETYLASE; EXPRESSION; SEARCH; IDENTIFICATION; DEGRADATION	Sirtuin 2 (SIRT2) is a sirtuin family deacetylase, which maintains genome integrity and prevents tumorigenesis. Although Sirt2 deficiency in mice leads to tumorigenesis, the functional significance of somatic SIRT2 mutations in human tumors is unclear. Using structural insight combined with bioinformatics and functional analyses, we show that naturally occurring cancer-associated SIRT2 mutations at evolutionarily conserved sites disrupt its deacetylation of DNA-damage response proteins by impairing SIRT2 catalytic activity or protein levels but not its localization or binding with substrate. We observed that these SIRT2 mutant proteins fail to restore the replication stress sensitivity, impairment in recovery from replication stress, and impairment in ATR-interacting protein (ATRIP) focus accumulation of SIRT2 deficiency. Moreover, the SIRT2 mutant proteins failed to rescue the spontaneous induction of DNA damage and micronuclei of SIRT2 deficiency in cancer cells. Our findings support a model for SIRT2's tumor-suppressive function in which somatic mutations in SIRT2 contribute to genomic instability by impairing its deacetylase activity or diminishing its protein levels in the DNA-damage response. In conclusion, our work provides a mechanistic basis for understanding the biological and clinical significance of SIRT2 mutations in genome maintenance and tumor suppression.	[Head, PamelaSara E.; Zhang, Hui; Bastien, Amanda J.; Koyen, Allyson E.; Withers, Allison E.; Daddacha, Waaqo B.; Yu, David S.] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Cheng, Xiaodong] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University; Emory University	Yu, DS (corresponding author), Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA.	dsyu@emory.edu		Head, PamelaSara/0000-0002-9822-9414	NCI, National Institutes of Health [R01CA178999, R01CA178999S1]; Basser Center for BRCA Innovation Award [32356]; Winship Cancer Institute/Brenda Nease Breast Cancer Research Fund Pilot Award [53237]; NATIONAL CANCER INSTITUTE [R01CA178999] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Basser Center for BRCA Innovation Award; Winship Cancer Institute/Brenda Nease Breast Cancer Research Fund Pilot Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI, National Institutes of Health Grants R01CA178999 and R01CA178999S1, Basser Center for BRCA Innovation Award 32356, and Winship Cancer Institute/Brenda Nease Breast Cancer Research Fund Pilot Award 53237 (all to D. S. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bartosch C, 2016, ONCOTARGET, V7, P1144, DOI 10.18632/oncotarget.6691; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Choi JE, 2014, CURR OPIN GENET DEV, V26, P24, DOI 10.1016/j.gde.2014.05.005; Colbert LE, 2014, CANCER RES, V74, P2677, DOI 10.1158/0008-5472.CAN-13-1996; Donmez G, 2013, EMBO MOL MED, V5, P344, DOI 10.1002/emmm.201302451; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Hall WA, 2014, ONCOGENE, V33, P5450, DOI 10.1038/onc.2013.488; Hiratsuka M, 2003, BIOCHEM BIOPH RES CO, V309, P558, DOI 10.1016/j.bbrc.2003.08.029; Inoue T, 2007, ONCOGENE, V26, P945, DOI 10.1038/sj.onc.1209857; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li ZM, 2016, ONCOTARGET, V7, P18927, DOI 10.18632/oncotarget.7816; Li ZM, 2013, LUNG CANCER, V82, P9, DOI 10.1016/j.lungcan.2013.05.013; Matsushita N, 2005, GENES CELLS, V10, P321, DOI 10.1111/j.1365-2443.2005.00836.x; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000784; North BJ, 2014, EMBO J, V33, P1438, DOI 10.15252/embj.201386907; Rumpf T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7263; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Serrano L, 2013, GENE DEV, V27, P639, DOI 10.1101/gad.211342.112; Smith SC, 2014, NUCLEIC ACIDS RES, V42, P11517, DOI 10.1093/nar/gku840; Song HY, 2016, ONCOTARGET, V7, P80336, DOI 10.18632/oncotarget.12015; Suematsu T, 2014, BIOCHEM BIOPH RES CO, V453, P588, DOI 10.1016/j.bbrc.2014.09.128; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Temel M, 2016, TUMOR BIOL, V37, P6429, DOI 10.1007/s13277-015-4522-8; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Zhang H, 2016, CELL CYCLE, V15, P2089, DOI 10.1080/15384101.2016.1184517; Zhang H, 2016, CELL REP, V14, P1435, DOI 10.1016/j.celrep.2016.01.018; Zhang H, 2013, P NATL ACAD SCI USA, V110, P13546, DOI 10.1073/pnas.1301463110	43	22	23	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					9919	9931		10.1074/jbc.M116.772566	http://dx.doi.org/10.1074/jbc.M116.772566			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28461331	Green Published, hybrid			2022-12-26	WOS:000403580600006
J	Choi, YJ; Lee, DH; Han, KD; Yoon, H; Shin, CM; Park, YS; Kim, N				Choi, Yoon Jin; Lee, Dong Ho; Han, Kyung-Do; Yoon, Hyuk; Shin, Cheol Min; Park, Young Soo; Kim, Nayoung			Elevated serum gamma-glutamyltransferase is associated with an increased risk of oesophageal carcinoma in a cohort of 8,388,256 Korean subjects	PLOS ONE			English	Article							BODY-MASS INDEX; CANCER INCIDENCE; LIVER-ENZYMES; GLUTAMYLTRANSFERASE; TRANSPEPTIDASE; POPULATION; RESISTANCE; PROGRESS; ALCOHOL; WEIGHT	Gamma-glutamyltransferase (GGT) is a marker for hepatic injury and alcohol consumption. However, the association of GGT with the risk of oesophageal carcinoma (OC) has not been fully recognized to date. Therefore, this study aimed to determine the association between elevated GGT and OC, by also considering the body mass index (BMI) of the subjects. Clinical data from 8,388,256 Korean individuals, who were aged 40 years and over and who received healthcare check-ups arranged by the national insurance program in 2007 and 2008, were analysed. Newly diagnosed OC was identified using claims data during a median follow-up duration of 8.72 years. During the study period, 6,863 individuals (0.08%) developed OC. We found that there was an increased risk of OC in subjects with serum GGT values >18 IU/L. Furthermore, a BMI <18.5 kg/m(2) (underweight) was associated with increased OC risk, while a BMI >= 23.0 kg/m(2) was associated with a reduced OC risk. Individuals who were both underweight and in the highest GGT quartile (>= 40 IU/L) had a far greater risk of OC compared to other individuals (hazard ratio: 3.65, 95% confidence interval: 3.10-4.30). In conclusion, increased serum GGT was associated with an increased risk of developing OC in the general Korean population, regardless of age, sex, smoker status, or alcohol consumption.	[Choi, Yoon Jin; Lee, Dong Ho; Yoon, Hyuk; Shin, Cheol Min; Park, Young Soo; Kim, Nayoung] Dept Internal Med, Seongnam, Gyeonggi Do, South Korea; [Choi, Yoon Jin; Lee, Dong Ho; Yoon, Hyuk; Shin, Cheol Min; Park, Young Soo; Kim, Nayoung] Seoul Natl Univ, Bundang Hosp, Seongnam, Gyeonggi Do, South Korea; [Lee, Dong Ho; Park, Young Soo; Kim, Nayoung] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Lee, Dong Ho; Park, Young Soo; Kim, Nayoung] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Han, Kyung-Do] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Catholic University of Korea	Lee, DH (corresponding author), Dept Internal Med, Seongnam, Gyeonggi Do, South Korea.; Lee, DH (corresponding author), Seoul Natl Univ, Bundang Hosp, Seongnam, Gyeonggi Do, South Korea.; Lee, DH (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Lee, DH (corresponding author), Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea.	dhljohn@yahoo.com	Yoon, Hyuk/AAT-4978-2020	Yoon, Hyuk/0000-0002-2657-0349; Choi, Yoon Jin/0000-0002-1922-9388; Shin, Cheol Min/0000-0003-2265-9845; Kim, Nayoung/0000-0002-9397-0406	Ministry of Science, ICT and Future Planning [2011-0030001]	Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the Ministry of Science, ICT and Future Planning (http://english.msip.go.kr/english/main/main.do) No. 2011-0030001 to DHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SS, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0097-7; AlSarraf M, 1997, J CLIN ONCOL, V15, P277, DOI 10.1200/JCO.1997.15.1.277; Bollschweiler E, 2001, CANCER, V92, P549, DOI 10.1002/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L; Borud O, 2000, INT J CANCER, V88, P464, DOI 10.1002/1097-0215(20001101)88:3<464::AID-IJC20>3.0.CO;2-F; Breitling LP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013116; Conigrave KM, 2002, ALCOHOL CLIN EXP RES, V26, P332, DOI 10.1097/00000374-200203000-00005; Corti A, 2009, MUTAT RES-FUND MOL M, V669, P112, DOI 10.1016/j.mrfmmm.2009.05.010; DAWSON J, 1979, CLIN CHIM ACTA, V96, P37, DOI 10.1016/0009-8981(79)90049-4; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Fahey PP, 2015, CANCER CAUSE CONTROL, V26, P1365, DOI 10.1007/s10552-015-0635-z; Hanigan MH, 1999, HUM PATHOL, V30, P300, DOI 10.1016/S0046-8177(99)90009-6; Johnson IT, 2015, EXPERT REV GASTROENT, V9, P1347, DOI 10.1586/17474124.2015.1088383; Kim DJ, 2005, DIABETIC MED, V22, P1134, DOI 10.1111/j.1464-5491.2005.01581.x; Kunutsor SK, 2015, INT J CANCER, V136, P1162, DOI 10.1002/ijc.29084; Kunutsor SK, 2014, INT J EPIDEMIOL, V43, P187, DOI 10.1093/ije/dyt192; Lahmann PH, 2012, CANCER-AM CANCER SOC, V118, P1901, DOI 10.1002/cncr.26455; Lee DH, 2004, FREE RADICAL RES, V38, P535, DOI 10.1080/10715760410001694026; Lee DH, 2003, DIABETOLOGIA, V46, P359, DOI 10.1007/s00125-003-1036-5; Lee J., 2016, INT J EPIDEMIOL; Lee MY, 2008, DIABETIC MED, V25, P469, DOI 10.1111/j.1464-5491.2008.02415.x; Lelijveld N, 2016, LANCET GLOB HEALTH, V4, pE654, DOI 10.1016/S2214-109X(16)30133-4; Lim JS, 2004, FREE RADICAL BIO MED, V37, P1018, DOI 10.1016/j.freeradbiomed.2004.06.032; Liu RM, 1996, AM J RESP CELL MOL, V14, P192, DOI 10.1165/ajrcmb.14.2.8630270; Mok Y, 2016, INT J CANCER, V138, P311, DOI 10.1002/ijc.29659; Oh SW, 2005, J CLIN ONCOL, V23, P4742, DOI 10.1200/JCO.2005.11.726; Shiwaku K, 2004, LANCET, V363, P1077, DOI 10.1016/S0140-6736(04)15856-X; Smith M, 2008, INT J CANCER, V122, P1604, DOI 10.1002/ijc.23198; Son Ju Ik, 2001, Korean Journal of Internal Medicine, V16, P250; Stoner GD, 2001, CARCINOGENESIS, V22, P1737, DOI 10.1093/carcin/22.11.1737; Strasak AM, 2008, INT J CANCER, V123, P1902, DOI 10.1002/ijc.23714; SZASZ G, 1976, CLIN CHEM, V22, P2051; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; Tsuboya T, 2012, J EPIDEMIOL, V22, P144, DOI 10.2188/jea.JE20110071; Umar SB, 2008, NAT CLIN PRACT GASTR, V5, P517, DOI 10.1038/ncpgasthep1223; Van Hemelrijck M, 2011, EUR J CANCER, V47, P2033, DOI 10.1016/j.ejca.2011.03.010; Venesky MD, 2012, OECOLOGIA, V169, P23, DOI 10.1007/s00442-011-2171-1; Wannamethee SG, 2010, ANN CLIN BIOCHEM, V47, P321, DOI 10.1258/acb.2010.009303; Zhang HQ, 2009, AM J RESP CELL MOL, V41, P509, DOI 10.1165/rcmb.2009-0169TR	38	11	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177053	10.1371/journal.pone.0177053	http://dx.doi.org/10.1371/journal.pone.0177053			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475598	Green Published, gold, Green Submitted			2022-12-26	WOS:000400649500037
J	Ren, Y; Lai, YH; Laverde, EE; Lei, RP; Rein, HL; Liu, Y				Ren, Yaou; Lai, Yanhao; Laverde, Eduardo E.; Lei, Ruipeng; Rein, Hayley L.; Liu, Yuan			Modulation of trinucleotide repeat instability by DNA polymerase beta polymorphic variant R137Q	PLOS ONE			English	Article							BASE-EXCISION-REPAIR; SINGLE-NUCLEOTIDE POLYMORPHISMS; ANDROGEN RECEPTOR; MICROSATELLITE INSTABILITY; MONOUBIQUITINATED PCNA; MOLECULAR-BASIS; BLADDER-CANCER; CAG REPEAT; CTG REPEAT; EXPANSION	Trinucleotide repeat (TNR) instability is associated with human neurodegenerative diseases and cancer. Recent studies have pointed out that DNA base excision repair (BER) mediated by DNA polymerase beta (pol beta) plays a crucial role in governing somatic TNR instability in a damage-location dependent manner. It has been shown that the activities and function of BER enzymes and cofactors can be modulated by their polymorphic variations. This could alter the function of BER in regulating TNR instability. However, the roles of BER polymorphism in modulating TNR instability remain to be elucidated. A previous study has shown that a pol beta polymorphic variant, pol beta R137Q is associated with cancer due to its impaired polymerase activity and its deficiency in interacting with a BER cofactor, proliferating cell nuclear antigen (PCNA). In this study, we have studied the effect of the pol beta R137Q variant on TNR instability. We showed that pol beta R137Q exhibited weak DNA synthesis activity to cause TNR deletion during BER. We demonstrated that similar to wild-type pol beta, the weak DNA synthesis activity of pol beta R137Q allowed it to skip over a small loop formed on the template strand, thereby facilitating TNR deletion during BER. Our results further suggest that carriers with pol beta R137Q polymorphic variant may not exhibit an elevated risk of developing human diseases that are associated with TNR instability.	[Ren, Yaou; Laverde, Eduardo E.; Lei, Ruipeng; Liu, Yuan] Florida Int Univ, Biochem PhD Program, Miami, FL 33199 USA; [Lai, Yanhao; Rein, Hayley L.; Liu, Yuan] Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA; [Liu, Yuan] Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA; [Rein, Hayley L.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL USA	State University System of Florida; Florida International University; State University System of Florida; Florida International University; State University System of Florida; Florida International University; State University System of Florida; University of South Florida	Liu, Y (corresponding author), Florida Int Univ, Biochem PhD Program, Miami, FL 33199 USA.; Liu, Y (corresponding author), Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA.; Liu, Y (corresponding author), Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA.	yualiu@fiu.edu	Lai, Yanhao/AAD-3392-2019	Lei, Ruipeng/0000-0002-4652-3400; Rein, Hayley/0000-0001-8939-3442	National Institutes of Health [ES023569]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES023569] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants ES023569 (to Y. Liu).	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Ali MF, 2008, ONCOL REP, V19, P1033; Beard WA, 2014, BIOCHEMISTRY-US, V53, P2768, DOI 10.1021/bi500139h; Berger F, 2013, MUTAT RES-GEN TOX EN, V755, P115, DOI 10.1016/j.mrgentox.2013.04.020; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; BROOKS BP, 1995, TRENDS NEUROSCI, V18, P459, DOI 10.1016/0166-2236(95)94497-S; Brouwer JR, 2009, BIOESSAYS, V31, P71, DOI 10.1002/bies.080122; Chan NLS, 2013, J BIOL CHEM, V288, P15015, DOI 10.1074/jbc.M113.464370; Chang-Claude J, 2005, CLIN CANCER RES, V11, P4802, DOI 10.1158/1078-0432.CCR-04-2657; Coppede F, 2010, TOXICOLOGY, V278, P199, DOI 10.1016/j.tox.2009.10.019; Desai NA, 2003, FEMS MICROBIOL REV, V26, P457, DOI 10.1016/S0168-6445(02)00129-8; Dianova II, 2004, NUCLEIC ACIDS RES, V32, P2550, DOI 10.1093/nar/gkh567; Dion V, 2014, TRENDS GENET, V30, P220, DOI 10.1016/j.tig.2014.04.005; Dogru-Abbasoglu S, 2007, NEUROL SCI, V28, P31, DOI 10.1007/s10072-007-0744-x; Dogru-Abbasoglu S, 2009, CELL BIOCHEM FUNCT, V27, P462, DOI 10.1002/cbf.1595; El-Andaloussi N, 2007, FASEB J, V21, P26, DOI 10.1096/fj.06-6194com; Entezam A, 2010, HUM MUTAT, V31, P611, DOI 10.1002/humu.21237; Freudenthal BD, 2010, NAT STRUCT MOL BIOL, V17, P479, DOI 10.1038/nsmb.1776; Gary R, 1999, J BIOL CHEM, V274, P4354, DOI 10.1074/jbc.274.7.4354; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Gates KS, 2009, CHEM RES TOXICOL, V22, P1747, DOI 10.1021/tx900242k; Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P3320, DOI 10.1073/pnas.94.7.3320; Guo ZG, 2009, NUCLEIC ACIDS RES, V37, P3431, DOI 10.1093/nar/gkp201; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hill JW, 2006, NUCLEIC ACIDS RES, V34, P1620, DOI 10.1093/nar/gkl060; Jakupciak JP, 2000, IUBMB LIFE, V50, P355, DOI 10.1080/152165400300089358; Jiang X, 2012, CHINESE J CANCER RES, V24, P181, DOI 10.1007/s11670-012-0181-0; Jin P, 2000, HUM MOL GENET, V9, P901, DOI 10.1093/hmg/9.6.901; KANG SM, 1995, J BIOL CHEM, V270, P27014, DOI 10.1074/jbc.270.45.27014; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kanvah S, 2010, ACCOUNTS CHEM RES, V43, P280, DOI 10.1021/ar900175a; KAZEMIESFARJANI P, 1995, HUM MOL GENET, V4, P523, DOI 10.1093/hmg/4.4.523; Kedar PS, 2002, J BIOL CHEM, V277, P31115, DOI 10.1074/jbc.M201497200; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Lai YH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12465; Lai YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093464; Lai YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056960; Lin GC, 2009, DNA REPAIR, V8, P182, DOI 10.1016/j.dnarep.2008.10.006; Lin YF, 2009, MOL CARCINOGEN, V48, P350, DOI 10.1002/mc.20488; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu Y, 2005, J BIOL CHEM, V280, P3665, DOI 10.1074/jbc.M412922200; Liu Y, 2012, TRENDS BIOCHEM SCI, V37, P162, DOI 10.1016/j.tibs.2011.12.002; Liu Y, 2009, J BIOL CHEM, V284, P28352, DOI 10.1074/jbc.M109.050286; LOEB LA, 1994, CANCER RES, V54, P5059; Lonergan PE, 2011, J CARCINOG, P10; Martins S, 2014, HUM GENET, V133, P1311, DOI 10.1007/s00439-014-1467-8; McMurray CT, 2010, NAT REV GENET, V11, P786, DOI 10.1038/nrg2828; Miao HK, 2015, INT J CLIN EXP PATHO, V8, P11060; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Mohrenweiser HW, 2002, CANCER EPIDEM BIOMAR, V11, P1054; Montermini L, 1997, HUM MOL GENET, V6, P1261, DOI 10.1093/hmg/6.8.1261; Morales F, 2016, DNA REPAIR, V40, P57, DOI 10.1016/j.dnarep.2016.01.001; Nazarkina ZK, 2007, DNA REPAIR, V6, P254, DOI 10.1016/j.dnarep.2006.10.002; Nolin SL, 2003, AM J HUM GENET, V72, P454, DOI 10.1086/367713; Oussatcheva EA, 2001, J BIOL CHEM, V276, P30878, DOI 10.1074/jbc.M104697200; Pan FY, 2016, SCI REP-UK, V6, DOI 10.1038/srep28614; Parildar-Karpuzoglu H, 2008, NEUROSCI LETT, V442, P287, DOI 10.1016/j.neulet.2008.07.047; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Paulson HL, 1996, ANNU REV NEUROSCI, V19, P79; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Rossner P, 2006, CANCER EPIDEM BIOMAR, V15, P811, DOI 10.1158/1055-9965.EPI-05-0659; Sak SC, 2006, CANCER EPIDEM BIOMAR, V15, P2537, DOI 10.1158/1055-9965.EPI-06-0288; Schaefer MH, 2012, NUCLEIC ACIDS RES, V40, P4273, DOI 10.1093/nar/gks011; Sobol RW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003086; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Terry PD, 2006, INT J CANCER, V118, P3170, DOI 10.1002/ijc.21768; Tirabassi G, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/298107; Tom S, 2001, J BIOL CHEM, V276, P24817, DOI 10.1074/jbc.M101673200; Tome S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003280; Turner C, 2010, J NEUROL NEUROSUR PS, V81, P358, DOI 10.1136/jnnp.2008.158261; Van Roon-Mom WMC, 2005, NEUROSCIENCE, V133, P863, DOI 10.1016/j.neuroscience.2005.03.024; Wells RD, 1996, J BIOL CHEM, V271, P2875, DOI 10.1074/jbc.271.6.2875; Xu M, 2014, NUCLEIC ACIDS RES, V42, P13749, DOI 10.1093/nar/gku1239; Xu M, 2014, NUCLEIC ACIDS RES, V42, P3675, DOI 10.1093/nar/gkt1372; Xu Meng, 2013, Nucleic Acids Res, V41, P1684, DOI 10.1093/nar/gks1306; Xu XL, 2015, GENET MOL RES, V14, P3525, DOI 10.4238/2015.April.15.16; Yamtich J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003052; Yamtich J, 2009, DNA REPAIR, V8, P579, DOI 10.1016/j.dnarep.2008.12.005; Zhang Jihong, 2012, Curr Mol Pharmacol, V5, P102; Zhang YW, 2006, CANCER EPIDEM BIOMAR, V15, P353, DOI 10.1158/1055-9965.EPI-05-0653	81	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177299	10.1371/journal.pone.0177299	http://dx.doi.org/10.1371/journal.pone.0177299			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475635	gold, Green Submitted, Green Published			2022-12-26	WOS:000400649500060
J	Valenchon, M; Levy, F; Moussu, C; Lansade, L				Valenchon, Mathilde; Levy, Frederic; Moussu, Chantal; Lansade, Lea			Stress affects instrumental learning based on positive or negative reinforcement in interaction with personality in domestic horses	PLOS ONE			English	Article							TEMPERAMENT TRAIT; TIME; FOOD; PERFORMANCE; FEARFULNESS; REACTIVITY; RESPONSES; ECOLOGY; HUMANS	The present study investigated how stress affects instrumental learning performance in horses (Equus caballus) depending on the type of reinforcement. Horses were assigned to four groups (N = 15 per group); each group received training with negative or positive reinforcement in the presence or absence of stressors unrelated to the learning task. The instrumental learning task consisted of the horse entering one of two compartments at the appearance of a visual signal given by the experimenter. In the absence of stressors unrelated to the task, learning performance did not differ between negative and positive reinforcements. The presence of stressors unrelated to the task (exposure to novel and sudden stimuli) impaired learning performance. Interestingly, this learning deficit was smaller when the negative reinforcement was used. The negative reinforcement, considered as a stressor related to the task, could have counterbalanced the impact of the extrinsic stressor by focusing attention toward the learning task. In addition, learning performance appears to differ between certain dimensions of personality depending on the presence of stressors and the type of reinforcement. These results suggest that when negative reinforcement is used (i.e. stressor related to the task), the most fearful horses may be the best performers in the absence of stressors but the worst performers when stressors are present. On the contrary, when positive reinforcement is used, the most fearful horses appear to be consistently the worst performers, with and without exposure to stressors unrelated to the learning task. This study is the first to demonstrate in ungulates that stress affects learning performance differentially according to the type of reinforcement and in interaction with personality. It provides fundamental and applied perspectives in the understanding of the relationships between personality and training abilities.	[Valenchon, Mathilde; Levy, Frederic; Moussu, Chantal; Lansade, Lea] INRA, Ctr Val Loire, UMR85, Physiol Reprod & Comportements, Nouzilly, France; [Valenchon, Mathilde; Levy, Frederic; Moussu, Chantal; Lansade, Lea] CNRS, UMR6175, Physiol Reprod & Comportements, Nouzilly, France; [Valenchon, Mathilde; Levy, Frederic; Moussu, Chantal; Lansade, Lea] Univ Tours, Tours, France; [Valenchon, Mathilde; Levy, Frederic; Moussu, Chantal; Lansade, Lea] IFCE, Nouzilly, France	INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; Universite de Tours	Valenchon, M; Lansade, L (corresponding author), INRA, Ctr Val Loire, UMR85, Physiol Reprod & Comportements, Nouzilly, France.; Valenchon, M; Lansade, L (corresponding author), CNRS, UMR6175, Physiol Reprod & Comportements, Nouzilly, France.; Valenchon, M; Lansade, L (corresponding author), Univ Tours, Tours, France.; Valenchon, M; Lansade, L (corresponding author), IFCE, Nouzilly, France.	mathilde.valenchon@yahoo.fr; lea.lansade@tours.inra.fr		Valenchon, Mathilde/0000-0003-0226-8433	Region Centre; French Horses and Riding Institute (IFCE)	Region Centre(Region Centre-Val de Loire); French Horses and Riding Institute (IFCE)	The Ph.D. grant of MV was funded by the 'Region Centre' (50%) and the French Horses and Riding Institute (IFCE) (50%). The French Horses and Riding Institut (IFCE) also funded this experiment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The first author was supported by a Ph.D. grant from the 'Region Centre' and from the French Horse and Riding Institute (IFCE). This institute also funded this experiment. We thank Guy Duchamp and Fabrice Reigner and their staff (INRA, Nouzilly, France) for allowing the use of the animals and facilities. We also thank Jean-Marie Yvon and Rejane Monteville for their assistance in data collection and Ludovic Calandreau for his help throughout this project. We are also very grateful to three anonymous reviewers for providing valuable comments on an earlier version of the manuscript.	Abbott DH, 2003, HORM BEHAV, V43, P67, DOI 10.1016/S0018-506X(02)00037-5; Akirav I, 2001, EUR J NEUROSCI, V14, P719, DOI 10.1046/j.0953-816x.2001.01687.x; Arnsten AFT, 1998, SCIENCE, V280, P1711, DOI 10.1126/science.280.5370.1711; Budaev SV, 1998, J COMP PSYCHOL, V112, P92, DOI 10.1037/0735-7036.112.1.92; Carere C, 2011, CURR ZOOL, V57, P491, DOI 10.1093/czoolo/57.4.491; Christensen JW, 2012, APPL ANIM BEHAV SCI, V140, P44, DOI 10.1016/j.applanim.2012.05.003; Cockrem JF, 2007, J ORNITHOL, V148, pS169, DOI 10.1007/s10336-007-0175-8; Cockrem JF, 2013, GEN COMP ENDOCR, V181, P45, DOI 10.1016/j.ygcen.2012.11.025; Folkedal O, 2012, PHYSIOL BEHAV, V105, P283, DOI 10.1016/j.physbeh.2011.07.015; Hausberger M, 2008, APPL ANIM BEHAV SCI, V109, P1, DOI 10.1016/j.applanim.2007.04.015; Hendriksen P, 2011, J VET BEHAV, V6, P261, DOI 10.1016/j.jveb.2011.02.007; Innes L, 2008, APPL ANIM BEHAV SCI, V112, P357, DOI 10.1016/j.applanim.2007.08.011; Jiao XL, 2011, BEHAV BRAIN RES, V221, P98, DOI 10.1016/j.bbr.2011.02.029; Joels M, 2006, TRENDS COGN SCI, V10, P152, DOI 10.1016/j.tics.2006.02.002; Joels M, 2009, NATURE REV NEUROSCIE, V10, P459; Kalat JW, 2016, INTRO PSYCHOL CENGAG; Lansade L, 2007, DEV PSYCHOBIOL, V49, P501, DOI 10.1002/dev.20233; Lansade L, 2005, ETUDE THEORIQUE APPL; Lansade L, 2008, APPL ANIM BEHAV SCI, V114, P534, DOI 10.1016/j.applanim.2008.02.012; Lansade L, 2008, APPL ANIM BEHAV SCI, V114, P492, DOI 10.1016/j.applanim.2008.04.012; Lansade L, 2008, APPL ANIM BEHAV SCI, V109, P355, DOI 10.1016/j.applanim.2007.03.003; Lansade L, 2010, APPL ANIM BEHAV SCI, V125, P30, DOI 10.1016/j.applanim.2010.02.010; Lansade L, 2008, APPL ANIM BEHAV SCI, V115, P182, DOI 10.1016/j.applanim.2008.06.011; Laraway S, 2003, J APPL BEHAV ANAL, V36, P407, DOI 10.1901/jaba.2003.36-407; LeScolan N, 1997, BEHAV PROCESS, V41, P257, DOI 10.1016/S0376-6357(97)00052-1; Lesimple C, 2011, APPL ANIM BEHAV SCI, V129, P92, DOI 10.1016/j.applanim.2010.11.005; McDonnell S.M, 2003, EQUID ETHOGRAM PRACT; McDonnell SM, 2002, APPL ANIM BEHAV SCI, V78, P263, DOI 10.1016/S0168-1591(02)00112-0; Mendl M, 1999, APPL ANIM BEHAV SCI, V65, P221, DOI 10.1016/S0168-1591(99)00088-X; Minero M, 2009, ITAL J ANIM SCI, V8, P219, DOI 10.4081/ijas.2009.s1.219; Murphy J, 2007, BEHAV PROCESS, V76, P1, DOI 10.1016/j.beproc.2006.06.009; Nicol CJ, 2002, APPL ANIM BEHAV SCI, V78, P193, DOI 10.1016/S0168-1591(02)00093-X; Pritchett LC, 2003, APPL ANIM BEHAV SCI, V80, P31, DOI 10.1016/S0168-1591(02)00205-8; Range F, 2006, BEHAV PROCESS, V73, P100, DOI 10.1016/j.beproc.2006.04.002; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Sandi Carmen, 2007, Neural Plasticity, V2007, DOI 10.1055/2007/78970; Sankey C, 2010, ANIM COGN, V13, P753, DOI 10.1007/s10071-010-0326-9; Sankey C, 2010, ANIM BEHAV, V79, P869, DOI 10.1016/j.anbehav.2009.12.037; Scheid C, 2010, ANIM COGN, V13, P545, DOI 10.1007/s10071-009-0305-1; Schwabe L, 2010, NEUROSCI BIOBEHAV R, V34, P584, DOI 10.1016/j.neubiorev.2009.11.015; Sih A, 2012, PHILOS T R SOC B, V367, P2762, DOI 10.1098/rstb.2012.0216; SORG BA, 1992, J RES PERS, V26, P235, DOI 10.1016/0092-6566(92)90041-2; Upton KR, 2013, DOMEST ANIM ENDOCRIN, V44, P157, DOI 10.1016/j.domaniend.2012.10.001; Valenchon M, 2013, ANIMAL COGNITION, P1; Valenchon M, 2013, ANIM BEHAV, V86, P1233, DOI 10.1016/j.anbehav.2013.09.026; Valenchon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062324; von Borstel UU, 2009, APPL ANIM BEHAV SCI, V116, P228, DOI 10.1016/j.applanim.2008.10.001; Warren-Smith AK, 2007, ANIM WELFARE, V16, P481	48	22	23	4	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0170783	10.1371/journal.pone.0170783	http://dx.doi.org/10.1371/journal.pone.0170783			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SX	28475581	Green Published, Green Submitted, gold			2022-12-26	WOS:000400649500001
J	Fakhraei, L; Gautam, SH; Shew, WL				Fakhraei, Leila; Gautam, Shree Hari; Shew, Woodrow L.			State-dependent intrinsic predictability of cortical network dynamics	PLOS ONE			English	Article							NEURONAL AVALANCHES; ACTIVITY PATTERNS; NEURAL ACTIVITY; SIMPLE-MODEL; VARIABILITY; CORTEX; EXCITATION/INHIBITION; CONSCIOUSNESS	The information encoded in cortical circuit dynamics is fleeting, changing from moment to moment as new input arrives and ongoing intracortical interactions progress. A combination of deterministic and stochastic biophysical mechanisms governs how cortical dynamics at one moment evolve from cortical dynamics in recently preceding moments. Such temporal continuity of cortical dynamics is fundamental to many aspects of cortex function but is not well understood. Here we study temporal continuity by attempting to predict cortical population dynamics (multisite local field potential) based on its own recent history in somatosensory cortex of anesthetized rats and in a computational network-level model. We found that the intrinsic predictability of cortical dynamics was dependent on multiple factors including cortical state, synaptic inhibition, and how far into the future the prediction extends. By pharmacologically tuning synaptic inhibition, we obtained a continuum of cortical states with asynchronous population activity at one extreme and stronger, spatially extended synchrony at the other extreme. Intermediate between these extremes we observed evidence for a special regime of population dynamics called criticality. Predictability of the near future (10-100 ms) increased as the cortical state was tuned from asynchronous to synchronous. Predictability of the more distant future (> 1 s) was generally poor, but, surprisingly, was higher for asynchronous states compared to synchronous states. These experimental results were confirmed in a computational network model of spiking excitatory and inhibitory neurons. Our findings demonstrate that determinism and predictability of network dynamics depend on cortical state and the time-scale of the dynamics.	[Fakhraei, Leila; Gautam, Shree Hari; Shew, Woodrow L.] Univ Arkansas, Dept Phys, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville	Shew, WL (corresponding author), Univ Arkansas, Dept Phys, Fayetteville, AR 72701 USA.	shew@uark.edu		Shew, Woodrow/0000-0003-0679-1766	Arkansas Biosciences Institute [0055, 0070]; University of Arkansas	Arkansas Biosciences Institute; University of Arkansas	WLS and SHG were funded by the Arkansas Biosciences Institute (Grants 0055 and 0070; http://arbiosciences.org/). WLS and LF were funded by University of Arkansas. There was no additional funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Beggs JM, 2003, J NEUROSCI, V23, P11167; Bellay T, 2015, ELIFE, V4, DOI 10.7554/eLife.07224; Ching SN, 2014, CURR OPIN NEUROBIOL, V25, P116, DOI 10.1016/j.conb.2013.12.011; Clement EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002004; Contreras EJB, 2013, NEURON, V79, P555, DOI 10.1016/j.neuron.2013.06.013; Curto C, 2009, J NEUROSCI, V29, P10600, DOI 10.1523/JNEUROSCI.2053-09.2009; Dehghani N, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00302; Fagerholm ED, 2015, J NEUROSCI, V35, P4626, DOI 10.1523/JNEUROSCI.3694-14.2015; Favero M, 2012, J NEUROPHYSIOL, V108, P1010, DOI 10.1152/jn.00256.2012; Gautam H, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004576; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Haimovici A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.178101; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Harris T. E., 1963, THEORY BRANCHING PRO; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Larremore DB, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.138103; Larremore DB, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066131; Meisel C, 2013, J NEUROSCI, V33, P17363, DOI 10.1523/JNEUROSCI.1516-13.2013; Munoz MA, 1999, PHYS REV E, V59, P6175, DOI 10.1103/PhysRevE.59.6175; Neumaier A, 2001, ACM T MATH SOFTWARE, V27, P27, DOI 10.1145/382043.382304; Okun M, 2010, J NEUROSCI, V30, P4440, DOI 10.1523/JNEUROSCI.5062-09.2010; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Poil SS, 2012, J NEUROSCI, V32, P9817, DOI 10.1523/JNEUROSCI.5990-11.2012; Populin LC, 2005, J NEUROSCI, V25, P5903, DOI 10.1523/JNEUROSCI.1147-05.2005; Renart A, 2014, CURR OPIN NEUROBIOL, V25, P211, DOI 10.1016/j.conb.2014.02.013; Ribeiro TL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014129; Scott G, 2014, J NEUROSCI, V34, P16611, DOI 10.1523/JNEUROSCI.3474-14.2014; Shew WL, 2015, NAT PHYS, V11, P659, DOI 10.1038/NPHYS3370; Shew WL, 2011, J NEUROSCI, V31, P55, DOI 10.1523/JNEUROSCI.4637-10.2011; Shew WL, 2009, J NEUROSCI, V29, P15595, DOI 10.1523/JNEUROSCI.3864-09.2009; Solovey G, 2015, J NEUROSCI, V35, P10866, DOI 10.1523/JNEUROSCI.4895-14.2015; Solovey G, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00044; Steriade M., 2003, NEURONAL SUBSTRATES; Truccolo W, 2010, NAT NEUROSCI, V13, P105, DOI 10.1038/nn.2455; Vinck M, 2015, NEURON, V86, P740, DOI 10.1016/j.neuron.2015.03.028	37	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0173658	10.1371/journal.pone.0173658	http://dx.doi.org/10.1371/journal.pone.0173658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472037	Green Published, gold			2022-12-26	WOS:000400648500002
J	Hartung, N; Huynh, CTK; Gaudy-Marqueste, C; Flavian, A; Malissen, N; Richard-Lallemand, MA; Hubert, F; Grob, JJ				Hartung, Niklas; Huynh, Cecilia T. -K.; Gaudy-Marqueste, Caroline; Flavian, Antonin; Malissen, Nausicaa; Richard-Lallemand, Marie-Aleth; Hubert, Florence; Grob, Jean-Jacques			Study of metastatic kinetics in metastatic melanoma treated with B-RAF inhibitors: Introducing mathematical modelling of kinetics into the therapeutic decision	PLOS ONE			English	Article							COMPETING RISKS; RESISTANCE; VEMURAFENIB; SURVIVAL; BRAF(V600E); REVEALS; PATHWAY	Background Evolution of metastatic melanoma (MM) under B-RAF inhibitors (BRAFi) is unpredictable, but anticipation is crucial for therapeutic decision. Kinetics changes in metastatic growth are driven by molecular and immune events, and thus we hypothesized that they convey relevant information for decision making. Patients and methods We used a retrospective cohort of 37 MM patients treated by BRAFi only with at least 2 close CT-scans available before BRAFi, as a model to study kinetics of metastatic growth before, under and after BRAFi. All metastases (mets) were individually measured at each CT-scan. From these measurements, different measures of growth kinetics of each met and total tumor volume were computed at different time points. A historical cohort permitted to build a reference model for the expected spontaneous disease kinetics without BRAFi. All variables were included in Cox and multistate regression models for survival, to select best candidates for predicting overall survival. Results Before starting BRAFi, fast kinetics and moreover a wide range of kinetics (fast and slow growing mets in a same patient) were pejorative markers. At the first assessment after BRAFi introduction, high heterogeneity of kinetics predicted short survival, and added independent information over RECIST progression in multivariate analysis. Metastatic growth rates after BRAFi discontinuation was usually not faster than before BRAFi introduction, but they were often more heterogeneous than before. Conclusions Monitoring kinetics of different mets before and under BRAFi by repeated CT-scan provides information for predictive mathematical modelling. Disease kinetics deserves more interest	[Hartung, Niklas] Free Univ Berlin, Inst Pharm, Dept Clin Pharm & Biochem, Berlin, Germany; [Huynh, Cecilia T. -K.; Gaudy-Marqueste, Caroline; Malissen, Nausicaa; Richard-Lallemand, Marie-Aleth; Grob, Jean-Jacques] Aix Marseille Univ, AP HM, Dermatol & Skin Cancers Dept, Marseille, France; [Gaudy-Marqueste, Caroline; Richard-Lallemand, Marie-Aleth; Grob, Jean-Jacques] Aix Marseille Univ, CRO2, UMR S 911, Marseille, France; [Flavian, Antonin] Hop La Timone, AP HM, Radiol Dept, Marseille, France; [Hubert, Florence] Aix Marseille Univ, CNRS, I2M, UMR 7373,Cent Marseille, Marseille, France; [Hartung, Niklas] Univ Potsdam, Inst Math, Potsdam, Germany	Free University of Berlin; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Aix-Marseille Universite; University of Potsdam	Gaudy-Marqueste, C (corresponding author), Aix Marseille Univ, AP HM, Dermatol & Skin Cancers Dept, Marseille, France.; Gaudy-Marqueste, C (corresponding author), Aix Marseille Univ, CRO2, UMR S 911, Marseille, France.	caroline.gaudy@ap-hm.fr	Gaudy-Marqueste, caroline/AAN-1402-2021	Gaudy-Marqueste, caroline/0000-0001-6955-5117; Hartung, Niklas/0000-0002-4000-6525; Sempe, Christine/0000-0001-6903-1575	F. Hoffmann-La Roche Pharmaceutical	F. Hoffmann-La Roche Pharmaceutical(Hoffmann-La Roche)	This work was funded by a grant from F. Hoffmann-La Roche Pharmaceutical. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PK, 2002, STAT METHODS MED RES, V11, P91, DOI 10.1191/0962280202SM276ra; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bucheit AD, 2014, BIOCHEM PHARMACOL, V87, P381, DOI 10.1016/j.bcp.2013.11.013; de Wreede LC, 2011, J STAT SOFTW, V38, P1; de Wreede LC, 2010, COMPUT METH PROG BIO, V99, P261, DOI 10.1016/j.cmpb.2010.01.001; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fallahi-Sichani M, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145877; Gaudy-Marqueste C, 2014, EUR J CANCER, V50, P1120, DOI 10.1016/j.ejca.2013.12.015; Girotti M. R., 2015, CANC DISCOVERY; Grob JJ, 2015, LANCET ONCOL, V16, pE522, DOI 10.1016/S1470-2045(15)00003-0; Hoogstraat Marlous, 2015, Pigment Cell Melanoma Res, V28, P318, DOI 10.1111/pcmr.12347; Kemper K, 2015, EMBO MOL MED, V7, P1104, DOI 10.15252/emmm.201404914; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Larkin J, 2014, LANCET ONCOL, V15, P436, DOI 10.1016/S1470-2045(14)70051-8; LEBLANC M, 1992, BIOMETRICS, V48, P411, DOI 10.2307/2532300; Long GV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6694; Ma XH, 2011, CLIN CANCER RES, V17, P3478, DOI 10.1158/1078-0432.CCR-10-2372; McArthur GA, 2014, LANCET ONCOL, V15, P323, DOI 10.1016/S1470-2045(14)70012-9; Menzies AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085004; Monsma DJ, 2015, AM J CANCER RES, V5, P1507; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Qendro V, 2014, J PROTEOME RES, V13, P5031, DOI 10.1021/pr5006789; R Core Team, 2013, R LANG ENV STAT COMP; Rizos H, 2014, CLIN CANCER RES, V20, P1965, DOI 10.1158/1078-0432.CCR-13-3122; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Smith MP, 2014, CANCER DISCOV, V4, P1214, DOI 10.1158/2159-8290.CD-13-1007; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Therneau T, 2015, RPART RECURSIVE PART; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Therneau T. M., 1990, BIOMETRIKA; Therneau T.M., 2000, MODELING SURVIVAL DA	31	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176080	10.1371/journal.pone.0176080	http://dx.doi.org/10.1371/journal.pone.0176080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472075	Green Submitted, Green Published, gold			2022-12-26	WOS:000400648500024
J	Jesus, DA; Majewska, M; Krzyzanowska-Berkowska, P; Iskander, DR				Jesus, Danilo A.; Majewska, Malgorzata; Krzyzanowska-Berkowska, Patrycja; Iskander, D. Robert			Influence of eye biometrics and corneal micro-structure on noncontact tonometry	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; INTRAOCULAR-PRESSURE; BIOMECHANICAL PROPERTIES; DIABETES-MELLITUS; IN-VIVO; THICKNESS; GLAUCOMA; SPECKLE; PARAMETERS; HYSTERESIS	Purpose Tonometry is widely used as the main screening tool supporting glaucoma diagnosis. Still, its accuracy could be improved if full knowledge about the variation of the corneal biomechanical properties was available. In this study, Optical Coherence Tomography (OCT) speckle statistics are used to infer the organisation of the corneal micro-structure and hence, to analyse its influence on intraocular pressure (IOP) measurements. Methods Fifty-six subjects were recruited for this prospective study. Macro and micro-structural corneal parameters as well as subject age were considered. Macro-structural analysis included the parameters that are associated with the ocular anatomy, such as central corneal thickness (CCT), corneal radius, axial length, anterior chamber depth and white-to-white corneal diameter. Micro-structural parameters which included OCT speckle statistics were related to the internal organisation of the corneal tissue and its physiological changes during lifetime. The corneal speckle obtained from OCT was modelled with the Generalised Gamma (GG) distribution that is characterised with a scale parameter and two shape parameters. Results In macro-structure analysis, only CCT showed a statistically significant correlation with IOP (R-2 = 0.25, p<0.001). The scale parameter and the ratio of the shape parameters of GG distribution showed statistically significant correlation with IOP (R-2 = 0.19, p<0.001 and R-2 = 0.17, p<0.001, respectively). For the studied group, a weak, although significant correlation was found between age and IOP (R-2 = 0.053, p = 0.04). Forward stepwise regression showed that CCT and the scale parameter of the Generalised Gamma distribution can be combined in a regression model (R-2 = 0.39, p<0.001) to study the role of the corneal structure on IOP. Conclusions We show, for the first time, that corneal micro-structure influences the IOP measurements obtained from noncontact tonometry. OCT speckle statistics can be employed to learn about the corneal micro-structure and hence, to further calibrate the IOP measurements.	[Jesus, Danilo A.; Majewska, Malgorzata; Iskander, D. Robert] Wroclaw Univ Sci & Technol, Dept Biomed Engn, Wroclaw, Poland; [Krzyzanowska-Berkowska, Patrycja] Wroclaw Med Univ, Dept Ophthalmol, Wroclaw, Poland	Wroclaw University of Science & Technology; Wroclaw Medical University	Jesus, DA (corresponding author), Wroclaw Univ Sci & Technol, Dept Biomed Engn, Wroclaw, Poland.	danilo.jesus@pwr.edu.pl	Iskander, D Robert/E-3576-2017; De Jesus, Danilo Andrade/R-3790-2019	Iskander, D Robert/0000-0002-5962-6206; De Jesus, Danilo Andrade/0000-0001-5799-4163; Krzyzanowska-Berkowska, Patrycja/0000-0001-8034-2534	National Science Centre, Poland [2014/15/B/ST7/05220]; Marie Curie Innovative Training Networks, Ageing Eye, AGEYE [608049]	National Science Centre, Poland(National Science Centre, Poland); Marie Curie Innovative Training Networks, Ageing Eye, AGEYE	This work was supported by the Marie Curie Innovative Training Networks, Ageing Eye, AGEYE, 608049 and partially funded by National Science Centre, Poland, Grant No: 2014/15/B/ST7/05220.	Abramowitz M., 1967, HDB MATH FUNCTIONS; Akman A, 2015, BR J OPHTHALMOL; Amini Z, 2016, IEEE T MED IMAGING, V35, P1544, DOI 10.1109/TMI.2016.2519439; Asejczyk-Widlicka M, 2008, BRIT J OPHTHALMOL, V92, P1415, DOI 10.1136/bjo.2008.140178; Baneros-Rojas P, 2014, Arch Soc Esp Oftalmol, V89, P260, DOI 10.1016/j.oftal.2014.02.001; Bao FJ, 2016, J GLAUCOMA, V25, P510, DOI 10.1097/IJG.0000000000000359; Caixinha M, 2014, IEEE T BIO-MED ENG, V61, P2921, DOI 10.1109/TBME.2014.2335739; Cavallotti CAP., 2008, AGE RELATED CHANGES, DOI 10.1007/978-1-59745-507-7; Elsheikh A, 2008, CURR EYE RES, V33, P205, DOI 10.1080/02713680701882519; Elsheikh A, 2013, J GLAUCOMA, V22, P156, DOI 10.1097/IJG.0b013e3182312010; Elsheikh A, 2010, J R SOC INTERFACE, V7, P1475, DOI 10.1098/rsif.2010.0108; Farage M. A., 2008, International Journal of Cosmetic Science, V30, P87, DOI 10.1111/j.1468-2494.2007.00415.x; Farhat G, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3544543; Galgauskas S, 2014, CLIN INTERV AGING, V9, DOI 10.2147/CIA.S61790; Glass DH, 2008, INVEST OPHTH VIS SCI, V49, P3919, DOI 10.1167/iovs.07-1321; Goldich Y, 2009, J CATARACT REFR SURG, V35, P715, DOI 10.1016/j.jcrs.2008.12.013; Good TJ, 2011, BRIT J OPHTHALMOL, V95, P1111, DOI 10.1136/bjo.2010.180729; Gronniger E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000971; Grzywacz NM, 2010, IEEE T MED IMAGING, V29, P1224, DOI 10.1109/TMI.2009.2038375; Gunvant P, 2004, BRIT J OPHTHALMOL, V88, P518, DOI 10.1136/bjo.2003.019331; Hoffmann EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066158; Hong JX, 2013, INVEST OPHTH VIS SCI, V54, P659, DOI 10.1167/iovs.12-10984; Jesus DA, 2017, BIOMED OPT EXPRESS, V8, P162, DOI 10.1364/BOE.8.000162; Jesus DA, 2015, IEEE ENG MED BIO, P5659, DOI 10.1109/EMBC.2015.7319676; Joda AA, 2016, COMPUT METHOD BIOMEC, V19, P943, DOI 10.1080/10255842.2015.1077515; Kirillin MY, 2014, OPT LETT, V39, P3472, DOI 10.1364/OL.39.003472; Kohlhaas M, 2006, ARCH OPHTHALMOL-CHIC, V124, P471, DOI 10.1001/archopht.124.4.471; Kotecha A, 2007, SURV OPHTHALMOL, V52, pS109, DOI 10.1016/j.survophthal.2007.08.004; LACHIN JM, 1981, CONTROL CLIN TRIALS, V2, P93, DOI 10.1016/0197-2456(81)90001-5; Lindenmaier AA, 2013, OPT LETT, V38, P1280, DOI 10.1364/OL.38.001280; Liu J, 2005, J CATARACT REFR SURG, V31, P146, DOI 10.1016/j.jcrs.2004.09.031; Patel SV, 2001, INVEST OPHTH VIS SCI, V42, P333; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Scheler A, 2012, ACTA OPHTHALMOL, V90, pe447, DOI 10.1111/j.1755-3768.2012.02437.x; Schmitt JM, 1999, J BIOMED OPT, V4, P95, DOI 10.1117/1.429925; Scholz F. W., 2006, ENCY STAT SCI; Shah S, 2007, INVEST OPHTH VIS SCI, V48, P3026, DOI 10.1167/iovs.04-0694; Shankar PM, 2001, IEEE T ULTRASON FERR, V48, P1716, DOI 10.1109/58.971725; Shimmyo M, 2003, AM J OPHTHALMOL, V136, P603, DOI 10.1016/S0002-9394(03)00424-0; Spoerl E, 2012, J GLAUCOMA, V1; STACY EW, 1965, TECHNOMETRICS, V7, P349, DOI 10.2307/1266594; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Tunis AS, 2005, ULTRASOUND MED BIOL, V31, P1041, DOI 10.1016/j.ultrasmedbio.2005.04.020; Urcola JH, 2006, EXP EYE RES, V83, P429, DOI 10.1016/j.exer.2006.01.025; Vinciguerra R, 2016, J REFRACT SURG, V32, P550, DOI 10.3928/1081597X-20160524-01; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192	46	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177180	10.1371/journal.pone.0177180	http://dx.doi.org/10.1371/journal.pone.0177180			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472178	Green Published, gold, Green Submitted			2022-12-26	WOS:000400648500150
J	Li, Q; Ye, HJ; Ding, YG; Chen, G; Liu, ZC; Xu, JA; Chen, RX; Yang, HS				Li, Qian; Ye, Huijing; Ding, Yungang; Chen, Guo; Liu, Zhichang; Xu, Jianan; Chen, Rongxin; Yang, Huasheng			Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases	PLOS ONE			English	Article								Thyroid associated ophthalmopathy (TAO) is an autoimmune inflammatory disorder which disfigures appearance, threatens vision, and results in a pronounced loss of quality of life. The diversity and ethnic difference of the disease manifestations have made it difficult to tailor therapies for each patient. Few studies have analyzed its characteristics in Chinese populations. We therefore enrolled 354 patients with moderate-to-severe TAO from February 2015 to July 2016. A single ophthalmologist consistently performed detailed ophthalmic examinations. Orbital computed tomography or magnetic resonance imaging scans were performed to verify enlarged extraocular muscles. Multiple linear regression was used to analyze the association between sex, age, smoking, family history of thyroid diseases, degree of proptosis and disease severity. The mean age of males (46.56 +/- 11.08 years) was significantly higher than that of females (41.39 +/- years), with a female-to-male ratio of 1.09. The females and males between 31 similar to 40 and 41 similar to 50 years, respectively, had the highest incidence of TAO. 81.48% of the patients suffered hyperthyroidism. TAO was diagnosed either after (47.17%) or simultaneously with thyroid dysfunction (27.68%). Proptosis (91.24%), eyelid retraction (83.33%), together with eyelid swelling (79.38%) and extraocular muscle enlargement (75.42%), were the most common clinical sign. 19.77% of patients manifested lower eyelid retraction. The mean values of exophthalmos and asymmetry on proptosis were 19.94 +/- 3.45mm and 2.1 +/- 2.06mm, respectively in males, 18.58 +/- 3.31mm and 1.61 +/- 1.53mm, respectively in females. The severity of disease was significantly associated with male, older age, smoking, family history of thyroid diseases and degree of proptosis. We found several differences in Chinese compared with White. The female-to-male ratio and mean value of exophthalmos were significantly lower than the data of White. Inferior and superior rectus became the most common extraocular muscles. Lower eyelid retraction should be included in diagnostic criteria in Asian patients. Understanding these differences, may allow better identification and treatment for TAO in China.	[Li, Qian; Ye, Huijing; Ding, Yungang; Chen, Guo; Liu, Zhichang; Xu, Jianan; Chen, Rongxin; Yang, Huasheng] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Ding, Yungang] Qingdao Ludong Eye Hosp, Qingdao, Shandong, Peoples R China	Sun Yat Sen University	Yang, HS (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China.	yanghs64@126.com		Yang, Huasheng/0000-0003-2767-8623	National Natural Science Foundation of China [81470664, 81670887]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Publication of this article was supported by the National Natural Science Foundation of China (81470664 and 81670887). The funding organizations had no role in the design or conduct of this research.; All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. All authors have no potential conflicts of interest. Publication of this article was supported by the National Natural Science Foundation of China (81470664). The funding organizations had no role in the design or conduct of this research. Qian Li and Huasheng Yang had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.	Abraham-Nordling M, 2011, EUR J ENDOCRINOL, V165, P899, DOI 10.1530/EJE-11-0548; Andersen S, 2012, J CLIN ENDOCR METAB, V97, P8; [Anonymous], 2015, HORM METAB RES, V447, P6; [Anonymous], 1992, THYROID, V2, P2; [Anonymous], 2002, EUR J ENDOCRINOL, V146, P9; Bahn RS, 2010, NEW ENGL J MED, V362, P726, DOI 10.1056/NEJMra0905750; Balazs C S V, 1990, LANCET, V336, P1; Bartalena L M C, 1998, ANN INTERN MED, V129, P4; Bartalena L P A, ENDOCR REV ENDOCR RE, V21, P31; Bartley GB, 1996, AM J OPHTHALMOL, V121, P200, DOI 10.1016/S0002-9394(14)70585-9; BARTLEY GB, 1995, AM J OPHTHALMOL, V119, P96, DOI 10.1016/S0002-9394(14)73821-8; BERGHOUT A, 1988, J ENDOCRINOL INVEST, V11, P15, DOI 10.1007/BF03350087; Blake CR L W, 2003, INT OPHTHALMOL CLIN, V43, P17; Chng CL, 2012, BEST PRACT RES CLIN, V26, P10; Cmelo J C M, 2006, CESK SLOV OFTALMOL, V62, P8; Douglas RS G S, 2011, CURR OPIN OPHTHALMOL, V22, P6; Eckstein AK P M, 2006, J CLIN ENDOCR METAB, V91, P7; Enzmann DR, 1979, J COMPUT ASSIST TOMO, V3, P5; Estcourt S H J, 2009, EUR J ENDOCRINOL, V161, P5; Ewa Fidor-Mikita WK, 2008, J PRECLINICAL CLIN R, V2, P5; FRUEH BR, 1986, OPHTHALMIC SURG LAS, V17, P37; GB B, 1994, T AM OPHTHALMOL SOC, P111; Hegedius L B T, 2004, J ENDOCRINOL INVEST, V27, P7; JH L, 2012, BEST PRACT RES CLIN, V26, P7; Kahaly G B H, 1990, J ENDOCRINOL INVEST, V13, P6; Kendler DL L J, 1993, ARCH OPHTHALMOL-CHIC, V111, P5; Kozaki A I R, 2010, OPTOMETRY VISION SCI, V87, P5; Kumari Sodhi P G V, 2001, ORBIT, V20, P9; Lee JH L S, 2010, KOREAN J OPHTHALMOL, V24, P8; Lim NC S G, 2015, BR J OPHTHALMOL, V99, P7; Lim SL L A, 2008, THYROID, V18, P5; Manji N J C-S, 2006, J CLIN ENDOCR METAB, V91, P8; Migliori ME G G., 1984, AM J OPHTHALMOL, V98, P5; Mourits MP, 1997, CLIN ENDOCRINOL, V47, P9, DOI 10.1046/j.1365-2265.1997.2331047.x; Murchison AP, 2009, ARCH FACIAL PLAST S, V11, P303, DOI 10.1001/archfacial.2009.9; Naik VM N M, 2010, SURV OPHTHALMOL, V55, P12; Perros P C A, 1993, CLIN ENDOCRINOL OXF, V38, P6; Perros P Z M, 2015, BR J OPHTHALMOL, V99, P5; Ponto KA H G, 2011, AM J OPHTHALMOL, V152, P8; Ponto KA K M, 2011, OPHTHALMOLOGY, V118, P7; Prummel MFWW, 1993, JAMA-J AM MED ASSOC, V269, P4; Rapoport B M S, 2007, THYROID, V17, P12; Scott IU, 1999, SEMIN OPHTHALMOL, V14, P10; Sheikh M A S, 2007, AUSTRALAS RADIOL, V51, P4; Smith TJ, 2015, NAT REV ENDOCRINOL, V11, P171, DOI 10.1038/nrendo.2014.226; Tsai CC K H, 2006, EYE LOND, V20, P5; Wang Y, 2014, INVEST OPHTH VIS SCI, V55, P1735, DOI 10.1167/iovs.14-14002; WIERSINGA WM, 1989, OPHTHALMIC RES, V21, P73, DOI 10.1159/000266782; WiersingaWilmar MK G J, 2010, GRAVES ORBITOPATHY M, P11; WMW, 2013, CLIN ENDOCRINOL OXF, V79, P7; WMW, 2012, INDIAN J ENDOCRIN S2, V16, P3; Wu D L X, 2015, SCI REP, V23	52	23	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176064	10.1371/journal.pone.0176064	http://dx.doi.org/10.1371/journal.pone.0176064			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472149	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500022
J	Langen, EMA; von Engelhardt, N; Goerlich-Jansson, VC				Langen, Esther M. A.; von Engelhardt, Nikolaus; Goerlich-Jansson, Vivian C.			Social environment during egg laying: Changes in plasma hormones with no consequences for yolk hormones or fecundity in female Japanese quail, Coturnix japonica	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; TESTOSTERONE LEVELS; GROUP-SIZE; MATERNAL TESTOSTERONE; ELEVATED TESTOSTERONE; INDIVIDUAL VARIATION; CHALLENGE HYPOTHESIS; INCUBATION BEHAVIOR; OFFSPRING PHENOTYPE; BREEDING DENSITY	The social environment can have profound effects on an individual's physiology and behaviour and on the transfer of resources to the next generation, with potential consequences for fecundity and reproduction. However, few studies investigate all of these aspects at once. The present study housed female Japanese quail (Coturnix japonica) in pairs or groups to examine the effects on hormone concentrations in plasma and yolk and on reproductive performance. Circulating levels of androgens (testosterone and 5-alpha-dihydrotestosterone) and corticosterone were measured in baseline samples and after standardised challenges to assess the responsiveness of the females' endocrine axes. Effects of the social environment on female fecundity were analysed by measuring egg production, egg mass, fertilization rates, and number of hatched offspring. Counter to expectation, females housed in pairs had higher plasma androgen concentrations and slightly higher corticosterone concentrations than females housed in groups, although the latter was not statistically significant. Pair vs. group housing did not affect the females' hormonal response to standardised challenges or yolk testosterone levels. In contrast to previous studies, the females' androgen response to a gonadotropin-releasing hormone challenge was not related to yolk testosterone levels. Non-significant trends emerged for pair-housed females to have higher egg-laying rates and higher fertility, but no differences arose in egg weight or in the number, weight or size of hatchlings. We propose that our unexpected findings are due to differences in the adult sex ratio in our social treatments. In pairs, the male may stimulate female circulating hormone levels more strongly than in groups where effects are diluted due to the presence of several females. Future studies should vary both group size and sex composition to disentangle the significance of sexual, competitive and affiliative social interactions for circulating and yolk hormone levels, and their consequences for subsequent generations.	[Langen, Esther M. A.] Bielefeld Univ, Dept Anim Behav, Bielefeld, Germany; [Langen, Esther M. A.; Goerlich-Jansson, Vivian C.] Univ Utrecht, Dept Anim Sci & Soc, Utrecht, Netherlands; [von Engelhardt, Nikolaus] Univ Plymouth, Fac Sci & Engn, Plymouth, Devon, England	University of Bielefeld; Utrecht University; University of Plymouth	Langen, EMA (corresponding author), Bielefeld Univ, Dept Anim Behav, Bielefeld, Germany.; Langen, EMA (corresponding author), Univ Utrecht, Dept Anim Sci & Soc, Utrecht, Netherlands.	emalangen@gmail.com	von Engelhardt, Nikolaus/B-6730-2008	von Engelhardt, Nikolaus/0000-0003-4971-6408	Volkswagen Foundation [Az 86 005]; German Research Foundation (DFG); Open Access Publication Fund of Bielefeld University	Volkswagen Foundation(Volkswagen); German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Fund of Bielefeld University	Funding was provided by the Volkswagen Foundation (www.volkswagenstiftung.de), Grant no. Az 86 005 (acquired by VGJ). We acknowledge the financial support of the German Research Foundation (DFG - www.dfg.de) and the Open Access Publication Fund of Bielefeld University (http://oa.uni-bielefeld.de/en/publikationsfonds.html) for the article processing charge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Aline Bertin and her colleagues at the INRA in Nouzilly, France for their helpful advice and for providing us with our first generation of Japanese quail. We also thank Irene de la Casa, Kathrin Engel, Judith Hendriks, Elke Hippauf and Susanne Kirchhoff for their help in the lab, Miriam Henning, Tim Ruploh, Serena Schmidt and Janina Schwenniger for helping with the experimental procedures, the animal caretakers for looking after the birds, and Suzanne von Engelhardt for editing the language of the manuscript. We thank two anonymous referees for their constructive comments. We gratefully acknowledge grant support from the Volkswagen Foundation (Az 86 005, acquired by VGJ), the financial support of the German Research Foundation (DFG) and the Open Access Publication Fund of Bielefeld University for the article processing charge.	Adkins-Regan E., 2005, HORMONES ANIMAL SOCI, P34; Adkins-Regan E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131786; ADKINSREGAN E, 1995, ANIM BEHAV, V50, P1405, DOI 10.1016/0003-3472(95)80055-7; Angelier F, 2010, BIOL LETTERS, V6, P846, DOI 10.1098/rsbl.2010.0376; BACON WL, 1971, POULTRY SCI, V50, P233, DOI 10.3382/ps.0500233; Badyaev AV, 2008, ANN NY ACAD SCI, V1133, P151, DOI 10.1196/annals.1438.009; Ball GF, 2008, PHILOS T R SOC B, V363, P1699, DOI 10.1098/rstb.2007.0010; BALTHAZART J, 1983, GEN COMP ENDOCR, V51, P191, DOI 10.1016/0016-6480(83)90072-2; Bentley GE, 2000, HORM BEHAV, V37, P179, DOI 10.1006/hbeh.2000.1573; Bentz AB, 2013, HORM BEHAV, V64, P729, DOI 10.1016/j.yhbeh.2013.08.009; Bonier F, 2009, TRENDS ECOL EVOL, V24, P634, DOI 10.1016/j.tree.2009.04.013; Bonier F, 2009, GEN COMP ENDOCR, V163, P208, DOI 10.1016/j.ygcen.2008.12.013; BROCKWAY BF, 1965, ANIM BEHAV, V13, P575, DOI 10.1016/0003-3472(65)90123-5; Burtka JL, 2016, GEN COMP ENDOCR, V229, P92, DOI 10.1016/j.ygcen.2016.03.010; Cain KE, 2013, HORM BEHAV, V64, P685, DOI 10.1016/j.yhbeh.2013.09.002; Cain KE, 2012, BEHAV ECOL SOCIOBIOL, V66, P241, DOI 10.1007/s00265-011-1272-5; Campo JL, 2002, POULTRY SCI, V81, P1099, DOI 10.1093/ps/81.8.1099; Cantarero A, 2015, ETHOLOGY, V121, P946, DOI 10.1111/eth.12407; Cheng K. M., 2010, The UFAW handbook on the care and management of laboratory and other research animals, P655, DOI 10.1002/9781444318777.ch42; CHENG MF, 1975, PSYCHONEUROENDOCRINO, V1, P95, DOI 10.1016/0306-4530(75)90026-8; Correa SM, 2011, HORM BEHAV, V59, P556, DOI 10.1016/j.yhbeh.2011.02.009; Creel S, 2013, FUNCT ECOL, V27, P66, DOI 10.1111/j.1365-2435.2012.02029.x; CUNNINGHAM DL, 1987, APPL ANIM BEHAV SCI, V17, P139, DOI 10.1016/0168-1591(87)90016-5; DAVAMI A, 1987, POULTRY SCI, V66, P251, DOI 10.3382/ps.0660251; de Jong B, 2016, GEN COMP ENDOCR, V230, P38, DOI 10.1016/j.ygcen.2016.02.017; DeVries MS, 2015, ANIM BEHAV, V107, P139, DOI 10.1016/j.anbehav.2015.06.016; Dufty AM, 2002, TRENDS ECOL EVOL, V17, P190, DOI 10.1016/S0169-5347(02)02498-9; Eisenegger C, 2011, TRENDS COGN SCI, V15, P263, DOI 10.1016/j.tics.2011.04.008; Eising CM, 2008, BEHAVIOUR, V145, P51, DOI 10.1163/156853908782687232; Elekonich MM, 2000, ETHOLOGY, V106, P493, DOI 10.1046/j.1439-0310.2000.00555.x; English S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116996; ERICKSON CJ, 1970, J COMP PHYSIOL PSYCH, V71, P210, DOI 10.1037/h0029131; FEDER HH, 1977, BIOL REPROD, V16, P666, DOI 10.1095/biolreprod16.5.666; Galef BG, 2008, COMP COGN BEHAV REV, V3, P1, DOI 10.3819/ccbr.2008.30001; Gil D, 2003, ARDEOLA, V50, P281; Gil D, 2008, ADV STUD BEHAV, V38, P337, DOI 10.1016/S0065-3454(08)00007-7; Gil D, 2007, J EXP ZOOL PART A, V307A, P91, DOI 10.1002/jez.a.340; Goerlich VC, 2012, HORM BEHAV, V61, P711, DOI 10.1016/j.yhbeh.2012.03.006; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Groothuis TGG, 2008, PHILOS T R SOC B, V363, P1647, DOI 10.1098/rstb.2007.0007; Guibert F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014069; Hargitai R, 2009, BEHAV ECOL SOCIOBIOL, V63, P869, DOI 10.1007/s00265-009-0727-4; Hau M, 2015, FRONT ZOOL, V12, DOI 10.1186/1742-9994-12-S1-S7; Hayward LS, 2006, GEN COMP ENDOCR, V146, P144, DOI 10.1016/j.ygcen.2005.10.016; Hennessy MB, 2009, FRONT NEUROENDOCRIN, V30, P470, DOI 10.1016/j.yfrne.2009.06.001; Hirschenhauser K, 2010, GEN COMP ENDOCR, V165, P195, DOI 10.1016/j.ygcen.2009.06.022; Hirschenhauser K, 1999, IBIS, V141, P577, DOI 10.1111/j.1474-919X.1999.tb07365.x; Hirschenhauser K, 2012, ETHOLOGY, V118, P799, DOI 10.1111/j.1439-0310.2012.02087.x; Houdelier C, 2002, CHRONOBIOL INT, V19, P377, DOI 10.1081/CBI-120002879; Jawor JM, 2006, HORM BEHAV, V49, P362, DOI 10.1016/j.yhbeh.2005.08.009; Jawor JM, 2007, FUNCT ECOL, V21, P767, DOI 10.1111/j.1365-2435.2007.01280.x; Jawor JM, 2006, GEN COMP ENDOCR, V149, P182, DOI 10.1016/j.ygcen.2006.05.013; Kaiser S, 2005, NEUROSCI BIOBEHAV R, V29, P283, DOI 10.1016/j.neubiorev.2004.09.015; Kayang BB, 2002, GENET SEL EVOL, V34, P233, DOI [10.1051/gse:2002006, 10.1186/1297-9686-34-2-233]; Ketterson ED, 2005, AM NAT, V166, pS85, DOI 10.1086/444602; KETTERSON ED, 1992, AM NAT, V140, pS33, DOI 10.1086/285396; KOELKEBECK KW, 1984, POULTRY SCI, V63, P2123, DOI 10.3382/ps.0632123; Kovach JK, 1974, APPL ANIM ETHOL, V1, P77, DOI DOI 10.1016/0304-3762(74)90010-8; Langmore NE, 2002, P ROY SOC B-BIOL SCI, V269, P2473, DOI 10.1098/rspb.2002.2167; LEHRMAN DS, 1964, SCI AM, V211, P48, DOI 10.1038/scientificamerican1164-48; LEHRMAN DS, 1961, ENDOCRINOLOGY, V68, P507, DOI 10.1210/endo-68-3-507; Leone EH, 2008, ANIM BEHAV, V76, P1673, DOI 10.1016/j.anbehav.2008.08.004; Lopez-Rull I, 2009, BEHAV PROCESS, V82, P312, DOI 10.1016/j.beproc.2009.07.012; Marasco V, 2012, J EXP BIOL, V215, P3955, DOI 10.1242/jeb.071423; Marshall DJ, 2007, OIKOS, V116, P1957, DOI 10.1111/j.2007.0030-1299.16203.x; Marshall RC, 2005, J EXP BIOL, V208, P4593, DOI 10.1242/jeb.01949; Mazuc J, 2003, ECOL LETT, V6, P1084, DOI 10.1046/j.1461-0248.2003.00535.x; Mills AD, 1997, NEUROSCI BIOBEHAV R, V21, P261, DOI 10.1016/S0149-7634(96)00028-0; MILLS AD, 1991, J COMP PSYCHOL, V105, P25, DOI 10.1037/0735-7036.105.1.25; Moore MC, 2008, INTEGR COMP BIOL, V48, P411, DOI 10.1093/icb/icn079; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Muller W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022675; Nephew BC, 2003, HORM BEHAV, V44, P222, DOI 10.1016/j.yhbeh.2003.06.002; Nichols CR., 1991, THESIS U BRIT COLUMB; Okuliarova M, 2009, COMP BIOCHEM PHYS A, V154, P530, DOI 10.1016/j.cbpa.2009.08.012; Oliveira RF, 2004, ADV STUD BEHAV, V34, P165, DOI 10.1016/S0065-3454(04)34005-2; Oliveira RF, 2009, INTEGR COMP BIOL, V49, P423, DOI 10.1093/icb/icp055; Onbasilar EE, 2005, LIVEST PROD SCI, V95, P255, DOI 10.1016/j.livprodsci.2005.01.006; Ouyang JQ, 2013, J EVOLUTION BIOL, V26, P1988, DOI 10.1111/jeb.12202; Ouyang JQ, 2011, P ROY SOC B-BIOL SCI, V278, P2537, DOI 10.1098/rspb.2010.2490; Peluc SI, 2012, J COMP PHYSIOL B, V182, P687, DOI 10.1007/s00360-011-0638-3; Persaud KN, 2003, ANIM BEHAV, V65, P89, DOI 10.1006/anbe.2002.2057; Pilz KM, 2004, FUNCT ECOL, V18, P58, DOI 10.1111/j.1365-2435.2004.00811.x; Poot H, 2012, PHYSIOL BEHAV, V105, P821, DOI 10.1016/j.physbeh.2011.10.013; Qvarnstrom A, 2001, TRENDS ECOL EVOL, V16, P95, DOI 10.1016/S0169-5347(00)02063-2; Raouf SA, 2006, ANIM BEHAV, V71, P39, DOI 10.1016/j.anbehav.2005.03.027; Reed WL, 2001, OECOLOGIA, V128, P164, DOI 10.1007/s004420100642; Roy AK, 1999, VITAM HORM, V55, P309; Rutkowska J, 2005, HORM BEHAV, V47, P585, DOI 10.1016/j.yhbeh.2004.12.006; Rutkowska J, 2006, ANIM BEHAV, V71, P1283, DOI 10.1016/j.anbehav.2005.07.025; Rutkowska J, 2011, PHYSIOL BEHAV, V104, P1037, DOI 10.1016/j.physbeh.2011.07.001; Sandell MI, 2007, BEHAV ECOL SOCIOBIOL, V62, P255, DOI 10.1007/s00265-007-0460-9; Schmid I, 1997, APPL ANIM BEHAV SCI, V55, P103, DOI 10.1016/S0168-1591(97)00039-7; Schmidt JB, 2009, POULTRY SCI, V88, P1352, DOI 10.3382/ps.2008-00513; SCHWABL H, 1988, BEHAVIOUR, V107, P107, DOI 10.1163/156853988X00223; Schwabl H, 1997, NATURWISSENSCHAFTEN, V84, P406, DOI 10.1007/s001140050418; SEARCY WA, 1988, ECOLOGY, V69, P85, DOI 10.2307/1943163; SILVERIN B, 1986, GEN COMP ENDOCR, V64, P67, DOI 10.1016/0016-6480(86)90029-8; Smith LC, 2005, HORM BEHAV, V47, P76, DOI 10.1016/j.yhbeh.2004.08.012; Veiga JP, 2008, AM NAT, V172, P42, DOI 10.1086/587850; Vitousek MN, 2014, HORM BEHAV, V66, P812, DOI 10.1016/j.yhbeh.2014.11.004; von Engelhardt N, 2011, HORMONES AND REPRODUCTION OF VERTEBRATES, VOL 4: BIRDS, P91; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Whittingham LA, 2002, ANIM BEHAV, V63, P63, DOI 10.1006/anbe.2001.1889; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; WINGFIELD JC, 1995, AM ZOOL, V35, P285; WOODARD AE, 1964, POULTRY SCI, V43, P1427, DOI 10.3382/ps.0431427; Zysling DA, 2006, HORM BEHAV, V50, P200, DOI 10.1016/j.yhbeh.2006.03.004	108	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176146	10.1371/journal.pone.0176146	http://dx.doi.org/10.1371/journal.pone.0176146			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SB	28467428	Green Published, Green Submitted, gold			2022-12-26	WOS:000400647000039
J	Takemoto, H; Kawamoto, Y; Higuchi, S; Makinose, E; Hart, JA; Hart, TB; Sakamaki, T; Tokuyama, N; Reinartz, GE; Guislain, P; Dupain, J; Cobden, AK; Mulavwa, MN; Yangozene, K; Darroze, S; Devos, C; Furuichi, T				Takemoto, Hiroyuki; Kawamoto, Yoshi; Higuchi, Shoko; Makinose, Emiko; Hart, John A.; Hart, Terese B.; Sakamaki, Tetsuya; Tokuyama, Nahoko; Reinartz, Gay E.; Guislain, Patrick; Dupain, Jef; Cobden, Amy K.; Mulavwa, Mbangi N.; Yangozene, Kumugo; Darroze, Serge; Devos, Celine; Furuichi, Takeshi			The mitochondrial ancestor of bonobos and the origin of their major haplogroups	PLOS ONE			English	Article							DISPERSAL-VICARIANCE ANALYSIS; ENVIRONMENTAL-CHANGE; TROPICAL AFRICA; CLIMATE CHANGES; RAIN-FOREST; VEGETATION; HISTORY; CHIMPANZEE; DIVERSITY; HOLOCENE	We report here where the most recent common ancestor (MRCA) of bonobos (Pan paniscus) ranged and how they dispersed throughout their current habitat. Mitochondrial DNA (mtDNA) molecular dating to analyze the time to MRCA (TMRCA) and the major mtDNA haplogroups of wild bonobos were performed using new estimations of divergence time of bonobos from other Pan species to investigate the dispersal routes of bonobos over the forest area of the Congo River's left bank. The TMRCA of bonobos was estimated to be 0.64 or 0.95 million years ago (Ma). Six major haplogroups had very old origins of 0.38 Ma or older. The reconstruction of the ancestral area revealed the mitochondrial ancestor of the bonobo populations ranged in the eastern area of the current bonobos' habitat. The haplogroups may have been formed from either the riparian forests along the Congo River or the center of the southern Congo Basin. Fragmentation of the forest refugia during the cooler periods may have greatly affected the formation of the genetic structure of bonobo populations.	[Takemoto, Hiroyuki; Kawamoto, Yoshi; Higuchi, Shoko; Makinose, Emiko; Sakamaki, Tetsuya; Tokuyama, Nahoko; Furuichi, Takeshi] Kyoto Univ, Primate Res Inst, Inuyama, Aichi, Japan; [Hart, John A.; Hart, Terese B.] Lukuru Fdn, Projet Tshuapa Lomami Lualaba TL2, Kinshasa, DEM REP CONGO; [Reinartz, Gay E.; Guislain, Patrick] Zool Soc Milwaukee, Bonobo & Congo Biodivers Initiat, Milwaukee, WI USA; [Dupain, Jef] African Wildlife Fdn, Nairobi, Kenya; [Cobden, Amy K.] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA; [Mulavwa, Mbangi N.; Yangozene, Kumugo] Minist High Educ & Sci Res, Res Ctr Ecol & Forestry, Mabali, DEM REP CONGO; [Devos, Celine] Univ Liege, Dept Behav Biol, Liege, Belgium; [Higuchi, Shoko] HASHIMOTO UNYU Co Ltd, Nagoya Head Off, Nagoya, Aichi, Japan	Kyoto University; Emory University; University of Liege	Takemoto, H; Furuichi, T (corresponding author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi, Japan.	takemoto.hiroyuki.7e@kyoto-u.ac.jp; furuichi.takeshi.7m@kyoto-u.ac.jp	Tokuyama, Nahoko/AAB-4866-2021		Ministry of the Environment, Japan [D-1007]; Global Environment Research Fund of the Ministry of the Environment, Japan [F-061]; Japan Society for the Promotion of Science (JSPS) [17255005, 22255007]; JSPS Asia-Africa Science Platform Program; JSPS Primate Origins of Human Evolution (HOPE) Project [19657074]; US Fish and Wildlife; Arcus Foundation; Wood Tiger Foundation; Full Circle Foundation; US Fish and Wildlife Service Assistance Award [96200-0-G017]; Columbus Zoo and Aquarium; Barron Wall; L.L. Leakey Foundation; Congo Basin Forest Partnership/USAID-WWF [623-A-00-06-00072-00]; Susan McConnell and Richard Scheller; AZA Ape TAG Conservation Initiative; WWF Belgium; WWF Netherlands; Belgian Cooperation; CARPE program (USAID)	Ministry of the Environment, Japan(Ministry of the Environment, Japan); Global Environment Research Fund of the Ministry of the Environment, Japan; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS Asia-Africa Science Platform Program; JSPS Primate Origins of Human Evolution (HOPE) Project; US Fish and Wildlife(US Fish & Wildlife Service); Arcus Foundation; Wood Tiger Foundation; Full Circle Foundation; US Fish and Wildlife Service Assistance Award; Columbus Zoo and Aquarium; Barron Wall; L.L. Leakey Foundation; Congo Basin Forest Partnership/USAID-WWF(United States Agency for International Development (USAID)); Susan McConnell and Richard Scheller; AZA Ape TAG Conservation Initiative; WWF Belgium; WWF Netherlands; Belgian Cooperation; CARPE program (USAID)(United States Agency for International Development (USAID))	This research was supported by the Ministry of the Environment, Japan (D-1007) (to TF); the Global Environment Research Fund (F-061) of the Ministry of the Environment, Japan (to Nishida); Japan Society for the Promotion of Science (JSPS) Grants-in-aid for Scientific Research (17255005 and 22255007, to TF); the JSPS Asia-Africa Science Platform Program (2009-2011, 2012-2014, 2014-2017 to TF); the JSPS Grant-in-Aid for Challenging Exploratory Research (19657074 to HT); the JSPS Primate Origins of Human Evolution (HOPE) Project (#8 to Primate Research Institute, Kyoto University); US Fish and Wildlife (2007-2009, 2010-2011, to Lukuru Wildlife Research Foundation); Arcus Foundation (2007-2008, 2010, 2012, to Lukuru Wildlife Research Foundation); Wood Tiger Foundation (2010, 2012, to Lukuru Wildlife Research Foundation); Full Circle Foundation (2011, to Lukuru Wildlife Research Foundation); the US Fish and Wildlife Service Assistance Award (96200-0-G017, to African Wildlife Foundation); Arcus Foundation, the Columbus Zoo and Aquarium, and Barron Wall (to AWF); the L.L. Leakey Foundation (to AKC); the Congo Basin Forest Partnership/USAID-WWF (623-A-00-06-00072-00, to ZSM); Susan McConnell and Richard Scheller (Wildlife Conservation Network) (to ZSM); the AZA Ape TAG Conservation Initiative (to ZSM); WWF Belgium, WWF Netherlands, Belgian Cooperation funding for co-financing; and CARPE program (USAID) for program coordination, for WWF bonobo project in the Lac Tumba Landscape. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie Hylton, 2011, Smithsonian Contributions to Botany, P79; Anhuf D, 2006, PALAEOGEOGR PALAEOCL, V239, P510, DOI 10.1016/j.palaeo.2006.01.017; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; COLYN M, 1991, J BIOGEOGR, V18, P403, DOI 10.2307/2845482; DALY MC, 1992, J GEOL SOC LONDON, V149, P539, DOI 10.1144/gsjgs.149.4.0539; de Manuel M, 2016, SCIENCE, V354, P477, DOI 10.1126/science.aag2602; Dupont LM, 2001, GEOLOGY, V29, P195, DOI 10.1130/0091-7613(2001)029<0195:MPECIT>2.0.CO;2; Dupont LM, 2007, VEG HIST ARCHAEOBOT, V16, P87, DOI 10.1007/s00334-006-0080-8; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; ELENGA H, 1994, PALAEOGEOGR PALAEOCL, V109, P345, DOI 10.1016/0031-0182(94)90184-8; Eriksson J, 2004, MOL ECOL, V13, P3425, DOI 10.1111/j.1365-294X.2004.02332.x; Fischer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021605; HAMILTON AC, 1991, CLIMATIC CHANGE, V19, P65, DOI 10.1007/BF00142215; Holtvoeth J, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2003GC000590; Jahns S, 1996, VEG HIST ARCHAEOBOT, V5, P207, DOI 10.1007/BF00217498; Kadima E, 2011, BASIN RES, V23, P499, DOI 10.1111/j.1365-2117.2011.00500.x; Kawamoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059660; KINGDON J S, 1980, Transactions of the Zoological Society of London, V35, P425; Kodandaramaiah U, 2010, J BIOGEOGR, V37, P3, DOI 10.1111/j.1365-2699.2009.02221.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maley J., 2001, African rain forest ecology and conservation: an interdisciplinary perspective, P68; Nei M., 1987, MOL EVOLUTIONARY GEN; Pilbrow V, 2013, INT J PRIMATOL, V34, P1244, DOI 10.1007/s10764-013-9737-1; Prufer K, 2012, NATURE, V486, P527, DOI 10.1038/nature11128; Ray N., 2001, INTERNET ARCHAEOLOGY, V11, P1, DOI [DOI 10.11141/IA.11.2, 10.11141/ia.11.2]; Rommerskirchen F, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001223; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Ronquist F, 2011, ANNU REV ECOL EVOL S, V42, P441, DOI 10.1146/annurev-ecolsys-102209-144710; Schefuss E, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000892; Schefuss E, 2003, NATURE, V422, P418, DOI 10.1038/nature01500; Schneider S., 2000, ARLEQUIN VER 2 000 S; Stanton DWG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101081; Stone AC, 2002, P NATL ACAD SCI USA, V99, P43, DOI 10.1073/pnas.012364999; Takemoto H, 2015, EVOL ANTHROPOL, V24, P170, DOI 10.1002/evan.21456; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Zsurka G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-270	37	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0174851	10.1371/journal.pone.0174851	http://dx.doi.org/10.1371/journal.pone.0174851			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467422	Green Published, Green Submitted, gold			2022-12-26	WOS:000400647000008
J	da Silva, AP; Silva, NDF; Andrade, EHA; Gratieri, T; Setzer, WN; Maia, JGS; da Silva, JKR				da Silva, Alessandra P.; Silva, Natalia de F.; Andrade, Eloisa Helena A.; Gratieri, Tais; Setzer, William N.; Maia, Jose Guilherme S.; da Silva, Joyce Kelly R.			Tyrosinase inhibitory activity, molecular docking studies and antioxidant potential of chemotypes of Lippia origanoides (Verbenaceae) essential oils	PLOS ONE			English	Article							MUSHROOM TYROSINASE; PHENOLIC-COMPOUNDS; ANTI-TYROSINASE; KOJIC ACID; ANTICANCER; COMPONENTS; THYMOL; L.	The essential oils (EOs) of the aerial parts of Lippia origanoides (LiOr), collected in different localities of the Amazon region, were obtained by hydrodistillation and analyzed by GC and CG-MS. Principle component analysis (PCA) based on chemical composition grouped the oils in four chemotypes rich in mono- and sesquiterpenoids. Group I was characterized by 1,8-cineole and a-terpineol (LiOr-1 and LiOr-4) and group II by thymol (LiOr-2). The oil LiOr-3 showed beta-caryophyllene, alpha-phellandrene and beta-phellandrene as predominant and LiOr-5 was rich in (E)-nerolidol and beta-caryophyllene. All samples were evaluated for antioxidant activity and inhibition of tyrosinase in vitro and in silico. The highest antioxidant activity by the DPPH free radical method was observed in LiOr-2 and LiOr-5 oils (132.1 and 82.7 mg TE.mL(-1), respectively). The tyrosinase inhibition potential was performed using L-tyrosine and L-DOPA as substrates and all samples were more effective in the first step of oxidation. The inhibition by samples LiOr-2 and LiOr-4 were 84.7% and 62.6%, respectively. The samples LiOr-1, LiOr-4 and LiOr-5 displayed an interaction with copper (II) ion with bathochromic shift around 15 nm. In order to elucidate the mechanism of inhibition of the main compounds, a molecular docking study was carried out. All compounds displayed an interaction between an oxygen and Cu or histidine residues with distances less than 4 (A) over circle. The best docking energies were observed with thymol and (E)-nerolidol (-79.8 kcal.mol(-1)), which suggested H-bonding interactions with Met281 and His263 (thymol) and His259, His263 ((E)-nerolidol).	[da Silva, Alessandra P.; da Silva, Joyce Kelly R.] Univ Fed Para, Programa Posgrad Biotecnol, Belem, Para, Brazil; [Silva, Natalia de F.] Univ Fed Para, Programa Posgrad Ciencias Farmaceut, Belem, Para, Brazil; [Andrade, Eloisa Helena A.] Museu Paraense Emilio Goeldi, Coordenacao Bot, Belem, Para, Brazil; [Gratieri, Tais] Univ Brasilia, Sch Hlth Sci, Lab Food Drug & Cosmet LTMAC, Brasilia, DF, Brazil; [Setzer, William N.] Univ Alabama, Dept Chem, Huntsville, AL USA; [Maia, Jose Guilherme S.] Univ Fed Oeste Para, Programa Posgrad Recursos Nat Amazonia, Santarem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para; Museu Paraense Emilio Goeldi; Universidade de Brasilia; University of Alabama System; University of Alabama Huntsville; Universidade Federal do Oeste do Para	da Silva, JKR (corresponding author), Univ Fed Para, Programa Posgrad Biotecnol, Belem, Para, Brazil.	joycekellys@ufpa.br	PEREIRA, ALESSANDRA/AAF-6628-2019; DA SILVA, JOYCE KELLY R./S-2494-2017; Gratieri, Tais/A-6542-2013; Andrade, Eloisa/P-3876-2019	DA SILVA, JOYCE KELLY R./0000-0002-9351-876X; Gratieri, Tais/0000-0001-6481-2364; Andrade, Eloisa/0000-0003-0640-7496; PEREIRA DA SILVA, ALESSANDRA/0000-0002-7982-3071	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) [047/2012]; L'OreAal-Unesco-ABC For Women In Science Awards (JKRS)	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); L'OreAal-Unesco-ABC For Women In Science Awards (JKRS)	This work was supported by the (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) CAPES for granting master's scholarship (APS); 2013 L'OreAal-Unesco-ABC For Women In Science Awards (JKRS); CAPES (047/2012) "Pro-Amazonia: Biodiversidade e Sustentabilidade" Program (JGSM). The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Adams R.P, 2017, IDENTIFICATION ESSEN, V5th; Amorati R, 2013, J AGR FOOD CHEM, V61, P10835, DOI 10.1021/jf403496k; Balasundram N, 2006, FOOD CHEM, V99, P191, DOI 10.1016/j.foodchem.2005.07.042; Barreto HM, 2014, EUR J INTEGR MED, V6, P560, DOI 10.1016/j.eujim.2014.03.011; Bayala B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092122; Chan EWC, 2008, FOOD CHEM, V109, P477, DOI 10.1016/j.foodchem.2008.02.016; Chang TS, 2012, MATERIALS, V5, P1661, DOI 10.3390/ma5091661; Choi HS, 2000, J AGR FOOD CHEM, V48, P4156, DOI 10.1021/jf000227d; Coelho AG, 2015, IND CROP PROD, V78, P124, DOI 10.1016/j.indcrop.2015.10.033; Comai S, 2010, FITOTERAPIA, V81, P11, DOI 10.1016/j.fitote.2009.06.017; CORRADI IF, 2012, RECENT PROGR MED PLA, V32, P53; Dahham SS, 2015, MOLECULES, V20, P11808, DOI 10.3390/molecules200711808; Damasceno EIT, 2011, REV BRAS FARMACOGN, V21, P78, DOI 10.1590/S0102-695X2011005000013; Videira IFD, 2013, AN BRAS DERMATOL, V88, P76, DOI 10.1590/S0365-05962013000100009; Ferguson LR, 2001, MUTAT RES-FUND MOL M, V475, P89, DOI 10.1016/S0027-5107(01)00073-2; Gomes MVS, 2016, KOSTERM LAURACEAE, V9, P1; Huang HC, 2015, INT J MOL SCI, V16, P10470, DOI 10.3390/ijms160510470; Ismaya WT, 2011, BIOCHEMISTRY-US, V50, P5477, DOI 10.1021/bi200395t; KAHN V, 1995, J FOOD BIOCHEM, V18, P253, DOI 10.1111/j.1745-4514.1994.tb00501.x; Kamkaen N, 2007, THAIL PHARM HLTH SCI, V2, P15; Kim YJ, 2005, CELL MOL LIFE SCI, V62, P1707, DOI 10.1007/s00018-005-5054-y; Kubo I, 2000, BIOORGAN MED CHEM, V8, P1749, DOI 10.1016/S0968-0896(00)00102-4; Lee S, 2016, J FLOOD RISK MANAG, V9, P224, DOI 10.1111/jfr3.12165; Lima CR, 2014, MOLECULES, V19, P9591, DOI 10.3390/molecules19079591; Lobo V, 2010, Pharmacogn Rev, V4, P118, DOI 10.4103/0973-7847.70902; Loizzo MR, 2012, COMPR REV FOOD SCI F, V11, P378, DOI 10.1111/j.1541-4337.2012.00191.x; Maia J.G.S., 2001, PLANTAS AROMATICAS A; Marsik P, 2005, PLANTA MED, V71, P739, DOI 10.1055/s-2005-871288; Morton J.F., 1981, ATLAS MED PLANTS MID; Nithitanakool S, 2009, MOLECULES, V14, P257, DOI 10.3390/molecules14010257; Nokinsee D, 2015, ENZYME RES, V2015, P12; Oliveira DR, 2014, REV BRAS FARMACOGN, V24, P206, DOI 10.1016/j.bjp.2014.03.001; Orhan IE, 2012, FOOD CHEM, V130, P882, DOI 10.1016/j.foodchem.2011.07.119; Ralchenko Y., 2005, MEMORIEDELLA SOCIETA, V8, P96, DOI DOI 10.1063/1.1336287; Ribeiro AF, 2014, BIOCHEM SYST ECOL, V55, P249, DOI 10.1016/j.bse.2014.03.014; Saewan N, 2011, J MED PLANTS RES, V5, P1018; Satooka H, 2011, J AGR FOOD CHEM, V59, P8908, DOI 10.1021/jf2014149; Stashenko EE, 2010, J SEP SCI, V33, P93, DOI 10.1002/jssc.200900452; Terblanche A F, 1996, J ESSENT OIL RES; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Uchida R, 2014, ACTA PHARM SIN B, V4, P141, DOI 10.1016/j.apsb.2013.12.008; Vinholes J, 2014, FOOD CHEM, V156, P204, DOI 10.1016/j.foodchem.2014.01.106; Wang W, 2008, FOOD CHEM, V108, P1019, DOI 10.1016/j.foodchem.2007.11.046; Wojdylo A, 2007, FOOD CHEM, V105, P940, DOI 10.1016/j.foodchem.2007.04.038	44	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0175598	10.1371/journal.pone.0175598	http://dx.doi.org/10.1371/journal.pone.0175598			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459864	Green Published, Green Submitted, gold			2022-12-26	WOS:000400645000003
J	Kastens, JH; Brown, JC; Coutinho, AC; Bishop, CR; Esquerdo, JCDM				Kastens, Jude H.; Brown, J. Christopher; Coutinho, Alexandre Camargo; Bishop, Christopher R.; Esquerdo, Julio Cesar D. M.			Soy moratorium impacts on soybean and deforestation dynamics in Mato Grosso, Brazil	PLOS ONE			English	Article							MODIS TIME-SERIES; EXPANSION; INTENSIFICATION; AGRICULTURE; FRONTIER; IMAGES	Previous research has established the usefulness of remotely sensed vegetation index (VI) data from the Moderate Resolution Imaging Spectroradiometer (MODIS) to characterize the spatial dynamics of agriculture in the state of Mato Grosso (MT), Brazil. With these data it has become possible to track MT agriculture, which accounts for similar to 85% of Brazilian Amazon soy production, across periods of several years. Annual land cover (LC) maps support investigation of the spatiotemporal dynamics of agriculture as they relate to forest cover and governance and policy efforts to lower deforestation rates. We use a unique, spatially extensive 9year (2005-2013) ground reference dataset to classify, with approximately 80% accuracy, MODIS VI data, merging the results with carefully processed annual forest and sugarcane coverages developed by Brazil's National Institute for Space Research to produce LC maps for MT for the 2001-2014 crop years. We apply the maps to an evaluation of forest and agricultural intensification dynamics before and after the Soy Moratorium (SoyM), a governance effort enacted in July 2006 to halt deforestation for the purpose of soy production in the Brazilian Amazon. We find the pre-SoyM deforestation rate to be more than five times the postSoyM rate, while simultaneously observing the pre-SoyM forest-to-soy conversion rate to be more than twice the post-SoyM rate. These observations support the hypothesis that SoyM has played a role in reducing both deforestation and subsequent use for soy production. Additional analyses explore the land use tendencies of deforested areas and the conceptual framework of horizontal and vertical agricultural intensification, which distinguishes production increases attributable to cropland expansion into newly deforested areas as opposed to implementation of multi-cropping systems on existing cropland. During the 14-year study period, soy production was found to shift from predominantly single-crop systems to majority double-crop systems.	[Kastens, Jude H.; Bishop, Christopher R.] Univ Kansas, Kansas Biol Survey, Kansas Appl Remote Sensing Program, 2101 Constant Ave, Lawrence, KS 66045 USA; [Brown, J. Christopher] Univ Kansas, Dept Geog & Atmospher Sci, 1475 Jayhawk Blvd 223, Lawrence, KS 66045 USA; [Coutinho, Alexandre Camargo; Esquerdo, Julio Cesar D. M.] Embrapa Informat Agr, Av Andre Tosello 209, Campinas, SP, Brazil	University of Kansas; University of Kansas; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Kastens, JH (corresponding author), Univ Kansas, Kansas Biol Survey, Kansas Appl Remote Sensing Program, 2101 Constant Ave, Lawrence, KS 66045 USA.	jkastens@ku.edu	Brown, J. Christopher/E-4511-2012; Esquerdo, Julio Cesar D. M./J-3403-2013	Brown, J. Christopher/0000-0002-1261-4574; Esquerdo, Julio Cesar D. M./0000-0001-7190-2931	National Science Foundation [EPS - 0903806]; Fulbright Scholar Program; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP - 2015/19437-5]; College of Liberal Arts and Sciences of the University of Kansas	National Science Foundation(National Science Foundation (NSF)); Fulbright Scholar Program; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); College of Liberal Arts and Sciences of the University of Kansas	JK, CB, and JB were funded by grants from the National Science Foundation (https://nsf.gov) (EPS - 0903806, with matching support from the State of Kansas through the Kansas Board of Regents; GSS - 1227160). JB was funded by the Fulbright Scholar Program (http://www.cies.org/) and the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br/en/) (FAPESP - 2015/19437-5). CB was funded by the College of Liberal Arts and Sciences of the University of Kansas (http://college.ku.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIOVE, 2015, SOY MOR 8 YEAR; ABIOVE, 2014, SOY MOR MAPP MON SOY; ABIOVE, 2011, SOY MOR SOYB PLANT A; ABIOVE, 2012, SOY MOR MAPP MON SOY; ABIOVE, 2013, SOY MOR 6 YEAR MAPP; ABIOVE, 2010, SOY MOR MAPP MON SOY; Anderson LO, 2005, IEEE GEOSCI REMOTE S, V2, P315, DOI 10.1109/LGRS.2005.850364; Angelsen A., 2001, Agricultural technologies and tropical deforestation, DOI 10.1079/9780851994512.0000; Arvor D, 2014, INT J CLIMATOL, V34, P2622, DOI 10.1002/joc.3863; Arvor D, 2013, GEOJOURNAL, V78, P833, DOI 10.1007/s10708-012-9469-3; Arvor D, 2012, APPL GEOGR, V32, P702, DOI 10.1016/j.apgeog.2011.08.007; Arvor D, 2010, INT GEOSCI REMOTE SE, P3190, DOI 10.1109/IGARSS.2010.5649659; Bailey R., 2000, REASON, V31, P30; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Brown JC, 2007, GISCI REMOTE SENS, V44, P117, DOI 10.2747/1548-1603.44.2.117; Brown JC, 2013, REMOTE SENS ENVIRON, V130, P39, DOI 10.1016/j.rse.2012.11.009; Brown JC, 2013, DEBATES ENV COMMUNIT; Clark ML, 2010, REMOTE SENS ENVIRON, V114, P2816, DOI 10.1016/j.rse.2010.07.001; de Oliveira JC, 2014, GISCI REMOTE SENS, V51, P253, DOI 10.1080/15481603.2014.909108; DeFries R, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0173; Galford GL, 2008, REMOTE SENS ENVIRON, V112, P576, DOI 10.1016/j.rse.2007.05.017; Galford GL, 2011, ECOL APPL, V21, P750, DOI 10.1890/09-1957.1; Galford GL, 2010, EARTH INTERACT, V14, DOI 10.1175/2010EI327.1; Gibbs HK, 2015, SCIENCE, V347, P377, DOI 10.1126/science.aaa0181; Jasinski E, 2009, EARTH INTERACT, V9, P1; Macedo MN, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0153; Macedo MN, 2012, P NATL ACAD SCI USA, V109, P1341, DOI 10.1073/pnas.1111374109; Morton D C, 2007, AMBIENTE AGUA INTERD, V2, P5, DOI DOI 10.4136/ambi-agua.16; Morton DC, 2006, P NATL ACAD SCI USA, V103, P14637, DOI 10.1073/pnas.0606377103; Nepstad D, 2009, SCIENCE, V326, P1350, DOI 10.1126/science.1182108; Pontius RG, 2011, INT J REMOTE SENS, V32, P4407, DOI 10.1080/01431161.2011.552923; Rudorff BFT, 2012, SUSTAINABILITY-BASEL, V4, P1074, DOI 10.3390/su4051074; Spera SA, 2014, ENVIRON RES LETT, V9, P1; Rudorff BFT, 2011, REMOTE SENS-BASEL, V3, P185, DOI 10.3390/rs3010185; Rudorff BFT, 2010, REMOTE SENS-BASEL, V2, P1057, DOI 10.3390/rs2041057; VanWey LK, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0168; Wardlow BD, 2008, REMOTE SENS ENVIRON, V112, P1096, DOI 10.1016/j.rse.2007.07.019; Wardlow BD, 2007, REMOTE SENS ENVIRON, V108, P290, DOI 10.1016/j.rse.2006.11.021; Wardlow BD, 2006, PHOTOGRAMM ENG REM S, V72, P1225, DOI 10.14358/PERS.72.11.1225	39	79	79	5	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176168	10.1371/journal.pone.0176168	http://dx.doi.org/10.1371/journal.pone.0176168			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453521	Green Published, gold			2022-12-26	WOS:000400383900016
J	Schreven, SJJ; Frago, E; Stens, A; de Jong, PW; van Loon, JJA				Schreven, Stijn J. J.; Frago, Enric; Stens, Annemiek; de Jong, Peter W.; van Loon, Joop J. A.			Contrasting effects of heat pulses on different trophic levels, an experiment with a herbivore- parasitoid model system	PLOS ONE			English	Article							XYLOSTELLA LEPIDOPTERA PLUTELLIDAE; DIAMONDBACK MOTH; CLIMATE-CHANGE; DEVELOPMENTAL RESPONSES; EXTREME WEATHER; TEMPERATURE; SIZE; GROWTH; HYMENOPTERA; IMPACTS	Under predicted global climate change, species will be gradually exposed to warmer temperatures, and to a more variable climate including more intense and more frequent heat-waves. Increased climatic variability is expected to have different effects on species and ecosystems than gradual warming. A key challenge to predict the impact of climate change is to understand how temperature changes will affect species interactions. Herbivorous insects and their natural enemies belong to some of the largest groups of terrestrial animals, and thus they have a great impact on the functioning of ecosystems and on the services these ecosystems provide. Here we studied the life history traits of the plant-feeding insect Plutella xylostella and its specialist endoparasitoid Diadegma semiclausum, when exposed to a daily heat pulse of 5 or 10 degrees C temperature increase during their entire immature phase. Growth and developmental responses differed with the amplitude of the heat pulse and they were different between host and parasitoid, indicating different thermal sensitivity of the two trophic levels. With a + 5 degrees C heat pulse, the adult parasitoids were larger which may result in a higher fitness, whereas a + 10 degrees C heat pulse retarded parasitoid development. These results show that the parasitoid is more sensitive than its host to brief intervals of temperature change, and this results in either positive or negative effects on life history traits, depending on the amplitude of the heat pulse. These findings suggest that more extreme fluctuations may disrupt host-parasitoid synchrony, whereas moderate fluctuations may improve parasitoid fitness.	[Schreven, Stijn J. J.; Frago, Enric; Stens, Annemiek; de Jong, Peter W.; van Loon, Joop J. A.] Wageningen Univ & Res, Lab Entomol, Plant Sci Grp, Wageningen, Netherlands; [Frago, Enric] CIRAD Agr Res Dev, St Pierre, La Reunion, France	Wageningen University & Research; CIRAD	Schreven, SJJ (corresponding author), Wageningen Univ & Res, Lab Entomol, Plant Sci Grp, Wageningen, Netherlands.	stijn.schreven@wur.nl	; van Loon, Joop J.A./B-3744-2009	Schreven, Stijn/0000-0002-5837-7025; van Loon, Joop J.A./0000-0002-4260-0501	Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme, FP7-PEOPLE-IEF [329648]	Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme, FP7-PEOPLE-IEF	EF was funded by Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme, FP7-PEOPLE-2012-IEF #329648 (http://cordis.europa.eu/project/rcn/108091_en.html), the Regional Council of Reunion, the Departmental Council of the Region Reunion, the European Union (EAFRD) and CIRAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare P, 2012, AM NAT, V179, P178, DOI 10.1086/663677; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Bannerman JA, 2011, ECOL ENTOMOL, V36, P490, DOI 10.1111/j.1365-2311.2011.01292.x; Barton BT, 2014, ECOLOGY, V95, P1479, DOI 10.1890/13-1977.1; Bauerfeind SS, 2014, POPUL ECOL, V56, P239, DOI 10.1007/s10144-013-0409-y; Benrey B, 1997, ECOLOGY, V78, P987, DOI 10.2307/2265852; Berg MP, 2010, GLOBAL CHANGE BIOL, V16, P587, DOI 10.1111/j.1365-2486.2009.02014.x; CHIHRANE J, 1993, ENTOMOPHAGA, V38, P185, DOI 10.1007/BF02372552; Chiu MC, 2015, ECOL ENTOMOL, V40, P175, DOI 10.1111/een.12173; Colinet H, 2007, OECOLOGIA, V152, P425, DOI 10.1007/s00442-007-0674-6; Colinet H, 2015, ANNU REV ENTOMOL, V60, P123, DOI 10.1146/annurev-ento-010814-021017; de Sassi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040557; Dosdall LM, 2012, B ENTOMOL RES, V102, P373, DOI 10.1017/S0007485311000708; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Edenhofer O., 2014, CONTRIBUTION WORKING; Ellers J, 1998, J ANIM ECOL, V67, P318, DOI 10.1046/j.1365-2656.1998.00195.x; Fischer K, 2014, J EXP BIOL, V217, P2892, DOI 10.1242/jeb.106245; Fischer K, 2011, OECOLOGIA, V166, P23, DOI 10.1007/s00442-011-1917-0; Forster J, 2011, AM NAT, V178, P668, DOI 10.1086/662174; Frago E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088039; Gillespie DR, 2012, OIKOS, V121, P149, DOI 10.1111/j.1600-0706.2011.19512.x; Godfray H. C. J., 1994, Parasitoids: behavioral and evolutionary ecology.; Gols R, 2009, ECOL ENTOMOL, V34, P755, DOI 10.1111/j.1365-2311.2009.01130.x; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Harvey JA, 2002, ECOLOGY, V83, P2439, DOI 10.1890/0012-9658(2002)083[2439:TDSOEW]2.0.CO;2; Hondo T, 2006, APPL ENTOMOL ZOOL, V41, P73, DOI 10.1303/aez.2006.73; Hoover JK, 2004, GLOBAL CHANGE BIOL, V10, P1197, DOI 10.1111/j.1529-8817.2003.00796.x; Huang F, 2008, INSECT SCI, V15, P237, DOI 10.1111/j.1744-7917.2008.00206.x; Jentsch A, 2009, GLOBAL CHANGE BIOL, V15, P837, DOI 10.1111/j.1365-2486.2008.01690.x; Kingsolver J. G., 2011, INTEGR COMP BIOL; Li BP, 2004, ENTOMOL EXP APPL, V110, P249, DOI 10.1111/j.0013-8703.2004.00144.x; Liu SS, 2002, ENVIRON ENTOMOL, V31, P221, DOI 10.1603/0046-225X-31.2.221; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Menendez Rosa, 2007, Tijdschrift voor Entomologie, V150, P355; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Potter KA, 2011, FUNCT ECOL, V25, P548, DOI 10.1111/j.1365-2435.2010.01807.x; Robinet C, 2010, INTEGR ZOOL, V5, P132, DOI 10.1111/j.1749-4877.2010.00196.x; Roux O, 2010, B ENTOMOL RES, V100, P543, DOI 10.1017/S0007485309990575; Sarfraz RM, 2011, ENTOMOL SCI, V14, P20, DOI 10.1111/j.1479-8298.2010.00413.x; Sentis A, 2013, GLOBAL CHANGE BIOL, V19, P833, DOI 10.1111/gcb.12094; Stireman JO, 2005, P NATL ACAD SCI USA, V102, P17384, DOI 10.1073/pnas.0508839102; TALEKAR NS, 1991, ENTOMOPHAGA, V36, P95, DOI 10.1007/BF02374640; Terblanche JS, 2010, ENTOMOL EXP APPL, V137, P304, DOI 10.1111/j.1570-7458.2010.01067.x; Thomas MB, 2003, TRENDS ECOL EVOL, V18, P344, DOI 10.1016/S0169-5347(03)00069-7; Thomson LJ, 2010, BIOL CONTROL, V52, P296, DOI 10.1016/j.biocontrol.2009.01.022; vanderHave TM, 1996, J THEOR BIOL, V183, P329, DOI 10.1006/jtbi.1996.0224; VISSER ME, 1994, J ANIM ECOL, V63, P963, DOI 10.2307/5273; Voigt W, 2003, ECOLOGY, V84, P2444, DOI 10.1890/02-0266; YANG JC, 1993, ENTOMOPHAGA, V38, P579, DOI 10.1007/BF02373092; Zalucki MP, 2012, J ECON ENTOMOL, V105, P1115, DOI 10.1603/EC12107; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zvereva EL, 2006, GLOBAL CHANGE BIOL, V12, P27, DOI 10.1111/j.1365-2486.2005.01086.x	55	22	22	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176704	10.1371/journal.pone.0176704	http://dx.doi.org/10.1371/journal.pone.0176704			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453570	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383900046
J	Villamuelas, M; Serrano, E; Espunyes, J; Fernandez, N; Lopez-Olvera, JR; Garel, M; Santos, J; Parra-Aguado, MA; Ramanzin, M; Fernandez-Aguilar, X; Colom-Cadena, A; Marco, I; Lavin, S; Bartolome, J; Albanell, E				Villamuelas, Miriam; Serrano, Emmanuel; Espunyes, Johan; Fernandez, Nestor; Lopez-Olvera, Jorge R.; Garel, Mathieu; Santos, Joao; Parra-Aguado, Maria Angeles; Ramanzin, Maurizio; Fernandez-Aguilar, Xavier; Colom-Cadena, Andreu; Marco, Ignasi; Lavin, Santiago; Bartolome, Jordi; Albanell, Elena			Predicting herbivore faecal nitrogen using a multispecies near-infrared reflectance spectroscopy calibration	PLOS ONE			English	Article							DIET QUALITY; RUMEN DEGRADABILITY; FORAGE QUALITY; FECES; NIRS; DIGESTIBILITY; FACTS; DIGESTION; SELECTION; RANGE	Optimal management of free-ranging herbivores requires the accurate assessment of an animal's nutritional status. For this purpose 'near-infrared reflectance spectroscopy' (NIRS) is very useful, especially when nutritional assessment is done through faecal indicators such as faecal nitrogen (FN). In order to perform an NIRS calibration, the default protocol recommends starting by generating an initial equation based on at least 50-75 samples from the given species. Although this protocol optimises prediction accuracy, it limits the use of NIRS with rare or endangered species where sample sizes are often small. To overcome this limitation we tested a single NIRS equation (i.e., multispecies calibration) to predict FN in herbivores. Firstly, we used five herbivore species with highly contrasting digestive physiologies to build monospecies and multispecies calibrations, namely horse, sheep, Pyrenean chamois, red deer and European rabbit. Secondly, the equation accuracy was evaluated by two procedures using: (1) an external validation with samples from the same species, which were not used in the calibration process; and (2) samples from different ungulate species, specifically Alpine ibex, domestic goat, European mouflon, roe deer and cattle. The multispecies equation was highly accurate in terms of the coefficient of determination for calibration R-2 = 0.98, standard error of validation SECV = 0.10, standard error of external validation SEP = 0.12, ratio of performance to deviation RPD = 5.3, and range error of prediction RER = 28.4. The accuracy of the multispecies equation to predict other herbivore species was also satisfactory (R-2 > 0.86, SEP < 0.27, RPD > 2.6, and RER > 8.1). Lastly, the agreement between multi-and monospecies calibrations was also confirmed by the Bland-Altman method. In conclusion, our single multispecies equation can be used as a reliable, cost-effective, easy and powerful analytical method to assess FN in a wide range of herbivore species.	[Villamuelas, Miriam; Serrano, Emmanuel; Espunyes, Johan; Lopez-Olvera, Jorge R.; Fernandez-Aguilar, Xavier; Colom-Cadena, Andreu; Marco, Ignasi; Lavin, Santiago] Univ Autonoma Barcelona, Fac Vet, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge, Barcelona, Spain; [Villamuelas, Miriam; Ramanzin, Maurizio] Univ Padova UNIPD, Dept Agron Food Nat Resources Anim & Environm DAF, Legnaro, Italy; [Serrano, Emmanuel; Santos, Joao] Univ Aveiro, Dept Biol, Aveiro, Portugal; [Serrano, Emmanuel; Santos, Joao] Univ Aveiro, CESAM, Aveiro, Portugal; [Fernandez, Nestor] CSIC, EBD, Dept Conservat Biol, Seville, Spain; [Garel, Mathieu] ONCFS, Unite Faune Montagne, Gieres, France; [Santos, Joao; Parra-Aguado, Maria Angeles] UCLM, CSIC, JCCM, Inst Invest Recursos Cineget IREC,Sanidad & Biote, Ciudad Real, Spain; [Bartolome, Jordi; Albanell, Elena] Univ Autonoma Barcelona, Dept Ciencia Anim & Aliments, Ruminant Res Grp, Barcelona, Spain	Autonomous University of Barcelona; University of Padua; Universidade de Aveiro; Universidade de Aveiro; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Autonomous University of Barcelona	Serrano, E (corresponding author), Univ Autonoma Barcelona, Fac Vet, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge, Barcelona, Spain.; Serrano, E (corresponding author), Univ Aveiro, Dept Biol, Aveiro, Portugal.; Serrano, E (corresponding author), Univ Aveiro, CESAM, Aveiro, Portugal.; Albanell, E (corresponding author), Univ Autonoma Barcelona, Dept Ciencia Anim & Aliments, Ruminant Res Grp, Barcelona, Spain.	emmanuel.serrano.ferron@gmail.com; elena.albanell@uab.cat	Albanell, Elena/H-7945-2015; Fernandez Aguilar, Xavier/P-9919-2017; Marco, Ignasi/E-8633-2015; Santos, João P.V./AAC-7646-2019; SERRANO-FERRON, Emmanuel/J-4489-2013; Bartolomé, Jordi/AAB-4362-2020; Fernández, Néstor/AAA-3523-2020; Lavín, Santiago/L-5975-2014; Espunyes, Johan/AAV-9517-2020; Fernandez, Nestor/N-5802-2014	Albanell, Elena/0000-0002-6158-7736; Fernandez Aguilar, Xavier/0000-0002-4939-6048; Marco, Ignasi/0000-0001-7479-3419; Santos, João P.V./0000-0003-1504-1035; SERRANO-FERRON, Emmanuel/0000-0002-9799-9804; Bartolomé, Jordi/0000-0002-3784-5248; Lavín, Santiago/0000-0001-5655-588X; Espunyes, Johan/0000-0002-8692-1593; RAMANZIN, MAURIZIO/0000-0002-8746-7281; Fernandez, Nestor/0000-0002-9645-8571	scientific program "Approche Integree de la Demographie des Populations d'Isard" - "Office National de la Chasse et de la Faune Sauvage"; Servei d'Ecopatologia de Fauna Salvatge	scientific program "Approche Integree de la Demographie des Populations d'Isard" - "Office National de la Chasse et de la Faune Sauvage"; Servei d'Ecopatologia de Fauna Salvatge	This work was funded by a grant from the scientific program "Approche Integree de la Demographie des Populations d'Isard" sponsored by the "Office National de la Chasse et de la Faune Sauvage" and the "Servei d'Ecopatologia de Fauna Salvatge". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; AOAC, 2012, OFFICIAL METHODS ANA; Barboza P. S., 2009, INT WILDL NUTR, P350, DOI 10. 1007/978-3-540-87885-8; Barnier F, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0446; Belanche A, 2013, J DAIRY SCI, V96, P7867, DOI 10.3168/jds.2013-7127; Blanchard P, 2003, J WILDLIFE MANAGE, V67, P477, DOI 10.2307/3802705; Bubb A, 2011, EUR J WILDLIFE RES, V57, P971, DOI 10.1007/s10344-010-0445-2; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Clauss M, 2013, PLOS ONE, V8; COLEMAN SW, 1993, ANIM FEED SCI TECH, V44, P237, DOI 10.1016/0377-8401(93)90050-T; Decruyenaere V, 2009, ANIM FEED SCI TECH, V148, P138, DOI 10.1016/j.anifeedsci.2008.03.007; Dixon R, 2009, J NEAR INFRARED SPEC, V17, P1, DOI 10.1255/jnirs.822; Fearn T, 2002, NIR NEWS; Foley WJ, 1998, OECOLOGIA, V116, P293, DOI 10.1007/s004420050591; Foskolos A, 2015, ANIMAL, V9, P1163, DOI 10.1017/S1751731115000191; Galvez-Ceron A, 2015, ECOL INDIC, V52, P161, DOI 10.1016/j.ecolind.2014.11.020; Galvez-Ceron A, 2013, EUR J WILDLIFE RES, V59, P115, DOI 10.1007/s10344-012-0672-9; Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015; Gil-Jimenez E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125190; HANLEY TA, 1982, J RANGE MANAGE, V35, P146, DOI 10.2307/3898379; Hewison AJM, 2009, ECOGRAPHY, V32, P1062, DOI 10.1111/j.1600-0587.2009.05888.x; Hibert F, 2011, EUR J WILDLIFE RES, V57, P495, DOI 10.1007/s10344-010-0458-x; HOLECHEK JL, 1982, J ANIM SCI, V54, P363, DOI 10.2527/jas1982.542363x; HUSTON JE, 1986, J ANIM SCI, V62, P208, DOI 10.2527/jas1986.621208x; Jean PO, 2015, ECOL APPL, V25, P1630, DOI 10.1890/14-1347.1; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kamler J, 2005, FOLIA ZOOL, V54, P89; Kamler J, 2003, FOLIA ZOOL, V52, P31; Kohn MH, 1997, TRENDS ECOL EVOL, V12, P223, DOI 10.1016/S0169-5347(97)01050-1; Lehnert B., BLANDALTMANLEH PLOTS; LEITE ER, 1995, SMALL RUMINANT RES, V15, P223, DOI 10.1016/0921-4488(94)00026-4; Leslie DM, 2008, J WILDLIFE MANAGE, V72, P1420, DOI 10.2193/2007-404; Li H, 2007, SMALL RUMINANT RES, V68, P263, DOI 10.1016/j.smallrumres.2005.10.017; Locher F, 2005, AGRON J, V97, P11, DOI 10.2134/agronj2005.0011; LYONS RK, 1995, J RANGE MANAGE, V48, P380, DOI 10.2307/4002493; Marten G.C, 1989, NEAR INFRARED REFLEC; MARTEN GC, 1984, CROP SCI, V24, P1179, DOI 10.2135/cropsci1984.0011183X002400060040x; McCaig TN, 2002, FOOD RES INT, V35, P731, DOI 10.1016/S0963-9969(02)00068-6; Mesochina P, 1998, GRASS FORAGE SCI, V53, P189, DOI 10.1046/j.1365-2494.1998.5320189.x; Murray I., 1987, NEAR INFRARED TECHNO, P17; Norman H., 2015, AUSTR AGRONOMY C IDE, P4; Nunez-Sanchez N, 2012, LIVEST SCI, V150, P386, DOI 10.1016/j.livsci.2012.07.030; ORSKOV E.R., 1982, NEW YORK; Poinar HN, 1998, SCIENCE, V281, P402, DOI 10.1126/science.281.5375.402; PUTMAN RJ, 1984, MAMMAL REV, V14, P79, DOI 10.1111/j.1365-2907.1984.tb00341.x; Rivera L, 2014, HOLOCENE, V24, P876, DOI 10.1177/0959683614530445; Robbins C.T., 1983, WILDLIFE FEEDING NUT; Shenk J.S., 1996, NEAR INFRARED SPECTR, P198; SHENK JS, 1979, J DAIRY SCI, V62, P807, DOI 10.3168/jds.S0022-0302(79)83330-5; Showers SE, 2006, RANGELAND ECOL MANAG, V59, P300, DOI 10.2111/04-069.1; Stuth J, 2003, FIELD CROP RES, V84, P45, DOI 10.1016/S0378-4290(03)00140-0; Team R, 2014, LANG ENV STAT COMP; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; Vance CK, 2016, J NEAR INFRARED SPEC, V24, P1, DOI 10.1255/jnirs.1199; Villamuelas M, 2016, ECOL INDIC, V61, P658, DOI 10.1016/j.ecolind.2015.10.017; Wang CJ, 2009, ANIM FEED SCI TECH, V149, P199, DOI 10.1016/j.anifeedsci.2008.06.005; Williams P, 2014, NIR NEWS, V25, P22, DOI 10.1255/nirn.1419; Williams P., 2001, NEAR INFRARED TECHNO, P143; Williams P. C., 1993, Journal of Near Infrared Spectroscopy, V1, P25; Williams PC, 1996, NEAR INFRARED SPECTR, P185; WINDHAM WR, 1991, CROP SCI, V31, P1345, DOI 10.2135/cropsci1991.0011183X003100050053x; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	63	18	20	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176635	10.1371/journal.pone.0176635	http://dx.doi.org/10.1371/journal.pone.0176635			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453544	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383900037
J	McGregor, G; Irving, AJ; Harvey, J				McGregor, Gemma; Irving, Andrew J.; Harvey, Jenni			Canonical JAK-STAT signaling is pivotal for long-term depression at adult hippocampal temporoammonic-CA1 synapses	FASEB JOURNAL			English	Article						AMPA receptor trafficking; gene transcription; synaptic plasticity	AMPA RECEPTOR TRAFFICKING; CA1 PYRAMIDAL NEURONS; PERFORANT PATH INPUT; SYNAPTIC PLASTICITY; POSTSYNAPTIC DENSITY; TRANSCRIPTION FACTOR; GLUTAMATE RECEPTORS; DORSAL HIPPOCAMPUS; JAK2/STAT3 AXIS; AMYLOID-BETA	The Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signaling pathway is involved in numerous cellular processes and it is implicated in neurodegenerative disorders, like Alzheimer disease. Recent studies identified a crucial role for this pathway in activity-dependent long-term depression (LTD) at hippocampal Schaffer collateral (SC)-CA1 synapses. However, it is unclear whether JAK-STAT signaling also regulates excitatory synaptic function at the anatomically distinct temporoammonic (TA) input to CA1 neurons. Here we demonstrate that LTD at adult TA-CA1 synapses involves JAK-STAT signaling, but unlike SC-CA1 synapses, requires rapid gene transcription. TA-CA1 LTD requires NMDA receptor activation and is independent of PI3K or ERK signaling. JAK-STAT signaling was critical for TA-CA1 LTD as inhibition of JAK or STAT blocked LTD induction and prevented NMDA-induced AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor internalization in hippocampal neurons. Moreover, an increase in phosphorylated JAK2 and STAT3 accompanied chemical induction of LTD and AMPA receptor internalization. STAT3-driven gene transcription was required for LTD as inhibition of STAT3-DNA binding, nuclear export, and gene transcription all prevented LTD induction. These data indicate an essential role for canonical JAK-STAT signaling in activity-dependent LTD at TA-CA1 synapses and provide valuable insight into the role of the TA input in hippocampal synaptic plasticity.	[McGregor, Gemma; Harvey, Jenni] Univ Dundee, Ninewells Hosp & Med Sch, Sch Med, Div Neurosci, Dundee DD1 9SY, Scotland; [Irving, Andrew J.] Univ Coll Dublin, Conway Inst, Sch Biomol & Biomed Sci, Dublin, Ireland	University of Dundee; University College Dublin	Harvey, J (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Sch Med, Div Neurosci, Dundee DD1 9SY, Scotland.	j.z.harvey@dundee.ac.uk			Tenovus; BBSRC EASTBIO studentship	Tenovus; BBSRC EASTBIO studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	J.H. is funded by the Anonymous Trust and Tenovus. G.M. is supported by a BBSRC EASTBIO studentship. The authors thank K.-A. Bollan (University of Dundee) for her technical assistance with the surface biotinylation assay and the members of W. Fuller's laboratory (University of Dundee) for use of the Bio-Rad ChemiDoc XRS imaging system and their technical help. The authors declare no conflicts of interest.	Ahmed MS, 2009, NEURON, V63, P372, DOI 10.1016/j.neuron.2009.07.013; Aksoy-Aksel Ayla, 2013, Front Synaptic Neurosci, V5, P5, DOI 10.3389/fnsyn.2013.00005; Anderson WW, 2007, J NEUROSCI METH, V162, P346, DOI 10.1016/j.jneumeth.2006.12.018; Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bhouri M, 2014, J NEUROSCI, V34, P12223, DOI 10.1523/JNEUROSCI.0753-14.2014; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chiba T, 2009, MOL PSYCHIATR, V14, P206, DOI 10.1038/mp.2008.105; Chiba T, 2009, EXPERT OPIN THER TAR, V13, P1155, DOI 10.1517/14728220903213426; Choquet D, 2010, EUR J NEUROSCI, V32, P250, DOI 10.1111/j.1460-9568.2010.07350.x; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; De-Fraja C, 1998, J NEUROSCI RES, V54, P320, DOI 10.1002/(SICI)1097-4547(19981101)54:3<320::AID-JNR3>3.0.CO;2-R; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Doherty GH, 2013, NEUROBIOL AGING, V34, P226, DOI 10.1016/j.neurobiolaging.2012.08.003; Duan Z, 2007, MOL PHARMACOL, V72, P1137, DOI 10.1124/mol.107.038117; Dvorak-Carbone H, 1999, J NEUROPHYSIOL, V81, P1036, DOI 10.1152/jn.1999.81.3.1036; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Fitzjohn SM, 1998, NEUROPHARMACOLOGY, V37, P1445, DOI 10.1016/S0028-3908(98)00145-2; Hu ZH, 2015, J CELL BIOL, V208, P949, DOI 10.1083/jcb.201404092; Hu ZH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4263; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Kallarackal AJ, 2013, J NEUROSCI, V33, P15669, DOI 10.1523/JNEUROSCI.2588-13.2013; Kandler K, 1998, NAT NEUROSCI, V1, P119, DOI 10.1038/368; Kauderer BS, 2000, P NATL ACAD SCI USA, V97, P13342, DOI 10.1073/pnas.97.24.13342; Kemp A, 2013, BEHAV BRAIN RES, V254, P83, DOI 10.1016/j.bbr.2013.04.036; Kemp N, 2001, PROG NEUROBIOL, V65, P339, DOI 10.1016/S0301-0082(01)00013-2; Kimura T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0144; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Levy WB, 1998, LEARN MEMORY, V4, P510, DOI 10.1101/lm.4.6.510; Li WX, 2008, TRENDS CELL BIOL, V18, P545, DOI 10.1016/j.tcb.2008.08.008; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Lindecke A, 2006, EUR J NEUROSCI, V24, P555, DOI 10.1111/j.1460-9568.2006.04909.x; Luo X, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0007-15.2015; Malekizadeh Y, 2017, CEREB CORTEX, V27, P4769, DOI 10.1093/cercor/bhw272; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Manabe T, 1997, REV NEUROSCIENCE, V8, P179, DOI 10.1515/REVNEURO.1997.8.3-4.179; Massey PV, 2007, TRENDS NEUROSCI, V30, P176, DOI 10.1016/j.tins.2007.02.005; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Moult PR, 2011, NEUROPHARMACOLOGY, V61, P924, DOI 10.1016/j.neuropharm.2011.06.021; Moult PR, 2010, J NEUROSCI, V30, P4088, DOI 10.1523/JNEUROSCI.3614-09.2010; Moutoussamy S, 1998, EUR J BIOCHEM, V255, P1, DOI 10.1046/j.1432-1327.1998.2550001.x; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Murata S, 2000, MOL BRAIN RES, V78, P80, DOI 10.1016/S0169-328X(00)00077-2; Nelson EA, 2008, BLOOD, V112, P5095, DOI 10.1182/blood-2007-12-129718; Nicholls RE, 2008, NEURON, V58, P104, DOI 10.1016/j.neuron.2008.01.039; Nicholson DA, 2006, NEURON, V50, P431, DOI 10.1016/j.neuron.2006.03.022; Nicolas Celine S, 2013, JAKSTAT, V2, pe22925, DOI 10.4161/jkst.22925; Nicolas CS, 2012, NEURON, V73, P374, DOI 10.1016/j.neuron.2011.11.024; Otmakhova NA, 1999, J NEUROSCI, V19, P1437; Palmer MJ, 1997, NEUROPHARMACOLOGY, V36, P1517, DOI 10.1016/S0028-3908(97)00181-0; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Pickard L, 2001, NEUROPHARMACOLOGY, V41, P700, DOI 10.1016/S0028-3908(01)00127-7; Remondes M, 2003, LEARN MEMORY, V10, P247, DOI 10.1101/lm.59103; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; SAMPEDRO MN, 1981, J CELL BIOL, V90, P675, DOI 10.1083/jcb.90.3.675; Sandberg EM, 2005, J MED CHEM, V48, P2526, DOI 10.1021/jm049470k; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Shanley LJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0001.2001; Stokes J, 2015, J COGNITIVE NEUROSCI, V27, P546, DOI 10.1162/jocn_a_00736; Vago DR, 2008, BEHAV BRAIN RES, V189, P273, DOI 10.1016/j.bbr.2008.01.002; Vago DR, 2007, HIPPOCAMPUS, V17, P977, DOI 10.1002/hipo.20329; Yamaoka K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-253; Yassa MA, 2010, P NATL ACAD SCI USA, V107, P12687, DOI 10.1073/pnas.1002113107; Zhang M, 2013, BRAIN RES, V1503, P43, DOI 10.1016/j.brainres.2013.01.052	69	21	21	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3449	3466		10.1096/fj.201601293RR	http://dx.doi.org/10.1096/fj.201601293RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28461339				2022-12-26	WOS:000405932400023
J	French, ME; Klosowiak, JL; Aslanian, A; Reed, SI; Yates, JR; Hunter, T				French, Michael E.; Klosowiak, Julian L.; Aslanian, Aaron; Reed, Steven I.; Yates, John R., III; Hunter, Tony			Mechanism of ubiquitin chain synthesis employed by a HECT domain ubiquitin ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; polyubiquitin chain; protein degradation; ubiquitin; ubiquitylation (ubiquitination); HECT	CONJUGATING ENZYMES E2S; E3 LIGASE; POLYUBIQUITIN CHAINS; MEMBRANE-PROTEIN; BINDING PROTEINS; LYS63 LINKAGES; DEGRADATION; FAMILY; NEDD4; UBIQUITYLATION	Homologous to E6AP C-terminal (HECT) ubiquitin (Ub) ligases (E3s) are a large class of enzymes that bind to their substrates and catalyze ubiquitination through the formation of a Ub thioester intermediate. The mechanisms by which these E3s assemble polyubiquitin chains on their substrates remain poorly defined. We report here that the Nedd4 family HECT E3, WWP1, assembles substrate-linked Ub chains containing Lys-63, Lys-48, and Lys-11 linkages (Lys-63 > Lys-48 > Lys-11). Our results demonstrate that WWP1 catalyzes the formation of Ub chains through a sequential addition mechanism, in which Ub monomers are transferred in a successive fashion to the substrate, and that ubiquitination by WWP1 requires the presence of a low-affinity, noncovalent Ub-binding site within the HECT domain. Unexpectedly, we find that the formation of Ub chains by WWP1 occurs in two distinct phases. In the first phase, chains are synthesized in a unidirectional manner and are linked exclusively through Lys-63 of Ub. In the second phase, chains are elongated in a multidirectional fashion characterized by the formation of mixed Ub linkages and branched structures. Our results provide new insight into the mechanism of Ub chain formation employed by Nedd4 family HECT E3s and suggest a framework for understanding how this family of E3s generates Ub signals that function in proteasome-independent and proteasome-dependent pathways.	[French, Michael E.; Aslanian, Aaron; Hunter, Tony] Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [French, Michael E.; Reed, Steven I.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Aslanian, Aaron; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Klosowiak, Julian L.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Salk Institute; Scripps Research Institute; Scripps Research Institute; Northwestern University; Feinberg School of Medicine	Hunter, T (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA.	hunter@salk.edu		Klosowiak, Julian/0000-0003-0880-7848	National Institutes of Health [P30CA014195, R01CA080100, R01CA082683]; National Institutes of Health Grant [R01GM072656, P41GM103533, R01GM115170]; American Cancer Society; George E. Hewitt Foundation for Medical Research; Helmsley Center for Genomic Medicine at the Salk Institute; NATIONAL CANCER INSTITUTE [P30CA014195, R01CA082683, R01CA080100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072656, P41GM103533, R01GM115170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); George E. Hewitt Foundation for Medical Research; Helmsley Center for Genomic Medicine at the Salk Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants P30CA014195, R01CA080100, and R01CA082683 (to T. H.); National Institutes of Health Grant R01GM072656 (in support of J. L. K., to Dr. Sarah Rice); National Institutes of Health Grant P41GM103533 (to J. R. Y.); and National Institutes of Health Grant R01GM115170 (to S. I. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by postdoctoral fellowships from the American Cancer Society and the George E. Hewitt Foundation for Medical Research. Additional financial support was provided by the Helmsley Center for Genomic Medicine at the Salk Institute.	Beaudenon S, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S4; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Boase NA, 2015, GENE, V557, P113, DOI 10.1016/j.gene.2014.12.020; Cao XX, 2011, J BIOL CHEM, V286, P33447, DOI 10.1074/jbc.M111.225565; Carrano AC, 2009, NATURE, V460, P396, DOI 10.1038/nature08130; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Dammer EB, 2011, J BIOL CHEM, V286, P10457, DOI 10.1074/jbc.M110.149633; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dores MR, 2015, MOL BIOL CELL, V26, P4660, DOI 10.1091/mbc.E15-05-0284; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fang NN, 2014, NAT CELL BIOL, V16, P1227, DOI 10.1038/ncb3054; French ME, 2009, J BIOL CHEM, V284, P12071, DOI 10.1074/jbc.M901106200; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Grice GL, 2015, CELL REP, V12, P545, DOI 10.1016/j.celrep.2015.06.061; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Hospenthal MK, 2013, NAT STRUCT MOL BIOL, V20, P555, DOI 10.1038/nsmb.2547; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Imamura T, 2013, J BIOCHEM, V154, P481, DOI 10.1093/jb/mvt097; Kamadurai HB, 2013, ELIFE, V2, DOI 10.7554/eLife.00828; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kathman SG, 2015, J AM CHEM SOC, V137, P12442, DOI 10.1021/jacs.5b06839; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim HC, 2011, EMBO REP, V12, P334, DOI 10.1038/embor.2011.23; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kristariyanto YA, 2015, BIOCHEM J, V467, P345, DOI 10.1042/BJ20141502; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Laine A, 2007, ONCOGENE, V26, P1477, DOI 10.1038/sj.onc.1209924; Lee YS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1469; Liao B, 2010, CELL RES, V20, P332, DOI 10.1038/cr.2009.136; Maspero E, 2013, NAT STRUCT MOL BIOL, V20, P696, DOI 10.1038/nsmb.2566; Maspero E, 2011, EMBO REP, V12, P342, DOI 10.1038/embor.2011.21; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Meyer HJ, 2014, CELL, V157, P910, DOI 10.1016/j.cell.2014.03.037; Michel MA, 2015, MOL CELL, V58, P95, DOI 10.1016/j.molcel.2015.01.042; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Ogunjimi AA, 2010, J BIOL CHEM, V285, P6308, DOI 10.1074/jbc.M109.044537; Ordureau A, 2014, MOL CELL, V56, P360, DOI 10.1016/j.molcel.2014.09.007; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Peschiaroli A, 2010, BIOCHEM BIOPH RES CO, V402, P425, DOI 10.1016/j.bbrc.2010.10.050; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Pirozzi G, 1997, J BIOL CHEM, V272, P14611, DOI 10.1074/jbc.272.23.14611; Ronchi VP, 2014, J BIOL CHEM, V289, P1033, DOI 10.1074/jbc.M113.517805; Ronchi VP, 2013, J BIOL CHEM, V288, P10349, DOI 10.1074/jbc.M113.458059; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; Sheng Y, 2012, MOL CELL PROTEOMICS, V11, P329, DOI 10.1074/mcp.O111.013706; Smit JJ, 2014, EMBO REP, V15, P142, DOI 10.1002/embr.201338166; Spratt DE, 2014, BIOCHEM J, V458, P421, DOI 10.1042/BJ20140006; Stawiecka-Mirota M, 2007, TRAFFIC, V8, P1280, DOI 10.1111/j.1600-0854.2007.00610.x; Sullivan JA, 2007, MOL BIOL CELL, V18, P2429, DOI 10.1091/mbc.e07-01-0011; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Valkevich EM, 2014, BIOCHEMISTRY-US, V53, P4979, DOI 10.1021/bi5006305; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Venuprasad K, 2015, IMMUNOL CELL BIOL, V93, P452, DOI 10.1038/icb.2014.118; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Vina-Vilaseca A, 2010, J BIOL CHEM, V285, P7645, DOI 10.1074/jbc.M109.058990; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Wang M, 2006, EMBO J, V25, P1710, DOI 10.1038/sj.emboj.7601061; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yang Y, 2013, P NATL ACAD SCI USA, V110, P5115, DOI 10.1073/pnas.1220271110; Zhang W, 2016, MOL CELL, V62, P121, DOI 10.1016/j.molcel.2016.02.005; Zhao YY, 2013, ELIFE, V2, DOI 10.7554/eLife.00459; Zou WG, 2011, NAT CELL BIOL, V13, P59, DOI 10.1038/ncb2134	72	37	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10398	10413		10.1074/jbc.M117.789479	http://dx.doi.org/10.1074/jbc.M117.789479			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28461335	hybrid, Green Published			2022-12-26	WOS:000404115400007
J	Ye, Q; Ji, QQ; Yan, W; Yang, F; Wang, ED				Ye, Qing; Ji, Quan-Quan; Yan, Wei; Yang, Fang; Wang, En-Duo			Acetylation of lysine E-amino groups regulates aminoacyl-tRNA synthetase activity in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; amino acid; aminoacyl tRNA synthetase; catalysis; transfer RNA (tRNA); translation	C-TERMINAL DOMAIN; PROTEIN ACETYLATION; SIGNATURE SEQUENCE; GENE CLONING; CRUCIAL ROLE; CP1 DOMAIN; PURIFICATION; SUCCINYLATION; ACTIVATION; DYNAMICS	Previous proteomic analyses have shown that aminoacyl-tRNA synthetases in many organisms can be modified by acetylation of Lys. In this present study, leucyl-tRNA synthetase and arginyl-tRNA synthetase from Escherichia coli (EcLeuRS and EcArgRS) were overexpressed and purified and found to be acetylated on Lys residues by MS. Gln scanning mutagenesis revealed that Lys(619), Lys(624), and Lys(809) in EcLeuRS and Lys(126) and Lys(408) in EcArgRS might play important roles in enzyme activity. Furthermore, we utilized a novel protein expression system to obtain enzymes harboring acetylated Lys at specific sites and investigated their catalytic activity. Acetylation of these Lys residues could affect their aminoacylation activity by influencing amino acid activation and/or the affinity for tRNA. In vitro assays showed that acetyl-phosphate nonenzymatically acetylates EcLeuRS and EcArgRS and suggested that the sirtuin class deacetylase CobB might regulate acetylation of these two enzymes. These findings imply a potential regulatory role for Lys acetylation in controlling the activity of aminoacyl-tRNA synthetases and thus protein synthesis.	[Ye, Qing; Ji, Quan-Quan; Yan, Wei; Yang, Fang; Wang, En-Duo] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Mol Biol,CAS Ctr Excellence Mol Cel, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Wang, En-Duo] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; ShanghaiTech University	Wang, ED (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Mol Biol,CAS Ctr Excellence Mol Cel, 320 Yueyang Rd, Shanghai 200031, Peoples R China.; Wang, ED (corresponding author), Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China.	edwang@sibcb.ac.cn			Strategic Priority Research Program of the Chinese Academy of Sciences Grant [XDB19000000]; National Natural Science Foundation of China [31570792, 31130064, 91440204]	Strategic Priority Research Program of the Chinese Academy of Sciences Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDB19000000 and National Natural Science Foundation of China Grants 31570792, 31130064, and 91440204. The authors declare that they have no conflicts of interest with the contents of this article.	AbouElfetouh A, 2015, MICROBIOLOGYOPEN, V4, P66, DOI 10.1002/mbo3.223; Cao XY, 2017, P NATL ACAD SCI USA, V114, P687, DOI 10.1073/pnas.1608488114; Cavarelli J, 1998, EMBO J, V17, P5438, DOI 10.1093/emboj/17.18.5438; Chen JF, 1999, PROTEIN EXPRES PURIF, V15, P115, DOI 10.1006/prep.1998.0999; Chen JF, 2000, BIOCHEMISTRY-US, V39, P6726, DOI 10.1021/bi000108r; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Colak G, 2013, MOL CELL PROTEOMICS, V12, P3509, DOI 10.1074/mcp.M113.031567; Delagoutte B, 2000, EMBO J, V19, P5599, DOI 10.1093/emboj/19.21.5599; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; FERSHT AR, 1988, BIOCHEMISTRY-US, V27, P1581, DOI 10.1021/bi00405a028; Germain E, 2013, MOL CELL, V52, P248, DOI 10.1016/j.molcel.2013.08.045; Geslain R, 2003, BIOCHEMISTRY-US, V42, P15092, DOI 10.1021/bi035581u; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Henriksen P, 2012, MOL CELL PROTEOMICS, V11, P1510, DOI 10.1074/mcp.M112.017251; Hsu JL, 2006, J BIOL CHEM, V281, P23075, DOI 10.1074/jbc.M601606200; Hu LI, 2010, MOL MICROBIOL, V77, P15, DOI 10.1111/j.1365-2958.2010.07204.x; Hu QH, 2013, NUCLEIC ACIDS RES, V41, P1859, DOI 10.1093/nar/gks1307; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Kim GW, 2011, TRENDS BIOCHEM SCI, V36, P211, DOI 10.1016/j.tibs.2010.10.001; Kosono S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131169; Kuhn ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094816; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lee JY, 2014, J CELL SCI, V127, P4234, DOI 10.1242/jcs.152470; Li J, 2003, BIOCHEM J, V376, P773, DOI 10.1042/BJ20030957; Li Y, 1998, SCI CHINA SER C, V41, P225, DOI 10.1007/BF02895095; LIN SX, 1988, BIOCHEMISTRY-US, V27, P6343, DOI 10.1021/bi00417a022; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Liu MF, 1999, BIOCHEMISTRY-US, V38, P11006, DOI 10.1021/bi990392q; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; MECHULAM Y, 1991, J MOL BIOL, V217, P465, DOI 10.1016/0022-2836(91)90750-Z; MEHLER AH, 1967, J BIOL CHEM, V242, P5495; Mizuno Y, 2016, MICROBIOLOGYOPEN, V5, P152, DOI 10.1002/mbo3.320; Nangle LA, 2002, J BIOL CHEM, V277, P45729, DOI 10.1074/jbc.M208093200; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Palencia A, 2012, NAT STRUCT MOL BIOL, V19, P677, DOI 10.1038/nsmb.2317; PERONA JJ, 1993, BIOCHEMISTRY-US, V32, P8758, DOI 10.1021/bi00085a006; Schilling B, 2015, MOL MICROBIOL, V98, P847, DOI 10.1111/mmi.13161; SCHULMAN LH, 1989, SCIENCE, V246, P1595, DOI 10.1126/science.2688091; Sekine S, 2001, J BIOL CHEM, V276, P3723, DOI 10.1074/jbc.C000756200; Shimada A, 2001, ACTA CRYSTALLOGR D, V57, P272, DOI 10.1107/S0907444900016255; Sissler M, 1996, EMBO J, V15, P5069, DOI 10.1002/j.1460-2075.1996.tb00887.x; Sol EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050545; Soppa J, 2010, ARCHAEA, V2010, DOI 10.1155/2010/820681; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; Tan M, 2013, BIOCHEM J, V449, P123, DOI 10.1042/BJ20121258; Tan M, 2010, J BIOL CHEM, V285, P3235, DOI 10.1074/jbc.M109.060616; Tu S, 2015, ELIFE, V4, DOI 10.7554/eLife.05322; Wagner GR, 2014, MOL CELL, V54, P5, DOI 10.1016/j.molcel.2014.03.027; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Weinert BT, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134766; Weinert BT, 2013, MOL CELL, V51, P265, DOI 10.1016/j.molcel.2013.06.003; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Wu JF, 1999, ACTA BIOCH BIOPH SIN, V31, P226; Yan W, 2015, J BIOL CHEM, V290, P12256, DOI 10.1074/jbc.M115.639492; Ye Q, 2015, J BIOL CHEM, V290, P24391, DOI 10.1074/jbc.M115.672824; [叶青 Ye Qingi], 2016, [生命科学, Chinese Bulletin of Life Sciences], V28, P427; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang K, 2013, J PROTEOME RES, V12, P844, DOI 10.1021/pr300912q; Zhang TF, 2012, CELL METAB, V15, P75, DOI 10.1016/j.cmet.2011.12.005; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zheng YG, 2004, NUCLEIC ACIDS RES, V32, P3294, DOI 10.1093/nar/gkh665; Zhu B, 2007, RNA, V13, P15, DOI 10.1261/rna.228707	64	12	12	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10709	10722		10.1074/jbc.M116.770826	http://dx.doi.org/10.1074/jbc.M116.770826			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28455447	Green Published, hybrid			2022-12-26	WOS:000404115400029
J	Chang, KK; Wang, S; Zhang, H; Guo, QQ; Hu, XR; Lin, ZL; Sun, HF; Jiang, M; Hu, JD				Chang, Keke; Wang, Shun; Zhang, Hao; Guo, Qingqian; Hu, Xinran; Lin, Zhili; Sun, Haifeng; Jiang, Min; Hu, Jiandong			Colorimetric detection of melamine in milk by using gold nanoparticles-based LSPR via optical fibers	PLOS ONE			English	Article							PLASMON RESONANCE SPECTROSCOPY; LINKED-IMMUNOSORBENT-ASSAY; DAIRY-PRODUCTS; SPECTROMETRY	A biosensing system with optical fibers is proposed for the colorimetric detection of melamine in liquid milk samples by using the localized surface plasmon resonance (LSPR) of unmodified gold nanoparticles (AuNPs). The biosensing system consists of a broadband light source that covers the spectral range from 200 nm to 1700 nm, an optical attenuator, three types of 600 mu m premium optical fibers with SMA905 connectors and a miniature spectrometer with a linear charge coupled device (CCD) array. The biosensing system with optical fibers is low-cost, simple and is well-proven for the detection of melamine. Its working principle is based on the color changes of AuNPs solution from wine-red to blue due to the inter-particle coupling effect that causes the shifts of wavelength and absorbance in LSPR band after the to-be-measured melamine samples were added. Under the optimized conditions, the detection response of the LSPR biosensing system was found to be linear in melamine detection in the concentration range from 0 mu M to 0.9 mu M with a correlation coefficient (R-2) 0.99 and a detection limit 33 nM. The experimental results obtained from the established LSPR biosensing system in the actual detection of melamine concentration in liquid milk samples show that this technique is highly specific and sensitive and would have a huge application prospects.	[Chang, Keke; Wang, Shun; Zhang, Hao; Guo, Qingqian; Sun, Haifeng; Hu, Jiandong] Henan Agr Univ, Coll Mech & Elect Engn, Zhengzhou, Peoples R China; [Chang, Keke; Wang, Shun; Guo, Qingqian; Sun, Haifeng; Hu, Jiandong] State Key Lab Wheat & Maize Crop Sci, Zhengzhou, Peoples R China; [Hu, Xinran] McGill Univ, Sch Human Nutr & Dietet, Macdonald Campus, Ste Anne De Bellevue, PQ, Canada; [Lin, Zhili] Huaqiao Univ, Coll Informat Sci & Engn, Xiamen, Peoples R China; [Jiang, Min] Henan Agr Univ, Coll Iife Sci, Zhengzhou, Peoples R China	Henan Agricultural University; McGill University; Huaqiao University; Henan Agricultural University	Hu, JD (corresponding author), Henan Agr Univ, Coll Mech & Elect Engn, Zhengzhou, Peoples R China.; Hu, JD (corresponding author), State Key Lab Wheat & Maize Crop Sci, Zhengzhou, Peoples R China.	jiandonghu@163.com	Lin, Zhili/D-6735-2013		National Natural Science Foundation of China [31671581]; Natural Science Foundation of Henan Province [162300410143]; Henan Province Collaborative Innovation Center of Biomass Energy; State Key Laboratory of Wheat and Maize Crop Science Funding [SKL2014ZH-06, 39990026]; Project 948 of the Ministry of Agriculture of China [2015-Z45]; Fujian Province Science Fund for Distinguished Young Scholars [2015J06015]; Zhengzhou Science and Technology Program [141PPTGG405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Henan Province; Henan Province Collaborative Innovation Center of Biomass Energy; State Key Laboratory of Wheat and Maize Crop Science Funding; Project 948 of the Ministry of Agriculture of China; Fujian Province Science Fund for Distinguished Young Scholars; Zhengzhou Science and Technology Program	The financial support was provided by the National Natural Science Foundation of China (31671581), Natural Science Foundation of Henan Province (162300410143), Henan Province Collaborative Innovation Center of Biomass Energy, State Key Laboratory of Wheat and Maize Crop Science Funding (SKL2014ZH-06, 39990026), Project 948 of the Ministry of Agriculture of China (2015-Z45), Fujian Province Science Fund for Distinguished Young Scholars (2015J06015), and the Zhengzhou Science and Technology Program (141PPTGG405).; We are grateful for the financial support provided by the National Natural Science Foundation of China (31671581), Natural Science Foundation of Henan Province (162300410143), Henan Province Collaborative Innovation Center of Biomass Energy, State Key Laboratory of Wheat and Maize Crop Science Funding (SKL2014ZH-06, 39990026), Project 948 of the Ministry of Agriculture of China (2015-Z45), Fujian Province Science Fund for Distinguished Young Scholars (2015J06015), and the Zhengzhou Science and Technology Program (141PPTGG405).	Aernouts B, 2015, J DAIRY SCI, V98, P6727, DOI 10.3168/jds.2015-9630; Chi H, 2010, ANALYST, V135, P1070, DOI 10.1039/c000285b; Chu CY, 2013, J ENVIRON SCI HEAL C, V31, P342, DOI 10.1080/10590501.2013.844758; Cretu V, 2016, J MATER CHEM A, V4, P6527, DOI 10.1039/c6ta01355d; Dalal RP, 2011, NAT REV NEPHROL, V7, P267, DOI 10.1038/nrneph.2011.24; Filazi A, 2012, J DAIRY SCI, V95, P602, DOI 10.3168/jds.2011-4926; Filigenzi MS, 2008, J AGR FOOD CHEM, V56, P7593, DOI 10.1021/jf801008s; Garber EAE, 2008, J FOOD PROTECT, V71, P590, DOI 10.4315/0362-028X-71.3.590; Haes AJ, 2002, J AM CHEM SOC, V124, P10596, DOI 10.1021/ja020393x; Hwang WS, 2012, ANAL BIOCHEM, V421, P213, DOI 10.1016/j.ab.2011.11.001; Jin X, 2014, PLOS ONE, V9; Kelly KL, 2003, J PHYS CHEM B, V107, P668, DOI 10.1021/jp026731y; Kumar N, 2014, ANAL BIOCHEM, V456, P43, DOI 10.1016/j.ab.2014.04.002; Lei HT, 2011, MOLECULES, V16, P5591, DOI 10.3390/molecules16075591; Li Y, 2015, RSC ADV, V5, P1125, DOI 10.1039/c4ra13080d; Li ZJ, 2015, BIOSENS BIOELECTRON, V68, P668, DOI 10.1016/j.bios.2015.01.062; Najim M, 2015, PHYS CHEM CHEM PHYS, V17, P22923, DOI 10.1039/c5cp03488d; Papavlassopoulos H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084983; Ping H, 2012, FOOD CONTROL, V23, P191, DOI 10.1016/j.foodcont.2011.07.009; Polavarapu L, 2015, CRYSTENGCOMM, V17, P3727, DOI 10.1039/c5ce00112a; Polavarapu L, 2014, J MATER CHEM C, V2, P7460, DOI 10.1039/c4tc01142b; Sepulveda B, 2009, NANO TODAY, V4, P244, DOI 10.1016/j.nantod.2009.04.001; Shiohara A, 2014, NANOSCALE, V6, P9817, DOI 10.1039/c4nr02648a; Song J, 2015, FOOD CONTROL, V50, P356, DOI 10.1016/j.foodcont.2014.08.049; Sun JF, 2011, BIOSENS BIOELECTRON, V28, P152, DOI 10.1016/j.bios.2011.07.012; Vail TM, 2007, J ANAL TOXICOL, V31, P304, DOI 10.1093/jat/31.6.304; Wang CL, 2014, CHEM SOC REV, V43, P7188, DOI 10.1039/c4cs00145a; Wei F, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3373325; Wei H, 2007, CHEM COMMUN, P3735, DOI 10.1039/b707642h; Wen YY, 2010, J SCI FOOD AGR, V90, P2178, DOI 10.1002/jsfa.4066; Willets KA, 2007, ANNU REV PHYS CHEM, V58, P267, DOI 10.1146/annurev.physchem.58.032806.104607; Xin JY, 2015, FOOD CHEM, V174, P473, DOI 10.1016/j.foodchem.2014.11.098; Xu XM, 2009, ANAL CHIM ACTA, V650, P39, DOI 10.1016/j.aca.2009.04.026; Zhang XF, 2010, J RAMAN SPECTROSC, V41, P1655, DOI 10.1002/jrs.2629; Zhu L, 2009, CHEM COMMUN, P559, DOI 10.1039/b818541g; Zhu YY, 2015, BIOSENS BIOELECTRON, V69, P174, DOI 10.1016/j.bios.2015.02.018	36	26	27	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177131	10.1371/journal.pone.0177131	http://dx.doi.org/10.1371/journal.pone.0177131			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475597	Green Published, gold, Green Submitted			2022-12-26	WOS:000400649500049
J	Nikolaev, MV; Dorofeeva, NA; Komarova, MS; Korolkova, YV; Andreev, YA; Mosharova, IV; Grishin, EV; Tikhonov, DB; Kozlov, SA				Nikolaev, Maxim V.; Dorofeeva, Natalia A.; Komarova, Margarita S.; Korolkova, Yuliya V.; Andreev, Yaroslav A.; Mosharova, Irina V.; Grishin, Eugene V.; Tikhonov, Denis B.; Kozlov, Sergey A.			TRPV1 activation power can switch an action mode for its polypeptide ligands	PLOS ONE			English	Article							ANEMONE HETERACTIS-CRISPA; VANILLOID RECEPTOR TRPV1; CAPSAICIN RECEPTOR; SEA-ANEMONE; ION-CHANNEL; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-BASIS; NUCLEIC-ACIDS; PORE DOMAIN; FORCE-FIELD	TRPV1 (vanilloid) receptors are activated by different types of stimuli including capsaicin, acidification and heat. Various ligands demonstrate stimulus-dependent action on TRPV1. In the present work we studied the action of polypeptides isolated from sea anemone Heteractis crispa (APHC1, APHC2 and APHC3) on rat TRPV1 receptors stably expressed in CHO cells using electrophysiological recordings, fluorescent Ca2+ measurements and molecular modeling. The APHCs potentiated TRPV1 responses to low (3-300 nM) concentrations of capsaicin but inhibited responses to high (> 3.0 mu M) concentrations. The activity-dependent action was also found for TRPV1 responses to 2APB and acidification. Thus the action mode of APHCs is bimodal and depended on the activation stimuli strength-potentiation of low-amplitude responses and no effect/inhibition of high-amplitude responses. The double-gate model of TRPV1 activation suggests that APHC-polypeptides may stabilize an intermediate state during the receptor activation. Molecular modeling revealed putative binding site at the outer loops of TRPV1. Binding to this site can directly affect activation by protons and can be allosterically coupled with capsaicin site. The results are important for further investigations of both TRPV1 and its ligands for potential therapeutic use.	[Nikolaev, Maxim V.; Dorofeeva, Natalia A.; Komarova, Margarita S.; Tikhonov, Denis B.] RAS, IM Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg, Russia; [Korolkova, Yuliya V.; Andreev, Yaroslav A.; Mosharova, Irina V.; Grishin, Eugene V.; Kozlov, Sergey A.] RAS, Shemyakin Ovchinnikov Inst Bioorgan, Moscow, Russia; [Andreev, Yaroslav A.] Sechenov First Moscow State Med Univ, Inst Mol Med, Moscow, Russia	Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Sechenov First Moscow State Medical University	Kozlov, SA (corresponding author), RAS, Shemyakin Ovchinnikov Inst Bioorgan, Moscow, Russia.	serg@ibch.ru	Komarova, Margarita/AAN-2166-2020; Nikolaev, Maxim/AAM-9380-2020; Kozlov, Sergey A/D-1548-2012; Tikhonov, Denis/AAK-9148-2020; Andreev, Yaroslav A/C-6627-2012	Komarova, Margarita/0000-0001-5035-6900; Nikolaev, Maxim/0000-0001-6501-7143; Kozlov, Sergey A/0000-0002-0242-4240; Andreev, Yaroslav/0000-0002-7628-0980; Tikhonov, Denis/0000-0001-8523-4305	program of Presidium of RAS "Molecular and Cell Biology"; RF science program [01201351571]; Russian Foundation for Basic Research [15-04-04666A]; President of RF [SSh-7676.2016.4]; RSF [16-15-00167]; Russian Science Foundation [16-15-00167] Funding Source: Russian Science Foundation	program of Presidium of RAS "Molecular and Cell Biology"; RF science program; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); President of RF; RSF(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	This research work was supported by the program of Presidium of RAS "Molecular and Cell Biology", RF science program 01201351571, the Russian Foundation for Basic Research (grant 15-04-04666A) and by the grant SSh-7676.2016.4 from the President of RF. YK and YA responsible for fluorescent based intracellular calcium assay are grateful to RSF (grant No 16-15-00167) for support.	Andreev YA, 2009, DOKL BIOCHEM BIOPHYS, V424, P46, DOI 10.1134/S160767290901013X; Andreev YA, 2008, J BIOL CHEM, V283, P23914, DOI 10.1074/jbc.M800776200; Andreev YA, 2013, MAR DRUGS, V11, P5100, DOI 10.3390/md11125100; Andreev YA, 2012, RECENT PATENTS INFLA, V6, P35, DOI 10.2174/187221312798889266; Andreev YA, 2010, ANAL BIOCHEM, V407, P144, DOI 10.1016/j.ab.2010.07.023; Aneiros E, 2011, EMBO J, V30, P994, DOI 10.1038/emboj.2011.19; Blumberg PM, 2011, CURR TOP MED CHEM, V11, P2151; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cuypers E, 2011, ACTA CHIM SLOV, V58, P735; Garden DP, 2010, J COMPUT AID MOL DES, V24, P91, DOI 10.1007/s10822-009-9317-9; Gavva NR, 2008, PAIN, V136, P202, DOI 10.1016/j.pain.2008.01.024; Grandl J, 2010, NAT NEUROSCI, V13, P708, DOI 10.1038/nn.2552; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Huang SM, 2002, P NATL ACAD SCI USA, V99, P8400, DOI 10.1073/pnas.122196999; Jakab B, 2005, EUR J PHARMACOL, V517, P35, DOI 10.1016/j.ejphar.2005.05.002; Johnson DM, 2006, MOL PHARMACOL, V70, P1005, DOI 10.1124/mol.106.023945; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kozlov SA, 2009, RUSS J BIOORG CHEM+, V35, P711, DOI 10.1134/S1068162009060065; Lazar J, 2009, EXPERT OPIN DRUG DIS, V4, P159, DOI 10.1517/17460440802681300; Lehto SG, 2008, J PHARMACOL EXP THER, V326, P218, DOI 10.1124/jpet.107.132233; LI ZQ, 1987, P NATL ACAD SCI USA, V84, P6611, DOI 10.1073/pnas.84.19.6611; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Makarieva TN, 2013, NAT PROD COMMUN, V8, P1229; MALMBERG AB, 2005, TURNING HEAT PAIN TR; Philyppov IB, 2012, LIFE SCI, V91, P912, DOI 10.1016/j.lfs.2012.09.001; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Romanovsky AA, 2009, PHARMACOL REV, V61, P228, DOI 10.1124/pr.109.001263; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Savidge J, 2002, NEUROPHARMACOLOGY, V43, P450, DOI 10.1016/S0028-3908(02)00122-3; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Sutton KG, 2005, BRIT J PHARMACOL, V146, P702, DOI 10.1038/sj.bjp.0706356; Tamayo N, 2008, J MED CHEM, V51, P2744, DOI 10.1021/jm7014638; Wang S, 2010, J BIOL CHEM, V285, P11547, DOI 10.1074/jbc.M109.058727; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Yang SL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9297; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	40	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177077	10.1371/journal.pone.0177077	http://dx.doi.org/10.1371/journal.pone.0177077			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475608	Green Published, Green Submitted, gold			2022-12-26	WOS:000400649500043
J	Mora, AR; Meniri, M; Gning, O; Glauser, G; Vallat, A; Helfenstein, F				Mora, Alfonso Rojas; Meniri, Magali; Gning, Ophelie; Glauser, Gaetan; Vallat, Armelle; Helfenstein, Fabrice			Antioxidant allocation modulates sperm quality across changing social environments	PLOS ONE			English	Article							HISTORY TRADE-OFFS; OXIDATIVE STRESS; HOUSE SPARROW; PASSER-DOMESTICUS; METABOLIC-RATE; EJACULATE QUALITY; SEXUAL SELECTION; BETA-CAROTENE; COMPETITION; EVOLUTION	In promiscuous species, male reproductive success depends on their ability to mate with fertile females and on the fertilizing ability of their sperm. In such species, theory predicts that, owing to a trade-off between pre-and post-copulatory reproductive traits, males with lesser access to females should increase resource investment into those sperm traits that enhance fertilization success-usually referred to as ejaculate quality. This prediction has been validated in several taxa, yet studies on the physiological mechanisms modulating ejaculate quality are lacking. Sperm cells are highly vulnerable to oxidative stress, which impairs male fertility. Therefore, males that better protect their sperm from oxidative stress are expected to achieve higher ejaculate quality. Based on theoretical expectations, and since social dominance is a major determinant of mating opportunity, we predicted that subordinate males should invest more into the antioxidant protection of their sperm in order to achieve higher ejaculate quality. We maintained 60 male and 60 female wild-caught house sparrows Passer domesticus in outdoor aviaries, where we experimentally manipulated male social status to test our predictions. We measured cellular oxidative stress and enzymatic antioxidant activity in blood and sperm both before and after manipulating social ranks. Before manipulating the social status, we found that ejaculate viability correlated with oxidative stress level in sperm, with dominant males producing more oxidized and less viable ejaculates. Further, males at the lower end of the hierarchy produced ejaculates of similar quality to those of dominant males, suggesting that restricted access to resources might limit male reproductive strategies. After experimentally manipulating the social status, males matched their ejaculate quality to their new rank, while increases in antioxidant investment into ejaculates paralleled increases in ejaculate viability. Oxidative stress has been proposed as a general constraint to the evolution of life histories. Our results highlight oxidative stress and strategic antioxidant allocation as important proximate physiological mechanisms underlying male reproductive strategies.	[Mora, Alfonso Rojas; Meniri, Magali; Gning, Ophelie; Helfenstein, Fabrice] Univ Neuchatel, Fac Sci, Inst Biol, Lab Evolutionary Ecophysiol, Neuchatel, Switzerland; [Glauser, Gaetan; Vallat, Armelle] Univ Neuchatel, Fac Sci, Inst Chem, Neuchatel Platform Analyt Chem, Neuchatel, Switzerland	University of Neuchatel; University of Neuchatel	Helfenstein, F (corresponding author), Univ Neuchatel, Fac Sci, Inst Biol, Lab Evolutionary Ecophysiol, Neuchatel, Switzerland.	fabrice.helfenstein@free.fr	Glauser, Gaetan/K-7574-2017; Helfenstein, Fabrice/I-5634-2013	Glauser, Gaetan/0000-0002-0983-8614; Helfenstein, Fabrice/0000-0001-8412-0461; Rojas Mora, Alfonso/0000-0002-1815-0424	Swiss National Science Foundation [PP00P3_139011]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We are very grateful to the Laboratory of Behavioural Ecology at the university of Bern for granting us access to their aviaries. We thank Sabrina Ciprietti for her help in conducting the experiment and Leif Engqvist for commenting an earlier version of the manuscript. We are also grateful to the farmers who allowed us to catch birds in their properties. This study was supported by a grant from the Swiss National Science Foundation no PP00P3_139011 to FH; This work was supported by the Swiss National Science Foundation (grant no PP00P3_139011 to FH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 1999, J REPROD FERTIL, V115, P1; Aitken RJ, 2004, REPROD FERT DEVELOP, V16, P581, DOI 10.1071/RD03089; Almbro M, 2011, ECOL LETT, V14, P891, DOI 10.1111/j.1461-0248.2011.01653.x; Alonso-Alvarez C, 2004, ECOL LETT, V7, P363, DOI 10.1111/j.1461-0248.2004.00594.x; Anderson TR., 2006, BIOL UBIQUITOUS HOUS; Atessahin A, 2006, REPROD TOXICOL, V21, P42, DOI 10.1016/j.reprotox.2005.05.003; BHAT G, 1988, ZOOL ANZ, V221, P430; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; BIRKHEAD TR, 1993, BIOL J LINN SOC, V50, P295, DOI 10.1111/j.1095-8312.1993.tb00933.x; Buchanan KL, 2010, J AVIAN BIOL, V41, P445, DOI 10.1111/j.1600-048X.2010.04929.x; Catoni C, 2008, ANIM BEHAV, V76, P1107, DOI 10.1016/j.anbehav.2008.05.027; Chitra KC, 2003, TOXICOLOGY, V185, P119, DOI 10.1016/S0300-483X(02)00597-8; CIERESZKO A, 1995, BIOL REPROD, V52, P982, DOI 10.1095/biolreprod52.5.982; Cohen AA, 2009, OECOLOGIA, V161, P673, DOI 10.1007/s00442-009-1423-9; Cohen AA, 2009, FUNCT ECOL, V23, P310, DOI 10.1111/j.1365-2435.2009.01540.x; Cornwallis CK, 2007, AM NAT, V170, P758, DOI 10.1086/521955; Cornwallis CK, 2009, P ROY SOC B-BIOL SCI, V276, P3467, DOI 10.1098/rspb.2009.0807; Costantini D, 2011, J COMP PHYSIOL B, V181, P447, DOI 10.1007/s00360-011-0566-2; delBarco-Trillo J, 2014, J EVOLUTION BIOL, V27, P55, DOI 10.1111/jeb.12275; Duru NK, 2000, FERTIL STERIL, V74, P1200; El-Demerdash FM, 2004, J ENVIRON SCI HEAL B, V39, P443, DOI 10.1081/PFC-120035929; Engqvist L, 2011, BEHAV ECOL, V22, P345, DOI 10.1093/beheco/arq211; Evans JP, 2010, P ROY SOC B-BIOL SCI, V277, P3195, DOI 10.1098/rspb.2010.0826; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Firman RC, 2015, J EVOLUTION BIOL, V28, P1373, DOI 10.1111/jeb.12661; Fitzpatrick JL, 2014, MOL HUM REPROD, V20, P1180, DOI 10.1093/molehr/gau067; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; Froman DP, 1999, BIOL REPROD, V61, P400, DOI 10.1095/biolreprod61.2.400; Froman DP, 2000, BIOL REPROD, V62, P303, DOI 10.1095/biolreprod62.2.303; Gammell MP, 2003, ANIM BEHAV, V66, P601, DOI 10.1006/anbe.2003.2226; Garcia-Gonzalez F, 2005, CURR BIOL, V15, P271, DOI 10.1016/j.cub.2005.01.032; Gonzalez G, 2002, ETHOLOGY, V108, P289, DOI 10.1046/j.1439-0310.2002.00779.x; Goymann W, 2004, ANIM BEHAV, V67, P591, DOI 10.1016/j.anbehav.2003.08.007; HAUSSMANN MF, 2010, ECOLOGY EVOLUTION, V56, P714; Helfenstein F, 2010, ECOL LETT, V13, P213, DOI 10.1111/j.1461-0248.2009.01419.x; Horak P, 2010, FUNCT ECOL, V24, P960, DOI 10.1111/j.1365-2435.2010.01755.x; Hulbert AJ, 2007, PHYSIOL REV, V87, P1175, DOI 10.1152/physrev.00047.2006; Immler S, 2010, EVOLUTION, V64, P1634, DOI 10.1111/j.1558-5646.2009.00924.x; JONES R, 1978, PROC R SOC SER B-BIO, V201, P413, DOI 10.1098/rspb.1978.0053; Jones R.C., 1993, Oxford Reviews of Reproductive Biology, V15, P233; Krishnan N, 2006, ARCH INSECT BIOCHEM, V63, P1, DOI 10.1002/arch.20135; Lemaitre JF, 2012, J EVOLUTION BIOL, V25, P1216, DOI 10.1111/j.1420-9101.2012.02511.x; Lindstrom KM, 2005, HORM BEHAV, V48, P311, DOI 10.1016/j.yhbeh.2005.04.002; Locatello L, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2891; Losdat S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022221; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; MOLLER AP, 1994, EVOLUTION, V48, P1089, DOI 10.1111/j.1558-5646.1994.tb05296.x; MOLLER AP, 1990, BEHAV ECOL SOCIOBIOL, V27, P23; MOLLER AP, 1987, ANIM BEHAV, V35, P203, DOI 10.1016/S0003-3472(87)80225-7; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Mora AR, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00067; Nakagawa S, 2007, BEHAV ECOL, V18, P831, DOI 10.1093/beheco/arm050; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Parker G.A., 1998, SPERM COMPETITION SE, P3, DOI DOI 10.1016/B978-012100543-6/50026-X; Parker GA, 1996, P ROY SOC B-BIOL SCI, V263, P1291, DOI 10.1098/rspb.1996.0189; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Parker GA, 2013, EVOLUTION, V67, P95, DOI 10.1111/j.1558-5646.2012.01741.x; Parker GA, 2010, BIOL REV, V85, P897, DOI 10.1111/j.1469-185X.2010.00140.x; Perry JC, 2013, TRENDS ECOL EVOL, V28, P414, DOI 10.1016/j.tree.2013.03.005; Pizzari T, 2008, TRENDS ECOL EVOL, V23, P131, DOI 10.1016/j.tree.2007.12.003; Pizzari T, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P207, DOI 10.1016/B978-0-12-372568-4.00006-9; Pizzari T, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-332; Preston BT, 2001, NATURE, V409, P681, DOI 10.1038/35055617; Ribou AC, 2012, P ROY SOC B-BIOL SCI, V279, P2196, DOI 10.1098/rspb.2011.2422; Rudolfsen G, 2006, P ROY SOC B-BIOL SCI, V273, P325, DOI 10.1098/rspb.2005.3305; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Simmons LW, 2012, REPRODUCTION, V144, P519, DOI 10.1530/REP-12-0285; Siva-Jothy MT, 2000, ECOL LETT, V3, P172; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; Tazzyman SJ, 2009, AM NAT, V174, pE71, DOI 10.1086/603612; Thomas ML, 2009, BEHAV ECOL, V20, P1118, DOI 10.1093/beheco/arp105; Tremellen K, 2008, HUM REPROD UPDATE, V14, P243, DOI 10.1093/humupd/dmn004; Wang Y, 2001, EXP GERONTOL, V36, P1349, DOI 10.1016/S0531-5565(01)00095-X; Wesseling C, 2016, J EXP BIOL, V219, P1363, DOI 10.1242/jeb.133843; WETTON JH, 1995, P ROY SOC B-BIOL SCI, V260, P91, DOI 10.1098/rspb.1995.0064; WETTON JH, 1991, P ROY SOC B-BIOL SCI, V245, P227, DOI 10.1098/rspb.1991.0114; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wilson-Leedy JG, 2007, THERIOGENOLOGY, V67, P661, DOI 10.1016/j.theriogenology.2006.10.003; Wolfson A., 1952, Bird-Banding, V23, P159	79	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176385	10.1371/journal.pone.0176385	http://dx.doi.org/10.1371/journal.pone.0176385			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472052	Green Submitted, Green Published, gold			2022-12-26	WOS:000400648500043
J	Yang, Y; Wang, FJ; Zheng, KY; Deng, LM; Yang, L; Zhang, N; Xu, CY; Ran, HT; Wang, ZX; Wang, ZG; Zheng, YY				Yang, Yang; Wang, Fengjuan; Zheng, Kaiyuan; Deng, Liming; Yang, Lu; Zhang, Nan; Xu, Chunyan; Ran, Haitao; Wang, Zhaoxia; Wang, Zhigang; Zheng, Yuanyi			Injectable PLGA/Fe3O4 implants carrying cisplatin for synergistic magnetic hyperthermal ablation of rabbit VX2 tumor	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; DRUG-RELEASE; IN-VIVO; FLUID HYPERTHERMIA; LIVER-TUMORS; CANCER; CHEMOTHERAPY; MODEL; CHAPERONE; DELIVERY	Magnetic hyperthermia ablation has attracted wide attention in tumor therapy for its minimal invasion. Although the chemo-hyperthermal synergism has been proven to be effective in subcutaneously xenografted tumors of nude mice in our previous experiment, the occurrence of residual tumors due to incomplete ablation is more common in relatively larger and deeper-seated tumors in anti-tumor therapy. Thus, a larger tumor and larger animal model are needed for further study of the therapeutic efficacy. In this study, we tested the efficiency of this newly developed technique using a rabbit tumor model. Furthermore, we chose cisplatin (DDP), which has been confirmed with high efficiency in enhancing hyperthermia therapy as the chemotherapeutic drug for the synergistic magnetic hyperthermal ablation therapy of tumors. In vitro studies demonstrated that developed DDP-loaded magnetic implants (DDP/PLGA-Fe3O4) have great heating efficacy and the drug release can be significantly boosted by an external alternating magnetic field (AMF). In vivo studies showed that the phase-transitional DDP/PLGA-Fe3O4 materials that are ultrasound (US) and computerized tomography (CT) visible can be well confined in the tumor tissues after injection. When exposed to AMF, efficient hyperthermia was induced, which led to the cancer cells' coagulative necrosis and accelerating release of the drug to kill residual tumors. Furthermore, an activated anti-tumor immune system can promote apoptosis of tumor cells. In conclusion, the DDP/PLGA-Fe3O4 implants can be used efficiently for the combined chemotherapy and magnetic-hyperthermia ablation of rabbit tumors.	[Yang, Yang; Wang, Fengjuan; Deng, Liming; Yang, Lu; Zhang, Nan; Xu, Chunyan; Ran, Haitao; Wang, Zhigang] Chongqing Med Univ, Affiliated Hosp 2, Chongqing Key Lab Ultrasound Mol Imaging, Chongqing, Peoples R China; [Zheng, Kaiyuan] Chongqing Peoples Hosp, Dept Nephrol, Chongqing, Peoples R China; [Wang, Zhaoxia] Chongqing Med Univ, Childrens Hosp, Dept Ultrasound, Chongqing, Peoples R China; [Zheng, Yuanyi] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Shanghai Inst Ultrasound Med, Shanghai, Peoples R China	Chongqing Medical University; Chongqing Medical University; Shanghai Jiao Tong University	Zheng, YY (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Shanghai Inst Ultrasound Med, Shanghai, Peoples R China.	zhengyuanyi@163.com			National Science Fund for Distinguished Young Scholars [81425014]; Chongqing Nature Science Fund [cstc2016jcyjA0823]; National Nature Science Fund of China [81227801, 81501482]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Chongqing Nature Science Fund; National Nature Science Fund of China(National Natural Science Foundation of China (NSFC))	This work is supported by the funds as follows: 1. National Science Fund for Distinguished Young Scholars (Grant No. 81425014), Y.Y. Zheng received the funding. The URLs is http://npd.nsfc.gov.cn/fundingProjectSearchAction!search.action. 2. Chongqing Nature Science Fund (Grant No. cstc2016jcyjA0823),Y. Yang received the funding. The URLs is http://wvw.cstc.gov.cn/Class.aspx?clsld=226. 3. The National Nature Science Fund of China (Grant No. 81227801), Z.G. Wang received the funding. The URLs is http://npd.nsfc.gov.cn/fundingProjectSearchAction!search.action. 4. The National Nature Science Fund of China (Grant No. 81501482), M. Ao received the funding. he URLs is http://npd.nsfc.gov.cn/fundingProjectSearchAction!search.action.	Ahmed M, 2013, BIOMED RES INT, V2013, P499; Al-Jamal WT, 2012, BIOMATERIALS, V33, P4608, DOI 10.1016/j.biomaterials.2012.03.018; Alvarez-Berrios MP, 2013, INT J NANOMED, V8, P1003, DOI 10.2147/IJN.S38842; Anayama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067355; Beckham JT, 2010, LASER SURG MED, V42, P752, DOI 10.1002/lsm.20983; Chen JH, 2004, LAB ANIM-UK, V38, P79, DOI 10.1258/00236770460734434; Chen X, 2008, IEEE T BIO-MED ENG, V55, P1004, DOI 10.1109/TBME.2008.915694; Chen Y, 2014, ADV MATER, V26, P7468, DOI 10.1002/adma.201402509; Dutz S, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/45/452001; Facy O, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-4; Gao W, 2016, ACTA BIOMATER, V29, P298, DOI 10.1016/j.actbio.2015.09.037; Huang L, 2001, MOL CELL BIOL, V21, P8575, DOI 10.1128/MCB.21.24.8575-8591.2001; Issels RD, 2008, EUR J CANCER, V44, P2546, DOI 10.1016/j.ejca.2008.07.038; Ito A, 2004, CANCER IMMUNOL IMMUN, V53, P26; Itoh Y, 2010, EXP THER MED, V1, P319, DOI 10.3892/etm_00000049; Kang JA, 2010, J ULTRAS MED, V29, P61, DOI 10.7863/jum.2010.29.1.61; Khandhar AP, 2012, J BIOMED MATER RES A, V100A, P728, DOI 10.1002/jbm.a.34011; Ko YH, 2001, CANCER LETT, V173, P83, DOI 10.1016/S0304-3835(01)00667-X; Kong SD, 2013, ACTA BIOMATER, V9, P5447, DOI 10.1016/j.actbio.2012.11.006; Kranz H, 2008, PHARM RES, V25, P1347, DOI 10.1007/s11095-007-9478-y; Krishnan S, 2010, INT J HYPERTHER, V26, P775, DOI 10.3109/02656736.2010.485593; Kruse AM, 2014, ACTA BIOMATER, V10, P2622, DOI 10.1016/j.actbio.2014.01.025; Kumar CSSR, 2011, ADV DRUG DELIVER REV, V63, P789, DOI 10.1016/j.addr.2011.03.008; Latorre M, 2009, P R HEALTH SCI J, V28, P227; Laurent S, 2011, ADV COLLOID INTERFAC, V166, P8, DOI 10.1016/j.cis.2011.04.003; Lee N, 2015, CHEM REV, V115, P10637, DOI 10.1021/acs.chemrev.5b00112; Luis S, 2012, THERANOSTICS, V2, P1064; Mahmoudi M, 2011, ADV DRUG DELIVER REV, V63, P24, DOI 10.1016/j.addr.2010.05.006; Matsumoto H, 1996, CANCER LETT, V110, P253, DOI 10.1016/S0304-3835(96)04508-9; Mohamed M, 2012, J DRUG DELIV SCI TEC, V22, P393, DOI 10.1016/S1773-2247(12)50066-3; Moroz P, 2001, J SURG ONCOL, V78, P22, DOI 10.1002/jso.1118; Patel RB, 2010, J CONTROL RELEASE, V147, P350, DOI 10.1016/j.jconrel.2010.08.020; Petryk AA, 2013, INT J HYPERTHER, V29, P845, DOI 10.3109/02656736.2013.825014; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Raman C, 2005, J CONTROL RELEASE, V102, P145, DOI 10.1016/j.jconrel.2004.09.022; Ren YY, 2012, INT J NANOMED, V7, P2261, DOI 10.2147/IJN.S29357; Skitzki JJ, 2009, CURR OPIN INVEST DR, V10, P550; Takahashi I, 2002, SURGERY, V131, pS78, DOI 10.1067/msy.2002.119308; Torres-Lugo M, 2016, NANOMEDICINE, V8, P1689; Wang H, 2012, EUR J RADIOL, V81, P104, DOI 10.1016/j.ejrad.2010.03.022; Westermann AM, 2001, EUR J CANCER, V37, P1111, DOI 10.1016/S0959-8049(01)00074-0; Wust P, 2002, LANCET ONCOL, V3, P487, DOI 10.1016/S1470-2045(02)00818-5; Zolnik BS, 2006, J CONTROL RELEASE, V112, P293, DOI 10.1016/j.jconrel.2006.02.015	43	14	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177049	10.1371/journal.pone.0177049	http://dx.doi.org/10.1371/journal.pone.0177049			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472102	gold, Green Submitted, Green Published			2022-12-26	WOS:000400648500130
J	Rana, MM				Rana, Md Masud			Least mean square fourth based microgrid state estimation algorithm using the internet of things technology	PLOS ONE			English	Article							SMART; MATRIX	This paper proposes an innovative internet of things (IoT) based communication framework for monitoring microgrid under the condition of packet dropouts in measurements. First of all, the microgrid incorporating the renewable distributed energy resources is represented by a state-space model. The IoT embedded wireless sensor network is adopted to sense the system states. Afterwards, the information is transmitted to the energy management system using the communication network. Finally, the least mean square fourth algorithm is explored for estimating the system states. The effectiveness of the developed approach is verified through numerical simulations.	[Rana, Md Masud] Khulna Univ Engn & Technol, Dept Elect & Commun Engn, Khulna, Bangladesh	Khulna University of Engineering & Technology (KUET)	Rana, MM (corresponding author), Khulna Univ Engn & Technol, Dept Elect & Commun Engn, Khulna, Bangladesh.	mamaraece28@yahoo.com						Ahmed A, 2015, AIRFIELD AND HIGHWAY PAVEMENTS 2015: INNOVATIVE AND COST-EFFECTIVE PAVEMENTS FOR A SUSTAINABLE FUTURE, P1; Areerak KN, 2008, PROC IEEE INT SYMP, P114; Areerak KN, 2009, P EUR C POW EL APPL; Ariff MAM, 2015, IEEE T POWER SYST, V30, P829, DOI 10.1109/TPWRS.2014.2331317; Chaijarurnudomrung K., 2011, WSEAS Transactions on Power Systems, V6, P31; Cho H, 2010, SIGNAL PROCESS, V90, P2792, DOI 10.1016/j.sigpro.2010.03.027; Dini DH, 2013, IEEE T INSTRUM MEAS, V62, P353, DOI 10.1109/TIM.2012.2214953; Elkhorchani H, 2016, J CLEAN PROD, V135, P950, DOI 10.1016/j.jclepro.2016.06.179; Farhang-Boroujeny B., 2013, ADAPTIVE FILTERS THE; Ghahremani E, 2011, IEEE T ENERGY CONVER, V26, P1099, DOI 10.1109/TEC.2011.2168225; Gong S., 2011, P INT C COMM, P1, DOI DOI 10.1109/FCS.2011.5977846; Haykin S., 2003, LEAST MEAN SQUARE AD, V31; Hu S, 2009, P JOINT 48 IEEE C DE; Kamwa I, 2006, IEEE IJCNN, P1710; Kanna S, 2015, IEEE T SIGNAL INF PR, V1, P45, DOI 10.1109/TSIPN.2015.2442834; Karimipour D, 2015, IEEE T CIRCUITS-II, V62, P696, DOI 10.1109/TCSII.2015.2406353; Kumarage H, 2016, IEEE CLOUD COMPUT, V3, P46, DOI 10.1109/MCC.2016.30; Malik MB, 2008, DIGIT SIGNAL PROCESS, V18, P334, DOI 10.1016/j.dsp.2007.05.003; Ni JG, 2010, IEEE T AUDIO SPEECH, V18, P1290, DOI 10.1109/TASL.2009.2032948; Rana MM, 2015, ELECTRON LETT, V51, P149, DOI 10.1049/el.2014.3635; Rawat DB, 2015, IEEE SIGNAL PROC LET, V22, P1652, DOI 10.1109/LSP.2015.2421935; Singh AK, 2015, IEEE T SMART GRID, V6, P381, DOI 10.1109/TSG.2014.2314494; Su L, 2015, P AMER CONTR CONF, P6010, DOI 10.1109/ACC.2015.7172283; Wang X., 2016, IEEE T POWE IN PRESS; Wu XH, 2016, J POWER SOURCES, V333, P203, DOI 10.1016/j.jpowsour.2016.09.157; Xiao N, 2012, IEEE T AUTOMAT CONTR, V57, P2176, DOI 10.1109/TAC.2012.2183450; Zhang F, 2015, IEEE T CONSUM ELECTR, V61, P10, DOI 10.1109/TCE.2015.7064105	27	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176099	10.1371/journal.pone.0176099	http://dx.doi.org/10.1371/journal.pone.0176099			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459848	Green Published, Green Submitted, gold			2022-12-26	WOS:000400645000014
J	Taghiyar, L; Hesaraki, M; Sayahpour, FA; Satarian, L; Hosseini, S; Aghdami, N; Baghaban Eslaminejad, M				Taghiyar, Leila; Hesaraki, Mahdi; Sayahpour, Forough Azam; Satarian, Leila; Hosseini, Samaneh; Aghdami, Naser; Baghaban Eslaminejad, Mohamadreza			Msh homeobox 1 (Msx1)- and Msx2-overexpressing bone marrow-derived mesenchymal stem cells resemble blastema cells and enhance regeneration in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						animal model; bone; differentiation; mesenchymal stem cells (MSCs); regeneration; blastema cells; bone differentiation; bone marrow-derived mesenchymal stem cells; limb regeneration; Msx gene transduction	MOUSE DIGIT TIP; LIMB REGENERATION; TRANSCRIPTION FACTOR; STROMAL CELLS; EXPRESSION; DIFFERENTIATION; AXOLOTL; MSX1; AMPUTATION; INDUCTION	Amputation of the proximal region in mammals is not followed by regeneration because blastema cells (BCs) and expression of regenerative genes, such as Msh homeobox (Msx) genes, are absent in this animal group. The lack of BCs and positional information in other cells is therefore the main obstacle to therapeutic approaches for limb regeneration. Hence, this study aimed to create blastema-like cells (BlCs) by overexpressing Msx1 and Msx2 genes in mouse bone marrow-derived mesenchymal stem cells (mBMSCs) to regenerate a proximally amputated digit tip. We transduced mBMSCs with Msx1 and Msx2 genes and compared osteogenic activity and expression levels of several Msx-regulated genes (Bmp4, Fgf8, and keratin 14 (K14)) in BlC groups, including MSX1, MSX2, and MSX1/2 (in a 1:1 ratio) with those in mBMSCs and BCs in vitro and in vivo following injection into the amputation site. We found that Msx gene overexpression increased expression of specific blastemal markers and enhanced the proliferation rate and osteogenesis of BlCs compared with mBMSCs and BCs via activation of Fgf8 and Bmp4. Histological analyses indicated full regrowth of digit tips in the Msx-overexpressing groups, particularly in MSX1/2, through endochondral ossification 6 weeks post-injection. In contrast, mBMSCs and BCs formed abnormal bone and nail. Full digit tip was regenerated only in the MSX1/2 group and was related to boosted Bmp4, Fgf8, and K14 gene expression and to limb-patterning properties resulting from Msx1 and Msx2 overexpression. We propose that Msx-transduced cells that can regenerate epithelial and mesenchymal tissues may potentially be utilized in limb regeneration.	[Taghiyar, Leila; Hesaraki, Mahdi; Sayahpour, Forough Azam; Satarian, Leila; Hosseini, Samaneh; Aghdami, Naser; Baghaban Eslaminejad, Mohamadreza] ACECR, Royan Inst Stem Cell Biol & Technol, Dept Stem Cells & Dev Biol, Cell Sci Res Ctr, Tehran 1665659911, Iran; [Taghiyar, Leila] Univ Sci & Culture, Dept Dev Biol, Tehran 13145871, Iran	Academic Center for Education, Culture & Research (ACECR)	Baghaban Eslaminejad, M (corresponding author), ACECR, Royan Inst Stem Cell Biol & Technol, Dept Stem Cells & Dev Biol, Cell Sci Res Ctr, Tehran 1665659911, Iran.	eslami@royaninstitute.org	Satarian, Leila/M-3835-2017; Eslaminejad, Mohamadreza Baghaban/S-3645-2017; Aghdami, Nasser/ABH-7238-2020; Hosseini, Samaneh/I-1232-2019	Satarian, Leila/0000-0002-5068-5031; Eslaminejad, Mohamadreza Baghaban/0000-0002-1036-0072; Hosseini, Samaneh/0000-0002-5701-6666	Royan Institute; Iranian Council of Stem Cell Research and Technology (ICSCR)	Royan Institute; Iranian Council of Stem Cell Research and Technology (ICSCR)	The present research was supported by the Royan Institute and the Iranian Council of Stem Cell Research and Technology (ICSCR). The authors declare that they have no conflicts of interest with the contents of this article.	Allan CH, 2006, WOUND REPAIR REGEN, V14, P398, DOI 10.1111/j.1743-6109.2006.00139.x; Bajek A, 2016, ARCH IMMUNOL THER EX, V64, P443, DOI 10.1007/s00005-016-0394-x; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Barker DM, 2009, DEV DYNAM, V238, P1366, DOI 10.1002/dvdy.21923; Bensoussan-Trigano V, 2011, DEV DYNAM, V240, P1190, DOI 10.1002/dvdy.22619; Cai TY, 2013, MOL MED REP, V8, P1323, DOI 10.3892/mmr.2013.1668; Carlson MRJ, 1998, J EXP ZOOL, V282, P715, DOI 10.1002/(SICI)1097-010X(19981215)282:6<715::AID-JEZ7>3.0.CO;2-F; COULOMBE PA, 1989, J CELL BIOL, V109, P2295, DOI 10.1083/jcb.109.5.2295; Dehghan S, 2016, NEUROSCIENCE, V318, P178, DOI 10.1016/j.neuroscience.2016.01.028; Eslaminejad MB, 2006, DEV GROWTH DIFFER, V48, P361, DOI 10.1111/j.1440-169x.2006.00874.x; Fernando WA, 2011, DEV BIOL, V350, P301, DOI 10.1016/j.ydbio.2010.11.035; Han MJ, 2003, DEVELOPMENT, V130, P5123, DOI 10.1242/dev.00710; Han MJ, 2001, DEV DYNAM, V220, P40, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1085>3.0.CO;2-8; Hu GZ, 2001, DEVELOPMENT, V128, P2373; Ide H, 2012, DEV DYNAM, V241, P435, DOI 10.1002/dvdy.23728; Klinker MW, 2015, WORLD J STEM CELLS, V7, P556, DOI 10.4252/wjsc.v7.i3.556; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Lehoczky JA, 2011, P NATL ACAD SCI USA, V108, P20609, DOI 10.1073/pnas.1118017108; Maleki Masoud, 2014, International Journal of Stem Cells, V7, P118, DOI 10.15283/ijsc.2014.7.2.118; Masaki H, 2007, DEV GROWTH DIFFER, V49, P89, DOI 10.1111/j.1440-169X.2007.00909.x; Muller I, 2008, BLOOD CELL MOL DIS, V40, P25, DOI 10.1016/j.bcmd.2007.06.021; Muller TL, 1999, SEMIN CELL DEV BIOL, V10, P405, DOI 10.1006/scdb.1999.0327; Nacu E, 2016, NATURE, V533, P407, DOI 10.1038/nature17972; Ono I, 2004, WOUND REPAIR REGEN, V12, P67, DOI 10.1111/j.1067-1927.2004.012113.x-1; Penfornis P, 2011, METHODS MOL BIOL, V698, P11, DOI 10.1007/978-1-60761-999-4_2; Pizette S, 2001, DEVELOPMENT, V128, P4463; Rao N, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-32; Reiser J, 2000, GENE THER, V7, P910, DOI 10.1038/sj.gt.3301188; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Satoh A, 2016, DEV BIOL, V417, P114, DOI 10.1016/j.ydbio.2016.07.005; SHAH M, 1995, J CELL SCI, V108, P985; SIMON HG, 1993, DEVELOPMENT, V117, P1397; Stoltz JF, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/734731; Suzuki M, 2006, THESCIENTIFICWORLDJO, V6, P26, DOI 10.1100/tsw.2006.325; Taghiyar L., 2017, CELL YAKHTE IN PRESS; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Vojnits K, 2015, SCI REP-UK, V5, DOI 10.1038/srep17355; WANG YQ, 1995, DEV BIOL, V168, P374, DOI 10.1006/dbio.1995.1087; Wu XH, 2013, ONCOL REP, V30, P2211, DOI 10.3892/or.2013.2687; Yu L, 2012, DEV BIOL, V372, P263, DOI 10.1016/j.ydbio.2012.09.021; Yu L, 2010, DEVELOPMENT, V137, P551, DOI 10.1242/dev.042424	41	13	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10520	10533		10.1074/jbc.M116.774265	http://dx.doi.org/10.1074/jbc.M116.774265			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28461333	hybrid, Green Published			2022-12-26	WOS:000404115400014
J	Papp, Z; Clark, RG; Parmley, EJ; Leighton, FA; Waldner, C; Soos, C				Papp, Zsuzsanna; Clark, Robert G.; Parmley, E. Jane; Leighton, Frederick A.; Waldner, Cheryl; Soos, Catherine			The ecology of avian influenza viruses in wild dabbling ducks (Anas spp.) in Canada	PLOS ONE			English	Article							A VIRUSES; MIGRATORY BIRDS; NORTH-AMERICA; A(H7N9) VIRUS; INFECTION; WATERFOWL; HOST; PREVALENCE; PATTERNS; CHINA	Avian influenza virus (AIV) occurrence and transmission remain important wildlife and human health issues in much of the world, including in North America. Through Canada's Inter-Agency Wild Bird Influenza Survey, close to 20,000 apparently healthy, wild dabbling ducks (of seven species) were tested for AIV between 2005 and 2011. We used these data to identify and evaluate ecological and demographic correlates of infection with low pathogenic AIVs in wild dabbling ducks (Anas spp.) across Canada. Generalized linear mixed effects model analyses revealed that risk of AIV infection was higher in hatch-year birds compared to adults, and was positively associated with a high proportion of hatch-year birds in the population. Males were more likely to be infected than females in British Columbia and in Eastern Provinces of Canada, but more complex relationships among age and sex cohorts were found in the Prairie Provinces. A species effect was apparent in Eastern Canada and British Columbia, where teal (A. discors and/or A. carolinensis) were less likely to be infected than mallards (A. platyrhynchos). Risk of AIV infection increased with the density of the breeding population, in both Eastern Canada and the Prairie Provinces, and lower temperatures preceding sampling were associated with a higher probability of AIV infection in Eastern Canada. Our results provide new insights into the ecological and demographic factors associated with AIV infection in waterfowl.	[Papp, Zsuzsanna; Clark, Robert G.; Soos, Catherine] Environm & Climate Change Canada, Sci & Technol Branch, Saskatoon, SK, Canada; [Parmley, E. Jane] Univ Guelph, Canadian Wildlife Hlth Cooperat, Guelph, ON, Canada; [Leighton, Frederick A.; Soos, Catherine] Univ Saskatchewan, Dept Vet Pathol, Saskatoon, SK, Canada; [Leighton, Frederick A.] Univ Saskatchewan, Canadian Wildlife Hlth Cooperat, Saskatoon, SK, Canada; [Waldner, Cheryl] Univ Saskatchewan, Dept Large Anim Sci, Saskatoon, SK, Canada	Environment & Climate Change Canada; University of Guelph; University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Soos, C (corresponding author), Environm & Climate Change Canada, Sci & Technol Branch, Saskatoon, SK, Canada.; Soos, C (corresponding author), Univ Saskatchewan, Dept Vet Pathol, Saskatoon, SK, Canada.	catherine.soos@canada.ca	Soos, Catherine/Q-4983-2019	Soos, Catherine/0000-0003-4610-3614; Waldner, Cheryl/0000-0002-7152-4261	Environment and Climate Change Canada (ECCC); ECCC; Canadian Food Inspection Agency; Public Health Agency of Canada; Provincial/Territorial departments responsible for agriculture (animal health), wildlife, and public health; Centre for Coastal Health; Ducks Unlimited Canada (Institute for Wetland and Waterfowl Research); Alberta Conservation Association; University of Saskatchewan	Environment and Climate Change Canada (ECCC); ECCC; Canadian Food Inspection Agency; Public Health Agency of Canada; Provincial/Territorial departments responsible for agriculture (animal health), wildlife, and public health; Centre for Coastal Health; Ducks Unlimited Canada (Institute for Wetland and Waterfowl Research); Alberta Conservation Association; University of Saskatchewan	Financial support for analysis of surveillance data was provided by Environment and Climate Change Canada (ECCC). Financial, field, and laboratory support for Canadas Inter-Agency Wild Bird Influenza Survey was provided by ECCC, the Canadian Food Inspection Agency, Public Health Agency of Canada, Provincial/Territorial departments responsible for agriculture (animal health), wildlife, and public health, the Centre for Coastal Health, Ducks Unlimited Canada (Institute for Wetland and Waterfowl Research), Alberta Conservation Association, and University of Saskatchewan.	[Anonymous], 2017, WILD BIRD HIGHLY PAT; [Anonymous], 2016, NAT WILDL HLTH CTR W; [Anonymous], 2017, CUM NUMB CONF HUM CA; [Anonymous], 2017, HUMAN INFECT AVIAN I; Avril A, 2016, J APPL ECOL, V53, P1289, DOI 10.1111/1365-2664.12699; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Buhnerkempe MG, 2016, ECOL APPL, V26, P740, DOI 10.1890/15-0934; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Costa TP, 2011, AVIAN PATHOL, V40, P119, DOI 10.1080/03079457.2010.540002; Cowling BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X; DEIBEL R, 1985, AVIAN DIS, V29, P970, DOI 10.2307/1590450; Farnsworth ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032729; Ferro PJ, 2010, EMERG INFECT DIS, V16, P1224, DOI 10.3201/eid1608.091864; Gaidet N, 2012, P ROY SOC B-BIOL SCI, V279, P1131, DOI 10.1098/rspb.2011.1417; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Groepper SR, 2014, AVIAN DIS, V58, P531, DOI 10.1637/10849-042214-Reg.1; Hill NJ, 2016, ECOL LETT, V19, P915, DOI 10.1111/ele.12629; Hill NJ, 2012, VECTOR-BORNE ZOONOT, V12, P243, DOI 10.1089/vbz.2010.0246; Hill NJ, 2010, AVIAN DIS, V54, P426, DOI 10.1637/8912-043009-Reg.1; HINSHAW VS, 1980, CAN J MICROBIOL, V26, P622, DOI 10.1139/m80-108; Horimoto T, 2001, CLIN MICROBIOL REV, V14, P129, DOI 10.1128/CMR.14.1.129-149.2001; Howerter DW, 2014, WILDLIFE MONOGR, V188, P1, DOI 10.1002/wmon.1012; Hoye BJ, 2016, INTEGR COMP BIOL, V56, P317, DOI 10.1093/icb/icw038; Hoye BJ, 2012, P ROY SOC B-BIOL SCI, V279, P529, DOI 10.1098/rspb.2011.0958; Ip HS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-71; Ip HS, 2015, EMERG INFECT DIS, V21, P886, DOI 10.3201/eid2105.142020; Ip HS, 2016, AVIAN DIS; Jennelle CS, 2016, EMERG INFECT DIS, V22, P1278, DOI 10.3201/eid2207.152032; JOHNSON DH, 1988, WILDLIFE MONOGR, P1; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Latorre-Margalef N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003443; Lebarbenchon C, 2010, EMERG INFECT DIS, V16, P1057, DOI 10.3201/eid1607.090389; Lee DH, 2015, J VIROL, V89, P6521, DOI 10.1128/JVI.00728-15; Liu CM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000191; Munster VJ, 2009, VACCINE, V27, P6340, DOI 10.1016/j.vaccine.2009.02.082; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Murray K, 2009, ECOLOGY, V90, P348, DOI 10.1890/07-1929.1; Murti M, 2015, CCDR; Nallar R, 2016, J WILDLIFE DIS, V52, P33, DOI 10.7589/2013-07-191; Nallar R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130662; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Parmley EJ, 2008, EMERG INFECT DIS, V14, P84, DOI 10.3201/eid1401.061562; Parmley J, 2009, INTEGR ZOOL, V4, P409, DOI 10.1111/j.1749-4877.2009.00177.x; Pasick J, 2010, AVIAN DIS, V54, P440, DOI 10.1637/8800-040109-Reg.1; Pasick J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09484; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reperant LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000854; Runstadler JA, 2007, ARCH VIROL, V152, P1901, DOI 10.1007/s00705-007-0994-1; Segovia KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170335; SHARP GB, 1993, EPIDEMIOL INFECT, V110, P161, DOI 10.1017/S0950268800050780; Soos C, 2012, J WILDLIFE DIS, V48, P444, DOI 10.7589/0090-3558-48.2.444; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Stallknecht DE, 2010, AVIAN DIS, V54, P461, DOI 10.1637/8760-033109-Reg.1; STALLKNECHT DE, 1988, VET RES COMMUN, V12, P125, DOI 10.1007/BF00362792; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; Takekawa JY, 2010, AVIAN BIOL RES, V3, P51, DOI 10.3184/175815510X12737339356701; van Dijk JGB, 2014, J ANIM ECOL, V83, P266, DOI 10.1111/1365-2656.12131; van Gils JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000184; Verhagen JH, 2015, SCIENCE, V347, P616, DOI 10.1126/science.aaa6724; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wilcox BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024010; Xiang NJ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2049-2; Xu CL, 2013, EMERG INFECT DIS, V19, P1289, DOI 10.3201/eid1908.130662	67	16	16	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e017629	10.1371/journal.pone.0176297	http://dx.doi.org/10.1371/journal.pone.0176297			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475626	gold, Green Published, Green Submitted			2022-12-26	WOS:000400649500007
J	Yang, JK; Xiong, W; Chen, FY; Xu, L; Han, ZG				Yang, Jiang-Ke; Xiong, Wei; Chen, Fang-Yuan; Xu, Li; Han, Zheng-Gang			Aromatic amino acids in the cellulose binding domain of Penicillium crustosum endoglucanase EGL1 differentially contribute to the cellulose affinity of the enzyme	PLOS ONE			English	Article							MODULE; CELLULASES; FIMI	The cellulose binding domain (CBD) of cellulase binding to cellulosic materials is the initiation of a synergistic action on the enzymatic hydrolysis of the most abundant renewable biomass resources in nature. The binding of the CBD domain to cellulosic substrates generally relies on the interaction between the aromatic amino acids structurally located on the flat face of the CBD domain and the glucose rings of cellulose. In this study, we found the CBD domain of a newly cloned Penicillium crustosum endoglucanase EGL1, which was phylogenetically related to Aspergillus, Fusarium and Rhizopus, and divergent from the well-characterized Trichoderma reeseis cellulase CBD domain, contain two conserved aromatic amino acid-rich regions, Y-451-Y-452 and Y-477-Y-478-Y-479, among which three amino acids Y-451, Y-477, and Y-478 structurally sited on a flat face of this domain. Cellulose binding assays with green fluorescence protein as the marker, adsorption isotherm assays and an isothermal titration calorimetry assays revealed that although these three amino acids participated in this process, the Y-451-Y-452 appears to contribute more to the cellulose binding than Y-477-Y-478-Y-479. Further glycine scanning mutagenesis and structural modelling revealed that the binding between CBD domain and cellulosic materials might be multi-amino-acids that participated in this process. The flexible poly-glucose molecule could contact Y-451, Y-477, and Y-478 which form the contacting flat face of CBD domain as the typical model, some other amino acids in or outside the flat face might also participate in the interaction. Thus, it is possible that the conserved Y-451-Y-452 of CBD might have a higher chance of contacting the cellulosic substrates, contributing more to the affinity of CBD than the other amino acids.	[Yang, Jiang-Ke; Xiong, Wei; Chen, Fang-Yuan; Xu, Li; Han, Zheng-Gang] Wuhan Polytech Univ, Coll Biol & Pharmaceut Engn, Wuhan, Peoples R China	Wuhan Polytechnic University	Yang, JK (corresponding author), Wuhan Polytech Univ, Coll Biol & Pharmaceut Engn, Wuhan, Peoples R China.	jiangke.yang@gmail.com	XU, LIWU/GYR-0963-2022	Yang, Jiangke/0000-0001-6234-451X	Wuhan Science and Technology Project, China [2016020101010084]	Wuhan Science and Technology Project, China	There has been no significant financial support for this work that could have influenced its outcome. This work was granted by Wuhan Science and Technology Project (No. 2016020101010084), China.	Arai T, 2003, J BACTERIOL, V185, P504, DOI 10.1128/JB.185.2.504-512.2003; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; Carrard G, 2000, P NATL ACAD SCI USA, V97, P10342, DOI 10.1073/pnas.160216697; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Ciolacu D, 2010, CARBOHYD RES, V345, P621, DOI 10.1016/j.carres.2009.12.023; Happs RM, 2015, FEBS J, V282, P4341, DOI 10.1111/febs.13500; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kormos J, 2000, BIOCHEMISTRY-US, V39, P8844, DOI 10.1021/bi000607s; LYND LR, 1991, SCIENCE, V251, P1318, DOI 10.1126/science.251.4999.1318; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Mattinen ML, 1997, PROTEIN SCI, V6, P294; McLean BW, 2000, PROTEIN ENG, V13, P801, DOI 10.1093/protein/13.11.801; Ohmiya K, 1997, BIOTECHNOL GENET ENG, V14, P365, DOI 10.1080/02648725.1997.10647949; Schreiber G, 2002, CURR OPIN STRUC BIOL, V12, P41, DOI 10.1016/S0959-440X(02)00287-7; Sharma A, 2016, APPL BIOCHEM BIOTECH, V179, P1346, DOI 10.1007/s12010-016-2070-3; Takashima S, 2007, FEBS LETT, V581, P5891, DOI 10.1016/j.febslet.2007.11.068; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; VANTILBEURGH H, 1986, FEBS LETT, V204, P223, DOI 10.1016/0014-5793(86)80816-X	20	6	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176444	10.1371/journal.pone.0176444	http://dx.doi.org/10.1371/journal.pone.0176444			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475645	Green Published, gold, Green Submitted			2022-12-26	WOS:000400649500009
J	Csutak, A; Steiber, Z; Tozser, J; Jakab, A; Berta, A; Silver, DM				Csutak, Adrienne; Steiber, Zita; Tozser, Jozsef; Jakab, Attila; Berta, Andras; Silver, David M.			Plasminogen activator activity in tears of pregnant women	PLOS ONE			English	Article							LASER PHOTOREFRACTIVE KERATECTOMY; SEVERE PREECLAMPSIA; PERIODONTAL HEALTH; PROTEIN-LEVELS; PLASMA-LEVELS; RABBIT TEARS; INHIBITORS; MYOPIA; FLUID; FIBRINOLYSIS	Purpose Plasminogen activator activity (PAA) in tears of pregnant women was investigated at various gestation times to assess the availability of plasminogen activator for aiding potential corneal wound healing processes during pregnancy. Methods PAA was measured by a spectrophotometric method. The analysis used 91 tear samples from pregnant and non-pregnant women, supplemented with 10 additional tear PAA measurements from non-pregnant women obtained in a previous study. Results Tear levels of PAA in pregnant women formed a bimodal distribution. Either the tear PAA level was zero or non-zero during pregnancy. When non-zero, the tear PAA level was dissociated from gestation time and not different than non-pregnant and post-pregnant levels. The frequency of occurrence of zero level tear PAA increased with gestation: 16%, 17% and 46% had zero tear PAA in samples taken from women in the first, second and third trimester, respectively. Conclusions Overall, of the tear samples taken from women during pregnancy, a total of 26% were at zero tear PAA. The remaining tear samples had non-zero tear PAA values throughout gestation equivalent to non-pregnant tear PAA values, suggesting local control of the source of PAA in tears. Given the importance of the plasminogen activator system in tears to wound healing in the cornea, and the high occurrence of zero tear PAA in our sample of pregnant women, elective corneal surgery would be contraindicated. If corneal surgery is nevertheless necessary, the tear PAA level would be worth checking and patients with low level should be closely observed during the postoperative period.	[Csutak, Adrienne; Steiber, Zita; Berta, Andras] Univ Debrecen, Fac Med, Dept Ophthalmol, Debrecen, Hungary; [Tozser, Jozsef] Univ Debrecen, Fac Med, Dept Biochem & Mol Biol, Debrecen, Hungary; [Jakab, Attila] Univ Debrecen, Fac Med, Dept Obstet & Gynecol, Debrecen, Hungary; [Silver, David M.] Johns Hopkins Univ, Bethesda, MD USA	University of Debrecen; University of Debrecen; University of Debrecen; Johns Hopkins University	Csutak, A (corresponding author), Univ Debrecen, Fac Med, Dept Ophthalmol, Debrecen, Hungary.	acsutak@med.unideb.hu	Tozser, Jozsef/A-7840-2008; Jakab, Attila/ABZ-9541-2022; Silver, David M/I-7734-2014	Tozser, Jozsef/0000-0003-0274-0056; Silver, David M/0000-0002-1631-1466; Csutak, Adrienne/0000-0002-7821-2412	Janos Bolyai Postdoctoral Fellowship; Lajos Szodoray Postdoctoral Fellowship	Janos Bolyai Postdoctoral Fellowship(Hungarian Academy of Sciences); Lajos Szodoray Postdoctoral Fellowship	Support was provided by Janos Bolyai and Lajos Szodoray Postdoctoral Fellowships to AC.	ASTEDT B, 1985, THROMB HAEMOSTASIS, V53, P122; Barbazetto Irene A, 2007, Compr Ophthalmol Update, V8, P155; Becerik S, 2010, J PERIODONTOL, V81, P673, DOI 10.1902/jop.2010.090590; BERTA A, 1983, AM J OPHTHALMOL, V96, P115, DOI 10.1016/0002-9394(83)90473-7; Bland M., 1995, INTRO MED STAT, P101; Bower KS, 2014, CURR OPIN OPHTHALMOL, V25, P251, DOI 10.1097/ICU.0000000000000055; Brenner B, 2004, THROMB RES, V114, P409, DOI 10.1016/j.thromres.2004.08.004; Buduneli N, 2010, AUST DENT J, V55, P292, DOI 10.1111/j.1834-7819.2010.01237.x; Carpintero A, 1996, CLIN CHIM ACTA, V255, P153, DOI 10.1016/0009-8981(96)06403-0; Coolman M, 2006, EUR J OBSTET GYN R B, V128, P22, DOI 10.1016/j.ejogrb.2006.02.004; Csutak A, 2000, INVEST OPHTH VIS SCI, V41, P3743; Csutak A, 2004, INVEST OPHTH VIS SCI, V45, P1329, DOI 10.1167/iovs.03-0881; Csutak A, 2003, EXP EYE RES, V77, P675, DOI 10.1016/j.exer.2003.08.012; Csutak A, 2008, J CATARACT REFR SURG, V34, P897, DOI 10.1016/j.jcrs.2008.02.024; ESTELLES A, 1989, BLOOD, V74, P1332; FULLARD RJ, 1991, INVEST OPHTH VIS SCI, V32, P2290; FULLARD RJ, 1990, INVEST OPHTH VIS SCI, V31, P1119; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Hellgren M, 2003, SEMIN THROMB HEMOST, V29, P125, DOI 10.1055/s-2003-38897; Kinnby B, 2002, BIOL CHEM, V383, P85, DOI 10.1515/BC.2002.008; Kleinbaum DG, 1998, APPL REGRESSION ANAL, P423; KOH CLS, 1992, INT J GYNECOL OBSTET, V38, P9, DOI 10.1016/0020-7292(92)90723-V; Koh SCL, 2002, THROMB HAEMOSTASIS, V87, P175; KRUITHOF EKO, 1987, BLOOD, V69, P460; Leonardi A, 2005, INVEST OPHTH VIS SCI, V46, P1364, DOI 10.1167/iovs.04-1196; Lindberg P, 2001, HISTOCHEM CELL BIOL, V116, P447, DOI 10.1007/s00418-001-0341-7; LOHMANN CP, 1993, REFRACT CORNEAL SURG, V9, P300; López-Prats M.J., 2012, Arch Soc Esp Oftalmol, V87, P173, DOI 10.1016/j.oftal.2011.09.021; Margetic S, 2012, BIOCHEM MEDICA, V22, P49; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Nakashima A, 1996, GYNECOL OBSTET INVES, V42, P95, DOI 10.1159/000291899; OBRART DPS, 1994, OPHTHALMOLOGY, V101, P1565; Olofsson A, 2002, J PERIODONTAL RES, V37, P60, DOI 10.1034/j.1600-0765.2002.00325.x; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Pizzarello LD, 2003, GRAEF ARCH CLIN EXP, V241, P484, DOI 10.1007/s00417-003-0674-0; Saleh Y., 2004, INTERNET J GYNECOL O, V5, P1; Saw SM, 1996, EPIDEMIOL REV, V18, P175, DOI 10.1093/oxfordjournals.epirev.a017924; Sharif K, 1997, J REFRACT SURG, V13, pS445; SHIMADA H, 1981, THROMB HAEMOSTASIS, V46, P507; SHIMADA H, 1989, THROMB RES, V54, P91, DOI 10.1016/0049-3848(89)90039-X; Shimizu N, 2003, JPN J OPHTHALMOL, V47, P6, DOI 10.1016/S0021-5155(02)00620-2; Steiber Z, 2015, INT J OPHTHALMOL EYE, V3, P121; Sulniute R, 2016, THROMB HAEMOSTASIS, V115, P1001, DOI 10.1160/TH15-08-0653; TOZSER J, 1990, EXP EYE RES, V51, P33, DOI 10.1016/0014-4835(90)90167-S; TOZSER J, 1989, CLIN CHIM ACTA, V183, P323, DOI 10.1016/0009-8981(89)90367-7; Uszynski M, 2004, EUR J OBSTET GYN R B, V114, P54, DOI 10.1016/j.ejogrb.2003.12.006; Uszynski M, 2001, GYNECOL OBSTET INVES, V52, P189, DOI 10.1159/000052971; VANWERSCH JWJ, 1991, EUR J CLIN CHEM CLIN, V29, P45; Watanabe M, 2003, INVEST OPHTH VIS SCI, V44, P3332, DOI 10.1167/iovs.02-1280; Williams DL, 1999, INVEST OPHTH VIS SCI, V40, P1669; Xiao Y, 2000, J CLIN PERIODONTOL, V27, P149	51	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177003	10.1371/journal.pone.0177003	http://dx.doi.org/10.1371/journal.pone.0177003			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472076	Green Submitted, Green Published, gold			2022-12-26	WOS:000400648500113
J	Olesen, SW; Duvallet, C; Alm, EJ				Olesen, Scott W.; Duvallet, Claire; Alm, Eric J.			dbOTU3: A new implementation of distribution-based OTU calling	PLOS ONE			English	Article								Distribution-based operational taxonomic unit-calling (dbOTU) improves on other approaches by incorporating information about the input sequences' distribution across samples. Previous implementations of dbOTU presented challenges for users. Here we introduce and evaluate a new implementation of dbOTU that is faster and more user-friendly. We show that this new implementation has theoretical and practical improvements over previous implementations of dbOTU, making the algorithm more accessible to microbial ecology and biomedical researchers.	[Olesen, Scott W.; Duvallet, Claire; Alm, Eric J.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Alm, Eric J.] Inst Med Engn & Sci, Ctr Microbiome Informat & Therapeut, Cambridge, MA USA	Massachusetts Institute of Technology (MIT)	Olesen, SW (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	swo@alum.mit.edu		Olesen, Scott/0000-0001-5400-4945	Center for Microbiome Informatics and Therapeutics at MIT; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	Center for Microbiome Informatics and Therapeutics at MIT; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This material is based on work supported by the Center for Microbiome Informatics and Therapeutics at MIT (microbiome.mit.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Preheim SP, 2013, APPL ENVIRON MICROB, V79, P6593, DOI 10.1128/AEM.00342-13; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107	9	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176335	10.1371/journal.pone.0176335	http://dx.doi.org/10.1371/journal.pone.0176335			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472072	Green Submitted, gold, Green Published			2022-12-26	WOS:000400648500038
J	Ross, A; Shamburek, R; Wehrlen, L; Klagholz, SD; Yang, L; Stoops, E; Flynn, SL; Remaley, AT; Pacak, K; Shelburne, N; Bevans, MF				Ross, Alyson; Shamburek, Robert; Wehrlen, Leslie; Klagholz, Stephen D.; Yang, Li; Stoops, Elyssa; Flynn, Sharon L.; Remaley, Alan T.; Pacak, Karel; Shelburne, Nonniekaye; Bevans, Margaret F.			Cardiometabolic risk factors and health behaviors in family caregivers	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; INTIMA-MEDIA THICKNESS; CORONARY-HEART-DISEASE; TERM-FOLLOW-UP; METABOLIC SYNDROME; CHRONIC STRESS; ASSOCIATION; FRAMINGHAM; MORTALITY; PATIENT	The purpose of this study was to compare components of cardiometabolic risk and health behaviors of 20 family caregivers of allogeneic hematopoietic stem cell transplant patients to those of age, gender, and race/ethnicity-matched controls. A prospective, repeated measures design was used to compare cardiometabolic risk and health behaviors in caregivers and controls at three time-points: pre-transplantation, discharge, and six weeks post-discharge. Measures included components of metabolic syndrome, Reynolds Risk Score, NMR serum lipoprotein particle analyses, and the Health-Promoting Lifestyle Profile II (HPLP-II). Mixed-model repeated measure analyses were used. There were no between or within group differences in LDL cholesterol, HDL cholesterol, and triglycerides. There was a significant interaction effect between time and role in large VLDL concentration (VLDL-P) (F (2, 76) = 4.36, p = .016), with the trajectory of large VLDL-P increasing over time in caregivers while remaining stable in controls. Within care-givers, VLDL particle size (VLDL-Z) was significantly larger at time-point three compared to time-points one (p = .015) and two (p = .048), and VLDL-Z was significantly larger in caregivers than in controls at time point three (p = .012). HPLP-II scores were lower in caregivers than controls at all time-points (p < .01). These findings suggest that caregiving may have a bigger impact on triglycerides than on other lipids, and it is through this pathway that caregivers may be at increased cardiometabolic risk. More sensitive measurement methods, such as NMR lipoprotein particle analyses, may be able to detect early changes in cardiometabolic risk.	[Ross, Alyson; Wehrlen, Leslie; Klagholz, Stephen D.; Yang, Li; Stoops, Elyssa; Flynn, Sharon L.; Bevans, Margaret F.] NIH, Ctr Clin, Dept Nursing, Bethesda, MD 20892 USA; [Shamburek, Robert] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA; [Remaley, Alan T.] NIH, Ctr Clin, Dept Lab Med, Bethesda, MD 20892 USA; [Pacak, Karel] NICHHD, NIH, Bethesda, MD 20892 USA; [Shelburne, Nonniekaye] NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ross, A (corresponding author), NIH, Ctr Clin, Dept Nursing, Bethesda, MD 20892 USA.	alyson.ross@nih.gov	Klagholz, Stephen/M-4119-2019		Intramural Research Program at the National Institutes of Health [11-CC-0265]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008735] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL001154] Funding Source: NIH RePORTER	Intramural Research Program at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); CLINICAL CENTER	This research was funded by the Intramural Research Program at the National Institutes of Health, Clinical Center 11-CC-0265 "A pilot study to examine physiological and clinical markers of chronic stress in caregivers of allogeneic hematopoietic stem cell transplant (HSCT) recipients".	Arnaout K, 2014, CANCER INVEST, V32, P349, DOI 10.3109/07357907.2014.919301; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Beattie S, 2011, PSYCHO-ONCOLOGY, V20, P1137, DOI 10.1002/pon.1962; Bevans M, 2012, JAMA-J AM MED ASSOC, V307, P398, DOI 10.1001/jama.2012.29; Bevans MF, 2016, STRESS, V19, P175, DOI 10.3109/10253890.2016.1146670; Bishop MM, 2011, PSYCHO-ONCOLOGY, V20, P926, DOI 10.1002/pon.1812; Bishop MM, 2009, BIOL BLOOD MARROW TR, V15, P29, DOI 10.1016/j.bbmt.2008.10.001; Brown SL, 2009, PSYCHOL SCI, V20, P488, DOI 10.1111/j.1467-9280.2009.02323.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; DeFilippis AP, 2011, J AM COLL CARDIOL, V58, P2076, DOI 10.1016/j.jacc.2011.08.022; Dimsdale JE, 2008, J AM COLL CARDIOL, V51, P1237, DOI 10.1016/j.jacc.2007.12.024; Foster LW, 2013, BONE MARROW TRANSPL, V48, P671, DOI 10.1038/bmt.2012.208; Frazier-Wood AC, 2012, METAB SYNDR RELAT D, V10, P244, DOI 10.1089/met.2011.0148; Gibbons SW, 2014, RES NURS HEALTH, V37, P423, DOI 10.1002/nur.21622; Golbidi S, 2015, AM J PHYSIOL-HEART C, V308, pH1476, DOI 10.1152/ajpheart.00859.2014; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Hashmi S, 2015, BIOL BLOOD MARROW TR, V21, P225, DOI 10.1016/j.bbmt.2014.06.035; Hering D, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0594-5; Laudenslager ML, 2014, BRAIN BEHAV IMMUN, V36, P1, DOI 10.1016/j.bbi.2013.08.012; Lee S, 2003, AM J PREV MED, V24, P113, DOI 10.1016/S0749-3797(02)00582-2; Mackey RH, 2015, DIABETES CARE, V38, P628, DOI 10.2337/dc14-0645; Mausbach BT, 2007, PSYCHOSOM MED, V69, P816, DOI 10.1097/PSY.0b013e318157d461; McEwen BS, 2010, ANN NY ACAD SCI, V1186, P190, DOI 10.1111/j.1749-6632.2009.05331.x; Mora S, 2010, DIABETES, V59, P1153, DOI 10.2337/db09-1114; Otvos JD, 2011, J CLIN LIPIDOL, V5, P105, DOI 10.1016/j.jacl.2011.02.001; Pavletic SZ, 2012, HEMATOL-AM SOC HEMAT, P251, DOI 10.1182/asheducation-2012.1.251; Peckett AJ, 2011, METABOLISM, V60, P1500, DOI 10.1016/j.metabol.2011.06.012; Phillips CM, 2015, ATHEROSCLEROSIS, V242, P399, DOI 10.1016/j.atherosclerosis.2015.07.040; Plaisance EP, 2009, PHYSICIAN SPORTSMED, V37, P11, DOI 10.3810/psm.2009.04.1678; Rasouli M, 2006, CLIN BIOCHEM, V39, P971, DOI 10.1016/j.clinbiochem.2006.07.003; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Roepke SK, 2012, STRESS, V15, P121, DOI 10.3109/10253890.2011.596866; Ross A, 2013, CANCER NURS, V36, P474, DOI 10.1097/NCC.0b013e3182747b75; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Sinha R, 2013, BIOL PSYCHIAT, V73, P827, DOI 10.1016/j.biopsych.2013.01.032; Stenberg U, 2010, PSYCHO-ONCOLOGY, V19, P1013, DOI 10.1002/pon.1670; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; von Kanel R, 2008, GERONTOLOGY, V54, P131, DOI 10.1159/000113649; WALKER SN, 1987, NURS RES, V36, P76; Wallenfeldt K, 2004, STROKE, V35, P2248, DOI 10.1161/01.STR.0000140629.65145.3c; Williams LA, 2007, ONCOL NURS FORUM, V34, P379, DOI 10.1188/07.ONF.379-387; Wulff-Burchfield EM, 2013, BONE MARROW TRANSPL, V48, P469, DOI 10.1038/bmt.2012.123	43	8	8	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176408	10.1371/journal.pone.0176408	http://dx.doi.org/10.1371/journal.pone.0176408			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SP	28472106	Green Submitted, gold, Green Published			2022-12-26	WOS:000400648500045
J	Sanchez-Diaz, PC; Chang, JC; Moses, ES; Dao, T; Chen, YD; Hung, JY				Sanchez-Diaz, Patricia C.; Chang, Judy C.; Moses, Emily S.; Dao, Tu; Chen, Yidong; Hung, Jaclyn Y.			Ubiquitin carboxyl-terminal esterase L1 (UCHL1) is associated with stem-like cancer cell functions in pediatric high-grade glioma	PLOS ONE			English	Article							HYDROLASE L1; UCH-L1; DIFFERENTIATION; EXPRESSION; ONCOGENE; INVASION; PATHWAY; SYSTEM; ROLES; AKT	Pediatric high-grade gliomas represent 8 - 12% of all primary tumors of the nervous system in children. Five-year survival for these pediatric aggressive tumors is poor (15 - 35%) indicating the need to develop better treatments for pediatric high-grade gliomas. In this work we used SF188 and SJ-GBM2 cell lines to study the function of the ubiquitin carboxyl-terminal esterase L1 (UCHL1), a deubiquitinase de-regulated in several cancers, in pediatric high-grade gliomas. UCHL1 depletion in SF188 and SJ-GBM2 glioma cells was associated with decreased cell proliferation and invasion, along with a reduced ability to grow in soft agar and to form spheres (i.e. self-renewal measure). A 70% reduction in Wnt signaling was also observed in the SF188 and SJ-GBM2 UCHL1 knockdowns (KDs) using a TCF-dependent TOPflash reporter assay. Transcriptome comparisons of UCHL1 KDs versus vector control identified a list of 306 differentially expressed genes (at least 2-fold change; p < 0.05) which included genes known to be involved in cancer like ACTA2, POSTN, LIF, FBXL7, FBXW11, GDF15, HEY2, but also potential novel genes such us IGLL5, ABCA4, AQP3, AQP4, CALB1, and ALK. Bioinformatics gene ontology (GO) analysis of these 306 genes revealed significant enrichment in "signal peptides", "extracellular matrix" and "secreted proteins "GO Terms. "Angiogenesis and blood vessel development", "neuron differentiation/development ",cell adhesion", and "cell migration" also showed significant enrichment in our GO analysis. Top canonical pathways identified by Ingenuity Pathway Analysis (IPA) included "Clathrin-mediated Endocytosis Signaling" (p = 5.14x10 (-4)), "Virus Entry via Endocytic Pathways" (p = 6.15x 10(-4)), and "High Mobility Group-Box 1 (HMGB1) Signaling" (p = 6.15x10(-4)). While FGF2, IL1B, TNF and PDGFB were predicted as top upstream regulators (p < 2x10(-16)) of the UCHL1 KD-associated transcriptome. Aberrant expression of UCHL1 in pediatric high-grade gliomas may promote cell invasion, transformation, and self-renewal properties, at least in part, by modulating Wnt/Beta catenin activity. UCHL1 might act as an oncogene in glioma within the gene network that imparts stem-like characteristics to these cancer cells.	[Sanchez-Diaz, Patricia C.; Chang, Judy C.; Moses, Emily S.; Chen, Yidong; Hung, Jaclyn Y.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Sanchez-Diaz, Patricia C.; Dao, Tu] Univ Incarnate Word, Rosenberg Sch Optometry, San Antonio, TX USA; [Moses, Emily S.] Univ Virginia, Dept Pediat, Charlottesville, VA USA; [Chen, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Epidemiol & Biostat, San Antonio, TX 78229 USA; [Hung, Jaclyn Y.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, Div Hematol & Oncol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Virginia; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Hung, JY (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA.; Hung, JY (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, Div Hematol & Oncol, San Antonio, TX 78229 USA.	hungj@uthscsa.edu			Shelby Rae Tengg Foundation; Greehey Cancer Research Institute Permanent Health Fund Permanent Endowments Higher Education (Children's Cancer Research) at the University of Texas Health Science Center at San Antonio; Greehey Graduate Fellowship in Children's Health (Greehey Family); Faculty Development Funds (University of the Incarnate Word); Summer Fellowship Training Program (University of the Incarnate Word); Beez Foundation	Shelby Rae Tengg Foundation; Greehey Cancer Research Institute Permanent Health Fund Permanent Endowments Higher Education (Children's Cancer Research) at the University of Texas Health Science Center at San Antonio; Greehey Graduate Fellowship in Children's Health (Greehey Family); Faculty Development Funds (University of the Incarnate Word); Summer Fellowship Training Program (University of the Incarnate Word); Beez Foundation	Funding for this work was provided in part by the Shelby Rae Tengg Foundation for Dr. Jaclyn Y Hung, the Greehey Cancer Research Institute Permanent Health Fund Permanent Endowments Higher Education (Children's Cancer Research) at the University of Texas Health Science Center at San Antonio for Dr. Jaclyn Y Hung, the Greehey Graduate Fellowship in Children's Health (Greehey Family) for Judy C Chang, the Faculty Development Funds and the Summer Fellowship Training Program (University of the Incarnate Word) for Dr. Patricia C Sanchez-Diaz, and The Beez Foundation for Dr. Jaclyn Y Hung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersson FI, 2011, J MOL BIOL, V407, P261, DOI 10.1016/j.jmb.2010.12.029; Bassermann F, 2014, BBA-MOL CELL RES, V1843, P150, DOI 10.1016/j.bbamcr.2013.02.028; Bheda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005955; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200; DORAN JF, 1983, J NEUROCHEM, V40, P1542, DOI 10.1111/j.1471-4159.1983.tb08124.x; Esteve-Rudd J, 2010, BRAIN RES, V1352, P70, DOI 10.1016/j.brainres.2010.07.019; Frisan T, 2012, FASEB J, V26, P5060, DOI 10.1096/fj.12-211946; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Goto Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7153; Gu YY, 2015, TUMOR BIOL, V36, P8379, DOI 10.1007/s13277-015-3566-0; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang XD, 2016, CELL RES, V26, P484, DOI 10.1038/cr.2016.31; Hurst-Kennedy J, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/123706; Hussain S, 2010, LEUKEMIA, V24, P1641, DOI 10.1038/leu.2010.138; Hussain S, 2013, MOL CELL BIOL, V33, P1188, DOI 10.1128/MCB.01389-12; Hussain S, 2009, CELL CYCLE, V8, P1688, DOI 10.4161/cc.8.11.8739; Isokpehi RD, 2015, CANCER INFORM, V14, P95, DOI 10.4137/CIN.S22058; Jang MJ, 2011, CANCER LETT, V302, P128, DOI 10.1016/j.canlet.2011.01.006; Kim HJ, 2009, ONCOGENE, V28, P117, DOI 10.1038/onc.2008.364; Kim HJ, 2015, ONCOTARGET, V6, P16287, DOI 10.18632/oncotarget.3843; Landre V, 2016, ONCOTARGET, V7, P11785, DOI 10.18632/oncotarget.7600; Luo JP, 2009, J CELL PHYSIOL, V220, P460, DOI 10.1002/jcp.21789; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Nager Mireia, 2012, Chemother Res Pract, V2012, P192362, DOI 10.1155/2012/192362; Naujokat C, 2007, STEM CELLS, V25, P2408, DOI 10.1634/stemcells.2007-0255; Park SY, 2016, MOL CANCER THER, V15, P2187, DOI 10.1158/1535-7163.MCT-15-0427; Pollock NL, 2011, FEBS J, V278, P3204, DOI 10.1111/j.1742-4658.2011.08169.x; Pulvirenti T, 2011, CANCER RES, V71, P7280, DOI 10.1158/0008-5472.CAN-11-1531; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; Shi DD, 2010, CANCER BIOL THER, V10, P737, DOI 10.4161/cbt.10.8.13417; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; Wobst H, 2012, FEBS J, V279, P4398, DOI 10.1111/febs.12029; Xiang TX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029783; Yang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067755; Zhang MM, 2014, SCI REP-UK, V4, DOI 10.1038/srep07298; Zheng HW, 2010, CANCER CELL, V17, P497, DOI 10.1016/j.ccr.2010.03.020; Zhong JL, 2012, INT J MOL MED, V30, P430, DOI 10.3892/ijmm.2012.1012; Zhou WC, 2015, NAT CELL BIOL, V17, P170, DOI 10.1038/ncb3090	48	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176879	10.1371/journal.pone.0176879	http://dx.doi.org/10.1371/journal.pone.0176879			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472177	Green Published, gold, Green Submitted			2022-12-26	WOS:000400648500092
J	Trochta, J; Krucek, M; Vrska, T; Kral, K				Trochta, Jan; Krucek, Martin; Vrska, Tomas; Kral, Kamil			3D Forest: An application for descriptions of three-dimensional forest structures using terrestrial LiDAR	PLOS ONE			English	Article							LASER SCANNER DATA; TREE MODELS; BIOMASS; COMPETITION; GROWTH	Terrestrial laser scanning is a powerful technology for capturing the three-dimensional structure of forests with a high level of detail and accuracy. Over the last decade, many algorithms have been developed to extract various tree parameters from terrestrial laser scanning data. Here we present 3D Forest, an open-source non-platform-specific software application with an easy-to-use graphical user interface with the compilation of algorithms focused on the forest environment and extraction of tree parameters. The current version (0.42) extracts important parameters of forest structure from the terrestrial laser scanning data, such as stem positions (X, Y, Z), tree heights, diameters at breast height (DBH), as well as more advanced parameters such as tree planar projections, stem profiles or detailed crown parameters including convex and concave crown surface and volume. Moreover, 3D Forest provides quantitative measures of between-crown interactions and their real arrangement in 3D space. 3D Forest also includes an original algorithm of automatic tree segmentation and crown segmentation. Comparison with field data measurements showed no significant difference in measuring DBH or tree height using 3D Forest, although for DBH only the Randomized Hough Transform algorithm proved to be sufficiently resistant to noise and provided results comparable to traditional field measurements.	[Trochta, Jan; Krucek, Martin; Vrska, Tomas; Kral, Kamil] Silva Tarouca Res Inst, Dept Forest Ecol, Brno, Czech Republic; [Krucek, Martin] Mendel Univ Brno, Fac Forestry & Wood Technol, Dept Geoinformat Technol, Brno, Czech Republic	Mendel University in Brno	Trochta, J (corresponding author), Silva Tarouca Res Inst, Dept Forest Ecol, Brno, Czech Republic.	j.trochta@gmail.com	Kral, Kamil/E-4415-2014; Trochta, Jan/B-9383-2015; Krůček, Martin/B-9394-2015	Trochta, Jan/0000-0002-1004-7465; Krůček, Martin/0000-0002-3137-2259	Czech Science Foundation (GACR) [P504/15-23242S];  [VUKOZ-IP-00027073]	Czech Science Foundation (GACR)(Grant Agency of the Czech Republic); 	This research was supported by the Czech Science Foundation (GACR), project No. P504/15-23242S and by Institutional subsidy VUKOZ-IP-00027073. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson-Teixeira KJ, 2015, GLOBAL CHANGE BIOL, V21, P528, DOI 10.1111/gcb.12712; Bienert A., 2006, INT ARCH PHOTOGRAMME, V36; Brolly G., 2009, ACTA SILV LIGNARIA H, V5, P119; Calders K, 2015, METHODS ECOL EVOL, V6, P198, DOI 10.1111/2041-210X.12301; Campbell J.B., 2011, INTRO REMOTE SENSING; Chernov N, 2005, J MATH IMAGING VIS, V23, P239, DOI 10.1007/s10851-005-0482-8; Condit R, 1998, TROPICAL FOREST CENS; Coomes DA, 2012, J ECOL, V100, P42, DOI 10.1111/j.1365-2745.2011.01920.x; Cote JF, 2012, AGR FOREST METEOROL, V166, P72, DOI 10.1016/j.agrformet.2012.06.007; Hackenberg J, 2015, FORESTS, V6, P4245, DOI 10.3390/f6114245; Hackenberg J, 2014, FORESTS, V5, P1069, DOI 10.3390/f5051069; Hanwell Marcus D., 2015, SoftwareX, V1-2, P9, DOI 10.1016/j.softx.2015.04.001; Isenburg M., 2014, LASTOOLS SOFTWARE RA, V1, P17071; Maas HG, 2008, INT J REMOTE SENS, V29, P1579, DOI 10.1080/01431160701736406; Metz J, 2013, FOREST ECOL MANAG, V310, P275, DOI 10.1016/j.foreco.2013.08.014; Piboule A, 2015, COMPUTREE COLLABORAT; PREPARATA FP, 1977, COMMUN ACM, V20, P87, DOI 10.1145/359423.359430; Raumonen P, 2013, REMOTE SENS-BASEL, V5, P491, DOI 10.3390/rs5020491; Rusu R. B., 2011, 3D IS HERE POINT CLO, P8; Seidel D, 2015, FOREST ECOL MANAG, V336, P119, DOI 10.1016/j.foreco.2014.10.020; Seidel D, 2011, AGR FOREST METEOROL, V151, P1305, DOI 10.1016/j.agrformet.2011.05.013; Seidel D, 2011, FOREST ECOL MANAG, V261, P2123, DOI 10.1016/j.foreco.2011.03.008; Tao SL, 2015, ISPRS J PHOTOGRAMM, V110, P66, DOI 10.1016/j.isprsjprs.2015.10.007; Trochta J, 2013, CAN J FOREST RES, V43, P355, DOI 10.1139/cjfr-2012-0347; van Leeuwen M, 2010, EUR J FOREST RES, V129, P749, DOI 10.1007/s10342-010-0381-4; XU L, 1993, CVGIP-IMAG UNDERSTAN, V57, P131, DOI 10.1006/ciun.1993.1009	26	104	106	12	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176871	10.1371/journal.pone.0176871	http://dx.doi.org/10.1371/journal.pone.0176871			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472167	Green Published, gold, Green Submitted			2022-12-26	WOS:000400648500090
J	Furrow, E; McCue, ME; Lulich, JP				Furrow, Eva; McCue, Molly E.; Lulich, Jody P.			Urinary metals in a spontaneous canine model of calcium oxalate urolithiasis	PLOS ONE			English	Article							IDIOPATHIC HYPERCALCIURIA; STONE FORMATION; CADMIUM; DOGS; METABOLISM; ABSORPTION; CREATININE; EXCRETION; ZINC; LITHOGENESIS	Calcium oxalate urolithiasis is a common and painful condition in people. The pathogenesis of this disease is complex and poorly understood. Laboratory animal and in vitro studies have demonstrated an effect of multiple trace metals in the crystallization process, and studies in humans have reported relationships between urinary metal concentrations and stone risk. Dogs are a spontaneous model of calcium oxalate urolithiasis, and the metal content of canine calcium oxalate stones mirrors that of human stones. The aim of this study was to test for a relationship between urinary metals and calcium oxalate urolithiasis in dogs. We hypothesized that urinary metals would differ between dogs with and without calcium oxalate urolithiasis. Urine from 122 dogs (71 cases and 51 stone-free controls) was analyzed for calcium and 12 other metals. The cases had higher urinary calcium, copper, iron, and vanadium and lower urinary cobalt. Higher urinary vanadium in the cases was associated with being fed a therapeutic stone-prevention diet. Urinary calcium had a strong positive correlation with strontium and moderate positive correlations with chromium, nickel, and zinc. The results of this study complement the findings of similar human studies and suggest a potential role of trace metals in calcium oxalate urolithiasis. Further investigation into how trace metals may affect stone formation is warranted.	[Furrow, Eva; Lulich, Jody P.] Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA; [McCue, Molly E.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Furrow, E (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA.	furro004@umn.edu	Furrow, Eva/W-9963-2018	Lulich, Jody/0000-0002-2338-1569; Furrow, Eva/0000-0002-7339-2354; McCue, Molly/0000-0002-6807-0318	Nestle Purina Veterinary Resident Research Grant [771371]; Morris Animal Foundation grant [D12CA-031]; Office of the Director, National Institutes of Health (NIH) [K010D019912]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD019912] Funding Source: NIH RePORTER	Nestle Purina Veterinary Resident Research Grant(Nestle SA); Morris Animal Foundation grant; Office of the Director, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by a Nestle Purina Veterinary Resident Research Grant (771371) and a Morris Animal Foundation grant (D12CA-031). Partial funding for E.F. was provided by the Office of the Director, National Institutes of Health (NIH) under award number K010D019912.	Allen HS, 2015, JAVMA-J AM VET MED A, V246, P1098, DOI 10.2460/javma.246.10.1098; Atakan IH, 2007, INT UROL NEPHROL, V39, P351, DOI 10.1007/s11255-006-9050-4; Barbier O, 2004, AM J PHYSIOL-RENAL, V287, pF1067, DOI 10.1152/ajprenal.00120.2004; Bazin D, 2007, UROL RES, V35, P179, DOI 10.1007/s00240-007-0099-z; Blaschko SD, 2013, J UROLOGY, V189, P735, DOI 10.1016/j.juro.2012.08.199; BULUSU L, 1970, CLIN SCI, V38, P601, DOI 10.1042/cs0380601; BYRNE AR, 1978, SCI TOTAL ENVIRON, V10, P17, DOI 10.1016/0048-9697(78)90046-3; Carpentier X, 2011, J TRACE ELEM MED BIO, V25, P160, DOI 10.1016/j.jtemb.2011.05.004; Cheungpasitporn W, 2016, J NEPHROL, V29, P211, DOI 10.1007/s40620-015-0210-4; Datta P, 2009, J CLIN LAB ANAL, V23, P399, DOI 10.1002/jcla.20353; Devuyst O, 2007, KIDNEY INT, V72, P1065, DOI 10.1038/sj.ki.5002441; Dijcker JC, 2012, VET REC, V171, P646, DOI 10.1136/vr.101130; Ferraro PM, 2011, J ENDOUROL, V25, P875, DOI 10.1089/end.2010.0572; Ferraro PM, 2016, J NEPHROL; Furrow E, 2015, J VET INTERN MED, V29, P113, DOI 10.1111/jvim.12527; Gallagher CM, 2008, ENVIRON HEALTH PERSP, V116, P1338, DOI 10.1289/ehp.11452; Hong YH, 2010, UROLOGY, V75, P1294, DOI 10.1016/j.urology.2009.08.061; HUNGERFORD LL, 1995, VET HUM TOXICOL, V37, P158; Isomura H, 2004, TOXICOLOGY, V197, P93, DOI 10.1016/j.tox.2003.12.006; JOHNSON CM, 1979, KIDNEY INT, V16, P624, DOI 10.1038/ki.1979.173; Kazantzis G, 2004, BIOMETALS, V17, P493, DOI 10.1023/B:BIOM.0000045727.76054.f3; Killilea DW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128374; KOMLEH K, 1990, International Urology and Nephrology, V22, P113, DOI 10.1007/BF02549826; Lieske JC, 1979, KIDNEY INT, V16, P624; Lulich JP, 2013, VET REC, V172, P363, DOI 10.1136/vr.101056; LULICH JP, 1991, AM J VET RES, V52, P1583; MATSUNO K, 1991, BIOL TRACE ELEM RES, V28, P99, DOI 10.1007/BF02863076; MATSUNO K, 1991, BIOL TRACE ELEM RES, V29, P111, DOI 10.1007/BF03032688; Munoz JA, 2005, UROL RES, V33, P267, DOI 10.1007/s00240-005-0468-4; NIELSEN FH, 1974, FOOD TECHNOL-CHICAGO, V28, P38; NUTTALL KL, 1995, ANN CLIN LAB SCI, V25, P264; Ogawa Y, 2003, FRONT BIOSCI, V8, pal67; Ozgurtas T, 2004, UROL INT, V72, P233, DOI 10.1159/000077122; Romero Victoriano, 2010, Rev Urol, V12, pe86; Singh P, 2015, MAYO CLIN PROC, V90, P1356, DOI 10.1016/j.mayocp.2015.07.016; Slojewski M, 2011, CENT EUR J UROL, V64, P58, DOI 10.5173/ceju.2011.02.art1; Slojewski M, 2010, BIOL TRACE ELEM RES, V137, P301, DOI 10.1007/s12011-009-8584-6; Stevenson AE, 2003, J SMALL ANIM PRACT, V44, P491, DOI 10.1111/j.1748-5827.2003.tb00109.x; Strohmaier WL, 1997, EUR UROL, V32, P294, DOI 10.1159/000480828; Swarup D, 2000, VET HUM TOXICOL, V42, P232; Vezzoli G, 2003, AM J KIDNEY DIS, V42, P1177, DOI 10.1053/j.ajkd.2003.08.018; Vezzoli G, 1999, CLIN CHEM, V45, P257; Vezzoli G, 1998, CLIN CHEM, V44, P586; Villena VP, 2010, J ANAL TOXICOL, V34, P39, DOI 10.1093/jat/34.1.39; Wong P, 2013, OSTEOPOROSIS INT, V24, P1965, DOI 10.1007/s00198-012-2260-y; Worcester EM, 2008, SEMIN NEPHROL, V28, P120, DOI 10.1016/j.semnephrol.2008.01.005; YAZAKI T, 1991, UROLOGY, V38, P290, DOI 10.1016/S0090-4295(91)80364-D	47	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176595	10.1371/journal.pone.0176595	http://dx.doi.org/10.1371/journal.pone.0176595			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467511	Green Published, gold, Green Submitted			2022-12-26	WOS:000400647000060
J	Schwinning, S; Meckel, H; Reichmann, LG; Polley, HW; Fay, PA				Schwinning, Susanne; Meckel, Heather; Reichmann, Lara G.; Polley, H. Wayne; Fay, Philip A.			Accelerated development in Johnsongrass seedlings (Sorghum halepense) suppresses the growth of native grasses through size-asymmetric competition	PLOS ONE			English	Article							WARM-SEASON GRASSES; PLANT INVASIONS; CORRELATED TRAITS; BASE TEMPERATURES; ONTOGENIC SHIFTS; GRASSLAND; COMMUNITY; POPULATIONS; PRODUCTIVITY; HIERARCHIES	Invasive plant species often dominate native species in competition, augmenting other potential advantages such as release from natural enemies. Resource pre-emption may be a particularly important mechanism for establishing dominance over competitors of the same functional type. We hypothesized that competitive success of an exotic grass against native grasses is mediated by establishing an early size advantage. We tested this prediction among four perennial C-4 warm-season grasses: the exotic weed Johnsongrass (Sorghum halepense), big bluestem (Andropogon gerardii), little bluestem (Schizachyrium scoparius) and switchgrass (Panicum virgatum). We predicted that a) the competitive effect of Johnsongrass on target species would be proportional to their initial biomass difference, b) competitive effect and response would be negatively correlated and c) soil fertility would have little effect on competitive relationships. In a greenhouse, plants of the four species were grown from seed either alone or with one Johnsongrass neighbor at two fertilizer levels and periodically harvested. The first two hypotheses were supported: The seedling biomass of single plants at first harvest (50 days after seeding) ranked the same way as the competitive effect of Johnsongrass on target species: Johnsongrass < big bluestem < little bluestem/switchgrass, while Johnsongrass responded more strongly to competition from Johnsongrass than from native species. At final harvest, native plants growing with Johnsongrass attained between 2-5% of their single-plant non-root biomass, while Johnsongrass growing with native species attained 89% of single-plant non-root biomass. Fertilization enhanced Johnsongrass' competitive effects on native species, but added little to the already severe competitive suppression. Accelerated early growth of Johnsongrass seedlings relative to native seedlings appeared to enable subsequent resource pre-emption. Size-asymmetric competition and resource-pre-emption may be a critical mechanism by which exotic invasive species displace functionally similar native species and alter the functional dynamics of native communities.	[Schwinning, Susanne; Meckel, Heather] Texas State Univ, Dept Biol, San Marcos, TX 78666 USA; [Reichmann, Lara G.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Reichmann, Lara G.; Polley, H. Wayne; Fay, Philip A.] USDA ARS Grassland, Soil & Water Res Lab, Temple, TX USA	Texas State University System; Texas State University San Marcos; University of Texas System; University of Texas Austin; United States Department of Agriculture (USDA)	Schwinning, S (corresponding author), Texas State Univ, Dept Biol, San Marcos, TX 78666 USA.	schwinn@txstate.edu	Schwinning, Susanne/G-6412-2015; Fay, Philip A./I-1853-2012	Schwinning, Susanne/0000-0002-9740-0291; Fay, Philip A./0000-0002-8291-6316; Reichmann, Lara/0000-0002-9737-7300	Texas State University; USDA-NIFA [2010-65615-20632]	Texas State University; USDA-NIFA(United States Department of Agriculture (USDA))	This work was supported in part by Texas State University and USDA-NIFA (2010-65615-20632), https://nifa.usda.gov/. The funders provided the necessary materials to conduct the experiment and a research scholarship to the project's graduate student. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badgery WB, 2005, ANN BOT-LONDON, V96, P799, DOI 10.1093/aob/mci230; BREDA N, 1995, PLANT SOIL, V172, P17, DOI 10.1007/BF00020856; CABI, 2016, SORGH HAL JOHNS GRAS; Corbin JD, 2010, PLANT ECOL, V209, P71, DOI 10.1007/s11258-010-9722-0; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Dante SK, 2013, FUNCT ECOL, V27, P555, DOI 10.1111/1365-2435.12061; Dickson TL, 2012, BIOL INVASIONS, V14, P2617, DOI 10.1007/s10530-012-0257-2; Fargione J, 2003, P NATL ACAD SCI USA, V100, P8916, DOI 10.1073/pnas.1033107100; Fay PA, 2009, ECOSYSTEMS, V12, P699, DOI 10.1007/s10021-009-9247-3; Foxcroft LC, 2010, BIOL INVASIONS, V12, P3913, DOI 10.1007/s10530-010-9823-7; Freckleton RP, 2001, FUNCT ECOL, V15, P615, DOI 10.1046/j.0269-8463.2001.00558.x; Funk JL, 2016, ECOLOGY, V97, P2206, DOI 10.1002/ecy.1484; Funk JL, 2016, ECOLOGY, V97, P75, DOI 10.1890/15-0974.1; Goldberg DE, 1996, PHILOS T R SOC B, V351, P1377, DOI 10.1098/rstb.1996.0121; GOLDBERG DE, 1991, J ECOL, V79, P1013, DOI 10.2307/2261095; Goldberg DE, 1999, ECOLOGY, V80, P1118, DOI 10.2307/177059; Hoffmann WA, 2004, DIVERS DISTRIB, V10, P99, DOI 10.1111/j.1366-9516.2004.00063.x; Hunt R, 1997, NEW PHYTOL, V135, P395, DOI 10.1046/j.1469-8137.1997.00671.x; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Korner C, 2008, NEW PHYTOL, V177, P698, DOI 10.1111/j.1469-8137.2007.02287.x; Lasky JR, 2015, ECOLOGY, V96, P2157, DOI 10.1890/14-1809.1; le Roux PC, 2013, NEW PHYTOL, V200, P241, DOI 10.1111/nph.12349; MacDougall AS, 2009, J ECOL, V97, P609, DOI 10.1111/j.1365-2745.2009.01514.x; MacDougall AS, 2004, CONSERV BIOL, V18, P455, DOI 10.1111/j.1523-1739.2004.00483.x; Madakadze IC, 2003, CROP SCI, V43, P874, DOI 10.2135/cropsci2003.0874; Madakadze IC, 2001, SEED SCI TECHNOL, V29, P31; McWHORTER C. G., 1961, WEEDS, V9, P558, DOI 10.2307/4040804; MCWHORTER C G, 1989, Reviews of Weed Science, V4, P85; Milton SJ, 2004, S AFR J SCI, V100, P69; Naeem S, 1998, CONSERV BIOL, V12, P39, DOI 10.1046/j.1523-1739.1998.96379.x; Pinto H, 2016, PLANT CELL ENVIRON, V39, P514, DOI 10.1111/pce.12636; Reichmann LG, 2016, J PLANT ECOL, V9, P1; Rout ME, 2013, BIOL INVASIONS, V15, P327, DOI 10.1007/s10530-012-0289-7; Schwinning S, 1998, OECOLOGIA, V113, P447, DOI 10.1007/s004420050397; SCHWINNING S, 1995, OIKOS, V72, P422, DOI 10.2307/3546128; Seabloom EW, 2003, P NATL ACAD SCI USA, V100, P13384, DOI 10.1073/pnas.1835728100; Smith MD, 1999, OECOLOGIA, V120, P605, DOI 10.1007/s004420050896; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Wainwright CE, 2012, J APPL ECOL, V49, P234, DOI 10.1111/j.1365-2664.2011.02088.x; Wang P, 2010, FUNCT ECOL, V24, P196, DOI 10.1111/j.1365-2435.2009.01612.x; WEINER J, 1985, ECOLOGY, V66, P743, DOI 10.2307/1940535; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; WEINER J, 1984, OECOLOGIA, V61, P334, DOI 10.1007/BF00379630; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141	44	13	13	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176042	10.1371/journal.pone.0176042	http://dx.doi.org/10.1371/journal.pone.0176042			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467488	gold, Green Published, Green Submitted			2022-12-26	WOS:000400647000034
J	Carvan, MJ; Kalluvila, TA; Klingler, RH; Larson, JK; Pickens, M; Mora-Zamorano, FX; Connaughton, VP; Sadler-Riggleman, I; Beck, D; Skinner, MK				Carvan, Michael J., III; Kalluvila, Thomas A.; Klingler, Rebekah H.; Larson, Jeremy K.; Pickens, Matthew; Mora-Zamorano, Francisco X.; Connaughton, Victoria P.; Sadler-Riggleman, Ingrid; Beck, Daniel; Skinner, Michael K.			Mercury-induced epigenetic transgenerational inheritance of abnormal neurobehavior is correlated with sperm epimutations in zebrafish	PLOS ONE			English	Article							DNA METHYLATION; DIFFERENTIAL EXPRESSION; METHYLMERCURY EXPOSURE; SEAFOOD CONSUMPTION; MODEL; INDUCTION; PATTERNS; PACKAGE; DISEASE; RECORD	Methylmercury (MeHg) is a ubiquitous environmental neurotoxicant, with human exposures predominantly resulting from fish consumption. Developmental exposure of zebrafish to MeHg is known to alter their neurobehavior. The current study investigated the direct exposure and transgenerational effects of MeHg, at tissue doses similar to those detected in exposed human populations, on sperm epimutations (i.e., differential DNA methylation regions [DMRs]) and neurobehavior (i.e., visual startle and spontaneous locomotion) in zebrafish, an established human health model. F0 generation embryos were exposed to MeHg (0, 1, 3, 10, 30, and 100 nM) for 24 hours ex vivo. F0 generation control and MeHg-exposed lineages were reared to adults and bred to yield the F1 generation, which was subsequently bred to the F2 generation. Direct exposure (F0 generation) and transgenerational actions (F2 generation) were then evaluated. Hyperactivity and visual deficit were observed in the unexposed descendants (F2 generation) of the MeHg-exposed lineage compared to control. An increase in F2 generation sperm epimutations was observed relative to the F0 generation. Investigation of the DMRs in the F2 generation MeHg-exposed lineage sperm revealed associated genes in the neuroactive ligand-receptor interaction and actin-cytoskeleton pathways being effected, which correlate to the observed neurobehavioral phenotypes. Developmental MeHg-induced epigenetic transgenerational inheritance of abnormal neurobehavior is correlated with sperm epimutations in F2 generation adult zebrafish. Therefore, mercury can promote the epigenetic transgenerational inheritance of disease in zebrafish, which significantly impacts its environmental health considerations in all species including humans.	[Carvan, Michael J., III; Kalluvila, Thomas A.; Klingler, Rebekah H.; Larson, Jeremy K.; Pickens, Matthew; Mora-Zamorano, Francisco X.] Univ Wisconsin, Sch Freshwater Sci, Milwaukee, WI 53201 USA; [Carvan, Michael J., III; Kalluvila, Thomas A.] Univ Wisconsin, Zilber Sch Publ Hlth, Milwaukee, WI 53201 USA; [Connaughton, Victoria P.] Amer Univ, Dept Biol, Washington, DC 20016 USA; [Sadler-Riggleman, Ingrid; Beck, Daniel; Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee; American University; Washington State University	Carvan, MJ (corresponding author), Univ Wisconsin, Sch Freshwater Sci, Milwaukee, WI 53201 USA.; Carvan, MJ (corresponding author), Univ Wisconsin, Zilber Sch Publ Hlth, Milwaukee, WI 53201 USA.	carvanmj@uwm.edu	Connaughton, Victoria P./N-9593-2019	Connaughton, Victoria P./0000-0001-6516-7299; Carvan, Michael/0000-0002-9190-9417	UWM Children's Environmental Health Sciences Core Center [2P30ES004184]; NIH [R21ES019104, R01ES01297410]; UWM Research Growth Initiative (MJC); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012974] Funding Source: NIH RePORTER	UWM Children's Environmental Health Sciences Core Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UWM Research Growth Initiative (MJC); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the UWM Children's Environmental Health Sciences Core Center (2P30ES004184) and other NIH grants to MJC (R21ES019104) and MKS (R01ES01297410), and by the UWM Research Growth Initiative (MJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Baker BB, 2016, ZEBRAFISH, V13, P413, DOI 10.1089/zeb.2016.1275; Baker TR, 2014, MOL CELL ENDOCRINOL, V398, P36, DOI 10.1016/j.mce.2014.08.011; Baker TR, 2014, TOXICOL SCI, V138, P403, DOI 10.1093/toxsci/kfu006; Bakulski KM, 2015, INT J EPIDEMIOL, V44, P1249, DOI 10.1093/ije/dyv032; Barbante C, 2004, ENVIRON SCI TECHNOL, V38, P4085, DOI 10.1021/es049759r; Batten KM, 2003, MICROBIAL ECOL, V46, P429, DOI 10.1007/s00248-003-1005-z; Bisen-Hersh EB, 2014, J TRACE ELEM MED BIO, V28, P117, DOI 10.1016/j.jtemb.2013.09.008; Bonasio R, 2015, J EXP BIOL, V218, P114, DOI 10.1242/jeb.110809; Bose R, 2012, TOXICOL SCI, V130, P383, DOI 10.1093/toxsci/kfs257; Boucher O, 2012, ENVIRON HEALTH PERSP, V120, P1456, DOI 10.1289/ehp.1204976; Connaughton V. P., 2003, Methods in Cell Science, V25, P49, DOI 10.1023/B:MICS.0000006853.54435.85; Connaughton VP, 2000, J PHYSIOL-LONDON, V524, P135, DOI 10.1111/j.1469-7793.2000.t01-1-00135.x; Connaughton VP, 1998, EUR J NEUROSCI, V10, P1350; Corrales J, 2014, AQUAT TOXICOL, V148, P16, DOI 10.1016/j.aquatox.2013.12.028; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Goodrich JM, 2013, ENVIRON MOL MUTAGEN, V54, P195, DOI 10.1002/em.21763; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Haque MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142274; Hightower JM, 2006, ENVIRON HEALTH PERSP, V114, P173, DOI 10.1289/ehp.8464; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kabasenche WP, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-62; Kainz M, 2006, SCI TOTAL ENVIRON, V368, P271, DOI 10.1016/j.scitotenv.2005.09.035; Kamstra JH, 2015, ENVIRON SCI POLLUT R, V22, P16262, DOI 10.1007/s11356-014-3466-7; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Karimi R, 2014, INT J HYG ENVIR HEAL, V217, P758, DOI 10.1016/j.ijheh.2014.03.007; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 1998, VISUAL NEUROSCI, V15, P851, DOI 10.1017/S0952523898155050; Lienhard M, 2014, BIOINFORMATICS, V30, P284, DOI 10.1093/bioinformatics/btt650; Lisu CH, 2007, CURR NEUROVASC RES, V4, P111, DOI 10.2174/156720207780637234; Llop Sabrina, 2015, Curr Environ Health Rep, V2, P179, DOI 10.1007/s40572-015-0047-y; Lombo M, 2015, ENVIRON POLLUT, V206, P667, DOI 10.1016/j.envpol.2015.08.016; Martin CC, 1999, DEV BIOL, V206, P189, DOI 10.1006/dbio.1998.9105; McCann P, 2011, DIVISION ENV HLTH MI, V11, P1; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mora-Zamorano FX, 2016, ENVIRON SCI TECHNOL, V50, P4808, DOI 10.1021/acs.est.6b00223; Mora-Zamorano FX, 2016, ENV SCI TEC IN PRESS; Nozawa M, 2007, P NATL ACAD SCI USA, V104, P20421, DOI 10.1073/pnas.0709956104; Peplow D, 2014, ENVIRON SCI-PROC IMP, V16, P2415, DOI 10.1039/c4em00268g; RANGELMENDEZ JA, 2016, SCI TOTAL ENVIRON, V543, DOI DOI 10.1016/J.SCIT0TENV.2015.10.152; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saxton HJ, 2013, ENVIRON TOXICOL CHEM, V32, P2630, DOI 10.1002/etc.2350; Schuster PF, 2002, ENVIRON SCI TECHNOL, V36, P2303, DOI 10.1021/es0157503; Sheehan MC, 2014, B WORLD HEALTH ORGAN, V92, P254, DOI 10.2471/BLT.12.116152; Skinner MK, 2015, EPIGENETICS-US, V10, P762, DOI 10.1080/15592294.2015.1062207; Skinner MK, 2014, MOL CELL ENDOCRINOL, V398, P4, DOI 10.1016/j.mce.2014.07.019; Skinner MK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-692; Skinner MK, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R91, 10.1186/gb-2012-13-10-r91]; Skinner MK, 2011, EPIGENETICS-US, V6, P838, DOI 10.4161/epi.6.7.16537; Smith LE, 2010, NEUROTOXICOL TERATOL, V32, P246, DOI 10.1016/j.ntt.2009.09.004; UNEP, 2012, RED MERC US ART SMAL; UNEP, 2013, GLOB MERC ASS 2013; Vignet C, 2015, ENVIRON SCI POLLUT R, V22, P16371, DOI 10.1007/s11356-015-4157-8; Waterland RA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001252; Weber DN, 2008, PHYSIOL BEHAV, V93, P250, DOI 10.1016/j.physbeh.2007.08.023; Wilson CA, 2014, GENETICS, V198, P1291, DOI 10.1534/genetics.114.169284; Xu XJ, 2016, NEUROTOXICOL TERATOL, V53, P19, DOI 10.1016/j.ntt.2015.11.003; Yorifuji T, 2015, ARCH ENVIRON OCCUP H, P1; Yorifuji T, 2015, ARCH ENVIRON OCCUP H, V70, P297, DOI 10.1080/19338244.2014.904268; Yorifuji T, 2009, SCI TOTAL ENVIRON, V408, P272, DOI 10.1016/j.scitotenv.2009.10.011	64	71	71	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176155	10.1371/journal.pone.0176155	http://dx.doi.org/10.1371/journal.pone.0176155			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28464002	Green Published, Green Submitted, gold			2022-12-26	WOS:000400646300012
J	Vazirpanah, N; Verhagen, FH; Rothova, A; Missotten, TOAR; van Velthoven, M; Den Hollander, AI; Hoyng, CB; Radstake, TRDJ; Broen, JCA; Kuiper, JJW				Vazirpanah, Nadia; Verhagen, Fleurieke H.; Rothova, Anna; Missotten, Tom O. A. R.; van Velthoven, Mirjam; Den Hollander, Anneke I.; Hoyng, Carel B.; Radstake, Timothy R. D. J.; Broen, Jasper C. A.; Kuiper, Jonas J. W.			Aberrant leukocyte telomere length in Birdshot Uveitis	PLOS ONE			English	Article							CD4(+) T-LYMPHOCYTES; DIABETIC-RETINOPATHY; S-ANTIGEN; CHORIORETINOPATHY; CELLS; RETINOCHOROIDOPATHY; DISEASE; INTERLEUKIN-17; INFLAMMATION; ASSOCIATION	Purpose Birdshot Uveitis (BU) is an archetypical chronic inflammatory eye disease, with poor visual prognosis, that provides an excellent model for studying chronic inflammation. BU typically affects patients in the fifth decade of life. This suggests that it may represent an age-related chronic inflammatory disease, which has been linked to increased erosion of telomere length of leukocytes. Methods To study this in detail, we exploited a sensitive standardized quantitative real-time polymerase chain reaction to determine the peripheral blood leukocyte telomere length (LTL) in 91 genotyped Dutch BU patients and 150 unaffected Dutch controls. Results Although LTL erosion rates were very similar between BU patients and healthy controls, we observed that BU patients displayed longer LTL, with a median of log (LTL) = 4.87 (= 74131 base pair) compared to 4.31 (= 20417 base pair) in unaffected controls (P<0.0001). The cause underpinning the difference in LTL could not be explained by clinical parameters, immune cell-subtype distribution, nor genetic predisposition based upon the computed weighted genetic risk score of genotyped validated variants in TERC, TERT, NAF1, OBFC1 and RTEL1. Conclusions These findings suggest that BU is accompanied by significantly longer LTL.	[Vazirpanah, Nadia; Verhagen, Fleurieke H.; Radstake, Timothy R. D. J.; Broen, Jasper C. A.; Kuiper, Jonas J. W.] Univ Med Ctr Utrecht, Dept Immunol, Lab Translat Immunol, Utrecht, Netherlands; [Rothova, Anna] Erasmus Univ, Med Ctr, Dept Ophthalmol, Rotterdam, Netherlands; [Rothova, Anna; Missotten, Tom O. A. R.] Rotterdam Eye Hosp, Rotterdam, Netherlands; [Den Hollander, Anneke I.; Hoyng, Carel B.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, Nijmegen, Netherlands; [Radstake, Timothy R. D. J.; Broen, Jasper C. A.] Univ Med Ctr Utrecht, Dept Clin Immunol & Rheumatol, Utrecht, Netherlands; [Kuiper, Jonas J. W.] Univ Med Ctr Utrecht, Dept Ophthalmol, Ophthalmoimmunol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Rotterdam Eye Hospital; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Vazirpanah, N (corresponding author), Univ Med Ctr Utrecht, Dept Immunol, Lab Translat Immunol, Utrecht, Netherlands.	N.Vazirpanah@umcutrecht.nl	Hollander, Anneke den/N-4911-2014		Netherlands Organization for Scientific Research (N.W.O.) [91614041]	Netherlands Organization for Scientific Research (N.W.O.)(Netherlands Organization for Scientific Research (NWO))	J.C.B. is supported by a VENI Award from the Netherlands Organization for Scientific Research (N.W.O. project number 91614041).; J.C.B. is supported by of a VENI Award from the Netherlands Organization for Scientific Research (N.W.O. project number 91614041). We would like to acknowledge Kamil G. Laban and Sanne Hiddingh for technical assistance.	Alvarez-Navarro C, 2015, MOL CELL PROTEOMICS, V14, P1770, DOI 10.1074/mcp.M115.048959; Boks MP, 2015, PSYCHONEUROENDOCRINO, V51, P506, DOI 10.1016/j.psyneuen.2014.07.011; CAWTHON, 1990, CELL, V62, P609; Chen WQ, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/534648; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Dagur PK, 2014, CLIN IMMUNOL, V152, P36, DOI 10.1016/j.clim.2014.01.009; Damjanovic AK, 2007, J IMMUNOL, V179, P4249, DOI 10.4049/jimmunol.179.6.4249; de Smet MD, 2001, PROG RETIN EYE RES, V20, P761, DOI 10.1016/S1350-9462(01)00011-8; Dehbi AZA, 2013, EXPERT REV CLIN IMMU, V9, P1193, DOI 10.1586/1744666X.2013.850031; DESMET MD, 1990, AM J OPHTHALMOL, V110, P135, DOI 10.1016/S0002-9394(14)76981-8; Donvito B, 2010, INVEST OPHTH VIS SCI, V51, P2525, DOI 10.1167/iovs.09-4329; Gupta R, 2006, DRUG AGING, V23, P535, DOI 10.2165/00002512-200623070-00001; Hohensinner PJ, 2011, AGING DIS, V2, P524; Honda M, 2001, CLIN IMMUNOL, V99, P211, DOI 10.1006/clim.2001.5023; JOBIN D, 1990, CURR EYE RES, V9, P91, DOI 10.3109/02713689008999426; Kaplan RC, 2009, J GERONTOL A-BIOL, V64; Karabatsiakis A, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-192; Koetz K, 2000, P NATL ACAD SCI USA, V97, P9203, DOI 10.1073/pnas.97.16.9203; Kuiper J, 2015, PROG RETIN EYE RES, V44, P99, DOI 10.1016/j.preteyeres.2014.11.003; Kuiper JJW, 2014, HUM MOL GENET, V23, P6081, DOI 10.1093/hmg/ddu307; Kuiper JJW, 2014, HUM IMMUNOL, V75, P570, DOI 10.1016/j.humimm.2014.02.012; Kuiper JJW, 2013, MOL VIS, V19, P2606; Kuiper JJW, 2011, AM J OPHTHALMOL, V152, P177, DOI 10.1016/j.ajo.2011.01.031; Levinson W, 2006, ARCH INTERN MED, V166, P16, DOI 10.1001/archinte.166.1.16; Li ZC, 2014, SCI REP-UK, V4, DOI 10.1038/srep07073; Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012; Martens UM, 2002, BRIT J HAEMATOL, V119, P810, DOI 10.1046/j.1365-2141.2002.03910.x; Menezo V, 2014, CLIN OPHTHALMOL, V8, P73, DOI 10.2147/OPTH.S54832; Menzel O, 2006, J IMMUNOL, V177, P3657, DOI 10.4049/jimmunol.177.6.3657; Najarro K, 2015, J INFECT DIS, V212, P1261, DOI 10.1093/infdis/jiv202; NUSSENBLATT RB, 1982, AM J OPHTHALMOL, V94, P147, DOI 10.1016/0002-9394(82)90069-1; O'Bryan JM, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-37; O'Callaghan NJ, 2008, BIOTECHNIQUES, V44, P807, DOI 10.2144/000112761; Pulido JS, 2012, EYE, V26, P862, DOI 10.1038/eye.2012.10; Raschenberger J, 2015, SCI REP-UK, V5, DOI 10.1038/srep11887; Rizvi Saliha, 2014, Curr Aging Sci, V7, P161; Roth A, 2005, BLOOD, V106, P43, DOI 10.1182/blood-2004-10-4144; Rufer N, 1999, J EXP MED, V190, P157, DOI 10.1084/jem.190.2.157; RYAN SJ, 1980, AM J OPHTHALMOL, V89, P31, DOI 10.1016/0002-9394(80)90226-3; Shah KH, 2005, SURV OPHTHALMOL, V50, P519, DOI 10.1016/j.survophthal.2005.08.004; Sharma R, 2015, SCI REP-UK, V5, DOI 10.1038/srep18368; Tamayo M, 2014, MUTAT RES-FUND MOL M, V765, P1, DOI 10.1016/j.mrfmmm.2014.04.006; Tamayo M, 2010, MUTAT RES-FUND MOL M, V683, P68, DOI 10.1016/j.mrfmmm.2009.10.010; Weng NP, 2002, SPRINGER SEMIN IMMUN, V24, P23, DOI 10.1007/s00281-001-0093-4; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Yang LP, 2013, NEURAL REGEN RES, V8, P3148, DOI 10.3969/j.issn.1673-5374.2013.33.009; Yudoh K, 2001, J BONE MINER RES, V16, P1453, DOI 10.1359/jbmr.2001.16.8.1453; Zhang CA, 2015, HUM MOL GENET, V24, P5356, DOI 10.1093/hmg/ddv252; Zhang JW, 2016, AGEING RES REV, V25, P55, DOI 10.1016/j.arr.2015.11.006	49	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176175	10.1371/journal.pone.0176175	http://dx.doi.org/10.1371/journal.pone.0176175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459868	Green Published, gold			2022-12-26	WOS:000400645000017
J	Wilson, MA; Iser, WB; Son, TG; Logie, A; Cabral-Costa, JV; Mattson, MP; Camandola, S				Wilson, Mark A.; Iser, Wendy B.; Son, Tae Gen; Logie, Anne; Cabral-Costa, Joao V.; Mattson, Mark P.; Camandola, Simonetta			skn-1 is required for interneuron sensory integration and foraging behavior in Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; LIFE-SPAN; MOUSE MODEL; LONGEVITY; EXPRESSION; NEURONS; PATHWAY; NEUROPROTECTION; SPECIFICATION; THERMOTAXIS	Nrf2/skn-1, a transcription factor known to mediate adaptive responses of cells to stress, also regulates energy metabolism in response to changes in nutrient availability. The ability to locate food sources depends upon chemosensation. Here we show that Nrf2/skn-1 is expressed in olfactory interneurons, and is required for proper integration of multiple food-related sensory cues in Caenorhabditis elegans. Compared to wild type worms, skn-1 mutants fail to perceive that food density is limiting, and display altered chemo-and thermotactic responses. These behavioral deficits are associated with aberrant AIY interneuron morphology and migration in skn-1 mutants. Both skn-1-dependent AIY autonomous and non-autonomous mechanisms regulate the neural circuitry underlying multisensory integration of environmental cues related to energy acquisition.	[Wilson, Mark A.; Iser, Wendy B.; Logie, Anne; Mattson, Mark P.; Camandola, Simonetta] Natl Inst Aging, Lab Neurosci, Intramural Res Program, Baltimore, MD 21224 USA; [Son, Tae Gen] Dongnam Inst Radiol & Med Sci, Res Ctr, Dept Expt Radiat, Busan, South Korea; [Cabral-Costa, Joao V.] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, Brazil; [Mattson, Mark P.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Korea Institute of Radiological & Medical Sciences; Universidade de Sao Paulo; Johns Hopkins University	Camandola, S (corresponding author), Natl Inst Aging, Lab Neurosci, Intramural Res Program, Baltimore, MD 21224 USA.	camandolasi@mail.nih.gov	Cabral-Costa, João Victor/F-6666-2012; Cabral-Costa, João Victor/GSI-6093-2022	Cabral-Costa, João Victor/0000-0001-5441-1807; Cabral-Costa, João Victor/0000-0001-5441-1807	Intramural Research Program of the National Institute on Aging; Brazilian Scientific Mobility Program (Ciencia sem Fronteiras) [7610-11-4]; NIH Office of Research Infrastructure Programs [P40 OD010440]	Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Brazilian Scientific Mobility Program (Ciencia sem Fronteiras); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the Intramural Research Program of the National Institute on Aging. JVCC was sponsored by the Brazilian Scientific Mobility Program (Ciencia sem Fronteiras #7610-11-4). Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440).	Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; Bargmann Cornelia I, 2006, WormBook, P1; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; BRENNER S, 1974, GENETICS, V77, P71; Bulow HE, 2002, P NATL ACAD SCI USA, V99, P6346, DOI 10.1073/pnas.092128099; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; Cook AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021907; Corenblum MJ, 2016, AGING CELL, V15, P725, DOI 10.1111/acel.12482; Done AJ, 2016, REDOX BIOL, V10, P191, DOI 10.1016/j.redox.2016.10.003; Faumont S, 2006, J NEUROPHYSIOL, V95, P3665, DOI 10.1152/jn.00052.2006; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Hunt PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021922; Jeong Dae-Eun, 2012, Frontiers in Genetics, V3, P218, DOI 10.3389/fgene.2012.00218; Karkkainen V, 2014, STEM CELLS, V32, P1904, DOI 10.1002/stem.1666; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; L'Episcopo F, 2013, J NEUROSCI, V33, P1462, DOI 10.1523/JNEUROSCI.3206-12.2013; Lee J, 2014, PHARMACOL REV, V66, P815, DOI 10.1124/pr.113.007757; Lewis KN, 2015, P NATL ACAD SCI USA, V112, P3722, DOI 10.1073/pnas.1417566112; Lewis KN, 2013, ANTIOXID REDOX SIGN, V19, P1388, DOI 10.1089/ars.2012.4911; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Otin C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; Mattson MP, 2015, SCI AM, V313, P40, DOI 10.1038/scientificamerican0715-40; Milward K, 2011, P NATL ACAD SCI USA, V108, P20672, DOI 10.1073/pnas.1106134109; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Paek J, 2012, CELL METAB, V16, P526, DOI 10.1016/j.cmet.2012.09.007; Remy JJ, 2005, SCIENCE, V309, P787, DOI 10.1126/science.1114209; Rugarli EI, 2002, DEVELOPMENT, V129, P1283; Satoh T, 2006, P NATL ACAD SCI USA, V103, P768, DOI 10.1073/pnas.0505723102; Satoh T, 2013, FREE RADICAL BIO MED, V65, P645, DOI 10.1016/j.freeradbiomed.2013.07.022; Shih AY, 2005, J NEUROSCI, V25, P10321, DOI 10.1523/JNEUROSCI.4014-05.2005; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Son TG, 2010, J NEUROCHEM, V112, P1316, DOI 10.1111/j.1471-4159.2009.06552.x; Son TG, 2008, NEUROMOL MED, V10, P236, DOI 10.1007/s12017-008-8037-y; Stack C, 2010, FREE RADICAL BIO MED, V49, P147, DOI 10.1016/j.freeradbiomed.2010.03.017; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Uchida O, 2003, DEVELOPMENT, V130, P1215, DOI 10.1242/dev.00341; VanDuyn N, 2010, TOXICOL SCI, V118, P613, DOI 10.1093/toxsci/kfq285; Wenick AS, 2004, DEV CELL, V6, P757, DOI 10.1016/j.devcel.2004.05.004	53	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176798	10.1371/journal.pone.0176798	http://dx.doi.org/10.1371/journal.pone.0176798			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459841	Green Submitted, Green Published, gold			2022-12-26	WOS:000400645000060
J	Pal, P; Balaban, AE; Diamond, MS; Sinnis, P; Klein, RS; Goldberg, DE				Pal, Priya; Balaban, Amanda E.; Diamond, Michael S.; Sinnis, Photini; Klein, Robyn S.; Goldberg, Daniel E.			Plasmodium falciparum histidine-rich protein II causes vascular leakage and exacerbates experimental cerebral malaria in mice	PLOS ONE			English	Article							CHILDREN; MODELS	A devastating complication of Plasmodium falciparum infection is cerebral malaria, in which vascular leakage and cerebral swelling lead to coma and often death. P. falciparum produces a protein called histidine-rich protein II (HRPII) that accumulates to high levels in the bloodstream of patients and serves as a diagnostic and prognostic marker for falciparum malaria. Using a human cerebral microvascular endothelial barrier model, we previously found that HRPII activates the endothelial cell inflammasome, resulting in decreased integrity of tight junctions and increased endothelial barrier permeability. Here, we report that intravenous administration of HRPII induced blood-brain barrier leakage in uninfected mice. Furthermore, HRPII infusion in P. berghei-infected mice increased early mortality from experimental cerebral malaria. These data support the hypothesis that HRPII is a virulence factor that contributes to cerebral malaria by compromising the integrity of the blood-brain barrier.	[Pal, Priya; Diamond, Michael S.; Klein, Robyn S.; Goldberg, Daniel E.] Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA; [Pal, Priya; Diamond, Michael S.; Goldberg, Daniel E.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Balaban, Amanda E.; Sinnis, Photini] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Balaban, Amanda E.; Sinnis, Photini] Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Malaria Res Inst, Baltimore, MD USA; [Diamond, Michael S.; Klein, Robyn S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Klein, Robyn S.] Washington Univ, Sch Med, Dept Neurobiol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Washington University (WUSTL); Washington University (WUSTL)	Goldberg, DE (corresponding author), Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA.; Goldberg, DE (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	dgoldberg@wustl.edu	Diamond, Michael/AAH-1733-2019	Diamond, Michael/0000-0002-8791-3165	National Institute of Allergy and Infectious Diseases [R01 AI26909, R01 AI056840]; National Institute of Heart, Lung and Blood [F30 HL119031]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056840, T32AI007172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052632] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Heart, Lung and Blood(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Allergy and Infectious Diseases (DEG) R01 AI26909; National Institute of Allergy and Infectious Diseases (PS) R01 AI056840; and National Institute of Heart, Lung and Blood (PP) F30 HL119031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas S, 2005, ANN TROP MED PARASIT, V99, P553, DOI 10.1179/136485905X51463; Craig AG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002401; Cruz-Orengo L, 2014, J CLIN INVEST, V124, P2571, DOI 10.1172/JCI73408; de Oca Marcela Montes, 2013, Methods Mol Biol, V1031, P203, DOI 10.1007/978-1-62703-481-4_23; de Souza JB, 2010, PARASITOLOGY, V137, P755, DOI 10.1017/S0031182009991715; de Souza JB, 2002, MICROBES INFECT, V4, P291, DOI 10.1016/S1286-4579(02)01541-1; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Gething PW, 2016, NEW ENGL J MED, V375, P2435, DOI 10.1056/NEJMoa1606701; Howland SW, 2013, EMBO MOL MED, V5, P984, DOI 10.1002/emmm.201202273; Medana IM, 2001, IMMUNOL CELL BIOL, V79, P101, DOI 10.1046/j.1440-1711.2001.00995.x; Moxon CA, 2014, J INFECT DIS, V209, P610, DOI 10.1093/infdis/jit419; Ndonwi M, 2011, BLOOD, V117, P6347, DOI 10.1182/blood-2010-12-326876; Pal P, 2016, MBIO, V7, DOI 10.1128/mBio.00617-16; PARRA ME, 1991, J CLIN MICROBIOL, V29, P1629, DOI 10.1128/JCM.29.8.1629-1634.1991; Riley EM, 2010, TRENDS PARASITOL, V26, P277, DOI 10.1016/j.pt.2010.03.002; Seydel KB, 2015, NEW ENGL J MED, V372, P1126, DOI 10.1056/NEJMoa1400116; Swarthout TD, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-58; White NJ, 2010, TRENDS PARASITOL, V26, P11, DOI 10.1016/j.pt.2009.10.007	18	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177142	10.1371/journal.pone.0177142	http://dx.doi.org/10.1371/journal.pone.0177142			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475625	gold, Green Published, Green Submitted			2022-12-26	WOS:000400649500051
J	Huth, S; Reverey, JF; Leippe, M; Selhuber-Unkel, C				Huth, Steven; Reverey, Julia F.; Leippe, Matthias; Selhuber-Unkel, Christine			Adhesion forces and mechanics in mannose-mediated acanthamoeba interactions	PLOS ONE			English	Article							BINDING PROTEIN; CELL-ADHESION; IN-VITRO; PATHOGENIC ACANTHAMOEBA; CONTACT-LENSES; KERATITIS; CASTELLANII; DISEASE; AMEBAS; SOFT	The human pathogenic amoeba Acanthamoeba castellanii (A. castellanii) causes severe diseases, including acanthamoeba keratitis and encephalitis. Pathogenicity arises from the killing of target-cells by an extracellular killing mechanism, where the crucial first step is the formation of a close contact between A. castellanii and the target-cell. This process is mediated by the glycocalix of the target-cell and mannose has been identified as key mediator. The aim of the present study was to carry out a detailed biophysical investigation of mannose-mediated adhesion of A. castellanii using force spectroscopy on single trophozoites. In detail, we studied the interaction of a mannose-coated cantilever with an A. castellanii trophozoite, as mannose is the decisive part of the cellular glycocalix in mediating pathogenicity. We observed a clear increase of the force to initiate cantilever detachment from the trophozoite with increasing contact time. This increase is also associated with an increase in the work of detachment. Furthermore, we also analyzed single rupture events during the detachment process and found that single rupture processes are associated with membrane tether formation, suggesting that the cytoskeleton is not involved in mannose binding events during the first few seconds of contact. Our study provides an experimental and conceptual basis for measuring interactions between pathogens and target-cells at different levels of complexity and as a function of interaction time, thus leading to new insights into the biophysical mechanisms of parasite pathogenicity.	[Huth, Steven; Reverey, Julia F.; Selhuber-Unkel, Christine] Christian Albrecht Univ Kiel, Inst Mat Sci Biocompatible Nanomat, Kaiserstr 2, D-24143 Kiel, Germany; [Leippe, Matthias] Christian Albrecht Univ Kiel, Zool Inst, Comparat Immunobiol, Botanischen Garten 1-9, D-24118 Kiel, Germany	University of Kiel; University of Kiel	Selhuber-Unkel, C (corresponding author), Christian Albrecht Univ Kiel, Inst Mat Sci Biocompatible Nanomat, Kaiserstr 2, D-24143 Kiel, Germany.	cse@tf.uni-kiel.de	Leippe, Matthias/AAP-1677-2020; Selhuber-Unkel, Christine/D-9715-2016	Selhuber-Unkel, Christine/0000-0002-5051-4822	DFG [SE-1801/2-1]; ERC [336104]	DFG(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission)	C. S., J. F. R. and S. H. acknowledge support from the DFG through the Emmy Noether program (grant SE-1801/2-1), as well as from the ERC (Starting grant no. 336104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; C. S., J. F. R. and S. H. acknowledge support from the DFG through the Emmy Noether program (grant SE-1801/2-1), as well as from the ERG (Starting grant no. 336104). We further acknowledge Constanze Lamprecht for her support with the AFM and Manuela Lieb for support in the lab.	Benoit M, 2011, METHODS MOL BIOL, V736, P355, DOI 10.1007/978-1-61779-105-5_21; Cao ZY, 1998, J BIOL CHEM, V273, P15838, DOI 10.1074/jbc.273.25.15838; Caumo K, 2011, ACANTHAMOEBA T3 T4 T; DART JKG, 1991, LANCET, V338, P650, DOI DOI 10.1016/0140-6736(91)91231-I; Dufour AC, 2015, SEMIN CELL DEV BIOL, V46, P128, DOI 10.1016/j.semcdb.2015.10.010; Friedrichs J, 2013, METHODS, V60, P169, DOI 10.1016/j.ymeth.2013.01.006; Garate M, 2006, INVEST OPHTH VIS SCI, V47, P1056, DOI 10.1167/iovs.05-0477; Garate M, 2004, J BIOL CHEM, V279, P29849, DOI 10.1074/jbc.M402334200; GORDON VR, 1993, INVEST OPHTH VIS SCI, V34, P658; Gutekunst SB, 2014, BEILSTEIN J NANOTECH, V5, P1393, DOI 10.3762/bjnano.5.152; Ithoi I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024327; Kadem LF, 2016, ADV MATER, V28, P1799, DOI 10.1002/adma.201504394; Khan, 2009, ACANTHAMOEBA BIOL PA; Khan NA, 2006, FEMS MICROBIOL REV, V30, P564, DOI 10.1111/j.1574-6976.2006.00023.x; Kim JH, 2012, EXP PARASITOL, V132, P287, DOI 10.1016/j.exppara.2012.08.007; Klink F, 1993, INVEST OPHTH VIS SCI, V34, P1937; LARKIN DFP, 1990, BRIT J OPHTHALMOL, V74, P133, DOI 10.1136/bjo.74.3.133; Leher H, 1998, INFECT IMMUN, V66, P5, DOI 10.1128/IAI.66.1.5-10.1998; Li Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep30452; Lorenzo-Morales J, 2013, TRENDS PARASITOL, V29, P181, DOI 10.1016/j.pt.2013.01.006; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Martinez AJ, 1997, BRAIN PATHOL, V7, P583, DOI 10.1111/j.1750-3639.1997.tb01076.x; Michalek M, 2013, NAT CHEM BIOL, V9, P37, DOI [10.1038/NCHEMBIO.1116, 10.1038/nchembio.1116]; Michel R, 2004, ACTA PROTOZOOL, V43, P37; MOORE MB, 1987, OPHTHALMOLOGY, V94, P1654, DOI 10.1016/S0161-6420(87)33238-5; Niederkorn JY, 1999, MICROBES INFECT, V1, P437, DOI 10.1016/S1286-4579(99)80047-1; Panjwani N, 2010, OCUL SURF, V8, P70, DOI 10.1016/S1542-0124(12)70071-X; Ralston KS, 2014, NATURE, V508, P526, DOI 10.1038/nature13242; Reverey JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11690; Reverey JF, 2014, CONTACT LENS ANTERIO, V37, P262, DOI 10.1016/j.clae.2013.11.010; Sariisik E, 2015, BIOPHYS J, V109, P1330, DOI 10.1016/j.bpj.2015.07.048; Selhuber-Unkel C, 2008, BIOPHYS J, V95, P5424, DOI 10.1529/biophysj.108.139584; Sharma S, 2000, BRIT J OPHTHALMOL, V84, P1103, DOI 10.1136/bjo.84.10.1103; Yang Z, 1997, INVEST OPHTHALMOL, V38, P439	34	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176207	10.1371/journal.pone.0176207	http://dx.doi.org/10.1371/journal.pone.0176207			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472161	gold, Green Published, Green Submitted			2022-12-26	WOS:000400648500028
J	Kiss, T; Szabo, A; Oszlanczi, G; Lukacs, A; Timar, Z; Tiszlavicz, L; Csupor, D				Kiss, Tivadar; Szabo, Andrea; Oszlanczi, Gabor; Lukacs, Anita; Timar, Zoltan; Tiszlavicz, Laszlo; Csupor, Dezso			Repeated-dose toxicity of common ragweed on rats	PLOS ONE			English	Article							AMBROSIA-ARTEMISIIFOLIA L.; SPECIES-MEDIATED APOPTOSIS; SESQUITERPENE LACTONES; INULA-HELENIUM; IN-VITRO; NRF2-MEDIATED INDUCTION; CHEMICAL-COMPOSITION; DETOXIFYING ENZYMES; TRYPANOSOMA-CRUZI; PSILOSTACHYIN-C	Ambrosia artemisiifolia L. is an invasive species with highly allergenic pollens. Ragweed originates from North America, but it also occurs and is spreading in Europe, causing seasonal allergic rhinitis for millions of people. Recently, the herb of A. artemisiifolia has gained popularity as medicinal plant and food. The effects of its long-term intake are unknown; there are no toxicological data to support the safe use of this plant. The aim of our study was to assess the repeated dose toxicity of A. artemisiifolia on animals. Ragweed puree was administered in low dose (500 mg/kg b. w.) and high dose (1000 mg/kg b. w.) to male Wistar rats according to 407 OECD Guidelines for the Testing of Chemicals. Clinical symptoms, various blood chemical parameters, body weight and organ weights of the rats were measured. Reduced liver function enzymes (AST, ALT), reduced triglyceride level in the low dose and increased carbamide level in the high dose group were observed. The weight of the liver relative to body weight was significantly reduced in both groups, while the brain weight relative to body weight was significantly elevated in both groups. According to our results, the repeated use of ragweed resulted in toxic effects in rats and these results question the safety of long-term human consumption of common ragweed.	[Kiss, Tivadar; Csupor, Dezso] Univ Szeged, Fac Pharm, Dept Pharmacognosy, Szeged, Hungary; [Kiss, Tivadar; Szabo, Andrea; Lukacs, Anita; Csupor, Dezso] Univ Szeged, Interdisciplinary Ctr Nat Prod, Szeged, Hungary; [Szabo, Andrea; Oszlanczi, Gabor; Lukacs, Anita] Univ Szeged, Fac Med, Dept Publ Hlth, Szeged, Hungary; [Timar, Zoltan] SOLVO Biotechnol, Szeged, Hungary; [Tiszlavicz, Laszlo] Univ Szeged, Fac Med, Dept Pathol, Szeged, Hungary	Szeged University; Szeged University; Szeged University; Szeged University	Csupor, D (corresponding author), Univ Szeged, Fac Pharm, Dept Pharmacognosy, Szeged, Hungary.; Csupor, D (corresponding author), Univ Szeged, Interdisciplinary Ctr Nat Prod, Szeged, Hungary.	csupor.dezso@pharm.u-szeged.hu	Csupor, Dezso/B-2952-2009; Kiss, Tivadar/L-3233-2013; Csupor, Dezső/ABE-1830-2021	Csupor, Dezso/0000-0002-4088-3333; Kiss, Tivadar/0000-0003-3538-377X; Csupor, Dezső/0000-0002-4088-3333; Lukacs, Anita/0000-0002-0746-8920; Timar, Zoltan/0000-0003-0316-9947	European Union and the State of Hungary; European Social Fund [TAMOP 4.2.4A/2-11-1-2012-0001]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; National Research, Development and Innovation Office [115796]; SOLVO Biotechnology;  [GINOP-2.3.2-15-2016-00012]	European Union and the State of Hungary; European Social Fund(European Social Fund (ESF)); Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); SOLVO Biotechnology; 	This research was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4A/2-11-1-2012-0001 'National Excellence Program'. This paper was supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences, the National Research, Development and Innovation Office (115796) and the project GINOP-2.3.2-15-2016-00012 (New ways in the natural product-based drug discovery system metabolomic approaches to discover biologically active terpenoids of herbal and microbial origin). The funder SOLVO Biotechnology provided support in the form of salaries for author ZT. The specific roles of the author are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4.A/2-11-1-2012-0001 'National Excellence Program'. This paper was supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences, the National Research, Development and Innovation Office (115796) and the project GINOP-2.3.2-15-2016-00012 (New ways in the natural product-based drug discovery-system metabolomic approaches to discover biologically active terpenoids of herbal and microbial origin). The funder SOLVO Biotechnology provided support in the form of salaries for author ZT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aziz M, 1991, ALEX J PHARM SCI, V5, P98; Abdelgaleil SAM, 2011, AFR J MICROBIOL RES, V5, P3385; AbouZid S, 2007, NAT PROD COMMUN, V2, P177; Amorim MHR, 2013, CRIT REV TOXICOL, V43, P559, DOI 10.3109/10408444.2013.813905; Aponte JC, 2010, PLANTA MED, V76, P705, DOI 10.1055/s-0029-1240681; ARNASON JT, 1985, J NAT PROD, V48, P581, DOI 10.1021/np50040a010; Bashir MEH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053337; BIANCHI E, 1968, AUST J CHEM, V21, P1109, DOI 10.1071/CH9681109; Blanco JG, 1997, FEBS LETT, V409, P396, DOI 10.1016/S0014-5793(97)00560-7; BLOSZYK E, 1992, COLLECT CZECH CHEM C, V57, P1092, DOI 10.1135/cccc19921092; Cai H, 2014, PHYTOTHER RES, V28, P1679, DOI 10.1002/ptr.5182; Cantrell CL, 1999, PLANTA MED, V65, P351, DOI 10.1055/s-1999-14001; [陈进军 Chen Jinjun], 2010, [癌变·畸变·突变, Carcinogenesis, Teratogenesis and Mutagenesis], V22, P440; Corbett A, 2012, LAB ANIM-UK, V46, P318, DOI 10.1258/la.2012.012018; Cotugno R, 2012, CELL PROLIFERAT, V45, P53, DOI 10.1111/j.1365-2184.2011.00796.x; Csubak M., 2012, PARAMEDICA, V8; Csupor-Loffler B, 2009, PHYTOTHER RES, V23, P672, DOI 10.1002/ptr.2697; da Silva CF, 2013, ANTIMICROB AGENTS CH, V57, P5307, DOI 10.1128/AAC.00595-13; David JP, 1999, PHARM BIOL, V37, P165, DOI 10.1076/phbi.37.2.165.6077; de Oliveira RB, 2011, J ETHNOPHARMACOL, V133, P434, DOI 10.1016/j.jep.2010.10.019; Ding WB, 2015, MOLECULES, V20, P4450, DOI 10.3390/molecules20034450; Dirsch VM, 2001, PLANTA MED, V67, P557, DOI 10.1055/s-2001-16478; Duan HuiPing, 2000, Acta Agriculturae Shanghai, V16, P73; El Kelish A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-176; Elufioye TO, 2009, J ETHNOPHARMACOL, V122, P410, DOI 10.1016/j.jep.2008.12.007; Ene-ojo AS, 2013, INT J BIOCH REREV, V3, P119; Essl F, 2015, J ECOL, V103, P1069, DOI 10.1111/1365-2745.12424; Foster S., 2000, FIELD GUIDE MED PLAN, V2nd ed.; Gattone VH, 2004, ANAT REC PART A, V277A, P384, DOI 10.1002/ar.a.20022; Gerber E, 2011, WEED RES, V51, P559, DOI 10.1111/j.1365-3180.2011.00879.x; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; Gilmore MR., 1913, COLLECTIONS NEBRASKA, V17, P358; Gowda S, 2009, PAN AFR MED J, V3, P1; Green D., RAGWEED; Hamel P.B., 1975, CHEROKEE PLANTS THEI; He Q, 2014, J CHEM-NY, V2014, DOI 10.1155/2014/738796; Herrick JW, 1977, IROQUOIS MED NOTANY; HERZ W, 1961, J ORG CHEM, V26, P5011, DOI 10.1021/jo01070a056; Heyl FW, 1917, J AM CHEM SOC, V39, P1470, DOI 10.1021/ja02252a022; ISSG, 2010, AMBR ART HERB; KELSEY RG, 1973, PHYTOCHEMISTRY, V12, P1345, DOI 10.1016/0031-9422(73)80562-X; Khan M, 2012, INT J BIOL SCI, V8, P533, DOI 10.7150/ijbs.3753; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; KING TP, 1964, BIOCHEMISTRY-US, V3, P458, DOI 10.1021/bi00891a026; Kiss T, 2012, GYOGYSZERESZET, V56, P560; Konishi T, 2002, BIOL PHARM BULL, V25, P1370, DOI 10.1248/bpb.25.1370; Kumar A, 2016, PHYTOCHEM LETT, V18, P117, DOI 10.1016/j.phytol.2016.09.004; Lake IR, 2016, ENV HLTH PERSPECT; Lastra AL, 2004, J ETHNOPHARMACOL, V95, P221, DOI 10.1016/j.jep.2004.07.020; Lawrence NJ, 2001, BIOORG MED CHEM LETT, V11, P429, DOI 10.1016/S0960-894X(00)00686-7; Leach MC, 2010, LAB ANIM-UK, V44, P54, DOI 10.1258/la.2009.009029; Leiblein M.C., 2013, ISRN ECOL, V2013, DOI [10.1155/2013/610126, DOI 10.1155/2013/610126]; Li M, 2013, HEBEI YIKE DAXUE XUE, V34, P869; Li M, 2013, TIANRAN CHANWU YANJI, V25, P529; [李明 Li Ming], 2013, [天然产物研究与开发, Natural Product R & D], V25, P555; Li Y, 2006, J NAT PROD, V69, P616, DOI 10.1021/np050480d; Li Y, 2010, ZHONG CAO YAO, V41, P1336; Li Y, 2012, Z NATURFORSCH C, V67, P375; Li Yong, 2010, Zhongguo Yaolixue Tongbao, V26, P112; Li ZL, 2016, ARCH PHARM RES, V39, P1441, DOI 10.1007/s12272-016-0815-8; Liu CH, 2001, CHINESE SCI BULL, V46, P498, DOI 10.1007/BF03187267; Mahesh A, 2010, ACTA BIOL HUNG, V61, P175, DOI 10.1556/ABiol.61.2010.2.6; Martino R, 2015, TOXICOL IN VITRO, V29, P1529, DOI 10.1016/j.tiv.2015.06.011; Milosavljevic S, 1999, J SERB CHEM SOC, V64, P397; Moller H, 2002, CONTACT DERMATITIS, V47, P157, DOI 10.1034/j.1600-0536.2002.470306.x; NARASIMHAN TR, 1985, PLANTA MED, V51, P194, DOI 10.1055/s-2007-969454; Nirogi R, 2014, INT J PHARM SCI RES, V5, P1525, DOI 10.13040/IJPSR.0975-8232.5(4).1525-32; Noori A, 2014, AVICENNA J PHYTOMEDI, V4, P371; OECD, 2008, TEST NO 407 REP DOS; Ognjenovic J, 2013, VET IMMUNOL IMMUNOP, V155, P38, DOI 10.1016/j.vetimm.2013.06.005; Parkhomenko A.Y., 2006, PHARM CHEM J, V40, P627, DOI DOI 10.1007/S11094-006-0208-2; Parkhomenko A.Yu., 2005, PHARM CHEM J+, V39, P149, DOI [10.1007/s11094-005-0106-z, DOI 10.1007/S11094-005-0106-Z]; PAYNE WW, 1966, BRITTONIA, V18, P28, DOI 10.2307/2805107; Piao Y, 2013, J TOXICOL PATHOL, V26, P29, DOI 10.1293/tox.26.29; PICMAN AK, 1982, CONTACT DERMATITIS, V8, P294, DOI 10.1111/j.1600-0536.1982.tb04234.x; PORTER TH, 1969, PHYTOCHEMISTRY, V8, P793, DOI 10.1016/S0031-9422(00)85858-6; Ramesh C, 2004, ARKIVOC, V2003, P126; Rasul A, 2013, ARCH PHARM RES, V36, P1262, DOI 10.1007/s12272-013-0217-0; RASZEJA W, 1977, PLANTA MED, V32, P319, DOI 10.1055/s-0028-1097606; RODRIGUEZ E, 1976, EXPERIENTIA, V32, P236, DOI 10.1007/BF01937785; Romero JB., 1954, BOT LORE CALIFORNIA, P13; Rugutt JK, 1997, J AGR FOOD CHEM, V45, P4845, DOI 10.1021/jf970420g; Schomburg C, 2013, EUR J MED CHEM, V63, P313, DOI 10.1016/j.ejmech.2013.02.018; Seo JY, 2009, J MED FOOD, V12, P1038, DOI 10.1089/jmf.2009.0072; Seo JY, 2008, PHYTOTHER RES, V22, P1500, DOI 10.1002/ptr.2521; Solujic S, 2008, J SERB CHEM SOC, V73, P1039, DOI 10.2298/JSC0811039S; Speck F.G., 1941, PRIMITIVE MAN, V14, P49; STEFANOVIC M, 1987, PHYTOCHEMISTRY, V26, P850, DOI 10.1016/S0031-9422(00)84804-9; Stefanovic M, 1972, GLAS HEM DRUG BEOGRA, V37, P463; Stojanovic-Radic Z, 2012, EUR J CLIN MICROBIOL, V31, P1015, DOI 10.1007/s10096-011-1400-1; Sturgeon CM, 2005, PLANTA MED, V71, P938, DOI 10.1055/s-2005-873109; Sulsen VP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002494; Sulsen VP, 2011, LAT AM J PHARM, V30, P202; Sulsen VP, 2011, INT J ANTIMICROB AG, V37, P536, DOI 10.1016/j.ijantimicag.2011.02.003; Sulsen V., 2011, EVID BASED COMPLEMEN, P1; Sulsen V, 2010, MOLECULES, V15, P545, DOI 10.3390/molecules15010545; Sulsen VP, 2008, ANTIMICROB AGENTS CH, V52, P2415, DOI 10.1128/AAC.01630-07; Sulsen VP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150526; Szigetvari C, 2004, ZONNOVENYEK BIOL INV, P337; Taglialatela-Scafati O, 2012, EUR J ORG CHEM, V2012, P5162, DOI 10.1002/ejoc.201200650; Tantaquidgeon G., 1972, PENN HIST COMM ANTH, V3, P28; Tantaquidgeon G., 1942, STUDY DELAWARE INDIA; TORRANCE SJ, 1975, J PHARM SCI, V64, P887, DOI 10.1002/jps.2600640542; Venables L, 2016, S AFR J BOT, V103, P216, DOI 10.1016/j.sajb.2015.08.016; Villagomez R., 2014, J BIOMEDICAL SCI ENG, DOI DOI 10.4236/JBISE.2014.710083; Villagomez R, 2013, ANTICANCER RES, V33, P3799; Wan F., 1995, P 8 INT S BIOLOGICAL, P193; Wayne P, 2002, ANN ALLERG ASTHMA IM, V88, P279, DOI 10.1016/S1081-1206(10)62009-1; Wopfner N, 2009, MOL IMMUNOL, V46, P2090, DOI 10.1016/j.molimm.2009.02.005; Wu MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076000; Zhao F, 2016, PLANT CELL ENVIRON, V39, P147, DOI 10.1111/pce.12601	113	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176818	10.1371/journal.pone.0176818	http://dx.doi.org/10.1371/journal.pone.0176818			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472131	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000400648500077
J	Chen, WC; Qiu, JT; Lai, CH; Huang, HJ; Lin, CT; Chen, MY; Chou, HH; Huang, KG; Chang, TC				Chen, Wei-Chun; Qiu, Jiantai Timothy; Lai, Chyong-Huey; Huang, Huei-Jean; Lin, Cheng-Tao; Chen, Min-Yu; Chou, Hung-Hsueh; Huang, Kuan-Gen; Chang, Ting-Chang			Outcomes and prognoses of patients with ovarian cancer using bevacizumab: 6-year experience in a tertiary care hospital of northern Taiwan	PLOS ONE			English	Article							RECURRENT EPITHELIAL OVARIAN; PLATINUM-RESISTANT; PRIMARY PERITONEAL; FALLOPIAN-TUBE; BLOOD-VESSELS; FRONT-LINE; CHEMOTHERAPY; DELIVERY; NORMALIZATION; THERAPY	Purpose Bevacizumab (BEV) has been used for ovarian cancer (OC) for years in Taiwan, but the associated data related to outcome is scant. This retrospective study reviewed patients with OC treated with BEV and analyzed their results. Patients and methods All patients with OC treated with BEV from 2009 to 2015 in the Linkou branch of Chang Gung Memorial Hospital in Northern Taiwan were included. According to the means of administration, the patients were classified into 6 groups as follows: A-BEV plus chemotherapy (C/T) for initial platinum-resistant (PR) recurrent OC, B-BEV plus C/T for initial platinum-sensitive (PS) recurrent OC, C-BEV alone for recurrent OC, D-BEV plus 1(st) adjuvant C/T, E-BEV plus neoadjuvant C/T, and F-intraperitoneal (IP) BEV. Progression-free survival (PFS), overall survival (OS), hazard ratios (HRs), overall response rate (ORR), and mean number of BEV cycles were analyzed for groups A to E. Clinical improvement of ascites was assessed for group F. Results A comparison of early use (only one round of prior C/T) versus late use (multiple rounds of prior C/T) in patients of groups A and B showed a superior PFS (8.27 vs. 3.67, p = 0.037) in the early use group. No significant differences were found between groups A and B (PFS: 4.24 vs. 4.17 months, p = 0.690; OS: 10.06 vs. 9.93 months, p = 0.819; mean BEV cycles: 4.63 vs. 5.0 p = 0.992; ORR: 48.1% vs. 53.5%, p = 0.425). Comparing the response and non-response subgroups of patients in groups A and B, a better outcome was associated with endometrioid type cell (HR = 0.28, p = 0.008), good ECOG performance status (HR = 0.51, p = 0.005), and lack of ascites (HR = 0.67, p = 0.004). Comparing group C with groups A plus B, the BEV alone group had a poorer PFS (1.02 VS. 4.19, p = 0.04) and OS (1.42 VS. 9.99 p = 0.001) than the BEV plus C/T group. In group F, a good clinical benefit rate (85.6%) of ascites improvement was noted. Two patients had grade 5 gastrointestinal bleeding and venous/arterial thromboembolic events after administration of BEV. Grade 3 neutropenia and thrombocytopenia occurred more frequently in our study. Conclusion Early use of BEV combined with chemotherapy had a significant benefit in PFS for patients with recurrent OC. BEV plus chemotherapy was better than BEV alone for recurrent OC. In addition, IP BEV was helpful for improving clinical ascites.	[Chen, Wei-Chun; Qiu, Jiantai Timothy; Lai, Chyong-Huey; Huang, Huei-Jean; Lin, Cheng-Tao; Chen, Min-Yu; Chou, Hung-Hsueh; Huang, Kuan-Gen; Chang, Ting-Chang] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Taoyuan, Taiwan; [Qiu, Jiantai Timothy; Lai, Chyong-Huey; Chou, Hung-Hsueh; Chang, Ting-Chang] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Qiu, Jiantai Timothy; Lai, Chyong-Huey; Huang, Huei-Jean; Lin, Cheng-Tao; Chen, Min-Yu; Chou, Hung-Hsueh; Huang, Kuan-Gen; Chang, Ting-Chang] Chang Gung Mem Hosp, Gynecol Canc Res Ctr, Taoyuan, Taiwan; [Qiu, Jiantai Timothy] Chang Gung Univ, Dept Biomed Sci, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Qiu, JT; Chang, TC (corresponding author), Chang Gung Mem Hosp, Dept Obstet & Gynecol, Taoyuan, Taiwan.; Qiu, JT; Chang, TC (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Qiu, JT; Chang, TC (corresponding author), Chang Gung Mem Hosp, Gynecol Canc Res Ctr, Taoyuan, Taiwan.; Qiu, JT (corresponding author), Chang Gung Univ, Dept Biomed Sci, Taoyuan, Taiwan.	jtqiu@mail.cgu.edu.tw; tinchang.chang@gmail.com	Lai, Chyong-Huey/AAE-5731-2022; Timothy, Qiu J./AAV-3086-2020	Meir, Yaa-Jyuhn/0000-0001-6084-3446; Chen, Wei-chun/0000-0002-6515-0996; Qiu, JT/0000-0001-7090-6906; Lai, Chyong-Huey/0000-0002-9977-9645	Chang Gung University Hospital (Taoyuan,Taiwan) [CMRPG3D00513, CMRPG3E2881]	Chang Gung University Hospital (Taoyuan,Taiwan)	This work was supported by CMRPG3D00513 and CMRPG3E2881, which were provided by Chang Gung University Hospital (Taoyuan,Taiwan)	Aghajanian C, ESMO CONGRESS2012; Aghajanian C, 2012, J CLIN ONCOL, V30, P2039, DOI 10.1200/JCO.2012.42.0505; [Anonymous], NCI COMM TERM CRIT A; Arjaans M, 2013, CANCER RES, V73, P3347, DOI 10.1158/0008-5472.CAN-12-3518; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Chatterjee S, 2014, CANCER RES, V74, P2816, DOI 10.1158/0008-5472.CAN-13-2986; Chauhan VP, 2012, NAT NANOTECHNOL, V7, P383, DOI [10.1038/NNANO.2012.45, 10.1038/nnano.2012.45]; Chou HH, 2006, GYNECOL ONCOL, V101, P423, DOI 10.1016/j.ygyno.2005.10.027; Ciccolini J, 2015, P NATL ACAD SCI USA, V112, pE3453, DOI 10.1073/pnas.1506689112; Conley SJ, 2012, P NATL ACAD SCI USA, V109, P2784, DOI 10.1073/pnas.1018866109; Dickson PV, 2007, CLIN CANCER RES, V13, P3942, DOI 10.1158/1078-0432.CCR-07-0278; Ferrara N, 2005, BIOCHEM BIOPH RES CO, V333, P328, DOI 10.1016/j.bbrc.2005.05.132; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2005, ONCOLOGY-BASEL, V69, P11, DOI 10.1159/000088479; Ferriss JS, 2015, GYNECOL ONCOL, V139, P17, DOI 10.1016/j.ygyno.2015.07.103; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fuh KC, 2015, GYNECOL ONCOL, V139, P413, DOI 10.1016/j.ygyno.2015.06.041; Health. NIo, 2007, CARB PACL GEMC HYDR; Hu CF, 2015, TAIWAN J OBSTET GYNE, V54, P43, DOI 10.1016/j.tjog.2014.11.005; Huang YH, 2012, P NATL ACAD SCI USA, V109, P17561, DOI 10.1073/pnas.1215397109; Institute. NC, 2016, FDA APPR BEV; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jayson GC, 2016, LANCET, V388, P518, DOI 10.1016/S0140-6736(15)01088-0; Jiang LX, 2016, ANTICANCER RES, V36, P1313; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kuczynski EA, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw030; Monk BJ, 2013, ANN ONCOL, V24, P53, DOI 10.1093/annonc/mdt472; Moserle L, 2014, CANCER DISCOV, V4, P31, DOI 10.1158/2159-8290.CD-13-0199; Network NCC, 2016, OV CANC INCL FALL TU; Oza AM, 2015, LANCET ONCOL, V16, P928, DOI 10.1016/S1470-2045(15)00086-8; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Pham E, 2015, CLIN CANCER RES, V21, P808, DOI 10.1158/1078-0432.CCR-14-2810; Piccioni DE, 2014, NEURO-ONCOLOGY, V16, P815, DOI 10.1093/neuonc/nou028; Pujade-Lauraine E, 2014, J CLIN ONCOL, V32, P1302, DOI 10.1200/JCO.2013.51.4489; Rustin GJS, 2011, INT J GYNECOL CANCER, V21, P419, DOI 10.1097/IGC.0b013e3182070f17; Stylianopoulos T, 2013, P NATL ACAD SCI USA, V110, P18632, DOI 10.1073/pnas.1318415110; Taiwan DoH, 2011, CANC REGISTRY ANN RE	39	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0175703	10.1371/journal.pone.0175703	http://dx.doi.org/10.1371/journal.pone.0175703			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467466	Green Published, Green Submitted, gold			2022-12-26	WOS:000400647000023
J	Kuczkowska, K; Myrbraten, I; Overland, L; Eijsink, VGH; Follmann, F; Mathiesen, G; Dietrich, J				Kuczkowska, Katarzyna; Myrbraten, Ine; Overland, Lise; Eijsink, Vincent G. H.; Follmann, Frank; Mathiesen, Geir; Dietrich, Jes			Lactobacillus plantarum producing a Chlamydia trachomatis antigen induces a specific IgA response after mucosal booster immunization	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; TOXIN FRAGMENT-C; IMMUNE-RESPONSES; TETANUS TOXIN; SUBUNIT VACCINES; PROTECTION; INFECTION; DELIVERY; DISPLAY; VACCINATION	Mucosal immunity is important for the protection against a wide variety of pathogens. Traditional vaccines administered via parenteral routes induce strong systemic immunity, but they often fail to generate mucosal IgA. In contrast, bacteria-based vaccines comprise an appealing strategy for antigen delivery to mucosal sites. Vaginal infection with Chlamydia trachomatis can develop into upper genital tract infections that can lead to infertility. Therefore, the development of an effective vaccine against Chlamydia is a high priority. In the present study, we have explored the use of a common lactic acid bacterium, Lactobacillus plantarum, as a vector for delivery of a C. trachomatis antigen to mucosal sites. The antigen, referred as Hirep2 (H2), was anchored to the surface of L. plantarum cells using an N-terminal lipoprotein anchor. After characterization, the constructed strain was used as an immunogenic agent in mice. We explored a heterologous prime-boost strategy, consisting of subcutaneous priming with soluble H2 antigen co-administered with CAF01 adjuvant, followed by an intranasal boost with H2-displaying L. plantarum. The results show that, when used as a booster, the recombinant L. plantarum strain was able to evoke cellular responses. Most importantly, booster immunization with the Lactobacillus-based vaccine induced generation of antigen-specific IgA in the vaginal cavity.	[Kuczkowska, Katarzyna; Myrbraten, Ine; Overland, Lise; Eijsink, Vincent G. H.; Mathiesen, Geir] Norwegian Univ Life Sci NMBU, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway; [Follmann, Frank; Dietrich, Jes] Statens Serum Inst, Dept Infect Dis Immunol, Copenhagen, Denmark	Norwegian University of Life Sciences; Statens Serum Institut	Mathiesen, G (corresponding author), Norwegian Univ Life Sci NMBU, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway.	geir.mathiesen@nmbu.no		Follmann, Frank/0000-0002-8373-7774; Myrbraten, Ine Storaker/0000-0002-3828-7508	Norwegian University of Life Sciences; Globvac program of the Research Council of Norway [234502]; Danish Council for Independent Research Medical Sciences [DFF-4004-00424]; Danish National Advanced Technology Foundation [069-2011-1]	Norwegian University of Life Sciences; Globvac program of the Research Council of Norway; Danish Council for Independent Research Medical Sciences(Det Frie Forskningsrad (DFF)); Danish National Advanced Technology Foundation	This work was funded by a PhD fellowship from the Norwegian University of Life Sciences and the Globvac program of the Research Council of Norway (http://www.forskningsradet.no/ en/Home_page/1177315753906), through grant number 234502. This study was supported partly by the Danish Council for Independent Research Medical Sciences [Grant no.: DFF-4004-00424] (http://ufm.dk/en/research-and-innovation/ councils-and-commissions/the-danish-council-for-independent-research) and The Danish National Advanced Technology Foundation [069-2011-1] (http://ufm.dk/en/research-and-innovation/ councils-and-commissions/the-danish-council-for-independent-researc) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003116; Almada G, 2015, IMMUNOBIOLOGY, V220, P109, DOI 10.1016/j.imbio.2014.08.013; Aukrust T W, 1995, Methods Mol Biol, V47, P201; Badamchi-Zadeh A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00162; Badamchi-Zadeh A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141209; BLOKSMA N, 1979, Z IMMUNITATSFORSCH, V156, P309, DOI 10.1016/S0340-904X(79)80052-4; BLOKSMA N, 1979, CLIN EXP IMMUNOL, V37, P367; Brown THT, 2012, VACCINE, V30, P350, DOI 10.1016/j.vaccine.2011.10.086; Chinchilla M, 2007, INFECT IMMUN, V75, P3769, DOI 10.1128/IAI.00356-07; Christensen D, 2016, MUCOSAL IMMUNOL; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Ciabattini A, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00430; Curiel TJ, 2004, J IMMUNOL, V172, P7425, DOI 10.4049/jimmunol.172.12.7425; Daniel C, 2011, TRENDS BIOTECHNOL, V29, P499, DOI 10.1016/j.tibtech.2011.05.002; Doherty TM, 2002, INFECT IMMUN, V70, P3111, DOI 10.1128/IAI.70.6.3111-3121.2002; Farris CM, 2011, INFECT IMMUN, V79, P986, DOI 10.1128/IAI.00881-10; Fredriksen L, 2012, APPL ENVIRON MICROB, V78, P5864, DOI 10.1128/AEM.01227-12; Gaydos CA, 2008, SEX TRANSM DIS, V35, P233, DOI 10.1097/OLQ.0b013e31815c11fe; Grangett C, 2001, INFECT IMMUN, V69, P1547, DOI 10.1128/IAI.69.3.1547-1553.2001; Grangette C, 2002, VACCINE, V20, P3304, DOI 10.1016/S0264-410X(02)00301-8; LeBlanc JG, 2013, FEMS MICROBIOL LETT, V344, P1, DOI 10.1111/1574-6968.12159; Hafner LM, 2014, VACCINE, V32, P1563, DOI 10.1016/j.vaccine.2013.08.020; Hosenfeld CB, 2009, SEX TRANSM DIS, V36, P478, DOI 10.1097/OLQ.0b013e3181a2a933; Ibnou-Zekri N, 2003, INFECT IMMUN, V71, P428, DOI 10.1128/IAI.71.1.428-436.2003; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kuczkowska K, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.02782-16, 10.1128/aem.02782-16]; Kuczkowska K, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0360-z; Lorenzen E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00628; Lu S, 2009, CURR OPIN IMMUNOL, V21, P346, DOI 10.1016/j.coi.2009.05.016; Lycke N, 2012, NAT REV IMMUNOL, V12, P592, DOI 10.1038/nri3251; Maassen CBM, 2000, VACCINE, V18, P2613, DOI 10.1016/S0264-410X(99)00378-3; Manam S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064917; Mathiesen G, 2008, J APPL MICROBIOL, V105, P215, DOI 10.1111/j.1365-2672.2008.03734.x; Matoba N, 2006, VACCINE, V24, P5047, DOI 10.1016/j.vaccine.2006.03.045; Medina E, 2001, VACCINE, V19, P1573, DOI 10.1016/S0264-410X(00)00354-6; Meijerink M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010632; Mohamadzadeh M, 2005, P NATL ACAD SCI USA, V102, P2880, DOI 10.1073/pnas.0500098102; Mohamadzadeh M, 2009, P NATL ACAD SCI USA, V106, P4331, DOI 10.1073/pnas.0900029106; Nizard M, 2014, HUM VACC IMMUNOTHER, V10, P2175, DOI 10.4161/hv.29269; Olsen AW, 2015, J INFECT DIS, V212, P978, DOI 10.1093/infdis/jiv137; Olsen AW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010768; Reveneau N, 2002, VACCINE, V20, P1769, DOI 10.1016/S0264-410X(02)00027-0; Shaw DM, 2000, IMMUNOLOGY, V100, P510, DOI 10.1046/j.1365-2567.2000.00069.x; Stary G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa8205; Tarahomjoo S, 2012, MOL BIOTECHNOL, V51, P183, DOI 10.1007/s12033-011-9450-2; Vasilevsky S, 2014, CLIN MICROBIOL REV, V27, P346, DOI 10.1128/CMR.00105-13; Wang M, 2016, APPL MICROBIOL BIOT, V100, P5691, DOI 10.1007/s00253-016-7557-x; Wells J, 2011, ANNU REV FOOD SCI T, V2, P423, DOI 10.1146/annurev-food-022510-133640; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; Wells JM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S17; Wyszynska A, 2015, APPL MICROBIOL BIOT, V99, P2967, DOI [10.1007/s00253-015-6498-0, 10.1007/s00253-015-6569-2]	51	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176401	10.1371/journal.pone.0176401	http://dx.doi.org/10.1371/journal.pone.0176401			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467432	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000400647000050
J	Nisar, N; Aleem, A; Saleem, F; Aslam, F; Shahid, A; Chaudhry, H; Malik, K; Albaser, A; Iqbal, A; Qadri, R; Yang, Y				Nisar, Numrah; Aleem, Amber; Saleem, Faiza; Aslam, Fakhra; Shahid, Ammara; Chaudhry, Hina; Malik, Kausar; Albaser, Abdulhadi; Iqbal, Amjad; Qadri, Rashad; Yang, Yaodong			Reduction of reactive red 241 by oxygen insensitive azoreductase purified from a novel strain Staphylococcus KU898286	PLOS ONE			English	Article							AZO DYES; BIODEGRADATION; TEXTILE; DECOLORIZATION; PURIFICATION; EFFLUENT; INDUSTRY	An oxygen insensitive azoreductase was purified from a novel bacterial strain (Staphylococcus sp. KU898286) that was isolated from an abandoned site of the textile waste discharge unit. The isolated enzyme had efficiently cleaved the azo-bonds through reductive transformation under aerobic conditions. Initial phenotypic characterization and final construction of phylogenetic tree on the basis of 16s rDNA demonstrated 99% resemblance of the isolate to Staphylococcus aureus. The purified azoreductase was found to have a broad spectrum activity that reduced RR241 at a concentration of 50mg/L with pH between 6-8 and 30 degrees C temperature). Besides, the reactive red 241 (RR241) was reduced at extracellular level as well as NADH dependent intracellular level. Complete reduction/decolourization of RR241 were achieved after 18 hrs of exposure. The final degradation product observed to be 2-nephthol was purified by High Pressure Liquid Chromatography (HPLC) and the molecular mass was computed by Gas Chromatography-Mass spectroscopy (GC-MS). The study revealed a cost effective and eco-friendly approach to degrade the toxic dyes into less toxic products by Staphylococcus sp. KU898286.	[Nisar, Numrah; Aleem, Amber; Aslam, Fakhra; Shahid, Ammara; Chaudhry, Hina] Lahore Coll Women Univ Lahore, Dept Environm Sci, Lahore, Pakistan; [Saleem, Faiza] Lahore Coll Women Univ Lahore, Dept Biotechnol, Lahore, Pakistan; [Malik, Kausar] Lahore Coll Women Univ Lahore, Dept ORIC, Lahore, Pakistan; [Albaser, Abdulhadi] Univ Sebha, Fac Sci, Sebha, Libya; [Iqbal, Amjad; Qadri, Rashad; Yang, Yaodong] Chinese Acad Trop Agr Sci, Hainan Key Lab Trop Oil Crops Biol, Coconut Res Inst, Wenchang, Hainan, Peoples R China; [Iqbal, Amjad] Abdul Wali Khan Univ Mardan, Dept Agr, Mardan, Pakistan; [Qadri, Rashad] Univ Faisalabad, Inst Hort Sci, Faisalabad, Pakistan	Sebha University; Chinese Academy of Tropical Agricultural Sciences	Qadri, R; Yang, Y (corresponding author), Chinese Acad Trop Agr Sci, Hainan Key Lab Trop Oil Crops Biol, Coconut Res Inst, Wenchang, Hainan, Peoples R China.; Qadri, R (corresponding author), Univ Faisalabad, Inst Hort Sci, Faisalabad, Pakistan.	waseemrana_83pk@hotmail.com; yangyd@tocri.com	Qadri, Rashad Waseem Khan/AAX-6327-2020; Yang, Yaodong/L-8445-2019; Iqbal, Amjad/E-2010-2014; Malik, Kausar/AAH-1686-2020; Albaser, Abdulhadi Ali/I-9624-2019	Qadri, Rashad Waseem Khan/0000-0002-0241-6048; Yang, Yaodong/0000-0002-6599-5665; Iqbal, Amjad/0000-0001-6141-8337; 	International Science and Technology Cooperation projects of Hainan Province [KJHZ2014-24]; Science and Technology Department of Hainan Province	International Science and Technology Cooperation projects of Hainan Province; Science and Technology Department of Hainan Province	The project was supported through International Science and Technology Cooperation projects of Hainan Province (no. KJHZ2014-24) funded by Science and Technology Department of Hainan Province.	Baron S., 1996, MED MICROBIOLOGY, V4th; Bin Y, 2004, FEMS MICROBIOL LETT, V236, P129, DOI 10.1016/j.femsle.2004.05.034; Blumel S, 2002, APPL ENVIRON MICROB, V68, P3948, DOI 10.1128/AEM.68.8.3948-3955.2002; Chen HZ, 2006, CURR PROTEIN PEPT SC, V7, P101, DOI 10.2174/138920306776359786; Chen HZ, 2005, MICROBIOL-SGM, V151, P1433, DOI 10.1099/mic.0.27805-0; Chung KT, 2000, J ENVIRON SCI HEAL C, V18, P51, DOI 10.1080/10590500009373515; Cui DZ, 2012, PROCESS BIOCHEM, V47, P544, DOI 10.1016/j.procbio.2011.12.013; Elbanna K., 2010, Journal of Bioremediation and Biodegradation, V1, P1000110, DOI 10.4172/2155-6199.1000110; Heinfling A, 1997, APPL MICROBIOL BIOT, V48, P261, DOI 10.1007/s002530051048; Kalyani DC, 2008, BIORESOURCE TECHNOL, V99, P4635, DOI 10.1016/j.biortech.2007.06.058; Lade HS, 2012, INT BIODETER BIODEGR, V72, P94, DOI 10.1016/j.ibiod.2012.06.001; Macwana SR, 2010, CURR ISSUES MOL BIOL, V12, P43; Misal SA, 2011, PROCESS BIOCHEM, V46, P1264, DOI 10.1016/j.procbio.2011.02.013; Nachiyar CV, 2005, ENZYME MICROB TECH, V36, P503, DOI 10.1016/j.enzmictec.2004.11.015; Nurk S, 2013, J COMPUT BIOL, V20, P714, DOI 10.1089/cmb.2013.0084; Rai HS, 2005, CRIT REV ENV SCI TEC, V35, P219, DOI 10.1080/10643380590917932; Singh RL, 2015, INT BIODETER BIODEGR, V104, P21, DOI 10.1016/j.ibiod.2015.04.027; Vos P., 2011, BERGEYS MANUAL SYSTE, V3; Wang ZW, 2013, INT BIODETER BIODEGR, V76, P41, DOI 10.1016/j.ibiod.2012.06.023; ZIMMERMANN T, 1984, ARCH MICROBIOL, V138, P37, DOI 10.1007/BF00425404	20	8	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0175551	10.1371/journal.pone.0175551	http://dx.doi.org/10.1371/journal.pone.0175551			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467413	gold, Green Submitted, Green Published			2022-12-26	WOS:000400647000017
J	Wingfield, JE; O'Brien, M; Lyubchich, V; Roberts, JJ; Halpin, PN; Rice, AN; Bailey, H				Wingfield, Jessica E.; O'Brien, Michael; Lyubchich, Vyacheslav; Roberts, Jason J.; Halpin, Patrick N.; Rice, Aaron N.; Bailey, Helen			Year-round spatiotemporal distribution of harbour porpoises within and around the Maryland wind energy area	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; PHOCOENA-PHOCOENA; NORTH-SEA; T-PODS; ECHOLOCATION ACTIVITY; FORAGING BEHAVIOR; DIVING BEHAVIOR; MODELS; DENSITY; ATLANTIC	Offshore windfarms provide renewable energy, but activities during the construction phase can affect marine mammals. To understand how the construction of an offshore windfarm in the Maryland Wind Energy Area (WEA) off Maryland, USA, might impact harbour porpoises (Phocoena phocoena), it is essential to determine their poorly understood year-round distribution. Although habitat-based models can help predict the occurrence of species in areas with limited or no sampling, they require validation to determine the accuracy of the predictions. Incorporating more than 18 months of harbour porpoise detection data from passive acoustic monitoring, generalized auto-regressive moving average and generalized additive models were used to investigate harbour porpoise occurrence within and around the Maryland WEA in relation to temporal and environmental variables. Acoustic detection metrics were compared to habitat-based density estimates derived from aerial and boat-based sightings to validate the model predictions. Harbour porpoises occurred significantly more frequently during January to May, and foraged significantly more often in the evenings to early mornings at sites within and outside the Maryland WEA. Harbour porpoise occurrence peaked at sea surface temperatures of 5 degrees C and chlorophyll a concentrations of 4.5 to 7.4 mg m(-3). The acoustic detections were significantly correlated with the predicted densities, except at the most inshore site. This study provides insight into previously unknown finescale spatial and temporal patterns in distribution of harbour porpoises offshore of Maryland. The results can be used to help inform future monitoring and mitigate the impacts of windfarm construction and other human activities.	[Wingfield, Jessica E.; O'Brien, Michael; Lyubchich, Vyacheslav; Bailey, Helen] Univ Maryland, Chesapeake Biol Lab, Ctr Environm Sci, Solomons, MD 20688 USA; [Roberts, Jason J.; Halpin, Patrick N.] Duke Univ, Nicholas Sch Environm, Marine Geospatial Ecol Lab, Durham, NC 27708 USA; [Rice, Aaron N.] Cornell Univ, Cornell Lab Ornithol, Biacoust Res Program, Ithaca, NY USA	University System of Maryland; University of Maryland Center for Environmental Science; Duke University; Cornell University	Wingfield, JE (corresponding author), Univ Maryland, Chesapeake Biol Lab, Ctr Environm Sci, Solomons, MD 20688 USA.	jwingfie@cbl.umces.edu	Lyubchich, Vyacheslav/M-9516-2016; O'Brien, Michael HP/ABF-9080-2021; Bailey, Helen/E-6813-2012	Lyubchich, Vyacheslav/0000-0001-7936-4285; O'Brien, Michael HP/0000-0003-1420-6395; Bailey, Helen/0000-0001-7445-4687	Maryland Department of Natural Resources	Maryland Department of Natural Resources	The Maryland Department of Natural Resources (http://dnr.maryland.gov/ccs) secured the funding for this project from the Maryland Energy Administration's Offshore Wind Development Fund (http://energy.maryland.gov) and the U.S. Department of Interior's Bureau of Ocean Energy Management, Environmental Studies	Anderwald P, 2013, ENDANGER SPECIES RES, V21, P231, DOI 10.3354/esr00523; Andrew RK, 2011, J ACOUST SOC AM, V129, P642, DOI 10.1121/1.3518770; Bailey Helen, 2014, Aquatic Biosystems, V10, P8, DOI 10.1186/2046-9063-10-8; Bailey H, 2010, AQUAT CONSERV, V20, P150, DOI 10.1002/aqc.1060; Benjamin MA, 2003, J AM STAT ASSOC, V98, P214, DOI 10.1198/016214503388619238; Benoit-Bird KJ, 2009, MAR ECOL PROG SER, V395, P119, DOI 10.3354/meps07793; Bos R, 2002, IEEE T INSTRUM MEAS, V51, P1289, DOI 10.1109/TIM.2002.808031; Boswell KM, 2008, N AM J FISH MANAGE, V28, P799, DOI 10.1577/M07-116.1; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Brandt MJ, 2011, MAR ECOL PROG SER, V421, P205, DOI 10.3354/meps08888; Brookes KL, 2013, J ACOUST SOC AM, V134, P2523, DOI 10.1121/1.4816577; Byrd BL, 2014, FISH B-NOAA, V112, P1, DOI 10.7755/FB.112.1.1; Carlstrom J, 2005, MAR MAMMAL SCI, V21, P1, DOI 10.1111/j.1748-7692.2005.tb01204.x; Carstensen J, 2006, MAR ECOL PROG SER, V321, P295, DOI 10.3354/meps321295; Connelly EE, 2015, WILDLIFE DENSITIES H, P34; Cox Tara M., 2001, Journal of Cetacean Research and Management, V3, P81; Cox TM, 1998, FISH B-NOAA, V96, P727; Dahne M., 2013, ENVIRON RES LETT, V8, P16; DEAN C, 1989, CAN J STAT, V17, P171, DOI 10.2307/3314846; Di Iorio L, 2010, BIOL LETTERS, V6, P51, DOI 10.1098/rsbl.2009.0651; Embling CB, 2010, BIOL CONSERV, V143, P267, DOI 10.1016/j.biocon.2009.09.005; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Finley K.J., 1990, Canadian Bulletin of Fisheries and Aquatic Sciences, V224, P97; Freeman EA, 2008, J STAT SOFTW, V23, P1; Gannon DP, 1998, FISH B-NOAA, V96, P428; Garrison LP, 2013, APPENDIX AERIAL ABUN, P17; Gaskin D. E., 1977, Report int Whal Commn, V27, P487; Guida V, 2015, REPORT BENTHIC HABIT; Hammond PS, 2002, J APPL ECOL, V39, P361, DOI 10.1046/j.1365-2664.2002.00713.x; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; HOHN AA, 2013, J MAR BIOL, V2013, DOI DOI 10.1155/2013/289892; Holt MM, 2009, J ACOUST SOC AM, V125, pEL27, DOI 10.1121/1.3040028; Johnston DW, 2005, MAR ECOL PROG SER, V295, P279, DOI 10.3354/meps295279; Jones RH., 1986, J APPL PROBABILITY A, V23, P89, DOI 10.1017/S0021900200117000; Koopman HN, 1998, J MAMMAL, V79, P260, DOI 10.2307/1382862; Koschinski Sven, 2008, Journal of Cetacean Research and Management, V10, P147; Kraus SD, 1983, HARBOR PORPOIS UNPUB; Kyhn LA, 2012, J ACOUST SOC AM, V131, P550, DOI 10.1121/1.3662070; Linnenschmidt M, 2013, MAR MAMMAL SCI, V29, pE77, DOI 10.1111/j.1748-7692.2012.00592.x; Marques TA, 2013, BIOL REV, V88, P287, DOI 10.1111/brv.12001; Marubini F, 2009, MAR ECOL PROG SER, V381, P297, DOI 10.3354/meps07893; McQuinn IH, 2009, CAN J FISH AQUAT SCI, V66, P2256, DOI 10.1139/F09-143; [National Oceanic and Atmospheric Administration (NOAA) Bureau of Ocean Energy Management (BOEM)], MARINECADASTRE GOV 2; NELSON G A, 1991, Journal of Northwest Atlantic Fishery Science, V11, P11; Nuuttila HK, 2013, AQUAT MAMM, V39, P147, DOI 10.1578/AM.39.2.2013.147; OREILLY JE, 1998, 139 NOAA NMFS US DEP; Otani S, 1998, MAR MAMMAL SCI, V14, P209, DOI 10.1111/j.1748-7692.1998.tb00711.x; Palka D, 1995, DEV MAR BIO, V4, P69; Palka D., 2012, CETACEAN ABUNDANCE E; Palka Debbie, 1995, Reports of the International Whaling Commission Special Issue, V16, P27; Pirotta E, 2015, BIOL CONSERV, V181, P82, DOI 10.1016/j.biocon.2014.11.003; Pirotta E, 2014, FUNCT ECOL, V28, P206, DOI 10.1111/1365-2435.12146; R-Core-Team, 2015, LANG ENV STAT COMP; Read AJ, 2006, CONSERV BIOL, V20, P163, DOI 10.1111/j.1523-1739.2006.00338.x; Read AJ, 1997, MAR BIOL, V130, P315, DOI 10.1007/s002270050251; RECCHIA CA, 1989, CAN J ZOOL, V67, P2140, DOI 10.1139/z89-304; Reid J.B., 2003, ATLAS CETACEAN DISTR; Reid RN, 1999, NMFSNE126  NOAA; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Robertson JD, 2016, SCI REP-UK, V6, DOI [10.1038/srep27494, 10.1038/srep22615]; Santos MB, 2003, OCEANOGR MAR BIOL, V41, P355; Sarnocinska J, 2016, P M AC, P27; Schaffeld T, 2016, MAR ECOL PROG SER, V547, P257, DOI 10.3354/meps11627; Scheidat M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/025102; Scott WB, 1988, ATLANTIC FISHES CANA; Shotton R, 82441982 CAN ATL FIS; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Soldevilla MS, 2011, MAR ECOL PROG SER, V423, P247, DOI 10.3354/meps08927; Stasinopoulos M, 2016, GAMLSS UTIL GAMLSS U; Swingle WM, 2016, 201601 VAQF; Teilmann Jonas, 2003, Journal of Cetacean Research and Management, V5, P85; Teilmann Jonas, 2002, Aquatic Mammals, V28, P275; Teilmann J, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045101; Thompson PM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2001; Thompson PM, 2010, MAR POLLUT BULL, V60, P1200, DOI 10.1016/j.marpolbul.2010.03.030; Todd VLG, 2009, ICES J MAR SCI, V66, P734, DOI 10.1093/icesjms/fsp035; Tougaard J, 2009, J ACOUST SOC AM, V126, P11, DOI 10.1121/1.3132523; Tyack PL, 2002, MARINE MAMMAL BIOLOGY: AN EVOLUTIONARY APPROACH, P142; Verfuss UK, 2009, J EXP BIOL, V212, P823, DOI 10.1242/jeb.022137; Villadsgaard A, 2007, J EXP BIOL, V210, P56, DOI 10.1242/jeb.02618; Waring G. T., 2015, 231 NOAA NMFS NE; Weilgart LS, 2007, CAN J ZOOL, V85, P1091, DOI 10.1139/Z07-101; WESTGATE AJ, 1995, CAN J FISH AQUAT SCI, V52, P1064, DOI 10.1139/f95-104; Williamson LD, 2016, METHODS ECOL EVOL, V7, P762, DOI 10.1111/2041-210X.12538; Wisniewska DM, 2016, CURR BIOL, V26, P1441, DOI 10.1016/j.cub.2016.03.069; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Xu Y, 2011, CONT SHELF RES	88	19	19	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176653	10.1371/journal.pone.0176653	http://dx.doi.org/10.1371/journal.pone.0176653			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467455	gold, Green Submitted, Green Published			2022-12-26	WOS:000400647000065
J	Obel, KB; Ntumba, KJM; Kalambayi, KP; Zalagile, AP; Kinkodi, KD; Munogolo, KZ				Obel, Kabengele Benoit; Ntumba, Kayembe Jean Marie; Kalambayi, Kayembe Patrick; Zalagile, Akilimali Pierre; Kinkodi, Kaba Didine; Munogolo, Kashongwe Zacharie			Prevalence and determinants of asthma in adults in Kinshasa	PLOS ONE			English	Article							SELF-REPORTED ASTHMA; CHILDHOOD ISAAC; GLOBAL BURDEN; URBAN; RATIONALE; ALLERGIES; CHILDREN; BIOMASS; IMPACT; INDIA	Background Epidemiological data on asthma among adults in sub-Saharan Africa are sparse. Objective To determine the prevalence of and factors associated with asthma among adults in Kinshasa. Methods A previously validated asthma questionnaire was administered to an adult population aged >= 18 years in urban and peri-urban suburbs of Kinshasa. A random stratified multi-stage sampling plan was used to select the study participants. Logistic regression was used to identify factors associated with asthma. Results The mean age of respondents was 36.7 (SD 15.36) years, 75% lived in an urban environment, and 57% were women. The prevalence of asthma-ever was 6.9% (95% CI: 5.4-8.4). Among asthmatic patients, intermittent asthma was estimated at 75.7% and severe asthma at 9.3%. Family atopy (OR: 3.97; 95% CI: 2.42-6.50; p<0.001), and the presence of a cat in the house (OR: 1.82; 95% CI: 1.01-3.28; p = 0.045) were associated with self-reported asthma. Conclusion Asthma is relatively frequent in adults in Kinshasa, a prevalence similar to those reported elsewhere in Africa. Family atopy and the presence of a cat in the house could be the most common determinants to be confirmed with national survey in order to design guidelines for the control of asthma.	[Obel, Kabengele Benoit; Ntumba, Kayembe Jean Marie; Munogolo, Kashongwe Zacharie] Univ Kinshasa, Dept Internal Med, Kinshasa, DEM REP CONGO; [Kalambayi, Kayembe Patrick; Zalagile, Akilimali Pierre; Kinkodi, Kaba Didine] Univ Kinshasa, Kinshasa Sch Publ Hlth, Kinshasa, DEM REP CONGO	Universite de Kinshasa; Universite de Kinshasa	Obel, KB (corresponding author), Univ Kinshasa, Dept Internal Med, Kinshasa, DEM REP CONGO.	benobel@yahoo.fr	Akilimali, Pierre Z/D-2564-2018	Akilimali, Pierre Z/0000-0002-3828-6214				Adeloye D, 2013, CROAT MED J, V54, P519, DOI 10.3325/cmj.2013.54.519; Agrawal S, 2012, J ASTHMA, V49, P355, DOI 10.3109/02770903.2012.663030; Anandan C, 2010, ALLERGY, V65, P152, DOI 10.1111/j.1398-9995.2009.02244.x; Annesi-Maesano I., 2012, EDITION MED COM, P17; Asher MI, 1998, EUR RESPIR J, V12, P315; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Awotedu AA, 2012, TETFUND, P5; Barnes PJ, 2012, FLAMMARION, P2102; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Beasley R, 2003, PEDIATR CLIN N AM, V50, P539, DOI 10.1016/S0031-3955(03)00050-6; Bousquet J, 2010, J ALLERGY CLIN IMMUN, V126, P926, DOI 10.1016/j.jaci.2010.07.019; Bouzignon E, 2012, EDITION MED COM, P49; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; Chan KY, 2012, J GLOB HEALTH, V2, P20101, DOI DOI 10.7189/J0GH.02.020101; Cruz AA, 2010, EUR RESPIR J, V35, P239, DOI 10.1183/09031936.00070309; da Cunha SS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-205; Delmas MC, 2008, ANAL DONNES ENQUETE; Ekici A, 2012, J ASTHMA, V49, P522, DOI 10.3109/02770903.2012.677893; Ellwood P, 2005, INT J TUBERC LUNG D, V9, P10; Ellwood P, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01605-2016; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Haahtela T, 2001, LANCET, V56, P805; Janson C, 2001, EUR RESPIR J, V18, P598, DOI 10.1183/09031936.01.00205801; Jie Y, REV LIT; Jie Y, 2013, REV ENVIRON CONTAM T, V226, P33, DOI 10.1007/978-1-4614-6898-1_2; Kayembe JM, 2012, ASTHMA AFRICA, P45; Lajoie P, 2003, ENV SANTE PUBLIQUE F, P713; Laprise C, 2011, CURR OPIN ALLERGY CL, V11, P391, DOI 10.1097/ACI.0b013e32834ae37e; Le Moual Nicole, 2013, Presse Med, V42, pe317, DOI 10.1016/j.lpm.2013.06.010; Leaderer BP, 2002, ENVIRON HEALTH PERSP, V110, P419, DOI 10.1289/ehp.02110419; Lemanske RF, 2010, J ALLERGY CLIN IMMUN, V125, pS95, DOI 10.1016/j.jaci.2009.10.047; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Lundback B, 2016, EXPERT REV RESP MED, V10, P39, DOI 10.1586/17476348.2016.1114417; Martinez FD, 2013, LANCET, V382, P1360, DOI 10.1016/S0140-6736(13)61536-6; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Mugusi F, 2004, TROP DOCT, V34, P209, DOI 10.1177/004947550403400408; Nikasinovic L, 2012, EDITION MED COM, P25; Nyembue TD, 2012, INT FORUM ALLERGY RH, V2, P285, DOI 10.1002/alr.21017; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Obaseki DO, 2014, RESP MED, V108, P1581, DOI 10.1016/j.rmed.2014.09.022; Patel PP, 2008, ENV HLTH, V7, P57; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; Pefura-Yone EW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123099; Platts-Mills TAE, 2005, ALLERGY, V60, P25, DOI 10.1111/j.1398-9995.2005.00854.x; Pongracic Jacqueline Ann, 2010, Adolesc Med State Art Rev, V21, P34; Sembajwe G, 2010, EUR RESPIR J, V35, P279, DOI 10.1183/09031936.00027509; The International Union against Tuberculosis and Lung Disease, 2011, GLOB ASTHM REP 2011; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; Trevor J, 2014, J ASTHMA, V51, P136, DOI 10.3109/02770903.2013.849269; van Gemert F, 2011, PRIM CARE RESP J, V20, P240, DOI 10.4104/pcrj.2011.00027; van Schayck CP, 2005, EUR RESPIR J, V26, P647, DOI 10.1183/09031936.05.00019805; VANNIEKERK CH, 1979, CLIN ALLERGY, V9, P319; Wjst M, 2007, PLOS MED, V4, P203, DOI 10.1371/journal.pmed.0040072	54	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176875	10.1371/journal.pone.0176875	http://dx.doi.org/10.1371/journal.pone.0176875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28464036	Green Published, gold, Green Submitted			2022-12-26	WOS:000400646300062
J	Catarino, D; Stefanni, S; Jorde, PE; Menezes, GM; Company, JB; Neat, F; Knutsen, H				Catarino, Diana; Stefanni, Sergio; Jorde, Per Erik; Menezes, Gui M.; Company, Joan B.; Neat, Francis; Knutsen, Halvor			The role of the Strait of Gibraltar in shaping the genetic structure of the Mediterranean Grenadier, Coryphaenoides mediterraneus, between the Atlantic and Mediterranean Sea	PLOS ONE			English	Article							APPROXIMATE BAYESIAN COMPUTATION; FALSE DISCOVERY RATE; POPULATION-STRUCTURE; NORTH-ATLANTIC; DEMERSAL FISH; GADIFORMES MACROURIDAE; SEQUENCE ALIGNMENT; COMPUTER-PROGRAM; DNA-SEQUENCE; LARVAL FISH	Population genetic studies of species inhabiting the deepest parts of the oceans are still scarce and only until recently we started to understand how oceanographic processes and topography affect dispersal and gene flow patterns. The aim of this study was to investigate the spatial population genetic structure of the bathyal bony fish Coryphaenoides mediterraneus, with a focus on the Atlantic-Mediterranean transition. We used nine nuclear microsatellites and the mitochondrial cytochrome c oxidase I gene from 6 different sampling areas. No population genetic structure was found within Mediterranean with both marker types (mean phi(ST) = 0.0960, F-ST = -0.0003, for both P > 0.05). However, within the Atlantic a contrasting pattern of genetic structure was found for the mtDNA and nuclear markers (mean phi(ST) = 0.2479, P < 0.001; F-ST = -0.0001, P > 0.05). When comparing samples from Atlantic and Mediterranean they exhibited high and significant levels of genetic divergence (mean phi(ST) = 0.7171, F-ST = 0.0245, for both P < 0.001) regardless the genetic marker used. Furthermore, no shared haplotypes were found between Atlantic and Mediterranean populations. These results suggest very limited genetic exchange between Atlantic and Mediterranean populations of C. mediterraneus, likely due to the shallow bathymetry of the Strait of Gibraltar acting as a barrier to gene flow. This physical barrier not only prevents the direct interactions between the deep-living adults, but also must prevent interchange of pelagic early life stages between the two basins. According to Bayesian simulations it is likely that Atlantic and Mediterranean populations of C. mediterraneus were separated during the late Pleistocene, which is congruent with results for other deep-sea fish from the same region.	[Catarino, Diana; Menezes, Gui M.] Univ Azores, MARE Marine & Environm Sci Ctr, Dept Oceanog & Fisheries, Horta, Azores, Portugal; [Catarino, Diana; Menezes, Gui M.] Univ Azores, Dept Oceanog & Fisheries, Horta, Azores, Portugal; [Stefanni, Sergio] Stazione Zool A Dohrn, Villa Comunale, Naples, Italy; [Jorde, Per Erik; Knutsen, Halvor] Univ Oslo, CEES, Dept Biosci, Oslo, Norway; [Company, Joan B.] CSIC, ICM, Barcelona, Spain; [Neat, Francis] Marine Scotland Sci, Marine Lab, Aberdeen, Scotland; [Knutsen, Halvor] Inst Marine Res, Flodevigen, Norway; [Knutsen, Halvor] Univ Agder, Ctr Coastal Res, Kristiansand, Norway	Universidade dos Acores; Universidade dos Acores; University of Oslo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Marine Scotland Science (MSS); Institute of Marine Research - Norway; University of Agder	Catarino, D (corresponding author), Univ Azores, MARE Marine & Environm Sci Ctr, Dept Oceanog & Fisheries, Horta, Azores, Portugal.; Catarino, D (corresponding author), Univ Azores, Dept Oceanog & Fisheries, Horta, Azores, Portugal.; Knutsen, H (corresponding author), Univ Oslo, CEES, Dept Biosci, Oslo, Norway.; Knutsen, H (corresponding author), Inst Marine Res, Flodevigen, Norway.; Knutsen, H (corresponding author), Univ Agder, Ctr Coastal Res, Kristiansand, Norway.	dscatarino@gmail.com; halvor.knutsen@imr.no	Catarino, Diana/AAJ-3193-2021; Knutsen, Halvor/A-4261-2009; Menezes, Gui M./A-3956-2009	Catarino, Diana/0000-0003-0635-6174; Knutsen, Halvor/0000-0002-7627-7634; Menezes, Gui M./0000-0003-0781-4579; Stefanni, Sergio/0000-0001-9477-0062; Jorde, Per Erik/0000-0001-5515-7257	ReDEco "Regional Drivers of Ecosystem Change and its Influence on Deep-Sea Populations in the Mediterranean" (FP6 ERA-NET) [MARIN-ERA/MAR/0003/2008]; Fundacao para a Ciencia e Tecnologia (FCT) [UID/MAR/04292/2013]; DC [SFRH/BD/65730/2009]; University of Agder	ReDEco "Regional Drivers of Ecosystem Change and its Influence on Deep-Sea Populations in the Mediterranean" (FP6 ERA-NET); Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); DC; University of Agder	This study was performed under the framework of ReDEco "Regional Drivers of Ecosystem Change and its Influence on Deep-Sea Populations in the Mediterranean" (FP6 ERA-NET, MARIN-ERA/MAR/0003/2008). This study had the support of Fundacao para a Ciencia e Tecnologia (FCT), through the strategic project UID/MAR/04292/2013 granted to MARE and the grant awarded to DC (SFRH/BD/65730/2009). HK is funded by the University of Agder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboim MA, 2005, MOL ECOL, V14, P1343, DOI 10.1111/j.1365-294X.2005.02518.x; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Astraldi M, 1999, PROG OCEANOGR, V44, P65, DOI 10.1016/S0079-6611(99)00021-X; Azzaro F, 2007, OCEAN SCI, V3, P451, DOI 10.5194/os-3-451-2007; Ball AO, 2000, MAR BIOL, V137, P1077, DOI 10.1007/s002270000392; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bargelloni L, 2005, MOL PHYLOGENET EVOL, V36, P523, DOI 10.1016/j.ympev.2005.04.017; Beaumont MA, 2002, GENETICS, V162, P2025; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergstad OA, 2008, DEEP-SEA RES PT II, V55, P185, DOI 10.1016/j.dsr2.2007.09.005; Bergstad OA, 2013, J FISH BIOL, V83, P1489, DOI 10.1111/jfb.12208; BERGSTAD OA, 1994, SARSIA, V79, P33; BIRKY CW, 1983, GENETICS, V103, P513; Busby MS, 2005, ICHTHYOL RES, V52, P86, DOI 10.1007/s10228-004-0255-1; Campbell N, 2011, ICES J MAR SCI, V68, P365, DOI 10.1093/icesjms/fsq070; Carpenter KE, 2002, LIVING MARINE RESOUR, V2; Carrasson M, 2002, MAR ECOL PROG SER, V234, P215, DOI 10.3354/meps234215; Catarino D, 2015, MOL ECOL, V24, P6061, DOI 10.1111/mec.13453; Charrier G, 2006, MOL PHYLOGENET EVOL, V38, P742, DOI 10.1016/j.ympev.2005.08.002; Clarke K.R., 2006, PRIMER V6 USER MANUA; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Cronin M, 1998, MAR ENVIRON RES, V45, P225, DOI 10.1016/S0141-1136(98)00024-5; Cuttitta A, 2004, HYDROBIOLOGIA, V527, P177, DOI 10.1023/B:HYDR.0000043299.65829.2f; D'Onghia G, 2004, SCI MAR, V68, P171, DOI 10.3989/scimar.2004.68s3171; Debes PV, 2008, MOL ECOL, V17, P3873, DOI 10.1111/j.1365-294X.2008.03872.x; Depaulis F, 2003, J MOL EVOL, V57, pS190, DOI 10.1007/s00239-003-0027-y; Emig C. C., 2004, CARNETS GEOL, V2004, P1, DOI DOI 10.4267/2042/3230; ENDO H, 1993, JPN J ICHTHYOL, V40, P219; Endo H, 2010, ICHTHYOL RES, V57, P272, DOI 10.1007/s10228-010-0164-4; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falkenhaug T, 2007, CM2007F07 ICES; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Fu YX, 1997, GENETICS, V147, P915; Fukui A, 2008, ICHTHYOL RES, V55, P284, DOI 10.1007/s10228-007-0024-z; Fukui A, 2010, ICHTHYOL RES, V57, P169, DOI 10.1007/s10228-009-0144-8; Gaither MR, 2016, MOL PHYLOGENET EVOL, V104, P73, DOI 10.1016/j.ympev.2016.07.027; Galarza JA, 2009, P NATL ACAD SCI USA, V106, P1473, DOI 10.1073/pnas.0806804106; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Goudet, 1999, PCA GEN VERSION 1 2; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Helyar S, 2010, CONSERV GENET RESOUR, V2, P1, DOI 10.1007/s12686-009-9049-0; Garcia-Merchan VH, 2012, MOL PHYLOGENET EVOL, V62, P664, DOI 10.1016/j.ympev.2011.11.009; Isari S, 2008, ESTUAR COAST SHELF S, V79, P607, DOI 10.1016/j.ecss.2008.06.001; Jones EG, 2003, MAR ECOL PROG SER, V251, P75, DOI 10.3354/meps251075; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Kellermanns E, 2009, ACTA PARASITOL, V54, P158, DOI 10.2478/s11686-009-0017-3; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knutsen H, 2008, MOL ECOL RESOUR, V8, P993, DOI 10.1111/j.1755-0998.2008.02132.x; Knutsen H, 2007, CAN J FISH AQUAT SCI, V64, P857, DOI 10.1139/F07-070; Knutsen H, 2012, MAR ECOL PROG SER, V460, P233, DOI 10.3354/meps09728; Knutsen H, 2009, MOL ECOL, V18, P3151, DOI 10.1111/j.1365-294X.2009.04253.x; Kukla G, 2005, QUATERNARY SCI REV, V24, P1573, DOI 10.1016/j.quascirev.2004.08.023; Lin HY, 2012, DEEP-SEA RES PT I, V61, P123, DOI 10.1016/j.dsr.2011.12.005; Longmore C, 2011, MAR ECOL PROG SER, V435, P209, DOI 10.3354/meps09197; Longmore C, 2014, CAN J FISH AQUAT SCI, V71, P1312, DOI 10.1139/cjfas-2013-0343; Lorance P, 2008, AM FISH S S, V63, P365; Marra A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117272; Marshall NB, 1973, FISHES W N ATLANTIC, V1, P496; Massuti E, 2004, SCI MAR, V68, P101, DOI 10.3989/scimar.2004.68s3101; MAUCHLINE J, 1984, MAR BIOL, V81, P107, DOI 10.1007/BF00393109; McClain CR, 2010, P ROY SOC B-BIOL SCI, V277, P3533, DOI 10.1098/rspb.2010.1057; MERRETT NR, 1978, DEEP-SEA RES, V25, P147, DOI 10.1016/0146-6291(78)90002-4; MORALES-NIN B, 1990, Scientia Marina, V54, P241; Naciri M, 1999, J HERED, V90, P591, DOI 10.1093/jhered/90.6.591; Neat F, 2010, DEEP-SEA RES PT I, V57, P434, DOI 10.1016/j.dsr.2009.12.003; NEI M, 1983, ANN HUM GENET, V47, P253, DOI 10.1111/j.1469-1809.1983.tb00993.x; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perez-Losada M, 2002, HEREDITY, V89, P417, DOI 10.1038/sj.hdy.6800160; Pineda J, 2007, OCEANOGRAPHY, V20, P22, DOI 10.5670/oceanog.2007.27; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Quere N, 2012, ECOL EVOL, V2, P3061, DOI 10.1002/ece3.406; QUESADA H, 1995, MOL BIOL EVOL, V12, P521; R Core Team, 2021, R LANGUAGE ENV STAT; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Read JF, 2010, DEEP-SEA RES PT I, V57, P307, DOI 10.1016/j.dsr.2009.11.010; Ritchie H, 2013, DEEP-SEA RES PT II, V98, P431, DOI 10.1016/j.dsr2.2013.06.014; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; Sala-Bozano M, 2009, MOL ECOL, V18, P4811, DOI 10.1111/j.1365-294X.2009.04404.x; Schneider M, 2009, CONSERV GENET, V10, P1869, DOI 10.1007/s10592-009-9838-8; Schunter C, 2011, MOL ECOL, V20, P5167, DOI 10.1111/j.1365-294X.2011.05355.x; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Serra IA, 2010, MOL ECOL, V19, P557, DOI 10.1111/j.1365-294X.2009.04462.x; Sobrino I., 2012, J ICHTHYOL+, V52, P690, DOI DOI 10.1134/S0032945212100128; Soiland H, 2008, DEEP-SEA RES PT II, V55, P29, DOI 10.1016/j.dsr2.2007.09.015; Somarakis S, 2002, J PLANKTON RES, V24, P339, DOI 10.1093/plankt/24.4.339; STEFANESCU C, 1992, MAR ECOL PROG SER, V81, P205, DOI 10.3354/meps081205; STEFANESCU C, 1992, J NAT HIST, V26, P197, DOI 10.1080/00222939200770081; STEIN DL, 1980, DEEP-SEA RES, V27, P889, DOI 10.1016/0198-0149(80)90002-3; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tecchio S, 2011, MAR ECOL PROG SER, V439, P181, DOI 10.3354/meps09333; Teixeira S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038521; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TINTORE J, 1988, J PHYS OCEANOGR, V18, P1384, DOI 10.1175/1520-0485(1988)018<1384:ASOAID>2.0.CO;2; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vecchione Michael, 2010, P103, DOI 10.1002/9781444325508.ch6; Verissimo A, 2012, MAR FRESHWATER RES, V63, P505, DOI 10.1071/MF11237; Fernandez MV, 2011, MAR ECOL PROG SER, V421, P163, DOI 10.3354/meps08881; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White TA, 2011, HEREDITY, V106, P690, DOI 10.1038/hdy.2010.108; White TA, 2011, MAR ECOL PROG SER, V434, P155, DOI 10.3354/meps09207; White TA, 2010, MOL ECOL, V19, P216, DOI 10.1111/j.1365-294X.2009.04446.x; White TA, 2009, MOL ECOL, V18, P2563, DOI 10.1111/j.1365-294X.2009.04218.x; Zitari-Chatti R, 2009, GENETICA, V136, P439, DOI 10.1007/s10709-008-9344-9	114	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0174988	10.1371/journal.pone.0174988	http://dx.doi.org/10.1371/journal.pone.0174988			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459855	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000400645000002
J	McBrien, KA; Naugler, C; Ivers, N; Weaver, RG; Campbell, D; Desveaux, L; Hemmelgarn, BR; Edwards, AL; Saad, N; Nicholas, D; Manns, BJ				McBrien, Kerry A.; Naugler, Christopher; Ivers, Noah; Weaver, Robert G.; Campbell, David; Desveaux, Laura; Hemmelgarn, Brenda R.; Edwards, Alun L.; Saad, Nathalie; Nicholas, David; Manns, Braden J.			Barriers to care in patients with diabetes and poor glycemic control-A cross-sectional survey	PLOS ONE			English	Article							CHRONIC RENAL-INSUFFICIENCY; MEDICATION ADHERENCE; CANADIAN PATIENTS; TREATMENT GAPS; LOW-INCOME; TYPE-2; MELLITUS; OUTCOMES; METAANALYSIS; IMPROVEMENT	Aims To determine and quantify the prevalence of patient, provider and system level barriers to achieving diabetes care goals; and to examine whether barriers were different for people with poor glycemic control (HbA1c >= 10%; 86 mmol/mol) compared to fair glycemic control (7 to <8%; 53-64 mmol/mol). Methods We administered a survey by telephone to community-dwelling patients with diabetes, to examine patient-reported barriers and facilitators to care. We compared responses in individuals with HbA1c >= 10% (86 mmol/mol) against those with HbA1c between 7-8% (53-64 mmol/mol). We examined associations between HbA1c group and barriers to care, adjusting for sociodemographic factors and diabetes duration. Results The survey included 805 people with HbA1c >= 10% (86 mmol/mol), and 405 people with HbA1c 7-8% (53-64 mmol/mol). Participants with HbA1c >= 10% (86 mmol/mol) reported good access to care, however 20% of participants with HbA1c >= 10% (86 mmol/mol) felt that their care was not well-coordinated and 9.6% reported having an unmet health care need. In adjusted analysis, patients with HbA1c >= 10% (86 mmol/mol) were more likely to report lack of confidence and inadequate social support, compared to patients with HbA1c 7-8% (53-64 mmol/mol). They were also significantly more likely not to have drug insurance nor to have received recommended treatments because of cost. Conclusions These results reinforce the importance of an individualized, yet multi-faceted approach. Specific attention to financial barriers seems warranted. These findings can inform the development of programs and initiatives to overcome barriers to care, and improve diabetes care and outcomes.	[McBrien, Kerry A.] Univ Calgary, Cumming Sch Med, Dept Family Med, Calgary, AB, Canada; [McBrien, Kerry A.; Hemmelgarn, Brenda R.; Manns, Braden J.] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada; [Naugler, Christopher] Univ Calgary, Cumming Sch Med, Dept Pathol & Lab Med, Calgary, AB, Canada; [Naugler, Christopher] Calgary Lab Serv, Calgary, AB, Canada; [Ivers, Noah] Univ Toronto, Fac Med, Dept Family & Community Med, Toronto, ON, Canada; [Ivers, Noah; Desveaux, Laura] Womens Coll Hosp, Toronto, ON, Canada; [Weaver, Robert G.; Campbell, David; Hemmelgarn, Brenda R.; Edwards, Alun L.; Saad, Nathalie; Manns, Braden J.] Univ Calgary, Cumming Sch Med, Dept Med, Calgary, AB, Canada; [Edwards, Alun L.] Alberta Hlth Serv, Diabet Obes & Nutr Strateg Clin Network, Edmonton, AB, Canada; [Nicholas, David] Univ Calgary, Fac Social Work, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Calgary; Alberta Health Services (AHS); University of Calgary	McBrien, KA (corresponding author), Univ Calgary, Cumming Sch Med, Dept Family Med, Calgary, AB, Canada.; McBrien, KA (corresponding author), Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada.	kamcbrie@ucalgary.ca	; Ivers, Noah/O-7643-2018	Weaver, Robert G/0000-0002-8403-857X; Ivers, Noah/0000-0003-2500-2435	Canadian Diabetes Association; Alberta Innovates - Health Solutions (AI-HS); Alberta Innovates [201300672, 201400589] Funding Source: researchfish	Canadian Diabetes Association; Alberta Innovates - Health Solutions (AI-HS); Alberta Innovates	This study was funded by a Canadian Diabetes Association operating grant and by an Alberta Innovates - Health Solutions (AI-HS) team grant to the Inter disciplinary Chronic Disease Collaboration (ICDC). The funders were not involved in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aday LA, 2006, DESIGNING CONDUCTING; Bailey GR, 2012, DIABETES EDUCATOR, V38, P271, DOI 10.1177/0145721711436134; Barriers to Care for People with Chronic Health Conditions (BCPCHC) Survey, 2013, BARR CAR PEOPL CHRON; Bohlen K, 2012, DIABETES CARE, V35, P47, DOI 10.2337/dc11-1082; Bresee LC, 2011, ALBERTA DIABETES ATL, P163; Campbell DJT, 2014, HEALTH REP, V25, P3; Chan J, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/903468; Coulter A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010523.pub2; Daly JM, 2009, J AM BOARD FAM MED, V22, P280, DOI 10.3122/jabfm.2009.03.080114; Ferlie EB, 2001, MILBANK Q, V79, P281, DOI 10.1111/1468-0009.00206; Freeman Harold P, 2013, Semin Oncol Nurs, V29, P72, DOI 10.1016/j.soncn.2013.02.002; Heerman WJ, 2016, DIABETIC MED, V33, P844, DOI 10.1111/dme.12896; Lerman I, 2009, ENDOCR PRACT, V15, P41, DOI 10.4158/EP.15.1.41; Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154; Manns BJ, 2012, CAN MED ASSOC J, V184, pE144, DOI 10.1503/cmaj.110755; Mayberry LS, 2012, DIABETES CARE, V35, P1239, DOI 10.2337/dc11-2103; Mayer VL, 2016, PUBLIC HEALTH NUTR, V19, P1103, DOI 10.1017/S1368980015002323; McAlister FA, 2007, QUAL SAF HEALTH CARE, V16, P6, DOI 10.1136/qshc.2006.018648; McBrien KA, 2012, DIABETES CARE; Papelbaum M, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-26; Paskett ED, 2011, CA-CANCER J CLIN, V61, P237, DOI 10.3322/caac.20111; Patel MR, 2016, MED CARE; Public Health Agency of Canada, 2011, DIAB CAN FACTS FIG P; Public Health Agency of Canada-Centre for Chronic Disease Prevention and Control, 2009, REP NAT DIAB SURV SY; Rosland AM, 2010, CHRONIC ILLN, V6, P22, DOI 10.1177/1742395309354608; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; Shah BR, 2007, DIABETES CARE, V30, P381, DOI 10.2337/dc06-1654; Sirois C, 2007, DIABETES CARE, V30, P1880, DOI 10.2337/dc06-2257; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Supina AL, 2004, CLIN THER, V26, P598, DOI 10.1016/S0149-2918(04)90062-8; Tamir O, 2012, DIABETES-METAB RES, V28, P246, DOI 10.1002/dmrr.1300; Tang KL, 2014, CAN MED ASSOC J, V186, P276, DOI 10.1503/cmaj.121637; Tonelli M, 2002, NEPHROL DIAL TRANSPL, V17, P1426, DOI 10.1093/ndt/17.8.1426; Tonelli M, 2001, AM J KIDNEY DIS, V37, P484, DOI 10.1053/ajkd.2001.22070; Toth EL, 2003, PHARMACOTHERAPY, V23, P659, DOI 10.1592/phco.23.5.659.32203; Tricco AC, 2012, LANCET, V379, P2252, DOI 10.1016/S0140-6736(12)60480-2; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	37	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176135	10.1371/journal.pone.0176135	http://dx.doi.org/10.1371/journal.pone.0176135			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459820	Green Published, Green Submitted, gold			2022-12-26	WOS:000400645000016
J	Ortiz, M; Levins, R				Ortiz, Marco; Levins, Richard			Self-feedbacks determine the sustainability of human interventions in eco-social complex systems: Impacts on biodiversity and ecosystem health	PLOS ONE			English	Article							FISHERIES MANAGEMENT; NORTHERN CHILE; PACIFIC COAST; MARINE; COMANAGEMENT; CONSERVATION; LAMINARIALES; HARVEST; ISSUES; SCALE	Several administrative polices have been implemented in order to reduce the negative impacts of fishing on natural ecosystems. Four eco-social models with different levels of complexity were constructed, which represent the seaweed harvest in central-northern Chile under two different regimes, Management and Exploitation Areas for Benthic Resources (MAEBRs) and Open Access Areas (OAAs). The dynamics of both regimes were analyzed using the following theoretical frameworks: (1) Loop Analysis, which allows the local stability or sustainability of the models and scenarios to be assessed; and (2) Hessian A s optimization procedure of a global fishery function (GFF) that represents each dynamics of each harvest. The results suggest that the current fishing dynamics in MAEBRs are not sustainable unless the market demand presents some type of control (i. e. taxes). Further, the results indicated that if the demand changes to a self-negative feedback (selfcontrol) in MAEBRs, the stability is increased and, simultaneously, a relative maximum for the GFF is reached. Contrarily, the sustainability of the model/system representing the harvest (principally by cutting plants) in OAAs is not reached. The implementation of an "ecological" tax for intensive artisanal fisheries with low operational cost is proposed. The network analysis developed here is proposed as a general strategy for studying the effects of human interventions in marine coastal ecosystems under transient (short-term) dynamics.	[Ortiz, Marco] Univ Antofagasta, Inst Ciencias Nat AvH, Inst Antofagasta, Casilla, Chile; [Levins, Richard] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave, Boston, MA 02115 USA	Universidad de Antofagasta; Harvard University; Harvard T.H. Chan School of Public Health	Ortiz, M (corresponding author), Univ Antofagasta, Inst Ciencias Nat AvH, Inst Antofagasta, Casilla, Chile.	marco.ortiz@uantof.cl						Agardy T, 2005, MAR ECOL PROG SER, V300, P242; Agardy T, 2003, AQUAT CONSERV, V13, P353, DOI 10.1002/aqc.583; Agliardi E, 1998, POSITIVE FEEDBACKS E; Vega JMA, 2014, J APPL PHYCOL, V26, P791, DOI 10.1007/s10811-013-0167-4; Bodini A, 2000, ENVIRON MANAGE, V26, P59, DOI 10.1007/s002670010071; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; Francis RC, 2007, FISHERIES, V32, P217, DOI 10.1577/1548-8446(2007)32[217:TCFBFS]2.0.CO;2; Frangoudes K, 2011, CAH BIOL MAR, V52, P517; Gelcich S, 2005, CONSERV BIOL, V19, P865, DOI 10.1111/j.1523-1739.2005.00534.x; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Gonzalez J, 2016, ECOL INDIC, V69, P390, DOI 10.1016/j.ecolind.2016.04.019; GOTTFRIED BS, 1973, INTRO OPTIMIZATION T; Guillen J, 2013, MAR POLICY, V40, P64, DOI 10.1016/j.marpol.2012.12.029; Hawkins SJ, 2004, AQUAT CONSERV, V14, P217, DOI 10.1002/aqc.637; IFOP, 2016, B EXP PESQ AC CHIL; Jentoft S, 1998, MAR POLICY, V22, P423, DOI 10.1016/S0308-597X(97)00040-7; Kompas T., 2005, Australian Commodities, V12, P152; LEVINS R, 1993, Q REV BIOL, V68, P547, DOI 10.1086/418302; LEVINS R, 1974, ANN NY ACAD SCI, V231, P123, DOI 10.1111/j.1749-6632.1974.tb20562.x; Levins R., 1966, PRINCETON MONOGRAPHS; Levins R., 1998, ECOSYSTEM HLTH EDITE, P178; LEVINS R, 1998, SCI CULTURE, V7, P557, DOI DOI 10.1080/09505439809526525; LEWONTIN R, 1998, CAPITALISM NATURE SO, V9, P85; LEWONTIN Richard, 2007, BIOL INFLUENCE DIALE; McCay BJ, 1996, SOC NATUR RESOUR, V9, P237, DOI 10.1080/08941929609380969; Ortiz M, 2003, AQUACULTURE, V220, P423, DOI 10.1016/S0044-8486(02)00580-X; Ortiz M, 2011, OIKOS, V120, P1402, DOI 10.1111/j.1600-0706.2011.19041.x; Scotti M, 2007, ECOL COMPLEX, V4, P148, DOI 10.1016/j.ecocom.2007.05.002; SERNAPESCA, 2014, DES ART AN EST PESC; Thrush SF, 2002, ANNU REV ECOL SYST, V33, P449, DOI 10.1146/annurev.ecolsys.33.010802.150515; Vasquez J.A., 1992, COASTAL PLANT COMMUN, P77, DOI 10.1016/b978-0-08-092567-7.50011-8; VASQUEZ JA, 1993, HYDROBIOLOGIA, V261, P313; Vasquez JA, 2012, J APPL PHYCOL, V24, P417, DOI 10.1007/s10811-012-9794-4; Vasquez J, 2008, J APPL PHYCOL, V20, P457, DOI 10.1007/s10811-007-9308-y; Zanetell BA, 2004, WORLD DEV, V32, P793, DOI 10.1016/j.worlddev.2004.01.002	35	23	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176163	10.1371/journal.pone.0176163	http://dx.doi.org/10.1371/journal.pone.0176163			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET6EO	28453548	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383900015
J	Serfass, JM; Takahashi, Y; Zhou, ZX; Kawasawa, YI; Liu, Y; Tsotakos, N; Young, MM; Tang, ZY; Yang, LL; Atkinson, JM; Chroneos, ZC; Wang, HG				Serfass, Jacob M.; Takahashi, Yoshinori; Zhou, Zhixiang; Kawasawa, Yuka Imamura; Liu, Ying; Tsotakos, Nikolaos; Young, Megan M.; Tang, Zhenyuan; Yang, Linlin; Atkinson, Jennifer M.; Chroneos, Zissis C.; Wang, Hong-Gang			Endophilin B2 facilitates endosome maturation in response to growth factor stimulation, autophagy induction, and influenza A virus infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERACTING FACTOR-I; CONFORMATIONAL-CHANGE; DECREASED EXPRESSION; BIF-1; PROTEIN; B1; ENDOCYTOSIS; TRAFFICKING; ACTIVATION; MACHINERY	Endocytosis, and the subsequent trafficking of endosomes, requires dynamic physical alterations in membrane shape that are mediated in part by endophilin proteins. The endophilin B family of proteins contains an N-terminal Bin/amphiphysin/Rvs (N-BAR) domain that induces membrane curvature to regulate intracellular membrane dynamics. Whereas endophilin B1 (SH3GLB1/Bif-1) is known to be involved in a number of cellular processes, including apoptosis, autophagy, and endocytosis, the cellular function of endophilin B2 (SH3GLB2) is not well understood. In this study, we used genetic approaches that revealed that endophilin B2 is not required for embryonic development in vivo but that endophilin B2 deficiency impairs endosomal trafficking in vitro, as evidenced by suppressed endosome acidification, EGFR degradation, autophagic flux, and influenza A viral RNA nuclear entry and replication. Mechanistically, although the loss of endophilin B2 did not affect endocytic internalization and lysosomal function, endophilin B2 appeared to regulate the trafficking of endocytic vesicles and autophago-somes to late endosomes or lysosomes. Moreover, we also found that despite having an intracellular localization and tissue distribution similar to endophilin B1, endophilin B2 is dispensable for mitochondrial apoptosis. Taken together, our findings suggest that endophilin B2 positively regulates the endocytic pathway in response to growth factor signaling, autophagy induction, and viral entry.	[Serfass, Jacob M.; Kawasawa, Yuka Imamura; Liu, Ying; Wang, Hong-Gang] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Takahashi, Yoshinori; Zhou, Zhixiang; Tsotakos, Nikolaos; Young, Megan M.; Tang, Zhenyuan; Yang, Linlin; Atkinson, Jennifer M.; Chroneos, Zissis C.; Wang, Hong-Gang] Penn State Univ, Coll Med, Dept Pediat, Hershey, PA 17033 USA; [Kawasawa, Yuka Imamura] Penn State Univ, Coll Med, Inst Personalized Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Chroneos, Zissis C.] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA; [Zhou, Zhixiang] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100124, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Beijing University of Technology	Wang, HG (corresponding author), Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA.; Takahashi, Y; Wang, HG (corresponding author), Penn State Univ, Coll Med, Dept Pediat, Hershey, PA 17033 USA.	ytakahashi@pennstatehealth.psu.edu; hwang3@pennstatehealth.psu.edu	Atkinson, Jennifer/AAE-5466-2019; Tsotakos, Nikolaos/AAZ-4789-2020	Atkinson, Jennifer/0000-0001-5164-5114; Tsotakos, Nikolaos/0000-0002-1028-3062; Takahashi, Yoshinori/0000-0002-8004-4817; Young, Megan/0000-0003-1751-9979; , Zissis/0000-0002-9841-7917; Serfass, Jacob/0000-0002-5726-5718	National Institutes of Health [CA82197, CA129682, HL128746]; Lois High Berstler Endowment Fund; Four Diamonds Fund of the Pennsylvania State University College of Medicine; Pennsylvania Department of Health using Tobacco Settlement Funds; NATIONAL CANCER INSTITUTE [R01CA082197, R01CA129682] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL128746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lois High Berstler Endowment Fund; Four Diamonds Fund of the Pennsylvania State University College of Medicine; Pennsylvania Department of Health using Tobacco Settlement Funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants CA82197 and CA129682 (to H.G.W.) and HL128746 (to Z.C.) and by the Lois High Berstler Endowment Fund and the Four Diamonds Fund of the Pennsylvania State University College of Medicine. Core facility services and instruments used in this project were funded, in part, under a grant with the Pennsylvania Department of Health using Tobacco Settlement Funds. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ao X, 2014, CELL DEATH DIFFER, V21, P348, DOI 10.1038/cdd.2013.187; Bainbridge MN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-246; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Coppola D, 2008, CANCER-AM CANCER SOC, V113, P2665, DOI 10.1002/cncr.23892; Coppola D, 2008, CLIN GENITOURIN CANC, V6, P117, DOI 10.3816/CGC.2008.n.018; Cuddeback SM, 2001, J BIOL CHEM, V276, P20559, DOI 10.1074/jbc.M101527200; DANIELS RS, 1985, CELL, V40, P431, DOI 10.1016/0092-8674(85)90157-6; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dutta Dipannita, 2012, Cell Logist, V2, P203; Edinger TO, 2014, J GEN VIROL, V95, P263, DOI 10.1099/vir.0.059477-0; Fasso M, 2008, P NATL ACAD SCI USA, V105, P3509, DOI 10.1073/pnas.0712269105; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Hahn DR, 2014, AM J RESP CELL MOL, V51, P400, DOI 10.1165/rcmb.2013-0437OC; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hrabchak C, 2007, BIOCHEMISTRY-US, V46, P4635, DOI 10.1021/bi6025837; Hullin-Matsuda F, 2014, SEMIN CELL DEV BIOL, V31, P48, DOI 10.1016/j.semcdb.2014.04.010; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Hyttinen JMT, 2013, BBA-MOL CELL RES, V1833, P503, DOI 10.1016/j.bbamcr.2012.11.018; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Kerr M, 2014, SEMIN CELL DEV BIOL, V31, P11, DOI 10.1016/j.semcdb.2014.03.027; Kim SY, 2008, PATHOLOGY, V40, P553, DOI 10.1080/00313020802320440; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kjaerulff O, 2011, CELL BIOCHEM BIOPHYS, V60, P137, DOI 10.1007/s12013-010-9137-5; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Lamb CA, 2013, BIOESSAYS, V35, P34, DOI 10.1002/bies.201200130; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lee JW, 2006, PATHOLOGY, V38, P312, DOI 10.1080/00313020600820880; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Liu Y., 2016, EVID-BASED COMPL ALT, V2016, P1, DOI DOI 10.1007/S10291-016-0529-X; Loebrich S, 2016, CURR BIOL, V26, P296, DOI 10.1016/j.cub.2015.11.071; Luzio JP, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016840; MAEDA T, 1980, FEBS LETT, V122, P283, DOI 10.1016/0014-5793(80)80457-1; Mim C, 2012, CELL, V149, P137, DOI 10.1016/j.cell.2012.01.048; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Pierrat B, 2001, GENOMICS, V71, P222, DOI 10.1006/geno.2000.6378; Pinilla-Macua I, 2015, METHOD CELL BIOL, V130, P347, DOI 10.1016/bs.mcb.2015.05.008; Pinon JD, 2008, ONCOGENE, V27, pS41, DOI 10.1038/onc.2009.42; Runkle KB, 2012, CANCER BIOL THER, V13, P956, DOI 10.4161/cbt.20951; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Scott CC, 2014, SEMIN CELL DEV BIOL, V31, P2, DOI 10.1016/j.semcdb.2014.03.034; Sever-Chroneos Z, 2011, ANTIVIR RES, V92, P319, DOI 10.1016/j.antiviral.2011.08.022; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; Styers ML, 2004, MOL BIOL CELL, V15, P5369, DOI 10.1091/mbc.E04-03-0272; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Takahashi Y, 2009, CELL DEATH DIFFER, V16, P947, DOI 10.1038/cdd.2009.19; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Takahashi Y, 2016, ONCOTARGET, V7, P20855, DOI 10.18632/oncotarget.8028; Takahashi Y, 2013, BLOOD, V121, P1622, DOI 10.1182/blood-2012-10-459826; Takahashi Y, 2011, AUTOPHAGY, V7, P61, DOI 10.4161/auto.7.1.14015; Thoresen SB, 2010, EXP CELL RES, V316, P3368, DOI 10.1016/j.yexcr.2010.07.008; Tooze Sharon A, 2015, Methods Mol Biol, V1270, P155, DOI 10.1007/978-1-4939-2309-0_12; Tooze SA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018358; Vannier C, 2013, J BIOL CHEM, V288, P27619, DOI 10.1074/jbc.M113.485482; Wan J, 2008, J NEUROSCI, V28, P9002, DOI 10.1523/JNEUROSCI.0767-08.2008; Wang DB, 2015, BRAIN, V138, P2005, DOI 10.1093/brain/awv128; Wang DB, 2014, J NEUROSCI, V34, P2674, DOI 10.1523/JNEUROSCI.4074-13.2014; Wang YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep25153; WHITE JM, 1987, J CELL BIOL, V105, P2887, DOI 10.1083/jcb.105.6.2887; Wong ASL, 2011, NAT CELL BIOL, V13, P568, DOI 10.1038/ncb2217; Wu W, 2016, VIROLOGY, V497, P41, DOI 10.1016/j.virol.2016.06.021; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; YOSHIMURA A, 1984, J VIROL, V51, P497, DOI 10.1128/JVI.51.2.497-504.1984; Young MM, 2012, J BIOL CHEM, V287, P12455, DOI 10.1074/jbc.M111.309104; Zhang CL, 2011, J BIOL CHEM, V286, P9373, DOI 10.1074/jbc.M110.207720	67	19	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10097	10111		10.1074/jbc.M117.792747	http://dx.doi.org/10.1074/jbc.M117.792747			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28455444	Green Published, hybrid			2022-12-26	WOS:000403580600021
J	Katevatis, C; Fan, A; Klapperich, CM				Katevatis, Constantinos; Fan, Andy; Klapperich, Catherine M.			Low concentration DNA extraction and recovery using a silica solid phase	PLOS ONE			English	Article							NUCLEIC-ACIDS; MICROFLUIDIC DEVICE; WATER INTERFACE; PURIFICATION; DIAGNOSTICS; ADSORPTION; POINT; SURFACES; CHIP	DNA extraction from clinical samples is commonly achieved with a silica solid phase extraction column in the presence of a chaotrope. Versions of these protocols have been adapted for point of care (POC) diagnostic devices in miniaturized platforms, but commercial kits require a high amount of input DNA. Thus, when the input clinical sample contains less than 1 mu g of total DNA, the target-specific DNA recovery from most of these protocols is low without supplementing the sample with exogenous carrier DNA. In fact, many clinical samples used in the development of POC diagnostics often exhibit target DNA concentrations as low as 3 ng/mL. With the broader goal of improving the yield and efficiency of nucleic acid-based POC devices for dilute samples, we investigated both DNA adsorption and recovery from silica particles by using 1 pg- 1 mu g of DNA with a set of adsorption and elution buffers ranging in pH and chaotropic presence. In terms of adsorption, we found that low pH and the presence of chaotropic guanidinium thiocyanate (GuSCN) enhanced DNA-silica adsorption. When eluting with a standard low-salt, high-pH buffer, > 70% of DNA was unrecoverable, except when DNA was initially adsorbed with 5 M GuSCN at pH 5.2. Unrecovered DNA was either not initially adsorbed or irreversibly bound on the silica surface. Recovery was improved when eluting with 95 degrees C formamide and 1 M NaOH, which suggested that DNA-silica- chaotrope interactions are dominated by hydrophobic interactions and hydrogen bonding. While heated formamide and NaOH are non-ideal elution buffers for practical POC devices, the salient results are important for engineering a set of optimized reagents that could maximize nucleic acid recovery from a microfluidic DNA-silica-chaotrope system.	[Katevatis, Constantinos; Klapperich, Catherine M.] Boston Univ, Div Mat Sci & Engn, Boston, MA 02215 USA; [Fan, Andy; Klapperich, Catherine M.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Boston University; Boston University	Klapperich, CM (corresponding author), Boston Univ, Div Mat Sci & Engn, Boston, MA 02215 USA.; Klapperich, CM (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.	catherin@bu.edu			National Institute of Health: National Institute of Biomedical Imaging and Bioengineering [5U54EB015403]; National Institute of Health: National of Allergy and Infectious Disease [1R56AI113927]; National Institutes of Health NIBIB [5U54EB015403]; NIAID grant [1R56AI113927]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI113927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB015403] Funding Source: NIH RePORTER	National Institute of Health: National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute of Health: National of Allergy and Infectious Disease; National Institutes of Health NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIAID grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by a) National Institute of Health: National Institute of Biomedical Imaging and Bioengineering Grant #5U54EB015403, Recipient: CMK, https://www.nibib.nih.gov; and b) National Institute of Health: National of Allergy and Infectious Disease Grant #1R56AI113927, Recipient: CMK, https://www. niaid.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the National Institutes of Health NIBIB grant 5U54EB015403 and NIAID grant 1R56AI113927.	Bhattacharyya A, 2006, ANAL CHEM, V78, P788, DOI 10.1021/ac051449j; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Byrnes S, 2013, ANAL METHODS-UK, V5, P3177, DOI 10.1039/c3ay40162f; Cady NC, 2003, BIOSENS BIOELECTRON, V19, P59, DOI 10.1016/S0956-5663(03)00123-4; Chatterjee A, 2010, ANAL CHEM, V82, P4344, DOI 10.1021/ac100063f; Chen X, 2007, ANAL CHIM ACTA, V584, P237, DOI 10.1016/j.aca.2006.11.057; Collins KD, 2012, BIOPHYS CHEM, V167, P43, DOI 10.1016/j.bpc.2012.04.002; CRAMERS CA, 1981, CHROMATOGRAPHIA, V14, P439, DOI 10.1007/BF02262882; Gillers S, 2009, J MICROBIOL METH, V78, P203, DOI 10.1016/j.mimet.2009.05.020; Gubala V, 2012, ANAL CHEM, V84, P487, DOI 10.1021/ac2030199; Harris DC., 1996, QUANTITATIVE CHEM AN; HAYNES CA, 1994, J COLLOID INTERF SCI, V164, P394, DOI 10.1006/jcis.1994.1182; Horsman KM, 2007, J FORENSIC SCI, V52, P784, DOI 10.1111/j.1556-4029.2007.00468.x; Kashkary L, 2012, ANAL CHIM ACTA, V750, P127, DOI 10.1016/j.aca.2012.05.019; Kunz W, 2004, CURR OPIN COLLOID IN, V9, P1, DOI 10.1016/j.cocis.2004.05.004; Li X, 2012, LANGMUIR, V28, P2827, DOI 10.1021/la204443j; Melzak KA, 1996, J COLLOID INTERF SCI, V181, P635, DOI 10.1006/jcis.1996.0421; ONG SW, 1992, CHEM PHYS LETT, V191, P327, DOI 10.1016/0009-2614(92)85309-X; Ostroverkhov V, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.046102; Pan WY, 2015, CLIN CHEM, V61, P514, DOI 10.1373/clinchem.2014.235457; Park S, 2011, BIOTECHNOL ADV, V29, P830, DOI 10.1016/j.biotechadv.2011.06.017; Pegram LM, 2010, P NATL ACAD SCI USA, V107, P7716, DOI 10.1073/pnas.0913376107; Poeckh T, 2008, ANAL BIOCHEM, V373, P253, DOI 10.1016/j.ab.2007.10.026; Qiagen Qiagen, 2012, RNEASY MINI HDB; Qiagen Qiagen, 2006, DNEASY BLOOD TISSUE, P1; Qiagen Qiagen, 2007, QIAPREP MINIPREP HDB, P1; Rhodes A, 2006, CRIT CARE, V10, DOI 10.1186/cc4894; Rimola A, 2013, CHEM REV, V113, P4216, DOI 10.1021/cr3003054; Salis A, 2014, CHEM SOC REV, V43, P7358, DOI 10.1039/c4cs00144c; Sambrook J., 2001, MOL CLONING LAB MANU, P1, DOI DOI 10.1002/HUMU.1186.ABS; Su YH, 2004, J MOL DIAGN, V6, P101, DOI 10.1016/S1525-1578(10)60497-7; Tan SC, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/574398; Tian HJ, 2000, ANAL BIOCHEM, V283, P175, DOI 10.1006/abio.2000.4577; Toner M, 2005, ANNU REV BIOMED ENG, V7, P77, DOI 10.1146/annurev.bioeng.7.011205.135108; Vandeventer PE, 2013, J PHYS CHEM B, V117, P10742, DOI 10.1021/jp405753m; Vandeventer PE, 2012, J PHYS CHEM B, V116, P5661, DOI 10.1021/jp3017776; Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020	37	52	55	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176848	10.1371/journal.pone.0176848	http://dx.doi.org/10.1371/journal.pone.0176848			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475611	Green Submitted, gold, Green Published			2022-12-26	WOS:000400649500019
J	Liu, CL; Zhang, Y; Jiang, H; Wu, H				Liu, Chunli; Zhang, Yi; Jiang, Hong; Wu, Hui			Association between social support and post-traumatic stress disorder symptoms among Chinese patients with ovarian cancer: A multiple mediation model	PLOS ONE			English	Article							BREAST-CANCER; PTSD SYMPTOMS; PSYCHOMETRIC PROPERTIES; PSYCHOLOGICAL DISTRESS; DEPRESSIVE SYMPTOMS; COST-EFFECTIVENESS; RESILIENCE; WOMEN; PREVALENCE; HOPE		[Liu, Chunli] Lib China Med Univ, Shenyang, Liaoning, Peoples R China; [Liu, Chunli; Wu, Hui] China Med Univ, Coll Publ Hlth, Dept Social Med, Shenyang, Liaoning, Peoples R China; [Zhang, Yi] China Med Univ, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China; [Jiang, Hong] China Med Univ, Sch Publ Hlth, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University	Wu, H (corresponding author), China Med Univ, Coll Publ Hlth, Dept Social Med, Shenyang, Liaoning, Peoples R China.	hwu@cmu.edu.cn	Liu, Chunli/K-4147-2019; 刘, 春丽/Y-6158-2018	刘, 春丽/0000-0002-3671-6487				Andrykowski MA, 1998, J TRAUMA STRESS, V11, P189, DOI 10.1023/A:1024490718043; [Anonymous], IOSR J HUMANITIES SO; Ardino V, 2013, EUR J PSYCHOTRAUMATO, V4; Auxemery Y, 2012, ENCEPHALE, V38, P373, DOI 10.1016/j.encep.2011.12.003; Bastani F, 2012, JOUNAL CLIN NURSING, V1, P23; Besser A, 2014, J CLIN PSYCHOL, V70, P1227, DOI 10.1002/jclp.22083; Bjorge T, 1998, INT J CANCER, V75, P663, DOI 10.1002/(SICI)1097-0215(19980302)75:5<663::AID-IJC1>3.0.CO;2-X; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Block J, 1996, J PERS SOC PSYCHOL, V70, P349, DOI 10.1037/0022-3514.70.2.349; Brancu M, 2014, PSYCHIAT RES, V217, P86, DOI 10.1016/j.psychres.2014.02.025; BROADHEAD WE, 1988, MED CARE, V26, P709, DOI 10.1097/00005650-198807000-00006; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Cohen J, 2003, J ROY STAT SOC, V52, P227; Solano JPC, 2016, BMC PALLIAT CARE, V15, DOI 10.1186/s12904-016-0139-y; Dahl AA, 2016, J CANCER SURVIV, V10, P842, DOI 10.1007/s11764-016-0529-4; Dai WJ, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2871-x; Dinenberg RE, 2014, AM J HEALTH PROMOT, V28, P294, DOI 10.4278/ajhp.121023-QUAN-511; DUNKELSCHETTER C, 1984, J SOC ISSUES, V40, P77, DOI 10.1111/j.1540-4560.1984.tb01108.x; Eskander RN, 2014, GYNECOL ONCOL, V132, P496, DOI 10.1016/j.ygyno.2013.11.029; Evren C, 2016, PSYCHIAT RES, V239, P320, DOI 10.1016/j.psychres.2016.03.049; Fava GA, 2009, J PERS, V77, P1903, DOI 10.1111/j.1467-6494.2009.00604.x; Goncalves V, 2011, J PSYCHOSOM RES, V70, P422, DOI 10.1016/j.jpsychores.2010.09.017; Hamilton AB, 1999, CANCER INVEST, V17, P335, DOI 10.3109/07357909909032875; Hao JH, 2015, INT J ENV RES PUB HE, V12, P6682, DOI 10.3390/ijerph120606682; Herth K, 1991, Sch Inq Nurs Pract, V5, P39; HERTH K, 1992, J ADV NURS, V17, P1251, DOI 10.1111/j.1365-2648.1992.tb01843.x; Holland KD, 2003, PSYCHOL HEALTH, V18, P15, DOI 10.1080/0887044031000080656; Howard S, 2012, ANXIETY STRESS COPIN, V25, P411, DOI 10.1080/10615806.2011.640933; Jacobsen PB, 2002, J CONSULT CLIN PSYCH, V70, P235, DOI 10.1037//0022-006X.70.1.235; Jeantieu M, 2014, J THORAC ONCOL, V9, P362, DOI 10.1097/JTO.0000000000000084; Joscelyne A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145188; Kangas M, 2002, CLIN PSYCHOL REV, V22, P499, DOI 10.1016/S0272-7358(01)00118-0; Kathleen T, 2004, HOLIST NURS PRACT, V10, P45; Kwakkenbos L, 2014, J PSYCHOSOM RES, V76, P485, DOI 10.1016/j.jpsychores.2014.03.103; Li MY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154729; Li RH, 2016, PSYCHOPHYSIOLOGY, V53, P705, DOI 10.1111/psyp.12603; Li YX, 2008, J HENAN U SOCIAL SCI, V48, P13; Litz B.T, 1993, PTSD CHECKL PCL REL; Liu L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145103; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Mackay HJ, 2010, INT J GYNECOL CANCER, V20, P945, DOI 10.1111/IGC.0b013e3181dd0110; Maley JH, 2016, ANN AM THORAC SOC, V13, P1351, DOI 10.1513/AnnalsATS.201511-782OC; Mattioli JL, 2008, ONCOL NURS FORUM, V35, P822, DOI 10.1188/08.ONF.822-829; McCanlies EC, 2014, STRESS HEALTH, V30, P405, DOI 10.1002/smi.2615; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; Mealer M, 2016, J NURS MEAS, V24, P28, DOI 10.1891/1061-3749.24.1.28; Mehnert A, 2007, PSYCHO-ONCOLOGY, V16, P181, DOI 10.1002/pon.1057; Mehnert A, 2009, PSYCHO-ONCOLOGY, V18, P1273, DOI 10.1002/pon.1481; Miller JF, 2007, NURS FORUM, V42, P12, DOI 10.1111/j.1744-6198.2007.00061.x; Miller K, 2006, CANCER J, V12, P388, DOI 10.1097/00130404-200609000-00008; Mo PKH, 2014, AIDS CARE, V26, P1526, DOI 10.1080/09540121.2014.923810; Muramatsu N, 2010, SOC SCI MED, V70, P1050, DOI 10.1016/j.socscimed.2009.12.005; National Cancer Institute, 2016, SEER STAT FACT SHEET; Norton TR, 2004, J CLIN ONCOL, V22, P919, DOI 10.1200/JCO.2004.07.028; O'Connor M, 2011, BRIT J CANCER, V104, P419, DOI 10.1038/sj.bjc.6606073; Office for National Statistics. Cancer Registration Statistics, 2015, ENGL STAT B; Palesh O, 2013, NAT REV CLIN ONCOL, V10, P252, DOI 10.1038/nrclinonc.2013.49; Palgi Y, 2011, EUR J ONCOL NURS, V15, P454, DOI 10.1016/j.ejon.2010.11.011; Phillips-Salimi CR, 2007, J NURS MEAS, V15, P3, DOI 10.1891/106137407780851769; Pinar G, 2012, CANCER NURS, V35, P229, DOI 10.1097/NCC.0b013e31822c47bd; Plamadeala V, 2015, GYNECOL ONCOL, V136, P94, DOI 10.1016/j.ygyno.2014.11.019; Poonawalla IB, 2015, VALUE HEALTH, V18, P387, DOI 10.1016/j.jval.2015.01.005; Posluszny DM, 2015, HEAD NECK-J SCI SPEC, V37, P1282, DOI 10.1002/hed.23760; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Ruiz-Robledillo N, 2014, RES DEV DISABIL, V35, P686, DOI 10.1016/j.ridd.2013.12.007; Shand LK, 2015, PSYCHO-ONCOLOGY, V24, P190, DOI 10.1002/pon.3627; Short NA, 2015, J ANXIETY DISORD, V35, P68, DOI 10.1016/j.janxdis.2015.09.004; Sippel LM, 2015, ECOL SOC, V20, DOI 10.5751/ES-07832-200410; Snyder C.R., 2000, HDB HOPE THEORY MEAS; Sripada RK, 2015, PSYCHIAT SERV, V66, P65, DOI 10.1176/appi.ps.201400029; Suryawanshi S, 2013, CLIN CANCER RES, V19, P1213, DOI 10.1158/1078-0432.CCR-12-2726; Tanimukai H, 2013, AM J HOSP PALLIAT ME, V30, P359, DOI 10.1177/1049909112452334; Terhakopian A, 2008, J TRAUMA STRESS, V21, P290, DOI 10.1002/jts.20341; Thomas KS, 2012, PSYCHONEUROENDOCRINO, V37, P1181, DOI 10.1016/j.psyneuen.2011.12.008; Vin-Raviv N, 2013, JNCI-J NATL CANCER I, V105, P563, DOI 10.1093/jnci/djt024; Wang Y., 2010, CHINESE NURSING RES, V24, P20, DOI [DOI 10.3969/J.ISSN.1009-6493.2010.01.008, 10.3969/j.issn.1009-6493.2010.01.008]; Wang Y, 2015, PSYCHO-ONCOLOGY, V24, P1701, DOI 10.1002/pon.3838; Wenzel LB, 2002, PSYCHO-ONCOLOGY, V11, P142, DOI 10.1002/pon.567; Wilks SE, 2008, AGING MENT HEALTH, V12, P357, DOI 10.1080/13607860801933323; Wright AM, 2016, J IMMIGR MINOR HLTH; Wu KK., 2008, HONG KONG J PSYCHIAT, V18, P144; [吴明 Wu Ming], 2015, [中国公共卫生, China Journal of Public Health], V31, P101; Yang YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155607	83	16	16	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177055	10.1371/journal.pone.0177055	http://dx.doi.org/10.1371/journal.pone.0177055			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SX	28475593	gold, Green Published, Green Submitted			2022-12-26	WOS:000400649500038
J	Qin, M; Li, L; Liu, X; Liu, T; Shi, SB				Qin, Mu; Li, Li; Liu, Xu; Liu, Tao; Shi, Shao Bo			Neural substrate of posterior left atrium: A novel modulation for inducibility and remodeling of atrial fibrillation in canine	PLOS ONE			English	Article							GANGLIONATED PLEXI ABLATION; PULMONARY VEINS; PARASYMPATHETIC BLOCKADE; HEART-FAILURE; STIMULATION; ACTIVATION	Background The neural mechanism of posterior left atrium (PLA) for genesis of atrial fibrillation has not been completely elucidated. We sought to assess the contribution of PLA denervation on atrial fibrillation (AF) inducibility and atrial remodeling. Methods and results After left thoracotomy in anesthetized dogs (n = 32), electrode catheters were attached to the PLA, left atrial roof, left pulmonary vein and left atrial appendage. Experiment 1 (n = 16): Vagal stimulation (VS group, n = 8) led to more pronounced ERP shortening in PLA than in other sites (CTL: 71 +/- 7 ms vs VS: 52 +/- 6 ms, P<0.05;). Compared with control group (CTL group, n = 8), atropine alone or with propranolol applied to PLA greatly inhibited VS-induced ERP shortening, ERP dispersion increase, and AF inducibility in the left atrium (P<0.05); but ERP was not significantly different between atropine alone and DB conditions (Atro: 85 +/- 8 ms vs DB: 90 +/- 9ms, P>0.05). In addition, domain frequency (DF) of VS-induced AF waveform was not affected by atropine alone, while selective double autonomic blockade at PLA significantly decreased DF at all sites (P<0.05). Experiment 2 (n = 16): In group 1 (n = 8), ERP was markedly shortened in the first 2 hours (11 +/- 19% decrease) and then stabilized; however, WOV was progressively widened throughout the 6 hours rapid atrial pacing (BS: 51 +/- 9ms vs 6th hour: 161 +/- 30ms, P<0.05). After drug application, ERP was increased in all sites of atria, the ERP dispersion was significantly decreased (Atro: 2.36 +/- 0.02 vs 6th hour: 5.09 +/- 0.07, P<0.05) and AF could be induced in only 1 of 8 dogs. In group 2 (n = 8), 6 hours rapid atrial pacing failed to shorten the ERP and increased ERP dispersion, and only 2 episodes of AF could be induced (WOV = 0). Conclusion Local denervation of PLA, as predominant atrial autonomic profile, greatly inhibits AF inducibility and atrial remodeling.	[Qin, Mu; Liu, Xu] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Cardiol, Shanghai, Peoples R China; [Li, Li] China Three Gorges Univ, Coll Clin Med Sci 1, Dept Cardiol, Yichang, Peoples R China; [Liu, Tao; Shi, Shao Bo] Wuhan Univ, Cardiovasc Res Inst, Wuhan, Peoples R China	Shanghai Jiao Tong University; China Three Gorges University; Wuhan University	Qin, M (corresponding author), Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Cardiol, Shanghai, Peoples R China.	qinmu-1001@live.cn			National Natural Science Foundation of China [81400246]; China Postdoctoral Science Foundation [2015M571570]; National Natural Science Foundation of China [81400246]; China Postdoctoral Science Foundation [2015M571570]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This research was supported by National Natural Science Foundation of China Grants (Grant No: 81400246) and China Postdoctoral Science Foundation Grant (Grant No: 2015M571570).	Armour JA, 2008, EXP PHYSIOL, V93, P165, DOI 10.1113/expphysiol.2007.041178; Arora R, 2008, AM J PHYSIOL-HEART C, V294, pH134, DOI 10.1152/ajpheart.00732.2007; Arora R, 2007, J AM COLL CARDIOL, V49, P1340, DOI 10.1016/j.jacc.2006.10.075; Atienza F, 2006, CIRCULATION, V114, P2434, DOI 10.1161/CIRCULATIONAHA.106.633735; Choi EK, 2010, CIRCULATION, V121, P2615, DOI 10.1161/CIRCULATIONAHA.109.919829; Driessen AHG, 2016, J AM COLL CARDIOL, V68, P1155, DOI 10.1016/j.jacc.2016.06.036; Gao CH, 2011, AUTON NEUROSCI-BASIC, V162, P42, DOI 10.1016/j.autneu.2011.03.004; Habel N, 2011, PACE, V34, P1460, DOI 10.1111/j.1540-8159.2011.03212.x; Hou YL, 2007, J AM COLL CARDIOL, V50, P61, DOI 10.1016/j.jacc.2007.02.066; Hou YL, 2007, HEART RHYTHM, V4, P56, DOI 10.1016/j.hrthm.2006.09.020; Ng J, 2011, CIRC-ARRHYTHMIA ELEC, V4, P388, DOI 10.1161/CIRCEP.110.959650; Jones DL, 2008, J INTERV CARD ELECTR, V21, P187, DOI 10.1007/s10840-008-9205-6; Katritsis DG, 2013, J AM COLL CARDIOL, V62, P2318, DOI 10.1016/j.jacc.2013.06.053; Lee KW, 2006, CIRCULATION, V114, P1703, DOI 10.1161/CIRCULATIONAHA.106.624320; Mikhaylov E, 2011, EUROPACE, V13, P362, DOI 10.1093/europace/euq416; Oliveira M, 2012, REV PORT CARDIOL, V31, P215, DOI 10.1016/j.repc.2012.01.007; Patterson E, 2005, HEART RHYTHM, V2, P624, DOI 10.1016/j.hrthm.2005.02.012; Pokushalov E, 2009, HEART RHYTHM, V6, P1257, DOI 10.1016/j.hrthm.2009.05.018; Suenari K, 2011, BASIC RES CARDIOL, V106, P65, DOI 10.1007/s00395-010-0132-1; Tamborero D, 2009, CIRC-ARRHYTHMIA ELEC, V2, P35, DOI 10.1161/CIRCEP.108.797944; Yamazaki M, 2012, PROG BIOPHYS MOL BIO, V110, P269, DOI 10.1016/j.pbiomolbio.2012.08.004; Zhao QY, 2008, INT J CARDIOL, V126, P352, DOI 10.1016/j.ijcard.2007.04.050	22	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176626	10.1371/journal.pone.0176626	http://dx.doi.org/10.1371/journal.pone.0176626			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475580	Green Published, Green Submitted, gold			2022-12-26	WOS:000400649500011
J	Wang, YH; Ding, FR; Wang, T; Liu, WJ; Lindquist, S; Hernell, O; Wang, JW; Li, J; Li, L; Zhao, YF; Dai, YP; Li, N				Wang, Yuhang; Ding, Fangrong; Wang, Tao; Liu, Wenjie; Lindquist, Susanne; Hernell, Olle; Wang, Jianwu; Li, Jing; Li, Ling; Zhao, Yaofeng; Dai, Yunping; Li, Ning			Purification and characterization of recombinant human bile salt-stimulated lipase expressed in milk of transgenic cloned cows	PLOS ONE			English	Article							CARBOXYL ESTER HYDROLASE; PROLINE-RICH REPEATS; BINDS DC-SIGN; ACTIVATED LIPASE; PRETERM INFANTS; PANCREATIC-JUICE; PICHIA-PASTORIS; LIPID DIGESTION; GLYCOSYLATION; ABSORPTION	Bile salt-stimulated lipase (BSSL) is a lipolytic digestive enzyme with broad substrate specificity secreted from exocrine pancreas into the intestinal lumen in all species and from the lactating mammary gland into the milk of some species, notably humans but not cows. BSSL in breast milk facilitates digestion and absorption of milk fat and promotes growth of small for gestational age preterm infants. Thus, purified recombinant human BSSL (rhBSSL) can be used for treatment of patients with fat malabsorption and expressing rhBSSL in the milk of transgenic cloned cows would therefore be a mean to meet a medical need. In the present study, a vector pBAC-hLF-hBSSL was constructed, which efficiently expressed active rhBSSL in milk of transgenic cloned cows to a concentration of 9.8 mg/ml. The rhBSSL purified from cow milk had the same enzymatic activity, N-terminal amino acid sequence, amino acid composition and isoelectric point and similar physicochemical characteristics as human native BSSL. Our study supports the use of transgenic cattle for the cost-competitive, large-scale production of therapeutic rhBSSL.	[Wang, Yuhang; Ding, Fangrong; Wang, Tao; Liu, Wenjie; Wang, Jianwu; Li, Jing; Li, Ling; Zhao, Yaofeng; Dai, Yunping; Li, Ning] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing, Peoples R China; [Lindquist, Susanne; Hernell, Olle] Umea Univ, Pediat, Dept Clin Sci, Umea, Sweden	China Agricultural University; Umea University	Dai, YP; Li, N (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing, Peoples R China.	daiyunping@sina.com; ninglcau@cau.edu.cn			China transgenic project [2016ZX08010005, 2014ZX08007001]	China transgenic project	This work was supported by China transgenic project. Project number 2016ZX08010005, 2014ZX08007001.; This study was supported by China transgenic project, 2016ZX08010005 to YZ and 2014ZX08007001 to YD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni C, 2009, J PEDIATR GASTR NUTR, V49, P112, DOI 10.1097/MPG.0b013e31819f1e05; Andersson EL, 2011, J LIPID RES, V52, P1949, DOI 10.1194/jlr.M015685; Andersson Y, 2007, ACTA PAEDIATR, V96, P1445, DOI 10.1111/j.1651-2227.2007.00450.x; BLACKBERG L, 1995, EUR J BIOCHEM, V228, P817, DOI 10.1111/j.1432-1033.1995.tb20327.x; BLACKBERG L, 1983, FEBS LETT, V157, P337, DOI 10.1016/0014-5793(83)80571-7; BLACKBERG L, 1981, EUR J BIOCHEM, V116, P221, DOI 10.1111/j.1432-1033.1981.tb05322.x; BLACKBERG L, 1985, J PEDIATR GASTR NUTR, V4, P441, DOI 10.1097/00005176-198506000-00020; Blackberg L, 1997, METHOD ENZYMOL, V284, P185; BLACKBERG L, 1981, FEBS LETT, V136, P284, DOI 10.1016/0014-5793(81)80636-9; Casper C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156071; Casper C, 2014, J PEDIATR GASTR NUTR, V59, P61, DOI 10.1097/MPG.0000000000000365; Fontbonne H, 2011, J BIOCHEM, V149, P145, DOI 10.1093/jb/mvq132; FREDRIKZON B, 1978, PEDIATR RES, V12, P1048, DOI 10.1203/00006450-197811000-00004; Garcia C, 2013, Cell Mol Biol (Noisy-le-grand), V59, P108; HANSSON L, 1993, J BIOL CHEM, V268, P26692; HERNELL O, 1982, PEDIATR RES, V16, P882, DOI 10.1203/00006450-198210000-00016; HERNELL O, 1974, BIOCHIM BIOPHYS ACTA, V369, P234, DOI 10.1016/0005-2760(74)90254-9; HERNELL O, 1975, EUR J CLIN INVEST, V5, P267, DOI 10.1111/j.1365-2362.1975.tb02294.x; HERNELL O, 1991, ENCY HUMAN BIOL, V3, P47; Hernell O, 2011, NESTLE NUTR WORKS SE, V67, P17, DOI 10.1159/000325572; Howles PN, 1999, AM J PHYSIOL-GASTR L, V277, pG653, DOI 10.1152/ajpgi.1999.277.3.G653; HUI DY, 1990, FEBS LETT, V276, P131, DOI 10.1016/0014-5793(90)80525-N; LEBENTHAL E, 1980, PEDIATRICS, V66, P556; Li X, 2007, PEDIATR RES, V62, P537, DOI 10.1203/PDR.0b013e3181559e75; Lindquist S, 2010, CURR OPIN CLIN NUTR, V13, P314, DOI 10.1097/MCO.0b013e328337bbf0; Liu B, 2013, BREASTFEED MED, V8, P354, DOI 10.1089/bfm.2013.0016; LOMBARDO D, 1980, BIOCHIM BIOPHYS ACTA, V611, P147, DOI 10.1016/0005-2744(80)90050-9; Lu D, 2016, SCI REP-UK, V6, DOI 10.1038/srep22947; Murasugi A, 2001, PROTEIN EXPRES PURIF, V23, P282, DOI 10.1006/prep.2001.1509; Naarding MA, 2005, J CLIN INVEST, V115, P3256, DOI 10.1172/JCI25105; Naarding MA, 2006, ANTIMICROB AGENTS CH, V50, P3367, DOI 10.1128/AAC.00593-06; Niemi LD, 2009, CARIES RES, V43, P171, DOI 10.1159/000213888; NILSSON J, 1990, EUR J BIOCHEM, V192, P543, DOI 10.1111/j.1432-1033.1990.tb19259.x; Nyberg L, 1998, J PEDIATR GASTR NUTR, V27, P560, DOI 10.1097/00005176-199811000-00013; Poorkhalkali N, 1998, HISTOCHEM CELL BIOL, V110, P367, DOI 10.1007/s004180050297; Ruvoen-Clouet N, 2006, BIOCHEM J, V393, P627, DOI 10.1042/BJ20050898; Sahasrabudhe AV, 1998, PROTEIN EXPRES PURIF, V14, P425, DOI 10.1006/prep.1998.0974; Stromqvist M, 1996, TRANSGENIC RES, V5, P475, DOI 10.1007/BF01980213; Stromqvist M, 1995, J CHROMATOGR A, V718, P53, DOI 10.1016/0021-9673(95)00632-X; Uauy R, 2003, J PEDIATR-US, V143, pS17, DOI 10.1067/S0022-3476(03)00398-6; WANG CS, 1989, AM J CLIN NUTR, V49, P457, DOI 10.1093/ajcn/49.3.457; WANG CS, 1980, ANAL BIOCHEM, V105, P398, DOI 10.1016/0003-2697(80)90476-5; WANG CS, 1983, ANAL BIOCHEM, V133, P457, DOI 10.1016/0003-2697(83)90108-2; Wang J, 2008, J DAIRY SCI, V91, P4466, DOI 10.3168/jds.2008-1189; Wang YY, 2015, MOL BIOTECHNOL, V57, P287, DOI 10.1007/s12033-014-9822-5; WARDELL JM, 1984, PEDIATR RES, V18, P382, DOI 10.1203/00006450-198404000-00017; WILLIAMSON S, 1978, ARCH DIS CHILD, V53, P555, DOI 10.1136/adc.53.7.555; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017593; Yang PH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003453; Zbacnik TJ, 2017, J PHARM SCI-US, V106, P713, DOI 10.1016/j.xphs.2016.11.014	50	9	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176864	10.1371/journal.pone.0176864	http://dx.doi.org/10.1371/journal.pone.0176864			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475629	Green Submitted, Green Published, gold			2022-12-26	WOS:000400649500022
J	Xu, WH; Hole, K; Goolia, M; Pickering, B; Salo, T; Lung, O; Nfon, C				Xu, Wanhong; Hole, Kate; Goolia, Melissa; Pickering, Bradley; Salo, Tim; Lung, Oliver; Nfon, Charles			Genome wide analysis of the evolution of Senecavirus A from swine clinical material and assembly yard environmental samples	PLOS ONE			English	Article							IDIOPATHIC VESICULAR DISEASE; PHYLOGENETIC ANALYSIS; ONCOLYTIC PICORNAVIRUS; VALLEY-VIRUS; TRANSMISSION; PIGS; INFECTION; OUTBREAK; GENUS	Senecavirus A (SVA), previously known as Seneca Valley virus, was first isolated in the United States in 2002. SVA was associated with porcine idiopathic vesicular disease in Canada and the USA in 2007 and 2012, respectively. Recent increase in SVA outbreaks resulting in neonatal mortality of piglets and/or vesicular lesions in sows in Brazil, the USA and Canada point to the necessity to study the pathogenicity and molecular epidemiology of the virus. Here, we report the analysis of the complete coding sequences of SVA from 2 clinical cases and 9 assembly yard environmental samples collected in 2015 in Canada, along with 22 previously released complete genomes in the GenBank. With this combined data set, the evolution of the SVA over a 12-month period in 2015/2016 was evaluated. These SVA isolates were characterized by a rapid accumulation of genetic variations driven mainly by a high nucleotide substitution rate and purifying selection. The SVA sequences clustered in clearly defined geographical areas with reported cases of SVA infection. No transmission links were identified between assembly yards, suggesting that point source introductions may have occurred. In addition, 25 fixed non-synonymous mutations were identified across all analyzed strains when compared to the prototype SVA strain (SVV-001). This study highlights the importance of monitoring SVA mutations for their role in increased virulence and impact on SVA diagnostics.	[Xu, Wanhong; Hole, Kate; Goolia, Melissa; Pickering, Bradley; Salo, Tim; Lung, Oliver; Nfon, Charles] Canadian Food Inspect Agcy, NCFAD, Winnipeg, MB, Canada	Canadian Food Inspection Agency	Nfon, C (corresponding author), Canadian Food Inspect Agcy, NCFAD, Winnipeg, MB, Canada.	Charles.nfon@inspection.gc.ca			CFIA; Canadian Food Inspection Agency	CFIA; Canadian Food Inspection Agency	We thank the Manitoba Agriculture and Rural Initiatives and Ontario CFIA staff veterinarians for sample collection, and the CFIA for funding this study. We also thank Drs. Alfonso Clavijo and John Copps for review of the manuscript.; This work was supported by the Canadian Food Inspection Agency. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Cattoli G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004842; Cottam EM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000050; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Drummond AJ, 2002, GENETICS, V161, P1307; Fukai K, 2015, J VET DIAGN INVEST, V27, P516, DOI 10.1177/1040638715584156; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Hales LM, 2008, J GEN VIROL, V89, P1265, DOI 10.1099/vir.0.83570-0; Hicks AL, 2011, J VIROL, V85, P7942, DOI 10.1128/JVI.02535-10; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Joshi LR, 2016, J GEN VIROL, V97, P3267, DOI 10.1099/jgv.0.000631; Kitching R.P., 1987, REV SCI TECH OIE, V6, P263, DOI DOI 10.20506/RST.6.1.291; Kittelberger R, 2015, TRANSBOUND EMERG DIS; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; Lam TTY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000130; LaRocco M, 2015, J CLIN MICROBIOL, V53, P755, DOI 10.1128/JCM.03220-14; Leme RA, 2015, TRANSBOUND EMERG DIS, V62, P603, DOI 10.1111/tbed.12430; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; MARTINEZ HM, 1983, NUCLEIC ACIDS RES, V11, P4629, DOI 10.1093/nar/11.13.4629; Montiel N, 2016, EMERG INFECT DIS, V22, P1246, DOI 10.3201/eid2207.151863; Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007; Pasma T, 2008, CAN VET J, V49, P84; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Rambaut A, FIGTREE V 1 4 2; RICOHESSE R, 1987, VIROLOGY, V160, P311, DOI 10.1016/0042-6822(87)90001-8; Singh K., 2012, J VET SCI TECHNOL, V3, P1; TAMURA K., 2015, MEGA7 MOL EVOLUTIONA; Vannucci FA, 2015, TRANSBOUND EMERG DIS, V62, P589, DOI 10.1111/tbed.12410; Venkataraman S, 2008, STRUCTURE, V16, P1555, DOI 10.1016/j.str.2008.07.013; VOSLOO W, 1992, EPIDEMIOL INFECT, V109, P547, DOI 10.1017/S0950268800050536; Wu Q., 2016, GENOME ANNOUNC, V4; Xu WH, 2016, SCI REP-UK, V6, DOI 10.1038/srep30858; Yang M, 2012, J VET DIAGN INVEST, V24, P42, DOI 10.1177/1040638711426323	35	36	43	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176964	10.1371/journal.pone.0176964	http://dx.doi.org/10.1371/journal.pone.0176964			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475630	gold, Green Published, Green Submitted			2022-12-26	WOS:000400649500031
J	Bwalya, EC; Kim, S; Fang, J; Wijekoon, HMS; Hosoya, K; Okumura, M				Bwalya, Eugene C.; Kim, Sangho; Fang, Jing; Wijekoon, H. M. Suranji; Hosoya, Kenji; Okumura, Masahiro			Pentosan polysulfate inhibits IL-1 beta-induced iNOS, c-Jun and HIF-1 alpha upregulation in canine articular chondrocytes	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; EXPERIMENTAL OSTEOARTHRITIS; NUCLEAR TRANSLOCATION; SELECTIVE-INHIBITION; HYPOXIA PROMOTES; CPG SITES; EXPRESSION; CARTILAGE; INTERLEUKIN-1	Osteoarthritic (OA) chondrocytes are shown to express inducible nitric oxide synthase (iNOS) which produces high concentrations of nitric oxide (NO), particularly when stimulated with proinflammatory cytokines. NO is involved in OA cartilage degradation. On the other hand, c-Jun N-terminal Kinase (JNK) pathway mediates the activation and transcription of c-Jun, which is required for interleukin-1 (IL-1)-induction of matrix metalloproteinases-13 (MMP-13) in OA pathogenesis. Therefore, the selective inhibition of iNOS and c-Jun is a promising target for treatment and prevention of OA. The purpose of the study was to investigate the inhibitory effects of pentosan polysulfate (PPS) on IL-1 beta-induced iNOS, c-Jun and HIF-alpha isoforms upregulation in canine articular chondrocytes (CACs). Primary (P0) chondrocytes were isolated and cultured from femoral head cartilages of three (3) dogs. First passage (P1) chondrocytes were preincubated with 0, 1, 5, 15 and 40 mu g/mL of PPS for 4 hr before treatment with 10 ng/mL rhIL-1 beta for a further 8 hr. In addition, we evaluated the effects of single and multiple cytokine with or without LPS on iNOS protein induction. PPS significantly inhibited (P < 0.05) IL-1 beta-induced iNOS, c-Jun and HIF-1 alpha mRNA upregulation in a dose-dependent pattern. iNOS mRNA was significantly inhibited at 15 and 40 mu g/mL whereas c-Jun and HIF-1 alpha were significantly downregulated at 5, 15 and 40 mu g/mL of PPS compared to chondrocytes treated with only rhIL-1 beta. Intriguingly, CACs were recalcitrant to single IL-1 beta, TNF-alpha or LPS-induction of iNOS protein including to a combination of IL-1 beta+TNF-alpha, IL-1 beta+LPS except to TNF-alpha+LPS and IL-1 beta+TNF-alpha+LPS suggestive of a protective mechanism from iNOS detrimental effects on perpetuating OA. IL-1 beta+TNF-alpha+LPS-induced iNOS protein expression was significantly abrogated by PPS. We demonstrate for the first time that PPS is a novel inhibitor of IL-1 beta-induced iNOS, c-Jun, and HIF-1 alpha mRNA upregulation and iNOS protein induction which may be beneficial for prevention and treatment OA.	[Bwalya, Eugene C.; Kim, Sangho; Fang, Jing; Wijekoon, H. M. Suranji; Hosoya, Kenji; Okumura, Masahiro] Hokkaido Univ, Grad Sch Vet Med, Dept Vet Clin Sci, Lab Vet Surg, Sapporo, Hokkaido, Japan	Hokkaido University	Bwalya, EC (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Vet Clin Sci, Lab Vet Surg, Sapporo, Hokkaido, Japan.	eugenelb2000@yahoo.com	Bwalya, Eugene/AAD-8172-2021; Okumura, Masahiro/AAO-4766-2021	Bwalya, Eugene/0000-0002-2887-3116; 	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of the government of Japan [MEXT 133003]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of the government of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors also state that the first author, Eugene C Bwalya has a scholarship (Scholarship ID: MEXT 133003) from The Ministry of Education, Culture, Sports, Science and Technology (MEXT) of the government of Japan. All the authors declare that the provider of the scholarship for the first author had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaganur V, 2014, J PHARM PHARMACOL, V66, P1021, DOI 10.1111/jphp.12228; Bohensky J, 2009, ARTHRITIS RHEUM-US, V60, P1406, DOI 10.1002/art.24444; Boileau C, 2002, ARTHRITIS RHEUM, V46, P2637, DOI 10.1002/art.10518; Budsberg SC, 2007, VET SURG, V36, P234, DOI 10.1111/j.1532-950X.2007.00256.x; Campo GM, 2009, J CELL BIOCHEM, V106, P83, DOI 10.1002/jcb.21981; Cheung KSC, 2009, RHEUMATOL INT, V29, P525, DOI 10.1007/s00296-008-0744-z; Coimbra IB, 2004, OSTEOARTHR CARTILAGE, V12, P336, DOI 10.1016/j.joca.2003.12.005; de Andres MC, 2013, ARTHRITIS RHEUM-US, V65, P732, DOI 10.1002/art.37806; Fernandes JC, 2002, BIORHEOLOGY, V39, P237; FORSTERMANN U, 1995, N-S ARCH PHARMACOL, V352, P351; Freshney I.R, 2010, CULTURE ANIMAL CELLS; Ghosh P, 1999, SEMIN ARTHRITIS RHEU, V28, P211, DOI 10.1016/S0049-0172(99)80021-3; Ghosh P, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2935; Giatromanolaki A, 2003, ARTHRITIS RES THER, V5, pR193, DOI 10.1186/ar756; Imagawa K, 2011, BIOCHEM BIOPH RES CO, V405, P362, DOI 10.1016/j.bbrc.2011.01.007; Innes JF, 2000, VET REC, V146, P433, DOI 10.1136/vr.146.15.433; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; JARVINEN TAH, 1995, MEDIAT INFLAMM, V4, P107, DOI 10.1155/S0962935195000184; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Korhonen Riku, 2005, Current Drug Targets - Inflammation and Allergy, V4, P471, DOI 10.2174/1568010054526359; Krasnokutsky S, 2008, OSTEOARTHR CARTILAGE, V16, pS1, DOI 10.1016/j.joca.2008.06.025; Lafont JE, 2008, J BIOL CHEM, V283, P4778, DOI 10.1074/jbc.M707729200; Lafont JE, 2007, ARTHRITIS RHEUM, V56, P3297, DOI 10.1002/art.22878; Le Graverand-Gastineau MPH, 2009, OSTEOARTHR CARTILAGE, V17, P1393, DOI 10.1016/j.joca.2009.04.009; Loeser RF, 2009, OSTEOARTHR CARTILAGE, V17, P513, DOI 10.1016/j.joca.2008.08.003; MacPhail CM, 2000, WALTHAM FOCUS, V10, P25; MCCARTNEYFRANCIS N, 1993, J EXP MED, V178, P749, DOI 10.1084/jem.178.2.749; Mendes AF, 2002, NITRIC OXIDE-BIOL CH, V6, P35, DOI 10.1006/niox.2001.0378; Mendes AF, 2002, INFLAMM RES, V51, P369, DOI 10.1007/PL00000317; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Murphy CL, 2010, CELL RES, V20, P977, DOI 10.1038/cr.2010.99; MURRELL GAC, 1995, BIOCHEM BIOPH RES CO, V206, P15, DOI 10.1006/bbrc.1995.1003; Otero M, 2005, ARTHRITIS RES THER, V7, pR581, DOI 10.1186/ar1708; PALMER RMJ, 1993, BIOCHEM BIOPH RES CO, V193, P398, DOI 10.1006/bbrc.1993.1637; Pelletier JP, 1999, J RHEUMATOL, V26, P2002; Pelletier JP, 1998, ARTHRITIS RHEUM-US, V41, P1275, DOI 10.1002/1529-0131(199807)41:7<1275::AID-ART19>3.0.CO;2-T; Richard F, 2005, REV ARTIC, V21, P104; Roach HI, 2005, ARTHRITIS RHEUM-US, V52, P3110, DOI 10.1002/art.21300; Sadhukhan PC, 2002, J UROLOGY, V168, P289, DOI 10.1016/S0022-5347(05)64909-9; Saito T, 2010, OSTEOARTHR CARTILAGE, V18, P1552, DOI 10.1016/j.joca.2010.10.006; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; SAKURAI H, 1995, J CLIN INVEST, V96, P2357, DOI 10.1172/JCI118292; Stichtenoth DO, 1998, BRIT J RHEUMATOL, V37, P246; Sunaga T, 2012, J VET MED SCI, V74, P707, DOI 10.1292/jvms.11-0511; TASKIRAN D, 1994, BIOCHEM BIOPH RES CO, V200, P142, DOI 10.1006/bbrc.1994.1426; Thoms BL, 2013, ARTHRITIS RHEUM-US, V65, P1302, DOI 10.1002/art.37867; Thoms BL, 2010, J BIOL CHEM, V285, P20472, DOI 10.1074/jbc.M110.115238; Tung JT, 2002, OSTEOARTHR CARTILAGE, V10, P5, DOI 10.1053/joca.2001.0476; VaughanScott T, 1997, J S AFR VET ASSOC, V68, P21; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153; Yudoh K, 2005, ARTHRITIS RES THER, V7, pR904, DOI 10.1186/ar1765; ZAFARULLAH M, 1992, FEBS LETT, V306, P169, DOI 10.1016/0014-5793(92)80992-P; Zhong HM, 2013, INT IMMUNOPHARMACOL, V17, P329, DOI 10.1016/j.intimp.2013.06.027	54	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177144	10.1371/journal.pone.0177144	http://dx.doi.org/10.1371/journal.pone.0177144			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472120	Green Submitted, Green Published, gold			2022-12-26	WOS:000400648500144
J	Dumont, F; Lucas, E; Reale, D				Dumont, Francois; Lucas, Eric; Reale, Denis			Coexistence of zoophytophagous and phytozoophagous strategies linked to genotypic diet specialization in plant bug	PLOS ONE			English	Article							TUTA ABSOLUTA LEPIDOPTERA; BIOLOGICAL-CONTROL; PREDATORY MIRIDS; PRACTICAL GUIDE; APPLE ORCHARD; POTENTIAL USE; MULLEIN BUG; HEMIPTERA; POPULATIONS; HETEROPTERA	Zoophytophagous predators can substitute zoophagy for phytophagy to complete their development and reproduction. In such predators, variation in feeding behaviour is observed both across and within populations. This may be caused by genetic variation in diet specialization, some genotypes specializing on plant resources, whereas others rely mostly on prey to meet their energy and nutriment requirements. We tested the hypothesis that genotypes specialize either on prey or plant resources in the zoophytophagous mullein bug Campylomma verbasci. In the laboratory, we reared 11 isogroup lines of the mullein bug and recorded feeding behaviour on two diets. The first diet was composed of two-spotted spider mites and leaves, and in the second we added pollen, a high-quality vegetal resource. Overall differences in zoophagy among isogroup lines remained consistent regardless of the presence or absence of pollen. While some lines were insensitive to changes in trophic resource composition others switched from prey to pollen feeding when the pollen was available, revealing a negative genetic correlation between the probabilities of feeding on both resources. A significant line by diet interaction in the proportion of time spent feeding on prey in presence or absence of pollen indicated a genetic basis for diet preference. In absence of the preferred resource, nymphs act as generalists, but exhibited individual diet specialisation when facing the choice between high-quality animal and vegetal resources. Results suggest that zoophytophagous predators can exhibit genetic variation in diet preference, which can generate important ecological and economic differences in natural or agricultural systems.	[Dumont, Francois; Lucas, Eric; Reale, Denis] Univ Quebec Montreal, Dept Sci Biol, CP,Succ Ctr Ville, Montreal, PQ, Canada	University of Quebec; University of Quebec Montreal	Dumont, F (corresponding author), Univ Quebec Montreal, Dept Sci Biol, CP,Succ Ctr Ville, Montreal, PQ, Canada.	dumont.francois.3@courrier.uqam.ca	REALE, Denis/AAG-1571-2020	REALE, Denis/0000-0002-0419-7125; Dumont, Francois/0000-0001-7587-072X	NSERC; NSERC Natural Sciences and Engineering Research Council fellowship; NSERC discovery grants program	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Natural Sciences and Engineering Research Council fellowship; NSERC discovery grants program	Thanks to Pascale Ayotte, Andreanne Lavallee, Laurent Fraser, Sheena-Emilie Boucher and Mailys Allirand for their help in maintenance the isogroup lines and tests. We are grateful to Olivier Aubry for help during rearing setting and discussion on this work. F.D. was supported by a NSERC fellowship. The project expenses were financed by NSERC discovery grants program to E.L and D.R.; FD was supported by a NSERC Natural Sciences and Engineering Research Council (http.//www.nserc-crsng.gc.ca) fellowship. The project expenses were financed by NSERC discovery grants program to EL and DR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Arno J, 2010, B ENTOMOL RES, V100, P105, DOI 10.1017/S0007485309006841; Arno J, 2011, J PEST SCI, V84, P513, DOI 10.1007/s10340-011-0384-z; ARNOLDI D, 1992, ENTOMOPHAGA, V37, P283, DOI 10.1007/BF02372429; Aubry O, 2010, FAUN ENTOMOL, V63, P91; Biondi A, 2016, BIOCONTROL, V61, P79, DOI 10.1007/s10526-015-9700-5; BOIVIN G, 1982, CAN ENTOMOL, V114, P1037, DOI 10.4039/Ent1141037-11; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bolnick DI, 2007, P NATL ACAD SCI USA, V104, P10075, DOI 10.1073/pnas.0703743104; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Calvo J, 2009, BIOCONTROL, V54, P237, DOI 10.1007/s10526-008-9164-y; Castane C, 2011, BIOL CONTROL, V59, P22, DOI 10.1016/j.biocontrol.2011.03.007; Coll M, 2002, ANNU REV ENTOMOL, V47, P267, DOI 10.1146/annurev.ento.47.091201.145209; Dall SRX, 2012, ECOL LETT, V15, P1189, DOI 10.1111/j.1461-0248.2012.01846.x; David JR, 2005, HEREDITY, V94, P3, DOI 10.1038/sj.hdy.6800562; Dumont F, 2016, BIOCONTROL, V61, P425, DOI 10.1007/s10526-016-9721-8; Frechette B, 2008, EUR J ENTOMOL, V105, P521, DOI 10.14411/eje.2008.069; HOFFMANN AA, 1988, GENET SEL EVOL, V20, P87, DOI 10.1186/1297-9686-20-1-87; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Kinkorova J, 2000, J APPL ENTOMOL, V124, P381, DOI 10.1046/j.1439-0418.2000.00488.x; Luna MG, 2007, ENVIRON ENTOMOL, V36, P887, DOI 10.1603/0046-225X(2007)36[887:POTALG]2.0.CO;2; Mcgregor RR, 1999, BIOL CONTROL, V16, P104, DOI 10.1006/bcon.1999.0743; MCMULLEN R D, 1970, Canadian Entomologist, V102, P1390; MORETEAU B, 1995, GENETICA, V96, P207, DOI 10.1007/BF01439574; Moser SE, 2009, BIOL CONTROL, V51, P487, DOI 10.1016/j.biocontrol.2009.09.001; Nachappa P, 2011, FUNCT ECOL, V25, P1309, DOI 10.1111/j.1365-2435.2011.01892.x; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Nannini M., 2012, Bulletin OEPP, V42, P255, DOI 10.1111/epp.2563; R Core Team, 2021, R LANGUAGE ENV STAT; Reding ME, 2001, J ECON ENTOMOL, V94, P33, DOI 10.1603/0022-0493-94.1.33; Roitberg BD, 2005, NATURWISSENSCHAFTEN, V92, P431, DOI 10.1007/s00114-005-0013-x; SANFORD KH, 1964, J ECON ENTOMOL, V57, P921, DOI 10.1093/jee/57.6.921; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Svanback R, 2005, EVOL ECOL RES, V7, P993; THISTLEWOOD HMA, 1990, CAN ENTOMOL, V122, P1045, DOI 10.4039/Ent1221045-11; Torres JB, 2010, ARTHROPOD-PLANT INTE, V4, P219, DOI 10.1007/s11829-010-9095-2; Torres X, 1999, INTEGRATED PLANT PRO, V6, P139; WESTOBY M, 1978, AM NAT, V112, P627, DOI 10.1086/283303; Wheeler AG, 2001, BIOL PLANT BUGS; Zappala L, 2013, J PEST SCI, V86, P635, DOI 10.1007/s10340-013-0531-9; Zuur Alain F., 2009, P1	43	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176369	10.1371/journal.pone.0176369	http://dx.doi.org/10.1371/journal.pone.0176369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472105	Green Published, gold, Green Submitted			2022-12-26	WOS:000400648500041
J	Hallman, DM; Jorgensen, MB; Holtermann, A				Hallman, David M.; Jorgensen, Marie Birk; Holtermann, Andreas			On the health paradox of occupational and leisure-time physical activity using objective measurements: Effects on autonomic imbalance	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; INFLAMMATORY MARKERS; RISK; EXERCISE; HYPERTENSION; ASSOCIATION; VALIDITY; FITNESS	Objective Leisure-time physical activity (LTPA) has considerable benefits for cardiovascular health and longevity, while occupational physical activity (OPA) is associated with an elevated cardiovascular risk. This "health paradox" may be explained by different effects on the autonomic nervous system from OPA and LTPA. Thus, we aimed to investigate whether objectively measured OPA and LTPA are differentially associated with autonomic regulation among workers. Methods The study comprised 514 blue-collar workers from the Danish cohort DPHACTO. Physical activity (i.e. walking, climbing stairs, running and cycling) was assessed objectively using accelerometers worn on the thigh, hip and trunk over multiple working days. During this period, a heart rate monitor was used to sample heart period intervals from the ECG signal. Heart rate and heart rate variability (HRV) indices were analyzed during nocturnal sleep as markers of autonomic regulation. Multiple regression analysis was used to determine the main effects of OPA and LTPA and their interaction on heart rate and HRV, adjusting for multiple confounders. Results Statistically significant interaction was found between OPA and LTPA on heart rate (adjusted p<0.0001) and HRV indices in time (rMSSD, adjusted p = 0.004) and frequencydomains (HF, adjusted p = 0.022; LF, adjusted p = 0.033). The beneficial effect of LTPA on nocturnal heart rate and HRV clearly diminished with higher levels of OPA, and high levels of both OPA and LTPA had a detrimental effect. Conclusion We found contrasting associations for objectively measured OPA and LTPA with heart rate and HRV during sleep. Differential effects of OPA and LTPA on autonomic regulation may contribute to the physical activity health paradox.	[Hallman, David M.] Univ Gavle, Ctr Musculoskeletal Res, Dept Occupat & Publ Hlth Sci, Gavle, Sweden; [Jorgensen, Marie Birk; Holtermann, Andreas] Natl Res Ctr Working Environm, Copenhagen, Denmark	University of Gavle; National Research Centre for the Working Environment	Hallman, DM (corresponding author), Univ Gavle, Ctr Musculoskeletal Res, Dept Occupat & Publ Hlth Sci, Gavle, Sweden.	david.hallman@hig.se		Jorgensen, Marie Birk/0000-0002-1479-2622; Hallman, David/0000-0002-2741-1868				Ahdesmaki M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-233; Allen K, 2018, EDUC PSYCHOL REV, V30, P1, DOI 10.1007/s10648-016-9389-8; Allesoe K, 2015, EUR J PREV CARDIOL, V22, P1601, DOI 10.1177/2047487314554866; [Anonymous], 2011, JOINT BONE SPINE, DOI DOI 10.1016/j.jbspin.2011.01.014; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Blair SN, 2009, ANN EPIDEMIOL, V19, P253, DOI 10.1016/j.annepidem.2009.01.019; Boyett MR, 2013, J APPL PHYSIOL, V114, P1351, DOI 10.1152/japplphysiol.01126.2012; Camm AJ, 1996, CIRCULATION, V93, P1043; Clays E, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1002; Dekker JM, 2000, CIRCULATION, V102, P1239, DOI 10.1161/01.CIR.102.11.1239; Gerritsen J, 2001, DIABETES CARE, V24, P1793, DOI 10.2337/diacare.24.10.1793; Gupta N, 2016, SCAND J WORK ENV HEA, V42, P237, DOI 10.5271/sjweh.3561; Habib GB, 1999, EUR HEART J SUPPL, V1, pH2; Hallman DM, 2017, PHYSIOL BEHAV, V169, P90, DOI 10.1016/j.physbeh.2016.11.031; Hallman DM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012689; Hallman DM, 2016, INT ARCH OCC ENV HEA, V89, P823, DOI 10.1007/s00420-016-1123-9; Hallman DM, 2015, INT J ENV RES PUB HE, V12, P14811, DOI 10.3390/ijerph121114811; Hallman DM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2339-4; Harari G, 2015, OCCUP ENVIRON MED, V72, P617, DOI 10.1136/oemed-2014-102613; Holtermann A, 2012, BRIT J SPORT MED, V46, P291, DOI 10.1136/bjsm.2010.079582; Holtermann A, 2016, SCAND J WORK ENV HEA, V42, P291, DOI 10.5271/sjweh.3563; Holtermann A, 2015, OCCUP ENVIRON MED, V72, P615, DOI 10.1136/oemed-2015-102933; Holtermann A, 2010, SCAND J WORK ENV HEA, V36, P357, DOI 10.5271/sjweh.2913; Ingebrigtsen J., 2013, J ERGON, V03, P2, DOI DOI 10.4172/2165-7556.1000119; Jensen MT, 2012, EUR J PREV CARDIOL, V19, P102, DOI 10.1177/1741826710394274; Johansen CD, 2013, EUR HEART J, V34, P1732, DOI 10.1093/eurheartj/ehs449; Jorgensen MB, 2013, BMC MUSCULOSKEL DIS, V14, DOI [10.1186/1471-2474-14-213, 10.1186/1471-2474-14-86]; Joyner MJ, 2009, J PHYSIOL-LONDON, V587, P5551, DOI 10.1113/jphysiol.2009.179432; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; Korshoj M, 2014, ERGONOMICS, V57, P247, DOI 10.1080/00140139.2013.869358; Krause N, 2015, SCAND J WORK ENV HEA, V41, P124, DOI 10.5271/sjweh.3476; Kristiansen J, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-27; Lahti J, 2014, PLOS ONE, V9; Li J, 2013, CURR OPIN CARDIOL, V28, P575, DOI 10.1097/HCO.0b013e328364289c; Li J, 2012, INT J ENV RES PUB HE, V9, P391, DOI 10.3390/ijerph9020391; Liao DP, 2002, DIABETES, V51, P3524, DOI 10.2337/diabetes.51.12.3524; Liao DP, 1996, AM J HYPERTENS, V9, P1147, DOI 10.1016/S0895-7061(96)00249-X; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; Myllymaki T, 2011, J SLEEP RES, V20, P146, DOI 10.1111/j.1365-2869.2010.00874.x; Nolan J, 1998, CIRCULATION, V98, P1510, DOI 10.1161/01.CIR.98.15.1510; Pejtersen JH, 2010, SCAND J PUBLIC HEALT, V38, P8, DOI 10.1177/1403494809349858; Reiner M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-813; Rennie KL, 2003, AM J EPIDEMIOL, V158, P135, DOI 10.1093/aje/kwg120; Sandercock GRH, 2005, MED SCI SPORT EXER, V37, P433, DOI 10.1249/01.MSS.0000155388.39002.9D; Schuster AK, 2016, INT J CARDIOL, V203, P728, DOI 10.1016/j.ijcard.2015.11.027; Skotte J, 2014, J PHYS ACT HEALTH, V11, P76, DOI 10.1123/jpah.2011-0347; Skotte JH, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-138; Sloan RP, 2007, MOL MED, V13, P178, DOI 10.2119/2006-00112.Sloan; Soares-Miranda L, 2014, CIRCULATION, V129, P2100, DOI 10.1161/CIRCULATIONAHA.113.005361; Stemland I, 2015, ERGONOMICS, V58, P953, DOI 10.1080/00140139.2014.998724; Thayer JF, 2007, BIOL PSYCHOL, V74, P224, DOI 10.1016/j.biopsycho.2005.11.013; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39	54	46	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177042	10.1371/journal.pone.0177042	http://dx.doi.org/10.1371/journal.pone.0177042			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472190	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500127
J	Lin, YC; Chang, SC; Juang, RH				Lin, Yi-Chen; Chang, Shih-Chung; Juang, Rong-Huay			Plastidial alpha-glucan phosphorylase 1 complexes with disproportionating enzyme 1 in Ipomoea batatas storage roots for elevating malto-oligosaccharide metabolism	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; SWEET-POTATO ROOTS; STARCH BIOSYNTHETIC-ENZYMES; CHLAMYDOMONAS-REINHARDTII; GRANULE BIOSYNTHESIS; RICE ENDOSPERM; AMYLOPECTIN; PURIFICATION; ARABIDOPSIS; AMYLOPLASTS	It has been proposed that malto-oligosaccharides (MOSs) are possibly recycled back into amylopectin biosynthesis via the sequential reactions catalyzed by plastidial a-glucan phosphorylase 1 (Pho1) and disproportionating enzyme 1 (Dpe1). In the present study, the reciprocal co-immunoprecipitation experiments using specific antibodies against Pho1 and Dpe1 demonstrated that these two enzymes can form a complex (the PD complex) in Ipomoea batatas storage roots. The immunohistochemistry analyses also revealed the co-localization of Pho1 and Dpe1 in the amyloplasts, and the protein levels of Pho1 and Dpe1 increased gradually throughout sweet potato storage root development. A high molecular weight PD complex was co-purified from sweet potato storage root lysates by size exclusion chromatography. Enzyme kinetic analyses showed that the PD complex can catalyze maltotriose and maltotetraose to generate glucose-1-phosphate in the presence of inorganic phosphate, and it also performs greater Dpe1 activity toward MOSs than does free form Dpe1. These data suggest that Pho1 and Dpe1 may form a metabolon complex, which provides elevated metabolic fluxes for MOS metabolism via a direct transfer of sugar intermediates, resulting in recycling of glucosyl units back into amylopectin biosynthesis more efficiently.	[Lin, Yi-Chen; Chang, Shih-Chung; Juang, Rong-Huay] Natl Taiwan Univ, Coll Life Sci, Dept Biochem Sci & Technol, Taipei, Taiwan	National Taiwan University	Chang, SC; Juang, RH (corresponding author), Natl Taiwan Univ, Coll Life Sci, Dept Biochem Sci & Technol, Taipei, Taiwan.	shihchung@ntu.edu.tw; juang@ntu.edu.tw	Hsiao, Wei-Hung/B-9931-2013	CHANG, SHIH-CHUNG/0000-0002-5015-8178	Ministry of Science and Technology, Taiwan [105-2119-M-001-014, 103-2313-B-002-030-MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the Ministry of Science and Technology, Taiwan (105-2119-M-001-014 awarded to SCC; 103-2313-B-002-030-MY3 awarded to RHJ), https://www.most.gov.tw/.. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2015, PLANT SCI, V233, P95, DOI 10.1016/j.plantsci.2014.12.016; Ball S, 1996, CELL, V86, P349, DOI 10.1016/S0092-8674(00)80107-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bresolin NS, 2006, PLANTA, V224, P20, DOI 10.1007/s00425-005-0187-7; BRISSON N, 1989, PLANT CELL, V1, P559, DOI 10.1105/tpc.1.5.559; Chang SC, 2000, BOT BULL ACAD SINICA, V41, P105; CHANG TC, 1987, AGR BIOL CHEM TOKYO, V51, P187, DOI 10.1080/00021369.1987.10867980; Chen HM, 2002, PHYSIOL PLANTARUM, V114, P506, DOI 10.1034/j.1399-3054.2002.1140402.x; Colleoni C, 1999, PLANT PHYSIOL, V120, P993, DOI 10.1104/pp.120.4.993; Colleoni C, 1999, PLANT PHYSIOL, V120, P1005, DOI 10.1104/pp.120.4.1005; Critchley JH, 2001, PLANT J, V26, P89, DOI 10.1046/j.1365-313x.2001.01012.x; Crofts N, 2015, J EXP BOT, V66, P4469, DOI 10.1093/jxb/erv212; da Mota RV, 2002, PLANTA, V216, P325, DOI 10.1007/s00425-002-0858-6; Dauvillee D, 2006, PLANT J, V48, P274, DOI 10.1111/j.1365-313X.2006.02870.x; Dong XB, 2015, PLANT PHYSIOL, V169, P2496, DOI 10.1104/pp.15.01411; Fettke J, 2006, PLANT J, V46, P668, DOI 10.1111/j.1365-313X.2006.02732.x; Hwang SK, 2010, ARCH BIOCHEM BIOPHYS, V495, P82, DOI 10.1016/j.abb.2009.12.023; Hwang SK, 2016, J BIOL CHEM; KAKEFUDA G, 1989, PLANT PHYSIOL, V91, P136, DOI 10.1104/pp.91.1.136; Ko YT, 2005, J AGR FOOD CHEM, V53, P5708, DOI 10.1021/jf050193f; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035336; Liu FS, 2009, J EXP BOT, V60, P4423, DOI 10.1093/jxb/erp297; Lutken H, 2010, PLANTA, V232, P1127, DOI 10.1007/s00425-010-1245-3; Mu HH, 2001, ARCH BIOCHEM BIOPHYS, V388, P155, DOI 10.1006/abbi.2000.2267; Myers AM, 2000, PLANT PHYSIOL, V122, P989, DOI 10.1104/pp.122.4.989; Nakamura Y, 2012, PLANT CELL PHYSIOL, V53, P869, DOI 10.1093/pcp/pcs030; Orawetz T, 2016, PLANT PHYSIOL BIOCH, V100, P141, DOI 10.1016/j.plaphy.2016.01.013; Satoh H, 2008, PLANT CELL, V20, P1833, DOI 10.1105/tpc.107.054007; Steup M., 1988, BIOCH PLANTS COMPREH, P255; Streb S, 2008, PLANT CELL, V20, P3448, DOI 10.1105/tpc.108.063487; Subasinghe RM, 2014, PLANT PHYSIOL BIOCH, V83, P168, DOI 10.1016/j.plaphy.2014.07.016; Sweetlove LJ, 2013, ANNU REV PLANT BIOL, V64, P723, DOI 10.1146/annurev-arplant-050312-120233; Tagami T, 2013, BIOSCI BIOTECH BIOCH, V77, P312, DOI 10.1271/bbb.120732; TAKAHA T, 1993, J BIOL CHEM, V268, P1391; Takaha T, 1998, PLANTA, V205, P445, DOI 10.1007/s004250050342; Tetlow IJ, 2004, PLANT CELL, V16, P694, DOI 10.1105/tpc.017400; Tickle P, 2009, J PLANT PHYSIOL, V166, P1465, DOI 10.1016/j.jplph.2009.05.004; Tiessen A, 2002, PLANT CELL, V14, P2191, DOI 10.1105/tpc.003640; Wattebled F, 2003, PLANT PHYSIOL, V132, P137, DOI 10.1104/pp.102.016527; Young GH, 2006, PLANTA, V223, P468, DOI 10.1007/s00425-005-0103-1; Yu Y, 2001, PLANT PHYSIOL, V125, P351, DOI 10.1104/pp.125.1.351; Zeeman SC, 2004, PLANT PHYSIOL, V135, P849, DOI 10.1104/pp.103.032631	43	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177115	10.1371/journal.pone.0177115	http://dx.doi.org/10.1371/journal.pone.0177115			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472155	Green Submitted, Green Published, gold			2022-12-26	WOS:000400648500137
J	Rosenberger, DW; Venette, RC; Maddox, MP; Aukema, BH				Rosenberger, Derek W.; Venette, Robert C.; Maddox, Mitchell P.; Aukema, Brian H.			Colonization behaviors of mountain pine beetle on novel hosts: Implications for range expansion into northeastern North America	PLOS ONE			English	Article							DENDROCTONUS-PONDEROSAE COLEOPTERA; BARK BEETLES; LODGEPOLE PINE; BRITISH-COLUMBIA; MONOTERPENE COMPOSITION; PHEROMONE PRODUCTION; CHEMICAL DEFENSES; PHLOEM THICKNESS; UNITED-STATES; EXOTIC BARK	As climates change, thermal limits may no longer constrain some native herbivores within their historical ranges. The mountain pine beetle, Dendroctonus ponderosae Hopkins, is a tree-killing bark beetle native to western North America that is currently expanding its range. Continued eastward expansion through the newly invaded and novel jack pine (Pinus bank-siana Lamb.) trees of the Canadian boreal forest could result in exposure of several species of novel potential host pines common in northeastern North America to this oligophagous herbivore. Due to the tightly co-evolved relationship between mountain pine beetle and western pine hosts, in which the insect utilizes the defensive chemistry of the host to stimulate mass attacks, we hypothesized that lack of co-evolutionary association would affect the host attraction and acceptance behaviors of this insect among novel hosts, particularly those with little known historical association with an aggressive stem-infesting insect. We studied how beetle behavior differed among the various stages of colonization on newly cut logs of four novel potential pine host species; jack, red (P. resinosa Ait.), eastern white (P. strobus L.) and Scots (P. sylvestris L.) pines, as well as two historical hosts, ponderosa (P. ponderosa Dougl. ex. Laws. var. scopulorum Engelm.) and lodgepole (P. contorta Dougl. var. latifolia Engelm.) pines. Overall, we found that beetle colonization behaviors at each stage in the colonization process differ between pine hosts, likely due to differing chemical and physical bark traits. Pines without co-evolved constitutive defenses against mountain pine beetle exhibited reduced amounts of defensive monoterpenoid chemicals; however, such patterns also reduced beetle attraction and colonization. Neither chemical nor physical defenses fully defended trees against the various stages of host procurement that can result in tree colonization and death.	[Rosenberger, Derek W.; Aukema, Brian H.] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA; [Rosenberger, Derek W.] Olivet Nazarene Univ, Dept Biol Sci, Bourbonnais, IL 60914 USA; [Venette, Robert C.] USDA, US Forest Serv, Northern Res Stn, St Paul, MN USA; [Maddox, Mitchell P.] Bethel Univ, Dept Chem, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA); United States Forest Service	Rosenberger, DW (corresponding author), Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA.; Rosenberger, DW (corresponding author), Olivet Nazarene Univ, Dept Biol Sci, Bourbonnais, IL 60914 USA.	dwrosenberger@olivet.edu			Minnesota Environment and Natural Resources Trust Fund; University of Minnesota Graduate Fellowship	Minnesota Environment and Natural Resources Trust Fund; University of Minnesota Graduate Fellowship(University of Minnesota System)	This research was funded by the Minnesota Environment and Natural Resources Trust Fund (Appropriation: M.L.2014 Chpt. 226, Sec. 2 subd.4e.) and a University of Minnesota Graduate Fellowship to DWR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta SJ, 2006, OIKOS, V114, P556, DOI 10.1111/j.2006.0030-1299.15025.x; Amman G.D., 1969, USDA FOREST SERVICE; Amman G.D, 1986, USDA FOREST SERVICE; AMMAN GD, 1972, J ECON ENTOMOL, V65, P138, DOI 10.1093/jee/65.1.138; Anderson RF, 1993, 66 N CAR FOR SERV; [Anonymous], 1971, ATLAS US TREES; Aukema JE, 2010, BIOSCIENCE, V60, P886, DOI 10.1525/bio.2010.60.11.5; Bentz BJ, 2017, NEW PHYTOL, V213, P611, DOI 10.1111/nph.14191; Bentz BJ, 2015, AGR FOREST ENTOMOL, V17, P421, DOI 10.1111/afe.12124; BERRYMAN AA, 1976, ENVIRON ENTOMOL, V5, P1225, DOI 10.1093/ee/5.6.1225; Bertheau C, 2010, ECOL LETT, V13, P506, DOI 10.1111/j.1461-0248.2010.01445.x; BILLINGS RF, 1976, ENVIRON ENTOMOL, V5, P171, DOI 10.1093/ee/5.1.171; Boone CK, 2011, CAN J FOREST RES, V41, P1174, DOI [10.1139/X11-041, 10.1139/x11-041]; Borden JH, 2008, J ECON ENTOMOL, V101, P1266, DOI 10.1603/0022-0493(2008)101[1266:SBOMFA]2.0.CO;2; Boyd IL, 2013, SCIENCE, V342, P823, DOI 10.1126/science.1235773; Brockerhoff EG, 2006, CAN J FOREST RES, V36, P289, DOI [10.1139/x05-250, 10.1139/X05-250]; Burke JL, 2016, FOREST ECOL MANAG, V359, P59, DOI 10.1016/j.foreco.2015.09.044; Cale JA, 2015, CAN J FOREST RES, V45, P1873, DOI 10.1139/cjfr-2015-0277; CARMER SG, 1973, J AM STAT ASSOC, V68, P66, DOI 10.2307/2284140; Carmona D, 2011, FUNCT ECOL, V25, P358, DOI 10.1111/j.1365-2435.2010.01794.x; Carrillo-Gavilan A, 2012, FUNCT ECOL, V26, P283, DOI 10.1111/j.1365-2435.2011.01931.x; Clark EL, 2012, ENVIRON ENTOMOL, V41, P392, DOI 10.1603/EN11295; Clark EL, 2014, PEERJ, V2, DOI 10.7717/peerj.240; Clark EL, 2010, CAN ENTOMOL, V142, P557, DOI 10.4039/n10-022; CONN JE, 1983, CAN J FOREST RES, V13, P320, DOI 10.1139/x83-045; Cullingham CI, 2011, MOL ECOL, V20, P2157, DOI 10.1111/j.1365-294X.2011.05086.x; Davis TS, 2014, FOREST SCI, V60, P270, DOI 10.5849/forsci.12-155; de la Giroday HMC, 2012, J BIOGEOGR, V39, P1112, DOI 10.1111/j.1365-2699.2011.02673.x; Dodds KJ, 2010, ANN ENTOMOL SOC AM, V103, P39, DOI 10.1603/008.103.0106; Elkin CM, 2004, ENVIRON ENTOMOL, V33, P1070, DOI 10.1603/0046-225X-33.4.1070; Emerick JJ, 2008, ENVIRON ENTOMOL, V37, P871, DOI 10.1603/0046-225X(2008)37[871:MPBAAW]2.0.CO;2; Erbilgin N, 2001, J ECON ENTOMOL, V94, P1113, DOI 10.1603/0022-0493-94.5.1113; Erbilgin N, 2014, NEW PHYTOL, V201, P940, DOI 10.1111/nph.12573; EVANS HF, 1994, FOREST ECOL MANAG, V65, P17, DOI 10.1016/0378-1127(94)90254-2; Ferrenberg S, 2014, FUNCT ECOL, V28, P837, DOI 10.1111/1365-2435.12228; Ferrenberg S, 2014, OECOLOGIA, V174, P1283, DOI 10.1007/s00442-013-2841-2; Franceschi VR, 2005, NEW PHYTOL, V167, P353, DOI 10.1111/j.1469-8137.2005.01436.x; FURNISS MM, 1969, J ECON ENTOMOL, V62, P518, DOI 10.1093/jee/62.2.518; Goodsman DW, 2016, ECOL APPL IN PRESS; Gray CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135752; Gripenberg S, 2010, ECOL LETT, V13, P383, DOI 10.1111/j.1461-0248.2009.01433.x; Haack RA, 2006, CAN J FOREST RES, V36, P269, DOI 10.1139/x05-249; Hain Fred P., 2011, U S Forest Service General Technical Report SRS, V140, P13; Harvey BJ, 2014, ECOL APPL, V24, P1608, DOI 10.1890/13-1851.1; Hassett M, 2015, MCDONNELL S NEW YORK; HAYES JL, 1994, J ECON ENTOMOL, V87, P1586, DOI 10.1093/jee/87.6.1586; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hubbard RM, 2013, FOREST ECOL MANAG, V289, P312, DOI 10.1016/j.foreco.2012.09.028; HYNUM BG, 1980, CAN ENTOMOL, V112, P185, DOI 10.4039/Ent112185-2; Kane JM, 2010, OECOLOGIA, V164, P601, DOI 10.1007/s00442-010-1683-4; Karst J, 2015, NEW PHYTOL, V208, P904, DOI 10.1111/nph.13492; Keefover-Ring K, 2016, J CHEM ECOL, V42, P1, DOI 10.1007/s10886-015-0659-6; Kim JJ, 2005, CAN J FOREST RES, V35, P274, DOI 10.1139/x04-178; Klepzig KD, 1996, J CHEM ECOL, V22, P1367, DOI 10.1007/BF02027719; KLEPZIG KD, 1995, J CHEM ECOL, V21, P601, DOI 10.1007/BF02033704; Kovacs KF, 2010, ECOL ECON, V69, P569, DOI 10.1016/j.ecolecon.2009.09.004; Krokene P., 2015, BARK BEETLES BIOL EC, P177, DOI [10.1016/B978-0-12-417156-5.00005-8, DOI 10.1016/B978-0-12-417156-5.00005-8]; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Kyto M, 1998, FOREST ECOL MANAG, V102, P121, DOI 10.1016/S0378-1127(97)00150-3; Latty TM, 2010, BEHAV ECOL SOCIOBIOL, V64, P639, DOI 10.1007/s00265-009-0881-8; LIEUTIER F, 1989, ENVIRON ENTOMOL, V18, P228, DOI 10.1093/ee/18.2.228; Lindgren BS, 2013, CAN ENTOMOL, V145, P471, DOI 10.4039/tce.2013.27; LINDGREN BS, 1983, CAN ENTOMOL, V115, P299, DOI 10.4039/Ent115299-3; Logan JA, 1999, ENVIRON ENTOMOL, V28, P924, DOI 10.1093/ee/28.6.924; Logan JA, 2010, ECOL APPL, V20, P895, DOI 10.1890/09-0655.1; Lovett GM, 2016, ECOL APPL, V26, P1437, DOI 10.1890/15-1176; Maness H., 2012, NAT GEOSCI, V5, P1; Manninen AM, 2002, J CHEM ECOL, V28, P211, DOI 10.1023/A:1013579222600; McKee FR, 2015, CAN ENTOMOL, V7, P1; McKee FR, 2013, AGR FOREST ENTOMOL, V15, P310, DOI 10.1111/afe.12019; Meddens AJH, 2012, ECOL APPL, V22, P1876, DOI 10.1890/11-1785.1; Miller Daniel R., 2000, Journal of the Entomological Society of British Columbia, V97, P41; Miller DR, 2000, CAN ENTOMOL, V132, P183, DOI 10.4039/Ent132183-2; MOECK HA, 1991, CAN ENTOMOL, V123, P299, DOI 10.4039/Ent123299-2; Moore DJP, 2013, ECOL LETT, V16, P731, DOI 10.1111/ele.12097; Nealis VG, 2014, RISK ASSESSMENT THRE; PITMAN GB, 1968, NATURE, V218, P168, DOI 10.1038/218168a0; Pureswaran DS, 2000, CHEMOECOLOGY, V10, P153, DOI 10.1007/PL00001818; Raffa K.F., 1991, P245; Raffa K.F., 1993, STRATEGIES MECH HOST, P103; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Raffa KF, 2014, J CHEM ECOL, V40, P1, DOI 10.1007/s10886-013-0368-y; Raffa KF, 2013, P NATL ACAD SCI USA, V110, P2193, DOI 10.1073/pnas.1216666110; RAFFA KF, 1982, CAN ENTOMOL, V114, P97, DOI 10.4039/Ent11497-2; RAFFA KF, 1983, ECOL MONOGR, V53, P27, DOI 10.2307/1942586; RAFFA KF, 1988, CAN J FOREST RES, V18, P581, DOI 10.1139/x88-084; RAFFA KF, 1995, OECOLOGIA, V102, P285, DOI 10.1007/BF00329795; Reed DE, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/10/105004; RICHMOND HECTOR A., 1933, FOREST CHRON, V9, P60; Robertson C, 2009, J BIOGEOGR, V36, P1446, DOI 10.1111/j.1365-2699.2009.02100.x; Rosenberger D.W., 2016, THESIS; Rosenberger DW, 2016, ENTOMOL EXP APPL, V160, P195, DOI 10.1111/eea.12463; Safranyik L., 2006, The mountain pine beetle: a synthesis of biology, management and impacts on lodgepole pine; SAFRANYIK L, 1971, CAN ENTOMOL, V103, P1607, DOI 10.4039/Ent1031607-11; Safranyik L, 2010, CAN ENTOMOL, V142, P415, DOI 10.4039/n08-CPA01; Safranyik L., 1975, MANAGEMENT LODGEPOLE, P406; Schaupp W. C, 1993, RM522 USDA FOR SERV; Seybold Steven J., 2006, Phytochemistry Reviews, V5, P143, DOI 10.1007/s11101-006-9002-8; SHRIMPTON DM, 1985, CAN J FOREST RES, V15, P1004, DOI 10.1139/x85-161; Six DL, 1998, ENVIRON ENTOMOL, V27, P1393, DOI 10.1093/ee/27.6.1393; Six DL, 2003, CAN J FOREST RES, V33, P1331, DOI [10.1139/x03-047, 10.1139/X03-047]; Smith R.H., 1981, PSW354 USDA FOR SERV; SMITH RH, 1963, J ECON ENTOMOL, V56, P827, DOI 10.1093/jee/56.6.827; Solheim H, 1998, CAN J BOT, V76, P561, DOI 10.1139/cjb-76-4-561; Strom BL, 1999, ECOL APPL, V9, P1028, DOI 10.1890/1051-0761(1999)009[1028:VASDOH]2.0.CO;2; Sun JH, 2013, ANNU REV ENTOMOL, V58, P293, DOI 10.1146/annurev-ento-120811-153624; Taft S, 2015, J CHEM ECOL, V41, P540, DOI 10.1007/s10886-015-0590-x; Taft S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00342; THOMPSON JN, 1988, ENTOMOL EXP APPL, V47, P3, DOI 10.1007/BF00186709; Wallin KF, 2000, ENVIRON ENTOMOL, V29, P442, DOI 10.1603/0046-225X-29.3.442; Weed AS, 2013, ECOL MONOGR, V83, P441, DOI 10.1890/13-0160.1; Werner RA., 1995, ENVIRON ENTOMOL, V24, P151; West DR, 2016, ENVIRON ENTOMOL, V45, P127, DOI 10.1093/ee/nvv167; West DR., 2013, THESIS; WOOD DL, 1982, ANNU REV ENTOMOL, V27, P411, DOI 10.1146/annurev.en.27.010182.002211; Wood SL, 1982, PROVO UTAH GREAT BAS, V6	116	33	33	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176269	10.1371/journal.pone.0176269	http://dx.doi.org/10.1371/journal.pone.0176269			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472047	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500034
J	Ackermann, M; Hatt, JM; Schetle, N; Steinmetz, H				Ackermann, Mathias; Hatt, Jean-Michel; Schetle, Nelli; Steinmetz, Hanspeter			Identification of shedders of elephant endotheliotropic herpesviruses among Asian elephants (Elephas maximus) in Switzerland	PLOS ONE			English	Article							INFECTION	Elephants, particularly Asian (Elephas maximus), are threatened by lethal elephant hemorrhagic disease (EHD) due to elephant endotheliotropic herpesviruses (EEHV). At least five of seven known EEHV types have been associated to EHD, with types 1, 4, and 5 predominantly affecting Asian elephants. In Switzerland, at least three Asian elephants have been lost due to EHD but nothing is known about the present EEHV1 circulation. Moreover, the prevalence of other EEHV types has never been assessed. Intermittent shedding of EEHV can be monitored through collecting trunk secretions and analyzing them by PCR methods that discriminate the different EEHV types. To identify EEHV shedders, seven of eight Asian elephants in a Swiss zoo were trained to provide trunk wash samples. These were collected at intervals over a period of four months and tested by PCR for presence of EEHV1 through 6. Moreover, the quality of each sample was assessed by testing for the elephant TNFalpha gene. Overall, 57% of the samples were valid with five of seven participating elephants identified as EEHV shedders. Two of those shed virus only once, whereas the other three, all closely related among each other, shed virus on multiple occasions. One of the frequent shedders had been in very close contact to all of the three EHD victims. Therefore, we speculate that this particular animal may represent the virus source in all three cases. However, when subtyping was conducted, the presently circulating virus was identified as EEHV1B, while the virus subtype causing EHD had been 1A in all three cases. In addition to four animals excreting EEHV1, a recently introduced animal was observed to shed EEHV3/4. We suggest that the policy of trunk washing to identify and characterize EEHV-shedders is to be endorsed in zoos with ongoing or planned elephant breeding programs.	[Ackermann, Mathias; Schetle, Nelli] Univ Zurich, Vetsuisse Fac, Inst Virol, Zurich, Switzerland; [Hatt, Jean-Michel] Univ Zurich, Clin Zoo Anim Exot Pets & Wildlife, Vetsuisse Fac, Zurich, Switzerland; [Steinmetz, Hanspeter] Walter Zoo, Gossau, Switzerland	University of Zurich; University of Zurich	Ackermann, M (corresponding author), Univ Zurich, Vetsuisse Fac, Inst Virol, Zurich, Switzerland.	mathias.ackermann@uzh.ch	Hatt, Jean-Michel/C-3850-2015	Steinmetz, Hanspeter W./0000-0002-5879-0207; Hatt, Jean-Michel/0000-0002-7043-7430	University of Zurich [F-52601-10-01]	University of Zurich	This work was supported by a private donation of the late Prof. Dr. Robert Wyler to MA (F-52601-10-01) as well as by general funds allocated to MA by the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript.	Fickel J, 2001, VET MICROBIOL, V82, P103, DOI 10.1016/S0378-1135(01)00363-7; Garner MM, 2009, VET PATHOL, V46, P97, DOI 10.1354/vp.46-1-97; Guttman-Yassky E, 2004, J INFECT DIS, V189, P2023, DOI 10.1086/386308; Hayward GS, 2012, VET REC, V170, P202, DOI 10.1136/vr.e1212; Latimer E, 2011, VET MICROBIOL, V147, P28, DOI 10.1016/j.vetmic.2010.05.042; Ling PD, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00106-13; Long SY, 2015, ILAR J, V56, P283, DOI 10.1093/ilar/ilv041; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; OSSENT P, 1990, VET PATHOL, V27, P131, DOI 10.1177/030098589002700212; Pellett PE, 2014, J VIROL, V88, P13520, DOI 10.1128/JVI.02359-14; Plancoulaine S, 2003, J INFECT DIS, V187, P1944, DOI 10.1086/375345; Richman LK, 1999, SCIENCE, V283, P1171, DOI 10.1126/science.283.5405.1171; Richman LK, 2014, J VIROL; Schmitt DL, 2000, J ZOO WILDLIFE MED, V31, P518, DOI 10.1638/1042-7260(2000)031[0518:UOFFTT]2.0.CO;2; Stanton JJ, 2013, J ZOO WILDLIFE MED, V44, P42, DOI 10.1638/1042-7260-44.1.42; Stanton JJ, 2012, J VIROL METHODS, V186, P73, DOI 10.1016/j.jviromet.2012.07.024; Stanton JJ, 2010, AM J VET RES, V71, P925, DOI 10.2460/ajvr.71.8.925; Wilkie GS, 2013, J VIROL, V87, P6700, DOI 10.1128/JVI.00655-13; Work TM, 2015, VET PATHOL, V52, P1195, DOI 10.1177/0300985814560236; Zong JC, 2014, J VIROL	20	12	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176891	10.1371/journal.pone.0176891	http://dx.doi.org/10.1371/journal.pone.0176891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467495	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000400647000083
J	Koc, I; Caetano-Anolles, G				Koc, Ibrahim; Caetano-Anolles, Gustavo			The natural history of molecular functions inferred from an extensive phylogenomic analysis of gene ontology data	PLOS ONE			English	Article							PROTEIN DOMAINS; EVOLUTIONARY HISTORY; AEROBIC METABOLISM; COMMON ANCESTOR; UNIVERSAL TREE; GENOMIC CENSUS; ORIGIN; PROTEOMES; FOLD; ANCIENT	The origin and natural history of molecular functions hold the key to the emergence of cellular organization and modern biochemistry. Here we use a genomic census of Gene Ontology (GO) terms to reconstruct phylogenies at the three highest (1, 2 and 3) and the lowest (terminal) levels of the hierarchy of molecular functions, which reflect the broadest and the most specific GO definitions, respectively. These phylogenies define evolutionary timelines of functional innovation. We analyzed 249 free-living organisms comprising the three super-kingdoms of life, Archaea, Bacteria, and Eukarya. Phylogenies indicate catalytic, binding and transport functions were the oldest, suggesting a `metabolism-first' origin scenario for biochemistry. Metabolism made use of increasingly complicated organic chemistry. Primordial features of ancient molecular functions and functional recruitments were further distilled by studying the oldest child terms of the oldest level 1 GO definitions. Network analyses showed the existence of an hourglass pattern of enzyme recruitment in the molecular functions of the directed acyclic graph of molecular functions. Older high-level molecular functions were thoroughly recruited at younger lower levels, while very young high-level functions were used throughout the timeline. This pattern repeated in every one of the three mappings, which gave a criss-cross pattern. The timelines and their mappings were remarkable. They revealed the progressive evolutionary development of functional toolkits, starting with the early rise of metabolic activities, followed chronologically by the rise of macromolecular biosynthesis, the establishment of controlled interactions with the environment and self, adaptation to oxygen, and enzyme coordinated regulation, and ending with the rise of structural and cellular complexity. This historical account holds important clues for dissection of the emergence of biomcomplexity and life.	[Koc, Ibrahim] Gebze Tech Univ, Mol Biol & Genet, Kocaeli, Turkey; [Caetano-Anolles, Gustavo] Univ Illinois, Evolutionary Bioinformat Lab, Dept Crop Sci, Urbana, IL 61801 USA	Gebze Technical University; University of Illinois System; University of Illinois Urbana-Champaign	Caetano-Anolles, G (corresponding author), Univ Illinois, Evolutionary Bioinformat Lab, Dept Crop Sci, Urbana, IL 61801 USA.	gca@illinois.edu			National Science Foundation [OISE-1132791]; United States Department of Agriculture [ILLU-802-909, ILLU-483-625]; Blue Waters computer grid allocation of the National Center for Supercomputer Applications (NCSA); Scientific and Technological Research Council of Turkey (TUBITAK) [1059B141400573]; TUBITAK	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA)); Blue Waters computer grid allocation of the National Center for Supercomputer Applications (NCSA); Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	Computational biology in the Evolutionary Bioinformatics Laboratory (EBL) is supported by grants from the National Science Foundation (OISE-1132791) and the United States Department of Agriculture (ILLU-802-909 and ILLU-483-625) and by a Blue Waters computer grid allocation of the National Center for Supercomputer Applications (NCSA) to GCA. The visit of IK to EBL was supported by a grant from Scientific and Technological Research Council of Turkey (TUBITAK, No. no. 1059B141400573). All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Arshan Nasir for his help and sugestions. IK spent a year working in the Evolutionary Bioinformatics Laboratory thanks to the support of TUBITAK.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balakrishnan R, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat054; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Caetano-Anolles G, 2005, J MOL EVOL, V60, P484, DOI 10.1007/s00239-004-0221-6; Caetano-Anolles G, 2003, GENOME RES, V13, P1563, DOI 10.1101/gr.1161903; Caetano-Anolles G, 2007, P NATL ACAD SCI USA, V104, P9358, DOI 10.1073/pnas.0701214104; Caetano-Anolles G, 2012, J MOL EVOL, V74, P1, DOI 10.1007/s00239-011-9480-1; Caetano-Anolles G, 2009, BIOCHEM J, V417, P621, DOI 10.1042/BJ20082063; Caetano-Anolles G, 2009, INT J BIOCHEM CELL B, V41, P285, DOI 10.1016/j.biocel.2008.08.022; Campbell IH, 2008, NAT GEOSCI, V1, P554, DOI 10.1038/ngeo259; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Carrigan MA, 2015, P NATL ACAD SCI USA, V112, P458, DOI 10.1073/pnas.1404167111; CASTRESANA J, 1994, EMBO J, V13, P2516, DOI 10.1002/j.1460-2075.1994.tb06541.x; Chang CW, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S27; Cummings MP, 2008, EVOLUTION, V62, P2411, DOI 10.1111/j.1558-5646.2008.00442.x; Devasagayam T P A, 2004, J Assoc Physicians India, V52, P794; Doolittle RF, 2005, CURR OPIN STRUC BIOL, V15, P248, DOI 10.1016/j.sbi.2005.04.001; Dupont CL, 2006, P NATL ACAD SCI USA, V103, P17822, DOI 10.1073/pnas.0605798103; Ebach MC, 1999, CLADISTICS, V15, P387, DOI 10.1111/j.1096-0031.1999.tb00275.x; FARRIS JS, 1989, SYST ZOOL, V38, P406, DOI 10.2307/2992406; Forterre P, 1999, BIOESSAYS, V21, P871, DOI 10.1002/(SICI)1521-1878(199910)21:10<871::AID-BIES10>3.0.CO;2-Q; Garcia-Vallve S, 2003, NUCLEIC ACIDS RES, V31, P187, DOI 10.1093/nar/gkg004; Garcia-Vallve S, 2000, GENOME RES, V10, P1719, DOI 10.1101/gr.130000; Gerstein M, 1998, PROTEINS, V33, P518, DOI 10.1002/(SICI)1097-0134(19981201)33:4<518::AID-PROT5>3.0.CO;2-J; Glansdorff N, 2000, MOL MICROBIOL, V38, P177, DOI 10.1046/j.1365-2958.2000.02126.x; Glansdorff N, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-29; GOGARTEN JP, 1989, P NATL ACAD SCI USA, V86, P6661, DOI 10.1073/pnas.86.17.6661; Gribaldo S, 2002, THEOR POPUL BIOL, V61, P391, DOI 10.1006/tpbi.2002.1593; Hakansson K, 2000, P NATL ACAD SCI USA, V97, P14097, DOI 10.1073/pnas.260376797; Harish A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032776; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hawkins JA, 1997, CLADISTICS, V13, P275, DOI 10.1111/j.1096-0031.1997.tb00320.x; Hlinkova V, 2008, ACTA CRYSTALLOGR D, V64, P941, DOI 10.1107/S0907444908021665; Huntley RP, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-4; Illergard K, 2009, PROTEINS, V77, P499, DOI 10.1002/prot.22458; IWABE N, 1989, P NATL ACAD SCI USA, V86, P9355, DOI 10.1073/pnas.86.23.9355; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; KACSER H, 1984, J MOL EVOL, V20, P38, DOI 10.1007/BF02101984; KASTING JF, 1993, SCIENCE, V259, P920, DOI 10.1126/science.11536547; Kazmierczak RA, 2002, NUCLEIC ACIDS RES, V30, P5193, DOI 10.1093/nar/gkf652; Kim KM, 2014, J MOL EVOL, V79, P240, DOI 10.1007/s00239-014-9637-9; Kim KM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-13; Kim KM, 2012, STRUCTURE, V20, P67, DOI 10.1016/j.str.2011.11.003; Kim KM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-140; Kim KM, 2010, MOL BIOL EVOL, V27, P1710, DOI 10.1093/molbev/msq106; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Kondrashov FA, 2004, TRENDS GENET, V20, P287, DOI 10.1016/j.tig.2004.05.001; Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Korza HJ, 2005, J BIOL CHEM, V280, P40802, DOI 10.1074/jbc.M506328200; Kump LR, 2014, NATURE GEOSCI, V7, P248; Kurland CG, 2006, SCIENCE, V312, P1011, DOI 10.1126/science.1121674; Kurland CG, 2005, BIOESSAYS, V27, P741, DOI 10.1002/bies.20258; LUNDBERG JG, 1972, SYST ZOOL, V21, P398, DOI 10.2307/2412433; Ma BG, 2008, BIOCHEM BIOPH RES CO, V366, P607, DOI 10.1016/j.bbrc.2007.12.014; Marcet-Houben M, 2007, BIOINFORMATION, V2, P135, DOI 10.6026/97320630002135; Martins BMC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003175; Mittenthal Jay, 2012, Frontiers in Genetics, V3, P147, DOI [10.3389/fgene.2012.00147, 10.3389/fgene.2012.00172]; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nasir A, 2014, ARCHAEA, V2014, P425; Nasir A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003452; Nasir A, 2013, ARCHAEA, V2013, DOI 10.1155/2013/648746; Nasir A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-156; Nasir A, 2011, GENES-BASEL, V2, P869, DOI 10.3390/genes2040869; Nath N, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003642; Newton MS, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0036; Pascal JM, 2006, MOL CELL, V24, P279, DOI 10.1016/j.molcel.2006.08.015; Penny D, 1999, CURR OPIN GENET DEV, V9, P672, DOI 10.1016/S0959-437X(99)00020-9; Pfeiffer T, 2005, PLOS BIOL, V3, P1269, DOI 10.1371/journal.pbio.0030228; Philippe H, 1999, J MOL EVOL, V49, P509, DOI 10.1007/PL00006573; Poole AM, 1998, J MOL EVOL, V46, P1, DOI 10.1007/PL00006275; Popa O, 2011, CURR OPIN MICROBIOL, V14, P615, DOI 10.1016/j.mib.2011.07.027; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Risso VA, 2013, J AM CHEM SOC, V135, P2899, DOI 10.1021/ja311630a; Sessions AL, 2009, CURR BIOL, V19, pR567, DOI 10.1016/j.cub.2009.05.054; Shegogue D, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-113; Skunca N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002533; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Swoford DL, 2002, PAUP PHYLOGENETIC AN; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; Trefil J, 2009, AM SCI, V97, P206, DOI 10.1511/2009.78.206; Turan S, 2011, FASEB J, V25, P4088, DOI 10.1096/fj.11-186940; Volkov AN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002807; Voordeckers K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001446; WACHTERSHAUSER G, 1992, PROG BIOPHYS MOL BIO, V58, P85, DOI 10.1016/0079-6107(92)90022-X; Wang M, 2007, GENOME RES, V17, P1572, DOI 10.1101/gr.6454307; Wang ML, 2006, MOL BIOL EVOL, V23, P2444, DOI 10.1093/molbev/msl117; Wang ML, 2006, COMPLEXITY, V12, P27, DOI 10.1002/cplx.20141; Wang ML, 2011, MOL BIOL EVOL, V28, P567, DOI 10.1093/molbev/msq232; Wang ML, 2009, STRUCTURE, V17, P66, DOI 10.1016/j.str.2008.11.008; Williams GJ, 2006, ACTA CRYSTALLOGR F, V62, P944, DOI 10.1107/S1744309106034075; Woese C, 1998, P NATL ACAD SCI USA, V95, P6854, DOI 10.1073/pnas.95.12.6854; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Xu Y, 2002, COMP BIOCHEM PHYS A, V133, P677, DOI 10.1016/S1095-6433(02)00197-6; Yang S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008378; YCAS M, 1974, J THEOR BIOL, V44, P145, DOI 10.1016/S0022-5193(74)80035-4; Ye JQ, 2004, BBA-BIOENERGETICS, V1659, P1, DOI 10.1016/j.bbabio.2004.06.003; Zhuang ZH, 2010, BBA-PROTEINS PROTEOM, V1804, P1081, DOI 10.1016/j.bbapap.2009.06.018; Zou TS, 2015, MOL BIOL EVOL, V32, P132, DOI 10.1093/molbev/msu281	101	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176129	10.1371/journal.pone.0176129	http://dx.doi.org/10.1371/journal.pone.0176129			56	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467492	gold, Green Submitted, Green Published			2022-12-26	WOS:000400647000038
J	Mihai-Alexandru, S; Noemi, G; Ioana, LR				Mihai-Alexandru, Suciu; Noemi, Gasko; Ioana, Lung Rodica			Approximation of Nash equilibria and the network community structure detection problem	PLOS ONE			English	Article							COMPLEX NETWORKS	Game theory based methods designed to solve the problem of community structure detection in complex networks have emerged in recent years as an alternative to classical and optimization based approaches. The Mixed Nash Extremal Optimization uses a generative relation for the characterization of Nash equilibria to identify the community structure of a network by converting the problem into a non-cooperative game. This paper proposes a method to enhance this algorithm by reducing the number of payoff function evaluations. Numerical experiments performed on synthetic and real-world networks show that this approach is efficient, with results better or just as good as other state-of the-art methods.	[Mihai-Alexandru, Suciu; Noemi, Gasko; Ioana, Lung Rodica] Babes Bolyai Univ, Ctr Study Complex, Cluj Napoca, Romania	Babes Bolyai University from Cluj	Ioana, LR (corresponding author), Babes Bolyai Univ, Ctr Study Complex, Cluj Napoca, Romania.	rodica.lung@econ.ubbcluj.ro	Suciu, Mihai/B-4564-2014	Suciu, Mihai/0000-0003-0659-4594; Lung, Rodica Ioana/0000-0002-5572-8141	Romanian National Authority for Scientific Research and Innovation, CNCS UEFISCDI [PN-II-RU-TE-2014-4-2332]	Romanian National Authority for Scientific Research and Innovation, CNCS UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	This work was supported by a grant of the Romanian National Authority for Scientific Research and Innovation, CNCS UEFISCDI (www.uefiscdtgov.ro), project number PN-II-RU-TE-2014-4-2332.	Alvari H, 2014, 2014 PROCEEDINGS OF THE IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2014), P101, DOI 10.1109/ASONAM.2014.6921567; [Anonymous], IIE ANN C EXP 2013 I; [Anonymous], NATURE; [Anonymous], LNCS; Basu S, 2015, SOC NETW ANAL MIN, V5, DOI 10.1007/s13278-015-0299-4; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Chen W, 2010, DATA MIN KNOWL DISC, V21, P224, DOI 10.1007/s10618-010-0186-6; Chira C, 2011, IEEE C EVOL COMPUTAT, P2200; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gao Z, 2013, 2013 INTERNATIONAL CONFERENCE ON SOCIAL INTELLIGENCE AND TECHNOLOGY (SOCIETY), P28, DOI 10.1109/SOCIETY.2013.10; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gleiser PM, 2003, ADV COMPLEX SYST, V6, P565, DOI 10.1142/S0219525903001067; Hu Y., 2008, PHYS REV E, V78, P1; Knuth D.E., 2008, ART COMPUTER PROGRAM, V4a; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016118; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Li CB, 2014, INTELL DECIS TECHNOL, V8, P207, DOI 10.3233/IDT-140189; Li JW, 2016, IEEE T EVOLUT COMPUT, V20, P460, DOI 10.1109/TEVC.2015.2490076; Li ZP, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036109; Lung RI, 2008, INT J COMPUT COMMUN, V3, P364; Lung RI, 2010, IEEE C EVOL COMPUTAT; Lung RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086891; Lung RI, 2011, STUD COMPUT INTELL, V387, P121; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Mandala S, 2014, INFORMS J COMPUT, V26, P629, DOI 10.1287/ijoc.2013.0588; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; McSweeney PJ, 2012, 2012 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM), P227, DOI 10.1109/ASONAM.2012.47; MOKKEN RJ, 1979, QUAL QUANT, V13, P161, DOI 10.1007/BF00139635; Narayanam R, 2012, INT C PATT RECOG, P1072; NASH J, 1951, ANN MATH, V54, P286, DOI 10.2307/1969529; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Palchykov V, 2016, EPJ DATA SCI, V5, DOI 10.1140/epjds/s13688-016-0090-4; Pavlidis NG, 2005, J COMPUT APPL MATH, V175, P113, DOI 10.1016/j.cam.2004.06.005; Pizzuti C, 2008, LECT NOTES COMPUT SC, V5199, P1081, DOI 10.1007/978-3-540-87700-4_107; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Steinhaeuser K, 2010, PATTERN RECOGN LETT, V31, P413, DOI 10.1016/j.patrec.2009.11.001; Suciu M, 2015, LECT NOTES COMPUT SC, V9026, P126, DOI 10.1007/978-3-319-16468-7_11; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zhou LH, 2016, EXPERT SYST, V33, P176, DOI 10.1111/exsy.12141	46	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0174963	10.1371/journal.pone.0174963	http://dx.doi.org/10.1371/journal.pone.0174963			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467496	gold, Green Published, Green Submitted			2022-12-26	WOS:000400647000010
J	Dou, RK; Liu, ZY; Yuan, X; Xiangfei, DZ; Bai, RX; Bi, ZF; Yang, PA; Yang, YL; Dong, YS; Su, W; Li, DQ; Mao, CQ				Dou, Rongkun; Liu, Zongying; Yuan, Xue; Xiangfei, Danzhou; Bai, Ruixue; Bi, Zhenfei; Yang, Piao; Yang, Yalan; Dong, Yinsong; Su, Wei; Li, Diqiang; Mao, Canquan			PAMs ameliorates the imiquimod-induced psoriasis-like skin disease in mice by inhibition of translocation of NF-kappa B and production of inflammatory cytokines	PLOS ONE			English	Article							KERATINOCYTES; EXPRESSION; MEDICINE; PATHOGENESIS; ADHESION; GAMMA	Psoriasis is a chronic and persistent inflammatory skin disease seriously affecting the quality of human life. In this study, we reported an ancient formula of Chinese folk medicine, the natural plant antimicrobial solution (PAMs) for its anti-inflammatory effects and proposed the primary mechanisms on inhibiting the inflammatory response in TNF-alpha/IFN-gamma-induced HaCaT cells and imiquimod-induced psoriasis-like skin disease mouse model. Two main functional components of hydroxysafflor Yellow A and allantoin in PAMs were quantified by HPLC to be 94.2 +/- 2.2 and 262.9 +/- 12.5 mu g/mL respectively. PAMs could significantly reduce the gene expression and inflammatory cytokines production of Macrophage-Derived Chemokine (MDC), IL-8 and IL-6 in TNF-alpha/IFN-gamma-induced HaCaT cells. PAMs also significantly ameliorates the psoriatic-like symptoms in a mouse model with the evaluation scores for both the single (scales, thickness, erythema) and cumulative features were in the order of blank control < Dexamethasone < PAMs < 50% ethanol < model groups. The results were further confirmed by hematoxylin-eosin staining, RT-qPCR and immunohistochemistry. The down-regulated gene expression of IL-8, TNF-alpha, ICAM-1 and IL-23 in mouse tissues was consistent with the results from those of the HaCaT cells. The inhibition of psoriasis-like skin inflammation by PAMs was correlated with the inactivation of the translocation of P65 protein into cellular nucleus, indicating the inhibition of the inflammatory NF-kappa B signaling pathway. Taken together, these findings suggest that PAMs may be a promising drug candidate for the treatment of inflammatory skin disorders, such as psoriasis.	[Dou, Rongkun; Liu, Zongying; Yuan, Xue; Bai, Ruixue; Bi, Zhenfei; Yang, Piao; Yang, Yalan; Mao, Canquan] Southwest Jiaotong Univ, Sch Life Sci & Engn, Chengdu, Peoples R China; [Xiangfei, Danzhou; Dong, Yinsong; Su, Wei] Inst Yunnan Folk Med Co Ltd, Kunming, Peoples R China; [Li, Diqiang] Chinese Acad Forestry, Inst Forest Ecol Environm & Protect, Beijing, Peoples R China	Southwest Jiaotong University; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Mao, CQ (corresponding author), Southwest Jiaotong Univ, Sch Life Sci & Engn, Chengdu, Peoples R China.; Li, DQ (corresponding author), Chinese Acad Forestry, Inst Forest Ecol Environm & Protect, Beijing, Peoples R China.	lidq@caf.ac.cn; maocq@swjtu.edu.cn	mao, canquan/AAZ-9694-2020		Son Program of Fundamental Platform of Science and Technology Resource Condition, Ministry of Science and Technology of China [2005DKA21404]; Institute of Yunnan Folk Medicine Co. Ltd	Son Program of Fundamental Platform of Science and Technology Resource Condition, Ministry of Science and Technology of China; Institute of Yunnan Folk Medicine Co. Ltd	The work was financially supported by the Son Program of Fundamental Platform of Science and Technology Resource Condition, Ministry of Science and Technology of China (2005DKA21404, Diqiang Li, Danzhou Xiangfei, and Canquan Mao). Institute of Yunnan Folk Medicine Co. Ltd provided support in the form of salary for Ms Danzhou Xiangfei (who is a Co-PI of the funded project), Mr. Yinsong Dong and Wei Su, whose main roles are the preparation and the quality control of PAMs. The company did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of these three authors is articulated in the 'author contributions' section.	Bito T, 2000, FREE RADICAL BIO MED, V28, P219, DOI 10.1016/S0891-5849(99)00229-4; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Corson TW, 2007, CELL, V130, P769, DOI 10.1016/j.cell.2007.08.021; Deng SQ, 2013, ARCH DERMATOL RES, V305, P179, DOI 10.1007/s00403-013-1316-y; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; DUSTIN ML, 1988, J EXP MED, V167, P1323, DOI 10.1084/jem.167.4.1323; Farzaneh V, 2015, IND CROP PROD, V65, P247, DOI 10.1016/j.indcrop.2014.10.057; Gottlieb AB, 2005, J IMMUNOL, V175, P2721, DOI 10.4049/jimmunol.175.4.2721; Hwang ST, 2017, J INVEST DERMATOL, V137, P550, DOI 10.1016/j.jid.2016.11.007; Jin M, 2016, CHIN J INTEGR MED, V22, P36, DOI 10.1007/s11655-015-1976-x; Kim HN, 2012, J PHARMACOPUNCT, V15, P7, DOI 10.3831/KPI.2012.15.2.007; Ko J, 2006, ANN ALLERG ASTHMA IM, V97, P365, DOI 10.1016/S1081-1206(10)60802-2; Lee JH, 2009, J DERMATOL SCI, V56, P64, DOI 10.1016/j.jdermsci.2009.07.001; Lizzul PF, 2005, J INVEST DERMATOL, V124, P1275, DOI 10.1111/j.0022-202X.2005.23735.x; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; McInturff JE, 2005, J INVEST DERMATOL, V125, P1, DOI 10.1111/j.0022-202X.2004.23459.x; Mizuno K, 2015, J DERMATOL SCI, V80, P45, DOI 10.1016/j.jdermsci.2015.06.016; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Novak N, 2008, DRUG NEWS PERSPECT, V21, P158, DOI 10.1358/dnp.2008.21.3.1203412; Peng WB, 2016, BIOMED CHROMATOGR, V30, P1854, DOI 10.1002/bmc.3772; Perera GK, 2012, ANNU REV PATHOL-MECH, V7, P385, DOI 10.1146/annurev-pathol-011811-132448; Quivy V, 2004, BIOCHEM PHARMACOL, V68, P1221, DOI 10.1016/j.bcp.2004.05.039; Rahman Mahfoozur, 2012, Endocrine Metabolic & Immune Disorders-Drug Targets, V12, P287; Saeki H, 2006, J DERMATOL SCI, V43, P75, DOI 10.1016/j.jdermsci.2006.06.002; Schon MP, 2006, J INVEST DERMATOL, V126, P1338, DOI 10.1038/sj.jid.5700286; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2015, STEROIDS, V103, P72, DOI 10.1016/j.steroids.2015.04.006; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Szeimies RM, 2004, J AM ACAD DERMATOL, V51, P547, DOI 10.1016/j.jaad.2004.02.022; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Weng ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090739; Williamson EM, 2013, J ETHNOPHARMACOL, V149, P453, DOI 10.1016/j.jep.2013.06.050; Xiong H, 2015, CELL PHYSIOL BIOCHEM, V35, P1335, DOI 10.1159/000373955; Ye J, 2009, J PHARMACEUT BIOMED, V49, P638, DOI 10.1016/j.jpba.2008.12.009; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	36	21	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176823	10.1371/journal.pone.0176823	http://dx.doi.org/10.1371/journal.pone.0176823			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28464025	gold, Green Submitted, Green Published			2022-12-26	WOS:000400646300061
J	Hill, VK; Kim, JS; James, CD; Waldman, T				Hill, Victoria K.; Kim, Jung-Sik; James, C. David; Waldman, Todd			Correction of PTEN mutations in glioblastoma cell lines via AAV-mediated gene editing	PLOS ONE			English	Article							RICTOR-MTOR COMPLEX; TUMOR-SUPPRESSOR; GERMLINE MUTATIONS; CANCER SUSCEPTIBILITY; COWDEN DISEASE; PHOSPHATASE; PHOSPHORYLATION; PTEN/MMAC1; IDENTIFICATION; SPECIFICITY	PTEN is among the most commonly mutated tumor suppressor genes in human cancer. However, studying the role of PTEN in the pathogenesis of cancer has been limited, in part, by the paucity of human cell-based isogenic systems that faithfully model PTEN loss. In an effort to remedy this problem, gene editing was used to correct an endogenous mutant allele of PTEN in two human glioblastoma multiforme (GBM) cell lines-42MGBA and T98G. PTEN correction resulted in reduced cellular proliferation that was Akt-dependent in 42MGBA cells and Akt-independent in T98G cells. This is the first report of human cancer cell lines in which mutant PTEN has been corrected by gene editing. The isogenic sets of gene edited cell lines reported here will likely prove useful for further study of PTEN mutations in the pathogenesis of cancer, and for the discovery and validation of novel therapeutics targeting the PTEN pathway.	[Hill, Victoria K.; Kim, Jung-Sik; Waldman, Todd] Georgetown Univ, Sch Med, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [James, C. David] Northwestern Univ, Feinberg Sch Med, Dept Neurol Surg, Chicago, IL 60611 USA	Georgetown University; Northwestern University; Feinberg School of Medicine	Waldman, T (corresponding author), Georgetown Univ, Sch Med, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA.	waldmant@georgetown.edu			NIH [R01CA115699, R01CA159467]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by NIH grants R01CA115699 and R01CA159467. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Blumenthal GM, 2008, EUR J HUM GENET, V16, P1289, DOI 10.1038/ejhg.2008.162; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Han SY, 2000, CANCER RES, V60, P3147; Hopkins BD, 2014, TRENDS BIOCHEM SCI, V39, P183, DOI 10.1016/j.tibs.2014.02.006; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kim JS, 2011, MOL CELL BIOL, V31, P2756, DOI 10.1128/MCB.01323-10; Kim JS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn566; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Marsh DJ, 1999, HUM MOL GENET, V8, P1461, DOI 10.1093/hmg/8.8.1461; Mounir Z, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000389; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Nelen MR, 1997, HUM MOL GENET, V6, P1383, DOI 10.1093/hmg/6.8.1383; Nguyen HN, 2015, ONCOGENE, V34, P3737, DOI 10.1038/onc.2014.293; Okumura K, 2005, P NATL ACAD SCI USA, V102, P2703, DOI 10.1073/pnas.0409370102; Perzelova A, 1998, NEOPLASMA, V45, P25; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Tan SX, 2011, BIOCHEM J, V435, P539, DOI 10.1042/BJ20110040; Vivanco I, 2007, CANCER CELL, V11, P555, DOI 10.1016/j.ccr.2007.04.021; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wang SI, 1997, CANCER RES, V57, P4183; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309	38	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176683	10.1371/journal.pone.0176683	http://dx.doi.org/10.1371/journal.pone.0176683			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28464039	Green Submitted, Green Published, gold			2022-12-26	WOS:000400646300042
J	Qin, SH; Yeboah, S; Cao, L; Zhang, JL; Shi, SL; Liu, YH				Qin, Shuhao; Yeboah, Stephen; Cao, Li; Zhang, Junlian; Shi, Shangli; Liu, Yuhui			Breaking continuous potato cropping with legumes improves soil microbial communities, enzyme activities and tuber yield	PLOS ONE			English	Article							QUALITY INDICATORS; KINETIC METHOD; ROTATION; RHIZOSPHERE; TILLAGE; AMENDMENTS; DISEASES; NUMBERS; SYSTEMS; CARBON	This study was conducted to explore the changes in soil microbial populations, enzyme activity, and tuber yield under the rotation sequences of Potato-Common vetch (P-C), Potato-Black medic (P-B) and Potato-Longdong alfalfa (P-L) in a semi-arid area of China. The study also determined the effects of continuous potato cropping (without legumes) on the above mentioned soil properties and yield. The number of bacteria increased significantly (p < 0.05) under P-B rotation by 78%, 85% and 83% in the 2, 4 and 7-year continuous cropping soils, respectively compared to P-C rotation. The highest fungi/bacteria ratio was found in P-C (0.218), followed by P-L (0.184) and then P-B (0.137) rotation over the different cropping years. In the continuous potato cropping soils, the greatest fungi/bacteria ratio was recorded in the 4-year (0.4067) and 7-year (0.4238) cropping soils and these were significantly higher than 1-year (0.3041), 2-year (0.2545) and 3-year (0.3030) cropping soils. Generally, actinomycetes numbers followed the trend P-L>P-C>P-B. The P-L rotation increased aerobic azotobacters in 2-year (by 26% and 18%) and 4-year (40% and 21%) continuous cropping soils compared to P-C and P-B rotation, respectively. Generally, the highest urease and alkaline phosphate activity, respectively, were observed in P-C (55.77 mg g(-1)) and (27.71 mg g(-1)), followed by P-B (50.72 mg mg(-1)) and (25.64 mg g(-1)) and then P-L (41.61 mg g(-1)) and (23.26 mg g(-1)) rotation. Soil urease, alkaline phosphatase and hydrogen peroxidase activities decreased with increasing years of continuous potato cropping. On average, the P-B rotation significantly increased (p < 0.05) tuber yield by 19% and 18%, compared to P-C and P-L rotation respectively. P-L rotation also increased potato tuber yield compared to P-C, but the effect was lesser relative to P-B rotation. These results suggest that adopting potato-legume rotation system has the potential to improve soil biology environment, alleviate continuous cropping obstacle and increase potato tuber yield in semi-arid region.	[Qin, Shuhao; Cao, Li; Zhang, Junlian; Liu, Yuhui] Gansu Agr Univ, Coll Hort, Lanzhou, Peoples R China; [Yeboah, Stephen] CSIR Crops Res Inst, Kumasi, Ghana; [Shi, Shangli] Gansu Agr Univ, Minist Educ, Key Lab Grassland Ecol Syst, Lanzhou, Peoples R China	Gansu Agricultural University; Gansu Agricultural University	Qin, SH (corresponding author), Gansu Agr Univ, Coll Hort, Lanzhou, Peoples R China.	qinsh@gsau.edu.cn			National Natural Science Foundation of China [31260311]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China (31260311).	Acosta-Martinez V, 2010, SOIL SCI SOC AM J, V74, P1181, DOI 10.2136/sssaj2008.0065; Allison VJ, 2007, SOIL BIOL BIOCHEM, V39, P1770, DOI 10.1016/j.soilbio.2007.02.006; Alvey S, 2003, BIOL FERT SOILS, V37, P73, DOI 10.1007/s00374-002-0573-2; Aparicio V, 2007, SOIL TILL RES, V96, P155, DOI 10.1016/j.still.2007.05.006; Bending GD, 2004, SOIL BIOL BIOCHEM, V36, P1785, DOI 10.1016/j.soilbio.2004.04.035; Burkert A., 2001, Plant nutrition: food security and sustainability of agro-ecosystems through basic and applied research. Fourteenth International Plant Nutrition Colloquium, Hannover, Germany, P972; *CHIN SOIL TAX COO, 1995, CHIN SOIL TAX; Crenshaw CL, 2008, BIOGEOCHEMISTRY, V87, P17, DOI 10.1007/s10533-007-9165-4; Ding LingLing, 2007, Acta Prataculturae Sinica, V16, P9; FEIGIN A, 1974, SOIL SCI SOC AM J, V38, P465, DOI 10.2136/sssaj1974.03615995003800030026x; Gan YT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14625; Gan YT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6012; Gonzalez-Chavez MDA, 2010, SOIL TILL RES, V106, P285, DOI 10.1016/j.still.2009.11.008; Grimsby LK, 2013, ENERGY SUSTAIN DEV, V17, P35, DOI 10.1016/j.esd.2012.10.009; Guang H., 1986, HDB ANAL SOIL MICROO; HAVLIN JL, 1990, SOIL SCI SOC AM J, V54, P448, DOI 10.2136/sssaj1990.03615995005400020026x; Hu Y., 2009, J ANHUI AGR SCI, V37, P5610; Hu Y, 2009, J ANHUI AGR SCI, V37, P5436; Jouquet P, 2016, APPL SOIL ECOL, V101, P117, DOI 10.1016/j.apsoil.2016.02.001; Kong FanLei, 2010, Transactions of the Chinese Society of Agricultural Engineering, V26, P150; Kouyate Z, 2000, PLANT SOIL, V225, P141, DOI 10.1023/A:1026589528352; Lanzen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072577; Larkin RP, 2008, SOIL BIOL BIOCHEM, V40, P1341, DOI 10.1016/j.soilbio.2007.03.005; Larkin RP, 2010, PLANT DIS, V94, P1491, DOI 10.1094/PDIS-03-10-0172; Lee SB, 2009, SOIL TILL RES, V104, P227, DOI 10.1016/j.still.2009.02.007; Li, 2006, CHINESE J SOIL SCI, V37, P563; [李春格 LI ChunGe], 2006, [生态学报, Acta Ecologica Sinica], V26, P1144; Lin X G., 2010, RES PRINCIPLES METHO, P38; [刘学玲 Liu Xueling], 2012, [环境工程学报, Chinese Journal of Environmental Engineering], V6, P1713; Lupwayi NZ, 1998, SOIL BIOL BIOCHEM, V30, P1733, DOI 10.1016/S0038-0717(98)00025-X; [马琨 Ma Kun], 2010, [水土保持学报, Journal of Soil and Water Conservation], V24, P229; Ma Yunhua, 2004, Yingyong Shengtai Xuebao, V15, P1005; Maltais-Landry G, 2015, PLANT SOIL, V394, P139, DOI 10.1007/s11104-015-2518-1; Marschner P, 2004, PLANT SOIL, V261, P199, DOI 10.1023/B:PLSO.0000035569.80747.c5; Maynard D.G., 2007, SOIL SAMPLING METHOD, P71; Meng Pin-pin, 2012, Yingyong Shengtai Xuebao, V23, P3079; Moeskops B, 2010, APPL SOIL ECOL, V45, P112, DOI 10.1016/j.apsoil.2010.03.005; Moulin AP, 2011, CAN J SOIL SCI, V91, P533, DOI [10.4141/CJSS10011, 10.4141/cjss10011]; Munkholm LJ, 2013, SOIL TILL RES, V127, P85, DOI 10.1016/j.still.2012.02.007; Nelson KL, 2009, AGR ECOSYST ENVIRON, V131, P220, DOI 10.1016/j.agee.2009.01.014; Panikov NS, 1996, J MICROBIOL METH, V24, P219, DOI 10.1016/0167-7012(95)00074-7; Peter Stougaard, 2015, PLOS ONE, V10; POPOV AI, 1990, MICROBIOLOGY+, V59, P482; Qin S. H., 2014, AGR WATER MANAGE, V22, P389, DOI DOI 10.1016/J.AGWAT.2013.09.015; Qin SH, 2013, AM J POTATO RES, V90, P33, DOI 10.1007/s12230-012-9267-y; [邱阳 Qiu Yang], 2011, [水土保持通报, Bulletin of Soil and Water Conservation], V31, P65; Rasool N, 2014, EUR J SOIL BIOL, V61, P94, DOI 10.1016/j.ejsobi.2014.02.002; Sandoval MA, 2007, ACTA AGR SCAND B-S P, V57, P255, DOI 10.1080/09064710600925836; Seo DC, 2010, WATER RES, V44, P2441, DOI 10.1016/j.watres.2010.01.006; Shirokikh IG, 2006, BIOL BULL+, V33, P404, DOI 10.1134/S1062359006040133; Studdert GA, 1997, SOIL SCI SOC AM J, V61, P1466, DOI 10.2136/sssaj1997.03615995006100050026x; Taylor JP, 2002, SOIL BIOL BIOCHEM, V34, P387, DOI 10.1016/S0038-0717(01)00199-7; Trabelsi D, 2012, SOIL BIOL BIOCHEM, V54, P1, DOI 10.1016/j.soilbio.2012.05.013; Wang Hong-wei, 2012, Yingyong Shengtai Xuebao, V23, P2693; Xing Fu, 2011, Acta Prataculturae Sinica, V20, P245; Yao Tuo, 2007, Acta Pedologica Sinica, V44, P122; ZAK JC, 1994, SOIL BIOL BIOCHEM, V26, P1101, DOI 10.1016/0038-0717(94)90131-7; Zhao H, 2012, AGR WATER MANAGE, V104, P68, DOI 10.1016/j.agwat.2011.11.016; Zheng HY, 1986, HDB SOIL MICROBIAL A; Zhou L.K., 1987, SOIL ENZYMOLOGY	60	43	58	7	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0175934	10.1371/journal.pone.0175934	http://dx.doi.org/10.1371/journal.pone.0175934			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28463981	Green Published, Green Submitted, gold			2022-12-26	WOS:000400646300009
J	Schelin, L; Tengman, E; Ryden, P; Hager, C				Schelin, Lina; Tengman, Eva; Ryden, Patrik; Hager, Charlotte			A statistically compiled test battery for feasible evaluation of knee function after rupture of the Anterior Cruciate Ligament - derived from long-term follow-up data	PLOS ONE			English	Article							OUTCOME SCORE KOOS; ONE-LEG HOP; ACL RECONSTRUCTION; MUSCLE STRENGTH; ACTIVITY LEVEL; LYSHOLM SCORE; INJURY RISK; PERFORMANCE; RELIABILITY; VALIDITY	Purpose Clinical test batteries for evaluation of knee function after injury to the Anterior Cruciate Ligament (ACL) should be valid and feasible, while reliably capturing the outcome of rehabilitation. There is currently a lack of consensus as to which of the many available assessment tools for knee function that should be included. The present aim was to use a statistical approach to investigate the contribution of frequently used tests to avoid redundancy, and filter them down to a proposed comprehensive and yet feasible test battery for long-term evaluation after ACL injury. Methods In total 48 outcome variables related to knee function, all potentially relevant for a long-term follow-up, were included from a cross-sectional study where 70 ACL-injured (17-28 years post injury) individuals were compared to 33 controls. Cluster analysis and logistic regression were used to group variables and identify an optimal test battery, from which a summarized estimator of knee function representing various functional aspects was derived. Results As expected, several variables were strongly correlated, and the variables also fell into logical clusters with higher within-correlation (max rho = 0.61) than between clusters (max rho = 0.19). An extracted test battery with just four variables assessing one-leg balance, isokinetic knee extension strength and hop performance (one-leg hop, side hop) were mathematically combined to an estimator of knee function, which acceptably classified ACL-injured individuals and controls. This estimator, derived from objective measures, correlated significantly with self-reported function, e.g. Lysholm score (rho = 0.66; p<0.001). Conclusions The proposed test battery, based on a solid statistical approach, includes assessments which are all clinically feasible, while also covering complementary aspects of knee function. Similar test batteries could be determined for earlier phases of ACL rehabilitation or to enable longitudinal monitoring. Such developments, established on a well-grounded consensus of measurements, would facilitate comparisons of studies and enable evidence-based rehabilitation.	[Schelin, Lina; Tengman, Eva; Hager, Charlotte] Umea Univ, Dept Community Med & Rehabil, Physiotherapy, Umea, Sweden; [Schelin, Lina] Umea Univ, Dept Stat, Umea Sch Business & Econ, Umea, Sweden; [Ryden, Patrik] Umea Univ, Dept Math & Math Stat, Umea, Sweden	Umea University; Umea University; Umea University	Schelin, L (corresponding author), Umea Univ, Dept Community Med & Rehabil, Physiotherapy, Umea, Sweden.; Schelin, L (corresponding author), Umea Univ, Dept Stat, Umea Sch Business & Econ, Umea, Sweden.	Lina.Schelin@umu.se	Rydén, Patrik/I-4201-2016; Häger, Charlotte K./ACG-7979-2022	Rydén, Patrik/0000-0002-0577-123X; Häger, Charlotte K./0000-0002-0366-4609	Swedish Scientific Research Council [K2011-69X-21876-01-3]; Umea University; Foundation for medical research; Vasterbotten county council; Swedish National Centre for Research in Sports (CIF) [P2012-0008]; Ingabritt & Arne Lundbergs research foundation; UMIT Research Lab at Umea University	Swedish Scientific Research Council(Swedish Research Council); Umea University; Foundation for medical research; Vasterbotten county council; Swedish National Centre for Research in Sports (CIF); Ingabritt & Arne Lundbergs research foundation; UMIT Research Lab at Umea University	We acknowledge support from the Swedish Scientific Research Council (project no. K2011-69X-21876-01-3), Umea University (Young Researcher Awardee, C Hager, and the Foundation for medical research), Vasterbotten county council, Swedish National Centre for Research in Sports (CIF, project no. P2012-0008), and Ingabritt & Arne Lundbergs research foundation. L Schelin was partially supported by the UMIT Research Lab at Umea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageberg E, 2001, SCAND J MED SCI SPOR, V11, P47, DOI 10.1034/j.1600-0838.2001.011001047.x; Ageberg E, 2008, ARTHRIT RHEUM-ARTHR, V59, P1773, DOI 10.1002/art.24066; Briggs KK, 2009, AM J SPORT MED, V37, P890, DOI 10.1177/0363546508330143; Briggs KK, 2009, AM J SPORT MED, V37, P898, DOI 10.1177/0363546508330149; Di Stasi SL, 2013, AM J SPORT MED, V41, P1310, DOI 10.1177/0363546513482718; Engelen-van Melick N, 2013, KNEE SURG SPORT TR A, V21, P869, DOI 10.1007/s00167-012-2030-6; Fox AS, 2014, SPORTS MED, V44, P815, DOI 10.1007/s40279-014-0168-8; Frobell RB, 2008, KNEE SURG SPORT TR A, V16, P713, DOI 10.1007/s00167-008-0509-y; Frobell RB, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f232; GRIMBY G, 1986, ACTA MED SCAND, P233; Grip H, 2015, J BIOMECH, V48, P3549, DOI 10.1016/j.jbiomech.2015.07.010; Gustavsson A, 2006, KNEE SURG SPORT TR A, V14, P778, DOI 10.1007/s00167-006-0045-6; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Hosmer Jr DW, 2004, APPL LOGISTIC REGRES; Irrgang JJ, 2001, AM J SPORT MED, V29, P600, DOI 10.1177/03635465010290051301; Lysholm J, 2007, ACTA ORTHOP, V78, P445, DOI 10.1080/17453670710014068; Meuffels DE, 2009, BRIT J SPORT MED, V43, P347, DOI 10.1136/bjsm.2008.049403; Meunier A, 2007, SCAND J MED SCI SPOR, V17, P230, DOI 10.1111/j.1600-0838.2006.00547.x; Moisala AS, 2007, INT J SPORTS MED, V28, P868, DOI 10.1055/s-2007-964912; Neeb TB, 1997, J ORTHOP SPORT PHYS, V26, P324, DOI 10.2519/jospt.1997.26.6.324; Neeter C, 2006, KNEE SURG SPORT TR A, V14, P571, DOI 10.1007/s00167-006-0040-y; Negahban H, 2014, KNEE SURG SPORT TR A, V22, P1491, DOI 10.1007/s00167-013-2501-4; Nordenvall R, 2012, AM J SPORT MED, V40, P1808, DOI 10.1177/0363546512449306; NOYES FR, 1991, AM J SPORT MED, V19, P513, DOI 10.1177/036354659101900518; Palmieri-Smith RM, 2008, CLIN SPORT MED, V27, P405, DOI 10.1016/j.csm.2008.02.001; Paradowski PT, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-38; Pua YH, 2008, ANN ACAD MED SINGAP, V37, P330; Reid A, 2007, PHYS THER, V87, P337, DOI 10.2522/ptj.20060143; Reinke EK, 2011, KNEE SURG SPORT TR A, V19, P1806, DOI 10.1007/s00167-011-1473-5; Roberts D, 2007, KNEE SURG SPORT TR A, V15, P9, DOI 10.1007/s00167-006-0128-4; Roberts D, 2000, J ORTHOPAED RES, V18, P565, DOI 10.1002/jor.1100180408; Roos EM, 1998, J ORTHOP SPORT PHYS, V28, P88, DOI 10.2519/jospt.1998.28.2.88; Salavati M, 2011, OSTEOARTHR CARTILAGE, V19, P406, DOI 10.1016/j.joca.2011.01.010; Sernert N, 1999, KNEE SURG SPORT TR A, V7, P160, DOI 10.1007/s001670050141; Sole G, 2016, CLIN BIOMECH, V32, P180, DOI 10.1016/j.clinbiomech.2015.11.013; Stensdotter AK, 2016, GAIT POSTURE, V46, P98, DOI 10.1016/j.gaitpost.2016.02.020; Stensdotter AK, 2013, EUR J PHYSIOTHER, V15, P78, DOI 10.3109/21679169.2013.791718; SULLIVAN M, 1995, SOC SCI MED, V41, P1349, DOI 10.1016/0277-9536(95)00125-Q; TEGNER Y, 1986, AM J SPORT MED, V14, P156, DOI 10.1177/036354658601400212; TEGNER Y, 1985, CLIN ORTHOP RELAT R, P43; Tengman E, 2015, SCAND J MED SCI SPOR, V25, P818, DOI 10.1111/sms.12434; Tengman E, 2014, SCAND J MED SCI SPOR, V24, pE491, DOI 10.1111/sms.12212; Tengman E, 2014, SCAND J MED SCI SPOR, V24, pE501, DOI 10.1111/sms.12215; Thomee R, 2011, KNEE SURG SPORTS TRA; Urbach D, 1999, MED SCI SPORT EXER, V31, P1691, DOI 10.1097/00005768-199912000-00001; von Porat A, 2004, ANN RHEUM DIS, V63, P269, DOI 10.1136/ard.2003.008136; WILK KE, 1994, J ORTHOP SPORT PHYS, V20, P60, DOI 10.2519/jospt.1994.20.2.60; Yoon T S, 1991, Yonsei Med J, V32, P33	48	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176247	10.1371/journal.pone.0176247	http://dx.doi.org/10.1371/journal.pone.0176247			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459885	Green Published, gold, Green Submitted			2022-12-26	WOS:000400645000024
J	Waese, J; Provart, NJ; Guttman, DS				Waese, Jamie; Provart, Nicholas J.; Guttman, David S.			Topo-phylogeny: Visualizing evolutionary relationships on a topographic landscape	PLOS ONE			English	Article							TREES; LIFE	Phylogenetic trees are the de facto standard for visualizing evolutionary relationships, but large trees can be difficult to interpret because they require a high cognitive load to identify relationships between multiple operational taxonomic units (OTUs). We present a new tool for displaying phylogenetic relationships as a topographic map in which OTUs autonomously attract or repel one another based on their individual branch lengths and distance to a common ancestor. This data visualization paradigm makes it possible to preattentively identify the nature of the relationship between items without having to trace a complex network of branches back to the root. This tool was developed for exploring phylogenetic data, but the technique could be extended for visualizing other hierarchical structures as well.	[Waese, Jamie; Provart, Nicholas J.; Guttman, David S.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Provart, Nicholas J.; Guttman, David S.] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada	University of Toronto; University of Toronto	Waese, J (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	jamie.waese@mail.utoronto.ca	Guttman, David S/A-7839-2011	Guttman, David S/0000-0001-8479-3869				[Anonymous], 2007, TREE LIFE WEB PROJEC; Bostock M., DS JS DATA DRIVEN DO; Carrizo S.F., 2004, P 2 C AS PAC BIOINF, V29, P315; Cortese PF, 2006, IEEE T VIS COMPUT GR, V12, P725, DOI 10.1109/TVCG.2006.185; Felsenstein J., 2008, PHYLOGENY PROGRAMS; Furbringer M., 1888, BIJDRAGEN DIERKUNDE, VXV; Healey CG, 2012, IEEE T VIS COMPUT GR, V18, P1170, DOI 10.1109/TVCG.2011.127; Hebrard M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158261; Hug LA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.48, 10.1038/nmicrobiol.2016.48]; Hughes T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-48; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Johnson B., 1991, Proceedings Visualization '91 (Cat. No.91CH3046-0), P284, DOI 10.1109/VISUAL.1991.175815; Jordan GE, 2008, BIOINFORMATICS, V24, P1641, DOI 10.1093/bioinformatics/btn235; Lu E H, 2008, P GRAPH INT 2008 CAN, P259; Maddison WP., 2019, CHROMASEQ MESQUITE P; Meirelles I., 2013, DESIGN INFORM INTRO; Munzner T, 2003, ACM T GRAPHIC, V22, P453, DOI 10.1145/882262.882291; Rambaut A., 2016, FIGTREE PRODUCE FIGU; Rizzo R, 2011, ADV ARTIF NEURAL SYS, V2011; Rosindell J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001406; Rost U, 2002, BIOINFORMATICS, V18, P109, DOI 10.1093/bioinformatics/18.1.109; Santamaria R, 2009, BIOINFORMATICS, V25, P1970, DOI 10.1093/bioinformatics/btp333; Swofford D., 2003, PHYLOGENETIC ANAL US; Ware C., 2013, INFORM VISUALIZATION, V3rd; Zhang JJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-248	25	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0175895	10.1371/journal.pone.0175895	http://dx.doi.org/10.1371/journal.pone.0175895			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459802	Green Published, Green Submitted, gold			2022-12-26	WOS:000400645000008
J	Paulo, AC; Sa-Leao, R				Paulo, Ana Cristina; Sa-Leao, Raquel			Periodic cycles of pneumococcal serotypes carried by children before and after 7-valent pneumococcal conjugate vaccine	PLOS ONE			English	Article							ACUTE OTITIS-MEDIA; DAY-CARE-CENTERS; STREPTOCOCCUS-PNEUMONIAE; ANTIMICROBIAL RESISTANCE; TEMPORAL TRENDS; YOUNG-CHILDREN; DISEASE; COLONIZATION; IMPACT; ASSOCIATION	Background Periodic cycles in the serotype-specific incidence of invasive pneumococcal disease have been described but less is known in carriage. Methods We analyzed serotype carriage prevalence among children 0-6 years old over a 15-year period that included pre-PCV7 data and a decade of PCV7 use. Mixed generalized additive models were used to study periodic cycles and how PCV7 impacted on them. Results Pneumococcal carriage data of 7,463 children were analyzed. Periodic cycles ranging from 3 to 6 years were observed for PCV7-serotypes (VT) 14, 19F and 23F and for non-PCV7 types (NVT) 3, 6A, 6C, 11A, and NT. An indirect impact of PCV7 on periodic cycles of NVT was observed and could be translated in three ways: (i) a higher amplitude in the PCV7 period (serotypes 3 and 11A), (ii) sustained increase in the prevalence of carriage (serotypes 6C, 19A and NT) and (iii) an increase in the inter-epidemic period (serotypes 3, 6A and NT). An increase in the child's mean age of carriage of VTs 6B, 19F and 23F was observed. Serotypes 3, 6C, 11A and 15A became more frequent in ages previously associated with carriage of VTs. Conclusions Periodic cycles among serotypes frequently carried exist and can be modeled. These cycles can be perturbed upon introduction of PCVs and can lead to shifts in the mean age of carriage. Cyclic re-emergence of VTs can occur in settings with non-universal vaccine use. These results should be taken into account when interpreting surveillance data on pneumococcal carriage.	[Paulo, Ana Cristina; Sa-Leao, Raquel] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Lab Mol Microbiol Human Pathogens, Oeiras, Portugal; [Sa-Leao, Raquel] Univ Lisbon, Fac Ciencias, Dept Biol Vegetal, Lisbon, Portugal	Universidade Nova de Lisboa; Universidade de Lisboa	Sa-Leao, R (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Lab Mol Microbiol Human Pathogens, Oeiras, Portugal.; Sa-Leao, R (corresponding author), Univ Lisbon, Fac Ciencias, Dept Biol Vegetal, Lisbon, Portugal.	rsaleao@itqb.unl.pt	Sá-Leão, Raquel/A-9341-2011	Sá-Leão, Raquel/0000-0001-9804-827X; PAULO, Ana Cristina/0000-0002-9249-2609	Fundacao para a Ciencia e Tecnologia, Portugal [PTDC/SAU-ESA/65048/2006, PTDC/BIA-BEC/098289/2008, SFRH/BPD/99638/2014]; FEDER through COMPETE Programa Operacional Competitividade e Internacionalizacao (POCI) [LISBOA-01-0145-FEDER]; FCT-Fundagao para a Ciencia e a Tecnologia, Portugal [LISBOA-01-0145-FEDER]	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); FEDER through COMPETE Programa Operacional Competitividade e Internacionalizacao (POCI); FCT-Fundagao para a Ciencia e a Tecnologia, Portugal	This work was supported by Fundacao para a Ciencia e Tecnologia, Portugal [PTDC/SAU-ESA/65048/2006 and PTDC/BIA-BEC/098289/2008 to R.S.L. and SFRH/BPD/99638/2014 to A.C.P.] and by Project LISBOA-01-0145-FEDER (Microbiologia Molecular, Estrutural e Celular) (funded by FEDER through COMPETE2020- Programa Operacional Competitividade e Internacionalizacao (POCI) and by FCT-Fundagao para a Ciencia e a Tecnologia, Portugal).	[Anonymous], 2014, R LANG ENV STAT COMP; Babadi B, 2014, IEEE T BIO-MED ENG, V61, P1555, DOI 10.1109/TBME.2014.2311996; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Bogaert D, 2001, J CLIN MICROBIOL, V39, P3316, DOI 10.1128/JCM.39.9.3316-3320.2001; Chang QZ, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0797-z; Cohen R, 2012, PEDIATR INFECT DIS J, V31, P297, DOI 10.1097/INF.0b013e318247ef84; Comissao de Vacinas Sociedade de Infecciologia Pediatrica e Sociedade Portuguesa de Pediatria, 2014, REC VAC ACT 2014; Dagan R, 2012, VACCINE, V30, P5132, DOI 10.1016/j.vaccine.2012.05.059; Domenech M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125636; dos Santos FFM, 2016, MATRICULADOS PRE ESC; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; Feikin DR, 2002, CLIN INFECT DIS, V35, P547, DOI 10.1086/341896; Fenoll A, 2009, J CLIN MICROBIOL, V47, P1012, DOI 10.1128/JCM.01454-08; Flasche S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1939; Givon-Lavi N, 2003, PEDIATR INFECT DIS J, V22, P524, DOI 10.1097/00006454-200306000-00008; Gladstone RA, 2015, VACCINE, V33, P2015, DOI 10.1016/j.vaccine.2015.03.012; Harboe ZB, 2010, CLIN INFECT DIS, V50, P329, DOI 10.1086/649872; Harboe ZB, 2014, CLIN INFECT DIS, V59, P1066, DOI 10.1093/cid/ciu524; Huang SS, 2005, CLIN INFECT DIS, V40, P1215, DOI 10.1086/428580; Huang SS, 2009, PEDIATRICS, V124, pE1, DOI 10.1542/peds.2008-3099; Imohl M, 2010, J CLIN MICROBIOL, V48, P1291, DOI 10.1128/JCM.01937-09; Jefferies JM, 2010, J CLIN MICROBIOL, V48, P87, DOI 10.1128/JCM.01485-09; Lagos R, 2008, J INFECT DIS, V198, P1809, DOI 10.1086/593334; Lipsitch M, 2000, VACCINE, V18, P2895, DOI 10.1016/S0264-410X(00)00046-3; Lipsitch M, 2005, PLOS MED, V2, P62, DOI 10.1371/journal.pmed.0020015; Torne AN, 2014, VACCINE, V32, P3644, DOI 10.1016/j.vaccine.2014.04.066; Nunes S, 2016, VACCINE, V34, P1648, DOI 10.1016/j.vaccine.2016.02.045; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Pessoa D, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-180; Richter SS, 2013, EMERG INFECT DIS, V19, P1074, DOI 10.3201/eid1907.121830; Sa-Leao R, 2000, J CLIN MICROBIOL, V38, P4137; Simoes AS, 2011, DIAGN MICR INFEC DIS, V71, P208, DOI 10.1016/j.diagmicrobio.2011.07.009; Soininen A, 2001, J INFECT DIS, V184, P569, DOI 10.1086/322794; Steens A, 2013, VACCINE, V31, P6232, DOI 10.1016/j.vaccine.2013.10.032; Tocheva AS, 2010, EMERG INFECT DIS, V16, P154, DOI 10.3201/eid1601.090650; Usonis V, 2015, EUROSURVEILLANCE, V20, P34, DOI 10.2807/1560-7917.ES2015.20.13.21079; Weinberger DM, 2008, J INFECT DIS, V197, P1511, DOI 10.1086/587941; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; White ANJ, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-196; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	41	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176723	10.1371/journal.pone.0176723	http://dx.doi.org/10.1371/journal.pone.0176723			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453533	Green Submitted, Green Published, gold			2022-12-26	WOS:000400383900048
J	Olsen, RR; Otero, JH; Garcia-Lopez, J; Wallace, K; Finkelstein, D; Rehg, JE; Yin, Z; Wang, D; Freeman, KW				Olsen, R. R.; Otero, J. H.; Garcia-Lopez, J.; Wallace, K.; Finkelstein, D.; Rehg, J. E.; Yin, Z.; Wang, D.; Freeman, K. W.			MYCN induces neuroblastoma in primary neural crest cells	ONCOGENE			English	Article							STEM-CELLS; NEURONAL DIFFERENTIATION; MOUSE MODEL; IN-VITRO; N-MYC; B-MYB; TUMORS; THERAPY; SENSITIVITY; EXPRESSION	Neuroblastoma (NBL) is an embryonal cancer of the sympathetic nervous system (SNS), which causes 15% of pediatric cancer deaths. High-risk NBL is characterized by N-Myc amplification and segmental chromosomal gains and losses. Owing to limited disease models, the etiology of NBL is largely unknown, including both the cell of origin and the majority of oncogenic drivers. We have established a novel system for studying NBL based on the transformation of neural crest cells (NCCs), the progenitor cells of the SNS, isolated from mouse embryonic day 9.5 trunk neural tube explants. Based on pathology and gene expression analysis, we report the first successful transformation of wild-type NCCs into NBL by enforced expression of N-Myc, to generate phenotypically and molecularly accurate tumors that closely model human MYCN-amplified NBL. Using comparative genomic hybridization, we found that NCC-derived NBL tumors acquired copy number gains and losses that are syntenic to those observed in human MYCN-amplified NBL including 17q gain, 2p gain and loss of 1p36. When p53-compromised NCCs were transformed with N-Myc, we generated primitive neuroectodermal tumors with divergent differentiation including osteosarcoma. These subcutaneous tumors were metastatic to regional lymph nodes, liver and lung. Our novel experimental approach accurately models human NBL and establishes a new system with potential to study early stages of NBL oncogenesis, to functionally assess NBL oncogenic drivers and to characterize NBL metastasis.	[Olsen, R. R.; Otero, J. H.; Garcia-Lopez, J.; Wallace, K.; Yin, Z.; Freeman, K. W.] St Jude Childrens Res Hosp, Dept Oncol, 262 Danny Thomas Pl,MS 354,Room D5048C, Memphis, TN 38105 USA; [Finkelstein, D.; Wang, D.] St Jude Childrens Res Hosp, Computat Biol Dept, 262 Danny Thomas Pl,MS 354,Room D5048C, Memphis, TN 38105 USA; [Rehg, J. E.] St Jude Childrens Res Hosp, Pathol Dept, 262 Danny Thomas Pl,MS 354,Room D5048C, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Freeman, KW (corresponding author), St Jude Childrens Res Hosp, Dept Oncol, 262 Danny Thomas Pl,MS 354,Room D5048C, Memphis, TN 38105 USA.	kevin.freeman@stjude.org	Rehg, Jerold E/N-8111-2018; Lopez, Jesus Garcia/N-7952-2019	Lopez, Jesus Garcia/0000-0002-1877-3402	Department of Defense [W81XWH-14-1-0090]; ALSAC	Department of Defense(United States Department of Defense); ALSAC(American Lebanese Syrian Associated Charities (ALSAC))	We thank the following for their contributions: Yasmine A Valentin-Vega for assistance with microscopy and secondary antibodies, Jamy Peng for antibodies to MAP2 and GFAP, Martine Roussel for N-Myc overexpression plasmids, Joe Opferman for providing TH-MycN tumor lysate, Manon Fortier and Michelle Mary-Sinclair for technical assistance, and the services provided by St. Jude core facilities including the Veterinary Pathology Core, the Microscopy Core, the Flow Cytometry Shared Resource and the Hartwell Center. This work was supported by research funds from the Department of Defense award number W81XWH-14-1-0090 and ALSAC.	Althoff K, 2015, ONCOGENE, V34, P3357, DOI 10.1038/onc.2014.269; Asghar U, 2015, NAT REV DRUG DISCOV, V14, P130, DOI 10.1038/nrd4504; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bielle F, 2012, AM J SURG PATHOL, V36, P1141, DOI 10.1097/PAS.0b013e31825a6895; Carr-Wilkinson J, 2010, CLIN CANCER RES, V16, P1108, DOI 10.1158/1078-0432.CCR-09-1865; Fukuta M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112291; Gualdrini F, 2010, ONCOTARGET, V1, P278; Hata JL, 2015, ARCH PATHOL LAB MED, V139, P543, DOI 10.5858/arpa.2014-0255-OA; Huber K, 2015, CELL TISSUE RES, V359, P333, DOI 10.1007/s00441-014-1947-0; Ikegaki N, 2013, P NATL ACAD SCI USA, V110, P6097, DOI 10.1073/pnas.1118262110; Joel M, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0398-x; Karunasena E, 2015, ONCOTARGET, V6, P22038, DOI 10.18632/oncotarget.4194; Kawauchi D, 2012, CANCER CELL, V21, P168, DOI 10.1016/j.ccr.2011.12.023; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Louis CU, 2015, ANNU REV MED, V66, P49, DOI 10.1146/annurev-med-011514-023121; Mahomed F, 2015, J ORAL MAXIL SURG, V73, P1314, DOI 10.1016/j.joms.2015.01.007; Meany HJ, 2014, PEDIATR BLOOD CANCER, V61, P1932, DOI 10.1002/pbc.25134; Montavon G, 2014, ONCOTARGET, V5, P4452, DOI 10.18632/oncotarget.2036; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Olsen RR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116998; Rao MS, 1997, J NEUROBIOL, V32, P722, DOI 10.1002/(SICI)1097-4695(19970620)32:7<722::AID-NEU7>3.0.CO;2-6; Russell MR, 2013, CANCER RES, V73, P776, DOI 10.1158/0008-5472.CAN-12-2669; Sadasivam S, 2012, GENE DEV, V26, P474, DOI 10.1101/gad.181933.111; Schulte JH, 2013, ONCOGENE, V32, P1059, DOI 10.1038/onc.2012.106; Schwermer M, 2015, ONCOTARGET, V6, P15425, DOI 10.18632/oncotarget.3908; Simoes-Costa M, 2015, DEVELOPMENT, V142, P242, DOI 10.1242/dev.105445; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Tornoczky T, 2004, CANCER-AM CANCER SOC, V100, P390, DOI 10.1002/cncr.20005; Tornoczky T, 2007, PATHOL ONCOL RES, V13, P269, DOI 10.1007/BF02940304; Valsesia-Wittmann S, 2004, CANCER CELL, V6, P625, DOI 10.1016/j.ccr.2004.09.033; Wang ZB, 2011, CANCER RES, V71, P4292, DOI 10.1158/0008-5472.CAN-10-4087; Watt F, 2007, CANCER GENE THER, V14, P287, DOI 10.1038/sj.cgt.7701012; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Wolter J, 2010, FUTURE ONCOL, V6, P429, DOI 10.2217/FON.09.176; Wylie LA, 2015, DIS MODEL MECH, V8, P429, DOI 10.1242/dmm.018630	36	54	54	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 31	2017	36	35					5075	5082		10.1038/onc.2017.128	http://dx.doi.org/10.1038/onc.2017.128			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FF3AV	28459463	hybrid, Green Published			2022-12-26	WOS:000408768800012
J	Angwin, AJ; Dissanayaka, NNW; McMahon, KL; Silburn, PA; Copland, DA				Angwin, Anthony J.; Dissanayaka, Nadeeka N. W.; McMahon, Katie L.; Silburn, Peter A.; Copland, David A.			Lexical ambiguity resolution during sentence processing in Parkinson's disease: An event-related potential study	PLOS ONE			English	Article							NONTHALAMIC SUBCORTICAL LESIONS; BASAL GANGLIA; SEMANTIC ACTIVATION; MEANING FREQUENCY; CORTICAL-LESIONS; TIME-COURSE; WORDS; COMPREHENSION; SELECTION; INDIVIDUALS	Event-related potentials (ERPs) were recorded to investigate lexical ambiguity resolution during sentence processing in 16 people with Parkinson's disease (PD) and 16 healthy controls. Sentences were presented word-by-word on computer screen, and participants were required to decide if a subsequent target word was related to the meaning of the sentence. The task consisted of related, unrelated and ambiguous trials. For the ambiguous trials, the sentence ended with an ambiguous word and the target was related to one of the meanings of that word, but not the one captured by the sentence context (e.g., 'He dug with the spade', Target 'ACE'). Both groups demonstrated slower reaction times and lower accuracy for the ambiguous condition relative to the unrelated condition, however accuracy was impacted by the ambiguous condition to a larger extent in the PD group. These results suggested that PD patients experience increased difficulties with contextual ambiguity resolution. The ERP results did not reflect increased ambiguity resolution difficulties in PD, as a similar N400 effect was evident for the unrelated and ambiguous condition in both groups. However, the magnitude of the N400 for these conditions was correlated with a measure of inhibition in the PD group, but not the control group. The ERP results suggest that semantic processing may be more compromised in PD patients with increased response inhibition deficits.	[Angwin, Anthony J.; Copland, David A.] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Dissanayaka, Nadeeka N. W.; Copland, David A.] Univ Queensland, Ctr Clin Res, Brisbane, Qld, Australia; [Dissanayaka, Nadeeka N. W.] Royal Brisbane & Womens Hosp, Neurol Res Ctr, Brisbane, Qld, Australia; [Dissanayaka, Nadeeka N. W.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [McMahon, Katie L.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia; [Silburn, Peter A.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	University of Queensland; University of Queensland; Royal Brisbane & Women's Hospital; University of Queensland; University of Queensland; University of Queensland	Angwin, AJ (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia.	a.angwin@uq.edu.au	Angwin, Anthony J/F-7888-2010; Copland, David/AAE-5334-2020; Dissanayaka, Nadeeka N/B-6658-2011; Angwin, Anthony/AAC-8524-2019; McMahon, Katie L/C-6440-2009; Copland, David A/F-1409-2010	Angwin, Anthony J/0000-0003-4547-9433; Copland, David/0000-0002-2257-4270; Dissanayaka, Nadeeka N/0000-0002-0164-3337; Angwin, Anthony/0000-0003-4547-9433; McMahon, Katie L/0000-0002-6357-615X; Copland, David A/0000-0002-2257-4270	Parkinson's Queensland Inc; Australian Research Council [DP120104420]; Lions Medical Research Fellowship	Parkinson's Queensland Inc; Australian Research Council(Australian Research Council); Lions Medical Research Fellowship	This research was supported by a Parkinson's Queensland Inc seeding grant (http://parkinsons-qld.org.au/) awarded to AJA, DAC, KLM and NNWD, and an Australian Research Council grant DP120104420 (http://www.arc.gov.au/) awarded to DAC, KLM, PAS and AJA. Nadeeka Dissanayaka is supported by the Lions Medical Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angwin AJ, 2006, J NEUROLINGUIST, V19, P239, DOI 10.1016/j.jneuroling.2005.11.004; Angwin AJ, 2005, COGNITIVE BRAIN RES, V25, P78, DOI 10.1016/j.cogbrainres.2005.04.008; Angwin AJ, 2007, J CLIN EXP NEUROPSYC, V29, P73, DOI 10.1080/13803390500507188; Angwin AJ, 2006, NEUROPSYCHOLOGY, V20, P299, DOI 10.1037/0894-4105.20.3.299; Angwin AJ, 2017, J INT NEUROPSYCH SOC, V23, P78, DOI 10.1017/S1355617716000953; Angwin AJ, 2009, CORTEX, V45, P950, DOI 10.1016/j.cortex.2009.02.012; Arnott WL, 2010, INT J SPEECH-LANG PA, V12, P437, DOI 10.3109/17549507.2010.492875; Arnott WL, 2001, J CLIN EXP NEUROPSYC, V23, P502, DOI 10.1076/jcen.23.4.502.1224; Bocanegra Y, 2015, CORTEX, V69, P237, DOI 10.1016/j.cortex.2015.05.022; Brandt J, 2001, HOPKINS VERBAL LEARN; Colman KSF, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/213983; Colman KSF, 2009, CORTEX, V45, P930, DOI 10.1016/j.cortex.2008.12.010; Copland D, 2003, J INT NEUROPSYCH SOC, V9, P1041, DOI 10.1017/S1355617703970081; Copland DA, 2000, BRAIN LANG, V74, P360; Copland DA, 2000, CORTEX, V36, P601, DOI 10.1016/S0010-9452(08)70541-0; Copland DA, 2001, J CLIN EXP NEUROPSYC, V23, P538, DOI 10.1076/jcen.23.4.538.1233; Copland DA, 2009, CORTEX, V45, P943, DOI 10.1016/j.cortex.2009.02.023; Cramer P, 1970, NORMS WORD ASS, P361; De Letter M, 2012, J NEUROLINGUIST, V25, P95, DOI 10.1016/j.jneuroling.2011.09.001; Debruille JB, 2008, BRAIN RES, V1187, P167, DOI 10.1016/j.brainres.2007.10.021; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Faust ME, 1997, BRAIN LANG, V57, P225, DOI 10.1006/brln.1997.1747; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Friederici AD, 2003, NEUROPSYCHOLOGY, V17, P133, DOI 10.1037/0894-4105.17.1.133; GERNSBACHER MA, 1990, J EXP PSYCHOL LEARN, V16, P430, DOI 10.1037/0278-7393.16.3.430; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Grossman M, 2002, NEUROPSYCHOLOGY, V16, P174, DOI 10.1037//0894-4105.16.2.174; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; KAUSLER DH, 1970, J VERB LEARN VERB BE, V9, P444, DOI 10.1016/S0022-5371(70)80086-X; Kehagia AA, 2010, LANCET NEUROL, V9, P1200, DOI 10.1016/S1474-4422(10)70212-X; Ketteler D, 2008, NEUROIMAGE, V39, P2002, DOI 10.1016/j.neuroimage.2007.10.023; Ketteler S, 2014, BRAIN RES, V1581, P51, DOI 10.1016/j.brainres.2014.06.030; Klepousniotou E, 2012, BRAIN LANG, V123, P11, DOI 10.1016/j.bandl.2012.06.007; Kotchoubey B, 2014, BRAIN COGNITION, V92, P48, DOI 10.1016/j.bandc.2014.10.007; Kutas M, 2014, COGNITIVE ELECTROPHYSIOLOGY OF ATTENTION: SIGNALS OF THE MIND, P254, DOI 10.1016/B978-0-12-398451-7.00020-8; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lee CL, 2012, NEUROPSYCHOLOGIA, V50, P869, DOI 10.1016/j.neuropsychologia.2012.01.027; Lee CL, 2011, PSYCHOPHYSIOLOGY, V48, P960, DOI 10.1111/j.1469-8986.2010.01158.x; Longworth CE, 2005, BRAIN, V128, P584, DOI 10.1093/brain/awh387; Mari-Beffa P, 2005, NEUROPSYCHOLOGIA, V43, P638, DOI 10.1016/j.neuropsychologia.2004.07.006; Meyer AM, 2007, BRAIN RES, V1183, P91, DOI 10.1016/j.brainres.2007.09.007; Meyer AM, 2010, PSYCHOPHYSIOLOGY, V47, P673, DOI 10.1111/j.1469-8986.2010.00983.x; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; NELSON DL, 1980, BEHAV RES METH INSTR, V12, P16, DOI 10.3758/BF03208320; Pagonabarraga J, 2008, MOVEMENT DISORD, V23, P998, DOI 10.1002/mds.22007; Raling R, 2015, NEUROPSYCHOLOGIA, V75, P186, DOI 10.1016/j.neuropsychologia.2015.05.031; Shang M, 2013, NEUROPSYCHOLOGIA, V51, P1989, DOI 10.1016/j.neuropsychologia.2013.06.006; SIMPSON GB, 1985, J EXP PSYCHOL HUMAN, V11, P28, DOI 10.1037/0096-1523.11.1.28; Swaab T, 2003, BRAIN LANG, V86, P326, DOI 10.1016/S0093-934X(02)00547-3; Swaab TY, 1998, NEUROPSYCHOLOGIA, V36, P737, DOI 10.1016/S0028-3932(97)00174-7; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; TWILLEY LC, 1994, MEM COGNITION, V22, P111, DOI 10.3758/BF03202766; VANPETTEN C, 1987, J MEM LANG, V26, P188, DOI 10.1016/0749-596X(87)90123-9	53	2	2	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176281	10.1371/journal.pone.0176281	http://dx.doi.org/10.1371/journal.pone.0176281			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SX	28475582	Green Submitted, Green Published, gold			2022-12-26	WOS:000400649500006
J	Esposti, MD; Romero, EM				Degli Esposti, Mauro; Martinez Romero, Esperanza			The functional microbiome of arthropods	PLOS ONE			English	Article							GUT MICROBIOTA; BACTERIAL COMMUNITY; GEN. NOV.; DIVERSITY; EVOLUTION; TREE; IDENTIFICATION; GENOMES; MEMBER; LIFE	Many studies on the microbiome of animals have been reported but a comprehensive analysis is lacking. Here we present a meta-analysis on the microbiomes of arthropods and their terrestrial habitat, focusing on the functional profile of bacterial communities derived from metabolic traits that are essential for microbial life. We report a detailed analysis of probably the largest set of biochemically defined functional traits ever examined in microbiome studies. This work deals with the phylum proteobacteria, which is usually dominant in marine and terrestrial environments and covers all functions associated with microbiomes. The considerable variation in the distribution and abundance of proteobacteria in microbiomes has remained fundamentally unexplained. This analysis reveals discrete functional groups characteristic for adaptation to anaerobic conditions, which appear to be defined by environmental filtering of taxonomically related taxa. The biochemical diversification of the functional groups suggests an evolutionary trajectory in the structure of arthropods' microbiome, from metabolically versatile to specialized proteobacterial organisms that are adapted to complex environments such as the gut of social insects. Bacterial distribution in arthropods' microbiomes also shows taxonomic clusters that do not correspond to functional groups and may derive from other factors, including common contaminants of soil and reagents.	[Degli Esposti, Mauro] Italian Inst Technol, Genoa, Italy; [Degli Esposti, Mauro; Martinez Romero, Esperanza] UNAM Campus Cuernavaca, Ctr Genom Sci, Cuernavaca, Morelos, Mexico	Istituto Italiano di Tecnologia - IIT	Esposti, MD (corresponding author), Italian Inst Technol, Genoa, Italy.; Esposti, MD (corresponding author), UNAM Campus Cuernavaca, Ctr Genom Sci, Cuernavaca, Morelos, Mexico.	mauro.degliesposti@iit.it			Consejo National de Ciencia y Tecnologia, Mexico [263876, 253116]; CONACyT [263876, 253116]	Consejo National de Ciencia y Tecnologia, Mexico; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the Consejo National de Ciencia y Tecnologia, Mexico (http://www.conacyt.gob.mx/#) Grants No. 263876 and 253116. Grant No. 263876 was awarded to finance the sabbatical period of MDE at CCG UNAM during 2016. Grant No. 253116 was awarded to EMR to continue here research program of environmental microbiology and genomics of gram negative bacteria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Julio Martinez Romero (CCG UNAM) for his help in data analysis. This work was sponsored by CONACyT grants No. 263876 and 253116.	Adams RI, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0108-3; Almagro G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115516; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Aujoulat F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083376; Aylward FO, 2012, ISME J, V6, P1688, DOI 10.1038/ismej.2012.10; Baldani JI, 2015, BERGEYS MANUAL SYSTE, P1, DOI [10. 1002/9781118960608. gbm00963, DOI 10.1002/9781118960608.GBM00891]; Berg M, 2016, ISME J, V10, P1998, DOI 10.1038/ismej.2015.253; Berlanga M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152400; Bhatt AS, 2013, NEW ENGL J MED, V369, P517, DOI 10.1056/NEJMoa1211115; Bolanos LM, 2016, ENVIRON MICROBIOL, V18, P1364, DOI 10.1111/1462-2920.12939; Boon E, 2014, FEMS MICROBIOL REV, V38, P90, DOI 10.1111/1574-6976.12035; Bouchon D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01472; Brune A, 2015, ANNU REV MICROBIOL, V69, P145, DOI 10.1146/annurev-micro-092412-155715; Burke C, 2011, P NATL ACAD SCI USA, V108, P14288, DOI 10.1073/pnas.1101591108; Cardona T, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00257; Castro-Nallar E, 2015, PEERJ, V3, DOI 10.7717/peerj.1140; Cecchini G, 2002, BBA-BIOENERGETICS, V1553, P140, DOI 10.1016/S0005-2728(01)00238-9; Chan AA, 2016, SCI REP-UK, V6, DOI 10.1038/srep28061; Chang YT, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00893; Chen MJ, 2013, J BACTERIOL, V195, P2768, DOI 10.1128/JB.00141-13; Chistoserdova L, 2009, ANNU REV MICROBIOL, V63, P477, DOI 10.1146/annurev.micro.091208.073600; Chou JH, 2007, INT J SYST EVOL MICR, V57, P887, DOI 10.1099/ijs.0.64551-0; Chouaia B, 2014, GENOME BIOL EVOL, V6, P912, DOI 10.1093/gbe/evu062; Colston TJ, 2016, MOL ECOL, V25, P3776, DOI 10.1111/mec.13730; Corby-Harris V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095056; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Esposti MD, 2016, GENOME BIOL EVOL, V8, P2031, DOI 10.1093/gbe/evw130; Esposti MD, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0136-3; Degli Esposti M, 2015, GENOME BIOL EVOL, V7, P801, DOI 10.1093/gbe/evv032; Esposti M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096566; Dirksen P, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0258-1; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Esposti MD, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw084; Esposti MD, 2016, GENOME BIOL EVOL, V8, P126, DOI 10.1093/gbe/evv239; Fan L, 2012, P NATL ACAD SCI USA, V109, pE1878, DOI 10.1073/pnas.1203287109; Gebhardt MJ, 2015, MBIO, V6, DOI 10.1128/mBio.01660-15; Glassing A, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0103-7; Greening C, 2016, ISME J, V10, P761, DOI 10.1038/ismej.2015.153; Hata H, 2016, MICROBIOL IMMUNOL, V60, P303, DOI 10.1111/1348-0421.12374; Hug LA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.48, 10.1038/nmicrobiol.2016.48]; Ikeda-Ohtsubo W, 2016, ENVIRON MICROBIOL, V18, P2548, DOI 10.1111/1462-2920.13234; Kaplan MM, 2004, AM J GASTROENTEROL, V99, P2147, DOI 10.1111/j.1572-0241.2004.41121.x; Kawamura Y, 2012, MICROBIOL IMMUNOL, V56, P21, DOI 10.1111/j.1348-0421.2011.00401.x; Kellner K, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv073; Ku C, 2015, NATURE, V524, P427, DOI 10.1038/nature14963; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lawrence AL, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv134; Levy R, 2013, P NATL ACAD SCI USA, V110, P12804, DOI 10.1073/pnas.1300926110; Liotenberg S, 2008, ENVIRON MICROBIOL, V10, P2267, DOI 10.1111/j.1462-2920.2008.01649.x; Liu JN, 2016, NEOTROP ENTOMOL, V45, P397, DOI 10.1007/s13744-016-0388-8; Louca S, 2016, SCIENCE, V353, P1272, DOI 10.1126/science.aaf4507; Lozano-Fernandez J, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0133; Martiny AC, 2013, ISME J, V7, P830, DOI 10.1038/ismej.2012.160; Mikaelyan A, 2016, APPL ENVIRON MICROB, V82, P1256, DOI 10.1128/AEM.03700-15; Montagna M, 2015, INSECT SCI, V22, P340, DOI 10.1111/1744-7917.12143; Montagna M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117439; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Nagai F, 2009, INT J SYST EVOL MICR, V59, P1793, DOI 10.1099/ijs.0.002519-0; Nakao R, 2013, ISME J, V7, P1003, DOI 10.1038/ismej.2012.171; Nayfach S, 2016, CELL, V166, P1103, DOI 10.1016/j.cell.2016.08.007; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Pan MM, 2015, J BASIC MICROB, V55, P1336, DOI 10.1002/jobm.201500124; Pascual J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146558; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Romano-Bertrand S, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.05.024; Rossmassler K, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0118-1; Roy P, 2014, J CLIN DIAGN RES, V8, pDD1, DOI 10.7860/JCDR/2014/7940.4329; Rungrassamee W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091853; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Schauer C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085861; Simon J, 2013, BBA-BIOENERGETICS, V1827, P114, DOI 10.1016/j.bbabio.2012.07.005; Smith RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129004; Thomas T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11870; Thomas V, 2006, APPL ENVIRON MICROB, V72, P2428, DOI 10.1128/AEM.72.4.2428-2438.2006; Tzeng TD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132860; van der Lelie D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036740; Vanthournout B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117297; Viklund J, 2012, MOL BIOL EVOL, V29, P599, DOI 10.1093/molbev/msr203; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; Wong ACN, 2015, APPL ENVIRON MICROB, V81, P6232, DOI 10.1128/AEM.01442-15; Xie FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028995; Xie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035181; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330	83	58	60	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176573	10.1371/journal.pone.0176573	http://dx.doi.org/10.1371/journal.pone.0176573			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475624	gold, Green Submitted, Green Published			2022-12-26	WOS:000400649500010
J	Starr, M; Lair, S; Michaud, S; Scarratt, M; Quilliam, M; Lefaivre, D; Robert, M; Wotherspoon, A; Michaud, R; Menard, N; Sauve, G; Lessard, S; Beland, P; Measures, L				Starr, Michel; Lair, Stephane; Michaud, Sonia; Scarratt, Michael; Quilliam, Michael; Lefaivre, Denis; Robert, Michel; Wotherspoon, Andrew; Michaud, Robert; Menard, Nadia; Sauve, Gilbert; Lessard, Sylvie; Beland, Pierre; Measures, Lena			Multispecies mass mortality of marine fauna linked to a toxic dinoflagellate bloom	PLOS ONE			English	Article							PORPOISE PHOCOENA-PHOCOENA; PARALYTIC SHELLFISH TOXINS; ATLANTIC RIGHT WHALES; POISONING PSP TOXINS; HARMFUL ALGAL BLOOMS; ST-LAWRENCE; ALEXANDRIUM-TAMARENSE; EUBALAENA-GLACIALIS; ESTUARY; GULF	Following heavy precipitation, we observed an intense algal bloom in the St. Lawrence Estuary (SLE) that coincided with an unusually high mortality of several species of marine fish, birds and mammals, including species designated at risk. The algal species was identified as Alexandrium tamarense and was determined to contain a potent mixture of paralytic shellfish toxins (PST). Significant levels of PST were found in the liver and/or gastrointestinal contents of several carcasses tested as well as in live planktivorous fish, molluscs and plankton samples collected during the bloom. This provided strong evidence for the trophic transfer of PST resulting in mortalities of multiple wildlife species. This conclusion was strengthened by the sequence of mortalities, which followed the drift of the bloom along the coast of the St. Lawrence Estuary. No other cause of mortality was identified in the majority of animals examined at necropsy. Reports of marine fauna presenting signs of neurological dysfunction were also supportive of exposure to these neurotoxins. The event reported here represents the first well-documented case of multispecies mass mortality of marine fish, birds and mammals linked to a PST-producing algal bloom.	[Starr, Michel; Michaud, Sonia; Scarratt, Michael; Lefaivre, Denis; Lessard, Sylvie; Measures, Lena] Maurice Lamontagne Inst, Fisheries & Oceans Canada, DFO, Mont Joli, PQ, Canada; [Lair, Stephane] Univ Montreal, Fac Med Vet, Canadian Cooperat Wildlife Hlth Ctr, St Hyacinthe, PQ, Canada; [Quilliam, Michael; Wotherspoon, Andrew] Natl Res Council Canada, Biotoxin Metrol, Halifax, NS, Canada; [Robert, Michel] Canadian Wildlife Serv, Environm & Climate Change Canada, Quebec City, PQ, Canada; [Michaud, Robert] GREMM, Tadoussac, PQ, Canada; [Menard, Nadia] Parks Canada, Saguenay St Lawrence Marine Pk, Tadoussac, PQ, Canada; [Sauve, Gilbert] Canadian Food Inspect Agcy, Quebec City, PQ, Canada	Fisheries & Oceans Canada; Universite de Montreal; International Business Machines (IBM); National Research Council Canada; Environment & Climate Change Canada; Canadian Wildlife Service; Parks Canada; Canadian Food Inspection Agency	Starr, M (corresponding author), Maurice Lamontagne Inst, Fisheries & Oceans Canada, DFO, Mont Joli, PQ, Canada.	Michel.Starr@dfo-mpo.gc.ca		Quilliam, Michael/0000-0002-2670-4220; Michaud, Sonia/0000-0001-9267-0404				ANDERSON DM, 1994, MAR BIOL, V120, P467, DOI 10.1007/BF00680222; [Anonymous], 2003, MANUAL HARMFUL MARIN, P347; Beck CA, 2005, CAN J ZOOL, V83, P377, DOI 10.1139/Z05-021; Benoit D, 1990, CAN B FISH AQUAT SCI, V222, P227; Berard-Therriault L, 1999, PUBLICATION SPECIALE; Breed GA, 2006, P R SOC B, V273, P2319, DOI 10.1098/rspb.2006.3581; Bricelj V. Monica, 1998, Reviews in Fisheries Science, V6, P315, DOI 10.1080/10641269891314294; Cembella AD, 2002, HARMFUL ALGAE, V1, P313, DOI 10.1016/S1568-9883(02)00048-3; Costa PR, 2011, MAR BIOL, V158, P2805, DOI 10.1007/s00227-011-1779-3; Dam HG, 2011, HARMFUL ALGAE, V10, P245, DOI 10.1016/j.hal.2010.10.004; Deeds JR, 2008, MAR DRUGS, V6, P308, DOI [10.3390/md6020308, 10.3390/md20080015]; Dell'Aversano C, 2005, J CHROMATOGR A, V1081, P190, DOI 10.1016/j.chroma.2005.05.056; Doucette G, 2006, ECOL STU AN, V189, P283, DOI 10.1007/978-3-540-32210-8_22; Doucette GJ, 2006, MAR ECOL PROG SER, V306, P303, DOI 10.3354/meps306303; Durbin E, 2002, HARMFUL ALGAE, V1, P243, DOI 10.1016/S1568-9883(02)00046-X; Fire SE, 2012, MAR ECOL PROG SER, V460, P145, DOI 10.3354/meps09768; FONTAINE PM, 1994, CAN J FISH AQUAT SCI, V51, P172, DOI 10.1139/f94-019; FRANKS PJS, 1992, MAR ECOL PROG SER, V82, P1, DOI 10.3354/meps082001; GERACI JR, 1989, CAN J FISH AQUAT SCI, V46, P1895, DOI 10.1139/f89-238; Geraci JR., 2005, MARINE MAMMALS ASHOR, V2; Gracia S, 2013, ESTUAR COAST SHELF S, V121, P20, DOI 10.1016/j.ecss.2013.01.019; Gulland FMD, 2007, ECOHEALTH, V4, P135, DOI 10.1007/s10393-007-0097-1; HALL S, 1990, ACS SYM SER, V418, P29; Hollingworth T, 1990, OFFICIAL METHODS ANA, V15th, P881; Kotaki Y, 1985, TOXIC DINOFLAGELLATE, P287; Lair S, 2015, DOCUMENTATION EVOLUT, V3143; Landsberg JH, 2002, REV FISH SCI, V10, P113, DOI 10.1080/20026491051695; LAROCQUE R, 1990, TOXIC MARINE PHYTOPLANKTON, P368; Lesage V, 2001, MAR ECOL PROG SER, V210, P203, DOI 10.3354/meps210203; Levasseur Maurice, 1995, P463; LUND J. W. G., 1958, HYDROBIOLOGIA, V11, P143, DOI 10.1007/BF00007865; MacIntyre JG, 1997, MAR ECOL PROG SER, V148, P201, DOI 10.3354/meps148201; OSHIMA Y, 1995, J AOAC INT, V78, P528; Oshima Yasukatsu, 1995, P475; Parkhill JP, 1999, J PLANKTON RES, V21, P939, DOI 10.1093/plankt/21.5.939; Rail Jean-Francois, 2009, Naturaliste Canadien (Quebec), V133, P33; Rail JF, 1998, CAN J ZOOL, V76, P635, DOI 10.1139/cjz-76-4-635; Reyero M, 1999, NAT TOXINS, V7, P311, DOI 10.1002/1522-7189(199911/12)7:6<311::AID-NT75>3.0.CO;2-I; Rourke WA, 2008, J AOAC INT, V91, P589; Saucier F.J., 2009, REV SCI EAU, V22, P159, DOI 10.7202/037480ar; Saucier FJ, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000686; Saucier FJ, 2000, ATMOS OCEAN, V38, P505, DOI 10.1080/07055900.2000.9649658; Selander E, 2006, P ROY SOC B-BIOL SCI, V273, P1673, DOI 10.1098/rspb.2006.3502; Senft-Batoh CD, 2015, HARMFUL ALGAE, V44, P20, DOI 10.1016/j.hal.2015.02.008; Senft-Batoh CD, 2015, LIMNOL OCEANOGR, V60, P318, DOI 10.1002/lno.10027; Shimizu Y., 1986, NATURAL TOXINS ANIMA, P115; SHUMWAY S E, 1990, Journal of the World Aquaculture Society, V21, P65, DOI 10.1111/j.1749-7345.1990.tb00529.x; Shumway SE, 2003, HARMFUL ALGAE, V2, P1, DOI 10.1016/S1568-9883(03)00002-7; SMITH RJ, 1992, CAN J ZOOL, V70, P1629, DOI 10.1139/z92-225; Stoskopf MK, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P703; Tan KS, 2015, REV ENVIRON CONTAM T, V235, P1, DOI 10.1007/978-3-319-10861-2_1; Therriault J.C., 1985, P141; Van Dolah FM, 2000, ENVIRON HEALTH PERSP, V108, P133, DOI 10.1289/ehp.00108s1133; Weise AM, 2002, CAN J FISH AQUAT SCI, V59, P464, DOI 10.1139/F02-024	54	37	44	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176299	10.1371/journal.pone.0176299	http://dx.doi.org/10.1371/journal.pone.0176299			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472048	Green Submitted, gold, Green Published			2022-12-26	WOS:000400648500036
J	Sui, M; Li, MY; Kunwar, S; Pandey, P; Zhang, Q; Lee, J				Sui, Mao; Li, Ming-Yu; Kunwar, Sundar; Pandey, Puran; Zhang, Quanzhen; Lee, Jihoon			Effects of annealing temperature and duration on the morphological and optical evolution of self-assembled Pt nanostructures on c-plane sapphire	PLOS ONE			English	Article							PLATINUM NANOPARTICLES; THIN-FILMS; RAYLEIGH INSTABILITY; SYSTEMATIC CONTROL; AG NANOSTRUCTURES; HYDROGEN STORAGE; CATALYSTS; SIZE; DEPOSITION; SCATTERING	Metallic nanostructures (NSs) have been widely adapted in various applications and their physical, chemical, optical and catalytic properties are strongly dependent on their surface morphologies. In this work, the morphological and optical evolution of self-assembled Pt nanostructures on c-plane sapphire (0001) is demonstrated by the control of annealing temperature and dwelling duration with the distinct thickness of Pt films. The formation of Pt NSs is led by the surface diffusion, agglomeration and surface and interface energy minimization of Pt thin films, which relies on the growth parameters such as system temperature, film thickness and annealing duration. The Pt layer of 10 nm shows the formation of overlaying NPs below 650 degrees C and isolated Pt nanoparticles above 700 degrees C based on the enhanced surface diffusion and Volmer-Weber growth model whereas larger wiggly nanostructures are formed with 20 nm thick Pt layers based on the coalescence growth model. The morphologies of Pt nanostructures demonstrate a sharp distinction depending on the growth parameters applied. By the control of dwelling duration, the gradual transition from dense Pt nanoparticles to networks-like and large clusters is observed as correlated to the Rayleigh instability and Ostwald ripening. The various Pt NSs show a significant distinction in the reflectance spectra depending on the morphology evolution: i.e. the enhancement in UV-visible and NIR regions and the related optical properties are discussed in conjunction with the Pt NSs morphology and the surface coverage.	[Sui, Mao; Li, Ming-Yu; Kunwar, Sundar; Pandey, Puran; Zhang, Quanzhen; Lee, Jihoon] Kwangwoon Univ, Coll Elect & Informat, Seoul, South Korea; [Lee, Jihoon] Univ Arkansas, Inst Nanoscale Sci & Engn, Fayetteville, AR 72701 USA	Kwangwoon University; University of Arkansas System; University of Arkansas Fayetteville	Lee, J (corresponding author), Kwangwoon Univ, Coll Elect & Informat, Seoul, South Korea.; Lee, J (corresponding author), Univ Arkansas, Inst Nanoscale Sci & Engn, Fayetteville, AR 72701 USA.	jihoonleenano@gmail.com	Pandey, Puran/AFR-7802-2022; Li, Ming-Yu/AAH-6879-2020; /B-7688-2019; KUNWAR, SUNDAR/AAD-1483-2020	Pandey, Puran/0000-0002-4993-2066; Li, Ming-Yu/0000-0003-4812-8604; /0000-0002-8768-8586; Kunwar, Sundar/0000-0001-6289-6613; SUI, MAO/0000-0002-3772-6986; Lee, Jihoon/0000-0002-0508-486X	National Research Foundation of Korea [2011-0030079, 2016R1A1A1A05005009]; Kwangwoon University	National Research Foundation of Korea(National Research Foundation of Korea); Kwangwoon University	Financial support from the National Research Foundation of Korea (no. 2011-0030079 and 2016R1A1A1A05005009), and in part by the research grant of Kwangwoon University in 2017 is gratefully acknowledged.	Baldizzone C, 2014, ANGEW CHEM INT EDIT, V53, P14250, DOI 10.1002/anie.201406812; Cai WB, 1998, SURF SCI, V406, P9, DOI 10.1016/S0039-6028(97)01030-3; Callegari G, 2002, LANGMUIR, V18, P4795, DOI 10.1021/la011862w; Eason R., 2007, PULSED LASER DEPOSIT, P628, DOI [10.1002/0470052120, DOI 10.1002/9780470052129]; Garbarino S, 2010, J PHYS CHEM C, V114, P2980, DOI 10.1021/jp908724k; Hong SH, 2013, OPT EXPRESS, V21, P3138, DOI 10.1364/OE.21.003138; Kaplan WD, 2013, J MATER SCI, V48, P5681, DOI 10.1007/s10853-013-7462-y; Kar JP, 2010, APPL SURF SCI, V256, P4995, DOI 10.1016/j.apsusc.2010.03.040; Kong L, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.165422; Kunwar S, 2016, CRYST GROWTH DES, V16, P6974, DOI 10.1021/acs.cgd.6b01185; Lando A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.133402; Langhammer C, 2006, NANO LETT, V6, P833, DOI 10.1021/nl060219x; Langhammer C, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2734550; Li Y, 2007, IND ENG CHEM RES, V46, P8277, DOI 10.1021/ie0712075; Li YW, 2007, J PHYS CHEM C, V111, P11086, DOI 10.1021/jp072867q; Liu CY, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3291041; Marshall MSJ, 2014, CHEM SOC REV, V43, P2226, DOI 10.1039/c3cs60458f; Mayrhofer KJJ, 2005, J PHYS CHEM B, V109, P14433, DOI 10.1021/jp051735z; Nakashima S, 2016, AIP ADV, V6, DOI 10.1063/1.4939985; Ovari L, 2010, LANGMUIR, V26, P2167, DOI 10.1021/la902674u; Pandey P, 2016, APPL SURF SCI, V368, P198, DOI 10.1016/j.apsusc.2016.02.001; Pandey P, 2015, RSC ADV, V5, P66212, DOI 10.1039/c5ra07631e; Park J, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2206580; Ruffino F, 2010, J APPL PHYS, V107, DOI 10.1063/1.3428467; Sau TK, 2010, ADV MATER, V22, P1781, DOI 10.1002/adma.200901271; SHEN ZY, 1992, IEEE T MICROW THEORY, V40, P2424, DOI 10.1109/22.179912; Shiraishi Y, 2013, ACS NANO, V7, P9287, DOI 10.1021/nn403954p; Shiraishi Y, 2012, ACS CATAL, V2, P1984, DOI 10.1021/cs300407e; Simonsen SB, 2010, J AM CHEM SOC, V132, P7968, DOI 10.1021/ja910094r; Simonsen SB, 2011, J CATAL, V281, P147, DOI 10.1016/j.jcat.2011.04.011; Stuchebnikov VM, 2005, J COMMUN TECHNOL EL+, V50, P622; Sui M, 2016, SUPERLATTICE MICROST, V100, P1128, DOI 10.1016/j.spmi.2016.10.083; Sui M, 2017, J MATER SCI, V52, P391, DOI 10.1007/s10853-016-0339-0; Sui M, 2014, J APPL CRYSTALLOGR, V47, P505, DOI 10.1107/S1600576713034316; Tan ST, 2006, J APPL PHYS, V100, DOI 10.1063/1.2218468; Tang ZY, 2013, NANO ENERGY, V2, P622, DOI 10.1016/j.nanoen.2013.07.014; Thouti E, 2013, J OPTICS-UK, V15, DOI 10.1088/2040-8978/15/3/035005; Tripathy S, 1999, J APPL PHYS, V85, P8386, DOI 10.1063/1.370686; VENABLES JA, 1984, REP PROG PHYS, V47, P399, DOI 10.1088/0034-4885/47/4/002; VOORHEES PW, 1985, J STAT PHYS, V38, P231, DOI 10.1007/BF01017860; WEAVER JH, 1975, PHYS REV B, V11, P1416, DOI 10.1103/PhysRevB.11.1416; Wiley BJ, 2006, J PHYS CHEM B, V110, P15666, DOI 10.1021/jp0608628; YAO JH, 1993, PHYS REV B, V47, P14110, DOI 10.1103/PhysRevB.47.14110; YUAN C, 1995, J ELECTROCHEM SOC, V142, pL163, DOI 10.1149/1.2048735; Zhang JM, 2004, APPL SURF SCI, V229, P34, DOI 10.1016/j.apsusc.2003.09.050; Zhang N, 2016, NAT PHOTONICS, V10, P473, DOI [10.1038/NPHOTON.2016.76, 10.1038/nphoton.2016.76]; Zhao YD, 2014, NANOSCALE, V6, P1311, DOI 10.1039/c3nr05303b; Zoric I, 2011, ACS NANO, V5, P2535, DOI 10.1021/nn102166t	48	21	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177048	10.1371/journal.pone.0177048	http://dx.doi.org/10.1371/journal.pone.0177048			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472142	gold, Green Published, Green Submitted			2022-12-26	WOS:000400648500129
J	Yamane, A; Kohno, H; Ikeda, T; Kaneko, K; Ugajin, A; Fujita, T; Kunieda, T; Kubo, T				Yamane, Atsuhiro; Kohno, Hiroki; Ikeda, Tsubomi; Kaneko, Kumi; Ugajin, Atsushi; Fujita, Toshiyuki; Kunieda, Takekazu; Kubo, Takeo			Gene expression and immunohistochemical analyses of mKast suggest its late pupal and adult-specific functions in the honeybee brain	PLOS ONE			English	Article							1ST OPTIC GANGLION; SHORT-TERM-MEMORY; MUSHROOM BODIES; APIS-MELLIFERA; SUBESOPHAGEAL GANGLION; EUROPEAN HONEYBEE; E3 LIGASE; BEE; ORGANIZATION; RECEPTOR	In insect brains, the mushroom bodies (MBs, a higher center) comprise intrinsic neurons, termed Kenyon cells (KCs). We previously showed that the honeybee (Apis mellifera L.) MBs comprise four types of KCs, in addition to the previously known three types of KCs: class I large-type KCs (lKCs), class I small-type KCs (sKCs) and class II KCs, novel class I 'middle-type' KCs (mKCs), which are characterized by the preferential expression of a gene, termed mKast. Although mKast was originally discovered during the search for genes whose expression is enriched in the optic lobes (OLs) in the worker brain, subsequent analysis revealed that the gene is expressed in an mKC-preferential manner in the MBs. To gain more insights into the function of mKast in the honeybee brain, we here performed expression analysis of mKast and immunohistochemistry of the mKast protein. Prominent mKast expression was first detected in the brain after the P7 pupal stage. In addition, mKast was expressed almost selectively in the brain, suggesting its late pupal and adult specific functions in the brain. Immunohistochemistry revealed that mKast-like immunoreactivity is detected in several regions in the worker brain: inside and around the MB calyces, at the outer edges of the OL lobula, at the outer surface of and posterior to the antennal lobes (ALs), along the dorsal midline of the anterior brain and at the outer surface of the subesophageal ganglions (SOG). mKast-like immunoreactivities in the MBs, OLs, ALs and SOG were due to the corresponding neurons, while mKast-like immunoreactivities beneath/between the MB calyces were assumed to most likely correspond to the lateral/medial neurosecretory cells.	[Yamane, Atsuhiro; Kohno, Hiroki; Ikeda, Tsubomi; Kaneko, Kumi; Ugajin, Atsushi; Fujita, Toshiyuki; Kunieda, Takekazu; Kubo, Takeo] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan	University of Tokyo	Kubo, T (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan.	stkubo@bs.s.u-tokyo.ac.jp	Kunieda, Takekazu/G-4946-2014; KUBO, TAKEO/G-4951-2014	Kunieda, Takekazu/0000-0002-6256-1335; Ugajin, Atsushi/0000-0003-1834-3565; Kubo, Takeo/0000-0002-5914-5269	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [26291068]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (grant number: 26291068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Hideaki Takeuchi (Okayama University), for his critical reading of this manuscript. We would also like to express our sincere gratitude to Dr. Wulfia Gronenberg (The University of Arizona) for his valuable comments in writing this manuscript. This work was supported by the Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	EICHMULLER S, 1991, J COMP NEUROL, V312, P164, DOI 10.1002/cne.903120112; ERBER J, 1980, PHYSIOL ENTOMOL, V5, P343, DOI 10.1111/j.1365-3032.1980.tb00244.x; Fahrbach SE, 2006, ANNU REV ENTOMOL, V51, P209, DOI 10.1146/annurev.ento.51.110104.150954; Farris SM, 2001, J NEUROSCI, V21, P6395, DOI 10.1523/JNEUROSCI.21-16-06395.2001; Farris SM, 2001, P BIOL SCI, V278, P940; Ganeshina O, 2000, J COMP NEUROL, V417, P349, DOI 10.1002/(SICI)1096-9861(20000214)417:3&lt;349::AID-CNE8&gt;3.0.CO;2-E; Gronenberg W, 2001, J COMP NEUROL, V435, P474, DOI 10.1002/cne.1045; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Han SO, 2013, EMBO REP, V14, P164, DOI 10.1038/embor.2012.187; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; HERTEL H, 1987, J EXP BIOL, V133, P283; HERTEL H, 1987, J EXP BIOL, V133, P301; HERTEL H, 1980, J COMP PHYSIOL, V137, P215, DOI 10.1007/BF00657117; Kamikouchi A, 1998, BIOCHEM BIOPH RES CO, V242, P181, DOI 10.1006/bbrc.1997.7870; Kaneko K, 2016, ZOOL LETT, V2, DOI 10.1186/s40851-016-0051-6; Kaneko K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071732; Kaneko K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009213; Kiya T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000371; Kohno H, 2016, ZOOL SCI, V33, P505, DOI 10.2108/zs160043; KREISSL S, 1994, J COMP NEUROL, V348, P583, DOI 10.1002/cne.903480408; Kubo T, 1996, J BIOCHEM-TOKYO, V119, P291, DOI 10.1093/oxfordjournals.jbchem.a021237; Kubo T, 2012, HONEYBEE NEUROBIOLOG, P341; Kucharski R, 1998, NATURWISSENSCHAFTEN, V85, P343, DOI 10.1007/s001140050512; Locatelli F, 2005, J NEUROSCI, V25, P11614, DOI 10.1523/JNEUROSCI.3180-05.2005; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Mobbs P.G., 1985, P299; MOBBS PG, 1982, PHILOS T ROY SOC B, V298, P309, DOI 10.1098/rstb.1982.0086; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Nishinaka Y, 2004, J BIOL CHEM, V279, P37559, DOI 10.1074/jbc.M405473200; Orihara-Ono M, 2011, DEV BIOL, V351, P163, DOI 10.1016/j.ydbio.2010.12.044; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Puca L, 2014, J CELL SCI, V127, P1359, DOI 10.1242/jcs.142539; Puca L, 2013, J CELL SCI, V126, P4457, DOI 10.1242/jcs.130500; REHDER V, 1988, PROC R SOC SER B-BIO, V235, P179, DOI 10.1098/rspb.1988.0071; RIBI WA, 1976, CELL TISSUE RES, V171, P359, DOI 10.1007/BF00224660; RIBI WA, 1981, CELL TISSUE RES, V221, P17, DOI 10.1007/BF00216567; RIBI WA, 1981, CELL TISSUE RES, V215, P443, DOI 10.1007/BF00233522; Rybak J, 1998, LEARN MEMORY, V5, P133; Rybak J, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00030; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Seeley T., 1995, WISDOM HIVE SOCIAL P; Shea FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050557; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2009, P NATL ACAD SCI USA, V106, P6650, DOI 10.1073/pnas.0901083106; Strausfeld NJ, 2002, J COMP NEUROL, V450, P4, DOI 10.1002/cne.10285; Suenami S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157841; VONFRISCH K, 1967, SCIENCE, V158, P1072; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Winston M. L, 1986, BIOL HONEYBEE; WITHERS GS, 1995, J NEUROBIOL, V26, P130, DOI 10.1002/neu.480260111; YAMAKI K, 1990, J BIOL CHEM, V265, P20757; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	52	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176809	10.1371/journal.pone.0176809	http://dx.doi.org/10.1371/journal.pone.0176809			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472083	Green Published, gold			2022-12-26	WOS:000400648500074
J	Yap, YC; King, AE; Guijt, RM; Jiang, TC; Blizzard, CA; Breadmore, MC; Dickson, TC				Yap, Yiing C.; King, Anna E.; Guijt, Rosanne M.; Jiang, Tongcui; Blizzard, Catherine A.; Breadmore, Michael C.; Dickson, Tracey C.			Mild and repetitive very mild axonal stretch injury triggers cystoskeletal mislocalization and growth cone collapse	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; TRANSGENIC MOUSE MODEL; COGNITIVE IMPAIRMENT; MICROTUBULES; DEGENERATION; TRANSPORT; NEUROFILAMENTS; VULNERABILITY; CYTOSKELETAL; REGENERATION	Diffuse axonal injury is a hallmark pathological consequence of non-penetrative traumatic brain injury (TBI) and yet the axonal responses to stretch injury are not fully understood at the cellular level. Here, we investigated the effects of mild (5%), very mild (0.5%) and repetitive very mild (2x0.5%) axonal stretch injury on primary cortical neurons using a recently developed compartmentalized in vitro model. We found that very mild and mild levels of stretch injury resulted in the formation of smaller growth cones at the tips of axons and a significantly higher number of collapsed structures compared to those present in uninjured cultures, when measured at both 24 h and 72 h post injury. Immunocytochemistry studies revealed that at 72 h following mild injury the axonal growth cones had a significantly higher colocalization of ss III tubulin and F-actin and higher percentage of collapsed morphology than those present following a very mild injury. Interestingly, cultures that received a second very mild stretch injury, 24 h after the first insult, had a further increased proportion of growth cone collapse and increased ss III tubulin and F-actin colocalization, compared with a single very mild injury at 72 h PI. In addition, our results demonstrated that microtubule stabilization of axons using brain penetrant Epothilone D (EpoD) (100 nM) resulted in a significant reduction in the number of fragmented axons following mild injury. Collectively, these results suggest that mild and very mild stretch injury to a very localized region of the cortical axon is able to trigger a degenerative response characterized by growth cone collapse and significant abnormal cytoskeletal rearrangement. Furthermore, repetitive very mild stretch injury significantly exacerbated this response. Results suggest that axonal degeneration following stretch injury involves destabilization of the microtubule cytoskeleton and hence treatment with EpoD reduced fragmentation. Together, these results contribute a better understanding of the pathogenesis of mild and repetitive TBI and highlight the therapeutic effect of microtubule targeted drugs on distal part of neurons using a compartmentalized culturing model.	[Yap, Yiing C.; Jiang, Tongcui; Blizzard, Catherine A.; Dickson, Tracey C.] Univ Tasmania, Menzies Inst Med Res, Hobart, Australia; [Yap, Yiing C.; King, Anna E.] Univ Tasmania, Wicking Dementia Res & Educ Ctr, Hobart, Australia; [Yap, Yiing C.; Guijt, Rosanne M.] Univ Tasmania, Pharm Sch Med, Australian Ctr Res Separat Sci ACROSS, Hobart, Australia; [Yap, Yiing C.; Breadmore, Michael C.] Univ Tasmania, Sch Phys Sci, ACROSS, Hobart, Australia	University of Tasmania; Menzies Institute for Medical Research; University of Tasmania; University of Tasmania; University of Tasmania	Dickson, TC (corresponding author), Univ Tasmania, Menzies Inst Med Res, Hobart, Australia.	Tracey.Dickson@utas.edu.au	Breadmore, Michael/J-7628-2014; Guijt, Rosanne Marieke/R-2428-2017; King, Anna/J-7927-2014	Breadmore, Michael/0000-0001-5591-4326; Guijt, Rosanne Marieke/0000-0003-0011-5708; King, Anna/0000-0003-1792-0965; Blizzard, Catherine/0000-0002-8683-2937; Dickson, Tracey/0000-0002-9196-1661	Select Foundation; Wicking Dementia Research and Education Centre; Australian Research Council; ARC Discovery Project [DP150100998]; UTAS Pro Vice Chancellor for Research; UTAS Cross Theme Grant; NHMRC project grant [APP1042556]; NHMRC project grant	Select Foundation; Wicking Dementia Research and Education Centre; Australian Research Council(Australian Research Council); ARC Discovery Project(Australian Research Council); UTAS Pro Vice Chancellor for Research; UTAS Cross Theme Grant; NHMRC project grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC project grant(National Health and Medical Research Council (NHMRC) of Australia)	This research is supported by Select Foundation (Fellowship to TD), the Wicking Dementia Research and Education Centre (Fellowship to AK), Australian Research Council (Future Fellowship to MCB), ARC Discovery Project Grant (DP150100998), UTAS Pro Vice Chancellor for Research and UTAS Cross Theme Grant and NHMRC project grant (APP1042556) to TD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Mr Graeme McCormark, Miss Clara Lee, Mr Justin Dittman and Mr John Davis for their technical assistance in completing this work. This research is supported by Select Foundation (Fellowship to TD), the Wicking Dementia Research and Education Centre (Fellowship to AK), Australian Research Council (Future Fellowship to MCB), ARC Discovery Project Grant (DP150100998), UTAS Pro Vice Chancellor for Research and UTAS Cross Theme Grant and NHMRC project grant to TD.	Adlard PA, 2000, ACTA NEUROPATHOL, V100, P183, DOI 10.1007/s004019900160; Andrieux A, 2006, BIOL PSYCHIAT, V60, P1224, DOI 10.1016/j.biopsych.2006.03.048; Blizzard CA, 2007, EUR J NEUROSCI, V26, P1100, DOI 10.1111/j.1460-9568.2007.05750.x; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; Brizuela M, 2015, MOL CELL NEUROSCI, V66, P129, DOI 10.1016/j.mcn.2015.02.006; Brunden KR, 2010, J NEUROSCI, V30, P13861, DOI 10.1523/JNEUROSCI.3059-10.2010; Childs WR, 2005, LANGMUIR, V21, P10096, DOI 10.1021/la050011b; Christman CW, 1997, ACTA NEUROPATHOL, V94, P329, DOI 10.1007/s004010050715; Chuckowree JA, 2003, J NEUROSCI, V23, P3715; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Erturk A, 2007, J NEUROSCI, V27, P9169, DOI 10.1523/JNEUROSCI.0612-07.2007; Farkas O, 2007, PROGR BRAIN RES, V161, P43; Finn JT, 2000, J NEUROSCI, V20, P1333; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; GOEDERT M, 1991, TRENDS NEUROSCI, V14, P193, DOI 10.1016/0166-2236(91)90105-4; Gordon-Weeks PR, 2004, J NEUROBIOL, V58, P70, DOI 10.1002/neu.10266; Hill CE, 2001, EXP NEUROL, V171, P153, DOI 10.1006/exnr.2001.7734; Huh JW, 2007, J NEUROTRAUM, V24, P15, DOI 10.1089/neu.2006.0072; Jang EH, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/5056418; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; King CE, 2000, CLIN EXP PHARMACOL P, V27, P548, DOI 10.1046/j.1440-1681.2000.03292.x; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller CCJ, 2002, CELL MOL LIFE SCI, V59, P323, DOI 10.1007/s00018-002-8425-7; Monnerie H, 2010, EXP NEUROL, V224, P415, DOI 10.1016/j.expneurol.2010.05.001; Mueller BK, 2009, BRIT J PHARMACOL, V157, P675, DOI 10.1111/j.1476-5381.2009.00220.x; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Peyrin JM, 2011, LAB CHIP, V11, P3663, DOI 10.1039/c1lc20014c; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Richter M, 2007, J NEUROSCI, V27, P14205, DOI 10.1523/JNEUROSCI.2746-07.2007; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor AM, 2003, LANGMUIR, V19, P1551, DOI 10.1021/la026417v; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Vickers JC, 2009, BRAIN RES BULL, V80, P217, DOI 10.1016/j.brainresbull.2009.08.004; Weber JT, 2007, PROG BRAIN RES, V161, P253, DOI 10.1016/S0079-6123(06)61018-2; Yap YC, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4891098; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161	54	20	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176997	10.1371/journal.pone.0176997	http://dx.doi.org/10.1371/journal.pone.0176997			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472086	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000400648500112
J	Mausbach, J; Braga Goncalves, I; Heistermann, M; Ganswindt, A; Manser, MB				Mausbach, Jelena; Braga Goncalves, Ines; Heistermann, Michael; Ganswindt, Andre; Manser, Marta B.			Meerkat close calling patterns are linked to sex, social category, season and wind, but not fecal glucocorticoid metabolite concentrations	PLOS ONE			English	Article							CORTISOL-LEVELS; INTRASEXUAL COMPETITION; ADRENOCORTICAL ACTIVITY; INDIVIDUAL RECOGNITION; REPRODUCTIVE-BIOLOGY; WILD MEERKATS; BODY-SIZE; MOLE-RAT; BEHAVIOR; TESTOSTERONE	It is well established that animal vocalizations can encode information regarding a sender's identity, sex, age, body size, social rank and group membership. However, the association between physiological parameters, particularly stress hormone levels, and vocal behavior is still not well understood. The cooperatively breeding African meerkats (Suricata suricatta) live in family groups with despotic social hierarchies. During foraging, individuals emit close calls that help maintain group cohesion. These contact calls are acoustically distinctive and variable in rate across individuals, yet, information on which factors influence close calling behavior is missing. The aim of this study was to identify proximate factors that influence variation in call rate and acoustic structure of meerkat close calls. Specifically, we investigated whether close calling behavior is associated with sex, age and rank, or stress hormone output (i.e., measured as fecal glucocorticoid metabolite (fGCM) concentrations) as individual traits of the caller, as well as with environmental conditions (weather) and reproductive seasonality. To disentangle the effects of these factors on vocal behavior, we analyzed sound recordings and assessed fGCM concentrations in 64 wild but habituated meerkats from 9 groups during the reproductive and non-reproductive seasons. Dominant females and one-year old males called at significantly higher rates compared to other social categories during the reproductive season. Additionally, dominant females produced close calls with the lowest mean fundamental frequencies (F0) and the longest mean pulse durations. Windy conditions were associated with significantly higher call rates during the nonreproductive season. Fecal GCM concentrations were unrelated to close calling behavior. Our findings suggest that meerkat close calling behavior conveys information regarding the sex and social category of the caller, but shows no association with fGCM concentrations. The change in call rate in response to variation in the social and ecological environments individuals experience indicates some degree of flexibility in vocal production.	[Mausbach, Jelena; Braga Goncalves, Ines; Manser, Marta B.] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Anim Behav, Zurich, Switzerland; [Mausbach, Jelena; Braga Goncalves, Ines; Manser, Marta B.] Kuruman River Reserve, Kalahari Meerkat Project, Northern Cape, South Africa; [Heistermann, Michael] Endocrinol Lab German Primate Ctr, Gottingen, Germany; [Ganswindt, Andre] Univ Pretoria, Endocrine Res Lab, Dept Anat & Physiol, Fac Vet Sci, Onderstepoort, South Africa; [Ganswindt, Andre; Manser, Marta B.] Univ Pretoria, Mammal Res Inst, Hatfield, South Africa	University of Zurich; University of Pretoria; University of Pretoria	Mausbach, J; Manser, MB (corresponding author), Univ Zurich, Dept Evolutionary Biol & Environm Studies, Anim Behav, Zurich, Switzerland.; Mausbach, J; Manser, MB (corresponding author), Kuruman River Reserve, Kalahari Meerkat Project, Northern Cape, South Africa.; Manser, MB (corresponding author), Univ Pretoria, Mammal Res Inst, Hatfield, South Africa.	jelena.mausbach@eawag.ch; marta.manser@ieu.uzh.ch	Ganswindt, Andre/G-9856-2014; Goncalves, Ines Braga/F-5859-2012	Ganswindt, Andre/0000-0002-1474-7602; Goncalves, Ines Braga/0000-0003-0659-9029	Swiss National Science Foundation [31003A-13676]; Cambridge University; Earthwatch	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Cambridge University(University of Cambridge); Earthwatch	This study was funded by the Swiss National Science Foundation (grant no. 31003A-13676, http://www.snf.ch) to Marta B. Manser. The long term field site KMP was financed by Cambridge University (https://www.can.ac.uk/), Zurich University (http://www.uzh.ch/en.htm) and Earthwatch (http://eu.earthwatch.org/bout). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers H.E., 2002, HORMONES BRAIN BEHAV, P393, DOI DOI 10.1016/B978-012532104-4/50008-1; Barrette M-F, 2012, HORMONES BEHAV, V61; BENNETT NC, 1988, J MAMMAL, V69, P293, DOI 10.2307/1381379; BENNETT NC, 1989, J ZOOL, V219, P45, DOI 10.1111/j.1469-7998.1989.tb02564.x; Blumstein DT, 2006, BIOL LETTERS, V2, P29, DOI 10.1098/rsbl.2005.0405; Bonier F, 2009, TRENDS ECOL EVOL, V24, P634, DOI 10.1016/j.tree.2009.04.013; Braga Goncalves I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153161; Briefer EF, 2012, J ZOOL, V288, P1, DOI 10.1111/j.1469-7998.2012.00920.x; Briefer E, 2011, APPL ANIM BEHAV SCI, V133, P175, DOI 10.1016/j.applanim.2011.05.012; Busch DS, 2009, BIOL CONSERV, V142, P2844, DOI 10.1016/j.biocon.2009.08.013; Carlson AA, 2004, HORM BEHAV, V46, P141, DOI 10.1016/j.yhbeh.2004.01.009; Charlton BD, 2012, ANIMAL COGNITION, V15; Clutton-Brock TH, 2006, NATURE, V444, P1065, DOI 10.1038/nature05386; Clutton-Brock TH, 1998, P ROY SOC B-BIOL SCI, V265, P185, DOI 10.1098/rspb.1998.0281; Clutton-Brock TH, 2001, SCIENCE, V291, P478, DOI 10.1126/science.291.5503.478; Clutton-Brock TH, 1999, J ANIM ECOL, V68, P672, DOI 10.1046/j.1365-2656.1999.00317.x; Dabbs JM, 1999, PERS INDIV DIFFER, V27, P801, DOI 10.1016/S0191-8869(98)00272-4; Dantzer B, INFLUENCE STRE UNPUB; Emerson SB, 2001, HORM BEHAV, V39, P59, DOI 10.1006/hbeh.2000.1635; Engesser S., 2011, SURICATA SURICATTA; English S, 2012, OECOLOGIA, V169, P143, DOI 10.1007/s00442-011-2192-9; Fichtel C, 2001, BEHAVIOUR, V138, P97, DOI 10.1163/15685390151067094; Gall G, 2012, ASSESSMENT SPATIO TE; Ganswindt A, 2003, GEN COMP ENDOCR, V134, P156, DOI 10.1016/S0016-6480(03)00251-X; Goymann W, 2012, METHODS ECOL EVOL, V3, P757, DOI 10.1111/j.2041-210X.2012.00203.x; Hamalainen A, 2014, GEN COMP ENDOCR, V195, P68, DOI 10.1016/j.ygcen.2013.10.017; Hay M, 2000, J ANIMAL SCI, V78; Heistermann M, 2006, AM J PRIMATOL, V68, P257, DOI 10.1002/ajp.20222; Heistermann M, 2004, INT J PRIMATOL, V25, P689, DOI 10.1023/B:IJOP.0000023581.17889.0f; Heistermann M, 1995, AM J PRIMATOLOGY, V37; Hodges K, 2010, WILD MAMMALS IN CAPT; Huck M, 2005, INT J PRIMATOL, V26, P159, DOI 10.1007/s10764-005-0728-8; Inagaki H, 2014, HORM BEHAV, V65, P42, DOI 10.1016/j.yhbeh.2013.11.003; Jordan NR, 2007, ANIM BEHAV, V73, P613, DOI 10.1016/j.anbehav.2006.06.010; Kaiser S, 2005, NEUROSCI BIOBEHAV R, V29, P283, DOI 10.1016/j.neubiorev.2004.09.015; Kaiser S, 2015, BEHAVIOUR, V152, P837, DOI 10.1163/1568539X-00003256; Kalbitzer U, 2013, METHODS ECOL EVOL, V4, P493, DOI 10.1111/2041-210X.12054; Koren L, 2008, HORM BEHAV, V54, P212, DOI 10.1016/j.yhbeh.2008.02.020; Kutsukake N, 2006, BEHAV ECOL SOCIOBIOL, V59, P541, DOI 10.1007/s00265-005-0079-7; Kutsukake N, 2008, P R SOC B, V275, P209, DOI 10.1098/rspb.2007.1311; Leary CJ, 2004, BEHAV ECOL, V15, P313, DOI 10.1093/beheco/arh015; Lemasson A, 2013, PRIMATES, V54, P283, DOI 10.1007/s10329-013-0347-5; Lewanzik D, 2012, GEN COMP ENDOCR, V177, P104, DOI 10.1016/j.ygcen.2012.02.021; Linhart P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135414; Manser MB, 2000, BEHAV ECOL SOCIOBIOL, V48, P429, DOI 10.1007/s002650000248; Manser MB, 1998, SURICATA SURICATTA; McEwen BS, 2015, J ENDOCRINOL, V226, pT67, DOI 10.1530/JOE-15-0121; O'Riain MJ, 2000, P NATL ACAD SCI USA, V97, P13194, DOI 10.1073/pnas.97.24.13194; Onyango PO, 2013, HORM BEHAV, V64, P240, DOI 10.1016/j.yhbeh.2013.02.014; Ostner J, 2008, HORM BEHAV, V54, P613, DOI 10.1016/j.yhbeh.2008.05.020; Palme R, 2013, WIEN TIERARZTL MONAT, V100, P238; Pfefferle D, 2011, INT J PRIMATOL, V32, P992, DOI 10.1007/s10764-011-9517-8; Pfluger FJ, 2012, ANIM COGN, V15, P823, DOI 10.1007/s10071-012-0507-9; Radford AN, 2008, ANIM BEHAV, V75, P519, DOI 10.1016/j.anbehav.2007.05.016; Ramallo MR, 2015, HORM BEHAV, V69, P139, DOI 10.1016/j.yhbeh.2015.01.008; Reber SA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1013; Rendall D, 2003, J ACOUST SOC AM, V113, P3390, DOI 10.1121/1.1568942; Rendall D, 2005, J ACOUST SOC AM, V117, P944, DOI 10.1121/1.1848011; Rimbach R, 2013, GEN COMP ENDOCR, V191, P13, DOI 10.1016/j.ygcen.2013.05.010; Russell AF, 2004, EVOLUTION, V58, P1600; SAYIGH LS, 1995, BEHAV ECOL SOCIOBIOL, V36, P171, DOI 10.1007/s002650050137; Setchell JM, 2015, PHYSIOL BEHAV, V147, P245, DOI 10.1016/j.physbeh.2015.04.051; Seyfarth RM, 2003, ANN NY ACAD SCI, V1000, P32, DOI 10.1196/annals.1280.004; Seyfarth RM, 2009, RES PER NEUROSCI, P69, DOI 10.1007/978-3-540-85897-3_7; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Shutt K, 2012, GENERAL AND COMPARAT, V179; Soltis J, 2005, ANIM BEHAV, V70, P589, DOI 10.1016/j.anbehav.2004.11.016; Sousa-Lima RS, 2002, ANIM BEHAV, V63, P301, DOI 10.1006/anbe.2001.1873; Stephens PA, 2005, AM NAT, V165, P120, DOI 10.1086/426597; Taylor AM, 2010, J ZOOLOGY, V280; TERKEL AS, 1976, HORM BEHAV, V7, P49, DOI 10.1016/0018-506X(76)90004-0; Tilgar V, 2010, HORM BEHAV, V57, P481, DOI 10.1016/j.yhbeh.2010.02.006; Tomaszycki ML, 2001, HORM BEHAV, V39, P267, DOI 10.1006/hbeh.2001.1659; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; Townsend SW, 2012, BIOL LETTERS, V8, P179, DOI 10.1098/rsbl.2011.0844; Townsend SW, 2010, ANIM BEHAV, V80, P133, DOI 10.1016/j.anbehav.2010.04.010; Turbe A., 2006, HABITAT USE RANGING; Velloso AL, 1998, GEN COMP ENDOCR, V112, P96, DOI 10.1006/gcen.1998.7147; Voellmy IK, 2014, HORM BEHAV, V66, P759, DOI 10.1016/j.yhbeh.2014.08.008; Wheeler BC, 2013, INT J PRIMATOL, V34, P879, DOI 10.1007/s10764-013-9703-y; Young AJ, 2007, P ROY SOC B-BIOL SCI, V274, P1603, DOI 10.1098/rspb.2007.0316; Young AJ, 2009, BIOL LETTERS, V5, P439, DOI 10.1098/rsbl.2009.0032	82	6	6	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0175371	10.1371/journal.pone.0175371	http://dx.doi.org/10.1371/journal.pone.0175371			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467419	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000400647000013
J	Sepanlou, SG; Barahimi, H; Najafi, I; Kamangar, F; Poustchi, H; Shakeri, R; Hakemi, MS; Pourshams, A; Khoshnia, M; Gharravi, A; Broumand, B; Nobakht-Haghighi, A; Kalantar-Zadeh, K; Malekzadeh, R				Sepanlou, Sadaf G.; Barahimi, Hamid; Najafi, Iraj; Kamangar, Farin; Poustchi, Hossein; Shakeri, Ramin; Hakemi, Monir Sadat; Pourshams, Akram; Khoshnia, Masoud; Gharravi, Abdolsamad; Broumand, Behrooz; Nobakht-Haghighi, Ali; Kalantar-Zadeh, Kamyar; Malekzadeh, Reza			Prevalence and determinants of chronic kidney disease in northeast of Iran: Results of the Golestan cohort study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; RISK-FACTORS; SYSTEMATIC ANALYSIS; SERUM CREATININE; GLOBAL BURDEN; ALBUMINURIA; KNOWLEDGE; MORTALITY; EQUATION; OBESITY	Background The burden of chronic kidney disease (CKD) is increasing globally in particular in fast emerging economies such as Iran. Population-based studies on prevalence of CKD in Iran are scarce. The objective of the current study was to explore the prevalence and determinants of CKD in the setting of Golestan Cohort Study (GCS), the largest prospective cohort in the Middle East. Methods In this observational study, 11,409 participants enrolled in the second phase of GCS were included. Sex, age, literacy, residence, anthropometric measurements, smoking, opium use, self-reported history of cardiovascular diseases (heart disease and/or stroke), hypertension, diabetes, and lipid profile were the predictors of interest. The outcomes of interest were eGFR and CKD defined as eGFR< 60 ml/min/1.73m(2). Results Mean (SD) of GFR was 70.0 +/- 14.7 ml/min/1.73m(2) among all participants, 68.2 +/- 14.2 among women, and 72.0 +/- 15.0 among men. Prevalence of CKD was 23.7% (26.6% in women, 20.6% in men). The prevalence of CKD stages 3a, 3b, 4, and 5 were 20.0%, 3.3%, 0.4% and 0.1%, respectively. Female sex, older age, urban residence, history of CVD, hypertension or diabetes, larger body mass and surrogates of body fat and opium use were all associated with CKD. Opium had a significant positive association with CKD in adjusted model. All anthropometric measurements had positive linear association with CKD. Being literate had inverse association. Sex had significant interaction with anthropometric indices, with higher odds ratios among men compared with women. A significantly high association was observed between the rate of change in waist circumference and systolic blood pressure with risk of CKD. Conclusion One in four people in this cohort had low eGFR. Obesity and overweight, diabetes, hypertension, and dyslipidemia are major risk factors for CKD. Halting the increase in waist circumference and blood pressure may be as important as reducing the current levels.	[Sepanlou, Sadaf G.; Barahimi, Hamid; Poustchi, Hossein; Shakeri, Ramin; Pourshams, Akram; Gharravi, Abdolsamad; Malekzadeh, Reza] Univ Tehran Med Sci, Digest Dis Res Inst, Digest Dis Res Ctr, Tehran, Iran; [Sepanlou, Sadaf G.; Malekzadeh, Reza] Shiraz Univ Med Sci, Noncommunicable Dis Res Ctr, Shiraz, Fars, Iran; [Barahimi, Hamid; Najafi, Iraj; Hakemi, Monir Sadat] Univ Tehran Med Sci, Shariati Hosp, Dept Nephrol, Tehran, Iran; [Kamangar, Farin] Morgan State Univ, Sch Community Hlth & Policy, Dept Publ Hlth Anal, Baltimore, MD 21239 USA; [Khoshnia, Masoud] Golestan Univ Med Sci, Golestan Res Ctr Gastroenterol & Hepatol, Gorgan, Iran; [Broumand, Behrooz; Nobakht-Haghighi, Ali] Acad Med Sci, Tehran, Iran; [Kalantar-Zadeh, Kamyar] Univ Calif Irvine, Sch Med, Div Nephrol & Hypertens, Irvine, CA 92717 USA; [Kalantar-Zadeh, Kamyar] Vet Affairs VA Long Beach Healthcare Syst, Long Beach, CA USA; [Kalantar-Zadeh, Kamyar] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA	Tehran University of Medical Sciences; Shiraz University of Medical Science; Tehran University of Medical Sciences; Morgan State University; Golestan University of Medical Sciences; University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of California System; University of California Los Angeles	Malekzadeh, R (corresponding author), Univ Tehran Med Sci, Digest Dis Res Inst, Digest Dis Res Ctr, Tehran, Iran.; Malekzadeh, R (corresponding author), Shiraz Univ Med Sci, Noncommunicable Dis Res Ctr, Shiraz, Fars, Iran.	malek@tums.ac.ir	Sepanlou, Sadaf G/H-9343-2016; Kalantar-Zadeh, Kamyar/Q-4734-2018; Malekzadeh, Reza/U-1382-2017	Sepanlou, Sadaf G/0000-0002-3669-5129; Kalantar-Zadeh, Kamyar/0000-0002-8666-0725; Malekzadeh, Reza/0000-0002-9820-6335; Pourshams, Akram/0000-0002-7950-3983	Social Security Organization of Iran, Golestan Branch; Tehran University of Medical Sciences [82-603]; Social Security Organization of Iran, Golestan Branch; Tehran University of Medical Sciences [82-603]	Social Security Organization of Iran, Golestan Branch; Tehran University of Medical Sciences(Tehran University of Medical Sciences); Social Security Organization of Iran, Golestan Branch; Tehran University of Medical Sciences(Tehran University of Medical Sciences)	Many individuals have contributed to this study. We wish to thank the study participants for their cooperation over many years and the Behvarz' working in the study areas for their help. We thank the directors of the public health districts of Gonbad and Kalaleh for their collaboration. We express our special thanks to general physicians, nurses, and nutritionists in the enrolment teams for their collaboration and assistance. We received special support from the Social Security Organization of Iran, Golestan Branch. We have enjoyed the close collaboration of the Golestan health deputies and the Chief of the Gonbad health district.r Tehran University of Medical Sciences was the funder of this study, grant number 82-603, at www.tums.ac.ir. RM received the fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi J, 2002, AM J NEPHROL, V22, P11, DOI 10.1159/000046668; Barahimi H, 2011, IRAN J KIDNEY DIS, V5, P374; Choukem Simeon-Pierre, 2016, BMC Res Notes, V9, P29, DOI 10.1186/s13104-016-1845-5; Coresh J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5553; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Hallan S, 2006, AM J KIDNEY DIS, V47, P396, DOI 10.1053/j.ajkd.2005.11.027; Huang MX, 2015, AM J KIDNEY DIS, V65, P58, DOI 10.1053/j.ajkd.2014.06.025; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Khademi H, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2502; Khademi H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011183; Kovesdy CP, 2012, LANCET, V379, P783, DOI 10.1016/S0140-6736(12)60115-9; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2015, CLIN CHEM, V61, P1226, DOI 10.1373/clinchem.2015.245282; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 2014, ANN INTERN MED, V161, P81, DOI 10.7326/L14-5013-2; Nafar Mohsen, 2008, Iran J Kidney Dis, V2, P183; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Naghibi M, 2015, IRAN J KIDNEY DIS, V9, P449; Najafi I, 2012, ARCH IRAN MED, V15, pVI, DOI 012152/AIM.003; Najafi I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014216; Pourshams A, 2010, INT J EPIDEMIOL, V39, P52, DOI 10.1093/ije/dyp161; Rhee CM, 2016, CURR OPIN NEPHROL HY, V25, P208, DOI 10.1097/MNH.0000000000000212; Rocco MV, 2012, AM J KIDNEY DIS, V60, P857, DOI 10.1053/j.ajkd.2012.07.005; Roomizadeh P, 2014, INT J HEALTH POLICY, V2, P161, DOI 10.15171/ijhpm.2014.37; Ryu S, 2008, J AM SOC NEPHROL, V19, P1798, DOI 10.1681/ASN.2007121286; Safarinejad MR, 2009, J NEPHROL, V22, P99; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4	29	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176540	10.1371/journal.pone.0176540	http://dx.doi.org/10.1371/journal.pone.0176540			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467510	Green Published, gold			2022-12-26	WOS:000400647000058
J	Dumas, P; Ham, J; Kaku, R; William, A; Kaltavara, J; Gereva, S; Leopold, M				Dumas, Pascal; Ham, Jayven; Kaku, Rocky; William, Andrew; Kaltavara, Jeremie; Gereva, Sompert; Leopold, Marc			Tectus (Trochus) niloticus search for suitable habitats can cause equivocal benefits of protection in village-based marine reserves	PLOS ONE			English	Article							CORAL-REEF MANAGEMENT; ENVIRONMENTAL IMPACTS; SPATIAL HETEROGENEITY; LITTORINA-UNIFASCIATA; FRENCH-POLYNESIA; INTERTIDAL SNAIL; FISHERIES; AREAS; CONSERVATION; MOVEMENTS	In the Pacific, the protection of coral reef resources is often achieved through the implementation of village-based marine reserves (VBMRs). While substantial fisheries benefits are often reported, results of quantitative approaches are controversial for benthic macroinvertebrates, whose life history traits may cause low congruence with protective measures implemented at non-ecologically relevant scales. This study investigated the structural and behavioral responses of the exploited topshell Tectus niloticus within a very small (0.2 km(2)) VBMR in Vanuatu, south Pacific. The results of underwater surveys and a nine-month tagging experiment emphasized contrasted, scale-dependent responses. At the reserve scale, our results failed to demonstrate any positive effect of protection after three years of closure. In contrast, abundance, density and biomass increased more than ten-fold in the southern part of the reserve, along with significantly larger |(25%) individual sizes. The dispersal of tagged specimens was also consistently lower after 2, 4 and 9 months in the latter zone. Analyses of 17 substratum variables revealed a marked small-scale patchiness delineating contrasted benthic microhabitats, the distribution of which closely matched that of trochus. We advocate that i) VBMRs have inherently unequal ecological potentials for protecting and managing highly habitat-dependent species such as trochus; ii) 'success' or 'failure' is to a certain extent pre-determined by the trajectory of species-specific microhabitats, which may outreach protection effects. This has strong implications in the Pacific where the location and size of reserves primarily depends upon marine tenure, and communities have little flexibility in setting reserve boundaries.	[Dumas, Pascal; Leopold, Marc] IRD, UMR ENTROPIE 9220, Noumea, New Caledonia; [Dumas, Pascal; Leopold, Marc] Lab Excellence LABEX Corail, Perpignan, France; [Ham, Jayven; Kaku, Rocky; William, Andrew; Kaltavara, Jeremie; Gereva, Sompert] Fisheries Dept Vanuatu, Port Vila, Vanuatu	Institut de Recherche pour le Developpement (IRD)	Dumas, P (corresponding author), IRD, UMR ENTROPIE 9220, Noumea, New Caledonia.; Dumas, P (corresponding author), Lab Excellence LABEX Corail, Perpignan, France.	ascal-paul.dumas@ird.fr		Dumas, Pascal/0000-0001-7369-8989	The Fisheries Department of Vanuatu [02-TAK-2011]; Government of New Caledonia	The Fisheries Department of Vanuatu; Government of New Caledonia	This project was funded by grants from: The Fisheries Department of Vanuatu (www.fisheries.gov.vu), grant #02-TAK-2011. This was the main grant for this work, which covered fieldwork and functioning costs of VFD technical staff and field officers during the entire study; The Government of New Caledonia (www.gouv.nc/portal/page/portal/gouv/), grant for project EFITAV2, which covered fieldwork for P. Dumas. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjeroud M, 1997, MAR ECOL PROG SER, V159, P105, DOI 10.3354/meps159105; AMOS M, 1995, COMBINATION FISHERIE; Andrefouet S, 2005, ICES J MAR SCI, V62, P1037, DOI 10.1016/j.icesjms.2005.04.006; Andrefouet S, 2006, 10 INT COR REEF S 20; Ban NC, 2013, FRONT ECOL ENVIRON, V11, P194, DOI 10.1890/110205; Bartlett CY, 2009, CONSERV BIOL, V23, P1475, DOI 10.1111/j.1523-1739.2009.01293.x; Benedetti-Cecchi L, 2003, MAR ENVIRON RES, V55, P429, DOI 10.1016/S0141-1136(02)00310-0; Bour W., 1989, BIOL COLOGIE EXPLOIT; BRANCH GM, 1981, AUST J MAR FRESH RES, V32, P573; Ceccarelli Daniela M., 2011, Pacific Conservation Biology, V17, P132; Chapman MG, 2000, J EXP MAR BIOL ECOL, V244, P181, DOI 10.1016/S0022-0981(99)00140-9; CHAPMAN MG, 1994, J EXP MAR BIOL ECOL, V179, P145, DOI 10.1016/0022-0981(94)90111-2; Chapman MR, 2000, ENVIRON BIOL FISH, V57, P11, DOI 10.1023/A:1004545724503; Cinner JE, 2005, CONSERV BIOL, V19, P1714, DOI 10.1111/j.1523-1739.2005.00209.x-i1; Cinner JE, 2007, BIOL CONSERV, V140, P201, DOI 10.1016/j.biocon.2007.08.008; Claudet J, 2004, AQUAT LIVING RESOUR, V17, P129, DOI 10.1051/alr:2004017; Cohen PJ, 2013, MAR POLICY, V37, P278, DOI 10.1016/j.marpol.2012.05.010; Cohen PJ, 2015, ENVIRON CONSERV, V42, P278, DOI 10.1017/S0376892914000423; Colquhoun J.R., 2001, SPC TROCHUS INFORM B, V7, P14; Dale Virginia H., 2001, Ecological Indicators, V1, P3, DOI 10.1016/S1470-160X(01)00003-6; Dalzell P, 1996, OCEANOGR MAR BIOL, V34, P395; Dumas P, 2007, J EXP MAR BIOL ECOL, V344, P88, DOI 10.1016/j.jembe.2006.12.015; Dumas P, 2010, ENVIRON CONSERV, V37, P364, DOI 10.1017/S0376892910000536; Dumas P, 2009, J EXP MAR BIOL ECOL, V368, P161, DOI 10.1016/j.jembe.2008.10.002; Dumas P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058998; Elliott M, 1998, MAR POLLUT BULL, V36, P174, DOI 10.1016/S0025-326X(98)00202-1; English S., 1997, SURVEY MANUAL TROPIC; Foale S, 1998, OCEAN COAST MANAGE, V40, P187, DOI 10.1016/S0964-5691(98)00044-1; Foale S., 2004, ASIA PAC VIEWP, V45, P373; Foale S, 2008, SPC TROCHUS B, V14, P12; Garcia-Charton JA, 2004, MAR BIOL, V144, P161, DOI 10.1007/s00227-003-1170-0; Garcia-Charton JA, 2000, ENVIRON CONSERV, V27, P159, DOI 10.1017/S0376892900000199; Gillett R, 2009, FISHERIES EC PACIFIC; Govan H., 2009, SPC TRAD MAR RESOUR, V25, P16; Govan H., 2009, STATUS POTENTIAL LOC; HESLINGA GA, 1981, AQUACULTURE, V22, P35, DOI 10.1016/0044-8486(81)90131-9; HESLINGA GA, 1984, US NMFS MAR FISH REV, V46, P73; HUGHES TP, 1989, ECOLOGY, V70, P275, DOI 10.2307/1938434; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; Jimenez H, 2011, FISH RES, V108, P195, DOI 10.1016/j.fishres.2010.12.021; Johannes RE, 2002, ANNU REV ECOL SYST, V33, P317, DOI 10.1146/annurev.ecolsys.33.010802.150524; Jolivet A, 2015, MOVEMENT ECOLOGY, V3, P1; Jupiter S.D., 2011, J MARINE BIOL, P1, DOI [10.1155/2011/940765, DOI 10.1155/2011/940765]; Kaku R, 2016, POSTCYCLONE ASSESSME; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Leopold M, 2013, ENVIRON CONSERV, V40, P367, DOI 10.1017/S037689291300009X; Leopold M, 2013, MAR POLICY, V42, P167, DOI 10.1016/j.marpol.2013.02.013; Leopold M, 2009, BIODIVERS CONSERV, V18, P3367, DOI 10.1007/s10531-009-9646-y; LONG BG, 1993, MAR BIOL, V115, P587, DOI 10.1007/BF00349366; MACKAY DA, 1977, OECOLOGIA, V30, P215, DOI 10.1007/BF01833629; McClanahan TR, 2006, CURR BIOL, V16, P1408, DOI 10.1016/j.cub.2006.05.062; McGowan J., 1958, TROCHUS FISHERY TRUS; Merchandise B., 1991, TROCHUS STOCK ASSESS; Nash W. J., 1993, NEARSHORE MARINE RES, P451; Pakoa K, 2009, STATUS TROCHUS TROC; Purcell SW, 2004, FISH RES, V67, P329, DOI 10.1016/j.fishres.2003.10.004; Purcell SW, 2004, STOCK ENHANCEMENT SE, P233; RAO H. SRINIVASA, 1937, REC INDIAN MUS, V39, P47; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Schiller A, 2001, CONSERV ECOL, V5; UNDERWOOD AJ, 1992, J EXP MAR BIOL ECOL, V161, P145, DOI 10.1016/0022-0981(92)90094-Q; UNDERWOOD AJ, 1991, AUST J MAR FRESH RES, V42, P569, DOI 10.1071/MF9910569; UNDERWOOD AJ, 1993, AUST J ECOL, V18, P99, DOI 10.1111/j.1442-9993.1993.tb00437.x; Underwood AJ, 2003, J EXP MAR BIOL ECOL, V296, P49, DOI 10.1016/S0022-0981(03)00304-6; UNDERWOOD AJ, 1989, J EXP MAR BIOL ECOL, V134, P175, DOI 10.1016/0022-0981(89)90068-3; Van Wynsberge S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040997	66	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176922	10.1371/journal.pone.0176922	http://dx.doi.org/10.1371/journal.pone.0176922			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28464034	Green Submitted, Green Published, gold			2022-12-26	WOS:000400646300065
J	Ieropoulos, I; Pasternak, G; Greenman, J				Ieropoulos, Ioannis; Pasternak, Grzegorz; Greenman, John			Urine disinfection and in situ pathogen killing using a Microbial Fuel Cell cascade system	PLOS ONE			English	Article							WASTE-WATER TREATMENT; SALMONELLA-ENTERITIDIS; ELECTRICITY PRODUCTION; POWER; SANITATION; PERFORMANCE; BACTERIA; GROWTH	Microbial Fuel Cells (MFCs) are emerging as an effective means of treating different types of waste including urine and wastewater. However, the fate of pathogens in an MFC-based system remains unknown, and in this study we investigated the effect of introducing the enteric pathogen Salmonella enterica serovar enteritidis in an MFC cascade system. The MFCs continuously fed with urine showed high disinfecting potential. As part of two independent trials, during which the bioluminescent S. enteritidis strain was introduced into the MFC cascade, the number of viable counts and the level of bioluminescence were reduced by up to 4.43 +/- 0.04 and 4.21 +/- 0.01 log-fold, respectively. The killing efficacy observed for the MFCs operating under closed-circuit conditions, were higher by 1.69 and 1.72 log-fold reduction than for the open circuit MFCs, in both independent trials. The results indicated that the bactericidal properties of a well performing anode were dependent on power performance and the oxidation-reduction potential recorded for the MFCs. This is the first time that the fate of pathogenic bacteria has been investigated in continuously operating MFC systems.	[Ieropoulos, Ioannis; Pasternak, Grzegorz; Greenman, John] Univ West England, Bristol Robot Lab, Bristol BioEnergy Ctr, Bristol, Avon, England; [Pasternak, Grzegorz] Univ Trento, Ctr Integrat Biol CIBIO, Povo, Trentino, Italy	University of Bristol; University of West England; University of Trento	Ieropoulos, I (corresponding author), Univ West England, Bristol Robot Lab, Bristol BioEnergy Ctr, Bristol, Avon, England.	ioannis.ieropoulos@brl.ac.uk	Pasternak, Grzegorz/N-3369-2019; Ieropoulos, Ioannis Andrea/AAI-3669-2020	Pasternak, Grzegorz/0000-0003-4347-791X; Ieropoulos, Ioannis Andrea/0000-0002-9641-5504	Bill and Melinda Gates Foundation [OPP1094890]; EPSRC Career Acceleration Fellow [EP/L002132/1]; EPSRC [EP/L002132/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/L002132/1] Funding Source: researchfish	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); EPSRC Career Acceleration Fellow(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the Bill and Melinda Gates Foundation (www.gatesfoundation.org) grant no. OPP1094890. Ioannis leropoulos is an EPSRC Career Acceleration Fellow (https://www.epsrc.ac.uk), grant number EP/L002132/1. Grzegorz Pasternak is a Polish Ministry of Science and Higher Education Fellow (http://www.nauka.gov.pl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Authors would like to acknowledge the Bill & Melinda Gates Foundation for funding this work, under grant no. OPP1094890. The authors would like to thank Dr Dann Turner for providing the biolumienscent strain and Mr Daniel Sanchez Herranz for his help and support.	Arends JBA, 2014, BIORESOURCE TECHNOL, V155, P352, DOI 10.1016/j.biortech.2013.12.058; Behera M, 2010, BIORESOURCE TECHNOL, V101, P1183, DOI 10.1016/j.biortech.2009.07.089; BENNETTO HP, 1983, BIOTECHNOL BIOENG, V25, P559, DOI 10.1002/bit.260250219; Boehm A. B., 2013, NANO LETT, P5; Brooks T, 1997, LETT APPL MICROBIOL, V24, P203, DOI 10.1046/j.1472-765X.1997.00378.x; Castro CJ, 2014, J WATER SANIT HYG DE, V4, P663, DOI 10.2166/washdev.2014.020; Cusick RD, 2011, APPL MICROBIOL BIOT, V89, P2053, DOI 10.1007/s00253-011-3130-9; Fu L, 2010, J CHEM TECHNOL BIOT, V85, P715, DOI 10.1002/jctb.2367; Gajda I, 2016, SCI REP-UK, V6, DOI 10.1038/srep25571; Gehr R, 2003, WATER RES, V37, P4573, DOI 10.1016/S0043-1354(03)00394-4; Giaouris ED, 2006, FOOD MICROBIOL, V23, P747, DOI 10.1016/j.fm.2006.02.006; Guard-Petter J, 2001, ENVIRON MICROBIOL, V3, P421, DOI 10.1046/j.1462-2920.2001.00213.x; Heidrich ES, 2014, BIORESOURCE TECHNOL, V173, P87, DOI 10.1016/j.biortech.2014.09.083; Hsu L., 2017, ECS Transactions, V75, P19, DOI 10.1149/07546.0019ecst; Ieropoulos IA, 2016, ENVIRON SCI-WAT RES, V2, P336, DOI 10.1039/c5ew00270b; Jadhav DA, 2014, BIORESOURCE TECHNOL, V163, P328, DOI 10.1016/j.biortech.2014.04.055; Jones K., 1996, J APPL MICROBIOL, V80, P428; Koivunen J, 2003, WATER RES, V37, P690, DOI 10.1016/S0043-1354(02)00305-6; Ledezma P, 2012, BIORESOURCE TECHNOL, V118, P615, DOI 10.1016/j.biortech.2012.05.054; MATSUNAGA T, 1994, BIOTECHNOL BIOENG, V43, P429, DOI 10.1002/bit.260430511; Merino Jimenez I., 2016, IN SITU ELECTROCHEMI, P3238; Montgomery MA, 2007, ENVIRON SCI TECHNOL, V41, P17, DOI 10.1021/es072435t; Pasternak G, 2016, APPL ENERG, V173, P431, DOI 10.1016/j.apenergy.2016.04.009; Pasternak G, 2016, CHEMSUSCHEM, V9, P88, DOI 10.1002/cssc.201501320; Turner D., 2013, CHARACTERISATION 3 B; Winfield J, 2014, J POWER SOURCES, V249, P327, DOI 10.1016/j.jpowsour.2013.10.096; Yazdi H, 2015, BIORESOURCE TECHNOL, V180, P258, DOI 10.1016/j.biortech.2014.12.100; Zelver N, 2001, METHOD ENZYMOL, V337, P363, DOI 10.1016/S0076-6879(01)37025-8	28	36	36	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176475	10.1371/journal.pone.0176475	http://dx.doi.org/10.1371/journal.pone.0176475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28463976	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000400646300023
J	Straney, LD; Udy, AA; Burrell, A; Bergmeir, C; Huckson, S; Cooper, DJ; Pilcher, DV				Straney, Lahn D.; Udy, Andrew A.; Burrell, Aidan; Bergmeir, Christoph; Huckson, Sue; Cooper, D. James; Pilcher, David V.			Modelling risk-adjusted variation in length of stay among Australian and New Zealand ICUs	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; HOSPITAL MORTALITY; APACHE-III; BENCHMARKING; PREDICTION; OUTCOMES	Purpose Comparisons between institutions of intensive care unit (ICU) length of stay (LOS) are significantly confounded by individual patient characteristics, and currently there is a paucity of methods available to calculate risk-adjusted metrics. Methods We extracted de-identified data from the Australian and New Zealand Intensive Care Society (ANZICS) Adult Patient Database for admissions between January 1 2011 and December 31 2015. We used a mixed-effects log-normal regression model to predict LOS using patient and admission characteristics. We calculated a risk-adjusted LOS ratio (RALOSR) by dividing the geometric mean observed LOS by the exponent of the expected Ln-LOS for each site and year. The RALOSR is scaled such that values <1 indicate a LOS shorter than expected, while values >1 indicate a LOS longer than expected. Secondary mixed effects regression modelling was used to assess the stability of the estimate in units over time. Results During the study there were a total of 662,525 admissions to 168 units (median annual admissions = 767, IQR:426-1121). The mean observed LOS was 3.21 days (median = 1.79 IQR = 0.92-3.52) over the entire period, and declined on average 1.97 hours per year (95% CI:1.76-2.18) from 2011 to 2015. The RALOSR varied considerably between units, ranging from 0.35 to 2.34 indicating large differences after accounting for case-mix. Conclusions There are large disparities in risk-adjusted LOS among Australian and New Zealand ICU swhich may reflect differences in resource utilization.	[Straney, Lahn D.; Udy, Andrew A.; Cooper, D. James; Pilcher, David V.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Udy, Andrew A.; Burrell, Aidan; Cooper, D. James; Pilcher, David V.] Alfred Hosp, Dept Intens Care & Hyperbar Med, Melbourne, Vic, Australia; [Bergmeir, Christoph] Monash Univ, Fac Informat Technol, Melbourne, Vic, Australia; [Huckson, Sue; Pilcher, David V.] Australian & New Zealand Intens Care Soc, Ctr Outcome & Resource Evaluat, Melbourne, Vic, Australia	Monash University; Florey Institute of Neuroscience & Mental Health; Monash University	Pilcher, DV (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia.; Pilcher, DV (corresponding author), Alfred Hosp, Dept Intens Care & Hyperbar Med, Melbourne, Vic, Australia.; Pilcher, DV (corresponding author), Australian & New Zealand Intens Care Soc, Ctr Outcome & Resource Evaluat, Melbourne, Vic, Australia.	d.pilcher@alfred.org.au	Burrell, Aidan/AAE-8768-2019; Cooper, D. James/G-7961-2013; Bergmeir, Christoph/Q-9911-2019; Burrell, Aidan/AGY-3244-2022; Udy, Andrew/G-2538-2010	Cooper, D. James/0000-0002-5872-9051; Burrell, Aidan/0000-0001-8430-9678; Udy, Andrew/0000-0002-6284-2022; Straney, Lahn/0000-0002-2615-2366; Pilcher, David/0000-0002-8939-7985	Monash Institute of Medica lEngineering (MIME) [2016-37]	Monash Institute of Medica lEngineering (MIME)	This research was funded in part by the Monash Institute of Medica lEngineering (MIME) under a MIME seed funding grant (2016-37). (LS, CB) [https://www.monash.edu/mime/seed]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKER RB, 1995, J CARDIOVASC SURG, V36, P1; Heidegger CP, 2005, INTENS CARE MED, V31, P1676, DOI 10.1007/s00134-005-2831-x; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Moitra VK, 2016, CRIT CARE MED, V44, P655, DOI 10.1097/CCM.0000000000001480; Paul E, 2016, CRIT CARE RESUSC, V18, P25; Paul E, 2013, J CRIT CARE, V28, P935, DOI 10.1016/j.jcrc.2013.07.058; Power GS, 2014, CURR OPIN CRIT CARE, V20, P544, DOI 10.1097/MCC.0000000000000136; Rapoport J, 2003, MED CARE, V41, P386, DOI 10.1097/00005650-200303000-00007; Strand K, 2010, CRIT CARE, V14, DOI 10.1186/cc9279; Straney L, 2012, HEALTH SERV RES, V47, P2190, DOI 10.1111/j.1475-6773.2012.01421.x; Straney L, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2008.028811; Straney LD, 2010, INTENS CARE MED, V36, P1410, DOI 10.1007/s00134-010-1916-3; Tsai TC, 2013, NEW ENGL J MED, V369, P1134, DOI 10.1056/NEJMsa1303118; Vicente FG, 2004, INTENS CARE MED, V30, P655, DOI 10.1007/s00134-003-2139-7; Zimmerman JE, 2006, CRIT CARE MED, V34, P2517, DOI 10.1097/01.CCM.0000240233.01711.D9	16	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176570	10.1371/journal.pone.0176570	http://dx.doi.org/10.1371/journal.pone.0176570			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28464035	Green Published, Green Submitted, gold			2022-12-26	WOS:000400646300035
J	Yamamoto, YY; Uno, Y; Sha, E; Ikegami, K; Ishii, N; Dohmae, N; Sekiguchi, H; Sasaki, YC; Yohda, M				Yamamoto, Yohei Y.; Uno, Yuko; Sha, Eiryo; Ikegami, Kentaro; Ishii, Noriyuki; Dohmae, Naoshi; Sekiguchi, Hiroshi; Sasaki, Yuji C.; Yohda, Masafumi			Asymmetry in the function and dynamics of the cytosolic group II chaperonin CCT/TRiC	PLOS ONE			English	Article							CRYO-EM STRUCTURE; CONFORMATIONAL-CHANGE; CRYSTAL-STRUCTURES; LID CLOSURE; EUKARYOTIC THERMOPHILE; ATP HYDROLYSIS; REACTION CYCLE; FOLDING CYCLE; CCT; TRIC/CCT	The eukaryotic group II chaperonin, the chaperonin-containing t-complex polypeptide 1 (CCT), plays an important role in cytosolic proteostasis. It has been estimated that as much as 10% of cytosolic proteins interact with CCT during their folding process. CCT is composed of 8 different paralogous subunits. Due to its complicated structure, molecular and biochemical investigations of CCT have been difficult. In this study, we constructed an expression system for CCT from a thermophilic fungus, Chaetomium thermophilum (CtCCT), by using E. coli as a host. As expected, we obtained recombinant CtCCT with a relatively high yield, and it exhibited fairly high thermal stability. We showed the advantages of the overproduction system by characterizing CtCCT variants containing ATPase-deficient subunits. For diffracted X-ray tracking experiment, we removed all surface exposed cysteine residues, and added cysteine residues at the tip of helical protrusions of selected two subunits. Gold nanocrystals were attached onto CtCCTs via gold-thiol bonds and applied for the analysis by diffracted X-ray tracking. Irrespective of the locations of cysteines, it was shown that ATP binding induces tilting motion followed by rotational motion in the CtCCT molecule, like the archaeal group II chaperonins. When gold nanocrystals were attached onto two subunits in the high ATPase activity hemisphere, the CtCCT complex exhibited a fairly rapid response to the motion. In contrast, the response of CtCCT, which had gold nanocrystals attached to the low-activity hemisphere, was slow. These results clearly support the possibility that ATP-dependent conformational change starts with the high-affinity hemisphere and progresses to the low-affinity hemisphere.	[Yamamoto, Yohei Y.; Uno, Yuko; Sha, Eiryo; Ikegami, Kentaro; Yohda, Masafumi] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo, Japan; [Ishii, Noriyuki] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki, Japan; [Ishii, Noriyuki] Gifu Univ, United Grad Sch Agr Sci, Tsukuba, Ibaraki, Japan; [Dohmae, Naoshi] RIKEN Ctr Sustainable Resource Sci, Biomol Characterizat Unit, Wako, Saitama, Japan; [Sekiguchi, Hiroshi] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo, Japan; [Sasaki, Yuji C.] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Yohda, Masafumi] Tokyo Univ Agr & Technol, Inst Global Innovat Res, Koganei, Tokyo, Japan	Tokyo University of Agriculture & Technology; National Institute of Advanced Industrial Science & Technology (AIST); Gifu University; RIKEN; Japan Synchrotron Radiation Research Institute; University of Tokyo; Tokyo University of Agriculture & Technology	Yohda, M (corresponding author), Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo, Japan.; Yohda, M (corresponding author), Tokyo Univ Agr & Technol, Inst Global Innovat Res, Koganei, Tokyo, Japan.	yohda@cc.tuat.ac.jp	SASAKI, Yuji/N-6880-2016; SEKIGUCHI, Hiroshi/C-7365-2011; Yohda, Masafumi/A-5149-2013; Ishii, Noriyuki/E-5661-2011; Dohmae, Naoshi/C-2040-2011	SASAKI, Yuji/0000-0003-3403-237X; SEKIGUCHI, Hiroshi/0000-0001-7590-3624; Yohda, Masafumi/0000-0001-8307-9671; Ishii, Noriyuki/0000-0002-4120-6203; Dohmae, Naoshi/0000-0002-5242-9410	Ministry of Education, Science, Sports, and Culture of Japan [JP16H04572, JP16H00753, JP15J08261]; Japan Synchrotron Radiation Research Institute [2015B1195, 2016A1223]; Grants-in-Aid for Scientific Research [15K21719, 15J08261, 26105001, 26105005] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Synchrotron Radiation Research Institute; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants-in aids for scientific research (JP16H04572, JP16H00753 and JP15J08261) from the Ministry of Education, Science, Sports, and Culture of Japan. DXT experiments were performed at BL40XU in the Japan Synchrotron Radiation Research Institute (Proposal Nos. 2015B1195 and 2016A1223).	Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Bigotti MG, 2005, J MOL BIOL, V348, P13, DOI 10.1016/j.jmb.2005.01.066; Bock T, 2014, NUCLEIC ACIDS RES, V42, P13525, DOI 10.1093/nar/gku1147; Booth CR, 2008, NAT STRUCT MOL BIOL, V15, P746, DOI 10.1038/nsmb.1436; Camasses A, 2003, MOL CELL, V12, P87, DOI 10.1016/S1097-2765(03)00244-2; Clare DK, 2008, STRUCTURE, V16, P528, DOI 10.1016/j.str.2008.01.016; Cong Y, 2010, P NATL ACAD SCI USA, V107, P4967, DOI 10.1073/pnas.0913774107; Cuellar J, 2008, NAT STRUCT MOL BIOL, V15, P858, DOI 10.1038/nsmb.1464; Dekker C, 2011, EMBO J, V30, P3078, DOI 10.1038/emboj.2011.208; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; Douglas NR, 2011, CELL, V144, P240, DOI 10.1016/j.cell.2010.12.017; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Iizuka R, 2003, J BIOL CHEM, V278, P44959, DOI 10.1074/jbc.M305484200; Joachimiak LA, 2014, CELL, V159, P1042, DOI 10.1016/j.cell.2014.10.042; Kalisman N, 2013, STRUCTURE, V21, P540, DOI 10.1016/j.str.2013.01.017; Kanzaki T, 2008, J BIOL CHEM, V283, P34773, DOI 10.1074/jbc.M805303200; Klumpp M, 1997, CELL, V91, P263, DOI 10.1016/S0092-8674(00)80408-0; Kumar CMS, 2015, CELL STRESS CHAPERON, V20, P555, DOI 10.1007/s12192-015-0598-8; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; Llorca O, 1999, NATURE, V402, P693, DOI 10.1038/45294; Llorca O, 2000, EMBO J, V19, P5971, DOI 10.1093/emboj/19.22.5971; Lopez T, 2015, J MOL BIOL, V427, P2919, DOI 10.1016/j.jmb.2015.04.013; Machida K, 2012, PROTEIN EXPRES PURIF, V82, P61, DOI 10.1016/j.pep.2011.11.010; Meyer AS, 2003, CELL, V113, P369, DOI 10.1016/S0092-8674(03)00307-6; Nakagawa A, 2014, J MOL BIOL, V426, P447, DOI 10.1016/j.jmb.2013.09.034; Noi K, 2009, BIOCHEMISTRY-US, V48, P9405, DOI 10.1021/bi900959c; Pereira JH, 2010, J BIOL CHEM, V285, P27958, DOI 10.1074/jbc.M110.125344; Plimpton RL, 2015, P NATL ACAD SCI USA, V112, P2413, DOI 10.1073/pnas.1419595112; Reissmann S, 2012, CELL REP, V2, P866, DOI 10.1016/j.celrep.2012.08.036; Ruepp A, 2001, J STRUCT BIOL, V135, P126, DOI 10.1006/jsbi.2001.4402; Sekiguchi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064176; Sergeeva OA, 2013, J BIOL CHEM, V288, P17734, DOI 10.1074/jbc.M112.443929; Shimon L, 2008, J MOL BIOL, V377, P469, DOI 10.1016/j.jmb.2008.01.011; Shomura Y, 2004, J MOL BIOL, V335, P1265, DOI 10.1016/j.jmb.2003.11.028; Skjaerven L, 2015, FEBS LETT; Steinbacher S, 2001, J STRUCT BIOL, V135, P147, DOI 10.1006/jsbi.2001.4382; Taguchi H, 2015, J MOL BIOL, V427, P2912, DOI 10.1016/j.jmb.2015.04.007; Yamamoto YY, 2014, J MOL BIOL, V426, P2667, DOI 10.1016/j.jmb.2014.05.013; Yamamoto YY, 2016, FEBS OPEN BIO; Yamamoto YY, 2016, THERMOSOME GROUP 2 C; Zako T, 2016, J MOL BIOL; Zhang JJ, 2011, STRUCTURE, V19, P633, DOI 10.1016/j.str.2011.03.005; Zscherp C, 2001, BIOCHEMISTRY-US, V40, P1875, DOI 10.1021/bi002567y	46	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176054	10.1371/journal.pone.0176054	http://dx.doi.org/10.1371/journal.pone.0176054			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28463997	gold, Green Published, Green Submitted			2022-12-26	WOS:000400646300011
J	Yang, X; Cui, Y; Yue, J; He, HH; Yu, C; Liu, PG; Liu, J; Ren, XD; Meng, Y				Yang, Xue; Cui, Yan; Yue, Jing; He, Honghong; Yu, Chuan; Liu, Penggang; Liu, Jun; Ren, Xiandong; Meng, Yun			The histological characteristics, age-related thickness change of skin, and expression of the HSPs in the skin during hair cycle in yak (Bos grunniens)	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; HUMAN KERATINOCYTES; STRESS-PROTEINS; CANCER-THERAPY; IN-VIVO; DIFFERENTIATION; PROGESTERONE; HYPERTHERMIA; MORPHOLOGY; CHAPERONES	Objective This experiment was conducted to study the histological characteristics, age-related thickness changes, and expression of HSPs in the skin of yak. Methods A total of 20 yaks (10 males and 10 females) were used. Different regions of the normal skin of three different ages (newborn, half-year-old and adult) of yaks were harvested for histological study and thickness measurement. Biopsy samples were taken from the scapula regions of the skin from the same five approximately 1-year-old yaks during the hair cycle (telogen, anagen and catagen). RT-PCR, western blot and immunohistochemistry methods using the mRNA and protein levels were used to detect the expression of HSP27, HSP70 and HSP90. RT-PCR method was used to detect the mRNA expression of CGI-58 and KDF1. The IPP6.0 software was used to analyze the immunohistochemistry and measure the thickness of the skin. Results The general histological structure of hairy yak skin was similar to other domestic mammals. The unique features included prominent cutaneous vascular plexuses, underdeveloped sweat glands, a large number of nasolabial glands in the nasolabial plate, and hair follicle groups composed of one primary follicle and several secondary follicles. The skin, epidermis and dermis thickness did vary significantly between different body regions and different ages. The thickness of the skin, epidermis and dermis increased from newborn to adult in yaks. Yak skin thickness decreased from dorsally to ventrally on the trunk. The skin on the lateral surface was thicker than the skin on the medial surface on the limbs. HSP27, HSP70 and HSP90 showed different expression patterns during the hair cycle using RT-PCR, western blot and immunohistochemistry methods. The expression of HSP27 mRNA and protein in the anagen stage was the highest, followed by the catagen stage, and the expression in the telogen stage was the lowest. The expression of HSP70 mRNA and protein in the telogen stage was the highest, followed by the anagen stage, and the expression in the catagen stage was the lowest. The expression of HSP90 mRNA and protein in the anagen stage was the highest, followed by the telogen stage, and the expression in the catagen stage was the lowest. HSPs were mainly expressed in the outer root sheath of hair follicle during the hair cycle, also expressed in epidermis, sebaceous gland and sweat gland in the skin of Yak. The expression of CGI-58 mRNA in the anagen stage was the highest, followed by the catagen stage, and the expression in the telogen stage was the lowest. The expression of KDF1 mRNA in the telogen stage was the highest, followed by the catagen stage, and the expression in the anagen stage was the lowest. Meaning In this study, we examined and fully described the histology of normal skin in Yak and measured the skin thickness of different ages and different regions in Yak. These data may be useful to better understand and appreciate the adaptability features of yak skin. Our investigation reports the expression patterns of HSPs in yak skin for the first time. The different expression pattern of HSPs during the hair cycle suggests they may play different roles in yak hair follicle biology.	[Yang, Xue; Cui, Yan; Yue, Jing; He, Honghong; Yu, Chuan; Liu, Penggang; Liu, Jun; Ren, Xiandong; Meng, Yun] Gansu Agr Univ, Coll Vet Med, Lanzhou, Gansu, Peoples R China	Gansu Agricultural University	Cui, Y (corresponding author), Gansu Agr Univ, Coll Vet Med, Lanzhou, Gansu, Peoples R China.	cuiyan@gsau.edu.cn			National Natural Science Foundation of China [31360594]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support was provided by The National Natural Science Foundation of China (Grant number: 31360594) received by Yan Cui.	Acunzo J, 2012, INT J BIOCHEM CELL B, V44, P1622, DOI 10.1016/j.biocel.2012.04.002; Akiyama M, 2008, AM J PATHOL, V173, P1349, DOI 10.2353/ajpath.2008.080005; [Anonymous], 1988, LARG AN DERM; Ansari-Renani H R, 2008, Pak J Biol Sci, V11, P410, DOI 10.3923/pjbs.2008.410.415; Ansari-Renani HR, 2011, ASIAN AUSTRAL J ANIM, V24, P5; Atlee BA, 1997, VET DERMATOLOGY, V12; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; BRANCHET MC, 1990, GERONTOLOGY, V36, P28; Calapre L, 2013, CANCER LETT, V337, P35, DOI 10.1016/j.canlet.2013.05.039; Commo S, 2000, DIFFERENTIATION, V66, P157, DOI 10.1046/j.1432-0436.2000.660401.x; Cui Y, 1999, VET J, V157, P192, DOI 10.1053/tvjl.1998.0283; Cui Y, 1999, VET J, V157, P197, DOI 10.1053/tvjl.1998.0282; Dix DJ, 1996, P NATL ACAD SCI USA, V93, P3264, DOI 10.1073/pnas.93.8.3264; Donald GL, 1962, ANAT REC, V143, P7; Duan DY, 2012, ANAT REC, V295, P2045, DOI 10.1002/ar.22591; Fan JF, 2011, ANIM REPROD SCI, V128, P107, DOI 10.1016/j.anireprosci.2011.09.008; Hashizume H, 1997, INT J DERMATOL, V36, P587, DOI 10.1046/j.1365-4362.1997.00178.x; He YY, 2010, ANAT REC, V293, P1519, DOI 10.1002/ar.21201; He YY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149947; HIGHTOWER LE, 1991, CELL, V66, P191, DOI 10.1016/0092-8674(91)90611-2; Jaattela M, 1999, ANN MED, V31, P261, DOI 10.3109/07853899908995889; Jantschitsch C, 1998, BRIT J DERMATOL, V139, P247; Jonak C, 2011, J DERMATOL SCI, V61, P32, DOI 10.1016/j.jdermsci.2010.10.009; Kindas-Mugge I, 2002, CELL BIOL INT, V26, P109, DOI 10.1006/cbir.2001.0822; KINDASMUGGE I, 1994, CELL GROWTH DIFFER, V5, P777; Lee S, 2013, DEV BIOL, V383, P201, DOI 10.1016/j.ydbio.2013.09.022; Lee Y, 2002, SURG RADIOL ANAT, V24, P183, DOI 10.1007/s00276-002-0034-5; Leveque JL, 1988, CUTAN AGEIG COSMET D, V1, P13; Liu B, 2010, ANAT REC, V293, P1873, DOI 10.1002/ar.21231; LYNE AG, 1968, AUST J BIOL SCI, V21, P499, DOI 10.1071/BI9680499; Maloney A, 2002, EXPERT OPIN BIOL TH, V2, P3, DOI 10.1517/14712598.2.1.3; Martin AL, 2007, VET DERMATOL, V18, P401, DOI 10.1111/j.1365-3164.2007.00627.x; MAYTIN EV, 1995, J INVEST DERMATOL, V104, P448, DOI 10.1111/1523-1747.ep12605702; Morris SD, 2002, CLIN EXP DERMATOL, V27, P220, DOI 10.1046/j.1365-2230.2002.01012.x; Mugale RR, 2002, INDIAN VET J, V79, P368; MURAKAMI H, 1988, J CELL BIOL, V107, P2051, DOI 10.1083/jcb.107.6.2051; NIXON AJ, 1993, BIOTECH HISTOCHEM, V68, P316, DOI 10.3109/10520299309105637; Normant E, 2011, ONCOGENE, V30, P2581, DOI 10.1038/onc.2010.625; PARRY AL, 1992, AUST J AGR RES, V43, P857, DOI 10.1071/AR9920857; Qian Z, 2013, ACTA VET ZOOTECHNICA, V44, P6; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; SHI YG, 1992, MOL CELL BIOL, V12, P2186, DOI 10.1128/MCB.12.5.2186; SHUSTER S, 1975, BRIT J DERMATOL, V93, P639, DOI 10.1111/j.1365-2133.1975.tb05113.x; Srivastava P, 2004, METHODS, V32, P1, DOI 10.1016/S1046-2023(03)00178-6; Sugiyama Y, 2000, J BIOL CHEM, V275, P1095, DOI 10.1074/jbc.275.2.1095; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; TAKEMA Y, 1994, BRIT J DERMATOL, V131, P641, DOI 10.1111/j.1365-2133.1994.tb04975.x; TRAUTINGER F, 1993, J INVEST DERMATOL, V101, P334, DOI 10.1111/1523-1747.ep12365491; Trautinger F, 1996, J INVEST DERMATOL, V107, P442, DOI 10.1111/1523-1747.ep12365498; TRAUTINGER F, 1995, BRIT J DERMATOL, V133, P194, DOI 10.1111/j.1365-2133.1995.tb02615.x; Trautinger F, 1996, J PHOTOCH PHOTOBIO B, V35, P141, DOI 10.1016/S1011-1344(96)07344-7; Trautinger F, 2001, J PHOTOCH PHOTOBIO B, V63, P70, DOI 10.1016/S1011-1344(01)00203-2; Volkering M.E., 2009, VARIATION SKIN THICK; Voss OH, 2007, J BIOL CHEM, V282, P25088, DOI 10.1074/jbc.M701740200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; WHITTON JT, 1973, BRIT J DERMATOL, V89, P467, DOI 10.1111/j.1365-2133.1973.tb03007.x; Wilson N, 2000, J CUTAN PATHOL, V27, P176, DOI 10.1034/j.1600-0560.2000.027004176.x; Xin-Hua K, 2014, ACTA VET ZOOTECHNICA, V45, P5; Yang B, 2010, ANAT HISTOL EMBRYOL, V39, P138, DOI 10.1111/j.1439-0264.2009.00988.x; Yang B, 2010, ANAT REC, V293, P1259, DOI 10.1002/ar.21056; Yu SJ, 2010, REPROD DOMEST ANIM, V45, P779, DOI 10.1111/j.1439-0531.2009.01347.x; YU SJ, 1993, BRIT VET J, V149, P579, DOI 10.1016/S0007-1935(05)80042-9; Yu SJ, 2000, VET J, V160, P157; Yu SJ, 2001, ANIM REPROD SCI, V65, P67, DOI 10.1016/S0378-4320(00)00216-5; Yusuf N, 2009, J IMMUNOL, V182, P675, DOI 10.4049/jimmunol.182.1.675; Zhang R. C., 2000, RECENT ADV YAK REPRO, P1; Zhou JX, 2013, ANAT REC, V296, P1775, DOI 10.1002/ar.22790; Zylicz M, 2001, EMBO J, V20, P4634, DOI 10.1093/emboj/20.17.4634	68	11	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176451	10.1371/journal.pone.0176451	http://dx.doi.org/10.1371/journal.pone.0176451			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28463974	Green Published, gold, Green Submitted			2022-12-26	WOS:000400646300021
J	Honda, H; Michihata, T; Shishido, K; Takahashi, K; Takahashi, G; Hosaka, N; Ikeda, M; Sanada, D; Shibata, T				Honda, Hirokazu; Michihata, Tetsuo; Shishido, Kanji; Takahashi, Keiko; Takahashi, Go; Hosaka, Nozomu; Ikeda, Misa; Sanada, Daisuke; Shibata, Takanori			High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients	PLOS ONE			English	Article							DOMINANT HYPOPHOSPHATEMIC RICKETS; CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR EVENTS; DEFICIENCY ANEMIA; DIALYSIS-THERAPY; JAPANESE-SOCIETY; DOUBLE-BLIND; FGF23; PHOSPHATE; METABOLISM	A recent study demonstrated the association between inflammation, iron metabolism and fibroblast growth factor (FGF) 23. The present clinical study aimed to assess associations between anemia, iron metabolism and FGF23 in hemodialysis (HD) patients. This prospective observational study examined a cohort of prevalent HD patients (n = 282). Blood samples were obtained before dialysis sessions to measure baseline levels of hemoglobin (Hb), transferrin saturation (TSAT), ferritin, albumin-adjusted calcium (Ca), phosphate (P), intact (i)-PTH, 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, intact (i)-FGF23, high sensitive (hs)-CRP, and interleukin-6. After the baseline measurement, study patients were followed-up for 6 months. Biochemical measurements were subsequently performed at 1 (Hb), 2 (TSAT and ferritin) or 3 (Ca, P and hs-CRP) month intervals. Doses of ESAs and intravenous iron supplementation during the study period were recorded. i-FGF23 was positively correlated with Ca, P, i-PTH and inversely correlated with TSAT and ferritin. However, levels of Hb and hs-CRP and doses of ESAs during the study period did not differ among the i-FGF23 tertiles, with levels of ferritin and TSAT in the higher i-FGF23 tertile being consistently lower than in the middle to lower i-FGF23 tertiles. Multivariate repeated measures analysis indicated that the higher i-FGF23 tertile was independently associated with repeated measurements of ferritin, but not of TSAT. Doses of intravenous iron supplementation were significantly increased in the higher i-FGF23 tertile in multivariate models. In conclusion, high i-FGF23 levels may be associated with prolongation of low levels of ferritin, resulting in increased usages of iron supplementation in HD patients.	[Honda, Hirokazu; Hosaka, Nozomu] Showa Univ, Koto Toyosu Hosp, Dept Med, Div Nephrol, Tokyo, Japan; [Honda, Hirokazu; Hosaka, Nozomu; Ikeda, Misa; Sanada, Daisuke] Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo, Japan; [Michihata, Tetsuo] Ebara Clin, Dept Dialysis, Tokyo, Japan; [Shishido, Kanji] Kawasaki Clin, Dept Dialysis, Kawasaki, Kanagawa, Japan; [Takahashi, Keiko] Kitami Higashiyama Clin, Div Dialysis, Tokyo, Japan; [Takahashi, Go; Shibata, Takanori] Showa Univ Northern Yokohama Hosp, Dept Internal Med, Yokohama, Kanagawa, Japan	Showa University; Showa University	Honda, H (corresponding author), Showa Univ, Koto Toyosu Hosp, Dept Med, Div Nephrol, Tokyo, Japan.; Honda, H (corresponding author), Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo, Japan.	hondah@med.showa-u.ac.jp		Honda, Hirokazu/0000-0002-5634-6145				Block GA, 2015, AM J KIDNEY DIS, V65, P728, DOI 10.1053/j.ajkd.2014.10.014; Block GA, 2012, J AM SOC NEPHROL, V23, P1407, DOI 10.1681/ASN.2012030223; Bozentowicz-Wikarek M, 2015, CLIN BIOCHEM, V48, P431, DOI 10.1016/j.clinbiochem.2014.12.027; Braithwaite V, 2012, BONE, V50, P1351, DOI 10.1016/j.bone.2012.03.010; Chang YM, 2017, CLIN EXP NE IN PRESS; Chonchol M, 2016, J AM SOC NEPHROL, V27, P227, DOI 10.1681/ASN.2014101009; Coe LM, 2014, J BIOL CHEM, V289, P9795, DOI 10.1074/jbc.M113.527150; David V, 2016, KIDNEY INT, V89, P135, DOI 10.1038/ki.2015.290; di Giuseppe R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133580; Farrow EG, 2011, P NATL ACAD SCI USA, V108, pE1146, DOI 10.1073/pnas.1110905108; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Gaweda AE, 2010, CLIN J AM SOC NEPHRO, V5, P576, DOI 10.2215/CJN.04710709; Gejyo F, 2004, THER APHER DIAL, V8, P443, DOI 10.1111/j.1774-9987.2004.00199.x; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Hanks LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122885; Hanudel MR, 2016, AM J PHYSIOL-RENAL, V311, pF1369, DOI 10.1152/ajprenal.00281.2016; Honda H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151601; Honda H, 2012, ATHEROSCLEROSIS, V220, P493, DOI 10.1016/j.atherosclerosis.2011.10.038; Imel EA, 2011, J CLIN ENDOCR METAB, V96, P3541, DOI 10.1210/jc.2011-1239; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Kazama JJ, 2007, THER APHER DIAL, V11, pS44, DOI 10.1111/j.1744-9987.2007.00516.x; Mendoza FA, 2012, CLIN J AM SOC NEPHRO, V7, P1155, DOI 10.2215/CJN.13281211; Mendoza JM, 2017, KIDNEY INT, V91, P711, DOI 10.1016/j.kint.2016.10.021; Nowak KL, 2017, J AM SOC NEPHROL, V28, P1239, DOI 10.1681/ASN.2016040401; Roberts MA, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0391-7; Scialla JJ, 2014, J AM SOC NEPHROL, V25, P349, DOI 10.1681/ASN.2013050465; Singh S, 2016, KIDNEY INT, V90, P985, DOI 10.1016/j.kint.2016.05.019; Takeda Y, 2011, AM J NEPHROL, V33, P421, DOI 10.1159/000327019; Urena-Torres P, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-71; Vaziri ND, 2016, SEMIN NEPHROL, V36, P112, DOI 10.1016/j.semnephrol.2016.02.005; Wolf M, 2013, J BONE MINER RES, V28, P1793, DOI 10.1002/jbmr.1923; Wolf M, 2010, J AM SOC NEPHROL, V21, P1427, DOI 10.1681/ASN.2009121293; Yokoyama K, 2014, CLIN J AM SOC NEPHRO, V9, P543, DOI 10.2215/CJN.05170513	33	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176984	10.1371/journal.pone.0176984	http://dx.doi.org/10.1371/journal.pone.0176984			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475601	Green Published, Green Submitted, gold			2022-12-26	WOS:000400649500034
J	Hultgren, EM; Patrick, ME; Evans, RL; Stoos, CT; Egland, KA				Hultgren, Elizabeth M.; Patrick, Mitch E.; Evans, Rick L.; Stoos, Catherine T.; Egland, Kristi A.			SUSD2 promotes tumor-associated macrophage recruitment by increasing levels of MCP-1 in breast cancer	PLOS ONE			English	Article							GROWTH-FACTOR; ANGIOGENESIS; CELLS; PROGRESSION; MICROENVIRONMENT; EXPRESSION; CCL2	Tumor-associated macrophages (TAMs) play a role in tumor angiogenesis and are recruited into the tumor microenvironment (TME) by secreted chemokines, including Monocyte Chemoattractant Protein-1 (MCP-1/CCL2). Angiogenesis is required to sustain proliferation and enable metastasis of breast cancer (BCa) cells. Understanding the underlying mechanisms of TAM recruitment would allow for the identification of desperately needed novel drug targets. Sushi Domain Containing 2 (SUSD2), a transmembrane protein on BCa cells, was previously shown to promote tumor angiogenesis in a murine model. To identify the role of SUSD2 in angiogenesis, 175 human breast tumors were surveyed by immunohistochemical analysis for the presence of SUSD2 and macrophages. Tumors with high levels of SUSD2 staining contained 2-fold more TAMs, mainly of the M2 pro-angiogenic phenotype. An in vitro co-culture model system was developed by differentiating SC monocytes into SC MO macrophages. A 2-fold increase in polarized M2 macrophages was observed when MO macrophages were incubated with SUSD2-expressing BCa cells compared to cancer cells that do not contain SUSD2. Since MCP-1 is known to recruit macrophages, levels of MCP-1 were compared between SUSD2-expressing MDA-MB-231 and MBA-MB-231-vector control cell lines. MCP-1 RNA, intracellular protein and secreted MCP-1 were all significantly increased compared to the vector control. Knockdown of SUSD2 in SKBR3 resulted in significantly decreased levels of secreted MCP-1. Consistently, increased levels of MCP-1 were observed in Susd2-expressing tumors generated from an in vivo isogeneic mouse model compared to the vector control tumors. Because SUSD2 recruits macrophages into the TME and promotes M2 polarization, inhibiting the function of SUSD2 may be an effective therapy for breast cancer patients.	[Hultgren, Elizabeth M.; Patrick, Mitch E.; Evans, Rick L.; Egland, Kristi A.] Univ South Dakota, Sanford Sch Med, Sanford Res, Canc Biol Res Ctr, Sioux Falls, SD USA; [Stoos, Catherine T.] Phys Lab, Sioux Falls, SD USA	Sanford Health; University of South Dakota	Egland, KA (corresponding author), Univ South Dakota, Sanford Sch Med, Sanford Res, Canc Biol Res Ctr, Sioux Falls, SD USA.	kristi.egland@sanfordhealth.org			National Institutes of Health, National Institute of General Medical Science (NIGMS), Center of Biomedical Research Excellence (COBRE) grant [P20GM103548]; NIH; NIH, NIGMS, COBRE grants [P20GM103548, P20GM103620]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103548, P20GM103620] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of General Medical Science (NIGMS), Center of Biomedical Research Excellence (COBRE) grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NIGMS, COBRE grants; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	CS is an employee of Physicians Laboratory, Sioux Falls, South Dakota, United States of America. This research was supported by a National Institutes of Health, National Institute of General Medical Science (NIGMS), Center of Biomedical Research Excellence (COBRE) grant, number P20GM103548, to Keith Miskimins, PhD. Kristi A Egland, PhD is a Project Leader on this grant. The Molecular Pathology Core is supported by two NIH, NIGMS, COBRE grants, numbers P20GM103548 & P20GM103620. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Barrionuevo P, 2007, J IMMUNOL, V178, P436, DOI 10.4049/jimmunol.178.1.436; Ben-Baruch A, 2003, BREAST CANCER RES, V5, P31, DOI 10.1186/bcr554; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Egland KA, 2003, P NATL ACAD SCI USA, V100, P1099, DOI 10.1073/pnas.0337425100; Evans RL, 2014, CANCER PREV RES, V7, P545, DOI 10.1158/1940-6207.CAPR-13-0416; Guo CQ, 2013, VASC CELL, V5, DOI 10.1186/2045-824X-5-20; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Jetten N, 2014, ANGIOGENESIS, V17, P109, DOI 10.1007/s10456-013-9381-6; Kau P, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-120; Kawano K, 2012, EXP THER MED, V4, P61, DOI 10.3892/etm.2012.564; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Kwon KY, 2007, ARCH PATHOL LAB MED, V131, P593; Leek RD, 1996, CANCER RES, V56, P4625; Low-Marchelli JM, 2013, CANCER RES, V73, P662, DOI 10.1158/0008-5472.CAN-12-0653; Mantovani A, 2009, HUM IMMUNOL, V70, P325, DOI 10.1016/j.humimm.2009.02.008; Matsunaga T, 2011, YONAGO ACTA MED, V54, P1; Mittal K, 2014, SEMIN ONCOL, V41, P235, DOI 10.1053/j.seminoncol.2014.02.007; Motz GT, 2011, NAT REV IMMUNOL, V11, P702, DOI 10.1038/nri3064; Owen JL, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00159; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Preusser M, 2008, HISTOPATHOLOGY, V53, P39, DOI 10.1111/j.1365-2559.2008.03065.x; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Starossom Sarah C, IMMUNITY, V37, P249; Ueno T, 2000, CLIN CANCER RES, V6, P3282; Wang J, 2015, INT J CLIN EXP MED, V8, P15684; Wang JB, 2012, PEPTIDES, V38, P457, DOI 10.1016/j.peptides.2012.09.007; Watson AP, 2013, MOL CANCER RES, V11, P74, DOI 10.1158/1541-7786.MCR-12-0501-T; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Wu H, 2012, J SURG ONCOL, V106, P462, DOI 10.1002/jso.23110; Yamamoto A, 2007, AATEX, V14, P647	36	19	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177089	10.1371/journal.pone.0177089	http://dx.doi.org/10.1371/journal.pone.0177089			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475599	Green Submitted, gold, Green Published			2022-12-26	WOS:000400649500045
J	Rivero-Segura, NA; Flores-Soto, E; de la Cadena, G; Coronado-Mares, I; Gomez-Verjan, JC; Ferreira, DG; Cabrera-Reyes, EA; Lopes, LV; Massieu, L; Cerbon, M				Rivero-Segura, Nadia A.; Flores-Soto, Edgar; Garcia de la Cadena, Selene; Coronado-Mares, Isabel; Gomez-Verjan, Juan C.; Ferreira, Diana G.; Alejandra Cabrera-Reyes, Erika; Lopes, Luisa V.; Massieu, Lourdes; Cerbon, Marco			Prolactin-induced neuroprotection against glutamate excitotoxicity is mediated by the reduction of [Ca2+]i overload and NF-kappa B activation	PLOS ONE			English	Article							INTRACELLULAR CALCIUM; CELL-PROLIFERATION; DORSAL HIPPOCAMPUS; BRAIN PROLACTIN; RECEPTOR; NEURONS; PROTEIN; EXPRESSION; APOPTOSIS; STIMULATION	Prolactin (PRL) is a peptidic hormone that displays pleiotropic functions in the organism including different actions in the brain. PRL exerts a neuroprotective effect against excitotoxicity produced by glutamate (Glu) or kainic acid in both in vitro and in vivo models. It is well known that Glu excitotoxicity causes cell death through apoptotic or necrotic pathways due to intracellular calcium ([Ca2+]i) overload. Therefore, the aim of the present study was to assess the molecular mechanisms by which PRL maintains cellular viability of primary cultures of rat hippocampal neurons exposed to Glu excitotoxicity. We determined cell viability by monitoring mitochondrial activity and using fluorescent markers for viable and dead cells. The intracellular calcium level was determined by a fluorometric assay and proteins involved in the apoptotic pathway were determined by immunoblot. Our results demonstrated that PRL afforded neuroprotection against Glu excitotoxicity, as evidenced by a decrease in propidium iodide staining and by the decrease of the LDH activity. In addition, the MTT assay shows that PRL maintains normal mitochondrial activity even in neurons exposed to Glu. Furthermore, the Glu-induced intracellular [Ca2+]i overload was attenuated by PRL. These data correlate with the reduction found in the level of active caspase-3 and the pro-apoptotic ratio (Bax/Bcl-2). Concomitantly, PRL elicited the nuclear translocation of the transcriptional factor NF-kappa B, which was detected by immunofluorescence and confocal microscopy. To our knowledge, this is the first report demonstrating that PRL prevents Glu excitotoxicity by a mechanism involving the restoration of the intracellular calcium homeostasis and mitochondrial activity, as well as an antiapoptotic action possibly mediated by the activity of NF-kappa B. Overall, the current results suggest that PRL could be of potential therapeutic advantage in the treatment of neurodegenerative diseases.	[Rivero-Segura, Nadia A.; Coronado-Mares, Isabel; Alejandra Cabrera-Reyes, Erika; Cerbon, Marco] Univ Nacl Autonoma Mexico, Fac Quim, Inst Nacl Perinatol, Unidad Invest Reprod & Humana, Ciudad De Mexico, Mexico; [Flores-Soto, Edgar] Univ Nacl Autonoma Mexico, Dept Farmacol, Fac Med, Ciudad De Mexico, Mexico; [Garcia de la Cadena, Selene; Massieu, Lourdes] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Ciudad De Mexico, Mexico; [Gomez-Verjan, Juan C.] Inst Nacl Geriatria, Dept Invest Basica, Ciudad De Mexico, Mexico; [Ferreira, Diana G.; Lopes, Luisa V.] Univ Lisbon, Fac Med Lisboa, Inst Med Mol, Lisbon, Portugal	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidade de Lisboa	Cerbon, M (corresponding author), Univ Nacl Autonoma Mexico, Fac Quim, Inst Nacl Perinatol, Unidad Invest Reprod & Humana, Ciudad De Mexico, Mexico.	mcerbon85@yahoo.com.mx	Rivero, Nadia/ABE-5424-2020; Massieu, Lourdes/GNW-3740-2022; Reyes, Erika Alejandra Cabrera/AAS-2336-2021; Flores Soto, Edgar/GZG-4426-2022	Rivero, Nadia/0000-0002-2659-6864; Reyes, Erika Alejandra Cabrera/0000-0003-4110-1660; Flores Soto, Edgar/0000-0003-2649-8751; Lopes, Luisa/0000-0001-8367-3005	CONACYT [290096, CB239607]; PAPIIT-UNAM [IN220315, IN205416, IN201216]; PAIP-UNAM [S000-9108]; Fundagao para a Ciencia e Tecnologia; Nadia Alejandra Rivero Segura is a doctoral student from Programa de Doctorado en Ciencias Biomedicas; Universidad Nacional Autonoma de Mexico (UNAM)	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); PAIP-UNAM; Fundagao para a Ciencia e Tecnologia; Nadia Alejandra Rivero Segura is a doctoral student from Programa de Doctorado en Ciencias Biomedicas; Universidad Nacional Autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico)	Nadia Alejandra Rivero Segura is a doctoral student from Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico (UNAM) and received fellowship 290096 from CONACYT. This work was submitted in fulfillment of the requirements to obtain a PhD degree at the Programa de Doctorado en Ciencias Biomedicas in the Universidad Nacional Auto A noma de Mexico (UNAM). The authors give thanks to Ana Margarida Santos do Nascimento (AMSN) and Antonio Temudo (AT) from the Bioimaging Unit of the Instituto de Medicina Molecular (iMM-Lisboa) and to Teresa Montiel (TM) from the Instituto de Fisiologia Celular-Division de Neurociencias (UNAM) for technical assistance.r This worked was supported by PAPIIT-UNAM (IN220315, MC; IN205416, LM; IN201216, EFS), PAIP-UNAM (S000-9108, MC), CONACyT (CB239607, LM), Fundagao para a Ciencia e Tecnologia (LVL) and Nadia Alejandra Rivero Segura is a doctoral student from Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico (UNAM) and received fellowship 290096 from CONACYT. This work was submitted in fulfillment of the requirements to obtain a PhD degree at the Programa de Doctorado en Ciencias Biomedicas in the Universidad Nacional Autonoma de Mexico (UNAM). The authors give thanks to Ana Margarida Santos do Nascimento (AMSN) and Antonio Temudo (AT) from the Bioimaging Unit of the Institute de Medicina Molecular (iMM-Lisboa) and to Teresa Montiel (TM) from the Institute de Fisiologia Celular-Division de Neurociencias (UNAM) for technical assistance.	Adan N, 2013, J CLIN INVEST, V123, P3902, DOI 10.1172/JCI69485; BenJonathan N, 1996, ENDOCR REV, V17, P639, DOI 10.1210/er.17.6.639; Bordin S, 2004, MOL CELL ENDOCRINOL, V220, P41, DOI 10.1016/j.mce.2004.04.001; Brown RSE, 2010, J COMP NEUROL, V518, P92, DOI 10.1002/cne.22208; Brunton PJ, 2010, BRAIN RES, V1364, P198, DOI 10.1016/j.brainres.2010.09.062; Cabrera V, 2009, NEUROSCI LETT, V461, P136, DOI 10.1016/j.neulet.2009.06.017; Chan Francis Ka-Ming, 2013, Methods Mol Biol, V979, P65, DOI 10.1007/978-1-62703-290-2_7; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; DEVITO WJ, 1992, ENDOCRINOLOGY, V130, P2549, DOI 10.1210/en.130.5.2549; DEVITO WJ, 1995, MOL CELL ENDOCRINOL, V108, P125, DOI 10.1016/0303-7207(94)03465-6; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Ducret T, 2002, GLIA, V38, P200, DOI 10.1002/glia.10056; Ferreira DG, 2017, CEREB CORTEX, V27, P718, DOI 10.1093/cercor/bhv268; Flores-Soto E, 2013, EUR J PHARMACOL, V721, P21, DOI 10.1016/j.ejphar.2013.09.060; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Gallardo-Perez JC, 2009, J CELL BIOCHEM, V108, P169, DOI 10.1002/jcb.22237; de la Cadena SC, 2014, APOPTOSIS, V19, P414, DOI 10.1007/s10495-013-0930-7; Gonzalez-Sanchez I, 2011, EUR J MED CHEM, V46, P2102, DOI 10.1016/j.ejmech.2011.02.063; Gorbacheva L, 2013, NEUROCHEM INT, V63, P101, DOI 10.1016/j.neuint.2013.05.008; Gregg C, 2009, J NEUROL SCI, V285, P22, DOI 10.1016/j.jns.2009.06.040; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; KAJITA J, 1993, AM J PHYSIOL, V264, pL496, DOI 10.1152/ajplung.1993.264.5.L496; Kochendoerfer SK, 2003, PROLACTIN REGULATION, P265; Konig HG, 2005, J CELL BIOL, V168, P1077, DOI 10.1083/jcb.200407027; Krumenacker JS, 1998, ENDOCRINE, V9, P163, DOI 10.1385/ENDO:9:2:163; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macotela Y, 2002, J ENDOCRINOL, V175, pR13, DOI 10.1677/joe.0.175R013; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Nylander E, 2016, NEUROSCIENCE, V339, P538, DOI 10.1016/j.neuroscience.2016.10.019; Paramo B, 2010, NEUROSCIENCE, V167, P1057, DOI 10.1016/j.neuroscience.2010.02.074; Pedros I, 2015, J NUTR HEALTH AGING, V19, P403, DOI 10.1007/s12603-014-0574-5; Prehn JHM, 1996, MOL PHARMACOL, V49, P319; PREHN JHM, 1994, P NATL ACAD SCI USA, V91, P12599, DOI 10.1073/pnas.91.26.12599; Pujianto DA, 2010, ENDOCRINOLOGY, V151, P1269, DOI 10.1210/en.2009-0964; Sapsford TJ, 2012, J COMP NEUROL, V520, P1062, DOI 10.1002/cne.22775; Tejadilla D, 2010, NEUROSCIENCE, V169, P1178, DOI 10.1016/j.neuroscience.2010.05.074; Tessier C, 2001, ENDOCRINOLOGY, V142, P4086, DOI 10.1210/en.142.9.4086; Torner L, 2001, J NEUROSCI, V21, P3207, DOI 10.1523/JNEUROSCI.21-09-03207.2001; Torner L, 2002, STRESS, V5, P249, DOI 10.1080/1025389021000048638; VACHER P, 1994, ENDOCRINOLOGY, V134, P1213, DOI 10.1210/en.134.3.1213; Valadas JS, 2012, J NEUROCHEM, V123, P1030, DOI 10.1111/jnc.12050; Vanoye-Carlo A, 2008, HORM BEHAV, V53, P112, DOI 10.1016/j.yhbeh.2007.09.004; Vergara-Castaneda E, 2016, BRAIN RES, V1636, P193, DOI 10.1016/j.brainres.2016.02.011; Walker TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044371; Weimann E, 1999, LEUKEMIA RES, V23, P751, DOI 10.1016/S0145-2126(99)00050-8; Yap YW, 2016, NEUROCHEM RES, V41, P554, DOI 10.1007/s11064-015-1666-2; Zermeno C, 2006, J ENDOCRINOL, V189, pR1, DOI 10.1677/joe.1.06766; Zhang F, 2007, STROKE, V38, P2329, DOI 10.1161/STROKEAHA.107.482786; Zhu Y, 2001, NEUROCHEM INT, V38, P227, DOI 10.1016/S0197-0186(00)00084-X; Zhu Y, 2004, NEUROSCIENCE, V123, P897, DOI 10.1016/j.neuroscience.2003.10.037	53	35	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176910	10.1371/journal.pone.0176910	http://dx.doi.org/10.1371/journal.pone.0176910			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475602	Green Published, Green Submitted, gold			2022-12-26	WOS:000400649500026
J	Bakhchane, A; Charif, M; Bousfiha, A; Boulouiz, R; Nahili, H; Rouba, H; Charoute, H; Lenaers, G; Barakat, A				Bakhchane, Amina; Charif, Majida; Bousfiha, Amale; Boulouiz, Redouane; Nahili, Halima; Rouba, Hassan; Charoute, Hicham; Lenaers, Guy; Barakat, Abdelhamid			Novel compound heterozygous MYO7A mutations in Moroccan families with autosomal recessive non-syndromic hearing loss	PLOS ONE			English	Article							MYOSIN-VIIA GENE; SYNDROME TYPE 1B; USHER-SYNDROME; MISSENSE MUTATIONS; PROTEIN STABILITY; DEAFNESS; DFNB2; PHENOTYPE; SERVER; SPECTRUM	The MYO7A gene encodes a protein belonging to the unconventional myosin super family. Mutations within MYO7A can lead to either non syndromic hearing loss or to the Usher syndrome type 1B (USH1B). Here, we report the results of genetic analyses performed on Moroccan families with autosomal recessive non syndromic hearing loss that identified two families with compound heterozygous MYO7A mutations. Five mutations (c.6025delG, c.6229T>A, c.3500T>A, c.5617C>T and c.4487C>A) were identified in these families, the latter presenting two differently affected branches. Multiple bioinformatics programs and molecular modelling predicted the pathogenic effect of these mutations. In conclusion, the absence of vestibular and retinal symptom in the affected patients suggests that these families have the isolated non-syndromic hearing loss DFNB2 (nonsyndromic autosomal recessive hearing loss) presentation, instead of USH1B.	[Bakhchane, Amina; Charif, Majida; Bousfiha, Amale; Boulouiz, Redouane; Nahili, Halima; Rouba, Hassan; Charoute, Hicham; Barakat, Abdelhamid] Inst Pasteur Maroc, Human Mol Genet Lab, Casablanca, Morocco; [Charif, Majida; Lenaers, Guy] Univ Angers, CHU Angers, INSERM, Inst MitoVasc,Equipe MitoLab,U1083, Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Barakat, A (corresponding author), Inst Pasteur Maroc, Human Mol Genet Lab, Casablanca, Morocco.	hamid.barakat@pasteur.ma	Lenaers, guy/X-4727-2019; lenaers, guy/K-2421-2015	BOULOUIZ, Redouane/0000-0003-4430-3612; lenaers, guy/0000-0003-2736-3349; Charoute, Hicham/0000-0002-9338-6744	Pasteur Institute of Morocco (IPM); French National Institute of Health and Medical Research (INSERM); Moroccan National Centre for Scientific and Technical Research (CNRST)	Pasteur Institute of Morocco (IPM); French National Institute of Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Moroccan National Centre for Scientific and Technical Research (CNRST)	This work was supported by Pasteur Institute of Morocco (IPM) and a collaborative project between the French National Institute of Health and Medical Research (INSERM) and the Moroccan National Centre for Scientific and Technical Research (CNRST).; The authors would like to thank all patients and their families for their collaboration. Pasteur Institute of Morocco (IPM) and a collaborative project between the French National Institute of Health and Medical Research (INSERM) supported this work and the Moroccan National Centre supported this work for Scientific and Technical Research (CNRST).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bakhchane A, 2016, EUR J MED GENET, V59, P325, DOI 10.1016/j.ejmg.2016.05.002; Bakhchane A, 2015, GENE, V574, P28, DOI 10.1016/j.gene.2015.07.075; Bakhchane A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138072; Ben-Salem S, 2014, MOL BIOL REP, V41, P193, DOI 10.1007/s11033-013-2851-5; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Boulouiz R, 2007, MOL VIS, V13, P1862; Charif M, 2012, MOL BIOL REP, V39, P11011, DOI 10.1007/s11033-012-2003-3; Finsterer J, 2005, INT J PEDIATR OTORHI, V69, P621, DOI 10.1016/j.ijporl.2004.12.002; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Hildebrand MS, 2010, CLIN GENET, V77, P563, DOI 10.1111/j.1399-0004.2009.01344.x; Inoue A, 2003, J BIOL CHEM, V278, P5478, DOI 10.1074/jbc.M210489200; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Laimer J, 2016, BIOINFORMATICS, V32, P1414, DOI 10.1093/bioinformatics/btv769; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; Liu YQ, 2014, FEBS LETT, V588, P2859, DOI 10.1016/j.febslet.2014.06.049; Millan JM, 2011, J OPHTHALMOL, V2011; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Petit C, 2001, ANNU REV GENOM HUM G, V2, P271, DOI 10.1146/annurev.genom.2.1.271; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Riazuddin S, 2008, HUM MUTAT, V29, P502, DOI 10.1002/humu.20677; Rong WN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097808; Sakai T, 2015, J BIOL CHEM, V290, P17587, DOI 10.1074/jbc.M114.599365; Sambrook J., 2001, MOL CLONING LAB MANU; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; Tamagawa Y, 2002, LARYNGOSCOPE, V112, P292, DOI 10.1097/00005537-200202000-00017; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Wu L, 2011, SCIENCE, V331, P757, DOI 10.1126/science.1198848; Yoshimura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090688; Zhai W, 2015, INT J OPHTHALMOL-CHI, V8, P670, DOI 10.3980/j.issn.2222-3959.2015.04.05	37	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176516	10.1371/journal.pone.0176516	http://dx.doi.org/10.1371/journal.pone.0176516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472130	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500050
J	Caudle, RM; Caudle, SL; Jenkins, AC; Ahn, AH; Neubert, JK				Caudle, Robert M.; Caudle, Stephanie L.; Jenkins, Alan C.; Ahn, Andrew H.; Neubert, John K.			Sex differences in mouse Transient Receptor Potential Cation Channel, Subfamily M, Member 8 expressing trigeminal ganglion neurons	PLOS ONE			English	Article							TRPM8 ION CHANNELS; PAIN SENSITIVITY; OROFACIAL PAIN; I-H; COLD HYPERSENSITIVITY; ACTIVATED CURRENTS; THERMAL PREFERENCE; HCN CHANNELS; SUBSTANCE-P; ASSAY	The detection of cool temperatures is thought to be mediated by primary afferent neurons that express the cool temperature sensing protein Transient Receptor Potential Cation Channel, Subfamily M, Member 8 (TRPM8). Using mice, this study tested the hypothesis that sex differences in sensitivity to cool temperatures were mediated by differences in neurons that express TRPM8. Ion currents from TRPM8 expressing trigeminal ganglion (TRG) neurons in females demonstrated larger hyperpolarization-activated cyclic nucleotide-gated currents (I-h) than male neurons at both 30 degrees and 18 degrees C. Additionally, female neurons' voltage gated potassium currents (I-k) were suppressed by cooling, whereas male Ik was not significantly affected. At the holding potential tested (-60mV) TRPM8 currents were not visibly activated in either sex by cooling. Modeling the effect of Ih and Ik on membrane potentials demonstrated that at 30 E the membrane potential in both sexes is unstable. At 18 E, female TRPM8 TRG neurons develop a large oscillating pattern in their membrane potential, whereas male neurons become highly stable. These findings suggest that the differences in Ih and Ik in the TRPM8 TRG neurons of male and female mice likely leads to greater sensitivity of female mice to the cool temperature. This hypothesis was confirmed in an operant reward/conflict assay. Female mice contacted an 18 degrees C surface for approximately half the time that males contacted the cool surface. At 33 degrees and 10 degrees C male and female mice contacted the stimulus for similar amounts of time. These data suggest that sex differences in the functioning of Ih and Ik in TRPM8 expressing primary afferent neurons leads to differences in cool temperature sensitivity.	[Caudle, Robert M.; Caudle, Stephanie L.] Univ Florida, Coll Dent, Dept Oral & Maxillofacial Surg, Gainesville, FL 32611 USA; [Caudle, Robert M.; Neubert, John K.] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32611 USA; [Jenkins, Alan C.; Neubert, John K.] Univ Florida, Coll Dent, Dept Orthodont, Gainesville, FL USA; [Ahn, Andrew H.] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA; [Ahn, Andrew H.] Eli Lilly & Co, Indianapolis, IN 46285 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Eli Lilly	Caudle, RM (corresponding author), Univ Florida, Coll Dent, Dept Oral & Maxillofacial Surg, Gainesville, FL 32611 USA.; Caudle, RM (corresponding author), Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32611 USA.	caudle@ufl.edu		Caudle, Robert/0000-0002-2394-4114	Pain Research and Intervention Center of Excellence at the University of Florida	Pain Research and Intervention Center of Excellence at the University of Florida	This research was funded by the Pain Research and Intervention Center of Excellence at the University of Florida (RMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Pain Research and Intervention Center of Excellence at the University of Florida.	Anderson EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089137; Anderson EM, 2013, JOVE-J VIS EXP, DOI 10.3791/50336; Babes A, 2011, CURR PHARM BIOTECHNO, V12, P78, DOI 10.2174/138920111793937835; Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Caudle RM, 2003, NEUROTOXICOLOGY, V24, P895, DOI 10.1016/S0161-813X(03)00146-3; Caudle RM, 2010, J PAIN, V11, P838, DOI 10.1016/j.jpain.2010.05.007; Daniels RL, 2009, J BIOL CHEM, V284, P1570, DOI 10.1074/jbc.M807270200; Descoeur J, 2011, EMBO MOL MED, V3, P266, DOI 10.1002/emmm.201100134; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Fernandez JA, 2011, J GEN PHYSIOL, V137, P173, DOI 10.1085/jgp.201010498; He C, 2014, PROG NEUROBIOL, V112, P1, DOI 10.1016/j.pneurobio.2013.10.001; Karjalainen S, 2012, INDOOR AIR, V22, P96, DOI 10.1111/j.1600-0668.2011.00747.x; Kim H, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036079; Knowlton WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025894; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; Luthi A, 1998, J NEUROPHYSIOL, V79, P3284, DOI 10.1152/jn.1998.79.6.3284; Luthi A, 1998, NEURON, V20, P553, DOI 10.1016/S0896-6273(00)80994-0; Madrid R, 2009, J NEUROSCI, V29, P3120, DOI 10.1523/JNEUROSCI.4778-08.2009; Mahieu F, 2010, J PHYSIOL-LONDON, V588, P315, DOI 10.1113/jphysiol.2009.183582; Malkia A, 2007, J PHYSIOL-LONDON, V581, P155, DOI 10.1113/jphysiol.2006.123059; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Mustafa G, 2013, PAIN, V154, P2547, DOI 10.1016/j.pain.2013.07.041; Nealen ML, 2003, J NEUROPHYSIOL, V90, P515, DOI 10.1152/jn.00843.2002; Neubert JK, 2006, BEHAV BRAIN RES, V170, P308, DOI 10.1016/j.bbr.2006.03.008; Neubert JK, 2005, PAIN, V116, P386, DOI 10.1016/j.pain.2005.05.011; Neubert JK, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-49; Neubert JK, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-43; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Nolan TA, 2012, PAIN, V153, P2009, DOI 10.1016/j.pain.2012.04.026; Nolan TA, 2011, BEHAV BRAIN RES, V217, P477, DOI 10.1016/j.bbr.2010.10.022; Nolan TA, 2011, BEHAV BRAIN RES, V216, P723, DOI 10.1016/j.bbr.2010.08.023; Olah Z, 2001, J BIOL CHEM, V276, P11021, DOI 10.1074/jbc.M008392200; Orio P, 2012, J NEUROPHYSIOL, V108, P3009, DOI 10.1152/jn.01033.2011; Orio P, 2009, J PHYSIOL-LONDON, V587, P1961, DOI 10.1113/jphysiol.2008.165738; Patel R, 2014, J PHARMACOL EXP THER, V349, P47, DOI 10.1124/jpet.113.211243; Pertusa M, 2014, J BIOL CHEM, V289, P21828, DOI 10.1074/jbc.M114.565994; Pertusa M, 2012, J BIOL CHEM, V287, P18218, DOI 10.1074/jbc.M111.312645; Petruska JC, 2000, J NEUROPHYSIOL, V84, P2365, DOI 10.1152/jn.2000.84.5.2365; Ramirez HE, 2012, J AM ASSOC LAB ANIM, V51, P638; Rau KK, 2007, J NEUROPHYSIOL, V97, P2651, DOI 10.1152/jn.00840.2006; Rau KK, 2005, J CHEM NEUROANAT, V29, P255, DOI 10.1016/j.jchemneu.2005.02.002; Rossi HL, 2012, NEUROSCIENCE, V224, P294, DOI 10.1016/j.neuroscience.2012.08.015; Rossi HL, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-37; Rossi HL, 2008, BEHAV BRAIN RES, V187, P478, DOI 10.1016/j.bbr.2007.09.021; Rossi HL, 2009, BEHAV BRAIN RES, V203, P240, DOI 10.1016/j.bbr.2009.05.009; Rusznak Z, 2013, EUR J NEUROSCI, V37, P876, DOI 10.1111/ejn.12116; Sartiani L, 2015, CURR DRUG TARGETS, V16, P868, DOI 10.2174/1389450116666150531152047; Teichert RW, 2014, P NATL ACAD SCI USA, V111, P2319, DOI 10.1073/pnas.1324019111; Vierck CJ, 2008, J PAIN, V9, P739, DOI 10.1016/j.jpain.2008.03.008; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Williams AD, 2015, J PHYSIOL-LONDON, V593, P2779, DOI 10.1113/JP270453; Zakharian E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005404; Zha QQ, 2008, J NEUROCHEM, V105, P68, DOI 10.1111/j.1471-4159.2007.05110.x	56	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176753	10.1371/journal.pone.0176753	http://dx.doi.org/10.1371/journal.pone.0176753			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472061	Green Submitted, Green Published, gold			2022-12-26	WOS:000400648500068
J	Sporrel, K; Caljouw, SR; Withagen, R				Sporrel, Karlijn; Caljouw, Simone R.; Withagen, Rob			Gap-crossing behavior in a standardized and a nonstandardized jumping stone configuration	PLOS ONE			English	Article							SCHEMA THEORY; AFFORDANCES	Over the last years, the omnipresent standardization of playgrounds - the distances between, for example, jumping stones tend to be equal - has been criticized by both scientists and architects. First, it has been argued that standardization fails to do justice to the variability in the children's action capabilities. Second, it might simplify play in that children repetitively cross over the same distance and, thus, do not have to worry about their movements anymore. In the present study we examined the gap-crossing behavior of children in both a standardized and a nonstandardized jumping stone configuration. Children, between 5 and 10 years of age, were to play in each configuration for two minutes. No significant differences between the configurations were found in the number of gaps the children crossed and the percentage of jumps (ps>0.05). However, more children crossed a gap that they perceived as challenging (i.e. gap width close to their estimated maximum jumping distance) in the nonstandardized configuration than in the standardized one. Interestingly, significant differences were found in variables reflecting the children's action preparation D the variation in both the time on a jumping stone and the numbers of steps on it was bigger in the nonstandardized playground than in the standardized one (ps<0.05). The implications of these findings are discussed for both the design of playgrounds and the academic discussions about them.	[Sporrel, Karlijn; Caljouw, Simone R.; Withagen, Rob] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands	University of Groningen	Withagen, R (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	r.g.withagen@umcg.nl		Caljouw, Simone R./0000-0002-3004-9900				Almendros G, 2018, J SOIL SEDIMENT, V18, P1303, DOI 10.1007/s11368-016-1595-y; Chow JY, 2011, NEW IDEAS PSYCHOL, V29, P189, DOI 10.1016/j.newideapsych.2010.10.001; Clark C, 2002, J ENVIRON PSYCHOL, V22, P95, DOI 10.1006/jevp.2001.0242; Gibson J.J., 1986, ECOLOGICAL APPROACH; Heft H., 1988, ENV Q, V5, P29; Jongeneel D, 2015, J ENVIRON PSYCHOL, V44, P45, DOI 10.1016/j.jenvp.2015.09.003; Kytta M, 2002, J ENVIRON PSYCHOL, V22, P109, DOI 10.1006/jevp.2001.0249; Lefaivre L., 1999, A VANEYCK HUMANIST R; Little H, 2010, EUR EARLY CHILD EDUC, V18, P497, DOI 10.1080/1350293X.2010.525949; Morrongiello BA, 2004, INJURY PREV, V10, P62, DOI 10.1136/ip.2003.003624; Olwig K.R., 1990, CHILD ENV Q, V7, P47; PLUMERT JM, 1995, DEV PSYCHOL, V31, P866, DOI 10.1037/0012-1649.31.5.866; Prieske B, 2015, J ENVIRON PSYCHOL, V41, P101, DOI 10.1016/j.jenvp.2014.11.011; Sandseter EBH, 2009, EARLY CHILD EDUC J, V36, P439, DOI 10.1007/s10643-009-0307-2; Schmidt R.A., 2003, MOTOR CONTROL LEARNI; SCHMIDT RA, 1975, PSYCHOL REV, V82, P225, DOI 10.1037/h0076770; Schollhorn WI, 2010, MEDICINA-LITHUANIA, V46, P365, DOI 10.3390/medicina46060052; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Solomon S.G., 2005, AM PLAYGROUNDS REVIT; VANROSSUM JHA, 1990, HUM MOVEMENT SCI, V9, P387, DOI 10.1016/0167-9457(90)90010-B; WARREN WH, 1984, J EXP PSYCHOL HUMAN, V10, P683, DOI 10.1037/0096-1523.10.5.683; [No title captured]; [No title captured]	23	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176165	10.1371/journal.pone.0176165	http://dx.doi.org/10.1371/journal.pone.0176165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SB	28467459	Green Published, gold, Green Submitted			2022-12-26	WOS:000400647000041
J	Zivanovic, V; Gojkovic-Bukarica, L; Scepanovic, R; Vitorovic, T; Novakovic, R; Milanov, N; Bukumiric, Z; Carevic, B; Trajkovic, J; Rajkovic, J; Djokic, V				Zivanovic, Vladimir; Gojkovic-Bukarica, Ljiljana; Scepanovic, Radisav; Vitorovic, Teodora; Novakovic, Radmila; Milanov, Nenad; Bukumiric, Zoran; Carevic, Biljana; Trajkovic, Jasmina; Rajkovic, Jovana; Djokic, Vladimir			Differences in antimicrobial consumption, prescribing and isolation rate of multidrug resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii on surgical and medical wards	PLOS ONE			English	Article							ANTIBIOTIC USE; SURVEILLANCE	In order to provide guidance data for clinically rational use of an antibiotics consuption, prescribing and prevalence of multidrug resistant (MDR) Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii were monitored on the surgical (S) and medical (M) wards of the University Hospital Center "Dr. Dragisa Misovic-Dedinje" (Belgrade, Serbia), in the study period from 2012 to 2015. Appropriateness of antimicrobial use was evaluated using the Global-Prevalence Survey method designed by the University of Antwerp. The percentages of MDR pathogens relative to the total number of isolates of K. pneumoniae and P. aeruginosa were higher on the S (86.2% and 49.1%) than on the M (63.2% and 36.9%) wards. The percentage of MDR A. baumannii was not different between S (93.7%) and M (79.5%) wards. An overall antibiotics consumption (defined daily doses/100 bed-days) during study was 369.7 and 261.5 on the S and M wards, respectively. A total of 225 prescriptions of antimicrobials were evaluated in 138 adults admitted to wards on the day of the survey. The percentage of antimicrobials prescribed for prophylaxis on the M and S wards were 0% and 25%, respectively. Therapies were more frequently empiric (S, 86.8% and M, 80%). The percentages of medical errors on the S and M wards were 74.6% and 27.3%, respectively. The quality indicators for antibiotic prescribing on the S and M wards were as follows: the incorrect choice of antimicrobials (35.6% vs. 20.0%), inappropriate dose interval (70.6% vs. 16.9%) or duration of therapy (72.5% vs. 23.1%), a non-documented stop/review data (73.6% vs. 16.9%) and divergence from guidelines (71.9% vs. 23.1%). Treatment based on biomarkers was more common on the M wards as compared to the S wards. The increasing prevalence of MDR pathogens, a very high consumption and incorrect prescribing of antimicrobials need special attention, particularly on the S wards. The increasing prevalence of MDR pathogens, a very high consumption and incorrect prescribing of antimicrobials need special attention, particularly on the S wards.	[Zivanovic, Vladimir; Gojkovic-Bukarica, Ljiljana; Scepanovic, Radisav; Vitorovic, Teodora; Milanov, Nenad] Univ Hosp Ctr Dr Dragisa Misovic Dedinje, Belgrade, Serbia; [Gojkovic-Bukarica, Ljiljana; Novakovic, Radmila; Trajkovic, Jasmina; Rajkovic, Jovana; Djokic, Vladimir] Univ Belgrade, Inst Pharmacol Clin Pharmacol & Toxicol, Fac Med, Belgrade, Serbia; [Bukumiric, Zoran] Univ Belgrade, Sch Med, Dept Med Stat, Belgrade, Serbia; [Carevic, Biljana] Clin Ctr Serbia, Dept Hosp Epidemiol, Belgrade, Serbia	University of Belgrade; University of Belgrade; Clinical Centre of Serbia	Djokic, V (corresponding author), Univ Belgrade, Inst Pharmacol Clin Pharmacol & Toxicol, Fac Med, Belgrade, Serbia.	v.djokic@yahoo.com	Rajkovic, Jovana/ABH-6038-2020	Rajkovic, Jovana/0000-0002-6173-2219; Djokic, Vladimir/0000-0003-2905-964X; zivanovic, vladimir/0000-0002-6282-7092; Novakovic, Dr Radmila/0000-0002-1097-2060	Ministry of Education, Science and Technological Development Government of the Republic of Serbia [TR31020]	Ministry of Education, Science and Technological Development Government of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the Scientific Research Grant from Ministry of Education, Science and Technological Development Government of the Republic of Serbia (No TR31020) http://www.mpn.gov.rs/nauka/.	[Anonymous], 2015, GLOBAL POINT PREVALE, P6; Antunes LCS, 2014, PATHOG DIS, V71, P292, DOI 10.1111/2049-632X.12125; Asuman IN, 2011, J MICROB INFECT DIS, V1, P128; Borg MA, 2008, J HOSP INFECT, V70, P228, DOI 10.1016/j.jhin.2008.07.002; Clinical and Laboratory Standard Institute (CLSI) document M02-A10, 2010, M02A10 CLSI, P52; Cusini A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014011; Datta S, 2012, INDIAN J MED RES, V135, P907; European Centre for Disease Prevention and Control, 2014, ANT RES SURV EUR 201, P22; European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2015, CLIN BREAKP, P6; Falagas ME, 2006, J HOSP INFECT, V64, P7, DOI 10.1016/j.jhin.2006.04.015; Friedland I, 2003, DIAGN MICR INFEC DIS, V45, P245, DOI 10.1016/S0732-8893(02)00503-5; Glibert DN, 2015, SANFORD GUIDE ANTIMI; Goel N, 2011, J ANTIMICROB CHEMOTH, V66, P1625, DOI 10.1093/jac/dkr167; Grabe M, 2012, GUIDELINES UROLOGICA; Karlowsky JA, 2003, ANTIMICROB AGENTS CH, V47, P1681, DOI 10.1128/AAC.47.5.1681-1688.2003; Lee HS, 2015, J MICROBIOL IMMUNOL, V48, P647, DOI 10.1016/j.jmii.2014.04.009; Llor C, 2014, THER ADV DRUG SAF, V5, P229, DOI 10.1177/2042098614554919; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Ozkurt Z, 2005, JPN J INFECT DIS, V58, P338; Scottish Intercollegiate Guidelines Network (SIGN), 2008, SIGN PUBL, V104, P3; Siegel JD, 2007, GUIDELINE ISOLATION, P14; Tunger O, 2000, INT J ANTIMICROB AG, V15, P131, DOI 10.1016/S0924-8579(00)00158-8; Velickovic-Radovanovic R, 2015, J CLIN PHARM THER, V40, P426, DOI 10.1111/jcpt.12283; Versporten A, 2014, LANCET INFECT DIS, V14, P381, DOI 10.1016/S1473-3099(14)70071-4; Woodhead M, 2011, CLIN MICROBIOL INFEC, V17, pE1, DOI 10.1111/j.1469-0691.2011.03672.x; World Health Organization, 2009, WHO STEPS INSTR CHRO, P12; World Health Organization (WHO), CENTR AS E EUR SURV, P38	27	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0175689	10.1371/journal.pone.0175689	http://dx.doi.org/10.1371/journal.pone.0175689			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467437	Green Submitted, gold, Green Published			2022-12-26	WOS:000400647000022
J	Geraets, RD; Langin, LM; Cain, JT; Parker, CM; Beraldi, R; Kovacs, AD; Weimer, JM; Pearce, DA				Geraets, Ryan D.; Langin, Logan M.; Cain, Jacob T.; Parker, Camille M.; Beraldi, Rosanna; Kovacs, Attila D.; Weimer, Jill M.; Pearce, David A.			A tailored mouse model of CLN2 disease: A nonsense mutant for testing personalized therapies	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSES; TRIPEPTIDYL-PEPTIDASE-I; BATTEN-DISEASE; ATP SYNTHASE; SUBUNIT C; CODON READTHROUGH; GLIAL ACTIVATION; READ-THROUGH; LOW-LEVEL; STORAGE	The Neuronal Ceroid Lipofuscinoses (NCLs), also known as Batten disease, result from mutations in over a dozen genes. Although, adults are susceptible, the NCLs are frequently classified as pediatric neurodegenerative diseases due to their greater pediatric prevalence. Initial clinical presentation usually consists of either seizures or retinopathy but develops to encompass both in conjunction with declining motor and cognitive function. The NCLs result in premature death due to the absence of curative therapies. Nevertheless, preclinical and clinical trials exist for various therapies. However, the genotypes of NCL animal models determine which therapeutic approaches can be assessed. Mutations of the CLN2 gene encoding a soluble lysosomal enzyme, tripeptidyl peptidase 1 (TPP1), cause late infantile NCL/CLN2 disease. The genotype of the original mouse model of CLN2 disease, Cln2(-/-), excludes mutation guided therapies like antisense oligonucleotides and nonsense suppression. Therefore, the purpose of this study was to develop a model of CLN2 disease that allows for the assessment of all therapeutic approaches. Nonsense mutations in CLN2 disease are frequent, the most common being CLN2(R208X). Thus, we created a mouse model that carries a mutation equivalent to the human p. R208X mutation. Molecular assessment of Cln2(R207X/R207X) tissues determined significant reduction in Cln2 transcript abundance and TPP1 enzyme activity. This reduction leads to the development of neurological impairment (e.g. tremors) and neuropathology (e.g. astrocytosis). Collectively, these assessments indicate that the Cln2(R207X/R207X) mouse is a valid CLN2 disease model which can be used for the preclinical evaluation of all therapeutic approaches including mutation guided therapies.	[Geraets, Ryan D.; Langin, Logan M.; Cain, Jacob T.; Parker, Camille M.; Beraldi, Rosanna; Kovacs, Attila D.; Weimer, Jill M.; Pearce, David A.] Sanford Res, Childrens Hlth Res Ctr, Sioux Falls, SD 57104 USA; [Geraets, Ryan D.; Kovacs, Attila D.; Weimer, Jill M.; Pearce, David A.] Univ S Dakota, Sanford Sch Med, Sioux Falls, SD 57105 USA	Sanford Health; University of South Dakota	Pearce, DA (corresponding author), Sanford Res, Childrens Hlth Res Ctr, Sioux Falls, SD 57104 USA.; Pearce, DA (corresponding author), Univ S Dakota, Sanford Sch Med, Sioux Falls, SD 57105 USA.	David.Pearce@sanfordhealth.org			Sanford Health; National Institutes of Health program [P20GM103620, P20GM103548]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082283] Funding Source: NIH RePORTER	Sanford Health; National Institutes of Health program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Sanford Health. The equipment used from the molecular, histology, and microscope cores at Sanford Research are funded by National Institutes of Health program grants P20GM103620 and P20GM103548 awarded to Sanford Research's Children's Health Research Center and Cancer Biology Research Center respectively.	Ballabio A, 2009, BBA-MOL CELL RES, V1793, P684, DOI 10.1016/j.bbamcr.2008.12.001; Baradaran-Heravi A, 2016, NUCLEIC ACIDS RES, V44, P6583, DOI 10.1093/nar/gkw638; Bilbo SD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.014.2009; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Brooks DA, 2006, TRENDS MOL MED, V12, P367, DOI 10.1016/j.molmed.2006.06.001; Chabrol B, 2013, HAND CLINIC, V113, P1701, DOI 10.1016/B978-0-444-59565-2.00038-1; Cheng SH, 2014, J LIPID RES; Cooper JD, 2003, CURR OPIN NEUROL, V16, P121, DOI 10.1097/00019052-200304000-00001; Cooper JD, 2006, BBA-MOL BASIS DIS, V1762, P873, DOI 10.1016/j.bbadis.2006.08.002; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Ezaki J, 1999, J NEUROCHEM, V72, P2573, DOI 10.1046/j.1471-4159.1999.0722573.x; Ezaki J, 2000, J BIOCHEM-TOKYO, V128, P509, DOI 10.1093/oxfordjournals.jbchem.a022781; Geraets RD, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0414-2; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Gunn G, 2014, MOL GENET METAB, V111, P374, DOI 10.1016/j.ymgme.2013.12.007; Haltia M, 2003, J NEUROPATH EXP NEUR, V62, P1; Haltia M, 2006, BBA-MOL BASIS DIS, V1762, P850, DOI 10.1016/j.bbadis.2006.06.010; Haltia M, 2013, BBA-MOL BASIS DIS, V1832, P1795, DOI 10.1016/j.bbadis.2012.08.012; Heneka MT, 2010, BRAIN RES REV, V63, P189, DOI 10.1016/j.brainresrev.2009.11.004; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; Jeyakumar Mylvaganam, 2005, Nat Rev Neurosci, V6, P713; Keeling KM, 2014, ANNU REV GENOM HUM G, V15, P371, DOI 10.1146/annurev-genom-091212-153527; Keeling KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060478; Keeling KM, 2001, HUM MOL GENET, V10, P291, DOI 10.1093/hmg/10.3.291; Kielar C, 2007, NEUROBIOL DIS, V25, P150, DOI 10.1016/j.nbd.2006.09.001; Kousi M, 2012, HUM MUTAT, V33, P42, DOI 10.1002/humu.21624; Kovacs AD, 2015, DIS MODEL MECH, V8, P351, DOI 10.1242/dmm.018804; Kovacs AD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02116; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; Macauley SL, 2011, J NEUROSCI, V31, P15575, DOI 10.1523/JNEUROSCI.3579-11.2011; Macauley SL, 2009, EXP NEUROL, V217, P124, DOI 10.1016/j.expneurol.2009.01.022; Mahmood F, 2013, BRAIN, V136, P1488, DOI 10.1093/brain/awt043; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Miller JN, 2013, HUM MOL GENET, V22, P2723, DOI 10.1093/hmg/ddt120; Miller JN, 2014, HUM MOL GENET; Mink JW, 2013, J CHILD NEUROL, V28, P1101, DOI 10.1177/0883073813494268; Mitchison HM, 2004, BRAIN PATHOL, V14, P86, DOI 10.1111/j.1750-3639.2004.tb00502.x; Mole S., 2011, NEURONAL CEROID LIPO, DOI DOI 10.1093/MED/9780199590018.003.0018; Mole SE, 2015, BBA-MOL BASIS DIS, V1852, P2237, DOI 10.1016/j.bbadis.2015.05.011; Mole SE, 2005, NEUROGENETICS, V6, P107, DOI 10.1007/s10048-005-0218-3; Mole SE, 2004, BRAIN PATHOL, V14, P70, DOI 10.1111/j.1750-3639.2004.tb00500.x; Mole SE, NCL RESOURCE 2014; Nagel-Wolfrum K, 2016, BIODRUGS, V30, P49, DOI 10.1007/s40259-016-0157-6; Neverman NJ, 2015, BIOCH BIOPHYS ACTA B, V1852, P2292; PALMER DN, 1992, AM J MED GENET, V42, P561, DOI 10.1002/ajmg.1320420428; Pontikis CC, 2005, NEUROBIOL DIS, V20, P823, DOI 10.1016/j.nbd.2005.05.018; Pontikis CC, 2004, BRAIN RES, V1023, P231, DOI 10.1016/j.brainres.2004.07.030; Schulz A, 2013, BBA-MOL BASIS DIS, V1832, P1801, DOI 10.1016/j.bbadis.2013.04.008; Shacka JJ, 2012, BRAIN RES BULL, V88, P43, DOI 10.1016/j.brainresbull.2012.03.003; Siintola E, 2006, BBA-MOL BASIS DIS, V1762, P857, DOI 10.1016/j.bbadis.2006.05.006; Sleat D E, 2001, Eur J Paediatr Neurol, V5 Suppl A, P57, DOI 10.1053/ejpn.2000.0436; Sleat DE, 2008, MOL GENET METAB, V94, P222, DOI 10.1016/j.ymgme.2008.01.014; Sleat David E., 2004, NEUROBIOL DIS, V24, P9117; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; Sohar I, 2000, CLIN CHEM, V46, P1005; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Tian Y, 2006, J BIOL CHEM, V281, P6559, DOI 10.1074/jbc.M507336200; Tyynela J, 2004, BRAIN PATHOL, V14, P349; van Diggelen OP, 1999, MOL GENET METAB, V66, P240, DOI 10.1006/mgme.1999.2809; Wang D, 2012, MOL GENET METAB, V105, P116; Wang RY, 2011, GENET MED, V13, P457, DOI 10.1097/GIM.0b013e318211a7e1; Warrier V, 2013, BBA-MOL BASIS DIS, V1832, P1827, DOI 10.1016/j.bbadis.2013.03.017; Watzlawik JO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128007; Williams RE, 2006, BBA-MOL BASIS DIS, V1762, P865, DOI 10.1016/j.bbadis.2006.07.001; Williams RE, 2012, NEUROLOGY, V79, P183, DOI 10.1212/WNL.0b013e31825f0547; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4	69	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176526	10.1371/journal.pone.0176526	http://dx.doi.org/10.1371/journal.pone.0176526			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28464005	Green Submitted, gold, Green Published			2022-12-26	WOS:000400646300027
J	Chalise, P; Fridley, BL				Chalise, Prabhakar; Fridley, Brooke L.			Integrative clustering of multi-level 'omic data based on non-negative matrix factorization algorithm	PLOS ONE			English	Article							CONSTRAINED LEAST-SQUARES; CANCER GENOMIC DATA; PATTERN DISCOVERY; MICROARRAY DATA; MODEL; CONVERGENCE; VALIDATION; BREAST	Integrative analyses of high-throughput 'omic data, such as DNA methylation, DNA copy number alteration, mRNA and protein expression levels, have created unprecedented opportunities to understand the molecular basis of human disease. In particular, integrative analyses have been the cornerstone in the study of cancer to determine molecular subtypes within a given cancer. As malignant tumors with similar morphological characteristics have been shown to exhibit entirely different molecular profiles, there has been significant interest in using multiple 'omic data for the identification of novel molecular subtypes of disease, which could impact treatment decisions. Therefore, we have developed intNMF, an integrative approach for disease subtype classification based on non-negative matrix factorization. The proposed approach carries out integrative clustering of multiple high dimensional molecular data in a single comprehensive analysis utilizing the information across multiple biological levels assessed on the same individual. As intNMF does not assume any distributional form for the data, it has obvious advantages over other model based clustering methods which require specific distributional assumptions. Application of intNMF is illustrated using both simulated and real data from The Cancer Genome Atlas (TCGA).	[Chalise, Prabhakar] Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS USA; [Fridley, Brooke L.] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL USA	University of Kansas; University of Kansas Medical Center; H Lee Moffitt Cancer Center & Research Institute	Chalise, P (corresponding author), Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS USA.	pchalise@kumc.edu			National Institute of Health [R21 CA182715]; CCSG grant [P30 CA168524]; University of Kansas Cancer Center pilot project; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCSG grant; University of Kansas Cancer Center pilot project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the National Institute of Health (R21 CA182715) and University of Kansas Cancer Center pilot project award supported by CCSG grant (P30 CA168524). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berry MW, 2007, COMPUT STAT DATA AN, V52, P155, DOI 10.1016/j.csda.2006.11.006; Bertsekas D., 1999, NONLINEAR PROGRAMMIN; Boutsidis C, 2008, PATTERN RECOGN, V41, P1350, DOI 10.1016/j.patcog.2007.09.010; Bro R, 1997, J CHEMOMETR, V11, P393, DOI 10.1002/(SICI)1099-128X(199709/10)11:5<393::AID-CEM483>3.3.CO;2-C; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Chalise P, 2016, COMPUT METH PROG BIO, V128, P69, DOI 10.1016/j.cmpb.2016.02.011; Chalise P, 2014, TRANSL CANCER RES, V3, P202, DOI 10.3978/j.issn.2218-676X.2014.06.03; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Duan Q, 2013, CPT PHARMACOMETRICS, V2, pe35; Dudoit S, 2002, GENOME BIOL, V3; Frigyesi A, 2008, CANCER INFORM, V6, P275; Gao Y, 2005, BIOINFORMATICS, V21, P3970, DOI 10.1093/bioinformatics/bti653; Gonzalez E.F., 2005, ACCELERATING LEE SEU; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Grippo L, 2000, OPER RES LETT, V26, P127, DOI 10.1016/S0167-6377(99)00074-7; Hoyer PO, 2004, J MACH LEARN RES, V5, P1457; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Hutchins LN, 2008, BIOINFORMATICS, V24, P2684, DOI 10.1093/bioinformatics/btn526; Kapp AV, 2007, BIOSTATISTICS, V8, P9, DOI 10.1093/biostatistics/kxj029; Kim H, 2007, BIOINFORMATICS, V23, P1495, DOI 10.1093/bioinformatics/btm134; Kirk P, 2012, BIOINFORMATICS, V28, P3290, DOI 10.1093/bioinformatics/bts595; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kormaksson M, 2012, ANN APPL STAT, V6, P1327, DOI 10.1214/11-AOAS533; Kristensen VN, 2014, NAT REV CANCER, V14, P299, DOI 10.1038/nrc3721; Langville A, 2014, INITIALIZATIONS CONV; Lawson CL, 1974, SOLVING LEAST SQUARE; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Mo QX, 2013, P NATL ACAD SCI USA, V110, P4245, DOI 10.1073/pnas.1208949110; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; PAATERO P, 1994, ENVIRONMETRICS, V5, P111, DOI 10.1002/env.3170050203; Pascual-Montano A, 2006, IEEE T PATTERN ANAL, V28, P403, DOI 10.1109/TPAMI.2006.60; Ponnapalli SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028072; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sankaranarayanan P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121396; Shahnaz F, 2006, INFORM PROCESS MANAG, V42, P373, DOI 10.1016/j.ipm.2004.11.005; Shen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035236; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Tibshirani R, 2005, J COMPUT GRAPH STAT, V14, P511, DOI 10.1198/106186005X59243; Van Benthem MH, 2004, J CHEMOMETR, V18, P441, DOI 10.1002/cem.889; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Xiao XL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004006; Zhang SH, 2012, NUCLEIC ACIDS RES, V40, P9379, DOI 10.1093/nar/gks725	45	59	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176278	10.1371/journal.pone.0176278	http://dx.doi.org/10.1371/journal.pone.0176278			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459819	Green Submitted, Green Published, gold			2022-12-26	WOS:000400645000028
J	Coffey, SR; Bragg, RM; Minnig, S; Ament, SA; Cantle, JP; Glickenhaus, A; Shelnut, D; Carrillo, JM; Shuttleworth, DD; Rodier, JA; Noguchi, K; Bennett, CF; Price, ND; Kordasiewicz, HB; Carroll, JB				Coffey, Sydney R.; Bragg, Robert M.; Minnig, Shawn; Ament, Seth A.; Cantle, Jeffrey P.; Glickenhaus, Anne; Shelnut, Daniel; Carrillo, Jose M.; Shuttleworth, Dominic D.; Rodier, Julie-Anne; Noguchi, Kimihiro; Bennett, C. Frank; Price, Nathan D.; Kordasiewicz, Holly B.; Carroll, Jeffrey B.			Peripheral huntingtin silencing does not ameliorate central signs of disease in the B6. Htt(Q111/+) mouse model of Huntington's disease	PLOS ONE			English	Article							HEPATIC MITOCHONDRIAL DYSFUNCTION; MICROGLIAL ACTIVATION; PREMANIFEST; BRAIN; MICE; INSTABILITY; EXPRESSION; REPEATS; ONSET; BODY	Huntington's disease (HD) is an autosomal dominant neurodegenerative disease whose predominant neuropathological signature is the selective loss of medium spiny neurons in the striatum. Despite this selective neuropathology, the mutant protein (huntingtin) is found in virtually every cell so far studied, and, consequently, phenotypes are observed in a wide range of organ systems both inside and outside the central nervous system. We, and others, have suggested that peripheral dysfunction could contribute to the rate of progression of striatal phenotypes of HD. To test this hypothesis, we lowered levels of huntingtin by treating mice with antisense oligonucleotides (ASOs) targeting the murine Huntingtin gene. To study the relationship between peripheral huntingtin levels and striatal HD phenotypes, we utilized a knock-in model of the human HD mutation (the B6. Htt(Q111/+) mouse). We treated mice with ASOs from 2-10 months of age, a time period over which significant HD-relevant signs progressively develop in the brains of Htt(Q111/+) mice. Peripheral treatment with ASOs led to persistent reduction of huntingtin protein in peripheral organs, including liver (64% knockdown), brown adipose (66% knockdown), and white adipose tissues (71% knockdown). This reduction was not associated with alterations in the severity of HD-relevant signs in the striatum of HttQ(111/+) mice at the end of the study, including transcriptional dysregulation, the accumulation of neuronal intranuclear inclusions, and behavioral changes such as subtle hypoactivity and reduced exploratory drive. These results suggest that the amount of peripheral reduction achieved in the current study does not significantly impact the progression of HD-relevant signs in the central nervous system.	[Coffey, Sydney R.; Bragg, Robert M.; Minnig, Shawn; Cantle, Jeffrey P.; Glickenhaus, Anne; Carrillo, Jose M.; Shuttleworth, Dominic D.; Carroll, Jeffrey B.] Western Washington Univ, Psychol Dept, Behav Neurosci Program, Bellingham, WA 98225 USA; [Ament, Seth A.; Price, Nathan D.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Price, Nathan D.] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [Ament, Seth A.] Inst Syst Biol, Seattle, WA USA; [Shelnut, Daniel; Noguchi, Kimihiro] Western Washington Univ, Dept Math, Bellingham, WA 98225 USA; [Rodier, Julie-Anne] INSERM, U1216, Grenoble Inst Neurosci, Grenoble, France; [Rodier, Julie-Anne] Univ Grenoble Alpes, Grenoble, France; [Bennett, C. Frank; Kordasiewicz, Holly B.] Ionis Pharmaceut, Carlsbad, CA USA	Western Washington University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Institute for Systems Biology (ISB); Western Washington University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Ionis Pharmaceuticals, Inc.	Carroll, JB (corresponding author), Western Washington Univ, Psychol Dept, Behav Neurosci Program, Bellingham, WA 98225 USA.	Jeff.Carroll@wwu.edu		Coffey, Sydney/0000-0002-1477-2197; RODIER, Julie-Anne/0000-0003-1156-0890; Price, Nathan/0000-0002-4157-0267	CHDI Foundation [A-8339]; Huntington Society of Canada New Pathways Program	CHDI Foundation; Huntington Society of Canada New Pathways Program	This work was supported by a research contract with the CHDI Foundation (http://chdifoundation.org/) under record identification number A-8339 and the Huntington Society of Canada New Pathways Program. The CHDI Foundation provided input on study design and support in the form of salaries for authors J.B.C., R.M.B., S.R.C., and J.P.C. The specific roles of these authors are articulated in the author contributions section. The CHDI Foundation did not have any additional role in data collection and analysis, decision to publish, or preparation of the manuscript. The Huntington Society of Canada did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ionis Pharmaceuticals employees (H.B.K., C.F.B.) provided all ASOs used in this study and played a role in the decision to publish and revision of the manuscript, as described in the author contributions. Ionis Pharmaceuticals did not have any additional role in the study design or data collection and analysis.	[Anonymous], 2021, LANG ENV STAT COMP; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Bragg RM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41570; Brito V, 2014, J CLIN INVEST, V124, P4411, DOI 10.1172/JCI74809; Busse ME, 2008, J NEUROL, V255, P1534, DOI 10.1007/s00415-008-0964-x; Carroll JB, 2015, LANCET NEUROL, V14, P1135, DOI 10.1016/S1474-4422(15)00177-5; Chiang MC, 2007, HUM MOL GENET, V16, P483, DOI 10.1093/hmg/ddl481; Cortes CJ, 2014, NEURON, V82, P295, DOI 10.1016/j.neuron.2014.03.001; COSSUM PA, 1993, J PHARMACOL EXP THER, V267, P1181; Felipo V, 2013, NAT REV NEUROSCI, V14, P851, DOI 10.1038/nrn3587; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Holter SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080923; Hoffmann R, 2014, MOVEMENT DISORD, V29, P831, DOI 10.1002/mds.25862; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Konietschke F, 2014, CONTEMP MATH, V622, P109, DOI 10.1090/conm/622/12431; Kwan W, 2012, J NEUROSCI, V32, P133, DOI 10.1523/JNEUROSCI.4846-11.2012; Langfelder P, 2016, NAT NEUROSCI, V19, P623, DOI 10.1038/nn.4256; Ma L, 2003, GLIA, V43, P274, DOI 10.1002/glia.10261; Macdonald D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096854; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1997, NAT GENET, V15, P197, DOI 10.1038/ng0297-197; Miller BR, 2010, FUTUR NEUROL, V5, P735, DOI 10.2217/FNL.10.41; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Noldus LPJJ, 2001, BEHAV RES METH INS C, V33, P398, DOI 10.3758/BF03195394; Oakeshott S, 2012, PLOS CURR, V4, DOI [10.1371/4f972cffe82c0, DOI 10.1371/4F972CFFE82C0]; Patassini S, 2015, BIOCHEM BIOPH RES CO, V468, P161, DOI 10.1016/j.bbrc.2015.10.140; Paulsen JS, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00078; Pavese N, 2006, NEUROLOGY, V66, P1638, DOI 10.1212/01.wnl.0000222734.56412.17; RIESS O, 1993, HUM MOL GENET, V2, P637, DOI 10.1093/hmg/2.6.637; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rosas HD, 2003, NEUROLOGY, V60, P1615, DOI 10.1212/01.WNL.0000065888.88988.6E; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Southwell AL, 2013, HUM MOL GENET, V22, P18, DOI 10.1093/hmg/dds397; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Stuwe SH, 2013, NEUROLOGY, V80, P743, DOI 10.1212/WNL.0b013e318282514e; Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7; Tai YF, 2007, BRAIN, V130, P1759, DOI 10.1093/brain/awm044; Thompson JC, 2002, J NEUROPSYCH CLIN N, V14, P37, DOI 10.1176/appi.neuropsych.14.1.37; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; Van Raamsdonk JM, 2006, HUM MOL GENET, V15, P1513, DOI 10.1093/hmg/ddl072; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wang GH, 2016, P NATL ACAD SCI USA, V113, P3359, DOI 10.1073/pnas.1524575113; Westfall PH, 2011, J BIOPHARM STAT, V21, P1187, DOI 10.1080/10543406.2011.607751; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Yhnell E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164072	50	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0175968	10.1371/journal.pone.0175968	http://dx.doi.org/10.1371/journal.pone.0175968			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453524	gold, Green Submitted, Green Published			2022-12-26	WOS:000400383900009
J	Sato, M; Kawana, K; Adachi, K; Fujimoto, A; Yoshida, M; Nakamura, H; Nishida, H; Inoue, T; Taguchi, A; Ogishima, J; Eguchi, S; Yamashita, A; Tomio, K; Wada-Hirake, O; Oda, K; Nagamatsu, T; Osuga, Y; Fujii, T				Sato, Masakazu; Kawana, Kei; Adachi, Katsuyuki; Fujimoto, Asaha; Yoshida, Mitsuyo; Nakamura, Hiroe; Nishida, Haruka; Inoue, Tomoko; Taguchi, Ayumi; Ogishima, Juri; Eguchi, Satoko; Yamashita, Aki; Tomio, Kensuke; Wada-Hirake, Osamu; Oda, Katsutoshi; Nagamatsu, Takeshi; Osuga, Yutaka; Fujii, Tomoyuki			Intracellular signaling entropy can be a biomarker for predicting the development of cervical intraepithelial neoplasia	PLOS ONE			English	Article							STEM-CELLS; CANCER; INTEGRATION; LANDSCAPE; RECEPTOR	While the mortality rates for cervical cancer have been drastically reduced after the introduction of the Pap smear test, it still is one of the leading causes of death in women worldwide. Additionally, studies that appropriately evaluate the risk of developing cervical lesions are needed. Therefore, we investigated whether intracellular signaling entropy, which is measured with microarray data, could be useful for predicting the risks of developing cervical lesions. We used three datasets, GSE63514 (histology), GSE27678 (cytology) and GSE75132 (cytology, a prospective study). From the data in GSE63514, the entropy rate was significantly increased with disease progression (normal < cervical intraepithelial neoplasia, CIN < cancer) (Kruskal-Wallis test, p < 0.0001). From the data in GSE27678, similar results (normal < low-grade squamous intraepithelial lesions, LSILs < high-grade squamous intraepithelial lesions, HSILs <= cancer) were obtained (Kruskal-Wallis test, p < 0.001). From the data in GSE75132, the entropy rate tended to be higher in the HPV-persistent groups than the HPV-negative group. The group that was destined to progress to CIN 3 or higher had a tendency to have a higher entropy rate than the HPV16-positive without progression group. In conclusion, signaling entropy was suggested to be different for different lesion statuses and could be a useful biomarker for predicting the development of cervical intraepithelial neoplasia.	[Sato, Masakazu; Kawana, Kei; Adachi, Katsuyuki; Fujimoto, Asaha; Yoshida, Mitsuyo; Nakamura, Hiroe; Nishida, Haruka; Inoue, Tomoko; Taguchi, Ayumi; Ogishima, Juri; Eguchi, Satoko; Yamashita, Aki; Tomio, Kensuke; Wada-Hirake, Osamu; Oda, Katsutoshi; Nagamatsu, Takeshi; Osuga, Yutaka; Fujii, Tomoyuki] Univ Tokyo, Grad Sch Med, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo, Japan; [Kawana, Kei] Nihon Univ, Sch Med, Dept Obstet & Gynecol, Itabashi Ku, Tokyo, Japan	University of Tokyo; Nihon University	Kawana, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo, Japan.; Kawana, K (corresponding author), Nihon Univ, Sch Med, Dept Obstet & Gynecol, Itabashi Ku, Tokyo, Japan.	kkawana-tky@umin.org	Nagamatsu, Takeshi/AAH-1402-2019; Nagamatsu, Takeshi/AAC-5201-2021; Sato, Masakazu/AAE-6336-2021	Nagamatsu, Takeshi/0000-0003-1480-5785; Wada-Hiraike, Osamu/0000-0002-3458-6711	Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development, AMED [15ck0106178h0001]; Grants-in-Aid for Scientific Research [16K19268] Funding Source: KAKEN	Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Support was provided by the Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development, AMED No. 15ck0106178h0001 (KK) [http://www.amed.go.jp]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerji CRS, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004115; Banerji CRS, 2013, SCI REP-UK, V3, DOI 10.1038/srep03039; Botting SK, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-66; Cook DA, 2017, J CLIN VIROL, V87, P23, DOI 10.1016/j.jcv.2016.12.004; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Demetrius L, 2005, PHYSICA A, V346, P682, DOI 10.1016/j.physa.2004.07.011; den Boon JA, 2015, P NATL ACAD SCI USA, V112, pE3255, DOI 10.1073/pnas.1509322112; El-Nashar SA, 2016, J LOWER GENITAL TRAC; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Greaves M, 2010, SEMIN CANCER BIOL, V20, P65, DOI 10.1016/j.semcancer.2010.03.002; Jacqueline Lopez V-M FJ, 2013, REPROD BIOL ENDOCRIN, V11; Kindinger LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163793; Klonisch T, 2008, TRENDS MOL MED, V14, P450, DOI 10.1016/j.molmed.2008.08.003; Kulmala SMA, 2006, J CLIN PATHOL, V59, P513, DOI 10.1136/jcp.2004.024570; Li Y., 2016, BRIEFINGS BIOINFORMA; Manawapat-Klopfer, 2016, AM J CANC RES, V6; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Newton PK, 2014, SCI REP-UK, V4, DOI 10.1038/srep07558; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Skibinski A, 2015, ONCOGENE, V34, P5309, DOI 10.1038/onc.2014.475; Teschendorff AE, 2014, METHODS, V67, P282, DOI 10.1016/j.ymeth.2014.03.013; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Williams VM, 2011, FUTURE VIROL, V6, P45, DOI 10.2217/FVL.10.73; Winder DM, 2011, J PATHOL, V225, P448, DOI 10.1002/path.2968; Zeki SS, 2011, NAT REV GASTRO HEPAT, V8, P90, DOI 10.1038/nrgastro.2010.211	25	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176353	10.1371/journal.pone.0176353	http://dx.doi.org/10.1371/journal.pone.0176353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453530	gold, Green Published, Green Submitted			2022-12-26	WOS:000400383900021
J	Kaisers, W; Boukamp, P; Stark, HJ; Schwender, H; Tigges, J; Krutmann, J; Schaal, H				Kaisers, Wolfgang; Boukamp, Petra; Stark, Hans-Juergen; Schwender, Holger; Tigges, Julia; Krutmann, Jean; Schaal, Heiner			Age, gender and UV-exposition related effects on gene expression in in vivo aged short term cultivated human dermal fibroblasts	PLOS ONE			English	Article							HUMAN SKIN FIBROBLASTS; HUMAN PERIPHERAL-BLOOD; TISSUE GROWTH-FACTOR; RNA-SEQ; CELLULAR SENESCENCE; MATRIX METALLOPROTEINASE-1; ULTRAVIOLET-IRRADIATION; TUMOR SUPPRESSION; AGING RESEARCH; II RECEPTOR	Ageing, the progressive functional decline of virtually all tissues, affects numerous living organisms. Main phenotypic alterations of human skin during the ageing process include reduced skin thickness and elasticity which are related to extracellular matrix proteins. Dermal fibroblasts, the main source of extracellular fibrillar proteins, exhibit complex alterations during in vivo ageing and any of these are likely to be accompanied or caused by changes in gene expression. We investigated gene expression of short term cultivated in vivo aged human dermal fibroblasts using RNA-seq. Therefore, fibroblast samples derived from unaffected skin were obtained from 30 human donors. The donors were grouped by gender and age 9Young: 19 to 25 years, Middle: 36 to 45 years, Old: 60 to 66 years). Two samples were taken from each donor, one from a sun-exposed and one from a sun-unexposed site. In our data, no consistently changed gene expression associated with donor age can be asserted. Instead, highly correlated expression of a small number of genes associated with transforming growth factor beta signalling was observed. Also, known gene expression alterations of in vivo aged dermal fibroblasts seem to be non-detectable in cultured fibroblasts.	[Kaisers, Wolfgang; Schwender, Holger] Heinrich Heine Univ Dusseldorf, BMFZ, Ctr Bioinformat & Biostat, Dusseldorf, Germany; [Schwender, Holger] Heinrich Heine Univ Dusseldorf, Math Inst, Dusseldorf, Germany; [Schaal, Heiner] Heinrich Heine Univ Dusseldorf, Inst Virol, Dusseldorf, Germany; [Boukamp, Petra; Tigges, Julia; Krutmann, Jean] IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany; [Boukamp, Petra; Stark, Hans-Juergen] German Canc Res Ctr, Heidelberg, Germany; [Krutmann, Jean] Heinrich Heine Univ Dusseldorf, Med Fac, Dusseldorf, Germany; [Kaisers, Wolfgang] Heinrich Heine Univ Dusseldorf, Dept Anaesthesiol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF); Helmholtz Association; German Cancer Research Center (DKFZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Kaisers, W (corresponding author), Heinrich Heine Univ Dusseldorf, BMFZ, Ctr Bioinformat & Biostat, Dusseldorf, Germany.; Kaisers, W (corresponding author), Heinrich Heine Univ Dusseldorf, Dept Anaesthesiol, Dusseldorf, Germany.	kaisers@med.uni-duesseldorf.de	Schaal, Heiner/A-5115-2008		Deutsche Forschungsgemeinschaft [SCHW 1508/3-1]; Ministerium fur Wissenschaft, Forschung und Kultur (DE) [Network Gerontosys, Stromal Aging WP3, PartC, Stromal Aging]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministerium fur Wissenschaft, Forschung und Kultur (DE)	This work was supported by Deutsche Forschungsgemeinschaft, Award Number: SCHW 1508/3-1, Grant Recipient: Holger Schwender; Ministerium fur Wissenschaft, Forschung und Kultur (DE), Award Number: Network Gerontosys, Stromal Aging WP3, PartC, Grant Recipient: Heiner Schaal; Ministerium fur Wissenschaft, Forschung und Kultur (DE), Award Number: Network Gerontosys, Stromal Aging, Grant Recipient: Jean Krutmann; and Ministerium fur Wissenschaft, Forschung und Kultur (DE), Award Number: Network Gerontosys, Stromal Aging, Grant Recipient: Petra Boukamp.	Barzilai N, 2012, NAT REV GENET, V13, P589, DOI 10.1038/nrg3290; Battie C, 2014, EXP DERMATOL, V23, P7, DOI 10.1111/exd.12388; Brun C, 2016, EXP DERMATOL, V25, P113, DOI 10.1111/exd.12874; Campisi J, 2005, MECH AGEING DEV, V126, P51, DOI 10.1016/j.mad.2004.09.024; Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000; Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; Deelen J, 2013, BIOESSAYS, V35, P386, DOI 10.1002/bies.201200148; Dekker P, 2012, MECH AGEING DEV, V133, P498, DOI 10.1016/j.mad.2012.06.002; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DUMAS M, 1994, MECH AGEING DEV, V73, P179, DOI 10.1016/0047-6374(94)90050-7; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Eckes B, 2006, J INVEST DERM SYMP P, V11, P66, DOI 10.1038/sj.jidsymp.5650003; Edfors F, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20167144; Fisher GJ, 2016, AGING CELL, V15, P67, DOI 10.1111/acel.12410; Fisher GJ, 2009, AM J PATHOL, V174, P101, DOI 10.2353/ajpath.2009.080599; Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462; Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003; Fligiel SEG, 2003, J INVEST DERMATOL, V120, P842, DOI 10.1046/j.1523-1747.2003.12148.x; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Glass D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r75; Guberman JM, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar041; Han ES, 2001, MECH AGEING DEV, V122, P999, DOI 10.1016/S0047-6374(01)00215-9; He TY, 2014, AGE, V36, P1079, DOI 10.1007/s11357-014-9623-6; Holick MF, 2016, ANTICANCER RES, V36, P1345; Hornsby PJ, 2010, PFLUG ARCH EUR J PHY, V459, P291, DOI 10.1007/s00424-009-0723-6; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Jansen R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-33; Kaisers W, 2016, REFGENOME GENE SPLIC; Kaisers W., 2012, SPLICESITES BIOCONDU; Kaisers W, 2016, RBAMTOOLS READ WRITE; Kaisers W, ARXIV14050114; Kaisers W, 2015, BIOINFORMATICS, V31, P1663, DOI 10.1093/bioinformatics/btu846; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Kirkwood TBL, 2011, CURR BIOL, V21, pR701, DOI 10.1016/j.cub.2011.07.020; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Macias MJ, 2015, TRENDS BIOCHEM SCI, V40, P296, DOI 10.1016/j.tibs.2015.03.012; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Mine S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004066; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Passtoors WM, 2008, J INTERN MED, V263, P153, DOI 10.1111/j.1365-2796.2007.01904.x; Peters MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9570; Pittayapruek P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060868; Purohit T, 2016, J DERMATOL SCI, V83, P80, DOI 10.1016/j.jdermsci.2016.04.004; Quan TH, 2010, J INVEST DERMATOL, V130, P415, DOI 10.1038/jid.2009.224; Quan TH, 2005, J BIOL CHEM, V280, P8079, DOI 10.1074/jbc.M409647200; Quan TH, 2002, J INVEST DERMATOL, V118, P402, DOI 10.1046/j.0022-202x.2001.01678.x; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schurch NJ, 2016, RNA, V22, P839, DOI 10.1261/rna.053959.115; Tigges J, 2013, J INVEST DERMATOL, V133, P87, DOI 10.1038/jid.2012.259; Tobin D.J., 2016, J TISSUE VIABILITY; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valdes AM, 2013, NAT REV GENET, V14, P601, DOI 10.1038/nrg3553; Varani J, 2006, AM J PATHOL, V168, P1861, DOI 10.2353/ajpath.2006.051302; Yang JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep15145; Zeng Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep21243; Zhang YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023506	65	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0175657	10.1371/journal.pone.0175657	http://dx.doi.org/10.1371/journal.pone.0175657			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475575	Green Published, gold			2022-12-26	WOS:000400649500004
J	Cavalleri, T; Angelici, L; Favero, C; Dioni, L; Mensi, C; Bareggi, C; Palleschi, A; Rimessi, A; Consonni, D; Bordini, L; Todaro, A; Bollati, V; Pesatori, AC				Cavalleri, Tommaso; Angelici, Laura; Favero, Chiara; Dioni, Laura; Mensi, Carolina; Bareggi, Claudia; Palleschi, Alessandro; Rimessi, Arianna; Consonni, Dario; Bordini, Lorenzo; Todaro, Aldo; Bollati, Valentina; Pesatori, Angela Cecilia			Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease	PLOS ONE			English	Article							TARGETS; EXPRESSION; EPIDEMIC; CELLS	Background Malignant Pleural Mesothelioma (MPM) is an aggressive cancer mainly caused by asbestos exposure and refractory to current therapies. Specific diagnostic markers for early MPM diagnosis are needed. Changes in miRNA expression have been implicated in several diseases and cancers, including MPM. We examined if a specific miRNA signature in plasmatic extracellular vesicles (EV) may help to discriminate between malignant pleural mesothelioma patients (MPM) and subjects with Past Asbestos Exposure (PAE). Methodology/Principal findings We investigated 23 MPM patients and 19 cancer-free subjects with past asbestos exposure (PAE). We screened 754 miRNAs in plasmatic EVs by OpenArray and found 55 differential miRNAs using logistic regression models adjusted for age, sex, BMI, and smoking. Among the top-20 differential miRNAs chosen for validation by Real time PCR, 16 were confirmed. Using receiver operating characteristic (ROC) curve analysis, the most discriminating miRNA combination was given by miR-103a-3p + miR-30e-3p, which generated an AUC of 0.942 (95% CI 0.87-1.00), with a sensitivity of 95.5% and a specificity of 80.0%. Using multi-variate Cox regression analysis including gender, age, BMI and smoking we found a Hazard Ratio for miR-103a-3p above the median of 0.37 (95% CI 0.13-1.13) and of 0.51 (95% CI 0.17-1.52) for miR-30e-3p. Conclusions This study suggests EV-associated miR-103a-3p and miR-30e-3p are able to discriminate MPM from PAE subjects. Larger and prospective studies are needed to confirm these two-miRNA signature alone or in combination with other biomarkers as diagnostic tools for MPM.	[Cavalleri, Tommaso] Humanitas Clin & Res Ctr, Dept Gastroenterol, Via Manzoni 56, Rozzano, Milan, Italy; [Angelici, Laura; Favero, Chiara; Dioni, Laura; Bollati, Valentina; Pesatori, Angela Cecilia] Univ Milan, Dept Clin Sci & Community Hlth, EPIGET, Epidemiol Epigenet & Toxicol Lab, Via San Barnaba 8, Milan, Italy; Ca Granda Osped Maggiore Policlin, Milan, Italy	IRCCS Humanitas Research Hospital; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico	Pesatori, AC (corresponding author), Univ Milan, Dept Clin Sci & Community Hlth, EPIGET, Epidemiol Epigenet & Toxicol Lab, Via San Barnaba 8, Milan, Italy.	angela.pesatori@unimi.it	Palleschi, Alessandro/J-6416-2015; Angelici, Laura/AAC-2633-2019; rimessi, alessandro/O-3335-2019; Consonni, Dario/AAM-2947-2020; Mensi, Carolina/J-9774-2014; Rimessi, Alessandro/K-5420-2016	Palleschi, Alessandro/0000-0003-4510-5167; rimessi, alessandro/0000-0001-7091-5765; Consonni, Dario/0000-0002-8935-3843; Mensi, Carolina/0000-0002-9075-3684; Rimessi, Alessandro/0000-0001-7091-5765; Cavalleri, Tommaso/0000-0002-8606-7382; Angelici, Laura/0000-0003-3731-1606	Associazione Italiana per la Ricerca sul Cancro (AIRC) [17692]	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This study was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC: http://www.airc.it/) Investigator Grant 2015, number 17692.	Babar IA, 2008, FUTURE ONCOL, V4, P289, DOI 10.2217/14796694.4.2.289; Baccarelli A, 2009, CURR OPIN PEDIATR, V21, P243, DOI 10.1097/MOP.0b013e32832925cc; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Busacca S, 2010, AM J RESP CELL MOL, V42, P312, DOI 10.1165/rcmb.2009-0060OC; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Kim Young-Kook, 2015, Chonnam Med J, V51, P51, DOI 10.4068/cmj.2015.51.2.51; Kirschner MB, 2012, J THORAC ONCOL, V7, P1184, DOI 10.1097/JTO.0b013e3182572e83; Lamberti M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135331; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marinaccio A, 2012, INT J CANCER, V130, P2146, DOI 10.1002/ijc.26229; MCDONALD JC, 1985, ENVIRON HEALTH PERSP, V62, P319, DOI 10.2307/3430132; Mensi C, 2016, OCCUPATIONAL ENV MED; Micolucci L, 2016, ONCOTARGET; Pass Harvey I, 2004, Curr Probl Cancer, V28, P93, DOI 10.1016/j.currproblcancer.2004.04.001; Peto J, 1999, BRIT J CANCER, V79, P666, DOI 10.1038/sj.bjc.6690105; Reid G, 2015, J THORAC DIS, V7, P1031, DOI 10.3978/j.issn.2072-1439.2015.04.56; Santarelli L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018232; Tomasetti M, 2012, CLIN BIOCHEM, V45, P575, DOI 10.1016/j.clinbiochem.2012.02.009; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Truini A, 2014, CELL MOL LIFE SCI, V71, P2865, DOI 10.1007/s00018-014-1584-5; Vigneri P, 2015, FUTURE ONCOL, V11, P29, DOI 10.2217/fon.15.317; Weber DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114483; Weber DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030221; Wu FT, 2009, CLIN CANCER RES, V15, P1550, DOI 10.1158/1078-0432.CCR-08-0820; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yang Q, 2016, J CLIN EPIGENETICS, V2; Zhou HL, 2014, RNA, V20, P1431, DOI 10.1261/rna.045757.114	28	44	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176680	10.1371/journal.pone.0176680	http://dx.doi.org/10.1371/journal.pone.0176680			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472171	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500062
J	Michelotto, MD; de Godoy, IJ; Pirotta, MZ; dos Santos, JF; Finoto, EL; Favero, AP				Michelotto, Marcos Doniseti; de Godoy, Ignacio Jose; Pirotta, Melina Zacarelli; dos Santos, Joao Francisco; Finoto, Everton Luiz; Favero, Alessandra Pereira			Resistance to thrips (Enneothrips flavens) in wild and amphidiploid Arachis species	PLOS ONE			English	Article							LATE LEAF-SPOT; CULTIVATED PEANUT; GROWING HABIT; MOULTON	Thrips (Enneothrips flavens) is a pest that causes severe damage and yield losses to peanut crop if not properly controlled. The main control method currently used by farmers is biweekly application of insecticides during crop development, which, in addition to its toxicity, is very costly. Thus, new sources of resistance must be identified in order to reduce the use of insecticides and effectively manage the pest. This study aimed to evaluate the occurrence and symptoms of E. flavens infestations in 12 accessions of 10 wild species of Arachis and nine amphidiploids, as well as to compare their morphoagronomic characteristics to those of commercial cultivars. To this end, we conducted experiments during two summer seasons, using a randomized block design with four replications. We conducted evaluations of the severity of infestation, noting visual symptoms of E. flavens and morphological and reproductive characteristics of the Arachis plants. Results indicated that wild accessions V 7635 (A. vallsii), V 13250 (A. kempff-mercadoi), K 9484 (A. batizocoi), Wi 1118 (A. williamsii), V 14167 (A. duranensis) and V 13751 (A. magna) are the most promising for obtaining useful new amphidiploids. Among the amphidiploids, An 12 (A. batizocoi x A. kempff-mercadoi)(4x), An 9 (A. gregoryi x A. stenosperma)(4x), and An 8 (A. magna x A. cardenasii)(4x) showed high level of resistance to E. flavens. The identified thrips resistant wild and amphidiploid Arachis species may be used in future breeding program to produce thrips resistant peanut cultivars.	[Michelotto, Marcos Doniseti; Finoto, Everton Luiz] Sao Paulo Agcy Agribusiness Technol APTA, Polo Ctr Norte, Sao Paulo, Brazil; [de Godoy, Ignacio Jose; dos Santos, Joao Francisco] Agron Inst IAC, Sao Paulo, Brazil; [Pirotta, Melina Zacarelli] Univ Estadual Paulista Julio Mesquite Filho FCAV, Fac Ciencias Agr & Vet, Sao Paulo, Brazil; [Favero, Alessandra Pereira] Embrapa Pecuaria Sudeste, Sao Carlos, SP, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Favero, AP (corresponding author), Embrapa Pecuaria Sudeste, Sao Carlos, SP, Brazil.	alessandra.favero@embrapa.br	Michelotto, Marcos Doniseti/AAY-6542-2020; Fávero, Alessandra P/I-3557-2012	Michelotto, Marcos Doniseti/0000-0002-2381-2090; Favero, Alessandra/0000-0001-9461-1539	Embrapa [0211080060000]; National Council for Scientific and Technological Development (CNPq) [480921/2013-0, 471657/2011-5]; Sao Paulo Agency for Agribusiness Technology (APTA); Fundacao de Apoio a Pesquisa Agricola (Fundag); Brazilian Agricultural Research Corporation (Embrapa)	Embrapa(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Agency for Agribusiness Technology (APTA); Fundacao de Apoio a Pesquisa Agricola (Fundag); Brazilian Agricultural Research Corporation (Embrapa)(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA))	This study was funded by Embrapa (grant number 0211080060000), National Council for Scientific and Technological Development (CNPq) (grant numbers 480921/2013-0 and 471657/2011-5) Sao Paulo Agency for Agribusiness Technology (APTA) and Fundacao de Apoio a Pesquisa Agricola (Fundag).; The authors thank Sao Paulo Agency for Agribusiness Technology (APTA), National Council for Scientific and Technological Development (CNPq), Fundacao de Apoio a Pesquisa Agricola (Fundag) and Brazilian Agricultural Research Corporation (Embrapa) for their financial support.	Boiça Junior A.L., 2012, Arq. Inst. Biol., V79, P33; Chagas Filho N.R., 2008, Arq. Inst. Biol., V75, P149, DOI 10.1590/1808-1657v75p1492008; COMPANY M, 1982, EUPHYTICA, V31, P885, DOI 10.1007/BF00039228; de Moraes ARA, 2005, SCI AGR, V62, P469, DOI 10.1590/S0103-90162005000500010; Favero AP, 2006, CROP SCI, V46, P1546, DOI 10.2135/cropsci2005.09-0331; Favero AP, 2009, SCI AGR, V66, P110, DOI 10.1590/S0103-90162009000100015; Gabriel Dalva, 1996, Bragantia, V55, P253, DOI 10.1590/S0006-87051996000200007; Gallo D, 2002, ENTOMOLOGIA AGR COLA; Holbrook CC, 2014, CSSA SPEC PUBL, V33, P173, DOI 10.2135/cssaspecpub33.c7; Janini Julio Cesar, 2010, Bragantia, V69, P891, DOI 10.1590/S0006-87052010000400015; Lourenção André Luiz, 2007, Bragantia, V66, P623, DOI 10.1590/S0006-87052007000400013; Mallikarjuna N, 2012, EUR J PLANT PATHOL, V132, P17, DOI 10.1007/s10658-011-9859-2; Michelotto MD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128811; Michelotto MD, 2013, BIOSCI J, V29, P115; Michereff Filho M, 2012, 108 MIN RIO AGR PEC; Moraes ARA, 2005, THESIS; Pereira JCVNA, 1999, PESQUISA AGROPECUARI, V34, P1183; Santos J.F., 2013, BIOSCI J, V29, P280, DOI DOI 10.1590/S0006-87052011005000001; SAS Institute Inc. Cary NC USA, 2002, SOFTW 9 3; Sharma HC, 2003, J ECON ENTOMOL, V96, P1886, DOI 10.1603/0022-0493-96.6.1886; Simpson C. E., 1991, Peanut Science, V18, P22, DOI 10.3146/i0095-3679-18-1-8; STALKER HT, 1987, ADV AGRON, V41, P1, DOI 10.1016/S0065-2113(08)60801-9	22	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176811	10.1371/journal.pone.0176811	http://dx.doi.org/10.1371/journal.pone.0176811			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472187	Green Submitted, Green Published, gold			2022-12-26	WOS:000400648500076
J	Typiak, M; Rebala, K; Haras, A; Skotarczak, M; Slominski, JM; Dubaniewicz, A				Typiak, Marlene; Rebala, Krzysztof; Haras, Agnieszka; Skotarczak, Monika; Slominski, Jan Marek; Dubaniewicz, Anna			Copy number variation of FCGR genes in etiopathogenesis of sarcoidosis	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ASSOCIATION; GAMMA; SUSCEPTIBILITY; POLYMORPHISM; AUTOIMMUNITY; PREDISPOSES; RECEPTORS; DISEASE	We have previously revealed that, in contrast to polymorphism of FCGR2B and FCGR3B, polymorphism of FCGR2A, FCGR2C and FCGR3A genes, encoding receptors for Fc fragment of immunoglobulin G (Fc gamma receptors), play a role in increased level of circulating immune complexes with occurrence of Mycobacterium tuberculosis heat shock proteins in patients with sarcoidosis. However, this immunocomplexemia might also be caused by decreased clearance by immune cells due to a changed copy number of FCGR genes. Thus, the next step of our study was to evaluate copy number variation of FCGR2A, FCGR2B, FCGR2C, FCGR3A and FCGR3B in this disease. The analysis was carried out by real-time quantitative PCR on 104 patients and 110 healthy volunteers. Despite previously detected variation in allele/genotype frequencies of FCGR in sarcoidosis and its particular stages, there was no copy number variation of the tested genes between sarcoidosis or its stages and healthy control, as well as between stages themselves. A relevant increase in copy number of FCGR2C and FCGR3B in Stage IV of sarcoidosis vs. other stages and controls was detected, but this observation was based on a limited number of Stage IV patients. Hence, polymorphism of FCGR genes seems to be more important than their copy number variation in etiopathogenesis of sarcoidosis in patients from the Polish population.	[Typiak, Marlene; Slominski, Jan Marek; Dubaniewicz, Anna] Med Univ Gdansk, Dept Pulmonol, Gdansk, Poland; [Rebala, Krzysztof; Haras, Agnieszka] Med Univ Gdansk, Dept Forens Med, Gdansk, Poland; [Skotarczak, Monika] Med Univ Gdansk, Dept Radiol 2, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Dubaniewicz, A (corresponding author), Med Univ Gdansk, Dept Pulmonol, Gdansk, Poland.	aduban@gumed.edu.pl	Typiak, Marlena/ABG-9726-2020; Rębała, Krzysztof/U-9856-2018; Dubaniewicz, Anna/Q-9523-2018; Haraś, Agnieszka/R-4357-2018; Słomiński, Jan Marek/U-5035-2018	Rębała, Krzysztof/0000-0003-2236-7455; Dubaniewicz, Anna/0000-0002-0557-2345; Haraś, Agnieszka/0000-0003-1012-339X; Słomiński, Jan Marek/0000-0003-2284-0740; Typiak, Marlena/0000-0002-9687-1016	Ministry of Science and Higher Education; National Science Centre in Poland; Medical University of Gdansk [5160/B/P01/2010/39, ST-02-0127/07/232]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Centre in Poland(National Science Centre, Poland); Medical University of Gdansk(Medical University Gdansk)	The study was funded by the Ministry of Science and Higher Education and the National Science Centre in Poland, and Medical University of Gdansk (grants number 5160/B/P01/2010/39 and ST-02-0127/07/232). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Asano K, 2013, INFLAMM BOWEL DIS, V19, P2061, DOI 10.1097/MIB.0b013e318298118e; Baughman RP, 2011, AM J RESP CRIT CARE, V183, P573, DOI 10.1164/rccm.201006-0865CI; Bournazos S, 2009, CLIN EXP IMMUNOL, V157, P244, DOI 10.1111/j.1365-2249.2009.03980.x; Breunis WB, 2009, HUM MUTAT, V30, pE640, DOI 10.1002/humu.20997; Breunis WB, 2008, BLOOD, V111, P1029, DOI 10.1182/blood-2007-03-079913; Chen JY, 2014, ARTHRITIS RHEUMATOL, V66, P3113, DOI 10.1002/art.38813; Chen K, 2012, BLOOD, V120, P4421, DOI 10.1182/blood-2011-12-401133; Dubaniewicz A, 2006, TUBERCULOSIS, V86, P60, DOI 10.1016/j.tube.2005.09.004; Dubaniewicz A, 2013, HUM IMMUNOL, V74, P1550, DOI 10.1016/j.humimm.2013.08.275; Dubaniewicz A, 2013, HUM IMMUNOL, V74, P45, DOI 10.1016/j.humimm.2012.10.007; Dubaniewicz A, 2012, HUM IMMUNOL, V73, P788, DOI 10.1016/j.humimm.2012.05.005; Dubaniewicz A, 2010, AUTOIMMUN REV, V9, P419, DOI 10.1016/j.autrev.2009.11.015; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Haldorsen K, 2013, GENES IMMUN, V14, P234, DOI 10.1038/gene.2013.12; Hunninghake GW, 1999, AM J RESP CRIT CARE, V160, P736; Kivity S, 2009, TRENDS IMMUNOL, V30, P409, DOI 10.1016/j.it.2009.05.005; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; Li X, 2009, GENES IMMUN, V10, P380, DOI 10.1038/gene.2009.35; Li XR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007097; Makowsky R, 2013, PHARMACOGENET GENOM, V23, P455, DOI 10.1097/FPC.0b013e328363686e; Mamtani M, 2010, GENES IMMUN, V11, P155, DOI 10.1038/gene.2009.71; McKinney C, 2012, HUM MOL GENET, V21, P2370, DOI 10.1093/hmg/dds039; Nagelkerke SQ, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00674; Niederer HA, 2010, HUM MOL GENET, V19, P3282, DOI 10.1093/hmg/ddq216; Olsson LM, 2012, EUR J IMMUNOL, V42, P1969, DOI 10.1002/eji.201242601; Robinson JI, 2012, HUM MUTAT, V33, P741, DOI 10.1002/humu.22031; SCADDING JG, 1961, BRIT MED J, V2, P1165, DOI 10.1136/bmj.2.5261.1165; Schaschl H, 2009, CLIN EXP IMMUNOL, V156, P12, DOI 10.1111/j.1365-2249.2008.03865.x; Typiak M, 2016, ADV EXP MED BIOL, V905, P57, DOI 10.1007/5584_2015_193; Typiak MJ, 2014, HUM IMMUNOL, V75, P283, DOI 10.1016/j.humimm.2014.02.011; Willcocks LC, 2008, J EXP MED, V205, P1573, DOI 10.1084/jem.20072413; Wu YM, 2014, DERMATOLOGY, V229, P70, DOI 10.1159/000360160; Zhou XJ, 2010, INT IMMUNOL, V22, P45, DOI 10.1093/intimm/dxp113	34	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177194	10.1371/journal.pone.0177194	http://dx.doi.org/10.1371/journal.pone.0177194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472129	gold, Green Published, Green Submitted			2022-12-26	WOS:000400648500151
J	Saarenpaa, T; Kogan, K; Sidorova, Y; Mahato, AK; Tascon, I; Kaljunen, H; Yu, LY; Kaiiijarvi, J; Jurvansuu, J; Saarma, M; Goldman, A				Saarenpaa, Tuulia; Kogan, Konstantin; Sidorova, Yulia; Mahato, Arun Kumar; Tascon, Igor; Kaljunen, Heidi; Yu, Liying; Kaiiijarvi, Jukka; Jurvansuu, Jaana; Saarma, Mart; Goldman, Adrian			Zebrafish GDNF and its co-receptor GFR alpha 1 activate the human RET receptor and promote the survival of dopaminergic neurons in vitro	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; TYROSINE KINASE; TRANSFORMING GENE; BINDING; DOMAIN; EXPRESSION; MECHANISM; COMPLEX; RECOGNITION; ONCOGENE	Glial cell line-derived neurotrophic factor ( GDNF) is a ligand that activates, through coreceptor GDNF family receptor alpha-1 (GFR alpha 1) and receptor tyrosine kinase "RET ", several signaling pathways crucial in the development and sustainment of multiple neuronal populations. We decided to study whether non-mammalian orthologs of these three proteins have conserved their function: can they activate the human counterparts? Using the baculovirus expression system, we expressed and purified Danio rerio RET, and its binding partners GFRa1 and GDNF, and Drosophila melanogaster RET and two isoforms of coreceptor GDNF receptor-like. Our results report high-level insect cell expression of posttranslationally modified and dimerized zebrafish RET and its binding partners. We also found that zebrafish GFRa1 and GDNF are comparably active as mammalian cell- produced ones. We also report the first measurements of the affinity of the complex to RET in solution: at least for zebrafish, the Kd for GFR alpha 1-GDNF binding RET is 5.9 mu M. Surprisingly, we also found that zebrafish GDNF as well as zebrafish GFRa1 robustly activated human RET signaling and promoted the survival of cultured mouse dopaminergic neurons with comparable efficiency to mammalian GDNF, unlike E. coli-produced human proteins. These results contradict previous studies suggesting that mammalian GFRa1 and GDNF cannot bind and activate non-mammalian RET and vice versa.	[Saarenpaa, Tuulia; Kogan, Konstantin; Tascon, Igor; Kaljunen, Heidi; Goldman, Adrian] Univ Helsinki, Dept Biochem, Fac Biol & Environm Sci, Helsinki, Finland; [Sidorova, Yulia; Mahato, Arun Kumar; Yu, Liying; Kaiiijarvi, Jukka; Jurvansuu, Jaana; Saarma, Mart] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Goldman, Adrian] Univ Leeds, Fac Biol Sci, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; [Tascon, Igor] Goethe Univ Frankfurt, Inst Biochem, Frankfurt, Germany; [Kaiiijarvi, Jukka] Univ Helsinki, Folkhalsan Res Ctr, Biomedicum, Helsinki, Finland; [Jurvansuu, Jaana] Univ Oulu, Dept Biol, Oulu, Finland	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Leeds; Goethe University Frankfurt; Folkhalsan Research Center; University of Helsinki; University of Oulu	Goldman, A (corresponding author), Univ Helsinki, Dept Biochem, Fac Biol & Environm Sci, Helsinki, Finland.; Goldman, A (corresponding author), Univ Leeds, Fac Biol Sci, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England.	a.goldman@leeds.ac.uk	Sidorova, Yulia/L-5340-2019; Tascón, Igor/AAA-9466-2019; Jurvansuu, Jaana/AAZ-8835-2020; Kallijarvi, Jukka/AAV-5091-2021	Tascón, Igor/0000-0003-2526-6238; Kallijarvi, Jukka/0000-0003-3773-7025; Kaljunen, Heidi/0000-0002-5962-9503; Kogan, Konstantin/0000-0003-3270-9391; Goldman, Adrian/0000-0001-8032-9700; Jurvansuu, Jaana/0000-0002-7801-3237; Sidorova, Yulia/0000-0001-8230-0530	Academy of Finland [1286429]; Biotechnology and Biological Sciences Research Council [BB/M021610/1]; Sigrid Juselius Foundation; European Union Seventh Framework Programme (FP7) [602919, 612275]; Parkinsons UK Innovation [K-1408]; Finnish Graduate School of Neuroscience/Brain Mind; BBSRC [BB/M021610/1] Funding Source: UKRI; Parkinson&quot;s UK [K-1408] Funding Source: researchfish	Academy of Finland(Academy of Finland); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Sigrid Juselius Foundation(Sigrid Juselius Foundation); European Union Seventh Framework Programme (FP7); Parkinsons UK Innovation; Finnish Graduate School of Neuroscience/Brain Mind; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Parkinson&quot;s UK(Parkinson&apos;s UK)	This study was funded by the Academy of Finland (grant no. 1286429), Biotechnology and Biological Sciences Research Council (grant no. BB/M021610/1) (AG), the Sigrid Juselius Foundation (AG and MS), the European Union Seventh Framework Programme (FP7/20072013) under grant agreements No 602919, 612275, Parkinsons UK Innovation grant K-1408 (MS) and Finnish Graduate School of Neuroscience/Brain & Mind (TS).	Abrescia C, 2005, FEBS LETT, V579, P3789, DOI 10.1016/j.febslet.2005.05.075; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Bieniossek Christoph, 2008, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0520s51; Bisgrove BW, 1997, J NEUROBIOL, V33, P749; Eigenbrot C, 1997, NAT STRUCT BIOL, V4, P435, DOI 10.1038/nsb0697-435; Eketjall S, 1999, EMBO J, V18, P5901, DOI 10.1093/emboj/18.21.5901; FUSCO A, 1987, NATURE, V328, P170, DOI 10.1038/328170a0; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Glerup S, 2013, CELL REP, V3, P186, DOI 10.1016/j.celrep.2012.12.011; Goodman KM, 2014, CELL REP, V8, P1894, DOI 10.1016/j.celrep.2014.08.040; GRIECO D, 1995, ONCOGENE, V11, P113; Haavik J, 1997, J NEUROCHEM, V68, P328; Hahn M, 2001, P NATL ACAD SCI USA, V98, P1053, DOI 10.1073/pnas.021558598; Hayashi Y, 2001, BIOCHEM BIOPH RES CO, V281, P682, DOI 10.1006/bbrc.2001.4338; HOFSTRA RMW, 1994, NATURE, V367, P375, DOI 10.1038/367375a0; Iwashita T, 1996, HUM MOL GENET, V5, P1577, DOI 10.1093/hmg/5.10.1577; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Kallijarvi J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051997; Kaslin J, 2004, J NEUROSCI, V24, P2678, DOI 10.1523/JNEUROSCI.4908-03.2004; Kato M, 2000, ANTIOXID REDOX SIGN, V2, P841, DOI 10.1089/ars.2000.2.4-841; Keinanen K, 1998, BIOCHEM J, V330, P1461, DOI 10.1042/bj3301461; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kjaer S, 2003, J BIOL CHEM, V278, P47898, DOI 10.1074/jbc.M309772200; Kjaer S, 2010, NAT STRUCT MOL BIOL, V17, P726, DOI 10.1038/nsmb.1808; Knowles PP, 2006, J BIOL CHEM, V281, P33577, DOI 10.1074/jbc.M605604200; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Nutt JG, 2003, NEUROLOGY, V60, P69, DOI 10.1212/WNL.60.1.69; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Parkash V, 2008, J BIOL CHEM, V283, P35164, DOI 10.1074/jbc.M802543200; Piccinini E, 2013, ANN MED, V45, P66, DOI 10.3109/07853890.2012.663927; Planken A, 2010, J NEUROSCI METH, V194, P122, DOI 10.1016/j.jneumeth.2010.10.005; Sallinen V, 2009, J NEUROCHEM, V108, P719, DOI 10.1111/j.1471-4159.2008.05793.x; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Schlee S, 2006, NAT CHEM BIOL, V2, P636, DOI 10.1038/nchembio823; Sidorova YA, 2010, MOL CELL NEUROSCI, V44, P223, DOI 10.1016/j.mcn.2010.03.009; Soba P, 2015, ELIFE, V4, DOI 10.7554/eLife.05491; TAKAHASHI M, 1985, CELL, V42, P581, DOI 10.1016/0092-8674(85)90115-1; TAKAHASHI M, 1987, MOL CELL BIOL, V7, P1378, DOI 10.1128/MCB.7.4.1378; TAKAHASHI M, 1988, ONCOGENE, V3, P571; Wang XQ, 2006, STRUCTURE, V14, P1083, DOI 10.1016/j.str.2006.05.010	41	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176166	10.1371/journal.pone.0176166	http://dx.doi.org/10.1371/journal.pone.0176166			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467503	Green Published, gold			2022-12-26	WOS:000400647000042
J	Penrose, B; Beresford, NA; Crout, NMJ; Lovatt, JA; Thomson, R; Broadley, MR				Penrose, Beth; Beresford, Nicholas A.; Crout, Neil M. J.; Lovatt, J. Alan; Thomson, Russell; Broadley, Martin R.			Forage grasses with lower uptake of caesium and strontium could provide 'safer' crops for radiologically contaminated areas	PLOS ONE			English	Article							MINERAL CONCENTRATIONS; GENETIC-VARIABILITY; COUNTERMEASURES; RADIOCESIUM; RADIOSTRONTIUM; POTASSIUM; PLANTS	Substitution of a species or cultivar with higher uptake of an element by one with lower uptake has been proposed as a remediation strategy following accidental releases of radioactivity. However, despite the importance of pasture systems for radiological dose, species/cultivar substitution has not been thoroughly investigated for forage grasses. 397 cultivars from four forage grass species; hybrid ryegrass (Lolium perenne L. x Lolium multiflorum Lam.), perennial ryegrass (Lolium perenne L.), Italian ryegrass (Lolium multiflorum Lam.) and tall fescue (Festuca arundinacea Shreb.); were sampled from 19 field-based breeding experiments in Aberystwyth and Edinburgh (UK) in spring 2013 and analysed for caesium (Cs) and strontium (Sr) concentrations. In order to calculate concentration ratios (CRs; the concentration of an element in a plant in relation to the concentration in the soil), soils from the experiments were also analysed to calculate extractable concentrations of Cs and Sr. To test if cultivars have consistently low Cs and Sr concentration ratios, 17 hybrid ryegrass cultivars were sampled from both sites again in summer 2013 and spring and summer 2014. Tall fescue cultivars had lower Cs and Sr CRs than the other species. Three of the selected 17 hybrid ryegrass cultivars had consistently low Cs CRs, two had consistently low Sr CRs and one had consistently low Cs and Sr CRs. Cultivar substitution could reduce Cs CRs by up to 14-fold and Sr CRs by 4-fold in hybrid ryegrass. The identification of species and cultivars with consistently low CRs suggests that species or cultivar substitution could be an effective remediation strategy for contaminated areas.	[Penrose, Beth; Crout, Neil M. J.; Broadley, Martin R.] Univ Nottingham, Sch Biosci, Loughborough, Leicestershire, England; [Penrose, Beth; Beresford, Nicholas A.] NERC, Ctr Ecol & Hydrol, Lancaster, Lancashire, England; [Lovatt, J. Alan] Aberystwyth Univ, IBERS, Aberystwyth, Ceredigion, Wales; [Thomson, Russell] SASA, Edinburgh, Midlothian, Scotland	University of Nottingham; UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Penrose, B (corresponding author), Univ Tasmania, Sch Land & Food, Tasmanian Inst Agr, Hobart, Tasmania, Australia.	Beth.Penrose@utas.edu.au	broadley, martin r/E-9081-2011; Broadley, Martin/AAW-4638-2021	broadley, martin r/0000-0003-3964-7226; Broadley, Martin/0000-0003-3964-7226; Penrose, Beth/0000-0001-9604-4953	Natural Environment Research Council [NE/K500951/1]; UK Natural Environment Research Council [NE/K500951/1]; Natural Environment Research Council [1197003] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funded by Natural Environment Research Council: http://www.nerc.ac.uk/. NE/K500951/1 received by BP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Scott Young (University of Nottingham) for ICP-MS analyses, Raymond Davies and Dylan Jones (IBERS) for their help harvesting the samples, and Peter Henrys (CEH Lancaster) for his advice on statistical methods. Beth Penrose was supported by a studentship from the UK Natural Environment Research Council (NE/K500951/1).	ALEXAKHIN RM, 1993, SCI TOTAL ENVIRON, V137, P9, DOI 10.1016/0048-9697(93)90374-F; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beresford NA, 2016, J ENVIRON RADIOACTIV, V157, P77, DOI 10.1016/j.jenvrad.2016.02.003; Beresford N. A., 2005, RADIOPROTECTION S1, V40, pS67; Beresford NA, 2000, J ENVIRON RADIOACTIV, V51, P321, DOI 10.1016/S0265-931X(00)00086-2; Beresford NA, 2001, J ENVIRON RADIOACTIV, V56, P215, DOI 10.1016/S0265-931X(01)00055-8; Beresford NA, EURANOS COMPENDIUM C; British Geological Survey, 2015, UKSO SOILS MAP VIEW; Broadley MR, 2012, PLANT SOIL, V355, P23, DOI 10.1007/s11104-012-1163-1; Cougnon M, 2014, GRASS FORAGE SCI, V69, P666, DOI 10.1111/gfs.12102; Ehlken S, 1996, J ENVIRON RADIOACTIV, V33, P147, DOI 10.1016/0265-931X(95)00094-Q; Emmett BA, 2008, 307 CS NAT ENV RES C; Fesenko SV, 2007, SCI TOTAL ENVIRON, V383, P1, DOI 10.1016/j.scitotenv.2007.05.011; HIDES DH, 1981, J SCI FOOD AGR, V32, P990; Howard BJ, 2005, J ENVIRON RADIOACTIV, V83, P275, DOI 10.1016/j.jenvrad.2005.01.013; IAEA, 2012, GUID REM STRAT RED R; IAEA, 2006, ENV CONS CHERN ACC T; International Atomic Energy Agency (IAEA), 2009, QUANT RAD TRANSF TER; Kolosha V., 2008, ATLAS UKRAINE RADIOA; Mayland HF, 1993, P 17 INT GRASSL C, P1095; Minson DJ., 1990, FORAGE RUMINANT NUTR; Moiseev I, 1977, VESTN MOSK U, V3, P105; Molchanova I, 2014, J ENVIRON RADIOACTIV, V138, P238, DOI 10.1016/j.jenvrad.2014.09.004; Nakanishi TM, 2013, AGR IMPLICATIONS FUK, DOI [10.1007/978-4-431-54328-2, DOI 10.1007/978-4-431-54328-2]; NGUYEN HT, 1981, THEOR APPL GENET, V59, P57, DOI 10.1007/BF00275779; Oehlenschlaeger M, 1989, RISOM2831 RIS NAT LA; OHLENSCHLAEGER M, 1991, ACTA AGR SCAND, V41, P321; Ohmori Y, 2014, J PLANT RES, V127, P57, DOI 10.1007/s10265-013-0616-9; Penrose B, 2016, J ENVIRON RADIOACTIV, V155, P112, DOI 10.1016/j.jenvrad.2016.02.020; Penrose B, 2015, J ENVIRON RADIOACTIV, V139, P103, DOI 10.1016/j.jenvrad.2014.10.005; Peverill K, 2001, SOIL ANAL INTERPRETA; PRISTER B, 1992, SCI TOTAL ENVIRON, V112, P79, DOI 10.1016/0048-9697(92)90240-S; R Core Team, 2021, R LANGUAGE ENV STAT; REEDER LR, 1986, CROP SCI, V26, P514, DOI 10.2135/cropsci1986.0011183X002600030016x; Salt CA, 2004, ENVIRON POLLUT, V130, P359, DOI 10.1016/j.envpol.2004.01.001; Shaw G, 2007, RADIOACTIV ENVIRONM, V10, P1; SLEPER DA, 1989, J ANIM SCI, V67, P3456; STUANES AO, 1984, COMMUN SOIL SCI PLAN, V15, P773, DOI 10.1080/00103628409367516; White PJ, 2003, PLANT SOIL, V249, P177, DOI 10.1023/A:1022593307224; Wright SM, 2003, RADIAT ENVIRON BIOPH, V42, P41, DOI 10.1007/s00411-003-0187-6	40	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176040	10.1371/journal.pone.0176040	http://dx.doi.org/10.1371/journal.pone.0176040			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459808	Green Published, gold, Green Accepted			2022-12-26	WOS:000400645000012
J	Uhlmann, V; Ramdya, P; Delgado-Gonzalo, R; Benton, R; Unser, M				Uhlmann, Virginie; Ramdya, Pavan; Delgado-Gonzalo, Ricard; Benton, Richard; Unser, Michael			FlyLimbTracker: An active contour based approach for leg segment tracking in unmarked, freely behaving Drosophila	PLOS ONE			English	Article							SNAKES	Understanding the biological underpinnings of movement and action requires the development of tools for quantitative measurements of animal behavior. Drosophila melanogaster provides an ideal model for developing such tools: the fly has unparalleled genetic accessibility and depends on a relatively compact nervous system to generate sophisticated limbed behaviors including walking, reaching, grooming, courtship, and boxing. Here we describe a method that uses active contours to semi-automatically track body and leg segments from video image sequences of unmarked, freely behaving D. melanogaster. We show that this approach yields a more than 6-fold reduction in user intervention when compared with fully manual annotation and can be used to annotate videos with low spatial or temporal resolution for a variety of locomotor and grooming behaviors. FlyLimbTracker, the software implementation of this method, is open-source and our approach is generalizable. This opens up the possibility of tracking leg movements in other species by modifications of underlying active contour models.	[Uhlmann, Virginie; Unser, Michael] Ecole Polytech Fed Lausanne, Biomed Imaging Grp, Lausanne, Switzerland; [Ramdya, Pavan] Ecole Polytech Fed Lausanne, Inst Microengn, Lausanne, Switzerland; [Ramdya, Pavan] Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, Lausanne, Switzerland; [Ramdya, Pavan] CALTECH, Div Biol & Bioengn, Pasadena, CA 91125 USA; [Delgado-Gonzalo, Ricard] CSEM, Neuchatel, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; California Institute of Technology; Swiss Center for Electronics & Microtechnology (CSEM)	Uhlmann, V (corresponding author), Ecole Polytech Fed Lausanne, Biomed Imaging Grp, Lausanne, Switzerland.; Ramdya, P (corresponding author), Ecole Polytech Fed Lausanne, Inst Microengn, Lausanne, Switzerland.; Ramdya, P (corresponding author), Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, Lausanne, Switzerland.; Ramdya, P (corresponding author), CALTECH, Div Biol & Bioengn, Pasadena, CA 91125 USA.	virginie.uhlmann@epfl.ch; pavan.ramdya@epfl.ch	Delgado-Gonzalo, Ricard/K-9714-2019	Delgado-Gonzalo, Ricard/0000-0002-7183-6257; Unser, Michael/0000-0003-1248-2513; Uhlmann, Virginie/0000-0002-2859-9241	Swiss SystemsX.ch Initiative [2008/005]; Swiss National Science Foundation [200020-121763, 200020-144355, P300P3_158511]; Human Frontier Science Program [LT000057/2009]; European Research Council [205202, 615094]	Swiss SystemsX.ch Initiative; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Human Frontier Science Program(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission)	This work was supported by Swiss SystemsX.ch Initiative, Grant#: 2008/005, http://www.systemsx.ch/, VU, RDG, MU; Swiss National Science Foundation, Grant#: 200020-121763 and 200020-144355, http://www.snf.ch/en/Pages/default.aspx, VU, RDG, MU; Human Frontier Science Program, Grant#: LT000057/2009, http://www.hfsp.org/, PR; Swiss National Science Foundation, Grant#: P300P3_158511, http://www.snf.ch/en/Pages/default.aspx, PR; European Research Council, Grant#: 205202 and 615094, https://erc.europa.eu/, RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013617; Berman GJ, 2016, P NATL ACAD SCI USA, V113, P11943, DOI 10.1073/pnas.1607601113; Berman GJ, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0672; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Brigger P, 2000, IEEE T IMAGE PROCESS, V9, P1484, DOI 10.1109/83.862624; Chenouard N, 2010, IEEE IMAGE PROC, P3657, DOI 10.1109/ICIP.2010.5652479; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; de Chaumont F, 2012, NAT METHODS, V9, P410, DOI [10.1038/NMETH.1924, 10.1038/nmeth.1924]; Delgado-Gonzalo R, 2012, COMPUT AIDED GEOM D, V29, P109, DOI 10.1016/j.cagd.2011.10.005; Delgado-Gonzalo R, 2015, IEEE T IMAGE PROCESS, V24, P3915, DOI 10.1109/TIP.2015.2457335; Delgado-Gonzalo R, 2015, IEEE SIGNAL PROC MAG, V32, P41, DOI 10.1109/MSP.2014.2344552; Delgado-Gonzalo R, 2013, IEEE T IMAGE PROCESS, V22, P3926, DOI 10.1109/TIP.2013.2264680; Delgado-Gonzalo R, 2012, IEEE T IMAGE PROCESS, V21, P1258, DOI 10.1109/TIP.2011.2169975; Denervaud N, 2013, CHEMOSTAT ARRAY ENAB, P15842; Deng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065769; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Donelson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037250; Felzenszwalb P.F., 2012, THEORY COMPUT, V8, P415, DOI DOI 10.4086/TOC.2012.V008A019; Isakov A, 2016, RECOVERY LOCOMOTION; Jacob M, 2004, IEEE T IMAGE PROCESS, V13, P1231, DOI 10.1109/TIP.2004.832919; Jacob M, 2004, IEEE T PATTERN ANAL, V26, P1007, DOI 10.1109/TPAMI.2004.44; Kain J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2908; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Mendes CS, 2013, ELIFE, V2; Noldus LPJJ, 2002, COMPUT ELECTRON AGR, V35, P201, DOI 10.1016/S0168-1699(02)00019-4; Olsen SR, 2008, TRENDS NEUROSCI, V31, P512, DOI 10.1016/j.tins.2008.07.006; Perez-Escudero A, 2014, NAT METHODS, V11, P743, DOI [10.1038/NMETH.2994, 10.1038/nmeth.2994]; Pick S, 2005, CURR BIOL, V15, P1473, DOI 10.1016/j.cub.2005.07.022; PRESS WH, 1986, NUMERICAL RECIPES AR; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; Schmitter D, 2013, CELL DIV, V8, DOI 10.1186/1747-1028-8-6; Seeds AM, 2014, ELIFE, V3, DOI 10.7554/eLife.02951; Wosnitza A, 2013, J EXP BIOL, V216, P480, DOI 10.1242/jeb.078139	35	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0173433	10.1371/journal.pone.0173433	http://dx.doi.org/10.1371/journal.pone.0173433			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453566	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000400383900001
J	Zhu, YT; Zhou, GY; Yu, XB; Xu, Q; Wang, K; Xie, D; Yang, QK; Wang, LN				Zhu, Yuting; Zhou, Guangyu; Yu, Xuebin; Xu, Qiang; Wang, Kai; Xie, Dan; Yang, Qingkai; Wang, Lina			LC-MS-MS quantitative analysis reveals the association between FTO and DNA methylation	PLOS ONE			English	Article							OBESITY-ASSOCIATED FTO; MEDIATED FORMATION; RNA METHYLATION; MAMMALIAN RNA; GENE; 5-METHYLCYTOSINE; 5-HYDROXYMETHYLCYTOSINE; N6-METHYLADENOSINE; MECHANISMS; EXPRESSION	Fat mass and obesity-associated protein (FTO) is a-ketoglutarate-dependent dioxygenase and responsible for demethylating N6-methyladenosine (m6A) in mRNA, 3-methylthymine (m3T) in single-stranded DNA (ssDNA) and 3-methyluracil (m3U) in single-stranded RNA (ssRNA). Its other function remains unknown but thousands of mammalian DNA show 5methyl-2'-deoxycytidine (5mdC) modification and 5mdC demethylases are required for mammalian energy homeostasis and fertility. Here, we aimed to confirm whether FTO proteins can demethylate 5mdC in DNA. However, we found that FTO exhibits no potent demethylation activity against 5mdC in vitro and in vivo by using liquid chromatography-tandem mass spectrometry (LC-MS-MS). The result showed FTO demethylase has the characteristics of high substrates specificity and selectivity. In addition, we also used immunofluorescence technique to demonstrate overexpression of wild type TET2, but not FTO and mutant TET2 in Hela cells results in higher levels of 5-hydroxymethyl-2'-deoxycytidine (5hmdC) generated from 5mdC. In conclusion, our results not only reveal the enzymatic activity of FTO, but also may facilitate the future discovery of proteins involved in epigenetic modification function.	[Zhu, Yuting; Zhou, Guangyu; Yu, Xuebin; Xu, Qiang; Wang, Kai; Xie, Dan; Yang, Qingkai; Wang, Lina] DaLian Med Univ, Inst Canc Stem Cell, Affiliated Hosp 2, Dept Oncol, Dalian, Liaoning, Peoples R China	Dalian Medical University	Yang, QK; Wang, LN (corresponding author), DaLian Med Univ, Inst Canc Stem Cell, Affiliated Hosp 2, Dept Oncol, Dalian, Liaoning, Peoples R China.	Linawang1109@hotmail.com; Qingkaiyang@hotmail.com			National Natural Science Foundation of China [81502622]; Natural Science Foundation of Liaoning Province [201602239]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province)	This work was supported by the National Natural Science Foundation of China (Nos. 81502622 to Lina Wang) and Natural Science Foundation of Liaoning Province (Nos. 201602239 to Lina Wang).; This study was also supported by grants from the National Natural Science Foundation of China (Nos. 81502622 to Lina Wang) and Natural Science Foundation of Liaoning Province (Nos. 201602239 to Lina Wang).	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Chandola U, 2015, BRIEF FUNCT GENOMICS, V14, P169, DOI 10.1093/bfgp/elu039; EHRLICH M, 1981, SCIENCE, V212, P1350, DOI 10.1126/science.6262918; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fu Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2822; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Hastings MH, 2013, CELL, V155, P740, DOI 10.1016/j.cell.2013.10.028; He C, 2010, NATURE CHEM BIOL, V6, P863; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hodge DR, 2001, J BIOL CHEM, V276, P39508, DOI 10.1074/jbc.C100343200; Huang Y, 2015, NUCLEIC ACIDS RES, V43, P373, DOI 10.1093/nar/gku1276; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Larder R, 2011, TRENDS ENDOCRIN MET, V22, P53, DOI 10.1016/j.tem.2010.11.001; Mizuno S, 2001, BLOOD, V97, P1172, DOI 10.1182/blood.V97.5.1172; Pan T, 2013, TRENDS BIOCHEM SCI, V38, P204, DOI 10.1016/j.tibs.2012.12.006; Peng SH, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-71; Pronier E, 2011, BLOOD, V118, P2551, DOI 10.1182/blood-2010-12-324707; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; SANEYOSHI M, 1969, BIOCHIM BIOPHYS ACTA, V190, P264, DOI 10.1016/0005-2787(69)90078-1; Shen L, 2014, ANNU REV BIOCHEM, V83, P585, DOI 10.1146/annurev-biochem-060713-035513; STORB U, 1983, P NATL ACAD SCI-BIOL, V80, P6642, DOI 10.1073/pnas.80.21.6642; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Wang LN, 2013, INT J MOL SCI, V14, P18470, DOI 10.3390/ijms140918470; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yang Q, 2013, ONCOGENE, V32, P3156, DOI 10.1038/onc.2012.332; Yang Q, 2013, J BIOMED NANOTECHNOL, V9, P1607, DOI 10.1166/jbn.2013.1713; Zhao X, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0486-0; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	31	16	17	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0175849	10.1371/journal.pone.0175849	http://dx.doi.org/10.1371/journal.pone.0175849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453518	gold, Green Submitted, Green Published			2022-12-26	WOS:000400383900006
J	Hanley, MP; Hahn, MA; Li, AX; Wu, X; Lin, J; Wang, J; Choi, AH; Ouyang, Z; Fong, Y; Pfeifer, GP; Devers, TJ; Rosenberg, DW				Hanley, M. P.; Hahn, M. A.; Li, A. X.; Wu, X.; Lin, J.; Wang, J.; Choi, A. H.; Ouyang, Z.; Fong, Y.; Pfeifer, G. P.; Devers, T. J.; Rosenberg, D. W.			Genome-wide DNA methylation profiling reveals cancer-associated changes within early colonic neoplasia	ONCOGENE			English	Article							ABERRANT CRYPT FOCI; CPG ISLAND METHYLATION; TUMOR-SUPPRESSOR GENES; COLORECTAL-CANCER; EXPRESSION; HYPERMETHYLATION; CELLS; HYPOMETHYLATION; TRANSCRIPTION; MUTATION	Colorectal cancer (CRC) is characterized by genome-wide alterations to DNA methylation that influence gene expression and genomic stability. Less is known about the extent to which methylation is disrupted in the earliest stages of CRC development. In this study, we have combined laser-capture microdissection with reduced representation bisulfite sequencing to identify cancer-associated DNA methylation changes in human aberrant crypt foci (ACF), the earliest putative precursor to CRC. Using this approach, methylation profiles have been generated for 10 KRAS-mutant ACF and 10 CRCs harboring a KRAS mutation, as well as matched samples of normal mucosa. Of 811 differentially methylated regions (DMRs) identified in ACF, 537 (66%) were hypermethylated and 274 (34%) were hypomethylated. DMRs located within intergenic regions were heavily enriched for AP-1 transcription factor binding sites and were frequently hypomethylated. Furthermore, gene ontology analysis demonstrated that DMRs associated with promoters were enriched for genes involved in intestinal development, including homeobox genes and targets of the Polycomb repressive complex 2. Consistent with their role in the earliest stages of colonic neoplasia, 75% of the loci harboring methylation changes in ACF were also altered in CRC samples, though the magnitude of change at these sites was lesser in ACF. Although aberrant promoter methylation was associated with altered gene expression in CRC, this was not the case in ACF, suggesting the insufficiency of methylation changes to modulate gene expression in early colonic neoplasia. Altogether, these data demonstrate that DNA methylation changes, including significant hypermethylation, occur more frequently in early colonic neoplasia than previously believed, and identify epigenomic features of ACF that may provide new targets for cancer chemoprevention or lead to the development of new biomarkers for CRC risk.	[Hanley, M. P.; Rosenberg, D. W.] UConn Hlth, Sch Med, Ctr Mol Med, Farmington, CT USA; [Hanley, M. P.; Rosenberg, D. W.] UConn Hlth, Dept Genet & Genome Sci, Farmington, CT USA; [Hahn, M. A.; Choi, A. H.; Fong, Y.] City Hope Natl Med Ctr, Dept Surg, Duarte, CA USA; [Li, A. X.] City Hope Natl Med Ctr, Dept Informat Sci, Duarte, CA USA; [Wu, X.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA USA; [Lin, J.; Ouyang, Z.] Jackson Lab Genom Med, Farmington, CT USA; [Wang, J.] City Hope Natl Med Ctr, Beckman Res Inst, Integrat Genom Core, Duarte, CA USA; [Ouyang, Z.] Univ Connecticut, Inst Syst Genom, Farmington, CT USA; [Pfeifer, G. P.] Van Andel Res Inst, Ctr Epigenet, Grand Rapids, MI USA; [Devers, T. J.] UConn Hlth, Sch Med, Div Gastroenterol, Farmington, CT USA; [Rosenberg, D. W.] UConn Hlth, Neag Comprehens Canc Ctr, Colon Canc Prevent Program, Farmington, CT USA	City of Hope; City of Hope; City of Hope; Beckman Research Institute of City of Hope; Jackson Laboratory; City of Hope; Beckman Research Institute of City of Hope; University of Connecticut; Van Andel Institute	Rosenberg, DW (corresponding author), Univ Connecticut, Ctr Hlth, 263 Farmington Ave, Farmington, CT 06030 USA.	rosenberg@uchc.edu	Lin, Jianan/T-7238-2019; Lin, Jianan/AAV-1954-2020	Lin, Jianan/0000-0003-3894-6902	NIH [CA159976, CA084469, CA160965]; NATIONAL CANCER INSTITUTE [R01CA084469, R01CA159976, P30CA034196, R01CA160965] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant CA159976 to DWR, and NIH grants CA084469 and CA160965 to GPP.	Ahlquist T, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-94; American Cancer Society, 2016, CANC FACTS FIGURES 2; Ashida Reiko, 2005, Inflammopharmacology, V13, P113, DOI 10.1163/156856005774423935; Bariol C, 2003, AM J PATHOL, V162, P1361, DOI 10.1016/S0002-9440(10)63932-6; Beggs AD, 2013, J PATHOL, V229, P697, DOI 10.1002/path.4132; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Benoit YD, 2012, J CELL SCI, V125, P3454, DOI 10.1242/jcs.102061; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bhatlekar S, 2014, J MOL MED, V92, P811, DOI 10.1007/s00109-014-1181-y; Campbell JD, 2016, CANCER PREV RES, V9, P119, DOI 10.1158/1940-6207.CAPR-16-0024; Chai H, 2009, ANN CLIN LAB SCI, V39, P331; Chan AOO, 2002, AM J PATHOL, V160, P1823, DOI 10.1016/S0002-9440(10)61128-5; Drew DA, 2014, MOL CANCER RES, V12, P823, DOI 10.1158/1541-7786.MCR-13-0624; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Enroth S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-450; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Fluge O, 2009, BRIT J CANCER, V101, P1282, DOI 10.1038/sj.bjc.6605333; Freschi G, 2005, INT J MOL MED, V16, P581; Greenspan EJ, 2006, CARCINOGENESIS, V27, P1316, DOI 10.1093/carcin/bgi373; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Haberland M, 2009, GENE DEV, V23, P1625, DOI 10.1101/gad.1809209; Hahn MA, 2015, METHODS MOL BIOL, V1238, P273, DOI 10.1007/978-1-4939-1804-1_14; Hahn MA, 2014, CANCER RES, V74, P3617, DOI 10.1158/0008-5472.CAN-13-3147; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hill ME, 1999, MOL ENDOCRINOL, V13, P1474, DOI 10.1210/me.13.9.1474; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inoue A, 2015, BRIT J CANCER, V112, P403, DOI 10.1038/bjc.2014.545; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Karlsson L, 2000, DEVELOPMENT, V127, P3457; Kawakami K, 2006, BRIT J CANCER, V94, P593, DOI 10.1038/sj.bjc.6602940; Kong HK, 2012, J BIOL CHEM, V287, P38889, DOI 10.1074/jbc.M112.394270; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Pabst O, 1999, DEVELOPMENT, V126, P2215; Rada-Iglesias A, 2009, EPIGENETICS-US, V4, P107, DOI 10.4161/epi.4.2.8038; Rauch T, 2007, P NATL ACAD SCI USA, V104, P5527, DOI 10.1073/pnas.0701059104; Rosenberg DW, 2007, CANCER RES, V67, P3551, DOI 10.1158/0008-5472.CAN-07-0343; Sakai E, 2014, WORLD J GASTROENTERO, V20, P978, DOI 10.3748/wjg.v20.i4.978; Sarabi MM, 2015, CELL BIOCHEM FUNCT, V33, P427, DOI 10.1002/cbf.3126; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Silviera ML, 2012, CANCER PREV RES, V5, P374, DOI 10.1158/1940-6207.CAPR-11-0336; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Tommasi S, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2233; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yagi K, 2012, AM J PATHOL, V180, P616, DOI 10.1016/j.ajpath.2011.10.010; Yagi K, 2010, CLIN CANCER RES, V16, P21, DOI 10.1158/1078-0432.CCR-09-2006; Zimmerman SG, 2010, DEV BIOL, V340, P54, DOI 10.1016/j.ydbio.2010.01.021	57	48	49	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 31	2017	36	35					5035	5044		10.1038/onc.2017.130	http://dx.doi.org/10.1038/onc.2017.130			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FF3AV	28459462	Green Accepted			2022-12-26	WOS:000408768800008
J	Zhao, L; Fan, J; Xia, SY; Pan, YZ; Liu, SP; Qian, GQ; Qian, ZY; Kang, HB; Arbiser, JL; Pollack, BP; Kudchadkar, RR; Lawson, DH; Rossi, M; Abdel-Wahab, O; Merghoub, T; Khoury, HJ; Khuri, FR; Boise, LH; Lonial, S; Chen, FP; Chen, J; Lin, RT				Zhao, Liang; Fan, Jun; Xia, Siyuan; Pan, Yaozhu; Liu, Shuangping; Qian, Guoqing; Qian, Zhiyu; Kang, Hee-Bum; Arbiser, Jack L.; Pollack, Brian P.; Kudchadkar, Ragini R.; Lawson, David H.; Rossi, Michael; Abdel-Wahab, Omar; Merghoub, Taha; Khoury, Hanna J.; Khuri, Fadlo R.; Boise, Lawrence H.; Lonial, Sagar; Chen, Fangping; Chen, Jing; Lin, Ruiting			HMG-CoA synthase 1 is a synthetic lethal partner of BRAF(V600E) in human cancers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRAF V600E MUTATION; KETOGENESIS	Contributions of metabolic changes to cancer development and maintenance have received increasing attention in recent years. Although many human cancers share similar metabolic alterations, it remains unclear whether oncogene-specific metabolic alterations are required for tumor development. Using an RNAi-based screen targeting the majority of the known metabolic proteins, we recently found that oncogenic BRAF(V600E) up-regulates HMG-CoA lyase (HMGCL), which converts HMG-CoA to acetyl-CoA and a ketone body, acetoacetate, that selectively enhances BRAF(V600E)-dependent MEK1 activation in human cancer. Here, we identified HMG-CoA synthase 1 (HMGCS1), the upstream ketogenic enzyme of HMGCL, as an additional "synthetic lethal" partner of BRAF(V600E). Although HMGCS1 expression did not correlate with BRAF(V600E) mutation in human melanoma cells, HMGCS1 was selectively important for proliferation of BRAF(V600E)-positive melanoma and colon cancer cells but not control cells harboring activeN/KRAS mutants, and stable knockdown of HMGCS1 only attenuated colony formation and tumor growth potential of BRAF(V600E) melanoma cells. Moreover, cytosolic HMGCS1 that co-localized with HMGCL and BRAF(V600E) was more important than the mitochondrial HMGCS2 isoform in BRAF(V600E)-expressing cancer cells in terms of acetoacetate production. Interestingly, HMGCL knockdown did not affect HMGCS1 expression levels, whereas HMGCS1 knockdown caused a compensating increase in HMGCL protein level because of attenuated protein degradation. However, this increase did not reverse the reduced ketogenesis in HMGCS1 knockdown cells. Mechanistically, HMGCS1 inhibition decreased intracellular acetoacetate levels, leading to reduced BRAF(V600E)-MEK1 binding and consequent MEK1 activation. We conclude that the ketogenic HMGCS1-HMGCL-acetoacetate axis may represent a promising therapeutic target for managing BRAF(V600E)-positive human cancers.	[Zhao, Liang; Xia, Siyuan; Pan, Yaozhu; Liu, Shuangping; Qian, Guoqing; Qian, Zhiyu; Kang, Hee-Bum; Kudchadkar, Ragini R.; Lawson, David H.; Rossi, Michael; Khoury, Hanna J.; Khuri, Fadlo R.; Boise, Lawrence H.; Lonial, Sagar; Chen, Jing; Lin, Ruiting] Emory Univ, Sch Med, Winship Canc Inst Emory, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Fan, Jun] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Arbiser, Jack L.; Pollack, Brian P.] Emory Univ, Sch Med, Dept Dermatol, Atlanta, GA 30322 USA; [Arbiser, Jack L.; Pollack, Brian P.] Atlanta Vet Adm Med Ctr, Decatur, GA 30033 USA; [Abdel-Wahab, Omar; Merghoub, Taha] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Zhao, Liang; Chen, Fangping] Cent S Univ, Xiangya Hosp, Dept Hematol, Changsha 410008, Hunan, Peoples R China	Emory University; Emory University; Emory University; Memorial Sloan Kettering Cancer Center; Central South University	Chen, FP (corresponding author), Cent S Univ, Xiangya Hosp, Dept Hematol, Changsha 410008, Hunan, Peoples R China.; Chen, J (corresponding author), 1365-C Clifton Rd NE C3002, Atlanta, GA 30322 USA.	hope058@163.com; jchen@emory.edu	Boise, Lawrence/AAD-2314-2019; Merghoub, Taha/ABD-8362-2021; Xia, Siyuan/AAM-9606-2020; Qian, Guoqing/ABH-1307-2021; Khuri, Fadlo R./AAU-4942-2020	Qian, Guoqing/0000-0003-1804-7993; Khuri, Fadlo R./0000-0002-8638-7618; Zhao, Liang/0000-0002-8077-4510; Kang, Hee-Bum/0000-0002-3781-6893; Boise, Lawrence/0000-0001-9436-8815; Xia, Siyuan/0000-0001-6756-3519	National Institutes of Health [CA140515, CA183594, CA174786, AR47901]; T.J. Martell Foundation/Winship Cancer Institute; Jamie Rabinowitch-Davis Foundation for Melanoma Research; Charles Harris Run For Leukemia, Inc.; Melanoma Research Foundation; Winship Cancer Institute Melanoma & Skin Cancer Fund; Joel A. Katz Music Medicine Fund; NATIONAL CANCER INSTITUTE [R01CA140515, P30CA008748, R01CA174786, R01CA183594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047901] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001922] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T.J. Martell Foundation/Winship Cancer Institute; Jamie Rabinowitch-Davis Foundation for Melanoma Research; Charles Harris Run For Leukemia, Inc.; Melanoma Research Foundation; Winship Cancer Institute Melanoma & Skin Cancer Fund; Joel A. Katz Music Medicine Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by National Institutes of Health Grants CA140515, CA183594, CA174786 (J.C.), and AR47901 (J.L.A.); Joel A. Katz Music Medicine Fund supported by the T.J. Martell Foundation/Winship Cancer Institute (J.C. and R.L.); the Jamie Rabinowitch-Davis Foundation for Melanoma Research (J.L.A.); the Charles Harris Run For Leukemia, Inc. (H.J.K.); and the Melanoma Research Foundation and the Winship Cancer Institute Melanoma & Skin Cancer Fund (B.P.P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arcaini L, 2012, BLOOD, V119, P188, DOI 10.1182/blood-2011-08-368209; BALASSE EO, 1989, DIABETES METAB REV, V5, P247, DOI 10.1002/dmr.5610050304; Benlloch S, 2006, J MOL DIAGN, V8, P540, DOI 10.2353/jmoldx.2006.060070; Bollag G, 2012, NAT REV DRUG DISCOV, V11, P873, DOI 10.1038/nrd3847; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Cotter DG, 2013, AM J PHYSIOL-HEART C, V304, pH1060, DOI 10.1152/ajpheart.00646.2012; Gibney GT, 2013, NAT REV CLIN ONCOL, V10, P390, DOI 10.1038/nrclinonc.2013.83; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569; Johnson DB, 2013, CURR TREAT OPTION ON, V14, P280, DOI 10.1007/s11864-013-0226-8; Kang HB, 2015, MOL CELL, V59, P345, DOI 10.1016/j.molcel.2015.05.037; McPherson PAC, 2012, J PHYSIOL BIOCHEM, V68, P141, DOI 10.1007/s13105-011-0112-4; Morris AAM, 2005, J INHERIT METAB DIS, V28, P109, DOI 10.1007/s10545-005-5518-0; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xia SY, 2017, CELL METAB, V25, P358, DOI 10.1016/j.cmet.2016.12.010	16	20	22	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					10142	10152		10.1074/jbc.M117.788778	http://dx.doi.org/10.1074/jbc.M117.788778			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28468827	Green Published, hybrid			2022-12-26	WOS:000403580600025
J	Valent, D; Arroyo, L; Pena, R; Yu, K; Carreras, R; Mainau, E; Velarde, A; Bassols, A				Valent, Daniel; Arroyo, Laura; Pena, Raquel; Yu, Kuai; Carreras, Ricard; Mainau, Eva; Velarde, Antonio; Bassols, Anna			Effects on pig immunophysiology, PBMC proteome and brain neurotransmitters caused by group mixing stress and human-animal relationship	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; LIPID-PEROXIDATION; TRANSPORT STRESS; OXIDATIVE STRESS; CYCLOPHILIN; CORTISOL; WELFARE; GLUCOCORTICOIDS; IDENTIFICATION; HAPTOGLOBIN	Peripheral blood mononuclear cells (PBMC) are an interesting sample for searching for biomarkers with proteomic techniques because they are easy to obtain and do not contain highly abundant, potentially masking proteins. Two groups of pigs (n = 56) were subjected to mixing under farm conditions and afterwards subjected to different management treatments: negative handling (NH) and positive handling (PH). Serum and PBMC samples were collected at the beginning of the experiment one week after mixing (t0) and after two months of different handling (t2). Brain areas were collected after slaughter and neurotransmitters quantified by HPLC. Hair cortisol and serum acute phase proteins decreased and serum glutathione peroxidase increased at t2, indicating a lower degree of stress at t2 after adaptation to the farm. Differential gel electrophoresis (DIGE) was applied to study the effects of time and treatment on the PBMC proteome. A total of 54 differentially expressed proteins were identified, which were involved in immune system modulation, cell adhesion and motility, gene expression, splicing and translation, protein degradation and folding, oxidative stress and metabolism. Thirty-seven protein spots were up-regulated at t2 versus t0 whereas 27 were down-regulated. Many of the identified proteins share the characteristic of being potentially up or down-regulated by cortisol, indicating that changes in protein abundance between t0 and t2 are, at least in part, consequence of lower stress upon adaptation to the farm conditions after group mixing. Only slight changes in brain neurotransmitters and PBMC oxidative stress markers were observed. In conclusion, the variation in hair cortisol and serum APPs as well as the careful analysis of the identified proteins indicate that changes in protein composition in PBMC throughout time is mainly due to a decrease in the stress status of the individuals, following accommodation to the farm and the new group.	[Valent, Daniel; Arroyo, Laura; Pena, Raquel; Yu, Kuai; Bassols, Anna] Univ Autonoma Barcelona, Fac Vet, Dept Bioquim & Biol Mol, Cerdanyola Del Valles, Spain; [Pena, Raquel; Bassols, Anna] Univ Autonoma Barcelona, Fac Vet, Serv Bioquim Clin Vet, Cerdanyola Del Valles, Spain; [Carreras, Ricard; Velarde, Antonio] IRTA, Subprograma Benestar Anim, Monells, Spain; [Mainau, Eva] Univ Autonoma Barcelona, Dept Ciencia Anim & Aliments, Fac Vet, Cerdanyola Del Valles, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona	Bassols, A (corresponding author), Univ Autonoma Barcelona, Fac Vet, Dept Bioquim & Biol Mol, Cerdanyola Del Valles, Spain.; Bassols, A (corresponding author), Univ Autonoma Barcelona, Fac Vet, Serv Bioquim Clin Vet, Cerdanyola Del Valles, Spain.	anna.bassols@uab.cat	Bassols, Anna/K-7961-2014; Mainau, Eva/L-7497-2014; Velarde, Antonio/L-4466-2014	Bassols, Anna/0000-0003-4213-2274; Mainau, Eva/0000-0003-4331-415X; Velarde, Antonio/0000-0002-2634-3138; Carreras, Ricard/0000-0003-1610-7630; Valent, Daniel/0000-0001-6927-3099; Yu, Kuai/0000-0002-6516-7616; Pena, Raquel/0000-0002-7193-9141	Spanish Ministerio de Economia y Competitividad [AGL2011-30598-C03-01, AG L2011-30598-C03-02]; Generalitat de Catalunya [2014SGR4]	Spanish Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	AGL2011-30598-C03-01 (to AV) and grant AG L2011-30598-C03-02 (to AB) from the Spanish Ministerio de Economia y Competitividad, and 2014SGR4 from the Generalitat de Catalunya (to AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEOLA O, 1993, J ANIM SCI, V71, P968, DOI 10.2527/1993.714968x; Albert PR, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00199; Almeida AM, 2015, ANIMAL, V9, P1, DOI 10.1017/S1751731114002602; Ammari M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S9; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; AREY DS, 1995, APPL ANIM BEHAV SCI, V45, P23, DOI 10.1016/0168-1591(95)00600-W; Arias MP, 2001, BIOCHEMISTRY-US, V40, P12974, DOI 10.1021/bi010098+; Asan E, 2013, HISTOCHEM CELL BIOL, V139, P785, DOI 10.1007/s00418-013-1081-1; Auboeuf D, 2007, TRENDS ENDOCRIN MET, V18, P122, DOI 10.1016/j.tem.2007.02.003; Bassols A, 2014, CURR PROTEIN PEPT SC, V15, P156, DOI 10.2174/1389203715666140221125958; Belujon P, 2011, ANN NY ACAD SCI, V1216, P114, DOI 10.1111/j.1749-6632.2010.05896.x; Bendixen E, 2011, J PROTEOMICS, V74, P282, DOI 10.1016/j.jprot.2010.11.005; Billing AM, 2007, J MASS SPECTROM, V42, P1433, DOI 10.1002/jms.1270; Braun TP, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00012; Brenes JC, 2008, PHARMACOL BIOCHEM BE, V89, P85, DOI 10.1016/j.pbb.2007.11.004; Brenner BG, 2001, EXPERT OPIN BIOL TH, V1, P67, DOI 10.1517/14712598.1.1.67; Burke NC, 2009, VET IMMUNOL IMMUNOP, V127, P365, DOI 10.1016/j.vetimm.2008.11.017; Bush BM, 1991, INTERPRETATION LAB R, P132; Cao S, 2008, J IMMUNOL, V181, P476, DOI 10.4049/jimmunol.181.1.476; Cappiello M, 2004, BIOCHEM J, V378, P35, DOI 10.1042/BJ20031336; Casal N, 2017, J VET BEHAV, V19, P1, DOI 10.1016/j.jveb.2017.01.002; Ceciliani F, 2014, PROTEOM CLIN APPL, V8, P677, DOI 10.1002/prca.201300080; Chae JI, 2012, ANIM REPROD SCI, V134, P164, DOI 10.1016/j.anireprosci.2012.07.008; Chirase NK, 2004, AM J VET RES, V65, P860, DOI 10.2460/ajvr.2004.65.860; Coutts AS, 2003, J CELL SCI, V116, P897, DOI 10.1242/jcs.00278; Cruzen SM, 2015, J PROTEOMICS, V128, P141, DOI 10.1016/j.jprot.2015.07.032; de Wilde AH, 2013, J VIROL, V87, P1454, DOI 10.1128/JVI.02078-12; Gonzalez-de-la-Vara MD, 2011, CAN J VET RES, V75, P216; Di Girolamo F, 2014, INT J MOL SCI, V15, P15396, DOI 10.3390/ijms150915396; Dupre L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00586; Flint MS, 2011, BRAIN BEHAV IMMUN, V25, P1187, DOI 10.1016/j.bbi.2011.03.009; Forster F, 2014, J IMMUNOL, V192, P771, DOI 10.4049/jimmunol.1300377; Frank MG, 2015, BRAIN BEHAV IMMUN, V48, P1, DOI 10.1016/j.bbi.2015.03.010; Frank MG, 2013, BRAIN BEHAV IMMUN, V33, P1, DOI 10.1016/j.bbi.2013.02.004; GAILANI D, 1990, BRIT J HAEMATOL, V74, P192, DOI 10.1111/j.1365-2141.1990.tb02565.x; Gow R, 2010, FORENSIC SCI INT, V196, P32, DOI 10.1016/j.forsciint.2009.12.040; Grantham J, 2006, EXP CELL RES, V312, P2309, DOI 10.1016/j.yexcr.2006.03.028; Hemsworth PH, 2003, APPL ANIM BEHAV SCI, V81, P185, DOI 10.1016/S0168-1591(02)00280-0; HEMSWORTH PH, 1986, APPL ANIM BEHAV SCI, V15, P303, DOI 10.1016/0168-1591(86)90123-1; Kandel E. R., 2013, PRINCIPLES NEURAL SC; Kaur H, 2009, J BIOL CHEM, V284, P14493, DOI 10.1074/jbc.M808952200; KIRBY LG, 1995, BRAIN RES, V682, P189, DOI 10.1016/0006-8993(95)00349-U; Kornblihtt AR, 2005, CURR OPIN CELL BIOL, V17, P262, DOI 10.1016/j.ceb.2005.04.014; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Kumar Balvinder, 2012, Front Biosci (Elite Ed), V4, P1759; Li YZ, 2006, J ANIM SCI, V84, P212, DOI 10.2527/jas.2006-144; Lissner MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132061; Liu XL, 2013, VIRUSES-BASEL, V5, P182, DOI 10.3390/v5010182; Marco-Ramell A, 2016, MOL BIOSYST, V12, P2024, DOI 10.1039/c5mb00788g; Marco-Ramell A, 2011, Vet J, V190, pe66, DOI 10.1016/j.tvjl.2011.01.003; Marco-Ramell A, 2012, J PROTEOMICS, V75, P4399, DOI 10.1016/j.jprot.2012.04.002; Martelli G, 2014, ANIMAL, V8, P810, DOI 10.1017/S1751731114000433; Masis-Calvo M, 2013, PHYSIOL BEHAV, V118, P212, DOI 10.1016/j.physbeh.2013.05.033; Mora F, 2012, BRAIN RES, V1476, P71, DOI 10.1016/j.brainres.2011.12.049; Olivan M., 2016, BR BIOTECHNOL J, V11, P1, DOI [DOI 10.9734/BBJ/2016/22402, 10.9734/BBJ/2016/22402]; Oliveira RAS, 2012, INT IMMUNOPHARMACOL, V14, P54, DOI 10.1016/j.intimp.2012.05.022; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; PAQUEREAU L, 1992, EUR J BIOCHEM, V209, P1053, DOI 10.1111/j.1432-1033.1992.tb17381.x; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Pineiro C, 2007, ANIMAL, V1, P133, DOI 10.1017/S1751731107283909; Pineiro M, 2007, VET J, V173, P669, DOI 10.1016/j.tvjl.2006.02.006; Poletto R, 2011, BRAIN RES, V1381, P11, DOI 10.1016/j.brainres.2010.11.035; Poletto R, 2010, APPL ANIM BEHAV SCI, V122, P98, DOI 10.1016/j.applanim.2009.11.015; Ramirez-Boo M, 2006, PROTEOMICS, V6, pS215, DOI 10.1002/pmic.200500386; Ramirez-Boo M, 2011, PROTEOMICS, V11, P3452, DOI 10.1002/pmic.201000610; Robinson CE, 1999, ANAL BIOCHEM, V266, P48, DOI 10.1006/abio.1998.2932; Rubio-Gonzalez A, 2015, ANIMAL, V9, P1188, DOI 10.1017/S1751731115000518; Rueter LE, 1996, BRAIN RES, V739, P57, DOI 10.1016/S0006-8993(96)00809-8; Rushen J, 1999, APPL ANIM BEHAV SCI, V65, P285, DOI 10.1016/S0168-1591(99)00089-1; Saco Y, 2003, ANIM WELFARE, V12, P403; Saco Y, 2010, ANIMAL, V4, P1561, DOI 10.1017/S1751731109991418; Saco Y, 2010, RES VET SCI, V89, P159, DOI 10.1016/j.rvsc.2010.02.006; Salamano G, 2008, VET J, V177, P110, DOI 10.1016/j.tvjl.2007.03.015; Sarr O, 2010, J ANIM SCI, V88, P1626, DOI 10.2527/jas.2009-2542; Sejersen H, 2013, J ANIM SCI, V91, P147, DOI 10.2527/jas.2012-5303; Shen YF, 2005, PROTEOMICS, V5, P4034, DOI 10.1002/pmic.200401246; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; STOLBA A, 1984, ANN RECH VET, V15, P287; Terlouw EMC, 2008, ANIMAL, V2, P1501, DOI 10.1017/S1751731108002723; Tonomura N, 2003, J IMMUNOL, V170, P2469, DOI 10.4049/jimmunol.170.5.2469; Truckenmiller ME, 2006, BRAIN BEHAV IMMUN, V20, P210, DOI 10.1016/j.bbi.2006.01.002; van Staaveren N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122841; Voegtli WC, 2003, J BIOL CHEM, V278, P34373, DOI 10.1074/jbc.M302773200; von Hahn T, 2015, CURR OPIN VIROL, V14, P47, DOI 10.1016/j.coviro.2015.07.012; Waiblinger S, 2006, APPL ANIM BEHAV SCI, V101, P185, DOI 10.1016/j.applanim.2006.02.001; Wu KC, 2008, CELL BIOCHEM BIOPHYS, V52, P139, DOI 10.1007/s12013-008-9031-6; Zelnickova P, 2008, VET IMMUNOL IMMUNOP, V124, P367, DOI 10.1016/j.vetimm.2008.04.016; Zhou DH, 2011, PARASITOL RES, V109, P1637, DOI 10.1007/s00436-011-2435-z; Zhou DJ, 2012, BIOCHEM BIOPH RES CO, V424, P647, DOI 10.1016/j.bbrc.2012.07.024	89	8	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176928	10.1371/journal.pone.0176928	http://dx.doi.org/10.1371/journal.pone.0176928			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475627	Green Published, Green Submitted, gold			2022-12-26	WOS:000400649500028
J	Li, YM; Zhang, TX; Zhou, JT; Yang, S; Fan, MY; Sun, XN; Zhang, MS; Xu, SH; Cha, MH; Hu, XL; Qi, L; Lin, SB; Liu, SQ; Hu, DF				Li, Yimeng; Zhang, Tianxiang; Zhou, Juntong; Yang, Shuang; Fan, Mengyuan; Sun, Xiaoning; Zhang, Meishan; Xu, Shanghua; Cha, Muha; Hu, Xiaolong; Qi, Lei; Lin, Shaobi; Liu, Shuqiang; Hu, Defu			Transcriptome analysis of muskrat scented glands degeneration mechanism	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; APOPTOSIS; DATABASE; CALCIUM; SMAD7; CELLS; MAPK; TOOL	The scented gland, a musk-secreting organ of male muskrats, shows clear seasonal changes. When entering the secreting season in March, scented glands gradually increase in size and active secretion starts. In September, scented glands become gradually smaller and secretion decreases. By November, scented glands are gradually replaced by adipose tissue. In this study, six healthy adult male muskrats were analysed: three from the secreting season (March) and three from the non-secreting season (November). Using RNA-Seq analysis, gene expression profiles of scented glands from both seasons were determined. Using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database, we found that genes involved in calcium and TGF-beta signalling pathways were significantly more expressed in the non-secreting than in the secreting season. These changes in gene expression correlated with alterations in scented gland size. Both calcium and TGF-beta signalling pathways are important regulators of cell apoptosis, which may thus be involved in muskrat scented gland degeneration.	[Li, Yimeng; Zhang, Tianxiang; Zhou, Juntong; Yang, Shuang; Fan, Mengyuan; Sun, Xiaoning; Zhang, Meishan; Xu, Shanghua; Cha, Muha; Hu, Xiaolong; Qi, Lei; Liu, Shuqiang; Hu, Defu] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China; [Lin, Shaobi; Liu, Shuqiang] Zhangzhou Pien Tze Huang Pharmaceut Co Ltd, Res Dept, Zhangzhou City, Fujian Province, Peoples R China	Beijing Forestry University	Liu, SQ; Hu, DF (corresponding author), Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China.; Liu, SQ (corresponding author), Zhangzhou Pien Tze Huang Pharmaceut Co Ltd, Res Dept, Zhangzhou City, Fujian Province, Peoples R China.	liushuqiang@bjfu.edu.cn; hudf@bjfu.edu.cn	Hu, Xiaolong/GRR-4875-2022	Hu, Xiaolong/0000-0001-9071-0177	China Postdoctoral Science Foundation [168033, 2016M591094]; Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd [2015HXFWBHQ-LSQ-001]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd	This work was supported by the China Postdoctoral Science Foundation (Postdoctor No. 168033, Grant No. 2016M591094) and Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd (grant no. 2015HXFWBHQ-LSQ-001). The Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd, an institution also have their own independent research department, mainly engaged in scientific research. This institution in addition to providing us with funding support, it also contributes to experimental design and manuscript content revise. The experimental facilities were provided by the College of Nature Conservation's Innovation Laboratory, Beijing Forestry University.	Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apati A, 2003, ANN NY ACAD SCI, V1010, P70, DOI 10.1196/annals.1299.010; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bilezikjian LM, 2001, ENDOCRINOLOGY, V142, P1065, DOI 10.1210/en.142.3.1065; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Brown TL, 1998, CELL GROWTH DIFFER, V9, P869; Caron PL, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-80; [陈心智 Chen Xinzhi], 2005, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V31, P414; Chen Yushan, 1996, Acta Theriologica Sinica, V16, P43; Dassanayake M, 2009, NEW PHYTOL, V183, P764, DOI 10.1111/j.1469-8137.2009.02913.x; [邓泱泱 DENG Yangyang], 2006, [计算机工程, Computer Engineering], V32, P71; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hentges S, 2000, ENDOCRINOLOGY, V141, P1528, DOI 10.1210/en.141.4.1528; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; Jie H, 2015, SPECIAL WILD EC ANIM, V3, P65; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Li BT, 1994, CHINESE PHARM J BEIJ, V29, P396; Li JH, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000014252.37680.E4; Li YB, 2001, FOR SCI TECHNOL, V26, P33; Liao JH, 2001, CELL RES, V11, P89, DOI 10.1038/sj.cr.7290072; Liu Na, 2007, Zhongguo Yaolixue Tongbao, V23, P298; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Marinova-Mutafchieva L, 2006, CLIN EXP IMMUNOL, V146, P287, DOI 10.1111/j.1365-2249.2006.03204.x; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Memon MA, 2008, MOL CELL ENDOCRINOL, V294, P70, DOI 10.1016/j.mce.2008.08.017; Niu J, 1999, INSPECTION QUARANTIN, V9, P41; Shereshkov VI, 2006, J EVOL BIOCHEM PHYS+, V42, P461, DOI 10.1134/S0022093006040120; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Ugarte G, 2006, J BIOL CHEM, V281, P18473, DOI 10.1074/jbc.M600918200; VANDORP DA, 1973, RECL TRAV CHIM PAY B, V92, P915; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wyatt L, 2007, J CELL BIOL, V178, P1223, DOI 10.1083/jcb.200705035; Yuan L, 2010, J NINGXIA MED U, V32, P1, DOI [10.16050/j.cnki.issn1674-6309.2010.01.019, DOI 10.16050/J.CNKI.ISSN1674-6309.2010.01.019]; Zhao WG, 2009, SPECIAL WILD EC ANIM, V4, P50, DOI DOI 10.16720/J.CNKI.TCYJ.2009.04.023	41	5	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176935	10.1371/journal.pone.0176935	http://dx.doi.org/10.1371/journal.pone.0176935			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472080	gold, Green Submitted, Green Published			2022-12-26	WOS:000400648500100
J	Megale, RZ; Pollack, A; Britt, H; Latimer, J; Naganathan, V; McLachlan, AJ; Ferreira, ML				Megale, Rodrigo Z.; Pollack, Allan; Britt, Helena; Latimer, Jane; Naganathan, Vasi; McLachlan, Andrew J.; Ferreira, Manuela L.			Management of vertebral compression fracture in general practice: BEACH program	PLOS ONE			English	Article							QUALITY-OF-LIFE; CONSERVATIVE TREATMENT; OLDER-PEOPLE; ACUTE PAIN; BACK-PAIN; OUTCOMES; EPIDEMIOLOGY; IMPACT; VERTEBROPLASTY; EFFICACY	Importance The pain associated with vertebral compression fractures can cause significant loss of function and quality of life for older adults. Despite this, there is little consensus on how best to manage this condition. Objective To describe usual care provided by general practitioners (GPs) in Australia for the management of vertebral compression fractures. Design, setting and participants Data from the Bettering the Evaluation And Care of Health (BEACH) program collected between April 2005 and March 2015 was used for this study. Each year, a random sample of approximately 1,000 GPs each recorded information on 100 consecutive encounters. We selected those encounters at which vertebral compression fracture was managed. Analyses of management options were limited to encounters with patients aged 50 years or over. Main outcome(s) and measure(s) i) patient demographics; ii) diagnoses/problems managed; iii) the management provided for vertebral compression fracture during the encounter. Robust 95% confidence intervals, adjusted for the cluster survey design, were used to assess significant differences between group means. Results Vertebral compression fractures were managed in 211 (0.022%; 95% CI: 0.018-0.025) of the 977,300 BEACH encounters recorded April 2005-March 2015. That provides a national annual estimate of 26,000 (95% CI: 22,000-29,000) encounters at which vertebral fractures were managed. At encounters with patients aged 50 years or over (those at higher risk of primary osteoporosis), prescription of analgesics was the most common management action, particularly opioids analgesics (47.1 per 100 vertebral fractures; 95% CI: 38.4-55.7). Prescriptions of paracetamol (8.2; 95% CI: 4-12.4) or non-steroidal anti-inflammatory drugs (4.1; 95% CI: 1.1-7.1) were less frequent. Non-pharmacological treatment was provided at a rate of 22.4 per 100 vertebral fractures (95% CI: 14.6-30.1). At least one referral (to hospital, specialist, allied health care or other) was given for 12.3 per 100 vertebral fractures (95% CI: 7.8-16.8). Conclusions and relevance The prescription of oral opioid analgesics remains the common general practice approach for vertebral compression fractures management, despite the lack of evidence to support this. Clinical trials addressing management of these fractures are urgently needed to improve the quality of care patients receive.	[Megale, Rodrigo Z.; Ferreira, Manuela L.] Univ Sydney, Sydney Med Sch, Kolling Inst, Inst Bone & Joint Res, Sydney, NSW, Australia; [Pollack, Allan] Univ Sydney, Family Med Res Ctr, Sch Publ Hlth, Sydney, NSW, Australia; [Britt, Helena] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Latimer, Jane] Univ Sydney, Sydney Med Sch, George Inst Global Hlth, Stdney, Australia; [Naganathan, Vasi; McLachlan, Andrew J.] Univ Sydney, Ctr Educ & Res Ageing, Concord Clin Sch, Sydney, NSW, Australia; [McLachlan, Andrew J.] Univ Sydney, Fac Pharm, Sydney, NSW, Australia	University of Sydney; Kolling Institute of Medical Research; University of Sydney; University of Sydney; George Institute for Global Health; University of Sydney; University of Sydney; University of Sydney	Megale, RZ (corresponding author), Univ Sydney, Sydney Med Sch, Kolling Inst, Inst Bone & Joint Res, Sydney, NSW, Australia.	rzun6620@uni.sydney.edu.au	Ferreira, Manuela/AAQ-5446-2020	Ferreira, Manuela/0000-0002-3479-0683; Naganathan, Vasikaran/0000-0001-7243-0796	Australian Government Department of Health; Novartis Pharmaceuticals Australia Pty Ltd; Merck; Sharp and Dohme (Australia) Pty Ltd; Pfizer Australia; National Prescribing Service Ltd; GlaxoSmithKline Australia Pty Ltd; Sanofi-Aventis Australia Pty Ltd; Bayer Australia Ltd; Roche Products Pty Ltd; Janssen-Cilag PtyLtd; Abbott Australasia Pty Ltd; Wyeth Australia Pty Ltd; AbbVie Pty Ltd; Australian Government Department of Veterans' Affairs; Sydney Medical Foundation Fellowship/Sydney Medical School; AstraZeneca Pty Ltd (Australia); bioCSL (Australia) Pty Ltd	Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing); Novartis Pharmaceuticals Australia Pty Ltd; Merck(Merck & Company); Sharp and Dohme (Australia) Pty Ltd; Pfizer Australia(PfizerPfizer Australia); National Prescribing Service Ltd; GlaxoSmithKline Australia Pty Ltd; Sanofi-Aventis Australia Pty Ltd(Sanofi-Aventis); Bayer Australia Ltd; Roche Products Pty Ltd; Janssen-Cilag PtyLtd(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Abbott Australasia Pty Ltd(Abbott Laboratories); Wyeth Australia Pty Ltd; AbbVie Pty Ltd(AbbVie); Australian Government Department of Veterans' Affairs(US Department of Veterans Affairs); Sydney Medical Foundation Fellowship/Sydney Medical School; AstraZeneca Pty Ltd (Australia)(AstraZeneca); bioCSL (Australia) Pty Ltd	The authors received no specific funding for this work; however, during the data collection period of this study, the BEACH program was funded by: the Australian Government Department of Health,AstraZeneca Pty Ltd (Australia), Novartis Pharmaceuticals Australia Pty Ltd,bioCSL (Australia) Pty Ltd, Merck, Sharp and Dohme (Australia) Pty Ltd, Pfizer Australia, National Prescribing Service Ltd, GlaxoSmithKline Australia Pty Ltd, Sanofi-Aventis Australia Pty Ltd, Bayer Australia Ltd, Roche Products Pty Ltd, Janssen-Cilag PtyLtd, Abbott Australasia Pty Ltd, Wyeth Australia Pty Ltd, AbbVie Pty Ltd, and the Australian Government Department of Veterans' Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RM thanks Fundacao Hospitalar do Estado de Minas Gerais (FHEMIG) for supporting his PhD. MLF holds a Sydney Medical Foundation Fellowship/Sydney Medical School.	American Geriatrics Society, 2009, J AM GERIATR SOC, V57, P1331, DOI [10.1111/j.1532-5415.2009.02376.x, DOI 10.1111/J.1532-5415.2009.02376.X]; [Anonymous], 2015, GUID ATC CLASS DDD A; Barr JD, 2014, J VASC INTERV RADIOL, V25, P171, DOI 10.1016/j.jvir.2013.10.001; Bennell KL, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-36; Borgstrom F, 2013, OSTEOPOROSIS INT, V24, P811, DOI 10.1007/s00198-012-2240-2; Brenneman SK, 2006, J BONE MINER RES, V21, P809, DOI 10.1359/JBMR.060301; Britt H.M.G., 2015, DECADE AUSTR GEN PRA; Britt H, 2007, AUST FAM PHYSICIAN, V36, P36; Britt H, 2015, AUST FAM PHYSICIAN, V44, P411; Chang V, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.4.FOCUS1477; Classification Commitee of the World Organization of Family Doctors W, 1997, ICPC 2 INT CLASS PRI; Comstock BA, 2013, RADIOLOGY, V269, P224, DOI 10.1148/radiol.13120821; COOPER C, 1993, BONE, V14, pS89; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; English KL, 2010, CURR OPIN CLIN NUTR, V13, P34, DOI 10.1097/MCO.0b013e328333aa66; Esses Stephen I, 2011, J Bone Joint Surg Am, V93, P1934, DOI 10.2106/JBJS.9320ebo; Francis RM, 2008, OSTEOPOROSIS INT, V19, P895, DOI 10.1007/s00198-007-0530-x; Gehlbach SH, 2000, OSTEOPOROSIS INT, V11, P577, DOI 10.1007/s001980070078; Giangregorio LM, 2013, COCHRANE DB SYST REV, V1; Hagino H, 2009, OSTEOPOROSIS INT, V20, P695, DOI 10.1007/s00198-008-0761-5; Hallberg I, 2004, OSTEOPOROSIS INT, V15, P834, DOI 10.1007/s00198-004-1622-5; Hegeman J, 2009, DRUG SAFETY, V32, P489, DOI 10.2165/00002018-200932060-00005; Henschke N, 2008, J CLIN EPIDEMIOL, V61, P110, DOI 10.1016/j.jclinepi.2007.04.013; Henschke N, 2009, ARTHRITIS RHEUM-US, V60, P3072, DOI 10.1002/art.24853; Kallmes DF, 2009, NEW ENGL J MED, V361, P569, DOI 10.1056/NEJMoa0900563; Karanges EA, 2016, BR J CLIN PHARM; Kim David H, 2006, Spine J, V6, P479, DOI 10.1016/j.spinee.2006.04.013; Kim HJ, 2014, J BONE JOINT SURG AM, V96A, P1959, DOI 10.2106/JBJS.N.00187; Klazen CAH, 2010, LANCET, V376, P1085, DOI 10.1016/S0140-6736(10)60954-3; Klazen CAH, 2010, J VASC INTERV RADIOL, V21, P1405, DOI 10.1016/j.jvir.2010.05.018; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; Kortebein P, 2007, JAMA-J AM MED ASSOC, V297, P1772, DOI 10.1001/jama.297.16.1772-b; Lee HM, 2012, SPINE J, V12, P998, DOI 10.1016/j.spinee.2012.08.024; Longo UG, 2012, J BONE JOINT SURG BR, V94B, P152, DOI 10.1302/0301-620X.94B2.26894; Majumdar SR, 2005, ARCH INTERN MED, V165, P905, DOI 10.1001/archinte.165.8.905; Makris UE, 2014, JAMA-J AM MED ASSOC, V312, P825, DOI 10.1001/jama.2014.9405; McLachlan AJ, 2011, BRIT J CLIN PHARMACO, V71, P351, DOI 10.1111/j.1365-2125.2010.03847.x; MELTON LJ, 1989, AM J EPIDEMIOL, V129, P1000, DOI 10.1093/oxfordjournals.aje.a115204; Papaioannou A, 2009, OSTEOPOROSIS INT, V20, P703, DOI 10.1007/s00198-008-0743-7; Papaioannou A, 2002, AM J MED, V113, P220, DOI 10.1016/S0002-9343(02)01190-7; Research Committee of the Faculty of Pain Medicine, 2014, OP CONV TABL; Rogers KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080095; Rzewuska M, 2015, EUR SPINE J, V24, P702, DOI 10.1007/s00586-015-3821-5; Schousboe JT, 2015, J CLIN DENSITOM; Suzuki N, 2008, EUR SPINE J, V17, P1380, DOI 10.1007/s00586-008-0753-3; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; Venmans A, 2012, AM J NEURORADIOL, V33, P519, DOI 10.3174/ajnr.A2817; Vitry AI, 2008, MED J AUSTRALIA, V189, P360, DOI 10.5694/j.1326-5377.2008.tb02079.x; Vorsanger GJ, 2013, PAIN MANAG, V3, P109, DOI [10.2217/pmt.13.5, 10.2217/PMT.13.5]; Wallace E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h176; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407; World Health Organization, 1996, CANC PAIN REL GUID O; Zambito A, 2007, OSTEOPOROSIS INT, V18, P1541, DOI 10.1007/s00198-007-0391-3; [张天浩 Zhang Tianhao], 2013, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V17, P6364	54	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176351	10.1371/journal.pone.0176351	http://dx.doi.org/10.1371/journal.pone.0176351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472151	Green Published, gold, Green Submitted			2022-12-26	WOS:000400648500039
J	Liu, XM; Yan, DD; Ouyang, CB; Yang, DS; Wang, QX; Li, Y; Guo, MX; Cao, AC				Liu, Xiaoman; Yan, Dongdong; Ouyang, Canbin; Yang, Dongsheng; Wang, Qiuxia; Li, Yuan; Guo, Meixia; Cao, Aocheng			Oils extracted from Eupatorium adenophorum leaves show potential to control Phythium myriotylum in commercially-grown ginger	PLOS ONE			English	Article							SOFT-ROT PATHOGEN; PYTHIUM-MYRIOTYLUM; CADINENE SESQUITERPENES; ASPERGILLUS-FLAVUS; NATURAL-PRODUCTS; GERMINATION; ANTIBACTERIAL; ANTIOXIDANT; SPRENG	Oils extracted from the leaves of Eupatorium adenophorum were tested in vitro and in vivo against the soilborne pathogen Pythium myriotylum which causes soft rot, a devastating disease of commercial ginger production in China. Twelve compounds accounting for 99.15% of the total oil composition were identified by GC-MS. The major components were 10H beta-9oxo-agerophorone (37.03%), 10H alpha-9-oxo-agerophorone (37.73%) and 9-oxo-10,11-dehydro-agerophorone (23.41%). Antifungal activity was tested by the poisoned food technique against P. myriotylum, indicating minimum inhibitory concentrations of 100 mu g/ml after 7 days incubation. In addition, the oil extracts greatly inhibited the formation of both wet and dry mycelial biomass. The combination of E. adenophorum oil extracts and synthetic fungicides showed a strong synergistic effect, inhibiting the mycelial growth in in vitro assays. The synergistic effect of oil extracts with fungicides could allow fungicides to be used at reduced rates in the future which has environmental advantages. Oil extracts applied at 160 and 200 mu g/ml concentrations to ginger rhizomes before inoculation with P. myriotylum significantly reduced the infection rate in ginger. Examination by light and transmission electron microscopy revealed that oil extracts caused swelling of the hyphae, disruption of the cell wall, degradation of the cytoplasmic organelles and shortening of the cytoplasmic inclusion. These results suggested that the plasma membrane and endomembrane systems of P. myriotylum were severely damaged by the oil extracts of E. adenophorum which offer significant potential for use as a fungicide to control P. myriotylum.	[Liu, Xiaoman; Yan, Dongdong; Ouyang, Canbin; Wang, Qiuxia; Li, Yuan; Guo, Meixia; Cao, Aocheng] Chinese Acad Agr Sci, Inst Plant Protect, Beijing, Peoples R China; [Yang, Dongsheng] Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS	Cao, AC (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Beijing, Peoples R China.	caoac@vip.sina.com		Yan, Dongdong/0000-0002-8196-4615	Special Fund for Agro-scientific Research in the Public Interest of China [20110327]	Special Fund for Agro-scientific Research in the Public Interest of China	This work was supported by the Special Fund for Agro-scientific Research in the Public Interest of China (No.20110327).; We thank Dr Tom Batchelor for editing the manuscript. This work was supported by the Special Fund for Agro-scientific Research in the Public Interest of China (No. 20110327).	Ahluwalia V, 2014, J PEST SCI, V87, P341, DOI 10.1007/s10340-013-0542-6; Anisha C, 2015, APPL BIOCHEM BIOTECH, V175, P3458, DOI 10.1007/s12010-015-1517-2; Bai J., 2011, CHIN B BOT, V46, P470; BALANDRIN MF, 1985, SCIENCE, V228, P1154, DOI 10.1126/science.3890182; BARUAH NC, 1994, J CHEM ECOL, V20, P1885, DOI 10.1007/BF02066230; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; Cardile V, 2009, J ETHNOPHARMACOL, V126, P265, DOI 10.1016/j.jep.2009.08.034; Chao LK, 2005, J AGR FOOD CHEM, V53, P7274, DOI 10.1021/jf051151u; Childers R, 2015, PHYTOPATHOLOGY, V105, P342, DOI 10.1094/PHYTO-05-14-0148-R; COLBY SR, 1967, WEEDS-U, V15, P20, DOI 10.2307/4041058; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; Dikbas N, 2008, INT J FOOD MICROBIOL, V124, P179, DOI 10.1016/j.ijfoodmicro.2008.03.034; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Hayashi K, 2003, PEST MANAG SCI, V59, P294, DOI 10.1002/ps.637; He L, 2006, CHINESE J CHEM, V24, P1375, DOI 10.1002/cjoc.200690256; Kundu A, 2013, TOXICOL ENVIRON CHEM, V95, P127, DOI 10.1080/02772248.2012.759577; Kundu A, 2013, J ENVIRON SCI HEAL B, V48, P516, DOI 10.1080/03601234.2013.761921; Liao F, 2014, EXP PARASITOL, V140, P8, DOI 10.1016/j.exppara.2014.02.009; Liu XM, 2016, J PLANT DIS PROTECT, V123, P93, DOI 10.1007/s41348-016-0006-3; Liu XM, 2016, J PLANT DIS PROTECTI; MANANDHAR NP, 1991, ECON BOT, V45, P58, DOI 10.1007/BF02860050; Mu L, 1994, RES METHODS CHEM PLA; Nogueira JHC, 2010, INT J FOOD MICROBIOL, V137, P55, DOI 10.1016/j.ijfoodmicro.2009.10.017; Ouyang CB, 2015, NAT PRODUCT BIOPROSP, V5, P29, DOI 10.1007/s13659-014-0050-2; Perneel M, 2006, MYCOL RES, V110, P583, DOI 10.1016/j.mycres.2005.12.002; PROKSCH P, 1990, PHYTOCHEMISTRY, V29, P453, DOI 10.1016/0031-9422(90)85096-X; Rahman MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093192; Stirling GR, 2009, AUSTRALAS PLANT PATH, V38, P453, DOI 10.1071/AP09023; Tian J, 2012, FOOD CHEM, V130, P520, DOI 10.1016/j.foodchem.2011.07.061; Tian J, 2011, INT J FOOD MICROBIOL, V145, P464, DOI 10.1016/j.ijfoodmicro.2011.01.023; TRIPATHI R S, 1981, Proceedings of the Indian National Science Academy Part B Biological Sciences, V47, P458; Varma J, 2001, INT J FOOD MICROBIOL, V68, P207, DOI 10.1016/S0168-1605(01)00506-2; Wang PH, 2003, LETT APPL MICROBIOL, V36, P116, DOI 10.1046/j.1472-765X.2003.01272.x; Wang PH, 2003, LETT APPL MICROBIOL, V36, P157, DOI 10.1046/j.1472-765X.2003.01287.x; Zhao X, 2009, J AGR FOOD CHEM, V57, P478, DOI 10.1021/jf803023x	35	7	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176126	10.1371/journal.pone.0176126	http://dx.doi.org/10.1371/journal.pone.0176126			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467445	Green Published, Green Submitted, gold			2022-12-26	WOS:000400647000037
J	Tiedge, K; Lohaus, G				Tiedge, Kira; Lohaus, Gertrud			Nectar sugars and amino acids in day- and night-flowering Nicotiana species are more strongly shaped by pollinators' preferences than organic acids and inorganic ions	PLOS ONE			English	Article							SECONDARY METABOLITES; FLORAL NECTAR; TREE TOBACCO; PLANT; TEMPERATURE; SECRETION; CHEMISTRY; RESPONSES; DEFENSE; COMPLEX	Floral nectar contains mainly sugars but also amino acids, organic acids, inorganic ions and secondary compounds to attract pollinators. The genus Nicotiana exhibits great diversity among species in floral morphology, flowering time, nectar compositions, and predominant pollinators. We studied nectar samples of 20 Nicotiana species, composed equally of day-and night-flowering plants and attracting different groups of pollinators (e.g. hummingbirds, moths or bats) to investigate whether sugars, amino acids, organic acids and inorganic ions are influenced by pollinator preferences. Glucose, fructose and sucrose were the only sugars found in the nectar of all examined species. Sugar concentration of the nectar of day-flowering species was 20% higher and amino acid concentration was 2-3-fold higher compared to the nectar of night-flowering species. The sucrose-to-hexose ratio was significantly higher in night-flowering species and the relative share of sucrose based on the total sugar correlated with the flower tube length in the nocturnal species. Flowers of different tobacco species contained varying volumes of nectar which led to about 150-fold higher amounts of total sugar per flower in bat-or sunbird-pollinated species than in bee-pollinated or autogamous species. This difference was even higher for total amino acids per flower (up to 1000-fold). As a consequence, some Nicotiana species invest large amounts of organic nitrogen for certain pollinators. Higher concentrations of inorganic ions, predominantly anions, were found in nectar of night-flowering species. Therefore, higher anion concentrations were also associated with pollinator types active at night. Malate, the main organic acid, was present in all nectar samples but the concentration was not correlated with pollinator type. In conclusion, statistical analyses revealed that pollinator types have a stronger effect on nectar composition than phylogenetic relations. In this context, nectar sugars and amino acids are more strongly correlated with the preferences of predominant pollinators than organic acids and inorganic ions.	[Tiedge, Kira; Lohaus, Gertrud] Univ Wuppertal, Mol Plant Sci Plant Biochem, Wuppertal, Germany	University of Wuppertal	Lohaus, G (corresponding author), Univ Wuppertal, Mol Plant Sci Plant Biochem, Wuppertal, Germany.	lohaus@uni-wuppertal.de		Tiedge, Kira/0000-0002-7239-6767	Deutsche Forschungsgemeinschaft [LO 734/10-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (LO 734/10-1). The funding organization had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LS, 2000, OIKOS, V91, P409, DOI 10.1034/j.1600-0706.2000.910301.x; Adler LS, 2012, ECOL LETT, V15, P1140, DOI 10.1111/j.1461-0248.2012.01838.x; Aigner PA, 2002, SOUTHWEST NAT, V47, P1, DOI 10.2307/3672796; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Baker H. G., 1975, Coevolution of animals and plants. Symposium 5 of the 1st International Congress of Systematic and Evolutionary Biology, Boulder, Colorado, USA. (Editors L. E. Gilbert and P. H. Raven)., P100; Baker H.G., 1983, P117; BAKER HG, 1973, NATURE, V241, P543, DOI 10.1038/241543b0; BAKER HG, 1977, BOT GAZ, V138, P183, DOI 10.1086/336914; Baker HG., 1982, BIOCH ASPECTS EVOLUT, P131; Bertazzini M, 2010, AMINO ACIDS, V39, P315, DOI 10.1007/s00726-010-0474-x; CALDER WA, 1979, J THEOR BIOL, V78, P185, DOI 10.1016/0022-5193(79)90263-7; CALDER WA, 1983, PHYSIOL ZOOL, V56, P325, DOI 10.1086/physzool.56.3.30152597; Carter C, 2004, TRENDS PLANT SCI, V9, P320, DOI 10.1016/j.tplants.2004.05.008; Carter C, 2007, PLANT PHYSIOL, V143, P389, DOI 10.1104/pp.106.089326; Chase MW, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-45; Clarkson JJ, 2004, MOL PHYLOGENET EVOL, V33, P75, DOI 10.1016/j.ympev.2004.05.002; DELRIO CM, 1990, PHYSIOL ZOOL, V63, P987, DOI 10.1086/physzool.63.5.30152625; GALETTO L, 1993, CAN J BOT, V71, P1394, DOI 10.1139/b93-167; Gardener MC, 2002, OIKOS, V98, P552, DOI 10.1034/j.1600-0706.2002.980322.x; Gardener MC, 2001, J CHEM ECOL, V27, P2545, DOI 10.1023/A:1013687701120; Gonzalez-Teuber M, 2014, PSB, V4, P809; Goodspeed TH, 1954, ORIGINS RELATIONSHIP; Goulson Dave, 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P185, DOI 10.1078/1433-8319-00070; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Heil M, 2011, TRENDS PLANT SCI, V16, P191, DOI 10.1016/j.tplants.2011.01.003; Herrera CM, 2009, ANN BOT-LONDON, V103, P1415, DOI 10.1093/aob/mcp026; HIEBERT SM, 1983, ECOLOGY, V64, P399, DOI 10.2307/1937086; HOCKING PJ, 1980, ANN BOT-LONDON, V45, P633, DOI 10.1093/oxfordjournals.aob.a085871; INOUYE DW, 1984, ECOLOGY, V65, P618, DOI 10.2307/1941424; Ippolito A, 2004, EVOLUTION, V58, P2634, DOI 10.1111/j.0014-3820.2004.tb01617.x; Jurgens A, 2004, S AFR J BOT, V70, P191, DOI 10.1016/S0254-6299(15)30235-0; Kaczorowski RL, 2005, AM J BOT, V92, P1270, DOI 10.3732/ajb.92.8.1270; Kelly LJ, 2013, EVOLUTION, V67, P80, DOI 10.1111/j.1558-5646.2012.01748.x; Kessler D, 2007, PLANT J, V49, P840, DOI 10.1111/j.1365-313X.2006.02995.x; Kessler D, 2012, PLANT J, V71, P529, DOI 10.1111/j.1365-313X.2012.05008.x; Kim W, 2011, P NATL ACAD SCI USA, V108, P16618, DOI 10.1073/pnas.1108642108; Knapp S, 2004, TAXON, V53, P73, DOI 10.2307/4135490; Kromer T, 2008, PLANT BIOLOGY, V10, P502, DOI 10.1111/j.1438-8677.2008.00058.x; KRUGER K, 1982, COMP BIOCHEM PHYS A, V73, P679, DOI 10.1016/0300-9629(82)90275-4; Lohaus G, 2000, J EXP BOT, V51, P1721, DOI 10.1093/jexbot/51.351.1721; Lohaus G, 2001, PHYSIOL PLANTARUM, V111, P457, DOI 10.1034/j.1399-3054.2001.1110405.x; Lohaus G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087689; Lotz CN, 2006, BIOTROPICA, V38, P3, DOI 10.1111/j.1744-7429.2005.00104.x; Marlin D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102661; Merxmuller H, 1975, MITTEILUNGEN BOT STA, P91; Nabhan G.P., 2004, CONSERVING MIGRATORY; Nadwodnik J, 2008, PLANTA, V227, P1079, DOI 10.1007/s00425-007-0682-0; Napier KR, 2013, PHYSIOL BIOCHEM ZOOL, V86, P499, DOI 10.1086/672013; Nattero J, 2003, PLANT SYST EVOL, V241, P47, DOI 10.1007/s00606-003-0027-9; Nattero J, 2007, BIOL J LINN SOC, V90, P657, DOI 10.1111/j.1095-8312.2007.00756.x; Nicolson SW, 2003, PLANT SYST EVOL, V238, P139, DOI 10.1007/s00606-003-0276-7; Noutsos C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124501; Oksanen J., 2007, COMMUNITY ECOLOGY PA, V10, P719; Ollerton J, 2009, ANN BOT-LONDON, V103, P1471, DOI 10.1093/aob/mcp031; Pacini Ettore, 2007, P167, DOI 10.1007/978-1-4020-5937-7_4; Pender RJ, 2014, AM J BOT, V101, P201, DOI 10.3732/ajb.1300338; PERCIVAL MARY S., 1961, NEW PHYTOL, V60, P235, DOI 10.1111/j.1469-8137.1961.tb06255.x; Petanidou T, 2000, PLANT SYST EVOL, V225, P103, DOI 10.1007/BF00985461; Petanidou T, 2006, OIKOS, V115, P155, DOI 10.1111/j.2006.0030-1299.14487.x; Peter CI, 2014, ANN BOT-LONDON, V113, P277, DOI 10.1093/aob/mct216; PRINZINGER R, 1989, COMP BIOCHEM PHYS A, V92, P393, DOI 10.1016/0300-9629(89)90581-1; Proctor M., 1996, The natural history of pollination.; PYKE GH, 1981, BIOTROPICA, V13, P260, DOI 10.2307/2387804; Raguso RA, 2003, PHYTOCHEMISTRY, V63, P265, DOI 10.1016/S0031-9422(03)00113-4; RIENS B, 1994, PLANTA, V192, P497, DOI 10.1007/BF00203587; RIENS B, 1991, PLANT PHYSIOL, V97, P227, DOI 10.1104/pp.97.1.227; Rodriguez-Riano T, 2014, PLANT BIOLOGY, V16, P1075, DOI 10.1111/plb.12159; Ruhlmann JM, 2010, J EXP BOT, V61, P395, DOI 10.1093/jxb/erp309; Schmidt-Lebuhn AN, 2007, FLORA, V202, P62, DOI 10.1016/j.flora.2006.02.005; Schueller SK, 2004, AM J BOT, V91, P672, DOI 10.3732/ajb.91.5.672; Soltis DE., 2005, ANGIOSPERM PHYLOGENY; SOUTHWICK EE, 1981, AM J BOT, V68, P994, DOI 10.2307/2443231; Stevenson PC, 2017, FUNCT ECOL, V31, P65, DOI 10.1111/1365-2435.12761; Stuurman J, 2004, GENETICS, V168, P1585, DOI 10.1534/genetics.104.031138; Torres C, 2002, PLANT BIOLOGY, V4, P360, DOI 10.1055/s-2002-32326; Torres CC., 2014, INT J PLANT REPROD B, V6, P174; WALLER GD, 1972, ANN ENTOMOL SOC AM, V65, P857, DOI 10.1093/aesa/65.4.857; Witt T, 2013, J EVOLUTION BIOL, V26, P2244, DOI 10.1111/jeb.12224	78	30	30	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176865	10.1371/journal.pone.0176865	http://dx.doi.org/10.1371/journal.pone.0176865			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467507	Green Published, Green Submitted, gold			2022-12-26	WOS:000400647000080
J	Johansson, P; Almqvist, EG; Wallin, A; Johansson, JO; Andreasson, U; Blennow, K; Zetterberg, H; Svensson, J				Johansson, Per; Almqvist, Erik G.; Wallin, Anders; Johansson, Jan-Ove; Andreasson, Ulf; Blennow, Kaj; Zetterberg, Henrik; Svensson, Johan			Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment	PLOS ONE			English	Article							PERIPHERAL INFLAMMATORY MARKERS; ANGIOGENIC FACTORS VEGF; ALZHEIMERS-DISEASE; SERUM-LEVELS; ANTIINFLAMMATORY DRUGS; INTRATHECAL LEVELS; DEMENTIA; TAU; CYTOKINES; NEUROINFLAMMATION	Background The role of inflammation in Alzheimer's disease (AD) and other cognitive disorders is unclear. In a well-defined mono-center population, we measured cytokines and chemokines in paired serum and cerebrospinal fluid (CSF) samples. Methods Consecutive patients with AD (n = 30), stable mild cognitive impairment (SMCI, n = 11), other dementias (n = 11), and healthy controls (n = 18) were included. None of the subjects was treated with glucocorticoids, cholinesterase inhibitors, or non-steroidal anti-inflammatory drugs. Serum and CSF concentrations of interleukin-6 (IL-6), IL-8, IL-12/23 p40, IL-15, IL-16, vascular endothelial growth factor-A (VEGF-A), and three chemokines were measured using a multiplex panel. Results After correction for multiple comparisons, only CSF IL-12/23 p40 concentration differed significantly between the total patient group (n = 52) and controls (n = 18; p = 0.002). Further analyses showed that CSF IL-12/23 p40 concentration was decreased in all patient subgroups (AD, other dementias, and SMCI) compared to healthy controls (p < 0.01, p < 0.05, and p < 0.05, respectively). In the total study population (n = 70), CSF IL-12/23 p40 concentrations correlated positively with CSF concentrations of beta-amyloid(1-42) (A beta(1-42)) and phosphorylated tau protein (P-tau) whereas in AD patients (n = 30), CSF IL-12/23 p40 only correlated positively with CSF P-Tau (r = 0.46, p = 0.01). Conclusions Most cytokines and chemokines were similar in patients and controls, but CSF IL-12/23 subunit p40 concentration was decreased in patients with cognitive impairment, and correlated with markers of AD disease status. Further studies are needed to evaluate the role of CSF IL-12/23 p40 in other dementias and SMCI.	[Johansson, Per] Skaraborg Cent Hosp, Dept Neuropsychiat, Falkoping, Sweden; [Johansson, Per; Johansson, Jan-Ove; Svensson, Johan] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden; [Almqvist, Erik G.; Svensson, Johan] Skaraborg Cent Hosp, Dept Endocrinol, Skovde, Sweden; [Wallin, Anders; Andreasson, Ulf; Blennow, Kaj; Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Queen Sq, London, England	University of Gothenburg; University of Gothenburg; University of London; University College London	Svensson, J (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden.; Svensson, J (corresponding author), Skaraborg Cent Hosp, Dept Endocrinol, Skovde, Sweden.	johan.svensson@medic.gu.se	Johansson, Per M/K-3961-2012	Johansson, Per M/0000-0003-0073-7654; Svensson, Johan/0000-0002-4487-6405	Swedish Research Council [523-2007-7111, 14003, 2013-2546, 521-2013-2572]; European Research Council [681712]; ALF/LUA research grant in Gothenburg [ALFGBG-438631, ALFGBG-139671, ALFGBG-441051, ALFGBG-73040]; Lundberg Foundation; Torsten and Ragnar Soderberg's Foundation; Swedish Brain foundation; Knut and Alice Wallenberg Foundation; Lundbeck Foundation; Sahlgrenska University Hospital; Sahlgrenska Academy; Stiftelsen Psykiatriska Forskningsfonden; Stiftelsen Gamla Tjanarinnor; Uppsala Universitets Medicinska Fakultet stiftelse for psykiatrisk och neurologisk forskning; Alzheimer Foundation, Sweden; Dementia Association, Sweden; Frimurarestiftelsen	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); ALF/LUA research grant in Gothenburg; Lundberg Foundation(European Commission); Torsten and Ragnar Soderberg's Foundation; Swedish Brain foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Lundbeck Foundation(Lundbeckfonden); Sahlgrenska University Hospital; Sahlgrenska Academy; Stiftelsen Psykiatriska Forskningsfonden; Stiftelsen Gamla Tjanarinnor; Uppsala Universitets Medicinska Fakultet stiftelse for psykiatrisk och neurologisk forskning; Alzheimer Foundation, Sweden; Dementia Association, Sweden; Frimurarestiftelsen	This work was supported by grants from the Swedish Research Council (523-2007-7111, 14003, 2013-2546, and 521-2013-2572), the European Research Council (681712), the ALF/LUA research grant in Gothenburg (ALFGBG-438631, ALFGBG-139671, ALFGBG-441051, and ALFGBG-73040), the Lundberg Foundation, the Torsten and Ragnar Soderberg's Foundation, the Swedish Brain foundation, the Knut and Alice Wallenberg Foundation, the Lundbeck Foundation, Sahlgrenska University Hospital, Sahlgrenska Academy, Stiftelsen Psykiatriska Forskningsfonden, Stiftelsen Gamla Tjanarinnor, Uppsala Universitets Medicinska Fakultet stiftelse for psykiatrisk och neurologisk forskning, the Alzheimer Foundation, Sweden, the Dementia Association, Sweden, and Frimurarestiftelsen. The funding source did not have any role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Alsadany MA, 2013, AM J ALZHEIMERS DIS, V28, P54, DOI 10.1177/1533317512467680; Blasko I, 2006, DEMENT GERIATR COGN, V21, P9, DOI 10.1159/000089137; Blennow K, 1995, MOL CHEM NEUROPATHOL, V26, P231, DOI 10.1007/BF02815140; Bonotis K, 2008, J NEUROIMMUNOL, V193, P183, DOI 10.1016/j.jneuroim.2007.10.020; Calsolaro V, 2016, ALZHEIMERS DEMENT, V12, P719, DOI 10.1016/j.jalz.2016.02.010; Chakrabarty P, 2010, FASEB J, V24, P548, DOI 10.1096/fj.09-141754; Chen AQ, 2016, NEUROBIOL AGING, V38, P56, DOI 10.1016/j.neurobiolaging.2015.10.021; Croxford AL, 2014, CYTOKINE GROWTH F R, V25, P415, DOI 10.1016/j.cytogfr.2014.07.017; Dinarello CA, 2007, EUR J IMMUNOL, V37, pS34, DOI 10.1002/eji.200737772; Engelborghs S, 1999, NEUROCHEM INT, V34, P523, DOI 10.1016/S0197-0186(99)00031-5; Erkinjuntti T, 2000, J NEURAL TRANSM-SUPP, P23; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galimberti D, 2007, EUR J NEUROL, V14, pE3, DOI 10.1111/j.1468-1331.2006.01637.x; Galimberti D, 2006, ARCH NEUROL-CHICAGO, V63, P538, DOI 10.1001/archneur.63.4.538; Galimberti D, 2008, J NEUROL, V255, P539, DOI 10.1007/s00415-008-0737-6; Ghosh S, 2013, J NEUROSCI, V33, P5053, DOI 10.1523/JNEUROSCI.4361-12.2013; Gupta PP, 2015, AM J ALZHEIMERS DIS, V30, P178, DOI 10.1177/1533317514542644; Helmy AA, 2012, NEURODEGENER DIS, V9, P81, DOI 10.1159/000329568; Horvath I, 2016, ACS CHEM NEUROSCI, V7, P34, DOI 10.1021/acschemneuro.5b00265; Huang L, 2013, NEUROSCI LETT, V550, P60, DOI 10.1016/j.neulet.2013.06.031; Jia JP, 2005, NEUROSCI LETT, V383, P12, DOI 10.1016/j.neulet.2005.03.051; Johansson P, 2011, J ALZHEIMERS DIS, V24, P537, DOI 10.3233/JAD-2011-101878; Kalb A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062679; Kim SM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-51; Kovacs GG, 2008, DEMENT GERIATR COGN, V26, P343, DOI 10.1159/000161560; Koyama A, 2013, J GERONTOL A-BIOL, V68, P433, DOI 10.1093/gerona/gls187; Liu Y, 2014, J NEUROIMMUNOL, V271, P43, DOI 10.1016/j.jneuroim.2014.03.013; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Motta M, 2007, IMMUNOL LETT, V114, P46, DOI 10.1016/j.imlet.2007.09.002; Pasqualetti G, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0531-7; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Rasmuson S, 2011, INT PSYCHOGERIATR, V23, P1386, DOI 10.1017/S1041610211000810; Rentzos M, 2006, J GERIATR PSYCH NEUR, V19, P114, DOI 10.1177/0891988706286226; Rentzos M, 2006, J NEUROL SCI, V249, P110, DOI 10.1016/j.jns.2006.05.063; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Rota E, 2006, NEUROL SCI, V27, P33, DOI 10.1007/s10072-006-0562-6; Swardfager W, 2010, BIOL PSYCHIAT, V68, P930, DOI 10.1016/j.biopsych.2010.06.012; Tan MS, 2014, J ALZHEIMERS DIS, V38, P633, DOI 10.3233/JAD-131148; Tarkowski E, 2002, NEUROBIOL AGING, V23, P237, DOI 10.1016/S0197-4580(01)00285-8; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Trollor JN, 2010, DEMENT GERIATR COGN, V30, P569, DOI 10.1159/000322092; Vanderstichele H, 2000, AMYLOID, V7, P245, DOI 10.3109/13506120009146438; Vanmechelen E, 2000, NEUROSCI LETT, V285, P49, DOI 10.1016/S0304-3940(00)01036-3; Vlad SC, 2008, NEUROLOGY, V70, P1672, DOI 10.1212/01.wnl.0000311269.57716.63; vom Berg J, 2012, NAT MED, V18, P1812, DOI 10.1038/nm.2965; Wang J, 2015, J ALZHEIMERS DIS, V44, P385, DOI 10.3233/JAD-141506; Westin K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030525; Xia MQ, 2000, J NEUROIMMUNOL, V108, P227, DOI 10.1016/S0165-5728(00)00285-X; Yan Q, 2003, J NEUROSCI, V23, P7504; Yip Agustin G, 2005, BMC Geriatr, V5, P2, DOI 10.1186/1471-2318-5-2; Zhang RZ, 2013, J NEUROIMMUNOL, V256, P38, DOI 10.1016/j.jneuroim.2013.01.002; Zhu XC, 2014, J NEUROIMMUNOL, V274, P180, DOI 10.1016/j.jneuroim.2014.06.026	52	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176760	10.1371/journal.pone.0176760	http://dx.doi.org/10.1371/journal.pone.0176760			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28464009	Green Submitted, gold, Green Published			2022-12-26	WOS:000400646300050
J	Przybylski, S; Gasch, M; Marschner, A; Ebert, M; Ewe, A; Helmig, G; Hilger, N; Fricke, S; Rudzok, S; Aigner, A; Burkhardt, J				Przybylski, Susanne; Gasch, Michaela; Marschner, Anne; Ebert, Marcus; Ewe, Alexander; Helmig, Gisa; Hilger, Nadja; Fricke, Stephan; Rudzok, Susanne; Aigner, Achim; Burkhardt, Jana			Influence of nanoparticle-mediated transfection on proliferation of primary immune cells in vitro and in vivo	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; GENE DELIVERY; T-LYMPHOCYTES; TRANSIENT TRANSFECTION; DENDRITIC CELLS; CONTRAST AGENT; POLYETHYLENIMINE; CANCER; THERAPY; MAGNETOFECTION	Introduction One of the main obstacles in the widespread application of gene therapeutic approaches is the necessity for efficient and safe transfection methods. For the introduction of small oligonucleotide gene therapeutics into a target cell, nanoparticle-based methods have been shown to be highly effective and safe. While immune cells are a most interesting target for gene therapy, transfection might influence basic immune functions such as cytokine expression and proliferation, and thus positively or negatively affect therapeutic intervention. Therefore, we investigated the effects of nanoparticle-mediated transfection such as polyethylenimine (PEI) or magnetic beads on immune cell proliferation. Methods Human adherent and non-adherent PBMCs were transfected by various methods (e.g. PEI, Lipofectamine (R) 2000, magnetofection) and stimulated. Proliferation was measured by lymphocyte transformation test (LTT). Cell cycle stages as well as expression of proliferation relevant genes were analyzed. Additionally, the impact of nanoparticles was investigated in vivo in a murine model of the severe systemic immune disease GvHD (graft versus host disease). Results The proliferation of primary immune cells was influenced by nanoparticle-mediated transfection. In particular in the case of magnetic beads, proliferation inhibition coincided with short-term cell cycle arrest and reduced expression of genes relevant for immune cell proliferation. Notably, proliferation inhibition translated into beneficial effects in a murine GvHD model with animals treated with PEI-nanoparticles showing increased survival (pPEI = 0.002) most likely due to reduced inflammation. Conclusion This study shows for the first time that nanoparticles utilized for gene therapeutic transfection are able to alter proliferation of immune cells and that this effect depends on the type of nanoparticle. For magnetic beads, this was accompanied by temporary cell cycle arrest. Notably, in GvHD this nonspecific anti-proliferative effect might contribute to reduced inflammation and increased survival.	[Przybylski, Susanne; Ebert, Marcus; Hilger, Nadja; Fricke, Stephan; Burkhardt, Jana] Fraunhofer Inst Cell Therapy & Immunol IZI, Leipzig, Germany; [Gasch, Michaela; Rudzok, Susanne] Univ Leipzig, Translat Zentrum Regenerat Med TRM, Leipzig, Germany; [Marschner, Anne; Helmig, Gisa] Univ Leipzig, Inst Clin Immunol, Leipzig, Germany; [Ewe, Alexander; Aigner, Achim] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, Clin Pharmacol, Leipzig, Germany	Fraunhofer Gesellschaft; Leipzig University; Leipzig University; Leipzig University	Burkhardt, J (corresponding author), Fraunhofer Inst Cell Therapy & Immunol IZI, Leipzig, Germany.	jana.burkhardt@izi.fraunhofer.de	Fricke, Stephan/AAF-1629-2021; Aigner, Achim/R-4429-2017	Aigner, Achim/0000-0002-2778-6256; Burkhardt, Jana/0000-0003-0781-2653	German Federal Ministry of Education and Research (BMBF) [1315883]; Saxonian Ministery for Science and Art (Sachsisches Staatsministerium fur Wissenschaft and Kunst; SMWK grant for the project "Verfahren zur effizienten, Nanopartikelvermittelten Einschleusung therapeutischer Nukleinsauren in Zellen des Immunsystems zur; Fraunhofer Internal Programs [Attract 131-600598]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Saxonian Ministery for Science and Art (Sachsisches Staatsministerium fur Wissenschaft and Kunst; SMWK grant for the project "Verfahren zur effizienten, Nanopartikelvermittelten Einschleusung therapeutischer Nukleinsauren in Zellen des Immunsystems zur; Fraunhofer Internal Programs	This work was supported by fundings from the German Federal Ministry of Education and Research (BMBF 1315883 to JB; https://www.bmbf.de/), and from the Saxonian Ministery for Science and Art (Sachsisches Staatsministerium fur Wissenschaft and Kunst; SMWK grant for the project "Verfahren zur effizienten, Nanopartikelvermittelten Einschleusung therapeutischer Nukleinsauren in Zellen des Immunsystems zur Gentherapie immunologischer Erkrankungen"; http://www.smwk.sachsen.de) to JB and AA. This work was also supported by the Fraunhofer Internal Programs under Grant No. Attract 131-600598 to JB (http://www.fraunhofer.de/en/jobs-and-career/seasoned-professionals/fraunhofer-attract.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AJ, 2009, J BIOMED NANOTECHNOL, V5, P364, DOI 10.1166/jbn.2009.1045; Asparuhova MB, 2008, J GENE MED, V10, P1059, DOI 10.1002/jgm.1238; Bourrinet P, 2006, INVEST RADIOL, V41, P313, DOI 10.1097/01.rli.0000197669.80475.dd; Brunner S, 2000, GENE THER, V7, P401, DOI 10.1038/sj.gt.3301102; Costello E, 2000, GENE THER, V7, P596, DOI 10.1038/sj.gt.3301135; Cron RQ, 1997, J IMMUNOL METHODS, V205, P145, DOI 10.1016/S0022-1759(97)00065-3; Dave SR, 2009, WIRES NANOMED NANOBI, V1, P583, DOI 10.1002/wnan.51; Felgner PL, 1997, HUM GENE THER, V8, P511, DOI 10.1089/hum.1997.8.5-511; Ferrara JLM, 1996, STEM CELLS, V14, P473, DOI 10.1002/stem.140473; Fielding AB, 2013, CELL MOL LIFE SCI, V70, P3423, DOI 10.1007/s00018-012-1250-8; Fricke S, 2014, CELL MOL LIFE SCI, V71, P2135, DOI 10.1007/s00018-013-1476-0; Fricke S, 2010, CELL MOL LIFE SCI, V67, P4095, DOI 10.1007/s00018-010-0427-2; Furthauer M, 2009, CELL CYCLE, V8, P3311; Gul-Uludag H, 2012, STEM CELLS DEV, V21, P1587, DOI 10.1089/scd.2011.0297; Hamad I, 2010, ACS NANO, V4, P6629, DOI 10.1021/nn101990a; Han HD, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-209; Hickman SP, 2005, PHILOS T R SOC B, V360, P1713, DOI 10.1098/rstb.2005.1699; Hobel S, 2013, WIRES NANOMED NANOBI, V5, P484, DOI 10.1002/wnan.1228; Huth S, 2004, J GENE MED, V6, P923, DOI 10.1002/jgm.577; Jeudy G, 2008, CANCER GENE THER, V15, P742, DOI 10.1038/cgt.2008.42; Jiao Y, 2012, ACTA PHARMACOL SIN, V33, P250, DOI 10.1038/aps.2011.163; Kawakami S, 2008, J PHARM SCI-US, V97, P726, DOI 10.1002/jps.21024; Koltsova EK, 2012, J CLIN INVEST, V122, P3114, DOI 10.1172/JCI61758; Kong MJ, 2012, ACTA BIOCH BIOPH SIN, V44, P591, DOI 10.1093/abbs/gms039; Liu SX, 2014, WORLD J GASTROENTERO, V20, P13343, DOI 10.3748/wjg.v20.i37.13343; Madeira C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/735349; MCMAHON SB, 1995, J IMMUNOL METHODS, V179, P251, DOI 10.1016/0022-1759(94)00292-5; Meacham JM, 2014, JALA-J LAB AUTOM, V19, P1, DOI 10.1177/2211068213494388; Moghimi SM, 2010, J CONTROL RELEASE, V146, P175, DOI 10.1016/j.jconrel.2010.04.003; MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845; O'Neill MM, 2001, GENE THER, V8, P362, DOI 10.1038/sj.gt.3301407; Park HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032847, 10.1371/journal.pone.0039921]; Plank C, 2011, ADV DRUG DELIVER REV, V63, P1300, DOI 10.1016/j.addr.2011.08.002; Prechtel AT, 2007, J IMMUNOL, V178, P5454, DOI 10.4049/jimmunol.178.9.5454; Raucher D, 1999, J CELL BIOL, V144, P497, DOI 10.1083/jcb.144.3.497; Rudoll T, 1996, GENE THER, V3, P695; Rughetti A, 2000, GENE THER, V7, P1458, DOI 10.1038/sj.gt.3301266; Santra S, 2012, ACS NANO, V6, P7281, DOI 10.1021/nn302393e; Scherer F, 2002, GENE THER, V9, P102, DOI 10.1038/sj.gt.3301624; Sharma R, 1999, JMRI-J MAGN RESON IM, V9, P291, DOI 10.1002/(SICI)1522-2586(199902)9:2<291::AID-JMRI21>3.0.CO;2-#; Shen JL, 2014, THERANOSTICS, V4, P487, DOI 10.7150/thno.8263; Stachurska A, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00513; Stroh A, 2009, MOL IMAGING, V8, P166, DOI 10.2310/7290.2009.00017; van Leeuwen L, 2002, BONE MARROW TRANSPL, V29, P151, DOI 10.1038/sj.bmt.1703328; von Boehmer H, 2010, NAT IMMUNOL, V11, P14, DOI 10.1038/ni.1794; Wang WW, 2013, CURR PHARM BIOTECHNO, V14, P46; Werth S, 2006, J CONTROL RELEASE, V112, P257, DOI 10.1016/j.jconrel.2006.02.009; Wilke M, 1996, GENE THER, V3, P1133; Young A, 2000, J ROY SOC MED, V93, P10, DOI 10.1177/014107680009300104; ZABNER J, 1995, J BIOL CHEM, V270, P18997, DOI 10.1074/jbc.270.32.18997; Zhao YB, 2006, MOL THER, V13, P151, DOI 10.1016/j.ymthe.2005.07.688	51	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176517	10.1371/journal.pone.0176517	http://dx.doi.org/10.1371/journal.pone.0176517			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28463994	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000400646300026
J	Jin, J; Li, YS; Liu, XB; Wang, GH; Tang, CX; Yu, ZH; Wang, XJ; Herbert, SJ				Jin, Jian; Li, Yansheng; Liu, Xiaobing; Wang, Guanghua; Tang, Caixian; Yu, Zhenhua; Wang, Xiaojuan; Herbert, Stephen J.			Elevated CO2 alters distribution of nodal leaf area and enhances nitrogen uptake contributing to yield increase of soybean cultivars grown in Mollisols	PLOS ONE			English	Article							ORYZA-SATIVA L.; CARBON-DIOXIDE; SEED YIELD; FUTURE CO2; ENRICHMENT; RESPONSES; PHOTOSYNTHESIS; PLANTS; METAANALYSIS; IMPROVEMENT	Understanding how elevated CO2 affects dynamics of nodal leaf growth and N assimilation is crucial for the construction of high-yielding canopy via breeding and N management to cope with the future climate change. Two soybean cultivars were grown in two Mollisols differing in soil organic carbon (SOC), and exposed to ambient CO2 (380 ppm) or elevated CO2 (580 ppm) throughout the growth stages. Elevated CO2 induced 4-5 more nodes, and nearly doubled the number of branches. Leaf area duration at the upper nodes from R5 to R6 was 4.3-fold greater and that on branches 2.4-fold higher under elevated CO2 than ambient CO2, irrespective of cultivar and soil type. As a result, elevated CO2 markedly increased the number of pods and seeds at these corresponding positions. The yield response to elevated CO2 varied between the cultivars but not soils. The cultivar-specific response was likely attributed to N content per unit leaf area, the capacity of C sink in seeds and N assimilation. Elevated CO2 did not change protein concentration in seeds of either cultivar. These results indicate that elevated CO2 increases leaf area towards the upper nodes and branches which in turn contributes yield increase.	[Jin, Jian; Li, Yansheng; Liu, Xiaobing; Wang, Guanghua; Yu, Zhenhua] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Mollisols Agroecol, Harbin, Peoples R China; [Jin, Jian; Tang, Caixian; Wang, Xiaojuan] La Trobe Univ, Ctr AgriBiosci, Melbourne Campus, Bundoora, Vic, Australia; [Herbert, Stephen J.] Univ Massachusetts, Stockbridge Sch Agr, Amherst, MA 01003 USA	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; La Trobe University; University of Massachusetts System; University of Massachusetts Amherst	Jin, J (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Mollisols Agroecol, Harbin, Peoples R China.; Jin, J (corresponding author), La Trobe Univ, Ctr AgriBiosci, Melbourne Campus, Bundoora, Vic, Australia.	jinjian29@hotmail.com	于, 镇华/AAR-6878-2021; Liu, Xiaobing/AAQ-3881-2020; Li, Yansheng/AAH-6018-2020; Tang, Caixian/S-8702-2019; Wang, Guanghua/ADE-3570-2022	Tang, Caixian/0000-0002-9138-8770; Wang, Guanghua/0000-0003-4737-8126	Hundred Talents Program of Chinese Academy of Sciences [Y3ZK161001]; National Natural Science Foundation of China [41271261]; Heilongjiang Provincial Funds for Distinguished Young Scientists [JC201413]	Hundred Talents Program of Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Provincial Funds for Distinguished Young Scientists	This work was supported by: (1) the Hundred Talents Program of Chinese Academy of Sciences (JJ) (Y3ZK161001), www.cas.ac.cn, this provided the financial support to the establishment of experimental facilities; (2) the National Natural Science Foundation of China (JJ) (41271261), www.nsfc.gov.cn, this project covered the expense on the experimental measurements and data analysis; (3) Heilongjiang Provincial Funds for Distinguished Young Scientists (JJ) (JC201413), www.hljkjt.gov.cn, this project sponsored the preparation of the manuscript and publication.	Ainsworth EA, 2002, GLOBAL CHANGE BIOL, V8, P695, DOI 10.1046/j.1365-2486.2002.00498.x; Aranjuelo I, 2013, J EXP BOT, V64, P1879, DOI 10.1093/jxb/ert081; Bishop KA, 2015, PLANT CELL ENVIRON, V38, P1765, DOI 10.1111/pce.12443; Booker FL, 2005, CROP SCI, V45, P883, DOI 10.2135/cropsci2004.0198; CAMPBELL WJ, 1990, J EXP BOT, V41, P427, DOI 10.1093/jxb/41.4.427; Castro JC, 2009, J EXP BOT, V60, P2945, DOI 10.1093/jxb/erp170; Cernusak LA, 2011, PLANT PHYSIOL, V157, P372, DOI 10.1104/pp.111.182436; Curtis PS, 1998, OECOLOGIA, V113, P299, DOI 10.1007/s004420050381; Drake BG, 1997, ANNU REV PLANT PHYS, V48, P609, DOI 10.1146/annurev.arplant.48.1.609; Evans J.R., 1989, PHOTOSYNTHESIS, P183; Feng GQ, 2014, CRIT REV PLANT SCI, V33, P238, DOI 10.1080/07352689.2014.870421; Goufo P, 2014, ENVIRON EXP BOT, V99, P28, DOI 10.1016/j.envexpbot.2013.10.021; Hao XY, 2012, PHOTOSYNTHETICA, V50, P362, DOI 10.1007/s11099-012-0043-5; Hasegawa T, 2013, FUNCT PLANT BIOL, V40, P148, DOI 10.1071/FP12357; Heagle AS, 1998, CROP SCI, V38, P128, DOI 10.2135/cropsci1998.0011183X003800010022x; Hogy P, 2009, PLANT BIOLOGY, V11, P60, DOI 10.1111/j.1438-8677.2009.00230.x; Hunt R., 1982, Plant growth curves. The functional approach to plant growth analysis.; Jin J, 2012, PLANT SOIL, V358, P86, DOI 10.1007/s11104-012-1270-z; Jin JA, 2011, AGRON J, V103, P441, DOI 10.2134/agronj2010.0344; Jin J, 2010, FIELD CROP RES, V115, P116, DOI 10.1016/j.fcr.2009.10.016; Joel G, 2001, GLOBAL CHANGE BIOL, V7, P435, DOI 10.1046/j.1365-2486.2001.00420.x; Kumudini S, 2002, CROP SCI, V42, P141, DOI 10.2135/cropsci2002.0141; Lam SK, 2012, BIOL FERT SOILS, V48, P603, DOI 10.1007/s00374-011-0648-z; Leakey ADB, 2009, J EXP BOT, V60, P2859, DOI 10.1093/jxb/erp096; Liu B, 2010, PLANT SOIL ENVIRON, V56, P384, DOI 10.17221/189/2009-PSE; Liu XB, 2005, FIELD CROP RES, V93, P85, DOI 10.1016/j.fcr.2004.09.005; Long SP, 2010, CURR OPIN PLANT BIOL, V13, P241, DOI 10.1016/j.pbi.2010.04.008; MAKINO A, 1991, PLANT PHYSIOL, V96, P355, DOI 10.1104/pp.96.2.355; McGrath JM, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014054; Morgan PB, 2005, GLOBAL CHANGE BIOL, V11, P1856, DOI 10.1111/j.1365-2486.2005.001017.x; Moya TB, 1998, GLOB CHANGE BIOL, V4, P645, DOI 10.1046/j.1365-2486.1998.00180.x; Myers SS, 2014, NATURE, V510, P139, DOI 10.1038/nature13179; Oikawa S, 2013, PLANT SOIL, V373, P627, DOI 10.1007/s11104-013-1826-6; Oikawa S, 2010, PLANT SOIL, V330, P163, DOI 10.1007/s11104-009-0189-5; Palta JA, 2005, AUST J AGR RES, V56, P105, DOI 10.1071/AR04118; Qin J, 2010, PLANT BREEDING, V129, P235, DOI 10.1111/j.1439-0523.2009.01719.x; Rascher U, 2010, PHOTOSYNTH RES, V105, P15, DOI 10.1007/s11120-010-9548-6; Sakurai G, 2014, SCI REP-UK, V4, DOI 10.1038/srep04978; Salvagiotti F, 2009, AGRON J, V101, P958, DOI 10.2134/agronj2008.0173x; Setiyono TD, 2011, AGRON J, V103, P1276, DOI 10.2134/agronj2011.0053; Sinclair T.R., 2004, SOYBEANS IMPROVEMENT, V16, P537, DOI [10.2134/agronmonogr16.3-d.c11, DOI 10.2134/AGRONMONOGR16.3-D.C11, DOI 10.2134/AGRONMONOGR16.3ED.FRONTMATTER]; SINCLAIR TR, 1989, CROP SCI, V29, P90, DOI 10.2135/cropsci1989.0011183X002900010023x; Steel R. G. D., 1980, Principles and procedures of statistics, a biometrical approach.; Stocklin J, 1999, FUNCT ECOL, V13, P200, DOI 10.1046/j.1365-2435.1999.00308.x; Sui YY, 2009, FIELD CROP RES, V111, P276, DOI 10.1016/j.fcr.2009.01.005; Taub DR, 2008, GLOBAL CHANGE BIOL, V14, P565, DOI 10.1111/j.1365-2486.2007.01511.x; Yin XY, 2013, ANN BOT-LONDON, V112, P465, DOI 10.1093/aob/mct016; Zhang Wei-wei, 2014, Huanjing Kexue, V35, P1473; Zhang WW, 2014, PLANT SCI, V226, P172, DOI 10.1016/j.plantsci.2014.04.020; Ziska LH, 2001, CROP SCI, V41, P385, DOI 10.2135/cropsci2001.412385x; Ziska LH, 1998, GLOBAL CHANGE BIOL, V4, P637, DOI 10.1046/j.1365-2486.1998.00179.x	51	7	7	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176688	10.1371/journal.pone.0176688	http://dx.doi.org/10.1371/journal.pone.0176688			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459840	gold, Green Published, Green Submitted			2022-12-26	WOS:000400645000047
J	Kaljun, D; Novak, T; Zerovnik, J				Kaljun, David; Novak, Tina; Zerovnik, Janez			Improved approximation of spatial light distribution	PLOS ONE			English	Article							SOLVING NONLINEAR EQUATIONS; LEAST-SQUARES PROBLEMS; NEWTONS METHOD	The rapid worldwide evolution of LEDs as light sources has brought new challenges, which means that new methods are needed and new algorithms have to be developed. Since the majority of LED luminaries are of the multi-source type, established methods for the design of light engines cannot be used in the design of LED light engines. This is because in the latter case what is involved is not just the design of a good reflector or projector lens, but the design of several lenses which have to work together in order to achieve satisfactory results. Since lenses can also be bought off the shelf from several manufacturers, it should be possible to combine together different off the shelf lenses in order to design a good light engine. However, with so many different lenses to choose from, it is almost impossible to find an optimal combination by hand, which means that some optimization algorithms need to be applied. In order for them to work properly, it is first necessary to describe the input data (i.e. spatial light distribution) in a functional form using as few as possible parameters. In this paper the focus is on the approximation of the input data, and the implementation of the well-known mathematical procedure for the separation of linear and nonlinear parameters, which can provide a substantial increase in performance.	[Kaljun, David; Novak, Tina; Zerovnik, Janez] Univ Ljubljana, Fac Mech Engn, Ljubljana 1000, Slovenia; [Zerovnik, Janez] Inst Math Phys & Mech, Ljubljana 1000, Slovenia	University of Ljubljana	Novak, T (corresponding author), Univ Ljubljana, Fac Mech Engn, Ljubljana 1000, Slovenia.	tina.novak@fs.uni-lj.si			Research Agency of Slovenia [P1-0285, P2-0248, ARRS-100015-0510]	Research Agency of Slovenia(Slovenian Research Agency - Slovenia)	This work was supported by Research Agency of Slovenia (https://www.arrs.gov.si/), P1-0285, P2-0248, and ARRS-100015-0510. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	GOLUB GH, 1973, SIAM J NUMER ANAL, V10, P413, DOI 10.1137/0710036; Herceg D, 2013, APPL MATH COMPUT, V219, P6126, DOI 10.1016/j.amc.2012.12.016; Kaljun D., 2015, ADV EVOLUTIONARY ALG, P11788; Kaljun D., 2015, INFORMATICA, V39, P317; Kaljun D, 2016, STROJ VESTN-J MECH E, V62, P307, DOI 10.5545/sv-jme.2015.3234; Kaljun D, 2014, OPT EXPRESS, V22, P29587, DOI 10.1364/OE.22.029587; KAUFMAN L, 1978, SIAM J NUMER ANAL, V15, P12, DOI 10.1137/0715002; Molina D, 2011, SOFT COMPUT, V15, P2201, DOI 10.1007/s00500-010-0647-2; Moreno I, 2008, OPT EXPRESS, V16, P1808, DOI 10.1364/OE.16.001808; Penrose R., 1955, MATH P CAMBRIDGE PHI, V51, P406, DOI [10.1017/S0305004100030401, DOI 10.1017/S0305004100030401]; Quateroni A, 2015, NUMERICAL MATH; Thukral R, 2008, APPL MATH COMPUT, V195, P663, DOI 10.1016/j.amc.2007.05.013; Yang H, 2008, ANAL MODEL ILLUMINAN	14	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							0176252	10.1371/journal.pone.0176252	http://dx.doi.org/10.1371/journal.pone.0176252			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453546	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383900019
J	Moretton, A; Morel, F; Macao, B; Lachaume, P; Ishak, L; Lefebvre, M; Garreau-Balandier, I; Vernet, P; Falkenberg, M; Farge, G				Moretton, Amandine; Morel, Frederic; Macao, Bertil; Lachaume, Philippe; Ishak, Layal; Lefebvre, Mathilde; Garreau-Balandier, Isabelle; Vernet, Patrick; Falkenberg, Maria; Farge, Geraldine			Selective mitochondrial DNA degradation following double-strand breaks	PLOS ONE			English	Article							TARGETED RESTRICTION-ENDONUCLEASE; TRANSCRIPTION FACTOR-A; INDUCIBLE EXPRESSION; MTDNA REPLICATION; REPAIR; DAMAGE; CELLS; RECOMBINATION; REMOVAL; DISEASE	Mitochondrial DNA ( mtDNA) can undergo double-strand breaks (DSBs), caused by defective replication, or by various endogenous or exogenous sources, such as reactive oxygen species, chemotherapeutic agents or ionizing radiations. MtDNA encodes for proteins involved in ATP production, and maintenance of genome integrity following DSBs is thus of crucial importance. However, the mechanisms involved in mtDNA maintenance after DSBs remain unknown. In this study, we investigated the consequences of the production of mtDNA DSBs using a human inducible cell system expressing the restriction enzyme PstI targeted to mitochondria. Using this system, we could not find any support for DSB repair of mtDNA. Instead we observed a loss of the damaged mtDNA molecules and a severe decrease in mtDNA content. We demonstrate that none of the known mitochondrial nucleases are involved in the mtDNA degradation and that the DNA loss is not due to autophagy, mitophagy or apoptosis. Our study suggests that a still uncharacterized pathway for the targeted degradation of damaged mtDNA in a mitophagy/autophagy-independent manner is present in mitochondria, and might provide the main mechanism used by the cells to deal with DSBs.	[Moretton, Amandine; Morel, Frederic; Lachaume, Philippe; Ishak, Layal; Lefebvre, Mathilde; Garreau-Balandier, Isabelle; Vernet, Patrick; Farge, Geraldine] Univ Clermont Auvergne, CNRS, IN2P3, Lab Phys Clermont, BP 10448, F-63000 Clermont Ferrand, France; [Macao, Bertil; Falkenberg, Maria] Univ Gothenburg, Inst Biomed, POB 440, SE-40530 Gothenburg, Sweden	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite Clermont Auvergne (UCA); University of Gothenburg	Farge, G (corresponding author), Univ Clermont Auvergne, CNRS, IN2P3, Lab Phys Clermont, BP 10448, F-63000 Clermont Ferrand, France.	geraldine.farge@uca.fr	farge, geraldine/M-2803-2018; VERNET, Patrick/F-1681-2018	VERNET, Patrick/0000-0003-0170-7545; farge, geraldine/0000-0003-1054-4274; Moretton, Amandine/0000-0003-1700-3999	Clermont University; Auvergne Region; LABEX PRIMES of Universite de Lyon, within the program "Investissements d'Avenir [ANR-11-LABX-0063, ANR-11-IDEX-0007]; Swedish Research Council [2013-3621]; Knut &Alice Wallenberg Foundation; Swedish Cancer Foundation [CAN 2016/816]; European Research Council	Clermont University; Auvergne Region(Region Auvergne-Rhone-Alpes); LABEX PRIMES of Universite de Lyon, within the program "Investissements d'Avenir(French National Research Agency (ANR)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut &Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Cancer Foundation; European Research Council(European Research Council (ERC)European Commission)	This work was supported by Clermont University; the Auvergne Region (Jeune Chercheur grant to GF); the LABEX PRIMES (ANR-11-LABX-0063) of Universite de Lyon, within the program "Investissements d'Avenir (ANR-11-IDEX-0007) operated by the French National Research Agency (ANR), the Swedish Research Council (2013-3621 to MF); Knut &Alice Wallenberg Foundation (to MF); The Swedish Cancer Foundation (CAN 2016/816 to MF); European Research Council (to MF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyev M, 2013, COLD SPRING HARB PER, V5; Alexeyev MF, 2008, GENE THER, V15, P516, DOI [10.1038/gt.2008.11, 10.1038/sj.gt.2008.11]; Bacman SR, 2014, METHOD ENZYMOL, V547, P373, DOI 10.1016/B978-0-12-801415-8.00018-7; Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348; Bess AS, 2012, NUCLEIC ACIDS RES, V40, P7916, DOI 10.1093/nar/gks532; Bruni F., 2016, FEBS J; Busch KB, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0442; Cha MY, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.122; Chen TJ, 2013, BIOCHEM BIOPH RES CO, V437, P108, DOI 10.1016/j.bbrc.2013.06.048; Chen Y, 2014, ANTIOXID REDOX SIGN, V21, P1949, DOI 10.1089/ars.2013.5432; Coffey G, 2000, NUCLEIC ACIDS RES, V28, P3793, DOI 10.1093/nar/28.19.3793; Diot A, 2016, MAMM GENOME, V27, P381, DOI 10.1007/s00335-016-9651-x; Duguay BA, 2013, J VIROL, V87, P11787, DOI 10.1128/JVI.02306-13; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Furda AM, 2012, DNA REPAIR, V11, P684, DOI 10.1016/j.dnarep.2012.06.002; Gammage PA, 2016, NUCLEIC ACIDS RES; Herbst A., 2016, AGING CELL; HOUTEN BV, 2016, FRONT BIOSCI-LANDMRK, V21, P42, DOI DOI 10.2741/4375; Huang KJ, 2006, P NATL ACAD SCI USA, V103, P8995, DOI 10.1073/pnas.0603445103; Jazayeri M, 2003, J BIOL CHEM, V278, P9823, DOI 10.1074/jbc.M211730200; Kalinowska M, 2005, APOPTOSIS, V10, P821, DOI 10.1007/s10495-005-0410-9; Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004; Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439; Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501; Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94; Kukat A, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn124; Liang C, 2014, BBA-GEN SUBJECTS, V1840, P1360, DOI 10.1016/j.bbagen.2013.10.040; Lin JLJ, 2016, NUCLEIC ACIDS RES, V44, P10480, DOI 10.1093/nar/gkw931; Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08; Malena A, 2016, AUTOPHAGY, V12, P2098, DOI 10.1080/15548627.2016.1226734; McCrow JP, 2016, PROSTATE, V76, P349, DOI 10.1002/pros.23126; Meyer-Ficca ML, 2004, ANAL BIOCHEM, V334, P9, DOI 10.1016/j.ab.2004.07.011; Milani L, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0057-6; Morel F, 2008, MUTAT RES-FUND MOL M, V637, P111, DOI 10.1016/j.mrfmmm.2007.07.007; Muftuoglu M, 2014, MITOCHONDRION, V17, P164, DOI 10.1016/j.mito.2014.03.007; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nicholls TJ, 2014, HUM MOL GENET, V23, P6147, DOI 10.1093/hmg/ddu336; Nightingale H, 2016, BRAIN, V139, P1633, DOI 10.1093/brain/aww081; Phillips AF, 2017, MOL CELL, V65, P527, DOI 10.1016/j.molcel.2016.12.014; Robertson AB, 2014, NUCLEIC ACIDS RES, V42, P13280, DOI 10.1093/nar/gku1032; Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275; Shokolenko IN, 2014, MITOCHONDR DNA, V27, P490; Shokolenko IN, 2013, DNA REPAIR, V12, P488, DOI 10.1016/j.dnarep.2013.04.023; Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082; Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093; Stein A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005664; Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107; Szczesny RJ, 2013, NUCLEIC ACIDS RES, V41, P3144, DOI 10.1093/nar/gkt029; Tadi SK, 2016, MOL BIOL CELL, V27, P223, DOI 10.1091/mbc.E15-05-0260; Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980; Tann AW, 2011, J BIOL CHEM, V286, P31975, DOI 10.1074/jbc.M110.215715; Uhler JP, 2015, DNA REPAIR, V34, P28, DOI 10.1016/j.dnarep.2015.07.003; Wisnovsky S, 2016, NAT CHEM BIOL, V12, P567, DOI [10.1038/NCHEMBIO.2102, 10.1038/nchembio.2102]; Zhdanov DD, 2015, DNA CELL BIOL, V34, P316, DOI 10.1089/dna.2014.2772; Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024	55	74	78	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176795	10.1371/journal.pone.0176795	http://dx.doi.org/10.1371/journal.pone.0176795			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453550	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383900057
J	Sadri, H; von Soosten, D; Meyer, U; Kluess, J; Danicke, S; Saremi, B; Sauerwein, H				Sadri, Hassan; von Soosten, Dirk; Meyer, Ulrich; Kluess, Jeannette; Daenicke, Sven; Saremi, Behnam; Sauerwein, Helga			Plasma amino acids and metabolic profiling of dairy cows in response to a bolus duodenal infusion of leucine	PLOS ONE			English	Article							CARNITINE-ACYLCARNITINE TRANSLOCASE; PROTEIN-SYNTHESIS; MILK-PRODUCTION; SKELETAL-MUSCLE; LACTATING COWS; METHIONINE SULFOXIDE; INSULIN-SECRETION; GLUCOSE; SUPPLEMENTATION; OXIDATION	Leucine (Leu), one of the three branch chain amino acids, acts as a signaling molecule in the regulation of overall amino acid (AA) and protein metabolism. Leucine is also considered to be a potent stimulus for the secretion of insulin from pancreatice beta-cells. Our objective was to study the effects of a duodenal bolus infusion of Leu on insulin and glucagon secretion, on plasma AA concentrations, and to do a metabolomic profiling of dairy cows as compared to infusions with either glucose or saline. Six duodenum-fistulated Holstein cows were studied in a replicated 3 x 3 Latin square design with 3 periods of 7 days, in which the treatments were applied at the end of each period. The treatments were duodenal bolus infusions of Leu (DIL; 0.15 g/kg body weight), glucose (DIG; at Leu equimolar dosage) or saline (SAL). On the day of infusion, the treatments were duodenally infused after 5 h of fasting. Blood samples were collected at -15, 0, 10, 20, 30, 40, 50, 60, 75, 90, 120, 180, 210, 240 and 300 min relative to the start of infusion. Blood plasma was assayed for concentrations of insulin, glucagon, glucose and AA. The metabolome was also characterized in selected plasma samples (i.e. from 0, 50, and 120 min relative to the infusion). Body weight, feed intake, milk yield and milk composition were recorded throughout the experiment. The Leu infusion resulted in significant increases of Leu in plasma reaching 20 and 15-fold greater values than that in DIG and SAL, respectively. The elevation of plasma Leu concentrations after the infusion led to a significant decrease (P<0.05) in the plasma concentrations of isoleucine, valine, glycine, and alanine. In addition, the mean concentrations of lysine, methionine, phenylalanine, proline, serine, taurine, threonine, and asparagine across all timepoints in plasma of DIL cows were reduced (P<0.05) compared with the other groups. In contrast to the working hypothesis about an insulinotropic effect of Leu, the circulating concentrations of insulin were not affected by Leu. In DIG, insulin and glucose concentrations peaked at 30-40 and 40-50 min after the infusion, respectively. Insulin concentrations were greater (P< 0.05) from 30-40 min in DIG than DIL and SAL, and glucose was elevated in DIG over DIL and SAL from 30-75 min and 40-50 min, respectively. Multivariate metabolomics data analysis (principal component analysis and partial least squares discriminant analysis) revealed a clear separation when the DIL cows were compared with the DIG and SAL cows at 50 and 120 min after the infusion. By using this analysis, several metabolites, mainly acylcarnitines, methionine sulfoxide and components from the kynurenine pathway were identified as the most relevant for separating the treatment groups. These results suggest that Leu regulates the plasma concentrations of branched-chain AA, and other AA, apparently by stimulating their influx into the cells from the circulation. A single-dose duodenal infusion of Leu did not elicit an apparent insulin response, but affected multiple intermediary metabolic pathways including AA and energy metabolism by mechanisms yet to be elucidated.	[Sadri, Hassan; Sauerwein, Helga] Univ Bonn, Inst Anim Sci, Physiol & Hyg Unit, Bonn, Germany; [Sadri, Hassan] Univ Tabriz, Fac Vet Med, Dept Clin Sci, Tabriz, Iran; [von Soosten, Dirk; Meyer, Ulrich; Kluess, Jeannette; Daenicke, Sven] FLI, Inst Anim Nutr, Braunschweig, Germany; [Saremi, Behnam] Evonik Nutr & Care GmbH, Rodenbacher Chaussee 4, Hanau, Germany	University of Bonn; University of Tabriz; Friedrich Loeffler Institute	Sauerwein, H (corresponding author), Univ Bonn, Inst Anim Sci, Physiol & Hyg Unit, Bonn, Germany.	sauerwein@uni-bonn.de	von Soosten, Dirk/AAA-9392-2019; Sauerwein, Helga/R-8242-2019	von Soosten, Dirk/0000-0003-3425-5055; Sadri, Hassan/0000-0003-1802-4169	Evonik Nutrition & Care GmbH, Hanau, Germany	Evonik Nutrition & Care GmbH, Hanau, Germany	This project was financially supported by Evonik Nutrition & Care GmbH, Rodenbacher Chaussee 4, 63457 Hanau, Germany. The funder did not have any additional role in the study design, data collection and statistical analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2003, BBA-MOL BASIS DIS, V1639, P121, DOI 10.1016/j.bbadis.2003.08.002; [Anonymous], 2009, **NON-TRADITIONAL**; [Anonymous], MERCK INDEX, V15; Anthony JC, 1999, J NUTR, V129, P1102, DOI 10.1093/jn/129.6.1102; AOAC, 1995, OFFICIAL METHODS ANA, V16th; Badawy AAB, 2014, INT J TRYPTOPHAN RES, V7, P23, DOI 10.4137/IJTR.S18231; Bassler R., 1976, CHEM UNTERSUCHUNG FU; Bell AW, 1997, J MAMMARY GLAND BIOL, V2, P265, DOI 10.1023/A:1026336505343; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; Chen YQ, 2009, INT J TRYPTOPHAN RES, V2, P1; CLARK JH, 1977, J NUTR, V107, P631, DOI 10.1093/jn/107.4.631; Crozier SJ, 2005, J NUTR, V135, P376, DOI 10.1093/jn/135.3.376; Curtis RV, 2014, J DAIRY SCI, V97, P430, DOI 10.3168/jds.2013-7252; Davis TA, 2001, AM J PHYSIOL-ENDOC M, V280, pE770, DOI 10.1152/ajpendo.2001.280.5.E770; de Ridder KAG, 2014, CAN J ANIM SCI, V94, P323, DOI [10.4141/CJAS2013-149, 10.4141/cjas2013-149]; Dodd KM, 2012, AM J PHYSIOL-ENDOC M, V302, pE1329, DOI 10.1152/ajpendo.00525.2011; Escobar J, 2006, AM J PHYSIOL-ENDOC M, V290, pE612, DOI 10.1152/ajpendo.00402.2005; Frayn K. N., 2010, METABOLIC REGULATION; GAINES W. L., 1928, ILLINOIS AGRIC EXP STA BULL, V308, P401; GfE. (German Society of Nutrition Physiology, 2001, AUSSCH BED GES EM 8; Griinari JM, 1997, J DAIRY SCI, V80, P2361, DOI 10.3168/jds.S0022-0302(97)76187-3; Huhtanen P, 2002, J DAIRY SCI, V85, P204, DOI 10.3168/jds.S0022-0302(02)74069-1; Hurtaud C, 1998, J DAIRY SCI, V81, P3239, DOI 10.3168/jds.S0022-0302(98)75888-6; Jaakson H, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-4; Jefferson LS, 2003, J NUTR, V133, p2046S, DOI 10.1093/jn/133.6.2046S; Korhonen M, 2002, J DAIRY SCI, V85, P1533, DOI 10.3168/jds.S0022-0302(02)74223-9; Krober TF, 2001, ANIM RES, V50, P5, DOI 10.1051/animres:2001102; Lemosquet S, 2004, J DAIRY SCI, V87, P1767, DOI 10.3168/jds.S0022-0302(04)73332-9; Levine RL, 2000, IUBMB LIFE, V50, P301, DOI 10.1080/15216540051081056; Mackle TR, 2000, J DAIRY SCI, V83, P93, DOI 10.3168/jds.S0022-0302(00)74860-0; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; Mashima R, 2003, ANAL BIOCHEM, V313, P28, DOI 10.1016/S0003-2697(02)00537-7; Matsumoto T, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-35; MCDOWELL GH, 1987, AUST J BIOL SCI, V40, P295, DOI 10.1071/BI9870295; Meier JJ, 2004, DIABETES, V53, pS220, DOI 10.2337/diabetes.53.suppl_3.S220; Muoio DM, 2012, CELL METAB, V15, P595, DOI 10.1016/j.cmet.2012.04.010; Nichols K, 2016, J DAIRY SCI, V99, P1145, DOI 10.3168/jds.2015-9912; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Ramsay SL, 2007, Patent No. [EP 1875401 A211, 1875401]; Richter M, 2010, CZECH J ANIM SCI, V55, P351, DOI 10.17221/210/2009-CJAS; Roe DS, 2000, MOL GENET METAB, V69, P69, DOI 10.1006/mgme.1999.2950; Rulquin H, 2006, J DAIRY RES, V73, P328, DOI 10.1017/S0022029906001841; SANO H, 1993, DOMEST ANIM ENDOCRIN, V10, P191, DOI 10.1016/0739-7240(93)90023-5; Shimomura Y, 2009, J NUTR SCI VITAMINOL, V55, P288, DOI 10.3177/jnsv.55.288; Stahlhut HS, 2006, ANIM FEED SCI TECH, V128, P253, DOI 10.1016/j.anifeedsci.2005.11.002; STANLEY CA, 1992, NEW ENGL J MED, V327, P19, DOI 10.1056/NEJM199207023270104; Suryawan A, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-8; Suryawan A, 2009, AMINO ACIDS, V37, P97, DOI 10.1007/s00726-008-0149-z; Tarrago L, 2015, NAT CHEM BIOL, V11, P332, DOI [10.1038/NCHEMBIO.1787, 10.1038/nchembio.1787]; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; Wessels AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150376; Wiltafsky MK, 2010, BRIT J NUTR, V103, P964, DOI 10.1017/S0007114509992212; Worley B, 2013, CURR METABOL, V1, P92, DOI 10.2174/2213235X11301010092; Wu GY, 2014, ANNU REV ANIM BIOSCI, V2, P387, DOI 10.1146/annurev-animal-022513-114113; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xu G, 2001, DIABETES, V50, P353, DOI 10.2337/diabetes.50.2.353; Yang J, 2012, J BIOL CHEM, V287, P24795, DOI 10.1074/jbc.M112.344259; Yu ZP, 2014, J ANIM PHYSIOL AN N, V98, P169, DOI 10.1111/jpn.12069; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123; Zhen HM, 2015, BIOSCI BIOTECH BIOCH, V79, P2057, DOI 10.1080/09168451.2015.1060845; Zheng Y, 2016, INT J EPIDEMIOL, V45, P1482, DOI 10.1093/ije/dyw143	61	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176647	10.1371/journal.pone.0176647	http://dx.doi.org/10.1371/journal.pone.0176647			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453535	gold, Green Submitted, Green Published			2022-12-26	WOS:000400383900038
J	Walker, ME; Souza, PR; Colas, RA; Dalli, J				Walker, Mary E.; Souza, Patricia R.; Colas, Romain A.; Dalli, Jesmond			13-Series resolvins mediate the leukocyte-platelet actions of atorvastatin and pravastatin in inflammatory arthritis	FASEB JOURNAL			English	Article						pharmacology; resolution; eicosanoids; omega-3; vascular inflammation	RHEUMATOID-ARTHRITIS; DISEASE-ACTIVITY; LIPID MEDIATORS; NEUTROPHIL APOPTOSIS; RESOLUTION; SIMVASTATIN; LOVASTATIN; REDUCE; ALPHA; RISK	Rheumatoid arthritis is an inflammatory condition characterized by overzealous inflammation that leads to joint damage and is associated with an increased incidence of cardiovascular disease. Statins are frontline therapeutics for patients with cardiovascular disease and exert beneficial actions in rheumatoid arthritis. The mechanism that mediates the beneficial actions of statins in rheumatoid arthritis remains of interest. In the present study, we found that the administration of 2 clinically relevant statins-atorvastatin (0.2 mg/kg) or pravastatin (0.2 mg/kg)-to mice during inflammatory arthritis up-regulated systemic and tissue amounts of a novel family of proresolving mediators, termed 13-series resolvins (RvTs), and significantly reduced joint disease. Of note, administration of simvastatin (0.2 mg/kg) did not significantly up-regulate RvTs or reduce joint inflammation. We also found that atorvastatin and pravastatin each reduced systemic leukocyte activation, including platelet-monocyte aggregates (similar to 25-60%). These statins decreased neutrophil trafficking to the joint as well as joint monocyte and macrophage numbers. Atorvastatin and pravastatin produced significant reductions (similar to 30-50%) in expression of CD11b and major histocompatibility complex class II on both monocytes and monocyte-derived macrophages in joints. Administration of an inhibitor to cyclooxygenase-2, the initiating enzyme in the RvT pathway, reversed the protective actions of these statins on both joint and systemic inflammation. Together, these findings provide evidence for the role of RvTs in mediating the protective actions of atorvastatin and pravastatin in reducing local and vascular inflammation, and suggest that RvTs may be useful in measuring the anti-inflammatory actions of statins.	[Walker, Mary E.; Souza, Patricia R.; Colas, Romain A.; Dalli, Jesmond] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, Lipid Mediator Unit,Ctr Biochem Pharmacol, London, England	University of London; Queen Mary University London	Dalli, J (corresponding author), John Vane Sci Ctr, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.	j.dalli@qmul.ac.uk	Souza, Patricia/GLQ-8979-2022	Souza, Patricia/0000-0003-3826-6261; Dalli, Jesmond/0000-0001-6328-3640	European Research Council under European Union [677542]; Sir Henry Dale Fellowship - Wellcome Trust; Royal Society [107613/Z/15/Z]; Barts Charity Grant [MGU0343]; Medical Research Council Advance Course Masters Grant [MR/J015741/1]	European Research Council under European Union(European Research Council (ERC)); Sir Henry Dale Fellowship - Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Barts Charity Grant; Medical Research Council Advance Course Masters Grant	This work was supported by funding from the European Research Council under the European Union's Horizon 2020 research and innovation program (Grant 677542), a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant 107613/Z/15/Z), and the Barts Charity (Grant MGU0343). This work was also funded, in part, by Medical Research Council Advance Course Masters (Grant MR/J015741/1). The authors declare no conflicts of interest.	Akiyama M, 2015, CLIN RHEUMATOL, V34, P1867, DOI 10.1007/s10067-015-3049-0; Barra LJ, 2017, RHEUMATOLOGY, V56, P768, DOI 10.1093/rheumatology/kew474; Birnbaum Y, 2006, CIRCULATION, V114, P929, DOI 10.1161/CIRCULATIONAHA.106.629907; Cojocaru L, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/326258; Colas RA, 2014, AM J PHYSIOL-CELL PH, V307, pC39, DOI 10.1152/ajpcell.00024.2014; Dalli J, 2015, NAT MED, V21, P1071, DOI 10.1038/nm.3911; Danninger K, 2014, INT J RHEUM DIS, V17, P606, DOI 10.1111/1756-185X.12415; El Kebir D, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00060; El Kebir D, 2012, P NATL ACAD SCI USA, V109, P14983, DOI 10.1073/pnas.1206641109; Filer A, 2006, CURR OPIN PHARMACOL, V6, P393, DOI 10.1016/j.coph.2006.03.007; Fredman G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12859; Fullerton JN, 2016, NAT REV DRUG DISCOV, V15, P551, DOI 10.1038/nrd.2016.39; Funk JL, 2008, J RHEUMATOL, V35, P1083; Giles JT, 2015, BEST PRACT RES CL RH, V29, P597, DOI 10.1016/j.berh.2015.09.003; Gittens BR, 2015, METHODS MOL BIOL, V1207, P133, DOI 10.1007/978-1-4939-1396-1_9; Haka AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044823; Haworth O, 2015, SEMIN IMMUNOL, V27, P194, DOI 10.1016/j.smim.2015.04.002; Ji H, 1999, IMMUNOL REV, V169, P139, DOI 10.1111/j.1600-065X.1999.tb01312.x; Kling D, 2013, THROMB RES, V131, P401, DOI 10.1016/j.thromres.2013.02.020; Lea AP, 1997, DRUGS, V53, P828, DOI 10.2165/00003495-199753050-00011; Maki-Petaja KM, 2007, J AM COLL CARDIOL, V50, P852, DOI 10.1016/j.jacc.2007.04.076; Misharin AV, 2014, CELL REP, V9, P591, DOI 10.1016/j.celrep.2014.09.032; Mowla K, 2016, J CLIN DIAGN RES, V10, pOC32, DOI 10.7860/JCDR/2016/16538.7814; Neuvonen PJ, 2008, CLIN PHARMACOKINET, V47, P463, DOI 10.2165/00003088-200847070-00003; Norling LV, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85922; Perretti M, 2017, NAT REV RHEUMATOL, V13, P87, DOI 10.1038/nrrheum.2016.193; Pfluecke C, 2016, CLIN RES CARDIOL, V105, P314, DOI 10.1007/s00392-015-0922-4; Planaguma A, 2010, MUCOSAL IMMUNOL, V3, P270, DOI 10.1038/mi.2009.141; Primdahl KG, 2016, J NAT PROD, V79, P2693, DOI 10.1021/acs.jnatprod.6b00634; Rathod KS, 2017, J CLIN INVEST, V127, P169, DOI 10.1172/JCI89429; Sarabi Zhaleh Shariati, 2016, Electron Physician, V8, P2700; Serhan CN, 2017, FASEB J, V31, P1273, DOI [10.1096/fj.201601222R, 10.1096/fj.201601222r]; Shinohara M, 2014, AM J PHYSIOL-LUNG C, V307, pL746, DOI 10.1152/ajplung.00166.2014; Shirinsky IV, 2009, SCAND J RHEUMATOL, V38, P23, DOI 10.1080/03009740802363776; Spite M, 2010, CIRC RES, V107, P1170, DOI 10.1161/CIRCRESAHA.110.223883; Taylor FC, 2013, JAMA-J AM MED ASSOC, V310, P2451, DOI 10.1001/jama.2013.281348; Thieblemont N, 2016, SEMIN IMMUNOL, V28, P159, DOI 10.1016/j.smim.2016.03.004; Viola JR, 2016, CIRC RES, V119, P1030, DOI 10.1161/CIRCRESAHA.116.309492; Wang YM, 2005, CIRCULATION, V112, P2993, DOI 10.1161/CIRCULATIONAHA.105.571315; WEYRICH AS, 1995, J CLIN INVEST, V95, P2297, DOI 10.1172/JCI117921	40	21	23	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3636	3648		10.1096/fj.201700268	http://dx.doi.org/10.1096/fj.201700268			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28465323	hybrid, Green Published			2022-12-26	WOS:000405932400035
J	Zhang, JZ; Johnson, JL; He, J; Napolitano, G; Ramadass, M; Rocca, C; Kiosses, WB; Bucci, C; Xin, QS; Gavathiotis, E; Cuervo, AM; Cherqui, S; Catz, SD				Zhang, Jinzhong; Johnson, Jennifer L.; He, Jing; Napolitano, Gennaro; Ramadass, Mahalakshmi; Rocca, Celine; Kiosses, William B.; Bucci, Cecilia; Xin, Qisheng; Gavathiotis, Evripidis; Cuervo, Ana Maria; Cherqui, Stephanie; Catz, Sergio D.			Cystinosin, the small GTPase Rab11, and the Rab7 effector RILP regulate intracellular trafficking of the chaperone-mediated autophagy receptor LAMP2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; cell biology; lysosomal storage disease; lysosome; membrane trafficking	OPTICAL RECONSTRUCTION MICROSCOPY; NEPHROPATHIC CYSTINOSIS; LYSOSOMAL MEMBRANE; OXIDATIVE-STRESS; SUBCELLULAR-LOCALIZATION; TRANSPORT; PROTEIN; ACTIVATION; CELLS; TFEB	The lysosomal storage disease cystinosis, caused by cystinosin deficiency, is characterized by cell malfunction, tissue failure, and progressive renal injury despite cystine-depletion therapies. Cystinosis is associated with defects in chaperone-mediated autophagy (CMA), but the molecular mechanisms are incompletely understood. Here, we show CMA substrate accumulation in cystinotic kidney proximal tubule cells. We also found mislocalization of the CMA lysosomal receptor LAMP2A and impaired substrate translocation into the lysosome caused by defective CMA in cystinosis. The impaired LAMP2A trafficking and localization were rescued either by the expression of wild-type cystinosin or by the disease-associated point mutant CTNS-K280R, which has no cystine transporter activity. Defective LAMP2A trafficking in cystinosis was found to associate with decreased expression of the small GTPase Rab11 and the Rab7 effector RILP. Defective Rab11 trafficking in cystinosis was rescued by treatment with small-molecule CMA activators. RILP expression was restored by up-regulation of the transcription factor EB (TFEB), which was down-regulated in cystinosis. Although LAMP2A expression is independent of TFEB, TFEB up-regulation corrected lysosome distribution and lysosomal LAMP2A localization in Ctns(-/-) cells but not Rab11 defects. The up-regulation of Rab11, Rab7, or RILP, but not its truncated form RILP-C33, rescued LAMP2A-defective trafficking in cystinosis, whereas dominant-negative Rab11 or Rab7 impaired LAMP2A trafficking. Treatment of cystinotic cells with a CMA activator increased LAMP2A localization at the lysosome and increased cell survival. Altogether, we show that LAMP2A trafficking is regulated by cystinosin, Rab11, and RILP and that CMA up-regulation is a potential clinically relevant mechanism to increase cell survival in cystinosis.	[Zhang, Jinzhong; Johnson, Jennifer L.; He, Jing; Napolitano, Gennaro; Ramadass, Mahalakshmi; Kiosses, William B.; Catz, Sergio D.] Scripps Res Inst, Dept Mol Med, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Rocca, Celine; Cherqui, Stephanie] Univ Calif San Diego, Div Genet, Dept Pediat, La Jolla, CA 92093 USA; [Bucci, Cecilia] Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, Via Provinciale Monteroni 165, I-73100 Lecce, Italy; [Xin, Qisheng; Gavathiotis, Evripidis] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Xin, Qisheng; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	Scripps Research Institute; University of California System; University of California San Diego; University of Salento; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Catz, SD (corresponding author), Scripps Res Inst, Dept Mol Med, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	scatz@scripps.edu	Bucci, Cecilia/F-6699-2012; Xin, Qisheng/F-4965-2015; Rocca, Céline/AAB-2940-2021; Napolitano, Gennaro/O-5377-2016; Zhang, Jinzhong/E-5670-2012	Bucci, Cecilia/0000-0002-6232-6183; Rocca, Céline/0000-0002-8706-3869; Zhang, Jinzhong/0000-0002-2540-2749; Gavathiotis, Evripidis/0000-0001-6319-8331; Napolitano, Gennaro/0000-0002-8615-4654; Cuervo, Ana Maria/0000-0002-0771-700X; Catz, Sergio/0000-0002-1873-0277	National Institutes of Health USPHS [HL088256, GM105894]; Cystinosis Research Foundation; National Institutes of Health [R01-DK090058]; Michael J. Fox Foundation (MJFF); RR Belfer; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090058, P30DK041296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG038072, P01AG031782, R37AG021904] Funding Source: NIH RePORTER	National Institutes of Health USPHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Cystinosis Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation (MJFF); RR Belfer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health USPHS Grants HL088256 and GM105894 (to S. D. C.), by Cystinosis Research Foundation fellowships (to J. Z. and J. H.), by National Institutes of Health Grant R01-DK090058 (to S. C.), by a Michael J. Fox Foundation (MJFF) grant (to A. M. C. and E. G.), and by the generous support of R&R Belfer (to A. M. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akasaki K, 1996, J BIOCHEM-TOKYO, V120, P1088; Ambrosio AL, 2012, BLOOD, V120, P4072, DOI 10.1182/blood-2012-04-420745; Anguiano J, 2013, NAT CHEM BIOL, V9, P374, DOI 10.1038/nchembio.1230; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Cherqui S, 2012, KIDNEY INT, V81, P127, DOI 10.1038/ki.2011.301; Cuervo AM, 1999, KIDNEY INT, V55, P529, DOI 10.1046/j.1523-1755.1999.00268.x; Cuervo AM, 2000, TRAFFIC, V1, P570, DOI 10.1034/j.1600-0854.2000.010707.x; Cuervo AM, 2000, J CELL SCI, V113, P4441; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Cuervo AM, 2010, TRENDS ENDOCRIN MET, V21, P142, DOI 10.1016/j.tem.2009.10.003; DASILVA VA, 1985, NEW ENGL J MED, V313, P1460, DOI 10.1056/NEJM198512053132307; Gahl WA, 2002, NEW ENGL J MED, V347, P111, DOI 10.1056/NEJMra020552; Galarreta CI, 2015, AM J PHYSIOL-RENAL, V308, pF1155, DOI 10.1152/ajprenal.00591.2014; Gough NR, 1997, J CELL BIOL, V137, P1161, DOI 10.1083/jcb.137.5.1161; Hanneken A, 2006, INVEST OPHTH VIS SCI, V47, P3164, DOI 10.1167/iovs.04-1369; Harrison F, 2013, MOL THER, V21, P433, DOI 10.1038/mt.2012.214; He J, 2016, MOL BIOL CELL, V27, P572, DOI 10.1091/mbc.E15-05-0283; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Janvier K, 2005, MOL BIOL CELL, V16, P4231, DOI 10.1091/mbc.E05-03-0213; Johnson JL, 2016, J BIOL CHEM, V291, P3423, DOI 10.1074/jbc.M115.705871; Johnson JL, 2013, MOL CELL BIOL, V33, P2950, DOI 10.1128/MCB.00417-13; Johnson JL, 2012, MOL BIOL CELL, V23, P1902, DOI 10.1091/mbc.E11-12-1001; Kalatzis V, 2004, HUM MOL GENET, V13, P1361, DOI 10.1093/hmg/ddh152; Karlsson K, 1998, J BIOL CHEM, V273, P18966, DOI 10.1074/jbc.273.30.18966; Kaushik S., 2008, V445, P227, DOI 10.1007/978-1-59745-157-4_15; Kaushik S, 2012, TRENDS CELL BIOL, V22, P407, DOI 10.1016/j.tcb.2012.05.006; Kaushik S, 2011, J CELL SCI, V124, P495, DOI 10.1242/jcs.073874; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kon M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003182; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Li WM, 2011, CELL MOL LIFE SCI, V68, P749, DOI 10.1007/s00018-010-0565-6; LIPPINCOTTSCHWARTZ J, 1986, J CELL BIOL, V102, P1593, DOI 10.1083/jcb.102.5.1593; Martina JA, 2013, J CELL BIOL, V200, P475, DOI 10.1083/jcb.201209135; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Massey AC, 2006, CURR TOP DEV BIOL, V73, P205, DOI 10.1016/S0070-2153(05)73007-6; Moskot M, 2014, J BIOL CHEM, V289, P17054, DOI 10.1074/jbc.M114.555300; Mudrakola HV, 2009, STRUCTURE, V17, P1433, DOI 10.1016/j.str.2009.09.008; Napolitano G, 2015, EMBO MOL MED, V7, P158, DOI 10.15252/emmm.201404223; Nevo N, 2010, NEPHROL DIAL TRANSPL, V25, P1059, DOI 10.1093/ndt/gfp553; Rega LR, 2016, KIDNEY INT, V89, P862, DOI 10.1016/j.kint.2015.12.045; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schneider JL, 2015, AGING CELL, V14, P249, DOI 10.1111/acel.12310; Schneider JL, 2014, CELL METAB, V20, P417, DOI 10.1016/j.cmet.2014.06.009; Sooparb S, 2004, KIDNEY INT, V65, P2135, DOI 10.1111/j.1523-1755.2004.00639.x; Taranta A, 2008, AM J PHYSIOL-RENAL, V294, pF1101, DOI 10.1152/ajprenal.00413.2007; Taranta A, 2012, HISTOCHEM CELL BIOL, V138, P351, DOI 10.1007/s00418-012-0958-8; Town M, 1998, NAT GENET, V18, P319, DOI 10.1038/ng0498-319; Vaisbich MH, 2011, NEPHRON EXTRA, V1, P73, DOI 10.1159/000331445; Wallace DME, 2002, BIOCHEM BIOPH RES CO, V299, P770, DOI 10.1016/S0006-291X(02)02720-1; Wilmer MJ, 2010, AM J PHYSIOL-RENAL, V299, pF905, DOI 10.1152/ajprenal.00318.2010; Xu K., 2013, FAR FIELD OPTICAL NA, P27	53	42	42	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10328	10346		10.1074/jbc.M116.764076	http://dx.doi.org/10.1074/jbc.M116.764076			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28465352	Green Published, hybrid			2022-12-26	WOS:000404115400002
J	Beasley, JT; Bonneau, JP; Johnson, AAT				Beasley, Jesse T.; Bonneau, Julien P.; Johnson, Alexander A. T.			Characterisation of the nicotianamine aminotransferase and deoxymugineic acid synthase genes essential to Strategy II iron uptake in bread wheat (Triticum aestivum L.)	PLOS ONE			English	Article							ORYZA-SATIVA L.; PHYTOSIDEROPHORE RELEASE; REGULATORY ELEMENTS; GRAMINEOUS PLANTS; DEFICIENT BARLEY; RICE PLANTS; EXPRESSION; IDENTIFICATION; PROMOTER; ZINC	Iron (Fe) uptake in graminaceous plant species occurs via the release and uptake of Fe-chelating compounds known as mugineic acid family phytosiderophores (MAs). In the MAs biosynthetic pathway, nicotianamine aminotransferase (NAAT) and deoxymugineic acid synthase (DMAS) enzymes catalyse the formation of 2'-deoxymugineic acid (DMA) from nicotianamine (NA). Here we describe the identification and characterisation of six TaNAAT and three TaDMAS1 genes in bread wheat (Triticum aestivum L.). The coding sequences of all six TaNAAT homeologs consist of seven exons with >= 88.0% nucleotide sequence identity and most sequence variation present in the first exon. The coding sequences of the three TaDMAS1 homeologs consist of three exons with >= 97.8% nucleotide sequence identity. Phylogenetic analysis revealed that the TaNAAT and TaDMAS1 proteins are most closely related to the HvNAAT and HvDMAS1 proteins of barley and that there are two distinct groups of TaNAAT proteins-TaNAAT1 and TaNAAT2 -that correspond to the HvNAATA and HvNAATB proteins, respectively. Quantitative reverse transcription-PCR analysis revealed that the TaNAAT2 genes are expressed at highest levels in anther tissues whilst the TaNAAT1 and TaDMAS1 genes are expressed at highest levels in root tissues of bread wheat. Furthermore, the TaNAAT1, TaNAAT2 and TaDMAS1 genes were differentially regulated by plant Fe status and their expression was significantly upregulated in root tissues from day five onwards during a seven-day Fe deficiency treatment. The identification and characterization of the TaNAAT1, TaNAAT2 and TaDMAS1 genes provides a valuable genetic resource for improving bread wheat growth on Fe deficient soils and enhancing grain Fe nutrition.	[Beasley, Jesse T.; Bonneau, Julien P.; Johnson, Alexander A. T.] Univ Melbourne, Sch Biosci, Melbourne, Vic, Australia	University of Melbourne	Johnson, AAT (corresponding author), Univ Melbourne, Sch Biosci, Melbourne, Vic, Australia.	johnsa@unimelb.edu.au			Australian Research Council [LP130100785]; HarvestPlus Challenge Program	Australian Research Council(Australian Research Council); HarvestPlus Challenge Program	This research was supported by grants from the Australian Research Council (http://www.arc.gov.au/grants; LP130100785) and the HarvestPlus Challenge Program (http://www.harvestplus.org) to AATJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov ED, 2013, PLANT PHYSIOL, V161, P252, DOI 10.1104/pp.112.205161; Aoyama T, 2009, PLANT MOL BIOL, V70, P681, DOI 10.1007/s11103-009-9500-3; Bartos J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-155; Bashir K, 2006, J BIOL CHEM, V281, P32395, DOI 10.1074/jbc.M604133200; Bate N, 1998, PLANT MOL BIOL, V37, P859, DOI 10.1023/A:1006095023050; Bonneau J, 2016, PLANT BIOTECHNOL J; Cheng LJ, 2007, PLANT PHYSIOL, V145, P1647, DOI 10.1104/pp.107.107912; Close TJ, 2004, PLANT PHYSIOL, V134, P960, DOI 10.1104/pp.103.034462; Daneshbakhsh B, 2013, J PLANT PHYSIOL, V170, P41, DOI 10.1016/j.jplph.2012.08.016; Dash S, 2012, NUCLEIC ACIDS RES, V40, pD1194, DOI 10.1093/nar/gkr938; Druka Arnis, 2006, Functional & Integrative Genomics, V6, P202, DOI 10.1007/s10142-006-0025-4; Eagling T, 2014, J AGR FOOD CHEM, V62, P10320, DOI 10.1021/jf5026295; Eagling T, 2014, J AGR FOOD CHEM, V62, P708, DOI 10.1021/jf403331p; GUERINOT ML, 1994, PLANT PHYSIOL, V104, P815, DOI 10.1104/pp.104.3.815; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hansen NC, 1996, CROP SCI, V36, P1473, DOI 10.2135/cropsci1996.0011183X003600060009x; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Inoue H, 2008, PLANT MOL BIOL, V66, P193, DOI 10.1007/s11103-007-9262-8; KANAZAWA K, 1995, J EXP BOT, V46, P1241, DOI 10.1093/jxb/46.9.1241; Kobayashi T, 2005, J EXP BOT, V56, P1305, DOI 10.1093/jxb/eri131; Kobayashi T, 2003, PLANT J, V36, P780, DOI 10.1046/j.1365-313X.2003.01920.x; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Leach LJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-276; LIU CJ, 1992, THEOR APPL GENET, V83, P305, DOI 10.1007/BF00224276; Liu XH, 2013, PLANTA, V238, P845, DOI 10.1007/s00425-013-1934-9; Liu ZS, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0511-8; MA JF, 1995, J BIOL CHEM, V270, P16549, DOI 10.1074/jbc.270.28.16549; Ma JF, 1999, J EXP BOT, V50, P723, DOI 10.1093/jexbot/50.334.723; Manimaran P, 2015, PLANT REPROD, V28, P133, DOI 10.1007/s00497-015-0264-4; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; MORTVEDT JJ, 1991, PLANT SOIL, V130, P273, DOI 10.1007/BF00011883; Nagasaka S, 2009, PLANT MOL BIOL, V69, P621, DOI 10.1007/s11103-008-9443-0; Nishiyama R, 2012, PLANT CELL PHYSIOL, V53, P381, DOI 10.1093/pcp/pcr188; Nozoye T, 2007, PLANT MOL BIOL, V64, P35, DOI 10.1007/s11103-007-9132-4; Nussbaumer T, 2015, G3-GENES GENOM GENET, V5, P2579, DOI 10.1534/g3.115.021550; Park JI, 2006, PLANT CELL REP, V25, P466, DOI 10.1007/s00299-005-0077-2; Pearce S, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0368-2; Riewe D, 2012, PLANT J, V71, P850, DOI 10.1111/j.1365-313X.2012.05035.x; ROMHELD V, 1990, PLANT SOIL, V123, P147, DOI 10.1007/BF00011260; Roschzttardtz H, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00350; Schreiber AW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-285; Sears E.R, 1954, ANEUPLOIDS COMMON WH; Sengupta D, 2015, J PLANT PHYSIOL, V179, P40, DOI 10.1016/j.jplph.2015.03.004; Shi RL, 2012, NEW PHYTOL, V195, P372, DOI 10.1111/j.1469-8137.2012.04165.x; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; Suzuki M, 2008, PLANT MOL BIOL, V66, P609, DOI 10.1007/s11103-008-9292-x; Suzuki M, 2006, PLANT J, V48, P85, DOI 10.1111/j.1365-313X.2006.02853.x; Swapna L, 2011, MOL BIOTECHNOL, V48, P49, DOI 10.1007/s12033-010-9347-5; TAKAGI S, 1984, J PLANT NUTR, V7, P469, DOI 10.1080/01904168409363213; Takahashi M, 1999, PLANT PHYSIOL, V121, P947, DOI 10.1104/pp.121.3.947; Takahashi M, 2003, PLANT CELL, V15, P1263, DOI 10.1105/tpc.010256; Takahashi M, 2001, NAT BIOTECHNOL, V19, P466, DOI 10.1038/88143; Tauris B, 2009, J EXP BOT, V60, P1333, DOI 10.1093/jxb/erp023; TWELL D, 1991, GENE DEV, V5, P496, DOI 10.1101/gad.5.3.496; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Widodo, 2010, NEW PHYTOL, V186, P400, DOI 10.1111/j.1469-8137.2009.03177.x	57	33	38	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177061	10.1371/journal.pone.0177061	http://dx.doi.org/10.1371/journal.pone.0177061			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475636	Green Published, gold			2022-12-26	WOS:000400649500039
J	Beghe, D; Dall'Asta, L; Garavelli, C; Pastorelli, AA; Muscarella, M; Saccani, G; Aiello, M; Crisafulli, E; Corradi, M; Stacchini, P; Chetta, A; Bertorelli, G				Beghe, Deborah; Dall'Asta, Luca; Garavelli, Claudia; Pastorelli, Augusto Alberto; Muscarella, Marilena; Saccani, Gloria; Aiello, Marina; Crisafulli, Ernesto; Corradi, Massimo; Stacchini, Paolo; Chetta, Alfredo; Bertorelli, Giuseppina			Sarcoidosis in an Italian province. Prevalence and environmental risk factors	PLOS ONE			English	Article							TRADE-CENTER DISASTER; GRANULOMATOUS PULMONARY-DISEASE; AIR-POLLUTION; PO VALLEY; EPIDEMIOLOGY; LICHENS; FIREFIGHTERS; MESOTHELIOMA; OPHIOLITES; MORTALITY	Background and aim Sarcoidosis is a systemic granulomatous inflammatory disease whose causes are still unknown and for which epidemiological data are often discordant. The aim of our study is to investigate prevalence and spatial distribution of cases, and identify environmental exposures associated with sarcoidosis in an Italian province. Methods After georeferentiation of cases, the area under study was subdivided with respect to Municipality and Health Districts and to the altitude in order to identify zonal differences in prevalence. The bioaccumulation levels of 12 metals in lichen tissues were analyzed, in order to determine sources of air pollution. Finally, the analysis of the correlation between metals and between pickup stations was performed. Results 223 patients were identified (58.3% female and 41.7% male of total) and the mean age was 50.6 +/- 15.4 years (53.5 +/- 15.5 years for the females and 46.5 +/- 14.4 for the males). The mean prevalence was 49 per 100.000 individuals. However, we observed very heterogeneous prevalence in the area under study. The correlations among metals revealed different deposition patterns in lowland area respect to hilly and mountain areas. Conclusions The study highlights a high prevalence of sarcoidosis cases, characterized by a very inhomogeneous and patchy distribution with phenomena of local aggregation. Moreover, the bioaccumulation analysis was an effective method to identify the mineral particles that mostly contribute to air pollution in the different areas, but it was not sufficient to establish a clear correlation between the onset of sarcoidosis and environmental risk factors.	[Beghe, Deborah] Univ Parma, Dept Food & Drug, Parma, Italy; [Dall'Asta, Luca] Polytech Univ Turin, Dept Appl Sci & Technol, Turin, Italy; [Dall'Asta, Luca] Coll Carlo Alberto, Turin, Italy; [Garavelli, Claudia; Corradi, Massimo] Univ Parma, Occupat Med Unit, Dept Med & Surg, Parma, Italy; [Pastorelli, Augusto Alberto; Stacchini, Paolo] Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, Natl Reference Lab Heavy Met Food, Rome, Italy; [Muscarella, Marilena] Ist Zooprofilatt Sperimentale Puglia & Basilicata, Foggia, Italy; [Saccani, Gloria] Univ Parma, Dept Med & Surg, Parma, Italy; [Aiello, Marina; Crisafulli, Ernesto; Chetta, Alfredo; Bertorelli, Giuseppina] Univ Parma, Dept Med & Surg, Resp Dis & Lung Funct Unit, Parma, Italy	University of Parma; Polytechnic University of Turin; Collegio Carlo Alberto; University of Parma; Istituto Superiore di Sanita (ISS); IZS Puglia e Basilicata; University of Parma; University of Parma	Crisafulli, E (corresponding author), Univ Parma, Dept Med & Surg, Resp Dis & Lung Funct Unit, Parma, Italy.	ernesto.crisafulli@unipr.it	Crisafulli, Ernesto/AAB-9595-2019; Beghè, Deborah/AAS-2940-2020; Aiello, Marina/ABD-1516-2021	Crisafulli, Ernesto/0000-0001-7298-7084; Chetta, Alfredo/0000-0002-0416-5334; Beghe, Deborah/0000-0002-0945-5365	Fondazione Cariparma-Parma, Italy	Fondazione Cariparma-Parma, Italy	This work was supported by a grant from the Fondazione Cariparma-Parma, Italy, to Prof. Giuseppina Bertorelli. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate E, 1980, APENNINE OPHIOLITES, P59; Agostini C, 2001, Monaldi Arch Chest Dis, V56, P364; Agrawal R, 2016, TUBERCULOSIS, V98, P21, DOI 10.1016/j.tube.2016.01.003; [Anonymous], 2005, 17025 UNI CEI EN ISO; Barnard J, 2005, J OCCUP ENVIRON MED, V47, P226, DOI 10.1097/01.jom.0000155711.88781.91; Baughman RP, 2001, AM J RESP CRIT CARE, V164, P1885, DOI 10.1164/ajrccm.164.10.2104046; Bayram M, 2013, CHEST, V143, P164, DOI 10.1378/chest.11-2727; Bernardini P, 2003, G Ital Med Lav Ergon, V25, P408; Bigi A, 2014, ATMOS CHEM PHYS, V14, P4895, DOI 10.5194/acp-14-4895-2014; Bigi A, 2012, J ENVIRON MONITOR, V14, P552, DOI 10.1039/c1em10728c; Brunialti G, 2007, SCI TOTAL ENVIRON, V387, P289, DOI 10.1016/j.scitotenv.2007.06.033; Comba P, 2003, ARCH ENVIRON HEALTH, V58, P229, DOI 10.3200/AEOH.58.4.229-232; Corradi M, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/4/046003; Crowley LE, 2011, AM J IND MED, V54, P175, DOI 10.1002/ajim.20924; Deubelbeiss U, 2010, EUR RESPIR J, V35, P1088, DOI 10.1183/09031936.00197808; Dongel I, 2013, RESP MED, V107, P870, DOI 10.1016/j.rmed.2013.03.006; Dubrey S, 2014, POSTGRAD MED J, V90, P582, DOI 10.1136/postgradmedj-2014-132584; Erdal BS, 2012, RESP MED, V106, P893, DOI 10.1016/j.rmed.2012.02.007; Fabrellas EF, 2007, ARCH BRONCONEUMOL, V43, P92, DOI 10.1016/S1579-2129(07)60030-5; GENTRY JT, 1955, J CLIN INVEST, V34, P1839, DOI 10.1172/JCI103240; Goldberg M, 2009, EUR J CANCER PREV, V18, P489, DOI 10.1097/CEJ.0b013e32832f9bee; Gorham ED, 2004, CHEST, V126, P1431, DOI 10.1378/chest.126.5.1431; Gribbin J, 2006, THORAX, V61, P980, DOI 10.1136/thx.2006.062836; Guevara SR, 1995, J RADIOAN NUCL CH AR, V198, P437, DOI 10.1007/BF02036560; Harmens H., 2008, SPATIAL TEMPORAL TRE; HUNNINGHAKE GW, 1981, NEW ENGL J MED, V305, P429, DOI 10.1056/NEJM198108203050804; ISTAT, 2013, HLTH ALL IT; Izbicki G, 2007, CHEST, V131, P1414, DOI 10.1378/chest.06-2114; Jordan HT, 2011, J OCCUP ENVIRON MED, V53, P966, DOI 10.1097/JOM.0b013e31822a3596; KERN DG, 1993, AM REV RESPIR DIS, V148, P974, DOI 10.1164/ajrccm/148.4_Pt_1.974; Lodenius M., 2014, WIT T ECOLOGY ENV, V183, P75, DOI [10.2495/AIR140071, DOI 10.2495/AIR140071]; Loppi S, 2003, ENVIRON POLLUT, V121, P327, DOI 10.1016/S0269-7491(02)00269-5; Maslow CB, 2012, AM J PUBLIC HEALTH, V102, P1186, DOI 10.2105/AJPH.2011.300561; Musellim B, 2009, RESP MED, V103, P907, DOI 10.1016/j.rmed.2008.12.011; Newman KL, 2012, CURR OPIN ALLERGY CL, V12, P145, DOI 10.1097/ACI.0b013e3283515173; Newman LS, 2004, AM J RESP CRIT CARE, V170, P1324, DOI 10.1164/rccm.200402-249OC; Nicholson TT, 2010, SARCOIDOSIS VASC DIF, V27, P111; Nimis PL, 2000, SCI TOTAL ENVIRON, V255, P97, DOI 10.1016/S0048-9697(00)00454-X; Nimis PL, 1999, P WORKSH BIOM QUAL A, V1999, P279; Perez-Simon MR, 2003, ANALES MED INTERNA, V20, P21; Prezant DJ, 1999, CHEST, V116, P1183, DOI 10.1378/chest.116.5.1183; Putaud JP, 2010, ATMOS ENVIRON, V44, P1308, DOI 10.1016/j.atmosenv.2009.12.011; R Development Core Team, 2005, R LANG ENV STAT COMP; Regione Emilia Romagna in collaborazione con: Arpa Amianto Stop Servizio Sanitario Regionale Emilia-Romagna Provincia di Piacenza Provincia di Parma Provincia di Reggio Emilia Provincia di Modena, 2004, PROG REG PIETR VERD; Saiki M, 2014, J RADIOANAL NUCL CH, V299, P773, DOI 10.1007/s10967-013-2698-1; SARTWELL PE, 1974, AM J EPIDEMIOL, V99, P250, DOI 10.1093/oxfordjournals.aje.a121609; Tinelli C, 2005, SARCOIDOSIS VASC DIF, V22, pS4; TYLER G, 1990, BOT J LINN SOC, V104, P231, DOI 10.1111/j.1095-8339.1990.tb02220.x; Valeyre D, 2014, CURR OPIN PULM MED, V20, P488, DOI 10.1097/MCP.0000000000000075; Wahlstrom J, 1999, THORAX, V54, P339, DOI 10.1136/thx.54.4.339; [No title captured]	51	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176859	10.1371/journal.pone.0176859	http://dx.doi.org/10.1371/journal.pone.0176859			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475583	Green Submitted, Green Published, gold			2022-12-26	WOS:000400649500021
J	Fabi, F; Grenier, K; Parent, S; Adam, P; Tardif, L; Leblanc, V; Asselin, E				Fabi, Francois; Grenier, Kathy; Parent, Sophie; Adam, Pascal; Tardif, Laurence; Leblanc, Valerie; Asselin, Eric			Regulation of the PI3K/Akt pathway during decidualization of endometrial stromal cells	PLOS ONE			English	Article							NF-KAPPA-B; EPITHELIAL-MESENCHYMAL TRANSITION; IN-VITRO DECIDUALIZATION; AKT ISOFORMS; PROLIFERATIVE ENDOMETRIUM; PROLACTIN EXPRESSION; CROSS-TALK; ACTIVATION; SURVIVAL; GROWTH	Infertility is constantly increasing in Canada, where 16% of Canadian couples are experiencing difficulty conceiving. It is thought that infertility can emanate from the dysregulated communication between the embryo and the maternal endometrium. In order to allow for this window of implantation to be open at the right moment, endometrial stromal cells proliferate and differentiate by a mechanism called decidualization. Intracellular and molecular mechanisms involved in the regulation of apoptosis and cell proliferation during decidualization of the endometrium are yet to be fully understood. It has been well demonstrated previously that Akt is importantly involved in cell survival and glycogen synthesis. Akt1, Akt2 and Akt3 isoforms have distinct physiological roles; this could also be the case during decidualization and pregnancy. The aim of this study is to investigate the regulation of PI3K/Akt pathway during the decidualization process of endometrial stromal cells. Expression of Akt isoforms, Akt activity (phospho-Akt), pI kappa B and substrates of Akt during decidualization were measured. To our knowledge, these results are the first to suggest a decrease in levels of Akt isoforms as well as a downregulation of Akt activity in the process of decidualization of human endometrial stromal cells. We also uncovered that decidualization induced nuclear localization of p65 through the phosphorylation of I.B, its inhibitory subunit; however, Par-4, a recently uncovered regulator of cell differentiation, was displaced from the nucleus upon decidualization. Our results also suggest that HIESC cells exhibit decreased motility during decidualization and that PI3K pathway inhibition could be involved in this process. Finally, we demonstrate that specific Akt isoforms present unique effects on the successful induction of decidualization. Further analyses will involve investigations to understand the precise signaling mechanisms by which this pathway is regulated.	[Fabi, Francois; Grenier, Kathy; Parent, Sophie; Adam, Pascal; Tardif, Laurence; Leblanc, Valerie; Asselin, Eric] Univ Quebec Trois Rivieres, Dept Med Biol, CP 500, Trois Rivieres, PQ, Canada	University of Quebec; University of Quebec Trois Rivieres	Asselin, E (corresponding author), Univ Quebec Trois Rivieres, Dept Med Biol, CP 500, Trois Rivieres, PQ, Canada.	eric.asselin@uqtr.ca		Fabi, Francois/0000-0003-3923-2880	Natural Sciences and Engineering Research Council of Canada (NSERC) [238501-01]; Reseau Quebecois en Reproduction (RQR); FRQ-S PhD Scholarship	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Reseau Quebecois en Reproduction (RQR); FRQ-S PhD Scholarship	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) (238501-01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Francois Fabi was holder of a FRQ-S PhD Scholarship and Kathy Grenier was holder of master scholarship from Reseau Quebecois en Reproduction (RQR). We are grateful to Michel A. Fortier for the HIESC cells.	Aksamitiene E, 2012, BIOCHEM SOC T, V40, P139, DOI 10.1042/BST20110609; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Bai D, 2009, INT J CANCER, V125, P2863, DOI 10.1002/ijc.24748; Brar AK, 1997, ENDOCRINE, V6, P301, DOI 10.1007/BF02820507; Brosens JJ, 1999, ENDOCRINOLOGY, V140, P4809, DOI 10.1210/en.140.10.4809; Brosens JJ, 1996, ENDOCRINOLOGY, V137, P2225, DOI 10.1210/en.137.6.2225; Bushnik T, 2012, HUM REPROD, V27, P738, DOI 10.1093/humrep/der465; Chaudhry P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.7; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Chin YR, 2009, CELL SIGNAL, V21, P470, DOI 10.1016/j.cellsig.2008.11.015; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; DALY DC, 1983, AM J OBSTET GYNECOL, V145, P672, DOI 10.1016/0002-9378(83)90572-0; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dery Marie-Claude, 2003, Reprod Biol Endocrinol, V1, P47; Dunn Carolyn L, 2003, Reprod Biomed Online, V7, P151; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Fabi F, 2014, REPRODUCTION, V148, pR85, DOI 10.1530/REP-14-0270; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Girouard J, 2013, GYNECOL ONCOL, V128, P335, DOI 10.1016/j.ygyno.2012.11.016; Grille SJ, 2003, CANCER RES, V63, P2172; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Haslinger P, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104778; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kong DH, 1997, NAT GENET, V17, P143, DOI 10.1038/ng1097-143; Logan PC, 2012, REPROD SCI, V19, P883, DOI 10.1177/1933719112438447; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Park BK, 2001, CANCER RES, V61, P7647; Patterson AL, 2013, STEM CELLS DEV, V22, P964, DOI 10.1089/scd.2012.0435; Risinger JI, 1998, CLIN CANCER RES, V4, P3005; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sekulic A, 2000, CANCER RES, V60, P3504; TANG BQ, 1994, ANN NY ACAD SCI, V734, P19, DOI 10.1111/j.1749-6632.1994.tb21731.x; TANG BQ, 1993, ENDOCRINOLOGY, V133, P2197, DOI 10.1210/en.133.5.2197; Telgmann R, 1998, HUM REPROD UPDATE, V4, P472, DOI 10.1093/humupd/4.5.472; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Veillette A, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107136; Yin XQ, 2012, J CLIN ENDOCR METAB, V97, pE35, DOI 10.1210/jc.2011-1527; Yu J, 2016, ENDOCRINOLOGY, V157, P2432, DOI 10.1210/en.2015-1942; Zhang XH, 2013, REPROD SCI, V20, P354, DOI 10.1177/1933719112472738; Zhao L, 2008, BIOCHEM PHARMACOL, V75, P1515, DOI 10.1016/j.bcp.2007.12.014	47	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177387	10.1371/journal.pone.0177387	http://dx.doi.org/10.1371/journal.pone.0177387			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475617	gold, Green Published, Green Submitted			2022-12-26	WOS:000400649500066
J	Nakamura, M; Kanda, T; Jiang, X; Haga, Y; Takahashi, K; Wu, S; Yasui, S; Nakamoto, S; Yokosuka, O				Nakamura, Masato; Kanda, Tatsuo; Jiang, Xia; Haga, Yuki; Takahashi, Koji; Wu, Shuang; Yasui, Shin; Nakamoto, Shingo; Yokosuka, Osamu			Serum microRNA-122 and Wisteria floribunda agglutinin-positive Mac-2 binding protein are useful tools for liquid biopsy of the patients with hepatitis B virus and advanced liver fibrosis	PLOS ONE			English	Article							C VIRUS; HEPATOCELLULAR-CARCINOMA; TRANSIENT ELASTOGRAPHY; EXPRESSION; INFECTION; MIR-122; GENES; RISK	Background Noninvasive methods to accurately and conveniently evaluate liver fibrosis are desirable. MicroRNA (miR) is one of the candidates. MiRs are small RNAs consisting of 19-25 nucleotides that negatively regulate many target genes at transcriptional levels. Recently, many researchers have focused on circulating miRs in the blood stream as biomarkers. Hepatic miR-122 has been reported to have an association with viral replication and hepatic fibrosis in chronic hepatitis B virus (HBV) and hepatic C virus (HCV) infection. Methods We measured serum miR-122 levels in HBV- and HCV-infected patients confirmed with liver biopsy. We also investigated a novel liver fibrosis marker Wisteria floribunda agglutinin-positive Mac-2 binding protein [WFA(+)-M2BP]. We evaluated the diagnostic usefulness of these markers in hepatic fibrosis and inflammation of patients with chronic viral infection. Results The serum miR-122 levels of HBV-infected patients were higher than those of the control subjects. In HBV-infected patients, the serum miR-122 levels of patients with advanced liver fibrosis were significantly lower. Serum WFA(+)-M2BP was significantly higher dependent on both the staging of fibrosis and the grading of inflammatory activity in patients with both HBV and HCV infection. We also observed that higher serum WFA(+)-M2BP levels augmented the prediction of advanced liver fibrosis among HBV-infected patients with lower serum miR-122 levels. Conclusions A lower serum miR-122 level is a useful predictor of advanced liver fibrosis in HBV-infected patients. Serum WFA(+)-M2BP could predict liver fibrosis in both HBV and HCV infection. The combination of these markers may result in the more accurate evaluation of liver fibrosis in HBV infection.	[Nakamura, Masato; Kanda, Tatsuo; Jiang, Xia; Haga, Yuki; Takahashi, Koji; Wu, Shuang; Yasui, Shin; Nakamoto, Shingo; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan; [Nakamoto, Shingo] Chiba Univ, Grad Sch Med, Dept Mol Virol, Chiba, Japan; [Yokosuka, Osamu] Japan Community Hlth Care Org, Dept Internal Med, Funabashi Chuo Hosp, Funabashi, Chiba, Japan	Chiba University; Chiba University	Kanda, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan.	kandat-cib@umin.ac.jp		Kanda, Tatsuo/0000-0002-1654-5385	MSD; Chugai Pharmaceutical [AC-1-2 0160603004715-334801]; Abbvie [201606_CASE, 58]; Sysmex; Japan Agency for Medical Research and Development, AMED	MSD; Chugai Pharmaceutical; Abbvie(AbbVie); Sysmex; Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This work was supported by are search grants from MSD, Chugai Pharmaceutical (AC-1-2 0160603004715-334801), Abbvie (201606_CASE No.58) and Sysmex. This research was (partially) supported by the Research Program on Hepatitis from the Japan Agency for Medical Research and Development, AMED. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekki Y, 2016, J GASTROENTEROL HEPA; Cheng HR, 2015, HEPATOL INT, V9, P35, DOI 10.1007/s12072-014-9591-z; Devhare PB, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2016.12.75; Fan CG, 2011, ONCOL REP, V26, P1281, DOI 10.3892/or.2011.1375; Haga Yuki, 2016, Diseases, V4, DOI 10.3390/diseases4040038; Hayes CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047490; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Ichida F, 1996, INT HEPATOL COMMUN, V6, P112, DOI 10.1016/S0928-4346(96)00325-8; Ichikawa Y, 2016, HEPATOL RES; Inohara H, 1996, CANCER RES, V56, P4530; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Jiang X, 2014, WORLD J GASTROENTERO, V20, P7197, DOI 10.3748/wjg.v20.i23.7197; Kamezaki H, 2011, SCAND J GASTROENTERO, V46, P1111, DOI 10.3109/00365521.2011.584898; Kim SU, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003434; Kumar S, 2017, EXP BIOL MED, V242, P436, DOI 10.1177/1535370216681548; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Masuzaki R, 2009, HEPATOLOGY, V49, P1954, DOI 10.1002/hep.22870; Nakamura M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144295; Nakamura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081312; Nishikawa H, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004679; Parikh P, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.01.28; Qiao DD, 2017, EUR REV MED PHARMACO, V21, P742; Qiu LP, 2010, BIOCHEM BIOPH RES CO, V398, P771, DOI 10.1016/j.bbrc.2010.07.021; Raitoharju E, 2016, SCI REP-UK, V6, DOI 10.1038/srep38262; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Sarkar N, 2015, J VIRAL HEPATITIS, V22, P817, DOI 10.1111/jvh.12390; Schwarzenbach H, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3446; TANAKA T, 1994, HEPATOLOGY, V19, P1347, DOI 10.1016/0270-9139(94)90226-7; Wang SF, 2012, HEPATOLOGY, V55, P730, DOI 10.1002/hep.24809; Witwer KW, 2015, CLIN CHEM, V61, P56, DOI 10.1373/clinchem.2014.221341; Wojcik K, 2016, ACTA BIOCHIM POL, V63, P527, DOI [10.18388/abp.2015_1216, 10.18388/abp.2016_1216]; Yamasaki K, 2014, HEPATOLOGY, V60, P1563, DOI 10.1002/hep.27305; Yarushkin AA, 2017, EUR J PHARMACOL, V797, P39, DOI 10.1016/j.ejphar.2017.01.016; Yoshimoto K, 2003, LEUKEMIA LYMPHOMA, V44, P229, DOI 10.1080/1042819021000029704	34	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177302	10.1371/journal.pone.0177302	http://dx.doi.org/10.1371/journal.pone.0177302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475652	Green Published, Green Submitted, gold			2022-12-26	WOS:000400649500063
J	Aung, WPP; Htoon, TT; Tina, HH; Thinn, KK; Sanpool, O; Jongthawin, J; Sadaow, L; Phosuk, I; Rodpai, R; Intapan, PM; Maleewong, W				Aung, Win Pa Pa; Htoon, Thi Thi; Tina, Htay Htay; Thinn, Kyi Kyi; Sanpool, Oranuch; Jongthawin, Jurairat; Sadaow, Lakkhana; Phosuk, Issarapong; Rodpai, Rutchanee; Intapan, Pewpan M.; Maleewong, Wanchai			First report and molecular identification of Opisthorchis viverrini infection in human communities from Lower Myanmar	PLOS ONE			English	Article							RISK-FACTORS; TREMATODA OPISTHORCHIIDAE; LIVER FLUKES; CHOLANGIOCARCINOMA; FISH; HELMINTHIASIS; PREVALENCE; PROVINCE; AREA; PCR	Opisthorchis viverrini is endemic in the South East Asian region, especially in Cambodia, Lao People's Democratic Republic, Vietnam and Thailand, but there have been no previous records from Myanmar. During stool surveys of rural populations in three regions of Lower Myanmar, Opisthorchis-like eggs were found in 34 out of 364 (9.3%) participants by stool microscopy after using the modified formalin-ether concentration technique. DNA was extracted from these positive stool samples and a portion of the mitochondrial cytochrome c oxidase subunit I (cox1) gene was amplified using the polymerase chain reaction and then sequenced. DNA sequences, successfully obtained from 18 of 34 positive samples (Bago Region, n = 13; Mon State, n = 3; Yangon Region, n = 2), confirmed that the eggs were of O. viverrini. Sequences showed 99.7% identity with O. viverrini mitochondrial cox1 (GenBank accession no. JF739555) but 95%, 88.7%, 82.6% and 81.4% identities with those of Opisthorchis lobatus from Lao People's Democratic Republic (GenBank accession nos. HQ328539-HQ328541), Metorchis orientalis from China (KT239342), Clonorchis sinensis from China (JF729303) and Opisthorchis felineus from Russia (EU921260), respectively. When alignement with other Opisthorchiidae trematodes, 81% similarity with Metorchis bilis from Czech Republic (GenBank accession nos. KT740966, KT740969, KT740970) and Slovakia (GenBank accession nos. KT740971-KT740973), 84.6% similarity with Metorchis xanthosomus from Czech Republic (GenBank accession no. KT740974), 78.6% similarity with M. xanthosomus from Poland (GenBank accession no. KT740968) and 82.2% similarity with Euamphimerus pancreaticus from Czech Republic (GenBank accession no. KT740975) were revealed. This study demonstrated, for the first time, O. viverrini from rural people in Myanmar using molecular methods and is an urgent call for surveillance and control activities against opisthorchiasis in Myanmar.	[Aung, Win Pa Pa; Sanpool, Oranuch; Jongthawin, Jurairat; Sadaow, Lakkhana; Phosuk, Issarapong; Rodpai, Rutchanee; Intapan, Pewpan M.; Maleewong, Wanchai] Khon Kaen Univ, Fac Med, Dept Parasitol, Khon Kaen, Thailand; [Aung, Win Pa Pa; Sanpool, Oranuch; Jongthawin, Jurairat; Sadaow, Lakkhana; Phosuk, Issarapong; Rodpai, Rutchanee; Intapan, Pewpan M.; Maleewong, Wanchai] Khon Kaen Univ, Res & Diagnost Ctr Emerging Infect Dis, Mekong Hlth Sci Res Inst, Khon Kaen, Thailand; [Aung, Win Pa Pa] Univ Med 2, Dept Microbiol, Minist Hlth & Sport, Yangon, Myanmar; [Htoon, Thi Thi; Tina, Htay Htay] Natl Hlth Lab, Dept Parasitol, Yangon, Myanmar; [Thinn, Kyi Kyi] Univ Med 1, Int Relat Div, Minist Hlth & Sport, Yangon, Myanmar; [Jongthawin, Jurairat] Mahasarakham Univ, Fac Med, Maha Sarakham, Thailand	Khon Kaen University; Khon Kaen University; Mahasarakham University	Maleewong, W (corresponding author), Khon Kaen Univ, Fac Med, Dept Parasitol, Khon Kaen, Thailand.; Maleewong, W (corresponding author), Khon Kaen Univ, Res & Diagnost Ctr Emerging Infect Dis, Mekong Hlth Sci Res Inst, Khon Kaen, Thailand.	wanch_ma@kku.ac.th		Maleewong, Wanchai/0000-0002-6726-3759	TRF Senior Research Scholar Grant; Thailand Research Fund [RTA5880001]; Higher Education Research Promotion and National Research University Project of Thailand; Office of the Higher Education Commission, Thailand; Faculty of Medicine, Khon Kaen University [TR57201, IN59211]; Research and Diagnostic Center for Emerging Infectious Disease, Mekong Health Science lnstitue, Khon Kaen University; Research Affairs and Graduate School, Khon Kaen University [58101]	TRF Senior Research Scholar Grant; Thailand Research Fund(Thailand Research Fund (TRF)); Higher Education Research Promotion and National Research University Project of Thailand; Office of the Higher Education Commission, Thailand; Faculty of Medicine, Khon Kaen University; Research and Diagnostic Center for Emerging Infectious Disease, Mekong Health Science lnstitue, Khon Kaen University; Research Affairs and Graduate School, Khon Kaen University	This study was supported by a TRF Senior Research Scholar Grant, Thailand Research Fund grant number RTA5880001; the Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission, Thailand, through the Health Cluster (SHeP-GMS); the Faculty of Medicine, Khon Kaen University (TR57201); Research and Diagnostic Center for Emerging Infectious Disease, Mekong Health Science lnstitue, Khon Kaen University through Wanchai Maleewong and Pewpan M. lntapan. Win Pa Pa Aung was partial supported by the Faculty of Medicine, Khon Kaen University (IN59211). Oranuch Sanpool was supported by the Post Doctoral Training Program from Research Affairs and Graduate School, Khon Kaen University (grant no. 58101). We also certified that all the funders and sources of support received during this specific study (whether external or internal to our organizations) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anamnart W, 2010, J CLIN MICROBIOL, V48, P97, DOI 10.1128/JCM.01613-09; [Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V61, P121; Buathong S, 2015, PARASITOL RES, V114, P3547, DOI 10.1007/s00436-015-4640-7; Chai JY, 2014, KOREAN J PARASITOL, V52, P35, DOI 10.3347/kjp.2014.52.1.35; Forrer A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001481; Honjo S, 2005, INT J CANCER, V117, P854, DOI 10.1002/ijc.21146; Jongsuksuntigul P, 2003, ACTA TROP, V88, P229, DOI 10.1016/j.actatropica.2003.01.002; Le TH, 2006, EXP PARASITOL, V112, P109, DOI 10.1016/j.exppara.2005.09.012; Miyamoto K, 2014, PARASITOL INT, V63, P366, DOI 10.1016/j.parint.2013.12.003; Na L, 2016, INFECT GENET EVOL, V39, P45, DOI 10.1016/j.meegid.2016.01.010; Hung NM, 2013, ACTA PARASITOL, V58, P231, DOI 10.2478/s11686-013-0155-5; Sahu R, 2016, J HELMINTHOL, V90, P607, DOI 10.1017/S0022149X15000851; Sanpool O, 2012, PARASITOL RES, V111, P89, DOI 10.1007/s00436-011-2804-7; Sayasone S, 2009, T ROY SOC TROP MED H, V103, P247, DOI 10.1016/j.trstmh.2008.10.011; Sithithaworn P, 2012, PARASITOL INT, V61, P10, DOI 10.1016/j.parint.2011.08.014; Sitko J, 2016, PARASITOL INT, V65, P258, DOI 10.1016/j.parint.2016.01.011; Sohn WM, 2012, ACTA TROP, V124, P215, DOI 10.1016/j.actatropica.2012.08.011; Sripa B, 2008, CURR OPIN GASTROEN, V24, P349, DOI 10.1097/MOG.0b013e3282fbf9b3; Sripa B, 2011, ACTA TROP, V120, pS158, DOI 10.1016/j.actatropica.2010.07.006; Sripa B, 2010, ADV PARASIT, V72, P305, DOI 10.1016/S0065-308X(10)72011-X; Thaenkham U, 2007, ACTA TROP, V103, P26, DOI 10.1016/j.actatropica.2007.05.006; Thaenkham U, 2011, J PARASITOL, V97, P1152, DOI 10.1645/GE-2764.1; Dao TTH, 2016, ACTA TROP, V157, P151, DOI 10.1016/j.actatropica.2016.01.029; Tun A, 2013, TROP MED INT HEALTH, V18, P1017, DOI 10.1111/tmi.12130; Dung VT, 2014, EMERG INFECT DIS, V20, P152, DOI 10.3201/eid2001.130168; Yong TS, 2014, KOREAN J PARASITOL, V52, P661, DOI 10.3347/kjp.2014.52.6.661; Yoon HJ, 2014, AM J TROP MED HYG, V91, P384, DOI 10.4269/ajtmh.13-0596; Zheng SH, 2017, PARASITOL RES, V116, P11, DOI 10.1007/s00436-016-5276-y	28	41	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177130	10.1371/journal.pone.0177130	http://dx.doi.org/10.1371/journal.pone.0177130			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472153	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500142
J	Almonacid, DE; Kraal, L; Ossandon, FJ; Budovskaya, YV; Cardenas, JP; Bik, EM; Goddard, AD; Richman, J; Apte, ZS				Almonacid, Daniel E.; Kraal, Laurens; Ossandon, Francisco J.; Budovskaya, Yelena V.; Cardenas, Juan Pablo; Bik, Elisabeth M.; Goddard, Audrey D.; Richman, Jessica; Apte, Zachary S.			16S rRNA gene sequencing and healthy reference ranges for 28 clinically relevant microbial taxa from the human gut microbiome	PLOS ONE			English	Article							BACTERIA; LACTOBACILLUS; OBESE	Changes in the relative abundances of many intestinal microorganisms, both those that naturally occur in the human gut microbiome and those that are considered pathogens, have been associated with a range of diseases. To more accurately diagnose health conditions, medical practitioners could benefit from a molecular, culture-independent assay for the quantification of these microorganisms in the context of a healthy reference range. Here we present the targeted sequencing of the microbial 16S rRNA gene of clinically relevant gut microorganisms as a method to provide a gut screening test that could assist in the clinical diagnosis of certain health conditions. We evaluated the possibility of detecting 46 clinical prokaryotic targets in the human gut, 28 of which could be identified with high precision and sensitivity by a bioinformatics pipeline that includes sequence analysis and taxonomic annotation. These targets included 20 commensal, 3 beneficial (probiotic), and 5 pathogenic intestinal microbial taxa. Using stool microbiome samples from a cohort of 897 healthy individuals, we established a reference range defining clinically relevant relative levels for each of the 28 targets. Our assay quantifies 28 targets in the context of a healthy reference range and correctly reflected 38/38 verification samples of real and synthetic stool material containing known gut pathogens. Thus, we have established a method to determine microbiome composition with a focus on clinically relevant taxa, which has the potential to contribute to patient diagnosis, treatment, and monitoring. More broadly, our method can facilitate epidemiological studies of the microbiome as it relates to overall human health and disease.	[Almonacid, Daniel E.; Kraal, Laurens; Ossandon, Francisco J.; Budovskaya, Yelena V.; Cardenas, Juan Pablo; Bik, Elisabeth M.; Goddard, Audrey D.; Richman, Jessica; Apte, Zachary S.] uBiome Inc, San Francisco, CA 94103 USA; [Apte, Zachary S.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Budovskaya, Yelena V.] Stanford Univ, Dept Dermatol, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Stanford University	Apte, ZS (corresponding author), uBiome Inc, San Francisco, CA 94103 USA.; Apte, ZS (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	zac@ubiome.com	Cardenas, Juan Pablo/AAB-2469-2020	Cardenas, Juan Pablo/0000-0001-6715-7270; Almonacid, Daniel E/0000-0002-1788-2084	uBiome, Inc.	uBiome, Inc.	All authors are or were full-time employees of uBiome, Inc. uBiome, Inc. funded the study design, collection, analysis, and interpretation of data; writing of the paper; and decision to submit for publication. The research was designed by the uBiome, Inc. research team. uBiome, Inc. non-research staff had no role in the study design, data collection and analysis, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Achtman M., 2008, NATURE REV MICROBIOL, V6, P1; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Backhed F, 2012, CELL HOST MICROBE, V12, P611, DOI 10.1016/j.chom.2012.10.012; Bhattarai Y, 2017, AM J PHYSIOL-GASTR L, V312, pG52, DOI 10.1152/ajpgi.00338.2016; Cady NC, 2003, BIOSENS BIOELECTRON, V19, P59, DOI 10.1016/S0956-5663(03)00123-4; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Collins SM, 2016, INT REV NEUROBIOL, V131, P247, DOI 10.1016/bs.irn.2016.08.003; Dawson LF, 2009, INFECT GENET EVOL, V9, P1410, DOI 10.1016/j.meegid.2009.06.005; De Filippis F, 2016, GUT, V65, P1812, DOI 10.1136/gutjnl-2015-309957; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06; Furuya-Kanamori L, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1258-4; Giammanco GM, 2002, J CLIN MICROBIOL, V40, P3502, DOI 10.1128/JCM.40.9.3502-3505.2002; Gilbert JA, 2016, NATURE, V535, P94, DOI 10.1038/nature18850; Grice EA, 2012, ANNU REV GENOM HUM G, V13, P151, DOI 10.1146/annurev-genom-090711-163814; LeBlanc JG, 2013, CURR OPIN BIOTECH, V24, P160, DOI 10.1016/j.copbio.2012.08.005; Haley BJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00691; HUMMEL W, 1989, J MICROBIOL METH, V9, P201, DOI 10.1016/S0167-7012(97)00050-X; Jaspers E, 2004, APPL ENVIRON MICROB, V70, P4831, DOI 10.1128/AEM.70.8.4831-4839.2004; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Kang S, 2010, INFLAMM BOWEL DIS, V16, P2034, DOI 10.1002/ibd.21319; Kitsios GD, 2017, J CRIT CARE, V38, P84, DOI 10.1016/j.jcrc.2016.09.029; Konstantinidis KT, 2007, CURR OPIN MICROBIOL, V10, P504, DOI 10.1016/j.mib.2007.08.006; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Lagier JC, 2015, CLIN MICROBIOL REV, V28, P208, DOI 10.1128/CMR.00110-14; Lahtinen SJ, 2009, AGE, V31, P59, DOI 10.1007/s11357-008-9081-0; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lloyd-Price J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0307-y; Mahe F, 2014, PEERJ, V2, DOI 10.7717/peerj.593; McInnes P., 2010, MANUAL PROCEDURES HU; Meyer D, 2009, EUR J CLIN NUTR, V63, P1277, DOI 10.1038/ejcn.2009.64; Million M, 2012, MICROB PATHOGENESIS, V53, P100, DOI 10.1016/j.micpath.2012.05.007; Minalla A, 2001, PROC SPIE, V4560, P90, DOI 10.1117/12.443044; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Navaneethan U, 2008, NAT CLIN PRACT GASTR, V5, P637, DOI 10.1038/ncpgasthep1264; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rettedal EA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5714; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Russell WR, 2011, AM J CLIN NUTR, V93, P1062, DOI 10.3945/ajcn.110.002188; Shukla SK, 2015, TRENDS MOL MED, V21, P461, DOI 10.1016/j.molmed.2015.06.002; Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846; Staley JT, 2006, PHILOS T R SOC B, V361, P1899, DOI 10.1098/rstb.2006.1914; Stecher B, 2011, CURR OPIN MICROBIOL, V14, P82, DOI 10.1016/j.mib.2010.10.003; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Thorkildsen LT, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/636785; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039; Wehkamp J, 2017, J MOL MED, V95, P21, DOI 10.1007/s00109-016-1495-z; Weinstock GM, 2012, NATURE, V489, P250, DOI 10.1038/nature11553; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Woo PCY, 2008, CLIN MICROBIOL INFEC, V14, P908, DOI 10.1111/j.1469-0691.2008.02070.x; Zmora N, 2016, CELL HOST MICROBE, V19, P12, DOI 10.1016/j.chom.2015.12.016; Zupancic ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043052	56	42	44	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176555	10.1371/journal.pone.0176555	http://dx.doi.org/10.1371/journal.pone.0176555			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467461	Green Submitted, Green Published, gold			2022-12-26	WOS:000400647000059
J	Garrison, P; Yue, SN; Hanson, J; Baron, J; Lui, JLC				Garrison, Presley; Yue, Shanna; Hanson, Jeffrey; Baron, Jeffrey; Lui, Julian C.			Spatial regulation of bone morphogenetic proteins (BMPs) in postnatal articular and growth plate cartilage	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; SKELETAL DEVELOPMENT; IN-VIVO; CHONDROGENESIS; CELLS; ZONE; IDENTIFICATION; CHONDROCYTES; INITIATION; ADIPOSE	Articular and growth plate cartilage both arise from condensations of mesenchymal cells, but ultimately develop important histological and functional differences. Each is composed of three layers-the superficial, mid and deep zones of articular cartilage and the resting, proliferative and hypertrophic zones of growth plate cartilage. The bone morphogenetic protein (BMP) system plays an important role in cartilage development. A gradient in expression of BMP-related genes has been observed across growth plate cartilage, likely playing a role in zonal differentiation. To investigate the presence of a similar expression gradient in articular cartilage, we used laser capture microdissection (LCM) to separate murine growth plate and articular cartilage from the proximal tibia into their six constituent zones, and used a solution hybridization assay with color-coded probes (nCounter) to quantify mRNAs for 30 different BMP-related genes in each zone. In situ hybridization and immunohistochemistry were then used to confirm spatial expression patterns. Expression gradients for Bmp2 and 6 were observed across growth plate cartilage with highest expression in hypertrophic zone. However, intracellular BMP signaling, assessed by phospho-Smad1/5/8 immunohistochemical staining, appeared to be higher in the proliferative zone and prehypertrophic area than in hypertrophic zone, possibly due to high expression of Smad7, an inhibitory Smad, in the hypertrophic zone. We also found BMP expression gradients across the articular cartilage with BMP agonists primarily expressed in the superficial zone and BMP functional antagonists primarily expressed in the deep zone. Phospho-Smad1/5/8 immunohistochemical staining showed a similar gradient. In combination with previous evidence that BMPs regulate chondrocyte proliferation and differentiation, the current findings suggest that BMP signaling gradients exist across both growth plate and articular cartilage and that these gradients may contribute to the spatial differentiation of chondrocytes in the postnatal endochondral skeleton.	[Garrison, Presley; Yue, Shanna; Baron, Jeffrey; Lui, Julian C.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Growth & Dev, NIH, Bethesda, MD 20892 USA; [Hanson, Jeffrey] NCI, Laser Capture Microdissect Core Facil, Pathol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lui, JLC (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Growth & Dev, NIH, Bethesda, MD 20892 USA.	luichunk@mail.nih.gov	Lui, Julian/E-2253-2012	Lui, Julian/0000-0002-0611-4901	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000640] Funding Source: NIH RePORTER	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH.; This work was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH. We thank the Center for Center Research (CCR) Genomics Core of National Center Institute (NCI) and NanoString Technologies Inc. for providing technical support for our experiments.	Abad V, 2002, ENDOCRINOLOGY, V143, P1851, DOI 10.1210/en.143.5.1851; Bandyopadhyay A, 2008, DEV BIOL, V321, P162, DOI 10.1016/j.ydbio.2008.06.012; Bentley-Hewitt KL, 2016, NEW BIOTECHNOL, V33, P380, DOI 10.1016/j.nbt.2016.01.002; Chau M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103061; COX KH, 1984, DEV BIOL, V101, P485, DOI 10.1016/0012-1606(84)90162-3; De Luca F, 2001, ENDOCRINOLOGY, V142, P430, DOI 10.1210/en.142.1.430; Erickson HS, 2009, NAT PROTOC, V4, P902, DOI 10.1038/nprot.2009.61; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Estrada KD, 2013, DEV BIOL, V382, P375, DOI 10.1016/j.ydbio.2013.08.021; GARDNER E, 1968, J ANAT, V102, P289; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; Jing JJ, 2013, INT J BIOL SCI, V9, P895, DOI 10.7150/ijbs.7508; Khalafi A, 2007, J ORTHOP RES, V25, P293, DOI 10.1002/jor.20329; Kobayashi T, 2005, P NATL ACAD SCI USA, V102, P18023, DOI 10.1073/pnas.0503617102; Kozhemyakina E, 2015, ARTHRITIS RHEUMATOL, V67, P1261, DOI 10.1002/art.39030; Lui JLC, 2015, PEDIATR RES, V77, P406, DOI 10.1038/pr.2014.208; Lui JCK, 2010, BONE, V46, P1380, DOI 10.1016/j.bone.2010.01.373; Malkov Vladislav A, 2009, BMC Res Notes, V2, P80, DOI 10.1186/1756-0500-2-80; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; Nilsson O, 2007, J ENDOCRINOL, V193, P75, DOI 10.1677/joe.1.07099; Ono N, 2014, NAT CELL BIOL, V16, P1157, DOI 10.1038/ncb3067; Pacifici Maurizio, 2005, Birth Defects Research, V75, P237, DOI 10.1002/bdrc.20050; Rountree RB, 2004, PLOS BIOL, V2, P1815, DOI 10.1371/journal.pbio.0020355; Salazar VS, 2016, NAT REV ENDOCRINOL, V12, P203, DOI 10.1038/nrendo.2016.12; Shi JJ, 2013, ARTHROSCOPY, V29, P2001, DOI 10.1016/j.arthro.2013.09.076; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Veldman-Jones MH, 2015, CANCER RES, V75, P2587, DOI 10.1158/0008-5472.CAN-15-0262; Yasuhara R, 2011, LAB INVEST, V91, P1739, DOI 10.1038/labinvest.2011.144; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Yoon BS, 2006, DEVELOPMENT, V133, P4667, DOI 10.1242/dev.02680	31	21	22	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176752	10.1371/journal.pone.0176752	http://dx.doi.org/10.1371/journal.pone.0176752			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467498	gold, Green Published, Green Submitted			2022-12-26	WOS:000400647000071
J	Krongdang, S; Evans, JD; Pettis, JS; Chantawannakul, P				Krongdang, Sasiprapa; Evans, Jay D.; Pettis, Jeffery S.; Chantawannakul, Panuwan			Multilocus sequence typing, biochemical and antibiotic resistance characterizations reveal diversity of North American strains of the honey bee pathogen Paenibacillus larvae	PLOS ONE			English	Article							SUBSP LARVAE; HOUSEKEEPING GENES; FOULBROOD DISEASE; MLST; TRANSMISSION; PULVIFACIENS; COLONIES; ORIGIN; SPORES	Paenibacillus larvae is a Gram positive bacterium and the causative agent of the most widespread fatal brood disease of honey bees, American foulbrood (AFB). A total of thirty-three independent Paenibacillus larvae isolates from various geographical origins in North America and five reference strains were investigated for genetic diversity using multilocus sequence typing (MLST). This technique is regarded to be a powerful tool for epidemiological studies of pathogenic bacteria and is widely used in genotyping assays. For MLST, seven housekeeping gene loci, ilvD (dihydroxy-acid dyhydrogenase), tri (triosephosphate isomerase), purH (phospharibosyl-aminoimidazolecarboxamide), recF (DNA replication and repair protein), pyrE (orotate phosphoribosyltransferase), sucC (succinyl coenzyme A synthetase beta subunit) and glpF (glycerol uptake facilitator protein) were studied and applied for primer designs. Previously, ERIC type DNA fingerprinting was applied to these same isolates and the data showed that almost all represented the ERIC I type, whereas using BOX-PCR gave an indication of more diversity. All isolates were screened for resistance to four antibiotics used by U.S. beekeepers, showing extensive resistance to tetracycline and the first records of resistance to tylosin and lincomycin. Our data highlight the intraspecies relationships of P. larvae and the potential application of MLST methods in enhancing our understanding of epidemiological relationships among bacterial isolates of different origins.	[Krongdang, Sasiprapa; Chantawannakul, Panuwan] Chiang Mai Univ, Fac Sci, Dept Biol, Bee Protect Lab, Chiang Mai, Thailand; [Evans, Jay D.; Pettis, Jeffery S.] USDA ARS, Bee Res Lab, Beltsville, MD USA; [Chantawannakul, Panuwan] Chiang Mai Univ, Fac Sci, Mat Sci Res Ctr, Chiang Mai, Thailand	Chiang Mai University; United States Department of Agriculture (USDA); Chiang Mai University	Chantawannakul, P (corresponding author), Chiang Mai Univ, Fac Sci, Dept Biol, Bee Protect Lab, Chiang Mai, Thailand.; Chantawannakul, P (corresponding author), Chiang Mai Univ, Fac Sci, Mat Sci Res Ctr, Chiang Mai, Thailand.	panuwan@gmail.com	Krongdang, Sasiprapa/AGT-3415-2022; Evans, Jay/C-8408-2012	Evans, Jay/0000-0002-0036-4651	Office of the Higher Education Commission, Thailand [CHE-SW215/2551]; Thailand Research Fund; Chiang Mai University fund	Office of the Higher Education Commission, Thailand; Thailand Research Fund(Thailand Research Fund (TRF)); Chiang Mai University fund	This research was financially supported by a grant under The Program of Strategic Scholarships for Frontier Research Network for the Joint Ph.D. Program Thai Doctoral degree from the Office of the Higher Education Commission, Thailand (Grant No. CHE-SW215/2551), Thailand Research Fund and Chiang Mai University fund. We wish to thank the USDA-ARS Bee Research Laboratory (Beltsville, MD, USA), and the Graduate School of Chiang Mai University. We are also grateful to M. Hamilton, D. Lopez, and B. Smith, S. Abban, Y. Melnikova and the staff of the USDA-ARS Bee Research Laboratory (Beltsville, MD, USA), for excellent technical help with the project. We also thank E. Forsgren for kindly providing isolates included in this study.; This research was financially supported by a grant under The Program of Strategic Scholarships for Frontier Research Network for the Joint Ph.D. Program Thai Doctoral degree from the Office of the Higher Education Commission, Thailand (Grant No. CHE-SW215/2551), Thailand Research Fund and Chiang Mai University fund. We wish to thank the USDA-ARS Bee Research Laboratory (Beltsville, MD, USA), and the Graduate School of Chiang Mai University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alippi AM, 1998, J APICULT RES, V37, P273, DOI 10.1080/00218839.1998.11100983; Alippi AM, 2005, VET MICROBIOL, V109, P47, DOI 10.1016/j.vetmic.2005.03.008; Alippi AM, 1998, J INVERTEBR PATHOL, V72, P21, DOI 10.1006/jipa.1998.4748; Alper I, 2013, APPL MICROBIOL BIOT, V97, P5907, DOI 10.1007/s00253-013-4776-2; Antunez K, 2007, VET MICROBIOL, V124, P178, DOI 10.1016/j.vetmic.2007.04.012; Chantawannakul P, 2001, BEE WORLD, V82, P168, DOI 10.1080/0005772X.2001.11099524; Debourgogne A, 2010, J MICROBIOL METH, V82, P319, DOI 10.1016/j.mimet.2010.07.008; Elzen P, 2002, J APICULT RES, V41, P97, DOI 10.1080/00218839.2002.11101075; Evans JD, 2003, J INVERTEBR PATHOL, V83, P46, DOI 10.1016/S0022-2011(03)00039-9; Feldlaufer MF, 2001, APIDOLOGIE, V32, P547, DOI 10.1051/apido:2001100; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Fries I, 2006, VET MICROBIOL, V114, P269, DOI 10.1016/j.vetmic.2005.11.068; Fu Y., 1989, GENETICS, V123, P585; FU YX, 1993, GENETICS, V133, P693; Genersch E, 2006, INT J SYST EVOL MICR, V56, P501, DOI 10.1099/ijs.0.63928-0; Genersch E, 2003, APIDOLOGIE, V34, P195, DOI 10.1051/apido:2003025; Genersch E, 2010, J INVERTEBR PATHOL, V103, pS10, DOI 10.1016/j.jip.2009.06.015; Hamdi C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/479893; Helgason E, 2004, APPL ENVIRON MICROB, V70, P191, DOI 10.1128/AEM.70.1.191-201.2004; Kilwinski J, 2004, VET MICROBIOL, V104, P31, DOI 10.1016/j.vetmic.2004.08.001; Kochansky J, 2001, APIDOLOGIE, V32, P215, DOI 10.1051/apido:2001123; Lindstrom A, 2008, APIDOLOGIE, V39, P515, DOI 10.1051/apido:2008032; Lindstrom A, 2008, J INVERTEBR PATHOL, V99, P82, DOI 10.1016/j.jip.2008.06.010; Loncaric I, 2009, J INVERTEBR PATHOL, V100, P44, DOI 10.1016/j.jip.2008.09.003; LOUWS FJ, 1994, APPL ENVIRON MICROB, V60, P2286, DOI 10.1128/AEM.60.7.2286-2295.1994; Margos G, 2008, P NATL ACAD SCI USA, V105, P8730, DOI 10.1073/pnas.0800323105; Masry SHD, 2014, BIOTECHNOL BIOTEC EQ, V28, P271, DOI 10.1080/13102818.2014.906826; Miyagi T, 2000, J INVERTEBR PATHOL, V75, P95, DOI 10.1006/jipa.1999.4888; Morrissey BJ, 2015, ENVIRON MICROBIOL, V17, P1414, DOI 10.1111/1462-2920.12625; Neuendorf S, 2004, MICROBIOL-SGM, V150, P2381, DOI 10.1099/mic.0.27125-0; Olsen JS, 2014, J MICROBIOL METH, V96, P84, DOI 10.1016/j.mimet.2013.11.003; PENG YSC, 1992, J INVERTEBR PATHOL, V60, P127, DOI 10.1016/0022-2011(92)90085-I; Pettis JS, 2005, J APICULT RES, V44, P106, DOI 10.1080/00218839.2005.11101158; Prajapati SK, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002425; Riessberger-Galle U, 2001, J INVERTEBR PATHOL, V77, P231, DOI 10.1006/jipa.2001.5032; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sorokin A, 2006, APPL ENVIRON MICROB, V72, P1295; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Versalovic James, 1994, Methods in Molecular and Cellular Biology, V5, P25	40	22	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176831	10.1371/journal.pone.0176831	http://dx.doi.org/10.1371/journal.pone.0176831			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467471	Green Submitted, Green Published, gold			2022-12-26	WOS:000400647000077
J	O'Hara, CC; Afflerbach, JC; Scarborough, C; Kaschner, K; Halpern, BS				O'Hara, Casey C.; Afflerbach, Jamie C.; Scarborough, Courtney; Kaschner, Kristin; Halpern, Benjamin S.			Aligning marine species range data to better serve science and conservation	PLOS ONE			English	Article								Species distribution data provide the foundation for a wide range of ecological research studies and conservation management decisions. Two major efforts to provide marine species distributions at a global scale are the International Union for Conservation of Nature (IUCN), which provides expert-generated range maps that outline the complete extent of a species' distribution; and AquaMaps, which provides model-generated species distribution maps that predict areas occupied by the species. Together these databases represent 24,586 species (93.1% within AquaMaps, 16.4% within IUCN), with only 2,330 shared species. Differences in intent and methodology can result in very different predictions of species distributions, which bear important implications for scientists and decision makers who rely upon these datasets when conducting research or informing conservation policy and management actions. Comparing distributions for the small subset of species with maps in both datasets, we found that AquaMaps and IUCN range maps show strong agreement for many well-studied species, but our analysis highlights several key examples in which introduced errors drive differences in predicted species ranges. In particular, we find that IUCN maps greatly overpredict coral presence into unsuitably deep waters, and we show that some AquaMaps computer-generated default maps (only 5.7% of which have been reviewed by experts) can produce odd discontinuities at the extremes of a species' predicted range. We illustrate the scientific and management implications of these tradeoffs by repeating a global analysis of gaps in coverage of marine protected areas, and find significantly different results depending on how the two datasets are used. By highlighting tradeoffs between the two datasets, we hope to encourage increased collaboration between taxa experts and large scale species distribution modeling efforts to further improve these foundational datasets, helping to better inform science and policy recommendations around understanding, managing, and protecting marine biodiversity.	[O'Hara, Casey C.; Afflerbach, Jamie C.; Scarborough, Courtney; Halpern, Benjamin S.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Kaschner, Kristin] Albert Ludwigs Univ, Dept Biometry & Environm Syst Anal, Tennenbacher Str 4, Freiburg, Germany; [Halpern, Benjamin S.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Halpern, Benjamin S.] Imperial Coll London, Dept Life Sci, Silwood Pk Campus, Ascot, Berks, England	National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; University of Freiburg; University of California System; University of California Santa Barbara; Imperial College London	O'Hara, CC (corresponding author), Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA.	ohara@nceas.ucsb.edu	O'Hara, Casey/AGF-2964-2022; Kaschner, Kristin/GQQ-6475-2022	O'Hara, Casey/0000-0003-2968-7005; Scarborough, Courtney/0000-0001-7270-9228; Kaschner, Kristin/0000-0002-4061-626X	Gordon and Betty Moore Foundation	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This study was supported by funding from the Gordon and Betty Moore Foundation (https://www.moore.org/) received by BSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; BirdLife International  & NatureServe, 2015, BIRD SPEC DISTR MAPS; [CBI Fl LBAL BioDIvERsiTY INFoRmATIoN FAcitsri, 2010, GLOB BIOD INF FAC GB; Chamberlain S, 2017, WORLD REGISTER MARIN; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; FAO Fisheries and Aquaculture Department, 2015, CWP HDB FISH STAT ST; Froese R., 2016, WORLD WIDE WEB ELECT; Garcia Molinos J., 2015, NATURE CLIMATE CHANG, DOI [10.1038/nclimate2769, DOI 10.1111/GCB]; Gaston KJ, 2009, J APPL ECOL, V46, P1, DOI 10.1111/j.1365-2664.2008.01596.x; Halpern BS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117863; Halpern BS, 2012, NATURE; IUCN, 2015, RED LIST MAPP STAND; IUCN Red list, 2022, ZOOL, Patent No. [eT158085A760192, 158085760192]; IUCN & UNEP-WCMC, 2014, WORLD DAT PROT AR WD; Kaschner K, 2006, MAR ECOL PROG SER, V316, P285, DOI 10.3354/meps316285; Kaschner K., 2015, AQUAMAPS PREDICTED R; Kaschner K., 2013, AQUAMAPS PREDICTED R; Kaschner K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019653; Klein CJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17539; Martin C, 2014, MANUAL MARINE COASTA; OBIS, 2016, DAT OC BIOG INF SYST; Palomares M, 2017, WORLD WIDE WEB ELECT; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Ramirez F, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601198; Ready J, 2010, ECOL MODEL, V221, P467, DOI 10.1016/j.ecolmodel.2009.10.025; Selig ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060284; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707	27	23	23	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0175739	10.1371/journal.pone.0175739	http://dx.doi.org/10.1371/journal.pone.0175739			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467508	Green Published, gold, Green Submitted			2022-12-26	WOS:000400647000025
J	Wang, Z; Zhou, XP; Lin, QX; Fang, WZ; Chen, XL				Wang, Zeng; Zhou, Xiaoping; Lin, Qingxian; Fang, Wenzhen; Chen, Xiaolin			Diversity and selection of MHC class I genes in the vulnerable Chinese egret (Egretta eulophotes)	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; NUCLEOTIDE SUBSTITUTION; EVOLUTION; POLYMORPHISM; LOCI; DNA; SOFTWARE; GENETICS; REVEALS; ALLELES	The genes of major histocompatibility complex (MHC) are important to vertebrate immune system. In this study, two new MHC class I genes, designated as Egeu-UAA and Egeu-UBA, were discovered in the vulnerable Chinese egret (Egretta eulophotes). Using a full length DNA and cDNA produced by PCR and RACE methods, these two MHC class I loci were characterized in the genome of the Chinese egret and were also found to be expressed in liver and blood. Both new genes showed the expected eight exons and were similar to two copies of the minimal essential MHC complex of chicken. In genetic diversity, 14 alleles (8 for UAA and 6 for UBA) in the MHC class I gene exon 3 were found in 60 individuals using locus-specific primers and showed little polymorphism. Only three potential amino acid residues were detected under positive selection in potential peptide-binding regions (PBRs) by Bayesian analysis. These new results provide the fundamental basis for further studies to elucidate the molecular mechanisms and significance of MHC molecular adaptation in vulnerable Chinese egret and other ardeids, finding that have not been previously reported.	[Wang, Zeng; Zhou, Xiaoping; Lin, Qingxian; Fang, Wenzhen; Chen, Xiaolin] Xiamen Univ, Coll Environm & Ecol, Minist Educ Coastal & Wetland Ecosyst, Key Lab, Xiamen, Fujian, Peoples R China	Xiamen University	Fang, WZ; Chen, XL (corresponding author), Xiamen Univ, Coll Environm & Ecol, Minist Educ Coastal & Wetland Ecosyst, Key Lab, Xiamen, Fujian, Peoples R China.	wzfang@xmu.edu.cn; xlchen@xmu.edu.cn		Chen, Xiaolin/0000-0001-8486-9747	National Natural Science Foundation of China [41476113, 41676123]; Fujian Natural Science Foundation of China [2010Y2007]; Ministry of Science and Technology of China [2016YFC0602900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Natural Science Foundation of China; Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This research was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn) (Grant #41476113 to XC, and 41676123 to WF), the Fujian Natural Science Foundation of China (http://xmgl.fikit.gov.cn/) (Grant #2010Y2007 to XC), and the Ministry of Science and Technology of China (http://service.most.gov.cn/) (Grant #2016YFC0602900 to XC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2007, J MOL EVOL, V65, P541, DOI 10.1007/s00239-007-9033-9; Alcaide M, 2014, ECOL EVOL, V4, P688, DOI 10.1002/ece3.974; Alcaide M, 2009, CONSERV GENET, V10, P1349, DOI 10.1007/s10592-008-9653-7; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; Bollmer JL, 2007, IMMUNOGENETICS, V59, P593, DOI 10.1007/s00251-007-0221-y; Bradley RD, 1997, MOL BIOL EVOL, V14, P592, DOI 10.1093/oxfordjournals.molbev.a025797; BUDOWLE B, 1991, AM J HUM GENET, V48, P137; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chappell P, 2015, ELIFE, V4, DOI 10.7554/eLife.05345; Chen LC, 2015, SCI REP-UK, V5, DOI 10.1038/srep07963; Cloutier A, 2011, IMMUNOGENETICS, V63, P377, DOI 10.1007/s00251-011-0516-x; Eizaguirre C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1632; Fain MA, 2001, TISSUE ANTIGENS, V57, P332, DOI 10.1034/j.1399-0039.2001.057004332.x; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gangoso L, 2012, J EVOLUTION BIOL, V25, P1438, DOI 10.1111/j.1420-9101.2012.02529.x; Garrigan D, 2001, IMMUNOGENETICS, V53, P483, DOI 10.1007/s002510100352; Goyos A, 2011, J IMMUNOL, V186, P372, DOI 10.4049/jimmunol.1001467; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hedrick PW, 1998, EVOLUTION, V52, P194, DOI 10.1111/j.1558-5646.1998.tb05152.x; Hess CM, 2002, BIOSCIENCE, V52, P423, DOI 10.1641/0006-3568(2002)052[0423:TEOTMH]2.0.CO;2; Huang XH, 2010, CONSERV GENET, V11, P1211, DOI 10.1007/s10592-009-9921-1; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; Kaufman J, 1994, Semin Immunol, V6, P411, DOI 10.1006/smim.1994.1050; Kaufman J, 1999, IMMUNOL REV, V167, P101, DOI 10.1111/j.1600-065X.1999.tb01385.x; KLEIN J, 1990, IMMUNOGENETICS, V31, P217, DOI 10.1007/BF00204890; Koch M, 2007, IMMUNITY, V27, P885, DOI 10.1016/j.immuni.2007.11.007; Krebs KC, 2005, J IMMUNOL, V175, P5230, DOI 10.4049/jimmunol.175.8.5230; Lei W, 2016, CONSERV GENET, V17, P1459, DOI 10.1007/s10592-016-0876-8; Li L, 2011, J MOL EVOL, V72, P474, DOI 10.1007/s00239-011-9446-3; Marshall D. R., 1975, Crop genetic resources for today and tomorrow. Genetic variation in plant populations., P53; Mesa CM, 2004, IMMUNOGENETICS, V56, P192, DOI 10.1007/s00251-004-0672-3; MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/nar/18.7.1687; Miller HC, 2007, J HERED, V98, P666, DOI 10.1093/jhered/esm095; Minias P, 2016, EVOLUTION; Murphy K., 2011, JANEWAYS IMMUNOBIOLO, V8th ed.; NEI M, 1986, MOL BIOL EVOL, V3, P418; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Reichard M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040780; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; Shum BP, 1999, IMMUNOGENETICS, V49, P479, DOI 10.1007/s002510050524; SJOGREN P, 1994, CONSERV BIOL, V8, P267, DOI 10.1046/j.1523-1739.1994.08010267.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Ujvari B, 2011, INT J MOL SCI, V12, P5168, DOI 10.3390/ijms12085168; Wan QH, 2006, MOL ECOL, V15, P2441, DOI 10.1111/j.1365-294X.2006.02966.x; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074185; Winternitz JC, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1605; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Zhou XP, 2008, MOL ECOL RESOUR, V8, P412, DOI 10.1111/j.1471-8286.2007.01975.x	52	0	0	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176671	10.1371/journal.pone.0176671	http://dx.doi.org/10.1371/journal.pone.0176671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467494	Green Published, Green Submitted, gold			2022-12-26	WOS:000400647000067
J	Zhang, DH; Zhou, EX; Yang, ZL				Zhang, Dan-hua; Zhou, En-xiang; Yang, Zhu-lin			Waterborne exposure to BPS causes thyroid endocrine disruption in zebrafish larvae	PLOS ONE			English	Article							UDP-GLUCURONOSYLTRANSFERASE INDUCERS; BISPHENOL S EXPOSURE; UNITED-STATES; HORMONE LEVELS; DANIO-RERIO; IN-VITRO; ANALOGS; EXPRESSION; GENES; REPRODUCTION	Bisphenol S (BPS) is widely used as a raw material in industry, resulting in its ubiquitous distribution in natural environment, including the aqueous environment. However, the effect of BPS on the thyroid endocrine system is largely unknown. In this study, zebrafish (Danio rerio) embryos were exposed to BPS at 1, 3, 10, and 30 mu g/L, from 2 h post-fertilization (hpf) to 168hpf. Bioconcentration of BPS and whole-body thyroid hormones (THs), thyroidstimulating hormone (TSH) concentrations as well as transcriptional profiling of key genes related to the hypothalamic-pituitary-thyroid (HPT) axis were examined. Chemical analysis indicated that BPS was accumulated in zebrafish larvae. Thyroxine (T4) and triiodothyronine (T3) levels were significantly decreased at >= 10 and 30 mu g/L of BPS, respectively. However, TSH concentration was significantly induced in the 10 and 30 mu g/L BPS-treated groups. After exposure to BPS, the mRNA expression of corticotrophin releasing hormone (crh) and thyroglobulin (tg) genes were up-regulated at >= 10 mu g/L of BPS, in a dose-response manner. The transcription of genes involved in thyroid development (pax8)and synthesis (sodium/iodide symporter, slc5a5) were also significantly increased in the 30 mu g/L of BPS treatment group. Moreover, exposure to 10 mu g/L or higher concentration of BPS significantly upregulated genes related to thyroid hormone metabolism (deiodinases, dio1, dio2 and uridinediphosphate glucoronosyltransferases, ugt1ab), which might be responsible for the altered THs levels. However, the transcript of transthyretin (ttr) was significantly downregulated at >= 3 mu g/L of BPS, while the mRNA levels of thyroid hormone receptors (tr alpha and tr beta) and dio3 remained unchanged. All the results indicated that exposure to BPS altered the whole-body THs and TSH concentrations and changed the expression profiling of key genes related to HPT axis, thus triggering thyroid endocrine disruption.	[Zhang, Dan-hua; Zhou, En-xiang] Cent S Univ, Xiangya Hosp 2, Dept Gen Surg, Changsha, Hunan, Peoples R China; [Yang, Zhu-lin] Cent S Univ, Xiangya Hosp 2, Res Lab Hepatobiliary Dis, Changsha, Hunan, Peoples R China	Central South University; Central South University	Zhou, EX (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Gen Surg, Changsha, Hunan, Peoples R China.	ex_zhou@sina.com						BARTER RA, 1992, TOXICOL APPL PHARM, V113, P36, DOI 10.1016/0041-008X(92)90006-E; BARTER RA, 1994, TOXICOL APPL PHARM, V128, P9, DOI 10.1006/taap.1994.1174; Chen Q, 2012, AQUAT TOXICOL, V110, P141, DOI 10.1016/j.aquatox.2012.01.008; De Groef B, 2006, GEN COMP ENDOCR, V146, P62, DOI 10.1016/j.ygcen.2005.10.014; Del Moral LI, 2016, TOXICOLOGY, V357, P11, DOI 10.1016/j.tox.2016.05.023; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Gallart-Ayala H, 2011, ANAL CHIM ACTA, V683, P227, DOI 10.1016/j.aca.2010.10.034; Grignard E, 2012, TOXICOL IN VITRO, V26, P727, DOI 10.1016/j.tiv.2012.03.013; Hood A, 2000, TOXICOL SCI, V55, P78, DOI 10.1093/toxsci/55.1.78; Huang GM, 2016, CHEMOSPHERE, V147, P188, DOI 10.1016/j.chemosphere.2015.12.080; Ji C, 2012, TOXICOL APPL PHARM, V262, P149, DOI 10.1016/j.taap.2012.04.029; Ji K, 2013, ENVIRON SCI TECHNOL, V47, P8793, DOI 10.1021/es400329t; Jia PP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155762; Kambe F, 1996, MOL ENDOCRINOL, V10, P801, DOI 10.1210/me.10.7.801; Kitamura S, 2005, TOXICOL SCI, V84, P249, DOI 10.1093/toxsci/kfi074; Kuruto-Niwa R, 2005, ENVIRON TOXICOL PHAR, V19, P121, DOI 10.1016/j.etap.2004.05.009; Liao CY, 2013, J AGR FOOD CHEM, V61, P4655, DOI 10.1021/jf400445n; Liao CY, 2012, ENVIRON SCI TECHNOL, V46, P11558, DOI 10.1021/es303191g; Liao CY, 2012, ENVIRON SCI TECHNOL, V46, P9138, DOI 10.1021/es302004w; Liao CY, 2012, ENVIRON SCI TECHNOL, V46, P6860, DOI 10.1021/es301334j; Liao CY, 2012, ENVIRON SCI TECHNOL, V46, P6515, DOI 10.1021/es300876n; Liao CY, 2012, ENVIRON SCI TECHNOL, V46, P5003, DOI 10.1021/es300115a; Liu YW, 2002, DIFFERENTIATION, V70, P36, DOI 10.1046/j.1432-0436.2002.700104.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchand O, 2001, J MOL ENDOCRINOL, V26, P51, DOI 10.1677/jme.0.0260051; Miller MD, 2009, ENVIRON HEALTH PERSP, V117, P1033, DOI 10.1289/ehp.0800247; Molina-Molina JM, 2013, TOXICOL APPL PHARM, V272, P127, DOI 10.1016/j.taap.2013.05.015; Morgado I, 2007, GEN COMP ENDOCR, V152, P189, DOI 10.1016/j.ygcen.2006.12.017; Naderi M, 2014, AQUAT TOXICOL, V148, P195, DOI 10.1016/j.aquatox.2014.01.009; Orozco A, 2005, THYROID, V15, P799, DOI 10.1089/thy.2005.15.799; Power DM, 2000, GEN COMP ENDOCR, V119, P241, DOI 10.1006/gcen.2000.7520; Raldua D, 2012, REPROD TOXICOL, V33, P188, DOI 10.1016/j.reprotox.2011.09.001; Rochester JR, 2015, ENVIRON HEALTH PERSP, V123, P643, DOI 10.1289/ehp.1408989; Rosenmai AK, 2014, TOXICOL SCI, V139, P35, DOI 10.1093/toxsci/kfu030; Saili KS, 2012, TOXICOLOGY, V291, P83, DOI 10.1016/j.tox.2011.11.001; Segner H, 2009, COMP BIOCHEM PHYS C, V149, P187, DOI 10.1016/j.cbpc.2008.10.099; Shi JC, 2015, CHEMOSPHERE, V128, P252, DOI 10.1016/j.chemosphere.2015.01.060; Song SJ, 2014, ENVIRON POLLUT, V186, P14, DOI 10.1016/j.envpol.2013.11.023; Tang TL, 2015, INT J ENV RES PUB HE, V12, P13069, DOI 10.3390/ijerph121013069; Thienpont B, 2011, ENVIRON SCI TECHNOL, V45, P7525, DOI 10.1021/es202248h; Tohme M, 2014, FASEB J, V28, P3124, DOI 10.1096/fj.13-240465; Ullah H, 2016, CHEMOSPHERE, V152, P383, DOI 10.1016/j.chemosphere.2016.02.125; Van der Geyten S, 2005, J ENDOCRINOL, V184, P467, DOI 10.1677/joe.1.05986; Vinas P, 2010, ANAL BIOANAL CHEM, V397, P115, DOI 10.1007/s00216-010-3464-7; Wang QW, 2013, AQUAT TOXICOL, V126, P207, DOI 10.1016/j.aquatox.2012.11.009; Wendl T, 2002, DEVELOPMENT, V129, P3751; Yamazaki E, 2015, ECOTOX ENVIRON SAFE, V122, P565, DOI 10.1016/j.ecoenv.2015.09.029; Yang YJ, 2014, J CHROMATOGR A, V1328, P26, DOI 10.1016/j.chroma.2013.12.074; Yu L, 2013, AQUAT TOXICOL, V138, P35, DOI [10.1016/j.aquatox.2013.04.001, 10.1016/j.aquatox.2013.04.010]; Zhai WH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092465; Zhang XN, 2013, GEN COMP ENDOCR, V193, P158, DOI 10.1016/j.ygcen.2013.08.003; Zheng XM, 2012, ENVIRON SCI TECHNOL, V46, P12943, DOI 10.1021/es303289n; Zoeller RT, 2007, CRIT REV TOXICOL, V37, P11, DOI 10.1080/10408440601123446	53	50	56	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176927	10.1371/journal.pone.0176927	http://dx.doi.org/10.1371/journal.pone.0176927			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467477	Green Submitted, Green Published, gold			2022-12-26	WOS:000400647000087
J	Abudulai, LN; Fernandez, S; Corscadden, K; Burrows, SA; Hunter, M; Tjiam, MC; Kirkham, LAS; Post, JJ; French, MA				Abudulai, Laila N.; Fernandez, Sonia; Corscadden, Karli; Burrows, Sally A.; Hunter, Michael; Tjiam, M. Christian; Kirkham, Lea-Ann S.; Post, Jeffrey J.; French, Martyn A.			Production of IgG antibodies to pneumococcal polysaccharides is associated with expansion of ICOS+ circulating memory T follicular-helper cells which is impaired by HIV infection	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; CD40-CD40 LIGAND INTERACTION; B-CELLS; IMMUNE-RESPONSE; STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINATION; SUBCLASS DISTRIBUTION; STRUCTURAL ISOFORMS; SIV INFECTION; HUMAN NAIVE	Dysfunction of T follicular-helper (T-FH) cells is a possible cause of impaired germinal centre (GC) and IgG antibody responses in individuals with human immunodeficiency virus-1 (HIV-1) infection and might contribute to decreased magnitude and isotype diversification of IgG antibodies to pneumococcal polysaccharides (PcPs). We examined the production of IgG1 and IgG2 antibodies to PcPs 4, 6B, 9V and 14 by enumerating antibody secreting cells (ASCs) at day (D) 7 and determining fold-increase in serum antibody levels at D28 after vaccination with unconjugated PcPs in HIV seronegative subjects (n = 20) and in HIV patients who were receiving antiretroviral therapy (ART) (n = 28) or who were ART-naive (n = 11) and determined their association with ICOS+ and ICOS- circulating memory T-FH (cmT(FH)) cells (CD4(+) CD45RA(-)CD27(+)CXCR5(+)PD-1(+)) and short lived plasmablasts (SPBs) at D7, and with PcP-specific and total IgM(+) and IgG(+) memory B cells at D0. In HIV seronegative subjects, production of IgG1(+) and IgG2(+) ASCs was consistently associated with the frequency of ICOS+ cmT(FH) cells but not ICOS(-)cmT(FH) cells or memory B cells. In contrast, post-vaccination ASCs in HIV patients, regardless of ART status, were lower than in HIV seronegative subjects and not associated with ICOS+ cmT(FH) cells, the expansion of which was absent (ART-naive patients) or much lower than in HIV seronegative subjects (ART-treated patients). Production of SPBs was also lower in ART-naive patients. Fold-increase in IgG2 Kantibodies at D28 also correlated with ICOS+ cmT(FH) cells at D7 in HIV seronegative subjects but not in HIV patients. These novel findings provide evidence that ICOS+ cmT(FH) cells contribute to the regulation of PcP-specific IgG antibody responses, including isotype diversification, and that T-FH cell dysfunction may be a cause of impaired PcP-specific IgG antibody responses and increased susceptibility to pneumococcal disease in HIV patients.	[Abudulai, Laila N.; Fernandez, Sonia; Tjiam, M. Christian; French, Martyn A.] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA, Australia; [Corscadden, Karli; Kirkham, Lea-Ann S.] Univ Western Australia, Telethon Kids Inst, Ctr Vaccine & Infect Dis Res, Perth, WA, Australia; [Corscadden, Karli] Univ Western Australia, Sch Med & Pharmacol, Perth, WA, Australia; [Hunter, Michael; Post, Jeffrey J.] Prince Wales Hosp, Dept Infect Dis, Sydney, NSW, Australia; [Hunter, Michael; Post, Jeffrey J.] Univ New South Wales, Prince Wales Clin Sch, Sydney, NSW, Australia; [Kirkham, Lea-Ann S.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA, Australia; [French, Martyn A.] Royal Perth Hosp, Dept Clin Immunol, Perth, WA, Australia; [French, Martyn A.] PathWest Lab Med, Perth, WA, Australia	University of Western Australia; Telethon Kids Institute; University of Western Australia; University of Western Australia; University of New South Wales Sydney; University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia	French, MA (corresponding author), Univ Western Australia, Sch Pathol & Lab Med, Perth, WA, Australia.; French, MA (corresponding author), Royal Perth Hosp, Dept Clin Immunol, Perth, WA, Australia.; French, MA (corresponding author), PathWest Lab Med, Perth, WA, Australia.	martyn.french@uwa.edu.au	Post, Jeffrey/AAL-7115-2020; Kirkham, Lea-Ann S/A-5847-2013; Post, Jeffrey/AAF-4960-2020; Fernandez, Sonia/H-9176-2014	Post, Jeffrey/0000-0003-1475-9272; Kirkham, Lea-Ann S/0000-0001-5421-8126; Abudulai, Laila/0000-0003-4083-0343; French, Martyn/0000-0002-4644-1982; Tjiam, Mark/0000-0002-1207-4811; Fernandez, Sonia/0000-0001-8753-466X	National Health and Medical Research Council, Australia [510448]; Australian Postgraduate Award; Raine Medical Research Foundation	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); Raine Medical Research Foundation	This study was supported by a program grant (510448) from the National Health and Medical Research Council, Australia held by MAF. LNA was supported by an Australian Postgraduate Award. SF was supported by the Raine Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASE A, 1994, SCAND J IMMUNOL, V39, P581, DOI 10.1111/j.1365-3083.1994.tb03416.x; Abudulai LN, 2016, JAIDS-J ACQ IMM DEF, V71, P381, DOI 10.1097/QAI.0000000000000869; Ackerman ME, 2013, J VIROL, V87, P5468, DOI 10.1128/JVI.03403-12; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1; Avery DT, 2008, J IMMUNOL, V181, P1767, DOI 10.4049/jimmunol.181.3.1767; Bentebibel SE, 2016, SCI REP-UK, V6, DOI 10.1038/srep26494; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Borgers H, 2012, CLIN IMMUNOL, V145, P136, DOI 10.1016/j.clim.2012.08.010; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; CARSON PJ, 1995, J INFECT DIS, V172, P340, DOI 10.1093/infdis/172.2.340; Corscadden KJ, 2013, VACCINE, V31, P1393, DOI 10.1016/j.vaccine.2012.12.078; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Crum-Cianflone NF, 2012, CLIN EXP IMMUNOL, V168, P135, DOI 10.1111/j.1365-2249.2011.04550.x; Crum-Cianflone NF, 2010, J INFECT DIS, V202, P1114, DOI 10.1086/656147; Cubas RA, 2013, NAT MED, V19, P494, DOI 10.1038/nm.3109; D'Orsogna LJ, 2007, AIDS, V21, P1747, DOI 10.1097/QAD.0b013e32828642c7; den Dunnen J, 2012, BLOOD, V120, P112, DOI 10.1182/blood-2011-12-399931; Dillon TM, 2008, J BIOL CHEM, V283, P16206, DOI 10.1074/jbc.M709988200; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Falco V, 2006, VACCINE, V24, P2567, DOI 10.1016/j.vaccine.2005.12.021; Frankel RE, 1996, CLIN INFECT DIS, V23, P577, DOI 10.1093/clinids/23.3.577; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Harboe ZB, 2014, CLIN INFECT DIS, V59, P1066, DOI 10.1093/cid/ciu524; Hart M, 2007, J IMMUNOL, V178, P8212, DOI 10.4049/jimmunol.178.12.8212; Hung CC, 2010, HIV MED, V11, P54, DOI 10.1111/j.1468-1293.2009.00744.x; Jackson KJL, 2014, IMMUNOL CELL BIOL, V92, P729, DOI 10.1038/icb.2014.44; Jeurissen A, 2004, EUR J IMMUNOL, V34, P850, DOI 10.1002/eji.200324381; Jung DJ, 2012, J IMMUNOL, V189, P4951, DOI 10.4049/jimmunol.1201294; KAWANO Y, 1994, J IMMUNOL, V153, P4948; Kondo N, 1997, SCAND J IMMUNOL, V45, P227, DOI 10.1046/j.1365-3083.1997.d01-387.x; Kyu SY, 2009, J IMMUNOL METHODS, V340, P42, DOI 10.1016/j.jim.2008.09.025; Lange CG, 2003, AIDS, V17, P2015, DOI 10.1097/00002030-200309260-00002; Leggat DJ, 2013, VACCINE, V31, P4632, DOI 10.1016/j.vaccine.2013.07.030; Leggat DJ, 2013, J INFECT DIS, V208, P101, DOI 10.1093/infdis/jit139; Levesque MC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000107; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Martinez T, 2008, BIOCHEMISTRY-US, V47, P7496, DOI 10.1021/bi800576c; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Mikolajczyk MG, 2004, CLIN DIAGN LAB IMMUN, V11, P1158, DOI 10.1128/CDLI.11.6.1158-1164.2004; Miles B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9608; Moens L, 2008, J IMMUNOL, V181, P5306, DOI 10.4049/jimmunol.181.8.5306; Moens L, 2008, J ALLERGY CLIN IMMUN, V122, P1231, DOI 10.1016/j.jaci.2008.09.006; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Pallikkuth S, 2012, BLOOD, V120, P985, DOI 10.1182/blood-2011-12-396648; Pan-Hammarstrom Q, 2007, ADV IMMUNOL, V93, P1, DOI 10.1016/S0065-2776(06)93001-6; Pene J, 2004, J IMMUNOL, V172, P5154, DOI 10.4049/jimmunol.172.9.5154; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; Petrovas C, 2012, J CLIN INVEST, V122, P3281, DOI 10.1172/JCI63039; Pinna D, 2009, EUR J IMMUNOL, V39, P1260, DOI 10.1002/eji.200839129; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; Raux M, 2000, AIDS RES HUM RETROV, V16, P583, DOI 10.1089/088922200309007; Schmitt N, 2014, TRENDS IMMUNOL, V35, P436, DOI 10.1016/j.it.2014.06.002; Seifert M, 2015, P NATL ACAD SCI USA, V112, pE546, DOI 10.1073/pnas.1416276112; Siemieniuk RAC, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-314; Snapper CM, 2012, ANN NY ACAD SCI, V1253, P92, DOI 10.1111/j.1749-6632.2011.06329.x; Sogaard OS, 2010, AIDS, V24, P1315, DOI 10.1097/QAD.0b013e328339fe0b; Soininen A, 1999, VACCINE, V17, P1889, DOI 10.1016/S0264-410X(98)00475-7; Stone EL, 2015, IMMUNITY, V42, P239, DOI 10.1016/j.immuni.2015.01.017; Subramaniam KS, 2003, J INFECT DIS, V187, P758, DOI 10.1086/368331; Swingler S, 2008, CELL HOST MICROBE, V4, P63, DOI 10.1016/j.chom.2008.05.015; Syam S, 2010, J IMMUNOL, V184, P2966, DOI 10.4049/jimmunol.0900016; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; Viisanen T, 2017, DIABETES, V66, P437, DOI 10.2337/db16-0714; Weber JP, 2015, J EXP MED, V212, P217, DOI 10.1084/jem.20141432; Weinberger DM, 2011, EPIDEMIOLOGY, V22, P199, DOI 10.1097/EDE.0b013e3182087634; Wypych J, 2008, J BIOL CHEM, V283, P16194, DOI 10.1074/jbc.M709987200; Yang J, 2014, MOL IMMUNOL, V58, P108, DOI 10.1016/j.molimm.2013.11.011; Yee AMF, 2000, CLIN INFECT DIS, V30, P25, DOI 10.1086/313588; Yoo EM, 2003, J IMMUNOL, V170, P3134, DOI 10.4049/jimmunol.170.6.3134; Zeng M, 2012, TRENDS IMMUNOL, V33, P306, DOI 10.1016/j.it.2012.04.002	75	19	19	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176641	10.1371/journal.pone.0176641	http://dx.doi.org/10.1371/journal.pone.0176641			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28463977	Green Published, Green Submitted, gold			2022-12-26	WOS:000400646300039
J	Wang, W; Hu, W; Yang, P; Deng, XQ; Li, XH; Wang, KZ				Wang, Wei; Hu, Wei; Yang, Pei; Deng, Xiao Qian; Li, Xiao Hui; Wang, Kun Zheng			Patient-specific core decompression surgery for early-stage ischemic necrosis of the femoral head	PLOS ONE			English	Article							ASSISTED ORTHOPEDIC-SURGERY; TRAUMA SURGERY; OSTEONECROSIS; NAVIGATION; HIP; ARTHROPLASTY; REDUCTION; TEMPLATE; ACCURACY; FUTURE	Introduction Core decompression is an efficient treatment for early stage ischemic necrosis of the femoral head. In conventional procedures, the pre-operative X-ray only shows one plane of the ischemic area, which often results in inaccurate drilling. This paper introduces a new method that uses computer-assisted technology and rapid prototyping to enhance drilling accuracy during core decompression surgeries and presents a validation study of cadaveric tests. Methods Twelve cadaveric human femurs were used to simulate early-stage ischemic necrosis. The core decompression target at the anterolateral femoral head was simulated using an embedded glass ball (target). Three positioning Kirschner wires were drilled into the top and bottom of the large rotor. The specimen was then subjected to computed tomography (CT). A CT image of the specimen was imported into the Mimics software to construct a three-dimensional model including the target. The best core decompression channel was then designed using the 3D model. A navigational template for the specimen was designed using the Pro/E software and manufactured by rapid prototyping technology to guide the drilling channel. The specimen-specific navigation template was installed on the specimen using positioning Kirschner wires. Drilling was performed using a guide needle through the guiding hole on the templates. The distance between the end point of the guide needle and the target was measured to validate the patient-specific surgical accuracy. Results The average distance between the tip of the guide needle drilled through the guiding template and the target was 1.92 +/- 0.071 mm. Conclusions Core decompression using a computer- rapid prototyping template is a reliable and accurate technique that could provide a new method of precision decompression for early-stage ischemic necrosis.	[Wang, Wei; Yang, Pei; Deng, Xiao Qian; Wang, Kun Zheng] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Orthopaed 1, Xian, Shaanxi Provinc, Peoples R China; [Hu, Wei] Xian Yang Cent Hosp, Dept Orthopaed, Xian Yang, Shaanxi Provinc, Peoples R China; [Li, Xiao Hui] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Radiol, Xian, Shaanxi Provinc, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Wang, KZ (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Orthopaed 1, Xian, Shaanxi Provinc, Peoples R China.	dr.wangwei@xjtu.edu.cn		Wang, Wei/0000-0002-1356-7247	National Natural Science Foundation of China [81472068]; Fundamental Research Funds for the Central Universities [xjj2014150]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was funded by the National Natural Science Foundation of China (81472068) and the Fundamental Research Funds for the Central Universities (xjj2014150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner N, 2002, INT ORTHOP, V26, P31, DOI 10.1007/s00264-001-0311-7; Beckmann J, 2006, ARCH ORTHOP TRAUM SU, V126, P374, DOI 10.1007/s00402-006-0155-0; Brown GA, 2003, J BONE JOINT SURG AM, V85A, P49, DOI 10.2106/00004623-200300004-00006; Castro F P Jr, 2000, Am J Orthop (Belle Mead NJ), V29, P187; FAIRBANK AC, 1995, J BONE JOINT SURG BR, V77B, P42, DOI 10.1302/0301-620X.77B1.7822394; Kahler DM, 2004, CLIN ORTHOP RELAT R, P70, DOI 10.1097/01.blo.0000126869.67208.2d; Khoury Amal, 2007, Am J Orthop (Belle Mead NJ), V36, P582; Lieberman JR, 2012, CLIN ORTHOP RELAT R, V470, P525, DOI 10.1007/s11999-011-2050-4; Lieberman JR, 2004, CLIN ORTHOP RELAT R, P29; Lu S, 2009, INT J MED ROBOT COMP, V5, P184, DOI 10.1002/rcs.249; Mayman D, 2005, J Orthop Trauma, V19, P610, DOI 10.1097/01.bot.0000177106.30837.28; Mont MA, 2006, J BONE JOINT SURG AM, V88A, P1117, DOI 10.2106/JBJS.E.01041; Mosheiff R, 2005, INJURY, V36, P866, DOI 10.1016/j.injury.2004.12.036; Pham AM, 2007, OTOLARYNG HEAD NECK, V137, P624, DOI 10.1016/j.otohns.2007.06.719; Pierannunzii L, 2012, ARTHROSC TEC, V1, pE225, DOI 10.1016/j.eats.2012.08.004; Schep NWL, 2003, INJURY, V34, P299, DOI 10.1016/S0020-1383(01)00208-X; Sidon E, 2012, EUR J RADIOL, V81, P4029, DOI 10.1016/j.ejrad.2012.07.016; Sikorski JM, 2003, J BONE JOINT SURG BR, V85B, P319, DOI 10.1302/0301-620X.85B3.14212; Song WS, 2007, CLIN ORTHOP RELAT R, P139, DOI 10.1097/01.blo.0000229342.92103.73; Soucacos PN, 2001, CLIN ORTHOP RELAT R, P120; Steinberg ME, 2001, CLIN ORTHOP RELAT R, P71; van der Jagt D, 2015, J AM ACAD ORTHOP SUR, V23, P69, DOI 10.5435/JAAOS-D-14-00431; Vlamis J, 2014, HIP INT, V24, P284, DOI 10.5301/hipint.5000118; Weil YA, 2007, COMPUT AIDED SURG, V12, P295, DOI 10.1080/10929080701657974; Yu PA, 2015, BIOMED J, V38, P257, DOI 10.4103/2319-4170.138307; Zhang YZ, 2011, INT J MED ROBOT COMP, V7, P469, DOI 10.1002/rcs.423; Zhang YZ, 2011, J ARTHROPLASTY, V26, P1083, DOI 10.1016/j.arth.2010.08.004	27	6	6	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0175366	10.1371/journal.pone.0175366	http://dx.doi.org/10.1371/journal.pone.0175366			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28464029	Green Submitted, Green Published, gold			2022-12-26	WOS:000400646300003
J	Cho, HJ; Park, DU; Yoon, J; Lee, E; Yang, SI; Kim, YH; Lee, SY; Hong, SJ				Cho, Hyun-Ju; Park, Dong-Uk; Yoon, Jisun; Lee, Eun; Yang, Song-I; Kim, Young-Ho; Lee, So-Yeon; Hong, Soo-Jong			Effects of a mixture of chloromethylisothiazolinone and methylisothiazolinone on peripheral airway dysfunction in children	PLOS ONE			English	Article							INTERSTITIAL LUNG-DISEASE; HOME HUMIDIFIER USE; TRADE-CENTER DUST; IMPULSE OSCILLOMETRY; BRONCHIOLITIS OBLITERANS; BRONCHODILATOR RESPONSE; PRESCHOOL-CHILDREN; INJURY; ASTHMA; DISINFECTANTS	Background Children who were only exposed to a mixture of chloromethylisothiazolinone (CMIT) and methylisothiazolinone (MIT) as humidifier disinfectant (HD) components were evaluated for humidifier disinfectant-associated lung injury (HDLI) from 2012. This study was to evaluate the pulmonary function using, impulse oscillometry (IOS) for children exposed to a mixture of CMIT/MIT from HD. Methods Twenty-four children who were only exposed to a mixture of CMIT/MIT, with no previous underlying disease, were assessed by IOS. Diagnostic criteria for HDLI were categorized as definite, probable, possible, or unlikely. Home visits and administration of a standardized questionnaire were arranged to assess exposure characteristics. Results Definite and probable cases showed higher airborne disinfectant exposure intensity during sleep (32.4 +/- 8.7 mu g/m(3)) and younger age at initial exposure (3.5 +/- 3.3 months) compared with unlikely cases (17.3 +/- 11.0 mu g/m(3), p = 0.026; 22.5 +/- 26.2 months, p = 0.039, respectively). Reactance at 5 Hz was significantly more negative in those with high-density exposure during sleep (mean, -0.463 kPa/L/s vs. low density, -0.296, p = 0.001). The reactance area was also higher with high-density exposure during sleep (mean, 3.240 kPa/L vs. low density, 1.922, p = 0.039). The mean bronchodilator response with high-density exposure was within the normal range for reactance. Conclusions Significant peripheral airway dysfunction were found in children with high levels of inhalation exposure to a mixture of CMIT/MIT during sleep. Strict regulation of a mixture of CMIT/MIT exposure were associated with positive effects on lung function of children.	[Cho, Hyun-Ju; Yoon, Jisun; Lee, So-Yeon; Hong, Soo-Jong] Univ Ulsan, Coll Med, Asan Med Ctr, Childhood Asthma Atopy Ctr,Environm Hlth Ctr,Dept, Seoul, South Korea; [Park, Dong-Uk] Korea Natl Open Univ, Dept Environm Hlth, Seoul, South Korea; [Lee, Eun] Chonnam Natl Univ Hosp, Dept Pediat, Gwangju, South Korea; [Yang, Song-I] Hallym Univ, Sacred Heart Hosp, Coll Med, Dept Pediat, Anyang, South Korea; [Kim, Young-Ho] Gyeongsang Natl Univ, Changwon Hosp, Dept Pediat, Chang Won, South Korea	University of Ulsan; Asan Medical Center; Korea National Open University; Chonnam National University; Chonnam National University Hospital; Hallym University; Gyeongsang National University	Hong, SJ (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Childhood Asthma Atopy Ctr,Environm Hlth Ctr,Dept, Seoul, South Korea.	sjhong@amc.seoul.kr	Hong, Soo-Jong/AAR-1788-2020	Hong, Soo-Jong/0000-0003-1409-2113	Environmental Health Center for Hazardous Chemical Exposure - Ministry of Environment Republic of Korea	Environmental Health Center for Hazardous Chemical Exposure - Ministry of Environment Republic of Korea	This research was supported by the Environmental Health Center for Hazardous Chemical Exposure funded by Ministry of Environment Republic of Korea (2017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpinar-Elci M, 2004, EUR RESPIR J, V24, P298, DOI 10.1183/09031936.04.00013903; Aronsson D, 2015, EUR CLIN RESPIR J, V2, DOI 10.3402/ecrj.v2.28667; Beydon N, 2007, AM J RESP CRIT CARE, V175, P1304, DOI 10.1164/rccm.200605-642ST; Bickel S, 2014, CHEST, V146, P841, DOI 10.1378/chest.13-1875; Bourke SJ, 1997, THORAX, V52, P746, DOI 10.1136/thx.52.8.746; Burnett CL, 2010, INT J TOXICOL, V29, p187S, DOI 10.1177/1091581810374651; Caplan-Shaw CE, 2011, J OCCUP ENVIRON MED, V53, P981, DOI 10.1097/JOM.0b013e31822fff60; CHIA KS, 1992, AM J IND MED, V22, P155, DOI 10.1002/ajim.4700220203; CHURG A, 1983, HUM PATHOL, V14, P688, DOI 10.1016/S0046-8177(83)80140-3; de Assumpcao MS, 2016, RESP CARE, V61, P1090, DOI 10.4187/respcare.04226; Dencker M, 2006, CLIN PHYSIOL FUNCT I, V26, P247, DOI 10.1111/j.1475-097X.2006.00682.x; Deterding RR, 2014, AM J RESP CRIT CARE, V189, P10, DOI 10.1164/rccm.201311-2050ED; Do KH, 2016, ENV HLTH TOXICOL, V31; Garcia-Gavin J, 2010, CONTACT DERMATITIS, V63, P96, DOI [10.1111/j.1600-0536.2010.01754.x, 10.1111/j.1600-0536.2010.01762.x]; Geier J, 2012, CONTACT DERMATITIS, V67, P334, DOI 10.1111/j.1600-0536.2012.02157.x; Goldman MD, 2005, RESP PHYSIOL NEUROBI, V148, P179, DOI 10.1016/j.resp.2005.05.026; GUERRYFORCE ML, 1987, AM REV RESPIR DIS, V135, P705; Hellinckx J, 1998, EUR RESPIR J, V12, P438, DOI 10.1183/09031936.98.12020438; Hong SB, 2014, THORAX, V69, P694, DOI 10.1136/thoraxjnl-2013-204135; 전종근, 2008, Clinical and Experimental Pediatrics, V51, P383; Kim HJ, 2014, THORAX, V69, P703, DOI 10.1136/thoraxjnl-2013-204132; Kim KW, 2014, AM J RESP CRIT CARE, V189, P48, DOI 10.1164/rccm.201306-1088OC; Kim WY, 2017, RESPIROLOGY, V22, P345, DOI 10.1111/resp.12918; King MS, 2011, NEW ENGL J MED, V365, P222, DOI 10.1056/NEJMoa1101388; Komarow HD, 2012, PEDIATR PULM, V47, P18, DOI 10.1002/ppul.21507; Komarow HD, 2011, ANN ALLERG ASTHMA IM, V106, P191, DOI 10.1016/j.anai.2010.11.011; Kubota M, 2009, RESP PHYSIOL NEUROBI, V166, P73, DOI 10.1016/j.resp.2009.01.007; Landrigan PJ, 2011, HEALTH AFFAIR, V30, P842, DOI 10.1377/hlthaff.2011.0151; Lee E, 2013, J KOREAN MED SCI, V28, P915, DOI 10.3346/jkms.2013.28.6.915; Lee JH, 2012, ENVIRON SCI TECHNOL, V46, P2498, DOI 10.1021/es300567j; Lundov MD, 2014, ENVIRON SCI TECHNOL, V48, P6989, DOI 10.1021/es500236m; Lundov MD, 2011, CONTACT DERMATITIS, V65, P176, DOI 10.1111/j.1600-0536.2011.01924.x; Malmberg LP, 2002, CLIN PHYSIOL FUNCT I, V22, P64, DOI 10.1046/j.1365-2281.2002.00396.x; Mann JM, 2005, AM J IND MED, V48, P225, DOI 10.1002/ajim.20196; Marotta A, 2003, J ALLERGY CLIN IMMUN, V112, P317, DOI 10.1067/mai.2003.1627; Nagorka R, 2015, INDOOR AIR, V25, P68, DOI 10.1111/ina.12126; Oppenheimer BW, 2007, CHEST, V132, P1275, DOI 10.1378/chest.07-0913; Paek D, 2015, ANN AM THORAC SOC, V12, P1813, DOI 10.1513/AnnalsATS.201504-221OC; Park DU, 2015, INDOOR AIR, V25, P631, DOI 10.1111/ina.12180; Park DU, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124610; Park D, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-70; Pisi R, 2015, INT J CHRONIC OBSTR, V10, P1191, DOI 10.2147/COPD.S82509; Pisi R, 2013, ALLERGY ASTHMA PROC, V34, pE14, DOI 10.2500/aap.2013.34.3641; Poon R, 2011, ARCH TOXICOL, V85, P1419, DOI 10.1007/s00204-011-0689-y; Song TW, 2008, PEDIAT ALLERG IMM-UK, V19, P763, DOI 10.1111/j.1399-3038.2008.00734.x; Wu MX, 2010, ENVIRON HEALTH PERSP, V118, P499, DOI 10.1289/ehp.0901159; Yang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064430	47	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176083	10.1371/journal.pone.0176083	http://dx.doi.org/10.1371/journal.pone.0176083			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453578	Green Submitted, Green Published, gold			2022-12-26	WOS:000400383900012
J	Tajima-Shirasaki, N; Ishil, KA; Takayama, H; Shirasaki, T; Iwama, H; Chikamoto, K; Saito, Y; Iwasaki, Y; Teraguchi, A; Lan, F; Kikuchi, A; Takeshita, Y; Murao, K; Matsugo, S; Kaneko, S; Misu, H; Takamura, T				Tajima-Shirasaki, Natsumi; Ishil, Kiyo-aki; Takayama, Hiroaki; Shirasaki, Takayoshi; Iwama, Hisakazu; Chikamoto, Keita; Saito, Yoshiro; Iwasaki, Yasumasa; Teraguchi, Atsushi; Lan, Fei; Kikuchi, Akihiro; Takeshita, Yumie; Murao, Koji; Matsugo, Seiichi; Kaneko, Shuichi; Misu, Hirofumi; Takamura, Toshinari			Eicosapentaenoic acid down-regulates expression of the selenoprotein P gene by inhibiting SREBP-1c protein independently of the AMP-activated protein kinase pathway in H4IIEC3 hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; ELEMENT-BINDING PROTEIN-1; INSULIN-RESISTANCE; TRANSCRIPTION FACTOR; HEPATIC STEATOSIS; PROMOTER ACTIVITY; ADIPOSE-TISSUE; MOUSE-LIVER; FED RATS; MICE	Selenoprotein P (encoded by SELENOP in humans, Selenop in rat), a liver-derived secretory protein, induces resistance to insulin and vascular endothelial growth factor (VEGF) in type 2 diabetes. Suppression of selenoprotein P may provide a novel therapeutic approach to treating type 2 diabetes; however, few drugs inhibiting SELENOP expression in hepatocytes have been identified. The present findings demonstrate that eicosapentaenoic acid (EPA) suppresses SELENOP expression by inactivating sterol regulatory element-binding protein-1c (SREBP-1c, encoded by Srebf1 in rat) in H4IIEC3 hepatocytes. Treatment with EPA caused concentration-and time-dependent reduction in SELENOP promoter activity. EPA activated AMP-activated protein kinase (AMPK); however, the inhibitory effect of EPA on SELENOP promoter activity was not canceled with an AMPK inhibitor compound C and dominant-negative AMPK transfection. Deletion mutant promoter assays and computational analysis of transcription factor-binding sites conserved among the species resulted in identification of a sterol regulatory element (SRE)-like site in the SELENOP promoter. A chromatin immunoprecipitation (ChIP) assay revealed that EPA decreases binding of SREBP-1c to the SELENOP promoter. Knockdown of Srebf1 resulted in a significant down-regulation of Selenop expression. Conversely, SREBP-1c overexpression inhibited the suppressive effect of EPA. These data provide a novel mechanism of action for EPA involving improvement of systemic insulin sensitivity through the regulation of selenoprotein P production independently of the AMPK pathway and suggest an additional approach to developing anti-diabetic drugs.	[Tajima-Shirasaki, Natsumi; Ishil, Kiyo-aki; Takayama, Hiroaki; Chikamoto, Keita; Teraguchi, Atsushi; Lan, Fei; Kikuchi, Akihiro; Takeshita, Yumie; Misu, Hirofumi; Takamura, Toshinari] Kanazawa Univ, Grad Sch Hlth Med, Dept Endocrinol & Metab, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan; [Tajima-Shirasaki, Natsumi; Ishil, Kiyo-aki; Takayama, Hiroaki; Shirasaki, Takayoshi; Kikuchi, Akihiro; Kaneko, Shuichi] Kanazawa Univ, Grad Sch Hlth Med, Dept Syst Biol, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan; [Shirasaki, Takayoshi] Kanazawa Univ, Grad Sch Hlth Med, Dept Adv Med Technol, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan; [Iwama, Hisakazu] Kagawa Univ, Life Sci Res Ctr, Ikenobe 1750-1, Miki, Kagawa 7610793, Japan; [Chikamoto, Keita; Matsugo, Seiichi] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Nat Syst, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan; [Saito, Yoshiro] Doshisha Univ, Fac Med & Life Sci, Dept Med Life Syst, Syst Life Sci, Kyotanabe, Kyoto 6100394, Japan; [Iwasaki, Yasumasa] Kochi Univ, Hlth Care Ctr, Kochi 7808520, Japan; [Murao, Koji] Kagawa Univ, Dept Adv Med, Ikenobe 1750-1, Miki, Kagawa 7610793, Japan; [Misu, Hirofumi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Kanazawa University; Kanazawa University; Kanazawa University; Kagawa University; Kanazawa University; Doshisha University; Kochi University; Kagawa University; Japan Science & Technology Agency (JST)	Takamura, T (corresponding author), Kanazawa Univ, Grad Sch Hlth Med, Dept Endocrinol & Metab, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	ttakamura@m-kanazawa.jp	Saito, Yoshiro/H-4597-2019; Takayama, Hiroaki/C-4694-2015	Saito, Yoshiro/0000-0002-0559-5889; Takayama, Hiroaki/0000-0003-4792-3868; Murao, Koji/0000-0002-7335-7196; Ishii, Kiyo-aki/0000-0001-9846-5575; Kikuchi, Akihiro/0000-0001-9332-1273	Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science KAKENHI [16K09740, 16K09739]; Grants-in-Aid for Scientific Research [26253046] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to H. M., S. K., and T. T.), and Japan Society for the Promotion of Science KAKENHI Grants 16K09740 (to H. M.) and 16K09739 (to Y. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Botolin D, 2006, J LIPID RES, V47, P181, DOI 10.1194/jlr.M500365-JLR200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Burk RF, 2005, ANNU REV NUTR, V25, P215, DOI 10.1146/annurev.nutr.24.012003.132120; Carlson BA, 2004, J BIOL CHEM, V279, P8011, DOI 10.1074/jbc.M310470200; Carpentier YA, 2006, AM J CLIN NUTR, V83, p1499S, DOI 10.1093/ajcn/83.6.1499S; Chen WL, 2012, BIOCHEM PHARMACOL, V84, P522, DOI 10.1016/j.bcp.2012.05.022; Choi HY, 2013, DIABETES METAB J, V37, P63, DOI 10.4093/dmj.2013.37.1.63; Dobrzyn A, 2005, BIOCHEM BIOPH RES CO, V332, P892, DOI 10.1016/j.bbrc.2005.05.026; Dreher I, 1997, J BIOL CHEM, V272, P29364, DOI 10.1074/jbc.272.46.29364; Flachs P, 2006, DIABETOLOGIA, V49, P394, DOI 10.1007/s00125-005-0053-y; Flachs P, 2009, CLIN SCI, V116, P1, DOI 10.1042/CS20070456; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Honda M, 2011, GASTROENTEROLOGY, V141, P128, DOI 10.1053/j.gastro.2011.03.051; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Ishii H, 2009, J HEPATOL, V50, P562, DOI 10.1016/j.jhep.2008.10.031; Ishikura K, 2014, DIABETOLOGIA, V57, P1968, DOI 10.1007/s00125-014-3306-9; Itoh M, 2007, ARTERIOSCL THROM VAS, V27, P1918, DOI 10.1161/ATVBAHA.106.136853; Jump DB, 2011, CURR OPIN CLIN NUTR, V14, P115, DOI 10.1097/MCO.0b013e328342991c; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kim HJ, 1999, J BIOL CHEM, V274, P25892, DOI 10.1074/jbc.274.36.25892; Kohjima M, 2008, INT J MOL MED, V21, P507; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Mater MK, 1999, J BIOL CHEM, V274, P32725, DOI 10.1074/jbc.274.46.32725; Misu H, 2017, NAT MED, V23, P508, DOI 10.1038/nm.4295; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Neschen S, 2007, DIABETES, V56, P1034, DOI 10.2337/db06-1206; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; Perez-Echarri N, 2009, BRIT J NUTR, V101, P1059, DOI 10.1017/S0007114508048307; Perez-Matute P, 2007, BRIT J NUTR, V97, P389, DOI 10.1017/S0007114507207627; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Rossi AS, 2005, AM J PHYSIOL-REG I, V289, pR486, DOI 10.1152/ajpregu.00846.2004; Saito Y, 2002, EUR J BIOCHEM, V269, P5746, DOI 10.1046/j.1432-1033.2002.03298.x; Sato A, 2010, DIABETES, V59, P2495, DOI 10.2337/db09-1554; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Sekiya M, 2003, HEPATOLOGY, V38, P1529, DOI 10.1016/j.hep.2003.09.028; Suchankova G, 2005, BIOCHEM BIOPH RES CO, V326, P851, DOI 10.1016/j.bbrc.2004.11.114; Suzuki-Kemuriyama N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157580; Takayama H, 2014, J BIOL CHEM, V289, P335, DOI 10.1074/jbc.M113.479386; Takeuchi Y, 2010, J BIOL CHEM, V285, P11681, DOI 10.1074/jbc.M109.096107; Tanaka N, 2010, BIOCHEM PHARMACOL, V80, P1601, DOI 10.1016/j.bcp.2010.07.031; Ungerfeld R, 2004, REPROD NUTR DEV, V44, P89, DOI 10.1051/rnd:2004010; Walter PL, 2008, BIOCHEM BIOPH RES CO, V365, P316, DOI 10.1016/j.bbrc.2007.10.171; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; Xu J, 1999, J BIOL CHEM, V274, P23577, DOI 10.1074/jbc.274.33.23577; Yahagi N, 1999, J BIOL CHEM, V274, P35840, DOI 10.1074/jbc.274.50.35840; Yang SJ, 2011, J CLIN ENDOCR METAB, V96, pE1325, DOI 10.1210/jc.2011-0620; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; Yoshikawa T, 2002, J BIOL CHEM, V277, P1705, DOI 10.1074/jbc.M105711200	54	27	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10791	10800		10.1074/jbc.M116.747006	http://dx.doi.org/10.1074/jbc.M116.747006			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28465347	hybrid, Green Published			2022-12-26	WOS:000404391000004
J	Bernardo, BS; Goodbourn, S; Baron, MD				Bernardo, Beatriz Sanz; Goodbourn, Stephen; Baron, Michael D.			Control of the induction of type I interferon by Peste des petits ruminants virus	PLOS ONE			English	Article							PARAMYXOVIRUS V-PROTEINS; NONSTRUCTURAL C PROTEIN; DOUBLE-STRANDED-RNA; DEFICIENT MEASLES-VIRUS; IFN-BETA PROMOTER; RIG-I; RINDERPEST VIRUS; MESSENGER-RNA; VIRAL-RNA; ANTIVIRAL RESPONSES	Peste des petits ruminants virus (PPRV) is a morbillivirus that produces clinical disease in goats and sheep. We have studied the induction of interferon-beta (IFN-beta) following infection of cultured cells with wild-type and vaccine strains of PPRV, and the effects of such infection with PPRV on the induction of IFN-beta through both MDA-5 and RIG-I mediated pathways. Using both reporter assays and direct measurement of IFN-beta mRNA, we have found that PPRV infection induces IFN-beta only weakly and transiently, and the virus can actively block the induction of IFN-beta. We have also generated mutant PPRV that lack expression of either of the viral accessory proteins (V&C) to characterize the role of these proteins in IFN-beta induction during virus infection. Both PPRV_Delta V and PPRV_Delta C were defective in growth in cell culture, although in different ways. While the PPRV V protein bound to MDA-5 and, to a lesser extent, RIG-I, and over-expression of the V protein inhibited both IFN-beta induction pathways, PPRV lacking V protein expression can still block IFN-beta induction. In contrast, PPRV C bound to neither MDA-5 nor RIG-I, but PPRV lacking C protein expression lost the ability to block both MDA-5 and RIG-I mediated activation of IFN-beta. These results shed new light on the inhibition of the induction of IFN-beta by PPRV.	[Bernardo, Beatriz Sanz; Baron, Michael D.] Pirbright Inst, Pirbright, Surrey, England; [Goodbourn, Stephen] St Georges Univ London, Inst Infect & Immun, London, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; St Georges University London	Baron, MD (corresponding author), Pirbright Inst, Pirbright, Surrey, England.	michael.baron@pirbright.ac.uk		Goodbourn, Stephen/0000-0002-4530-1179; Sanz Bernardo, Beatriz/0000-0001-6965-3497	Biotechnology and Biological Sciences Research Council; Institute Strategic Programme on Livestock Viral Diseases at The Pirbright Institute; Wellcome Trust [101792/Z/13/Z]; BBSRC [BBS/E/I/00001576, BBS/E/I/00001719] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001576, BBS/E/I/00001719] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Institute Strategic Programme on Livestock Viral Diseases at The Pirbright Institute; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was funded by the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk) Institute Strategic Programme on Livestock Viral Diseases at The Pirbright Institute (BSB and MDB), and grant 101792/Z/13/Z from the Wellcome Trust (www.wellcome.ac.uk) (SG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABREU SL, 1979, J BIOL CHEM, V254, P4114; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Bankamp B, 2005, VIROLOGY, V336, P120, DOI 10.1016/j.virol.2005.03.009; Baron J, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-22; Baron MD, 2016, ADV VIRUS RES, V95, P1, DOI 10.1016/bs.aivir.2016.02.001; Baron MD, 2000, J VIROL, V74, P2603, DOI 10.1128/JVI.74.6.2603-2611.2000; BELLINI WJ, 1985, J VIROL, V53, P908, DOI 10.1128/JVI.53.3.908-919.1985; Boxer EL, 2009, VIROLOGY, V385, P134, DOI 10.1016/j.virol.2008.11.022; BROWN CC, 1991, VET PATHOL, V28, P166, DOI 10.1177/030098589102800209; Bruns AM, 2014, MOL CELL, V55, P771, DOI 10.1016/j.molcel.2014.07.003; CATTANEO R, 1989, CELL, V56, P759, DOI 10.1016/0092-8674(89)90679-X; CAVALIERI RL, 1977, P NATL ACAD SCI USA, V74, P4415, DOI 10.1073/pnas.74.10.4415; Childs KS, 2009, J VIROL, V83, P1465, DOI 10.1128/JVI.01768-08; Childs K, 2007, VIROLOGY, V359, P190, DOI 10.1016/j.virol.2006.09.023; Childs K, 2012, J VIROL, V86, P3411, DOI 10.1128/JVI.06405-11; Childs KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064202; Chinnakannan SK, 2014, J GEN VIROL, V95, P44, DOI 10.1099/vir.0.056739-0; Chinnakannan SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057063; Couacy-Hymann E, 2007, VET J, V173, P178, DOI 10.1016/j.tvjl.2005.08.020; Davis ME, 2014, CELL HOST MICROBE, V16, P19, DOI 10.1016/j.chom.2014.06.007; DESMYTER J, 1968, J VIROL, V2, P955, DOI 10.1128/JVI.2.10.955-961.1968; Devaux P, 2008, J VIROL, V82, P5359, DOI 10.1128/JVI.00169-08; Dhar P, 2002, VET MICROBIOL, V88, P153, DOI 10.1016/S0378-1135(02)00102-5; Diallo A, 1989, Rev Elev Med Vet Pays Trop, V42, P311; DIAZ MO, 1988, P NATL ACAD SCI USA, V85, P5259, DOI 10.1073/pnas.85.14.5259; Didcock L, 1999, J VIROL, V73, P9928, DOI 10.1128/JVI.73.12.9928-9933.1999; DINTER H, 1987, EMBO J, V6, P599, DOI 10.1002/j.1460-2075.1987.tb04796.x; Escoffier C, 1999, J VIROL, V73, P1695, DOI 10.1128/JVI.73.2.1695-1698.1999; Finney D. J., 1964, STAT METHOD BIOL ASS, V2nd; Fontana JM, 2008, IMMUNOL REV, V225, P46, DOI 10.1111/j.1600-065X.2008.00669.x; GOODBOURN S, 1986, CELL, V45, P601, DOI 10.1016/0092-8674(86)90292-8; GOODBOURN S, 1985, CELL, V41, P509, DOI 10.1016/S0092-8674(85)80024-6; Goodbourn S, 2009, J INTERF CYTOK RES, V29, P539, DOI 10.1089/jir.2009.0071; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Hata N, 2001, BIOCHEM BIOPH RES CO, V285, P518, DOI 10.1006/bbrc.2001.5159; Hausmann S, 1999, J VIROL, V73, P5568, DOI 10.1128/JVI.73.7.5568-5576.1999; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Holzer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028594; Horikami SM, 1996, VIROLOGY, V222, P383, DOI 10.1006/viro.1996.0435; HU A, 1993, ARCH VIROL, V133, P201, DOI 10.1007/BF01309756; Hu QQ, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-48; Ikegame S, 2010, J VIROL, V84, P372, DOI 10.1128/JVI.01690-09; Irie T, 2012, J VIROL, V86, P7136, DOI 10.1128/JVI.06705-11; Ito M, 2013, J VIROL, V87, P9633, DOI 10.1128/JVI.00714-13; Killip MJ, 2011, VIROLOGY, V415, P39, DOI 10.1016/j.virol.2011.03.027; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; KING P, 1992, NUCLEIC ACIDS RES, V20, P1039, DOI 10.1093/nar/20.5.1039; Komatsu T, 2004, VIROLOGY, V325, P137, DOI 10.1016/j.virol.2004.04.025; Kul O, 2007, VET PATHOL, V44, P479, DOI 10.1354/vp.44-4-479; Kumar P, 2004, J VET MED B, V51, P153, DOI 10.1111/j.1439-0450.2004.00747.x; Kwiatek O, 2011, EMERG INFECT DIS, V17, P1223, DOI 10.3201/eid1707.101216; Lasecka L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094656; MASSON N, 1992, MOL CELL BIOL, V12, P1096, DOI 10.1128/MCB.12.3.1096; McAllister CS, 2010, J VIROL, V84, P380, DOI 10.1128/JVI.02630-08; MOSCA JD, 1986, MOL CELL BIOL, V6, P2279, DOI 10.1128/MCB.6.6.2279; Motz C, 2013, SCIENCE, V339, P690, DOI 10.1126/science.1230949; Nakatsu Y, 2008, J VIROL, V82, P8296, DOI 10.1128/JVI.00108-08; Nakatsu Y, 2006, J VIROL, V80, P11861, DOI 10.1128/JVI.00751-06; Nanda SK, 2006, J VIROL, V80, P7555, DOI 10.1128/JVI.02720-05; Nishie T, 2015, BIOCHEM BIOPH RES CO, V463, P1262, DOI 10.1016/j.bbrc.2015.06.099; Parisien JP, 2009, J VIROL, V83, P7252, DOI 10.1128/JVI.00153-09; Parks GD, 2013, J MOL BIOL, V425, P4872, DOI 10.1016/j.jmb.2013.09.015; Patterson JB, 2000, VIROLOGY, V267, P80, DOI 10.1006/viro.1999.0118; Pfaller CK, 2015, J VIROL, V89, P7735, DOI 10.1128/JVI.01017-15; Pfaller CK, 2014, J VIROL, V88, P456, DOI 10.1128/JVI.02572-13; Pfaller CK, 2008, J VIROL, V82, P12365, DOI 10.1128/JVI.01321-08; Plumet S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000279; Pope RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055830; Radecke F, 1996, VIROLOGY, V217, P418, DOI 10.1006/viro.1996.0134; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rodriguez KR, 2014, J VIROL, V88, P8180, DOI 10.1128/JVI.00737-14; Rodriguez KR, 2013, J VIROL, V87, P2974, DOI 10.1128/JVI.02843-12; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schneider H, 1997, VIROLOGY, V227, P314, DOI 10.1006/viro.1996.8339; Shaffer JA, 2003, VIROLOGY, V315, P389, DOI 10.1016/S0042-6822(03)00537-3; Shaila MS, 1996, VIRUS RES, V43, P149, DOI 10.1016/0168-1702(96)01312-3; Son KN, 2015, J VIROL, V89, P9383, DOI 10.1128/JVI.01299-15; Sparrer KMJ, 2012, J VIROL, V86, P796, DOI 10.1128/JVI.05899-11; SUGIYAMA M, 1989, J GEN VIROL, V70, P2605, DOI 10.1099/0022-1317-70-10-2605; Sweetman DA, 2001, VIROLOGY, V281, P193, DOI 10.1006/viro.2000.0805; Takeuchi K, 2005, J VIROL, V79, P7838, DOI 10.1128/JVI.79.12.7838-7844.2005; Takeuchi K, 2008, J VIROL, V82, P10102, DOI 10.1128/JVI.00599-08; Tatsuo H, 2001, J VIROL, V75, P5842, DOI 10.1128/JVI.75.13.5842-5850.2001; Truong T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087145; Tober C, 1998, J VIROL, V72, P8124, DOI 10.1128/JVI.72.10.8124-8132.1998; Toth AM, 2009, J VIROL, V83, P961, DOI 10.1128/JVI.01669-08; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VIDAL S, 1990, EMBO J, V9, P2017, DOI 10.1002/j.1460-2075.1990.tb08330.x; Watanabe N, 1996, MED MICROBIOL IMMUN, V185, P89, DOI 10.1007/s004300050019; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Wemike K, 2014, VET MICROBIOL, V172, P140, DOI 10.1016/j.vetmic.2014.05.010; WHITTEMORE LA, 1990, P NATL ACAD SCI USA, V87, P7799, DOI 10.1073/pnas.87.20.7799; Yount JS, 2006, J IMMUNOL, V177, P4503, DOI 10.4049/jimmunol.177.7.4503; Zahur A, 2014, J BIOSCIENCES MED, V2, P8	96	24	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177300	10.1371/journal.pone.0177300	http://dx.doi.org/10.1371/journal.pone.0177300			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475628	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000400649500061
J	Chao, G; Tian, XN; Zhang, WT; Ou, XH; Cong, F; Song, T				Chao, Gao; Tian, Xiaoning; Zhang, Wentao; Ou, Xuehai; Cong, Fei; Song, Tao			Blocking Smad2 signalling with loganin attenuates SW10 cell cycle arrest induced by TNF-alpha	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; TRANSCRIPTION FACTORS; ACTIVATION; PROTEINS; DEATH; E2F; PROLIFERATION; EXPRESSION; PATHWAY	The activity of Schwann cells (SWCs) is very important in trauma-induced nerve repair, and tumour necrosis factor-alpha (TNF-alpha) produced during tissue injury inhibits the viability of SWCs, which delays the repair of peripheral nerves. Loganin is an iridoid glycoside that has been shown to alleviate a variety of cytotoxic effects. In the current study, we evaluated the potential efficacy and the mechanism of action of loganin in TNF-alpha induced cytotoxicity in SW10 cells. The experimental results indicated that loganin blocked TNF-alpha-mediated Smad2 activation, downregulated the expression of the G1 phase cell cycle inhibitor p15(IN4KB), and upregulated the expression of the G1 phase cell cycle activator cyclin D1CDK4/6, which upregulated E2F-1-dependent survivin expression and relieved TNF-ainduced apoptosis in SW10 cells. The protective effect of loganin on SWCs has potential medicinal value in the promotion of peripheral nerve repair and is significant for studies in the field of tissue regeneration.	[Chao, Gao; Tian, Xiaoning; Zhang, Wentao; Ou, Xuehai; Cong, Fei; Song, Tao] Xi An Jiao Tong Univ, Honghui Hosp, Coll Med, Dept Bone Microsurg, Xian, Peoples R China	Xi'an Jiaotong University	Song, T (corresponding author), Xi An Jiao Tong Univ, Honghui Hosp, Coll Med, Dept Bone Microsurg, Xian, Peoples R China.	st0325@163.com						Amrita Chatterjee, 2015, CANC LETT, V360, P134; Boyle K, 2005, NEUROBIOL DIS, V20, P412, DOI 10.1016/j.nbd.2005.03.022; Chen HS, 2015, INT J ONCOL, V46, P1730, DOI 10.3892/ijo.2015.2870; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; Howard BA, 2000, J MAMMARY GLAND BIOL, V5, P119, DOI 10.1023/A:1026487120779; Hyeri Kim, 2015, Food & Function, V6, P1108, DOI 10.1039/C5FO00055F; Jessen KR, 2015, COLD SPRING HARBOR P, V7; Jiang YY, 2004, J BIOL CHEM, V279, P40511, DOI 10.1074/jbc.M404496200; Kantari C, 2011, BBA-MOL CELL RES, V1813, P558, DOI 10.1016/j.bbamcr.2011.01.026; Kay S., 1973, PLASTIC RECONSTRUCTI, V105, P365; Kim MJ, 2015, EUR J PHARMACOL, V765, P541, DOI 10.1016/j.ejphar.2015.09.019; Kurimchak A, 2015, CELL CYCLE, V14, P18, DOI 10.4161/15384101.2014.985069; Li Y, 2016, INT IMMUNOPHARMACOL, V36, P173, DOI 10.1016/j.intimp.2016.04.026; Liu K, 2015, LIFE SCI, V123, P78, DOI 10.1016/j.lfs.2014.12.028; Llobet Navas D, 2014, MOL CELL BIOL, V34, P4216; Macias H, 1995, ADV DENT RES, P533; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mulleman D, 2006, JOINT BONE SPINE, V73, P270, DOI 10.1016/j.jbspin.2005.03.004; Park Kyung-Soon, 2011, Int J Stem Cells, V4, P18; Pollheimer J, 2005, PLACENTA, V26, pS21, DOI 10.1016/j.placenta.2004.11.013; Reed JC, 1999, NAT CELL BIOL, V1, pE199, DOI 10.1038/70227; Schafers M, 2002, J NEUROSCI, V22, P536, DOI 10.1523/JNEUROSCI.22-02-00536.2002; Takahashi Y, 2000, GENE DEV, V14, P804; Tseng YT, 2016, PHARMACOL RES, V111, P58, DOI 10.1016/j.phrs.2016.05.023; Wagner R, 1996, NEUROSCIENCE, V73, P625, DOI 10.1016/0306-4522(96)00127-3; Wajant H, TNFR1 INDUCED ACTIVA, V278, P862; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Yao L, 2017, J CELL BIOCHEM, V118, P615, DOI 10.1002/jcb.25749; Zhao M, 2016, J CHROMATOGR B, V1009, P122, DOI 10.1016/j.jchromb.2015.12.020	31	13	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176965	10.1371/journal.pone.0176965	http://dx.doi.org/10.1371/journal.pone.0176965			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475649	gold, Green Published, Green Submitted			2022-12-26	WOS:000400649500032
J	Lee, SH; Yang, JH; Choi, SH; Park, TK; Jang, WJ; Song, YB; Hahn, JY; Choi, JH; Gwon, HC				Lee, Seung Hwa; Yang, Jeong Hoon; Choi, Seung-Hyuk; Park, Taek Kyu; Jang, Woo Jin; Song, Young Bin; Hahn, Joo-Yong; Choi, Jin-Ho; Gwon, Hyeon-Cheol			Duration of dual antiplatelet therapy in patients treated with percutaneous coronary intervention for coronary chronic total occlusion	PLOS ONE			English	Article							ELUTING STENT IMPLANTATION; ELDERLY-PATIENTS; OUTCOMES; REVASCULARIZATION; RECANALIZATION; METAANALYSIS; EFFICACY	Background The duration of dual antiplatelet therapy (DAPT) after drug-eluting stent implantation in coronary chronic total occlusion (CTO) remains unclear. Methods We retrospectively analyzed a total of 512 patients treated with percutaneous coronary intervention (PCI) in the Samsung Medical Center CTO registry. Patients were separated into <= 12-month (199, 38.9%) vs. > 12 month (313, 61.1%) based on DAPT duration with aspirin and clopidogrel. The primary outcome was major adverse cardiac and cerebrovascular event (MACCE) during follow-up. Results Median follow-up duration was 67 (interquartile range: 51-84) months. MACCE occurred in 43 patients (21.6%) in the <= 12-month and 55 patients (17.6%) in the > 12-month groups. In the propensity-matched population, the rate of MACCE did not differ significantly between the <= 12-month and > 12-month group (19.4% vs. 18.8%; hazard ratio [HR], 0.95; 95% confidential interval [CI], 0.52-1.76, p = 0.88). Moreover, moderate or severe bleeding according to BARC criteria (type 2, 3 or 5) was also similar between the <= 12-month and > 12month group (2.5% vs. 1.9%; HR, 1.00; 95% CI, 0.20-4.96, p = 0.99). Conclusion Among patients treated with PCI for CTO, DAPT with durations of <= 12-month showed similar long-term clinical outcomes compared to > 12-month DAPT.	[Lee, Seung Hwa; Yang, Jeong Hoon; Choi, Seung-Hyuk; Park, Taek Kyu; Song, Young Bin; Hahn, Joo-Yong; Choi, Jin-Ho; Gwon, Hyeon-Cheol] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Heart Stroke & Vasc Inst, Seoul, South Korea; [Jang, Woo Jin] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Div Cardiol,Dept Med, Chang Won, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Choi, SH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Heart Stroke & Vasc Inst, Seoul, South Korea.	sh1214.choi@samsung.com	Hahn, Joo-Yong/AAU-7250-2020	Hahn, Joo-Yong/0000-0002-4412-377X; Lee, Seung Hwa/0000-0001-5508-7519				Abo-salem E, 2015, CARDIOVASC THER, V33, P253, DOI 10.1111/1755-5922.12137; Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; Costa F, 2015, EUR HEART J, V36, P1242, DOI 10.1093/eurheartj/ehv038; Fefer P, 2012, J AM COLL CARDIOL, V59, P991, DOI 10.1016/j.jacc.2011.12.007; Feres F, 2013, JAMA-J AM MED ASSOC, V310, P2510, DOI 10.1001/jama.2013.282183; Galassi AR, 2011, J INTERV CARDIOL, V24, P426, DOI 10.1111/j.1540-8183.2011.00648.x; Gilard M, 2015, J AM COLL CARDIOL, V65, P2222, DOI 10.1016/j.jacc.2015.03.541; Giustino G, 2016, J AM COLL CARDIOL, V68, P1851, DOI 10.1016/j.jacc.2016.07.760; Giustino G, 2015, J AM COLL CARDIOL, V65, P1298, DOI 10.1016/j.jacc.2015.01.039; Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; Iannaccone M, 2016, EUR HEART J-CARD IMG, V17, P1128, DOI 10.1093/ehjci/jev283; Ikegami Y, 2015, CIRC J, V79, P2598, DOI 10.1253/circj.CJ-15-0484; Lee CW, 2014, CIRCULATION, V129, P304, DOI 10.1161/CIRCULATIONAHA.113.003303; Lee KH, 2011, J AM COLL CARDIOL, V58, P1664, DOI 10.1016/j.jacc.2011.05.057; Lee SH, 2015, CIRC J, V79, P1780, DOI 10.1253/circj.CJ-15-0041; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Patel MR, 2012, JACC-CARDIOVASC INTE, V5, P1054, DOI 10.1016/j.jcin.2012.05.017; Reifart N, 2010, EUROINTERVENTION, V6, P356, DOI 10.4244/EIJV6I3A59; Schulz-Schupke S, 2015, EUR HEART J, V36, P1252, DOI 10.1093/eurheartj/ehu523; Stone GW, 2005, CIRCULATION, V112, P2364, DOI 10.1161/CIRCULATIONAHA.104.481283; Tamburino C, 2013, AM HEART J, V165, P133, DOI 10.1016/j.ahj.2012.10.017; Valgimigli M, 2012, CIRCULATION, V125, P2015, DOI 10.1161/CIRCULATIONAHA.111.071589; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/ejcts/ezu366, 10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224]; Yeh RW, 2015, J AM COLL CARDIOL, V65, P2211, DOI 10.1016/j.jacc.2015.03.003	26	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176737	10.1371/journal.pone.0176737	http://dx.doi.org/10.1371/journal.pone.0176737			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475584	Green Published, Green Submitted, gold			2022-12-26	WOS:000400649500013
J	Ma, LX; Saiyin, H				Ma, Lixiang; Saiyin, Hexige			LSL-Kras(G12D); LSL-Trp53(R172H/+); Ink4 (flox/+); Ptf1/p48-Cre mice are an applicable model for locally invasive and metastatic pancreatic cancer	PLOS ONE			English	Article							ENGINEERED MOUSE MODELS; ONCOGENIC K-RAS; DUCTAL ADENOCARCINOMA; MUTANT P53; MESENCHYMAL TRANSITION; CELLS; PROGRESSION; CHEMORESISTANCE; KRAS(G12D); COOPERATE	Pancreatic cancer (PC) accumulates multiple genetic mutations, including activating KRAS mutations and inactivating TP53, SMAD4 and CDKN2A mutations, during progression. The combination of mutant KRAS with a single inactivating TP53, SMAD4 or CDKN2A mutation in genetically engineered mouse models (GEMMs) showed that these mutations exert different synergistic effects in PC. However, the effect of the combination of TP53, CDKN2A and KRAS mutations on the trajectory of PC progression is unknown. Here, we report a GEMM that harbors KRAS (Kras(G12D)), TP53 (Trp53(R172H/+)), CDKN2A (Ink4(flox/+)) and Ptf1/ p48-Cre (KPIC) mutations. Histopathology showed that KPIC mice developed adenocarcinoma that strongly resembled the pathology of human PC, characterized by rich desmoplastic stroma and low microvascularity. The median survival of KPIC mice was longer than that of LSL-Kras(G12D); Ink4(flox/flox); Ptf1/p48-Cre mice (KIC) (89 vs 62 days) and shorter than that of KRAS (Kras(G12D)), TP53 (Trp53(R172H/+)) and Ptf1/p48-Cre (KPC) mice. Moreover, the neoplastic cells of KPIC mice were epithelial, highly proliferative tumor cells that exhibited ERK and MAPK pathway activation and high glucose uptake. Isolated neoplastic cells from spontaneous KPIC tumors showed all molecular profiles and cellular behaviors of spontaneous KPIC tumors, including epithelial-mesenchymal transition (EMT) under drug stress as well as tumorigenic, metastatic and invasive abilities in immunocompetent mice. Furthermore, orthotopic and metastatic tumors of KPIC cells almost recapitulated the pathology of spontaneous KPIC tumors. These data show that in addition to spontaneous KPIC tumors, KPIC cells are a valuable tool for preclinical studies of locally invasive and metastatic PC.	[Ma, Lixiang] Shanghai Med Coll, Dept Anat Histol & Embryol, Shanghai, Peoples R China; [Saiyin, Hexige] Fudan Univ, Sch Life Sci, Shanghai, Peoples R China	Fudan University	Saiyin, H (corresponding author), Fudan Univ, Sch Life Sci, Shanghai, Peoples R China.	saiyin@fudan.edu.cn		ma, lixiang/0000-0001-9399-155X; Saiyin, Hexige/0000-0003-2993-6817				Acin S, 2011, J PATHOL, V225, P479, DOI 10.1002/path.2971; Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Alexandrova EM, 2015, NATURE, V523, P352, DOI 10.1038/nature14430; Bang S, 2006, J CLIN GASTROENTEROL, V40, P923, DOI 10.1097/01.mcg.0000225672.68852.05; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Cowan RW, 2014, CANCER J, V20, P80, DOI 10.1097/PPO.0000000000000011; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Fiorini C, 2015, BBA-MOL CELL RES, V1853, P89, DOI 10.1016/j.bbamcr.2014.10.003; Fitzgerald Timothy L., 2015, Advances in Biological Regulation, V59, P65, DOI 10.1016/j.jbior.2015.06.003; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hruban RH, 2006, CANCER RES, V66, P95, DOI 10.1158/0008-5472.CAN-05-2168; Hwang CI, 2016, J PATHOL, V238, P197, DOI 10.1002/path.4651; Izeradjene K, 2007, CANCER CELL, V11, P229, DOI 10.1016/j.ccr.2007.01.017; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jacobetz MA, 2013, GUT, V62, P112, DOI 10.1136/gutjnl-2012-302529; Kajiyama H, 2007, INT J ONCOL, V31, P277; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kim JJ, 2013, J CELL BIOCHEM, V114, P1286, DOI 10.1002/jcb.24464; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Majumder K, 2015, J GASTROINTEST SURG; Majumder K, 2016, J GASTROINTEST SURG, V20, P53, DOI 10.1007/s11605-015-2985-y; Miura Fumihiko, 2006, HPB (Oxford), V8, P337, DOI 10.1080/13651820500540949; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Rozenblum E, 1997, CANCER RES, V57, P1731; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Saiyin H, 2015, J PATHOL, V236, P142, DOI 10.1002/path.4506; Sangwan V, 2015, PANCREAS, V44, P583, DOI 10.1097/MPA.0000000000000317; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Shah AN, 2007, ANN SURG ONCOL, V14, P3629, DOI 10.1245/s10434-007-9583-5; Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sheikhbahaei S, 2016, NUCL MED COMMUN, V37, P231, DOI 10.1097/MNM.0000000000000436; Shetzer Y., 2016, COLD SPRING HARB PER; Shroff S, 2014, HUM PATHOL, V45, P456, DOI 10.1016/j.humpath.2013.10.008; Torres MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080580; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Westphalen CB, 2012, CANCER J, V18, P502, DOI 10.1097/PPO.0b013e31827ab4c4; Ying HQ, 2016, GENE DEV, V30, P355, DOI 10.1101/gad.275776.115; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	43	9	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176844	10.1371/journal.pone.0176844	http://dx.doi.org/10.1371/journal.pone.0176844			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475592	Green Submitted, Green Published, gold			2022-12-26	WOS:000400649500017
J	Restivo, MR; McKinnon, MC; Frey, BN; Hall, GB; Syed, W; Taylor, VH				Restivo, Maria R.; McKinnon, Margaret C.; Frey, Benicio N.; Hall, Geoffrey B.; Syed, Wasimuddin; Taylor, Valerie H.			The impact of obesity on neuropsychological functioning in adults with and without major depressive disorder	PLOS ONE			English	Article							COGNITIVE FUNCTION; EXECUTIVE DYSFUNCTION; BIPOLAR DISORDER; ASSOCIATION; METAANALYSIS; QUESTIONNAIRE; HYPERTENSION; HEALTH; MEMORY; MANIA	Background Evidence suggests obesity exerts a negative impact on cognition. Major Depressive Disorder (MDD) is also linked to problems in cognitive functioning. Obesity is highly prevalent in individuals with MDD and is linked to a failure to return to a full level of functioning. The study's objective was to investigate the effect of obesity on cognitive impairment in participants with MDD. Methods This study compared cognitive performance in obese individuals with MDD and two control populations (obese individuals without a psychiatric illness and non-obese controls). A standardized battery of neuropsychological tests specifically designed to assess performance in declarative memory, executive functioning, processing speed and attention was administered. Mood ratings, physical measurements, nutritional and health questionnaires were also completed. Results We observed a consistent pattern across measures of memory, executive functioning, attention and processing speed. Whereas healthy controls performed better than both bariatric groups across the majority of measures administered, bariatric controls tended to outperform bariatric MDD patients. Limitations The overall sample size of our study was small and thus largely explorative in nature. However, it provides compelling results (while controlling for extraneous variables such as medication load, nutritional status and common metabolic comordidities) that strongly urges for further investigation and study replication with larger sample sizes. Conclusions We found obesity has a subtle impact on cognition in obese individuals, and when obesity is present in individuals with MDD, this impact may be significant. It is important to minimize all modifiable variables that can add to cognitive burden in this population.	[Restivo, Maria R.; Taylor, Valerie H.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [McKinnon, Margaret C.; Frey, Benicio N.] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [McKinnon, Margaret C.; Frey, Benicio N.] St Josephs Healthcare Hamilton, Mood Disorders Program, Hamilton, ON, Canada; [McKinnon, Margaret C.; Frey, Benicio N.] St Josephs Healthcare Hamilton, Womens Hlth Concerns Clin, Hamilton, ON, Canada; [Hall, Geoffrey B.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada; [Syed, Wasimuddin] McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada; [Taylor, Valerie H.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; University of Toronto	Restivo, MR (corresponding author), Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada.	maria.restivo@wchospital.ca	McKinnon, Margaret/AAT-5821-2021; Frey, Benicio/AAJ-8212-2021	McKinnon, Margaret/0000-0002-8315-7657; /0000-0002-3398-6692; Taylor, Valerie/0000-0002-8948-638X; Frey, Benicio N./0000-0001-8267-943X	Bristol Myers Squibb; Canadian Institute of Health Research; Government of Ontario	Bristol Myers Squibb(Bristol-Myers Squibb); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Government of Ontario	Dr .Valerie Taylor received an unrestricted educational grant from Bristol Myers Squibb to help fund this study. They had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MR has been supported by fellowships from the Canadian Institute of Health Research and Government of Ontario.	Alonso-Alonso M, 2007, JAMA-J AM MED ASSOC, V297, P1819, DOI 10.1001/jama.297.16.1819; Alosco ML, 2014, AM J SURG, V207, P870, DOI 10.1016/j.amjsurg.2013.05.018; Altman EG, 1997, BIOL PSYCHIAT, V42, P948, DOI 10.1016/S0006-3223(96)00548-3; Anvari M SA, 2015, REGISTRY DATA PRODUC; Barrett-Connor E, 2013, CARDIOLOGY, V125, P94; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benito-Leon J, 2013, EUR J NEUROL, V20, P899, DOI 10.1111/ene.12083; Benton AL, 1983, MULTILINGUAL APHASIA; Berstein D.P, 1998, CHILDHOOD TRAUMA QUE; Birt Julie, 2003, Ann Clin Psychiatry, V15, P49, DOI 10.1023/A:1023280610379; Boeka AG, 2008, ARCH CLIN NEUROPSYCH, V23, P467, DOI 10.1016/j.acn.2008.03.003; Bora E, 2013, PSYCHOL MED, V43, P2017, DOI 10.1017/S0033291712002085; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Chung F, 2008, ANESTHESIOLOGY, V108, P822, DOI 10.1097/ALN.0b013e31816d91b5; Cook R, 2013, OBESITY FACTS, V6, P173; Costa E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/871656; Delis DC., 2000, CALIFORNIA VERBAL LE; Elias MF, 2003, INT J OBESITY, V27, P260, DOI 10.1038/sj.ijo.802225; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; First M. B, 2007, SCID I P; Golden J.C., 1978, STROOP COLOR WORD TE; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Harvey PO, 2004, J PSYCHIATR RES, V38, P567, DOI 10.1016/j.jpsychires.2004.03.003; Hassel S, 2008, BIPOLAR DISORD, V10, P916, DOI 10.1111/j.1399-5618.2008.00641.x; Hasselbalch BJ, 2011, J AFFECT DISORDERS, V134, P20, DOI 10.1016/j.jad.2010.11.011; Heaton EK, 1993, WISCONSIN CARD SORTI; Hedlund J.L., 1979, J OPER PSYCHIATR, V10, P149, DOI DOI 10.1192/BJP.BP.106.032532; Janssen I, 2013, CAN J DIABETES, V37, P90, DOI 10.1016/j.jcjd.2013.02.059; Jean MDK, 2014, DIABETES, V63, pA212; Lee RSC, 2012, J AFFECT DISORDERS, V140, P113, DOI 10.1016/j.jad.2011.10.023; Liang J, 2014, INT J OBESITY, V38, P494, DOI 10.1038/ijo.2013.142; McDermott LM, 2009, J AFFECT DISORDERS, V119, P1, DOI 10.1016/j.jad.2009.04.022; McIntyre RS, 2011, J AFFECT DISORDERS, V128, pS29, DOI 10.1016/S0165-0327(11)70006-4; McIntyre RS, 2006, CAN J PSYCHIAT, V51, P274, DOI 10.1177/070674370605100502; McLennan SN, 2010, INT J GERIATR PSYCH, V25, P933, DOI 10.1002/gps.2431; Oliveira de Lima Queiroz L, 2013, 21 WORLD C NEUR VIEN, pe537; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Reitan RM, 1985, HALSTEAD REITAN NEUR; Restivo MR, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009347; Restivo MR, 2014, BIOL PSYCHIAT, V75, p55S; Rock PL, 2014, PSYCHOL MED, V44, P2029, DOI 10.1017/S0033291713002535; Sackeim Harold A., 2001, Journal of Clinical Psychiatry, V62, P10; Schoedel KA, 2012, J CLIN PSYCHOPHARM, V32, P492, DOI 10.1097/JCP.0b013e31825d380d; Sheehan DV, 1996, INT CLIN PSYCHOPHARM, V11, P89, DOI 10.1097/00004850-199606003-00015; Simon GE, 2008, GEN HOSP PSYCHIAT, V30, P32, DOI 10.1016/j.genhosppsych.2007.09.001; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Smith E, 2011, OBES REV, V12, P740, DOI 10.1111/j.1467-789X.2011.00920.x; Snyder HR, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00328; Snyder HR, 2013, PSYCHOL BULL, V139, P81, DOI 10.1037/a0028727; Spitznagel MB, 2013, SURG OBES RELAT DIS, V9, P765, DOI 10.1016/j.soard.2013.04.011; Talarowska M, 2010, ADV MED SCI-POLAND, V55, P317, DOI 10.2478/v10039-010-0053-0; Trivedi MH, J AFFECTIVE DISORDER, V152-154, P19; van den Berg E, 2009, BBA-MOL BASIS DIS, V1792, P470, DOI 10.1016/j.bbadis.2008.09.004; Wagner S, 2012, ACTA PSYCHIAT SCAND, V125, P281, DOI 10.1111/j.1600-0447.2011.01762.x; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Willett WC, 2002, AM J MED, V113, P47, DOI 10.1016/S0002-9343(01)00992-5; World Health Organization, 2008, WHO STEPWISE APPR SU; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	60	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176898	10.1371/journal.pone.0176898	http://dx.doi.org/10.1371/journal.pone.0176898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SX	28475603	Green Published, gold, Green Submitted			2022-12-26	WOS:000400649500025
J	Chang, PA; Heier, C; Qin, WZ; Han, LP; Huang, FF; Sun, Q				Chang, Ping'an; Heier, Christoph; Qin, Wenzhen; Han, Liping; Huang, Feifei; Sun, Quan			Molecular identification of transmembrane protein 68 as an endoplasmic reticulum-anchored and brain-specific protein	PLOS ONE			English	Article							ACYL-COA; TRIACYLGLYCEROL SYNTHESIS; ACYLTRANSFERASE; DOMAIN; ENZYMES; ACID; LOCALIZATION; DIVERSITY; MUTANT; SIGNAL	Acyltransferases catalyze essential reactions in the buildup and remodeling of glycerophospholipids and contribute to the maintenance and diversity of cellular membranes. Transmembrane protein 68 (TMEM68) is an evolutionarily conserved protein of unknown function, that forms a distinct subgroup within the glycerophospholipid acyltransferase family. In the current study we expressed murine TMEM68 for the first time in mammalian cells to characterize its subcellular localization, topology, and possible biological function(s). We show that TMEM68 is an integral membrane protein and orients both, the N- and C-terminus towards the cytosol. Live cell imaging demonstrated that TMEM68 is localized mainly at the endoplasmic reticulum (ER), but not at cellular lipid droplets (LDs). The positioning of TMEM68 at the ER was dependent on its first transmembrane domain (TMD), which by itself was sufficient to target cytosolic green fluorescence protein (GFP) to the ER. In contrast, a second TMD was dispensable for ER localization of TMEM68. Finally, we found that among multiple murine tissues the expression level of TMEM68 transcripts was highest in brain. We conclude that TMEM68 is an integral ER membrane protein and a putative acyltransferase involved in brain glycerolipid metabolism.	[Chang, Ping'an; Qin, Wenzhen; Han, Liping; Huang, Feifei; Sun, Quan] Chongqing Univ Posts & Telecommun, Sch Bioinformat, Key Lab Mol Biol, Chongqing, Peoples R China; [Heier, Christoph] Karl Franzens Univ Graz, Inst Mol Biosci, Heinrichstr 31-11, Graz, Austria	Chongqing University of Posts & Telecommunications; University of Graz	Chang, PA (corresponding author), Chongqing Univ Posts & Telecommun, Sch Bioinformat, Key Lab Mol Biol, Chongqing, Peoples R China.	changpa@cqupt.edu.cn		Heier, Christoph/0000-0001-6858-408X	Natural Science Foundation Project of CQ CSTC [2014jcyjA10033, cstc2016jcyjA0572]; Science and Technology Project from Chongqing Municipal Education Committee [KJ1400424]	Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC); Science and Technology Project from Chongqing Municipal Education Committee	This researching work is supported both by the Natural Science Foundation Project of CQ CSTC (2014jcyjA10033, cstc2016jcyjA0572) and by the Science and Technology Project from Chongqing Municipal Education Committee (KJ1400424). The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao JS, 2008, J BIOL CHEM, V283, P19049, DOI 10.1074/jbc.M800364200; Chang PA, 2013, MOL BIOL REP, V40, P5597, DOI 10.1007/s11033-013-2661-9; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Eto M, 2014, BIOCHEM BIOPH RES CO, V443, P718, DOI 10.1016/j.bbrc.2013.12.043; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gimeno RE, 2008, J LIPID RES, V49, P2079, DOI 10.1194/jlr.R800013-JLR200; Hishikawa D, 2014, J LIPID RES, V55, P799, DOI 10.1194/jlr.R046094; Honsho M, 1998, J BIOL CHEM, V273, P20860, DOI 10.1074/jbc.273.33.20860; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; Kory N, 2016, TRENDS CELL BIOL, V26, P535, DOI 10.1016/j.tcb.2016.02.007; Lands WEM, 2000, BBA-MOL CELL BIOL L, V1483, P1, DOI 10.1016/S1388-1981(99)00177-8; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Moessinger C, 2011, J BIOL CHEM, V286, P21330, DOI 10.1074/jbc.M110.202424; Shan DD, 2010, J LIPID RES, V51, P1971, DOI 10.1194/jlr.M006304; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Shindou H, 2013, J BIOCHEM, V154, P21, DOI 10.1093/jb/mvt048; Shindou H, 2009, BIOCHEM BIOPH RES CO, V383, P320, DOI 10.1016/j.bbrc.2009.04.013; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Wendel AA, 2009, BBA-MOL CELL BIOL L, V1791, P501, DOI 10.1016/j.bbalip.2008.10.010; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Yamashita Atsushi, 2014, Biology (Basel), V3, P801, DOI 10.3390/biology3040801; Yang M, 1997, J BIOL CHEM, V272, P1970, DOI 10.1074/jbc.272.3.1970	27	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176980	10.1371/journal.pone.0176980	http://dx.doi.org/10.1371/journal.pone.0176980			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472192	Green Published, gold, Green Submitted			2022-12-26	WOS:000400648500108
J	Edelman, EJ; So-Armah, K; Cheng, DM; Doyley, MF; Coleman, SM; Bridden, C; Gnatienko, N; Lioznov, DA; Blokhina, E; Freiberg, MS; Krupitsky, EM; Emu, B; Samet, JH				Edelman, E. Jennifer; So-Armah, Kaku; Cheng, Debbie M.; Doyley, Margaret F.; Coleman, Sharon M.; Bridden, Carly; Gnatienko, Natalia; Lioznov, Dmitry A.; Blokhina, Elena; Freiberg, Matthew S.; Krupitsky, Evgeny M.; Emu, Brinda; Samet, Jeffrey H.			Impact of illicit opioid use on T cell subsets among HIV-infected adults	PLOS ONE			English	Article							DRUG-USE; REPLICATIVE SENESCENCE; ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; LENINGRAD REGION; FAGERSTROM TEST; HEROIN-ADDICTS; ST-PETERSBURG; IMMUNOSENESCENCE; WITHDRAWAL	Objectives Opioids have immunosuppressive properties, yet opioid effects on T cell abnormalities consistent with the immune risk phenotype among HIV-infected individuals are understudied. Methods To assess associations between illicit opioid use and T cell characteristics (CD4/CD8 ratio, memory profiles based on CD45RO and CD28 expression, and senescence based on CD57 expression), we conducted an exploratory cross-sectional analysis of Russia ARCH, a cohort of antiretroviral therapy (ART)-naive HIV-infected individuals recruited 11/2012 to 10/2014 in St. Petersburg, Russia. The main independent variable was past 30 day illicit opioid use (yes vs. no). Secondary analyses evaluated none (0 days), intermittent (1 to 7 days), and persistent (8 to 30 days) opioid use. Outcomes were determined with flow cytometry. Analyses were conducted using linear regression models. Results Among 186 participants, 38% reported any illicit opioid use (18% intermittent and 20% persistent). Any illicit opioid use was not significantly associated with T cell characteristics. Intermittent opioid use appeared to be associated with decreased memory CD8+ T cells proportion (CD45RO+ CD45RA-CD8+T cells: adjusted mean difference [AMD] [95% CI] = -6.15 [-11.50, -0.79], p = 0.02) and borderline significant increased senescent T cells (% CD57+ of total CD28-CD8+ T cells (AMD [95% CI] = 7.70 [-0.06, 15.46], p = 0.05). Conclusions Among ART-naive HIV-infected Russians, any illicit opioid use was not significantly associated with T cell abnormalities although intermittent illicit opioid use may be associated with CD8 T cell abnormalities. Longitudinal studies are warranted to confirm these findings given increased risk of infections and comorbidities seen among HIV-infected individuals with illicit opioid use.	[Edelman, E. Jennifer] Yale Univ, Sch Med, Dept Med, Gen Internal Med Sect, New Haven, CT 06520 USA; [Edelman, E. Jennifer] Yale Univ, Sch Publ Hlth, Ctr Interdisciplinary Res AIDS, New Haven, CT 06520 USA; [So-Armah, Kaku] Boston Med Ctr, Dept Med, Gen Internal Med Sect, Clin Addict Res & Educ Unit, Boston, MA USA; [Cheng, Debbie M.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Doyley, Margaret F.] Univ Vermont, Dept Pathol, Colchester, VT USA; [Doyley, Margaret F.] Univ Vermont, Lab Med, Colchester, VT USA; [Coleman, Sharon M.] Boston Univ, Data Coordinating Ctr, Sch Publ Hlth, Boston, MA 02215 USA; [Lioznov, Dmitry A.; Blokhina, Elena; Krupitsky, Evgeny M.] First Pavlov State Med Univ St Petersburg, St Petersburg, Russia; [Freiberg, Matthew S.] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA; [Freiberg, Matthew S.] Nashville Vet Affairs Med Ctr, Nashville, TN USA; [Krupitsky, Evgeny M.] St Petersburg Bekhterev Res Psychoneurol Inst, St Petersburg, Russia; [Emu, Brinda] Yale Univ, Dept Med, Sch Med, Sect Infect Dis, New Haven, CT 06520 USA; [Samet, Jeffrey H.] Boston Univ, Boston Med Ctr, Sch Med, Dept Med,Sect Gen Internal Med,Clin Addict Res &, Boston, MA 02215 USA; [Samet, Jeffrey H.] Boston Univ, Sch Publ Hlth, Dept Community Hlth Sci, Boston, MA 02215 USA	Yale University; Yale University; Boston Medical Center; Boston University; University of Vermont; University of Vermont; Boston University; Pavlov First Saint Petersburg State Medical University; Vanderbilt University; V.M. Bekhterev National Research Medical Center Psychiatry & Neurology; Yale University; Boston Medical Center; Boston University; Boston University	Edelman, EJ (corresponding author), Yale Univ, Sch Med, Dept Med, Gen Internal Med Sect, New Haven, CT 06520 USA.; Edelman, EJ (corresponding author), Yale Univ, Sch Publ Hlth, Ctr Interdisciplinary Res AIDS, New Haven, CT 06520 USA.	ejennifer.edelman@yale.edu	Blokhina, Elena A/V-6040-2018; Lioznov, Dmitry/J-2539-2013; Krupitsky, Evgeny/M-5935-2016	Blokhina, Elena A/0000-0001-5811-9897; Lioznov, Dmitry/0000-0003-3643-7354; Krupitsky, Evgeny/0000-0002-0529-4525; Samet, Jeffrey/0000-0002-0897-3400; Doyle, Margaret/0000-0001-6769-5386; So-Armah, Kaku/0000-0003-1505-6384	National Institute on Alcohol Abuse and Alcoholism (NIAAA) [U01AA020780, U24AA020779, U24AA020778, U01AA020780-02S1, U01AA021989]; National Institute on Drug Abuse (NIDA) [R25DA013582]; Yale-Drug Abuse, Addiction and HIV Research Scholars Program (Yale-DAHRS) [NIDA K12DA033312]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U24AA020779, U24AA020778, U01AA020780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K12DA033312] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Yale-Drug Abuse, Addiction and HIV Research Scholars Program (Yale-DAHRS); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was supported by grants from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) (U01AA020780, U24AA020779, U24AA020778, U01AA020780-02S1, and U01AA021989) and National Institute on Drug Abuse (NIDA) (R25DA013582). EJ Edelman was supported during the conduct of this work by a career development award through the Yale-Drug Abuse, Addiction and HIV Research Scholars Program (Yale-DAHRS, NIDA K12DA033312). The funding source had no role in the study design, the data collection, analysis and interpretation of the data; in the writing of this manuscript or decision to submit this article for publication.	Barrett L, 2014, AIDS, V28, P2045, DOI 10.1097/QAD.0000000000000405; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Cherny NI, 2010, ANN ONCOL, V21, P615, DOI 10.1093/annonc/mdp581; Chisenga CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129928; Chishinga N, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-75; Cofrancesco J, 2008, AIDS, V22, P357, DOI 10.1097/QAD.0b013e3282f3cc21; Cornwell WD, 2013, J NEUROIMMUNOL, V265, P43, DOI 10.1016/j.jneuroim.2013.09.013; D'Abramo A, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/192594; de Meneses-Gaya IC, 2009, J BRAS PNEUMOL, V35, P73, DOI 10.1590/S1806-37132009000100011; Dock JN, 2011, AGING DIS, V2, P382; Dowling-Guyer SJ M, 1994, ASSESSMENT, V1, P1383; Edelman EJ, 2014, AIDS BEHAV; Eisenstein TK, 2006, J NEUROIMMUNE PHARM, V1, P237, DOI 10.1007/s11481-006-9019-1; Emu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085613; Govitrapong P, 1998, J PHARMACOL EXP THER, V286, P883; Hao L, 2007, QUANTILE REGRESSION; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Henson SM, 2012, CURR OPIN IMMUNOL, V24, P476, DOI 10.1016/j.coi.2012.04.001; Kapadia F, 2005, CLIN INFECT DIS, V41, P1027, DOI 10.1086/433175; Kazis LE, 1998, ARCH INTERN MED, V158, P626, DOI 10.1001/archinte.158.6.626; Khademi H, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2502; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; Krupitsky E, 2004, HIV MED, V5, P30, DOI 10.1111/j.1468-1293.2004.00182.x; Krupitsky EM, 2006, EUR ADDICT RES, V12, P12, DOI 10.1159/000088578; Lee SA, 2014, J INFECT DIS, V210, P374, DOI 10.1093/infdis/jiu109; Lee SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089444; Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037/0882-7974.12.2.277; Li L, 2013, J INTERN MED, V273, P511, DOI 10.1111/joim.12035; Long EF, 2006, AIDS, V20, P2207, DOI 10.1097/QAD.0b013e328010c7d0; Lucas GM, 2006, AM J EPIDEMIOL, V163, P412, DOI 10.1093/aje/kwj059; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Moorman J, 2009, BBA-MOL CELL RES, V1793, P1366, DOI 10.1016/j.bbamcr.2009.05.007; Mudd JC, 2014, CURR OPIN HIV AIDS, V9, P500, DOI 10.1097/COH.0000000000000086; NEEDLE R, 1995, PSYCHOL ADDICT BEHAV, V9, P242, DOI 10.1037/0893-164X.9.4.242; NOVICK DM, 1989, J PHARMACOL EXP THER, V250, P606; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Riss GL, 2012, BRAIN BEHAV IMMUN, V26, P972, DOI 10.1016/j.bbi.2012.05.008; Roy S, 2011, J NEUROIMMUNE PHARM; Sacerdote P, 2008, BRAIN BEHAV IMMUN, V22, P606, DOI 10.1016/j.bbi.2007.12.013; Sacerdote Paola, 2008, Curr Opin Support Palliat Care, V2, P14, DOI 10.1097/SPC.0b013e3282f5272e; Samet JH, 2007, PANMINERVA MED, V49, P67; Serrano-Villar S, 2014, HIV MED, V15, P40, DOI 10.1111/hiv.12081; Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078; Sobell L.C., 1996, ALCOHOL TIMELINE FOL; Solomon DH, 2010, ARCH INTERN MED, V170, P1968, DOI 10.1001/archinternmed.2010.391; Strioga M, 2011, IMMUNOLOGY, V134, P17, DOI 10.1111/j.1365-2567.2011.03470.x; Suzuki S, 2003, BIOCHEM BIOPH RES CO, V308, P802, DOI 10.1016/S0006-291X(03)01472-4; Tassiopoulos K, 2012, J INFECT DIS, V205, P1730, DOI 10.1093/infdis/jis260; Tsoukas C, 2014, CURR OPIN HIV AIDS, V9, P398, DOI 10.1097/COH.0000000000000077; Unemori P, 2013, AIDS, V27, P1735, DOI 10.1097/QAD.0b013e3283601144; WEATHERBY NL, 1994, EVAL PROGRAM PLANN, V17, P347, DOI 10.1016/0149-7189(94)90035-3; Weed MR, 2006, J NEUROIMMUNE PHARM, V1, P250, DOI 10.1007/s11481-006-9029-z; Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013; Zhang EY, 2011, BRIT J PHARMACOL, V164, P1829, DOI 10.1111/j.1476-5381.2011.01475.x	54	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176617	10.1371/journal.pone.0176617	http://dx.doi.org/10.1371/journal.pone.0176617			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472064	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500059
J	Gebremedhin, D; Zhang, DX; Weihrauch, D; Uche, NN; Harder, DR				Gebremedhin, Debebe; Zhang, David X.; Weihrauch, Dorothee; Uche, Nnamdi N.; Harder, David R.			Detection of TRPV4 channel current-like activity in Fawn Hooded hypertensive (FHH) rat cerebral arterial muscle cells	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; RECEPTOR POTENTIAL CHANNELS; SMOOTH-MUSCLE; MEMBRANE STRETCH; CA2+ CHANNELS; BLOOD-FLOW; ACTIVATION; VASOCONSTRICTION; CHANNELOPATHIES; AUTOREGULATION	The transient receptor potential vallinoid type 4 (TRPV4) is a calcium entry channel known to modulate vascular function by mediating endothelium-dependent vasodilation. The present study investigated if isolated cerebral arterial myocytes of the Fawn Hooded hypertensive (FHH) rat, known to display exaggerated K-Ca channel current activity and impaired myogenic tone, express TRPV4 channels at the transcript and protein level and exhibit TRPV4-like single-channel cationic current activity. Reverse transcription polymerase chain reaction (RT-PCR), Western blot, and immunostaining analysis detected the expression of mRNA transcript and translated protein of TRPV4 channel in FHH rat cerebral arterial myocytes. Patch clamp recording of single-channel current activity identified the presence of a single-channel cationic current with unitary conductance of similar to 85 pS and similar to 96 pS at hyper-polarizing and depolarizing potentials, respectively, that was inhibited by the TRPV4 channel antagonist RN 1734 or HC 067074 and activated by the potent TRPV4 channel agonist GSK1016790A. Application of negative pressure via the interior of the patch pipette increased the NPo of the TRPV4-like single-channel cationic current recorded in cell-attached patches at a patch potential of 60 mV that was inhibited by prior application of the TRPV4 channel antagonist RN 1734 or HC 067047. Treatment with the TRPV4 channel agonist GSK1016790A caused concentration-dependent increase in the NPo of KCa single-channel current recorded in cell-attached patches of cerebral arterial myocytes at a patch potential of 40 mV, which was not influenced by pretreatment with the voltage-gated L-type Ca2+ channel blocker nifedipine or the T-type Ca2+ channel blocker Ni2+. These findings demonstrate that FHH rat cerebral arterial myocytes express mRNA transcript and translated protein for TRPV4 channel and display TRPV4-like single-channel cationic current activity that was stretch-sensitive and activation of which increased the open state probability of KCa single-channel current in these arterial myocytes.	[Gebremedhin, Debebe; Uche, Nnamdi N.; Harder, David R.] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Gebremedhin, Debebe; Zhang, David X.; Harder, David R.] Med Coll Wisconsin, Cardiovasc Res Ctr, Milwaukee, WI 53226 USA; [Zhang, David X.] Med Coll Wisconsin, Milwaukee, WI USA; [Zhang, David X.] Dept Med, Milwaukee, WI USA; [Weihrauch, Dorothee] Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI USA; [Harder, David R.] Clement Zablocki VA Med Ctr, Milwaukee, WI USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Gebremedhin, D (corresponding author), Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA.; Gebremedhin, D (corresponding author), Med Coll Wisconsin, Cardiovasc Res Ctr, Milwaukee, WI 53226 USA.	dgebreme@mcw.edu			National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI) [R01 HL033833, R01 HL092105, R01 HL105997]; VA Research Career Scientist Award from Clement Zablocki VA Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096647, R01HL033833] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); VA Research Career Scientist Award from Clement Zablocki VA Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI) Grants R01 HL033833, R01 HL092105, R01 HL105997 and by the VA Research Career Scientist Award from the Clement Zablocki VA Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai JZ, 2010, NEUROTOXICOLOGY, V31, P204, DOI 10.1016/j.neuro.2010.01.001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brayden JE, 2008, CLIN EXP PHARMACOL P, V35, P1116, DOI 10.1111/j.1440-1681.2007.04855.x; Butenko O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039959; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; Clapp LH, 2003, CIRC RES, V93, P893, DOI 10.1161/01.RES.0000103309.55054.3E; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; Earley S, 2015, PHYSIOL REV, V95, P645, DOI 10.1152/physrev.00026.2014; Everaerts W, 2010, AM J PHYSIOL-RENAL, V298, pF692, DOI 10.1152/ajprenal.00599.2009; Everaerts W, 2010, PROG BIOPHYS MOL BIO, V103, P2, DOI 10.1016/j.pbiomolbio.2009.10.002; Fan F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112878; Gao F, 2010, J HYPERTENS, V28, P102, DOI 10.1097/HJH.0b013e328332b865; Gasull X, 2003, INVEST OPHTH VIS SCI, V44, P706, DOI 10.1167/iovs.02-0384; Gebremedhin D, 2003, J NEUROSCI, V23, P1678; GEBREMEDHIN D, 1994, PFLUG ARCH EUR J PHY, V428, P621, DOI 10.1007/BF00374586; Gebremedhin D, 2008, AM J PHYSIOL-HEART C, V294, pH107, DOI 10.1152/ajpheart.01416.2006; Gebremedhin D, 2010, J CEREBR BLOOD F MET, V30, P1777, DOI 10.1038/jcbfm.2010.70; Goldenberg NM, 2015, ANESTHESIOLOGY, V122, P1338, DOI 10.1097/ALN.0000000000000647; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Harraz OF, 2013, J CELL SCI, V126, P2944, DOI 10.1242/jcs.128363; Harraz OF, 2013, MICROCIRCULATION, V20, P299, DOI 10.1111/micc.12038; Isozumi K, 1996, HUM MOL GENET, V5, P1377, DOI 10.1093/hmg/5.9.1377; Jie P, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.146; Jo AO, 2015, J NEUROSCI, V35, P13525, DOI 10.1523/JNEUROSCI.1987-15.2015; Kim KJ, 2015, J NEUROSCI, V35, P8245, DOI 10.1523/JNEUROSCI.4486-14.2015; KNAUS HG, 1994, BIOCHEMISTRY-US, V33, P5819, DOI 10.1021/bi00185a021; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liu YP, 1998, CIRC RES, V82, P729, DOI 10.1161/01.RES.82.6.729; Ma X, 2011, BBA-BIOMEMBRANES, V1808, P2789, DOI 10.1016/j.bbamem.2011.07.049; Mendoza SA, 2010, AM J PHYSIOL-HEART C, V298, pH466, DOI 10.1152/ajpheart.00854.2009; Mercado J, 2014, J GEN PHYSIOL, V143, P559, DOI 10.1085/jgp.201311050; Mobasheri A, 2011, VET J, V187, P145, DOI 10.1016/j.tvjl.2010.02.003; Mobasheri A, 2010, J CELL PHYSIOL, V223, P511, DOI 10.1002/jcp.22075; Mufti RE, 2010, J PHYSIOL-LONDON, V588, P3983, DOI 10.1113/jphysiol.2010.193300; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Nilius B., 2004, NOVART FDN SYMP, V258, P149; Nilius B, 2004, NOVARTIS FDN S, V258, P263; Nilius Bernd, 2004, Novartis Found Symp, V258, P140; Nilius B, 2013, EMBO REP, V14, P152, DOI 10.1038/embor.2012.219; Nilius Bernd, 2005, Sci STKE, V2005, pre8, DOI 10.1126/stke.2952005re8; Nilius B, 2010, NAT GENET, V42, P98, DOI 10.1038/ng0210-98; Pabbidi MR, 2014, AM J PHYSIOL-HEART C, V306, pH989, DOI 10.1152/ajpheart.00636.2013; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Retailleau K, 2015, CELL REP, V13, P1161, DOI 10.1016/j.celrep.2015.09.072; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Strotmann R, 2003, J BIOL CHEM, V278, P26541, DOI 10.1074/jbc.M302590200; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; van Dokkum RPE, 1999, AM J PHYSIOL-REG I, V276, pR189, DOI 10.1152/ajpregu.1999.276.1.R189; Vincent F, 2009, BIOCHEM BIOPH RES CO, V389, P490, DOI 10.1016/j.bbrc.2009.09.007; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Wu SN, 2003, J CARDIOVASC ELECTR, V14, P44, DOI 10.1046/j.1540-8167.2003.02040.x; Zhang LQ, 2013, BRIT J PHARMACOL, V170, P661, DOI 10.1111/bph.12315; Zheng XD, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000080	53	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176796	10.1371/journal.pone.0176796	http://dx.doi.org/10.1371/journal.pone.0176796			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472069	gold, Green Published			2022-12-26	WOS:000400648500072
J	Tripp, EA; Tsai, YHE				Tripp, Erin A.; Tsai, Yi-Hsin Erica			Disentangling geographical, biotic, and abiotic drivers of plant diversity in neotropical Ruellia (Acanthaceae)	PLOS ONE			English	Article							LATITUDINAL GRADIENT; EXTINCTION RATES; DIVERSIFICATION; EVOLUTION; POLLINATION; SPECIATION; PATTERNS; SHIFTS; MODEL; SPECIALIZATION	has long been hypothesized that biotic interactions are important drivers of biodiversity evolution, yet such interactions have been relatively less studied than abiotic factors owing to the inherent complexity in and the number of types of such interactions. Amongst the most prominent of biotic interactions worldwide are those between plants and pollinators. In the Neotropics, the most biodiverse region on Earth, hummingbird and bee pollination have contributed substantially to plant fitness. Using comparative methods, we test the macroevolutionary consequences of bird and bee pollination within a species rich lineage of flowering plants: Ruellia. We additionally explore impacts of species occupancy of ever-wet rainforests vs. dry ecosystems including cerrado and seasonally dry tropical forests. We compared outcomes based on two different methods of model selection: a traditional approach that utilizes a series of transitive likelihood ratio tests as well as a weighted model averaging approach. Analyses yield evidence for increased net diversification rates among Neotropical Ruellia ( compared to Paleotropical lineages) as well as among hummingbirdadapted species. In contrast, we recovered no evidence of higher diversification rates among either bee-or non-bee-adapted lineages and no evidence for higher rates among wet or dry habitat lineages. Understanding fully the factors that have contributed to biases in biodiversity across the planet will ultimately depend upon incorporating knowledge of biotic interactions as well as connecting microevolutionary processes to macroevolutionary patterns.	[Tripp, Erin A.; Tsai, Yi-Hsin Erica] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Tripp, Erin A.; Tsai, Yi-Hsin Erica] Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Tripp, EA (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.; Tripp, EA (corresponding author), Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA.	erin.tripp@colorado.edu		TRIPP, ERIN/0000-0001-9340-8723	US National Science Foundation [DEB-1354963, DEB-1355138]	US National Science Foundation(National Science Foundation (NSF))	Financial support for this research was provided by the US National Science Foundation Awards DEB-1354963 & DEB-1355138 to Erin A. Tripp and Lucinda McDade. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamczyk S, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0388-z; Antonelli A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00130; Antonelli A, 2011, TAXON, V60, P403, DOI 10.1002/tax.602010; Armbruster WS, 2009, P NATL ACAD SCI USA, V106, P18085, DOI 10.1073/pnas.0907051106; Banda-R K, 2016, SCIENCE, V353, P1383, DOI 10.1126/science.aaf5080; Bardon L, 2013, BOT J LINN SOC, V171, P19, DOI 10.1111/j.1095-8339.2012.01289.x; Bloom DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098430; Borg AJ, 2008, TAXON, V57, P811, DOI 10.1002/tax.573012; Bradshaw HD, 2003, NATURE, V426, P176, DOI 10.1038/nature02106; Burnham RJ, 2004, PHILOS T R SOC B, V359, P1595, DOI 10.1098/rstb.2004.1531; Cardinal S, 2013, P ROYAL SOC B, V30, P280; Daniel TF, 2008, SYST BOT, V33, P416, DOI 10.1600/036364408784571581; Darwin C., 1877, VARIOUS CONTRIVANCES; Davis MP, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-38; Dobzhansky T., 1950, AM SCI, V38, P208, DOI DOI 10.2307/2989767; Fine PVA, 2006, AM NAT, V168, P796, DOI 10.1086/508635; FitzJohn RG, 2012, METHODS ECOL EVOL, V3, P1084, DOI 10.1111/j.2041-210X.2012.00234.x; FitzJohn RG, 2009, SYST BIOL, V58, P595, DOI 10.1093/sysbio/syp067; Forest F, 2014, ANN BOT-LONDON, V113, P357, DOI 10.1093/aob/mct248; Gamisch A, 2016, EVOL BIOINFORM, V12, P165, DOI 10.4137/EBO.S39732; GENTRY AH, 1982, EVOL BIOL, V15, P1; Givnish TJ, 2014, MOL PHYLOGENET EVOL, V71, P55, DOI 10.1016/j.ympev.2013.10.010; Graham A, 2011, AM J BOT, V98, P336, DOI 10.3732/ajb.1000353; GRANT V, 1949, EVOLUTION, V3, P82, DOI 10.2307/2405454; Grant V., 1965, FLOWER POLLINATION P; Guernier V, 2004, PLOS BIOL, V2, P740, DOI 10.1371/journal.pbio.0020141; Hernandez-Hernandez T, 2014, NEW PHYTOL, V202, P1382, DOI 10.1111/nph.12752; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Johnson SD, 2010, PHILOS T R SOC B, V365, P499, DOI 10.1098/rstb.2009.0243; Kay KM, 2006, EVOLUTION, V60, P538; Kay KM, 2003, BIOTROPICA, V35, P198, DOI 10.1111/j.1744-7429.2003.tb00279.x; Kiel CA, 2006, TAXON, V55, P683, DOI 10.2307/25065644; Kiel CK, 2015, THESIS; Kursar TA, 2009, P NATL ACAD SCI USA, V106, P18073, DOI 10.1073/pnas.0904786106; Lindberg AB, 2001, J TROP ECOL, V17, P323, DOI 10.1017/S0266467401001213; Malecot G., 1969, MATH HEREDITY; McCain C.M., 2010, ENCY LIFE SCI; McDade LA, 2005, SYST BOT, V30, P834, DOI 10.1600/036364405775097734; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; O'Meara BC, 2016, AM J BOT, V103, P792, DOI 10.3732/ajb.1600012; Odegaard F., 2015, BIOL J LINN SOC, V71, P583; Pennington RT, 2009, ANNU REV ECOL EVOL S, V40, P437, DOI 10.1146/annurev.ecolsys.110308.120327; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Rabosky DL, 2015, SYST BIOL, V64, P340, DOI 10.1093/sysbio/syu131; Rabosky DL, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001381; Rabosky DL, 2010, EVOLUTION, V64, P1816, DOI 10.1111/j.1558-5646.2009.00926.x; Roalson EH, 2016, SYST BIOL, V65, P662, DOI 10.1093/sysbio/syw012; Rousset F, 1997, GENETICS, V145, P1219; Schemske DM, 2009, BIOTIC INTERACTIONS, P228; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Schiestl FP, 2009, ANNU REV ENTOMOL, V54, P425, DOI 10.1146/annurev.ento.54.110807.090603; Schmidt-Lebuhn AN, 2007, TRENDS PLANT SCI, V12, P329, DOI 10.1016/j.tplants.2007.06.009; Schnitzler J, 2011, SYST BIOL, V60, P343, DOI 10.1093/sysbio/syr006; Simon MF, 2009, P NATL ACAD SCI USA, V106, P20359, DOI 10.1073/pnas.0903410106; STEBBINS G. L., 1970, Annual review of ecology and systematics., V1, P307, DOI 10.1146/annurev.es.01.110170.001515; Stebbins GL, 1989, EVOLUTIONARY ECOLOGY, P39; Temeles EJ, 2003, SCIENCE, V300, P630, DOI 10.1126/science.1080003; Toon A, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-43; Toussaint EFA, 2015, SYST BIOL, V64, P3, DOI 10.1093/sysbio/syu067; Tripp E, 2017, SYSTEMATIC IN PRESS; Tripp Erin, 2013, Aliso, V31, P89; Tripp EA, 2008, EVOLUTION, V62, P1712, DOI 10.1111/j.1558-5646.2008.00398.x; Tripp EA, 2007, SYST BOT, V32, P628, DOI 10.1600/036364407782250625; Valente LM, 2012, AM NAT, V180, P83, DOI 10.1086/666003; van der Niet T, 2012, TRENDS ECOL EVOL, V27, P353, DOI 10.1016/j.tree.2012.02.002; Vermeij Geerat J., 2005, Proceedings of the California Academy of Sciences, V56, P12; WILLIS EO, 1978, ANNU REV ECOL SYST, V9, P243, DOI 10.1146/annurev.es.09.110178.001331; WRIGHT S, 1946, GENETICS, V31, P39	68	14	15	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176021	10.1371/journal.pone.0176021	http://dx.doi.org/10.1371/journal.pone.0176021			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472046	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500021
J	Wang, YX; Ren, BA; Zhou, XD; Liu, SY; Zhou, YJ; Li, BL; Jiang, YL; Li, MY; Feng, MY; Cheng, L				Wang, Yuxia; Ren, Biao; Zhou, Xuedong; Liu, Shiyu; Zhou, Yujie; Li, Bolei; Jiang, Yaling; Li, Mingyun; Feng, Mingye; Cheng, Lei			Growth and adherence of Staphylococcus aureus were enhanced through the PGE(2) produced by the activated COX-2/PGE(2) pathway of infected oral epithelial cells	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEINS; PROSTAGLANDIN E-2 SYNTHESIS; CYCLOOXYGENASE-2 PATHWAY; ALVEOLAR MACROPHAGES; MYCOSIS-FUNGOIDES; CANDIDA-ALBICANS; SUPPRESSOR-CELLS; COX-2 EXPRESSION; FACTOR RECEPTOR; CYCLIC-AMP	Staphylococcus aureus is a major pathogen of varieties of oral mucous infection. Prostaglandin E2 (PGE(2)) is a pro-inflammatory factor and Cyclooxygenase 2 (COX-2) is a critical enzyme of PGE(2) biosynthesis. The purpose of this study is to investigate whether Staphylococcus aureus can increase PGE(2) production of oral epithelial cells and how PGE(2) functions in the growth and adherence of Staphylococcus aureus. mRNA levels of COX-2, fnbpA and fnbpB were estimated by quantitative PCR. PGE(2) production was measured by Enzyme Linked Immunosorbent Assay (ELISA). The binding biomass of Staphylococcus aureus to human fibronectin was investigated by crystal violet staining and confocal laser scanning microscopy and the adherent force was measured by atomic force microscope (AFM). The COX-2 mRNA level and PGE(2) production were increased by Staphylococcus aureus. PGE(2) promoted the growth and biofilm formation of Staphylococcus aureus, enhanced the attachment of Staphylococcus aureus to the human fibronectin as well as to the HOK cells. The transcription of fnbpB was up-regulated by PGE(2) in both early and middle exponential phase but not fnbpA. These results suggest that the activation of COX-2/PGE(2) pathway in oral epithelial cell by Staphylococcus aureus can in turn facilitate the growth and the ability to adhere of the pathogen. These findings uncover a new function of PGE(2) and may lead to the potential of COX-2/PGE(2) targeting in the therapy of inflammation and cancer in both which the COX-2/PGE(2) pathway were observed activated.	[Wang, Yuxia; Ren, Biao; Zhou, Xuedong; Liu, Shiyu; Zhou, Yujie; Li, Bolei; Jiang, Yaling; Li, Mingyun; Feng, Mingye; Cheng, Lei] Sichuan Univ, State Key Lab Oral Dis, Chengdu, Peoples R China; [Wang, Yuxia; Zhou, Xuedong; Liu, Shiyu; Zhou, Yujie; Li, Bolei; Jiang, Yaling; Feng, Mingye; Cheng, Lei] Sichuan Univ, West China Hosp Stomatol, Dept Operat Dent & Endodont, Chengdu, Peoples R China	Sichuan University; Sichuan University	Feng, MY; Cheng, L (corresponding author), Sichuan Univ, State Key Lab Oral Dis, Chengdu, Peoples R China.; Feng, MY; Cheng, L (corresponding author), Sichuan Univ, West China Hosp Stomatol, Dept Operat Dent & Endodont, Chengdu, Peoples R China.	tengmingye@gmail.com; chenglei@scu.edu.cn	ZHOU, XUE/F-6129-2013; Zhou, Yu/HHN-3071-2022; Ren, Biao/P-1067-2015	Ren, Biao/0000-0003-4215-2873; Cheng, Lei/0000-0002-2762-4740; Zhou, Xuedong/0000-0002-9319-7302	National Key Research and Development Program of China [2016YFC1102700]; National Natural Science Foundation of China [81372889, 81600858, 81372890, 81430011]; Open Fund of State Key Laboratory of Oral Diseases [2040305193002]; Recruitment Program for Young Professionals	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Fund of State Key Laboratory of Oral Diseases; Recruitment Program for Young Professionals	This study was supported by the National Key Research and Development Program of China (http://www.nsfc.gov.cn/) 2016YFC1102700 to X.Z.; National Natural Science Foundation of China grant (http://www.nsfv.gov.cn/) 81372889 to L.C., 81600858 to B.R., 81372890 to M.F. and 81430011 to X.Z.; and Open Fund of State Key Laboratory of Oral Diseases (http://www.sklod.org/CN/index_cn.html) 2040305193002; Recruitment Program for Young Professionals to M.F.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agard M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00045; Agerer F, 2003, J BIOL CHEM, V278, P42524, DOI 10.1074/jbc.M302096200; Altrock E., 2015, Z GASTROENTEROL, V53, pA1; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Chan G, 1999, CANCER RES, V59, P991; Chandrasekharan NV, 2002, P NATL ACAD SCI USA, V99, P13926, DOI 10.1073/pnas.162468699; Chen JH, 2015, NAT MED, V21, P327, DOI 10.1038/nm.3831; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Dziewanowska K, 2000, INFECT IMMUN, V68, P6321, DOI 10.1128/IAI.68.11.6321-6328.2000; Foster T., 2016, EUR J CLIN MICROBIOL, P1; FUTAKI N, 1994, PROSTAGLANDINS, V47, P55, DOI 10.1016/0090-6980(94)90074-4; Gallo O, 2002, HUM PATHOL, V33, P708, DOI 10.1053/hupa.2002.125376; Gallo O, 2001, NEOPLASIA, V3, P53, DOI 10.1038/sj.neo.7900127; GOTO T, 1983, J IMMUNOL, V130, P1350; Green AW, 2001, BRIT DENT J, V190, P529, DOI 10.1038/sj.bdj.4801024a; GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Griffin EW, 2013, J NEUROSCI, V33, P15248, DOI 10.1523/JNEUROSCI.6361-11.2013; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hara S, 2010, BIOCHIMIE, V92, P651, DOI 10.1016/j.biochi.2010.02.007; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; HOOk M, 1989, FIBRONECTIN, V1, P295; Hussain M, 2008, INFECT IMMUN, V76, P5615, DOI 10.1128/IAI.00480-08; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; KALOKLEIN A, 1990, INFECT IMMUN, V58, P260, DOI 10.1128/IAI.58.1.260-262.1990; Kim J, 2016, MOL CARCINOG; Kintarak S, 2004, INFECT IMMUN, V72, P5668, DOI 10.1128/IAI.72.10.5668-5675.2004; Kopp KLM, 2010, LEUKEMIA, V24, P1179, DOI 10.1038/leu.2010.66; Krause J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135404; Kullander J, 2009, CANCER EPIDEM BIOMAR, V18, P472, DOI 10.1158/1055-9965.EPI-08-0905; Kyzas PA, 2005, MODERN PATHOL, V18, P153, DOI 10.1038/modpathol.3800244; LINNEMEYER PA, 1993, J IMMUNOL, V150, P3747; McCormack MG, 2015, AM J INFECT CONTROL, V43, P35, DOI 10.1016/j.ajic.2014.09.015; McCrae M., 1997, MOL ASPECTS HOST PAT, P50; Mei L, 2009, J DENT RES, V88, P841, DOI 10.1177/0022034509342523; Menter DG, 2010, CLIN CANCER RES, V16, P1384, DOI 10.1158/1078-0432.CCR-09-0788; Mirvish ED, 2011, J AM ACAD DERMATOL, V64, P423, DOI 10.1016/j.jaad.2009.11.692; Mongodin E, 2002, INFECT IMMUN, V70, P620; Moraitis D, 2005, CANCER RES, V65, P664; Nakanishi M, 2013, SEMIN IMMUNOPATHOL, V21; Nakayama T, 2006, J LEUKOCYTE BIOL, V79, P95, DOI 10.1189/jlb.0405226; Nguyen V, 2008, J AM ACAD DERMATOL, V59, P949, DOI 10.1016/j.jaad.2008.08.030; Noverr MC, 2001, INFECT IMMUN, V69, P2957, DOI 10.1128/IAI.69.5.2957-2963.2001; Obermajer N, 2012, IMMUNOL INVEST, V41, P635, DOI 10.3109/08820139.2012.695417; Obermajer N, 2011, BLOOD, V118, P5498, DOI 10.1182/blood-2011-07-365825; Ohara-Nemoto Y, 2008, J MED MICROBIOL, V57, P95, DOI 10.1099/jmm.0.47561-0; Ondrey FG, 1996, LARYNGOSCOPE, V106, P129, DOI 10.1097/00005537-199602000-00003; OUELLET M, 1995, BIOCHEM J, V306, P247, DOI 10.1042/bj3060247; Park JY, 2006, CLIN IMMUNOL, V119, P229, DOI 10.1016/j.clim.2006.01.016; Paupiere S, 2013, JOINT BONE SPINE, V80, P669, DOI 10.1016/j.jbspin.2013.03.016; Peacock SJ, 2000, J INFECTION, V41, P23, DOI 10.1053/jinf.2000.0657; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Perez-Novo CA, 2008, J INFECT DIS, V197, P1036, DOI 10.1086/528989; PHIPPS RP, 1991, IMMUNOL TODAY, V12, P349, DOI 10.1016/0167-5699(91)90064-Z; Pietra G, 2012, CANCER RES, V72, P1407, DOI 10.1158/0008-5472.CAN-11-2544; Ridley RA, 2012, J MED MICROBIOL, V61, P1654, DOI 10.1099/jmm.0.049650-0; Roelofs HMJ, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-1; Sakata D, 2010, J PHARMACOL SCI, V112, P1, DOI 10.1254/jphs.09R03CP; Serezani CH, 2007, AM J RESP CELL MOL, V37, P562, DOI 10.1165/rcmb.2007-0153OC; Sheng HM, 1997, J CLIN INVEST, V99, P2254, DOI 10.1172/JCI119400; Sierra JC, 2013, AM J PHYSIOL-GASTR L, V305, pG196, DOI 10.1152/ajpgi.00495.2012; Somayaji SN, 2008, INFECT IMMUN, V76, P5120, DOI 10.1128/IAI.00228-08; Sreeramkumar V, 2012, MED HUMANIT, V90, P579; Takagi M, 2008, VET J, V177, P398, DOI 10.1016/j.tvjl.2007.05.017; Talpur R, 2008, BRIT J DERMATOL, V159, P105, DOI 10.1111/j.1365-2133.2008.08612.x; Thun MJ, 2012, NAT REV CLIN ONCOL, V9, P259, DOI 10.1038/nrclinonc.2011.199; VANDEWATER L, 1983, SCIENCE, V220, P201, DOI 10.1126/science.6338594; VERBRUGH HA, 1981, INFECT IMMUN, V33, P811, DOI 10.1128/IAI.33.3.811-819.1981; Walia IS, 2014, J MAXILLOFAC ORAL SU, V13, P16, DOI 10.1007/s12663-012-0455-6; Wang CY, 2015, SCANNING, V37, P313, DOI 10.1002/sca.21218; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Zaleckas Linas, 2010, Stomatologija, V12, P23; Zbinden C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087374; Zhu YM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-218	76	27	30	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177166	10.1371/journal.pone.0177166	http://dx.doi.org/10.1371/journal.pone.0177166			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472126	gold, Green Submitted, Green Published			2022-12-26	WOS:000400648500148
J	Watson, SC; Liu, Y; Lund, RB; Gettings, JR; Nordone, SK; McMahan, CS; Yabsley, MJ				Watson, Stella C.; Liu, Yan; Lund, Robert B.; Gettings, Jenna R.; Nordone, Shila K.; McMahan, Christopher S.; Yabsley, Michael J.			A Bayesian spatio-temporal model for forecasting the prevalence of antibodies to Borrelia burgdorferi, causative agent of Lyme disease, in domestic dogs within the contiguous United States	PLOS ONE			English	Article							IXODES-SCAPULARIS TICKS; DIROFILARIA-IMMITIS; ANAPLASMA-PHAGOCYTOPHILUM; BLACKLEGGED TICKS; ACARI IXODIDAE; SENSU-LATO; DIAGNOSIS; INFECTION; PREVENTION; ELISA	This paper models the prevalence of antibodies to Borrelia burgdorferi in domestic dogs in the United States using climate, geographic, and societal factors. We then use this model to forecast the prevalence of antibodies to B. burgdorferi in dogs for 2016. The data available for this study consists of 11,937,925 B. burgdorferi serologic test results collected at the county level within the 48 contiguous United States from 2011-2015. Using the serologic data, a baseline B. burgdorferi antibody prevalence map was constructed through the use of spatial smoothing techniques after temporal aggregation; i.e., head-banging and Kriging. In addition, several covariates purported to be associated with B. burgdorferi prevalence were collected on the same spatio-temporal granularity, and include forestation, elevation, water coverage, temperature, relative humidity, precipitation, population density, and median household income. A Bayesian spatio-temporal conditional autoregressive (CAR) model was used to analyze these data, for the purposes of identifying significant risk factors and for constructing disease forecasts. The fidelity of the forecasting technique was assessed using historical data, and a Lyme disease forecast for dogs in 2016 was constructed. The correlation between the county level model and baseline B. burgdorferi antibody prevalence estimates from 2011 to 2015 is 0.894, illustrating that the Bayesian spatio-temporal CAR model provides a good fit to these data. The fidelity of the forecasting technique was assessed in the usual fashion; i.e., the 2011-2014 data was used to forecast the 2015 county level prevalence, with comparisons between observed and predicted being made. The weighted (to acknowledge sample size) correlation between 2015 county level observed prevalence and 2015 forecasted prevalence is 0.978. A forecast for the prevalence of B. burgdorferi antibodies in domestic dogs in 2016 is also provided. The forecast presented from this model can be used to alert veterinarians in areas likely to see above average B. burgdorferi antibody prevalence in dogs in the upcoming year. In addition, because dogs and humans can be exposed to ticks in similar habitats, these data may ultimately prove useful in predicting areas where human Lyme disease risk may emerge.	[Watson, Stella C.; Liu, Yan; Lund, Robert B.; Gettings, Jenna R.; McMahan, Christopher S.] Clemson Univ, Dept Math Sci, Clemson, SC 29634 USA; [Nordone, Shila K.] North Carolina State Univ, Coll Vet Med, Comparat Med Inst, Dept Mol & Biomed Sci, Raleigh, NC 27695 USA; [Nordone, Shila K.; Yabsley, Michael J.] Univ Georgia, Coll Vet Med, Dept Populat Hlth, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA; [Yabsley, Michael J.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA	Clemson University; University of North Carolina; North Carolina State University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	McMahan, CS (corresponding author), Clemson Univ, Dept Math Sci, Clemson, SC 29634 USA.; Yabsley, MJ (corresponding author), Univ Georgia, Coll Vet Med, Dept Populat Hlth, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA.; Yabsley, MJ (corresponding author), Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.	mcmaha2@clemson.edu; myabsley@uga.edu		mcmahan, christopher/0000-0001-5056-9615; Liu, Yan/0000-0002-3787-5906; Yabsley, Michael/0000-0003-2452-5015	Companion Animal Parasite Council; National Science Foundation Grant [DMS 1407480]; National Institutes of Health [R01 A1121351]; Boehringer Ingelheim Vetmedica-CAPC Infectious Disease Postdoctoral Fellowship	Companion Animal Parasite Council; National Science Foundation Grant(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Vetmedica-CAPC Infectious Disease Postdoctoral Fellowship(Boehringer Ingelheim)	IDEXX Laboratories, Inc. is thanked for their data contribution. The Companion Animal Parasite Council financially supported this work. YL and RBL also thank National Science Foundation Grant DMS 1407480. CSM was partially supported by Grant R01 A1121351 from the National Institutes of Health. JRG is supported by The Boehringer Ingelheim Vetmedica-CAPC Infectious Disease Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; IDEXX Laboratories, Inc. is thanked for their data contribution. The Companion Animal Parasite Council financially supported this work. YL and RBL also thank National Science Foundation Grant DMS 1407480. CSM was partially supported by Grant R01 AI121351 from the National Institutes of Health. JRG is supported by The Boehringer Ingelheim Vetmedica-CAPC Infectious Disease Postdoctoral Fellowship.	Adams Deborah A, 2014, MMWR Morb Mortal Wkly Rep, V61, P1; Adams Deborah A., 2012, Morbidity and Mortality Weekly Report, V59, P1; Adrion ER, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116767; [Anonymous], 2013, TEXTS STAT SCI SERIE; Arvikar SL, 2015, INFECT DIS CLIN N AM, V29, P269, DOI 10.1016/j.idc.2015.02.004; Bachur RG, 2015, J PEDIATR-US, V166, P407, DOI 10.1016/j.jpeds.2014.09.040; Bacon RM, 2003, J INFECT DIS, V187, P1187, DOI 10.1086/374395; Banerjee S., 2014, HIERARCHICAL MODELIN; Benito J, 2013, VET J, V196, P368, DOI 10.1016/j.tvjl.2012.12.015; BESAG J, 1974, J ROY STAT SOC B MET, V36, P192; Besag J, 2013, BIOMETRICS, V69, P488, DOI 10.1111/biom.12009; Bowman D, 2009, VET PARASITOL, V160, P138, DOI 10.1016/j.vetpar.2008.10.093; Bowman DD, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1804-y; Branda JA, 2010, CLIN INFECT DIS, V50, P20, DOI 10.1086/648674; Brockwell PJ, 2006, INTRO TIME SERIES FO; Cohn KA, 2012, PEDIATRICS, V129, pE46, DOI 10.1542/peds.2011-1215; Conlon J A, 2000, Vet Ther, V1, P96; Costello JM, 2009, PEDIATRICS, V123, pE835, DOI 10.1542/peds.2008-3058; Cressie NAC, 2011, WILEY SERIES PROBABI; Daniels TJ, 1998, APPL ENVIRON MICROB, V64, P4663; Detmer SE, 2016, J VET DIAGN INVEST, V28, P144, DOI 10.1177/1040638715626486; Eisen RJ, 2008, J MED ENTOMOL, V45, P181, DOI 10.1603/0022-2585(2008)45[181:SMOHRO]2.0.CO;2; Eisen RJ, 2015, J MED ENTOMOL; Eisen RJ, 2016, J MED ENTOMOL; Embers ME, 2016, CLIN VACCINE IMMUNOL, V23, P294, DOI 10.1128/CVI.00685-15; Environmental Systems Research Institute I, 2016, DOCUMENTATION; Eschner AK, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0676-x; Gasmi S, 2016, TICKS TICK-BORNE DIS, V7, P1075, DOI 10.1016/j.ttbdis.2016.09.006; Hanzlicek GA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151924; Harrison Jeff, 1999, BAYESIAN FORECASTING; Hinckley AF, 2014, CLIN INFECT DIS, V59, P676, DOI 10.1093/cid/ciu397; Hosking FJ, 2008, GENET EPIDEMIOL, V32, P497, DOI 10.1002/gepi.20322; Hutchinson ML, 2015, J MED ENTOMOL, V52, P693, DOI 10.1093/jme/tjv037; Krupka I, 2010, VET CLIN N AM-SMALL, V40, P1103, DOI 10.1016/j.cvsm.2010.07.011; LaFleur RL, 2009, CLIN VACCINE IMMUNOL, V16, P253, DOI 10.1128/CVI.00373-08; Levi T, 2016, ECOL APPL, V26, P484, DOI 10.1890/15-0122; LEVY SA, 1993, J AM VET MED ASSOC, V202, P1834; Levy SA, 2008, CLIN VACCINE IMMUNOL, V15, P115, DOI 10.1128/CVI.00340-07; Levy Steven A, 2002, Vet Ther, V3, P420; Liang FT, 2000, J CLIN MICROBIOL, V38, P4160, DOI 10.1128/JCM.38.11.4160-4166.2000; Lipsett SC, 2015, PEDIATR INFECT DIS J, V34, P1260, DOI 10.1097/INF.0000000000000858; Little SE, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-257; Little SE, 2010, TRENDS PARASITOL, V26, P213, DOI 10.1016/j.pt.2010.01.006; Littman MP, 2006, J VET INTERN MED, V20, P422, DOI 10.1892/0891-6640(2006)20[422:ASACSO]2.0.CO;2; Liu Y, 2016, PARASIT VEC IN PRESS; Lopez-Quilez A, 2009, ZENODO; Madhav NK, 2004, J MED ENTOMOL, V41, P842, DOI 10.1603/0022-2585-41.5.842; Maggi RG, 2010, TICKS TICK-BORNE DIS, V1, P168, DOI 10.1016/j.ttbdis.2010.08.003; Martinez-Beneito MA, 2008, STAT MED, V27, P2874, DOI 10.1002/sim.3103; Mathews K, 2014, J SMALL ANIM PRACT, V55, pE10, DOI 10.1111/jsap.12200; McNabb SJ, 2007, MMWR-MORBID MORTAL W, V54, P1; Mead P, 2011, EMERG INFECT DIS, V17, P1710, DOI 10.3201/eid1709.110210; Mead PS, 2015, INFECT DIS CLIN N AM, V29, P187, DOI 10.1016/j.idc.2015.02.010; Millen K, 2013, VECTOR-BORNE ZOONOT, V13, P340, DOI 10.1089/vbz.2012.1025; Nelder MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105358; Nelson CA, 2015, EMERG INFECT DIS, V21, P1625, DOI 10.3201/eid2109.150417; Nieto NC, 2010, J VECTOR ECOL, V35, P43, DOI 10.1111/j.1948-7134.2010.00026.x; Nobre AA, 2005, ENVIRONMETRICS, V16, P291, DOI 10.1002/env.704; Nyman D, 2006, CLIN MICROBIOL INFEC, V12, P496, DOI 10.1111/j.1469-0691.2006.01374.x; Ogden NH, 2007, PARASITOLOGY, V134, P209, DOI 10.1017/S0031182006001417; Ogden NH, 2014, ENVIRON HEALTH PERSP, V122, P631, DOI 10.1289/ehp.1307799; Ogden NH, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00046; Parham PE, 2015, PHILOS T R SOC LON B, V370; Raghavan RK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150180; Raghavan RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100850; Rhodes DVL, 2013, VET J, V198, P412, DOI 10.1016/j.tvjl.2013.07.019; Scott JD, 2016, INT J MED SCI, V13, P881, DOI 10.7150/ijms.16922; Scott JD, 2016, TICKS TICK-BORNE DIS, V7, P327, DOI 10.1016/j.ttbdis.2015.12.001; Spencer JA, 2003, PARASITOL RES, V90, pS106, DOI 10.1007/s00436-003-0904-8; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; Steere AC, 2003, AM J MED, V114, P58, DOI 10.1016/S0002-9343(02)01440-7; Stich RW, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-417; Stillman BA, 2014, JAVMA-J AM VET MED A, V245, P80, DOI 10.2460/javma.245.1.80; Stone BL, 2015, APPL ENVIRON MICROB, V81, P48, DOI 10.1128/AEM.02422-14; Thompson A, 2009, PEDIATRICS, V123, P959, DOI 10.1542/peds.2008-1511; Wagner B, 2012, CLIN VACCINE IMMUNOL, V19, P527, DOI 10.1128/CVI.05653-11; Wang DM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-264; Wengenmayer C, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0525-3; Wiseman-Orr ML, 2004, AM J VET RES, V65, P1077, DOI 10.2460/ajvr.2004.65.1077; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Xia H, 1998, STAT MED, V17, P2025, DOI 10.1002/(SICI)1097-0258(19980930)17:18<2025::AID-SIM865>3.0.CO;2-M; Zoetis, 2016, B865RUS12018 ZOET IN	83	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0174428	10.1371/journal.pone.0174428	http://dx.doi.org/10.1371/journal.pone.0174428			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472096	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500004
J	Fernandes-Matano, L; Monroy-Munoz, IE; Angeles-Martinez, J; Sarquiz-Martinez, B; Palomec-Nava, ID; Pardave-Alejandre, HD; Coy-Arechavaleta, AS; Santacruz-Tinoco, CE; Gonzalez-Ibarra, J; Gonzalez-Bonilla, CR; Munoz-Medina, JE				Fernandes-Matano, Larissa; Eloisa Monroy-Munoz, Irma; Angeles-Martinez, Javier; Sarquiz-Martinez, Brenda; Donaji Palomec-Nava, Iliana; Daniel Pardave-Alejandre, Hector; Santos Coy-Arechavaleta, Andrea; Esperanza Santacruz-Tinoco, Clara; Gonzalez-Ibarra, Joaquin; Raul Gonzalez-Bonilla, Cesar; Esteban Munoz-Medina, Jose			Prevalence of non-influenza respiratory viruses in acute respiratory infection cases in Mexico	PLOS ONE			English	Article							HUMAN METAPNEUMOVIRUS; HUMAN BOCAVIRUS; VIRAL ETIOLOGY; TRACT INFECTIONS; SYNCYTIAL VIRUS; HOSPITALIZED CHILDREN; SYMPTOMATIC CHILDREN; DISEASE SEVERITY; RHINOVIRUS; SEASONALITY	Background Acute respiratory infections are the leading cause of morbidity and mortality worldwide. Although a viral aetiological agent is estimated to be involved in up to 80% of cases, the majority of these agents have never been specifically identified. Since 2009, diagnostic and surveillance efforts for influenza virus have been applied worldwide. However, insufficient epidemiological information is available for the many other respiratory viruses that can cause Acute respiratory infections. Methods This study evaluated the presence of 14 non-influenza respiratory viruses in 872 pharyngeal exudate samples using RT-qPCR. All samples met the operational definition of a probable case of an influenza-like illness or severe acute respiratory infection and had a previous negative result for influenza by RT-qPCR. Results The presence of at least one non-influenza virus was observed in 312 samples (35.8%). The most frequent viruses were rhinovirus (RV; 33.0%), human respiratory syncytial virus (HRSV; 30.8%) and human metapneumovirus (HMPV; 10.6%). A total of 56 cases of coinfection (17.9%) caused by 2, 3, or 4 viruses were identified. Approximately 62.5% of all positive cases were in children under 9 years of age. Conclusion In this study, we identified 13 non-influenza respiratory viruses that could occur in any season of the year. This study provides evidence for the prevalence and seasonality of a wide range of respiratory viruses that circulate in Mexico and constitute a risk for the population. Additionally, our data suggest that including these tests more widely in the diagnostic algorithm for influenza may reduce the use of unnecessary antibiotics, reduce the hospitalisation time, and enrich national epidemiological data with respect to the infections caused by these viruses.	[Fernandes-Matano, Larissa] Univ Valle Mexico, Campus Chapultepec, Mexico City, DF, Mexico; [Eloisa Monroy-Munoz, Irma] Inst Nacl Perinatol Isidro Espinosa de los Reyes, Lab Genom, Dept Genet & Genom Humana, Mexico City, DF, Mexico; [Angeles-Martinez, Javier] Inst Nacl Cardiol Ignacio Chavez, Lab Genom, Dept Biol Mol, Mexico City, DF, Mexico; [Sarquiz-Martinez, Brenda; Donaji Palomec-Nava, Iliana; Daniel Pardave-Alejandre, Hector; Santos Coy-Arechavaleta, Andrea; Esperanza Santacruz-Tinoco, Clara; Esteban Munoz-Medina, Jose] Inst Mexicano Seguro Social, Ctr Med Nacl La Raza, Lab Cent Epidemiol, Mexico City, DF, Mexico; [Gonzalez-Ibarra, Joaquin; Raul Gonzalez-Bonilla, Cesar] Inst Mexicano Seguro Social, Div Labs Vigilancia & Invest Epidemiol, Mexico City, DF, Mexico	National Institute of Cardiology - Mexico; Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social	Munoz-Medina, JE (corresponding author), Inst Mexicano Seguro Social, Ctr Med Nacl La Raza, Lab Cent Epidemiol, Mexico City, DF, Mexico.	eban10@hotmail.com	Esteban, Muñoz Medina José/B-6186-2015	Esteban, Muñoz Medina José/0000-0002-1289-4457; Sarquiz, Brenda/0000-0003-1931-0781; Gonzalez Bonilla, Cesar/0000-0002-2225-5069; Angeles Martinez, Javier/0000-0001-5405-0482; Santos Coy-Arechavaleta, Andrea/0000-0001-7096-2545				Ahn JG, 2014, J MED VIROL, V86, P2011, DOI 10.1002/jmv.23880; Aldana RS, 2016, PRACTICA MED EFECTIV, V3, P1; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Arango M, 2002, MEADICA PANAMERICANA; Asner SA, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.08.024; Talavera GA, 2007, AM J TROP MED HYG, V76, P182, DOI 10.4269/ajtmh.2007.76.182; Bloom Barbara, 2009, Vital Health Stat 10, P1; Breiman RF, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0827-x; Broberg E, 2011, J CLIN VIROL, V51, P79, DOI 10.1016/j.jcv.2011.01.018; Cabello C, 2006, MEM I OSWALDO CRUZ, V101, P21, DOI 10.1590/S0074-02762006000100005; Canducci F, 2008, J MED VIROL, V80, P716, DOI 10.1002/jmv.21108; Centers for Disease Control and Prevention, 2012, REAL TIM RT PCR ASS; Costa LF, 2014, PEDIATRICS, V133, pE312, DOI 10.1542/peds.2013-2216; Cui BL, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0863-6; Diaz J, 2015, ITAL J PEDIATR, V41, DOI 10.1186/s13052-015-0133-7; Direccion General de Epidemiologia, 2015, AN MORB 1984 2014; Flores JC, 2011, REV CHIL INFECTOL, V28, P504, DOI /S0716-10182011000700001; Friedlander SL, 2005, J ALLERGY CLIN IMMUN, V116, P267, DOI 10.1016/j.jaci.2005.06.003; Fry AM, 2007, J INFECT DIS, V195, P1038, DOI 10.1086/512163; Gern JE, 2010, J VIROL, V84, P7418, DOI 10.1128/JVI.02290-09; Haas LEM, 2013, VIRUSES-BASEL, V5, P87, DOI 10.3390/v5010087; Harada Y, 2013, PEDIATR INFECT DIS J, V32, P441, DOI 10.1097/INF.0b013e31828ba08c; Health Protection Agency, 2014, RESP PATH CIRC; Henrickson KJ, 2003, CLIN MICROBIOL REV, V16, P242, DOI 10.1128/CMR.16.2.242-264.2003; Huijskens EG, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-276; Instituto de Diagnostico y Referencia Epidemiologicos, 2015, LIN VIG INF LAB; Jevsnik M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-365; Justo Iván, 2004, Rev Cubana Med Gen Integr, V20; Kaida A, 2014, JPN J INFECT DIS, V67, P469, DOI 10.7883/yoken.67.469; Kennedy JL, 2012, CURR OPIN VIROL, V2, P287, DOI 10.1016/j.coviro.2012.03.008; Landes MB, 2013, INFLUENZA OTHER RESP, V7, P1122, DOI 10.1111/irv.12145; Lekana-Douki SE, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-373; Liu T, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0388-z; Liu WK, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-28; Longtin J, 2008, EMERG INFECT DIS, V14, P217, DOI 10.3201/eid1402.070851; Makela MJ, 1998, J CLIN MICROBIOL, V36, P539; Manjarrez ME, 2003, J MED MICROBIOL, V52, P579, DOI 10.1099/jmm.0.05007-0; Martin ET, 2010, J INFECT DIS, V201, P1625, DOI 10.1086/652405; Martinez-Roig A, 2015, ARCH BRONCONEUMOL, V51, P5, DOI 10.1016/j.arbres.2014.01.018; Meerhoff TJ, 2010, EUR J CLIN MICROBIOL, V29, P365, DOI 10.1007/s10096-009-0865-7; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Mizuta K, 2012, MICROBIOL IMMUNOL, V56, P855, DOI 10.1111/j.1348-0421.2012.00507.x; Montejano-Elias L, 2009, PEDIATR INFECT DIS J, V28, P1024, DOI 10.1097/INF.0b013e3181aa6c3e; Moore ML, 2013, CURR OPIN IMMUNOL, V25, P761, DOI 10.1016/j.coi.2013.09.016; Moreno-Valencia Y, 2015, INFLUENZA OTHER RESP; Nascimento-Carvalho CM, 2010, SCAND J INFECT DIS, V42, P839, DOI 10.3109/00365548.2010.498020; Noyola DE, 2005, J MED MICROBIOL, V54, P969, DOI 10.1099/jmm.0.46052-0; Organizacion Mundial de la Salud, 2009, PREP RESP ANT PAND I; Pancer Katarzyna W, 2014, Przegl Epidemiol, V68, P627; Panda S, 2014, INT J INFECT DIS, V25, P45, DOI 10.1016/j.ijid.2014.03.1394; Pascalis H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044755; Peng D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-155; Public Health Agency of Canada, 2014, RESP VIR DET SURV; Rodriguez OI, 2015, REV ARCH MEADICO, V14; Ruohola A, 2009, EMERG INFECT DIS, V15, P344, DOI 10.3201/eid1502.081468; Schildgen O, 2013, PATHOGENS, V2, P1, DOI 10.3390/pathogens2010001; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Tanner H, 2012, EUR J CLIN MICROBIOL, V31, P3001, DOI 10.1007/s10096-012-1653-3; Teeratakulpisarn J, 2014, ASIAN PAC J ALLERGY, V32, P226, DOI [10.12932/ap0417.32.3.2014, 10.12932/AP0417.32.3.2014]; Viegas M, 2004, J INFECTION, V49, P222, DOI 10.1016/j.jinf.2003.10.006; Wansaula Z, 2016, INFLUENZA OTHER RESP, V10, P161, DOI 10.1111/irv.12360; Wong-Chew Rosa M, 2015, BMC Res Notes, V8, P261, DOI 10.1186/s13104-015-1239-0; Yu XF, 2015, J CLIN VIROL, V69, P1, DOI 10.1016/j.jcv.2015.05.015; Zimmerman RK, 2014, INFLUENZA OTHER RESP, V8, P397, DOI 10.1111/irv.12247	64	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176298	10.1371/journal.pone.0176298	http://dx.doi.org/10.1371/journal.pone.0176298			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467515	gold, Green Published, Green Submitted			2022-12-26	WOS:000400647000047
J	Wijnans, L; Dodd, CN; Weibel, D; Sturkenboom, M				Wijnans, Leonoor; Dodd, Caitlin N.; Weibel, Daniel; Sturkenboom, Miriam			Bell's palsy and influenza(H1N1) pdm09 containing vaccines: A self-controlled case series	PLOS ONE			English	Article							POSTMARKETING EVALUATION; SAFETY; CHILDREN; LIVE; IMMUNIZATION; SYSTEM; H1N1; AGE	Background An association between AS03 adjuvanted pandemic influenza vaccine and the occurrence of Bell's palsy was found in a population based cohort study in Stockholm, Sweden. To evaluate this association in a different population, we conducted a self-controlled case series in a primary health care database, THIN, in the United Kingdom. The aim of this study was to determine whether there was an increased risk of Bell's palsy following vaccination with any influenza vaccine containing A/California/7/2009 (H1N1)-like viral strains. Secondly, we investigated whether risks were different following pandemic influenza A(H1N1) pdm09 vaccines and seasonal influenza vaccines containing the influenza A(H1N1) pdm09 strain. Methods The study population comprised all incident Bell's palsy cases between 1 June 2009 and 30 June 2013 identified in THIN. We determined the relative incidence (RI) of Bell's palsy during the 6 weeks following vaccination with either pandemic or seasonal influenza vaccine. All analyses were adjusted for seasonality and confounding variables. Results We found an incidence rate of Bell's palsy of 38.7 per 100,000 person years. Both acute respiratory infection (ARI) consultations and pregnancy were found to be confounders. When adjusted for seasonality, ARI consultations and pregnancies, the RI during the 42 days after vaccination with an influenza vaccine was 0.85 (95% CI: 0.72-1.01). The RI was similar during the 42 days following seasonal vaccine (0.96, 95% CI: 0.82-1.13) or pandemic vaccine (0.73, 95% CI: 0.47-1.12). Conclusion We found no evidence for an increased incidence of Bell's palsy following seasonal influenza vaccination overall, nor for monovalent pandemic influenza vaccine in 2009.	[Wijnans, Leonoor; Dodd, Caitlin N.; Weibel, Daniel; Sturkenboom, Miriam] Erasmus Univ, Med Ctr, Dept Med Informat, Rotterdam, Netherlands; [Wijnans, Leonoor] Med Evaluat Board, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC	Dodd, CN (corresponding author), Erasmus Univ, Med Ctr, Dept Med Informat, Rotterdam, Netherlands.	c.dodd@erasmusmc.nl		Sturkenboom, Miriam/0000-0003-1360-2388				Bardage C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5956; Baxter R, 2012, VACCINE, V30, P3053, DOI 10.1016/j.vaccine.2012.02.080; Baxter R, 2012, VACCINE, V30, P2989, DOI 10.1016/j.vaccine.2012.02.039; Blak Betina T, 2011, Inform Prim Care, V19, P251; Chou CH, 2007, VACCINE, V25, P2839, DOI 10.1016/j.vaccine.2006.10.006; Department of Health, 2010, DHHPA28; FARRINGTON CP, 1995, BIOMETRICS, V51, P228, DOI 10.2307/2533328; Gilden DH, 2004, NEW ENGL J MED, V351, P1323, DOI 10.1056/NEJMcp041120; Greco A, 2012, AUTOIMMUN REV, V12, P323, DOI 10.1016/j.autrev.2012.05.008; Holland NJ, 2004, BMJ-BRIT MED J, V329, P553, DOI 10.1136/bmj.329.7465.553; Huang WT, 2012, VACCINE, V30, P2168, DOI 10.1016/j.vaccine.2012.01.013; Izurieta HS, 2005, JAMA-J AM MED ASSOC, V294, P2720, DOI 10.1001/jama.294.21.2720; Lee GM, 2011, AM J PREV MED, V41, P121, DOI 10.1016/j.amepre.2011.04.004; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Rath B, 2007, VACCINE, V26, P1, DOI 10.1016/j.vaccine.2007.10.043; Rowhani-Rahbar A, 2012, NEUROEPIDEMIOLOGY, V38, P252, DOI 10.1159/000338303; Rowhani-Rahbar A, 2012, AM J EPIDEMIOL, V175, P878, DOI 10.1093/aje/kws011; Rowlands S, 2002, EUR J NEUROL, V9, P63, DOI 10.1046/j.1468-1331.2002.00343.x; Stowe J, 2006, HUM VACCINES, V2, P110, DOI 10.4161/hv.2790; Weldeselassie YG, 2011, EPIDEMIOL INFECT, V139, P1805, DOI 10.1017/S0950268811001531; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Zhou WG, 2004, PHARMACOEPIDEM DR S, V13, P505, DOI 10.1002/pds.998	23	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0175539	10.1371/journal.pone.0175539	http://dx.doi.org/10.1371/journal.pone.0175539			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467420	Green Published, gold, Green Submitted			2022-12-26	WOS:000400647000016
J	Bartel, CA; Jackson, MW				Bartel, Courtney A.; Jackson, Mark W.			HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; ERBB SIGNALING NETWORK; TRASTUZUMAB RESISTANCE; MONOCLONAL-ANTIBODY; METASTATIC BREAST; RECEPTOR; HER2; MECHANISMS; HETERODIMERIZATION; PATHWAYS	HER2-positive breast cancer (HER2+ BC) is an aggressive subtype with a poor prognosis. Although the antibody trastuzumab, which targets the HER2 growth factor receptor, has improved survival rates, patients often present with de novo resistance or acquire resistance after an initial response. Identifying new ways to target HER2 signaling will be critical for overcoming trastuzumab resistance. FAM83A is a novel oncogene identified by its ability to confer resistance to EGFR therapies, a receptor closely related to HER2. Moreover, a prior study identified hyper-tyrosine phosphorylated FAM83A in trastuzumab-resistant HER2+ BC. Here, we find that FAM83A expression is elevated in 36% of HER2+ BC tumors. In a panel of HER2+ BC cell lines, FAM83A expression is significantly increased in the trastuzumab-resistant derivatives relative to parental controls. shRNA-mediated ablation of FAM83A in the panel of HER2+ BC cell lines suppresses HER2+ BC cell growth in both 2D and 3D cell cultures, elevates apoptosis markers, and suppresses PI3K signaling. Growth inhibition following FAM83A knock-down, however, was independent of trastuzumab sensitivity, suggesting that FAM83A is a key signaling component in HER2+ BCs that could serve as a novel therapeutic target in both trastuzumab-resistant and trastuzumab-sensitive cancers.	[Bartel, Courtney A.; Jackson, Mark W.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Jackson, Mark W.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Jackson, MW (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.; Jackson, MW (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	mark.w.jackson@case.edu			US National Institutes of Health [T32 CA059366, R01CA138421, T32 GM007250, R21CA194902]; American Cancer Society [RSG CCG-122517]; Case Comprehensive Cancer Center (Cytometry & Imaging Microscopy) [P30 CA43703]; NATIONAL CANCER INSTITUTE [R21CA194902, T32CA059366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Case Comprehensive Cancer Center (Cytometry & Imaging Microscopy); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	CAB was supported by the US National Institutes of Health T32 CA059366 (https://projectreporter.nih.gov/project_info_descriptioncfm?aid=8334515&icde=324940838&ddparam=&ddvalue&ddsub=&cr=2&csb,default&cs=ASC&pball=) and T32 GM007250 (https://projectreporter.nih.gov/project_info_description.cfm?aid=90968478&icde=33971446&ddparam=&ddvalue-Sddsub=&cr-3&csb=default&cs=ASC&pball=). MWJ is supported by the US National Institutes of Health (R01CA138421 https://projectreporter.nih.gov/project_info_details.cfm?aid=9105892&icde=32493945&ddparam= &ddvalue=&ddsub=&cr=4&csb=default&cs=ASC&pball=) and (R21CA194902 https://projectreporter.nih.gov/project_info_details.cfm?aid=9022860&icde=32493945&ddparam= &ddvalue=&ddsub=&cr=15&csb-default&cs=ASC&pball=) and the American Cancer Society (Research Scholar Award #RSG CCG-122517 www.cancer.org). Additional support was provided by the Case Comprehensive Cancer Center (P30 CA43703; Cytometry & Imaging Microscopy https://projectreporter.nih.gov/project_info_description.cfm?aid=9138282&icde=32494062& ddparam=&ddvalue=&ddsub=&cr=84&csb=default&cs=ASC&pball=). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIMANDI M, 1995, ONCOGENE, V10, P1813; Anders CK, 2009, SEMIN ONCOL, V36, P237, DOI 10.1053/j.seminoncol.2009.03.001; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Bacus SS, 2002, ONCOGENE, V21, P3532, DOI 10.1038/sj.onc.1205438; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bartel CA, 2016, ONCOTARGET, V7, P52597, DOI 10.18632/oncotarget.9544; Baselga J, 1996, J CLIN ONCOL, V14, P737, DOI 10.1200/JCO.1996.14.3.737; Boulbes DR, 2015, BREAST CANCER RES TR, V151, P501, DOI 10.1007/s10549-015-3414-3; Boyer AP, 2013, MOL CELL PROTEOMICS, V12, P180, DOI 10.1074/mcp.M112.020115; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; Cipriano R, J CLIN INVESTIGATION, V122, P3197; Cipriano R, 2014, MOL CANCER RES, V12, P1156, DOI 10.1158/1541-7786.MCR-13-0289; Cipriano R, 2013, ONCOTARGET, V4, P729, DOI 10.18632/oncotarget.1027; Cipriano R, 2010, CELL CYCLE, V9, P1373, DOI 10.4161/cc.9.7.11193; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Ghosh R, 2011, CANCER RES, V71, P1871, DOI 10.1158/0008-5472.CAN-10-1872; Ginestier C, 2007, ONCOGENE, V26, P7163, DOI 10.1038/sj.onc.1210528; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Henson ES, 2006, CELL SIGNAL, V18, P2089, DOI 10.1016/j.cellsig.2006.05.015; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jameson KL, 2013, NAT MED, V19, P626, DOI 10.1038/nm.3165; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Lee S-Y, J CLIN INVESTIGATION, V122, P3211; Leicht DT, 2007, BBA-MOL CELL RES, V1773, P1196, DOI 10.1016/j.bbamcr.2007.05.001; Li GC, 2014, ONCOTARGET, V5, P8317, DOI 10.18632/oncotarget.2135; LI J, CANC CELL, V31, P225; Luque-Cabal M, 2016, CLIN MED INSIGHTS-ON, V10, P21, DOI 10.4137/CMO.S34537; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Molina MA, 2001, CANCER RES, V61, P4744; Nahta R, 2007, ONCOGENE, V26, P3637, DOI 10.1038/sj.onc.1210379; O'Brien NA, 2010, MOL CANCER THER, V9, P1489, DOI 10.1158/1535-7163.MCT-09-1171; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Sahin O, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-1; Schramm A, 2015, BREAST CARE, V10, P173, DOI 10.1159/000431029; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Tanizaki J, 2011, BRIT J CANCER, V105, P807, DOI 10.1038/bjc.2011.322; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Wang YC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3067; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Xu K, 2014, BBA-REV CANCER, V1846, P638, DOI 10.1016/j.bbcan.2014.10.007; Yan M, 2014, CHINESE J CANCER RES, V26, P486, DOI 10.3978/j.issn.1000-9604.2014.08.10; Yap TA, 2015, CURR OPIN PHARMACOL, V23, P98, DOI 10.1016/j.coph.2015.05.016; Yap TA, 2013, J CLIN ONCOL, V31, P1592, DOI 10.1200/JCO.2011.37.6418; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yarden Y., EUROPEAN J CANC, V37, P3; Zuo Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep11634	54	25	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176778	10.1371/journal.pone.0176778	http://dx.doi.org/10.1371/journal.pone.0176778			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28463969	Green Submitted, Green Published, gold			2022-12-26	WOS:000400646300052
J	Matsuda, R; Iehisa, JCM; Sakaguchi, K; Ohno, R; Yoshida, K; Takumi, S				Matsuda, Ryusuke; Iehisa, Julio Cesar Masaru; Sakaguchi, Kouhei; Ohno, Ryoko; Yoshida, Kentaro; Takumi, Shigeo			Global gene expression profiling related to temperature-sensitive growth abnormalities in interspecific crosses between tetraploid wheat and Aegilops tauschii	PLOS ONE			English	Article							MITOTIC CELL-DIVISION; NATURAL VARIATION; ALLOPOLYPLOID SPECIATION; TRANSCRIPTION FACTORS; DRAFT GENOME; F-1 HYBRID; SMALL RNAS; MICRORNAS; TRITICUM; NECROSIS	Triploid wheat hybrids between tetraploid wheat and Aegilops tauschii sometimes show abnormal growth phenotypes, and the growth abnormalities inhibit generation of wheat synthetic hexaploids. In type II necrosis, one of the growth abnormalities, necrotic cell death accompanied by marked growth repression occurs only under low temperature conditions. At normal temperature, the type II necrosis lines show grass-clump dwarfism with no necrotic symptoms, excess tillers, severe dwarfism and delayed flowering. Here, we report comparative expression analyses to elucidate the molecular mechanisms of the temperature-dependent phenotypic plasticity in the triploid wheat hybrids. We compared gene and small RNA expression profiles in crown tissues to characterize the temperature-dependent phenotypic plasticity. No up-regulation of defense-related genes was observed under the normal temperature, and down-regulation of wheat APETALA1-like MADS-box genes, considered to act as flowering promoters, was found in the grass-clump dwarf lines. Some microRNAs, including miR156, were up-regulated, whereas the levels of transcripts of the miR156 target genes SPLs, known to inhibit tiller and branch number, were reduced in crown tissues of the grass-clump dwarf lines at the normal temperature. Unusual expression of the miR156/SPLs module could explain the grass-clump dwarf phenotype. Dramatic alteration of gene expression profiles, including miRNA levels, in crown tissues is associated with the temperature-dependent phenotypic plasticity in type II necrosis/grass-clump dwarf wheat hybrids.	[Matsuda, Ryusuke; Sakaguchi, Kouhei; Yoshida, Kentaro; Takumi, Shigeo] Kobe Univ, Grad Sch Agr Sci, Lab Plant Genet, Kobe, Hyogo, Japan; [Iehisa, Julio Cesar Masaru] Univ Nacl Asuncion, Fac Ciencias Quim, Dept Biotecnol, San Lorenzo, Paraguay; [Ohno, Ryoko] Kobe Univ, Grad Sch Sci Technol & Innovat, Kobe, Hyogo, Japan	Kobe University; Universidad Nacional de Asuncion; Kobe University	Takumi, S (corresponding author), Kobe Univ, Grad Sch Agr Sci, Lab Plant Genet, Kobe, Hyogo, Japan.	takumi@kobe-u.ac.jp		Iehisa, Julio/0000-0002-2133-9340	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [25292008, 16H04862]; KANEKA Co. Ltd.; Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative BioProduction Kobe), MEXT, Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KANEKA Co. Ltd.; Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative BioProduction Kobe), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (Grant-in-Aid for Scientific Research (B) Nos. 25292008 and 16H04862), by cooperative research funds from KANEKA Co. Ltd., and by the Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative BioProduction Kobe), MEXT, Japan. JST, PRESTO (No. JPMJPR15QB) to KY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpinar BA, 2015, FUNCT INTEGR GENOMIC, V15, P587, DOI 10.1007/s10142-015-0453-0; Alcazar R, 2009, P NATL ACAD SCI USA, V106, P334, DOI 10.1073/pnas.0811734106; Alcazar R, 2010, NAT GENET, V42, P1135, DOI 10.1038/ng.704; Alptekin B., 2016, FUNCT INTEGR GENOMIC; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; Bomblies K, 2007, NAT REV GENET, V8, P382, DOI 10.1038/nrg2082; Budak H, 2015, FUNCT INTEGR GENOMIC, V15, P523, DOI 10.1007/s10142-015-0451-2; Budak H, 2015, PLANT SCI, V235, P1, DOI 10.1016/j.plantsci.2015.02.008; Budak H, 2011, OMICS, V15, P791, DOI 10.1089/omi.2011.0073; Burge SW, 2010, NUCLEIC ACIDS RES, V41, pD226; CANVIN DT, 1976, EUPHYTICA, V25, P471, DOI 10.1007/BF00041581; Chague V, 2010, NEW PHYTOL, V187, P1181, DOI 10.1111/j.1469-8137.2010.03339.x; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; Comai L, 2000, PLANT MOL BIOL, V43, P387, DOI 10.1023/A:1006480722854; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Dryanova A, 2008, GENOME, V51, P433, DOI 10.1139/G08-025; Fornara F, 2004, PLANT PHYSIOL, V135, P2207, DOI 10.1104/pp.104.045039; Fu CX, 2012, PLANT BIOTECHNOL J, V10, P443, DOI 10.1111/j.1467-7652.2011.00677.x; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; Fujiwara Y, 2010, BREEDING SCI, V60, P286, DOI 10.1270/jsbbs.60.286; Ha M, 2009, P NATL ACAD SCI USA, V106, P17835, DOI 10.1073/pnas.0907003106; Hatano H, 2012, NEW PHYTOL, V194, P1143, DOI 10.1111/j.1469-8137.2012.04125.x; Hayashi-Tsugane M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14357; He GM, 2010, PLANT CELL, V22, P17, DOI 10.1105/tpc.109.072041; Jeuken MJW, 2009, PLANT CELL, V21, P3368, DOI 10.1105/tpc.109.070334; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Jones H, 2013, THEOR APPL GENET, V126, P1793, DOI 10.1007/s00122-013-2093-x; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kajimura T, 2011, BREEDING SCI, V61, P130, DOI 10.1270/jsbbs.61.130; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Kawaura K, 2008, FUNCT INTEGR GENOMIC, V8, P277, DOI 10.1007/s10142-008-0076-9; Kenan-Eichler M, 2011, GENETICS, V188, P263, DOI 10.1534/genetics.111.128348; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li AL, 2014, PLANT CELL, V26, P1878, DOI 10.1105/tpc.114.124388; Lin ZQ, 2007, CELL RES, V17, P815, DOI 10.1038/cr.2007.71; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuoka Y, 2004, THEOR APPL GENET, V109, P1710, DOI 10.1007/s00122-004-1806-6; Matsuoka Y, 2007, THEOR APPL GENET, V115, P509, DOI 10.1007/s00122-007-0584-3; Matsuoka Y, 2014, INT REV CEL MOL BIO, V309, P199, DOI 10.1016/B978-0-12-800255-1.00004-1; Matsuoka Y, 2011, PLANT CELL PHYSIOL, V52, P750, DOI 10.1093/pcp/pcr018; Mizuno N, 2011, PLANT J, V68, P114, DOI 10.1111/j.1365-313X.2011.04667.x; Mizuno N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011326; MOORE K, 1969, EUPHYTICA, V18, P190; Murai K, 2003, PLANT CELL PHYSIOL, V44, P1255, DOI 10.1093/pcp/pcg171; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Ng DWK, 2012, CURR OPIN PLANT BIOL, V15, P154, DOI 10.1016/j.pbi.2012.01.007; Ng DWK, 2011, PLANT CELL, V23, P1729, DOI 10.1105/tpc.111.083915; Ori N, 2007, NAT GENET, V39, P787, DOI 10.1038/ng2036; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pandey R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095800; Paollacci AR, 2007, MOL GENET GENOMICS, V278, P689, DOI 10.1007/s00438-007-0285-2; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Rubio-Somoza I, 2011, TRENDS PLANT SCI, V16, P258, DOI 10.1016/j.tplants.2011.03.001; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Shivaprasad PV, 2012, EMBO J, V31, P257, DOI 10.1038/emboj.2011.458; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Takamatsu K, 2015, PLANT MOL BIOL, V88, P487, DOI 10.1007/s11103-015-0338-6; Takumi S, 2011, PLANT SIGNAL BEHAV, V6, P1431, DOI 10.4161/psb.6.10.17065; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang CX, 2006, PLANT CELL, V18, P350, DOI 10.1105/tpc.105.037044; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang KJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000818; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Xin MM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-123; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96	73	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176497	10.1371/journal.pone.0176497	http://dx.doi.org/10.1371/journal.pone.0176497			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28463975	Green Submitted, Green Published, gold			2022-12-26	WOS:000400646300025
J	Kamble, AS; Fandilolu, PM; Sambhare, SB; Sonawane, KD				Kamble, Asmita S.; Fandilolu, Prayagraj M.; Sambhare, Susmit B.; Sonawane, Kailas D.			Idiosyncratic recognition of UUG/UUA codons by modified nucleoside 5-taurinomethyluridine, tau m(5)U present at 'wobble' position in anticodon loop of tRNA(Leu) : A molecular modeling approach	PLOS ONE			English	Article							AMBER FORCE-FIELD; TRANSFER-RNA; RIBOSOMAL-A; STRUCTURAL SIGNIFICANCE; DYNAMICS; MECHANISM; INSIGHTS; SYSTEM; T(6)A; AUA	Lack of naturally occurring modified nucleoside 5-taurinomethyluridine (tau m(5)U) at the 'wobble' 34th position in tRNA(Leu) causes mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). The tau m(5)U(34) specifically recognizes UUG and UUA codons. Structural consequences of tau m(5)U(34) to read cognate codons have not been studied so far in detail at the atomic level. Hence, 50ns multiple molecular dynamics (MD) simulations of various anticodon stem loop (ASL) models of tRNA(Leu) in presence and absence of tau m(5)U(34) along with UUG and UUA codons were performed to explore the dynamic behaviour of tau m(5)U(34) during codon recognition process. The MD simulation results revealed that tau m(5)U(34) recognizes G/A ending codons by 'wobble' as well as a novel 'single' hydrogen bonding interactions. RMSD and RMSF values indicate the comparative stability of the ASL models containing tau m(5)U(34) modification over the other models, lacking tau m(5)U(34). Another MD simulation study of 55S mammalian mitochondrial rRNA with tRNA(Leu) showed crucial interactions between the A-site residues, A918, A919, G256 and codon-anticodon bases. Thus, these results could improve our understanding about the decoding efficiency of human mt tRNA(Leu) with tau m(5)U(34) to recognize UUG and UUA codons.	[Kamble, Asmita S.; Fandilolu, Prayagraj M.; Sambhare, Susmit B.; Sonawane, Kailas D.] Shivaji Univ, Dept Biochem, Struct Bioinformat Unit, Kolhapur, Maharashtra, India; [Sonawane, Kailas D.] Shivaji Univ, Dept Microbiol, Kolhapur, Maharashtra, India	Shivaji University; Shivaji University	Sonawane, KD (corresponding author), Shivaji Univ, Dept Biochem, Struct Bioinformat Unit, Kolhapur, Maharashtra, India.; Sonawane, KD (corresponding author), Shivaji Univ, Dept Microbiol, Kolhapur, Maharashtra, India.	kds_biochem@unishivaji.ac.in	Fandilolu, Prayagraj/AAA-2208-2020; Kamble, Asmita/H-1910-2019; Sambhare, Susmit B/F-6195-2018	Kamble, Asmita/0000-0001-7152-3317; Sambhare, Susmit B/0000-0002-3875-6669	University Grants Commission (UGC), New Delhi, India; UGC, New Delhi, India	University Grants Commission (UGC), New Delhi, India(University Grants Commission, India); UGC, New Delhi, India(University Grants Commission, India)	This work was supported by University Grants Commission (UGC), New Delhi, India for financial assistance to KDS under the UGC-SAP-DRS-II scheme sanctioned to Department of Biochemistry, Shivaji University, Kolhapur, Maharashtra, India. PMF is thankful to UGC, New Delhi, India for a fellowship under the UGC-BSR scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; KDS gratefully acknowledges University Grants Commission, New Delhi, India for financial support under the UGC-SAP-DRS-II scheme (vide letter No. F.4-8/2015/DRS-II (SAP-II) dated 01 January 2015) sanctioned to Department of Biochemistry, Shivaji University, Kolhapur, Maharashtra, India. PMF is thankful to UGC for fellowship under UGC-BSR scheme. Authors are thankful to Department of Biochemistry and Computer Center, Shivaji University, Kolhapur, Maharashtra, India for providing necessary infrastructural and computational facilities.	Aduri R, 2007, J CHEM THEORY COMPUT, V3, P1464, DOI 10.1021/ct600329w; Agris PF, 2008, EMBO REP, V9, P629, DOI 10.1038/embor.2008.104; Agris PF, 2004, NUCLEIC ACIDS RES, V32, P223, DOI 10.1093/nar/gkh185; [Anonymous], 2008, AMBER 10; Auffinger P, 1996, FARADAY DISCUSS, V103, P151, DOI 10.1039/fd9960300151; Auffinger P, 1999, J MOL BIOL, V292, P467, DOI 10.1006/jmbi.1999.3080; AUFFINGER P, 1995, J AM CHEM SOC, V117, P6720, DOI 10.1021/ja00130a011; Auffinger P, 2001, RNA, V7, P334, DOI 10.1017/S1355838201002382; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Fahlman RP, 2004, MOL CELL, V16, P799, DOI 10.1016/j.molcel.2004.10.030; Greber BJ, 2015, SCIENCE, V348, P303, DOI 10.1126/science.aaa3872; Ibba M, 1999, SCIENCE, V286, P1893, DOI 10.1126/science.286.5446.1893; Kamble AS, 2016, STRUCT CHEM, V27, P839, DOI 10.1007/s11224-015-0642-4; Kamble AS, 2015, CELL BIOCHEM BIOPHYS, V71, P1589, DOI 10.1007/s12013-014-0382-x; Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101; Konevega AL, 2004, RNA, V10, P90, DOI 10.1261/rna.5142404; Kumbhar BV, 2013, CELL BIOCHEM BIOPHYS, V66, P797, DOI 10.1007/s12013-013-9525-8; Kurata S, 2008, J BIOL CHEM, V283, P18801, DOI 10.1074/jbc.M800233200; LABUDA D, 1985, NUCLEIC ACIDS RES, V13, P3667, DOI 10.1093/nar/13.10.3667; Ledoux S, 2009, NAT STRUCT MOL BIOL, V16, P359, DOI 10.1038/nsmb.1581; Ogle JM, 2003, TRENDS BIOCHEM SCI, V28, P259, DOI 10.1016/S0968-0004(03)00066-5; Panecka J, 2014, J PHYS CHEM B, V118, P6687, DOI 10.1021/jp5030685; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rodnina MV, 2002, BIOCHIMIE, V84, P745, DOI 10.1016/S0300-9084(02)01409-8; Rozov A, 2015, NAT COMMUN; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sambhare SB, 2014, RSC ADV, V4, P14176, DOI 10.1039/c3ra47335j; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; Sonawane KD, 2015, INTEGR BIOL-UK, V7, P1387, DOI 10.1039/c5ib00058k; Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656; *TRIP INT, 2006, SYBYL 7 3; Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001; Voorhees RM, 2013, NAT STRUCT MOL BIOL, V20, P641, DOI 10.1038/nsmb.2545	35	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176756	10.1371/journal.pone.0176756	http://dx.doi.org/10.1371/journal.pone.0176756			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453549	gold, Green Submitted, Green Published			2022-12-26	WOS:000400383900052
J	Qin, JS; Mai, YX; Li, Y; Jiang, ZS; Gao, Y				Qin, Jiasheng; Mai, Yanxing; Li, Yang; Jiang, Zesheng; Gao, Yi			Effect of mild hypothermia preconditioning against low temperature (4 degrees C) induced rat liver cell injury in vitro	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; OXIDATIVE STRESS; MODERATE HYPOTHERMIA; BIOARTIFICIAL LIVER; RECOMBINANT HEPG2; APOPTOSIS; PROTECTS; HEPATOCYTES; ACTIVATION; INHIBITION	Bioartificial liver holds special position in the field of regenerative medicine, and cold environment at 4 degrees C is widely used for the short storage of both organ and liver cell for later application. However, the disadvantages of such cold storage could influence cell viability and lead to cell apoptosis in different degrees. In this study, we mainly explore the pre-protective effect of mild hypothermia against low temperature (4 degrees C) -induced rat liver cell injury in vitro. Our results indicated that the precondition with mild hypothermia could increase cell viability, such as cell proliferation, LDH regulation and glycogen synthesis ability of liver cell. The precondition also decreased the ROS production and relieved cell apoptosis in liver cells. Compared with the model group, the mitochondrial membrane potential was restored in the mild hypothermia group, as well as the mitochondrial membrane permeability transition pore opening, indicating that the therapeutic mechanism was related to mitochondrial protection. Further analysis showed that PI3K-Akt-GSK3 beta signal pathway might be associated with the pre-protective effect of mild hypothermia. Thus, our study suggested that the precondition with mild hypothermia hold the protective effect for liver cell in cold environment, and further developed a novel strategy for the storage of liver seed cells, even bioartificial liver.	[Qin, Jiasheng; Li, Yang; Jiang, Zesheng; Gao, Yi] Southern Med Univ, Zhujiang Hosp, Dept Hepatobiliary Surg 2, Guangzhou, Guangdong, Peoples R China; [Qin, Jiasheng; Li, Yang; Jiang, Zesheng; Gao, Yi] Southern Med Univ, Inst Regenerat Med, Guangzhou, Guangdong, Peoples R China; [Mai, Yanxing] Southern Med Univ, Zhujiang Hosp, Dept Geriatr, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Gao, Y (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Hepatobiliary Surg 2, Guangzhou, Guangdong, Peoples R China.; Gao, Y (corresponding author), Southern Med Univ, Inst Regenerat Med, Guangzhou, Guangdong, Peoples R China.	gaoyi6146@163.com			National High Technology Research and Development Program of China ("863" Program) [2012AA020505]; National Natural Science Foundation of China [81470875]; Science and Technology Planning Project of Guangdong Province [201413020227002, 201513020229002, 20156090903069]; Natural Science Foundation of Guangdong Province [2014A030312013]; Educational Commission of Guangdong Province [C10319040]	National High Technology Research and Development Program of China ("863" Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Educational Commission of Guangdong Province	This study was supported by the grants from the National High Technology Research and Development Program of China ("863" Program 2012AA020505); National Natural Science Foundation of China (81470875); Science and Technology Planning Project of Guangdong Province (201413020227002,201513020229002,20156090903069); Natural Science Foundation of Guangdong Province (2014A030312013); Educational Commission of Guangdong Province (C10319040).	Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Baines CP, 2009, BASIC RES CARDIOL, V104, P181, DOI 10.1007/s00395-009-0004-8; Blei A, 2000, LIVER TRANSPLANT, V6, P245, DOI 10.1002/lt.500060206; Cai Jinglei, 2013, Cell Regen, V2, P6, DOI 10.1186/2045-9769-2-6; Chen WN, 2015, AM J PATHOL, V185, P1033, DOI 10.1016/j.ajpath.2014.12.020; Dai HB, 2016, MOL NEUROBIOL, V53, P4865, DOI 10.1007/s12035-015-9391-z; Diestel A, 2008, CRYOBIOLOGY, V57, P216, DOI 10.1016/j.cryobiol.2008.08.005; Enosawa S, 2001, CELL TRANSPLANT, V10, P429; Enosawa S, 2006, CELL TRANSPLANT, V15, P873, DOI 10.3727/000000006783981350; Ferrigno A, 2011, CRYOBIOLOGY, V62, P152, DOI 10.1016/j.cryobiol.2011.02.004; Fu T, 2004, CELL TRANSPLANT, V13, P667, DOI 10.3727/000000004783983495; Gao XY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07091; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Gong P, 2013, J CEREBR BLOOD F MET, V33, P928, DOI 10.1038/jcbfm.2013.33; Guo XL, 2016, EUR J PHARMACOL, V791, P578, DOI 10.1016/j.ejphar.2016.09.031; Hong MF, 2005, CURR OPIN CARDIOL, V20, P1; Hosseini MJ, 2016, ENVIRON TOXICOL, V31, P979, DOI 10.1002/tox.22107; Huang K, 2014, SCI CHINA LIFE SCI, V57, P162, DOI 10.1007/s11427-013-4598-6; Iqbal J, 2013, J BIOL CHEM, V288, P36994, DOI 10.1074/jbc.M113.492314; Jacobs S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127368; Jacobs Susan E, 2005, J Pediatr, V147, P122, DOI 10.1016/j.jpeds.2005.04.047; Khaliulin I, 2007, J PHYSIOL-LONDON, V581, P1147, DOI 10.1113/jphysiol.2007.130369; Kim HJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/306421; Lai SS, 2016, J HEPATOL, V64, P352, DOI 10.1016/j.jhep.2015.09.025; Lakshmanan J, 2015, J CELL BIOCHEM, V116, P133, DOI 10.1002/jcb.24951; Lian F, 2015, MOL MED REP, V12, P5821, DOI 10.3892/mmr.2015.4159; Liu PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097123; Liu PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069617; Liu PF, 2013, LIFE SCI, V92, P829, DOI 10.1016/j.lfs.2013.02.016; Mochizuki T, 2012, RESUSCITATION, V83, P238, DOI 10.1016/j.resuscitation.2011.08.013; Pan CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039151; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Puts CF, 2015, CRYOBIOLOGY, V71, P125, DOI 10.1016/j.cryobiol.2015.04.010; Qadir XV, 2015, AM J PATHOL, V185, P3141, DOI 10.1016/j.ajpath.2015.08.020; Sabir H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109845; Sakurai T, 2006, BBA-MOL CELL RES, V1763, P290, DOI 10.1016/j.bbamcr.2006.02.007; Sakurai T, 2013, DIGEST DIS, V31, P440, DOI 10.1159/000355242; Sakurai T, 2013, CANCER RES, V73, P215, DOI 10.1158/0008-5472.CAN-12-1602; Selden C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082312; Takahara I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170591; Tanoi T, 2016, HEPATOL RES, V46, P697, DOI 10.1111/hepr.12607; Wu TC, 2013, LANCET NEUROL, V12, P275, DOI 10.1016/S1474-4422(13)70013-9; Xiao J, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/607271; Xiong W, 2016, J SURG RES, V200, P250, DOI 10.1016/j.jss.2015.06.068; Yu YH, 2015, MOL CELL BIOCHEM, V403, P287, DOI 10.1007/s11010-015-2358-6; Zhang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113107; Zheng T, 2015, BRIT J PHARMACOL, V172, P3284, DOI 10.1111/bph.13120; Zuo DY, 2016, COLLOID SURFACE B, V145, P232, DOI 10.1016/j.colsurfb.2016.05.006	48	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176652	10.1371/journal.pone.0176652	http://dx.doi.org/10.1371/journal.pone.0176652			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453529	Green Submitted, Green Published, gold			2022-12-26	WOS:000400383900040
J	Qin, Y; Conley, AP; Grimm, EA; Roszik, J				Qin, Yong; Conley, Anthony P.; Grimm, Elizabeth A.; Roszik, Jason			A tool for discovering drug sensitivity and gene expression associations in cancer cells	PLOS ONE			English	Article							LANDSCAPE; LINE	The sensitivity of cancer cells to anticancer drugs is a crucial factor for developing effective treatments. However, it is still challenging to precisely predict the effectiveness of therapeutics in humans within a complex genomic and molecular context. We developed an interface which allows the user to rapidly explore drug sensitivity and gene expression associations. Predictions for how expression of various genes affect anticancer drug activity are available for all genes for a set of therapeutics based on data from various cell lines of different origin in the Cancer Cell Line Encyclopedia and the Genomics of Drug Sensitivity in Cancer projects. Our application makes discovery or validation of drug sensitivity and gene expression associations efficient. Effectiveness of this tool is demonstrated by multiple known and novel examples.	[Qin, Yong; Grimm, Elizabeth A.; Roszik, Jason] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; [Conley, Anthony P.] Univ Texas MD Anderson Canc Ctr, Dept Sarcoma Med Oncol, Houston, TX 77030 USA; [Roszik, Jason] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Roszik, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA.; Roszik, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA.	jroszik@mdanderson.org		Roszik, Jason/0000-0002-4561-6170; Qin, Yong/0000-0003-4743-938X; Conley, Anthony/0000-0002-6232-1163	generous philanthropic contributions to The University of Texas MD Anderson Moon Shots Program; MD Anderson Cancer Center SPORE in Melanoma [P50 CA093459]; MD Anderson Cancer Center Support Grant [P30-CA016672]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Miriam and Jim Mulva and Aim Foundations	generous philanthropic contributions to The University of Texas MD Anderson Moon Shots Program; MD Anderson Cancer Center SPORE in Melanoma; MD Anderson Cancer Center Support Grant; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Miriam and Jim Mulva and Aim Foundations	This work has been supported by the generous philanthropic contributions to The University of Texas MD Anderson Moon Shots Program (JR). This work was also supported by the MD Anderson Cancer Center SPORE in Melanoma P50 CA093459 (EAG, YQ), the MD Anderson Cancer Center Support Grant P30-CA016672, the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (YQ, EAG), and the Miriam and Jim Mulva and Aim Foundations.; This work has been supported by the generous philanthropic contributions to The University of Texas MD Anderson Moon Shots Program (JR). This work was also supported by the MD Anderson Cancer Center SPORE in Melanoma P50 CA093459 (EAG, YQ), the MD Anderson Cancer Center Support Grant P30-CA016672 (EAG), the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (YQ, EAG), and the Miriam and Jim Mulva and Aim Foundations (YQ, EAG).	Azuaje F., 2016, BRIEF BIOINFORM; Bailey P, 2016, SCI REP-UK, V6, DOI 10.1038/srep35848; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Kasai S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153181; Kogita A, 2014, INT J ONCOL, V45, P1430, DOI 10.3892/ijo.2014.2574; Mayor-Lopez L, 2014, TRANSL ONCOL, V7, P590, DOI 10.1016/j.tranon.2014.08.001; Qin Y, 2016, MOL CANCER THER, V15, P2442, DOI 10.1158/1535-7163.MCT-15-0963; Roden DM, 2002, NAT REV DRUG DISCOV, V1, P37, DOI 10.1038/nrd705; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Ye WL, 2016, DEV CELL, V37, P114, DOI 10.1016/j.devcel.2016.03.015	11	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176763	10.1371/journal.pone.0176763	http://dx.doi.org/10.1371/journal.pone.0176763			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453553	gold, Green Published, Green Submitted			2022-12-26	WOS:000400383900053
J	Zhou, Q; Sun, Y; Tan, WX; Liu, X; Qian, YC; Ma, XH; Wang, T; Wang, XY; Gao, XM				Zhou, Qian; Sun, Yan; Tan, Wangxiao; Liu, Xiao; Qian, Yuchen; Ma, Xianghui; Wang, Ting; Wang, Xiaoying; Gao, Xiumei			Effect of Shenmai injection on preventing the development of nitroglycerin-induced tolerance in rats	PLOS ONE			English	Article							VASODILATOR-STIMULATED PHOSPHOPROTEIN; MITOCHONDRIAL ALDEHYDE DEHYDROGENASE; INDUCED ENDOTHELIAL DYSFUNCTION; SERINE 239 PHOSPHORYLATION; DEPENDENT PROTEIN-KINASE; SOLUBLE GUANYLYL CYCLASE; HUMAN BLOOD-VESSELS; NITRATE TOLERANCE; NITRIC-OXIDE; CORONARY-ARTERIES	Long-term nitroglycerin (NTG) therapy causes tolerance to its effects attributing to increased oxidative stress and endothelial dysfunction. Shenmai injection (SMI), which is clinically used to treat cardiovascular diseases, consists of two herbal medicines, Ginseng Rubra and Ophiopogonjaponicas, and is reported to have antioxidant effects. The present study was designed to investigate the potential preventive effects of Shenmai injection on development of nitroglycerin- induced tolerance. The present study involves both in vivo and in vitro experiments to investigate nitroglycerin-induced tolerance. We examined the effect of Shenmai injection on the cardiovascular oxidative stress by measuring the serum levels of malondialdehyde (MDA) and superoxide dismutase (SOD). Endothelial dysfunction was determined by an endothelium-dependent vasorelaxation method in aortic rings and NOS activity. Inhibition of the cGMP/cGK-I signalling pathway was determined from released serum levels of cGMP and the protein expression levels of sGC, cGK-I, PDE1A and P-VASP by western blot. Here, we showed that SMI ameliorated the decrease in AV Peak Vel, the attenuation in the vasodilation response to nitroglycerin and endothelial dysfunction. SMI also reduced the cardiovascular oxidative stress by reducing the release of MDA and increasing the activity of SOD. Shenmai injection further ameliorated inhibition of the cGMP/ cGK-I signalling pathway triggered by nitroglycerin- induced tolerance through up-regulating the protein expression of sGC, cGK-I, and P-VASP and down-regulating the proteins expression of PDE1A. In vitro studies showed that Shenmai injection could recover the attenuated vasodilation response to nitroglycerin following incubation (of aortic rings) with nitroglycerin via activating the enzymes of sGC and cGK-I. Therefore, we conclude that Shenmai injection could prevent NTG nitroglycerin- induced tolerance at least in part by decreasing the cardiovascular oxidative stress, meliorating the endothelial dysfunction and ameliorating the inhibition of the cGMP/cGK-I signalling pathway. These findings indicate the potential of Shenmai injection (SMI) as a promising medicine for preventing the development of nitroglycerin- induced tolerance.	[Zhou, Qian; Sun, Yan; Tan, Wangxiao; Liu, Xiao; Qian, Yuchen; Ma, Xianghui; Wang, Ting; Wang, Xiaoying; Gao, Xiumei] Tianjin Univ Tradit Chinese Med, State Key Lab Modern Chinese Med, Tianjin, Peoples R China; [Wang, Xiaoying] Tianjin Univ Tradit Chinese Med, Coll Tradit Chinese Med, Tianjin, Peoples R China	Tianjin University of Traditional Chinese Medicine; Tianjin University of Traditional Chinese Medicine	Wang, XY (corresponding author), Tianjin Univ Tradit Chinese Med, State Key Lab Modern Chinese Med, Tianjin, Peoples R China.; Wang, XY (corresponding author), Tianjin Univ Tradit Chinese Med, Coll Tradit Chinese Med, Tianjin, Peoples R China.	wxy@tjutcm.edu.cn			National Program for Key Basic Research Projects [2012CB518404]; NSFC [81673708, 81630106]; Ministry of Education of PRC "Program for Innovative Research Team in University" [IRT1276, IRT_16R54, IRT_14R41]	National Program for Key Basic Research Projects; NSFC(National Natural Science Foundation of China (NSFC)); Ministry of Education of PRC "Program for Innovative Research Team in University"	This work was supported by the National Program for Key Basic Research Projects (2012CB518404), the NSFC (81673708 and 81630106), the Ministry of Education of PRC "Program for Innovative Research Team in University" (NO. IRT1276).; This work was supported by the National Program for Key Basic Research Projects (2012CB518404), the NSFC (81673708 and 81630106), the Ministry of Education of PRC "Program for Innovative Research Team in University" (NO. IRT_16R54 and IRT_14R41).	Abou-Mohamed G, 2004, J PHARMACOL EXP THER, V308, P289, DOI 10.1124/jpet.103.056119; Azarmi Y, 2014, J CARDIOVASC PHARM, V63, P113, DOI 10.1097/FJC.0000000000000029; Chen YR, 2007, EUR J PHARMACOL, V571, P44, DOI 10.1016/j.ejphar.2007.05.042; Colussi C, 2012, ARTERIOSCL THROM VAS, V32, P2435, DOI 10.1161/ATVBAHA.112.254011; Daiber A, 2015, ANTIOXID REDOX SIGN, V23, P899, DOI 10.1089/ars.2015.6376; Dudek M, 2010, FUND CLIN PHARMACOL, V24, P47, DOI 10.1111/j.1472-8206.2009.00728.x; El-Demerdash E, 2006, PHARMACOL RES, V53, P380, DOI 10.1016/j.phrs.2006.01.007; Fekete V, 2013, J CARDIOVASC PHARM, V62, P298, DOI 10.1097/FJC.0b013e3182993ae0; Garcia-Bou R, 2012, BBA-BIOENERGETICS, V1817, P828, DOI 10.1016/j.bbabio.2012.02.013; Hink U, 2007, J AM COLL CARDIOL, V50, P2226, DOI 10.1016/j.jacc.2007.08.031; Hu R, 2014, TRENDS PHARMACOL SCI, V35, P369, DOI 10.1016/j.tips.2014.06.001; IGNARRO LJ, 1981, J PHARMACOL EXP THER, V218, P739; Jabs A, 2015, VASC PHARMACOL, V71, P181, DOI 10.1016/j.vph.2015.03.007; Jiao Hong, 2014, Zhongguo Zhong Yao Za Zhi, V39, P2956; Kim D, 2001, CIRCULATION, V104, P2338, DOI 10.1161/hc4401.098432; Knorr M, 2011, ARTERIOSCL THROM VAS, V31, P2223, DOI 10.1161/ATVBAHA.111.232058; Kosmicki MA, 2009, CURR CLIN PHARMACOL, V4, P132, DOI 10.2174/157488409788185016; Lei S., 2013, OXIDATIVE MED CELLUL, V2013; Levine GN, 2016, J AM COLL CARDIOLOGY; Li YJ, 2003, MED HYPOTHESES, V60, P693, DOI 10.1016/S0306-9877(03)00024-0; Lin Lina, 2009, Zhongguo Zhong Yao Za Zhi, V34, P1155; Liuni A, 2011, J AM COLL CARDIOL, V57, P93, DOI 10.1016/j.jacc.2010.07.037; Major TC, 2013, BIOMATERIALS, V34, P8086, DOI 10.1016/j.biomaterials.2013.07.041; Matsuzaki T, 2002, CLIN EXP PHARMACOL P, V29, P1091, DOI 10.1046/j.1440-1681.2002.03776.x; Mink SN, 2005, J MOL CELL CARDIOL, V39, P615, DOI 10.1016/j.yjmcc.2005.06.009; Mulsch A, 2001, CIRCULATION, V103, P2188; Munzel T, 2005, ARTERIOSCL THROM VAS, V25, P1551, DOI 10.1161/01.ATV.0000168896.64927.bb; Nossaman BD, 2013, OCHSNER J, V13, P147; PACKER M, 1990, J AM COLL CARDIOL, V16, P932, DOI 10.1016/S0735-1097(10)80343-2; Sage PR, 2000, CIRCULATION, V102, P2810; Schulz E, 2002, CIRCULATION, V105, P1170, DOI 10.1161/hc1002.105186; Shi LW, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0939-2; Smolenski A, 1998, J BIOL CHEM, V273, P20029, DOI 10.1074/jbc.273.32.20029; Sydow K, 2004, J CLIN INVEST, V113, P482, DOI 10.1172/JCI200419267; Szocs K, 2007, J MOL CELL CARDIOL, V42, P1111, DOI 10.1016/j.yjmcc.2007.03.904; Tan T, 2010, CARDIOVASC DRUG THER, V24, P95, DOI 10.1007/s10557-010-6229-9; Tawa M, 2014, J PHARMACOL SCI, V125, P169, DOI 10.1254/jphs.14046FP; Tsou PS, 2009, J PHARMACOL EXP THER, V329, P649, DOI 10.1124/jpet.108.149997; Van Hove CE, 2009, BRIT J PHARMACOL, V158, P920, DOI 10.1111/j.1476-5381.2009.00396.x; Wang XY, 2015, PHYTOMEDICINE, V22, P875, DOI 10.1016/j.phymed.2015.06.010; [吴茵 Wu Yin], 2014, [中草药, Chinese Traditional and Herbal Drugs], V45, P2625; Yu J, 2014, J ETHNOPHARMACOL, V154, P391, DOI 10.1016/j.jep.2014.04.014; Yu K, 2007, J PHARMACEUT BIOMED, V44, P532, DOI 10.1016/j.jpba.2007.01.032; Zhang GG, 2008, LIFE SCI, V82, P699, DOI 10.1016/j.lfs.2008.01.002; Zhao Xiyue, 2011, Zhongguo Zhong Yao Za Zhi, V36, P2153; Zheng Xiaojun, 2011, Zhongguo Zhong Yao Za Zhi, V36, P3023; Zhu JQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078026	47	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176777	10.1371/journal.pone.0176777	http://dx.doi.org/10.1371/journal.pone.0176777			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453571	Green Submitted, Green Published, gold			2022-12-26	WOS:000400383900054
J	Pek, M; Yatim, SMJM; Chen, Y; Li, J; Gong, M; Jiang, X; Zhang, F; Zheng, J; Wu, X; Yu, Q				Pek, M.; Yatim, S. M. J. M.; Chen, Y.; Li, J.; Gong, M.; Jiang, X.; Zhang, F.; Zheng, J.; Wu, X.; Yu, Q.			Oncogenic KRAS-associated gene signature defines co-targeting of CDK4/6 and MEK as a viable therapeutic strategy in colorectal cancer	ONCOGENE			English	Article							SYNTHETIC LETHAL INTERACTION; RECEPTOR TYROSINE KINASES; PANCREATIC-CANCER; MUTATION STATUS; DNA-DAMAGE; CELL-CYCLE; FOXM1; PROLIFERATION; SUPPRESSION; TRANSCRIPTION	Therapeutic strategies against KRAS mutant colorectal cancers are developed using cell line models, which do not accurately represent the transcriptome driven by oncogenic KRAS in tumors. We sought to identify a KRAS-associated gene signature from colorectal tumors to develop a precise treatment strategy. Integrative analysis of quantitative KRAS mutation detection and matched gene expression profiling in 55 CRC bulk tumors was carried out to define a gene signature enriched in CRC tumors with high KRAS mutation. The KRAS-associated gene signature identified exhibits functional enrichment in cell cycle and mitosis processes, and includes mitotic transcription factor, FOXM1. Combination treatment of CDK4/6 inhibitor Palbociclib and MEK inhibitor PD0325901 was tested in KRAS-mutant, BRAF-mutant CRC, normal colon epithelial lines and xenografts models to determine their efficacy and toxicity and to monitor the changes in the gene signature. Inhibiting CDK4/6, an upstream regulator of FOXM1, and MEK synergistically depleted FOXM1 and KRAS-associated gene signature, suggesting that CDK4/6 and MEK regulate the KRAS gene signature. The combined inhibition of CDK4/6 and MEK elicited a robust therapeutic response in KRAS-dependent and BRAF-mutant CRC, both in vitro and in vivo and this correlated with downregulation of the KRAS-associated gene signature. Our preclinical study demonstrated the efficacy of Palbociclib and PD0325901 combinatorial treatment selectively in KRAS-dependent and BRAF-mutant CRC but not in normal colon epithelial cells. The KRAS-associated gene signature could facilitate the identification of responsive metastatic CRC to this therapeutic strategy in clinical settings.	[Pek, M.; Yatim, S. M. J. M.; Chen, Y.; Gong, M.; Jiang, X.; Yu, Q.] ASTAR, Genome Inst Singapore, Canc Therapeut & Stratified Oncol, Singapore, Singapore; [Pek, M.] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore, Singapore; [Chen, Y.; Wu, X.] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Colorectal Surg, Guangzhou, Guangdong, Peoples R China; [Chen, Y.; Wu, X.] Sun Yat Sen Univ, Affiliated Hosp 6, Guangdong Prov Key Lab Colorectal & Pelv Floor Di, Guangzhou, Guangdong, Peoples R China; [Li, J.] ASTAR, Genome Inst Singapore, Computat Biol, Singapore, Singapore; [Zhang, F.; Zheng, J.] Nanyang Technol Univ, Sch Comp Engn, 50 Nanyang Ave, Singapore, Singapore; [Wu, X.] Guangdong Inst Gastroenterol, Guangzhou, Guangdong, Peoples R China; [Yu, Q.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore; [Yu, Q.] Jinan Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China; [Yu, Q.] Duke Natl Univ Singapore, Grad Med Sch Singapore, Canc & Stem Cell Biol, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Sun Yat Sen University; Sun Yat Sen University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Jinan University; National University of Singapore	Yu, Q (corresponding author), Genome Inst Singapore, Canc Therapeut & Stratified Oncol, 60 Biopolis St,02-01, Singapore 138672, Singapore.	yuq@gis.a-star.edu.sg	Zheng, Jie/C-1356-2011; Zheng, Jie/AAX-1454-2021	Zheng, Jie/0000-0001-6774-9786; Yu, Qiang/0000-0003-2132-8278; Zhang, Fan/0000-0001-8377-0235	A*STAR of Singapore; International S&T Cooperation Program of China (ISTCP) [2013DFG32990]; National High Technology Research and Development Program (863) of China [2012AA02A520]	A*STAR of Singapore(Agency for Science Technology & Research (A*STAR)); International S&T Cooperation Program of China (ISTCP); National High Technology Research and Development Program (863) of China(National High Technology Research and Development Program of China)	This work was supported by the A*STAR of Singapore, International S&T Cooperation Program of China (ISTCP) (No. 2013DFG32990) and National High Technology Research and Development Program (863) of China (No. 2012AA02A520). We thank Puay Leng Lee for technical assistance in western blot analysis.	Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Bertoli C, 2016, CELL REP, V15, P1412, DOI 10.1016/j.celrep.2016.04.036; Bryant KL, 2014, TRENDS BIOCHEM SCI, V39, P91, DOI 10.1016/j.tibs.2013.12.004; Calon A, 2015, NAT GENET, V47, P320, DOI 10.1038/ng.3225; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Choi YJ, 2014, ONCOGENE, V33, P1890, DOI 10.1038/onc.2013.137; Ciardiello F, 2014, ANN ONCOL, V25, P1756, DOI 10.1093/annonc/mdu230; Corcoran RB, 2013, CANCER CELL, V23, P121, DOI 10.1016/j.ccr.2012.11.007; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Ebi H, 2011, J CLIN INVEST, V121, P4311, DOI 10.1172/JCI57909; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gilad O, 2010, CANCER RES, V70, P9693, DOI 10.1158/0008-5472.CAN-10-2286; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Hayes TK, 2016, CANCER CELL, V29, P75, DOI 10.1016/j.ccell.2015.11.011; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Kosmidou V, 2014, HUM MUTAT, V35, P329, DOI 10.1002/humu.22496; Kwong LN, 2012, NAT MED, V18, P1503, DOI 10.1038/nm.2941; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Liu XL, 2011, AM J CLIN PATHOL, V135, P245, DOI 10.1309/AJCP7FO2VAXIVSTP; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; McMurray HR, 2008, NATURE, V453, P1112, DOI 10.1038/nature06973; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Putzer BM, 2013, TRENDS MOL MED, V19, P89, DOI 10.1016/j.molmed.2012.10.009; Russo A, 2005, ANN ONCOL, V16, P44, DOI 10.1093/annonc/mdi907; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tan Y, 2010, CELL PROLIFERAT, V43, P494, DOI 10.1111/j.1365-2184.2010.00699.x; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Yeh JJ, 2009, MOL CANCER THER, V8, P834, DOI 10.1158/1535-7163.MCT-08-0972; Ziemke EK, 2016, CLIN CANCER RES, V22, P405, DOI 10.1158/1078-0432.CCR-15-0829; Zona S, 2014, BBA-GENE REGUL MECH, V1839, P1316, DOI 10.1016/j.bbagrm.2014.09.016	43	49	51	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 31	2017	36	35					4975	4986		10.1038/onc.2017.120	http://dx.doi.org/10.1038/onc.2017.120			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FF3AV	28459468				2022-12-26	WOS:000408768800003
J	Marcinko, TM; Dong, J; LeBlanc, R; Daborowski, KV; Vachet, RW				Marcinko, Tyler M.; Dong, Jia; LeBlanc, Raquel; Daborowski, Kate V.; Vachet, Richard W.			Small molecule-mediated inhibition of-2-microglobulin-based amyloid fibril formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; copper; HPLC; inhibitor; MS; -2-microglobulin; ion mobility	MOBILITY-MASS-SPECTROMETRY; ION-TETRACYCLINE INTERACTIONS; PROTEIN MISFOLDING DISEASES; CAPILLARY-ELECTROPHORESIS; COPPER(II) COMPLEXES; BIOLOGICAL-FLUIDS; BETA-2-MICROGLOBULIN; BETA(2)-MICROGLOBULIN; AGGREGATION; BINDING	In dialysis patients, -2 microglobulin (2m) can aggregate and eventually form amyloid fibrils in a condition known as dialysis-related amyloidosis, which deleteriously affects joint and bone function. Recently, several small molecules have been identified as potential inhibitors of 2m amyloid formation in vitro. Here we investigated whether these molecules are more broadly applicable inhibitors of 2m amyloid formation by studying their effect on Cu(II)-induced 2m amyloid formation. Using a variety of biophysical techniques, we also examined their inhibitory mechanisms. We found that two molecules, doxycycline and rifamycin SV, can inhibit 2m amyloid formation in vitro by causing the formation of amorphous, redissolvable aggregates. Rather than interfering with 2m amyloid formation at the monomer stage, we found that doxycycline and rifamycin SV exert their effect by binding to oligomeric species both in solution and in gas phase. Their binding results in a diversion of the expected Cu(II)-induced progression of oligomers toward a heterogeneous collection of oligomers, including trimers and pentamers, that ultimately matures into amorphous aggregates. Using ion mobility mass spectrometry, we show that both inhibitors promote the compaction of the initially formed 2m dimer, which causes the formation of other off-pathway and amyloid-incompetent oligomers that are isomeric with amyloid-competent oligomers in some cases. Overall, our results suggest that doxycycline and rifamycin are general inhibitors of Cu(II)-induced 2m amyloid formation. Interestingly, the putative mechanism of their activity is different depending on how amyloid formation is initiated with 2m, which underscores the complexity of how these structures assemble in vitro.	[Marcinko, Tyler M.; Dong, Jia; LeBlanc, Raquel; Daborowski, Kate V.; Vachet, Richard W.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Vachet, RW (corresponding author), Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA.	rwvachet@chem.umass.edu		Marcinko, Tyler/0000-0003-0230-7308	National Institutes of Health [R01 GM 075092]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM 075092. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antwi K, 2008, PROTEIN SCI, V17, P748, DOI 10.1110/ps.073249008; Beveridge R, 2013, ANALYST, V138, P32, DOI 10.1039/c2an35665a; Bleiholder C, 2013, J AM CHEM SOC, V135, P16926, DOI 10.1021/ja406197f; BRION M, 1986, INORG CHIM A-BIOINOR, V123, P61, DOI 10.1016/S0020-1693(00)84302-9; Bush MF, 2010, ANAL CHEM, V82, P9557, DOI 10.1021/ac1022953; Carazzone C, 2008, ELECTROPHORESIS, V29, P1502, DOI 10.1002/elps.200700677; Cerasoli E, 2015, FRONT CHEM, V3, DOI 10.3389/fchem.2015.00017; Cheng B, 2013, BBA-GEN SUBJECTS, V1830, P4860, DOI 10.1016/j.bbagen.2013.06.029; Danesh F, 2001, SEMIN DIALYSIS, V14, P80, DOI 10.1046/j.1525-139x.2001.00035.x; Doig AJ, 2015, CURR OPIN STRUC BIOL, V30, P50, DOI 10.1016/j.sbi.2014.12.004; Dong J, 2014, BIOCHEMISTRY-US, V53, P1263, DOI 10.1021/bi4016583; Drueke TB, 2009, SEMIN DIALYSIS, V22, P378, DOI 10.1111/j.1525-139X.2009.00584.x; Eakin CM, 2004, BIOCHEMISTRY-US, V43, P7808, DOI 10.1021/bi049792q; Eakin CM, 2002, BIOCHEMISTRY-US, V41, P10646, DOI 10.1021/bi025944a; Eichner T, 2011, FEBS J, V278, P3868, DOI 10.1111/j.1742-4658.2011.08186.x; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; GEJYO F, 1986, KIDNEY INT, V30, P385, DOI 10.1038/ki.1986.196; Giorgetti S, 2011, J BIOL CHEM, V286, P2121, DOI 10.1074/jbc.M110.178376; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Hyung SJ, 2012, PROTEOMICS, V12, P1547, DOI 10.1002/pmic.201100520; JEZOWSKABOJCZUK M, 1993, INORG CHEM, V32, P428, DOI 10.1021/ic00056a015; Katou H, 2002, PROTEIN SCI, V11, P2218, DOI 10.1110/ps.0213202; Lanucara F, 2014, NAT CHEM, V6, P281, DOI [10.1038/NCHEM.1889, 10.1038/nchem.1889]; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Mendoza VL, 2010, BIOCHEMISTRY-US, V49, P1522, DOI 10.1021/bi901748h; Liang YF, 2012, BIOCHEMISTRY-US, V51, P3523, DOI 10.1021/bi3002727; Lim J, 2004, ANAL CHEM, V76, P3498, DOI 10.1021/ac049716t; Marshall KE, 2014, PRION, V8, P192, DOI 10.4161/pri.28860; Maurer MM, 2015, ANALYST, V14, P6782, DOI 10.1039/c5an00922g; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Mendoza VL, 2011, BIOCHEMISTRY-US, V50, P6711, DOI 10.1021/bi2004894; Meng FL, 2008, BIOCHEMISTRY-US, V47, P6016, DOI 10.1021/bi702518m; Morgan CJ, 2001, J MOL BIOL, V309, P339, DOI 10.1006/jmbi.2001.4661; Ookoshi T, 2008, NEPHROL DIAL TRANSPL, V23, P3247, DOI 10.1093/ndt/gfn231; Quaglia M, 2005, ELECTROPHORESIS, V26, P4055, DOI 10.1002/elps.200500313; Regazzoni L, 2011, ANAL CHIM ACTA, V685, P153, DOI 10.1016/j.aca.2010.11.025; Rennella E, 2010, J MOL BIOL, V401, P286, DOI 10.1016/j.jmb.2010.06.016; Ruotolo BT, 2008, NAT PROTOC, V3, P1139, DOI 10.1038/nprot.2008.78; Ruotolo BT, 2005, SCIENCE, V310, P1658, DOI 10.1126/science.1120177; Sasahara K, 2007, J MOL BIOL, V372, P981, DOI 10.1016/j.jmb.2007.06.088; Scarff CA, 2009, J AM SOC MASS SPECTR, V20, P625, DOI 10.1016/j.jasms.2008.11.023; Sengupta U, 2016, EBIOMEDICINE, V6, P42, DOI 10.1016/j.ebiom.2016.03.035; Seo J, 2016, ANGEW CHEM INT EDIT, V55, P14173, DOI 10.1002/anie.201606029; Soto-Ortega DD, 2011, BIOORGAN MED CHEM, V19, P2596, DOI 10.1016/j.bmc.2011.03.010; Srikanth R, 2009, BIOCHEMISTRY-US, V48, P9871, DOI 10.1021/bi901172y; Sun Y, 2016, J AM SOC MASS SPECTR, V27, P31, DOI 10.1007/s13361-015-1244-5; Williams DM, 2013, MASS SPECTROM REV, V32, P169, DOI 10.1002/mas.21358; Woods LA, 2013, BBA-PROTEINS PROTEOM, V1834, P1257, DOI 10.1016/j.bbapap.2012.10.002; Woods LA, 2011, NAT CHEM BIOL, V7, P730, DOI [10.1038/nchembio.635, 10.1038/NCHEMBIO.635]	49	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10630	10638		10.1074/jbc.M116.774083	http://dx.doi.org/10.1074/jbc.M116.774083			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28468825	hybrid, Green Published			2022-12-26	WOS:000404115400022
J	Fisher, P; Aumann, C; Chia, K; O'Halloran, N; Chandra, S				Fisher, Peter; Aumann, Colin; Chia, Kohleth; O'Halloran, Nick; Chandra, Subhash			Adequacy of laser diffraction for soil particle size analysis	PLOS ONE			English	Article							SODIUM-HYPOCHLORITE; PLUMMET BALANCE; ORGANIC-MATTER; CLAY; DIFFRACTOMETRY; DISTRIBUTIONS; SENSITIVITY; INSTRUMENT; HYDROMETER; FRACTIONS	Sedimentation has been a standard methodology for particle size analysis since the early 1900s. In recent years laser diffraction is beginning to replace sedimentation as the prefered technique in some industries, such as marine sediment analysis. However, for the particle size analysis of soils, which have a diverse range of both particle size and shape, laser diffraction still requires evaluation of its reliability. In this study, the sedimentation based sieve plummet balance method and the laser diffraction method were used to measure the particle size distribution of 22 soil samples representing four contrasting Australian Soil Orders. Initially, a precise wet riffling methodology was developed capable of obtaining representative samples within the recommended obscuration range for laser diffraction. It was found that repeatable results were obtained even if measurements were made at the extreme ends of the manufacturer's recommended obscuration range. Results from statistical analysis suggested that the use of sample pretreatment to remove soil organic carbon ( and possible traces of calcium-carbonate content) made minor differences to the laser diffraction particle size distributions compared to no pretreatment. These differences were found to be marginally statistically significant in the Podosol topsoil and Vertosol subsoil. There are well known reasons why sedimentation methods may be considered to 'overestimate' plate-like clay particles, while laser diffraction will 'underestimate' the proportion of clay particles. In this study we used Lin's concordance correlation coefficient to determine the equivalence of laser diffraction and sieve plummet balance results. The results suggested that the laser diffraction equivalent thresholds corresponding to the sieve plummet balance cumulative particle sizes of < 2 mu m, < 20 mu m, and < 200 mu m, were < 9 mu m, < 26 mu m, < 275 mu m respectively. The many advantages of laser diffraction for soil particle size analysis, and the empirical results of this study, suggest that deployment of laser diffraction as a standard test procedure can provide reliable results, provided consistent sample preparation is used.	[Fisher, Peter; Aumann, Colin; Chia, Kohleth; O'Halloran, Nick; Chandra, Subhash] Dept Econ Dev Jobs Transport & Resources, Agr Res & Dev Div, Tatura, Vic, Australia		Fisher, P (corresponding author), Dept Econ Dev Jobs Transport & Resources, Agr Res & Dev Div, Tatura, Vic, Australia.	peter.fisher@ecodev.vic.gov.au	Fisher, Peter/T-4121-2019		Victorian Department of Economic Development, Jobs, Transport Resources	Victorian Department of Economic Development, Jobs, Transport Resources	The research was undertaken with funding from the Victorian Department of Economic Development, Jobs, Transport & Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; Allen, 1997, POWDER SAMPLING PART; Altman D.G., 1990, PRACTICAL STAT MED R, DOI DOI 10.1201/9780429258589; [Anonymous], 2002, D11277 ISO; Arriaga FJ, 2006, SOIL SCI, V171, P663, DOI 10.1097/01.ss.0000228056.92839.88; Blott SJ, 2006, SEDIMENTOLOGY, V53, P671, DOI 10.1111/j.1365-3091.2006.00786.x; Buurman P, 2001, GEOL MIJNBOUW-N J G, V80, P49, DOI 10.1017/S0016774600022319; Buurman P, 1997, SOIL SCI, V162, P211, DOI 10.1097/00010694-199703000-00007; Cheshire MV, 2000, EUR J SOIL SCI, V51, P497, DOI 10.1111/j.1365-2389.2000.00325.x; Cochran W.G., 1967, STAT METHODS; Di Stefano C, 2010, BIOSYST ENG, V106, P205, DOI 10.1016/j.biosystemseng.2010.03.013; Emerson WW, 2000, AUST J SOIL RES, V38, P203, DOI 10.1071/SR97105; Ernst MD, 2004, PERMUTATION METHODS, P676; Eshel G, 2004, SOIL SCI SOC AM J, V68, P736, DOI 10.2136/sssaj2004.0736; Fedotov GN, 2007, EURASIAN SOIL SCI+, V40, P281, DOI 10.1134/S1064229307030064; Galwey N. W., 2014, INTRO MIXED MODELLIN; GEE GW, 1979, SOIL SCI SOC AM J, V43, P1004, DOI 10.2136/sssaj1979.03615995004300050038x; Goossens D, 2008, SEDIMENTOLOGY, V55, P65, DOI 10.1111/j.1365-3091.2007.00893.x; GUGGENHEIM S, 1995, CLAY CLAY MINER, V43, P255, DOI 10.1346/CCMN.1995.0430213; Hall AD, 1904, J CHEM SOC, V85, P950, DOI 10.1039/ct9048500950; Hutton JT, 1955, 11 CSIRO DIV SOILS; Isbell R.F., 2002, AUSTR SOIL CLASSIFIC; Kerry R, 2009, GEODERMA, V152, P324, DOI 10.1016/j.geoderma.2009.06.018; Konert M, 1997, SEDIMENTOLOGY, V44, P523, DOI 10.1046/j.1365-3091.1997.d01-38.x; Kowalenko CG, 2013, GEODERMA, V193, P22, DOI 10.1016/j.geoderma.2012.09.006; Lin L., 2000, BIOMETRICS, V56, P324, DOI [10.1111/j.0006-341X.2000.00324.x, DOI 10.1111/J.0006-341X.2000.00324.X]; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lu N, 2000, GEOTECH TEST J, V23, P487; Ma ZH, 2000, POWDER TECHNOL, V111, P66, DOI 10.1016/S0032-5910(00)00242-4; MARSHALL T. J., 1956, AUSTRALIAN JOUR APPL SCI, V7, P142; Mason C., 2011, NMBAQCS BEST PRACTIC; Matthews MD, 1991, PRINCIPLES METHODS A; Mcintyre D, 1974, METHODS ANAL IRRIGAT, V11; MIKHAIL EH, 1978, AUST J SOIL RES, V16, P241, DOI 10.1071/SR9780241; Mikutta R, 2005, SOIL SCI SOC AM J, V69, P120, DOI 10.2136/sssaj2005.0120; Miller BA, 2012, SOIL SCI SOC AM J, V76, P1719, DOI 10.2136/sssaj2011.0303; Miller W.P., 1988, J AGRONOMY ED, V17, P24; NELSON DW, 1973, AGRON J, V65, P109, DOI 10.2134/agronj1973.00021962006500010033x; OMUETI JAI, 1980, SOIL SCI SOC AM J, V44, P878, DOI 10.2136/sssaj1980.03615995004400040044x; Ozer M, 2010, ENVIRON ENG GEOSCI, V16, P163, DOI 10.2113/gseegeosci.16.2.163; Pabst W, 2000, J EUR CERAM SOC, V20, P1429, DOI 10.1016/S0955-2219(00)00016-9; Payne R, 2016, GENSTAT WINDOWS INTR; Pearson K., 1896, P ROY SOC LONDON, V60, P489, DOI DOI 10.1098/RSPL.1896.0076; Piper C.S, 1942, SOIL PLANT ANAL LAB; Rayment G.E., 1992, AUSTR SOIL LAND SURV; Roberson S, 2014, SEDIMENTOLOGY, V61, P1157, DOI 10.1111/sed.12093; Ryzak M, 2011, J PLANT NUTR SOIL SC, V174, P624, DOI 10.1002/jpln.201000255; Scealy JL, 2014, AUST NZ J STAT, V56, P145, DOI 10.1111/anzs.12073; Scott-Jackson JE, 2005, J ARCHAEOL SCI, V32, P969, DOI 10.1016/j.jas.2005.01.013; SHELDRICK BH, 1976, CAN J SOIL SCI, V56, P55, DOI 10.4141/cjss76-008; SLAGER S, 1964, SEDIMENTOLOGY, V3, P240, DOI 10.1111/j.1365-3091.1964.tb00463.x; Sochan A, 2015, SOIL SCI SOC AM J, V79, P37, DOI 10.2136/sssaj2013.07.0308n; Sperazza M, 2004, J SEDIMENT RES, V74, P736, DOI 10.1306/031104740736; Standards Australia, 2003, 1289332003 AS; Vdovic N, 2010, EUR J SOIL SCI, V61, P854, DOI 10.1111/j.1365-2389.2010.01298.x; Watson DF., 1989, MATH GEOL, V21, P233, DOI 10.1007/bf00893217; WEIPENG W, 2015, PLOS ONE, V0010; Zobeck TM, 2004, APPL ENG AGRIC, V20, P633	58	65	67	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176510	10.1371/journal.pone.0176510	http://dx.doi.org/10.1371/journal.pone.0176510			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472043	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500049
J	He, JB; Chen, YH; Lin, Y; Zhang, WY; Cai, YJ; Chen, F; Liao, QH; Yin, ZH; Wang, Y; Tao, SB; Lin, XL; Huang, PR; Cui, LL; Shao, YM				He, Junbing; Chen, Yuhua; Lin, Yao; Zhang, Wenying; Cai, Yujie; Chen, Feng; Liao, Qinghui; Yin, Zihan; Wang, Yan; Tao, Shoubao; Lin, Xiaoli; Huang, Pengru; Cui, Lili; Shao, Yiming			Association study of MCP-1 promoter polymorphisms with the susceptibility and progression of sepsis	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; SINGLE-NUCLEOTIDE POLYMORPHISMS; CHEMOTACTIC PROTEIN-1; SEPTIC SHOCK; GENETIC POLYMORPHISMS; MICE; RECRUITMENT; CHEMOKINES; CYTOKINES; SEVERITY	Previous studies have indicated that the monocyte chemo-attractant protein 1 (MCP-1), also referred to as C-C motif chemokine ligand 2 (CCL2), plays a significant role in the pathogenesis of sepsis, and this study investigated the clinical relevance of two MCP-1 gene polymorphisms on sepsis onset and progression. The Multiplex SNaPshot genotyping method was used to detect MCP-1 gene polymorphisms in the Chinese Han population (403 sepsis patients and 400 controls). MCP-1 mRNA expression levels were measured using real-time quantitative PCR, and enzyme-linked immunosorbent assays were used to analyze MCP-1, tumor necrosis factor-alpha (TNF-alpha), interleukin 6 (IL-6) and interleukin-1 beta (IL-1 beta) plasma concentrations. The rs1024611 polymorphism analysis showed lower frequencies of minor homozygous genotype (AA) and allele (A) in sepsis patients compared to the healthy controls (19.4% vs. 31.5%, P = 0.0001 and 45.9% vs. 54.8%, P = 0.0004, respectively). And the frequencies of GG genotype and G allele were lower in sepsis patients compared to the controls (19.6% vs. 31.3%, P = 0.0002 and 46.0% vs. 54.5%, P = 0.0007, respectively). The rs1024611 AG/GG and rs2857656 GC/CC genotypes were both overrepresented in patients with severe sepsis (both P = 0.0005) and septic shock (P = 0.010 and P = 0.015, respectively) compared to the patients with mild sepsis. Moreover, among sepsis patients, the rs1024611 AG/GG and rs2857656 GC/CC carriers exhibited significant increases in expression levels of MCP-1 (P = 0.025), TNF-alpha (P = 0.034) and IL-6 (P = 0.043) compared with the rs1024611 AA or rs2857656 GG carriers. This study provides valuable clinical evidence that the MCP-1/CCL2 polymorphisms rs1024611 and rs2857656 are associated with sepsis susceptibility and development. We conclude that MCP-1/CCL2 plays a significant role in the pathogenesis of sepsis, which has potentially important therapeutic implications.	[He, Junbing; Zhang, Wenying; Chen, Feng; Yin, Zihan; Tao, Shoubao; Shao, Yiming] Guangdong Med Univ, Affiliated Hosp, Guangdong Key Lab Age Related Cardiac & Cerebral, Intens Care Unit, Zhanjiang, Guangdong, Peoples R China; [Chen, Yuhua; Liao, Qinghui] Longgang Dist Peoples Hosp Shenzhen, Dept Endocrinol & Metab, Shenzhen, Guangdong, Peoples R China; [Lin, Yao; Lin, Xiaoli] Sun Yat Sen Univ, Jieyang Affiliated Hosp, Dept Stomatol, Jieyang, Guangdong, Peoples R China; [Cai, Yujie; Wang, Yan; Huang, Pengru; Cui, Lili] Guangdong Med Univ, Affiliated Hosp, Guangdong Key Lab Age Related Cardiac & Cerebral, Inst Neurol, Zhanjiang, Guangdong, Peoples R China	Guangdong Medical University; Sun Yat Sen University; Guangdong Medical University	Shao, YM (corresponding author), Guangdong Med Univ, Affiliated Hosp, Guangdong Key Lab Age Related Cardiac & Cerebral, Intens Care Unit, Zhanjiang, Guangdong, Peoples R China.; Cui, LL (corresponding author), Guangdong Med Univ, Affiliated Hosp, Guangdong Key Lab Age Related Cardiac & Cerebral, Inst Neurol, Zhanjiang, Guangdong, Peoples R China.	cuilili@gdmu.edu.cn; yimingshao_gmc@126.com	, YoMo/AGX-5555-2022	, YoMo/0000-0003-0273-2531	National Nature Science Foundation of China [81471326, 81301038, 81401061]; special competitive assignment funds of Zhanjiang City [2016A01026]; Startup Fund of Affiliated Hospital of Guangdong Medical College [BJ201507]; Health Science and Technology Funds of Longgang District, Shenzhen City [20160612104602724]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); special competitive assignment funds of Zhanjiang City; Startup Fund of Affiliated Hospital of Guangdong Medical College; Health Science and Technology Funds of Longgang District, Shenzhen City	This work was supported by funding from the National Nature Science Foundation of China (81471326, 81301038 and 81401061), the special competitive assignment fiscal funds of Zhanjiang City (2016A01026), the PhD Startup Fund of Affiliated Hospital of Guangdong Medical College (BJ201507), and the Health Science and Technology Funds of Longgang District, Shenzhen City (20160612104602724).	Aguilar F, 2001, TISSUE ANTIGENS, V58, P335, DOI 10.1034/j.1399-0039.2001.580508.x; BOSSINK AWJ, 1995, BLOOD, V86, P3841, DOI 10.1182/blood.V86.10.3841.bloodjournal86103841; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Cui LL, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0796-x; Da LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082855; Damas JK, 2001, BASIC RES CARDIOL, V96, P345, DOI 10.1007/s003950170042; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Guo CF, 2014, DIAGN MICR INFEC DIS, V78, P49, DOI 10.1016/j.diagmicrobio.2013.07.024; Han YL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035506, 10.1371/journal.pone.0048966]; Hanemann ALP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080421; Holtkamp GM, 1999, CLIN EXP IMMUNOL, V118, P35; Hotchkiss RS, 2015, SCIENCE, V347, P1201, DOI 10.1126/science.aaa8334; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kimura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091522; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Labbe K, 2010, CRIT CARE, V14, DOI 10.1186/cc9295; Li YW, 2015, J DIGEST DIS, V16, P177, DOI 10.1111/1751-2980.12232; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Matsukawa A, 2000, EXP MOL PATHOL, V68, P77, DOI 10.1006/exmp.1999.2296; Namath A, 2011, CRIT CARE NURS CLIN, V23, P181, DOI 10.1016/j.ccell.2010.12.011; Nyquist P, 2010, CEREBROVASC DIS, V29, P242, DOI 10.1159/000267849; Nyquist PA, 2009, CEREBROVASC DIS, V28, P124, DOI 10.1159/000223437; Ozyurek AR, 2007, CLIN RHEUMATOL, V26, P546, DOI 10.1007/s10067-006-0347-6; Palmieri O, 2010, AM J GASTROENTEROL, V105, P1586, DOI 10.1038/ajg.2010.4; Ping DS, 1996, IMMUNITY, V4, P455, DOI 10.1016/S1074-7613(00)80412-4; Ramnath RD, INT IMMUNOPHARMACOL; Rovin BH, 1999, BIOCHEM BIOPH RES CO, V259, P344, DOI 10.1006/bbrc.1999.0796; Salama MK, 2014, WORLD J GASTROENTERO, V20, P11793, DOI 10.3748/wjg.v20.i33.11793; Shao Y, 2017, CLIN GENET, V91, P564, DOI 10.1111/cge.12800; Shao YM, 2016, CELL PHYSIOL BIOCHEM, V39, P1247, DOI 10.1159/000447830; Shimada T, 2011, CYTOKINE, V54, P79, DOI 10.1016/j.cyto.2010.12.001; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sipahi T, 2006, CLIN APPL THROMB-HEM, V12, P47, DOI 10.1177/107602960601200108; Slimani H, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0527-8; Speyer CL, 2004, AM J PATHOL, V165, P2187, DOI 10.1016/S0002-9440(10)63268-3; Suffredini AF, 2011, JAMA-J AM MED ASSOC, V306, P194, DOI 10.1001/jama.2011.909; Szakmany T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167230; Taub Dennis D., 1996, Cytokine and Growth Factor Reviews, V7, P355, DOI 10.1016/S1359-6101(97)89237-4; Thye T, 2009, HUM MOL GENET, V18, P381, DOI 10.1093/hmg/ddn352; Tsuda Y, 2004, J LEUKOCYTE BIOL, V76, P368, DOI 10.1189/jlb.1203645; Turler A, 2002, AM J PHYSIOL-GASTR L, V282, pG145, DOI 10.1152/ajpgi.00263.2001; UEDA A, 1994, J IMMUNOL, V153, P2052; Valente AJ, 1998, J IMMUNOL, V161, P3719; Walczak Anna, 2012, Pol Przegl Chir, V84, P238, DOI 10.2478/v10035-012-0039-7; Zhang HL, 2007, AM J PHYSIOL-LUNG C, V292, pL960, DOI 10.1152/ajplung.00388.2006; Ziraldo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079804	51	21	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176781	10.1371/journal.pone.0176781	http://dx.doi.org/10.1371/journal.pone.0176781			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472164	Green Submitted, gold, Green Published			2022-12-26	WOS:000400648500071
J	Kroeger, T; Frieg, B; Zhang, T; Hansen, FK; Marmann, A; Proksch, P; Nagel-Steger, L; Groth, G; Smits, SHJ; Gohlke, H				Kroeger, Tobias; Frieg, Benedikt; Zhang, Tao; Hansen, Finn K.; Marmann, Andreas; Proksch, Peter; Nagel-Steger, Luitgard; Groth, Georg; Smits, Sander H. J.; Gohlke, Holger			EDTA aggregates induce SYPRO orange-based fluorescence in thermal shift assay	PLOS ONE			English	Article							DIFFERENTIAL SCANNING FLUOROMETRY; RANGE ELECTROSTATIC INTERACTIONS; MOLECULAR-DYNAMICS SIMULATIONS; X-RAY; TEMPERATURE-DEPENDENCE; PROTEIN; BINDING; SODIUM; WATER; FIBRINOGEN	Ethylenediaminetetraacetic acid (EDTA) is widely used in the life sciences as chelating ligand of metal ions. However, formation of supramolecular EDTA aggregates at pH > 8 has been reported, which may lead to artifactual assay results. When applied as a buffer component at pH approximate to 10 in differential scanning fluorimetry (TSA) using SYPRO Orange as fluorescent dye, we observed a sharp change in fluorescence intensity about 20 degrees C lower than expected for the investigated protein. We hypothesized that this change results from SYPRO Orange/EDTA interactions. TSA experiments in the presence of SYPRO Orange using solutions that contain EDTA-Na+ but no protein were performed. The TSA experiments provide evidence that suggests that at pH > 9, EDTA(4-) interacts with SYPRO Orange in a temperature-dependent manner, leading to a fluorescence signal yielding a "denaturation temperature" of similar to 68 degrees C. Titrating Ca2+ to SYPRO Orange and EDTA solutions quenched fluorescence. Ethylene glycol tetraacetic acid (EGTA) behaved similarly to EDTA. Analytical ultracentrifugation corroborated the formation of EDTA aggregates. Molecular dynamics simulations of free diffusion of EDTA-Na+ and SYPRO Orange of in total 27 mu s suggested the first structural model of EDTA aggregates in which U-shaped EDTA(4-) arrange in an inverse bilayer-like manner, exposing ethylene moieties to the solvent, with which SYPRO Orange interacts. We conclude that EDTA aggregates induce a SYPRO Orange-based fluorescence in TSA. These results make it relevant to ascertain that future TSA results are not influenced by interference between EDTA, or EDTA-related molecules, and the fluorescent dye.	[Kroeger, Tobias; Frieg, Benedikt; Hansen, Finn K.; Gohlke, Holger] Heinrich Heine Univ Dusseldorf, Inst Pharmaceut & Med Chem, Dusseldorf, Germany; [Zhang, Tao; Nagel-Steger, Luitgard] Heinrich Heine Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany; [Zhang, Tao; Nagel-Steger, Luitgard] Forschungszentrum Julich, Inst Complex Syst Struct Biochem ICS 6, Julich, Germany; [Marmann, Andreas; Proksch, Peter] Heinrich Heine Univ Dusseldorf, Inst Pharmaceut Biol & Biotechnol, Dusseldorf, Germany; [Groth, Georg] Heinrich Heine Univ Dusseldorf, Inst Biochem Plant Physiol, Dusseldorf, Germany; [Smits, Sander H. J.] Heinrich Heine Univ Dusseldorf, Inst Biochem, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Gohlke, H (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Pharmaceut & Med Chem, Dusseldorf, Germany.	gohlke@uni-duesseldorf.de	Zhang, Tao/O-6541-2019; Nagel-Steger, Luitgard/H-6415-2013; Proksch, Peter/AAR-4593-2020	Zhang, Tao/0000-0003-2970-0468; Nagel-Steger, Luitgard/0000-0001-5232-2149; Hansen, Finn Kristian/0000-0001-9765-5975; Frieg, Benedikt/0000-0002-7877-0262	Deutsche Forschungsgemeinschaft (DFG) [INST 208/704-1 FUGG]; Deutsche Forschungsgemeinschaft (DFG) through the Graduate School ("Natural products and natural product analogs against therapy resistant tumors and microorganisms: new lead structures and modes of action", Dusseldorf) [GRK2158]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG) through the Graduate School ("Natural products and natural product analogs against therapy resistant tumors and microorganisms: new lead structures and modes of action", Dusseldorf)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) by funds (INST 208/704-1 FUGG) to purchase the hybrid computer cluster used in this study, and the Deutsche Forschungsgemeinschaft (DFG) through the Graduate School GRK2158 ("Natural products and natural product analogs against therapy resistant tumors and microorganisms: new lead structures and modes of action", Dusseldorf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassopoulou J, 2012, INFRARED SPECTROSCOPY - LIFE AND BIOMEDICAL SCIENCES, P259; AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; Aziz EF, 2008, J PHYS CHEM B, V112, P12567, DOI 10.1021/jp805177v; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Boonyarattanakalin K, 2015, SCI PHARM, V83, P387, DOI 10.3797/scipharm.1412-08; Bradbrook GM, 1998, J CHEM SOC FARADAY T, V94, P1603, DOI 10.1039/a800429c; Carballo-Pacheco M, 2016, J PHYS CHEM B, V120, P2991, DOI 10.1021/acs.jpcb.6b00059; Case DA, 2014, AMBER 14; Case DA, 2012, AMBER 12; Chen CY, 2015, J PHYS CHEM LETT, V6, P2733, DOI 10.1021/acs.jpclett.5b01134; Cheng SY, 2016, DATA BRIEF, V7, P658, DOI 10.1016/j.dib.2016.03.015; Cherif S, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-221; Ciglia E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096031; Cimmperman P, 2008, BIOPHYS J, V95, P3222, DOI 10.1529/biophysj.108.134973; Collins KD, 1997, BIOPHYS J, V72, P65, DOI 10.1016/S0006-3495(97)78647-8; Corradini D, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4930542; DANG LX, 1992, J CHEM PHYS, V97, P1919, DOI 10.1063/1.463128; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Darden T, 1998, J CHEM PHYS, V109, P10921, DOI 10.1063/1.477788; Diedrich D, 2016, CHEM D EUR J; Dorn T, 2006, NEW J CHEM, V30, P156, DOI 10.1039/b510617f; Dror RO, 2012, ANNU REV BIOPHYS, V41, P429, DOI 10.1146/annurev-biophys-042910-155245; Elber R, 2005, CURR OPIN STRUC BIOL, V15, P151, DOI 10.1016/j.sbi.2005.02.004; Elcock AH, 1998, J MOL BIOL, V284, P489, DOI 10.1006/jmbi.1998.2159; Fedorov MV, 2009, J AM CHEM SOC, V131, P10854, DOI 10.1021/ja9030374; Forneris F, 2009, FEBS J, V276, P2833, DOI 10.1111/j.1742-4658.2009.07006.x; Frieg B, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004693; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Han S., 2007, J CHEM-NY, V1, P1; HARRISON DG, 1968, J PHYSIOL-LONDON, V199, P367, DOI 10.1113/jphysiol.1968.sp008658; Haugland RP, 1996, World patent, Patent No. [WO96368821996, 96368821996]; Hess B, 2009, P NATL ACAD SCI USA, V106, P13296, DOI 10.1073/pnas.0902904106; Huynh Kathy, 2015, Curr Protoc Protein Sci, V79, DOI 10.1002/0471140864.ps2809s79; Jager CM, 2010, LANGMUIR, V26, P10460, DOI 10.1021/la9038123; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joubert MK, 2011, J BIOL CHEM, V286, P25118, DOI 10.1074/jbc.M110.160457; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Kang I, 1999, FEBS LETT, V462, P89, DOI 10.1016/S0014-5793(99)01509-4; Keshwani N, 2013, BIOPHYS J, V105, P1681, DOI 10.1016/j.bpj.2013.08.018; Kohagen M, 2014, J PHYS CHEM B, V118, P7902, DOI 10.1021/jp5005693; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; MacGregor IK, 2004, BIOPHYS CHEM, V108, P165, DOI 10.1016/j.bpc.2003.10.018; Maestro v Schrodinger LLC New York, 2013, MAESTR VERS 9 5; Martinez L, 2009, J COMPUT CHEM, V30, P2157, DOI 10.1002/jcc.21224; Mobasheri M, 2016, MOLECULES, V21, DOI 10.3390/molecules21010006; Mountain RD, 2015, J SOLUTION CHEM, V44, P2179, DOI 10.1007/s10953-015-0401-6; MULLER M, 1994, FEBS LETT, V340, P17, DOI 10.1016/0014-5793(94)80164-9; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; NIEUWENHUIZEN W, 1981, THROMB RES, V22, P659, DOI 10.1016/0049-3848(81)90064-5; Panneerselvam S, 2015, MOLECULES, V20, P14915, DOI 10.3390/molecules200814915; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Paschek D, 2004, J CHEM PHYS, V120, P6674, DOI 10.1063/1.1652015; Patel TR, 2016, METHODS, V95, P55, DOI 10.1016/j.ymeth.2015.11.006; PERIZZOLO KE, 1985, ARCH BIOCHEM BIOPHYS, V237, P520, DOI 10.1016/0003-9861(85)90305-4; RAAFLAUB J, 1956, Methods Biochem Anal, V3, P301; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Rosenlehner K, 2010, CHEM-EUR J, V16, P9544, DOI 10.1002/chem.201001150; ROTI JLR, 1985, CYTOMETRY, V6, P101, DOI 10.1002/cyto.990060204; Saeki K, 2007, J BIOSCI BIOENG, V103, P501, DOI 10.1263/jbb.103.501; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; SANDO JJ, 1979, J BIOL CHEM, V254, P4779; Satoh M, 2015, FEBS OPEN BIO, V5, P557, DOI 10.1016/j.fob.2015.06.011; Schafmeister CEAF, 1995, U CALIFORNIA; Steinberg TH, 1996, ANAL BIOCHEM, V239, P223, DOI 10.1006/abio.1996.0319; Steinberg TH, 2009, METHOD ENZYMOL, V463, P541, DOI 10.1016/S0076-6879(09)63031-7; Vrbka L, 2006, P NATL ACAD SCI USA, V103, P15440, DOI 10.1073/pnas.0606959103; Wan KF, 2009, CELL CYCLE, V8, P3943, DOI 10.4161/cc.8.23.10114; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wichmann C, 2010, BLOOD, V116, P603, DOI 10.1182/blood-2009-10-248047; Wildman J, 2016, J CHEM THEORY COMPUT, V12, P3813, DOI 10.1021/acs.jctc.5b01195; Yeh AP, 2006, BIOL CRYSTALLOGRAP 4, V62, P451; YORK DM, 1993, J CHEM PHYS, V99, P8345, DOI 10.1063/1.465608	72	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177024	10.1371/journal.pone.0177024	http://dx.doi.org/10.1371/journal.pone.0177024			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472107	Green Published, gold, Green Submitted			2022-12-26	WOS:000400648500123
J	Li, XW; Xu, HX; Feng, L; Fu, X; Zhang, YL; Nansen, C				Li, Xiaowei; Xu, Hongxing; Feng, Ling; Fu, Xiao; Zhang, Yalin; Nansen, Christian			Using proximal remote sensing in non-invasive phenotyping of invertebrates	PLOS ONE			English	Article							IDENTIFICATION; PHENOMICS; EYES	Proximal imaging remote sensing technologies are used to phenotype and to characterize organisms based on specific external body reflectance features. These imaging technologies are gaining interest and becoming more widely used and applied in ecological, systematic, evolutionary, and physiological studies of plants and also of animals. However, important factors may impact the quality and consistency of body reflectance features and therefore the ability to use these technologies as part of non-invasive phenotyping and characterization of organisms. We acquired hyperspectral body reflectance profiles from three insect species, and we examined how preparation procedures and preservation time affected the ability to detect reflectance responses to gender, origin, and age. Different portions of the radiometric spectrum varied markedly in their sensitivity to preparation procedures and preservation time. Based on studies of three insect species, we successfully identified specific radiometric regions, in which phenotypic traits become significantly more pronounced based on either: 1) gentle cleaning of museum specimens with distilled water, or 2) killing and preserving insect specimens in 70% ethanol. Standardization of killing and preservation procedures will greatly increase the ability to use proximal imaging remote sensing technologies as part of phenotyping and also when used in ecological and evolutionary studies of invertebrates.	[Li, Xiaowei; Xu, Hongxing; Nansen, Christian] Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China; [Feng, Ling; Fu, Xiao; Zhang, Yalin] Northwest A&F Univ, Key Lab Plant Protect Resources & Pest Management, Minist Educ, Entomol Museum, Yangling, Shaanxi, Peoples R China; [Nansen, Christian] Univ Calif Davis, Dept Entomol & Nematol, Briggs Hall, Davis, CA 95616 USA	Zhejiang Academy of Agricultural Sciences; Northwest A&F University - China; University of California System; University of California Davis	Nansen, C (corresponding author), Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China.; Nansen, C (corresponding author), Univ Calif Davis, Dept Entomol & Nematol, Briggs Hall, Davis, CA 95616 USA.	chrnansen@ucdavis.edu	nansen, christian/H-5003-2014	nansen, christian/0000-0003-1324-1949	National Natural Science Foundation of China [31570387]; National Key Research AMP; Development (RAMP;D) Plan of China; State Key Laboratory Breeding Base for Zhejiang Sustainable Pest and Disease Control [2010DS700124-ZM1601, 2010DS700124-ZZ1601, 2010DS700124-KF1603]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research AMP; Development (RAMP;D) Plan of China; State Key Laboratory Breeding Base for Zhejiang Sustainable Pest and Disease Control	We would like to thank Dr. Mielewczik and an anonymous reviewer for their careful reviews of an early version of this study. This work was supported by the National Natural Science Foundation of China (grant number 31570387), the National Key Research & Development (R&D) Plan of China (Synergistic technologies for biological pesticides and mechanisms of ecological control of pests), and the State Key Laboratory Breeding Base for Zhejiang Sustainable Pest and Disease Control (grant number 2010DS700124-ZM1601, 2010DS700124-ZZ1601 and 2010DS700124-KF1603).r This work was supported by the National Natural Science Foundation of China (grant number 31570387), the National Key Research & Development (R&D) Plan of China (Synergistic technologies for biological pesticides and mechanisms of ecological control of pests), and the State Key Laboratory Breeding Base for Zhejiang Sustainable Pest and Disease Control (grant number 2010DS700124-ZM1601, 2010DS700124-ZZ1601 and 2010DS700124-KF1603).	Arbuckle T, 2002, INT S INF ENV PROT; Aw WC, 2012, G3-GENES GENOM GENET, V2, P1057, DOI 10.1534/g3.112.003103; Burleigh JG, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.085c713acafc8711b2ff7010a4b03733; Cao Y, 2015, PEST MANAG SCI, V71, P1113, DOI 10.1002/ps.3893; Chiao CC, 2011, P NATL ACAD SCI USA, V108, P9148, DOI 10.1073/pnas.1019090108; Chiao CC, 2009, J EXP BIOL, V212, P2269, DOI 10.1242/jeb.030734; Dowell FE, 1999, J ECON ENTOMOL, V92, P165, DOI 10.1093/jee/92.1.165; Faria FA, 2014, J VIS COMMUN IMAGE R, V25, P1516, DOI 10.1016/j.jvcir.2014.06.014; Fiorani F, 2013, ANNU REV PLANT BIOL, V64, P267, DOI 10.1146/annurev-arplant-050312-120137; Houle D, 2010, NAT REV GENET, V11, P855, DOI 10.1038/nrg2897; Jia FY, 2007, J ECON ENTOMOL, V100, P759, DOI 10.1603/0022-0493(2007)100[759:DTBACE]2.0.CO;2; Klarica J, 2011, J CHEM ECOL, V37, P549, DOI 10.1007/s10886-011-9956-x; Araus JL, 2014, TRENDS PLANT SCI, V19, P52, DOI 10.1016/j.tplants.2013.09.008; Luo CQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118554; Matzrafi M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00474; Mielewczik M., 2012, ENTOMOLOGIE BEUTE, V24, P183; Nansen C, 2016, J FOOD ENG, V190, P34, DOI 10.1016/j.jfoodeng.2016.06.010; Nansen C, 2016, ANNU REV ENTOMOL, V61, P139, DOI 10.1146/annurev-ento-010715-023834; Nansen C, 2016, PEST MANAG SCI, V72, P653, DOI 10.1002/ps.4209; Nansen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124866; Nansen C, 2015, J PHOTOCH PHOTOBIO B, V145, P19, DOI 10.1016/j.jphotobiol.2015.02.015; Nansen C, 2014, J EXP BIOL, V217, P1187, DOI 10.1242/jeb.095661; Nansen C, 2013, APPL SPECTROSC, V67, P1332, DOI 10.1366/12-06933; Nansen C, 2011, OPT EXPRESS, V19, P15173, DOI 10.1364/OE.19.015173; Nguyen CV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094346; Pinto F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073234; Singh CB, 2009, J STORED PROD RES, V45, P151, DOI 10.1016/j.jspr.2008.12.002; Singh CB, 2010, BIOSYST ENG, V105, P380, DOI 10.1016/j.biosystemseng.2009.12.009; Teixeira R, 2015, NEOTROP ENTOMOL, V44, P129, DOI 10.1007/s13744-015-0272-y; Voss SC, 2017, INT J LEGAL MED, V131, P263, DOI 10.1007/s00414-016-1458-5; Wang Y, 2016, ZOOLOGICAL J LINNEAN; Watson Anna T., 2003, Systematics and Biodiversity, V1, P287; White JW, 2012, FIELD CROP RES, V133, P101, DOI 10.1016/j.fcr.2012.04.003; Zhu L, 2014, J COMPUTATIONAL INFO, V10, P3031	34	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176392	10.1371/journal.pone.0176392	http://dx.doi.org/10.1371/journal.pone.0176392			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472152	Green Published, gold, Green Submitted			2022-12-26	WOS:000400648500044
J	Kang, SH; Do, JY; Lee, SY; Kim, JC				Kang, Seok Hui; Do, Jun Young; Lee, So-Young; Kim, Jun Chul			Effect of dialysis modality on frailty phenotype, disability, and health-related quality of life in maintenance dialysis patients	PLOS ONE			English	Article							PERITONEAL-DIALYSIS; KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS; REPLACEMENT THERAPY; INCIDENT PATIENTS; BODY-COMPOSITION; SURVEY SF-36; MORTALITY; IMPACT; HOSPITALIZATION	Background Health-related quality of life (HRQoL) surveys are needed to evaluate regional and ethnic specificies. The aim of the present study was to evaluate the differences in HRQoL, frailty, and disability according to dialysis modality in the Korean population. Patients and methods We enrolled relatively stable maintenance dialysis patients. A total of 1,616 patients were recruited into our study. The demographic and laboratory data collected at enrollment included age, sex, comorbidities, frailty, disability, and HRQoL scales. Results A total of 1,250 and 366 participants underwent hemodialysis (HD) and peritoneal dialysis (PD), respectively. The numbers of participants with pre-frailty and frailty were 578 (46.2%) and 422 (33.8%) in HD patients, and 165 (45.1%) and 137 (37.4%) in PD patients, respectively (P = 0.349). Participants with a disability included 195 (15.6%) HD patients and 109 (29.8%) PD patients (P < 0.001). On multivariate analysis, the mean physical component scale (PCS) and mental component scale (MCS), symptom/problems, and sleep scores were higher in HD patients than in PD patients. Cox regression analyses showed that an increased PCS in both HD and PD patients was positively associated with patient survival and first hospitalization-free survival. An increased MCS in both HD and PD patients was positively associated with first hospitalization-free survival only. Conclusion There was no significant difference in frailty between patients treated with the two dialysis modalities; however, disability was more common in PD patients than in HD patients. The MCS and PCS were more favorable in HD patients than in PD patients. Symptom/problems, sleep, quality of social interaction, and social support were more favorable in HD patients than in PD patients; however, patient satisfaction and dialysis staff encouragement were more favorable in PD patients than in HD patients.	[Kang, Seok Hui; Do, Jun Young] Yeungnam Univ Hosp, Dept Internal Med, Div Nephrol, Daegu, South Korea; [Lee, So-Young] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Internal Med,Div Nephrol, Seongnam, South Korea; [Kim, Jun Chul] CHA Univ, CHA Gumi Med Ctr, Dept Internal Med, Div Nephrol, Gumi, South Korea	Yeungnam University; Yeungnam University Hospital; Pochon Cha University; Pochon Cha University	Kim, JC (corresponding author), CHA Univ, CHA Gumi Med Ctr, Dept Internal Med, Div Nephrol, Gumi, South Korea.	truedoc1@hanmail.net			Medical Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2015R1A5A2009124]	Medical Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	This work was supported by the Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvares J, 2012, QUAL LIFE RES, V21, P983, DOI 10.1007/s11136-011-0013-6; Balasubramanian G, 2011, NEPHROL DIAL TRANSPL, V26, P1702, DOI 10.1093/ndt/gfq607; Boateng EA, 2011, J RENAL CARE, V37, P190, DOI 10.1111/j.1755-6686.2011.00244.x; Collins A., 2000, Journal of the American Society of Nephrology, V11, p227A; de Abreu MM, 2011, VALUE HEALTH, V14, pS119, DOI 10.1016/j.jval.2011.05.016; Diaz-Buxo JA, 2000, AM J KIDNEY DIS, V35, P293, DOI 10.1016/S0272-6386(00)70339-8; Grincenkov FRD, 2015, NEPHRON, V129, P97, DOI 10.1159/000369139; Friedman AN, 2010, J AM SOC NEPHROL, V21, P223, DOI 10.1681/ASN.2009020213; Griva K, 2014, QUAL LIFE RES, V23, P57, DOI 10.1007/s11136-013-0431-8; Hill KE, 2016, NEPHROLOGY CARLTON; Hsu J, 2008, CLIN J AM SOC NEPHRO, V3, P992, DOI 10.2215/CJN.00090108; Jin DC, 2015, P 35 ANN SPRING M KO, P117; Johansen KL, 2007, J AM SOC NEPHROL, V18, P2960, DOI 10.1681/ASN.2007020221; Johansen KL, 2013, SEMIN DIALYSIS, V26, P690, DOI 10.1111/sdi.12126; Juergensen E, 2006, CLIN J AM SOC NEPHRO, V1, P1191, DOI 10.2215/CJN.01220406; Jung HY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003795; Kalantar-Zadeh K, 2001, J AM SOC NEPHROL, V12, P2797, DOI 10.1681/ASN.V12122797; Karopadi AN, 2013, NEPHROL DIAL TRANSPL, V28, P2553, DOI 10.1093/ndt/gft214; Kim JC, 2013, J AM SOC NEPHROL, V24, P337, DOI 10.1681/ASN.2012010047; [Korean Society of Nephrology ESRD Registry Committee], 2017, CURR REN REPL THER K; Kutner NG, 2005, NEPHROL DIAL TRANSPL, V20, P2159, DOI 10.1093/ndt/gfh973; Lee SY, 2015, P 35 ANN SPRING M KO, P215; LEVINE J, 1990, AM J KIDNEY DIS, V15, P285, DOI 10.1016/S0272-6386(12)80073-4; Liem YS, 2007, VALUE HEALTH, V10, P390, DOI 10.1111/j.1524-4733.2007.00193.x; Lopes AA, 2003, AM J KIDNEY DIS, V41, P605, DOI 10.1053/ajkd.2003.50122; Lowrie EG, 2003, AM J KIDNEY DIS, V41, P1286, DOI 10.1016/S0272-6386(03)00361-5; Mazairac AHA, 2013, CLIN J AM SOC NEPHRO, V8, P82, DOI 10.2215/CJN.00010112; McAdams-DeMarco MA, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-224; McAdams-DeMarco MA, 2013, J AM GERIATR SOC, V61, P896, DOI 10.1111/jgs.12266; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Michels WM, 2011, PERITON DIALYSIS INT, V31, P138, DOI 10.3747/pdi.2010.00063; Mozes B, 1997, J CLIN EPIDEMIOL, V50, P1035, DOI 10.1016/S0895-4356(97)00127-3; Osthus TBH, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-46; Park HJ, 2007, TOHOKU J EXP MED, V211, P321, DOI 10.1620/tjem.211.321; Park J. H., 1995, J KOREAN NEUROPSYCHI, V34, P475; Pecoits R, 2002, NEPHROL DIAL TRANSPL, V17, P28, DOI 10.1093/ndt/17.suppl_11.28; Roshanravan B, 2012, AM J KIDNEY DIS, V60, P912, DOI 10.1053/j.ajkd.2012.05.017; Rubin HR, 2004, JAMA-J AM MED ASSOC, V291, P697, DOI 10.1001/jama.291.6.697; Turkmen K, 2014, RENAL FAILURE, V36, P859, DOI 10.3109/0886022X.2014.899874; U.S. Renal Data System, 2015, USRDS 2015 ANN DAT R; van Biesen W, 2013, NEPHROL DIAL TRANSPL, V28, P2620, DOI 10.1093/ndt/gft296; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wasserfallen JB, 2004, NEPHROL DIAL TRANSPL, V19, P1594, DOI 10.1093/ndt/gfh175; Woods NF, 2005, J AM GERIATR SOC, V53, P1321, DOI 10.1111/j.1532-5415.2005.53405.x; Wu AW, 2004, J AM SOC NEPHROL, V15, P743, DOI 10.1097/01.ASN.0000113315.81448.CA	45	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176814	10.1371/journal.pone.0176814	http://dx.doi.org/10.1371/journal.pone.0176814			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SB	28467472	gold, Green Published, Green Submitted			2022-12-26	WOS:000400647000076
J	Ncogo, P; Romay-Barja, M; Benito, A; Aparicio, P; Nseng, G; Berzosa, P; Santana-Morales, MA; Riloha, M; Valladares, B; Herrador, Z				Ncogo, Policarpo; Romay-Barja, Maria; Benito, Agustin; Aparicio, Pilar; Nseng, Gloria; Berzosa, Pedro; Santana-Morales, Maria A.; Riloha, Matilde; Valladares, Basilio; Herrador, Zaida			Prevalence of anemia and associated factors in children living in urban and rural settings from Bata District, Equatorial Guinea, 2013	PLOS ONE			English	Article							PRESCHOOL-CHILDREN; NUTRITIONAL-STATUS; MALARIA; BURDEN; AFRICA; MALNUTRITION; INFECTIONS; ISLAND; AGE	Anemia in children under 5 years of age is a global public health problem. According to the World Health Organization the current rate of anemia among preschool aged children in Equatorial Guinea is 66%. No information is available above this age. The cross-sectional Prevamal Survey was conducted in 2013 aimed at providing baseline data on malaria prevalence in children aged 2 months-15 years old. Sampling was carried out with the use of a multistage, stratified cluster strategy in the district of Bata, Equatorial Guinea. The chi(2) test and adjusted Poisson regression models were applied to assess the association between social-demographic and economic factors, malaria and anemia. A total of 1436 children were tested, out of which 1,421 children (99%) were tested for anemia. Over 85% were anemic; out of them, 284 (24%), 815 (67%) and 111 (9%) children had mild, moderate and severe anemia, respectively. Severe anemia was more frequent among children aged 2 - 12 months old and those living in rural sites. About 47% tested positive for malaria via a rapid diagnostic test (RDT). This rate was significantly higher in rural villages (66%; p< 0.001). The prevalence of anemia and malaria was higher in rural settings (p< 0.001). On the other hand, anemia in urban areas displayed a heterogeneity and complexity that differed from the rural environment: in urban neighbourhoods, children with concomitant malaria infection were more likely to be anemic (adjusted prevalence rate (aPR): 1.19; CI 95%: 1.12 - 1.28). Moreover, the prevalence of anemia was higher in children aged above 13 months compared to younger children (p< 0.005). Belonging to the poorest wealth tertile were positively (aPR: 1.14, 95% CI: 1.05 - 1.24) and children' parents being employees (aPR: 0.86, 95% CI: 0.76 - 0.96) or self-employed (aPR: 0.86, 95% CI: 0.76 - 0.97) vs. working in agriculture and/or fishing negatively associated with anemia among urban children. This marked urban-rural variation indicates the importance of targeting specific areas or districts. Strategies aimed at reducing malaria are clearly paramount in this country. Prevention and treatment of other factors associated with the etiology of anemia (e.g., iron deficiency) are also likely necessary to combat the burden of anemia in Equatorial Guinea.	[Ncogo, Policarpo] CRCE, Malabo, Equat Guinea; [Romay-Barja, Maria; Benito, Agustin; Aparicio, Pilar; Berzosa, Pedro; Herrador, Zaida] Inst Salud Carlos III ISCIII, Natl Ctr Trop Med, Madrid, Spain; [Romay-Barja, Maria; Benito, Agustin; Aparicio, Pilar; Berzosa, Pedro; Santana-Morales, Maria A.; Valladares, Basilio; Herrador, Zaida] Spanish Trop Dis Res Network RICET Spanish, Madrid, Spain; [Nseng, Gloria; Riloha, Matilde] Minist Hlth & Social Welf, Malabo, Equat Guinea; [Santana-Morales, Maria A.; Valladares, Basilio] Univ La Laguna, Inst Univ Enfermedades Trop & Salud Publ Canarias, San Cristobal la Laguna, Canary Islands, Spain	Instituto de Salud Carlos III; Centro Nacional de Medicina Tropical (CNMT); Universidad de la Laguna	Herrador, Z (corresponding author), Inst Salud Carlos III ISCIII, Natl Ctr Trop Med, Madrid, Spain.; Herrador, Z (corresponding author), Spanish Trop Dis Res Network RICET Spanish, Madrid, Spain.	zherrador@isciii.es		Herrador, Zaida/0000-0002-6508-3818; Romay-Barja, Maria/0000-0002-0177-6885; Berzosa, Pedro/0000-0002-8768-717X; Benito, Agustin/0000-0001-8229-5540	Agencia Espanola de Cooperacion Internacional AECID [TREG1415/11]; Tropical Diseases Research Network [RD06/0021/0000]	Agencia Espanola de Cooperacion Internacional AECID; Tropical Diseases Research Network	This study was funding by the Agencia Espanola de Cooperacion Internacional AECID http://www.aecid.es/ES TREG1415/11 and the Tropical Diseases Research Network RD06/0021/0000; RICET http://www.ricet.es/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, WHO TECHN REP SER; Austin AM, 2012, MATERN CHILD NUTR, V8, P522, DOI 10.1111/j.1740-8709.2011.00339.x; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bhaskaram P, 2002, NUTR REV, V60, pS40, DOI 10.1301/00296640260130722; Bradley J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0579-5; Crawley J, 2004, AM J TROP MED HYG, V71, P25, DOI 10.4269/ajtmh.2004.71.25; Custodio E, 2009, MALARIA J, V8, P1; Custodio E, 2008, FOOD NUTR BULL, V29, P49, DOI 10.1177/156482650802900106; Ehrhardt S, 2006, J INFECT DIS, V194, P108, DOI 10.1086/504688; English M, 2000, T ROY SOC TROP MED H, V94, P585, DOI 10.1016/S0035-9203(00)90197-4; Friedman JF, 2005, AM J TROP MED HYG, V73, P698, DOI 10.4269/ajtmh.2005.73.698; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; [ICF International Planificacion e Inversiones Publicas Ministerio de Sanidad y Bienestar Social inisterio de Economia], 2012, ENC DEM SAL EDSGE I; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; Klinkenberg E, 2006, TROP MED INT HEALTH, V11, P578, DOI 10.1111/j.1365-3156.2006.01609.x; Korenromp EL, 2004, TROP MED INT HEALTH, V9, P1050, DOI 10.1111/j.1365-3156.2004.01317.x; Koukounari A, 2008, INT J PARASITOL, V38, P1663, DOI 10.1016/j.ijpara.2008.05.013; Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9; Menon MP, 2015, AM J TROP MED HYG, V93, P521, DOI 10.4269/ajtmh.15-0102; Mesfin F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123615; Muhimbula H. S., 2010, African Journal of Food Science, V4, P679; Murphy SC, 2001, AM J TROP MED HYG, V64, P57, DOI 10.4269/ajtmh.2001.64.57; Ncogo P, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0986-7; Ngnie-Teta I, 2007, FOOD NUTR BULL, V28, P76, DOI 10.1177/156482650702800109; Oladeinde BH, 2012, IRAN J PARASITOL, V7, P31; Rehman AM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-154; Roche J, 1999, AM J TROP MED HYG, V60, P257, DOI 10.4269/ajtmh.1999.60.257; ROCHE J, 1996, RES REV PARASITOL, V56, P99; Romay-Barja M, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1239-0; Romay-Barja M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135887; Ronald LA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-105; Schellenberg D, 2003, B WORLD HEALTH ORGAN, V81, P581; Semedo RML, 2014, J HEALTH POPUL NUTR, V32, P646; Sumbele IUN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123549; The DHS Program, 2011 FIN REP; WHO, 2007, ASS IR STAT POP INCL; World Health Organisation (WHO), 2015, GLOB MAL PROGR WORLD; [World Health Organization (WHO) Regional Office for Africa], 2006, HLTH PEOPL AFR REG H; World Health Organization (WHO), 2015, GLOB PREV AN 2011, DOI DOI 10.1017/S1368980008002401	40	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176613	10.1371/journal.pone.0176613	http://dx.doi.org/10.1371/journal.pone.0176613			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467452	gold, Green Published, Green Submitted			2022-12-26	WOS:000400647000062
J	Kayode, O; Huang, Z; Soares, AS; Caulfield, TR; Dong, Z; Bode, AM; Radisky, ES				Kayode, Olumide; Huang, Zunnan; Soares, Alexei S.; Caulfield, Thomas R.; Dong, Zigang; Bode, Ann M.; Radisky, Evette S.			Small molecule inhibitors of mesotrypsin from a structure-based docking screen	PLOS ONE			English	Article							CIS-TRANS ISOMERIZATION; PROTEIN DATA-BANK; TRYPSIN-INHIBITORS; CANCER; DEGRADATION; TARGET; METASTASIS; EXPRESSION; DISCOVERY; AFFINITY	PRSS3/mesotrypsin is an atypical isoform of trypsin, the upregulation of which has been implicated in promoting tumor progression. To date there are no mesotrypsin-selective pharmacological inhibitors which could serve as tools for deciphering the pathological role of this enzyme, and could potentially form the basis for novel therapeutic strategies targeting mesotrypsin. A virtual screen of the Natural Product Database (NPD) and Food and Drug Administration (FDA) approved Drug Database was conducted by high-throughput molecular docking utilizing crystal structures of mesotrypsin. Twelve high-scoring compounds were selected for testing based on lowest free energy docking scores, interaction with key mesotrypsin active site residues, and commercial availability. Diminazene (CID22956468), along with two similar compounds presenting the bis-benzamidine substructure, was validated as a competitive inhibitor of mesotrypsin and other human trypsin isoforms. Diminazene is the most potent small molecule inhibitor of mesotrypsin reported to date with an inhibitory constant (Ki) of 3.6 +/- 0.3 mu M. Diminazene was subsequently co-crystalized with mesotrypsin and the crystal structure was solved and refined to 1.25 angstrom resolution. This high resolution crystal structure can now offer a foundation for structure-guided efforts to develop novel and potentially more selective mesotrypsin inhibitors based on similar molecular substructures.	[Kayode, Olumide; Radisky, Evette S.] Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Jacksonville, FL 32224 USA; [Huang, Zunnan; Dong, Zigang; Bode, Ann M.] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA; [Soares, Alexei S.] Brookhaven Natl Lab, Photon Sci Directorate, Upton, NY 11973 USA; [Caulfield, Thomas R.] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA; [Huang, Zunnan] Guangdong Med Univ, Dongguan Sci Res Ctr, Guangdong Prov Key Lab Med Mol Diagnost, Dongguan, Peoples R China	Mayo Clinic; University of Minnesota System; United States Department of Energy (DOE); Brookhaven National Laboratory; Mayo Clinic; Guangdong Medical University	Radisky, ES (corresponding author), Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Jacksonville, FL 32224 USA.	radisky.evette@mayo.edu	Radisky, Evette S/C-8526-2012; Huang, Zunnan/M-5214-2019	Radisky, Evette S/0000-0003-3121-109X; Huang, Zunnan/0000-0002-5821-703X; Caulfield, Thomas/0000-0002-1055-3069	United Stated National Institutes of Health [R01CA54387]; Office of Biological and Environmental Research of the United States Department of Energy; Office of Basic Energy Sciences of the United States Department of Energy; National Center for Research Resources of the National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA154387] Funding Source: NIH RePORTER	United Stated National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Biological and Environmental Research of the United States Department of Energy(United States Department of Energy (DOE)); Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by United Stated National Institutes of Health grant R01CA54387 to E.S.R. Diffraction data were measured at beamline X25 of the National Synchrotron Light Source, which is supported by the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy, and the National Center for Research Resources of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by United Stated National Institutes of Health grant R01CA154387 to E.S.R. Diffraction data were measured at beamline X25 of the National Synchrotron Light Source, which is supported by the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy, and the National Center for Research Resources of the National Institutes of Health.	Alloy AP, 2015, J BIOL CHEM, V290, P21523, DOI 10.1074/jbc.M115.662429; Barra M, 2000, J ORG CHEM, V65, P5739, DOI 10.1021/jo000599l; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chowdhury S, 2011, BIOORG MED CHEM LETT, V21, P3676, DOI 10.1016/j.bmcl.2011.04.088; Cohen I, 2016, BIOCHEM J, V473, P1329, DOI 10.1042/BJ20151410; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Diederichs S, 2004, CANCER RES, V64, P5564, DOI 10.1158/0008-5472.CAN-04-2004; Dugave C, 2003, CHEM REV, V103, P2475, DOI 10.1021/cr0104375; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Ghilardi C, 2015, ONCOTARGET, V6, P28389, DOI 10.18632/oncotarget.4949; Grishina Z, 2005, BRIT J PHARMACOL, V146, P990, DOI 10.1038/sj.bjp.0706410; Han S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076667; Hockla A, 2012, MOL CANCER RES, V10, P1555, DOI 10.1158/1541-7786.MCR-12-0314; Hockla A, 2010, BREAST CANCER RES TR, V124, P27, DOI 10.1007/s10549-009-0699-0; Jiang GZ, 2010, GUT, V59, P1535, DOI 10.1136/gut.2009.200105; Karle M, 2012, BIOORG MED CHEM LETT, V22, P4839, DOI 10.1016/j.bmcl.2012.05.046; Katona G, 2002, J MOL BIOL, V315, P1209, DOI 10.1006/jmbi.2001.5305; Kayode O, 2016, J BIOL CHEM, V291, P26304, DOI 10.1074/jbc.M116.758417; Knecht W, 2007, J BIOL CHEM, V282, P26089, DOI 10.1074/jbc.M703840200; LaPlante SR, 2014, J MED CHEM, V57, P1777, DOI 10.1021/jm401338c; LaPlante SR, 2014, J MED CHEM, V57, P1845, DOI 10.1021/jm4011862; Lorber DM, 1998, PROTEIN SCI, V7, P938; Ma RQ, 2015, GYNECOL ONCOL, V137, P546, DOI 10.1016/j.ygyno.2015.02.022; Mahalingam P, 2014, J MED CHEM, V57, P5094, DOI 10.1021/jm401733v; Miyai M, 2014, J INVEST DERMATOL, V134, P1665, DOI 10.1038/jid.2014.3; Morty RE, 1998, FEBS LETT, V433, P251, DOI 10.1016/S0014-5793(98)00914-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakanishi J, 2010, J INVEST DERMATOL, V130, P944, DOI 10.1038/jid.2009.364; Nemeth AL, 2007, FEBS J, V274, P1610, DOI 10.1111/j.1742-4658.2007.05708.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pendlebury D, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.609560; Perilo CS, 2010, INT J BIOL MACROMOL, V46, P502, DOI 10.1016/j.ijbiomac.2010.03.006; Read RJ, 2011, STRUCTURE, V19, P1395, DOI 10.1016/j.str.2011.08.006; RINDERKNECHT H, 1984, GASTROENTEROLOGY, V86, P681; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; Salameh MA, 2011, BIOCHEM J, V440, P95, DOI 10.1042/BJ20110788; Salameh MA, 2010, J BIOL CHEM, V285, P36884, DOI 10.1074/jbc.M110.171348; Salameh MA, 2010, J BIOL CHEM, V285, P1939, DOI 10.1074/jbc.M109.057216; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wu P, 2010, BIOL CHEM, V391, P283, DOI [10.1515/BC.2010.030, 10.1515/bc.2010.030]; Yamamoto-Tanaka M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.145; Yamamoto-Tanaka M, 2014, J BIOL CHEM, V289, P20026, DOI 10.1074/jbc.M113.543421	46	8	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176694	10.1371/journal.pone.0176694	http://dx.doi.org/10.1371/journal.pone.0176694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28463992	Green Submitted, Green Published, gold			2022-12-26	WOS:000400646300045
J	Dumke, J; Vollmer, T; Akkermann, O; Knabbe, C; Dreier, J				Dumke, Jessika; Vollmer, Tanja; Akkermann, Oke; Knabbe, Cornelius; Dreier, Jens			Case-control study: Determination of potential risk factors for the colonization of healthy volunteers with Streptococcus gallolyticus subsp gallolyticus	PLOS ONE			English	Article							COLORECTAL-CANCER; BOVIS INFECTIONS; EQUINUS COMPLEX; ENDOCARDITIS; IDENTIFICATION; BACTEREMIA; CHEESE; ASSOCIATION; MICROBIOTA; TAXONOMY	Streptococcus gallolyticus subsp. gallolyticus was identified in humans and animals as commensal of the gut and can act as a causative agent of endocarditis and septicemia. A case-control study was performed to identify yet unknown risk factors for the transmission of this facultative pathogen. The prevalence in the gut of 99 healthy volunteers was determined using real-time polymerase chain reaction resulting in 62.5% S. gallolyticus subsp. gallolyticus positive excrements. Subsequent cultivation offered three isolates and epidemiological analysis based on MLST revealed sequence type (ST) 3 and ST 7, previously detected from bovine and endocarditis patients. These results support the hypotheses of the zoonotic potential of this bacterium. Participant questionnaires were evaluated concerning personal characteristics, nutritional habits and animal contact. Specifically, closer contact between participants and animals influenced the colonization of the human gut significantly and was further affected if volunteers used excrement for the fertilization of plants.	[Dumke, Jessika; Vollmer, Tanja; Knabbe, Cornelius; Dreier, Jens] Ruhr Univ Bochum, Herz & Diabet Zentrum Nordrhein Westfalen, Inst Lab & Transfus Med, Bad Oeynhausen, Germany; [Akkermann, Oke] Johannes Wesling Klinikum Minden, Minden, Germany	Ruhr University Bochum; Ruhr University Bochum	Dreier, J (corresponding author), Ruhr Univ Bochum, Herz & Diabet Zentrum Nordrhein Westfalen, Inst Lab & Transfus Med, Bad Oeynhausen, Germany.	jdreier@hdz-nrw.de	Vollmer, Tanja/F-1149-2013	Vollmer, Tanja/0000-0001-7032-5423	Forschungsforderung Ruhr-Universitat Medizin (FoRUM)	Forschungsforderung Ruhr-Universitat Medizin (FoRUM)	This work was supported by the Forschungsforderung Ruhr-Universitat Medizin (FoRUM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Ruhr-Universitat Bochum Medizinische Fakultat (FoRUM). We thank Philip Saunders (LL.B., B.Ed., FRSA) for his linguistic advice.	Abdulamir AS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-249; Abeni Chiara, 2013, J Med Case Rep, V7, P185, DOI 10.1186/1752-1947-7-185; Al-Jashamy K, 2010, ASIAN PAC J CANCER P, V11, P1765; Boleij A, 2013, LANCET INFECT DIS; Boleij A, 2011, J INFECT DIS, V203, P1101, DOI 10.1093/infdis/jiq169; Boleij A, 2009, J CLIN MICROBIOL, V47, P516, DOI 10.1128/JCM.01755-08; Boltin D, 2015, EUROPEAN J GASTROENT; Bordes-Benitez A, 2006, EUR J CLIN MICROBIOL, V25, P242, DOI 10.1007/s10096-006-0119-x; Chirouze C, 2013, EUROPEAN J CLIN MICR, P1; Coffey S, 2012, INT J CARDIOL, V161, P111, DOI 10.1016/j.ijcard.2012.06.031; Corredoira J, 2015, J INFECT; Danne C, 2011, J INFECT DIS, V204, P1960, DOI 10.1093/infdis/jir666; DEHERDT P, 1994, VET MICROBIOL, V41, P321, DOI 10.1016/0378-1135(94)90028-0; DEVRIESE LA, 1990, AVIAN PATHOL, V19, P429, DOI 10.1080/03079459008418697; Droual R, 1997, AVIAN PATHOL, V26, P433, DOI 10.1080/03079459708419225; Dumke J, 2014, J CLIN MICROBIOL, V52, P2472, DOI 10.1128/JCM.03329-13; Dumke J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126507; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fortin M, 2003, J CLIN MICROBIOL, V41, P106, DOI 10.1128/JCM.41.1.106-109.2003; Francois B, 1998, J CLIN MICROBIOL, V36, P2395; Giannitsioti E, 2007, CLIN MICROBIOL INFEC, V13, P770, DOI 10.1111/j.1469-0691.2007.01753.x; HEADINGS DL, 1978, J PEDIATR-US, V92, P282, DOI 10.1016/S0022-3476(78)80026-2; Hinse D, 2011, SYST APPL MICROBIOL, V34, P52, DOI 10.1016/j.syapm.2010.11.010; Hoen B, 2005, EUR J CLIN MICROBIOL, V24, P12, DOI 10.1007/s10096-004-1266-6; Hoen B, 2002, JAMA-J AM MED ASSOC, V288, P75, DOI 10.1001/jama.288.1.75; Holland JL, 2000, J CLIN MICROBIOL, V38, P4108, DOI 10.1128/JCM.38.11.4108-4113.2000; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; KLEIN RS, 1977, NEW ENGL J MED, V297, P800, DOI 10.1056/NEJM197710132971503; Kupferwasser I, 1998, HEART, V80, P276, DOI 10.1136/hrt.80.3.276; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Mager DL, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-14; Lopes PGM, 2014, J CLIN MICROBIOL, V52, P974, DOI 10.1128/JCM.03253-13; Randazzo CL, 2006, INT J FOOD MICROBIOL, V109, P1, DOI 10.1016/j.ijfoodmicro.2005.11.002; Rashid MU, 2015, CLIN INFECT DIS, V60, pS77, DOI 10.1093/cid/civ137; Romero B, 2011, J CLIN MICROBIOL, V49, P3228, DOI 10.1128/JCM.00524-11; Sasaki E, 2004, J VET MED SCI, V66, P1467, DOI 10.1292/jvms.66.1467; Schlegel L, 2003, INT J SYST EVOL MICR, V53, P631, DOI 10.1099/ijs.0.02361-0; Schulz J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144412; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sekizaki T, 2008, AVIAN DIS, V52, P183, DOI 10.1637/8048-070307-Case; Shanan S, 2011, INT J MICROBIOLOGY, V2011; Sillanpaa J, 2009, J BACTERIOL, V191, P6643, DOI 10.1128/JB.00909-09; Sillanpaa J, 2008, FEMS MICROBIOL LETT, V289, P104, DOI 10.1111/j.1574-6968.2008.01378.x; Tripodi MF, 2005, CLIN MICROBIOL INFEC, V11, P814, DOI 10.1111/j.1469-0691.2005.01248.x; Tsakalidou E, 1998, INT J SYST BACTERIOL, V48, P519, DOI 10.1099/00207713-48-2-519; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vollmer T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-78; Werdan K, 2013, NATURE REV CARDIOLOG; Wingstrand A, 2006, EMERG INFECT DIS, V12, P280; Yun ZB, 2000, TRANSPLANTATION, V69, P1733	50	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176515	10.1371/journal.pone.0176515	http://dx.doi.org/10.1371/journal.pone.0176515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459818	Green Submitted, Green Published, gold			2022-12-26	WOS:000400645000036
J	Nueda, ML; Naranjo, AI; Baladron, V; Laborda, J				Nueda, Maria-Luisa; Naranjo, Ana-Isabel; Baladron, Victoriano; Laborda, Jorge			Different expression levels of DLK1 inversely modulate the oncogenic potential of human MDA-MB-231 breast cancer cells through inhibition of NOTCH1 signaling	FASEB JOURNAL			English	Article						PREF-1/DLK1; cell growth; cell invasion; MAPK/ERK signaling; rpS6 signaling	DELTA-LIKE PROTEIN; MESENCHYMAL TRANSITION; NEGATIVE REGULATOR; TRANSGENIC MICE; E-CADHERIN; ACTIVATION; GENE; GROWTH; LINES; OVEREXPRESSION	NOTCH receptors participate in cancer cell proliferation and survival. Accumulated evidence indicates that, depending on the cellular context, these receptors can function as oncogenes or as tumor-suppressor genes. The epidermal growth factor-like protein delta-like homolog (DLK) 1 acts as a NOTCH inhibitor and is involved in the regulation of normal and tumoral growth. In this work, we focused on the role of DLK1 in the control of breast cancer cell growth, a tumor type in which NOTCH receptors have been shown to play both opposite roles. We found that human DLK1 inhibits NOTCH signaling in MDA-MB-231 breast cancer cells. The proliferation rate and invasion capabilities of these cells depended on the level of NOTCH activation and signaling, as regulated by DLK1. High levels of DLK1 expression led to a significant decrease in NOTCH signaling, which was associated with a decrease in breast cancer cell proliferation and invasion. On the contrary, lower levels of NOTCH inhibition, caused by lower levels of DLK1 overexpression, led to enhanced in vitro MDA-MB-231 cell invasion, and to both in vitro and in vivo increased cell proliferation. The data presented in this work suggest that a fine regulation of NOTCH signaling plays an important role in the control of breast cancer cell proliferation and invasion.	[Nueda, Maria-Luisa; Naranjo, Ana-Isabel; Baladron, Victoriano; Laborda, Jorge] Univ Castilla La Mancha, Spanish Natl Res Council CSIC, Dept Inorgan & Organ Chem & Biochem, Biochem & Mol Biol Branch, Albacete, Spain; [Nueda, Maria-Luisa; Laborda, Jorge] Univ Castilla La Mancha, Spanish Natl Res Council CSIC, Sch Pharm, Albacete, Spain; [Naranjo, Ana-Isabel; Baladron, Victoriano] Univ Castilla La Mancha, Spanish Natl Res Council CSIC, Sch Med, Albacete, Spain; [Naranjo, Ana-Isabel; Baladron, Victoriano] Univ Castilla La Mancha, Spanish Natl Res Council CSIC, Reg Ctr Biomed Res CRIB, Biomed Unit, Albacete, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Castilla-La Mancha; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Castilla-La Mancha; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Castilla-La Mancha; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Castilla-La Mancha	Nueda, ML; Laborda, J (corresponding author), Univ Castilla La Mancha, CRIB, Sch Pharm, Lab Biochem & Mol Biol, C Almansa 14, Albacete 02006, Spain.	marialuisa.nueda@uclm.es; jorge.laborda@uclm.es	Nueda, María-Luisa/L-3044-2014; Laborda, Jorge/L-5726-2014; Baladron, Victoriano/L-1758-2014	Nueda, María-Luisa/0000-0002-5456-5045; Laborda, Jorge/0000-0002-9210-838X; Baladron, Victoriano/0000-0003-4574-8760	Spanish Cancer Association (AECC) [PI-2008/20]; Health Council of the Regional Government of Castilla-La Mancha, Spain [PEI-2014-033]; Fonds Europeen de Developpement Regional (FEDER); Ministry of Economy and Competitiveness [BFU2010-16433]	Spanish Cancer Association (AECC); Health Council of the Regional Government of Castilla-La Mancha, Spain; Fonds Europeen de Developpement Regional (FEDER)(European Commission); Ministry of Economy and Competitiveness	This work was supported by Grant PI-2008/20 (to M.L.N.) from the Spanish Cancer Association (AECC), Grant PEI-2014-033 (to J.L.) from the Health Council of the Regional Government of Castilla-La Mancha, Spain, supported by the Fonds Europeen de Developpement Regional (FEDER), and Grant BFU2010-16433 (to J.L.) from the Ministry of Economy and Competitiveness. The authors declare no conflicts of interest.	Acar A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2498764; Baker AT, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00360; Baladron V, 2005, EXP CELL RES, V303, P343, DOI 10.1016/j.yexcr.2004.10.001; Beatus P, 1999, DEVELOPMENT, V126, P3925; Bolos V, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3447; Bray SJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-11; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Callahan R, 1998, BIOCHEM SOC SYMP, P211; Chen CF, 2016, CELL CYCLE, V15, P432, DOI 10.1080/15384101.2015.1127474; Chen L, 2011, J BIOL CHEM, V286, P32140, DOI 10.1074/jbc.M111.230110; Dezso K, 2008, VIRCHOWS ARCH, V452, P443, DOI 10.1007/s00428-007-0571-8; Difeo A, 2006, ONCOGENE, V25, P6026, DOI 10.1038/sj.onc.1209611; DUMONT FJ, 1990, J IMMUNOL, V144, P251; Falix FA, 2012, BBA-MOL BASIS DIS, V1822, P988, DOI 10.1016/j.bbadis.2012.02.003; Fender AW, 2015, J CELL BIOCHEM, V116, P2517, DOI 10.1002/jcb.25196; Friedrichsen BN, 2003, J ENDOCRINOL, V176, P257, DOI 10.1677/joe.0.1760257; Fukazawa H, 2002, MOL CANCER THER, V1, P303; Gallahan D, 1996, CANCER RES, V56, P1775; Gil-Garcia B, 2016, BIOL CELL, V108, P29, DOI 10.1111/boc.201500029; Grishina IB, 2015, AM J CLIN EXP UROL, V3, P24; Gubina E, 1999, CYTOGENET CELL GENET, V84, P206, DOI 10.1159/000015259; Hajra KM, 2002, CANCER RES, V62, P1613; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Hu CY, 2006, AM J PATHOL, V168, P973, DOI 10.2353/ajpath.2006.050416; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Izrailit J, 2013, P NATL ACAD SCI USA, V110, P1714, DOI 10.1073/pnas.1214014110; Jolicoeur P, 1998, BIOCHEM SOC SYMP, P159; Kawakami T, 2006, HUM MOL GENET, V15, P821, DOI 10.1093/hmg/ddl001; Laborda J, 2000, HISTOL HISTOPATHOL, V15, P119, DOI 10.14670/HH-15.119; LABORDA J, 1993, J BIOL CHEM, V268, P3817; LEE YL, 1995, BBA-GENE STRUCT EXPR, V1261, P223; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Li L, 2005, ONCOGENE, V24, P4472, DOI 10.1038/sj.onc.1208637; Lobry C, 2014, BLOOD, V123, P2451, DOI 10.1182/blood-2013-08-355818; Mazzone M, 2010, P NATL ACAD SCI USA, V107, P5012, DOI 10.1073/pnas.1000896107; Mirshekar-Syahkal B, 2013, HAEMATOLOGICA, V98, P163, DOI 10.3324/haematol.2012.070789; Nueda ML, 2008, J MOL BIOL, V379, P428, DOI 10.1016/j.jmb.2008.03.070; Nueda ML, 2007, J MOL BIOL, V367, P1281, DOI 10.1016/j.jmb.2006.10.043; Nueda ML, 2014, BBA-MOL CELL RES, V1843, P2674, DOI 10.1016/j.bbamcr.2014.07.015; Pinnix CC, 2009, CANCER RES, V69, P5312, DOI 10.1158/0008-5472.CAN-08-3767; Qi XF, 2008, INT J MOL MED, V22, P61; ROBBINS J, 1992, J VIROL, V66, P2594, DOI 10.1128/JVI.66.4.2594-2599.1992; Ruiz-Hidalgo MJ, 2002, EXP CELL RES, V274, P178, DOI 10.1006/excr.2001.5464; Samulewicz SJ, 2002, WOUND REPAIR REGEN, V10, P215, DOI 10.1046/j.1524-475X.2002.10404.x; Sanchez-Solana B, 2011, BBA-MOL CELL RES, V1813, P1153, DOI 10.1016/j.bbamcr.2011.03.004; SATYAPRAKASH KL, 1981, CANCER GENET CYTOGEN, V3, P61, DOI 10.1016/0165-4608(81)90057-1; Savagner P, 1997, J CELL BIOL, V137, P1403, DOI 10.1083/jcb.137.6.1403; Shao S, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0295-3; Sul HS, 2009, MOL ENDOCRINOL, V23, P1717, DOI 10.1210/me.2009-0160; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Weber D, 2014, CURR TOP DEV BIOL, V110, P285, DOI 10.1016/B978-0-12-405943-6.00008-7; Xu JM, 2016, TUMOR BIOL, V37, P1871, DOI 10.1007/s13277-015-3961-6; Yanai H, 2010, J BIOCHEM, V148, P85, DOI 10.1093/jb/mvq034; Yin D, 2006, ONCOGENE, V25, P1852, DOI 10.1038/sj.onc.1209219; Yu F, 2010, LIVER INT, V30, P703, DOI 10.1111/j.1478-3231.2010.02214.x; Zhang HB, 2003, J BIOL CHEM, V278, P20906, DOI 10.1074/jbc.M300022200; Zhang ZY, 2010, AM J PATHOL, V177, P1459, DOI 10.2353/ajpath.2010.090476	57	13	16	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3484	3496		10.1096/fj.201601341RRR	http://dx.doi.org/10.1096/fj.201601341RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28461338				2022-12-26	WOS:000405932400025
J	Temple, MJ; Cuskin, F; Basle, A; Hickey, N; Speciale, G; Williams, SJ; Gilbert, HJ; Lowe, EC				Temple, Max J.; Cuskin, Fiona; Basle, Arnaud; Hickey, Niall; Speciale, Gaetano; Williams, Spencer J.; Gilbert, Harry J.; Lowe, Elisabeth C.			A Bacteroidetes locus dedicated to fungal 1,6--glucan degradation: Unique substrate conformation drives specificity of the key endo-1,6--glucanase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate-binding protein; glycosidase; glycoside hydrolase; microbiome; X-ray crystallography	HUMAN GUT MICROBIOTA; GLYCOSYL HYDROLASES; STRUCTURAL BASIS; TRICHODERMA-HARZIANUM; MOLECULAR REPLACEMENT; METABOLISM; SYMBIONT; ENDO-BETA-1,6-GLUCANASE; THETAIOTAOMICRON; CRYSTALLOGRAPHY	Glycans are major nutrients available to the human gut microbiota. The Bacteroides are generalist glycan degraders, and this function is mediated largely by polysaccharide utilization loci (PULs). The genomes of several Bacteroides species contain a PUL, PUL1,6--glucan, that was predicted to target mixed linked plant 1,3;1,4--glucans. To test this hypothesis we characterized the proteins encoded by this locus in Bacteroides thetaiotaomicron, a member of the human gut microbiota. We show here that PUL1,6--glucan does not orchestrate the degradation of a plant polysaccharide but targets a fungal cell wall glycan, 1,6--glucan, which is a growth substrate for the bacterium. The locus is up-regulated by 1,6--glucan and encodes two enzymes, a surface endo-1,6--glucanase, BT3312, and a periplasmic -glucosidase that targets primarily 1,6--glucans. The non-catalytic proteins encoded by PUL1,6--glucan target 1,6--glucans and comprise a surface glycan-binding protein and a SusD homologue that delivers glycans to the outer membrane transporter. We identified the central role of the endo-1,6--glucanase in 1,6--glucan depolymerization by deleting bt3312, which prevented the growth of B. thetaiotaomicron on 1,6--glucan. The crystal structure of BT3312 in complex with -glucosyl-1,6-deoxynojirimycin revealed a TIM barrel catalytic domain that contains a deep substrate-binding cleft tailored to accommodate the hook-like structure adopted by 1,6--glucan. Specificity is driven by the complementarity of the enzyme active site cleft and the conformation of the substrate. We also noted that PUL1,6--glucan is syntenic to many PULs from other Bacteroidetes, suggesting that utilization of yeast and fungal cell wall 1,6--glucans is a widespread adaptation within the human microbiota.	[Temple, Max J.; Cuskin, Fiona; Basle, Arnaud; Hickey, Niall; Gilbert, Harry J.; Lowe, Elisabeth C.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE4 2HH, Tyne & Wear, England; [Speciale, Gaetano; Williams, Spencer J.] Univ Melbourne, Sch Chem, Parkville, Vic 3010, Australia; [Speciale, Gaetano; Williams, Spencer J.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia	Newcastle University - UK; University of Melbourne; University of Melbourne	Gilbert, HJ; Lowe, EC (corresponding author), Newcastle Univ, Med Sch, Inst Cell & Mol Biosci, Framlington Pl, Newcastle Upon Tyne NE4 2HH, Tyne & Wear, England.	harry.gilbert@ncl.ac.uk; Elisabeth.lowe@ncl.ac.uk	Hickey, Niall/S-2338-2019	Hickey, Niall/0000-0002-1722-0558; Lowe, Elisabeth/0000-0001-9812-0614; Temple, Max/0000-0003-4678-9396; Cuskin, Fiona/0000-0003-4287-4921; Basle, Arnaud/0000-0002-4899-3086	Wellcome Trust Grant [WT097907/Z/11/Z]; Biotechnology and Biological Research Council [BB/K020358/1]; BBSRC [BB/K020358/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K020358/1] Funding Source: researchfish	Wellcome Trust Grant(Wellcome Trust); Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Wellcome Trust Grant WT097907/Z/11/Z and Biotechnology and Biological Research Council Grant BB/K020358/1. The authors declare that they have no conflicts of interest with the contents of this article.	ANDERSON KL, 1989, J BACTERIOL, V171, P3192, DOI 10.1128/jb.171.6.3192-3198.1989; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Blattner R, 2006, CARBOHYD RES, V341, P2115, DOI 10.1016/j.carres.2006.05.004; Boisrame A, 2009, APPL MICROBIOL BIOT, V82, P663, DOI 10.1007/s00253-008-1780-z; Charnock SJ, 1998, J BIOL CHEM, V273, P32187, DOI 10.1074/jbc.273.48.32187; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cuskin F, 2015, NATURE, V517, P165, DOI 10.1038/nature13995; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 2012, ACCOUNTS CHEM RES, V45, P308, DOI 10.1021/ar2001765; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DELACRUZ J, 1995, J BACTERIOL, V177, P1864, DOI 10.1128/jb.177.7.1864-1871.1995; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erwig LP, 2016, NAT REV MICROBIOL, V14, P163, DOI 10.1038/nrmicro.2015.21; Furstner A, 2003, CHEM-EUR J, V9, P307, DOI 10.1002/chem.200390025; Glenwright AJ, 2017, NATURE, V541, P407, DOI 10.1038/nature20828; Harvey AJ, 2000, PROTEINS, V41, P257, DOI 10.1002/1097-0134(20001101)41:2<257::AID-PROT100>3.0.CO;2-C; Henekendorff M, 2010, CHEM-EUR J, V16, P13982, DOI 10.1002/chem.201002313; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; LORA JM, 1995, MOL GEN GENET, V247, P639, DOI 10.1007/BF00290356; Lowman DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027614; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Mewis K, 2016, APPL ENVIRON MICROB, V82, P1686, DOI 10.1128/AEM.03453-15; MIAO SC, 1994, J BIOL CHEM, V269, P10975; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ndeh D, 2017, NATURE, V544, P65, DOI 10.1038/nature21725; Pell G, 2004, J BIOL CHEM, V279, P11777, DOI 10.1074/jbc.M311947200; Simpson PJ, 2000, J BIOL CHEM, V275, P41137, DOI 10.1074/jbc.M006948200; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Speciale G, 2014, CURR OPIN STRUC BIOL, V28, P1, DOI 10.1016/j.sbi.2014.06.003; Terrapon N, 2015, BIOINFORMATICS, V31, P647, DOI 10.1093/bioinformatics/btu716; Urbanikova L, 2011, FEBS J, V278, P2105, DOI 10.1111/j.1742-4658.2011.08127.x; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; van Bueren AL, 2015, APPL ENVIRON MICROB, V81, P3973, DOI 10.1128/AEM.00149-15; Wang D, 2017, APPL MICROBIOL BIOT, V101, P197, DOI 10.1007/s00253-016-7753-8; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	42	42	45	4	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10639	10650		10.1074/jbc.M117.787606	http://dx.doi.org/10.1074/jbc.M117.787606			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28461332	Green Published, hybrid			2022-12-26	WOS:000404115400023
J	Yang, SZ; Xu, F; Zhou, T; Zhao, XY; McDonald, JM; Chen, YB				Yang, Shan-zhong; Xu, Fei; Zhou, Tong; Zhao, Xinyang; McDonald, Jay M.; Chen, Yabing			The long non-coding RNA HOTAIR enhances pancreatic cancer resistance to TNF-related apoptosis-inducing ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; histone methylation; long non-coding RNA (long ncRNA; lncRNA); pancreatic cancer; TRAIL; death receptor 5; DR5	TRAIL-INDUCED APOPTOSIS; MONOCLONAL-ANTIBODY; VASCULAR CALCIFICATION; GEMCITABINE; CELLS; COMBINATION; DISEASE; TRIAL; DR5; DIFFERENTIATION	Pancreatic cancer is a malignant neoplasm with a high mortality rate. Therapeutic agents that activate TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis have shown promising efficacy, but many pancreatic cancers are resistant to TRAIL therapy. Epigenetic regulation plays important roles in tumor pathogenesis and resistance, and a recent study indicated that the long non-coding RNA HOX transcript antisense RNA (HOTAIR) is overexpressed in pancreatic cancer. However, the role of HOTAIR in pancreatic cancer resistance to anticancer agents is unknown. The present study determined the role of HOTAIR in pancreatic cancer TRAIL resistance and investigated the underlying molecular mechanisms. We observed that TRAIL-resistant pancreatic cancer cells had higher levels of HOTAIR expression, whereas TRAIL-sensitive pancreatic cancer cells had lower HOTAIR levels. Overexpressing HOTAIR in TRAIL-sensitive cells attenuated TRAIL-induced apoptosis, and shRNA-mediated HOTAIR knockdown in TRAIL-resistant PANC-1 cells sensitized them to TRAIL-induced apoptosis. These results support a causative effect of HOTAIR on TRAIL sensitivity. Mechanistically, we found that increased HOTAIR expression inhibited the expression of the TRAIL receptor death receptor 5 (DR5), whereas HOTAIR knockdown increased DR5 expression. We further demonstrated that HOTAIR regulates DR5 expression via the epigenetic regulator enhancer of zeste homolog 2 (EZH2) and that EZH2 controls histone H3 lysine 27 trimethylation on the DR5 gene. Taken together, these results demonstrate that high HOTAIR levels increase the resistance of pancreatic cancer cells to TRAIL-induced apoptosis via epigenetic regulation of DR5 expression. Our study therefore supports the notion that targeting HOTAIR function may represent a strategy to overcome TRAIL resistance in pancreatic cancer.	[Yang, Shan-zhong; Xu, Fei; McDonald, Jay M.; Chen, Yabing] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Zhou, Tong] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Zhao, Xinyang] Univ Alabama Birmingham, Dept Biochem, Birmingham, AL 35294 USA; [McDonald, Jay M.; Chen, Yabing] Birmingham Vet Affairs Med Ctr, Res Dept, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Chen, YB (corresponding author), 1825 Univ Blvd,614 Shelby Biomed Res Bldg, Birmingham, AL 35294 USA.	yabingchen@uabmc.edu		Zhao, Xinyang/0000-0001-6677-7072	Veterans Affairs Research Department Grants [BX002296, BX003617]; Veterans Affairs [IK6BX003617, I01BX002296] Funding Source: NIH RePORTER	Veterans Affairs Research Department Grants; Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Veterans Affairs Research Department Grants BX002296 and BX003617 (Y.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Avan A, 2012, MOL CANCER THER, V11, P1735, DOI 10.1158/1535-7163.MCT-12-0037; Bergmann L, 2015, EUR J CANCER, V51, P27, DOI 10.1016/j.ejca.2014.10.010; Byon CH, 2011, ARTERIOSCL THROM VAS, V31, P1387, DOI 10.1161/ATVBAHA.110.222547; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Chen JF, 2012, J BONE MINER RES, V27, P1659, DOI 10.1002/jbmr.1607; Dimberg LY, 2013, ONCOGENE, V32, P1341, DOI 10.1038/onc.2012.164; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Forero-Torres A, 2010, CANCER BIOTHER RADIO, V25, P13, DOI 10.1089/cbr.2009.0673; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heath JM, 2014, CIRC RES, V114, P1094, DOI 10.1161/CIRCRESAHA.114.302968; Herbst RS, 2010, CLIN CANCER RES, V16, P5883, DOI 10.1158/1078-0432.CCR-10-0631; Holoch PA, 2009, EUR J PHARMACOL, V625, P63, DOI 10.1016/j.ejphar.2009.06.066; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Ichikawa K, 2001, NAT MED, V7, P954, DOI 10.1038/91000; Ishibashi M, 2013, ONCOL REP, V29, P946, DOI 10.3892/or.2012.2219; Joshi P, 2015, P NATL ACAD SCI USA, V112, P8650, DOI 10.1073/pnas.1500886112; Keane MM, 1999, CANCER RES, V59, P734; Kim K, 2013, ONCOGENE, V32, P1616, DOI 10.1038/onc.2012.193; Kindler HL, 2012, ANN ONCOL, V23, P2834, DOI 10.1093/annonc/mds142; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Kornfeld JW, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00057; Matsuzaki H, 2001, CLIN CANCER RES, V7, P407; Mayor S, 2015, LANCET ONCOL, V16, pE58, DOI 10.1016/S1470-2045(15)70017-3; Mocan T, 2014, J CANCER, V5, P679, DOI 10.7150/jca.9481; Montano M, 2011, TRANSL RES, V157, P157, DOI 10.1016/j.trsl.2011.02.001; Tran NT, 2016, EMBO REP, V17, P887, DOI 10.15252/embr.201541970; Ovcharenko D, 2007, CANCER RES, V67, P10782, DOI 10.1158/0008-5472.CAN-07-1484; Ozawa F, 2001, CANCER LETT, V163, P71, DOI 10.1016/S0304-3835(00)00660-1; Rajeshkumar NV, 2010, MOL CANCER THER, V9, P2582, DOI 10.1158/1535-7163.MCT-10-0370; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Sun Y, 2012, CIRC RES, V111, P543, DOI 10.1161/CIRCRESAHA.112.267237; Takahashi Y, 2000, GENE DEV, V14, P804; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wang S, 2010, CURR MED CHEM, V17, P3309, DOI 10.2174/092986710793176285; Wiezorek J, 2010, CLIN CANCER RES, V16, P1701, DOI 10.1158/1078-0432.CCR-09-1692; Younes A, 2010, BRIT J CANCER, V103, P1783, DOI 10.1038/sj.bjc.6605987; Yuan KY, 2015, ONCOTARGET, V6, P25308, DOI 10.18632/oncotarget.4490; Yuan KY, 2013, CLIN CANCER RES, V19, P4750, DOI 10.1158/1078-0432.CCR-13-0516	45	55	58	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10390	10397		10.1074/jbc.M117.786830	http://dx.doi.org/10.1074/jbc.M117.786830			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28476883	Green Published, hybrid			2022-12-26	WOS:000404115400006
J	De Cesare, A; Sirri, F; Manfreda, G; Moniaci, P; Giardini, A; Zampiga, M; Meluzzi, A				De Cesare, Alessandra; Sirri, Federico; Manfreda, Gerardo; Moniaci, Paola; Giardini, Alberto; Zampiga, Marco; Meluzzi, Adele			Effect of dietary supplementation with Lactobacillus acidophilus D2/CSL (CECT 4529) on caecum microbioma and productive performance in broiler chickens	PLOS ONE			English	Article							GROWTH-PERFORMANCE; CAMPYLOBACTER-JEJUNI; BACTERIAL COMMUNITY; IMMUNE-RESPONSES; BETA-GLUCOSIDASE; PROBIOTICS; BIFIDOBACTERIUM; CULTURES; DATABASE; STRAINS	This study examines the effects of the dietary supplementation with Lactobacillus acidophilus D2/CSL (CECT 4529) (LA) on productive performances, incidence of foot pad dermatitis and caecum microbioma in broiler chickens. A total of 1,100 one-day old male Ross 308 chicks were divided into 2 groups of 16 replicates with 25 birds each and reared from 1-41 d. One group was fed a basal diet (CON) and the other group the same diet supplemented with LA. Caecum contents were collected from 4 selected birds at day one and 5 selected birds at the end of the rearing period. Then, they were submitted to DNA extraction and whole DNA shotgun metagenomic sequencing. Overall, the LA supplementation produced a significant beneficial effect on body weight gain between 15-28 d and improved feed conversion rate in the overall period. On the contrary, litter moisture, pH and incidence of the foot pad lesions were not affected by LA. Birds treated with LA showed a lower occurrence of pasty vent at both 14 and 28 d. At the end of the rearing period, Lachanospiraceae were significantly higher in LA birds in comparison to CON (17.07 vs 14.39%; P = 0.036). Moreover, Ruminococcus obeum, Clostridium clostridioforme, Roseburia intestinalis, Lachnospiraceae bacterium 14-2T and Coprococcus eutactus were significantly higher in LA birds in comparison to CON. The relative abundance of Lactobacillus acidophilus was comparable between LA and CON groups. However, a positive effect was observed in relation to the metabolic functions in the treated group, with particular reference to the higher abundance of beta-glucosidase. In conclusion, the LA supplementation improved broiler productive performances and metabolic functions promoting animal health.	[De Cesare, Alessandra; Sirri, Federico; Manfreda, Gerardo; Moniaci, Paola; Zampiga, Marco; Meluzzi, Adele] Univ Bologna, Alma Mater Studiorum, Dept Agr & Food Sci, Bologna, Italy; [Giardini, Alberto] Ctr Sperimentale Latte, Lodi, Italy	University of Bologna	Sirri, F (corresponding author), Univ Bologna, Alma Mater Studiorum, Dept Agr & Food Sci, Bologna, Italy.	federico.sirri@unibo.it	Zampiga, Marco/ABC-5257-2020	Zampiga, Marco/0000-0001-8074-7283; SIRRI, FEDERICO/0000-0002-4640-7346	Centro Sperimentale del Latte S.r.l	Centro Sperimentale del Latte S.r.l	The Centro Sperimentale del Latte S.r.l. provided support in the form of salary for Alberto Giardini, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelakis E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010463; Askelson TE, 2014, APPL ENVIRON MICROB, V80, P943, DOI 10.1128/AEM.03155-13; Awad WA, 2009, POULTRY SCI, V88, P49, DOI 10.3382/ps.2008-00244; BARNES EM, 1972, BRIT POULTRY SCI, V13, P311, DOI 10.1080/00071667208415953; Bjerrum L, 2006, POULTRY SCI, V85, P1151, DOI 10.1093/ps/85.7.1151; Bouzaine T, 2005, LETT APPL MICROBIOL, V40, P391, DOI 10.1111/j.1472-765X.2005.01684.x; Brisbin JT, 2011, CLIN VACCINE IMMUNOL, V18, P1447, DOI 10.1128/CVI.05100-11; Brouns F, 2002, FOOD RES INT, V35, P187, DOI 10.1016/S0963-9969(01)00182-X; Camaschella P, 1985, MICROBIOLOGIE ALIMEN, V3, P73; Chen CY, 2012, POULTRY SCI, V91, P2139, DOI 10.3382/ps.2012-02237; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Dalmasso G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002476; Danzeisen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027949; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dominguez-Bello MG, 2008, MICROBES INFECT, V10, P1072, DOI 10.1016/j.micinf.2008.07.036; Donkor ON, 2008, J FOOD SCI, V73, pM15, DOI 10.1111/j.1750-3841.2007.00547.x; Edelman S, 2002, APPL ENVIRON MICROB, V68, P5155, DOI 10.1128/AEM.68.10.5155-5159.2002; Ekstrand C, 1998, BRIT POULTRY SCI, V39, P318, DOI 10.1080/00071669888845; FAO/WHO, 2002, WORK GROUP REP DRAFT; Fernandez-Rubio C, 2009, POULTRY SCI, V88, P943, DOI 10.3382/ps.2008-00484; Fritz WA, 1998, CARCINOGENESIS, V19, P2151, DOI 10.1093/carcin/19.12.2151; FULLER R, 1989, J APPL BACTERIOL, V66, P365; Gallazzi D, 2008, ITAL J ANIM SCI, V7, P27; Gaskins HR, 2002, ANIM BIOTECHNOL, V13, P29, DOI 10.1081/ABIO-120005768; Ghareeb K, 2012, POULTRY SCI, V91, P1825, DOI 10.3382/ps.2012-02168; Gong J, 2008, J APPL MICROBIOL, V104, P1372, DOI 10.1111/j.1365-2672.2007.03699.x; Gong JH, 2002, FEMS MICROBIOL LETT, V208, P1, DOI 10.1111/j.1574-6968.2002.tb11051.x; Gong JH, 2007, FEMS MICROBIOL ECOL, V59, P147, DOI 10.1111/j.1574-6941.2006.00193.x; Haghighi HR, 2005, CLIN DIAGN LAB IMMUN, V12, P1387, DOI 10.1128/CDLI.12.12.1387-1392.2005; HOSKINS LC, 1981, J CLIN INVEST, V67, P163, DOI 10.1172/JCI110009; Huang MK, 2004, POULTRY SCI, V83, P788, DOI 10.1093/ps/83.5.788; Huyghebaert G, 2011, VET J, V187, P182, DOI 10.1016/j.tvjl.2010.03.003; Ismail B, 2005, J AGR FOOD CHEM, V53, P4918, DOI 10.1021/jf0404694; Izumi T, 2000, J NUTR, V130, P1695, DOI 10.1093/jn/130.7.1695; Jin LZ, 1998, POULTRY SCI, V77, P1259, DOI 10.1093/ps/77.9.1259; Jin LZ, 1996, LETT APPL MICROBIOL, V22, P229, DOI 10.1111/j.1472-765X.1996.tb01149.x; Kalavathy R, 2003, BRIT POULTRY SCI, V44, P139, DOI 10.1080/0007166031000085445; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kenneth HW, 1997, CLIN INFECT DIS, V25, pS114; Kim JS, 2012, J ANIM PHYSIOL AN N, V96, P618, DOI 10.1111/j.1439-0396.2011.01187.x; La Ragione RM, 2004, LETT APPL MICROBIOL, V38, P197, DOI 10.1111/j.1472-765X.2004.01474.x; Loh TC, 2010, ANIM SCI J, V81, P205, DOI 10.1111/j.1740-0929.2009.00701.x; Lund M, 2010, POULTRY SCI, V89, P1217, DOI 10.3382/ps.2010-00653; Meluzzi A, 2008, BRIT POULTRY SCI, V49, P509, DOI 10.1080/00071660802290424; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mountzouris KC, 2007, POULTRY SCI, V86, P309, DOI 10.1093/ps/86.2.309; Neal-McKinney JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043928; Nousiainen J., 2004, Lactic acid bacteria: microbiology and functional aspects, P547; Oakley BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057190; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Patterson JA, 2003, POULTRY SCI, V82, P627, DOI 10.1093/ps/82.4.627; Petrosino JF, 2009, CLIN CHEM, V55, P856, DOI 10.1373/clinchem.2008.107565; Pineiro M, 2007, J NUTR, V137, p850S, DOI 10.1093/jn/137.3.850S; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qian LC, 2009, ASIAN AUSTRAL J ANIM, V22, P260, DOI 10.5713/ajas.2009.80416; Reese ET., 1977, STRUCTURE BIOSYNTHES, P311; Rekha CR, 2011, INT J FOOD SCI NUTR, V62, P111, DOI 10.3109/09637486.2010.513680; Roy A, 2010, VET MED INT; RUSELERVANEMBDEN JGH, 1995, SCAND J GASTROENTERO, V30, P675, DOI 10.3109/00365529509096312; SAS Institute, 1988, SAS STAT USERS GUIDE; Scupham AJ, 2007, FEMS MICROBIOL ECOL, V60, P136, DOI 10.1111/j.1574-6941.2006.00245.x; Shim YH, 2012, BRIT POULTRY SCI, V53, P482, DOI 10.1080/00071668.2012.690508; Souza MR, 2007, VET MICROBIOL, V120, P142, DOI 10.1016/j.vetmic.2006.10.019; TANNOCK GW, 1990, APPL ENVIRON MICROB, V56, P1310, DOI 10.1128/AEM.56.5.1310-1316.1990; Tannock GW, 2004, APPL ENVIRON MICROB, V70, P3189, DOI 10.1128/AEM.70.6.3189-3194.2004; Timmerman HM, 2006, POULTRY SCI, V85, P1383, DOI 10.1093/ps/85.8.1383; Van den Abbeele P, 2010, APPL ENVIRON MICROB, V76, P5237, DOI 10.1128/AEM.00759-10; Willis WL, 2008, POULTRY SCI, V87, P606, DOI 10.3382/ps.2006-00458; Wise MG, 2007, J APPL MICROBIOL, V102, P1138, DOI 10.1111/j.1365-2672.2006.03153.x; Zhao RX, 2007, WORLD J MICROB BIOT, V23, P195, DOI 10.1007/s11274-006-9209-2; Zulkifli I, 2000, BRIT POULTRY SCI, V41, P593, DOI 10.1080/713654979	72	56	56	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176309	10.1371/journal.pone.0176309	http://dx.doi.org/10.1371/journal.pone.0176309			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472118	Green Submitted, Green Published, gold			2022-12-26	WOS:000400648500037
J	Kagan, P; Sultan, M; Tachlytski, I; Safran, M; Ben-Ari, Z				Kagan, Polina; Sultan, Maya; Tachlytski, Irina; Safran, Michal; Ben-Ari, Ziv			Both MAPK and STAT3 signal transduction pathways are necessary for IL-6-dependent hepatic stellate cells activation	PLOS ONE			English	Article							LIVER FIBROSIS; OXIDATIVE-STRESS; MICE; INJURY; TRANSCRIPTION-3; INFLAMMATION; PROGRESSION; EXPRESSION; STEATOSIS; DISEASES	Background During liver injury, hepatic stellate cells (HSCs) can undergo activation and transform into alpha-smooth muscle actin (alpha SMA)-expressing contractile myofibroblast-like cells, leading to deposition of excessive scar matrix. We have recently demonstrated that depletion of adenosine deaminase acting on double-stranded RNA (ADAR1) from mouse hepatocytes leads to HSC activation and induction of inflammation and hepatic fibrosis that is mediated by interleukin 6 (IL-6). Our aim was to identify and characterize the molecular pathways involved in the direct, inflammation-independent activation of HSCs by IL-6. Methods Primary HSCs were isolated from mouse livers. mRNA levels of alpha SMA and Col1a were analyzed using qRT-PCR. Protein levels of alpha SMA, MAPK, p-MAPK, p38, p-p38, STAT3 and p-STAT3 were assessed by Western Blot analysis. The effect of specific signal transduction pathway inhibitors (i.e., SB203580 (P-38 inhibitor), U0126 (MAPK inhibitor), S3I-201 (STAT3 inhibitor) and Ruxolitinib (Jak1/2 inhibitor)) was also studied. Results Primary HSCs treated with IL-6 demonstrated upregulation of alpha SMA and Col1a mRNA levels as well as increased alpha SMA protein levels. Moreover, the phenotypic transition of quiescent HSCs toward myofibroblast-like cells was noted upon administration of IL-6 and not in untreated samples. In addition, the phosphorylation levels of p38, MAPK and STAT3 increased 30 minutes after treatment, and was followed by a decline in the phosphorylation levels 2-4 hours post-treatment. However, addition of specific signal transduction pathway inhibitors curbed this effect, and resulted in alpha SMA and Col1a expression levels similar to those measured in untreated control samples. Conclusion IL-6 can directly induce the transition of HSCs toward myofibroblast-like cells. The effect is mediated by the activation of both MAPK and JAK/STAT signaling pathways. Elimination of either MAPK or JAK/STAT signaling pathways inhibits HSC stimulation. These results might pave the road toward the development of potential therapeutic interventions for hepatic fibrosis.	[Kagan, Polina; Sultan, Maya; Tachlytski, Irina; Safran, Michal; Ben-Ari, Ziv] Sheba Med Ctr, Liver Res Lab, Ramat Gan, Israel; [Kagan, Polina; Ben-Ari, Ziv] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Ben-Ari, Ziv] Sheba Med Ctr, Liver Dis Ctr, Ramat Gan, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center	Ben-Ari, Z (corresponding author), Sheba Med Ctr, Liver Res Lab, Ramat Gan, Israel.; Ben-Ari, Z (corresponding author), Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.; Ben-Ari, Z (corresponding author), Sheba Med Ctr, Liver Dis Ctr, Ramat Gan, Israel.	ziv.ben-ari@sheba.health.gov.il		Kagan, Polina/0000-0001-8150-4494	Israel Cancer association	Israel Cancer association	This work was supported by Israel Cancer association (M. Safran and Z. Ben-Ari) http://en.cancer.org.il/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by Israel Cancer Association (M.S. and Z.B.).	Ben-Shoshan SO, 2016, RNA BIOL, P1; CHOI I, 1994, CLIN EXP IMMUNOL, V95, P530; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; Kovalovich K, 2000, HEPATOLOGY, V31, P149, DOI 10.1002/hep.510310123; Kroy DC, 2010, HEPATOLOGY, V51, P463, DOI 10.1002/hep.23322; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Liu YD, 2011, ALCOHOL CLIN EXP RES, V35, P921, DOI 10.1111/j.1530-0277.2010.01422.x; Mair M, 2010, GASTROENTEROLOGY, V138, P2499, DOI 10.1053/j.gastro.2010.02.049; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Natsume M, 1999, J LEUKOCYTE BIOL, V66, P601, DOI 10.1002/jlb.66.4.601; Neubauer K, 2001, CAN J GASTROENTEROL, V15, P187, DOI 10.1155/2001/870205; Nieto N, 2006, HEPATOLOGY, V44, P1487, DOI 10.1002/hep.21427; Plum W, 2010, AM J PATHOL, V176, P2236, DOI 10.2353/ajpath.2010.090469; Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Reeves HL, 2002, FRONT BIOSCI-LANDMRK, V7, pD808, DOI 10.2741/reeves; Schaper F, 1998, BIOCHEM J, V335, P557, DOI 10.1042/bj3350557; Schmidt-Arras D, 2016, J HEPATOL, V64, P1403, DOI 10.1016/j.jhep.2016.02.004; Shah R, 2013, ALCOHOL CLIN EXP RES, V37, P1838, DOI 10.1111/acer.12167; Shu M, 2016, BIOCHEM BIOPH RES CO, V471, P233, DOI 10.1016/j.bbrc.2016.01.119; Silver JS, 2010, J LEUKOCYTE BIOL, V88, P1145, DOI 10.1189/jlb.0410217; Sinha-Hikim I, 2011, EXP MOL PATHOL, V91, P419, DOI 10.1016/j.yexmp.2011.04.009; Starkel P, 2007, LAB INVEST, V87, P173, DOI 10.1038/labinvest.3700496; Streetz KL, 2003, HEPATOLOGY, V38, P218, DOI 10.1053/jhep.2003.50268; Wang H, 2011, AM J PATHOL, V179, P714, DOI 10.1016/j.ajpath.2011.05.005; Wang H, 2011, INT J BIOL SCI, V7, P536, DOI 10.7150/ijbs.7.536; Zauberman A, 1999, ONCOGENE, V18, P3886, DOI 10.1038/sj.onc.1202738	28	40	45	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176173	10.1371/journal.pone.0176173	http://dx.doi.org/10.1371/journal.pone.0176173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472150	gold, Green Published, Green Submitted			2022-12-26	WOS:000400648500026
J	Kim, MJ; Lee, SR; Lee, MY; Sohn, JW; Yun, HG; Choi, JY; Jeon, SW; Suh, TS				Kim, Min-Joo; Lee, Seu-Ran; Lee, Min-Young; Sohn, Jason W.; Yun, Hyong Geon; Choi, Joon Yong; Jeon, Sang Won; Suh, Tae Suk			Characterization of 3D printing techniques: Toward patient specific quality assurance spine-shaped phantom for stereotactic body radiation therapy	PLOS ONE			English	Article							BONE-MINERAL DENSITY; HOUNSFIELD UNITS; RADIOSURGERY; RADIOTHERAPY; ACCURACY; CORD; MRI; CT	Development and comparison of spine-shaped phantoms generated by two different 3D-printing technologies, digital light processing (DLP) and Polyjet has been purposed to utilize in patient-specific quality assurance (QA) of stereotactic body radiation treatment. The developed 3D-printed spine QA phantom consisted of an acrylic body phantom and a 3D-printed spine shaped object. DLP and Polyjet 3D printers using a high-density acrylic polymer were employed to produce spine-shaped phantoms based on CT images. Image fusion was performed to evaluate the reproducibility of our phantom, and the Hounsfield units (HUs) were measured based on each CT image. Two different intensity-modulated radio-therapy plans based on both CT phantom image sets from the two printed spine-shaped phantoms with acrylic body phantoms were designed to deliver 16 Gy dose to the planning target volume (PTV) and were compared for target coverage and normal organ-sparing. Image fusion demonstrated good reproducibility of the developed phantom. The HU values of the DLP-and Polyjet-printed spine vertebrae differed by 54.3 on average. The PTV D-max dose for the DLP-generated phantom was about 1.488 Gy higher than that for the Polyjet-generated phantom. The organs at risk received a lower dose for the 3D printed spine-shaped phantom image using the DLP technique than for the phantom image using the Polyjet technique. Despite using the same material for printing the spine-shaped phantom, these phantoms generated by different 3D printing techniques, DLP and Polyjet, showed different HU values and these differently appearing HU values according to the printing technique could be an extra consideration for developing the 3D printed spine-shaped phantom depending on the patient's age and the density of the spinal bone. Therefore, the 3D printing technique and materials should be carefully chosen by taking into account the condition of the patient in order to accurately produce 3D printed patient-specific QA phantom.	[Kim, Min-Joo; Lee, Seu-Ran; Lee, Min-Young; Suh, Tae Suk] Catholic Univ Korea, Coll Med, Res Inst Biomed Engn, Dept Biomed Engn, Seoul, South Korea; [Kim, Min-Joo] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Radiat Oncol, Seoul, South Korea; [Sohn, Jason W.] Case Western Reserve Univ, Sch Med, Dept Radiat Oncol, Cleveland, OH USA; [Yun, Hyong Geon; Choi, Joon Yong; Jeon, Sang Won] DongGuk Univ Hosp, Coll Med, Dept Radiat Oncol, Goyang, South Korea	Catholic University of Korea; Yonsei University; Yonsei University Health System; Case Western Reserve University; Dongguk University	Suh, TS (corresponding author), Catholic Univ Korea, Coll Med, Res Inst Biomed Engn, Dept Biomed Engn, Seoul, South Korea.	suhsanta@catholic.ac.kr			National Research Foundation (NRF) of Korea - Ministry of Science, ICT & Future Planning [2014R1A2A1A10050270, 2017R1C1B1011798]	National Research Foundation (NRF) of Korea - Ministry of Science, ICT & Future Planning	This study was supported by the National Research Foundation (NRF) of Korea funded by the Ministry of Science, ICT & Future Planning (2014R1A2A1A10050270,2017R1C1B1011798).	Avanzo M, 2009, NEUROSURG REV, V32, P1, DOI 10.1007/s10143-008-0167-z; Bache ST, 2015, MED PHYS, V42, P846, DOI 10.1118/1.4905489; Bartels RHMA, 2008, CA-CANCER J CLIN, V58, P245, DOI 10.3322/CA.2007.0016; Batawil N, 2016, RADIOGRAPHY, V22, pE93, DOI 10.1016/j.radi.2015.11.004; Benedict SH, 2010, MED PHYS, V37, P4078, DOI 10.1118/1.3438081; Burfeindt MJ, 2012, IEEE ANTENN WIREL PR, V11, P1610, DOI 10.1109/LAWP.2012.2236293; Cai J, 2007, RADIOTHER ONCOL, V84, P279, DOI 10.1016/j.radonc.2007.06.008; Crump SS., 1992, United States Patent, Patent No. [No. 5,121,329A, 5121329, 5,121,329]; Deckard CR, 1989, United States Patent, Patent No. [US4863538A, 4863538, 4,863,538]; Du JY, 2014, SPINE, V39, pE593, DOI 10.1097/BRS.0000000000000255; Ehler ED, 2014, PHYS MED BIOL, V59, P5763, DOI 10.1088/0031-9155/59/19/5763; Gagnon GJ, 2009, NEUROSURGERY, V64, P297, DOI 10.1227/01.NEU.0000338072.30246.BD; Gallo JJ, 2015, J APPL CLIN MED PHYS, V16, P170, DOI 10.1120/jacmp.v16i1.5120; Gear JI, 2014, MED PHYS, V41, P525, DOI 10.1118/1.4887854; Gerszten PC, 2004, NEUROSURGERY, V55, P89, DOI 10.1227/01.NEU.0000126873.00845.A7; Hattori K, 2013, MED PHYS, V40, DOI 10.1118/1.4790023; Heyns M, 2013, NORTHEAST BIOENGIN C, P171, DOI 10.1109/NEBEC.2013.75; Hull CW, 1986, US Patent, Patent No. [4575330A, 4575330, 4,575,330]; International Commission on Radiation Units and Measurements, 1999, PRESCR REC REP PHOT; Ionita CN, 2014, PROC SPIE, V9038, DOI 10.1117/12.2042266; Jung J, 2015, INT J RADIAT ONCOL, V92, P745, DOI 10.1016/j.ijrobp.2015.02.055; Kato H, 2005, MED PHYS, V32, P3199, DOI 10.1118/1.2047807; Khan R, 2015, PHYS MED IN PRESS; Kuijper IT, 2010, RADIOTHER ONCOL, V94, P224, DOI 10.1016/j.radonc.2009.12.027; 윤경준, 2014, [PROGRESS in MEDICAL PHYSICS, 의학물리], V25, P100, DOI 10.14316/pmp.2014.25.2.100; Leary M, 2015, MATER DESIGN, V86, P487, DOI 10.1016/j.matdes.2015.07.052; Lee S, 2013, J KOREAN NEUROSURG S, V54, P384, DOI 10.3340/jkns.2013.54.5.384; National Industrial Chemicals Notification and Assessment Scheme, 1996, MOD ACR POL; Ryu S, 2007, CANCER, V109, P628, DOI 10.1002/cncr.22442; Schreiber JJ, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.5.FOCUS1483; Solomon J, 2015, RADIOLOGY, V275, P735, DOI 10.1148/radiol.15142005; Solomon J, 2014, MED PHYS, V41, DOI 10.1118/1.4893497; Xu XG, 2014, PHYS MED BIOL, V59, pR233, DOI 10.1088/0031-9155/59/18/R233; Yamane M., 1991, brevet US, Patent No. [US 5,059,266, 5059266]	34	27	29	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176227	10.1371/journal.pone.0176227	http://dx.doi.org/10.1371/journal.pone.0176227			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472175	gold, Green Published, Green Submitted			2022-12-26	WOS:000400648500031
J	Tongyoo, P; Avihingsanon, Y; Prom-On, S; Mutirangura, A; Mhuantong, W; Hirankarn, N				Tongyoo, Pumipat; Avihingsanon, Yingyos; Prom-On, Santhitham; Mutirangura, Apiwat; Mhuantong, Wuttichai; Hirankarn, Nattiya			EnHERV: Enrichment analysis of specific human endogenous retrovirus patterns and their neighboring genes	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; EMBRYONIC STEM-CELLS; LONG TERMINAL REPEAT; DNA METHYLATION; TRANSPOSABLE ELEMENTS; HERV-E; NONCODING RNAS; HUMAN GENOME; EXPRESSION; SEQUENCES	Human endogenous retroviruses (HERVs) are flanked by long terminal repeats (LTRs), which contain the regulation part of the retrovirus. Remaining HERVs constitute 7% to 8% of the present day human genome, and most have been identified as solo LTRs. The HERV sequences have been associated with several molecular functions as well as certain diseases in human, but their roles in human diseases are yet to be established. We designed EnHERV to make accessible the identified endogenous retrovirus repetitive sequences from Repbase Update (a database of eukaryotic repetitive elements) that are present in the human genome. Defragmentation process was done to improve the Repeat-Masker annotation output. The defragmented elements were used as core database in EnHERV. EnHERV is available at http://sysbio.chula.ac.th/enherv and can be searched using either gene lists of user interest or HERV characteristics. Besides the search function, EnHERV also provides an enrichment analysis function that allows users to perform enrichment analysis between selected HERV characteristics and user-input gene lists, especially genes with the expression profile of a certain disease. EnHERV will facilitate exploratory studies of specific HERV characteristics that control gene expression patterns related to various disease conditions. Here we analyzed 25 selected HERV groups/names from all four HERV superfamilies, using the sense and anti-sense directions of the HERV and gene expression profiles from 49 specific tissue and disease conditions. We found that intragenic HERVs were associated with down-regulated genes in most cancer conditions and in psoriatic skin tissues and associated with up-regulated genes in immune cells particularly from systemic lupus erythematosus (SLE) patients. EnHERV allowed the analysis of how different types of LTRs were differentially associated with specific gene expression profiles in particular disease conditions for further studies into their mechanisms and functions.	[Tongyoo, Pumipat] Chulalongkorn Univ, Fac Grad Sch, Interdept Program Biomed Sci, Bangkok, Thailand; [Avihingsanon, Yingyos; Hirankarn, Nattiya] Chulalongkorn Univ, Fac Med, Ctr Excellence Immunol & Immune Mediated Dis, Bangkok, Thailand; [Avihingsanon, Yingyos] Chulalongkorn Univ, Dept Med, Div Nephrol, Bangkok, Thailand; [Avihingsanon, Yingyos] King Chulalongkorn Mem Hosp, Bangkok, Thailand; [Prom-On, Santhitham] King Mongkuts Univ Technol Thonburi, Fac Engn, Comp Engn Dept, Bangkok, Thailand; [Mutirangura, Apiwat] Chulalongkorn Univ, Fac Med, Ctr Excellence Mol Genet Canc & Human Dis, Dept Anat, Bangkok, Thailand; [Mhuantong, Wuttichai] Natl Ctr Genet Engn & Biotechnol BIOTEC, Enzyme Technol Lab, Microbial Biotechnol & Biochem Res Unit, Khlong Luang, Pathum Thani, Thailand; [Hirankarn, Nattiya] Chulalongkorn Univ, Fac Med, Dept Microbiol, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; King Mongkuts University of Technology Thonburi; Chulalongkorn University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chulalongkorn University	Hirankarn, N (corresponding author), Chulalongkorn Univ, Fac Med, Ctr Excellence Immunol & Immune Mediated Dis, Bangkok, Thailand.; Hirankarn, N (corresponding author), Chulalongkorn Univ, Fac Med, Dept Microbiol, Bangkok, Thailand.	Nattiya.H@gmail.com		Tongyoo, Pumipat/0000-0002-3274-5475; Hirankarn, Nattiya/0000-0003-2224-6856	Thailand Research Fund; Chulalongkorn University [PHD/0200/2552, CU-58-001-HR]; Ratchadapisek Somphot Endowment Fund; International Research Integration, Chula Research Scholar, Ratchadapisek Somphot Endowment Fund	Thailand Research Fund(Thailand Research Fund (TRF)); Chulalongkorn University(Chulalongkorn University); Ratchadapisek Somphot Endowment Fund; International Research Integration, Chula Research Scholar, Ratchadapisek Somphot Endowment Fund	This work was supported by the Thailand Research Fund under Royal Golden Jubilee Ph.D. Program and Chulalongkorn University (PHD/0200/2552, to PT); the Ratchadapisek Sompoch Endowment Fund (2015), Chulalongkorn University (CU-58-001-HR, to NH); and the Grant for International Research Integration, Chula Research Scholar, Ratchadapisek Somphot Endowment Fund (to NH).	Absher DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003678; Aporntewan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017934; Babaian A, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0080-x; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bergman CM, 2007, BRIEF BIOINFORM, V8, P382, DOI 10.1093/bib/bbm048; Chen SH, 2016, CLIN EXP IMMUNOL; Chuong EB, 2017, NAT REV GENET, V18, P71, DOI 10.1038/nrg.2016.139; Cohen CJ, 2009, GENE, V448, P105, DOI 10.1016/j.gene.2009.06.020; Nogueira MAD, 2015, ARCH DERMATOL RES, V307, P259, DOI 10.1007/s00403-014-1524-0; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; FEUCHTERMURTHY AE, 1993, NUCLEIC ACIDS RES, V21, P135, DOI 10.1093/nar/21.1.135; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Giordano J, 2007, PLOS COMPUT BIOL, V3, P1321, DOI 10.1371/journal.pcbi.0030137; Glinsky GV, 2015, GENOME BIOL EVOL, V7, P1432, DOI 10.1093/gbe/evv081; Goodier JL, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0070-z; Grandi N, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0301-x; Griffiths DJ, 2001, GENOME BIOL, V2; Haase K, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0146-5; Hubley R., 2013, REPEATMASKER OPEN 40; Johnson R, 2014, RNA, V20, P959, DOI 10.1261/rna.044560.114; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kapusta A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003470; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Katoh I, 2011, NEOPLASIA, V13, P1081, DOI 10.1593/neo.11794; Kelley D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r107; Kronung SK, 2016, ONCOTARGET, V7, P33484, DOI 10.18632/oncotarget.9255; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lamprecht B, 2010, NAT MED, V16, P571, DOI 10.1038/nm.2129; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Le Dantec C, 2015, VIRUSES-BASEL, V7, P1238, DOI 10.3390/v7031238; Levy A, 2008, NUCLEIC ACIDS RES, V36, pD47, DOI 10.1093/nar/gkm949; Lock FE, 2014, P NATL ACAD SCI USA, V111, pE3534, DOI 10.1073/pnas.1405507111; Long H, 2016, J AUTOIMMUN; Lu XY, 2014, NAT STRUCT MOL BIOL, V21, P423, DOI 10.1038/nsmb.2799; Mameli G, 2015, J NEUROIMMUNOL, V280, P66, DOI 10.1016/j.jneuroim.2015.03.003; Mavragani CP, 2016, ARTHRITIS RHEUMATOL, V68, P2686, DOI 10.1002/art.39795; Miao CG, 2014, LUPUS, V23, P730, DOI 10.1177/0961203314527365; Nakkuntod J, 2013, J HUM GENET, V58, P241, DOI 10.1038/jhg.2013.6; Nakkuntod J, 2011, CLIN CHIM ACTA, V412, P1457, DOI 10.1016/j.cca.2011.04.002; Okada M, 2002, J RHEUMATOL, V29, P1678; Paces J, 2002, NUCLEIC ACIDS RES, V30, P205, DOI 10.1093/nar/30.1.205; Pereira V, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r79; Pereira Vini, 2008, BMC Genomics, V9, P614, DOI 10.1186/1471-2164-9-614; Perron H, 2005, J NEUROVIROL, V11, P23, DOI 10.1080/13550280590901741; Pi WH, 2010, P NATL ACAD SCI USA, V107, P12992, DOI 10.1073/pnas.1004139107; Piotrowski PC, 2005, CLIN RHEUMATOL, V24, P620, DOI 10.1007/s10067-005-1123-8; Renaudineau Y, 2005, GENES IMMUN, V6, P663, DOI 10.1038/sj.gene.6364253; Schmitt K, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0035-7; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; SMIT AFA, 1993, NUCLEIC ACIDS RES, V21, P1863, DOI 10.1093/nar/21.8.1863; Sukapan P, 2014, J HUM GENET, V59, P178, DOI 10.1038/jhg.2013.140; Suntsova M, 2015, CELL MOL LIFE SCI, V72, P3653, DOI 10.1007/s00018-015-1947-6; Taruscio D, 2002, MAMM GENOME, V13, P216, DOI 10.1007/s00335-001-2118-7; Tsai HC, 2011, CELL RES, V21, P502, DOI 10.1038/cr.2011.24; Wang JC, 2016, NAT PROTOC, V11, P327, DOI 10.1038/nprot.2016.016; Watanabe Y, 2000, GENE, V252, P163, DOI 10.1016/S0378-1119(00)00208-0; Wu ZW, 2015, J DERMATOL SCI, V77, P110, DOI 10.1016/j.jdermsci.2014.12.004; Yooyongsatit S, 2015, J HUM GENET, V60, P349, DOI 10.1038/jhg.2015.33	60	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177119	10.1371/journal.pone.0177119	http://dx.doi.org/10.1371/journal.pone.0177119			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472109	gold, Green Submitted, Green Published			2022-12-26	WOS:000400648500139
J	Sato, M; Inoue, A; Shima, H				Sato, Motohiro; Inoue, Akio; Shima, Hiroyuki			Bamboo-inspired optimal design for functionally graded hollow cylinders	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; VASCULAR BUNDLES; STRENGTH; MOSO	The optimal distribution of the reinforcing fibers for stiffening hollow cylindrical composites is explored using the linear elasticity theory. The spatial distribution of the vascular bundles in wild bamboo, a nature-designed functionally graded material, is the basis for the design. Our results suggest that wild bamboos maximize their flexural rigidity by optimally regulating the radial gradation of their vascular bundle distribution. This fact provides us with a plantmimetic design principle that enables the realization of high-stiffness and lightweight cylindrical composites.	[Sato, Motohiro] Hokkaido Univ, Div Engn & Policy Sustainable Environm, Fac Engn, Sapporo, Hokkaido, Japan; [Inoue, Akio] Prefectural Univ Kumamoto, Fac Environm & Symbiot Sci, Kumamoto, Japan; [Shima, Hiroyuki] Univ Yamanashi, Dept Environm Sci, Kofu, Yamanashi, Japan	Hokkaido University; University of Yamanashi	Shima, H (corresponding author), Univ Yamanashi, Dept Environm Sci, Kofu, Yamanashi, Japan.	hshima@yamanashi.ac.jp	Inoue, Akio/AAK-6509-2020; Sato, Motohiro/D-6788-2012		Japan Society for the Promotion of Science KAKENHI Grant [JP25390147, JP26292088, JP15H04207, JP16K12823, JP16K14948]; Grants-in-Aid for Scientific Research [16K14948] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (https://www. isps.go jp/english/index.html) KAKENHI Grant Numbers JP25390147 (HS), JP26292088 (Al), JP15H04207 (MS), JP16K12823 (MS) and JP16K14948 (Al). The first author (MS) expresses astudy design, data collection and analysis, decision to publish, or preparation of the manuscript.ppreciation for the research grant from the Suhara memorial foundation. The funders had no role in	Amada S, 1997, COMPOS PART B-ENG, V28, P13, DOI 10.1016/S1359-8368(96)00020-0; Birman V, 2007, APPL MECH REV, V60, P195, DOI 10.1115/1.2777164; Clark LG, 2015, TROP FOREST, P1, DOI 10.1007/978-3-319-14133-6_1; Dixon PG, 2015, CONSTR BUILD MATER, V90, P11, DOI 10.1016/j.conbuildmat.2015.04.042; Dixon PG, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0321; Ghavami K., 2003, ASIAN J CIV ENG, V4, P1; GROSSER D, 1971, WOOD SCI TECHNOL, V5, P290, DOI 10.1007/BF00365061; Habibi MK, 2015, ACTA BIOMATER, V16, P178, DOI 10.1016/j.actbio.2015.01.038; Habibi MK, 2014, SCI REP-UK, V4, DOI 10.1038/srep05598; Inoue A, 2011, LANDSC ECOL ENG, V7, P153, DOI 10.1007/s11355-010-0121-4; Garcia JJ, 2012, CONSTR BUILD MATER, V31, P52, DOI 10.1016/j.conbuildmat.2011.12.089; Jha DK, 2013, COMPOS STRUCT, V96, P833, DOI 10.1016/j.compstruct.2012.09.001; Koizumi M, 1997, COMPOS PART B-ENG, V28, P1, DOI 10.1016/S1359-8368(96)00016-9; Lee PH, 2014, CONSTR BUILD MATER, V51, P235, DOI 10.1016/j.conbuildmat.2013.10.051; Li HB, 2011, J MATER RES, V26, P2749, DOI 10.1557/jmr.2011.314; Li Shihong, 1994, Biomimetics, V2, P15; Muller E, 2003, MAT SCI ENG A-STRUCT, V362, P17, DOI 10.1016/S0921-5093(03)00581-1; NOGATA F, 1995, COMPOS ENG, V5, P743, DOI 10.1016/0961-9526(95)00037-N; Pompe W, 2003, MAT SCI ENG A-STRUCT, V362, P40, DOI 10.1016/S0921-5093(03)00580-X; Ray AK, 2005, J MATER SCI, V40, P5249, DOI 10.1007/s10853-005-4419-9; Richard MJ, 2015, WOOD SCI TECHNOL, V49, P99, DOI 10.1007/s00226-014-0681-9; Shang LL, 2015, J WOOD SCI, V61, P562, DOI 10.1007/s10086-015-1510-y; Shima H, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.022406; Silva ECN, 2006, J MATER SCI, V41, P6991, DOI 10.1007/s10853-006-0232-3; Sun YM, 2015, NANO LETT, V15, P3899, DOI 10.1021/acs.nanolett.5b00738; Tan T, 2011, ACTA BIOMATER, V7, P3796, DOI 10.1016/j.actbio.2011.06.008; Wegst UGK, 2011, J MECH BEHAV BIOMED, V4, P744, DOI 10.1016/j.jmbbm.2011.02.013; Youssefian S, 2015, SCI REP-UK, V5, DOI 10.1038/srep11116; Yu Y, 2014, ADV MATER, V26, P2494, DOI 10.1002/adma.201304974; Zhou AP, 2012, CONSTR BUILD MATER, V35, P191, DOI 10.1016/j.conbuildmat.2012.03.011; Zou M, 2016, THIN WALL STRUCT, V101, P222, DOI 10.1016/j.tws.2015.12.023	31	23	24	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0175029	10.1371/journal.pone.0175029	http://dx.doi.org/10.1371/journal.pone.0175029			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467441	Green Submitted, Green Published, gold			2022-12-26	WOS:000400647000011
J	Lin, YP; Edwards, RD; Kondo, T; Semple, TL; Cook, LG				Lin, Yen-Po; Edwards, Robert D.; Kondo, Takumasa; Semple, Thomas L.; Cook, Lyn G.			Species delimitation in asexual insects of economic importance: The case of black scale (Parasaissetia nigra), a cosmopolitan parthenogenetic pest scale insect	PLOS ONE			English	Article							PHYLOGENETIC UTILITY; MOLECULAR PHYLOGENY; BAYESIAN-INFERENCE; CRYPTIC DIVERSITY; GENETIC DIVERSITY; HOST-SPECIFICITY; DNA BARCODES; HEMIPTERA; GENUS; COCCOIDEA	Asexual lineages provide a challenge to species delimitation because species concepts either have little biological meaning for them or are arbitrary, since every individual is monophyletic and reproductively isolated from all other individuals. However, recognition and naming of asexual species is important to conservation and economic applications. Some scale insects are widespread and polyphagous pests of plants, and several species have been found to comprise cryptic species complexes. Parasaissetia nigra (Nietner, 1861) (Hemiptera: Coccidae) is a parthenogenetic, cosmopolitan and polyphagous pest that feeds on plant species from more than 80 families. Here, we implement multiple approaches to assess the species status of P. nigra, including coalescence-based analyses of mitochondrial and nuclear genes, and ecological niche modelling. Our results indicate that the sampled specimens of P. nigra should be considered to comprise at least two ecotypes (or "species") that are ecologically differentiated, particularly in relation to temperature and moisture. The presence of more than one ecotype under the current concept of P. nigra has implications for biosecurity because the geographic extent of each type is not fully known: some countries may currently have only one of the biotypes. Introduction of additional lineages could expand the geographic extent of damage by the pest in some countries.	[Lin, Yen-Po] Shanxi Univ, Coll Life Sci, Taiyuan, Shanxi, Peoples R China; [Lin, Yen-Po; Cook, Lyn G.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Lin, Yen-Po; Semple, Thomas L.] Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia; [Edwards, Robert D.] Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA; [Kondo, Takumasa] Corp Colombiana Invest Agropecuaria CORPOI, Ctr Invest Palmira, Valle Del Cauca, Colombia	Shanxi University; University of Queensland; Australian National University; Smithsonian Institution; Smithsonian National Museum of Natural History; Corporacion Colombiana de Investigacion Agropecuaria, AGROSAVIA	Lin, YP (corresponding author), Shanxi Univ, Coll Life Sci, Taiyuan, Shanxi, Peoples R China.; Lin, YP (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.; Lin, YP (corresponding author), Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia.	yenpo.lin@uqconnect.edu.au	Lin, Yen-Po/D-6517-2015; Semple, Tom/L-3322-2019; Cook, Lyn/G-7336-2012	Lin, Yen-Po/0000-0003-3103-1777; Cook, Lyn/0000-0002-3172-4920; Semple, Thomas/0000-0003-2291-8034	Australian Research Council Discovery Projects [DP130101141]; University of Queensland, Australia; College of Life Science, Shanxi University, China [140975]; Australian Biological Resources Study [RF212-52]	Australian Research Council Discovery Projects(Australian Research Council); University of Queensland, Australia(University of Queensland); College of Life Science, Shanxi University, China; Australian Biological Resources Study	This project was supported, in part, by an Australian Research Council Discovery Projects grant (DP130101141) and funding from The University of Queensland, Australia to LGC, and the College of Life Science, Shanxi University, China to YPL (National Serial Number of Postdoctoral Fellowship: 140975).Some specimens were collected on field trips funded by an Australian Biological Resources Study grant (RF212-52) to LGC.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous DJ, 2001, STAT SCI, V16, P23, DOI 10.1214/ss/998929474; Andersen JC, 2010, ANN ENTOMOL SOC AM, V103, P844, DOI 10.1603/AN10060; ANDERSSON L, 1990, TAXON, V39, P375, DOI 10.2307/1223084; [Anonymous], 2012, EVOL BIOINFORM, V8, P1, DOI 10.4137/EBO.S8532; [Anonymous], 2014, TRACER V1 6; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Australian Trade Commission, 2015, TRAD IMP EXP; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Ben-Dov Y, 2012, COCCIDAE SCALENET DA; Ben-Dov Yair, 1997, World Crop Pests, V7A, P389; BENDOV Y, 1978, PHYTOPARASITICA, V6, P115, DOI 10.1007/BF02981211; Birky CW, 2011, ZOOL J LINN SOC-LOND, V161, P723, DOI 10.1111/j.1096-3642.2010.00674.x; Birky CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010609; Blair CP, 2005, EVOLUTION, V59, P304; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; Brady Sean G., 2000, P131; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Causton CE, 2006, ANN ENTOMOL SOC AM, V99, P121, DOI 10.1603/0013-8746(2006)099[0121:AITAIF]2.0.CO;2; CHO SW, 1995, MOL BIOL EVOL, V12, P650; CHUA TH, 1997, WORLD CROP PESTS B, V7, P395; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Condon M, 2008, BIOL J LINN SOC, V93, P779, DOI 10.1111/j.1095-8312.2007.00943.x; Cook LG, 2003, AUST J ENTOMOL, V42, P327, DOI 10.1046/j.1440-6055.2003.00370.x; Cook LG, 2007, ECOL ENTOMOL, V32, P506, DOI 10.1111/j.1365-2311.2007.00893.x; Correa M, 2011, ZOOTAXA, P46, DOI 10.11646/zootaxa.2926.1.2; Cotterill FPD, 2014, SYST BIOL, V63, P819, DOI 10.1093/sysbio/syu003; Crisp Michael D., 1996, Telopea, V6, P813; DE LOTTO G., 1967, S AFR J AGR SCI, V10, P781; De Lotto G., 1956, Bulletin of Entomological Research London, V47, P239, DOI 10.1017/S0007485300046691; de Queiroz K, 1998, ENDLESS FORMS, P57; DOBZHANSKY T, 1950, AM NAT, V84, P401, DOI 10.1086/281638; DOBZHANSKY T., 1951, Genetics and the origin of species.; Dowton M, 1998, MOL PHYLOGENET EVOL, V10, P354, DOI 10.1006/mpev.1998.0533; Drummond A, 2006, ANAL BEASI OUPUT; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; European and Mediterranean Plant Protection Organization, 2002, Bulletin OEPP, V32, P293; European and Mediterranean Plant Protection Organization (EPPO), 2013, EPPO A1 A2 LISTS PES; Ezard T, 2009, PACKAGE SPLITS SPECI; Fitzhugh K, 2009, ACTA BIOTHEOR, V57, P201, DOI 10.1007/s10441-009-9071-3; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Food and Agriculture Organization (FAO), 2002, GLOSS PHYT TERM INT; Frankham R, 2012, BIOL CONSERV, V153, P25, DOI 10.1016/j.biocon.2012.04.034; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Gamble T, 2012, MOL PHYLOGENET EVOL, V62, P943, DOI 10.1016/j.ympev.2011.11.033; Gernhard T, 2008, J MATH BIOL, V57, P713, DOI 10.1007/s00285-008-0186-y; Gill Raymond J., 1988, Technical Series in Agricultural Biosystematics and Plant Pathology, V1, P1; Green EE, 1904, COCCIDAE CEYLON, VIII; Gullan PJ, 2010, SYST ENTOMOL, V35, P329, DOI 10.1111/j.1365-3113.2009.00513.x; Gwiazdowski RA, 2011, BIOL J LINN SOC, V104, P47, DOI 10.1111/j.1095-8312.2011.01716.x; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hamon AB, 1984, SOFT SCALE INSECTS F; Hardy NB, 2008, INVERTEBR SYST, V22, P365, DOI 10.1071/IS07032; Hardy NB, 2007, SYST ENTOMOL, V32, P396, DOI 10.1111/j.1365-3113.2007.00377.x; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hodgson CJ, 1994, SCALE INSECT FAMILY; Hoy MA, 1994, INSECT MOL GENETICS, P337; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hulcr J, 2007, MOL ECOL NOTES, V7, P549, DOI 10.1111/j.1471-8286.2007.01786.x; Jermiin LS, 2004, SYST BIOL, V53, P638, DOI 10.1080/10635150490468648; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kingman J., 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Kosztarab M., 1997, WORLD CROP PESTS B, V7B, P357; Lin Y.-P., 2010, Entomologia Hellenica, V19, P90; Lin YP, 2015, ECOL ENTOMOL, V40, P299, DOI 10.1111/een.12191; Lin YP, 2013, SYST ENTOMOL, V38, P249, DOI 10.1111/j.1365-3113.2012.00664.x; Lohse K, 2009, SYST BIOL, V58, P439, DOI 10.1093/sysbio/syp039; Malenke JR, 2009, EVOLUTION, V63, P1427, DOI 10.1111/j.1558-5646.2009.00642.x; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; Maynard GV, 2004, AUST J ENTOMOL, V43, P318, DOI 10.1111/j.1326-6756.2004.00441.x; Mayr E., 1942, P1; Miller Douglass R., 1997, World Crop Pests, V7A, P229; Miller GL, 1991, THESIS; Mills PJ, 2014, MOL PHYLOGENET EVOL, V77, P126, DOI 10.1016/j.ympev.2014.03.015; MISHLER BD, 1985, BRYOLOGIST, V88, P207, DOI 10.2307/3243030; MISHLER BD, 1982, SYST ZOOL, V31, P491, DOI 10.2307/2413371; NEI M, 1993, J MOL EVOL, V37, P240, DOI 10.1007/BF00175500; NEWTON MA, 1994, J R STAT SOC B, V56, P3; Nietner J, 1861, CEYLON TIMES; Nylander J.A.A, 2004, MRMODELTEST V2; Omland KE, 2006, MOL ECOL, V15, P795, DOI 10.1111/j.1365-294X.2005.02827.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Park DS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-423; Paterson H.E.H., 1985, Transvaal Museum Monograph, P21; Pedersen AG, 2007, BAYESIAN PHYLOGENETI; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; R Core Team, 2021, R LANGUAGE ENV STAT; Raftery AE, 2007, BAYESIAN STAT, V8, P1; Rakimov A, 2013, AUST J ENTOMOL, V52, P371, DOI 10.1111/aen.12039; Rambaut A, 1998, SE AL SEQUENCE ALIGN; RIESEBERG LH, 1994, TAXON, V43, P21, DOI 10.2307/1223457; Rodriguero MS, 2013, MOL PHYLOGENET EVOL, V68, P644, DOI 10.1016/j.ympev.2013.04.011; ROGERS J, 1980, P NATL ACAD SCI-BIOL, V77, P1877, DOI 10.1073/pnas.77.4.1877; Rosenblueth M, 2012, J EVOLUTION BIOL, V25, P2357, DOI 10.1111/j.1420-9101.2012.02611.x; Schon I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039844; Schoonhoven L. M., 2005, Insect-plant biology; Shree M. P., 2000, Entomon, V25, P91; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Smith Ralph H., 1944, HILGARDIA, V16, P225; SOKAL RR, 1970, AM NAT, V104, P127, DOI 10.1086/282646; Statistics New Zealand, 2015, GOODS SERV TRAD COUN; Strong D., 1984, INSECTS PLANTS COMMU; Sukumaran J, 2017, P NATL ACAD SCI USA, V114, P1607, DOI 10.1073/pnas.1607921114; Swirski E, 1997, WORLD CROP PESTS B, V7B, P271; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Takahashi R., 1955, Insecta Matsumurana Sapporo, V19, P23; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; van Nieukerken EJ, 1986, ZOOLOGISCHE VERHANDE, V236, P1; VANVALEN L, 1976, TAXON, V25, P233, DOI 10.2307/1219444; VONDOHLEN CD, 1995, J MOL EVOL, V41, P211, DOI 10.1007/BF00170675; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Whiting MF, 1997, SYST BIOL, V46, P1, DOI 10.1093/sysbio/46.1.1; WILEY EO, 1978, SYST ZOOL, V27, P17, DOI 10.2307/2412809; Williams DJ, 1990, SCALE INSECTS TROP 3; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002	125	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0175889	10.1371/journal.pone.0175889	http://dx.doi.org/10.1371/journal.pone.0175889			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459805	Green Published, gold, Green Submitted			2022-12-26	WOS:000400645000007
J	Verma, G; Dhar, YV; Srivastava, D; Kidwai, M; Chauhan, PS; Bag, SK; Asif, MH; Chakrabarty, D				Verma, Giti; Dhar, Yogeshwar Vikram; Srivastava, Dipali; Kidwai, Maria; Chauhan, Puneet Singh; Bag, Sumit Kumar; Asif, Mehar Hasan; Chakrabarty, Debasis			Genome-wide analysis of rice dehydrin gene family: Its evolutionary conservedness and expression pattern in response to PEG induced dehydration stress	PLOS ONE			English	Article							ENHANCES TOLERANCE; ABIOTIC STRESSES; COLD TOLERANCE; OSMOTIC-STRESS; PROTEINS; OVEREXPRESSION; IDENTIFICATION; DROUGHT; SALT	Abiotic stresses adversely affect cellular homeostasis, impairing overall growth and development of plants. These initial stress signals activate downstream signalling processes, which, subsequently, activate stress-responsive mechanisms to re-establish homeostasis. Dehydrins (DHNs) play an important role in combating dehydration stress. Rice (Oryza sativa L.), which is a paddy crop, is susceptible to drought stress. As drought survival in rice might be viewed as a trait with strong evolutionary selection pressure, we observed DHNs in the light of domestication during the course of evolution. Overall, 65 DHNs were identified by a genome-wide survey of 11 rice species, and 3 DHNs were found to be highly conserved. The correlation of a conserved pattern of DHNs with domestication and diversification of wild to cultivated rice was validated by synonymous substitution rates, indicating that Oryza rufipogon and Oryza sativa ssp. japonica follow an adaptive evolutionary pattern; whereas Oryza nivara and Oryza sativa ssp. indica demonstrate a conserved evolutionary pattern. A comprehensive analysis of tissue-specific expression of DHN genes in japonica and their expression profiles in normal and PEG (poly ethylene glycol)-induced dehydration stress exhibited a spatiotemporal expression pattern. Their interaction network reflects the cross-talk between gene expression and the physiological processes mediating adaptation to dehydration stress. The results obtained strongly indicated the importance of DHNs, as they are conserved during the course of domestication.	[Verma, Giti; Dhar, Yogeshwar Vikram; Srivastava, Dipali; Kidwai, Maria; Chauhan, Puneet Singh; Bag, Sumit Kumar; Asif, Mehar Hasan; Chakrabarty, Debasis] CSIR, Natl Bot Res Inst, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI)	Verma, G; Chakrabarty, D (corresponding author), CSIR, Natl Bot Res Inst, Lucknow, Uttar Pradesh, India.	gitivermabiochem@gmail.com; chakrabartyd@nbri.res.in	Bag, Sumit/AAP-5728-2020; Bag, Sumit K/B-4010-2013; Chakrabarty, Debasis/AAF-3680-2019; Chakrabarty, Debasis/H-4102-2017; Chauhan, Puneet Singh/AAB-7606-2019	Bag, Sumit/0000-0001-8907-2841; Bag, Sumit K/0000-0001-8907-2841; Chakrabarty, Debasis/0000-0003-4795-199X; Chakrabarty, Debasis/0000-0003-4795-199X; Chauhan, Puneet Singh/0000-0001-5955-8656; Srivastava, Dipali/0000-0002-4451-8317	Science and Engineering Research Board, New Delhi, India [SBNS/LS-74/2014]; network project - Council of Scientific and Industrial Research, New Delhi [BSC-204]; CSIR-National Botanical Research Institute, Lucknow	Science and Engineering Research Board, New Delhi, India; network project - Council of Scientific and Industrial Research, New Delhi; CSIR-National Botanical Research Institute, Lucknow	This research was supported by the Science and Engineering Research Board, New Delhi, India (project file no. SBNS/LS-74/2014) and also by the network project (BSC-204) funded by the Council of Scientific and Industrial Research, New Delhi. The authors are also thankful to Director, CSIR-National Botanical Research Institute, Lucknow, for the facilities and the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors sincerely thank Dr. K. N. Nair for his role in extensive correction of the manuscript. This research was supported by the Science and Engineering Research Board, New Delhi, India (project file no. SB/YS/LS-74/2014) and also by the network project (BSC-204) funded by the Council of Scientific and Industrial Research, New Delhi. The authors are also thankful to Director, CSIR-National Botanical Research Institute, Lucknow for the facilities and the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bailey-Serres J, 2012, PLANT PHYSIOL, V160, P1698, DOI 10.1104/pp.112.208173; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Bouman BAM, 2005, AGR WATER MANAGE, V74, P87, DOI 10.1016/j.agwat.2004.11.007; Brini F, 2007, PLANT CELL REP, V26, P2017, DOI 10.1007/s00299-007-0412-x; Close TJ, 1997, PHYSIOL PLANTARUM, V100, P291, DOI 10.1034/j.1399-3054.1997.1000210.x; Du H, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00397; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Flagel LE, 2009, NEW PHYTOL, V183, P557, DOI 10.1111/j.1469-8137.2009.02923.x; Ge S, 1999, P NATL ACAD SCI USA, V96, P14400, DOI 10.1073/pnas.96.25.14400; Graether SP, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00576; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; Hara M, 2003, PLANTA, V217, P290, DOI 10.1007/s00425-003-0986-7; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Koag MC, 2009, PLANT PHYSIOL, V150, P1503, DOI 10.1104/pp.109.136697; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar M, 2014, J PLANT BIOL, V57, P383, DOI 10.1007/s12374-014-0487-1; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu CC, 2012, PLANT MOL BIOL REP, V30, P848, DOI 10.1007/s11105-011-0395-1; Liu H, 2015, PLANT SCI, V231, P198, DOI 10.1016/j.plantsci.2014.12.006; Liu J, 2016, GENES GENOM, V1, P13; McCouch SR, 2008, RICE, V1, P72, DOI 10.1007/s12284-008-9004-9; Mostajeran A., 2009, American-Eurasian Journal of Agricultural and Environmental Science, V5, P264; Mouillon JM, 2008, PLANT PHYSIOL, V148, P1925, DOI 10.1104/pp.108.124099; Nylander M, 2001, PLANT MOL BIOL, V45, P263, DOI 10.1023/A:1006469128280; Passricha N, 2016, PROTOPLASMA, V1, P16; Peng YH, 2008, PHYSIOL PLANTARUM, V134, P583, DOI 10.1111/j.1399-3054.2008.01164.x; Perdiguero P, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00682; Puhakainen T, 2004, PLANT MOL BIOL, V54, P743, DOI 10.1023/B:PLAN.0000040903.66496.a4; Sang T, 2013, CURR OPIN PLANT BIOL, V16, P139, DOI 10.1016/j.pbi.2013.03.003; Sato Y., 2012, NUCLEIC ACIDS RES; Shekhawat UKS, 2011, PLANTA, V234, P915, DOI 10.1007/s00425-011-1455-3; Vaughan DA, 2003, CURR OPIN PLANT BIOL, V6, P139, DOI 10.1016/S1369-5266(03)00009-8; Vaughan DA, 2008, PLANT SCI, V174, P394, DOI 10.1016/j.plantsci.2008.01.016; Wang MH, 2014, NAT GENET, V46, P982, DOI 10.1038/ng.3044; Wang XS, 2007, PLANT SCI, V172, P414, DOI 10.1016/j.plantsci.2006.10.004; Wang Y.P., 2012, NUCLEIC ACIDS RES, V40, P49; Wu SB, 2011, APPL ENVIRON MICROB, V77, P1135, DOI 10.1128/AEM.01803-10; Xing X, 2011, PLANT GROWTH REGUL, V65, P109, DOI 10.1007/s10725-011-9580-3; Xu J, 2008, MOL BIOTECHNOL, V38, P91, DOI 10.1007/s12033-007-9005-8; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yang YZ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-140; Yin ZM, 2006, PLANT SCI, V170, P1164, DOI 10.1016/j.plantsci.2006.02.002; Yue RQ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00576; Zhang YX, 2006, MOL BIOTECHNOL, V32, P205, DOI 10.1385/MB:32:3:205; Zhou JL, 2007, PLANT MOL BIOL, V63, P591, DOI 10.1007/s11103-006-9111-1; [No title captured]	50	34	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176399	10.1371/journal.pone.0176399	http://dx.doi.org/10.1371/journal.pone.0176399			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459834	gold, Green Published, Green Submitted			2022-12-26	WOS:000400645000031
J	Zhao, ZY; Huang, TM; Tang, CZ; Ni, KJ; Pan, XD; Yan, C; Fan, XD; Xu, DR; Luo, YL				Zhao, Zhiyong; Huang, Tianming; Tang, Chaozheng; Ni, Kaiji; Pan, Xiandi; Yan, Chao; Fan, Xiaoduo; Xu, Dongrong; Luo, Yanli			Altered resting-state intra- and inter-network functional connectivity in patients with persistent somatoform pain disorder	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; HUMAN BRAIN; PREFRONTAL CORTEX; NEUROPATHIC PAIN; FMRI; REPRESENTATIONS; TOMOGRAPHY; PERCEPTION; MODULATION; ACTIVATION	Patients with persistent somatoform pain disorder (PSPD) usually experience various functional impairments in pain, emotion, and cognition, which cannot be fully explained by a physiological process or a physical disorder. However, it is still not clear for the mechanism underlying the pathogenesis of PSPD. The present study aimed to explore the intra-and inter-network functional connectivity (FC) differences between PSPD patients and healthy controls (HCs). Functional magnetic resonance imaging (fMRI) was performed in 13 PSPD patients and 23 age- and gender-matched HCs. We used independent component analysis on resting-state fMRI data to calculate intra-and inter-network FCs, and we used the two-sample t-test to detect the FC differences between groups. Spearman correlation analysis was employed to evaluate the correlations between FCs and clinical assessments. As compared to HCs, PSPD patients showed decreased coactivations in the right superior temporal gyrus within the anterior default-mode network and the anterior cingulate cortex within the salience network, and increased coactivations in the bilateral supplementary motor areas within the sensorimotor network and both the left posterior cingulate cortex and the medial prefrontal cortex within the anterior default-mode network. In addition, we found that the PSPD patients showed decreased FNCs between sensorimotor network and audio network as well as visual network, between default-mode network and executive control network as well as audio network and between salience network and executive control network as well as right frontoparietal network, and increased FNCs between sensorimotor network and left frontoparietal network, salience network as well as cerebellum network, which were negatively correlated with the clinical assessments in PSPD patients. Our findings suggest that PSPD patients experience large-scale reorganization at the level of the functional networks, which suggests a possible mechanism underlying the pathogenesis of PSPD.	[Zhao, Zhiyong] East China Normal Univ, Inst Cognit Neurosci, Shanghai Key Lab Magnet Resonance, MOE, Shanghai, Peoples R China; [Zhao, Zhiyong] East China Normal Univ, Inst Cognit Neurosci, Shanghai Key Lab Brain Funct Genom, Shanghai Key Lab Magnet Resonance, Shanghai, Peoples R China; [Huang, Tianming] Shanghai Changning Mental Hlth Ctr, Dept Gen Psychiat, Shanghai, Peoples R China; [Tang, Chaozheng] Fudan Univ, Huashan Hosp, Dept Rehabil Med, Shanghai, Peoples R China; [Ni, Kaiji] HongKou Dist Mental Hlth Ctr Shanghai, Dept Psychiat, Shanghai, Peoples R China; [Pan, Xiandi] Tongji Univ, Tongji Hosp, Dept Psychiat, Shanghai, Peoples R China; [Yan, Chao] East China Normal Univ, Sch Psychol & Cognit Sci, Shanghai Key Lab Brain Funct Genom MOE & STCSM, Shanghai, Peoples R China; [Fan, Xiaoduo] Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA; [Xu, Dongrong] New York State Psychiat Inst & Hosp, MRI Unit, New York, NY 10032 USA; [Xu, Dongrong] Columbia Univ, New York, NY 10027 USA; [Luo, Yanli] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Psychol Med, Shanghai, Peoples R China	East China Normal University; East China Normal University; Fudan University; Tongji University; East China Normal University; University of Massachusetts System; University of Massachusetts Worcester; New York State Psychiatry Institute; Columbia University; Shanghai Jiao Tong University	Xu, DR (corresponding author), New York State Psychiat Inst & Hosp, MRI Unit, New York, NY 10032 USA.; Xu, DR (corresponding author), Columbia Univ, New York, NY 10027 USA.; Luo, YL (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Psychol Med, Shanghai, Peoples R China.	xu.dongrong@columbia.edu; luoluoyanli@163.com	Fan, Xiaoduo/AAV-1268-2020	Fan, Xiaoduo/0000-0003-4299-8924	National Natural Science Foundation of China [81100821]; Shanghai Science and Technology Committee [16ZR1432300]; China National Science Foundation [81471734]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); China National Science Foundation(National Natural Science Foundation of China (NSFC))	This work is supported by National Natural Science Foundation of China (No. 81100821) and a grant from Shanghai Science and Technology Committee (16ZR1432300), and China National Science Foundation (No. 81471734).	Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Burba B, 2006, CAN J PSYCHIAT, V51, P468, DOI 10.1177/070674370605100709; Cauda F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004542; de Souza JH, 2010, CLIN THER, V32, P2088, DOI 10.1016/j.clinthera.2010.11.002; Erhardt EB, 2011, HUM BRAIN MAPP, V32, P2075, DOI 10.1002/hbm.21170; Fang X, 2016, J NEUROL, V263, P1; Gundel H, 2008, PAIN, V137, P413, DOI 10.1016/j.pain.2007.10.003; Gureje O, 2015, CURR OPIN PSYCHIATR, V28, P345, DOI 10.1097/YCO.0000000000000186; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; HSIEH JC, 1995, PAIN, V63, P225, DOI 10.1016/0304-3959(95)00048-W; Huang TM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151360; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jiang LL, 2015, BRAIN STRUCT FUNCT, V220, P2485, DOI 10.1007/s00429-014-0795-8; Karibe H, 2010, PSYCHIAT CLIN NEUROS, V64, P476, DOI 10.1111/j.1440-1819.2010.02119.x; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Luo YF, 2014, J NANOMATER, V2014, DOI 10.1155/2014/654512; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; May A, 2011, NEUROSCIENTIST, V17, P209, DOI 10.1177/1073858410396220; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Otti A, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-84; Otti A, 2013, J PSYCHIATR NEUROSCI, V38, P57, DOI 10.1503/jpn.110187; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Quintero GC, 2013, J PAIN RES, V6, P713, DOI 10.2147/JPR.S45958; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Riedl V, 2011, NEUROIMAGE, V57, P206, DOI 10.1016/j.neuroimage.2011.04.011; Schmithorst VJ, 2004, J MAGN RESON IMAGING, V19, P365, DOI 10.1002/jmri.20009; Schonenberg M, 2014, EUR J PAIN, V18, P949, DOI 10.1002/j.1532-2149.2013.00440.x; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seifert F, 2011, CURR OPIN ANESTHESIO, V24, P515, DOI 10.1097/ACO.0b013e32834a1079; Sewards TV, 2002, BRAIN RES BULL, V59, P163, DOI 10.1016/S0361-9230(02)00864-X; Shi Y, 2015, EVID-BASED COMPL ALT, V501; Shilyansky C, 2016, LANCET PSYCHIAT, V3, P425, DOI 10.1016/S2215-0366(16)00012-2; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Stefanie K, 2011, EUR ARCH PSY CLIN N, V261, P267, DOI 10.1007/s00406-010-0148-4; Stoeter P, 2007, NEUROIMAGE, V36, P418, DOI 10.1016/j.neuroimage.2007.01.052; TALBOT JD, 1991, SCIENCE, V251, P1355, DOI 10.1126/science.2003220; Tang CZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152875; Valet M, 2009, PSYCHOSOM MED, V71, P49, DOI 10.1097/PSY.0b013e31818d1e02; Wang DW, 2014, HUM BRAIN MAPP, V35, P2573, DOI 10.1002/hbm.22350; Xie YF, 2009, ACTA PHARMACOL SIN, V30, P31, DOI 10.1038/aps.2008.14; Yoshino A, 2013, NEUROIMAGE-CLIN, V2, P782, DOI 10.1016/j.nicl.2013.06.001; Zhang SS, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-115; Zhao ZY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166210	50	31	34	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176494	10.1371/journal.pone.0176494	http://dx.doi.org/10.1371/journal.pone.0176494			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET6EO	28453543	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383900030
J	Dai, L; Lin, Z; Qiao, J; Chen, Y; Flemington, EK; Qin, Z				Dai, L.; Lin, Z.; Qiao, J.; Chen, Y.; Flemington, E. K.; Qin, Z.			Ribonucleotide reductase represents a novel therapeutic target in primary effusion lymphoma	ONCOGENE			English	Article							CELL-CYCLE ARREST; KAPOSIS-SARCOMA; DNA-SEQUENCES; HERPESVIRUS; IRON; CANCER; APOPTOSIS; AIDS; INHIBITORS; COMPONENT	Primary effusion lymphoma (PEL) is a highly aggressive B-cell malignancy that is closely associated with one of oncogenic viruses infection, Kaposi's sarcoma-associated herpesvirus. PEL prognosis is poor and patients barely survive >6 months even following active chemotherapy interventions. There is therefore an urgent need to discover more effective targets for PEL management. We recently found that the ribonucleotide reductase (RR) subunit M2 is potentially regulated by the key oncogenic hepatocyte growth factor/c-MET pathway in PEL. In this study, we set to investigate the role of RR in PEL pathogenesis and to evaluate its potential as a therapeutic target. We report that the RR inhibitor 3-AP actively induces PEL cell cycle arrest through inhibiting the activity of the nuclear factor-kappa B pathway. Using a xenograft model, we found that 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) effectively suppresses PEL progression in immunodeficient mice. Transcriptome analysis of 3-AP-treated PEL cell lines reveals altered cellular genes, most of whose roles in PEL have not yet been reported. Taken together, we propose that RR and its signaling pathway may serve as novel actionable targets for PEL management.	[Dai, L.; Qiao, J.; Qin, Z.] Tongji Univ, Sch Med, Dept Pediat, East Hosp, Shanghai, Peoples R China; [Dai, L.; Qin, Z.] Tongji Univ, Sch Med, Res Ctr Translat Med, Shanghai, Peoples R China; [Dai, L.; Qin, Z.] Tongji Univ, Sch Med, East Hosp, Key Lab Arrhythmias, Shanghai, Peoples R China; [Dai, L.; Qin, Z.] Louisiana State Univ, Hlth Sci Ctr, Louisiana Canc Res Ctr, Dept Genet, 1700 Tulane Ave,Suite 902, New Orleans, LA 70112 USA; [Lin, Z.; Flemington, E. K.] Tulane Univ, Hlth Sci Ctr, Tulane Canc Ctr, Dept Pathol, New Orleans, LA 70118 USA	Tongji University; Tongji University; Tongji University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Tulane University	Qin, Z (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Louisiana Canc Res Ctr, Dept Genet, 1700 Tulane Ave,Suite 902, New Orleans, LA 70112 USA.	zqin@lsuhsc.edu			DOD [CA140437]; Leukemia Research Foundation; Louisiana Clinical and Translational Science Center from NIH [U54GM104940]; NIH [AI101046, AI106676]; National Natural Science Foundation of China [81472547, 81672924, 81400164]; NATIONAL CANCER INSTITUTE [P01CA214091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106676, R01AI101046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940] Funding Source: NIH RePORTER	DOD(United States Department of Defense); Leukemia Research Foundation; Louisiana Clinical and Translational Science Center from NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by grants from a DOD Career Development Award (CA140437), the Leukemia Research Foundation, the Louisiana Clinical and Translational Science Center Pilot grants (U54GM104940 from NIH), NIH RO1s (AI101046 and AI106676), as well as awards from the National Natural Science Foundation of China (81472547, 81672924 and 81400164). Funding sources had no role in the study design, data collection/analysis, decision to publish and/or manuscript preparation.	Boulanger E, 2005, J CLIN ONCOL, V23, P4372, DOI 10.1200/JCO.2005.07.084; CAZZOLA M, 1990, BLOOD, V75, P1903; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chen WG, 2010, J VIROL, V84, P3898, DOI 10.1128/JVI.01321-09; Chen YB, 2007, ONCOLOGIST, V12, P569, DOI 10.1634/theoncologist.12-5-569; Dai L, 2016, ONCOTARGET, V7, P3806, DOI 10.18632/oncotarget.6584; Dai L, 2015, BLOOD, V126, P2821, DOI 10.1182/blood-2015-07-658823; Dai L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090349; Defee MR, 2011, AM J CANCER RES, V1, P687; Falchook GS, 2015, SEMIN ONCOL, V42, P832, DOI 10.1053/j.seminoncol.2015.09.022; Fan HZ, 1998, CANCER RES, V58, P1650; Fan HZ, 1997, P NATL ACAD SCI USA, V94, P13181, DOI 10.1073/pnas.94.24.13181; Flepisi BT, 2014, BIOMED PHARMACOTHER, V68, P665, DOI 10.1016/j.biopha.2014.04.010; Georgakilas AG, 2017, TRENDS MOL MED, V23, P310, DOI 10.1016/j.molmed.2017.02.001; Gottwein E, 2010, J VIROL, V84, P5229, DOI 10.1128/JVI.00202-10; IWAKI T, 1995, BRAIN RES, V673, P47, DOI 10.1016/0006-8993(94)01393-V; LARSSON A, 1986, ANTIMICROB AGENTS CH, V30, P598, DOI 10.1128/AAC.30.4.598; LIU SQ, 1995, NAT MED, V1, P267, DOI 10.1038/nm0395-267; NYHOLM S, 1993, BIOCHEMISTRY-US, V32, P11569, DOI 10.1021/bi00094a013; Qin Z, 2011, LEUKEMIA, V25, P1598, DOI 10.1038/leu.2011.144; Qin ZQ, 2014, MOL CANCER THER, V13, P154, DOI 10.1158/1535-7163.MCT-13-0466; Sarek G, 2013, ONCOGENE, V32, P1091, DOI 10.1038/onc.2012.118; Sasai K, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00247; Shao JM, 2005, BIOCHEM PHARMACOL, V69, P627, DOI 10.1016/j.bcp.2004.11.016; Simonart T, 2000, J INVEST DERMATOL, V115, P893, DOI 10.1046/j.1523-1747.2000.00119.x; Simonart T, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-1; Simonelli C, 2003, J CLIN ONCOL, V21, P3948, DOI 10.1200/JCO.2003.06.013; Stadler WM, 2008, CANCER CHEMOTH PHARM, V61, P689, DOI 10.1007/s00280-007-0524-6; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Weinberg ED, 1996, EUR J CANCER PREV, V5, P19, DOI 10.1097/00008469-199609001-00004; Yen Y, 2004, CANCER CHEMOTH PHARM, V54, P331, DOI 10.1007/s00280-004-0821-2; Zhou BS, 2013, CANCER RES, V73, P6484, DOI 10.1158/0008-5472.CAN-13-1094	33	12	12	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 31	2017	36	35					5068	5074		10.1038/onc.2017.122	http://dx.doi.org/10.1038/onc.2017.122			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FF3AV	28459467	Green Accepted			2022-12-26	WOS:000408768800011
J	Montesdeoca, N; Calabuig, P; Corbera, JA; Oros, J				Montesdeoca, Natalia; Calabuig, Pascual; Corbera, Juan A.; Oros, Jorge			A long-term retrospective study on rehabilitation of seabirds in Gran Canaria Island, Spain (2003-2013)	PLOS ONE			English	Article							PENGUINS SPHENISCUS-DEMERSUS; LIGHT-INDUCED MORTALITY; OIL-SPILL; ARTIFICIAL LIGHTS; CORYS SHEARWATER; SOUTH-AFRICA; WESTERN CAPE; PETRELS; ATTRACTION; SURVIVAL	Aims The aims of this study were to analyze the causes of morbidity and mortality in a large population of seabirds admitted to the Tafira Wildlife Rehabilitation Center (TWRC) in Gran Canaria Island, Spain, from 2003 to 2013, and to analyze the outcomes of the rehabilitation process. Methods We included 1,956 seabirds (133 dead on admission and 1,823 admitted alive) in this study. Causes of morbidity were classified into nine categories: light pollution (fallout), fishing gear interaction, crude oil, poisoning/intoxication, other traumas, metabolic/ nutritional disorder, orphaned young birds, other causes, and unknown/undetermined. The crude and stratified (by causes of admission) rates of the three final disposition categories (euthanasia Er, unassisted mortality M-r, and release R-r), the time until death, and the length of stay were also studied for the seabirds admitted alive. Results Yellow-legged Gull (Larus michahellis) was the species most frequently admitted (46.52%), followed by Cory's Shearwater (Calonectris diomedea borealis) (20.09%). The most frequent causes of morbidity were light pollution (fallout) (25.81%), poisoning/intoxication (24.69%), and other traumas (18.14%). The final disposition rates were: E-r = 15.35%, M-r = 16.29%, and R-r = 68.34%. The highest E-r was observed in the 'other traumas' category (58.08%). Seabirds admitted due to metabolic/ nutritional disorder had the highest M-r (50%). The highest R-r was observed in the light pollution (fallout) category (99.20%). Conclusions This survey provides useful information for the conservation of several seabird species. We suggest that at least the stratified analysis by causes of admission of the three final disposition rates, and the parameters time until death and length of stay at the center should be included in the outcome research of the rehabilitation of seabirds. The high release rate for seabirds (68.34%) achieved at the TWRC emphasizes the importance of wildlife rehabilitation centers for the conservation of seabirds.	[Montesdeoca, Natalia; Corbera, Juan A.] Univ Las Palmas Gran Canaria, Vet Fac, Dept Anim Pathol, Arucas, Las Palmas, Spain; [Calabuig, Pascual] Tafira Wildlife Rehabil Ctr, Cabildo Gran Canaria, Las Palmas Gran Canaria, Spain; [Oros, Jorge] Univ Las Palmas Gran Canaria, Vet Fac, Dept Morphol, Arucas, Las Palmas, Spain	Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria	Oros, J (corresponding author), Univ Las Palmas Gran Canaria, Vet Fac, Dept Morphol, Arucas, Las Palmas, Spain.	jorge.oros@ulpgc.es	Corbera, Juan Alberto/K-2289-2014; Orós, Jorge/G-8824-2015; Calabuig, Pascual/AAB-1723-2019	Corbera, Juan Alberto/0000-0001-7812-2065; Orós, Jorge/0000-0002-8346-5393; 				Altwegg R, 2008, BIOL CONSERV, V141, P1924, DOI 10.1016/j.biocon.2008.04.030; [Anonymous], 2004, EFFECTS PETROLEUM EX; Balseiro A, 2005, J WILDLIFE DIS, V41, P371, DOI 10.7589/0090-3558-41.2.371; Camacho M, 2013, J WILDLIFE DIS, V49, P637, DOI 10.7589/2012-03-093; Cooper JE, 2006, IN PRACTICE, V28, P2, DOI 10.1136/inpract.28.1.2; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; De la Cruz SEW, 2013, MAR POLLUT BULL, V67, P100, DOI 10.1016/j.marpolbul.2012.11.027; Duerr Rebecca S., 2015, Marine Ornithology, V43, P11; Einoder LD, 2009, FISH RES, V95, P6, DOI 10.1016/j.fishres.2008.09.024; EURING, 1994, AN AV HERR CIENT GES; Fauquier DA, 2013, J WILDLIFE DIS, V49, P246, DOI 10.7589/2011-09-270; Fontaine R, 2011, BIOL CONSERV, V144, P1998, DOI 10.1016/j.biocon.2011.04.022; Haman KH, 2013, J WILDLIFE DIS, V49, P235, DOI 10.7589/2012-04-119; IUCN SSC, 2014, IUCN RED LIST THREAT; Joys AC, 2003, 234 BTO; Le Corre M, 2002, BIOL CONSERV, V105, P93, DOI 10.1016/S0006-3207(01)00207-5; Li Y, 2012, B MAR SCI, V88, P559, DOI 10.5343/bms.2011.1039; Longcore T, 2004, FRONT ECOL ENVIRON, V2, P191, DOI 10.2307/3868314; Lorenzo J. A, 2007, ATLAS AVES NIDIFICAN; Martin A., 2001, AVES ARCHIPIELAGO CA; McNeil Raymond, 1993, Current Ornithology, V10, P187; Miles W, 2010, BIRD STUDY, V57, P244, DOI 10.1080/00063651003605064; Miller E.A., 2012, MINIMUM STANDARDS WI, V4th ed.; Molina-Lopez RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060242; Montesdeoca N, 2016, J WILDLIFE DIS, V52, P647, DOI 10.7589/2015-09-255; Neimanis A, 2007, J WILDLIFE DIS, V43, P327, DOI 10.7589/0090-3558-43.3.327; Newman SH, 2007, MAR ECOL PROG SER, V352, P299, DOI 10.3354/meps07076; Oro D, 2005, J ZOOL, V265, P421, DOI 10.1017/S0952836905006515; Oros J, 2005, DIS AQUAT ORGAN, V63, P13, DOI 10.3354/dao063013; Oros J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149398; Paleczny M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129342; Parsons N., 2016, SO AFRICAN SEABIRD C, P53; Parsons NJ, 2017, VET PARASITOL, V233, P52, DOI 10.1016/j.vetpar.2016.12.001; Parsons NJ, 2005, AFR J MAR SCI, V27, P289, DOI 10.2989/18142320509504087; Parsons NJ, 2015, DIS AQUAT ORGAN, V116, P149, DOI 10.3354/dao02907; Piatt JF, 2007, MAR ECOL PROG SER, V352, P199, DOI 10.3354/meps07070; REED JR, 1985, AUK, V102, P377, DOI 10.2307/4086782; Rodrigues P, 2012, EUR J WILDLIFE RES, V58, P147, DOI 10.1007/s10344-011-0555-5; Rodriguez A, 2012, ANIM CONSERV, V15, P519, DOI 10.1111/j.1469-1795.2012.00544.x; Rodriguez A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10670; Rodriguez A, 2012, IBIS, V154, P167, DOI 10.1111/j.1474-919X.2011.01175.x; Rodriguez A, 2009, IBIS, V151, P299, DOI 10.1111/j.1474-919X.2009.00925.x; Sherley RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110794; Shutt JL, 2014, J GREAT LAKES RES, V40, P58, DOI 10.1016/j.jglr.2014.01.001; Siebert U, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-43; Sleeman JM, 2003, J AVIAN MED SURG, V17, P33, DOI 10.1647/1082-6742(2003)017[0033:CWMANP]2.0.CO;2; Sleeman Jonathan M., 2008, P97; TELFER TC, 1987, WILDLIFE SOC B, V15, P406; van Deventer M, 2012, BOT MAR, V55, P31, DOI [10.1515/BOT.2011.122, 10.1515/bot.2011.122]; Weimerskirch H, 2004, POLAR BIOL, V27, P374, DOI 10.1007/s00300-004-0600-x; WERNHAM CV, 1997, 186 BTO; Woodford M.H., 2000, QUARANTINE HLTH SCRE; WORK TM, 1993, J ZOO WILDLIFE MED, V24, P54	53	10	10	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177366	10.1371/journal.pone.0177366	http://dx.doi.org/10.1371/journal.pone.0177366			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475653	Green Published, Green Submitted, gold			2022-12-26	WOS:000400649500065
J	Reynolds, TH; Soriano, RA; Obadi, OA; Murkland, S; Possidente, B				Reynolds, Thomas H.; Soriano, Rachelle A.; Obadi, Obadi A.; Murkland, Stanley; Possidente, Bernard			Long term rebaudioside A treatment does not alter circadian activity rhythms, adiposity, or insulin action in male mice	PLOS ONE			English	Article							WEIGHT-LOSS MAINTENANCE; METABOLIC SYNDROME; STEVIA-REBAUDIANA; OBESITY; BERTONI; RISK; CONSUMPTION; STEVIOSIDE; SACCHARIN; EXTRACT	Obesity is a major public health problem that is highly associated with insulin resistance and type 2 diabetes, two conditions associated with circadian disruption. To date, dieting is one of the only interventions that result in substantial weight loss, but restricting caloric intake is difficult to maintain long-term. The use of artificial sweeteners, particularly in individuals that consume sugar sweetened beverages (energy drinks, soda), can reduce caloric intake and possibly facilitate weight loss. The purpose of the present study was to examine the effects of the artificial sweetener, rebaudioside A (Reb-A), on circadian rhythms, in vivo insulin action, and the susceptibility to diet-induced obesity. Six month old male C57BL/6 mice were assigned to a control or Reb-A (0.1% Reb-A supplemented drinking water) group for six months. Circadian wheel running rhythms, body weight, caloric intake, insulin action, and susceptibility to diet-induced obesity were assessed. Time of peak physical activity under a 12: 12 light-dark (LD) cycle, mean activity levels, and circadian period in constant dark were not significantly different in mice that consumed Reb-A supplemented water compared to normal drinking water, indicating that circadian rhythms and biological clock function were unaltered. Although wheel running significantly reduced body weight in both Reb-A and control mice (P = 0.0001), consuming Reb-A supplemented water did not alter the changes in body weight following wheel running (P = 0.916). In vivo insulin action, as assessed by glucose, insulin, and pyruvate tolerance tests, was not different between mice that consumed Reb-A treated water compared to normal drinking water. Finally, Reb-A does not appear to change the susceptibility to diet-induced obesity as both groups of mice gained similar amounts of body weight when placed on a high fat diet. Our results indicate that consuming Reb-A supplemented water does not promote circadian disruption, insulin resistance, or obesity.	[Reynolds, Thomas H.] Skidmore Coll, Dept Hlth & Exercise Sci, Saratoga Springs, NY 12866 USA; Skidmore Coll, Dept Biol, Saratoga Springs, NY 12866 USA	Skidmore College; Skidmore College	Reynolds, TH (corresponding author), Skidmore Coll, Dept Hlth & Exercise Sci, Saratoga Springs, NY 12866 USA.	treynold@skidmore.edu		Reynolds, Thomas/0000-0002-0290-528X	Skidmore College Faculty Development	Skidmore College Faculty Development	This work was supported by a Skidmore College Faculty Development grant awarded to BP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported, in part, by a Skidmore College Faculty Development grant awarded to BP.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Anderson JW, 2001, AM J CLIN NUTR, V74, P579; Atteh JO, 2008, J ANIM PHYSIOL AN N, V92, P640, DOI 10.1111/j.1439-0396.2007.00760.x; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Davidson TL, 2014, NEUROBIOL LEARN MEM, V108, P172, DOI 10.1016/j.nlm.2013.07.014; Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935; Fowler SP, 2008, OBESITY, V16, P1894, DOI 10.1038/oby.2008.284; HORWITZ DL, 1988, DIABETES CARE, V11, P230, DOI 10.2337/diacare.11.3.230; Kim MJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1204; Kraschnewski JL, 2010, INT J OBESITY, V34, P1644, DOI 10.1038/ijo.2010.94; Laermans J, 2016, OBES REV, V17, P108, DOI 10.1111/obr.12351; Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159; MacLean PS, 2015, OBES REV, V16, P45, DOI 10.1111/obr.12255; Nettleton JA, 2009, DIABETES CARE, V32, P688, DOI 10.2337/dc08-1799; Ogden CL, 2014, JAMA-J AM MED ASSOC, V312, P189, DOI [10.1001/jama.2014.6228, 10.1001/jama.2014.6219]; Oishi K, 2016, NUTRITION, V32, P1159, DOI 10.1016/j.nut.2016.03.013; OLIVEIRAFILHO RM, 1989, GEN PHARMACOL-VASC S, V20, P187, DOI 10.1016/0306-3623(89)90013-X; Park JE, 2010, J SCI FOOD AGR, V90, P1099, DOI 10.1002/jsfa.3906; Pepino MY, 2013, DIABETES CARE, V36, P2530, DOI 10.2337/dc12-2221; Peplonska B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133761; Reiter RJ, 2012, ANN MED, V44, P564, DOI 10.3109/07853890.2011.586365; Sridhar GR, 2016, WORLD J DIABETES, V7, P515, DOI 10.4239/wjd.v7.i19.515; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Weiss EC, 2007, AM J PREV MED, V33, P34, DOI 10.1016/j.amepre.2007.02.040; Welsh JA, 2011, AM J CLIN NUTR, V94, P726, DOI 10.3945/ajcn.111.018366; Wheeler A, 2008, FOOD CHEM TOXICOL, V46, pS54, DOI 10.1016/j.fct.2008.04.041; Yadav SK, 2012, CRIT REV FOOD SCI, V52, P988, DOI 10.1080/10408398.2010.519447	27	3	3	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177138	10.1371/journal.pone.0177138	http://dx.doi.org/10.1371/journal.pone.0177138			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475596	Green Published, gold, Green Submitted			2022-12-26	WOS:000400649500050
J	Celewicz-Goldyn, S; Kuczynska-Kippen, N				Celewicz-Goldyn, Sofia; Kuczynska-Kippen, Natalia			Ecological value of macrophyte cover in creating habitat for microalgae (diatoms) and zooplankton (rotifers and crustaceans) in small field and forest water bodies	PLOS ONE			English	Article							STRUCTURAL COMPLEXITY; EPIPHYTIC DIATOMS; SMALL LAKES; LAND-USE; PONDS; ASSEMBLAGES; DIVERSITY; GRADIENTS; COMMUNITY; PHYTOPLANKTON	Due to their small area and shallow depth ponds are usually treated as a single sampling unit, while various microhabitats offer different environmental conditions. Thus, we tested the effect of different habitat types typically found within small ponds on the microalgae and zooplankton communities. We found that submerged macrophytes have the strongest impact on microalgae and zooplankton communities out of all the analysed habitats. Some epontic diatoms (e.g. Fragilaria dilatata, Cymbella affinis) and littoral-associated zooplankton species (e.g. Simocephalus vetulus, Lecane bulla) were significantly related to elodeids. However, pelagic species (e.g. bosminids) preferred less complex helophytes, which suggests that the most heterogeneous elodeid habitats were not an anti-predator shelter for cladocerans. Selection of different macrophyte types by taxonomically various organisms suggests that it is not only macrophyte cover that is desired for healthy aquatic environment but that a level of habitat mosaic is required to ensure the well-being of aquatic food webs. Species-specific preferences for different types of macrophytes indicate the high ecological value of macrophyte cover in ponds and a potential direction for the management of small water bodies towards maintaining a great variation of aquatic plants. Moreover, the type of surrounding landscape, reflecting human-induced disturbance (28 field ponds) and natural catchment (26 forest ponds), significantly influenced only zooplankton, while diatoms were affected indirectly through the level of conductivity. Nutrient overload (higher content of TRP) and increased conductivity in the field landscape contributed to a rise in microalgae (e.g. Amphora pediculus, Gomphonema parvulum) and zooplankton (e.g. Thermocyclops oithonoides, Eubosmina coregoni) abundance. An awareness of the responses of both components of plankton communities to environmental factors is necessary for maintaining the good state of small water bodies in various types of landscape.	[Celewicz-Goldyn, Sofia] Poznan Univ Life Sci, Fac Hort & Landscape Architecture, Dept Bot, Poznan, Poland; [Kuczynska-Kippen, Natalia] Adam Mickiewicz Univ, Fac Biol, Dept Water Protect, Poznan, Poland	Poznan University of Life Sciences; Adam Mickiewicz University	Celewicz-Goldyn, S (corresponding author), Poznan Univ Life Sci, Fac Hort & Landscape Architecture, Dept Bot, Poznan, Poland.	celewicz@up.poznan.pl	Kuczyńska-Kippen, Natalia/AAC-1955-2022; Celewicz, Sofia/Q-9399-2018	Celewicz, Sofia/0000-0003-2033-2777	Department of Botany, Poznah University of Life Sciences; Department of Water Protection, Adam Mickiewicz University in Poznah	Department of Botany, Poznah University of Life Sciences; Department of Water Protection, Adam Mickiewicz University in Poznah	The study was supported by these Departments: Department of Botany, Poznah University of Life Sciences (SCG) and Department of Water Protection, Adam Mickiewicz University in Poznah (NKK).	Anas MUM, 2013, ECOL INDIC, V30, P90, DOI 10.1016/j.ecolind.2013.01.038; Barinova S, 2013, PLANT BIOSYST, V147, P397, DOI 10.1080/11263504.2012.749956; Biggs J, 2005, AQUAT CONSERV, V15, P693, DOI 10.1002/aqc.745; Blanco S, 2014, CLEAN-SOIL AIR WATER, V42, P229, DOI 10.1002/clen.201200630; CARPENTER SR, 1986, AQUAT BOT, V26, P341, DOI 10.1016/0304-3770(86)90031-8; Carrino-Kyker SR, 2007, WETLANDS, V27, P749, DOI 10.1672/0277-5212(2007)27[749:SPCOTN]2.0.CO;2; Cazzanelli M, 2008, HYDROBIOLOGIA, V605, P113, DOI 10.1007/s10750-008-9324-1; Cereghino R, 2008, HYDROBIOLOGIA, V597, P1, DOI 10.1007/s10750-007-9225-8; Cereghino R, 2014, HYDROBIOLOGIA, V723, P1, DOI 10.1007/s10750-013-1719-y; Davies B, 2008, AGR ECOSYST ENVIRON, V125, P1, DOI 10.1016/j.agee.2007.10.006; Della Bella V, 2009, HYDROBIOLOGIA, V634, P25, DOI 10.1007/s10750-009-9890-x; DENYS L., 1991, INTRO ECOLOGICAL COD, V246; Dodson SI, 2007, HYDROBIOLOGIA, V579, P393, DOI 10.1007/s10750-006-0392-9; Dominy JN, 2012, SOUTHEAST NAT, V11, P263, DOI 10.1656/058.011.0208; Downing JA, 2010, LIMNETICA, V29, P9; Elbanowska H, 1999, PHYSICO CHEM WATER A; Erhard D, 2006, AQUAT BOT, V85, P203, DOI 10.1016/j.aquabot.2006.04.002; Frutos SM, 2008, REV BIOL TROP, V56, P1135; Gautam S, 2017, ECOL INDIC, V72, P67, DOI 10.1016/j.ecolind.2016.08.002; George DG, 2000, FRESHWATER BIOL, V43, P557, DOI 10.1046/j.1365-2427.2000.00539.x; Goldyn B, 2015, LIMNOLOGICA, V54, P14, DOI 10.1016/j.limno.2015.07.002; HATANO H, 1981, HYDROBIOLOGIA, V85, P161, DOI 10.1007/BF00006626; Joniak T, 2017, HYDROBIOLOGIA, V793, P121, DOI 10.1007/s10750-016-2913-5; Kollar J, 2015, FOTTEA, V15, P259, DOI 10.5507/fot.2015.022; Kuczynska-Kippen N, 2016, HYDROBIOLOGIA, V774, P39, DOI 10.1007/s10750-015-2595-4; Kuczynska-Kippen N, 2014, INT REV HYDROBIOL, V99, P58, DOI 10.1002/iroh.201301704; Lemmens P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072538; Leps J, 2003, MULTIVARIATE ANALYSE; Manatunge J, 2000, ENVIRON BIOL FISH, V58, P425, DOI 10.1023/A:1007691425268; de Faria DM, 2014, BRAZ J BIOL, V73, P681, DOI 10.1590/S1519-69842013000400002; Michelutti N, 2013, J PHYCOL, V49, P41, DOI 10.1111/jpy.12024; Nessimian JL, 2008, HYDROBIOLOGIA, V614, P117, DOI 10.1007/s10750-008-9441-x; Oertli B., 2010, POND CONSERVATION EU; Pereira HM, 2012, ANNU REV ENV RESOUR, V37, P25, DOI 10.1146/annurev-environ-042911-093511; Ryden L., 2003, ENV SCI UNDERSTANDIN; Sagrario G, 2009, FRESHWATER BIOL, V54, P1042, DOI 10.1111/j.1365-2427.2008.02152.x; Semlitsch RD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123055; Simkhada B, 2006, INT REV HYDROBIOL, V91, P574, DOI 10.1002/iroh.200610852; Simkhada B, 2006, ARCH HYDROBIOL, V166, P41, DOI 10.1127/0003-9136/2006/0166-0041; Soininen J, 2012, ECOL APPL, V22, P624, DOI 10.1890/11-1126.1; Sousa E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154440; Spoljar M, 2017, ECOL INDIC, V75, P145, DOI 10.1016/j.ecolind.2016.12.038; Spoljar M, 2013, J ENG RES-KUWAIT, V1, P29; Spoljar M, 2012, ANN LIMNOL-INT J LIM, V48, P161, DOI 10.1051/limn/2012005; Svanys A, 2014, HYDROBIOLOGIA, V737, P57, DOI 10.1007/s10750-013-1782-4; Tonno I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154526; Trigal C, 2014, AQUAT SCI, V76, P61, DOI 10.1007/s00027-013-0312-9; Vanderstukken M, 2011, FRESHWATER BIOL, V56, P1837, DOI 10.1111/j.1365-2427.2011.02624.x; Warfe DM, 2004, OECOLOGIA, V141, P171, DOI 10.1007/s00442-004-1644-x; Wen XL, 2017, SCI REP-UK, V7, DOI [10.1038/s41598-017-00666-Y, 10.1038/s41598-017-00666-y]; Wetzel R.G., 2000, LIMNOLOGICAL ANAL, V3; Wood RJ, 2016, SCI TOTAL ENVIRON, V557, P636, DOI 10.1016/j.scitotenv.2016.03.142; Yerli SV, 2012, TURK J FISH AQUAT SC, V12, P91, DOI 10.4194/1303-2712-v12_1_12; Zhang YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep23867; Zhou YW, 2017, SCI TOTAL ENVIRON, V580, P1421, DOI 10.1016/j.scitotenv.2016.12.108	55	37	39	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177317	10.1371/journal.pone.0177317	http://dx.doi.org/10.1371/journal.pone.0177317			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472138	Green Submitted, Green Published, gold			2022-12-26	WOS:000400648500157
J	Elhadyl, A; Gine, A; Topalovic, O; Jacquiod, S; Sorensen, SJ; Sorribas, FJ; Heuer, H				Elhadyl, Ahmed; Gine, Ariadna; Topalovic, Olivera; Jacquiod, Samuel; Sorensen, Soren J.; Javier Sorribas, Francisco; Heuer, Holger			Microbiomes associated with infective stages of root-knot and lesion nematodes in soil	PLOS ONE			English	Article							PLANT-PARASITIC NEMATODES; MELOIDOGYNE SPP. EGGS; SURFACE-COAT; PASTEURIA-PENETRANS; ESCHERICHIA-COLI; POPULATIONS; INCOGNITA; COMMUNITIES; ATTACHMENT; BIOCONTROL	Endoparasitic root-knot (Meloidogyne spp.) and lesion (Pratylenchus spp.) nematodes cause considerable damage in agriculture. Before they invade roots to complete their life cycle, soil microbes can attach to their cuticle or surface coat and antagonize the nematode directly or by induction of host plant defenses. We investigated whether the nematode-associated microbiome in soil differs between infective stages of Meloidogyne incognita and Pratylenchus penetrans, and whether it is affected by variation in the composition of microbial communities among soils. Nematodes were incubated in suspensions of five organically and two integrated horticultural production soils, recovered by sieving and analyzed for attached bacteria and fungi after washing off loosely adhering microbes. Significant effects of the soil type and nematode species on nematode-associated fungi and bacteria were revealed as analyzed by community profiling using denaturing gradient gel electrophoresis. Attached microbes represented a small specific subset of the soil microbiome. Two organic soils had very similar bacterial and fungal community profiles, but one of them was strongly suppressive towards root-knot nematodes. They were selected for deep amplicon sequencing of bacterial 16S rRNA genes and fungal ITS. Significant differences among the microbiomes associated with the two species in both soils suggested specific surface epitopes. Among the 28 detected bacterial classes, Betaproteobacteria, Bacilli and Actinobacteria were the most abundant. The most frequently detected fungal genera were Malassezia, Aspergillus and Cladosporium. Attached microbiomes did not statistically differ between these two soils. However, Malassezia globosa and four fungal species of the family Plectosphaerellaceae, and the bacterium Neorhizobium galegae were strongly enriched on M. incognita in the suppressive soil. In conclusion, the highly specific attachment of microbes to infective stages of phytonematodes in soil suggested an ecological role of this association and might be involved in soil suppressiveness towards them.	[Elhadyl, Ahmed; Topalovic, Olivera; Heuer, Holger] Julius Kuhn Inst, Fed Res Ctr Cultivated Plants, Dept Epidemiol & Pathogen Diagnost, Braunschweig, Germany; [Elhadyl, Ahmed] Benha Univ, Fac Agr, Dept Plant Protect, Banha, Egypt; [Gine, Ariadna; Javier Sorribas, Francisco] Univ Politecn Cataluna, Dept Engn Agroalimentaria & Biotecnol, Castelldefels, Spain; [Jacquiod, Samuel; Sorensen, Soren J.] Univ Copenhagen, Dept Biol, Sect Microbiol, Copenhagen, Denmark	Julius Kuhn-Institut; Egyptian Knowledge Bank (EKB); Benha University; Universitat Politecnica de Catalunya; University of Copenhagen	Heuer, H (corresponding author), Julius Kuhn Inst, Fed Res Ctr Cultivated Plants, Dept Epidemiol & Pathogen Diagnost, Braunschweig, Germany.	holger.heuer@julius-kuehn.de	Elhady, Ahmed/AAJ-7013-2020; Jacquiod, Samuel/M-2259-2014; Topalović, Olivera/AAM-2208-2020; Sorribas, F Javier/L-4896-2017; Blasco, Ariadna Giné/AAA-5545-2020; Sørensen, Søren J/J-5015-2014; Sørensen, Søren Johannes/N-2120-2019	Jacquiod, Samuel/0000-0002-0713-7996; Blasco, Ariadna Giné/0000-0002-3598-4818; Sørensen, Søren J/0000-0001-6227-9906; Sørensen, Søren Johannes/0000-0001-6227-9906; Sorribas, Francisco Javier/0000-0001-7465-7353; Heuer, Holger/0000-0001-6044-8171; Topalovic, Olivera/0000-0003-3839-1839	German Research Foundation [DFG HE695/1-1]; Deutscher Akademischer Austauschdienst; Gisela und Hermann Stegemann Stiftung; Ministerio de Economia y Competitividad project [AGL2013-49040-C2-1]	German Research Foundation(German Research Foundation (DFG)); Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); Gisela und Hermann Stegemann Stiftung; Ministerio de Economia y Competitividad project	OT was financed by the German Research Foundation (http://www.dfg.de) grant DFG HE695/1-1, AE by the Deutscher Akademischer Austauschdienst (https://www.daad.eg/de), AG by the 'Gisela und Hermann Stegemann Stiftung' (travel and daily allowance) and Ministerio de Economia y Competitividad (http://www.mineco.gob.es) project AGL2013-49040-C2-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam M, 2014, APPL ENVIRON MICROB, V80, P2679, DOI 10.1128/AEM.03905-13; Agrios G. N., 2005, PLANT PATHOL; Ashbee HR, 2002, CLIN MICROBIOL REV, V15, P21, DOI 10.1128/CMR.15.1.21-57.2002; Atkins SD, 2003, APPL ENVIRON MICROB, V69, P4788, DOI 10.1128/AEM.69.8.4788-4793.2003; Back MA, 2002, PLANT PATHOL, V51, P683, DOI 10.1046/j.1365-3059.2002.00785.x; Bent E, 2008, J NEMATOL, V40, P109; BIRD A F, 1988, Revue de Nematologie, V11, P75; BIRD AF, 1989, INT J PARASITOL, V19, P235, DOI 10.1016/0020-7519(89)90134-3; Brown AMV, 2016, SCI REP-UK, V6, DOI 10.1038/srep34955; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cao Y, 2015, J BASIC MICROB, V55, P950, DOI 10.1002/jobm.201400816; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chen ZX, 1998, J NEMATOL, V30, P313; Cook RJ, 1983, THE NATURE AND PRACT; Davies KG, 2006, NEMATOLOGY, V8, P475, DOI 10.1163/156854106778493493; Davies KG, 2011, ANNU REV PHYTOPATHOL, V49, P135, DOI 10.1146/annurev-phyto-121310-111406; DAVIES KG, 1992, PARASITOLOGY, V105, P475, DOI 10.1017/S0031182000074655; Davies KG, 2001, PARASITOLOGY, V122, P111, DOI 10.1017/S0031182000006958; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Evans D., 2016, FIELD MYCOLOGY, V17, P51; Fatima N, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-016-2138-2; Gine A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00164; Gine A, 2013, BIOCONTROL, V58, P407, DOI 10.1007/s10526-012-9495-6; Gotlieb D, 2003, PHYTOPARASITICA, V31, P217, DOI 10.1007/BF02980831; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hansen CHF, 2012, DIABETOLOGIA, V55, P2285, DOI 10.1007/s00125-012-2564-7; Heuer H, 2002, APPL ENVIRON MICROB, V68, P1325, DOI 10.1128/AEM.68.3.1325-1335.2002; Hora R, 2005, J FOOD PROTECT, V68, P2506, DOI 10.4315/0362-028X-68.12.2506; Iglesias-Garcia AM, 2013, PLANT DIS, V97, P1457, DOI 10.1094/PDIS-01-13-0016-RE; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Jacquiod S, 2016, RES MICROBIOL, V167, P436, DOI 10.1016/j.resmic.2016.03.003; KERRY B, 1988, AGR ECOSYST ENVIRON, V24, P293, DOI 10.1016/0167-8809(88)90073-4; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kropfa S, 2004, J MICROBIOL METH, V57, P187, DOI 10.1016/j.mimet.2004.01.002; Maghodia AB, 2008, J APPL MICROBIOL, V105, P1810, DOI 10.1111/j.1365-2672.2008.03945.x; Nunes I, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw175; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Omarjee J, 2008, APPL SOIL ECOL, V39, P1, DOI 10.1016/j.apsoil.2007.11.001; Orion D, 2001, J NEMATOL, V33, P203; Page Antony P., 2001, P167, DOI 10.1079/9780851994239.0167; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; R Development Core team, 2014, R A LANGUAGE AND ENV; Renker C, 2003, BIOL FERT SOILS, V37, P70, DOI 10.1007/s00374-002-0556-3; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROCCUZZO G, 1993, FUND APPL NEMATOL, V16, P151; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Siddiqui ZA, 2012, BACTERIA AGROBIOLOGY, DOI DOI 10.1007/978-3-642-27515-9_14; Siddiqui ZA, 2009, PEST MANAG SCI, V65, P943, DOI 10.1002/ps.1777; SKOTLAND CB, 1971, PHYTOPATHOLOGY, V61, P435, DOI 10.1094/Phyto-61-435; SPIEGEL Y, 1995, EXP PARASITOL, V80, P220, DOI 10.1006/expr.1995.1027; SPIEGEL Y, 1995, J NEMATOL, V27, P127; STIRLING GR, 1979, J NEMATOL, V11, P99; Stirling GR, 2011, AUSTRALAS PLANT PATH, V40, P416, DOI 10.1007/s13313-011-0059-5; Sun MH, 2006, J INVERTEBR PATHOL, V93, P22, DOI 10.1016/j.jip.2006.03.006; Verdejo-Lucas S, 2002, J NEMATOL, V34, P405; Vogel JL, 2002, PROC S AFR SUG TECHN; Weinert N, 2009, APPL ENVIRON MICROB, V75, P3859, DOI 10.1128/AEM.00414-09; Weisskopf L, 2011, APPL ENVIRON MICROB, V77, P7715, DOI 10.1128/AEM.05845-11; Westphal A, 1999, PHYTOPATHOLOGY, V89, P434, DOI 10.1094/PHYTO.1999.89.5.434; Zakir Hussain, 2009, Indian Journal of Nematology, V39, P41	66	50	50	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177145	10.1371/journal.pone.0177145	http://dx.doi.org/10.1371/journal.pone.0177145			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472099	Green Submitted, Green Published, gold			2022-12-26	WOS:000400648500145
J	Graumann, R; Di Capua, GA; Oyarzun, JE; Vasquez, MA; Liao, C; Branes, JA; Roa, I; Casanello, P; Corvalan, AH; Owen, GI; Delgado, I; Zangemeister-Wittke, U; Ziegler, A				Graumann, Rebecca; Di Capua, Gabriella A.; Oyarzun, Juan E.; Vasquez, Marcos A.; Liao, Christine; Branes, Jorge A.; Roa, Ivan; Casanello, Paola; Corvalan, Alejandro H.; Owen, Gareth I.; Delgado, Iris; Zangemeister-Wittke, Uwe; Ziegler, Annemarie			Expression of teneurins is associated with tumor differentiation and patient survival in ovarian cancer	PLOS ONE			English	Article							PAIR-RULE GENE; CELL-CELL ADHESION; BREAST-CANCER; CAENORHABDITIS-ELEGANS; TRANSMEMBRANE PROTEINS; INTRACELLULAR DOMAIN; NEURITE OUTGROWTH; VISUAL-SYSTEM; FGF RECEPTORS; ODZ GENE	Teneurins are a family of highly conserved pair-rule proteins involved in morphogenesis and development of the central nervous system. Their function in adult tissues and in disease is largely unknown. Recent evidence suggests a role for dysregulated expression of Teneurins in human tumors, but systematic investigations are missing. Here, we investigated Teneurin-2 and Teneurin-4 expression in various cancer cell lines and in ovarian tumor tissues. Teneurin-2 and Teneurin-4 were expressed in most of the breast cancer cell lines tested. Teneurin-4 was also detected in ovarian cancer cell lines, and throughout ovarian tumors and normal ovary tissue. Ovarian tumors with low Teneurin-4 expression showed less differentiated phenotypes and these patients had shorter mean overall survival. Similarly, Teneurin-2 expression correlated with overall survival as well, especially in patients with serous tumors. In the various cell lines, 5-Aza-cytidine-induced changes in DNA methylation did not alter expression of Teneurin-2 and Teneurin-4, despite the existence of predicted CpG islands in both genes. Interestingly, however, we found evidence for the control of Teneurin-2 expression by the oncogenic growth factor FGF8. Furthermore, we identified multiple transcript splicing variants for Teneurin-2 and Teneurin-4, indicating complex gene expression patterns in malignant cells. Finally, downregulation of Teneurin-4 expression using siRNA caused a cell-type dependent increase in proliferation and resistance to cisplatin. Altogether, our data suggest that low Teneurin-4 expression provides a growth advantage to cancer cells and marks an undifferentiated state characterized by increased drug resistance and clinical aggressiveness. We conclude that Teneurin-2 and Teneurin-4 expression levels could be of prognostic value in ovarian cancer.	[Graumann, Rebecca; Di Capua, Gabriella A.; Oyarzun, Juan E.; Vasquez, Marcos A.; Liao, Christine; Ziegler, Annemarie] Univ Desarrollo, Fac Med, Ctr Genet & Gen, Clin Alemana, Santiago, Chile; [Branes, Jorge A.] Pontificia Univ Catolica Chile, Sch Med, Div Obstet & Gynecol, Santiago, Chile; [Roa, Ivan] Clin Alemana Santiago, Div Pathol, Santiago, Chile; [Casanello, Paola] Pontificia Univ Catolica Chile, Sch Med, Perinatol Res Lab, Santiago, Chile; [Corvalan, Alejandro H.; Owen, Gareth I.] Pontificia Univ Catolica Chile, Adv Ctr Chron Dis ACCDiS, Santiago, Chile; [Corvalan, Alejandro H.; Owen, Gareth I.] Pontificia Univ Catolica Chile, UC Ctr Invest Oncol CITO, Santiago, Chile; [Owen, Gareth I.] Pontificia Univ Catolica Chile, Fac Biol Sci, Dept Physiol, Santiago, Chile; [Delgado, Iris] Univ Desarrollo, Clin Alemana, Fac Med, Ctr Epidemiol & Hlth Policies, Santiago, Chile; [Zangemeister-Wittke, Uwe] Univ Bern, Inst Pharmacol, Bern, Switzerland; [Oyarzun, Juan E.] Pontificia Univ Catolica Chile, Sch Med, Dept Gastroenterol, Santiago, Chile; [Vasquez, Marcos A.] Ctr Appl Med Res CIMA, Program Immunol & Immunotherapy, Pamplona, Spain; [Roa, Ivan] Creat Biosci, Santiago, Chile	Clinica Alemana; Universidad del Desarrollo; Pontificia Universidad Catolica de Chile; Clinica Alemana; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Clinica Alemana; Universidad del Desarrollo; University of Bern; Pontificia Universidad Catolica de Chile	Ziegler, A (corresponding author), Univ Desarrollo, Fac Med, Ctr Genet & Gen, Clin Alemana, Santiago, Chile.	aziegler@udd.cl	Casanello, Paola/X-7443-2019	Casanello, Paola/0000-0002-2355-1476; Di Capua, Gabriella A/0000-0002-2525-2568; Oyarzun, Juan Esteban/0000-0002-9695-7207; Corvalan, Alejandro/0000-0001-5492-3853	"Fondo Nacional de Desarrollo Cientifico y Tecnologico" (Fondecyt) [1100605]; "Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias" (FONDAP) [15130011]; "Comision Nacional de Investigacion Cientifica y Tecnologica" (CONICYT), from the Government of Chile	"Fondo Nacional de Desarrollo Cientifico y Tecnologico" (Fondecyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); "Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias" (FONDAP)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); "Comision Nacional de Investigacion Cientifica y Tecnologica" (CONICYT), from the Government of Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by grant No 1100605 from the "Fondo Nacional de Desarrollo Cientifico y Tecnologico" (Fondecyt) (A.Z.), https://www.conicyt.cl/fondecyt/. The activities performed by A.H.C. were financed by a "Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias" (FONDAP) grant No 15130011, http://www.conicyt.cl/fondap/. Both funding sources depend from the "Comision Nacional de Investigacion Cientifica y Tecnologica" (CONICYT), from the Government of Chile (http://www.conicyt.cl/).	Aldahmesh MA, 2012, GENET MED, V14, P900, DOI 10.1038/gim.2012.71; Antinucci P, 2013, CELL REP, V5, P582, DOI 10.1016/j.celrep.2013.09.045; Bagutti C, 2003, J CELL SCI, V116, P2957, DOI 10.1242/jcs.00603; BAUMGARTNER S, 1993, MECH DEVELOP, V40, P165, DOI 10.1016/0925-4773(93)90074-8; BAUMGARTNER S, 1994, EMBO J, V13, P3728, DOI 10.1002/j.1460-2075.1994.tb06682.x; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Beckmann J, 2013, NANO LETT, V13, P2937, DOI 10.1021/nl4013248; Beckmann J, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-35; Ben-Zur T, 2000, DEV BIOL, V217, P107, DOI 10.1006/dbio.1999.9532; Birrer MJ, 2007, J CLIN ONCOL, V25, P2281, DOI 10.1200/JCO.2006.09.0795; Boeva V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072182; Broz DK, 2010, INT J DEV BIOL, V54, P1509, DOI 10.1387/ijdb.103139dk; Buys TPH, 2007, GENE CHROMOSOME CANC, V46, P1069, DOI 10.1002/gcc.20492; Byron SA, 2010, GYNECOL ONCOL, V117, P125, DOI 10.1016/j.ygyno.2009.12.002; Chaffer CL, 2007, DIFFERENTIATION, V75, P831, DOI 10.1111/j.1432-0436.2007.00210.x; Chand D, 2013, MOL CELL NEUROSCI, V52, P38, DOI 10.1016/j.mcn.2012.09.006; Chandler LA, 1999, INT J CANCER, V81, P451, DOI 10.1002/(SICI)1097-0215(19990505)81:3<451::AID-IJC20>3.3.CO;2-8; Chang JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105524; Cheng S-P, 2016, CLIN EXP MED; Cole C, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.5.12585; Dasari S, 2014, EUR J PHARMACOL, V740, P364, DOI 10.1016/j.ejphar.2014.07.025; Dharmaratne N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043083; Drabikowski K, 2005, DEV BIOL, V282, P27, DOI 10.1016/j.ydbio.2005.02.017; Feng K, 2002, J BIOL CHEM, V277, P26128, DOI 10.1074/jbc.M203722200; Hong WZ, 2012, NATURE, V484, P201, DOI 10.1038/nature10926; Hor H, 2015, HUM MOL GENET, V24, P5677, DOI 10.1093/hmg/ddv281; Kenzelmann D, 2007, CELL MOL LIFE SCI, V64, P1452, DOI 10.1007/s00018-007-7108-9; Kenzelmann D, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-30; Kenzelmann-Broz D., 2008, TENEURINS DEV DIS; Kinel-Tahan Y, 2007, DEV DYNAM, V236, P2541, DOI 10.1002/dvdy.21284; Leamey CA, 2007, PLOS BIOL, V5, P2077, DOI 10.1371/journal.pbio.0050241; LEVINE A, 1994, CELL, V77, P587, DOI 10.1016/0092-8674(94)90220-8; Li H, 2006, MOL CELL NEUROSCI, V33, P136, DOI 10.1016/j.mcn.2006.06.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Marsh SK, 1999, ONCOGENE, V18, P1053, DOI 10.1038/sj.onc.1202392; Mattila MA, 2007, CYTOKINE GROWTH F R, V18, P257, DOI 10.1016/j.cytogfr.2007.04.010; Mejstrikova E, 2012, PEDIATRICS, V129, pE523, DOI 10.1542/peds.2011-0870; Miyamoto N, 1997, DEVELOPMENT, V124, P1653; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Mosca TJ, 2012, NATURE, V484, P237, DOI 10.1038/nature10923; Mott NN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010143; Noonan FC, 2001, GENOMICS, V76, P37, DOI 10.1006/geno.2001.6590; Nunes SM, 2005, EXP CELL RES, V305, P122, DOI 10.1016/j.yexcr.2004.12.020; Okamoto J, 2010, ONCOGENE, V29, P5969, DOI 10.1038/onc.2010.330; Petrini I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060572; Rubin BP, 2002, DEVELOPMENT, V129, P4697; Salah Z, 2012, FRONT BIOSCI-LANDMRK, V17, P331, DOI 10.2741/3930; Stanton RA, 2011, MED RES REV, V31, P443, DOI 10.1002/med.20242; Suzuki N, 2014, J ORTHOP RES, V32, P915, DOI 10.1002/jor.22616; Suzuki N, 2014, FASEB J, V28, P1386, DOI 10.1096/fj.13-241034; Suzuki N, 2012, J NEUROSCI, V32, P11586, DOI 10.1523/JNEUROSCI.2045-11.2012; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Tommasi S, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2233; Tran H, 2015, EUR J NEUROSCI, V41, P55, DOI 10.1111/ejn.12767; Trzebiatowska A, 2008, MOL BIOL CELL, V19, P3898, DOI 10.1091/mbc.E08-01-0028; Tucker RP, 2007, INT J BIOCHEM CELL B, V39, P292, DOI 10.1016/j.biocel.2006.09.012; Tucker RP, 2001, DEV DYNAM, V220, P27, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1084>3.0.CO;2-B; Valve E, 2000, INT J CANCER, V88, P718, DOI 10.1002/1097-0215(20001201)88:5<718::AID-IJC6>3.0.CO;2-F; Vang R, 2009, ADV ANAT PATHOL, V16, P267, DOI 10.1097/PAP.0b013e3181b4fffa; Vater I, 2015, LEUKEMIA, V29, P677, DOI 10.1038/leu.2014.264; Vinatzer U, 2008, CLIN CANCER RES, V14, P6426, DOI 10.1158/1078-0432.CCR-08-0702; Wang XZ, 1999, ONCOGENE, V18, P5718, DOI 10.1038/sj.onc.1202950; Wei W, 2013, J CLIN INVEST, V123, P4435, DOI 10.1172/JCI70625; Young TR, 2013, J NEUROSCI, V33, P12490, DOI 10.1523/JNEUROSCI.4708-12.2013; Young TR, 2009, INT J BIOCHEM CELL B, V41, P990, DOI 10.1016/j.biocel.2008.06.014; Yue DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132134; Zhang HT, 2013, J BIOL CHEM, V288, P20966, DOI 10.1074/jbc.M113.484535; Zhang W, 2014, MOL MED REP, V10, P113, DOI 10.3892/mmr.2014.2152; Zheng LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022956; Zhou XH, 2003, GENE EXPR PATTERNS, V3, P397, DOI 10.1016/S1567-133X(03)00087-5; Zhu Y, 2016, REPROD BIOMED ONLINE, V32, P388, DOI 10.1016/j.rbmo.2016.01.005; Ziegler A, 2012, CANCER LETT, V326, P1, DOI 10.1016/j.canlet.2012.07.021; Ziegler A, 2012, LUNG CANCER, V75, P189, DOI 10.1016/j.lungcan.2011.07.009	74	12	12	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177244	10.1371/journal.pone.0177244	http://dx.doi.org/10.1371/journal.pone.0177244			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472127	Green Published, gold, Green Submitted			2022-12-26	WOS:000400648500155
J	Kratzer, RF; Espenlaub, S; Hoffmeister, A; Kron, MW; Kreppel, F				Kratzer, Ramona F.; Espenlaub, Sigrid; Hoffmeister, Andrea; Kron, Matthias W.; Kreppel, Florian			Covalent decoration of adenovirus vector capsids with the carbohydrate epitope alpha Gal does not improve vector immunogenicity, but allows to study the in vivo fate of adenovirus immunocomplexes	PLOS ONE			English	Article							T-CELL RESPONSES; ANTIGEN-PRESENTING CELLS; DENDRITIC CELLS; HIV VACCINE; NEUTRALIZING ANTIBODIES; IMMUNE-RESPONSE; RECOMBINANT ADENOVIRUS; SEROTYPE 5; DC-SIGN; PROTEIN	Adenovirus-based vectors are promising tools for genetic vaccination. However, several obstacles have to be overcome prior to a routine clinical application of adenovirus-based vectors as efficacious vectored vaccines. The linear trisaccharide epitope alpha Gal (alpha-Gal) with the carbohydrate sequence galactose-alpha-1,3-galactosyl-beta-1,4-N-acetylglucosamine has been described as a potent adjuvant for recombinant or attenuated vaccines. Humans and alpha-1,3-galactosyltransferase knockout mice do not express this epitope. Upon exposure of alpha-1,3-galactosyltransferase-deficient organisms to alpha Gal in the environment, large amounts of circulating anti-Gal antibodies are produced consistently. Immunocomplexes formed between recombinant alpha Gal-decorated vaccines and anti-Gal antibodies exhibit superior immunogenicity. We studied the effects of the trisaccharide epitope on CD8 T cell responses that are directed specifically to vector-encoded transgenic antigens. For that, covalently alpha Gal-decorated adenovirus vectors were delivered to anti-Gal alpha-1,3-galactosyltransferase knockout mice. We generated replication-defective, E1-deleted adenovirus type 5 vectors that were decorated with aGal at the hexon hypervariable regions 1 or 5, at fiber knob, or at penton base. Surprisingly, none of the adenovirus immunocomplexes being formed from alpha Gal-decorated adenovirus vectors and anti-Gal immunoglobulins improved the frequencies of CD8 T cell responses against the transgenic antigen ovalbumin. Humoral immunity directed to the adenovirus vector was neither increased. However, our data indicated that decoration of Ad vectors with the aGal epitope is a powerful tool to analyze the fate of adenovirus immunocomplexes in vivo.	[Kratzer, Ramona F.; Espenlaub, Sigrid; Hoffmeister, Andrea; Kron, Matthias W.; Kreppel, Florian] Ulm Univ, Dept Gene Therapy, Ulm, Germany; [Kreppel, Florian] Herdecke Univ, Fac Hlth, Ctr Biomed Educ & Res ZBAF, Sch Med,Chair Biochem & Mol Med, Witten, Germany	Ulm University	Kreppel, F (corresponding author), Ulm Univ, Dept Gene Therapy, Ulm, Germany.; Kreppel, F (corresponding author), Herdecke Univ, Fac Hlth, Ctr Biomed Educ & Res ZBAF, Sch Med,Chair Biochem & Mol Med, Witten, Germany.	Forian.Kreppel@uni-wh.de			BMBF Go-Bio grant [0315562]; International Graduate School in Molecular Medicine Ulm (IGradU); International Graduate School in Molecular Medicine Ulm (Excellence Initiative of the German Federal and State Governments); ZBAF/Center for Biomedical Research and Education	BMBF Go-Bio grant(Federal Ministry of Education & Research (BMBF)); International Graduate School in Molecular Medicine Ulm (IGradU); International Graduate School in Molecular Medicine Ulm (Excellence Initiative of the German Federal and State Governments); ZBAF/Center for Biomedical Research and Education	Support was provided by BMBF Go-Bio grant #0315562, International Graduate School in Molecular Medicine Ulm (IGradU) (IGradU, and Excellence Initiative of the German Federal and State Governments). Additionally, the work was supported by ZBAF/Center for Biomedical Research and Education (to FK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Motal U, 2006, J VIROL, V80, P6943, DOI 10.1128/JVI.00310-06; Abdel-Motal UM, 2007, J VIROL, V81, P9131, DOI 10.1128/JVI.00647-07; Abdel-Motal UM, 2010, VACCINE, V28, P1758, DOI 10.1016/j.vaccine.2009.12.015; Abdel-Motal UM, 2009, VACCINE, V27, P3072, DOI 10.1016/j.vaccine.2009.03.019; Benlahrech A, 2009, P NATL ACAD SCI USA, V106, P19940, DOI 10.1073/pnas.0907898106; Brandao JG, 2003, VACCINE, V21, P2268, DOI 10.1016/S0264-410X(03)00050-1; Chaitra MG, 2007, VACCINE, V25, P7168, DOI 10.1016/j.vaccine.2007.07.026; Chiang TR, 2000, TRANSPLANTATION, V69, P2593, DOI 10.1097/00007890-200006270-00020; Curlin ME, 2011, AIDS, V25, P153, DOI 10.1097/QAD.0b013e328342115c; Dai YF, 2002, NAT BIOTECHNOL, V20, P251, DOI 10.1038/nbt0302-251; de Cassan SC, 2011, J IMMUNOL, V187, P2602, DOI 10.4049/jimmunol.1101004; De Geest BR, 2003, BLOOD, V101, P2551, DOI 10.1182/blood-2002-07-2146; Deriy L, 2005, CANCER GENE THER, V12, P528, DOI 10.1038/sj.cgt.7700812; Douglas AD, 2010, VACCINE, V28, P7167, DOI 10.1016/j.vaccine.2010.08.068; Duerr A, 2012, J INFECT DIS, V206, P258, DOI 10.1093/infdis/jis342; Fonseca JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154819; GALILI U, 1993, BLOOD, V82, P2485, DOI 10.1182/blood.V82.8.2485.bloodjournal8282485; GALILI U, 1988, J BIOL CHEM, V263, P17755; Galili U, 1998, TRANSPLANTATION, V65, P1129, DOI 10.1097/00007890-199804270-00020; GALILI U, 1991, P NATL ACAD SCI USA, V88, P7401, DOI 10.1073/pnas.88.16.7401; GALILI U, 1984, J EXP MED, V160, P1519, DOI 10.1084/jem.160.5.1519; GALILI U, 1987, P NATL ACAD SCI USA, V84, P1369, DOI 10.1073/pnas.84.5.1369; GALILI U, 1988, INFECT IMMUN, V56, P1730, DOI 10.1128/IAI.56.7.1730-1737.1988; Galili U., 1999, SUBCELLULAR BIOCH GA; Gray G, 2010, CURR OPIN HIV AIDS, V5, P357, DOI 10.1097/COH.0b013e32833d2d2b; Hesse C, 2013, EUR J IMMUNOL, V43, P2543, DOI 10.1002/eji.201343429; Hutnick NA, 2009, NAT MED, V15, P876, DOI 10.1038/nm.1989; Jooss K, 1998, J VIROL, V72, P4212, DOI 10.1128/JVI.72.5.4212-4223.1998; Kreppel F, 2005, MOL THER, V12, P107, DOI 10.1016/j.ymthe.2005.03.006; Kreppel F, 2002, HUM GENE THER, V13, P1151, DOI 10.1089/104303402320138934; Krutzke L, 2016, J CONTROL RELEASE, V235, P379, DOI 10.1016/j.jconrel.2016.06.022; LARSEN RD, 1990, J BIOL CHEM, V265, P7055; Lasaro MO, 2009, MOL THER, V17, P1333, DOI 10.1038/mt.2009.130; Ludwig SL, 1998, J INFECT DIS, V178, P1776, DOI 10.1086/314498; Mast TC, 2010, VACCINE, V28, P950, DOI 10.1016/j.vaccine.2009.10.145; Matthews QL, 2011, MOL PHARMACEUT, V8, P3, DOI 10.1021/mp100214b; Matthews QL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011815; McKelvey T, 2004, GENE THER, V11, P791, DOI 10.1038/sj.gt.3302232; McKenzie IFC, 1998, TRANSPLANTATION, V66, P754, DOI 10.1097/00007890-199809270-00010; Molinier-Frenkel V, 2002, J VIROL, V76, P127, DOI 10.1128/JVI.76.1.127-135.2002; Nwanegbo E, 2004, CLIN DIAGN LAB IMMUN, V11, P351, DOI 10.1128/CDLI.11.2.351-357.2004; Palmetshofer A, 1998, TRANSPLANTATION, V65, P971, DOI 10.1097/00007890-199804150-00018; Phelps CJ, 2003, SCIENCE, V299, P411, DOI 10.1126/science.1078942; PREVEC L, 1989, J GEN VIROL, V70, P429, DOI 10.1099/0022-1317-70-2-429; Prill JM, 2011, MOL THER, V19, P83, DOI 10.1038/mt.2010.229; RIBI E, 1984, J BIOL RESP MODIF, V3, P1; Sapinoro R, 2007, J GENE MED, V9, P1033, DOI 10.1002/jgm.1112; Schiedner G, 2000, HUM GENE THER, V11, P2105, DOI 10.1089/104303400750001417; Schirmbeck R, 2008, MOL THER, V16, P1609, DOI 10.1038/mt.2008.141; Suleman M, 2011, VACCINE, V29, P5892, DOI 10.1016/j.vaccine.2011.06.071; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; Tearle RG, 1996, TRANSPLANTATION, V61, P13, DOI 10.1097/00007890-199601150-00004; Unger WWJ, 2012, J CONTROL RELEASE, V160, P88, DOI 10.1016/j.jconrel.2012.02.007; Yu B, 2012, J MED VIROL, V84, P1408, DOI 10.1002/jmv.23325	54	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176852	10.1371/journal.pone.0176852	http://dx.doi.org/10.1371/journal.pone.0176852			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472163	Green Published, gold, Green Submitted			2022-12-26	WOS:000400648500086
J	Losina, E; Yang, HY; Deshpande, BR; Katz, JN; Collins, JE				Losina, Elena; Yang, Heidi Y.; Deshpande, Bhushan R.; Katz, Jeffrey N.; Collins, Jamie E.			Physical activity and unplanned illness-related work absenteeism: Data from an employee wellness program	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; INTEGRATED HEALTH-PROGRAM; QUALITY-OF-LIFE; LOW-BACK-PAIN; SICKNESS ABSENCE; PROSPECTIVE COHORT; GRADED ACTIVITY; EXERCISE; CARE; ASSOCIATION	Background Illness-related absenteeism is a major threat to work productivity. Our objective was to assess the relationship between physical activity and unplanned illness-related absenteeism from work. Methods We implemented physical activity program for sedentary non-clinician employees of a tertiary medical center. Financial rewards were available for reaching accelerometermeasured ambulatory physical activity goals over a 24-week period. We categorized participants into three groups based on mean levels of physical activity: low (0 - 74 min/week), medium (75 - 149 min/week) and meeting CDC guidelines (>= 150 min/week). We built a multivariable Poisson regression model to evaluate the relationship between physical activity and rates of unplanned illness-related absenteeism. Results The sample consisted of 292 employees who participated in the program. Their mean age was 38 years (SD 11), 83% were female, and 38% were obese. Over the 24 intervention weeks, participants engaged in a mean of 90 min/week (SD 74) of physical activity and missed a mean of 14 hours of work (SD 38) due to illness. Unplanned absenteeism due to illness was associated with physical activity. As compared to the group meeting CDC guidelines, in multivariable analyses those in the medium physical activity group had a 2.4 (95% CI 1.3 - 4.5) fold higher rate of illness-related absenteeism and those in the lowest physical activity group had a 3.5 ( 95% CI 1.7 - 7.2) fold higher rate of illness-related absenteeism. Discussion Less physical activity was associated with more illness-related absenteeism. Workforce-based interventions to increase physical activity may thus be a promising vehicle to reduce unplanned illness-related absenteeism.	[Losina, Elena; Yang, Heidi Y.; Deshpande, Bhushan R.; Katz, Jeffrey N.; Collins, Jamie E.] Brigham & Womens Hosp, Orthopaed & Arthrit Ctr Outcomes Res OrACORe, Dept Orthopaed Surg, Boston, MA 02115 USA; [Losina, Elena; Yang, Heidi Y.; Deshpande, Bhushan R.; Katz, Jeffrey N.; Collins, Jamie E.] Brigham & Womens Hosp, Policy & Innovat EValuat Orthopaed Treatments PI, Dept Orthopaed Surg, Boston, MA 02115 USA; [Losina, Elena; Deshpande, Bhushan R.; Katz, Jeffrey N.; Collins, Jamie E.] Harvard Med Sch, Boston, MA 02115 USA; [Losina, Elena; Katz, Jeffrey N.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Katz, Jeffrey N.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Katz, Jeffrey N.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Losina, E (corresponding author), Brigham & Womens Hosp, Orthopaed & Arthrit Ctr Outcomes Res OrACORe, Dept Orthopaed Surg, Boston, MA 02115 USA.; Losina, E (corresponding author), Brigham & Womens Hosp, Policy & Innovat EValuat Orthopaed Treatments PI, Dept Orthopaed Surg, Boston, MA 02115 USA.; Losina, E (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Losina, E (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA.; Losina, E (corresponding author), Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA.	elosina@partners.org		Losina, ELENA/0000-0002-3424-0892; Deshpande, Bhushan/0000-0003-0918-6836	BWH Presidential Fund	BWH Presidential Fund	The B-Well program and this present analysis were sponsored by the BWH Presidential Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alharbi M, 2016, EUR J PREV CARDIOL, V23, P1476, DOI 10.1177/2047487316634883; Amlani NM, 2014, SPORTS MED, V44, P887, DOI 10.1007/s40279-014-0171-0; [Anonymous], 2015, EMPL BEN US MARCH 20; Baicker K, 2010, HEALTH AFFAIR, V29, DOI 10.1377/hlthaff.2009.0626; Baumgartel H, 2013, INT ORG HLTH, V1, P280; Bort-Roig J, 2014, SPORTS MED, V44, P671, DOI 10.1007/s40279-014-0142-5; Brox JI, 2005, OCCUP MED-OXFORD, V55, P558, DOI 10.1093/occmed/kqi153; Eriksen HR, 2002, OCCUP MED-OXFORD, V52, P383, DOI 10.1093/occmed/52.7.383; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Goodwin RD, 2003, PREV MED, V36, P698, DOI 10.1016/S0091-7435(03)00042-2; Hanebuth D, 2006, J OCCUP ENVIRON MED, V48, P28, DOI 10.1097/01.jom.0000195319.24750.f8; Hill HD, 2013, WORK OCCUPATION, V40, P143, DOI 10.1177/0730888413480893; James P T, 2001, Obes Res, V9 Suppl 4, p228S, DOI 10.1038/oby.2001.123; Khera AV, 2016, NEW ENGL J MED, V375, P2349, DOI 10.1056/NEJMoa1605086; King AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062613; Kooiman TJM, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0018-5; Kristensen TR, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-643; Lahti J, 2010, SCAND J MED SCI SPOR, V20, P191, DOI 10.1111/j.1600-0838.2009.00886.x; Lahti J, 2012, PREV MED, V55, P618, DOI 10.1016/j.ypmed.2012.10.006; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; LINDSTROM I, 1992, PHYS THER, V72, P279, DOI 10.1093/ptj/72.4.279; Marshall SJ, 2009, AM J PREV MED, V36, P410, DOI 10.1016/j.amepre.2009.01.021; Mattke S, 2015, INCENTIVES WORKPLACE; Mattke S, 2013, WORKPLACE WELLNESS P; Melchior M, 2003, J EPIDEMIOL COMMUN H, V57, P285, DOI 10.1136/jech.57.4.285; Mitchell RJ, 2011, POPUL HEALTH MANAG, V14, P93, DOI 10.1089/pop.2010.0014; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; NORTH F, 1993, BRIT MED J, V306, P361, DOI 10.1136/bmj.306.6874.361; Nurminen E, 2002, SCAND J WORK ENV HEA, V28, P85, DOI 10.5271/sjweh.652; Patel MS, 2016, J GEN INTERN MED, V31, P746, DOI 10.1007/s11606-016-3627-0; Patel MS, 2016, ANN INTERN MED, V164, P385, DOI 10.7326/M15-1635; Patel MS, 2015, JAMA-J AM MED ASSOC, V313, P459, DOI 10.1001/jama.2014.14781; Peipins LA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-520; Quist HG, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1084; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Seidell JC, 1997, BRIT MED BULL, V53, P238, DOI 10.1093/oxfordjournals.bmb.a011611; Staal JB, 2004, ANN INTERN MED, V140, P77, DOI 10.7326/0003-4819-140-2-200401200-00007; Sumanen H, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1718-1; Sushames A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161224; Tudor-Locke C, 2005, CAN J APPL PHYSIOL, V30, P666, DOI 10.1139/h05-147; Tveito TH, 2009, J ADV NURS, V65, P110, DOI 10.1111/j.1365-2648.2008.04846.x; U.S. Department of Health and Human Services, 2018, PHYS ACT GUID AM; van Rhenen W, 2007, INT ARCH OCC ENV HEA, V80, P505, DOI 10.1007/s00420-006-0157-9; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351	44	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176872	10.1371/journal.pone.0176872	http://dx.doi.org/10.1371/journal.pone.0176872			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472084	gold, Green Submitted, Green Published			2022-12-26	WOS:000400648500091
J	Wary, A; Wary, N; Baruah, J; Mastej, V; Wary, KK				Wary, Anita; Wary, Neil; Baruah, Jugajyoti; Mastej, Victoria; Wary, Kishore K.			Chromatin-modifying agents convert fibroblasts to OCT4+and VEGFR-2+capillary tube-forming cells	PLOS ONE			English	Article							ENDOTHELIAL BARRIER FUNCTION; PLURIPOTENT STEM-CELLS; PROGENITOR CELLS; IN-VITRO; DISEASE; FIBROSIS; REPAIR; HEART; TIDEGLUSIB; SKIN	Rationale The human epigenome is plastic. The goal of this study was to address if fibroblast cells can be epigenetically modified to promote neovessel formation. Methods and results Here, we used highly abundant human adult dermal fibroblast cells (hADFCs) that were treated with the chromatin-modifying agents 5-aza-2'-deoxycytidine and trichostatin A, and subsequently subjected to differentiation by activating Wnt signaling. Our results show that these epigenetically modified hADFCs increasingly expressed beta-catenin, pluripotency factor octamer-binding transcription factor-4 (OCT4, also known as POU5F1), and endothelial cell (EC) marker called vascular endothelial growth factor receptor-2 (VEGFR-2, also known as Fetal Liver Kinase-1). In microscopic analysis, beta-catenin localized to cell-cell contact points, while OCT4 was found to be localized primarily to the nucleus of these cells. Furthermore, in a chromatin immunoprecipitation experiment, OCT4 bound to the VEGFR-2/FLK1 promoter. Finally, these modified hADFCs also transduced Wnt signaling. Importantly, on a two-dimensional (2D) gel substrate, a subset of the converted cells formed vascular network- like structures in the presence of VEGF. Conclusion Chromatin-modifying agents converted hADFCs to OCT4+ and VEGFR-2+ capillary tubeforming cells in a 2D matrix in VEGF-dependent manner.	[Wary, Anita] York Community High Sch, Elmhurst, IL USA; [Wary, Neil] Illinois Math & Sci Acad, Aurora, IL USA; [Baruah, Jugajyoti; Mastej, Victoria; Wary, Kishore K.] Univ Illinois, Dept Pharmacol, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wary, KK (corresponding author), Univ Illinois, Dept Pharmacol, Chicago, IL 60607 USA.	kkwary@uic.edu	Baruah, Jugajyoti/AAJ-7545-2020	Wary, Neil/0000-0002-0712-276X; Wary, Kishore/0000-0001-8851-8565	American Heart Association [HL079356, GRNT25710129]; University of Illinois at Chicago Center for Clinical and Translation Science Award [UL1RR029879]; AHA pre-doctoral fellowship Mid-West affiliate [15PRE22760004]; CCTS-PECTs [1UL1TR002003]; NIH [NIH-T32-HL07829]; National Institute of Health [R01-HL079356]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002003] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029879] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079356, T32HL007829] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); University of Illinois at Chicago Center for Clinical and Translation Science Award; AHA pre-doctoral fellowship Mid-West affiliate; CCTS-PECTs; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The first two authors (A.W. and N.W.) and the corresponding author, K.K.W., are related by family. Studies were supported by the HL079356 (nih.gov/;and (American Heart Association, http://www.heart.org/HEARTORG/; GRNT25710129) and by the University of Illinois at Chicago Center for Clinical and Translation Science Award (UL1RR029879) to K.K.W. J.B was supported by AHA pre-doctoral fellowship Mid-West affiliate (15PRE22760004) and CCTS-PECTs (1UL1TR002003). V.M. was supported by NIH-T32-HL07829 pre-doctoral training grant from the NIH. The UIC, RRC Core Imaging Facility, at the University of Illinois Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.National Institute of Health, https://www.; Studies were supported by the R01-HL079356 (National Institute of Health, http://www.nih.gov/; and (American Heart Association, http://www.heart.org/HEARTORG/; GRNT25710129) and by the University of Illinois at Chicago Center for Clinical and Translation Science Award (UL1RR029879) to KKW. JB was supported by AHA pre-doctoral fellowship Mid-West affiliate (15RRE22760004) and CCTS-PECTs (1UL1TR002003). VM was supported by NIH-T32-HL07829 pre-doctoral training grant from the NIH. The UIC, RRC Core Imaging Facility, at the University of Illinois Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anversa P, 2013, J CLIN INVEST, V123, P62, DOI 10.1172/JCI63068; Araki H, 2007, BLOOD, V109, P3570, DOI 10.1182/blood-2006-07-035287; Armagan G, 2015, PHARMACOL REP, V67, P823, DOI 10.1016/j.pharep.2015.01.007; Ashen MD, 2005, NEW ENGL J MED, V353, P1252, DOI 10.1056/NEJMcp044370; Baeyens N, 2016, J CLIN INVEST, V126, P821, DOI 10.1172/JCI83083; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Brunzell JD, 2007, NEW ENGL J MED, V357, P1009, DOI 10.1056/NEJMcp070061; Chatterjee I, 2016, CARDIOVASC RES, V111, P105, DOI 10.1093/cvr/cvw090; Chen W, 2013, BBA-MOL CELL RES, V1833, P945, DOI 10.1016/j.bbamcr.2012.08.023; Cines DB, 1998, BLOOD, V91, P3527; Cowan CE, 2010, CIRC RES, V107, P959, DOI 10.1161/CIRCRESAHA.110.219592; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; Dorans KS, 2016, ARTERIOSCL THROM VAS, V36, P1679, DOI 10.1161/ATVBAHA.116.307141; Driskell RR, 2015, TRENDS CELL BIOL, V25, P92, DOI 10.1016/j.tcb.2014.10.001; Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; Escalante-Alcalde D, 2003, DEVELOPMENT, V130, P4623, DOI 10.1242/dev.00635; Foraker RE, 2016, AM HEART J, V177, P25, DOI 10.1016/j.ahj.2016.04.007; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Gifford CA, 2012, CURR OPIN GENET DEV, V22, P409, DOI 10.1016/j.gde.2012.08.002; GOLDSTEI.S, 1972, EXP CELL RES, V70, P436, DOI 10.1016/0014-4827(72)90157-7; GOLDSTEIN S, 1971, NEW ENGL J MED, V285, P1120, DOI 10.1056/NEJM197111112852005; Gu PL, 2009, MOL CELL BIOL, V29, P1987, DOI 10.1128/MCB.00019-09; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Harrison DG, 1997, J CLIN INVEST, V100, P2153, DOI 10.1172/JCI119751; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; HOCKEL M, 1988, J CLIN INVEST, V82, P1075, DOI 10.1172/JCI113664; Hu Qidong, 2012, Frontiers in Genetics, V3, P238, DOI 10.3389/fgene.2012.00238; Humtsoe JO, 2003, EMBO J, V22, P1539, DOI 10.1093/emboj/cdg165; Humtsoe JO, 2010, MOL CELL BIOL, V30, P1593, DOI 10.1128/MCB.00038-09; Joyce NC, 2005, EXP EYE RES, V81, P629, DOI 10.1016/j.exer.2005.06.012; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kohler EE, 2014, STEM CELLS, V32, P1538, DOI 10.1002/stem.1658; Kohler EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085549; Kohler EE, 2011, BLOOD, V117, P1761, DOI 10.1182/blood-2010-07-295261; KOLOUCH F, 1947, ANAT REC, V97, P349; Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lovestone S, 2015, J ALZHEIMERS DIS, V45, P75, DOI 10.3233/JAD-141959; Mammen AL, 2016, NEW ENGL J MED, V374, P664, DOI 10.1056/NEJMra1515161; Dominguez JM, 2012, J BIOL CHEM, V287, P893, DOI 10.1074/jbc.M111.306472; Meneghin A, 2007, J CLIN INVEST, V117, P530, DOI 10.1172/JCI30595; MILO GE, 1986, CANCER LETT, V31, P1, DOI 10.1016/0304-3835(86)90161-8; Mozaffarian D, 2016, CIRCULATION, V133, P447, DOI 10.1161/CIR.0000000000000366; Ohtani K, 2011, CARDIOVASC RES, V90, P404, DOI 10.1093/cvr/cvr019; Park C, 2013, CIRC RES, V112, P1380, DOI 10.1161/CIRCRESAHA.113.301078; Patel U, 2016, DRUG DISCOV IN PRESS; Pober JS, 2014, J CLIN INVEST, V124, P4234, DOI 10.1172/JCI77766; Psaltis PJ, 2015, CIRC RES, V116, P1392, DOI 10.1161/CIRCRESAHA.116.305368; Rafii S, 2016, NATURE, V529, P316, DOI 10.1038/nature17040; Rajasingh J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022550; Ramasamy SK, 2015, TRENDS CELL BIOL, V25, P148, DOI 10.1016/j.tcb.2014.11.007; Rauscher FM, 2003, CIRCULATION, V108, P457, DOI 10.1161/01.CIR.0000082924.75945.48; ROSS R, 1965, J CELL BIOL, V27, P83, DOI 10.1083/jcb.27.1.83; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sancho-Martinez I, 2012, NAT CELL BIOL, V14, P892, DOI 10.1038/ncb2567; Saraf S, 2015, TRANSFUSION, V55, P864, DOI 10.1111/trf.12904; Sasaki K, 2015, CELL STEM CELL, V17, P178, DOI 10.1016/j.stem.2015.06.014; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SHIMOKADO K, 1985, CELL, V43, P277, DOI 10.1016/0092-8674(85)90033-9; Smith U, 2015, J CLIN INVEST, V125, P1790, DOI 10.1172/JCI81507; Srivastava D, 2016, CELL, V166, P1386, DOI 10.1016/j.cell.2016.08.055; Srivastava D, 2015, CURR OPIN GENET DEV, V34, P77, DOI 10.1016/j.gde.2015.09.004; Suen CM, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0265-x; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi K, 2016, NAT REV MOL CELL BIO, V17, P183, DOI 10.1038/nrm.2016.8; TANNOCK IF, 1972, CANCER RES, V32, P77; Thannickal VJ, 2014, J CLIN INVEST, V124, P4673, DOI 10.1172/JCI74368; Toya SP, 2015, STEM CELLS, V33, P1719, DOI 10.1002/stem.1974; Ubil E, 2014, NATURE, V514, P585, DOI 10.1038/nature13839; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Wagner RT, 2009, CELL RES, V19, P527, DOI 10.1038/cr.2009.48; Xu HS, 2011, NAT CELL BIOL, V13, P191, DOI 10.1038/ncb0311-191	74	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176496	10.1371/journal.pone.0176496	http://dx.doi.org/10.1371/journal.pone.0176496			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467484	Green Published, gold			2022-12-26	WOS:000400647000056
J	Kim, J; Hwang, J; Choi, JH; Choi, HI; Kim, MS; Jung, SH; Nam, GB; Choi, KJ; Lee, JW; Kim, YH; Kim, JJ				Kim, Jun; Hwang, Jongmin; Choi, Jin Hee; Choi, Hyo-In; Kim, Min-Seok; Jung, Sung-Ho; Nam, Gi-Byoung; Choi, Kee-Joon; Lee, Jae Won; Kim, You-Ho; Kim, Jae-Joong			Frequency and clinical impact of retained implantable cardioverter defibrillator lead materials in heart transplant recipients	PLOS ONE			English	Article							SINGLE-CENTER; LUNG TRANSPLANTATION; PACEMAKER LEADS; PACING LEADS; EXTRACTION; EXPERIENCE; OUTCOMES; PREDICTORS; COMPLICATIONS; REGISTRY	End-stage heart failure patients with implantable cardioverter-defibrillator (ICD) with/without cardiac resynchronization therapy (CRT-D) often require heart transplantation (HTPL) as a last-resort treatment. We aimed to assess the frequency and clinical impact of retained ICD lead materials in HTPL patients. In this retrospective single center study, we examined the clinical records and chest radiographs of patients with ICD and CRT-D who underwent HTPL between January 1992 and July 2014. Of 40 patients with ICD and CRT-D at HTPL, 19 (47.5%) patients had retained ICD lead materials within the central venous system. Retained ICD lead materials following HTPL were more frequently noted in patients with longer implantation durations until HTPL. None of the patients underwent extraction procedures after HTPL. All patients were asymptomatic and did not exhibit significant complications or death related to the retained ICD lead materials. Seven (7/40, 17.5%) patients without any retained ICD lead materials underwent magnetic resonance imaging (MRI) during the follow-up period (median, 29.5 months); none of the patients with retained lead materials were given MRI. Considering the common use of MRI in HTPL patients, further studies on the prophylactic extraction of retained ICD lead materials and safety of MRI in these patients are needed.	[Kim, Jun; Hwang, Jongmin; Choi, Jin Hee; Choi, Hyo-In; Kim, Min-Seok; Nam, Gi-Byoung; Choi, Kee-Joon; Kim, You-Ho; Kim, Jae-Joong] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol, Seoul, South Korea; [Jung, Sung-Ho; Lee, Jae Won] Univ Ulsan, Coll Med, Asan Med Ctr, Thorac & Cardiovasc Surg, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Kim, JJ (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol, Seoul, South Korea.	jjkim@amc.seoul.kr						Amelot M, 2011, ARCH CARDIOVASC DIS, V104, P572, DOI 10.1016/j.acvd.2011.08.004; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bode F, 2012, EUROPACE, V14, P1764, DOI 10.1093/europace/eus202; Bohm A, 2001, PACE, V24, P1721, DOI 10.1046/j.1460-9592.2001.01721.x; Borhani AA, 2009, RADIOGRAPHICS, V29, P981, DOI 10.1148/rg.294095020; Bracke F, 2002, PACE, V25, P1037, DOI 10.1046/j.1460-9592.2002.01037.x; Brunner MP, 2014, HEART RHYTHM, V11, P799, DOI 10.1016/j.hrthm.2014.01.016; Chitsaz S, 2009, TRANSPL P, V41, P2927, DOI 10.1016/j.transproceed.2009.07.001; Choo SJ, 2004, YONSEI MED J, V45, P1173, DOI 10.3349/ymj.2004.45.6.1173; Drachman BM, 1996, J HEART LUNG TRANSPL, V15, P1158; Epstein AE, 1998, CIRCULATION, V98, P1517, DOI 10.1161/01.CIR.98.15.1517; Epstein LM, 2013, J AM COLL CARDIOL, V61, P987, DOI 10.1016/j.jacc.2012.12.014; FURMAN S, 1987, J THORAC CARDIOV SUR, V94, P770; Gomes S, 2014, EUROPACE, V16, P1350, DOI 10.1093/europace/eut424; Higgins JV, 2014, PACE, V37, P1284, DOI 10.1111/pace.12419; Jones SO, 2008, HEART RHYTHM, V5, P520, DOI 10.1016/j.hrthm.2008.01.009; Jung SH, 2011, J KOREAN MED SCI, V26, P599, DOI 10.3346/jkms.2011.26.5.599; Kennergren C, 2009, EUROPACE, V11, P612, DOI 10.1093/europace/eup054; Kusmierski K, 2013, KARDIOL POL, V71, P159, DOI 10.5603/KP.2013.0009; Langman DA, 2011, J MAGN RESON IMAGING, V33, P426, DOI 10.1002/jmri.22463; Levine GN, 2007, CIRCULATION, V116, P2878, DOI 10.1161/CIRCULATIONAHA.107.187256; Martin A, 2014, PACE, V37, P242, DOI 10.1111/pace.12274; Mattei E, 2015, MAGN RESON MED, V73, P390, DOI 10.1002/mrm.25106; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Nazarian S, 2011, ANN INTERN MED, V155, P415, DOI 10.7326/0003-4819-155-7-201110040-00004; Roux JF, 2007, PACE, V30, P214, DOI 10.1111/j.1540-8159.2007.00652.x; Segreti L, 2014, HEART RHYTHM, V11, P2196, DOI 10.1016/j.hrthm.2014.08.011; Stehlik J, 2012, J HEART LUNG TRANSPL, V31, P1052, DOI 10.1016/j.healun.2012.08.002; Suga C, 2000, J INTERV CARD ELECTR, V4, P493, DOI 10.1023/A:1009860514724; Taillandier J, 1997, J HEART LUNG TRANSPL, V16, P436; ZERBE F, 1985, BRIT HEART J, V54, P76	32	8	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176925	10.1371/journal.pone.0176925	http://dx.doi.org/10.1371/journal.pone.0176925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28464008	gold, Green Submitted, Green Published			2022-12-26	WOS:000400646300066
J	Selby, K; Mascher, G; Somervuo, P; Lindstrom, M; Korkeala, H				Selby, Katja; Mascher, Gerald; Somervuo, Panu; Lindstrom, Miia; Korkeala, Hannu			Heat shock and prolonged heat stress attenuate neurotoxin and sporulation gene expression in group I Clostridium botulinum strain ATCC 3502	PLOS ONE			English	Article							ACIDOGENIC CHEMOSTAT CELLS; BACILLUS-SUBTILIS; SIGMA-FACTOR; ESCHERICHIA-COLI; TRANSCRIPTIONAL ANALYSIS; TOXIN PRODUCTION; HIGH-TEMPERATURE; BACTERIAL; GROWTH; ACETOBUTYLICUM	Foodborne pathogenic bacteria are exposed to a number of environmental stresses during food processing, storage, and preparation, and in the human body. In order to improve the safety of food, the understanding of molecular stress response mechanisms foodborne pathogens employ is essential. Many response mechanisms that are activated during heat shock may cross-protect bacteria against other environmental stresses. To better understand the molecular mechanisms Clostridium botulinum, the causative agent of botulism, utilizes during acute heat stress and during adaptation to stressfully high temperature, the C. botulinum Group I strain ATCC 3502 was grown in continuous culture at 39 degrees C and exposed to heat shock at 45 degrees C, followed by prolonged heat stress at 45 degrees C to allow adaptation of the culture to the high temperature. Growth in continuous culture was performed to exclude secondary growth phase effects or other environmental impacts on bacterial gene transcription. Changes in global gene expression profiles were studied using DNA microarray hybridization. During acute heat stress, Class I and III heat shock genes as well as members of the SOS regulon were activated. The neurotoxin gene botA and genes encoding the neurotoxin-associated proteins were suppressed throughout the study. Prolonged heat stress led to suppression of the sporulation machinery whereas genes related to chemotaxis and motility were activated. Induced expression of a large proportion of prophage genes was detected, suggesting an important role of acquired genes in the stress resistance of C. botulinum. Finally, changes in the expression of a large number of genes related to carbohydrate and amino acid metabolism indicated remodeling of the cellular metabolism.	[Selby, Katja; Mascher, Gerald; Somervuo, Panu; Lindstrom, Miia; Korkeala, Hannu] Univ Helsinki, Fac Vet Med, Dept Food Hyg & Environm Hlth, Helsinki, Finland	University of Helsinki	Lindstrom, M (corresponding author), Univ Helsinki, Fac Vet Med, Dept Food Hyg & Environm Hlth, Helsinki, Finland.	miia.lindstrom@helsinki.fi			Academy of Finland [118602, 1115133, 1120180, 206319]; ABS Graduate School; Doctoral Programme in Microbiology and Biotechnology; Walter Ehrstrom Foundation; Finnish Foundation of Veterinary Research	Academy of Finland(Academy of Finland); ABS Graduate School; Doctoral Programme in Microbiology and Biotechnology; Walter Ehrstrom Foundation; Finnish Foundation of Veterinary Research	This research was performed in the Finnish Centre of Excellence in Microbial Food Safety Research (http://www.vetmed.helsinki.fi/mifosa/) and was funded by the Academy of Finland (http://www.aka.fi/en-GB/A/)(grants 118602, 1115133, 1120180, and 206319), the ABS Graduate School (http://www.vetmed.helsinki.fi/abs/index.htm), the Doctoral Programme in Microbiology and Biotechnology (http://www.helsinki.fi/af-faculty/research/mbdp.html), the Walter Ehrstrom Foundation (http://www.maitohygienialiitto.fi/walter-ehrstromin-saatio), and the Finnish Foundation of Veterinary Research (http://www.sels.fi/index_eng.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler E, 2001, J BACTERIOL, V183, P3574, DOI 10.1128/JB.183.12.3574-3581.2001; Aizawa S-I, 2002, BACILLUS SUBTILIS IT, P437; Al-Hinai MA, 2015, MICROBIOL MOL BIOL R, V79, P19, DOI 10.1128/MMBR.00025-14; Al-Hinai MA, 2014, J BACTERIOL, V196, P287, DOI 10.1128/JB.01103-13; Alsaker KV, 2010, BIOTECHNOL BIOENG, V105, P1131, DOI 10.1002/bit.22628; Alsaker KV, 2004, J BACTERIOL, V186, P1959, DOI 10.1128/JB.186.7.1959-1971.2004; ARMENTROUT RW, 1971, J VIROL, V8, P455, DOI 10.1128/JVI.8.4.455-468.1971; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Au N, 2005, J BACTERIOL, V187, P7655, DOI 10.1128/JB.187.22.7655-7666.2005; BACK JF, 1979, BIOCHEMISTRY-US, V18, P5191, DOI 10.1021/bi00590a025; Bejerano-Sagie M, 2006, CELL, V125, P679, DOI 10.1016/j.cell.2006.03.039; BIRAN D, 1995, J BACTERIOL, V177, P1374, DOI 10.1128/jb.177.5.1374-1379.1995; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Butala M, 2009, CELL MOL LIFE SCI, V66, P82, DOI 10.1007/s00018-008-8378-6; Carter GP, 2014, MOL MICROBIOL, V91, P221, DOI 10.1111/mmi.12469; Connan C, 2013, TOXICON, V75, P90, DOI 10.1016/j.toxicon.2013.06.001; Connan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041848; Couesnon A, 2006, MICROBIOL-SGM, V152, P759, DOI 10.1099/mic.0.28561-0; Dahlsten E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089958; Dahlsten E, 2014, APPL ENVIRON MICROB, V80, P306, DOI 10.1128/AEM.03173-13; Dahlsten E, 2013, APPL ENVIRON MICROB, V79, P3867, DOI 10.1128/AEM.04036-12; Dapa T, 2013, J BACTERIOL, V195, P545, DOI 10.1128/JB.01980-12; Dodds KL, 1993, CLOSTRIDIUM BOTULINU, P21; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elsholz AKW, 2010, EMBO J, V29, P3621, DOI 10.1038/emboj.2010.228; Fortier LC, 2013, VIRULENCE, V4, P354, DOI 10.4161/viru.24498; Gur E, 2002, MOL MICROBIOL, V46, P1391, DOI 10.1046/j.1365-2958.2002.03257.x; Harry KH, 2009, J BACTERIOL, V191, P2728, DOI 10.1128/JB.01839-08; Hatheway C.L., 1993, CLOSTRIDIUM BOTULINU, P3; Hecker M, 1996, MOL MICROBIOL, V19, P417, DOI 10.1046/j.1365-2958.1996.396932.x; Helmann JD, 2001, J BACTERIOL, V183, P7318, DOI 10.1128/JB.183.24.7318-7328.2001; Hinderink K, 2009, J FOOD PROTECT, V72, P375, DOI 10.4315/0362-028X-72.2.375; Hoskisson PA, 2005, MICROBIOL-SGM, V151, P3153, DOI 10.1099/mic.0.27924-0; Janssen H, 2012, J BIOTECHNOL, V161, P354, DOI 10.1016/j.jbiotec.2012.03.027; Jones SW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r114; Karlsson S, 2003, INFECT IMMUN, V71, P1784, DOI 10.1128/IAI.71.4.1784-1793.2003; Karlsson S, 2000, INFECT IMMUN, V68, P5881, DOI 10.1128/IAI.68.10.5881-5888.2000; Kirk DG, 2014, APPL ENVIRON MICROB, V80, P5141, DOI 10.1128/AEM.01015-14; Kirk DG, 2014, ANAEROBE, V26, P14, DOI 10.1016/j.anaerobe.2013.12.003; Kirk DG, 2012, APPL ENVIRON MICROB, V78, P4590, DOI 10.1128/AEM.00304-12; Leifson E, 1931, J BACTERIOL, V21, P331, DOI 10.1128/JB.21.5.331-356.1931; Liang WD, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/760904; LIEB M, 1964, SCIENCE, V145, P175, DOI 10.1126/science.145.3628.175; Lindstrom M, 2006, CLIN MICROBIOL REV, V19, P298, DOI 10.1128/CMR.19.2.298-314.2006; Lulko AT, 2007, APPL ENVIRON MICROB, V73, P5354, DOI 10.1128/AEM.00472-07; Martin-Verstraete I, 2016, TOXINS, V8, DOI 10.3390/toxins8050153; Marvaud JC, 1998, MOL MICROBIOL, V29, P1009, DOI 10.1046/j.1365-2958.1998.00985.x; Matsushita C, 1996, MICROBIOL-SGM, V142, P2561, DOI 10.1099/00221287-142-9-2561; Mostertz J, 2004, MICROBIOL-SGM, V150, P497, DOI 10.1099/mic.0.26665-0; Msadek T, 1998, MOL MICROBIOL, V27, P899, DOI 10.1046/j.1365-2958.1998.00735.x; Pettit LJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-160; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Roe AJ, 2002, MICROBIOL-SGM, V148, P2215, DOI 10.1099/00221287-148-7-2215; RON EZ, 1971, J BACTERIOL, V107, P391, DOI 10.1128/JB.107.2.391-396.1971; Rothenbacher FP, 2012, J BACTERIOL, V194, P3464, DOI 10.1128/JB.00217-12; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saujet L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003756; SCHMIDT A, 1992, J BACTERIOL, V174, P3993, DOI 10.1128/jb.174.12.3993-3999.1992; Schroeter M, 2009, EPIDEMIOL INFECT, V137, P1602, DOI 10.1017/S0950268809002544; Schuch R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006532; Schumann W, 2003, CELL STRESS CHAPERON, V8, P207, DOI 10.1379/1466-1268(2003)008<0207:TBSHSS>2.0.CO;2; Schwarz KM, 2012, J BIOTECHNOL, V161, P366, DOI 10.1016/j.jbiotec.2012.03.018; Sebaihia M, 2007, GENOME RES, V17, P1082, DOI 10.1101/gr.6282807; Selby K, 2011, APPL ENVIRON MICROB, V77, P2823, DOI 10.1128/AEM.02633-10; SETLOW P, 1997, FOOD MICROBIOLOGY FU, P30; Shukla HD, 2009, BOTULINUM J, V1, P309; SIEGEL LS, 1979, APPL ENVIRON MICROB, V38, P606, DOI 10.1128/AEM.38.4.606-611.1979; SMITH LDS, 1988, ORGANISM ITS TOXINS; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Soderholm H, 2015, INT J FOOD MICROBIOL, V208, P51, DOI 10.1016/j.ijfoodmicro.2015.05.013; Sootsuwan K, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-180; Stephens C, 1998, CURR BIOL, V8, pR45, DOI 10.1016/S0960-9822(98)70031-4; Stickland LH, 1934, BIOCHEM J, V28, P1746, DOI 10.1042/bj0281746; Ternan NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042410; Tomas CA, 2003, J BACTERIOL, V185, P4539, DOI 10.1128/JB.185.15.4539-4547.2003; Wesche AM, 2009, J FOOD PROTECT, V72, P1121, DOI 10.4315/0362-028X-72.5.1121; WETZSTEIN M, 1992, J BACTERIOL, V174, P3300, DOI 10.1128/jb.174.10.3300-3310.1992; Wood JM, 2001, COMP BIOCHEM PHYS A, V130, P437, DOI 10.1016/S1095-6433(01)00442-1; Zancan P, 2005, ARCH BIOCHEM BIOPHYS, V444, P52, DOI 10.1016/j.abb.2005.09.014; Zhang Z, 2014, APPL ENVIRON MICROB, V80, P7651, DOI 10.1128/AEM.02838-14; Zhang Z, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003252	84	7	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176944	10.1371/journal.pone.0176944	http://dx.doi.org/10.1371/journal.pone.0176944			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28464023	Green Submitted, gold, Green Published			2022-12-26	WOS:000400646300068
J	Ekchaweng, K; Evangelisti, E; Schornack, S; Tian, MY; Churngchow, N				Ekchaweng, Kitiya; Evangelisti, Edouard; Schornack, Sebastian; Tian, Miaoying; Churngchow, Nunta			The plant defense and pathogen counterdefense mediated by Hevea brasiliensis serine protease HbSPA and Phytophthora palmivora extracellular protease inhibitor PpEPI10	PLOS ONE			English	Article							SUBTILASE GENE FAMILY; TOMATO PLANTS; MOLECULAR-CLONING; EXPRESSION; RESISTANCE; EFFECTORS; PROTEINS; IDENTIFICATION; ARABIDOPSIS; SUPPRESSION	Rubber tree (Hevea brasiliensis Muell. Arg) is an important economic crop in Thailand. Leaf fall and black stripe diseases caused by the aggressive oomycete pathogen Phytophthora palmivora, cause deleterious damage on rubber tree growth leading to decrease of latex production. To gain insights into the molecular function of H. brasiliensis subtilisin-like serine proteases, the HbSPA, HbSPB, and HbSPC genes were transiently expressed in Nicotiana benthamiana via agroinfiltration. A functional protease encoded by HbSPA was successfully expressed in the apoplast of N. benthamiana leaves. Transient expression of HbSPA in N. benthamiana leaves enhanced resistance to P. palmivora, suggesting that HbSPA plays an important role in plant defense. P. palmivora Kazal-like extracellular protease inhibitor 10 (PpEPI10), an apoplastic effector, has been implicated in pathogenicity through the suppression of H. brasiliensis protease. Semi-quantitative RT-PCR revealed that the PpEPI10 gene was significantly up-regulated during colonization of rubber tree by P. palmivora. Concurrently, the HbSPA gene was highly expressed during infection. To investigate a possible interaction between HbSPA and PpEPI10, the recombinant PpEPI10 protein (rPpEPI10) was expressed in Escherichia coli and purified using affinity chromatography. In-gel zymo-gram and co-immunoprecipitation (co-IP) assays demonstrated that rPpEPI10 specifically inhibited and interacted with HbSPA. The targeting of HbSPA by PpEPI10 revealed a defense-counterdefense mechanism, which is mediated by plant protease and pathogen protease inhibitor, in H. brasiliensis-P. palmivora interactions.	[Ekchaweng, Kitiya; Churngchow, Nunta] Prince Songkla Univ, Fac Sci, Dept Biochem, Hat Yai, Songkhla, Thailand; [Ekchaweng, Kitiya; Tian, Miaoying] Univ Hawaii, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA; [Ekchaweng, Kitiya] East West Ctr, Honolulu, HI USA; [Evangelisti, Edouard; Schornack, Sebastian] Univ Cambridge, Sainsbury Lab, Cambridge, England	Prince of Songkla University; University of Hawaii System; East West Center; University of Cambridge	Churngchow, N (corresponding author), Prince Songkla Univ, Fac Sci, Dept Biochem, Hat Yai, Songkhla, Thailand.; Tian, MY (corresponding author), Univ Hawaii, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA.	mtian@hawaii.edu; nunta.c@psu.ac.th	Schornack, Sebastian/A-3650-2011; Schornack, Sebastian/AAE-4897-2020	Schornack, Sebastian/0000-0002-7836-5881; Schornack, Sebastian/0000-0002-7836-5881; Tian, Miaoying/0000-0001-8900-6414; Evangelisti, Edouard/0000-0002-7218-7850	Thailand Research Fund (TRF) [PHD/0030/2555]; Graduate School of Prince of Songkla University, Thailand; University Academic Excellence Strengthening Program in Biochemistry, Faculty of Science, Prince of Songkla University, Thailand	Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); Graduate School of Prince of Songkla University, Thailand; University Academic Excellence Strengthening Program in Biochemistry, Faculty of Science, Prince of Songkla University, Thailand	This work was financially supported in part by the Thailand Research Fund (TRF) through the Royal Golden Jubilee Ph.D. Program (RGJ-PHD) to Miss Kitiya Ekchaweng (Grant No. PHD/0030/2555; www.trf.or.th); the University Academic Excellence Strengthening Program in Biochemistry, Faculty of Science, Prince of Songkla University, Thailand (www.sci.psu.ac.th); the Graduate School of Prince of Songkla University, Thailand (www.psu.ac.th). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHBY AM, 1988, J BACTERIOL, V170, P4181, DOI 10.1128/jb.170.9.4181-4187.1988; Cao J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1116; Chinnapun D, 2009, PHYSIOL MOL PLANT P, V74, P27, DOI 10.1016/j.pmpp.2009.08.005; DEWIT PJGM, 1982, PHYSIOL PLANT PATHOL, V21, P1, DOI 10.1016/0048-4059(82)90002-9; DIXON RA, 1990, ANNU REV PLANT PHYS, V41, P339, DOI 10.1146/annurev.pp.41.060190.002011; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Duan XP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153988; Ekchaweng K, 2017, PHYSIOL MOL PLANT P, V97, P79, DOI 10.1016/j.pmpp.2016.12.007; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; Evangelisti E, 2017, BIORXIV; Fawke S, 2015, MICROBIOL MOL BIOL R, V79, P263, DOI 10.1128/MMBR.00010-15; Figueiredo A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00739; Giraldo MC, 2013, NAT REV MICROBIOL, V11, P800, DOI 10.1038/nrmicro3119; Goodin MM, 2002, PLANT J, V31, P375, DOI 10.1046/j.1365-313X.2002.01360.x; Jorda L, 1999, J BIOL CHEM, V274, P2360, DOI 10.1074/jbc.274.4.2360; Kamoun S, 2007, CURR OPIN PLANT BIOL, V10, P358, DOI 10.1016/j.pbi.2007.04.017; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Khunjan U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157591; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Li HP, 2011, PLANT SCI, V181, P132, DOI 10.1016/j.plantsci.2011.04.014; Lindbo JA, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-52; LIYANAGE NIS, 1989, PLANT PATHOL, V38, P592, DOI 10.1111/j.1365-3059.1989.tb01456.x; Loon L. C. van, 1994, Plant Molecular Biology Reporter, V12, P245, DOI 10.1007/BF02668748; Meichtry J, 1999, PLANT MOL BIOL, V39, P749, DOI 10.1023/A:1006193414434; Ramirez V, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003445; Rautengarten C, 2005, PLOS COMPUT BIOL, V1, P297, DOI 10.1371/journal.pcbi.0010040; Rose JKC, 2002, PLANT CELL, V14, P1329, DOI 10.1105/tpc.002253; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Song J, 2009, P NATL ACAD SCI USA, V106, P1654, DOI 10.1073/pnas.0809201106; Tian MY, 2007, PLANT PHYSIOL, V143, P364, DOI 10.1104/pp.106.090050; Tian MY, 2004, J BIOL CHEM, V279, P26370, DOI 10.1074/jbc.M400941200; Tian MY, 2005, PLANT PHYSIOL, V138, P1785, DOI 10.1104/pp.105.061226; Tornero P, 1996, P NATL ACAD SCI USA, V93, P6332, DOI 10.1073/pnas.93.13.6332; Tornero P, 1997, J BIOL CHEM, V272, P14412, DOI 10.1074/jbc.272.22.14412; Tornero P, 1996, PLANT J, V10, P315, DOI 10.1046/j.1365-313X.1996.10020315.x; Tripathi LP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-200; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Vlot AC, 2008, PLANT J, V56, P445, DOI 10.1111/j.1365-313X.2008.03618.x; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Wawra S, 2012, CURR OPIN MICROBIOL, V15, P685, DOI 10.1016/j.mib.2012.10.008; Widmer T. L., 2014, FOR PHYTOPHTHORAS, V4, P3557; Wu DL, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0825-1; Zhao YF, 2003, PLANT J, V36, P485, DOI 10.1046/j.1365-313X.2003.01895.x	44	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0175795	10.1371/journal.pone.0175795	http://dx.doi.org/10.1371/journal.pone.0175795			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459807	Green Published, gold, Green Submitted			2022-12-26	WOS:000400645000004
J	Milovanovic, I; Busarcevic, M; Trbovich, A; Ivovic, V; Uzelac, A; Djurkovic-Djakovic, O				Milovanovic, Ivan; Busarcevic, Milos; Trbovich, Alexander; Ivovic, Vladimir; Uzelac, Aleksandra; Djurkovic-Djakovic, Olgica			Evidence for host genetic regulation of altered lipid metabolism in experimental toxoplasmosis supported with gene data mining results	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN; CHOLESTEROL; INFECTION; INFLAMMATION; RECEPTOR; RAFTS; MICE; ATHEROSCLEROSIS; MECHANISM; BLOOD	Toxoplasma gondii is one of the most successful parasites on Earth, infecting a wide array of mammals including one third of the global human population. The obligate intracellular protozoon is not capable of synthesizing cholesterol (Chl), and thus depends on uptake of host Chl for its own development. To explore the genetic regulation of previously observed lipid metabolism alterations during acute murine T. gondii infection, we here assessed total Chl and its fractions in serum and selected tissues at the pathophysiological and molecular level, and integrated the observed gene expression of selected molecules relevant for Chl metabolism, including its biosynthetic and export KEGG pathways, with the results of published transcriptomes obtained in similar murine models of T. gondii infection. The serum lipid status as well as the transcript levels of relevant genes in the brain and the liver were assessed in experimental models of acute and chronic toxoplasmosis in wild-type mice. The results showed that acute infection was associated with a decrease in Chl content in both the liver and periphery (brain, peripheral lymphocytes), and a decrease in Chl reverse transport. In contrast, in chronic infection, a return to normal levels of Chl metabolism has been noted. These changes corresponded to the brain and liver gene expression results as well as to data obtained via mining. We propose that the observed changes in Chl metabolism are part of the host defense response. Further insight into the lipid metabolism in T. gondii infection may provide novel targets for therapeutic agents.	[Milovanovic, Ivan; Trbovich, Alexander] Univ Belgrade, Inst Pathol Physiol, Sch Med, Belgrade, Serbia; [Busarcevic, Milos; Trbovich, Alexander; Ivovic, Vladimir; Uzelac, Aleksandra; Djurkovic-Djakovic, Olgica] Univ Belgrade, Inst Med Res, Ctr Excellence Food & Vector Borne Zoonoses, Natl Reference Lab Toxoplasmosis, Belgrade, Serbia; [Milovanovic, Ivan] Univ Childrens Hosp, Belgrade, Serbia; [Ivovic, Vladimir] Univ Primorska, Dept Biodivers, Fac Math Nat Sci & Informat Technol, Koper, Slovenia	University of Belgrade; University of Belgrade; University of Belgrade; University of Primorska	Djurkovic-Djakovic, O (corresponding author), Univ Belgrade, Inst Med Res, Ctr Excellence Food & Vector Borne Zoonoses, Natl Reference Lab Toxoplasmosis, Belgrade, Serbia.	olgicadj@imi.bg.ac.rs	Djurkovic-Djakovic, Olgica/AAD-1811-2020; Uzelac, Aleksandra/GQI-2085-2022; Ivovic, Vladimir/L-3577-2013	Djurkovic-Djakovic, Olgica/0000-0001-7521-8598; Uzelac, Aleksandra/0000-0002-1424-0123; Busarcevic, Milos/0000-0003-1649-1249; Ivovic, Vladimir/0000-0002-1562-9528	Ministry of Education, Science and Technological Development of Serbia [III 41019]	Ministry of Education, Science and Technological Development of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This study was supported by the Ministry of Education, Science and Technological Development of Serbia (http://www.mpn.gov.rs), project No. III 41019, to ODjDj. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso F, 2003, J LIPID RES, V44, P296, DOI 10.1194/jlr.M200414-JLR200; Cabral CM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005447; Coppens I, 2006, CELL MICROBIOL, V8, P1, DOI 10.1111/j.1462-5822.2005.00647.x; Coppens I, 2003, MOL BIOL CELL, V14, P3804, DOI 10.1091/mbc.E02-12-0830; Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167; Djurkovic-Djakovic O, 2006, MICROBES INFECT, V8, P2206, DOI 10.1016/j.micinf.2006.04.016; Djurkovic-Djakovic O, 2012, EXP PARASITOL, V131, P372, DOI 10.1016/j.exppara.2012.05.006; Doenhoff MJ, 2002, PARASITOLOGY, V125, P415, DOI 10.1017/S0031182002002275; Edvinsson M, 2017, PATHOG DIS, V75, DOI 10.1093/femspd/ftx004; Feingold KR, 2008, ATHEROSCLEROSIS, V199, P19, DOI 10.1016/j.atherosclerosis.2007.10.007; FIELDING CJ, 1995, J LIPID RES, V36, P211; Haks MC, 2003, J IMMUNOL, V170, P2853, DOI 10.4049/jimmunol.170.6.2853; He JJ, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1716-x; Hill RD, 2012, INFECT IMMUN, V80, P968, DOI 10.1128/IAI.05421-11; Jia BY, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-161; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Lagor WR, 2009, ARTERIOSCL THROM VAS, V29, P40, DOI 10.1161/ATVBAHA.108.177105; Lee JMS, 2007, HEART, V93, P559, DOI 10.1136/hrt.2005.066050; Li L, 2008, J LIPID RES, V49, P1782, DOI 10.1194/jlr.M800172-JLR200; Lou ZK, 2000, J EXP MED, V191, P347, DOI 10.1084/jem.191.2.347; Marangoni A, 2015, ATHEROSCLEROSIS, V241, P471, DOI 10.1016/j.atherosclerosis.2015.05.023; Matko J, 2002, IMMUNOL LETT, V82, P3, DOI 10.1016/S0165-2478(02)00011-1; Milovanovic I, 2009, MEM I OSWALDO CRUZ, V104, P175, DOI 10.1590/S0074-02762009000200008; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Pfrieger FW, 2011, PROG LIPID RES, V50, P357, DOI 10.1016/j.plipres.2011.06.002; Pierce SK, 2002, NAT REV IMMUNOL, V2, P96, DOI 10.1038/nri726; Poloso NJ, 2004, CURR OPIN IMMUNOL, V16, P103, DOI 10.1016/j.coi.2003.11.009; Portugal LR, 2004, INFECT IMMUN, V72, P3571, DOI 10.1128/IAI.72.6.3571-3576.2004; Portugal LR, 2008, MICROBES INFECT, V10, P276, DOI 10.1016/j.micinf.2007.12.001; Rodrigues CD, 2008, CELL HOST MICROBE, V4, P271, DOI 10.1016/j.chom.2008.07.012; Sunnemark D, 2000, ATHEROSCLEROSIS, V153, P273, DOI 10.1016/S0021-9150(00)00406-8; Weiss L. M., 2007, P341, DOI 10.1016/B978-012369542-0/50015-5; Weiss LM, 2009, INT J PARASITOL, V39, P895, DOI 10.1016/j.ijpara.2009.02.004	33	7	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176700	10.1371/journal.pone.0176700	http://dx.doi.org/10.1371/journal.pone.0176700			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459857	Green Published, gold, Green Submitted			2022-12-26	WOS:000400645000050
J	Shin, SJ; Chun, SM; Kim, TI; Kim, YJ; Choi, HJ; Jong, SJ; Kim, J				Shin, Su-Jin; Chun, Sung-Min; Kim, Tae-Im; Kim, Yu Jin; Choi, Hyun-Jeung; Jong, Se Jin; Kim, Jihun			Feasibility of multiplexed gene mutation detection in plasma samples of colorectal cancer patients by mass spectrometric genotyping	PLOS ONE			English	Article							CIRCULATING TUMOR DNA; ANTI-EGFR THERAPY; ACQUIRED-RESISTANCE; KRAS MUTATIONS; EVOLUTION; CETUXIMAB; CELLS; BRAF	Mutation analysis of circulating tumor DNA (ctDNA) has recently been introduced as a non-invasive tumor monitoring method. In this study, we tested the mass spectrometric-based MassARRAY platform for multiplexed gene mutation analysis of plasma samples from colorectal cancer (CRC) patients. A total of 160 patients, who underwent curative resection of either primary or metastatic CRC harboring KRAS mutations between 2005 and 2012, were included. Circulating DNA was isolated from plasma was analyzed on the MassARRAY platform with or without selective amplification of mutant DNA fragments. Tumor-specific KRAS mutations were detected in 39.6% (42/106) of patients with distant metastasis, and in 5.6% (3/54) of patients without distant metastasis. Selective amplification of the mutant allele increased sensitivity to 58.5% (62/106) for patients with distant metastasis, and 16.7% (9/54) for patients without distant metastasis. These mutation detection rates were no less than those of droplet digital polymerase chain reaction. Among patients with distant metastasis, detectable plasma KRAS mutations correlated with larger primary tumors and shorter overall survival rate (P = 0.014 and P = 0.003, respectively). In addition, activating PIK3CA mutations were detected together with KRAS mutations in two plasma samples. Taken together, massARRAY platform is a cost-effective, multigene mutation profiling technique for ctDNA with reasonable sensitivity and specificity.	[Shin, Su-Jin; Jong, Se Jin; Kim, Jihun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea; [Chun, Sung-Min; Kim, Tae-Im; Kim, Yu Jin; Jong, Se Jin; Kim, Jihun] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Choi, Hyun-Jeung] Seoul Natl Univ, Ctr Anticanc CDx, N Bio, Seoul, South Korea; [Shin, Su-Jin] Hanyang Univ, Dept Pathol, Coll Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Seoul National University (SNU); Hanyang University	Kim, J (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea.; Kim, J (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea.	jihunkim@amc.seoul.kr	Shin, Su-Jin/K-3248-2017	Shin, Su-Jin/0000-0001-9114-8438; Chun, Sung-Min/0000-0002-3357-1382	Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea [2011-483]; Korea Research Foundation [KRF2011-0030105]; Basic Science Research Program through the National Research Foundation of Korea NRF - Ministry of Education [NRF-2015R1D1A1A01056895]	Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea; Korea Research Foundation(National Research Foundation of Korea); Basic Science Research Program through the National Research Foundation of Korea NRF - Ministry of Education	This study was supported by a grant (2011-483) from the Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea. Further support was provided by the Korea Research Foundation (KRF2011-0030105; grant to SJJ), and Basic Science Research Program through the National Research Foundation of Korea NRF) funded by the Ministry of Education (NRF-2015R1D1A1A01056895; grant to SMC).	Baselga J, 2008, J CLIN ONCOL, V26, P1582, DOI 10.1200/JCO.2007.15.3700; Beiter T, 2011, CLIN CHEM, V57, P633, DOI 10.1373/clinchem.2010.158030; Bidard FC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006305; Chang CPY, 2003, CLIN CHIM ACTA, V327, P95, DOI 10.1016/S0009-8981(02)00337-6; Chen GL, 2014, MOL DIAGN THER, V18, P587, DOI 10.1007/s40291-014-0115-2; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Fabbri F, 2013, CANCER LETT, V335, P225, DOI 10.1016/j.canlet.2013.02.015; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Holdhoff M, 2009, JNCI-J NATL CANCER I, V101, P1284, DOI 10.1093/jnci/djp240; Jung KW, 2015, CANC RES TREATMENT O; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Koerkamp BG, 2013, ANN SURG ONCOL, V20, P2156, DOI 10.1245/s10434-013-2907-8; Luo HY, 2014, WORLD J GASTROENTERO, V20, P3858, DOI 10.3748/wjg.v20.i14.3858; Macher H, 2012, CLIN CHIM ACTA, V414, P12, DOI 10.1016/j.cca.2012.08.001; Misale S, 2014, CANCER DISCOV, V4, P1269, DOI 10.1158/2159-8290.CD-14-0462; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Oeth P, 2009, METHODS MOL BIOL, V578, P307, DOI 10.1007/978-1-60327-411-1_20; Roth AD, 2010, J CLIN ONCOL, V28, P466, DOI 10.1200/JCO.2009.23.3452; Sato KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146275; Seki Y, 2016, ONCOLOGIST, V21, P156, DOI 10.1634/theoncologist.2015-0288; Tabernero J, 2015, LANCET ONCOL, V16, P937, DOI 10.1016/S1470-2045(15)00138-2; Thierry AR, 2014, NAT MED, V20, P430, DOI 10.1038/nm.3511; Yen LC, 2009, CLIN CANCER RES, V15, P4508, DOI 10.1158/1078-0432.CCR-08-3179	30	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176340	10.1371/journal.pone.0176340	http://dx.doi.org/10.1371/journal.pone.0176340			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459822	gold, Green Published, Green Submitted			2022-12-26	WOS:000400645000029
J	Thorpe, RS				Thorpe, Roger S.			Predictability in evolution: Adaptation of the Bonaire anole (Anolis bonairensis) to an extreme environment	PLOS ONE			English	Article							NATURAL-SELECTION; DOMINICAN ANOLE; PHYLOGENY; PHYLOGEOGRAPHY; PATTERNS; LIZARDS; COLOR	The extent to which evolution is deterministic (predictable), or random, is a fundamental question in evolution. This case study attempts to determine the extent to which interspecific divergence can be predicted from intraspecific trends related species. The mountainous Lesser Antilles are occupied by one or two anole species with very substantial intraspecific differences in the quantitative traits between xeric and rainforest habitats. These ecologically determined differences tend to be in parallel in each island species. A related species (Anolis bonairensis) lives on the far more xeric island of Bonaire, and this study tests the extent to which its interspecific divergence in hue and pattern traits can be predicted from the parallel intraspecific variation exhibited in Lesser Antillean anoles. Regression against a multivariate climate variable suggests that the hue and pattern of the Bonaire anole are consistently predicted from the ecologically determined intraspecific variation of its Lesser Antillean relatives. However, this predictability may be less consistent with other character systems, for example, scalation.	[Thorpe, Roger S.] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales	Bangor University	Thorpe, RS (corresponding author), Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales.	r.s.thorpe@bangor.ac.uk			Leverhulme Trust [RF/2/RFG/2010/0008]	Leverhulme Trust(Leverhulme Trust)	This work was supported by the Leverhulme Trust (RF/2/RFG/2010/0008) https://www.leverhulme.ac.uk/. The early part of thos work (data collection) was carried out under the above Research Fellowhip, the latter part)data analysis and writing) was unfunded. PLOS provided publication fee assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt J, 2008, TRENDS ECOL EVOL, V23, P26, DOI 10.1016/j.tree.2007.09.011; Bennett K, 2010, NEW SCI, V208, P28, DOI 10.1016/S0262-4079(10)62530-4; BROWN RP, 1991, NATURE, V352, P60, DOI 10.1038/352060a0; Calsbeek R, 2006, EVOL ECOL, V20, P377, DOI 10.1007/s10682-006-0007-y; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Eales J, 2010, MOL ECOL, V19, P2858, DOI 10.1111/j.1365-294X.2010.04710.x; Funk JL, 2015, ECOL EVOL, V5, P940, DOI 10.1002/ece3.1406; GOULD S J, 1977, Paleobiology, V3, P115; Greene H. W., 1997, SNAKES EVOLUTION MYS; GREENE HW, 1981, SCIENCE, V213, P1207, DOI 10.1126/science.213.4513.1207; Gubitz T, 2000, MOL ECOL, V9, P1213, DOI 10.1046/j.1365-294x.2000.00997.x; HORTON DR, 1972, SYST ZOOL, V21, P441, DOI 10.2307/2412438; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Malhotra A, 2000, EVOLUTION, V54, P245, DOI 10.1111/j.0014-3820.2000.tb00025.x; MALHOTRA A, 1991, NATURE, V353, P347, DOI 10.1038/353347a0; Malhotra A, 1997, HERPETOLOGICA, V53, P49; Rambaut A., 2014, TRACER V 1 6; SOULE M, 1972, SYST ZOOL, V21, P97, DOI 10.2307/2412262; Stanley S. M., 1979, MACROEVOLUTION PATTE; Surget-Groba Y, 2013, J BIOGEOGR, V40, P105, DOI 10.1111/j.1365-2699.2012.02778.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thorpe RS, 2008, PHILOS T R SOC B, V363, P3071, DOI 10.1098/rstb.2008.0077; Thorpe RS, 2015, MOL ECOL, V24, P1019, DOI 10.1111/mec.13093; Thorpe RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000929; Thorpe RS, 2005, AM NAT, V165, P495, DOI 10.1086/428408; Thorpe RS, 2003, MOL ECOL, V12, P117, DOI 10.1046/j.1365-294X.2003.01704.x; Thorpe RS, 2002, SYST BIOL, V51, P554, DOI 10.1080/10635150290069986; Thorpe RS, 2001, P NATL ACAD SCI USA, V98, P3929, DOI 10.1073/pnas.071576798; Townsend TM, 2011, MOL PHYLOGENET EVOL, V61, P363, DOI 10.1016/j.ympev.2011.07.008; Wake DB, 2011, SCIENCE, V331, P1032, DOI 10.1126/science.1188545; Wood TE, 2005, GENETICA, V123, P157, DOI 10.1007/s10709-003-2738-9; [No title captured]	32	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176434	10.1371/journal.pone.0176434	http://dx.doi.org/10.1371/journal.pone.0176434			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459829	gold, Green Published, Green Submitted			2022-12-26	WOS:000400645000033
J	Wang, Q; Xue, HJ; Li, SQ; Chen, Y; Tian, XL; Xu, X; Xiao, W; Fu, YV				Wang, Qian; Xue, Huijun; Li, Siqi; Chen, Ying; Tian, Xuelei; Xu, Xin; Xiao, Wei; Fu, Yu Vincent			A method for labeling proteins with tags at the native genomic loci in budding yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE DISRUPTION; FLUORESCENT PROTEIN; DNA-REPLICATION; CASSETTES; SELECTION; MUTANTS; RESISTANCE; VERSATILE; PLASMIDS	Fluorescent proteins and epitope tags are often used as protein fusion tags to study target proteins. One prevailing technique in the budding yeast Saccharomyces cerevisiae is to fuse these tags to a target gene at the precise chromosomal location via homologous recombination. However, several limitations hamper the application of this technique, such as the selectable markers not being reusable, tagging of only the C-terminal being possible, and a "scar" sequence being left in the genome. Here, we describe a strategy to solve these problems by tagging target genes based on a pop-in/pop-out and counter-selection system. Three fluorescent protein tag (mCherry, sfGFP, and mKikGR) and two epitope tag (HA and 3xFLAG) constructs were developed and utilized to tag HHT1, UBC13 or RAD5 at the chromosomal locus as proof-of-concept.	[Wang, Qian; Li, Siqi; Chen, Ying; Tian, Xuelei; Xiao, Wei] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Xue, Huijun; Xu, Xin; Fu, Yu Vincent] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China; [Xue, Huijun; Fu, Yu Vincent] Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China; [Tian, Xuelei] Natl Inst Radiol Protect, China CDC, Beijing, Peoples R China; [Xiao, Wei] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada	Capital Normal University; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Center for Disease Control & Prevention; National Institute for Radiological Protection, Chinese Center for Disease Control & Prevention; University of Saskatchewan	Fu, YV (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China.; Fu, YV (corresponding author), Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China.	fuyu@im.ac.cn	FU, YU Vincent/AAX-4936-2021	FU, YU Vincent/0000-0001-8251-2306	National Natural Science Foundation of China [31670068, 31371264]; Royal Society and CAS Interdisciplinary Innovation Team [NA140085]; Student's Platform for Innovation and Entrepreneurship Training Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Royal Society and CAS Interdisciplinary Innovation Team; Student's Platform for Innovation and Entrepreneurship Training Program	This study was supported by the National Natural Science Foundation of China grant 31371264 for (YVF), the National Natural Science Foundation of China, 31670068 for (XW), the the Newton Advanced Fellowship (NA140085) for (YVF) from the Royal Society and CAS Interdisciplinary Innovation Team for (YVF). It was partially funded by Student's Platform for Innovation and Entrepreneurship Training Program for (QW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; Ball LG, 2014, DNA REPAIR, V16, P74, DOI 10.1016/j.dnarep.2014.02.016; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Brachmann CB, 1998, YEAST, V14, P115; Chang VK, 2003, J BIOL CHEM, V278, P6093, DOI 10.1074/jbc.M209827200; CHATTOO BB, 1979, GENETICS, V93, P51; Davidson JF, 2000, CURR GENET, V38, P188, DOI 10.1007/s002940000154; DOLLARD C, 1994, MOL CELL BIOL, V14, P5223, DOI 10.1128/MCB.14.8.5223; Finkelstein IJ, 2010, NATURE, V468, P983, DOI 10.1038/nature09561; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Habuchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003944; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kuang LS, 2013, DNA REPAIR, V12, P27, DOI 10.1016/j.dnarep.2012.10.003; Kumar A, 2002, GENE DEV, V12, P47; Landgraf D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163950; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Loveland AB, 2012, NAT METHODS, V9, P987, DOI [10.1038/nmeth.2174, 10.1038/NMETH.2174]; Moqtaderi Z, 2008, YEAST, V25, P287, DOI 10.1002/yea.1581; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; SINGH A, 1974, NATURE, V247, P227, DOI 10.1038/247227a0; Solis-Escalante D, 2013, FEMS YEAST RES, V13, P126, DOI 10.1111/1567-1364.12024; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tian XL, 2013, APPL ENVIRON MICROB, V79, P7042, DOI 10.1128/AEM.02159-13; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Xie XS, 2008, ANNU REV BIOPHYS, V37, P417, DOI 10.1146/annurev.biophys.37.092607.174640; Xu X., 2016, NUCL ACIDS RES; Yardimci H, 2012, METHODS, V57, P179, DOI 10.1016/j.ymeth.2012.03.033; Yeeles JTP, 2015, NATURE, V519, P431, DOI 10.1038/nature14285	39	7	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176184	10.1371/journal.pone.0176184	http://dx.doi.org/10.1371/journal.pone.0176184			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459859	Green Submitted, Green Published, gold			2022-12-26	WOS:000400645000019
J	Lee, DH; Hwang, SH; Lim, MK; Oh, JK; Song, DY; Yun, EH; Park, EY				Lee, Do-Hoon; Hwang, Sang-Hyun; Lim, Min Kyung; Oh, Jin-Kyoung; Song, Da Young; Yun, E. Hwa; Park, Eun Young			Performance of urine cotinine and hypomethylation of AHRR and F2RL3 as biomarkers for smoking exposure in a population-based cohort	PLOS ONE			English	Article							DIFFERENTIAL DNA METHYLATION; LUNG-CANCER DEVELOPMENT; CIGARETTE-SMOKING; SERUM COTININE; TOBACCO-SMOKE; BLOOD DNA; RECEPTOR; METABOLITES; EXPRESSION; SAMPLES	There is a growing body of evidence demonstrating an association between smoking and DNA methylation. Accordingly, DNA methylation is now considered a promising biomarker of smoking exposure. We evaluated the relationship between methylation markers (AHRR and F2RL3) and urine cotinine as well as self-reported smoking status. DNA methylation levels of AHRR and F2RL3 in blood as well as urine cotinine were measured in 330 adults (46 to 87 years of age). Pyrosequencing was performed to measure DNA methylation of AHRR and F2RL3 associated with smoking exposure. The lung cancer risk associated with DNA methylation and urine cotinine was analyzed using logistic regression analysis. The AHRR and F2RL3 genes were significantly hypomethylated in current smokers compared to in individuals who have never smoked. An inverse relationship was observed between urine cotinine and methylation levels. Methylation of AHRR and F2RL3 distinguished current smokers from never-smokers with high accuracy. Logistic multivariate analysis showed that AHRR methylation is significantly associated with the risk of lung cancer (OR = 0.96, P = 0.011). Our study validated the smoking-associated DNA methylation markers reported in a Korean population-based cohort. In conclusion, DNA methylation of AHRR and F2RL3 provided accurate measures for smoking exposure. Methylation markers reflecting the long-term effect of smoking on the risk of lung cancer showed better performance in distinguishing former smokers from never-smokers.	[Lee, Do-Hoon; Hwang, Sang-Hyun] Res Inst & Hosp, Natl Canc Ctr, Ctr Diagnost Oncol, Dept Lab Med, Goyang Si, Gyeinggi Do, South Korea; [Hwang, Sang-Hyun] Res Inst & Hosp, Natl Canc Ctr, Hematol Malignancy Branch, Goyang Si, Gyeinggi Do, South Korea; [Lim, Min Kyung; Oh, Jin-Kyoung; Yun, E. Hwa] Grad Sch Canc Sci & Policy, Dept Canc Control Policy, Goyang Si, Gyeinggi Do, South Korea; [Lim, Min Kyung; Oh, Jin-Kyoung; Yun, E. Hwa] Natl Canc Control Inst, Natl Canc Ctr, Goyang Si, Gyeinggi Do, South Korea; [Lim, Min Kyung; Oh, Jin-Kyoung; Song, Da Young; Yun, E. Hwa] Natl Canc Control Inst, Natl Canc Ctr, Canc Risk Appraisal & Prevent Branch, Goyang Si, Gyeinggi Do, South Korea; [Park, Eun Young] Natl Canc Control Inst, Natl Canc Ctr, Carcinogen Hazard Branch, Goyang Si, Gyeinggi Do, South Korea; [Hwang, Sang-Hyun] Univ Ulsan, Coll Med, Dept Lab Med, Seoul, South Korea; [Hwang, Sang-Hyun] Asan Med Ctr, Seoul, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); University of Ulsan	Hwang, SH (corresponding author), Res Inst & Hosp, Natl Canc Ctr, Ctr Diagnost Oncol, Dept Lab Med, Goyang Si, Gyeinggi Do, South Korea.; Hwang, SH (corresponding author), Res Inst & Hosp, Natl Canc Ctr, Hematol Malignancy Branch, Goyang Si, Gyeinggi Do, South Korea.; Hwang, SH (corresponding author), Univ Ulsan, Coll Med, Dept Lab Med, Seoul, South Korea.; Hwang, SH (corresponding author), Asan Med Ctr, Seoul, South Korea.	mindcatch@amc.seoul.kr	Lim, Min Kyung/AAL-5271-2020; Hwang, Sanghyun/L-5314-2019	Lim, Min Kyung/0000-0002-8224-2171; Hwang, Sanghyun/0000-0003-3201-5728; Oh, Jin-Kyoung/0000-0001-9331-3054	National Cancer Center Grant [NCC-1210090, NCC-1510100]	National Cancer Center Grant	This research was supported by the National Cancer Center Grant- NCC-1210090 and NCC-1510100.	Ambatipudi S, 2016, EPIGENOMICS; Baglietto L, 2017, INT J CANCER, V140, P50, DOI 10.1002/ijc.30431; BENOWITZ NL, 1983, CLIN PHARMACOL THER, V34, P604, DOI 10.1038/clpt.1983.222; Bosse Y, 2012, CANCER RES, V72, P3753, DOI 10.1158/0008-5472.CAN-12-1160; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Chen HT, 2010, J CELL PHYSIOL, V223, P737, DOI 10.1002/jcp.22083; Chiba T, 2011, INT ARCH ALLERGY IMM, V155, P129, DOI 10.1159/000327499; Fasanelli F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10192; Gorber SC, 2009, NICOTINE TOB RES, V11, P12, DOI 10.1093/ntr/ntn010; Guida F, 2015, HUM MOL GENET, V24, P2349, DOI 10.1093/hmg/ddu751; Harlid S, 2014, ENVIRON HEALTH PERSP, V122, P673, DOI 10.1289/ehp.1307480; Hecht SS, 1998, CHEM RES TOXICOL, V11, P559, DOI 10.1021/tx980005y; Hwang SH, 2011, CLIN CHEM LAB MED, V49, P699, DOI 10.1515/CCLM.2011.108; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kim J, 2015, NICOTINE TOB RES, V17, P1337, DOI 10.1093/ntr/ntv012; Liu F, 2010, ONCOGENE, V29, P3650, DOI 10.1038/onc.2010.129; Martey CA, 2005, AM J PHYSIOL-LUNG C, V289, pL391, DOI 10.1152/ajplung.00062.2005; Monick MM, 2012, AM J MED GENET B, V159B, P141, DOI 10.1002/ajmg.b.32021; Oh JK, 2015, INT J EPIDEMIOLOGY; PEREZSTABLE EJ, 1995, PREV MED, V24, P171, DOI 10.1006/pmed.1995.1031; Rebagliato M, 2002, J EPIDEMIOL COMMUN H, V56, P163, DOI 10.1136/jech.56.3.163; Ryu HJ, 2006, RAPID COMMUN MASS SP, V20, P2781, DOI 10.1002/rcm.2659; Shenker NS, 2013, HUM MOL GENET, V22, P843, DOI 10.1093/hmg/dds488; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; Vineis P, 2005, BRIT MED J, V330, P277, DOI 10.1136/bmj.38327.648472.82; Wan ES, 2015, AM J RESP CELL MOL, V53, P246, DOI 10.1165/rcmb.2014-0103OC; Wan ES, 2012, HUM MOL GENET, V21, P3073, DOI 10.1093/hmg/dds135; Yuan JM, 2014, CANCER RES, V74, P401, DOI 10.1158/0008-5472.CAN-13-3178; Yuan JM, 2011, CANCER RES, V71, P6749, DOI 10.1158/0008-5472.CAN-11-0209; Yuan JM, 2009, CANCER RES, V69, P2990, DOI 10.1158/0008-5472.CAN-08-4330; Zeilinger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063812; Zhang Y, 2016, ENVIRON RES, V146, P395, DOI 10.1016/j.envres.2016.01.026; Zhang Y, 2015, INT J CANCER, V137, P1739, DOI 10.1002/ijc.29537; Zhang Y, 2014, INT J EPIDEMIOL, V43, P1215, DOI 10.1093/ije/dyu006; Zhang Y, 2014, ENVIRON HEALTH PERSP, V122, P131, DOI 10.1289/ehp.1306937	35	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176783	10.1371/journal.pone.0176783	http://dx.doi.org/10.1371/journal.pone.0176783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453567	Green Published, Green Submitted, gold			2022-12-26	WOS:000400383900055
J	Toews, I; Binder, N; Wolff, RF; Toprak, G; von Elm, E; Meerpohl, JJ				Toews, Ingrid; Binder, Nadine; Wolff, Robert F.; Toprak, Guenes; von Elm, Erik; Meerpohl, Joerg J.			Guidance in author instructions of hematology and oncology journals: A cross sectional and longitudinal study	PLOS ONE			English	Article							CONFLICT-OF-INTEREST; RANDOMIZED CONTROLLED-TRIALS; REDUCING WASTE; REPORTING GUIDELINES; CONSORT STATEMENT; INTEREST POLICIES; MEDICAL JOURNALS; INCREASING VALUE; PUBLICATION; IMPACT	Background The debate about the value of biomedical publications led to recommendations for improving reporting quality. It is unclear to what extent these recommendations have been endorsed by journals. We analyzed whether specific recommendations were included in author instructions, which journal characteristics were associated with their endorsement, how endorsement of the domains changed and whether endorsement was associated with change of impact factor between 2010 and 2015. Methods We considered two study samples consisting of "Hematology" and "Oncology" journals of the Journal Citation Report 2008 and 2014, respectively. We extracted information regarding endorsement of the (1) recommendations of the International Committee of Medical Journal Editors, of (2) reporting guidelines, (3) requirement for trial registration and (4) disclosure of conflicts of interest. Data extraction was done by reading the author instructions before conducting a text search with keywords. We calculated a global generalized linear mixed effects model for endorsement of each of the four domains followed by separate multivariable logistic regression models and a longitudinal analysis. We defined endorsement as the author instructions saying that they approve the use of the recommendations. Results In 2015, the ICMJE recommendations were mentioned in author instructions of 156 journals (67.5%). CONSORT was referred to by 77 journals (33.3%); MOOSE, PRISMA, STARD and STROBE were referred to by less than 15% of journals. There were 99 journals (42.9%) that recommended or required trial registration, 211 (91.3%) required authors to disclose conflicts of interest. Journal impact factor, journal start year and geographical region were positively associated with endorsement of any of the four domains. The overall endorsement of all domains increased between 2010 and 2015. The endorsement of any domain in 2010 seemed to be associated with an increased impact factor in 2014. Conclusion Hematology and oncology journals endorse major recommendations to various degrees. Endorsement is increasing slowly over time and might be positively associated with the journals' impact factor.	[Toews, Ingrid; Toprak, Guenes; Meerpohl, Joerg J.] Univ Freiburg, Med Ctr, Cochrane Germany, Fac Med, Freiburg, Germany; [Binder, Nadine] Univ Freiburg, Fac Med, Inst Med Biometry & Stat, Freiburg, Germany; [Binder, Nadine] Univ Freiburg, Med Ctr, Freiburg, Germany; [Wolff, Robert F.] Kleijnen Systemat Reviews Ltd, Unit 6, Escrick Business Pk, York, N Yorkshire, England; [von Elm, Erik] Lausanne Univ Hosp, Cochrane Switzerland, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Meerpohl, Joerg J.] Univ Paris 05, Hop Hotel Dieu, Cochrane France,U1153, Ctr Rech Epiderniol & Stat,Inserm,Sorbonne Paris, Paris, France	University of Freiburg; University of Freiburg; University of Freiburg; Kleijnen Systematic Reviews; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Meerpohl, JJ (corresponding author), Univ Freiburg, Cochrane Germany, Fac Med, Med Ctr, Freiburg, Germany.; Meerpohl, JJ (corresponding author), Univ Paris 05, Hop Hotel Dieu, Cochrane France,U1153, Ctr Rech Epiderniol & Stat,Inserm,Sorbonne Paris, Paris, France.	meerpohl.jj@gmail.com	Wolff, Robert F/E-2322-2016; Meerpohl, Joerg J/J-4224-2013; Binder, Nadine/AAP-6261-2021	Wolff, Robert F/0000-0003-3270-7791; Meerpohl, Joerg J/0000-0002-1333-5403; Binder, Nadine/0000-0002-1919-4154; von Elm, Erik/0000-0002-7412-0406	German Research Foundation (DFG); University of Freiburg in the funding programme Open Access Publishing	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg in the funding programme Open Access Publishing	The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of the authors (RFW) is employed at Kleijnen Systematic Reviews Ltd. The funder provided support in the form of salary for author RFW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Altman DG, 2005, BMJ-BRIT MED J, V330, P1056, DOI 10.1136/bmj.330.7499.1056; Altman DG, 2013, BMJ, V347, P1669; Ancker JS, 2007, SCI ENG ETHICS, V13, P147, DOI 10.1007/s11948-007-9011-z; [Anonymous], 2014, J CITATION REPORT 20; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Bhargava N, 2007, AM J GASTROENTEROL, V102, P1146, DOI 10.1111/j.1572-0241.2007.01268.x; Blum JA, 2009, JAMA-J AM MED ASSOC, V302, P2230, DOI 10.1001/jama.2009.1669; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Brown H, 2006, STAT PRACTICE APPL M, P456; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Dancey JE, 2010, JNCI-J NATL CANCER I, V102, P670, DOI 10.1093/jnci/djq142; Duff JM, 2010, JNCI-J NATL CANCER I, V102, P702, DOI 10.1093/jnci/djq117; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Hernan MA, 2009, EPIDEMIOLOGY, V20, P317, DOI 10.1097/EDE.0b013e31819ed4a6; Hopewell S, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-20; Hui D, 2011, SUPPORTIVE CARE CANC; International Committee of Medical Journal Editors, 2015, REC COND REP ED PUBL; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Ioannidis JPA, 2009, ARCH INTERN MED, V169, P1737, DOI 10.1001/archinternmed.2009.313; Kesselheim AS, 2012, CANCER-AM CANCER SOC, V118, P188, DOI 10.1002/cncr.26237; Kesselheim AS, 2011, CANCER; Knuppel H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075995; Kunath F, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000430; Kunath F, 2012, UROL INT, V88, P54, DOI 10.1159/000332742; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Li XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030683; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; McGinn T, 2004, CAN MED ASSOC J, V171, P1369, DOI 10.1503/cmaj.1031981; McLeroy KR, 2012, AM J PUBLIC HEALTH, V102, P780, DOI 10.2105/AJPH.2011.300630; Meerpohl JJ, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-27; Meerpohl JJ, 2010, ARCH PEDIAT ADOL MED, V164, P268, DOI 10.1001/archpediatrics.2009.287; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Pellizzon RD, 2007, ACTA CIR BRAS, V22, P503, DOI 10.1590/S0102-86502007000600016; Pitrou I, 2009, ARCH INTERN MED, V169, P1756, DOI 10.1001/archinternmed.2009.306; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; R Core Team, 2021, R LANGUAGE ENV STAT; Reveiz L, 2013, CAD SAUDE PUBLICA, V29, P1095, DOI [10.1590/S0102-311X2013000600006, 10.1590/S0102-311X2013001000006]; Schriger DL, 2006, ANN EMERG MED, V48, P743, DOI 10.1016/j.annemergmed.2006.03.028; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.1186/1741-7015-8-18, 10.1016/j.ijsu.2011.09.004, 10.4103/0976-500X.72352]; Shantikumar S, 2012, ANN ROY COLL SURG, V94, P468, DOI 10.1308/003588412X13373405386619; Sim I, 2006, LANCET, V367, P1631, DOI 10.1016/S0140-6736(06)68708-4; Sinha S, 2009, J AM COLL SURGEONS, V209, P565, DOI 10.1016/j.jamcollsurg.2009.07.019; Smidt N, 2007, CLIN CHEM, V53, P1983, DOI 10.1373/clinchem.2007.090167; Smith R, 1998, BMJ-BRIT MED J, V317, P291, DOI 10.1136/bmj.317.7154.291; Smith TA, 2015, ANN MED SURG, V4, P17, DOI 10.1016/j.amsu.2014.12.003; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tao KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027611; Toulmonde M, 2011, J CLIN ONCOL, V29, P1204, DOI 10.1200/JCO.2010.30.9369; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; You BO, 2012, J CLIN ONCOL, V30, P210, DOI 10.1200/JCO.2011.37.0890	55	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176489	10.1371/journal.pone.0176489	http://dx.doi.org/10.1371/journal.pone.0176489			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453528	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383900029
J	Wang, X; Haring, MF; Rathjen, T; Lockhart, SM; Sorensen, D; Ussar, S; Rasmussen, LM; Bertagnolli, MM; Kahn, CR; Rask-Madsen, C				Wang, X.; Haering, M-F; Rathjen, T.; Lockhart, S. M.; Sorensen, D.; Ussar, S.; Rasmussen, L. M.; Bertagnolli, M. M.; Kahn, C. R.; Rask-Madsen, C.			Insulin resistance in vascular endothelial cells promotes intestinal tumour formation	ONCOGENE			English	Article							BODY-MASS INDEX; GROWTH-FACTOR; BREAST-CANCER; COLORECTAL ADENOMAS; COLON-CANCER; RISK-FACTOR; OBESITY; INFLAMMATION; MECHANISMS; NEOPLASIA	The risk of several cancers, including colorectal cancer, is increased in patients with obesity and type 2 diabetes, conditions characterised by hyperinsulinaemia and insulin resistance. Because hyperinsulinaemia itself is an independent risk factor for cancer development, we examined tissue-specific insulin action in intestinal tumour formation. In vitro, insulin increased proliferation of intestinal tumour epithelial cells by almost two-fold in primary culture of tumour cells from Apc(Min/+) mice. Surprisingly, targeted deletion of insulin receptors in intestinal epithelial cells in Apc(Min/+) mice did not change intestinal tumour number or size distribution on either a low or high-fat diet. We therefore asked whether cells in the tumour stroma might explain the association between tumour formation and insulin resistance. To this end, we generated Apc(Min/+) mice with loss of insulin receptors in vascular endothelial cells. Strikingly, these mice had 42% more intestinal tumours than controls, no change in tumour angiogenesis, but increased expression of vascular cell adhesion molecule-1 (VCAM-1) in primary culture of tumour endothelial cells. Insulin decreased VCAM-1 expression and leukocyte adhesion in quiescent tumour endothelial cells with intact insulin receptors and partly prevented increases in VCAM-1 and leukocyte adhesion after treatment with tumour necrosis factor-a. Knockout of insulin receptors in endothelial cells also increased leukocyte adhesion in mesenteric venules and increased the frequency of neutrophils in tumours. We conclude that although insulin is mitogenic for intestinal tumour cells in vitro, impaired insulin action in the tumour microenvironment may be more important in conditions where hyperinsulinaemia is secondary to insulin resistance. Insulin resistance in tumour endothelial cells produces an activated, proinflammatory state that promotes tumorigenesis. Improvement of endothelial dysfunction may reduce colorectal cancer risk in patients with obesity and type 2 diabetes.	[Wang, X.; Haering, M-F; Rathjen, T.; Lockhart, S. M.; Sorensen, D.; Ussar, S.; Kahn, C. R.; Rask-Madsen, C.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Wang, X.; Haering, M-F; Rathjen, T.; Lockhart, S. M.; Sorensen, D.; Ussar, S.; Bertagnolli, M. M.; Kahn, C. R.; Rask-Madsen, C.] Harvard Med Sch, One Joslin Pl, Boston, MA 02215 USA; [Wang, X.] Fudan Univ, Huashan Hosp, Shanghai, Peoples R China; [Haering, M-F] Univ Hosp Tuebingen, Dept Internal Med 4, Div Clin Chem & Pathobiochem, Tubingen, Germany; [Rathjen, T.] Novo Nordisk AS, Malov, Denmark; [Lockhart, S. M.] Queens Univ Belfast, Belfast, Antrim, North Ireland; [Sorensen, D.; Rasmussen, L. M.] Univ Southern Denmark, Odense Univ Hosp, Odense, Denmark; [Sorensen, D.] Danish Diabet Acad, Odense, Denmark; [Ussar, S.] Helmholtz Ctr Munich Neuherberg, Inst Diabet & Obes, JRG Adipocytes & Metab, Munich, Germany; [Ussar, S.] German Ctr Diabet Res DZD, Neuherberg, Germany; [Bertagnolli, M. M.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Fudan University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Novo Nordisk; Queens University Belfast; University of Southern Denmark; Odense University Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Harvard University; Brigham & Women's Hospital	Rask-Madsen, C (corresponding author), Harvard Med Sch, Joslin Diabet Ctr, Vasc Biol & Complicat, One Joslin Pl, Boston, MA 02215 USA.	christian.rask-madsen@joslin.harvard.edu	Lockhart, Sam/Q-2604-2015; Kahn, Ronald/AAY-2435-2021; Ussar, Siegfried/AAL-4331-2021	Lockhart, Sam/0000-0003-2092-4350; Kahn, Ronald/0000-0002-7583-9228; Ussar, Siegfried/0000-0001-7575-0920; Rasmussen, Lars Melholt/0000-0001-5795-4794; Rask-Madsen, Christian/0000-0002-8548-466X	NIH [R21 CA185196, DK031036, DK033201, 5P30DK036836]; National Natural Science Foundation of China [81370936]; Diabetes Research and Wellness Foundation; Danish Diabetes Academy - Novo Nordisk Foundation; Mary K. Iacocca Professorship; STAR Programme; NATIONAL CANCER INSTITUTE [R21CA185196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, R37DK031036, R01DK033201, R01DK031036] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021740] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Diabetes Research and Wellness Foundation; Danish Diabetes Academy - Novo Nordisk Foundation; Mary K. Iacocca Professorship; STAR Programme; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant R21 CA185196 (to CRM), the National Natural Science Foundation of China grant 81370936 (XW), the Diabetes Research and Wellness Foundation (SML), the Danish Diabetes Academy which receives funding from the Novo Nordisk Foundation (DS), as well as NIH grants DK031036, DK033201 and the Mary K. Iacocca Professorship (CRK). TR was an employee of Novo Nordisk and was supported by the STAR Programme. Measurement of plasma insulin and flow cytometry was done using cores in the Diabetes Research Center, supported by NIH grant 5P30DK036836, at Joslin Diabetes Center. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.	Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Anderson JC, J CLIN GASTROENTEROL, DOI [10.1136/gutjnl-2016-312893, DOI 10.1136/GUTJNL-2016-312893]; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Bickston SJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007571.pub2; Bruce WR, 2000, NUTR CANCER, V37, P19, DOI 10.1207/S15327914NC3701_2; Carothers AM, 2006, CANCER RES, V66, P6432, DOI 10.1158/0008-5472.CAN-06-0992; Chan AT, 2012, CANCER PREV RES, V5, P164, DOI 10.1158/1940-6207.CAPR-11-0391; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Davenport JR, 2018, GUT, V67, P456, DOI 10.1136/gutjnl-2016-312893; Dow LE, 2015, CELL, V161, P1539, DOI 10.1016/j.cell.2015.05.033; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Elmunzer BJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001352; Fischer A, 2016, GUT, V65, P1642, DOI 10.1136/gutjnl-2015-310022; Flores MBS, 2012, GASTROENTEROLOGY, V143, P741, DOI 10.1053/j.gastro.2012.05.045; FUKUMURA D, 1995, CANCER RES, V55, P4824; Gallagher EJ, 2015, PHYSIOL REV, V95, P727, DOI 10.1152/physrev.00030.2014; Gey GO, 1924, JAMA-J AM MED ASSOC, V82, P1609, DOI [DOI 10.1001/JAMA.1924.26520460003014D, 10.1001/jama.1924.26520460003014d]; GIOVANNUCCI E, 1995, CANCER CAUSE CONTROL, V6, P164, DOI 10.1007/BF00052777; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; IshShalom D, 1997, DIABETOLOGIA, V40, pS25, DOI 10.1007/s001250051393; Jamieson T, 2012, J CLIN INVEST, V122, P3127, DOI 10.1172/JCI61067; Jiang ZY, 1999, J CLIN INVEST, V104, P447, DOI 10.1172/JCI5971; Khandekar MJ, 2011, NAT REV CANCER, V11, P886, DOI 10.1038/nrc3174; Kim F, 2008, ARTERIOSCL THROM VAS, V28, P1982, DOI 10.1161/ATVBAHA.108.169722; KOENUMA M, 1989, JPN J CANCER RES, V80, P51, DOI 10.1111/j.1349-7006.1989.tb02244.x; Kurtzhals P, 2000, DIABETES, V49, P999, DOI 10.2337/diabetes.49.6.999; LAAKSO M, 1992, DIABETES, V41, P1076, DOI 10.2337/diabetes.41.9.1076; Luck H, 2015, CELL METAB, V21, P527, DOI 10.1016/j.cmet.2015.03.001; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Makinen J, 2015, DIABETOLOGIA, V58, P1055, DOI 10.1007/s00125-015-3501-3; Melder RJ, 1996, NAT MED, V2, P992, DOI 10.1038/nm0996-992; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Monteiro-Sepulveda M, 2015, CELL METAB, V22, P113, DOI 10.1016/j.cmet.2015.05.020; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Naruse K, 2006, DIABETES, V55, P691, DOI 10.2337/diabetes.55.03.06.db05-0771; Novosyadlyy R, 2010, CANCER RES, V70, P741, DOI 10.1158/0008-5472.CAN-09-2141; Okabayashi K, 2012, AM J GASTROENTEROL, V107, P1175, DOI 10.1038/ajg.2012.180; OSBORNE CK, 1976, P NATL ACAD SCI USA, V73, P4536, DOI 10.1073/pnas.73.12.4536; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; RAIZADA MK, 1976, J BIOL CHEM, V251, P6445; Rask-Madsen C, 2001, DIABETES, V50, P2611, DOI 10.2337/diabetes.50.11.2611; Rask-Madsen C, 2012, ARTERIOSCL THROM VAS, V32, P2052, DOI 10.1161/ATVBAHA.111.241919; Rask-Madsen C, 2010, CELL METAB, V11, P379, DOI 10.1016/j.cmet.2010.03.013; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Rostoker R, 2015, ENDOCR-RELAT CANCER, V22, P145, DOI 10.1530/ERC-14-0490; Sandhu MS, 2002, J NATL CANCER I, V94, P972; Steinberg HO, 1996, J CLIN INVEST, V97, P2601, DOI 10.1172/JCI118709; Steyers CM, 2014, INT J MOL SCI, V15, P11324, DOI 10.3390/ijms150711324; Tabit CE, 2013, CIRCULATION, V127, P86, DOI 10.1161/CIRCULATIONAHA.112.127514; Targan SR, 2007, GASTROENTEROLOGY, V132, P1672, DOI 10.1053/j.gastro.2007.03.024; TEMIN HM, 1968, INT J CANCER, V3, P771, DOI 10.1002/ijc.2910030611; Treffers LW, 2016, IMMUNOL REV, V273, P312, DOI 10.1111/imr.12444; Vicent D, 2003, J CLIN INVEST, V111, P1373, DOI 10.1172/JCI200315211; Yoon YS, 2015, METABOLISM, V64, P1324, DOI 10.1016/j.metabol.2015.06.013; Yuhara H, 2011, AM J GASTROENTEROL, V106, P1911, DOI 10.1038/ajg.2011.301; Zhao LN, 2015, CLIN SCI, V129, P1025, DOI 10.1042/CS20150143	58	19	22	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 31	2017	36	35					4987	4996		10.1038/onc.2017.107	http://dx.doi.org/10.1038/onc.2017.107			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FF3AV	28459466	Green Submitted, Green Accepted			2022-12-26	WOS:000408768800004
J	Hutchens, S; Liu, CY; Jursa, T; Shawlot, W; Chaffee, BK; Yin, WL; Gore, AC; Aschner, M; Smith, DR; Mukhopadhyay, S				Hutchens, Steven; Liu, Chunyi; Jursa, Thomas; Shawlot, William; Chaffee, Beth K.; Yin, Weiling; Gore, Andrea C.; Aschner, Michael; Smith, Donald R.; Mukhopadhyay, Somshuvra			Deficiency in the manganese efflux transporter SLC30A10 induces severe hypothyroidism in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR TRAFFICKING; INTELLECTUAL FUNCTION; ZINC TRANSPORTERS; DRINKING-WATER; EXPOSURE; PARKINSONISM; IMPAIRMENT; MUTATIONS; ESTROGEN; FAMILY	Manganese is an essential metal that becomes toxic at elevated levels. Loss-of-function mutations in SLC30A10, a cell-surface-localized manganese efflux transporter, cause a heritable manganese metabolism disorder resulting in elevated manganese levels and parkinsonian-like movement deficits. The underlying disease mechanisms are unclear; therefore, treatment is challenging. To understand the consequences of loss of SLC30A10 function at the organism level, we generated Slc30a10 knock-out mice. During early development, knock-outs were indistinguishable from controls. Surprisingly, however, after weaning and compared with controls, knock-out mice failed to gain weight, were smaller, and died prematurely (by similar to 6-8 weeks of age). At 6 weeks, manganese levels in the brain, blood, and liver of the knock-outs were similar to 20-60-fold higher than controls. Unexpectedly, histological analyses revealed that the brain and liver of the knock-outs were largely unaffected, but their thyroid exhibited extensive alterations. Because hypothyroidism leads to growth defects and premature death in mice, we assayed for changes in thyroid and pituitary hormones. At 6 weeks and compared with controls, the knock-outs had markedly reduced thyroxine levels (similar to 50-80%) and profoundly increased thyroid-stimulating hormone levels (similar to 800-1000-fold), indicating that Slc30a10 knock-out mice develop hypothyroidism. Importantly, a low-manganese diet produced lower tissue manganese levels in the knock-outs and rescued the phenotype, suggesting that manganese toxicity was the underlying cause. Our unanticipated discovery highlights the importance of determining the role of thyroid dysfunction in the onset and progression of manganese-induced disease and identifies Slc30a10 knock-out mice as a new model for studying thyroid biology.	[Hutchens, Steven; Liu, Chunyi; Yin, Weiling; Gore, Andrea C.; Mukhopadhyay, Somshuvra] Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Hutchens, Steven; Liu, Chunyi; Yin, Weiling; Gore, Andrea C.; Mukhopadhyay, Somshuvra] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [Shawlot, William] Univ Texas Austin, Inst Cellular & Mol Biol, Mouse Genet Engn Facil, Austin, TX 78712 USA; [Jursa, Thomas; Smith, Donald R.] Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA; [Chaffee, Beth K.] MD Anderson Canc Ctr, Michale E Keeling Ctr Comparat Med & Res, Dept Vet Sci, Bastrop, TX 78602 USA; [Aschner, Michael] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of California System; University of California Santa Cruz; University of Texas System; UTMD Anderson Cancer Center; Yeshiva University; Albert Einstein College of Medicine	Mukhopadhyay, S (corresponding author), Univ Texas Austin, Div Pharmacol & Toxicol, 3-510E BME,107 W Dean Keeton, Austin, TX 78712 USA.	som@austin.utexas.edu	Liu, Chunyi/AAJ-9340-2021	Mukhopadhyay, Somshuvra/0000-0002-3420-7830	NIEHS, National Institutes of Health [R01-ES024812, R00-ES020844]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES020844, R01ES024812] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIEHS, National Institutes of Health Grants R01-ES024812 and R00-ES020844 (to S. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aschner M, 2009, NEUROMOL MED, V11, P252, DOI 10.1007/s12017-009-8083-0; Beaudin SA, 2017, ENVIRON HEALTH PERSP, V125, P230, DOI 10.1289/EHP258; Beaudin SA, 2013, NEUROTOXICOL TERATOL, V38, P36, DOI 10.1016/j.ntt.2013.04.004; Behringer R, 2014, MANIPULATING MOUSE E, V4; Bhang SY, 2013, ENVIRON RES, V126, P9, DOI 10.1016/j.envres.2013.05.006; Bouchard M, 2007, ENVIRON HEALTH PERSP, V115, P122, DOI 10.1289/ehp.9504; Bouchard MF, 2011, ENVIRON HEALTH PERSP, V119, P138, DOI 10.1289/ehp.1002321; BUTHIEAU AM, 1983, ARCH TOXICOL, V54, P243, DOI 10.1007/BF01239208; BUTHIEAU AM, 1977, CR SOC BIOL, V171, P1024; Butterworth RF, 2013, METAB BRAIN DIS, V28, P261, DOI 10.1007/s11011-012-9341-7; Chen Pan, 2015, Worm, V4, pe1042648, DOI 10.1080/21624054.2015.1042648; Ebert BL, 1999, BLOOD, V94, P1864; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Hall J. E., 2016, TXB MED PHYSL, P951; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Henn BC, 2010, EPIDEMIOLOGY, V21, P433, DOI 10.1097/EDE.0b013e3181df8e52; Huang LP, 2013, MOL ASPECTS MED, V34, P548, DOI 10.1016/j.mam.2012.05.008; Kambe T, 2015, PHYSIOL REV, V95, P749, DOI 10.1152/physrev.00035.2014; KAWADA J, 1985, ENDOCRINOL JAPON, V32, P635; Kern CH, 2010, SYNAPSE, V64, P363, DOI 10.1002/syn.20736; Khan K, 2012, NEUROTOXICOLOGY, V33, P91, DOI 10.1016/j.neuro.2011.12.002; Khan K, 2011, ENVIRON HEALTH PERSP, V119, P1501, DOI 10.1289/ehp.1003397; Kolaj-Robin O, 2015, FEBS LETT, V589, P1283, DOI 10.1016/j.febslet.2015.04.007; Lechpammer M, 2014, ANN NEUROL, V75, P608, DOI 10.1002/ana.24131; Lee ESY, 2009, TOXICOL SCI, V110, P156, DOI 10.1093/toxsci/kfp081; Lee ESY, 2009, J NEUROCHEM, V110, P530, DOI 10.1111/j.1471-4159.2009.06105.x; Leyva-Illades D, 2014, J NEUROSCI, V34, P14079, DOI 10.1523/JNEUROSCI.2329-14.2014; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Lucchini RG, 2014, NEUROTOXICOLOGY, V45, P309, DOI 10.1016/j.neuro.2014.05.006; Lucchini RG, 2012, NEUROTOXICOLOGY, V33, P687, DOI 10.1016/j.neuro.2012.01.005; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; Marians RC, 2002, P NATL ACAD SCI USA, V99, P15776, DOI 10.1073/pnas.242322099; Moreno JA, 2011, TOXICOL SCI, V122, P121, DOI 10.1093/toxsci/kfr091; Morshed SA, 2012, IMMUNOL RES, V54, P191, DOI 10.1007/s12026-012-8312-8; Mukhopadhyay S, 2012, SCIENCE, V335, P332, DOI 10.1126/science.1215930; Mukhopadhyay S, 2011, P NATL ACAD SCI USA, V108, P858, DOI 10.1073/pnas.1013642108; Mukhopadhyay S, 2010, MOL BIOL CELL, V21, P1282, DOI 10.1091/mbc.E09-11-0985; National Toxicology Program, 1993, Natl Toxicol Program Tech Rep Ser, V428, P1; Nishito Y, 2016, J BIOL CHEM, V291, P14773, DOI 10.1074/jbc.M116.728014; Olanow CW, 2004, ANN NY ACAD SCI, V1012, P209, DOI 10.1196/annals.1306.018; Oulhote Y, 2014, ENVIRON HEALTH PERSP, V122, P1343, DOI 10.1289/ehp.1307918; Perl DP, 2007, J NEUROPATH EXP NEUR, V66, P675, DOI 10.1097/nen.0b013e31812503cf; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Riojas-Rodriguez H, 2010, ENVIRON HEALTH PERSP, V118, P1465, DOI 10.1289/ehp.0901229; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Soldin OP, 2007, NEUROTOXICOLOGY, V28, P951, DOI 10.1016/j.neuro.2007.05.003; Tuschl K, 2008, J INHERIT METAB DIS, V31, P151, DOI 10.1007/s10545-008-0813-1; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Wasserman GA, 2006, ENVIRON HEALTH PERSP, V114, P124, DOI 10.1289/ehp.8030; Yin WL, 2015, ENDOCRINOLOGY, V156, P2918, DOI 10.1210/en.2015-1032; Zhong ML, 2012, HISTOCHEM CELL BIOL, V138, P605, DOI 10.1007/s00418-012-0979-3; Zoeller RT, 2007, CRIT REV TOXICOL, V37, P11, DOI 10.1080/10408440601123446; Zogzas CE, 2016, J BIOL CHEM, V291, P15940, DOI 10.1074/jbc.M116.726935	54	46	48	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9760	9773		10.1074/jbc.M117.783605	http://dx.doi.org/10.1074/jbc.M117.783605			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28461334	Green Published, hybrid			2022-12-26	WOS:000403113000025
J	Bekalu, ZE; Madsen, CK; Dionisio, G; Brinch-Pedersen, H				Bekalu, Zelalem Eshetu; Madsen, Claus Krogh; Dionisio, Giuseppe; Brinch-Pedersen, Henrik			Aspergillus ficuum phytase activity is inhibited by cereal grain components	PLOS ONE			English	Article							PURIFICATION; RESISTANCE; PATHOGENS; CELLULASE; DEFENSES; ENZYMES; MAIZE; NIGER	In the current study, we report for the first time that grain components of barley, rice, wheat and maize can inhibit the activity of Aspergillus ficuum phytase. The phytase inhibition is dose dependent and varies significantly between cereal species, between cultivars of barley and cultivars of wheat and between Fusarium graminearum infected and non-infected wheat grains. The highest endpoint level of phytase activity inhibition was 90%, observed with grain protein extracts (GPE) from F. graminearum infected wheat. Wheat GPE from grains infected with F. graminearum inhibits phytase activity significantly more than GPE from non-infected grains. For four barley cultivars studied, the IC50 value ranged from 0.978 +/- 0.271 to 3.616 +/- 0.087 mgxml(-1). For two non-infected wheat cultivars investigated, the IC50 values were varying from 2.478 +/- 0.114 to 3.038 +/- 0.097 mgxml(-1). The maize and rice cultivars tested gaveIC(50) values on 0.983 +/- 0.205 and 1.972 +/- 0.019 mgxml(-1), respectively. After purifying the inhibitor from barley grains via Superdex G200, an approximately 30-35 kDa protein was identified. No clear trend for the mechanism of inhibition could be identified via Michaelis-Menten kinetics and Lineweaver-Burk plots. However, testing of the purified phytase inhibitor together with the A. ficuum phytase and the specific protease inhibitors pepstatin A, E64, EDTA and PMSF revealed that pepstatin A repealed the phytase inhibition. This indicates that the observed inhibition of A. ficuum phytase by cereal grain extracts is caused by protease activity of the aspartic proteinase type.	[Bekalu, Zelalem Eshetu; Madsen, Claus Krogh; Dionisio, Giuseppe; Brinch-Pedersen, Henrik] Aarhus Univ, Res Ctr Flakkebjerg, Dept Mol Biol & Genet, Slagelse, Denmark	Aarhus University	Brinch-Pedersen, H (corresponding author), Aarhus Univ, Res Ctr Flakkebjerg, Dept Mol Biol & Genet, Slagelse, Denmark.	hbp@mbg.au.dk	Madsen, Claus/AAC-2154-2022; Brinch-Pedersen, Henrik/AAY-8420-2021	Madsen, Claus/0000-0002-8921-3920; Brinch-Pedersen, Henrik/0000-0002-9773-8903; Dionisio, Giuseppe/0000-0003-4416-0519				Abul H JU, 1988, ANN NY ACAD SCI, V542, P102; BIRK Y, 1989, RECENT ADVANCES OF RESEARCH IN ANTINUTRITIONAL FACTORS IN LEGUME SEEDS, P83; Bostock RM, 2005, ANNU REV PHYTOPATHOL, V43, P545, DOI 10.1146/annurev.phyto.41.052002.095505; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brinch-Pedersen H, 2014, J CEREAL SCI, V59, P373, DOI 10.1016/j.jcs.2013.10.003; Dionisio G, 2007, PLANT BIOTECHNOL J, V5, P325, DOI 10.1111/j.1467-7652.2007.00244.x; ENGELEN AJ, 1994, J AOAC INT, V77, P760; GIBSON DM, 1988, ARCH BIOCHEM BIOPHYS, V260, P503, DOI 10.1016/0003-9861(88)90475-4; GIBSON DM, 1990, PLANT BIOL, V9, P77; GOEL M, 1979, PHYTOCHEMISTRY, V18, P939, DOI 10.1016/S0031-9422(00)91453-5; GREINER R, 1993, ARCH BIOCHEM BIOPHYS, V303, P107, DOI 10.1006/abbi.1993.1261; Greiner R, 1997, ARCH BIOCHEM BIOPHYS, V341, P201, DOI 10.1006/abbi.1997.9942; Gusakov AV, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1185, DOI 10.1134/S0006297910100019; Heil M, 2002, ANN BOT-LONDON, V89, P503, DOI 10.1093/aob/mcf076; Howarth EB, 2000, IMPROVING HUMAN NUTR; Huang ZY, 1997, PHYTOPATHOLOGY, V87, P622, DOI 10.1094/PHYTO.1997.87.6.622; Hubel F, 1996, PLANT PHYSIOL, V112, P1429, DOI 10.1104/pp.112.4.1429; Huma H., 2007, BIOTECHNOLOGY MOL BI, V2; HURST PL, 1977, BIOCHEM J, V165, P33, DOI 10.1042/bj1650033; Kostrewa D, 1997, NAT STRUCT BIOL, V4, P185, DOI 10.1038/nsb0397-185; Lott JNA., 1984, SEED PHYSL, P139; Nelson HE, 2014, BIOCONTROL, V59, P625, DOI 10.1007/s10526-014-9593-8; ODELL BL, 1972, J AGR FOOD CHEM, V20, P718, DOI 10.1021/jf60181a021; Palencia ER, 2010, TOXINS, V2, P399, DOI 10.3390/toxins2040399; Perrone G, 2007, STUD MYCOL, P53, DOI 10.3114/sim.2007.59.07; Ponte PIP, 2004, J APPL POULTRY RES, V13, P660, DOI 10.1093/japr/13.4.660; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Sami AJ, 2011, J MED PLANTS RES, V5, P184; SEGUEILHA L, 1992, J FERMENT BIOENG, V74, P7, DOI 10.1016/0922-338X(92)90259-W; Slusarenko AJ, 2000, SYSTEMIC INDUCED RES; ULLAH AHJ, 1987, PREP BIOCHEM, V17, P63, DOI 10.1080/00327488708062477; Valueva TA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1305, DOI 10.1007/s10541-005-0015-5; VANHARTINGSVELDT W, 1993, GENE, V127, P87, DOI 10.1016/0378-1119(93)90620-I; Verhoeven T, 2005, HGCA RES REV; Yanke LJ, 1999, LETT APPL MICROBIOL, V29, P20, DOI 10.1046/j.1365-2672.1999.00568.x	35	13	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176838	10.1371/journal.pone.0176838	http://dx.doi.org/10.1371/journal.pone.0176838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472144	Green Published, gold, Green Submitted			2022-12-26	WOS:000400648500082
J	Bloemen, S; Zwaveling, S; ten Cate, H; ten Cate-Hoek, A; de Laat, B				Bloemen, Saartje; Zwaveling, Suzanne; ten Cate, Hugo; ten Cate-Hoek, Anna; de laat, Bas			Prediction of bleeding risk in patients taking vitamin K antagonists using thrombin generation testing	PLOS ONE			English	Article							INTERNATIONAL NORMALIZED RATIO; HAS-BLED SCORES; ATRIAL-FIBRILLATION; ANTICOAGULATED PATIENTS; THROMBOGRAM; MANAGEMENT; WARFARIN; THERAPY; PLASMA	Until recently, vitamin K antagonists (VKAs) were the mainstay of oral anticoagulant treatment with bleeding as the most prevalent adverse effect. One to four percent of patients experience major bleeding episodes, while clinically relevant bleeding occurs in up to 20%. At this moment no laboratory assays are available to identify patients at risk for bleeding. With this study we aimed to investigate whether thrombin generation tests might identify a bleeding risk in patients taking VKAs. This prospective cohort study included 129 patients taking VKAs for more than three months. Calibrated automated thrombinography (CAT) was performed in whole blood, platelet rich and platelet poor plasma. Hematocrit, hemoglobin concentrations and the International Normalized Ratio (INR) were defined and coagulation factor levels were measured. Forty clinically relevant bleeding episodes were registered in 26 patients during follow-up. No differences were found in plasma CAT parameters or INR values. Bleeding was not associated with age, sex, hematocrit, hemoglobin levels or coagulation factor levels. In whole blood a significantly lower endogenous thrombin potential (ETP) and peak were found in patients with bleeding (median ETP: 182.5 versus 256.2 nM. min, p = 0.002; peak: 23.9 versus 39.1 nM, p = 0.029). Additionally, the area under the receiver operating curve (AUC ROC) was significantly associated with bleeding (ETP: 0.700, p = 0.002; peak: 0.642, p = 0.029). HAS-BLED scores were also significantly higher in bleeding patients (3 versus 2, p = 0.003), with an AUC ROC 0.682 (p = 0.004). In conclusion, bleeding in patients taking VKAs is associated with a decreased whole blood ETP and peak as well as with an increased HAS-BLED score.	[Bloemen, Saartje; Zwaveling, Suzanne; de laat, Bas] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Synapse Res Inst, Maastricht, Netherlands; [Bloemen, Saartje; Zwaveling, Suzanne; de laat, Bas] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands; [ten Cate, Hugo; ten Cate-Hoek, Anna] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Internal Med,Lab Clin Thrombosis & Hemostasi, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University	Bloemen, S (corresponding author), Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Synapse Res Inst, Maastricht, Netherlands.; Bloemen, S (corresponding author), Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands.	s.bloemen@thrombin.com	Cate, Hugo ten/AAM-4000-2021	Bloemen, Saartje/0000-0003-3297-8196; ten Cate, Hugo/0000-0001-7796-4463				Al Dieri R, 2002, THROMB HAEMOSTASIS, V88, P576, DOI 10.1055/s-0037-1613258; Al Dieri R, 2012, BLOOD REV, V26, P197, DOI 10.1016/j.blre.2012.06.001; Ansell J, 2004, CHEST, V126, p204S, DOI 10.1378/chest.126.3_suppl.204S; Apostolakis S, 2013, THROMB HAEMOSTASIS, V110, P1074, DOI 10.1160/TH13-07-0552; Bloemen S, 2013, HAEMATOLOGICA, V98, P549, DOI 10.3324/haematol.2012.073601; Bosch Y, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-154; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Dargaud Y, 2005, THROMB HAEMOSTASIS, V93, P475, DOI 10.1160/TH04-10-0706; Dargaud Y, 2013, J THROMB HAEMOST, V11, P1043, DOI 10.1111/jth.12244; Gallego P, 2012, CIRC-ARRHYTHMIA ELEC, V5, P312, DOI 10.1161/CIRCEP.111.967000; Halbritter K, 2013, J THROMB HAEMOST, V11, P651, DOI 10.1111/jth.12148; Hallas J, 2006, BMJ-BRIT MED J, V333, P726, DOI 10.1136/bmj.38947.697558.AE; Hemker HC, 2009, THROMB HAEMOSTASIS, V101, P171, DOI 10.1160/TH08-09-0562; Hemker HC, 2013, THROMB RES, V131, P3, DOI 10.1016/j.thromres.2012.10.011; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Lane DA, 2012, CIRCULATION, V126, P860, DOI 10.1161/CIRCULATIONAHA.111.060061; Levine MN, 2004, CHEST, V126, p287S, DOI 10.1378/chest.126.3_suppl.287S; Lip GYH, 2015, STROKE, V46, P143, DOI 10.1161/STROKEAHA.114.007199; Luna-Zaizar H, 2015, THROMB RES, V136, P1291, DOI 10.1016/j.thromres.2015.10.026; Ninivaggi M, 2012, CLIN CHEM, V58, P1252, DOI 10.1373/clinchem.2012.184077; Olesen JB, 2011, J THROMB HAEMOST, V9, P1460, DOI 10.1111/j.1538-7836.2011.04378.x; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Poli D, 2011, CIRCULATION, V124, P824, DOI 10.1161/CIRCULATIONAHA.110.007864; Rothberg MB, 2005, ANN INTERN MED, V143, P241, DOI 10.7326/0003-4819-143-4-200508160-00005; Sanden P, 2017, THROMB HAEMOSTASIS, V117, P27, DOI 10.1160/TH16-06-0489; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; van der Meijden PEJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064112; van Rein N, 2016, J THROMB HAEMOST, V14, P948, DOI 10.1111/jth.13306; Veeger NJGM, 2011, BRIT J HAEMATOL, V153, P508, DOI 10.1111/j.1365-2141.2011.08656.x; Vlieg AV, 2007, BRIT J HAEMATOL, V138, P769, DOI 10.1111/j.1365-2141.2007.06738.x; Whelihan MF, 2013, THROMB RES, V131, P377, DOI 10.1016/j.thromres.2013.01.023	32	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176967	10.1371/journal.pone.0176967	http://dx.doi.org/10.1371/journal.pone.0176967			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472104	Green Published, gold, Green Submitted			2022-12-26	WOS:000400648500106
J	Welle, PD; Small, MJ; Doney, SC; Azevedo, IL				Welle, Paul D.; Small, Mitchell J.; Doney, Scott C.; Azevedo, Ines L.			Estimating the effect of multiple environmental stressors on coral bleaching and mortality	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CLIMATE-CHANGE; OCEAN ACIDIFICATION; GLOBAL ASSESSMENT; TEMPERATURE; RESILIENCE; IMPACTS; ADAPTATION; SCIENCE; LIMITS	Coral cover has been declining in recent decades due to increased temperatures and environmental stressors. However, the extent to which different stressors contribute both individually and in concert to bleaching and mortality is still very uncertain. We develop and use a novel regression approach, using non-linear parametric models that control for unobserved time invariant effects to estimate the effects on coral bleaching and mortality due to temperature, solar radiation, depth, hurricanes and anthropogenic stressors using historical data from a large bleaching event in 2005 across the Caribbean. Two separate models are created, one to predict coral bleaching, and the other to predict near-term mortality. A large ensemble of supporting data is assembled to control for omitted variable bias and improve fit, and a significant improvement in fit is observed from univariate linear regression based on temperature alone. The results suggest that climate stressors (temperature and radiation) far outweighed direct anthropogenic stressors (using distance from shore and nearby human population density as a proxy for such stressors) in driving coral health outcomes during the 2005 event. Indeed, temperature was found to play a role similar to 4 times greater in both the bleaching and mortality response than population density across their observed ranges. The empirical models tested in this study have large advantages over ordinary-least squares-they offer unbiased estimates for censored data, correct for spatial correlation, and are capable of handling more complex relationships between dependent and independent variables. The models offer a framework for preparing for future warming events and climate change; guiding monitoring and attribution of other bleaching and mortality events regionally and around the globe; and informing adaptive management and conservation efforts.	[Welle, Paul D.; Small, Mitchell J.; Azevedo, Ines L.] Carnegie Mellon Univ, Dept Engn & Publ Policy, 5000 Forbes Ave, Pittsburgh, PA 15213 USA; [Small, Mitchell J.] Carnegie Mellon Univ, Dept Civil & Environm Engn, 5000 Forbes Ave, Pittsburgh, PA 15213 USA; [Doney, Scott C.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, MS 25, Woods Hole, MA 02543 USA	Carnegie Mellon University; Carnegie Mellon University; Woods Hole Oceanographic Institution	Azevedo, IL (corresponding author), Carnegie Mellon Univ, Dept Engn & Publ Policy, 5000 Forbes Ave, Pittsburgh, PA 15213 USA.	iazevedo@cmu.edu	Doney, Scott C/F-9247-2010	Doney, Scott C/0000-0002-3683-2437	center for Climate and Energy Decision Making through National Science Foundation [SES-0949710]; center for Climate and Energy Decision Making through Carnegie Mellon University [SES-0949710]; National Science Foundation Graduate Research Fellowship [DGE-1252522]; Direct For Social, Behav & Economic Scie [1463492] Funding Source: National Science Foundation	center for Climate and Energy Decision Making through National Science Foundation; center for Climate and Energy Decision Making through Carnegie Mellon University; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported by the center for Climate and Energy Decision Making (SES-0949710), through a cooperative agreement between the National Science Foundation and Carnegie Mellon University. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. (DGE-1252522). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright R, 2010, P NATL ACAD SCI USA, V107, P20400, DOI 10.1073/pnas.1007273107; Anthony KRN, 2007, LIMNOL OCEANOGR, V52, P716, DOI 10.4319/lo.2007.52.2.0716; Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P1798, DOI 10.1111/j.1365-2486.2010.02364.x; Berkelmans R, 1999, CORAL REEFS, V18, P219, DOI 10.1007/s003380050186; Brown BE, 2002, CORAL REEFS, V21, P119, DOI 10.1007/s00338-002-0215-z; Cesar H., 2003, EC WORLDWIDE CORAL R; Christie P, 2007, CORAL REEFS, V26, P1047, DOI 10.1007/s00338-007-0235-9; Claudet, 2015, AQUATIC FUNCTIONAL B, P211, DOI DOI 10.1016/B978-0-12-417015-5.00009-8; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; Davenport J, 2006, ESTUAR COAST SHELF S, V67, P280, DOI 10.1016/j.ecss.2005.11.026; DeBose JL, 2013, CORAL REEFS, V32, P255, DOI 10.1007/s00338-012-0971-3; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Donner SD, 2007, P NATL ACAD SCI USA, V104, P5483, DOI 10.1073/pnas.0610122104; Downs CA, 2000, MAR BIOTECHNOL, V2, P533, DOI 10.1007/s101260000038; Dunne RP, 2001, CORAL REEFS, V20, P201; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Erftemeijer PLA, 2012, MAR POLLUT BULL, V64, P1737, DOI 10.1016/j.marpolbul.2012.05.008; Fabricius KE, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P493, DOI 10.1007/978-94-007-0114-4_28; Fisk D. A, 1985, P 5 INT COR REEF C; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; GLYNN PW, 1990, CORAL REEFS, V8, P181, DOI 10.1007/BF00265009; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O., 2000, P 9 INT COR REEF S B, V2, P23; HOEGHGULDBERG O, 1989, J EXP MAR BIOL ECOL, V129, P279, DOI 10.1016/0022-0981(89)90109-3; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jameson SC, 1999, CORAL REEFS, V18, P333, DOI 10.1007/s003380050208; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; LESSER MP, 1990, CORAL REEFS, V8, P225, DOI 10.1007/BF00265015; Maina J, 2008, ECOL MODEL, V212, P180, DOI 10.1016/j.ecolmodel.2007.10.033; Maire E, 2016, ECOL LETT, V19, P351, DOI 10.1111/ele.12577; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McWilliams JP, 2005, ECOLOGY, V86, P2055, DOI 10.1890/04-1657; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; Mumby PJ, 2001, MAR BIOL, V139, P183; Nagelkerken I, 2015, P NATL ACAD SCI USA, V112, P13272, DOI 10.1073/pnas.1510856112; Papke LE, 1996, J APPL ECONOM, V11, P619, DOI 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1; Ramanathan V, 2001, SCIENCE, V294, P2119, DOI 10.1126/science.1064034; Rehr AP, 2012, ENVIRON MANAGE, V50, P1204, DOI 10.1007/s00267-012-9941-3; Richmond RH, 2007, BIOSCIENCE, V57, P598, DOI 10.1641/B570710; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; Wilkinson C, 2008, STATUS CARIBBEAN COR; WILLIAMS E H JR, 1990, Atoll Research Bulletin, P1; Williams EH, 1988, P 6 INT COR REEF S, V3, P313; Yee SH, 2008, ECOL MODEL, V218, P162, DOI 10.1016/j.ecolmodel.2008.06.037; Yee SH, 2010, ENVIRON MONIT ASSESS, V161, P423, DOI 10.1007/s10661-009-0758-3	49	13	13	1	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0175018	10.1371/journal.pone.0175018	http://dx.doi.org/10.1371/journal.pone.0175018			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472031	Green Published, gold, Green Submitted			2022-12-26	WOS:000400648500007
J	Coppes, J; Burghardt, F; Hagen, R; Suchant, R; Braunisch, V				Coppes, Joy; Burghardt, Friedrich; Hagen, Robert; Suchant, Rudi; Braunisch, Veronika			Human recreation affects spatio-temporal habitat use patterns in red deer (Cervus elaphus)	PLOS ONE			English	Article							HUMAN DISTURBANCE; WILDLIFE RESPONSES; SEED DISPERSAL; FOREST; PREDATION; STRESS; POPULATIONS; COLLISIONS; DYNAMICS; DIFFERS	The rapid spread and diversification of outdoor recreation can impact on wildlife in various ways, often leading to the avoidance of disturbed habitats. To mitigate human-wildlife conflicts, spatial zonation schemes can be implemented to separate human activities from key wildlife habitats, e.g., by designating undisturbed wildlife refuges or areas with some level of restriction to human recreation and land use. However, mitigation practice rarely considers temporal differences in human-wildlife interactions. We used GPS telemetry data from 15 red deer to study the seasonal (winter vs. summer) and diurnal (day vs. night) variation in recreation effects on habitat use in a study region in south-western Germany where a spatial zonation scheme has been established. Our study aimed to determine if recreation infrastructure and spatial zonation affected red deer habitat use and whether these effects varied daily or seasonally. Recreation infrastructure did not affect home range selection in the study area, but strongly determined habitat use within the home range. The spatial zonation scheme was reflected in both of these two levels of habitat selection, with refuges and core areas being more frequently used than the border zones. Habitat use differed significantly between day and night in both seasons. Both summer and winter recreation trails, and nearby foraging habitats, were avoided during day, whereas a positive association was found during night. We conclude that human recreation has an effect on red deer habitat use, and when designing mitigation measures daily and seasonal variation in human-wildlife interactions should be taken into account. We advocate using spatial zonation in conjunction with temporal restrictions (i.e., banning nocturnal recreation activities) and the creation of suitable foraging habitats away from recreation trails.	[Coppes, Joy; Burghardt, Friedrich; Hagen, Robert; Suchant, Rudi; Braunisch, Veronika] Forest Res Inst Baden Wurtlemberg FVA, Freiburg, Germany; [Burghardt, Friedrich] Black Forest Natl Pk, Seebach, Germany; [Braunisch, Veronika] Univ Bern, Inst Ecol & Evolut, Conservat Biol, Bern, Switzerland	University of Bern	Coppes, J (corresponding author), Forest Res Inst Baden Wurtlemberg FVA, Freiburg, Germany.	Joy.Coppes@forst.bwl.de	Braunisch, Veronika/AAH-8260-2020	Braunisch, Veronika/0000-0001-7035-4662; Coppes, Joy/0000-0002-5295-8638	state of Baden-WOrttemberg, Germany; German Research Foundation (DFG); University of Freiburg	state of Baden-WOrttemberg, Germany; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	This study was funded by the state of Baden-WOrttemberg, Germany. The article processing charge was funded by the German Research Foundation (DFG), the University of Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlettaz R, 2007, P R SOC B, V274, P1219, DOI 10.1098/rspb.2006.0434; Arnold Walter, 2004, Am J Physiol Regul Integr Comp Physiol, V286, pR174; Barton K., 2014, MUMIN MULTIMODEL INF; Beale CM, 2004, J APPL ECOL, V41, P335, DOI 10.1111/j.0021-8901.2004.00900.x; Bruinderink GWTAG, 1996, CONSERV BIOL, V10, P1059, DOI 10.1046/j.1523-1739.1996.10041059.x; Burghardt F, 2012, REAKTIONEN UNBEJAGTE; Burnham K. P., 1998, MODEL SELECTION INFE; Butzler W, 2001, ROTWILD BIOL; Ciuti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050611; Coppes J, 2013, WILDLIFE BIOL, V19, P1, DOI 10.2981/12-054; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Dudley N., 2008, GUIDELINES APPL PROT, DOI [10.2305/IUCN.CH.2008.PAPS.2.en, DOI 10.2305/IUCN.CH.2008.PAPS.2.EN]; Fernandez-Juricic E, 2004, BIOL CONSERV, V117, P407, DOI 10.1016/j.biocon.2003.02.001; Fernandez-Juricic E, 2000, BIRD STUDY, V47, P13, DOI 10.1080/00063650009461156; Flather CH, 1995, WILDLIFE RECREATIONI, P3; Formenti N, 2015, J ORNITHOL, V156, P317, DOI 10.1007/s10336-014-1103-3; Fox Jr J., 2015, APPL REGRESSION ANAL; Frid A, 2002, CONSERV ECOL, V6; GILL RMA, 1992, FORESTRY, V65, P363, DOI 10.1093/forestry/65.4.363-a; Gill RMA, 2001, FORESTRY, V74, P209, DOI 10.1093/forestry/74.3.209; Gunson KE, 2011, J ENVIRON MANAGE, V92, P1074, DOI 10.1016/j.jenvman.2010.11.027; Hegland SJ, 2013, FOREST ECOL MANAG, V310, P267, DOI 10.1016/j.foreco.2013.08.031; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Immitzer M, 2014, J ORNITHOL, V155, P173, DOI 10.1007/s10336-013-0999-3; Iravani M, 2011, BASIC APPL ECOL, V12, P505, DOI 10.1016/j.baae.2011.07.004; Jayakody S, 2008, WILDLIFE BIOL, V14, P81, DOI 10.2981/0909-6396(2008)14[81:RDCEVB]2.0.CO;2; Jayakody S, 2011, EUR J WILDLIFE RES, V57, P939, DOI 10.1007/s10344-011-0508-z; Jedrzejewski W, 2000, J MAMMAL, V81, P197, DOI 10.1644/1545-1542(2000)081&lt;0197:PSAPBW&gt;2.0.CO;2; JEPPESEN J L, 1987, Danish Review of Game Biology, V13, P1; Jiang GS, 2009, ACTA THERIOL, V54, P61, DOI 10.1007/BF03193138; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kiffner C, 2008, SILVA FENN, V42, P125, DOI 10.14214/sf.269; Kloppers EL, 2005, ECOL SOC, V10; Knight Richard L., 1995, P51; Koubek P., 1999, ATLAS EUROPEAN MAMMA; Krishna YC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151748; Leblond M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073695; Lima SL, 2015, BIOL REV, V90, P60, DOI 10.1111/brv.12093; Lone K, 2015, ANIM BEHAV, V102, P127, DOI 10.1016/j.anbehav.2015.01.012; Lubow BC, 2002, J WILDLIFE MANAGE, V66, P757, DOI 10.2307/3803141; MARQUARDT DW, 1970, TECHNOMETRICS, V12, P591, DOI 10.2307/1267205; Mazerolle M. J., 2014, AICCMODAVG MODEL SEL; Melis C, 2005, BIODIVERS CONSERV, V15, P2249; Miller AD, 2017, ENVIRON MANAGE, V59, P50, DOI 10.1007/s00267-016-0777-0; Miller SG, 2001, WILDLIFE SOC B, V29, P124; Milner JM, 2006, J APPL ECOL, V43, P721, DOI 10.1111/j.1365-2664.2006.01183.x; Morellet N, 2007, J APPL ECOL, V44, P634, DOI 10.1111/j.1365-2664.2007.01307.x; Mysterud A, 2006, BIOL LETTERS, V2, P632, DOI 10.1098/rsbl.2006.0533; Phillips GE, 2000, J WILDLIFE MANAGE, V64, P521, DOI 10.2307/3803250; Picton HD, 2000, EFFECTS WINTER RECRE; Putman R.J., 2011, UNGULATE MANAGEMENT; Putman RJ, 2004, MAMMAL REV, V34, P285, DOI 10.1111/j.1365-2907.2004.00044.x; Reimoser F., 1988, OSTERREICHISCHE FORS, P24; Reimoser S, 2012, CONTEXT THEIR DAILY; Ruiz-Fons F, 2010, INT J PARASITOL, V40, P1013, DOI 10.1016/j.ijpara.2010.02.006; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Seiler A, 2004, WILDLIFE BIOL, V10, P301, DOI 10.2981/wlb.2004.036; Sheriff MJ, 2009, J ANIM ECOL, V78, P1249, DOI 10.1111/j.1365-2656.2009.01552.x; Sibbald AM, 2011, EUR J WILDLIFE RES, V57, P817, DOI 10.1007/s10344-011-0493-2; Sonnichsen L, 2013, ETHOLOGY, V119, P233, DOI 10.1111/eth.12057; Stache Anja, 2012, Silva Gabreta, V18, P35; Staines BW, 1989, MAMMALS PESTS, P128; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Stankowich T, 2008, BIOL CONSERV, V141, P2159, DOI 10.1016/j.biocon.2008.06.026; Statistisches Landesamt, 2016, TOUR ABS 2004 2015 N; Suchant R, 2008, ROTWILD SUDSCHWARZWA; Suchant Rudi, 2003, Journal for Nature Conservation (Jena), V10, P253, DOI 10.1078/1617-1381-00026; Taylor AR, 2003, ECOL APPL, V13, P951, DOI 10.1890/1051-0761(2003)13[951:WRTRAA]2.0.CO;2; Thiel D, 2008, J APPL ECOL, V45, P845, DOI 10.1111/j.1365-2664.2008.01465.x; Thompson MJ, 1998, WILDLIFE SOC B, V26, P477; von Oheimb G, 2005, EUR J FOREST RES, V124, P55, DOI 10.1007/s10342-005-0053-y; Yasue M, 2006, BIOL CONSERV, V128, P47, DOI 10.1016/j.biocon.2005.09.015; Zuur Alain F., 2009, P1	73	42	43	8	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0175134	10.1371/journal.pone.0175134	http://dx.doi.org/10.1371/journal.pone.0175134			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467429	Green Published, Green Submitted, gold			2022-12-26	WOS:000400647000012
J	Doppler, C; Arnhard, K; Dumfarth, J; Heinz, K; Messner, B; Stern, C; Koal, T; Klavins, K; Danzl, K; Pitterl, F; Grimm, M; Oberacher, H; Bernhard, D				Doppler, Christian; Arnhard, Kathrin; Dumfarth, Julia; Heinz, Katharina; Messner, Barbara; Stern, Christian; Koal, Therese; Klavins, Kristaps; Danzl, Katarina; Pitterl, Florian; Grimm, Michael; Oberacher, Herbert; Bernhard, David			Metabolomic profiling of ascending thoracic aortic aneurysms and dissections - Implications for pathophysiology and biomarker discovery	PLOS ONE			English	Article							NIEMANN-PICK-DISEASE; ACID SPHINGOMYELINASE; VALVE; PLASMA; CELLS; SPHINGOLIPIDS; INFLAMMATION; VIRUS	Objective Our basic understanding of ascending thoracic aortic aneurysm (ATAA) pathogenesis is still very limited, hampering early diagnosis, risk prediction, and development of treatment options. "Omics"-technologies, ideal to reveal tissue alterations from the normal physiological state due to disease have hardly been applied in the field. Using a metabolomic approach, with this study the authors seek to define tissue differences between controls and various forms of ATAAs. Methods Using a targeted FIA-MS/MS metabolomics approach, we analysed and compared the metabolic profiles of ascending thoracic aortic wall tissue of age-matched controls (n = 8), bicuspid aortic valve-associated aneurysms (BAV-A; n = 9), tricuspid aortic valve-associated aneurysms (TAV-A; n = 14), and tricuspid aortic valve-associated aortic dissections (TAV-Diss; n = 6). Results With sphingomyelin (SM) (OH) C22:2, SM C18:1, SM C22:1, and SM C24:1 only 4 out of 92 detectable metabolites differed significantly between controls and BAV-A samples. Between controls and TAV-Diss samples only phosphatidylcholine (PC) ae C32:1 differed. Importantly, our analyses revealed a general increase in the amount of total sphingomyelin levels in BAV-A and TAV-Diss samples compared to controls. Conclusions Significantly increased levels of sphingomyelins in BAV-A and TAV-Diss samples compared to controls may argue for a repression of sphingomyelinase activity and the sphingomyelinase-ceramide pathway, which may result in an inhibition of tissue regeneration; a potential basis for disease initiation and progression.	[Doppler, Christian; Dumfarth, Julia; Heinz, Katharina; Danzl, Katarina; Grimm, Michael; Bernhard, David] Innsbruck Med Univ, Univ Clin Cardiac Surg, Cardiac Surg Res Lab, Innsbruck, Austria; [Doppler, Christian; Bernhard, David] Johannes Kepler Univ Linz, Fac Med, Cardiac Vasc & Thorac Surg, Linz, Austria; [Arnhard, Kathrin; Pitterl, Florian; Oberacher, Herbert] Innsbruck Med Univ, Inst Legal Med & Core Facil Metabol, Innsbruck, Austria; [Messner, Barbara; Stern, Christian] Vienna Med Univ, Dept Cardiac Surg, Vienna, Austria; [Koal, Therese; Klavins, Kristaps] Biocrates Life Sci AG, Innsbruck, Austria	Medical University of Innsbruck; Johannes Kepler University Linz; Medical University of Innsbruck; Medical University of Vienna	Bernhard, D (corresponding author), Innsbruck Med Univ, Univ Clin Cardiac Surg, Cardiac Surg Res Lab, Innsbruck, Austria.; Bernhard, D (corresponding author), Johannes Kepler Univ Linz, Fac Med, Cardiac Vasc & Thorac Surg, Linz, Austria.	david.bernhard@i-med.ac.at	Klavins, Kristaps/AAJ-1644-2020; Dumfarth, Julia/ABE-4935-2020; Messner, Barbara/GLS-8150-2022; Parson, Walther/AAD-6845-2020	Klavins, Kristaps/0000-0001-9577-9990; Messner, Barbara/0000-0001-8331-6497; Oberacher, Herbert/0000-0002-0963-8268; Bernhard, David/0000-0002-2383-6607	Austrian National Bank [14745, 14590]; Tiroler Wissenschaftsfonds (TWF) [TWF-2016-1-9]; Biocrates Life Sciences AG, Tirol, Austria	Austrian National Bank; Tiroler Wissenschaftsfonds (TWF); Biocrates Life Sciences AG, Tirol, Austria	This work was supported by the Austrian National Bank [14745 to DB, and 14590 to BM], and the Tiroler Wissenschaftsfonds (TWF) [TWF-2016-1-9 to CD] Further, this study was supported by the Biocrates Life Sciences AG, Tirol, Austria in the form of salaries of the following authors (TK, KK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adada M, 2016, CHEM PHYS LIPIDS, V197, P45, DOI 10.1016/j.chemphyslip.2015.07.008; Bao JX, 2016, FRONT BIOSCI-LANDMRK, V21, P1168, DOI 10.2741/4448; Berntorp E, 2016, HAEMOPHILIA OFFICIAL; Bienias K, 2016, PHARMACOL REP, V68, P570, DOI 10.1016/j.pharep.2015.12.008; Blaas I, 2016, J THROMBOSIS HAEMOST; Black KM, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000138; BRADY RO, 1966, P NATL ACAD SCI USA, V55, P366, DOI 10.1073/pnas.55.2.366; Chakravarthy H, 2016, STEM CELLS, V34, P972, DOI 10.1002/stem.2259; Chaurasia B, 2015, TRENDS ENDOCRIN MET, V26, P538, DOI 10.1016/j.tem.2015.07.006; Chen Y, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0137-8; Ciborowski Michal, 2013, Methods Mol Biol, V1000, P103, DOI 10.1007/978-1-62703-405-0_9; Ciborowski M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031982; Ciborowski M, 2011, J PROTEOME RES, V10, P1374, DOI 10.1021/pr101138m; Edsfeldt A, 2016, ARTERIOSCL THROM VAS, V36, P1132, DOI 10.1161/ATVBAHA.116.305675; El-Hamamsy I, 2009, NAT REV CARDIOL, V6, P771, DOI 10.1038/nrcardio.2009.191; Elefteriades JA, 2013, PROG CARDIOVASC DIS, V56, P57, DOI 10.1016/j.pcad.2013.06.002; Ellison JW, 2007, J SURG RES, V142, P28, DOI 10.1016/j.jss.2006.04.040; Fedak PWM, 2002, CIRCULATION, V106, P900, DOI 10.1161/01.CIR.0000027905.26586.E8; Foffa I, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-44; Gabande-Rodriguez E, 2014, CELL DEATH DIFFER, V21, P864, DOI 10.1038/cdd.2014.4; Goldfinger JZ, 2014, J AM COLL CARDIOL, V64, P1725, DOI 10.1016/j.jacc.2014.08.025; Grewal N, 2016, HEART VESSELS, V31, P795, DOI 10.1007/s00380-015-0703-z; Guo DC, 2006, ANN NY ACAD SCI, V1085, P339, DOI 10.1196/annals.1383.013; Hammad SM, 2010, J LIPID RES, V51, P3074, DOI 10.1194/jlr.D008532; Holzinger A, 2016, METHODS MOL BIOL, V1365, P243, DOI 10.1007/978-1-4939-3124-8_13; Iakoubova OA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091437; Ikonomidis JS, 2013, J THORAC CARDIOV SUR, V145, P1326, DOI 10.1016/j.jtcvs.2012.12.027; Kirsch E W Matthias, 2006, Asian Cardiovasc Thorac Ann, V14, P254; Matt Peter, 2007, Asian Cardiovasc Thorac Ann, V15, P185; Otahal A, 2015, J VIROL, V89, P11723, DOI 10.1128/JVI.01869-15; Othman A, 2015, ATHEROSCLEROSIS, V240, P216, DOI 10.1016/j.atherosclerosis.2015.03.011; Peters DG, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.24.e39; Pillai PS, 2012, INFLAMMATION, V35, P98, DOI 10.1007/s10753-011-9294-8; Puck Alexander, 2015, Results Immunol, V5, P23, DOI 10.1016/j.rinim.2015.10.001; Ruperez FJ, 2012, ANAL BIOANAL CHEM, V403, P1651, DOI 10.1007/s00216-012-5982-y; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Slebos DJ, 2015, RESPIRATION, V90, P136, DOI 10.1159/000431384; STCRAWFORD E, 1982, ARCH SURG-CHICAGO, V117, P1393; Tadros TM, 2009, CIRCULATION, V119, P880, DOI 10.1161/CIRCULATIONAHA.108.795401; Tung WS, 2001, J VASC SURG, V34, P143, DOI 10.1067/mva.2001.113310; van den Elzen S, 2016, IEEE T VIS COMPUT GR, V22, P1, DOI 10.1109/TVCG.2015.2468078; van den Elzen S, 2014, IEEE T VIS COMPUT GR, V20, P1087, DOI 10.1109/TVCG.2013.263; Weiss VU, 2015, ANAL CHEM, V87, P8709, DOI 10.1021/acs.analchem.5b01450; Zack F, 2016, INT J LEGAL MED, V130, P173, DOI 10.1007/s00414-015-1287-y; Zilz C, 2016, MULTIDISCIP RESP MED, V11, DOI 10.1186/s40248-016-0041-8	45	17	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176727	10.1371/journal.pone.0176727	http://dx.doi.org/10.1371/journal.pone.0176727			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467501	gold, Green Submitted, Green Published			2022-12-26	WOS:000400647000070
J	Ian, E; Kirkerud, NH; Galizia, CG; Berg, BG				Ian, Elena; Kirkerud, Nicholas H.; Galizia, C. Giovanni; Berg, Bente G.			Coincidence of pheromone and plant odor leads to sensory plasticity in the heliothine olfactory system	PLOS ONE			English	Article							MOTH MANDUCA-SEXTA; ANTENNAL LOBE; RECEPTOR NEURONS; BOMBYX-MORI; REPRESENTATION; VIRESCENS; RESPONSES; BRAIN; DISCRIMINATION; DROSOPHILA	Male moths possess a highly specialized olfactory system comprised of two segregated sub-arrangements dedicated to processing information about plant odors and pheromones, respectively. Communication between these two sub-systems has been described at the peripheral level, but relatively little is known about putative interactions at subsequent synaptic relays. The male moth faces the challenge of seeking out the conspecific female in a highly dynamic odor world. The female-produced pheromone blend, which is a limited resource serving as guidance for the male, will reach his antennae in intermittent pockets of odor filaments mixed with volatiles from various plants. In the present study we performed calcium imaging for measuring odor-evoked responses in the uni-glomerular antennal-lobe projection neurons (analog to mitral cells in the vertebrate olfactory bulb) of Helicoverpa armigera. In order to investigate putative interactions between the two sub-systems tuned to plant volatiles and pheromones, respectively, we performed repeated stimulations with a selection of biologically relevant odors. We found that paired stimulation with a plant odor and the pheromone led to suppressed responses in both sub-systems as compared to those evoked during initial stimulation including application of each odor stimulus alone. The fact that the suppression persisted also after pairing, indicates the existence of a Hebbian-like plasticity in the primary olfactory center established by temporal pairing of the two odor stimulation categories.	[Ian, Elena; Kirkerud, Nicholas H.; Berg, Bente G.] Norwegian Univ Sci & Technol NTNU, Dept Psychol, Trondheim, Norway; [Kirkerud, Nicholas H.; Galizia, C. Giovanni] Univ Konstanz, Fachbereich Biol, Constance, Germany	Norwegian University of Science & Technology (NTNU); University of Konstanz	Berg, BG (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Psychol, Trondheim, Norway.	bente.berg@ntnu.no	; Galizia, C Giovanni/A-1771-2009	Berg, Bente Gunnveig/0000-0003-4035-9125; Kirkerud, Nicholas/0000-0002-8310-5523; Galizia, C Giovanni/0000-0001-8292-6031				Badeke E, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00143; Berg BG, 2009, CELL TISSUE RES, V335, P593, DOI 10.1007/s00441-008-0744-z; Berg BG, 1998, J COMP PHYSIOL A, V183, P669, DOI 10.1007/s003590050290; Biergans SD, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00082; Biergans SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039349; Chaffiol A, 2014, CHEM SENSES, V39, P451, DOI 10.1093/chemse/bju017; Deisig N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033159; Deng JY, 2004, J CHEM ECOL, V30, P2037, DOI 10.1023/B:JOEC.0000045593.62422.73; Dickens Joseph C., 1993, Chemoecology, V4, P175, DOI 10.1007/BF01256553; Galizia CG, 2014, EUR J NEUROSCI, V39, P1784, DOI 10.1111/ejn.12558; Galizia CG, 1999, NAT NEUROSCI, V2, P473, DOI 10.1038/8144; Galizia CG, 2000, J COMP PHYSIOL A, V186, P1049, DOI 10.1007/s003590000156; Hansson BS, 2000, ANNU REV ENTOMOL, V45, P203, DOI 10.1146/annurev.ento.45.1.203; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Hillier NK, 2011, CHEM SENSES, V36, P93, DOI 10.1093/chemse/bjq102; HOMBERG U, 1988, CELL TISSUE RES, V254, P255; HOSKINS SG, 1986, CELL TISSUE RES, V244, P243; Ian E, 2016, CELL TISSUE RES; Kanzaki R, 2003, CHEM SENSES, V28, P113, DOI 10.1093/chemse/28.2.113; Light Douglas M., 1993, Chemoecology, V4, P145, DOI 10.1007/BF01256549; Namiki S, 2008, J COMP PHYSIOL A, V194, P501, DOI 10.1007/s00359-008-0325-3; Ochieng SA, 2002, J COMP PHYSIOL A, V188, P325, DOI 10.1007/s00359-002-0308-8; Olsen SR, 2008, TRENDS NEUROSCI, V31, P512, DOI 10.1016/j.tins.2008.07.006; Pregitzer P, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00042; Reisenman CE, 2008, J NEUROPHYSIOL, V100, P554, DOI 10.1152/jn.90231.2008; Reisenman CE, 2011, J COMP PHYSIOL A, V197, P653, DOI 10.1007/s00359-011-0625-x; Riffell Jeffrey A, 2009, Proc Natl Acad Sci U S A, V106, P19219, DOI 10.1073/pnas.0910592106; Rostelien T, 2005, CHEM SENSES, V30, P443, DOI 10.1093/chemse/bji039; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; Sachse S, 1999, EUR J NEUROSCI, V11, P3970, DOI 10.1046/j.1460-9568.1999.00826.x; Schmidt-Busser D, 2009, J COMP PHYSIOL A, V195, P853, DOI 10.1007/s00359-009-0464-1; Seki Y, 2008, J COMP NEUROL, V506, P93, DOI 10.1002/cne.21528; Silbering AF, 2007, J NEUROSCI, V27, P11966, DOI 10.1523/JNEUROSCI.3099-07.2007; Silbering AF, 2008, J NEUROSCI, V28, P13075, DOI 10.1523/JNEUROSCI.2973-08.2008; Skiri HT, 2004, CHEM SENSES, V29, P253, DOI 10.1093/chemse/bjh026; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Trona F, 2010, J EXP BIOL, V213, P4291, DOI 10.1242/jeb.047365; Vickers NJ, 1998, J COMP NEUROL, V400, P35; Wilson DA, 2003, NEUROSCI BIOBEHAV R, V27, P307, DOI 10.1016/S0149-7634(03)00050-2; Wu H, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00206; Wu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070078; Zhao X-C, 2014, FRONTIERS SYSTEMS NE, P8	42	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0175513	10.1371/journal.pone.0175513	http://dx.doi.org/10.1371/journal.pone.0175513			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467500	Green Published, Green Submitted, gold			2022-12-26	WOS:000400647000015
J	Mao, K; Yang, YP; Wu, W; Liang, S; Deng, HR; Liu, JQ				Mao, Kai; Yang, Yaping; Wu, Wei; Liang, Shi; Deng, Heran; Liu, Jieqiong			Risk of second breast cancers after lobular carcinoma in situ according to hormone receptor status	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; BRCA1; WOMEN; PREVENTION; MANAGEMENT; TAMOXIFEN; DISEASE; PROFILE; MARKER; TUMOR	Background Although subsequent breast cancer risk after primary lobular carcinoma in situ (LCIS) has been studied intensively, whether the risk of second breast cancer after first LCIS varies with hormone receptor (HR) status of primary tumor remains unclear. Methods We identified 10,304 women with primary pure unilateral LCIS between 1998 and 2007 from the Surveillance, Epidemiology and End Results (SEER) 18 Registries. Kaplan-Meier estimates of 5 or 10-year probabilities of second ipsilateral breast cancers (IBCs) and contralateral breast cancers (CBCs) were calculated. Multivariable Cox proportional model was performed to identify impact of HR status of primary LCIS, and other demographic, clinicopathologic or treatment characteristics on risk of second IBCs or CBCs. Results Of the 10,304 women with primary LCIS included in this study, 9949 (96.5%) patients had HR+ tumors, and 355 (3.5%) had HR-tumors. Multivariable-adjusted analyses showed that although there was no difference in risk of total second IBCs between women with HR+ and HR-LCIS (P = 0.152), patients with HR+ LCIS had a statistically lower risk of second invasive IBCs compared to those with HR-LCIS (hazard ratio 0.356, 95% CI 0.141 -0.899, P = 0.029). Women with primary HR+ LCIS had lower risks of both second total and invasive CBCs compared to those with HR-LCIS (total CBCs: hazard ratio 0.340, 95% CI 0.228- 0.509, P<0.001; invasive CBCs: hazard ratio 0.172, 95% CI 0.108-0.274, P<0.001). Additionally, black women had a 2-fold risk of developing subsequent total IBCs than white women (P = 0.028). Conclusions This population-based study demonstrated that the risk of second breast cancers was significantly increased in women with HR-first LCIS compared to those with HR+ LCIS. These findings warrant intensive surveillance for second breast cancers in HR-LCIS survivors.	[Mao, Kai] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Gen Surg, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Guangdong, Peoples R China; [Yang, Yaping; Wu, Wei; Liang, Shi; Deng, Heran; Liu, Jieqiong] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Breast Tumor Ctr,Dept Breast Surg, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Liu, JQ (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Breast Tumor Ctr,Dept Breast Surg, Guangzhou, Guangdong, Peoples R China.	liujieqiong01@163.com		Liang, Shi/0000-0003-4307-4416	National Natural Science Foundation of China [81602673]; Key Laboratory of Malignant Tumor Molecular Mechanism [163]; Translational Medicine of Guangzhou Bureau of Science and Information Technology [KLB09001]; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Malignant Tumor Molecular Mechanism; Translational Medicine of Guangzhou Bureau of Science and Information Technology; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes	This study was supported by a grant from the National Natural Science Foundation of China (No. 81602673); grant [2013]163 from Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology; grant KLB09001 from the Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes. Data were from the Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 18 Regs Research Data, Nov 2015 submission.	Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chappuis PO, 2000, SEMIN SURG ONCOL, V18, P287, DOI 10.1002/(SICI)1098-2388(200006)18:4<287::AID-SSU3>3.3.CO;2-X; Chen YY, 2009, AM J SURG PATHOL, V33, P1683, DOI 10.1097/PAS.0b013e3181b18a89; Chuba PJ, 2005, J CLIN ONCOL, V23, P5534, DOI 10.1200/JCO.2005.04.038; Claus EB, 2003, BREAST, V12, P451, DOI 10.1016/S0960-9776(03)00152-8; Coradini D, 1998, EUR J CANCER, V34, P825, DOI 10.1016/S0959-8049(97)10121-6; Cutuli B, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0379-7; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Foote FW, 1941, AM J PATHOL, V17, P491; Franceschi S, 1998, INT J CANCER, V77, P392, DOI 10.1002/(SICI)1097-0215(19980729)77:3<392::AID-IJC14>3.0.CO;2-A; Haile RW, 2006, CANCER EPIDEM BIOMAR, V15, P1863, DOI 10.1158/1055-9965.EPI-06-0258; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, pE48, DOI 10.1043/1543-2165-134.7.e48; Innos K, 2008, BREAST CANCER RES TR, V111, P531, DOI 10.1007/s10549-007-9807-1; Kakarala M, 2008, J CLIN ONCOL, V26, P2813, DOI 10.1200/JCO.2008.16.3931; King TA, 2015, J CLIN ONCOL, V33, P3945, DOI 10.1200/JCO.2015.61.4743; Kurian AW, 2009, JNCI-J NATL CANCER I, V101, P1058, DOI 10.1093/jnci/djp181; Lakhani SR, 2002, J CLIN ONCOL, V20, P2310, DOI 10.1200/JCO.2002.09.023; Li CI, 2006, CANCER-AM CANCER SOC, V106, P2104, DOI 10.1002/cncr.21864; Li CI, 2002, BREAST CANCER RES TR, V75, P259, DOI 10.1023/A:1019950918046; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Liu Y, 2014, BREAST CANCER RES TR, V148, P163, DOI 10.1007/s10549-014-3151-z; Mohsin SK, 2005, BREAST CANCER RES TR, V90, P249, DOI 10.1007/s10549-004-4493-8; Obeng-Gyasi S, 2016, CHIN CLIN ONCOL, V5, DOI 10.21037/cco.2016.04.02; PAGE DL, 1985, CANCER, V55, P2698, DOI 10.1002/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A; PAGE DL, 1991, HUM PATHOL, V22, P1232, DOI 10.1016/0046-8177(91)90105-X; Portschy PR, 2013, ANN SURG ONCOL, V20, P3240, DOI 10.1245/s10434-013-3121-4; Swain SM, 2004, J NATL CANCER I, V96, P516, DOI 10.1093/jnci/djh097; Vincent-Salomon A, 2012, BREAST, V21, P380, DOI 10.1016/j.breast.2012.03.005; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074	29	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176417	10.1371/journal.pone.0176417	http://dx.doi.org/10.1371/journal.pone.0176417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467490	Green Published, gold, Green Submitted			2022-12-26	WOS:000400647000051
J	Sato, Y; Tanino, Y; Wang, XT; Nikaido, T; Sato, S; Misa, K; Togawa, R; Frevert, CW; Munakata, M				Sato, Yuki; Tanino, Yoshinori; Wang, Xintao; Nikaido, Takefumi; Sato, Suguru; Misa, Kenichi; Togawa, Ryuichi; Frevert, Charles W.; Munakata, Mitsuru			Baseline serum syndecan-4 predicts prognosis after the onset of acute exacerbation of idiopathic interstitial pneumonia	PLOS ONE			English	Article							ACUTE LUNG INJURY; PULMONARY-FIBROSIS; RISK-FACTORS; BIOMARKER; LIPOPOLYSACCHARIDE; CLASSIFICATION; INFLAMMATION; OSTEOPONTIN; GUIDELINES; FEATURES	Background Patients with idiopathic interstitial pneumonia can experience acute respiratory worsening, also known as acute exacerbation, with a large deterioration on prognosis. The precise mechanism remains unclear; however, syndecan-4 may be involved. Syndecan-4, a transmembrane heparan sulfate proteoglycan expressed in a variety of cells (e.g., epithelial cells, macrophages, fibroblasts, etc.), performs various biological roles by binding to several proteins through its heparan sulfate glycosaminoglycan side chains. The goal of this study was to clarify the role of syndecan-4 in acute exacerbation of idiopathic interstitial pneumonia. Methods Patients with idiopathic interstitial pneumonia who had been sequentially admitted to our hospital due to acute exacerbation were retrospectively analyzed. First, serum syndecan-4 levels in the acute exacerbation and clinically stable phases were compared. Second, the relationship between serum syndecan-4 levels and clinical parameters was analyzed. Third, the relationship between serum syndecan-4 levels and prognosis was evaluated. Results Serum syndecan-4 levels were significantly lower in patients with acute exacerbation of idiopathic interstitial pneumonia than in patients in the clinically stable phase. Serum syndecan-4 levels also showed a significant positive correlation with white blood cell count and a weak positive tendency with KL-6 and baseline %VC. Prognosis was significantly worse in patients with idiopathic interstitial pneumonia with high baseline serum syndecan-4 levels than with low baseline levels. Multiple logistic analysis indicated baseline serum syndecan-4 level as the only prognostic predictor following acute exacerbation. Conclusions Baseline serum syndecan-4 is a possible prognostic biomarker after the onset of acute exacerbation of idiopathic interstitial pneumonia.	[Sato, Yuki; Tanino, Yoshinori; Wang, Xintao; Nikaido, Takefumi; Sato, Suguru; Misa, Kenichi; Togawa, Ryuichi; Munakata, Mitsuru] Fukushima Med Univ, Sch Med, Dept Pulm Med, Fukushima, Fukushima, Japan; [Frevert, Charles W.] Univ Washington, Dept Comparat Med, Div Pulm Crit Care Med, Seattle, WA 98195 USA; [Frevert, Charles W.] Univ Washington, Dept Comparat Med, Comparat Pathol Program, Seattle, WA 98195 USA; [Frevert, Charles W.] Univ Washington, Ctr Lung Biol, Seattle, WA 98195 USA	Fukushima Medical University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Tanino, Y (corresponding author), Fukushima Med Univ, Sch Med, Dept Pulm Med, Fukushima, Fukushima, Japan.	ytanino@fmu.ac.jp	TANINO, YOSHINORI/AAF-8773-2019	Sato, Yuki/0000-0002-8986-8388; Tanino, Yoshinori/0000-0003-2384-601X				Akira M, 1997, AM J ROENTGENOL, V168, P79, DOI 10.2214/ajr.168.1.8976924; Akira M, 2008, AM J RESP CRIT CARE, V178, P372, DOI 10.1164/rccm.200709-1365OC; Ambrosini V, 2003, EUR RESPIR J, V22, P821, DOI 10.1183/09031936.03.00022703; Antoniou KM, 2013, RESPIRATION, V86, P265, DOI 10.1159/000355485; Bensadoun ES, 1996, AM J RESP CRIT CARE, V154, P1819, DOI 10.1164/ajrccm.154.6.8970376; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Churg A, 2007, AM J SURG PATHOL, V31, P277, DOI 10.1097/01.pas.0000213341.70852.9d; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Collard HR, 2016, AM J RESP CRIT CARE, V194, P265, DOI 10.1164/rccm.201604-0801CI; Collard HR, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-73; Collard HR, 2010, AM J PHYSIOL-LUNG C, V299, pL3, DOI 10.1152/ajplung.90637.2008; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Fujimoto K, 2012, EUR RADIOL, V22, P83, DOI 10.1007/s00330-011-2211-6; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; Guiot J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171344; Inokoshi Y, 2013, RESPIROLOGY, V18, P1236, DOI 10.1111/resp.12144; Ishiguro K, 2001, J BIOL CHEM, V276, P47483, DOI 10.1074/jbc.M106268200; Jenkins RG, 2015, LANCET RESP MED, V3, P462, DOI 10.1016/S2213-2600(15)00048-X; Jiang DH, 2010, J CLIN INVEST, V120, P2049, DOI 10.1172/JCI38644; Johannson KA, 2014, EUR RESPIR J, V43, P1124, DOI 10.1183/09031936.00122213; Kim DS, 2006, EUR RESPIR J, V27, P143, DOI 10.1183/09031936.06.00114004; Kishaba T, 2014, LUNG, V192, P141, DOI 10.1007/s00408-013-9530-0; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kon S, 2008, J EXP MED, V205, P25, DOI 10.1084/jem.20071324; KONDO A, 1989, INTERSTITIAL PNEUMON, P33; Kondoh Y, 2005, EUR RESPIR J, V25, P528, DOI 10.1183/09031936.05.00071004; Kondoh Y, 2010, SARCOIDOSIS VASC DIF, V27, P103; KONDOH Y, 1993, CHEST, V103, P1808, DOI 10.1378/chest.103.6.1808; Kondoh Y, 2015, RESPIR INVESTIG, V53, P271, DOI 10.1016/j.resinv.2015.04.005; Kubo H, 2005, CHEST, V128, P1475, DOI 10.1378/chest.128.3.1475; Kurosu K, 2008, J IMMUNOL, V181, P756, DOI 10.4049/jimmunol.181.1.756; Ley B, 2011, AM J RESP CRIT CARE, V37, P356; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Manon-Jensen T, 2010, FEBS J, V277, P3876, DOI 10.1111/j.1742-4658.2010.07798.x; Nagata K, 2013, RESPIROLOGY, V18, P439, DOI 10.1111/resp.12018; Natsuizaka M, 2014, AM J RESP CRIT CARE, V190, P773, DOI 10.1164/rccm.201403-0566OC; Nikaido T, 2015, J INFECT DIS, V212, P1500, DOI 10.1093/infdis/jiv234; Papiris SA, 2014, EXPERT REV RESP MED, V8, P271, DOI 10.1586/17476348.2014.896206; Parambil JG, 2005, CHEST, V128, P3310, DOI 10.1378/chest.128.5.3310; Park IN, 2007, CHEST, V132, P214, DOI 10.1378/chest.07-0323; Pruessmeyer J, 2010, J BIOL CHEM, V285, P555, DOI 10.1074/jbc.M109.059394; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rapraeger AC, 2000, J CELL BIOL, V149, P995, DOI 10.1083/jcb.149.5.995; Rice AJ, 2003, AM J CLIN PATHOL, V119, P709, DOI 10.1309/UVARMDY8FE9FJDKU; Richeldi L, 2015, ANN AM THORAC SOC, V12, pS181, DOI 10.1513/AnnalsATS.201504-210AW; Ryerson CJ, 2015, EUR RESPIR J, V46, P512, DOI 10.1183/13993003.00419-2015; Santoso A, 2016, MOL THER, V24, P41, DOI 10.1038/mt.2015.153; Schmidt EP, 2016, AM J RESP CRIT CARE, V194, P439, DOI 10.1164/rccm.201511-2281OC; Schupp JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116775; Song JW, 2011, EUR RESPIR J, V37, P356, DOI 10.1183/09031936.00159709; Tanino Y, 2012, AM J RESP CELL MOL, V47, P196, DOI 10.1165/rcmb.2011-0294OC; Tiitto L, 2006, THORAX, V61, P1091, DOI 10.1136/thx.2005.055814; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Usui Y, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002971; Vuga LJ, 2014, AM J RESP CRIT CARE, V189, P966, DOI 10.1164/rccm.201309-1592OC; White ES, 2016, AM J RESP CRIT CARE, V194, P1242, DOI 10.1164/rccm.201505-0862OC	56	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176789	10.1371/journal.pone.0176789	http://dx.doi.org/10.1371/journal.pone.0176789			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467516	Green Submitted, Green Published, gold			2022-12-26	WOS:000400647000075
J	Bayha, KM; Ortell, N; Ryan, CN; Griffitt, KJ; Krasnec, M; Sena, J; Ramaraj, T; Takeshita, R; Mayer, GD; Schilkey, F; Griffitt, RJ				Bayha, Keith M.; Ortell, Natalie; Ryan, Caitlin N.; Griffitt, Kimberly J.; Krasnec, Michelle; Sena, Johnny; Ramaraj, Thiruvarangan; Takeshita, Ryan; Mayer, Gregory D.; Schilkey, Faye; Griffitt, Robert J.			Crude oil impairs immune function and increases susceptibility to pathogenic bacteria in southern flounder	PLOS ONE			English	Article							WATER-HORIZON OIL; POLYCYCLIC AROMATIC-HYDROCARBONS; MEDAKA ORYZIAS-LATIPES; GULF-OF-MEXICO; JAPANESE FLOUNDER; DEGRADING BACTERIA; GENE-EXPRESSION; RAINBOW-TROUT; FISH DISEASES; DISPERSED OIL	Exposure to crude oil or its individual constituents can have detrimental impacts on fish species, including impairment of the immune response. Increased observations of skin lesions in northern Gulf of Mexico fish during the 2010 Deepwater Horizon oil spill indicated the possibility of oil-induced immunocompromisation resulting in bacterial or viral infection. This study used a full factorial design of oil exposure and bacterial challenge to examine how oil exposure impairs southern flounder (Paralichthys lethostigma) immune function and increases susceptibility to the bacteria Vibrio anguillarum, a causative agent of vibriosis. Fish exposed to oil prior to bacterial challenge exhibited 94.4% mortality within 48 hours of bacterial exposure. Flounder challenged with V. anguillarum without prior oil exposure had <10% mortality. Exposure resulted in taxonomically distinct gill and intestine bacterial communities. Mortality strongly correlated with V. anguillarum levels, where it comprised a significantly higher percentage of the microbiome in Oil/Pathogen challenged fish and was nearly non-existent in the No Oil/Pathogen challenged fish bacterial community. Elevated V. anguillarum levels were a direct result of oil exposure-induced immunosuppression. Oil-exposure reduced expression of immunoglobulin M, the major systemic fish antibody, and resulted in an overall downregulation in transcriptome response, particularly in genes related to immune function, response to stimulus and hemostasis. Ultimately, sediment-borne oil exposure impairs immune function, leading to increased incidences of bacterial infections. This type of sediment-borne exposure may result in long-term marine ecosystem effects, as oil-bound sediment in the northern Gulf of Mexico will likely remain a contamination source for years to come.	[Bayha, Keith M.; Ortell, Natalie; Griffitt, Kimberly J.; Griffitt, Robert J.] Univ Southern Mississippi, Sch Ocean Sci & Technol, Gulf Coast Res Lab, Ocean Springs, MS 39564 USA; [Ryan, Caitlin N.; Mayer, Gregory D.] Texas Tech Univ, Dept Environm Toxicol, Lubbock, TX 79409 USA; [Krasnec, Michelle; Takeshita, Ryan] Abt Associates Inc, Suite 201, Boulder, CO USA; [Sena, Johnny; Ramaraj, Thiruvarangan; Schilkey, Faye] Natl Ctr Genome Resources, 2935 Rodeo Pk Dr E, Santa Fe, NM USA; [Bayha, Keith M.] Smithsonian Inst, Natl Museum Nat Hist, Dept Invertebrate Zool, Constitution Ave NW, Washington, DC 20560 USA; [Ortell, Natalie] Alabama Sch Math & Sci, Mobile, AL USA	University of Southern Mississippi; Texas Tech University System; Texas Tech University; ABT Associates; National Center for Genome Resources (NCGR); Smithsonian Institution; Smithsonian National Museum of Natural History	Griffitt, RJ (corresponding author), Univ Southern Mississippi, Sch Ocean Sci & Technol, Gulf Coast Res Lab, Ocean Springs, MS 39564 USA.	joe.griffitt@usm.edu	Mayer, Gregory/N-1401-2019	Mayer, Gregory/0000-0002-2652-9856; Ramaraj, Thiruvarangan/0000-0002-7333-1041	State of Louisiana through Stratus Consulting as part of the Deepwater Horizon Natural Resource Damage Assessment [S161-1814]; State of Louisiana as part of the Deepwater Horizon Natural Resource Damage Assessment awarded [S161-1814]	State of Louisiana through Stratus Consulting as part of the Deepwater Horizon Natural Resource Damage Assessment; State of Louisiana as part of the Deepwater Horizon Natural Resource Damage Assessment awarded	All funding for this study was provided by the State of Louisiana through Stratus Consulting (master contract S161-1814) as part of the Deepwater Horizon Natural Resource Damage Assessment to the University of Southern Mississippi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Michelle Krasnec and Ryan Takeshita are employees of Stratus Consulting (now Abt Associates). Stratus Consulting (now Abt Associates) provided support in the form of salaries for authors MK and RT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The authors wish to thank D Simning, J Johnson and B Baily from the Tox Lab at GCRL for technical assistance with fish culture, data collection and sampling during experimentation, and data entry and organization. All funding for this study was provided by the State of Louisiana as part of the Deepwater Horizon Natural Resource Damage Assessment awarded to the University of Southern Mississippi (master contract number S161-1814).	Alkindi AYA, 1996, J FISH BIOL, V49, P1291; Almeda R, 2014, ECOTOXICOLOGY, V23, P988, DOI 10.1007/s10646-014-1242-6; Almeda R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074476; Anderson JA, 2014, B ENVIRON CONTAM TOX, V92, P375, DOI 10.1007/s00128-014-1216-7; Andrews S., 2010, REF SOURCE; Arkoosh MR, 1998, J AQUAT ANIM HEALTH, V10, P182, DOI 10.1577/1548-8667(1998)010&lt;0182:EOPOFD&gt;2.0.CO;2; Atlas RM, 2011, ENVIRON SCI TECHNOL, V45, P6709, DOI 10.1021/es2013227; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bilbao E, 2010, AQUAT TOXICOL, V98, P282, DOI 10.1016/j.aquatox.2010.02.018; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bravo CF, 2005, ASSESSING MECH IMMUN; Brewton RA, 2013, J TOXICOL ENV HEAL A, V76, P1198, DOI 10.1080/15287394.2013.848394; Brown-Peterson NJ, 2015, AQUAT TOXICOL, V165, P197, DOI 10.1016/j.aquatox.2015.06.001; Brown-Peterson NJ, 2016, ENV TOXICOL CHEM; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carlson EA, 2004, MAR ENVIRON RES, V58, P731, DOI 10.1016/j.marenvres.2004.03.023; Carlson EA, 2004, TOXICOL APPL PHARM, V201, P40, DOI 10.1016/j.taap.2004.04.018; Carlson EA, 2002, AQUAT TOXICOL, V56, P289, DOI 10.1016/S0166-445X(01)00223-5; Castro R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003098; CRIDER JY, 1982, B ENVIRON CONTAM TOX, V28, P52, DOI 10.1007/BF01608412; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Danilova N, 2005, NAT IMMUNOL, V6, P295, DOI 10.1038/ni1166; Diercks AR, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045046; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dussauze M, 2015, ECOTOX ENVIRON SAFE, V120, P215, DOI 10.1016/j.ecoenv.2015.05.018; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; FAISAL M, 1993, MAR ENVIRON RES, V35, P121, DOI 10.1016/0141-1136(93)90024-T; Fodrie FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021609; Force F., 2000, FLOUNDER FISHERY GUL; Frans I, 2011, J FISH DIS, V34, P643, DOI 10.1111/j.1365-2761.2011.01279.x; Graham WM, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/4/045301; Gutierrez T, 2013, ISME J, V7, P2091, DOI 10.1038/ismej.2013.98; LeBlanc JG, 2013, CURR OPIN BIOTECH, V24, P160, DOI 10.1016/j.copbio.2012.08.005; Hansen JD, 2005, P NATL ACAD SCI USA, V102, P6919, DOI 10.1073/pnas.0500027102; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Head IM, 2006, NAT REV MICROBIOL, V4, P173, DOI 10.1038/nrmicro1348; HOOD MA, 1987, MICROBIAL ECOL, V14, P113, DOI 10.1007/BF02013017; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hur D, 2013, COMP BIOCHEM PHYS B, V165, P49, DOI 10.1016/j.cbpb.2013.03.001; Kasai Y, 2002, ENVIRON MICROBIOL, V4, P141, DOI 10.1046/j.1462-2920.2002.00275.x; Khan RA, 2003, ARCH ENVIRON CON TOX, V44, P485, DOI 10.1007/s00244-002-2063-9; Kostka JE, 2011, APPL ENVIRON MICROB, V77, P7962, DOI 10.1128/AEM.05402-11; Krasnov A, 2005, AQUAT TOXICOL, V74, P70, DOI 10.1016/j.aquatox.2005.04.009; Kuo Dave T.F., 2020, ENVIRON TOXICOL CHEM, V40, P57, DOI [10.1002/etc.4898, DOI 10.1002/ETC.245, DOI 10.1002/ETC.4898]; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Laramore S, 2014, J SHELLFISH RES, V33, P709, DOI 10.2983/035.033.0305; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu ZF, 2013, MICROBIOLOGYOPEN, V2, P492, DOI 10.1002/mbo3.89; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Mason OU, 2012, ISME J, V6, P1715, DOI 10.1038/ismej.2012.59; McCrea-Strub A, 2011, FISHERIES, V36, P332, DOI 10.1080/03632415.2011.589334; McCrea-Strub A, 2010, OCEAN COAST LAW J, V16; McGenity TJ, 2014, CURR OPIN BIOTECH, V27, P46, DOI 10.1016/j.copbio.2013.10.010; McNutt MK, 2012, P NATL ACAD SCI USA, V109, P20260, DOI 10.1073/pnas.1112139108; Michel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065087; Moody RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058376; Mos L, 2008, ENVIRON SCI TECHNOL, V42, P2656, DOI 10.1021/es702215c; Murawski SA, 2014, T AM FISH SOC; Nakayama K, 2008, MAR POLLUT BULL, V57, P445, DOI 10.1016/j.marpolbul.2008.02.021; Nayak SK, 2010, AQUAC RES, V41, P1553, DOI 10.1111/j.1365-2109.2010.02546.x; Ning Leng, 2013, BIOINFORMATICS, V29; Ortmann AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042548; Passow U, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035301; Perez T., 2010, MUCOSAL IMMUNOL; Prietl B, 2013, NUTRIENTS, V5, P2502, DOI 10.3390/nu5072502; Ray K, 2012, NAT REV GASTRO HEPAT, V9, P555, DOI [10.1038/nrgastro.2012.172, 10.1038/nrgastro.2012.165]; Reynaud S, 2006, AQUAT TOXICOL, V77, P229, DOI 10.1016/j.aquatox.2005.10.018; Rhee KJ, 2004, J IMMUNOL, V172, P1118, DOI 10.4049/jimmunol.172.2.1118; Rozas LP, 2014, ESTUAR COAST, V37, P1403, DOI 10.1007/s12237-013-9766-1; Sarasquete C, 2000, SCI TOTAL ENVIRON, V247, P313, DOI 10.1016/S0048-9697(99)00500-8; Schwacke LH, 2014, ENVIRON SCI TECHNOL, V48, P93, DOI 10.1021/es403610f; Sekirov I, 2009, J PHYSIOL-LONDON, V587, P4159, DOI 10.1113/jphysiol.2009.172742; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shapiro H, 2014, CURR OPIN IMMUNOL, V30, P54, DOI 10.1016/j.coi.2014.07.003; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Song JY, 2008, MAR POLLUT BULL, V57, P889, DOI 10.1016/j.marpolbul.2008.01.024; Song JY, 2012, ENVIRON TOXICOL CHEM, V31, P828, DOI 10.1002/etc.1743; Song JY, 2011, MAR POLLUT BULL, V63, P362, DOI 10.1016/j.marpolbul.2011.01.020; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; SUGITA H, 1991, AQUACULTURE, V92, P267, DOI 10.1016/0044-8486(91)90028-6; Sumaila UR, 2012, CAN J FISH AQUAT SCI, V69, P499, DOI [10.1139/F2011-171, 10.1139/f2011-171]; Sunyer JO, 2013, NAT IMMUNOL, V14, P320, DOI 10.1038/ni.2549; Tao Z., 2013, VIBRIOS ASS MARINE S; Toranzo AE, 2005, AQUACULTURE, V246, P37, DOI 10.1016/j.aquaculture.2005.01.002; Umesaki Y, 2000, MICROBES INFECT, V2, P1343, DOI 10.1016/S1286-4579(00)01288-0; Valledor AF, 1998, J LEUKOCYTE BIOL, V63, P405, DOI 10.1002/jlb.63.4.405; Warr GW., 1997, DEV COMP IMMUNOL, V2, P157; White HK, 2012, P NATL ACAD SCI USA, V109, P20303, DOI 10.1073/pnas.1118029109; Whitehead A, 2012, P NATL ACAD SCI USA, V109, P20298, DOI 10.1073/pnas.1109545108; Yednock BK, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1739-2; YOUSSOUFIAN H, 1993, BLOOD, V81, P2223; Zhu L, 2016, MAR POLLUT BULL, V106, P283, DOI 10.1016/j.marpolbul.2015.12.022	96	28	29	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2017	12	5							e0176559	10.1371/journal.pone.0176559	http://dx.doi.org/10.1371/journal.pone.0176559			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RV	28464028	Green Submitted, Green Published, gold			2022-12-26	WOS:000400646300033
J	Ashaba, S; Kaida, A; Coleman, JN; Burns, BF; Dunkley, E; O'Neil, K; Kastner, J; Sanyu, N; Akatukwasa, C; Bangsberg, DR; Matthews, LT; Psaros, C				Ashaba, Scholastic; Kaida, Angela; Coleman, Jessica N.; Burns, Bridget F.; Dunkley, Emma; O'Neil, Kasey; Kastner, Jasmine; Sanyu, Naomi; Akatukwasa, Cecilia; Bangsberg, David R.; Matthews, Lynn T.; Psaros, Christina			Psychosocial challenges facing women living with HIV during the perinatal period in rural Uganda	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; INTIMATE PARTNER VIOLENCE; QUALITY-OF-LIFE; ANTIRETROVIRAL THERAPY; PREGNANT-WOMEN; SOCIAL SUPPORT; DEVELOPING-COUNTRIES; DEPRESSIVE SYMPTOMS; ANTENATAL CLINICS; HEALTH-SERVICES	The complexities of navigating pregnancy while living with HIV predispose women to additional stress. Finding ways to minimize psychosocial challenges during the perinatal period may maximize the well-being of mothers living with HIV and their children. The goal of this study was to explore psychosocial challenges experienced by women living with HIV (WLWH) during pregnancy and the postpartum. larger structural environment including partners, family and community member as well as policy makers, funders and program implementers to work together for the common cause. These consolidated efforts may not only lower the risk of psychological distress but has potential to create long lasting solutions to benefit the wider community.We conducted individual in-depth interviews with 20 WLWH recruited from an HIV treatment cohort study in Mbarara, Uganda as part of a larger study exploring perinatal depression. We conducted content analyses to identify themes related to challenges of WLWH during pregnancy and the postpartum. Participants had a median age of 33 years [IQR: 28- 35], a median of 3 living children [IQR: 2-5], and 95% had achieved HIV-RNA suppression. Challenges were organized around the following themes: HIV-related stigma from health professionals, HIV status disclosure dilemma, unintended pregnancy and intimate partner violence, HIV and environmental structural barriers and distress and fear related to maternal and child health. Stigma centered on discrimination by health care professionals and personal shame associated with being pregnant as a WLWH. This led to difficulty engaging in HIV care, particularly when coupled with structural barriers, such as lack of transportation to clinic. Participants experienced intimate partner violence and lacked support from their partners and family members. Distress and fear about the health and uncertainty about the future of the unborn baby due to maternal deteriorating physical health was common. The perinatal period is a time of stress for WLWH. Challenges experienced by WLWH may compromise successful engagement in HIV care and may reduce quality of life for women and their children. Strategies aimed at alleviating the challenges of WLWH should involve the larger structural environment including partners, family and community member as well as policy makers, funders and program implementers to work together for the common cause. These consolidated efforts may not only lower the risk of psychological distress but has potential to create long lasting solutions to benefit the wider community.	[Ashaba, Scholastic; Sanyu, Naomi; Akatukwasa, Cecilia] Mbarara Univ Sci & Technol, Dept Psychiat, Mbarara, Uganda; [Kaida, Angela; Dunkley, Emma] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada; [Coleman, Jessica N.; Psaros, Christina] Massachusetts Gen Hosp, Dept Psychiat, Behav Med Program, Boston, MA 02114 USA; [Burns, Bridget F.; O'Neil, Kasey; Matthews, Lynn T.] Massachusetts Gen Hosp, Div Global Hlth, Boston, MA USA; [Kastner, Jasmine] McGill Univ, Res Inst, Hlth Ctr, Montreal, PQ, Canada; [Bangsberg, David R.] Portland State Univ, Oregon Hlth Sci Univ, Sch Publ Hlth, Portland, OR 97207 USA; [Matthews, Lynn T.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Psaros, Christina] Harvard Med Sch, Boston, MA USA	Mbarara University of Science & Technology; Simon Fraser University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; McGill University; Oregon Health & Science University; Portland State University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ashaba, S (corresponding author), Mbarara Univ Sci & Technol, Dept Psychiat, Mbarara, Uganda.	sashaba@must.ac.ug		Coleman, Jessica/0000-0002-4808-1036	National institutes of health [R21HD069194 PI AK, K23MH095655 PI LTM, R01MH054907 PI DRB, P30AI027763, U01CA066529, K24MH87227 PI DRB, K23MH099916 PI CP, R01MH087328 PI DRB, D43TW010128]; Sullivan Family Foundation; FOGARTY INTERNATIONAL CENTER [D43TW010128] Funding Source: NIH RePORTER	National institutes of health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sullivan Family Foundation; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The study was funded by National institutes of health R21HD069194 PI AK, K23MH095655 PI LTM, R01MH054907 PI DRB, P30AI027763, U01CA066529, K24MH87227 PI DRB, K23MH099916 PI CP, R01MH087328 PI DRB; D43TW010128; and the Sullivan Family Foundation. The authors acknowledge U.S salary support through National Institute of Health D43TW010128 (SA).The funders have no role in the study design, data collection and analysis, decision to publish, or preparationof the manuscript.; The authors acknowledge U.S salary support through National Institute of Health D43TW010128 (SA).	Africa IE, 2014, UND PERSP EXP WOM LI; Africa IE, 2013, UND PERSP EXP WOM LI; Aggleton P., 2001, CURR SOCIOL, V49, P23, DOI [DOI 10.1177/0011392101496005, 10.1177/0011392101496005]; [Anonymous], 2014, GLOB UPD HLTH SECT R; Antelman G, 2007, JAIDS-J ACQ IMM DEF, V44, P470, DOI 10.1097/QAI.0b013e31802f1318; Ashton E, 2005, AIDS PATIENT CARE ST, V19, P587, DOI 10.1089/apc.2005.19.587; Beauliere A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011213; Bernstein M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011999; Bolton P, 2001, J NERV MENT DIS, V189, P238, DOI 10.1097/00005053-200104000-00005; Brou H, 2007, PLOS MED, V4, P1912, DOI 10.1371/journal.pmed.0040342; Bwirire LD, 2008, T ROY SOC TROP MED H, V102, P1195, DOI 10.1016/j.trstmh.2008.04.002; Campbell C, 2010, AIDS CARE, V22, P1569, DOI 10.1080/09540121.2010.525812; Campbell JC, 2008, INT J INJ CONTROL SA, V15, P221, DOI 10.1080/17457300802423224; Chi BH, 2012, JAIDS-J ACQ IMM DEF, V60, pS78, DOI 10.1097/QAI.0b013e31825f3284; Chinkonde JR, 2009, REPROD HEALTH MATTER, V17, P143, DOI 10.1016/S0968-8080(09)33440-0; Clouse K, 2014, JAIDS-J ACQ IMM DEF, V67, pE12, DOI 10.1097/QAI.0000000000000263; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Desgrees-du-Lou A, 2009, SOC SCI MED, V69, P892, DOI 10.1016/j.socscimed.2009.05.045; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Eyal Nir, 2015, 10 INT C HIV TREATM; Ezechi OC, 2009, ARCH GYNECOL OBSTET, V280, P745, DOI 10.1007/s00404-009-0956-9; Gielen AC, 2001, SOC SCI MED, V52, P315, DOI 10.1016/S0277-9536(00)00135-0; Gillespie S, 2007, AIDS, V21, pS5, DOI 10.1097/01.aids.0000300531.74730.72; HIV/AIDS JUNPo, 2014, THE GAP REP; HIV/AIDS JUNPo, 2015, THE GAP REP; Homsy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004149; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Kaida A, 1999, J ACQUIRED IMMUNE S4, V67, pS179; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Kiarie JN, 2006, AIDS, V20, P1763, DOI 10.1097/01.aids.0000242823.51754.0c; Kim J, 2008, AIDS, V22, pS57, DOI 10.1097/01.aids.0000341777.78876.40; King R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-530; Kiula ES, 2013, BMC PUBLIC HEALTH, V13, P1; Koricho AT, 2010, INT BREASTFEED J, V5, DOI 10.1186/1746-4358-5-12; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Levy NC, 2005, J URBAN HEALTH, V82, P498, DOI 10.1093/jurban/jti090; Lwanda J., 2002, POLITICS CULTURE MED; Maman S, 2002, AM J PUBLIC HEALTH, V92, P1331, DOI 10.2105/AJPH.92.8.1331; Martinez P, 2008, AIDS BEHAV, V12, P605, DOI 10.1007/s10461-007-9312-x; Matheson R, 2015, J INT AIDS SOC S5, V18; Matseke G, 2016, J PSYCHOL AFR, V26, P259, DOI 10.1080/14330237.2016.1185912; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; Medley AM, 2009, QUAL HEALTH RES, V19, P1744, DOI 10.1177/1049732309353417; Mellins CA, 2008, AIDS CARE, V20, P958, DOI 10.1080/09540120701767208; Miles M.B., 1994, ANAL DONNEES QUALITA, V2nd; MOH ICF, 2012, UG AIDS IND SURV 201; Okello ES, 2012, AJAR-AFR J AIDS RES, V11, P37, DOI 10.2989/16085906.2012.671260; Pereira M, 2012, SPAN J PSYCHOL, V15, P1303, DOI 10.5209/rev_SJOP.2012.v15.n3.39416; Pettifor AE, 2004, EMERG INFECT DIS, V10, P1996, DOI 10.3201/eid1011.040252; Piot P, 2007, PLOS MED, V4, P1571, DOI 10.1371/journal.pmed.0040314; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Programme' SAC, 2010, STAT HIV AIDS EP UG; Quinn TC, 2005, SCIENCE, V308, P1582, DOI 10.1126/science.1112489; Rahangdale L, 2010, AIDS CARE, V22, P836, DOI 10.1080/09540120903499212; Ramasundaram S., 2001, AIDS PATIENT CARE ST, V15, P255; Rotheram-Borus MJ, 2015, AIDS, V29, P2361, DOI 10.1097/QAD.0000000000000837; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; Sanders LB, 2008, J ASSOC NURSE AIDS C, V19, P47, DOI 10.1016/j.jana.2007.10.002; Shamu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109447; Shannon M, 2008, J ASSOC NURSE AIDS C, V19, P114, DOI 10.1016/j.jana.2007.10.004; Shannon MT, 2015, RES NURS HEALTH, V38, P142, DOI 10.1002/nur.21646; Spangler SA, 2014, JAIDS-J ACQ IMM DEF, V67, pS235, DOI 10.1097/QAI.0000000000000376; Stinson K, 2012, AJAR-AFR J AIDS RES, V11, P65, DOI 10.2989/16085906.2012.671263; Strauss A., 1998, BASICS QUALITATIVE R; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; Tsai AC, 2016, SOC SCI MED, V151, P69, DOI 10.1016/j.socscimed.2015.12.042; Tsai AC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001943; Tsai AC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001557; Tsai AC, 2013, ANN BEHAV MED, V46, P285, DOI 10.1007/s12160-013-9514-6; Tsai AC, 2012, SOC SCI MED, V74, P2012, DOI 10.1016/j.socscimed.2012.02.033; Turan B, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0400-4; Turan JM, 2013, AIDS BEHAV, V17, P2528, DOI 10.1007/s10461-013-0446-8; Turan JM, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001295; Turan JM, 2011, AIDS BEHAV, V15, P1111, DOI 10.1007/s10461-010-9798-5; Turmen T, 2003, INT J GYNECOL OBSTET, V82, P411, DOI 10.1016/S0020-7292(03)00202-9; UBOS, 2014, POP REG REP UG ALL C; Uganda AIDS Indicator Survey (UAIS), 2014, UG HIV AIDS COUNTR P; UNAIDS, 1998, GEND HIVYAIDS UNAIDS; van den Borne F., 2003, SERIES HIV AIDS SUBS, V13; Visser MJ, 2008, AIDS CARE, V20, P1138, DOI 10.1080/09540120701842779; Vu L, 2012, AIDS BEHAV, V16, P132, DOI 10.1007/s10461-010-9873-y; Vyavaharkar M, 2010, J ASSOC NURSE AIDS C, V21, P144, DOI 10.1016/j.jana.2009.07.008; Watson-Jones D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040091; Winestone LE, 2012, GLOB PUBLIC HEALTH, V7, P149, DOI 10.1080/17441692.2011.621964; Wolfe WR, 2008, AM J PUBLIC HEALTH, V98, P1865, DOI 10.2105/AJPH.2007.122044; World Health Organization, 2009, PMTCT STRAT VIS 2010; World Health Organization, 2010, PMTCT STRAT VIS 2010; World Health Organization, 2014, MARCH 2014 2013 CO S; World Vision, 2017, INT LIV ASS TARG REF; Zunner B, 2015, J AFFECT DISORDERS, V174, P619, DOI 10.1016/j.jad.2014.12.017	91	49	51	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176256	10.1371/journal.pone.0176256	http://dx.doi.org/10.1371/journal.pone.0176256			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9RJ	28459866	Green Submitted, Green Published, gold			2022-12-26	WOS:000400645000026
J	Bendtsen, KM; Hansen, CHF; Krych, L; Skovgaard, K; Kot, W; Vogensen, FK; Hansen, AK				Bendtsen, Katja Maria; Hansen, Camilla Hartmann Friis; Krych, Lukasz; Skovgaard, Kerstin; Kot, Witold; Vogensen, Finn Kvist; Hansen, Axel Kornerup			Immunological effects of reduced mucosal integrity in the early life of BALB/c mice	PLOS ONE			English	Article							SODIUM-INDUCED COLITIS; REGULATORY T-CELLS; AKKERMANSIA-MUCINIPHILA; DIABETES INCIDENCE; MURINE MICROBIOTA; INFLAMMATION; MODEL; BACTERIA; HYGIENE; MICROFLORA	Certain stimuli at the gut barrier may be necessary in early life to establish a proper balance of immune tolerance. We evaluated a compromised barrier in juvenile mice in relation to microbiota and local and systemic immunity. BALB/c mice were treated with a low dose of dextran sulfate sodium (DSS) with or without ampicillin and lipopolysaccharide (LPS) to clarify the importance of microbial antigens and interaction between microbial-associated patterns and toll-like receptors. The barrier breach resulted in increased plasma LPS, which was highest in mice treated simultaneously with ampicillin. Adding LPS in the food reduced its levels in plasma. Regulatory T cells were acutely increased in mesenteric lymph nodes (MLN) and spleen during DSS treatment regardless of simultaneous ampicillin treatment. In contrast, NK T and NK cells decreased in MLN and in spleen. This acute DSS effect was reflected in fold changes of haptoglobin and ll1a in colon, and this was also more pronounced in mice simultaneously treated with ampicillin. On day 1 post-treatment, major upregulations of lfng, Foxp3, ll1b, ll2, and ll6 genes in colon were only observed in the mice simultaneously treated with ampicillin. A two-fold upregulation of colonic Foxp3 and ll1a was evident 25 days post-treatment. DSS skewed the microbiota in favor of Gram negative phyla. Therefore, increased permeability induced tolerogenic immunity independent of microbiota, and this was enhanced by LPS stimulation.	[Bendtsen, Katja Maria; Hansen, Camilla Hartmann Friis; Hansen, Axel Kornerup] Univ Copenhagen, Fac Hlth & Med Sci, Sect Expt Anim Models, Dept Vet & Anim Sci, Copenhagen, Denmark; [Krych, Lukasz; Vogensen, Finn Kvist] Univ Copenhagen, Dept Food Sci, Fac Sci, Copenhagen, Denmark; [Skovgaard, Kerstin] Tech Univ Denmark, Natl Vet Inst, Sect Immunol & Vaccinol, Copenhagen, Denmark; [Kot, Witold] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark	University of Copenhagen; University of Copenhagen; Technical University of Denmark; Aarhus University	Bendtsen, KM (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Sect Expt Anim Models, Dept Vet & Anim Sci, Copenhagen, Denmark.	kab@sund.ku.dk	; Kot, Witold/M-2170-2014; Krych, Lukasz/F-4446-2015	Hansen, Camilla Hartmann Friis/0000-0002-1860-385X; Kot, Witold/0000-0002-0188-4587; Krych, Lukasz/0000-0003-3224-1346; skovgaard, kerstin/0000-0001-5663-4879	Novo Nordisk Life Pharm In Vivo Pharmacology Centre and Gut, Grain and Greens	Novo Nordisk Life Pharm In Vivo Pharmacology Centre and Gut, Grain and Greens	The study was sponsored by the Novo Nordisk Life Pharm In Vivo Pharmacology Centre and Gut, Grain and Greens under the Danish Innovation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Calcinaro F, 2005, DIABETOLOGIA, V48, P1565, DOI 10.1007/s00125-005-1831-2; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; De Fazio L, 2014, WORLD J GASTROENTERO, V20, P2051, DOI 10.3748/wjg.v20.i8.2051; Derrien M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00166; Dewhirst FE, 1999, APPL ENVIRON MICROB, V65, P3287; Ducatelle R, 2015, ANIMAL, V9, P43, DOI 10.1017/S1751731114002584; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Egger B, 2000, DIGESTION; Faure M, 2003, DIGEST DIS SCI, V48, P1366, DOI 10.1023/A:1024175629909; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Guarner F, 2006, NAT CLIN PRACT GASTR, V3, P275, DOI 10.1038/ncpgasthep0471; Hall LJ, 2011, DIGEST DIS SCI, V56, P79, DOI 10.1007/s10620-010-1240-3; Hansen AK, 2015, ILAR J, V56, P250, DOI 10.1093/ilar/ilv010; Hansen CHF, 2012, DIABETOLOGIA, V55, P2285, DOI 10.1007/s00125-012-2564-7; Hansen CHF, 2014, J IMMUNOL, V193, P1213, DOI 10.4049/jimmunol.1400085; Hansen CHF, 2014, DIABETES, V63, P2821, DOI 10.2337/db13-1612; Hansen CHF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034043; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; Hoebler C, 2006, DIGEST DIS SCI, V51, P381, DOI 10.1007/s10620-006-3142-y; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Jorgensen BP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103398; Kitajima S, 1999, EXPT ANIMALS JAPANES; La Cava A, 2006, TRENDS IMMUNOL, V27, P322, DOI 10.1016/j.it.2006.05.003; Landreth KS, 2002, HUM EXP TOXICOL, V21, P493, DOI 10.1191/0960327102ht287oa; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Lundberg R, 2016, GUT MICROBES; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Neu J, 2011, CLIN PERINATOL, V38, P321, DOI 10.1016/j.clp.2011.03.008; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Pedroza-Pacheco I, 2013, CELL MOL IMMUNOL, V10, P222, DOI 10.1038/cmi.2013.2; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reunanen J., 2015, APPL ENV MICROBIOL; Schwab C, 2014, ISME J, V8, P1101, DOI 10.1038/ismej.2013.223; Skovgaard K, 2009, VET RES, V40, DOI 10.1051/vetres/2009006; Soerensen KE, 2013, J COMP PATHOL, V149, P463, DOI 10.1016/j.jcpa.2013.04.003; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Swidsinski A, 2011, GUT, V60, P34, DOI 10.1136/gut.2009.191320; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Ubeda C, 2012, TRENDS IMMUNOL, V33, P459, DOI 10.1016/j.it.2012.05.003; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vowinkel T, 2004, DIGEST DIS SCI, V49, P556, DOI 10.1023/B:DDAS.0000026298.72088.f7; Wang L, 2011, APPL ENVIRON MICROB, V77, P6718, DOI 10.1128/AEM.05212-11; Wingender G, 2012, GASTROENTEROLOGY, V143, P418, DOI 10.1053/j.gastro.2012.04.017	48	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176662	10.1371/journal.pone.0176662	http://dx.doi.org/10.1371/journal.pone.0176662			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459871	gold, Green Published			2022-12-26	WOS:000400645000043
J	Castilho, SRA; Godoy, CSDM; Guilarde, AO; Cardoso, JL; Andre, MCP; Junqueira-Kipnis, AP; Kipnis, A				Araujo Castilho, Suellen Rocha; de Miranda Godoy, Cassia Silva; Guilarde, Adriana Oliveira; Cardoso, Juliana Lamaro; Porfirio Andre, Maria Claudia; Junqueira-Kipnis, Ana Paula; Kipnis, Andre			Acinetobacter baumannii strains isolated from patients in intensive care units in Goiania, Brazil: Molecular and drug susceptibility profiles	PLOS ONE			English	Article							CARBAPENEM-RESISTANT; STENOTROPHOMONAS-MALTOPHILIA; ANTIMICROBIAL SUSCEPTIBILITY; LATIN-AMERICA; POLYMYXIN-B; OUTBREAK; BIOFILM; OXA-23; TIGECYCLINE; PREVALENCE	Resistance to antimicrobial agents is increasing worldwide and imposes significant life-threatening risks to several different populations, especially those in intensive care units (ICUs). Bacteria can quickly develop or acquire resistance to antimicrobial drugs, and combined with their intrinsic potential to cause disease in humans, these bacteria can become deadly. Among Gram-negative bacteria, Acinetobacter baumannii is notorious as a frequent opportunistic pathogen associated with critically ill patients, and understanding the genetic basis of A. baumannii resistance to beta-lactams among patients in ICUs will result in better protocols to prevent the development of resistance as well as improved treatment regimens. In this study, we assessed 1333 patients in five ICUs, 56 of whom developed A. baumannii infections. Most of the A. baumannii isolates were resistant to beta-lactam antimicrobial drugs, specifically, 3rd-and 4th-generation cephalosporins and carbapenems, and 91.1% of the isolates were multi-drug resistant (MDR). The most frequent OXA gene present was OXA-23 (55.1%), which is significantly associated with MDR strains. Most of the A. baumannii isolates (76.8%) were capable of forming a biofilm. The antimicrobial drug classes that were effective against most of these isolates were polymyxins and tigecycline. The molecular profile of the isolates allowed detection of 12 different clusters comprising 2 to 8 isolates each. In conclusion, our data indicate a high incidence of resistance to carbapenems as well as MDR strains among the observed A. baumannii isolates, most of which exhibited a high prevalence of OXA-23 gene expression. Only a few selective drugs were effective, reinforcing the notion that bacterial resistance is an emerging problem that should be prioritized in every healthcare facility.	[Araujo Castilho, Suellen Rocha; de Miranda Godoy, Cassia Silva; Guilarde, Adriana Oliveira; Cardoso, Juliana Lamaro; Porfirio Andre, Maria Claudia; Junqueira-Kipnis, Ana Paula; Kipnis, Andre] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil; [de Miranda Godoy, Cassia Silva; Guilarde, Adriana Oliveira] Hosp Trop Dis Dr Anuar Auad, Goiania, Go, Brazil	Universidade Federal de Goias	Kipnis, A (corresponding author), Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil.	andre.kipnis@gmail.com	Kipnis, Andre/ABG-5707-2020; Kipnis, Andre/M-7485-2017; Junqueira-Kipnis, Ana Paula/I-5534-2012	Kipnis, Andre/0000-0001-5950-106X; Kipnis, Andre/0000-0001-5950-106X; 	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [307186/2013-0]; Fundacao de Apoio a Pesquisa de Goias (FAPEG) [200910267000398]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio a Pesquisa de Goias (FAPEG)	This work was financially supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, #307186/2013-0) and Fundacao de Apoio a Pesquisa de Goias (FAPEG, #200910267000398).	Azizun Nahar, 2013, Journal of Medicine, V14, P28; Badave GK, 2015, J CLIN DIAGN RES, V9, pDC8, DOI 10.7860/JCDR/2015/11014.5398; Barchitta M, 2009, INT J HYG ENVIR HEAL, V212, P330, DOI 10.1016/j.ijheh.2008.07.001; Chan JZM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-302; Dalla-Costa LM, 2003, J CLIN MICROBIOL, V41, P3403, DOI 10.1128/JCM.41.7.3403-3406.2003; Dias VC, 2016, J INFECT DEV COUNTR, V10, P544, DOI 10.3855/jidc.6640; Dizbay M, 2008, INT J ANTIMICROB AG, V32, P29, DOI 10.1016/j.ijantimicag.2008.02.016; Duarte A, 2016, COMP IMMUNOL MICROB, V45, P29, DOI 10.1016/j.cimid.2016.02.002; European Centre for Disease Prevention and Control, 2013, ANN EP REP 2013; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202; Gales AC, 2001, CLIN INFECT DIS, V32, pS104, DOI 10.1086/320183; Gales AC, 2001, J CLIN MICROBIOL, V39, P183, DOI 10.1128/JCM.39.1.183-190.2001; Gales AC, 2012, DIAGN MICR INFEC DIS, V73, P354, DOI 10.1016/j.diagmicrobio.2012.04.007; Gusatti CD, 2012, BRAZ J MICROBIOL, V43, P243, DOI [10.1590/S1517-83822012000100027, 10.1590/S1517-838220120001000027]; Hagihara M, 2014, ANTIMICROB AGENTS CH, V58, P874, DOI 10.1128/AAC.01624-13; Jeon BC, 2005, J CLIN MICROBIOL, V43, P2241, DOI 10.1128/JCM.43.5.2241-2245.2005; Kim DH, 2013, ANTIMICROB AGENTS CH, V57, P5239, DOI 10.1128/AAC.00633-13; Lee HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/j.1469-0691.2007.01842.x; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Martins AF, 2009, INFECTION, V37, P474, DOI 10.1007/s15010-009-9003-9; Moradi Jale, 2015, Osong Public Health Res Perspect, V6, P79, DOI 10.1016/j.phrp.2014.12.006; Naas T, 2005, J CLIN MICROBIOL, V43, P4826, DOI 10.1128/JCM.43.9.4826-4829.2005; Oliveira MS, 2008, J ANTIMICROB CHEMOTH, V61, P1369, DOI 10.1093/jac/dkn128; Pagano M, 2013, EPIDEMIOL INFECT, V141, P330, DOI 10.1017/S095026881200074X; Park SY, 2013, INFECT CHEMOTHER, V45, P325, DOI 10.3947/ic.2013.45.3.325; Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06; Poirel L, 2006, CLIN MICROBIOL INFEC, V12, P826, DOI 10.1111/j.1469-0691.2006.01456.x; Ruiz M, 2007, CLIN MICROBIOL INFEC, V13, P1192, DOI 10.1111/j.1469-0691.2007.01825.x; Sanchez CJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-47; Seifert H, 2005, J CLIN MICROBIOL, V43, P4328, DOI 10.1128/JCM.43.9.4328-4335.2005; Sohrabi N, 2012, MICROB DRUG RESIST, V18, P385, DOI 10.1089/mdr.2011.0077; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Tendolkar PM, 2004, INFECT IMMUN, V72, P6032, DOI 10.1128/IAI.72.10.6032-6039.2004; Tognim MCB, 2004, INT J INFECT DIS, V8, P284, DOI 10.1016/j.ijid.2003.11.009; Turton JF, 2006, J CLIN MICROBIOL, V44, P2974, DOI 10.1128/JCM.01021-06; Turton JF, 2006, FEMS MICROBIOL LETT, V258, P72, DOI 10.1111/j.1574-6968.2006.00195.x; VANSOOLINGEN D, 1994, METHOD ENZYMOL, V235, P196; Viehman JA, 2014, DRUGS, V74, P1315, DOI 10.1007/s40265-014-0267-8; Villegas MV, 2003, INFECT CONT HOSP EP, V24, P284, DOI 10.1086/502205; Villoria-Gonzalez AM, 2016, J PATHOG, V2016; Walther-Rasmussen J, 2006, J ANTIMICROB CHEMOTH, V57, P373, DOI 10.1093/jac/dki482; World Health Organization, 2016, UN HIGH LEV M ANT RE	42	25	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176790	10.1371/journal.pone.0176790	http://dx.doi.org/10.1371/journal.pone.0176790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475585	Green Published, gold, Green Submitted			2022-12-26	WOS:000400649500014
J	Cybulsky, AV; Guillemette, J; Papillon, J; Abouelazm, NT				Cybulsky, Andrey V.; Guillemette, Julie; Papillon, Joan; Abouelazm, Nihad T.			Regulation of Ste20-like kinase, SLK, activity: Dimerization and activation segment phosphorylation	PLOS ONE			English	Article							FOCAL ADHESION TURNOVER; GERMINAL CENTER KINASE; STE20-RELATED KINASE; MICROTUBULE ORGANIZATION; PROTEIN-PHOSPHORYLATION; DEPENDENT ACTIVATION; ACTIN CYTOSKELETON; SIGNALING PATHWAYS; GLOMERULAR INJURY; CELL-MIGRATION	The Ste20-like kinase, SLK, has diverse cellular functions. SLK mediates organ development, cell cycle progression, cytoskeletal remodeling, cytokinesis, and cell survival. Expression and activity of SLK are enhanced in renal ischemia-reperfusion injury, and overexpression of SLK was shown to induce apoptosis in cultured glomerular epithelial cells (GECs) and renal tubular cells, as well as GEC/podocyte injury in vivo. The SLK protein consists of a N-terminal catalytic domain and an extensive C-terminal domain, which contains coiled-coils. The present study addresses the regulation of SLK activity. Controlled dimerization of the SLK catalytic domain enhanced autophosphorylation of SLK at T183 and S189, which are located in the activation segment. The full-length ectopically- and endogenously-expressed SLK was also autophosphorylated at T183 and S189. Using ezrin as a model SLK substrate (to address exogenous kinase activity), we demonstrate that dimerized SLK 1-373 or full-length SLK can effectively induce activation-specific phosphorylation of ezrin. Mutations in SLK, including T183A, S189A or T193A reduced T183 or S189 autophosphorylation, and showed a greater reduction in ezrin phosphorylation. Mutations in the coiled-coil region of full-length SLK that impair dimerization, in particular I848G, significantly reduced ezrin phosphorylation and tended to reduce autophosphorylation of SLK at T183. In experimental membranous nephropathy in rats, proteinuria and GEC/podocyte injury were associated with increased glomerular SLK activity and ezrin phosphorylation. In conclusion, dimerization via coiled-coils and phosphorylation of T183, S189 and T193 play key roles in the activation and signaling of SLK, and provide targets for novel therapeutic approaches.	[Cybulsky, Andrey V.; Guillemette, Julie; Papillon, Joan; Abouelazm, Nihad T.] McGill Univ, Hlth Ctr, Res Inst, Dept Med, Montreal, PQ, Canada; [Abouelazm, Nihad T.] Alexandria Univ, Fac Med, Dept Clin Pharmacol, Alexandria, Egypt	McGill University; Egyptian Knowledge Bank (EKB); Alexandria University	Cybulsky, AV (corresponding author), McGill Univ, Hlth Ctr, Res Inst, Dept Med, Montreal, PQ, Canada.	andrey.cybulsky@mcgill.ca	Cybulsky, Andrey V./AAG-8238-2020	Cybulsky, Andrey V./0000-0003-4348-2348	Canadian Institutes of Health Research [MOP-125988, MOP-133492]; Catherine McLaughlin Hakim Chair	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Catherine McLaughlin Hakim Chair	This work was supported by Research Grants from the Canadian Institutes of Health Research MOP-125988, MOP-133492 (www.cihr-irsc.gc.ca/e/193.html), and the Catherine McLaughlin Hakim Chair (AVC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zahrani KN, 2014, DEV DYNAM, V243, P640, DOI 10.1002/dvdy.24106; Al-Zahrani KN, 2013, CELL ADHES MIGR, V7, P1, DOI 10.4161/cam.22495; Baron KD, 2015, BBA-MOL CELL RES, V1853, P1683, DOI 10.1016/j.bbamcr.2015.04.003; Brinkkoetter PT, 2013, NAT REV NEPHROL, V9, P328, DOI 10.1038/nrneph.2013.78; Coers W, 1996, EXP NEPHROL, V4, P184; Conradt L, 2011, NEOPLASIA, V13, P1026, DOI 10.1593/neo.111016; Cybulsky AV, 2007, AM J PHYSIOL-RENAL, V292, pF845, DOI 10.1152/ajprenal.00234.2006; Cybulsky AV, 2011, CONTRIB NEPHROL, V169, P107, DOI 10.1159/000313948; Cybulsky AV, 2010, AM J PATHOL, V177, P2290, DOI 10.2353/ajpath.2010.100263; Cybulsky AV, 2004, AM J PHYSIOL-RENAL, V286, pF16, DOI 10.1152/ajprenal.00144.2003; Cybulsky AV, 2015, J AM SOC NEPHROL, V26, p435A; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Delarosa S, 2011, AM J PHYSIOL-RENAL, V301, pF554, DOI 10.1152/ajprenal.00062.2011; Delpire E, 2009, PFLUG ARCH EUR J PHY, V458, P953, DOI 10.1007/s00424-009-0674-y; Elimam H, 2016, J BIOL CHEM, V291, P14468, DOI 10.1074/jbc.M115.696781; Ellinger-Ziegelbauer H, 2000, GENES CELLS, V5, P491, DOI 10.1046/j.1365-2443.2000.00337.x; Fokin AI, 2016, CYTOSKELETON, V73, P83, DOI 10.1002/cm.21276; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Guilluy C, 2008, CIRC RES, V102, P1265, DOI 10.1161/CIRCRESAHA.107.164764; Hao JJ, 2009, J CELL BIOL, V184, P451, DOI 10.1083/jcb.200807047; Hao W, 2006, J BIOL CHEM, V281, P3075, DOI 10.1074/jbc.M511744200; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hugo C, 1998, KIDNEY INT, V54, P1934, DOI 10.1046/j.1523-1755.1998.00195.x; Hugo C, 1996, J CLIN INVEST, V97, P2499, DOI 10.1172/JCI118697; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jaberi A, 2015, BBA-MOL CELL RES, V1853, P2539, DOI 10.1016/j.bbamcr.2015.06.005; Kim Y, 2015, MOL CANCER RES, V13, P765, DOI 10.1158/1541-7786.MCR-14-0326; Lee SJ, 2009, PROTEIN SCI, V18, P304, DOI 10.1002/pro.27; Luhovy AY, 2012, J BIOL CHEM, V287, P5446, DOI 10.1074/jbc.M111.302018; Machicoane M, 2014, J CELL BIOL, V205, P791, DOI 10.1083/jcb.201401049; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Muller S, 2015, NAT CHEM BIOL, V11, P818, DOI 10.1038/nchembio.1938; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; O'Reilly PG, 2005, J BIOL CHEM, V280, P42383, DOI 10.1074/jbc.M510763200; Oliver AW, 2007, TRENDS BIOCHEM SCI, V32, P351, DOI 10.1016/j.tibs.2007.06.004; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Orlando RA, 2001, J AM SOC NEPHROL, V12, P1589, DOI 10.1681/ASN.V1281589; Panneton V, 2015, J BIOL CHEM, V290, P20960, DOI 10.1074/jbc.M115.645952; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Quizi JL, 2013, ONCOGENE, V32, P4656, DOI 10.1038/onc.2012.488; Rinschen MM, 2010, P NATL ACAD SCI USA, V107, P3882, DOI 10.1073/pnas.0910646107; Sabourin LA, 2000, MOL CELL BIOL, V20, P684, DOI 10.1128/MCB.20.2.684-696.2000; Sabourin LA, 1999, ONCOGENE, V18, P7566, DOI 10.1038/sj.onc.1203119; SALANT DJ, 1988, METHOD ENZYMOL, V162, P421; Storbeck CJ, 2009, MOL BIOL CELL, V20, P4174, DOI 10.1091/mbc.E08-07-0707; Storbeck CJ, 2004, MUSCLE NERVE, V29, P553, DOI 10.1002/mus.20000; Takeda T, 2001, J CLIN INVEST, V108, P289, DOI 10.1172/JCI12539; Viswanatha R, 2012, J CELL BIOL, V199, P969, DOI 10.1083/jcb.201207047; Wagner S, 2002, J BIOL CHEM, V277, P37685, DOI 10.1074/jbc.M205899200; Wagner S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001868; Weintz G, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.29; Welsh GI, 2012, NAT REV NEPHROL, V8, P14, DOI 10.1038/nrneph.2011.151; Yamada E, 2000, BBA-MOL CELL RES, V1495, P250, DOI 10.1016/S0167-4889(99)00164-0; Yi TF, 2014, P NATL ACAD SCI USA, V111, pE2182, DOI 10.1073/pnas.1404943111; Zhapparova ON, 2013, MOL BIOL CELL, V24, P3205, DOI 10.1091/mbc.E13-03-0137	55	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177226	10.1371/journal.pone.0177226	http://dx.doi.org/10.1371/journal.pone.0177226			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475647	Green Published, Green Submitted, gold			2022-12-26	WOS:000400649500055
J	Honorio, ICG; Bertoni, BW; Telles, MPD; Braga, RD; Franca, SD; Coppede, JD; Correa, VSC; Diniz, JAF; Pereira, AMS				Gomes Honorio, Isabela Cristina; Bertoni, Bianca Waleria; de Campos Telles, Mariana Pires; Braga, Ramilla dos Santos; Franca, Suzelei de Castro; Coppede, Juliana da Silva; Conde Correa, Valeria Siero; Felizola Diniz Filho, Jose Alexandre; Soares Pereira, Ana Maria			Genetic and chemical diversity of Uncaria tomentosa (Willd. ex. Schult.) DC. in the Brazilian Amazon	PLOS ONE			English	Article							SOLAR UV-RADIATION; ALKALOID PROFILE; POPULATION; SOFTWARE; GUIANENSIS; NUMBER; SRAP	Uncaria tomentosa (Willd. ex Schult.) DC., a plant native to the Amazon region, is used widely in popular medicine and by the pharmaceutical industry because of its anti-inflammatory activity. However, the survival of this species is endangered by deforestation and indiscriminate collection, and a preservation plan is urgently required. The objectives of this study were to determine the genetic and chemical variability between and within eight populations of U. tomentosa from the Brazilian states of Acre, Para and Amapa, and to investigate possible correlations between genetic and geographical distances, and between geographical distances or altitude and the accumulation of bioactive oxindole alkaloids. Three sequence-related amplified polymorphism (SRAP) markers were employed to fingerprint genomic DNA, and the amounts of mitraphylline and isomitraphylline in leaf samples were established by high-performance liquid chromatography. Although significant divergence existed between the tested populations (F-ST = 0.246), the largest genetic diversity and the highest percentage of polymorphism (95.68%) was found within the population from Mancio Lima, Acre. Gene flow was considered rather limited (Nm = 1.57), and no correlations between genetic and geographical distances were detected, suggesting that population structure followed an island model. Accumulations of mitraphylline and isomitraphylline varied in the range 32.94 to 0.57 and 3.75 to 0.36 mg g(-1) dry weight, respectively. The concentration of isomitraphylline was positively influenced by altitude, such that the population collected at the site with the highest elevation (Tarauaca, Acre) exhibited the greatest alkaloid content. SRAP markers were very efficient in fingerprinting genomic DNA from U. tomentosa populations and clearly showed that genetic variability within populations was greater than between populations. A conservation and management plan should prioritize the creation of germplasm banks to prevent the loss of existing genetic variability, particularly within alkaloid-rich populations such as those of Tarauaca	[Gomes Honorio, Isabela Cristina] Univ Estadual Paulista, Campus Lageado, Botucatu, SP, Brazil; [Bertoni, Bianca Waleria; Franca, Suzelei de Castro; Coppede, Juliana da Silva; Soares Pereira, Ana Maria] Univ Ribeirao Preto, Unidade Biotecnol, Ribeirao Preto, SP, Brazil; [de Campos Telles, Mariana Pires] Pontificia Univ Catolica Goias, Escola Ciencias Agr & Biol, Goiania, Go, Brazil; [de Campos Telles, Mariana Pires; Braga, Ramilla dos Santos] Univ Fed Goias, Lab Genet & Biodiversidade, Goiania, Go, Brazil; [Conde Correa, Valeria Siero] Reserva EcoCerrado Brasil, Araxa, MG, Brazil; [Felizola Diniz Filho, Jose Alexandre] Univ Fed Goias, Dept Ecol, ICB, Goiania, Go, Brazil	Universidade Estadual Paulista; Universidade de Ribeirao Preto; Pontificia Universidade Catolica de Goias; Universidade Federal de Goias; Universidade Federal de Goias	Pereira, AMS (corresponding author), Univ Ribeirao Preto, Unidade Biotecnol, Ribeirao Preto, SP, Brazil.	apereira@unaerp.br	Honório, Isabela Cristina ICGH Gomes/M-1391-2016; de Campos Telles, Mariana Pires/I-2670-2012; Braga, Ramilla/AAS-1010-2021; Franca, Suzelei C/E-4069-2013; Diniz-Filho, José Alexandre Felizola/D-9405-2013; Soares Pereira, Ana Maria/P-5646-2014	Honório, Isabela Cristina ICGH Gomes/0000-0002-5029-2238; Diniz-Filho, José Alexandre Felizola/0000-0002-0967-9684; Soares Pereira, Ana Maria/0000-0002-3478-4718	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [405167/2013-0]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by a grant from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq Process No 405167/2013-0).; The authors would like to thank Dr. Piero Giuseppe Delprete for botanical identification of Uncaria tomentosa. Authors also thank Conselho Nacional de desenvolvimento Cientifico e Tecnologico (CNPq) Proc. No 405167/2013-0 for financial support.	Pereira RDA, 2006, CIENC AGROTEC, V30, P637, DOI 10.1590/S1413-70542006000400007; Andola HC, 2010, CHEM BIODIVERS, V7, P415, DOI 10.1002/cbdv.200900041; Auguie B, 2017, GRIDEXTRA MISCELLANE; Bertol G, 2012, PHYTOCHEM ANALYSIS, V23, P143, DOI 10.1002/pca.1335; Blumthaler M, 1997, J PHOTOCH PHOTOBIO B, V39, P130, DOI 10.1016/S1011-1344(96)00018-8; Cardoso SRS, 2000, MOL ECOL, V9, P1753, DOI 10.1046/j.1365-294x.2000.01056.x; Ceylan A, 2014, BIOCHEM SYST ECOL, V54, P219, DOI 10.1016/j.bse.2014.01.014; CHANDRA P, 1980, BIOCHEM SYST ECOL, V8, P379, DOI 10.1016/0305-1978(80)90040-X; Penaloza EMC, 2015, QUIM NOVA, V38, P378, DOI 10.5935/0100-4042.20150007; Creste S, 2001, PLANT MOL BIOL REP, V19, P299, DOI 10.1007/BF02772828; Cruz CD, 2013, ACTA SCI-AGRON, V35, P271, DOI 10.4025/actasciagron.v35i3.21251; da Silva MD, 2013, BIOCHEM SYST ECOL, V51, P189, DOI 10.1016/j.bse.2013.08.032; Dandrea A, 1995, 9 REUN COM CIENT TEC; Diniz JAF, 2013, GENET MOL BIOL, V36, P475, DOI 10.1590/S1415-47572013000400002; Domínguez Torrejón Gilberto, 2010, Rev. Soc. Quím. Perú, V76, P271; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falk DA., 2001, INTRO RESTORATION GE; Falkiewicz B, 2001, AM J CASE REP, V2, P305; Frankham R., 2008, FUNDAMENTOS GENETICA; Ganga Rita Maria Devós, 2004, Rev. Bras. Frutic., V26, P494, DOI 10.1590/S0100-29452004000300029; Honorio ICG, 2016, CIENC RURAL, V46, P1401, DOI 10.1590/0103-8478cr20150138; Gregianini TS, 2003, PHOTOCHEM PHOTOBIOL, V78, P470, DOI 10.1562/0031-8655(2003)078<0470:TABIIB>2.0.CO;2; Hu Y, 2007, BIOMED CHROMATOGR, V21, P967, DOI 10.1002/bmc.841; Laus G, 1997, PHYTOCHEMISTRY, V45, P855, DOI 10.1016/S0031-9422(97)00061-7; Li G, 2001, THEOR APPL GENET, V103, P455, DOI 10.1007/s001220100570; LINHART YB, 1981, HEREDITY, V46, P407, DOI 10.1038/hdy.1981.49; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Luna-Palencia GR, 2013, BIOTECHNOL LETT, V35, P791, DOI 10.1007/s10529-012-1128-8; Lydon J, 2009, PHOTOCHEM PHOTOBIOL, V85, P1156, DOI 10.1111/j.1751-1097.2009.00562.x; Marcon G, 1988, THESIS; Ministerio da Saude do Brasil, 2014, REL MED ESS RENAME 2; NEI M, 1978, GENETICS, V89, P583; Nejadhabibvash F., 2012, Australian Journal of Crop Science, V6, P1428; Ouwerkerk PBF, 1999, MOL GEN GENET, V261, P610, DOI 10.1007/s004380050003; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pereira RCA, 2006, ASPECTOS BOTANICOS E; Pritchard JK, 2000, GENETICS, V155, P945; Seoane CRS., 2000, SCI FOR, V57, P123; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; TEMPLETON A. R., 2011, GENETICA POPULACOES; Ter Steege Hans, 2015, Sci Adv, V1, pe1500936, DOI 10.1126/sciadv.1500936; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157; Zhang F, 2011, EUPHYTICA, V177, P15, DOI 10.1007/s10681-010-0239-3; Zhang Q, 2015, J ETHNOPHARMACOL, V173, P48, DOI 10.1016/j.jep.2015.06.011	46	9	9	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177103	10.1371/journal.pone.0177103	http://dx.doi.org/10.1371/journal.pone.0177103			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475604	Green Submitted, gold, Green Published			2022-12-26	WOS:000400649500048
J	Kashkooli, OB; Groger, J; Nunez-Riboni, I				Kashkooli, Omid Beyraghdar; Groeger, Joachim; Nunez-Riboni, Ismael			Qualitative assessment of climate-driven ecological shifts in the Caspian Sea	PLOS ONE			English	Article							GOLDEN GREY MULLET; CTENOPHORE MNEMIOPSIS-LEIDYI; IRANIAN COASTAL WATERS; REGIME SHIFTS; ANCHOVY KILKA; LIZA-AURATA; LEVEL CHANGES; BALTIC SEA; VARIABILITY; MARINE	The worldwide occurrence of complex climate-induced ecological shifts in marine systems is one of the major challenges in sustainable bio-resources management. The occurrence of ecological environment-driven shifts was studied in the Southern Caspian Sea using the "shiftogram" method on available fisheries-related (i.e. commercially important bentho-pelagic fish stocks) ecological and climatic variables. As indicators of potential environmentally driven shift patterns we used indices for the North Atlantic Oscillation, the Southern Oscillation, the Siberian High, the East Atlantic-West Russia pattern, as well as Sea Surface Temperature and surface chlorophyll-a concentration. Given the explorative findings from the serial shift analyses, the cascading and serial order of multiple shift events in climatic-ecologic conditions of the southern Caspian Sea suggested a linkage between external forces and dynamics of ecosystem components and structures in the following order: global-scale climate forces lead to local environmental processes, which in turn lead to biological components dynamics. For the first time, this study indicates that ecological shifts are an integral component of bentho-pelagic subsystem regulatory processes and dynamics. Qualitative correspondence of biological responses of bentho-pelagic stocks to climatic events is one of the supporting evidences that overall Caspian ecosystem structures and functioning might have-at least partially-been impacted by global-scale climatic or local environmental shifts. These findings may help to foster a regional Ecosystem-based Approach to Management (EAM) as an integral part of bentho-pelagic fisheries management plans.	[Kashkooli, Omid Beyraghdar; Groeger, Joachim; Nunez-Riboni, Ismael] Thunen Inst Sea Fisheries, Hamburg, Germany; [Kashkooli, Omid Beyraghdar; Groeger, Joachim] Univ Rostock, Inst Biosci, Rostock, Germany; [Kashkooli, Omid Beyraghdar] Isfahan Univ Technol, Dept Nat Resources, Esfahan, Iran	Johann Heinrich von Thunen Institute; University of Rostock; Isfahan University of Technology	Kashkooli, OB (corresponding author), Thunen Inst Sea Fisheries, Hamburg, Germany.; Kashkooli, OB (corresponding author), Univ Rostock, Inst Biosci, Rostock, Germany.; Kashkooli, OB (corresponding author), Isfahan Univ Technol, Dept Nat Resources, Esfahan, Iran.	omid.kashkooli@thuenen.de	Nunez-Riboni, Ismael/HGB-9167-2022		Ministry of Science, Research and Technology (MSRT) of Iran	Ministry of Science, Research and Technology (MSRT) of Iran	OBK was supported by the Ministry of Science, Research and Technology (MSRT) of Iran with a PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Sincere thanks are expressed to the Ministry of Science, Research and Technology (MSRT) of Iran for granting Omid Beyraghdar Kashkooli a PhD scholarship for studying in Germany. This work was achieved in partial fulfillment of the requirements of Omid Beyraghdar Kashkooli's PhD degree submitted to the University of Rostock. Thunen Institute (TI) of Sea Fisheries in Hamburg and University of Rostock are acknowledged for providing all the scientific facilities and requirements during the course of this work. Authors would like to express their thanks to the Caspian Sea Ecology Research Center, Iranian Fisheries Research Organization for providing the regional fisheries datasets and information. Omid Beyraghdar Kashkooli would like thank his co-supervisor Dr. Hasan Fazli (Caspian Sea Ecology Research Center, Iranian Fisheries Research Organization) for providing the fisheries-derived data, his support and scientific guidance during his doctoral research. We are grateful to Dr. Boris Cisewski (TI) for his help with the chlorophyll-a data series. Dr. Maria Shahgedanova (University of Reading) is acknowledged for providing the relevant information regarding the calculation of the Siberian High Index.	Abdolmalaki S, 2007, ICES J MAR SCI, V64, P973, DOI 10.1093/icesjms/fsm062; Afraei Bandpei Mohammad Ali, 2010, International Aquatic Research, V2, P25; Allan RJ, 1996, SO OSCILLATION CLIMA; Arpe K, 2000, GEOPHYS RES LETT, V27, P2693, DOI 10.1029/1999GL002374; Arula T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091304; Askarova MA, 2014, PROCD SOC BEHV, V120, P455, DOI 10.1016/j.sbspro.2014.02.124; Barale V, 2008, REMOTE SENSING EUROP, P3, DOI [10.1007/978-1-4020-6772-3_1, DOI 10.1007/978-1-4020-6772-3_1]; Blenckner T, 2002, GLOBAL CHANGE BIOL, V8, P203, DOI 10.1046/j.1365-2486.2002.00469.x; Brander KM, 2007, P NATL ACAD SCI USA, V104, P19709, DOI 10.1073/pnas.0702059104; Daskalov GM, 2007, ICES J MAR SCI, V64, P503, DOI 10.1093/icesjms/fsl047; de Mora S, 2004, MAR POLLUT BULL, V48, P30, DOI 10.1016/j.marpolbul.2003.10.001; Deyle ER, 2013, P NATL ACAD SCI USA, V110, P6430, DOI 10.1073/pnas.1215506110; deYoung B, 2004, PROG OCEANOGR, V60, P143, DOI 10.1016/j.pocean.2004.02.017; Dippner JW, 2012, J MARINE SYST, V105, P115, DOI 10.1016/j.jmarsys.2012.07.001; Elguindi N, 2006, CLIM DYNAM, V26, P167, DOI 10.1007/s00382-005-0077-5; Fazli H, 2008, J APPL ICHTHYOL, V24, P610, DOI 10.1111/j.1439-0426.2008.01098.x; Fazli H, 2012, STOCK ASSESSMENT REP; Fazli H, 2007, FISHERIES SCI, V73, P285, DOI 10.1111/j.1444-2906.2007.01334.x; Fazli H, 2012, CYBIUM, V36, P545; Fendereski F, 2014, BIOGEOSCIENCES, V11, P6451, DOI 10.5194/bg-11-6451-2014; Finenko GA, 2006, MAR ECOL PROG SER, V314, P171, DOI 10.3354/meps314171; Ghaninejad D, 2010, IRAN J FISH SCI, V9, P402; Groger JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087525; Groger JP, 2010, ICES J MAR SCI, V67, P454, DOI 10.1093/icesjms/fsp259; Groger JP, 2011, ECOL INDIC, V11, P1084, DOI 10.1016/j.ecolind.2010.12.008; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; Hurrell J. W., 2003, N ATLANTIC OSCILLATI, V134, P1, DOI [10.1029/134GM01, DOI 10.1029/134GM01]; Hurrell JW, 2004, MARINE ECOSYSTEMS AND CLIMATE VARIATION, P15; Hurvich CM., 1993, J TIME SER ANAL, V14, P271, DOI DOI 10.1111/J.1467-9892.1993.TB00144.X; Ibrayev RA, 2010, OCEAN SCI, V6, P311, DOI 10.5194/os-6-311-2010; Jeong JH, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015904; Jiao Y, 2009, REV FISH BIOL FISHER, V19, P177, DOI 10.1007/s11160-008-9096-8; Johnson JE, 2010, REV FISH SCI, V18, P106, DOI 10.1080/10641260903434557; Karpinsky MG, 2005, HANDB ENVIRON CHEM, V5, P191, DOI 10.1007/698_5_010; Khodorevskaya RP, 1999, J APPL ICHTHYOL, V15, P106, DOI 10.1111/j.1439-0426.1999.tb00218.x; Kideys AE, 2003, MAR BIOL, V142, P163, DOI 10.1007/s00227-002-0932-4; Kideys Ahmet Erkan, 2005, Oceanography, V18, P76; King JR, 2006, FISHERIES MANAG ECOL, V13, P93, DOI 10.1111/j.1365-2400.2006.00480.x; Krichak SO, 2005, INT J CLIMATOL, V25, P183, DOI 10.1002/joc.1124; Lees K, 2006, FISH FISH, V7, P104, DOI 10.1111/j.1467-2979.2006.00215.x; Lehodey P, 2006, J CLIMATE, V19, P5009, DOI 10.1175/JCLI3898.1; Leonov AV, 2001, WATER RESOUR, V28, P535; Levin PS, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0275; Lim YK, 2015, CLIM DYNAM, V44, P3211, DOI 10.1007/s00382-014-2381-4; Lindegren M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038410; Lydolph P.E., 1977, WORLD SURV CLIMATOL, V7, P1; Mackenzie BR, 2007, GLOBAL CHANGE BIOL, V13, P1348, DOI 10.1111/j.1365-2486.2007.01369.x; Mathews CP, 2006, J APPL ICHTHYOL, V22, P132, DOI 10.1111/j.1439-0426.2007.00941.x; Mollmann C, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0260; Mollmann C, 2012, ADV ECOL RES, V47, P303, DOI 10.1016/B978-0-12-398315-2.00004-1; Mollmann C, 2009, GLOBAL CHANGE BIOL, V15, P1377, DOI 10.1111/j.1365-2486.2008.01814.x; Nasrollahzadeh HS, 2008, CONT SHELF RES, V28, P1153, DOI 10.1016/j.csr.2008.02.015; Nazemosadat MJ, 2004, J CLIMATE, V17, P4005, DOI 10.1175/1520-0442(2004)017<4005:QTESIT>2.0.CO;2; Nezlin NP, 2005, HANDB ENVIRON CHEM, V5, P143; Ottersen G, 2004, MARINE ECOSYSTEMS AND CLIMATE VARIATION, P73; Ottersen G, 2010, J MARINE SYST, V79, P343, DOI 10.1016/j.jmarsys.2008.12.013; Panagiotopoulos F, 2005, J CLIMATE, V18, P1411, DOI 10.1175/JCLI3352.1; Panin GN, 2014, IZV ATMOS OCEAN PHY+, V50, P266, DOI 10.1134/S000143381402008X; Philander S.G, 1989, NINO NINA SO OSCILLA, V46; Pourkazemi M, 2006, J APPL ICHTHYOL, V22, P12, DOI 10.1111/j.1439-0426.2007.00923.x; RASMUSSON EM, 1983, SCIENCE, V222, P1195, DOI 10.1126/science.222.4629.1195; Renssen H, 2007, EARTH PLANET SC LETT, V261, P685, DOI 10.1016/j.epsl.2007.07.037; Ricel JC, 2011, ICES J MAR SCI, V68, P1343, DOI 10.1093/icesjms/fsr041; Roessig JM, 2004, REV FISH BIOL FISHER, V14, P251, DOI 10.1007/s11160-004-6749-0; Roohi A, 2010, BIOL INVASIONS, V12, P2343, DOI 10.1007/s10530-009-9648-4; Ruban GI, 2011, J APPL ICHTHYOL, V27, P199, DOI 10.1111/j.1439-0426.2011.01725.x; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Sissenwine M, 2004, MAR ECOL PROG SER, V274, P291; Stolberg F, 2006, CASPIAN SEA GIWA REG; TRENBERTH KE, 1980, MON WEATHER REV, V108, P855, DOI 10.1175/1520-0493(1980)108<0855:TNHSLP>2.0.CO;2; Ustarbekova DA, 2014, ARID ECOSYST, V4, P44, DOI 10.1134/S2079096114010077; Valipour A, 2006, KUTUM JEWEL CASPIAN; Wilsey CB, 2013, J FISH WILDL MANAG, V4, P220, DOI 10.3996/062012-JFWM-055; Yousefian M, 2008, ASIAN J ANIM VET ADV, V3, P437, DOI 10.3923/ajava.2008.437.442; ZHANG CI, 1988, T AM FISH SOC, V117, P180, DOI 10.1577/1548-8659(1988)117<0180:BBCATI>2.3.CO;2; Zorriehzahra Mohammad Jalil, 2014, VirusDisease, V25, P430, DOI 10.1007/s13337-014-0238-4	77	10	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0176892	10.1371/journal.pone.0176892	http://dx.doi.org/10.1371/journal.pone.0176892			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475609	Green Published, Green Submitted, gold			2022-12-26	WOS:000400649500024
J	Yu, H; Zhang, YL; Wang, ZF; Liu, LS; Chen, Z; Qi, W				Yu, Haibin; Zhang, Yili; Wang, Zhaofeng; Liu, Linshan; Chen, Zhao; Qi, Wei			Diverse range dynamics and dispersal routes of plants on the Tibetan Plateau during the late Quaternary	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; DNA-SEQUENCE VARIATION; COMPARATIVE PHYLOGEOGRAPHY; EVOLUTIONARY HISTORY; MOLECULAR PHYLOGEOGRAPHY; PICEA-LIKIANGENSIS; POPULATION-GROWTH; ADJACENT REGIONS; GLACIAL REFUGIA; ALPINE PLANTS	Phylogeographical studies have suggested that several plant species on the Tibetan Plateau (TP) underwent recolonization during the Quaternary and may have had distinct range dynamics in response to the last glacial. To further test this hypothesis and locate the possible historical dispersal routes, we selected 20 plant species from different parts of the TP and modeled their geographical distributions over four time periods using species distribution models (SDMs). Furthermore, we applied the least-cost path method together with SDMs and shared haplotypes to estimate their historical dispersal corridors. We identified three general scenarios of species distribution change during the late Quaternary: the 'contraction-expansion' scenario for species in the northeastern TP, the 'expansion-contraction' scenario for species in the southeast and the 'stable' scenario for widespread species. During the Quaternary, we identified that these species were likely to recolonize along the low-elevation valleys, huge mountain ranges and flat plateau platform (e.g. the Yarlung Zangbo Valley and the Himalaya). We inferred that Quaternary cyclic glaciations along with the various topographic and climatic conditions of the TP could have resulted in the diverse patterns of range shift and dispersal of Tibetan plant species. Finally, we believe that this study would provide valuable insights for the conservation of alpine species under future climate change.	[Yu, Haibin; Zhang, Yili; Wang, Zhaofeng; Liu, Linshan; Qi, Wei] Chinese Acad Sci, Inst Geog Sci & Nat Resource Res, Key Lab Land Surface Pattern & Simulat, Beijing, Peoples R China; [Yu, Haibin] Sun Yat Sen Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China; [Zhang, Yili] Univ Chinese Acad Sci, Beijing, Peoples R China; [Chen, Zhao] Guangdong Inst Ecoenvironm Sci & Technol, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Sun Yat Sen University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Guangdong Academy of Sciences; Institute of Eco-environmental & Soil Sciences, Guangdong Academy of Sciences	Zhang, YL (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resource Res, Key Lab Land Surface Pattern & Simulat, Beijing, Peoples R China.; Zhang, YL (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	zhangyl@igsnrr.ac.cn	Qi, Wei/S-7651-2017	Qi, Wei/0000-0003-4898-6350; zhang, yili/0000-0002-9474-1664	Open Foundation of Key Laboratory of Land Surface Pattern and Simulation (CAS); Strategic Priority Research Program of the Chinese Academy of Sciences [XDB03030500]; National Natural Science Foundation of China [41271068, 41371120]	Open Foundation of Key Laboratory of Land Surface Pattern and Simulation (CAS); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Open Foundation of Key Laboratory of Land Surface Pattern and Simulation (CAS), the Strategic Priority Research Program of the Chinese Academy of Sciences (No.XDB03030500) and the National Natural Science Foundation of China (No.41271068, No.41371120).	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; [Anonymous], 2021, LANG ENV STAT COMP; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Brown JL, 2014, METHODS ECOL EVOL, V5, P694, DOI 10.1111/2041-210X.12200; Chan LM, 2011, MOL PHYLOGENET EVOL, V59, P523, DOI 10.1016/j.ympev.2011.01.020; Chen JM, 2014, J SYST EVOL, V52, P313, DOI 10.1111/jse.12093; Chen JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060948; Chen SY, 2008, BOT J LINN SOC, V157, P125, DOI 10.1111/j.1095-8339.2008.00785.x; Cun YZ, 2010, MOL PHYLOGENET EVOL, V56, P972, DOI 10.1016/j.ympev.2010.05.007; Du FK, 2017, J BIOGEOGR, V44, P294, DOI 10.1111/jbi.12836; Du ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep20883; Duan YZ, 2011, NORD J BOT, V29, P615, DOI 10.1111/j.1756-1051.2011.00999.x; Etherington TR, 2013, LANDSCAPE ECOL, V28, P1223, DOI 10.1007/s10980-013-9880-2; Favre A, 2015, BIOL REV, V90, P236, DOI 10.1111/brv.12107; Fu YX, 1997, GENETICS, V147, P915; Gao QB, 2012, BOT J LINN SOC, V168, P204, DOI 10.1111/j.1095-8339.2011.01193.x; Gao YD, 2015, SCI REP-UK, V5, DOI 10.1038/srep11698; Hampe A, 2003, MOL ECOL, V12, P3415, DOI 10.1046/j.1365-294X.2003.02006.x; Harrison SP, 2001, NATURE, V413, P129, DOI 10.1038/35093166; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2012, ECOLOGY, V93, P679, DOI 10.1890/11-0826.1; Ho T.N., 2001, WORLDWIDE MONOGRAPH; Li B., 1991, MAP QUATERNARY GLACI; Li HL, 2010, ECOL MODEL, V221, P944, DOI 10.1016/j.ecolmodel.2009.12.006; Li L, 2013, MOL ECOL, V22, P5237, DOI 10.1111/mec.12466; Liang H, 1995, ACTA BOT YUNN, V17, P380; Lin Z-Y, 1990, GEOGRAPHICAL RES, V9, P33; Liu JQ, 2014, J SYST EVOL, V52, P241, DOI 10.1111/jse.12094; Liu J, 2013, NEW PHYTOL, V199, P1093, DOI 10.1111/nph.12336; Liu YP, 2015, BIOCHEM SYST ECOL, V59, P159, DOI 10.1016/j.bse.2015.01.014; Liu Z, 2001, ACTA ECOL SIN, V22, P715; LUEBERT F, 2014, FRONTIERS ECOLOGY EV, V2, P27, DOI DOI 10.3389/FEVO.2014.00027; Matuszak S, 2016, J BIOGEOGR, V43, P580, DOI 10.1111/jbi.12617; Meng LH, 2007, MOL ECOL, V16, P4128, DOI 10.1111/j.1365-294X.2007.03459.x; Opgenoorth L, 2010, NEW PHYTOL, V185, P332, DOI 10.1111/j.1469-8137.2009.03007.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Shi Y.F., 1998, UPLIFT ENV CHANGES Q; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Song Z, 1982, EARLY TERTIARY PALYN; Sun YS, 2010, PLANT ECOL DIVERS, V3, P249, DOI 10.1080/17550874.2010.516279; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAJIMA F, 1989, GENETICS, V123, P585; Tang L, 1995, ACTA MICROPALAEONTOL, V13, P321; Tang LY, 1998, J GLACIOL GEOCRYOL, V20, P133; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; Vignieri SN, 2005, MOL ECOL, V14, P1925, DOI 10.1111/j.1365-294X.2005.02568.x; Wan DS, 2016, ECOL EVOL, V6, P1977, DOI 10.1002/ece3.2019; [万和文 Wan Hewen], 2008, [第四纪研究, Quaternary Sciences], V28, P112; Wang GN, 2014, J SYST EVOL, V52, P289, DOI 10.1111/jse.12089; Wang IJ, 2009, MOL ECOL, V18, P1365, DOI 10.1111/j.1365-294X.2009.04122.x; Wen J, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00004; Wu LL, 2010, MOL ECOL, V19, P1691, DOI 10.1111/j.1365-294X.2010.04613.x; Wu Z. Y., 1988, THE FLORA OF TIBET; Yan YJ, 2013, ECOL EVOL, V3, P4584, DOI 10.1002/ece3.847; Yao TD, 2012, NAT CLIM CHANGE, V2, P663, DOI [10.1038/NCLIMATE1580, 10.1038/nclimate1580]; Yu G, 2000, J BIOGEOGR, V27, P635, DOI 10.1046/j.1365-2699.2000.00431.x; Yu Hai-bin, 2014, Yingyong Shengtai Xuebao, V25, P1669; Yu HB, 2015, ECOL EVOL, V5, pS781, DOI 10.1002/ece3.1840; Yu Haibin, 2013, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V33, P1268; Yue LL, 2014, J SYST EVOL, V52, P326, DOI 10.1111/jse.12038; Yue LL, 2012, AM J BOT, V99, P1726, DOI 10.3732/ajb.1100506; Zhang DC, 2016, J BIOGEOGR, V43, P2465, DOI 10.1111/jbi.12819; Zhang FQ, 2012, J SYST EVOL, V50, P276, DOI 10.1111/j.1759-6831.2012.00194.x; Zhang JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112923; Zhang Q, 2005, MOL ECOL, V14, P3513, DOI 10.1111/j.1365-294X.2005.02677.x; Zhang XM, 2013, J SYST EVOL, V51, P564, DOI 10.1111/jse.12026; [张镱锂 Zhang Yili], 2002, [地理研究, Geographical Research], V21, P1; Zhao C, 2013, J SYST EVOL, V51, P382, DOI 10.1111/jse.12005; Zou JB, 2012, J SYST EVOL, V50, P341, DOI 10.1111/j.1759-6831.2012.00207.x	75	17	20	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2017	12	5							e0177101	10.1371/journal.pone.0177101	http://dx.doi.org/10.1371/journal.pone.0177101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SX	28475607	Green Submitted, Green Published, gold			2022-12-26	WOS:000400649500046
J	Iwamoto, N; Tsuji, S; Takatani, A; Shimizu, T; Fukui, S; Umeda, M; Nishino, A; Horai, Y; Koga, T; Kawashiri, SY; Aramaki, T; Ichinose, K; Hirai, Y; Tamai, M; Nakamura, H; Terada, K; Origuchi, T; Eguchi, K; Ueki, Y; Kawakami, A				Iwamoto, Naoki; Tsuji, Sosuke; Takatani, Ayuko; Shimizu, Toshimasa; Fukui, Shoichi; Umeda, Masataka; Nishino, Ayako; Horai, Yoshiro; Koga, Tomohiro; Kawashiri, Shin-ya; Aramaki, Toshiyuki; Ichinose, Kunihiro; Hirai, Yasuko; Tamai, Mami; Nakamura, Hideki; Terada, Kaoru; Origuchi, Tomoki; Eguchi, Katsumi; Ueki, Yukitaka; Kawakami, Atsushi			Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritis	PLOS ONE			English	Article							METHOTREXATE; CP-690,550; PLACEBO; COMBINATION; INHIBITION; ADALIMUMAB; OUTCOMES	Objective We evaluated the efficacy and safety of tofacitinib in patients with rheumatoid arthritis (RA) in a real-world setting. Methods Seventy consecutive patients, for whom tofacitinib was initiated between November 2013 and May 2016, were enrolled. All patients fulfilled the 2010 ACR/EULAR classification criteria for RA. All patients received 5 mg of tofacitinib twice daily and were followed for 24 weeks. Clinical disease activity indicated by disease activity score (DAS) 28-ESR, the simplified disease activity index, and the clinical disease activity index as well as adverse events (AEs) were evaluated. Statistical analysis was performed to determine which baseline variables influenced the efficacy of tofacitinib at 24 weeks. Results Fifty-eight patients (82.9%) continued tofacitinib at 24 weeks. Clinical disease activity rapidly and significantly decreased, and this efficacy continued throughout the 24 weeks: i.e., DAS28-ESR decreased from 5.04 +/- 1.33 at baseline to 3.83 +/- 1.11 at 4 weeks and 3.53 +/- 1.17 at 24 weeks (P<0.0001, vs. baseline). 15 AEs including 5 herpes zoster infection occurred during tofacitinib treatment. The efficacy of tofacitinib was not changed in patients without concomitant use of methotrexate (MTX) or patients whose treatment with tocilizumab (TCZ) failed. Multivariable logistic analysis showed that the number of biologic DMARDs (bDMARDs) previously used was independently associated with achievement of DAS-low disease activity. Conclusions Our present study suggests that tofacitinib is effective in real-world settings even without concomitant MTX use or after switching from TCZ. Our results also suggest that its efficacy diminishes if started after use of multiple bDMARDs.	[Iwamoto, Naoki; Takatani, Ayuko; Shimizu, Toshimasa; Fukui, Shoichi; Umeda, Masataka; Nishino, Ayako; Horai, Yoshiro; Koga, Tomohiro; Ichinose, Kunihiro; Hirai, Yasuko; Tamai, Mami; Nakamura, Hideki; Kawakami, Atsushi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Immunol & Rheumatol, Unit Adv Prevent Med Sci, Nagasaki, Japan; [Tsuji, Sosuke; Aramaki, Toshiyuki; Terada, Kaoru; Eguchi, Katsumi; Ueki, Yukitaka] Sasebo Chuo Hosp, Dept Rheumatol, Sasebo, Japan; [Kawashiri, Shin-ya] Nagasaki Univ, Grad Sch Biomed Sci, Dept Community Med, Unit Adv Prevent Med Sci, Nagasaki, Japan; [Origuchi, Tomoki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Phys Therapy, Nagasaki, Japan	Nagasaki University; Nagasaki University; Nagasaki University	Iwamoto, N (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Immunol & Rheumatol, Unit Adv Prevent Med Sci, Nagasaki, Japan.	naoki-iwa@nagasaki-u.ac.jp	Koga, Tomohiro/V-9397-2019; Umeda, Masataka/GVT-5444-2022; Ichinose, Kunihiro/I-2126-2019; Koga, Tomohiro/AAU-9697-2020	Umeda, Masataka/0000-0002-6647-7130; Ichinose, Kunihiro/0000-0001-8794-7106; Koga, Tomohiro/0000-0003-2077-4428	Grants-in-Aid for Scientific Research [16K19605, 17K16210] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Aletaha D, 2005, CLIN EXP RHEUMATOL, V23, pS100; Burmester GR, 2013, LANCET, V381, P451, DOI 10.1016/S0140-6736(12)61424-X; Conklyn M, 2004, J LEUKOCYTE BIOL, V76, P1248, DOI 10.1189/jlb.0504282; Curtis JR, 2016, ANN RHEUM DIS, V75, P831, DOI 10.1136/annrheumdis-2014-205847; Emery P, 2008, ANN RHEUM DIS, V67, P1516, DOI 10.1136/ard.2008.092932; Emery P, 2015, ANN RHEUM DIS, V74, P979, DOI 10.1136/annrheumdis-2013-203993; Fleischmann R, 2012, NEW ENGL J MED, V367, P495, DOI 10.1056/NEJMoa1109071; Hyrich KL, 2007, ARTHRITIS RHEUM-US, V56, P13, DOI 10.1002/art.22331; Inoue E, 2007, ANN RHEUM DIS, V66, P407, DOI 10.1136/ard.2006.054205; Karisson JA, 2008, RHEUMATOLOGY, V47, P507, DOI 10.1093/rheumatology/ken034; Keystone E, 2009, ANN RHEUM DIS, V68, P216, DOI 10.1136/ard.2007.085787; Kiltz U, 2017, ANN RHEUM DIS, V76, DOI 10.1136/annrheumdis-2016-209467; Kremer J, 2013, ANN INTERN MED, V159, P253, DOI 10.7326/0003-4819-159-4-201308200-00006; Lee EB, 2014, NEW ENGL J MED, V370, P2377, DOI 10.1056/NEJMoa1310476; Lee YH, 2015, RHEUMATOL INT, V35, P1965, DOI 10.1007/s00296-015-3291-4; Maeshima K, 2012, ARTHRITIS RHEUM-US, V64, P1790, DOI 10.1002/art.34329; Malmgaard L, 2004, J INTERF CYTOK RES, V24, P439, DOI 10.1089/1079990041689665; Paniagua R, 2005, TRANSPLANTATION, V80, P1283, DOI 10.1097/01.tp.0000177643.05739.cd; SCOTT DL, 2010, ANN RHEUM DIS, V69, DOI DOI 10.1016/S0140-6736(10)60826-4; Singh JA, 2016, ARTHRIT CARE RES, V68, P1, DOI 10.1002/acr.22783; Takeuchi T, 2012, MOD RHEUMATOL, V22, P327, DOI 10.1007/s10165-011-0516-6; van der Heijde D, 2013, ARTHRITIS RHEUM-US, V65, P559, DOI 10.1002/art.37816; van Vollenhoven RF, 2012, NEW ENGL J MED, V367, P508, DOI 10.1056/NEJMoa1112072; Winthrop KL, 2014, ARTHRITIS RHEUMATOL, V66, P2675, DOI 10.1002/art.38745	24	18	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177057	10.1371/journal.pone.0177057	http://dx.doi.org/10.1371/journal.pone.0177057			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472115	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500131
J	Kim, HJ; Jo, MJ; Kim, BR; Kim, JL; Jeong, YA; Na, YJ; Park, SH; Lee, SY; Lee, DH; Lee, HS; Kim, BH; Lee, SI; Min, BW; Do Yoo, Y; Oh, SC				Kim, Hong Jun; Jo, Min Jee; Kim, Bo Ram; Kim, Jung Lim; Jeong, Yoon A.; Na, Yoo Jin; Park, Seong Hye; Lee, Suk-young; Lee, Dae-Hee; Lee, Hye Seung; Kim, Beek-hui; Lee, Sun Il; Min, Byung Wook; Do Yoo, Young; Oh, Sang Cheul			Reactive oxygen species modulator-1 (Romo1) predicts unfavorable prognosis in colorectal cancer patients	PLOS ONE			English	Article							NF-KAPPA-B; III COLON-CANCER; LYMPH-NODE RATIO; OXIDATIVE STRESS; ADJUVANT TREATMENT; VASCULAR INVASION; STAGE-II; TUMOR; FLUOROURACIL; OXALIPLATIN	Background Reactive oxygen species modulator-1 (Romo1) is a novel protein that has been reported to be crucial for cancer cell proliferation and invasion. However, its clinical implications in colorectal cancer patients are not well-known. For the first time, we investigated the association between Romo1 and the clinical outcomes of colorectal cancer patients. Study We examined Romo1 expression in resected tumor tissues immunohistochemically and assessed it with histological scores. We conducted survival analyses for patients who had curative resection (n = 190) in accordance with clinical parameters including level of Romo1 expression, and we examined the association between Romo1 expression and cell invasion using Matrigel invasion assay in colorectal cancer cells. Results We observed significantly longer mean disease-free survival in the low Romo1 group compared with the high Romo1 group (161 vs 127.6 months, p = 0.035), and the median overall survival of the low Romo1 group was significantly longer than that of the high Romo1 group (196.9 vs 171.3 months, p = 0.036). Cell invasiveness decreased in the Romo1 knockdown colorectal cancer cells in contrast to the controlled cells. Romo1 overexpression in tumor tissue was associated with a high lymph node ratio between the metastatic and examined lymph nodes (p = 0.025). Conclusions Romo1 overexpression in tumor tissue was significantly associated with survival in curatively resected colorectal cancer patients, suggesting Romo1 expression as a potential adverse prognostic marker. Increased Romo1 expression was found to be associated with high lymph node ratio. Cancer invasiveness appeared to be a key reason for the poor survival related to highly expressed Romo1.	Korea Univ, Coll Med, Dept Internal Med, Div Oncol Hematol, Seoul, South Korea; [Jo, Min Jee; Kim, Bo Ram; Kim, Jung Lim; Jeong, Yoon A.; Na, Yoo Jin; Park, Seong Hye; Lee, Dae-Hee; Oh, Sang Cheul] Korea Univ, Korea Univ Coll Med, Grad Sch Med, Seoul, South Korea; [Lee, Hye Seung; Kim, Beek-hui] Korea Univ, Korea Univ Guro Hosp, Coll Med, Dept Pathol, Seoul, South Korea; [Lee, Sun Il; Min, Byung Wook] Korea Univ, Korea Univ Guro Hosp, Coll Med, Dept Surg, Seoul, South Korea; [Do Yoo, Young] Korea Univ, Grad Sch Med, Lab Mol Cell Biol, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Oh, SC (corresponding author), Korea Univ, Korea Univ Coll Med, Grad Sch Med, Seoul, South Korea.	sachoh@korea.ac.kr		Yoo, Doo-Yeol/0000-0003-2814-5482; Min, Byung Wook/0000-0002-3621-5113	Business for Cooperative RAMP;D between Industry, Academy, and Research Institute [C0421445]; Brain Korea (BK) 21 Plus Program	Business for Cooperative RAMP;D between Industry, Academy, and Research Institute; Brain Korea (BK) 21 Plus Program	This work was supported (Grants No. C0421445) by Business for Cooperative R&D between Industry, Academy, and Research Institute funded Korea Small and Medium Business Administration in 20. This research was supported by the Brain Korea (BK) 21 Plus Program also.	Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3; Benedix F, 2010, DIS COLON RECTUM, V53, P57, DOI 10.1007/DCR.0b013e3181c703a4; Chung JS, 2014, BIOCHEM BIOPH RES CO, V450, P1656, DOI 10.1016/j.bbrc.2014.07.059; Chung JS, 2012, GASTROENTEROLOGY, V143, P1084, DOI 10.1053/j.gastro.2012.06.038; Chung YM, 2006, BIOCHEM BIOPH RES CO, V347, P649, DOI 10.1016/j.bbrc.2006.06.140; Dua RS, 2005, EJSO-EUR J SURG ONC, V31, P824, DOI 10.1016/j.ejso.2005.05.015; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fujii T, 2014, ANTICANCER RES, V34, P1255; Hwang IT, 2007, BIOCHEM BIOPH RES CO, V359, P304, DOI 10.1016/j.bbrc.2007.05.088; Jackson AL, 2001, MUTAT RES-FUND MOL M, V477, P7, DOI 10.1016/S0027-5107(01)00091-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060; Karkkainen MJ, 2002, NAT CELL BIOL, V4, pE2, DOI 10.1038/ncb0102-e2; Kim HJ, 2006, CELL DEATH DIFFER, V13, P738, DOI 10.1038/sj.cdd.4401877; Kuebler JP, 2007, J CLIN ONCOL, V25, P2198, DOI 10.1200/JCO.2006.08.2974; Ladas EJ, 2004, J CLIN ONCOL, V22, P517, DOI 10.1200/JCO.2004.03.086; Lee HY, 2007, ANN SURG ONCOL, V14, P1712, DOI 10.1245/s10434-006-9322-3; Lee SH, 2015, LUNG CANCER, V87, P45, DOI 10.1016/j.lungcan.2014.11.004; Lee SH, 2014, LUNG CANCER, V85, P175, DOI 10.1016/j.lungcan.2014.05.023; Lee SH, 2016, CANC RES TREATMENT O; Lee S, 2015, INT J ONCOL, V46, P2021, DOI 10.3892/ijo.2015.2889; Lupinacci RM, 2014, WORLD J SURG, V38, P2089, DOI 10.1007/s00268-014-2511-5; Na AR, 2008, BIOCHEM BIOPH RES CO, V369, P672, DOI 10.1016/j.bbrc.2008.02.098; O'Connor ES, 2011, J CLIN ONCOL; Park YJ, 1999, WORLD J SURG, V23, P721, DOI 10.1007/PL00012376; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Sasaki N, 2001, CLIN CANCER RES, V7, P4136; Shyamsunder P, 2015, CANCER LETT, V361, P33, DOI 10.1016/j.canlet.2015.02.020; Sosa V, 2013, AGEING RES REV, V12, P376, DOI 10.1016/j.arr.2012.10.004; Stacker SA, 2002, NAT REV CANCER, V2, P573, DOI 10.1038/nrc863; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Ushio-Fukai M, 2007, ANTIOXID REDOX SIGN, V9, P731, DOI 10.1089/ars.2007.1556; Wang JP, 2008, ANN SURG ONCOL, V15, P1600, DOI 10.1245/s10434-007-9716-x; Wang ZB, 2001, BIOCHEM BIOPH RES CO, V285, P669, DOI 10.1006/bbrc.2001.5232; Wolpin BM, 2008, GASTROENTEROLOGY, V134, P1296, DOI 10.1053/j.gastro.2008.02.098; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Yamaki S, 2013, SURG TODAY, V43, P901, DOI 10.1007/s00595-012-0378-3; Yokota J, 2000, CARCINOGENESIS, V21, P497, DOI 10.1093/carcin/21.3.497	43	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176834	10.1371/journal.pone.0176834	http://dx.doi.org/10.1371/journal.pone.0176834			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472059	Green Submitted, Green Published, gold			2022-12-26	WOS:000400648500081
J	Perez-Padilla, R; Fernandez-Plata, R; de Oca, MM; Lopez-Varela, MV; Jardim, JR; Muino, A; Valdivia, G; Menezes, AMB				Perez-Padilla, Rogelio; Fernandez-Plata, Rosario; Montes de Oca, Maria; Victorina Lopez-Varela, Maria; Jardim, Jose R.; Muino, Adriana; Valdivia, Gonzalo; Menezes, Ana Maria B.		PLATINO Grp	Lung function decline in subjects with and without COPD in a population-based cohort in Latin-America	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIR-FLOW OBSTRUCTION; FEV1 DECLINE; SPIROMETRY; CITIES; RISK; TUBERCULOSIS; ASSOCIATION; DIAGNOSIS; PHENOTYPE	Background Lung-function decline is one of the possible mechanisms leading to Chronic Obstructive Pulmonary Disease (COPD). Methods We analyzed data obtained from two population-based surveys of adults (n = 2026) conducted in the same individuals 5-9 years (y) after their baseline examination in three Latin-American cities. Post BronchoDilator (postBD) FEV1 decline in mL/y, as % predicted/y (% P/y) and % of baseline/y (% B/y) was calculated and the influence of age, gender, BMI, baseline lung function, BD response, exacerbations rate evaluated using multivariate models. Results Expressed in ml/y, the mean annual postBD FEV1 decline was 27 mL (0.22%P, 1.32%B) in patients with baseline COPD and 36 (0.14%P, 1.36%B) in those without. Faster decline (in mL/y) was associated with higher baseline lung function, with significant response to bron-chodilators, older age and smoking at baseline, also in women with chronic cough and phlegm, or >= 2 respiratory exacerbations in the previous year, and in men with asthma. Conclusions Lung function decline in a population- based cohort did not differ in obstructed and nonobstructed individuals, it was proportional to baseline FEV1, and was higher in smokers, elderly, and women with respiratory symptoms.	[Perez-Padilla, Rogelio; Fernandez-Plata, Rosario] Natl Inst Resp Dis, Mexico City, DF, Mexico; [Montes de Oca, Maria] Univ Cent Venezuela, Hosp Univ Caracas, Pulm Div, Caracas, Venezuela; [Victorina Lopez-Varela, Maria; Muino, Adriana] Univ Republica, Fac Med, Montevideo, Uruguay; [Jardim, Jose R.] Univ Fed Sao Paulo, Sch Med, Pelotas, Brazil; [Menezes, Ana Maria B.] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil	University of Central Venezuela; Universidad de la Republica, Uruguay; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Pelotas	Perez-Padilla, R (corresponding author), Natl Inst Resp Dis, Mexico City, DF, Mexico.	perezpad@gmail.com	Menezes, Ana MB/G-7266-2012; de, Maria Montes/AAP-7687-2021	Menezes, Ana MB/0000-0002-2996-9427; Perez-Padilla, Rogelio/0000-0002-1132-5308; Reis, AlessanRSS/0000-0001-8486-7469; Valdivia, Gonzalo/0000-0001-5368-6745	ALAT; Boehringer; GSK; Novartis	ALAT; Boehringer(Boehringer Ingelheim); GSK(GlaxoSmithKline); Novartis(Novartis)	The study was sponsored by ALAT, Boehringer, GSK, and Novartis. This does not alter our adherence to PLUS ONE policies on sharing data and materials, in a public repository.	Allwood BW, 2013, RESPIRATION, V86, P76, DOI 10.1159/000350917; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Casanova C, 2011, AM J RESP CRIT CARE, V184, P1015, DOI 10.1164/rccm.201105-0831OC; Ferguson GT, 2000, CHEST, V117, P1146, DOI 10.1378/chest.117.4.1146; Grol MH, 1999, AM J RESP CRIT CARE, V160, P1830, DOI 10.1164/ajrccm.160.6.9812100; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Hardie JA, 2002, EUR RESPIR J, V20, P1117, DOI 10.1183/09031936.02.00023202; Hnizdo E, 2000, THORAX, V55, P32, DOI 10.1136/thorax.55.1.32; Lange P, 2015, NEW ENGL J MED, V373, P111, DOI 10.1056/NEJMoa1411532; Menezes AMB, 2005, LANCET, V366, P1875, DOI 10.1016/S0140-6736(05)67632-5; Menezes Ana M B, 2004, BMC Med Res Methodol, V4, P15, DOI 10.1186/1471-2288-4-15; Menezes AMB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109732; Menezes AMB, 2014, CHEST, V145, P297, DOI 10.1378/chest.13-0622; Menezes AMB, 2014, ARCH BRONCONEUMOL, V50, P10, DOI 10.1016/j.arbres.2013.07.014; de Oca MM, 2012, EUR RESPIR J, V40, P28, DOI 10.1183/09031936.00141611; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Perez-Padilla Rogelio, 2007, COPD, V4, P113, DOI 10.1080/15412550701341012; Perez-Padilla R, 2006, ARCH BRONCONEUMOL, V42, P317, DOI 10.1157/13090581; Perez-Padilla R, 2012, ARCH MED RES, V43, P159, DOI 10.1016/j.arcmed.2012.03.007; Postma DS, 2015, LANCET, V385, P899, DOI 10.1016/S0140-6736(14)60446-3; Ramirez-Venegas A, 2014, AM J RESP CRIT CARE, V190, P996, DOI 10.1164/rccm.201404-0720OC; Skloot GS, 2009, CHEST, V135, P492, DOI 10.1378/chest.08-1391; Tantucci C, 2012, INT J CHRONIC OBSTR, V7, P95, DOI 10.2147/COPD.S27480; Thomsen LH, 2014, COPD, V11, P96, DOI 10.3109/15412555.2013.830096; Vestbo J, 1996, AM J RESP CRIT CARE, V153, P1530, DOI 10.1164/ajrccm.153.5.8630597; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Vollmer WM, 2009, EUR RESPIR J, V34, P588, DOI 10.1183/09031936.00164608	27	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177032	10.1371/journal.pone.0177032	http://dx.doi.org/10.1371/journal.pone.0177032			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472184	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500124
J	Rios-Anjos, RM; Camandona, VDL; Bleicher, L; Ferreira, JR				Rios-Anjos, Rafaela Maria; Camandona, Vittoria de Lima; Bleicher, Lucas; Ferreira-Junior, Jose Ribamar			Structural and functional mapping of Rtg2p determinants involved in retrograde signaling and aging of Saccharomyces cerevisiae	PLOS ONE			English	Article							REPLICATIVE LIFE-SPAN; MITOCHONDRIAL DYSFUNCTION; ESCHERICHIA-COLI; DEPENDENT MITOCHONDRIA; STRUCTURE PREDICTION; RESPONSE PATHWAY; GENE-EXPRESSION; YEAST LONGEVITY; PROTEIN; NUCLEUS	In Saccharomyces cerevisiae mitochondrial dysfunction induces retrograde signaling, a pathway of communication from mitochondria to the nucleus that promotes a metabolic remodeling to ensure sufficient biosynthetic precursors for replication. Rtg2p is a positive modulator of this pathway that is also required for cellular longevity. This protein belongs to the ASKHA superfamily, and contains a putative N-terminal ATP-binding domain, but there is no detailed structural and functional map of the residues in this domain that accounts for their contribution to retrograde signaling and aging. Here we use Decomposition of Residue Correlation Networks and site-directed mutagenesis to identify Rtg2p structural determinants of retrograde signaling and longevity. We found that most of the residues involved in retrograde signaling surround the ATP-binding loops, and that Rtg2p N-terminus is divided in three regions whose mutants have different aging phenotypes. We also identified E137, D158 and S163 as possible residues involved in stabilization of ATP at the active site. The mutants shown here may be used to map other Rtg2p activities that crosstalk to other pathways of the cell related to genomic stability and aging.	[Rios-Anjos, Rafaela Maria; Camandona, Vittoria de Lima; Ferreira-Junior, Jose Ribamar] Univ Sao Paulo, Escola Aries Ciencias & Humanidades, Sao Paulo, Brazil; [Bleicher, Lucas] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil	Universidade de Sao Paulo; Universidade Federal de Minas Gerais	Ferreira, JR (corresponding author), Univ Sao Paulo, Escola Aries Ciencias & Humanidades, Sao Paulo, Brazil.	zeribajr@usp.br	Bleicher, Lucas/AAH-9397-2021; Bleicher, Lucas/R-5153-2019; Ferreira-Junior, Jose Ribamar S/B-6951-2012; Bleicher, Lucas/B-7967-2013	Bleicher, Lucas/0000-0001-7121-4952; Ferreira-Junior, Jose Ribamar S/0000-0001-5539-5298; Bleicher, Lucas/0000-0001-7121-4952	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (www.fapesp.br) to JRFJ.	AKIYAMA M, 1993, J BIOL CHEM, V268, P633; Alvarado J, 2006, STRUCTURE, V14, P1263, DOI 10.1016/j.str.2006.06.009; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bhattacharya D, 2013, PROTEINS, V81, P119, DOI 10.1002/prot.24167; Bhattacharyya S, 2002, GENETICS, V162, P579; Bleicher L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027786; Borghouts C, 2004, GENETICS, V166, P765, DOI 10.1534/genetics.166.2.765; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUNYA M, 1991, MOL CELL BIOL, V11, P3229, DOI 10.1128/MCB.11.6.3229; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Chen S, 2008, MOL BIOL CELL, V19, P5047, DOI 10.1091/mbc.E08-05-0486; CONRADWEBB H, 1995, MOL CELL BIOL, V15, P2420; Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297; Ferreira JR, 2005, GENE, V354, P2, DOI 10.1016/j.gene.2005.03.048; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Giannattasio S, 2005, J BIOL CHEM, V280, P42528, DOI 10.1074/jbc.M509187200; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GLAB N, 1993, MOL GEN GENET, V236, P299, DOI 10.1007/BF00277126; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Hurley JH, 1996, ANNU REV BIOPH BIOM, V25, P137; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jazwinski SM, 2005, FEMS YEAST RES, V5, P1253, DOI 10.1016/j.femsyr.2005.07.001; Jia YK, 1997, MOL CELL BIOL, V17, P1110, DOI 10.1128/MCB.17.3.1110; Jiang JC, 2016, GENETICS, V204, P659, DOI 10.1534/genetics.116.188086; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kirchman PA, 1999, GENETICS, V152, P179; KOONIN EV, 1994, TRENDS BIOCHEM SCI, V19, P156, DOI 10.1016/0968-0004(94)90275-5; Kristensen O, 2004, BIOCHEMISTRY-US, V43, P8894, DOI 10.1021/bi049083c; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; LIAO XS, 1991, MOL CELL BIOL, V11, P38, DOI 10.1128/MCB.11.1.38; Liu ZC, 2003, MOL CELL, V12, P401, DOI 10.1016/S1097-2765(03)00285-5; Liu ZC, 1999, MOL CELL BIOL, V19, P6720; Liu ZC, 2001, EMBO J, V20, P7209, DOI 10.1093/emboj/20.24.7209; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; PARIKH VS, 1987, SCIENCE, V235, P576, DOI 10.1126/science.3027892; Pray-Grant MG, 2002, MOL CELL BIOL, V22, P8774, DOI 10.1128/MCB.22.24.8774-8786.2002; Rangarajan ES, 2006, J MOL BIOL, V359, P1249, DOI 10.1016/j.jmb.2006.04.031; Rupp S, 2002, METHOD ENZYMOL, V350, P112, DOI 10.1016/S0076-6879(02)50959-9; Schuler H, 2001, BBA-PROTEIN STRUCT M, V1549, P137, DOI 10.1016/S0167-4838(01)00255-2; Sekito T, 2000, MOL BIOL CELL, V11, P2103, DOI 10.1091/mbc.11.6.2103; Sekito T, 2002, MOL BIOL CELL, V13, P795, DOI 10.1091/mbc.01-10-0473; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Sinclair DA, 2013, METHODS MOL BIOL, V1048, P49, DOI 10.1007/978-1-62703-556-9_5; Sippl MJ, 2012, STRUCTURE, V20, P718, DOI 10.1016/j.str.2012.01.024; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Wiederstein M, 2014, STRUCTURE, V22, P1063, DOI 10.1016/j.str.2014.05.005; Wykoff DD, 2001, GENETICS, V159, P1491; Zhang F, 2013, GENES-BASEL, V4, P86, DOI 10.3390/genes4010086; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	55	4	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0177090	10.1371/journal.pone.0177090	http://dx.doi.org/10.1371/journal.pone.0177090			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472157	Green Submitted, gold, Green Published			2022-12-26	WOS:000400648500133
J	Tabori, H; Arnold, C; Jaudszus, A; Mentzel, HJ; Renz, DM; Reinsch, S; Lorenz, M; Michl, R; Gerber, A; Lehmann, T; Mainz, JG				Tabori, Harold; Arnold, Christin; Jaudszus, Anke; Mentzel, Hans-Joachim; Renz, Diane M.; Reinsch, Steffen; Lorenz, Michael; Michl, Ruth; Gerber, Andrea; Lehmann, Thomas; Mainz, Jochen G.			Abdominal symptoms in cystic fibrosis and their relation to genotype, history, clinical and laboratory findings	PLOS ONE			English	Article							QUALITY-OF-LIFE; G551D MUTATION; LIVER-DISEASE; INTESTINAL INFLAMMATION; SCHOOL-CHILDREN; CHRONIC PAIN; CFTR; ADOLESCENTS; MANIFESTATIONS; CIPROFLOXACIN	Background & aims Abdominal symptoms ( AS) are a hallmark of the multiorgan-disease cystic fibrosis CF). However, the abdominal involvement in CF is insufficiently understood and, compared to the pulmonary manifestation, still receives little scientific attention. Aims were to assess and quantify AS and to relate them to laboratory parameters, clinical findings, and medical history. Methods A total of 131 patients with CF of all ages were assessed with a new CF-specific questionnaire JenAbdomen- CF score 1.0) on abdominal pain and non-pain symptoms, disorders of appetite, eating, and bowel movements as well as symptom-related quality of life. Results were metrically dimensioned and related to abdominal manifestations, history of surgery, P. aeruginosa and S. aureus colonization, genotype, liver enzymes, antibiotic therapy, lung function, and nutritional status. Results AS during the preceding 3 months were reported by all of our patients. Most common were lack of appetite 130/131) and loss of taste 119/131) followed by abdominal pain 104/131), flatulence 102/131), and distention 83/131). Significantly increased AS were found in patients with history of rectal prolapse p = 0.013), distal intestinal obstruction syndrome p = 0.013), laparotomy p = 0.022), meconium ileus p = 0.037), pancreas insufficiency p = 0.042), or small bowel resection p = 0.048) as well as in patients who have been intermittently colonized with P. aeruginosa p = 0.006) compared to patients without history of these events. In contrast, no statistically significant associations were found to CF-associated liver disease, chronic pathogen colonization, lung function, CF-related diabetes, and nutritional status. Conclusion As the complex abdominal involvement in CF is still not fully understood, the assessment of the common AS is of major interest. In this regard, symptom questionnaires like the herein presented are meaningful and practical tools facilitating a wider understanding of the abdominal symptoms in CF. Furthermore, they render to evaluate possible abdominal effects of novel modulators of the underlying cystic fibrosis transmembrane (conductance) regulator (CFTR) defect.	[Tabori, Harold; Arnold, Christin; Jaudszus, Anke; Lorenz, Michael; Michl, Ruth; Gerber, Andrea; Mainz, Jochen G.] Jena Univ Hosp, Cyst Fibrosis Ctr, Jena, Germany; [Mentzel, Hans-Joachim; Renz, Diane M.] Jena Univ Hosp, Pediat Radiol, Jena, Germany; [Reinsch, Steffen] Jena Univ Hosp, Pediat Gastroenterol, Jena, Germany; [Lehmann, Thomas] Jena Univ Hosp, Inst Med Stat, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Mainz, JG (corresponding author), Jena Univ Hosp, Cyst Fibrosis Ctr, Jena, Germany.	Jochen.Mainz@med.uni-jena.de	Mainz, Jochen G/AFO-0929-2022	Lorenz, Michael/0000-0001-6153-2068; Mainz, Jochen G./0000-0003-3780-7759	German Academic Exchange Service (DAAD) [57130097]	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This research was supported by the German Academic Exchange Service (DAAD, Grant: 57130097) to HT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APLEY J, 1958, ARCH DIS CHILD, V33, P165, DOI 10.1136/adc.33.168.165; Blackwell LS, 2015, PEDIATR PULM, V50, P244, DOI 10.1002/ppul.23091; Borowitz D, 2002, J PEDIATR GASTR NUTR, V35, P246, DOI 10.1097/00005176-200209000-00004; Borzio M, 1997, ITAL J GASTROENTEROL, V29, P262; Britto MT, 2002, CHEST, V121, P64, DOI 10.1378/chest.121.1.64; Bruzzese E, 2004, ALIMENT PHARM THER, V20, P813, DOI 10.1111/j.1365-2036.2004.02174.x; Bruzzese E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087796; Chaudry G, 2006, PEDIATR RADIOL, V36, P233, DOI 10.1007/s00247-005-0049-2; Chumpitazi BP, 2010, J PEDIATR-US, V157, P594, DOI 10.1016/j.jpeds.2010.04.040; Colombo C, 2007, CURR OPIN PULM MED, V13, P529, DOI 10.1097/MCP.0b013e3282f10a16; Comer DM, 2009, QJM-INT J MED, V102, P793, DOI 10.1093/qjmed/hcp120; Davies JC, 2013, AM J RESP CRIT CARE, V187, P1219, DOI 10.1164/rccm.201301-0153OC; Debray D, 2011, J CYST FIBROS, V10, pS29, DOI 10.1016/S1569-1993(11)60006-4; Dhaliwal J, 2015, J PEDIATR GASTR NUTR, V60, P521, DOI 10.1097/MPG.0000000000000683; Dray X, 2004, CLIN GASTROENTEROL H, V2, P498, DOI 10.1016/S1542-3565(04)00169-7; Festini Filippo, 2004, J Cyst Fibros, V3, P51, DOI 10.1016/j.jcf.2003.12.001; Food and Drug Administration U.S. Department of Health and Human Services, 2009, GUID IND PAT REP OUT; Fraquelli M, 2016, DIGEST LIVER DIS, V48, P271, DOI 10.1016/j.dld.2015.09.010; Gu YH, 2015, J PEDIATR-US, V166, P897, DOI 10.1016/j.jpeds.2014.12.063; Harland NJ, 2015, PHYSIOTHERAPY, V101, P50, DOI 10.1016/j.physio.2014.06.004; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Kainzwaldner V, 2013, ANAESTHESIST, V62, P453, DOI 10.1007/s00101-013-2177-7; Kelly T, 2015, DIGEST DIS SCI, V60, P1903, DOI 10.1007/s10620-015-3546-7; Koh JL, 2005, PEDIATR PULM, V40, P330, DOI 10.1002/ppul.20292; Kromeyer-Hauschild K, 1999, INT J OBESITY, V23, P1143, DOI 10.1038/sj.ijo.0801044; Lane MM, 2011, J PEDIATR-US, V159, P437, DOI 10.1016/j.jpeds.2011.03.002; Lee AL, 2016, CHRON RESP DIS, V13, P102, DOI 10.1177/1479972316631135; Lee Tim W R, 2003, J Cyst Fibros, V2, P29, DOI 10.1016/S1569-1993(02)00141-8; Li L, 2014, CLIN NUTR, V33, P571, DOI 10.1016/j.clnu.2014.04.004; MCGRATH PA, 1987, PAIN, V31, P147, DOI 10.1016/0304-3959(87)90033-9; McKay K, 2015, J CYST FIBROS, V14, pS117; Modi AC, 2006, J CYST FIBROS, V5, P177, DOI 10.1016/j.jcf.2006.03.002; Munck A, 2014, INT J BIOCHEM CELL B, V52, P180, DOI 10.1016/j.biocel.2014.02.005; Munck A, 2012, J CYST FIBROS, V11, P46, DOI 10.1016/j.jcf.2011.07.010; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Ooi CY, 2016, NAT REV GASTRO HEPAT, V13, P175, DOI 10.1038/nrgastro.2015.226; Ooi CY, 2012, J CYST FIBROS, V11, P355, DOI 10.1016/j.jcf.2012.05.001; Ooi CY, 2011, GASTROENTEROLOGY, V140, P153, DOI 10.1053/j.gastro.2010.09.046; Palermo TM, 2006, CLIN J PAIN, V22, P532, DOI 10.1097/01.ajp.0000210996.45459.76; Parad RB, 1996, J MED GENET, V33, P711, DOI 10.1136/jmg.33.8.711; Perquin CW, 2000, PAIN, V87, P51, DOI 10.1016/S0304-3959(00)00269-4; Quittner AL, 2005, CHEST, V128, P2347, DOI 10.1378/chest.128.4.2347; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Ravilly S, 1996, PEDIATRICS, V98, P741; RIORDAN JR, 1989, SCIENCE, V245, P1066; Robertson MB, 2006, RADIOGRAPHICS, V26, P679, DOI 10.1148/rg.263055101; ROTH PL, 1994, PERS PSYCHOL, V47, P537, DOI 10.1111/j.1744-6570.1994.tb01736.x; SAVEDRA MC, 1989, RES NURS HEALTH, V12, P307, DOI 10.1002/nur.4770120506; Schmidt A, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-97; Sermet-Gaudelus I, 2009, J PAIN SYMPTOM MANAG, V38, P281, DOI 10.1016/j.jpainsymman.2008.08.009; Shoff SM, 2013, J CYST FIBROS, V12, P746, DOI 10.1016/j.jcf.2013.01.006; Staufer K, 2014, INT J MOL SCI, V15, P13529, DOI 10.3390/ijms150813529; Stenekes SJ, 2009, J PAIN SYMPTOM MANAG, V38, P837, DOI 10.1016/j.jpainsymman.2009.04.029; Sullivan A, 2001, Lancet Infect Dis, V1, P101, DOI 10.1016/S1473-3099(01)00066-4; Uusijarvi A, 2014, NEUROGASTROENT MOTIL, V26, P841, DOI 10.1111/nmo.12340; van der Doef Hubert P J, 2011, Curr Gastroenterol Rep, V13, P265, DOI 10.1007/s11894-011-0185-9; Venuti E, 2015, J CYST FIBROS, V14, pS51, DOI DOI 10.1016/s1569-1993(15)30165-x; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547; Werlin SL, 2010, J PEDIATR GASTR NUTR, V51, P304, DOI 10.1097/MPG.0b013e3181d1b013; WISTROM J, 1992, J ANTIMICROB CHEMOTH, V30, P693, DOI 10.1093/jac/30.5.693	60	33	34	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0174463	10.1371/journal.pone.0174463	http://dx.doi.org/10.1371/journal.pone.0174463			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472055	Green Submitted, Green Published, gold			2022-12-26	WOS:000400648500005
J	Xu, TS; Gu, LH; Huang, W; Xia, WL; Zhang, YS; Zhang, YG; Rong, G; Schachtschneider, K; Hou, SS				Xu, Tie-Shan; Gu, Li-Hong; Huang, Wei; Xia, Wan-Liang; Zhang, Yun-Sheng; Zhang, Ya-Ge; Rong, Guang; Schachtschneider, Kyle; Hou, Shui-Sheng			Gene expression profiling in Pekin duck embryonic breast muscle	PLOS ONE			English	Article							RNA-SEQ; PECTORALIS-MUSCLE; SKELETAL; ADIPOGENESIS; HYPERTROPHY; MYOGENESIS; PROTEINS; ATROPHY; TOOL	Lean-type Pekin duck is a breed gained through long-term selection and great effort has been exerted to understand the mechanisms underlying increased muscle yields. However, the genes involved in Pekin duck embryonic breast muscle development have not been explored to date. In this study, we investigated gene expression profiles in Pekin Duck embryonic breast muscle at hatched day 13 (E13), E19, and E27 using RNA-seq. In total, we produced 519,312,178 raw reads resulting in 497,348,158 high-quality reads after filtering. The mapping, distribution of reads along annotated genes, and consistency across replicates demonstrates the high quality of the RNA-seq data used in this study, allowing us to continue with the downstream analysis. Significantly fewer differentially expressed genes (DEGs) were identified between E13 and E19 (203 DEGs) compared to E27 and E19 (2,797 DEGs). Many DEGs highly expressed in E19 are involved in metabolic processes and cell division. KEGG analysis showed many pathways associated with fat development were significantly enriched for DEGs highly expressed in E27. These results provide a basis for the further investigation of the mechanisms involved in Pekin duck embryonic breast muscle development.	[Xu, Tie-Shan; Xia, Wan-Liang; Zhang, Ya-Ge; Rong, Guang] Chinese Acad Trop Agr Sci, Trop Crop Genet Resource Res Inst, Danzhou, Hainan, Peoples R China; [Gu, Li-Hong] Inst Anim Sci Vet, Hainan Acad Agr Sci, Haikou, Peoples R China; [Huang, Wei; Zhang, Yun-Sheng; Hou, Shui-Sheng] Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China; [Schachtschneider, Kyle] Univ Illinois, Dept Radiol, Chicago, IL USA	Chinese Academy of Tropical Agricultural Sciences; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Hou, SS (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China.	houss2010@163.com	zhang, yunsheng/AAP-8347-2021	Schachtschneider, Kyle/0000-0002-7293-8642	earmarked fund for China Agriculture Research System [CARS-43-1, CARS-43-42]	earmarked fund for China Agriculture Research System	Financial support of this work was provided by the earmarked fund for China Agriculture Research System (grant numbers: CARS-43-1, CARS-43-42). This grant is awarded to Shui-Sheng Hou, who is engaged in the Institute of Animal Science, Chinese Academy of Agricultural Sciences. In this study, Shui-Sheng Hou conformed the conceptualization and designed the study.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, ANN STAT, V29, P1165; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Chen W, 2012, EXP PHYSIOL, V97, P861, DOI 10.1113/expphysiol.2011.01083.x; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Fan RW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-389; Garin-Shkolnik T, 2014, DIABETES, V63, P900, DOI 10.2337/db13-0436; Goswami SC, 2014, J PAIN, V15, P1338, DOI 10.1016/j.jpain.2014.09.010; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Grifone R, 2007, DEV BIOL, V302, P602, DOI 10.1016/j.ydbio.2006.08.059; Gu LH, 2013, GENET MOL RES, V12, P6733, DOI 10.4238/2013.December.13.6; Gu LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086150; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Himes BE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099625; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kazantzis M, 2012, BBA-MOL CELL BIOL L, V1821, P852, DOI 10.1016/j.bbalip.2011.09.010; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Moore DT., 2005, INFLUENCE EARLY NUTR; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Patel K, 2002, RES PRO CEL, V38, P163; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Smith S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-375; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Velleman S. G., 2010, International Journal of Poultry Science, V9, P417; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; Wu WJ, 2014, INT J BIOL SCI, V10, P983, DOI 10.7150/ijbs.9442; Xu TS, 2015, GENET MOL RES, V14, P4448, DOI 10.4238/2015.May.4.2; Xu T. S., 2013, Journal of Animal and Veterinary Advances, V12, P852; Xu TS, 2013, GENET MOL RES, V12, P3166, DOI 10.4238/2013.February.28.18; Xu TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107574; Xu TS, 2012, MOL BIOL REP, V39, P7647, DOI 10.1007/s11033-012-1599-7; Zhang B, 2016, LIPIDS HLTH DIS, V15, P1; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644	39	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0174612	10.1371/journal.pone.0174612	http://dx.doi.org/10.1371/journal.pone.0174612			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	28472139	Green Submitted, Green Published, gold			2022-12-26	WOS:000400648500006
J	Rogiers, B; Mallants, D; Batelaan, O; Gedeon, M; Huysmans, M; Dassargues, A				Rogiers, Bart; Mallants, Dirk; Batelaan, Okke; Gedeon, Matej; Huysmans, Marijke; Dassargues, Alain			Model-based classification of CPT data and automated lithostratigraphic mapping for high-resolution characterization of a heterogeneous sedimentary aquifer	PLOS ONE			English	Article							HYDRAULIC CONDUCTIVITY; PENETRATION	Cone penetration testing (CPT) is one of the most efficient and versatile methods currently available for geotechnical, lithostratigraphic and hydrogeological site characterization. Currently available methods for soil behaviour type classification (SBT) of CPT data however have severe limitations, often restricting their application to a local scale. For parameterization of regional groundwater flow or geotechnical models, and delineation of regional hydroor lithostratigraphy, regional SBT classification would be very useful. This paper investigates the use of model-based clustering for SBT classification, and the influence of different clustering approaches on the properties and spatial distribution of the obtained soil classes. We additionally propose a methodology for automated lithostratigraphic mapping of regionally occurring sedimentary units using SBT classification. The methodology is applied to a large CPT dataset, covering a groundwater basin of similar to 60 km(2) with predominantly unconsolidated sandy sediments in northern Belgium. Results show that the model-based approach is superior in detecting the true lithological classes when compared to more frequently applied unsupervised classification approaches or literature classification diagrams. We demonstrate that automated mapping of lithostratigraphic units using advanced SBT classification techniques can provide a large gain in efficiency, compared to more time-consuming manual approaches and yields at least equally accurate results.	[Rogiers, Bart; Gedeon, Matej] Belgian Nucl Res Ctr SCK CEN, Inst Environm Hlth & Safety, Mol, Belgium; [Mallants, Dirk] CSIRO Land & Water, Glen Osmond, SA, Australia; [Batelaan, Okke] Flinders Univ S Australia, Sch Environm, Adelaide, SA, Australia; [Huysmans, Marijke] Katholieke Univ Leuven, Dept Earth & Environm Sci, Heverlee, Belgium; [Huysmans, Marijke] Vrije Univ Brussel, Dept Hydrol & Hydraul Engn, Brussels, Belgium; [Dassargues, Alain] Univ Liege, Dept Architecture Geol Environm & Civil Engn ArGE, Hydrogeol & Environm Geol, Liege, Belgium	Belgian Nuclear Research Centre (SCK-CEN); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Flinders University South Australia; KU Leuven; Vrije Universiteit Brussel; University of Liege	Rogiers, B (corresponding author), Belgian Nucl Res Ctr SCK CEN, Inst Environm Hlth & Safety, Mol, Belgium.	brogiers@sckcen.be	Huysmans, Marijke/C-3020-2012; Batelaan, Okke/M-9940-2019; Mallants, Dirk/A-5727-2012	Huysmans, Marijke/0000-0002-8499-8933; Batelaan, Okke/0000-0003-1443-6385; Mallants, Dirk/0000-0001-7282-1981; Dassargues, Alain/0000-0003-2247-8390; Rogiers, Bart/0000-0002-8836-0988	Fund for Scientific Research - Flanders	Fund for Scientific Research - Flanders(FWO)	The authors further wish to acknowledge the Fund for Scientific Research - Flanders for providing a Postdoctoral Fellowship to Marijke Huysmans.	Beach Robertson P.K., 2010, CPT 10 2 INT S CON P; Beerten K, 2012, CATENA, V95, P73, DOI 10.1016/j.catena.2012.03.005; Beerten K, 2010, 200905E NIRONDTR, P261; Bhattacharya B, 2006, NEURAL NETWORKS, V19, P186, DOI 10.1016/j.neunet.2006.01.005; Bilski P, 2009, INT C NEW DEV SOIL M, P368; Cetin KO, 2009, J GEOTECH GEOENVIRON, V135, P84, DOI 10.1061/(ASCE)1090-0241(2009)135:1(84); Das SK, 2009, COMPUT GEOTECH, V36, P241, DOI 10.1016/j.compgeo.2008.02.005; Depina I, 2016, GEORISK, V10, P27, DOI 10.1080/17499518.2015.1072637; Dietrich P., 2009, GROUNDWATER GEOPHYS, P347, DOI [10.1007/978-3-540-88405-7_12, DOI 10.1007/978-3-540-88405-7_12]; Facciorusso J, 2004, Geotechnical and Geophysical Site Characterization Vols 1 and 2, P905; Fenton GA, 1999, J GEOTECH GEOENVIRON, V125, P486, DOI 10.1061/(ASCE)1090-0241(1999)125:6(486); Flachs GP, 2005, ENV GEOSCI, V12, P1; FORGY EW, 1965, BIOMETRICS, V21, P768; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Fraley C, 2009, 504 MCLUST VERS 3 R, P56; Fraley C, 2012, 597 U WASH; Friedel MJ, 2016, HYDROGEOL J, V24, P2103, DOI 10.1007/s10040-016-1452-5; GABRIEL KR, 1971, BIOMETRIKA, V58, P453, DOI 10.1093/biomet/58.3.453; Goovaerts P., 1997, GEOSTATISTICS NATURA, P483; GOWER JC, 1996, BIPLOTS; Gulinck M, 1962, HYDROGEOLOGIE II GIS; Gullentops F., 1996, DELFSTOFFEN VLAANDER; Gullentops Frans, 2001, Geologica Belgica, V4, P153; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hegazy YA, 2002, J GEOTECH GEOENVIRON, V128, P986, DOI 10.1061/(ASCE)1090-0241(2002)128:12(986); Ishioka T, 2005, PROCEEDINGS OF THE IASTED INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE, P91; Ishioka T, 2000, IDEAL 00 P 2 INT C I; JAKSA MB, 1993, PROBABILISTIC METHODS IN GEOTECHNICAL ENGINEERING, P185; Jaksa MB, 1997, QUANT GEO G, V8, P1284; Jefferies MG., 1993, GEOTECH TEST J, V16, P458, DOI [10.1520/GTJ10286J, DOI 10.1520/GTJ10286J]; Kulatilake PHSW., 2003, GEOTECH GEOLOG ENG, V21, P149, DOI [10.1023/A:1023526614301, DOI 10.1023/A:1023526614301]; Kurup PU, 2006, J COMPUT CIVIL ENG, V20, P281, DOI 10.1061/(ASCE)0887-3801(2006)20:4(281); Kurup PU, 2010, CPT 10 2 INT S CON P; Laga Pieter, 2001, Geologica Belgica, V4, P135; Lenz JA, 2007, SOIL DYN EARTHQ ENG, V27, P690, DOI 10.1016/j.soildyn.2006.11.005; Liu CN, 2010, ENG GEOL, V111, P43, DOI 10.1016/j.enggeo.2009.12.002; Lloyd S, 1982, IEEE T INFORM THEORY, V56; Lunne T., 1997, CONE PENETRATION TES; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Mlynarek Z, 2008, 12 INT C INT ASS COM, P1291; Paradis D, 2015, WATER RESOUR RES, V51, P481, DOI 10.1002/2014WR015452; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; PELLEG D, 2000, P 17 INT C MACH LEAR; Robertson P, 2010, GUIDE CONE PENETRATI, P138; Robertson P, 1986, IN SITU 86 ASCE SPEC; Robertson PK, 2016, CAN GEOTECH J, V53, P1910, DOI 10.1139/cgj-2016-0044; Robertson PK, 1998, CAN GEOTECH J, V35, P442, DOI 10.1139/cgj-35-3-442; ROBERTSON PK, 1990, CAN GEOTECH J, V27, P151, DOI 10.1139/t90-014; Rogiers B, 2010, IAHR INT GROUNDW S V, P19; Rogiers B, 2014, HYDROL PROCESS, V28, P5176, DOI 10.1002/hyp.10007; Rogiers B, 2013, GEOL BELG, V16, P129; Samui P, 2016, GEOTECH GEOL ENG, V34, P735, DOI 10.1007/s10706-015-9969-2; Schiltz M, 2008, LITHOLOGICAL STRATIG; Schiltz M, 2010, LITHOLOGICAL STRATIG; Sibelco, 2010, TECHNICAL DATASHEET; Telgarsky M., 2010, P 13 INT C ARTIFICIA, P820; Tillmann A, 2008, J CONTAM HYDROL, V95, P57, DOI 10.1016/j.jconhyd.2007.07.013; Uzielli M, 2005, GEOTECHNIQUE, V55, P3, DOI 10.1680/geot.55.1.3.58591; Vermeiden J, 1948, P 2 INT C SOIL MECH, P280; Wouters L, 2012, 201142 NIRONDTR; Zhang Z, 1999, J GEOTECH GEOENVIRON, V125, P577	61	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176656	10.1371/journal.pone.0176656	http://dx.doi.org/10.1371/journal.pone.0176656			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467468	Green Published, gold			2022-12-26	WOS:000400647000066
J	Zhu, YC; Yao, JX; Adamczyk, J; Luttrell, R				Zhu, Yu Cheng; Yao, Jianxiu; Adamczyk, John; Luttrell, Randall			Synergistic toxicity and physiological impact of imidacloprid alone and binary mixtures with seven representative pesticides on honey bee (Apis mellifera)	PLOS ONE			English	Article							SEED-TREATED CANOLA; TARNISHED PLANT BUG; NEONICOTINOID INSECTICIDES; COLORIMETRIC DETERMINATION; PYRETHROID INSECTICIDE; RESISTANT STRAIN; MECHANISM; ACETYLCHOLINESTERASE; HYMENOPTERA; MANAGEMENT	Imidacloprid is the most widely used insecticide in the world. In this study, we used spraying methods to simulate field exposures of bees to formulated imidacloprid (Advise (R) 2FL) alone and binary mixtures with seven pesticides from different classes. Synergistic toxicity was detected from mixtures of Advise (58.6 mg a.i./L imidacloprid)+Domark (512.5 mg a.i./L tetraconazole), Advise+Transform (58.5 mg a.i./L sulfoxaflor), and Advise+Vydate (68 mg a. i./L oxamyl), and mortality was significantly increased by 20%, 15%, and 26% respectively. The mixtures of Advise+Bracket (88.3 mg a.i./L acephate) and Advise+Karate (62.2 mg a.i./L L-cyhalothrin) showed additive interaction, while Advise+Belay (9.4 mg a.i./L clothianidin) and Advise+Roundup (1217.5 mg a.i./L glyphosate) had no additive/synergistic interaction. Spraying bees with the mixture of all eight pesticides increased mortality to 100%, significantly higher than all other treatments. Except Bracket which significantly suppressed esterase and acetylcholinesterase (AChE) activities, other treatments of Advise-only and mixtures with other pesticides did not suppress enzyme activities significantly, including invertase, glutathione S-transferase (GST), and esterase and AChE. Immunity-related phenoloxidase (PO) activities in survivors tended to be more variable among treatments, but mostly still statistically similar to the control. By using specific enzyme inhibitors, we demonstrated that honey bees mainly rely on cytochrome P450 monooxygenases (P450s) for detoxifying Advise, while esterases and GSTs play substantially less roles in the detoxification. This study provided valuable information for guiding pesticide selection in premixing and tank mixing in order to alleviate toxicity risk to honey bees. Our findings indicated mixtures of Advise with detoxification-enzyme-inducing pesticides may help bees to detoxify Advise, while toxicity synergists may pose further risk to bees, such as the Bracket which not only suppressed esterase and AChE activities, but also increased toxicity to bees.	[Zhu, Yu Cheng; Yao, Jianxiu; Luttrell, Randall] USDA ARS, Stoneville, MS 38776 USA; [Adamczyk, John] USDA ARS, Poplarville, DC USA; [Yao, Jianxiu] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Kansas State University	Zhu, YC (corresponding author), USDA ARS, Stoneville, MS 38776 USA.	yc.zhu@ars.usda.gov		Adamczyk, John/0000-0002-6536-7255				Altmann R., 2003, Pflanzenschutz-Nachrichten Bayer, V56, P102; [Anonymous], 2015, IRAC MOD ACT CLASS S; [Anonymous], 2013, MIDSOUTH ENTOMOL; [Anonymous], 1985, COMPREHENSIVE INSECT; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; BECERRIL JM, 1989, PHYTOCHEMISTRY, V28, P695, DOI 10.1016/0031-9422(89)80095-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandon H, 2015, DELTA AGR DIGEST; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; Casida JE, 2013, ANNU REV ENTOMOL, V58, P99, DOI 10.1146/annurev-ento-120811-153645; Catchot A, 2016, MISSISSIPPI STATE U, V2471; Cedergreen N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096580; Cutler GC, 2007, J ECON ENTOMOL, V100, P765, DOI 10.1603/0022-0493(2007)100[765:ETCSCH]2.0.CO;2; Cutler GC, 2014, PEERJ, V2, DOI 10.7717/peerj.652; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Decourtye A, 2013, NATURE, V497, P188, DOI 10.1038/497188a; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; DONER LW, 1977, J SCI FOOD AGR, V28, P443, DOI 10.1002/jsfa.2740280508; Douglas MR, 2015, ENVIRON SCI TECHNOL, V49, P5088, DOI 10.1021/es506141g; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; Girolami V, 2011, J APPL ENTOMOL; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Greene JK, 1999, J ECON ENTOMOL, V92, P941, DOI 10.1093/jee/92.4.941; Hodgson E., 1985, COMP INSECT PHYSIOL, V12, P225; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Johnson R, 2014, BEE HLTH BACKGR ISS; Johnson RM, 2015, ANNU REV ENTOMOL, V60, P415, DOI 10.1146/annurev-ento-011613-162005; Khandekar DC, 2014, BIOPROC BIOSYST ENG, V37, P2529, DOI 10.1007/s00449-014-1230-5; Krupke CH, 2016, PURDUE U EXTENSION P; Larson JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066375; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Lu YH, 2008, CROP PROT, V27, P465, DOI 10.1016/j.cropro.2007.07.017; Marzaro M, 2011, B INSECTOL, V64, P119; Nauen R, 2001, PEST MANAG SCI, V57, P577, DOI 10.1002/ps.331; Palumbo JC, 2001, CROP PROT, V20, P739, DOI 10.1016/S0261-2194(01)00117-X; PapeLindstrom PA, 1997, ENVIRON TOXICOL CHEM, V16, P2415, DOI [10.1002/etc.5620161130, 10.1897/1551-5028(1997)016&lt;2415:STOAAO&gt;2.3.CO;2]; PILLING ED, 1995, PESTIC BIOCHEM PHYS, V51, P1, DOI 10.1006/pest.1995.1001; PILLING ED, 1993, PESTIC SCI, V39, P293, DOI 10.1002/ps.2780390407; Pilling E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077193; Pistorius J., 2009, P118; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Riviere JE, 2008, VET PHARM THERAPEUTI, P1019; Sanchez-Bayo F, 2016, ENVIRON INT, V89-90, P7, DOI 10.1016/j.envint.2016.01.009; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Schmid MR, 2008, J INSECT PHYSIOL, V54, P439, DOI 10.1016/j.jinsphys.2007.11.002; Suchail S, 2004, PEST MANAG SCI, V60, P1056, DOI 10.1002/ps.895; van Engelsdorp Dennis, 2007, COLONY COLLAPSE DISO, P22; Van Leeuwen T, 2006, PEST MANAG SCI, V62, P425, DOI 10.1002/ps.1183; VANDENBOSSCHE H, 1991, AM J OBSTET GYNECOL, V165, P1193, DOI 10.1016/S0002-9378(12)90726-7; WILCE MCJ, 1994, BBA-PROTEIN STRUCT M, V1205, P1, DOI 10.1016/0167-4838(94)90086-8; Williams MR, COTTON INSECT LOSSES; Yamamoto Izuru, 1999, NICOTINOID INSECTICI, P3, DOI DOI 10.1007/978-4-431-67933-2_1; YU SJ, 1982, PESTIC BIOCHEM PHYS, V18, P101, DOI 10.1016/0048-3575(82)90092-X; Zhu KY, 1999, PESTIC SCI, V55, P11, DOI 10.1002/(SICI)1096-9063(199901)55:1<11::AID-PS850>3.0.CO;2-4; Zhu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0077547; Zhu YC, 2004, INSECT BIOCHEM MOLEC, V34, P1175, DOI 10.1016/j.ibmb.2004.07.008; Zhu YC, 2015, J ECON ENTOMOL, V108, P2640, DOI 10.1093/jee/tov269; Zhu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037586	63	69	73	12	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2017	12	5							e0176837	10.1371/journal.pone.0176837	http://dx.doi.org/10.1371/journal.pone.0176837			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SB	28467462	Green Submitted, Green Published, gold			2022-12-26	WOS:000400647000078
J	Stockinger, C; Thurer, B; Stein, T				Stockinger, Christian; Thuerer, Benjamin; Stein, Thorsten			Consecutive learning of opposing unimanual motor tasks using the right arm followed by the left arm causes intermanual interference	PLOS ONE			English	Article							FORCE-FIELD ADAPTATION; INTERLIMB TRANSFER; CROSS EDUCATION; CATCH TRIALS; CONSOLIDATION; DYNAMICS; MEMORY; CUES; REPRESENTATION; PERFORMANCE	Intermanual transfer (motor memory generalization across arms) and motor memory interference (impairment of retest performance in consecutive motor learning) are well-investigated motor learning phenomena. However, the interplay of these phenomena remains elusive, i.e., whether intermanual interference occurs when two unimanual tasks are consecutively learned using different arms. Here, we examine intermanual interference when subjects consecutively adapt their right and left arm movements to novel dynamics. We considered two force field tasks A and B which were of the same structure but mirrored orientation (B = -A). The first test group (ABA-group) consecutively learned task A using their right arm and task B using their left arm before being retested for task A with their right arm. Another test group (AAA-group) learned only task A in the same right-left-right arm schedule. Control subjects learned task A using their right arm without intermediate left arm learning. All groups were able to adapt their right arm movements to force field A and both test groups showed significant intermanual transfer of this initial learning to the contralateral left arm of 21.9% (ABA-group) and 27.6% (AAA-group). Consecutively, both test groups adapted their left arm movements to force field B (ABA-group) or force field A (AAA-group). For the ABA-group, left arm learning caused significant intermanual interference of the initially learned right arm task (68.3% performance decrease). The performance decrease of the AAA-group (10.2%) did not differ from controls (15.5%). These findings suggest that motor control and learning of right and left arm movements involve partly similar neural networks or underlie a vital interhemispheric connectivity. Moreover, our results suggest a preferred internal task representation in extrinsic Cartesian-based coordinates rather than in intrinsic joint-based coordinates because interference was absent when learning was performed in extrinsically equivalent fashion (AAA-group) but interference occurred when learning was performed in intrinsically equivalent fashion (ABA-group).	[Stockinger, Christian; Thuerer, Benjamin; Stein, Thorsten] Karlsruhe Inst Technol, BioMot Ctr, Inst Sports & Sports Sci, Karlsruhe, Germany; [Stockinger, Christian; Stein, Thorsten] Heidelberg Univ, Karlsruhe Inst Technol, HEiKA Heidelberg Karlsruhe Res Partnership, Karlsruhe, Germany; [Stockinger, Christian] Tech Univ Munich, Dept Sport & Hlth Sci, Neuromuscular Diagnost, Munich, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Ruprecht Karls University Heidelberg; Technical University of Munich	Stockinger, C (corresponding author), Karlsruhe Inst Technol, BioMot Ctr, Inst Sports & Sports Sci, Karlsruhe, Germany.; Stockinger, C (corresponding author), Heidelberg Univ, Karlsruhe Inst Technol, HEiKA Heidelberg Karlsruhe Res Partnership, Karlsruhe, Germany.; Stockinger, C (corresponding author), Tech Univ Munich, Dept Sport & Hlth Sci, Neuromuscular Diagnost, Munich, Germany.	christian.stockinger@tum.de		Stockinger, Christian/0000-0001-5352-3911; Thurer, Benjamin/0000-0003-0834-7212	Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Karlsruhe Institute of Technology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Karlsruhe Institute of Technology	This work was supported by Deutsche Forschungsgemeinschaft (www.dfg.de) and Open Access Publishing Fund of Karlsruhe Institute of Technology (www.bibliothek.kit.edu/cms/english/kit-publcation-fund.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addou T, 2011, J NEUROPHYSIOL, V106, P163, DOI 10.1152/jn.00869.2010; Anguera JA, 2007, BRAIN RES, V1185, P136, DOI 10.1016/j.brainres.2007.09.088; Berniker M, 2014, J NEUROPHYSIOL, V111, P1165, DOI 10.1152/jn.00493.2013; Bock O, 2005, EXP BRAIN RES, V162, P513, DOI 10.1007/s00221-005-2222-0; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Brayanov JB, 2012, J NEUROSCI, V32, P14951, DOI 10.1523/JNEUROSCI.1928-12.2012; Caithness G, 2004, J NEUROSCI, V24, P8662, DOI 10.1523/JNEUROSCI.2214-04.2004; Carroll TJ, 2016, J NEUROPHYSIOL, V115, P445, DOI 10.1152/jn.00485.2015; Carson RG, 2005, BRAIN RES REV, V49, P641, DOI 10.1016/j.brainresrev.2005.03.005; Choo PL, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.411; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cothros N, 2009, J NEUROPHYSIOL, V102, P2112, DOI 10.1152/jn.00493.2009; Criscimagna-Hemminger SE, 2003, J NEUROPHYSIOL, V89, P168, DOI 10.1152/jn.00622.2002; Focke A, 2016, EUR J SPORT SCI, V16, P787, DOI 10.1080/17461391.2016.1141996; Focke A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00479; Franklin DW, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0070-16.2016; Galea JM, 2006, EXP BRAIN RES, V175, P676, DOI 10.1007/s00221-006-0585-5; Hendy AM, 2012, J SCI MED SPORT, V15, P94, DOI 10.1016/j.jsams.2011.07.007; HOLM S, 1979, SCAND J STAT, V6, P65; Howard IS, 2013, J NEUROPHYSIOL, V109, P2632, DOI 10.1152/jn.00773.2012; Joiner WM, 2013, J NEUROPHYSIOL, V110, P984, DOI 10.1152/jn.01072.2012; Kantak SS, 2012, BEHAV BRAIN RES, V228, P219, DOI 10.1016/j.bbr.2011.11.028; Karniel A, 2003, BIOL CYBERN, V89, P10, DOI 10.1007/s00422-003-0397-7; Krakauer JW, 2005, J NEUROSCI, V25, P473, DOI 10.1523/JNEUROSCI.4218-04.2005; Lauber B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081038; Lefumat HZ, 2015, J NEUROPHYSIOL, V114, P2764, DOI 10.1152/jn.00749.2015; Magill R.A., 2007, MOTOR LEARNING CONTR; Malfait N, 2004, J NEUROSCI, V24, P8084, DOI 10.1523/JNEUROSCI.1742-04.2004; Nozaki D, 2006, NAT NEUROSCI, V9, P1364, DOI 10.1038/nn1785; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Overduin SA, 2006, J NEUROSCI, V26, P11888, DOI 10.1523/JNEUROSCI.1320-06.2006; Richter S, 2004, PSYCHOL RES-PSYCH FO, V68, P245, DOI 10.1007/s00426-003-0140-y; Ruddy KL, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00397; Scheidt RA, 2000, J NEUROPHYSIOL, V84, P853, DOI 10.1152/jn.2000.84.2.853; Schmidt R.A., 2011, MOTOR CONTROL LEARNI, V5th ed., P581; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; Shadmehr R, 2000, J NEUROSCI, V20, P7807; Sing GC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000893; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Stockinger C., 2012, INT J COMPUT SCI SPO, V11, P52; Stockinger C, 2015, J NEUROPHYSIOL, V114, P3166, DOI 10.1152/jn.00727.2015; Stockinger C, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00231; Swinnen SP, 2002, NAT REV NEUROSCI, V3, P350, DOI 10.1038/nrn807; Thurer B, 2016, NEUROIMAGE, V125, P172, DOI 10.1016/j.neuroimage.2015.10.008; Wada Y, 2003, NEUROSCI RES, V46, P319, DOI 10.1016/S0168-0102(03)00094-4; Wang JS, 2004, J NEUROPHYSIOL, V92, P349, DOI 10.1152/jn.00960.2003	47	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2017	12	5							e0176594	10.1371/journal.pone.0176594	http://dx.doi.org/10.1371/journal.pone.0176594			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9RJ	28459833	Green Published, gold			2022-12-26	WOS:000400645000038
J	Faller, S; Seiler, R; Donus, R; Engelstaedter, H; Hoetzel, A; Spassov, SG				Faller, Simone; Seiler, Raphael; Donus, Rosa; Engelstaedter, Helen; Hoetzel, Alexander; Spassov, Sashko Gregoriev			Pre- and posttreatment with hydrogen sulfide prevents ventilator-induced lung injury by limiting inflammation and oxidation	PLOS ONE			English	Article							ISCHEMIA/REPERFUSION INJURY; MITOCHONDRIAL DYSFUNCTION; SMALL-INTESTINE; PROTECTS; H2S; PATHWAY; CARDIOPROTECTION; INHIBITION; APOPTOSIS; CELLS	Although essential in critical care medicine, mechanical ventilation often results in ventilator-induced lung injury. Low concentrations of hydrogen sulfide have been proven to have antiinflammatory and anti-oxidative effects in the lung. The aim of this study was to analyze the kinetic effects of pre- and posttreatment with hydrogen sulfide in order to prevent lung injury as well as inflammatory and oxidative stress upon mechanical ventilation. Mice were either non-ventilated or mechanically ventilated with a tidal volume of 12 ml/kg for 6 h. Pretreated mice inhaled hydrogen sulfide in low dose for 1, 3, or 5 h prior to mechanical ventilation. Posttreated mice were ventilated with air followed by ventilation with hydrogen sulfide in various combinations. In addition, mice were ventilated with air for 10 h, or with air for 5 h and subsequently with hydrogen sulfide for 5 h. Histology, interleukin-1 beta, neutrophil counts, and reactive oxygen species formation were examined in the lungs. Both pre- and posttreatment with hydrogen sulfide time-dependently reduced or even prevented edema formation, gross histological damage, neutrophil influx and reactive oxygen species production in the lung. These results were also observed in posttreatment, when the experimental time was extended and hydrogen sulfide administration started as late as after 5 h air ventilation. In conclusion, hydrogen sulfide exerts lung protection even when its application is limited to a short or delayed period. The observed lung protection is mediated by inhibition of inflammatory and oxidative signaling.	[Faller, Simone; Seiler, Raphael; Donus, Rosa; Engelstaedter, Helen; Hoetzel, Alexander; Spassov, Sashko Gregoriev] Univ Med Ctr Freiburg, Dept Anesthesiol & Crit Care Med, Freiburg, Germany	University of Freiburg	Faller, S (corresponding author), Univ Med Ctr Freiburg, Dept Anesthesiol & Crit Care Med, Freiburg, Germany.	simone.faller@uniklinik-freiburg.de	; Spassov, Sashko/C-2105-2013	Faller, Simone/0000-0001-5345-8523; Seiler, Raphael/0000-0002-8842-7572; Spassov, Sashko/0000-0002-3585-3682	German Research Foundation (DFG); University of Freiburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing.	Ahmad A, 2016, SHOCK, V45, P88, DOI 10.1097/SHK.0000000000000478; Andreadou I, 2015, BRIT J PHARMACOL, V172, P1587, DOI 10.1111/bph.12811; Aslami H, 2010, INTENS CARE MED, V36, P1946, DOI 10.1007/s00134-010-2022-2; BEAUCHAMP RO, 1984, CRC CR REV TOXICOL, V13, P25, DOI 10.3109/10408448409029321; Biermann J, 2011, MOL VIS, V17, P1275; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Chapman KE, 2005, AM J PHYSIOL-LUNG C, V289, pL834, DOI 10.1152/ajplung.00069.2005; Faller S, 2013, CURR PHARM DESIGN, V19, P2715, DOI 10.2174/1381612811319150006; Faller S, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-26; Faller S, 2010, ANESTHESIOLOGY, V113, P104, DOI 10.1097/ALN.0b013e3181de7107; Francis RC, 2011, ANESTHESIOLOGY, V115, P1012, DOI 10.1097/ALN.0b013e31823306cf; Fu ZF, 2008, LIFE SCI, V82, P1196, DOI 10.1016/j.lfs.2008.04.005; Guo RM, 2013, CELL PHYSIOL BIOCHEM, V32, P1668, DOI 10.1159/000356602; Guo RM, 2013, INT J MOL MED, V31, P644, DOI 10.3892/ijmm.2013.1246; Ji KX, 2016, BRAIN RES BULL, V121, P68, DOI 10.1016/j.brainresbull.2015.12.007; Lan AP, 2013, NEUROCHEM RES, V38, P1454, DOI 10.1007/s11064-013-1044-x; Li CY, 2015, INT J CLIN EXP PATHO, V8, P7740; Li HD, 2013, EUR J APPL PHYSIOL, V113, P1555, DOI 10.1007/s00421-012-2584-5; Lionetti V, 2005, CURR OPIN CRIT CARE, V11, P82, DOI 10.1097/00075198-200502000-00013; Liu YJ, 2012, AM J PHYSIOL-GASTR L, V302, pG44, DOI 10.1152/ajpgi.00413.2010; Liu YY, 2013, NEUROCHEM INT, V62, P603, DOI 10.1016/j.neuint.2012.12.010; Luo YG, 2013, NEUROCHEM INT, V63, P826, DOI 10.1016/j.neuint.2013.06.004; Neto AS, 2015, CRIT CARE MED, V43, P2155, DOI 10.1097/CCM.0000000000001189; Ning JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059100; Pan TT, 2009, EUR J PHARMACOL, V616, P160, DOI 10.1016/j.ejphar.2009.05.023; Ricard JD, 2001, AM J RESP CRIT CARE, V163, P1176, DOI 10.1164/ajrccm.163.5.2006053; Roberts ES, 2008, TOXICOL PATHOL, V36, P560, DOI 10.1177/0192623308317422; Neto AS, 2015, ANESTHESIOLOGY, V123, P66, DOI 10.1097/ALN.0000000000000706; Spassov S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102401; SPASSOV SG, 2017, OXID MED CELL LONGEV, V2017, DOI DOI 10.1155/2017/3715037; Strosing K. M., 2016, ANESTH ANALG; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Wagner F, 2011, J TRAUMA, V71, P1659, DOI 10.1097/TA.0b013e318228842e; WRIGHT DT, 1994, ENVIRON HEALTH PERSP, V102, P85, DOI 10.2307/3432221; Yusof M, 2009, AM J PHYSIOL-HEART C, V296, pH868, DOI 10.1152/ajpheart.01111.2007; Zhang QQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074422; Zuidema MY, 2015, METHOD ENZYMOL, V555, P93, DOI 10.1016/bs.mie.2014.11.022; Zuidema MY, 2011, AM J PHYSIOL-HEART C, V301, pH888, DOI 10.1152/ajpheart.00432.2010	39	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176649	10.1371/journal.pone.0176649	http://dx.doi.org/10.1371/journal.pone.0176649			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453540	Green Published, gold, Green Submitted			2022-12-26	WOS:000400383900039
J	Wang, ML; Li, QH; Xin, HH; Chen, X; Zhu, XJ; Li, XH				Wang, Ming-Le; Li, Qing-Hui; Xin, Hua-Hong; Chen, Xuan; Zhu, Xu-Jun; Li, Xing-Hui			Reliable reference genes for normalization of gene expression data in tea plants (Camellia sinensis) exposed to metal stresses	PLOS ONE			English	Article							REAL-TIME PCR; L. O. KUNTZE; RT-PCR; ARABIDOPSIS-THALIANA; MOLECULAR-CLONING; QUANTITATIVE PCR; INTERNAL CONTROL; ABIOTIC STRESS; DROUGHT STRESS; SELECTION	Tea plants [Camellia sinensis (L.) O. Kuntze] are an important leaf-type crop that are widely used for the production of non-alcoholic beverages in the world. Exposure to excessive amounts of heavy metals adversely affects the quality and yield of tea leaves. To analyze the molecular responses of tea plants to heavy metals, a reliable quantification of gene expression is important and of major importance herein is the normalization of the measured expression levels for the target genes. Ideally, stably expressed reference genes should be evaluated in all experimental systems. In this study, 12 candidate reference genes (i.e., 18S rRNA, Actin, CYP, EF-1 alpha, eIF-4 alpha, GAPDH, MON1, PP2AA3, TBP, TIP41, TUA, and UBC) were cloned from tea plants, and the stability of their expression was examined systematically in 60 samples exposed to diverse heavy metals (i.e., manganese, aluminum, copper, iron, and zinc). Three Excel-based algorithms (geNorm, NormFinder, and BestKeeper) were used to evaluate the expression stability of these genes. PP2AA3 and 18S rRNA were the most stably expressed genes, even though their expression profiles exhibited some variability. Moreover, commonly used reference genes (i.e., GAPDH and TBP) were the least appropriate reference genes for most samples. To further validate the suitability of the analyzed reference genes, the expression level of a phytochelatin synthase gene (i.e., CsPCS1) was determined using the putative reference genes for data normalizations. Our results may be beneficial for future studies involving the quantification of relative gene expression levels in tea plants.	[Wang, Ming-Le; Li, Qing-Hui; Xin, Hua-Hong; Chen, Xuan; Zhu, Xu-Jun; Li, Xing-Hui] Nanjing Agr Univ, Coll Hort, Tea Res Inst, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Li, XH (corresponding author), Nanjing Agr Univ, Coll Hort, Tea Res Inst, Nanjing, Jiangsu, Peoples R China.	lxh@njau.edu.cn			National Natural Science Foundation of China [31570689, 31470690]; China Earmarked Fund for Modern Agro-industry Technology Research System [CARS-23]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Earmarked Fund for Modern Agro-industry Technology Research System; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported financially by the National Natural Science Foundation of China (31570689, 31470690), http://www.nsfc.gov.cn/; the China Earmarked Fund for Modern Agro-industry Technology Research System (CARS-23), http://www.moa.gov.cn/; the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), http://www.ec.js.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Basa B, 2009, FUNCT PLANT BIOL, V36, P1079, DOI 10.1071/FP09073; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; Cobbett CS, 2000, CURR OPIN PLANT BIOL, V3, P211, DOI 10.1016/S1369-5266(00)00066-2; Dekkers BJW, 2012, PLANT CELL PHYSIOL, V53, P28, DOI 10.1093/pcp/pcr113; Deng WW, 2013, J PLANT PHYSIOL, V170, P272, DOI 10.1016/j.jplph.2012.10.010; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; dos Santos LF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160646; Gong L, 2016, SCI REP-UK, V6, DOI 10.1038/srep37031; Goulao LF, 2012, PLANT MOL BIOL REP, V30, P741, DOI 10.1007/s11105-011-0382-6; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gutierrez L, 2008, PLANT CELL, V20, P1734, DOI 10.1105/tpc.108.059774; Hao XY, 2014, INT J MOL SCI, V15, P22155, DOI 10.3390/ijms151222155; Huang GY, 2009, CHEMOSPHERE, V77, P1026, DOI 10.1016/j.chemosphere.2009.07.073; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Ishibashi Y, 2004, WATER RES, V38, P2821, DOI 10.1016/j.watres.2004.04.006; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Janska A, 2013, MOL GENET GENOMICS, V288, P639, DOI 10.1007/s00438-013-0774-4; Jiang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092262; Kumar A, 2016, SCI REP-UK, V6, DOI 10.1038/srep37244; Kumar D, 2016, FOOD ANAL METHOD, V9, P1666, DOI 10.1007/s12161-015-0343-z; Li HP, 2011, PLANT SCI, V181, P132, DOI 10.1016/j.plantsci.2011.04.014; Li QH, 2017, SCI REP-UK, V7, DOI 10.1038/srep39915; Liu M, 2015, HORTIC RES-ENGLAND, V2, DOI 10.1038/hortres.2015.11; Liu SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147306; [刘小文 Liu Xiaowen], 2010, [广东农业科学, Guangdong Agricultural Sciences], V37, P162; Liu ZW, 2016, GENE, V576, P52, DOI 10.1016/j.gene.2015.09.076; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Ma QP, 2016, RUSS J PLANT PHYSL+, V63, P423, DOI 10.1134/S1021443716030080; Martins PK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28348; [孙美莲 Meilian Sun], 2010, [植物学报, Chinese Bulletin of Botany], V45, P579; Migocka M, 2011, MOL BREEDING, V28, P343, DOI 10.1007/s11032-010-9487-0; Mukhopadhyay M, 2013, BIOL PLANTARUM, V57, P474, DOI 10.1007/s10535-012-0300-2; Mukhopadhyay M, 2015, NATL ACAD SCI LETT, V38, P283, DOI 10.1007/s40009-015-0381-5; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Remans T, 2014, PLANT CELL, V26, P3829, DOI 10.1105/tpc.114.130641; Sharangi AB, 2009, FOOD RES INT, V42, P529, DOI 10.1016/j.foodres.2009.01.007; Taylor CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148300; Tian C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117569; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan Q, 2012, PLANT SOIL ENVIRON, V58, P429, DOI 10.17221/326/2012-PSE; Wang WD, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00385; Wang Y, 2016, BIOL PLANTARUM, V60, P443, DOI 10.1007/s10535-016-0618-2; Wang YX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166727; Wu ZJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19748; Yadav SK, 2009, BIOL PLANTARUM, V53, P737, DOI 10.1007/s10535-009-0134-8; Zhu XJ, 2016, MOL BIOL REP, V43, P1119, DOI 10.1007/s11033-016-4045-4; Zhu XJ, 2015, APPL BIOCHEM BIOTECH, V177, P1055, DOI 10.1007/s12010-015-1796-7	53	25	28	6	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0175863	10.1371/journal.pone.0175863	http://dx.doi.org/10.1371/journal.pone.0175863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453515	Green Submitted, Green Published, gold			2022-12-26	WOS:000400383900007
J	Wang, Q; Feng, YH; Huang, JC; Wang, TJ; Cheng, GQ				Wang, Qi; Feng, YangHe; Huang, JinCai; Wang, TengJiao; Cheng, GuangQuan			A novel framework for the identification of drug target proteins: Combining stacked auto-encoders with a biased support vector machine	PLOS ONE			English	Article							RESIDUE-SPECIFIC QUALITY; PREDICTION; NETWORKS; INTEGRATION; FEATURES; OPINION; LEARN; MODEL	The identification of drug target proteins (IDTP) plays a critical role in biometrics. The aim of this study was to retrieve potential drug target proteins (DTPs) from a collected protein dataset, which represents an overwhelming task of great significance. Previously reported methodologies for this task generally employ protein-protein interactive networks but neglect informative biochemical attributes. We formulated a novel framework utilizing biochemical attributes to address this problem. In the framework, a biased support vector machine (BSVM) was combined with the deep embedded representation extracted using a deep learning model, stacked auto-encoders (SAEs). In cases of non-drug target proteins (NDTPs) contaminated by DTPs, the framework is beneficial due to the efficient representation of the SAE and relief of the imbalance effect by the BSVM. The experimental results demonstrated the effectiveness of our framework, and the generalization capability was confirmed via comparisons to other models. This study is the first to exploit a deep learning model for IDTP. In summary, nearly 23% of the NDTPs were predicted as likely DTPs, which are awaiting further verification based on biomedical experiments.	[Wang, Qi; Feng, YangHe; Huang, JinCai; Cheng, GuangQuan] Natl Univ Def Technol, Sci & Technol Informat Syst Engn Lab, Changsha, Hunan, Peoples R China; [Wang, TengJiao] Second Med Mil Univ, Shanghai, Peoples R China	National University of Defense Technology - China; Naval Medical University	Huang, JC (corresponding author), Natl Univ Def Technol, Sci & Technol Informat Syst Engn Lab, Changsha, Hunan, Peoples R China.	huangjincai@nudt.edu.cn	wang, tengjiao/E-2118-2015	wang, tengjiao/0000-0002-7790-7407				Alain G, 2014, J MACH LEARN RES, V15, P3563; Bakheet TM, 2009, BIOINFORMATICS, V25, P451, DOI 10.1093/bioinformatics/btp002; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bengio Y, 2009, FOUND TRENDS MACH LE, V2, P1, DOI 10.1561/2200000006; Bing L, 2003, THIRD IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P179, DOI 10.1109/icdm.2003.1250918; Bultinck J, 2012, CURR PHARM DESIGN, V18, P4619, DOI 10.2174/138161212802651562; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Cao RZ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-120; Chautard E, 2009, PATHOL BIOL, V57, P324, DOI 10.1016/j.patbio.2008.10.004; Chen HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062975; Chollet F., 2015, KERAS DEEP LEARNING; Ciresan D, 2012, PROC CVPR IEEE, P3642, DOI 10.1109/CVPR.2012.6248110; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; HINTON GE, 1989, ARTIF INTELL, V40, P185, DOI 10.1016/0004-3702(89)90049-0; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; Hughes JP, 2011, BRIT J PHARMACOL, V162, P1239, DOI 10.1111/j.1476-5381.2010.01127.x; Imming P, 2006, NAT REV DRUG DISCOV, V5, P821, DOI 10.1038/nrd2132; Jensen LJ, 2003, BIOINFORMATICS, V19, P635, DOI 10.1093/bioinformatics/btg036; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kushmerick N, 1997, INT JOINT CONF ARTIF, P729; Lindsay MA, 2003, NAT REV DRUG DISCOV, V2, P831, DOI 10.1038/nrd1202; Liu T, 2016, SCI REP-UK, V6, DOI 10.1038/srep19301; Mora A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-294; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Quang D, 2015, BIOINFORMATICS, V31, P761, DOI 10.1093/bioinformatics/btu703; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rifai S., 2011, ADV NEURAL INFORM PR, V24, P2294; Rousseau A, 2012, P NAACL HLT 2012 WOR, P11; Royer L, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000108; Spencer M, 2015, IEEE ACM T COMPUT BI, V12, P103, DOI 10.1109/TCBB.2014.2343960; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wang YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep19598; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; Yang YL, 2009, DRUG DISCOV TODAY, V14, P147, DOI 10.1016/j.drudis.2008.12.005; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Yu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037608; Zhang S, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1025; Zhu M, 2009, J DRUG TARGET, V17, P524, DOI 10.1080/10611860903046610; Zhu MZ, 2009, SCI CHINA SER C, V52, P398, DOI 10.1007/s11427-009-0055-y	47	11	12	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2017	12	4							e0176486	10.1371/journal.pone.0176486	http://dx.doi.org/10.1371/journal.pone.0176486			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET6EO	28453576	Green Submitted, gold, Green Published			2022-12-26	WOS:000400383900028
J	Islam, MJ; Broidy, L; Baird, K; Mazerolle, P				Islam, Md. Jahirul; Broidy, Lisa; Baird, Kathleen; Mazerolle, Paul			Intimate partner violence around the time of pregnancy and postpartum depression: The experience of women of Bangladesh	PLOS ONE			English	Article							MATERNAL DEPRESSION; POSTNATAL DEPRESSION; RISK-FACTORS; DOMESTIC VIOLENCE; PHYSICAL VIOLENCE; MENTAL-HEALTH; PERINATAL DEPRESSION; PERCEIVED STRESS; SOCIAL SUPPORT; MARRIED-WOMEN	Background and objectives Intimate partner violence (IPV) around the time of pregnancy is a serious public health concern and is known to have an adverse effect on perinatal mental health. In order to craft appropriate and effective interventions, it is important to understand how the association between IPV and postpartum depression (PPD) may differ as a function of the type and timing of IPV victimization. Here we evaluate the influence of physical, sexual and psychological IPV before, during and after pregnancy on PPD. Methods Cross-sectional survey data was collected between October 2015 and January 2016 in the Chandpur District of Bangladesh from 426 new mothers, aged 15-49 years, who were in the first six months postpartum. Multivariate logistic regression models were used to estimate the association between IPV and PPD, adjusted for socio-demographic, reproductive and psychosocial confounding factors. Results Approximately 35.2% of women experienced PPD within the first six months following childbirth. Controlling for confounders, the odds of PPD was significantly greater among women who reported exposure to physical (AOR: 1.79, 95% CI [1.25, 3.43]), sexual (AOR: 2.25, 95% CI [1.14, 4.45]) or psychological (AOR: 6.92, 95% CI [1.71, 28.04]) IPV during pregnancy as opposed to those who did not. However, both before and after pregnancy, only physical IPV evidences a direct effect on PPD. Results highlight the mental health consequences of IPV for women of Bangladesh, as well as the influence of timing and type of IPV on PPD outcomes. Conclusions and implications The findings confirm that exposure to IPV significantly increases the odds of PPD. The association is particularly strong for physical IPV during all periods and psychological IPV during pregnancy. Results reinforce the need to conduct routine screening during pregnancy to identify women with a history of IPV who may at risk for PPD and to offer them necessary support.	[Islam, Md. Jahirul; Broidy, Lisa; Mazerolle, Paul] Griffith Univ Brisbane, Sch Criminol & Criminal Justice, Brisbane, Qld, Australia; [Islam, Md. Jahirul] Bangladesh Planning Commiss, Minist Planning, Dhaka, Bangladesh; [Broidy, Lisa] 1 Univ New Mexico, Dept Sociol, Albuquerque, NM USA; [Baird, Kathleen] Griffith Univ, Sch Nursing & Midwifery, Menzies Hlth Inst Queensland, Brisbane, Qld, Australia	Griffith University; University of New Mexico; Griffith University; Menzies Health Institute Queensland	Islam, MJ (corresponding author), Griffith Univ Brisbane, Sch Criminol & Criminal Justice, Brisbane, Qld, Australia.; Islam, MJ (corresponding author), Bangladesh Planning Commiss, Minist Planning, Dhaka, Bangladesh.	mdjahirul.islam@griffithuni.edu.au	Baird, Kathleen/AAP-1894-2021; Islam, Dr Md Jahirul/J-4093-2019	Baird, Kathleen/0000-0003-0142-6962; Islam, Dr Md Jahirul/0000-0001-6409-6724; Hossain, Mohammad/0000-0003-4615-5086; Mazerolle, Paul/0000-0002-5894-996X; Islam, Mohammad Mainul/0000-0002-0937-5082	Joint Donors Technical Assistance Fund (JDTAF) at the Ministry of Health and Family Welfare, Bangladesh	Joint Donors Technical Assistance Fund (JDTAF) at the Ministry of Health and Family Welfare, Bangladesh	The study was partially funded by the Joint Donors Technical Assistance Fund (JDTAF) at the Ministry of Health and Family Welfare, Bangladesh. The funding authority had no role in study design, data collection, data analysis, data interpretation, or writing of the manuscript. The corresponding author had full access to all data in the study and had final responsibility for the decision to submit for publication.	Adesina O, 2011, J OBSTET GYNAECOL, V31, P232, DOI 10.3109/01443615.2010.547954; Ahmed A M, 2005, East Mediterr Health J, V11, P164; Almond P, 2009, PERSPECT PUBLIC HEAL, V129, P221, DOI 10.1177/1757913909343882; Annagur A, 2013, BREASTFEED MED, V8, P53, DOI 10.1089/bfm.2012.0036; Azziz-Baumgartner E, 2014, VIOLENCE AGAINST WOM, V20, P59; Bangladesh Bureau of Statistics (BBS), 2013, VIOL WOM SURV 2011; Beck CT, 2008, MCN-AM J MATERN-CHIL, V33, P151, DOI 10.1097/01.NMC.0000318349.70364.1c; Beck CT, 2001, NURS RES, V50, P275, DOI 10.1097/00006199-200109000-00004; Beydoun HA, 2012, SOC SCI MED, V75, P959, DOI 10.1016/j.socscimed.2012.04.025; Beydoun HA, 2010, ANN EPIDEMIOL, V20, P575, DOI 10.1016/j.annepidem.2010.05.011; Bondas T, 2001, QUAL HEALTH RES, V11, P824, DOI 10.1177/104973201129119415; Brownridge DA, 2011, VIOLENCE AGAINST WOM, V17, P858, DOI 10.1177/1077801211412547; Cerulli C, 2010, BREASTFEED MED, V5, P225, DOI 10.1089/bfm.2010.0054; Chambliss LR, 2008, CLIN OBSTET GYNECOL, V51, P385, DOI 10.1097/GRF.0b013e31816f29ce; Chan KL, 2011, J INTERPERS VIOLENCE, V26, P1478, DOI 10.1177/0886260510369134; Chandran M, 2002, BRIT J PSYCHIAT, V181, P499, DOI 10.1192/bjp.181.6.499; Chibanda D, 2010, ARCH WOMEN MENT HLTH, V13, P201, DOI 10.1007/s00737-009-0073-6; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Craig M, 2009, CLIN EVIDENCE, V1, P1407; Dalal K, 2009, J BIOSOC SCI, V41, P561, DOI 10.1017/S0021932009990046; Desmarais SL, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-132; Devries KM, 2010, REPROD HEALTH MATTER, V18, P158, DOI 10.1016/S0968-8080(10)36533-5; Edwards GD, 2006, INT J MENT HEALTH, V35, P62, DOI 10.2753/IMH0020-7411350105; Ege E, 2008, J OBSTET GYNAECOL RE, V34, P585, DOI 10.1111/j.1447-0756.2008.00718.x; Ellsberg M, 2001, STUD FAMILY PLANN, V32, P1, DOI 10.1111/j.1728-4465.2001.00001.x; Evans J, 2001, BRIT MED J, V323, P257, DOI 10.1136/bmj.323.7307.257; Faisal-Cury A, 2013, MATERN CHILD HLTH J, V17, P1297, DOI 10.1007/s10995-012-1127-3; Farid M, 2008, INT J GYNECOL OBSTET, V101, P141, DOI 10.1016/j.ijgo.2007.11.015; Field T, 2006, INFANT BEHAV DEV, V29, P445, DOI 10.1016/j.infbeh.2006.03.003; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; Fisher JRW, 2004, BJOG-INT J OBSTET GY, V111, P1353, DOI 10.1111/j.1471-0528.2004.00394.x; Garabedian MJ, 2011, J WOMENS HEALTH, V20, P447, DOI 10.1089/jwh.2010.1960; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gausia K, 2009, PSYCHOL MED, V39, P999, DOI 10.1017/S0033291708004455; Gausia K, 2007, J REPROD INFANT PSYC, V25, P308, DOI 10.1080/02646830701644896; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Glover V, 2014, BEST PRACT RES CL OB, V28, P25, DOI 10.1016/j.bpobgyn.2013.08.017; Gomez-Beloz A, 2009, VIOLENCE VICTIMS, V24, P380, DOI 10.1891/0886-6708.24.3.380; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Gulamani SS, 2013, J PERINAT NEONAT NUR, V27, P52, DOI 10.1097/JPN.0b013e31827fcf24; Hegarty K, 2011, BRIT J PSYCHIAT, V198, P169, DOI 10.1192/bjp.bp.110.083758; Henderson JJ, 2003, BIRTH-ISS PERINAT C, V30, P175, DOI 10.1046/j.1523-536X.2003.00242.x; Heron J, 2004, J AFFECT DISORDERS, V80, P65, DOI 10.1016/j.jad.2003.08.004; Howard LM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001452; Husain N, 2011, ARCH WOMEN MENT HLTH, V14, P395, DOI 10.1007/s00737-011-0233-3; Illanes E, 2007, REV MED CHILE, V135, P326; Islam MJ, 2017, MIDWIFERY, V47, P43, DOI 10.1016/j.midw.2017.02.002; Islam MJ, 2017, ARCH WOMEN MENT HLTH, V20, P173, DOI 10.1007/s00737-016-0692-7; Isomaa R, 2013, HEALTH EDUC BEHAV, V40, P392, DOI 10.1177/1090198112445481; James L, 2013, VIOLENCE VICTIMS, V28, P359, DOI 10.1891/0886-6708.VV-D-12-00034; Jeanjot I, 2008, J WOMENS HEALTH, V17, P557, DOI 10.1089/jwh.2007.0639; Johnson PL, 2007, PSYCHIAT ANN, V37, P404; Kabir ZN, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24725; Kan ML, 2012, J FAM ISSUES, V33, P115, DOI 10.1177/0192513X11412037; Kantor G. K., 1999, REPORT USAF FAMILY N; Kendall-Tackett KA, 2007, TRAUMA VIOLENCE ABUS, V8, P344, DOI 10.1177/1524838007304406; Klainin P, 2009, INT J NURS STUD, V46, P1355, DOI 10.1016/j.ijnurstu.2009.02.012; Krug E. G., 2002, WORLD HLTH REPORT VI; Leung SSK, 2005, RES NURS HEALTH, V28, P27, DOI 10.1002/nur.20053; Lovejoy MC, 2000, CLIN PSYCHOL REV, V20, P561, DOI 10.1016/S0272-7358(98)00100-7; Ludermir AB, 2010, LANCET, V376, P903, DOI 10.1016/S0140-6736(10)60887-2; Malta LA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-153; Marcotte D, 2002, J EMOT BEHAV DISORD, V10, P29, DOI 10.1177/106342660201000104; Martin SL, 2006, VIOLENCE AGAINST WOM, V12, P221, DOI 10.1177/1077801205285106; Martin SL, 2004, J FAM VIOLENCE, V19, P201, DOI 10.1023/B:JOFV.0000032630.50593.93; Milgrom J, 2006, STRESS HEALTH, V22, P229, DOI 10.1002/smi.1101; Moraes CL, 2011, PUBLIC HEALTH NUTR, V14, P2148, DOI 10.1017/S1368980011000802; Naved RT, 2013, ARCH SEX BEHAV, V42, P595, DOI 10.1007/s10508-012-0045-1; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Patel M, 2012, J HEALTH CARE POOR U, V23, P534, DOI 10.1353/hpu.2012.0037; Peedicayil A, 2004, BJOG-INT J OBSTET GY, V111, P682, DOI 10.1111/j.1471-0528.2004.00151.x; Quelopana AM, 2012, WOMEN HEALTH, V52, P437, DOI 10.1080/03630242.2012.687443; Rahman A, 2004, ARCH GEN PSYCHIAT, V61, P946, DOI 10.1001/archpsyc.61.9.946; Rahman A, 2003, PSYCHOL MED, V33, P1161, DOI 10.1017/S0033291703008286; Rahman A, 2008, TROP MED INT HEALTH, V13, P579, DOI 10.1111/j.1365-3156.2008.02036.x; Rahman M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-913; Righetti-Veltema M, 2002, J AFFECT DISORDERS, V70, P291, DOI 10.1016/S0165-0327(01)00367-6; Rodriguez MA, 2010, VIOLENCE AGAINST WOM, V16, P543, DOI 10.1177/1077801210366959; Romito P, 2009, J PSYCHOSOM OBST GYN, V30, P115, DOI 10.1080/01674820802545834; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Saito A, 2012, NURS HEALTH SCI, V14, P345, DOI 10.1111/j.1442-2018.2012.00735.x; Sambisa W, 2010, STUD FAMILY PLANN, V41, P165, DOI 10.1111/j.1728-4465.2010.00241.x; Savarimuthu RJS, 2010, INT J SOC PSYCHIATR, V56, P94, DOI 10.1177/0020764008097756; Scribano PV, 2013, MATERN CHILD HLTH J, V17, P307, DOI 10.1007/s10995-012-0986-y; Shah M, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-2; Shamu S, 2016, GEN HOSP PSYCHIAT, V38, P109, DOI 10.1016/j.genhosppsych.2015.10.005; Silverman JG, 2006, J WOMENS HEALTH, V15, P934, DOI 10.1089/jwh.2006.15.934; Sorbo MF, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-316; Stewart RC, 2008, MATERN CHILD NUTR, V4, P209, DOI 10.1111/j.1740-8709.2008.00147.x; Stewart RC, 2007, MATERN CHILD NUTR, V3, P94, DOI 10.1111/j.1740-8709.2007.00088.x; Swapan G, 2013, J OBSTET GYN INDIA, V63, P223, DOI 10.1007/s13224-013-0399-x; Taveras EM, 2003, PEDIATRICS, V112, P108, DOI 10.1542/peds.112.1.108; Tiwari A, 2008, BJOG-INT J OBSTET GY, V115, P377, DOI 10.1111/j.1471-0528.2007.01593.x; Tsai AC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001943; Uddin MK, 2012, J BEHAV SCI, V22, P26; Urquia ML, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-42; Valentine JM, 2011, ARCH WOMEN MENT HLTH, V14, P135, DOI 10.1007/s00737-010-0191-1; Verreault N, 2014, J PSYCHOSOM OBST GYN, V35, P84, DOI 10.3109/0167482X.2014.947953; Vizcarra Beatriz, 2004, Inj Control Saf Promot, V11, P125, DOI 10.1080/15660970412331292351; Wachs TD, 2009, CHILD DEV PERSPECT, V3, P51, DOI 10.1111/j.1750-8606.2008.00077.x; Wang SY, 2006, J PSYCHOSOM RES, V60, P303, DOI 10.1016/j.jpsychores.2005.08.012; Wang SY, 2003, AM J OBSTET GYNECOL, V189, P1407, DOI 10.1067/S0002-9378(03)00673-2; White RS, 2014, J AM GERIATR SOC, V62, P2350, DOI 10.1111/jgs.13135; WHO, 2013, RESPONDING INTIMATE; WHO, 2012, WORLD FED MENT HLTH; WHO UNFPA, 2009, MENT HLTH ASP WOM PE; Woolhouse H, 2012, BJOG-INT J OBSTET GY, V119, P315, DOI 10.1111/j.1471-0528.2011.03219.x; World Health Organization & Pan American Health Organization, 2012, UNDERSTANDING ADDRES; Zlotnick C, 2006, J INTERPERS VIOLENCE, V21, P262, DOI 10.1177/0886260505282564	111	65	67	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176211	10.1371/journal.pone.0176211	http://dx.doi.org/10.1371/journal.pone.0176211			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET9SP	28472056	Green Published, Green Submitted, gold			2022-12-26	WOS:000400648500029
